Network	GO Branch	Term	Term name	P-value	Term_size	Intersection	Expected	Observed/Expected	Avg AUPRC	Degree Null AUPRC
APID	CC	GO:0005815	microtubule organizing center	5.42E-26	843	824	742	1.11	-	-
APID	CC	GO:0005615	extracellular space	1.69E-21	3190	2958	2807	1.05	-	-
APID	CC	GO:0005768	endosome	7.70E-20	1037	995	912	1.09	-	-
APID	CC	GO:0005783	endoplasmic reticulum	9.78E-17	2020	1885	1777	1.06	-	-
APID	CC	GO:0005764	lysosome	1.04E-14	747	717	657	1.09	-	-
APID	CC	GO:0005794	Golgi apparatus	1.47E-12	1636	1523	1439	1.06	-	-
APID	CC	GO:0005840	ribosome	2.25E-11	222	221	195	1.13	-	-
APID	CC	GO:0005635	nuclear envelope	6.17E-09	493	471	434	1.09	-	-
APID	CC	GO:0000228	nuclear chromosome	2.11E-07	206	202	181	1.11	-	-
APID	CC	GO:0005777	peroxisome	6.47E-04	142	137	125	1.10	-	-
APID	CC	GO:0005929	cilium	1.04E-01	842	756	741	1.02	-	-
APID	CC	GO:0005811	lipid droplet	1.26E-01	102	95	90	1.06	-	-
APID	CC	GO:0031012	extracellular matrix	5.11E-01	564	502	496	1.01	-	-
APID	BP	GO:0050877	nervous system process	2.06E-98	1527	1050	1343	0.78	-	-
APID	BP	GO:0016192	vesicle-mediated transport	1.65E-41	1894	1826	1666	1.10	-	-
APID	BP	GO:0007010	cytoskeleton organization	1.43E-30	1639	1571	1442	1.09	-	-
APID	BP	GO:0012501	programmed cell death	2.13E-29	1954	1858	1719	1.08	-	-
APID	BP	GO:0006355	regulation of DNA-templated transcription	8.26E-24	3342	3103	2940	1.06	-	-
APID	BP	GO:0048870	cell motility	2.70E-23	1659	1574	1460	1.08	-	-
APID	BP	GO:0006914	autophagy	5.36E-22	568	560	500	1.12	-	-
APID	BP	GO:0006886	intracellular protein transport	1.83E-21	664	650	584	1.11	-	-
APID	BP	GO:0006281	DNA repair	5.08E-21	587	577	516	1.12	-	-
APID	BP	GO:0002376	immune system process	1.03E-19	2448	2282	2154	1.06	-	-
APID	BP	GO:0030163	protein catabolic process	1.37E-18	990	949	871	1.09	-	-
APID	BP	GO:0007155	cell adhesion	4.31E-18	1444	1365	1270	1.07	-	-
APID	BP	GO:0016071	mRNA metabolic process	7.30E-18	713	691	627	1.10	-	-
APID	BP	GO:0065003	protein-containing complex assembly	8.81E-18	1648	1550	1450	1.07	-	-
APID	BP	GO:0007059	chromosome segregation	9.45E-14	403	395	355	1.11	-	-
APID	BP	GO:0007005	mitochondrion organization	1.02E-13	484	471	426	1.11	-	-
APID	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.95E-13	729	698	641	1.09	-	-
APID	BP	GO:0072659	protein localization to plasma membrane	2.08E-13	284	282	250	1.13	-	-
APID	BP	GO:0042254	ribosome biogenesis	4.56E-13	297	294	261	1.13	-	-
APID	BP	GO:0006091	generation of precursor metabolites and energy	6.97E-12	502	485	442	1.10	-	-
APID	BP	GO:0006913	nucleocytoplasmic transport	7.95E-11	326	319	287	1.11	-	-
APID	BP	GO:0042060	wound healing	9.68E-11	431	417	379	1.10	-	-
APID	BP	GO:0034330	cell junction organization	3.40E-10	727	689	640	1.08	-	-
APID	BP	GO:0006260	DNA replication	3.47E-10	279	274	245	1.12	-	-
APID	BP	GO:0006310	DNA recombination	6.54E-09	333	323	293	1.10	-	-
APID	BP	GO:0006520	amino acid metabolic process	1.71E-08	292	284	257	1.11	-	-
APID	BP	GO:0007018	microtubule-based movement	4.18E-08	640	604	563	1.07	-	-
APID	BP	GO:0006629	lipid metabolic process	8.70E-08	1355	1251	1192	1.05	-	-
APID	BP	GO:0003012	muscle system process	9.25E-08	425	406	374	1.09	-	-
APID	BP	GO:0007163	establishment or maintenance of cell polarity	5.27E-07	227	221	200	1.11	-	-
APID	BP	GO:0002181	cytoplasmic translation	1.15E-06	153	151	135	1.12	-	-
APID	BP	GO:0140053	mitochondrial gene expression	2.75E-06	164	161	144	1.12	-	-
APID	BP	GO:0006954	inflammatory response	2.76E-06	820	762	721	1.06	-	-
APID	BP	GO:0003013	circulatory system process	9.94E-06	584	546	514	1.06	-	-
APID	BP	GO:0098542	defense response to other organism	1.54E-05	1171	1075	1030	1.04	-	-
APID	BP	GO:0044782	cilium organization	1.59E-05	399	377	351	1.07	-	-
APID	BP	GO:0006325	chromatin organization	4.04E-05	720	667	633	1.05	-	-
APID	BP	GO:0055085	transmembrane transport	1.49E-04	1784	1618	1570	1.03	-	-
APID	BP	GO:0006399	tRNA metabolic process	2.22E-04	196	188	172	1.09	-	-
APID	BP	GO:0005975	carbohydrate metabolic process	3.11E-04	551	511	485	1.05	-	-
APID	BP	GO:0140013	meiotic nuclear division	5.55E-04	279	263	245	1.07	-	-
APID	BP	GO:0006457	protein folding	1.26E-03	210	199	185	1.08	-	-
APID	BP	GO:0006790	sulfur compound metabolic process	1.70E-03	320	299	282	1.06	-	-
APID	BP	GO:0006486	protein glycosylation	2.59E-03	225	212	198	1.07	-	-
APID	BP	GO:0098754	detoxification	4.68E-03	134	128	118	1.09	-	-
APID	BP	GO:0030198	extracellular matrix organization	4.89E-03	314	292	276	1.06	-	-
APID	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	6.50E-03	119	114	105	1.09	-	-
APID	BP	GO:0007040	lysosome organization	1.61E-02	107	102	94	1.08	-	-
APID	BP	GO:0000910	cytokinesis	1.68E-02	186	174	164	1.06	-	-
APID	BP	GO:0006575	cellular modified amino acid metabolic process	1.68E-02	186	174	164	1.06	-	-
APID	BP	GO:0003014	renal system process	5.36E-02	127	119	112	1.07	-	-
APID	BP	GO:0022600	digestive system process	1.41E-01	110	102	97	1.05	-	-
APID	BP	GO:0006766	vitamin metabolic process	1.79E-01	107	99	94	1.05	-	-
APID	BP	GO:0032200	telomere organization	7.33E-01	186	162	164	0.99	-	-
APID	MF	GO:0016740	transferase activity	3.60E-37	3074	2899	2705	1.07	-	-
APID	MF	GO:0003723	RNA binding	1.10E-35	1679	1617	1477	1.09	-	-
APID	MF	GO:0140096	"catalytic activity, acting on a protein"	6.93E-29	3198	2989	2814	1.06	-	-
APID	MF	GO:0008092	cytoskeletal protein binding	6.82E-26	1023	992	900	1.10	-	-
APID	MF	GO:0140657	ATP-dependent activity	2.43E-19	729	708	641	1.10	-	-
APID	MF	GO:0003924	GTPase activity	1.14E-12	658	631	579	1.09	-	-
APID	MF	GO:0016491	oxidoreductase activity	5.85E-12	888	841	781	1.08	-	-
APID	MF	GO:0003677	DNA binding	8.91E-12	2865	2626	2521	1.04	-	-
APID	MF	GO:0140097	"catalytic activity, acting on DNA"	8.18E-10	383	371	337	1.10	-	-
APID	MF	GO:0140110	transcription regulator activity	1.45E-09	2033	1869	1789	1.04	-	-
APID	MF	GO:0016874	ligase activity	9.56E-09	283	276	249	1.11	-	-
APID	MF	GO:0140098	"catalytic activity, acting on RNA"	6.79E-08	417	399	367	1.09	-	-
APID	MF	GO:0008289	lipid binding	2.74E-07	836	780	736	1.06	-	-
APID	MF	GO:0045182	translation regulator activity	1.75E-06	151	149	133	1.12	-	-
APID	MF	GO:0016853	isomerase activity	3.40E-06	252	243	222	1.10	-	-
APID	MF	GO:0042393	histone binding	1.69E-04	237	226	209	1.08	-	-
APID	MF	GO:0140104	molecular carrier activity	3.91E-04	105	103	92	1.11	-	-
APID	MF	GO:0003774	cytoskeletal motor activity	6.29E-03	116	111	102	1.09	-	-
APID	MF	GO:0005215	transporter activity	1.20E-02	1462	1316	1286	1.02	-	-
APID	MF	GO:0038024	cargo receptor activity	8.74E-02	117	109	103	1.06	-	-
APID	MF	GO:0016829	lyase activity	1.58E-01	538	484	473	1.02	-	-
APID	MF	GO:0005198	structural molecule activity	1.64E-01	798	715	702	1.02	-	-
APID	MF	GO:0009975	cyclase activity	2.25E-01	277	237	244	0.97	-	-
APID	MF	GO:0048018	receptor ligand activity	9.45E-01	504	443	443	1.00	-	-
APID	BP	GO:0008038	neuron recognition	-	46	43	-	-	1.29E-03	2.07E-03
APID	BP	GO:1905145	cellular response to acetylcholine	-	33	31	-	-	5.61E-03	1.48E-03
APID	BP	GO:0097094	craniofacial suture morphogenesis	-	18	15	-	-	2.33E-04	7.08E-04
APID	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	2.30E-03	1.00E-03
APID	BP	GO:0051931	regulation of sensory perception	-	36	34	-	-	3.03E-03	1.65E-03
APID	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	1.65E-03	1.18E-03
APID	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.75E-04	6.49E-04
APID	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	1.72E-04	6.49E-04
APID	BP	GO:0009268	response to pH	-	43	38	-	-	3.54E-02	1.83E-03
APID	BP	GO:0045666	positive regulation of neuron differentiation	-	91	81	-	-	4.97E-03	3.84E-03
APID	BP	GO:0043543	protein acylation	-	107	100	-	-	6.20E-03	4.72E-03
APID	MF	GO:0051349	positive regulation of lyase activity	-	41	36	-	-	1.39E-03	1.71E-03
APID	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	12	-	-	5.72E-04	5.90E-04
APID	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	9.87E-04	1.18E-03
APID	BP	GO:0022401	negative adaptation of signaling pathway	-	21	19	-	-	9.97E-03	9.44E-04
APID	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	122	-	-	1.87E-02	5.78E-03
APID	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	3.96E-02	2.01E-03
APID	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	34	-	-	2.75E-03	1.65E-03
APID	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	11	-	-	8.33E-02	5.31E-04
APID	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	2.88E-02	3.25E-03
APID	BP	GO:0022038	corpus callosum development	-	25	25	-	-	3.56E-03	1.18E-03
APID	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0021548	pons development	-	11	11	-	-	1.73E-04	5.31E-04
APID	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0043299	leukocyte degranulation	-	82	78	-	-	1.20E-02	3.72E-03
APID	BP	GO:0048864	stem cell development	-	88	82	-	-	5.29E-03	3.89E-03
APID	BP	GO:0009310	amine catabolic process	-	20	16	-	-	2.71E-03	7.67E-04
APID	BP	GO:0051651	maintenance of location in cell	-	236	217	-	-	6.19E-03	1.03E-02
APID	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	1.09E-02	1.30E-03
APID	BP	GO:0014004	microglia differentiation	-	12	12	-	-	2.39E-03	5.90E-04
APID	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	4.07E-04	1.48E-03
APID	BP	GO:1905962	glutamatergic neuron differentiation	-	14	12	-	-	1.76E-04	5.90E-04
APID	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	5.31E-03	7.08E-04
APID	BP	GO:0046415	urate metabolic process	-	12	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	8.10E-03	1.42E-03
APID	BP	GO:0006949	syncytium formation	-	66	57	-	-	5.30E-03	2.71E-03
APID	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.30E-04	7.08E-04
APID	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	2.23E-02	7.08E-04
APID	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	51	-	-	2.64E-02	2.42E-03
APID	BP	GO:0030574	collagen catabolic process	-	45	36	-	-	1.05E-02	1.71E-03
APID	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	4.04E-03	2.18E-03
APID	BP	GO:0060343	trabecula formation	-	26	25	-	-	5.70E-04	1.18E-03
APID	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.40E-03	1.12E-03
APID	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	1.40E-01	7.67E-04
APID	BP	GO:1900424	regulation of defense response to bacterium	-	21	19	-	-	3.67E-04	9.44E-04
APID	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	3.05E-02	1.95E-03
APID	BP	GO:0006413	translational initiation	-	122	119	-	-	3.38E-02	5.66E-03
APID	BP	GO:0072176	nephric duct development	-	15	15	-	-	7.62E-03	7.08E-04
APID	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	4.68E-03	2.42E-03
APID	CC	GO:0005200	structural constituent of cytoskeleton	-	112	110	-	-	7.56E-03	5.19E-03
APID	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	3.02E-03	2.42E-03
APID	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	8.46E-03	7.08E-04
APID	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	8.44E-02	1.18E-03
APID	BP	GO:1903036	positive regulation of response to wounding	-	76	69	-	-	6.43E-03	3.30E-03
APID	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	7.88E-03	1.00E-03
APID	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	208	-	-	8.88E-03	9.85E-03
APID	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.16E-03	1.30E-03
APID	BP	GO:0032528	microvillus organization	-	24	21	-	-	9.40E-03	1.00E-03
APID	BP	GO:0021954	central nervous system neuron development	-	85	80	-	-	1.44E-03	3.78E-03
APID	BP	GO:0055017	cardiac muscle tissue growth	-	92	73	-	-	6.17E-03	3.48E-03
APID	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	30	-	-	4.21E-03	1.42E-03
APID	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	12	-	-	1.74E-04	5.90E-04
APID	BP	GO:0048524	positive regulation of viral process	-	64	63	-	-	1.79E-03	3.01E-03
APID	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	12	-	-	8.11E-02	5.90E-04
APID	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	20	-	-	4.28E-03	9.44E-04
APID	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	22	-	-	7.30E-03	1.06E-03
APID	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	1.61E-02	8.26E-04
APID	BP	GO:0098661	inorganic anion transmembrane transport	-	140	122	-	-	1.69E-02	5.78E-03
APID	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	2.21E-02	1.53E-03
APID	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	4.28E-04	8.85E-04
APID	BP	GO:0009612	response to mechanical stimulus	-	215	205	-	-	3.73E-03	9.68E-03
APID	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	4.47E-03	3.72E-03
APID	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	138	-	-	6.22E-03	6.55E-03
APID	BP	GO:1905874	regulation of postsynaptic density organization	-	13	12	-	-	8.27E-03	5.90E-04
APID	BP	GO:0071542	dopaminergic neuron differentiation	-	36	32	-	-	3.80E-03	1.53E-03
APID	BP	GO:0140115	export across plasma membrane	-	82	61	-	-	1.20E-02	2.89E-03
APID	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	4.59E-03	5.90E-04
APID	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	1.67E-03	1.83E-03
APID	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	3.01E-02	5.90E-04
APID	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.41E-03	5.31E-04
APID	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	27	-	-	1.44E-03	1.30E-03
APID	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	39	-	-	9.58E-03	1.89E-03
APID	MF	GO:0003714	transcription corepressor activity	-	190	184	-	-	1.08E-02	8.73E-03
APID	BP	GO:0035878	nail development	-	11	11	-	-	2.24E-02	5.31E-04
APID	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	54	-	-	3.03E-03	2.60E-03
APID	BP	GO:0061101	neuroendocrine cell differentiation	-	16	15	-	-	2.43E-03	7.08E-04
APID	CC	GO:0006858	extracellular transport	-	45	44	-	-	1.95E-03	2.12E-03
APID	BP	GO:0006304	DNA modification	-	30	29	-	-	1.15E-02	1.42E-03
APID	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	4.48E-02	8.85E-04
APID	BP	GO:0046835	carbohydrate phosphorylation	-	49	48	-	-	4.03E-02	2.30E-03
APID	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	4.56E-04	8.85E-04
APID	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	6.34E-03	7.08E-04
APID	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	35	-	-	1.99E-02	1.65E-03
APID	BP	GO:0070417	cellular response to cold	-	13	12	-	-	5.28E-03	5.90E-04
APID	BP	GO:0043523	regulation of neuron apoptotic process	-	218	207	-	-	6.44E-03	9.79E-03
APID	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	2.91E-03	1.06E-03
APID	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	1.70E-04	7.08E-04
APID	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	4.44E-03	2.71E-03
APID	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	4.20E-02	6.49E-04
APID	BP	GO:2000209	regulation of anoikis	-	25	24	-	-	2.97E-03	1.18E-03
APID	BP	GO:0014029	neural crest formation	-	15	15	-	-	1.93E-02	7.08E-04
APID	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	2.04E-03	1.12E-03
APID	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	36	-	-	1.62E-03	1.71E-03
APID	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	68	-	-	2.98E-03	3.25E-03
APID	BP	GO:0003188	heart valve formation	-	16	16	-	-	1.10E-03	7.67E-04
APID	CC	GO:0045324	late endosome to vacuole transport	-	37	36	-	-	7.65E-02	1.71E-03
APID	BP	GO:0043954	cellular component maintenance	-	72	66	-	-	2.34E-03	3.13E-03
APID	BP	GO:0050435	amyloid-beta metabolic process	-	65	50	-	-	3.06E-03	2.36E-03
APID	BP	GO:0014823	response to activity	-	70	67	-	-	3.13E-03	3.19E-03
APID	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	17	-	-	1.75E-03	8.26E-04
APID	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	3.14E-02	1.36E-03
APID	BP	GO:0034502	protein localization to chromosome	-	130	114	-	-	7.07E-03	5.43E-03
APID	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	2.08E-03	5.31E-04
APID	BP	GO:0060457	negative regulation of digestive system process	-	17	16	-	-	2.40E-02	7.67E-04
APID	BP	GO:0019233	sensory perception of pain	-	103	97	-	-	3.39E-03	4.60E-03
APID	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	1.52E-01	1.06E-03
APID	BP	GO:0031343	positive regulation of cell killing	-	75	70	-	-	9.28E-02	3.30E-03
APID	BP	GO:0090077	foam cell differentiation	-	39	37	-	-	2.86E-03	1.77E-03
APID	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	112	-	-	2.24E-02	5.31E-03
APID	BP	GO:0017148	negative regulation of translation	-	390	114	-	-	9.44E-03	5.43E-03
APID	BP	GO:0030220	platelet formation	-	22	21	-	-	3.58E-02	1.00E-03
APID	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	78	-	-	5.10E-03	3.72E-03
APID	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	8.05E-03	5.90E-04
APID	BP	GO:1901142	insulin metabolic process	-	14	13	-	-	4.68E-03	6.49E-04
APID	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	12	-	-	2.39E-02	5.90E-04
APID	BP	GO:1903509	liposaccharide metabolic process	-	109	102	-	-	1.75E-02	4.84E-03
APID	BP	GO:0009582	detection of abiotic stimulus	-	140	116	-	-	4.60E-03	5.49E-03
APID	BP	GO:0045683	negative regulation of epidermis development	-	13	12	-	-	1.72E-04	5.90E-04
APID	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	15	-	-	2.34E-04	7.08E-04
APID	CC	GO:0140238	presynaptic endocytosis	-	72	70	-	-	1.34E-02	3.30E-03
APID	BP	GO:0051236	establishment of RNA localization	-	161	154	-	-	5.31E-02	7.32E-03
APID	BP	GO:0042178	xenobiotic catabolic process	-	26	24	-	-	5.20E-02	1.18E-03
APID	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	2.34E-04	8.26E-04
APID	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	191	-	-	1.24E-02	9.03E-03
APID	BP	GO:0034067	protein localization to Golgi apparatus	-	30	29	-	-	9.76E-04	1.42E-03
APID	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	2.62E-03	1.53E-03
APID	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	4.87E-03	5.31E-04
APID	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	8.19E-03	8.26E-04
APID	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	47	-	-	1.60E-03	2.24E-03
APID	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	1.04E-03	1.89E-03
APID	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	2.74E-03	2.48E-03
APID	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	4.13E-03	7.67E-04
APID	BP	GO:0050779	RNA destabilization	-	135	100	-	-	4.36E-02	4.72E-03
APID	BP	GO:0006023	aminoglycan biosynthetic process	-	74	69	-	-	2.37E-02	3.30E-03
APID	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	1.32E-02	3.25E-03
APID	BP	GO:0010762	regulation of fibroblast migration	-	40	38	-	-	8.55E-03	1.83E-03
APID	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	8.61E-03	1.42E-03
APID	BP	GO:0035272	exocrine system development	-	46	46	-	-	3.59E-03	2.18E-03
APID	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	6.45E-03	8.26E-04
APID	BP	GO:0022406	membrane docking	-	90	89	-	-	2.64E-02	4.25E-03
APID	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	3.15E-02	7.08E-04
APID	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	3.99E-04	7.67E-04
APID	BP	GO:0050777	negative regulation of immune response	-	196	185	-	-	6.93E-03	8.73E-03
APID	MF	GO:0005035	death receptor activity	-	16	16	-	-	7.51E-03	7.67E-04
APID	BP	GO:0002063	chondrocyte development	-	33	32	-	-	6.00E-04	1.53E-03
APID	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	1.67E-03	8.26E-04
APID	BP	GO:0099068	postsynapse assembly	-	40	38	-	-	1.88E-02	1.83E-03
APID	BP	GO:0021782	glial cell development	-	120	107	-	-	2.98E-03	5.07E-03
APID	BP	GO:0051782	negative regulation of cell division	-	18	16	-	-	1.47E-02	7.67E-04
APID	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	1.53E-03	5.31E-04
APID	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	86	-	-	2.78E-03	4.07E-03
APID	BP	GO:0001655	urogenital system development	-	66	65	-	-	3.82E-03	3.07E-03
APID	BP	GO:0071827	plasma lipoprotein particle organization	-	86	69	-	-	5.19E-03	3.30E-03
APID	BP	GO:0045494	photoreceptor cell maintenance	-	43	40	-	-	1.90E-02	1.89E-03
APID	BP	GO:0055088	lipid homeostasis	-	173	149	-	-	5.29E-03	7.08E-03
APID	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	25	-	-	2.52E-03	1.18E-03
APID	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	193	-	-	4.66E-03	9.15E-03
APID	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	27	-	-	1.52E-03	1.30E-03
APID	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	34	-	-	4.10E-03	1.65E-03
APID	BP	GO:0045667	regulation of osteoblast differentiation	-	147	121	-	-	1.83E-02	5.72E-03
APID	BP	GO:2001212	regulation of vasculogenesis	-	16	15	-	-	1.04E-02	7.08E-04
APID	BP	GO:0061037	negative regulation of cartilage development	-	32	29	-	-	7.41E-04	1.42E-03
APID	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	4.49E-02	1.89E-03
APID	BP	GO:0001704	formation of primary germ layer	-	195	183	-	-	5.94E-03	8.67E-03
APID	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	1.69E-02	6.49E-04
APID	BP	GO:0045778	positive regulation of ossification	-	51	50	-	-	5.88E-03	2.36E-03
APID	BP	GO:0060174	limb bud formation	-	11	11	-	-	7.54E-03	5.31E-04
APID	BP	GO:0048708	astrocyte differentiation	-	88	84	-	-	4.30E-03	4.01E-03
APID	BP	GO:0042092	type 2 immune response	-	41	41	-	-	5.46E-03	1.95E-03
APID	BP	GO:0048588	developmental cell growth	-	233	216	-	-	5.35E-03	1.02E-02
APID	CC	GO:0000963	mitochondrial RNA processing	-	20	19	-	-	6.04E-02	9.44E-04
APID	BP	GO:0021872	forebrain generation of neurons	-	52	50	-	-	1.56E-03	2.36E-03
APID	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	3.08E-03	1.06E-03
APID	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	1.53E-01	1.89E-03
APID	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	48	-	-	1.86E-02	2.30E-03
APID	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0034367	protein-containing complex remodeling	-	35	34	-	-	1.02E-02	1.65E-03
APID	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	25	-	-	4.64E-04	1.18E-03
APID	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	44	-	-	5.95E-03	2.12E-03
APID	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	18	-	-	7.90E-02	8.85E-04
APID	BP	GO:0015810	aspartate transmembrane transport	-	19	18	-	-	1.47E-02	8.85E-04
APID	BP	GO:0010232	vascular transport	-	87	81	-	-	1.80E-03	3.84E-03
APID	BP	GO:0021987	cerebral cortex development	-	125	121	-	-	3.87E-03	5.72E-03
APID	BP	GO:0008637	apoptotic mitochondrial changes	-	108	100	-	-	1.33E-02	4.72E-03
APID	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	1.46E-02	1.65E-03
APID	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	9.35E-04	7.08E-04
APID	BP	GO:0060999	positive regulation of dendritic spine development	-	35	33	-	-	4.52E-03	1.59E-03
APID	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	1.11E-02	8.85E-04
APID	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	5.62E-03	3.66E-03
APID	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	2.83E-04	9.44E-04
APID	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	2.73E-03	9.44E-04
APID	BP	GO:0002064	epithelial cell development	-	210	203	-	-	4.98E-03	9.62E-03
APID	BP	GO:0071318	cellular response to ATP	-	18	16	-	-	6.07E-04	7.67E-04
APID	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	39	-	-	5.91E-03	1.89E-03
APID	BP	GO:2001222	regulation of neuron migration	-	46	40	-	-	3.62E-03	1.89E-03
APID	BP	GO:0034389	lipid droplet organization	-	38	36	-	-	7.18E-03	1.71E-03
APID	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	5.26E-04	2.12E-03
APID	BP	GO:0042177	negative regulation of protein catabolic process	-	109	103	-	-	2.25E-03	4.90E-03
APID	MF	GO:0038024	cargo receptor activity	-	121	109	-	-	9.72E-03	5.19E-03
APID	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	17	-	-	2.58E-03	8.26E-04
APID	BP	GO:0033120	positive regulation of RNA splicing	-	46	41	-	-	2.95E-02	1.95E-03
APID	BP	GO:0051445	regulation of meiotic cell cycle	-	64	60	-	-	8.50E-02	2.83E-03
APID	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	6.03E-04	5.90E-04
APID	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	6.69E-03	2.83E-03
APID	BP	GO:0038065	collagen-activated signaling pathway	-	15	14	-	-	7.94E-03	7.08E-04
APID	BP	GO:0090087	regulation of peptide transport	-	195	181	-	-	7.38E-03	8.56E-03
APID	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	97	-	-	2.52E-03	4.60E-03
APID	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	2.43E-03	1.18E-03
APID	BP	GO:0006929	substrate-dependent cell migration	-	26	24	-	-	4.14E-04	1.18E-03
APID	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	12	-	-	1.74E-04	5.90E-04
APID	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	6.27E-02	1.30E-03
APID	BP	GO:0099118	microtubule-based protein transport	-	14	13	-	-	1.38E-03	6.49E-04
APID	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	6.76E-03	7.08E-04
APID	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	6.77E-02	9.44E-04
APID	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	2.25E-03	6.49E-04
APID	BP	GO:0022404	molting cycle process	-	95	93	-	-	3.01E-03	4.43E-03
APID	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	6.10E-04	5.31E-04
APID	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	3.51E-03	8.26E-04
APID	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	1.53E-02	9.44E-04
APID	BP	GO:0042754	negative regulation of circadian rhythm	-	12	11	-	-	7.86E-03	5.31E-04
APID	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	1.14E-03	8.26E-04
APID	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	3.27E-03	1.53E-03
APID	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	1.68E-02	7.08E-04
APID	BP	GO:0008299	isoprenoid biosynthetic process	-	30	30	-	-	1.37E-02	1.42E-03
APID	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	225	-	-	1.35E-02	1.06E-02
APID	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.24E-03	1.48E-03
APID	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	6.93E-04	1.06E-03
APID	CC	GO:0098926	postsynaptic signal transduction	-	39	37	-	-	6.91E-03	1.77E-03
APID	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	137	-	-	4.06E-03	6.49E-03
APID	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	1.80E-02	9.44E-04
APID	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	46	-	-	9.52E-04	2.18E-03
APID	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	133	-	-	8.71E-03	6.31E-03
APID	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	2.14E-03	1.06E-03
APID	BP	GO:0061548	ganglion development	-	17	16	-	-	5.44E-02	7.67E-04
APID	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	96	-	-	7.05E-03	4.54E-03
APID	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.37E-03	7.08E-04
APID	BP	GO:0042832	defense response to protozoan	-	28	24	-	-	4.65E-02	1.18E-03
APID	BP	GO:0048799	animal organ maturation	-	33	31	-	-	1.52E-03	1.48E-03
APID	BP	GO:0006925	inflammatory cell apoptotic process	-	23	21	-	-	7.56E-04	1.00E-03
APID	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	5.27E-04	7.67E-04
APID	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	167	-	-	5.78E-03	7.91E-03
APID	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.76E-04	5.31E-04
APID	BP	GO:1903035	negative regulation of response to wounding	-	93	87	-	-	7.57E-03	4.13E-03
APID	BP	GO:0015697	quaternary ammonium group transport	-	16	15	-	-	7.87E-03	7.08E-04
APID	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	8.37E-04	1.24E-03
APID	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	2.37E-03	1.30E-03
APID	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	131	-	-	3.57E-02	6.20E-03
APID	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	93	-	-	3.20E-03	4.43E-03
APID	BP	GO:0045056	transcytosis	-	20	20	-	-	1.28E-03	9.44E-04
APID	BP	GO:0018342	protein prenylation	-	15	15	-	-	1.54E-02	7.08E-04
APID	BP	GO:0009267	cellular response to starvation	-	170	168	-	-	1.03E-02	7.97E-03
APID	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	3.68E-03	2.54E-03
APID	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	2.34E-04	7.67E-04
APID	BP	GO:0007343	egg activation	-	11	11	-	-	1.74E-04	5.31E-04
APID	CC	GO:0140239	postsynaptic endocytosis	-	23	22	-	-	2.25E-03	1.06E-03
APID	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	24	-	-	2.89E-04	1.18E-03
APID	BP	GO:0046931	pore complex assembly	-	21	20	-	-	9.07E-03	9.44E-04
APID	CC	GO:0032008	positive regulation of TOR signaling	-	52	50	-	-	8.33E-02	2.36E-03
APID	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	6.13E-02	1.59E-03
APID	BP	GO:0046618	xenobiotic export from cell	-	27	13	-	-	9.93E-03	6.49E-04
APID	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	14	-	-	1.02E-02	7.08E-04
APID	BP	GO:0060428	lung epithelium development	-	43	43	-	-	1.39E-03	2.07E-03
APID	BP	GO:0030431	sleep	-	30	27	-	-	7.99E-03	1.30E-03
APID	BP	GO:1903318	negative regulation of protein maturation	-	29	28	-	-	6.27E-03	1.36E-03
APID	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	95	-	-	2.88E-01	4.48E-03
APID	BP	GO:0071732	cellular response to nitric oxide	-	17	16	-	-	8.42E-04	7.67E-04
APID	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	2.30E-02	7.08E-04
APID	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	1.72E-04	5.31E-04
APID	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.74E-04	6.49E-04
APID	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	70	-	-	1.03E-03	3.30E-03
APID	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	3.99E-03	3.07E-03
APID	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	16	-	-	5.27E-03	7.67E-04
APID	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	1.76E-04	7.08E-04
APID	CC	GO:0006406	mRNA export from nucleus	-	69	67	-	-	6.62E-02	3.19E-03
APID	BP	GO:0009880	embryonic pattern specification	-	70	66	-	-	2.51E-03	3.13E-03
APID	BP	GO:0015791	polyol transmembrane transport	-	14	12	-	-	2.79E-03	5.90E-04
APID	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	4.54E-01	1.89E-03
APID	BP	GO:0043043	peptide biosynthetic process	-	25	25	-	-	5.01E-02	1.18E-03
APID	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	5.82E-02	5.31E-04
APID	BP	GO:0002367	cytokine production involved in immune response	-	121	119	-	-	7.17E-03	5.66E-03
APID	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	12	-	-	2.47E-03	5.90E-04
APID	BP	GO:0044848	biological phase	-	211	198	-	-	1.75E-02	9.38E-03
APID	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	7.94E-03	5.90E-04
APID	BP	GO:0046660	female sex differentiation	-	125	120	-	-	5.41E-03	5.66E-03
APID	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	4.42E-04	8.26E-04
APID	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	40	-	-	4.25E-03	1.89E-03
APID	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	6.62E-03	3.30E-03
APID	BP	GO:0071248	cellular response to metal ion	-	201	194	-	-	8.42E-03	9.20E-03
APID	BP	GO:0030308	negative regulation of cell growth	-	191	183	-	-	5.63E-03	8.67E-03
APID	BP	GO:0097306	cellular response to alcohol	-	99	92	-	-	4.87E-03	4.37E-03
APID	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	125	-	-	4.82E-02	5.90E-03
APID	BP	GO:0010453	regulation of cell fate commitment	-	40	34	-	-	1.07E-02	1.65E-03
APID	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	57	-	-	2.09E-03	2.71E-03
APID	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	52	-	-	1.29E-03	2.48E-03
APID	BP	GO:0002026	regulation of the force of heart contraction	-	26	24	-	-	6.31E-04	1.18E-03
APID	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	22	-	-	1.60E-03	1.06E-03
APID	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	44	-	-	1.73E-02	2.12E-03
APID	BP	GO:0032890	regulation of organic acid transport	-	78	75	-	-	4.74E-03	3.54E-03
APID	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	2.04E-03	9.44E-04
APID	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	2.44E-02	1.18E-03
APID	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	91	-	-	3.60E-03	4.31E-03
APID	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	25	-	-	1.13E-03	1.18E-03
APID	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	4.47E-03	5.31E-04
APID	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	51	-	-	3.78E-03	2.42E-03
APID	BP	GO:0051259	protein complex oligomerization	-	251	239	-	-	1.25E-02	1.13E-02
APID	BP	GO:0009163	nucleoside biosynthetic process	-	16	15	-	-	2.38E-03	7.08E-04
APID	BP	GO:0098743	cell aggregation	-	24	22	-	-	1.62E-03	1.06E-03
APID	BP	GO:0035112	genitalia morphogenesis	-	12	11	-	-	9.22E-04	5.31E-04
APID	BP	GO:0009994	oocyte differentiation	-	57	53	-	-	9.44E-04	2.54E-03
APID	MF	GO:0031952	regulation of protein autophosphorylation	-	43	41	-	-	8.56E-04	1.95E-03
APID	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	1.02E-02	7.08E-04
APID	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	148	-	-	7.04E-03	7.02E-03
APID	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	3.49E-03	1.65E-03
APID	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	1.64E-03	1.36E-03
APID	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	1.20E-03	1.65E-03
APID	BP	GO:0072665	protein localization to vacuole	-	84	81	-	-	7.17E-03	3.84E-03
APID	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	45	-	-	5.43E-02	2.12E-03
APID	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	23	-	-	3.55E-03	1.12E-03
APID	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	73	-	-	7.10E-03	3.48E-03
APID	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	1.79E-03	7.67E-04
APID	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	1.08E-02	7.08E-04
APID	BP	GO:0042044	fluid transport	-	35	33	-	-	3.57E-03	1.59E-03
APID	BP	GO:0070633	transepithelial transport	-	35	34	-	-	3.42E-03	1.65E-03
APID	BP	GO:0033015	tetrapyrrole catabolic process	-	13	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0045661	regulation of myoblast differentiation	-	74	72	-	-	1.73E-02	3.42E-03
APID	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	12	-	-	1.75E-04	5.90E-04
APID	BP	GO:0030307	positive regulation of cell growth	-	164	154	-	-	3.43E-03	7.32E-03
APID	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	1.41E-02	1.18E-03
APID	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	3.72E-04	8.85E-04
APID	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	8.40E-04	6.49E-04
APID	BP	GO:0014812	muscle cell migration	-	110	84	-	-	3.81E-03	4.01E-03
APID	BP	GO:0048525	negative regulation of viral process	-	90	85	-	-	3.14E-03	4.01E-03
APID	BP	GO:0072044	collecting duct development	-	16	15	-	-	2.27E-02	7.08E-04
APID	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	13	-	-	1.09E-01	6.49E-04
APID	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	3.93E-03	3.30E-03
APID	BP	GO:0030238	male sex determination	-	14	14	-	-	3.36E-02	7.08E-04
APID	BP	GO:0051781	positive regulation of cell division	-	93	83	-	-	4.21E-03	3.95E-03
APID	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	6.30E-03	1.00E-03
APID	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	9.54E-03	5.31E-04
APID	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	1.03E-01	1.12E-03
APID	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	21	-	-	8.98E-04	1.00E-03
APID	BP	GO:0060711	labyrinthine layer development	-	47	46	-	-	9.44E-04	2.18E-03
APID	BP	GO:0007272	ensheathment of neurons	-	146	138	-	-	4.28E-03	6.55E-03
APID	CC	GO:0050806	positive regulation of synaptic transmission	-	171	146	-	-	4.90E-03	6.90E-03
APID	BP	GO:0060021	roof of mouth development	-	91	90	-	-	4.17E-03	4.25E-03
APID	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	4.57E-03	1.89E-03
APID	BP	GO:0050819	negative regulation of coagulation	-	54	52	-	-	2.57E-02	2.48E-03
APID	BP	GO:0017004	cytochrome complex assembly	-	40	36	-	-	7.21E-02	1.71E-03
APID	BP	GO:0018410	C-terminal protein amino acid modification	-	15	12	-	-	2.53E-02	5.90E-04
APID	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	1.43E-01	2.95E-03
APID	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	6.87E-02	7.08E-04
APID	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	13	-	-	7.36E-04	6.49E-04
APID	CC	GO:0050805	negative regulation of synaptic transmission	-	55	53	-	-	5.32E-03	2.54E-03
APID	BP	GO:0043248	proteasome assembly	-	13	13	-	-	1.85E-02	6.49E-04
APID	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	57	-	-	1.20E-02	2.71E-03
APID	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	1.13E-02	5.31E-04
APID	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	73	-	-	3.22E-03	3.48E-03
APID	BP	GO:0016054	organic acid catabolic process	-	251	239	-	-	1.46E-02	1.13E-02
APID	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	2.37E-03	6.49E-04
APID	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	2.06E-02	1.36E-03
APID	BP	GO:0065005	protein-lipid complex assembly	-	29	27	-	-	4.57E-03	1.30E-03
APID	BP	GO:0008033	tRNA processing	-	136	130	-	-	1.24E-01	6.14E-03
APID	BP	GO:0046661	male sex differentiation	-	171	165	-	-	5.92E-03	7.79E-03
APID	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	5.00E-04	7.08E-04
APID	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	6.91E-03	8.26E-04
APID	BP	GO:0035188	hatching	-	27	24	-	-	2.85E-04	1.18E-03
APID	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	83	-	-	2.35E-03	3.95E-03
APID	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	2.33E-04	7.08E-04
APID	BP	GO:0090713	immunological memory process	-	18	18	-	-	2.62E-02	8.85E-04
APID	BP	GO:0061326	renal tubule development	-	103	98	-	-	5.67E-03	4.66E-03
APID	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	5.21E-02	2.60E-03
APID	BP	GO:0006450	regulation of translational fidelity	-	18	16	-	-	2.01E-03	7.67E-04
APID	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	4.99E-03	9.44E-04
APID	BP	GO:0060325	face morphogenesis	-	31	30	-	-	8.16E-04	1.42E-03
APID	BP	GO:0090559	regulation of membrane permeability	-	72	63	-	-	6.11E-03	3.01E-03
APID	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	13	-	-	4.05E-02	6.49E-04
APID	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	2.02E-02	5.90E-04
APID	BP	GO:0031579	membrane raft organization	-	25	24	-	-	2.09E-03	1.18E-03
APID	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	1.12E-03	1.18E-03
APID	BP	GO:0060033	anatomical structure regression	-	16	14	-	-	2.54E-03	7.08E-04
APID	BP	GO:0046460	neutral lipid biosynthetic process	-	50	43	-	-	1.15E-02	2.07E-03
APID	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	140	-	-	4.16E-03	6.61E-03
APID	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	1.76E-04	5.31E-04
APID	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	160	-	-	4.11E-03	7.55E-03
APID	BP	GO:0002251	organ or tissue specific immune response	-	43	33	-	-	1.69E-03	1.59E-03
APID	CC	GO:0048167	regulation of synaptic plasticity	-	210	185	-	-	5.98E-03	8.73E-03
APID	BP	GO:1903708	positive regulation of hemopoiesis	-	184	174	-	-	1.34E-02	8.26E-03
APID	BP	GO:1903008	organelle disassembly	-	154	153	-	-	1.19E-02	7.26E-03
APID	BP	GO:0001709	cell fate determination	-	44	41	-	-	3.07E-03	1.95E-03
APID	BP	GO:0051873	killing by host of symbiont cells	-	28	25	-	-	3.36E-02	1.18E-03
APID	BP	GO:0045058	T cell selection	-	53	53	-	-	2.97E-02	2.54E-03
APID	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	2.09E-03	2.30E-03
APID	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	2.14E-03	9.44E-04
APID	BP	GO:0072091	regulation of stem cell proliferation	-	91	77	-	-	3.35E-03	3.66E-03
APID	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	39	-	-	5.38E-03	1.89E-03
APID	BP	GO:0099084	postsynaptic specialization organization	-	44	41	-	-	3.95E-03	1.95E-03
APID	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	1.06E-03	5.31E-04
APID	BP	GO:0071501	cellular response to sterol depletion	-	15	14	-	-	3.87E-02	7.08E-04
APID	BP	GO:0060384	innervation	-	27	27	-	-	4.93E-02	1.30E-03
APID	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	1.93E-03	5.90E-04
APID	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	34	-	-	3.69E-03	1.65E-03
APID	MF	GO:0031281	positive regulation of cyclase activity	-	40	36	-	-	1.92E-03	1.71E-03
APID	MF	GO:0098631	cell adhesion mediator activity	-	64	60	-	-	5.05E-03	2.83E-03
APID	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	17	-	-	2.34E-04	8.26E-04
APID	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	1.98E-02	5.90E-04
APID	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	1.72E-02	8.85E-04
APID	BP	GO:0071453	cellular response to oxygen levels	-	168	151	-	-	5.17E-03	7.14E-03
APID	BP	GO:0090399	replicative senescence	-	17	16	-	-	2.10E-03	7.67E-04
APID	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	1.75E-04	7.08E-04
APID	BP	GO:0031342	negative regulation of cell killing	-	29	28	-	-	1.84E-02	1.36E-03
APID	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	1.86E-02	5.90E-03
APID	BP	GO:0006855	xenobiotic transmembrane transport	-	14	12	-	-	1.87E-02	5.90E-04
APID	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	7.00E-04	1.18E-03
APID	BP	GO:0044242	cellular lipid catabolic process	-	224	209	-	-	9.03E-03	9.91E-03
APID	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	5.35E-04	6.49E-04
APID	BP	GO:0002931	response to ischemia	-	58	56	-	-	1.04E-02	2.66E-03
APID	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	1.97E-02	5.90E-04
APID	BP	GO:0014047	glutamate secretion	-	25	25	-	-	2.12E-02	1.18E-03
APID	BP	GO:0061005	cell differentiation involved in kidney development	-	58	57	-	-	1.13E-02	2.71E-03
APID	BP	GO:0030397	membrane disassembly	-	11	11	-	-	1.14E-03	5.31E-04
APID	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	71	-	-	1.97E-02	3.36E-03
APID	BP	GO:0060420	regulation of heart growth	-	74	58	-	-	6.94E-03	2.77E-03
APID	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	4.45E-04	7.08E-04
APID	BP	GO:0009755	hormone-mediated signaling pathway	-	221	203	-	-	1.15E-02	9.62E-03
APID	BP	GO:0022612	gland morphogenesis	-	124	120	-	-	4.37E-03	5.66E-03
APID	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	34	-	-	6.27E-04	1.65E-03
APID	MF	GO:0140416	transcription regulator inhibitor activity	-	26	24	-	-	1.30E-03	1.18E-03
APID	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	23	-	-	1.11E-01	1.12E-03
APID	BP	GO:0048935	peripheral nervous system neuron development	-	15	14	-	-	1.75E-04	7.08E-04
APID	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	2.13E-02	8.26E-04
APID	BP	GO:1990845	adaptive thermogenesis	-	166	160	-	-	4.27E-03	7.55E-03
APID	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	2.82E-02	2.54E-03
APID	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	4.53E-02	5.31E-04
APID	BP	GO:0015844	monoamine transport	-	88	87	-	-	2.47E-02	4.13E-03
APID	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	5.24E-03	1.06E-03
APID	BP	GO:0060039	pericardium development	-	19	19	-	-	6.19E-04	9.44E-04
APID	BP	GO:0071392	cellular response to estradiol stimulus	-	40	39	-	-	4.57E-03	1.89E-03
APID	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	12	-	-	5.04E-03	5.90E-04
APID	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	2.09E-02	9.44E-04
APID	BP	GO:0009451	RNA modification	-	169	157	-	-	2.64E-02	7.43E-03
APID	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	38	-	-	2.27E-03	1.83E-03
APID	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	1.63E-03	8.26E-04
APID	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	109	-	-	6.62E-03	5.19E-03
APID	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	36	-	-	1.47E-02	1.71E-03
APID	BP	GO:0015807	L-amino acid transport	-	94	85	-	-	2.89E-03	4.01E-03
APID	BP	GO:0032941	secretion by tissue	-	85	80	-	-	3.71E-03	3.78E-03
APID	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	11	-	-	1.29E-02	5.31E-04
APID	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	8.58E-03	2.60E-03
APID	BP	GO:0048753	pigment granule organization	-	40	39	-	-	1.04E-01	1.89E-03
APID	BP	GO:0021516	dorsal spinal cord development	-	20	17	-	-	2.31E-04	8.26E-04
APID	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	17	-	-	2.33E-04	8.26E-04
APID	BP	GO:0032196	transposition	-	11	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0003014	renal system process	-	130	122	-	-	4.98E-03	5.78E-03
APID	CC	GO:0070286	axonemal dynein complex assembly	-	40	36	-	-	3.40E-03	1.71E-03
APID	BP	GO:0045598	regulation of fat cell differentiation	-	148	125	-	-	3.67E-03	5.90E-03
APID	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	189	-	-	7.51E-03	8.97E-03
APID	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	2.47E-03	1.83E-03
APID	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	4.07E-04	1.18E-03
APID	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	197	-	-	3.07E-02	9.32E-03
APID	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.68E-04	6.49E-04
APID	BP	GO:0008340	determination of adult lifespan	-	23	21	-	-	6.59E-04	1.00E-03
APID	BP	GO:0018158	protein oxidation	-	15	13	-	-	1.48E-03	6.49E-04
APID	BP	GO:0039694	viral RNA genome replication	-	30	29	-	-	3.09E-03	1.42E-03
APID	BP	GO:0009404	toxin metabolic process	-	17	16	-	-	2.34E-04	7.67E-04
APID	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	1.42E-03	1.30E-03
APID	BP	GO:0071709	membrane assembly	-	68	63	-	-	3.71E-02	3.01E-03
APID	BP	GO:0008217	regulation of blood pressure	-	186	164	-	-	5.45E-03	7.79E-03
APID	BP	GO:0031643	positive regulation of myelination	-	19	17	-	-	2.32E-04	8.26E-04
APID	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	4.48E-02	7.08E-04
APID	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	58	-	-	3.44E-03	2.77E-03
APID	CC	GO:0042770	signal transduction in response to DNA damage	-	186	183	-	-	9.97E-03	8.67E-03
APID	BP	GO:0002200	somatic diversification of immune receptors	-	78	78	-	-	2.26E-02	3.72E-03
APID	BP	GO:0035315	hair cell differentiation	-	52	49	-	-	2.90E-03	2.36E-03
APID	BP	GO:0048645	animal organ formation	-	62	61	-	-	4.21E-03	2.89E-03
APID	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	157	-	-	4.82E-03	7.43E-03
APID	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	1.73E-04	7.08E-04
APID	BP	GO:0033627	cell adhesion mediated by integrin	-	87	84	-	-	1.59E-02	4.01E-03
APID	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	1.57E-02	1.00E-03
APID	BP	GO:0015824	proline transport	-	13	11	-	-	1.59E-02	5.31E-04
APID	BP	GO:0035107	appendage morphogenesis	-	147	144	-	-	5.60E-03	6.84E-03
APID	BP	GO:1903707	negative regulation of hemopoiesis	-	116	104	-	-	4.10E-03	4.96E-03
APID	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	2.29E-04	9.44E-04
APID	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	4.68E-02	1.18E-03
APID	BP	GO:0030149	sphingolipid catabolic process	-	32	29	-	-	6.92E-04	1.42E-03
APID	BP	GO:0050994	regulation of lipid catabolic process	-	61	56	-	-	1.22E-03	2.66E-03
APID	BP	GO:0035988	chondrocyte proliferation	-	24	21	-	-	5.51E-03	1.00E-03
APID	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	4.76E-03	1.42E-03
APID	BP	GO:0009593	detection of chemical stimulus	-	511	115	-	-	7.74E-03	5.43E-03
APID	BP	GO:0060788	ectodermal placode formation	-	12	11	-	-	1.18E-03	5.31E-04
APID	BP	GO:0045727	positive regulation of translation	-	141	137	-	-	6.20E-03	6.49E-03
APID	BP	GO:0036315	cellular response to sterol	-	24	19	-	-	3.10E-03	9.44E-04
APID	CC	GO:0032388	positive regulation of intracellular transport	-	137	134	-	-	2.53E-03	6.37E-03
APID	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	5.24E-03	6.49E-04
APID	BP	GO:0002027	regulation of heart rate	-	106	92	-	-	2.84E-02	4.37E-03
APID	BP	GO:0050879	multicellular organismal movement	-	118	106	-	-	2.62E-03	5.02E-03
APID	BP	GO:0120305	regulation of pigmentation	-	15	13	-	-	3.87E-03	6.49E-04
APID	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	71	-	-	2.08E-03	3.36E-03
APID	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	61	-	-	4.88E-03	2.89E-03
APID	BP	GO:0048515	spermatid differentiation	-	208	187	-	-	3.42E-03	8.85E-03
APID	BP	GO:0072132	mesenchyme morphogenesis	-	57	56	-	-	3.40E-03	2.66E-03
APID	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	1.73E-03	1.48E-03
APID	BP	GO:0007130	synaptonemal complex assembly	-	23	22	-	-	5.09E-02	1.06E-03
APID	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	33	-	-	3.59E-03	1.59E-03
APID	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	30	-	-	1.11E-03	1.42E-03
APID	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	34	-	-	3.54E-02	1.65E-03
APID	BP	GO:0060119	inner ear receptor cell development	-	44	41	-	-	2.56E-03	1.95E-03
APID	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	8.83E-03	8.85E-04
APID	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	33	-	-	6.17E-02	1.59E-03
APID	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	1.09E-03	1.18E-03
APID	BP	GO:0014854	response to inactivity	-	12	12	-	-	2.67E-03	5.90E-04
APID	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	240	-	-	1.13E-02	1.13E-02
APID	BP	GO:1900006	positive regulation of dendrite development	-	17	16	-	-	3.58E-03	7.67E-04
APID	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	47	-	-	7.70E-02	2.24E-03
APID	BP	GO:0010883	regulation of lipid storage	-	53	48	-	-	2.08E-03	2.30E-03
APID	BP	GO:0072170	metanephric tubule development	-	26	25	-	-	1.40E-02	1.18E-03
APID	BP	GO:0007635	chemosensory behavior	-	20	17	-	-	8.14E-04	8.26E-04
APID	BP	GO:1905954	positive regulation of lipid localization	-	110	101	-	-	6.69E-03	4.78E-03
APID	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	2.22E-03	5.90E-04
APID	BP	GO:0002209	behavioral defense response	-	39	38	-	-	1.40E-03	1.83E-03
APID	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	28	-	-	6.94E-02	1.36E-03
APID	BP	GO:0072523	purine-containing compound catabolic process	-	146	139	-	-	8.50E-03	6.61E-03
APID	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	31	-	-	7.59E-03	1.48E-03
APID	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	26	-	-	2.14E-03	1.24E-03
APID	BP	GO:0021535	cell migration in hindbrain	-	16	15	-	-	2.31E-04	7.08E-04
APID	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	94	-	-	7.95E-03	4.48E-03
APID	BP	GO:0007218	neuropeptide signaling pathway	-	113	91	-	-	7.63E-02	4.31E-03
APID	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	6.51E-03	5.90E-04
APID	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	153	-	-	5.46E-03	7.26E-03
APID	BP	GO:0031345	negative regulation of cell projection organization	-	195	185	-	-	6.80E-03	8.73E-03
APID	BP	GO:0048278	vesicle docking	-	64	64	-	-	2.25E-02	3.07E-03
APID	BP	GO:0035050	embryonic heart tube development	-	86	84	-	-	3.96E-03	4.01E-03
APID	BP	GO:0030168	platelet activation	-	135	130	-	-	6.65E-03	6.14E-03
APID	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	3.45E-02	7.67E-04
APID	CC	GO:0098810	neurotransmitter reuptake	-	35	33	-	-	1.29E-02	1.59E-03
APID	BP	GO:0008213	protein alkylation	-	58	52	-	-	5.23E-03	2.48E-03
APID	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	4.85E-03	6.49E-04
APID	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	2.17E-02	1.18E-03
APID	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.71E-04	6.49E-04
APID	BP	GO:0031529	ruffle organization	-	55	53	-	-	7.22E-03	2.54E-03
APID	BP	GO:0010842	retina layer formation	-	25	24	-	-	1.63E-03	1.18E-03
APID	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	81	-	-	1.86E-02	3.84E-03
APID	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	68	-	-	6.15E-03	3.25E-03
APID	MF	GO:0170055	lipid transmembrane transporter activity	-	56	53	-	-	1.56E-03	2.54E-03
APID	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	33	-	-	2.56E-03	1.59E-03
APID	BP	GO:0035304	regulation of protein dephosphorylation	-	87	82	-	-	1.63E-03	3.89E-03
APID	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	224	-	-	5.40E-03	1.06E-02
APID	BP	GO:0099637	neurotransmitter receptor transport	-	26	24	-	-	2.36E-03	1.18E-03
APID	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	34	-	-	1.08E-03	1.65E-03
APID	BP	GO:0051775	response to redox state	-	13	13	-	-	2.60E-02	6.49E-04
APID	BP	GO:0051785	positive regulation of nuclear division	-	61	59	-	-	3.62E-03	2.83E-03
APID	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	2.19E-03	7.67E-04
APID	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	15	-	-	4.40E-03	7.08E-04
APID	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	1.75E-03	9.44E-04
APID	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	4.85E-02	5.90E-04
APID	BP	GO:0044786	cell cycle DNA replication	-	45	43	-	-	8.54E-03	2.07E-03
APID	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	13	-	-	1.37E-03	6.49E-04
APID	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	3.89E-03	8.26E-04
APID	BP	GO:0051299	centrosome separation	-	15	14	-	-	1.12E-03	7.08E-04
APID	BP	GO:0048145	regulation of fibroblast proliferation	-	87	84	-	-	3.20E-03	4.01E-03
APID	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	85	-	-	2.06E-01	4.01E-03
APID	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	4.46E-03	5.31E-04
APID	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	220	-	-	5.08E-03	1.04E-02
APID	BP	GO:0032098	regulation of appetite	-	20	20	-	-	5.80E-03	9.44E-04
APID	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	2.42E-02	7.08E-04
APID	CC	GO:0008333	endosome to lysosome transport	-	73	71	-	-	3.97E-02	3.36E-03
APID	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	21	-	-	4.54E-02	1.00E-03
APID	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	14	-	-	2.16E-03	7.08E-04
APID	BP	GO:0003016	respiratory system process	-	39	37	-	-	7.42E-04	1.77E-03
APID	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	1.86E-02	1.12E-03
APID	BP	GO:0045732	positive regulation of protein catabolic process	-	202	199	-	-	5.43E-03	9.44E-03
APID	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	71	-	-	9.63E-03	3.36E-03
APID	BP	GO:0007588	excretion	-	40	37	-	-	1.20E-02	1.77E-03
APID	BP	GO:1904018	positive regulation of vasculature development	-	185	151	-	-	1.31E-02	7.14E-03
APID	BP	GO:0050953	sensory perception of light stimulus	-	223	194	-	-	1.11E-02	9.20E-03
APID	BP	GO:0009164	nucleoside catabolic process	-	25	22	-	-	1.78E-02	1.06E-03
APID	BP	GO:0002357	defense response to tumor cell	-	13	11	-	-	1.72E-04	5.31E-04
APID	BP	GO:0009303	rRNA transcription	-	37	37	-	-	6.04E-03	1.77E-03
APID	BP	GO:0035601	protein deacylation	-	56	55	-	-	5.50E-03	2.60E-03
APID	BP	GO:0061952	midbody abscission	-	18	17	-	-	2.13E-01	8.26E-04
APID	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	2.78E-03	5.31E-04
APID	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	4.16E-03	9.44E-04
APID	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	1.88E-03	1.42E-03
APID	BP	GO:0071300	cellular response to retinoic acid	-	66	64	-	-	6.35E-03	3.07E-03
APID	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	14	-	-	1.75E-04	7.08E-04
APID	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	4.17E-02	1.36E-03
APID	BP	GO:0031069	hair follicle morphogenesis	-	33	31	-	-	4.20E-03	1.48E-03
APID	BP	GO:0046697	decidualization	-	26	25	-	-	8.75E-04	1.18E-03
APID	BP	GO:0008212	mineralocorticoid metabolic process	-	14	12	-	-	1.75E-04	5.90E-04
APID	BP	GO:0051588	regulation of neurotransmitter transport	-	99	96	-	-	3.11E-03	4.54E-03
APID	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	28	-	-	4.74E-02	1.36E-03
APID	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	11	-	-	2.35E-03	5.31E-04
APID	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	1.00E-02	3.01E-03
APID	BP	GO:0044703	multi-organism reproductive process	-	209	194	-	-	6.44E-03	9.20E-03
APID	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	138	-	-	8.53E-03	6.55E-03
APID	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	50	-	-	9.93E-03	2.36E-03
APID	BP	GO:0099022	vesicle tethering	-	32	31	-	-	2.07E-01	1.48E-03
APID	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	36	-	-	2.11E-03	1.71E-03
APID	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	1.07E-02	5.90E-04
APID	BP	GO:0048857	neural nucleus development	-	65	59	-	-	1.20E-03	2.83E-03
APID	BP	GO:0048663	neuron fate commitment	-	74	67	-	-	4.03E-03	3.19E-03
APID	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	159	-	-	3.30E-03	7.55E-03
APID	BP	GO:0106027	neuron projection organization	-	90	87	-	-	4.87E-03	4.13E-03
APID	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	125	-	-	6.49E-03	5.90E-03
APID	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	3.24E-03	1.65E-03
APID	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	5.69E-03	5.31E-04
APID	BP	GO:0045685	regulation of glial cell differentiation	-	77	70	-	-	3.86E-03	3.30E-03
APID	BP	GO:0051608	histamine transport	-	14	12	-	-	5.77E-03	5.90E-04
APID	BP	GO:0043414	macromolecule methylation	-	138	126	-	-	1.08E-02	5.96E-03
APID	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	1.75E-04	5.90E-04
APID	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	2.83E-02	7.67E-04
APID	BP	GO:0050886	endocrine process	-	93	87	-	-	7.22E-03	4.13E-03
APID	MF	GO:0015562	efflux transmembrane transporter activity	-	15	13	-	-	1.75E-04	6.49E-04
APID	BP	GO:0050951	sensory perception of temperature stimulus	-	28	25	-	-	1.75E-03	1.18E-03
APID	BP	GO:0045807	positive regulation of endocytosis	-	155	147	-	-	4.60E-03	6.96E-03
APID	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	1.28E-03	5.31E-04
APID	BP	GO:0002418	immune response to tumor cell	-	29	27	-	-	3.63E-02	1.30E-03
APID	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	3.82E-03	2.77E-03
APID	BP	GO:0048308	organelle inheritance	-	14	14	-	-	2.93E-03	7.08E-04
APID	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	4.66E-04	8.85E-04
APID	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	8.36E-04	9.44E-04
APID	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	45	-	-	3.34E-03	2.12E-03
APID	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.65E-03	3.19E-03
APID	BP	GO:0042447	hormone catabolic process	-	12	11	-	-	1.74E-04	5.31E-04
APID	BP	GO:0009110	vitamin biosynthetic process	-	23	21	-	-	2.88E-04	1.00E-03
APID	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	4.68E-03	1.06E-03
APID	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	2.75E-02	8.26E-04
APID	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	21	-	-	8.06E-04	1.00E-03
APID	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	93	-	-	3.00E-03	4.43E-03
APID	MF	GO:0051100	negative regulation of binding	-	161	154	-	-	4.20E-03	7.32E-03
APID	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	4.03E-03	3.72E-03
APID	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	2.75E-03	2.83E-03
APID	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	9.31E-04	9.44E-04
APID	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	1.74E-04	5.90E-04
APID	BP	GO:0061036	positive regulation of cartilage development	-	33	32	-	-	1.22E-02	1.53E-03
APID	BP	GO:0046184	aldehyde biosynthetic process	-	16	14	-	-	1.43E-03	7.08E-04
APID	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	1.78E-03	6.49E-04
APID	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	46	-	-	2.38E-03	2.18E-03
APID	BP	GO:0046621	negative regulation of organ growth	-	39	31	-	-	1.65E-02	1.48E-03
APID	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	1.89E-01	2.36E-03
APID	BP	GO:0032368	regulation of lipid transport	-	149	125	-	-	6.53E-03	5.90E-03
APID	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	2.02E-03	1.42E-03
APID	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	177	-	-	6.30E-03	8.38E-03
APID	BP	GO:0033002	muscle cell proliferation	-	249	199	-	-	6.12E-03	9.44E-03
APID	BP	GO:0043331	response to dsRNA	-	56	54	-	-	8.45E-02	2.60E-03
APID	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	8.89E-03	5.90E-04
APID	BP	GO:0051904	pigment granule transport	-	23	22	-	-	3.66E-02	1.06E-03
APID	BP	GO:1901679	nucleotide transmembrane transport	-	32	31	-	-	3.00E-03	1.48E-03
APID	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	1.36E-03	1.59E-03
APID	BP	GO:0033363	secretory granule organization	-	63	58	-	-	1.99E-02	2.77E-03
APID	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	3.16E-03	1.36E-03
APID	BP	GO:0120009	intermembrane lipid transfer	-	52	50	-	-	5.19E-02	2.36E-03
APID	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	1.06E-02	7.08E-04
APID	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	37	-	-	1.95E-03	1.77E-03
APID	BP	GO:0033622	integrin activation	-	26	26	-	-	6.50E-03	1.24E-03
APID	BP	GO:0098751	bone cell development	-	18	16	-	-	7.82E-04	7.67E-04
APID	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.20E-03	1.00E-03
APID	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	2.99E-03	2.42E-03
APID	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.52E-02	1.42E-03
APID	BP	GO:0002076	osteoblast development	-	17	17	-	-	1.26E-02	8.26E-04
APID	BP	GO:0072164	mesonephric tubule development	-	98	94	-	-	6.87E-03	4.48E-03
APID	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	16	-	-	2.32E-04	7.67E-04
APID	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	103	-	-	4.77E-03	4.90E-03
APID	BP	GO:1903524	positive regulation of blood circulation	-	39	32	-	-	1.26E-03	1.53E-03
APID	BP	GO:0030901	midbrain development	-	87	80	-	-	2.47E-03	3.78E-03
APID	BP	GO:0048485	sympathetic nervous system development	-	22	21	-	-	2.80E-02	1.00E-03
APID	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	8.59E-04	7.67E-04
APID	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	1.44E-03	6.49E-04
APID	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	66	-	-	2.09E-03	3.13E-03
APID	MF	GO:1901474	azole transmembrane transporter activity	-	13	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0002687	positive regulation of leukocyte migration	-	147	142	-	-	5.37E-03	6.73E-03
APID	BP	GO:0019755	one-carbon compound transport	-	28	24	-	-	1.98E-02	1.18E-03
APID	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.72E-04	6.49E-04
APID	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	2.07E-02	7.67E-04
APID	BP	GO:0110154	RNA decapping	-	19	19	-	-	3.34E-02	9.44E-04
APID	BP	GO:0034605	cellular response to heat	-	66	65	-	-	2.99E-03	3.07E-03
APID	BP	GO:0005996	monosaccharide metabolic process	-	250	236	-	-	1.15E-02	1.12E-02
APID	BP	GO:0033555	multicellular organismal response to stress	-	90	83	-	-	5.69E-03	3.95E-03
APID	BP	GO:0002262	myeloid cell homeostasis	-	172	165	-	-	5.06E-03	7.79E-03
APID	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	1.49E-01	1.83E-03
APID	BP	GO:0050688	regulation of defense response to virus	-	65	62	-	-	1.43E-02	2.95E-03
APID	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	2.82E-03	9.44E-04
APID	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	222	-	-	9.14E-03	1.05E-02
APID	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	6.55E-04	1.48E-03
APID	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	7.64E-04	7.08E-04
APID	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	2.31E-03	1.53E-03
APID	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	17	-	-	9.78E-04	8.26E-04
APID	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	1.56E-02	1.36E-03
APID	BP	GO:0022618	protein-RNA complex assembly	-	227	190	-	-	4.30E-02	8.97E-03
APID	BP	GO:0051147	regulation of muscle cell differentiation	-	162	133	-	-	4.14E-03	6.31E-03
APID	BP	GO:0090102	cochlea development	-	50	47	-	-	7.57E-04	2.24E-03
APID	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	1.41E-03	1.24E-03
APID	BP	GO:0045933	positive regulation of muscle contraction	-	49	45	-	-	1.93E-03	2.12E-03
APID	BP	GO:0015803	branched-chain amino acid transport	-	14	13	-	-	6.58E-03	6.49E-04
APID	BP	GO:0002679	respiratory burst involved in defense response	-	16	15	-	-	2.18E-03	7.08E-04
APID	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	35	-	-	4.98E-03	1.65E-03
APID	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	90	-	-	8.88E-02	4.25E-03
APID	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.74E-04	5.90E-04
APID	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	2.74E-03	1.06E-03
APID	BP	GO:0032922	circadian regulation of gene expression	-	71	69	-	-	8.19E-03	3.30E-03
APID	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	47	-	-	1.37E-02	2.24E-03
APID	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	143	-	-	3.27E-03	6.79E-03
APID	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	19	-	-	5.86E-03	9.44E-04
APID	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	53	-	-	4.22E-03	2.54E-03
APID	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	4.36E-03	5.31E-04
APID	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	7.59E-03	1.83E-03
APID	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.72E-04	5.90E-04
APID	BP	GO:0140253	cell-cell fusion	-	62	54	-	-	6.46E-03	2.60E-03
APID	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	1.73E-04	5.90E-04
APID	BP	GO:0071599	otic vesicle development	-	15	15	-	-	5.84E-03	7.08E-04
APID	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	42	-	-	1.16E-01	2.01E-03
APID	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	6.13E-04	7.08E-04
APID	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	4.77E-03	2.83E-03
APID	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	4.45E-03	1.71E-03
APID	BP	GO:0051293	establishment of spindle localization	-	57	54	-	-	2.80E-03	2.60E-03
APID	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	1.71E-04	5.90E-04
APID	BP	GO:0043114	regulation of vascular permeability	-	49	43	-	-	3.44E-03	2.07E-03
APID	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	4.78E-03	1.24E-03
APID	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	61	-	-	2.39E-03	2.89E-03
APID	BP	GO:0008360	regulation of cell shape	-	139	133	-	-	9.70E-03	6.31E-03
APID	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	2.56E-03	7.67E-04
APID	BP	GO:0051222	positive regulation of protein transport	-	249	237	-	-	5.84E-03	1.12E-02
APID	CC	GO:0140632	canonical inflammasome complex assembly	-	40	39	-	-	1.17E-02	1.89E-03
APID	MF	GO:0034260	negative regulation of GTPase activity	-	36	33	-	-	8.32E-04	1.59E-03
APID	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	5.62E-03	1.06E-03
APID	BP	GO:0045739	positive regulation of DNA repair	-	128	126	-	-	7.38E-02	5.96E-03
APID	BP	GO:0001845	phagolysosome assembly	-	19	17	-	-	9.51E-03	8.26E-04
APID	BP	GO:0045185	maintenance of protein location	-	95	88	-	-	3.10E-03	4.19E-03
APID	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	11	-	-	1.43E-02	5.31E-04
APID	BP	GO:0003158	endothelium development	-	140	126	-	-	6.39E-03	5.96E-03
APID	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	1.99E-03	1.95E-03
APID	BP	GO:0051224	negative regulation of protein transport	-	122	105	-	-	6.77E-03	4.96E-03
APID	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	142	-	-	3.79E-03	6.73E-03
APID	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	2.92E-03	6.49E-04
APID	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	28	-	-	4.73E-03	1.36E-03
APID	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	4.79E-02	9.44E-04
APID	BP	GO:0021885	forebrain cell migration	-	63	60	-	-	4.58E-03	2.83E-03
APID	BP	GO:0007405	neuroblast proliferation	-	81	76	-	-	4.02E-03	3.60E-03
APID	BP	GO:0009581	detection of external stimulus	-	137	113	-	-	1.27E-02	5.37E-03
APID	BP	GO:1990542	mitochondrial transmembrane transport	-	93	88	-	-	1.78E-02	4.19E-03
APID	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	3.31E-03	1.48E-03
APID	BP	GO:0033504	floor plate development	-	11	11	-	-	9.49E-04	5.31E-04
APID	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	1.75E-04	5.31E-04
APID	BP	GO:0097186	amelogenesis	-	26	22	-	-	2.60E-02	1.06E-03
APID	BP	GO:0031128	developmental induction	-	26	26	-	-	2.54E-03	1.24E-03
APID	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	2.17E-03	7.08E-04
APID	BP	GO:0031100	animal organ regeneration	-	66	65	-	-	1.14E-03	3.07E-03
APID	BP	GO:0021533	cell differentiation in hindbrain	-	23	19	-	-	1.02E-02	9.44E-04
APID	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	9.35E-04	1.48E-03
APID	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	2.07E-03	5.90E-04
APID	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	1.77E-02	2.42E-03
APID	BP	GO:0021517	ventral spinal cord development	-	47	43	-	-	1.11E-02	2.07E-03
APID	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	5.45E-03	3.54E-03
APID	BP	GO:0032328	alanine transport	-	19	17	-	-	1.50E-02	8.26E-04
APID	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	3.68E-03	7.67E-04
APID	BP	GO:0097722	sperm motility	-	133	117	-	-	2.78E-03	5.55E-03
APID	BP	GO:0051231	spindle elongation	-	14	14	-	-	1.72E-02	7.08E-04
APID	BP	GO:0042490	mechanoreceptor differentiation	-	67	63	-	-	3.85E-03	3.01E-03
APID	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	28	-	-	1.41E-03	1.36E-03
APID	BP	GO:0035148	tube formation	-	155	149	-	-	4.24E-03	7.08E-03
APID	BP	GO:0048520	positive regulation of behavior	-	27	24	-	-	6.36E-04	1.18E-03
APID	BP	GO:0098543	detection of other organism	-	19	17	-	-	1.11E-02	8.26E-04
APID	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	8.50E-03	2.07E-03
APID	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	118	-	-	5.41E-03	5.61E-03
APID	BP	GO:0031123	RNA 3'-end processing	-	79	77	-	-	2.95E-02	3.66E-03
APID	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	1.52E-02	5.31E-04
APID	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	104	-	-	4.08E-03	4.96E-03
APID	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	1.17E-02	8.85E-04
APID	CC	GO:0007097	nuclear migration	-	24	23	-	-	2.91E-03	1.12E-03
APID	BP	GO:0006885	regulation of pH	-	104	94	-	-	1.32E-02	4.48E-03
APID	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.81E-03	7.08E-04
APID	BP	GO:1990840	response to lectin	-	22	19	-	-	7.38E-03	9.44E-04
APID	BP	GO:0071800	podosome assembly	-	19	19	-	-	8.50E-04	9.44E-04
APID	BP	GO:0031018	endocrine pancreas development	-	47	43	-	-	5.38E-03	2.07E-03
APID	BP	GO:0001708	cell fate specification	-	108	102	-	-	6.73E-03	4.84E-03
APID	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	67	-	-	3.35E-03	3.19E-03
APID	BP	GO:0030279	negative regulation of ossification	-	39	36	-	-	1.41E-03	1.71E-03
APID	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	7.59E-03	7.08E-04
APID	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	2.27E-03	5.90E-04
APID	BP	GO:0042440	pigment metabolic process	-	80	72	-	-	2.57E-02	3.42E-03
APID	BP	GO:1901606	alpha-amino acid catabolic process	-	101	98	-	-	1.58E-02	4.66E-03
APID	BP	GO:1901890	positive regulation of cell junction assembly	-	106	95	-	-	3.81E-03	4.48E-03
APID	BP	GO:0070988	demethylation	-	27	25	-	-	2.48E-02	1.18E-03
APID	BP	GO:1901655	cellular response to ketone	-	107	104	-	-	3.51E-03	4.96E-03
APID	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	1.73E-04	7.08E-04
APID	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	1.24E-02	7.08E-04
APID	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	2.97E-02	8.26E-04
APID	BP	GO:0006968	cellular defense response	-	52	48	-	-	1.55E-03	2.30E-03
APID	BP	GO:0055006	cardiac cell development	-	93	83	-	-	2.76E-03	3.95E-03
APID	BP	GO:0031365	N-terminal protein amino acid modification	-	30	28	-	-	1.09E-02	1.36E-03
APID	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	1.75E-04	5.90E-04
APID	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	27	-	-	1.57E-03	1.30E-03
APID	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	3.49E-04	5.90E-04
APID	BP	GO:0060004	reflex	-	63	58	-	-	2.49E-03	2.77E-03
APID	BP	GO:0044706	multi-multicellular organism process	-	217	203	-	-	4.68E-03	9.62E-03
APID	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	1.58E-03	5.90E-04
APID	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	139	-	-	5.08E-03	6.61E-03
APID	BP	GO:0006026	aminoglycan catabolic process	-	34	32	-	-	9.00E-04	1.53E-03
APID	BP	GO:0031294	lymphocyte costimulation	-	47	45	-	-	8.67E-03	2.12E-03
APID	BP	GO:0050768	negative regulation of neurogenesis	-	150	141	-	-	6.36E-03	6.67E-03
APID	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	93	-	-	2.55E-03	4.43E-03
APID	BP	GO:0090068	positive regulation of cell cycle process	-	262	239	-	-	7.54E-03	1.13E-02
APID	BP	GO:0043605	amide catabolic process	-	16	16	-	-	1.44E-03	7.67E-04
APID	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	3.42E-04	1.30E-03
APID	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	2.59E-02	1.65E-03
APID	BP	GO:1902115	regulation of organelle assembly	-	210	205	-	-	6.95E-03	9.68E-03
APID	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	64	-	-	2.93E-03	3.07E-03
APID	BP	GO:0047484	regulation of response to osmotic stress	-	16	15	-	-	2.32E-04	7.08E-04
APID	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	138	-	-	5.61E-03	6.55E-03
APID	BP	GO:0043171	peptide catabolic process	-	19	17	-	-	2.33E-04	8.26E-04
APID	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	7.87E-04	2.01E-03
APID	BP	GO:0051952	regulation of amine transport	-	98	98	-	-	2.66E-02	4.66E-03
APID	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	2.16E-02	1.12E-03
APID	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	19	-	-	8.29E-03	9.44E-04
APID	BP	GO:0040019	positive regulation of embryonic development	-	23	21	-	-	1.28E-03	1.00E-03
APID	BP	GO:0097154	GABAergic neuron differentiation	-	20	19	-	-	2.30E-04	9.44E-04
APID	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	15	-	-	2.29E-04	7.08E-04
APID	CC	GO:0032365	intracellular lipid transport	-	51	49	-	-	1.78E-02	2.36E-03
APID	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	5.38E-02	1.42E-03
APID	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	67	-	-	3.44E-03	3.19E-03
APID	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	112	-	-	3.51E-03	5.31E-03
APID	BP	GO:0018149	peptide cross-linking	-	28	27	-	-	1.40E-02	1.30E-03
APID	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	1.20E-03	1.18E-03
APID	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	7.27E-04	6.49E-04
APID	BP	GO:0021859	pyramidal neuron differentiation	-	14	13	-	-	1.72E-04	6.49E-04
APID	BP	GO:0061000	negative regulation of dendritic spine development	-	13	12	-	-	1.70E-04	5.90E-04
APID	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	2.54E-02	1.65E-03
APID	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	6.09E-03	4.25E-03
APID	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	1.92E-02	1.42E-03
APID	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	1.86E-02	8.85E-04
APID	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	3.43E-03	1.00E-03
APID	BP	GO:0015669	gas transport	-	23	22	-	-	3.61E-02	1.06E-03
APID	BP	GO:0016485	protein processing	-	248	236	-	-	8.71E-03	1.12E-02
APID	BP	GO:0009649	entrainment of circadian clock	-	30	28	-	-	3.91E-03	1.36E-03
APID	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	153	-	-	1.42E-02	7.26E-03
APID	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	1.22E-03	1.18E-03
APID	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	127	-	-	1.42E-02	6.02E-03
APID	BP	GO:0000101	sulfur amino acid transport	-	12	11	-	-	5.29E-02	5.31E-04
APID	BP	GO:0099054	presynapse assembly	-	49	43	-	-	8.59E-03	2.07E-03
APID	BP	GO:0003353	positive regulation of cilium movement	-	12	11	-	-	1.76E-04	5.31E-04
APID	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	24	-	-	9.64E-03	1.18E-03
APID	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	9.49E-04	1.18E-03
APID	BP	GO:0031348	negative regulation of defense response	-	282	234	-	-	5.55E-03	1.11E-02
APID	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	75	-	-	4.20E-03	3.54E-03
APID	BP	GO:0007606	sensory perception of chemical stimulus	-	535	131	-	-	8.78E-03	6.20E-03
APID	BP	GO:0061180	mammary gland epithelium development	-	68	67	-	-	4.54E-03	3.19E-03
APID	BP	GO:0071496	cellular response to external stimulus	-	74	72	-	-	4.14E-03	3.42E-03
APID	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	2.32E-02	6.49E-04
APID	BP	GO:0042753	positive regulation of circadian rhythm	-	18	15	-	-	3.28E-03	7.08E-04
APID	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	1.70E-04	5.31E-04
APID	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	5.40E-02	5.90E-04
APID	BP	GO:0032094	response to food	-	37	36	-	-	9.69E-04	1.71E-03
APID	BP	GO:0001964	startle response	-	27	27	-	-	2.75E-03	1.30E-03
APID	BP	GO:0007340	acrosome reaction	-	38	33	-	-	3.13E-02	1.59E-03
APID	BP	GO:0046434	organophosphate catabolic process	-	232	218	-	-	6.78E-03	1.03E-02
APID	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	4.26E-02	1.42E-03
APID	BP	GO:0009566	fertilization	-	205	172	-	-	1.34E-02	8.14E-03
APID	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	58	-	-	3.58E-01	2.77E-03
APID	BP	GO:0120255	olefinic compound biosynthetic process	-	24	21	-	-	2.90E-04	1.00E-03
APID	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	2.47E-03	6.49E-04
APID	BP	GO:0045907	positive regulation of vasoconstriction	-	30	27	-	-	6.64E-03	1.30E-03
APID	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	21	-	-	1.06E-02	1.00E-03
APID	BP	GO:0033044	regulation of chromosome organization	-	249	247	-	-	3.11E-02	1.17E-02
APID	BP	GO:0009309	amine biosynthetic process	-	38	34	-	-	2.11E-02	1.65E-03
APID	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	1.74E-03	9.44E-04
APID	BP	GO:0061900	glial cell activation	-	56	51	-	-	2.23E-02	2.42E-03
APID	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	133	-	-	1.39E-02	6.31E-03
APID	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	11	-	-	5.30E-03	5.31E-04
APID	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	5.14E-03	7.08E-04
APID	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	1.48E-02	1.95E-03
APID	BP	GO:0035902	response to immobilization stress	-	20	18	-	-	2.28E-04	8.85E-04
APID	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	2.58E-03	7.08E-04
APID	BP	GO:0072537	fibroblast activation	-	13	13	-	-	2.23E-02	6.49E-04
APID	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	6.14E-03	6.49E-04
APID	BP	GO:0043647	inositol phosphate metabolic process	-	44	40	-	-	3.40E-03	1.89E-03
APID	BP	GO:0016180	snRNA processing	-	28	27	-	-	1.49E-01	1.30E-03
APID	BP	GO:0051303	establishment of chromosome localization	-	104	102	-	-	1.26E-02	4.84E-03
APID	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	1.16E-02	7.67E-04
APID	BP	GO:0007164	establishment of tissue polarity	-	38	37	-	-	2.92E-03	1.77E-03
APID	BP	GO:0097164	ammonium ion metabolic process	-	23	22	-	-	2.92E-04	1.06E-03
APID	BP	GO:0021515	cell differentiation in spinal cord	-	51	47	-	-	5.83E-03	2.24E-03
APID	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	6.00E-03	8.85E-04
APID	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	20	-	-	1.79E-03	9.44E-04
APID	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	6.24E-04	1.36E-03
APID	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.99E-03	8.85E-04
APID	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	36	-	-	2.93E-02	1.71E-03
APID	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	4.47E-02	1.06E-03
APID	BP	GO:0007566	embryo implantation	-	57	51	-	-	8.46E-04	2.42E-03
APID	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	1.76E-03	1.59E-03
APID	BP	GO:0031268	pseudopodium organization	-	17	15	-	-	3.89E-02	7.08E-04
APID	BP	GO:0060306	regulation of membrane repolarization	-	38	30	-	-	8.01E-03	1.42E-03
APID	BP	GO:0051017	actin filament bundle assembly	-	161	153	-	-	5.46E-03	7.26E-03
APID	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	1.86E-03	2.01E-03
APID	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	17	-	-	1.01E-03	8.26E-04
APID	BP	GO:0021542	dentate gyrus development	-	19	18	-	-	3.86E-04	8.85E-04
APID	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	1.71E-04	6.49E-04
APID	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	36	-	-	4.32E-03	1.71E-03
APID	BP	GO:0021756	striatum development	-	21	21	-	-	3.45E-03	1.00E-03
APID	BP	GO:1901343	negative regulation of vasculature development	-	154	100	-	-	4.18E-03	4.72E-03
APID	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	149	-	-	1.34E-02	7.08E-03
APID	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	27	-	-	1.71E-03	1.30E-03
APID	BP	GO:1902414	protein localization to cell junction	-	107	104	-	-	4.05E-03	4.96E-03
APID	BP	GO:0071305	cellular response to vitamin D	-	23	21	-	-	1.77E-03	1.00E-03
APID	BP	GO:0051304	chromosome separation	-	80	80	-	-	1.14E-02	3.78E-03
APID	BP	GO:0045780	positive regulation of bone resorption	-	18	17	-	-	2.90E-03	8.26E-04
APID	BP	GO:0048709	oligodendrocyte differentiation	-	101	94	-	-	2.22E-03	4.48E-03
APID	BP	GO:0045017	glycerolipid biosynthetic process	-	254	244	-	-	1.15E-02	1.16E-02
APID	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	4.79E-01	7.08E-04
APID	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	7.60E-03	1.12E-03
APID	BP	GO:0001776	leukocyte homeostasis	-	108	99	-	-	3.49E-03	4.72E-03
APID	BP	GO:0050769	positive regulation of neurogenesis	-	240	225	-	-	5.42E-03	1.06E-02
APID	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	7.67E-02	7.08E-04
APID	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	1.35E-02	3.30E-03
APID	BP	GO:0050866	negative regulation of cell activation	-	216	200	-	-	6.97E-03	9.44E-03
APID	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	34	-	-	1.58E-03	1.65E-03
APID	BP	GO:0033500	carbohydrate homeostasis	-	251	223	-	-	5.74E-03	1.06E-02
APID	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	29	-	-	1.72E-02	1.42E-03
APID	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	5.70E-03	2.66E-03
APID	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	4.29E-03	1.12E-03
APID	CC	GO:0099522	cytosolic region	-	20	20	-	-	6.43E-04	9.44E-04
APID	CC	GO:0000791	euchromatin	-	60	55	-	-	4.19E-03	2.60E-03
APID	CC	GO:0030666	endocytic vesicle membrane	-	196	190	-	-	1.37E-02	8.97E-03
APID	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	7.21E-02	7.08E-04
APID	CC	GO:1990752	microtubule end	-	34	34	-	-	1.27E-02	1.65E-03
APID	CC	GO:0043204	perikaryon	-	156	150	-	-	3.47E-03	7.08E-03
APID	CC	GO:0061702	canonical inflammasome complex	-	17	15	-	-	6.90E-02	7.08E-04
APID	CC	GO:0098643	banded collagen fibril	-	12	11	-	-	5.92E-03	5.31E-04
APID	CC	GO:0097542	ciliary tip	-	48	48	-	-	1.44E-01	2.30E-03
APID	CC	GO:1905368	peptidase complex	-	124	120	-	-	1.45E-01	5.66E-03
APID	CC	GO:0000792	heterochromatin	-	98	97	-	-	1.09E-02	4.60E-03
APID	CC	GO:0097546	ciliary base	-	47	43	-	-	1.04E-02	2.07E-03
APID	CC	GO:0071819	DUBm complex	-	25	23	-	-	2.94E-01	1.12E-03
APID	CC	GO:0031201	SNARE complex	-	48	48	-	-	3.16E-01	2.30E-03
APID	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.98E-03	6.49E-04
APID	CC	GO:0033260	nuclear DNA replication	-	40	38	-	-	9.79E-03	1.83E-03
APID	CC	GO:0044391	ribosomal subunit	-	203	200	-	-	4.22E-01	9.44E-03
APID	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	8.43E-02	5.31E-04
APID	CC	GO:0071013	catalytic step 2 spliceosome	-	88	87	-	-	5.72E-02	4.13E-03
APID	CC	GO:0031907	microbody lumen	-	51	49	-	-	2.06E-02	2.36E-03
APID	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.77E-01	5.31E-04
APID	CC	GO:0098862	cluster of actin-based cell projections	-	162	143	-	-	1.65E-02	6.79E-03
APID	CC	GO:0016363	nuclear matrix	-	127	126	-	-	5.15E-03	5.96E-03
APID	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	1.07E-01	2.18E-03
APID	CC	GO:0032432	actin filament bundle	-	249	231	-	-	1.53E-02	1.09E-02
APID	CC	GO:0008088	axo-dendritic transport	-	78	76	-	-	1.01E-02	3.60E-03
APID	CC	GO:0031519	PcG protein complex	-	38	37	-	-	8.30E-02	1.77E-03
APID	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	39	-	-	5.16E-03	1.89E-03
APID	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	216	-	-	2.62E-02	1.02E-02
APID	CC	GO:0000313	organellar ribosome	-	89	89	-	-	4.90E-01	4.25E-03
APID	CC	GO:0099643	signal release from synapse	-	147	142	-	-	1.71E-02	6.73E-03
APID	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	1.87E-02	2.18E-03
APID	CC	GO:0005818	aster	-	11	11	-	-	1.01E-02	5.31E-04
APID	CC	GO:0030018	Z disc	-	129	124	-	-	1.14E-02	5.90E-03
APID	CC	GO:0032580	Golgi cisterna membrane	-	93	75	-	-	7.13E-03	3.54E-03
APID	CC	GO:0097381	photoreceptor disc membrane	-	25	18	-	-	6.20E-03	8.85E-04
APID	CC	GO:1905360	GTPase complex	-	41	39	-	-	1.53E-01	1.89E-03
APID	CC	GO:0097540	axonemal central pair	-	161	138	-	-	5.62E-03	6.55E-03
APID	CC	GO:0042641	actomyosin	-	77	74	-	-	8.72E-03	3.54E-03
APID	CC	GO:0097386	glial cell projection	-	38	36	-	-	1.57E-03	1.71E-03
APID	CC	GO:0032588	trans-Golgi network membrane	-	102	100	-	-	1.70E-02	4.72E-03
APID	CC	GO:0070382	exocytic vesicle	-	224	217	-	-	1.60E-02	1.03E-02
APID	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	45	-	-	1.85E-02	2.12E-03
APID	CC	GO:0031903	microbody membrane	-	65	63	-	-	1.08E-01	3.01E-03
APID	CC	GO:0046930	pore complex	-	26	24	-	-	1.56E-02	1.18E-03
APID	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	7.85E-03	5.31E-04
APID	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	1.15E-03	7.67E-04
APID	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	241	-	-	1.99E-02	1.14E-02
APID	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	23	-	-	4.01E-03	1.12E-03
APID	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.42E-01	5.31E-04
APID	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	4.50E-03	8.85E-04
APID	CC	GO:0044298	cell body membrane	-	32	31	-	-	1.35E-02	1.48E-03
APID	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	5.53E-02	5.31E-04
APID	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	2.95E-03	1.00E-03
APID	CC	GO:0045495	pole plasm	-	25	20	-	-	2.90E-04	9.44E-04
APID	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	1.79E-03	7.08E-04
APID	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	3.75E-01	9.44E-04
APID	CC	GO:0010369	chromocenter	-	14	14	-	-	8.09E-03	7.08E-04
APID	CC	GO:0002177	manchette	-	19	17	-	-	2.29E-04	8.26E-04
APID	CC	GO:0016323	basolateral plasma membrane	-	239	223	-	-	7.32E-03	1.06E-02
APID	CC	GO:0045009	chitosome	-	21	21	-	-	1.46E-02	1.00E-03
APID	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	4.04E-03	5.90E-04
APID	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	1.19E-02	2.12E-03
APID	CC	GO:0098636	protein complex involved in cell adhesion	-	57	53	-	-	1.69E-02	2.54E-03
APID	CC	GO:0001917	photoreceptor inner segment	-	71	66	-	-	4.27E-03	3.13E-03
APID	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	2.18E-03	7.08E-04
APID	CC	GO:0019897	extrinsic component of plasma membrane	-	156	149	-	-	2.10E-02	7.08E-03
APID	CC	GO:0031594	neuromuscular junction	-	73	72	-	-	4.81E-03	3.42E-03
APID	CC	GO:0045120	pronucleus	-	14	14	-	-	5.00E-04	7.08E-04
APID	CC	GO:0043083	synaptic cleft	-	21	19	-	-	8.02E-02	9.44E-04
APID	CC	GO:0000922	spindle pole	-	172	167	-	-	7.76E-03	7.91E-03
APID	CC	GO:0120111	neuron projection cytoplasm	-	94	90	-	-	2.17E-02	4.25E-03
APID	CC	GO:0070971	endoplasmic reticulum exit site	-	32	28	-	-	6.51E-02	1.36E-03
APID	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	2.19E-01	6.49E-04
APID	CC	GO:0004879	nuclear receptor activity	-	63	61	-	-	1.83E-02	2.89E-03
APID	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	163	-	-	1.68E-02	7.73E-03
APID	CC	GO:0000123	histone acetyltransferase complex	-	93	90	-	-	1.25E-01	4.25E-03
APID	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	6.42E-04	6.49E-04
APID	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	107	-	-	8.57E-02	5.07E-03
APID	CC	GO:0048786	presynaptic active zone	-	80	79	-	-	4.87E-03	3.78E-03
APID	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	1.19E-01	5.90E-04
APID	CC	GO:0007034	vacuolar transport	-	168	163	-	-	2.61E-02	7.73E-03
APID	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	1.19E-02	1.00E-03
APID	CC	GO:0043194	axon initial segment	-	21	20	-	-	2.92E-04	9.44E-04
APID	CC	GO:0005776	autophagosome	-	111	108	-	-	1.59E-02	5.13E-03
APID	CC	GO:0031430	M band	-	22	21	-	-	2.77E-03	1.00E-03
APID	CC	GO:0001931	uropod	-	13	13	-	-	1.71E-02	6.49E-04
APID	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	2.84E-01	3.54E-03
APID	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	95	-	-	1.48E-01	4.48E-03
APID	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	4.20E-01	6.49E-04
APID	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	5.56E-02	9.44E-04
APID	CC	GO:0071203	WASH complex	-	12	12	-	-	3.57E-01	5.90E-04
APID	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	4.64E-02	1.42E-03
APID	CC	GO:0032994	protein-lipid complex	-	39	38	-	-	1.55E-02	1.83E-03
APID	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	147	-	-	8.52E-02	6.96E-03
APID	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	7.87E-03	5.90E-04
APID	CC	GO:0001527	microfibril	-	13	13	-	-	1.18E-01	6.49E-04
APID	CC	GO:0072562	blood microparticle	-	144	120	-	-	5.94E-03	5.66E-03
APID	CC	GO:0005883	neurofilament	-	11	11	-	-	2.88E-02	5.31E-04
APID	CC	GO:0051233	spindle midzone	-	36	35	-	-	6.12E-03	1.65E-03
APID	CC	GO:0005811	lipid droplet	-	102	95	-	-	8.43E-03	4.48E-03
APID	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	1.34E-02	2.12E-03
APID	CC	GO:0043113	receptor clustering	-	51	50	-	-	2.55E-03	2.36E-03
APID	CC	GO:0005940	septin ring	-	14	13	-	-	4.52E-01	6.49E-04
APID	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	7.63E-02	5.31E-04
APID	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	21	-	-	5.08E-02	1.00E-03
APID	CC	GO:0044853	plasma membrane raft	-	114	111	-	-	5.89E-03	5.25E-03
APID	CC	GO:0005881	cytoplasmic microtubule	-	256	224	-	-	6.63E-03	1.06E-02
APID	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	2.37E-03	7.08E-04
APID	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	2.46E-02	8.26E-04
APID	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	56	-	-	4.69E-02	2.66E-03
APID	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	1.63E-02	3.42E-03
APID	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	1.14E-02	5.90E-04
APID	CC	GO:0043034	costamere	-	18	17	-	-	3.68E-03	8.26E-04
APID	CC	GO:0031904	endosome lumen	-	38	36	-	-	1.66E-02	1.71E-03
APID	CC	GO:0060170	ciliary membrane	-	76	62	-	-	2.22E-02	2.95E-03
APID	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	5.69E-01	6.49E-04
APID	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	6.69E-03	5.90E-04
APID	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	1.05E-01	1.18E-03
APID	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	1.82E-01	7.08E-04
APID	CC	GO:0032154	cleavage furrow	-	54	52	-	-	4.95E-03	2.48E-03
APID	CC	GO:0005640	nuclear outer membrane	-	30	25	-	-	8.11E-04	1.18E-03
APID	CC	GO:0005652	nuclear lamina	-	12	12	-	-	1.10E-03	5.90E-04
APID	CC	GO:0007006	mitochondrial membrane organization	-	117	110	-	-	2.62E-02	5.19E-03
APID	CC	GO:0001772	immunological synapse	-	44	44	-	-	5.39E-03	2.12E-03
APID	CC	GO:0030904	retromer complex	-	12	12	-	-	5.88E-02	5.90E-04
APID	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	1.59E-02	5.90E-04
APID	CC	GO:0030863	cortical cytoskeleton	-	104	99	-	-	9.21E-03	4.72E-03
APID	CC	GO:1905348	endonuclease complex	-	38	36	-	-	1.37E-01	1.71E-03
APID	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	2.22E-01	5.31E-04
APID	CC	GO:0030315	T-tubule	-	52	51	-	-	5.80E-03	2.42E-03
APID	CC	GO:0060076	excitatory synapse	-	64	56	-	-	1.37E-02	2.66E-03
APID	CC	GO:0036019	endolysosome	-	29	29	-	-	9.84E-03	1.42E-03
APID	CC	GO:0001891	phagocytic cup	-	28	28	-	-	2.76E-03	1.36E-03
APID	CC	GO:0099086	synaptonemal structure	-	40	38	-	-	3.98E-02	1.83E-03
APID	CC	GO:0030427	site of polarized growth	-	172	169	-	-	4.91E-03	8.02E-03
APID	CC	GO:0044309	neuron spine	-	213	207	-	-	7.09E-03	9.79E-03
APID	CC	GO:0030658	transport vesicle membrane	-	231	226	-	-	2.27E-02	1.07E-02
APID	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	2.78E-03	1.30E-03
APID	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	8.97E-02	5.90E-04
APID	CC	GO:0000940	outer kinetochore	-	17	17	-	-	6.17E-02	8.26E-04
APID	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	1.68E-01	8.26E-04
APID	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	1.41E-02	2.36E-03
APID	CC	GO:0098803	respiratory chain complex	-	39	35	-	-	2.18E-01	1.65E-03
APID	CC	GO:0097545	axonemal outer doublet	-	164	140	-	-	5.17E-03	6.61E-03
APID	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	18	-	-	3.92E-03	8.85E-04
APID	CC	GO:0070069	cytochrome complex	-	42	38	-	-	1.46E-01	1.83E-03
APID	CC	GO:0031143	pseudopodium	-	18	18	-	-	3.33E-03	8.85E-04
APID	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	1.41E-02	1.30E-03
APID	CC	GO:0055037	recycling endosome	-	200	191	-	-	9.11E-03	9.03E-03
APID	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	91	-	-	5.46E-03	4.31E-03
APID	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	5.19E-01	6.49E-04
APID	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	1.13E-03	5.90E-04
APID	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	1.66E-03	1.06E-03
APID	CC	GO:0030684	preribosome	-	76	73	-	-	3.11E-02	3.48E-03
APID	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	2.70E-01	8.85E-04
APID	CC	GO:1990391	DNA repair complex	-	22	22	-	-	1.80E-02	1.06E-03
APID	CC	GO:0005775	vacuolar lumen	-	176	167	-	-	5.50E-03	7.91E-03
APID	CC	GO:0032433	filopodium tip	-	19	19	-	-	4.42E-03	9.44E-04
APID	CC	GO:0032982	myosin filament	-	24	24	-	-	9.65E-03	1.18E-03
APID	CC	GO:0016327	apicolateral plasma membrane	-	23	22	-	-	2.28E-03	1.06E-03
APID	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	1.36E-01	1.12E-03
APID	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	1.73E-04	5.90E-04
APID	CC	GO:0044306	neuron projection terminus	-	164	156	-	-	6.28E-03	7.38E-03
APID	CC	GO:0034455	t-UTP complex	-	53	51	-	-	3.10E-02	2.42E-03
APID	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	8.79E-01	8.26E-04
APID	CC	GO:0031970	organelle envelope lumen	-	94	90	-	-	1.08E-02	4.25E-03
APID	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	2.79E-02	6.49E-04
APID	CC	GO:0120293	dynein axonemal particle	-	20	18	-	-	1.46E-03	8.85E-04
APID	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	2.13E-03	1.18E-03
APID	CC	GO:0043292	contractile muscle fiber	-	245	235	-	-	1.94E-02	1.11E-02
APID	CC	GO:0018995	host cellular component	-	12	12	-	-	9.25E-03	5.90E-04
APID	CC	GO:0034709	methylosome	-	13	13	-	-	3.67E-02	6.49E-04
APID	CC	GO:0032426	stereocilium tip	-	21	16	-	-	4.35E-03	7.67E-04
APID	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	6.52E-03	5.90E-04
APID	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	1.54E-01	9.44E-04
APID	CC	GO:0000803	sex chromosome	-	32	29	-	-	3.37E-03	1.42E-03
APID	CC	GO:0098982	GABA-ergic synapse	-	84	75	-	-	2.17E-02	3.54E-03
APID	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	1.56E-01	7.67E-04
APID	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	5.50E-02	3.01E-03
APID	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	3.21E-01	7.08E-04
APID	CC	GO:0000242	pericentriolar material	-	22	22	-	-	6.33E-03	1.06E-03
APID	CC	GO:1903293	phosphatase complex	-	54	53	-	-	3.80E-02	2.54E-03
APID	CC	GO:0097470	ribbon synapse	-	13	13	-	-	1.81E-03	6.49E-04
APID	CC	GO:0031941	filamentous actin	-	27	26	-	-	1.36E-03	1.24E-03
APID	CC	GO:0000786	nucleosome	-	149	102	-	-	2.12E-02	4.84E-03
APID	CC	GO:0001533	cornified envelope	-	59	55	-	-	8.80E-03	2.60E-03
APID	CC	GO:1904724	tertiary granule lumen	-	55	53	-	-	1.81E-03	2.54E-03
APID	CC	GO:0030027	lamellipodium	-	202	199	-	-	1.03E-02	9.44E-03
APID	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	6.58E-03	7.08E-04
APID	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	25	-	-	3.25E-02	1.18E-03
APID	CC	GO:0000800	lateral element	-	14	14	-	-	1.18E-02	7.08E-04
APID	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	3.71E-03	5.90E-04
APID	CC	GO:0060077	inhibitory synapse	-	20	19	-	-	8.25E-02	9.44E-04
APID	CC	GO:0031209	SCAR complex	-	12	12	-	-	3.95E-02	5.90E-04
APID	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	3.67E-01	7.67E-04
APID	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	20	-	-	6.57E-02	9.44E-04
APID	CC	GO:0002102	podosome	-	31	31	-	-	2.66E-03	1.48E-03
APID	CC	GO:0090543	Flemming body	-	33	32	-	-	2.05E-02	1.53E-03
APID	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	4.96E-03	3.13E-03
APID	CC	GO:0001650	fibrillar center	-	151	148	-	-	4.57E-03	7.02E-03
APID	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	3.22E-02	7.08E-04
APID	CC	GO:1990204	oxidoreductase complex	-	90	84	-	-	8.94E-02	4.01E-03
APID	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	1.13E-01	7.67E-04
APID	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	7.22E-01	5.31E-04
APID	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	4.58E-03	5.90E-03
APID	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	1.57E-01	8.85E-04
APID	CC	GO:0001726	ruffle	-	181	179	-	-	7.24E-03	8.50E-03
APID	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	3.37E-03	6.49E-04
APID	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	7.17E-02	8.85E-04
APID	CC	GO:0043198	dendritic shaft	-	38	37	-	-	1.01E-03	1.77E-03
APID	CC	GO:0043073	germ cell nucleus	-	67	64	-	-	2.27E-03	3.07E-03
APID	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	8.75E-03	1.00E-03
APID	CC	GO:0016592	mediator complex	-	38	38	-	-	7.33E-01	1.83E-03
APID	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	4.04E-02	9.44E-04
APID	CC	GO:0022626	cytosolic ribosome	-	118	115	-	-	3.05E-01	5.43E-03
APID	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	7.37E-02	2.12E-03
APID	CC	GO:0034451	centriolar satellite	-	120	117	-	-	1.19E-02	5.55E-03
APID	CC	GO:0045171	intercellular bridge	-	91	90	-	-	1.54E-02	4.25E-03
APID	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	80	-	-	1.33E-02	3.78E-03
APID	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	3.69E-02	7.08E-04
APID	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.89E-02	5.31E-04
APID	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	5.18E-02	5.31E-04
APID	CC	GO:0044292	dendrite terminus	-	13	13	-	-	1.14E-03	6.49E-04
APID	CC	GO:0032039	integrator complex	-	19	18	-	-	3.41E-01	8.85E-04
APID	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	2.40E-03	7.08E-04
APID	CC	GO:0033268	node of Ranvier	-	16	15	-	-	2.32E-04	7.08E-04
APID	CC	GO:0036038	MKS complex	-	13	13	-	-	9.98E-03	6.49E-04
APID	CC	GO:0030527	structural constituent of chromatin	-	97	51	-	-	8.71E-03	2.42E-03
APID	CC	GO:0036379	myofilament	-	26	24	-	-	2.74E-02	1.18E-03
APID	CC	GO:0030286	dynein complex	-	210	182	-	-	1.09E-02	8.61E-03
APID	CC	GO:0031105	septin complex	-	14	13	-	-	4.63E-01	6.49E-04
APID	CC	GO:0097228	sperm principal piece	-	33	26	-	-	1.79E-02	1.24E-03
APID	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	8.87E-03	5.90E-04
APID	CC	GO:0016482	cytosolic transport	-	135	133	-	-	1.33E-02	6.31E-03
APID	CC	GO:0090665	glycoprotein complex	-	23	21	-	-	3.07E-02	1.00E-03
APID	CC	GO:0005796	Golgi lumen	-	106	90	-	-	5.88E-03	4.25E-03
APID	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	36	-	-	1.69E-01	1.71E-03
APID	CC	GO:0034358	plasma lipoprotein particle	-	36	35	-	-	2.01E-02	1.65E-03
APID	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	1.05E-01	2.24E-03
APID	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	24	-	-	6.14E-03	1.18E-03
APID	CC	GO:0030662	coated vesicle membrane	-	202	199	-	-	3.11E-02	9.44E-03
APID	CC	GO:0007039	protein catabolic process in the vacuole	-	61	59	-	-	7.03E-02	2.83E-03
APID	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	65	-	-	2.50E-01	3.07E-03
APID	CC	GO:0090734	site of DNA damage	-	118	116	-	-	2.26E-02	5.49E-03
APID	MF	GO:0051861	glycolipid binding	-	30	30	-	-	4.78E-03	1.42E-03
APID	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.75E-04	5.31E-04
APID	MF	GO:0051087	protein-folding chaperone binding	-	135	131	-	-	4.43E-03	6.20E-03
APID	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	5.93E-03	1.30E-03
APID	CC	GO:0015464	acetylcholine receptor activity	-	21	17	-	-	1.95E-02	8.26E-04
APID	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	5.29E-03	5.90E-04
APID	MF	GO:0016594	glycine binding	-	12	12	-	-	2.87E-02	5.90E-04
APID	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	2.88E-04	9.44E-04
APID	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	1.06E-03	1.77E-03
APID	MF	GO:0035613	RNA stem-loop binding	-	21	17	-	-	2.23E-03	8.26E-04
APID	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	231	-	-	7.70E-03	1.09E-02
APID	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	2.87E-04	9.44E-04
APID	MF	GO:0033691	sialic acid binding	-	22	20	-	-	2.81E-02	9.44E-04
APID	MF	GO:0048306	calcium-dependent protein binding	-	61	58	-	-	1.72E-02	2.77E-03
APID	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	2.16E-02	1.36E-03
APID	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	9.82E-02	6.49E-04
APID	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	134	-	-	6.58E-03	6.37E-03
APID	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	59	-	-	8.39E-02	2.83E-03
APID	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	126	-	-	1.55E-02	5.96E-03
APID	MF	GO:0045504	dynein heavy chain binding	-	16	14	-	-	1.04E-01	7.08E-04
APID	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	3.31E-02	1.42E-03
APID	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	3.88E-03	1.06E-03
APID	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	2.70E-03	7.08E-04
APID	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	2.80E-02	7.08E-04
APID	MF	GO:0061980	regulatory RNA binding	-	52	44	-	-	9.58E-03	2.12E-03
APID	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	7.93E-03	1.53E-03
APID	MF	GO:0000182	rDNA binding	-	11	11	-	-	5.87E-03	5.31E-04
APID	MF	GO:0001671	ATPase activator activity	-	29	28	-	-	1.22E-03	1.36E-03
APID	MF	GO:0070840	dynein complex binding	-	25	23	-	-	2.21E-03	1.12E-03
APID	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.09E-03	1.18E-03
APID	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	7.81E-04	7.67E-04
APID	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	1.85E-03	1.65E-03
APID	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	3.54E-02	8.85E-04
APID	MF	GO:0005178	integrin binding	-	153	147	-	-	2.35E-02	6.96E-03
APID	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	5.93E-04	8.26E-04
APID	MF	GO:0005549	odorant binding	-	128	19	-	-	6.69E-02	9.44E-04
APID	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.45E-02	7.08E-04
APID	MF	GO:0008327	methyl-CpG binding	-	31	28	-	-	6.09E-03	1.36E-03
APID	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	1.94E-03	9.44E-04
APID	MF	GO:0048019	receptor antagonist activity	-	31	18	-	-	4.52E-04	8.85E-04
APID	MF	GO:0005521	lamin binding	-	15	15	-	-	3.63E-03	7.08E-04
APID	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	4.72E-03	8.26E-04
APID	MF	GO:0140318	protein transporter activity	-	40	40	-	-	5.33E-02	1.89E-03
APID	MF	GO:0070628	proteasome binding	-	17	17	-	-	5.15E-03	8.26E-04
APID	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	1.46E-02	5.31E-04
APID	MF	GO:0031432	titin binding	-	13	11	-	-	4.55E-03	5.31E-04
APID	MF	GO:0046812	host cell surface binding	-	11	11	-	-	2.24E-03	5.31E-04
APID	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	5.32E-03	1.77E-03
APID	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	2.34E-04	8.26E-04
APID	MF	GO:0002039	p53 binding	-	66	65	-	-	2.70E-03	3.07E-03
APID	MF	GO:0005496	steroid binding	-	110	102	-	-	6.76E-03	4.84E-03
APID	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	3.31E-02	1.30E-03
APID	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.74E-04	5.31E-04
APID	MF	GO:0003684	damaged DNA binding	-	89	84	-	-	2.19E-02	4.01E-03
APID	MF	GO:0000339	RNA cap binding	-	20	19	-	-	1.83E-02	9.44E-04
APID	MF	GO:0016500	protein-hormone receptor activity	-	21	16	-	-	5.88E-03	7.67E-04
APID	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	123	-	-	1.60E-02	5.84E-03
APID	MF	GO:0005523	tropomyosin binding	-	15	14	-	-	4.32E-03	7.08E-04
APID	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	2.86E-03	5.90E-04
APID	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	3.41E-02	5.31E-04
APID	MF	GO:0070063	RNA polymerase binding	-	61	59	-	-	2.91E-03	2.83E-03
APID	MF	GO:0050811	GABA receptor binding	-	18	16	-	-	5.12E-03	7.67E-04
APID	MF	GO:0030971	receptor tyrosine kinase binding	-	76	71	-	-	2.79E-03	3.36E-03
APID	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	82	-	-	4.12E-02	3.89E-03
APID	MF	GO:0140030	modification-dependent protein binding	-	179	176	-	-	7.08E-03	8.32E-03
APID	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	2.91E-04	1.18E-03
APID	MF	GO:0009881	photoreceptor activity	-	17	11	-	-	1.05E-03	5.31E-04
APID	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	17	-	-	5.13E-02	8.26E-04
APID	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	5.83E-04	6.49E-04
APID	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	8.61E-03	7.67E-04
APID	MF	GO:0141047	molecular tag activity	-	13	13	-	-	4.40E-04	6.49E-04
APID	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.30E-02	5.31E-04
APID	MF	GO:0033130	acetylcholine receptor binding	-	12	11	-	-	1.75E-04	5.31E-04
APID	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	1.26E-03	7.08E-04
APID	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	3.90E-02	5.90E-04
APID	MF	GO:0044548	S100 protein binding	-	14	14	-	-	6.34E-03	7.08E-04
APID	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	1.73E-04	7.08E-04
APID	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.86E-02	7.08E-04
APID	MF	GO:0030276	clathrin binding	-	70	69	-	-	3.85E-02	3.30E-03
APID	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	3.13E-03	1.42E-03
APID	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	6.50E-04	7.08E-04
APID	MF	GO:0046790	virion binding	-	19	17	-	-	2.98E-03	8.26E-04
APID	MF	GO:0030552	cAMP binding	-	48	44	-	-	9.97E-03	2.12E-03
APID	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	1.34E-03	1.83E-03
APID	MF	GO:0035173	histone kinase activity	-	17	17	-	-	8.86E-04	8.26E-04
APID	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	8.31E-03	1.24E-03
APID	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	4.89E-02	5.90E-04
APID	MF	GO:0004984	olfactory receptor activity	-	429	62	-	-	7.66E-04	2.95E-03
APID	MF	GO:0016209	antioxidant activity	-	92	85	-	-	1.03E-02	4.01E-03
APID	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	3.11E-03	1.42E-03
APID	MF	GO:0044325	transmembrane transporter binding	-	159	148	-	-	5.70E-03	7.02E-03
APID	MF	GO:0048156	tau protein binding	-	43	43	-	-	1.52E-03	2.07E-03
APID	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	3.78E-02	1.71E-03
APID	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	4.14E-03	6.49E-04
APID	MF	GO:0140272	exogenous protein binding	-	79	77	-	-	5.68E-03	3.66E-03
APID	MF	GO:0030145	manganese ion binding	-	65	64	-	-	1.99E-03	3.07E-03
APID	MF	GO:0071814	protein-lipid complex binding	-	52	46	-	-	7.88E-03	2.18E-03
APID	MF	GO:0008066	glutamate receptor activity	-	70	64	-	-	1.08E-02	3.07E-03
APID	MF	GO:0017069	snRNA binding	-	54	46	-	-	3.19E-02	2.18E-03
APID	MF	GO:0030215	semaphorin receptor binding	-	23	21	-	-	2.11E-02	1.00E-03
APID	MF	GO:0031996	thioesterase binding	-	11	11	-	-	1.19E-03	5.31E-04
APID	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	1.48E-02	1.48E-03
APID	MF	GO:0019843	rRNA binding	-	69	68	-	-	1.97E-02	3.25E-03
APID	MF	GO:0004713	protein tyrosine kinase activity	-	213	210	-	-	1.56E-02	9.91E-03
APID	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	3.60E-03	2.42E-03
APID	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.35E-03	1.18E-03
APID	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	2.89E-04	9.44E-04
APID	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	26	-	-	3.24E-03	1.24E-03
APID	MF	GO:0016208	AMP binding	-	22	22	-	-	2.09E-02	1.06E-03
APID	MF	GO:0000287	magnesium ion binding	-	225	213	-	-	5.43E-03	1.01E-02
APID	MF	GO:0031490	chromatin DNA binding	-	120	116	-	-	7.32E-03	5.49E-03
APID	MF	GO:0017022	myosin binding	-	73	70	-	-	3.27E-03	3.30E-03
APID	MF	GO:0004896	cytokine receptor activity	-	93	86	-	-	1.28E-02	4.07E-03
APID	MF	GO:0017166	vinculin binding	-	12	12	-	-	9.82E-03	5.90E-04
APID	MF	GO:0008301	"DNA binding, bending"	-	18	17	-	-	3.65E-03	8.26E-04
APID	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	1.63E-02	5.90E-04
APID	MF	GO:0005539	glycosaminoglycan binding	-	236	215	-	-	1.53E-02	1.01E-02
APID	MF	GO:0140666	annealing activity	-	11	11	-	-	6.97E-04	5.31E-04
APID	MF	GO:0071933	Arp2/3 complex binding	-	14	12	-	-	1.72E-04	5.90E-04
APID	MF	GO:0010181	FMN binding	-	15	15	-	-	2.71E-03	7.08E-04
APID	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	17	-	-	2.31E-04	8.26E-04
APID	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	23	-	-	1.91E-03	1.12E-03
APID	MF	GO:0031420	alkali metal ion binding	-	17	16	-	-	2.31E-04	7.67E-04
APID	MF	GO:0044183	protein folding chaperone	-	67	63	-	-	2.09E-03	3.01E-03
APID	MF	GO:0005132	type I interferon receptor binding	-	17	15	-	-	3.04E-01	7.08E-04
APID	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	107	-	-	1.21E-02	5.07E-03
APID	MF	GO:0003725	double-stranded RNA binding	-	72	68	-	-	7.87E-03	3.25E-03
APID	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	2.42E-01	7.67E-04
APID	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	3.78E-02	2.48E-03
APID	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	2.08E-03	1.65E-03
APID	MF	GO:0004618	phosphoglycerate kinase activity	-	89	88	-	-	7.38E-03	4.19E-03
APID	MF	GO:0042805	actinin binding	-	36	36	-	-	3.56E-03	1.71E-03
APID	MF	GO:0043531	ADP binding	-	38	38	-	-	1.84E-03	1.83E-03
APID	MF	GO:0043394	proteoglycan binding	-	36	34	-	-	2.92E-03	1.65E-03
APID	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	2.11E-02	5.31E-04
APID	MF	GO:0046332	SMAD binding	-	77	75	-	-	1.37E-02	3.54E-03
APID	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.28E-03	6.49E-04
APID	MF	GO:0001968	fibronectin binding	-	30	30	-	-	3.95E-03	1.42E-03
APID	MF	GO:0048038	quinone binding	-	16	15	-	-	9.80E-03	7.08E-04
APID	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	120	-	-	2.60E-02	5.66E-03
APID	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	78	-	-	3.44E-03	3.72E-03
APID	MF	GO:0003756	protein disulfide isomerase activity	-	18	17	-	-	1.31E-03	8.26E-04
APID	MF	GO:0051117	ATPase binding	-	85	83	-	-	4.64E-03	3.95E-03
APID	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	3.09E-03	2.18E-03
APID	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	4.29E-03	9.44E-04
APID	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	8.07E-03	5.31E-04
APID	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.34E-04	7.08E-04
APID	MF	GO:0031404	chloride ion binding	-	14	12	-	-	1.76E-04	5.90E-04
APID	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	1.01E-02	2.89E-03
APID	MF	GO:0036002	pre-mRNA binding	-	57	36	-	-	1.59E-02	1.71E-03
APID	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	34	-	-	4.80E-04	1.65E-03
APID	MF	GO:0051540	metal cluster binding	-	71	68	-	-	4.79E-03	3.25E-03
APID	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	1.46E-03	5.31E-04
APID	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	4.19E-03	4.37E-03
APID	MF	GO:0019894	kinesin binding	-	45	44	-	-	7.37E-03	2.12E-03
APID	MF	GO:0042287	MHC protein binding	-	68	55	-	-	4.73E-02	2.60E-03
APID	MF	GO:0019003	GDP binding	-	89	88	-	-	1.53E-02	4.19E-03
APID	MF	GO:0017171	serine hydrolase activity	-	207	173	-	-	9.12E-03	8.20E-03
APID	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	4.21E-03	3.13E-03
APID	MF	GO:0003774	cytoskeletal motor activity	-	117	112	-	-	6.34E-03	5.31E-03
APID	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	4.26E-03	1.42E-03
APID	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	2.29E-03	8.26E-04
APID	MF	GO:0061134	peptidase regulator activity	-	224	196	-	-	6.23E-03	9.26E-03
APID	MF	GO:0008013	beta-catenin binding	-	86	83	-	-	6.99E-03	3.95E-03
APID	MF	GO:0051015	actin filament binding	-	208	201	-	-	2.66E-02	9.50E-03
APID	MF	GO:0019208	phosphatase regulator activity	-	107	98	-	-	8.50E-03	4.66E-03
APID	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	30	-	-	6.20E-03	1.42E-03
APID	MF	GO:0043236	laminin binding	-	29	27	-	-	5.46E-03	1.30E-03
APID	MF	GO:0030507	spectrin binding	-	26	26	-	-	4.38E-03	1.24E-03
APID	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	4.56E-03	1.95E-03
APID	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	113	-	-	2.65E-02	5.37E-03
APID	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	7.93E-03	1.18E-03
APID	MF	GO:0042393	histone binding	-	240	228	-	-	1.87E-02	1.08E-02
APID	MF	GO:0019838	growth factor binding	-	182	176	-	-	8.69E-03	8.32E-03
APID	MF	GO:0000149	SNARE binding	-	107	105	-	-	5.96E-02	4.96E-03
APID	MF	GO:0003727	single-stranded RNA binding	-	90	83	-	-	4.77E-03	3.95E-03
APID	MF	GO:0051378	serotonin binding	-	24	20	-	-	5.55E-03	9.44E-04
APID	MF	GO:0005516	calmodulin binding	-	206	200	-	-	6.53E-03	9.44E-03
APID	MF	GO:0019825	oxygen binding	-	40	36	-	-	2.34E-02	1.71E-03
APID	MF	GO:0045505	dynein intermediate chain binding	-	37	36	-	-	1.10E-02	1.71E-03
APID	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	85	-	-	1.53E-03	4.01E-03
APID	MF	GO:0032182	ubiquitin-like protein binding	-	117	115	-	-	7.61E-03	5.43E-03
APID	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	2.26E-02	1.71E-03
APID	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	4.55E-03	1.06E-03
APID	MF	GO:0043274	phospholipase binding	-	23	22	-	-	2.85E-03	1.06E-03
APID	MF	GO:0031072	heat shock protein binding	-	128	124	-	-	5.93E-03	5.90E-03
APID	MF	GO:0030515	snoRNA binding	-	33	33	-	-	2.03E-02	1.59E-03
APID	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	66	-	-	3.12E-02	3.13E-03
APID	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	20	-	-	1.38E-02	9.44E-04
APID	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	3.41E-04	1.24E-03
APID	MF	GO:0001530	lipopolysaccharide binding	-	38	30	-	-	4.55E-03	1.42E-03
APID	MF	GO:0140223	general transcription initiation factor activity	-	55	53	-	-	2.55E-01	2.54E-03
APID	MF	GO:0070403	NAD+ binding	-	16	15	-	-	1.85E-03	7.08E-04
APID	MF	GO:0000049	tRNA binding	-	75	70	-	-	1.40E-02	3.30E-03
APID	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	8.31E-03	2.12E-03
APID	MF	GO:0015026	coreceptor activity	-	48	43	-	-	1.75E-02	2.07E-03
APID	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.71E-04	5.90E-04
APID	MF	GO:0001653	peptide receptor activity	-	128	101	-	-	8.17E-03	4.78E-03
APID	MF	GO:0031005	filamin binding	-	15	14	-	-	2.81E-03	7.08E-04
APID	MF	GO:0030506	ankyrin binding	-	19	19	-	-	1.08E-03	9.44E-04
APID	MF	GO:0006469	negative regulation of protein kinase activity	-	222	205	-	-	4.09E-03	9.68E-03
APID	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	1.34E-03	9.44E-04
APID	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	2.32E-04	7.08E-04
APID	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	1.05E-02	1.48E-03
APID	MF	GO:0051427	hormone receptor binding	-	31	27	-	-	1.54E-03	1.30E-03
APID	MF	GO:0070851	growth factor receptor binding	-	141	136	-	-	7.72E-03	6.43E-03
APID	MF	GO:0031210	phosphatidylcholine binding	-	32	31	-	-	2.14E-02	1.48E-03
APID	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	42	-	-	5.84E-03	2.01E-03
APID	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	1.03E-03	9.44E-04
APID	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	2.10E-03	8.26E-04
APID	MF	GO:0005506	iron ion binding	-	154	133	-	-	3.22E-02	6.31E-03
APID	MF	GO:0003925	G protein activity	-	45	44	-	-	3.59E-03	2.12E-03
APID	MF	GO:0038187	pattern recognition receptor activity	-	33	30	-	-	2.94E-03	1.42E-03
APID	MF	GO:0008276	protein methyltransferase activity	-	96	89	-	-	6.08E-03	4.25E-03
APID	MF	GO:0004396	hexokinase activity	-	16	16	-	-	1.86E-01	7.67E-04
APID	MF	GO:0070888	E-box binding	-	59	57	-	-	2.69E-02	2.71E-03
APID	MF	GO:0039706	co-receptor binding	-	14	14	-	-	4.56E-03	7.08E-04
APID	MF	GO:0015399	primary active transmembrane transporter activity	-	190	184	-	-	6.66E-02	8.73E-03
APID	MF	GO:0035254	glutamate receptor binding	-	47	44	-	-	2.11E-03	2.12E-03
APID	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	5.32E-03	1.59E-03
APID	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	2.29E-03	5.31E-04
APID	MF	GO:0043021	ribonucleoprotein complex binding	-	158	155	-	-	6.91E-03	7.32E-03
APID	MF	GO:0030170	pyridoxal phosphate binding	-	56	52	-	-	3.13E-03	2.48E-03
APID	MF	GO:0032393	MHC class I receptor activity	-	15	13	-	-	8.51E-02	6.49E-04
APID	MF	GO:0005112	Notch binding	-	26	23	-	-	1.21E-03	1.12E-03
APID	MF	GO:0048185	activin binding	-	16	16	-	-	4.02E-02	7.67E-04
APID	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	27	-	-	2.98E-03	1.30E-03
APID	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	8.83E-03	5.31E-04
APID	MF	GO:0140299	small molecule sensor activity	-	39	32	-	-	4.54E-02	1.53E-03
APID	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.01E-02	1.06E-03
APID	MF	GO:0016917	GABA receptor activity	-	23	17	-	-	2.52E-01	8.26E-04
APID	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	3.77E-03	7.08E-04
APID	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	24	-	-	2.88E-04	1.18E-03
APID	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	42	-	-	1.17E-02	2.01E-03
APID	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.15E-03	1.18E-03
APID	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	5.50E-03	5.90E-04
APID	MF	GO:0030594	neurotransmitter receptor activity	-	160	139	-	-	2.60E-02	6.61E-03
APID	MF	GO:0034452	dynactin binding	-	12	12	-	-	5.33E-04	5.90E-04
APID	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	6.82E-03	1.18E-03
APID	MF	GO:0120227	acyl-CoA binding	-	22	19	-	-	3.83E-03	9.44E-04
APID	MF	GO:0005507	copper ion binding	-	63	59	-	-	6.26E-03	2.83E-03
APID	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	4.84E-03	1.06E-03
APID	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.20E-02	1.06E-03
APID	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	1.75E-04	5.90E-04
BIND	CC	GO:0005730	nucleolus	3.69E-43	988	524	320	1.64	-	-
BIND	CC	GO:0005615	extracellular space	7.49E-42	3190	1365	1033	1.32	-	-
BIND	CC	GO:0005739	mitochondrion	3.07E-25	1671	735	541	1.36	-	-
BIND	CC	GO:0005768	endosome	7.50E-23	1037	484	336	1.44	-	-
BIND	CC	GO:0005840	ribosome	1.83E-20	222	139	72	1.93	-	-
BIND	CC	GO:0005764	lysosome	2.37E-14	747	340	242	1.41	-	-
BIND	CC	GO:0005815	microtubule organizing center	1.51E-12	843	369	273	1.35	-	-
BIND	CC	GO:0005794	Golgi apparatus	6.16E-11	1636	650	530	1.23	-	-
BIND	CC	GO:0000228	nuclear chromosome	1.65E-10	206	111	67	1.66	-	-
BIND	CC	GO:0005783	endoplasmic reticulum	2.12E-10	2020	782	654	1.20	-	-
BIND	CC	GO:0005635	nuclear envelope	9.14E-08	493	216	160	1.35	-	-
BIND	CC	GO:0005777	peroxisome	5.10E-03	142	62	46	1.35	-	-
BIND	CC	GO:0005929	cilium	2.15E-02	842	242	273	0.89	-	-
BIND	CC	GO:0031012	extracellular matrix	4.43E-02	564	205	183	1.12	-	-
BIND	CC	GO:0005811	lipid droplet	8.32E-01	102	34	33	1.03	-	-
BIND	BP	GO:0012501	programmed cell death	1.33E-100	1954	1064	633	1.68	-	-
BIND	BP	GO:0065003	protein-containing complex assembly	9.18E-81	1648	891	534	1.67	-	-
BIND	BP	GO:0002376	immune system process	1.42E-60	2448	1156	793	1.46	-	-
BIND	BP	GO:0006355	regulation of DNA-templated transcription	1.77E-52	3342	1463	1082	1.35	-	-
BIND	BP	GO:0016071	mRNA metabolic process	4.14E-47	713	415	231	1.80	-	-
BIND	BP	GO:0006886	intracellular protein transport	6.75E-36	664	369	215	1.72	-	-
BIND	BP	GO:0006281	DNA repair	3.50E-32	587	327	190	1.72	-	-
BIND	BP	GO:0030163	protein catabolic process	4.38E-30	990	489	321	1.53	-	-
BIND	BP	GO:0042060	wound healing	8.10E-30	431	253	140	1.81	-	-
BIND	BP	GO:0048870	cell motility	4.22E-29	1659	746	537	1.39	-	-
BIND	BP	GO:0006913	nucleocytoplasmic transport	7.95E-29	326	203	106	1.92	-	-
BIND	BP	GO:0032200	telomere organization	6.27E-28	186	133	60	2.21	-	-
BIND	BP	GO:0007155	cell adhesion	5.70E-27	1444	656	468	1.40	-	-
BIND	BP	GO:0006325	chromatin organization	8.51E-25	720	364	233	1.56	-	-
BIND	BP	GO:0006914	autophagy	6.29E-24	568	299	184	1.63	-	-
BIND	BP	GO:0002181	cytoplasmic translation	3.21E-22	153	108	50	2.18	-	-
BIND	BP	GO:0016192	vesicle-mediated transport	6.64E-22	1894	803	613	1.31	-	-
BIND	BP	GO:0006260	DNA replication	1.00E-21	279	168	90	1.86	-	-
BIND	BP	GO:0006954	inflammatory response	8.79E-19	820	385	266	1.45	-	-
BIND	BP	GO:0098542	defense response to other organism	1.07E-16	1171	511	379	1.35	-	-
BIND	BP	GO:0042254	ribosome biogenesis	3.40E-16	297	164	96	1.71	-	-
BIND	BP	GO:0050877	nervous system process	4.40E-15	1527	360	494	0.73	-	-
BIND	BP	GO:0007059	chromosome segregation	9.10E-14	403	202	130	1.55	-	-
BIND	BP	GO:0007010	cytoskeleton organization	1.40E-13	1639	667	531	1.26	-	-
BIND	BP	GO:0034330	cell junction organization	3.31E-13	727	328	235	1.39	-	-
BIND	BP	GO:0006457	protein folding	9.57E-12	210	116	68	1.71	-	-
BIND	BP	GO:0006091	generation of precursor metabolites and energy	6.82E-11	502	232	163	1.43	-	-
BIND	BP	GO:0006310	DNA recombination	7.30E-11	333	165	108	1.53	-	-
BIND	BP	GO:0072659	protein localization to plasma membrane	1.29E-09	284	141	92	1.53	-	-
BIND	BP	GO:0007163	establishment or maintenance of cell polarity	2.01E-09	227	117	74	1.59	-	-
BIND	BP	GO:0003012	muscle system process	2.49E-09	425	196	138	1.42	-	-
BIND	BP	GO:0007005	mitochondrion organization	1.28E-08	484	216	157	1.38	-	-
BIND	BP	GO:0005975	carbohydrate metabolic process	4.39E-08	551	239	178	1.34	-	-
BIND	BP	GO:0003013	circulatory system process	1.34E-07	584	249	189	1.32	-	-
BIND	BP	GO:0006399	tRNA metabolic process	6.91E-07	196	97	63	1.53	-	-
BIND	BP	GO:0000910	cytokinesis	7.79E-07	186	93	60	1.54	-	-
BIND	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.61E-06	119	64	39	1.66	-	-
BIND	BP	GO:0055086	nucleobase-containing small molecule metabolic process	7.41E-05	729	286	236	1.21	-	-
BIND	BP	GO:0006629	lipid metabolic process	1.01E-03	1355	494	439	1.13	-	-
BIND	BP	GO:0098754	detoxification	1.55E-03	134	61	43	1.41	-	-
BIND	BP	GO:0006520	amino acid metabolic process	2.45E-03	292	119	95	1.26	-	-
BIND	BP	GO:0140053	mitochondrial gene expression	3.29E-03	164	71	53	1.34	-	-
BIND	BP	GO:0140013	meiotic nuclear division	6.67E-03	279	112	90	1.24	-	-
BIND	BP	GO:0006766	vitamin metabolic process	1.27E-02	107	47	35	1.36	-	-
BIND	BP	GO:0022600	digestive system process	1.39E-02	110	48	36	1.35	-	-
BIND	BP	GO:0006486	protein glycosylation	1.48E-02	225	56	73	0.77	-	-
BIND	BP	GO:0055085	transmembrane transport	2.92E-02	1784	619	578	1.07	-	-
BIND	BP	GO:0044782	cilium organization	3.04E-02	399	109	129	0.84	-	-
BIND	BP	GO:0007040	lysosome organization	3.78E-02	107	45	35	1.30	-	-
BIND	BP	GO:0003014	renal system process	3.43E-01	127	46	41	1.12	-	-
BIND	BP	GO:0030198	extracellular matrix organization	3.95E-01	314	109	102	1.07	-	-
BIND	BP	GO:0006790	sulfur compound metabolic process	5.08E-01	320	109	104	1.05	-	-
BIND	BP	GO:0006575	cellular modified amino acid metabolic process	6.94E-01	186	63	60	1.05	-	-
BIND	BP	GO:0007018	microtubule-based movement	7.64E-01	640	211	207	1.02	-	-
BIND	MF	GO:0003723	RNA binding	5.61E-77	1679	895	544	1.65	-	-
BIND	MF	GO:0140096	"catalytic activity, acting on a protein"	1.87E-68	3198	1466	1035	1.42	-	-
BIND	MF	GO:0016740	transferase activity	8.47E-57	3074	1380	995	1.39	-	-
BIND	MF	GO:0003677	DNA binding	2.15E-46	2865	1264	928	1.36	-	-
BIND	MF	GO:0140097	"catalytic activity, acting on DNA"	2.90E-32	383	236	124	1.90	-	-
BIND	MF	GO:0140110	transcription regulator activity	3.82E-25	2033	869	658	1.32	-	-
BIND	MF	GO:0008092	cytoskeletal protein binding	1.28E-21	1023	474	331	1.43	-	-
BIND	MF	GO:0140657	ATP-dependent activity	1.15E-15	729	338	236	1.43	-	-
BIND	MF	GO:0005198	structural molecule activity	3.80E-15	798	363	258	1.40	-	-
BIND	MF	GO:0140098	"catalytic activity, acting on RNA"	1.21E-11	417	201	135	1.49	-	-
BIND	MF	GO:0016491	oxidoreductase activity	2.64E-08	888	365	288	1.27	-	-
BIND	MF	GO:0003924	GTPase activity	6.60E-08	658	278	213	1.30	-	-
BIND	MF	GO:0140104	molecular carrier activity	5.32E-07	105	59	34	1.74	-	-
BIND	MF	GO:0042393	histone binding	5.53E-07	237	114	77	1.49	-	-
BIND	MF	GO:0016874	ligase activity	6.53E-06	283	128	92	1.40	-	-
BIND	MF	GO:0045182	translation regulator activity	1.04E-05	151	75	49	1.53	-	-
BIND	MF	GO:0016853	isomerase activity	1.26E-05	252	115	82	1.41	-	-
BIND	MF	GO:0008289	lipid binding	9.66E-05	836	323	271	1.19	-	-
BIND	MF	GO:0016829	lyase activity	1.45E-03	538	209	174	1.20	-	-
BIND	MF	GO:0038024	cargo receptor activity	1.37E-01	117	30	38	0.79	-	-
BIND	MF	GO:0009975	cyclase activity	1.55E-01	277	101	90	1.13	-	-
BIND	MF	GO:0005215	transporter activity	1.62E-01	1462	449	473	0.95	-	-
BIND	MF	GO:0048018	receptor ligand activity	4.69E-01	504	171	163	1.05	-	-
BIND	MF	GO:0003774	cytoskeletal motor activity	4.87E-01	116	41	38	1.09	-	-
BIND	BP	GO:0008038	neuron recognition	-	46	20	-	-	8.05E-04	2.62E-03
BIND	BP	GO:1905145	cellular response to acetylcholine	-	33	19	-	-	6.51E-04	2.62E-03
BIND	BP	GO:0098780	response to mitochondrial depolarisation	-	21	12	-	-	4.88E-04	1.64E-03
BIND	BP	GO:0051931	regulation of sensory perception	-	36	12	-	-	4.90E-04	1.64E-03
BIND	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	13	-	-	4.22E-02	1.80E-03
BIND	BP	GO:0009268	response to pH	-	43	11	-	-	4.89E-04	1.47E-03
BIND	BP	GO:0045666	positive regulation of neuron differentiation	-	91	38	-	-	2.96E-03	5.07E-03
BIND	BP	GO:0043543	protein acylation	-	107	47	-	-	4.85E-03	6.22E-03
BIND	MF	GO:0051349	positive regulation of lyase activity	-	41	17	-	-	3.95E-02	2.29E-03
BIND	BP	GO:0048679	regulation of axon regeneration	-	28	15	-	-	7.95E-03	1.96E-03
BIND	BP	GO:0022401	negative adaptation of signaling pathway	-	21	12	-	-	4.89E-04	1.64E-03
BIND	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	33	-	-	1.14E-03	4.42E-03
BIND	BP	GO:0071763	nuclear membrane organization	-	44	26	-	-	2.13E-01	3.44E-03
BIND	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	17	-	-	2.65E-03	2.29E-03
BIND	BP	GO:0071806	protein transmembrane transport	-	68	36	-	-	8.22E-02	4.75E-03
BIND	BP	GO:0022038	corpus callosum development	-	25	14	-	-	4.90E-04	1.96E-03
BIND	BP	GO:0043299	leukocyte degranulation	-	82	36	-	-	1.74E-02	4.75E-03
BIND	BP	GO:0048864	stem cell development	-	88	42	-	-	9.97E-03	5.57E-03
BIND	BP	GO:0051651	maintenance of location in cell	-	236	112	-	-	1.17E-02	1.47E-02
BIND	BP	GO:0033119	negative regulation of RNA splicing	-	27	20	-	-	1.34E-02	2.62E-03
BIND	CC	GO:0016197	endosomal transport	-	282	139	-	-	7.41E-02	1.83E-02
BIND	BP	GO:0070663	regulation of leukocyte proliferation	-	268	149	-	-	1.70E-02	1.96E-02
BIND	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	22	-	-	9.33E-03	2.95E-03
BIND	BP	GO:0006949	syncytium formation	-	66	30	-	-	3.01E-03	3.93E-03
BIND	BP	GO:0045861	negative regulation of proteolysis	-	320	150	-	-	6.90E-03	1.96E-02
BIND	BP	GO:0043144	sno(s)RNA processing	-	14	11	-	-	1.05E-02	1.47E-03
BIND	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	23	-	-	8.19E-04	3.11E-03
BIND	BP	GO:0030574	collagen catabolic process	-	45	15	-	-	1.30E-02	1.96E-03
BIND	CC	GO:0006984	ER-nucleus signaling pathway	-	46	27	-	-	4.71E-02	3.60E-03
BIND	BP	GO:0060343	trabecula formation	-	26	16	-	-	6.30E-03	2.13E-03
BIND	BP	GO:0009914	hormone transport	-	315	130	-	-	5.48E-03	1.70E-02
BIND	BP	GO:0140112	extracellular vesicle biogenesis	-	23	16	-	-	9.91E-02	2.13E-03
BIND	BP	GO:0085029	extracellular matrix assembly	-	42	18	-	-	6.45E-04	2.46E-03
BIND	BP	GO:0006413	translational initiation	-	122	72	-	-	2.93E-02	9.49E-03
BIND	BP	GO:1902895	positive regulation of miRNA transcription	-	51	39	-	-	3.74E-03	5.24E-03
BIND	CC	GO:0005200	structural constituent of cytoskeleton	-	112	50	-	-	7.47E-02	6.55E-03
BIND	BP	GO:0030865	cortical cytoskeleton organization	-	51	29	-	-	9.69E-04	3.93E-03
BIND	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	17	-	-	8.83E-03	2.29E-03
BIND	BP	GO:1903036	positive regulation of response to wounding	-	76	46	-	-	1.17E-02	6.06E-03
BIND	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	66	-	-	2.12E-02	8.68E-03
BIND	BP	GO:1903319	positive regulation of protein maturation	-	27	11	-	-	4.88E-04	1.47E-03
BIND	BP	GO:0002263	cell activation involved in immune response	-	304	152	-	-	1.16E-02	2.00E-02
BIND	BP	GO:0021954	central nervous system neuron development	-	85	35	-	-	6.47E-03	4.58E-03
BIND	BP	GO:0055017	cardiac muscle tissue growth	-	92	45	-	-	2.95E-02	5.89E-03
BIND	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	17	-	-	3.80E-03	2.29E-03
BIND	BP	GO:0048524	positive regulation of viral process	-	64	39	-	-	6.47E-03	5.24E-03
BIND	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	14	-	-	4.90E-04	1.96E-03
BIND	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	16	-	-	7.24E-02	2.13E-03
BIND	BP	GO:0098661	inorganic anion transmembrane transport	-	140	37	-	-	1.30E-03	4.91E-03
BIND	BP	GO:0006099	tricarboxylic acid cycle	-	33	17	-	-	6.55E-04	2.29E-03
BIND	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	13	-	-	2.41E-02	1.80E-03
BIND	BP	GO:0009612	response to mechanical stimulus	-	215	117	-	-	1.44E-02	1.54E-02
BIND	BP	GO:0048644	muscle organ morphogenesis	-	81	42	-	-	4.74E-02	5.57E-03
BIND	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	92	-	-	3.88E-02	1.21E-02
BIND	BP	GO:0071542	dopaminergic neuron differentiation	-	36	17	-	-	2.76E-02	2.29E-03
BIND	BP	GO:0140115	export across plasma membrane	-	82	19	-	-	6.67E-03	2.62E-03
BIND	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	21	-	-	9.89E-03	2.78E-03
BIND	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	15	-	-	6.54E-04	1.96E-03
BIND	MF	GO:0003714	transcription corepressor activity	-	190	115	-	-	1.31E-02	1.51E-02
BIND	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	17	-	-	6.49E-04	2.29E-03
BIND	BP	GO:0006304	DNA modification	-	30	17	-	-	8.05E-03	2.29E-03
BIND	MF	GO:0140312	cargo adaptor activity	-	19	13	-	-	3.35E-01	1.80E-03
BIND	BP	GO:0046835	carbohydrate phosphorylation	-	49	23	-	-	2.06E-02	3.11E-03
BIND	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	13	-	-	4.81E-04	1.80E-03
BIND	CC	GO:1905349	ciliary transition zone assembly	-	371	104	-	-	6.28E-03	1.38E-02
BIND	BP	GO:0043523	regulation of neuron apoptotic process	-	218	118	-	-	1.57E-02	1.56E-02
BIND	BP	GO:1902894	negative regulation of miRNA transcription	-	22	16	-	-	6.82E-03	2.13E-03
BIND	BP	GO:0044380	protein localization to cytoskeleton	-	57	32	-	-	1.13E-03	4.26E-03
BIND	BP	GO:0051918	negative regulation of fibrinolysis	-	13	11	-	-	3.20E-02	1.47E-03
BIND	BP	GO:2000209	regulation of anoikis	-	25	19	-	-	2.62E-03	2.62E-03
BIND	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	15	-	-	6.43E-04	1.96E-03
BIND	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	23	-	-	1.41E-03	3.11E-03
BIND	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	38	-	-	6.33E-03	5.07E-03
BIND	CC	GO:0045324	late endosome to vacuole transport	-	37	19	-	-	6.57E-01	2.62E-03
BIND	BP	GO:0043954	cellular component maintenance	-	72	37	-	-	4.46E-03	4.91E-03
BIND	BP	GO:0050435	amyloid-beta metabolic process	-	65	37	-	-	2.55E-02	4.91E-03
BIND	BP	GO:0014823	response to activity	-	70	37	-	-	1.38E-02	4.91E-03
BIND	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	235	-	-	2.57E-02	3.08E-02
BIND	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	12	-	-	6.34E-03	1.64E-03
BIND	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	12	-	-	4.87E-04	1.64E-03
BIND	BP	GO:0034502	protein localization to chromosome	-	130	76	-	-	1.02E-02	9.99E-03
BIND	BP	GO:0048562	embryonic organ morphogenesis	-	295	121	-	-	1.80E-02	1.59E-02
BIND	BP	GO:0019233	sensory perception of pain	-	103	47	-	-	2.44E-02	6.22E-03
BIND	CC	GO:0043574	peroxisomal transport	-	22	15	-	-	4.94E-01	1.96E-03
BIND	BP	GO:0031343	positive regulation of cell killing	-	75	36	-	-	5.86E-02	4.75E-03
BIND	BP	GO:0090077	foam cell differentiation	-	39	20	-	-	8.02E-04	2.62E-03
BIND	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	30	-	-	5.32E-03	3.93E-03
BIND	BP	GO:0017148	negative regulation of translation	-	390	55	-	-	1.31E-02	7.20E-03
BIND	BP	GO:0030220	platelet formation	-	22	15	-	-	6.42E-04	1.96E-03
BIND	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	44	-	-	6.65E-03	5.89E-03
BIND	BP	GO:1903509	liposaccharide metabolic process	-	109	28	-	-	9.78E-04	3.76E-03
BIND	BP	GO:0009582	detection of abiotic stimulus	-	140	43	-	-	3.76E-02	5.73E-03
BIND	CC	GO:0140238	presynaptic endocytosis	-	72	37	-	-	1.42E-02	4.91E-03
BIND	BP	GO:0051236	establishment of RNA localization	-	161	88	-	-	5.66E-02	1.16E-02
BIND	BP	GO:0042178	xenobiotic catabolic process	-	26	12	-	-	2.00E-01	1.64E-03
BIND	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	117	-	-	3.24E-02	1.54E-02
BIND	BP	GO:0034067	protein localization to Golgi apparatus	-	30	14	-	-	4.90E-04	1.96E-03
BIND	BP	GO:0061842	microtubule organizing center localization	-	32	20	-	-	8.12E-04	2.62E-03
BIND	MF	GO:0048018	receptor ligand activity	-	510	171	-	-	1.85E-02	2.24E-02
BIND	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	11	-	-	4.90E-04	1.47E-03
BIND	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	14	-	-	4.91E-04	1.96E-03
BIND	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	25	-	-	2.24E-03	3.27E-03
BIND	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	28	-	-	4.47E-03	3.76E-03
BIND	BP	GO:0050779	RNA destabilization	-	135	50	-	-	1.27E-02	6.55E-03
BIND	BP	GO:0006023	aminoglycan biosynthetic process	-	74	20	-	-	8.15E-04	2.62E-03
BIND	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	30	-	-	1.15E-03	3.93E-03
BIND	BP	GO:0061025	membrane fusion	-	532	231	-	-	7.87E-02	3.03E-02
BIND	BP	GO:0010762	regulation of fibroblast migration	-	40	23	-	-	3.75E-03	3.11E-03
BIND	BP	GO:0090311	regulation of protein deacetylation	-	29	15	-	-	6.45E-04	1.96E-03
BIND	BP	GO:0035272	exocrine system development	-	46	31	-	-	7.38E-03	4.09E-03
BIND	BP	GO:0022406	membrane docking	-	90	58	-	-	1.12E-01	7.69E-03
BIND	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	12	-	-	4.81E-04	1.64E-03
BIND	BP	GO:0050777	negative regulation of immune response	-	196	95	-	-	6.20E-03	1.24E-02
BIND	BP	GO:0016053	organic acid biosynthetic process	-	335	131	-	-	1.46E-02	1.72E-02
BIND	MF	GO:0005035	death receptor activity	-	16	11	-	-	4.80E-02	1.47E-03
BIND	BP	GO:0099068	postsynapse assembly	-	40	14	-	-	4.88E-04	1.96E-03
BIND	BP	GO:0021782	glial cell development	-	120	54	-	-	9.31E-03	7.20E-03
BIND	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	41	-	-	7.51E-03	5.40E-03
BIND	BP	GO:0001655	urogenital system development	-	66	41	-	-	1.11E-02	5.40E-03
BIND	BP	GO:0071827	plasma lipoprotein particle organization	-	86	28	-	-	9.76E-04	3.76E-03
BIND	BP	GO:0055088	lipid homeostasis	-	173	63	-	-	2.80E-03	8.35E-03
BIND	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	13	-	-	4.87E-04	1.80E-03
BIND	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	121	-	-	6.89E-03	1.59E-02
BIND	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	24	-	-	1.03E-02	3.27E-03
BIND	BP	GO:0045667	regulation of osteoblast differentiation	-	147	74	-	-	5.93E-02	9.82E-03
BIND	BP	GO:0050801	monoatomic ion homeostasis	-	609	249	-	-	1.58E-02	3.27E-02
BIND	BP	GO:0061037	negative regulation of cartilage development	-	32	14	-	-	4.74E-04	1.96E-03
BIND	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	212	-	-	2.65E-02	2.78E-02
BIND	BP	GO:0045738	negative regulation of DNA repair	-	40	17	-	-	6.49E-04	2.29E-03
BIND	BP	GO:0001704	formation of primary germ layer	-	195	103	-	-	9.80E-03	1.36E-02
BIND	BP	GO:0045778	positive regulation of ossification	-	51	25	-	-	9.46E-03	3.27E-03
BIND	BP	GO:0048708	astrocyte differentiation	-	88	53	-	-	7.23E-03	7.04E-03
BIND	BP	GO:0042092	type 2 immune response	-	41	20	-	-	7.70E-03	2.62E-03
BIND	BP	GO:0048588	developmental cell growth	-	233	104	-	-	7.47E-03	1.38E-02
BIND	BP	GO:0021872	forebrain generation of neurons	-	52	25	-	-	9.69E-04	3.27E-03
BIND	BP	GO:0045023	G0 to G1 transition	-	41	20	-	-	8.72E-02	2.62E-03
BIND	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	35	-	-	1.54E-02	4.58E-03
BIND	BP	GO:0034367	protein-containing complex remodeling	-	35	18	-	-	6.55E-04	2.46E-03
BIND	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	17	-	-	6.69E-03	2.29E-03
BIND	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	19	-	-	6.55E-04	2.62E-03
BIND	BP	GO:0010232	vascular transport	-	87	27	-	-	9.79E-04	3.60E-03
BIND	BP	GO:0021987	cerebral cortex development	-	125	55	-	-	1.35E-02	7.20E-03
BIND	BP	GO:0008637	apoptotic mitochondrial changes	-	108	61	-	-	5.29E-02	8.02E-03
BIND	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	21	-	-	1.16E-02	2.78E-03
BIND	BP	GO:0060999	positive regulation of dendritic spine development	-	35	12	-	-	4.89E-04	1.64E-03
BIND	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	11	-	-	4.88E-04	1.47E-03
BIND	BP	GO:2000736	regulation of stem cell differentiation	-	78	48	-	-	4.86E-03	6.38E-03
BIND	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	13	-	-	4.89E-04	1.80E-03
BIND	BP	GO:0002064	epithelial cell development	-	210	109	-	-	4.91E-03	1.44E-02
BIND	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	19	-	-	2.56E-02	2.62E-03
BIND	BP	GO:2001222	regulation of neuron migration	-	46	17	-	-	6.51E-04	2.29E-03
BIND	BP	GO:0034389	lipid droplet organization	-	38	13	-	-	4.85E-04	1.80E-03
BIND	BP	GO:0051602	response to electrical stimulus	-	44	19	-	-	3.55E-03	2.62E-03
BIND	BP	GO:0042177	negative regulation of protein catabolic process	-	109	61	-	-	3.39E-03	8.02E-03
BIND	MF	GO:0038024	cargo receptor activity	-	121	30	-	-	2.85E-03	3.93E-03
BIND	BP	GO:0033120	positive regulation of RNA splicing	-	46	25	-	-	1.57E-03	3.27E-03
BIND	BP	GO:0051445	regulation of meiotic cell cycle	-	64	26	-	-	8.60E-03	3.44E-03
BIND	BP	GO:0033619	membrane protein proteolysis	-	60	35	-	-	2.93E-02	4.58E-03
BIND	BP	GO:0090087	regulation of peptide transport	-	195	89	-	-	1.76E-02	1.18E-02
BIND	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	52	-	-	5.96E-03	6.88E-03
BIND	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	12	-	-	4.90E-04	1.64E-03
BIND	BP	GO:0006929	substrate-dependent cell migration	-	26	16	-	-	6.50E-04	2.13E-03
BIND	BP	GO:0072662	protein localization to peroxisome	-	20	13	-	-	3.72E-01	1.80E-03
BIND	BP	GO:0022404	molting cycle process	-	95	47	-	-	7.16E-03	6.22E-03
BIND	BP	GO:1903358	regulation of Golgi organization	-	17	14	-	-	3.07E-02	1.96E-03
BIND	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	13	-	-	6.17E-02	1.80E-03
BIND	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	15	-	-	6.51E-04	1.96E-03
BIND	BP	GO:0007281	germ cell development	-	334	102	-	-	4.20E-03	1.34E-02
BIND	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	109	-	-	7.69E-03	1.44E-02
BIND	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	19	-	-	3.38E-03	2.62E-03
BIND	BP	GO:0034104	negative regulation of tissue remodeling	-	22	11	-	-	4.88E-04	1.47E-03
BIND	CC	GO:0098926	postsynaptic signal transduction	-	39	23	-	-	8.11E-04	3.11E-03
BIND	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	61	-	-	1.07E-02	8.02E-03
BIND	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	26	-	-	9.73E-04	3.44E-03
BIND	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	72	-	-	4.27E-03	9.49E-03
BIND	BP	GO:0034249	negative regulation of amide metabolic process	-	34	15	-	-	6.47E-04	1.96E-03
BIND	BP	GO:0061548	ganglion development	-	17	13	-	-	7.40E-02	1.80E-03
BIND	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	67	-	-	1.25E-02	8.84E-03
BIND	BP	GO:0048799	animal organ maturation	-	33	12	-	-	4.88E-04	1.64E-03
BIND	BP	GO:0006925	inflammatory cell apoptotic process	-	23	12	-	-	4.86E-04	1.64E-03
BIND	BP	GO:0003013	circulatory system process	-	602	249	-	-	2.17E-02	3.27E-02
BIND	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	105	-	-	4.91E-03	1.38E-02
BIND	BP	GO:1903035	negative regulation of response to wounding	-	93	49	-	-	1.00E-02	6.55E-03
BIND	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	17	-	-	6.51E-04	2.29E-03
BIND	BP	GO:0036010	protein localization to endosome	-	27	19	-	-	4.67E-03	2.62E-03
BIND	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	67	-	-	1.08E-02	8.84E-03
BIND	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	54	-	-	5.78E-03	7.20E-03
BIND	BP	GO:0045056	transcytosis	-	20	13	-	-	8.92E-03	1.80E-03
BIND	BP	GO:0009267	cellular response to starvation	-	170	95	-	-	5.44E-03	1.24E-02
BIND	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	32	-	-	3.89E-03	4.26E-03
BIND	CC	GO:0140239	postsynaptic endocytosis	-	23	15	-	-	6.52E-04	1.96E-03
BIND	BP	GO:0046931	pore complex assembly	-	21	12	-	-	4.86E-04	1.64E-03
BIND	CC	GO:0032008	positive regulation of TOR signaling	-	52	22	-	-	3.80E-02	2.95E-03
BIND	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	18	-	-	6.52E-04	2.46E-03
BIND	BP	GO:0060428	lung epithelium development	-	43	27	-	-	1.51E-02	3.60E-03
BIND	BP	GO:0030431	sleep	-	30	17	-	-	6.49E-04	2.29E-03
BIND	BP	GO:1903318	negative regulation of protein maturation	-	29	12	-	-	4.89E-04	1.64E-03
BIND	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	38	-	-	1.31E-03	5.07E-03
BIND	BP	GO:0071732	cellular response to nitric oxide	-	17	14	-	-	3.81E-03	1.96E-03
BIND	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	16	-	-	6.54E-04	2.13E-03
BIND	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	43	-	-	6.34E-03	5.73E-03
BIND	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	13	-	-	4.89E-04	1.80E-03
BIND	BP	GO:0065004	protein-DNA complex assembly	-	307	203	-	-	3.98E-02	2.67E-02
BIND	CC	GO:0006406	mRNA export from nucleus	-	69	42	-	-	8.22E-02	5.57E-03
BIND	BP	GO:0009880	embryonic pattern specification	-	70	30	-	-	2.73E-03	3.93E-03
BIND	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	30	-	-	1.14E-01	3.93E-03
BIND	BP	GO:0002367	cytokine production involved in immune response	-	121	70	-	-	4.15E-02	9.17E-03
BIND	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	11	-	-	4.89E-04	1.47E-03
BIND	BP	GO:0044848	biological phase	-	211	99	-	-	6.71E-02	1.31E-02
BIND	BP	GO:0046660	female sex differentiation	-	125	69	-	-	2.31E-02	9.17E-03
BIND	BP	GO:0019693	ribose phosphate metabolic process	-	556	230	-	-	9.46E-03	3.01E-02
BIND	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	24	-	-	5.88E-03	3.27E-03
BIND	BP	GO:0060411	cardiac septum morphogenesis	-	72	42	-	-	4.61E-03	5.57E-03
BIND	BP	GO:0071248	cellular response to metal ion	-	201	87	-	-	7.78E-03	1.15E-02
BIND	BP	GO:0030308	negative regulation of cell growth	-	191	93	-	-	1.50E-02	1.23E-02
BIND	BP	GO:0097306	cellular response to alcohol	-	99	42	-	-	7.18E-03	5.57E-03
BIND	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	63	-	-	8.62E-03	8.35E-03
BIND	BP	GO:0010453	regulation of cell fate commitment	-	40	23	-	-	9.66E-03	3.11E-03
BIND	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	33	-	-	1.19E-02	4.42E-03
BIND	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	241	-	-	1.88E-02	3.16E-02
BIND	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	22	-	-	8.16E-04	2.95E-03
BIND	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	13	-	-	4.91E-04	1.80E-03
BIND	BP	GO:0032890	regulation of organic acid transport	-	78	37	-	-	1.29E-03	4.91E-03
BIND	BP	GO:0071498	cellular response to fluid shear stress	-	21	15	-	-	8.50E-03	1.96E-03
BIND	BP	GO:0098771	inorganic ion homeostasis	-	531	218	-	-	1.35E-02	2.86E-02
BIND	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	39	-	-	1.79E-03	5.24E-03
BIND	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	13	-	-	1.77E-03	1.80E-03
BIND	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	21	-	-	3.10E-03	2.78E-03
BIND	BP	GO:0051259	protein complex oligomerization	-	251	108	-	-	1.41E-02	1.42E-02
BIND	BP	GO:0098743	cell aggregation	-	24	11	-	-	4.84E-04	1.47E-03
BIND	BP	GO:0009994	oocyte differentiation	-	57	24	-	-	8.04E-04	3.27E-03
BIND	MF	GO:0031952	regulation of protein autophosphorylation	-	43	28	-	-	4.64E-03	3.76E-03
BIND	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	72	-	-	7.21E-03	9.49E-03
BIND	BP	GO:0044319	"wound healing, spreading of cells"	-	37	16	-	-	1.03E-02	2.13E-03
BIND	BP	GO:0033688	regulation of osteoblast proliferation	-	31	17	-	-	1.18E-03	2.29E-03
BIND	BP	GO:0060251	regulation of glial cell proliferation	-	39	23	-	-	1.02E-03	3.11E-03
BIND	BP	GO:0072665	protein localization to vacuole	-	84	44	-	-	5.26E-02	5.89E-03
BIND	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	38	-	-	8.63E-03	5.07E-03
BIND	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	12	-	-	6.72E-03	1.64E-03
BIND	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	38	-	-	1.39E-03	5.07E-03
BIND	BP	GO:0070633	transepithelial transport	-	35	14	-	-	4.89E-04	1.96E-03
BIND	BP	GO:0045661	regulation of myoblast differentiation	-	74	36	-	-	1.99E-02	4.75E-03
BIND	BP	GO:0030307	positive regulation of cell growth	-	164	84	-	-	8.48E-03	1.11E-02
BIND	BP	GO:0034250	positive regulation of amide metabolic process	-	27	16	-	-	4.85E-02	2.13E-03
BIND	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	189	-	-	1.86E-02	2.49E-02
BIND	BP	GO:0014812	muscle cell migration	-	110	53	-	-	1.20E-02	7.04E-03
BIND	BP	GO:0048525	negative regulation of viral process	-	90	44	-	-	9.98E-03	5.89E-03
BIND	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	38	-	-	6.71E-02	5.07E-03
BIND	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	92	-	-	2.15E-02	1.21E-02
BIND	BP	GO:0051781	positive regulation of cell division	-	93	49	-	-	2.87E-03	6.55E-03
BIND	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	12	-	-	4.88E-04	1.64E-03
BIND	BP	GO:0035493	SNARE complex assembly	-	23	12	-	-	1.47E-02	1.64E-03
BIND	BP	GO:0002696	positive regulation of leukocyte activation	-	358	212	-	-	2.73E-02	2.78E-02
BIND	BP	GO:0060711	labyrinthine layer development	-	47	28	-	-	2.04E-03	3.76E-03
BIND	BP	GO:0007272	ensheathment of neurons	-	146	58	-	-	6.24E-03	7.69E-03
BIND	CC	GO:0050806	positive regulation of synaptic transmission	-	171	66	-	-	5.92E-03	8.68E-03
BIND	BP	GO:0060021	roof of mouth development	-	91	40	-	-	1.88E-02	5.24E-03
BIND	BP	GO:0034504	protein localization to nucleus	-	312	199	-	-	1.13E-02	2.62E-02
BIND	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	22	-	-	5.15E-02	2.95E-03
BIND	BP	GO:0050819	negative regulation of coagulation	-	54	34	-	-	6.77E-02	4.58E-03
BIND	BP	GO:0031647	regulation of protein stability	-	327	191	-	-	1.16E-02	2.50E-02
BIND	BP	GO:0017004	cytochrome complex assembly	-	40	12	-	-	4.91E-04	1.64E-03
BIND	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	49	-	-	9.02E-02	6.55E-03
BIND	CC	GO:0050805	negative regulation of synaptic transmission	-	55	24	-	-	7.28E-02	3.27E-03
BIND	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	28	-	-	9.73E-04	3.76E-03
BIND	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	37	-	-	3.10E-03	4.91E-03
BIND	BP	GO:0016054	organic acid catabolic process	-	251	101	-	-	2.13E-02	1.33E-02
BIND	BP	GO:0050890	cognition	-	317	139	-	-	1.40E-02	1.83E-02
BIND	BP	GO:1900048	positive regulation of hemostasis	-	28	19	-	-	1.56E-02	2.62E-03
BIND	BP	GO:0065005	protein-lipid complex assembly	-	29	13	-	-	4.90E-04	1.80E-03
BIND	BP	GO:0008033	tRNA processing	-	136	63	-	-	7.51E-02	8.35E-03
BIND	BP	GO:0046661	male sex differentiation	-	171	97	-	-	7.18E-03	1.28E-02
BIND	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	48	-	-	7.00E-03	6.38E-03
BIND	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	11	-	-	4.87E-04	1.47E-03
BIND	BP	GO:1990778	protein localization to cell periphery	-	346	168	-	-	1.31E-02	2.21E-02
BIND	BP	GO:0061326	renal tubule development	-	103	49	-	-	2.33E-03	6.55E-03
BIND	BP	GO:0051258	protein polymerization	-	280	148	-	-	1.77E-02	1.95E-02
BIND	BP	GO:0071985	multivesicular body sorting pathway	-	56	30	-	-	4.86E-01	3.93E-03
BIND	BP	GO:0060325	face morphogenesis	-	31	15	-	-	6.47E-04	1.96E-03
BIND	BP	GO:0090559	regulation of membrane permeability	-	72	35	-	-	1.34E-02	4.58E-03
BIND	BP	GO:0031579	membrane raft organization	-	25	13	-	-	4.89E-04	1.80E-03
BIND	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	17	-	-	6.89E-03	2.29E-03
BIND	BP	GO:0046460	neutral lipid biosynthetic process	-	50	15	-	-	1.58E-02	1.96E-03
BIND	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	28	-	-	9.81E-04	3.76E-03
BIND	BP	GO:0002250	adaptive immune response	-	753	243	-	-	8.48E-02	3.19E-02
BIND	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	100	-	-	1.23E-02	1.31E-02
BIND	BP	GO:0002251	organ or tissue specific immune response	-	43	19	-	-	3.40E-02	2.62E-03
BIND	CC	GO:0048167	regulation of synaptic plasticity	-	210	90	-	-	2.48E-02	1.18E-02
BIND	BP	GO:1903708	positive regulation of hemopoiesis	-	184	103	-	-	2.09E-02	1.36E-02
BIND	BP	GO:1903008	organelle disassembly	-	154	71	-	-	4.75E-03	9.33E-03
BIND	BP	GO:0001709	cell fate determination	-	44	22	-	-	8.05E-04	2.95E-03
BIND	BP	GO:0045058	T cell selection	-	53	34	-	-	5.91E-02	4.58E-03
BIND	CC	GO:0032387	negative regulation of intracellular transport	-	51	25	-	-	1.08E-02	3.27E-03
BIND	BP	GO:0072091	regulation of stem cell proliferation	-	91	49	-	-	1.98E-03	6.55E-03
BIND	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	15	-	-	6.54E-04	1.96E-03
BIND	BP	GO:0099084	postsynaptic specialization organization	-	44	17	-	-	6.49E-04	2.29E-03
BIND	BP	GO:0032535	regulation of cellular component size	-	360	171	-	-	1.22E-02	2.24E-02
BIND	MF	GO:0031281	positive regulation of cyclase activity	-	40	20	-	-	2.16E-02	2.62E-03
BIND	MF	GO:0098631	cell adhesion mediator activity	-	64	28	-	-	4.52E-02	3.76E-03
BIND	BP	GO:0071453	cellular response to oxygen levels	-	168	92	-	-	5.58E-03	1.21E-02
BIND	BP	GO:0090399	replicative senescence	-	17	12	-	-	1.33E-02	1.64E-03
BIND	BP	GO:0031342	negative regulation of cell killing	-	29	16	-	-	6.50E-04	2.13E-03
BIND	BP	GO:0070585	protein localization to mitochondrion	-	125	70	-	-	7.48E-03	9.17E-03
BIND	BP	GO:0010623	programmed cell death involved in cell development	-	25	18	-	-	4.50E-03	2.46E-03
BIND	BP	GO:0044242	cellular lipid catabolic process	-	224	90	-	-	1.33E-02	1.18E-02
BIND	BP	GO:0002931	response to ischemia	-	58	30	-	-	2.96E-03	3.93E-03
BIND	BP	GO:0043062	extracellular structure organization	-	317	109	-	-	1.05E-02	1.44E-02
BIND	BP	GO:0061005	cell differentiation involved in kidney development	-	58	25	-	-	9.69E-04	3.27E-03
BIND	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	239	-	-	1.33E-02	3.14E-02
BIND	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	33	-	-	1.41E-02	4.42E-03
BIND	BP	GO:0060420	regulation of heart growth	-	74	36	-	-	7.71E-03	4.75E-03
BIND	BP	GO:0009755	hormone-mediated signaling pathway	-	221	133	-	-	1.82E-02	1.75E-02
BIND	BP	GO:0022612	gland morphogenesis	-	124	80	-	-	1.68E-02	1.05E-02
BIND	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	19	-	-	6.50E-04	2.62E-03
BIND	MF	GO:0140416	transcription regulator inhibitor activity	-	26	17	-	-	1.65E-03	2.29E-03
BIND	BP	GO:0044782	cilium organization	-	400	109	-	-	5.70E-03	1.44E-02
BIND	BP	GO:0090130	tissue migration	-	379	194	-	-	1.45E-02	2.55E-02
BIND	BP	GO:1990845	adaptive thermogenesis	-	166	84	-	-	3.60E-03	1.11E-02
BIND	BP	GO:0071320	cellular response to cAMP	-	54	30	-	-	1.04E-02	3.93E-03
BIND	BP	GO:0015844	monoamine transport	-	88	40	-	-	2.40E-02	5.24E-03
BIND	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	12	-	-	4.86E-04	1.64E-03
BIND	BP	GO:0071392	cellular response to estradiol stimulus	-	40	27	-	-	2.50E-03	3.60E-03
BIND	BP	GO:0009314	response to radiation	-	449	245	-	-	1.51E-02	3.21E-02
BIND	BP	GO:0000272	polysaccharide catabolic process	-	19	11	-	-	5.60E-02	1.47E-03
BIND	BP	GO:0009451	RNA modification	-	169	73	-	-	1.54E-02	9.66E-03
BIND	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	23	-	-	8.05E-04	3.11E-03
BIND	BP	GO:1903729	regulation of plasma membrane organization	-	17	14	-	-	4.87E-04	1.96E-03
BIND	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	67	-	-	9.34E-03	8.84E-03
BIND	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	24	-	-	4.08E-03	3.27E-03
BIND	BP	GO:0015807	L-amino acid transport	-	94	24	-	-	8.13E-04	3.27E-03
BIND	BP	GO:0032941	secretion by tissue	-	85	43	-	-	6.09E-03	5.73E-03
BIND	BP	GO:0046605	regulation of centrosome cycle	-	54	28	-	-	7.14E-02	3.76E-03
BIND	BP	GO:0048753	pigment granule organization	-	40	26	-	-	2.90E-01	3.44E-03
BIND	BP	GO:0003014	renal system process	-	130	46	-	-	5.40E-03	6.06E-03
BIND	BP	GO:0045598	regulation of fat cell differentiation	-	148	61	-	-	4.57E-03	8.02E-03
BIND	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	127	-	-	3.32E-02	1.67E-02
BIND	BP	GO:1904646	cellular response to amyloid-beta	-	44	29	-	-	1.12E-02	3.93E-03
BIND	BP	GO:1901863	positive regulation of muscle tissue development	-	24	15	-	-	6.45E-04	1.96E-03
BIND	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	86	-	-	5.27E-02	1.13E-02
BIND	BP	GO:0008340	determination of adult lifespan	-	23	13	-	-	6.42E-03	1.80E-03
BIND	BP	GO:0039694	viral RNA genome replication	-	30	16	-	-	6.49E-04	2.13E-03
BIND	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	16	-	-	7.78E-03	2.13E-03
BIND	BP	GO:0071709	membrane assembly	-	68	28	-	-	2.12E-01	3.76E-03
BIND	BP	GO:0008217	regulation of blood pressure	-	186	72	-	-	4.05E-03	9.49E-03
BIND	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	34	-	-	2.00E-03	4.58E-03
BIND	CC	GO:0042770	signal transduction in response to DNA damage	-	186	121	-	-	1.83E-02	1.59E-02
BIND	BP	GO:0002200	somatic diversification of immune receptors	-	78	53	-	-	2.04E-02	7.04E-03
BIND	BP	GO:0035315	hair cell differentiation	-	52	18	-	-	6.46E-04	2.46E-03
BIND	BP	GO:0048645	animal organ formation	-	62	32	-	-	7.03E-02	4.26E-03
BIND	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	66	-	-	1.47E-02	8.68E-03
BIND	BP	GO:0033627	cell adhesion mediated by integrin	-	87	59	-	-	5.26E-02	7.86E-03
BIND	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	13	-	-	2.00E-01	1.80E-03
BIND	BP	GO:0035107	appendage morphogenesis	-	147	67	-	-	2.80E-02	8.84E-03
BIND	BP	GO:1903707	negative regulation of hemopoiesis	-	116	53	-	-	2.38E-03	7.04E-03
BIND	CC	GO:0048208	COPII vesicle coating	-	27	12	-	-	4.91E-04	1.64E-03
BIND	BP	GO:0030149	sphingolipid catabolic process	-	32	11	-	-	4.90E-04	1.47E-03
BIND	BP	GO:0050994	regulation of lipid catabolic process	-	61	25	-	-	8.16E-03	3.27E-03
BIND	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	14	-	-	4.89E-04	1.96E-03
BIND	BP	GO:0009593	detection of chemical stimulus	-	511	17	-	-	7.06E-03	2.29E-03
BIND	BP	GO:0045727	positive regulation of translation	-	141	79	-	-	3.10E-03	1.05E-02
BIND	CC	GO:0032388	positive regulation of intracellular transport	-	137	83	-	-	3.58E-03	1.10E-02
BIND	BP	GO:0002027	regulation of heart rate	-	106	39	-	-	1.16E-02	5.24E-03
BIND	BP	GO:0050879	multicellular organismal movement	-	118	45	-	-	5.29E-03	5.89E-03
BIND	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	42	-	-	1.44E-03	5.57E-03
BIND	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	37	-	-	7.46E-03	4.91E-03
BIND	BP	GO:0048515	spermatid differentiation	-	208	49	-	-	1.62E-03	6.55E-03
BIND	BP	GO:0072132	mesenchyme morphogenesis	-	57	39	-	-	8.02E-03	5.24E-03
BIND	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	13	-	-	1.96E-02	1.80E-03
BIND	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	17	-	-	6.47E-04	2.29E-03
BIND	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	12	-	-	4.90E-04	1.64E-03
BIND	BP	GO:0060119	inner ear receptor cell development	-	44	12	-	-	4.90E-04	1.64E-03
BIND	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	12	-	-	2.03E-02	1.64E-03
BIND	BP	GO:1901983	regulation of protein acetylation	-	26	12	-	-	4.85E-04	1.64E-03
BIND	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	152	-	-	2.42E-02	2.00E-02
BIND	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	24	-	-	7.57E-03	3.27E-03
BIND	BP	GO:0010883	regulation of lipid storage	-	53	27	-	-	7.61E-03	3.60E-03
BIND	BP	GO:1905954	positive regulation of lipid localization	-	110	45	-	-	5.71E-03	5.89E-03
BIND	BP	GO:0002209	behavioral defense response	-	39	22	-	-	3.18E-03	2.95E-03
BIND	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	17	-	-	1.23E-01	2.29E-03
BIND	BP	GO:0072523	purine-containing compound catabolic process	-	146	58	-	-	4.64E-03	7.69E-03
BIND	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	21	-	-	3.51E-03	2.78E-03
BIND	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	18	-	-	3.19E-03	2.46E-03
BIND	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	45	-	-	5.05E-03	5.89E-03
BIND	BP	GO:0007218	neuropeptide signaling pathway	-	113	27	-	-	2.01E-01	3.60E-03
BIND	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	68	-	-	1.25E-02	9.00E-03
BIND	BP	GO:0031345	negative regulation of cell projection organization	-	195	90	-	-	1.02E-02	1.18E-02
BIND	BP	GO:0048278	vesicle docking	-	64	39	-	-	7.72E-02	5.24E-03
BIND	BP	GO:0035050	embryonic heart tube development	-	86	37	-	-	9.69E-03	4.91E-03
BIND	BP	GO:0030168	platelet activation	-	135	77	-	-	3.25E-02	1.01E-02
BIND	CC	GO:0098810	neurotransmitter reuptake	-	35	13	-	-	1.24E-02	1.80E-03
BIND	BP	GO:0008213	protein alkylation	-	58	25	-	-	7.98E-03	3.27E-03
BIND	BP	GO:0031529	ruffle organization	-	55	28	-	-	1.49E-02	3.76E-03
BIND	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	23	-	-	8.13E-04	3.11E-03
BIND	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	26	-	-	2.27E-02	3.44E-03
BIND	MF	GO:0170055	lipid transmembrane transporter activity	-	56	16	-	-	1.34E-01	2.13E-03
BIND	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	13	-	-	4.90E-04	1.80E-03
BIND	BP	GO:0035304	regulation of protein dephosphorylation	-	87	50	-	-	3.91E-03	6.55E-03
BIND	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	104	-	-	8.14E-03	1.38E-02
BIND	BP	GO:0099637	neurotransmitter receptor transport	-	26	12	-	-	4.90E-04	1.64E-03
BIND	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	17	-	-	7.29E-03	2.29E-03
BIND	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	201	-	-	1.80E-02	2.64E-02
BIND	BP	GO:0051785	positive regulation of nuclear division	-	61	33	-	-	1.12E-03	4.42E-03
BIND	BP	GO:0060749	mammary gland alveolus development	-	20	14	-	-	1.56E-03	1.96E-03
BIND	BP	GO:0044786	cell cycle DNA replication	-	45	33	-	-	4.35E-02	4.42E-03
BIND	BP	GO:0051299	centrosome separation	-	15	11	-	-	4.90E-04	1.47E-03
BIND	BP	GO:0048145	regulation of fibroblast proliferation	-	87	53	-	-	2.02E-03	7.04E-03
BIND	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	33	-	-	1.27E-01	4.42E-03
BIND	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	152	-	-	1.16E-02	2.00E-02
BIND	BP	GO:0009306	protein secretion	-	376	161	-	-	7.21E-03	2.11E-02
BIND	CC	GO:0008333	endosome to lysosome transport	-	73	36	-	-	7.04E-02	4.75E-03
BIND	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	16	-	-	1.06E-02	2.13E-03
BIND	BP	GO:0003016	respiratory system process	-	39	12	-	-	4.87E-04	1.64E-03
BIND	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	13	-	-	4.33E-02	1.80E-03
BIND	BP	GO:0045732	positive regulation of protein catabolic process	-	202	121	-	-	2.59E-02	1.59E-02
BIND	BP	GO:0031589	cell-substrate adhesion	-	360	195	-	-	1.77E-02	2.55E-02
BIND	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	28	-	-	9.82E-04	3.76E-03
BIND	BP	GO:0007588	excretion	-	40	16	-	-	6.54E-04	2.13E-03
BIND	BP	GO:1904018	positive regulation of vasculature development	-	185	91	-	-	9.76E-03	1.19E-02
BIND	BP	GO:0010948	negative regulation of cell cycle process	-	317	175	-	-	3.36E-02	2.29E-02
BIND	BP	GO:0050953	sensory perception of light stimulus	-	223	47	-	-	1.22E-02	6.22E-03
BIND	BP	GO:0009303	rRNA transcription	-	37	23	-	-	1.69E-03	3.11E-03
BIND	BP	GO:0035601	protein deacylation	-	56	29	-	-	1.09E-02	3.93E-03
BIND	BP	GO:0061952	midbody abscission	-	18	11	-	-	7.62E-01	1.47E-03
BIND	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	14	-	-	3.12E-03	1.96E-03
BIND	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	21	-	-	2.08E-03	2.78E-03
BIND	BP	GO:0071300	cellular response to retinoic acid	-	66	27	-	-	9.66E-04	3.60E-03
BIND	BP	GO:0045830	positive regulation of isotype switching	-	28	20	-	-	8.11E-04	2.62E-03
BIND	BP	GO:0031069	hair follicle morphogenesis	-	33	19	-	-	1.01E-02	2.62E-03
BIND	BP	GO:0046697	decidualization	-	26	17	-	-	6.48E-04	2.29E-03
BIND	BP	GO:0048284	organelle fusion	-	456	206	-	-	6.73E-02	2.70E-02
BIND	BP	GO:0051588	regulation of neurotransmitter transport	-	99	36	-	-	6.42E-03	4.75E-03
BIND	BP	GO:0051784	negative regulation of nuclear division	-	63	34	-	-	3.10E-02	4.58E-03
BIND	BP	GO:0044703	multi-organism reproductive process	-	209	108	-	-	7.16E-03	1.42E-02
BIND	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	87	-	-	1.49E-02	1.15E-02
BIND	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	26	-	-	1.35E-02	3.44E-03
BIND	BP	GO:0099022	vesicle tethering	-	32	16	-	-	6.55E-04	2.13E-03
BIND	MF	GO:0004930	G protein-coupled receptor activity	-	873	114	-	-	3.53E-02	1.51E-02
BIND	BP	GO:0048857	neural nucleus development	-	65	29	-	-	1.56E-03	3.93E-03
BIND	BP	GO:0048663	neuron fate commitment	-	74	27	-	-	1.21E-03	3.60E-03
BIND	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	59	-	-	6.34E-03	7.86E-03
BIND	BP	GO:0106027	neuron projection organization	-	90	52	-	-	7.03E-03	6.88E-03
BIND	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	65	-	-	9.18E-03	8.51E-03
BIND	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	23	-	-	2.48E-03	3.11E-03
BIND	BP	GO:0045685	regulation of glial cell differentiation	-	77	38	-	-	6.23E-03	5.07E-03
BIND	BP	GO:0043414	macromolecule methylation	-	138	61	-	-	1.54E-02	8.02E-03
BIND	BP	GO:0050886	endocrine process	-	93	36	-	-	4.23E-03	4.75E-03
BIND	BP	GO:0050951	sensory perception of temperature stimulus	-	28	13	-	-	3.40E-02	1.80E-03
BIND	BP	GO:0045807	positive regulation of endocytosis	-	155	83	-	-	7.47E-03	1.10E-02
BIND	BP	GO:0002418	immune response to tumor cell	-	29	14	-	-	5.04E-02	1.96E-03
BIND	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	41	-	-	3.97E-03	5.40E-03
BIND	BP	GO:0048308	organelle inheritance	-	14	11	-	-	4.29E-02	1.47E-03
BIND	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	13	-	-	1.45E-02	1.80E-03
BIND	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	20	-	-	8.17E-04	2.62E-03
BIND	BP	GO:0034394	protein localization to cell surface	-	69	35	-	-	2.57E-03	4.58E-03
BIND	BP	GO:0009110	vitamin biosynthetic process	-	23	15	-	-	6.51E-04	1.96E-03
BIND	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	16	-	-	4.63E-02	2.13E-03
BIND	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	13	-	-	4.88E-04	1.80E-03
BIND	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	13	-	-	7.67E-04	1.80E-03
BIND	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	63	-	-	3.90E-02	8.35E-03
BIND	MF	GO:0051100	negative regulation of binding	-	161	96	-	-	4.79E-03	1.26E-02
BIND	BP	GO:0001818	negative regulation of cytokine production	-	379	136	-	-	7.28E-03	1.78E-02
BIND	BP	GO:0003151	outflow tract morphogenesis	-	81	45	-	-	1.61E-02	5.89E-03
BIND	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	34	-	-	5.43E-03	4.58E-03
BIND	BP	GO:0055093	response to hyperoxia	-	20	12	-	-	4.87E-04	1.64E-03
BIND	BP	GO:0061036	positive regulation of cartilage development	-	33	13	-	-	1.22E-02	1.80E-03
BIND	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	26	-	-	1.46E-03	3.44E-03
BIND	BP	GO:0046621	negative regulation of organ growth	-	39	18	-	-	3.40E-03	2.46E-03
BIND	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	32	-	-	1.38E-01	4.26E-03
BIND	BP	GO:0032368	regulation of lipid transport	-	149	62	-	-	5.93E-03	8.18E-03
BIND	BP	GO:0055094	response to lipoprotein particle	-	34	13	-	-	6.57E-03	1.80E-03
BIND	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	105	-	-	7.74E-03	1.38E-02
BIND	BP	GO:0033002	muscle cell proliferation	-	249	129	-	-	1.48E-02	1.70E-02
BIND	BP	GO:0048880	sensory system development	-	399	161	-	-	8.23E-03	2.11E-02
BIND	BP	GO:0043331	response to dsRNA	-	56	26	-	-	4.16E-02	3.44E-03
BIND	BP	GO:0051904	pigment granule transport	-	23	13	-	-	1.71E-02	1.80E-03
BIND	BP	GO:1901679	nucleotide transmembrane transport	-	32	12	-	-	4.90E-04	1.64E-03
BIND	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	26	-	-	2.46E-03	3.44E-03
BIND	BP	GO:0033363	secretory granule organization	-	63	27	-	-	1.13E-01	3.60E-03
BIND	BP	GO:0060479	lung cell differentiation	-	28	18	-	-	3.57E-03	2.46E-03
BIND	BP	GO:0120009	intermembrane lipid transfer	-	52	17	-	-	6.54E-04	2.29E-03
BIND	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	24	-	-	7.96E-04	3.27E-03
BIND	BP	GO:0033622	integrin activation	-	26	12	-	-	5.04E-02	1.64E-03
BIND	BP	GO:2000773	negative regulation of cellular senescence	-	25	19	-	-	6.40E-04	2.62E-03
BIND	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	30	-	-	1.28E-02	3.93E-03
BIND	BP	GO:0050820	positive regulation of coagulation	-	30	21	-	-	1.74E-02	2.78E-03
BIND	BP	GO:0072164	mesonephric tubule development	-	98	52	-	-	1.42E-02	6.88E-03
BIND	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	61	-	-	2.83E-02	8.02E-03
BIND	BP	GO:1903524	positive regulation of blood circulation	-	39	13	-	-	4.89E-04	1.80E-03
BIND	BP	GO:0030901	midbrain development	-	87	37	-	-	1.87E-03	4.91E-03
BIND	BP	GO:0007162	negative regulation of cell adhesion	-	310	142	-	-	1.46E-02	1.87E-02
BIND	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	11	-	-	7.80E-03	1.47E-03
BIND	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	42	-	-	6.21E-03	5.57E-03
BIND	BP	GO:0002687	positive regulation of leukocyte migration	-	147	75	-	-	6.79E-03	9.82E-03
BIND	BP	GO:0034605	cellular response to heat	-	66	46	-	-	4.59E-03	6.06E-03
BIND	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	219	-	-	1.61E-02	2.88E-02
BIND	BP	GO:0005996	monosaccharide metabolic process	-	250	127	-	-	1.19E-02	1.67E-02
BIND	BP	GO:0033555	multicellular organismal response to stress	-	90	44	-	-	6.89E-03	5.89E-03
BIND	BP	GO:0002262	myeloid cell homeostasis	-	172	101	-	-	5.62E-03	1.33E-02
BIND	BP	GO:0000966	RNA 5'-end processing	-	39	25	-	-	1.87E-01	3.27E-03
BIND	BP	GO:0050688	regulation of defense response to virus	-	65	32	-	-	5.22E-03	4.26E-03
BIND	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	161	-	-	2.81E-02	2.11E-02
BIND	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	15	-	-	6.46E-04	1.96E-03
BIND	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	171	-	-	1.60E-02	2.24E-02
BIND	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	20	-	-	9.19E-03	2.62E-03
BIND	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	15	-	-	6.47E-04	1.96E-03
BIND	BP	GO:0003272	endocardial cushion formation	-	28	20	-	-	9.84E-03	2.62E-03
BIND	BP	GO:0022618	protein-RNA complex assembly	-	227	128	-	-	6.26E-02	1.69E-02
BIND	BP	GO:0051147	regulation of muscle cell differentiation	-	162	71	-	-	1.79E-02	9.33E-03
BIND	BP	GO:0006066	alcohol metabolic process	-	374	156	-	-	8.36E-03	2.05E-02
BIND	BP	GO:0090102	cochlea development	-	50	19	-	-	6.51E-04	2.62E-03
BIND	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	20	-	-	8.12E-04	2.62E-03
BIND	BP	GO:0045933	positive regulation of muscle contraction	-	49	22	-	-	8.09E-04	2.95E-03
BIND	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	20	-	-	4.78E-03	2.62E-03
BIND	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	25	-	-	2.35E-03	3.27E-03
BIND	BP	GO:0043555	regulation of translation in response to stress	-	22	15	-	-	4.92E-03	1.96E-03
BIND	BP	GO:0032922	circadian regulation of gene expression	-	71	49	-	-	7.27E-03	6.55E-03
BIND	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	26	-	-	4.16E-02	3.44E-03
BIND	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	22	-	-	2.08E-02	2.95E-03
BIND	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	11	-	-	7.38E-02	1.47E-03
BIND	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	33	-	-	1.32E-02	4.42E-03
BIND	BP	GO:0038179	neurotrophin signaling pathway	-	38	24	-	-	3.80E-02	3.27E-03
BIND	BP	GO:0140253	cell-cell fusion	-	62	28	-	-	9.50E-03	3.76E-03
BIND	BP	GO:0071599	otic vesicle development	-	15	11	-	-	2.00E-01	1.47E-03
BIND	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	14	-	-	2.92E-02	1.96E-03
BIND	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	26	-	-	9.83E-04	3.44E-03
BIND	BP	GO:0001941	postsynaptic membrane organization	-	37	12	-	-	4.90E-04	1.64E-03
BIND	BP	GO:0051293	establishment of spindle localization	-	57	32	-	-	5.39E-03	4.26E-03
BIND	BP	GO:0023061	signal release	-	491	195	-	-	1.04E-02	2.55E-02
BIND	BP	GO:0043114	regulation of vascular permeability	-	49	17	-	-	7.25E-03	2.29E-03
BIND	BP	GO:0018126	protein hydroxylation	-	26	14	-	-	4.91E-04	1.96E-03
BIND	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	33	-	-	4.39E-03	4.42E-03
BIND	BP	GO:0008360	regulation of cell shape	-	139	62	-	-	4.94E-03	8.18E-03
BIND	BP	GO:0051222	positive regulation of protein transport	-	249	136	-	-	1.12E-02	1.78E-02
BIND	CC	GO:0140632	canonical inflammasome complex assembly	-	40	23	-	-	2.34E-02	3.11E-03
BIND	MF	GO:0034260	negative regulation of GTPase activity	-	36	17	-	-	1.27E-02	2.29E-03
BIND	BP	GO:0045932	negative regulation of muscle contraction	-	24	11	-	-	5.40E-02	1.47E-03
BIND	BP	GO:0045739	positive regulation of DNA repair	-	128	67	-	-	6.07E-03	8.84E-03
BIND	BP	GO:0045185	maintenance of protein location	-	95	46	-	-	5.32E-03	6.06E-03
BIND	BP	GO:0003158	endothelium development	-	140	72	-	-	3.80E-03	9.49E-03
BIND	CC	GO:0072595	maintenance of protein localization in organelle	-	42	21	-	-	8.07E-04	2.78E-03
BIND	BP	GO:0051224	negative regulation of protein transport	-	122	49	-	-	3.21E-03	6.55E-03
BIND	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	77	-	-	3.22E-03	1.01E-02
BIND	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	12	-	-	1.25E-01	1.64E-03
BIND	MF	GO:0003713	transcription coactivator activity	-	281	163	-	-	1.38E-02	2.14E-02
BIND	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	11	-	-	4.55E-02	1.47E-03
BIND	BP	GO:0021885	forebrain cell migration	-	63	30	-	-	1.75E-02	3.93E-03
BIND	BP	GO:0007405	neuroblast proliferation	-	81	39	-	-	4.02E-03	5.24E-03
BIND	BP	GO:0009581	detection of external stimulus	-	137	40	-	-	1.60E-02	5.24E-03
BIND	BP	GO:1990542	mitochondrial transmembrane transport	-	93	37	-	-	1.31E-03	4.91E-03
BIND	BP	GO:0045862	positive regulation of proteolysis	-	353	206	-	-	1.38E-02	2.70E-02
BIND	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	21	-	-	5.36E-03	2.78E-03
BIND	BP	GO:0031128	developmental induction	-	26	17	-	-	3.52E-02	2.29E-03
BIND	BP	GO:0031100	animal organ regeneration	-	66	48	-	-	9.44E-03	6.38E-03
BIND	BP	GO:0045684	positive regulation of epidermis development	-	33	17	-	-	1.56E-03	2.29E-03
BIND	BP	GO:1900047	negative regulation of hemostasis	-	51	32	-	-	7.38E-02	4.26E-03
BIND	BP	GO:0021517	ventral spinal cord development	-	47	11	-	-	4.89E-04	1.47E-03
BIND	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	52	-	-	4.00E-03	6.88E-03
BIND	BP	GO:0097722	sperm motility	-	133	23	-	-	8.17E-04	3.11E-03
BIND	BP	GO:0042490	mechanoreceptor differentiation	-	67	24	-	-	3.91E-02	3.27E-03
BIND	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	21	-	-	8.27E-03	2.78E-03
BIND	BP	GO:0035148	tube formation	-	155	79	-	-	6.08E-03	1.05E-02
BIND	BP	GO:0048520	positive regulation of behavior	-	27	11	-	-	4.90E-04	1.47E-03
BIND	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	26	-	-	4.16E-03	3.44E-03
BIND	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	52	-	-	3.74E-02	6.88E-03
BIND	BP	GO:0031123	RNA 3'-end processing	-	79	40	-	-	3.97E-02	5.24E-03
BIND	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	49	-	-	3.62E-03	6.55E-03
BIND	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	13	-	-	1.10E-01	1.80E-03
BIND	BP	GO:0045229	external encapsulating structure organization	-	319	109	-	-	1.18E-02	1.44E-02
BIND	BP	GO:0006885	regulation of pH	-	104	34	-	-	1.52E-02	4.58E-03
BIND	BP	GO:0001667	ameboidal-type cell migration	-	495	246	-	-	1.69E-02	3.22E-02
BIND	BP	GO:0002467	germinal center formation	-	14	11	-	-	1.86E-02	1.47E-03
BIND	BP	GO:1990840	response to lectin	-	22	13	-	-	4.78E-04	1.80E-03
BIND	BP	GO:0071800	podosome assembly	-	19	12	-	-	4.86E-04	1.64E-03
BIND	BP	GO:0031018	endocrine pancreas development	-	47	24	-	-	2.28E-03	3.27E-03
BIND	BP	GO:0001708	cell fate specification	-	108	53	-	-	3.11E-03	7.04E-03
BIND	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	47	-	-	1.60E-03	6.22E-03
BIND	BP	GO:0030279	negative regulation of ossification	-	39	16	-	-	6.48E-04	2.13E-03
BIND	BP	GO:0032970	regulation of actin filament-based process	-	368	174	-	-	1.87E-02	2.29E-02
BIND	BP	GO:0042440	pigment metabolic process	-	80	30	-	-	1.14E-03	3.93E-03
BIND	BP	GO:1901606	alpha-amino acid catabolic process	-	101	37	-	-	1.30E-03	4.91E-03
BIND	BP	GO:0062197	cellular response to chemical stress	-	299	162	-	-	9.51E-03	2.13E-02
BIND	BP	GO:1901890	positive regulation of cell junction assembly	-	106	36	-	-	4.01E-03	4.75E-03
BIND	BP	GO:0070988	demethylation	-	27	12	-	-	4.90E-04	1.64E-03
BIND	BP	GO:1901655	cellular response to ketone	-	107	60	-	-	3.18E-03	7.86E-03
BIND	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	12	-	-	5.81E-02	1.64E-03
BIND	BP	GO:0006968	cellular defense response	-	52	17	-	-	6.46E-04	2.29E-03
BIND	BP	GO:0055006	cardiac cell development	-	93	48	-	-	5.80E-03	6.38E-03
BIND	BP	GO:0031365	N-terminal protein amino acid modification	-	30	16	-	-	6.44E-04	2.13E-03
BIND	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	14	-	-	4.88E-04	1.96E-03
BIND	BP	GO:0060004	reflex	-	63	31	-	-	4.04E-03	4.09E-03
BIND	BP	GO:0044706	multi-multicellular organism process	-	217	109	-	-	9.36E-03	1.44E-02
BIND	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	92	-	-	3.07E-02	1.21E-02
BIND	BP	GO:0031294	lymphocyte costimulation	-	47	32	-	-	1.19E-02	4.26E-03
BIND	BP	GO:0050768	negative regulation of neurogenesis	-	150	63	-	-	4.20E-03	8.35E-03
BIND	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	63	-	-	3.67E-03	8.35E-03
BIND	BP	GO:0090068	positive regulation of cell cycle process	-	262	135	-	-	1.00E-02	1.77E-02
BIND	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	14	-	-	4.89E-04	1.96E-03
BIND	MF	GO:0022803	passive transmembrane transporter activity	-	676	197	-	-	2.11E-02	2.59E-02
BIND	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	20	-	-	7.67E-02	2.62E-03
BIND	BP	GO:1902115	regulation of organelle assembly	-	210	108	-	-	1.54E-02	1.42E-02
BIND	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	40	-	-	9.72E-03	5.24E-03
BIND	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	68	-	-	6.09E-03	9.00E-03
BIND	BP	GO:0046622	positive regulation of organ growth	-	52	25	-	-	4.03E-03	3.27E-03
BIND	BP	GO:0051952	regulation of amine transport	-	98	40	-	-	1.01E-02	5.24E-03
BIND	BP	GO:0006730	one-carbon metabolic process	-	24	12	-	-	4.91E-04	1.64E-03
BIND	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	11	-	-	4.90E-04	1.47E-03
BIND	BP	GO:0040019	positive regulation of embryonic development	-	23	11	-	-	4.89E-04	1.47E-03
BIND	CC	GO:0032365	intracellular lipid transport	-	51	16	-	-	1.47E-01	2.13E-03
BIND	BP	GO:0045048	protein insertion into ER membrane	-	30	15	-	-	5.62E-02	1.96E-03
BIND	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	35	-	-	6.09E-03	4.58E-03
BIND	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	67	-	-	7.26E-03	8.84E-03
BIND	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	15	-	-	2.47E-02	1.96E-03
BIND	BP	GO:0071398	cellular response to fatty acid	-	35	20	-	-	7.63E-04	2.62E-03
BIND	BP	GO:0097581	lamellipodium organization	-	91	54	-	-	9.74E-03	7.20E-03
BIND	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	13	-	-	4.91E-04	1.80E-03
BIND	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	85	-	-	7.87E-03	1.11E-02
BIND	BP	GO:0060326	cell chemotaxis	-	311	137	-	-	1.88E-02	1.80E-02
BIND	BP	GO:0015669	gas transport	-	23	12	-	-	6.90E-02	1.64E-03
BIND	BP	GO:0016485	protein processing	-	248	109	-	-	2.83E-02	1.44E-02
BIND	BP	GO:0009649	entrainment of circadian clock	-	30	18	-	-	6.37E-04	2.46E-03
BIND	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	61	-	-	1.82E-02	8.02E-03
BIND	BP	GO:1903523	negative regulation of blood circulation	-	27	11	-	-	1.95E-02	1.47E-03
BIND	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	40	-	-	3.80E-02	5.24E-03
BIND	BP	GO:0099054	presynapse assembly	-	49	12	-	-	8.61E-03	1.64E-03
BIND	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	13	-	-	1.35E-02	1.80E-03
BIND	BP	GO:0031348	negative regulation of defense response	-	282	120	-	-	6.64E-03	1.57E-02
BIND	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	40	-	-	2.13E-03	5.24E-03
BIND	BP	GO:0007606	sensory perception of chemical stimulus	-	535	16	-	-	6.50E-04	2.13E-03
BIND	BP	GO:0061180	mammary gland epithelium development	-	68	42	-	-	4.87E-03	5.57E-03
BIND	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	111	-	-	6.52E-03	1.46E-02
BIND	CC	GO:0051169	nuclear transport	-	325	203	-	-	3.51E-02	2.67E-02
BIND	BP	GO:0071496	cellular response to external stimulus	-	74	45	-	-	6.32E-03	5.89E-03
BIND	BP	GO:0032094	response to food	-	37	13	-	-	4.88E-04	1.80E-03
BIND	BP	GO:0001964	startle response	-	27	14	-	-	4.86E-04	1.96E-03
BIND	BP	GO:0046434	organophosphate catabolic process	-	232	91	-	-	4.88E-03	1.19E-02
BIND	BP	GO:0060037	pharyngeal system development	-	29	16	-	-	1.35E-02	2.13E-03
BIND	BP	GO:0009566	fertilization	-	205	54	-	-	1.76E-03	7.20E-03
BIND	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	29	-	-	9.84E-04	3.93E-03
BIND	BP	GO:0045907	positive regulation of vasoconstriction	-	30	15	-	-	8.78E-02	1.96E-03
BIND	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	12	-	-	3.79E-03	1.64E-03
BIND	BP	GO:0033044	regulation of chromosome organization	-	249	158	-	-	1.46E-02	2.08E-02
BIND	BP	GO:0009309	amine biosynthetic process	-	38	14	-	-	4.91E-04	1.96E-03
BIND	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	178	-	-	1.30E-02	2.34E-02
BIND	BP	GO:0061900	glial cell activation	-	56	27	-	-	1.75E-02	3.60E-03
BIND	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	79	-	-	2.31E-02	1.05E-02
BIND	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	189	-	-	3.00E-02	2.49E-02
BIND	CC	GO:0140467	integrated stress response signaling	-	41	30	-	-	6.77E-02	3.93E-03
BIND	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	150	-	-	6.83E-03	1.96E-02
BIND	BP	GO:0090235	regulation of metaphase plate congression	-	13	11	-	-	2.10E-02	1.47E-03
BIND	BP	GO:0043647	inositol phosphate metabolic process	-	44	18	-	-	6.54E-04	2.46E-03
BIND	BP	GO:0016180	snRNA processing	-	28	15	-	-	3.66E-02	1.96E-03
BIND	BP	GO:0051303	establishment of chromosome localization	-	104	54	-	-	4.89E-02	7.20E-03
BIND	BP	GO:0031349	positive regulation of defense response	-	473	217	-	-	4.44E-02	2.85E-02
BIND	BP	GO:0007164	establishment of tissue polarity	-	38	13	-	-	1.71E-02	1.80E-03
BIND	BP	GO:0021515	cell differentiation in spinal cord	-	51	13	-	-	4.89E-04	1.80E-03
BIND	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	11	-	-	4.84E-04	1.47E-03
BIND	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	15	-	-	1.49E-03	1.96E-03
BIND	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	13	-	-	4.89E-04	1.80E-03
BIND	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	20	-	-	8.04E-04	2.62E-03
BIND	BP	GO:0006605	protein targeting	-	327	168	-	-	1.62E-02	2.21E-02
BIND	BP	GO:0007566	embryo implantation	-	57	31	-	-	2.35E-03	4.09E-03
BIND	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	17	-	-	3.82E-03	2.29E-03
BIND	BP	GO:0061512	protein localization to cilium	-	394	111	-	-	1.69E-02	1.46E-02
BIND	BP	GO:0051017	actin filament bundle assembly	-	161	85	-	-	6.52E-03	1.11E-02
BIND	BP	GO:1905953	negative regulation of lipid localization	-	63	27	-	-	6.59E-03	3.60E-03
BIND	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	12	-	-	4.86E-04	1.64E-03
BIND	BP	GO:0021542	dentate gyrus development	-	19	11	-	-	4.89E-04	1.47E-03
BIND	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	24	-	-	5.35E-02	3.27E-03
BIND	BP	GO:1901343	negative regulation of vasculature development	-	154	53	-	-	1.33E-02	7.04E-03
BIND	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	71	-	-	1.10E-02	9.33E-03
BIND	BP	GO:1902414	protein localization to cell junction	-	107	52	-	-	5.27E-03	6.88E-03
BIND	BP	GO:0071305	cellular response to vitamin D	-	23	12	-	-	1.04E-02	1.64E-03
BIND	BP	GO:0051304	chromosome separation	-	80	49	-	-	3.67E-02	6.55E-03
BIND	BP	GO:0090596	sensory organ morphogenesis	-	272	110	-	-	7.24E-03	1.44E-02
BIND	BP	GO:0048709	oligodendrocyte differentiation	-	101	42	-	-	5.23E-03	5.57E-03
BIND	BP	GO:0045017	glycerolipid biosynthetic process	-	254	84	-	-	4.25E-03	1.11E-02
BIND	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	16	-	-	5.28E-02	2.13E-03
BIND	BP	GO:0001776	leukocyte homeostasis	-	108	61	-	-	4.95E-03	8.02E-03
BIND	BP	GO:0050769	positive regulation of neurogenesis	-	240	125	-	-	6.62E-03	1.64E-02
BIND	BP	GO:0030193	regulation of blood coagulation	-	70	43	-	-	4.07E-02	5.73E-03
BIND	BP	GO:0050866	negative regulation of cell activation	-	216	89	-	-	9.01E-03	1.18E-02
BIND	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	21	-	-	1.63E-02	2.78E-03
BIND	BP	GO:0033500	carbohydrate homeostasis	-	251	118	-	-	7.20E-03	1.56E-02
BIND	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	13	-	-	1.47E-02	1.80E-03
BIND	BP	GO:0044088	regulation of vacuole organization	-	56	27	-	-	1.01E-02	3.60E-03
BIND	CC	GO:0051457	maintenance of protein location in nucleus	-	23	13	-	-	4.86E-04	1.80E-03
BIND	CC	GO:0099522	cytosolic region	-	20	11	-	-	4.85E-04	1.47E-03
BIND	CC	GO:0000791	euchromatin	-	60	37	-	-	3.73E-03	4.91E-03
BIND	CC	GO:0030666	endocytic vesicle membrane	-	196	98	-	-	2.03E-02	1.29E-02
BIND	CC	GO:0098857	membrane microdomain	-	324	175	-	-	1.38E-02	2.29E-02
BIND	CC	GO:0030312	external encapsulating structure	-	567	205	-	-	3.11E-02	2.68E-02
BIND	CC	GO:0071027	nuclear RNA surveillance	-	14	12	-	-	1.26E-01	1.64E-03
BIND	CC	GO:1990752	microtubule end	-	34	15	-	-	1.88E-02	1.96E-03
BIND	CC	GO:0043204	perikaryon	-	156	58	-	-	3.02E-03	7.69E-03
BIND	CC	GO:0097542	ciliary tip	-	48	21	-	-	8.17E-04	2.78E-03
BIND	CC	GO:1905368	peptidase complex	-	124	74	-	-	3.31E-02	9.82E-03
BIND	CC	GO:0000792	heterochromatin	-	98	61	-	-	1.44E-02	8.02E-03
BIND	CC	GO:0097546	ciliary base	-	47	14	-	-	4.88E-04	1.96E-03
BIND	CC	GO:0071819	DUBm complex	-	25	13	-	-	5.22E-02	1.80E-03
BIND	CC	GO:0031201	SNARE complex	-	48	27	-	-	3.93E-02	3.60E-03
BIND	CC	GO:0016324	apical plasma membrane	-	392	135	-	-	1.21E-02	1.77E-02
BIND	CC	GO:0005677	chromatin silencing complex	-	13	11	-	-	7.70E-03	1.47E-03
BIND	CC	GO:0033260	nuclear DNA replication	-	40	30	-	-	3.31E-02	3.93E-03
BIND	CC	GO:0044391	ribosomal subunit	-	203	124	-	-	7.98E-03	1.64E-02
BIND	CC	GO:0071013	catalytic step 2 spliceosome	-	88	68	-	-	6.21E-02	9.00E-03
BIND	CC	GO:0031907	microbody lumen	-	51	24	-	-	8.17E-04	3.27E-03
BIND	CC	GO:0098862	cluster of actin-based cell projections	-	162	52	-	-	9.47E-03	6.88E-03
BIND	CC	GO:0098978	glutamatergic synapse	-	411	197	-	-	1.82E-02	2.59E-02
BIND	CC	GO:0016363	nuclear matrix	-	127	77	-	-	6.56E-03	1.01E-02
BIND	CC	GO:0031261	DNA replication preinitiation complex	-	46	30	-	-	5.64E-02	3.93E-03
BIND	CC	GO:0097060	synaptic membrane	-	413	156	-	-	4.40E-02	2.05E-02
BIND	CC	GO:0032432	actin filament bundle	-	249	97	-	-	6.47E-03	1.28E-02
BIND	CC	GO:0008088	axo-dendritic transport	-	78	52	-	-	8.28E-02	6.88E-03
BIND	CC	GO:0031519	PcG protein complex	-	38	23	-	-	1.90E-01	3.11E-03
BIND	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	11	-	-	4.90E-04	1.47E-03
BIND	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	98	-	-	4.19E-02	1.29E-02
BIND	CC	GO:0000313	organellar ribosome	-	89	44	-	-	1.48E-03	5.89E-03
BIND	CC	GO:0098791	Golgi apparatus subcompartment	-	378	140	-	-	1.31E-02	1.83E-02
BIND	CC	GO:0099643	signal release from synapse	-	147	56	-	-	2.92E-02	7.37E-03
BIND	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	17	-	-	6.50E-04	2.29E-03
BIND	CC	GO:0030018	Z disc	-	129	71	-	-	8.65E-02	9.33E-03
BIND	CC	GO:0032580	Golgi cisterna membrane	-	93	18	-	-	2.88E-02	2.46E-03
BIND	CC	GO:1905360	GTPase complex	-	41	20	-	-	1.10E-01	2.62E-03
BIND	CC	GO:0097540	axonemal central pair	-	161	39	-	-	5.84E-03	5.24E-03
BIND	CC	GO:0042641	actomyosin	-	77	35	-	-	5.74E-03	4.58E-03
BIND	CC	GO:0097386	glial cell projection	-	38	12	-	-	4.87E-04	1.64E-03
BIND	CC	GO:0032588	trans-Golgi network membrane	-	102	46	-	-	7.89E-03	6.06E-03
BIND	CC	GO:0070382	exocytic vesicle	-	224	95	-	-	2.80E-02	1.24E-02
BIND	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	15	-	-	6.53E-04	1.96E-03
BIND	CC	GO:0031903	microbody membrane	-	65	35	-	-	1.94E-01	4.58E-03
BIND	CC	GO:0046930	pore complex	-	26	14	-	-	2.93E-02	1.96E-03
BIND	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	133	-	-	2.20E-02	1.75E-02
BIND	CC	GO:0044298	cell body membrane	-	32	12	-	-	4.90E-04	1.64E-03
BIND	CC	GO:0051882	mitochondrial depolarization	-	21	12	-	-	1.68E-03	1.64E-03
BIND	CC	GO:0070993	translation preinitiation complex	-	19	15	-	-	1.12E-01	1.96E-03
BIND	CC	GO:0016323	basolateral plasma membrane	-	239	97	-	-	2.04E-02	1.28E-02
BIND	CC	GO:0042645	mitochondrial nucleoid	-	45	27	-	-	3.03E-02	3.60E-03
BIND	CC	GO:1902495	transmembrane transporter complex	-	408	118	-	-	2.70E-02	1.56E-02
BIND	CC	GO:0098636	protein complex involved in cell adhesion	-	57	35	-	-	1.29E-01	4.58E-03
BIND	CC	GO:0001917	photoreceptor inner segment	-	71	14	-	-	4.90E-04	1.96E-03
BIND	CC	GO:0019897	extrinsic component of plasma membrane	-	156	69	-	-	9.30E-03	9.17E-03
BIND	CC	GO:0031594	neuromuscular junction	-	73	38	-	-	5.58E-03	5.07E-03
BIND	CC	GO:0000793	condensed chromosome	-	274	142	-	-	3.41E-02	1.87E-02
BIND	CC	GO:0000922	spindle pole	-	172	90	-	-	5.98E-03	1.18E-02
BIND	CC	GO:0120111	neuron projection cytoplasm	-	94	60	-	-	1.28E-01	7.86E-03
BIND	CC	GO:0070971	endoplasmic reticulum exit site	-	32	14	-	-	4.90E-04	1.96E-03
BIND	CC	GO:0004879	nuclear receptor activity	-	63	48	-	-	8.72E-03	6.38E-03
BIND	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	89	-	-	7.95E-03	1.18E-02
BIND	CC	GO:0000123	histone acetyltransferase complex	-	93	43	-	-	1.75E-02	5.73E-03
BIND	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	46	-	-	1.64E-03	6.06E-03
BIND	CC	GO:0048786	presynaptic active zone	-	80	32	-	-	1.34E-02	4.26E-03
BIND	CC	GO:0007034	vacuolar transport	-	168	89	-	-	8.39E-02	1.18E-02
BIND	CC	GO:0005776	autophagosome	-	111	48	-	-	6.46E-03	6.38E-03
BIND	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	49	-	-	2.58E-01	6.55E-03
BIND	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	47	-	-	3.51E-03	6.22E-03
BIND	CC	GO:0030677	ribonuclease P complex	-	14	11	-	-	8.67E-01	1.47E-03
BIND	CC	GO:0000164	protein phosphatase type 1 complex	-	19	13	-	-	2.88E-02	1.80E-03
BIND	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	18	-	-	3.00E-02	2.46E-03
BIND	CC	GO:0032994	protein-lipid complex	-	39	18	-	-	6.51E-04	2.46E-03
BIND	CC	GO:0150034	distal axon	-	309	143	-	-	9.92E-03	1.88E-02
BIND	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	112	-	-	4.25E-02	1.47E-02
BIND	CC	GO:0072562	blood microparticle	-	144	70	-	-	3.26E-02	9.17E-03
BIND	CC	GO:0051233	spindle midzone	-	36	23	-	-	8.06E-04	3.11E-03
BIND	CC	GO:0005811	lipid droplet	-	102	34	-	-	2.86E-03	4.58E-03
BIND	CC	GO:0045022	early endosome to late endosome transport	-	44	26	-	-	3.96E-02	3.44E-03
BIND	CC	GO:0043113	receptor clustering	-	51	23	-	-	5.80E-03	3.11E-03
BIND	CC	GO:0044853	plasma membrane raft	-	114	57	-	-	7.44E-03	7.53E-03
BIND	CC	GO:0005881	cytoplasmic microtubule	-	256	74	-	-	2.40E-02	9.82E-03
BIND	CC	GO:0008180	COP9 signalosome	-	17	14	-	-	2.25E-01	1.96E-03
BIND	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	29	-	-	7.62E-02	3.93E-03
BIND	CC	GO:0005905	clathrin-coated pit	-	73	41	-	-	6.52E-02	5.40E-03
BIND	CC	GO:0031904	endosome lumen	-	38	29	-	-	7.63E-03	3.93E-03
BIND	CC	GO:0060170	ciliary membrane	-	76	18	-	-	1.07E-01	2.46E-03
BIND	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	18	-	-	2.54E-01	2.46E-03
BIND	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	13	-	-	8.93E-02	1.80E-03
BIND	CC	GO:0000139	Golgi membrane	-	646	241	-	-	1.56E-02	3.16E-02
BIND	CC	GO:0032154	cleavage furrow	-	54	27	-	-	3.18E-03	3.60E-03
BIND	CC	GO:0005640	nuclear outer membrane	-	30	12	-	-	4.89E-04	1.64E-03
BIND	CC	GO:0007006	mitochondrial membrane organization	-	117	56	-	-	8.88E-03	7.37E-03
BIND	CC	GO:0001772	immunological synapse	-	44	27	-	-	5.98E-03	3.60E-03
BIND	CC	GO:0009897	external side of plasma membrane	-	425	159	-	-	5.55E-02	2.10E-02
BIND	CC	GO:0030863	cortical cytoskeleton	-	104	51	-	-	5.79E-03	6.71E-03
BIND	CC	GO:1905348	endonuclease complex	-	38	22	-	-	5.69E-01	2.95E-03
BIND	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	6.49E-04	2.46E-03
BIND	CC	GO:0030315	T-tubule	-	52	19	-	-	4.80E-03	2.62E-03
BIND	CC	GO:0060076	excitatory synapse	-	64	19	-	-	8.63E-03	2.62E-03
BIND	CC	GO:0036019	endolysosome	-	29	16	-	-	4.51E-02	2.13E-03
BIND	CC	GO:0099086	synaptonemal structure	-	40	13	-	-	4.75E-02	1.80E-03
BIND	CC	GO:0030427	site of polarized growth	-	172	88	-	-	8.79E-03	1.16E-02
BIND	CC	GO:0044309	neuron spine	-	213	101	-	-	8.65E-03	1.33E-02
BIND	CC	GO:0030658	transport vesicle membrane	-	231	94	-	-	1.19E-02	1.24E-02
BIND	CC	GO:0098918	structural constituent of synapse	-	27	11	-	-	4.88E-04	1.47E-03
BIND	CC	GO:0034719	SMN-Sm protein complex	-	18	15	-	-	3.98E-01	1.96E-03
BIND	CC	GO:0044232	organelle membrane contact site	-	50	12	-	-	4.86E-04	1.64E-03
BIND	CC	GO:0098803	respiratory chain complex	-	39	14	-	-	4.91E-04	1.96E-03
BIND	CC	GO:0030667	secretory granule membrane	-	319	128	-	-	8.30E-03	1.69E-02
BIND	CC	GO:0097545	axonemal outer doublet	-	164	39	-	-	5.60E-03	5.24E-03
BIND	CC	GO:0070069	cytochrome complex	-	42	16	-	-	6.55E-04	2.13E-03
BIND	CC	GO:0031143	pseudopodium	-	18	14	-	-	2.97E-02	1.96E-03
BIND	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	12	-	-	1.08E-02	1.64E-03
BIND	CC	GO:0055037	recycling endosome	-	200	95	-	-	2.05E-02	1.24E-02
BIND	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	52	-	-	5.34E-03	6.88E-03
BIND	CC	GO:0071682	endocytic vesicle lumen	-	23	16	-	-	3.95E-02	2.13E-03
BIND	CC	GO:0030684	preribosome	-	76	32	-	-	1.14E-03	4.26E-03
BIND	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	184	-	-	1.15E-02	2.42E-02
BIND	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	13	-	-	2.50E-01	1.80E-03
BIND	CC	GO:1990391	DNA repair complex	-	22	15	-	-	1.83E-01	1.96E-03
BIND	CC	GO:0005775	vacuolar lumen	-	176	90	-	-	8.65E-03	1.18E-02
BIND	CC	GO:0032433	filopodium tip	-	19	12	-	-	4.89E-04	1.64E-03
BIND	CC	GO:0044306	neuron projection terminus	-	164	68	-	-	3.87E-03	9.00E-03
BIND	CC	GO:0034455	t-UTP complex	-	53	21	-	-	8.16E-04	2.78E-03
BIND	CC	GO:0005770	late endosome	-	299	130	-	-	5.24E-02	1.70E-02
BIND	CC	GO:0031970	organelle envelope lumen	-	94	53	-	-	2.79E-03	7.04E-03
BIND	CC	GO:0019866	organelle inner membrane	-	546	217	-	-	7.26E-03	2.85E-02
BIND	CC	GO:0098687	chromosomal region	-	397	245	-	-	3.51E-02	3.21E-02
BIND	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	15	-	-	1.13E-02	1.96E-03
BIND	CC	GO:0043292	contractile muscle fiber	-	245	122	-	-	5.39E-02	1.60E-02
BIND	CC	GO:0034709	methylosome	-	13	12	-	-	1.31E-01	1.64E-03
BIND	CC	GO:0005849	mRNA cleavage factor complex	-	22	13	-	-	4.91E-04	1.80E-03
BIND	CC	GO:0000803	sex chromosome	-	32	16	-	-	2.19E-03	2.13E-03
BIND	CC	GO:0098982	GABA-ergic synapse	-	84	32	-	-	1.13E-03	4.26E-03
BIND	CC	GO:0035097	histone methyltransferase complex	-	63	47	-	-	4.59E-03	6.22E-03
BIND	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	13	-	-	1.62E-01	1.80E-03
BIND	CC	GO:0000242	pericentriolar material	-	22	11	-	-	4.90E-04	1.47E-03
BIND	CC	GO:1903293	phosphatase complex	-	54	34	-	-	3.27E-02	4.58E-03
BIND	CC	GO:0031941	filamentous actin	-	27	14	-	-	4.90E-04	1.96E-03
BIND	CC	GO:0000786	nucleosome	-	149	86	-	-	1.74E-02	1.13E-02
BIND	CC	GO:0001533	cornified envelope	-	59	24	-	-	1.09E-01	3.27E-03
BIND	CC	GO:1904724	tertiary granule lumen	-	55	25	-	-	9.77E-04	3.27E-03
BIND	CC	GO:0030027	lamellipodium	-	202	131	-	-	1.75E-02	1.72E-02
BIND	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	11	-	-	5.74E-03	1.47E-03
BIND	CC	GO:0001056	RNA polymerase III activity	-	16	11	-	-	1.53E-01	1.47E-03
BIND	CC	GO:0002102	podosome	-	31	16	-	-	3.63E-03	2.13E-03
BIND	CC	GO:0090543	Flemming body	-	33	16	-	-	3.54E-02	2.13E-03
BIND	CC	GO:0016328	lateral plasma membrane	-	66	34	-	-	2.14E-02	4.58E-03
BIND	CC	GO:0001650	fibrillar center	-	151	86	-	-	5.47E-03	1.13E-02
BIND	CC	GO:0031332	RNAi effector complex	-	413	11	-	-	1.66E-01	1.47E-03
BIND	CC	GO:1990204	oxidoreductase complex	-	90	39	-	-	5.76E-02	5.24E-03
BIND	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	81	-	-	5.35E-03	1.06E-02
BIND	CC	GO:0001726	ruffle	-	181	100	-	-	2.09E-02	1.31E-02
BIND	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	11	-	-	6.71E-02	1.47E-03
BIND	CC	GO:0043198	dendritic shaft	-	38	14	-	-	1.05E-02	1.96E-03
BIND	CC	GO:0043073	germ cell nucleus	-	67	37	-	-	1.02E-02	4.91E-03
BIND	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	11	-	-	4.82E-04	1.47E-03
BIND	CC	GO:0005788	endoplasmic reticulum lumen	-	313	145	-	-	9.23E-03	1.90E-02
BIND	CC	GO:0016592	mediator complex	-	38	24	-	-	2.25E-01	3.27E-03
BIND	CC	GO:0022626	cytosolic ribosome	-	118	82	-	-	4.16E-03	1.08E-02
BIND	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	24	-	-	9.05E-02	3.27E-03
BIND	CC	GO:0034451	centriolar satellite	-	120	53	-	-	4.79E-03	7.04E-03
BIND	CC	GO:0045171	intercellular bridge	-	91	41	-	-	1.69E-02	5.40E-03
BIND	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	36	-	-	1.30E-03	4.75E-03
BIND	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.17E-01	1.47E-03
BIND	CC	GO:0098984	neuron to neuron synapse	-	384	181	-	-	3.15E-02	2.37E-02
BIND	CC	GO:0030527	structural constituent of chromatin	-	97	66	-	-	2.31E-02	8.68E-03
BIND	CC	GO:0036379	myofilament	-	26	11	-	-	2.67E-01	1.47E-03
BIND	CC	GO:0030286	dynein complex	-	210	59	-	-	3.81E-03	7.86E-03
BIND	CC	GO:0016482	cytosolic transport	-	135	63	-	-	2.78E-02	8.35E-03
BIND	CC	GO:0005796	Golgi lumen	-	106	39	-	-	7.53E-03	5.24E-03
BIND	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	22	-	-	2.72E-01	2.95E-03
BIND	CC	GO:0034358	plasma lipoprotein particle	-	36	15	-	-	6.51E-04	1.96E-03
BIND	CC	GO:0008023	transcription elongation factor complex	-	47	27	-	-	1.16E-01	3.60E-03
BIND	CC	GO:0030662	coated vesicle membrane	-	202	109	-	-	3.64E-02	1.44E-02
BIND	CC	GO:0007039	protein catabolic process in the vacuole	-	61	34	-	-	4.78E-01	4.58E-03
BIND	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	33	-	-	1.15E-03	4.42E-03
BIND	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	185	-	-	1.96E-02	2.42E-02
BIND	CC	GO:0005769	early endosome	-	425	209	-	-	3.29E-02	2.75E-02
BIND	CC	GO:0090734	site of DNA damage	-	118	62	-	-	3.29E-02	8.18E-03
BIND	MF	GO:0051861	glycolipid binding	-	30	13	-	-	4.90E-04	1.80E-03
BIND	MF	GO:0051087	protein-folding chaperone binding	-	135	83	-	-	1.14E-02	1.10E-02
BIND	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	16	-	-	6.51E-04	2.13E-03
BIND	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	105	-	-	1.24E-02	1.38E-02
BIND	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	12	-	-	4.88E-04	1.64E-03
BIND	MF	GO:0016757	glycosyltransferase activity	-	286	64	-	-	5.96E-03	8.51E-03
BIND	MF	GO:0048306	calcium-dependent protein binding	-	61	29	-	-	3.82E-02	3.93E-03
BIND	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	17	-	-	6.53E-04	2.29E-03
BIND	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	42	-	-	5.89E-03	5.57E-03
BIND	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	31	-	-	4.46E-02	4.09E-03
BIND	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	44	-	-	2.47E-02	5.89E-03
BIND	MF	GO:0051020	GTPase binding	-	311	150	-	-	7.16E-03	1.96E-02
BIND	MF	GO:0140457	protein demethylase activity	-	31	14	-	-	4.88E-04	1.96E-03
BIND	MF	GO:0005158	insulin receptor binding	-	22	17	-	-	3.14E-02	2.29E-03
BIND	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	14	-	-	1.05E-02	1.96E-03
BIND	MF	GO:0061980	regulatory RNA binding	-	52	24	-	-	4.29E-02	3.27E-03
BIND	MF	GO:0015035	protein-disulfide reductase activity	-	32	12	-	-	4.90E-04	1.64E-03
BIND	MF	GO:0001671	ATPase activator activity	-	29	15	-	-	6.52E-04	1.96E-03
BIND	MF	GO:0070840	dynein complex binding	-	25	14	-	-	4.90E-04	1.96E-03
BIND	MF	GO:0035035	histone acetyltransferase binding	-	24	16	-	-	6.13E-03	2.13E-03
BIND	MF	GO:0061684	chaperone-mediated autophagy	-	16	12	-	-	5.52E-02	1.64E-03
BIND	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	15	-	-	1.64E-02	1.96E-03
BIND	MF	GO:0003688	DNA replication origin binding	-	18	17	-	-	2.26E-01	2.29E-03
BIND	MF	GO:0005178	integrin binding	-	153	84	-	-	4.68E-02	1.11E-02
BIND	MF	GO:0070064	proline-rich region binding	-	17	14	-	-	4.87E-04	1.96E-03
BIND	MF	GO:0008327	methyl-CpG binding	-	31	11	-	-	4.85E-04	1.47E-03
BIND	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	18	-	-	2.85E-03	2.46E-03
BIND	MF	GO:0140318	protein transporter activity	-	40	24	-	-	5.15E-03	3.27E-03
BIND	MF	GO:0070628	proteasome binding	-	17	11	-	-	4.90E-04	1.47E-03
BIND	MF	GO:0000217	DNA secondary structure binding	-	37	23	-	-	4.66E-03	3.11E-03
BIND	MF	GO:0002039	p53 binding	-	66	45	-	-	4.56E-03	5.89E-03
BIND	MF	GO:0005496	steroid binding	-	110	49	-	-	2.95E-02	6.55E-03
BIND	MF	GO:0008443	phosphofructokinase activity	-	27	12	-	-	4.89E-04	1.64E-03
BIND	MF	GO:0003684	damaged DNA binding	-	89	66	-	-	1.01E-01	8.68E-03
BIND	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	84	-	-	6.60E-02	1.11E-02
BIND	MF	GO:0070063	RNA polymerase binding	-	61	34	-	-	4.67E-03	4.58E-03
BIND	MF	GO:0030971	receptor tyrosine kinase binding	-	76	42	-	-	3.13E-03	5.57E-03
BIND	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	46	-	-	4.93E-02	6.06E-03
BIND	MF	GO:0140030	modification-dependent protein binding	-	179	90	-	-	6.00E-03	1.18E-02
BIND	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.98E-01	1.96E-03
BIND	MF	GO:0030276	clathrin binding	-	70	30	-	-	7.94E-02	3.93E-03
BIND	MF	GO:0046875	ephrin receptor binding	-	29	24	-	-	1.00E-01	3.27E-03
BIND	MF	GO:0106310	protein serine kinase activity	-	362	197	-	-	1.97E-02	2.59E-02
BIND	MF	GO:0140311	protein sequestering activity	-	14	11	-	-	4.84E-04	1.47E-03
BIND	MF	GO:0030552	cAMP binding	-	48	20	-	-	8.04E-04	2.62E-03
BIND	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	13	-	-	4.87E-04	1.80E-03
BIND	MF	GO:0004857	enzyme inhibitor activity	-	395	184	-	-	6.52E-03	2.42E-02
BIND	MF	GO:0035173	histone kinase activity	-	17	11	-	-	4.87E-04	1.47E-03
BIND	MF	GO:0016209	antioxidant activity	-	92	41	-	-	2.43E-02	5.40E-03
BIND	MF	GO:0070325	lipoprotein particle receptor binding	-	32	26	-	-	9.13E-03	3.44E-03
BIND	MF	GO:0044325	transmembrane transporter binding	-	159	78	-	-	2.34E-02	1.03E-02
BIND	MF	GO:0048156	tau protein binding	-	43	29	-	-	2.75E-03	3.93E-03
BIND	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	14	-	-	4.86E-04	1.96E-03
BIND	MF	GO:0140272	exogenous protein binding	-	79	48	-	-	9.20E-03	6.38E-03
BIND	MF	GO:0030145	manganese ion binding	-	65	27	-	-	2.25E-03	3.60E-03
BIND	MF	GO:0071814	protein-lipid complex binding	-	52	15	-	-	2.43E-02	1.96E-03
BIND	MF	GO:0008066	glutamate receptor activity	-	70	27	-	-	5.70E-02	3.60E-03
BIND	MF	GO:0017069	snRNA binding	-	54	32	-	-	3.56E-02	4.26E-03
BIND	MF	GO:0031369	translation initiation factor binding	-	32	20	-	-	5.17E-02	2.62E-03
BIND	MF	GO:0019843	rRNA binding	-	69	34	-	-	3.91E-03	4.58E-03
BIND	MF	GO:0004713	protein tyrosine kinase activity	-	213	134	-	-	2.94E-02	1.77E-02
BIND	MF	GO:0016779	nucleotidyltransferase activity	-	264	148	-	-	3.89E-02	1.95E-02
BIND	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	36	-	-	5.42E-03	4.75E-03
BIND	MF	GO:0008093	cytoskeletal anchor activity	-	24	12	-	-	4.88E-04	1.64E-03
BIND	MF	GO:0000287	magnesium ion binding	-	225	100	-	-	5.39E-03	1.31E-02
BIND	MF	GO:0031490	chromatin DNA binding	-	120	68	-	-	1.15E-02	9.00E-03
BIND	MF	GO:0017022	myosin binding	-	73	37	-	-	2.68E-03	4.91E-03
BIND	MF	GO:0004896	cytokine receptor activity	-	93	39	-	-	3.60E-03	5.24E-03
BIND	MF	GO:0008301	"DNA binding, bending"	-	18	11	-	-	4.89E-04	1.47E-03
BIND	MF	GO:0015631	tubulin binding	-	410	182	-	-	1.45E-02	2.39E-02
BIND	MF	GO:0005539	glycosaminoglycan binding	-	236	100	-	-	4.06E-02	1.31E-02
BIND	MF	GO:0019207	kinase regulator activity	-	267	148	-	-	1.47E-02	1.95E-02
BIND	MF	GO:0044183	protein folding chaperone	-	67	35	-	-	9.45E-03	4.58E-03
BIND	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	68	-	-	1.23E-02	9.00E-03
BIND	MF	GO:0003725	double-stranded RNA binding	-	72	39	-	-	2.78E-02	5.24E-03
BIND	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	15	-	-	4.77E-03	1.96E-03
BIND	MF	GO:0051018	protein kinase A binding	-	52	26	-	-	1.90E-02	3.44E-03
BIND	MF	GO:0071889	14-3-3 protein binding	-	34	20	-	-	1.94E-03	2.62E-03
BIND	MF	GO:0004618	phosphoglycerate kinase activity	-	89	44	-	-	3.77E-03	5.89E-03
BIND	MF	GO:0042805	actinin binding	-	36	22	-	-	2.58E-03	2.95E-03
BIND	MF	GO:0043531	ADP binding	-	38	20	-	-	1.16E-02	2.62E-03
BIND	MF	GO:0043394	proteoglycan binding	-	36	18	-	-	6.51E-04	2.46E-03
BIND	MF	GO:0046332	SMAD binding	-	77	58	-	-	7.48E-03	7.69E-03
BIND	MF	GO:0001968	fibronectin binding	-	30	18	-	-	4.90E-02	2.46E-03
BIND	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	62	-	-	5.24E-03	8.18E-03
BIND	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	22	-	-	5.14E-03	2.95E-03
BIND	MF	GO:0051117	ATPase binding	-	85	49	-	-	2.56E-03	6.55E-03
BIND	MF	GO:0005216	monoatomic ion channel activity	-	618	181	-	-	2.13E-02	2.37E-02
BIND	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	23	-	-	1.07E-03	3.11E-03
BIND	MF	GO:0051787	misfolded protein binding	-	20	13	-	-	4.86E-04	1.80E-03
BIND	MF	GO:0001098	basal transcription machinery binding	-	61	39	-	-	6.44E-03	5.24E-03
BIND	MF	GO:0036002	pre-mRNA binding	-	57	21	-	-	1.09E-02	2.78E-03
BIND	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	22	-	-	8.15E-04	2.95E-03
BIND	MF	GO:0051540	metal cluster binding	-	71	30	-	-	1.14E-03	3.93E-03
BIND	MF	GO:0051219	phosphoprotein binding	-	92	66	-	-	8.20E-03	8.68E-03
BIND	MF	GO:0019894	kinesin binding	-	45	21	-	-	8.27E-03	2.78E-03
BIND	MF	GO:0042287	MHC protein binding	-	68	27	-	-	3.83E-02	3.60E-03
BIND	MF	GO:0019003	GDP binding	-	89	61	-	-	1.04E-02	8.02E-03
BIND	MF	GO:0017171	serine hydrolase activity	-	207	64	-	-	7.95E-03	8.51E-03
BIND	MF	GO:0097110	scaffold protein binding	-	66	37	-	-	9.75E-03	4.91E-03
BIND	MF	GO:0003774	cytoskeletal motor activity	-	117	41	-	-	3.01E-02	5.40E-03
BIND	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	25	-	-	6.45E-03	3.27E-03
BIND	MF	GO:0061134	peptidase regulator activity	-	224	103	-	-	3.12E-02	1.36E-02
BIND	MF	GO:0008013	beta-catenin binding	-	86	52	-	-	1.40E-02	6.88E-03
BIND	MF	GO:0051015	actin filament binding	-	208	83	-	-	4.58E-02	1.10E-02
BIND	MF	GO:0019208	phosphatase regulator activity	-	107	53	-	-	7.29E-03	7.04E-03
BIND	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	14	-	-	1.47E-02	1.96E-03
BIND	MF	GO:0043236	laminin binding	-	29	12	-	-	2.20E-02	1.64E-03
BIND	MF	GO:0030507	spectrin binding	-	26	12	-	-	4.90E-04	1.64E-03
BIND	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	18	-	-	1.22E-02	2.46E-03
BIND	MF	GO:0045860	positive regulation of protein kinase activity	-	397	237	-	-	2.21E-02	3.11E-02
BIND	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	56	-	-	2.94E-03	7.37E-03
BIND	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	21	-	-	7.07E-03	2.78E-03
BIND	MF	GO:0042393	histone binding	-	240	114	-	-	5.52E-03	1.51E-02
BIND	MF	GO:0019838	growth factor binding	-	182	109	-	-	1.00E-02	1.44E-02
BIND	MF	GO:0000149	SNARE binding	-	107	45	-	-	8.45E-02	5.89E-03
BIND	MF	GO:0003727	single-stranded RNA binding	-	90	41	-	-	4.19E-03	5.40E-03
BIND	MF	GO:0051378	serotonin binding	-	24	11	-	-	6.23E-02	1.47E-03
BIND	MF	GO:0005516	calmodulin binding	-	206	79	-	-	2.92E-03	1.05E-02
BIND	MF	GO:0019825	oxygen binding	-	40	18	-	-	1.21E-01	2.46E-03
BIND	MF	GO:0045505	dynein intermediate chain binding	-	37	13	-	-	4.86E-04	1.80E-03
BIND	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	29	-	-	9.82E-04	3.93E-03
BIND	MF	GO:0032182	ubiquitin-like protein binding	-	117	71	-	-	7.78E-03	9.33E-03
BIND	MF	GO:0023023	MHC protein complex binding	-	36	19	-	-	7.02E-02	2.62E-03
BIND	MF	GO:0030742	GTP-dependent protein binding	-	22	14	-	-	8.79E-03	1.96E-03
BIND	MF	GO:0043274	phospholipase binding	-	23	15	-	-	3.71E-03	1.96E-03
BIND	MF	GO:0031072	heat shock protein binding	-	128	76	-	-	1.37E-02	9.99E-03
BIND	MF	GO:0030515	snoRNA binding	-	33	13	-	-	1.81E-02	1.80E-03
BIND	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	25	-	-	9.83E-04	3.27E-03
BIND	MF	GO:0001965	G-protein alpha-subunit binding	-	26	11	-	-	4.89E-04	1.47E-03
BIND	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	192	-	-	1.39E-02	2.52E-02
BIND	MF	GO:0001530	lipopolysaccharide binding	-	38	19	-	-	1.17E-02	2.62E-03
BIND	MF	GO:0046982	protein heterodimerization activity	-	343	219	-	-	1.85E-02	2.88E-02
BIND	MF	GO:0140223	general transcription initiation factor activity	-	55	38	-	-	1.75E-01	5.07E-03
BIND	MF	GO:0000049	tRNA binding	-	75	28	-	-	4.77E-03	3.76E-03
BIND	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	32	-	-	1.26E-02	4.26E-03
BIND	MF	GO:0015026	coreceptor activity	-	48	28	-	-	5.57E-03	3.76E-03
BIND	MF	GO:0001653	peptide receptor activity	-	128	37	-	-	1.31E-03	4.91E-03
BIND	MF	GO:0006469	negative regulation of protein kinase activity	-	222	118	-	-	1.17E-02	1.56E-02
BIND	MF	GO:0070182	DNA polymerase binding	-	22	13	-	-	4.85E-04	1.80E-03
BIND	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	17	-	-	6.52E-02	2.29E-03
BIND	MF	GO:0051427	hormone receptor binding	-	31	15	-	-	6.49E-04	1.96E-03
BIND	MF	GO:0070851	growth factor receptor binding	-	141	78	-	-	1.95E-02	1.03E-02
BIND	MF	GO:0031210	phosphatidylcholine binding	-	32	12	-	-	4.91E-04	1.64E-03
BIND	MF	GO:0005525	GTP binding	-	396	175	-	-	8.50E-03	2.29E-02
BIND	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	28	-	-	1.44E-02	3.76E-03
BIND	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	152	-	-	1.93E-02	2.00E-02
BIND	MF	GO:0051346	negative regulation of hydrolase activity	-	332	150	-	-	6.35E-03	1.96E-02
BIND	MF	GO:0005506	iron ion binding	-	154	60	-	-	4.10E-03	7.86E-03
BIND	MF	GO:0003925	G protein activity	-	45	28	-	-	9.73E-04	3.76E-03
BIND	MF	GO:0038187	pattern recognition receptor activity	-	33	11	-	-	2.00E-01	1.47E-03
BIND	MF	GO:0008276	protein methyltransferase activity	-	96	44	-	-	4.04E-02	5.89E-03
BIND	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	230	-	-	2.06E-02	3.01E-02
BIND	MF	GO:0070888	E-box binding	-	59	27	-	-	1.34E-03	3.60E-03
BIND	MF	GO:0015399	primary active transmembrane transporter activity	-	190	80	-	-	1.20E-02	1.05E-02
BIND	MF	GO:0035254	glutamate receptor binding	-	47	25	-	-	8.25E-03	3.27E-03
BIND	MF	GO:0050321	tau-protein kinase activity	-	36	21	-	-	7.96E-04	2.78E-03
BIND	MF	GO:0043021	ribonucleoprotein complex binding	-	158	92	-	-	5.17E-03	1.21E-02
BIND	MF	GO:0030170	pyridoxal phosphate binding	-	56	23	-	-	8.18E-04	3.11E-03
BIND	MF	GO:0048185	activin binding	-	16	14	-	-	5.56E-03	1.96E-03
BIND	MF	GO:0001664	G protein-coupled receptor binding	-	299	113	-	-	8.40E-03	1.49E-02
BIND	MF	GO:0140299	small molecule sensor activity	-	39	21	-	-	1.97E-01	2.78E-03
BIND	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	11	-	-	6.56E-02	1.47E-03
BIND	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	23	-	-	1.61E-03	3.11E-03
BIND	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	14	-	-	1.57E-03	1.96E-03
BIND	MF	GO:0030594	neurotransmitter receptor activity	-	160	55	-	-	2.41E-02	7.20E-03
BIND	MF	GO:0005507	copper ion binding	-	63	25	-	-	1.24E-02	3.27E-03
BIND	MF	GO:0033558	protein lysine deacetylase activity	-	22	12	-	-	7.33E-02	1.64E-03
BIND	MF	GO:0070034	telomerase RNA binding	-	22	14	-	-	1.99E-02	1.96E-03
BioGRID	CC	GO:0005615	extracellular space	2.58E-24	3190	3131	3028	1.03	-	-
BioGRID	CC	GO:0005739	mitochondrion	8.52E-21	1671	1654	1586	1.04	-	-
BioGRID	CC	GO:0005783	endoplasmic reticulum	9.10E-15	2020	1982	1917	1.03	-	-
BioGRID	CC	GO:0005730	nucleolus	3.10E-13	988	979	938	1.04	-	-
BioGRID	CC	GO:0005815	microtubule organizing center	9.19E-13	843	837	800	1.05	-	-
BioGRID	CC	GO:0005768	endosome	5.85E-12	1037	1025	984	1.04	-	-
BioGRID	CC	GO:0005794	Golgi apparatus	1.42E-10	1636	1602	1553	1.03	-	-
BioGRID	CC	GO:0005635	nuclear envelope	4.15E-09	493	491	468	1.05	-	-
BioGRID	CC	GO:0005764	lysosome	5.54E-08	747	737	709	1.04	-	-
BioGRID	CC	GO:0005840	ribosome	1.75E-05	222	222	211	1.05	-	-
BioGRID	CC	GO:0031012	extracellular matrix	4.28E-04	564	552	535	1.03	-	-
BioGRID	CC	GO:0000228	nuclear chromosome	5.89E-04	206	205	196	1.05	-	-
BioGRID	CC	GO:0005777	peroxisome	1.09E-02	142	141	135	1.05	-	-
BioGRID	CC	GO:0005929	cilium	1.27E-01	842	809	799	1.01	-	-
BioGRID	CC	GO:0005811	lipid droplet	1.78E-01	102	100	97	1.03	-	-
BioGRID	BP	GO:0050877	nervous system process	1.24E-89	1527	1245	1449	0.86	-	-
BioGRID	BP	GO:0007010	cytoskeleton organization	6.60E-21	1639	1623	1556	1.04	-	-
BioGRID	BP	GO:0016192	vesicle-mediated transport	6.61E-18	1894	1866	1798	1.04	-	-
BioGRID	BP	GO:0065003	protein-containing complex assembly	1.99E-16	1648	1625	1564	1.04	-	-
BioGRID	BP	GO:0012501	programmed cell death	1.31E-14	1954	1918	1855	1.03	-	-
BioGRID	BP	GO:0048870	cell motility	3.14E-14	1659	1632	1575	1.04	-	-
BioGRID	BP	GO:0006355	regulation of DNA-templated transcription	1.07E-13	3342	3252	3172	1.03	-	-
BioGRID	BP	GO:0030163	protein catabolic process	3.19E-13	990	981	940	1.04	-	-
BioGRID	BP	GO:0006281	DNA repair	2.23E-12	587	586	557	1.05	-	-
BioGRID	BP	GO:0007155	cell adhesion	9.87E-12	1444	1419	1370	1.04	-	-
BioGRID	BP	GO:0002376	immune system process	2.82E-11	2448	2386	2323	1.03	-	-
BioGRID	BP	GO:0006886	intracellular protein transport	6.50E-11	664	660	630	1.05	-	-
BioGRID	BP	GO:0006914	autophagy	8.54E-11	568	566	539	1.05	-	-
BioGRID	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.58E-10	729	723	692	1.04	-	-
BioGRID	BP	GO:0007005	mitochondrion organization	3.60E-10	484	483	459	1.05	-	-
BioGRID	BP	GO:0006325	chromatin organization	2.00E-09	720	713	683	1.04	-	-
BioGRID	BP	GO:0034330	cell junction organization	7.28E-09	727	719	690	1.04	-	-
BioGRID	BP	GO:0016071	mRNA metabolic process	9.81E-09	713	705	677	1.04	-	-
BioGRID	BP	GO:0006629	lipid metabolic process	3.99E-08	1355	1325	1286	1.03	-	-
BioGRID	BP	GO:0007059	chromosome segregation	2.53E-07	403	401	382	1.05	-	-
BioGRID	BP	GO:0042254	ribosome biogenesis	3.24E-07	297	297	282	1.05	-	-
BioGRID	BP	GO:0072659	protein localization to plasma membrane	7.54E-07	284	284	270	1.05	-	-
BioGRID	BP	GO:0006091	generation of precursor metabolites and energy	8.55E-07	502	497	476	1.04	-	-
BioGRID	BP	GO:0006913	nucleocytoplasmic transport	1.30E-06	326	325	309	1.05	-	-
BioGRID	BP	GO:0003013	circulatory system process	2.12E-06	584	576	554	1.04	-	-
BioGRID	BP	GO:0005975	carbohydrate metabolic process	2.64E-06	551	544	523	1.04	-	-
BioGRID	BP	GO:0006260	DNA replication	1.27E-05	279	278	265	1.05	-	-
BioGRID	BP	GO:0042060	wound healing	1.88E-05	431	426	409	1.04	-	-
BioGRID	BP	GO:0030198	extracellular matrix organization	2.24E-05	314	312	298	1.05	-	-
BioGRID	BP	GO:0003012	muscle system process	2.68E-05	425	420	403	1.04	-	-
BioGRID	BP	GO:0006310	DNA recombination	4.52E-05	333	330	316	1.04	-	-
BioGRID	BP	GO:0006399	tRNA metabolic process	5.57E-05	196	196	186	1.05	-	-
BioGRID	BP	GO:0098542	defense response to other organism	6.23E-05	1171	1139	1111	1.02	-	-
BioGRID	BP	GO:0006520	amino acid metabolic process	6.84E-05	292	290	277	1.05	-	-
BioGRID	BP	GO:0140013	meiotic nuclear division	9.35E-05	279	277	265	1.05	-	-
BioGRID	BP	GO:0007018	microtubule-based movement	1.05E-04	640	627	607	1.03	-	-
BioGRID	BP	GO:0055085	transmembrane transport	1.79E-04	1784	1725	1693	1.02	-	-
BioGRID	BP	GO:0006790	sulfur compound metabolic process	4.45E-04	320	316	304	1.04	-	-
BioGRID	BP	GO:0002181	cytoplasmic translation	6.17E-04	153	153	145	1.05	-	-
BioGRID	BP	GO:0044782	cilium organization	7.77E-04	399	392	379	1.04	-	-
BioGRID	BP	GO:0006954	inflammatory response	8.07E-04	820	798	778	1.03	-	-
BioGRID	BP	GO:0007163	establishment or maintenance of cell polarity	1.16E-03	227	225	215	1.04	-	-
BioGRID	BP	GO:0032200	telomere organization	1.16E-03	186	185	177	1.05	-	-
BioGRID	BP	GO:0006457	protein folding	2.33E-03	210	208	199	1.04	-	-
BioGRID	BP	GO:0140053	mitochondrial gene expression	3.58E-03	164	163	156	1.05	-	-
BioGRID	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	4.87E-03	119	119	113	1.05	-	-
BioGRID	BP	GO:0006575	cellular modified amino acid metabolic process	6.59E-03	186	184	177	1.04	-	-
BioGRID	BP	GO:0007040	lysosome organization	6.73E-03	107	107	102	1.05	-	-
BioGRID	BP	GO:0006486	protein glycosylation	2.05E-02	225	221	214	1.03	-	-
BioGRID	BP	GO:0000910	cytokinesis	2.74E-02	186	183	177	1.04	-	-
BioGRID	BP	GO:0022600	digestive system process	4.61E-02	110	109	104	1.04	-	-
BioGRID	BP	GO:0003014	renal system process	6.86E-02	127	125	121	1.04	-	-
BioGRID	BP	GO:0006766	vitamin metabolic process	1.81E-01	107	105	102	1.03	-	-
BioGRID	BP	GO:0098754	detoxification	6.91E-01	134	129	127	1.01	-	-
BioGRID	MF	GO:0016740	transferase activity	3.76E-28	3074	3026	2918	1.04	-	-
BioGRID	MF	GO:0003723	RNA binding	4.68E-27	1679	1669	1594	1.05	-	-
BioGRID	MF	GO:0140096	"catalytic activity, acting on a protein"	6.07E-21	3198	3132	3035	1.03	-	-
BioGRID	MF	GO:0003677	DNA binding	1.08E-15	2865	2799	2719	1.03	-	-
BioGRID	MF	GO:0008092	cytoskeletal protein binding	1.09E-15	1023	1016	971	1.05	-	-
BioGRID	MF	GO:0140657	ATP-dependent activity	2.24E-14	729	727	692	1.05	-	-
BioGRID	MF	GO:0003924	GTPase activity	4.05E-09	658	652	625	1.04	-	-
BioGRID	MF	GO:0008289	lipid binding	1.87E-08	836	824	793	1.04	-	-
BioGRID	MF	GO:0016491	oxidoreductase activity	1.16E-07	888	873	843	1.04	-	-
BioGRID	MF	GO:0140098	"catalytic activity, acting on RNA"	1.88E-07	417	415	396	1.05	-	-
BioGRID	MF	GO:0140110	transcription regulator activity	1.78E-06	2033	1972	1929	1.02	-	-
BioGRID	MF	GO:0140097	"catalytic activity, acting on DNA"	5.38E-06	383	380	364	1.05	-	-
BioGRID	MF	GO:0005198	structural molecule activity	1.38E-04	798	779	757	1.03	-	-
BioGRID	MF	GO:0016874	ligase activity	5.28E-04	283	280	269	1.04	-	-
BioGRID	MF	GO:0042393	histone binding	8.38E-04	237	235	225	1.04	-	-
BioGRID	MF	GO:0016853	isomerase activity	2.06E-03	252	249	239	1.04	-	-
BioGRID	MF	GO:0003774	cytoskeletal motor activity	4.59E-03	116	116	110	1.05	-	-
BioGRID	MF	GO:0140104	molecular carrier activity	6.67E-03	105	105	100	1.05	-	-
BioGRID	MF	GO:0005215	transporter activity	7.57E-03	1462	1409	1388	1.02	-	-
BioGRID	MF	GO:0016829	lyase activity	1.24E-02	538	523	511	1.02	-	-
BioGRID	MF	GO:0045182	translation regulator activity	3.74E-02	151	149	143	1.04	-	-
BioGRID	MF	GO:0048018	receptor ligand activity	1.23E-01	504	486	478	1.02	-	-
BioGRID	MF	GO:0038024	cargo receptor activity	2.89E-01	117	114	111	1.03	-	-
BioGRID	MF	GO:0009975	cyclase activity	4.90E-01	277	266	263	1.01	-	-
BioGRID	BP	GO:0008038	neuron recognition	-	46	45	-	-	2.27E-03	1.81E-03
BioGRID	BP	GO:1905145	cellular response to acetylcholine	-	33	31	-	-	2.55E-03	1.26E-03
BioGRID	BP	GO:0097094	craniofacial suture morphogenesis	-	18	17	-	-	4.21E-03	7.03E-04
BioGRID	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	9.81E-04	8.53E-04
BioGRID	BP	GO:0051931	regulation of sensory perception	-	36	36	-	-	2.05E-03	1.46E-03
BioGRID	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	2.25E-03	1.00E-03
BioGRID	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	12	-	-	2.95E-03	5.02E-04
BioGRID	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	1.45E-04	5.52E-04
BioGRID	BP	GO:0009268	response to pH	-	43	40	-	-	6.61E-03	1.61E-03
BioGRID	BP	GO:0045666	positive regulation of neuron differentiation	-	91	87	-	-	2.99E-03	3.51E-03
BioGRID	BP	GO:0043543	protein acylation	-	107	106	-	-	3.14E-03	4.27E-03
BioGRID	MF	GO:0051349	positive regulation of lyase activity	-	41	39	-	-	6.34E-04	1.61E-03
BioGRID	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	5.62E-04	6.02E-04
BioGRID	BP	GO:0048679	regulation of axon regeneration	-	28	26	-	-	1.12E-03	1.05E-03
BioGRID	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	9.04E-03	8.03E-04
BioGRID	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	136	-	-	2.06E-02	5.47E-03
BioGRID	BP	GO:0071763	nuclear membrane organization	-	44	44	-	-	7.02E-03	1.81E-03
BioGRID	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	39	-	-	2.37E-03	1.61E-03
BioGRID	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	12	-	-	9.77E-03	5.02E-04
BioGRID	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	9.60E-03	2.76E-03
BioGRID	BP	GO:0022038	corpus callosum development	-	25	25	-	-	2.53E-03	1.00E-03
BioGRID	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	13	-	-	1.45E-04	5.52E-04
BioGRID	BP	GO:0021548	pons development	-	11	11	-	-	1.45E-04	4.52E-04
BioGRID	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	1.48E-04	5.02E-04
BioGRID	BP	GO:0043299	leukocyte degranulation	-	82	79	-	-	3.34E-03	3.21E-03
BioGRID	BP	GO:0048864	stem cell development	-	88	86	-	-	8.43E-03	3.46E-03
BioGRID	BP	GO:0097384	cellular lipid biosynthetic process	-	11	11	-	-	1.31E-03	4.52E-04
BioGRID	BP	GO:0009310	amine catabolic process	-	20	19	-	-	4.32E-03	8.03E-04
BioGRID	BP	GO:0051651	maintenance of location in cell	-	236	230	-	-	7.40E-03	9.24E-03
BioGRID	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	1.73E-03	1.10E-03
BioGRID	BP	GO:0014004	microglia differentiation	-	12	12	-	-	1.92E-03	5.02E-04
BioGRID	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	2.03E-03	1.26E-03
BioGRID	BP	GO:1905962	glutamatergic neuron differentiation	-	14	13	-	-	1.47E-04	5.52E-04
BioGRID	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.10E-03	6.02E-04
BioGRID	BP	GO:0046415	urate metabolic process	-	12	11	-	-	1.48E-04	4.52E-04
BioGRID	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	35	-	-	1.84E-03	1.41E-03
BioGRID	BP	GO:0006949	syncytium formation	-	66	60	-	-	1.98E-03	2.41E-03
BioGRID	BP	GO:0045176	apical protein localization	-	15	15	-	-	5.57E-04	6.02E-04
BioGRID	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	8.47E-03	6.02E-04
BioGRID	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	57	-	-	3.05E-02	2.31E-03
BioGRID	BP	GO:0030574	collagen catabolic process	-	45	45	-	-	2.44E-01	1.81E-03
BioGRID	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	2.05E-03	1.86E-03
BioGRID	BP	GO:0060343	trabecula formation	-	26	26	-	-	9.54E-04	1.05E-03
BioGRID	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	18	-	-	3.02E-04	7.53E-04
BioGRID	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	1.00E-03	9.54E-04
BioGRID	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	1.00E-01	6.53E-04
BioGRID	BP	GO:1900424	regulation of defense response to bacterium	-	21	20	-	-	1.11E-03	8.03E-04
BioGRID	BP	GO:0085029	extracellular matrix assembly	-	42	42	-	-	5.99E-03	1.71E-03
BioGRID	BP	GO:0006413	translational initiation	-	122	119	-	-	1.57E-02	4.82E-03
BioGRID	BP	GO:0072176	nephric duct development	-	15	15	-	-	1.54E-03	6.02E-04
BioGRID	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	2.16E-03	2.06E-03
BioGRID	CC	GO:0005200	structural constituent of cytoskeleton	-	112	112	-	-	4.81E-03	4.52E-03
BioGRID	BP	GO:1901298	regulation of hydrogen peroxide-mediated programmed cell death	-	13	13	-	-	1.07E-03	5.52E-04
BioGRID	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	2.86E-03	2.06E-03
BioGRID	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	7.47E-03	6.02E-04
BioGRID	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	26	-	-	2.36E-02	1.05E-03
BioGRID	BP	GO:1903036	positive regulation of response to wounding	-	76	75	-	-	9.76E-03	3.01E-03
BioGRID	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	6.32E-03	8.53E-04
BioGRID	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	221	-	-	8.21E-03	8.89E-03
BioGRID	CC	GO:0001055	RNA polymerase II activity	-	11	11	-	-	1.62E-02	4.52E-04
BioGRID	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	3.90E-04	1.10E-03
BioGRID	BP	GO:0032528	microvillus organization	-	24	22	-	-	1.88E-03	9.04E-04
BioGRID	BP	GO:0021954	central nervous system neuron development	-	85	84	-	-	1.56E-03	3.41E-03
BioGRID	BP	GO:0055017	cardiac muscle tissue growth	-	92	84	-	-	2.54E-03	3.41E-03
BioGRID	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	4.25E-03	1.26E-03
BioGRID	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	12	-	-	3.55E-03	5.02E-04
BioGRID	BP	GO:0048524	positive regulation of viral process	-	64	64	-	-	1.29E-03	2.61E-03
BioGRID	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	12	-	-	6.51E-02	5.02E-04
BioGRID	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	20	-	-	4.23E-03	8.03E-04
BioGRID	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	25	-	-	8.71E-04	1.00E-03
BioGRID	BP	GO:0001946	lymphangiogenesis	-	18	18	-	-	1.53E-03	7.53E-04
BioGRID	BP	GO:0098661	inorganic anion transmembrane transport	-	140	134	-	-	1.66E-02	5.42E-03
BioGRID	BP	GO:0006099	tricarboxylic acid cycle	-	33	33	-	-	2.33E-02	1.36E-03
BioGRID	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	1.31E-03	7.53E-04
BioGRID	BP	GO:0009612	response to mechanical stimulus	-	215	214	-	-	5.02E-03	8.63E-03
BioGRID	BP	GO:0043697	cell dedifferentiation	-	12	12	-	-	6.85E-04	5.02E-04
BioGRID	BP	GO:0048644	muscle organ morphogenesis	-	81	80	-	-	5.48E-03	3.21E-03
BioGRID	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	156	-	-	4.51E-03	6.28E-03
BioGRID	BP	GO:1905874	regulation of postsynaptic density organization	-	13	12	-	-	5.80E-03	5.02E-04
BioGRID	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	5.43E-03	1.41E-03
BioGRID	BP	GO:0140115	export across plasma membrane	-	82	72	-	-	1.41E-02	2.91E-03
BioGRID	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	8.12E-04	5.02E-04
BioGRID	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	1.29E-03	1.56E-03
BioGRID	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	3.26E-02	5.02E-04
BioGRID	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.46E-04	4.52E-04
BioGRID	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	29	-	-	1.46E-03	1.20E-03
BioGRID	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	42	-	-	2.61E-03	1.71E-03
BioGRID	MF	GO:0003714	transcription corepressor activity	-	190	189	-	-	6.46E-03	7.63E-03
BioGRID	BP	GO:0035878	nail development	-	11	11	-	-	5.81E-03	4.52E-04
BioGRID	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	55	-	-	9.79E-03	2.21E-03
BioGRID	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	2.04E-03	6.53E-04
BioGRID	CC	GO:0006858	extracellular transport	-	45	44	-	-	2.27E-03	1.81E-03
BioGRID	BP	GO:0006304	DNA modification	-	30	30	-	-	6.28E-03	1.20E-03
BioGRID	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	3.74E-02	8.03E-04
BioGRID	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	5.24E-03	2.01E-03
BioGRID	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	23	-	-	7.07E-04	9.54E-04
BioGRID	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	8.71E-04	6.02E-04
BioGRID	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	42	-	-	5.47E-03	1.71E-03
BioGRID	BP	GO:0070417	cellular response to cold	-	13	13	-	-	6.48E-04	5.52E-04
BioGRID	BP	GO:0043523	regulation of neuron apoptotic process	-	218	216	-	-	3.90E-03	8.69E-03
BioGRID	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.82E-03	9.04E-04
BioGRID	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	7.54E-04	6.02E-04
BioGRID	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	5.61E-03	2.31E-03
BioGRID	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	4.49E-02	5.52E-04
BioGRID	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	2.31E-03	1.00E-03
BioGRID	BP	GO:0014029	neural crest formation	-	15	15	-	-	1.66E-02	6.02E-04
BioGRID	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	30	-	-	1.26E-03	1.20E-03
BioGRID	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	41	-	-	1.12E-03	1.66E-03
BioGRID	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	76	-	-	2.74E-03	3.06E-03
BioGRID	BP	GO:0003188	heart valve formation	-	16	16	-	-	1.12E-02	6.53E-04
BioGRID	CC	GO:0045324	late endosome to vacuole transport	-	37	37	-	-	3.53E-02	1.51E-03
BioGRID	BP	GO:0043954	cellular component maintenance	-	72	69	-	-	3.10E-03	2.81E-03
BioGRID	BP	GO:0050435	amyloid-beta metabolic process	-	65	59	-	-	8.42E-03	2.41E-03
BioGRID	BP	GO:0014823	response to activity	-	70	69	-	-	4.21E-03	2.81E-03
BioGRID	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	1.57E-03	7.53E-04
BioGRID	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	1.84E-02	1.15E-03
BioGRID	BP	GO:0034502	protein localization to chromosome	-	130	129	-	-	6.07E-03	5.22E-03
BioGRID	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	1.32E-04	4.52E-04
BioGRID	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	2.51E-03	4.52E-04
BioGRID	BP	GO:0060457	negative regulation of digestive system process	-	17	16	-	-	8.89E-02	6.53E-04
BioGRID	BP	GO:0019233	sensory perception of pain	-	103	102	-	-	1.65E-03	4.12E-03
BioGRID	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	1.22E-01	9.04E-04
BioGRID	BP	GO:0031343	positive regulation of cell killing	-	75	70	-	-	1.75E-02	2.81E-03
BioGRID	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	2.46E-03	1.56E-03
BioGRID	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	125	-	-	2.21E-02	5.02E-03
BioGRID	BP	GO:0017148	negative regulation of translation	-	390	204	-	-	3.25E-02	8.23E-03
BioGRID	BP	GO:0030220	platelet formation	-	22	22	-	-	9.85E-03	9.04E-04
BioGRID	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	94	-	-	2.55E-03	3.82E-03
BioGRID	MF	GO:1903624	regulation of DNA catabolic process	-	14	13	-	-	1.69E-03	5.52E-04
BioGRID	BP	GO:1901142	insulin metabolic process	-	14	13	-	-	9.25E-04	5.52E-04
BioGRID	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	3.31E-02	6.02E-04
BioGRID	BP	GO:1903509	liposaccharide metabolic process	-	109	108	-	-	6.02E-03	4.37E-03
BioGRID	BP	GO:0009582	detection of abiotic stimulus	-	140	134	-	-	5.44E-03	5.42E-03
BioGRID	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	1.12E-03	5.52E-04
BioGRID	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	18	-	-	1.48E-03	7.53E-04
BioGRID	CC	GO:0140238	presynaptic endocytosis	-	72	72	-	-	6.29E-03	2.91E-03
BioGRID	BP	GO:0051236	establishment of RNA localization	-	161	159	-	-	1.08E-02	6.43E-03
BioGRID	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	3.51E-02	1.00E-03
BioGRID	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	18	-	-	3.32E-03	7.53E-04
BioGRID	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	191	-	-	7.45E-03	7.68E-03
BioGRID	BP	GO:0034067	protein localization to Golgi apparatus	-	30	29	-	-	1.32E-03	1.20E-03
BioGRID	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	1.37E-03	1.31E-03
BioGRID	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	3.86E-03	4.52E-04
BioGRID	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	3.32E-03	7.03E-04
BioGRID	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	49	-	-	7.85E-04	2.01E-03
BioGRID	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	41	-	-	9.61E-04	1.66E-03
BioGRID	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	1.30E-03	2.11E-03
BioGRID	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	2.64E-03	6.53E-04
BioGRID	BP	GO:0050779	RNA destabilization	-	135	116	-	-	2.23E-02	4.67E-03
BioGRID	BP	GO:0006023	aminoglycan biosynthetic process	-	74	74	-	-	1.42E-02	3.01E-03
BioGRID	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	69	-	-	6.40E-03	2.81E-03
BioGRID	BP	GO:0010762	regulation of fibroblast migration	-	40	40	-	-	3.21E-03	1.61E-03
BioGRID	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	4.60E-03	1.20E-03
BioGRID	BP	GO:0035272	exocrine system development	-	46	46	-	-	2.33E-03	1.86E-03
BioGRID	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	8.24E-03	7.03E-04
BioGRID	BP	GO:0022406	membrane docking	-	90	90	-	-	1.33E-02	3.61E-03
BioGRID	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	1.10E-02	6.02E-04
BioGRID	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	17	-	-	5.87E-04	7.03E-04
BioGRID	BP	GO:0050777	negative regulation of immune response	-	196	192	-	-	1.15E-02	7.73E-03
BioGRID	MF	GO:0005035	death receptor activity	-	16	16	-	-	2.39E-03	6.53E-04
BioGRID	BP	GO:0002063	chondrocyte development	-	33	33	-	-	2.45E-03	1.36E-03
BioGRID	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	19	-	-	1.74E-03	8.03E-04
BioGRID	BP	GO:0099068	postsynapse assembly	-	40	39	-	-	7.07E-03	1.61E-03
BioGRID	BP	GO:0021782	glial cell development	-	120	115	-	-	2.10E-03	4.62E-03
BioGRID	BP	GO:0051782	negative regulation of cell division	-	18	17	-	-	1.18E-03	7.03E-04
BioGRID	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	6.15E-04	4.52E-04
BioGRID	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	84	-	-	2.25E-03	3.41E-03
BioGRID	BP	GO:0001655	urogenital system development	-	66	66	-	-	2.01E-03	2.66E-03
BioGRID	BP	GO:0071827	plasma lipoprotein particle organization	-	86	79	-	-	4.69E-03	3.21E-03
BioGRID	BP	GO:0045494	photoreceptor cell maintenance	-	43	43	-	-	1.52E-02	1.76E-03
BioGRID	BP	GO:0055088	lipid homeostasis	-	173	162	-	-	4.49E-03	6.53E-03
BioGRID	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	1.03E-03	1.05E-03
BioGRID	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	197	-	-	5.50E-03	7.93E-03
BioGRID	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	30	-	-	3.94E-02	1.20E-03
BioGRID	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	36	-	-	1.58E-03	1.46E-03
BioGRID	BP	GO:0045667	regulation of osteoblast differentiation	-	147	141	-	-	6.73E-03	5.67E-03
BioGRID	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	2.52E-03	6.53E-04
BioGRID	BP	GO:0061037	negative regulation of cartilage development	-	32	32	-	-	1.96E-03	1.31E-03
BioGRID	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	1.34E-02	1.61E-03
BioGRID	BP	GO:0001704	formation of primary germ layer	-	195	191	-	-	4.86E-03	7.68E-03
BioGRID	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	8.19E-03	5.52E-04
BioGRID	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	5.60E-03	2.06E-03
BioGRID	BP	GO:0060174	limb bud formation	-	11	11	-	-	5.96E-03	4.52E-04
BioGRID	BP	GO:0048708	astrocyte differentiation	-	88	86	-	-	1.40E-03	3.46E-03
BioGRID	BP	GO:0042092	type 2 immune response	-	41	40	-	-	7.73E-03	1.61E-03
BioGRID	BP	GO:0048588	developmental cell growth	-	233	225	-	-	4.31E-03	9.04E-03
BioGRID	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	1.08E-02	8.03E-04
BioGRID	BP	GO:0021872	forebrain generation of neurons	-	52	51	-	-	1.60E-03	2.06E-03
BioGRID	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	7.83E-04	9.04E-04
BioGRID	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	2.62E-02	1.61E-03
BioGRID	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	52	-	-	1.99E-02	2.11E-03
BioGRID	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	1.47E-03	4.52E-04
BioGRID	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	1.68E-02	1.41E-03
BioGRID	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	27	-	-	4.98E-04	1.10E-03
BioGRID	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	50	-	-	1.72E-03	2.01E-03
BioGRID	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	1.91E-02	8.03E-04
BioGRID	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	2.03E-03	8.03E-04
BioGRID	BP	GO:0010232	vascular transport	-	87	87	-	-	2.29E-03	3.51E-03
BioGRID	BP	GO:0021987	cerebral cortex development	-	125	122	-	-	2.40E-03	4.92E-03
BioGRID	BP	GO:0008637	apoptotic mitochondrial changes	-	108	107	-	-	1.38E-02	4.32E-03
BioGRID	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	36	-	-	1.89E-02	1.46E-03
BioGRID	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	6.68E-03	6.02E-04
BioGRID	BP	GO:0060999	positive regulation of dendritic spine development	-	35	35	-	-	4.31E-03	1.41E-03
BioGRID	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	1.76E-03	7.53E-04
BioGRID	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	2.50E-03	3.11E-03
BioGRID	BP	GO:0060973	cell migration involved in heart development	-	21	21	-	-	3.26E-03	8.53E-04
BioGRID	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	2.14E-03	8.03E-04
BioGRID	BP	GO:0002064	epithelial cell development	-	210	208	-	-	4.67E-03	8.38E-03
BioGRID	BP	GO:0071318	cellular response to ATP	-	18	17	-	-	3.32E-04	7.03E-04
BioGRID	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	40	-	-	2.62E-03	1.61E-03
BioGRID	BP	GO:2001222	regulation of neuron migration	-	46	46	-	-	5.67E-04	1.86E-03
BioGRID	BP	GO:0034389	lipid droplet organization	-	38	37	-	-	1.44E-03	1.51E-03
BioGRID	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	5.86E-04	1.81E-03
BioGRID	BP	GO:0042177	negative regulation of protein catabolic process	-	109	107	-	-	1.57E-03	4.32E-03
BioGRID	MF	GO:0038024	cargo receptor activity	-	121	115	-	-	4.22E-03	4.62E-03
BioGRID	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	18	-	-	8.47E-04	7.53E-04
BioGRID	BP	GO:0033120	positive regulation of RNA splicing	-	46	46	-	-	2.60E-02	1.86E-03
BioGRID	BP	GO:0051445	regulation of meiotic cell cycle	-	64	63	-	-	1.48E-02	2.56E-03
BioGRID	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	5.75E-04	5.02E-04
BioGRID	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	2.59E-03	2.41E-03
BioGRID	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	2.75E-03	6.02E-04
BioGRID	BP	GO:0090087	regulation of peptide transport	-	195	189	-	-	4.48E-03	7.63E-03
BioGRID	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	100	-	-	4.00E-03	4.02E-03
BioGRID	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	8.15E-04	1.00E-03
BioGRID	BP	GO:0006929	substrate-dependent cell migration	-	26	26	-	-	5.74E-04	1.05E-03
BioGRID	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	1.97E-04	6.02E-04
BioGRID	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	4.18E-02	1.10E-03
BioGRID	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	2.89E-03	6.02E-04
BioGRID	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	2.37E-03	6.02E-04
BioGRID	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	1.09E-01	8.03E-04
BioGRID	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	2.72E-03	5.52E-04
BioGRID	BP	GO:0022404	molting cycle process	-	95	95	-	-	2.01E-03	3.82E-03
BioGRID	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	12	-	-	2.03E-04	5.02E-04
BioGRID	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	2.85E-03	7.03E-04
BioGRID	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	1.39E-02	8.03E-04
BioGRID	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	1.42E-03	5.02E-04
BioGRID	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	19	-	-	5.36E-04	8.03E-04
BioGRID	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	33	-	-	1.48E-03	1.36E-03
BioGRID	BP	GO:0017014	protein nitrosylation	-	17	16	-	-	4.40E-03	6.53E-04
BioGRID	BP	GO:0008299	isoprenoid biosynthetic process	-	30	30	-	-	5.11E-03	1.20E-03
BioGRID	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	237	-	-	6.23E-03	9.54E-03
BioGRID	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.87E-03	1.26E-03
BioGRID	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	1.89E-03	9.04E-04
BioGRID	CC	GO:0098926	postsynaptic signal transduction	-	39	37	-	-	2.04E-03	1.51E-03
BioGRID	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	139	-	-	3.19E-03	5.62E-03
BioGRID	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	3.74E-02	8.03E-04
BioGRID	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	8.30E-04	1.91E-03
BioGRID	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	159	-	-	4.46E-03	6.43E-03
BioGRID	BP	GO:0034249	negative regulation of amide metabolic process	-	34	28	-	-	1.09E-03	1.15E-03
BioGRID	BP	GO:0061548	ganglion development	-	17	17	-	-	1.16E-02	7.03E-04
BioGRID	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	105	-	-	5.98E-03	4.22E-03
BioGRID	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	3.61E-03	6.02E-04
BioGRID	BP	GO:0042832	defense response to protozoan	-	28	27	-	-	2.31E-02	1.10E-03
BioGRID	BP	GO:0048799	animal organ maturation	-	33	33	-	-	1.88E-03	1.36E-03
BioGRID	BP	GO:0006925	inflammatory cell apoptotic process	-	23	22	-	-	5.37E-04	9.04E-04
BioGRID	BP	GO:2000291	regulation of myoblast proliferation	-	25	20	-	-	5.32E-04	8.03E-04
BioGRID	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	180	-	-	3.64E-03	7.23E-03
BioGRID	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.47E-04	4.52E-04
BioGRID	BP	GO:1903035	negative regulation of response to wounding	-	93	90	-	-	6.85E-03	3.61E-03
BioGRID	BP	GO:0015697	quaternary ammonium group transport	-	16	16	-	-	4.84E-03	6.53E-04
BioGRID	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	35	-	-	7.82E-04	1.41E-03
BioGRID	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	1.78E-03	1.10E-03
BioGRID	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	152	-	-	2.95E-02	6.12E-03
BioGRID	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	97	-	-	2.64E-03	3.92E-03
BioGRID	BP	GO:0045056	transcytosis	-	20	20	-	-	1.16E-03	8.03E-04
BioGRID	BP	GO:0018342	protein prenylation	-	15	15	-	-	1.16E-02	6.02E-04
BioGRID	BP	GO:0009267	cellular response to starvation	-	170	169	-	-	5.32E-03	6.83E-03
BioGRID	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	4.95E-03	4.52E-04
BioGRID	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	56	-	-	4.86E-03	2.26E-03
BioGRID	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	1.25E-01	6.53E-04
BioGRID	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	1.37E-03	9.54E-04
BioGRID	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	26	-	-	9.43E-03	1.05E-03
BioGRID	BP	GO:0046931	pore complex assembly	-	21	21	-	-	1.97E-03	8.53E-04
BioGRID	CC	GO:0032008	positive regulation of TOR signaling	-	52	52	-	-	3.06E-02	2.11E-03
BioGRID	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	1.11E-02	1.36E-03
BioGRID	BP	GO:0046618	xenobiotic export from cell	-	27	18	-	-	2.15E-03	7.53E-04
BioGRID	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	14	-	-	2.41E-03	6.02E-04
BioGRID	BP	GO:0060428	lung epithelium development	-	43	43	-	-	1.27E-03	1.76E-03
BioGRID	BP	GO:0030431	sleep	-	30	29	-	-	9.29E-03	1.20E-03
BioGRID	BP	GO:1903318	negative regulation of protein maturation	-	29	28	-	-	1.77E-03	1.15E-03
BioGRID	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	101	-	-	1.27E-01	4.07E-03
BioGRID	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	4.82E-04	7.03E-04
BioGRID	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	3.96E-03	6.02E-04
BioGRID	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	1.08E-02	4.52E-04
BioGRID	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.45E-04	5.52E-04
BioGRID	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	72	-	-	1.58E-02	2.91E-03
BioGRID	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	79	-	-	1.83E-03	3.21E-03
BioGRID	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	2.53E-03	7.03E-04
BioGRID	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	1.49E-04	6.02E-04
BioGRID	CC	GO:0006406	mRNA export from nucleus	-	69	69	-	-	9.91E-03	2.81E-03
BioGRID	BP	GO:0009880	embryonic pattern specification	-	70	68	-	-	3.08E-03	2.76E-03
BioGRID	BP	GO:0015791	polyol transmembrane transport	-	14	13	-	-	1.24E-03	5.52E-04
BioGRID	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	1.67E-01	1.61E-03
BioGRID	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	1.03E-02	1.00E-03
BioGRID	BP	GO:0034105	positive regulation of tissue remodeling	-	23	22	-	-	4.42E-02	9.04E-04
BioGRID	BP	GO:0002367	cytokine production involved in immune response	-	121	118	-	-	4.76E-03	4.77E-03
BioGRID	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	15	-	-	4.80E-04	6.02E-04
BioGRID	BP	GO:0044848	biological phase	-	211	209	-	-	9.85E-03	8.43E-03
BioGRID	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	5.32E-02	5.02E-04
BioGRID	BP	GO:0046660	female sex differentiation	-	125	124	-	-	5.88E-03	5.02E-03
BioGRID	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	7.67E-04	7.03E-04
BioGRID	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	45	-	-	7.82E-04	1.81E-03
BioGRID	BP	GO:0060411	cardiac septum morphogenesis	-	72	72	-	-	3.67E-03	2.91E-03
BioGRID	BP	GO:0071248	cellular response to metal ion	-	201	198	-	-	3.20E-03	7.98E-03
BioGRID	BP	GO:0030308	negative regulation of cell growth	-	191	188	-	-	3.85E-03	7.58E-03
BioGRID	BP	GO:0097306	cellular response to alcohol	-	99	92	-	-	6.09E-03	3.72E-03
BioGRID	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	127	-	-	2.89E-02	5.12E-03
BioGRID	BP	GO:0010453	regulation of cell fate commitment	-	40	38	-	-	1.65E-02	1.56E-03
BioGRID	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	58	-	-	2.36E-03	2.36E-03
BioGRID	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	56	-	-	1.85E-03	2.26E-03
BioGRID	BP	GO:0002026	regulation of the force of heart contraction	-	26	25	-	-	2.18E-03	1.00E-03
BioGRID	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	2.12E-02	1.00E-03
BioGRID	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	44	-	-	2.58E-03	1.81E-03
BioGRID	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	1.58E-03	3.11E-03
BioGRID	BP	GO:0071498	cellular response to fluid shear stress	-	21	20	-	-	1.79E-03	8.03E-04
BioGRID	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	7.61E-03	1.00E-03
BioGRID	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	94	-	-	2.51E-03	3.82E-03
BioGRID	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	25	-	-	1.56E-03	1.00E-03
BioGRID	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	2.67E-03	4.52E-04
BioGRID	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	54	-	-	4.89E-03	2.21E-03
BioGRID	BP	GO:0051259	protein complex oligomerization	-	251	249	-	-	6.20E-03	1.00E-02
BioGRID	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	5.16E-03	6.53E-04
BioGRID	BP	GO:0098743	cell aggregation	-	24	24	-	-	3.10E-04	1.00E-03
BioGRID	BP	GO:0035112	genitalia morphogenesis	-	12	11	-	-	3.76E-04	4.52E-04
BioGRID	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	6.59E-03	4.52E-04
BioGRID	BP	GO:0009994	oocyte differentiation	-	57	55	-	-	2.04E-03	2.21E-03
BioGRID	MF	GO:0031952	regulation of protein autophosphorylation	-	43	43	-	-	1.10E-03	1.76E-03
BioGRID	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	2.58E-04	6.02E-04
BioGRID	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	161	-	-	4.95E-03	6.48E-03
BioGRID	BP	GO:0044319	"wound healing, spreading of cells"	-	37	36	-	-	1.62E-03	1.46E-03
BioGRID	BP	GO:0033688	regulation of osteoblast proliferation	-	31	30	-	-	1.41E-03	1.20E-03
BioGRID	BP	GO:0060251	regulation of glial cell proliferation	-	39	38	-	-	5.79E-04	1.56E-03
BioGRID	BP	GO:0072665	protein localization to vacuole	-	84	84	-	-	5.36E-03	3.41E-03
BioGRID	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	46	-	-	2.55E-02	1.86E-03
BioGRID	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	25	-	-	1.97E-03	1.00E-03
BioGRID	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	72	-	-	4.60E-03	2.91E-03
BioGRID	BP	GO:0042953	lipoprotein transport	-	20	17	-	-	3.13E-03	7.03E-04
BioGRID	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	1.69E-02	6.02E-04
BioGRID	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.46E-04	4.52E-04
BioGRID	BP	GO:0042044	fluid transport	-	35	34	-	-	1.01E-03	1.41E-03
BioGRID	BP	GO:0070633	transepithelial transport	-	35	33	-	-	6.34E-04	1.36E-03
BioGRID	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	1.07E-02	5.52E-04
BioGRID	BP	GO:0045661	regulation of myoblast differentiation	-	74	74	-	-	8.40E-03	3.01E-03
BioGRID	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	15	-	-	2.79E-03	6.02E-04
BioGRID	BP	GO:0030307	positive regulation of cell growth	-	164	161	-	-	2.53E-03	6.48E-03
BioGRID	BP	GO:0034250	positive regulation of amide metabolic process	-	27	27	-	-	1.11E-03	1.10E-03
BioGRID	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	20	-	-	1.84E-03	8.03E-04
BioGRID	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	16	-	-	8.98E-04	6.53E-04
BioGRID	BP	GO:0014812	muscle cell migration	-	110	96	-	-	2.20E-03	3.87E-03
BioGRID	BP	GO:0048525	negative regulation of viral process	-	90	90	-	-	1.88E-03	3.61E-03
BioGRID	BP	GO:0072044	collecting duct development	-	16	16	-	-	5.91E-03	6.53E-04
BioGRID	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	6.29E-02	6.02E-04
BioGRID	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	73	-	-	3.21E-03	2.96E-03
BioGRID	BP	GO:0030238	male sex determination	-	14	14	-	-	8.00E-03	6.02E-04
BioGRID	BP	GO:0051781	positive regulation of cell division	-	93	90	-	-	2.22E-03	3.61E-03
BioGRID	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	6.80E-03	8.53E-04
BioGRID	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	1.39E-03	4.52E-04
BioGRID	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	2.90E-02	9.54E-04
BioGRID	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	22	-	-	1.45E-03	9.04E-04
BioGRID	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.13E-03	1.91E-03
BioGRID	BP	GO:0007272	ensheathment of neurons	-	146	143	-	-	3.79E-03	5.77E-03
BioGRID	CC	GO:0050806	positive regulation of synaptic transmission	-	171	153	-	-	3.63E-03	6.18E-03
BioGRID	BP	GO:0060021	roof of mouth development	-	91	90	-	-	4.29E-03	3.61E-03
BioGRID	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	40	-	-	3.67E-03	1.61E-03
BioGRID	BP	GO:0050819	negative regulation of coagulation	-	54	54	-	-	2.66E-02	2.21E-03
BioGRID	BP	GO:0017004	cytochrome complex assembly	-	40	40	-	-	5.97E-02	1.61E-03
BioGRID	BP	GO:0018410	C-terminal protein amino acid modification	-	15	15	-	-	5.67E-03	6.02E-04
BioGRID	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	4.14E-02	2.51E-03
BioGRID	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	2.98E-02	6.02E-04
BioGRID	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	15	-	-	1.16E-03	6.02E-04
BioGRID	CC	GO:0050805	negative regulation of synaptic transmission	-	55	53	-	-	6.07E-03	2.16E-03
BioGRID	BP	GO:0043248	proteasome assembly	-	13	13	-	-	1.49E-02	5.52E-04
BioGRID	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	59	-	-	1.25E-03	2.41E-03
BioGRID	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	1.48E-04	4.52E-04
BioGRID	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	82	-	-	4.36E-03	3.31E-03
BioGRID	BP	GO:0016054	organic acid catabolic process	-	251	246	-	-	1.45E-02	9.89E-03
BioGRID	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	4.62E-04	5.52E-04
BioGRID	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	5.96E-02	1.15E-03
BioGRID	BP	GO:0065005	protein-lipid complex assembly	-	29	29	-	-	2.42E-02	1.20E-03
BioGRID	BP	GO:0008033	tRNA processing	-	136	135	-	-	3.06E-02	5.42E-03
BioGRID	BP	GO:0046661	male sex differentiation	-	171	170	-	-	4.61E-03	6.83E-03
BioGRID	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	6.00E-04	6.02E-04
BioGRID	BP	GO:0000098	sulfur amino acid catabolic process	-	11	11	-	-	1.48E-04	4.52E-04
BioGRID	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	18	-	-	2.19E-03	7.53E-04
BioGRID	BP	GO:0035188	hatching	-	27	27	-	-	3.68E-04	1.10E-03
BioGRID	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	88	-	-	2.26E-03	3.56E-03
BioGRID	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	1.95E-04	6.02E-04
BioGRID	BP	GO:0090713	immunological memory process	-	18	17	-	-	1.00E-01	7.03E-04
BioGRID	BP	GO:0061326	renal tubule development	-	103	103	-	-	2.50E-03	4.17E-03
BioGRID	BP	GO:0071985	multivesicular body sorting pathway	-	56	55	-	-	1.80E-02	2.21E-03
BioGRID	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	1.88E-03	7.03E-04
BioGRID	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	1.23E-03	8.03E-04
BioGRID	BP	GO:0060325	face morphogenesis	-	31	31	-	-	1.04E-03	1.26E-03
BioGRID	BP	GO:0090559	regulation of membrane permeability	-	72	70	-	-	2.50E-03	2.81E-03
BioGRID	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	14	-	-	3.06E-03	6.02E-04
BioGRID	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	1.14E-02	5.02E-04
BioGRID	BP	GO:0031579	membrane raft organization	-	25	25	-	-	1.75E-03	1.00E-03
BioGRID	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	7.69E-04	1.00E-03
BioGRID	BP	GO:0060033	anatomical structure regression	-	16	16	-	-	9.89E-04	6.53E-04
BioGRID	BP	GO:0046460	neutral lipid biosynthetic process	-	50	49	-	-	6.40E-03	2.01E-03
BioGRID	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	149	-	-	1.17E-02	6.02E-03
BioGRID	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	4.22E-03	4.52E-04
BioGRID	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	162	-	-	2.93E-03	6.53E-03
BioGRID	BP	GO:0002251	organ or tissue specific immune response	-	43	42	-	-	2.08E-03	1.71E-03
BioGRID	CC	GO:0048167	regulation of synaptic plasticity	-	210	193	-	-	5.19E-03	7.78E-03
BioGRID	BP	GO:1903708	positive regulation of hemopoiesis	-	184	179	-	-	1.23E-02	7.23E-03
BioGRID	BP	GO:1903008	organelle disassembly	-	154	154	-	-	5.29E-03	6.23E-03
BioGRID	BP	GO:0001709	cell fate determination	-	44	44	-	-	1.78E-03	1.81E-03
BioGRID	BP	GO:0051873	killing by host of symbiont cells	-	28	28	-	-	5.11E-02	1.15E-03
BioGRID	BP	GO:0045058	T cell selection	-	53	53	-	-	1.44E-02	2.16E-03
BioGRID	CC	GO:0032387	negative regulation of intracellular transport	-	51	50	-	-	1.36E-03	2.01E-03
BioGRID	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	2.11E-03	8.03E-04
BioGRID	BP	GO:0072091	regulation of stem cell proliferation	-	91	83	-	-	1.80E-03	3.36E-03
BioGRID	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	42	-	-	3.52E-03	1.71E-03
BioGRID	BP	GO:0099084	postsynaptic specialization organization	-	44	43	-	-	8.05E-03	1.76E-03
BioGRID	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	5.91E-03	4.52E-04
BioGRID	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	3.90E-03	6.02E-04
BioGRID	BP	GO:0060384	innervation	-	27	27	-	-	6.69E-03	1.10E-03
BioGRID	BP	GO:2000774	positive regulation of cellular senescence	-	19	17	-	-	3.70E-04	7.03E-04
BioGRID	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	35	-	-	2.60E-03	1.41E-03
BioGRID	MF	GO:0031281	positive regulation of cyclase activity	-	40	38	-	-	1.22E-03	1.56E-03
BioGRID	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	4.26E-03	2.56E-03
BioGRID	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	17	-	-	1.95E-04	7.03E-04
BioGRID	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	1.63E-02	5.02E-04
BioGRID	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	2.57E-03	7.53E-04
BioGRID	BP	GO:0071453	cellular response to oxygen levels	-	168	164	-	-	4.47E-03	6.63E-03
BioGRID	BP	GO:0090399	replicative senescence	-	17	17	-	-	1.45E-03	7.03E-04
BioGRID	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	1.48E-04	6.02E-04
BioGRID	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	6.62E-03	1.20E-03
BioGRID	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	4.39E-03	5.02E-03
BioGRID	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	4.08E-02	6.02E-04
BioGRID	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	8.71E-04	1.00E-03
BioGRID	BP	GO:0044242	cellular lipid catabolic process	-	224	220	-	-	7.37E-03	8.84E-03
BioGRID	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	3.65E-04	5.52E-04
BioGRID	BP	GO:0002931	response to ischemia	-	58	56	-	-	2.55E-03	2.26E-03
BioGRID	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	2.42E-02	5.02E-04
BioGRID	BP	GO:0014047	glutamate secretion	-	25	25	-	-	9.62E-03	1.00E-03
BioGRID	BP	GO:0061005	cell differentiation involved in kidney development	-	58	57	-	-	2.57E-03	2.31E-03
BioGRID	BP	GO:0030397	membrane disassembly	-	11	11	-	-	6.86E-04	4.52E-04
BioGRID	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	76	-	-	8.86E-03	3.06E-03
BioGRID	BP	GO:0060420	regulation of heart growth	-	74	68	-	-	8.21E-03	2.76E-03
BioGRID	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	3.50E-04	6.02E-04
BioGRID	BP	GO:0009755	hormone-mediated signaling pathway	-	221	218	-	-	6.46E-03	8.79E-03
BioGRID	BP	GO:0022612	gland morphogenesis	-	124	123	-	-	2.95E-03	4.97E-03
BioGRID	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	35	-	-	6.66E-04	1.41E-03
BioGRID	MF	GO:0140416	transcription regulator inhibitor activity	-	26	26	-	-	1.99E-03	1.05E-03
BioGRID	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	26	-	-	1.41E-01	1.05E-03
BioGRID	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	2.54E-03	6.02E-04
BioGRID	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	8.45E-03	7.03E-04
BioGRID	BP	GO:1990845	adaptive thermogenesis	-	166	165	-	-	4.27E-03	6.63E-03
BioGRID	BP	GO:0071320	cellular response to cAMP	-	54	54	-	-	2.48E-02	2.21E-03
BioGRID	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	4.65E-03	4.52E-04
BioGRID	BP	GO:0015844	monoamine transport	-	88	88	-	-	7.89E-03	3.56E-03
BioGRID	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	23	-	-	4.62E-03	9.54E-04
BioGRID	BP	GO:0060039	pericardium development	-	19	19	-	-	5.88E-04	8.03E-04
BioGRID	BP	GO:0071392	cellular response to estradiol stimulus	-	40	40	-	-	1.25E-03	1.61E-03
BioGRID	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	16	-	-	3.44E-03	6.53E-04
BioGRID	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	1.01E-02	8.03E-04
BioGRID	BP	GO:0009451	RNA modification	-	169	166	-	-	1.35E-02	6.68E-03
BioGRID	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	2.53E-01	4.52E-04
BioGRID	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	39	-	-	1.26E-03	1.61E-03
BioGRID	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	1.62E-03	7.03E-04
BioGRID	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	113	-	-	5.75E-03	4.57E-03
BioGRID	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	44	-	-	7.43E-03	1.81E-03
BioGRID	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	1.49E-04	4.52E-04
BioGRID	BP	GO:0015807	L-amino acid transport	-	94	89	-	-	5.86E-03	3.61E-03
BioGRID	BP	GO:0032941	secretion by tissue	-	85	83	-	-	1.97E-03	3.36E-03
BioGRID	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	5.07E-03	5.52E-04
BioGRID	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	4.45E-03	2.21E-03
BioGRID	BP	GO:0048753	pigment granule organization	-	40	40	-	-	4.28E-02	1.61E-03
BioGRID	BP	GO:0021516	dorsal spinal cord development	-	20	16	-	-	3.70E-03	6.53E-04
BioGRID	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	2.43E-04	8.03E-04
BioGRID	BP	GO:0032196	transposition	-	11	11	-	-	3.77E-03	4.52E-04
BioGRID	BP	GO:0003014	renal system process	-	130	128	-	-	3.83E-03	5.17E-03
BioGRID	CC	GO:0070286	axonemal dynein complex assembly	-	40	39	-	-	3.22E-03	1.61E-03
BioGRID	BP	GO:0045598	regulation of fat cell differentiation	-	148	142	-	-	4.18E-03	5.72E-03
BioGRID	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	197	-	-	7.56E-03	7.93E-03
BioGRID	BP	GO:1904646	cellular response to amyloid-beta	-	44	43	-	-	1.09E-03	1.76E-03
BioGRID	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	1.08E-03	1.00E-03
BioGRID	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	226	-	-	3.22E-02	9.09E-03
BioGRID	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.38E-04	5.52E-04
BioGRID	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	5.51E-04	9.54E-04
BioGRID	BP	GO:0018158	protein oxidation	-	15	14	-	-	1.39E-03	6.02E-04
BioGRID	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	2.21E-03	1.20E-03
BioGRID	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	7.91E-03	7.03E-04
BioGRID	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	28	-	-	7.76E-04	1.15E-03
BioGRID	BP	GO:0071709	membrane assembly	-	68	67	-	-	1.69E-02	2.71E-03
BioGRID	BP	GO:0008217	regulation of blood pressure	-	186	182	-	-	6.69E-03	7.33E-03
BioGRID	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	1.91E-04	7.53E-04
BioGRID	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	5.56E-02	6.02E-04
BioGRID	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	61	-	-	2.11E-03	2.46E-03
BioGRID	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	8.17E-03	7.48E-03
BioGRID	BP	GO:0002200	somatic diversification of immune receptors	-	78	76	-	-	8.84E-03	3.06E-03
BioGRID	BP	GO:0035315	hair cell differentiation	-	52	52	-	-	2.04E-03	2.11E-03
BioGRID	BP	GO:0048645	animal organ formation	-	62	62	-	-	2.50E-03	2.51E-03
BioGRID	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	163	-	-	7.18E-03	6.58E-03
BioGRID	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	15	-	-	3.26E-02	6.02E-04
BioGRID	BP	GO:0033627	cell adhesion mediated by integrin	-	87	87	-	-	6.60E-03	3.51E-03
BioGRID	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	8.97E-03	8.53E-04
BioGRID	BP	GO:0035107	appendage morphogenesis	-	147	147	-	-	4.81E-03	5.92E-03
BioGRID	BP	GO:1903707	negative regulation of hemopoiesis	-	116	113	-	-	2.78E-03	4.57E-03
BioGRID	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	1.89E-04	8.03E-04
BioGRID	CC	GO:0048208	COPII vesicle coating	-	27	26	-	-	1.43E-02	1.05E-03
BioGRID	BP	GO:0030149	sphingolipid catabolic process	-	32	32	-	-	1.19E-03	1.31E-03
BioGRID	BP	GO:0050994	regulation of lipid catabolic process	-	61	59	-	-	2.89E-03	2.41E-03
BioGRID	BP	GO:0035988	chondrocyte proliferation	-	24	24	-	-	2.04E-03	1.00E-03
BioGRID	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	1.98E-02	1.20E-03
BioGRID	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	4.43E-03	4.52E-04
BioGRID	BP	GO:0009593	detection of chemical stimulus	-	511	238	-	-	5.13E-03	9.59E-03
BioGRID	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	1.31E-03	5.02E-04
BioGRID	BP	GO:0045727	positive regulation of translation	-	141	138	-	-	3.58E-03	5.57E-03
BioGRID	BP	GO:0036315	cellular response to sterol	-	24	20	-	-	4.71E-03	8.03E-04
BioGRID	CC	GO:0032388	positive regulation of intracellular transport	-	137	135	-	-	2.13E-03	5.42E-03
BioGRID	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	2.10E-03	5.52E-04
BioGRID	BP	GO:0002027	regulation of heart rate	-	106	102	-	-	2.32E-02	4.12E-03
BioGRID	BP	GO:0050879	multicellular organismal movement	-	118	116	-	-	2.19E-03	4.67E-03
BioGRID	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	3.99E-03	6.02E-04
BioGRID	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	77	-	-	1.77E-03	3.11E-03
BioGRID	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	62	-	-	1.57E-03	2.51E-03
BioGRID	BP	GO:0048515	spermatid differentiation	-	208	196	-	-	4.77E-03	7.88E-03
BioGRID	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	3.55E-03	2.31E-03
BioGRID	MF	GO:0042887	amide transmembrane transporter activity	-	33	32	-	-	1.57E-03	1.31E-03
BioGRID	BP	GO:0007130	synaptonemal complex assembly	-	23	23	-	-	8.91E-03	9.54E-04
BioGRID	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	35	-	-	3.00E-03	1.41E-03
BioGRID	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	34	-	-	4.55E-04	1.41E-03
BioGRID	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	38	-	-	3.06E-03	1.56E-03
BioGRID	BP	GO:0060119	inner ear receptor cell development	-	44	44	-	-	2.78E-03	1.81E-03
BioGRID	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	5.12E-03	7.53E-04
BioGRID	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	4.73E-02	1.41E-03
BioGRID	BP	GO:1901983	regulation of protein acetylation	-	26	26	-	-	7.89E-04	1.05E-03
BioGRID	BP	GO:0014854	response to inactivity	-	12	12	-	-	7.17E-04	5.02E-04
BioGRID	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	248	-	-	5.75E-03	9.99E-03
BioGRID	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	5.92E-04	7.03E-04
BioGRID	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	1.59E-02	1.96E-03
BioGRID	BP	GO:0010883	regulation of lipid storage	-	53	52	-	-	3.04E-03	2.11E-03
BioGRID	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	1.09E-03	1.05E-03
BioGRID	BP	GO:0007635	chemosensory behavior	-	20	20	-	-	2.28E-04	8.03E-04
BioGRID	BP	GO:1905954	positive regulation of lipid localization	-	110	110	-	-	3.35E-03	4.42E-03
BioGRID	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.77E-03	5.02E-04
BioGRID	BP	GO:0002209	behavioral defense response	-	39	39	-	-	7.06E-03	1.61E-03
BioGRID	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	4.19E-02	1.20E-03
BioGRID	BP	GO:0072523	purine-containing compound catabolic process	-	146	145	-	-	4.07E-03	5.82E-03
BioGRID	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	34	-	-	3.96E-03	1.41E-03
BioGRID	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	27	-	-	1.11E-03	1.10E-03
BioGRID	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	1.84E-03	6.53E-04
BioGRID	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	95	-	-	3.60E-03	3.82E-03
BioGRID	BP	GO:0007218	neuropeptide signaling pathway	-	113	104	-	-	3.24E-02	4.22E-03
BioGRID	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	13	-	-	8.51E-03	5.52E-04
BioGRID	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	160	-	-	4.77E-03	6.43E-03
BioGRID	BP	GO:0031345	negative regulation of cell projection organization	-	195	188	-	-	4.06E-03	7.58E-03
BioGRID	BP	GO:0048278	vesicle docking	-	64	64	-	-	1.58E-02	2.61E-03
BioGRID	BP	GO:0035050	embryonic heart tube development	-	86	85	-	-	4.35E-03	3.41E-03
BioGRID	BP	GO:0051593	response to folic acid	-	12	12	-	-	1.46E-04	5.02E-04
BioGRID	BP	GO:0030168	platelet activation	-	135	134	-	-	6.98E-03	5.42E-03
BioGRID	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	17	-	-	1.06E-02	7.03E-04
BioGRID	CC	GO:0098810	neurotransmitter reuptake	-	35	34	-	-	3.14E-03	1.41E-03
BioGRID	BP	GO:0008213	protein alkylation	-	58	57	-	-	3.78E-03	2.31E-03
BioGRID	BP	GO:0009812	flavonoid metabolic process	-	14	14	-	-	3.46E-01	6.02E-04
BioGRID	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	5.15E-03	5.52E-04
BioGRID	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	8.17E-03	1.00E-03
BioGRID	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	3.28E-04	5.52E-04
BioGRID	BP	GO:0031529	ruffle organization	-	55	55	-	-	2.16E-03	2.21E-03
BioGRID	BP	GO:0010842	retina layer formation	-	25	25	-	-	1.39E-03	1.00E-03
BioGRID	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	94	-	-	1.59E-02	3.82E-03
BioGRID	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	13	-	-	1.18E-01	5.52E-04
BioGRID	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	70	-	-	2.82E-03	2.81E-03
BioGRID	MF	GO:0170055	lipid transmembrane transporter activity	-	56	52	-	-	1.27E-02	2.11E-03
BioGRID	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	34	-	-	1.81E-03	1.41E-03
BioGRID	BP	GO:0035304	regulation of protein dephosphorylation	-	87	86	-	-	2.31E-03	3.46E-03
BioGRID	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	230	-	-	4.13E-03	9.24E-03
BioGRID	BP	GO:0099637	neurotransmitter receptor transport	-	26	26	-	-	1.51E-03	1.05E-03
BioGRID	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	38	-	-	1.56E-03	1.56E-03
BioGRID	BP	GO:0051775	response to redox state	-	13	13	-	-	9.25E-03	5.52E-04
BioGRID	BP	GO:0051785	positive regulation of nuclear division	-	61	60	-	-	1.67E-03	2.41E-03
BioGRID	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	1.89E-03	6.53E-04
BioGRID	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	2.72E-03	6.53E-04
BioGRID	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	6.26E-04	8.03E-04
BioGRID	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	4.69E-03	5.02E-04
BioGRID	BP	GO:0044786	cell cycle DNA replication	-	45	45	-	-	8.05E-03	1.81E-03
BioGRID	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	15	-	-	4.78E-03	6.02E-04
BioGRID	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	1.18E-03	7.03E-04
BioGRID	BP	GO:0051299	centrosome separation	-	15	15	-	-	1.58E-03	6.02E-04
BioGRID	BP	GO:0048145	regulation of fibroblast proliferation	-	87	85	-	-	2.06E-03	3.41E-03
BioGRID	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	89	-	-	2.10E-01	3.61E-03
BioGRID	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	4.61E-03	4.52E-04
BioGRID	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	231	-	-	4.12E-03	9.29E-03
BioGRID	BP	GO:0032098	regulation of appetite	-	20	20	-	-	1.09E-03	8.03E-04
BioGRID	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	5.31E-03	6.02E-04
BioGRID	CC	GO:0008333	endosome to lysosome transport	-	73	73	-	-	1.28E-02	2.96E-03
BioGRID	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	23	-	-	5.07E-02	9.54E-04
BioGRID	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	17	-	-	1.46E-02	7.03E-04
BioGRID	BP	GO:0003016	respiratory system process	-	39	38	-	-	7.84E-04	1.56E-03
BioGRID	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	1.00E-03	9.54E-04
BioGRID	BP	GO:0045732	positive regulation of protein catabolic process	-	202	201	-	-	4.21E-03	8.08E-03
BioGRID	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	73	-	-	7.34E-03	2.96E-03
BioGRID	BP	GO:0007588	excretion	-	40	40	-	-	1.84E-03	1.61E-03
BioGRID	BP	GO:1904018	positive regulation of vasculature development	-	185	174	-	-	4.50E-03	7.03E-03
BioGRID	BP	GO:0050953	sensory perception of light stimulus	-	223	214	-	-	1.71E-02	8.63E-03
BioGRID	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	4.72E-02	1.00E-03
BioGRID	BP	GO:0002357	defense response to tumor cell	-	13	12	-	-	4.52E-04	5.02E-04
BioGRID	BP	GO:0009303	rRNA transcription	-	37	37	-	-	4.27E-03	1.51E-03
BioGRID	BP	GO:0035601	protein deacylation	-	56	56	-	-	3.99E-03	2.26E-03
BioGRID	BP	GO:0061952	midbody abscission	-	18	18	-	-	2.29E-02	7.53E-04
BioGRID	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	5.44E-03	4.52E-04
BioGRID	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	21	-	-	1.34E-03	8.53E-04
BioGRID	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	36	-	-	8.99E-04	1.46E-03
BioGRID	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	2.65E-03	2.61E-03
BioGRID	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	16	-	-	1.94E-04	6.53E-04
BioGRID	BP	GO:0045830	positive regulation of isotype switching	-	28	26	-	-	1.43E-02	1.05E-03
BioGRID	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	2.35E-03	1.36E-03
BioGRID	BP	GO:0046697	decidualization	-	26	26	-	-	5.02E-04	1.05E-03
BioGRID	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	1.47E-04	6.02E-04
BioGRID	BP	GO:0051588	regulation of neurotransmitter transport	-	99	98	-	-	3.67E-03	3.97E-03
BioGRID	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	31	-	-	8.97E-02	1.26E-03
BioGRID	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	1.01E-03	5.02E-04
BioGRID	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	4.70E-03	2.56E-03
BioGRID	BP	GO:0044703	multi-organism reproductive process	-	209	208	-	-	5.72E-03	8.38E-03
BioGRID	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	141	-	-	5.26E-03	5.67E-03
BioGRID	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	9.04E-02	4.52E-04
BioGRID	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	52	-	-	7.78E-03	2.11E-03
BioGRID	BP	GO:0099022	vesicle tethering	-	32	32	-	-	6.90E-02	1.31E-03
BioGRID	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	37	-	-	1.28E-03	1.51E-03
BioGRID	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	1.44E-04	5.02E-04
BioGRID	BP	GO:0048857	neural nucleus development	-	65	65	-	-	5.45E-03	2.61E-03
BioGRID	BP	GO:0048663	neuron fate commitment	-	74	73	-	-	3.56E-03	2.96E-03
BioGRID	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	175	-	-	3.62E-03	7.03E-03
BioGRID	BP	GO:0106027	neuron projection organization	-	90	90	-	-	2.74E-03	3.61E-03
BioGRID	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	134	-	-	9.20E-03	5.42E-03
BioGRID	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	38	-	-	1.94E-03	1.56E-03
BioGRID	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	1.58E-03	4.52E-04
BioGRID	BP	GO:0045685	regulation of glial cell differentiation	-	77	75	-	-	2.55E-03	3.01E-03
BioGRID	BP	GO:0051608	histamine transport	-	14	14	-	-	1.76E-03	6.02E-04
BioGRID	BP	GO:0043414	macromolecule methylation	-	138	136	-	-	8.12E-03	5.47E-03
BioGRID	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	1.46E-04	5.02E-04
BioGRID	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	2.56E-02	6.53E-04
BioGRID	BP	GO:0050886	endocrine process	-	93	91	-	-	1.45E-03	3.66E-03
BioGRID	MF	GO:0015562	efflux transmembrane transporter activity	-	15	14	-	-	5.47E-04	6.02E-04
BioGRID	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	5.70E-04	1.15E-03
BioGRID	BP	GO:0045807	positive regulation of endocytosis	-	155	153	-	-	5.29E-03	6.18E-03
BioGRID	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	8.29E-04	4.52E-04
BioGRID	BP	GO:0002418	immune response to tumor cell	-	29	28	-	-	1.01E-02	1.15E-03
BioGRID	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	62	-	-	1.74E-03	2.51E-03
BioGRID	BP	GO:0048308	organelle inheritance	-	14	14	-	-	9.81E-04	6.02E-04
BioGRID	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	23	-	-	6.00E-04	9.54E-04
BioGRID	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	6.37E-04	8.03E-04
BioGRID	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	52	-	-	1.35E-03	2.11E-03
BioGRID	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.44E-03	2.71E-03
BioGRID	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	1.45E-04	5.02E-04
BioGRID	BP	GO:0009110	vitamin biosynthetic process	-	23	22	-	-	8.11E-04	9.04E-04
BioGRID	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	23	-	-	2.68E-03	9.54E-04
BioGRID	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	1.79E-03	7.03E-04
BioGRID	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	21	-	-	1.24E-03	8.53E-04
BioGRID	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	103	-	-	2.29E-03	4.17E-03
BioGRID	BP	GO:0009111	vitamin catabolic process	-	13	12	-	-	1.00E-02	5.02E-04
BioGRID	MF	GO:0051100	negative regulation of binding	-	161	157	-	-	3.54E-03	6.33E-03
BioGRID	BP	GO:0003151	outflow tract morphogenesis	-	81	81	-	-	4.27E-03	3.26E-03
BioGRID	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	1.48E-03	2.41E-03
BioGRID	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	1.24E-03	8.03E-04
BioGRID	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	13	-	-	3.92E-04	5.52E-04
BioGRID	BP	GO:0046504	glycerol ether biosynthetic process	-	11	11	-	-	5.27E-04	4.52E-04
BioGRID	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	4.35E-02	1.36E-03
BioGRID	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	9.90E-04	6.53E-04
BioGRID	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	5.58E-04	5.52E-04
BioGRID	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	1.78E-03	1.91E-03
BioGRID	BP	GO:0046621	negative regulation of organ growth	-	39	37	-	-	1.52E-03	1.51E-03
BioGRID	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	8.47E-02	2.01E-03
BioGRID	BP	GO:0032368	regulation of lipid transport	-	149	141	-	-	3.27E-03	5.67E-03
BioGRID	BP	GO:0055094	response to lipoprotein particle	-	34	32	-	-	3.35E-03	1.31E-03
BioGRID	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	182	-	-	7.55E-03	7.33E-03
BioGRID	BP	GO:0033002	muscle cell proliferation	-	249	223	-	-	6.05E-03	8.99E-03
BioGRID	BP	GO:0043331	response to dsRNA	-	56	56	-	-	2.90E-02	2.26E-03
BioGRID	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	5.73E-03	5.02E-04
BioGRID	BP	GO:0051904	pigment granule transport	-	23	23	-	-	2.15E-02	9.54E-04
BioGRID	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	1.35E-03	1.31E-03
BioGRID	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	34	-	-	1.20E-03	1.41E-03
BioGRID	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	12	-	-	2.29E-03	5.02E-04
BioGRID	BP	GO:0033363	secretory granule organization	-	63	61	-	-	9.76E-03	2.46E-03
BioGRID	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	1.09E-03	1.15E-03
BioGRID	BP	GO:0120009	intermembrane lipid transfer	-	52	52	-	-	2.03E-02	2.11E-03
BioGRID	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	4.23E-03	6.02E-04
BioGRID	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	9.91E-04	1.56E-03
BioGRID	BP	GO:0097250	mitochondrial respirasome assembly	-	11	11	-	-	9.48E-03	4.52E-04
BioGRID	BP	GO:0033622	integrin activation	-	26	26	-	-	2.23E-03	1.05E-03
BioGRID	BP	GO:0098751	bone cell development	-	18	16	-	-	4.68E-04	6.53E-04
BioGRID	BP	GO:2000773	negative regulation of cellular senescence	-	25	23	-	-	8.74E-04	9.54E-04
BioGRID	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	1.83E-03	2.06E-03
BioGRID	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.49E-02	1.20E-03
BioGRID	BP	GO:0002076	osteoblast development	-	17	17	-	-	1.39E-02	7.03E-04
BioGRID	BP	GO:0072164	mesonephric tubule development	-	98	98	-	-	5.12E-03	3.97E-03
BioGRID	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	1.94E-04	7.03E-04
BioGRID	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	114	-	-	3.21E-03	4.62E-03
BioGRID	BP	GO:1903524	positive regulation of blood circulation	-	39	37	-	-	2.41E-03	1.51E-03
BioGRID	BP	GO:0030901	midbrain development	-	87	86	-	-	2.38E-03	3.46E-03
BioGRID	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	8.03E-03	9.04E-04
BioGRID	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	1.13E-03	6.53E-04
BioGRID	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	14	-	-	1.40E-03	6.02E-04
BioGRID	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	68	-	-	1.66E-03	2.76E-03
BioGRID	MF	GO:1901474	azole transmembrane transporter activity	-	13	13	-	-	4.19E-03	5.52E-04
BioGRID	BP	GO:0002687	positive regulation of leukocyte migration	-	147	145	-	-	5.85E-03	5.82E-03
BioGRID	BP	GO:0019755	one-carbon compound transport	-	28	27	-	-	4.27E-02	1.10E-03
BioGRID	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.41E-04	5.52E-04
BioGRID	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	4.53E-03	6.53E-04
BioGRID	BP	GO:0110154	RNA decapping	-	19	19	-	-	2.11E-02	8.03E-04
BioGRID	BP	GO:0034605	cellular response to heat	-	66	66	-	-	1.72E-03	2.66E-03
BioGRID	BP	GO:0005996	monosaccharide metabolic process	-	250	243	-	-	6.21E-03	9.79E-03
BioGRID	BP	GO:0033555	multicellular organismal response to stress	-	90	90	-	-	4.18E-03	3.61E-03
BioGRID	BP	GO:0002262	myeloid cell homeostasis	-	172	170	-	-	3.95E-03	6.83E-03
BioGRID	BP	GO:0000966	RNA 5'-end processing	-	39	39	-	-	4.97E-02	1.61E-03
BioGRID	BP	GO:0050688	regulation of defense response to virus	-	65	65	-	-	4.05E-03	2.61E-03
BioGRID	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	27	-	-	1.31E-03	1.10E-03
BioGRID	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	227	-	-	8.24E-03	9.14E-03
BioGRID	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	6.65E-04	1.26E-03
BioGRID	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	3.96E-04	6.02E-04
BioGRID	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	35	-	-	2.59E-03	1.41E-03
BioGRID	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	20	-	-	2.35E-04	8.03E-04
BioGRID	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	6.58E-03	1.15E-03
BioGRID	BP	GO:0022618	protein-RNA complex assembly	-	227	214	-	-	2.39E-02	8.63E-03
BioGRID	BP	GO:0051147	regulation of muscle cell differentiation	-	162	153	-	-	5.13E-03	6.18E-03
BioGRID	BP	GO:0014745	negative regulation of muscle adaptation	-	11	11	-	-	2.82E-03	4.52E-04
BioGRID	BP	GO:0090102	cochlea development	-	50	48	-	-	2.53E-03	1.96E-03
BioGRID	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	3.06E-03	1.05E-03
BioGRID	BP	GO:0061303	cornea development in camera-type eye	-	12	12	-	-	1.48E-04	5.02E-04
BioGRID	BP	GO:0045933	positive regulation of muscle contraction	-	49	48	-	-	9.56E-04	1.96E-03
BioGRID	BP	GO:0015803	branched-chain amino acid transport	-	14	14	-	-	5.31E-03	6.02E-04
BioGRID	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	1.83E-03	6.53E-04
BioGRID	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	35	-	-	4.32E-03	1.41E-03
BioGRID	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	93	-	-	4.90E-02	3.77E-03
BioGRID	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.63E-03	5.02E-04
BioGRID	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	1.75E-03	9.04E-04
BioGRID	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	7.04E-03	2.86E-03
BioGRID	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	54	-	-	1.92E-02	2.21E-03
BioGRID	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	21	-	-	3.48E-02	8.53E-04
BioGRID	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	57	-	-	6.79E-03	2.31E-03
BioGRID	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	8.75E-04	4.52E-04
BioGRID	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	3.75E-03	1.56E-03
BioGRID	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.44E-04	5.02E-04
BioGRID	BP	GO:0140253	cell-cell fusion	-	62	57	-	-	3.37E-03	2.31E-03
BioGRID	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	5.08E-03	5.02E-04
BioGRID	BP	GO:0071599	otic vesicle development	-	15	15	-	-	6.89E-03	6.02E-04
BioGRID	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	43	-	-	2.07E-02	1.76E-03
BioGRID	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	1.30E-03	6.02E-04
BioGRID	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	61	-	-	5.88E-03	2.46E-03
BioGRID	BP	GO:0001941	postsynaptic membrane organization	-	37	37	-	-	2.85E-02	1.51E-03
BioGRID	BP	GO:0051293	establishment of spindle localization	-	57	56	-	-	3.03E-03	2.26E-03
BioGRID	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	2.70E-04	5.02E-04
BioGRID	BP	GO:0043114	regulation of vascular permeability	-	49	46	-	-	2.81E-03	1.86E-03
BioGRID	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	2.68E-03	1.05E-03
BioGRID	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	64	-	-	9.55E-04	2.61E-03
BioGRID	BP	GO:0008360	regulation of cell shape	-	139	139	-	-	6.62E-03	5.62E-03
BioGRID	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	1.28E-03	6.53E-04
BioGRID	BP	GO:0051222	positive regulation of protein transport	-	249	241	-	-	4.34E-03	9.69E-03
BioGRID	CC	GO:0140632	canonical inflammasome complex assembly	-	40	39	-	-	5.82E-03	1.61E-03
BioGRID	MF	GO:0034260	negative regulation of GTPase activity	-	36	35	-	-	3.33E-03	1.41E-03
BioGRID	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	2.99E-03	9.04E-04
BioGRID	BP	GO:0045739	positive regulation of DNA repair	-	128	127	-	-	2.29E-02	5.12E-03
BioGRID	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	4.75E-03	8.03E-04
BioGRID	BP	GO:0045185	maintenance of protein location	-	95	91	-	-	1.60E-03	3.66E-03
BioGRID	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	1.79E-01	5.52E-04
BioGRID	BP	GO:0003158	endothelium development	-	140	132	-	-	7.76E-03	5.32E-03
BioGRID	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	1.11E-03	1.66E-03
BioGRID	BP	GO:0051224	negative regulation of protein transport	-	122	118	-	-	2.07E-03	4.77E-03
BioGRID	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	158	-	-	2.92E-03	6.38E-03
BioGRID	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	6.12E-03	5.52E-04
BioGRID	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	1.25E-02	1.26E-03
BioGRID	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	5.30E-02	8.03E-04
BioGRID	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	1.91E-03	2.56E-03
BioGRID	BP	GO:0007405	neuroblast proliferation	-	81	78	-	-	2.97E-03	3.16E-03
BioGRID	BP	GO:0009581	detection of external stimulus	-	137	131	-	-	6.93E-03	5.27E-03
BioGRID	BP	GO:1990542	mitochondrial transmembrane transport	-	93	92	-	-	1.55E-02	3.72E-03
BioGRID	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	32	-	-	1.84E-03	1.31E-03
BioGRID	BP	GO:0033504	floor plate development	-	11	11	-	-	5.23E-03	4.52E-04
BioGRID	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	5.88E-03	4.52E-04
BioGRID	BP	GO:0097186	amelogenesis	-	26	25	-	-	2.79E-04	1.00E-03
BioGRID	BP	GO:0070572	positive regulation of neuron projection regeneration	-	13	12	-	-	2.70E-04	5.02E-04
BioGRID	BP	GO:0031128	developmental induction	-	26	26	-	-	9.62E-04	1.05E-03
BioGRID	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	1.81E-03	6.02E-04
BioGRID	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	9.67E-04	2.66E-03
BioGRID	BP	GO:0021533	cell differentiation in hindbrain	-	23	21	-	-	3.56E-03	8.53E-04
BioGRID	BP	GO:0045684	positive regulation of epidermis development	-	33	33	-	-	1.81E-03	1.36E-03
BioGRID	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	5.27E-04	5.02E-04
BioGRID	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	1.78E-02	2.06E-03
BioGRID	BP	GO:0021517	ventral spinal cord development	-	47	46	-	-	8.61E-03	1.86E-03
BioGRID	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	2.65E-03	3.01E-03
BioGRID	BP	GO:0032328	alanine transport	-	19	17	-	-	2.01E-03	7.03E-04
BioGRID	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	1.27E-03	6.53E-04
BioGRID	BP	GO:0097722	sperm motility	-	133	123	-	-	1.49E-02	4.97E-03
BioGRID	BP	GO:0051231	spindle elongation	-	14	14	-	-	6.61E-03	6.02E-04
BioGRID	BP	GO:0042490	mechanoreceptor differentiation	-	67	67	-	-	2.02E-03	2.71E-03
BioGRID	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.74E-03	1.20E-03
BioGRID	BP	GO:0035148	tube formation	-	155	153	-	-	4.18E-03	6.18E-03
BioGRID	BP	GO:0048520	positive regulation of behavior	-	27	26	-	-	5.38E-02	1.05E-03
BioGRID	BP	GO:0098543	detection of other organism	-	19	18	-	-	4.54E-02	7.53E-04
BioGRID	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	4.63E-03	1.76E-03
BioGRID	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	123	-	-	5.66E-03	4.97E-03
BioGRID	BP	GO:0031123	RNA 3'-end processing	-	79	78	-	-	5.73E-03	3.16E-03
BioGRID	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	17	-	-	7.87E-04	7.03E-04
BioGRID	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	111	-	-	7.83E-03	4.47E-03
BioGRID	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	4.13E-03	7.53E-04
BioGRID	CC	GO:0007097	nuclear migration	-	24	24	-	-	1.60E-03	1.00E-03
BioGRID	BP	GO:0006885	regulation of pH	-	104	99	-	-	1.08E-02	4.02E-03
BioGRID	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.22E-03	6.02E-04
BioGRID	BP	GO:1990840	response to lectin	-	22	20	-	-	2.06E-03	8.03E-04
BioGRID	BP	GO:0071800	podosome assembly	-	19	19	-	-	7.62E-04	8.03E-04
BioGRID	BP	GO:0031018	endocrine pancreas development	-	47	46	-	-	5.06E-03	1.86E-03
BioGRID	BP	GO:0001708	cell fate specification	-	108	107	-	-	6.88E-03	4.32E-03
BioGRID	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	88	-	-	1.38E-02	3.56E-03
BioGRID	BP	GO:0060354	negative regulation of cell adhesion molecule production	-	15	11	-	-	1.47E-04	4.52E-04
BioGRID	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	1.19E-03	1.51E-03
BioGRID	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	20	-	-	6.53E-03	8.03E-04
BioGRID	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	16	-	-	1.03E-03	6.53E-04
BioGRID	BP	GO:0032966	negative regulation of collagen biosynthetic process	-	13	11	-	-	1.46E-04	4.52E-04
BioGRID	BP	GO:0042440	pigment metabolic process	-	80	79	-	-	1.33E-02	3.21E-03
BioGRID	BP	GO:1901606	alpha-amino acid catabolic process	-	101	100	-	-	9.06E-03	4.02E-03
BioGRID	BP	GO:1901890	positive regulation of cell junction assembly	-	106	102	-	-	6.35E-03	4.12E-03
BioGRID	BP	GO:0070988	demethylation	-	27	27	-	-	1.44E-02	1.10E-03
BioGRID	BP	GO:1901655	cellular response to ketone	-	107	104	-	-	6.64E-03	4.22E-03
BioGRID	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	2.33E-03	6.02E-04
BioGRID	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	4.09E-03	6.02E-04
BioGRID	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	6.03E-02	7.03E-04
BioGRID	BP	GO:0006968	cellular defense response	-	52	51	-	-	5.48E-03	2.06E-03
BioGRID	BP	GO:0055006	cardiac cell development	-	93	89	-	-	1.52E-03	3.61E-03
BioGRID	BP	GO:0031365	N-terminal protein amino acid modification	-	30	29	-	-	6.50E-03	1.20E-03
BioGRID	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	1.49E-04	5.02E-04
BioGRID	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	29	-	-	1.41E-03	1.20E-03
BioGRID	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	13	-	-	1.93E-04	5.52E-04
BioGRID	BP	GO:0060004	reflex	-	63	62	-	-	5.28E-03	2.51E-03
BioGRID	BP	GO:0044706	multi-multicellular organism process	-	217	216	-	-	5.16E-03	8.69E-03
BioGRID	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	1.93E-03	5.02E-04
BioGRID	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	139	-	-	3.11E-03	5.62E-03
BioGRID	BP	GO:0006026	aminoglycan catabolic process	-	34	34	-	-	1.24E-02	1.41E-03
BioGRID	BP	GO:0031294	lymphocyte costimulation	-	47	45	-	-	3.97E-03	1.81E-03
BioGRID	BP	GO:0050768	negative regulation of neurogenesis	-	150	144	-	-	2.65E-03	5.82E-03
BioGRID	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	96	-	-	2.14E-03	3.87E-03
BioGRID	BP	GO:0042118	endothelial cell activation	-	11	11	-	-	4.83E-03	4.52E-04
BioGRID	BP	GO:0043605	amide catabolic process	-	16	16	-	-	1.45E-02	6.53E-04
BioGRID	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	4.79E-02	1.10E-03
BioGRID	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	5.39E-02	1.41E-03
BioGRID	BP	GO:1902115	regulation of organelle assembly	-	210	208	-	-	4.86E-03	8.38E-03
BioGRID	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	76	-	-	1.96E-03	3.06E-03
BioGRID	BP	GO:0047484	regulation of response to osmotic stress	-	16	15	-	-	3.31E-03	6.02E-04
BioGRID	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	144	-	-	3.21E-03	5.82E-03
BioGRID	BP	GO:0043171	peptide catabolic process	-	19	19	-	-	4.53E-04	8.03E-04
BioGRID	BP	GO:0046622	positive regulation of organ growth	-	52	48	-	-	1.92E-03	1.96E-03
BioGRID	BP	GO:0051952	regulation of amine transport	-	98	98	-	-	3.59E-03	3.97E-03
BioGRID	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	3.06E-03	9.54E-04
BioGRID	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	9.70E-03	8.03E-04
BioGRID	BP	GO:0015801	aromatic amino acid transport	-	13	12	-	-	5.46E-03	5.02E-04
BioGRID	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	3.46E-03	9.54E-04
BioGRID	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	1.01E-03	8.03E-04
BioGRID	BP	GO:1903242	regulation of cardiac muscle hypertrophy in response to stress	-	18	17	-	-	4.65E-04	7.03E-04
BioGRID	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	1.92E-04	6.53E-04
BioGRID	CC	GO:0032365	intracellular lipid transport	-	51	51	-	-	2.47E-02	2.06E-03
BioGRID	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	1.38E-02	1.20E-03
BioGRID	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	80	-	-	1.82E-03	3.21E-03
BioGRID	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	116	-	-	2.41E-03	4.67E-03
BioGRID	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	3.66E-02	1.15E-03
BioGRID	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	29	-	-	7.00E-04	1.20E-03
BioGRID	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	1.18E-03	5.52E-04
BioGRID	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	3.41E-04	6.02E-04
BioGRID	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	1.37E-04	5.52E-04
BioGRID	BP	GO:0071398	cellular response to fatty acid	-	35	35	-	-	4.72E-03	1.41E-03
BioGRID	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	6.96E-02	4.52E-04
BioGRID	BP	GO:0097581	lamellipodium organization	-	91	90	-	-	5.16E-03	3.61E-03
BioGRID	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	30	-	-	1.80E-02	1.20E-03
BioGRID	BP	GO:1903975	regulation of glial cell migration	-	20	20	-	-	1.18E-02	8.03E-04
BioGRID	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	1.34E-03	8.53E-04
BioGRID	BP	GO:0015669	gas transport	-	23	23	-	-	1.92E-02	9.54E-04
BioGRID	BP	GO:0016485	protein processing	-	248	242	-	-	6.91E-03	9.74E-03
BioGRID	BP	GO:0009649	entrainment of circadian clock	-	30	30	-	-	2.72E-03	1.20E-03
BioGRID	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	164	-	-	1.44E-02	6.63E-03
BioGRID	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	5.58E-04	1.00E-03
BioGRID	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	135	-	-	8.52E-03	5.42E-03
BioGRID	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	6.75E-02	5.02E-04
BioGRID	BP	GO:0099054	presynapse assembly	-	49	46	-	-	2.06E-03	1.86E-03
BioGRID	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	1.51E-01	5.02E-04
BioGRID	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	27	-	-	2.10E-03	1.10E-03
BioGRID	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	3.58E-03	1.00E-03
BioGRID	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	79	-	-	3.57E-03	3.21E-03
BioGRID	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	2.11E-03	2.76E-03
BioGRID	BP	GO:0071496	cellular response to external stimulus	-	74	74	-	-	4.33E-03	3.01E-03
BioGRID	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	16	-	-	1.71E-02	6.53E-04
BioGRID	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	1.50E-02	7.03E-04
BioGRID	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	13	-	-	6.74E-04	5.52E-04
BioGRID	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	3.41E-03	5.02E-04
BioGRID	BP	GO:0032094	response to food	-	37	37	-	-	8.73E-04	1.51E-03
BioGRID	BP	GO:0001964	startle response	-	27	27	-	-	1.73E-03	1.10E-03
BioGRID	BP	GO:0007340	acrosome reaction	-	38	34	-	-	1.14E-03	1.41E-03
BioGRID	BP	GO:0046434	organophosphate catabolic process	-	232	231	-	-	5.20E-03	9.29E-03
BioGRID	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	1.25E-02	1.20E-03
BioGRID	BP	GO:0009566	fertilization	-	205	189	-	-	5.20E-03	7.63E-03
BioGRID	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	2.10E-01	2.41E-03
BioGRID	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	2.42E-04	1.00E-03
BioGRID	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	2.78E-03	5.52E-04
BioGRID	BP	GO:0045907	positive regulation of vasoconstriction	-	30	30	-	-	1.33E-03	1.20E-03
BioGRID	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	23	-	-	8.27E-03	9.54E-04
BioGRID	BP	GO:0033044	regulation of chromosome organization	-	249	249	-	-	1.15E-02	1.00E-02
BioGRID	BP	GO:0009309	amine biosynthetic process	-	38	37	-	-	1.80E-02	1.51E-03
BioGRID	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	20	-	-	2.39E-04	8.03E-04
BioGRID	BP	GO:0061900	glial cell activation	-	56	54	-	-	1.18E-03	2.21E-03
BioGRID	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	131	-	-	6.68E-03	5.27E-03
BioGRID	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	12	-	-	5.60E-04	5.02E-04
BioGRID	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	2.80E-03	6.02E-04
BioGRID	BP	GO:0021794	thalamus development	-	12	12	-	-	1.07E-03	5.02E-04
BioGRID	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	1.19E-02	1.66E-03
BioGRID	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	3.31E-04	8.03E-04
BioGRID	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	8.59E-04	6.02E-04
BioGRID	BP	GO:0072537	fibroblast activation	-	13	13	-	-	2.73E-03	5.52E-04
BioGRID	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	2.52E-03	5.52E-04
BioGRID	BP	GO:0043647	inositol phosphate metabolic process	-	44	44	-	-	4.92E-03	1.81E-03
BioGRID	BP	GO:0016180	snRNA processing	-	28	27	-	-	6.10E-02	1.10E-03
BioGRID	BP	GO:0051303	establishment of chromosome localization	-	104	104	-	-	5.51E-03	4.22E-03
BioGRID	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	5.41E-03	6.53E-04
BioGRID	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	3.60E-03	1.56E-03
BioGRID	BP	GO:0097164	ammonium ion metabolic process	-	23	23	-	-	2.25E-02	9.54E-04
BioGRID	BP	GO:0021515	cell differentiation in spinal cord	-	51	48	-	-	5.91E-03	1.96E-03
BioGRID	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	7.29E-04	7.53E-04
BioGRID	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	1.98E-03	8.53E-04
BioGRID	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	1.93E-03	1.15E-03
BioGRID	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.38E-03	7.53E-04
BioGRID	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	37	-	-	2.55E-03	1.51E-03
BioGRID	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	2.18E-02	9.04E-04
BioGRID	BP	GO:0007566	embryo implantation	-	57	56	-	-	1.83E-03	2.26E-03
BioGRID	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	34	-	-	6.51E-03	1.41E-03
BioGRID	BP	GO:0031268	pseudopodium organization	-	17	17	-	-	1.08E-02	7.03E-04
BioGRID	BP	GO:0060306	regulation of membrane repolarization	-	38	34	-	-	7.58E-03	1.41E-03
BioGRID	BP	GO:0051017	actin filament bundle assembly	-	161	160	-	-	5.04E-03	6.43E-03
BioGRID	BP	GO:1905953	negative regulation of lipid localization	-	63	54	-	-	1.60E-03	2.21E-03
BioGRID	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	20	-	-	8.58E-04	8.03E-04
BioGRID	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	3.18E-04	8.03E-04
BioGRID	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	9.99E-04	5.52E-04
BioGRID	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	37	-	-	2.71E-03	1.51E-03
BioGRID	BP	GO:0021756	striatum development	-	21	21	-	-	2.13E-03	8.53E-04
BioGRID	BP	GO:1901343	negative regulation of vasculature development	-	154	131	-	-	2.15E-03	5.27E-03
BioGRID	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	149	-	-	8.42E-03	6.02E-03
BioGRID	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	31	-	-	6.92E-04	1.26E-03
BioGRID	BP	GO:1902414	protein localization to cell junction	-	107	107	-	-	5.99E-03	4.32E-03
BioGRID	BP	GO:0071305	cellular response to vitamin D	-	23	23	-	-	1.26E-03	9.54E-04
BioGRID	BP	GO:0051304	chromosome separation	-	80	80	-	-	6.55E-03	3.21E-03
BioGRID	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	2.39E-03	7.53E-04
BioGRID	BP	GO:0048709	oligodendrocyte differentiation	-	101	100	-	-	3.01E-03	4.02E-03
BioGRID	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	2.22E-01	6.02E-04
BioGRID	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	24	-	-	3.13E-03	1.00E-03
BioGRID	BP	GO:0001776	leukocyte homeostasis	-	108	103	-	-	2.73E-03	4.17E-03
BioGRID	BP	GO:0014744	positive regulation of muscle adaptation	-	14	12	-	-	1.48E-04	5.02E-04
BioGRID	BP	GO:0050769	positive regulation of neurogenesis	-	240	238	-	-	4.87E-03	9.59E-03
BioGRID	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	1.45E-02	6.02E-04
BioGRID	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	1.96E-02	2.81E-03
BioGRID	BP	GO:0050866	negative regulation of cell activation	-	216	208	-	-	4.95E-03	8.38E-03
BioGRID	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	9.82E-04	1.46E-03
BioGRID	BP	GO:0033500	carbohydrate homeostasis	-	251	234	-	-	4.27E-03	9.44E-03
BioGRID	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	31	-	-	8.44E-03	1.26E-03
BioGRID	BP	GO:0038183	bile acid signaling pathway	-	12	11	-	-	1.03E-01	4.52E-04
BioGRID	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	2.96E-03	2.26E-03
BioGRID	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	2.05E-03	9.54E-04
BioGRID	CC	GO:0099522	cytosolic region	-	20	20	-	-	9.39E-04	8.03E-04
BioGRID	CC	GO:0000791	euchromatin	-	60	60	-	-	3.87E-03	2.41E-03
BioGRID	CC	GO:0030666	endocytic vesicle membrane	-	196	195	-	-	9.60E-03	7.83E-03
BioGRID	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	4.42E-02	6.02E-04
BioGRID	CC	GO:1990752	microtubule end	-	34	34	-	-	9.87E-03	1.41E-03
BioGRID	CC	GO:0043204	perikaryon	-	156	155	-	-	3.00E-03	6.23E-03
BioGRID	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	5.11E-02	7.03E-04
BioGRID	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	1.94E-03	5.02E-04
BioGRID	CC	GO:0097542	ciliary tip	-	48	48	-	-	8.28E-02	1.96E-03
BioGRID	CC	GO:1905368	peptidase complex	-	124	122	-	-	3.97E-02	4.92E-03
BioGRID	CC	GO:0000792	heterochromatin	-	98	98	-	-	7.15E-03	3.97E-03
BioGRID	CC	GO:0097546	ciliary base	-	47	44	-	-	6.07E-03	1.81E-03
BioGRID	CC	GO:0071819	DUBm complex	-	25	24	-	-	1.32E-01	1.00E-03
BioGRID	CC	GO:0031201	SNARE complex	-	48	48	-	-	1.34E-01	1.96E-03
BioGRID	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	1.67E-03	5.52E-04
BioGRID	CC	GO:0000815	ESCRT III complex	-	11	11	-	-	2.54E-02	4.52E-04
BioGRID	CC	GO:0033260	nuclear DNA replication	-	40	40	-	-	8.58E-03	1.61E-03
BioGRID	CC	GO:0044391	ribosomal subunit	-	203	203	-	-	9.80E-02	8.18E-03
BioGRID	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	2.87E-02	4.52E-04
BioGRID	CC	GO:0071013	catalytic step 2 spliceosome	-	88	88	-	-	2.06E-02	3.56E-03
BioGRID	CC	GO:0031907	microbody lumen	-	51	51	-	-	4.62E-02	2.06E-03
BioGRID	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	9.20E-02	5.02E-04
BioGRID	CC	GO:0098862	cluster of actin-based cell projections	-	162	157	-	-	5.50E-03	6.33E-03
BioGRID	CC	GO:0016363	nuclear matrix	-	127	127	-	-	3.64E-03	5.12E-03
BioGRID	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	2.22E-02	1.86E-03
BioGRID	CC	GO:0032432	actin filament bundle	-	249	244	-	-	8.31E-03	9.84E-03
BioGRID	CC	GO:0008088	axo-dendritic transport	-	78	78	-	-	4.69E-03	3.16E-03
BioGRID	CC	GO:0031519	PcG protein complex	-	38	38	-	-	2.35E-02	1.56E-03
BioGRID	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	42	-	-	1.35E-02	1.71E-03
BioGRID	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	219	-	-	1.48E-02	8.84E-03
BioGRID	CC	GO:0000313	organellar ribosome	-	89	89	-	-	1.53E-01	3.61E-03
BioGRID	CC	GO:0099643	signal release from synapse	-	147	145	-	-	8.24E-03	5.82E-03
BioGRID	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	1.09E-02	1.86E-03
BioGRID	CC	GO:0005818	aster	-	11	11	-	-	7.80E-03	4.52E-04
BioGRID	CC	GO:0030018	Z disc	-	129	129	-	-	8.94E-03	5.22E-03
BioGRID	CC	GO:0032580	Golgi cisterna membrane	-	93	84	-	-	9.07E-03	3.41E-03
BioGRID	CC	GO:0097381	photoreceptor disc membrane	-	25	21	-	-	2.70E-02	8.53E-04
BioGRID	CC	GO:1905360	GTPase complex	-	41	39	-	-	7.08E-02	1.61E-03
BioGRID	CC	GO:0097540	axonemal central pair	-	161	151	-	-	5.76E-03	6.07E-03
BioGRID	CC	GO:0042641	actomyosin	-	77	77	-	-	5.23E-03	3.11E-03
BioGRID	CC	GO:0097386	glial cell projection	-	38	37	-	-	1.29E-03	1.51E-03
BioGRID	CC	GO:0032588	trans-Golgi network membrane	-	102	102	-	-	1.27E-02	4.12E-03
BioGRID	CC	GO:0070382	exocytic vesicle	-	224	223	-	-	1.25E-02	8.99E-03
BioGRID	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	46	-	-	1.58E-02	1.86E-03
BioGRID	CC	GO:0031903	microbody membrane	-	65	65	-	-	7.72E-02	2.61E-03
BioGRID	CC	GO:0046930	pore complex	-	26	26	-	-	1.57E-02	1.05E-03
BioGRID	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	6.74E-03	4.52E-04
BioGRID	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	1.10E-03	6.53E-04
BioGRID	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	4.48E-03	1.00E-03
BioGRID	CC	GO:1990071	TRAPPII protein complex	-	12	12	-	-	8.64E-02	5.02E-04
BioGRID	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	4.77E-03	7.53E-04
BioGRID	CC	GO:0044298	cell body membrane	-	32	32	-	-	4.35E-02	1.31E-03
BioGRID	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	4.45E-02	4.52E-04
BioGRID	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	6.40E-04	8.53E-04
BioGRID	CC	GO:0045495	pole plasm	-	25	25	-	-	3.93E-03	1.00E-03
BioGRID	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	9.22E-03	6.02E-04
BioGRID	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	4.94E-02	8.03E-04
BioGRID	CC	GO:0010369	chromocenter	-	14	14	-	-	2.02E-03	6.02E-04
BioGRID	CC	GO:0002177	manchette	-	19	17	-	-	1.92E-04	7.03E-04
BioGRID	CC	GO:0016323	basolateral plasma membrane	-	239	235	-	-	5.34E-03	9.44E-03
BioGRID	CC	GO:0045009	chitosome	-	21	21	-	-	1.11E-03	8.53E-04
BioGRID	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	1.58E-03	5.02E-04
BioGRID	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	4.68E-03	1.81E-03
BioGRID	CC	GO:0098636	protein complex involved in cell adhesion	-	57	56	-	-	1.14E-02	2.26E-03
BioGRID	CC	GO:0001917	photoreceptor inner segment	-	71	69	-	-	6.42E-03	2.81E-03
BioGRID	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	5.78E-04	6.02E-04
BioGRID	CC	GO:0019897	extrinsic component of plasma membrane	-	156	154	-	-	1.19E-02	6.23E-03
BioGRID	CC	GO:0031594	neuromuscular junction	-	73	73	-	-	2.10E-03	2.96E-03
BioGRID	CC	GO:0045120	pronucleus	-	14	14	-	-	4.64E-04	6.02E-04
BioGRID	CC	GO:0043083	synaptic cleft	-	21	20	-	-	7.65E-02	8.03E-04
BioGRID	CC	GO:0000922	spindle pole	-	172	172	-	-	5.84E-03	6.93E-03
BioGRID	CC	GO:0120111	neuron projection cytoplasm	-	94	93	-	-	7.77E-03	3.77E-03
BioGRID	CC	GO:0070971	endoplasmic reticulum exit site	-	32	29	-	-	5.12E-02	1.20E-03
BioGRID	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	6.16E-02	5.52E-04
BioGRID	CC	GO:0004879	nuclear receptor activity	-	63	63	-	-	1.02E-02	2.56E-03
BioGRID	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	169	-	-	1.24E-02	6.83E-03
BioGRID	CC	GO:0000123	histone acetyltransferase complex	-	93	92	-	-	7.26E-02	3.72E-03
BioGRID	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	2.07E-03	5.52E-04
BioGRID	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	111	-	-	7.82E-02	4.47E-03
BioGRID	CC	GO:0048786	presynaptic active zone	-	80	79	-	-	3.78E-03	3.21E-03
BioGRID	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	1.47E-04	4.52E-04
BioGRID	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	6.59E-02	5.02E-04
BioGRID	CC	GO:0007034	vacuolar transport	-	168	168	-	-	1.11E-02	6.78E-03
BioGRID	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	3.10E-03	8.53E-04
BioGRID	CC	GO:0043194	axon initial segment	-	21	21	-	-	8.74E-03	8.53E-04
BioGRID	CC	GO:1900115	extracellular regulation of signal transduction	-	13	12	-	-	1.78E-03	5.02E-04
BioGRID	CC	GO:0005776	autophagosome	-	111	110	-	-	1.24E-02	4.42E-03
BioGRID	CC	GO:0031430	M band	-	22	22	-	-	1.55E-03	9.04E-04
BioGRID	CC	GO:0001931	uropod	-	13	13	-	-	2.07E-03	5.52E-04
BioGRID	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	78	-	-	8.42E-02	3.16E-03
BioGRID	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	99	-	-	1.49E-01	4.02E-03
BioGRID	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	1.90E-01	5.52E-04
BioGRID	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	6.63E-02	8.03E-04
BioGRID	CC	GO:0071203	WASH complex	-	12	12	-	-	1.58E-01	5.02E-04
BioGRID	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	5.76E-03	1.20E-03
BioGRID	CC	GO:0032994	protein-lipid complex	-	39	39	-	-	1.64E-02	1.61E-03
BioGRID	CC	GO:0031838	haptoglobin-hemoglobin complex	-	11	11	-	-	2.69E-01	4.52E-04
BioGRID	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	167	-	-	4.91E-02	6.73E-03
BioGRID	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	6.76E-03	5.02E-04
BioGRID	CC	GO:0001527	microfibril	-	13	13	-	-	3.15E-02	5.52E-04
BioGRID	CC	GO:0072562	blood microparticle	-	144	142	-	-	7.62E-03	5.72E-03
BioGRID	CC	GO:0005883	neurofilament	-	11	11	-	-	1.57E-02	4.52E-04
BioGRID	CC	GO:0051233	spindle midzone	-	36	36	-	-	1.32E-03	1.46E-03
BioGRID	CC	GO:0005811	lipid droplet	-	102	100	-	-	1.15E-02	4.02E-03
BioGRID	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	4.90E-03	1.81E-03
BioGRID	CC	GO:0043113	receptor clustering	-	51	51	-	-	5.58E-03	2.06E-03
BioGRID	CC	GO:0005940	septin ring	-	14	14	-	-	2.34E-01	6.02E-04
BioGRID	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	6.07E-02	4.52E-04
BioGRID	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	25	-	-	1.71E-02	1.00E-03
BioGRID	CC	GO:0044853	plasma membrane raft	-	114	114	-	-	5.25E-03	4.62E-03
BioGRID	CC	GO:0005881	cytoplasmic microtubule	-	256	242	-	-	5.97E-03	9.74E-03
BioGRID	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	9.45E-04	6.02E-04
BioGRID	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	1.70E-02	7.03E-04
BioGRID	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	57	-	-	2.35E-02	2.31E-03
BioGRID	CC	GO:0005905	clathrin-coated pit	-	73	73	-	-	6.93E-03	2.96E-03
BioGRID	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	9.08E-02	5.02E-04
BioGRID	CC	GO:0043034	costamere	-	18	18	-	-	2.91E-03	7.53E-04
BioGRID	CC	GO:0031904	endosome lumen	-	38	38	-	-	1.46E-02	1.56E-03
BioGRID	CC	GO:0060170	ciliary membrane	-	76	69	-	-	1.34E-02	2.81E-03
BioGRID	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	3.86E-01	5.52E-04
BioGRID	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	1.32E-02	5.02E-04
BioGRID	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	29	-	-	4.56E-02	1.20E-03
BioGRID	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	2.22E-02	6.02E-04
BioGRID	CC	GO:0032154	cleavage furrow	-	54	54	-	-	2.68E-03	2.21E-03
BioGRID	CC	GO:0005640	nuclear outer membrane	-	30	30	-	-	5.10E-03	1.20E-03
BioGRID	CC	GO:0005652	nuclear lamina	-	12	12	-	-	4.72E-04	5.02E-04
BioGRID	CC	GO:0007006	mitochondrial membrane organization	-	117	116	-	-	8.36E-03	4.67E-03
BioGRID	CC	GO:0001772	immunological synapse	-	44	43	-	-	3.55E-03	1.76E-03
BioGRID	CC	GO:0030904	retromer complex	-	12	12	-	-	2.46E-02	5.02E-04
BioGRID	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	3.70E-02	5.02E-04
BioGRID	CC	GO:0030863	cortical cytoskeleton	-	104	103	-	-	7.17E-03	4.17E-03
BioGRID	CC	GO:1905348	endonuclease complex	-	38	37	-	-	1.98E-02	1.51E-03
BioGRID	CC	GO:0005833	hemoglobin complex	-	12	12	-	-	1.71E-01	5.02E-04
BioGRID	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	3.33E-03	7.53E-04
BioGRID	CC	GO:0030315	T-tubule	-	52	52	-	-	2.00E-02	2.11E-03
BioGRID	CC	GO:0060076	excitatory synapse	-	64	62	-	-	1.32E-02	2.51E-03
BioGRID	CC	GO:0036019	endolysosome	-	29	29	-	-	2.08E-03	1.20E-03
BioGRID	CC	GO:0001891	phagocytic cup	-	28	28	-	-	2.38E-03	1.15E-03
BioGRID	CC	GO:0099086	synaptonemal structure	-	40	39	-	-	1.55E-02	1.61E-03
BioGRID	CC	GO:0030427	site of polarized growth	-	172	172	-	-	3.94E-03	6.93E-03
BioGRID	CC	GO:0044309	neuron spine	-	213	213	-	-	6.36E-03	8.58E-03
BioGRID	CC	GO:0030658	transport vesicle membrane	-	231	229	-	-	1.95E-02	9.24E-03
BioGRID	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	2.77E-03	1.10E-03
BioGRID	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	5.82E-02	5.02E-04
BioGRID	CC	GO:0000940	outer kinetochore	-	17	17	-	-	4.03E-02	7.03E-04
BioGRID	CC	GO:0034719	SMN-Sm protein complex	-	18	18	-	-	5.48E-02	7.53E-04
BioGRID	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	2.41E-03	2.01E-03
BioGRID	CC	GO:0098803	respiratory chain complex	-	39	37	-	-	2.72E-01	1.51E-03
BioGRID	CC	GO:0097545	axonemal outer doublet	-	164	153	-	-	4.97E-03	6.18E-03
BioGRID	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	2.71E-02	8.03E-04
BioGRID	CC	GO:0070069	cytochrome complex	-	42	40	-	-	2.73E-01	1.61E-03
BioGRID	CC	GO:0031143	pseudopodium	-	18	18	-	-	4.81E-03	7.53E-04
BioGRID	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	1.63E-02	1.10E-03
BioGRID	CC	GO:0055037	recycling endosome	-	200	198	-	-	9.72E-03	7.98E-03
BioGRID	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	94	-	-	4.17E-03	3.82E-03
BioGRID	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	1.14E-01	5.52E-04
BioGRID	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	7.75E-04	5.52E-04
BioGRID	CC	GO:0071682	endocytic vesicle lumen	-	23	23	-	-	2.31E-03	9.54E-04
BioGRID	CC	GO:0030684	preribosome	-	76	76	-	-	2.20E-02	3.06E-03
BioGRID	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	19	-	-	8.56E-02	8.03E-04
BioGRID	CC	GO:1990391	DNA repair complex	-	22	22	-	-	3.85E-03	9.04E-04
BioGRID	CC	GO:0005775	vacuolar lumen	-	176	175	-	-	5.60E-03	7.03E-03
BioGRID	CC	GO:0032433	filopodium tip	-	19	19	-	-	6.75E-04	8.03E-04
BioGRID	CC	GO:0032982	myosin filament	-	24	24	-	-	6.04E-03	1.00E-03
BioGRID	CC	GO:0016327	apicolateral plasma membrane	-	23	23	-	-	2.01E-03	9.54E-04
BioGRID	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	6.19E-02	9.54E-04
BioGRID	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	3.77E-02	5.02E-04
BioGRID	CC	GO:0044306	neuron projection terminus	-	164	164	-	-	8.56E-03	6.63E-03
BioGRID	CC	GO:0034455	t-UTP complex	-	53	53	-	-	1.77E-02	2.16E-03
BioGRID	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	5.10E-01	7.03E-04
BioGRID	CC	GO:0031970	organelle envelope lumen	-	94	94	-	-	5.44E-03	3.82E-03
BioGRID	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	8.81E-03	5.52E-04
BioGRID	CC	GO:0120293	dynein axonemal particle	-	20	19	-	-	3.16E-03	8.03E-04
BioGRID	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	1.14E-03	1.00E-03
BioGRID	CC	GO:0043292	contractile muscle fiber	-	245	244	-	-	1.61E-02	9.84E-03
BioGRID	CC	GO:0018995	host cellular component	-	12	12	-	-	6.82E-03	5.02E-04
BioGRID	CC	GO:0034709	methylosome	-	13	12	-	-	7.69E-03	5.02E-04
BioGRID	CC	GO:0032426	stereocilium tip	-	21	20	-	-	1.41E-03	8.03E-04
BioGRID	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	6.88E-03	5.02E-04
BioGRID	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	7.77E-02	8.03E-04
BioGRID	CC	GO:0000803	sex chromosome	-	32	31	-	-	2.74E-03	1.26E-03
BioGRID	CC	GO:0098982	GABA-ergic synapse	-	84	82	-	-	7.47E-03	3.31E-03
BioGRID	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	17	-	-	2.07E-02	7.03E-04
BioGRID	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	2.58E-02	2.56E-03
BioGRID	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	6.99E-02	6.02E-04
BioGRID	CC	GO:0000242	pericentriolar material	-	22	22	-	-	4.69E-03	9.04E-04
BioGRID	CC	GO:1903293	phosphatase complex	-	54	53	-	-	2.23E-02	2.16E-03
BioGRID	CC	GO:0097470	ribbon synapse	-	13	13	-	-	2.61E-03	5.52E-04
BioGRID	CC	GO:0031941	filamentous actin	-	27	27	-	-	1.37E-03	1.10E-03
BioGRID	CC	GO:0000786	nucleosome	-	149	144	-	-	2.47E-02	5.82E-03
BioGRID	CC	GO:0001533	cornified envelope	-	59	59	-	-	7.55E-03	2.41E-03
BioGRID	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	2.21E-03	2.21E-03
BioGRID	CC	GO:0030027	lamellipodium	-	202	202	-	-	8.26E-03	8.13E-03
BioGRID	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	2.38E-03	6.02E-04
BioGRID	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	26	-	-	3.29E-02	1.05E-03
BioGRID	CC	GO:0000800	lateral element	-	14	14	-	-	1.14E-02	6.02E-04
BioGRID	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	6.05E-04	5.02E-04
BioGRID	CC	GO:0060077	inhibitory synapse	-	20	20	-	-	2.23E-02	8.03E-04
BioGRID	CC	GO:0031209	SCAR complex	-	12	12	-	-	3.38E-02	5.02E-04
BioGRID	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	5.56E-02	4.52E-04
BioGRID	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	1.18E-01	6.53E-04
BioGRID	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	22	-	-	2.71E-02	9.04E-04
BioGRID	CC	GO:0002102	podosome	-	31	31	-	-	2.10E-03	1.26E-03
BioGRID	CC	GO:0090543	Flemming body	-	33	33	-	-	3.00E-03	1.36E-03
BioGRID	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	3.03E-03	2.66E-03
BioGRID	CC	GO:0001650	fibrillar center	-	151	151	-	-	3.56E-03	6.07E-03
BioGRID	CC	GO:0031332	RNAi effector complex	-	413	137	-	-	3.98E-02	5.52E-03
BioGRID	CC	GO:1990204	oxidoreductase complex	-	90	87	-	-	7.85E-02	3.51E-03
BioGRID	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	6.61E-02	6.53E-04
BioGRID	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.08E-02	4.52E-04
BioGRID	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	4.39E-03	5.02E-03
BioGRID	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	4.91E-02	8.03E-04
BioGRID	CC	GO:0001726	ruffle	-	181	181	-	-	4.76E-03	7.28E-03
BioGRID	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	3.31E-03	4.52E-04
BioGRID	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	2.62E-03	5.52E-04
BioGRID	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	8.14E-02	7.53E-04
BioGRID	CC	GO:0043198	dendritic shaft	-	38	38	-	-	7.84E-04	1.56E-03
BioGRID	CC	GO:0043073	germ cell nucleus	-	67	66	-	-	3.17E-03	2.66E-03
BioGRID	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	2.40E-03	8.53E-04
BioGRID	CC	GO:0016592	mediator complex	-	38	38	-	-	4.59E-01	1.56E-03
BioGRID	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	2.17E-02	8.03E-04
BioGRID	CC	GO:0022626	cytosolic ribosome	-	118	118	-	-	5.56E-02	4.77E-03
BioGRID	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	2.17E-02	1.81E-03
BioGRID	CC	GO:0034451	centriolar satellite	-	120	118	-	-	1.19E-02	4.77E-03
BioGRID	CC	GO:0045171	intercellular bridge	-	91	90	-	-	4.62E-03	3.61E-03
BioGRID	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	81	-	-	5.24E-03	3.26E-03
BioGRID	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	4.07E-02	6.02E-04
BioGRID	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.16E-02	4.52E-04
BioGRID	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	3.57E-02	4.52E-04
BioGRID	CC	GO:0044292	dendrite terminus	-	13	13	-	-	1.21E-03	5.52E-04
BioGRID	CC	GO:0032039	integrator complex	-	19	18	-	-	2.65E-01	7.53E-04
BioGRID	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	1.77E-03	6.02E-04
BioGRID	CC	GO:0033268	node of Ranvier	-	16	16	-	-	5.38E-03	6.53E-04
BioGRID	CC	GO:0036038	MKS complex	-	13	13	-	-	6.15E-02	5.52E-04
BioGRID	CC	GO:0030527	structural constituent of chromatin	-	97	92	-	-	1.22E-02	3.72E-03
BioGRID	CC	GO:0036379	myofilament	-	26	25	-	-	3.10E-02	1.00E-03
BioGRID	CC	GO:0030286	dynein complex	-	210	198	-	-	9.01E-03	7.98E-03
BioGRID	CC	GO:0031105	septin complex	-	14	14	-	-	2.58E-01	6.02E-04
BioGRID	CC	GO:0097228	sperm principal piece	-	33	29	-	-	5.37E-02	1.20E-03
BioGRID	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	6.95E-03	5.02E-04
BioGRID	CC	GO:0016482	cytosolic transport	-	135	135	-	-	7.80E-03	5.42E-03
BioGRID	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	1.07E-02	9.54E-04
BioGRID	CC	GO:0005796	Golgi lumen	-	106	103	-	-	4.25E-03	4.17E-03
BioGRID	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	37	-	-	7.54E-02	1.51E-03
BioGRID	CC	GO:0034358	plasma lipoprotein particle	-	36	36	-	-	1.28E-02	1.46E-03
BioGRID	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	5.17E-02	1.91E-03
BioGRID	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	3.11E-03	1.00E-03
BioGRID	CC	GO:0030662	coated vesicle membrane	-	202	201	-	-	1.39E-02	8.08E-03
BioGRID	CC	GO:0007039	protein catabolic process in the vacuole	-	61	60	-	-	1.13E-02	2.41E-03
BioGRID	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	67	-	-	1.68E-01	2.71E-03
BioGRID	CC	GO:0090734	site of DNA damage	-	118	117	-	-	9.60E-03	4.72E-03
BioGRID	MF	GO:0051861	glycolipid binding	-	30	29	-	-	2.08E-03	1.20E-03
BioGRID	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	12	-	-	1.45E-04	5.02E-04
BioGRID	MF	GO:0051087	protein-folding chaperone binding	-	135	135	-	-	3.88E-03	5.42E-03
BioGRID	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	2.10E-02	1.10E-03
BioGRID	CC	GO:0015464	acetylcholine receptor activity	-	21	19	-	-	4.84E-03	8.03E-04
BioGRID	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	1.15E-02	5.02E-04
BioGRID	MF	GO:0016594	glycine binding	-	12	12	-	-	1.23E-01	5.02E-04
BioGRID	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	1.48E-03	8.03E-04
BioGRID	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	2.40E-03	1.51E-03
BioGRID	MF	GO:0035613	RNA stem-loop binding	-	21	18	-	-	9.08E-04	7.53E-04
BioGRID	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	247	-	-	6.23E-03	9.94E-03
BioGRID	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	2.38E-04	8.03E-04
BioGRID	MF	GO:0033691	sialic acid binding	-	22	21	-	-	6.11E-02	8.53E-04
BioGRID	MF	GO:0048306	calcium-dependent protein binding	-	61	61	-	-	1.59E-02	2.46E-03
BioGRID	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	29	-	-	2.34E-02	1.20E-03
BioGRID	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	6.49E-02	5.52E-04
BioGRID	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	147	-	-	5.30E-03	5.92E-03
BioGRID	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	60	-	-	1.12E-01	2.41E-03
BioGRID	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	137	-	-	7.33E-03	5.52E-03
BioGRID	MF	GO:0045504	dynein heavy chain binding	-	16	16	-	-	3.58E-02	6.53E-04
BioGRID	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	2.57E-03	1.20E-03
BioGRID	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	3.54E-03	9.04E-04
BioGRID	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	1.75E-03	6.53E-04
BioGRID	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	1.10E-02	6.02E-04
BioGRID	MF	GO:0061980	regulatory RNA binding	-	52	51	-	-	3.33E-03	2.06E-03
BioGRID	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	8.15E-03	1.31E-03
BioGRID	MF	GO:0000182	rDNA binding	-	11	11	-	-	2.58E-03	4.52E-04
BioGRID	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	9.12E-04	1.20E-03
BioGRID	MF	GO:0070840	dynein complex binding	-	25	23	-	-	1.36E-03	9.54E-04
BioGRID	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.19E-03	1.00E-03
BioGRID	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	9.46E-04	6.53E-04
BioGRID	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	4.03E-03	1.41E-03
BioGRID	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	1.47E-02	7.53E-04
BioGRID	MF	GO:0005178	integrin binding	-	153	153	-	-	8.90E-03	6.18E-03
BioGRID	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	7.85E-04	7.03E-04
BioGRID	MF	GO:0005549	odorant binding	-	128	47	-	-	2.83E-02	1.91E-03
BioGRID	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.75E-02	6.02E-04
BioGRID	MF	GO:0008327	methyl-CpG binding	-	31	29	-	-	3.61E-03	1.20E-03
BioGRID	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	1.43E-03	8.03E-04
BioGRID	MF	GO:0048019	receptor antagonist activity	-	31	19	-	-	4.58E-04	8.03E-04
BioGRID	MF	GO:0005521	lamin binding	-	15	15	-	-	1.44E-03	6.02E-04
BioGRID	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	2.42E-03	8.03E-04
BioGRID	MF	GO:0140318	protein transporter activity	-	40	40	-	-	3.25E-02	1.61E-03
BioGRID	MF	GO:0070628	proteasome binding	-	17	17	-	-	4.72E-03	7.03E-04
BioGRID	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	1.01E-03	4.52E-04
BioGRID	MF	GO:0031432	titin binding	-	13	13	-	-	7.35E-03	5.52E-04
BioGRID	MF	GO:0046812	host cell surface binding	-	11	11	-	-	3.65E-03	4.52E-04
BioGRID	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	3.71E-03	1.51E-03
BioGRID	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	5.23E-02	7.03E-04
BioGRID	MF	GO:0002039	p53 binding	-	66	66	-	-	2.14E-03	2.66E-03
BioGRID	MF	GO:0005496	steroid binding	-	110	108	-	-	6.23E-03	4.37E-03
BioGRID	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.42E-02	1.10E-03
BioGRID	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	7.86E-04	4.52E-04
BioGRID	MF	GO:0003684	damaged DNA binding	-	89	88	-	-	1.38E-02	3.56E-03
BioGRID	MF	GO:0000339	RNA cap binding	-	20	19	-	-	4.26E-03	8.03E-04
BioGRID	MF	GO:0016500	protein-hormone receptor activity	-	21	18	-	-	6.29E-04	7.53E-04
BioGRID	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	132	-	-	2.29E-02	5.32E-03
BioGRID	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	1.46E-02	6.02E-04
BioGRID	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	9.85E-04	5.02E-04
BioGRID	MF	GO:1900121	negative regulation of receptor binding	-	13	12	-	-	1.97E-03	5.02E-04
BioGRID	MF	GO:0070063	RNA polymerase binding	-	61	61	-	-	6.99E-03	2.46E-03
BioGRID	MF	GO:0008179	adenylate cyclase binding	-	11	11	-	-	3.15E-03	4.52E-04
BioGRID	MF	GO:0050811	GABA receptor binding	-	18	18	-	-	1.50E-03	7.53E-04
BioGRID	MF	GO:0030971	receptor tyrosine kinase binding	-	76	76	-	-	3.03E-03	3.06E-03
BioGRID	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	84	-	-	1.47E-02	3.41E-03
BioGRID	MF	GO:0140030	modification-dependent protein binding	-	179	179	-	-	5.62E-03	7.23E-03
BioGRID	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	1.75E-03	1.00E-03
BioGRID	MF	GO:0009881	photoreceptor activity	-	17	14	-	-	1.14E-03	6.02E-04
BioGRID	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	19	-	-	4.40E-02	8.03E-04
BioGRID	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.51E-03	5.52E-04
BioGRID	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	6.72E-03	6.53E-04
BioGRID	MF	GO:0141047	molecular tag activity	-	13	13	-	-	1.23E-03	5.52E-04
BioGRID	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.70E-02	4.52E-04
BioGRID	MF	GO:0033130	acetylcholine receptor binding	-	12	11	-	-	1.46E-04	4.52E-04
BioGRID	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	5.76E-04	6.02E-04
BioGRID	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	4.03E-02	5.02E-04
BioGRID	MF	GO:0044548	S100 protein binding	-	14	14	-	-	5.23E-03	6.02E-04
BioGRID	MF	GO:0010851	cyclase regulator activity	-	17	16	-	-	8.07E-04	6.53E-04
BioGRID	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.35E-02	6.02E-04
BioGRID	MF	GO:0030276	clathrin binding	-	70	70	-	-	2.15E-02	2.81E-03
BioGRID	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	2.81E-03	1.20E-03
BioGRID	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	2.33E-04	6.02E-04
BioGRID	MF	GO:0046790	virion binding	-	19	19	-	-	2.05E-03	8.03E-04
BioGRID	MF	GO:0030552	cAMP binding	-	48	45	-	-	1.20E-02	1.81E-03
BioGRID	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	40	-	-	1.53E-03	1.61E-03
BioGRID	MF	GO:0035173	histone kinase activity	-	17	17	-	-	8.94E-04	7.03E-04
BioGRID	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	2.70E-03	1.05E-03
BioGRID	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	2.17E-02	5.02E-04
BioGRID	MF	GO:0004984	olfactory receptor activity	-	429	168	-	-	1.55E-02	6.78E-03
BioGRID	MF	GO:0016209	antioxidant activity	-	92	88	-	-	1.10E-02	3.56E-03
BioGRID	MF	GO:0070325	lipoprotein particle receptor binding	-	32	31	-	-	2.61E-03	1.26E-03
BioGRID	MF	GO:0044325	transmembrane transporter binding	-	159	156	-	-	8.88E-03	6.28E-03
BioGRID	MF	GO:0048156	tau protein binding	-	43	43	-	-	2.11E-03	1.76E-03
BioGRID	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	3.27E-03	1.46E-03
BioGRID	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	1.98E-03	5.52E-04
BioGRID	MF	GO:0140272	exogenous protein binding	-	79	79	-	-	2.48E-03	3.21E-03
BioGRID	MF	GO:0030145	manganese ion binding	-	65	65	-	-	2.05E-03	2.61E-03
BioGRID	MF	GO:0071814	protein-lipid complex binding	-	52	50	-	-	4.16E-03	2.01E-03
BioGRID	MF	GO:0008066	glutamate receptor activity	-	70	70	-	-	2.36E-02	2.81E-03
BioGRID	MF	GO:0030553	cGMP binding	-	15	14	-	-	2.59E-02	6.02E-04
BioGRID	MF	GO:0017069	snRNA binding	-	54	52	-	-	2.36E-02	2.11E-03
BioGRID	MF	GO:0030215	semaphorin receptor binding	-	23	22	-	-	7.46E-02	9.04E-04
BioGRID	MF	GO:0031996	thioesterase binding	-	11	11	-	-	7.86E-04	4.52E-04
BioGRID	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	1.55E-02	1.26E-03
BioGRID	MF	GO:0019843	rRNA binding	-	69	69	-	-	1.33E-02	2.81E-03
BioGRID	MF	GO:0004713	protein tyrosine kinase activity	-	213	213	-	-	6.28E-03	8.58E-03
BioGRID	MF	GO:0061783	peptidoglycan muralytic activity	-	14	12	-	-	1.48E-04	5.02E-04
BioGRID	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	52	-	-	5.13E-03	2.11E-03
BioGRID	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.40E-03	1.00E-03
BioGRID	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	6.84E-04	8.03E-04
BioGRID	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	29	-	-	1.35E-03	1.20E-03
BioGRID	MF	GO:0016208	AMP binding	-	22	22	-	-	4.89E-03	9.04E-04
BioGRID	MF	GO:0000287	magnesium ion binding	-	225	225	-	-	5.89E-03	9.04E-03
BioGRID	MF	GO:0031490	chromatin DNA binding	-	120	119	-	-	5.59E-03	4.82E-03
BioGRID	MF	GO:0017022	myosin binding	-	73	73	-	-	7.87E-03	2.96E-03
BioGRID	MF	GO:0004896	cytokine receptor activity	-	93	91	-	-	5.23E-03	3.66E-03
BioGRID	MF	GO:0017166	vinculin binding	-	12	12	-	-	5.30E-03	5.02E-04
BioGRID	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	3.18E-03	7.53E-04
BioGRID	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	2.43E-03	5.02E-04
BioGRID	MF	GO:0005539	glycosaminoglycan binding	-	236	230	-	-	1.39E-02	9.24E-03
BioGRID	MF	GO:0140666	annealing activity	-	11	11	-	-	5.83E-04	4.52E-04
BioGRID	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	4.15E-03	6.02E-04
BioGRID	MF	GO:0010181	FMN binding	-	15	15	-	-	5.28E-04	6.02E-04
BioGRID	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	18	-	-	1.94E-04	7.53E-04
BioGRID	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	25	-	-	2.32E-03	1.00E-03
BioGRID	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	1.57E-03	7.03E-04
BioGRID	MF	GO:0044183	protein folding chaperone	-	67	67	-	-	2.50E-03	2.71E-03
BioGRID	MF	GO:0005132	type I interferon receptor binding	-	17	17	-	-	4.49E-01	7.03E-04
BioGRID	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	4.91E-03	4.37E-03
BioGRID	MF	GO:0003725	double-stranded RNA binding	-	72	71	-	-	2.87E-03	2.86E-03
BioGRID	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	1.71E-01	6.53E-04
BioGRID	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	8.84E-03	2.11E-03
BioGRID	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	2.03E-03	1.41E-03
BioGRID	MF	GO:0004618	phosphoglycerate kinase activity	-	89	89	-	-	3.66E-03	3.61E-03
BioGRID	MF	GO:0042805	actinin binding	-	36	36	-	-	2.38E-03	1.46E-03
BioGRID	MF	GO:0043531	ADP binding	-	38	38	-	-	1.29E-03	1.56E-03
BioGRID	MF	GO:0043394	proteoglycan binding	-	36	35	-	-	1.94E-03	1.41E-03
BioGRID	MF	GO:0005542	folic acid binding	-	13	11	-	-	1.18E-01	4.52E-04
BioGRID	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	1.54E-02	4.52E-04
BioGRID	MF	GO:0046332	SMAD binding	-	77	77	-	-	1.42E-02	3.11E-03
BioGRID	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	2.73E-03	5.52E-04
BioGRID	MF	GO:0001968	fibronectin binding	-	30	30	-	-	4.98E-03	1.20E-03
BioGRID	MF	GO:0048038	quinone binding	-	16	16	-	-	7.66E-03	6.53E-04
BioGRID	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	121	-	-	1.20E-02	4.87E-03
BioGRID	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	82	-	-	3.67E-03	3.31E-03
BioGRID	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	1.46E-03	7.53E-04
BioGRID	MF	GO:0051117	ATPase binding	-	85	84	-	-	2.62E-03	3.41E-03
BioGRID	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	5.52E-04	1.86E-03
BioGRID	MF	GO:0051787	misfolded protein binding	-	20	20	-	-	1.65E-03	8.03E-04
BioGRID	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	5.13E-03	4.52E-04
BioGRID	MF	GO:0070402	NADPH binding	-	16	15	-	-	1.94E-04	6.02E-04
BioGRID	MF	GO:0031404	chloride ion binding	-	14	14	-	-	1.48E-04	6.02E-04
BioGRID	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	4.03E-03	2.46E-03
BioGRID	MF	GO:0036002	pre-mRNA binding	-	57	48	-	-	2.69E-03	1.96E-03
BioGRID	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	36	-	-	6.13E-03	1.46E-03
BioGRID	MF	GO:0051540	metal cluster binding	-	71	71	-	-	4.49E-03	2.86E-03
BioGRID	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	7.57E-04	4.52E-04
BioGRID	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	3.78E-03	3.72E-03
BioGRID	MF	GO:0019894	kinesin binding	-	45	45	-	-	4.39E-03	1.81E-03
BioGRID	MF	GO:0042287	MHC protein binding	-	68	58	-	-	3.45E-02	2.36E-03
BioGRID	MF	GO:0019003	GDP binding	-	89	89	-	-	5.52E-03	3.61E-03
BioGRID	MF	GO:0017171	serine hydrolase activity	-	207	196	-	-	1.99E-02	7.88E-03
BioGRID	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	3.37E-03	2.66E-03
BioGRID	MF	GO:0003774	cytoskeletal motor activity	-	117	116	-	-	5.77E-03	4.67E-03
BioGRID	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.51E-03	1.20E-03
BioGRID	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	3.68E-03	7.03E-04
BioGRID	MF	GO:0061134	peptidase regulator activity	-	224	212	-	-	5.40E-03	8.53E-03
BioGRID	MF	GO:0008013	beta-catenin binding	-	86	86	-	-	4.31E-03	3.46E-03
BioGRID	MF	GO:0051015	actin filament binding	-	208	207	-	-	1.15E-02	8.33E-03
BioGRID	MF	GO:0019208	phosphatase regulator activity	-	107	105	-	-	8.19E-03	4.22E-03
BioGRID	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	33	-	-	3.03E-03	1.36E-03
BioGRID	MF	GO:0043236	laminin binding	-	29	29	-	-	2.28E-03	1.20E-03
BioGRID	MF	GO:0030507	spectrin binding	-	26	26	-	-	5.10E-03	1.05E-03
BioGRID	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	2.32E-03	1.66E-03
BioGRID	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	114	-	-	1.34E-02	4.62E-03
BioGRID	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	6.02E-03	1.00E-03
BioGRID	MF	GO:0042393	histone binding	-	240	237	-	-	1.39E-02	9.54E-03
BioGRID	MF	GO:0019838	growth factor binding	-	182	178	-	-	7.05E-03	7.18E-03
BioGRID	MF	GO:0000149	SNARE binding	-	107	107	-	-	3.28E-02	4.32E-03
BioGRID	MF	GO:0003727	single-stranded RNA binding	-	90	87	-	-	3.42E-03	3.51E-03
BioGRID	MF	GO:0051378	serotonin binding	-	24	22	-	-	1.48E-02	9.04E-04
BioGRID	MF	GO:0005516	calmodulin binding	-	206	203	-	-	6.38E-03	8.18E-03
BioGRID	MF	GO:0019825	oxygen binding	-	40	39	-	-	2.46E-02	1.61E-03
BioGRID	MF	GO:0045505	dynein intermediate chain binding	-	37	37	-	-	8.05E-03	1.51E-03
BioGRID	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	85	-	-	2.88E-03	3.41E-03
BioGRID	MF	GO:0032182	ubiquitin-like protein binding	-	117	116	-	-	3.85E-03	4.67E-03
BioGRID	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	5.62E-02	1.46E-03
BioGRID	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	9.16E-03	9.04E-04
BioGRID	MF	GO:0043274	phospholipase binding	-	23	22	-	-	1.14E-03	9.04E-04
BioGRID	MF	GO:0031072	heat shock protein binding	-	128	128	-	-	5.91E-03	5.17E-03
BioGRID	MF	GO:0030515	snoRNA binding	-	33	33	-	-	6.27E-03	1.36E-03
BioGRID	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	80	-	-	6.31E-02	3.21E-03
BioGRID	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	22	-	-	3.85E-03	9.04E-04
BioGRID	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	4.94E-04	1.05E-03
BioGRID	MF	GO:0001530	lipopolysaccharide binding	-	38	36	-	-	1.81E-02	1.46E-03
BioGRID	MF	GO:0140223	general transcription initiation factor activity	-	55	54	-	-	8.23E-02	2.21E-03
BioGRID	MF	GO:0070403	NAD+ binding	-	16	16	-	-	3.01E-03	6.53E-04
BioGRID	MF	GO:0000049	tRNA binding	-	75	74	-	-	5.04E-03	3.01E-03
BioGRID	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	45	-	-	4.29E-03	1.81E-03
BioGRID	MF	GO:0015026	coreceptor activity	-	48	45	-	-	9.02E-03	1.81E-03
BioGRID	MF	GO:0005527	macrolide binding	-	12	12	-	-	6.76E-04	5.02E-04
BioGRID	MF	GO:0001653	peptide receptor activity	-	128	118	-	-	1.08E-02	4.77E-03
BioGRID	MF	GO:0031005	filamin binding	-	15	15	-	-	5.38E-03	6.02E-04
BioGRID	MF	GO:0030506	ankyrin binding	-	19	19	-	-	8.16E-04	8.03E-04
BioGRID	MF	GO:0006469	negative regulation of protein kinase activity	-	222	218	-	-	3.79E-03	8.79E-03
BioGRID	MF	GO:0070182	DNA polymerase binding	-	22	22	-	-	7.05E-04	9.04E-04
BioGRID	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	7.19E-04	6.02E-04
BioGRID	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	6.30E-03	1.26E-03
BioGRID	MF	GO:0051427	hormone receptor binding	-	31	30	-	-	1.38E-02	1.20E-03
BioGRID	MF	GO:0070851	growth factor receptor binding	-	141	141	-	-	5.84E-03	5.67E-03
BioGRID	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	3.31E-03	1.31E-03
BioGRID	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	1.56E-02	4.52E-04
BioGRID	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	43	-	-	3.14E-03	1.76E-03
BioGRID	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	8.15E-03	8.03E-04
BioGRID	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	18	-	-	5.10E-03	7.53E-04
BioGRID	MF	GO:0005506	iron ion binding	-	154	145	-	-	1.23E-02	5.82E-03
BioGRID	MF	GO:0003925	G protein activity	-	45	44	-	-	2.16E-03	1.81E-03
BioGRID	MF	GO:0038187	pattern recognition receptor activity	-	33	32	-	-	2.66E-03	1.31E-03
BioGRID	MF	GO:0008276	protein methyltransferase activity	-	96	94	-	-	3.71E-03	3.82E-03
BioGRID	MF	GO:0004396	hexokinase activity	-	16	16	-	-	2.19E-03	6.53E-04
BioGRID	MF	GO:0070888	E-box binding	-	59	59	-	-	2.16E-02	2.41E-03
BioGRID	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.43E-04	6.02E-04
BioGRID	MF	GO:0015399	primary active transmembrane transporter activity	-	190	188	-	-	7.33E-02	7.58E-03
BioGRID	MF	GO:0035254	glutamate receptor binding	-	47	47	-	-	1.96E-03	1.91E-03
BioGRID	MF	GO:0050321	tau-protein kinase activity	-	36	35	-	-	4.81E-03	1.41E-03
BioGRID	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	3.02E-03	4.52E-04
BioGRID	MF	GO:0043021	ribonucleoprotein complex binding	-	158	158	-	-	6.42E-03	6.38E-03
BioGRID	MF	GO:0030170	pyridoxal phosphate binding	-	56	56	-	-	4.78E-03	2.26E-03
BioGRID	MF	GO:0032393	MHC class I receptor activity	-	15	13	-	-	1.99E-01	5.52E-04
BioGRID	MF	GO:0005112	Notch binding	-	26	25	-	-	1.81E-03	1.00E-03
BioGRID	MF	GO:0048185	activin binding	-	16	16	-	-	3.34E-02	6.53E-04
BioGRID	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	6.15E-04	1.15E-03
BioGRID	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	2.59E-03	4.52E-04
BioGRID	MF	GO:0140299	small molecule sensor activity	-	39	37	-	-	2.21E-02	1.51E-03
BioGRID	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.31E-02	9.04E-04
BioGRID	MF	GO:0016917	GABA receptor activity	-	23	21	-	-	1.74E-01	8.53E-04
BioGRID	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	2.23E-03	6.02E-04
BioGRID	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	26	-	-	5.31E-04	1.05E-03
BioGRID	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	46	-	-	1.24E-02	1.86E-03
BioGRID	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.22E-03	1.00E-03
BioGRID	MF	GO:0008527	taste receptor activity	-	28	17	-	-	7.52E-02	7.03E-04
BioGRID	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	1.43E-03	5.02E-04
BioGRID	MF	GO:0030594	neurotransmitter receptor activity	-	160	153	-	-	1.26E-02	6.18E-03
BioGRID	MF	GO:0034452	dynactin binding	-	12	12	-	-	4.68E-04	5.02E-04
BioGRID	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	5.64E-02	1.00E-03
BioGRID	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	6.90E-03	8.53E-04
BioGRID	MF	GO:0005507	copper ion binding	-	63	60	-	-	2.80E-03	2.41E-03
BioGRID	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	3.21E-03	9.04E-04
BioGRID	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	1.27E-02	4.52E-04
BioGRID	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	7.13E-03	9.04E-04
BioGRID	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	1.49E-01	5.02E-04
BioPlex 293T	CC	GO:0005739	mitochondrion	2.40E-37	1671	1417	1205	1.18	-	-
BioPlex 293T	CC	GO:0005730	nucleolus	1.08E-36	988	873	712	1.23	-	-
BioPlex 293T	CC	GO:0005815	microtubule organizing center	2.39E-26	843	734	608	1.21	-	-
BioPlex 293T	CC	GO:0005840	ribosome	1.30E-18	222	211	160	1.32	-	-
BioPlex 293T	CC	GO:0005768	endosome	6.01E-15	1037	853	748	1.14	-	-
BioPlex 293T	CC	GO:0005794	Golgi apparatus	6.89E-15	1636	1311	1180	1.11	-	-
BioPlex 293T	CC	GO:0005615	extracellular space	8.30E-14	3190	2470	2300	1.07	-	-
BioPlex 293T	CC	GO:0005764	lysosome	2.23E-13	747	623	539	1.16	-	-
BioPlex 293T	CC	GO:0000228	nuclear chromosome	6.15E-11	206	187	149	1.26	-	-
BioPlex 293T	CC	GO:0005783	endoplasmic reticulum	1.16E-10	2020	1577	1457	1.08	-	-
BioPlex 293T	CC	GO:0005635	nuclear envelope	3.21E-07	493	404	355	1.14	-	-
BioPlex 293T	CC	GO:0005777	peroxisome	3.05E-02	142	114	102	1.11	-	-
BioPlex 293T	CC	GO:0005811	lipid droplet	1.84E-01	102	80	74	1.09	-	-
BioPlex 293T	CC	GO:0031012	extracellular matrix	7.39E-01	564	403	407	0.99	-	-
BioPlex 293T	CC	GO:0005929	cilium	1.00E+00	842	607	607	1.00	-	-
BioPlex 293T	BP	GO:0050877	nervous system process	2.03E-49	1527	842	1101	0.76	-	-
BioPlex 293T	BP	GO:0065003	protein-containing complex assembly	6.95E-31	1648	1380	1188	1.16	-	-
BioPlex 293T	BP	GO:0042254	ribosome biogenesis	5.30E-29	297	287	214	1.34	-	-
BioPlex 293T	BP	GO:0006281	DNA repair	5.62E-29	587	532	423	1.26	-	-
BioPlex 293T	BP	GO:0006886	intracellular protein transport	2.15E-27	664	592	479	1.24	-	-
BioPlex 293T	BP	GO:0016192	vesicle-mediated transport	3.14E-27	1894	1558	1366	1.14	-	-
BioPlex 293T	BP	GO:0030163	protein catabolic process	9.57E-27	990	852	714	1.19	-	-
BioPlex 293T	BP	GO:0016071	mRNA metabolic process	5.43E-26	713	629	514	1.22	-	-
BioPlex 293T	BP	GO:0007010	cytoskeleton organization	8.89E-23	1639	1346	1182	1.14	-	-
BioPlex 293T	BP	GO:0006914	autophagy	2.18E-20	568	500	410	1.22	-	-
BioPlex 293T	BP	GO:0006325	chromatin organization	3.84E-17	720	613	519	1.18	-	-
BioPlex 293T	BP	GO:0007059	chromosome segregation	2.25E-16	403	358	291	1.23	-	-
BioPlex 293T	BP	GO:0007005	mitochondrion organization	1.16E-15	484	422	349	1.21	-	-
BioPlex 293T	BP	GO:0006260	DNA replication	5.00E-15	279	254	201	1.26	-	-
BioPlex 293T	BP	GO:0140053	mitochondrial gene expression	5.62E-15	164	157	118	1.33	-	-
BioPlex 293T	BP	GO:0006913	nucleocytoplasmic transport	1.10E-14	326	292	235	1.24	-	-
BioPlex 293T	BP	GO:0006399	tRNA metabolic process	1.58E-14	196	184	141	1.30	-	-
BioPlex 293T	BP	GO:0072659	protein localization to plasma membrane	9.03E-11	284	250	205	1.22	-	-
BioPlex 293T	BP	GO:0002181	cytoplasmic translation	1.60E-10	153	142	110	1.29	-	-
BioPlex 293T	BP	GO:0007163	establishment or maintenance of cell polarity	2.12E-10	227	203	164	1.24	-	-
BioPlex 293T	BP	GO:0032200	telomere organization	1.63E-09	186	168	134	1.25	-	-
BioPlex 293T	BP	GO:0012501	programmed cell death	1.90E-09	1954	1520	1409	1.08	-	-
BioPlex 293T	BP	GO:0006310	DNA recombination	2.27E-09	333	286	240	1.19	-	-
BioPlex 293T	BP	GO:0006091	generation of precursor metabolites and energy	7.32E-09	502	417	362	1.15	-	-
BioPlex 293T	BP	GO:0055086	nucleobase-containing small molecule metabolic process	6.34E-08	729	588	526	1.12	-	-
BioPlex 293T	BP	GO:0006457	protein folding	9.72E-08	210	184	151	1.22	-	-
BioPlex 293T	BP	GO:0005975	carbohydrate metabolic process	2.86E-07	551	449	397	1.13	-	-
BioPlex 293T	BP	GO:0000910	cytokinesis	3.33E-06	186	161	134	1.20	-	-
BioPlex 293T	BP	GO:0002376	immune system process	7.68E-06	2448	1857	1765	1.05	-	-
BioPlex 293T	BP	GO:0007018	microtubule-based movement	8.57E-06	640	510	461	1.11	-	-
BioPlex 293T	BP	GO:0006790	sulfur compound metabolic process	9.58E-06	320	265	231	1.15	-	-
BioPlex 293T	BP	GO:0006355	regulation of DNA-templated transcription	1.88E-05	3342	2510	2410	1.04	-	-
BioPlex 293T	BP	GO:0034330	cell junction organization	1.72E-04	727	568	524	1.08	-	-
BioPlex 293T	BP	GO:0048870	cell motility	1.91E-04	1659	1261	1196	1.05	-	-
BioPlex 293T	BP	GO:0006629	lipid metabolic process	2.32E-04	1355	1035	977	1.06	-	-
BioPlex 293T	BP	GO:0055085	transmembrane transport	3.41E-04	1784	1221	1286	0.95	-	-
BioPlex 293T	BP	GO:0044782	cilium organization	1.27E-03	399	316	288	1.10	-	-
BioPlex 293T	BP	GO:0098542	defense response to other organism	7.82E-03	1171	884	844	1.05	-	-
BioPlex 293T	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.34E-02	119	98	86	1.14	-	-
BioPlex 293T	BP	GO:0006486	protein glycosylation	2.02E-02	225	178	162	1.10	-	-
BioPlex 293T	BP	GO:0006520	amino acid metabolic process	2.13E-02	292	228	211	1.08	-	-
BioPlex 293T	BP	GO:0042060	wound healing	2.24E-02	431	332	311	1.07	-	-
BioPlex 293T	BP	GO:0007155	cell adhesion	7.15E-02	1444	1071	1041	1.03	-	-
BioPlex 293T	BP	GO:0022600	digestive system process	8.74E-02	110	71	79	0.90	-	-
BioPlex 293T	BP	GO:0003013	circulatory system process	9.16E-02	584	403	421	0.96	-	-
BioPlex 293T	BP	GO:0007040	lysosome organization	1.04E-01	107	85	77	1.10	-	-
BioPlex 293T	BP	GO:0140013	meiotic nuclear division	1.22E-01	279	213	201	1.06	-	-
BioPlex 293T	BP	GO:0030198	extracellular matrix organization	3.42E-01	314	219	226	0.97	-	-
BioPlex 293T	BP	GO:0006766	vitamin metabolic process	4.50E-01	107	81	77	1.05	-	-
BioPlex 293T	BP	GO:0006575	cellular modified amino acid metabolic process	5.66E-01	186	138	134	1.03	-	-
BioPlex 293T	BP	GO:0003014	renal system process	6.20E-01	127	89	92	0.97	-	-
BioPlex 293T	BP	GO:0003012	muscle system process	7.43E-01	425	310	306	1.01	-	-
BioPlex 293T	BP	GO:0098754	detoxification	8.47E-01	134	98	97	1.01	-	-
BioPlex 293T	BP	GO:0006954	inflammatory response	8.73E-01	820	589	591	1.00	-	-
BioPlex 293T	MF	GO:0003723	RNA binding	1.20E-68	1679	1494	1211	1.23	-	-
BioPlex 293T	MF	GO:0016740	transferase activity	2.05E-43	3074	2520	2217	1.14	-	-
BioPlex 293T	MF	GO:0140096	"catalytic activity, acting on a protein"	3.44E-28	3198	2554	2306	1.11	-	-
BioPlex 293T	MF	GO:0008092	cytoskeletal protein binding	1.29E-19	1023	858	738	1.16	-	-
BioPlex 293T	MF	GO:0140098	"catalytic activity, acting on RNA"	3.24E-18	417	373	301	1.24	-	-
BioPlex 293T	MF	GO:0140657	ATP-dependent activity	4.10E-18	729	623	526	1.19	-	-
BioPlex 293T	MF	GO:0140097	"catalytic activity, acting on DNA"	1.16E-12	383	334	276	1.21	-	-
BioPlex 293T	MF	GO:0016874	ligase activity	1.25E-11	283	251	204	1.23	-	-
BioPlex 293T	MF	GO:0009975	cyclase activity	7.70E-10	277	152	200	0.76	-	-
BioPlex 293T	MF	GO:0003924	GTPase activity	9.99E-09	658	537	474	1.13	-	-
BioPlex 293T	MF	GO:0042393	histone binding	1.67E-07	237	205	171	1.20	-	-
BioPlex 293T	MF	GO:0016853	isomerase activity	1.79E-06	252	214	182	1.18	-	-
BioPlex 293T	MF	GO:0016491	oxidoreductase activity	3.34E-06	888	700	640	1.09	-	-
BioPlex 293T	MF	GO:0140104	molecular carrier activity	5.45E-06	105	95	76	1.25	-	-
BioPlex 293T	MF	GO:0045182	translation regulator activity	9.54E-06	151	132	109	1.21	-	-
BioPlex 293T	MF	GO:0005215	transporter activity	2.08E-05	1462	983	1054	0.93	-	-
BioPlex 293T	MF	GO:0016829	lyase activity	7.27E-03	538	360	388	0.93	-	-
BioPlex 293T	MF	GO:0003677	DNA binding	1.28E-02	2865	2121	2066	1.03	-	-
BioPlex 293T	MF	GO:0008289	lipid binding	3.31E-02	836	630	603	1.05	-	-
BioPlex 293T	MF	GO:0005198	structural molecule activity	1.16E-01	798	595	575	1.03	-	-
BioPlex 293T	MF	GO:0003774	cytoskeletal motor activity	2.13E-01	116	90	84	1.08	-	-
BioPlex 293T	MF	GO:0038024	cargo receptor activity	2.57E-01	117	90	84	1.07	-	-
BioPlex 293T	MF	GO:0048018	receptor ligand activity	4.50E-01	504	356	363	0.98	-	-
BioPlex 293T	MF	GO:0140110	transcription regulator activity	9.17E-01	2033	1464	1466	1.00	-	-
BioPlex 293T	BP	GO:0008038	neuron recognition	-	46	31	-	-	1.14E-03	1.80E-03
BioPlex 293T	BP	GO:1905145	cellular response to acetylcholine	-	33	26	-	-	1.20E-03	1.51E-03
BioPlex 293T	BP	GO:0097094	craniofacial suture morphogenesis	-	18	13	-	-	2.15E-04	7.90E-04
BioPlex 293T	BP	GO:0098780	response to mitochondrial depolarisation	-	21	20	-	-	2.00E-03	1.15E-03
BioPlex 293T	BP	GO:0051931	regulation of sensory perception	-	36	22	-	-	3.48E-04	1.29E-03
BioPlex 293T	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	14	-	-	2.14E-04	8.62E-04
BioPlex 293T	BP	GO:0009268	response to pH	-	43	28	-	-	3.30E-03	1.65E-03
BioPlex 293T	BP	GO:0045666	positive regulation of neuron differentiation	-	91	60	-	-	4.91E-03	3.45E-03
BioPlex 293T	BP	GO:0043543	protein acylation	-	107	84	-	-	8.16E-03	4.88E-03
BioPlex 293T	MF	GO:0051349	positive regulation of lyase activity	-	41	19	-	-	4.94E-02	1.15E-03
BioPlex 293T	BP	GO:0048679	regulation of axon regeneration	-	28	16	-	-	3.38E-03	9.34E-04
BioPlex 293T	BP	GO:0022401	negative adaptation of signaling pathway	-	21	15	-	-	2.23E-01	8.62E-04
BioPlex 293T	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	80	-	-	3.83E-02	4.60E-03
BioPlex 293T	BP	GO:0071763	nuclear membrane organization	-	44	36	-	-	7.94E-03	2.08E-03
BioPlex 293T	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	30	-	-	4.43E-03	1.72E-03
BioPlex 293T	BP	GO:0071806	protein transmembrane transport	-	68	53	-	-	1.17E-02	3.09E-03
BioPlex 293T	BP	GO:0022038	corpus callosum development	-	25	23	-	-	8.15E-04	1.36E-03
BioPlex 293T	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	11	-	-	2.13E-04	6.46E-04
BioPlex 293T	BP	GO:0043299	leukocyte degranulation	-	82	57	-	-	8.22E-04	3.30E-03
BioPlex 293T	BP	GO:0048864	stem cell development	-	88	64	-	-	1.85E-02	3.73E-03
BioPlex 293T	BP	GO:0009310	amine catabolic process	-	20	13	-	-	4.60E-02	7.90E-04
BioPlex 293T	BP	GO:0051651	maintenance of location in cell	-	236	169	-	-	3.63E-03	9.77E-03
BioPlex 293T	BP	GO:0033119	negative regulation of RNA splicing	-	27	23	-	-	4.03E-03	1.36E-03
BioPlex 293T	BP	GO:0014004	microglia differentiation	-	12	11	-	-	6.35E-03	6.46E-04
BioPlex 293T	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	20	-	-	3.55E-04	1.15E-03
BioPlex 293T	CC	GO:0016197	endosomal transport	-	282	245	-	-	2.27E-02	1.41E-02
BioPlex 293T	BP	GO:0070663	regulation of leukocyte proliferation	-	268	198	-	-	4.92E-03	1.14E-02
BioPlex 293T	BP	GO:1905962	glutamatergic neuron differentiation	-	14	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	2.13E-03	8.62E-04
BioPlex 293T	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	26	-	-	1.24E-02	1.51E-03
BioPlex 293T	BP	GO:0006949	syncytium formation	-	66	43	-	-	8.98E-04	2.51E-03
BioPlex 293T	BP	GO:0045176	apical protein localization	-	15	13	-	-	2.12E-04	7.90E-04
BioPlex 293T	BP	GO:0045861	negative regulation of proteolysis	-	320	247	-	-	4.64E-03	1.42E-02
BioPlex 293T	BP	GO:0043144	sno(s)RNA processing	-	14	13	-	-	6.23E-02	7.90E-04
BioPlex 293T	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	37	-	-	4.34E-02	2.15E-03
BioPlex 293T	BP	GO:0030574	collagen catabolic process	-	45	29	-	-	7.83E-03	1.72E-03
BioPlex 293T	CC	GO:0006984	ER-nucleus signaling pathway	-	46	43	-	-	3.30E-03	2.51E-03
BioPlex 293T	BP	GO:0060343	trabecula formation	-	26	20	-	-	3.34E-03	1.15E-03
BioPlex 293T	BP	GO:0009914	hormone transport	-	315	231	-	-	5.94E-03	1.33E-02
BioPlex 293T	BP	GO:0140112	extracellular vesicle biogenesis	-	23	22	-	-	1.19E-02	1.29E-03
BioPlex 293T	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	1.88E-01	9.34E-04
BioPlex 293T	BP	GO:1900424	regulation of defense response to bacterium	-	21	16	-	-	4.74E-03	9.34E-04
BioPlex 293T	BP	GO:0085029	extracellular matrix assembly	-	42	30	-	-	7.23E-04	1.72E-03
BioPlex 293T	BP	GO:0006413	translational initiation	-	122	108	-	-	1.44E-01	6.25E-03
BioPlex 293T	BP	GO:0072176	nephric duct development	-	15	13	-	-	2.04E-03	7.90E-04
BioPlex 293T	BP	GO:1902895	positive regulation of miRNA transcription	-	51	38	-	-	2.16E-03	2.23E-03
BioPlex 293T	CC	GO:0005200	structural constituent of cytoskeleton	-	112	94	-	-	1.73E-02	5.46E-03
BioPlex 293T	BP	GO:0030865	cortical cytoskeleton organization	-	51	46	-	-	6.46E-03	2.66E-03
BioPlex 293T	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	11	-	-	4.24E-02	6.46E-04
BioPlex 293T	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	24	-	-	9.61E-02	1.44E-03
BioPlex 293T	BP	GO:1903036	positive regulation of response to wounding	-	76	50	-	-	2.70E-03	2.87E-03
BioPlex 293T	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	18	-	-	1.13E-03	1.08E-03
BioPlex 293T	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	138	-	-	1.20E-02	7.97E-03
BioPlex 293T	CC	GO:0001055	RNA polymerase II activity	-	11	11	-	-	7.16E-02	6.46E-04
BioPlex 293T	BP	GO:1903319	positive regulation of protein maturation	-	27	23	-	-	3.48E-04	1.36E-03
BioPlex 293T	BP	GO:0032528	microvillus organization	-	24	20	-	-	1.23E-02	1.15E-03
BioPlex 293T	BP	GO:0002263	cell activation involved in immune response	-	304	220	-	-	7.31E-03	1.26E-02
BioPlex 293T	BP	GO:0021954	central nervous system neuron development	-	85	71	-	-	1.78E-03	4.09E-03
BioPlex 293T	BP	GO:0055017	cardiac muscle tissue growth	-	92	53	-	-	7.30E-03	3.09E-03
BioPlex 293T	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	25	-	-	1.69E-03	1.44E-03
BioPlex 293T	BP	GO:0048524	positive regulation of viral process	-	64	54	-	-	1.39E-03	3.16E-03
BioPlex 293T	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	16	-	-	2.66E-03	9.34E-04
BioPlex 293T	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	20	-	-	1.09E-02	1.15E-03
BioPlex 293T	BP	GO:0001946	lymphangiogenesis	-	18	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	BP	GO:0098661	inorganic anion transmembrane transport	-	140	77	-	-	3.66E-02	4.45E-03
BioPlex 293T	BP	GO:0006099	tricarboxylic acid cycle	-	33	28	-	-	9.16E-02	1.65E-03
BioPlex 293T	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	16	-	-	2.18E-03	9.34E-04
BioPlex 293T	BP	GO:0009612	response to mechanical stimulus	-	215	151	-	-	9.97E-03	8.69E-03
BioPlex 293T	BP	GO:0048644	muscle organ morphogenesis	-	81	58	-	-	9.53E-04	3.38E-03
BioPlex 293T	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	114	-	-	2.56E-03	6.61E-03
BioPlex 293T	BP	GO:0071542	dopaminergic neuron differentiation	-	36	25	-	-	3.42E-03	1.44E-03
BioPlex 293T	BP	GO:0140115	export across plasma membrane	-	82	46	-	-	3.78E-03	2.66E-03
BioPlex 293T	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	11	-	-	2.13E-04	6.46E-04
BioPlex 293T	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	33	-	-	1.18E-03	1.94E-03
BioPlex 293T	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	18	-	-	4.17E-02	1.08E-03
BioPlex 293T	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	32	-	-	5.47E-03	1.87E-03
BioPlex 293T	MF	GO:0003714	transcription corepressor activity	-	190	166	-	-	1.09E-02	9.55E-03
BioPlex 293T	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	39	-	-	3.61E-03	2.30E-03
BioPlex 293T	BP	GO:0061101	neuroendocrine cell differentiation	-	16	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	CC	GO:0006858	extracellular transport	-	45	27	-	-	6.69E-03	1.58E-03
BioPlex 293T	BP	GO:0006304	DNA modification	-	30	21	-	-	2.11E-02	1.22E-03
BioPlex 293T	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	6.67E-02	1.08E-03
BioPlex 293T	BP	GO:0046835	carbohydrate phosphorylation	-	49	45	-	-	1.06E-01	2.59E-03
BioPlex 293T	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	16	-	-	8.87E-04	9.34E-04
BioPlex 293T	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	31	-	-	5.52E-03	1.80E-03
BioPlex 293T	BP	GO:0043523	regulation of neuron apoptotic process	-	218	164	-	-	5.77E-03	9.48E-03
BioPlex 293T	BP	GO:1902894	negative regulation of miRNA transcription	-	22	18	-	-	2.84E-04	1.08E-03
BioPlex 293T	BP	GO:0044380	protein localization to cytoskeleton	-	57	52	-	-	5.50E-03	3.02E-03
BioPlex 293T	BP	GO:2000209	regulation of anoikis	-	25	19	-	-	3.66E-03	1.15E-03
BioPlex 293T	BP	GO:0014029	neural crest formation	-	15	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	20	-	-	3.55E-04	1.15E-03
BioPlex 293T	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	31	-	-	4.90E-04	1.80E-03
BioPlex 293T	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	53	-	-	2.04E-03	3.09E-03
BioPlex 293T	CC	GO:0045324	late endosome to vacuole transport	-	37	26	-	-	7.50E-02	1.51E-03
BioPlex 293T	BP	GO:0043954	cellular component maintenance	-	72	55	-	-	1.11E-03	3.16E-03
BioPlex 293T	BP	GO:0050435	amyloid-beta metabolic process	-	65	46	-	-	1.99E-03	2.66E-03
BioPlex 293T	BP	GO:0014823	response to activity	-	70	53	-	-	1.94E-03	3.09E-03
BioPlex 293T	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	14	-	-	1.13E-02	8.62E-04
BioPlex 293T	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	26	-	-	8.76E-03	1.51E-03
BioPlex 293T	BP	GO:0034502	protein localization to chromosome	-	130	117	-	-	3.33E-02	6.75E-03
BioPlex 293T	BP	GO:0048562	embryonic organ morphogenesis	-	295	222	-	-	1.21E-02	1.28E-02
BioPlex 293T	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	9.56E-04	6.46E-04
BioPlex 293T	BP	GO:0019233	sensory perception of pain	-	103	62	-	-	1.11E-03	3.59E-03
BioPlex 293T	CC	GO:0043574	peroxisomal transport	-	22	19	-	-	1.29E-01	1.15E-03
BioPlex 293T	BP	GO:0031343	positive regulation of cell killing	-	75	58	-	-	3.83E-02	3.38E-03
BioPlex 293T	BP	GO:0090077	foam cell differentiation	-	39	30	-	-	2.10E-03	1.72E-03
BioPlex 293T	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	71	-	-	8.27E-03	4.09E-03
BioPlex 293T	BP	GO:0017148	negative regulation of translation	-	390	100	-	-	4.64E-02	5.75E-03
BioPlex 293T	BP	GO:0030220	platelet formation	-	22	18	-	-	2.84E-04	1.08E-03
BioPlex 293T	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	65	-	-	1.43E-03	3.73E-03
BioPlex 293T	BP	GO:1903509	liposaccharide metabolic process	-	109	84	-	-	7.77E-03	4.88E-03
BioPlex 293T	BP	GO:0009582	detection of abiotic stimulus	-	140	82	-	-	4.17E-03	4.74E-03
BioPlex 293T	BP	GO:0045683	negative regulation of epidermis development	-	13	11	-	-	2.12E-04	6.46E-04
BioPlex 293T	CC	GO:0140238	presynaptic endocytosis	-	72	64	-	-	2.05E-02	3.73E-03
BioPlex 293T	BP	GO:0051236	establishment of RNA localization	-	161	140	-	-	1.14E-01	8.04E-03
BioPlex 293T	BP	GO:0042178	xenobiotic catabolic process	-	26	22	-	-	4.03E-02	1.29E-03
BioPlex 293T	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	12	-	-	2.15E-04	7.18E-04
BioPlex 293T	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	163	-	-	7.87E-03	9.41E-03
BioPlex 293T	BP	GO:0034067	protein localization to Golgi apparatus	-	30	26	-	-	5.23E-03	1.51E-03
BioPlex 293T	BP	GO:0061842	microtubule organizing center localization	-	32	31	-	-	4.72E-03	1.80E-03
BioPlex 293T	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	13	-	-	2.47E-03	7.90E-04
BioPlex 293T	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	25	-	-	3.41E-03	1.44E-03
BioPlex 293T	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	36	-	-	8.96E-04	2.08E-03
BioPlex 293T	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	44	-	-	2.23E-03	2.59E-03
BioPlex 293T	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	2.53E-03	9.34E-04
BioPlex 293T	BP	GO:0050779	RNA destabilization	-	135	88	-	-	4.78E-02	5.10E-03
BioPlex 293T	BP	GO:0006023	aminoglycan biosynthetic process	-	74	63	-	-	5.63E-03	3.66E-03
BioPlex 293T	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	54	-	-	8.08E-03	3.16E-03
BioPlex 293T	BP	GO:0010762	regulation of fibroblast migration	-	40	32	-	-	3.73E-03	1.87E-03
BioPlex 293T	BP	GO:0090311	regulation of protein deacetylation	-	29	26	-	-	4.54E-02	1.51E-03
BioPlex 293T	BP	GO:0035272	exocrine system development	-	46	36	-	-	1.84E-03	2.08E-03
BioPlex 293T	BP	GO:1901096	regulation of autophagosome maturation	-	17	16	-	-	7.00E-02	9.34E-04
BioPlex 293T	BP	GO:0022406	membrane docking	-	90	84	-	-	1.49E-02	4.88E-03
BioPlex 293T	BP	GO:0006999	nuclear pore organization	-	15	12	-	-	2.21E-02	7.18E-04
BioPlex 293T	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	14	-	-	2.37E-03	8.62E-04
BioPlex 293T	BP	GO:0050777	negative regulation of immune response	-	196	155	-	-	5.14E-03	8.91E-03
BioPlex 293T	BP	GO:0016053	organic acid biosynthetic process	-	335	234	-	-	1.89E-02	1.35E-02
BioPlex 293T	MF	GO:0005035	death receptor activity	-	16	11	-	-	1.48E-03	6.46E-04
BioPlex 293T	BP	GO:0002063	chondrocyte development	-	33	25	-	-	9.62E-04	1.44E-03
BioPlex 293T	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	16	-	-	1.23E-03	9.34E-04
BioPlex 293T	BP	GO:0099068	postsynapse assembly	-	40	28	-	-	2.16E-02	1.65E-03
BioPlex 293T	BP	GO:0021782	glial cell development	-	120	88	-	-	2.84E-03	5.10E-03
BioPlex 293T	BP	GO:0051782	negative regulation of cell division	-	18	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	68	-	-	5.86E-03	3.95E-03
BioPlex 293T	BP	GO:0001655	urogenital system development	-	66	50	-	-	1.34E-02	2.87E-03
BioPlex 293T	BP	GO:0071827	plasma lipoprotein particle organization	-	86	58	-	-	3.02E-03	3.38E-03
BioPlex 293T	BP	GO:0045494	photoreceptor cell maintenance	-	43	27	-	-	3.70E-02	1.58E-03
BioPlex 293T	BP	GO:0055088	lipid homeostasis	-	173	123	-	-	3.65E-03	7.11E-03
BioPlex 293T	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	21	-	-	3.51E-04	1.22E-03
BioPlex 293T	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	165	-	-	3.73E-03	9.48E-03
BioPlex 293T	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	23	-	-	3.34E-03	1.36E-03
BioPlex 293T	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	32	-	-	1.25E-02	1.87E-03
BioPlex 293T	BP	GO:0045667	regulation of osteoblast differentiation	-	147	95	-	-	3.08E-03	5.46E-03
BioPlex 293T	BP	GO:2001212	regulation of vasculogenesis	-	16	11	-	-	1.85E-02	6.46E-04
BioPlex 293T	BP	GO:0061037	negative regulation of cartilage development	-	32	17	-	-	1.38E-01	1.01E-03
BioPlex 293T	BP	GO:0045738	negative regulation of DNA repair	-	40	36	-	-	3.02E-03	2.08E-03
BioPlex 293T	BP	GO:0001704	formation of primary germ layer	-	195	148	-	-	9.44E-03	8.55E-03
BioPlex 293T	BP	GO:0045778	positive regulation of ossification	-	51	40	-	-	1.16E-03	2.30E-03
BioPlex 293T	BP	GO:0048708	astrocyte differentiation	-	88	65	-	-	3.05E-03	3.73E-03
BioPlex 293T	BP	GO:0042092	type 2 immune response	-	41	29	-	-	4.01E-03	1.72E-03
BioPlex 293T	BP	GO:0048588	developmental cell growth	-	233	175	-	-	6.31E-03	1.01E-02
BioPlex 293T	CC	GO:0000963	mitochondrial RNA processing	-	20	19	-	-	6.37E-02	1.15E-03
BioPlex 293T	BP	GO:0021872	forebrain generation of neurons	-	52	44	-	-	6.23E-04	2.59E-03
BioPlex 293T	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	18	-	-	1.04E-03	1.08E-03
BioPlex 293T	BP	GO:0045023	G0 to G1 transition	-	41	37	-	-	1.68E-01	2.15E-03
BioPlex 293T	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	33	-	-	6.32E-03	1.94E-03
BioPlex 293T	BP	GO:0034367	protein-containing complex remodeling	-	35	27	-	-	1.05E-03	1.58E-03
BioPlex 293T	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	23	-	-	3.25E-03	1.36E-03
BioPlex 293T	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	33	-	-	3.48E-03	1.94E-03
BioPlex 293T	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	16	-	-	1.72E-01	9.34E-04
BioPlex 293T	BP	GO:0015810	aspartate transmembrane transport	-	19	16	-	-	5.31E-02	9.34E-04
BioPlex 293T	BP	GO:0010232	vascular transport	-	87	62	-	-	1.71E-03	3.59E-03
BioPlex 293T	BP	GO:0021987	cerebral cortex development	-	125	99	-	-	7.23E-03	5.75E-03
BioPlex 293T	BP	GO:0008637	apoptotic mitochondrial changes	-	108	86	-	-	2.38E-02	4.96E-03
BioPlex 293T	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	28	-	-	8.34E-03	1.65E-03
BioPlex 293T	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	13	-	-	4.69E-02	7.90E-04
BioPlex 293T	BP	GO:0060999	positive regulation of dendritic spine development	-	35	29	-	-	5.87E-03	1.72E-03
BioPlex 293T	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	14	-	-	4.73E-02	8.62E-04
BioPlex 293T	BP	GO:2000736	regulation of stem cell differentiation	-	78	66	-	-	4.87E-03	3.81E-03
BioPlex 293T	BP	GO:0060973	cell migration involved in heart development	-	21	15	-	-	2.85E-04	8.62E-04
BioPlex 293T	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	14	-	-	2.12E-04	8.62E-04
BioPlex 293T	BP	GO:0002064	epithelial cell development	-	210	169	-	-	1.30E-02	9.77E-03
BioPlex 293T	BP	GO:0071318	cellular response to ATP	-	18	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	33	-	-	4.13E-03	1.94E-03
BioPlex 293T	BP	GO:2001222	regulation of neuron migration	-	46	33	-	-	4.91E-04	1.94E-03
BioPlex 293T	BP	GO:0034389	lipid droplet organization	-	38	31	-	-	4.37E-03	1.80E-03
BioPlex 293T	BP	GO:0051602	response to electrical stimulus	-	44	35	-	-	8.52E-04	2.01E-03
BioPlex 293T	BP	GO:0042177	negative regulation of protein catabolic process	-	109	99	-	-	2.88E-03	5.75E-03
BioPlex 293T	MF	GO:0038024	cargo receptor activity	-	121	90	-	-	4.21E-03	5.17E-03
BioPlex 293T	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	13	-	-	3.97E-03	7.90E-04
BioPlex 293T	BP	GO:0033120	positive regulation of RNA splicing	-	46	35	-	-	2.21E-03	2.01E-03
BioPlex 293T	BP	GO:0051445	regulation of meiotic cell cycle	-	64	47	-	-	6.18E-02	2.73E-03
BioPlex 293T	BP	GO:0033619	membrane protein proteolysis	-	60	50	-	-	3.40E-03	2.87E-03
BioPlex 293T	BP	GO:0038065	collagen-activated signaling pathway	-	15	11	-	-	5.64E-02	6.46E-04
BioPlex 293T	BP	GO:0090087	regulation of peptide transport	-	195	141	-	-	2.35E-03	8.12E-03
BioPlex 293T	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	75	-	-	3.39E-03	4.31E-03
BioPlex 293T	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	18	-	-	2.80E-04	1.08E-03
BioPlex 293T	BP	GO:0006929	substrate-dependent cell migration	-	26	20	-	-	7.87E-04	1.15E-03
BioPlex 293T	BP	GO:0042537	benzene-containing compound metabolic process	-	27	19	-	-	1.47E-01	1.15E-03
BioPlex 293T	BP	GO:0099118	microtubule-based protein transport	-	14	12	-	-	2.14E-04	7.18E-04
BioPlex 293T	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	BP	GO:0072662	protein localization to peroxisome	-	20	18	-	-	7.98E-02	1.08E-03
BioPlex 293T	BP	GO:0022404	molting cycle process	-	95	77	-	-	2.38E-03	4.45E-03
BioPlex 293T	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	1.01E-02	1.01E-03
BioPlex 293T	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	16	-	-	2.85E-04	9.34E-04
BioPlex 293T	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	13	-	-	2.13E-04	7.90E-04
BioPlex 293T	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	27	-	-	1.57E-03	1.58E-03
BioPlex 293T	BP	GO:0017014	protein nitrosylation	-	17	14	-	-	1.21E-01	8.62E-04
BioPlex 293T	BP	GO:0007281	germ cell development	-	334	237	-	-	5.42E-03	1.36E-02
BioPlex 293T	BP	GO:0008299	isoprenoid biosynthetic process	-	30	27	-	-	5.74E-03	1.58E-03
BioPlex 293T	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	177	-	-	4.63E-03	1.02E-02
BioPlex 293T	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	27	-	-	4.23E-04	1.58E-03
BioPlex 293T	BP	GO:0034104	negative regulation of tissue remodeling	-	22	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	CC	GO:0098926	postsynaptic signal transduction	-	39	32	-	-	1.12E-03	1.87E-03
BioPlex 293T	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	117	-	-	3.47E-03	6.75E-03
BioPlex 293T	CC	GO:0016082	synaptic vesicle priming	-	19	18	-	-	2.67E-03	1.08E-03
BioPlex 293T	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	40	-	-	6.26E-04	2.30E-03
BioPlex 293T	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	116	-	-	9.92E-03	6.68E-03
BioPlex 293T	BP	GO:0034249	negative regulation of amide metabolic process	-	34	20	-	-	2.88E-03	1.15E-03
BioPlex 293T	BP	GO:0061548	ganglion development	-	17	13	-	-	2.12E-04	7.90E-04
BioPlex 293T	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	90	-	-	3.46E-02	5.17E-03
BioPlex 293T	BP	GO:0042832	defense response to protozoan	-	28	15	-	-	3.85E-02	8.62E-04
BioPlex 293T	BP	GO:0048799	animal organ maturation	-	33	25	-	-	4.25E-04	1.44E-03
BioPlex 293T	BP	GO:0006925	inflammatory cell apoptotic process	-	23	17	-	-	2.83E-04	1.01E-03
BioPlex 293T	BP	GO:2000291	regulation of myoblast proliferation	-	25	12	-	-	2.12E-04	7.18E-04
BioPlex 293T	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	126	-	-	4.21E-03	7.25E-03
BioPlex 293T	BP	GO:1903035	negative regulation of response to wounding	-	93	68	-	-	3.15E-03	3.95E-03
BioPlex 293T	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	20	-	-	2.80E-03	1.15E-03
BioPlex 293T	BP	GO:0036010	protein localization to endosome	-	27	23	-	-	5.58E-02	1.36E-03
BioPlex 293T	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	112	-	-	2.55E-02	6.46E-03
BioPlex 293T	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	87	-	-	2.28E-03	5.03E-03
BioPlex 293T	BP	GO:0045056	transcytosis	-	20	16	-	-	2.07E-03	9.34E-04
BioPlex 293T	BP	GO:0018342	protein prenylation	-	15	13	-	-	5.20E-03	7.90E-04
BioPlex 293T	BP	GO:0009267	cellular response to starvation	-	170	146	-	-	6.29E-03	8.40E-03
BioPlex 293T	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	43	-	-	1.35E-03	2.51E-03
BioPlex 293T	BP	GO:0046834	lipid phosphorylation	-	16	12	-	-	8.49E-02	7.18E-04
BioPlex 293T	CC	GO:0140239	postsynaptic endocytosis	-	23	19	-	-	7.31E-03	1.15E-03
BioPlex 293T	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	20	-	-	1.15E-03	1.15E-03
BioPlex 293T	BP	GO:0046931	pore complex assembly	-	21	16	-	-	5.03E-02	9.34E-04
BioPlex 293T	CC	GO:0032008	positive regulation of TOR signaling	-	52	47	-	-	9.49E-02	2.73E-03
BioPlex 293T	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	29	-	-	4.32E-02	1.72E-03
BioPlex 293T	BP	GO:0060428	lung epithelium development	-	43	33	-	-	1.07E-03	1.94E-03
BioPlex 293T	BP	GO:0030431	sleep	-	30	19	-	-	2.82E-04	1.15E-03
BioPlex 293T	BP	GO:1903318	negative regulation of protein maturation	-	29	19	-	-	1.92E-02	1.15E-03
BioPlex 293T	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	87	-	-	1.86E-01	5.03E-03
BioPlex 293T	BP	GO:0071732	cellular response to nitric oxide	-	17	14	-	-	1.23E-03	8.62E-04
BioPlex 293T	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	5.33E-03	8.62E-04
BioPlex 293T	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	47	-	-	8.27E-03	2.73E-03
BioPlex 293T	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	53	-	-	8.57E-04	3.09E-03
BioPlex 293T	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	12	-	-	2.14E-04	7.18E-04
BioPlex 293T	CC	GO:0006406	mRNA export from nucleus	-	69	63	-	-	1.96E-01	3.66E-03
BioPlex 293T	BP	GO:0009880	embryonic pattern specification	-	70	52	-	-	5.38E-03	3.02E-03
BioPlex 293T	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	38	-	-	2.55E-01	2.23E-03
BioPlex 293T	BP	GO:0043043	peptide biosynthetic process	-	25	18	-	-	2.65E-02	1.08E-03
BioPlex 293T	BP	GO:0002367	cytokine production involved in immune response	-	121	89	-	-	3.37E-03	5.17E-03
BioPlex 293T	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	BP	GO:0044848	biological phase	-	211	166	-	-	1.17E-02	9.55E-03
BioPlex 293T	BP	GO:0002645	positive regulation of tolerance induction	-	12	11	-	-	1.04E-01	6.46E-04
BioPlex 293T	BP	GO:0046660	female sex differentiation	-	125	100	-	-	3.33E-03	5.75E-03
BioPlex 293T	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	16	-	-	2.82E-04	9.34E-04
BioPlex 293T	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	36	-	-	1.69E-03	2.08E-03
BioPlex 293T	BP	GO:0060411	cardiac septum morphogenesis	-	72	58	-	-	3.97E-03	3.38E-03
BioPlex 293T	BP	GO:0071248	cellular response to metal ion	-	201	150	-	-	1.57E-02	8.62E-03
BioPlex 293T	BP	GO:0030308	negative regulation of cell growth	-	191	146	-	-	6.38E-03	8.40E-03
BioPlex 293T	BP	GO:0097306	cellular response to alcohol	-	99	68	-	-	1.81E-03	3.95E-03
BioPlex 293T	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	120	-	-	4.94E-02	6.89E-03
BioPlex 293T	BP	GO:0010453	regulation of cell fate commitment	-	40	29	-	-	8.91E-03	1.72E-03
BioPlex 293T	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	45	-	-	1.10E-03	2.59E-03
BioPlex 293T	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	34	-	-	4.39E-02	2.01E-03
BioPlex 293T	BP	GO:0002026	regulation of the force of heart contraction	-	26	19	-	-	2.83E-04	1.15E-03
BioPlex 293T	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	16	-	-	1.02E-03	9.34E-04
BioPlex 293T	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	33	-	-	2.67E-02	1.94E-03
BioPlex 293T	BP	GO:0032890	regulation of organic acid transport	-	78	52	-	-	7.66E-04	3.02E-03
BioPlex 293T	BP	GO:0071498	cellular response to fluid shear stress	-	21	15	-	-	3.84E-02	8.62E-04
BioPlex 293T	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	12	-	-	2.14E-04	7.18E-04
BioPlex 293T	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	64	-	-	2.24E-03	3.73E-03
BioPlex 293T	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	19	-	-	2.84E-04	1.15E-03
BioPlex 293T	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	36	-	-	5.72E-03	2.08E-03
BioPlex 293T	BP	GO:0051259	protein complex oligomerization	-	251	193	-	-	1.83E-02	1.11E-02
BioPlex 293T	BP	GO:0009163	nucleoside biosynthetic process	-	16	15	-	-	2.85E-04	8.62E-04
BioPlex 293T	BP	GO:0098743	cell aggregation	-	24	13	-	-	2.13E-04	7.90E-04
BioPlex 293T	BP	GO:0009994	oocyte differentiation	-	57	43	-	-	9.47E-04	2.51E-03
BioPlex 293T	MF	GO:0031952	regulation of protein autophosphorylation	-	43	35	-	-	9.48E-03	2.01E-03
BioPlex 293T	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	12	-	-	2.13E-04	7.18E-04
BioPlex 293T	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	131	-	-	1.08E-02	7.54E-03
BioPlex 293T	BP	GO:0044319	"wound healing, spreading of cells"	-	37	31	-	-	5.84E-03	1.80E-03
BioPlex 293T	BP	GO:0033688	regulation of osteoblast proliferation	-	31	20	-	-	3.53E-04	1.15E-03
BioPlex 293T	BP	GO:0060251	regulation of glial cell proliferation	-	39	25	-	-	2.84E-03	1.44E-03
BioPlex 293T	BP	GO:0072665	protein localization to vacuole	-	84	81	-	-	1.15E-02	4.67E-03
BioPlex 293T	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	42	-	-	8.47E-02	2.44E-03
BioPlex 293T	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	19	-	-	2.18E-03	1.15E-03
BioPlex 293T	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	60	-	-	1.89E-02	3.45E-03
BioPlex 293T	BP	GO:0042953	lipoprotein transport	-	20	13	-	-	3.07E-03	7.90E-04
BioPlex 293T	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	2.85E-04	8.62E-04
BioPlex 293T	BP	GO:0042044	fluid transport	-	35	19	-	-	7.05E-04	1.15E-03
BioPlex 293T	BP	GO:0070633	transepithelial transport	-	35	21	-	-	9.48E-04	1.22E-03
BioPlex 293T	BP	GO:0045661	regulation of myoblast differentiation	-	74	61	-	-	2.02E-02	3.52E-03
BioPlex 293T	BP	GO:0030307	positive regulation of cell growth	-	164	126	-	-	4.09E-03	7.25E-03
BioPlex 293T	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	8.32E-03	1.44E-03
BioPlex 293T	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	13	-	-	5.65E-03	7.90E-04
BioPlex 293T	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	11	-	-	8.26E-03	6.46E-04
BioPlex 293T	BP	GO:0014812	muscle cell migration	-	110	74	-	-	4.18E-03	4.31E-03
BioPlex 293T	BP	GO:0048525	negative regulation of viral process	-	90	72	-	-	4.49E-03	4.17E-03
BioPlex 293T	BP	GO:0072044	collecting duct development	-	16	12	-	-	2.14E-04	7.18E-04
BioPlex 293T	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	57	-	-	1.64E-02	3.30E-03
BioPlex 293T	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	182	-	-	1.73E-02	1.05E-02
BioPlex 293T	BP	GO:0051781	positive regulation of cell division	-	93	73	-	-	1.12E-02	4.24E-03
BioPlex 293T	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	17	-	-	2.84E-04	1.01E-03
BioPlex 293T	BP	GO:0035493	SNARE complex assembly	-	23	21	-	-	7.68E-02	1.22E-03
BioPlex 293T	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	17	-	-	2.81E-04	1.01E-03
BioPlex 293T	BP	GO:0060711	labyrinthine layer development	-	47	42	-	-	3.84E-03	2.44E-03
BioPlex 293T	BP	GO:0007272	ensheathment of neurons	-	146	115	-	-	2.74E-03	6.61E-03
BioPlex 293T	CC	GO:0050806	positive regulation of synaptic transmission	-	171	112	-	-	9.25E-03	6.46E-03
BioPlex 293T	BP	GO:0060021	roof of mouth development	-	91	71	-	-	4.17E-03	4.09E-03
BioPlex 293T	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	30	-	-	7.48E-03	1.72E-03
BioPlex 293T	BP	GO:0050819	negative regulation of coagulation	-	54	39	-	-	7.04E-03	2.30E-03
BioPlex 293T	BP	GO:0017004	cytochrome complex assembly	-	40	29	-	-	8.00E-02	1.72E-03
BioPlex 293T	BP	GO:0018410	C-terminal protein amino acid modification	-	15	14	-	-	3.60E-02	8.62E-04
BioPlex 293T	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	60	-	-	3.27E-01	3.45E-03
BioPlex 293T	CC	GO:0050805	negative regulation of synaptic transmission	-	55	30	-	-	4.90E-04	1.72E-03
BioPlex 293T	BP	GO:0043248	proteasome assembly	-	13	13	-	-	1.47E-02	7.90E-04
BioPlex 293T	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	45	-	-	2.62E-03	2.59E-03
BioPlex 293T	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	44	-	-	6.21E-04	2.59E-03
BioPlex 293T	BP	GO:0016054	organic acid catabolic process	-	251	194	-	-	1.92E-02	1.12E-02
BioPlex 293T	BP	GO:0050890	cognition	-	317	233	-	-	6.70E-03	1.34E-02
BioPlex 293T	BP	GO:1900048	positive regulation of hemostasis	-	28	23	-	-	3.65E-03	1.36E-03
BioPlex 293T	BP	GO:0065005	protein-lipid complex assembly	-	29	22	-	-	2.36E-03	1.29E-03
BioPlex 293T	BP	GO:0008033	tRNA processing	-	136	126	-	-	1.06E-01	7.25E-03
BioPlex 293T	BP	GO:0046661	male sex differentiation	-	171	137	-	-	5.11E-03	7.90E-03
BioPlex 293T	BP	GO:0072520	seminiferous tubule development	-	15	13	-	-	2.12E-04	7.90E-04
BioPlex 293T	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	14	-	-	1.02E-02	8.62E-04
BioPlex 293T	BP	GO:0035188	hatching	-	27	15	-	-	2.84E-04	8.62E-04
BioPlex 293T	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	73	-	-	1.93E-03	4.24E-03
BioPlex 293T	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	BP	GO:0090713	immunological memory process	-	18	11	-	-	1.54E-03	6.46E-04
BioPlex 293T	BP	GO:0061326	renal tubule development	-	103	78	-	-	3.45E-03	4.52E-03
BioPlex 293T	BP	GO:0051258	protein polymerization	-	280	236	-	-	1.52E-02	1.36E-02
BioPlex 293T	BP	GO:0071985	multivesicular body sorting pathway	-	56	44	-	-	4.31E-02	2.59E-03
BioPlex 293T	BP	GO:0006450	regulation of translational fidelity	-	18	14	-	-	4.73E-03	8.62E-04
BioPlex 293T	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	12	-	-	7.04E-02	7.18E-04
BioPlex 293T	BP	GO:0060325	face morphogenesis	-	31	25	-	-	4.20E-04	1.44E-03
BioPlex 293T	BP	GO:0090559	regulation of membrane permeability	-	72	54	-	-	1.28E-02	3.16E-03
BioPlex 293T	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	1.15E-01	7.18E-04
BioPlex 293T	BP	GO:0031579	membrane raft organization	-	25	16	-	-	2.36E-02	9.34E-04
BioPlex 293T	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	23	-	-	3.50E-04	1.36E-03
BioPlex 293T	BP	GO:0046460	neutral lipid biosynthetic process	-	50	39	-	-	1.23E-02	2.30E-03
BioPlex 293T	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	102	-	-	4.61E-03	5.89E-03
BioPlex 293T	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	147	-	-	7.27E-03	8.47E-03
BioPlex 293T	BP	GO:0002251	organ or tissue specific immune response	-	43	26	-	-	8.25E-04	1.51E-03
BioPlex 293T	CC	GO:0048167	regulation of synaptic plasticity	-	210	141	-	-	5.44E-03	8.12E-03
BioPlex 293T	BP	GO:1903708	positive regulation of hemopoiesis	-	184	140	-	-	1.05E-02	8.04E-03
BioPlex 293T	BP	GO:1903008	organelle disassembly	-	154	140	-	-	1.73E-02	8.04E-03
BioPlex 293T	BP	GO:0001709	cell fate determination	-	44	28	-	-	3.16E-03	1.65E-03
BioPlex 293T	BP	GO:0051873	killing by host of symbiont cells	-	28	20	-	-	5.87E-02	1.15E-03
BioPlex 293T	BP	GO:0045058	T cell selection	-	53	34	-	-	9.28E-04	2.01E-03
BioPlex 293T	CC	GO:0032387	negative regulation of intracellular transport	-	51	40	-	-	9.42E-04	2.30E-03
BioPlex 293T	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	18	-	-	2.34E-03	1.08E-03
BioPlex 293T	BP	GO:0072091	regulation of stem cell proliferation	-	91	60	-	-	1.10E-03	3.45E-03
BioPlex 293T	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	32	-	-	7.07E-03	1.87E-03
BioPlex 293T	BP	GO:0099084	postsynaptic specialization organization	-	44	28	-	-	4.20E-04	1.65E-03
BioPlex 293T	BP	GO:0071501	cellular response to sterol depletion	-	15	13	-	-	3.71E-03	7.90E-04
BioPlex 293T	BP	GO:0060384	innervation	-	27	23	-	-	4.39E-03	1.36E-03
BioPlex 293T	BP	GO:2000774	positive regulation of cellular senescence	-	19	11	-	-	2.13E-04	6.46E-04
BioPlex 293T	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	25	-	-	1.17E-02	1.44E-03
BioPlex 293T	MF	GO:0031281	positive regulation of cyclase activity	-	40	21	-	-	2.70E-03	1.22E-03
BioPlex 293T	MF	GO:0098631	cell adhesion mediator activity	-	64	44	-	-	3.99E-03	2.59E-03
BioPlex 293T	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	13	-	-	2.13E-04	7.90E-04
BioPlex 293T	BP	GO:0046112	nucleobase biosynthetic process	-	18	17	-	-	4.69E-02	1.01E-03
BioPlex 293T	BP	GO:0071453	cellular response to oxygen levels	-	168	125	-	-	6.55E-03	7.18E-03
BioPlex 293T	BP	GO:0090399	replicative senescence	-	17	14	-	-	2.13E-04	8.62E-04
BioPlex 293T	BP	GO:0031342	negative regulation of cell killing	-	29	25	-	-	8.54E-03	1.44E-03
BioPlex 293T	BP	GO:0070585	protein localization to mitochondrion	-	125	109	-	-	3.05E-02	6.32E-03
BioPlex 293T	BP	GO:0010623	programmed cell death involved in cell development	-	25	17	-	-	3.43E-02	1.01E-03
BioPlex 293T	BP	GO:0044242	cellular lipid catabolic process	-	224	178	-	-	9.61E-03	1.03E-02
BioPlex 293T	BP	GO:0071236	cellular response to antibiotic	-	13	11	-	-	1.06E-03	6.46E-04
BioPlex 293T	BP	GO:0002931	response to ischemia	-	58	42	-	-	4.42E-03	2.44E-03
BioPlex 293T	BP	GO:0043062	extracellular structure organization	-	317	219	-	-	1.46E-02	1.26E-02
BioPlex 293T	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	6.61E-02	7.18E-04
BioPlex 293T	BP	GO:0014047	glutamate secretion	-	25	14	-	-	1.31E-03	8.62E-04
BioPlex 293T	BP	GO:0061005	cell differentiation involved in kidney development	-	58	44	-	-	7.98E-04	2.59E-03
BioPlex 293T	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	50	-	-	2.02E-02	2.87E-03
BioPlex 293T	BP	GO:0060420	regulation of heart growth	-	74	44	-	-	1.35E-02	2.59E-03
BioPlex 293T	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	11	-	-	2.13E-04	6.46E-04
BioPlex 293T	BP	GO:0009755	hormone-mediated signaling pathway	-	221	175	-	-	1.08E-02	1.01E-02
BioPlex 293T	BP	GO:0022612	gland morphogenesis	-	124	95	-	-	2.00E-03	5.46E-03
BioPlex 293T	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	31	-	-	4.94E-04	1.80E-03
BioPlex 293T	MF	GO:0140416	transcription regulator inhibitor activity	-	26	24	-	-	5.20E-03	1.44E-03
BioPlex 293T	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	17	-	-	1.33E-01	1.01E-03
BioPlex 293T	BP	GO:0048935	peripheral nervous system neuron development	-	15	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	BP	GO:0110096	cellular response to aldehyde	-	17	11	-	-	2.15E-04	6.46E-04
BioPlex 293T	BP	GO:1990845	adaptive thermogenesis	-	166	125	-	-	3.76E-03	7.18E-03
BioPlex 293T	BP	GO:0071320	cellular response to cAMP	-	54	40	-	-	3.13E-02	2.30E-03
BioPlex 293T	BP	GO:0015844	monoamine transport	-	88	55	-	-	4.11E-03	3.16E-03
BioPlex 293T	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	20	-	-	6.56E-04	1.15E-03
BioPlex 293T	BP	GO:0060039	pericardium development	-	19	15	-	-	5.90E-03	8.62E-04
BioPlex 293T	BP	GO:0071392	cellular response to estradiol stimulus	-	40	28	-	-	7.99E-03	1.65E-03
BioPlex 293T	BP	GO:0000272	polysaccharide catabolic process	-	19	17	-	-	1.06E-01	1.01E-03
BioPlex 293T	BP	GO:0009451	RNA modification	-	169	149	-	-	2.41E-02	8.62E-03
BioPlex 293T	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	32	-	-	2.37E-02	1.87E-03
BioPlex 293T	BP	GO:1903729	regulation of plasma membrane organization	-	17	16	-	-	5.98E-02	9.34E-04
BioPlex 293T	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	100	-	-	1.10E-02	5.75E-03
BioPlex 293T	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	29	-	-	2.32E-02	1.72E-03
BioPlex 293T	BP	GO:0015807	L-amino acid transport	-	94	63	-	-	7.25E-03	3.66E-03
BioPlex 293T	BP	GO:0032941	secretion by tissue	-	85	56	-	-	2.80E-03	3.23E-03
BioPlex 293T	BP	GO:0046605	regulation of centrosome cycle	-	54	46	-	-	1.85E-03	2.66E-03
BioPlex 293T	BP	GO:0048753	pigment granule organization	-	40	37	-	-	5.96E-02	2.15E-03
BioPlex 293T	BP	GO:0021516	dorsal spinal cord development	-	20	15	-	-	2.85E-04	8.62E-04
BioPlex 293T	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	15	-	-	2.85E-04	8.62E-04
BioPlex 293T	BP	GO:0003014	renal system process	-	130	91	-	-	3.93E-03	5.24E-03
BioPlex 293T	CC	GO:0070286	axonemal dynein complex assembly	-	40	25	-	-	4.23E-04	1.44E-03
BioPlex 293T	BP	GO:0045598	regulation of fat cell differentiation	-	148	103	-	-	2.67E-03	5.96E-03
BioPlex 293T	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	152	-	-	5.31E-03	8.76E-03
BioPlex 293T	BP	GO:1904646	cellular response to amyloid-beta	-	44	32	-	-	1.84E-03	1.87E-03
BioPlex 293T	BP	GO:1901863	positive regulation of muscle tissue development	-	24	18	-	-	2.85E-04	1.08E-03
BioPlex 293T	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	123	-	-	1.84E-02	7.11E-03
BioPlex 293T	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	12	-	-	2.12E-04	7.18E-04
BioPlex 293T	BP	GO:0008340	determination of adult lifespan	-	23	19	-	-	2.85E-04	1.15E-03
BioPlex 293T	BP	GO:0018158	protein oxidation	-	15	13	-	-	2.13E-04	7.90E-04
BioPlex 293T	BP	GO:0039694	viral RNA genome replication	-	30	24	-	-	1.52E-03	1.44E-03
BioPlex 293T	BP	GO:0009404	toxin metabolic process	-	17	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	21	-	-	3.50E-04	1.22E-03
BioPlex 293T	BP	GO:0071709	membrane assembly	-	68	52	-	-	1.19E-02	3.02E-03
BioPlex 293T	BP	GO:0008217	regulation of blood pressure	-	186	120	-	-	5.97E-03	6.89E-03
BioPlex 293T	BP	GO:0031643	positive regulation of myelination	-	19	14	-	-	2.12E-04	8.62E-04
BioPlex 293T	BP	GO:0043101	purine-containing compound salvage	-	15	14	-	-	4.37E-02	8.62E-04
BioPlex 293T	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	47	-	-	4.28E-03	2.73E-03
BioPlex 293T	CC	GO:0042770	signal transduction in response to DNA damage	-	186	163	-	-	1.17E-02	9.41E-03
BioPlex 293T	BP	GO:0002200	somatic diversification of immune receptors	-	78	63	-	-	1.07E-02	3.66E-03
BioPlex 293T	BP	GO:0035315	hair cell differentiation	-	52	38	-	-	7.83E-04	2.23E-03
BioPlex 293T	BP	GO:0048645	animal organ formation	-	62	44	-	-	2.07E-02	2.59E-03
BioPlex 293T	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	134	-	-	8.07E-03	7.76E-03
BioPlex 293T	BP	GO:0033627	cell adhesion mediated by integrin	-	87	66	-	-	1.35E-02	3.81E-03
BioPlex 293T	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	1.42E-02	1.22E-03
BioPlex 293T	BP	GO:0035107	appendage morphogenesis	-	147	120	-	-	4.42E-03	6.89E-03
BioPlex 293T	BP	GO:1903707	negative regulation of hemopoiesis	-	116	86	-	-	6.22E-03	4.96E-03
BioPlex 293T	BP	GO:0036342	post-anal tail morphogenesis	-	19	16	-	-	2.83E-04	9.34E-04
BioPlex 293T	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	1.18E-01	1.44E-03
BioPlex 293T	BP	GO:0030149	sphingolipid catabolic process	-	32	24	-	-	6.23E-03	1.44E-03
BioPlex 293T	BP	GO:0050994	regulation of lipid catabolic process	-	61	44	-	-	9.30E-04	2.59E-03
BioPlex 293T	BP	GO:0035988	chondrocyte proliferation	-	24	17	-	-	2.83E-04	1.01E-03
BioPlex 293T	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	15	-	-	9.13E-02	8.62E-04
BioPlex 293T	BP	GO:0009593	detection of chemical stimulus	-	511	116	-	-	7.36E-03	6.68E-03
BioPlex 293T	BP	GO:0045727	positive regulation of translation	-	141	115	-	-	8.40E-03	6.61E-03
BioPlex 293T	BP	GO:0036315	cellular response to sterol	-	24	16	-	-	3.98E-03	9.34E-04
BioPlex 293T	CC	GO:0032388	positive regulation of intracellular transport	-	137	117	-	-	1.16E-02	6.75E-03
BioPlex 293T	BP	GO:0021979	hypothalamus cell differentiation	-	13	11	-	-	2.12E-04	6.46E-04
BioPlex 293T	BP	GO:0002027	regulation of heart rate	-	106	70	-	-	7.42E-03	4.02E-03
BioPlex 293T	BP	GO:0050879	multicellular organismal movement	-	118	90	-	-	2.74E-03	5.17E-03
BioPlex 293T	BP	GO:0120305	regulation of pigmentation	-	15	11	-	-	4.20E-02	6.46E-04
BioPlex 293T	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	62	-	-	3.07E-03	3.59E-03
BioPlex 293T	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	49	-	-	3.20E-03	2.87E-03
BioPlex 293T	BP	GO:0048515	spermatid differentiation	-	208	146	-	-	3.82E-03	8.40E-03
BioPlex 293T	BP	GO:0072132	mesenchyme morphogenesis	-	57	45	-	-	8.44E-03	2.59E-03
BioPlex 293T	MF	GO:0042887	amide transmembrane transporter activity	-	33	22	-	-	8.85E-04	1.29E-03
BioPlex 293T	BP	GO:0007130	synaptonemal complex assembly	-	23	14	-	-	2.12E-04	8.62E-04
BioPlex 293T	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	31	-	-	5.44E-03	1.80E-03
BioPlex 293T	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	23	-	-	3.52E-04	1.36E-03
BioPlex 293T	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	24	-	-	1.25E-03	1.44E-03
BioPlex 293T	BP	GO:0060119	inner ear receptor cell development	-	44	34	-	-	8.86E-03	2.01E-03
BioPlex 293T	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	16	-	-	1.27E-03	9.34E-04
BioPlex 293T	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	23	-	-	1.36E-01	1.36E-03
BioPlex 293T	BP	GO:1901983	regulation of protein acetylation	-	26	20	-	-	3.52E-04	1.15E-03
BioPlex 293T	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	189	-	-	5.33E-03	1.09E-02
BioPlex 293T	BP	GO:1900006	positive regulation of dendrite development	-	17	15	-	-	1.43E-02	8.62E-04
BioPlex 293T	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	45	-	-	1.20E-01	2.59E-03
BioPlex 293T	BP	GO:0010883	regulation of lipid storage	-	53	40	-	-	1.03E-03	2.30E-03
BioPlex 293T	BP	GO:0072170	metanephric tubule development	-	26	17	-	-	4.38E-02	1.01E-03
BioPlex 293T	BP	GO:0007635	chemosensory behavior	-	20	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	BP	GO:1905954	positive regulation of lipid localization	-	110	81	-	-	1.77E-03	4.67E-03
BioPlex 293T	BP	GO:0002209	behavioral defense response	-	39	30	-	-	2.00E-02	1.72E-03
BioPlex 293T	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	21	-	-	1.75E-01	1.22E-03
BioPlex 293T	BP	GO:0072523	purine-containing compound catabolic process	-	146	125	-	-	7.14E-02	7.18E-03
BioPlex 293T	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	29	-	-	3.45E-03	1.72E-03
BioPlex 293T	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	23	-	-	2.75E-03	1.36E-03
BioPlex 293T	BP	GO:0021535	cell migration in hindbrain	-	16	13	-	-	2.13E-04	7.90E-04
BioPlex 293T	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	83	-	-	9.25E-02	4.81E-03
BioPlex 293T	BP	GO:0007218	neuropeptide signaling pathway	-	113	54	-	-	2.19E-03	3.16E-03
BioPlex 293T	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	2.79E-02	7.18E-04
BioPlex 293T	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	100	-	-	1.99E-03	5.75E-03
BioPlex 293T	BP	GO:0031345	negative regulation of cell projection organization	-	195	151	-	-	5.90E-03	8.69E-03
BioPlex 293T	BP	GO:0048278	vesicle docking	-	64	60	-	-	1.70E-02	3.45E-03
BioPlex 293T	BP	GO:0035050	embryonic heart tube development	-	86	62	-	-	4.47E-03	3.59E-03
BioPlex 293T	BP	GO:0030168	platelet activation	-	135	98	-	-	2.93E-03	5.67E-03
BioPlex 293T	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	13	-	-	1.27E-02	7.90E-04
BioPlex 293T	CC	GO:0098810	neurotransmitter reuptake	-	35	19	-	-	2.83E-04	1.15E-03
BioPlex 293T	BP	GO:0008213	protein alkylation	-	58	47	-	-	1.54E-03	2.73E-03
BioPlex 293T	BP	GO:0009812	flavonoid metabolic process	-	14	11	-	-	9.61E-02	6.46E-04
BioPlex 293T	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	11	-	-	2.12E-04	6.46E-04
BioPlex 293T	BP	GO:0031338	regulation of vesicle fusion	-	24	22	-	-	3.68E-03	1.29E-03
BioPlex 293T	BP	GO:0031529	ruffle organization	-	55	45	-	-	1.77E-03	2.59E-03
BioPlex 293T	BP	GO:0010842	retina layer formation	-	25	17	-	-	2.39E-02	1.01E-03
BioPlex 293T	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	59	-	-	4.65E-02	3.45E-03
BioPlex 293T	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	46	-	-	8.87E-03	2.66E-03
BioPlex 293T	MF	GO:0170055	lipid transmembrane transporter activity	-	56	31	-	-	2.95E-03	1.80E-03
BioPlex 293T	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	27	-	-	1.44E-03	1.58E-03
BioPlex 293T	BP	GO:0035304	regulation of protein dephosphorylation	-	87	74	-	-	2.93E-03	4.31E-03
BioPlex 293T	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	186	-	-	5.25E-03	1.07E-02
BioPlex 293T	BP	GO:0099637	neurotransmitter receptor transport	-	26	21	-	-	2.00E-03	1.22E-03
BioPlex 293T	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	24	-	-	3.50E-04	1.44E-03
BioPlex 293T	BP	GO:0051785	positive regulation of nuclear division	-	61	43	-	-	3.18E-03	2.51E-03
BioPlex 293T	BP	GO:0060456	positive regulation of digestive system process	-	16	13	-	-	2.03E-03	7.90E-04
BioPlex 293T	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	12	-	-	7.22E-04	7.18E-04
BioPlex 293T	BP	GO:0060749	mammary gland alveolus development	-	20	14	-	-	2.14E-04	8.62E-04
BioPlex 293T	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	11	-	-	2.17E-01	6.46E-04
BioPlex 293T	BP	GO:0044786	cell cycle DNA replication	-	45	43	-	-	2.01E-02	2.51E-03
BioPlex 293T	BP	GO:0044539	long-chain fatty acid import into cell	-	17	15	-	-	1.80E-02	8.62E-04
BioPlex 293T	BP	GO:0051299	centrosome separation	-	15	15	-	-	1.22E-03	8.62E-04
BioPlex 293T	BP	GO:0048145	regulation of fibroblast proliferation	-	87	71	-	-	1.30E-03	4.09E-03
BioPlex 293T	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	51	-	-	6.49E-03	2.94E-03
BioPlex 293T	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	192	-	-	4.74E-03	1.11E-02
BioPlex 293T	BP	GO:0032098	regulation of appetite	-	20	13	-	-	2.13E-04	7.90E-04
BioPlex 293T	BP	GO:0021819	layer formation in cerebral cortex	-	14	11	-	-	6.71E-03	6.46E-04
BioPlex 293T	CC	GO:0008333	endosome to lysosome transport	-	73	59	-	-	1.64E-02	3.45E-03
BioPlex 293T	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	18	-	-	2.84E-04	1.08E-03
BioPlex 293T	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	11	-	-	1.59E-03	6.46E-04
BioPlex 293T	BP	GO:0003016	respiratory system process	-	39	29	-	-	4.17E-04	1.72E-03
BioPlex 293T	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	15	-	-	3.92E-03	8.62E-04
BioPlex 293T	BP	GO:0045732	positive regulation of protein catabolic process	-	202	179	-	-	6.75E-03	1.03E-02
BioPlex 293T	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	49	-	-	2.08E-02	2.87E-03
BioPlex 293T	BP	GO:0007588	excretion	-	40	26	-	-	6.37E-04	1.51E-03
BioPlex 293T	BP	GO:1904018	positive regulation of vasculature development	-	185	116	-	-	1.19E-02	6.68E-03
BioPlex 293T	BP	GO:0050953	sensory perception of light stimulus	-	223	151	-	-	5.04E-03	8.69E-03
BioPlex 293T	BP	GO:0009164	nucleoside catabolic process	-	25	15	-	-	2.63E-03	8.62E-04
BioPlex 293T	BP	GO:0009303	rRNA transcription	-	37	36	-	-	6.75E-03	2.08E-03
BioPlex 293T	BP	GO:0035601	protein deacylation	-	56	49	-	-	1.52E-02	2.87E-03
BioPlex 293T	BP	GO:0061952	midbody abscission	-	18	12	-	-	4.36E-02	7.18E-04
BioPlex 293T	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	14	-	-	2.12E-03	8.62E-04
BioPlex 293T	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	23	-	-	3.51E-04	1.36E-03
BioPlex 293T	BP	GO:0071300	cellular response to retinoic acid	-	66	56	-	-	9.31E-03	3.23E-03
BioPlex 293T	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	BP	GO:0045830	positive regulation of isotype switching	-	28	22	-	-	4.05E-03	1.29E-03
BioPlex 293T	BP	GO:0031069	hair follicle morphogenesis	-	33	23	-	-	3.52E-04	1.36E-03
BioPlex 293T	BP	GO:0046697	decidualization	-	26	19	-	-	2.82E-04	1.15E-03
BioPlex 293T	BP	GO:0051588	regulation of neurotransmitter transport	-	99	79	-	-	1.02E-02	4.60E-03
BioPlex 293T	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	23	-	-	1.02E-01	1.36E-03
BioPlex 293T	BP	GO:0051784	negative regulation of nuclear division	-	63	57	-	-	1.77E-02	3.30E-03
BioPlex 293T	BP	GO:0044703	multi-organism reproductive process	-	209	147	-	-	4.27E-03	8.47E-03
BioPlex 293T	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	121	-	-	2.19E-02	6.97E-03
BioPlex 293T	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	40	-	-	1.23E-03	2.30E-03
BioPlex 293T	BP	GO:0099022	vesicle tethering	-	32	32	-	-	1.33E-01	1.87E-03
BioPlex 293T	MF	GO:0004930	G protein-coupled receptor activity	-	873	247	-	-	6.70E-03	1.42E-02
BioPlex 293T	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	29	-	-	3.63E-03	1.72E-03
BioPlex 293T	BP	GO:1903867	extraembryonic membrane development	-	12	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	BP	GO:0048857	neural nucleus development	-	65	54	-	-	8.57E-04	3.16E-03
BioPlex 293T	BP	GO:0048663	neuron fate commitment	-	74	51	-	-	7.69E-03	2.94E-03
BioPlex 293T	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	120	-	-	6.37E-03	6.89E-03
BioPlex 293T	BP	GO:0106027	neuron projection organization	-	90	75	-	-	1.77E-03	4.31E-03
BioPlex 293T	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	86	-	-	1.90E-03	4.96E-03
BioPlex 293T	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	34	-	-	1.29E-03	2.01E-03
BioPlex 293T	BP	GO:0045685	regulation of glial cell differentiation	-	77	57	-	-	2.02E-03	3.30E-03
BioPlex 293T	BP	GO:0051608	histamine transport	-	14	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	BP	GO:0043414	macromolecule methylation	-	138	119	-	-	2.11E-02	6.89E-03
BioPlex 293T	BP	GO:0048268	clathrin coat assembly	-	16	14	-	-	8.66E-02	8.62E-04
BioPlex 293T	BP	GO:0050886	endocrine process	-	93	68	-	-	9.71E-04	3.95E-03
BioPlex 293T	MF	GO:0015562	efflux transmembrane transporter activity	-	15	12	-	-	2.13E-04	7.18E-04
BioPlex 293T	BP	GO:0050951	sensory perception of temperature stimulus	-	28	13	-	-	2.12E-04	7.90E-04
BioPlex 293T	BP	GO:0045807	positive regulation of endocytosis	-	155	125	-	-	5.49E-03	7.18E-03
BioPlex 293T	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	1.36E-03	6.46E-04
BioPlex 293T	BP	GO:0002418	immune response to tumor cell	-	29	21	-	-	4.21E-03	1.22E-03
BioPlex 293T	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	52	-	-	1.79E-03	3.02E-03
BioPlex 293T	BP	GO:0048308	organelle inheritance	-	14	13	-	-	5.18E-03	7.90E-04
BioPlex 293T	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	16	-	-	9.58E-04	9.34E-04
BioPlex 293T	BP	GO:0001829	trophectodermal cell differentiation	-	19	13	-	-	3.96E-03	7.90E-04
BioPlex 293T	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	37	-	-	2.33E-03	2.15E-03
BioPlex 293T	BP	GO:0034394	protein localization to cell surface	-	69	55	-	-	2.85E-03	3.16E-03
BioPlex 293T	BP	GO:0009110	vitamin biosynthetic process	-	23	15	-	-	2.00E-02	8.62E-04
BioPlex 293T	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	19	-	-	5.36E-02	1.15E-03
BioPlex 293T	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	1.06E-02	1.01E-03
BioPlex 293T	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	15	-	-	2.01E-03	8.62E-04
BioPlex 293T	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	77	-	-	1.45E-03	4.45E-03
BioPlex 293T	MF	GO:0051100	negative regulation of binding	-	161	129	-	-	5.62E-03	7.47E-03
BioPlex 293T	BP	GO:0001818	negative regulation of cytokine production	-	379	215	-	-	4.32E-03	1.24E-02
BioPlex 293T	BP	GO:0003151	outflow tract morphogenesis	-	81	61	-	-	3.52E-03	3.52E-03
BioPlex 293T	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	52	-	-	2.62E-03	3.02E-03
BioPlex 293T	BP	GO:0055093	response to hyperoxia	-	20	18	-	-	2.83E-04	1.08E-03
BioPlex 293T	BP	GO:0061036	positive regulation of cartilage development	-	33	26	-	-	1.28E-02	1.51E-03
BioPlex 293T	BP	GO:0046184	aldehyde biosynthetic process	-	16	12	-	-	2.14E-04	7.18E-04
BioPlex 293T	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	40	-	-	2.38E-02	2.30E-03
BioPlex 293T	BP	GO:0046621	negative regulation of organ growth	-	39	22	-	-	1.51E-03	1.29E-03
BioPlex 293T	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	47	-	-	3.13E-01	2.73E-03
BioPlex 293T	BP	GO:0032368	regulation of lipid transport	-	149	101	-	-	3.87E-03	5.82E-03
BioPlex 293T	BP	GO:0055094	response to lipoprotein particle	-	34	21	-	-	3.56E-04	1.22E-03
BioPlex 293T	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	152	-	-	9.28E-03	8.76E-03
BioPlex 293T	BP	GO:0033002	muscle cell proliferation	-	249	161	-	-	2.74E-03	9.26E-03
BioPlex 293T	BP	GO:0043331	response to dsRNA	-	56	48	-	-	4.93E-02	2.80E-03
BioPlex 293T	BP	GO:0051904	pigment granule transport	-	23	22	-	-	3.28E-02	1.29E-03
BioPlex 293T	BP	GO:1901679	nucleotide transmembrane transport	-	32	28	-	-	1.31E-03	1.65E-03
BioPlex 293T	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	31	-	-	1.71E-03	1.80E-03
BioPlex 293T	BP	GO:0033363	secretory granule organization	-	63	46	-	-	1.74E-02	2.66E-03
BioPlex 293T	BP	GO:0060479	lung cell differentiation	-	28	23	-	-	3.53E-04	1.36E-03
BioPlex 293T	BP	GO:0120009	intermembrane lipid transfer	-	52	40	-	-	5.66E-02	2.30E-03
BioPlex 293T	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	1.28E-02	8.62E-04
BioPlex 293T	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	28	-	-	2.91E-03	1.65E-03
BioPlex 293T	BP	GO:0033622	integrin activation	-	26	22	-	-	1.96E-02	1.29E-03
BioPlex 293T	BP	GO:0098751	bone cell development	-	18	13	-	-	2.11E-04	7.90E-04
BioPlex 293T	BP	GO:2000773	negative regulation of cellular senescence	-	25	20	-	-	2.26E-03	1.15E-03
BioPlex 293T	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	35	-	-	1.25E-02	2.01E-03
BioPlex 293T	BP	GO:0050820	positive regulation of coagulation	-	30	25	-	-	2.76E-03	1.44E-03
BioPlex 293T	BP	GO:0002076	osteoblast development	-	17	12	-	-	2.13E-04	7.18E-04
BioPlex 293T	BP	GO:0072164	mesonephric tubule development	-	98	77	-	-	9.04E-03	4.45E-03
BioPlex 293T	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	16	-	-	2.84E-04	9.34E-04
BioPlex 293T	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	82	-	-	2.46E-03	4.74E-03
BioPlex 293T	BP	GO:1903524	positive regulation of blood circulation	-	39	26	-	-	4.21E-04	1.51E-03
BioPlex 293T	BP	GO:0030901	midbrain development	-	87	69	-	-	1.54E-03	4.02E-03
BioPlex 293T	BP	GO:0048485	sympathetic nervous system development	-	22	16	-	-	2.84E-04	9.34E-04
BioPlex 293T	BP	GO:0007162	negative regulation of cell adhesion	-	310	213	-	-	5.27E-03	1.23E-02
BioPlex 293T	BP	GO:0048532	anatomical structure arrangement	-	16	15	-	-	2.80E-04	8.62E-04
BioPlex 293T	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	52	-	-	2.54E-03	3.02E-03
BioPlex 293T	BP	GO:0002687	positive regulation of leukocyte migration	-	147	106	-	-	2.80E-03	6.10E-03
BioPlex 293T	BP	GO:0019755	one-carbon compound transport	-	28	15	-	-	5.80E-02	8.62E-04
BioPlex 293T	BP	GO:1901862	negative regulation of muscle tissue development	-	13	12	-	-	2.12E-04	7.18E-04
BioPlex 293T	BP	GO:0060856	establishment of blood-brain barrier	-	16	12	-	-	2.13E-04	7.18E-04
BioPlex 293T	BP	GO:0110154	RNA decapping	-	19	15	-	-	7.04E-02	8.62E-04
BioPlex 293T	BP	GO:0034605	cellular response to heat	-	66	55	-	-	3.05E-03	3.16E-03
BioPlex 293T	BP	GO:0005996	monosaccharide metabolic process	-	250	204	-	-	2.46E-02	1.18E-02
BioPlex 293T	BP	GO:0033555	multicellular organismal response to stress	-	90	61	-	-	6.78E-03	3.52E-03
BioPlex 293T	BP	GO:0002262	myeloid cell homeostasis	-	172	136	-	-	2.96E-03	7.83E-03
BioPlex 293T	BP	GO:0000966	RNA 5'-end processing	-	39	37	-	-	1.56E-01	2.15E-03
BioPlex 293T	BP	GO:0050688	regulation of defense response to virus	-	65	47	-	-	3.64E-03	2.73E-03
BioPlex 293T	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	19	-	-	3.10E-03	1.15E-03
BioPlex 293T	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	186	-	-	1.26E-02	1.07E-02
BioPlex 293T	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	23	-	-	9.64E-04	1.36E-03
BioPlex 293T	BP	GO:0061029	eyelid development in camera-type eye	-	14	11	-	-	2.53E-03	6.46E-04
BioPlex 293T	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	23	-	-	3.55E-04	1.36E-03
BioPlex 293T	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	14	-	-	8.65E-04	8.62E-04
BioPlex 293T	BP	GO:0003272	endocardial cushion formation	-	28	23	-	-	4.49E-03	1.36E-03
BioPlex 293T	BP	GO:0022618	protein-RNA complex assembly	-	227	181	-	-	1.17E-01	1.04E-02
BioPlex 293T	BP	GO:0051147	regulation of muscle cell differentiation	-	162	105	-	-	2.02E-03	6.03E-03
BioPlex 293T	BP	GO:0090102	cochlea development	-	50	40	-	-	2.57E-03	2.30E-03
BioPlex 293T	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	24	-	-	4.28E-02	1.44E-03
BioPlex 293T	BP	GO:0045933	positive regulation of muscle contraction	-	49	31	-	-	4.88E-04	1.80E-03
BioPlex 293T	BP	GO:0002679	respiratory burst involved in defense response	-	16	13	-	-	2.12E-04	7.90E-04
BioPlex 293T	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	32	-	-	3.87E-03	1.87E-03
BioPlex 293T	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	62	-	-	5.64E-02	3.59E-03
BioPlex 293T	BP	GO:0043555	regulation of translation in response to stress	-	22	20	-	-	2.34E-03	1.15E-03
BioPlex 293T	BP	GO:0032922	circadian regulation of gene expression	-	71	60	-	-	1.22E-02	3.45E-03
BioPlex 293T	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	19	-	-	2.83E-04	1.15E-03
BioPlex 293T	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	132	-	-	3.96E-03	7.61E-03
BioPlex 293T	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	43	-	-	5.24E-02	2.51E-03
BioPlex 293T	BP	GO:0038179	neurotrophin signaling pathway	-	38	29	-	-	4.74E-03	1.72E-03
BioPlex 293T	BP	GO:0021670	lateral ventricle development	-	12	11	-	-	1.14E-02	6.46E-04
BioPlex 293T	BP	GO:0140253	cell-cell fusion	-	62	40	-	-	1.32E-03	2.30E-03
BioPlex 293T	BP	GO:0071599	otic vesicle development	-	15	13	-	-	1.18E-02	7.90E-04
BioPlex 293T	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	35	-	-	3.39E-02	2.01E-03
BioPlex 293T	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	5.15E-04	8.62E-04
BioPlex 293T	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	48	-	-	1.22E-02	2.80E-03
BioPlex 293T	BP	GO:0001941	postsynaptic membrane organization	-	37	28	-	-	4.91E-02	1.65E-03
BioPlex 293T	BP	GO:0051293	establishment of spindle localization	-	57	49	-	-	5.69E-03	2.87E-03
BioPlex 293T	BP	GO:0043114	regulation of vascular permeability	-	49	35	-	-	7.03E-04	2.01E-03
BioPlex 293T	BP	GO:0018126	protein hydroxylation	-	26	23	-	-	5.69E-03	1.36E-03
BioPlex 293T	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	47	-	-	7.05E-04	2.73E-03
BioPlex 293T	BP	GO:0008360	regulation of cell shape	-	139	111	-	-	1.76E-02	6.39E-03
BioPlex 293T	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	15	-	-	2.83E-04	8.62E-04
BioPlex 293T	BP	GO:0051222	positive regulation of protein transport	-	249	197	-	-	3.41E-03	1.13E-02
BioPlex 293T	CC	GO:0140632	canonical inflammasome complex assembly	-	40	28	-	-	1.94E-03	1.65E-03
BioPlex 293T	MF	GO:0034260	negative regulation of GTPase activity	-	36	27	-	-	8.72E-04	1.58E-03
BioPlex 293T	BP	GO:0045932	negative regulation of muscle contraction	-	24	14	-	-	8.45E-03	8.62E-04
BioPlex 293T	BP	GO:0045739	positive regulation of DNA repair	-	128	119	-	-	1.11E-01	6.89E-03
BioPlex 293T	BP	GO:0001845	phagolysosome assembly	-	19	16	-	-	2.85E-04	9.34E-04
BioPlex 293T	BP	GO:0045185	maintenance of protein location	-	95	78	-	-	2.51E-03	4.52E-03
BioPlex 293T	BP	GO:0003158	endothelium development	-	140	92	-	-	1.64E-02	5.31E-03
BioPlex 293T	CC	GO:0072595	maintenance of protein localization in organelle	-	42	37	-	-	1.39E-03	2.15E-03
BioPlex 293T	BP	GO:0051224	negative regulation of protein transport	-	122	82	-	-	4.39E-03	4.74E-03
BioPlex 293T	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	108	-	-	1.13E-02	6.25E-03
BioPlex 293T	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	25	-	-	4.25E-04	1.44E-03
BioPlex 293T	MF	GO:0003713	transcription coactivator activity	-	281	237	-	-	1.94E-02	1.36E-02
BioPlex 293T	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	15	-	-	1.03E-01	8.62E-04
BioPlex 293T	BP	GO:0021885	forebrain cell migration	-	63	45	-	-	1.14E-02	2.59E-03
BioPlex 293T	BP	GO:0007405	neuroblast proliferation	-	81	60	-	-	1.63E-03	3.45E-03
BioPlex 293T	BP	GO:0009581	detection of external stimulus	-	137	81	-	-	4.34E-03	4.67E-03
BioPlex 293T	BP	GO:1990542	mitochondrial transmembrane transport	-	93	79	-	-	1.39E-02	4.60E-03
BioPlex 293T	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	27	-	-	4.23E-04	1.58E-03
BioPlex 293T	BP	GO:0097186	amelogenesis	-	26	14	-	-	2.13E-04	8.62E-04
BioPlex 293T	BP	GO:0031128	developmental induction	-	26	18	-	-	2.84E-04	1.08E-03
BioPlex 293T	BP	GO:0035672	oligopeptide transmembrane transport	-	15	11	-	-	2.13E-04	6.46E-04
BioPlex 293T	BP	GO:0031100	animal organ regeneration	-	66	51	-	-	1.65E-03	2.94E-03
BioPlex 293T	BP	GO:0021533	cell differentiation in hindbrain	-	23	15	-	-	2.83E-04	8.62E-04
BioPlex 293T	BP	GO:0045684	positive regulation of epidermis development	-	33	28	-	-	7.44E-04	1.65E-03
BioPlex 293T	BP	GO:1900047	negative regulation of hemostasis	-	51	39	-	-	2.47E-03	2.30E-03
BioPlex 293T	BP	GO:0021517	ventral spinal cord development	-	47	32	-	-	1.08E-02	1.87E-03
BioPlex 293T	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	68	-	-	9.55E-03	3.95E-03
BioPlex 293T	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	1.50E-03	9.34E-04
BioPlex 293T	BP	GO:0097722	sperm motility	-	133	85	-	-	4.55E-03	4.88E-03
BioPlex 293T	BP	GO:0051231	spindle elongation	-	14	14	-	-	2.45E-01	8.62E-04
BioPlex 293T	BP	GO:0042490	mechanoreceptor differentiation	-	67	49	-	-	8.72E-03	2.87E-03
BioPlex 293T	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	22	-	-	5.32E-04	1.29E-03
BioPlex 293T	BP	GO:0035148	tube formation	-	155	134	-	-	5.17E-03	7.76E-03
BioPlex 293T	BP	GO:0048520	positive regulation of behavior	-	27	16	-	-	2.84E-04	9.34E-04
BioPlex 293T	BP	GO:0098543	detection of other organism	-	19	11	-	-	1.23E-01	6.46E-04
BioPlex 293T	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	41	-	-	1.03E-01	2.37E-03
BioPlex 293T	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	87	-	-	2.76E-03	5.03E-03
BioPlex 293T	BP	GO:0031123	RNA 3'-end processing	-	79	73	-	-	8.15E-02	4.24E-03
BioPlex 293T	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	87	-	-	5.24E-03	5.03E-03
BioPlex 293T	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	3.50E-02	1.08E-03
BioPlex 293T	CC	GO:0007097	nuclear migration	-	24	21	-	-	1.16E-02	1.22E-03
BioPlex 293T	BP	GO:0045229	external encapsulating structure organization	-	319	221	-	-	1.33E-02	1.27E-02
BioPlex 293T	BP	GO:0006885	regulation of pH	-	104	78	-	-	4.86E-02	4.52E-03
BioPlex 293T	BP	GO:1990840	response to lectin	-	22	18	-	-	1.15E-03	1.08E-03
BioPlex 293T	BP	GO:0071800	podosome assembly	-	19	17	-	-	1.89E-03	1.01E-03
BioPlex 293T	BP	GO:0031018	endocrine pancreas development	-	47	37	-	-	2.26E-03	2.15E-03
BioPlex 293T	BP	GO:0001708	cell fate specification	-	108	75	-	-	1.35E-02	4.31E-03
BioPlex 293T	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	56	-	-	5.50E-03	3.23E-03
BioPlex 293T	BP	GO:0030279	negative regulation of ossification	-	39	23	-	-	5.18E-04	1.36E-03
BioPlex 293T	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	13	-	-	7.06E-02	7.90E-04
BioPlex 293T	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	11	-	-	3.79E-03	6.46E-04
BioPlex 293T	BP	GO:0042440	pigment metabolic process	-	80	60	-	-	1.15E-02	3.45E-03
BioPlex 293T	BP	GO:1901606	alpha-amino acid catabolic process	-	101	71	-	-	1.67E-02	4.09E-03
BioPlex 293T	BP	GO:0062197	cellular response to chemical stress	-	299	237	-	-	5.62E-03	1.36E-02
BioPlex 293T	BP	GO:1901890	positive regulation of cell junction assembly	-	106	76	-	-	3.69E-03	4.38E-03
BioPlex 293T	BP	GO:0070988	demethylation	-	27	23	-	-	2.37E-02	1.36E-03
BioPlex 293T	BP	GO:1901655	cellular response to ketone	-	107	76	-	-	1.64E-03	4.38E-03
BioPlex 293T	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	1.43E-01	8.62E-04
BioPlex 293T	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	2.56E-02	1.01E-03
BioPlex 293T	BP	GO:0006968	cellular defense response	-	52	37	-	-	5.58E-04	2.15E-03
BioPlex 293T	BP	GO:0055006	cardiac cell development	-	93	60	-	-	1.47E-03	3.45E-03
BioPlex 293T	BP	GO:0031365	N-terminal protein amino acid modification	-	30	25	-	-	2.34E-02	1.44E-03
BioPlex 293T	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	18	-	-	1.82E-02	1.08E-03
BioPlex 293T	BP	GO:0060004	reflex	-	63	44	-	-	3.07E-03	2.59E-03
BioPlex 293T	BP	GO:0044706	multi-multicellular organism process	-	217	153	-	-	5.15E-03	8.83E-03
BioPlex 293T	BP	GO:0043589	skin morphogenesis	-	12	11	-	-	2.83E-02	6.46E-04
BioPlex 293T	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	121	-	-	6.37E-03	6.97E-03
BioPlex 293T	BP	GO:0006026	aminoglycan catabolic process	-	34	27	-	-	8.42E-03	1.58E-03
BioPlex 293T	BP	GO:0031294	lymphocyte costimulation	-	47	33	-	-	6.62E-03	1.94E-03
BioPlex 293T	BP	GO:0050768	negative regulation of neurogenesis	-	150	109	-	-	4.23E-03	6.32E-03
BioPlex 293T	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	84	-	-	2.47E-03	4.88E-03
BioPlex 293T	BP	GO:0090068	positive regulation of cell cycle process	-	262	215	-	-	9.61E-03	1.24E-02
BioPlex 293T	BP	GO:0043605	amide catabolic process	-	16	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	17	-	-	4.59E-02	1.01E-03
BioPlex 293T	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	23	-	-	9.48E-02	1.36E-03
BioPlex 293T	BP	GO:1902115	regulation of organelle assembly	-	210	179	-	-	1.20E-02	1.03E-02
BioPlex 293T	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	55	-	-	1.17E-03	3.16E-03
BioPlex 293T	BP	GO:0047484	regulation of response to osmotic stress	-	16	13	-	-	5.91E-03	7.90E-04
BioPlex 293T	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	117	-	-	6.19E-03	6.75E-03
BioPlex 293T	BP	GO:0043171	peptide catabolic process	-	19	15	-	-	2.84E-04	8.62E-04
BioPlex 293T	BP	GO:0046622	positive regulation of organ growth	-	52	30	-	-	2.18E-03	1.72E-03
BioPlex 293T	BP	GO:0051952	regulation of amine transport	-	98	66	-	-	4.30E-03	3.81E-03
BioPlex 293T	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	1.60E-01	1.36E-03
BioPlex 293T	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	4.19E-03	1.15E-03
BioPlex 293T	BP	GO:0040019	positive regulation of embryonic development	-	23	15	-	-	2.83E-04	8.62E-04
BioPlex 293T	BP	GO:0097154	GABAergic neuron differentiation	-	20	13	-	-	2.14E-04	7.90E-04
BioPlex 293T	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	13	-	-	2.12E-04	7.90E-04
BioPlex 293T	CC	GO:0032365	intracellular lipid transport	-	51	40	-	-	1.87E-03	2.30E-03
BioPlex 293T	BP	GO:0045048	protein insertion into ER membrane	-	30	23	-	-	3.64E-01	1.36E-03
BioPlex 293T	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	54	-	-	1.43E-03	3.16E-03
BioPlex 293T	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	97	-	-	3.66E-03	5.60E-03
BioPlex 293T	BP	GO:0018149	peptide cross-linking	-	28	24	-	-	1.01E-03	1.44E-03
BioPlex 293T	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	19	-	-	4.62E-04	1.15E-03
BioPlex 293T	BP	GO:0061000	negative regulation of dendritic spine development	-	13	11	-	-	2.12E-04	6.46E-04
BioPlex 293T	BP	GO:0071398	cellular response to fatty acid	-	35	25	-	-	5.70E-02	1.44E-03
BioPlex 293T	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	7.19E-02	6.46E-04
BioPlex 293T	BP	GO:0097581	lamellipodium organization	-	91	82	-	-	1.40E-02	4.74E-03
BioPlex 293T	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	26	-	-	8.95E-02	1.51E-03
BioPlex 293T	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	219	-	-	1.02E-01	1.26E-02
BioPlex 293T	BP	GO:0060326	cell chemotaxis	-	311	215	-	-	1.11E-02	1.24E-02
BioPlex 293T	BP	GO:1903975	regulation of glial cell migration	-	20	17	-	-	1.25E-03	1.01E-03
BioPlex 293T	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	19	-	-	1.44E-03	1.15E-03
BioPlex 293T	BP	GO:0015669	gas transport	-	23	17	-	-	5.35E-03	1.01E-03
BioPlex 293T	BP	GO:0016485	protein processing	-	248	192	-	-	5.99E-03	1.11E-02
BioPlex 293T	BP	GO:0009649	entrainment of circadian clock	-	30	28	-	-	1.10E-02	1.65E-03
BioPlex 293T	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	113	-	-	1.17E-02	6.54E-03
BioPlex 293T	BP	GO:1903523	negative regulation of blood circulation	-	27	12	-	-	2.14E-04	7.18E-04
BioPlex 293T	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	86	-	-	1.40E-02	4.96E-03
BioPlex 293T	BP	GO:0099054	presynapse assembly	-	49	39	-	-	8.68E-03	2.30E-03
BioPlex 293T	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	19	-	-	2.81E-04	1.15E-03
BioPlex 293T	BP	GO:0006517	protein deglycosylation	-	26	22	-	-	1.21E-03	1.29E-03
BioPlex 293T	BP	GO:0031348	negative regulation of defense response	-	282	195	-	-	5.53E-03	1.12E-02
BioPlex 293T	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	57	-	-	1.19E-03	3.30E-03
BioPlex 293T	BP	GO:0007606	sensory perception of chemical stimulus	-	535	128	-	-	8.50E-03	7.40E-03
BioPlex 293T	BP	GO:0061180	mammary gland epithelium development	-	68	55	-	-	5.91E-03	3.16E-03
BioPlex 293T	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	215	-	-	1.56E-02	1.24E-02
BioPlex 293T	BP	GO:0071496	cellular response to external stimulus	-	74	59	-	-	4.75E-03	3.45E-03
BioPlex 293T	BP	GO:0042753	positive regulation of circadian rhythm	-	18	12	-	-	8.38E-03	7.18E-04
BioPlex 293T	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	2.13E-04	7.18E-04
BioPlex 293T	BP	GO:0032094	response to food	-	37	26	-	-	4.24E-04	1.51E-03
BioPlex 293T	BP	GO:0001964	startle response	-	27	15	-	-	2.83E-04	8.62E-04
BioPlex 293T	BP	GO:0007340	acrosome reaction	-	38	27	-	-	4.25E-04	1.58E-03
BioPlex 293T	BP	GO:0046434	organophosphate catabolic process	-	232	195	-	-	3.04E-02	1.12E-02
BioPlex 293T	BP	GO:0060037	pharyngeal system development	-	29	24	-	-	2.03E-02	1.44E-03
BioPlex 293T	BP	GO:0009566	fertilization	-	205	138	-	-	3.62E-03	7.97E-03
BioPlex 293T	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	57	-	-	2.42E-01	3.30E-03
BioPlex 293T	BP	GO:0120255	olefinic compound biosynthetic process	-	24	20	-	-	3.55E-04	1.15E-03
BioPlex 293T	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	9.77E-04	7.90E-04
BioPlex 293T	BP	GO:0045907	positive regulation of vasoconstriction	-	30	17	-	-	1.36E-03	1.01E-03
BioPlex 293T	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	21	-	-	3.54E-04	1.22E-03
BioPlex 293T	BP	GO:0033044	regulation of chromosome organization	-	249	239	-	-	5.08E-02	1.38E-02
BioPlex 293T	BP	GO:0009309	amine biosynthetic process	-	38	23	-	-	4.74E-02	1.36E-03
BioPlex 293T	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	18	-	-	4.06E-02	1.08E-03
BioPlex 293T	BP	GO:0061900	glial cell activation	-	56	41	-	-	4.28E-03	2.37E-03
BioPlex 293T	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	99	-	-	6.13E-03	5.75E-03
BioPlex 293T	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	11	-	-	2.64E-02	6.46E-04
BioPlex 293T	CC	GO:0140467	integrated stress response signaling	-	41	35	-	-	5.81E-03	2.01E-03
BioPlex 293T	BP	GO:0035902	response to immobilization stress	-	20	14	-	-	2.13E-04	8.62E-04
BioPlex 293T	BP	GO:0072537	fibroblast activation	-	13	13	-	-	5.82E-03	7.90E-04
BioPlex 293T	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	6.86E-02	7.90E-04
BioPlex 293T	BP	GO:0043647	inositol phosphate metabolic process	-	44	32	-	-	2.11E-02	1.87E-03
BioPlex 293T	BP	GO:0016180	snRNA processing	-	28	26	-	-	1.62E-01	1.51E-03
BioPlex 293T	BP	GO:0051303	establishment of chromosome localization	-	104	89	-	-	1.59E-02	5.17E-03
BioPlex 293T	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	9.07E-02	9.34E-04
BioPlex 293T	BP	GO:0007164	establishment of tissue polarity	-	38	31	-	-	1.47E-02	1.80E-03
BioPlex 293T	BP	GO:0097164	ammonium ion metabolic process	-	23	17	-	-	2.83E-04	1.01E-03
BioPlex 293T	BP	GO:0021515	cell differentiation in spinal cord	-	51	36	-	-	1.63E-02	2.08E-03
BioPlex 293T	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	12	-	-	1.17E-01	7.18E-04
BioPlex 293T	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	18	-	-	1.71E-03	1.08E-03
BioPlex 293T	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	23	-	-	3.55E-04	1.36E-03
BioPlex 293T	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	11	-	-	2.15E-04	6.46E-04
BioPlex 293T	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	30	-	-	2.48E-02	1.72E-03
BioPlex 293T	BP	GO:0061318	renal filtration cell differentiation	-	22	16	-	-	1.33E-03	9.34E-04
BioPlex 293T	BP	GO:0007566	embryo implantation	-	57	42	-	-	7.74E-04	2.44E-03
BioPlex 293T	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	25	-	-	3.56E-02	1.44E-03
BioPlex 293T	BP	GO:0031268	pseudopodium organization	-	17	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	BP	GO:0060306	regulation of membrane repolarization	-	38	22	-	-	5.91E-04	1.29E-03
BioPlex 293T	BP	GO:0051017	actin filament bundle assembly	-	161	129	-	-	5.84E-03	7.47E-03
BioPlex 293T	BP	GO:1905953	negative regulation of lipid localization	-	63	34	-	-	3.78E-03	2.01E-03
BioPlex 293T	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	14	-	-	2.12E-04	8.62E-04
BioPlex 293T	BP	GO:0021542	dentate gyrus development	-	19	14	-	-	6.43E-03	8.62E-04
BioPlex 293T	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	33	-	-	2.96E-02	1.94E-03
BioPlex 293T	BP	GO:0021756	striatum development	-	21	18	-	-	9.42E-03	1.08E-03
BioPlex 293T	BP	GO:1901343	negative regulation of vasculature development	-	154	83	-	-	2.56E-03	4.81E-03
BioPlex 293T	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	136	-	-	2.41E-02	7.83E-03
BioPlex 293T	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	26	-	-	9.14E-04	1.51E-03
BioPlex 293T	BP	GO:1902414	protein localization to cell junction	-	107	86	-	-	1.85E-03	4.96E-03
BioPlex 293T	BP	GO:0071305	cellular response to vitamin D	-	23	17	-	-	2.84E-04	1.01E-03
BioPlex 293T	BP	GO:0051304	chromosome separation	-	80	76	-	-	1.75E-02	4.38E-03
BioPlex 293T	BP	GO:0090596	sensory organ morphogenesis	-	272	203	-	-	5.58E-03	1.17E-02
BioPlex 293T	BP	GO:0048709	oligodendrocyte differentiation	-	101	78	-	-	1.79E-03	4.52E-03
BioPlex 293T	BP	GO:0045017	glycerolipid biosynthetic process	-	254	210	-	-	1.24E-02	1.21E-02
BioPlex 293T	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	5.35E-01	8.62E-04
BioPlex 293T	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	17	-	-	2.87E-02	1.01E-03
BioPlex 293T	BP	GO:0001776	leukocyte homeostasis	-	108	84	-	-	3.19E-03	4.88E-03
BioPlex 293T	BP	GO:0050769	positive regulation of neurogenesis	-	240	181	-	-	3.81E-03	1.04E-02
BioPlex 293T	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	1.21E-01	8.62E-04
BioPlex 293T	BP	GO:0030193	regulation of blood coagulation	-	70	55	-	-	4.76E-03	3.16E-03
BioPlex 293T	BP	GO:0050866	negative regulation of cell activation	-	216	153	-	-	3.48E-03	8.83E-03
BioPlex 293T	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	27	-	-	3.82E-03	1.58E-03
BioPlex 293T	BP	GO:0033500	carbohydrate homeostasis	-	251	176	-	-	7.01E-03	1.01E-02
BioPlex 293T	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	23	-	-	2.80E-02	1.36E-03
BioPlex 293T	BP	GO:0044088	regulation of vacuole organization	-	56	52	-	-	9.21E-03	3.02E-03
BioPlex 293T	CC	GO:0051457	maintenance of protein location in nucleus	-	23	21	-	-	2.40E-03	1.22E-03
BioPlex 293T	CC	GO:0099522	cytosolic region	-	20	19	-	-	9.37E-04	1.15E-03
BioPlex 293T	CC	GO:0000791	euchromatin	-	60	54	-	-	1.09E-02	3.16E-03
BioPlex 293T	CC	GO:0030666	endocytic vesicle membrane	-	196	170	-	-	2.45E-02	9.77E-03
BioPlex 293T	CC	GO:0098857	membrane microdomain	-	324	244	-	-	8.59E-03	1.41E-02
BioPlex 293T	CC	GO:0071027	nuclear RNA surveillance	-	14	13	-	-	4.17E-01	7.90E-04
BioPlex 293T	CC	GO:1990752	microtubule end	-	34	33	-	-	2.36E-02	1.94E-03
BioPlex 293T	CC	GO:0043204	perikaryon	-	156	119	-	-	2.27E-03	6.89E-03
BioPlex 293T	CC	GO:0097542	ciliary tip	-	48	45	-	-	7.05E-02	2.59E-03
BioPlex 293T	CC	GO:1905368	peptidase complex	-	124	114	-	-	2.72E-01	6.61E-03
BioPlex 293T	CC	GO:0000792	heterochromatin	-	98	92	-	-	1.02E-02	5.31E-03
BioPlex 293T	CC	GO:0097546	ciliary base	-	47	40	-	-	1.72E-02	2.30E-03
BioPlex 293T	CC	GO:0071819	DUBm complex	-	25	22	-	-	6.48E-01	1.29E-03
BioPlex 293T	CC	GO:0031201	SNARE complex	-	48	47	-	-	2.07E-01	2.73E-03
BioPlex 293T	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	2.56E-03	7.90E-04
BioPlex 293T	CC	GO:0033260	nuclear DNA replication	-	40	38	-	-	2.95E-02	2.23E-03
BioPlex 293T	CC	GO:0044391	ribosomal subunit	-	203	190	-	-	3.39E-01	1.09E-02
BioPlex 293T	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	3.05E-01	6.46E-04
BioPlex 293T	CC	GO:0071013	catalytic step 2 spliceosome	-	88	86	-	-	9.34E-02	4.96E-03
BioPlex 293T	CC	GO:0031907	microbody lumen	-	51	42	-	-	1.14E-02	2.44E-03
BioPlex 293T	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	2.15E-01	7.18E-04
BioPlex 293T	CC	GO:0098862	cluster of actin-based cell projections	-	162	112	-	-	5.51E-03	6.46E-03
BioPlex 293T	CC	GO:0016363	nuclear matrix	-	127	115	-	-	1.43E-02	6.61E-03
BioPlex 293T	CC	GO:0031261	DNA replication preinitiation complex	-	46	44	-	-	1.31E-01	2.59E-03
BioPlex 293T	CC	GO:0032432	actin filament bundle	-	249	184	-	-	1.23E-02	1.06E-02
BioPlex 293T	CC	GO:0008088	axo-dendritic transport	-	78	73	-	-	1.46E-02	4.24E-03
BioPlex 293T	CC	GO:0031519	PcG protein complex	-	38	36	-	-	2.04E-01	2.08E-03
BioPlex 293T	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	27	-	-	3.00E-02	1.58E-03
BioPlex 293T	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	198	-	-	2.51E-02	1.14E-02
BioPlex 293T	CC	GO:0000313	organellar ribosome	-	89	87	-	-	4.46E-01	5.03E-03
BioPlex 293T	CC	GO:0099643	signal release from synapse	-	147	119	-	-	7.05E-03	6.89E-03
BioPlex 293T	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	44	-	-	1.05E-02	2.59E-03
BioPlex 293T	CC	GO:0030018	Z disc	-	129	87	-	-	9.15E-03	5.03E-03
BioPlex 293T	CC	GO:0032580	Golgi cisterna membrane	-	93	66	-	-	2.16E-02	3.81E-03
BioPlex 293T	CC	GO:0097381	photoreceptor disc membrane	-	25	15	-	-	3.54E-02	8.62E-04
BioPlex 293T	CC	GO:1905360	GTPase complex	-	41	37	-	-	2.84E-01	2.15E-03
BioPlex 293T	CC	GO:0097540	axonemal central pair	-	161	104	-	-	7.60E-03	6.03E-03
BioPlex 293T	CC	GO:0042641	actomyosin	-	77	68	-	-	9.70E-03	3.95E-03
BioPlex 293T	CC	GO:0097386	glial cell projection	-	38	24	-	-	3.53E-04	1.44E-03
BioPlex 293T	CC	GO:0032588	trans-Golgi network membrane	-	102	86	-	-	3.26E-02	4.96E-03
BioPlex 293T	CC	GO:0070382	exocytic vesicle	-	224	180	-	-	4.32E-02	1.03E-02
BioPlex 293T	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	44	-	-	2.25E-02	2.59E-03
BioPlex 293T	CC	GO:0031903	microbody membrane	-	65	50	-	-	1.85E-02	2.87E-03
BioPlex 293T	CC	GO:0046930	pore complex	-	26	23	-	-	4.33E-02	1.36E-03
BioPlex 293T	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	12	-	-	2.13E-04	7.18E-04
BioPlex 293T	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	207	-	-	3.20E-02	1.19E-02
BioPlex 293T	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	21	-	-	2.61E-03	1.22E-03
BioPlex 293T	CC	GO:1990071	TRAPPII protein complex	-	12	12	-	-	8.37E-02	7.18E-04
BioPlex 293T	CC	GO:0099571	postsynaptic cytoskeleton	-	18	15	-	-	4.35E-03	8.62E-04
BioPlex 293T	CC	GO:0044298	cell body membrane	-	32	24	-	-	2.65E-03	1.44E-03
BioPlex 293T	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	2.25E-01	6.46E-04
BioPlex 293T	CC	GO:0051882	mitochondrial depolarization	-	21	15	-	-	1.27E-02	8.62E-04
BioPlex 293T	CC	GO:0045495	pole plasm	-	25	13	-	-	6.69E-02	7.90E-04
BioPlex 293T	CC	GO:0070993	translation preinitiation complex	-	19	18	-	-	7.40E-01	1.08E-03
BioPlex 293T	CC	GO:0010369	chromocenter	-	14	12	-	-	1.16E-01	7.18E-04
BioPlex 293T	CC	GO:0016323	basolateral plasma membrane	-	239	165	-	-	3.69E-03	9.48E-03
BioPlex 293T	CC	GO:0045009	chitosome	-	21	18	-	-	1.57E-02	1.08E-03
BioPlex 293T	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	5.91E-03	7.18E-04
BioPlex 293T	CC	GO:0042645	mitochondrial nucleoid	-	45	43	-	-	1.84E-02	2.51E-03
BioPlex 293T	CC	GO:0098636	protein complex involved in cell adhesion	-	57	40	-	-	3.54E-02	2.30E-03
BioPlex 293T	CC	GO:0001917	photoreceptor inner segment	-	71	56	-	-	4.07E-03	3.23E-03
BioPlex 293T	CC	GO:0098845	postsynaptic endosome	-	14	12	-	-	2.12E-04	7.18E-04
BioPlex 293T	CC	GO:0019897	extrinsic component of plasma membrane	-	156	128	-	-	6.92E-02	7.40E-03
BioPlex 293T	CC	GO:0031594	neuromuscular junction	-	73	59	-	-	1.21E-02	3.45E-03
BioPlex 293T	CC	GO:0000793	condensed chromosome	-	274	248	-	-	3.48E-02	1.43E-02
BioPlex 293T	CC	GO:0045120	pronucleus	-	14	12	-	-	2.13E-04	7.18E-04
BioPlex 293T	CC	GO:0043083	synaptic cleft	-	21	17	-	-	2.83E-04	1.01E-03
BioPlex 293T	CC	GO:0000922	spindle pole	-	172	157	-	-	6.39E-03	9.05E-03
BioPlex 293T	CC	GO:0120111	neuron projection cytoplasm	-	94	82	-	-	1.22E-02	4.74E-03
BioPlex 293T	CC	GO:0070971	endoplasmic reticulum exit site	-	32	25	-	-	1.18E-01	1.44E-03
BioPlex 293T	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	3.74E-01	7.90E-04
BioPlex 293T	CC	GO:0004879	nuclear receptor activity	-	63	47	-	-	1.20E-01	2.73E-03
BioPlex 293T	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	141	-	-	5.19E-02	8.12E-03
BioPlex 293T	CC	GO:0000123	histone acetyltransferase complex	-	93	89	-	-	1.25E-01	5.17E-03
BioPlex 293T	CC	GO:0034982	mitochondrial protein processing	-	13	11	-	-	2.13E-04	6.46E-04
BioPlex 293T	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	93	-	-	1.47E-01	5.39E-03
BioPlex 293T	CC	GO:0048786	presynaptic active zone	-	80	67	-	-	6.07E-03	3.88E-03
BioPlex 293T	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	3.84E-01	7.18E-04
BioPlex 293T	CC	GO:0007034	vacuolar transport	-	168	143	-	-	1.24E-02	8.26E-03
BioPlex 293T	CC	GO:0090741	pigment granule membrane	-	21	18	-	-	3.61E-03	1.08E-03
BioPlex 293T	CC	GO:0043194	axon initial segment	-	21	15	-	-	2.82E-04	8.62E-04
BioPlex 293T	CC	GO:0005776	autophagosome	-	111	93	-	-	1.34E-02	5.39E-03
BioPlex 293T	CC	GO:0031430	M band	-	22	15	-	-	2.84E-04	8.62E-04
BioPlex 293T	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	74	-	-	2.28E-01	4.31E-03
BioPlex 293T	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	84	-	-	3.20E-01	4.88E-03
BioPlex 293T	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	6.12E-01	7.90E-04
BioPlex 293T	CC	GO:0000164	protein phosphatase type 1 complex	-	19	15	-	-	4.42E-02	8.62E-04
BioPlex 293T	CC	GO:0071203	WASH complex	-	12	12	-	-	4.15E-01	7.18E-04
BioPlex 293T	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	26	-	-	4.85E-02	1.51E-03
BioPlex 293T	CC	GO:0032994	protein-lipid complex	-	39	29	-	-	2.34E-02	1.72E-03
BioPlex 293T	CC	GO:0150034	distal axon	-	309	246	-	-	6.17E-03	1.41E-02
BioPlex 293T	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	143	-	-	2.20E-01	8.26E-03
BioPlex 293T	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	2.31E-02	7.18E-04
BioPlex 293T	CC	GO:0072562	blood microparticle	-	144	111	-	-	5.47E-03	6.39E-03
BioPlex 293T	CC	GO:0051233	spindle midzone	-	36	34	-	-	1.36E-02	2.01E-03
BioPlex 293T	CC	GO:0005811	lipid droplet	-	102	80	-	-	3.35E-03	4.60E-03
BioPlex 293T	CC	GO:0045022	early endosome to late endosome transport	-	44	43	-	-	4.29E-02	2.51E-03
BioPlex 293T	CC	GO:0043113	receptor clustering	-	51	43	-	-	1.03E-03	2.51E-03
BioPlex 293T	CC	GO:0005940	septin ring	-	14	13	-	-	8.50E-01	7.90E-04
BioPlex 293T	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	16	-	-	5.26E-02	9.34E-04
BioPlex 293T	CC	GO:0044853	plasma membrane raft	-	114	84	-	-	2.95E-03	4.88E-03
BioPlex 293T	CC	GO:0005881	cytoplasmic microtubule	-	256	176	-	-	9.82E-03	1.01E-02
BioPlex 293T	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	13	-	-	1.04E-03	7.90E-04
BioPlex 293T	CC	GO:0008180	COP9 signalosome	-	17	16	-	-	7.23E-02	9.34E-04
BioPlex 293T	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	48	-	-	9.13E-02	2.80E-03
BioPlex 293T	CC	GO:0005905	clathrin-coated pit	-	73	64	-	-	4.37E-02	3.73E-03
BioPlex 293T	CC	GO:0043034	costamere	-	18	15	-	-	2.83E-04	8.62E-04
BioPlex 293T	CC	GO:0031904	endosome lumen	-	38	31	-	-	4.36E-02	1.80E-03
BioPlex 293T	CC	GO:0060170	ciliary membrane	-	76	44	-	-	3.37E-02	2.59E-03
BioPlex 293T	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	12	-	-	2.01E-01	7.18E-04
BioPlex 293T	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	3.84E-01	7.18E-04
BioPlex 293T	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	1.06E-01	1.44E-03
BioPlex 293T	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	8.80E-01	8.62E-04
BioPlex 293T	CC	GO:0032154	cleavage furrow	-	54	48	-	-	5.89E-03	2.80E-03
BioPlex 293T	CC	GO:0005640	nuclear outer membrane	-	30	23	-	-	2.67E-03	1.36E-03
BioPlex 293T	CC	GO:0005652	nuclear lamina	-	12	11	-	-	5.24E-03	6.46E-04
BioPlex 293T	CC	GO:0007006	mitochondrial membrane organization	-	117	95	-	-	1.54E-02	5.46E-03
BioPlex 293T	CC	GO:0001772	immunological synapse	-	44	33	-	-	9.28E-03	1.94E-03
BioPlex 293T	CC	GO:0030904	retromer complex	-	12	12	-	-	5.89E-02	7.18E-04
BioPlex 293T	CC	GO:0030863	cortical cytoskeleton	-	104	81	-	-	6.56E-03	4.67E-03
BioPlex 293T	CC	GO:1905348	endonuclease complex	-	38	34	-	-	2.38E-01	2.01E-03
BioPlex 293T	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	1.34E-01	6.46E-04
BioPlex 293T	CC	GO:0061638	CENP-A containing chromatin	-	18	11	-	-	4.98E-03	6.46E-04
BioPlex 293T	CC	GO:0030315	T-tubule	-	52	36	-	-	3.39E-02	2.08E-03
BioPlex 293T	CC	GO:0060076	excitatory synapse	-	64	48	-	-	9.96E-03	2.80E-03
BioPlex 293T	CC	GO:0036019	endolysosome	-	29	29	-	-	4.91E-02	1.72E-03
BioPlex 293T	CC	GO:0001891	phagocytic cup	-	28	24	-	-	3.54E-04	1.44E-03
BioPlex 293T	CC	GO:0099086	synaptonemal structure	-	40	27	-	-	2.64E-03	1.58E-03
BioPlex 293T	CC	GO:0030427	site of polarized growth	-	172	146	-	-	5.37E-03	8.40E-03
BioPlex 293T	CC	GO:0044309	neuron spine	-	213	165	-	-	5.50E-03	9.48E-03
BioPlex 293T	CC	GO:0030658	transport vesicle membrane	-	231	184	-	-	4.39E-02	1.06E-02
BioPlex 293T	CC	GO:0098918	structural constituent of synapse	-	27	20	-	-	1.88E-03	1.15E-03
BioPlex 293T	CC	GO:0000940	outer kinetochore	-	17	17	-	-	1.60E-01	1.01E-03
BioPlex 293T	CC	GO:0034719	SMN-Sm protein complex	-	18	18	-	-	1.90E-01	1.08E-03
BioPlex 293T	CC	GO:0044232	organelle membrane contact site	-	50	45	-	-	5.77E-03	2.59E-03
BioPlex 293T	CC	GO:0098803	respiratory chain complex	-	39	27	-	-	6.42E-01	1.58E-03
BioPlex 293T	CC	GO:0030667	secretory granule membrane	-	319	246	-	-	6.83E-03	1.41E-02
BioPlex 293T	CC	GO:0097545	axonemal outer doublet	-	164	104	-	-	6.52E-03	6.03E-03
BioPlex 293T	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	17	-	-	6.62E-03	1.01E-03
BioPlex 293T	CC	GO:0070069	cytochrome complex	-	42	30	-	-	4.65E-01	1.72E-03
BioPlex 293T	CC	GO:0031143	pseudopodium	-	18	17	-	-	2.59E-03	1.01E-03
BioPlex 293T	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	23	-	-	6.58E-02	1.36E-03
BioPlex 293T	CC	GO:0055037	recycling endosome	-	200	171	-	-	3.02E-02	9.84E-03
BioPlex 293T	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	74	-	-	2.79E-03	4.31E-03
BioPlex 293T	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	3.65E-01	7.90E-04
BioPlex 293T	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	1.16E-02	7.18E-04
BioPlex 293T	CC	GO:0071682	endocytic vesicle lumen	-	23	21	-	-	3.52E-04	1.22E-03
BioPlex 293T	CC	GO:0030684	preribosome	-	76	74	-	-	3.21E-02	4.31E-03
BioPlex 293T	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	1.90E-01	1.08E-03
BioPlex 293T	CC	GO:1990391	DNA repair complex	-	22	21	-	-	2.74E-02	1.22E-03
BioPlex 293T	CC	GO:0005775	vacuolar lumen	-	176	155	-	-	4.01E-03	8.91E-03
BioPlex 293T	CC	GO:0032433	filopodium tip	-	19	19	-	-	1.31E-03	1.15E-03
BioPlex 293T	CC	GO:0032982	myosin filament	-	24	18	-	-	7.03E-03	1.08E-03
BioPlex 293T	CC	GO:0016327	apicolateral plasma membrane	-	23	13	-	-	6.79E-03	7.90E-04
BioPlex 293T	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	20	-	-	3.05E-01	1.15E-03
BioPlex 293T	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	11	-	-	3.00E-01	6.46E-04
BioPlex 293T	CC	GO:0044306	neuron projection terminus	-	164	120	-	-	4.44E-03	6.89E-03
BioPlex 293T	CC	GO:0034455	t-UTP complex	-	53	51	-	-	3.06E-02	2.94E-03
BioPlex 293T	CC	GO:0005770	late endosome	-	299	249	-	-	1.22E-02	1.44E-02
BioPlex 293T	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	6.07E-01	1.01E-03
BioPlex 293T	CC	GO:0031970	organelle envelope lumen	-	94	82	-	-	3.13E-02	4.74E-03
BioPlex 293T	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.53E-02	7.90E-04
BioPlex 293T	CC	GO:0120293	dynein axonemal particle	-	20	16	-	-	2.41E-03	9.34E-04
BioPlex 293T	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	21	-	-	1.42E-02	1.22E-03
BioPlex 293T	CC	GO:0043292	contractile muscle fiber	-	245	174	-	-	7.33E-03	1.01E-02
BioPlex 293T	CC	GO:0034709	methylosome	-	13	12	-	-	2.97E-02	7.18E-04
BioPlex 293T	CC	GO:0032426	stereocilium tip	-	21	14	-	-	2.14E-04	8.62E-04
BioPlex 293T	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	11	-	-	1.02E-02	6.46E-04
BioPlex 293T	CC	GO:0005849	mRNA cleavage factor complex	-	22	18	-	-	4.08E-01	1.08E-03
BioPlex 293T	CC	GO:0000803	sex chromosome	-	32	26	-	-	4.29E-03	1.51E-03
BioPlex 293T	CC	GO:0098982	GABA-ergic synapse	-	84	56	-	-	1.05E-02	3.23E-03
BioPlex 293T	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	15	-	-	1.26E-01	8.62E-04
BioPlex 293T	CC	GO:0035097	histone methyltransferase complex	-	63	58	-	-	1.37E-01	3.38E-03
BioPlex 293T	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	6.34E-01	8.62E-04
BioPlex 293T	CC	GO:0000242	pericentriolar material	-	22	20	-	-	2.46E-03	1.15E-03
BioPlex 293T	CC	GO:1903293	phosphatase complex	-	54	47	-	-	2.88E-02	2.73E-03
BioPlex 293T	CC	GO:0097470	ribbon synapse	-	13	13	-	-	2.11E-04	7.90E-04
BioPlex 293T	CC	GO:0031941	filamentous actin	-	27	22	-	-	1.30E-03	1.29E-03
BioPlex 293T	CC	GO:0000786	nucleosome	-	149	104	-	-	9.22E-02	6.03E-03
BioPlex 293T	CC	GO:0001533	cornified envelope	-	59	48	-	-	7.60E-04	2.80E-03
BioPlex 293T	CC	GO:1904724	tertiary granule lumen	-	55	49	-	-	7.45E-03	2.87E-03
BioPlex 293T	CC	GO:0030027	lamellipodium	-	202	176	-	-	1.21E-02	1.01E-02
BioPlex 293T	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	14	-	-	5.44E-02	8.62E-04
BioPlex 293T	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	22	-	-	1.17E-01	1.29E-03
BioPlex 293T	CC	GO:0060077	inhibitory synapse	-	20	15	-	-	3.95E-02	8.62E-04
BioPlex 293T	CC	GO:0031209	SCAR complex	-	12	11	-	-	1.75E-01	6.46E-04
BioPlex 293T	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	2.27E-01	9.34E-04
BioPlex 293T	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	20	-	-	2.77E-01	1.15E-03
BioPlex 293T	CC	GO:0002102	podosome	-	31	28	-	-	1.34E-03	1.65E-03
BioPlex 293T	CC	GO:0090543	Flemming body	-	33	28	-	-	5.01E-02	1.65E-03
BioPlex 293T	CC	GO:0016328	lateral plasma membrane	-	66	48	-	-	1.22E-02	2.80E-03
BioPlex 293T	CC	GO:0001650	fibrillar center	-	151	136	-	-	4.34E-03	7.83E-03
BioPlex 293T	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	5.44E-02	8.62E-04
BioPlex 293T	CC	GO:1990204	oxidoreductase complex	-	90	69	-	-	2.47E-01	4.02E-03
BioPlex 293T	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	1.77E-01	9.34E-04
BioPlex 293T	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	9.47E-01	6.46E-04
BioPlex 293T	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	112	-	-	4.52E-03	6.46E-03
BioPlex 293T	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	3.24E-01	1.08E-03
BioPlex 293T	CC	GO:0001726	ruffle	-	181	164	-	-	5.60E-03	9.48E-03
BioPlex 293T	CC	GO:1990909	Wnt signalosome	-	13	11	-	-	3.44E-03	6.46E-04
BioPlex 293T	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	15	-	-	1.03E-01	8.62E-04
BioPlex 293T	CC	GO:0043198	dendritic shaft	-	38	25	-	-	1.12E-03	1.44E-03
BioPlex 293T	CC	GO:0043073	germ cell nucleus	-	67	49	-	-	6.67E-03	2.87E-03
BioPlex 293T	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	19	-	-	6.35E-03	1.15E-03
BioPlex 293T	CC	GO:0016592	mediator complex	-	38	38	-	-	8.51E-01	2.23E-03
BioPlex 293T	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	6.64E-02	1.15E-03
BioPlex 293T	CC	GO:0022626	cytosolic ribosome	-	118	107	-	-	1.21E-01	6.18E-03
BioPlex 293T	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	43	-	-	2.12E-01	2.51E-03
BioPlex 293T	CC	GO:0034451	centriolar satellite	-	120	101	-	-	6.70E-03	5.82E-03
BioPlex 293T	CC	GO:0045171	intercellular bridge	-	91	83	-	-	1.63E-02	4.81E-03
BioPlex 293T	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	72	-	-	1.42E-02	4.17E-03
BioPlex 293T	CC	GO:0008250	oligosaccharyltransferase complex	-	14	12	-	-	1.92E-01	7.18E-04
BioPlex 293T	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	2.26E-02	6.46E-04
BioPlex 293T	CC	GO:0044292	dendrite terminus	-	13	13	-	-	8.38E-04	7.90E-04
BioPlex 293T	CC	GO:0032039	integrator complex	-	19	17	-	-	1.22E-01	1.01E-03
BioPlex 293T	CC	GO:0036038	MKS complex	-	13	11	-	-	3.19E-01	6.46E-04
BioPlex 293T	CC	GO:0030527	structural constituent of chromatin	-	97	56	-	-	5.57E-02	3.23E-03
BioPlex 293T	CC	GO:0036379	myofilament	-	26	17	-	-	4.43E-02	1.01E-03
BioPlex 293T	CC	GO:0030286	dynein complex	-	210	140	-	-	1.63E-02	8.04E-03
BioPlex 293T	CC	GO:0031105	septin complex	-	14	13	-	-	8.33E-01	7.90E-04
BioPlex 293T	CC	GO:0097228	sperm principal piece	-	33	19	-	-	2.15E-03	1.15E-03
BioPlex 293T	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.02E-02	7.18E-04
BioPlex 293T	CC	GO:0016482	cytosolic transport	-	135	120	-	-	8.25E-03	6.89E-03
BioPlex 293T	CC	GO:0090665	glycoprotein complex	-	23	18	-	-	6.77E-02	1.08E-03
BioPlex 293T	CC	GO:0005796	Golgi lumen	-	106	77	-	-	5.50E-03	4.45E-03
BioPlex 293T	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	34	-	-	1.61E-01	2.01E-03
BioPlex 293T	CC	GO:0034358	plasma lipoprotein particle	-	36	27	-	-	3.44E-02	1.58E-03
BioPlex 293T	CC	GO:0008023	transcription elongation factor complex	-	47	46	-	-	1.40E-01	2.66E-03
BioPlex 293T	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	21	-	-	2.48E-03	1.22E-03
BioPlex 293T	CC	GO:0030662	coated vesicle membrane	-	202	174	-	-	4.76E-02	1.01E-02
BioPlex 293T	CC	GO:0007039	protein catabolic process in the vacuole	-	61	53	-	-	3.25E-02	3.09E-03
BioPlex 293T	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	60	-	-	4.68E-01	3.45E-03
BioPlex 293T	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	226	-	-	1.86E-01	1.30E-02
BioPlex 293T	CC	GO:0090734	site of DNA damage	-	118	106	-	-	2.31E-02	6.10E-03
BioPlex 293T	MF	GO:0051861	glycolipid binding	-	30	23	-	-	5.45E-02	1.36E-03
BioPlex 293T	MF	GO:0051087	protein-folding chaperone binding	-	135	120	-	-	4.75E-03	6.89E-03
BioPlex 293T	MF	GO:0051959	dynein light intermediate chain binding	-	27	16	-	-	2.17E-03	9.34E-04
BioPlex 293T	CC	GO:0015464	acetylcholine receptor activity	-	21	12	-	-	5.11E-03	7.18E-04
BioPlex 293T	MF	GO:0042301	phosphate ion binding	-	12	11	-	-	9.54E-02	6.46E-04
BioPlex 293T	MF	GO:0031681	G-protein beta-subunit binding	-	22	15	-	-	2.83E-04	8.62E-04
BioPlex 293T	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	29	-	-	4.66E-03	1.72E-03
BioPlex 293T	MF	GO:0035613	RNA stem-loop binding	-	21	13	-	-	2.15E-04	7.90E-04
BioPlex 293T	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	205	-	-	1.13E-02	1.18E-02
BioPlex 293T	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	13	-	-	2.09E-04	7.90E-04
BioPlex 293T	MF	GO:0033691	sialic acid binding	-	22	14	-	-	5.84E-02	8.62E-04
BioPlex 293T	MF	GO:0016757	glycosyltransferase activity	-	286	227	-	-	1.56E-02	1.31E-02
BioPlex 293T	MF	GO:0048306	calcium-dependent protein binding	-	61	50	-	-	8.80E-04	2.87E-03
BioPlex 293T	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	23	-	-	2.03E-02	1.36E-03
BioPlex 293T	MF	GO:0035325	Toll-like receptor binding	-	13	11	-	-	1.20E-02	6.46E-04
BioPlex 293T	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	111	-	-	6.41E-03	6.39E-03
BioPlex 293T	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	47	-	-	6.21E-02	2.73E-03
BioPlex 293T	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	102	-	-	2.45E-02	5.89E-03
BioPlex 293T	MF	GO:0045504	dynein heavy chain binding	-	16	13	-	-	8.97E-02	7.90E-04
BioPlex 293T	MF	GO:0140457	protein demethylase activity	-	31	21	-	-	2.81E-03	1.22E-03
BioPlex 293T	MF	GO:0005158	insulin receptor binding	-	22	20	-	-	8.24E-03	1.15E-03
BioPlex 293T	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	7.17E-03	9.34E-04
BioPlex 293T	MF	GO:0061980	regulatory RNA binding	-	52	40	-	-	7.90E-03	2.30E-03
BioPlex 293T	MF	GO:0015035	protein-disulfide reductase activity	-	32	27	-	-	2.80E-02	1.58E-03
BioPlex 293T	MF	GO:0000182	rDNA binding	-	11	11	-	-	2.13E-04	6.46E-04
BioPlex 293T	MF	GO:0001671	ATPase activator activity	-	29	22	-	-	7.80E-03	1.29E-03
BioPlex 293T	MF	GO:0070840	dynein complex binding	-	25	19	-	-	4.91E-03	1.15E-03
BioPlex 293T	MF	GO:0035035	histone acetyltransferase binding	-	24	21	-	-	3.55E-04	1.22E-03
BioPlex 293T	MF	GO:0061684	chaperone-mediated autophagy	-	16	14	-	-	7.27E-04	8.62E-04
BioPlex 293T	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	28	-	-	1.12E-02	1.65E-03
BioPlex 293T	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	2.82E-04	1.08E-03
BioPlex 293T	MF	GO:0005178	integrin binding	-	153	118	-	-	6.11E-03	6.82E-03
BioPlex 293T	MF	GO:0070064	proline-rich region binding	-	17	16	-	-	3.72E-03	9.34E-04
BioPlex 293T	MF	GO:0005549	odorant binding	-	128	18	-	-	3.39E-02	1.08E-03
BioPlex 293T	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	3.87E-02	8.62E-04
BioPlex 293T	MF	GO:0008327	methyl-CpG binding	-	31	23	-	-	1.73E-02	1.36E-03
BioPlex 293T	MF	GO:0031418	L-ascorbic acid binding	-	20	17	-	-	3.37E-03	1.01E-03
BioPlex 293T	MF	GO:0048019	receptor antagonist activity	-	31	13	-	-	2.13E-04	7.90E-04
BioPlex 293T	MF	GO:0005521	lamin binding	-	15	11	-	-	2.13E-04	6.46E-04
BioPlex 293T	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	2.18E-02	1.01E-03
BioPlex 293T	MF	GO:0140318	protein transporter activity	-	40	30	-	-	3.04E-02	1.72E-03
BioPlex 293T	MF	GO:0070628	proteasome binding	-	17	16	-	-	3.42E-03	9.34E-04
BioPlex 293T	MF	GO:0000217	DNA secondary structure binding	-	37	33	-	-	2.21E-02	1.94E-03
BioPlex 293T	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	14	-	-	2.14E-04	8.62E-04
BioPlex 293T	MF	GO:0002039	p53 binding	-	66	56	-	-	2.78E-03	3.23E-03
BioPlex 293T	MF	GO:0005496	steroid binding	-	110	78	-	-	1.02E-02	4.52E-03
BioPlex 293T	MF	GO:0008443	phosphofructokinase activity	-	27	24	-	-	1.76E-01	1.44E-03
BioPlex 293T	MF	GO:0003684	damaged DNA binding	-	89	78	-	-	3.79E-02	4.52E-03
BioPlex 293T	MF	GO:0000339	RNA cap binding	-	20	16	-	-	4.65E-02	9.34E-04
BioPlex 293T	MF	GO:0016500	protein-hormone receptor activity	-	21	17	-	-	9.33E-03	1.01E-03
BioPlex 293T	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	117	-	-	1.06E-01	6.75E-03
BioPlex 293T	MF	GO:0005523	tropomyosin binding	-	15	11	-	-	2.13E-04	6.46E-04
BioPlex 293T	MF	GO:0070063	RNA polymerase binding	-	61	53	-	-	7.60E-03	3.09E-03
BioPlex 293T	MF	GO:0050811	GABA receptor binding	-	18	14	-	-	1.43E-03	8.62E-04
BioPlex 293T	MF	GO:0030971	receptor tyrosine kinase binding	-	76	59	-	-	8.71E-03	3.45E-03
BioPlex 293T	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	76	-	-	1.87E-01	4.38E-03
BioPlex 293T	MF	GO:0140030	modification-dependent protein binding	-	179	158	-	-	5.35E-03	9.12E-03
BioPlex 293T	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	20	-	-	3.53E-04	1.15E-03
BioPlex 293T	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	15	-	-	2.55E-02	8.62E-04
BioPlex 293T	MF	GO:0032794	GTPase activating protein binding	-	13	12	-	-	3.08E-02	7.18E-04
BioPlex 293T	MF	GO:0042813	Wnt receptor activity	-	16	15	-	-	7.51E-03	8.62E-04
BioPlex 293T	MF	GO:0141047	molecular tag activity	-	13	11	-	-	2.32E-02	6.46E-04
BioPlex 293T	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	1.13E-02	8.62E-04
BioPlex 293T	MF	GO:0010851	cyclase regulator activity	-	17	12	-	-	2.12E-04	7.18E-04
BioPlex 293T	MF	GO:0030276	clathrin binding	-	70	56	-	-	5.62E-02	3.23E-03
BioPlex 293T	MF	GO:0046875	ephrin receptor binding	-	29	26	-	-	7.88E-03	1.51E-03
BioPlex 293T	MF	GO:0046790	virion binding	-	19	16	-	-	1.28E-02	9.34E-04
BioPlex 293T	MF	GO:0030552	cAMP binding	-	48	37	-	-	5.94E-02	2.15E-03
BioPlex 293T	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	32	-	-	4.94E-04	1.87E-03
BioPlex 293T	MF	GO:0035173	histone kinase activity	-	17	16	-	-	4.22E-03	9.34E-04
BioPlex 293T	MF	GO:0097602	cullin family protein binding	-	26	25	-	-	7.89E-03	1.44E-03
BioPlex 293T	MF	GO:0017154	semaphorin receptor activity	-	12	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	MF	GO:0004984	olfactory receptor activity	-	429	72	-	-	2.11E-02	4.17E-03
BioPlex 293T	MF	GO:0016209	antioxidant activity	-	92	65	-	-	2.25E-02	3.73E-03
BioPlex 293T	MF	GO:0070325	lipoprotein particle receptor binding	-	32	28	-	-	1.49E-03	1.65E-03
BioPlex 293T	MF	GO:0044325	transmembrane transporter binding	-	159	125	-	-	1.33E-02	7.18E-03
BioPlex 293T	MF	GO:0048156	tau protein binding	-	43	43	-	-	2.72E-03	2.51E-03
BioPlex 293T	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	34	-	-	1.17E-03	2.01E-03
BioPlex 293T	MF	GO:0045295	gamma-catenin binding	-	13	12	-	-	2.14E-04	7.18E-04
BioPlex 293T	MF	GO:0140272	exogenous protein binding	-	79	56	-	-	2.17E-03	3.23E-03
BioPlex 293T	MF	GO:0030145	manganese ion binding	-	65	55	-	-	5.42E-03	3.16E-03
BioPlex 293T	MF	GO:0071814	protein-lipid complex binding	-	52	40	-	-	1.07E-03	2.30E-03
BioPlex 293T	MF	GO:0008066	glutamate receptor activity	-	70	41	-	-	5.98E-02	2.37E-03
BioPlex 293T	MF	GO:0017069	snRNA binding	-	54	45	-	-	1.39E-01	2.59E-03
BioPlex 293T	MF	GO:0030215	semaphorin receptor binding	-	23	18	-	-	1.50E-01	1.08E-03
BioPlex 293T	MF	GO:0031369	translation initiation factor binding	-	32	29	-	-	7.87E-02	1.72E-03
BioPlex 293T	MF	GO:0019843	rRNA binding	-	69	66	-	-	1.78E-02	3.81E-03
BioPlex 293T	MF	GO:0004713	protein tyrosine kinase activity	-	213	167	-	-	1.02E-02	9.62E-03
BioPlex 293T	MF	GO:0016779	nucleotidyltransferase activity	-	264	229	-	-	3.98E-02	1.32E-02
BioPlex 293T	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	43	-	-	4.35E-03	2.51E-03
BioPlex 293T	MF	GO:0008093	cytoskeletal anchor activity	-	24	21	-	-	2.33E-03	1.22E-03
BioPlex 293T	MF	GO:0070300	phosphatidic acid binding	-	20	16	-	-	4.47E-02	9.34E-04
BioPlex 293T	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	22	-	-	2.85E-03	1.29E-03
BioPlex 293T	MF	GO:0016208	AMP binding	-	22	21	-	-	1.48E-01	1.22E-03
BioPlex 293T	MF	GO:0000287	magnesium ion binding	-	225	182	-	-	3.29E-02	1.05E-02
BioPlex 293T	MF	GO:0031490	chromatin DNA binding	-	120	96	-	-	1.27E-02	5.53E-03
BioPlex 293T	MF	GO:0017022	myosin binding	-	73	61	-	-	5.03E-03	3.52E-03
BioPlex 293T	MF	GO:0004896	cytokine receptor activity	-	93	52	-	-	1.21E-03	3.02E-03
BioPlex 293T	MF	GO:0017166	vinculin binding	-	12	11	-	-	4.33E-03	6.46E-04
BioPlex 293T	MF	GO:0008301	"DNA binding, bending"	-	18	12	-	-	5.45E-02	7.18E-04
BioPlex 293T	MF	GO:0005539	glycosaminoglycan binding	-	236	156	-	-	7.00E-03	8.98E-03
BioPlex 293T	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.50E-02	8.62E-04
BioPlex 293T	MF	GO:0019207	kinase regulator activity	-	267	227	-	-	1.68E-02	1.31E-02
BioPlex 293T	MF	GO:0010181	FMN binding	-	15	11	-	-	3.71E-03	6.46E-04
BioPlex 293T	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	21	-	-	3.54E-04	1.22E-03
BioPlex 293T	MF	GO:0031420	alkali metal ion binding	-	17	13	-	-	1.45E-02	7.90E-04
BioPlex 293T	MF	GO:0044183	protein folding chaperone	-	67	60	-	-	2.89E-03	3.45E-03
BioPlex 293T	MF	GO:0005132	type I interferon receptor binding	-	17	16	-	-	1.50E-01	9.34E-04
BioPlex 293T	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	87	-	-	2.61E-02	5.03E-03
BioPlex 293T	MF	GO:0003725	double-stranded RNA binding	-	72	59	-	-	6.95E-03	3.45E-03
BioPlex 293T	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	12	-	-	7.20E-02	7.18E-04
BioPlex 293T	MF	GO:0051018	protein kinase A binding	-	52	39	-	-	5.07E-02	2.30E-03
BioPlex 293T	MF	GO:0071889	14-3-3 protein binding	-	34	27	-	-	2.43E-03	1.58E-03
BioPlex 293T	MF	GO:0004618	phosphoglycerate kinase activity	-	89	77	-	-	2.45E-02	4.45E-03
BioPlex 293T	MF	GO:0042805	actinin binding	-	36	22	-	-	3.60E-03	1.29E-03
BioPlex 293T	MF	GO:0043531	ADP binding	-	38	35	-	-	1.46E-02	2.01E-03
BioPlex 293T	MF	GO:0043394	proteoglycan binding	-	36	30	-	-	2.70E-03	1.72E-03
BioPlex 293T	MF	GO:0046332	SMAD binding	-	77	67	-	-	2.58E-02	3.88E-03
BioPlex 293T	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.30E-02	7.90E-04
BioPlex 293T	MF	GO:0001968	fibronectin binding	-	30	24	-	-	3.11E-03	1.44E-03
BioPlex 293T	MF	GO:0048038	quinone binding	-	16	13	-	-	1.53E-02	7.90E-04
BioPlex 293T	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	109	-	-	1.92E-02	6.32E-03
BioPlex 293T	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	67	-	-	1.07E-02	3.88E-03
BioPlex 293T	MF	GO:0003756	protein disulfide isomerase activity	-	18	15	-	-	2.83E-04	8.62E-04
BioPlex 293T	MF	GO:0051117	ATPase binding	-	85	70	-	-	3.92E-03	4.02E-03
BioPlex 293T	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	31	-	-	7.11E-04	1.80E-03
BioPlex 293T	MF	GO:0051787	misfolded protein binding	-	20	17	-	-	6.10E-03	1.01E-03
BioPlex 293T	MF	GO:0070402	NADPH binding	-	16	12	-	-	2.14E-04	7.18E-04
BioPlex 293T	MF	GO:0001098	basal transcription machinery binding	-	61	55	-	-	1.50E-02	3.16E-03
BioPlex 293T	MF	GO:0036002	pre-mRNA binding	-	57	31	-	-	3.41E-02	1.80E-03
BioPlex 293T	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	29	-	-	4.22E-04	1.72E-03
BioPlex 293T	MF	GO:0051540	metal cluster binding	-	71	59	-	-	1.24E-02	3.45E-03
BioPlex 293T	MF	GO:0051219	phosphoprotein binding	-	92	80	-	-	1.27E-02	4.60E-03
BioPlex 293T	MF	GO:0019894	kinesin binding	-	45	41	-	-	8.76E-03	2.37E-03
BioPlex 293T	MF	GO:0042287	MHC protein binding	-	68	50	-	-	2.42E-02	2.87E-03
BioPlex 293T	MF	GO:0019003	GDP binding	-	89	82	-	-	3.63E-02	4.74E-03
BioPlex 293T	MF	GO:0017171	serine hydrolase activity	-	207	148	-	-	9.93E-03	8.55E-03
BioPlex 293T	MF	GO:0097110	scaffold protein binding	-	66	47	-	-	1.28E-02	2.73E-03
BioPlex 293T	MF	GO:0003774	cytoskeletal motor activity	-	117	90	-	-	1.60E-02	5.17E-03
BioPlex 293T	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	2.65E-03	1.72E-03
BioPlex 293T	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	15	-	-	3.48E-02	8.62E-04
BioPlex 293T	MF	GO:0061134	peptidase regulator activity	-	224	162	-	-	5.81E-03	9.34E-03
BioPlex 293T	MF	GO:0008013	beta-catenin binding	-	86	70	-	-	7.04E-03	4.02E-03
BioPlex 293T	MF	GO:0051015	actin filament binding	-	208	175	-	-	4.49E-02	1.01E-02
BioPlex 293T	MF	GO:0019208	phosphatase regulator activity	-	107	88	-	-	1.03E-02	5.10E-03
BioPlex 293T	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	28	-	-	2.97E-03	1.65E-03
BioPlex 293T	MF	GO:0043236	laminin binding	-	29	25	-	-	2.72E-03	1.44E-03
BioPlex 293T	MF	GO:0030507	spectrin binding	-	26	22	-	-	1.44E-02	1.29E-03
BioPlex 293T	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	35	-	-	8.52E-03	2.01E-03
BioPlex 293T	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	102	-	-	1.72E-02	5.89E-03
BioPlex 293T	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	3.43E-02	1.44E-03
BioPlex 293T	MF	GO:0042393	histone binding	-	240	205	-	-	2.13E-02	1.18E-02
BioPlex 293T	MF	GO:0019838	growth factor binding	-	182	142	-	-	5.08E-03	8.19E-03
BioPlex 293T	MF	GO:0000149	SNARE binding	-	107	93	-	-	6.63E-02	5.39E-03
BioPlex 293T	MF	GO:0003727	single-stranded RNA binding	-	90	75	-	-	1.08E-02	4.31E-03
BioPlex 293T	MF	GO:0005516	calmodulin binding	-	206	155	-	-	1.11E-02	8.91E-03
BioPlex 293T	MF	GO:0019825	oxygen binding	-	40	30	-	-	3.40E-02	1.72E-03
BioPlex 293T	MF	GO:0045505	dynein intermediate chain binding	-	37	21	-	-	2.55E-03	1.22E-03
BioPlex 293T	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	73	-	-	4.62E-03	4.24E-03
BioPlex 293T	MF	GO:0032182	ubiquitin-like protein binding	-	117	109	-	-	6.30E-03	6.32E-03
BioPlex 293T	MF	GO:0023023	MHC protein complex binding	-	36	29	-	-	4.57E-02	1.72E-03
BioPlex 293T	MF	GO:0030742	GTP-dependent protein binding	-	22	21	-	-	1.15E-02	1.22E-03
BioPlex 293T	MF	GO:0043274	phospholipase binding	-	23	15	-	-	2.81E-04	8.62E-04
BioPlex 293T	MF	GO:0031072	heat shock protein binding	-	128	115	-	-	4.38E-03	6.61E-03
BioPlex 293T	MF	GO:0030515	snoRNA binding	-	33	31	-	-	2.62E-02	1.80E-03
BioPlex 293T	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	66	-	-	6.34E-02	3.81E-03
BioPlex 293T	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	19	-	-	1.98E-03	1.15E-03
BioPlex 293T	MF	GO:0001965	G-protein alpha-subunit binding	-	26	22	-	-	1.00E-03	1.29E-03
BioPlex 293T	MF	GO:0001530	lipopolysaccharide binding	-	38	25	-	-	1.59E-03	1.44E-03
BioPlex 293T	MF	GO:0140223	general transcription initiation factor activity	-	55	49	-	-	1.82E-01	2.87E-03
BioPlex 293T	MF	GO:0070403	NAD+ binding	-	16	14	-	-	2.12E-04	8.62E-04
BioPlex 293T	MF	GO:0000049	tRNA binding	-	75	67	-	-	1.71E-02	3.88E-03
BioPlex 293T	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	40	-	-	1.48E-02	2.30E-03
BioPlex 293T	MF	GO:0015026	coreceptor activity	-	48	26	-	-	2.99E-03	1.51E-03
BioPlex 293T	MF	GO:0001653	peptide receptor activity	-	128	48	-	-	1.19E-03	2.80E-03
BioPlex 293T	MF	GO:0030506	ankyrin binding	-	19	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	MF	GO:0006469	negative regulation of protein kinase activity	-	222	172	-	-	4.34E-03	9.91E-03
BioPlex 293T	MF	GO:0070182	DNA polymerase binding	-	22	19	-	-	9.05E-04	1.15E-03
BioPlex 293T	MF	GO:1901611	phosphatidylglycerol binding	-	15	11	-	-	2.14E-04	6.46E-04
BioPlex 293T	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	27	-	-	1.27E-02	1.58E-03
BioPlex 293T	MF	GO:0051427	hormone receptor binding	-	31	23	-	-	1.98E-02	1.36E-03
BioPlex 293T	MF	GO:0070851	growth factor receptor binding	-	141	102	-	-	2.50E-03	5.89E-03
BioPlex 293T	MF	GO:0031210	phosphatidylcholine binding	-	32	24	-	-	2.71E-02	1.44E-03
BioPlex 293T	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	31	-	-	1.22E-02	1.80E-03
BioPlex 293T	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	205	-	-	5.62E-03	1.18E-02
BioPlex 293T	MF	GO:0034185	apolipoprotein binding	-	20	15	-	-	2.82E-04	8.62E-04
BioPlex 293T	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	14	-	-	6.44E-03	8.62E-04
BioPlex 293T	MF	GO:0005506	iron ion binding	-	154	107	-	-	7.16E-03	6.18E-03
BioPlex 293T	MF	GO:0003925	G protein activity	-	45	41	-	-	2.31E-02	2.37E-03
BioPlex 293T	MF	GO:0038187	pattern recognition receptor activity	-	33	19	-	-	2.84E-04	1.15E-03
BioPlex 293T	MF	GO:0008276	protein methyltransferase activity	-	96	78	-	-	6.79E-03	4.52E-03
BioPlex 293T	MF	GO:0004396	hexokinase activity	-	16	14	-	-	5.85E-02	8.62E-04
BioPlex 293T	MF	GO:0070888	E-box binding	-	59	41	-	-	6.94E-02	2.37E-03
BioPlex 293T	MF	GO:0039706	co-receptor binding	-	14	13	-	-	2.12E-04	7.90E-04
BioPlex 293T	MF	GO:0015399	primary active transmembrane transporter activity	-	190	153	-	-	1.69E-01	8.83E-03
BioPlex 293T	MF	GO:0035254	glutamate receptor binding	-	47	34	-	-	2.62E-03	2.01E-03
BioPlex 293T	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	6.83E-03	1.94E-03
BioPlex 293T	MF	GO:0043021	ribonucleoprotein complex binding	-	158	139	-	-	1.39E-02	8.04E-03
BioPlex 293T	MF	GO:0030170	pyridoxal phosphate binding	-	56	41	-	-	8.45E-03	2.37E-03
BioPlex 293T	MF	GO:0032393	MHC class I receptor activity	-	15	13	-	-	3.00E-01	7.90E-04
BioPlex 293T	MF	GO:0005112	Notch binding	-	26	16	-	-	1.09E-03	9.34E-04
BioPlex 293T	MF	GO:0048185	activin binding	-	16	13	-	-	1.45E-01	7.90E-04
BioPlex 293T	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	23	-	-	2.01E-03	1.36E-03
BioPlex 293T	MF	GO:0001664	G protein-coupled receptor binding	-	299	220	-	-	1.09E-02	1.26E-02
BioPlex 293T	MF	GO:0140299	small molecule sensor activity	-	39	29	-	-	5.10E-02	1.72E-03
BioPlex 293T	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	19	-	-	1.61E-02	1.15E-03
BioPlex 293T	MF	GO:0016917	GABA receptor activity	-	23	13	-	-	2.02E-01	7.90E-04
BioPlex 293T	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	14	-	-	7.65E-02	8.62E-04
BioPlex 293T	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	19	-	-	2.83E-04	1.15E-03
BioPlex 293T	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	40	-	-	5.66E-02	2.30E-03
BioPlex 293T	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	21	-	-	3.55E-04	1.22E-03
BioPlex 293T	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	2.13E-04	7.18E-04
BioPlex 293T	MF	GO:0030594	neurotransmitter receptor activity	-	160	94	-	-	3.01E-02	5.46E-03
BioPlex 293T	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	20	-	-	3.86E-02	1.15E-03
BioPlex 293T	MF	GO:0120227	acyl-CoA binding	-	22	18	-	-	2.84E-04	1.08E-03
BioPlex 293T	MF	GO:0005507	copper ion binding	-	63	40	-	-	3.71E-03	2.30E-03
BioPlex 293T	MF	GO:0033558	protein lysine deacetylase activity	-	22	21	-	-	2.35E-03	1.22E-03
BioPlex 293T	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.57E-02	1.29E-03
BioPlex HCT116	CC	GO:0005739	mitochondrion	4.72E-44	1671	1149	881	1.30	-	-
BioPlex HCT116	CC	GO:0005730	nucleolus	5.18E-41	988	722	521	1.39	-	-
BioPlex HCT116	CC	GO:0005840	ribosome	2.42E-34	222	201	117	1.72	-	-
BioPlex HCT116	CC	GO:0005768	endosome	6.23E-30	1037	722	547	1.32	-	-
BioPlex HCT116	CC	GO:0005764	lysosome	2.74E-21	747	519	394	1.32	-	-
BioPlex HCT116	CC	GO:0005815	microtubule organizing center	5.85E-18	843	566	445	1.27	-	-
BioPlex HCT116	CC	GO:0005783	endoplasmic reticulum	7.50E-16	2020	1236	1066	1.16	-	-
BioPlex HCT116	CC	GO:0005615	extracellular space	8.33E-16	3190	1889	1683	1.12	-	-
BioPlex HCT116	CC	GO:0005794	Golgi apparatus	9.89E-16	1636	1017	863	1.18	-	-
BioPlex HCT116	CC	GO:0005635	nuclear envelope	8.89E-15	493	344	260	1.32	-	-
BioPlex HCT116	CC	GO:0000228	nuclear chromosome	1.16E-11	206	156	109	1.44	-	-
BioPlex HCT116	CC	GO:0005777	peroxisome	3.67E-04	142	96	75	1.28	-	-
BioPlex HCT116	CC	GO:0005811	lipid droplet	6.57E-04	102	71	54	1.32	-	-
BioPlex HCT116	CC	GO:0005929	cilium	1.58E-01	842	424	444	0.95	-	-
BioPlex HCT116	CC	GO:0031012	extracellular matrix	3.25E-01	564	286	298	0.96	-	-
BioPlex HCT116	BP	GO:0050877	nervous system process	1.37E-64	1527	490	805	0.61	-	-
BioPlex HCT116	BP	GO:0065003	protein-containing complex assembly	2.91E-46	1648	1142	869	1.31	-	-
BioPlex HCT116	BP	GO:0042254	ribosome biogenesis	7.45E-38	297	260	157	1.66	-	-
BioPlex HCT116	BP	GO:0030163	protein catabolic process	2.84E-36	990	711	522	1.36	-	-
BioPlex HCT116	BP	GO:0016071	mRNA metabolic process	1.43E-35	713	535	376	1.42	-	-
BioPlex HCT116	BP	GO:0006886	intracellular protein transport	2.30E-35	664	503	350	1.44	-	-
BioPlex HCT116	BP	GO:0016192	vesicle-mediated transport	2.74E-35	1894	1252	999	1.25	-	-
BioPlex HCT116	BP	GO:0006914	autophagy	5.32E-34	568	438	300	1.46	-	-
BioPlex HCT116	BP	GO:0006281	DNA repair	3.89E-24	587	428	310	1.38	-	-
BioPlex HCT116	BP	GO:0007059	chromosome segregation	1.80E-23	403	309	213	1.45	-	-
BioPlex HCT116	BP	GO:0140053	mitochondrial gene expression	2.42E-23	164	146	87	1.69	-	-
BioPlex HCT116	BP	GO:0007005	mitochondrion organization	1.61E-18	484	349	255	1.37	-	-
BioPlex HCT116	BP	GO:0006325	chromatin organization	3.23E-16	720	486	380	1.28	-	-
BioPlex HCT116	BP	GO:0006399	tRNA metabolic process	4.18E-16	196	158	103	1.53	-	-
BioPlex HCT116	BP	GO:0006913	nucleocytoplasmic transport	4.36E-16	326	243	172	1.41	-	-
BioPlex HCT116	BP	GO:0007010	cytoskeleton organization	5.49E-15	1639	1015	865	1.17	-	-
BioPlex HCT116	BP	GO:0006260	DNA replication	2.56E-14	279	209	147	1.42	-	-
BioPlex HCT116	BP	GO:0055086	nucleobase-containing small molecule metabolic process	3.68E-13	729	480	385	1.25	-	-
BioPlex HCT116	BP	GO:0002181	cytoplasmic translation	1.25E-12	153	123	81	1.52	-	-
BioPlex HCT116	BP	GO:0006457	protein folding	6.95E-12	210	159	111	1.44	-	-
BioPlex HCT116	BP	GO:0006091	generation of precursor metabolites and energy	1.08E-11	502	339	265	1.28	-	-
BioPlex HCT116	BP	GO:0072659	protein localization to plasma membrane	2.15E-10	284	202	150	1.35	-	-
BioPlex HCT116	BP	GO:0012501	programmed cell death	1.36E-08	1954	1149	1031	1.11	-	-
BioPlex HCT116	BP	GO:0000910	cytokinesis	3.26E-08	186	135	98	1.38	-	-
BioPlex HCT116	BP	GO:0032200	telomere organization	3.26E-08	186	135	98	1.38	-	-
BioPlex HCT116	BP	GO:0055085	transmembrane transport	4.08E-07	1784	839	941	0.89	-	-
BioPlex HCT116	BP	GO:0007163	establishment or maintenance of cell polarity	5.96E-07	227	157	120	1.31	-	-
BioPlex HCT116	BP	GO:0006310	DNA recombination	2.30E-06	333	218	176	1.24	-	-
BioPlex HCT116	BP	GO:0007040	lysosome organization	3.62E-06	107	80	56	1.42	-	-
BioPlex HCT116	BP	GO:0005975	carbohydrate metabolic process	5.21E-06	551	343	291	1.18	-	-
BioPlex HCT116	BP	GO:0006790	sulfur compound metabolic process	1.63E-05	320	207	169	1.23	-	-
BioPlex HCT116	BP	GO:0006629	lipid metabolic process	1.90E-04	1355	781	715	1.09	-	-
BioPlex HCT116	BP	GO:0042060	wound healing	3.58E-04	431	264	227	1.16	-	-
BioPlex HCT116	BP	GO:0006520	amino acid metabolic process	9.25E-04	292	182	154	1.18	-	-
BioPlex HCT116	BP	GO:0002376	immune system process	1.41E-03	2448	1365	1291	1.06	-	-
BioPlex HCT116	BP	GO:0007018	microtubule-based movement	1.66E-03	640	377	338	1.12	-	-
BioPlex HCT116	BP	GO:0006355	regulation of DNA-templated transcription	2.22E-03	3342	1843	1763	1.05	-	-
BioPlex HCT116	BP	GO:0006486	protein glycosylation	4.68E-03	225	140	119	1.18	-	-
BioPlex HCT116	BP	GO:0098542	defense response to other organism	1.11E-02	1171	660	618	1.07	-	-
BioPlex HCT116	BP	GO:0003013	circulatory system process	3.53E-02	584	283	308	0.92	-	-
BioPlex HCT116	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	6.53E-02	119	73	63	1.16	-	-
BioPlex HCT116	BP	GO:0034330	cell junction organization	1.03E-01	727	405	383	1.06	-	-
BioPlex HCT116	BP	GO:0006575	cellular modified amino acid metabolic process	1.21E-01	186	109	98	1.11	-	-
BioPlex HCT116	BP	GO:0140013	meiotic nuclear division	1.31E-01	279	160	147	1.09	-	-
BioPlex HCT116	BP	GO:0030198	extracellular matrix organization	1.90E-01	314	154	166	0.93	-	-
BioPlex HCT116	BP	GO:0003014	renal system process	2.86E-01	127	61	67	0.91	-	-
BioPlex HCT116	BP	GO:0098754	detoxification	3.86E-01	134	76	71	1.08	-	-
BioPlex HCT116	BP	GO:0003012	muscle system process	4.04E-01	425	233	224	1.04	-	-
BioPlex HCT116	BP	GO:0022600	digestive system process	4.45E-01	110	54	58	0.93	-	-
BioPlex HCT116	BP	GO:0044782	cilium organization	4.48E-01	399	218	210	1.04	-	-
BioPlex HCT116	BP	GO:0048870	cell motility	8.57E-01	1659	879	875	1.00	-	-
BioPlex HCT116	BP	GO:0007155	cell adhesion	9.13E-01	1444	764	762	1.00	-	-
BioPlex HCT116	BP	GO:0006954	inflammatory response	9.43E-01	820	434	433	1.00	-	-
BioPlex HCT116	BP	GO:0006766	vitamin metabolic process	1.00E+00	107	56	56	0.99	-	-
BioPlex HCT116	MF	GO:0003723	RNA binding	5.26E-84	1679	1256	886	1.42	-	-
BioPlex HCT116	MF	GO:0016740	transferase activity	6.59E-40	3074	1954	1621	1.21	-	-
BioPlex HCT116	MF	GO:0140096	"catalytic activity, acting on a protein"	1.46E-24	3198	1949	1687	1.16	-	-
BioPlex HCT116	MF	GO:0140657	ATP-dependent activity	6.04E-23	729	513	385	1.33	-	-
BioPlex HCT116	MF	GO:0008092	cytoskeletal protein binding	1.22E-22	1023	690	540	1.28	-	-
BioPlex HCT116	MF	GO:0140098	"catalytic activity, acting on RNA"	1.27E-18	417	307	220	1.40	-	-
BioPlex HCT116	MF	GO:0016874	ligase activity	1.04E-11	283	205	149	1.37	-	-
BioPlex HCT116	MF	GO:0140097	"catalytic activity, acting on DNA"	2.40E-11	383	266	202	1.32	-	-
BioPlex HCT116	MF	GO:0009975	cyclase activity	6.02E-10	277	95	146	0.65	-	-
BioPlex HCT116	MF	GO:0016491	oxidoreductase activity	8.10E-09	888	552	468	1.18	-	-
BioPlex HCT116	MF	GO:0005215	transporter activity	2.93E-08	1462	669	771	0.87	-	-
BioPlex HCT116	MF	GO:0048018	receptor ligand activity	3.93E-08	504	205	266	0.77	-	-
BioPlex HCT116	MF	GO:0140104	molecular carrier activity	1.10E-07	105	82	55	1.48	-	-
BioPlex HCT116	MF	GO:0003924	GTPase activity	7.81E-07	658	409	347	1.18	-	-
BioPlex HCT116	MF	GO:0042393	histone binding	1.07E-06	237	162	125	1.30	-	-
BioPlex HCT116	MF	GO:0016853	isomerase activity	1.17E-06	252	171	133	1.29	-	-
BioPlex HCT116	MF	GO:0005198	structural molecule activity	3.38E-06	798	485	421	1.15	-	-
BioPlex HCT116	MF	GO:0045182	translation regulator activity	3.66E-05	151	105	80	1.32	-	-
BioPlex HCT116	MF	GO:0140110	transcription regulator activity	8.33E-04	2033	1001	1072	0.93	-	-
BioPlex HCT116	MF	GO:0008289	lipid binding	7.07E-03	836	479	441	1.09	-	-
BioPlex HCT116	MF	GO:0016829	lyase activity	2.54E-02	538	258	284	0.91	-	-
BioPlex HCT116	MF	GO:0003774	cytoskeletal motor activity	1.13E-01	116	70	61	1.14	-	-
BioPlex HCT116	MF	GO:0003677	DNA binding	6.55E-01	2865	1500	1511	0.99	-	-
BioPlex HCT116	MF	GO:0038024	cargo receptor activity	7.81E-01	117	60	62	0.97	-	-
BioPlex HCT116	BP	GO:0008038	neuron recognition	-	46	17	-	-	4.26E-02	1.39E-03
BioPlex HCT116	BP	GO:1905145	cellular response to acetylcholine	-	33	15	-	-	4.83E-03	1.19E-03
BioPlex HCT116	BP	GO:0098780	response to mitochondrial depolarisation	-	21	20	-	-	4.04E-03	1.59E-03
BioPlex HCT116	BP	GO:0051931	regulation of sensory perception	-	36	17	-	-	3.92E-04	1.39E-03
BioPlex HCT116	BP	GO:0009268	response to pH	-	43	23	-	-	6.25E-03	1.88E-03
BioPlex HCT116	BP	GO:0045666	positive regulation of neuron differentiation	-	91	36	-	-	3.88E-03	2.87E-03
BioPlex HCT116	BP	GO:0043543	protein acylation	-	107	74	-	-	1.15E-02	5.94E-03
BioPlex HCT116	MF	GO:0051349	positive regulation of lyase activity	-	41	13	-	-	2.92E-04	1.09E-03
BioPlex HCT116	BP	GO:0048679	regulation of axon regeneration	-	28	15	-	-	4.42E-03	1.19E-03
BioPlex HCT116	BP	GO:0022401	negative adaptation of signaling pathway	-	21	12	-	-	2.92E-04	9.91E-04
BioPlex HCT116	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	48	-	-	1.68E-02	3.86E-03
BioPlex HCT116	BP	GO:0071763	nuclear membrane organization	-	44	37	-	-	3.27E-02	2.97E-03
BioPlex HCT116	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	26	-	-	2.35E-02	2.08E-03
BioPlex HCT116	BP	GO:0071806	protein transmembrane transport	-	68	46	-	-	6.42E-03	3.67E-03
BioPlex HCT116	BP	GO:0022038	corpus callosum development	-	25	21	-	-	4.86E-04	1.68E-03
BioPlex HCT116	BP	GO:0043299	leukocyte degranulation	-	82	47	-	-	7.20E-03	3.76E-03
BioPlex HCT116	BP	GO:0048864	stem cell development	-	88	50	-	-	7.32E-03	3.96E-03
BioPlex HCT116	BP	GO:0051651	maintenance of location in cell	-	236	135	-	-	4.62E-03	1.07E-02
BioPlex HCT116	BP	GO:0033119	negative regulation of RNA splicing	-	27	22	-	-	1.98E-02	1.78E-03
BioPlex HCT116	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	18	-	-	3.93E-04	1.49E-03
BioPlex HCT116	CC	GO:0016197	endosomal transport	-	282	233	-	-	4.81E-02	1.85E-02
BioPlex HCT116	BP	GO:0070663	regulation of leukocyte proliferation	-	268	139	-	-	6.63E-03	1.11E-02
BioPlex HCT116	BP	GO:0001833	inner cell mass cell proliferation	-	14	13	-	-	3.16E-02	1.09E-03
BioPlex HCT116	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	21	-	-	3.35E-03	1.68E-03
BioPlex HCT116	BP	GO:0006949	syncytium formation	-	66	28	-	-	2.00E-03	2.28E-03
BioPlex HCT116	BP	GO:0045861	negative regulation of proteolysis	-	320	192	-	-	5.15E-03	1.53E-02
BioPlex HCT116	BP	GO:0043144	sno(s)RNA processing	-	14	12	-	-	9.84E-02	9.91E-04
BioPlex HCT116	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	26	-	-	2.01E-02	2.08E-03
BioPlex HCT116	BP	GO:0030574	collagen catabolic process	-	45	24	-	-	4.05E-02	1.98E-03
BioPlex HCT116	CC	GO:0006984	ER-nucleus signaling pathway	-	46	37	-	-	3.21E-03	2.97E-03
BioPlex HCT116	BP	GO:0009914	hormone transport	-	315	158	-	-	4.72E-03	1.26E-02
BioPlex HCT116	BP	GO:0140112	extracellular vesicle biogenesis	-	23	20	-	-	1.26E-02	1.59E-03
BioPlex HCT116	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	1.54E-01	1.29E-03
BioPlex HCT116	BP	GO:1900424	regulation of defense response to bacterium	-	21	14	-	-	2.90E-04	1.19E-03
BioPlex HCT116	BP	GO:0085029	extracellular matrix assembly	-	42	23	-	-	1.76E-03	1.88E-03
BioPlex HCT116	BP	GO:0006413	translational initiation	-	122	88	-	-	2.11E-01	7.03E-03
BioPlex HCT116	BP	GO:1902895	positive regulation of miRNA transcription	-	51	24	-	-	3.91E-02	1.98E-03
BioPlex HCT116	CC	GO:0005200	structural constituent of cytoskeleton	-	112	82	-	-	2.87E-02	6.54E-03
BioPlex HCT116	BP	GO:0030865	cortical cytoskeleton organization	-	51	36	-	-	1.70E-03	2.87E-03
BioPlex HCT116	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	20	-	-	1.85E-01	1.59E-03
BioPlex HCT116	BP	GO:1903036	positive regulation of response to wounding	-	76	47	-	-	3.92E-03	3.76E-03
BioPlex HCT116	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	13	-	-	4.00E-01	1.09E-03
BioPlex HCT116	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	84	-	-	3.59E-03	6.74E-03
BioPlex HCT116	BP	GO:1903319	positive regulation of protein maturation	-	27	16	-	-	8.71E-03	1.29E-03
BioPlex HCT116	BP	GO:0032528	microvillus organization	-	24	12	-	-	2.96E-04	9.91E-04
BioPlex HCT116	BP	GO:0002263	cell activation involved in immune response	-	304	166	-	-	6.82E-03	1.32E-02
BioPlex HCT116	BP	GO:0021954	central nervous system neuron development	-	85	44	-	-	3.59E-03	3.57E-03
BioPlex HCT116	BP	GO:0055017	cardiac muscle tissue growth	-	92	43	-	-	1.27E-03	3.47E-03
BioPlex HCT116	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	12	-	-	2.95E-04	9.91E-04
BioPlex HCT116	BP	GO:0048524	positive regulation of viral process	-	64	49	-	-	1.82E-03	3.96E-03
BioPlex HCT116	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	17	-	-	1.40E-02	1.39E-03
BioPlex HCT116	BP	GO:0098661	inorganic anion transmembrane transport	-	140	49	-	-	2.02E-02	3.96E-03
BioPlex HCT116	BP	GO:0006099	tricarboxylic acid cycle	-	33	20	-	-	1.44E-01	1.59E-03
BioPlex HCT116	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	14	-	-	9.85E-03	1.19E-03
BioPlex HCT116	BP	GO:0009612	response to mechanical stimulus	-	215	103	-	-	6.45E-03	8.22E-03
BioPlex HCT116	BP	GO:0048644	muscle organ morphogenesis	-	81	42	-	-	1.16E-02	3.37E-03
BioPlex HCT116	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	78	-	-	2.80E-03	6.24E-03
BioPlex HCT116	BP	GO:0071542	dopaminergic neuron differentiation	-	36	13	-	-	9.66E-03	1.09E-03
BioPlex HCT116	BP	GO:0140115	export across plasma membrane	-	82	35	-	-	1.99E-02	2.77E-03
BioPlex HCT116	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	28	-	-	1.23E-03	2.28E-03
BioPlex HCT116	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	14	-	-	2.96E-04	1.19E-03
BioPlex HCT116	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	27	-	-	4.44E-03	2.18E-03
BioPlex HCT116	MF	GO:0003714	transcription corepressor activity	-	190	142	-	-	7.29E-03	1.13E-02
BioPlex HCT116	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	20	-	-	4.90E-04	1.59E-03
BioPlex HCT116	CC	GO:0006858	extracellular transport	-	45	17	-	-	3.95E-04	1.39E-03
BioPlex HCT116	BP	GO:0006304	DNA modification	-	30	16	-	-	1.97E-02	1.29E-03
BioPlex HCT116	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	1.09E-01	1.49E-03
BioPlex HCT116	BP	GO:0046835	carbohydrate phosphorylation	-	49	33	-	-	9.84E-02	2.68E-03
BioPlex HCT116	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	12	-	-	2.87E-04	9.91E-04
BioPlex HCT116	CC	GO:1905349	ciliary transition zone assembly	-	371	204	-	-	5.12E-02	1.62E-02
BioPlex HCT116	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	12	-	-	8.34E-03	9.91E-04
BioPlex HCT116	BP	GO:0043523	regulation of neuron apoptotic process	-	218	111	-	-	1.60E-02	8.82E-03
BioPlex HCT116	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	11	-	-	3.17E-03	8.92E-04
BioPlex HCT116	BP	GO:0044380	protein localization to cytoskeleton	-	57	48	-	-	7.68E-02	3.86E-03
BioPlex HCT116	BP	GO:2000209	regulation of anoikis	-	25	19	-	-	2.37E-02	1.59E-03
BioPlex HCT116	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	16	-	-	3.93E-04	1.29E-03
BioPlex HCT116	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	24	-	-	4.84E-04	1.98E-03
BioPlex HCT116	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	41	-	-	2.82E-03	3.27E-03
BioPlex HCT116	CC	GO:0045324	late endosome to vacuole transport	-	37	30	-	-	4.18E-01	2.38E-03
BioPlex HCT116	BP	GO:0043954	cellular component maintenance	-	72	40	-	-	9.35E-03	3.17E-03
BioPlex HCT116	BP	GO:0050435	amyloid-beta metabolic process	-	65	37	-	-	4.86E-03	2.97E-03
BioPlex HCT116	BP	GO:0014823	response to activity	-	70	41	-	-	1.02E-02	3.27E-03
BioPlex HCT116	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	20	-	-	3.59E-03	1.59E-03
BioPlex HCT116	BP	GO:0034502	protein localization to chromosome	-	130	94	-	-	1.77E-02	7.53E-03
BioPlex HCT116	BP	GO:0048562	embryonic organ morphogenesis	-	295	137	-	-	9.06E-03	1.09E-02
BioPlex HCT116	BP	GO:0019233	sensory perception of pain	-	103	42	-	-	1.11E-03	3.37E-03
BioPlex HCT116	CC	GO:0043574	peroxisomal transport	-	22	16	-	-	4.28E-02	1.29E-03
BioPlex HCT116	BP	GO:0031343	positive regulation of cell killing	-	75	46	-	-	1.21E-02	3.67E-03
BioPlex HCT116	BP	GO:0090077	foam cell differentiation	-	39	17	-	-	3.91E-04	1.39E-03
BioPlex HCT116	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	47	-	-	2.90E-02	3.76E-03
BioPlex HCT116	BP	GO:0017148	negative regulation of translation	-	390	79	-	-	2.24E-02	6.34E-03
BioPlex HCT116	BP	GO:0030220	platelet formation	-	22	12	-	-	2.95E-04	9.91E-04
BioPlex HCT116	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	51	-	-	2.77E-03	4.06E-03
BioPlex HCT116	BP	GO:1903509	liposaccharide metabolic process	-	109	74	-	-	1.28E-02	5.94E-03
BioPlex HCT116	BP	GO:0009582	detection of abiotic stimulus	-	140	50	-	-	3.21E-03	3.96E-03
BioPlex HCT116	CC	GO:0140238	presynaptic endocytosis	-	72	55	-	-	7.17E-02	4.36E-03
BioPlex HCT116	BP	GO:0051236	establishment of RNA localization	-	161	119	-	-	9.73E-02	9.51E-03
BioPlex HCT116	BP	GO:0042178	xenobiotic catabolic process	-	26	15	-	-	3.69E-01	1.19E-03
BioPlex HCT116	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	124	-	-	7.98E-03	9.91E-03
BioPlex HCT116	BP	GO:0034067	protein localization to Golgi apparatus	-	30	22	-	-	1.07E-02	1.78E-03
BioPlex HCT116	BP	GO:0061842	microtubule organizing center localization	-	32	28	-	-	3.91E-03	2.28E-03
BioPlex HCT116	MF	GO:0048018	receptor ligand activity	-	510	205	-	-	2.85E-02	1.62E-02
BioPlex HCT116	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	11	-	-	2.96E-04	8.92E-04
BioPlex HCT116	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	12	-	-	6.03E-03	9.91E-04
BioPlex HCT116	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	27	-	-	3.08E-03	2.18E-03
BioPlex HCT116	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	35	-	-	1.92E-03	2.77E-03
BioPlex HCT116	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	3.89E-04	1.29E-03
BioPlex HCT116	BP	GO:0050779	RNA destabilization	-	135	69	-	-	4.37E-02	5.55E-03
BioPlex HCT116	BP	GO:0006023	aminoglycan biosynthetic process	-	74	48	-	-	2.49E-02	3.86E-03
BioPlex HCT116	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	44	-	-	2.31E-02	3.57E-03
BioPlex HCT116	BP	GO:0010762	regulation of fibroblast migration	-	40	29	-	-	5.82E-04	2.38E-03
BioPlex HCT116	BP	GO:0090311	regulation of protein deacetylation	-	29	22	-	-	2.71E-01	1.78E-03
BioPlex HCT116	BP	GO:0035272	exocrine system development	-	46	26	-	-	1.66E-02	2.08E-03
BioPlex HCT116	BP	GO:1901096	regulation of autophagosome maturation	-	17	13	-	-	8.69E-02	1.09E-03
BioPlex HCT116	BP	GO:0022406	membrane docking	-	90	76	-	-	7.00E-02	6.04E-03
BioPlex HCT116	BP	GO:0006999	nuclear pore organization	-	15	13	-	-	5.85E-02	1.09E-03
BioPlex HCT116	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	12	-	-	1.99E-03	9.91E-04
BioPlex HCT116	BP	GO:0050777	negative regulation of immune response	-	196	116	-	-	3.15E-03	9.21E-03
BioPlex HCT116	BP	GO:0016053	organic acid biosynthetic process	-	335	181	-	-	2.69E-02	1.44E-02
BioPlex HCT116	BP	GO:0002063	chondrocyte development	-	33	12	-	-	2.95E-04	9.91E-04
BioPlex HCT116	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	13	-	-	9.60E-03	1.09E-03
BioPlex HCT116	BP	GO:0099068	postsynapse assembly	-	40	15	-	-	3.92E-04	1.19E-03
BioPlex HCT116	BP	GO:0021782	glial cell development	-	120	71	-	-	5.20E-03	5.65E-03
BioPlex HCT116	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	57	-	-	5.21E-03	4.56E-03
BioPlex HCT116	BP	GO:0001655	urogenital system development	-	66	31	-	-	6.78E-04	2.48E-03
BioPlex HCT116	BP	GO:0071827	plasma lipoprotein particle organization	-	86	39	-	-	3.12E-03	3.17E-03
BioPlex HCT116	BP	GO:0045494	photoreceptor cell maintenance	-	43	14	-	-	2.74E-02	1.19E-03
BioPlex HCT116	BP	GO:0055088	lipid homeostasis	-	173	84	-	-	3.10E-03	6.74E-03
BioPlex HCT116	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	19	-	-	3.90E-04	1.59E-03
BioPlex HCT116	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	133	-	-	6.26E-03	1.06E-02
BioPlex HCT116	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	12	-	-	2.79E-02	9.91E-04
BioPlex HCT116	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	29	-	-	1.17E-02	2.38E-03
BioPlex HCT116	BP	GO:0045667	regulation of osteoblast differentiation	-	147	63	-	-	5.22E-03	5.05E-03
BioPlex HCT116	BP	GO:0061037	negative regulation of cartilage development	-	32	12	-	-	9.80E-03	9.91E-04
BioPlex HCT116	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	221	-	-	7.26E-03	1.75E-02
BioPlex HCT116	BP	GO:0045738	negative regulation of DNA repair	-	40	23	-	-	3.26E-03	1.88E-03
BioPlex HCT116	BP	GO:0001704	formation of primary germ layer	-	195	108	-	-	8.62E-03	8.62E-03
BioPlex HCT116	BP	GO:0045778	positive regulation of ossification	-	51	23	-	-	1.42E-02	1.88E-03
BioPlex HCT116	BP	GO:0048708	astrocyte differentiation	-	88	45	-	-	4.10E-03	3.57E-03
BioPlex HCT116	BP	GO:0042092	type 2 immune response	-	41	22	-	-	4.92E-04	1.78E-03
BioPlex HCT116	BP	GO:0048588	developmental cell growth	-	233	126	-	-	5.80E-03	1.00E-02
BioPlex HCT116	CC	GO:0000963	mitochondrial RNA processing	-	20	19	-	-	4.17E-02	1.59E-03
BioPlex HCT116	BP	GO:0021872	forebrain generation of neurons	-	52	20	-	-	4.87E-04	1.59E-03
BioPlex HCT116	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	16	-	-	3.90E-04	1.29E-03
BioPlex HCT116	BP	GO:0045023	G0 to G1 transition	-	41	34	-	-	4.20E-01	2.77E-03
BioPlex HCT116	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	23	-	-	1.10E-01	1.88E-03
BioPlex HCT116	BP	GO:0034367	protein-containing complex remodeling	-	35	18	-	-	3.90E-04	1.49E-03
BioPlex HCT116	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	17	-	-	3.91E-04	1.39E-03
BioPlex HCT116	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	24	-	-	9.20E-04	1.98E-03
BioPlex HCT116	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	16	-	-	1.03E-01	1.29E-03
BioPlex HCT116	BP	GO:0015810	aspartate transmembrane transport	-	19	12	-	-	8.11E-03	9.91E-04
BioPlex HCT116	BP	GO:0010232	vascular transport	-	87	34	-	-	5.65E-03	2.77E-03
BioPlex HCT116	BP	GO:0021987	cerebral cortex development	-	125	73	-	-	6.37E-03	5.85E-03
BioPlex HCT116	BP	GO:0008637	apoptotic mitochondrial changes	-	108	72	-	-	9.59E-02	5.75E-03
BioPlex HCT116	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	20	-	-	1.98E-02	1.59E-03
BioPlex HCT116	BP	GO:0060999	positive regulation of dendritic spine development	-	35	21	-	-	4.86E-04	1.68E-03
BioPlex HCT116	BP	GO:2000736	regulation of stem cell differentiation	-	78	54	-	-	1.56E-02	4.36E-03
BioPlex HCT116	BP	GO:0002064	epithelial cell development	-	210	119	-	-	5.31E-03	9.51E-03
BioPlex HCT116	BP	GO:0071318	cellular response to ATP	-	18	11	-	-	2.92E-04	8.92E-04
BioPlex HCT116	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	21	-	-	1.59E-02	1.68E-03
BioPlex HCT116	BP	GO:2001222	regulation of neuron migration	-	46	21	-	-	4.83E-04	1.68E-03
BioPlex HCT116	BP	GO:0034389	lipid droplet organization	-	38	26	-	-	6.72E-03	2.08E-03
BioPlex HCT116	BP	GO:0051602	response to electrical stimulus	-	44	21	-	-	4.89E-04	1.68E-03
BioPlex HCT116	BP	GO:0042177	negative regulation of protein catabolic process	-	109	80	-	-	2.70E-03	6.34E-03
BioPlex HCT116	MF	GO:0038024	cargo receptor activity	-	121	60	-	-	6.94E-03	4.76E-03
BioPlex HCT116	BP	GO:0033120	positive regulation of RNA splicing	-	46	34	-	-	4.53E-03	2.77E-03
BioPlex HCT116	BP	GO:0051445	regulation of meiotic cell cycle	-	64	39	-	-	1.74E-01	3.17E-03
BioPlex HCT116	BP	GO:0033619	membrane protein proteolysis	-	60	40	-	-	3.16E-03	3.17E-03
BioPlex HCT116	BP	GO:0090087	regulation of peptide transport	-	195	97	-	-	4.12E-03	7.73E-03
BioPlex HCT116	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	54	-	-	3.11E-02	4.36E-03
BioPlex HCT116	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	11	-	-	2.93E-04	8.92E-04
BioPlex HCT116	BP	GO:0006929	substrate-dependent cell migration	-	26	15	-	-	3.88E-04	1.19E-03
BioPlex HCT116	BP	GO:0042537	benzene-containing compound metabolic process	-	27	13	-	-	2.10E-01	1.09E-03
BioPlex HCT116	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	11	-	-	2.96E-04	8.92E-04
BioPlex HCT116	BP	GO:0072662	protein localization to peroxisome	-	20	13	-	-	3.97E-03	1.09E-03
BioPlex HCT116	BP	GO:0022404	molting cycle process	-	95	52	-	-	1.36E-03	4.16E-03
BioPlex HCT116	BP	GO:1903358	regulation of Golgi organization	-	17	15	-	-	6.25E-03	1.19E-03
BioPlex HCT116	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	22	-	-	2.09E-03	1.78E-03
BioPlex HCT116	BP	GO:0017014	protein nitrosylation	-	17	13	-	-	5.58E-02	1.09E-03
BioPlex HCT116	BP	GO:0007281	germ cell development	-	334	157	-	-	4.87E-03	1.25E-02
BioPlex HCT116	BP	GO:0008299	isoprenoid biosynthetic process	-	30	16	-	-	2.44E-02	1.29E-03
BioPlex HCT116	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	125	-	-	1.36E-02	9.91E-03
BioPlex HCT116	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	20	-	-	4.86E-04	1.59E-03
BioPlex HCT116	CC	GO:0098926	postsynaptic signal transduction	-	39	18	-	-	1.58E-03	1.49E-03
BioPlex HCT116	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	94	-	-	2.94E-03	7.53E-03
BioPlex HCT116	CC	GO:0016082	synaptic vesicle priming	-	19	13	-	-	2.11E-02	1.09E-03
BioPlex HCT116	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	28	-	-	1.75E-02	2.28E-03
BioPlex HCT116	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	80	-	-	3.93E-02	6.34E-03
BioPlex HCT116	BP	GO:0034249	negative regulation of amide metabolic process	-	34	18	-	-	1.86E-02	1.49E-03
BioPlex HCT116	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	70	-	-	1.47E-02	5.55E-03
BioPlex HCT116	BP	GO:0042832	defense response to protozoan	-	28	11	-	-	1.35E-02	8.92E-04
BioPlex HCT116	BP	GO:0048799	animal organ maturation	-	33	17	-	-	2.87E-03	1.39E-03
BioPlex HCT116	BP	GO:0006925	inflammatory cell apoptotic process	-	23	13	-	-	2.94E-04	1.09E-03
BioPlex HCT116	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	99	-	-	4.88E-03	7.93E-03
BioPlex HCT116	BP	GO:1903035	negative regulation of response to wounding	-	93	47	-	-	5.95E-03	3.76E-03
BioPlex HCT116	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	15	-	-	3.92E-04	1.19E-03
BioPlex HCT116	BP	GO:0036010	protein localization to endosome	-	27	21	-	-	9.77E-02	1.68E-03
BioPlex HCT116	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	95	-	-	2.97E-02	7.53E-03
BioPlex HCT116	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	70	-	-	2.92E-03	5.55E-03
BioPlex HCT116	BP	GO:0045056	transcytosis	-	20	15	-	-	3.98E-03	1.19E-03
BioPlex HCT116	BP	GO:0018342	protein prenylation	-	15	12	-	-	1.49E-02	9.91E-04
BioPlex HCT116	BP	GO:0009267	cellular response to starvation	-	170	112	-	-	3.22E-02	8.92E-03
BioPlex HCT116	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	35	-	-	8.77E-03	2.77E-03
BioPlex HCT116	CC	GO:0140239	postsynaptic endocytosis	-	23	17	-	-	1.60E-02	1.39E-03
BioPlex HCT116	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	15	-	-	3.91E-04	1.19E-03
BioPlex HCT116	BP	GO:0046931	pore complex assembly	-	21	18	-	-	6.87E-02	1.49E-03
BioPlex HCT116	CC	GO:0032008	positive regulation of TOR signaling	-	52	43	-	-	1.30E-01	3.47E-03
BioPlex HCT116	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	24	-	-	7.63E-02	1.98E-03
BioPlex HCT116	BP	GO:0060428	lung epithelium development	-	43	24	-	-	1.34E-03	1.98E-03
BioPlex HCT116	BP	GO:0030431	sleep	-	30	13	-	-	2.96E-04	1.09E-03
BioPlex HCT116	BP	GO:1903318	negative regulation of protein maturation	-	29	17	-	-	1.61E-02	1.39E-03
BioPlex HCT116	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	78	-	-	2.14E-01	6.24E-03
BioPlex HCT116	BP	GO:0071732	cellular response to nitric oxide	-	17	11	-	-	2.18E-03	8.92E-04
BioPlex HCT116	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	27	-	-	2.11E-02	2.18E-03
BioPlex HCT116	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	36	-	-	1.72E-03	2.87E-03
BioPlex HCT116	BP	GO:0065004	protein-DNA complex assembly	-	307	205	-	-	1.15E-01	1.62E-02
BioPlex HCT116	CC	GO:0006406	mRNA export from nucleus	-	69	51	-	-	2.69E-01	4.06E-03
BioPlex HCT116	BP	GO:0009880	embryonic pattern specification	-	70	33	-	-	8.89E-04	2.68E-03
BioPlex HCT116	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	36	-	-	4.50E-01	2.87E-03
BioPlex HCT116	BP	GO:0043043	peptide biosynthetic process	-	25	15	-	-	1.84E-02	1.19E-03
BioPlex HCT116	BP	GO:0002367	cytokine production involved in immune response	-	121	65	-	-	9.52E-03	5.15E-03
BioPlex HCT116	BP	GO:0044848	biological phase	-	211	123	-	-	2.82E-02	9.81E-03
BioPlex HCT116	BP	GO:0046660	female sex differentiation	-	125	62	-	-	6.06E-03	4.95E-03
BioPlex HCT116	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	13	-	-	2.93E-04	1.09E-03
BioPlex HCT116	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	29	-	-	1.03E-02	2.38E-03
BioPlex HCT116	BP	GO:0060411	cardiac septum morphogenesis	-	72	39	-	-	3.10E-03	3.17E-03
BioPlex HCT116	BP	GO:0071248	cellular response to metal ion	-	201	107	-	-	7.69E-03	8.52E-03
BioPlex HCT116	BP	GO:0030308	negative regulation of cell growth	-	191	108	-	-	2.67E-03	8.62E-03
BioPlex HCT116	BP	GO:0097306	cellular response to alcohol	-	99	44	-	-	5.95E-03	3.57E-03
BioPlex HCT116	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	108	-	-	1.00E-01	8.62E-03
BioPlex HCT116	BP	GO:0010453	regulation of cell fate commitment	-	40	27	-	-	3.11E-02	2.18E-03
BioPlex HCT116	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	38	-	-	1.21E-02	3.07E-03
BioPlex HCT116	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	29	-	-	1.72E-02	2.38E-03
BioPlex HCT116	BP	GO:0002026	regulation of the force of heart contraction	-	26	15	-	-	3.92E-04	1.19E-03
BioPlex HCT116	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	13	-	-	2.93E-04	1.09E-03
BioPlex HCT116	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	32	-	-	5.17E-03	2.58E-03
BioPlex HCT116	BP	GO:0032890	regulation of organic acid transport	-	78	36	-	-	5.41E-03	2.87E-03
BioPlex HCT116	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	42	-	-	1.24E-03	3.37E-03
BioPlex HCT116	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	13	-	-	2.94E-04	1.09E-03
BioPlex HCT116	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	21	-	-	8.30E-03	1.68E-03
BioPlex HCT116	BP	GO:0051259	protein complex oligomerization	-	251	139	-	-	1.26E-02	1.11E-02
BioPlex HCT116	BP	GO:0009163	nucleoside biosynthetic process	-	16	11	-	-	2.96E-04	8.92E-04
BioPlex HCT116	BP	GO:0009994	oocyte differentiation	-	57	32	-	-	1.31E-03	2.58E-03
BioPlex HCT116	MF	GO:0031952	regulation of protein autophosphorylation	-	43	26	-	-	5.85E-04	2.08E-03
BioPlex HCT116	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	105	-	-	1.11E-02	8.32E-03
BioPlex HCT116	BP	GO:0044319	"wound healing, spreading of cells"	-	37	27	-	-	1.96E-02	2.18E-03
BioPlex HCT116	BP	GO:0033688	regulation of osteoblast proliferation	-	31	16	-	-	3.91E-04	1.29E-03
BioPlex HCT116	BP	GO:0060251	regulation of glial cell proliferation	-	39	20	-	-	4.88E-04	1.59E-03
BioPlex HCT116	BP	GO:0072665	protein localization to vacuole	-	84	67	-	-	5.13E-02	5.35E-03
BioPlex HCT116	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	30	-	-	1.58E-01	2.38E-03
BioPlex HCT116	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	17	-	-	3.92E-04	1.39E-03
BioPlex HCT116	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	44	-	-	2.66E-02	3.57E-03
BioPlex HCT116	BP	GO:0042044	fluid transport	-	35	12	-	-	2.91E-04	9.91E-04
BioPlex HCT116	BP	GO:0070633	transepithelial transport	-	35	14	-	-	2.55E-03	1.19E-03
BioPlex HCT116	BP	GO:0045661	regulation of myoblast differentiation	-	74	48	-	-	8.56E-02	3.86E-03
BioPlex HCT116	BP	GO:0030307	positive regulation of cell growth	-	164	103	-	-	4.69E-03	8.22E-03
BioPlex HCT116	BP	GO:0034250	positive regulation of amide metabolic process	-	27	21	-	-	7.62E-03	1.68E-03
BioPlex HCT116	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	195	-	-	1.00E-02	1.55E-02
BioPlex HCT116	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	11	-	-	2.94E-04	8.92E-04
BioPlex HCT116	BP	GO:0014812	muscle cell migration	-	110	45	-	-	2.06E-03	3.57E-03
BioPlex HCT116	BP	GO:0048525	negative regulation of viral process	-	90	53	-	-	3.76E-03	4.26E-03
BioPlex HCT116	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	52	-	-	2.02E-02	4.16E-03
BioPlex HCT116	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	112	-	-	4.30E-03	8.92E-03
BioPlex HCT116	BP	GO:0051781	positive regulation of cell division	-	93	47	-	-	1.89E-02	3.76E-03
BioPlex HCT116	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	13	-	-	2.95E-04	1.09E-03
BioPlex HCT116	BP	GO:0035493	SNARE complex assembly	-	23	21	-	-	8.63E-02	1.68E-03
BioPlex HCT116	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	16	-	-	8.49E-03	1.29E-03
BioPlex HCT116	BP	GO:0002696	positive regulation of leukocyte activation	-	358	193	-	-	1.68E-02	1.54E-02
BioPlex HCT116	BP	GO:0060711	labyrinthine layer development	-	47	34	-	-	2.16E-03	2.77E-03
BioPlex HCT116	BP	GO:0007272	ensheathment of neurons	-	146	84	-	-	5.67E-03	6.74E-03
BioPlex HCT116	CC	GO:0050806	positive regulation of synaptic transmission	-	171	73	-	-	3.55E-03	5.85E-03
BioPlex HCT116	BP	GO:0060021	roof of mouth development	-	91	46	-	-	5.44E-03	3.67E-03
BioPlex HCT116	BP	GO:0034504	protein localization to nucleus	-	312	238	-	-	1.15E-02	1.89E-02
BioPlex HCT116	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	25	-	-	8.86E-03	1.98E-03
BioPlex HCT116	BP	GO:0050819	negative regulation of coagulation	-	54	30	-	-	1.25E-02	2.38E-03
BioPlex HCT116	BP	GO:0017004	cytochrome complex assembly	-	40	26	-	-	3.05E-02	2.08E-03
BioPlex HCT116	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	56	-	-	3.25E-01	4.46E-03
BioPlex HCT116	BP	GO:0097212	lysosomal membrane organization	-	15	11	-	-	1.38E-01	8.92E-04
BioPlex HCT116	CC	GO:0050805	negative regulation of synaptic transmission	-	55	18	-	-	3.89E-04	1.49E-03
BioPlex HCT116	BP	GO:0043248	proteasome assembly	-	13	13	-	-	3.79E-02	1.09E-03
BioPlex HCT116	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	35	-	-	4.23E-03	2.77E-03
BioPlex HCT116	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	30	-	-	6.69E-04	2.38E-03
BioPlex HCT116	BP	GO:0016054	organic acid catabolic process	-	251	152	-	-	1.90E-02	1.21E-02
BioPlex HCT116	BP	GO:0050890	cognition	-	317	154	-	-	4.53E-03	1.23E-02
BioPlex HCT116	BP	GO:1900048	positive regulation of hemostasis	-	28	22	-	-	5.83E-03	1.78E-03
BioPlex HCT116	BP	GO:0065005	protein-lipid complex assembly	-	29	20	-	-	7.27E-03	1.59E-03
BioPlex HCT116	BP	GO:0008033	tRNA processing	-	136	110	-	-	1.41E-01	8.72E-03
BioPlex HCT116	BP	GO:0046661	male sex differentiation	-	171	93	-	-	6.44E-03	7.43E-03
BioPlex HCT116	BP	GO:0072520	seminiferous tubule development	-	15	11	-	-	2.94E-04	8.92E-04
BioPlex HCT116	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	11	-	-	2.95E-04	8.92E-04
BioPlex HCT116	BP	GO:0035188	hatching	-	27	13	-	-	2.94E-04	1.09E-03
BioPlex HCT116	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	59	-	-	5.29E-03	4.76E-03
BioPlex HCT116	BP	GO:1990778	protein localization to cell periphery	-	346	246	-	-	1.16E-02	1.95E-02
BioPlex HCT116	BP	GO:0090713	immunological memory process	-	18	11	-	-	1.41E-03	8.92E-04
BioPlex HCT116	BP	GO:0061326	renal tubule development	-	103	44	-	-	1.61E-03	3.57E-03
BioPlex HCT116	BP	GO:0051258	protein polymerization	-	280	185	-	-	1.62E-02	1.47E-02
BioPlex HCT116	BP	GO:0071985	multivesicular body sorting pathway	-	56	46	-	-	1.82E-01	3.67E-03
BioPlex HCT116	BP	GO:0006450	regulation of translational fidelity	-	18	15	-	-	5.17E-03	1.19E-03
BioPlex HCT116	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	11	-	-	2.91E-04	8.92E-04
BioPlex HCT116	BP	GO:0060325	face morphogenesis	-	31	15	-	-	3.89E-04	1.19E-03
BioPlex HCT116	BP	GO:0090559	regulation of membrane permeability	-	72	44	-	-	6.26E-02	3.57E-03
BioPlex HCT116	BP	GO:0031579	membrane raft organization	-	25	17	-	-	2.73E-02	1.39E-03
BioPlex HCT116	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	16	-	-	3.89E-04	1.29E-03
BioPlex HCT116	BP	GO:0046460	neutral lipid biosynthetic process	-	50	31	-	-	1.26E-02	2.48E-03
BioPlex HCT116	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	58	-	-	5.32E-03	4.66E-03
BioPlex HCT116	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	122	-	-	5.75E-03	9.71E-03
BioPlex HCT116	BP	GO:0002251	organ or tissue specific immune response	-	43	12	-	-	2.96E-04	9.91E-04
BioPlex HCT116	CC	GO:0048167	regulation of synaptic plasticity	-	210	90	-	-	2.34E-03	7.13E-03
BioPlex HCT116	BP	GO:1903708	positive regulation of hemopoiesis	-	184	106	-	-	1.40E-02	8.42E-03
BioPlex HCT116	BP	GO:1903008	organelle disassembly	-	154	121	-	-	1.70E-02	9.61E-03
BioPlex HCT116	BP	GO:0001709	cell fate determination	-	44	12	-	-	2.93E-04	9.91E-04
BioPlex HCT116	BP	GO:0051873	killing by host of symbiont cells	-	28	16	-	-	3.89E-04	1.29E-03
BioPlex HCT116	BP	GO:0045058	T cell selection	-	53	27	-	-	1.37E-03	2.18E-03
BioPlex HCT116	CC	GO:0032387	negative regulation of intracellular transport	-	51	29	-	-	2.81E-03	2.38E-03
BioPlex HCT116	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	15	-	-	5.22E-03	1.19E-03
BioPlex HCT116	BP	GO:0072091	regulation of stem cell proliferation	-	91	49	-	-	9.56E-04	3.96E-03
BioPlex HCT116	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	27	-	-	3.18E-03	2.18E-03
BioPlex HCT116	BP	GO:0099084	postsynaptic specialization organization	-	44	14	-	-	2.94E-04	1.19E-03
BioPlex HCT116	BP	GO:0071501	cellular response to sterol depletion	-	15	12	-	-	2.72E-02	9.91E-04
BioPlex HCT116	BP	GO:0060384	innervation	-	27	11	-	-	1.95E-02	8.92E-04
BioPlex HCT116	BP	GO:0032535	regulation of cellular component size	-	360	212	-	-	1.59E-02	1.68E-02
BioPlex HCT116	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	17	-	-	3.90E-04	1.39E-03
BioPlex HCT116	MF	GO:0031281	positive regulation of cyclase activity	-	40	15	-	-	5.50E-03	1.19E-03
BioPlex HCT116	MF	GO:0098631	cell adhesion mediator activity	-	64	39	-	-	3.37E-03	3.17E-03
BioPlex HCT116	BP	GO:0046112	nucleobase biosynthetic process	-	18	15	-	-	3.92E-04	1.19E-03
BioPlex HCT116	BP	GO:0071453	cellular response to oxygen levels	-	168	97	-	-	9.23E-03	7.73E-03
BioPlex HCT116	BP	GO:0031342	negative regulation of cell killing	-	29	21	-	-	3.16E-03	1.68E-03
BioPlex HCT116	BP	GO:0070585	protein localization to mitochondrion	-	125	94	-	-	2.72E-02	7.53E-03
BioPlex HCT116	BP	GO:0010623	programmed cell death involved in cell development	-	25	16	-	-	1.45E-02	1.29E-03
BioPlex HCT116	BP	GO:0044242	cellular lipid catabolic process	-	224	144	-	-	9.25E-03	1.15E-02
BioPlex HCT116	BP	GO:0002931	response to ischemia	-	58	32	-	-	6.69E-04	2.58E-03
BioPlex HCT116	BP	GO:0043062	extracellular structure organization	-	317	154	-	-	2.25E-02	1.23E-02
BioPlex HCT116	BP	GO:0014047	glutamate secretion	-	25	11	-	-	2.95E-04	8.92E-04
BioPlex HCT116	BP	GO:0061005	cell differentiation involved in kidney development	-	58	26	-	-	7.86E-04	2.08E-03
BioPlex HCT116	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	26	-	-	5.69E-04	2.08E-03
BioPlex HCT116	BP	GO:0060420	regulation of heart growth	-	74	36	-	-	1.79E-03	2.87E-03
BioPlex HCT116	BP	GO:0009755	hormone-mediated signaling pathway	-	221	119	-	-	5.07E-03	9.51E-03
BioPlex HCT116	BP	GO:0022612	gland morphogenesis	-	124	57	-	-	1.47E-02	4.56E-03
BioPlex HCT116	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	25	-	-	1.50E-02	1.98E-03
BioPlex HCT116	MF	GO:0140416	transcription regulator inhibitor activity	-	26	17	-	-	6.50E-03	1.39E-03
BioPlex HCT116	BP	GO:0044782	cilium organization	-	400	218	-	-	8.55E-02	1.73E-02
BioPlex HCT116	BP	GO:0090130	tissue migration	-	379	182	-	-	1.37E-02	1.45E-02
BioPlex HCT116	BP	GO:1990845	adaptive thermogenesis	-	166	94	-	-	8.56E-03	7.53E-03
BioPlex HCT116	BP	GO:0071320	cellular response to cAMP	-	54	27	-	-	1.37E-03	2.18E-03
BioPlex HCT116	BP	GO:0015844	monoamine transport	-	88	40	-	-	4.09E-02	3.17E-03
BioPlex HCT116	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	17	-	-	1.79E-03	1.39E-03
BioPlex HCT116	BP	GO:0060039	pericardium development	-	19	12	-	-	2.96E-04	9.91E-04
BioPlex HCT116	BP	GO:0071392	cellular response to estradiol stimulus	-	40	22	-	-	1.93E-03	1.78E-03
BioPlex HCT116	BP	GO:0000272	polysaccharide catabolic process	-	19	15	-	-	3.74E-01	1.19E-03
BioPlex HCT116	BP	GO:0009451	RNA modification	-	169	123	-	-	5.29E-02	9.81E-03
BioPlex HCT116	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	25	-	-	5.83E-04	1.98E-03
BioPlex HCT116	BP	GO:1903729	regulation of plasma membrane organization	-	17	14	-	-	2.96E-04	1.19E-03
BioPlex HCT116	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	79	-	-	1.48E-02	6.34E-03
BioPlex HCT116	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	24	-	-	4.79E-03	1.98E-03
BioPlex HCT116	BP	GO:0015807	L-amino acid transport	-	94	46	-	-	2.09E-03	3.67E-03
BioPlex HCT116	BP	GO:0032941	secretion by tissue	-	85	50	-	-	3.66E-03	3.96E-03
BioPlex HCT116	BP	GO:0046605	regulation of centrosome cycle	-	54	36	-	-	3.12E-03	2.87E-03
BioPlex HCT116	BP	GO:0048753	pigment granule organization	-	40	32	-	-	9.97E-02	2.58E-03
BioPlex HCT116	BP	GO:0003014	renal system process	-	130	63	-	-	2.59E-03	5.05E-03
BioPlex HCT116	CC	GO:0070286	axonemal dynein complex assembly	-	40	12	-	-	3.28E-03	9.91E-04
BioPlex HCT116	BP	GO:0045598	regulation of fat cell differentiation	-	148	70	-	-	2.08E-03	5.55E-03
BioPlex HCT116	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	120	-	-	4.82E-03	9.51E-03
BioPlex HCT116	BP	GO:1904646	cellular response to amyloid-beta	-	44	20	-	-	8.78E-04	1.59E-03
BioPlex HCT116	BP	GO:1901863	positive regulation of muscle tissue development	-	24	16	-	-	3.92E-04	1.29E-03
BioPlex HCT116	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	77	-	-	2.63E-02	6.14E-03
BioPlex HCT116	BP	GO:0008340	determination of adult lifespan	-	23	14	-	-	2.53E-02	1.19E-03
BioPlex HCT116	BP	GO:0018158	protein oxidation	-	15	12	-	-	2.92E-04	9.91E-04
BioPlex HCT116	BP	GO:0039694	viral RNA genome replication	-	30	21	-	-	3.65E-03	1.68E-03
BioPlex HCT116	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	17	-	-	1.18E-02	1.39E-03
BioPlex HCT116	BP	GO:0071709	membrane assembly	-	68	47	-	-	3.78E-02	3.76E-03
BioPlex HCT116	BP	GO:0008217	regulation of blood pressure	-	186	85	-	-	1.99E-03	6.74E-03
BioPlex HCT116	BP	GO:0031643	positive regulation of myelination	-	19	12	-	-	2.95E-04	9.91E-04
BioPlex HCT116	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	27	-	-	2.75E-03	2.18E-03
BioPlex HCT116	CC	GO:0042770	signal transduction in response to DNA damage	-	186	121	-	-	1.92E-02	9.61E-03
BioPlex HCT116	BP	GO:0002200	somatic diversification of immune receptors	-	78	43	-	-	1.16E-02	3.47E-03
BioPlex HCT116	BP	GO:0035315	hair cell differentiation	-	52	27	-	-	5.82E-04	2.18E-03
BioPlex HCT116	BP	GO:0048645	animal organ formation	-	62	29	-	-	5.22E-03	2.38E-03
BioPlex HCT116	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	100	-	-	1.51E-02	7.93E-03
BioPlex HCT116	BP	GO:0033627	cell adhesion mediated by integrin	-	87	50	-	-	5.23E-03	3.96E-03
BioPlex HCT116	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	20	-	-	8.93E-03	1.59E-03
BioPlex HCT116	BP	GO:0035107	appendage morphogenesis	-	147	82	-	-	4.77E-03	6.54E-03
BioPlex HCT116	BP	GO:1903707	negative regulation of hemopoiesis	-	116	54	-	-	8.66E-03	4.36E-03
BioPlex HCT116	BP	GO:0036342	post-anal tail morphogenesis	-	19	11	-	-	2.94E-04	8.92E-04
BioPlex HCT116	CC	GO:0048208	COPII vesicle coating	-	27	24	-	-	3.14E-01	1.98E-03
BioPlex HCT116	BP	GO:0030149	sphingolipid catabolic process	-	32	21	-	-	2.96E-02	1.68E-03
BioPlex HCT116	BP	GO:0050994	regulation of lipid catabolic process	-	61	30	-	-	1.13E-02	2.38E-03
BioPlex HCT116	BP	GO:0009593	detection of chemical stimulus	-	511	34	-	-	1.22E-03	2.77E-03
BioPlex HCT116	BP	GO:0045727	positive regulation of translation	-	141	96	-	-	1.57E-02	7.63E-03
BioPlex HCT116	CC	GO:0032388	positive regulation of intracellular transport	-	137	95	-	-	2.47E-03	7.53E-03
BioPlex HCT116	BP	GO:0002027	regulation of heart rate	-	106	49	-	-	4.12E-03	3.96E-03
BioPlex HCT116	BP	GO:0050879	multicellular organismal movement	-	118	63	-	-	1.30E-02	5.05E-03
BioPlex HCT116	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	45	-	-	1.54E-03	3.57E-03
BioPlex HCT116	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	37	-	-	3.97E-03	2.97E-03
BioPlex HCT116	BP	GO:0048515	spermatid differentiation	-	208	97	-	-	2.62E-03	7.73E-03
BioPlex HCT116	BP	GO:0072132	mesenchyme morphogenesis	-	57	33	-	-	2.81E-03	2.68E-03
BioPlex HCT116	MF	GO:0042887	amide transmembrane transporter activity	-	33	18	-	-	3.88E-04	1.49E-03
BioPlex HCT116	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	24	-	-	1.65E-02	1.98E-03
BioPlex HCT116	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	19	-	-	3.89E-04	1.59E-03
BioPlex HCT116	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	19	-	-	2.99E-03	1.59E-03
BioPlex HCT116	BP	GO:0060119	inner ear receptor cell development	-	44	22	-	-	2.53E-03	1.78E-03
BioPlex HCT116	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	12	-	-	2.93E-04	9.91E-04
BioPlex HCT116	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	14	-	-	2.95E-04	1.19E-03
BioPlex HCT116	BP	GO:1901983	regulation of protein acetylation	-	26	19	-	-	3.93E-04	1.59E-03
BioPlex HCT116	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	149	-	-	6.83E-03	1.19E-02
BioPlex HCT116	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	40	-	-	1.68E-01	3.17E-03
BioPlex HCT116	BP	GO:0010883	regulation of lipid storage	-	53	29	-	-	5.82E-04	2.38E-03
BioPlex HCT116	BP	GO:1905954	positive regulation of lipid localization	-	110	56	-	-	2.83E-03	4.46E-03
BioPlex HCT116	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.91E-03	9.91E-04
BioPlex HCT116	BP	GO:0002209	behavioral defense response	-	39	25	-	-	8.65E-03	1.98E-03
BioPlex HCT116	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	20	-	-	4.90E-04	1.59E-03
BioPlex HCT116	BP	GO:0072523	purine-containing compound catabolic process	-	146	97	-	-	3.28E-02	7.73E-03
BioPlex HCT116	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	26	-	-	2.00E-02	2.08E-03
BioPlex HCT116	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	18	-	-	2.52E-03	1.49E-03
BioPlex HCT116	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	67	-	-	4.65E-02	5.35E-03
BioPlex HCT116	BP	GO:0007218	neuropeptide signaling pathway	-	113	33	-	-	4.69E-03	2.68E-03
BioPlex HCT116	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	64	-	-	2.84E-03	5.15E-03
BioPlex HCT116	BP	GO:0031345	negative regulation of cell projection organization	-	195	110	-	-	5.13E-03	8.72E-03
BioPlex HCT116	BP	GO:0048278	vesicle docking	-	64	55	-	-	9.59E-02	4.36E-03
BioPlex HCT116	BP	GO:0035050	embryonic heart tube development	-	86	45	-	-	9.08E-03	3.57E-03
BioPlex HCT116	BP	GO:0030168	platelet activation	-	135	74	-	-	2.30E-03	5.94E-03
BioPlex HCT116	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	11	-	-	2.96E-04	8.92E-04
BioPlex HCT116	CC	GO:0098810	neurotransmitter reuptake	-	35	14	-	-	2.96E-04	1.19E-03
BioPlex HCT116	BP	GO:0008213	protein alkylation	-	58	41	-	-	1.20E-03	3.27E-03
BioPlex HCT116	BP	GO:0031338	regulation of vesicle fusion	-	24	20	-	-	2.92E-02	1.59E-03
BioPlex HCT116	BP	GO:0031529	ruffle organization	-	55	34	-	-	6.80E-04	2.77E-03
BioPlex HCT116	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	47	-	-	1.02E-02	3.76E-03
BioPlex HCT116	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	36	-	-	4.01E-03	2.87E-03
BioPlex HCT116	MF	GO:0170055	lipid transmembrane transporter activity	-	56	23	-	-	2.74E-03	1.88E-03
BioPlex HCT116	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	23	-	-	1.13E-03	1.88E-03
BioPlex HCT116	BP	GO:0035304	regulation of protein dephosphorylation	-	87	61	-	-	2.43E-03	4.85E-03
BioPlex HCT116	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	129	-	-	4.27E-03	1.03E-02
BioPlex HCT116	BP	GO:0099637	neurotransmitter receptor transport	-	26	18	-	-	3.87E-04	1.49E-03
BioPlex HCT116	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	17	-	-	3.93E-04	1.39E-03
BioPlex HCT116	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	235	-	-	6.89E-03	1.86E-02
BioPlex HCT116	BP	GO:0051785	positive regulation of nuclear division	-	61	32	-	-	7.36E-03	2.58E-03
BioPlex HCT116	BP	GO:0044786	cell cycle DNA replication	-	45	34	-	-	3.14E-02	2.77E-03
BioPlex HCT116	BP	GO:0044539	long-chain fatty acid import into cell	-	17	11	-	-	5.65E-02	8.92E-04
BioPlex HCT116	BP	GO:0051299	centrosome separation	-	15	12	-	-	2.59E-02	9.91E-04
BioPlex HCT116	BP	GO:0048145	regulation of fibroblast proliferation	-	87	54	-	-	2.45E-03	4.36E-03
BioPlex HCT116	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	26	-	-	4.34E-03	2.08E-03
BioPlex HCT116	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	150	-	-	1.02E-02	1.19E-02
BioPlex HCT116	BP	GO:0009306	protein secretion	-	376	206	-	-	7.96E-03	1.63E-02
BioPlex HCT116	CC	GO:0008333	endosome to lysosome transport	-	73	58	-	-	4.59E-02	4.66E-03
BioPlex HCT116	BP	GO:0003016	respiratory system process	-	39	24	-	-	1.96E-03	1.98E-03
BioPlex HCT116	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	11	-	-	2.92E-04	8.92E-04
BioPlex HCT116	BP	GO:0045732	positive regulation of protein catabolic process	-	202	136	-	-	1.50E-02	1.08E-02
BioPlex HCT116	BP	GO:0031589	cell-substrate adhesion	-	360	209	-	-	1.82E-02	1.66E-02
BioPlex HCT116	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	35	-	-	1.57E-02	2.77E-03
BioPlex HCT116	BP	GO:0007588	excretion	-	40	17	-	-	3.92E-04	1.39E-03
BioPlex HCT116	BP	GO:1904018	positive regulation of vasculature development	-	185	84	-	-	3.48E-03	6.74E-03
BioPlex HCT116	BP	GO:0010948	negative regulation of cell cycle process	-	317	209	-	-	1.86E-02	1.66E-02
BioPlex HCT116	BP	GO:0050953	sensory perception of light stimulus	-	223	85	-	-	4.61E-03	6.74E-03
BioPlex HCT116	BP	GO:0009164	nucleoside catabolic process	-	25	13	-	-	6.13E-03	1.09E-03
BioPlex HCT116	BP	GO:0009303	rRNA transcription	-	37	31	-	-	2.91E-02	2.48E-03
BioPlex HCT116	BP	GO:0035601	protein deacylation	-	56	41	-	-	9.21E-02	3.27E-03
BioPlex HCT116	BP	GO:0061952	midbody abscission	-	18	14	-	-	8.54E-02	1.19E-03
BioPlex HCT116	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	15	-	-	3.93E-04	1.19E-03
BioPlex HCT116	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	18	-	-	3.91E-04	1.49E-03
BioPlex HCT116	BP	GO:0071300	cellular response to retinoic acid	-	66	35	-	-	2.58E-03	2.77E-03
BioPlex HCT116	BP	GO:0045830	positive regulation of isotype switching	-	28	15	-	-	4.50E-03	1.19E-03
BioPlex HCT116	BP	GO:0031069	hair follicle morphogenesis	-	33	11	-	-	2.55E-03	8.92E-04
BioPlex HCT116	BP	GO:0046697	decidualization	-	26	15	-	-	2.42E-03	1.19E-03
BioPlex HCT116	BP	GO:0051588	regulation of neurotransmitter transport	-	99	58	-	-	6.26E-03	4.66E-03
BioPlex HCT116	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	21	-	-	2.70E-03	1.68E-03
BioPlex HCT116	BP	GO:0051784	negative regulation of nuclear division	-	63	50	-	-	6.51E-02	3.96E-03
BioPlex HCT116	BP	GO:0044703	multi-organism reproductive process	-	209	111	-	-	2.74E-03	8.82E-03
BioPlex HCT116	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	100	-	-	7.44E-03	7.93E-03
BioPlex HCT116	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	22	-	-	1.44E-02	1.78E-03
BioPlex HCT116	BP	GO:0099022	vesicle tethering	-	32	32	-	-	5.13E-01	2.58E-03
BioPlex HCT116	MF	GO:0004930	G protein-coupled receptor activity	-	873	112	-	-	3.70E-03	8.92E-03
BioPlex HCT116	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	18	-	-	3.92E-04	1.49E-03
BioPlex HCT116	BP	GO:0048857	neural nucleus development	-	65	38	-	-	9.11E-04	3.07E-03
BioPlex HCT116	BP	GO:0048663	neuron fate commitment	-	74	26	-	-	1.42E-03	2.08E-03
BioPlex HCT116	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	69	-	-	4.50E-03	5.55E-03
BioPlex HCT116	BP	GO:0106027	neuron projection organization	-	90	57	-	-	5.46E-03	4.56E-03
BioPlex HCT116	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	64	-	-	3.70E-03	5.15E-03
BioPlex HCT116	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	28	-	-	1.25E-03	2.28E-03
BioPlex HCT116	BP	GO:0045685	regulation of glial cell differentiation	-	77	33	-	-	1.20E-03	2.68E-03
BioPlex HCT116	BP	GO:0043414	macromolecule methylation	-	138	97	-	-	1.02E-02	7.73E-03
BioPlex HCT116	BP	GO:0048268	clathrin coat assembly	-	16	13	-	-	2.83E-02	1.09E-03
BioPlex HCT116	BP	GO:0050886	endocrine process	-	93	43	-	-	1.74E-03	3.47E-03
BioPlex HCT116	BP	GO:0045807	positive regulation of endocytosis	-	155	100	-	-	7.03E-03	7.93E-03
BioPlex HCT116	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	7.06E-03	8.92E-04
BioPlex HCT116	BP	GO:0002418	immune response to tumor cell	-	29	19	-	-	4.29E-03	1.59E-03
BioPlex HCT116	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	46	-	-	1.10E-02	3.67E-03
BioPlex HCT116	BP	GO:0048308	organelle inheritance	-	14	13	-	-	5.76E-03	1.09E-03
BioPlex HCT116	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	12	-	-	2.88E-04	9.91E-04
BioPlex HCT116	BP	GO:0001829	trophectodermal cell differentiation	-	19	13	-	-	2.66E-02	1.09E-03
BioPlex HCT116	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	28	-	-	8.46E-03	2.28E-03
BioPlex HCT116	BP	GO:0034394	protein localization to cell surface	-	69	47	-	-	3.54E-03	3.76E-03
BioPlex HCT116	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	17	-	-	2.07E-01	1.39E-03
BioPlex HCT116	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	16	-	-	5.23E-02	1.29E-03
BioPlex HCT116	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	57	-	-	3.30E-03	4.56E-03
BioPlex HCT116	MF	GO:0051100	negative regulation of binding	-	161	106	-	-	2.84E-03	8.42E-03
BioPlex HCT116	BP	GO:0001818	negative regulation of cytokine production	-	379	159	-	-	5.24E-03	1.27E-02
BioPlex HCT116	BP	GO:0003151	outflow tract morphogenesis	-	81	39	-	-	7.94E-03	3.17E-03
BioPlex HCT116	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	43	-	-	5.92E-03	3.47E-03
BioPlex HCT116	BP	GO:0061036	positive regulation of cartilage development	-	33	12	-	-	2.94E-04	9.91E-04
BioPlex HCT116	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	29	-	-	5.85E-04	2.38E-03
BioPlex HCT116	BP	GO:0046621	negative regulation of organ growth	-	39	19	-	-	8.41E-03	1.59E-03
BioPlex HCT116	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	46	-	-	2.83E-01	3.67E-03
BioPlex HCT116	BP	GO:0032368	regulation of lipid transport	-	149	72	-	-	4.25E-03	5.75E-03
BioPlex HCT116	BP	GO:0055094	response to lipoprotein particle	-	34	16	-	-	3.93E-04	1.29E-03
BioPlex HCT116	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	114	-	-	1.35E-02	9.12E-03
BioPlex HCT116	BP	GO:0033002	muscle cell proliferation	-	249	116	-	-	3.84E-03	9.21E-03
BioPlex HCT116	BP	GO:0048880	sensory system development	-	399	200	-	-	1.59E-02	1.59E-02
BioPlex HCT116	BP	GO:0043331	response to dsRNA	-	56	38	-	-	3.60E-02	3.07E-03
BioPlex HCT116	BP	GO:0051904	pigment granule transport	-	23	18	-	-	5.16E-02	1.49E-03
BioPlex HCT116	BP	GO:1901679	nucleotide transmembrane transport	-	32	23	-	-	1.38E-02	1.88E-03
BioPlex HCT116	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	18	-	-	1.24E-03	1.49E-03
BioPlex HCT116	BP	GO:0033363	secretory granule organization	-	63	41	-	-	2.61E-02	3.27E-03
BioPlex HCT116	BP	GO:0060479	lung cell differentiation	-	28	16	-	-	3.93E-04	1.29E-03
BioPlex HCT116	BP	GO:0120009	intermembrane lipid transfer	-	52	32	-	-	7.88E-02	2.58E-03
BioPlex HCT116	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	8.35E-02	1.19E-03
BioPlex HCT116	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	19	-	-	3.90E-04	1.59E-03
BioPlex HCT116	BP	GO:0033622	integrin activation	-	26	17	-	-	3.11E-03	1.39E-03
BioPlex HCT116	BP	GO:0098751	bone cell development	-	18	12	-	-	2.93E-04	9.91E-04
BioPlex HCT116	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	23	-	-	4.89E-04	1.88E-03
BioPlex HCT116	BP	GO:0050820	positive regulation of coagulation	-	30	24	-	-	4.87E-04	1.98E-03
BioPlex HCT116	BP	GO:0072164	mesonephric tubule development	-	98	45	-	-	8.06E-03	3.57E-03
BioPlex HCT116	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	65	-	-	4.72E-03	5.15E-03
BioPlex HCT116	BP	GO:1903524	positive regulation of blood circulation	-	39	16	-	-	3.87E-04	1.29E-03
BioPlex HCT116	BP	GO:0030901	midbrain development	-	87	52	-	-	3.02E-03	4.16E-03
BioPlex HCT116	BP	GO:0007162	negative regulation of cell adhesion	-	310	160	-	-	8.05E-03	1.27E-02
BioPlex HCT116	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	35	-	-	3.17E-03	2.77E-03
BioPlex HCT116	BP	GO:0002687	positive regulation of leukocyte migration	-	147	70	-	-	3.51E-03	5.55E-03
BioPlex HCT116	BP	GO:0110154	RNA decapping	-	19	15	-	-	1.72E-01	1.19E-03
BioPlex HCT116	BP	GO:0034605	cellular response to heat	-	66	49	-	-	2.14E-03	3.96E-03
BioPlex HCT116	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	189	-	-	2.78E-02	1.51E-02
BioPlex HCT116	BP	GO:0005996	monosaccharide metabolic process	-	250	149	-	-	6.46E-03	1.19E-02
BioPlex HCT116	BP	GO:0033555	multicellular organismal response to stress	-	90	43	-	-	3.77E-03	3.47E-03
BioPlex HCT116	BP	GO:0002262	myeloid cell homeostasis	-	172	106	-	-	3.51E-03	8.42E-03
BioPlex HCT116	BP	GO:0000966	RNA 5'-end processing	-	39	37	-	-	1.27E-01	2.97E-03
BioPlex HCT116	BP	GO:0050688	regulation of defense response to virus	-	65	39	-	-	1.77E-03	3.17E-03
BioPlex HCT116	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	203	-	-	8.09E-03	1.61E-02
BioPlex HCT116	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	16	-	-	1.98E-02	1.29E-03
BioPlex HCT116	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	140	-	-	1.39E-02	1.11E-02
BioPlex HCT116	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	14	-	-	7.92E-03	1.19E-03
BioPlex HCT116	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	17	-	-	3.93E-04	1.39E-03
BioPlex HCT116	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	11	-	-	2.95E-04	8.92E-04
BioPlex HCT116	BP	GO:0003272	endocardial cushion formation	-	28	14	-	-	1.11E-02	1.19E-03
BioPlex HCT116	BP	GO:0022618	protein-RNA complex assembly	-	227	171	-	-	1.40E-01	1.36E-02
BioPlex HCT116	BP	GO:0051147	regulation of muscle cell differentiation	-	162	78	-	-	4.42E-03	6.24E-03
BioPlex HCT116	BP	GO:0006066	alcohol metabolic process	-	374	212	-	-	2.42E-02	1.68E-02
BioPlex HCT116	BP	GO:0090102	cochlea development	-	50	21	-	-	4.20E-03	1.68E-03
BioPlex HCT116	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	17	-	-	7.17E-03	1.39E-03
BioPlex HCT116	BP	GO:0045933	positive regulation of muscle contraction	-	49	18	-	-	3.90E-04	1.49E-03
BioPlex HCT116	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	28	-	-	9.81E-04	2.28E-03
BioPlex HCT116	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	38	-	-	6.72E-02	3.07E-03
BioPlex HCT116	BP	GO:0043555	regulation of translation in response to stress	-	22	19	-	-	1.55E-03	1.59E-03
BioPlex HCT116	BP	GO:0032922	circadian regulation of gene expression	-	71	56	-	-	4.65E-02	4.46E-03
BioPlex HCT116	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	43	-	-	8.70E-04	3.47E-03
BioPlex HCT116	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	34	-	-	1.56E-02	2.77E-03
BioPlex HCT116	BP	GO:0038179	neurotrophin signaling pathway	-	38	20	-	-	1.32E-02	1.59E-03
BioPlex HCT116	BP	GO:0140253	cell-cell fusion	-	62	27	-	-	2.13E-03	2.18E-03
BioPlex HCT116	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	28	-	-	5.87E-04	2.28E-03
BioPlex HCT116	BP	GO:0061635	regulation of protein complex stability	-	14	11	-	-	1.01E-03	8.92E-04
BioPlex HCT116	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	39	-	-	2.98E-02	3.17E-03
BioPlex HCT116	BP	GO:0001941	postsynaptic membrane organization	-	37	17	-	-	4.18E-02	1.39E-03
BioPlex HCT116	BP	GO:0051293	establishment of spindle localization	-	57	37	-	-	1.27E-02	2.97E-03
BioPlex HCT116	BP	GO:0023061	signal release	-	491	248	-	-	9.73E-03	1.97E-02
BioPlex HCT116	BP	GO:0043114	regulation of vascular permeability	-	49	23	-	-	4.87E-04	1.88E-03
BioPlex HCT116	BP	GO:0018126	protein hydroxylation	-	26	21	-	-	1.82E-02	1.68E-03
BioPlex HCT116	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	37	-	-	9.70E-04	2.97E-03
BioPlex HCT116	BP	GO:0008360	regulation of cell shape	-	139	83	-	-	1.16E-02	6.64E-03
BioPlex HCT116	BP	GO:0051222	positive regulation of protein transport	-	249	146	-	-	3.79E-03	1.16E-02
BioPlex HCT116	CC	GO:0140632	canonical inflammasome complex assembly	-	40	24	-	-	5.07E-03	1.98E-03
BioPlex HCT116	MF	GO:0034260	negative regulation of GTPase activity	-	36	21	-	-	4.88E-04	1.68E-03
BioPlex HCT116	BP	GO:0045932	negative regulation of muscle contraction	-	24	11	-	-	2.96E-04	8.92E-04
BioPlex HCT116	BP	GO:0045739	positive regulation of DNA repair	-	128	98	-	-	1.81E-01	7.83E-03
BioPlex HCT116	BP	GO:0001845	phagolysosome assembly	-	19	12	-	-	2.95E-04	9.91E-04
BioPlex HCT116	BP	GO:0045185	maintenance of protein location	-	95	61	-	-	1.74E-03	4.85E-03
BioPlex HCT116	BP	GO:0003158	endothelium development	-	140	69	-	-	7.92E-03	5.55E-03
BioPlex HCT116	CC	GO:0072595	maintenance of protein localization in organelle	-	42	31	-	-	1.40E-03	2.48E-03
BioPlex HCT116	BP	GO:0051224	negative regulation of protein transport	-	122	56	-	-	1.55E-03	4.46E-03
BioPlex HCT116	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	75	-	-	2.68E-03	5.94E-03
BioPlex HCT116	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	11	-	-	1.46E-02	8.92E-04
BioPlex HCT116	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	14	-	-	2.94E-04	1.19E-03
BioPlex HCT116	MF	GO:0003713	transcription coactivator activity	-	281	194	-	-	2.45E-02	1.55E-02
BioPlex HCT116	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	14	-	-	1.65E-02	1.19E-03
BioPlex HCT116	BP	GO:0021885	forebrain cell migration	-	63	32	-	-	9.15E-03	2.58E-03
BioPlex HCT116	BP	GO:0007405	neuroblast proliferation	-	81	36	-	-	2.13E-03	2.87E-03
BioPlex HCT116	BP	GO:0009581	detection of external stimulus	-	137	48	-	-	1.44E-03	3.86E-03
BioPlex HCT116	BP	GO:1990542	mitochondrial transmembrane transport	-	93	64	-	-	6.78E-03	5.15E-03
BioPlex HCT116	BP	GO:0045862	positive regulation of proteolysis	-	353	227	-	-	1.05E-02	1.80E-02
BioPlex HCT116	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	27	-	-	3.46E-03	2.18E-03
BioPlex HCT116	BP	GO:0097186	amelogenesis	-	26	11	-	-	2.92E-04	8.92E-04
BioPlex HCT116	BP	GO:0031100	animal organ regeneration	-	66	40	-	-	3.35E-03	3.17E-03
BioPlex HCT116	BP	GO:0045684	positive regulation of epidermis development	-	33	22	-	-	6.55E-03	1.78E-03
BioPlex HCT116	BP	GO:1900047	negative regulation of hemostasis	-	51	29	-	-	8.00E-03	2.38E-03
BioPlex HCT116	BP	GO:0021517	ventral spinal cord development	-	47	18	-	-	3.85E-04	1.49E-03
BioPlex HCT116	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	57	-	-	2.05E-02	4.56E-03
BioPlex HCT116	MF	GO:0034497	protein localization to phagophore assembly site	-	16	13	-	-	2.95E-04	1.09E-03
BioPlex HCT116	BP	GO:0097722	sperm motility	-	133	47	-	-	4.35E-03	3.76E-03
BioPlex HCT116	BP	GO:0042490	mechanoreceptor differentiation	-	67	34	-	-	1.91E-03	2.77E-03
BioPlex HCT116	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	20	-	-	4.84E-04	1.59E-03
BioPlex HCT116	BP	GO:0035148	tube formation	-	155	103	-	-	6.24E-03	8.22E-03
BioPlex HCT116	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	37	-	-	9.62E-02	2.97E-03
BioPlex HCT116	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	69	-	-	1.73E-03	5.55E-03
BioPlex HCT116	BP	GO:0031123	RNA 3'-end processing	-	79	65	-	-	9.14E-02	5.15E-03
BioPlex HCT116	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	57	-	-	8.13E-03	4.56E-03
BioPlex HCT116	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	14	-	-	9.19E-02	1.19E-03
BioPlex HCT116	CC	GO:0007097	nuclear migration	-	24	18	-	-	7.43E-03	1.49E-03
BioPlex HCT116	BP	GO:0045229	external encapsulating structure organization	-	319	157	-	-	2.30E-02	1.25E-02
BioPlex HCT116	BP	GO:0006885	regulation of pH	-	104	66	-	-	5.49E-02	5.25E-03
BioPlex HCT116	BP	GO:1990840	response to lectin	-	22	15	-	-	3.88E-04	1.19E-03
BioPlex HCT116	BP	GO:0071800	podosome assembly	-	19	13	-	-	2.94E-04	1.09E-03
BioPlex HCT116	BP	GO:0031018	endocrine pancreas development	-	47	24	-	-	1.34E-03	1.98E-03
BioPlex HCT116	BP	GO:0001708	cell fate specification	-	108	46	-	-	1.67E-02	3.67E-03
BioPlex HCT116	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	35	-	-	7.73E-04	2.77E-03
BioPlex HCT116	BP	GO:0030279	negative regulation of ossification	-	39	22	-	-	4.78E-04	1.78E-03
BioPlex HCT116	BP	GO:0032970	regulation of actin filament-based process	-	368	222	-	-	2.97E-02	1.76E-02
BioPlex HCT116	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	13	-	-	2.36E-03	1.09E-03
BioPlex HCT116	BP	GO:0042440	pigment metabolic process	-	80	41	-	-	5.73E-03	3.27E-03
BioPlex HCT116	BP	GO:1901606	alpha-amino acid catabolic process	-	101	55	-	-	5.03E-03	4.36E-03
BioPlex HCT116	BP	GO:0062197	cellular response to chemical stress	-	299	188	-	-	4.82E-03	1.50E-02
BioPlex HCT116	BP	GO:1901890	positive regulation of cell junction assembly	-	106	45	-	-	2.93E-03	3.57E-03
BioPlex HCT116	BP	GO:0070988	demethylation	-	27	20	-	-	3.38E-02	1.59E-03
BioPlex HCT116	BP	GO:1901655	cellular response to ketone	-	107	58	-	-	2.45E-03	4.66E-03
BioPlex HCT116	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	15	-	-	8.24E-02	1.19E-03
BioPlex HCT116	BP	GO:0006968	cellular defense response	-	52	26	-	-	9.07E-04	2.08E-03
BioPlex HCT116	BP	GO:0055006	cardiac cell development	-	93	46	-	-	1.52E-03	3.67E-03
BioPlex HCT116	BP	GO:0031365	N-terminal protein amino acid modification	-	30	23	-	-	7.75E-02	1.88E-03
BioPlex HCT116	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	17	-	-	1.19E-03	1.39E-03
BioPlex HCT116	BP	GO:0060004	reflex	-	63	31	-	-	4.95E-03	2.48E-03
BioPlex HCT116	BP	GO:0044706	multi-multicellular organism process	-	217	117	-	-	2.88E-03	9.31E-03
BioPlex HCT116	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	99	-	-	2.38E-02	7.93E-03
BioPlex HCT116	BP	GO:0006026	aminoglycan catabolic process	-	34	25	-	-	2.24E-02	1.98E-03
BioPlex HCT116	BP	GO:0031294	lymphocyte costimulation	-	47	23	-	-	6.80E-04	1.88E-03
BioPlex HCT116	BP	GO:0050768	negative regulation of neurogenesis	-	150	78	-	-	2.98E-03	6.24E-03
BioPlex HCT116	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	72	-	-	1.74E-02	5.75E-03
BioPlex HCT116	BP	GO:0090068	positive regulation of cell cycle process	-	262	173	-	-	1.56E-02	1.38E-02
BioPlex HCT116	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	11	-	-	2.95E-04	8.92E-04
BioPlex HCT116	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	18	-	-	8.59E-03	1.49E-03
BioPlex HCT116	BP	GO:1902115	regulation of organelle assembly	-	210	135	-	-	1.02E-02	1.07E-02
BioPlex HCT116	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	32	-	-	2.42E-03	2.58E-03
BioPlex HCT116	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	97	-	-	9.47E-03	7.73E-03
BioPlex HCT116	BP	GO:0046622	positive regulation of organ growth	-	52	20	-	-	2.51E-03	1.59E-03
BioPlex HCT116	BP	GO:0051952	regulation of amine transport	-	98	45	-	-	3.77E-02	3.57E-03
BioPlex HCT116	BP	GO:0006730	one-carbon metabolic process	-	24	22	-	-	8.79E-02	1.78E-03
BioPlex HCT116	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	16	-	-	3.91E-04	1.29E-03
BioPlex HCT116	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	11	-	-	2.93E-04	8.92E-04
BioPlex HCT116	CC	GO:0032365	intracellular lipid transport	-	51	35	-	-	6.66E-03	2.77E-03
BioPlex HCT116	BP	GO:0045048	protein insertion into ER membrane	-	30	25	-	-	2.67E-01	1.98E-03
BioPlex HCT116	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	44	-	-	1.66E-03	3.57E-03
BioPlex HCT116	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	84	-	-	5.46E-03	6.74E-03
BioPlex HCT116	BP	GO:0018149	peptide cross-linking	-	28	19	-	-	3.92E-04	1.59E-03
BioPlex HCT116	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	15	-	-	3.92E-04	1.19E-03
BioPlex HCT116	BP	GO:0071398	cellular response to fatty acid	-	35	20	-	-	6.17E-02	1.59E-03
BioPlex HCT116	BP	GO:0097581	lamellipodium organization	-	91	61	-	-	3.05E-02	4.85E-03
BioPlex HCT116	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	25	-	-	1.69E-01	1.98E-03
BioPlex HCT116	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	164	-	-	1.25E-01	1.31E-02
BioPlex HCT116	BP	GO:0060326	cell chemotaxis	-	311	136	-	-	5.97E-03	1.08E-02
BioPlex HCT116	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	15	-	-	3.90E-04	1.19E-03
BioPlex HCT116	BP	GO:0015669	gas transport	-	23	12	-	-	2.96E-04	9.91E-04
BioPlex HCT116	BP	GO:0016485	protein processing	-	248	152	-	-	1.66E-02	1.21E-02
BioPlex HCT116	BP	GO:0009649	entrainment of circadian clock	-	30	25	-	-	4.13E-02	1.98E-03
BioPlex HCT116	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	54	-	-	5.43E-03	4.36E-03
BioPlex HCT116	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	47	-	-	4.28E-03	3.76E-03
BioPlex HCT116	BP	GO:0099054	presynapse assembly	-	49	22	-	-	4.89E-04	1.78E-03
BioPlex HCT116	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	18	-	-	3.90E-04	1.49E-03
BioPlex HCT116	BP	GO:0006517	protein deglycosylation	-	26	20	-	-	4.19E-03	1.59E-03
BioPlex HCT116	BP	GO:0031348	negative regulation of defense response	-	282	150	-	-	4.17E-03	1.19E-02
BioPlex HCT116	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	39	-	-	8.94E-04	3.17E-03
BioPlex HCT116	BP	GO:0007606	sensory perception of chemical stimulus	-	535	50	-	-	6.86E-03	3.96E-03
BioPlex HCT116	BP	GO:0061180	mammary gland epithelium development	-	68	34	-	-	3.87E-03	2.77E-03
BioPlex HCT116	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	126	-	-	3.24E-02	1.00E-02
BioPlex HCT116	CC	GO:0051169	nuclear transport	-	325	242	-	-	3.07E-02	1.92E-02
BioPlex HCT116	BP	GO:0071496	cellular response to external stimulus	-	74	41	-	-	1.54E-02	3.27E-03
BioPlex HCT116	BP	GO:0032094	response to food	-	37	16	-	-	3.93E-04	1.29E-03
BioPlex HCT116	BP	GO:0007340	acrosome reaction	-	38	12	-	-	2.94E-04	9.91E-04
BioPlex HCT116	BP	GO:0046434	organophosphate catabolic process	-	232	152	-	-	3.34E-02	1.21E-02
BioPlex HCT116	BP	GO:0060037	pharyngeal system development	-	29	15	-	-	6.16E-03	1.19E-03
BioPlex HCT116	BP	GO:0009566	fertilization	-	205	86	-	-	2.73E-03	6.84E-03
BioPlex HCT116	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	53	-	-	3.12E-01	4.26E-03
BioPlex HCT116	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	12	-	-	4.02E-03	9.91E-04
BioPlex HCT116	BP	GO:0033044	regulation of chromosome organization	-	249	210	-	-	1.04E-01	1.66E-02
BioPlex HCT116	BP	GO:0009309	amine biosynthetic process	-	38	14	-	-	1.67E-01	1.19E-03
BioPlex HCT116	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	219	-	-	5.85E-03	1.74E-02
BioPlex HCT116	BP	GO:0061900	glial cell activation	-	56	28	-	-	3.96E-03	2.28E-03
BioPlex HCT116	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	75	-	-	9.86E-03	5.94E-03
BioPlex HCT116	CC	GO:0140467	integrated stress response signaling	-	41	27	-	-	6.47E-03	2.18E-03
BioPlex HCT116	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	1.57E-01	1.09E-03
BioPlex HCT116	BP	GO:0043647	inositol phosphate metabolic process	-	44	25	-	-	5.32E-02	1.98E-03
BioPlex HCT116	BP	GO:0016180	snRNA processing	-	28	25	-	-	1.25E-01	1.98E-03
BioPlex HCT116	BP	GO:0051303	establishment of chromosome localization	-	104	84	-	-	3.43E-02	6.74E-03
BioPlex HCT116	BP	GO:0051382	kinetochore assembly	-	16	11	-	-	4.70E-02	8.92E-04
BioPlex HCT116	BP	GO:0007164	establishment of tissue polarity	-	38	22	-	-	2.96E-02	1.78E-03
BioPlex HCT116	BP	GO:0021515	cell differentiation in spinal cord	-	51	20	-	-	1.95E-02	1.59E-03
BioPlex HCT116	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	14	-	-	2.95E-04	1.19E-03
BioPlex HCT116	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	14	-	-	2.94E-04	1.19E-03
BioPlex HCT116	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	23	-	-	1.82E-02	1.88E-03
BioPlex HCT116	BP	GO:0006605	protein targeting	-	327	239	-	-	1.42E-02	1.90E-02
BioPlex HCT116	BP	GO:0061318	renal filtration cell differentiation	-	22	13	-	-	1.81E-03	1.09E-03
BioPlex HCT116	BP	GO:0007566	embryo implantation	-	57	30	-	-	1.04E-03	2.38E-03
BioPlex HCT116	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	20	-	-	4.85E-04	1.59E-03
BioPlex HCT116	BP	GO:0061512	protein localization to cilium	-	394	219	-	-	8.96E-02	1.74E-02
BioPlex HCT116	BP	GO:0060306	regulation of membrane repolarization	-	38	16	-	-	3.89E-04	1.29E-03
BioPlex HCT116	BP	GO:0051017	actin filament bundle assembly	-	161	96	-	-	1.23E-02	7.63E-03
BioPlex HCT116	BP	GO:1905953	negative regulation of lipid localization	-	63	25	-	-	1.81E-02	1.98E-03
BioPlex HCT116	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	13	-	-	1.18E-02	1.09E-03
BioPlex HCT116	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	27	-	-	3.00E-02	2.18E-03
BioPlex HCT116	BP	GO:1901343	negative regulation of vasculature development	-	154	52	-	-	1.54E-03	4.16E-03
BioPlex HCT116	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	120	-	-	1.36E-02	9.51E-03
BioPlex HCT116	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	19	-	-	1.31E-02	1.59E-03
BioPlex HCT116	BP	GO:1902414	protein localization to cell junction	-	107	69	-	-	2.02E-03	5.55E-03
BioPlex HCT116	BP	GO:0051304	chromosome separation	-	80	69	-	-	5.30E-02	5.55E-03
BioPlex HCT116	BP	GO:0090596	sensory organ morphogenesis	-	272	120	-	-	3.75E-03	9.51E-03
BioPlex HCT116	BP	GO:0048709	oligodendrocyte differentiation	-	101	54	-	-	9.73E-03	4.36E-03
BioPlex HCT116	BP	GO:0045017	glycerolipid biosynthetic process	-	254	165	-	-	2.01E-02	1.31E-02
BioPlex HCT116	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	4.92E-01	1.19E-03
BioPlex HCT116	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	13	-	-	2.41E-02	1.09E-03
BioPlex HCT116	BP	GO:0001776	leukocyte homeostasis	-	108	67	-	-	5.07E-03	5.35E-03
BioPlex HCT116	BP	GO:0050769	positive regulation of neurogenesis	-	240	126	-	-	3.84E-03	1.00E-02
BioPlex HCT116	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	14	-	-	4.11E-01	1.19E-03
BioPlex HCT116	BP	GO:0030193	regulation of blood coagulation	-	70	45	-	-	7.01E-03	3.57E-03
BioPlex HCT116	BP	GO:0050866	negative regulation of cell activation	-	216	116	-	-	6.14E-03	9.21E-03
BioPlex HCT116	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	25	-	-	5.77E-04	1.98E-03
BioPlex HCT116	BP	GO:0033500	carbohydrate homeostasis	-	251	129	-	-	4.78E-03	1.03E-02
BioPlex HCT116	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	11	-	-	2.95E-04	8.92E-04
BioPlex HCT116	BP	GO:0044088	regulation of vacuole organization	-	56	40	-	-	1.36E-02	3.17E-03
BioPlex HCT116	CC	GO:0051457	maintenance of protein location in nucleus	-	23	16	-	-	1.46E-02	1.29E-03
BioPlex HCT116	CC	GO:0099522	cytosolic region	-	20	15	-	-	3.85E-04	1.19E-03
BioPlex HCT116	CC	GO:0000791	euchromatin	-	60	41	-	-	5.77E-03	3.27E-03
BioPlex HCT116	CC	GO:0030666	endocytic vesicle membrane	-	196	134	-	-	1.62E-02	1.07E-02
BioPlex HCT116	CC	GO:0098857	membrane microdomain	-	324	175	-	-	8.08E-03	1.39E-02
BioPlex HCT116	CC	GO:0071027	nuclear RNA surveillance	-	14	13	-	-	1.85E-01	1.09E-03
BioPlex HCT116	CC	GO:1990752	microtubule end	-	34	27	-	-	1.42E-01	2.18E-03
BioPlex HCT116	CC	GO:0043204	perikaryon	-	156	72	-	-	5.72E-03	5.75E-03
BioPlex HCT116	CC	GO:0097542	ciliary tip	-	48	36	-	-	3.00E-01	2.87E-03
BioPlex HCT116	CC	GO:1905368	peptidase complex	-	124	109	-	-	3.21E-01	8.72E-03
BioPlex HCT116	CC	GO:0000792	heterochromatin	-	98	76	-	-	3.68E-02	6.04E-03
BioPlex HCT116	CC	GO:0097546	ciliary base	-	47	32	-	-	2.73E-02	2.58E-03
BioPlex HCT116	CC	GO:0071819	DUBm complex	-	25	23	-	-	5.29E-01	1.88E-03
BioPlex HCT116	CC	GO:0031201	SNARE complex	-	48	42	-	-	3.64E-01	3.37E-03
BioPlex HCT116	CC	GO:0016324	apical plasma membrane	-	392	170	-	-	9.87E-03	1.35E-02
BioPlex HCT116	CC	GO:0005677	chromatin silencing complex	-	13	11	-	-	6.35E-02	8.92E-04
BioPlex HCT116	CC	GO:0033260	nuclear DNA replication	-	40	32	-	-	4.02E-02	2.58E-03
BioPlex HCT116	CC	GO:0044391	ribosomal subunit	-	203	185	-	-	3.64E-01	1.47E-02
BioPlex HCT116	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	2.36E-01	8.92E-04
BioPlex HCT116	CC	GO:0071013	catalytic step 2 spliceosome	-	88	82	-	-	9.59E-02	6.54E-03
BioPlex HCT116	CC	GO:0031907	microbody lumen	-	51	32	-	-	2.06E-02	2.58E-03
BioPlex HCT116	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	7.77E-01	9.91E-04
BioPlex HCT116	CC	GO:0098862	cluster of actin-based cell projections	-	162	73	-	-	6.51E-03	5.85E-03
BioPlex HCT116	CC	GO:0098978	glutamatergic synapse	-	411	240	-	-	9.72E-03	1.90E-02
BioPlex HCT116	CC	GO:0016363	nuclear matrix	-	127	93	-	-	2.61E-02	7.43E-03
BioPlex HCT116	CC	GO:0031261	DNA replication preinitiation complex	-	46	41	-	-	1.91E-01	3.27E-03
BioPlex HCT116	CC	GO:0097060	synaptic membrane	-	413	174	-	-	9.97E-03	1.39E-02
BioPlex HCT116	CC	GO:0032432	actin filament bundle	-	249	136	-	-	1.56E-02	1.08E-02
BioPlex HCT116	CC	GO:0008088	axo-dendritic transport	-	78	68	-	-	5.38E-02	5.45E-03
BioPlex HCT116	CC	GO:0031519	PcG protein complex	-	38	33	-	-	2.27E-01	2.68E-03
BioPlex HCT116	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	20	-	-	1.53E-02	1.59E-03
BioPlex HCT116	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	148	-	-	3.01E-02	1.18E-02
BioPlex HCT116	CC	GO:0000313	organellar ribosome	-	89	85	-	-	7.15E-01	6.74E-03
BioPlex HCT116	CC	GO:0099643	signal release from synapse	-	147	85	-	-	2.99E-02	6.74E-03
BioPlex HCT116	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	33	-	-	1.36E-02	2.68E-03
BioPlex HCT116	CC	GO:0030018	Z disc	-	129	72	-	-	8.03E-03	5.75E-03
BioPlex HCT116	CC	GO:0032580	Golgi cisterna membrane	-	93	56	-	-	8.89E-03	4.46E-03
BioPlex HCT116	CC	GO:1905360	GTPase complex	-	41	28	-	-	9.12E-02	2.28E-03
BioPlex HCT116	CC	GO:0097540	axonemal central pair	-	161	69	-	-	4.60E-03	5.55E-03
BioPlex HCT116	CC	GO:0042641	actomyosin	-	77	59	-	-	1.62E-02	4.76E-03
BioPlex HCT116	CC	GO:0097386	glial cell projection	-	38	19	-	-	8.17E-04	1.59E-03
BioPlex HCT116	CC	GO:0032588	trans-Golgi network membrane	-	102	75	-	-	7.32E-02	5.94E-03
BioPlex HCT116	CC	GO:0070382	exocytic vesicle	-	224	147	-	-	4.95E-02	1.17E-02
BioPlex HCT116	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	37	-	-	1.24E-02	2.97E-03
BioPlex HCT116	CC	GO:0031903	microbody membrane	-	65	45	-	-	1.23E-02	3.57E-03
BioPlex HCT116	CC	GO:0046930	pore complex	-	26	19	-	-	7.26E-02	1.59E-03
BioPlex HCT116	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	169	-	-	4.19E-02	1.35E-02
BioPlex HCT116	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	19	-	-	2.18E-03	1.59E-03
BioPlex HCT116	CC	GO:1990071	TRAPPII protein complex	-	12	12	-	-	1.74E-01	9.91E-04
BioPlex HCT116	CC	GO:0099571	postsynaptic cytoskeleton	-	18	14	-	-	3.76E-02	1.19E-03
BioPlex HCT116	CC	GO:0044298	cell body membrane	-	32	13	-	-	2.77E-03	1.09E-03
BioPlex HCT116	CC	GO:0051882	mitochondrial depolarization	-	21	12	-	-	4.93E-02	9.91E-04
BioPlex HCT116	CC	GO:0070993	translation preinitiation complex	-	19	17	-	-	7.91E-01	1.39E-03
BioPlex HCT116	CC	GO:0016323	basolateral plasma membrane	-	239	119	-	-	6.74E-03	9.51E-03
BioPlex HCT116	CC	GO:0045009	chitosome	-	21	12	-	-	8.09E-03	9.91E-04
BioPlex HCT116	CC	GO:0042645	mitochondrial nucleoid	-	45	36	-	-	1.33E-02	2.87E-03
BioPlex HCT116	CC	GO:1902495	transmembrane transporter complex	-	408	156	-	-	7.10E-02	1.24E-02
BioPlex HCT116	CC	GO:0098636	protein complex involved in cell adhesion	-	57	25	-	-	3.28E-02	1.98E-03
BioPlex HCT116	CC	GO:0001917	photoreceptor inner segment	-	71	31	-	-	2.77E-03	2.48E-03
BioPlex HCT116	CC	GO:0019897	extrinsic component of plasma membrane	-	156	96	-	-	2.36E-02	7.63E-03
BioPlex HCT116	CC	GO:0031594	neuromuscular junction	-	73	47	-	-	1.07E-02	3.76E-03
BioPlex HCT116	CC	GO:0000793	condensed chromosome	-	274	213	-	-	7.41E-02	1.69E-02
BioPlex HCT116	CC	GO:0000922	spindle pole	-	172	130	-	-	7.81E-03	1.03E-02
BioPlex HCT116	CC	GO:0120111	neuron projection cytoplasm	-	94	75	-	-	3.26E-02	5.94E-03
BioPlex HCT116	CC	GO:0070971	endoplasmic reticulum exit site	-	32	22	-	-	2.05E-01	1.78E-03
BioPlex HCT116	CC	GO:0005736	RNA polymerase I complex	-	13	12	-	-	3.29E-01	9.91E-04
BioPlex HCT116	CC	GO:0004879	nuclear receptor activity	-	63	20	-	-	4.88E-04	1.59E-03
BioPlex HCT116	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	111	-	-	1.69E-02	8.82E-03
BioPlex HCT116	CC	GO:0000123	histone acetyltransferase complex	-	93	88	-	-	3.90E-01	7.03E-03
BioPlex HCT116	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	72	-	-	6.83E-02	5.75E-03
BioPlex HCT116	CC	GO:0048786	presynaptic active zone	-	80	41	-	-	4.91E-03	3.27E-03
BioPlex HCT116	CC	GO:0001054	RNA polymerase I activity	-	12	11	-	-	2.82E-01	8.92E-04
BioPlex HCT116	CC	GO:0007034	vacuolar transport	-	168	132	-	-	3.24E-02	1.05E-02
BioPlex HCT116	CC	GO:0090741	pigment granule membrane	-	21	12	-	-	2.60E-03	9.91E-04
BioPlex HCT116	CC	GO:0005776	autophagosome	-	111	80	-	-	2.11E-02	6.34E-03
BioPlex HCT116	CC	GO:0031430	M band	-	22	11	-	-	2.95E-04	8.92E-04
BioPlex HCT116	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	71	-	-	4.27E-01	5.65E-03
BioPlex HCT116	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	80	-	-	2.57E-01	6.34E-03
BioPlex HCT116	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	3.28E-01	1.09E-03
BioPlex HCT116	CC	GO:0000164	protein phosphatase type 1 complex	-	19	11	-	-	6.58E-02	8.92E-04
BioPlex HCT116	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	25	-	-	3.95E-02	1.98E-03
BioPlex HCT116	CC	GO:0032994	protein-lipid complex	-	39	24	-	-	4.89E-04	1.98E-03
BioPlex HCT116	CC	GO:0150034	distal axon	-	309	181	-	-	7.66E-03	1.44E-02
BioPlex HCT116	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	138	-	-	2.31E-01	1.10E-02
BioPlex HCT116	CC	GO:0071012	catalytic step 1 spliceosome	-	12	11	-	-	2.91E-02	8.92E-04
BioPlex HCT116	CC	GO:0072562	blood microparticle	-	144	100	-	-	2.56E-03	7.93E-03
BioPlex HCT116	CC	GO:0051233	spindle midzone	-	36	27	-	-	7.01E-02	2.18E-03
BioPlex HCT116	CC	GO:0005811	lipid droplet	-	102	71	-	-	1.43E-02	5.65E-03
BioPlex HCT116	CC	GO:0045022	early endosome to late endosome transport	-	44	40	-	-	9.04E-02	3.17E-03
BioPlex HCT116	CC	GO:0043113	receptor clustering	-	51	28	-	-	9.78E-03	2.28E-03
BioPlex HCT116	CC	GO:0005940	septin ring	-	14	13	-	-	1.00E+00	1.09E-03
BioPlex HCT116	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	13	-	-	2.96E-04	1.09E-03
BioPlex HCT116	CC	GO:0044853	plasma membrane raft	-	114	61	-	-	2.53E-03	4.85E-03
BioPlex HCT116	CC	GO:0005881	cytoplasmic microtubule	-	256	123	-	-	1.27E-02	9.81E-03
BioPlex HCT116	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	11	-	-	4.53E-03	8.92E-04
BioPlex HCT116	CC	GO:0008180	COP9 signalosome	-	17	14	-	-	1.36E-01	1.19E-03
BioPlex HCT116	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	44	-	-	1.05E-01	3.57E-03
BioPlex HCT116	CC	GO:0005905	clathrin-coated pit	-	73	50	-	-	6.03E-02	3.96E-03
BioPlex HCT116	CC	GO:0043034	costamere	-	18	13	-	-	2.96E-04	1.09E-03
BioPlex HCT116	CC	GO:0031904	endosome lumen	-	38	24	-	-	8.14E-02	1.98E-03
BioPlex HCT116	CC	GO:0060170	ciliary membrane	-	76	36	-	-	6.14E-02	2.87E-03
BioPlex HCT116	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	11	-	-	4.52E-01	8.92E-04
BioPlex HCT116	CC	GO:0000783	nuclear telomere cap complex	-	12	11	-	-	6.17E-01	8.92E-04
BioPlex HCT116	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	23	-	-	1.31E-01	1.88E-03
BioPlex HCT116	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	8.07E-01	1.19E-03
BioPlex HCT116	CC	GO:0032154	cleavage furrow	-	54	33	-	-	1.62E-02	2.68E-03
BioPlex HCT116	CC	GO:0005640	nuclear outer membrane	-	30	18	-	-	3.91E-04	1.49E-03
BioPlex HCT116	CC	GO:0007006	mitochondrial membrane organization	-	117	85	-	-	4.48E-02	6.74E-03
BioPlex HCT116	CC	GO:0001772	immunological synapse	-	44	25	-	-	2.91E-03	1.98E-03
BioPlex HCT116	CC	GO:0030904	retromer complex	-	12	11	-	-	1.89E-01	8.92E-04
BioPlex HCT116	CC	GO:0009897	external side of plasma membrane	-	425	195	-	-	1.64E-02	1.55E-02
BioPlex HCT116	CC	GO:0030863	cortical cytoskeleton	-	104	54	-	-	5.86E-03	4.36E-03
BioPlex HCT116	CC	GO:1905348	endonuclease complex	-	38	34	-	-	2.38E-01	2.77E-03
BioPlex HCT116	CC	GO:0030315	T-tubule	-	52	29	-	-	2.05E-02	2.38E-03
BioPlex HCT116	CC	GO:0060076	excitatory synapse	-	64	29	-	-	1.95E-03	2.38E-03
BioPlex HCT116	CC	GO:0036019	endolysosome	-	29	23	-	-	2.89E-02	1.88E-03
BioPlex HCT116	CC	GO:0001891	phagocytic cup	-	28	18	-	-	3.90E-04	1.49E-03
BioPlex HCT116	CC	GO:0099086	synaptonemal structure	-	40	17	-	-	2.25E-02	1.39E-03
BioPlex HCT116	CC	GO:0030427	site of polarized growth	-	172	113	-	-	7.98E-03	9.02E-03
BioPlex HCT116	CC	GO:0044309	neuron spine	-	213	115	-	-	5.78E-03	9.12E-03
BioPlex HCT116	CC	GO:0030658	transport vesicle membrane	-	231	159	-	-	5.50E-02	1.27E-02
BioPlex HCT116	CC	GO:0098918	structural constituent of synapse	-	27	19	-	-	2.77E-03	1.59E-03
BioPlex HCT116	CC	GO:0000940	outer kinetochore	-	17	16	-	-	2.97E-01	1.29E-03
BioPlex HCT116	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	2.86E-01	1.39E-03
BioPlex HCT116	CC	GO:0044232	organelle membrane contact site	-	50	41	-	-	1.30E-02	3.27E-03
BioPlex HCT116	CC	GO:0098803	respiratory chain complex	-	39	22	-	-	1.31E-01	1.78E-03
BioPlex HCT116	CC	GO:0030667	secretory granule membrane	-	319	213	-	-	1.21E-02	1.69E-02
BioPlex HCT116	CC	GO:0097545	axonemal outer doublet	-	164	69	-	-	8.27E-03	5.55E-03
BioPlex HCT116	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	16	-	-	2.77E-03	1.29E-03
BioPlex HCT116	CC	GO:0070069	cytochrome complex	-	42	24	-	-	1.29E-01	1.98E-03
BioPlex HCT116	CC	GO:0031143	pseudopodium	-	18	15	-	-	3.66E-03	1.19E-03
BioPlex HCT116	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	19	-	-	2.25E-01	1.59E-03
BioPlex HCT116	CC	GO:0055037	recycling endosome	-	200	149	-	-	1.99E-02	1.19E-02
BioPlex HCT116	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	55	-	-	1.41E-03	4.36E-03
BioPlex HCT116	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	5.33E-01	1.09E-03
BioPlex HCT116	CC	GO:0035253	ciliary rootlet	-	13	11	-	-	5.78E-02	8.92E-04
BioPlex HCT116	CC	GO:0071682	endocytic vesicle lumen	-	23	19	-	-	3.91E-04	1.59E-03
BioPlex HCT116	CC	GO:0030684	preribosome	-	76	66	-	-	2.23E-02	5.25E-03
BioPlex HCT116	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	239	-	-	7.96E-03	1.90E-02
BioPlex HCT116	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	17	-	-	4.96E-01	1.39E-03
BioPlex HCT116	CC	GO:1990391	DNA repair complex	-	22	19	-	-	1.11E-01	1.59E-03
BioPlex HCT116	CC	GO:0005775	vacuolar lumen	-	176	135	-	-	4.68E-03	1.07E-02
BioPlex HCT116	CC	GO:0032433	filopodium tip	-	19	13	-	-	4.28E-03	1.09E-03
BioPlex HCT116	CC	GO:0032982	myosin filament	-	24	21	-	-	4.93E-04	1.68E-03
BioPlex HCT116	CC	GO:0016327	apicolateral plasma membrane	-	23	11	-	-	2.95E-04	8.92E-04
BioPlex HCT116	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	14	-	-	2.67E-02	1.19E-03
BioPlex HCT116	CC	GO:0044306	neuron projection terminus	-	164	82	-	-	4.98E-03	6.54E-03
BioPlex HCT116	CC	GO:0034455	t-UTP complex	-	53	46	-	-	2.76E-02	3.67E-03
BioPlex HCT116	CC	GO:0005770	late endosome	-	299	215	-	-	2.28E-02	1.70E-02
BioPlex HCT116	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	9.73E-01	1.39E-03
BioPlex HCT116	CC	GO:0031970	organelle envelope lumen	-	94	65	-	-	2.09E-02	5.15E-03
BioPlex HCT116	CC	GO:0097550	transcription preinitiation complex	-	13	11	-	-	1.63E-01	8.92E-04
BioPlex HCT116	CC	GO:0120293	dynein axonemal particle	-	20	12	-	-	1.16E-02	9.91E-04
BioPlex HCT116	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	22	-	-	7.29E-03	1.78E-03
BioPlex HCT116	CC	GO:0043292	contractile muscle fiber	-	245	147	-	-	2.30E-02	1.17E-02
BioPlex HCT116	CC	GO:0034709	methylosome	-	13	12	-	-	2.65E-02	9.91E-04
BioPlex HCT116	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	11	-	-	1.28E-02	8.92E-04
BioPlex HCT116	CC	GO:0005849	mRNA cleavage factor complex	-	22	17	-	-	3.67E-01	1.39E-03
BioPlex HCT116	CC	GO:0000803	sex chromosome	-	32	23	-	-	7.40E-03	1.88E-03
BioPlex HCT116	CC	GO:0098982	GABA-ergic synapse	-	84	28	-	-	3.03E-03	2.28E-03
BioPlex HCT116	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	14	-	-	1.36E-01	1.19E-03
BioPlex HCT116	CC	GO:0035097	histone methyltransferase complex	-	63	54	-	-	1.30E-01	4.36E-03
BioPlex HCT116	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	5.11E-01	1.19E-03
BioPlex HCT116	CC	GO:0000242	pericentriolar material	-	22	18	-	-	2.94E-03	1.49E-03
BioPlex HCT116	CC	GO:1903293	phosphatase complex	-	54	41	-	-	3.99E-02	3.27E-03
BioPlex HCT116	CC	GO:0097470	ribbon synapse	-	13	11	-	-	2.91E-04	8.92E-04
BioPlex HCT116	CC	GO:0031941	filamentous actin	-	27	14	-	-	2.95E-04	1.19E-03
BioPlex HCT116	CC	GO:0000786	nucleosome	-	149	77	-	-	9.73E-02	6.14E-03
BioPlex HCT116	CC	GO:0001533	cornified envelope	-	59	45	-	-	2.63E-03	3.57E-03
BioPlex HCT116	CC	GO:1904724	tertiary granule lumen	-	55	41	-	-	1.65E-03	3.27E-03
BioPlex HCT116	CC	GO:0030027	lamellipodium	-	202	150	-	-	1.74E-02	1.19E-02
BioPlex HCT116	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	12	-	-	6.68E-02	9.91E-04
BioPlex HCT116	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	17	-	-	6.53E-02	1.39E-03
BioPlex HCT116	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	3.02E-01	1.29E-03
BioPlex HCT116	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	14	-	-	1.11E-01	1.19E-03
BioPlex HCT116	CC	GO:0002102	podosome	-	31	21	-	-	1.43E-02	1.68E-03
BioPlex HCT116	CC	GO:0090543	Flemming body	-	33	20	-	-	5.41E-02	1.59E-03
BioPlex HCT116	CC	GO:0016328	lateral plasma membrane	-	66	43	-	-	2.07E-02	3.47E-03
BioPlex HCT116	CC	GO:0001650	fibrillar center	-	151	108	-	-	8.06E-03	8.62E-03
BioPlex HCT116	CC	GO:0031332	RNAi effector complex	-	413	14	-	-	6.94E-03	1.19E-03
BioPlex HCT116	CC	GO:1990204	oxidoreductase complex	-	90	59	-	-	8.82E-02	4.76E-03
BioPlex HCT116	CC	GO:0000930	gamma-tubulin complex	-	16	12	-	-	3.80E-01	9.91E-04
BioPlex HCT116	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.00E+00	8.92E-04
BioPlex HCT116	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	102	-	-	7.92E-03	8.12E-03
BioPlex HCT116	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	17	-	-	2.75E-01	1.39E-03
BioPlex HCT116	CC	GO:0001726	ruffle	-	181	129	-	-	8.85E-03	1.03E-02
BioPlex HCT116	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	15	-	-	2.76E-01	1.19E-03
BioPlex HCT116	CC	GO:0043198	dendritic shaft	-	38	19	-	-	2.41E-03	1.59E-03
BioPlex HCT116	CC	GO:0043073	germ cell nucleus	-	67	42	-	-	6.52E-03	3.37E-03
BioPlex HCT116	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	17	-	-	1.21E-03	1.39E-03
BioPlex HCT116	CC	GO:0005788	endoplasmic reticulum lumen	-	313	192	-	-	1.70E-02	1.53E-02
BioPlex HCT116	CC	GO:0016592	mediator complex	-	38	37	-	-	8.66E-01	2.97E-03
BioPlex HCT116	CC	GO:0034045	phagophore assembly site membrane	-	19	14	-	-	5.93E-02	1.19E-03
BioPlex HCT116	CC	GO:0022626	cytosolic ribosome	-	118	103	-	-	1.56E-01	8.22E-03
BioPlex HCT116	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	37	-	-	2.99E-01	2.97E-03
BioPlex HCT116	CC	GO:0034451	centriolar satellite	-	120	75	-	-	3.13E-02	5.94E-03
BioPlex HCT116	CC	GO:0045171	intercellular bridge	-	91	60	-	-	3.72E-02	4.76E-03
BioPlex HCT116	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	60	-	-	1.55E-02	4.76E-03
BioPlex HCT116	CC	GO:0098984	neuron to neuron synapse	-	384	207	-	-	7.76E-03	1.64E-02
BioPlex HCT116	CC	GO:0044292	dendrite terminus	-	13	11	-	-	1.29E-02	8.92E-04
BioPlex HCT116	CC	GO:0032039	integrator complex	-	19	14	-	-	2.92E-02	1.19E-03
BioPlex HCT116	CC	GO:0030527	structural constituent of chromatin	-	97	34	-	-	1.60E-02	2.77E-03
BioPlex HCT116	CC	GO:0036379	myofilament	-	26	18	-	-	8.57E-02	1.49E-03
BioPlex HCT116	CC	GO:0030286	dynein complex	-	210	95	-	-	1.26E-01	7.53E-03
BioPlex HCT116	CC	GO:0031105	septin complex	-	14	13	-	-	9.67E-01	1.09E-03
BioPlex HCT116	CC	GO:0097228	sperm principal piece	-	33	12	-	-	1.60E-02	9.91E-04
BioPlex HCT116	CC	GO:0044615	nuclear pore nuclear basket	-	12	11	-	-	9.71E-03	8.92E-04
BioPlex HCT116	CC	GO:0016482	cytosolic transport	-	135	109	-	-	1.34E-02	8.72E-03
BioPlex HCT116	CC	GO:0090665	glycoprotein complex	-	23	16	-	-	2.07E-01	1.29E-03
BioPlex HCT116	CC	GO:0005796	Golgi lumen	-	106	48	-	-	5.75E-03	3.86E-03
BioPlex HCT116	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	33	-	-	2.72E-01	2.68E-03
BioPlex HCT116	CC	GO:0034358	plasma lipoprotein particle	-	36	22	-	-	8.15E-03	1.78E-03
BioPlex HCT116	CC	GO:0008023	transcription elongation factor complex	-	47	37	-	-	4.26E-01	2.97E-03
BioPlex HCT116	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	18	-	-	1.80E-02	1.49E-03
BioPlex HCT116	CC	GO:0030662	coated vesicle membrane	-	202	155	-	-	8.04E-02	1.23E-02
BioPlex HCT116	CC	GO:0007039	protein catabolic process in the vacuole	-	61	50	-	-	3.27E-01	3.96E-03
BioPlex HCT116	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	59	-	-	6.27E-01	4.76E-03
BioPlex HCT116	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	184	-	-	2.46E-01	1.47E-02
BioPlex HCT116	CC	GO:0090734	site of DNA damage	-	118	80	-	-	7.29E-02	6.34E-03
BioPlex HCT116	MF	GO:0051861	glycolipid binding	-	30	22	-	-	5.21E-02	1.78E-03
BioPlex HCT116	MF	GO:0051087	protein-folding chaperone binding	-	135	98	-	-	5.09E-03	7.83E-03
BioPlex HCT116	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	23	-	-	3.68E-02	1.88E-03
BioPlex HCT116	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	161	-	-	5.43E-03	1.28E-02
BioPlex HCT116	MF	GO:0016757	glycosyltransferase activity	-	286	178	-	-	1.86E-02	1.42E-02
BioPlex HCT116	MF	GO:0048306	calcium-dependent protein binding	-	61	37	-	-	2.60E-02	2.97E-03
BioPlex HCT116	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	14	-	-	1.31E-02	1.19E-03
BioPlex HCT116	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	83	-	-	2.86E-03	6.64E-03
BioPlex HCT116	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	40	-	-	9.28E-02	3.17E-03
BioPlex HCT116	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	85	-	-	2.39E-02	6.74E-03
BioPlex HCT116	MF	GO:0051020	GTPase binding	-	311	228	-	-	1.03E-02	1.81E-02
BioPlex HCT116	MF	GO:0140457	protein demethylase activity	-	31	21	-	-	4.88E-04	1.68E-03
BioPlex HCT116	MF	GO:0005158	insulin receptor binding	-	22	13	-	-	9.17E-03	1.09E-03
BioPlex HCT116	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	11	-	-	5.11E-03	8.92E-04
BioPlex HCT116	MF	GO:0061980	regulatory RNA binding	-	52	28	-	-	8.23E-03	2.28E-03
BioPlex HCT116	MF	GO:0015035	protein-disulfide reductase activity	-	32	21	-	-	6.43E-03	1.68E-03
BioPlex HCT116	MF	GO:0001671	ATPase activator activity	-	29	19	-	-	1.06E-03	1.59E-03
BioPlex HCT116	MF	GO:0070840	dynein complex binding	-	25	16	-	-	2.68E-02	1.29E-03
BioPlex HCT116	MF	GO:0035035	histone acetyltransferase binding	-	24	13	-	-	2.95E-04	1.09E-03
BioPlex HCT116	MF	GO:0061684	chaperone-mediated autophagy	-	16	13	-	-	2.35E-03	1.09E-03
BioPlex HCT116	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	22	-	-	5.23E-02	1.78E-03
BioPlex HCT116	MF	GO:0003688	DNA replication origin binding	-	18	15	-	-	3.91E-04	1.19E-03
BioPlex HCT116	MF	GO:0005178	integrin binding	-	153	82	-	-	5.09E-03	6.54E-03
BioPlex HCT116	MF	GO:0070064	proline-rich region binding	-	17	13	-	-	1.51E-02	1.09E-03
BioPlex HCT116	MF	GO:0008327	methyl-CpG binding	-	31	17	-	-	1.87E-02	1.39E-03
BioPlex HCT116	MF	GO:0031418	L-ascorbic acid binding	-	20	17	-	-	5.28E-03	1.39E-03
BioPlex HCT116	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	13	-	-	7.49E-03	1.09E-03
BioPlex HCT116	MF	GO:0140318	protein transporter activity	-	40	25	-	-	4.65E-03	1.98E-03
BioPlex HCT116	MF	GO:0070628	proteasome binding	-	17	15	-	-	3.03E-03	1.19E-03
BioPlex HCT116	MF	GO:0000217	DNA secondary structure binding	-	37	25	-	-	1.35E-01	1.98E-03
BioPlex HCT116	MF	GO:0002039	p53 binding	-	66	49	-	-	2.10E-03	3.96E-03
BioPlex HCT116	MF	GO:0005496	steroid binding	-	110	58	-	-	7.97E-03	4.66E-03
BioPlex HCT116	MF	GO:0008443	phosphofructokinase activity	-	27	17	-	-	8.90E-02	1.39E-03
BioPlex HCT116	MF	GO:0003684	damaged DNA binding	-	89	58	-	-	7.51E-02	4.66E-03
BioPlex HCT116	MF	GO:0000339	RNA cap binding	-	20	16	-	-	1.77E-01	1.29E-03
BioPlex HCT116	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	94	-	-	1.59E-01	7.53E-03
BioPlex HCT116	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	11	-	-	7.38E-02	8.92E-04
BioPlex HCT116	MF	GO:0070063	RNA polymerase binding	-	61	41	-	-	1.44E-02	3.27E-03
BioPlex HCT116	MF	GO:0030971	receptor tyrosine kinase binding	-	76	43	-	-	4.21E-03	3.47E-03
BioPlex HCT116	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	63	-	-	2.68E-01	5.05E-03
BioPlex HCT116	MF	GO:0140030	modification-dependent protein binding	-	179	132	-	-	6.76E-03	1.05E-02
BioPlex HCT116	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	13	-	-	8.59E-03	1.09E-03
BioPlex HCT116	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	13	-	-	2.94E-04	1.09E-03
BioPlex HCT116	MF	GO:0030276	clathrin binding	-	70	52	-	-	9.48E-02	4.16E-03
BioPlex HCT116	MF	GO:0046875	ephrin receptor binding	-	29	20	-	-	2.25E-02	1.59E-03
BioPlex HCT116	MF	GO:0106310	protein serine kinase activity	-	362	249	-	-	2.40E-02	1.98E-02
BioPlex HCT116	MF	GO:0046790	virion binding	-	19	15	-	-	3.91E-04	1.19E-03
BioPlex HCT116	MF	GO:0030552	cAMP binding	-	48	23	-	-	4.61E-02	1.88E-03
BioPlex HCT116	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	26	-	-	1.70E-03	2.08E-03
BioPlex HCT116	MF	GO:0004857	enzyme inhibitor activity	-	395	238	-	-	7.18E-03	1.89E-02
BioPlex HCT116	MF	GO:0035173	histone kinase activity	-	17	14	-	-	2.46E-03	1.19E-03
BioPlex HCT116	MF	GO:0097602	cullin family protein binding	-	26	21	-	-	1.54E-03	1.68E-03
BioPlex HCT116	MF	GO:0016209	antioxidant activity	-	92	52	-	-	1.25E-03	4.16E-03
BioPlex HCT116	MF	GO:0070325	lipoprotein particle receptor binding	-	32	26	-	-	5.83E-04	2.08E-03
BioPlex HCT116	MF	GO:0044325	transmembrane transporter binding	-	159	101	-	-	5.79E-03	8.03E-03
BioPlex HCT116	MF	GO:0048156	tau protein binding	-	43	37	-	-	1.65E-03	2.97E-03
BioPlex HCT116	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	25	-	-	5.88E-04	1.98E-03
BioPlex HCT116	MF	GO:0140272	exogenous protein binding	-	79	50	-	-	2.88E-03	3.96E-03
BioPlex HCT116	MF	GO:0030145	manganese ion binding	-	65	45	-	-	9.66E-04	3.57E-03
BioPlex HCT116	MF	GO:0071814	protein-lipid complex binding	-	52	26	-	-	5.76E-04	2.08E-03
BioPlex HCT116	MF	GO:0008066	glutamate receptor activity	-	70	19	-	-	3.86E-04	1.59E-03
BioPlex HCT116	MF	GO:0017069	snRNA binding	-	54	40	-	-	1.27E-01	3.17E-03
BioPlex HCT116	MF	GO:0030215	semaphorin receptor binding	-	23	13	-	-	5.03E-02	1.09E-03
BioPlex HCT116	MF	GO:0031369	translation initiation factor binding	-	32	24	-	-	8.85E-02	1.98E-03
BioPlex HCT116	MF	GO:0019843	rRNA binding	-	69	62	-	-	1.43E-02	4.95E-03
BioPlex HCT116	MF	GO:0004713	protein tyrosine kinase activity	-	213	121	-	-	6.92E-03	9.61E-03
BioPlex HCT116	MF	GO:0016779	nucleotidyltransferase activity	-	264	191	-	-	3.66E-02	1.52E-02
BioPlex HCT116	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	30	-	-	2.18E-03	2.38E-03
BioPlex HCT116	MF	GO:0008093	cytoskeletal anchor activity	-	24	16	-	-	9.49E-03	1.29E-03
BioPlex HCT116	MF	GO:0070300	phosphatidic acid binding	-	20	14	-	-	2.95E-04	1.19E-03
BioPlex HCT116	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	17	-	-	3.92E-04	1.39E-03
BioPlex HCT116	MF	GO:0016208	AMP binding	-	22	16	-	-	2.68E-01	1.29E-03
BioPlex HCT116	MF	GO:0000287	magnesium ion binding	-	225	148	-	-	1.36E-02	1.18E-02
BioPlex HCT116	MF	GO:0031490	chromatin DNA binding	-	120	74	-	-	9.32E-03	5.94E-03
BioPlex HCT116	MF	GO:0017022	myosin binding	-	73	51	-	-	1.45E-02	4.06E-03
BioPlex HCT116	MF	GO:0004896	cytokine receptor activity	-	93	32	-	-	1.27E-03	2.58E-03
BioPlex HCT116	MF	GO:0017166	vinculin binding	-	12	11	-	-	2.96E-04	8.92E-04
BioPlex HCT116	MF	GO:0005539	glycosaminoglycan binding	-	236	119	-	-	1.31E-02	9.51E-03
BioPlex HCT116	MF	GO:0019207	kinase regulator activity	-	267	187	-	-	2.11E-02	1.49E-02
BioPlex HCT116	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	11	-	-	2.89E-04	8.92E-04
BioPlex HCT116	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	17	-	-	3.89E-04	1.39E-03
BioPlex HCT116	MF	GO:0044183	protein folding chaperone	-	67	54	-	-	3.20E-03	4.36E-03
BioPlex HCT116	MF	GO:0005132	type I interferon receptor binding	-	17	12	-	-	2.49E-01	9.91E-04
BioPlex HCT116	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	59	-	-	2.17E-02	4.76E-03
BioPlex HCT116	MF	GO:0003725	double-stranded RNA binding	-	72	52	-	-	1.09E-02	4.16E-03
BioPlex HCT116	MF	GO:0051018	protein kinase A binding	-	52	31	-	-	8.23E-02	2.48E-03
BioPlex HCT116	MF	GO:0071889	14-3-3 protein binding	-	34	22	-	-	4.84E-04	1.78E-03
BioPlex HCT116	MF	GO:0004618	phosphoglycerate kinase activity	-	89	63	-	-	6.57E-02	5.05E-03
BioPlex HCT116	MF	GO:0042805	actinin binding	-	36	17	-	-	7.30E-03	1.39E-03
BioPlex HCT116	MF	GO:0043531	ADP binding	-	38	28	-	-	1.29E-02	2.28E-03
BioPlex HCT116	MF	GO:0043394	proteoglycan binding	-	36	22	-	-	1.59E-02	1.78E-03
BioPlex HCT116	MF	GO:0046332	SMAD binding	-	77	47	-	-	5.26E-03	3.76E-03
BioPlex HCT116	MF	GO:0043560	insulin receptor substrate binding	-	13	12	-	-	6.71E-03	9.91E-04
BioPlex HCT116	MF	GO:0001968	fibronectin binding	-	30	17	-	-	1.15E-02	1.39E-03
BioPlex HCT116	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	91	-	-	5.13E-02	7.23E-03
BioPlex HCT116	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	47	-	-	9.68E-04	3.76E-03
BioPlex HCT116	MF	GO:0003756	protein disulfide isomerase activity	-	18	12	-	-	1.24E-02	9.91E-04
BioPlex HCT116	MF	GO:0051117	ATPase binding	-	85	54	-	-	1.05E-02	4.36E-03
BioPlex HCT116	MF	GO:0005216	monoatomic ion channel activity	-	618	234	-	-	2.61E-02	1.86E-02
BioPlex HCT116	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	22	-	-	1.14E-03	1.78E-03
BioPlex HCT116	MF	GO:0051787	misfolded protein binding	-	20	16	-	-	8.39E-03	1.29E-03
BioPlex HCT116	MF	GO:0001098	basal transcription machinery binding	-	61	45	-	-	2.78E-02	3.57E-03
BioPlex HCT116	MF	GO:0036002	pre-mRNA binding	-	57	20	-	-	5.35E-03	1.59E-03
BioPlex HCT116	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	24	-	-	1.61E-03	1.98E-03
BioPlex HCT116	MF	GO:0051540	metal cluster binding	-	71	49	-	-	3.42E-02	3.96E-03
BioPlex HCT116	MF	GO:0051219	phosphoprotein binding	-	92	59	-	-	2.30E-03	4.76E-03
BioPlex HCT116	MF	GO:0019894	kinesin binding	-	45	36	-	-	1.69E-02	2.87E-03
BioPlex HCT116	MF	GO:0042287	MHC protein binding	-	68	43	-	-	3.43E-02	3.47E-03
BioPlex HCT116	MF	GO:0019003	GDP binding	-	89	68	-	-	3.32E-02	5.45E-03
BioPlex HCT116	MF	GO:0017171	serine hydrolase activity	-	207	108	-	-	2.34E-02	8.62E-03
BioPlex HCT116	MF	GO:0097110	scaffold protein binding	-	66	41	-	-	8.34E-03	3.27E-03
BioPlex HCT116	MF	GO:0003774	cytoskeletal motor activity	-	117	70	-	-	2.69E-02	5.55E-03
BioPlex HCT116	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	26	-	-	1.66E-03	2.08E-03
BioPlex HCT116	MF	GO:0061134	peptidase regulator activity	-	224	122	-	-	1.92E-02	9.71E-03
BioPlex HCT116	MF	GO:0008013	beta-catenin binding	-	86	49	-	-	8.69E-03	3.96E-03
BioPlex HCT116	MF	GO:0051015	actin filament binding	-	208	144	-	-	4.61E-02	1.15E-02
BioPlex HCT116	MF	GO:0019208	phosphatase regulator activity	-	107	72	-	-	2.22E-02	5.75E-03
BioPlex HCT116	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	17	-	-	1.61E-03	1.39E-03
BioPlex HCT116	MF	GO:0043236	laminin binding	-	29	20	-	-	3.81E-03	1.59E-03
BioPlex HCT116	MF	GO:0030507	spectrin binding	-	26	19	-	-	3.84E-02	1.59E-03
BioPlex HCT116	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	30	-	-	2.76E-02	2.38E-03
BioPlex HCT116	MF	GO:0045860	positive regulation of protein kinase activity	-	397	209	-	-	1.01E-02	1.66E-02
BioPlex HCT116	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	84	-	-	5.54E-02	6.74E-03
BioPlex HCT116	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	15	-	-	9.15E-03	1.19E-03
BioPlex HCT116	MF	GO:0042393	histone binding	-	240	163	-	-	2.05E-02	1.30E-02
BioPlex HCT116	MF	GO:0019838	growth factor binding	-	182	102	-	-	7.19E-03	8.12E-03
BioPlex HCT116	MF	GO:0000149	SNARE binding	-	107	81	-	-	9.47E-02	6.44E-03
BioPlex HCT116	MF	GO:0003727	single-stranded RNA binding	-	90	65	-	-	5.08E-03	5.15E-03
BioPlex HCT116	MF	GO:0005516	calmodulin binding	-	206	118	-	-	9.18E-03	9.41E-03
BioPlex HCT116	MF	GO:0019825	oxygen binding	-	40	18	-	-	2.17E-02	1.49E-03
BioPlex HCT116	MF	GO:0045505	dynein intermediate chain binding	-	37	19	-	-	1.34E-02	1.59E-03
BioPlex HCT116	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	57	-	-	1.35E-03	4.56E-03
BioPlex HCT116	MF	GO:0032182	ubiquitin-like protein binding	-	117	97	-	-	2.55E-02	7.73E-03
BioPlex HCT116	MF	GO:0023023	MHC protein complex binding	-	36	27	-	-	4.36E-02	2.18E-03
BioPlex HCT116	MF	GO:0030742	GTP-dependent protein binding	-	22	17	-	-	5.72E-02	1.39E-03
BioPlex HCT116	MF	GO:0043274	phospholipase binding	-	23	12	-	-	2.94E-04	9.91E-04
BioPlex HCT116	MF	GO:0031072	heat shock protein binding	-	128	100	-	-	5.13E-03	7.93E-03
BioPlex HCT116	MF	GO:0030515	snoRNA binding	-	33	30	-	-	2.31E-02	2.38E-03
BioPlex HCT116	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	46	-	-	7.35E-02	3.67E-03
BioPlex HCT116	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	12	-	-	2.65E-02	9.91E-04
BioPlex HCT116	MF	GO:0001965	G-protein alpha-subunit binding	-	26	17	-	-	6.74E-03	1.39E-03
BioPlex HCT116	MF	GO:0001530	lipopolysaccharide binding	-	38	18	-	-	1.67E-03	1.49E-03
BioPlex HCT116	MF	GO:0046982	protein heterodimerization activity	-	343	185	-	-	3.10E-02	1.47E-02
BioPlex HCT116	MF	GO:0140223	general transcription initiation factor activity	-	55	45	-	-	3.40E-01	3.57E-03
BioPlex HCT116	MF	GO:0070403	NAD+ binding	-	16	11	-	-	2.95E-04	8.92E-04
BioPlex HCT116	MF	GO:0000049	tRNA binding	-	75	53	-	-	2.66E-02	4.26E-03
BioPlex HCT116	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	34	-	-	2.12E-02	2.77E-03
BioPlex HCT116	MF	GO:0015026	coreceptor activity	-	48	15	-	-	3.88E-04	1.19E-03
BioPlex HCT116	MF	GO:0001653	peptide receptor activity	-	128	29	-	-	1.10E-03	2.38E-03
BioPlex HCT116	MF	GO:0030506	ankyrin binding	-	19	12	-	-	2.96E-04	9.91E-04
BioPlex HCT116	MF	GO:0006469	negative regulation of protein kinase activity	-	222	146	-	-	3.34E-03	1.16E-02
BioPlex HCT116	MF	GO:0070182	DNA polymerase binding	-	22	17	-	-	2.58E-03	1.39E-03
BioPlex HCT116	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	23	-	-	1.71E-03	1.88E-03
BioPlex HCT116	MF	GO:0051427	hormone receptor binding	-	31	18	-	-	1.23E-01	1.49E-03
BioPlex HCT116	MF	GO:0070851	growth factor receptor binding	-	141	72	-	-	4.73E-03	5.75E-03
BioPlex HCT116	MF	GO:0031210	phosphatidylcholine binding	-	32	23	-	-	5.88E-02	1.88E-03
BioPlex HCT116	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	27	-	-	6.99E-03	2.18E-03
BioPlex HCT116	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	149	-	-	1.51E-02	1.19E-02
BioPlex HCT116	MF	GO:0034185	apolipoprotein binding	-	20	11	-	-	2.92E-04	8.92E-04
BioPlex HCT116	MF	GO:0051346	negative regulation of hydrolase activity	-	332	191	-	-	4.77E-03	1.52E-02
BioPlex HCT116	MF	GO:0005506	iron ion binding	-	154	78	-	-	9.63E-03	6.24E-03
BioPlex HCT116	MF	GO:0003925	G protein activity	-	45	32	-	-	7.33E-03	2.58E-03
BioPlex HCT116	MF	GO:0038187	pattern recognition receptor activity	-	33	12	-	-	2.93E-04	9.91E-04
BioPlex HCT116	MF	GO:0008276	protein methyltransferase activity	-	96	64	-	-	4.16E-03	5.15E-03
BioPlex HCT116	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	235	-	-	7.31E-03	1.86E-02
BioPlex HCT116	MF	GO:0070888	E-box binding	-	59	29	-	-	7.95E-02	2.38E-03
BioPlex HCT116	MF	GO:0015399	primary active transmembrane transporter activity	-	190	127	-	-	1.63E-01	1.01E-02
BioPlex HCT116	MF	GO:0035254	glutamate receptor binding	-	47	29	-	-	3.07E-03	2.38E-03
BioPlex HCT116	MF	GO:0050321	tau-protein kinase activity	-	36	27	-	-	9.79E-03	2.18E-03
BioPlex HCT116	MF	GO:0043021	ribonucleoprotein complex binding	-	158	116	-	-	1.20E-02	9.21E-03
BioPlex HCT116	MF	GO:0030170	pyridoxal phosphate binding	-	56	29	-	-	4.45E-02	2.38E-03
BioPlex HCT116	MF	GO:0032393	MHC class I receptor activity	-	15	11	-	-	3.24E-01	8.92E-04
BioPlex HCT116	MF	GO:0005112	Notch binding	-	26	16	-	-	3.91E-04	1.29E-03
BioPlex HCT116	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	20	-	-	4.90E-04	1.59E-03
BioPlex HCT116	MF	GO:0001664	G protein-coupled receptor binding	-	299	137	-	-	9.55E-03	1.09E-02
BioPlex HCT116	MF	GO:0140299	small molecule sensor activity	-	39	24	-	-	1.28E-01	1.98E-03
BioPlex HCT116	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	17	-	-	3.72E-02	1.39E-03
BioPlex HCT116	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	14	-	-	5.96E-02	1.19E-03
BioPlex HCT116	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	18	-	-	3.89E-04	1.49E-03
BioPlex HCT116	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	35	-	-	1.37E-01	2.77E-03
BioPlex HCT116	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	13	-	-	2.95E-04	1.09E-03
BioPlex HCT116	MF	GO:0030594	neurotransmitter receptor activity	-	160	45	-	-	3.42E-03	3.57E-03
BioPlex HCT116	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	16	-	-	7.42E-02	1.29E-03
BioPlex HCT116	MF	GO:0005507	copper ion binding	-	63	35	-	-	1.53E-02	2.77E-03
BioPlex HCT116	MF	GO:0033558	protein lysine deacetylase activity	-	22	15	-	-	1.10E-02	1.19E-03
BioPlex HCT116	MF	GO:0070034	telomerase RNA binding	-	22	19	-	-	7.69E-02	1.59E-03
ComPPI	CC	GO:0005739	mitochondrion	1.82E-30	1671	1614	1491	1.08	-	-
ComPPI	CC	GO:0005615	extracellular space	2.13E-27	3190	3009	2847	1.06	-	-
ComPPI	CC	GO:0005730	nucleolus	3.80E-27	988	968	882	1.10	-	-
ComPPI	CC	GO:0005815	microtubule organizing center	1.12E-17	843	818	752	1.09	-	-
ComPPI	CC	GO:0005768	endosome	1.59E-16	1037	997	926	1.08	-	-
ComPPI	CC	GO:0005783	endoplasmic reticulum	1.89E-16	2020	1904	1803	1.06	-	-
ComPPI	CC	GO:0005764	lysosome	1.25E-14	747	723	667	1.08	-	-
ComPPI	CC	GO:0005794	Golgi apparatus	4.17E-12	1636	1538	1460	1.05	-	-
ComPPI	CC	GO:0005840	ribosome	5.07E-10	222	221	198	1.12	-	-
ComPPI	CC	GO:0005635	nuclear envelope	9.11E-09	493	475	440	1.08	-	-
ComPPI	CC	GO:0000228	nuclear chromosome	1.20E-05	206	201	184	1.09	-	-
ComPPI	CC	GO:0005777	peroxisome	1.82E-04	142	139	127	1.10	-	-
ComPPI	CC	GO:0031012	extracellular matrix	1.29E-02	564	521	503	1.04	-	-
ComPPI	CC	GO:0005811	lipid droplet	2.34E-02	102	98	91	1.08	-	-
ComPPI	CC	GO:0005929	cilium	5.69E-01	842	757	751	1.01	-	-
ComPPI	BP	GO:0050877	nervous system process	1.22E-98	1527	1080	1363	0.79	-	-
ComPPI	BP	GO:0016192	vesicle-mediated transport	3.20E-36	1894	1832	1690	1.08	-	-
ComPPI	BP	GO:0012501	programmed cell death	1.48E-34	1954	1885	1744	1.08	-	-
ComPPI	BP	GO:0006355	regulation of DNA-templated transcription	4.47E-28	3342	3150	2983	1.06	-	-
ComPPI	BP	GO:0007155	cell adhesion	2.34E-25	1444	1393	1289	1.08	-	-
ComPPI	BP	GO:0048870	cell motility	7.49E-25	1659	1592	1481	1.08	-	-
ComPPI	BP	GO:0002376	immune system process	2.28E-22	2448	2314	2185	1.06	-	-
ComPPI	BP	GO:0007010	cytoskeleton organization	2.85E-22	1639	1568	1463	1.07	-	-
ComPPI	BP	GO:0006886	intracellular protein transport	4.92E-22	664	655	593	1.11	-	-
ComPPI	BP	GO:0006914	autophagy	1.21E-19	568	561	507	1.11	-	-
ComPPI	BP	GO:0030163	protein catabolic process	1.37E-19	990	959	884	1.09	-	-
ComPPI	BP	GO:0006281	DNA repair	1.42E-19	587	579	524	1.11	-	-
ComPPI	BP	GO:0055086	nucleobase-containing small molecule metabolic process	7.95E-16	729	708	651	1.09	-	-
ComPPI	BP	GO:0065003	protein-containing complex assembly	4.64E-15	1648	1558	1471	1.06	-	-
ComPPI	BP	GO:0016071	mRNA metabolic process	4.64E-15	713	692	636	1.09	-	-
ComPPI	BP	GO:0007005	mitochondrion organization	2.93E-14	484	475	432	1.10	-	-
ComPPI	BP	GO:0006091	generation of precursor metabolites and energy	1.68E-13	502	491	448	1.10	-	-
ComPPI	BP	GO:0034330	cell junction organization	7.26E-13	727	701	649	1.08	-	-
ComPPI	BP	GO:0003012	muscle system process	1.78E-12	425	417	379	1.10	-	-
ComPPI	BP	GO:0072659	protein localization to plasma membrane	1.08E-11	284	282	253	1.11	-	-
ComPPI	BP	GO:0042254	ribosome biogenesis	2.15E-11	297	294	265	1.11	-	-
ComPPI	BP	GO:0003013	circulatory system process	6.26E-11	584	564	521	1.08	-	-
ComPPI	BP	GO:0042060	wound healing	1.47E-10	431	420	385	1.09	-	-
ComPPI	BP	GO:0006913	nucleocytoplasmic transport	6.50E-10	326	320	291	1.10	-	-
ComPPI	BP	GO:0006260	DNA replication	1.95E-09	279	275	249	1.10	-	-
ComPPI	BP	GO:0006954	inflammatory response	3.22E-09	820	779	732	1.06	-	-
ComPPI	BP	GO:0007059	chromosome segregation	7.46E-09	403	391	360	1.09	-	-
ComPPI	BP	GO:0007163	establishment or maintenance of cell polarity	3.37E-08	227	224	203	1.11	-	-
ComPPI	BP	GO:0006629	lipid metabolic process	9.08E-08	1355	1265	1209	1.05	-	-
ComPPI	BP	GO:0006520	amino acid metabolic process	9.56E-08	292	285	261	1.09	-	-
ComPPI	BP	GO:0140053	mitochondrial gene expression	3.26E-07	164	163	146	1.11	-	-
ComPPI	BP	GO:0002181	cytoplasmic translation	1.08E-06	153	152	137	1.11	-	-
ComPPI	BP	GO:0006457	protein folding	1.52E-06	210	206	187	1.10	-	-
ComPPI	BP	GO:0007018	microtubule-based movement	2.57E-06	640	605	571	1.06	-	-
ComPPI	BP	GO:0006310	DNA recombination	2.60E-06	333	321	297	1.08	-	-
ComPPI	BP	GO:0005975	carbohydrate metabolic process	6.79E-06	551	522	492	1.06	-	-
ComPPI	BP	GO:0098542	defense response to other organism	2.15E-05	1171	1087	1045	1.04	-	-
ComPPI	BP	GO:0006399	tRNA metabolic process	2.34E-05	196	191	175	1.09	-	-
ComPPI	BP	GO:0055085	transmembrane transport	8.06E-05	1784	1640	1592	1.03	-	-
ComPPI	BP	GO:0006325	chromatin organization	1.73E-04	720	672	643	1.05	-	-
ComPPI	BP	GO:0003014	renal system process	7.62E-04	127	124	113	1.09	-	-
ComPPI	BP	GO:0007040	lysosome organization	8.41E-04	107	105	95	1.10	-	-
ComPPI	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.53E-03	119	116	106	1.09	-	-
ComPPI	BP	GO:0044782	cilium organization	2.42E-03	399	374	356	1.05	-	-
ComPPI	BP	GO:0000910	cytokinesis	2.67E-03	186	178	166	1.07	-	-
ComPPI	BP	GO:0022600	digestive system process	3.02E-03	110	107	98	1.09	-	-
ComPPI	BP	GO:0140013	meiotic nuclear division	4.57E-03	279	263	249	1.06	-	-
ComPPI	BP	GO:0030198	extracellular matrix organization	5.59E-03	314	295	280	1.05	-	-
ComPPI	BP	GO:0006790	sulfur compound metabolic process	1.36E-02	320	299	286	1.05	-	-
ComPPI	BP	GO:0098754	detoxification	3.53E-02	134	127	120	1.06	-	-
ComPPI	BP	GO:0006766	vitamin metabolic process	4.08E-02	107	102	95	1.07	-	-
ComPPI	BP	GO:0006575	cellular modified amino acid metabolic process	1.20E-01	186	173	166	1.04	-	-
ComPPI	BP	GO:0006486	protein glycosylation	1.30E-01	225	208	201	1.04	-	-
ComPPI	BP	GO:0032200	telomere organization	3.40E-01	186	162	166	0.98	-	-
ComPPI	MF	GO:0016740	transferase activity	4.99E-40	3074	2934	2744	1.07	-	-
ComPPI	MF	GO:0003723	RNA binding	4.78E-35	1679	1629	1499	1.09	-	-
ComPPI	MF	GO:0140096	"catalytic activity, acting on a protein"	2.72E-31	3198	3027	2854	1.06	-	-
ComPPI	MF	GO:0008092	cytoskeletal protein binding	8.04E-20	1023	990	913	1.08	-	-
ComPPI	MF	GO:0140657	ATP-dependent activity	4.97E-17	729	710	651	1.09	-	-
ComPPI	MF	GO:0003677	DNA binding	2.26E-13	2865	2664	2557	1.04	-	-
ComPPI	MF	GO:0140110	transcription regulator activity	3.40E-13	2033	1905	1814	1.05	-	-
ComPPI	MF	GO:0003924	GTPase activity	1.59E-11	658	634	587	1.08	-	-
ComPPI	MF	GO:0016491	oxidoreductase activity	3.81E-11	888	847	793	1.07	-	-
ComPPI	MF	GO:0140097	"catalytic activity, acting on DNA"	9.87E-11	383	375	342	1.10	-	-
ComPPI	MF	GO:0140098	"catalytic activity, acting on RNA"	1.19E-10	417	407	372	1.09	-	-
ComPPI	MF	GO:0008289	lipid binding	6.34E-09	836	793	746	1.06	-	-
ComPPI	MF	GO:0016853	isomerase activity	3.01E-06	252	245	225	1.09	-	-
ComPPI	MF	GO:0016874	ligase activity	3.98E-06	283	274	253	1.08	-	-
ComPPI	MF	GO:0016829	lyase activity	5.51E-06	538	510	480	1.06	-	-
ComPPI	MF	GO:0045182	translation regulator activity	1.45E-05	151	149	135	1.11	-	-
ComPPI	MF	GO:0042393	histone binding	4.84E-05	237	229	212	1.08	-	-
ComPPI	MF	GO:0140104	molecular carrier activity	1.25E-03	105	103	94	1.10	-	-
ComPPI	MF	GO:0048018	receptor ligand activity	2.70E-03	504	470	450	1.04	-	-
ComPPI	MF	GO:0009975	cyclase activity	1.88E-02	277	259	247	1.05	-	-
ComPPI	MF	GO:0003774	cytoskeletal motor activity	2.28E-02	116	111	104	1.07	-	-
ComPPI	MF	GO:0038024	cargo receptor activity	2.32E-02	117	112	104	1.07	-	-
ComPPI	MF	GO:0005215	transporter activity	6.47E-02	1462	1326	1305	1.02	-	-
ComPPI	MF	GO:0005198	structural molecule activity	3.81E-01	798	720	712	1.01	-	-
ComPPI	BP	GO:0008038	neuron recognition	-	46	44	-	-	2.61E-03	2.09E-03
ComPPI	BP	GO:1905145	cellular response to acetylcholine	-	33	32	-	-	7.61E-03	1.51E-03
ComPPI	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	3.44E-03	8.69E-04
ComPPI	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	2.92E-03	9.85E-04
ComPPI	BP	GO:0051931	regulation of sensory perception	-	36	34	-	-	3.47E-03	1.62E-03
ComPPI	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	1.25E-03	1.16E-03
ComPPI	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.71E-04	6.37E-04
ComPPI	BP	GO:0060049	regulation of protein glycosylation	-	13	11	-	-	1.69E-03	5.22E-04
ComPPI	BP	GO:0009268	response to pH	-	43	39	-	-	2.65E-02	1.85E-03
ComPPI	BP	GO:0045666	positive regulation of neuron differentiation	-	91	85	-	-	4.77E-03	3.94E-03
ComPPI	BP	GO:0043543	protein acylation	-	107	102	-	-	3.97E-03	4.75E-03
ComPPI	MF	GO:0051349	positive regulation of lyase activity	-	41	38	-	-	2.09E-03	1.80E-03
ComPPI	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	13	-	-	7.29E-04	6.37E-04
ComPPI	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.34E-03	1.16E-03
ComPPI	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	5.57E-03	9.27E-04
ComPPI	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	123	-	-	1.75E-02	5.74E-03
ComPPI	BP	GO:0071763	nuclear membrane organization	-	44	43	-	-	3.48E-02	2.03E-03
ComPPI	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	35	-	-	3.47E-03	1.62E-03
ComPPI	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	11	-	-	1.26E-01	5.22E-04
ComPPI	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	1.86E-02	3.19E-03
ComPPI	BP	GO:0022038	corpus callosum development	-	25	25	-	-	3.59E-03	1.16E-03
ComPPI	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	11	-	-	1.00E-02	5.22E-04
ComPPI	BP	GO:0021548	pons development	-	11	11	-	-	1.69E-04	5.22E-04
ComPPI	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	11	-	-	1.72E-04	5.22E-04
ComPPI	BP	GO:0043299	leukocyte degranulation	-	82	79	-	-	7.15E-03	3.71E-03
ComPPI	BP	GO:0048864	stem cell development	-	88	83	-	-	1.41E-02	3.88E-03
ComPPI	BP	GO:0009310	amine catabolic process	-	20	17	-	-	6.28E-03	8.11E-04
ComPPI	BP	GO:0051651	maintenance of location in cell	-	236	218	-	-	7.97E-03	1.01E-02
ComPPI	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	1.74E-03	1.27E-03
ComPPI	BP	GO:0014004	microglia differentiation	-	12	12	-	-	6.29E-04	5.80E-04
ComPPI	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	1.58E-03	1.45E-03
ComPPI	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	1.72E-04	6.95E-04
ComPPI	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	8.05E-04	6.95E-04
ComPPI	BP	GO:0046415	urate metabolic process	-	12	11	-	-	1.73E-04	5.22E-04
ComPPI	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	4.21E-03	1.39E-03
ComPPI	BP	GO:0006949	syncytium formation	-	66	60	-	-	7.59E-03	2.78E-03
ComPPI	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.22E-04	6.95E-04
ComPPI	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	2.07E-02	6.95E-04
ComPPI	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	52	-	-	1.15E-02	2.43E-03
ComPPI	BP	GO:0030574	collagen catabolic process	-	45	43	-	-	1.20E-02	2.03E-03
ComPPI	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	6.14E-03	2.14E-03
ComPPI	BP	GO:0060343	trabecula formation	-	26	26	-	-	1.26E-03	1.22E-03
ComPPI	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.78E-03	1.10E-03
ComPPI	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	1.01E-01	7.53E-04
ComPPI	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	4.88E-03	8.69E-04
ComPPI	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	3.21E-03	1.91E-03
ComPPI	BP	GO:0006413	translational initiation	-	122	119	-	-	2.50E-02	5.56E-03
ComPPI	BP	GO:0072176	nephric duct development	-	15	15	-	-	3.96E-03	6.95E-04
ComPPI	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	3.50E-03	2.38E-03
ComPPI	CC	GO:0005200	structural constituent of cytoskeleton	-	112	108	-	-	7.37E-03	5.04E-03
ComPPI	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	3.78E-03	2.38E-03
ComPPI	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	2.07E-02	6.95E-04
ComPPI	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	5.15E-02	1.16E-03
ComPPI	BP	GO:1903036	positive regulation of response to wounding	-	76	69	-	-	4.89E-03	3.25E-03
ComPPI	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	1.24E-02	9.85E-04
ComPPI	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	208	-	-	1.68E-02	9.68E-03
ComPPI	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.17E-03	1.27E-03
ComPPI	BP	GO:0032528	microvillus organization	-	24	22	-	-	2.61E-03	1.04E-03
ComPPI	BP	GO:0021954	central nervous system neuron development	-	85	82	-	-	1.89E-03	3.82E-03
ComPPI	BP	GO:0055017	cardiac muscle tissue growth	-	92	73	-	-	6.96E-03	3.42E-03
ComPPI	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	3.07E-03	1.45E-03
ComPPI	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	2.55E-03	6.37E-04
ComPPI	BP	GO:0048524	positive regulation of viral process	-	64	63	-	-	1.52E-03	2.96E-03
ComPPI	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	12	-	-	6.07E-02	5.80E-04
ComPPI	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	1.14E-02	9.85E-04
ComPPI	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	23	-	-	5.21E-03	1.10E-03
ComPPI	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	1.10E-03	8.11E-04
ComPPI	BP	GO:0098661	inorganic anion transmembrane transport	-	140	122	-	-	1.49E-02	5.68E-03
ComPPI	BP	GO:0006099	tricarboxylic acid cycle	-	33	33	-	-	3.38E-02	1.56E-03
ComPPI	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	7.83E-04	8.69E-04
ComPPI	BP	GO:0009612	response to mechanical stimulus	-	215	203	-	-	5.23E-03	9.45E-03
ComPPI	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	7.77E-03	3.65E-03
ComPPI	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	139	-	-	5.55E-03	6.49E-03
ComPPI	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	1.74E-03	6.37E-04
ComPPI	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	1.08E-02	1.62E-03
ComPPI	BP	GO:0140115	export across plasma membrane	-	82	61	-	-	2.64E-02	2.84E-03
ComPPI	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	4.00E-03	5.80E-04
ComPPI	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	2.31E-03	1.80E-03
ComPPI	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	8.53E-02	5.80E-04
ComPPI	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.72E-04	5.22E-04
ComPPI	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	27	-	-	7.23E-04	1.27E-03
ComPPI	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	40	-	-	9.17E-03	1.85E-03
ComPPI	MF	GO:0003714	transcription corepressor activity	-	190	186	-	-	1.24E-02	8.63E-03
ComPPI	BP	GO:0035878	nail development	-	11	11	-	-	1.23E-02	5.22E-04
ComPPI	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	54	-	-	1.51E-02	2.55E-03
ComPPI	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	2.19E-03	7.53E-04
ComPPI	CC	GO:0006858	extracellular transport	-	45	43	-	-	9.20E-03	2.03E-03
ComPPI	BP	GO:0006304	DNA modification	-	30	30	-	-	3.21E-02	1.39E-03
ComPPI	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	3.80E-02	9.27E-04
ComPPI	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	2.03E-02	2.32E-03
ComPPI	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	1.07E-03	8.69E-04
ComPPI	BP	GO:0003207	cardiac chamber formation	-	14	13	-	-	1.22E-02	6.37E-04
ComPPI	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	36	-	-	4.25E-03	1.68E-03
ComPPI	BP	GO:0070417	cellular response to cold	-	13	12	-	-	4.30E-02	5.80E-04
ComPPI	BP	GO:0043523	regulation of neuron apoptotic process	-	218	210	-	-	7.68E-03	9.74E-03
ComPPI	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.83E-03	1.04E-03
ComPPI	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	1.66E-03	6.95E-04
ComPPI	BP	GO:0044380	protein localization to cytoskeleton	-	57	56	-	-	4.83E-03	2.61E-03
ComPPI	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	2.78E-02	6.37E-04
ComPPI	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	1.28E-03	1.16E-03
ComPPI	BP	GO:0014029	neural crest formation	-	15	15	-	-	1.55E-02	6.95E-04
ComPPI	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	8.35E-03	1.10E-03
ComPPI	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	37	-	-	1.38E-02	1.74E-03
ComPPI	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	68	-	-	2.92E-03	3.19E-03
ComPPI	BP	GO:0003188	heart valve formation	-	16	16	-	-	1.02E-02	7.53E-04
ComPPI	CC	GO:0045324	late endosome to vacuole transport	-	37	37	-	-	8.09E-02	1.74E-03
ComPPI	BP	GO:0043954	cellular component maintenance	-	72	70	-	-	8.77E-03	3.25E-03
ComPPI	BP	GO:0050435	amyloid-beta metabolic process	-	65	52	-	-	4.73E-02	2.43E-03
ComPPI	BP	GO:0014823	response to activity	-	70	69	-	-	2.97E-03	3.25E-03
ComPPI	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	3.59E-02	8.69E-04
ComPPI	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	3.52E-02	1.33E-03
ComPPI	BP	GO:0034502	protein localization to chromosome	-	130	113	-	-	6.92E-03	5.27E-03
ComPPI	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	1.65E-04	5.22E-04
ComPPI	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	3.34E-03	5.22E-04
ComPPI	BP	GO:0060457	negative regulation of digestive system process	-	17	16	-	-	6.37E-02	7.53E-04
ComPPI	BP	GO:0019233	sensory perception of pain	-	103	99	-	-	2.77E-03	4.64E-03
ComPPI	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	1.82E-01	1.04E-03
ComPPI	BP	GO:0031343	positive regulation of cell killing	-	75	73	-	-	7.36E-02	3.42E-03
ComPPI	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	3.21E-03	1.80E-03
ComPPI	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	118	-	-	2.05E-02	5.51E-03
ComPPI	BP	GO:0017148	negative regulation of translation	-	390	113	-	-	9.68E-03	5.27E-03
ComPPI	BP	GO:0030220	platelet formation	-	22	22	-	-	1.57E-02	1.04E-03
ComPPI	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	79	-	-	4.40E-03	3.71E-03
ComPPI	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	2.97E-03	5.80E-04
ComPPI	BP	GO:1901142	insulin metabolic process	-	14	13	-	-	2.07E-03	6.37E-04
ComPPI	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	3.74E-02	6.95E-04
ComPPI	BP	GO:1903509	liposaccharide metabolic process	-	109	102	-	-	3.85E-02	4.75E-03
ComPPI	BP	GO:0009582	detection of abiotic stimulus	-	140	119	-	-	1.19E-02	5.56E-03
ComPPI	BP	GO:0045683	negative regulation of epidermis development	-	13	12	-	-	3.31E-03	5.80E-04
ComPPI	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	15	-	-	2.30E-04	6.95E-04
ComPPI	CC	GO:0140238	presynaptic endocytosis	-	72	72	-	-	1.38E-02	3.36E-03
ComPPI	BP	GO:0051236	establishment of RNA localization	-	161	155	-	-	5.40E-02	7.19E-03
ComPPI	BP	GO:0042178	xenobiotic catabolic process	-	26	24	-	-	5.20E-02	1.16E-03
ComPPI	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	1.30E-02	8.11E-04
ComPPI	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	191	-	-	1.18E-02	8.87E-03
ComPPI	BP	GO:0034067	protein localization to Golgi apparatus	-	30	29	-	-	1.21E-03	1.39E-03
ComPPI	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	2.70E-03	1.51E-03
ComPPI	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	8.89E-03	5.22E-04
ComPPI	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	16	-	-	1.06E-02	7.53E-04
ComPPI	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	48	-	-	7.95E-03	2.26E-03
ComPPI	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	1.69E-03	1.85E-03
ComPPI	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	2.34E-03	2.43E-03
ComPPI	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	4.77E-03	7.53E-04
ComPPI	BP	GO:0050779	RNA destabilization	-	135	99	-	-	4.63E-02	4.64E-03
ComPPI	BP	GO:0006023	aminoglycan biosynthetic process	-	74	69	-	-	2.47E-02	3.25E-03
ComPPI	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	7.38E-03	3.19E-03
ComPPI	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	2.43E-03	1.85E-03
ComPPI	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	1.46E-02	1.39E-03
ComPPI	BP	GO:0035272	exocrine system development	-	46	46	-	-	1.87E-03	2.14E-03
ComPPI	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	1.38E-02	8.11E-04
ComPPI	BP	GO:0022406	membrane docking	-	90	88	-	-	2.48E-02	4.11E-03
ComPPI	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	5.44E-02	6.95E-04
ComPPI	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	6.51E-04	7.53E-04
ComPPI	BP	GO:0050777	negative regulation of immune response	-	196	184	-	-	6.51E-03	8.58E-03
ComPPI	MF	GO:0005035	death receptor activity	-	16	16	-	-	4.12E-03	7.53E-04
ComPPI	BP	GO:0002063	chondrocyte development	-	33	32	-	-	2.56E-03	1.51E-03
ComPPI	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	1.39E-03	8.11E-04
ComPPI	BP	GO:0099068	postsynapse assembly	-	40	39	-	-	1.31E-02	1.85E-03
ComPPI	BP	GO:0021782	glial cell development	-	120	111	-	-	2.18E-03	5.16E-03
ComPPI	BP	GO:0051782	negative regulation of cell division	-	18	16	-	-	4.43E-03	7.53E-04
ComPPI	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	3.61E-04	5.22E-04
ComPPI	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	85	-	-	7.73E-03	3.94E-03
ComPPI	BP	GO:0001655	urogenital system development	-	66	65	-	-	3.08E-03	3.01E-03
ComPPI	BP	GO:0071827	plasma lipoprotein particle organization	-	86	70	-	-	1.75E-02	3.25E-03
ComPPI	BP	GO:0045494	photoreceptor cell maintenance	-	43	42	-	-	3.37E-02	1.97E-03
ComPPI	BP	GO:0055088	lipid homeostasis	-	173	150	-	-	1.95E-02	6.95E-03
ComPPI	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	1.10E-03	1.22E-03
ComPPI	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	193	-	-	4.84E-03	8.98E-03
ComPPI	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	27	-	-	5.70E-02	1.27E-03
ComPPI	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	5.40E-03	1.62E-03
ComPPI	BP	GO:0045667	regulation of osteoblast differentiation	-	147	122	-	-	8.23E-03	5.68E-03
ComPPI	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	1.72E-03	7.53E-04
ComPPI	BP	GO:0061037	negative regulation of cartilage development	-	32	30	-	-	5.64E-03	1.39E-03
ComPPI	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	5.95E-03	1.85E-03
ComPPI	BP	GO:0001704	formation of primary germ layer	-	195	186	-	-	1.51E-02	8.63E-03
ComPPI	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	1.48E-02	6.37E-04
ComPPI	BP	GO:0045778	positive regulation of ossification	-	51	50	-	-	4.49E-03	2.32E-03
ComPPI	BP	GO:0060174	limb bud formation	-	11	11	-	-	1.71E-04	5.22E-04
ComPPI	BP	GO:0048708	astrocyte differentiation	-	88	84	-	-	2.38E-03	3.94E-03
ComPPI	BP	GO:0042092	type 2 immune response	-	41	41	-	-	3.78E-03	1.91E-03
ComPPI	BP	GO:0048588	developmental cell growth	-	233	220	-	-	4.74E-03	1.02E-02
ComPPI	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	3.61E-02	9.27E-04
ComPPI	BP	GO:0021872	forebrain generation of neurons	-	52	49	-	-	1.43E-03	2.32E-03
ComPPI	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	1.90E-03	1.04E-03
ComPPI	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	1.48E-01	1.85E-03
ComPPI	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	50	-	-	4.22E-02	2.32E-03
ComPPI	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	1.72E-04	5.22E-04
ComPPI	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	2.92E-02	1.62E-03
ComPPI	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	25	-	-	5.48E-04	1.16E-03
ComPPI	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	45	-	-	3.71E-03	2.09E-03
ComPPI	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	1.01E-01	9.27E-04
ComPPI	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	1.65E-02	9.27E-04
ComPPI	BP	GO:0010232	vascular transport	-	87	82	-	-	3.17E-03	3.82E-03
ComPPI	BP	GO:0021987	cerebral cortex development	-	125	121	-	-	4.00E-03	5.62E-03
ComPPI	BP	GO:0008637	apoptotic mitochondrial changes	-	108	101	-	-	1.97E-02	4.69E-03
ComPPI	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	7.32E-03	1.62E-03
ComPPI	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	7.66E-03	6.95E-04
ComPPI	BP	GO:0060999	positive regulation of dendritic spine development	-	35	34	-	-	7.13E-03	1.62E-03
ComPPI	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	1.01E-03	8.69E-04
ComPPI	BP	GO:2000736	regulation of stem cell differentiation	-	78	76	-	-	6.13E-03	3.54E-03
ComPPI	BP	GO:0060973	cell migration involved in heart development	-	21	19	-	-	9.43E-04	9.27E-04
ComPPI	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	3.13E-03	9.27E-04
ComPPI	BP	GO:0002064	epithelial cell development	-	210	207	-	-	5.81E-03	9.62E-03
ComPPI	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	2.24E-04	8.69E-04
ComPPI	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	40	-	-	2.07E-02	1.85E-03
ComPPI	BP	GO:2001222	regulation of neuron migration	-	46	43	-	-	8.96E-03	2.03E-03
ComPPI	BP	GO:0034389	lipid droplet organization	-	38	37	-	-	1.59E-03	1.74E-03
ComPPI	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	6.02E-04	2.09E-03
ComPPI	BP	GO:0042177	negative regulation of protein catabolic process	-	109	106	-	-	1.89E-03	4.93E-03
ComPPI	MF	GO:0038024	cargo receptor activity	-	121	112	-	-	7.39E-03	5.22E-03
ComPPI	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	18	-	-	2.27E-03	8.69E-04
ComPPI	BP	GO:0033120	positive regulation of RNA splicing	-	46	43	-	-	1.58E-02	2.03E-03
ComPPI	BP	GO:0051445	regulation of meiotic cell cycle	-	64	62	-	-	4.76E-02	2.90E-03
ComPPI	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.70E-04	5.80E-04
ComPPI	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	2.71E-02	2.78E-03
ComPPI	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	4.59E-03	6.95E-04
ComPPI	BP	GO:0090087	regulation of peptide transport	-	195	186	-	-	7.87E-03	8.63E-03
ComPPI	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	100	-	-	4.57E-03	4.64E-03
ComPPI	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	1.41E-03	1.16E-03
ComPPI	BP	GO:0006929	substrate-dependent cell migration	-	26	26	-	-	6.39E-04	1.22E-03
ComPPI	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	2.14E-02	1.27E-03
ComPPI	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	1.51E-03	6.95E-04
ComPPI	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	2.69E-03	6.95E-04
ComPPI	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	1.20E-01	9.27E-04
ComPPI	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	3.83E-03	6.37E-04
ComPPI	BP	GO:0022404	molting cycle process	-	95	94	-	-	1.97E-03	4.40E-03
ComPPI	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	4.47E-04	5.22E-04
ComPPI	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	3.14E-03	8.11E-04
ComPPI	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	9.48E-03	9.27E-04
ComPPI	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	2.43E-03	5.80E-04
ComPPI	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	18	-	-	9.31E-04	8.69E-04
ComPPI	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	3.10E-03	1.51E-03
ComPPI	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	5.21E-03	6.95E-04
ComPPI	BP	GO:0008299	isoprenoid biosynthetic process	-	30	29	-	-	9.80E-03	1.39E-03
ComPPI	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	230	-	-	1.69E-02	1.07E-02
ComPPI	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.63E-03	1.45E-03
ComPPI	BP	GO:0034104	negative regulation of tissue remodeling	-	22	21	-	-	1.01E-03	9.85E-04
ComPPI	CC	GO:0098926	postsynaptic signal transduction	-	39	38	-	-	4.41E-03	1.80E-03
ComPPI	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	137	-	-	3.13E-03	6.37E-03
ComPPI	CC	GO:0016082	synaptic vesicle priming	-	19	18	-	-	3.53E-02	8.69E-04
ComPPI	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	1.24E-03	2.20E-03
ComPPI	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	140	-	-	1.19E-02	6.49E-03
ComPPI	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	1.71E-03	1.04E-03
ComPPI	BP	GO:0061548	ganglion development	-	17	17	-	-	1.77E-02	8.11E-04
ComPPI	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	96	-	-	5.86E-03	4.46E-03
ComPPI	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.61E-03	6.95E-04
ComPPI	BP	GO:0042832	defense response to protozoan	-	28	23	-	-	1.56E-02	1.10E-03
ComPPI	BP	GO:0048799	animal organ maturation	-	33	32	-	-	2.70E-03	1.51E-03
ComPPI	BP	GO:0006925	inflammatory cell apoptotic process	-	23	21	-	-	8.38E-04	9.85E-04
ComPPI	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	4.47E-04	7.53E-04
ComPPI	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	169	-	-	5.53E-03	7.88E-03
ComPPI	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.72E-04	5.22E-04
ComPPI	BP	GO:1903035	negative regulation of response to wounding	-	93	87	-	-	1.13E-02	4.06E-03
ComPPI	BP	GO:0015697	quaternary ammonium group transport	-	16	14	-	-	1.99E-02	6.95E-04
ComPPI	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	1.04E-03	1.22E-03
ComPPI	BP	GO:0036010	protein localization to endosome	-	27	26	-	-	3.84E-03	1.22E-03
ComPPI	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	132	-	-	3.17E-02	6.14E-03
ComPPI	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	96	-	-	3.65E-03	4.46E-03
ComPPI	BP	GO:0045056	transcytosis	-	20	19	-	-	1.86E-03	9.27E-04
ComPPI	BP	GO:0018342	protein prenylation	-	15	15	-	-	1.21E-02	6.95E-04
ComPPI	BP	GO:0009267	cellular response to starvation	-	170	166	-	-	1.46E-02	7.71E-03
ComPPI	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	2.62E-03	5.22E-04
ComPPI	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	6.70E-03	2.49E-03
ComPPI	BP	GO:0046834	lipid phosphorylation	-	16	15	-	-	3.17E-02	6.95E-04
ComPPI	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	2.93E-03	1.10E-03
ComPPI	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	23	-	-	2.84E-04	1.10E-03
ComPPI	BP	GO:0046931	pore complex assembly	-	21	20	-	-	7.90E-03	9.27E-04
ComPPI	CC	GO:0032008	positive regulation of TOR signaling	-	52	50	-	-	5.51E-02	2.32E-03
ComPPI	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	2.66E-02	1.56E-03
ComPPI	BP	GO:0046618	xenobiotic export from cell	-	27	12	-	-	6.10E-03	5.80E-04
ComPPI	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	13	-	-	2.18E-03	6.37E-04
ComPPI	BP	GO:0060428	lung epithelium development	-	43	43	-	-	3.11E-03	2.03E-03
ComPPI	BP	GO:0030431	sleep	-	30	30	-	-	3.88E-02	1.39E-03
ComPPI	BP	GO:1903318	negative regulation of protein maturation	-	29	28	-	-	1.05E-02	1.33E-03
ComPPI	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	97	-	-	2.11E-01	4.52E-03
ComPPI	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	4.85E-04	8.11E-04
ComPPI	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	8.43E-03	6.95E-04
ComPPI	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	1.04E-02	5.22E-04
ComPPI	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.71E-04	6.37E-04
ComPPI	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	68	-	-	8.84E-03	3.19E-03
ComPPI	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	2.12E-03	3.01E-03
ComPPI	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	5.21E-03	8.11E-04
ComPPI	CC	GO:0090660	cerebrospinal fluid circulation	-	15	13	-	-	1.72E-04	6.37E-04
ComPPI	CC	GO:0006406	mRNA export from nucleus	-	69	67	-	-	3.17E-02	3.13E-03
ComPPI	BP	GO:0009880	embryonic pattern specification	-	70	68	-	-	3.53E-03	3.19E-03
ComPPI	BP	GO:0015791	polyol transmembrane transport	-	14	12	-	-	1.72E-04	5.80E-04
ComPPI	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	3.91E-01	1.85E-03
ComPPI	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	2.28E-03	1.16E-03
ComPPI	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	3.53E-03	5.22E-04
ComPPI	BP	GO:0002367	cytokine production involved in immune response	-	121	120	-	-	1.09E-02	5.56E-03
ComPPI	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	12	-	-	1.68E-03	5.80E-04
ComPPI	BP	GO:0044848	biological phase	-	211	198	-	-	1.40E-02	9.21E-03
ComPPI	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	7.31E-03	5.80E-04
ComPPI	BP	GO:0046660	female sex differentiation	-	125	122	-	-	1.13E-02	5.68E-03
ComPPI	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	2.20E-03	8.11E-04
ComPPI	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	41	-	-	7.09E-04	1.91E-03
ComPPI	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	1.70E-04	5.22E-04
ComPPI	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	1.41E-02	3.25E-03
ComPPI	BP	GO:0071248	cellular response to metal ion	-	201	195	-	-	3.75E-03	9.04E-03
ComPPI	BP	GO:0030308	negative regulation of cell growth	-	191	182	-	-	4.25E-03	8.46E-03
ComPPI	BP	GO:0097306	cellular response to alcohol	-	99	91	-	-	3.90E-03	4.23E-03
ComPPI	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	125	-	-	4.46E-02	5.80E-03
ComPPI	BP	GO:0010453	regulation of cell fate commitment	-	40	34	-	-	2.24E-02	1.62E-03
ComPPI	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	58	-	-	3.70E-03	2.72E-03
ComPPI	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	51	-	-	7.28E-04	2.38E-03
ComPPI	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	3.71E-03	1.22E-03
ComPPI	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	4.04E-02	1.16E-03
ComPPI	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	43	-	-	4.03E-03	2.03E-03
ComPPI	BP	GO:0032890	regulation of organic acid transport	-	78	76	-	-	5.88E-03	3.54E-03
ComPPI	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	8.00E-04	9.27E-04
ComPPI	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	1.80E-02	1.16E-03
ComPPI	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	91	-	-	3.27E-03	4.23E-03
ComPPI	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	25	-	-	2.82E-03	1.16E-03
ComPPI	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	4.27E-03	5.22E-04
ComPPI	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	53	-	-	3.37E-03	2.49E-03
ComPPI	BP	GO:0051259	protein complex oligomerization	-	251	244	-	-	8.25E-03	1.14E-02
ComPPI	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	6.80E-03	7.53E-04
ComPPI	BP	GO:0098743	cell aggregation	-	24	23	-	-	9.19E-04	1.10E-03
ComPPI	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	4.85E-04	5.80E-04
ComPPI	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	1.72E-04	5.22E-04
ComPPI	BP	GO:0009994	oocyte differentiation	-	57	54	-	-	2.01E-03	2.55E-03
ComPPI	MF	GO:0031952	regulation of protein autophosphorylation	-	43	41	-	-	9.21E-04	1.91E-03
ComPPI	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	6.27E-03	6.95E-04
ComPPI	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	152	-	-	7.96E-03	7.07E-03
ComPPI	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	5.67E-03	1.62E-03
ComPPI	BP	GO:0033688	regulation of osteoblast proliferation	-	31	27	-	-	2.71E-03	1.27E-03
ComPPI	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	9.37E-04	1.62E-03
ComPPI	BP	GO:0072665	protein localization to vacuole	-	84	83	-	-	7.75E-03	3.88E-03
ComPPI	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	45	-	-	4.01E-02	2.09E-03
ComPPI	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	24	-	-	9.20E-03	1.16E-03
ComPPI	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	72	-	-	5.13E-03	3.36E-03
ComPPI	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	2.56E-03	7.53E-04
ComPPI	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	4.48E-03	6.95E-04
ComPPI	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.71E-04	5.22E-04
ComPPI	BP	GO:0042044	fluid transport	-	35	32	-	-	2.15E-03	1.51E-03
ComPPI	BP	GO:0070633	transepithelial transport	-	35	34	-	-	1.59E-03	1.62E-03
ComPPI	BP	GO:0033015	tetrapyrrole catabolic process	-	13	12	-	-	6.59E-03	5.80E-04
ComPPI	BP	GO:0045661	regulation of myoblast differentiation	-	74	73	-	-	1.15E-02	3.42E-03
ComPPI	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	11	-	-	1.73E-04	5.22E-04
ComPPI	BP	GO:0030307	positive regulation of cell growth	-	164	154	-	-	3.17E-03	7.19E-03
ComPPI	BP	GO:0034250	positive regulation of amide metabolic process	-	27	25	-	-	2.11E-02	1.16E-03
ComPPI	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	2.45E-03	8.69E-04
ComPPI	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	2.23E-03	6.37E-04
ComPPI	BP	GO:0014812	muscle cell migration	-	110	85	-	-	3.67E-03	3.94E-03
ComPPI	BP	GO:0048525	negative regulation of viral process	-	90	87	-	-	3.63E-03	4.06E-03
ComPPI	BP	GO:0072044	collecting duct development	-	16	16	-	-	1.75E-03	7.53E-04
ComPPI	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	8.71E-02	6.95E-04
ComPPI	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	4.78E-03	3.25E-03
ComPPI	BP	GO:0030238	male sex determination	-	14	14	-	-	2.41E-02	6.95E-04
ComPPI	BP	GO:0051781	positive regulation of cell division	-	93	87	-	-	3.80E-03	4.06E-03
ComPPI	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	2.13E-02	9.85E-04
ComPPI	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	7.40E-04	5.22E-04
ComPPI	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	3.01E-02	1.10E-03
ComPPI	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	22	-	-	1.20E-03	1.04E-03
ComPPI	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.18E-03	2.20E-03
ComPPI	BP	GO:0007272	ensheathment of neurons	-	146	140	-	-	6.12E-03	6.49E-03
ComPPI	CC	GO:0050806	positive regulation of synaptic transmission	-	171	144	-	-	4.12E-03	6.72E-03
ComPPI	BP	GO:0060021	roof of mouth development	-	91	90	-	-	5.73E-03	4.17E-03
ComPPI	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	3.55E-03	1.85E-03
ComPPI	BP	GO:0050819	negative regulation of coagulation	-	54	51	-	-	2.55E-02	2.38E-03
ComPPI	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	5.75E-03	5.22E-04
ComPPI	BP	GO:0017004	cytochrome complex assembly	-	40	37	-	-	5.19E-02	1.74E-03
ComPPI	BP	GO:0018410	C-terminal protein amino acid modification	-	15	14	-	-	1.42E-02	6.95E-04
ComPPI	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	9.90E-02	2.90E-03
ComPPI	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	7.58E-02	6.95E-04
ComPPI	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	13	-	-	1.04E-03	6.37E-04
ComPPI	CC	GO:0050805	negative regulation of synaptic transmission	-	55	53	-	-	7.11E-03	2.49E-03
ComPPI	BP	GO:0043248	proteasome assembly	-	13	13	-	-	1.73E-02	6.37E-04
ComPPI	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	58	-	-	6.85E-03	2.72E-03
ComPPI	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	5.45E-02	5.22E-04
ComPPI	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	81	-	-	1.86E-02	3.77E-03
ComPPI	BP	GO:0016054	organic acid catabolic process	-	251	240	-	-	2.51E-02	1.11E-02
ComPPI	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	1.49E-03	6.37E-04
ComPPI	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	2.48E-02	1.33E-03
ComPPI	BP	GO:0065005	protein-lipid complex assembly	-	29	27	-	-	1.46E-02	1.27E-03
ComPPI	BP	GO:0008033	tRNA processing	-	136	132	-	-	6.03E-02	6.14E-03
ComPPI	BP	GO:0046661	male sex differentiation	-	171	166	-	-	5.92E-03	7.71E-03
ComPPI	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	5.41E-04	6.95E-04
ComPPI	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	3.42E-03	8.11E-04
ComPPI	BP	GO:0035188	hatching	-	27	24	-	-	3.72E-04	1.16E-03
ComPPI	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	85	-	-	4.12E-03	3.94E-03
ComPPI	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	2.27E-04	6.95E-04
ComPPI	BP	GO:0090713	immunological memory process	-	18	18	-	-	4.30E-02	8.69E-04
ComPPI	BP	GO:0061326	renal tubule development	-	103	102	-	-	5.12E-03	4.75E-03
ComPPI	BP	GO:0071985	multivesicular body sorting pathway	-	56	55	-	-	5.08E-02	2.55E-03
ComPPI	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	3.57E-03	8.11E-04
ComPPI	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	1.58E-03	9.27E-04
ComPPI	BP	GO:0060325	face morphogenesis	-	31	30	-	-	1.10E-03	1.39E-03
ComPPI	BP	GO:0090559	regulation of membrane permeability	-	72	63	-	-	5.94E-03	2.96E-03
ComPPI	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	13	-	-	5.17E-02	6.37E-04
ComPPI	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	4.00E-02	5.80E-04
ComPPI	BP	GO:0031579	membrane raft organization	-	25	24	-	-	3.56E-03	1.16E-03
ComPPI	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	1.33E-03	1.16E-03
ComPPI	BP	GO:0060033	anatomical structure regression	-	16	15	-	-	1.04E-02	6.95E-04
ComPPI	BP	GO:0046460	neutral lipid biosynthetic process	-	50	43	-	-	5.54E-03	2.03E-03
ComPPI	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	140	-	-	1.26E-02	6.49E-03
ComPPI	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	1.72E-04	5.22E-04
ComPPI	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	159	-	-	3.47E-03	7.42E-03
ComPPI	BP	GO:0002251	organ or tissue specific immune response	-	43	35	-	-	2.58E-02	1.62E-03
ComPPI	CC	GO:0048167	regulation of synaptic plasticity	-	210	184	-	-	5.57E-03	8.58E-03
ComPPI	BP	GO:1903708	positive regulation of hemopoiesis	-	184	177	-	-	1.16E-02	8.23E-03
ComPPI	BP	GO:1903008	organelle disassembly	-	154	152	-	-	9.39E-03	7.07E-03
ComPPI	BP	GO:0001709	cell fate determination	-	44	42	-	-	2.20E-03	1.97E-03
ComPPI	BP	GO:0051873	killing by host of symbiont cells	-	28	26	-	-	1.91E-02	1.22E-03
ComPPI	BP	GO:0045058	T cell selection	-	53	53	-	-	4.05E-02	2.49E-03
ComPPI	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	2.22E-03	2.26E-03
ComPPI	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	1.25E-03	9.27E-04
ComPPI	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	2.60E-03	3.65E-03
ComPPI	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	40	-	-	8.69E-03	1.85E-03
ComPPI	BP	GO:0099084	postsynaptic specialization organization	-	44	43	-	-	7.62E-03	2.03E-03
ComPPI	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	4.59E-03	5.22E-04
ComPPI	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	2.83E-02	6.95E-04
ComPPI	BP	GO:0060384	innervation	-	27	27	-	-	1.02E-02	1.27E-03
ComPPI	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	2.14E-03	5.80E-04
ComPPI	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	31	-	-	1.01E-02	1.45E-03
ComPPI	MF	GO:0031281	positive regulation of cyclase activity	-	40	38	-	-	2.83E-03	1.80E-03
ComPPI	MF	GO:0098631	cell adhesion mediator activity	-	64	61	-	-	9.39E-03	2.84E-03
ComPPI	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	2.73E-03	8.69E-04
ComPPI	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	6.92E-02	5.80E-04
ComPPI	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	5.20E-03	8.69E-04
ComPPI	BP	GO:0071453	cellular response to oxygen levels	-	168	151	-	-	4.88E-03	7.01E-03
ComPPI	BP	GO:0090399	replicative senescence	-	17	16	-	-	1.75E-03	7.53E-04
ComPPI	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	13	-	-	7.51E-02	6.37E-04
ComPPI	BP	GO:0031342	negative regulation of cell killing	-	29	28	-	-	1.57E-02	1.33E-03
ComPPI	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	7.74E-03	5.80E-03
ComPPI	BP	GO:0006855	xenobiotic transmembrane transport	-	14	12	-	-	2.17E-02	5.80E-04
ComPPI	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	2.12E-03	1.16E-03
ComPPI	BP	GO:0044242	cellular lipid catabolic process	-	224	213	-	-	1.86E-02	9.91E-03
ComPPI	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	3.21E-04	6.37E-04
ComPPI	BP	GO:0002931	response to ischemia	-	58	54	-	-	5.18E-03	2.55E-03
ComPPI	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	2.99E-02	5.80E-04
ComPPI	BP	GO:0014047	glutamate secretion	-	25	25	-	-	2.58E-02	1.16E-03
ComPPI	BP	GO:0061005	cell differentiation involved in kidney development	-	58	57	-	-	5.15E-03	2.67E-03
ComPPI	BP	GO:0030397	membrane disassembly	-	11	11	-	-	8.59E-04	5.22E-04
ComPPI	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	72	-	-	2.28E-02	3.36E-03
ComPPI	BP	GO:0060420	regulation of heart growth	-	74	58	-	-	9.39E-03	2.72E-03
ComPPI	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	1.63E-04	6.95E-04
ComPPI	BP	GO:0009755	hormone-mediated signaling pathway	-	221	214	-	-	1.43E-02	9.97E-03
ComPPI	BP	GO:0022612	gland morphogenesis	-	124	123	-	-	4.34E-03	5.74E-03
ComPPI	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	35	-	-	9.86E-04	1.62E-03
ComPPI	MF	GO:0140416	transcription regulator inhibitor activity	-	26	25	-	-	2.33E-03	1.16E-03
ComPPI	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	25	-	-	7.98E-02	1.16E-03
ComPPI	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	6.65E-03	6.95E-04
ComPPI	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	2.22E-02	8.11E-04
ComPPI	BP	GO:1990845	adaptive thermogenesis	-	166	163	-	-	5.85E-03	7.59E-03
ComPPI	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	2.78E-02	2.49E-03
ComPPI	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	1.47E-02	5.22E-04
ComPPI	BP	GO:0015844	monoamine transport	-	88	87	-	-	3.09E-02	4.06E-03
ComPPI	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	23	-	-	3.43E-03	1.10E-03
ComPPI	BP	GO:0060039	pericardium development	-	19	18	-	-	5.17E-03	8.69E-04
ComPPI	BP	GO:0071392	cellular response to estradiol stimulus	-	40	39	-	-	3.14E-03	1.85E-03
ComPPI	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	12	-	-	4.01E-03	5.80E-04
ComPPI	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	5.16E-03	9.27E-04
ComPPI	BP	GO:0009451	RNA modification	-	169	160	-	-	2.30E-02	7.42E-03
ComPPI	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	2.37E-01	5.22E-04
ComPPI	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	39	-	-	2.36E-03	1.85E-03
ComPPI	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	2.00E-03	8.11E-04
ComPPI	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	109	-	-	7.88E-03	5.10E-03
ComPPI	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	36	-	-	1.51E-02	1.68E-03
ComPPI	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	1.73E-04	5.22E-04
ComPPI	BP	GO:0015807	L-amino acid transport	-	94	84	-	-	6.08E-03	3.94E-03
ComPPI	BP	GO:0032941	secretion by tissue	-	85	84	-	-	2.99E-03	3.94E-03
ComPPI	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	11	-	-	6.23E-03	5.22E-04
ComPPI	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	4.88E-03	2.55E-03
ComPPI	BP	GO:0048753	pigment granule organization	-	40	40	-	-	6.08E-02	1.85E-03
ComPPI	BP	GO:0021516	dorsal spinal cord development	-	20	17	-	-	2.00E-02	8.11E-04
ComPPI	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	6.98E-02	9.27E-04
ComPPI	BP	GO:0032196	transposition	-	11	11	-	-	1.88E-03	5.22E-04
ComPPI	BP	GO:0003014	renal system process	-	130	127	-	-	9.17E-03	5.91E-03
ComPPI	CC	GO:0070286	axonemal dynein complex assembly	-	40	36	-	-	6.51E-03	1.68E-03
ComPPI	BP	GO:0045598	regulation of fat cell differentiation	-	148	128	-	-	4.84E-03	5.97E-03
ComPPI	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	188	-	-	1.40E-02	8.75E-03
ComPPI	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	1.09E-03	1.80E-03
ComPPI	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	1.86E-03	1.16E-03
ComPPI	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	217	-	-	5.08E-02	1.01E-02
ComPPI	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.64E-04	6.37E-04
ComPPI	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	1.11E-03	1.10E-03
ComPPI	BP	GO:0018158	protein oxidation	-	15	14	-	-	1.81E-03	6.95E-04
ComPPI	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	4.81E-03	1.39E-03
ComPPI	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	2.29E-04	8.11E-04
ComPPI	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	26	-	-	4.13E-03	1.22E-03
ComPPI	BP	GO:0071709	membrane assembly	-	68	65	-	-	2.69E-02	3.01E-03
ComPPI	BP	GO:0008217	regulation of blood pressure	-	186	177	-	-	2.73E-02	8.23E-03
ComPPI	BP	GO:0031643	positive regulation of myelination	-	19	17	-	-	1.97E-03	8.11E-04
ComPPI	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	1.59E-02	6.95E-04
ComPPI	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	60	-	-	5.61E-03	2.78E-03
ComPPI	CC	GO:0042770	signal transduction in response to DNA damage	-	186	185	-	-	1.73E-02	8.58E-03
ComPPI	BP	GO:0002200	somatic diversification of immune receptors	-	78	78	-	-	6.21E-03	3.65E-03
ComPPI	BP	GO:0035315	hair cell differentiation	-	52	47	-	-	2.98E-03	2.20E-03
ComPPI	BP	GO:0048645	animal organ formation	-	62	60	-	-	5.02E-03	2.78E-03
ComPPI	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	159	-	-	8.99E-03	7.42E-03
ComPPI	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	13	-	-	2.30E-02	6.37E-04
ComPPI	BP	GO:0033627	cell adhesion mediated by integrin	-	87	85	-	-	1.84E-02	3.94E-03
ComPPI	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	1.08E-02	9.85E-04
ComPPI	BP	GO:0035107	appendage morphogenesis	-	147	145	-	-	6.86E-03	6.72E-03
ComPPI	BP	GO:1903707	negative regulation of hemopoiesis	-	116	104	-	-	4.37E-03	4.87E-03
ComPPI	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	2.24E-04	9.27E-04
ComPPI	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	3.21E-02	1.16E-03
ComPPI	BP	GO:0030149	sphingolipid catabolic process	-	32	30	-	-	2.14E-03	1.39E-03
ComPPI	BP	GO:0050994	regulation of lipid catabolic process	-	61	57	-	-	5.25E-03	2.67E-03
ComPPI	BP	GO:0035988	chondrocyte proliferation	-	24	23	-	-	2.06E-03	1.10E-03
ComPPI	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	1.15E-02	1.39E-03
ComPPI	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	9.67E-03	5.22E-04
ComPPI	BP	GO:0009593	detection of chemical stimulus	-	511	115	-	-	2.47E-02	5.33E-03
ComPPI	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	1.59E-03	5.80E-04
ComPPI	BP	GO:0045727	positive regulation of translation	-	141	136	-	-	3.92E-03	6.32E-03
ComPPI	BP	GO:0036315	cellular response to sterol	-	24	18	-	-	1.60E-02	8.69E-04
ComPPI	CC	GO:0032388	positive regulation of intracellular transport	-	137	135	-	-	2.15E-03	6.26E-03
ComPPI	BP	GO:0021979	hypothalamus cell differentiation	-	13	12	-	-	1.49E-03	5.80E-04
ComPPI	BP	GO:0002027	regulation of heart rate	-	106	99	-	-	3.84E-02	4.64E-03
ComPPI	BP	GO:0050879	multicellular organismal movement	-	118	113	-	-	2.01E-03	5.27E-03
ComPPI	BP	GO:0120305	regulation of pigmentation	-	15	14	-	-	2.48E-03	6.95E-04
ComPPI	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	74	-	-	2.50E-03	3.48E-03
ComPPI	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	61	-	-	2.99E-03	2.84E-03
ComPPI	BP	GO:0048515	spermatid differentiation	-	208	187	-	-	4.87E-03	8.69E-03
ComPPI	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	5.86E-03	2.67E-03
ComPPI	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	5.17E-03	1.45E-03
ComPPI	BP	GO:0007130	synaptonemal complex assembly	-	23	19	-	-	2.22E-04	9.27E-04
ComPPI	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	34	-	-	3.57E-03	1.62E-03
ComPPI	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	31	-	-	4.60E-04	1.45E-03
ComPPI	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	36	-	-	3.58E-02	1.68E-03
ComPPI	BP	GO:0060119	inner ear receptor cell development	-	44	40	-	-	5.46E-03	1.85E-03
ComPPI	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	7.50E-03	8.69E-04
ComPPI	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	6.56E-02	1.62E-03
ComPPI	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	1.13E-03	1.16E-03
ComPPI	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.69E-04	5.80E-04
ComPPI	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	240	-	-	8.28E-03	1.11E-02
ComPPI	BP	GO:1900006	positive regulation of dendrite development	-	17	16	-	-	1.06E-03	7.53E-04
ComPPI	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	5.15E-02	2.26E-03
ComPPI	BP	GO:0010883	regulation of lipid storage	-	53	49	-	-	3.40E-03	2.32E-03
ComPPI	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	4.20E-03	1.22E-03
ComPPI	BP	GO:0007635	chemosensory behavior	-	20	18	-	-	8.98E-04	8.69E-04
ComPPI	BP	GO:1905954	positive regulation of lipid localization	-	110	105	-	-	1.78E-02	4.87E-03
ComPPI	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.67E-04	5.80E-04
ComPPI	BP	GO:0002209	behavioral defense response	-	39	39	-	-	9.78E-03	1.85E-03
ComPPI	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	1.26E-01	1.39E-03
ComPPI	BP	GO:0072523	purine-containing compound catabolic process	-	146	143	-	-	5.28E-03	6.66E-03
ComPPI	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	31	-	-	1.13E-02	1.45E-03
ComPPI	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	27	-	-	2.90E-03	1.27E-03
ComPPI	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	2.26E-04	7.53E-04
ComPPI	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	94	-	-	7.65E-03	4.40E-03
ComPPI	BP	GO:0007218	neuropeptide signaling pathway	-	113	102	-	-	8.47E-02	4.75E-03
ComPPI	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	7.04E-03	5.80E-04
ComPPI	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	161	-	-	1.15E-02	7.48E-03
ComPPI	BP	GO:0031345	negative regulation of cell projection organization	-	195	185	-	-	8.23E-03	8.58E-03
ComPPI	BP	GO:0048278	vesicle docking	-	64	63	-	-	2.74E-02	2.96E-03
ComPPI	BP	GO:0035050	embryonic heart tube development	-	86	83	-	-	8.32E-03	3.88E-03
ComPPI	BP	GO:0030168	platelet activation	-	135	131	-	-	1.88E-02	6.08E-03
ComPPI	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	8.48E-02	7.53E-04
ComPPI	CC	GO:0098810	neurotransmitter reuptake	-	35	33	-	-	7.94E-03	1.56E-03
ComPPI	BP	GO:0008213	protein alkylation	-	58	53	-	-	5.89E-03	2.49E-03
ComPPI	BP	GO:0009812	flavonoid metabolic process	-	14	12	-	-	1.39E-01	5.80E-04
ComPPI	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	4.58E-03	6.37E-04
ComPPI	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	1.35E-02	1.16E-03
ComPPI	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	5.79E-04	6.37E-04
ComPPI	BP	GO:0031529	ruffle organization	-	55	55	-	-	2.77E-03	2.55E-03
ComPPI	BP	GO:0010842	retina layer formation	-	25	25	-	-	6.52E-03	1.16E-03
ComPPI	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	88	-	-	4.67E-02	4.11E-03
ComPPI	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	1.72E-04	5.22E-04
ComPPI	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	70	-	-	6.67E-03	3.25E-03
ComPPI	MF	GO:0170055	lipid transmembrane transporter activity	-	56	53	-	-	2.58E-02	2.49E-03
ComPPI	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	32	-	-	3.77E-03	1.51E-03
ComPPI	BP	GO:0035304	regulation of protein dephosphorylation	-	87	83	-	-	2.46E-03	3.88E-03
ComPPI	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	227	-	-	4.66E-03	1.05E-02
ComPPI	BP	GO:0099637	neurotransmitter receptor transport	-	26	25	-	-	1.57E-03	1.16E-03
ComPPI	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	1.12E-03	1.62E-03
ComPPI	BP	GO:0051775	response to redox state	-	13	13	-	-	6.76E-03	6.37E-04
ComPPI	BP	GO:0051785	positive regulation of nuclear division	-	61	59	-	-	2.64E-03	2.78E-03
ComPPI	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	2.66E-02	7.53E-04
ComPPI	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	7.25E-03	7.53E-04
ComPPI	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	2.19E-03	9.27E-04
ComPPI	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	2.01E-02	5.80E-04
ComPPI	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	9.38E-03	2.09E-03
ComPPI	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	13	-	-	3.83E-03	6.37E-04
ComPPI	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	2.08E-03	8.11E-04
ComPPI	BP	GO:0051299	centrosome separation	-	15	15	-	-	1.55E-03	6.95E-04
ComPPI	BP	GO:0048145	regulation of fibroblast proliferation	-	87	84	-	-	2.33E-03	3.94E-03
ComPPI	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	88	-	-	2.95E-01	4.11E-03
ComPPI	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	1.71E-02	5.22E-04
ComPPI	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	224	-	-	4.83E-03	1.04E-02
ComPPI	BP	GO:0032098	regulation of appetite	-	20	20	-	-	5.66E-02	9.27E-04
ComPPI	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	1.75E-03	6.95E-04
ComPPI	CC	GO:0008333	endosome to lysosome transport	-	73	72	-	-	3.95E-02	3.36E-03
ComPPI	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	21	-	-	2.34E-02	9.85E-04
ComPPI	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	14	-	-	1.20E-02	6.95E-04
ComPPI	BP	GO:0003016	respiratory system process	-	39	37	-	-	5.95E-04	1.74E-03
ComPPI	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	2.53E-02	1.10E-03
ComPPI	BP	GO:0045732	positive regulation of protein catabolic process	-	202	200	-	-	5.48E-03	9.27E-03
ComPPI	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	70	-	-	1.26E-02	3.25E-03
ComPPI	BP	GO:0007588	excretion	-	40	38	-	-	1.42E-02	1.80E-03
ComPPI	BP	GO:1904018	positive regulation of vasculature development	-	185	157	-	-	1.30E-02	7.30E-03
ComPPI	BP	GO:0050953	sensory perception of light stimulus	-	223	205	-	-	4.80E-02	9.50E-03
ComPPI	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	7.03E-02	1.16E-03
ComPPI	BP	GO:0009303	rRNA transcription	-	37	37	-	-	1.63E-02	1.74E-03
ComPPI	BP	GO:0035601	protein deacylation	-	56	54	-	-	5.70E-03	2.55E-03
ComPPI	BP	GO:0061952	midbody abscission	-	18	18	-	-	1.56E-01	8.69E-04
ComPPI	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	2.12E-03	5.22E-04
ComPPI	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	1.90E-03	9.27E-04
ComPPI	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	5.78E-03	1.39E-03
ComPPI	BP	GO:0071300	cellular response to retinoic acid	-	66	64	-	-	6.39E-03	3.01E-03
ComPPI	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	16	-	-	6.82E-02	7.53E-04
ComPPI	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	1.37E-02	1.33E-03
ComPPI	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	2.63E-03	1.56E-03
ComPPI	BP	GO:0046697	decidualization	-	26	25	-	-	7.96E-03	1.16E-03
ComPPI	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	1.71E-04	6.95E-04
ComPPI	BP	GO:0051588	regulation of neurotransmitter transport	-	99	93	-	-	4.35E-03	4.35E-03
ComPPI	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	28	-	-	4.94E-03	1.33E-03
ComPPI	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	1.68E-03	5.80E-04
ComPPI	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	8.93E-03	2.96E-03
ComPPI	BP	GO:0044703	multi-organism reproductive process	-	209	197	-	-	9.41E-03	9.16E-03
ComPPI	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	139	-	-	1.23E-02	6.49E-03
ComPPI	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	51	-	-	6.41E-03	2.38E-03
ComPPI	BP	GO:0099022	vesicle tethering	-	32	31	-	-	1.95E-01	1.45E-03
ComPPI	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	37	-	-	1.43E-03	1.74E-03
ComPPI	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	3.86E-03	5.80E-04
ComPPI	BP	GO:0048857	neural nucleus development	-	65	62	-	-	1.72E-03	2.90E-03
ComPPI	BP	GO:0048663	neuron fate commitment	-	74	67	-	-	7.95E-03	3.13E-03
ComPPI	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	156	-	-	4.62E-03	7.24E-03
ComPPI	BP	GO:0106027	neuron projection organization	-	90	87	-	-	3.38E-03	4.06E-03
ComPPI	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	126	-	-	2.33E-02	5.85E-03
ComPPI	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	3.90E-03	1.62E-03
ComPPI	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	4.18E-03	5.22E-04
ComPPI	BP	GO:0045685	regulation of glial cell differentiation	-	77	71	-	-	1.34E-02	3.30E-03
ComPPI	BP	GO:0051608	histamine transport	-	14	12	-	-	1.37E-03	5.80E-04
ComPPI	BP	GO:0043414	macromolecule methylation	-	138	129	-	-	1.16E-02	6.03E-03
ComPPI	BP	GO:0048521	negative regulation of behavior	-	12	11	-	-	5.02E-02	5.22E-04
ComPPI	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	9.87E-02	7.53E-04
ComPPI	BP	GO:0050886	endocrine process	-	93	91	-	-	1.21E-02	4.23E-03
ComPPI	MF	GO:0015562	efflux transmembrane transporter activity	-	15	13	-	-	1.71E-04	6.37E-04
ComPPI	BP	GO:0050951	sensory perception of temperature stimulus	-	28	25	-	-	5.82E-03	1.16E-03
ComPPI	BP	GO:0045807	positive regulation of endocytosis	-	155	149	-	-	7.23E-03	6.95E-03
ComPPI	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	1.05E-03	5.22E-04
ComPPI	BP	GO:0002418	immune response to tumor cell	-	29	27	-	-	7.28E-03	1.27E-03
ComPPI	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	4.80E-03	2.72E-03
ComPPI	BP	GO:0048308	organelle inheritance	-	14	14	-	-	4.65E-03	6.95E-04
ComPPI	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	1.02E-03	8.69E-04
ComPPI	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	1.57E-03	9.27E-04
ComPPI	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	47	-	-	1.96E-03	2.20E-03
ComPPI	BP	GO:0034394	protein localization to cell surface	-	69	66	-	-	1.29E-03	3.07E-03
ComPPI	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	1.70E-04	5.80E-04
ComPPI	BP	GO:0009110	vitamin biosynthetic process	-	23	21	-	-	2.99E-03	9.85E-04
ComPPI	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	5.43E-03	1.04E-03
ComPPI	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	7.03E-03	8.11E-04
ComPPI	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	20	-	-	4.57E-03	9.27E-04
ComPPI	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	91	-	-	2.31E-03	4.23E-03
ComPPI	BP	GO:0009111	vitamin catabolic process	-	13	11	-	-	2.01E-02	5.22E-04
ComPPI	MF	GO:0051100	negative regulation of binding	-	161	156	-	-	3.37E-03	7.24E-03
ComPPI	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	7.39E-03	3.65E-03
ComPPI	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	2.07E-03	2.78E-03
ComPPI	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	1.34E-03	9.27E-04
ComPPI	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	1.70E-04	5.80E-04
ComPPI	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	1.77E-02	1.56E-03
ComPPI	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	9.21E-03	7.53E-04
ComPPI	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	5.60E-04	6.37E-04
ComPPI	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	46	-	-	4.24E-03	2.14E-03
ComPPI	BP	GO:0046621	negative regulation of organ growth	-	39	31	-	-	2.77E-03	1.45E-03
ComPPI	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	1.36E-01	2.32E-03
ComPPI	BP	GO:0032368	regulation of lipid transport	-	149	128	-	-	5.83E-03	5.97E-03
ComPPI	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	4.43E-03	1.39E-03
ComPPI	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	175	-	-	6.09E-03	8.11E-03
ComPPI	BP	GO:0033002	muscle cell proliferation	-	249	200	-	-	7.33E-03	9.27E-03
ComPPI	BP	GO:0043331	response to dsRNA	-	56	55	-	-	5.60E-02	2.55E-03
ComPPI	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	8.04E-03	5.80E-04
ComPPI	BP	GO:0051904	pigment granule transport	-	23	23	-	-	2.78E-02	1.10E-03
ComPPI	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	7.82E-03	1.51E-03
ComPPI	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	1.41E-03	1.56E-03
ComPPI	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	11	-	-	2.84E-02	5.22E-04
ComPPI	BP	GO:0033363	secretory granule organization	-	63	60	-	-	1.83E-02	2.78E-03
ComPPI	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	2.31E-03	1.33E-03
ComPPI	BP	GO:0120009	intermembrane lipid transfer	-	52	48	-	-	1.28E-02	2.26E-03
ComPPI	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	9.70E-03	6.95E-04
ComPPI	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	1.96E-03	1.80E-03
ComPPI	BP	GO:0033622	integrin activation	-	26	26	-	-	9.25E-03	1.22E-03
ComPPI	BP	GO:0098751	bone cell development	-	18	16	-	-	1.00E-03	7.53E-04
ComPPI	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.07E-03	9.85E-04
ComPPI	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	2.86E-03	2.38E-03
ComPPI	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.54E-02	1.39E-03
ComPPI	BP	GO:0002076	osteoblast development	-	17	17	-	-	2.55E-03	8.11E-04
ComPPI	BP	GO:0072164	mesonephric tubule development	-	98	97	-	-	6.66E-03	4.52E-03
ComPPI	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	2.26E-04	8.11E-04
ComPPI	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	104	-	-	4.07E-03	4.87E-03
ComPPI	BP	GO:1903524	positive regulation of blood circulation	-	39	36	-	-	5.70E-03	1.68E-03
ComPPI	BP	GO:0030901	midbrain development	-	87	83	-	-	4.09E-03	3.88E-03
ComPPI	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	1.39E-02	1.04E-03
ComPPI	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	8.46E-03	7.53E-04
ComPPI	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	2.67E-03	6.37E-04
ComPPI	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	67	-	-	2.88E-03	3.13E-03
ComPPI	BP	GO:0002687	positive regulation of leukocyte migration	-	147	145	-	-	1.33E-02	6.72E-03
ComPPI	BP	GO:0019755	one-carbon compound transport	-	28	25	-	-	1.90E-02	1.16E-03
ComPPI	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.67E-04	6.37E-04
ComPPI	BP	GO:0060856	establishment of blood-brain barrier	-	16	15	-	-	1.69E-02	6.95E-04
ComPPI	BP	GO:0110154	RNA decapping	-	19	18	-	-	2.99E-02	8.69E-04
ComPPI	BP	GO:0034605	cellular response to heat	-	66	65	-	-	1.81E-03	3.01E-03
ComPPI	BP	GO:0005996	monosaccharide metabolic process	-	250	237	-	-	1.13E-02	1.10E-02
ComPPI	BP	GO:0033555	multicellular organismal response to stress	-	90	86	-	-	7.94E-03	4.00E-03
ComPPI	BP	GO:0002262	myeloid cell homeostasis	-	172	167	-	-	4.66E-03	7.77E-03
ComPPI	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	1.12E-01	1.80E-03
ComPPI	BP	GO:0050688	regulation of defense response to virus	-	65	63	-	-	2.01E-02	2.96E-03
ComPPI	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	2.18E-03	9.27E-04
ComPPI	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	222	-	-	1.24E-02	1.03E-02
ComPPI	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	1.01E-03	1.45E-03
ComPPI	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	4.44E-04	6.95E-04
ComPPI	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	9.24E-03	1.51E-03
ComPPI	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	18	-	-	7.20E-04	8.69E-04
ComPPI	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	2.50E-02	1.33E-03
ComPPI	BP	GO:0022618	protein-RNA complex assembly	-	227	190	-	-	2.85E-02	8.81E-03
ComPPI	BP	GO:0051147	regulation of muscle cell differentiation	-	162	131	-	-	6.11E-03	6.08E-03
ComPPI	BP	GO:0090102	cochlea development	-	50	47	-	-	1.82E-03	2.20E-03
ComPPI	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	2.50E-03	1.22E-03
ComPPI	BP	GO:0061303	cornea development in camera-type eye	-	12	11	-	-	1.72E-04	5.22E-04
ComPPI	BP	GO:0045933	positive regulation of muscle contraction	-	49	46	-	-	9.86E-03	2.14E-03
ComPPI	BP	GO:0015803	branched-chain amino acid transport	-	14	13	-	-	5.29E-02	6.37E-04
ComPPI	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	1.79E-03	7.53E-04
ComPPI	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	34	-	-	3.59E-03	1.62E-03
ComPPI	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	91	-	-	1.07E-01	4.23E-03
ComPPI	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.70E-04	5.80E-04
ComPPI	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	3.51E-03	1.04E-03
ComPPI	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	9.52E-03	3.30E-03
ComPPI	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	54	-	-	8.63E-03	2.55E-03
ComPPI	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	144	-	-	8.45E-03	6.72E-03
ComPPI	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	22	-	-	5.27E-02	1.04E-03
ComPPI	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	56	-	-	4.64E-03	2.61E-03
ComPPI	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	2.61E-03	5.22E-04
ComPPI	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	6.13E-03	1.80E-03
ComPPI	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.67E-04	5.80E-04
ComPPI	BP	GO:0140253	cell-cell fusion	-	62	57	-	-	9.01E-03	2.67E-03
ComPPI	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	6.10E-03	5.80E-04
ComPPI	BP	GO:0071599	otic vesicle development	-	15	15	-	-	6.13E-03	6.95E-04
ComPPI	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	41	-	-	1.04E-01	1.91E-03
ComPPI	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	1.02E-03	6.95E-04
ComPPI	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	8.32E-03	2.78E-03
ComPPI	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	3.51E-02	1.68E-03
ComPPI	BP	GO:0051293	establishment of spindle localization	-	57	56	-	-	3.74E-03	2.61E-03
ComPPI	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	3.01E-03	6.37E-04
ComPPI	BP	GO:0043114	regulation of vascular permeability	-	49	44	-	-	6.01E-03	2.09E-03
ComPPI	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	6.22E-03	1.22E-03
ComPPI	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	62	-	-	3.19E-03	2.90E-03
ComPPI	BP	GO:0008360	regulation of cell shape	-	139	133	-	-	8.01E-03	6.20E-03
ComPPI	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	1.98E-02	7.53E-04
ComPPI	BP	GO:0051222	positive regulation of protein transport	-	249	239	-	-	5.01E-03	1.11E-02
ComPPI	CC	GO:0140632	canonical inflammasome complex assembly	-	40	40	-	-	2.63E-02	1.85E-03
ComPPI	MF	GO:0034260	negative regulation of GTPase activity	-	36	33	-	-	9.41E-04	1.56E-03
ComPPI	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	7.58E-03	1.04E-03
ComPPI	BP	GO:0045739	positive regulation of DNA repair	-	128	126	-	-	5.75E-02	5.85E-03
ComPPI	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	4.48E-04	9.27E-04
ComPPI	BP	GO:0045185	maintenance of protein location	-	95	87	-	-	2.62E-03	4.06E-03
ComPPI	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	7.83E-02	6.37E-04
ComPPI	BP	GO:0003158	endothelium development	-	140	128	-	-	8.10E-03	5.97E-03
ComPPI	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	2.44E-03	1.91E-03
ComPPI	BP	GO:0051224	negative regulation of protein transport	-	122	105	-	-	5.25E-03	4.87E-03
ComPPI	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	145	-	-	2.87E-03	6.72E-03
ComPPI	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	4.44E-03	6.37E-04
ComPPI	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	1.19E-02	1.45E-03
ComPPI	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	1.28E-01	9.27E-04
ComPPI	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	2.98E-03	2.96E-03
ComPPI	BP	GO:0007405	neuroblast proliferation	-	81	75	-	-	2.98E-03	3.48E-03
ComPPI	BP	GO:0009581	detection of external stimulus	-	137	116	-	-	1.17E-02	5.39E-03
ComPPI	BP	GO:1990542	mitochondrial transmembrane transport	-	93	92	-	-	3.90E-02	4.29E-03
ComPPI	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	2.51E-03	1.45E-03
ComPPI	BP	GO:0033504	floor plate development	-	11	11	-	-	5.92E-03	5.22E-04
ComPPI	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	1.37E-02	5.22E-04
ComPPI	BP	GO:0097186	amelogenesis	-	26	22	-	-	5.90E-02	1.04E-03
ComPPI	BP	GO:0031128	developmental induction	-	26	26	-	-	1.47E-03	1.22E-03
ComPPI	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	1.26E-02	6.95E-04
ComPPI	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.40E-03	3.07E-03
ComPPI	BP	GO:0021533	cell differentiation in hindbrain	-	23	21	-	-	1.48E-03	9.85E-04
ComPPI	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	1.01E-03	1.45E-03
ComPPI	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	5.49E-03	5.80E-04
ComPPI	BP	GO:1900047	negative regulation of hemostasis	-	51	50	-	-	3.04E-02	2.32E-03
ComPPI	BP	GO:0021517	ventral spinal cord development	-	47	44	-	-	2.38E-02	2.09E-03
ComPPI	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	3.32E-03	3.48E-03
ComPPI	BP	GO:0032328	alanine transport	-	19	16	-	-	2.60E-02	7.53E-04
ComPPI	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	2.73E-03	7.53E-04
ComPPI	BP	GO:0097722	sperm motility	-	133	117	-	-	1.95E-02	5.45E-03
ComPPI	BP	GO:0051231	spindle elongation	-	14	13	-	-	2.14E-02	6.37E-04
ComPPI	BP	GO:0042490	mechanoreceptor differentiation	-	67	61	-	-	2.43E-03	2.84E-03
ComPPI	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	2.97E-03	1.39E-03
ComPPI	BP	GO:0035148	tube formation	-	155	153	-	-	6.09E-03	7.13E-03
ComPPI	BP	GO:0048520	positive regulation of behavior	-	27	26	-	-	5.67E-02	1.22E-03
ComPPI	BP	GO:0098543	detection of other organism	-	19	16	-	-	4.63E-02	7.53E-04
ComPPI	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	1.03E-02	2.03E-03
ComPPI	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	118	-	-	8.88E-03	5.51E-03
ComPPI	BP	GO:0031123	RNA 3'-end processing	-	79	78	-	-	4.43E-02	3.65E-03
ComPPI	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	1.22E-02	5.22E-04
ComPPI	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	107	-	-	4.68E-03	4.98E-03
ComPPI	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	1.60E-02	8.69E-04
ComPPI	CC	GO:0007097	nuclear migration	-	24	23	-	-	3.21E-03	1.10E-03
ComPPI	BP	GO:0006885	regulation of pH	-	104	97	-	-	1.50E-02	4.52E-03
ComPPI	BP	GO:0002467	germinal center formation	-	14	14	-	-	7.92E-04	6.95E-04
ComPPI	BP	GO:1990840	response to lectin	-	22	20	-	-	1.10E-02	9.27E-04
ComPPI	BP	GO:0071800	podosome assembly	-	19	19	-	-	9.04E-04	9.27E-04
ComPPI	BP	GO:0031018	endocrine pancreas development	-	47	45	-	-	4.22E-03	2.09E-03
ComPPI	BP	GO:0001708	cell fate specification	-	108	103	-	-	1.35E-02	4.81E-03
ComPPI	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	67	-	-	8.88E-03	3.13E-03
ComPPI	BP	GO:0030279	negative regulation of ossification	-	39	36	-	-	2.20E-02	1.68E-03
ComPPI	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	4.71E-03	6.95E-04
ComPPI	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	3.08E-03	5.80E-04
ComPPI	BP	GO:0042440	pigment metabolic process	-	80	75	-	-	2.69E-02	3.48E-03
ComPPI	BP	GO:1901606	alpha-amino acid catabolic process	-	101	97	-	-	1.35E-02	4.52E-03
ComPPI	BP	GO:1901890	positive regulation of cell junction assembly	-	106	101	-	-	6.05E-03	4.69E-03
ComPPI	BP	GO:0070988	demethylation	-	27	25	-	-	3.07E-02	1.16E-03
ComPPI	BP	GO:1901655	cellular response to ketone	-	107	104	-	-	6.31E-03	4.87E-03
ComPPI	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	1.13E-03	6.95E-04
ComPPI	BP	GO:0051255	spindle midzone assembly	-	14	13	-	-	1.50E-02	6.37E-04
ComPPI	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	9.95E-02	8.11E-04
ComPPI	BP	GO:0006968	cellular defense response	-	52	52	-	-	1.41E-02	2.43E-03
ComPPI	BP	GO:0055006	cardiac cell development	-	93	81	-	-	2.67E-03	3.77E-03
ComPPI	BP	GO:0031365	N-terminal protein amino acid modification	-	30	28	-	-	2.15E-02	1.33E-03
ComPPI	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	1.72E-04	5.80E-04
ComPPI	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	27	-	-	3.44E-03	1.27E-03
ComPPI	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	7.47E-04	5.80E-04
ComPPI	BP	GO:0060004	reflex	-	63	59	-	-	2.50E-03	2.78E-03
ComPPI	BP	GO:0044706	multi-multicellular organism process	-	217	206	-	-	1.18E-02	9.56E-03
ComPPI	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	1.81E-03	5.80E-04
ComPPI	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	139	-	-	4.61E-03	6.49E-03
ComPPI	BP	GO:0006026	aminoglycan catabolic process	-	34	31	-	-	3.03E-03	1.45E-03
ComPPI	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	1.08E-02	2.14E-03
ComPPI	BP	GO:0050768	negative regulation of neurogenesis	-	150	140	-	-	4.71E-03	6.49E-03
ComPPI	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	94	-	-	2.13E-03	4.40E-03
ComPPI	BP	GO:0090068	positive regulation of cell cycle process	-	262	243	-	-	6.51E-03	1.13E-02
ComPPI	BP	GO:0043605	amide catabolic process	-	16	16	-	-	2.75E-02	7.53E-04
ComPPI	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	26	-	-	2.60E-03	1.22E-03
ComPPI	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	33	-	-	3.17E-02	1.56E-03
ComPPI	BP	GO:1902115	regulation of organelle assembly	-	210	204	-	-	6.51E-03	9.50E-03
ComPPI	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	65	-	-	3.29E-03	3.01E-03
ComPPI	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	2.25E-04	7.53E-04
ComPPI	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	139	-	-	5.62E-03	6.49E-03
ComPPI	BP	GO:0043171	peptide catabolic process	-	19	16	-	-	2.27E-04	7.53E-04
ComPPI	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	1.34E-03	1.97E-03
ComPPI	BP	GO:0051952	regulation of amine transport	-	98	97	-	-	1.74E-02	4.52E-03
ComPPI	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	1.60E-02	1.10E-03
ComPPI	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	2.10E-03	9.27E-04
ComPPI	BP	GO:0015801	aromatic amino acid transport	-	13	11	-	-	9.51E-04	5.22E-04
ComPPI	BP	GO:0040019	positive regulation of embryonic development	-	23	22	-	-	1.79E-02	1.04E-03
ComPPI	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	2.85E-04	9.27E-04
ComPPI	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	5.80E-04	7.53E-04
ComPPI	CC	GO:0032365	intracellular lipid transport	-	51	48	-	-	1.34E-02	2.26E-03
ComPPI	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	5.68E-02	1.39E-03
ComPPI	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	68	-	-	2.01E-03	3.19E-03
ComPPI	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	112	-	-	5.34E-03	5.22E-03
ComPPI	BP	GO:0018149	peptide cross-linking	-	28	27	-	-	1.40E-01	1.27E-03
ComPPI	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	24	-	-	9.43E-04	1.16E-03
ComPPI	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	9.26E-04	6.37E-04
ComPPI	BP	GO:0021859	pyramidal neuron differentiation	-	14	13	-	-	1.68E-04	6.37E-04
ComPPI	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	1.65E-04	6.37E-04
ComPPI	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	1.16E-02	1.62E-03
ComPPI	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	1.25E-02	5.22E-04
ComPPI	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	5.65E-03	4.17E-03
ComPPI	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	1.11E-02	1.39E-03
ComPPI	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	2.26E-04	8.69E-04
ComPPI	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	8.07E-03	9.85E-04
ComPPI	BP	GO:0015669	gas transport	-	23	22	-	-	6.39E-02	1.04E-03
ComPPI	BP	GO:0016485	protein processing	-	248	241	-	-	1.03E-02	1.12E-02
ComPPI	BP	GO:0009649	entrainment of circadian clock	-	30	27	-	-	6.70E-03	1.27E-03
ComPPI	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	161	-	-	3.42E-02	7.48E-03
ComPPI	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	9.59E-04	1.16E-03
ComPPI	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	125	-	-	1.72E-02	5.80E-03
ComPPI	BP	GO:0000101	sulfur amino acid transport	-	12	11	-	-	2.19E-02	5.22E-04
ComPPI	BP	GO:0099054	presynapse assembly	-	49	47	-	-	1.71E-03	2.20E-03
ComPPI	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	1.81E-01	5.80E-04
ComPPI	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	4.93E-03	1.16E-03
ComPPI	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	2.12E-03	1.16E-03
ComPPI	BP	GO:0031348	negative regulation of defense response	-	282	236	-	-	6.39E-03	1.10E-02
ComPPI	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	76	-	-	3.48E-03	3.54E-03
ComPPI	BP	GO:0007606	sensory perception of chemical stimulus	-	535	133	-	-	3.02E-02	6.20E-03
ComPPI	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	4.63E-03	3.19E-03
ComPPI	BP	GO:0071496	cellular response to external stimulus	-	74	72	-	-	4.65E-03	3.36E-03
ComPPI	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	1.49E-02	6.37E-04
ComPPI	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	7.81E-02	8.11E-04
ComPPI	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	1.60E-04	5.22E-04
ComPPI	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	6.08E-03	5.80E-04
ComPPI	BP	GO:0032094	response to food	-	37	37	-	-	1.91E-02	1.74E-03
ComPPI	BP	GO:0001964	startle response	-	27	27	-	-	2.58E-03	1.27E-03
ComPPI	BP	GO:0007340	acrosome reaction	-	38	34	-	-	1.77E-02	1.62E-03
ComPPI	BP	GO:0046434	organophosphate catabolic process	-	232	224	-	-	7.08E-03	1.04E-02
ComPPI	BP	GO:0060037	pharyngeal system development	-	29	28	-	-	2.15E-02	1.33E-03
ComPPI	BP	GO:0009566	fertilization	-	205	173	-	-	1.39E-02	8.06E-03
ComPPI	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	59	-	-	3.22E-01	2.78E-03
ComPPI	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	3.99E-02	1.16E-03
ComPPI	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	2.40E-02	6.37E-04
ComPPI	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	1.70E-02	1.39E-03
ComPPI	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	22	-	-	2.63E-03	1.04E-03
ComPPI	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	2.37E-02	1.15E-02
ComPPI	BP	GO:0009309	amine biosynthetic process	-	38	36	-	-	2.30E-02	1.68E-03
ComPPI	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	2.29E-03	9.27E-04
ComPPI	BP	GO:0061900	glial cell activation	-	56	52	-	-	2.58E-03	2.43E-03
ComPPI	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	133	-	-	1.66E-02	6.20E-03
ComPPI	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	2.16E-03	6.37E-04
ComPPI	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	6.95E-03	6.95E-04
ComPPI	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	1.23E-02	1.91E-03
ComPPI	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	2.77E-04	9.27E-04
ComPPI	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	3.39E-04	6.95E-04
ComPPI	BP	GO:0072537	fibroblast activation	-	13	13	-	-	9.97E-03	6.37E-04
ComPPI	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	7.49E-03	6.37E-04
ComPPI	BP	GO:0043647	inositol phosphate metabolic process	-	44	42	-	-	1.13E-03	1.97E-03
ComPPI	BP	GO:0016180	snRNA processing	-	28	27	-	-	2.02E-01	1.27E-03
ComPPI	BP	GO:0051303	establishment of chromosome localization	-	104	101	-	-	1.01E-02	4.69E-03
ComPPI	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	1.79E-02	7.53E-04
ComPPI	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	4.30E-03	1.80E-03
ComPPI	BP	GO:0097164	ammonium ion metabolic process	-	23	22	-	-	2.86E-04	1.04E-03
ComPPI	BP	GO:0021515	cell differentiation in spinal cord	-	51	48	-	-	2.48E-02	2.26E-03
ComPPI	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	2.18E-03	8.69E-04
ComPPI	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	1.97E-03	9.85E-04
ComPPI	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	1.56E-03	1.33E-03
ComPPI	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	3.17E-03	8.69E-04
ComPPI	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	35	-	-	1.36E-02	1.62E-03
ComPPI	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	1.03E-02	1.04E-03
ComPPI	BP	GO:0007566	embryo implantation	-	57	52	-	-	1.96E-03	2.43E-03
ComPPI	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	32	-	-	1.07E-03	1.51E-03
ComPPI	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	5.91E-02	7.53E-04
ComPPI	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	1.61E-02	1.51E-03
ComPPI	BP	GO:0051017	actin filament bundle assembly	-	161	152	-	-	6.21E-03	7.07E-03
ComPPI	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	4.47E-03	1.97E-03
ComPPI	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	17	-	-	9.74E-04	8.11E-04
ComPPI	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	6.78E-04	9.27E-04
ComPPI	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	1.47E-03	6.37E-04
ComPPI	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	36	-	-	4.33E-03	1.68E-03
ComPPI	BP	GO:0021756	striatum development	-	21	21	-	-	2.22E-03	9.85E-04
ComPPI	BP	GO:1901343	negative regulation of vasculature development	-	154	100	-	-	5.89E-03	4.64E-03
ComPPI	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	149	-	-	1.36E-02	6.95E-03
ComPPI	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	28	-	-	6.95E-03	1.33E-03
ComPPI	BP	GO:1902414	protein localization to cell junction	-	107	105	-	-	7.35E-03	4.87E-03
ComPPI	BP	GO:0071305	cellular response to vitamin D	-	23	21	-	-	1.56E-03	9.85E-04
ComPPI	BP	GO:0051304	chromosome separation	-	80	80	-	-	1.09E-02	3.71E-03
ComPPI	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	3.31E-03	8.69E-04
ComPPI	BP	GO:0048709	oligodendrocyte differentiation	-	101	97	-	-	3.69E-03	4.52E-03
ComPPI	BP	GO:0045017	glycerolipid biosynthetic process	-	254	241	-	-	1.80E-02	1.12E-02
ComPPI	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	3.35E-01	6.95E-04
ComPPI	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	6.58E-03	1.10E-03
ComPPI	BP	GO:0001776	leukocyte homeostasis	-	108	100	-	-	3.58E-03	4.64E-03
ComPPI	BP	GO:0050769	positive regulation of neurogenesis	-	240	228	-	-	6.46E-03	1.06E-02
ComPPI	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	4.02E-02	6.95E-04
ComPPI	BP	GO:0030193	regulation of blood coagulation	-	70	69	-	-	2.54E-02	3.25E-03
ComPPI	BP	GO:0050866	negative regulation of cell activation	-	216	202	-	-	7.20E-03	9.39E-03
ComPPI	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	35	-	-	1.64E-03	1.62E-03
ComPPI	BP	GO:0033500	carbohydrate homeostasis	-	251	228	-	-	6.14E-03	1.06E-02
ComPPI	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	29	-	-	1.09E-02	1.39E-03
ComPPI	BP	GO:0044088	regulation of vacuole organization	-	56	55	-	-	4.70E-03	2.55E-03
ComPPI	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	2.83E-03	1.10E-03
ComPPI	CC	GO:0099522	cytosolic region	-	20	20	-	-	8.00E-04	9.27E-04
ComPPI	CC	GO:0000791	euchromatin	-	60	58	-	-	4.58E-03	2.72E-03
ComPPI	CC	GO:0030666	endocytic vesicle membrane	-	196	192	-	-	1.36E-02	8.92E-03
ComPPI	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	5.62E-02	6.95E-04
ComPPI	CC	GO:1990752	microtubule end	-	34	34	-	-	1.95E-02	1.62E-03
ComPPI	CC	GO:0043204	perikaryon	-	156	148	-	-	3.34E-03	6.90E-03
ComPPI	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	7.58E-02	8.11E-04
ComPPI	CC	GO:0098643	banded collagen fibril	-	12	11	-	-	1.10E-01	5.22E-04
ComPPI	CC	GO:0097542	ciliary tip	-	48	48	-	-	1.58E-01	2.26E-03
ComPPI	CC	GO:1905368	peptidase complex	-	124	122	-	-	8.05E-02	5.68E-03
ComPPI	CC	GO:0000792	heterochromatin	-	98	97	-	-	1.01E-02	4.52E-03
ComPPI	CC	GO:0097546	ciliary base	-	47	43	-	-	8.24E-03	2.03E-03
ComPPI	CC	GO:0071819	DUBm complex	-	25	23	-	-	2.99E-01	1.10E-03
ComPPI	CC	GO:0031201	SNARE complex	-	48	48	-	-	2.36E-01	2.26E-03
ComPPI	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.34E-03	6.37E-04
ComPPI	CC	GO:0000815	ESCRT III complex	-	11	11	-	-	1.08E-01	5.22E-04
ComPPI	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	9.82E-03	1.85E-03
ComPPI	CC	GO:0044391	ribosomal subunit	-	203	201	-	-	4.14E-01	9.33E-03
ComPPI	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	4.88E-02	5.22E-04
ComPPI	CC	GO:0071013	catalytic step 2 spliceosome	-	88	88	-	-	7.21E-02	4.11E-03
ComPPI	CC	GO:0031907	microbody lumen	-	51	51	-	-	7.76E-02	2.38E-03
ComPPI	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.44E-01	5.22E-04
ComPPI	CC	GO:0098862	cluster of actin-based cell projections	-	162	143	-	-	9.27E-03	6.66E-03
ComPPI	CC	GO:0016363	nuclear matrix	-	127	127	-	-	5.12E-03	5.91E-03
ComPPI	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	4.26E-02	2.14E-03
ComPPI	CC	GO:0032432	actin filament bundle	-	249	233	-	-	1.59E-02	1.08E-02
ComPPI	CC	GO:0008088	axo-dendritic transport	-	78	77	-	-	6.23E-03	3.59E-03
ComPPI	CC	GO:0031519	PcG protein complex	-	38	38	-	-	4.54E-02	1.80E-03
ComPPI	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	41	-	-	2.11E-02	1.91E-03
ComPPI	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	217	-	-	2.73E-02	1.01E-02
ComPPI	CC	GO:0000313	organellar ribosome	-	89	89	-	-	4.10E-01	4.17E-03
ComPPI	CC	GO:0099643	signal release from synapse	-	147	141	-	-	1.70E-02	6.55E-03
ComPPI	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	3.40E-02	2.14E-03
ComPPI	CC	GO:0030018	Z disc	-	129	124	-	-	1.44E-02	5.80E-03
ComPPI	CC	GO:0032580	Golgi cisterna membrane	-	93	72	-	-	5.07E-03	3.36E-03
ComPPI	CC	GO:0097381	photoreceptor disc membrane	-	25	20	-	-	1.31E-01	9.27E-04
ComPPI	CC	GO:1905360	GTPase complex	-	41	39	-	-	7.01E-02	1.85E-03
ComPPI	CC	GO:0097540	axonemal central pair	-	161	139	-	-	7.85E-03	6.49E-03
ComPPI	CC	GO:0042641	actomyosin	-	77	74	-	-	7.56E-03	3.48E-03
ComPPI	CC	GO:0097386	glial cell projection	-	38	35	-	-	1.14E-03	1.62E-03
ComPPI	CC	GO:0032588	trans-Golgi network membrane	-	102	100	-	-	1.11E-02	4.64E-03
ComPPI	CC	GO:0070382	exocytic vesicle	-	224	213	-	-	1.50E-02	9.91E-03
ComPPI	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	46	-	-	2.39E-02	2.14E-03
ComPPI	CC	GO:0031903	microbody membrane	-	65	64	-	-	9.39E-02	3.01E-03
ComPPI	CC	GO:0046930	pore complex	-	26	26	-	-	7.12E-02	1.22E-03
ComPPI	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	9.19E-03	5.22E-04
ComPPI	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	8.44E-04	7.53E-04
ComPPI	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	244	-	-	1.41E-02	1.14E-02
ComPPI	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	7.27E-03	1.16E-03
ComPPI	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.16E-01	5.22E-04
ComPPI	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	4.36E-03	8.11E-04
ComPPI	CC	GO:0044298	cell body membrane	-	32	32	-	-	3.08E-02	1.51E-03
ComPPI	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	4.16E-02	5.22E-04
ComPPI	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	1.61E-03	9.85E-04
ComPPI	CC	GO:0045495	pole plasm	-	25	23	-	-	7.60E-03	1.10E-03
ComPPI	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	2.65E-03	6.95E-04
ComPPI	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	2.01E-01	9.27E-04
ComPPI	CC	GO:0010369	chromocenter	-	14	14	-	-	3.97E-03	6.95E-04
ComPPI	CC	GO:0002177	manchette	-	19	16	-	-	2.26E-04	7.53E-04
ComPPI	CC	GO:0016323	basolateral plasma membrane	-	239	228	-	-	1.06E-02	1.06E-02
ComPPI	CC	GO:0045009	chitosome	-	21	20	-	-	7.96E-02	9.27E-04
ComPPI	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	1.73E-03	5.80E-04
ComPPI	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	5.25E-03	2.09E-03
ComPPI	CC	GO:0098636	protein complex involved in cell adhesion	-	57	54	-	-	3.68E-02	2.55E-03
ComPPI	CC	GO:0001917	photoreceptor inner segment	-	71	67	-	-	6.23E-03	3.13E-03
ComPPI	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	1.46E-03	6.95E-04
ComPPI	CC	GO:0019897	extrinsic component of plasma membrane	-	156	152	-	-	2.43E-02	7.07E-03
ComPPI	CC	GO:0031594	neuromuscular junction	-	73	72	-	-	5.31E-03	3.36E-03
ComPPI	CC	GO:0045120	pronucleus	-	14	14	-	-	6.06E-04	6.95E-04
ComPPI	CC	GO:0043083	synaptic cleft	-	21	20	-	-	3.67E-03	9.27E-04
ComPPI	CC	GO:0000922	spindle pole	-	172	167	-	-	7.85E-03	7.77E-03
ComPPI	CC	GO:0120111	neuron projection cytoplasm	-	94	92	-	-	1.17E-02	4.29E-03
ComPPI	CC	GO:0070971	endoplasmic reticulum exit site	-	32	28	-	-	9.71E-02	1.33E-03
ComPPI	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	1.10E-01	6.37E-04
ComPPI	CC	GO:0004879	nuclear receptor activity	-	63	62	-	-	1.21E-02	2.90E-03
ComPPI	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	166	-	-	1.75E-02	7.71E-03
ComPPI	CC	GO:0000123	histone acetyltransferase complex	-	93	89	-	-	9.42E-02	4.17E-03
ComPPI	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	2.03E-03	6.37E-04
ComPPI	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	106	-	-	1.32E-01	4.93E-03
ComPPI	CC	GO:0048786	presynaptic active zone	-	80	78	-	-	6.95E-03	3.65E-03
ComPPI	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	7.86E-02	5.80E-04
ComPPI	CC	GO:0007034	vacuolar transport	-	168	165	-	-	2.16E-02	7.65E-03
ComPPI	CC	GO:0090741	pigment granule membrane	-	21	20	-	-	1.48E-02	9.27E-04
ComPPI	CC	GO:0043194	axon initial segment	-	21	21	-	-	5.80E-02	9.85E-04
ComPPI	CC	GO:1900115	extracellular regulation of signal transduction	-	13	11	-	-	2.01E-02	5.22E-04
ComPPI	CC	GO:0005776	autophagosome	-	111	108	-	-	1.80E-02	5.04E-03
ComPPI	CC	GO:0031430	M band	-	22	21	-	-	2.86E-03	9.85E-04
ComPPI	CC	GO:0001931	uropod	-	13	13	-	-	8.82E-03	6.37E-04
ComPPI	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	2.50E-01	3.48E-03
ComPPI	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	93	-	-	1.68E-01	4.35E-03
ComPPI	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	3.41E-01	6.37E-04
ComPPI	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	2.97E-02	9.27E-04
ComPPI	CC	GO:0071203	WASH complex	-	12	12	-	-	1.93E-01	5.80E-04
ComPPI	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	2.18E-02	1.39E-03
ComPPI	CC	GO:0032994	protein-lipid complex	-	39	38	-	-	5.93E-02	1.80E-03
ComPPI	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	148	-	-	1.22E-01	6.90E-03
ComPPI	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	9.19E-03	5.80E-04
ComPPI	CC	GO:0001527	microfibril	-	13	13	-	-	6.05E-02	6.37E-04
ComPPI	CC	GO:0072562	blood microparticle	-	144	131	-	-	2.37E-02	6.08E-03
ComPPI	CC	GO:0005883	neurofilament	-	11	11	-	-	1.89E-02	5.22E-04
ComPPI	CC	GO:0051233	spindle midzone	-	36	34	-	-	1.94E-03	1.62E-03
ComPPI	CC	GO:0005811	lipid droplet	-	102	98	-	-	1.03E-02	4.58E-03
ComPPI	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	8.32E-03	2.09E-03
ComPPI	CC	GO:0043113	receptor clustering	-	51	50	-	-	8.57E-03	2.32E-03
ComPPI	CC	GO:0005940	septin ring	-	14	13	-	-	4.87E-01	6.37E-04
ComPPI	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	2.85E-02	5.22E-04
ComPPI	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	22	-	-	5.29E-02	1.04E-03
ComPPI	CC	GO:0044853	plasma membrane raft	-	114	113	-	-	8.30E-03	5.27E-03
ComPPI	CC	GO:0005881	cytoplasmic microtubule	-	256	221	-	-	6.99E-03	1.03E-02
ComPPI	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	1.80E-03	6.95E-04
ComPPI	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	1.60E-02	8.11E-04
ComPPI	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	57	-	-	3.13E-02	2.67E-03
ComPPI	CC	GO:0005905	clathrin-coated pit	-	73	73	-	-	8.42E-03	3.42E-03
ComPPI	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	4.33E-02	5.80E-04
ComPPI	CC	GO:0043034	costamere	-	18	18	-	-	8.67E-03	8.69E-04
ComPPI	CC	GO:0031904	endosome lumen	-	38	36	-	-	1.48E-02	1.68E-03
ComPPI	CC	GO:0060170	ciliary membrane	-	76	67	-	-	1.27E-02	3.13E-03
ComPPI	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	5.88E-01	6.37E-04
ComPPI	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	1.57E-02	5.80E-04
ComPPI	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	8.52E-02	1.16E-03
ComPPI	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	8.61E-02	6.95E-04
ComPPI	CC	GO:0032154	cleavage furrow	-	54	52	-	-	4.24E-03	2.43E-03
ComPPI	CC	GO:0005640	nuclear outer membrane	-	30	27	-	-	1.26E-03	1.27E-03
ComPPI	CC	GO:0005652	nuclear lamina	-	12	12	-	-	1.57E-03	5.80E-04
ComPPI	CC	GO:0007006	mitochondrial membrane organization	-	117	110	-	-	1.67E-02	5.10E-03
ComPPI	CC	GO:0001772	immunological synapse	-	44	44	-	-	5.36E-03	2.09E-03
ComPPI	CC	GO:0030904	retromer complex	-	12	12	-	-	3.31E-02	5.80E-04
ComPPI	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	1.08E-02	5.80E-04
ComPPI	CC	GO:0030863	cortical cytoskeleton	-	104	100	-	-	1.06E-02	4.64E-03
ComPPI	CC	GO:1905348	endonuclease complex	-	38	36	-	-	1.11E-01	1.68E-03
ComPPI	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	2.67E-01	5.22E-04
ComPPI	CC	GO:0030315	T-tubule	-	52	50	-	-	1.92E-02	2.32E-03
ComPPI	CC	GO:0060076	excitatory synapse	-	64	58	-	-	1.44E-02	2.72E-03
ComPPI	CC	GO:0036019	endolysosome	-	29	29	-	-	5.76E-03	1.39E-03
ComPPI	CC	GO:0001891	phagocytic cup	-	28	28	-	-	1.11E-02	1.33E-03
ComPPI	CC	GO:0099086	synaptonemal structure	-	40	38	-	-	1.29E-02	1.80E-03
ComPPI	CC	GO:0030427	site of polarized growth	-	172	170	-	-	4.33E-03	7.88E-03
ComPPI	CC	GO:0044309	neuron spine	-	213	208	-	-	6.93E-03	9.68E-03
ComPPI	CC	GO:0030658	transport vesicle membrane	-	231	221	-	-	2.03E-02	1.03E-02
ComPPI	CC	GO:0098918	structural constituent of synapse	-	27	26	-	-	5.06E-03	1.22E-03
ComPPI	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.09E-01	5.80E-04
ComPPI	CC	GO:0000940	outer kinetochore	-	17	17	-	-	8.23E-02	8.11E-04
ComPPI	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	1.96E-01	8.11E-04
ComPPI	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	1.47E-02	2.32E-03
ComPPI	CC	GO:0098803	respiratory chain complex	-	39	33	-	-	1.23E-01	1.56E-03
ComPPI	CC	GO:0097545	axonemal outer doublet	-	164	142	-	-	5.86E-03	6.61E-03
ComPPI	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	18	-	-	1.28E-03	8.69E-04
ComPPI	CC	GO:0070069	cytochrome complex	-	42	36	-	-	1.44E-01	1.68E-03
ComPPI	CC	GO:0031143	pseudopodium	-	18	18	-	-	8.25E-03	8.69E-04
ComPPI	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	26	-	-	5.84E-02	1.22E-03
ComPPI	CC	GO:0055037	recycling endosome	-	200	190	-	-	7.97E-03	8.81E-03
ComPPI	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	94	-	-	1.25E-02	4.40E-03
ComPPI	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	8.01E-02	6.37E-04
ComPPI	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	1.65E-03	5.80E-04
ComPPI	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	2.12E-03	1.04E-03
ComPPI	CC	GO:0030684	preribosome	-	76	74	-	-	7.46E-02	3.48E-03
ComPPI	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	3.22E-01	8.69E-04
ComPPI	CC	GO:1990391	DNA repair complex	-	22	22	-	-	1.24E-02	1.04E-03
ComPPI	CC	GO:0005775	vacuolar lumen	-	176	172	-	-	1.11E-02	8.00E-03
ComPPI	CC	GO:0032433	filopodium tip	-	19	19	-	-	1.20E-03	9.27E-04
ComPPI	CC	GO:0032982	myosin filament	-	24	24	-	-	7.76E-03	1.16E-03
ComPPI	CC	GO:0016327	apicolateral plasma membrane	-	23	22	-	-	2.31E-03	1.04E-03
ComPPI	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	8.02E-02	1.10E-03
ComPPI	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	1.92E-03	5.80E-04
ComPPI	CC	GO:0044306	neuron projection terminus	-	164	159	-	-	1.22E-02	7.42E-03
ComPPI	CC	GO:0034455	t-UTP complex	-	53	51	-	-	5.74E-02	2.38E-03
ComPPI	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	7.06E-01	8.11E-04
ComPPI	CC	GO:0031970	organelle envelope lumen	-	94	92	-	-	5.78E-03	4.29E-03
ComPPI	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.23E-02	6.37E-04
ComPPI	CC	GO:0120293	dynein axonemal particle	-	20	18	-	-	4.96E-03	8.69E-04
ComPPI	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	1.14E-03	1.16E-03
ComPPI	CC	GO:0043292	contractile muscle fiber	-	245	235	-	-	2.41E-02	1.09E-02
ComPPI	CC	GO:0018995	host cellular component	-	12	12	-	-	1.94E-03	5.80E-04
ComPPI	CC	GO:0034709	methylosome	-	13	12	-	-	1.47E-02	5.80E-04
ComPPI	CC	GO:0032426	stereocilium tip	-	21	15	-	-	5.49E-03	6.95E-04
ComPPI	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	3.48E-02	5.80E-04
ComPPI	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	1.28E-01	9.27E-04
ComPPI	CC	GO:0000803	sex chromosome	-	32	29	-	-	3.03E-03	1.39E-03
ComPPI	CC	GO:0098982	GABA-ergic synapse	-	84	82	-	-	1.55E-02	3.82E-03
ComPPI	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	3.70E-02	7.53E-04
ComPPI	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	4.94E-02	2.96E-03
ComPPI	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	1.73E-01	6.95E-04
ComPPI	CC	GO:0000242	pericentriolar material	-	22	22	-	-	5.27E-03	1.04E-03
ComPPI	CC	GO:1903293	phosphatase complex	-	54	53	-	-	2.46E-02	2.49E-03
ComPPI	CC	GO:0097470	ribbon synapse	-	13	13	-	-	2.16E-03	6.37E-04
ComPPI	CC	GO:0031941	filamentous actin	-	27	26	-	-	2.34E-03	1.22E-03
ComPPI	CC	GO:0000786	nucleosome	-	149	103	-	-	4.38E-02	4.81E-03
ComPPI	CC	GO:0001533	cornified envelope	-	59	57	-	-	2.82E-02	2.67E-03
ComPPI	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	7.11E-03	2.55E-03
ComPPI	CC	GO:0030027	lamellipodium	-	202	201	-	-	1.02E-02	9.33E-03
ComPPI	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	3.33E-03	6.95E-04
ComPPI	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	25	-	-	2.58E-02	1.16E-03
ComPPI	CC	GO:0000800	lateral element	-	14	14	-	-	2.18E-02	6.95E-04
ComPPI	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	5.28E-03	5.80E-04
ComPPI	CC	GO:0060077	inhibitory synapse	-	20	19	-	-	1.44E-02	9.27E-04
ComPPI	CC	GO:0031209	SCAR complex	-	12	12	-	-	4.65E-02	5.80E-04
ComPPI	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	2.81E-01	7.53E-04
ComPPI	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	5.17E-02	9.85E-04
ComPPI	CC	GO:0002102	podosome	-	31	31	-	-	2.08E-03	1.45E-03
ComPPI	CC	GO:0090543	Flemming body	-	33	32	-	-	1.12E-02	1.51E-03
ComPPI	CC	GO:0016328	lateral plasma membrane	-	66	65	-	-	5.83E-03	3.01E-03
ComPPI	CC	GO:0001650	fibrillar center	-	151	150	-	-	4.47E-03	6.95E-03
ComPPI	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	1.15E-02	6.95E-04
ComPPI	CC	GO:1990204	oxidoreductase complex	-	90	83	-	-	9.82E-02	3.88E-03
ComPPI	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	6.99E-02	7.53E-04
ComPPI	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.18E-01	5.22E-04
ComPPI	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	4.93E-03	5.80E-03
ComPPI	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	1.40E-01	9.27E-04
ComPPI	CC	GO:0001726	ruffle	-	181	180	-	-	7.50E-03	8.34E-03
ComPPI	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	1.38E-02	6.37E-04
ComPPI	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	1.04E-01	8.69E-04
ComPPI	CC	GO:0043198	dendritic shaft	-	38	37	-	-	9.23E-04	1.74E-03
ComPPI	CC	GO:0043073	germ cell nucleus	-	67	63	-	-	3.27E-03	2.96E-03
ComPPI	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	8.34E-03	9.85E-04
ComPPI	CC	GO:0016592	mediator complex	-	38	38	-	-	6.52E-01	1.80E-03
ComPPI	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	3.13E-02	9.27E-04
ComPPI	CC	GO:0022626	cytosolic ribosome	-	118	116	-	-	3.39E-01	5.39E-03
ComPPI	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	3.83E-02	2.09E-03
ComPPI	CC	GO:0034451	centriolar satellite	-	120	117	-	-	1.46E-02	5.45E-03
ComPPI	CC	GO:0045171	intercellular bridge	-	91	88	-	-	5.79E-03	4.11E-03
ComPPI	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	80	-	-	8.88E-03	3.71E-03
ComPPI	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	3.64E-01	6.95E-04
ComPPI	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.89E-02	5.22E-04
ComPPI	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	6.56E-02	5.22E-04
ComPPI	CC	GO:0044292	dendrite terminus	-	13	13	-	-	1.72E-03	6.37E-04
ComPPI	CC	GO:0032039	integrator complex	-	19	18	-	-	5.99E-01	8.69E-04
ComPPI	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	1.17E-02	6.95E-04
ComPPI	CC	GO:0033268	node of Ranvier	-	16	16	-	-	2.89E-02	7.53E-04
ComPPI	CC	GO:0036038	MKS complex	-	13	13	-	-	1.08E-02	6.37E-04
ComPPI	CC	GO:0030527	structural constituent of chromatin	-	97	53	-	-	1.11E-02	2.49E-03
ComPPI	CC	GO:0036379	myofilament	-	26	24	-	-	4.86E-02	1.16E-03
ComPPI	CC	GO:0030286	dynein complex	-	210	183	-	-	1.17E-02	8.52E-03
ComPPI	CC	GO:0031105	septin complex	-	14	13	-	-	5.32E-01	6.37E-04
ComPPI	CC	GO:0097228	sperm principal piece	-	33	25	-	-	6.33E-02	1.16E-03
ComPPI	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.16E-02	5.80E-04
ComPPI	CC	GO:0016482	cytosolic transport	-	135	134	-	-	1.16E-02	6.26E-03
ComPPI	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	5.66E-02	1.10E-03
ComPPI	CC	GO:0005796	Golgi lumen	-	106	97	-	-	4.37E-03	4.52E-03
ComPPI	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	37	-	-	1.18E-01	1.74E-03
ComPPI	CC	GO:0034358	plasma lipoprotein particle	-	36	35	-	-	7.18E-02	1.62E-03
ComPPI	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	8.98E-02	2.20E-03
ComPPI	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	1.70E-02	1.16E-03
ComPPI	CC	GO:0030662	coated vesicle membrane	-	202	198	-	-	2.98E-02	9.21E-03
ComPPI	CC	GO:0007039	protein catabolic process in the vacuole	-	61	60	-	-	4.30E-02	2.78E-03
ComPPI	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	66	-	-	2.72E-01	3.07E-03
ComPPI	CC	GO:0090734	site of DNA damage	-	118	117	-	-	1.42E-02	5.45E-03
ComPPI	MF	GO:0051861	glycolipid binding	-	30	29	-	-	2.44E-03	1.39E-03
ComPPI	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.70E-04	5.22E-04
ComPPI	MF	GO:0051087	protein-folding chaperone binding	-	135	134	-	-	6.25E-03	6.26E-03
ComPPI	MF	GO:0051959	dynein light intermediate chain binding	-	27	26	-	-	3.53E-03	1.22E-03
ComPPI	CC	GO:0015464	acetylcholine receptor activity	-	21	20	-	-	1.95E-01	9.27E-04
ComPPI	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	9.43E-03	5.80E-04
ComPPI	MF	GO:0016594	glycine binding	-	12	12	-	-	3.65E-02	5.80E-04
ComPPI	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	2.83E-04	9.27E-04
ComPPI	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	1.14E-03	1.74E-03
ComPPI	MF	GO:0035613	RNA stem-loop binding	-	21	17	-	-	1.95E-03	8.11E-04
ComPPI	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	239	-	-	8.39E-03	1.11E-02
ComPPI	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	1.50E-03	9.27E-04
ComPPI	MF	GO:0033691	sialic acid binding	-	22	21	-	-	4.51E-03	9.85E-04
ComPPI	MF	GO:0048306	calcium-dependent protein binding	-	61	58	-	-	3.72E-02	2.72E-03
ComPPI	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	2.17E-02	1.33E-03
ComPPI	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	1.70E-01	6.37E-04
ComPPI	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	137	-	-	8.53E-03	6.37E-03
ComPPI	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	59	-	-	8.78E-02	2.78E-03
ComPPI	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	130	-	-	7.69E-03	6.03E-03
ComPPI	MF	GO:0045504	dynein heavy chain binding	-	16	15	-	-	1.10E-01	6.95E-04
ComPPI	MF	GO:0140457	protein demethylase activity	-	31	28	-	-	1.46E-03	1.33E-03
ComPPI	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	4.61E-03	1.04E-03
ComPPI	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	3.46E-03	6.95E-04
ComPPI	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	1.70E-02	6.95E-04
ComPPI	MF	GO:0061980	regulatory RNA binding	-	52	45	-	-	4.42E-03	2.09E-03
ComPPI	MF	GO:0015035	protein-disulfide reductase activity	-	32	31	-	-	1.88E-02	1.45E-03
ComPPI	MF	GO:0000182	rDNA binding	-	11	11	-	-	5.40E-03	5.22E-04
ComPPI	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	1.38E-03	1.39E-03
ComPPI	MF	GO:0070840	dynein complex binding	-	25	23	-	-	1.47E-03	1.10E-03
ComPPI	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.18E-03	1.16E-03
ComPPI	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.70E-03	7.53E-04
ComPPI	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	2.10E-03	1.62E-03
ComPPI	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	2.62E-02	8.69E-04
ComPPI	MF	GO:0005178	integrin binding	-	153	149	-	-	3.87E-02	6.95E-03
ComPPI	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	7.01E-04	8.11E-04
ComPPI	MF	GO:0005549	odorant binding	-	128	19	-	-	6.37E-02	9.27E-04
ComPPI	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.45E-02	6.95E-04
ComPPI	MF	GO:0008327	methyl-CpG binding	-	31	28	-	-	8.54E-03	1.33E-03
ComPPI	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	3.26E-03	9.27E-04
ComPPI	MF	GO:0048019	receptor antagonist activity	-	31	20	-	-	5.52E-04	9.27E-04
ComPPI	MF	GO:0005521	lamin binding	-	15	15	-	-	5.00E-03	6.95E-04
ComPPI	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	5.28E-03	8.11E-04
ComPPI	MF	GO:0140318	protein transporter activity	-	40	40	-	-	1.58E-02	1.85E-03
ComPPI	MF	GO:0070628	proteasome binding	-	17	17	-	-	5.58E-03	8.11E-04
ComPPI	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	2.70E-03	5.22E-04
ComPPI	MF	GO:0031432	titin binding	-	13	11	-	-	1.34E-02	5.22E-04
ComPPI	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.88E-03	5.22E-04
ComPPI	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	5.43E-03	1.74E-03
ComPPI	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	16	-	-	4.39E-03	7.53E-04
ComPPI	MF	GO:0002039	p53 binding	-	66	66	-	-	3.88E-03	3.07E-03
ComPPI	MF	GO:0005496	steroid binding	-	110	102	-	-	6.88E-03	4.75E-03
ComPPI	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.38E-02	1.27E-03
ComPPI	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.71E-04	5.22E-04
ComPPI	MF	GO:0003684	damaged DNA binding	-	89	86	-	-	2.23E-02	4.00E-03
ComPPI	MF	GO:0000339	RNA cap binding	-	20	19	-	-	8.14E-03	9.27E-04
ComPPI	MF	GO:0016500	protein-hormone receptor activity	-	21	20	-	-	3.17E-03	9.27E-04
ComPPI	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	123	-	-	1.39E-02	5.74E-03
ComPPI	MF	GO:0005523	tropomyosin binding	-	15	14	-	-	1.70E-04	6.95E-04
ComPPI	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	2.46E-03	5.80E-04
ComPPI	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	6.18E-03	5.22E-04
ComPPI	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	7.66E-03	2.78E-03
ComPPI	MF	GO:0050811	GABA receptor binding	-	18	16	-	-	3.67E-03	7.53E-04
ComPPI	MF	GO:0030971	receptor tyrosine kinase binding	-	76	72	-	-	3.54E-03	3.36E-03
ComPPI	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	84	-	-	3.37E-02	3.94E-03
ComPPI	MF	GO:0140030	modification-dependent protein binding	-	179	175	-	-	5.85E-03	8.11E-03
ComPPI	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	3.39E-02	1.16E-03
ComPPI	MF	GO:0009881	photoreceptor activity	-	17	12	-	-	1.17E-03	5.80E-04
ComPPI	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	17	-	-	2.44E-02	8.11E-04
ComPPI	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	4.52E-04	6.37E-04
ComPPI	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	1.19E-02	7.53E-04
ComPPI	MF	GO:0141047	molecular tag activity	-	13	13	-	-	8.77E-04	6.37E-04
ComPPI	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	2.57E-02	5.22E-04
ComPPI	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	1.71E-04	5.80E-04
ComPPI	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	9.46E-04	6.95E-04
ComPPI	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	6.22E-03	5.80E-04
ComPPI	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.95E-02	6.95E-04
ComPPI	MF	GO:0010851	cyclase regulator activity	-	17	13	-	-	2.19E-03	6.37E-04
ComPPI	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.67E-02	6.95E-04
ComPPI	MF	GO:0030276	clathrin binding	-	70	69	-	-	4.30E-02	3.25E-03
ComPPI	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	3.52E-03	1.39E-03
ComPPI	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	1.38E-03	6.95E-04
ComPPI	MF	GO:0046790	virion binding	-	19	19	-	-	1.14E-03	9.27E-04
ComPPI	MF	GO:0030552	cAMP binding	-	48	45	-	-	4.36E-02	2.09E-03
ComPPI	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	39	-	-	4.39E-03	1.85E-03
ComPPI	MF	GO:0035173	histone kinase activity	-	17	17	-	-	5.84E-04	8.11E-04
ComPPI	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	1.11E-02	1.22E-03
ComPPI	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	1.04E-02	5.80E-04
ComPPI	MF	GO:0004984	olfactory receptor activity	-	429	58	-	-	6.93E-04	2.72E-03
ComPPI	MF	GO:0016209	antioxidant activity	-	92	85	-	-	2.29E-02	3.94E-03
ComPPI	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	3.34E-03	1.39E-03
ComPPI	MF	GO:0044325	transmembrane transporter binding	-	159	152	-	-	9.02E-03	7.07E-03
ComPPI	MF	GO:0048156	tau protein binding	-	43	43	-	-	2.61E-03	2.03E-03
ComPPI	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	2.34E-02	1.68E-03
ComPPI	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	2.49E-03	6.37E-04
ComPPI	MF	GO:0140272	exogenous protein binding	-	79	79	-	-	3.96E-03	3.71E-03
ComPPI	MF	GO:0030145	manganese ion binding	-	65	63	-	-	1.58E-03	2.96E-03
ComPPI	MF	GO:0071814	protein-lipid complex binding	-	52	46	-	-	1.14E-02	2.14E-03
ComPPI	MF	GO:0008066	glutamate receptor activity	-	70	66	-	-	9.69E-03	3.07E-03
ComPPI	MF	GO:0030553	cGMP binding	-	15	12	-	-	7.87E-02	5.80E-04
ComPPI	MF	GO:0017069	snRNA binding	-	54	47	-	-	2.13E-02	2.20E-03
ComPPI	MF	GO:0030215	semaphorin receptor binding	-	23	20	-	-	6.83E-02	9.27E-04
ComPPI	MF	GO:0031996	thioesterase binding	-	11	11	-	-	9.64E-04	5.22E-04
ComPPI	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	1.38E-02	1.45E-03
ComPPI	MF	GO:0019843	rRNA binding	-	69	69	-	-	2.08E-02	3.25E-03
ComPPI	MF	GO:0004713	protein tyrosine kinase activity	-	213	209	-	-	1.21E-02	9.74E-03
ComPPI	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	4.92E-03	2.38E-03
ComPPI	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.18E-03	1.16E-03
ComPPI	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	8.94E-04	9.27E-04
ComPPI	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	29	-	-	1.01E-03	1.39E-03
ComPPI	MF	GO:0016208	AMP binding	-	22	22	-	-	9.61E-03	1.04E-03
ComPPI	MF	GO:0000287	magnesium ion binding	-	225	218	-	-	5.96E-03	1.01E-02
ComPPI	MF	GO:0031490	chromatin DNA binding	-	120	114	-	-	7.55E-03	5.33E-03
ComPPI	MF	GO:0017022	myosin binding	-	73	71	-	-	6.09E-03	3.30E-03
ComPPI	MF	GO:0004896	cytokine receptor activity	-	93	91	-	-	1.23E-02	4.23E-03
ComPPI	MF	GO:0017166	vinculin binding	-	12	12	-	-	1.27E-02	5.80E-04
ComPPI	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	1.73E-02	8.69E-04
ComPPI	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	1.15E-02	5.80E-04
ComPPI	MF	GO:0005539	glycosaminoglycan binding	-	236	219	-	-	1.59E-02	1.02E-02
ComPPI	MF	GO:0140666	annealing activity	-	11	11	-	-	2.53E-03	5.22E-04
ComPPI	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.68E-04	6.95E-04
ComPPI	MF	GO:0010181	FMN binding	-	15	15	-	-	1.25E-03	6.95E-04
ComPPI	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	18	-	-	7.37E-02	8.69E-04
ComPPI	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	23	-	-	1.40E-03	1.10E-03
ComPPI	MF	GO:0031420	alkali metal ion binding	-	17	16	-	-	4.57E-04	7.53E-04
ComPPI	MF	GO:0044183	protein folding chaperone	-	67	65	-	-	3.62E-03	3.01E-03
ComPPI	MF	GO:0005132	type I interferon receptor binding	-	17	16	-	-	3.67E-01	7.53E-04
ComPPI	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	107	-	-	7.29E-03	4.98E-03
ComPPI	MF	GO:0003725	double-stranded RNA binding	-	72	71	-	-	5.95E-03	3.30E-03
ComPPI	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	1.55E-01	7.53E-04
ComPPI	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	3.01E-02	2.43E-03
ComPPI	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.66E-03	1.62E-03
ComPPI	MF	GO:0004618	phosphoglycerate kinase activity	-	89	88	-	-	4.89E-03	4.11E-03
ComPPI	MF	GO:0042805	actinin binding	-	36	35	-	-	3.10E-03	1.62E-03
ComPPI	MF	GO:0043531	ADP binding	-	38	38	-	-	1.67E-03	1.80E-03
ComPPI	MF	GO:0043394	proteoglycan binding	-	36	34	-	-	1.07E-02	1.62E-03
ComPPI	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	2.63E-02	5.22E-04
ComPPI	MF	GO:0046332	SMAD binding	-	77	76	-	-	9.86E-03	3.54E-03
ComPPI	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.06E-03	6.37E-04
ComPPI	MF	GO:0001968	fibronectin binding	-	30	30	-	-	7.41E-03	1.39E-03
ComPPI	MF	GO:0048038	quinone binding	-	16	16	-	-	1.14E-02	7.53E-04
ComPPI	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	119	-	-	1.38E-02	5.56E-03
ComPPI	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	81	-	-	3.21E-03	3.77E-03
ComPPI	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	1.53E-03	8.69E-04
ComPPI	MF	GO:0051117	ATPase binding	-	85	83	-	-	3.48E-03	3.88E-03
ComPPI	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	45	-	-	1.82E-03	2.09E-03
ComPPI	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	5.12E-03	9.27E-04
ComPPI	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	9.51E-03	5.22E-04
ComPPI	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.29E-04	6.95E-04
ComPPI	MF	GO:0031404	chloride ion binding	-	14	13	-	-	1.72E-04	6.37E-04
ComPPI	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	4.40E-03	2.84E-03
ComPPI	MF	GO:0036002	pre-mRNA binding	-	57	36	-	-	2.44E-03	1.68E-03
ComPPI	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	36	-	-	1.36E-02	1.68E-03
ComPPI	MF	GO:0051540	metal cluster binding	-	71	69	-	-	6.35E-03	3.25E-03
ComPPI	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	1.48E-03	5.22E-04
ComPPI	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	4.83E-03	4.29E-03
ComPPI	MF	GO:0019894	kinesin binding	-	45	44	-	-	6.65E-03	2.09E-03
ComPPI	MF	GO:0042287	MHC protein binding	-	68	57	-	-	4.36E-02	2.67E-03
ComPPI	MF	GO:0019003	GDP binding	-	89	87	-	-	1.45E-02	4.06E-03
ComPPI	MF	GO:0017171	serine hydrolase activity	-	207	186	-	-	1.55E-02	8.63E-03
ComPPI	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	5.10E-03	3.07E-03
ComPPI	MF	GO:0003774	cytoskeletal motor activity	-	117	111	-	-	6.46E-03	5.16E-03
ComPPI	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	2.33E-03	1.39E-03
ComPPI	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	6.95E-03	8.11E-04
ComPPI	MF	GO:0061134	peptidase regulator activity	-	224	200	-	-	1.17E-02	9.27E-03
ComPPI	MF	GO:0008013	beta-catenin binding	-	86	86	-	-	9.34E-03	4.00E-03
ComPPI	MF	GO:0051015	actin filament binding	-	208	204	-	-	2.09E-02	9.50E-03
ComPPI	MF	GO:0019208	phosphatase regulator activity	-	107	101	-	-	9.87E-03	4.69E-03
ComPPI	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	32	-	-	8.13E-03	1.51E-03
ComPPI	MF	GO:0043236	laminin binding	-	29	28	-	-	4.02E-03	1.33E-03
ComPPI	MF	GO:0030507	spectrin binding	-	26	25	-	-	3.95E-03	1.16E-03
ComPPI	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	3.01E-03	1.91E-03
ComPPI	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	112	-	-	2.29E-02	5.22E-03
ComPPI	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	2.96E-03	1.16E-03
ComPPI	MF	GO:0042393	histone binding	-	240	230	-	-	1.58E-02	1.07E-02
ComPPI	MF	GO:0019838	growth factor binding	-	182	177	-	-	9.06E-03	8.23E-03
ComPPI	MF	GO:0000149	SNARE binding	-	107	104	-	-	7.22E-02	4.87E-03
ComPPI	MF	GO:0003727	single-stranded RNA binding	-	90	84	-	-	6.64E-03	3.94E-03
ComPPI	MF	GO:0051378	serotonin binding	-	24	23	-	-	4.19E-02	1.10E-03
ComPPI	MF	GO:0005516	calmodulin binding	-	206	200	-	-	1.01E-02	9.27E-03
ComPPI	MF	GO:0019825	oxygen binding	-	40	36	-	-	1.30E-02	1.68E-03
ComPPI	MF	GO:0045505	dynein intermediate chain binding	-	37	35	-	-	6.48E-03	1.62E-03
ComPPI	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	83	-	-	2.30E-03	3.88E-03
ComPPI	MF	GO:0032182	ubiquitin-like protein binding	-	117	115	-	-	6.53E-03	5.33E-03
ComPPI	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	7.46E-02	1.68E-03
ComPPI	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	4.56E-03	1.04E-03
ComPPI	MF	GO:0043274	phospholipase binding	-	23	22	-	-	1.85E-03	1.04E-03
ComPPI	MF	GO:0031072	heat shock protein binding	-	128	127	-	-	1.41E-02	5.91E-03
ComPPI	MF	GO:0030515	snoRNA binding	-	33	33	-	-	1.19E-02	1.56E-03
ComPPI	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	65	-	-	2.13E-02	3.01E-03
ComPPI	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	20	-	-	1.32E-02	9.27E-04
ComPPI	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	3.35E-04	1.22E-03
ComPPI	MF	GO:0001530	lipopolysaccharide binding	-	38	32	-	-	9.74E-03	1.51E-03
ComPPI	MF	GO:0140223	general transcription initiation factor activity	-	55	52	-	-	3.28E-01	2.43E-03
ComPPI	MF	GO:0070403	NAD+ binding	-	16	16	-	-	1.90E-03	7.53E-04
ComPPI	MF	GO:0000049	tRNA binding	-	75	72	-	-	1.02E-02	3.36E-03
ComPPI	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	3.84E-03	2.09E-03
ComPPI	MF	GO:0015026	coreceptor activity	-	48	47	-	-	8.83E-03	2.20E-03
ComPPI	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.80E-03	5.80E-04
ComPPI	MF	GO:0001653	peptide receptor activity	-	128	115	-	-	1.07E-02	5.33E-03
ComPPI	MF	GO:0031005	filamin binding	-	15	14	-	-	3.59E-03	6.95E-04
ComPPI	MF	GO:0030506	ankyrin binding	-	19	19	-	-	1.95E-03	9.27E-04
ComPPI	MF	GO:0006469	negative regulation of protein kinase activity	-	222	207	-	-	4.31E-03	9.62E-03
ComPPI	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	1.18E-03	9.27E-04
ComPPI	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	9.44E-04	6.95E-04
ComPPI	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	8.50E-03	1.45E-03
ComPPI	MF	GO:0051427	hormone receptor binding	-	31	31	-	-	6.50E-03	1.45E-03
ComPPI	MF	GO:0070851	growth factor receptor binding	-	141	139	-	-	5.73E-03	6.49E-03
ComPPI	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	1.79E-02	1.51E-03
ComPPI	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	42	-	-	6.84E-03	1.97E-03
ComPPI	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	4.16E-03	9.27E-04
ComPPI	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	16	-	-	4.62E-03	7.53E-04
ComPPI	MF	GO:0005506	iron ion binding	-	154	139	-	-	1.66E-02	6.49E-03
ComPPI	MF	GO:0003925	G protein activity	-	45	44	-	-	7.42E-03	2.09E-03
ComPPI	MF	GO:0038187	pattern recognition receptor activity	-	33	30	-	-	1.01E-02	1.39E-03
ComPPI	MF	GO:0008276	protein methyltransferase activity	-	96	92	-	-	4.20E-03	4.29E-03
ComPPI	MF	GO:0004396	hexokinase activity	-	16	16	-	-	8.85E-02	7.53E-04
ComPPI	MF	GO:0070888	E-box binding	-	59	56	-	-	1.63E-02	2.61E-03
ComPPI	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.67E-03	6.95E-04
ComPPI	MF	GO:0015399	primary active transmembrane transporter activity	-	190	183	-	-	7.68E-02	8.52E-03
ComPPI	MF	GO:0035254	glutamate receptor binding	-	47	45	-	-	2.57E-03	2.09E-03
ComPPI	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	4.18E-03	1.56E-03
ComPPI	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	3.71E-03	5.22E-04
ComPPI	MF	GO:0043021	ribonucleoprotein complex binding	-	158	156	-	-	5.70E-03	7.24E-03
ComPPI	MF	GO:0030170	pyridoxal phosphate binding	-	56	52	-	-	4.87E-03	2.43E-03
ComPPI	MF	GO:0032393	MHC class I receptor activity	-	15	13	-	-	8.71E-02	6.37E-04
ComPPI	MF	GO:0005112	Notch binding	-	26	24	-	-	2.48E-02	1.16E-03
ComPPI	MF	GO:0048185	activin binding	-	16	16	-	-	2.19E-02	7.53E-04
ComPPI	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	3.30E-03	1.33E-03
ComPPI	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	5.30E-03	5.22E-04
ComPPI	MF	GO:0140299	small molecule sensor activity	-	39	35	-	-	1.56E-02	1.62E-03
ComPPI	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.31E-02	1.04E-03
ComPPI	MF	GO:0016917	GABA receptor activity	-	23	20	-	-	7.97E-02	9.27E-04
ComPPI	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	3.12E-03	6.95E-04
ComPPI	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	25	-	-	3.40E-04	1.16E-03
ComPPI	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	44	-	-	8.87E-03	2.09E-03
ComPPI	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.58E-03	1.16E-03
ComPPI	MF	GO:0003916	DNA topoisomerase activity	-	12	11	-	-	7.06E-03	5.22E-04
ComPPI	MF	GO:0030594	neurotransmitter receptor activity	-	160	150	-	-	4.08E-02	6.95E-03
ComPPI	MF	GO:0034452	dynactin binding	-	12	12	-	-	1.91E-03	5.80E-04
ComPPI	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	23	-	-	5.66E-02	1.10E-03
ComPPI	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	3.55E-03	9.85E-04
ComPPI	MF	GO:0005507	copper ion binding	-	63	60	-	-	5.19E-03	2.78E-03
ComPPI	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	3.62E-03	1.04E-03
ComPPI	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	2.29E-02	1.04E-03
ComPPI	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	11	-	-	4.18E-02	5.22E-04
ConsensusPathDB	CC	GO:0005615	extracellular space	6.60E-26	3190	3055	2914	1.05	-	-
ConsensusPathDB	CC	GO:0005783	endoplasmic reticulum	7.04E-19	2020	1942	1845	1.05	-	-
ConsensusPathDB	CC	GO:0005730	nucleolus	5.16E-17	988	965	902	1.07	-	-
ConsensusPathDB	CC	GO:0005768	endosome	1.04E-16	1037	1011	947	1.07	-	-
ConsensusPathDB	CC	GO:0005739	mitochondrion	1.23E-16	1671	1609	1526	1.05	-	-
ConsensusPathDB	CC	GO:0005815	microtubule organizing center	5.00E-15	843	824	770	1.07	-	-
ConsensusPathDB	CC	GO:0005794	Golgi apparatus	4.95E-11	1636	1561	1494	1.04	-	-
ConsensusPathDB	CC	GO:0005764	lysosome	6.84E-11	747	726	682	1.06	-	-
ConsensusPathDB	CC	GO:0005635	nuclear envelope	5.70E-08	493	480	450	1.07	-	-
ConsensusPathDB	CC	GO:0031012	extracellular matrix	7.31E-08	564	547	515	1.06	-	-
ConsensusPathDB	CC	GO:0005840	ribosome	5.73E-06	222	219	203	1.08	-	-
ConsensusPathDB	CC	GO:0000228	nuclear chromosome	1.69E-05	206	203	188	1.08	-	-
ConsensusPathDB	CC	GO:0005777	peroxisome	2.39E-03	142	139	130	1.07	-	-
ConsensusPathDB	CC	GO:0005811	lipid droplet	3.37E-02	102	99	93	1.06	-	-
ConsensusPathDB	CC	GO:0005929	cilium	8.02E-01	842	767	769	1.00	-	-
ConsensusPathDB	BP	GO:0050877	nervous system process	1.36E-80	1527	1161	1395	0.83	-	-
ConsensusPathDB	BP	GO:0016192	vesicle-mediated transport	6.34E-29	1894	1844	1730	1.07	-	-
ConsensusPathDB	BP	GO:0007155	cell adhesion	2.51E-26	1444	1413	1319	1.07	-	-
ConsensusPathDB	BP	GO:0006355	regulation of DNA-templated transcription	2.71E-25	3342	3195	3052	1.05	-	-
ConsensusPathDB	BP	GO:0012501	programmed cell death	8.16E-25	1954	1893	1785	1.06	-	-
ConsensusPathDB	BP	GO:0007010	cytoskeleton organization	1.62E-24	1639	1595	1497	1.07	-	-
ConsensusPathDB	BP	GO:0048870	cell motility	5.95E-22	1659	1609	1515	1.06	-	-
ConsensusPathDB	BP	GO:0006281	DNA repair	3.20E-17	587	582	536	1.09	-	-
ConsensusPathDB	BP	GO:0006886	intracellular protein transport	2.57E-16	664	655	606	1.08	-	-
ConsensusPathDB	BP	GO:0002376	immune system process	2.80E-16	2448	2335	2236	1.04	-	-
ConsensusPathDB	BP	GO:0006914	autophagy	1.48E-14	568	561	519	1.08	-	-
ConsensusPathDB	BP	GO:0030163	protein catabolic process	1.28E-13	990	961	904	1.06	-	-
ConsensusPathDB	BP	GO:0034330	cell junction organization	2.67E-13	727	711	664	1.07	-	-
ConsensusPathDB	BP	GO:0006629	lipid metabolic process	9.29E-12	1355	1300	1238	1.05	-	-
ConsensusPathDB	BP	GO:0055086	nucleobase-containing small molecule metabolic process	6.37E-11	729	709	666	1.06	-	-
ConsensusPathDB	BP	GO:0007059	chromosome segregation	1.41E-10	403	398	368	1.08	-	-
ConsensusPathDB	BP	GO:0006954	inflammatory response	5.02E-10	820	793	749	1.06	-	-
ConsensusPathDB	BP	GO:0042060	wound healing	3.42E-09	431	423	394	1.07	-	-
ConsensusPathDB	BP	GO:0003012	muscle system process	4.81E-09	425	417	388	1.07	-	-
ConsensusPathDB	BP	GO:0016071	mRNA metabolic process	5.46E-09	713	690	651	1.06	-	-
ConsensusPathDB	BP	GO:0003013	circulatory system process	5.61E-09	584	568	533	1.06	-	-
ConsensusPathDB	BP	GO:0007005	mitochondrion organization	6.15E-09	484	473	442	1.07	-	-
ConsensusPathDB	BP	GO:0006091	generation of precursor metabolites and energy	7.11E-09	502	490	459	1.07	-	-
ConsensusPathDB	BP	GO:0030198	extracellular matrix organization	2.37E-08	314	310	287	1.08	-	-
ConsensusPathDB	BP	GO:0006913	nucleocytoplasmic transport	7.49E-08	326	321	298	1.08	-	-
ConsensusPathDB	BP	GO:0065003	protein-containing complex assembly	1.22E-07	1648	1560	1505	1.04	-	-
ConsensusPathDB	BP	GO:0006260	DNA replication	4.59E-07	279	275	255	1.08	-	-
ConsensusPathDB	BP	GO:0072659	protein localization to plasma membrane	1.84E-06	284	279	259	1.08	-	-
ConsensusPathDB	BP	GO:0055085	transmembrane transport	2.06E-06	1784	1681	1629	1.03	-	-
ConsensusPathDB	BP	GO:0006310	DNA recombination	4.42E-06	333	325	304	1.07	-	-
ConsensusPathDB	BP	GO:0007163	establishment or maintenance of cell polarity	2.31E-05	227	223	207	1.08	-	-
ConsensusPathDB	BP	GO:0098542	defense response to other organism	4.35E-05	1171	1106	1070	1.03	-	-
ConsensusPathDB	BP	GO:0006457	protein folding	6.46E-05	210	206	192	1.07	-	-
ConsensusPathDB	BP	GO:0140053	mitochondrial gene expression	7.28E-05	164	162	150	1.08	-	-
ConsensusPathDB	BP	GO:0005975	carbohydrate metabolic process	1.10E-04	551	527	503	1.05	-	-
ConsensusPathDB	BP	GO:0006520	amino acid metabolic process	2.07E-04	292	283	267	1.06	-	-
ConsensusPathDB	BP	GO:0002181	cytoplasmic translation	2.27E-04	153	151	140	1.08	-	-
ConsensusPathDB	BP	GO:0042254	ribosome biogenesis	3.73E-04	297	287	271	1.06	-	-
ConsensusPathDB	BP	GO:0007018	microtubule-based movement	4.37E-04	640	608	585	1.04	-	-
ConsensusPathDB	BP	GO:0140013	meiotic nuclear division	5.20E-04	279	270	255	1.06	-	-
ConsensusPathDB	BP	GO:0003014	renal system process	1.36E-03	127	125	116	1.08	-	-
ConsensusPathDB	BP	GO:0006790	sulfur compound metabolic process	1.78E-03	320	307	292	1.05	-	-
ConsensusPathDB	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	2.82E-03	119	117	109	1.08	-	-
ConsensusPathDB	BP	GO:0006399	tRNA metabolic process	2.99E-03	196	190	179	1.06	-	-
ConsensusPathDB	BP	GO:0000910	cytokinesis	5.45E-03	186	180	170	1.06	-	-
ConsensusPathDB	BP	GO:0022600	digestive system process	5.76E-03	110	108	100	1.07	-	-
ConsensusPathDB	BP	GO:0006486	protein glycosylation	2.26E-02	225	215	206	1.05	-	-
ConsensusPathDB	BP	GO:0044782	cilium organization	2.40E-02	399	377	364	1.03	-	-
ConsensusPathDB	BP	GO:0007040	lysosome organization	2.45E-02	107	104	98	1.06	-	-
ConsensusPathDB	BP	GO:0006575	cellular modified amino acid metabolic process	3.48E-02	186	178	170	1.05	-	-
ConsensusPathDB	BP	GO:0098754	detoxification	4.34E-02	134	129	122	1.05	-	-
ConsensusPathDB	BP	GO:0032200	telomere organization	4.81E-02	186	162	170	0.95	-	-
ConsensusPathDB	BP	GO:0006325	chromatin organization	5.81E-02	720	672	658	1.02	-	-
ConsensusPathDB	BP	GO:0006766	vitamin metabolic process	8.21E-02	107	103	98	1.05	-	-
ConsensusPathDB	MF	GO:0140096	"catalytic activity, acting on a protein"	2.19E-29	3198	3071	2921	1.05	-	-
ConsensusPathDB	MF	GO:0016740	transferase activity	6.57E-29	3074	2954	2808	1.05	-	-
ConsensusPathDB	MF	GO:0003723	RNA binding	6.14E-22	1679	1628	1534	1.06	-	-
ConsensusPathDB	MF	GO:0008092	cytoskeletal protein binding	1.93E-19	1023	1002	934	1.07	-	-
ConsensusPathDB	MF	GO:0140657	ATP-dependent activity	2.05E-15	729	716	666	1.08	-	-
ConsensusPathDB	MF	GO:0140110	transcription regulator activity	3.78E-13	2033	1938	1857	1.04	-	-
ConsensusPathDB	MF	GO:0003677	DNA binding	4.34E-13	2865	2712	2617	1.04	-	-
ConsensusPathDB	MF	GO:0016491	oxidoreductase activity	7.01E-13	888	863	811	1.06	-	-
ConsensusPathDB	MF	GO:0003924	GTPase activity	1.27E-10	658	641	601	1.07	-	-
ConsensusPathDB	MF	GO:0140097	"catalytic activity, acting on DNA"	3.89E-09	383	377	350	1.08	-	-
ConsensusPathDB	MF	GO:0008289	lipid binding	1.14E-08	836	805	764	1.05	-	-
ConsensusPathDB	MF	GO:0140098	"catalytic activity, acting on RNA"	4.77E-08	417	408	381	1.07	-	-
ConsensusPathDB	MF	GO:0016829	lyase activity	7.76E-06	538	518	491	1.05	-	-
ConsensusPathDB	MF	GO:0016874	ligase activity	8.99E-06	283	277	258	1.07	-	-
ConsensusPathDB	MF	GO:0016853	isomerase activity	1.42E-05	252	247	230	1.07	-	-
ConsensusPathDB	MF	GO:0045182	translation regulator activity	2.21E-04	151	149	138	1.08	-	-
ConsensusPathDB	MF	GO:0003774	cytoskeletal motor activity	6.79E-04	116	115	106	1.09	-	-
ConsensusPathDB	MF	GO:0140104	molecular carrier activity	1.41E-03	105	104	96	1.08	-	-
ConsensusPathDB	MF	GO:0042393	histone binding	2.26E-03	237	229	216	1.06	-	-
ConsensusPathDB	MF	GO:0005215	transporter activity	3.63E-03	1462	1365	1335	1.02	-	-
ConsensusPathDB	MF	GO:0048018	receptor ligand activity	3.70E-03	504	478	460	1.04	-	-
ConsensusPathDB	MF	GO:0038024	cargo receptor activity	4.24E-03	117	115	107	1.08	-	-
ConsensusPathDB	MF	GO:0009975	cyclase activity	5.25E-02	277	262	253	1.04	-	-
ConsensusPathDB	MF	GO:0005198	structural molecule activity	4.03E-01	798	736	729	1.01	-	-
ConsensusPathDB	BP	GO:0008038	neuron recognition	-	46	46	-	-	2.64E-03	2.08E-03
ConsensusPathDB	BP	GO:1905145	cellular response to acetylcholine	-	33	32	-	-	8.73E-03	1.46E-03
ConsensusPathDB	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	3.43E-03	8.41E-04
ConsensusPathDB	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	1.43E-03	9.54E-04
ConsensusPathDB	BP	GO:0051931	regulation of sensory perception	-	36	36	-	-	4.87E-03	1.63E-03
ConsensusPathDB	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	6.41E-03	1.12E-03
ConsensusPathDB	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.75E-03	6.17E-04
ConsensusPathDB	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	1.12E-03	6.17E-04
ConsensusPathDB	BP	GO:0009268	response to pH	-	43	39	-	-	1.07E-02	1.79E-03
ConsensusPathDB	BP	GO:0045666	positive regulation of neuron differentiation	-	91	87	-	-	3.90E-03	3.93E-03
ConsensusPathDB	BP	GO:0043543	protein acylation	-	107	102	-	-	2.73E-03	4.60E-03
ConsensusPathDB	MF	GO:0051349	positive regulation of lyase activity	-	41	40	-	-	4.41E-03	1.79E-03
ConsensusPathDB	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	13	-	-	1.59E-04	6.17E-04
ConsensusPathDB	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.11E-03	1.12E-03
ConsensusPathDB	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	4.17E-03	8.97E-04
ConsensusPathDB	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	131	-	-	6.63E-02	5.89E-03
ConsensusPathDB	BP	GO:0071763	nuclear membrane organization	-	44	43	-	-	3.19E-03	1.96E-03
ConsensusPathDB	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	34	-	-	2.64E-03	1.57E-03
ConsensusPathDB	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	12	-	-	9.86E-03	5.61E-04
ConsensusPathDB	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	1.14E-02	3.08E-03
ConsensusPathDB	BP	GO:0022038	corpus callosum development	-	25	25	-	-	4.60E-03	1.12E-03
ConsensusPathDB	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	11	-	-	1.37E-02	5.05E-04
ConsensusPathDB	BP	GO:0021548	pons development	-	11	11	-	-	1.53E-04	5.05E-04
ConsensusPathDB	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	11	-	-	4.31E-02	5.05E-04
ConsensusPathDB	BP	GO:0043299	leukocyte degranulation	-	82	81	-	-	6.92E-03	3.65E-03
ConsensusPathDB	BP	GO:0048864	stem cell development	-	88	84	-	-	5.78E-03	3.81E-03
ConsensusPathDB	BP	GO:0009310	amine catabolic process	-	20	17	-	-	1.58E-03	7.85E-04
ConsensusPathDB	BP	GO:0051651	maintenance of location in cell	-	236	218	-	-	5.79E-03	9.82E-03
ConsensusPathDB	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	1.16E-03	1.23E-03
ConsensusPathDB	BP	GO:0014004	microglia differentiation	-	12	12	-	-	1.17E-03	5.61E-04
ConsensusPathDB	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	30	-	-	1.27E-03	1.35E-03
ConsensusPathDB	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	1.41E-04	6.73E-04
ConsensusPathDB	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	9.13E-04	6.73E-04
ConsensusPathDB	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	2.23E-03	1.35E-03
ConsensusPathDB	BP	GO:0006949	syncytium formation	-	66	61	-	-	2.68E-03	2.75E-03
ConsensusPathDB	BP	GO:0045176	apical protein localization	-	15	15	-	-	4.90E-04	6.73E-04
ConsensusPathDB	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	8.27E-04	6.73E-04
ConsensusPathDB	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	54	-	-	3.73E-03	2.47E-03
ConsensusPathDB	BP	GO:0030574	collagen catabolic process	-	45	45	-	-	8.94E-03	2.02E-03
ConsensusPathDB	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	3.19E-03	2.08E-03
ConsensusPathDB	BP	GO:0060343	trabecula formation	-	26	26	-	-	7.00E-04	1.18E-03
ConsensusPathDB	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	3.55E-04	5.61E-04
ConsensusPathDB	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	1.01E-03	1.07E-03
ConsensusPathDB	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	3.92E-02	7.29E-04
ConsensusPathDB	BP	GO:1900424	regulation of defense response to bacterium	-	21	19	-	-	2.70E-03	8.97E-04
ConsensusPathDB	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	2.95E-02	1.85E-03
ConsensusPathDB	BP	GO:0006413	translational initiation	-	122	118	-	-	8.25E-03	5.33E-03
ConsensusPathDB	BP	GO:0072176	nephric duct development	-	15	15	-	-	1.44E-03	6.73E-04
ConsensusPathDB	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	4.44E-03	2.30E-03
ConsensusPathDB	CC	GO:0005200	structural constituent of cytoskeleton	-	112	112	-	-	3.16E-03	5.05E-03
ConsensusPathDB	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	1.50E-03	2.30E-03
ConsensusPathDB	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	1.39E-02	6.73E-04
ConsensusPathDB	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	5.33E-03	1.12E-03
ConsensusPathDB	BP	GO:1903036	positive regulation of response to wounding	-	76	69	-	-	3.05E-03	3.14E-03
ConsensusPathDB	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	3.53E-03	9.54E-04
ConsensusPathDB	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	210	-	-	1.07E-02	9.42E-03
ConsensusPathDB	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.35E-03	1.23E-03
ConsensusPathDB	BP	GO:0032528	microvillus organization	-	24	23	-	-	2.48E-02	1.07E-03
ConsensusPathDB	BP	GO:0021954	central nervous system neuron development	-	85	82	-	-	2.26E-03	3.70E-03
ConsensusPathDB	BP	GO:0055017	cardiac muscle tissue growth	-	92	73	-	-	3.74E-03	3.31E-03
ConsensusPathDB	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	4.80E-03	1.40E-03
ConsensusPathDB	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	2.89E-03	6.17E-04
ConsensusPathDB	BP	GO:0048524	positive regulation of viral process	-	64	63	-	-	1.34E-03	2.86E-03
ConsensusPathDB	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	12	-	-	7.38E-02	5.61E-04
ConsensusPathDB	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	7.22E-03	9.54E-04
ConsensusPathDB	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	23	-	-	8.93E-04	1.07E-03
ConsensusPathDB	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	4.26E-03	7.85E-04
ConsensusPathDB	BP	GO:0098661	inorganic anion transmembrane transport	-	140	128	-	-	5.78E-02	5.78E-03
ConsensusPathDB	BP	GO:0006099	tricarboxylic acid cycle	-	33	30	-	-	1.18E-02	1.35E-03
ConsensusPathDB	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	2.28E-03	8.41E-04
ConsensusPathDB	BP	GO:0009612	response to mechanical stimulus	-	215	213	-	-	7.25E-03	9.59E-03
ConsensusPathDB	BP	GO:0048644	muscle organ morphogenesis	-	81	77	-	-	5.12E-03	3.48E-03
ConsensusPathDB	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	139	-	-	5.68E-03	6.28E-03
ConsensusPathDB	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	5.82E-02	6.17E-04
ConsensusPathDB	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	1.46E-02	1.57E-03
ConsensusPathDB	BP	GO:0140115	export across plasma membrane	-	82	62	-	-	2.98E-02	2.80E-03
ConsensusPathDB	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	1.67E-03	5.61E-04
ConsensusPathDB	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	37	-	-	2.38E-03	1.68E-03
ConsensusPathDB	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	1.15E-02	5.61E-04
ConsensusPathDB	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	2.84E-03	5.05E-04
ConsensusPathDB	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	25	-	-	3.87E-03	1.12E-03
ConsensusPathDB	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	40	-	-	3.51E-03	1.79E-03
ConsensusPathDB	MF	GO:0003714	transcription corepressor activity	-	190	186	-	-	8.21E-03	8.36E-03
ConsensusPathDB	BP	GO:0035878	nail development	-	11	11	-	-	7.04E-03	5.05E-04
ConsensusPathDB	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	54	-	-	4.90E-03	2.47E-03
ConsensusPathDB	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	4.07E-03	7.29E-04
ConsensusPathDB	CC	GO:0006858	extracellular transport	-	45	43	-	-	9.19E-03	1.96E-03
ConsensusPathDB	BP	GO:0006304	DNA modification	-	30	30	-	-	9.65E-03	1.35E-03
ConsensusPathDB	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	9.43E-03	8.41E-04
ConsensusPathDB	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	1.72E-02	2.24E-03
ConsensusPathDB	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	7.30E-04	8.41E-04
ConsensusPathDB	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	6.36E-03	6.73E-04
ConsensusPathDB	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	38	-	-	1.04E-02	1.74E-03
ConsensusPathDB	BP	GO:0070417	cellular response to cold	-	13	13	-	-	2.54E-02	6.17E-04
ConsensusPathDB	BP	GO:0043523	regulation of neuron apoptotic process	-	218	211	-	-	7.30E-03	9.48E-03
ConsensusPathDB	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.98E-03	1.01E-03
ConsensusPathDB	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	1.50E-03	6.73E-04
ConsensusPathDB	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	3.26E-03	2.58E-03
ConsensusPathDB	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	5.80E-02	6.17E-04
ConsensusPathDB	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	1.23E-03	1.12E-03
ConsensusPathDB	BP	GO:0014029	neural crest formation	-	15	15	-	-	2.73E-03	6.73E-04
ConsensusPathDB	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	1.81E-03	1.07E-03
ConsensusPathDB	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	40	-	-	2.91E-02	1.79E-03
ConsensusPathDB	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	68	-	-	3.67E-03	3.08E-03
ConsensusPathDB	BP	GO:0003188	heart valve formation	-	16	16	-	-	1.03E-02	7.29E-04
ConsensusPathDB	CC	GO:0045324	late endosome to vacuole transport	-	37	37	-	-	1.64E-02	1.68E-03
ConsensusPathDB	BP	GO:0043954	cellular component maintenance	-	72	71	-	-	4.62E-03	3.20E-03
ConsensusPathDB	BP	GO:0050435	amyloid-beta metabolic process	-	65	52	-	-	1.00E-02	2.36E-03
ConsensusPathDB	BP	GO:0014823	response to activity	-	70	68	-	-	4.06E-03	3.08E-03
ConsensusPathDB	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	2.43E-02	8.41E-04
ConsensusPathDB	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	8.71E-03	1.29E-03
ConsensusPathDB	BP	GO:0034502	protein localization to chromosome	-	130	113	-	-	3.50E-03	5.10E-03
ConsensusPathDB	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	9.45E-03	5.05E-04
ConsensusPathDB	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	7.41E-04	5.05E-04
ConsensusPathDB	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	3.03E-02	7.85E-04
ConsensusPathDB	BP	GO:0019233	sensory perception of pain	-	103	103	-	-	4.88E-03	4.66E-03
ConsensusPathDB	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	8.24E-02	1.01E-03
ConsensusPathDB	BP	GO:0031343	positive regulation of cell killing	-	75	74	-	-	8.18E-02	3.37E-03
ConsensusPathDB	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	2.93E-03	1.74E-03
ConsensusPathDB	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	120	-	-	2.21E-02	5.38E-03
ConsensusPathDB	BP	GO:0017148	negative regulation of translation	-	390	114	-	-	3.96E-03	5.16E-03
ConsensusPathDB	BP	GO:0030220	platelet formation	-	22	22	-	-	1.64E-03	1.01E-03
ConsensusPathDB	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	81	-	-	4.09E-03	3.65E-03
ConsensusPathDB	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	1.71E-03	5.61E-04
ConsensusPathDB	BP	GO:1901142	insulin metabolic process	-	14	13	-	-	7.07E-04	6.17E-04
ConsensusPathDB	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	1.09E-02	6.73E-04
ConsensusPathDB	BP	GO:1903509	liposaccharide metabolic process	-	109	106	-	-	4.04E-02	4.77E-03
ConsensusPathDB	BP	GO:0009582	detection of abiotic stimulus	-	140	132	-	-	1.58E-02	5.95E-03
ConsensusPathDB	BP	GO:0045683	negative regulation of epidermis development	-	13	12	-	-	9.55E-04	5.61E-04
ConsensusPathDB	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	16	-	-	3.14E-04	7.29E-04
ConsensusPathDB	CC	GO:0140238	presynaptic endocytosis	-	72	70	-	-	5.22E-03	3.14E-03
ConsensusPathDB	BP	GO:0051236	establishment of RNA localization	-	161	156	-	-	8.50E-03	7.01E-03
ConsensusPathDB	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	3.64E-02	1.12E-03
ConsensusPathDB	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	3.98E-03	7.85E-04
ConsensusPathDB	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	192	-	-	9.91E-03	8.64E-03
ConsensusPathDB	BP	GO:0034067	protein localization to Golgi apparatus	-	30	29	-	-	7.51E-04	1.35E-03
ConsensusPathDB	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	1.67E-03	1.46E-03
ConsensusPathDB	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	6.52E-03	5.05E-04
ConsensusPathDB	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	9.74E-03	7.85E-04
ConsensusPathDB	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	50	-	-	2.75E-03	2.24E-03
ConsensusPathDB	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	1.73E-03	1.79E-03
ConsensusPathDB	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	1.31E-03	2.36E-03
ConsensusPathDB	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	1.74E-03	7.29E-04
ConsensusPathDB	BP	GO:0050779	RNA destabilization	-	135	100	-	-	1.08E-02	4.49E-03
ConsensusPathDB	BP	GO:0006023	aminoglycan biosynthetic process	-	74	72	-	-	3.52E-02	3.25E-03
ConsensusPathDB	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	66	-	-	7.49E-03	2.97E-03
ConsensusPathDB	BP	GO:0010762	regulation of fibroblast migration	-	40	38	-	-	1.79E-03	1.74E-03
ConsensusPathDB	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	2.16E-03	1.35E-03
ConsensusPathDB	BP	GO:0035272	exocrine system development	-	46	46	-	-	3.50E-03	2.08E-03
ConsensusPathDB	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	5.01E-03	7.85E-04
ConsensusPathDB	BP	GO:0022406	membrane docking	-	90	89	-	-	8.48E-03	4.04E-03
ConsensusPathDB	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	1.25E-03	6.73E-04
ConsensusPathDB	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	8.45E-04	7.29E-04
ConsensusPathDB	BP	GO:0050777	negative regulation of immune response	-	196	187	-	-	5.85E-03	8.41E-03
ConsensusPathDB	MF	GO:0005035	death receptor activity	-	16	16	-	-	7.57E-03	7.29E-04
ConsensusPathDB	BP	GO:0002063	chondrocyte development	-	33	32	-	-	2.51E-03	1.46E-03
ConsensusPathDB	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	2.17E-03	7.85E-04
ConsensusPathDB	BP	GO:0099068	postsynapse assembly	-	40	40	-	-	1.29E-02	1.79E-03
ConsensusPathDB	BP	GO:0021782	glial cell development	-	120	111	-	-	2.71E-03	4.99E-03
ConsensusPathDB	BP	GO:0051782	negative regulation of cell division	-	18	16	-	-	2.83E-03	7.29E-04
ConsensusPathDB	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	1.73E-03	5.05E-04
ConsensusPathDB	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	86	-	-	2.89E-03	3.87E-03
ConsensusPathDB	BP	GO:0001655	urogenital system development	-	66	65	-	-	3.11E-03	2.92E-03
ConsensusPathDB	BP	GO:0071827	plasma lipoprotein particle organization	-	86	71	-	-	1.66E-02	3.20E-03
ConsensusPathDB	BP	GO:0045494	photoreceptor cell maintenance	-	43	42	-	-	1.60E-02	1.91E-03
ConsensusPathDB	BP	GO:0055088	lipid homeostasis	-	173	151	-	-	9.05E-03	6.79E-03
ConsensusPathDB	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	1.27E-03	1.18E-03
ConsensusPathDB	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	194	-	-	4.88E-03	8.75E-03
ConsensusPathDB	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	28	-	-	1.86E-02	1.29E-03
ConsensusPathDB	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	1.23E-03	1.57E-03
ConsensusPathDB	BP	GO:0045667	regulation of osteoblast differentiation	-	147	123	-	-	7.70E-03	5.55E-03
ConsensusPathDB	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	1.24E-02	7.29E-04
ConsensusPathDB	BP	GO:0061037	negative regulation of cartilage development	-	32	29	-	-	9.72E-03	1.35E-03
ConsensusPathDB	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	1.79E-03	1.79E-03
ConsensusPathDB	BP	GO:0001704	formation of primary germ layer	-	195	188	-	-	1.00E-02	8.47E-03
ConsensusPathDB	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	1.28E-02	6.17E-04
ConsensusPathDB	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	2.99E-03	2.30E-03
ConsensusPathDB	BP	GO:0060174	limb bud formation	-	11	11	-	-	2.51E-03	5.05E-04
ConsensusPathDB	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	3.18E-03	3.81E-03
ConsensusPathDB	BP	GO:0042092	type 2 immune response	-	41	41	-	-	4.22E-03	1.85E-03
ConsensusPathDB	BP	GO:0048588	developmental cell growth	-	233	222	-	-	5.08E-03	9.98E-03
ConsensusPathDB	CC	GO:0000963	mitochondrial RNA processing	-	20	19	-	-	4.94E-03	8.97E-04
ConsensusPathDB	BP	GO:0021872	forebrain generation of neurons	-	52	51	-	-	3.15E-03	2.30E-03
ConsensusPathDB	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	9.53E-04	1.01E-03
ConsensusPathDB	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	5.56E-03	1.79E-03
ConsensusPathDB	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	50	-	-	4.65E-02	2.24E-03
ConsensusPathDB	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	6.81E-04	5.05E-04
ConsensusPathDB	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	1.70E-02	1.57E-03
ConsensusPathDB	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	25	-	-	1.39E-03	1.12E-03
ConsensusPathDB	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	47	-	-	4.20E-03	2.13E-03
ConsensusPathDB	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	4.72E-02	8.97E-04
ConsensusPathDB	BP	GO:0015810	aspartate transmembrane transport	-	19	17	-	-	2.75E-03	7.85E-04
ConsensusPathDB	BP	GO:0010232	vascular transport	-	87	83	-	-	5.48E-03	3.76E-03
ConsensusPathDB	BP	GO:0021987	cerebral cortex development	-	125	122	-	-	3.67E-03	5.50E-03
ConsensusPathDB	BP	GO:0008637	apoptotic mitochondrial changes	-	108	100	-	-	1.56E-02	4.49E-03
ConsensusPathDB	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	8.37E-03	1.57E-03
ConsensusPathDB	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	5.65E-04	6.73E-04
ConsensusPathDB	BP	GO:0060999	positive regulation of dendritic spine development	-	35	33	-	-	2.92E-03	1.51E-03
ConsensusPathDB	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	5.50E-03	8.41E-04
ConsensusPathDB	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	2.66E-03	3.48E-03
ConsensusPathDB	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	1.85E-03	8.97E-04
ConsensusPathDB	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	2.72E-03	8.97E-04
ConsensusPathDB	BP	GO:0002064	epithelial cell development	-	210	207	-	-	5.53E-03	9.31E-03
ConsensusPathDB	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	3.06E-04	8.41E-04
ConsensusPathDB	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	40	-	-	9.53E-03	1.79E-03
ConsensusPathDB	BP	GO:2001222	regulation of neuron migration	-	46	44	-	-	3.14E-02	2.02E-03
ConsensusPathDB	BP	GO:0034389	lipid droplet organization	-	38	37	-	-	3.17E-03	1.68E-03
ConsensusPathDB	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	1.16E-03	2.02E-03
ConsensusPathDB	BP	GO:0042177	negative regulation of protein catabolic process	-	109	106	-	-	1.69E-03	4.77E-03
ConsensusPathDB	MF	GO:0038024	cargo receptor activity	-	121	115	-	-	1.02E-02	5.16E-03
ConsensusPathDB	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	17	-	-	1.28E-03	7.85E-04
ConsensusPathDB	BP	GO:0033120	positive regulation of RNA splicing	-	46	42	-	-	5.55E-03	1.91E-03
ConsensusPathDB	BP	GO:0051445	regulation of meiotic cell cycle	-	64	62	-	-	1.34E-02	2.80E-03
ConsensusPathDB	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.99E-03	5.61E-04
ConsensusPathDB	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	1.18E-02	2.69E-03
ConsensusPathDB	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	1.25E-02	6.73E-04
ConsensusPathDB	BP	GO:0090087	regulation of peptide transport	-	195	185	-	-	1.11E-02	8.30E-03
ConsensusPathDB	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	100	-	-	4.34E-03	4.49E-03
ConsensusPathDB	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	8.77E-04	1.12E-03
ConsensusPathDB	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	1.36E-03	1.12E-03
ConsensusPathDB	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	8.73E-02	6.73E-04
ConsensusPathDB	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	4.68E-02	1.23E-03
ConsensusPathDB	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	2.96E-03	6.73E-04
ConsensusPathDB	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	5.33E-04	6.73E-04
ConsensusPathDB	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	3.16E-02	8.97E-04
ConsensusPathDB	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	1.97E-03	6.17E-04
ConsensusPathDB	BP	GO:0022404	molting cycle process	-	95	95	-	-	3.59E-03	4.26E-03
ConsensusPathDB	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	4.54E-04	5.05E-04
ConsensusPathDB	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	9.74E-04	7.85E-04
ConsensusPathDB	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	6.59E-03	8.97E-04
ConsensusPathDB	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	4.40E-03	5.61E-04
ConsensusPathDB	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	1.27E-03	7.85E-04
ConsensusPathDB	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	4.18E-03	1.46E-03
ConsensusPathDB	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	2.81E-03	6.73E-04
ConsensusPathDB	BP	GO:0008299	isoprenoid biosynthetic process	-	30	30	-	-	1.33E-02	1.35E-03
ConsensusPathDB	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	234	-	-	1.74E-02	1.05E-02
ConsensusPathDB	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.29E-03	1.40E-03
ConsensusPathDB	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	1.80E-03	1.01E-03
ConsensusPathDB	CC	GO:0098926	postsynaptic signal transduction	-	39	38	-	-	7.22E-03	1.74E-03
ConsensusPathDB	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	139	-	-	3.41E-03	6.28E-03
ConsensusPathDB	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	1.28E-02	8.97E-04
ConsensusPathDB	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	2.20E-03	2.13E-03
ConsensusPathDB	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	141	-	-	6.54E-03	6.34E-03
ConsensusPathDB	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	8.47E-04	1.01E-03
ConsensusPathDB	BP	GO:0061548	ganglion development	-	17	17	-	-	1.11E-02	7.85E-04
ConsensusPathDB	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	98	-	-	5.23E-03	4.43E-03
ConsensusPathDB	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.64E-03	6.73E-04
ConsensusPathDB	BP	GO:0042832	defense response to protozoan	-	28	24	-	-	5.23E-02	1.12E-03
ConsensusPathDB	BP	GO:0048799	animal organ maturation	-	33	32	-	-	2.28E-03	1.46E-03
ConsensusPathDB	BP	GO:0006925	inflammatory cell apoptotic process	-	23	21	-	-	1.81E-03	9.54E-04
ConsensusPathDB	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	3.67E-03	7.29E-04
ConsensusPathDB	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	170	-	-	6.08E-03	7.63E-03
ConsensusPathDB	BP	GO:0010269	response to selenium ion	-	11	11	-	-	4.91E-04	5.05E-04
ConsensusPathDB	BP	GO:1903035	negative regulation of response to wounding	-	93	88	-	-	5.53E-03	3.98E-03
ConsensusPathDB	BP	GO:0015697	quaternary ammonium group transport	-	16	15	-	-	8.53E-03	6.73E-04
ConsensusPathDB	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	1.20E-03	1.18E-03
ConsensusPathDB	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	8.88E-04	1.23E-03
ConsensusPathDB	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	132	-	-	1.84E-02	5.95E-03
ConsensusPathDB	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	97	-	-	2.73E-03	4.37E-03
ConsensusPathDB	BP	GO:0045056	transcytosis	-	20	20	-	-	3.08E-03	8.97E-04
ConsensusPathDB	BP	GO:0018342	protein prenylation	-	15	15	-	-	3.43E-03	6.73E-04
ConsensusPathDB	BP	GO:0009267	cellular response to starvation	-	170	167	-	-	7.60E-03	7.52E-03
ConsensusPathDB	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	3.63E-02	5.05E-04
ConsensusPathDB	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	3.58E-03	2.41E-03
ConsensusPathDB	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	2.94E-03	7.29E-04
ConsensusPathDB	BP	GO:0007343	egg activation	-	11	11	-	-	5.18E-02	5.05E-04
ConsensusPathDB	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	6.82E-04	1.07E-03
ConsensusPathDB	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	25	-	-	2.94E-02	1.12E-03
ConsensusPathDB	BP	GO:0046931	pore complex assembly	-	21	20	-	-	3.06E-03	8.97E-04
ConsensusPathDB	CC	GO:0032008	positive regulation of TOR signaling	-	52	49	-	-	1.37E-02	2.24E-03
ConsensusPathDB	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	4.23E-02	1.51E-03
ConsensusPathDB	BP	GO:0046618	xenobiotic export from cell	-	27	13	-	-	2.86E-03	6.17E-04
ConsensusPathDB	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	15	-	-	2.60E-03	6.73E-04
ConsensusPathDB	BP	GO:0060428	lung epithelium development	-	43	43	-	-	2.04E-03	1.96E-03
ConsensusPathDB	BP	GO:0030431	sleep	-	30	30	-	-	1.69E-02	1.35E-03
ConsensusPathDB	BP	GO:1903318	negative regulation of protein maturation	-	29	28	-	-	1.13E-02	1.29E-03
ConsensusPathDB	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	96	-	-	4.67E-02	4.32E-03
ConsensusPathDB	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	5.76E-04	7.85E-04
ConsensusPathDB	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	2.56E-03	6.73E-04
ConsensusPathDB	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	2.16E-03	5.61E-04
ConsensusPathDB	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	3.78E-04	6.17E-04
ConsensusPathDB	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	69	-	-	1.21E-02	3.14E-03
ConsensusPathDB	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	2.60E-03	2.92E-03
ConsensusPathDB	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	2.37E-03	7.85E-04
ConsensusPathDB	CC	GO:0090660	cerebrospinal fluid circulation	-	15	13	-	-	1.52E-04	6.17E-04
ConsensusPathDB	CC	GO:0006406	mRNA export from nucleus	-	69	68	-	-	8.01E-03	3.08E-03
ConsensusPathDB	BP	GO:0009880	embryonic pattern specification	-	70	70	-	-	4.02E-03	3.14E-03
ConsensusPathDB	BP	GO:0015791	polyol transmembrane transport	-	14	13	-	-	1.83E-03	6.17E-04
ConsensusPathDB	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	5.73E-02	1.79E-03
ConsensusPathDB	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	1.49E-03	1.12E-03
ConsensusPathDB	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	9.27E-03	5.05E-04
ConsensusPathDB	BP	GO:0002367	cytokine production involved in immune response	-	121	118	-	-	1.66E-02	5.33E-03
ConsensusPathDB	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	12	-	-	6.27E-04	5.61E-04
ConsensusPathDB	BP	GO:0044848	biological phase	-	211	204	-	-	1.62E-02	9.20E-03
ConsensusPathDB	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	7.71E-03	5.61E-04
ConsensusPathDB	BP	GO:0046660	female sex differentiation	-	125	123	-	-	6.53E-03	5.55E-03
ConsensusPathDB	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	16	-	-	5.11E-04	7.29E-04
ConsensusPathDB	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	41	-	-	1.01E-03	1.85E-03
ConsensusPathDB	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	2.79E-04	5.05E-04
ConsensusPathDB	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	1.09E-02	3.14E-03
ConsensusPathDB	BP	GO:0071248	cellular response to metal ion	-	201	197	-	-	4.21E-03	8.86E-03
ConsensusPathDB	BP	GO:0030308	negative regulation of cell growth	-	191	184	-	-	4.51E-03	8.30E-03
ConsensusPathDB	BP	GO:0097306	cellular response to alcohol	-	99	93	-	-	3.65E-03	4.21E-03
ConsensusPathDB	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	125	-	-	1.03E-02	5.61E-03
ConsensusPathDB	BP	GO:0010453	regulation of cell fate commitment	-	40	35	-	-	8.95E-03	1.57E-03
ConsensusPathDB	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	58	-	-	3.46E-03	2.64E-03
ConsensusPathDB	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	52	-	-	1.24E-02	2.36E-03
ConsensusPathDB	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	3.36E-03	1.18E-03
ConsensusPathDB	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	1.39E-02	1.12E-03
ConsensusPathDB	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	44	-	-	2.53E-03	2.02E-03
ConsensusPathDB	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	6.69E-03	3.48E-03
ConsensusPathDB	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	9.45E-04	8.97E-04
ConsensusPathDB	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	2.93E-04	1.12E-03
ConsensusPathDB	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	95	-	-	4.30E-03	4.26E-03
ConsensusPathDB	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	1.98E-03	1.18E-03
ConsensusPathDB	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	2.20E-03	5.05E-04
ConsensusPathDB	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	51	-	-	6.54E-03	2.30E-03
ConsensusPathDB	BP	GO:0051259	protein complex oligomerization	-	251	248	-	-	1.21E-02	1.12E-02
ConsensusPathDB	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	7.78E-04	7.29E-04
ConsensusPathDB	BP	GO:0098743	cell aggregation	-	24	23	-	-	3.21E-03	1.07E-03
ConsensusPathDB	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	4.32E-04	5.61E-04
ConsensusPathDB	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	4.63E-04	5.05E-04
ConsensusPathDB	BP	GO:0009994	oocyte differentiation	-	57	54	-	-	5.42E-03	2.47E-03
ConsensusPathDB	MF	GO:0031952	regulation of protein autophosphorylation	-	43	41	-	-	2.05E-03	1.85E-03
ConsensusPathDB	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	2.48E-03	6.73E-04
ConsensusPathDB	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	150	-	-	4.90E-03	6.73E-03
ConsensusPathDB	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	1.80E-03	1.57E-03
ConsensusPathDB	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	2.44E-03	1.29E-03
ConsensusPathDB	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	1.39E-03	1.57E-03
ConsensusPathDB	BP	GO:0072665	protein localization to vacuole	-	84	83	-	-	5.61E-03	3.76E-03
ConsensusPathDB	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	45	-	-	7.84E-03	2.02E-03
ConsensusPathDB	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	25	-	-	4.09E-03	1.12E-03
ConsensusPathDB	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	73	-	-	4.24E-03	3.31E-03
ConsensusPathDB	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	1.09E-03	7.29E-04
ConsensusPathDB	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	1.75E-03	6.73E-04
ConsensusPathDB	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.36E-04	5.05E-04
ConsensusPathDB	BP	GO:0042044	fluid transport	-	35	34	-	-	2.11E-03	1.57E-03
ConsensusPathDB	BP	GO:0070633	transepithelial transport	-	35	35	-	-	1.61E-03	1.57E-03
ConsensusPathDB	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	2.17E-02	6.17E-04
ConsensusPathDB	BP	GO:0045661	regulation of myoblast differentiation	-	74	73	-	-	4.65E-03	3.31E-03
ConsensusPathDB	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	14	-	-	1.73E-03	6.73E-04
ConsensusPathDB	BP	GO:0030307	positive regulation of cell growth	-	164	158	-	-	3.16E-03	7.12E-03
ConsensusPathDB	BP	GO:0034250	positive regulation of amide metabolic process	-	27	25	-	-	1.46E-03	1.12E-03
ConsensusPathDB	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	3.12E-03	8.41E-04
ConsensusPathDB	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	9.41E-04	6.17E-04
ConsensusPathDB	BP	GO:0014812	muscle cell migration	-	110	85	-	-	3.67E-03	3.81E-03
ConsensusPathDB	BP	GO:0048525	negative regulation of viral process	-	90	87	-	-	2.82E-03	3.93E-03
ConsensusPathDB	BP	GO:0072044	collecting duct development	-	16	16	-	-	1.73E-03	7.29E-04
ConsensusPathDB	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	6.77E-02	6.73E-04
ConsensusPathDB	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	2.62E-03	3.14E-03
ConsensusPathDB	BP	GO:0030238	male sex determination	-	14	14	-	-	3.58E-02	6.73E-04
ConsensusPathDB	BP	GO:0051781	positive regulation of cell division	-	93	89	-	-	5.88E-03	4.04E-03
ConsensusPathDB	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	8.63E-03	9.54E-04
ConsensusPathDB	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	7.13E-04	5.05E-04
ConsensusPathDB	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	5.71E-03	1.07E-03
ConsensusPathDB	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	21	-	-	5.35E-04	9.54E-04
ConsensusPathDB	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.63E-03	2.13E-03
ConsensusPathDB	BP	GO:0007272	ensheathment of neurons	-	146	139	-	-	4.16E-03	6.28E-03
ConsensusPathDB	CC	GO:0050806	positive regulation of synaptic transmission	-	171	148	-	-	4.05E-03	6.67E-03
ConsensusPathDB	BP	GO:0060021	roof of mouth development	-	91	90	-	-	4.85E-03	4.04E-03
ConsensusPathDB	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	4.01E-03	1.79E-03
ConsensusPathDB	BP	GO:0050819	negative regulation of coagulation	-	54	53	-	-	1.65E-02	2.41E-03
ConsensusPathDB	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	3.34E-03	5.05E-04
ConsensusPathDB	BP	GO:0017004	cytochrome complex assembly	-	40	35	-	-	1.89E-02	1.57E-03
ConsensusPathDB	BP	GO:0018410	C-terminal protein amino acid modification	-	15	13	-	-	7.93E-03	6.17E-04
ConsensusPathDB	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	1.21E-02	2.80E-03
ConsensusPathDB	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	1.61E-02	6.73E-04
ConsensusPathDB	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	14	-	-	1.45E-03	6.73E-04
ConsensusPathDB	CC	GO:0050805	negative regulation of synaptic transmission	-	55	54	-	-	7.31E-03	2.47E-03
ConsensusPathDB	BP	GO:0043248	proteasome assembly	-	13	13	-	-	8.28E-03	6.17E-04
ConsensusPathDB	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	59	-	-	5.46E-03	2.69E-03
ConsensusPathDB	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	7.15E-03	5.05E-04
ConsensusPathDB	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	82	-	-	1.89E-02	3.70E-03
ConsensusPathDB	BP	GO:0016054	organic acid catabolic process	-	251	241	-	-	1.79E-02	1.08E-02
ConsensusPathDB	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	4.59E-04	6.17E-04
ConsensusPathDB	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.99E-02	1.29E-03
ConsensusPathDB	BP	GO:0065005	protein-lipid complex assembly	-	29	28	-	-	6.84E-03	1.29E-03
ConsensusPathDB	BP	GO:0008033	tRNA processing	-	136	130	-	-	2.41E-02	5.83E-03
ConsensusPathDB	BP	GO:0046661	male sex differentiation	-	171	167	-	-	9.78E-03	7.52E-03
ConsensusPathDB	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	5.31E-04	6.73E-04
ConsensusPathDB	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	2.38E-03	7.85E-04
ConsensusPathDB	BP	GO:0035188	hatching	-	27	24	-	-	4.12E-04	1.12E-03
ConsensusPathDB	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	86	-	-	3.93E-03	3.87E-03
ConsensusPathDB	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	8.06E-04	6.73E-04
ConsensusPathDB	BP	GO:0090713	immunological memory process	-	18	18	-	-	2.60E-02	8.41E-04
ConsensusPathDB	BP	GO:0061326	renal tubule development	-	103	103	-	-	6.76E-03	4.66E-03
ConsensusPathDB	BP	GO:0071985	multivesicular body sorting pathway	-	56	55	-	-	1.23E-02	2.47E-03
ConsensusPathDB	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	1.25E-03	7.85E-04
ConsensusPathDB	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	19	-	-	1.59E-03	8.97E-04
ConsensusPathDB	BP	GO:0060325	face morphogenesis	-	31	31	-	-	1.35E-03	1.40E-03
ConsensusPathDB	BP	GO:0090559	regulation of membrane permeability	-	72	63	-	-	5.43E-03	2.86E-03
ConsensusPathDB	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	12	-	-	3.34E-02	5.61E-04
ConsensusPathDB	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	1.28E-02	5.61E-04
ConsensusPathDB	BP	GO:0031579	membrane raft organization	-	25	24	-	-	1.59E-03	1.12E-03
ConsensusPathDB	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	1.05E-03	1.12E-03
ConsensusPathDB	BP	GO:0060033	anatomical structure regression	-	16	15	-	-	1.67E-03	6.73E-04
ConsensusPathDB	BP	GO:0046460	neutral lipid biosynthetic process	-	50	44	-	-	5.72E-03	2.02E-03
ConsensusPathDB	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	141	-	-	1.64E-02	6.34E-03
ConsensusPathDB	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	4.10E-03	5.05E-04
ConsensusPathDB	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	161	-	-	3.76E-03	7.24E-03
ConsensusPathDB	BP	GO:0002251	organ or tissue specific immune response	-	43	35	-	-	8.29E-03	1.57E-03
ConsensusPathDB	CC	GO:0048167	regulation of synaptic plasticity	-	210	188	-	-	6.91E-03	8.47E-03
ConsensusPathDB	BP	GO:1903708	positive regulation of hemopoiesis	-	184	178	-	-	6.77E-03	8.02E-03
ConsensusPathDB	BP	GO:1903008	organelle disassembly	-	154	152	-	-	4.97E-03	6.84E-03
ConsensusPathDB	BP	GO:0001709	cell fate determination	-	44	43	-	-	4.18E-03	1.96E-03
ConsensusPathDB	BP	GO:0051873	killing by host of symbiont cells	-	28	26	-	-	2.77E-02	1.18E-03
ConsensusPathDB	BP	GO:0045058	T cell selection	-	53	53	-	-	1.54E-02	2.41E-03
ConsensusPathDB	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	1.19E-03	2.19E-03
ConsensusPathDB	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	9.68E-04	8.97E-04
ConsensusPathDB	BP	GO:0072091	regulation of stem cell proliferation	-	91	77	-	-	3.93E-03	3.48E-03
ConsensusPathDB	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	40	-	-	4.36E-03	1.79E-03
ConsensusPathDB	BP	GO:0099084	postsynaptic specialization organization	-	44	44	-	-	6.65E-03	2.02E-03
ConsensusPathDB	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	5.39E-03	5.05E-04
ConsensusPathDB	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	2.34E-02	6.73E-04
ConsensusPathDB	BP	GO:0060384	innervation	-	27	26	-	-	3.91E-03	1.18E-03
ConsensusPathDB	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	2.71E-03	5.61E-04
ConsensusPathDB	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	33	-	-	4.67E-03	1.51E-03
ConsensusPathDB	MF	GO:0031281	positive regulation of cyclase activity	-	40	39	-	-	3.81E-03	1.79E-03
ConsensusPathDB	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	4.99E-03	2.86E-03
ConsensusPathDB	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	2.78E-03	8.41E-04
ConsensusPathDB	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	5.30E-02	5.61E-04
ConsensusPathDB	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	1.21E-03	8.41E-04
ConsensusPathDB	BP	GO:0071453	cellular response to oxygen levels	-	168	153	-	-	4.71E-03	6.90E-03
ConsensusPathDB	BP	GO:0090399	replicative senescence	-	17	16	-	-	1.27E-03	7.29E-04
ConsensusPathDB	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	3.44E-02	6.73E-04
ConsensusPathDB	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	1.79E-02	1.35E-03
ConsensusPathDB	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	5.35E-03	5.61E-03
ConsensusPathDB	BP	GO:0006855	xenobiotic transmembrane transport	-	14	13	-	-	6.87E-02	6.17E-04
ConsensusPathDB	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	1.85E-03	1.12E-03
ConsensusPathDB	BP	GO:0044242	cellular lipid catabolic process	-	224	215	-	-	1.43E-02	9.65E-03
ConsensusPathDB	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	2.54E-04	6.17E-04
ConsensusPathDB	BP	GO:0002931	response to ischemia	-	58	56	-	-	5.25E-03	2.52E-03
ConsensusPathDB	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	2.13E-03	5.61E-04
ConsensusPathDB	BP	GO:0014047	glutamate secretion	-	25	25	-	-	2.02E-02	1.12E-03
ConsensusPathDB	BP	GO:0061005	cell differentiation involved in kidney development	-	58	57	-	-	3.24E-03	2.58E-03
ConsensusPathDB	BP	GO:0030397	membrane disassembly	-	11	11	-	-	3.53E-04	5.05E-04
ConsensusPathDB	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	73	-	-	4.03E-02	3.31E-03
ConsensusPathDB	BP	GO:0060420	regulation of heart growth	-	74	58	-	-	3.17E-03	2.64E-03
ConsensusPathDB	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	9.06E-04	6.73E-04
ConsensusPathDB	BP	GO:0009755	hormone-mediated signaling pathway	-	221	214	-	-	8.36E-03	9.65E-03
ConsensusPathDB	BP	GO:0022612	gland morphogenesis	-	124	124	-	-	5.36E-03	5.61E-03
ConsensusPathDB	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	36	-	-	1.00E-03	1.63E-03
ConsensusPathDB	MF	GO:0140416	transcription regulator inhibitor activity	-	26	25	-	-	2.75E-03	1.12E-03
ConsensusPathDB	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	26	-	-	1.80E-01	1.18E-03
ConsensusPathDB	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	1.10E-03	6.73E-04
ConsensusPathDB	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	2.26E-02	7.85E-04
ConsensusPathDB	BP	GO:1990845	adaptive thermogenesis	-	166	163	-	-	6.26E-03	7.35E-03
ConsensusPathDB	BP	GO:0071320	cellular response to cAMP	-	54	54	-	-	2.19E-02	2.47E-03
ConsensusPathDB	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	4.60E-03	5.05E-04
ConsensusPathDB	BP	GO:0015844	monoamine transport	-	88	87	-	-	1.62E-02	3.93E-03
ConsensusPathDB	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	21	-	-	1.96E-03	9.54E-04
ConsensusPathDB	BP	GO:0060039	pericardium development	-	19	19	-	-	1.42E-03	8.97E-04
ConsensusPathDB	BP	GO:0071392	cellular response to estradiol stimulus	-	40	39	-	-	8.36E-04	1.79E-03
ConsensusPathDB	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	12	-	-	4.89E-03	5.61E-04
ConsensusPathDB	BP	GO:0000272	polysaccharide catabolic process	-	19	18	-	-	4.43E-03	8.41E-04
ConsensusPathDB	BP	GO:0009451	RNA modification	-	169	159	-	-	2.07E-02	7.18E-03
ConsensusPathDB	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	2.39E-01	5.05E-04
ConsensusPathDB	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	39	-	-	1.38E-03	1.79E-03
ConsensusPathDB	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	9.30E-04	7.85E-04
ConsensusPathDB	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	109	-	-	5.46E-03	4.94E-03
ConsensusPathDB	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	36	-	-	3.60E-03	1.63E-03
ConsensusPathDB	BP	GO:0015807	L-amino acid transport	-	94	84	-	-	1.20E-02	3.81E-03
ConsensusPathDB	BP	GO:0032941	secretion by tissue	-	85	84	-	-	2.63E-03	3.81E-03
ConsensusPathDB	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	11	-	-	4.57E-03	5.05E-04
ConsensusPathDB	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	2.76E-03	2.47E-03
ConsensusPathDB	BP	GO:0048753	pigment granule organization	-	40	40	-	-	4.63E-02	1.79E-03
ConsensusPathDB	BP	GO:0021516	dorsal spinal cord development	-	20	18	-	-	1.43E-02	8.41E-04
ConsensusPathDB	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	1.85E-02	8.97E-04
ConsensusPathDB	BP	GO:0032196	transposition	-	11	11	-	-	2.53E-04	5.05E-04
ConsensusPathDB	BP	GO:0003014	renal system process	-	130	128	-	-	5.33E-03	5.78E-03
ConsensusPathDB	CC	GO:0070286	axonemal dynein complex assembly	-	40	36	-	-	2.92E-02	1.63E-03
ConsensusPathDB	BP	GO:0045598	regulation of fat cell differentiation	-	148	131	-	-	5.80E-03	5.89E-03
ConsensusPathDB	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	190	-	-	8.22E-03	8.53E-03
ConsensusPathDB	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	1.35E-03	1.74E-03
ConsensusPathDB	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	1.51E-03	1.12E-03
ConsensusPathDB	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	220	-	-	6.65E-02	9.87E-03
ConsensusPathDB	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	5.90E-04	6.17E-04
ConsensusPathDB	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	6.26E-04	1.07E-03
ConsensusPathDB	BP	GO:0018158	protein oxidation	-	15	13	-	-	1.17E-03	6.17E-04
ConsensusPathDB	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	2.59E-03	1.35E-03
ConsensusPathDB	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	1.89E-04	7.85E-04
ConsensusPathDB	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	3.79E-03	1.23E-03
ConsensusPathDB	BP	GO:0071709	membrane assembly	-	68	65	-	-	1.37E-02	2.92E-03
ConsensusPathDB	BP	GO:0008217	regulation of blood pressure	-	186	180	-	-	2.19E-02	8.08E-03
ConsensusPathDB	BP	GO:0031643	positive regulation of myelination	-	19	17	-	-	4.28E-03	7.85E-04
ConsensusPathDB	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	3.03E-03	6.73E-04
ConsensusPathDB	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	61	-	-	3.32E-03	2.75E-03
ConsensusPathDB	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	1.31E-02	8.36E-03
ConsensusPathDB	BP	GO:0002200	somatic diversification of immune receptors	-	78	77	-	-	5.35E-03	3.48E-03
ConsensusPathDB	BP	GO:0035315	hair cell differentiation	-	52	49	-	-	5.51E-03	2.24E-03
ConsensusPathDB	BP	GO:0048645	animal organ formation	-	62	61	-	-	5.60E-03	2.75E-03
ConsensusPathDB	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	160	-	-	9.59E-03	7.18E-03
ConsensusPathDB	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	3.55E-04	6.73E-04
ConsensusPathDB	BP	GO:0033627	cell adhesion mediated by integrin	-	87	87	-	-	6.02E-02	3.93E-03
ConsensusPathDB	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	5.21E-03	9.54E-04
ConsensusPathDB	BP	GO:0015824	proline transport	-	13	11	-	-	7.97E-04	5.05E-04
ConsensusPathDB	BP	GO:0035107	appendage morphogenesis	-	147	142	-	-	6.87E-03	6.39E-03
ConsensusPathDB	BP	GO:1903707	negative regulation of hemopoiesis	-	116	106	-	-	4.53E-03	4.77E-03
ConsensusPathDB	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	8.59E-04	8.97E-04
ConsensusPathDB	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	6.81E-03	1.12E-03
ConsensusPathDB	BP	GO:0030149	sphingolipid catabolic process	-	32	30	-	-	1.35E-03	1.35E-03
ConsensusPathDB	BP	GO:0050994	regulation of lipid catabolic process	-	61	59	-	-	3.50E-03	2.69E-03
ConsensusPathDB	BP	GO:0035988	chondrocyte proliferation	-	24	23	-	-	1.48E-03	1.07E-03
ConsensusPathDB	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	9.50E-03	1.35E-03
ConsensusPathDB	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	7.02E-03	5.05E-04
ConsensusPathDB	BP	GO:0009593	detection of chemical stimulus	-	511	163	-	-	3.72E-03	7.35E-03
ConsensusPathDB	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	1.15E-03	5.61E-04
ConsensusPathDB	BP	GO:0045727	positive regulation of translation	-	141	138	-	-	3.23E-03	6.23E-03
ConsensusPathDB	BP	GO:0036315	cellular response to sterol	-	24	20	-	-	3.13E-03	8.97E-04
ConsensusPathDB	CC	GO:0032388	positive regulation of intracellular transport	-	137	135	-	-	2.06E-03	6.06E-03
ConsensusPathDB	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	1.91E-02	6.17E-04
ConsensusPathDB	BP	GO:0002027	regulation of heart rate	-	106	98	-	-	1.94E-02	4.43E-03
ConsensusPathDB	BP	GO:0050879	multicellular organismal movement	-	118	113	-	-	2.69E-03	5.10E-03
ConsensusPathDB	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	3.38E-03	6.73E-04
ConsensusPathDB	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	75	-	-	3.39E-03	3.37E-03
ConsensusPathDB	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	61	-	-	5.68E-03	2.75E-03
ConsensusPathDB	BP	GO:0048515	spermatid differentiation	-	208	191	-	-	5.67E-03	8.58E-03
ConsensusPathDB	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	5.58E-03	2.58E-03
ConsensusPathDB	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	3.61E-03	1.40E-03
ConsensusPathDB	BP	GO:0007130	synaptonemal complex assembly	-	23	22	-	-	7.97E-02	1.01E-03
ConsensusPathDB	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	34	-	-	3.62E-03	1.57E-03
ConsensusPathDB	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	32	-	-	2.23E-03	1.46E-03
ConsensusPathDB	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	36	-	-	3.92E-02	1.63E-03
ConsensusPathDB	BP	GO:0060119	inner ear receptor cell development	-	44	42	-	-	6.96E-03	1.91E-03
ConsensusPathDB	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	1.57E-03	8.41E-04
ConsensusPathDB	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	6.07E-02	1.57E-03
ConsensusPathDB	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	6.07E-04	1.12E-03
ConsensusPathDB	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.57E-03	5.61E-04
ConsensusPathDB	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	242	-	-	1.25E-02	1.09E-02
ConsensusPathDB	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	1.70E-03	7.85E-04
ConsensusPathDB	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	5.95E-03	2.19E-03
ConsensusPathDB	BP	GO:0010883	regulation of lipid storage	-	53	49	-	-	4.29E-03	2.24E-03
ConsensusPathDB	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	5.03E-03	1.18E-03
ConsensusPathDB	BP	GO:0007635	chemosensory behavior	-	20	20	-	-	2.13E-03	8.97E-04
ConsensusPathDB	BP	GO:1905954	positive regulation of lipid localization	-	110	106	-	-	5.42E-03	4.77E-03
ConsensusPathDB	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	2.19E-04	5.61E-04
ConsensusPathDB	BP	GO:0002209	behavioral defense response	-	39	39	-	-	1.32E-03	1.79E-03
ConsensusPathDB	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	2.82E-02	1.35E-03
ConsensusPathDB	BP	GO:0072523	purine-containing compound catabolic process	-	146	144	-	-	3.10E-03	6.51E-03
ConsensusPathDB	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	31	-	-	5.69E-03	1.40E-03
ConsensusPathDB	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	26	-	-	1.26E-03	1.18E-03
ConsensusPathDB	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	9.58E-04	7.29E-04
ConsensusPathDB	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	95	-	-	2.63E-03	4.26E-03
ConsensusPathDB	BP	GO:0007218	neuropeptide signaling pathway	-	113	107	-	-	1.11E-01	4.82E-03
ConsensusPathDB	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	6.61E-03	5.61E-04
ConsensusPathDB	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	162	-	-	1.23E-02	7.29E-03
ConsensusPathDB	BP	GO:0031345	negative regulation of cell projection organization	-	195	187	-	-	6.19E-03	8.41E-03
ConsensusPathDB	BP	GO:0048278	vesicle docking	-	64	64	-	-	8.89E-03	2.92E-03
ConsensusPathDB	BP	GO:0035050	embryonic heart tube development	-	86	84	-	-	5.82E-03	3.81E-03
ConsensusPathDB	BP	GO:0051593	response to folic acid	-	12	11	-	-	7.67E-04	5.05E-04
ConsensusPathDB	BP	GO:0030168	platelet activation	-	135	132	-	-	8.52E-03	5.95E-03
ConsensusPathDB	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	1.86E-02	7.29E-04
ConsensusPathDB	CC	GO:0098810	neurotransmitter reuptake	-	35	34	-	-	3.94E-03	1.57E-03
ConsensusPathDB	BP	GO:0008213	protein alkylation	-	58	55	-	-	8.22E-03	2.47E-03
ConsensusPathDB	BP	GO:0009812	flavonoid metabolic process	-	14	13	-	-	2.18E-01	6.17E-04
ConsensusPathDB	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	4.19E-04	6.17E-04
ConsensusPathDB	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	9.37E-03	1.12E-03
ConsensusPathDB	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	5.68E-04	6.17E-04
ConsensusPathDB	BP	GO:0031529	ruffle organization	-	55	53	-	-	2.93E-03	2.41E-03
ConsensusPathDB	BP	GO:0010842	retina layer formation	-	25	25	-	-	1.15E-03	1.12E-03
ConsensusPathDB	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	89	-	-	5.17E-02	4.04E-03
ConsensusPathDB	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	6.28E-04	5.05E-04
ConsensusPathDB	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	70	-	-	5.58E-03	3.14E-03
ConsensusPathDB	MF	GO:0170055	lipid transmembrane transporter activity	-	56	55	-	-	8.24E-03	2.47E-03
ConsensusPathDB	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	33	-	-	3.00E-03	1.51E-03
ConsensusPathDB	BP	GO:0035304	regulation of protein dephosphorylation	-	87	84	-	-	2.19E-03	3.81E-03
ConsensusPathDB	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	230	-	-	5.38E-03	1.03E-02
ConsensusPathDB	BP	GO:0099637	neurotransmitter receptor transport	-	26	25	-	-	1.03E-03	1.12E-03
ConsensusPathDB	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	3.97E-03	1.57E-03
ConsensusPathDB	BP	GO:0051775	response to redox state	-	13	13	-	-	7.32E-03	6.17E-04
ConsensusPathDB	BP	GO:0051785	positive regulation of nuclear division	-	61	60	-	-	6.71E-03	2.69E-03
ConsensusPathDB	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	8.63E-03	7.29E-04
ConsensusPathDB	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	9.74E-03	7.29E-04
ConsensusPathDB	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	3.63E-03	8.97E-04
ConsensusPathDB	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	4.03E-03	5.61E-04
ConsensusPathDB	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	5.13E-03	2.02E-03
ConsensusPathDB	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	13	-	-	5.42E-03	6.17E-04
ConsensusPathDB	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	8.37E-04	7.85E-04
ConsensusPathDB	BP	GO:0051299	centrosome separation	-	15	15	-	-	2.06E-03	6.73E-04
ConsensusPathDB	BP	GO:0048145	regulation of fibroblast proliferation	-	87	84	-	-	2.75E-03	3.81E-03
ConsensusPathDB	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	88	-	-	2.75E-01	3.98E-03
ConsensusPathDB	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	4.30E-02	5.05E-04
ConsensusPathDB	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	223	-	-	5.25E-03	1.00E-02
ConsensusPathDB	BP	GO:0032098	regulation of appetite	-	20	20	-	-	1.38E-02	8.97E-04
ConsensusPathDB	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	9.14E-03	6.73E-04
ConsensusPathDB	CC	GO:0008333	endosome to lysosome transport	-	73	71	-	-	7.20E-03	3.20E-03
ConsensusPathDB	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	22	-	-	3.10E-02	1.01E-03
ConsensusPathDB	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	15	-	-	1.14E-02	6.73E-04
ConsensusPathDB	BP	GO:0003016	respiratory system process	-	39	38	-	-	6.79E-04	1.74E-03
ConsensusPathDB	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	4.60E-03	1.07E-03
ConsensusPathDB	BP	GO:0045732	positive regulation of protein catabolic process	-	202	201	-	-	4.67E-03	9.03E-03
ConsensusPathDB	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	70	-	-	9.15E-03	3.14E-03
ConsensusPathDB	BP	GO:0007588	excretion	-	40	40	-	-	6.67E-03	1.79E-03
ConsensusPathDB	BP	GO:1904018	positive regulation of vasculature development	-	185	158	-	-	1.12E-02	7.12E-03
ConsensusPathDB	BP	GO:0050953	sensory perception of light stimulus	-	223	215	-	-	5.44E-02	9.65E-03
ConsensusPathDB	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	6.45E-02	1.12E-03
ConsensusPathDB	BP	GO:0002357	defense response to tumor cell	-	13	11	-	-	2.22E-04	5.05E-04
ConsensusPathDB	BP	GO:0009303	rRNA transcription	-	37	37	-	-	5.72E-03	1.68E-03
ConsensusPathDB	BP	GO:0035601	protein deacylation	-	56	55	-	-	2.40E-03	2.47E-03
ConsensusPathDB	BP	GO:0061952	midbody abscission	-	18	18	-	-	7.55E-03	8.41E-04
ConsensusPathDB	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	2.26E-03	5.05E-04
ConsensusPathDB	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	1.50E-03	8.97E-04
ConsensusPathDB	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	1.80E-03	1.35E-03
ConsensusPathDB	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	3.29E-03	2.92E-03
ConsensusPathDB	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	16	-	-	4.48E-02	7.29E-04
ConsensusPathDB	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	1.85E-03	1.29E-03
ConsensusPathDB	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	2.07E-03	1.51E-03
ConsensusPathDB	BP	GO:0046697	decidualization	-	26	25	-	-	3.13E-03	1.12E-03
ConsensusPathDB	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	1.70E-02	6.73E-04
ConsensusPathDB	BP	GO:0051588	regulation of neurotransmitter transport	-	99	98	-	-	8.82E-03	4.43E-03
ConsensusPathDB	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	32	-	-	3.64E-02	1.46E-03
ConsensusPathDB	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	1.11E-03	5.61E-04
ConsensusPathDB	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	4.07E-03	2.86E-03
ConsensusPathDB	BP	GO:0044703	multi-organism reproductive process	-	209	199	-	-	9.05E-03	8.97E-03
ConsensusPathDB	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	138	-	-	4.80E-03	6.23E-03
ConsensusPathDB	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	53	-	-	5.82E-03	2.41E-03
ConsensusPathDB	BP	GO:0099022	vesicle tethering	-	32	31	-	-	9.60E-03	1.40E-03
ConsensusPathDB	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	37	-	-	5.25E-03	1.68E-03
ConsensusPathDB	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	1.03E-03	5.61E-04
ConsensusPathDB	BP	GO:0048857	neural nucleus development	-	65	62	-	-	8.29E-03	2.80E-03
ConsensusPathDB	BP	GO:0048663	neuron fate commitment	-	74	70	-	-	4.63E-03	3.14E-03
ConsensusPathDB	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	172	-	-	1.07E-02	7.74E-03
ConsensusPathDB	BP	GO:0106027	neuron projection organization	-	90	86	-	-	2.74E-03	3.87E-03
ConsensusPathDB	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	127	-	-	1.09E-02	5.72E-03
ConsensusPathDB	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	34	-	-	1.83E-03	1.57E-03
ConsensusPathDB	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	9.76E-04	5.05E-04
ConsensusPathDB	BP	GO:0045685	regulation of glial cell differentiation	-	77	73	-	-	1.08E-02	3.31E-03
ConsensusPathDB	BP	GO:0051608	histamine transport	-	14	13	-	-	1.08E-03	6.17E-04
ConsensusPathDB	BP	GO:0043414	macromolecule methylation	-	138	130	-	-	6.87E-03	5.83E-03
ConsensusPathDB	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	1.14E-02	5.61E-04
ConsensusPathDB	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	8.05E-03	7.29E-04
ConsensusPathDB	BP	GO:0050886	endocrine process	-	93	92	-	-	9.98E-03	4.15E-03
ConsensusPathDB	MF	GO:0015562	efflux transmembrane transporter activity	-	15	12	-	-	2.32E-03	5.61E-04
ConsensusPathDB	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	4.29E-03	1.29E-03
ConsensusPathDB	BP	GO:0045807	positive regulation of endocytosis	-	155	149	-	-	6.02E-03	6.73E-03
ConsensusPathDB	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	6.79E-04	5.05E-04
ConsensusPathDB	BP	GO:0002418	immune response to tumor cell	-	29	29	-	-	1.29E-02	1.35E-03
ConsensusPathDB	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	1.49E-03	2.64E-03
ConsensusPathDB	BP	GO:0048308	organelle inheritance	-	14	14	-	-	8.70E-04	6.73E-04
ConsensusPathDB	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	7.99E-04	8.41E-04
ConsensusPathDB	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	2.41E-03	8.97E-04
ConsensusPathDB	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	48	-	-	4.49E-03	2.19E-03
ConsensusPathDB	BP	GO:0034394	protein localization to cell surface	-	69	66	-	-	1.53E-03	2.97E-03
ConsensusPathDB	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	7.65E-04	5.61E-04
ConsensusPathDB	BP	GO:0009110	vitamin biosynthetic process	-	23	22	-	-	7.96E-04	1.01E-03
ConsensusPathDB	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	1.47E-03	1.01E-03
ConsensusPathDB	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	5.13E-03	7.85E-04
ConsensusPathDB	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	21	-	-	4.84E-03	9.54E-04
ConsensusPathDB	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	94	-	-	2.53E-03	4.26E-03
ConsensusPathDB	BP	GO:0009111	vitamin catabolic process	-	13	11	-	-	1.26E-02	5.05E-04
ConsensusPathDB	MF	GO:0051100	negative regulation of binding	-	161	156	-	-	3.41E-03	7.01E-03
ConsensusPathDB	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	5.44E-03	3.53E-03
ConsensusPathDB	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	59	-	-	1.43E-03	2.69E-03
ConsensusPathDB	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	1.25E-03	8.97E-04
ConsensusPathDB	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	2.35E-04	5.61E-04
ConsensusPathDB	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	9.17E-03	1.51E-03
ConsensusPathDB	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	3.04E-02	7.29E-04
ConsensusPathDB	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	2.70E-03	6.17E-04
ConsensusPathDB	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	3.81E-03	2.13E-03
ConsensusPathDB	BP	GO:0046621	negative regulation of organ growth	-	39	31	-	-	1.13E-03	1.40E-03
ConsensusPathDB	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	48	-	-	7.12E-03	2.19E-03
ConsensusPathDB	BP	GO:0032368	regulation of lipid transport	-	149	129	-	-	5.54E-03	5.83E-03
ConsensusPathDB	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	4.09E-03	1.35E-03
ConsensusPathDB	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	178	-	-	5.17E-03	8.02E-03
ConsensusPathDB	BP	GO:0033002	muscle cell proliferation	-	249	200	-	-	7.60E-03	8.97E-03
ConsensusPathDB	BP	GO:0043331	response to dsRNA	-	56	53	-	-	6.58E-03	2.41E-03
ConsensusPathDB	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	8.07E-03	5.61E-04
ConsensusPathDB	BP	GO:0051904	pigment granule transport	-	23	23	-	-	1.11E-02	1.07E-03
ConsensusPathDB	BP	GO:1901679	nucleotide transmembrane transport	-	32	31	-	-	2.66E-03	1.40E-03
ConsensusPathDB	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	3.81E-03	1.51E-03
ConsensusPathDB	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	11	-	-	2.44E-03	5.05E-04
ConsensusPathDB	BP	GO:0033363	secretory granule organization	-	63	59	-	-	7.84E-03	2.69E-03
ConsensusPathDB	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	2.59E-03	1.29E-03
ConsensusPathDB	BP	GO:0120009	intermembrane lipid transfer	-	52	49	-	-	4.88E-02	2.24E-03
ConsensusPathDB	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	5.78E-04	6.73E-04
ConsensusPathDB	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	9.72E-04	1.74E-03
ConsensusPathDB	BP	GO:0097250	mitochondrial respirasome assembly	-	11	11	-	-	2.96E-03	5.05E-04
ConsensusPathDB	BP	GO:0033622	integrin activation	-	26	26	-	-	2.06E-03	1.18E-03
ConsensusPathDB	BP	GO:0098751	bone cell development	-	18	16	-	-	7.81E-04	7.29E-04
ConsensusPathDB	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.47E-03	9.54E-04
ConsensusPathDB	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	6.33E-03	2.30E-03
ConsensusPathDB	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.34E-02	1.35E-03
ConsensusPathDB	BP	GO:0002076	osteoblast development	-	17	17	-	-	3.49E-03	7.85E-04
ConsensusPathDB	BP	GO:0072164	mesonephric tubule development	-	98	98	-	-	1.02E-02	4.43E-03
ConsensusPathDB	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	2.97E-03	7.85E-04
ConsensusPathDB	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	106	-	-	4.63E-03	4.77E-03
ConsensusPathDB	BP	GO:1903524	positive regulation of blood circulation	-	39	36	-	-	3.91E-03	1.63E-03
ConsensusPathDB	BP	GO:0030901	midbrain development	-	87	84	-	-	2.87E-03	3.81E-03
ConsensusPathDB	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	1.08E-02	1.01E-03
ConsensusPathDB	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	3.13E-03	7.29E-04
ConsensusPathDB	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	2.88E-03	6.17E-04
ConsensusPathDB	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	66	-	-	2.14E-03	2.97E-03
ConsensusPathDB	MF	GO:1901474	azole transmembrane transporter activity	-	13	11	-	-	1.79E-03	5.05E-04
ConsensusPathDB	BP	GO:0002687	positive regulation of leukocyte migration	-	147	146	-	-	7.61E-03	6.56E-03
ConsensusPathDB	BP	GO:0019755	one-carbon compound transport	-	28	26	-	-	2.18E-03	1.18E-03
ConsensusPathDB	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.23E-03	6.17E-04
ConsensusPathDB	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	1.95E-03	7.29E-04
ConsensusPathDB	BP	GO:0110154	RNA decapping	-	19	19	-	-	3.73E-03	8.97E-04
ConsensusPathDB	BP	GO:0034605	cellular response to heat	-	66	66	-	-	1.98E-03	2.97E-03
ConsensusPathDB	BP	GO:0005996	monosaccharide metabolic process	-	250	238	-	-	6.56E-03	1.07E-02
ConsensusPathDB	BP	GO:0033555	multicellular organismal response to stress	-	90	89	-	-	3.58E-03	4.04E-03
ConsensusPathDB	BP	GO:0002262	myeloid cell homeostasis	-	172	167	-	-	4.12E-03	7.52E-03
ConsensusPathDB	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	5.82E-03	1.74E-03
ConsensusPathDB	BP	GO:0050688	regulation of defense response to virus	-	65	62	-	-	6.25E-03	2.80E-03
ConsensusPathDB	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	8.52E-04	8.97E-04
ConsensusPathDB	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	222	-	-	9.20E-03	9.98E-03
ConsensusPathDB	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	2.53E-03	1.40E-03
ConsensusPathDB	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	5.98E-04	6.73E-04
ConsensusPathDB	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	4.51E-03	1.46E-03
ConsensusPathDB	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	18	-	-	5.91E-04	8.41E-04
ConsensusPathDB	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	3.12E-02	1.29E-03
ConsensusPathDB	BP	GO:0022618	protein-RNA complex assembly	-	227	189	-	-	7.60E-03	8.53E-03
ConsensusPathDB	BP	GO:0051147	regulation of muscle cell differentiation	-	162	134	-	-	4.95E-03	6.06E-03
ConsensusPathDB	BP	GO:0090102	cochlea development	-	50	49	-	-	1.84E-03	2.24E-03
ConsensusPathDB	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	2.45E-03	1.18E-03
ConsensusPathDB	BP	GO:0061303	cornea development in camera-type eye	-	12	11	-	-	2.82E-03	5.05E-04
ConsensusPathDB	BP	GO:0045933	positive regulation of muscle contraction	-	49	46	-	-	3.52E-03	2.08E-03
ConsensusPathDB	BP	GO:0015803	branched-chain amino acid transport	-	14	13	-	-	1.80E-03	6.17E-04
ConsensusPathDB	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	1.58E-03	7.29E-04
ConsensusPathDB	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	35	-	-	8.87E-04	1.57E-03
ConsensusPathDB	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	91	-	-	2.72E-02	4.09E-03
ConsensusPathDB	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.42E-03	5.61E-04
ConsensusPathDB	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	7.12E-04	1.01E-03
ConsensusPathDB	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	5.71E-03	3.20E-03
ConsensusPathDB	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	55	-	-	1.31E-02	2.47E-03
ConsensusPathDB	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	203	-	-	1.63E-02	9.14E-03
ConsensusPathDB	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	2.35E-02	1.07E-03
ConsensusPathDB	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	57	-	-	5.44E-03	2.58E-03
ConsensusPathDB	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	8.40E-04	5.05E-04
ConsensusPathDB	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	3.87E-03	1.74E-03
ConsensusPathDB	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	2.45E-04	5.61E-04
ConsensusPathDB	BP	GO:0140253	cell-cell fusion	-	62	58	-	-	2.75E-03	2.64E-03
ConsensusPathDB	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	3.73E-04	5.61E-04
ConsensusPathDB	BP	GO:0071599	otic vesicle development	-	15	15	-	-	2.67E-03	6.73E-04
ConsensusPathDB	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	43	-	-	1.01E-01	1.96E-03
ConsensusPathDB	BP	GO:0061635	regulation of protein complex stability	-	14	13	-	-	4.72E-03	6.17E-04
ConsensusPathDB	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	58	-	-	1.45E-02	2.64E-03
ConsensusPathDB	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	1.51E-02	1.63E-03
ConsensusPathDB	BP	GO:0051293	establishment of spindle localization	-	57	56	-	-	2.54E-03	2.52E-03
ConsensusPathDB	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	3.56E-03	6.17E-04
ConsensusPathDB	BP	GO:0043114	regulation of vascular permeability	-	49	44	-	-	4.47E-03	2.02E-03
ConsensusPathDB	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	2.99E-03	1.18E-03
ConsensusPathDB	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	63	-	-	2.55E-03	2.86E-03
ConsensusPathDB	BP	GO:0008360	regulation of cell shape	-	139	134	-	-	4.96E-03	6.06E-03
ConsensusPathDB	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	1.14E-02	7.29E-04
ConsensusPathDB	BP	GO:0051222	positive regulation of protein transport	-	249	239	-	-	5.20E-03	1.08E-02
ConsensusPathDB	CC	GO:0140632	canonical inflammasome complex assembly	-	40	40	-	-	1.55E-02	1.79E-03
ConsensusPathDB	MF	GO:0034260	negative regulation of GTPase activity	-	36	33	-	-	1.26E-03	1.51E-03
ConsensusPathDB	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	3.29E-03	1.01E-03
ConsensusPathDB	BP	GO:0045739	positive regulation of DNA repair	-	128	127	-	-	6.93E-03	5.72E-03
ConsensusPathDB	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	1.95E-03	8.97E-04
ConsensusPathDB	BP	GO:0045185	maintenance of protein location	-	95	87	-	-	1.93E-03	3.93E-03
ConsensusPathDB	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	2.46E-02	6.17E-04
ConsensusPathDB	BP	GO:0003158	endothelium development	-	140	129	-	-	5.44E-03	5.83E-03
ConsensusPathDB	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	1.67E-03	1.85E-03
ConsensusPathDB	BP	GO:0051224	negative regulation of protein transport	-	122	105	-	-	3.84E-03	4.71E-03
ConsensusPathDB	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	146	-	-	7.64E-03	6.56E-03
ConsensusPathDB	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	1.24E-03	6.17E-04
ConsensusPathDB	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	5.19E-03	1.40E-03
ConsensusPathDB	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	4.79E-02	8.97E-04
ConsensusPathDB	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	4.38E-03	2.86E-03
ConsensusPathDB	BP	GO:0007405	neuroblast proliferation	-	81	79	-	-	3.88E-03	3.59E-03
ConsensusPathDB	BP	GO:0009581	detection of external stimulus	-	137	129	-	-	1.62E-02	5.83E-03
ConsensusPathDB	BP	GO:1990542	mitochondrial transmembrane transport	-	93	86	-	-	1.48E-02	3.87E-03
ConsensusPathDB	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	2.98E-03	1.40E-03
ConsensusPathDB	BP	GO:0033504	floor plate development	-	11	11	-	-	1.47E-04	5.05E-04
ConsensusPathDB	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	8.38E-04	5.05E-04
ConsensusPathDB	BP	GO:0097186	amelogenesis	-	26	25	-	-	4.47E-02	1.12E-03
ConsensusPathDB	BP	GO:0031128	developmental induction	-	26	26	-	-	9.20E-03	1.18E-03
ConsensusPathDB	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	6.14E-03	6.73E-04
ConsensusPathDB	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.30E-03	2.97E-03
ConsensusPathDB	BP	GO:0021533	cell differentiation in hindbrain	-	23	23	-	-	9.81E-03	1.07E-03
ConsensusPathDB	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	2.75E-03	1.40E-03
ConsensusPathDB	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	11	-	-	4.20E-03	5.05E-04
ConsensusPathDB	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	1.96E-02	2.30E-03
ConsensusPathDB	BP	GO:0021517	ventral spinal cord development	-	47	44	-	-	1.31E-02	2.02E-03
ConsensusPathDB	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	1.50E-03	3.37E-03
ConsensusPathDB	BP	GO:0032328	alanine transport	-	19	17	-	-	2.05E-02	7.85E-04
ConsensusPathDB	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	2.23E-03	7.29E-04
ConsensusPathDB	BP	GO:0097722	sperm motility	-	133	116	-	-	1.70E-02	5.22E-03
ConsensusPathDB	BP	GO:0051231	spindle elongation	-	14	14	-	-	2.96E-03	6.73E-04
ConsensusPathDB	BP	GO:0042490	mechanoreceptor differentiation	-	67	64	-	-	5.36E-03	2.92E-03
ConsensusPathDB	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.00E-03	1.35E-03
ConsensusPathDB	BP	GO:0035148	tube formation	-	155	154	-	-	7.32E-03	6.95E-03
ConsensusPathDB	BP	GO:0048520	positive regulation of behavior	-	27	27	-	-	1.91E-02	1.23E-03
ConsensusPathDB	BP	GO:0098543	detection of other organism	-	19	19	-	-	7.74E-02	8.97E-04
ConsensusPathDB	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	2.93E-03	1.96E-03
ConsensusPathDB	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	118	-	-	5.94E-03	5.33E-03
ConsensusPathDB	BP	GO:0031123	RNA 3'-end processing	-	79	78	-	-	6.66E-03	3.53E-03
ConsensusPathDB	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	3.81E-03	5.05E-04
ConsensusPathDB	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	107	-	-	5.27E-03	4.82E-03
ConsensusPathDB	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	1.20E-03	8.41E-04
ConsensusPathDB	CC	GO:0007097	nuclear migration	-	24	24	-	-	3.30E-03	1.12E-03
ConsensusPathDB	BP	GO:0006885	regulation of pH	-	104	97	-	-	1.87E-02	4.37E-03
ConsensusPathDB	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.38E-03	6.73E-04
ConsensusPathDB	BP	GO:1990840	response to lectin	-	22	21	-	-	2.36E-02	9.54E-04
ConsensusPathDB	BP	GO:0071800	podosome assembly	-	19	19	-	-	7.46E-04	8.97E-04
ConsensusPathDB	BP	GO:0031018	endocrine pancreas development	-	47	45	-	-	5.40E-03	2.02E-03
ConsensusPathDB	BP	GO:0001708	cell fate specification	-	108	105	-	-	1.14E-02	4.71E-03
ConsensusPathDB	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	67	-	-	4.23E-03	3.03E-03
ConsensusPathDB	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	1.01E-02	1.68E-03
ConsensusPathDB	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	2.84E-03	6.73E-04
ConsensusPathDB	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	13	-	-	6.73E-04	6.17E-04
ConsensusPathDB	BP	GO:0042440	pigment metabolic process	-	80	78	-	-	3.37E-02	3.53E-03
ConsensusPathDB	BP	GO:1901606	alpha-amino acid catabolic process	-	101	97	-	-	9.17E-03	4.37E-03
ConsensusPathDB	BP	GO:1901890	positive regulation of cell junction assembly	-	106	101	-	-	5.69E-03	4.54E-03
ConsensusPathDB	BP	GO:0070988	demethylation	-	27	27	-	-	5.57E-02	1.23E-03
ConsensusPathDB	BP	GO:1901655	cellular response to ketone	-	107	104	-	-	3.89E-03	4.71E-03
ConsensusPathDB	BP	GO:0046185	aldehyde catabolic process	-	14	13	-	-	1.15E-03	6.17E-04
ConsensusPathDB	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	6.33E-03	6.73E-04
ConsensusPathDB	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	1.36E-02	7.85E-04
ConsensusPathDB	BP	GO:0006968	cellular defense response	-	52	51	-	-	1.61E-02	2.30E-03
ConsensusPathDB	BP	GO:0055006	cardiac cell development	-	93	83	-	-	2.55E-03	3.76E-03
ConsensusPathDB	BP	GO:0031365	N-terminal protein amino acid modification	-	30	28	-	-	6.85E-03	1.29E-03
ConsensusPathDB	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	9.24E-03	5.61E-04
ConsensusPathDB	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	28	-	-	2.71E-03	1.29E-03
ConsensusPathDB	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	2.06E-04	5.61E-04
ConsensusPathDB	BP	GO:0060004	reflex	-	63	62	-	-	8.11E-03	2.80E-03
ConsensusPathDB	BP	GO:0044706	multi-multicellular organism process	-	217	208	-	-	8.02E-03	9.37E-03
ConsensusPathDB	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	6.99E-04	5.61E-04
ConsensusPathDB	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	139	-	-	3.89E-03	6.28E-03
ConsensusPathDB	BP	GO:0006026	aminoglycan catabolic process	-	34	34	-	-	3.51E-02	1.57E-03
ConsensusPathDB	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	5.86E-03	2.08E-03
ConsensusPathDB	BP	GO:0050768	negative regulation of neurogenesis	-	150	144	-	-	5.60E-03	6.51E-03
ConsensusPathDB	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	93	-	-	1.90E-03	4.21E-03
ConsensusPathDB	BP	GO:0090068	positive regulation of cell cycle process	-	262	247	-	-	5.41E-03	1.11E-02
ConsensusPathDB	BP	GO:0043605	amide catabolic process	-	16	16	-	-	6.87E-02	7.29E-04
ConsensusPathDB	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	9.49E-04	1.23E-03
ConsensusPathDB	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	2.83E-02	1.57E-03
ConsensusPathDB	BP	GO:1902115	regulation of organelle assembly	-	210	207	-	-	4.50E-03	9.31E-03
ConsensusPathDB	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	65	-	-	4.62E-03	2.92E-03
ConsensusPathDB	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	4.86E-03	7.29E-04
ConsensusPathDB	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	139	-	-	4.21E-03	6.28E-03
ConsensusPathDB	BP	GO:0043171	peptide catabolic process	-	19	17	-	-	1.95E-03	7.85E-04
ConsensusPathDB	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	2.90E-03	1.91E-03
ConsensusPathDB	BP	GO:0051952	regulation of amine transport	-	98	98	-	-	1.75E-02	4.43E-03
ConsensusPathDB	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	2.55E-03	1.07E-03
ConsensusPathDB	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	3.81E-03	8.97E-04
ConsensusPathDB	BP	GO:0040019	positive regulation of embryonic development	-	23	22	-	-	5.90E-02	1.01E-03
ConsensusPathDB	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	7.08E-04	8.97E-04
ConsensusPathDB	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	7.03E-04	7.29E-04
ConsensusPathDB	CC	GO:0032365	intracellular lipid transport	-	51	49	-	-	1.34E-02	2.24E-03
ConsensusPathDB	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	1.90E-02	1.35E-03
ConsensusPathDB	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	68	-	-	2.58E-03	3.08E-03
ConsensusPathDB	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	113	-	-	2.80E-03	5.10E-03
ConsensusPathDB	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	4.78E-02	1.29E-03
ConsensusPathDB	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	1.03E-03	1.12E-03
ConsensusPathDB	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	8.27E-04	6.17E-04
ConsensusPathDB	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	2.31E-04	6.73E-04
ConsensusPathDB	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	3.10E-04	6.17E-04
ConsensusPathDB	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	1.92E-02	1.57E-03
ConsensusPathDB	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	8.76E-02	5.05E-04
ConsensusPathDB	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	3.32E-03	4.04E-03
ConsensusPathDB	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	1.23E-02	1.35E-03
ConsensusPathDB	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	1.25E-02	8.41E-04
ConsensusPathDB	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	3.25E-03	9.54E-04
ConsensusPathDB	BP	GO:0015669	gas transport	-	23	22	-	-	5.56E-02	1.01E-03
ConsensusPathDB	BP	GO:0016485	protein processing	-	248	243	-	-	9.50E-03	1.09E-02
ConsensusPathDB	BP	GO:0009649	entrainment of circadian clock	-	30	29	-	-	8.15E-03	1.35E-03
ConsensusPathDB	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	164	-	-	4.40E-02	7.40E-03
ConsensusPathDB	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	1.26E-03	1.12E-03
ConsensusPathDB	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	128	-	-	1.60E-02	5.78E-03
ConsensusPathDB	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	2.60E-02	5.61E-04
ConsensusPathDB	BP	GO:0099054	presynapse assembly	-	49	47	-	-	2.00E-03	2.13E-03
ConsensusPathDB	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	4.33E-01	5.61E-04
ConsensusPathDB	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	1.86E-03	1.12E-03
ConsensusPathDB	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	2.87E-03	1.12E-03
ConsensusPathDB	BP	GO:0031348	negative regulation of defense response	-	282	237	-	-	6.02E-03	1.07E-02
ConsensusPathDB	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	76	-	-	4.28E-03	3.42E-03
ConsensusPathDB	BP	GO:0007606	sensory perception of chemical stimulus	-	535	184	-	-	2.92E-02	8.30E-03
ConsensusPathDB	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	3.08E-03	3.08E-03
ConsensusPathDB	BP	GO:0071496	cellular response to external stimulus	-	74	73	-	-	6.06E-03	3.31E-03
ConsensusPathDB	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	2.25E-02	6.17E-04
ConsensusPathDB	BP	GO:0042753	positive regulation of circadian rhythm	-	18	18	-	-	4.81E-02	8.41E-04
ConsensusPathDB	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	1.11E-03	5.05E-04
ConsensusPathDB	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.23E-03	5.61E-04
ConsensusPathDB	BP	GO:0032094	response to food	-	37	37	-	-	7.68E-03	1.68E-03
ConsensusPathDB	BP	GO:0001964	startle response	-	27	27	-	-	4.57E-03	1.23E-03
ConsensusPathDB	BP	GO:0007340	acrosome reaction	-	38	34	-	-	1.97E-02	1.57E-03
ConsensusPathDB	BP	GO:0046434	organophosphate catabolic process	-	232	227	-	-	5.22E-03	1.02E-02
ConsensusPathDB	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	2.25E-02	1.35E-03
ConsensusPathDB	BP	GO:0009566	fertilization	-	205	186	-	-	2.48E-02	8.36E-03
ConsensusPathDB	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	4.51E-02	2.69E-03
ConsensusPathDB	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	3.88E-03	1.12E-03
ConsensusPathDB	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	12	-	-	1.71E-03	5.61E-04
ConsensusPathDB	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	1.29E-02	1.35E-03
ConsensusPathDB	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	23	-	-	2.38E-03	1.07E-03
ConsensusPathDB	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	7.78E-03	1.12E-02
ConsensusPathDB	BP	GO:0009309	amine biosynthetic process	-	38	35	-	-	1.29E-02	1.57E-03
ConsensusPathDB	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	5.19E-04	8.97E-04
ConsensusPathDB	BP	GO:0061900	glial cell activation	-	56	52	-	-	2.48E-03	2.36E-03
ConsensusPathDB	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	132	-	-	8.50E-03	5.95E-03
ConsensusPathDB	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	3.67E-02	6.17E-04
ConsensusPathDB	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	4.60E-03	6.73E-04
ConsensusPathDB	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	9.28E-03	1.85E-03
ConsensusPathDB	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	4.22E-04	8.97E-04
ConsensusPathDB	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	8.33E-04	6.73E-04
ConsensusPathDB	BP	GO:0072537	fibroblast activation	-	13	13	-	-	3.40E-03	6.17E-04
ConsensusPathDB	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	9.51E-04	6.17E-04
ConsensusPathDB	BP	GO:0043647	inositol phosphate metabolic process	-	44	42	-	-	2.81E-03	1.91E-03
ConsensusPathDB	BP	GO:0016180	snRNA processing	-	28	27	-	-	1.63E-02	1.23E-03
ConsensusPathDB	BP	GO:0051303	establishment of chromosome localization	-	104	103	-	-	6.76E-03	4.66E-03
ConsensusPathDB	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	1.38E-02	7.29E-04
ConsensusPathDB	BP	GO:0007164	establishment of tissue polarity	-	38	37	-	-	4.17E-03	1.68E-03
ConsensusPathDB	BP	GO:0097164	ammonium ion metabolic process	-	23	22	-	-	3.08E-04	1.01E-03
ConsensusPathDB	BP	GO:0021515	cell differentiation in spinal cord	-	51	49	-	-	1.19E-02	2.24E-03
ConsensusPathDB	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	5.61E-03	8.41E-04
ConsensusPathDB	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	9.79E-04	9.54E-04
ConsensusPathDB	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	1.28E-03	1.29E-03
ConsensusPathDB	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.81E-03	8.41E-04
ConsensusPathDB	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	35	-	-	6.13E-03	1.57E-03
ConsensusPathDB	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	8.26E-03	1.01E-03
ConsensusPathDB	BP	GO:0007566	embryo implantation	-	57	52	-	-	2.00E-03	2.36E-03
ConsensusPathDB	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	1.84E-03	1.51E-03
ConsensusPathDB	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	6.10E-02	7.29E-04
ConsensusPathDB	BP	GO:0060306	regulation of membrane repolarization	-	38	31	-	-	2.77E-02	1.40E-03
ConsensusPathDB	BP	GO:0051017	actin filament bundle assembly	-	161	154	-	-	4.90E-03	6.95E-03
ConsensusPathDB	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	2.57E-03	1.91E-03
ConsensusPathDB	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	8.83E-04	8.41E-04
ConsensusPathDB	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	2.13E-03	8.97E-04
ConsensusPathDB	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	2.08E-04	6.17E-04
ConsensusPathDB	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	36	-	-	1.42E-03	1.63E-03
ConsensusPathDB	BP	GO:0021756	striatum development	-	21	21	-	-	1.75E-03	9.54E-04
ConsensusPathDB	BP	GO:1901343	negative regulation of vasculature development	-	154	100	-	-	5.13E-03	4.49E-03
ConsensusPathDB	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	146	-	-	7.96E-03	6.56E-03
ConsensusPathDB	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	30	-	-	1.52E-03	1.35E-03
ConsensusPathDB	BP	GO:1902414	protein localization to cell junction	-	107	106	-	-	4.85E-03	4.77E-03
ConsensusPathDB	BP	GO:0071305	cellular response to vitamin D	-	23	21	-	-	1.72E-02	9.54E-04
ConsensusPathDB	BP	GO:0051304	chromosome separation	-	80	80	-	-	4.48E-03	3.59E-03
ConsensusPathDB	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	5.62E-03	8.41E-04
ConsensusPathDB	BP	GO:0048709	oligodendrocyte differentiation	-	101	99	-	-	5.16E-03	4.49E-03
ConsensusPathDB	BP	GO:0045017	glycerolipid biosynthetic process	-	254	244	-	-	2.27E-02	1.10E-02
ConsensusPathDB	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	8.37E-03	6.73E-04
ConsensusPathDB	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	4.74E-03	1.07E-03
ConsensusPathDB	BP	GO:0001776	leukocyte homeostasis	-	108	101	-	-	4.04E-03	4.54E-03
ConsensusPathDB	BP	GO:0050769	positive regulation of neurogenesis	-	240	231	-	-	1.04E-02	1.04E-02
ConsensusPathDB	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	3.04E-03	6.73E-04
ConsensusPathDB	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	1.01E-02	3.14E-03
ConsensusPathDB	BP	GO:0050866	negative regulation of cell activation	-	216	204	-	-	6.65E-03	9.20E-03
ConsensusPathDB	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	1.99E-03	1.63E-03
ConsensusPathDB	BP	GO:0033500	carbohydrate homeostasis	-	251	225	-	-	5.49E-03	1.01E-02
ConsensusPathDB	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	30	-	-	1.16E-02	1.35E-03
ConsensusPathDB	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	1.58E-02	5.61E-04
ConsensusPathDB	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	2.50E-03	2.52E-03
ConsensusPathDB	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	1.46E-03	1.07E-03
ConsensusPathDB	CC	GO:0099522	cytosolic region	-	20	20	-	-	8.08E-04	8.97E-04
ConsensusPathDB	CC	GO:0000791	euchromatin	-	60	56	-	-	2.58E-03	2.52E-03
ConsensusPathDB	CC	GO:0030666	endocytic vesicle membrane	-	196	192	-	-	1.20E-02	8.64E-03
ConsensusPathDB	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.50E-03	6.73E-04
ConsensusPathDB	CC	GO:1990752	microtubule end	-	34	34	-	-	3.73E-03	1.57E-03
ConsensusPathDB	CC	GO:0043204	perikaryon	-	156	152	-	-	3.69E-03	6.84E-03
ConsensusPathDB	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	9.66E-02	7.85E-04
ConsensusPathDB	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	6.40E-02	5.61E-04
ConsensusPathDB	CC	GO:0097542	ciliary tip	-	48	47	-	-	1.85E-02	2.13E-03
ConsensusPathDB	CC	GO:1905368	peptidase complex	-	124	122	-	-	1.98E-02	5.50E-03
ConsensusPathDB	CC	GO:0000792	heterochromatin	-	98	97	-	-	5.69E-03	4.37E-03
ConsensusPathDB	CC	GO:0097546	ciliary base	-	47	42	-	-	2.74E-03	1.91E-03
ConsensusPathDB	CC	GO:0071819	DUBm complex	-	25	24	-	-	6.43E-03	1.12E-03
ConsensusPathDB	CC	GO:0031201	SNARE complex	-	48	48	-	-	3.26E-02	2.19E-03
ConsensusPathDB	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	1.84E-03	6.17E-04
ConsensusPathDB	CC	GO:0000815	ESCRT III complex	-	11	11	-	-	2.27E-02	5.05E-04
ConsensusPathDB	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	5.01E-03	1.79E-03
ConsensusPathDB	CC	GO:0044391	ribosomal subunit	-	203	200	-	-	1.68E-02	8.97E-03
ConsensusPathDB	CC	GO:0071013	catalytic step 2 spliceosome	-	88	87	-	-	8.55E-03	3.93E-03
ConsensusPathDB	CC	GO:0031907	microbody lumen	-	51	50	-	-	9.02E-02	2.24E-03
ConsensusPathDB	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.27E-02	5.05E-04
ConsensusPathDB	CC	GO:0098862	cluster of actin-based cell projections	-	162	151	-	-	1.72E-02	6.79E-03
ConsensusPathDB	CC	GO:0016363	nuclear matrix	-	127	127	-	-	2.97E-03	5.72E-03
ConsensusPathDB	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	1.35E-02	2.08E-03
ConsensusPathDB	CC	GO:0032432	actin filament bundle	-	249	239	-	-	1.43E-02	1.08E-02
ConsensusPathDB	CC	GO:0008088	axo-dendritic transport	-	78	77	-	-	3.26E-03	3.48E-03
ConsensusPathDB	CC	GO:0031519	PcG protein complex	-	38	38	-	-	1.07E-02	1.74E-03
ConsensusPathDB	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	41	-	-	1.27E-02	1.85E-03
ConsensusPathDB	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	218	-	-	1.52E-02	9.82E-03
ConsensusPathDB	CC	GO:0000313	organellar ribosome	-	89	89	-	-	3.34E-02	4.04E-03
ConsensusPathDB	CC	GO:0099643	signal release from synapse	-	147	146	-	-	7.50E-03	6.56E-03
ConsensusPathDB	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	1.08E-02	2.08E-03
ConsensusPathDB	CC	GO:0005818	aster	-	11	11	-	-	5.47E-03	5.05E-04
ConsensusPathDB	CC	GO:0030018	Z disc	-	129	126	-	-	9.04E-03	5.66E-03
ConsensusPathDB	CC	GO:0032580	Golgi cisterna membrane	-	93	81	-	-	9.46E-03	3.65E-03
ConsensusPathDB	CC	GO:0097381	photoreceptor disc membrane	-	25	22	-	-	1.38E-01	1.01E-03
ConsensusPathDB	CC	GO:1905360	GTPase complex	-	41	39	-	-	5.94E-02	1.79E-03
ConsensusPathDB	CC	GO:0097540	axonemal central pair	-	161	142	-	-	3.85E-03	6.39E-03
ConsensusPathDB	CC	GO:0042641	actomyosin	-	77	76	-	-	4.49E-03	3.42E-03
ConsensusPathDB	CC	GO:0097386	glial cell projection	-	38	36	-	-	9.23E-04	1.63E-03
ConsensusPathDB	CC	GO:0032588	trans-Golgi network membrane	-	102	102	-	-	9.86E-03	4.60E-03
ConsensusPathDB	CC	GO:0070382	exocytic vesicle	-	224	219	-	-	1.16E-02	9.87E-03
ConsensusPathDB	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	45	-	-	6.40E-03	2.02E-03
ConsensusPathDB	CC	GO:0031903	microbody membrane	-	65	64	-	-	5.70E-02	2.92E-03
ConsensusPathDB	CC	GO:0046930	pore complex	-	26	26	-	-	1.38E-01	1.18E-03
ConsensusPathDB	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	5.45E-03	5.05E-04
ConsensusPathDB	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	8.74E-04	7.29E-04
ConsensusPathDB	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	249	-	-	8.48E-03	1.12E-02
ConsensusPathDB	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	4.49E-03	1.12E-03
ConsensusPathDB	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.38E-02	5.05E-04
ConsensusPathDB	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	1.34E-03	8.41E-04
ConsensusPathDB	CC	GO:0044298	cell body membrane	-	32	32	-	-	2.63E-02	1.46E-03
ConsensusPathDB	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	6.81E-03	5.05E-04
ConsensusPathDB	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	1.67E-03	9.54E-04
ConsensusPathDB	CC	GO:0045495	pole plasm	-	25	25	-	-	1.20E-01	1.12E-03
ConsensusPathDB	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	9.78E-04	6.73E-04
ConsensusPathDB	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	8.31E-03	8.97E-04
ConsensusPathDB	CC	GO:0010369	chromocenter	-	14	14	-	-	2.72E-03	6.73E-04
ConsensusPathDB	CC	GO:0002177	manchette	-	19	16	-	-	1.04E-01	7.29E-04
ConsensusPathDB	CC	GO:0016323	basolateral plasma membrane	-	239	233	-	-	9.86E-03	1.05E-02
ConsensusPathDB	CC	GO:0045009	chitosome	-	21	21	-	-	1.35E-01	9.54E-04
ConsensusPathDB	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	4.74E-04	5.61E-04
ConsensusPathDB	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	2.68E-03	2.02E-03
ConsensusPathDB	CC	GO:0098636	protein complex involved in cell adhesion	-	57	55	-	-	1.22E-01	2.47E-03
ConsensusPathDB	CC	GO:0001917	photoreceptor inner segment	-	71	67	-	-	9.09E-03	3.03E-03
ConsensusPathDB	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	1.80E-03	6.73E-04
ConsensusPathDB	CC	GO:0019897	extrinsic component of plasma membrane	-	156	152	-	-	4.86E-02	6.84E-03
ConsensusPathDB	CC	GO:0031594	neuromuscular junction	-	73	72	-	-	4.24E-03	3.25E-03
ConsensusPathDB	CC	GO:0045120	pronucleus	-	14	14	-	-	3.12E-04	6.73E-04
ConsensusPathDB	CC	GO:0043083	synaptic cleft	-	21	21	-	-	7.65E-02	9.54E-04
ConsensusPathDB	CC	GO:0000922	spindle pole	-	172	169	-	-	5.90E-03	7.63E-03
ConsensusPathDB	CC	GO:0120111	neuron projection cytoplasm	-	94	92	-	-	3.76E-03	4.15E-03
ConsensusPathDB	CC	GO:0070971	endoplasmic reticulum exit site	-	32	29	-	-	2.49E-02	1.35E-03
ConsensusPathDB	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	1.96E-02	6.17E-04
ConsensusPathDB	CC	GO:0004879	nuclear receptor activity	-	63	62	-	-	1.18E-02	2.80E-03
ConsensusPathDB	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	168	-	-	1.93E-02	7.57E-03
ConsensusPathDB	CC	GO:0000123	histone acetyltransferase complex	-	93	91	-	-	1.25E-02	4.09E-03
ConsensusPathDB	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	3.25E-03	6.17E-04
ConsensusPathDB	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	108	-	-	6.35E-02	4.88E-03
ConsensusPathDB	CC	GO:0048786	presynaptic active zone	-	80	79	-	-	3.15E-03	3.59E-03
ConsensusPathDB	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	5.07E-02	5.05E-04
ConsensusPathDB	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	8.62E-03	5.61E-04
ConsensusPathDB	CC	GO:0007034	vacuolar transport	-	168	165	-	-	8.54E-03	7.40E-03
ConsensusPathDB	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	1.16E-01	9.54E-04
ConsensusPathDB	CC	GO:0043194	axon initial segment	-	21	20	-	-	4.81E-02	8.97E-04
ConsensusPathDB	CC	GO:1900115	extracellular regulation of signal transduction	-	13	11	-	-	2.78E-03	5.05E-04
ConsensusPathDB	CC	GO:0005776	autophagosome	-	111	110	-	-	1.06E-02	4.94E-03
ConsensusPathDB	CC	GO:0031430	M band	-	22	22	-	-	2.31E-03	1.01E-03
ConsensusPathDB	CC	GO:0001931	uropod	-	13	13	-	-	7.11E-03	6.17E-04
ConsensusPathDB	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	4.02E-02	3.37E-03
ConsensusPathDB	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	98	-	-	9.99E-02	4.43E-03
ConsensusPathDB	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	3.77E-02	6.17E-04
ConsensusPathDB	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	1.49E-02	8.97E-04
ConsensusPathDB	CC	GO:0071203	WASH complex	-	12	12	-	-	4.56E-02	5.61E-04
ConsensusPathDB	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	1.31E-02	1.35E-03
ConsensusPathDB	CC	GO:0032994	protein-lipid complex	-	39	39	-	-	4.34E-02	1.79E-03
ConsensusPathDB	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	145	-	-	2.00E-02	6.51E-03
ConsensusPathDB	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	3.73E-03	5.61E-04
ConsensusPathDB	CC	GO:0001527	microfibril	-	13	13	-	-	4.56E-02	6.17E-04
ConsensusPathDB	CC	GO:0072562	blood microparticle	-	144	139	-	-	2.47E-02	6.28E-03
ConsensusPathDB	CC	GO:0005883	neurofilament	-	11	11	-	-	3.00E-03	5.05E-04
ConsensusPathDB	CC	GO:0051233	spindle midzone	-	36	35	-	-	2.64E-03	1.57E-03
ConsensusPathDB	CC	GO:0005811	lipid droplet	-	102	99	-	-	1.06E-02	4.49E-03
ConsensusPathDB	CC	GO:0045022	early endosome to late endosome transport	-	44	43	-	-	2.59E-03	1.96E-03
ConsensusPathDB	CC	GO:0043113	receptor clustering	-	51	50	-	-	6.39E-03	2.24E-03
ConsensusPathDB	CC	GO:0005940	septin ring	-	14	13	-	-	1.39E-01	6.17E-04
ConsensusPathDB	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	1.86E-02	5.05E-04
ConsensusPathDB	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	21	-	-	4.04E-02	9.54E-04
ConsensusPathDB	CC	GO:0044853	plasma membrane raft	-	114	112	-	-	4.82E-03	5.05E-03
ConsensusPathDB	CC	GO:0005881	cytoplasmic microtubule	-	256	221	-	-	6.78E-03	9.93E-03
ConsensusPathDB	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	7.17E-04	6.73E-04
ConsensusPathDB	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	1.52E-02	7.85E-04
ConsensusPathDB	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	58	-	-	1.13E-02	2.64E-03
ConsensusPathDB	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	2.93E-03	3.25E-03
ConsensusPathDB	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	6.71E-03	5.61E-04
ConsensusPathDB	CC	GO:0043034	costamere	-	18	18	-	-	5.09E-03	8.41E-04
ConsensusPathDB	CC	GO:0031904	endosome lumen	-	38	37	-	-	3.18E-03	1.68E-03
ConsensusPathDB	CC	GO:0060170	ciliary membrane	-	76	70	-	-	6.60E-02	3.14E-03
ConsensusPathDB	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	1.10E-01	6.17E-04
ConsensusPathDB	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	4.03E-03	5.61E-04
ConsensusPathDB	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	8.68E-03	1.12E-03
ConsensusPathDB	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	2.39E-03	6.73E-04
ConsensusPathDB	CC	GO:0032154	cleavage furrow	-	54	53	-	-	2.73E-03	2.41E-03
ConsensusPathDB	CC	GO:0005640	nuclear outer membrane	-	30	29	-	-	1.10E-03	1.35E-03
ConsensusPathDB	CC	GO:0005652	nuclear lamina	-	12	12	-	-	5.84E-04	5.61E-04
ConsensusPathDB	CC	GO:0007006	mitochondrial membrane organization	-	117	109	-	-	8.91E-03	4.94E-03
ConsensusPathDB	CC	GO:0001772	immunological synapse	-	44	44	-	-	6.42E-03	2.02E-03
ConsensusPathDB	CC	GO:0030904	retromer complex	-	12	12	-	-	4.30E-03	5.61E-04
ConsensusPathDB	CC	GO:0030863	cortical cytoskeleton	-	104	102	-	-	5.84E-03	4.60E-03
ConsensusPathDB	CC	GO:1905348	endonuclease complex	-	38	36	-	-	4.29E-02	1.63E-03
ConsensusPathDB	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	1.25E-01	5.05E-04
ConsensusPathDB	CC	GO:0030315	T-tubule	-	52	51	-	-	2.40E-02	2.30E-03
ConsensusPathDB	CC	GO:0060076	excitatory synapse	-	64	63	-	-	1.58E-02	2.86E-03
ConsensusPathDB	CC	GO:0036019	endolysosome	-	29	29	-	-	4.60E-03	1.35E-03
ConsensusPathDB	CC	GO:0001891	phagocytic cup	-	28	28	-	-	1.89E-03	1.29E-03
ConsensusPathDB	CC	GO:0099086	synaptonemal structure	-	40	38	-	-	5.76E-02	1.74E-03
ConsensusPathDB	CC	GO:0030427	site of polarized growth	-	172	172	-	-	3.91E-03	7.74E-03
ConsensusPathDB	CC	GO:0044309	neuron spine	-	213	210	-	-	5.88E-03	9.42E-03
ConsensusPathDB	CC	GO:0030658	transport vesicle membrane	-	231	227	-	-	1.37E-02	1.02E-02
ConsensusPathDB	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	2.02E-03	1.23E-03
ConsensusPathDB	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.90E-02	5.61E-04
ConsensusPathDB	CC	GO:0000940	outer kinetochore	-	17	17	-	-	3.81E-03	7.85E-04
ConsensusPathDB	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	2.54E-03	7.85E-04
ConsensusPathDB	CC	GO:0044232	organelle membrane contact site	-	50	48	-	-	4.96E-03	2.19E-03
ConsensusPathDB	CC	GO:0098803	respiratory chain complex	-	39	36	-	-	8.12E-02	1.63E-03
ConsensusPathDB	CC	GO:0097545	axonemal outer doublet	-	164	145	-	-	5.90E-03	6.51E-03
ConsensusPathDB	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	3.88E-03	8.97E-04
ConsensusPathDB	CC	GO:0070069	cytochrome complex	-	42	39	-	-	7.30E-02	1.79E-03
ConsensusPathDB	CC	GO:0031143	pseudopodium	-	18	18	-	-	1.76E-03	8.41E-04
ConsensusPathDB	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	1.98E-02	1.23E-03
ConsensusPathDB	CC	GO:0055037	recycling endosome	-	200	195	-	-	6.40E-03	8.75E-03
ConsensusPathDB	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	94	-	-	4.74E-03	4.26E-03
ConsensusPathDB	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	1.05E-01	6.17E-04
ConsensusPathDB	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	4.26E-04	6.17E-04
ConsensusPathDB	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	1.13E-03	1.01E-03
ConsensusPathDB	CC	GO:0030684	preribosome	-	76	72	-	-	7.21E-03	3.25E-03
ConsensusPathDB	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	19	-	-	7.35E-02	8.97E-04
ConsensusPathDB	CC	GO:1990391	DNA repair complex	-	22	22	-	-	6.29E-03	1.01E-03
ConsensusPathDB	CC	GO:0005775	vacuolar lumen	-	176	174	-	-	6.50E-03	7.85E-03
ConsensusPathDB	CC	GO:0032433	filopodium tip	-	19	19	-	-	9.81E-04	8.97E-04
ConsensusPathDB	CC	GO:0032982	myosin filament	-	24	24	-	-	1.57E-02	1.12E-03
ConsensusPathDB	CC	GO:0016327	apicolateral plasma membrane	-	23	22	-	-	1.17E-03	1.01E-03
ConsensusPathDB	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	3.08E-02	1.07E-03
ConsensusPathDB	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	3.13E-03	5.61E-04
ConsensusPathDB	CC	GO:0044306	neuron projection terminus	-	164	162	-	-	1.18E-02	7.29E-03
ConsensusPathDB	CC	GO:0034455	t-UTP complex	-	53	50	-	-	5.76E-03	2.24E-03
ConsensusPathDB	CC	GO:0030992	intraciliary transport particle B	-	17	15	-	-	3.25E-02	6.73E-04
ConsensusPathDB	CC	GO:0031970	organelle envelope lumen	-	94	92	-	-	5.67E-03	4.15E-03
ConsensusPathDB	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	3.01E-03	6.17E-04
ConsensusPathDB	CC	GO:0120293	dynein axonemal particle	-	20	16	-	-	8.41E-03	7.29E-04
ConsensusPathDB	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	8.77E-04	1.12E-03
ConsensusPathDB	CC	GO:0043292	contractile muscle fiber	-	245	237	-	-	1.86E-02	1.07E-02
ConsensusPathDB	CC	GO:0018995	host cellular component	-	12	12	-	-	4.23E-03	5.61E-04
ConsensusPathDB	CC	GO:0034709	methylosome	-	13	13	-	-	6.31E-04	6.17E-04
ConsensusPathDB	CC	GO:0032426	stereocilium tip	-	21	19	-	-	9.01E-03	8.97E-04
ConsensusPathDB	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	1.33E-02	5.61E-04
ConsensusPathDB	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	7.04E-02	8.97E-04
ConsensusPathDB	CC	GO:0000803	sex chromosome	-	32	29	-	-	2.68E-03	1.35E-03
ConsensusPathDB	CC	GO:0098982	GABA-ergic synapse	-	84	83	-	-	2.20E-02	3.76E-03
ConsensusPathDB	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	1.81E-02	7.29E-04
ConsensusPathDB	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	1.80E-02	2.86E-03
ConsensusPathDB	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	6.24E-03	6.73E-04
ConsensusPathDB	CC	GO:0000242	pericentriolar material	-	22	22	-	-	1.69E-03	1.01E-03
ConsensusPathDB	CC	GO:1903293	phosphatase complex	-	54	53	-	-	1.09E-02	2.41E-03
ConsensusPathDB	CC	GO:0097470	ribbon synapse	-	13	13	-	-	1.49E-03	6.17E-04
ConsensusPathDB	CC	GO:0031941	filamentous actin	-	27	27	-	-	1.80E-02	1.23E-03
ConsensusPathDB	CC	GO:0000786	nucleosome	-	149	106	-	-	1.90E-02	4.77E-03
ConsensusPathDB	CC	GO:0001533	cornified envelope	-	59	59	-	-	1.34E-02	2.69E-03
ConsensusPathDB	CC	GO:1904724	tertiary granule lumen	-	55	54	-	-	3.26E-03	2.47E-03
ConsensusPathDB	CC	GO:0030027	lamellipodium	-	202	200	-	-	5.62E-03	8.97E-03
ConsensusPathDB	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	2.61E-03	6.73E-04
ConsensusPathDB	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	25	-	-	2.50E-01	1.12E-03
ConsensusPathDB	CC	GO:0000800	lateral element	-	14	14	-	-	1.15E-02	6.73E-04
ConsensusPathDB	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	4.95E-03	5.61E-04
ConsensusPathDB	CC	GO:0060077	inhibitory synapse	-	20	20	-	-	2.88E-02	8.97E-04
ConsensusPathDB	CC	GO:0031209	SCAR complex	-	12	12	-	-	5.94E-03	5.61E-04
ConsensusPathDB	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	3.05E-02	7.29E-04
ConsensusPathDB	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	20	-	-	9.15E-02	8.97E-04
ConsensusPathDB	CC	GO:0002102	podosome	-	31	30	-	-	2.85E-03	1.35E-03
ConsensusPathDB	CC	GO:0090543	Flemming body	-	33	32	-	-	1.42E-03	1.46E-03
ConsensusPathDB	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	2.55E-03	2.97E-03
ConsensusPathDB	CC	GO:0001650	fibrillar center	-	151	151	-	-	3.11E-03	6.79E-03
ConsensusPathDB	CC	GO:0031332	RNAi effector complex	-	413	16	-	-	1.72E-03	7.29E-04
ConsensusPathDB	CC	GO:1990204	oxidoreductase complex	-	90	87	-	-	3.91E-02	3.93E-03
ConsensusPathDB	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	5.26E-03	7.29E-04
ConsensusPathDB	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	6.64E-04	5.05E-04
ConsensusPathDB	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	2.95E-03	5.61E-03
ConsensusPathDB	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	2.74E-02	8.97E-04
ConsensusPathDB	CC	GO:0001726	ruffle	-	181	180	-	-	5.75E-03	8.08E-03
ConsensusPathDB	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	1.80E-03	6.17E-04
ConsensusPathDB	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	9.31E-03	8.41E-04
ConsensusPathDB	CC	GO:0043198	dendritic shaft	-	38	37	-	-	7.69E-04	1.68E-03
ConsensusPathDB	CC	GO:0043073	germ cell nucleus	-	67	64	-	-	1.87E-03	2.92E-03
ConsensusPathDB	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	3.13E-03	9.54E-04
ConsensusPathDB	CC	GO:0016592	mediator complex	-	38	38	-	-	9.04E-03	1.74E-03
ConsensusPathDB	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	1.77E-02	8.97E-04
ConsensusPathDB	CC	GO:0022626	cytosolic ribosome	-	118	115	-	-	7.29E-03	5.16E-03
ConsensusPathDB	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	1.00E-02	2.02E-03
ConsensusPathDB	CC	GO:0034451	centriolar satellite	-	120	116	-	-	6.54E-03	5.22E-03
ConsensusPathDB	CC	GO:0045171	intercellular bridge	-	91	91	-	-	2.15E-03	4.09E-03
ConsensusPathDB	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	80	-	-	4.38E-03	3.59E-03
ConsensusPathDB	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	1.16E-01	6.73E-04
ConsensusPathDB	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.08E-02	5.05E-04
ConsensusPathDB	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	7.03E-02	5.05E-04
ConsensusPathDB	CC	GO:0044292	dendrite terminus	-	13	13	-	-	4.99E-04	6.17E-04
ConsensusPathDB	CC	GO:0032039	integrator complex	-	19	17	-	-	7.11E-02	7.85E-04
ConsensusPathDB	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	2.63E-02	6.73E-04
ConsensusPathDB	CC	GO:0033268	node of Ranvier	-	16	16	-	-	6.16E-02	7.29E-04
ConsensusPathDB	CC	GO:0036038	MKS complex	-	13	13	-	-	2.90E-02	6.17E-04
ConsensusPathDB	CC	GO:0030527	structural constituent of chromatin	-	97	55	-	-	2.94E-02	2.47E-03
ConsensusPathDB	CC	GO:0036379	myofilament	-	26	25	-	-	1.01E-01	1.12E-03
ConsensusPathDB	CC	GO:0030286	dynein complex	-	210	188	-	-	9.35E-03	8.47E-03
ConsensusPathDB	CC	GO:0031105	septin complex	-	14	13	-	-	1.39E-01	6.17E-04
ConsensusPathDB	CC	GO:0097228	sperm principal piece	-	33	26	-	-	7.11E-02	1.18E-03
ConsensusPathDB	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	2.33E-03	5.61E-04
ConsensusPathDB	CC	GO:0016482	cytosolic transport	-	135	133	-	-	9.19E-03	6.00E-03
ConsensusPathDB	CC	GO:0090665	glycoprotein complex	-	23	22	-	-	9.01E-02	1.01E-03
ConsensusPathDB	CC	GO:0005796	Golgi lumen	-	106	101	-	-	7.07E-03	4.54E-03
ConsensusPathDB	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	36	-	-	2.42E-02	1.63E-03
ConsensusPathDB	CC	GO:0034358	plasma lipoprotein particle	-	36	36	-	-	2.93E-02	1.63E-03
ConsensusPathDB	CC	GO:0008023	transcription elongation factor complex	-	47	46	-	-	1.54E-02	2.08E-03
ConsensusPathDB	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	24	-	-	1.70E-03	1.12E-03
ConsensusPathDB	CC	GO:0030662	coated vesicle membrane	-	202	199	-	-	1.49E-02	8.97E-03
ConsensusPathDB	CC	GO:0007039	protein catabolic process in the vacuole	-	61	60	-	-	7.21E-03	2.69E-03
ConsensusPathDB	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	67	-	-	9.12E-02	3.03E-03
ConsensusPathDB	CC	GO:0090734	site of DNA damage	-	118	116	-	-	7.75E-03	5.22E-03
ConsensusPathDB	MF	GO:0051861	glycolipid binding	-	30	30	-	-	1.41E-03	1.35E-03
ConsensusPathDB	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	2.60E-04	5.05E-04
ConsensusPathDB	MF	GO:0051087	protein-folding chaperone binding	-	135	134	-	-	3.60E-03	6.06E-03
ConsensusPathDB	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	2.74E-03	1.23E-03
ConsensusPathDB	CC	GO:0015464	acetylcholine receptor activity	-	21	20	-	-	2.51E-01	8.97E-04
ConsensusPathDB	MF	GO:0042301	phosphate ion binding	-	12	11	-	-	2.02E-02	5.05E-04
ConsensusPathDB	MF	GO:0016594	glycine binding	-	12	12	-	-	6.51E-02	5.61E-04
ConsensusPathDB	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	1.34E-01	8.97E-04
ConsensusPathDB	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	1.03E-03	1.68E-03
ConsensusPathDB	MF	GO:0035613	RNA stem-loop binding	-	21	18	-	-	2.25E-03	8.41E-04
ConsensusPathDB	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	238	-	-	1.01E-02	1.07E-02
ConsensusPathDB	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	4.80E-03	8.97E-04
ConsensusPathDB	MF	GO:0033691	sialic acid binding	-	22	22	-	-	3.33E-03	1.01E-03
ConsensusPathDB	MF	GO:0048306	calcium-dependent protein binding	-	61	58	-	-	6.39E-03	2.64E-03
ConsensusPathDB	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	27	-	-	1.79E-02	1.23E-03
ConsensusPathDB	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	1.37E-01	6.17E-04
ConsensusPathDB	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	141	-	-	7.81E-03	6.34E-03
ConsensusPathDB	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	59	-	-	6.46E-02	2.69E-03
ConsensusPathDB	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	132	-	-	9.31E-03	5.95E-03
ConsensusPathDB	MF	GO:0045504	dynein heavy chain binding	-	16	16	-	-	5.96E-02	7.29E-04
ConsensusPathDB	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	3.09E-03	1.35E-03
ConsensusPathDB	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	1.55E-03	1.01E-03
ConsensusPathDB	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	1.81E-03	6.73E-04
ConsensusPathDB	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	5.81E-03	6.73E-04
ConsensusPathDB	MF	GO:0061980	regulatory RNA binding	-	52	44	-	-	2.23E-03	2.02E-03
ConsensusPathDB	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	3.08E-03	1.46E-03
ConsensusPathDB	MF	GO:0000182	rDNA binding	-	11	11	-	-	4.40E-03	5.05E-04
ConsensusPathDB	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	7.75E-04	1.35E-03
ConsensusPathDB	MF	GO:0070840	dynein complex binding	-	25	23	-	-	1.05E-03	1.07E-03
ConsensusPathDB	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.14E-03	1.12E-03
ConsensusPathDB	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	5.56E-04	7.29E-04
ConsensusPathDB	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	1.52E-03	1.57E-03
ConsensusPathDB	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	2.87E-03	8.41E-04
ConsensusPathDB	MF	GO:0005178	integrin binding	-	153	150	-	-	7.81E-02	6.73E-03
ConsensusPathDB	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	8.28E-04	7.85E-04
ConsensusPathDB	MF	GO:0005549	odorant binding	-	128	33	-	-	5.04E-02	1.51E-03
ConsensusPathDB	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	3.86E-02	6.73E-04
ConsensusPathDB	MF	GO:0008327	methyl-CpG binding	-	31	28	-	-	4.97E-03	1.29E-03
ConsensusPathDB	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	4.27E-03	8.97E-04
ConsensusPathDB	MF	GO:0048019	receptor antagonist activity	-	31	19	-	-	1.06E-02	8.97E-04
ConsensusPathDB	MF	GO:0005521	lamin binding	-	15	15	-	-	6.18E-04	6.73E-04
ConsensusPathDB	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	1.98E-03	7.85E-04
ConsensusPathDB	MF	GO:0140318	protein transporter activity	-	40	40	-	-	2.03E-02	1.79E-03
ConsensusPathDB	MF	GO:0070628	proteasome binding	-	17	17	-	-	1.99E-03	7.85E-04
ConsensusPathDB	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	3.58E-03	5.05E-04
ConsensusPathDB	MF	GO:0031432	titin binding	-	13	11	-	-	8.70E-03	5.05E-04
ConsensusPathDB	MF	GO:0046812	host cell surface binding	-	11	11	-	-	4.20E-04	5.05E-04
ConsensusPathDB	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	2.29E-03	1.68E-03
ConsensusPathDB	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	1.22E-03	7.85E-04
ConsensusPathDB	MF	GO:0002039	p53 binding	-	66	66	-	-	2.48E-03	2.97E-03
ConsensusPathDB	MF	GO:0005496	steroid binding	-	110	108	-	-	6.27E-03	4.88E-03
ConsensusPathDB	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	2.14E-02	1.23E-03
ConsensusPathDB	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	4.66E-04	5.05E-04
ConsensusPathDB	MF	GO:0003684	damaged DNA binding	-	89	86	-	-	1.16E-02	3.87E-03
ConsensusPathDB	MF	GO:0000339	RNA cap binding	-	20	19	-	-	5.41E-03	8.97E-04
ConsensusPathDB	MF	GO:0016500	protein-hormone receptor activity	-	21	20	-	-	8.53E-03	8.97E-04
ConsensusPathDB	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	125	-	-	8.82E-03	5.61E-03
ConsensusPathDB	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	1.80E-02	6.73E-04
ConsensusPathDB	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	6.39E-03	5.61E-04
ConsensusPathDB	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	6.51E-03	5.05E-04
ConsensusPathDB	MF	GO:0070063	RNA polymerase binding	-	61	61	-	-	5.00E-03	2.75E-03
ConsensusPathDB	MF	GO:0050811	GABA receptor binding	-	18	17	-	-	4.67E-03	7.85E-04
ConsensusPathDB	MF	GO:0030971	receptor tyrosine kinase binding	-	76	74	-	-	3.48E-03	3.37E-03
ConsensusPathDB	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	83	-	-	7.27E-03	3.76E-03
ConsensusPathDB	MF	GO:0140030	modification-dependent protein binding	-	179	176	-	-	5.65E-03	7.91E-03
ConsensusPathDB	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	7.31E-03	1.12E-03
ConsensusPathDB	MF	GO:0009881	photoreceptor activity	-	17	13	-	-	1.60E-04	6.17E-04
ConsensusPathDB	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	18	-	-	1.84E-03	8.41E-04
ConsensusPathDB	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	9.55E-04	6.17E-04
ConsensusPathDB	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	6.35E-03	7.29E-04
ConsensusPathDB	MF	GO:0141047	molecular tag activity	-	13	13	-	-	9.24E-04	6.17E-04
ConsensusPathDB	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	9.85E-03	5.05E-04
ConsensusPathDB	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	3.65E-03	5.61E-04
ConsensusPathDB	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	1.16E-03	6.73E-04
ConsensusPathDB	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	1.40E-03	5.61E-04
ConsensusPathDB	MF	GO:0044548	S100 protein binding	-	14	14	-	-	4.13E-03	6.73E-04
ConsensusPathDB	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	1.27E-03	6.73E-04
ConsensusPathDB	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.30E-02	6.73E-04
ConsensusPathDB	MF	GO:0030276	clathrin binding	-	70	69	-	-	7.35E-03	3.14E-03
ConsensusPathDB	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	4.06E-03	1.35E-03
ConsensusPathDB	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	1.12E-03	6.73E-04
ConsensusPathDB	MF	GO:0046790	virion binding	-	19	19	-	-	1.88E-03	8.97E-04
ConsensusPathDB	MF	GO:0030552	cAMP binding	-	48	46	-	-	4.51E-02	2.08E-03
ConsensusPathDB	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	2.15E-03	1.74E-03
ConsensusPathDB	MF	GO:0035173	histone kinase activity	-	17	17	-	-	1.07E-03	7.85E-04
ConsensusPathDB	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	5.89E-03	1.18E-03
ConsensusPathDB	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	5.60E-03	5.61E-04
ConsensusPathDB	MF	GO:0004984	olfactory receptor activity	-	429	105	-	-	3.47E-03	4.71E-03
ConsensusPathDB	MF	GO:0016209	antioxidant activity	-	92	86	-	-	6.40E-03	3.87E-03
ConsensusPathDB	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	1.21E-03	1.35E-03
ConsensusPathDB	MF	GO:0044325	transmembrane transporter binding	-	159	152	-	-	7.49E-03	6.84E-03
ConsensusPathDB	MF	GO:0048156	tau protein binding	-	43	43	-	-	1.32E-03	1.96E-03
ConsensusPathDB	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	3.21E-03	1.63E-03
ConsensusPathDB	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	3.99E-03	6.17E-04
ConsensusPathDB	MF	GO:0140272	exogenous protein binding	-	79	77	-	-	4.70E-03	3.48E-03
ConsensusPathDB	MF	GO:0030145	manganese ion binding	-	65	64	-	-	1.86E-03	2.92E-03
ConsensusPathDB	MF	GO:0071814	protein-lipid complex binding	-	52	47	-	-	7.92E-03	2.13E-03
ConsensusPathDB	MF	GO:0008066	glutamate receptor activity	-	70	67	-	-	2.75E-02	3.03E-03
ConsensusPathDB	MF	GO:0030553	cGMP binding	-	15	14	-	-	2.81E-01	6.73E-04
ConsensusPathDB	MF	GO:0017069	snRNA binding	-	54	47	-	-	5.96E-03	2.13E-03
ConsensusPathDB	MF	GO:0030215	semaphorin receptor binding	-	23	22	-	-	3.33E-02	1.01E-03
ConsensusPathDB	MF	GO:0031996	thioesterase binding	-	11	11	-	-	1.11E-03	5.05E-04
ConsensusPathDB	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	5.24E-03	1.40E-03
ConsensusPathDB	MF	GO:0019843	rRNA binding	-	69	67	-	-	3.21E-03	3.03E-03
ConsensusPathDB	MF	GO:0004713	protein tyrosine kinase activity	-	213	210	-	-	1.13E-02	9.42E-03
ConsensusPathDB	MF	GO:0061783	peptidoglycan muralytic activity	-	14	11	-	-	1.29E-01	5.05E-04
ConsensusPathDB	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	4.26E-03	2.30E-03
ConsensusPathDB	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.36E-03	1.12E-03
ConsensusPathDB	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	5.46E-04	8.97E-04
ConsensusPathDB	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	28	-	-	1.17E-03	1.29E-03
ConsensusPathDB	MF	GO:0016208	AMP binding	-	22	22	-	-	3.47E-03	1.01E-03
ConsensusPathDB	MF	GO:0000287	magnesium ion binding	-	225	221	-	-	4.84E-03	9.93E-03
ConsensusPathDB	MF	GO:0031490	chromatin DNA binding	-	120	118	-	-	5.10E-03	5.33E-03
ConsensusPathDB	MF	GO:0017022	myosin binding	-	73	72	-	-	4.26E-03	3.25E-03
ConsensusPathDB	MF	GO:0004896	cytokine receptor activity	-	93	91	-	-	1.77E-01	4.09E-03
ConsensusPathDB	MF	GO:0017166	vinculin binding	-	12	11	-	-	5.77E-03	5.05E-04
ConsensusPathDB	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	1.80E-02	8.41E-04
ConsensusPathDB	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	5.10E-03	5.61E-04
ConsensusPathDB	MF	GO:0005539	glycosaminoglycan binding	-	236	226	-	-	9.67E-03	1.02E-02
ConsensusPathDB	MF	GO:0140666	annealing activity	-	11	11	-	-	5.56E-04	5.05E-04
ConsensusPathDB	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	8.97E-04	6.73E-04
ConsensusPathDB	MF	GO:0010181	FMN binding	-	15	15	-	-	1.87E-04	6.73E-04
ConsensusPathDB	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	19	-	-	5.52E-02	8.97E-04
ConsensusPathDB	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	24	-	-	5.84E-03	1.12E-03
ConsensusPathDB	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	7.19E-04	7.85E-04
ConsensusPathDB	MF	GO:0044183	protein folding chaperone	-	67	66	-	-	1.56E-03	2.97E-03
ConsensusPathDB	MF	GO:0005132	type I interferon receptor binding	-	17	15	-	-	3.19E-02	6.73E-04
ConsensusPathDB	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	1.09E-02	4.88E-03
ConsensusPathDB	MF	GO:0003725	double-stranded RNA binding	-	72	70	-	-	3.47E-03	3.14E-03
ConsensusPathDB	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	1.53E-01	7.29E-04
ConsensusPathDB	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	1.33E-02	2.36E-03
ConsensusPathDB	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.68E-03	1.57E-03
ConsensusPathDB	MF	GO:0004618	phosphoglycerate kinase activity	-	89	89	-	-	2.37E-03	4.04E-03
ConsensusPathDB	MF	GO:0042805	actinin binding	-	36	36	-	-	3.38E-03	1.63E-03
ConsensusPathDB	MF	GO:0043531	ADP binding	-	38	38	-	-	1.16E-03	1.74E-03
ConsensusPathDB	MF	GO:0043394	proteoglycan binding	-	36	36	-	-	3.42E-03	1.63E-03
ConsensusPathDB	MF	GO:0005542	folic acid binding	-	13	11	-	-	1.49E-04	5.05E-04
ConsensusPathDB	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	1.85E-02	5.05E-04
ConsensusPathDB	MF	GO:0046332	SMAD binding	-	77	77	-	-	2.15E-02	3.48E-03
ConsensusPathDB	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.30E-03	6.17E-04
ConsensusPathDB	MF	GO:0001968	fibronectin binding	-	30	30	-	-	4.08E-03	1.35E-03
ConsensusPathDB	MF	GO:0048038	quinone binding	-	16	16	-	-	1.05E-02	7.29E-04
ConsensusPathDB	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	121	-	-	1.13E-02	5.44E-03
ConsensusPathDB	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	80	-	-	2.64E-03	3.59E-03
ConsensusPathDB	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	1.78E-03	8.41E-04
ConsensusPathDB	MF	GO:0051117	ATPase binding	-	85	83	-	-	3.12E-03	3.76E-03
ConsensusPathDB	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	3.67E-03	2.08E-03
ConsensusPathDB	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	8.48E-04	8.97E-04
ConsensusPathDB	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	1.83E-03	5.05E-04
ConsensusPathDB	MF	GO:0070402	NADPH binding	-	16	15	-	-	3.72E-04	6.73E-04
ConsensusPathDB	MF	GO:0031404	chloride ion binding	-	14	12	-	-	2.16E-03	5.61E-04
ConsensusPathDB	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	3.23E-03	2.75E-03
ConsensusPathDB	MF	GO:0036002	pre-mRNA binding	-	57	36	-	-	4.78E-03	1.63E-03
ConsensusPathDB	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	36	-	-	1.71E-02	1.63E-03
ConsensusPathDB	MF	GO:0051540	metal cluster binding	-	71	69	-	-	4.58E-03	3.14E-03
ConsensusPathDB	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	9.02E-04	5.05E-04
ConsensusPathDB	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	4.13E-03	4.15E-03
ConsensusPathDB	MF	GO:0019894	kinesin binding	-	45	44	-	-	2.29E-03	2.02E-03
ConsensusPathDB	MF	GO:0042287	MHC protein binding	-	68	62	-	-	7.94E-02	2.80E-03
ConsensusPathDB	MF	GO:0019003	GDP binding	-	89	89	-	-	7.47E-03	4.04E-03
ConsensusPathDB	MF	GO:0017171	serine hydrolase activity	-	207	191	-	-	2.85E-02	8.58E-03
ConsensusPathDB	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	2.25E-03	2.97E-03
ConsensusPathDB	MF	GO:0003774	cytoskeletal motor activity	-	117	116	-	-	5.82E-03	5.22E-03
ConsensusPathDB	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.58E-03	1.35E-03
ConsensusPathDB	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	4.50E-03	7.85E-04
ConsensusPathDB	MF	GO:0061134	peptidase regulator activity	-	224	207	-	-	1.53E-02	9.31E-03
ConsensusPathDB	MF	GO:0008013	beta-catenin binding	-	86	85	-	-	1.85E-02	3.81E-03
ConsensusPathDB	MF	GO:0051015	actin filament binding	-	208	206	-	-	1.01E-02	9.25E-03
ConsensusPathDB	MF	GO:0019208	phosphatase regulator activity	-	107	103	-	-	8.33E-03	4.66E-03
ConsensusPathDB	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	32	-	-	2.65E-03	1.46E-03
ConsensusPathDB	MF	GO:0043236	laminin binding	-	29	28	-	-	1.19E-03	1.29E-03
ConsensusPathDB	MF	GO:0030507	spectrin binding	-	26	26	-	-	3.98E-03	1.18E-03
ConsensusPathDB	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	2.14E-03	1.85E-03
ConsensusPathDB	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	114	-	-	1.83E-02	5.16E-03
ConsensusPathDB	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	3.81E-03	1.12E-03
ConsensusPathDB	MF	GO:0042393	histone binding	-	240	231	-	-	1.08E-02	1.04E-02
ConsensusPathDB	MF	GO:0019838	growth factor binding	-	182	179	-	-	1.14E-02	8.08E-03
ConsensusPathDB	MF	GO:0000149	SNARE binding	-	107	107	-	-	1.83E-02	4.82E-03
ConsensusPathDB	MF	GO:0003727	single-stranded RNA binding	-	90	83	-	-	3.05E-03	3.76E-03
ConsensusPathDB	MF	GO:0051378	serotonin binding	-	24	24	-	-	1.96E-02	1.12E-03
ConsensusPathDB	MF	GO:0005516	calmodulin binding	-	206	202	-	-	6.85E-03	9.09E-03
ConsensusPathDB	MF	GO:0019825	oxygen binding	-	40	37	-	-	3.70E-02	1.68E-03
ConsensusPathDB	MF	GO:0045505	dynein intermediate chain binding	-	37	37	-	-	4.31E-03	1.68E-03
ConsensusPathDB	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	85	-	-	3.95E-03	3.81E-03
ConsensusPathDB	MF	GO:0032182	ubiquitin-like protein binding	-	117	114	-	-	3.78E-03	5.16E-03
ConsensusPathDB	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	8.79E-02	1.63E-03
ConsensusPathDB	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	5.31E-03	1.01E-03
ConsensusPathDB	MF	GO:0043274	phospholipase binding	-	23	23	-	-	1.49E-03	1.07E-03
ConsensusPathDB	MF	GO:0031072	heat shock protein binding	-	128	127	-	-	1.46E-02	5.72E-03
ConsensusPathDB	MF	GO:0030515	snoRNA binding	-	33	32	-	-	2.71E-03	1.46E-03
ConsensusPathDB	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	71	-	-	1.80E-02	3.20E-03
ConsensusPathDB	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	20	-	-	3.64E-03	8.97E-04
ConsensusPathDB	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	1.17E-03	1.18E-03
ConsensusPathDB	MF	GO:0001530	lipopolysaccharide binding	-	38	33	-	-	1.41E-02	1.51E-03
ConsensusPathDB	MF	GO:0140223	general transcription initiation factor activity	-	55	54	-	-	2.97E-02	2.47E-03
ConsensusPathDB	MF	GO:0070403	NAD+ binding	-	16	16	-	-	1.64E-03	7.29E-04
ConsensusPathDB	MF	GO:0000049	tRNA binding	-	75	71	-	-	3.73E-03	3.20E-03
ConsensusPathDB	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	2.96E-03	2.02E-03
ConsensusPathDB	MF	GO:0015026	coreceptor activity	-	48	47	-	-	6.14E-03	2.13E-03
ConsensusPathDB	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.63E-03	5.61E-04
ConsensusPathDB	MF	GO:0001653	peptide receptor activity	-	128	119	-	-	1.18E-02	5.38E-03
ConsensusPathDB	MF	GO:0031005	filamin binding	-	15	14	-	-	5.37E-04	6.73E-04
ConsensusPathDB	MF	GO:0030506	ankyrin binding	-	19	19	-	-	4.34E-03	8.97E-04
ConsensusPathDB	MF	GO:0006469	negative regulation of protein kinase activity	-	222	207	-	-	4.42E-03	9.31E-03
ConsensusPathDB	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	1.12E-03	8.97E-04
ConsensusPathDB	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	4.34E-03	6.73E-04
ConsensusPathDB	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	3.52E-03	1.40E-03
ConsensusPathDB	MF	GO:0051427	hormone receptor binding	-	31	31	-	-	6.38E-03	1.40E-03
ConsensusPathDB	MF	GO:0070851	growth factor receptor binding	-	141	141	-	-	1.26E-02	6.34E-03
ConsensusPathDB	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	1.68E-02	1.46E-03
ConsensusPathDB	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	42	-	-	4.31E-03	1.91E-03
ConsensusPathDB	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	6.87E-03	8.97E-04
ConsensusPathDB	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	5.35E-03	7.85E-04
ConsensusPathDB	MF	GO:0005506	iron ion binding	-	154	144	-	-	1.90E-02	6.51E-03
ConsensusPathDB	MF	GO:0003925	G protein activity	-	45	44	-	-	2.99E-03	2.02E-03
ConsensusPathDB	MF	GO:0038187	pattern recognition receptor activity	-	33	32	-	-	4.05E-02	1.46E-03
ConsensusPathDB	MF	GO:0008276	protein methyltransferase activity	-	96	93	-	-	3.95E-03	4.21E-03
ConsensusPathDB	MF	GO:0004396	hexokinase activity	-	16	16	-	-	3.91E-02	7.29E-04
ConsensusPathDB	MF	GO:0070888	E-box binding	-	59	58	-	-	2.73E-02	2.64E-03
ConsensusPathDB	MF	GO:0039706	co-receptor binding	-	14	14	-	-	3.41E-02	6.73E-04
ConsensusPathDB	MF	GO:0015399	primary active transmembrane transporter activity	-	190	187	-	-	5.21E-02	8.41E-03
ConsensusPathDB	MF	GO:0035254	glutamate receptor binding	-	47	46	-	-	1.55E-03	2.08E-03
ConsensusPathDB	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	1.69E-03	1.51E-03
ConsensusPathDB	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	1.07E-03	5.05E-04
ConsensusPathDB	MF	GO:0043021	ribonucleoprotein complex binding	-	158	151	-	-	3.51E-03	6.79E-03
ConsensusPathDB	MF	GO:0030170	pyridoxal phosphate binding	-	56	52	-	-	7.43E-03	2.36E-03
ConsensusPathDB	MF	GO:0032393	MHC class I receptor activity	-	15	13	-	-	2.39E-01	6.17E-04
ConsensusPathDB	MF	GO:0005112	Notch binding	-	26	25	-	-	7.47E-03	1.12E-03
ConsensusPathDB	MF	GO:0048185	activin binding	-	16	16	-	-	3.66E-02	7.29E-04
ConsensusPathDB	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	7.24E-04	1.29E-03
ConsensusPathDB	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	4.51E-04	5.05E-04
ConsensusPathDB	MF	GO:0140299	small molecule sensor activity	-	39	35	-	-	1.69E-02	1.57E-03
ConsensusPathDB	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	7.75E-03	1.01E-03
ConsensusPathDB	MF	GO:0016917	GABA receptor activity	-	23	20	-	-	6.16E-01	8.97E-04
ConsensusPathDB	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	2.28E-03	6.73E-04
ConsensusPathDB	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	25	-	-	4.49E-03	1.12E-03
ConsensusPathDB	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	44	-	-	4.85E-03	2.02E-03
ConsensusPathDB	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.53E-03	1.12E-03
ConsensusPathDB	MF	GO:0008527	taste receptor activity	-	28	11	-	-	3.00E-01	5.05E-04
ConsensusPathDB	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	1.25E-03	5.61E-04
ConsensusPathDB	MF	GO:0030594	neurotransmitter receptor activity	-	160	153	-	-	5.28E-02	6.90E-03
ConsensusPathDB	MF	GO:0034452	dynactin binding	-	12	12	-	-	5.56E-04	5.61E-04
ConsensusPathDB	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	4.30E-02	1.12E-03
ConsensusPathDB	MF	GO:0120227	acyl-CoA binding	-	22	20	-	-	1.45E-03	8.97E-04
ConsensusPathDB	MF	GO:0005507	copper ion binding	-	63	60	-	-	3.49E-03	2.69E-03
ConsensusPathDB	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	2.74E-03	1.01E-03
ConsensusPathDB	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	3.08E-03	5.05E-04
ConsensusPathDB	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	3.26E-03	1.01E-03
ConsensusPathDB	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	1.96E-03	5.61E-04
DIP	CC	GO:0005615	extracellular space	1.21E-37	3190	802	544	1.48	-	-
DIP	CC	GO:0005815	microtubule organizing center	4.92E-30	843	276	144	1.92	-	-
DIP	CC	GO:0000228	nuclear chromosome	3.49E-29	206	105	35	2.99	-	-
DIP	CC	GO:0005730	nucleolus	3.55E-22	988	288	168	1.71	-	-
DIP	CC	GO:0005768	endosome	2.27E-21	1037	296	177	1.67	-	-
DIP	CC	GO:0005635	nuclear envelope	6.01E-13	493	148	84	1.76	-	-
DIP	CC	GO:0005764	lysosome	2.13E-07	747	182	127	1.43	-	-
DIP	CC	GO:0005794	Golgi apparatus	6.36E-06	1636	346	279	1.24	-	-
DIP	CC	GO:0005840	ribosome	2.04E-04	222	60	38	1.59	-	-
DIP	CC	GO:0005777	peroxisome	9.75E-03	142	13	24	0.54	-	-
DIP	CC	GO:0005739	mitochondrion	1.05E-02	1671	323	285	1.13	-	-
DIP	CC	GO:0005783	endoplasmic reticulum	1.88E-02	2020	382	344	1.11	-	-
DIP	CC	GO:0005929	cilium	4.82E-01	842	151	143	1.05	-	-
DIP	CC	GO:0031012	extracellular matrix	6.91E-01	564	92	96	0.96	-	-
DIP	CC	GO:0005811	lipid droplet	7.93E-01	102	16	17	0.92	-	-
DIP	BP	GO:0012501	programmed cell death	1.13E-150	1954	789	333	2.37	-	-
DIP	BP	GO:0002376	immune system process	3.65E-134	2448	883	417	2.12	-	-
DIP	BP	GO:0006355	regulation of DNA-templated transcription	3.83E-106	3342	1028	570	1.81	-	-
DIP	BP	GO:0065003	protein-containing complex assembly	9.42E-105	1648	631	281	2.25	-	-
DIP	BP	GO:0006325	chromatin organization	7.86E-85	720	344	123	2.80	-	-
DIP	BP	GO:0048870	cell motility	3.69E-76	1659	578	283	2.04	-	-
DIP	BP	GO:0006281	DNA repair	9.02E-75	587	289	100	2.89	-	-
DIP	BP	GO:0030163	protein catabolic process	7.78E-65	990	387	169	2.29	-	-
DIP	BP	GO:0006954	inflammatory response	3.14E-60	820	333	140	2.38	-	-
DIP	BP	GO:0098542	defense response to other organism	1.07E-57	1171	419	200	2.10	-	-
DIP	BP	GO:0007059	chromosome segregation	2.42E-52	403	200	69	2.91	-	-
DIP	BP	GO:0007155	cell adhesion	7.67E-46	1444	457	246	1.86	-	-
DIP	BP	GO:0032200	telomere organization	1.14E-45	186	118	32	3.72	-	-
DIP	BP	GO:0006914	autophagy	1.13E-40	568	229	97	2.37	-	-
DIP	BP	GO:0016071	mRNA metabolic process	2.06E-40	713	267	122	2.20	-	-
DIP	BP	GO:0006310	DNA recombination	9.82E-40	333	160	57	2.82	-	-
DIP	BP	GO:0007010	cytoskeleton organization	4.99E-37	1639	477	279	1.71	-	-
DIP	BP	GO:0042060	wound healing	3.69E-36	431	183	73	2.49	-	-
DIP	BP	GO:0006260	DNA replication	9.17E-35	279	136	48	2.86	-	-
DIP	BP	GO:0006913	nucleocytoplasmic transport	2.91E-30	326	143	56	2.57	-	-
DIP	BP	GO:0016192	vesicle-mediated transport	1.61E-28	1894	504	323	1.56	-	-
DIP	BP	GO:0034330	cell junction organization	3.02E-23	727	231	124	1.86	-	-
DIP	BP	GO:0006886	intracellular protein transport	1.07E-21	664	212	113	1.87	-	-
DIP	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.12E-20	119	65	20	3.21	-	-
DIP	BP	GO:0140013	meiotic nuclear division	4.09E-18	279	108	48	2.27	-	-
DIP	BP	GO:0000910	cytokinesis	4.57E-18	186	82	32	2.59	-	-
DIP	BP	GO:0003012	muscle system process	4.21E-17	425	143	72	1.97	-	-
DIP	BP	GO:0007163	establishment or maintenance of cell polarity	4.92E-17	227	92	39	2.38	-	-
DIP	BP	GO:0003013	circulatory system process	1.03E-12	584	168	100	1.69	-	-
DIP	BP	GO:0007005	mitochondrion organization	5.14E-11	484	140	82	1.70	-	-
DIP	BP	GO:0002181	cytoplasmic translation	1.78E-09	153	57	26	2.19	-	-
DIP	BP	GO:0072659	protein localization to plasma membrane	6.07E-09	284	88	48	1.82	-	-
DIP	BP	GO:0006457	protein folding	4.91E-08	210	68	36	1.90	-	-
DIP	BP	GO:0006486	protein glycosylation	5.12E-08	225	11	38	0.29	-	-
DIP	BP	GO:0006790	sulfur compound metabolic process	1.90E-06	320	25	55	0.46	-	-
DIP	BP	GO:0006575	cellular modified amino acid metabolic process	1.17E-03	186	16	32	0.50	-	-
DIP	BP	GO:0006091	generation of precursor metabolites and energy	4.59E-03	502	110	86	1.29	-	-
DIP	BP	GO:0005975	carbohydrate metabolic process	1.82E-02	551	115	94	1.22	-	-
DIP	BP	GO:0022600	digestive system process	2.21E-02	110	28	19	1.49	-	-
DIP	BP	GO:0050877	nervous system process	2.76E-02	1527	229	260	0.88	-	-
DIP	BP	GO:0007018	microtubule-based movement	2.82E-02	640	130	109	1.19	-	-
DIP	BP	GO:0006520	amino acid metabolic process	4.94E-02	292	37	50	0.74	-	-
DIP	BP	GO:0042254	ribosome biogenesis	1.87E-01	297	59	51	1.17	-	-
DIP	BP	GO:0006629	lipid metabolic process	1.89E-01	1355	213	231	0.92	-	-
DIP	BP	GO:0044782	cilium organization	2.26E-01	399	77	68	1.13	-	-
DIP	BP	GO:0007040	lysosome organization	2.44E-01	107	23	18	1.26	-	-
DIP	BP	GO:0003014	renal system process	2.88E-01	127	26	22	1.20	-	-
DIP	BP	GO:0006399	tRNA metabolic process	2.93E-01	196	39	33	1.17	-	-
DIP	BP	GO:0140053	mitochondrial gene expression	3.48E-01	164	23	28	0.82	-	-
DIP	BP	GO:0030198	extracellular matrix organization	5.96E-01	314	57	54	1.07	-	-
DIP	BP	GO:0098754	detoxification	6.44E-01	134	25	23	1.09	-	-
DIP	BP	GO:0006766	vitamin metabolic process	6.98E-01	107	16	18	0.88	-	-
DIP	BP	GO:0055086	nucleobase-containing small molecule metabolic process	8.80E-01	729	122	124	0.98	-	-
DIP	BP	GO:0055085	transmembrane transport	8.95E-01	1784	306	304	1.01	-	-
DIP	MF	GO:0140096	"catalytic activity, acting on a protein"	5.10E-96	3198	973	545	1.79	-	-
DIP	MF	GO:0003677	DNA binding	5.86E-85	2865	874	488	1.79	-	-
DIP	MF	GO:0016740	transferase activity	1.29E-76	3074	898	524	1.71	-	-
DIP	MF	GO:0140097	"catalytic activity, acting on DNA"	5.20E-49	383	189	65	2.90	-	-
DIP	MF	GO:0003723	RNA binding	1.10E-48	1679	518	286	1.81	-	-
DIP	MF	GO:0140110	transcription regulator activity	1.67E-38	2033	567	346	1.64	-	-
DIP	MF	GO:0140657	ATP-dependent activity	1.45E-26	729	240	124	1.93	-	-
DIP	MF	GO:0008092	cytoskeletal protein binding	1.44E-25	1023	306	174	1.76	-	-
DIP	MF	GO:0048018	receptor ligand activity	1.06E-22	504	176	86	2.05	-	-
DIP	MF	GO:0042393	histone binding	3.48E-21	237	102	40	2.53	-	-
DIP	MF	GO:0140098	"catalytic activity, acting on RNA"	3.31E-09	417	119	71	1.67	-	-
DIP	MF	GO:0003924	GTPase activity	3.78E-09	658	171	112	1.52	-	-
DIP	MF	GO:0005198	structural molecule activity	6.17E-08	798	195	136	1.43	-	-
DIP	MF	GO:0016874	ligase activity	5.79E-07	283	82	48	1.70	-	-
DIP	MF	GO:0005215	transporter activity	8.01E-07	1462	183	249	0.73	-	-
DIP	MF	GO:0009975	cyclase activity	1.63E-06	277	79	47	1.67	-	-
DIP	MF	GO:0140104	molecular carrier activity	1.93E-05	105	36	18	2.01	-	-
DIP	MF	GO:0016829	lyase activity	5.57E-05	538	128	92	1.40	-	-
DIP	MF	GO:0045182	translation regulator activity	1.15E-04	151	45	26	1.75	-	-
DIP	MF	GO:0008289	lipid binding	4.10E-04	836	181	142	1.27	-	-
DIP	MF	GO:0016853	isomerase activity	7.01E-04	252	64	43	1.49	-	-
DIP	MF	GO:0038024	cargo receptor activity	8.46E-02	117	27	20	1.35	-	-
DIP	MF	GO:0003774	cytoskeletal motor activity	4.56E-01	116	23	20	1.16	-	-
DIP	MF	GO:0016491	oxidoreductase activity	7.49E-01	888	155	151	1.02	-	-
DIP	BP	GO:0008038	neuron recognition	-	46	16	-	-	2.30E-02	4.06E-03
DIP	BP	GO:1905145	cellular response to acetylcholine	-	33	13	-	-	9.29E-04	3.44E-03
DIP	BP	GO:0098780	response to mitochondrial depolarisation	-	21	14	-	-	4.57E-02	3.75E-03
DIP	BP	GO:0001525	angiogenesis	-	616	213	-	-	6.09E-02	5.34E-02
DIP	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	13	-	-	3.99E-03	3.44E-03
DIP	BP	GO:0045666	positive regulation of neuron differentiation	-	91	30	-	-	4.88E-03	7.50E-03
DIP	BP	GO:0043543	protein acylation	-	107	31	-	-	4.41E-03	7.81E-03
DIP	MF	GO:0051349	positive regulation of lyase activity	-	41	19	-	-	6.40E-03	5.00E-03
DIP	BP	GO:0048679	regulation of axon regeneration	-	28	12	-	-	8.37E-03	3.12E-03
DIP	BP	GO:0071763	nuclear membrane organization	-	44	27	-	-	1.94E-01	6.87E-03
DIP	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	11	-	-	4.58E-02	2.81E-03
DIP	BP	GO:0071806	protein transmembrane transport	-	68	16	-	-	6.50E-03	4.06E-03
DIP	BP	GO:0043299	leukocyte degranulation	-	82	33	-	-	2.01E-02	8.43E-03
DIP	BP	GO:0048864	stem cell development	-	88	30	-	-	8.52E-03	7.50E-03
DIP	BP	GO:0051651	maintenance of location in cell	-	236	98	-	-	3.35E-02	2.47E-02
DIP	CC	GO:0016197	endosomal transport	-	282	90	-	-	2.11E-01	2.25E-02
DIP	BP	GO:0070663	regulation of leukocyte proliferation	-	268	141	-	-	2.53E-02	3.53E-02
DIP	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	22	-	-	1.14E-02	5.62E-03
DIP	BP	GO:0006949	syncytium formation	-	66	20	-	-	1.55E-03	5.00E-03
DIP	BP	GO:0045861	negative regulation of proteolysis	-	320	98	-	-	3.27E-02	2.47E-02
DIP	CC	GO:0006984	ER-nucleus signaling pathway	-	46	21	-	-	4.35E-03	5.31E-03
DIP	BP	GO:0009914	hormone transport	-	315	104	-	-	3.63E-02	2.62E-02
DIP	BP	GO:0140112	extracellular vesicle biogenesis	-	23	17	-	-	3.97E-03	4.37E-03
DIP	BP	GO:0045785	positive regulation of cell adhesion	-	482	230	-	-	6.58E-02	5.75E-02
DIP	BP	GO:0085029	extracellular matrix assembly	-	42	13	-	-	6.72E-02	3.44E-03
DIP	BP	GO:0006413	translational initiation	-	122	50	-	-	3.81E-01	1.25E-02
DIP	BP	GO:1902895	positive regulation of miRNA transcription	-	51	42	-	-	8.37E-03	1.06E-02
DIP	CC	GO:0005200	structural constituent of cytoskeleton	-	112	40	-	-	2.13E-01	9.99E-03
DIP	BP	GO:0030865	cortical cytoskeleton organization	-	51	26	-	-	5.63E-03	6.56E-03
DIP	BP	GO:1903036	positive regulation of response to wounding	-	76	31	-	-	1.71E-02	7.81E-03
DIP	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	20	-	-	3.91E-02	5.00E-03
DIP	BP	GO:0002263	cell activation involved in immune response	-	304	144	-	-	2.79E-02	3.62E-02
DIP	BP	GO:0021954	central nervous system neuron development	-	85	26	-	-	6.74E-03	6.56E-03
DIP	BP	GO:0055017	cardiac muscle tissue growth	-	92	37	-	-	1.09E-02	9.37E-03
DIP	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	14	-	-	7.69E-03	3.75E-03
DIP	BP	GO:0048524	positive regulation of viral process	-	64	32	-	-	3.63E-03	8.12E-03
DIP	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	12	-	-	3.07E-02	3.12E-03
DIP	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	11	-	-	9.25E-04	2.81E-03
DIP	BP	GO:0009612	response to mechanical stimulus	-	215	98	-	-	1.21E-02	2.47E-02
DIP	BP	GO:0048644	muscle organ morphogenesis	-	81	30	-	-	5.94E-02	7.50E-03
DIP	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	80	-	-	2.38E-02	2.00E-02
DIP	BP	GO:0071542	dopaminergic neuron differentiation	-	36	11	-	-	1.17E-02	2.81E-03
DIP	MF	GO:0003714	transcription corepressor activity	-	190	89	-	-	6.87E-02	2.25E-02
DIP	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	19	-	-	3.24E-02	5.00E-03
DIP	BP	GO:0006304	DNA modification	-	30	12	-	-	5.03E-02	3.12E-03
DIP	BP	GO:0046835	carbohydrate phosphorylation	-	49	13	-	-	8.08E-02	3.44E-03
DIP	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	12	-	-	4.42E-03	3.12E-03
DIP	CC	GO:1905349	ciliary transition zone assembly	-	371	73	-	-	1.57E-01	1.84E-02
DIP	BP	GO:0043523	regulation of neuron apoptotic process	-	218	92	-	-	2.05E-02	2.31E-02
DIP	BP	GO:1902894	negative regulation of miRNA transcription	-	22	16	-	-	7.18E-03	4.06E-03
DIP	BP	GO:0044380	protein localization to cytoskeleton	-	57	33	-	-	1.02E-01	8.43E-03
DIP	BP	GO:2000209	regulation of anoikis	-	25	14	-	-	1.35E-02	3.75E-03
DIP	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	12	-	-	9.21E-04	3.12E-03
DIP	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	14	-	-	3.10E-02	3.75E-03
DIP	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	31	-	-	5.83E-03	7.81E-03
DIP	CC	GO:0045324	late endosome to vacuole transport	-	37	19	-	-	2.17E-01	5.00E-03
DIP	BP	GO:0043954	cellular component maintenance	-	72	28	-	-	1.64E-02	7.18E-03
DIP	BP	GO:0050435	amyloid-beta metabolic process	-	65	26	-	-	1.16E-02	6.56E-03
DIP	BP	GO:0014823	response to activity	-	70	30	-	-	2.70E-02	7.50E-03
DIP	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	190	-	-	5.61E-02	4.75E-02
DIP	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	13	-	-	3.19E-01	3.44E-03
DIP	BP	GO:0034502	protein localization to chromosome	-	130	82	-	-	3.95E-02	2.06E-02
DIP	BP	GO:0048562	embryonic organ morphogenesis	-	295	72	-	-	1.95E-02	1.81E-02
DIP	BP	GO:0019233	sensory perception of pain	-	103	29	-	-	9.06E-03	7.50E-03
DIP	BP	GO:0031343	positive regulation of cell killing	-	75	34	-	-	8.80E-02	8.74E-03
DIP	BP	GO:0090077	foam cell differentiation	-	39	17	-	-	1.17E-02	4.37E-03
DIP	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	19	-	-	3.22E-02	5.00E-03
DIP	BP	GO:0017148	negative regulation of translation	-	390	45	-	-	6.02E-02	1.12E-02
DIP	BP	GO:0030220	platelet formation	-	22	16	-	-	2.76E-02	4.06E-03
DIP	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	39	-	-	1.13E-02	9.99E-03
DIP	BP	GO:0009582	detection of abiotic stimulus	-	140	26	-	-	3.46E-02	6.56E-03
DIP	CC	GO:0140238	presynaptic endocytosis	-	72	25	-	-	1.83E-03	6.25E-03
DIP	BP	GO:0051236	establishment of RNA localization	-	161	65	-	-	1.52E-01	1.62E-02
DIP	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	94	-	-	5.83E-02	2.37E-02
DIP	BP	GO:0061842	microtubule organizing center localization	-	32	15	-	-	7.59E-02	3.75E-03
DIP	BP	GO:0042246	tissue regeneration	-	496	198	-	-	4.76E-02	4.97E-02
DIP	MF	GO:0048018	receptor ligand activity	-	510	176	-	-	1.46E-02	4.40E-02
DIP	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	17	-	-	2.66E-03	4.37E-03
DIP	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	32	-	-	2.67E-02	8.12E-03
DIP	BP	GO:0050779	RNA destabilization	-	135	46	-	-	3.25E-01	1.16E-02
DIP	BP	GO:0061025	membrane fusion	-	532	157	-	-	7.43E-02	3.94E-02
DIP	BP	GO:0010762	regulation of fibroblast migration	-	40	15	-	-	3.82E-03	3.75E-03
DIP	BP	GO:0090311	regulation of protein deacetylation	-	29	12	-	-	1.89E-03	3.12E-03
DIP	BP	GO:0035272	exocrine system development	-	46	22	-	-	1.00E-02	5.62E-03
DIP	BP	GO:0022406	membrane docking	-	90	33	-	-	1.44E-01	8.43E-03
DIP	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	11	-	-	2.77E-03	2.81E-03
DIP	BP	GO:0050777	negative regulation of immune response	-	196	86	-	-	2.15E-02	2.15E-02
DIP	BP	GO:0016053	organic acid biosynthetic process	-	335	46	-	-	1.36E-02	1.16E-02
DIP	MF	GO:0005035	death receptor activity	-	16	11	-	-	1.55E-02	2.81E-03
DIP	BP	GO:0099068	postsynapse assembly	-	40	13	-	-	9.30E-04	3.44E-03
DIP	BP	GO:0021782	glial cell development	-	120	40	-	-	2.26E-02	9.99E-03
DIP	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	40	-	-	1.51E-02	9.99E-03
DIP	BP	GO:0001655	urogenital system development	-	66	28	-	-	1.00E-02	7.18E-03
DIP	BP	GO:0071827	plasma lipoprotein particle organization	-	86	14	-	-	6.68E-02	3.75E-03
DIP	BP	GO:0045494	photoreceptor cell maintenance	-	43	12	-	-	1.62E-01	3.12E-03
DIP	BP	GO:0055088	lipid homeostasis	-	173	39	-	-	4.04E-02	9.99E-03
DIP	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	11	-	-	9.19E-04	2.81E-03
DIP	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	115	-	-	2.13E-02	2.87E-02
DIP	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	24	-	-	1.15E-02	6.25E-03
DIP	BP	GO:0045667	regulation of osteoblast differentiation	-	147	58	-	-	5.46E-02	1.47E-02
DIP	BP	GO:0050801	monoatomic ion homeostasis	-	609	165	-	-	4.37E-02	4.12E-02
DIP	BP	GO:0009792	embryo development ending in birth or egg hatching	-	683	242	-	-	3.83E-02	6.06E-02
DIP	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	177	-	-	3.48E-02	4.43E-02
DIP	BP	GO:0045738	negative regulation of DNA repair	-	40	15	-	-	1.22E-03	3.75E-03
DIP	BP	GO:0001704	formation of primary germ layer	-	195	78	-	-	3.37E-02	1.97E-02
DIP	BP	GO:0045778	positive regulation of ossification	-	51	20	-	-	1.51E-01	5.00E-03
DIP	BP	GO:0048708	astrocyte differentiation	-	88	46	-	-	1.25E-02	1.16E-02
DIP	BP	GO:0042092	type 2 immune response	-	41	24	-	-	1.74E-02	6.25E-03
DIP	BP	GO:0048588	developmental cell growth	-	233	86	-	-	1.19E-02	2.15E-02
DIP	BP	GO:0021872	forebrain generation of neurons	-	52	18	-	-	1.17E-03	4.68E-03
DIP	BP	GO:0045023	G0 to G1 transition	-	41	25	-	-	3.43E-01	6.25E-03
DIP	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	29	-	-	3.27E-02	7.50E-03
DIP	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	16	-	-	1.23E-03	4.06E-03
DIP	BP	GO:0021987	cerebral cortex development	-	125	45	-	-	1.51E-02	1.12E-02
DIP	BP	GO:0008637	apoptotic mitochondrial changes	-	108	48	-	-	5.43E-02	1.22E-02
DIP	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	15	-	-	1.28E-02	3.75E-03
DIP	BP	GO:0060999	positive regulation of dendritic spine development	-	35	11	-	-	9.31E-04	2.81E-03
DIP	BP	GO:2000736	regulation of stem cell differentiation	-	78	45	-	-	4.54E-02	1.12E-02
DIP	BP	GO:0002064	epithelial cell development	-	210	74	-	-	8.99E-03	1.87E-02
DIP	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	15	-	-	3.33E-02	3.75E-03
DIP	BP	GO:2001222	regulation of neuron migration	-	46	15	-	-	1.23E-03	3.75E-03
DIP	BP	GO:0034389	lipid droplet organization	-	38	13	-	-	1.51E-02	3.44E-03
DIP	BP	GO:0051602	response to electrical stimulus	-	44	15	-	-	1.22E-03	3.75E-03
DIP	BP	GO:0042177	negative regulation of protein catabolic process	-	109	49	-	-	1.08E-02	1.25E-02
DIP	MF	GO:0038024	cargo receptor activity	-	121	27	-	-	1.87E-02	6.87E-03
DIP	BP	GO:0033120	positive regulation of RNA splicing	-	46	19	-	-	4.31E-02	5.00E-03
DIP	BP	GO:0051445	regulation of meiotic cell cycle	-	64	33	-	-	4.69E-01	8.43E-03
DIP	BP	GO:0033619	membrane protein proteolysis	-	60	25	-	-	3.81E-02	6.25E-03
DIP	BP	GO:0090087	regulation of peptide transport	-	195	67	-	-	2.46E-02	1.69E-02
DIP	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	43	-	-	3.88E-02	1.09E-02
DIP	BP	GO:0006929	substrate-dependent cell migration	-	26	13	-	-	5.75E-03	3.44E-03
DIP	BP	GO:0022404	molting cycle process	-	95	39	-	-	1.28E-02	9.99E-03
DIP	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	13	-	-	2.56E-01	3.44E-03
DIP	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	13	-	-	1.97E-02	3.44E-03
DIP	BP	GO:0007281	germ cell development	-	334	81	-	-	7.78E-03	2.03E-02
DIP	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	54	-	-	6.48E-02	1.37E-02
DIP	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	12	-	-	1.55E-02	3.12E-03
DIP	CC	GO:0098926	postsynaptic signal transduction	-	39	16	-	-	1.23E-03	4.06E-03
DIP	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	63	-	-	7.07E-03	1.59E-02
DIP	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	24	-	-	1.54E-03	6.25E-03
DIP	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	53	-	-	1.01E-02	1.34E-02
DIP	BP	GO:0034249	negative regulation of amide metabolic process	-	34	11	-	-	9.29E-04	2.81E-03
DIP	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	55	-	-	1.96E-02	1.37E-02
DIP	BP	GO:0048799	animal organ maturation	-	33	12	-	-	9.31E-04	3.12E-03
DIP	BP	GO:0006925	inflammatory cell apoptotic process	-	23	11	-	-	9.20E-04	2.81E-03
DIP	BP	GO:0003013	circulatory system process	-	602	168	-	-	4.50E-02	4.22E-02
DIP	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	81	-	-	1.37E-02	2.03E-02
DIP	BP	GO:1903035	negative regulation of response to wounding	-	93	35	-	-	1.34E-01	8.74E-03
DIP	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	15	-	-	2.91E-03	3.75E-03
DIP	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	62	-	-	2.71E-01	1.56E-02
DIP	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	39	-	-	1.32E-02	9.99E-03
DIP	BP	GO:0009267	cellular response to starvation	-	170	78	-	-	6.47E-02	1.97E-02
DIP	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	33	-	-	6.65E-02	8.43E-03
DIP	CC	GO:0140239	postsynaptic endocytosis	-	23	11	-	-	9.29E-04	2.81E-03
DIP	CC	GO:0032008	positive regulation of TOR signaling	-	52	26	-	-	1.56E-01	6.56E-03
DIP	BP	GO:0060428	lung epithelium development	-	43	26	-	-	1.00E-02	6.56E-03
DIP	BP	GO:0071732	cellular response to nitric oxide	-	17	11	-	-	9.31E-03	2.81E-03
DIP	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	35	-	-	8.26E-03	8.74E-03
DIP	BP	GO:0065004	protein-DNA complex assembly	-	307	171	-	-	1.61E-01	4.28E-02
DIP	CC	GO:0006406	mRNA export from nucleus	-	69	27	-	-	1.22E-01	6.87E-03
DIP	BP	GO:0009880	embryonic pattern specification	-	70	20	-	-	1.22E-02	5.00E-03
DIP	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	27	-	-	5.38E-01	6.87E-03
DIP	BP	GO:0002367	cytokine production involved in immune response	-	121	63	-	-	2.13E-02	1.59E-02
DIP	BP	GO:0044848	biological phase	-	211	80	-	-	7.91E-02	2.00E-02
DIP	BP	GO:0046660	female sex differentiation	-	125	45	-	-	4.24E-02	1.12E-02
DIP	BP	GO:0019693	ribose phosphate metabolic process	-	556	103	-	-	2.77E-02	2.59E-02
DIP	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	19	-	-	1.21E-03	5.00E-03
DIP	BP	GO:0060411	cardiac septum morphogenesis	-	72	34	-	-	6.32E-02	8.74E-03
DIP	BP	GO:0071248	cellular response to metal ion	-	201	66	-	-	1.16E-02	1.66E-02
DIP	BP	GO:0030308	negative regulation of cell growth	-	191	68	-	-	8.95E-03	1.72E-02
DIP	BP	GO:0097306	cellular response to alcohol	-	99	37	-	-	1.16E-02	9.37E-03
DIP	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	42	-	-	2.14E-01	1.06E-02
DIP	BP	GO:0010453	regulation of cell fate commitment	-	40	24	-	-	8.86E-02	6.25E-03
DIP	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	28	-	-	4.96E-03	7.18E-03
DIP	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	116	-	-	1.19E-01	2.90E-02
DIP	BP	GO:0002026	regulation of the force of heart contraction	-	26	11	-	-	1.15E-02	2.81E-03
DIP	BP	GO:0032890	regulation of organic acid transport	-	78	25	-	-	1.83E-03	6.25E-03
DIP	BP	GO:0071498	cellular response to fluid shear stress	-	21	12	-	-	9.22E-04	3.12E-03
DIP	BP	GO:0098771	inorganic ion homeostasis	-	531	155	-	-	3.83E-02	3.87E-02
DIP	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	33	-	-	9.89E-03	8.43E-03
DIP	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	13	-	-	7.79E-03	3.44E-03
DIP	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	13	-	-	2.58E-02	3.44E-03
DIP	BP	GO:0051259	protein complex oligomerization	-	251	65	-	-	2.85E-02	1.62E-02
DIP	BP	GO:0009994	oocyte differentiation	-	57	18	-	-	1.94E-03	4.68E-03
DIP	MF	GO:0031952	regulation of protein autophosphorylation	-	43	21	-	-	3.54E-03	5.31E-03
DIP	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	50	-	-	7.16E-03	1.25E-02
DIP	BP	GO:0044319	"wound healing, spreading of cells"	-	37	20	-	-	2.38E-02	5.00E-03
DIP	BP	GO:0033688	regulation of osteoblast proliferation	-	31	14	-	-	6.33E-03	3.75E-03
DIP	BP	GO:0060251	regulation of glial cell proliferation	-	39	19	-	-	3.91E-03	5.00E-03
DIP	BP	GO:0072665	protein localization to vacuole	-	84	26	-	-	5.32E-02	6.56E-03
DIP	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	33	-	-	3.49E-01	8.43E-03
DIP	BP	GO:0006914	autophagy	-	574	229	-	-	1.16E-01	5.75E-02
DIP	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	26	-	-	1.04E-02	6.56E-03
DIP	BP	GO:0048858	cell projection morphogenesis	-	643	221	-	-	5.32E-02	5.53E-02
DIP	BP	GO:0045661	regulation of myoblast differentiation	-	74	37	-	-	8.18E-02	9.37E-03
DIP	BP	GO:0030307	positive regulation of cell growth	-	164	77	-	-	2.57E-02	1.94E-02
DIP	BP	GO:0034250	positive regulation of amide metabolic process	-	27	13	-	-	2.28E-02	3.44E-03
DIP	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	126	-	-	3.54E-02	3.15E-02
DIP	BP	GO:0014812	muscle cell migration	-	110	37	-	-	1.79E-02	9.37E-03
DIP	BP	GO:0048525	negative regulation of viral process	-	90	29	-	-	8.39E-03	7.50E-03
DIP	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	22	-	-	3.24E-02	5.62E-03
DIP	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	25	-	-	3.87E-02	6.25E-03
DIP	BP	GO:0051781	positive regulation of cell division	-	93	52	-	-	2.49E-02	1.31E-02
DIP	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	11	-	-	9.23E-04	2.81E-03
DIP	BP	GO:0002696	positive regulation of leukocyte activation	-	358	187	-	-	1.05E-01	4.68E-02
DIP	BP	GO:0060711	labyrinthine layer development	-	47	16	-	-	9.19E-03	4.06E-03
DIP	BP	GO:0007272	ensheathment of neurons	-	146	35	-	-	2.66E-02	8.74E-03
DIP	CC	GO:0050806	positive regulation of synaptic transmission	-	171	46	-	-	1.17E-02	1.16E-02
DIP	BP	GO:0060021	roof of mouth development	-	91	29	-	-	1.78E-02	7.50E-03
DIP	BP	GO:0034504	protein localization to nucleus	-	312	159	-	-	2.45E-02	4.00E-02
DIP	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	15	-	-	1.78E-02	3.75E-03
DIP	BP	GO:0050819	negative regulation of coagulation	-	54	20	-	-	2.85E-01	5.00E-03
DIP	BP	GO:0031647	regulation of protein stability	-	327	151	-	-	2.97E-02	3.78E-02
DIP	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	43	-	-	4.93E-01	1.09E-02
DIP	CC	GO:0050805	negative regulation of synaptic transmission	-	55	21	-	-	1.06E-02	5.31E-03
DIP	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	15	-	-	1.24E-03	3.75E-03
DIP	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	23	-	-	2.97E-03	5.93E-03
DIP	BP	GO:0016054	organic acid catabolic process	-	251	27	-	-	8.85E-02	6.87E-03
DIP	BP	GO:0050890	cognition	-	317	105	-	-	1.92E-02	2.62E-02
DIP	BP	GO:1900048	positive regulation of hemostasis	-	28	12	-	-	1.26E-01	3.12E-03
DIP	BP	GO:0008033	tRNA processing	-	136	18	-	-	2.50E-01	4.68E-03
DIP	BP	GO:0046661	male sex differentiation	-	171	61	-	-	1.17E-02	1.53E-02
DIP	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	33	-	-	1.49E-02	8.43E-03
DIP	BP	GO:1990778	protein localization to cell periphery	-	346	107	-	-	2.46E-02	2.69E-02
DIP	BP	GO:0061326	renal tubule development	-	103	31	-	-	1.50E-02	7.81E-03
DIP	BP	GO:0051258	protein polymerization	-	280	114	-	-	3.35E-02	2.87E-02
DIP	BP	GO:0071985	multivesicular body sorting pathway	-	56	26	-	-	1.76E-01	6.56E-03
DIP	BP	GO:0090559	regulation of membrane permeability	-	72	24	-	-	9.94E-02	6.25E-03
DIP	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	12	-	-	9.25E-04	3.12E-03
DIP	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	12	-	-	3.92E-02	3.12E-03
DIP	BP	GO:0002250	adaptive immune response	-	753	197	-	-	7.87E-02	4.93E-02
DIP	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	91	-	-	2.09E-02	2.28E-02
DIP	BP	GO:0002251	organ or tissue specific immune response	-	43	14	-	-	1.34E-02	3.75E-03
DIP	CC	GO:0048167	regulation of synaptic plasticity	-	210	68	-	-	3.15E-02	1.72E-02
DIP	BP	GO:1903708	positive regulation of hemopoiesis	-	184	94	-	-	6.95E-02	2.37E-02
DIP	BP	GO:1903008	organelle disassembly	-	154	66	-	-	6.98E-02	1.66E-02
DIP	BP	GO:0001709	cell fate determination	-	44	13	-	-	9.18E-04	3.44E-03
DIP	BP	GO:0045058	T cell selection	-	53	32	-	-	9.72E-03	8.12E-03
DIP	CC	GO:0032387	negative regulation of intracellular transport	-	51	22	-	-	3.08E-02	5.62E-03
DIP	BP	GO:0072091	regulation of stem cell proliferation	-	91	33	-	-	1.16E-02	8.43E-03
DIP	BP	GO:0099084	postsynaptic specialization organization	-	44	17	-	-	1.71E-02	4.37E-03
DIP	BP	GO:0032535	regulation of cellular component size	-	360	128	-	-	2.42E-02	3.22E-02
DIP	MF	GO:0031281	positive regulation of cyclase activity	-	40	21	-	-	5.50E-03	5.31E-03
DIP	MF	GO:0098631	cell adhesion mediator activity	-	64	17	-	-	2.01E-02	4.37E-03
DIP	BP	GO:0071453	cellular response to oxygen levels	-	168	67	-	-	3.61E-02	1.69E-02
DIP	BP	GO:0090399	replicative senescence	-	17	11	-	-	4.69E-03	2.81E-03
DIP	BP	GO:0031342	negative regulation of cell killing	-	29	17	-	-	1.24E-03	4.37E-03
DIP	BP	GO:0070585	protein localization to mitochondrion	-	125	46	-	-	6.56E-03	1.16E-02
DIP	BP	GO:0010623	programmed cell death involved in cell development	-	25	15	-	-	6.04E-03	3.75E-03
DIP	BP	GO:0044242	cellular lipid catabolic process	-	224	23	-	-	1.81E-02	5.93E-03
DIP	BP	GO:0002931	response to ischemia	-	58	28	-	-	6.84E-02	7.18E-03
DIP	BP	GO:0043062	extracellular structure organization	-	317	57	-	-	1.32E-02	1.44E-02
DIP	BP	GO:0061005	cell differentiation involved in kidney development	-	58	21	-	-	1.43E-02	5.31E-03
DIP	BP	GO:0055082	intracellular chemical homeostasis	-	706	203	-	-	3.80E-02	5.09E-02
DIP	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	170	-	-	5.51E-02	4.25E-02
DIP	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	22	-	-	2.46E-02	5.62E-03
DIP	BP	GO:0060420	regulation of heart growth	-	74	27	-	-	1.45E-02	6.87E-03
DIP	BP	GO:0009755	hormone-mediated signaling pathway	-	221	94	-	-	3.88E-02	2.37E-02
DIP	BP	GO:0022612	gland morphogenesis	-	124	67	-	-	1.02E-02	1.69E-02
DIP	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	12	-	-	6.70E-03	3.12E-03
DIP	MF	GO:0140416	transcription regulator inhibitor activity	-	26	18	-	-	5.52E-03	4.68E-03
DIP	BP	GO:0044782	cilium organization	-	400	77	-	-	1.79E-01	1.94E-02
DIP	BP	GO:0090130	tissue migration	-	379	150	-	-	4.21E-02	3.75E-02
DIP	BP	GO:1990845	adaptive thermogenesis	-	166	68	-	-	1.27E-02	1.72E-02
DIP	BP	GO:0071320	cellular response to cAMP	-	54	20	-	-	1.67E-02	5.00E-03
DIP	BP	GO:0015844	monoamine transport	-	88	28	-	-	2.79E-02	7.18E-03
DIP	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	12	-	-	6.27E-02	3.12E-03
DIP	BP	GO:0071392	cellular response to estradiol stimulus	-	40	20	-	-	2.97E-03	5.00E-03
DIP	BP	GO:0009314	response to radiation	-	449	200	-	-	5.43E-02	5.00E-02
DIP	BP	GO:0009451	RNA modification	-	169	33	-	-	6.26E-02	8.43E-03
DIP	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	25	-	-	1.35E-02	6.25E-03
DIP	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	54	-	-	8.61E-02	1.37E-02
DIP	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	19	-	-	1.06E-02	5.00E-03
DIP	BP	GO:0015807	L-amino acid transport	-	94	11	-	-	9.24E-04	2.81E-03
DIP	BP	GO:0032941	secretion by tissue	-	85	31	-	-	2.04E-02	7.81E-03
DIP	BP	GO:0046605	regulation of centrosome cycle	-	54	30	-	-	4.60E-02	7.50E-03
DIP	BP	GO:0003014	renal system process	-	130	26	-	-	1.96E-02	6.56E-03
DIP	BP	GO:0045598	regulation of fat cell differentiation	-	148	61	-	-	6.93E-03	1.53E-02
DIP	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	104	-	-	2.74E-02	2.62E-02
DIP	BP	GO:1904646	cellular response to amyloid-beta	-	44	24	-	-	7.23E-03	6.25E-03
DIP	BP	GO:1901863	positive regulation of muscle tissue development	-	24	13	-	-	9.16E-04	3.44E-03
DIP	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	63	-	-	2.02E-01	1.59E-02
DIP	BP	GO:0008340	determination of adult lifespan	-	23	12	-	-	4.75E-02	3.12E-03
DIP	BP	GO:0039694	viral RNA genome replication	-	30	14	-	-	4.68E-02	3.75E-03
DIP	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	11	-	-	3.46E-03	2.81E-03
DIP	BP	GO:0071709	membrane assembly	-	68	23	-	-	2.18E-01	5.93E-03
DIP	BP	GO:0008217	regulation of blood pressure	-	186	48	-	-	7.13E-03	1.22E-02
DIP	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	29	-	-	3.65E-03	7.50E-03
DIP	CC	GO:0042770	signal transduction in response to DNA damage	-	186	99	-	-	4.17E-02	2.50E-02
DIP	BP	GO:0002200	somatic diversification of immune receptors	-	78	56	-	-	6.03E-02	1.41E-02
DIP	BP	GO:0035315	hair cell differentiation	-	52	15	-	-	5.62E-02	3.75E-03
DIP	BP	GO:0048645	animal organ formation	-	62	25	-	-	1.44E-02	6.25E-03
DIP	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	63	-	-	1.99E-02	1.59E-02
DIP	BP	GO:0033627	cell adhesion mediated by integrin	-	87	40	-	-	1.16E-01	9.99E-03
DIP	BP	GO:0035107	appendage morphogenesis	-	147	48	-	-	3.63E-02	1.22E-02
DIP	BP	GO:1903707	negative regulation of hemopoiesis	-	116	45	-	-	1.74E-02	1.12E-02
DIP	CC	GO:0048208	COPII vesicle coating	-	27	15	-	-	3.07E-01	3.75E-03
DIP	BP	GO:0050994	regulation of lipid catabolic process	-	61	19	-	-	1.22E-03	5.00E-03
DIP	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	13	-	-	9.35E-04	3.44E-03
DIP	BP	GO:0009593	detection of chemical stimulus	-	511	14	-	-	1.18E-02	3.75E-03
DIP	BP	GO:0045727	positive regulation of translation	-	141	55	-	-	1.55E-02	1.37E-02
DIP	CC	GO:0032388	positive regulation of intracellular transport	-	137	60	-	-	6.19E-03	1.50E-02
DIP	BP	GO:0002027	regulation of heart rate	-	106	40	-	-	2.03E-02	9.99E-03
DIP	BP	GO:0050879	multicellular organismal movement	-	118	28	-	-	3.59E-02	7.18E-03
DIP	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	37	-	-	1.17E-02	9.37E-03
DIP	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	30	-	-	1.69E-02	7.50E-03
DIP	BP	GO:0048515	spermatid differentiation	-	208	40	-	-	3.71E-03	9.99E-03
DIP	BP	GO:0072132	mesenchyme morphogenesis	-	57	30	-	-	1.57E-02	7.50E-03
DIP	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	15	-	-	5.09E-03	3.75E-03
DIP	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	12	-	-	2.09E-02	3.12E-03
DIP	BP	GO:1901983	regulation of protein acetylation	-	26	17	-	-	1.20E-03	4.37E-03
DIP	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	133	-	-	2.34E-02	3.34E-02
DIP	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	27	-	-	2.06E-02	6.87E-03
DIP	BP	GO:0010883	regulation of lipid storage	-	53	18	-	-	5.44E-03	4.68E-03
DIP	BP	GO:1905954	positive regulation of lipid localization	-	110	27	-	-	5.68E-03	6.87E-03
DIP	BP	GO:0002209	behavioral defense response	-	39	12	-	-	1.90E-02	3.12E-03
DIP	BP	GO:0072523	purine-containing compound catabolic process	-	146	43	-	-	2.70E-02	1.09E-02
DIP	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	18	-	-	1.21E-03	4.68E-03
DIP	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	12	-	-	1.61E-02	3.12E-03
DIP	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	39	-	-	3.40E-02	9.99E-03
DIP	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	57	-	-	1.40E-02	1.44E-02
DIP	BP	GO:0031345	negative regulation of cell projection organization	-	195	64	-	-	1.34E-02	1.62E-02
DIP	BP	GO:0048278	vesicle docking	-	64	19	-	-	5.62E-02	5.00E-03
DIP	BP	GO:0035050	embryonic heart tube development	-	86	27	-	-	8.74E-03	6.87E-03
DIP	BP	GO:0030168	platelet activation	-	135	58	-	-	5.19E-02	1.47E-02
DIP	CC	GO:0098810	neurotransmitter reuptake	-	35	13	-	-	3.42E-02	3.44E-03
DIP	BP	GO:0008213	protein alkylation	-	58	12	-	-	1.49E-02	3.12E-03
DIP	BP	GO:0002253	activation of immune response	-	529	201	-	-	8.65E-02	5.03E-02
DIP	BP	GO:0031529	ruffle organization	-	55	19	-	-	2.52E-02	5.00E-03
DIP	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	16	-	-	5.45E-02	4.06E-03
DIP	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	12	-	-	1.28E-02	3.12E-03
DIP	BP	GO:0035304	regulation of protein dephosphorylation	-	87	39	-	-	4.22E-03	9.99E-03
DIP	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	90	-	-	1.38E-02	2.25E-02
DIP	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	12	-	-	7.11E-03	3.12E-03
DIP	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	146	-	-	3.55E-02	3.65E-02
DIP	BP	GO:0051785	positive regulation of nuclear division	-	61	34	-	-	1.84E-02	8.74E-03
DIP	BP	GO:0060749	mammary gland alveolus development	-	20	13	-	-	3.89E-03	3.44E-03
DIP	BP	GO:0044786	cell cycle DNA replication	-	45	30	-	-	6.82E-02	7.50E-03
DIP	BP	GO:0048145	regulation of fibroblast proliferation	-	87	51	-	-	1.97E-02	1.28E-02
DIP	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	59	-	-	7.54E-01	1.50E-02
DIP	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	117	-	-	1.78E-02	2.94E-02
DIP	BP	GO:0009306	protein secretion	-	376	117	-	-	2.14E-02	2.94E-02
DIP	CC	GO:0008333	endosome to lysosome transport	-	73	23	-	-	1.45E-01	5.93E-03
DIP	MF	GO:0043086	negative regulation of catalytic activity	-	717	232	-	-	2.35E-02	5.81E-02
DIP	BP	GO:0045732	positive regulation of protein catabolic process	-	202	106	-	-	2.50E-02	2.65E-02
DIP	BP	GO:0031589	cell-substrate adhesion	-	360	123	-	-	8.84E-02	3.09E-02
DIP	BP	GO:1904018	positive regulation of vasculature development	-	185	73	-	-	8.42E-02	1.84E-02
DIP	BP	GO:0010948	negative regulation of cell cycle process	-	317	159	-	-	5.81E-02	4.00E-02
DIP	BP	GO:0050953	sensory perception of light stimulus	-	223	29	-	-	7.63E-02	7.50E-03
DIP	BP	GO:0009303	rRNA transcription	-	37	22	-	-	9.79E-02	5.62E-03
DIP	BP	GO:0035601	protein deacylation	-	56	26	-	-	7.24E-03	6.56E-03
DIP	BP	GO:0061952	midbody abscission	-	18	13	-	-	3.45E-01	3.44E-03
DIP	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	13	-	-	5.29E-03	3.44E-03
DIP	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	19	-	-	1.22E-03	5.00E-03
DIP	BP	GO:0071300	cellular response to retinoic acid	-	66	24	-	-	1.49E-03	6.25E-03
DIP	BP	GO:0045830	positive regulation of isotype switching	-	28	19	-	-	7.86E-03	5.00E-03
DIP	BP	GO:0031069	hair follicle morphogenesis	-	33	12	-	-	2.25E-02	3.12E-03
DIP	BP	GO:0046697	decidualization	-	26	11	-	-	2.80E-03	2.81E-03
DIP	BP	GO:0048284	organelle fusion	-	456	139	-	-	1.01E-01	3.50E-02
DIP	BP	GO:0051588	regulation of neurotransmitter transport	-	99	27	-	-	3.27E-03	6.87E-03
DIP	BP	GO:0051784	negative regulation of nuclear division	-	63	39	-	-	1.34E-01	9.99E-03
DIP	BP	GO:0044703	multi-organism reproductive process	-	209	69	-	-	1.49E-02	1.75E-02
DIP	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	84	-	-	2.10E-02	2.12E-02
DIP	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	20	-	-	1.31E-01	5.00E-03
DIP	BP	GO:0099022	vesicle tethering	-	32	16	-	-	6.07E-01	4.06E-03
DIP	MF	GO:0004930	G protein-coupled receptor activity	-	873	69	-	-	8.96E-03	1.75E-02
DIP	BP	GO:0048857	neural nucleus development	-	65	24	-	-	1.79E-02	6.25E-03
DIP	BP	GO:0048663	neuron fate commitment	-	74	19	-	-	2.24E-03	5.00E-03
DIP	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	33	-	-	7.58E-03	8.43E-03
DIP	BP	GO:0106027	neuron projection organization	-	90	42	-	-	1.95E-02	1.06E-02
DIP	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	57	-	-	3.75E-02	1.44E-02
DIP	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	12	-	-	1.56E-02	3.12E-03
DIP	CC	GO:0043410	positive regulation of MAPK cascade	-	494	235	-	-	5.85E-02	5.87E-02
DIP	BP	GO:0045685	regulation of glial cell differentiation	-	77	36	-	-	3.45E-03	9.06E-03
DIP	BP	GO:0043414	macromolecule methylation	-	138	26	-	-	6.58E-02	6.56E-03
DIP	BP	GO:0050886	endocrine process	-	93	27	-	-	2.33E-02	6.87E-03
DIP	BP	GO:0045807	positive regulation of endocytosis	-	155	66	-	-	8.46E-03	1.66E-02
DIP	BP	GO:0002418	immune response to tumor cell	-	29	15	-	-	5.28E-02	3.75E-03
DIP	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	34	-	-	6.98E-03	8.74E-03
DIP	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	12	-	-	2.63E-03	3.12E-03
DIP	BP	GO:0001829	trophectodermal cell differentiation	-	19	11	-	-	1.04E-01	2.81E-03
DIP	BP	GO:0034394	protein localization to cell surface	-	69	26	-	-	6.67E-03	6.56E-03
DIP	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	17	-	-	4.88E-02	4.37E-03
DIP	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	14	-	-	3.26E-02	3.75E-03
DIP	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	57	-	-	1.93E-02	1.44E-02
DIP	MF	GO:0051100	negative regulation of binding	-	161	72	-	-	9.57E-03	1.81E-02
DIP	BP	GO:0001818	negative regulation of cytokine production	-	379	114	-	-	1.29E-02	2.87E-02
DIP	BP	GO:0003151	outflow tract morphogenesis	-	81	36	-	-	4.22E-02	9.06E-03
DIP	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	34	-	-	9.18E-03	8.74E-03
DIP	BP	GO:0055093	response to hyperoxia	-	20	11	-	-	9.11E-04	2.81E-03
DIP	BP	GO:0061036	positive regulation of cartilage development	-	33	13	-	-	2.82E-02	3.44E-03
DIP	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	20	-	-	1.03E-02	5.00E-03
DIP	BP	GO:0046621	negative regulation of organ growth	-	39	15	-	-	1.48E-02	3.75E-03
DIP	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	28	-	-	2.30E-01	7.18E-03
DIP	BP	GO:0032368	regulation of lipid transport	-	149	44	-	-	1.49E-02	1.12E-02
DIP	BP	GO:0055094	response to lipoprotein particle	-	34	16	-	-	1.23E-03	4.06E-03
DIP	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	84	-	-	1.57E-02	2.12E-02
DIP	BP	GO:0033002	muscle cell proliferation	-	249	107	-	-	3.67E-02	2.69E-02
DIP	BP	GO:0048880	sensory system development	-	399	106	-	-	2.00E-02	2.65E-02
DIP	BP	GO:0043331	response to dsRNA	-	56	25	-	-	1.07E-02	6.25E-03
DIP	BP	GO:0051904	pigment granule transport	-	23	14	-	-	9.37E-02	3.75E-03
DIP	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	24	-	-	5.07E-03	6.25E-03
DIP	BP	GO:0060479	lung cell differentiation	-	28	19	-	-	1.22E-03	5.00E-03
DIP	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	12	-	-	2.01E-01	3.12E-03
DIP	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	20	-	-	2.74E-03	5.00E-03
DIP	BP	GO:2000773	negative regulation of cellular senescence	-	25	17	-	-	3.06E-03	4.37E-03
DIP	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	24	-	-	6.53E-03	6.25E-03
DIP	BP	GO:0050820	positive regulation of coagulation	-	30	13	-	-	3.13E-02	3.44E-03
DIP	BP	GO:0072164	mesonephric tubule development	-	98	37	-	-	8.13E-03	9.37E-03
DIP	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	57	-	-	2.88E-02	1.44E-02
DIP	BP	GO:0030901	midbrain development	-	87	32	-	-	2.03E-02	8.12E-03
DIP	BP	GO:0048485	sympathetic nervous system development	-	22	11	-	-	9.22E-04	2.81E-03
DIP	BP	GO:0007162	negative regulation of cell adhesion	-	310	112	-	-	1.77E-02	2.81E-02
DIP	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	38	-	-	1.15E-02	9.68E-03
DIP	BP	GO:0002687	positive regulation of leukocyte migration	-	147	78	-	-	4.21E-02	1.97E-02
DIP	BP	GO:0034605	cellular response to heat	-	66	33	-	-	3.80E-03	8.43E-03
DIP	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	123	-	-	5.48E-02	3.09E-02
DIP	BP	GO:0005996	monosaccharide metabolic process	-	250	69	-	-	2.92E-02	1.75E-02
DIP	BP	GO:0033555	multicellular organismal response to stress	-	90	22	-	-	2.07E-02	5.62E-03
DIP	BP	GO:0002262	myeloid cell homeostasis	-	172	80	-	-	2.08E-02	2.00E-02
DIP	BP	GO:0050688	regulation of defense response to virus	-	65	30	-	-	3.58E-02	7.50E-03
DIP	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	122	-	-	3.55E-02	3.06E-02
DIP	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	129	-	-	3.50E-02	3.25E-02
DIP	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	18	-	-	1.05E-02	4.68E-03
DIP	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	17	-	-	1.23E-03	4.37E-03
DIP	BP	GO:0003272	endocardial cushion formation	-	28	14	-	-	5.28E-02	3.75E-03
DIP	BP	GO:0022618	protein-RNA complex assembly	-	227	81	-	-	2.76E-01	2.03E-02
DIP	BP	GO:0051147	regulation of muscle cell differentiation	-	162	62	-	-	3.08E-02	1.56E-02
DIP	BP	GO:0006066	alcohol metabolic process	-	374	58	-	-	1.04E-01	1.47E-02
DIP	BP	GO:0090102	cochlea development	-	50	15	-	-	1.23E-03	3.75E-03
DIP	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	16	-	-	9.02E-02	4.06E-03
DIP	BP	GO:0045933	positive regulation of muscle contraction	-	49	15	-	-	1.24E-03	3.75E-03
DIP	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	16	-	-	3.65E-03	4.06E-03
DIP	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	16	-	-	7.61E-02	4.06E-03
DIP	BP	GO:0043555	regulation of translation in response to stress	-	22	11	-	-	2.71E-02	2.81E-03
DIP	BP	GO:0032922	circadian regulation of gene expression	-	71	52	-	-	7.14E-02	1.31E-02
DIP	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	17	-	-	1.91E-02	4.37E-03
DIP	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	15	-	-	4.89E-03	3.75E-03
DIP	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	26	-	-	1.34E-02	6.56E-03
DIP	BP	GO:0038179	neurotrophin signaling pathway	-	38	20	-	-	1.52E-01	5.00E-03
DIP	BP	GO:0140253	cell-cell fusion	-	62	19	-	-	3.05E-02	5.00E-03
DIP	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	12	-	-	6.12E-02	3.12E-03
DIP	BP	GO:0051293	establishment of spindle localization	-	57	28	-	-	7.01E-03	7.18E-03
DIP	BP	GO:0023061	signal release	-	491	147	-	-	5.18E-02	3.69E-02
DIP	BP	GO:0043114	regulation of vascular permeability	-	49	18	-	-	4.78E-03	4.68E-03
DIP	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	26	-	-	1.24E-02	6.56E-03
DIP	BP	GO:0008360	regulation of cell shape	-	139	44	-	-	1.13E-02	1.12E-02
DIP	BP	GO:0051222	positive regulation of protein transport	-	249	104	-	-	2.97E-02	2.62E-02
DIP	CC	GO:0140632	canonical inflammasome complex assembly	-	40	19	-	-	9.50E-02	5.00E-03
DIP	MF	GO:0034260	negative regulation of GTPase activity	-	36	13	-	-	7.48E-03	3.44E-03
DIP	BP	GO:0045932	negative regulation of muscle contraction	-	24	11	-	-	3.90E-02	2.81E-03
DIP	BP	GO:0045739	positive regulation of DNA repair	-	128	66	-	-	1.15E-01	1.66E-02
DIP	BP	GO:0045185	maintenance of protein location	-	95	45	-	-	1.00E-02	1.12E-02
DIP	BP	GO:0003158	endothelium development	-	140	48	-	-	4.69E-02	1.22E-02
DIP	CC	GO:0072595	maintenance of protein localization in organelle	-	42	22	-	-	1.26E-02	5.62E-03
DIP	BP	GO:0051224	negative regulation of protein transport	-	122	36	-	-	9.45E-03	9.06E-03
DIP	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	55	-	-	7.13E-03	1.37E-02
DIP	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	15	-	-	4.48E-02	3.75E-03
DIP	MF	GO:0003713	transcription coactivator activity	-	281	134	-	-	3.06E-02	3.37E-02
DIP	BP	GO:0021885	forebrain cell migration	-	63	25	-	-	1.40E-02	6.25E-03
DIP	BP	GO:0007405	neuroblast proliferation	-	81	31	-	-	1.15E-02	7.81E-03
DIP	BP	GO:0009581	detection of external stimulus	-	137	25	-	-	2.42E-02	6.25E-03
DIP	BP	GO:1990542	mitochondrial transmembrane transport	-	93	13	-	-	1.91E-01	3.44E-03
DIP	BP	GO:0045862	positive regulation of proteolysis	-	353	170	-	-	2.89E-02	4.25E-02
DIP	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	14	-	-	2.02E-02	3.75E-03
DIP	BP	GO:0031128	developmental induction	-	26	11	-	-	4.75E-03	2.81E-03
DIP	BP	GO:0031100	animal organ regeneration	-	66	32	-	-	5.37E-03	8.12E-03
DIP	BP	GO:0045684	positive regulation of epidermis development	-	33	14	-	-	1.52E-02	3.75E-03
DIP	BP	GO:1900047	negative regulation of hemostasis	-	51	19	-	-	3.74E-01	5.00E-03
DIP	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	47	-	-	4.88E-02	1.19E-02
DIP	BP	GO:0030001	metal ion transport	-	933	215	-	-	1.01E-01	5.37E-02
DIP	BP	GO:0042490	mechanoreceptor differentiation	-	67	18	-	-	2.14E-01	4.68E-03
DIP	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	11	-	-	2.55E-03	2.81E-03
DIP	BP	GO:0035148	tube formation	-	155	61	-	-	6.89E-03	1.53E-02
DIP	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	28	-	-	1.05E-01	7.18E-03
DIP	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	32	-	-	1.64E-02	8.12E-03
DIP	BP	GO:0031123	RNA 3'-end processing	-	79	37	-	-	2.73E-01	9.37E-03
DIP	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	38	-	-	1.05E-02	9.68E-03
DIP	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	13	-	-	1.13E-01	3.44E-03
DIP	CC	GO:0007097	nuclear migration	-	24	12	-	-	8.01E-02	3.12E-03
DIP	BP	GO:0045229	external encapsulating structure organization	-	319	57	-	-	1.72E-02	1.44E-02
DIP	BP	GO:0006885	regulation of pH	-	104	13	-	-	1.15E-02	3.44E-03
DIP	BP	GO:0001667	ameboidal-type cell migration	-	495	190	-	-	3.04E-02	4.75E-02
DIP	BP	GO:1990840	response to lectin	-	22	11	-	-	1.53E-02	2.81E-03
DIP	BP	GO:0031018	endocrine pancreas development	-	47	20	-	-	5.62E-02	5.00E-03
DIP	BP	GO:0001708	cell fate specification	-	108	42	-	-	4.83E-02	1.06E-02
DIP	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	37	-	-	3.59E-03	9.37E-03
DIP	BP	GO:0030279	negative regulation of ossification	-	39	16	-	-	3.12E-02	4.06E-03
DIP	BP	GO:0032970	regulation of actin filament-based process	-	368	132	-	-	3.95E-02	3.31E-02
DIP	BP	GO:0062197	cellular response to chemical stress	-	299	127	-	-	2.24E-02	3.19E-02
DIP	BP	GO:1901890	positive regulation of cell junction assembly	-	106	26	-	-	5.60E-03	6.56E-03
DIP	BP	GO:1901655	cellular response to ketone	-	107	46	-	-	1.12E-02	1.16E-02
DIP	MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	-	925	126	-	-	1.01E-01	3.15E-02
DIP	BP	GO:0006968	cellular defense response	-	52	22	-	-	7.19E-03	5.62E-03
DIP	BP	GO:0055006	cardiac cell development	-	93	37	-	-	2.22E-02	9.37E-03
DIP	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	11	-	-	3.89E-03	2.81E-03
DIP	BP	GO:0060004	reflex	-	63	21	-	-	1.50E-02	5.31E-03
DIP	BP	GO:0044706	multi-multicellular organism process	-	217	69	-	-	1.43E-02	1.75E-02
DIP	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	83	-	-	1.97E-02	2.09E-02
DIP	BP	GO:0031294	lymphocyte costimulation	-	47	31	-	-	8.43E-02	7.81E-03
DIP	BP	GO:0050768	negative regulation of neurogenesis	-	150	51	-	-	6.11E-03	1.28E-02
DIP	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	50	-	-	3.50E-02	1.25E-02
DIP	BP	GO:0090068	positive regulation of cell cycle process	-	262	130	-	-	5.56E-02	3.25E-02
DIP	MF	GO:0022803	passive transmembrane transporter activity	-	676	117	-	-	8.53E-02	2.94E-02
DIP	BP	GO:1902115	regulation of organelle assembly	-	210	93	-	-	2.27E-02	2.34E-02
DIP	BP	GO:0006397	mRNA processing	-	482	151	-	-	3.32E-01	3.78E-02
DIP	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	31	-	-	2.29E-02	7.81E-03
DIP	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	48	-	-	1.04E-02	1.22E-02
DIP	BP	GO:0046622	positive regulation of organ growth	-	52	20	-	-	1.12E-02	5.00E-03
DIP	BP	GO:0051952	regulation of amine transport	-	98	28	-	-	9.77E-03	7.18E-03
DIP	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	27	-	-	1.24E-02	6.87E-03
DIP	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	49	-	-	4.08E-02	1.25E-02
DIP	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	12	-	-	3.27E-03	3.12E-03
DIP	MF	GO:0140537	transcription regulator activator activity	-	13	11	-	-	5.83E-03	2.81E-03
DIP	BP	GO:0071398	cellular response to fatty acid	-	35	12	-	-	9.09E-04	3.12E-03
DIP	BP	GO:0097581	lamellipodium organization	-	91	45	-	-	2.65E-02	1.12E-02
DIP	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	22	-	-	2.47E-02	5.62E-03
DIP	BP	GO:0060326	cell chemotaxis	-	311	132	-	-	8.60E-02	3.31E-02
DIP	BP	GO:0016485	protein processing	-	248	68	-	-	5.09E-02	1.72E-02
DIP	BP	GO:0009649	entrainment of circadian clock	-	30	15	-	-	2.94E-02	3.75E-03
DIP	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	38	-	-	3.13E-02	9.68E-03
DIP	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	18	-	-	6.68E-02	4.68E-03
DIP	BP	GO:0099054	presynapse assembly	-	49	17	-	-	1.24E-03	4.37E-03
DIP	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	14	-	-	1.45E-02	3.75E-03
DIP	BP	GO:0031348	negative regulation of defense response	-	282	102	-	-	1.06E-02	2.56E-02
DIP	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	35	-	-	7.53E-03	8.74E-03
DIP	BP	GO:0061180	mammary gland epithelium development	-	68	41	-	-	9.12E-03	1.03E-02
DIP	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	56	-	-	4.70E-02	1.41E-02
DIP	CC	GO:0051169	nuclear transport	-	325	143	-	-	3.53E-02	3.59E-02
DIP	BP	GO:0071496	cellular response to external stimulus	-	74	43	-	-	7.78E-03	1.09E-02
DIP	BP	GO:0032094	response to food	-	37	11	-	-	1.42E-02	2.81E-03
DIP	BP	GO:0001964	startle response	-	27	11	-	-	9.32E-04	2.81E-03
DIP	BP	GO:0046434	organophosphate catabolic process	-	232	55	-	-	1.76E-02	1.37E-02
DIP	BP	GO:0060037	pharyngeal system development	-	29	15	-	-	2.34E-01	3.75E-03
DIP	BP	GO:0009566	fertilization	-	205	35	-	-	4.47E-02	8.74E-03
DIP	BP	GO:0045907	positive regulation of vasoconstriction	-	30	12	-	-	2.20E-01	3.12E-03
DIP	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	11	-	-	1.52E-01	2.81E-03
DIP	BP	GO:0033044	regulation of chromosome organization	-	249	155	-	-	1.90E-01	3.87E-02
DIP	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	140	-	-	1.24E-02	3.50E-02
DIP	BP	GO:0061900	glial cell activation	-	56	28	-	-	1.05E-02	7.18E-03
DIP	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	72	-	-	4.97E-02	1.81E-02
DIP	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	122	-	-	9.94E-02	3.06E-02
DIP	CC	GO:0140467	integrated stress response signaling	-	41	20	-	-	9.17E-02	5.00E-03
DIP	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	56	-	-	3.51E-02	1.41E-02
DIP	BP	GO:0090235	regulation of metaphase plate congression	-	13	12	-	-	1.85E-01	3.12E-03
DIP	BP	GO:0016180	snRNA processing	-	28	14	-	-	3.84E-01	3.75E-03
DIP	BP	GO:0051303	establishment of chromosome localization	-	104	57	-	-	9.43E-02	1.44E-02
DIP	BP	GO:0031349	positive regulation of defense response	-	473	202	-	-	6.58E-02	5.06E-02
DIP	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	16	-	-	7.85E-03	4.06E-03
DIP	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	12	-	-	9.32E-04	3.12E-03
DIP	BP	GO:0006605	protein targeting	-	327	97	-	-	2.64E-02	2.44E-02
DIP	BP	GO:0007566	embryo implantation	-	57	24	-	-	1.52E-03	6.25E-03
DIP	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	17	-	-	1.33E-02	4.37E-03
DIP	BP	GO:0061512	protein localization to cilium	-	394	75	-	-	1.38E-01	1.87E-02
DIP	BP	GO:0060306	regulation of membrane repolarization	-	38	13	-	-	1.40E-02	3.44E-03
DIP	BP	GO:0051017	actin filament bundle assembly	-	161	56	-	-	1.37E-02	1.41E-02
DIP	BP	GO:1905953	negative regulation of lipid localization	-	63	21	-	-	1.11E-02	5.31E-03
DIP	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	22	-	-	8.81E-02	5.62E-03
DIP	BP	GO:0021756	striatum development	-	21	12	-	-	7.77E-02	3.12E-03
DIP	BP	GO:1901343	negative regulation of vasculature development	-	154	41	-	-	3.67E-03	1.03E-02
DIP	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	49	-	-	2.71E-01	1.25E-02
DIP	BP	GO:1902414	protein localization to cell junction	-	107	39	-	-	6.55E-03	9.99E-03
DIP	BP	GO:0051304	chromosome separation	-	80	55	-	-	1.82E-01	1.37E-02
DIP	BP	GO:0090596	sensory organ morphogenesis	-	272	69	-	-	2.19E-02	1.75E-02
DIP	BP	GO:0048709	oligodendrocyte differentiation	-	101	32	-	-	2.16E-02	8.12E-03
DIP	BP	GO:0045017	glycerolipid biosynthetic process	-	254	41	-	-	7.65E-02	1.03E-02
DIP	BP	GO:0001776	leukocyte homeostasis	-	108	49	-	-	2.54E-02	1.25E-02
DIP	BP	GO:0050769	positive regulation of neurogenesis	-	240	105	-	-	1.26E-02	2.62E-02
DIP	BP	GO:0030193	regulation of blood coagulation	-	70	28	-	-	1.06E-01	7.18E-03
DIP	BP	GO:0050866	negative regulation of cell activation	-	216	88	-	-	2.03E-02	2.22E-02
DIP	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	15	-	-	8.36E-03	3.75E-03
DIP	BP	GO:0033500	carbohydrate homeostasis	-	251	82	-	-	1.80E-02	2.06E-02
DIP	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	12	-	-	4.05E-02	3.12E-03
DIP	BP	GO:0120035	regulation of plasma membrane bounded cell projection organization	-	647	235	-	-	4.71E-02	5.87E-02
DIP	BP	GO:0044088	regulation of vacuole organization	-	56	19	-	-	3.89E-03	5.00E-03
DIP	CC	GO:0051457	maintenance of protein location in nucleus	-	23	14	-	-	2.58E-02	3.75E-03
DIP	CC	GO:0000791	euchromatin	-	60	33	-	-	1.15E-02	8.43E-03
DIP	CC	GO:0030666	endocytic vesicle membrane	-	196	77	-	-	1.68E-02	1.94E-02
DIP	CC	GO:0098857	membrane microdomain	-	324	133	-	-	4.78E-02	3.34E-02
DIP	CC	GO:0030312	external encapsulating structure	-	567	93	-	-	6.55E-02	2.34E-02
DIP	CC	GO:0043204	perikaryon	-	156	31	-	-	6.93E-03	7.81E-03
DIP	CC	GO:1905368	peptidase complex	-	124	58	-	-	2.62E-01	1.47E-02
DIP	CC	GO:0000792	heterochromatin	-	98	53	-	-	4.60E-02	1.34E-02
DIP	CC	GO:0097546	ciliary base	-	47	11	-	-	8.69E-02	2.81E-03
DIP	CC	GO:0071819	DUBm complex	-	25	11	-	-	2.41E-01	2.81E-03
DIP	CC	GO:0031201	SNARE complex	-	48	20	-	-	4.90E-01	5.00E-03
DIP	CC	GO:0016324	apical plasma membrane	-	392	67	-	-	1.58E-02	1.69E-02
DIP	CC	GO:0033260	nuclear DNA replication	-	40	28	-	-	4.77E-02	7.18E-03
DIP	CC	GO:0044391	ribosomal subunit	-	203	52	-	-	5.03E-01	1.31E-02
DIP	CC	GO:0071013	catalytic step 2 spliceosome	-	88	46	-	-	1.69E-01	1.16E-02
DIP	CC	GO:0098862	cluster of actin-based cell projections	-	162	22	-	-	1.66E-02	5.62E-03
DIP	CC	GO:0098978	glutamatergic synapse	-	411	142	-	-	3.24E-02	3.56E-02
DIP	CC	GO:0016363	nuclear matrix	-	127	69	-	-	6.75E-02	1.75E-02
DIP	CC	GO:0031261	DNA replication preinitiation complex	-	46	28	-	-	4.49E-01	7.18E-03
DIP	CC	GO:0031966	mitochondrial membrane	-	746	109	-	-	9.06E-02	2.75E-02
DIP	CC	GO:0097060	synaptic membrane	-	413	90	-	-	5.51E-02	2.25E-02
DIP	CC	GO:0032432	actin filament bundle	-	249	53	-	-	5.74E-03	1.34E-02
DIP	CC	GO:0008088	axo-dendritic transport	-	78	27	-	-	1.44E-02	6.87E-03
DIP	CC	GO:0031519	PcG protein complex	-	38	30	-	-	2.00E-01	7.50E-03
DIP	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	60	-	-	1.04E-02	1.50E-02
DIP	CC	GO:0000313	organellar ribosome	-	89	11	-	-	7.34E-01	2.81E-03
DIP	CC	GO:0098791	Golgi apparatus subcompartment	-	378	60	-	-	7.20E-02	1.50E-02
DIP	CC	GO:0099643	signal release from synapse	-	147	31	-	-	1.19E-01	7.81E-03
DIP	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	18	-	-	3.13E-01	4.68E-03
DIP	CC	GO:0030018	Z disc	-	129	50	-	-	4.36E-02	1.25E-02
DIP	CC	GO:0005814	centriole	-	692	234	-	-	1.03E-01	5.87E-02
DIP	CC	GO:1905360	GTPase complex	-	41	11	-	-	3.68E-01	2.81E-03
DIP	CC	GO:0097540	axonemal central pair	-	161	18	-	-	2.79E-02	4.68E-03
DIP	CC	GO:0042641	actomyosin	-	77	23	-	-	4.45E-03	5.93E-03
DIP	CC	GO:0097386	glial cell projection	-	38	11	-	-	6.87E-03	2.81E-03
DIP	CC	GO:0032588	trans-Golgi network membrane	-	102	21	-	-	2.36E-01	5.31E-03
DIP	CC	GO:0070382	exocytic vesicle	-	224	48	-	-	2.50E-02	1.22E-02
DIP	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	105	-	-	1.17E-01	2.62E-02
DIP	CC	GO:0070993	translation preinitiation complex	-	19	16	-	-	9.33E-01	4.06E-03
DIP	CC	GO:0016323	basolateral plasma membrane	-	239	51	-	-	1.10E-02	1.28E-02
DIP	CC	GO:1902495	transmembrane transporter complex	-	408	52	-	-	1.23E-01	1.31E-02
DIP	CC	GO:0098636	protein complex involved in cell adhesion	-	57	23	-	-	1.73E-01	5.93E-03
DIP	CC	GO:0001917	photoreceptor inner segment	-	71	13	-	-	3.30E-02	3.44E-03
DIP	CC	GO:0019897	extrinsic component of plasma membrane	-	156	54	-	-	4.04E-02	1.37E-02
DIP	CC	GO:0031594	neuromuscular junction	-	73	25	-	-	3.78E-02	6.25E-03
DIP	CC	GO:0000793	condensed chromosome	-	274	134	-	-	9.74E-02	3.37E-02
DIP	CC	GO:0000922	spindle pole	-	172	70	-	-	3.41E-02	1.75E-02
DIP	CC	GO:0120111	neuron projection cytoplasm	-	94	34	-	-	1.48E-02	8.74E-03
DIP	CC	GO:0005736	RNA polymerase I complex	-	13	11	-	-	1.01E-01	2.81E-03
DIP	CC	GO:0004879	nuclear receptor activity	-	63	32	-	-	1.98E-02	8.12E-03
DIP	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	67	-	-	4.58E-02	1.69E-02
DIP	CC	GO:0000123	histone acetyltransferase complex	-	93	33	-	-	4.29E-02	8.43E-03
DIP	CC	GO:0048786	presynaptic active zone	-	80	14	-	-	5.03E-03	3.75E-03
DIP	CC	GO:0007034	vacuolar transport	-	168	57	-	-	8.29E-02	1.44E-02
DIP	CC	GO:0005776	autophagosome	-	111	45	-	-	3.03E-02	1.12E-02
DIP	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	54	-	-	5.95E-01	1.37E-02
DIP	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	13	-	-	6.96E-02	3.44E-03
DIP	CC	GO:0150034	distal axon	-	309	95	-	-	1.96E-02	2.37E-02
DIP	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	60	-	-	2.91E-01	1.50E-02
DIP	CC	GO:0072562	blood microparticle	-	144	40	-	-	1.00E-01	9.99E-03
DIP	CC	GO:0051233	spindle midzone	-	36	19	-	-	5.07E-02	5.00E-03
DIP	CC	GO:0005811	lipid droplet	-	102	16	-	-	1.99E-02	4.06E-03
DIP	CC	GO:0045022	early endosome to late endosome transport	-	44	19	-	-	5.57E-02	5.00E-03
DIP	CC	GO:0043113	receptor clustering	-	51	15	-	-	1.23E-03	3.75E-03
DIP	CC	GO:0044853	plasma membrane raft	-	114	53	-	-	7.20E-02	1.34E-02
DIP	CC	GO:0005881	cytoplasmic microtubule	-	256	34	-	-	1.57E-02	8.74E-03
DIP	CC	GO:0008180	COP9 signalosome	-	17	12	-	-	2.18E-01	3.12E-03
DIP	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	11	-	-	3.10E-01	2.81E-03
DIP	CC	GO:0005905	clathrin-coated pit	-	73	26	-	-	4.47E-03	6.56E-03
DIP	CC	GO:0031904	endosome lumen	-	38	13	-	-	9.30E-04	3.44E-03
DIP	CC	GO:0060170	ciliary membrane	-	76	19	-	-	1.30E-01	5.00E-03
DIP	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	2.65E-01	3.12E-03
DIP	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	14	-	-	9.00E-01	3.75E-03
DIP	CC	GO:0000139	Golgi membrane	-	646	111	-	-	4.20E-02	2.78E-02
DIP	CC	GO:0032154	cleavage furrow	-	54	18	-	-	3.07E-02	4.68E-03
DIP	CC	GO:0007006	mitochondrial membrane organization	-	117	32	-	-	3.44E-02	8.12E-03
DIP	CC	GO:0001772	immunological synapse	-	44	20	-	-	6.07E-02	5.00E-03
DIP	CC	GO:0009897	external side of plasma membrane	-	425	136	-	-	6.10E-02	3.40E-02
DIP	CC	GO:0030863	cortical cytoskeleton	-	104	33	-	-	9.92E-02	8.43E-03
DIP	CC	GO:1905348	endonuclease complex	-	38	14	-	-	1.48E-01	3.75E-03
DIP	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	4.47E-02	4.68E-03
DIP	CC	GO:0030315	T-tubule	-	52	17	-	-	6.63E-02	4.37E-03
DIP	CC	GO:0060076	excitatory synapse	-	64	16	-	-	3.63E-02	4.06E-03
DIP	CC	GO:0099086	synaptonemal structure	-	40	11	-	-	2.74E-02	2.81E-03
DIP	CC	GO:0030427	site of polarized growth	-	172	67	-	-	1.07E-02	1.69E-02
DIP	CC	GO:0044309	neuron spine	-	213	67	-	-	2.40E-02	1.69E-02
DIP	CC	GO:0030658	transport vesicle membrane	-	231	47	-	-	1.02E-01	1.19E-02
DIP	CC	GO:0034719	SMN-Sm protein complex	-	18	13	-	-	5.52E-01	3.44E-03
DIP	CC	GO:0044232	organelle membrane contact site	-	50	11	-	-	1.28E-01	2.81E-03
DIP	CC	GO:0030667	secretory granule membrane	-	319	70	-	-	2.15E-02	1.75E-02
DIP	CC	GO:0097545	axonemal outer doublet	-	164	18	-	-	2.12E-02	4.68E-03
DIP	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	14	-	-	4.03E-01	3.75E-03
DIP	CC	GO:0055037	recycling endosome	-	200	53	-	-	5.01E-02	1.34E-02
DIP	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	32	-	-	2.13E-03	8.12E-03
DIP	CC	GO:0071682	endocytic vesicle lumen	-	23	12	-	-	9.25E-04	3.12E-03
DIP	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	116	-	-	1.91E-02	2.90E-02
DIP	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	13	-	-	8.20E-02	3.44E-03
DIP	CC	GO:1990391	DNA repair complex	-	22	17	-	-	7.44E-02	4.37E-03
DIP	CC	GO:0005775	vacuolar lumen	-	176	37	-	-	5.72E-02	9.37E-03
DIP	CC	GO:0044306	neuron projection terminus	-	164	44	-	-	2.61E-02	1.12E-02
DIP	CC	GO:0005770	late endosome	-	299	88	-	-	1.00E-01	2.22E-02
DIP	CC	GO:0031970	organelle envelope lumen	-	94	23	-	-	1.72E-02	5.93E-03
DIP	CC	GO:0019866	organelle inner membrane	-	546	59	-	-	2.04E-01	1.50E-02
DIP	CC	GO:0098687	chromosomal region	-	397	233	-	-	1.10E-01	5.84E-02
DIP	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	12	-	-	1.13E-02	3.12E-03
DIP	CC	GO:0043292	contractile muscle fiber	-	245	71	-	-	3.70E-02	1.78E-02
DIP	CC	GO:0034709	methylosome	-	13	12	-	-	2.27E-01	3.12E-03
DIP	CC	GO:0000803	sex chromosome	-	32	19	-	-	2.29E-02	5.00E-03
DIP	CC	GO:0098982	GABA-ergic synapse	-	84	14	-	-	5.21E-03	3.75E-03
DIP	CC	GO:0035097	histone methyltransferase complex	-	63	44	-	-	1.91E-01	1.12E-02
DIP	CC	GO:0000323	lytic vacuole	-	749	182	-	-	1.15E-01	4.56E-02
DIP	CC	GO:0000242	pericentriolar material	-	22	12	-	-	2.55E-02	3.12E-03
DIP	CC	GO:1903293	phosphatase complex	-	54	21	-	-	1.70E-01	5.31E-03
DIP	CC	GO:0000786	nucleosome	-	149	81	-	-	1.52E-01	2.03E-02
DIP	CC	GO:1904724	tertiary granule lumen	-	55	13	-	-	1.44E-02	3.44E-03
DIP	CC	GO:0030027	lamellipodium	-	202	87	-	-	3.19E-02	2.19E-02
DIP	CC	GO:0090543	Flemming body	-	33	18	-	-	1.08E-01	4.68E-03
DIP	CC	GO:0016328	lateral plasma membrane	-	66	29	-	-	2.08E-02	7.50E-03
DIP	CC	GO:0001650	fibrillar center	-	151	56	-	-	2.60E-02	1.41E-02
DIP	CC	GO:0031332	RNAi effector complex	-	413	13	-	-	1.18E-01	3.44E-03
DIP	CC	GO:1990204	oxidoreductase complex	-	90	21	-	-	1.83E-01	5.31E-03
DIP	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	51	-	-	2.94E-02	1.28E-02
DIP	CC	GO:0001726	ruffle	-	181	77	-	-	2.56E-02	1.94E-02
DIP	CC	GO:0043198	dendritic shaft	-	38	14	-	-	1.25E-02	3.75E-03
DIP	CC	GO:0043073	germ cell nucleus	-	67	34	-	-	9.67E-03	8.74E-03
DIP	CC	GO:0005788	endoplasmic reticulum lumen	-	313	75	-	-	4.00E-02	1.87E-02
DIP	CC	GO:0016592	mediator complex	-	38	21	-	-	6.83E-01	5.31E-03
DIP	CC	GO:0022626	cytosolic ribosome	-	118	41	-	-	4.35E-01	1.03E-02
DIP	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	41	-	-	3.90E-01	1.03E-02
DIP	CC	GO:0034451	centriolar satellite	-	120	43	-	-	9.02E-02	1.09E-02
DIP	CC	GO:0045171	intercellular bridge	-	91	25	-	-	1.84E-03	6.25E-03
DIP	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	18	-	-	1.08E-01	4.68E-03
DIP	CC	GO:0098984	neuron to neuron synapse	-	384	113	-	-	1.78E-02	2.84E-02
DIP	CC	GO:0030527	structural constituent of chromatin	-	97	60	-	-	1.79E-01	1.50E-02
DIP	CC	GO:0030286	dynein complex	-	210	28	-	-	1.85E-02	7.18E-03
DIP	CC	GO:0016482	cytosolic transport	-	135	35	-	-	2.02E-01	8.74E-03
DIP	CC	GO:0005796	Golgi lumen	-	106	27	-	-	4.81E-02	6.87E-03
DIP	CC	GO:0008023	transcription elongation factor complex	-	47	24	-	-	2.65E-01	6.25E-03
DIP	CC	GO:0030662	coated vesicle membrane	-	202	64	-	-	7.46E-02	1.62E-02
DIP	CC	GO:0007039	protein catabolic process in the vacuole	-	61	24	-	-	1.81E-01	6.25E-03
DIP	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	142	-	-	2.13E-01	3.56E-02
DIP	CC	GO:0005769	early endosome	-	425	115	-	-	3.15E-02	2.87E-02
DIP	CC	GO:0090734	site of DNA damage	-	118	64	-	-	5.23E-02	1.62E-02
DIP	MF	GO:0051087	protein-folding chaperone binding	-	135	51	-	-	7.83E-03	1.28E-02
DIP	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	19	-	-	4.61E-03	5.00E-03
DIP	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	57	-	-	1.03E-01	1.44E-02
DIP	MF	GO:0016757	glycosyltransferase activity	-	286	17	-	-	1.76E-02	4.37E-03
DIP	MF	GO:0048306	calcium-dependent protein binding	-	61	21	-	-	5.23E-02	5.31E-03
DIP	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	19	-	-	4.87E-02	5.00E-03
DIP	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	26	-	-	1.72E-02	6.56E-03
DIP	MF	GO:0051020	GTPase binding	-	311	104	-	-	2.47E-02	2.62E-02
DIP	MF	GO:0140457	protein demethylase activity	-	31	15	-	-	5.36E-03	3.75E-03
DIP	MF	GO:0005158	insulin receptor binding	-	22	14	-	-	3.22E-02	3.75E-03
DIP	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	13	-	-	2.91E-02	3.44E-03
DIP	MF	GO:0061980	regulatory RNA binding	-	52	21	-	-	2.34E-02	5.31E-03
DIP	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	208	-	-	6.87E-02	5.22E-02
DIP	MF	GO:0070840	dynein complex binding	-	25	11	-	-	9.30E-04	2.81E-03
DIP	MF	GO:0003688	DNA replication origin binding	-	18	14	-	-	3.41E-01	3.75E-03
DIP	MF	GO:0005178	integrin binding	-	153	58	-	-	4.29E-02	1.47E-02
DIP	MF	GO:0070064	proline-rich region binding	-	17	11	-	-	9.18E-04	2.81E-03
DIP	MF	GO:0008233	peptidase activity	-	998	224	-	-	5.62E-02	5.62E-02
DIP	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	1.86E-02	4.37E-03
DIP	MF	GO:0000217	DNA secondary structure binding	-	37	26	-	-	4.87E-02	6.56E-03
DIP	MF	GO:0002039	p53 binding	-	66	44	-	-	3.94E-02	1.12E-02
DIP	MF	GO:0005496	steroid binding	-	110	24	-	-	3.27E-02	6.25E-03
DIP	MF	GO:0003684	damaged DNA binding	-	89	57	-	-	4.50E-02	1.44E-02
DIP	MF	GO:0000339	RNA cap binding	-	20	12	-	-	9.27E-02	3.12E-03
DIP	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	67	-	-	9.62E-02	1.69E-02
DIP	MF	GO:0070063	RNA polymerase binding	-	61	32	-	-	3.45E-02	8.12E-03
DIP	MF	GO:0030971	receptor tyrosine kinase binding	-	76	28	-	-	1.24E-02	7.18E-03
DIP	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	28	-	-	5.58E-01	7.18E-03
DIP	MF	GO:0140030	modification-dependent protein binding	-	179	83	-	-	1.76E-02	2.09E-02
DIP	MF	GO:0030276	clathrin binding	-	70	16	-	-	2.13E-02	4.06E-03
DIP	MF	GO:0003712	transcription coregulator activity	-	499	220	-	-	6.38E-02	5.50E-02
DIP	MF	GO:0046875	ephrin receptor binding	-	29	22	-	-	1.55E-01	5.62E-03
DIP	MF	GO:0106310	protein serine kinase activity	-	362	132	-	-	3.23E-02	3.31E-02
DIP	MF	GO:0016788	"hydrolase activity, acting on ester bonds"	-	936	225	-	-	3.33E-02	5.62E-02
DIP	MF	GO:0030552	cAMP binding	-	48	18	-	-	1.91E-02	4.68E-03
DIP	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	14	-	-	5.09E-02	3.75E-03
DIP	MF	GO:0004857	enzyme inhibitor activity	-	395	93	-	-	8.93E-03	2.34E-02
DIP	MF	GO:0035173	histone kinase activity	-	17	11	-	-	1.49E-02	2.81E-03
DIP	MF	GO:0016209	antioxidant activity	-	92	19	-	-	1.70E-02	5.00E-03
DIP	MF	GO:0070325	lipoprotein particle receptor binding	-	32	11	-	-	9.32E-04	2.81E-03
DIP	MF	GO:0044325	transmembrane transporter binding	-	159	71	-	-	5.11E-02	1.78E-02
DIP	MF	GO:0048156	tau protein binding	-	43	27	-	-	2.34E-02	6.87E-03
DIP	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	19	-	-	1.44E-02	5.00E-03
DIP	MF	GO:0140272	exogenous protein binding	-	79	38	-	-	1.92E-02	9.68E-03
DIP	MF	GO:0030145	manganese ion binding	-	65	14	-	-	4.86E-03	3.75E-03
DIP	MF	GO:0071814	protein-lipid complex binding	-	52	14	-	-	7.64E-02	3.75E-03
DIP	MF	GO:0008066	glutamate receptor activity	-	70	17	-	-	1.34E-01	4.37E-03
DIP	MF	GO:0017069	snRNA binding	-	54	21	-	-	1.72E-01	5.31E-03
DIP	MF	GO:0008270	zinc ion binding	-	821	183	-	-	3.27E-02	4.59E-02
DIP	MF	GO:0031369	translation initiation factor binding	-	32	13	-	-	6.42E-02	3.44E-03
DIP	MF	GO:0019843	rRNA binding	-	69	16	-	-	8.24E-02	4.06E-03
DIP	MF	GO:0004713	protein tyrosine kinase activity	-	213	100	-	-	2.33E-02	2.50E-02
DIP	MF	GO:0016779	nucleotidyltransferase activity	-	264	117	-	-	8.64E-02	2.94E-02
DIP	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	23	-	-	2.33E-02	5.93E-03
DIP	MF	GO:0008093	cytoskeletal anchor activity	-	24	11	-	-	9.26E-04	2.81E-03
DIP	MF	GO:0000287	magnesium ion binding	-	225	56	-	-	1.24E-02	1.41E-02
DIP	MF	GO:0031490	chromatin DNA binding	-	120	70	-	-	3.15E-02	1.75E-02
DIP	MF	GO:0017022	myosin binding	-	73	21	-	-	2.70E-02	5.31E-03
DIP	MF	GO:0004896	cytokine receptor activity	-	93	64	-	-	6.40E-03	1.62E-02
DIP	MF	GO:0015631	tubulin binding	-	410	130	-	-	3.51E-02	3.25E-02
DIP	MF	GO:0005539	glycosaminoglycan binding	-	236	62	-	-	5.24E-02	1.56E-02
DIP	MF	GO:0019207	kinase regulator activity	-	267	118	-	-	2.21E-02	2.97E-02
DIP	MF	GO:0044183	protein folding chaperone	-	67	28	-	-	3.25E-02	7.18E-03
DIP	MF	GO:0008047	enzyme activator activity	-	697	224	-	-	2.93E-02	5.62E-02
DIP	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	63	-	-	2.82E-02	1.59E-02
DIP	MF	GO:0003725	double-stranded RNA binding	-	72	24	-	-	8.09E-02	6.25E-03
DIP	MF	GO:0051018	protein kinase A binding	-	52	24	-	-	6.34E-02	6.25E-03
DIP	MF	GO:0071889	14-3-3 protein binding	-	34	16	-	-	2.42E-03	4.06E-03
DIP	MF	GO:0004618	phosphoglycerate kinase activity	-	89	39	-	-	2.56E-02	9.99E-03
DIP	MF	GO:0042805	actinin binding	-	36	13	-	-	4.68E-03	3.44E-03
DIP	MF	GO:0043531	ADP binding	-	38	18	-	-	7.51E-03	4.68E-03
DIP	MF	GO:0043394	proteoglycan binding	-	36	11	-	-	9.34E-04	2.81E-03
DIP	MF	GO:0046332	SMAD binding	-	77	45	-	-	2.05E-02	1.12E-02
DIP	MF	GO:0001968	fibronectin binding	-	30	12	-	-	5.27E-02	3.12E-03
DIP	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	54	-	-	7.70E-02	1.37E-02
DIP	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	17	-	-	1.24E-03	4.37E-03
DIP	MF	GO:0051117	ATPase binding	-	85	34	-	-	5.77E-03	8.74E-03
DIP	MF	GO:0005216	monoatomic ion channel activity	-	618	111	-	-	1.11E-01	2.78E-02
DIP	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	28	-	-	4.76E-03	7.18E-03
DIP	MF	GO:0001098	basal transcription machinery binding	-	61	39	-	-	1.87E-02	9.99E-03
DIP	MF	GO:0036002	pre-mRNA binding	-	57	18	-	-	3.96E-02	4.68E-03
DIP	MF	GO:0051540	metal cluster binding	-	71	11	-	-	1.34E-01	2.81E-03
DIP	MF	GO:0051219	phosphoprotein binding	-	92	54	-	-	9.01E-03	1.37E-02
DIP	MF	GO:0019894	kinesin binding	-	45	15	-	-	1.23E-03	3.75E-03
DIP	MF	GO:0042287	MHC protein binding	-	68	16	-	-	4.00E-02	4.06E-03
DIP	MF	GO:0019003	GDP binding	-	89	29	-	-	7.14E-03	7.50E-03
DIP	MF	GO:0017171	serine hydrolase activity	-	207	22	-	-	1.34E-02	5.62E-03
DIP	MF	GO:0097110	scaffold protein binding	-	66	41	-	-	1.67E-02	1.03E-02
DIP	MF	GO:0003774	cytoskeletal motor activity	-	117	23	-	-	1.63E-02	5.93E-03
DIP	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	17	-	-	5.64E-03	4.37E-03
DIP	MF	GO:0061134	peptidase regulator activity	-	224	46	-	-	1.47E-02	1.16E-02
DIP	MF	GO:0008013	beta-catenin binding	-	86	47	-	-	1.31E-02	1.19E-02
DIP	MF	GO:0051015	actin filament binding	-	208	48	-	-	2.21E-01	1.22E-02
DIP	MF	GO:0019208	phosphatase regulator activity	-	107	28	-	-	5.30E-03	7.18E-03
DIP	MF	GO:0043236	laminin binding	-	29	13	-	-	2.59E-02	3.44E-03
DIP	MF	GO:0030507	spectrin binding	-	26	11	-	-	6.30E-02	2.81E-03
DIP	MF	GO:0045860	positive regulation of protein kinase activity	-	397	190	-	-	4.10E-02	4.75E-02
DIP	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	48	-	-	7.64E-02	1.22E-02
DIP	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	12	-	-	9.55E-02	3.12E-03
DIP	MF	GO:0042393	histone binding	-	240	102	-	-	3.45E-02	2.56E-02
DIP	MF	GO:0019838	growth factor binding	-	182	99	-	-	3.68E-02	2.50E-02
DIP	MF	GO:0000149	SNARE binding	-	107	29	-	-	2.63E-01	7.50E-03
DIP	MF	GO:0003727	single-stranded RNA binding	-	90	35	-	-	2.59E-02	8.74E-03
DIP	MF	GO:0005516	calmodulin binding	-	206	54	-	-	1.49E-02	1.37E-02
DIP	MF	GO:0005198	structural molecule activity	-	823	195	-	-	1.28E-01	4.87E-02
DIP	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	16	-	-	1.30E-02	4.06E-03
DIP	MF	GO:0032182	ubiquitin-like protein binding	-	117	67	-	-	2.03E-02	1.69E-02
DIP	MF	GO:0023023	MHC protein complex binding	-	36	15	-	-	1.96E-01	3.75E-03
DIP	MF	GO:0043274	phospholipase binding	-	23	12	-	-	6.94E-03	3.12E-03
DIP	MF	GO:0031072	heat shock protein binding	-	128	55	-	-	1.92E-02	1.37E-02
DIP	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	104	-	-	2.92E-02	2.62E-02
DIP	MF	GO:0001530	lipopolysaccharide binding	-	38	16	-	-	7.44E-02	4.06E-03
DIP	MF	GO:0046982	protein heterodimerization activity	-	343	167	-	-	8.09E-02	4.18E-02
DIP	MF	GO:0140223	general transcription initiation factor activity	-	55	32	-	-	4.94E-01	8.12E-03
DIP	MF	GO:0000049	tRNA binding	-	75	16	-	-	2.10E-02	4.06E-03
DIP	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	19	-	-	7.85E-03	5.00E-03
DIP	MF	GO:0015026	coreceptor activity	-	48	33	-	-	5.97E-02	8.43E-03
DIP	MF	GO:0001653	peptide receptor activity	-	128	21	-	-	4.22E-02	5.31E-03
DIP	MF	GO:0006469	negative regulation of protein kinase activity	-	222	91	-	-	1.14E-02	2.28E-02
DIP	MF	GO:0070182	DNA polymerase binding	-	22	13	-	-	2.16E-02	3.44E-03
DIP	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	14	-	-	2.69E-02	3.75E-03
DIP	MF	GO:0070851	growth factor receptor binding	-	141	86	-	-	3.39E-02	2.15E-02
DIP	MF	GO:0005525	GTP binding	-	396	75	-	-	1.11E-02	1.87E-02
DIP	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	19	-	-	9.48E-03	5.00E-03
DIP	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	138	-	-	3.71E-02	3.47E-02
DIP	MF	GO:0042803	protein homodimerization activity	-	699	220	-	-	2.76E-02	5.50E-02
DIP	MF	GO:0051346	negative regulation of hydrolase activity	-	332	88	-	-	1.15E-02	2.22E-02
DIP	MF	GO:0005506	iron ion binding	-	154	18	-	-	1.98E-02	4.68E-03
DIP	MF	GO:0003925	G protein activity	-	45	18	-	-	2.19E-03	4.68E-03
DIP	MF	GO:0038187	pattern recognition receptor activity	-	33	12	-	-	8.50E-02	3.12E-03
DIP	MF	GO:0008276	protein methyltransferase activity	-	96	34	-	-	7.29E-02	8.74E-03
DIP	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	198	-	-	4.19E-02	4.97E-02
DIP	MF	GO:0051345	positive regulation of hydrolase activity	-	535	200	-	-	2.93E-02	5.00E-02
DIP	MF	GO:0070888	E-box binding	-	59	27	-	-	6.86E-02	6.87E-03
DIP	MF	GO:0015399	primary active transmembrane transporter activity	-	190	21	-	-	6.09E-02	5.31E-03
DIP	MF	GO:0035254	glutamate receptor binding	-	47	17	-	-	5.43E-03	4.37E-03
DIP	MF	GO:0050321	tau-protein kinase activity	-	36	16	-	-	2.55E-02	4.06E-03
DIP	MF	GO:0043021	ribonucleoprotein complex binding	-	158	49	-	-	1.96E-02	1.25E-02
DIP	MF	GO:0048185	activin binding	-	16	12	-	-	2.29E-01	3.12E-03
DIP	MF	GO:0001664	G protein-coupled receptor binding	-	299	97	-	-	1.35E-02	2.44E-02
DIP	MF	GO:0140299	small molecule sensor activity	-	39	20	-	-	1.31E-01	5.00E-03
DIP	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	14	-	-	9.98E-02	3.75E-03
DIP	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	20	-	-	4.45E-03	5.00E-03
DIP	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	16	-	-	2.59E-03	4.06E-03
DIP	MF	GO:0030594	neurotransmitter receptor activity	-	160	29	-	-	3.37E-02	7.50E-03
DIP	MF	GO:0005507	copper ion binding	-	63	12	-	-	4.52E-02	3.12E-03
DIP	MF	GO:0033558	protein lysine deacetylase activity	-	22	13	-	-	8.98E-03	3.44E-03
DIP	MF	GO:0070034	telomerase RNA binding	-	22	12	-	-	1.53E-01	3.12E-03
FunCoup	CC	GO:0005783	endoplasmic reticulum	1.48E-31	2020	1988	1880	1.06	-	-
FunCoup	CC	GO:0005615	extracellular space	1.01E-28	3190	3101	2969	1.04	-	-
FunCoup	CC	GO:0005768	endosome	5.79E-22	1037	1028	965	1.07	-	-
FunCoup	CC	GO:0005730	nucleolus	6.15E-19	988	977	920	1.06	-	-
FunCoup	CC	GO:0005764	lysosome	2.23E-17	747	742	695	1.07	-	-
FunCoup	CC	GO:0005794	Golgi apparatus	1.15E-14	1636	1591	1523	1.04	-	-
FunCoup	CC	GO:0005815	microtubule organizing center	3.67E-14	843	831	785	1.06	-	-
FunCoup	CC	GO:0005739	mitochondrion	3.25E-13	1671	1621	1555	1.04	-	-
FunCoup	CC	GO:0005635	nuclear envelope	4.27E-12	493	490	459	1.07	-	-
FunCoup	CC	GO:0000228	nuclear chromosome	5.82E-07	206	206	192	1.07	-	-
FunCoup	CC	GO:0005929	cilium	8.16E-04	842	807	784	1.03	-	-
FunCoup	CC	GO:0005840	ribosome	3.11E-03	222	217	207	1.05	-	-
FunCoup	CC	GO:0031012	extracellular matrix	5.29E-03	564	541	525	1.03	-	-
FunCoup	CC	GO:0005777	peroxisome	1.89E-02	142	139	132	1.05	-	-
FunCoup	CC	GO:0005811	lipid droplet	4.80E-02	102	100	95	1.05	-	-
FunCoup	BP	GO:0016192	vesicle-mediated transport	8.02E-29	1894	1863	1763	1.06	-	-
FunCoup	BP	GO:0007010	cytoskeleton organization	3.76E-22	1639	1608	1525	1.05	-	-
FunCoup	BP	GO:0055085	transmembrane transport	1.32E-21	1784	1746	1660	1.05	-	-
FunCoup	BP	GO:0007155	cell adhesion	1.89E-18	1444	1415	1344	1.05	-	-
FunCoup	BP	GO:0012501	programmed cell death	7.27E-18	1954	1901	1819	1.05	-	-
FunCoup	BP	GO:0048870	cell motility	1.58E-16	1659	1617	1544	1.05	-	-
FunCoup	BP	GO:0002376	immune system process	6.00E-16	2448	2366	2278	1.04	-	-
FunCoup	BP	GO:0065003	protein-containing complex assembly	2.60E-15	1648	1604	1534	1.05	-	-
FunCoup	BP	GO:0030163	protein catabolic process	3.87E-15	990	974	921	1.06	-	-
FunCoup	BP	GO:0006886	intracellular protein transport	4.78E-15	664	659	618	1.07	-	-
FunCoup	BP	GO:0006355	regulation of DNA-templated transcription	1.72E-14	3342	3207	3110	1.03	-	-
FunCoup	BP	GO:0034330	cell junction organization	2.75E-13	727	718	677	1.06	-	-
FunCoup	BP	GO:0006914	autophagy	2.16E-11	568	562	529	1.06	-	-
FunCoup	BP	GO:0016071	mRNA metabolic process	8.07E-11	713	701	664	1.06	-	-
FunCoup	BP	GO:0042060	wound healing	2.23E-09	431	427	401	1.06	-	-
FunCoup	BP	GO:0003012	muscle system process	3.23E-09	425	421	396	1.06	-	-
FunCoup	BP	GO:0006954	inflammatory response	2.03E-08	820	799	763	1.05	-	-
FunCoup	BP	GO:0006281	DNA repair	2.04E-08	587	576	546	1.05	-	-
FunCoup	BP	GO:0006629	lipid metabolic process	4.35E-08	1355	1307	1261	1.04	-	-
FunCoup	BP	GO:0003013	circulatory system process	3.25E-07	584	571	544	1.05	-	-
FunCoup	BP	GO:0050877	nervous system process	6.83E-07	1527	1466	1421	1.03	-	-
FunCoup	BP	GO:0072659	protein localization to plasma membrane	7.04E-07	284	282	264	1.07	-	-
FunCoup	BP	GO:0006325	chromatin organization	2.07E-06	720	699	670	1.04	-	-
FunCoup	BP	GO:0005975	carbohydrate metabolic process	2.14E-06	551	538	513	1.05	-	-
FunCoup	BP	GO:0007059	chromosome segregation	2.25E-06	403	396	375	1.06	-	-
FunCoup	BP	GO:0000910	cytokinesis	3.02E-06	186	186	173	1.07	-	-
FunCoup	BP	GO:0032200	telomere organization	3.02E-06	186	186	173	1.07	-	-
FunCoup	BP	GO:0007005	mitochondrion organization	4.71E-06	484	473	450	1.05	-	-
FunCoup	BP	GO:0006260	DNA replication	6.98E-06	279	276	260	1.06	-	-
FunCoup	BP	GO:0042254	ribosome biogenesis	1.38E-05	297	293	276	1.06	-	-
FunCoup	BP	GO:0007018	microtubule-based movement	3.33E-05	640	620	596	1.04	-	-
FunCoup	BP	GO:0006913	nucleocytoplasmic transport	3.79E-05	326	320	303	1.05	-	-
FunCoup	BP	GO:0007163	establishment or maintenance of cell polarity	1.73E-04	227	224	211	1.06	-	-
FunCoup	BP	GO:0006399	tRNA metabolic process	1.75E-04	196	194	182	1.06	-	-
FunCoup	BP	GO:0002181	cytoplasmic translation	3.39E-04	153	152	142	1.07	-	-
FunCoup	BP	GO:0007040	lysosome organization	8.32E-04	107	107	100	1.07	-	-
FunCoup	BP	GO:0098542	defense response to other organism	8.51E-04	1171	1117	1090	1.02	-	-
FunCoup	BP	GO:0006310	DNA recombination	9.88E-04	333	324	310	1.05	-	-
FunCoup	BP	GO:0044782	cilium organization	1.92E-03	399	386	371	1.04	-	-
FunCoup	BP	GO:0006575	cellular modified amino acid metabolic process	1.93E-03	186	183	173	1.06	-	-
FunCoup	BP	GO:0003014	renal system process	2.30E-03	127	126	118	1.07	-	-
FunCoup	BP	GO:0006520	amino acid metabolic process	7.06E-03	292	283	272	1.04	-	-
FunCoup	BP	GO:0006790	sulfur compound metabolic process	1.03E-02	320	309	298	1.04	-	-
FunCoup	BP	GO:0006091	generation of precursor metabolites and energy	1.23E-02	502	481	467	1.03	-	-
FunCoup	BP	GO:0030198	extracellular matrix organization	1.32E-02	314	303	292	1.04	-	-
FunCoup	BP	GO:0006457	protein folding	1.89E-02	210	204	195	1.04	-	-
FunCoup	BP	GO:0140053	mitochondrial gene expression	1.93E-02	164	160	153	1.05	-	-
FunCoup	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.08E-02	729	694	678	1.02	-	-
FunCoup	BP	GO:0006486	protein glycosylation	2.35E-02	225	218	209	1.04	-	-
FunCoup	BP	GO:0022600	digestive system process	3.52E-02	110	108	102	1.05	-	-
FunCoup	BP	GO:0006766	vitamin metabolic process	1.22E-01	107	104	100	1.04	-	-
FunCoup	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.47E-01	119	115	111	1.04	-	-
FunCoup	BP	GO:0098754	detoxification	3.09E-01	134	128	125	1.03	-	-
FunCoup	BP	GO:0140013	meiotic nuclear division	8.13E-01	279	259	260	1.00	-	-
FunCoup	MF	GO:0003723	RNA binding	1.90E-24	1679	1650	1563	1.06	-	-
FunCoup	MF	GO:0008092	cytoskeletal protein binding	2.60E-18	1023	1010	952	1.06	-	-
FunCoup	MF	GO:0005215	transporter activity	1.40E-16	1462	1429	1361	1.05	-	-
FunCoup	MF	GO:0016740	transferase activity	3.99E-15	3074	2956	2861	1.03	-	-
FunCoup	MF	GO:0003677	DNA binding	1.14E-14	2865	2757	2666	1.03	-	-
FunCoup	MF	GO:0140096	"catalytic activity, acting on a protein"	8.96E-13	3198	3065	2976	1.03	-	-
FunCoup	MF	GO:0140657	ATP-dependent activity	1.07E-12	729	719	678	1.06	-	-
FunCoup	MF	GO:0140110	transcription regulator activity	6.18E-10	2033	1955	1892	1.03	-	-
FunCoup	MF	GO:0140098	"catalytic activity, acting on RNA"	6.98E-09	417	413	388	1.06	-	-
FunCoup	MF	GO:0005198	structural molecule activity	1.07E-06	798	774	743	1.04	-	-
FunCoup	MF	GO:0140097	"catalytic activity, acting on DNA"	6.07E-06	383	376	356	1.05	-	-
FunCoup	MF	GO:0008289	lipid binding	6.63E-05	836	805	778	1.03	-	-
FunCoup	MF	GO:0016829	lyase activity	6.70E-05	538	522	501	1.04	-	-
FunCoup	MF	GO:0016491	oxidoreductase activity	3.13E-04	888	852	826	1.03	-	-
FunCoup	MF	GO:0003774	cytoskeletal motor activity	3.66E-04	116	116	108	1.07	-	-
FunCoup	MF	GO:0140104	molecular carrier activity	8.20E-04	105	105	98	1.07	-	-
FunCoup	MF	GO:0009975	cyclase activity	1.77E-03	277	270	258	1.05	-	-
FunCoup	MF	GO:0016853	isomerase activity	5.68E-03	252	245	235	1.04	-	-
FunCoup	MF	GO:0003924	GTPase activity	7.74E-03	658	629	612	1.03	-	-
FunCoup	MF	GO:0016874	ligase activity	2.40E-02	283	273	263	1.04	-	-
FunCoup	MF	GO:0045182	translation regulator activity	3.51E-02	151	147	141	1.05	-	-
FunCoup	MF	GO:0038024	cargo receptor activity	6.59E-02	117	114	109	1.05	-	-
FunCoup	MF	GO:0042393	histone binding	1.21E-01	237	227	221	1.03	-	-
FunCoup	MF	GO:0048018	receptor ligand activity	4.76E-01	504	465	469	0.99	-	-
FunCoup	BP	GO:0008038	neuron recognition	-	46	44	-	-	5.75E-03	2.01E-03
FunCoup	BP	GO:1905145	cellular response to acetylcholine	-	33	33	-	-	7.33E-03	1.51E-03
FunCoup	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	1.24E-03	8.37E-04
FunCoup	BP	GO:0098780	response to mitochondrial depolarisation	-	21	20	-	-	2.81E-03	8.93E-04
FunCoup	BP	GO:0051931	regulation of sensory perception	-	36	34	-	-	2.51E-03	1.56E-03
FunCoup	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	7.84E-03	1.12E-03
FunCoup	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	2.87E-03	6.14E-04
FunCoup	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	3.08E-04	6.14E-04
FunCoup	BP	GO:0009268	response to pH	-	43	43	-	-	2.05E-02	1.95E-03
FunCoup	BP	GO:0045666	positive regulation of neuron differentiation	-	91	84	-	-	4.30E-03	3.80E-03
FunCoup	BP	GO:0043543	protein acylation	-	107	102	-	-	7.81E-03	4.58E-03
FunCoup	MF	GO:0051349	positive regulation of lyase activity	-	41	39	-	-	3.67E-03	1.79E-03
FunCoup	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	2.68E-03	6.70E-04
FunCoup	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.62E-03	1.12E-03
FunCoup	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	2.58E-02	8.93E-04
FunCoup	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	138	-	-	2.34E-02	6.19E-03
FunCoup	BP	GO:0071763	nuclear membrane organization	-	44	43	-	-	1.85E-03	1.95E-03
FunCoup	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	35	-	-	6.04E-03	1.56E-03
FunCoup	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	8.09E-03	3.07E-03
FunCoup	BP	GO:0022038	corpus callosum development	-	25	25	-	-	1.13E-03	1.12E-03
FunCoup	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	12	-	-	1.81E-04	5.58E-04
FunCoup	BP	GO:0021548	pons development	-	11	11	-	-	1.71E-03	5.02E-04
FunCoup	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	4.21E-02	5.58E-04
FunCoup	BP	GO:0043299	leukocyte degranulation	-	82	81	-	-	8.81E-03	3.63E-03
FunCoup	BP	GO:0048864	stem cell development	-	88	85	-	-	3.61E-03	3.80E-03
FunCoup	BP	GO:0097384	cellular lipid biosynthetic process	-	11	11	-	-	3.09E-03	5.02E-04
FunCoup	BP	GO:0009310	amine catabolic process	-	20	18	-	-	2.01E-03	8.37E-04
FunCoup	BP	GO:0051651	maintenance of location in cell	-	236	228	-	-	9.03E-03	1.02E-02
FunCoup	BP	GO:0033119	negative regulation of RNA splicing	-	27	26	-	-	2.38E-03	1.17E-03
FunCoup	BP	GO:0014004	microglia differentiation	-	12	12	-	-	1.72E-03	5.58E-04
FunCoup	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	30	-	-	3.84E-03	1.34E-03
FunCoup	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	3.04E-02	6.70E-04
FunCoup	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.01E-03	6.70E-04
FunCoup	BP	GO:0046415	urate metabolic process	-	12	12	-	-	1.14E-02	5.58E-04
FunCoup	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	3.92E-03	1.34E-03
FunCoup	BP	GO:0006949	syncytium formation	-	66	62	-	-	1.81E-03	2.79E-03
FunCoup	BP	GO:0045176	apical protein localization	-	15	14	-	-	7.63E-04	6.70E-04
FunCoup	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	1.92E-03	6.70E-04
FunCoup	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	58	-	-	1.64E-02	2.62E-03
FunCoup	BP	GO:0030574	collagen catabolic process	-	45	43	-	-	8.69E-02	1.95E-03
FunCoup	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	3.08E-03	2.06E-03
FunCoup	BP	GO:0060343	trabecula formation	-	26	26	-	-	9.01E-04	1.17E-03
FunCoup	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	1.35E-04	5.58E-04
FunCoup	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	1.01E-03	1.06E-03
FunCoup	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	9.56E-04	7.26E-04
FunCoup	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	2.37E-02	8.37E-04
FunCoup	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	1.41E-02	1.84E-03
FunCoup	BP	GO:0006413	translational initiation	-	122	117	-	-	1.70E-02	5.25E-03
FunCoup	BP	GO:0072176	nephric duct development	-	15	14	-	-	2.09E-03	6.70E-04
FunCoup	BP	GO:1902895	positive regulation of miRNA transcription	-	51	50	-	-	6.40E-03	2.23E-03
FunCoup	CC	GO:0005200	structural constituent of cytoskeleton	-	112	110	-	-	1.59E-02	4.91E-03
FunCoup	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	2.56E-03	2.29E-03
FunCoup	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	6.28E-03	6.70E-04
FunCoup	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	2.70E-02	1.12E-03
FunCoup	BP	GO:1903036	positive regulation of response to wounding	-	76	70	-	-	6.99E-03	3.13E-03
FunCoup	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	1.69E-02	9.49E-04
FunCoup	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	224	-	-	2.36E-02	1.00E-02
FunCoup	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.08E-03	1.23E-03
FunCoup	BP	GO:0032528	microvillus organization	-	24	24	-	-	5.60E-02	1.12E-03
FunCoup	BP	GO:0021954	central nervous system neuron development	-	85	84	-	-	3.48E-03	3.80E-03
FunCoup	BP	GO:0055017	cardiac muscle tissue growth	-	92	73	-	-	4.10E-03	3.29E-03
FunCoup	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	6.79E-03	1.40E-03
FunCoup	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	3.85E-03	6.14E-04
FunCoup	BP	GO:0048524	positive regulation of viral process	-	64	64	-	-	1.26E-03	2.90E-03
FunCoup	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	14	-	-	1.04E-01	6.70E-04
FunCoup	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	4.13E-03	9.49E-04
FunCoup	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	24	-	-	8.40E-04	1.12E-03
FunCoup	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	4.52E-03	7.81E-04
FunCoup	BP	GO:0098661	inorganic anion transmembrane transport	-	140	137	-	-	2.02E-02	6.14E-03
FunCoup	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	3.78E-03	1.45E-03
FunCoup	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	1.29E-03	8.37E-04
FunCoup	BP	GO:0009612	response to mechanical stimulus	-	215	212	-	-	8.04E-03	9.49E-03
FunCoup	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	1.19E-02	3.52E-03
FunCoup	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	137	-	-	6.00E-03	6.14E-03
FunCoup	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	7.22E-03	6.14E-04
FunCoup	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	9.86E-03	1.56E-03
FunCoup	BP	GO:0140115	export across plasma membrane	-	82	67	-	-	1.11E-02	3.01E-03
FunCoup	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	4.62E-03	5.58E-04
FunCoup	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	37	-	-	2.77E-03	1.67E-03
FunCoup	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	6.82E-03	5.58E-04
FunCoup	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	2.08E-03	5.02E-04
FunCoup	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	29	-	-	8.34E-03	1.34E-03
FunCoup	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	41	-	-	3.72E-03	1.84E-03
FunCoup	MF	GO:0003714	transcription corepressor activity	-	190	184	-	-	1.46E-02	8.26E-03
FunCoup	BP	GO:0035878	nail development	-	11	11	-	-	1.83E-02	5.02E-04
FunCoup	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	54	-	-	3.79E-03	2.46E-03
FunCoup	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	2.54E-03	7.26E-04
FunCoup	CC	GO:0006858	extracellular transport	-	45	43	-	-	5.74E-02	1.95E-03
FunCoup	BP	GO:0006304	DNA modification	-	30	30	-	-	5.13E-02	1.34E-03
FunCoup	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	2.56E-03	8.93E-04
FunCoup	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	2.98E-03	2.23E-03
FunCoup	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	2.93E-04	8.37E-04
FunCoup	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	2.33E-03	6.70E-04
FunCoup	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	40	-	-	9.12E-03	1.79E-03
FunCoup	BP	GO:0070417	cellular response to cold	-	13	13	-	-	6.70E-04	6.14E-04
FunCoup	BP	GO:0043523	regulation of neuron apoptotic process	-	218	209	-	-	5.40E-03	9.38E-03
FunCoup	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	9.98E-03	1.00E-03
FunCoup	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	7.39E-04	6.70E-04
FunCoup	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	6.56E-03	2.57E-03
FunCoup	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	1.22E-02	6.14E-04
FunCoup	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	1.98E-03	1.12E-03
FunCoup	BP	GO:0014029	neural crest formation	-	15	15	-	-	2.01E-03	6.70E-04
FunCoup	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	1.21E-03	1.06E-03
FunCoup	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	43	-	-	1.85E-03	1.95E-03
FunCoup	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	71	-	-	5.94E-03	3.18E-03
FunCoup	BP	GO:0003188	heart valve formation	-	16	16	-	-	5.70E-03	7.26E-04
FunCoup	CC	GO:0045324	late endosome to vacuole transport	-	37	36	-	-	4.48E-03	1.62E-03
FunCoup	BP	GO:0043954	cellular component maintenance	-	72	71	-	-	4.33E-03	3.18E-03
FunCoup	BP	GO:0050435	amyloid-beta metabolic process	-	65	52	-	-	4.62E-03	2.34E-03
FunCoup	BP	GO:0014823	response to activity	-	70	67	-	-	2.91E-03	3.01E-03
FunCoup	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	2.96E-03	8.37E-04
FunCoup	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	6.91E-03	1.28E-03
FunCoup	BP	GO:0034502	protein localization to chromosome	-	130	127	-	-	9.29E-03	5.69E-03
FunCoup	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	2.19E-03	5.02E-04
FunCoup	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	1.57E-03	5.02E-04
FunCoup	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	1.94E-02	7.81E-04
FunCoup	BP	GO:0019233	sensory perception of pain	-	103	101	-	-	4.33E-03	4.52E-03
FunCoup	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	4.51E-02	1.00E-03
FunCoup	BP	GO:0031343	positive regulation of cell killing	-	75	71	-	-	2.74E-02	3.18E-03
FunCoup	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	5.10E-03	1.73E-03
FunCoup	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	127	-	-	2.26E-02	5.69E-03
FunCoup	BP	GO:0017148	negative regulation of translation	-	390	111	-	-	1.03E-02	4.97E-03
FunCoup	BP	GO:0030220	platelet formation	-	22	22	-	-	1.18E-03	1.00E-03
FunCoup	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	79	-	-	1.86E-02	3.57E-03
FunCoup	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	1.74E-03	5.58E-04
FunCoup	BP	GO:1901142	insulin metabolic process	-	14	13	-	-	5.01E-04	6.14E-04
FunCoup	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	8.09E-03	6.70E-04
FunCoup	BP	GO:1903509	liposaccharide metabolic process	-	109	107	-	-	8.38E-03	4.80E-03
FunCoup	BP	GO:0009582	detection of abiotic stimulus	-	140	136	-	-	2.55E-02	6.08E-03
FunCoup	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	1.41E-04	6.14E-04
FunCoup	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	19	-	-	1.78E-02	8.93E-04
FunCoup	CC	GO:0140238	presynaptic endocytosis	-	72	72	-	-	6.59E-03	3.24E-03
FunCoup	BP	GO:0051236	establishment of RNA localization	-	161	154	-	-	1.02E-02	6.92E-03
FunCoup	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	4.52E-02	1.12E-03
FunCoup	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	18	-	-	1.25E-02	8.37E-04
FunCoup	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	190	-	-	1.25E-02	8.48E-03
FunCoup	BP	GO:0034067	protein localization to Golgi apparatus	-	30	30	-	-	5.65E-03	1.34E-03
FunCoup	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	2.77E-03	1.45E-03
FunCoup	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	4.47E-03	7.81E-04
FunCoup	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	50	-	-	1.55E-02	2.23E-03
FunCoup	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	2.43E-03	1.79E-03
FunCoup	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	51	-	-	1.87E-03	2.29E-03
FunCoup	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	1.39E-03	7.26E-04
FunCoup	BP	GO:0050779	RNA destabilization	-	135	100	-	-	3.58E-02	4.46E-03
FunCoup	BP	GO:0006023	aminoglycan biosynthetic process	-	74	73	-	-	1.95E-02	3.29E-03
FunCoup	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	67	-	-	7.90E-03	3.01E-03
FunCoup	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	1.62E-03	1.79E-03
FunCoup	BP	GO:0090311	regulation of protein deacetylation	-	29	28	-	-	2.50E-03	1.28E-03
FunCoup	BP	GO:0035272	exocrine system development	-	46	46	-	-	9.09E-03	2.06E-03
FunCoup	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	3.27E-03	7.81E-04
FunCoup	BP	GO:0022406	membrane docking	-	90	88	-	-	5.36E-03	3.96E-03
FunCoup	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	8.95E-04	6.70E-04
FunCoup	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	4.82E-04	7.26E-04
FunCoup	BP	GO:0050777	negative regulation of immune response	-	196	189	-	-	7.86E-03	8.48E-03
FunCoup	MF	GO:0005035	death receptor activity	-	16	16	-	-	1.05E-02	7.26E-04
FunCoup	BP	GO:0002063	chondrocyte development	-	33	31	-	-	4.96E-03	1.40E-03
FunCoup	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	18	-	-	4.81E-04	8.37E-04
FunCoup	BP	GO:0099068	postsynapse assembly	-	40	39	-	-	3.33E-02	1.79E-03
FunCoup	BP	GO:0021782	glial cell development	-	120	114	-	-	3.20E-03	5.13E-03
FunCoup	BP	GO:0051782	negative regulation of cell division	-	18	16	-	-	2.43E-03	7.26E-04
FunCoup	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	8.34E-04	5.02E-04
FunCoup	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	88	-	-	2.99E-03	3.96E-03
FunCoup	BP	GO:0001655	urogenital system development	-	66	64	-	-	3.82E-03	2.90E-03
FunCoup	BP	GO:0071827	plasma lipoprotein particle organization	-	86	71	-	-	3.54E-02	3.18E-03
FunCoup	BP	GO:0045494	photoreceptor cell maintenance	-	43	42	-	-	1.69E-02	1.90E-03
FunCoup	BP	GO:0055088	lipid homeostasis	-	173	155	-	-	2.17E-02	6.92E-03
FunCoup	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	1.62E-03	1.17E-03
FunCoup	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	195	-	-	6.37E-03	8.71E-03
FunCoup	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	29	-	-	3.71E-03	1.34E-03
FunCoup	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	34	-	-	1.52E-03	1.56E-03
FunCoup	BP	GO:0045667	regulation of osteoblast differentiation	-	147	122	-	-	1.04E-02	5.47E-03
FunCoup	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	1.09E-02	7.26E-04
FunCoup	BP	GO:0061037	negative regulation of cartilage development	-	32	27	-	-	4.34E-03	1.23E-03
FunCoup	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	3.35E-02	1.79E-03
FunCoup	BP	GO:0001704	formation of primary germ layer	-	195	188	-	-	8.50E-03	8.43E-03
FunCoup	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	3.87E-03	6.14E-04
FunCoup	BP	GO:0045778	positive regulation of ossification	-	51	48	-	-	5.40E-03	2.18E-03
FunCoup	BP	GO:0060174	limb bud formation	-	11	11	-	-	7.23E-03	5.02E-04
FunCoup	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	4.31E-03	3.80E-03
FunCoup	BP	GO:0042092	type 2 immune response	-	41	41	-	-	2.49E-03	1.84E-03
FunCoup	BP	GO:0048588	developmental cell growth	-	233	221	-	-	6.90E-03	9.88E-03
FunCoup	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	1.24E-02	8.93E-04
FunCoup	BP	GO:0021872	forebrain generation of neurons	-	52	52	-	-	4.34E-03	2.34E-03
FunCoup	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	23	-	-	1.44E-02	1.06E-03
FunCoup	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	2.85E-03	1.79E-03
FunCoup	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	51	-	-	6.03E-02	2.29E-03
FunCoup	BP	GO:0072488	ammonium transmembrane transport	-	12	12	-	-	1.12E-02	5.58E-04
FunCoup	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	6.66E-02	1.56E-03
FunCoup	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	5.08E-04	1.17E-03
FunCoup	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	51	-	-	1.00E-02	2.29E-03
FunCoup	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	2.95E-03	8.93E-04
FunCoup	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	6.07E-03	8.93E-04
FunCoup	BP	GO:0010232	vascular transport	-	87	87	-	-	1.60E-02	3.91E-03
FunCoup	BP	GO:0021987	cerebral cortex development	-	125	123	-	-	6.91E-03	5.53E-03
FunCoup	BP	GO:0008637	apoptotic mitochondrial changes	-	108	100	-	-	2.25E-02	4.46E-03
FunCoup	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	2.98E-02	1.56E-03
FunCoup	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.01E-03	6.70E-04
FunCoup	BP	GO:0060999	positive regulation of dendritic spine development	-	35	34	-	-	1.27E-02	1.56E-03
FunCoup	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	9.27E-04	8.37E-04
FunCoup	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	2.39E-03	3.46E-03
FunCoup	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	2.54E-03	8.93E-04
FunCoup	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	19	-	-	1.11E-03	8.93E-04
FunCoup	BP	GO:0002064	epithelial cell development	-	210	206	-	-	9.55E-03	9.21E-03
FunCoup	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	4.33E-04	8.37E-04
FunCoup	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	40	-	-	3.35E-03	1.79E-03
FunCoup	BP	GO:2001222	regulation of neuron migration	-	46	43	-	-	2.59E-03	1.95E-03
FunCoup	BP	GO:0034389	lipid droplet organization	-	38	38	-	-	4.08E-03	1.73E-03
FunCoup	BP	GO:0051602	response to electrical stimulus	-	44	42	-	-	1.88E-03	1.90E-03
FunCoup	BP	GO:0042177	negative regulation of protein catabolic process	-	109	104	-	-	1.83E-03	4.69E-03
FunCoup	MF	GO:0038024	cargo receptor activity	-	121	114	-	-	6.93E-03	5.13E-03
FunCoup	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	16	-	-	9.78E-04	7.26E-04
FunCoup	BP	GO:0033120	positive regulation of RNA splicing	-	46	44	-	-	3.88E-02	2.01E-03
FunCoup	BP	GO:0051445	regulation of meiotic cell cycle	-	64	57	-	-	7.28E-03	2.57E-03
FunCoup	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	4.00E-03	5.58E-04
FunCoup	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	2.62E-03	2.68E-03
FunCoup	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	1.54E-02	6.70E-04
FunCoup	BP	GO:0090087	regulation of peptide transport	-	195	192	-	-	6.31E-03	8.59E-03
FunCoup	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	101	-	-	2.86E-03	4.52E-03
FunCoup	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	3.23E-03	1.12E-03
FunCoup	BP	GO:0006929	substrate-dependent cell migration	-	26	26	-	-	1.68E-03	1.17E-03
FunCoup	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	14	-	-	2.96E-03	6.70E-04
FunCoup	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	8.79E-03	1.23E-03
FunCoup	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	2.06E-03	6.70E-04
FunCoup	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	1.07E-03	6.70E-04
FunCoup	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	4.58E-02	8.93E-04
FunCoup	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	2.08E-02	6.14E-04
FunCoup	BP	GO:0022404	molting cycle process	-	95	93	-	-	5.55E-03	4.19E-03
FunCoup	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	1.06E-03	5.02E-04
FunCoup	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	2.18E-03	7.81E-04
FunCoup	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	4.20E-03	8.93E-04
FunCoup	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	5.74E-04	5.58E-04
FunCoup	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	1.76E-03	7.81E-04
FunCoup	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	2.98E-03	1.45E-03
FunCoup	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	1.95E-02	6.70E-04
FunCoup	BP	GO:0008299	isoprenoid biosynthetic process	-	30	29	-	-	3.24E-03	1.34E-03
FunCoup	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	234	-	-	1.22E-02	1.05E-02
FunCoup	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.85E-03	1.40E-03
FunCoup	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	1.88E-03	1.00E-03
FunCoup	CC	GO:0098926	postsynaptic signal transduction	-	39	39	-	-	7.05E-03	1.79E-03
FunCoup	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	136	-	-	8.43E-03	6.08E-03
FunCoup	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	2.77E-03	8.93E-04
FunCoup	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	2.61E-03	2.12E-03
FunCoup	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	138	-	-	8.67E-03	6.19E-03
FunCoup	BP	GO:0034249	negative regulation of amide metabolic process	-	34	23	-	-	2.95E-03	1.06E-03
FunCoup	BP	GO:0061548	ganglion development	-	17	17	-	-	9.04E-03	7.81E-04
FunCoup	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	97	-	-	1.57E-02	4.35E-03
FunCoup	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	8.76E-03	6.70E-04
FunCoup	BP	GO:0042832	defense response to protozoan	-	28	27	-	-	4.34E-03	1.23E-03
FunCoup	BP	GO:0048799	animal organ maturation	-	33	30	-	-	1.95E-03	1.34E-03
FunCoup	BP	GO:0006925	inflammatory cell apoptotic process	-	23	22	-	-	7.94E-04	1.00E-03
FunCoup	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	1.85E-04	7.26E-04
FunCoup	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	169	-	-	8.48E-03	7.59E-03
FunCoup	BP	GO:1903035	negative regulation of response to wounding	-	93	86	-	-	8.24E-03	3.85E-03
FunCoup	BP	GO:0015697	quaternary ammonium group transport	-	16	16	-	-	2.80E-02	7.26E-04
FunCoup	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	27	-	-	9.13E-04	1.23E-03
FunCoup	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	1.42E-03	1.23E-03
FunCoup	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	135	-	-	3.55E-02	6.03E-03
FunCoup	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	96	-	-	9.65E-03	4.30E-03
FunCoup	BP	GO:0045056	transcytosis	-	20	20	-	-	9.47E-04	8.93E-04
FunCoup	BP	GO:0018342	protein prenylation	-	15	15	-	-	2.88E-03	6.70E-04
FunCoup	BP	GO:0009267	cellular response to starvation	-	170	167	-	-	8.63E-03	7.48E-03
FunCoup	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	4.40E-02	5.02E-04
FunCoup	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	4.07E-03	2.40E-03
FunCoup	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	1.10E-03	7.26E-04
FunCoup	BP	GO:0007343	egg activation	-	11	11	-	-	8.19E-04	5.02E-04
FunCoup	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	1.21E-03	1.06E-03
FunCoup	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	27	-	-	7.15E-03	1.23E-03
FunCoup	BP	GO:0046931	pore complex assembly	-	21	21	-	-	2.10E-03	9.49E-04
FunCoup	CC	GO:0032008	positive regulation of TOR signaling	-	52	51	-	-	7.30E-03	2.29E-03
FunCoup	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	3.27E-03	1.51E-03
FunCoup	BP	GO:0046618	xenobiotic export from cell	-	27	14	-	-	4.38E-03	6.70E-04
FunCoup	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	14	-	-	2.03E-03	6.70E-04
FunCoup	BP	GO:0060428	lung epithelium development	-	43	42	-	-	8.57E-03	1.90E-03
FunCoup	BP	GO:0030431	sleep	-	30	30	-	-	1.33E-02	1.34E-03
FunCoup	BP	GO:1903318	negative regulation of protein maturation	-	29	27	-	-	1.62E-03	1.23E-03
FunCoup	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	96	-	-	3.37E-02	4.30E-03
FunCoup	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	8.22E-04	7.81E-04
FunCoup	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	2.94E-03	6.70E-04
FunCoup	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	1.01E-03	5.58E-04
FunCoup	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	2.03E-03	6.14E-04
FunCoup	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	75	-	-	1.22E-02	3.35E-03
FunCoup	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	63	-	-	2.44E-03	2.85E-03
FunCoup	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	1.21E-03	7.81E-04
FunCoup	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	1.19E-01	6.70E-04
FunCoup	CC	GO:0006406	mRNA export from nucleus	-	69	65	-	-	6.83E-03	2.90E-03
FunCoup	BP	GO:0009880	embryonic pattern specification	-	70	68	-	-	2.99E-03	3.07E-03
FunCoup	BP	GO:0015791	polyol transmembrane transport	-	14	12	-	-	4.91E-03	5.58E-04
FunCoup	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	2.59E-02	1.79E-03
FunCoup	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	1.23E-03	1.12E-03
FunCoup	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	1.09E-02	5.02E-04
FunCoup	BP	GO:0002367	cytokine production involved in immune response	-	121	120	-	-	8.83E-03	5.36E-03
FunCoup	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	3.17E-04	6.14E-04
FunCoup	BP	GO:0044848	biological phase	-	211	197	-	-	2.64E-02	8.82E-03
FunCoup	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	2.06E-03	5.58E-04
FunCoup	BP	GO:0046660	female sex differentiation	-	125	120	-	-	5.84E-03	5.36E-03
FunCoup	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	3.39E-04	7.81E-04
FunCoup	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	43	-	-	1.02E-03	1.95E-03
FunCoup	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	2.17E-03	5.02E-04
FunCoup	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	6.50E-03	3.13E-03
FunCoup	BP	GO:0071248	cellular response to metal ion	-	201	194	-	-	7.47E-03	8.71E-03
FunCoup	BP	GO:0030308	negative regulation of cell growth	-	191	182	-	-	4.53E-03	8.15E-03
FunCoup	BP	GO:0097306	cellular response to alcohol	-	99	93	-	-	3.42E-03	4.19E-03
FunCoup	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	127	-	-	1.14E-02	5.69E-03
FunCoup	BP	GO:0010453	regulation of cell fate commitment	-	40	36	-	-	7.47E-03	1.62E-03
FunCoup	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	56	-	-	5.30E-03	2.51E-03
FunCoup	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	57	-	-	1.40E-02	2.57E-03
FunCoup	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	7.02E-03	1.17E-03
FunCoup	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	5.85E-04	1.12E-03
FunCoup	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	44	-	-	2.08E-03	2.01E-03
FunCoup	BP	GO:0032890	regulation of organic acid transport	-	78	76	-	-	3.70E-03	3.40E-03
FunCoup	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	1.17E-03	8.93E-04
FunCoup	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	21	-	-	5.83E-02	9.49E-04
FunCoup	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	93	-	-	5.96E-03	4.19E-03
FunCoup	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	1.61E-03	1.17E-03
FunCoup	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	3.61E-03	5.02E-04
FunCoup	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	49	-	-	4.54E-03	2.23E-03
FunCoup	BP	GO:0051259	protein complex oligomerization	-	251	248	-	-	1.11E-02	1.11E-02
FunCoup	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	1.29E-03	7.26E-04
FunCoup	BP	GO:0098743	cell aggregation	-	24	24	-	-	3.85E-03	1.12E-03
FunCoup	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	2.07E-04	5.58E-04
FunCoup	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	1.64E-04	5.02E-04
FunCoup	BP	GO:0009994	oocyte differentiation	-	57	51	-	-	4.78E-03	2.29E-03
FunCoup	MF	GO:0031952	regulation of protein autophosphorylation	-	43	42	-	-	5.36E-03	1.90E-03
FunCoup	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	13	-	-	1.25E-03	6.14E-04
FunCoup	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	155	-	-	7.44E-03	6.92E-03
FunCoup	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	3.08E-03	1.56E-03
FunCoup	BP	GO:0033688	regulation of osteoblast proliferation	-	31	25	-	-	1.33E-03	1.12E-03
FunCoup	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	1.33E-03	1.56E-03
FunCoup	BP	GO:0072665	protein localization to vacuole	-	84	83	-	-	5.48E-03	3.74E-03
FunCoup	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	46	-	-	5.04E-03	2.06E-03
FunCoup	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	25	-	-	4.01E-02	1.12E-03
FunCoup	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	71	-	-	3.76E-02	3.18E-03
FunCoup	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	4.05E-03	7.26E-04
FunCoup	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	8.45E-03	6.70E-04
FunCoup	BP	GO:0042044	fluid transport	-	35	33	-	-	5.64E-03	1.51E-03
FunCoup	BP	GO:0070633	transepithelial transport	-	35	35	-	-	4.25E-03	1.56E-03
FunCoup	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	4.64E-04	6.14E-04
FunCoup	BP	GO:0045661	regulation of myoblast differentiation	-	74	72	-	-	2.62E-03	3.24E-03
FunCoup	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	15	-	-	9.16E-03	6.70E-04
FunCoup	BP	GO:0030307	positive regulation of cell growth	-	164	158	-	-	4.00E-03	7.09E-03
FunCoup	BP	GO:0034250	positive regulation of amide metabolic process	-	27	26	-	-	2.77E-03	1.17E-03
FunCoup	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	16	-	-	9.41E-03	7.26E-04
FunCoup	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	14	-	-	1.66E-03	6.70E-04
FunCoup	BP	GO:0014812	muscle cell migration	-	110	84	-	-	5.50E-03	3.80E-03
FunCoup	BP	GO:0048525	negative regulation of viral process	-	90	88	-	-	1.39E-02	3.96E-03
FunCoup	BP	GO:0072044	collecting duct development	-	16	16	-	-	2.08E-02	7.26E-04
FunCoup	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	13	-	-	2.22E-03	6.14E-04
FunCoup	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	4.44E-03	3.13E-03
FunCoup	BP	GO:0030238	male sex determination	-	14	14	-	-	1.40E-02	6.70E-04
FunCoup	BP	GO:0051781	positive regulation of cell division	-	93	92	-	-	4.92E-03	4.13E-03
FunCoup	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	3.94E-03	9.49E-04
FunCoup	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	6.23E-04	5.02E-04
FunCoup	BP	GO:0035524	proline transmembrane transport	-	12	12	-	-	7.73E-03	5.58E-04
FunCoup	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	1.03E-02	1.06E-03
FunCoup	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	22	-	-	1.22E-03	1.00E-03
FunCoup	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.72E-03	2.12E-03
FunCoup	BP	GO:0007272	ensheathment of neurons	-	146	143	-	-	5.08E-03	6.42E-03
FunCoup	CC	GO:0050806	positive regulation of synaptic transmission	-	171	152	-	-	1.09E-02	6.81E-03
FunCoup	BP	GO:0060021	roof of mouth development	-	91	89	-	-	1.01E-02	4.02E-03
FunCoup	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	40	-	-	3.48E-03	1.79E-03
FunCoup	BP	GO:0050819	negative regulation of coagulation	-	54	52	-	-	1.21E-02	2.34E-03
FunCoup	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	5.76E-04	5.02E-04
FunCoup	BP	GO:0017004	cytochrome complex assembly	-	40	39	-	-	1.89E-02	1.79E-03
FunCoup	BP	GO:0018410	C-terminal protein amino acid modification	-	15	14	-	-	1.48E-02	6.70E-04
FunCoup	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	1.43E-02	2.79E-03
FunCoup	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	1.68E-03	6.70E-04
FunCoup	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	15	-	-	2.26E-04	6.70E-04
FunCoup	CC	GO:0050805	negative regulation of synaptic transmission	-	55	54	-	-	5.10E-03	2.46E-03
FunCoup	BP	GO:0043248	proteasome assembly	-	13	13	-	-	2.03E-03	6.14E-04
FunCoup	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	59	-	-	9.10E-03	2.68E-03
FunCoup	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	1.63E-04	5.02E-04
FunCoup	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	89	-	-	1.95E-02	4.02E-03
FunCoup	BP	GO:0016054	organic acid catabolic process	-	251	245	-	-	4.95E-02	1.09E-02
FunCoup	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	4.16E-03	6.14E-04
FunCoup	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	8.10E-03	1.28E-03
FunCoup	BP	GO:0065005	protein-lipid complex assembly	-	29	28	-	-	2.73E-02	1.28E-03
FunCoup	BP	GO:0008033	tRNA processing	-	136	135	-	-	1.99E-02	6.03E-03
FunCoup	BP	GO:0046661	male sex differentiation	-	171	165	-	-	9.53E-03	7.37E-03
FunCoup	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	4.81E-03	6.70E-04
FunCoup	BP	GO:0000098	sulfur amino acid catabolic process	-	11	11	-	-	5.70E-03	5.02E-04
FunCoup	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	4.36E-03	7.81E-04
FunCoup	BP	GO:0035188	hatching	-	27	25	-	-	8.55E-04	1.12E-03
FunCoup	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	87	-	-	1.17E-02	3.91E-03
FunCoup	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	16	-	-	4.66E-03	7.26E-04
FunCoup	BP	GO:0090713	immunological memory process	-	18	18	-	-	1.03E-02	8.37E-04
FunCoup	BP	GO:0061326	renal tubule development	-	103	102	-	-	7.65E-03	4.58E-03
FunCoup	BP	GO:0071985	multivesicular body sorting pathway	-	56	55	-	-	9.56E-03	2.46E-03
FunCoup	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	1.30E-03	7.81E-04
FunCoup	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	18	-	-	1.00E-03	8.37E-04
FunCoup	BP	GO:0060325	face morphogenesis	-	31	31	-	-	1.65E-03	1.40E-03
FunCoup	BP	GO:0090559	regulation of membrane permeability	-	72	63	-	-	1.12E-02	2.85E-03
FunCoup	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	14	-	-	1.48E-02	6.70E-04
FunCoup	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	5.14E-03	5.58E-04
FunCoup	BP	GO:0031579	membrane raft organization	-	25	24	-	-	1.53E-03	1.12E-03
FunCoup	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	6.60E-04	1.12E-03
FunCoup	BP	GO:0060033	anatomical structure regression	-	16	15	-	-	3.61E-03	6.70E-04
FunCoup	BP	GO:0046460	neutral lipid biosynthetic process	-	50	47	-	-	7.97E-03	2.12E-03
FunCoup	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	147	-	-	5.29E-02	6.59E-03
FunCoup	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	1.12E-02	5.02E-04
FunCoup	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	160	-	-	3.41E-03	7.14E-03
FunCoup	BP	GO:0002251	organ or tissue specific immune response	-	43	42	-	-	5.95E-03	1.90E-03
FunCoup	CC	GO:0048167	regulation of synaptic plasticity	-	210	191	-	-	1.68E-02	8.54E-03
FunCoup	BP	GO:1903708	positive regulation of hemopoiesis	-	184	181	-	-	7.23E-03	8.09E-03
FunCoup	BP	GO:1903008	organelle disassembly	-	154	152	-	-	6.40E-03	6.81E-03
FunCoup	BP	GO:0001709	cell fate determination	-	44	44	-	-	8.94E-03	2.01E-03
FunCoup	BP	GO:0051873	killing by host of symbiont cells	-	28	28	-	-	1.38E-02	1.28E-03
FunCoup	BP	GO:0045058	T cell selection	-	53	53	-	-	1.51E-02	2.40E-03
FunCoup	CC	GO:0032387	negative regulation of intracellular transport	-	51	49	-	-	2.05E-03	2.23E-03
FunCoup	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	18	-	-	6.42E-03	8.37E-04
FunCoup	BP	GO:0072091	regulation of stem cell proliferation	-	91	77	-	-	3.15E-03	3.46E-03
FunCoup	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	41	-	-	4.17E-03	1.84E-03
FunCoup	BP	GO:0099084	postsynaptic specialization organization	-	44	43	-	-	1.41E-02	1.95E-03
FunCoup	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	3.92E-03	5.02E-04
FunCoup	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	2.01E-03	6.70E-04
FunCoup	BP	GO:0060384	innervation	-	27	26	-	-	1.53E-03	1.17E-03
FunCoup	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	6.10E-03	5.58E-04
FunCoup	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	33	-	-	5.82E-03	1.51E-03
FunCoup	MF	GO:0031281	positive regulation of cyclase activity	-	40	39	-	-	3.81E-03	1.79E-03
FunCoup	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	4.67E-03	2.85E-03
FunCoup	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	2.09E-03	8.37E-04
FunCoup	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	3.69E-03	5.58E-04
FunCoup	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	1.07E-03	8.37E-04
FunCoup	BP	GO:0071453	cellular response to oxygen levels	-	168	153	-	-	3.96E-03	6.86E-03
FunCoup	BP	GO:0090399	replicative senescence	-	17	16	-	-	1.99E-03	7.26E-04
FunCoup	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	1.51E-02	6.70E-04
FunCoup	BP	GO:0031342	negative regulation of cell killing	-	29	28	-	-	7.84E-03	1.28E-03
FunCoup	BP	GO:0070585	protein localization to mitochondrion	-	125	124	-	-	8.14E-03	5.58E-03
FunCoup	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	1.77E-03	6.70E-04
FunCoup	BP	GO:0010623	programmed cell death involved in cell development	-	25	23	-	-	6.38E-03	1.06E-03
FunCoup	BP	GO:0044242	cellular lipid catabolic process	-	224	220	-	-	1.67E-02	9.82E-03
FunCoup	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	2.72E-04	6.14E-04
FunCoup	BP	GO:0002931	response to ischemia	-	58	55	-	-	3.68E-03	2.46E-03
FunCoup	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	2.13E-03	5.58E-04
FunCoup	BP	GO:0014047	glutamate secretion	-	25	25	-	-	7.12E-03	1.12E-03
FunCoup	BP	GO:0061005	cell differentiation involved in kidney development	-	58	58	-	-	7.92E-03	2.62E-03
FunCoup	BP	GO:0030397	membrane disassembly	-	11	11	-	-	7.31E-04	5.02E-04
FunCoup	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	76	-	-	1.13E-02	3.40E-03
FunCoup	BP	GO:0060420	regulation of heart growth	-	74	58	-	-	2.80E-03	2.62E-03
FunCoup	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	1.49E-03	6.70E-04
FunCoup	BP	GO:0009755	hormone-mediated signaling pathway	-	221	217	-	-	1.06E-02	9.71E-03
FunCoup	BP	GO:0022612	gland morphogenesis	-	124	123	-	-	6.50E-03	5.53E-03
FunCoup	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	36	-	-	8.11E-04	1.62E-03
FunCoup	MF	GO:0140416	transcription regulator inhibitor activity	-	26	26	-	-	1.04E-02	1.17E-03
FunCoup	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	28	-	-	1.08E-02	1.28E-03
FunCoup	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	8.15E-03	6.70E-04
FunCoup	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	4.12E-02	7.81E-04
FunCoup	BP	GO:1990845	adaptive thermogenesis	-	166	166	-	-	3.92E-03	7.42E-03
FunCoup	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	3.35E-03	2.40E-03
FunCoup	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	5.89E-03	5.02E-04
FunCoup	BP	GO:0015844	monoamine transport	-	88	86	-	-	1.10E-02	3.85E-03
FunCoup	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	23	-	-	3.31E-03	1.06E-03
FunCoup	BP	GO:0060039	pericardium development	-	19	19	-	-	1.09E-03	8.93E-04
FunCoup	BP	GO:0071392	cellular response to estradiol stimulus	-	40	39	-	-	1.38E-03	1.79E-03
FunCoup	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	1.19E-03	6.14E-04
FunCoup	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	3.37E-03	8.93E-04
FunCoup	BP	GO:0009451	RNA modification	-	169	164	-	-	1.59E-02	7.37E-03
FunCoup	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	1.15E-01	5.02E-04
FunCoup	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	40	-	-	1.31E-03	1.79E-03
FunCoup	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	1.30E-03	7.81E-04
FunCoup	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	107	-	-	1.02E-02	4.80E-03
FunCoup	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	36	-	-	4.79E-03	1.62E-03
FunCoup	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	4.00E-02	5.02E-04
FunCoup	BP	GO:0015807	L-amino acid transport	-	94	91	-	-	8.14E-03	4.07E-03
FunCoup	BP	GO:0032941	secretion by tissue	-	85	81	-	-	3.61E-03	3.63E-03
FunCoup	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	14	-	-	1.67E-03	6.70E-04
FunCoup	BP	GO:0046605	regulation of centrosome cycle	-	54	53	-	-	3.56E-03	2.40E-03
FunCoup	BP	GO:0048753	pigment granule organization	-	40	40	-	-	1.54E-02	1.79E-03
FunCoup	BP	GO:0021516	dorsal spinal cord development	-	20	20	-	-	4.77E-03	8.93E-04
FunCoup	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	6.85E-02	8.93E-04
FunCoup	BP	GO:0003014	renal system process	-	130	128	-	-	1.10E-02	5.75E-03
FunCoup	CC	GO:0070286	axonemal dynein complex assembly	-	40	39	-	-	6.56E-02	1.79E-03
FunCoup	BP	GO:0045598	regulation of fat cell differentiation	-	148	127	-	-	6.02E-03	5.69E-03
FunCoup	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	191	-	-	2.20E-02	8.54E-03
FunCoup	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	2.18E-03	1.73E-03
FunCoup	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	2.13E-03	1.12E-03
FunCoup	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	227	-	-	3.40E-02	1.02E-02
FunCoup	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	2.86E-04	6.14E-04
FunCoup	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	8.56E-04	1.06E-03
FunCoup	BP	GO:0018158	protein oxidation	-	15	15	-	-	1.62E-02	6.70E-04
FunCoup	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	3.07E-02	1.34E-03
FunCoup	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	3.13E-02	7.81E-04
FunCoup	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	5.76E-04	1.23E-03
FunCoup	BP	GO:0071709	membrane assembly	-	68	66	-	-	3.04E-03	2.96E-03
FunCoup	BP	GO:0008217	regulation of blood pressure	-	186	173	-	-	2.03E-02	7.76E-03
FunCoup	BP	GO:0031643	positive regulation of myelination	-	19	19	-	-	1.96E-03	8.93E-04
FunCoup	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	1.93E-03	6.70E-04
FunCoup	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	60	-	-	1.59E-03	2.68E-03
FunCoup	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	7.52E-03	8.32E-03
FunCoup	BP	GO:0002200	somatic diversification of immune receptors	-	78	78	-	-	2.11E-02	3.52E-03
FunCoup	BP	GO:0035315	hair cell differentiation	-	52	49	-	-	5.03E-03	2.23E-03
FunCoup	BP	GO:0048645	animal organ formation	-	62	60	-	-	5.66E-03	2.68E-03
FunCoup	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	156	-	-	6.49E-03	6.98E-03
FunCoup	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	1.21E-03	6.70E-04
FunCoup	BP	GO:0033627	cell adhesion mediated by integrin	-	87	87	-	-	9.84E-03	3.91E-03
FunCoup	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	4.42E-03	9.49E-04
FunCoup	BP	GO:0015824	proline transport	-	13	13	-	-	5.93E-03	6.14E-04
FunCoup	BP	GO:0035107	appendage morphogenesis	-	147	145	-	-	9.99E-03	6.47E-03
FunCoup	BP	GO:1903707	negative regulation of hemopoiesis	-	116	109	-	-	7.66E-03	4.91E-03
FunCoup	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	1.28E-03	8.93E-04
FunCoup	CC	GO:0048208	COPII vesicle coating	-	27	26	-	-	5.48E-03	1.17E-03
FunCoup	BP	GO:0030149	sphingolipid catabolic process	-	32	31	-	-	1.50E-03	1.40E-03
FunCoup	BP	GO:0050994	regulation of lipid catabolic process	-	61	61	-	-	3.79E-03	2.73E-03
FunCoup	BP	GO:0035988	chondrocyte proliferation	-	24	22	-	-	1.61E-03	1.00E-03
FunCoup	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	5.01E-03	1.34E-03
FunCoup	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	1.65E-01	5.02E-04
FunCoup	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	2.36E-03	5.58E-04
FunCoup	BP	GO:0045727	positive regulation of translation	-	141	136	-	-	5.51E-03	6.08E-03
FunCoup	BP	GO:0036315	cellular response to sterol	-	24	21	-	-	1.02E-03	9.49E-04
FunCoup	CC	GO:0032388	positive regulation of intracellular transport	-	137	135	-	-	2.36E-03	6.03E-03
FunCoup	BP	GO:0021979	hypothalamus cell differentiation	-	13	12	-	-	3.37E-03	5.58E-04
FunCoup	BP	GO:0002027	regulation of heart rate	-	106	97	-	-	1.65E-02	4.35E-03
FunCoup	BP	GO:0050879	multicellular organismal movement	-	118	114	-	-	6.93E-03	5.13E-03
FunCoup	BP	GO:0120305	regulation of pigmentation	-	15	14	-	-	6.86E-03	6.70E-04
FunCoup	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	74	-	-	3.05E-03	3.35E-03
FunCoup	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	62	-	-	3.40E-03	2.79E-03
FunCoup	BP	GO:0048515	spermatid differentiation	-	208	191	-	-	1.51E-02	8.54E-03
FunCoup	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	4.36E-03	2.57E-03
FunCoup	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	3.30E-03	1.40E-03
FunCoup	BP	GO:0007130	synaptonemal complex assembly	-	23	21	-	-	2.86E-02	9.49E-04
FunCoup	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	36	-	-	7.70E-03	1.62E-03
FunCoup	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	34	-	-	3.90E-03	1.56E-03
FunCoup	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	36	-	-	4.71E-02	1.62E-03
FunCoup	BP	GO:0060119	inner ear receptor cell development	-	44	42	-	-	6.00E-03	1.90E-03
FunCoup	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	5.15E-03	8.37E-04
FunCoup	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	2.39E-02	1.56E-03
FunCoup	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	1.11E-03	1.12E-03
FunCoup	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.45E-03	5.58E-04
FunCoup	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	241	-	-	1.65E-02	1.08E-02
FunCoup	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	2.92E-03	7.81E-04
FunCoup	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	1.34E-02	2.18E-03
FunCoup	BP	GO:0010883	regulation of lipid storage	-	53	48	-	-	2.89E-03	2.18E-03
FunCoup	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	4.18E-03	1.17E-03
FunCoup	BP	GO:0007635	chemosensory behavior	-	20	19	-	-	2.73E-03	8.93E-04
FunCoup	BP	GO:1905954	positive regulation of lipid localization	-	110	104	-	-	5.67E-03	4.69E-03
FunCoup	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.05E-03	5.58E-04
FunCoup	BP	GO:0002209	behavioral defense response	-	39	38	-	-	5.12E-03	1.73E-03
FunCoup	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	7.92E-02	1.34E-03
FunCoup	BP	GO:0072523	purine-containing compound catabolic process	-	146	139	-	-	4.57E-03	6.25E-03
FunCoup	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	32	-	-	1.74E-03	1.45E-03
FunCoup	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	27	-	-	1.25E-03	1.23E-03
FunCoup	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	2.51E-03	7.26E-04
FunCoup	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	93	-	-	3.73E-03	4.19E-03
FunCoup	BP	GO:0007218	neuropeptide signaling pathway	-	113	100	-	-	4.81E-02	4.46E-03
FunCoup	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	7.50E-04	5.58E-04
FunCoup	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	167	-	-	1.51E-02	7.48E-03
FunCoup	BP	GO:0031345	negative regulation of cell projection organization	-	195	187	-	-	7.27E-03	8.37E-03
FunCoup	BP	GO:0048278	vesicle docking	-	64	63	-	-	4.96E-03	2.85E-03
FunCoup	BP	GO:0035050	embryonic heart tube development	-	86	86	-	-	6.44E-03	3.85E-03
FunCoup	BP	GO:0051593	response to folic acid	-	12	12	-	-	4.68E-04	5.58E-04
FunCoup	BP	GO:0030168	platelet activation	-	135	133	-	-	1.60E-02	5.97E-03
FunCoup	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	17	-	-	8.17E-03	7.81E-04
FunCoup	CC	GO:0098810	neurotransmitter reuptake	-	35	35	-	-	7.50E-03	1.56E-03
FunCoup	BP	GO:0008213	protein alkylation	-	58	57	-	-	2.27E-03	2.57E-03
FunCoup	BP	GO:0009812	flavonoid metabolic process	-	14	13	-	-	9.01E-02	6.14E-04
FunCoup	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	1.16E-03	6.14E-04
FunCoup	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	3.86E-03	1.12E-03
FunCoup	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.59E-03	6.14E-04
FunCoup	BP	GO:0031529	ruffle organization	-	55	55	-	-	4.07E-03	2.46E-03
FunCoup	BP	GO:0010842	retina layer formation	-	25	25	-	-	4.26E-03	1.12E-03
FunCoup	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	91	-	-	2.15E-02	4.07E-03
FunCoup	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	7.85E-03	5.02E-04
FunCoup	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	70	-	-	5.58E-03	3.13E-03
FunCoup	MF	GO:0170055	lipid transmembrane transporter activity	-	56	56	-	-	7.79E-03	2.51E-03
FunCoup	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	35	-	-	5.18E-03	1.56E-03
FunCoup	BP	GO:0035304	regulation of protein dephosphorylation	-	87	84	-	-	2.08E-03	3.80E-03
FunCoup	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	229	-	-	7.20E-03	1.03E-02
FunCoup	BP	GO:0099637	neurotransmitter receptor transport	-	26	26	-	-	4.06E-03	1.17E-03
FunCoup	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	33	-	-	3.61E-03	1.51E-03
FunCoup	BP	GO:0051775	response to redox state	-	13	13	-	-	2.07E-03	6.14E-04
FunCoup	BP	GO:0051785	positive regulation of nuclear division	-	61	57	-	-	1.87E-03	2.57E-03
FunCoup	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	4.64E-04	7.26E-04
FunCoup	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	2.57E-02	7.26E-04
FunCoup	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	4.71E-03	8.93E-04
FunCoup	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	2.17E-03	5.58E-04
FunCoup	BP	GO:0044786	cell cycle DNA replication	-	45	45	-	-	2.84E-03	2.01E-03
FunCoup	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	15	-	-	3.18E-03	6.70E-04
FunCoup	BP	GO:0044539	long-chain fatty acid import into cell	-	17	16	-	-	1.07E-03	7.26E-04
FunCoup	BP	GO:0051299	centrosome separation	-	15	15	-	-	3.98E-03	6.70E-04
FunCoup	BP	GO:0048145	regulation of fibroblast proliferation	-	87	83	-	-	3.99E-03	3.74E-03
FunCoup	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	89	-	-	2.68E-01	4.02E-03
FunCoup	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	4.55E-02	5.02E-04
FunCoup	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	224	-	-	4.71E-03	1.00E-02
FunCoup	BP	GO:0032098	regulation of appetite	-	20	19	-	-	7.83E-03	8.93E-04
FunCoup	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	5.74E-04	6.70E-04
FunCoup	CC	GO:0008333	endosome to lysosome transport	-	73	73	-	-	7.30E-03	3.29E-03
FunCoup	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	21	-	-	2.89E-03	9.49E-04
FunCoup	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	15	-	-	1.02E-03	6.70E-04
FunCoup	BP	GO:0003016	respiratory system process	-	39	38	-	-	1.63E-02	1.73E-03
FunCoup	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	24	-	-	1.23E-03	1.12E-03
FunCoup	BP	GO:0045732	positive regulation of protein catabolic process	-	202	200	-	-	4.62E-03	8.93E-03
FunCoup	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	70	-	-	2.26E-02	3.13E-03
FunCoup	BP	GO:0007588	excretion	-	40	39	-	-	3.68E-03	1.79E-03
FunCoup	BP	GO:1904018	positive regulation of vasculature development	-	185	157	-	-	1.60E-02	7.03E-03
FunCoup	BP	GO:0050953	sensory perception of light stimulus	-	223	216	-	-	6.33E-02	9.66E-03
FunCoup	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	9.31E-02	1.12E-03
FunCoup	BP	GO:0002357	defense response to tumor cell	-	13	12	-	-	2.66E-03	5.58E-04
FunCoup	BP	GO:0009303	rRNA transcription	-	37	37	-	-	3.36E-03	1.67E-03
FunCoup	BP	GO:0035601	protein deacylation	-	56	55	-	-	2.47E-03	2.46E-03
FunCoup	BP	GO:0061952	midbody abscission	-	18	17	-	-	1.30E-03	7.81E-04
FunCoup	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	18	-	-	1.78E-03	8.37E-04
FunCoup	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	4.29E-03	1.34E-03
FunCoup	BP	GO:0071300	cellular response to retinoic acid	-	66	63	-	-	2.09E-03	2.85E-03
FunCoup	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	16	-	-	8.76E-04	7.26E-04
FunCoup	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	5.08E-02	1.28E-03
FunCoup	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	8.62E-03	1.51E-03
FunCoup	BP	GO:0046697	decidualization	-	26	26	-	-	2.19E-03	1.17E-03
FunCoup	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	2.08E-01	6.70E-04
FunCoup	BP	GO:0051588	regulation of neurotransmitter transport	-	99	97	-	-	1.36E-02	4.35E-03
FunCoup	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	30	-	-	3.73E-02	1.34E-03
FunCoup	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	1.28E-03	5.58E-04
FunCoup	BP	GO:0051784	negative regulation of nuclear division	-	63	62	-	-	6.39E-03	2.79E-03
FunCoup	BP	GO:0044703	multi-organism reproductive process	-	209	195	-	-	4.91E-03	8.71E-03
FunCoup	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	138	-	-	2.32E-02	6.19E-03
FunCoup	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	2.66E-03	5.02E-04
FunCoup	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	50	-	-	1.17E-02	2.23E-03
FunCoup	BP	GO:0099022	vesicle tethering	-	32	32	-	-	1.14E-02	1.45E-03
FunCoup	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	37	-	-	2.01E-02	1.67E-03
FunCoup	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	5.18E-04	5.58E-04
FunCoup	BP	GO:0048857	neural nucleus development	-	65	65	-	-	1.88E-03	2.90E-03
FunCoup	BP	GO:0048663	neuron fate commitment	-	74	74	-	-	1.92E-02	3.35E-03
FunCoup	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	171	-	-	1.16E-02	7.65E-03
FunCoup	BP	GO:0106027	neuron projection organization	-	90	88	-	-	5.15E-03	3.96E-03
FunCoup	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	132	-	-	1.32E-02	5.92E-03
FunCoup	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	2.82E-03	1.56E-03
FunCoup	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	1.27E-03	5.02E-04
FunCoup	BP	GO:0045685	regulation of glial cell differentiation	-	77	73	-	-	3.89E-03	3.29E-03
FunCoup	BP	GO:0051608	histamine transport	-	14	14	-	-	5.96E-04	6.70E-04
FunCoup	BP	GO:0043414	macromolecule methylation	-	138	132	-	-	9.47E-03	5.92E-03
FunCoup	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	7.05E-03	5.58E-04
FunCoup	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	2.65E-03	7.26E-04
FunCoup	BP	GO:0050886	endocrine process	-	93	92	-	-	5.12E-03	4.13E-03
FunCoup	MF	GO:0015562	efflux transmembrane transporter activity	-	15	15	-	-	5.43E-03	6.70E-04
FunCoup	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	2.82E-03	1.28E-03
FunCoup	BP	GO:0045807	positive regulation of endocytosis	-	155	150	-	-	6.71E-03	6.70E-03
FunCoup	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	2.35E-03	5.02E-04
FunCoup	BP	GO:0002418	immune response to tumor cell	-	29	25	-	-	1.89E-03	1.12E-03
FunCoup	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	2.48E-03	2.62E-03
FunCoup	BP	GO:0048308	organelle inheritance	-	14	14	-	-	7.14E-04	6.70E-04
FunCoup	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	5.31E-04	8.37E-04
FunCoup	BP	GO:0001829	trophectodermal cell differentiation	-	19	18	-	-	3.09E-03	8.37E-04
FunCoup	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	52	-	-	7.77E-03	2.34E-03
FunCoup	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.64E-03	3.01E-03
FunCoup	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	1.74E-03	5.58E-04
FunCoup	BP	GO:0009110	vitamin biosynthetic process	-	23	22	-	-	4.73E-04	1.00E-03
FunCoup	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	3.09E-03	1.00E-03
FunCoup	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	9.74E-04	7.81E-04
FunCoup	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	21	-	-	2.67E-03	9.49E-04
FunCoup	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	95	-	-	3.62E-03	4.24E-03
FunCoup	BP	GO:0009111	vitamin catabolic process	-	13	13	-	-	1.28E-02	6.14E-04
FunCoup	MF	GO:0051100	negative regulation of binding	-	161	156	-	-	3.84E-03	6.98E-03
FunCoup	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	7.03E-03	3.52E-03
FunCoup	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	59	-	-	1.85E-03	2.68E-03
FunCoup	BP	GO:0055093	response to hyperoxia	-	20	18	-	-	1.39E-03	8.37E-04
FunCoup	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	11	-	-	1.05E-03	5.02E-04
FunCoup	BP	GO:0046504	glycerol ether biosynthetic process	-	11	11	-	-	4.04E-03	5.02E-04
FunCoup	BP	GO:0061036	positive regulation of cartilage development	-	33	31	-	-	2.00E-02	1.40E-03
FunCoup	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	5.10E-02	7.26E-04
FunCoup	BP	GO:1901857	positive regulation of cellular respiration	-	13	12	-	-	2.10E-04	5.58E-04
FunCoup	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	1.84E-03	2.12E-03
FunCoup	BP	GO:0046621	negative regulation of organ growth	-	39	32	-	-	3.10E-03	1.45E-03
FunCoup	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	48	-	-	3.42E-02	2.18E-03
FunCoup	BP	GO:0032368	regulation of lipid transport	-	149	128	-	-	5.27E-03	5.75E-03
FunCoup	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	2.58E-03	1.34E-03
FunCoup	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	179	-	-	7.69E-03	8.04E-03
FunCoup	BP	GO:0033002	muscle cell proliferation	-	249	199	-	-	6.69E-03	8.93E-03
FunCoup	BP	GO:0043331	response to dsRNA	-	56	56	-	-	8.53E-02	2.51E-03
FunCoup	BP	GO:0033327	Leydig cell differentiation	-	12	11	-	-	7.39E-03	5.02E-04
FunCoup	BP	GO:0051904	pigment granule transport	-	23	23	-	-	5.09E-03	1.06E-03
FunCoup	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	6.76E-03	1.45E-03
FunCoup	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	34	-	-	1.43E-03	1.56E-03
FunCoup	BP	GO:0033363	secretory granule organization	-	63	61	-	-	4.03E-03	2.73E-03
FunCoup	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	2.37E-03	1.28E-03
FunCoup	BP	GO:0120009	intermembrane lipid transfer	-	52	49	-	-	7.07E-03	2.23E-03
FunCoup	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	3.19E-04	6.70E-04
FunCoup	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	37	-	-	1.15E-03	1.67E-03
FunCoup	BP	GO:0033622	integrin activation	-	26	26	-	-	3.09E-03	1.17E-03
FunCoup	BP	GO:0098751	bone cell development	-	18	18	-	-	9.13E-04	8.37E-04
FunCoup	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.14E-03	9.49E-04
FunCoup	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	8.88E-03	2.29E-03
FunCoup	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.16E-02	1.34E-03
FunCoup	BP	GO:0002076	osteoblast development	-	17	16	-	-	4.26E-03	7.26E-04
FunCoup	BP	GO:0072164	mesonephric tubule development	-	98	97	-	-	5.26E-03	4.35E-03
FunCoup	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	16	-	-	5.48E-04	7.26E-04
FunCoup	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	105	-	-	4.76E-03	4.69E-03
FunCoup	BP	GO:1903524	positive regulation of blood circulation	-	39	34	-	-	1.21E-03	1.56E-03
FunCoup	BP	GO:0030901	midbrain development	-	87	87	-	-	3.72E-03	3.91E-03
FunCoup	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	4.36E-03	1.00E-03
FunCoup	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	4.49E-03	7.26E-04
FunCoup	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	8.09E-04	6.14E-04
FunCoup	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	67	-	-	2.70E-03	3.01E-03
FunCoup	MF	GO:1901474	azole transmembrane transporter activity	-	13	13	-	-	1.70E-02	6.14E-04
FunCoup	BP	GO:0002687	positive regulation of leukocyte migration	-	147	146	-	-	1.35E-02	6.53E-03
FunCoup	BP	GO:0019755	one-carbon compound transport	-	28	26	-	-	6.60E-02	1.17E-03
FunCoup	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	7.56E-04	6.14E-04
FunCoup	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	4.09E-03	7.26E-04
FunCoup	BP	GO:0110154	RNA decapping	-	19	19	-	-	1.03E-02	8.93E-04
FunCoup	BP	GO:0034605	cellular response to heat	-	66	60	-	-	1.77E-03	2.68E-03
FunCoup	BP	GO:0005996	monosaccharide metabolic process	-	250	243	-	-	7.40E-03	1.09E-02
FunCoup	BP	GO:0033555	multicellular organismal response to stress	-	90	89	-	-	3.47E-03	4.02E-03
FunCoup	BP	GO:0002262	myeloid cell homeostasis	-	172	168	-	-	6.03E-03	7.53E-03
FunCoup	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	5.07E-03	1.73E-03
FunCoup	BP	GO:0050688	regulation of defense response to virus	-	65	64	-	-	6.15E-03	2.90E-03
FunCoup	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	21	-	-	1.85E-03	9.49E-04
FunCoup	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	224	-	-	1.10E-02	1.00E-02
FunCoup	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	1.06E-02	1.40E-03
FunCoup	BP	GO:0061029	eyelid development in camera-type eye	-	14	13	-	-	2.35E-03	6.14E-04
FunCoup	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	2.77E-03	1.45E-03
FunCoup	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	19	-	-	1.15E-03	8.93E-04
FunCoup	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	7.02E-03	1.28E-03
FunCoup	BP	GO:0022618	protein-RNA complex assembly	-	227	190	-	-	1.10E-02	8.48E-03
FunCoup	BP	GO:0051147	regulation of muscle cell differentiation	-	162	134	-	-	4.30E-03	6.03E-03
FunCoup	BP	GO:0090102	cochlea development	-	50	48	-	-	5.19E-03	2.18E-03
FunCoup	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	1.54E-03	1.17E-03
FunCoup	BP	GO:0061303	cornea development in camera-type eye	-	12	11	-	-	1.63E-04	5.02E-04
FunCoup	BP	GO:0045933	positive regulation of muscle contraction	-	49	46	-	-	3.16E-03	2.06E-03
FunCoup	BP	GO:0015803	branched-chain amino acid transport	-	14	14	-	-	1.56E-02	6.70E-04
FunCoup	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	3.01E-03	7.26E-04
FunCoup	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	32	-	-	1.55E-03	1.45E-03
FunCoup	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	93	-	-	5.87E-02	4.19E-03
FunCoup	BP	GO:0097264	self proteolysis	-	12	12	-	-	3.52E-02	5.58E-04
FunCoup	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	1.77E-03	1.00E-03
FunCoup	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	2.14E-02	3.18E-03
FunCoup	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	56	-	-	3.53E-02	2.51E-03
FunCoup	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	1.60E-02	1.06E-03
FunCoup	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	56	-	-	5.27E-03	2.51E-03
FunCoup	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	4.29E-04	5.02E-04
FunCoup	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	4.41E-03	1.73E-03
FunCoup	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	3.89E-04	5.58E-04
FunCoup	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	2.75E-03	5.02E-04
FunCoup	BP	GO:0140253	cell-cell fusion	-	62	59	-	-	2.56E-03	2.68E-03
FunCoup	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	1.48E-04	5.58E-04
FunCoup	BP	GO:0071599	otic vesicle development	-	15	15	-	-	2.95E-03	6.70E-04
FunCoup	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	43	-	-	2.60E-02	1.95E-03
FunCoup	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	3.92E-03	6.70E-04
FunCoup	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	59	-	-	1.02E-02	2.68E-03
FunCoup	BP	GO:0001941	postsynaptic membrane organization	-	37	37	-	-	5.12E-03	1.67E-03
FunCoup	BP	GO:0051293	establishment of spindle localization	-	57	55	-	-	3.21E-03	2.46E-03
FunCoup	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	9.00E-04	6.14E-04
FunCoup	BP	GO:0043114	regulation of vascular permeability	-	49	45	-	-	2.21E-02	2.01E-03
FunCoup	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	1.25E-02	1.17E-03
FunCoup	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	67	-	-	2.57E-03	3.01E-03
FunCoup	BP	GO:0008360	regulation of cell shape	-	139	135	-	-	8.29E-03	6.03E-03
FunCoup	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	3.00E-02	7.26E-04
FunCoup	BP	GO:0051222	positive regulation of protein transport	-	249	243	-	-	4.88E-03	1.09E-02
FunCoup	CC	GO:0140632	canonical inflammasome complex assembly	-	40	40	-	-	8.81E-03	1.79E-03
FunCoup	MF	GO:0034260	negative regulation of GTPase activity	-	36	32	-	-	1.43E-03	1.45E-03
FunCoup	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	4.71E-03	1.00E-03
FunCoup	BP	GO:0045739	positive regulation of DNA repair	-	128	125	-	-	2.66E-02	5.58E-03
FunCoup	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	2.00E-03	8.93E-04
FunCoup	BP	GO:0045185	maintenance of protein location	-	95	91	-	-	2.01E-03	4.07E-03
FunCoup	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	6.25E-03	6.14E-04
FunCoup	BP	GO:0003158	endothelium development	-	140	128	-	-	7.81E-03	5.75E-03
FunCoup	CC	GO:0072595	maintenance of protein localization in organelle	-	42	40	-	-	1.11E-03	1.79E-03
FunCoup	BP	GO:0051224	negative regulation of protein transport	-	122	105	-	-	2.41E-03	4.69E-03
FunCoup	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	147	-	-	4.97E-03	6.59E-03
FunCoup	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	4.96E-03	6.14E-04
FunCoup	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	1.49E-03	1.40E-03
FunCoup	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	18	-	-	2.90E-02	8.37E-04
FunCoup	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	7.71E-03	2.85E-03
FunCoup	BP	GO:0007405	neuroblast proliferation	-	81	77	-	-	9.34E-03	3.46E-03
FunCoup	BP	GO:0009581	detection of external stimulus	-	137	133	-	-	2.91E-02	5.97E-03
FunCoup	BP	GO:1990542	mitochondrial transmembrane transport	-	93	92	-	-	3.19E-02	4.13E-03
FunCoup	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	32	-	-	1.35E-03	1.45E-03
FunCoup	BP	GO:0033504	floor plate development	-	11	11	-	-	4.18E-04	5.02E-04
FunCoup	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	2.08E-02	5.02E-04
FunCoup	BP	GO:0097186	amelogenesis	-	26	25	-	-	3.86E-02	1.12E-03
FunCoup	BP	GO:0031128	developmental induction	-	26	26	-	-	8.44E-03	1.17E-03
FunCoup	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	3.20E-03	6.70E-04
FunCoup	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.24E-03	2.96E-03
FunCoup	BP	GO:0021533	cell differentiation in hindbrain	-	23	22	-	-	1.12E-02	1.00E-03
FunCoup	BP	GO:0045684	positive regulation of epidermis development	-	33	32	-	-	1.09E-03	1.45E-03
FunCoup	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	5.18E-04	5.58E-04
FunCoup	BP	GO:1900047	negative regulation of hemostasis	-	51	50	-	-	1.27E-02	2.23E-03
FunCoup	BP	GO:0021517	ventral spinal cord development	-	47	47	-	-	1.04E-02	2.12E-03
FunCoup	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	1.75E-03	3.35E-03
FunCoup	BP	GO:0032328	alanine transport	-	19	19	-	-	3.82E-03	8.93E-04
FunCoup	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	4.73E-03	7.26E-04
FunCoup	BP	GO:0097722	sperm motility	-	133	122	-	-	3.39E-02	5.47E-03
FunCoup	BP	GO:0051231	spindle elongation	-	14	14	-	-	1.66E-03	6.70E-04
FunCoup	BP	GO:0042490	mechanoreceptor differentiation	-	67	64	-	-	8.45E-03	2.90E-03
FunCoup	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.43E-03	1.34E-03
FunCoup	BP	GO:0035148	tube formation	-	155	153	-	-	6.59E-03	6.86E-03
FunCoup	BP	GO:0048520	positive regulation of behavior	-	27	26	-	-	9.78E-03	1.17E-03
FunCoup	BP	GO:0098543	detection of other organism	-	19	18	-	-	2.20E-02	8.37E-04
FunCoup	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	42	-	-	7.41E-03	1.90E-03
FunCoup	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	122	-	-	2.32E-02	5.47E-03
FunCoup	BP	GO:0031123	RNA 3'-end processing	-	79	76	-	-	7.09E-03	3.40E-03
FunCoup	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	1.79E-02	5.02E-04
FunCoup	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	111	-	-	6.77E-03	4.97E-03
FunCoup	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	1.95E-03	8.37E-04
FunCoup	CC	GO:0007097	nuclear migration	-	24	24	-	-	1.21E-02	1.12E-03
FunCoup	BP	GO:0006885	regulation of pH	-	104	103	-	-	5.32E-03	4.63E-03
FunCoup	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.63E-03	6.70E-04
FunCoup	BP	GO:1990840	response to lectin	-	22	20	-	-	4.48E-03	8.93E-04
FunCoup	BP	GO:0071800	podosome assembly	-	19	19	-	-	9.37E-04	8.93E-04
FunCoup	BP	GO:0031018	endocrine pancreas development	-	47	46	-	-	5.46E-03	2.06E-03
FunCoup	BP	GO:0001708	cell fate specification	-	108	107	-	-	1.51E-02	4.80E-03
FunCoup	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	68	-	-	2.03E-03	3.07E-03
FunCoup	BP	GO:0030279	negative regulation of ossification	-	39	35	-	-	1.05E-03	1.56E-03
FunCoup	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	3.65E-02	6.70E-04
FunCoup	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	7.23E-04	5.58E-04
FunCoup	BP	GO:0042440	pigment metabolic process	-	80	78	-	-	1.31E-02	3.52E-03
FunCoup	BP	GO:1901606	alpha-amino acid catabolic process	-	101	96	-	-	3.93E-02	4.30E-03
FunCoup	BP	GO:1901890	positive regulation of cell junction assembly	-	106	102	-	-	8.11E-03	4.58E-03
FunCoup	BP	GO:0070988	demethylation	-	27	27	-	-	5.31E-03	1.23E-03
FunCoup	BP	GO:1901655	cellular response to ketone	-	107	104	-	-	3.05E-03	4.69E-03
FunCoup	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	1.64E-03	6.70E-04
FunCoup	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	1.65E-03	6.70E-04
FunCoup	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	3.90E-03	7.81E-04
FunCoup	BP	GO:0006968	cellular defense response	-	52	50	-	-	2.04E-02	2.23E-03
FunCoup	BP	GO:0055006	cardiac cell development	-	93	82	-	-	4.52E-03	3.68E-03
FunCoup	BP	GO:0031365	N-terminal protein amino acid modification	-	30	29	-	-	1.69E-03	1.34E-03
FunCoup	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	6.84E-03	5.58E-04
FunCoup	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	27	-	-	1.76E-03	1.23E-03
FunCoup	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	8.93E-04	5.58E-04
FunCoup	BP	GO:0060004	reflex	-	63	59	-	-	2.85E-03	2.68E-03
FunCoup	BP	GO:0044706	multi-multicellular organism process	-	217	202	-	-	5.43E-03	9.04E-03
FunCoup	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	2.92E-03	5.58E-04
FunCoup	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	135	-	-	5.28E-03	6.03E-03
FunCoup	BP	GO:0006026	aminoglycan catabolic process	-	34	32	-	-	7.42E-03	1.45E-03
FunCoup	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	7.53E-03	2.06E-03
FunCoup	BP	GO:0050768	negative regulation of neurogenesis	-	150	145	-	-	4.87E-03	6.47E-03
FunCoup	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	95	-	-	2.42E-03	4.24E-03
FunCoup	BP	GO:0090068	positive regulation of cell cycle process	-	262	244	-	-	6.69E-03	1.09E-02
FunCoup	BP	GO:0043605	amide catabolic process	-	16	16	-	-	1.19E-01	7.26E-04
FunCoup	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	2.07E-03	1.23E-03
FunCoup	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	7.12E-03	1.56E-03
FunCoup	BP	GO:1902115	regulation of organelle assembly	-	210	205	-	-	7.31E-03	9.15E-03
FunCoup	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	64	-	-	6.54E-03	2.90E-03
FunCoup	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	3.75E-04	7.26E-04
FunCoup	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	143	-	-	4.01E-03	6.42E-03
FunCoup	BP	GO:0043171	peptide catabolic process	-	19	17	-	-	6.28E-03	7.81E-04
FunCoup	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	1.09E-03	1.90E-03
FunCoup	BP	GO:0051952	regulation of amine transport	-	98	96	-	-	1.09E-02	4.30E-03
FunCoup	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	2.60E-03	1.06E-03
FunCoup	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	1.41E-03	8.93E-04
FunCoup	BP	GO:0015801	aromatic amino acid transport	-	13	13	-	-	2.91E-03	6.14E-04
FunCoup	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	8.94E-04	1.06E-03
FunCoup	BP	GO:0097154	GABAergic neuron differentiation	-	20	19	-	-	2.75E-03	8.93E-04
FunCoup	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	6.11E-04	7.26E-04
FunCoup	CC	GO:0032365	intracellular lipid transport	-	51	48	-	-	4.36E-03	2.18E-03
FunCoup	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	5.49E-03	1.34E-03
FunCoup	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	70	-	-	3.53E-03	3.13E-03
FunCoup	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	111	-	-	4.04E-03	4.97E-03
FunCoup	BP	GO:0018149	peptide cross-linking	-	28	27	-	-	5.26E-02	1.23E-03
FunCoup	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	2.23E-03	1.12E-03
FunCoup	MF	GO:0140537	transcription regulator activator activity	-	13	12	-	-	1.23E-03	5.58E-04
FunCoup	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	2.54E-04	6.70E-04
FunCoup	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	6.36E-04	6.14E-04
FunCoup	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	1.16E-03	1.56E-03
FunCoup	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	4.95E-03	4.02E-03
FunCoup	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	30	-	-	2.98E-03	1.34E-03
FunCoup	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	8.49E-03	8.37E-04
FunCoup	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	20	-	-	2.57E-03	8.93E-04
FunCoup	BP	GO:0015669	gas transport	-	23	23	-	-	1.51E-01	1.06E-03
FunCoup	BP	GO:0016485	protein processing	-	248	244	-	-	9.30E-03	1.09E-02
FunCoup	BP	GO:0009649	entrainment of circadian clock	-	30	29	-	-	4.77E-02	1.34E-03
FunCoup	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	166	-	-	4.51E-02	7.42E-03
FunCoup	BP	GO:1903523	negative regulation of blood circulation	-	27	22	-	-	1.48E-03	1.00E-03
FunCoup	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	137	-	-	1.56E-02	6.14E-03
FunCoup	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	3.46E-03	5.58E-04
FunCoup	BP	GO:0099054	presynapse assembly	-	49	44	-	-	5.07E-03	2.01E-03
FunCoup	BP	GO:0003353	positive regulation of cilium movement	-	12	11	-	-	1.61E-03	5.02E-04
FunCoup	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	4.15E-03	1.12E-03
FunCoup	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	2.50E-03	1.12E-03
FunCoup	BP	GO:0031348	negative regulation of defense response	-	282	242	-	-	5.72E-03	1.08E-02
FunCoup	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	75	-	-	3.16E-03	3.35E-03
FunCoup	BP	GO:0061180	mammary gland epithelium development	-	68	67	-	-	4.40E-03	3.01E-03
FunCoup	BP	GO:0071496	cellular response to external stimulus	-	74	74	-	-	9.19E-03	3.35E-03
FunCoup	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	2.30E-03	6.14E-04
FunCoup	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	5.09E-03	7.81E-04
FunCoup	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	4.36E-03	5.02E-04
FunCoup	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.08E-03	5.58E-04
FunCoup	BP	GO:0032094	response to food	-	37	35	-	-	1.40E-03	1.56E-03
FunCoup	BP	GO:0001964	startle response	-	27	25	-	-	6.89E-03	1.12E-03
FunCoup	BP	GO:0007340	acrosome reaction	-	38	36	-	-	6.96E-03	1.62E-03
FunCoup	BP	GO:0046434	organophosphate catabolic process	-	232	223	-	-	6.14E-03	9.99E-03
FunCoup	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	1.60E-02	1.34E-03
FunCoup	BP	GO:0009566	fertilization	-	205	184	-	-	6.56E-03	8.26E-03
FunCoup	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	55	-	-	1.82E-02	2.46E-03
FunCoup	BP	GO:0120255	olefinic compound biosynthetic process	-	24	23	-	-	3.77E-02	1.06E-03
FunCoup	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	1.67E-03	6.14E-04
FunCoup	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	4.85E-03	1.34E-03
FunCoup	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	22	-	-	2.24E-03	1.00E-03
FunCoup	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	1.78E-02	1.11E-02
FunCoup	BP	GO:0009309	amine biosynthetic process	-	38	34	-	-	3.26E-03	1.56E-03
FunCoup	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	1.96E-03	8.93E-04
FunCoup	BP	GO:0061900	glial cell activation	-	56	52	-	-	3.40E-03	2.34E-03
FunCoup	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	133	-	-	1.46E-02	5.97E-03
FunCoup	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	2.95E-03	6.14E-04
FunCoup	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	5.70E-03	6.70E-04
FunCoup	BP	GO:0021794	thalamus development	-	12	12	-	-	1.98E-03	5.58E-04
FunCoup	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	2.79E-02	1.84E-03
FunCoup	BP	GO:0035902	response to immobilization stress	-	20	19	-	-	2.75E-04	8.93E-04
FunCoup	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	5.21E-03	6.70E-04
FunCoup	BP	GO:0072537	fibroblast activation	-	13	13	-	-	4.17E-03	6.14E-04
FunCoup	BP	GO:0090235	regulation of metaphase plate congression	-	13	12	-	-	1.20E-03	5.58E-04
FunCoup	BP	GO:0043647	inositol phosphate metabolic process	-	44	43	-	-	2.54E-03	1.95E-03
FunCoup	BP	GO:0016180	snRNA processing	-	28	26	-	-	7.35E-03	1.17E-03
FunCoup	BP	GO:0051303	establishment of chromosome localization	-	104	100	-	-	1.01E-02	4.46E-03
FunCoup	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	1.30E-02	7.26E-04
FunCoup	BP	GO:0007164	establishment of tissue polarity	-	38	37	-	-	5.05E-03	1.67E-03
FunCoup	BP	GO:0097164	ammonium ion metabolic process	-	23	21	-	-	8.17E-04	9.49E-04
FunCoup	BP	GO:0021515	cell differentiation in spinal cord	-	51	51	-	-	1.09E-02	2.29E-03
FunCoup	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	3.63E-03	8.37E-04
FunCoup	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	3.44E-03	9.49E-04
FunCoup	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	1.41E-03	1.28E-03
FunCoup	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.45E-03	8.37E-04
FunCoup	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	37	-	-	2.35E-03	1.67E-03
FunCoup	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	1.48E-03	1.00E-03
FunCoup	BP	GO:0007566	embryo implantation	-	57	53	-	-	1.01E-03	2.40E-03
FunCoup	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	1.95E-03	1.51E-03
FunCoup	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	7.53E-02	7.26E-04
FunCoup	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	8.23E-03	1.45E-03
FunCoup	BP	GO:0051017	actin filament bundle assembly	-	161	155	-	-	8.92E-03	6.92E-03
FunCoup	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	3.75E-03	1.90E-03
FunCoup	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	1.95E-03	8.37E-04
FunCoup	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	1.00E-03	8.93E-04
FunCoup	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	6.02E-03	6.14E-04
FunCoup	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	37	-	-	3.74E-03	1.67E-03
FunCoup	BP	GO:0021756	striatum development	-	21	21	-	-	2.75E-03	9.49E-04
FunCoup	BP	GO:1901343	negative regulation of vasculature development	-	154	99	-	-	5.27E-03	4.46E-03
FunCoup	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	144	-	-	7.47E-03	6.47E-03
FunCoup	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	31	-	-	8.85E-03	1.40E-03
FunCoup	BP	GO:1902414	protein localization to cell junction	-	107	107	-	-	1.14E-02	4.80E-03
FunCoup	BP	GO:0071305	cellular response to vitamin D	-	23	21	-	-	1.40E-03	9.49E-04
FunCoup	BP	GO:0051304	chromosome separation	-	80	79	-	-	7.39E-03	3.57E-03
FunCoup	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	6.77E-03	8.37E-04
FunCoup	BP	GO:0048709	oligodendrocyte differentiation	-	101	98	-	-	5.22E-03	4.41E-03
FunCoup	BP	GO:0045017	glycerolipid biosynthetic process	-	254	246	-	-	1.40E-02	1.10E-02
FunCoup	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	7.17E-02	6.70E-04
FunCoup	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	1.15E-02	1.06E-03
FunCoup	BP	GO:0001776	leukocyte homeostasis	-	108	106	-	-	2.94E-03	4.74E-03
FunCoup	BP	GO:0050769	positive regulation of neurogenesis	-	240	232	-	-	9.34E-03	1.04E-02
FunCoup	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	2.18E-03	6.70E-04
FunCoup	BP	GO:0030193	regulation of blood coagulation	-	70	69	-	-	1.15E-02	3.13E-03
FunCoup	BP	GO:0050866	negative regulation of cell activation	-	216	204	-	-	8.67E-03	9.15E-03
FunCoup	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	3.98E-03	1.62E-03
FunCoup	BP	GO:0033500	carbohydrate homeostasis	-	251	231	-	-	4.92E-03	1.03E-02
FunCoup	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	31	-	-	6.93E-03	1.40E-03
FunCoup	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	1.53E-02	5.58E-04
FunCoup	BP	GO:0044088	regulation of vacuole organization	-	56	55	-	-	4.94E-03	2.46E-03
FunCoup	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	1.09E-03	1.06E-03
FunCoup	CC	GO:0099522	cytosolic region	-	20	20	-	-	2.46E-03	8.93E-04
FunCoup	CC	GO:0000791	euchromatin	-	60	59	-	-	4.57E-03	2.68E-03
FunCoup	CC	GO:0030666	endocytic vesicle membrane	-	196	192	-	-	2.16E-02	8.59E-03
FunCoup	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.84E-03	6.70E-04
FunCoup	CC	GO:1990752	microtubule end	-	34	33	-	-	1.22E-02	1.51E-03
FunCoup	CC	GO:0043204	perikaryon	-	156	155	-	-	1.56E-02	6.92E-03
FunCoup	CC	GO:0061702	canonical inflammasome complex	-	17	16	-	-	4.31E-01	7.26E-04
FunCoup	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	2.39E-01	5.58E-04
FunCoup	CC	GO:0097542	ciliary tip	-	48	47	-	-	5.35E-02	2.12E-03
FunCoup	CC	GO:1905368	peptidase complex	-	124	119	-	-	1.18E-02	5.36E-03
FunCoup	CC	GO:0000792	heterochromatin	-	98	97	-	-	1.03E-02	4.35E-03
FunCoup	CC	GO:0097546	ciliary base	-	47	43	-	-	1.09E-02	1.95E-03
FunCoup	CC	GO:0071819	DUBm complex	-	25	22	-	-	4.03E-02	1.00E-03
FunCoup	CC	GO:0031201	SNARE complex	-	48	46	-	-	1.04E-02	2.06E-03
FunCoup	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.14E-03	6.14E-04
FunCoup	CC	GO:0033260	nuclear DNA replication	-	40	40	-	-	2.23E-03	1.79E-03
FunCoup	CC	GO:0044391	ribosomal subunit	-	203	194	-	-	1.75E-02	8.71E-03
FunCoup	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	12	-	-	3.94E-03	5.58E-04
FunCoup	CC	GO:0071013	catalytic step 2 spliceosome	-	88	86	-	-	7.88E-03	3.85E-03
FunCoup	CC	GO:0031907	microbody lumen	-	51	51	-	-	1.22E-01	2.29E-03
FunCoup	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	6.07E-02	5.58E-04
FunCoup	CC	GO:0098862	cluster of actin-based cell projections	-	162	158	-	-	4.05E-02	7.09E-03
FunCoup	CC	GO:0016363	nuclear matrix	-	127	125	-	-	7.06E-03	5.58E-03
FunCoup	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	4.50E-03	2.06E-03
FunCoup	CC	GO:0032432	actin filament bundle	-	249	246	-	-	3.13E-02	1.10E-02
FunCoup	CC	GO:0008088	axo-dendritic transport	-	78	78	-	-	2.01E-02	3.52E-03
FunCoup	CC	GO:0031519	PcG protein complex	-	38	38	-	-	1.80E-02	1.73E-03
FunCoup	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	43	-	-	1.40E-01	1.95E-03
FunCoup	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	219	-	-	2.46E-02	9.82E-03
FunCoup	CC	GO:0000313	organellar ribosome	-	89	85	-	-	3.21E-02	3.80E-03
FunCoup	CC	GO:0099643	signal release from synapse	-	147	145	-	-	1.84E-02	6.47E-03
FunCoup	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	5.40E-03	2.06E-03
FunCoup	CC	GO:0005818	aster	-	11	11	-	-	9.18E-03	5.02E-04
FunCoup	CC	GO:0030018	Z disc	-	129	128	-	-	6.31E-02	5.75E-03
FunCoup	CC	GO:0032580	Golgi cisterna membrane	-	93	84	-	-	1.33E-01	3.80E-03
FunCoup	CC	GO:0097381	photoreceptor disc membrane	-	25	24	-	-	1.28E-01	1.12E-03
FunCoup	CC	GO:1905360	GTPase complex	-	41	39	-	-	3.83E-02	1.79E-03
FunCoup	CC	GO:0097540	axonemal central pair	-	161	151	-	-	5.16E-02	6.75E-03
FunCoup	CC	GO:0042641	actomyosin	-	77	76	-	-	3.93E-02	3.40E-03
FunCoup	CC	GO:0097386	glial cell projection	-	38	37	-	-	3.85E-03	1.67E-03
FunCoup	CC	GO:0032588	trans-Golgi network membrane	-	102	99	-	-	1.22E-02	4.46E-03
FunCoup	CC	GO:0070382	exocytic vesicle	-	224	222	-	-	4.74E-02	9.93E-03
FunCoup	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	47	-	-	1.16E-02	2.12E-03
FunCoup	CC	GO:0031903	microbody membrane	-	65	65	-	-	7.18E-02	2.90E-03
FunCoup	CC	GO:0046930	pore complex	-	26	26	-	-	5.10E-03	1.17E-03
FunCoup	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	7.92E-03	5.02E-04
FunCoup	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	15	-	-	1.59E-03	6.70E-04
FunCoup	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	246	-	-	8.75E-02	1.10E-02
FunCoup	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	5.76E-03	1.12E-03
FunCoup	CC	GO:1990071	TRAPPII protein complex	-	12	12	-	-	3.53E-02	5.58E-04
FunCoup	CC	GO:0099571	postsynaptic cytoskeleton	-	18	16	-	-	1.03E-02	7.26E-04
FunCoup	CC	GO:0044298	cell body membrane	-	32	32	-	-	6.89E-03	1.45E-03
FunCoup	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	1.39E-02	5.02E-04
FunCoup	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	1.06E-03	9.49E-04
FunCoup	CC	GO:0045495	pole plasm	-	25	22	-	-	3.40E-01	1.00E-03
FunCoup	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	1.33E-03	6.70E-04
FunCoup	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	1.51E-02	8.93E-04
FunCoup	CC	GO:0010369	chromocenter	-	14	14	-	-	1.82E-03	6.70E-04
FunCoup	CC	GO:0002177	manchette	-	19	17	-	-	3.55E-03	7.81E-04
FunCoup	CC	GO:0016323	basolateral plasma membrane	-	239	235	-	-	2.09E-02	1.05E-02
FunCoup	CC	GO:0045009	chitosome	-	21	21	-	-	1.59E-01	9.49E-04
FunCoup	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	2.00E-03	5.58E-04
FunCoup	CC	GO:0042645	mitochondrial nucleoid	-	45	44	-	-	1.56E-02	2.01E-03
FunCoup	CC	GO:0098636	protein complex involved in cell adhesion	-	57	56	-	-	2.11E-02	2.51E-03
FunCoup	CC	GO:0001917	photoreceptor inner segment	-	71	69	-	-	6.28E-02	3.13E-03
FunCoup	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	1.67E-03	6.70E-04
FunCoup	CC	GO:0019897	extrinsic component of plasma membrane	-	156	153	-	-	3.15E-02	6.86E-03
FunCoup	CC	GO:0031594	neuromuscular junction	-	73	73	-	-	5.71E-03	3.29E-03
FunCoup	CC	GO:0045120	pronucleus	-	14	12	-	-	8.20E-04	5.58E-04
FunCoup	CC	GO:0043083	synaptic cleft	-	21	21	-	-	6.52E-02	9.49E-04
FunCoup	CC	GO:0000922	spindle pole	-	172	172	-	-	2.07E-02	7.70E-03
FunCoup	CC	GO:0120111	neuron projection cytoplasm	-	94	92	-	-	2.13E-02	4.13E-03
FunCoup	CC	GO:0070971	endoplasmic reticulum exit site	-	32	29	-	-	1.14E-02	1.34E-03
FunCoup	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	3.63E-03	6.14E-04
FunCoup	CC	GO:0004879	nuclear receptor activity	-	63	61	-	-	7.57E-02	2.73E-03
FunCoup	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	166	-	-	3.59E-02	7.42E-03
FunCoup	CC	GO:0000123	histone acetyltransferase complex	-	93	87	-	-	1.84E-02	3.91E-03
FunCoup	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	3.81E-03	6.14E-04
FunCoup	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	103	-	-	3.45E-02	4.63E-03
FunCoup	CC	GO:0048786	presynaptic active zone	-	80	78	-	-	9.35E-03	3.52E-03
FunCoup	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	9.38E-03	5.02E-04
FunCoup	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	1.22E-03	5.58E-04
FunCoup	CC	GO:0007034	vacuolar transport	-	168	164	-	-	1.21E-02	7.37E-03
FunCoup	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	1.38E-01	9.49E-04
FunCoup	CC	GO:0043194	axon initial segment	-	21	20	-	-	7.66E-03	8.93E-04
FunCoup	CC	GO:0005776	autophagosome	-	111	105	-	-	1.68E-02	4.69E-03
FunCoup	CC	GO:0031430	M band	-	22	22	-	-	3.68E-02	1.00E-03
FunCoup	CC	GO:0001931	uropod	-	13	13	-	-	9.56E-03	6.14E-04
FunCoup	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	76	-	-	1.74E-02	3.40E-03
FunCoup	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	86	-	-	1.80E-02	3.85E-03
FunCoup	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	3.42E-02	6.14E-04
FunCoup	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	1.21E-01	8.93E-04
FunCoup	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	26	-	-	8.75E-03	1.17E-03
FunCoup	CC	GO:0032994	protein-lipid complex	-	39	39	-	-	1.38E-01	1.79E-03
FunCoup	CC	GO:0031838	haptoglobin-hemoglobin complex	-	11	11	-	-	4.46E-01	5.02E-04
FunCoup	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	145	-	-	1.72E-02	6.47E-03
FunCoup	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	7.46E-04	5.58E-04
FunCoup	CC	GO:0001527	microfibril	-	13	13	-	-	1.66E-01	6.14E-04
FunCoup	CC	GO:0072562	blood microparticle	-	144	135	-	-	3.42E-02	6.03E-03
FunCoup	CC	GO:0005883	neurofilament	-	11	11	-	-	2.34E-02	5.02E-04
FunCoup	CC	GO:0051233	spindle midzone	-	36	36	-	-	3.29E-03	1.62E-03
FunCoup	CC	GO:0005811	lipid droplet	-	102	100	-	-	3.28E-02	4.46E-03
FunCoup	CC	GO:0045022	early endosome to late endosome transport	-	44	43	-	-	5.46E-03	1.95E-03
FunCoup	CC	GO:0043113	receptor clustering	-	51	51	-	-	2.52E-03	2.29E-03
FunCoup	CC	GO:0005940	septin ring	-	14	14	-	-	3.77E-02	6.70E-04
FunCoup	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	6.77E-03	5.02E-04
FunCoup	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	25	-	-	4.12E-02	1.12E-03
FunCoup	CC	GO:0044853	plasma membrane raft	-	114	114	-	-	1.71E-02	5.13E-03
FunCoup	CC	GO:0005881	cytoplasmic microtubule	-	256	243	-	-	5.85E-02	1.09E-02
FunCoup	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	1.44E-03	6.70E-04
FunCoup	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	1.75E-02	7.81E-04
FunCoup	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	58	-	-	6.75E-03	2.62E-03
FunCoup	CC	GO:0005905	clathrin-coated pit	-	73	73	-	-	7.63E-03	3.29E-03
FunCoup	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	1.40E-02	5.58E-04
FunCoup	CC	GO:0043034	costamere	-	18	18	-	-	1.29E-02	8.37E-04
FunCoup	CC	GO:0031904	endosome lumen	-	38	38	-	-	6.47E-03	1.73E-03
FunCoup	CC	GO:0060170	ciliary membrane	-	76	76	-	-	2.26E-02	3.40E-03
FunCoup	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	4.28E-01	6.14E-04
FunCoup	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	2.14E-02	5.58E-04
FunCoup	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	2.63E-03	1.12E-03
FunCoup	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	1.17E-02	6.70E-04
FunCoup	CC	GO:0032154	cleavage furrow	-	54	54	-	-	1.10E-02	2.46E-03
FunCoup	CC	GO:0005640	nuclear outer membrane	-	30	30	-	-	1.01E-02	1.34E-03
FunCoup	CC	GO:0005652	nuclear lamina	-	12	11	-	-	5.59E-04	5.02E-04
FunCoup	CC	GO:0007006	mitochondrial membrane organization	-	117	109	-	-	2.05E-02	4.91E-03
FunCoup	CC	GO:0001772	immunological synapse	-	44	44	-	-	9.97E-03	2.01E-03
FunCoup	CC	GO:0030904	retromer complex	-	12	12	-	-	1.30E-03	5.58E-04
FunCoup	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	6.09E-03	5.58E-04
FunCoup	CC	GO:0030863	cortical cytoskeleton	-	104	104	-	-	1.22E-02	4.69E-03
FunCoup	CC	GO:1905348	endonuclease complex	-	38	36	-	-	1.72E-02	1.62E-03
FunCoup	CC	GO:0005833	hemoglobin complex	-	12	12	-	-	4.90E-01	5.58E-04
FunCoup	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	5.91E-03	8.37E-04
FunCoup	CC	GO:0030315	T-tubule	-	52	52	-	-	1.81E-02	2.34E-03
FunCoup	CC	GO:0060076	excitatory synapse	-	64	63	-	-	1.21E-02	2.85E-03
FunCoup	CC	GO:0036019	endolysosome	-	29	29	-	-	2.72E-03	1.34E-03
FunCoup	CC	GO:0001891	phagocytic cup	-	28	28	-	-	2.39E-03	1.28E-03
FunCoup	CC	GO:0099086	synaptonemal structure	-	40	40	-	-	3.51E-02	1.79E-03
FunCoup	CC	GO:0030427	site of polarized growth	-	172	171	-	-	1.91E-02	7.65E-03
FunCoup	CC	GO:0044309	neuron spine	-	213	213	-	-	3.49E-02	9.54E-03
FunCoup	CC	GO:0030658	transport vesicle membrane	-	231	225	-	-	3.67E-02	1.00E-02
FunCoup	CC	GO:0000813	ESCRT I complex	-	11	11	-	-	2.29E-02	5.02E-04
FunCoup	CC	GO:0098918	structural constituent of synapse	-	27	25	-	-	4.85E-03	1.12E-03
FunCoup	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.10E-01	5.58E-04
FunCoup	CC	GO:0000940	outer kinetochore	-	17	17	-	-	1.46E-02	7.81E-04
FunCoup	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	1.74E-02	7.81E-04
FunCoup	CC	GO:0044232	organelle membrane contact site	-	50	49	-	-	1.10E-02	2.23E-03
FunCoup	CC	GO:0098803	respiratory chain complex	-	39	32	-	-	5.66E-02	1.45E-03
FunCoup	CC	GO:0097545	axonemal outer doublet	-	164	154	-	-	5.00E-02	6.92E-03
FunCoup	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	3.24E-03	8.93E-04
FunCoup	CC	GO:0070069	cytochrome complex	-	42	35	-	-	5.39E-02	1.56E-03
FunCoup	CC	GO:0031143	pseudopodium	-	18	18	-	-	5.35E-03	8.37E-04
FunCoup	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	5.84E-02	1.23E-03
FunCoup	CC	GO:0055037	recycling endosome	-	200	196	-	-	1.82E-02	8.76E-03
FunCoup	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	93	-	-	8.23E-03	4.19E-03
FunCoup	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	1.10E-02	6.14E-04
FunCoup	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	8.20E-04	6.14E-04
FunCoup	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	3.35E-03	1.00E-03
FunCoup	CC	GO:0030684	preribosome	-	76	75	-	-	1.79E-02	3.35E-03
FunCoup	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	4.11E-03	8.37E-04
FunCoup	CC	GO:1990391	DNA repair complex	-	22	22	-	-	7.32E-03	1.00E-03
FunCoup	CC	GO:0005775	vacuolar lumen	-	176	175	-	-	4.28E-02	7.81E-03
FunCoup	CC	GO:0032433	filopodium tip	-	19	19	-	-	6.88E-03	8.93E-04
FunCoup	CC	GO:0032982	myosin filament	-	24	24	-	-	3.07E-02	1.12E-03
FunCoup	CC	GO:0016327	apicolateral plasma membrane	-	23	23	-	-	6.51E-03	1.06E-03
FunCoup	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	4.64E-03	1.06E-03
FunCoup	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	4.22E-03	5.58E-04
FunCoup	CC	GO:0044306	neuron projection terminus	-	164	162	-	-	3.10E-02	7.26E-03
FunCoup	CC	GO:0034455	t-UTP complex	-	53	52	-	-	4.98E-03	2.34E-03
FunCoup	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	8.39E-02	7.81E-04
FunCoup	CC	GO:0031970	organelle envelope lumen	-	94	93	-	-	1.56E-02	4.19E-03
FunCoup	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	5.44E-03	6.14E-04
FunCoup	CC	GO:0033270	paranode region of axon	-	11	11	-	-	8.42E-03	5.02E-04
FunCoup	CC	GO:0120293	dynein axonemal particle	-	20	18	-	-	5.84E-03	8.37E-04
FunCoup	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	1.78E-03	1.12E-03
FunCoup	CC	GO:0043292	contractile muscle fiber	-	245	241	-	-	2.02E-01	1.08E-02
FunCoup	CC	GO:0018995	host cellular component	-	12	12	-	-	7.56E-03	5.58E-04
FunCoup	CC	GO:0034709	methylosome	-	13	13	-	-	6.21E-04	6.14E-04
FunCoup	CC	GO:0032426	stereocilium tip	-	21	18	-	-	1.94E-02	8.37E-04
FunCoup	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	1.62E-02	5.58E-04
FunCoup	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	4.44E-02	8.93E-04
FunCoup	CC	GO:0000803	sex chromosome	-	32	29	-	-	1.08E-02	1.34E-03
FunCoup	CC	GO:0098982	GABA-ergic synapse	-	84	83	-	-	2.28E-02	3.74E-03
FunCoup	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	17	-	-	1.74E-03	7.81E-04
FunCoup	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	3.12E-02	2.85E-03
FunCoup	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	3.30E-03	6.70E-04
FunCoup	CC	GO:0000242	pericentriolar material	-	22	22	-	-	6.34E-03	1.00E-03
FunCoup	CC	GO:1903293	phosphatase complex	-	54	54	-	-	8.78E-02	2.46E-03
FunCoup	CC	GO:0097470	ribbon synapse	-	13	13	-	-	1.74E-03	6.14E-04
FunCoup	CC	GO:0031941	filamentous actin	-	27	27	-	-	5.15E-03	1.23E-03
FunCoup	CC	GO:0000786	nucleosome	-	149	139	-	-	3.07E-02	6.25E-03
FunCoup	CC	GO:0001533	cornified envelope	-	59	54	-	-	3.20E-02	2.46E-03
FunCoup	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	2.84E-02	2.46E-03
FunCoup	CC	GO:0030027	lamellipodium	-	202	201	-	-	2.39E-02	8.99E-03
FunCoup	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	1.75E-03	6.70E-04
FunCoup	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	24	-	-	2.23E-03	1.12E-03
FunCoup	CC	GO:0000800	lateral element	-	14	14	-	-	1.70E-02	6.70E-04
FunCoup	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	1.86E-03	5.58E-04
FunCoup	CC	GO:0060077	inhibitory synapse	-	20	20	-	-	1.39E-02	8.93E-04
FunCoup	CC	GO:0031209	SCAR complex	-	12	12	-	-	3.58E-03	5.58E-04
FunCoup	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	9.50E-02	5.02E-04
FunCoup	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	1.69E-03	7.26E-04
FunCoup	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	19	-	-	4.41E-03	8.93E-04
FunCoup	CC	GO:0002102	podosome	-	31	31	-	-	3.75E-03	1.40E-03
FunCoup	CC	GO:0090543	Flemming body	-	33	33	-	-	3.84E-03	1.51E-03
FunCoup	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	6.53E-03	2.96E-03
FunCoup	CC	GO:0001650	fibrillar center	-	151	148	-	-	8.50E-03	6.64E-03
FunCoup	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	9.88E-03	6.70E-04
FunCoup	CC	GO:1990204	oxidoreductase complex	-	90	80	-	-	1.09E-02	3.57E-03
FunCoup	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	4.75E-03	7.26E-04
FunCoup	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	5.26E-04	5.02E-04
FunCoup	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	1.04E-02	5.58E-03
FunCoup	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	7.38E-04	8.37E-04
FunCoup	CC	GO:0001726	ruffle	-	181	181	-	-	4.62E-02	8.09E-03
FunCoup	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	9.72E-02	5.02E-04
FunCoup	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	4.53E-03	6.14E-04
FunCoup	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	4.14E-03	8.37E-04
FunCoup	CC	GO:0043198	dendritic shaft	-	38	38	-	-	3.37E-03	1.73E-03
FunCoup	CC	GO:0043073	germ cell nucleus	-	67	62	-	-	1.80E-03	2.79E-03
FunCoup	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	22	-	-	2.79E-03	1.00E-03
FunCoup	CC	GO:0016592	mediator complex	-	38	38	-	-	5.20E-02	1.73E-03
FunCoup	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	5.20E-03	8.93E-04
FunCoup	CC	GO:0022626	cytosolic ribosome	-	118	113	-	-	4.72E-03	5.08E-03
FunCoup	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	43	-	-	1.68E-02	1.95E-03
FunCoup	CC	GO:0034451	centriolar satellite	-	120	118	-	-	1.41E-02	5.30E-03
FunCoup	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	3.29E-03	5.02E-04
FunCoup	CC	GO:0045171	intercellular bridge	-	91	89	-	-	9.08E-03	4.02E-03
FunCoup	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	80	-	-	1.17E-02	3.57E-03
FunCoup	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	1.60E-03	6.70E-04
FunCoup	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.91E-03	5.02E-04
FunCoup	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	9.63E-03	5.02E-04
FunCoup	CC	GO:0044292	dendrite terminus	-	13	13	-	-	1.36E-03	6.14E-04
FunCoup	CC	GO:0032039	integrator complex	-	19	17	-	-	1.92E-02	7.81E-04
FunCoup	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	1.89E-03	6.70E-04
FunCoup	CC	GO:0033268	node of Ranvier	-	16	16	-	-	4.89E-03	7.26E-04
FunCoup	CC	GO:0036038	MKS complex	-	13	13	-	-	3.25E-02	6.14E-04
FunCoup	CC	GO:0030527	structural constituent of chromatin	-	97	87	-	-	4.05E-02	3.91E-03
FunCoup	CC	GO:0036379	myofilament	-	26	25	-	-	4.68E-02	1.12E-03
FunCoup	CC	GO:0030286	dynein complex	-	210	198	-	-	6.75E-02	8.87E-03
FunCoup	CC	GO:0031105	septin complex	-	14	14	-	-	6.54E-02	6.70E-04
FunCoup	CC	GO:0097228	sperm principal piece	-	33	27	-	-	1.76E-02	1.23E-03
FunCoup	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.05E-03	5.58E-04
FunCoup	CC	GO:0016482	cytosolic transport	-	135	132	-	-	1.11E-02	5.92E-03
FunCoup	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	2.18E-01	1.06E-03
FunCoup	CC	GO:0005796	Golgi lumen	-	106	98	-	-	4.66E-02	4.41E-03
FunCoup	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	37	-	-	1.20E-02	1.67E-03
FunCoup	CC	GO:0034358	plasma lipoprotein particle	-	36	36	-	-	2.35E-01	1.62E-03
FunCoup	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	1.14E-02	2.12E-03
FunCoup	CC	GO:0043220	Schmidt-Lanterman incisure	-	11	11	-	-	2.71E-03	5.02E-04
FunCoup	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	4.94E-03	1.12E-03
FunCoup	CC	GO:0030662	coated vesicle membrane	-	202	196	-	-	2.20E-02	8.76E-03
FunCoup	CC	GO:0007039	protein catabolic process in the vacuole	-	61	60	-	-	5.52E-03	2.68E-03
FunCoup	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	57	-	-	9.72E-03	2.57E-03
FunCoup	CC	GO:0090734	site of DNA damage	-	118	116	-	-	1.40E-02	5.19E-03
FunCoup	MF	GO:0051861	glycolipid binding	-	30	30	-	-	1.19E-03	1.34E-03
FunCoup	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	3.70E-04	5.02E-04
FunCoup	MF	GO:0051087	protein-folding chaperone binding	-	135	131	-	-	3.58E-03	5.86E-03
FunCoup	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	9.53E-03	1.23E-03
FunCoup	CC	GO:0015464	acetylcholine receptor activity	-	21	21	-	-	7.23E-02	9.49E-04
FunCoup	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	5.06E-04	5.58E-04
FunCoup	MF	GO:0016594	glycine binding	-	12	12	-	-	7.20E-03	5.58E-04
FunCoup	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	4.71E-02	8.93E-04
FunCoup	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	1.12E-02	1.67E-03
FunCoup	MF	GO:0035613	RNA stem-loop binding	-	21	16	-	-	1.90E-03	7.26E-04
FunCoup	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	237	-	-	1.45E-02	1.06E-02
FunCoup	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	3.60E-04	8.93E-04
FunCoup	MF	GO:0033691	sialic acid binding	-	22	20	-	-	3.01E-03	8.93E-04
FunCoup	MF	GO:0004875	complement receptor activity	-	12	11	-	-	6.32E-03	5.02E-04
FunCoup	MF	GO:0048306	calcium-dependent protein binding	-	61	61	-	-	5.23E-03	2.73E-03
FunCoup	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	4.17E-02	1.28E-03
FunCoup	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	1.15E-01	6.14E-04
FunCoup	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	143	-	-	1.48E-02	6.42E-03
FunCoup	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	60	-	-	9.77E-03	2.68E-03
FunCoup	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	135	-	-	1.01E-02	6.03E-03
FunCoup	MF	GO:0045504	dynein heavy chain binding	-	16	16	-	-	2.76E-02	7.26E-04
FunCoup	MF	GO:0140457	protein demethylase activity	-	31	30	-	-	6.44E-03	1.34E-03
FunCoup	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	6.58E-03	1.00E-03
FunCoup	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	5.85E-03	7.26E-04
FunCoup	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	6.59E-04	6.70E-04
FunCoup	MF	GO:0061980	regulatory RNA binding	-	52	44	-	-	9.91E-03	2.01E-03
FunCoup	MF	GO:0015035	protein-disulfide reductase activity	-	32	31	-	-	1.55E-03	1.40E-03
FunCoup	MF	GO:0001671	ATPase activator activity	-	29	28	-	-	1.00E-03	1.28E-03
FunCoup	MF	GO:0070840	dynein complex binding	-	25	24	-	-	2.44E-03	1.12E-03
FunCoup	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	3.00E-03	1.12E-03
FunCoup	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.23E-03	7.26E-04
FunCoup	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	1.12E-03	1.56E-03
FunCoup	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	6.73E-04	8.37E-04
FunCoup	MF	GO:0005178	integrin binding	-	153	150	-	-	1.73E-02	6.70E-03
FunCoup	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	1.08E-03	7.81E-04
FunCoup	MF	GO:0005549	odorant binding	-	128	110	-	-	2.83E-02	4.91E-03
FunCoup	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	5.93E-03	6.70E-04
FunCoup	MF	GO:0008327	methyl-CpG binding	-	31	25	-	-	1.35E-03	1.12E-03
FunCoup	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	1.37E-02	8.93E-04
FunCoup	MF	GO:0048019	receptor antagonist activity	-	31	15	-	-	2.10E-04	6.70E-04
FunCoup	MF	GO:0005521	lamin binding	-	15	15	-	-	6.32E-03	6.70E-04
FunCoup	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	1.23E-03	8.93E-04
FunCoup	MF	GO:0140318	protein transporter activity	-	40	40	-	-	4.81E-03	1.79E-03
FunCoup	MF	GO:0070628	proteasome binding	-	17	17	-	-	9.42E-04	7.81E-04
FunCoup	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	1.54E-02	5.02E-04
FunCoup	MF	GO:0031432	titin binding	-	13	13	-	-	1.33E-02	6.14E-04
FunCoup	MF	GO:0046812	host cell surface binding	-	11	11	-	-	9.40E-03	5.02E-04
FunCoup	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	2.84E-03	1.67E-03
FunCoup	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	7.82E-04	7.81E-04
FunCoup	MF	GO:0002039	p53 binding	-	66	65	-	-	3.44E-03	2.90E-03
FunCoup	MF	GO:0005496	steroid binding	-	110	107	-	-	6.07E-03	4.80E-03
FunCoup	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.46E-03	1.23E-03
FunCoup	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.59E-03	5.02E-04
FunCoup	MF	GO:0003684	damaged DNA binding	-	89	84	-	-	6.85E-03	3.80E-03
FunCoup	MF	GO:0000339	RNA cap binding	-	20	20	-	-	3.62E-02	8.93E-04
FunCoup	MF	GO:0016500	protein-hormone receptor activity	-	21	20	-	-	2.36E-03	8.93E-04
FunCoup	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	124	-	-	3.12E-02	5.58E-03
FunCoup	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	9.94E-03	6.70E-04
FunCoup	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	9.03E-04	5.58E-04
FunCoup	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	1.52E-03	5.02E-04
FunCoup	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	2.74E-03	2.68E-03
FunCoup	MF	GO:0008179	adenylate cyclase binding	-	11	11	-	-	4.19E-03	5.02E-04
FunCoup	MF	GO:0050811	GABA receptor binding	-	18	17	-	-	9.36E-04	7.81E-04
FunCoup	MF	GO:0030971	receptor tyrosine kinase binding	-	76	73	-	-	5.57E-03	3.29E-03
FunCoup	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	83	-	-	6.28E-03	3.74E-03
FunCoup	MF	GO:0140030	modification-dependent protein binding	-	179	175	-	-	1.23E-02	7.81E-03
FunCoup	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	3.05E-03	1.12E-03
FunCoup	MF	GO:0009881	photoreceptor activity	-	17	17	-	-	1.34E-02	7.81E-04
FunCoup	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	18	-	-	2.22E-02	8.37E-04
FunCoup	MF	GO:0032794	GTPase activating protein binding	-	13	12	-	-	4.18E-04	5.58E-04
FunCoup	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	1.01E-02	7.26E-04
FunCoup	MF	GO:0141047	molecular tag activity	-	13	12	-	-	8.20E-04	5.58E-04
FunCoup	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.42E-03	5.02E-04
FunCoup	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	1.39E-04	5.58E-04
FunCoup	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	7.99E-04	6.70E-04
FunCoup	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	1.64E-02	5.58E-04
FunCoup	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.41E-03	6.70E-04
FunCoup	MF	GO:0010851	cyclase regulator activity	-	17	16	-	-	8.05E-02	7.26E-04
FunCoup	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	6.39E-03	6.70E-04
FunCoup	MF	GO:0030276	clathrin binding	-	70	70	-	-	9.23E-03	3.13E-03
FunCoup	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	3.65E-03	1.34E-03
FunCoup	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	2.65E-03	6.70E-04
FunCoup	MF	GO:0046790	virion binding	-	19	18	-	-	3.69E-03	8.37E-04
FunCoup	MF	GO:0030552	cAMP binding	-	48	46	-	-	8.68E-03	2.06E-03
FunCoup	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	40	-	-	2.95E-03	1.79E-03
FunCoup	MF	GO:0035173	histone kinase activity	-	17	17	-	-	1.20E-03	7.81E-04
FunCoup	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	7.12E-03	1.17E-03
FunCoup	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	1.74E-02	5.58E-04
FunCoup	MF	GO:0016209	antioxidant activity	-	92	84	-	-	3.28E-02	3.80E-03
FunCoup	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	4.96E-03	1.34E-03
FunCoup	MF	GO:0044325	transmembrane transporter binding	-	159	157	-	-	6.83E-03	7.03E-03
FunCoup	MF	GO:0048156	tau protein binding	-	43	43	-	-	1.96E-03	1.95E-03
FunCoup	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	5.43E-03	1.62E-03
FunCoup	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	2.05E-03	6.14E-04
FunCoup	MF	GO:0140272	exogenous protein binding	-	79	79	-	-	5.29E-03	3.57E-03
FunCoup	MF	GO:0030145	manganese ion binding	-	65	62	-	-	2.72E-03	2.79E-03
FunCoup	MF	GO:0071814	protein-lipid complex binding	-	52	46	-	-	9.01E-03	2.06E-03
FunCoup	MF	GO:0008066	glutamate receptor activity	-	70	69	-	-	1.81E-02	3.13E-03
FunCoup	MF	GO:0030553	cGMP binding	-	15	14	-	-	2.03E-02	6.70E-04
FunCoup	MF	GO:0017069	snRNA binding	-	54	46	-	-	6.46E-03	2.06E-03
FunCoup	MF	GO:0030215	semaphorin receptor binding	-	23	22	-	-	3.00E-02	1.00E-03
FunCoup	MF	GO:0031996	thioesterase binding	-	11	11	-	-	5.07E-03	5.02E-04
FunCoup	MF	GO:0031369	translation initiation factor binding	-	32	29	-	-	1.65E-03	1.34E-03
FunCoup	MF	GO:0019843	rRNA binding	-	69	67	-	-	3.21E-03	3.01E-03
FunCoup	MF	GO:0004713	protein tyrosine kinase activity	-	213	209	-	-	1.31E-02	9.38E-03
FunCoup	MF	GO:0061783	peptidoglycan muralytic activity	-	14	11	-	-	2.55E-03	5.02E-04
FunCoup	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	8.64E-03	2.29E-03
FunCoup	MF	GO:0008093	cytoskeletal anchor activity	-	24	23	-	-	2.28E-03	1.06E-03
FunCoup	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	1.25E-03	8.93E-04
FunCoup	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	29	-	-	7.92E-03	1.34E-03
FunCoup	MF	GO:0016208	AMP binding	-	22	22	-	-	6.57E-02	1.00E-03
FunCoup	MF	GO:0000287	magnesium ion binding	-	225	216	-	-	7.13E-03	9.66E-03
FunCoup	MF	GO:0031490	chromatin DNA binding	-	120	117	-	-	6.75E-03	5.25E-03
FunCoup	MF	GO:0017022	myosin binding	-	73	72	-	-	4.61E-03	3.24E-03
FunCoup	MF	GO:0004896	cytokine receptor activity	-	93	92	-	-	3.86E-02	4.13E-03
FunCoup	MF	GO:0017166	vinculin binding	-	12	12	-	-	3.01E-03	5.58E-04
FunCoup	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	5.64E-03	8.37E-04
FunCoup	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	1.26E-03	5.58E-04
FunCoup	MF	GO:0005539	glycosaminoglycan binding	-	236	225	-	-	2.28E-02	1.00E-02
FunCoup	MF	GO:0140666	annealing activity	-	11	11	-	-	1.53E-03	5.02E-04
FunCoup	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.13E-03	6.70E-04
FunCoup	MF	GO:0010181	FMN binding	-	15	15	-	-	4.38E-04	6.70E-04
FunCoup	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	20	-	-	2.65E-02	8.93E-04
FunCoup	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	25	-	-	3.68E-04	1.12E-03
FunCoup	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	7.26E-04	7.81E-04
FunCoup	MF	GO:0044183	protein folding chaperone	-	67	57	-	-	1.13E-03	2.57E-03
FunCoup	MF	GO:0005132	type I interferon receptor binding	-	17	17	-	-	3.94E-01	7.81E-04
FunCoup	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	1.24E-02	4.86E-03
FunCoup	MF	GO:0003725	double-stranded RNA binding	-	72	72	-	-	7.67E-03	3.24E-03
FunCoup	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	1.83E-02	7.26E-04
FunCoup	MF	GO:0051018	protein kinase A binding	-	52	49	-	-	1.55E-02	2.23E-03
FunCoup	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	2.98E-03	1.56E-03
FunCoup	MF	GO:0004618	phosphoglycerate kinase activity	-	89	87	-	-	3.35E-03	3.91E-03
FunCoup	MF	GO:0042805	actinin binding	-	36	36	-	-	8.07E-03	1.62E-03
FunCoup	MF	GO:0043531	ADP binding	-	38	38	-	-	1.75E-03	1.73E-03
FunCoup	MF	GO:0043394	proteoglycan binding	-	36	34	-	-	1.49E-02	1.56E-03
FunCoup	MF	GO:0005542	folic acid binding	-	13	11	-	-	9.75E-03	5.02E-04
FunCoup	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	4.34E-03	5.02E-04
FunCoup	MF	GO:0046332	SMAD binding	-	77	76	-	-	7.75E-03	3.40E-03
FunCoup	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.01E-03	6.14E-04
FunCoup	MF	GO:0001968	fibronectin binding	-	30	30	-	-	3.90E-03	1.34E-03
FunCoup	MF	GO:0048038	quinone binding	-	16	15	-	-	1.10E-02	6.70E-04
FunCoup	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	117	-	-	9.70E-03	5.25E-03
FunCoup	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	77	-	-	7.15E-03	3.46E-03
FunCoup	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	1.52E-03	8.37E-04
FunCoup	MF	GO:0051117	ATPase binding	-	85	84	-	-	2.97E-03	3.80E-03
FunCoup	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	45	-	-	2.42E-03	2.01E-03
FunCoup	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	1.54E-03	8.93E-04
FunCoup	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	5.30E-02	5.02E-04
FunCoup	MF	GO:0070402	NADPH binding	-	16	15	-	-	1.21E-03	6.70E-04
FunCoup	MF	GO:0031404	chloride ion binding	-	14	14	-	-	6.69E-03	6.70E-04
FunCoup	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	3.57E-03	2.73E-03
FunCoup	MF	GO:0036002	pre-mRNA binding	-	57	34	-	-	5.66E-03	1.56E-03
FunCoup	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	35	-	-	1.96E-03	1.56E-03
FunCoup	MF	GO:0051540	metal cluster binding	-	71	70	-	-	3.16E-03	3.13E-03
FunCoup	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	3.76E-03	5.02E-04
FunCoup	MF	GO:0051219	phosphoprotein binding	-	92	91	-	-	5.95E-03	4.07E-03
FunCoup	MF	GO:0019894	kinesin binding	-	45	45	-	-	2.47E-03	2.01E-03
FunCoup	MF	GO:0042287	MHC protein binding	-	68	60	-	-	1.67E-02	2.68E-03
FunCoup	MF	GO:0019003	GDP binding	-	89	85	-	-	5.77E-03	3.80E-03
FunCoup	MF	GO:0017171	serine hydrolase activity	-	207	187	-	-	1.01E-01	8.37E-03
FunCoup	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	2.82E-03	2.96E-03
FunCoup	MF	GO:0003774	cytoskeletal motor activity	-	117	116	-	-	3.38E-02	5.19E-03
FunCoup	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	28	-	-	7.24E-04	1.28E-03
FunCoup	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	6.23E-03	7.81E-04
FunCoup	MF	GO:0061134	peptidase regulator activity	-	224	204	-	-	2.74E-02	9.15E-03
FunCoup	MF	GO:0008013	beta-catenin binding	-	86	85	-	-	9.98E-03	3.80E-03
FunCoup	MF	GO:0051015	actin filament binding	-	208	206	-	-	2.71E-02	9.21E-03
FunCoup	MF	GO:0019208	phosphatase regulator activity	-	107	102	-	-	8.39E-03	4.58E-03
FunCoup	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	28	-	-	4.75E-02	1.28E-03
FunCoup	MF	GO:0043236	laminin binding	-	29	28	-	-	2.63E-03	1.28E-03
FunCoup	MF	GO:0030507	spectrin binding	-	26	26	-	-	4.34E-02	1.17E-03
FunCoup	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	2.25E-03	1.84E-03
FunCoup	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	110	-	-	1.50E-02	4.91E-03
FunCoup	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	23	-	-	4.24E-03	1.06E-03
FunCoup	MF	GO:0042393	histone binding	-	240	227	-	-	2.05E-02	1.02E-02
FunCoup	MF	GO:0019838	growth factor binding	-	182	178	-	-	1.14E-02	7.98E-03
FunCoup	MF	GO:0000149	SNARE binding	-	107	104	-	-	1.78E-02	4.69E-03
FunCoup	MF	GO:0003727	single-stranded RNA binding	-	90	87	-	-	9.70E-03	3.91E-03
FunCoup	MF	GO:0051378	serotonin binding	-	24	24	-	-	1.82E-02	1.12E-03
FunCoup	MF	GO:0005516	calmodulin binding	-	206	203	-	-	1.11E-02	9.10E-03
FunCoup	MF	GO:0019825	oxygen binding	-	40	39	-	-	1.01E-01	1.79E-03
FunCoup	MF	GO:0045505	dynein intermediate chain binding	-	37	37	-	-	1.56E-02	1.67E-03
FunCoup	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	86	-	-	1.26E-02	3.85E-03
FunCoup	MF	GO:0032182	ubiquitin-like protein binding	-	117	117	-	-	4.07E-03	5.25E-03
FunCoup	MF	GO:0023023	MHC protein complex binding	-	36	34	-	-	1.38E-02	1.56E-03
FunCoup	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	2.88E-03	1.00E-03
FunCoup	MF	GO:0043274	phospholipase binding	-	23	23	-	-	9.47E-04	1.06E-03
FunCoup	MF	GO:0031072	heat shock protein binding	-	128	125	-	-	3.54E-03	5.58E-03
FunCoup	MF	GO:0030515	snoRNA binding	-	33	33	-	-	2.87E-03	1.51E-03
FunCoup	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	76	-	-	4.61E-02	3.40E-03
FunCoup	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	22	-	-	1.09E-02	1.00E-03
FunCoup	MF	GO:0001965	G-protein alpha-subunit binding	-	26	25	-	-	1.34E-03	1.12E-03
FunCoup	MF	GO:0001530	lipopolysaccharide binding	-	38	35	-	-	1.48E-03	1.56E-03
FunCoup	MF	GO:0140223	general transcription initiation factor activity	-	55	51	-	-	2.00E-02	2.29E-03
FunCoup	MF	GO:0070403	NAD+ binding	-	16	15	-	-	1.47E-03	6.70E-04
FunCoup	MF	GO:0000049	tRNA binding	-	75	74	-	-	5.20E-03	3.35E-03
FunCoup	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	43	-	-	3.44E-03	1.95E-03
FunCoup	MF	GO:0015026	coreceptor activity	-	48	48	-	-	9.88E-03	2.18E-03
FunCoup	MF	GO:0005527	macrolide binding	-	12	12	-	-	3.09E-03	5.58E-04
FunCoup	MF	GO:0001653	peptide receptor activity	-	128	121	-	-	7.33E-02	5.41E-03
FunCoup	MF	GO:0031005	filamin binding	-	15	13	-	-	8.92E-04	6.14E-04
FunCoup	MF	GO:0030506	ankyrin binding	-	19	19	-	-	3.51E-03	8.93E-04
FunCoup	MF	GO:0006469	negative regulation of protein kinase activity	-	222	207	-	-	5.03E-03	9.26E-03
FunCoup	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	1.56E-03	8.93E-04
FunCoup	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	2.65E-03	6.70E-04
FunCoup	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	30	-	-	6.01E-03	1.34E-03
FunCoup	MF	GO:0051427	hormone receptor binding	-	31	30	-	-	7.19E-02	1.34E-03
FunCoup	MF	GO:0070851	growth factor receptor binding	-	141	136	-	-	1.09E-02	6.08E-03
FunCoup	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	2.41E-03	1.45E-03
FunCoup	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	41	-	-	4.42E-03	1.84E-03
FunCoup	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	4.03E-03	8.93E-04
FunCoup	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	18	-	-	1.40E-03	8.37E-04
FunCoup	MF	GO:0005506	iron ion binding	-	154	148	-	-	7.94E-02	6.64E-03
FunCoup	MF	GO:0003925	G protein activity	-	45	41	-	-	3.17E-03	1.84E-03
FunCoup	MF	GO:0034987	immunoglobulin receptor binding	-	11	11	-	-	3.61E-02	5.02E-04
FunCoup	MF	GO:0038187	pattern recognition receptor activity	-	33	32	-	-	4.39E-03	1.45E-03
FunCoup	MF	GO:0008276	protein methyltransferase activity	-	96	93	-	-	5.65E-03	4.19E-03
FunCoup	MF	GO:0004396	hexokinase activity	-	16	16	-	-	2.23E-02	7.26E-04
FunCoup	MF	GO:0070888	E-box binding	-	59	59	-	-	1.38E-02	2.68E-03
FunCoup	MF	GO:0039706	co-receptor binding	-	14	12	-	-	6.22E-04	5.58E-04
FunCoup	MF	GO:0015399	primary active transmembrane transporter activity	-	190	177	-	-	1.63E-02	7.92E-03
FunCoup	MF	GO:0035254	glutamate receptor binding	-	47	46	-	-	4.30E-03	2.06E-03
FunCoup	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	2.57E-03	1.51E-03
FunCoup	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	5.01E-03	5.02E-04
FunCoup	MF	GO:0043021	ribonucleoprotein complex binding	-	158	156	-	-	4.54E-03	6.98E-03
FunCoup	MF	GO:0030170	pyridoxal phosphate binding	-	56	52	-	-	2.17E-02	2.34E-03
FunCoup	MF	GO:0032393	MHC class I receptor activity	-	15	11	-	-	1.72E-02	5.02E-04
FunCoup	MF	GO:0005112	Notch binding	-	26	25	-	-	2.17E-03	1.12E-03
FunCoup	MF	GO:0048185	activin binding	-	16	16	-	-	8.75E-03	7.26E-04
FunCoup	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	9.72E-04	1.28E-03
FunCoup	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	5.45E-03	5.02E-04
FunCoup	MF	GO:0140299	small molecule sensor activity	-	39	33	-	-	3.41E-03	1.51E-03
FunCoup	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	3.22E-03	1.00E-03
FunCoup	MF	GO:0016917	GABA receptor activity	-	23	23	-	-	3.07E-02	1.06E-03
FunCoup	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	1.02E-02	6.70E-04
FunCoup	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	25	-	-	2.54E-02	1.12E-03
FunCoup	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	45	-	-	3.83E-02	2.01E-03
FunCoup	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.40E-03	1.12E-03
FunCoup	MF	GO:0008527	taste receptor activity	-	28	26	-	-	9.26E-02	1.17E-03
FunCoup	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	2.93E-03	5.58E-04
FunCoup	MF	GO:0030594	neurotransmitter receptor activity	-	160	159	-	-	6.00E-02	7.14E-03
FunCoup	MF	GO:0034452	dynactin binding	-	12	12	-	-	1.09E-03	5.58E-04
FunCoup	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	1.96E-02	1.12E-03
FunCoup	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	1.60E-03	9.49E-04
FunCoup	MF	GO:0005507	copper ion binding	-	63	57	-	-	2.92E-03	2.57E-03
FunCoup	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	2.24E-03	1.00E-03
FunCoup	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	5.44E-03	5.02E-04
FunCoup	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	2.69E-02	1.00E-03
FunCoup	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	1.73E-03	5.58E-04
GeneMANIA	CC	GO:0005739	mitochondrion	7.34E-08	1671	1666	1643	1.01	-	-
GeneMANIA	CC	GO:0005615	extracellular space	1.53E-05	3190	3163	3136	1.01	-	-
GeneMANIA	CC	GO:0005794	Golgi apparatus	3.21E-05	1636	1627	1608	1.01	-	-
GeneMANIA	CC	GO:0005764	lysosome	6.21E-05	747	746	734	1.02	-	-
GeneMANIA	CC	GO:0005783	endoplasmic reticulum	7.35E-05	2020	2006	1986	1.01	-	-
GeneMANIA	CC	GO:0005730	nucleolus	3.18E-04	988	984	971	1.01	-	-
GeneMANIA	CC	GO:0005815	microtubule organizing center	2.34E-03	843	839	829	1.01	-	-
GeneMANIA	CC	GO:0005768	endosome	6.00E-03	1037	1030	1019	1.01	-	-
GeneMANIA	CC	GO:0005635	nuclear envelope	1.96E-02	493	491	485	1.01	-	-
GeneMANIA	CC	GO:0031012	extracellular matrix	2.89E-02	564	561	554	1.01	-	-
GeneMANIA	CC	GO:0000228	nuclear chromosome	5.35E-02	206	206	203	1.02	-	-
GeneMANIA	CC	GO:0005840	ribosome	1.92E-01	222	221	218	1.01	-	-
GeneMANIA	CC	GO:0005929	cilium	3.36E-01	842	832	828	1.01	-	-
GeneMANIA	CC	GO:0005811	lipid droplet	4.23E-01	102	102	100	1.02	-	-
GeneMANIA	CC	GO:0005777	peroxisome	7.36E-01	142	141	140	1.01	-	-
GeneMANIA	BP	GO:0007010	cytoskeleton organization	5.66E-07	1639	1633	1611	1.01	-	-
GeneMANIA	BP	GO:0055085	transmembrane transport	1.04E-06	1784	1776	1754	1.01	-	-
GeneMANIA	BP	GO:0016192	vesicle-mediated transport	1.15E-06	1894	1885	1862	1.01	-	-
GeneMANIA	BP	GO:0007155	cell adhesion	9.67E-06	1444	1438	1420	1.01	-	-
GeneMANIA	BP	GO:0012501	programmed cell death	5.71E-05	1954	1941	1921	1.01	-	-
GeneMANIA	BP	GO:0002376	immune system process	1.39E-04	2448	2428	2407	1.01	-	-
GeneMANIA	BP	GO:0065003	protein-containing complex assembly	2.79E-04	1648	1637	1620	1.01	-	-
GeneMANIA	BP	GO:0006886	intracellular protein transport	2.98E-04	664	663	653	1.02	-	-
GeneMANIA	BP	GO:0006091	generation of precursor metabolites and energy	3.09E-04	502	502	493	1.02	-	-
GeneMANIA	BP	GO:0050877	nervous system process	5.58E-04	1527	1483	1501	0.99	-	-
GeneMANIA	BP	GO:0048870	cell motility	6.32E-04	1659	1647	1631	1.01	-	-
GeneMANIA	BP	GO:0006281	DNA repair	8.84E-04	587	586	577	1.02	-	-
GeneMANIA	BP	GO:0006629	lipid metabolic process	9.69E-04	1355	1346	1332	1.01	-	-
GeneMANIA	BP	GO:0005975	carbohydrate metabolic process	1.26E-03	551	550	542	1.02	-	-
GeneMANIA	BP	GO:0006914	autophagy	1.31E-03	568	567	558	1.02	-	-
GeneMANIA	BP	GO:0006355	regulation of DNA-templated transcription	1.82E-03	3342	3306	3285	1.01	-	-
GeneMANIA	BP	GO:0006913	nucleocytoplasmic transport	7.51E-03	326	326	320	1.02	-	-
GeneMANIA	BP	GO:0006520	amino acid metabolic process	1.08E-02	292	292	287	1.02	-	-
GeneMANIA	BP	GO:0016071	mRNA metabolic process	1.13E-02	713	709	701	1.01	-	-
GeneMANIA	BP	GO:0007018	microtubule-based movement	1.13E-02	640	637	629	1.01	-	-
GeneMANIA	BP	GO:0006325	chromatin organization	1.14E-02	720	716	708	1.01	-	-
GeneMANIA	BP	GO:0034330	cell junction organization	1.16E-02	727	723	715	1.01	-	-
GeneMANIA	BP	GO:0072659	protein localization to plasma membrane	1.69E-02	284	284	279	1.02	-	-
GeneMANIA	BP	GO:0007005	mitochondrion organization	1.93E-02	484	482	476	1.01	-	-
GeneMANIA	BP	GO:0003013	circulatory system process	2.09E-02	584	581	574	1.01	-	-
GeneMANIA	BP	GO:0006954	inflammatory response	2.58E-02	820	814	806	1.01	-	-
GeneMANIA	BP	GO:0007163	establishment or maintenance of cell polarity	3.58E-02	227	227	223	1.02	-	-
GeneMANIA	BP	GO:0003012	muscle system process	5.33E-02	425	423	418	1.01	-	-
GeneMANIA	BP	GO:0030198	extracellular matrix organization	7.11E-02	314	313	309	1.01	-	-
GeneMANIA	BP	GO:0044782	cilium organization	7.31E-02	399	397	392	1.01	-	-
GeneMANIA	BP	GO:0006399	tRNA metabolic process	8.43E-02	196	196	193	1.02	-	-
GeneMANIA	BP	GO:0006260	DNA replication	9.71E-02	279	278	274	1.01	-	-
GeneMANIA	BP	GO:0030163	protein catabolic process	9.86E-02	990	980	973	1.01	-	-
GeneMANIA	BP	GO:0002181	cytoplasmic translation	1.19E-01	153	153	150	1.02	-	-
GeneMANIA	BP	GO:0140053	mitochondrial gene expression	1.21E-01	164	164	161	1.02	-	-
GeneMANIA	BP	GO:0042060	wound healing	1.28E-01	431	428	424	1.01	-	-
GeneMANIA	BP	GO:0006310	DNA recombination	1.35E-01	333	331	327	1.01	-	-
GeneMANIA	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.41E-01	729	722	717	1.01	-	-
GeneMANIA	BP	GO:0007059	chromosome segregation	1.70E-01	403	400	396	1.01	-	-
GeneMANIA	BP	GO:0006486	protein glycosylation	1.92E-01	225	224	221	1.01	-	-
GeneMANIA	BP	GO:0042254	ribosome biogenesis	2.51E-01	297	295	292	1.01	-	-
GeneMANIA	BP	GO:0006766	vitamin metabolic process	2.68E-01	107	107	105	1.02	-	-
GeneMANIA	BP	GO:0007040	lysosome organization	2.68E-01	107	107	105	1.02	-	-
GeneMANIA	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	2.74E-01	119	119	117	1.02	-	-
GeneMANIA	BP	GO:0003014	renal system process	2.82E-01	127	127	125	1.02	-	-
GeneMANIA	BP	GO:0140013	meiotic nuclear division	3.41E-01	279	277	274	1.01	-	-
GeneMANIA	BP	GO:0006575	cellular modified amino acid metabolic process	3.82E-01	186	185	183	1.01	-	-
GeneMANIA	BP	GO:0032200	telomere organization	3.82E-01	186	185	183	1.01	-	-
GeneMANIA	BP	GO:0006790	sulfur compound metabolic process	3.84E-01	320	317	315	1.01	-	-
GeneMANIA	BP	GO:0098542	defense response to other organism	4.81E-01	1171	1155	1151	1.00	-	-
GeneMANIA	BP	GO:0000910	cytokinesis	1.00E+00	186	183	183	1.00	-	-
GeneMANIA	BP	GO:0006457	protein folding	1.00E+00	210	207	206	1.00	-	-
GeneMANIA	BP	GO:0022600	digestive system process	1.00E+00	110	109	108	1.01	-	-
GeneMANIA	BP	GO:0098754	detoxification	1.00E+00	134	132	132	1.00	-	-
GeneMANIA	MF	GO:0016740	transferase activity	1.78E-10	3074	3059	3022	1.01	-	-
GeneMANIA	MF	GO:0140096	"catalytic activity, acting on a protein"	4.32E-08	3198	3177	3144	1.01	-	-
GeneMANIA	MF	GO:0003723	RNA binding	5.95E-06	1679	1671	1651	1.01	-	-
GeneMANIA	MF	GO:0005215	transporter activity	2.96E-05	1462	1455	1437	1.01	-	-
GeneMANIA	MF	GO:0140657	ATP-dependent activity	9.31E-05	729	728	717	1.02	-	-
GeneMANIA	MF	GO:0140097	"catalytic activity, acting on DNA"	2.23E-03	383	383	377	1.02	-	-
GeneMANIA	MF	GO:0008289	lipid binding	2.31E-03	836	832	822	1.01	-	-
GeneMANIA	MF	GO:0008092	cytoskeletal protein binding	2.51E-03	1023	1017	1006	1.01	-	-
GeneMANIA	MF	GO:0016491	oxidoreductase activity	4.63E-03	888	883	873	1.01	-	-
GeneMANIA	MF	GO:0016829	lyase activity	9.89E-03	538	536	529	1.01	-	-
GeneMANIA	MF	GO:0016874	ligase activity	1.68E-02	283	283	278	1.02	-	-
GeneMANIA	MF	GO:0003924	GTPase activity	2.08E-02	658	654	647	1.01	-	-
GeneMANIA	MF	GO:0140098	"catalytic activity, acting on RNA"	5.22E-02	417	415	410	1.01	-	-
GeneMANIA	MF	GO:0009975	cyclase activity	9.67E-02	277	276	272	1.01	-	-
GeneMANIA	MF	GO:0016853	isomerase activity	1.37E-01	252	251	248	1.01	-	-
GeneMANIA	MF	GO:0045182	translation regulator activity	1.89E-01	151	151	148	1.02	-	-
GeneMANIA	MF	GO:0005198	structural molecule activity	2.60E-01	798	789	784	1.01	-	-
GeneMANIA	MF	GO:0003774	cytoskeletal motor activity	2.71E-01	116	116	114	1.02	-	-
GeneMANIA	MF	GO:0038024	cargo receptor activity	2.72E-01	117	117	115	1.02	-	-
GeneMANIA	MF	GO:0003677	DNA binding	3.45E-01	2865	2823	2816	1.00	-	-
GeneMANIA	MF	GO:0140104	molecular carrier activity	4.28E-01	105	105	103	1.02	-	-
GeneMANIA	MF	GO:0042393	histone binding	4.46E-01	237	235	233	1.01	-	-
GeneMANIA	MF	GO:0140110	transcription regulator activity	7.16E-01	2033	2001	1999	1.00	-	-
GeneMANIA	MF	GO:0048018	receptor ligand activity	8.60E-01	504	495	495	1.00	-	-
GeneMANIA	BP	GO:0008038	neuron recognition	-	46	46	-	-	1.34E-02	1.94E-03
GeneMANIA	BP	GO:1905145	cellular response to acetylcholine	-	33	33	-	-	3.20E-03	1.42E-03
GeneMANIA	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	3.26E-03	7.87E-04
GeneMANIA	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	3.34E-03	8.92E-04
GeneMANIA	BP	GO:0051931	regulation of sensory perception	-	36	36	-	-	3.04E-03	1.52E-03
GeneMANIA	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	3.76E-03	1.05E-03
GeneMANIA	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	4.60E-03	5.77E-04
GeneMANIA	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	5.66E-04	5.77E-04
GeneMANIA	BP	GO:0009268	response to pH	-	43	42	-	-	5.91E-03	1.78E-03
GeneMANIA	BP	GO:0045666	positive regulation of neuron differentiation	-	91	87	-	-	6.13E-03	3.67E-03
GeneMANIA	BP	GO:0043543	protein acylation	-	107	104	-	-	1.36E-01	4.41E-03
GeneMANIA	MF	GO:0051349	positive regulation of lyase activity	-	41	40	-	-	3.36E-02	1.68E-03
GeneMANIA	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	3.55E-03	6.29E-04
GeneMANIA	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.52E-03	1.05E-03
GeneMANIA	BP	GO:0022401	negative adaptation of signaling pathway	-	21	21	-	-	2.72E-03	8.92E-04
GeneMANIA	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	141	-	-	1.16E-01	5.93E-03
GeneMANIA	BP	GO:0071763	nuclear membrane organization	-	44	43	-	-	4.16E-02	1.84E-03
GeneMANIA	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	35	-	-	1.97E-03	1.47E-03
GeneMANIA	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	7.37E-02	2.88E-03
GeneMANIA	BP	GO:0022038	corpus callosum development	-	25	25	-	-	4.07E-03	1.05E-03
GeneMANIA	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	14	-	-	2.15E-03	6.29E-04
GeneMANIA	BP	GO:0021548	pons development	-	11	11	-	-	7.91E-04	4.72E-04
GeneMANIA	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	1.97E-03	5.24E-04
GeneMANIA	BP	GO:0043299	leukocyte degranulation	-	82	82	-	-	1.31E-02	3.46E-03
GeneMANIA	BP	GO:0048864	stem cell development	-	88	88	-	-	9.32E-02	3.72E-03
GeneMANIA	BP	GO:0009310	amine catabolic process	-	20	17	-	-	1.57E-02	7.34E-04
GeneMANIA	BP	GO:0051651	maintenance of location in cell	-	236	227	-	-	1.33E-02	9.54E-03
GeneMANIA	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	1.78E-02	1.15E-03
GeneMANIA	BP	GO:0014004	microglia differentiation	-	12	12	-	-	7.64E-03	5.24E-04
GeneMANIA	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	2.66E-02	1.31E-03
GeneMANIA	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	3.50E-04	6.29E-04
GeneMANIA	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	6.62E-03	6.29E-04
GeneMANIA	BP	GO:0046415	urate metabolic process	-	12	12	-	-	5.77E-02	5.24E-04
GeneMANIA	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	4.23E-03	1.26E-03
GeneMANIA	BP	GO:0006949	syncytium formation	-	66	64	-	-	1.55E-02	2.73E-03
GeneMANIA	BP	GO:0045176	apical protein localization	-	15	15	-	-	7.23E-04	6.29E-04
GeneMANIA	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	2.56E-02	6.29E-04
GeneMANIA	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	57	-	-	1.56E-02	2.41E-03
GeneMANIA	BP	GO:0030574	collagen catabolic process	-	45	45	-	-	2.04E-01	1.89E-03
GeneMANIA	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	1.85E-02	1.94E-03
GeneMANIA	BP	GO:0060343	trabecula formation	-	26	26	-	-	2.09E-03	1.10E-03
GeneMANIA	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	2.55E-03	5.24E-04
GeneMANIA	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	1.47E-02	9.96E-04
GeneMANIA	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	1.23E-01	6.82E-04
GeneMANIA	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	4.08E-03	7.87E-04
GeneMANIA	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	8.52E-03	1.73E-03
GeneMANIA	BP	GO:0006413	translational initiation	-	122	122	-	-	1.34E-01	5.14E-03
GeneMANIA	BP	GO:0072176	nephric duct development	-	15	15	-	-	2.43E-03	6.29E-04
GeneMANIA	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	9.61E-03	2.15E-03
GeneMANIA	CC	GO:0005200	structural constituent of cytoskeleton	-	112	111	-	-	9.28E-02	4.67E-03
GeneMANIA	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	8.31E-03	2.15E-03
GeneMANIA	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	4.57E-03	6.29E-04
GeneMANIA	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	1.18E-01	1.05E-03
GeneMANIA	BP	GO:1903036	positive regulation of response to wounding	-	76	70	-	-	6.69E-03	2.94E-03
GeneMANIA	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	1.18E-01	8.92E-04
GeneMANIA	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	228	-	-	1.23E-01	9.60E-03
GeneMANIA	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.22E-03	1.15E-03
GeneMANIA	BP	GO:0032528	microvillus organization	-	24	24	-	-	2.06E-03	1.05E-03
GeneMANIA	BP	GO:0021954	central nervous system neuron development	-	85	85	-	-	3.63E-03	3.57E-03
GeneMANIA	BP	GO:0055017	cardiac muscle tissue growth	-	92	74	-	-	6.39E-03	3.15E-03
GeneMANIA	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	6.11E-03	1.31E-03
GeneMANIA	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	9.66E-04	5.77E-04
GeneMANIA	BP	GO:0048524	positive regulation of viral process	-	64	64	-	-	2.35E-03	2.73E-03
GeneMANIA	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	14	-	-	8.74E-03	6.29E-04
GeneMANIA	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	1.47E-02	8.92E-04
GeneMANIA	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	24	-	-	1.48E-03	1.05E-03
GeneMANIA	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	2.17E-03	7.34E-04
GeneMANIA	BP	GO:0098661	inorganic anion transmembrane transport	-	140	139	-	-	9.29E-02	5.87E-03
GeneMANIA	BP	GO:0006099	tricarboxylic acid cycle	-	33	33	-	-	7.62E-02	1.42E-03
GeneMANIA	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	6.87E-03	7.87E-04
GeneMANIA	BP	GO:0009612	response to mechanical stimulus	-	215	214	-	-	1.20E-02	9.02E-03
GeneMANIA	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	1.30E-02	3.30E-03
GeneMANIA	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	140	-	-	7.11E-03	5.87E-03
GeneMANIA	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	2.79E-03	5.77E-04
GeneMANIA	BP	GO:0071542	dopaminergic neuron differentiation	-	36	36	-	-	8.73E-03	1.52E-03
GeneMANIA	BP	GO:0140115	export across plasma membrane	-	82	65	-	-	4.36E-02	2.73E-03
GeneMANIA	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	1.45E-03	5.24E-04
GeneMANIA	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	1.87E-03	1.63E-03
GeneMANIA	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	4.61E-03	5.24E-04
GeneMANIA	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	2.27E-03	4.72E-04
GeneMANIA	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	29	-	-	4.50E-02	1.26E-03
GeneMANIA	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	41	-	-	8.82E-03	1.73E-03
GeneMANIA	MF	GO:0003714	transcription corepressor activity	-	190	189	-	-	4.05E-02	7.97E-03
GeneMANIA	BP	GO:0035878	nail development	-	11	11	-	-	8.52E-04	4.72E-04
GeneMANIA	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	55	-	-	8.71E-03	2.31E-03
GeneMANIA	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	1.11E-03	6.82E-04
GeneMANIA	CC	GO:0006858	extracellular transport	-	45	45	-	-	3.03E-02	1.89E-03
GeneMANIA	BP	GO:0006304	DNA modification	-	30	30	-	-	8.92E-02	1.26E-03
GeneMANIA	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	4.26E-02	7.87E-04
GeneMANIA	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	2.71E-02	2.10E-03
GeneMANIA	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	5.97E-04	7.87E-04
GeneMANIA	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	1.43E-02	6.29E-04
GeneMANIA	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	42	-	-	1.08E-01	1.78E-03
GeneMANIA	BP	GO:0070417	cellular response to cold	-	13	13	-	-	4.43E-03	5.77E-04
GeneMANIA	BP	GO:0043523	regulation of neuron apoptotic process	-	218	213	-	-	5.46E-03	8.97E-03
GeneMANIA	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	2.72E-03	9.44E-04
GeneMANIA	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	2.31E-03	6.29E-04
GeneMANIA	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	8.71E-03	2.41E-03
GeneMANIA	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	3.21E-02	5.77E-04
GeneMANIA	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	1.24E-03	1.05E-03
GeneMANIA	BP	GO:0014029	neural crest formation	-	15	15	-	-	2.61E-03	6.29E-04
GeneMANIA	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	3.85E-03	9.96E-04
GeneMANIA	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	43	-	-	2.70E-02	1.84E-03
GeneMANIA	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	69	-	-	8.03E-03	2.94E-03
GeneMANIA	BP	GO:0003188	heart valve formation	-	16	16	-	-	3.92E-02	6.82E-04
GeneMANIA	CC	GO:0045324	late endosome to vacuole transport	-	37	36	-	-	3.41E-01	1.52E-03
GeneMANIA	BP	GO:0043954	cellular component maintenance	-	72	70	-	-	7.77E-03	2.94E-03
GeneMANIA	BP	GO:0050435	amyloid-beta metabolic process	-	65	52	-	-	8.09E-03	2.20E-03
GeneMANIA	BP	GO:0014823	response to activity	-	70	69	-	-	2.36E-03	2.94E-03
GeneMANIA	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	1.04E-02	7.87E-04
GeneMANIA	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	1.24E-01	1.21E-03
GeneMANIA	BP	GO:0034502	protein localization to chromosome	-	130	128	-	-	7.52E-02	5.40E-03
GeneMANIA	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	9.11E-04	4.72E-04
GeneMANIA	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	1.88E-02	4.72E-04
GeneMANIA	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	3.20E-03	7.34E-04
GeneMANIA	BP	GO:0019233	sensory perception of pain	-	103	103	-	-	3.95E-03	4.35E-03
GeneMANIA	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	6.25E-02	9.44E-04
GeneMANIA	BP	GO:0031343	positive regulation of cell killing	-	75	73	-	-	7.99E-02	3.09E-03
GeneMANIA	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	5.47E-03	1.63E-03
GeneMANIA	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	128	-	-	1.02E-01	5.40E-03
GeneMANIA	BP	GO:0017148	negative regulation of translation	-	390	117	-	-	3.12E-02	4.93E-03
GeneMANIA	BP	GO:0030220	platelet formation	-	22	22	-	-	1.74E-03	9.44E-04
GeneMANIA	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	82	-	-	7.08E-03	3.46E-03
GeneMANIA	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	8.25E-03	5.24E-04
GeneMANIA	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	6.73E-03	6.29E-04
GeneMANIA	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	2.46E-02	6.29E-04
GeneMANIA	BP	GO:1903509	liposaccharide metabolic process	-	109	107	-	-	1.04E-01	4.51E-03
GeneMANIA	BP	GO:0009582	detection of abiotic stimulus	-	140	136	-	-	8.61E-03	5.72E-03
GeneMANIA	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	1.53E-03	5.77E-04
GeneMANIA	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	19	-	-	4.11E-02	8.39E-04
GeneMANIA	CC	GO:0140238	presynaptic endocytosis	-	72	71	-	-	3.11E-02	2.99E-03
GeneMANIA	BP	GO:0051236	establishment of RNA localization	-	161	159	-	-	1.07E-01	6.71E-03
GeneMANIA	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	1.28E-02	1.05E-03
GeneMANIA	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	2.73E-02	7.34E-04
GeneMANIA	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	193	-	-	3.84E-02	8.13E-03
GeneMANIA	BP	GO:0034067	protein localization to Golgi apparatus	-	30	30	-	-	7.50E-03	1.26E-03
GeneMANIA	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	2.14E-03	1.36E-03
GeneMANIA	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	1.33E-02	4.72E-04
GeneMANIA	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	1.99E-02	7.34E-04
GeneMANIA	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	51	-	-	1.26E-01	2.15E-03
GeneMANIA	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	39	-	-	5.42E-03	1.68E-03
GeneMANIA	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	3.93E-03	2.20E-03
GeneMANIA	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	3.67E-03	6.82E-04
GeneMANIA	BP	GO:0050779	RNA destabilization	-	135	101	-	-	1.51E-01	4.25E-03
GeneMANIA	BP	GO:0006023	aminoglycan biosynthetic process	-	74	74	-	-	5.89E-02	3.15E-03
GeneMANIA	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	3.06E-02	2.88E-03
GeneMANIA	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	1.70E-03	1.68E-03
GeneMANIA	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	5.42E-02	1.26E-03
GeneMANIA	BP	GO:0035272	exocrine system development	-	46	46	-	-	3.82E-03	1.94E-03
GeneMANIA	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	1.44E-02	7.34E-04
GeneMANIA	BP	GO:0022406	membrane docking	-	90	89	-	-	9.45E-02	3.78E-03
GeneMANIA	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	5.38E-02	6.29E-04
GeneMANIA	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	1.40E-03	6.82E-04
GeneMANIA	BP	GO:0050777	negative regulation of immune response	-	196	189	-	-	8.39E-03	7.97E-03
GeneMANIA	MF	GO:0005035	death receptor activity	-	16	15	-	-	1.09E-01	6.29E-04
GeneMANIA	BP	GO:0002063	chondrocyte development	-	33	32	-	-	4.01E-03	1.36E-03
GeneMANIA	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	4.99E-04	7.34E-04
GeneMANIA	BP	GO:0099068	postsynapse assembly	-	40	40	-	-	1.17E-02	1.68E-03
GeneMANIA	BP	GO:0021782	glial cell development	-	120	115	-	-	6.23E-03	4.82E-03
GeneMANIA	BP	GO:0051782	negative regulation of cell division	-	18	17	-	-	3.84E-03	7.34E-04
GeneMANIA	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	5.30E-04	4.72E-04
GeneMANIA	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	87	-	-	6.78E-03	3.67E-03
GeneMANIA	BP	GO:0001655	urogenital system development	-	66	66	-	-	3.40E-03	2.78E-03
GeneMANIA	BP	GO:0071827	plasma lipoprotein particle organization	-	86	71	-	-	1.59E-02	2.99E-03
GeneMANIA	BP	GO:0045494	photoreceptor cell maintenance	-	43	43	-	-	8.79E-03	1.84E-03
GeneMANIA	BP	GO:0055088	lipid homeostasis	-	173	157	-	-	2.73E-02	6.61E-03
GeneMANIA	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	9.97E-04	1.10E-03
GeneMANIA	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	198	-	-	9.35E-03	8.34E-03
GeneMANIA	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	30	-	-	6.59E-03	1.26E-03
GeneMANIA	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	1.63E-02	1.47E-03
GeneMANIA	BP	GO:0045667	regulation of osteoblast differentiation	-	147	124	-	-	1.30E-02	5.24E-03
GeneMANIA	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	1.92E-03	6.82E-04
GeneMANIA	BP	GO:0061037	negative regulation of cartilage development	-	32	30	-	-	2.82E-03	1.26E-03
GeneMANIA	BP	GO:0045738	negative regulation of DNA repair	-	40	38	-	-	7.43E-03	1.63E-03
GeneMANIA	BP	GO:0001704	formation of primary germ layer	-	195	189	-	-	1.85E-02	7.97E-03
GeneMANIA	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	2.13E-03	5.77E-04
GeneMANIA	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	4.55E-03	2.15E-03
GeneMANIA	BP	GO:0060174	limb bud formation	-	11	11	-	-	5.44E-03	4.72E-04
GeneMANIA	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	4.25E-03	3.57E-03
GeneMANIA	BP	GO:0042092	type 2 immune response	-	41	41	-	-	2.55E-03	1.73E-03
GeneMANIA	BP	GO:0048588	developmental cell growth	-	233	223	-	-	4.78E-02	9.39E-03
GeneMANIA	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	4.77E-02	8.39E-04
GeneMANIA	BP	GO:0021872	forebrain generation of neurons	-	52	52	-	-	5.97E-03	2.20E-03
GeneMANIA	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	23	-	-	5.43E-04	9.96E-04
GeneMANIA	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	1.20E-01	1.68E-03
GeneMANIA	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	50	-	-	3.10E-02	2.10E-03
GeneMANIA	BP	GO:0072488	ammonium transmembrane transport	-	12	12	-	-	1.78E-01	5.24E-04
GeneMANIA	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	2.28E-02	1.47E-03
GeneMANIA	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	4.41E-04	1.10E-03
GeneMANIA	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	51	-	-	3.06E-02	2.15E-03
GeneMANIA	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	3.02E-02	8.39E-04
GeneMANIA	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	5.84E-02	8.39E-04
GeneMANIA	BP	GO:0010232	vascular transport	-	87	87	-	-	2.13E-02	3.67E-03
GeneMANIA	BP	GO:0021987	cerebral cortex development	-	125	125	-	-	8.93E-03	5.24E-03
GeneMANIA	BP	GO:0008637	apoptotic mitochondrial changes	-	108	102	-	-	5.63E-03	4.30E-03
GeneMANIA	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	8.87E-02	1.47E-03
GeneMANIA	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.36E-02	6.29E-04
GeneMANIA	BP	GO:0060999	positive regulation of dendritic spine development	-	35	35	-	-	2.96E-03	1.47E-03
GeneMANIA	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	1.65E-03	7.87E-04
GeneMANIA	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	7.61E-03	3.25E-03
GeneMANIA	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	1.75E-03	8.39E-04
GeneMANIA	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	1.07E-03	8.39E-04
GeneMANIA	BP	GO:0002064	epithelial cell development	-	210	207	-	-	7.41E-03	8.71E-03
GeneMANIA	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	6.97E-03	7.87E-04
GeneMANIA	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	40	-	-	6.43E-03	1.68E-03
GeneMANIA	BP	GO:2001222	regulation of neuron migration	-	46	46	-	-	1.88E-03	1.94E-03
GeneMANIA	BP	GO:0034389	lipid droplet organization	-	38	38	-	-	5.71E-03	1.63E-03
GeneMANIA	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	8.36E-04	1.89E-03
GeneMANIA	BP	GO:0042177	negative regulation of protein catabolic process	-	109	105	-	-	1.83E-03	4.41E-03
GeneMANIA	MF	GO:0038024	cargo receptor activity	-	121	117	-	-	6.84E-02	4.93E-03
GeneMANIA	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	27	-	-	4.08E-01	1.15E-03
GeneMANIA	BP	GO:0033120	positive regulation of RNA splicing	-	46	44	-	-	1.40E-01	1.89E-03
GeneMANIA	BP	GO:0051445	regulation of meiotic cell cycle	-	64	64	-	-	4.20E-02	2.73E-03
GeneMANIA	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.11E-03	5.24E-04
GeneMANIA	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	3.50E-02	2.52E-03
GeneMANIA	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	1.62E-02	6.29E-04
GeneMANIA	BP	GO:0090087	regulation of peptide transport	-	195	194	-	-	7.06E-03	8.18E-03
GeneMANIA	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	101	-	-	4.31E-03	4.25E-03
GeneMANIA	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	2.32E-03	1.05E-03
GeneMANIA	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	2.10E-03	1.05E-03
GeneMANIA	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	4.82E-03	6.29E-04
GeneMANIA	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	2.25E-02	1.15E-03
GeneMANIA	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	2.69E-03	6.29E-04
GeneMANIA	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	6.00E-03	6.29E-04
GeneMANIA	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	6.67E-02	8.39E-04
GeneMANIA	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	1.24E-02	5.77E-04
GeneMANIA	BP	GO:0022404	molting cycle process	-	95	95	-	-	3.09E-03	3.99E-03
GeneMANIA	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	6.04E-04	4.72E-04
GeneMANIA	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	1.08E-02	7.34E-04
GeneMANIA	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	2.87E-02	8.39E-04
GeneMANIA	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	3.10E-02	5.24E-04
GeneMANIA	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	18	-	-	1.58E-03	7.87E-04
GeneMANIA	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	4.07E-03	1.36E-03
GeneMANIA	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	5.88E-03	6.29E-04
GeneMANIA	BP	GO:0008299	isoprenoid biosynthetic process	-	30	30	-	-	2.29E-02	1.26E-03
GeneMANIA	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	238	-	-	2.66E-02	1.00E-02
GeneMANIA	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.02E-03	1.31E-03
GeneMANIA	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	6.75E-04	9.44E-04
GeneMANIA	CC	GO:0098926	postsynaptic signal transduction	-	39	39	-	-	3.51E-03	1.68E-03
GeneMANIA	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	139	-	-	1.32E-02	5.87E-03
GeneMANIA	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	5.05E-02	8.39E-04
GeneMANIA	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	2.35E-03	1.99E-03
GeneMANIA	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	143	-	-	5.78E-02	6.03E-03
GeneMANIA	BP	GO:0034249	negative regulation of amide metabolic process	-	34	23	-	-	2.00E-02	9.96E-04
GeneMANIA	BP	GO:0061548	ganglion development	-	17	17	-	-	3.49E-03	7.34E-04
GeneMANIA	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	108	-	-	1.49E-01	4.56E-03
GeneMANIA	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	3.24E-03	6.29E-04
GeneMANIA	BP	GO:0042832	defense response to protozoan	-	28	27	-	-	4.44E-02	1.15E-03
GeneMANIA	BP	GO:0048799	animal organ maturation	-	33	32	-	-	4.06E-03	1.36E-03
GeneMANIA	BP	GO:0006925	inflammatory cell apoptotic process	-	23	22	-	-	3.79E-04	9.44E-04
GeneMANIA	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	7.66E-04	6.82E-04
GeneMANIA	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	172	-	-	6.24E-03	7.24E-03
GeneMANIA	BP	GO:1903035	negative regulation of response to wounding	-	93	88	-	-	1.52E-02	3.72E-03
GeneMANIA	BP	GO:0015697	quaternary ammonium group transport	-	16	16	-	-	7.66E-03	6.82E-04
GeneMANIA	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	27	-	-	1.90E-03	1.15E-03
GeneMANIA	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	1.11E-02	1.15E-03
GeneMANIA	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	136	-	-	1.65E-01	5.72E-03
GeneMANIA	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	96	-	-	1.28E-02	4.04E-03
GeneMANIA	BP	GO:0045056	transcytosis	-	20	20	-	-	1.26E-03	8.39E-04
GeneMANIA	BP	GO:0018342	protein prenylation	-	15	15	-	-	1.05E-02	6.29E-04
GeneMANIA	BP	GO:0009267	cellular response to starvation	-	170	169	-	-	3.44E-02	7.13E-03
GeneMANIA	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	1.73E-03	4.72E-04
GeneMANIA	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	7.03E-03	2.26E-03
GeneMANIA	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	5.55E-01	6.82E-04
GeneMANIA	BP	GO:0007343	egg activation	-	11	11	-	-	6.03E-03	4.72E-04
GeneMANIA	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	4.40E-03	9.96E-04
GeneMANIA	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	27	-	-	4.54E-02	1.15E-03
GeneMANIA	BP	GO:0046931	pore complex assembly	-	21	21	-	-	3.25E-02	8.92E-04
GeneMANIA	CC	GO:0032008	positive regulation of TOR signaling	-	52	51	-	-	3.62E-02	2.15E-03
GeneMANIA	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	1.72E-01	1.42E-03
GeneMANIA	BP	GO:0046618	xenobiotic export from cell	-	27	14	-	-	1.32E-02	6.29E-04
GeneMANIA	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	15	-	-	3.85E-03	6.29E-04
GeneMANIA	BP	GO:0060428	lung epithelium development	-	43	43	-	-	1.64E-03	1.84E-03
GeneMANIA	BP	GO:0030431	sleep	-	30	30	-	-	2.76E-03	1.26E-03
GeneMANIA	BP	GO:1903318	negative regulation of protein maturation	-	29	29	-	-	4.13E-03	1.26E-03
GeneMANIA	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	101	-	-	1.44E-01	4.25E-03
GeneMANIA	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	7.14E-04	7.34E-04
GeneMANIA	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	8.95E-03	6.29E-04
GeneMANIA	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	3.16E-03	5.24E-04
GeneMANIA	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.07E-03	5.77E-04
GeneMANIA	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	75	-	-	8.88E-02	3.15E-03
GeneMANIA	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	1.88E-03	2.73E-03
GeneMANIA	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	1.74E-03	7.34E-04
GeneMANIA	CC	GO:0090660	cerebrospinal fluid circulation	-	15	15	-	-	4.12E-02	6.29E-04
GeneMANIA	CC	GO:0006406	mRNA export from nucleus	-	69	69	-	-	1.13E-01	2.94E-03
GeneMANIA	BP	GO:0009880	embryonic pattern specification	-	70	68	-	-	3.88E-03	2.88E-03
GeneMANIA	BP	GO:0015791	polyol transmembrane transport	-	14	13	-	-	2.02E-01	5.77E-04
GeneMANIA	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	2.26E-01	1.68E-03
GeneMANIA	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	1.66E-02	1.05E-03
GeneMANIA	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	1.08E-02	4.72E-04
GeneMANIA	BP	GO:0002367	cytokine production involved in immune response	-	121	121	-	-	1.49E-02	5.09E-03
GeneMANIA	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	9.83E-04	5.77E-04
GeneMANIA	BP	GO:0044848	biological phase	-	211	208	-	-	2.65E-02	8.76E-03
GeneMANIA	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	2.19E-03	5.24E-04
GeneMANIA	BP	GO:0046660	female sex differentiation	-	125	125	-	-	4.87E-03	5.24E-03
GeneMANIA	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	18	-	-	2.96E-03	7.87E-04
GeneMANIA	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	41	-	-	1.51E-03	1.73E-03
GeneMANIA	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	2.61E-03	4.72E-04
GeneMANIA	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	1.44E-02	2.94E-03
GeneMANIA	BP	GO:0071248	cellular response to metal ion	-	201	199	-	-	4.91E-02	8.39E-03
GeneMANIA	BP	GO:0030308	negative regulation of cell growth	-	191	185	-	-	3.94E-02	7.76E-03
GeneMANIA	BP	GO:0097306	cellular response to alcohol	-	99	95	-	-	3.56E-03	3.99E-03
GeneMANIA	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	128	-	-	1.56E-01	5.40E-03
GeneMANIA	BP	GO:0010453	regulation of cell fate commitment	-	40	36	-	-	1.27E-02	1.52E-03
GeneMANIA	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	57	-	-	6.36E-03	2.41E-03
GeneMANIA	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	57	-	-	6.57E-02	2.41E-03
GeneMANIA	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	8.11E-03	1.10E-03
GeneMANIA	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	3.49E-03	1.05E-03
GeneMANIA	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	44	-	-	3.05E-02	1.89E-03
GeneMANIA	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	2.50E-03	3.25E-03
GeneMANIA	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	8.00E-04	8.39E-04
GeneMANIA	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	3.13E-02	1.05E-03
GeneMANIA	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	96	-	-	6.65E-03	4.04E-03
GeneMANIA	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	1.26E-03	1.10E-03
GeneMANIA	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	1.00E-03	4.72E-04
GeneMANIA	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	53	-	-	3.26E-03	2.26E-03
GeneMANIA	BP	GO:0051259	protein complex oligomerization	-	251	249	-	-	9.53E-02	1.05E-02
GeneMANIA	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	2.49E-02	6.82E-04
GeneMANIA	BP	GO:0098743	cell aggregation	-	24	23	-	-	1.12E-03	9.96E-04
GeneMANIA	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	4.58E-04	5.24E-04
GeneMANIA	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	1.14E-03	4.72E-04
GeneMANIA	BP	GO:0006369	termination of RNA polymerase II transcription	-	12	12	-	-	1.28E-01	5.24E-04
GeneMANIA	BP	GO:0009994	oocyte differentiation	-	57	57	-	-	5.28E-03	2.41E-03
GeneMANIA	MF	GO:0031952	regulation of protein autophosphorylation	-	43	41	-	-	2.21E-03	1.73E-03
GeneMANIA	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	9.04E-04	6.29E-04
GeneMANIA	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	156	-	-	1.87E-02	6.56E-03
GeneMANIA	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	2.73E-03	1.47E-03
GeneMANIA	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	2.05E-03	1.21E-03
GeneMANIA	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	5.65E-04	1.47E-03
GeneMANIA	BP	GO:0072665	protein localization to vacuole	-	84	83	-	-	3.67E-02	3.51E-03
GeneMANIA	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	46	-	-	4.30E-02	1.94E-03
GeneMANIA	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	25	-	-	3.30E-03	1.05E-03
GeneMANIA	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	74	-	-	1.86E-02	3.15E-03
GeneMANIA	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	2.84E-03	6.82E-04
GeneMANIA	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	6.32E-02	6.29E-04
GeneMANIA	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	3.09E-04	4.72E-04
GeneMANIA	BP	GO:0042044	fluid transport	-	35	34	-	-	1.12E-01	1.47E-03
GeneMANIA	BP	GO:0070633	transepithelial transport	-	35	35	-	-	3.10E-03	1.47E-03
GeneMANIA	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	4.41E-03	5.77E-04
GeneMANIA	BP	GO:0045661	regulation of myoblast differentiation	-	74	73	-	-	2.22E-02	3.09E-03
GeneMANIA	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	15	-	-	5.52E-03	6.29E-04
GeneMANIA	BP	GO:0030307	positive regulation of cell growth	-	164	159	-	-	5.06E-03	6.71E-03
GeneMANIA	BP	GO:0034250	positive regulation of amide metabolic process	-	27	26	-	-	9.14E-04	1.10E-03
GeneMANIA	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	9.63E-03	7.87E-04
GeneMANIA	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	14	-	-	2.42E-03	6.29E-04
GeneMANIA	BP	GO:0014812	muscle cell migration	-	110	85	-	-	4.41E-03	3.57E-03
GeneMANIA	BP	GO:0048525	negative regulation of viral process	-	90	88	-	-	3.19E-02	3.72E-03
GeneMANIA	BP	GO:0072044	collecting duct development	-	16	16	-	-	1.95E-03	6.82E-04
GeneMANIA	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	2.33E-02	6.29E-04
GeneMANIA	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	70	-	-	3.07E-02	2.94E-03
GeneMANIA	BP	GO:0030238	male sex determination	-	14	14	-	-	9.58E-04	6.29E-04
GeneMANIA	BP	GO:0051781	positive regulation of cell division	-	93	92	-	-	1.49E-02	3.88E-03
GeneMANIA	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	7.20E-03	8.92E-04
GeneMANIA	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	1.46E-03	4.72E-04
GeneMANIA	BP	GO:0035524	proline transmembrane transport	-	12	12	-	-	1.56E-01	5.24E-04
GeneMANIA	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	5.45E-02	9.96E-04
GeneMANIA	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	21	-	-	2.16E-03	8.92E-04
GeneMANIA	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.79E-03	1.99E-03
GeneMANIA	BP	GO:0070857	regulation of bile acid biosynthetic process	-	12	11	-	-	1.88E-03	4.72E-04
GeneMANIA	BP	GO:0007272	ensheathment of neurons	-	146	144	-	-	8.63E-03	6.08E-03
GeneMANIA	CC	GO:0050806	positive regulation of synaptic transmission	-	171	154	-	-	6.93E-03	6.50E-03
GeneMANIA	BP	GO:0060021	roof of mouth development	-	91	91	-	-	7.10E-03	3.83E-03
GeneMANIA	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	3.42E-03	1.68E-03
GeneMANIA	BP	GO:0050819	negative regulation of coagulation	-	54	53	-	-	2.42E-02	2.26E-03
GeneMANIA	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	1.47E-02	4.72E-04
GeneMANIA	BP	GO:0017004	cytochrome complex assembly	-	40	40	-	-	6.43E-02	1.68E-03
GeneMANIA	BP	GO:0018410	C-terminal protein amino acid modification	-	15	14	-	-	3.77E-02	6.29E-04
GeneMANIA	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	2.85E-01	2.62E-03
GeneMANIA	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	9.80E-02	6.29E-04
GeneMANIA	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	15	-	-	2.49E-02	6.29E-04
GeneMANIA	CC	GO:0050805	negative regulation of synaptic transmission	-	55	55	-	-	3.45E-03	2.31E-03
GeneMANIA	BP	GO:0043248	proteasome assembly	-	13	13	-	-	1.74E-02	5.77E-04
GeneMANIA	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	60	-	-	1.44E-02	2.52E-03
GeneMANIA	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	1.14E-03	4.72E-04
GeneMANIA	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	88	-	-	3.11E-02	3.72E-03
GeneMANIA	BP	GO:0016054	organic acid catabolic process	-	251	249	-	-	7.40E-02	1.05E-02
GeneMANIA	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	3.09E-03	5.77E-04
GeneMANIA	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.51E-02	1.21E-03
GeneMANIA	BP	GO:0065005	protein-lipid complex assembly	-	29	28	-	-	9.49E-03	1.21E-03
GeneMANIA	BP	GO:0008033	tRNA processing	-	136	135	-	-	8.14E-02	5.66E-03
GeneMANIA	BP	GO:0046661	male sex differentiation	-	171	170	-	-	1.19E-02	7.13E-03
GeneMANIA	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	4.26E-04	6.29E-04
GeneMANIA	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	1.67E-03	7.34E-04
GeneMANIA	BP	GO:0035188	hatching	-	27	27	-	-	3.34E-04	1.15E-03
GeneMANIA	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	88	-	-	1.01E-02	3.72E-03
GeneMANIA	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	16	-	-	1.25E-02	6.82E-04
GeneMANIA	BP	GO:0090713	immunological memory process	-	18	18	-	-	5.23E-03	7.87E-04
GeneMANIA	BP	GO:0061326	renal tubule development	-	103	103	-	-	5.51E-03	4.35E-03
GeneMANIA	BP	GO:0071985	multivesicular body sorting pathway	-	56	55	-	-	2.39E-01	2.31E-03
GeneMANIA	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	9.50E-02	7.34E-04
GeneMANIA	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	8.79E-04	8.39E-04
GeneMANIA	BP	GO:0060325	face morphogenesis	-	31	31	-	-	1.11E-03	1.31E-03
GeneMANIA	BP	GO:0090559	regulation of membrane permeability	-	72	65	-	-	4.72E-03	2.73E-03
GeneMANIA	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	15	-	-	2.39E-02	6.29E-04
GeneMANIA	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	1.94E-01	5.24E-04
GeneMANIA	BP	GO:0031579	membrane raft organization	-	25	24	-	-	1.99E-03	1.05E-03
GeneMANIA	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	25	-	-	3.16E-03	1.05E-03
GeneMANIA	BP	GO:0060033	anatomical structure regression	-	16	16	-	-	6.50E-03	6.82E-04
GeneMANIA	BP	GO:0046460	neutral lipid biosynthetic process	-	50	47	-	-	1.05E-01	1.99E-03
GeneMANIA	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	158	-	-	4.40E-02	6.66E-03
GeneMANIA	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	4.33E-03	4.72E-04
GeneMANIA	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	161	-	-	9.92E-03	6.77E-03
GeneMANIA	BP	GO:0002251	organ or tissue specific immune response	-	43	42	-	-	4.03E-02	1.78E-03
GeneMANIA	CC	GO:0048167	regulation of synaptic plasticity	-	210	193	-	-	1.46E-02	8.13E-03
GeneMANIA	BP	GO:1903708	positive regulation of hemopoiesis	-	184	181	-	-	1.70E-02	7.60E-03
GeneMANIA	BP	GO:1903008	organelle disassembly	-	154	153	-	-	2.12E-02	6.45E-03
GeneMANIA	BP	GO:0001709	cell fate determination	-	44	44	-	-	3.75E-03	1.89E-03
GeneMANIA	BP	GO:0051873	killing by host of symbiont cells	-	28	27	-	-	1.23E-02	1.15E-03
GeneMANIA	BP	GO:0045058	T cell selection	-	53	53	-	-	1.10E-02	2.26E-03
GeneMANIA	CC	GO:0032387	negative regulation of intracellular transport	-	51	49	-	-	2.32E-03	2.10E-03
GeneMANIA	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	3.06E-02	8.39E-04
GeneMANIA	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	3.15E-03	3.30E-03
GeneMANIA	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	41	-	-	9.30E-03	1.73E-03
GeneMANIA	BP	GO:0099084	postsynaptic specialization organization	-	44	44	-	-	1.59E-02	1.89E-03
GeneMANIA	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	2.60E-03	4.72E-04
GeneMANIA	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	2.15E-02	6.29E-04
GeneMANIA	BP	GO:0060384	innervation	-	27	27	-	-	1.39E-03	1.15E-03
GeneMANIA	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	1.08E-03	5.24E-04
GeneMANIA	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	35	-	-	3.53E-02	1.47E-03
GeneMANIA	MF	GO:0031281	positive regulation of cyclase activity	-	40	39	-	-	5.84E-02	1.68E-03
GeneMANIA	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	1.46E-02	2.67E-03
GeneMANIA	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	5.49E-03	7.87E-04
GeneMANIA	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	1.27E-01	5.24E-04
GeneMANIA	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	2.07E-02	7.87E-04
GeneMANIA	BP	GO:0071453	cellular response to oxygen levels	-	168	153	-	-	4.87E-03	6.45E-03
GeneMANIA	BP	GO:0090399	replicative senescence	-	17	16	-	-	2.12E-03	6.82E-04
GeneMANIA	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	9.81E-04	6.29E-04
GeneMANIA	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	4.55E-03	1.26E-03
GeneMANIA	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	9.27E-02	5.24E-03
GeneMANIA	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	1.25E-02	6.29E-04
GeneMANIA	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	1.31E-03	1.05E-03
GeneMANIA	BP	GO:0044242	cellular lipid catabolic process	-	224	221	-	-	5.58E-02	9.28E-03
GeneMANIA	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	7.37E-04	5.77E-04
GeneMANIA	BP	GO:0002931	response to ischemia	-	58	56	-	-	2.56E-03	2.36E-03
GeneMANIA	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	5.86E-03	5.24E-04
GeneMANIA	BP	GO:0014047	glutamate secretion	-	25	25	-	-	1.34E-03	1.05E-03
GeneMANIA	BP	GO:0061005	cell differentiation involved in kidney development	-	58	58	-	-	3.07E-03	2.46E-03
GeneMANIA	BP	GO:0030397	membrane disassembly	-	11	11	-	-	6.30E-04	4.72E-04
GeneMANIA	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	76	-	-	8.52E-02	3.20E-03
GeneMANIA	BP	GO:0060420	regulation of heart growth	-	74	59	-	-	4.61E-03	2.52E-03
GeneMANIA	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	4.60E-04	6.29E-04
GeneMANIA	BP	GO:0009755	hormone-mediated signaling pathway	-	221	219	-	-	3.15E-02	9.23E-03
GeneMANIA	BP	GO:0022612	gland morphogenesis	-	124	124	-	-	7.23E-03	5.24E-03
GeneMANIA	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	36	-	-	1.25E-03	1.52E-03
GeneMANIA	MF	GO:0140416	transcription regulator inhibitor activity	-	26	24	-	-	1.11E-03	1.05E-03
GeneMANIA	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	28	-	-	6.30E-02	1.21E-03
GeneMANIA	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	2.01E-03	6.29E-04
GeneMANIA	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	5.21E-03	7.34E-04
GeneMANIA	BP	GO:1990845	adaptive thermogenesis	-	166	166	-	-	5.26E-03	6.98E-03
GeneMANIA	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	3.53E-03	2.26E-03
GeneMANIA	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	5.39E-03	4.72E-04
GeneMANIA	BP	GO:0015844	monoamine transport	-	88	88	-	-	5.64E-02	3.72E-03
GeneMANIA	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	1.26E-02	9.44E-04
GeneMANIA	BP	GO:0060039	pericardium development	-	19	19	-	-	1.35E-03	8.39E-04
GeneMANIA	BP	GO:0071392	cellular response to estradiol stimulus	-	40	40	-	-	4.90E-03	1.68E-03
GeneMANIA	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	2.01E-03	5.77E-04
GeneMANIA	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	8.87E-03	8.39E-04
GeneMANIA	BP	GO:0009451	RNA modification	-	169	166	-	-	1.14E-01	6.98E-03
GeneMANIA	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	4.33E-02	4.72E-04
GeneMANIA	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	40	-	-	2.68E-03	1.68E-03
GeneMANIA	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	3.57E-03	7.34E-04
GeneMANIA	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	112	-	-	6.25E-02	4.72E-03
GeneMANIA	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	37	-	-	6.54E-03	1.57E-03
GeneMANIA	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	1.77E-01	4.72E-04
GeneMANIA	BP	GO:0015807	L-amino acid transport	-	94	93	-	-	1.45E-01	3.93E-03
GeneMANIA	BP	GO:0032941	secretion by tissue	-	85	83	-	-	3.76E-03	3.51E-03
GeneMANIA	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	12	-	-	7.17E-03	5.24E-04
GeneMANIA	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	1.73E-02	2.31E-03
GeneMANIA	BP	GO:0048753	pigment granule organization	-	40	40	-	-	1.61E-01	1.68E-03
GeneMANIA	BP	GO:0021516	dorsal spinal cord development	-	20	19	-	-	7.40E-03	8.39E-04
GeneMANIA	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	2.10E-03	8.39E-04
GeneMANIA	BP	GO:0032196	transposition	-	11	11	-	-	3.30E-03	4.72E-04
GeneMANIA	BP	GO:0003014	renal system process	-	130	127	-	-	1.17E-02	5.35E-03
GeneMANIA	CC	GO:0070286	axonemal dynein complex assembly	-	40	40	-	-	3.60E-02	1.68E-03
GeneMANIA	BP	GO:0045598	regulation of fat cell differentiation	-	148	134	-	-	7.19E-03	5.66E-03
GeneMANIA	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	191	-	-	1.16E-02	8.02E-03
GeneMANIA	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	1.46E-03	1.63E-03
GeneMANIA	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	3.20E-03	1.05E-03
GeneMANIA	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	234	-	-	5.06E-02	9.86E-03
GeneMANIA	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	8.32E-04	5.77E-04
GeneMANIA	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	1.02E-03	9.96E-04
GeneMANIA	BP	GO:0018158	protein oxidation	-	15	14	-	-	9.46E-02	6.29E-04
GeneMANIA	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	7.68E-02	1.26E-03
GeneMANIA	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	6.36E-03	7.34E-04
GeneMANIA	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	1.11E-03	1.15E-03
GeneMANIA	BP	GO:0071709	membrane assembly	-	68	66	-	-	3.12E-02	2.78E-03
GeneMANIA	BP	GO:0008217	regulation of blood pressure	-	186	183	-	-	1.85E-02	7.71E-03
GeneMANIA	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	4.84E-04	7.87E-04
GeneMANIA	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	2.19E-02	6.29E-04
GeneMANIA	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	62	-	-	5.44E-03	2.62E-03
GeneMANIA	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	1.80E-02	7.81E-03
GeneMANIA	BP	GO:0002200	somatic diversification of immune receptors	-	78	77	-	-	1.17E-02	3.25E-03
GeneMANIA	BP	GO:0035315	hair cell differentiation	-	52	51	-	-	4.90E-03	2.15E-03
GeneMANIA	BP	GO:0048645	animal organ formation	-	62	61	-	-	5.36E-03	2.57E-03
GeneMANIA	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	163	-	-	2.24E-02	6.87E-03
GeneMANIA	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	4.06E-03	6.29E-04
GeneMANIA	BP	GO:0033627	cell adhesion mediated by integrin	-	87	87	-	-	4.70E-02	3.67E-03
GeneMANIA	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	5.07E-02	8.92E-04
GeneMANIA	BP	GO:0015824	proline transport	-	13	13	-	-	1.09E-01	5.77E-04
GeneMANIA	BP	GO:0035107	appendage morphogenesis	-	147	146	-	-	1.47E-02	6.14E-03
GeneMANIA	BP	GO:1903707	negative regulation of hemopoiesis	-	116	109	-	-	3.59E-03	4.62E-03
GeneMANIA	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	3.37E-03	8.39E-04
GeneMANIA	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	5.65E-02	1.05E-03
GeneMANIA	BP	GO:0030149	sphingolipid catabolic process	-	32	31	-	-	4.17E-02	1.31E-03
GeneMANIA	BP	GO:0050994	regulation of lipid catabolic process	-	61	61	-	-	6.44E-03	2.57E-03
GeneMANIA	BP	GO:0035988	chondrocyte proliferation	-	24	23	-	-	1.66E-03	9.96E-04
GeneMANIA	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	1.97E-02	1.26E-03
GeneMANIA	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	1.79E-01	4.72E-04
GeneMANIA	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	8.13E-04	5.24E-04
GeneMANIA	BP	GO:0045727	positive regulation of translation	-	141	138	-	-	3.14E-02	5.82E-03
GeneMANIA	BP	GO:0036315	cellular response to sterol	-	24	21	-	-	2.73E-03	8.92E-04
GeneMANIA	CC	GO:0032388	positive regulation of intracellular transport	-	137	135	-	-	2.65E-03	5.66E-03
GeneMANIA	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	3.30E-03	5.77E-04
GeneMANIA	BP	GO:0002027	regulation of heart rate	-	106	100	-	-	2.04E-02	4.20E-03
GeneMANIA	BP	GO:0050879	multicellular organismal movement	-	118	118	-	-	1.16E-02	4.98E-03
GeneMANIA	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	3.07E-02	6.29E-04
GeneMANIA	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	73	-	-	8.37E-03	3.09E-03
GeneMANIA	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	61	-	-	3.60E-03	2.57E-03
GeneMANIA	BP	GO:0048515	spermatid differentiation	-	208	206	-	-	1.79E-02	8.65E-03
GeneMANIA	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	6.62E-03	2.41E-03
GeneMANIA	MF	GO:0042887	amide transmembrane transporter activity	-	33	32	-	-	4.86E-02	1.36E-03
GeneMANIA	BP	GO:0007130	synaptonemal complex assembly	-	23	22	-	-	8.34E-02	9.44E-04
GeneMANIA	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	36	-	-	8.22E-03	1.52E-03
GeneMANIA	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	34	-	-	1.06E-03	1.47E-03
GeneMANIA	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	37	-	-	1.26E-01	1.57E-03
GeneMANIA	BP	GO:0060119	inner ear receptor cell development	-	44	43	-	-	3.50E-03	1.84E-03
GeneMANIA	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	6.38E-03	7.87E-04
GeneMANIA	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	1.16E-02	1.47E-03
GeneMANIA	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	2.64E-03	1.05E-03
GeneMANIA	BP	GO:0014854	response to inactivity	-	12	12	-	-	3.08E-03	5.24E-04
GeneMANIA	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	242	-	-	1.44E-02	1.02E-02
GeneMANIA	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	1.59E-03	7.34E-04
GeneMANIA	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	7.08E-02	2.05E-03
GeneMANIA	BP	GO:0010883	regulation of lipid storage	-	53	49	-	-	9.54E-03	2.10E-03
GeneMANIA	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	1.92E-03	1.10E-03
GeneMANIA	BP	GO:0007635	chemosensory behavior	-	20	20	-	-	9.67E-04	8.39E-04
GeneMANIA	BP	GO:1905954	positive regulation of lipid localization	-	110	106	-	-	1.07E-02	4.46E-03
GeneMANIA	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.19E-03	5.24E-04
GeneMANIA	BP	GO:0002209	behavioral defense response	-	39	39	-	-	1.66E-03	1.68E-03
GeneMANIA	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	7.68E-02	1.26E-03
GeneMANIA	BP	GO:0072523	purine-containing compound catabolic process	-	146	145	-	-	7.03E-02	6.08E-03
GeneMANIA	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	32	-	-	1.84E-03	1.36E-03
GeneMANIA	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	28	-	-	1.25E-03	1.21E-03
GeneMANIA	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	1.66E-03	6.82E-04
GeneMANIA	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	96	-	-	4.09E-02	4.04E-03
GeneMANIA	BP	GO:0007218	neuropeptide signaling pathway	-	113	109	-	-	9.93E-02	4.62E-03
GeneMANIA	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	1.73E-02	5.24E-04
GeneMANIA	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	167	-	-	3.80E-02	7.03E-03
GeneMANIA	BP	GO:0031345	negative regulation of cell projection organization	-	195	189	-	-	3.36E-02	7.97E-03
GeneMANIA	BP	GO:0048278	vesicle docking	-	64	64	-	-	1.04E-01	2.73E-03
GeneMANIA	BP	GO:0035050	embryonic heart tube development	-	86	85	-	-	8.82E-03	3.57E-03
GeneMANIA	BP	GO:0030168	platelet activation	-	135	135	-	-	1.82E-02	5.66E-03
GeneMANIA	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	1.46E-02	6.82E-04
GeneMANIA	CC	GO:0098810	neurotransmitter reuptake	-	35	35	-	-	1.18E-02	1.47E-03
GeneMANIA	BP	GO:0008213	protein alkylation	-	58	57	-	-	1.19E-01	2.41E-03
GeneMANIA	BP	GO:0009812	flavonoid metabolic process	-	14	13	-	-	8.59E-02	5.77E-04
GeneMANIA	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	8.44E-04	5.77E-04
GeneMANIA	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	9.82E-03	1.05E-03
GeneMANIA	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	2.87E-03	5.77E-04
GeneMANIA	BP	GO:0031529	ruffle organization	-	55	54	-	-	3.36E-03	2.31E-03
GeneMANIA	BP	GO:0010842	retina layer formation	-	25	25	-	-	1.11E-03	1.05E-03
GeneMANIA	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	93	-	-	4.39E-02	3.93E-03
GeneMANIA	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	3.35E-04	4.72E-04
GeneMANIA	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	71	-	-	4.74E-03	2.99E-03
GeneMANIA	MF	GO:0170055	lipid transmembrane transporter activity	-	56	56	-	-	7.16E-02	2.36E-03
GeneMANIA	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	35	-	-	1.38E-01	1.47E-03
GeneMANIA	BP	GO:0035304	regulation of protein dephosphorylation	-	87	84	-	-	7.55E-03	3.57E-03
GeneMANIA	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	232	-	-	4.79E-02	9.75E-03
GeneMANIA	BP	GO:0099637	neurotransmitter receptor transport	-	26	26	-	-	1.02E-02	1.10E-03
GeneMANIA	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	9.57E-03	1.47E-03
GeneMANIA	BP	GO:0051775	response to redox state	-	13	13	-	-	1.01E-03	5.77E-04
GeneMANIA	BP	GO:0051785	positive regulation of nuclear division	-	61	60	-	-	4.63E-03	2.52E-03
GeneMANIA	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	1.53E-03	6.82E-04
GeneMANIA	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	1.73E-01	6.82E-04
GeneMANIA	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	1.47E-03	8.39E-04
GeneMANIA	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	5.60E-03	5.24E-04
GeneMANIA	BP	GO:0044786	cell cycle DNA replication	-	45	45	-	-	2.15E-02	1.89E-03
GeneMANIA	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	13	-	-	1.35E-02	5.77E-04
GeneMANIA	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	2.14E-02	7.34E-04
GeneMANIA	BP	GO:0051299	centrosome separation	-	15	15	-	-	3.31E-03	6.29E-04
GeneMANIA	BP	GO:0048145	regulation of fibroblast proliferation	-	87	85	-	-	4.34E-03	3.57E-03
GeneMANIA	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	89	-	-	2.89E-01	3.78E-03
GeneMANIA	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	7.11E-03	4.72E-04
GeneMANIA	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	225	-	-	6.41E-03	9.44E-03
GeneMANIA	BP	GO:0032098	regulation of appetite	-	20	20	-	-	2.44E-03	8.39E-04
GeneMANIA	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	2.48E-03	6.29E-04
GeneMANIA	CC	GO:0008333	endosome to lysosome transport	-	73	73	-	-	4.79E-02	3.09E-03
GeneMANIA	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	22	-	-	1.16E-03	9.44E-04
GeneMANIA	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	16	-	-	1.20E-03	6.82E-04
GeneMANIA	BP	GO:0003016	respiratory system process	-	39	39	-	-	1.39E-03	1.68E-03
GeneMANIA	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	24	-	-	3.42E-02	1.05E-03
GeneMANIA	BP	GO:0045732	positive regulation of protein catabolic process	-	202	200	-	-	1.35E-02	8.39E-03
GeneMANIA	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	72	-	-	2.78E-02	3.04E-03
GeneMANIA	BP	GO:0007588	excretion	-	40	40	-	-	3.64E-03	1.68E-03
GeneMANIA	BP	GO:1904018	positive regulation of vasculature development	-	185	160	-	-	1.18E-02	6.71E-03
GeneMANIA	BP	GO:0050953	sensory perception of light stimulus	-	223	220	-	-	7.57E-02	9.23E-03
GeneMANIA	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	1.81E-01	1.05E-03
GeneMANIA	BP	GO:0002357	defense response to tumor cell	-	13	12	-	-	4.34E-04	5.24E-04
GeneMANIA	BP	GO:0009303	rRNA transcription	-	37	37	-	-	6.11E-02	1.57E-03
GeneMANIA	BP	GO:0035601	protein deacylation	-	56	56	-	-	5.13E-02	2.36E-03
GeneMANIA	BP	GO:0061952	midbody abscission	-	18	17	-	-	1.32E-01	7.34E-04
GeneMANIA	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	1.82E-03	4.72E-04
GeneMANIA	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	1.06E-03	8.39E-04
GeneMANIA	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	1.84E-03	1.26E-03
GeneMANIA	BP	GO:0071300	cellular response to retinoic acid	-	66	66	-	-	2.70E-02	2.78E-03
GeneMANIA	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	15	-	-	1.42E-02	6.29E-04
GeneMANIA	BP	GO:0045830	positive regulation of isotype switching	-	28	27	-	-	2.56E-02	1.15E-03
GeneMANIA	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	5.52E-03	1.42E-03
GeneMANIA	BP	GO:0046697	decidualization	-	26	26	-	-	1.05E-03	1.10E-03
GeneMANIA	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	1.47E-03	6.29E-04
GeneMANIA	BP	GO:0051588	regulation of neurotransmitter transport	-	99	97	-	-	1.25E-02	4.09E-03
GeneMANIA	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	31	-	-	1.02E-01	1.31E-03
GeneMANIA	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	2.19E-03	5.24E-04
GeneMANIA	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	1.98E-02	2.67E-03
GeneMANIA	BP	GO:0044703	multi-organism reproductive process	-	209	204	-	-	1.37E-02	8.60E-03
GeneMANIA	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	141	-	-	2.15E-02	5.93E-03
GeneMANIA	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	8.67E-02	4.72E-04
GeneMANIA	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	53	-	-	5.17E-03	2.26E-03
GeneMANIA	BP	GO:0099022	vesicle tethering	-	32	31	-	-	1.83E-01	1.31E-03
GeneMANIA	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	38	-	-	9.21E-03	1.63E-03
GeneMANIA	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	8.83E-04	5.24E-04
GeneMANIA	BP	GO:0048857	neural nucleus development	-	65	62	-	-	1.66E-03	2.62E-03
GeneMANIA	BP	GO:0048663	neuron fate commitment	-	74	73	-	-	8.60E-03	3.09E-03
GeneMANIA	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	174	-	-	8.90E-03	7.34E-03
GeneMANIA	BP	GO:0106027	neuron projection organization	-	90	89	-	-	5.86E-03	3.78E-03
GeneMANIA	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	130	-	-	1.54E-02	5.45E-03
GeneMANIA	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	3.37E-03	1.47E-03
GeneMANIA	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	9.40E-04	4.72E-04
GeneMANIA	BP	GO:0045685	regulation of glial cell differentiation	-	77	74	-	-	2.85E-03	3.15E-03
GeneMANIA	BP	GO:0051608	histamine transport	-	14	14	-	-	1.39E-03	6.29E-04
GeneMANIA	BP	GO:0043414	macromolecule methylation	-	138	134	-	-	1.07E-01	5.66E-03
GeneMANIA	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	1.99E-03	5.24E-04
GeneMANIA	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	4.23E-02	6.82E-04
GeneMANIA	BP	GO:0050886	endocrine process	-	93	93	-	-	1.04E-02	3.93E-03
GeneMANIA	MF	GO:0015562	efflux transmembrane transporter activity	-	15	15	-	-	1.21E-02	6.29E-04
GeneMANIA	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	1.44E-03	1.21E-03
GeneMANIA	BP	GO:0045807	positive regulation of endocytosis	-	155	151	-	-	6.29E-03	6.35E-03
GeneMANIA	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	3.91E-03	4.72E-04
GeneMANIA	BP	GO:0002418	immune response to tumor cell	-	29	27	-	-	2.91E-03	1.15E-03
GeneMANIA	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	59	-	-	3.25E-03	2.52E-03
GeneMANIA	BP	GO:0048308	organelle inheritance	-	14	14	-	-	1.59E-03	6.29E-04
GeneMANIA	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	5.59E-04	7.87E-04
GeneMANIA	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	9.78E-04	8.39E-04
GeneMANIA	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	52	-	-	7.30E-02	2.20E-03
GeneMANIA	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.24E-03	2.83E-03
GeneMANIA	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	6.32E-04	5.24E-04
GeneMANIA	BP	GO:0009110	vitamin biosynthetic process	-	23	23	-	-	3.94E-03	9.96E-04
GeneMANIA	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	1.82E-02	9.44E-04
GeneMANIA	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	20	-	-	7.80E-02	8.39E-04
GeneMANIA	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	22	-	-	7.55E-03	9.44E-04
GeneMANIA	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	97	-	-	2.26E-03	4.09E-03
GeneMANIA	BP	GO:0009111	vitamin catabolic process	-	13	13	-	-	4.16E-02	5.77E-04
GeneMANIA	MF	GO:0051100	negative regulation of binding	-	161	158	-	-	2.93E-03	6.66E-03
GeneMANIA	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	1.18E-02	3.30E-03
GeneMANIA	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	4.59E-03	2.52E-03
GeneMANIA	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	9.76E-04	8.39E-04
GeneMANIA	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	1.56E-03	5.24E-04
GeneMANIA	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	5.91E-02	1.42E-03
GeneMANIA	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	1.48E-03	6.82E-04
GeneMANIA	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	3.56E-03	5.77E-04
GeneMANIA	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	1.13E-03	1.99E-03
GeneMANIA	BP	GO:0046621	negative regulation of organ growth	-	39	32	-	-	1.53E-03	1.36E-03
GeneMANIA	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	4.15E-01	2.10E-03
GeneMANIA	BP	GO:0032368	regulation of lipid transport	-	149	129	-	-	1.51E-02	5.45E-03
GeneMANIA	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	4.26E-03	1.26E-03
GeneMANIA	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	181	-	-	1.51E-02	7.60E-03
GeneMANIA	BP	GO:0033002	muscle cell proliferation	-	249	203	-	-	9.60E-03	8.55E-03
GeneMANIA	BP	GO:0043331	response to dsRNA	-	56	56	-	-	1.72E-01	2.36E-03
GeneMANIA	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	1.91E-03	5.24E-04
GeneMANIA	BP	GO:0051904	pigment granule transport	-	23	23	-	-	4.44E-02	9.96E-04
GeneMANIA	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	1.58E-01	1.36E-03
GeneMANIA	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	34	-	-	1.23E-02	1.47E-03
GeneMANIA	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	12	-	-	1.22E-01	5.24E-04
GeneMANIA	BP	GO:0033363	secretory granule organization	-	63	63	-	-	2.32E-02	2.67E-03
GeneMANIA	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	1.50E-03	1.21E-03
GeneMANIA	BP	GO:0120009	intermembrane lipid transfer	-	52	51	-	-	5.64E-02	2.15E-03
GeneMANIA	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	1.78E-02	6.29E-04
GeneMANIA	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	1.97E-03	1.63E-03
GeneMANIA	BP	GO:0033622	integrin activation	-	26	26	-	-	3.90E-03	1.10E-03
GeneMANIA	BP	GO:0098751	bone cell development	-	18	18	-	-	1.01E-03	7.87E-04
GeneMANIA	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.08E-03	8.92E-04
GeneMANIA	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	2.24E-03	2.15E-03
GeneMANIA	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.46E-02	1.26E-03
GeneMANIA	BP	GO:0002076	osteoblast development	-	17	17	-	-	5.72E-03	7.34E-04
GeneMANIA	BP	GO:0072164	mesonephric tubule development	-	98	98	-	-	7.10E-03	4.14E-03
GeneMANIA	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	5.87E-04	7.34E-04
GeneMANIA	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	106	-	-	3.77E-03	4.46E-03
GeneMANIA	BP	GO:1903524	positive regulation of blood circulation	-	39	38	-	-	1.80E-03	1.63E-03
GeneMANIA	BP	GO:0030901	midbrain development	-	87	84	-	-	5.32E-03	3.57E-03
GeneMANIA	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	3.94E-03	9.44E-04
GeneMANIA	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	6.26E-03	6.82E-04
GeneMANIA	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	1.30E-03	5.77E-04
GeneMANIA	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	68	-	-	8.51E-03	2.88E-03
GeneMANIA	MF	GO:1901474	azole transmembrane transporter activity	-	13	13	-	-	4.59E-03	5.77E-04
GeneMANIA	BP	GO:0002687	positive regulation of leukocyte migration	-	147	147	-	-	1.74E-02	6.19E-03
GeneMANIA	BP	GO:0019755	one-carbon compound transport	-	28	27	-	-	1.23E-01	1.15E-03
GeneMANIA	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	6.07E-04	5.77E-04
GeneMANIA	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	1.42E-03	6.82E-04
GeneMANIA	BP	GO:0110154	RNA decapping	-	19	19	-	-	1.42E-01	8.39E-04
GeneMANIA	BP	GO:0034605	cellular response to heat	-	66	60	-	-	4.31E-03	2.52E-03
GeneMANIA	BP	GO:0005996	monosaccharide metabolic process	-	250	247	-	-	1.97E-02	1.04E-02
GeneMANIA	BP	GO:0033555	multicellular organismal response to stress	-	90	89	-	-	3.73E-03	3.78E-03
GeneMANIA	BP	GO:0002262	myeloid cell homeostasis	-	172	168	-	-	8.07E-03	7.08E-03
GeneMANIA	BP	GO:0000966	RNA 5'-end processing	-	39	39	-	-	8.26E-02	1.68E-03
GeneMANIA	BP	GO:0050688	regulation of defense response to virus	-	65	64	-	-	9.45E-03	2.73E-03
GeneMANIA	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	21	-	-	5.51E-03	8.92E-04
GeneMANIA	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	224	-	-	2.40E-02	9.44E-03
GeneMANIA	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	2.43E-03	1.31E-03
GeneMANIA	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	2.27E-04	6.29E-04
GeneMANIA	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	4.26E-03	1.36E-03
GeneMANIA	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	19	-	-	9.62E-04	8.39E-04
GeneMANIA	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	9.73E-03	1.21E-03
GeneMANIA	BP	GO:0022618	protein-RNA complex assembly	-	227	191	-	-	7.49E-02	8.02E-03
GeneMANIA	BP	GO:0051147	regulation of muscle cell differentiation	-	162	136	-	-	4.60E-03	5.72E-03
GeneMANIA	BP	GO:0090102	cochlea development	-	50	50	-	-	3.36E-03	2.10E-03
GeneMANIA	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	1.51E-03	1.10E-03
GeneMANIA	BP	GO:0061303	cornea development in camera-type eye	-	12	12	-	-	1.02E-02	5.24E-04
GeneMANIA	BP	GO:0045933	positive regulation of muscle contraction	-	49	47	-	-	7.49E-03	1.99E-03
GeneMANIA	BP	GO:0015803	branched-chain amino acid transport	-	14	14	-	-	1.95E-02	6.29E-04
GeneMANIA	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	1.61E-03	6.82E-04
GeneMANIA	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	34	-	-	1.55E-02	1.47E-03
GeneMANIA	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	92	-	-	3.98E-01	3.88E-03
GeneMANIA	BP	GO:0097264	self proteolysis	-	12	12	-	-	5.88E-03	5.24E-04
GeneMANIA	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	4.75E-03	9.44E-04
GeneMANIA	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	2.81E-02	2.99E-03
GeneMANIA	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	56	-	-	3.37E-02	2.36E-03
GeneMANIA	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	3.99E-02	9.96E-04
GeneMANIA	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	58	-	-	3.35E-03	2.46E-03
GeneMANIA	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	1.94E-03	4.72E-04
GeneMANIA	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	1.30E-02	1.63E-03
GeneMANIA	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	3.62E-04	5.24E-04
GeneMANIA	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	8.68E-04	4.72E-04
GeneMANIA	BP	GO:0140253	cell-cell fusion	-	62	61	-	-	1.46E-02	2.57E-03
GeneMANIA	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	1.06E-03	5.24E-04
GeneMANIA	BP	GO:0071599	otic vesicle development	-	15	15	-	-	2.08E-03	6.29E-04
GeneMANIA	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	44	-	-	5.12E-01	1.89E-03
GeneMANIA	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	9.89E-03	6.29E-04
GeneMANIA	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	2.55E-02	2.52E-03
GeneMANIA	BP	GO:0001941	postsynaptic membrane organization	-	37	37	-	-	1.58E-02	1.57E-03
GeneMANIA	BP	GO:0051293	establishment of spindle localization	-	57	57	-	-	1.44E-02	2.41E-03
GeneMANIA	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	2.39E-04	5.77E-04
GeneMANIA	BP	GO:0043114	regulation of vascular permeability	-	49	48	-	-	3.40E-03	2.05E-03
GeneMANIA	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	2.60E-01	1.10E-03
GeneMANIA	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	67	-	-	6.36E-03	2.83E-03
GeneMANIA	BP	GO:0008360	regulation of cell shape	-	139	137	-	-	3.42E-02	5.77E-03
GeneMANIA	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	5.79E-03	6.82E-04
GeneMANIA	BP	GO:0051222	positive regulation of protein transport	-	249	244	-	-	5.54E-03	1.03E-02
GeneMANIA	CC	GO:0140632	canonical inflammasome complex assembly	-	40	40	-	-	4.56E-02	1.68E-03
GeneMANIA	MF	GO:0034260	negative regulation of GTPase activity	-	36	33	-	-	6.22E-04	1.42E-03
GeneMANIA	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	4.28E-03	9.44E-04
GeneMANIA	BP	GO:0045739	positive regulation of DNA repair	-	128	126	-	-	1.04E-01	5.30E-03
GeneMANIA	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	2.75E-04	8.39E-04
GeneMANIA	BP	GO:0045185	maintenance of protein location	-	95	92	-	-	3.30E-03	3.88E-03
GeneMANIA	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	2.73E-03	5.77E-04
GeneMANIA	BP	GO:0003158	endothelium development	-	140	128	-	-	1.30E-02	5.40E-03
GeneMANIA	CC	GO:0072595	maintenance of protein localization in organelle	-	42	42	-	-	4.42E-03	1.78E-03
GeneMANIA	BP	GO:0051224	negative regulation of protein transport	-	122	106	-	-	3.66E-03	4.46E-03
GeneMANIA	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	150	-	-	9.47E-03	6.29E-03
GeneMANIA	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	2.77E-03	5.77E-04
GeneMANIA	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	1.78E-03	1.31E-03
GeneMANIA	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	7.67E-02	8.39E-04
GeneMANIA	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	3.27E-03	2.67E-03
GeneMANIA	BP	GO:0007405	neuroblast proliferation	-	81	80	-	-	8.52E-03	3.36E-03
GeneMANIA	BP	GO:0009581	detection of external stimulus	-	137	133	-	-	7.03E-03	5.61E-03
GeneMANIA	BP	GO:1990542	mitochondrial transmembrane transport	-	93	93	-	-	1.75E-01	3.93E-03
GeneMANIA	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	32	-	-	2.41E-03	1.36E-03
GeneMANIA	BP	GO:0033504	floor plate development	-	11	11	-	-	6.53E-04	4.72E-04
GeneMANIA	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	5.02E-04	4.72E-04
GeneMANIA	BP	GO:0097186	amelogenesis	-	26	26	-	-	7.63E-03	1.10E-03
GeneMANIA	BP	GO:0031128	developmental induction	-	26	26	-	-	6.71E-03	1.10E-03
GeneMANIA	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	1.55E-02	6.29E-04
GeneMANIA	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.93E-03	2.78E-03
GeneMANIA	BP	GO:0021533	cell differentiation in hindbrain	-	23	23	-	-	1.83E-03	9.96E-04
GeneMANIA	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	2.77E-03	1.31E-03
GeneMANIA	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	2.95E-03	5.24E-04
GeneMANIA	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	2.06E-02	2.15E-03
GeneMANIA	BP	GO:0021517	ventral spinal cord development	-	47	45	-	-	1.18E-02	1.89E-03
GeneMANIA	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	4.74E-03	3.15E-03
GeneMANIA	BP	GO:0032328	alanine transport	-	19	19	-	-	1.50E-01	8.39E-04
GeneMANIA	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	1.18E-02	6.82E-04
GeneMANIA	BP	GO:0097722	sperm motility	-	133	132	-	-	2.38E-02	5.56E-03
GeneMANIA	BP	GO:0051231	spindle elongation	-	14	14	-	-	1.08E-02	6.29E-04
GeneMANIA	BP	GO:0042490	mechanoreceptor differentiation	-	67	66	-	-	6.51E-03	2.78E-03
GeneMANIA	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	2.78E-03	1.26E-03
GeneMANIA	BP	GO:0035148	tube formation	-	155	154	-	-	9.90E-03	6.50E-03
GeneMANIA	BP	GO:0048520	positive regulation of behavior	-	27	27	-	-	3.08E-03	1.15E-03
GeneMANIA	BP	GO:0098543	detection of other organism	-	19	19	-	-	1.88E-02	8.39E-04
GeneMANIA	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	3.81E-02	1.84E-03
GeneMANIA	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	124	-	-	3.74E-02	5.24E-03
GeneMANIA	BP	GO:0031123	RNA 3'-end processing	-	79	78	-	-	4.35E-02	3.30E-03
GeneMANIA	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	3.31E-03	4.72E-04
GeneMANIA	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	109	-	-	5.18E-03	4.62E-03
GeneMANIA	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	5.96E-03	7.87E-04
GeneMANIA	CC	GO:0007097	nuclear migration	-	24	24	-	-	5.56E-03	1.05E-03
GeneMANIA	BP	GO:0006885	regulation of pH	-	104	103	-	-	1.05E-01	4.35E-03
GeneMANIA	BP	GO:0002467	germinal center formation	-	14	14	-	-	3.78E-04	6.29E-04
GeneMANIA	BP	GO:1990840	response to lectin	-	22	21	-	-	1.65E-02	8.92E-04
GeneMANIA	BP	GO:0071800	podosome assembly	-	19	19	-	-	5.39E-04	8.39E-04
GeneMANIA	BP	GO:0031018	endocrine pancreas development	-	47	46	-	-	6.66E-03	1.94E-03
GeneMANIA	BP	GO:0001708	cell fate specification	-	108	106	-	-	7.16E-02	4.46E-03
GeneMANIA	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	68	-	-	2.22E-03	2.88E-03
GeneMANIA	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	8.64E-03	1.57E-03
GeneMANIA	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	3.98E-03	6.29E-04
GeneMANIA	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	13	-	-	8.36E-04	5.77E-04
GeneMANIA	BP	GO:0042440	pigment metabolic process	-	80	78	-	-	3.05E-02	3.30E-03
GeneMANIA	BP	GO:1901606	alpha-amino acid catabolic process	-	101	99	-	-	4.93E-02	4.20E-03
GeneMANIA	BP	GO:1901890	positive regulation of cell junction assembly	-	106	105	-	-	8.21E-03	4.41E-03
GeneMANIA	BP	GO:0070988	demethylation	-	27	27	-	-	5.43E-02	1.15E-03
GeneMANIA	BP	GO:1901655	cellular response to ketone	-	107	106	-	-	2.84E-03	4.46E-03
GeneMANIA	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	4.54E-03	6.29E-04
GeneMANIA	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	1.08E-02	6.29E-04
GeneMANIA	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	2.95E-02	7.34E-04
GeneMANIA	BP	GO:0006968	cellular defense response	-	52	52	-	-	2.58E-02	2.20E-03
GeneMANIA	BP	GO:0055006	cardiac cell development	-	93	84	-	-	8.16E-03	3.57E-03
GeneMANIA	BP	GO:0031365	N-terminal protein amino acid modification	-	30	30	-	-	5.93E-02	1.26E-03
GeneMANIA	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	5.33E-02	5.24E-04
GeneMANIA	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	28	-	-	8.76E-03	1.21E-03
GeneMANIA	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	7.29E-04	5.24E-04
GeneMANIA	BP	GO:0060004	reflex	-	63	62	-	-	2.36E-03	2.62E-03
GeneMANIA	BP	GO:0044706	multi-multicellular organism process	-	217	212	-	-	1.52E-02	8.92E-03
GeneMANIA	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	7.20E-04	5.24E-04
GeneMANIA	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	138	-	-	9.25E-03	5.82E-03
GeneMANIA	BP	GO:0006026	aminoglycan catabolic process	-	34	34	-	-	5.27E-02	1.47E-03
GeneMANIA	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	1.36E-02	1.94E-03
GeneMANIA	BP	GO:0050768	negative regulation of neurogenesis	-	150	146	-	-	4.02E-02	6.14E-03
GeneMANIA	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	94	-	-	1.99E-03	3.99E-03
GeneMANIA	BP	GO:0090068	positive regulation of cell cycle process	-	262	247	-	-	2.03E-02	1.04E-02
GeneMANIA	BP	GO:0043605	amide catabolic process	-	16	16	-	-	3.59E-02	6.82E-04
GeneMANIA	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	6.24E-02	1.15E-03
GeneMANIA	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	3.81E-02	1.47E-03
GeneMANIA	BP	GO:1902115	regulation of organelle assembly	-	210	206	-	-	1.25E-02	8.65E-03
GeneMANIA	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	65	-	-	4.01E-03	2.73E-03
GeneMANIA	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	2.95E-04	6.82E-04
GeneMANIA	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	143	-	-	2.35E-02	6.03E-03
GeneMANIA	BP	GO:0043171	peptide catabolic process	-	19	18	-	-	2.28E-01	7.87E-04
GeneMANIA	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	3.22E-03	1.78E-03
GeneMANIA	BP	GO:0051952	regulation of amine transport	-	98	98	-	-	4.35E-02	4.14E-03
GeneMANIA	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	2.63E-02	9.96E-04
GeneMANIA	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	6.75E-04	8.39E-04
GeneMANIA	BP	GO:0015801	aromatic amino acid transport	-	13	13	-	-	1.21E-02	5.77E-04
GeneMANIA	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	3.43E-02	9.96E-04
GeneMANIA	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	4.51E-03	8.39E-04
GeneMANIA	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	2.55E-04	6.82E-04
GeneMANIA	CC	GO:0032365	intracellular lipid transport	-	51	48	-	-	1.69E-02	2.05E-03
GeneMANIA	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	1.11E-01	1.26E-03
GeneMANIA	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	71	-	-	2.91E-03	2.99E-03
GeneMANIA	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	113	-	-	2.80E-03	4.77E-03
GeneMANIA	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	1.09E-01	1.21E-03
GeneMANIA	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	6.60E-04	1.05E-03
GeneMANIA	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	5.23E-04	5.77E-04
GeneMANIA	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	1.45E-04	6.29E-04
GeneMANIA	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	5.52E-04	5.77E-04
GeneMANIA	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	4.46E-03	1.47E-03
GeneMANIA	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	1.00E-02	4.72E-04
GeneMANIA	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	2.07E-02	3.78E-03
GeneMANIA	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	30	-	-	1.50E-01	1.26E-03
GeneMANIA	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	5.20E-04	7.87E-04
GeneMANIA	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	4.00E-03	8.92E-04
GeneMANIA	BP	GO:0015669	gas transport	-	23	23	-	-	2.30E-01	9.96E-04
GeneMANIA	BP	GO:0016485	protein processing	-	248	246	-	-	2.17E-02	1.03E-02
GeneMANIA	BP	GO:0009649	entrainment of circadian clock	-	30	29	-	-	6.65E-03	1.26E-03
GeneMANIA	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	167	-	-	3.65E-02	7.03E-03
GeneMANIA	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	1.19E-03	1.05E-03
GeneMANIA	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	140	-	-	1.91E-01	5.87E-03
GeneMANIA	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	3.60E-02	5.24E-04
GeneMANIA	BP	GO:0099054	presynapse assembly	-	49	48	-	-	1.21E-02	2.05E-03
GeneMANIA	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	4.63E-03	5.24E-04
GeneMANIA	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	3.83E-03	1.05E-03
GeneMANIA	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	5.29E-02	1.05E-03
GeneMANIA	BP	GO:0031348	negative regulation of defense response	-	282	243	-	-	8.29E-03	1.02E-02
GeneMANIA	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	76	-	-	4.72E-03	3.20E-03
GeneMANIA	BP	GO:0061180	mammary gland epithelium development	-	68	67	-	-	3.01E-03	2.83E-03
GeneMANIA	BP	GO:0071496	cellular response to external stimulus	-	74	74	-	-	1.94E-02	3.15E-03
GeneMANIA	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	8.88E-04	5.77E-04
GeneMANIA	BP	GO:0042753	positive regulation of circadian rhythm	-	18	18	-	-	2.99E-03	7.87E-04
GeneMANIA	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	2.70E-04	4.72E-04
GeneMANIA	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	6.45E-03	5.24E-04
GeneMANIA	BP	GO:0032094	response to food	-	37	37	-	-	3.05E-02	1.57E-03
GeneMANIA	BP	GO:0001964	startle response	-	27	27	-	-	4.42E-03	1.15E-03
GeneMANIA	BP	GO:0007340	acrosome reaction	-	38	38	-	-	2.16E-03	1.63E-03
GeneMANIA	BP	GO:0046434	organophosphate catabolic process	-	232	228	-	-	5.20E-02	9.60E-03
GeneMANIA	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	6.20E-03	1.26E-03
GeneMANIA	BP	GO:0009566	fertilization	-	205	203	-	-	2.34E-02	8.55E-03
GeneMANIA	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	1.91E-01	2.52E-03
GeneMANIA	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	1.62E-03	1.05E-03
GeneMANIA	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	1.74E-03	5.77E-04
GeneMANIA	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	4.06E-03	1.26E-03
GeneMANIA	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	23	-	-	9.82E-04	9.96E-04
GeneMANIA	BP	GO:0033044	regulation of chromosome organization	-	249	249	-	-	4.49E-02	1.05E-02
GeneMANIA	BP	GO:0009309	amine biosynthetic process	-	38	37	-	-	9.02E-03	1.57E-03
GeneMANIA	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	2.13E-03	8.39E-04
GeneMANIA	BP	GO:0061900	glial cell activation	-	56	52	-	-	4.44E-03	2.20E-03
GeneMANIA	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	133	-	-	1.35E-02	5.61E-03
GeneMANIA	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	2.45E-03	5.77E-04
GeneMANIA	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	8.47E-03	6.29E-04
GeneMANIA	BP	GO:0021794	thalamus development	-	12	12	-	-	8.68E-04	5.24E-04
GeneMANIA	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	4.31E-02	1.73E-03
GeneMANIA	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	1.19E-03	8.39E-04
GeneMANIA	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	2.96E-04	6.29E-04
GeneMANIA	BP	GO:0072537	fibroblast activation	-	13	13	-	-	2.94E-03	5.77E-04
GeneMANIA	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	4.67E-03	5.77E-04
GeneMANIA	BP	GO:0043647	inositol phosphate metabolic process	-	44	43	-	-	6.50E-02	1.84E-03
GeneMANIA	BP	GO:0016180	snRNA processing	-	28	27	-	-	1.15E-01	1.15E-03
GeneMANIA	BP	GO:0051303	establishment of chromosome localization	-	104	102	-	-	4.38E-02	4.30E-03
GeneMANIA	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	1.77E-02	6.82E-04
GeneMANIA	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	2.24E-02	1.63E-03
GeneMANIA	BP	GO:0097164	ammonium ion metabolic process	-	23	23	-	-	2.29E-03	9.96E-04
GeneMANIA	BP	GO:0021515	cell differentiation in spinal cord	-	51	50	-	-	1.83E-02	2.10E-03
GeneMANIA	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	1.28E-03	7.87E-04
GeneMANIA	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	1.13E-03	8.92E-04
GeneMANIA	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	3.34E-03	1.21E-03
GeneMANIA	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	7.07E-03	7.87E-04
GeneMANIA	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	38	-	-	2.86E-02	1.63E-03
GeneMANIA	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	3.10E-03	9.44E-04
GeneMANIA	BP	GO:0007566	embryo implantation	-	57	54	-	-	2.11E-03	2.31E-03
GeneMANIA	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	32	-	-	9.65E-03	1.36E-03
GeneMANIA	BP	GO:0031268	pseudopodium organization	-	17	17	-	-	9.49E-03	7.34E-04
GeneMANIA	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	2.79E-02	1.36E-03
GeneMANIA	BP	GO:0051017	actin filament bundle assembly	-	161	156	-	-	1.78E-02	6.56E-03
GeneMANIA	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	2.62E-03	1.78E-03
GeneMANIA	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	7.48E-04	7.87E-04
GeneMANIA	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	3.49E-03	8.39E-04
GeneMANIA	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	4.41E-03	5.77E-04
GeneMANIA	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	37	-	-	2.25E-02	1.57E-03
GeneMANIA	BP	GO:0021756	striatum development	-	21	21	-	-	2.39E-03	8.92E-04
GeneMANIA	BP	GO:1901343	negative regulation of vasculature development	-	154	102	-	-	3.48E-03	4.30E-03
GeneMANIA	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	147	-	-	3.42E-02	6.19E-03
GeneMANIA	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	31	-	-	9.89E-02	1.31E-03
GeneMANIA	BP	GO:1902414	protein localization to cell junction	-	107	107	-	-	1.20E-02	4.51E-03
GeneMANIA	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	1.14E-03	9.44E-04
GeneMANIA	BP	GO:0051304	chromosome separation	-	80	80	-	-	3.14E-02	3.36E-03
GeneMANIA	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	2.05E-03	7.87E-04
GeneMANIA	BP	GO:0048709	oligodendrocyte differentiation	-	101	100	-	-	6.95E-03	4.20E-03
GeneMANIA	BP	GO:0045017	glycerolipid biosynthetic process	-	254	248	-	-	1.37E-01	1.04E-02
GeneMANIA	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	6.30E-01	6.29E-04
GeneMANIA	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	8.72E-03	9.96E-04
GeneMANIA	BP	GO:0001776	leukocyte homeostasis	-	108	107	-	-	4.25E-03	4.51E-03
GeneMANIA	BP	GO:0050769	positive regulation of neurogenesis	-	240	236	-	-	1.10E-02	9.91E-03
GeneMANIA	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	3.32E-02	6.29E-04
GeneMANIA	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	2.25E-02	2.94E-03
GeneMANIA	BP	GO:0050866	negative regulation of cell activation	-	216	208	-	-	1.51E-02	8.76E-03
GeneMANIA	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	2.36E-03	1.52E-03
GeneMANIA	BP	GO:0033500	carbohydrate homeostasis	-	251	234	-	-	7.94E-03	9.86E-03
GeneMANIA	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	31	-	-	1.88E-02	1.31E-03
GeneMANIA	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	4.75E-03	5.24E-04
GeneMANIA	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	1.55E-02	2.36E-03
GeneMANIA	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	6.40E-03	9.96E-04
GeneMANIA	CC	GO:0099522	cytosolic region	-	20	20	-	-	9.32E-04	8.39E-04
GeneMANIA	CC	GO:0000791	euchromatin	-	60	60	-	-	9.41E-03	2.52E-03
GeneMANIA	CC	GO:0030666	endocytic vesicle membrane	-	196	193	-	-	3.54E-02	8.13E-03
GeneMANIA	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.01E-01	6.29E-04
GeneMANIA	CC	GO:1990752	microtubule end	-	34	34	-	-	3.66E-02	1.47E-03
GeneMANIA	CC	GO:0043204	perikaryon	-	156	156	-	-	7.54E-03	6.56E-03
GeneMANIA	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	9.35E-02	7.34E-04
GeneMANIA	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	4.39E-02	5.24E-04
GeneMANIA	CC	GO:0097542	ciliary tip	-	48	48	-	-	9.06E-02	2.05E-03
GeneMANIA	CC	GO:1905368	peptidase complex	-	124	121	-	-	1.11E-01	5.09E-03
GeneMANIA	CC	GO:0000792	heterochromatin	-	98	97	-	-	2.16E-02	4.09E-03
GeneMANIA	CC	GO:0097546	ciliary base	-	47	46	-	-	8.02E-03	1.94E-03
GeneMANIA	CC	GO:0071819	DUBm complex	-	25	23	-	-	4.38E-01	9.96E-04
GeneMANIA	CC	GO:0031201	SNARE complex	-	48	48	-	-	6.40E-01	2.05E-03
GeneMANIA	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.05E-03	5.77E-04
GeneMANIA	CC	GO:0033260	nuclear DNA replication	-	40	40	-	-	2.07E-02	1.68E-03
GeneMANIA	CC	GO:0044391	ribosomal subunit	-	203	198	-	-	4.19E-01	8.34E-03
GeneMANIA	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	1.07E-01	4.72E-04
GeneMANIA	CC	GO:0071013	catalytic step 2 spliceosome	-	88	86	-	-	9.14E-02	3.62E-03
GeneMANIA	CC	GO:0031907	microbody lumen	-	51	51	-	-	6.48E-02	2.15E-03
GeneMANIA	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.11E-01	4.72E-04
GeneMANIA	CC	GO:0098862	cluster of actin-based cell projections	-	162	159	-	-	1.47E-02	6.71E-03
GeneMANIA	CC	GO:0016363	nuclear matrix	-	127	127	-	-	8.88E-03	5.35E-03
GeneMANIA	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	5.95E-02	1.94E-03
GeneMANIA	CC	GO:0032432	actin filament bundle	-	249	247	-	-	2.51E-02	1.04E-02
GeneMANIA	CC	GO:0008088	axo-dendritic transport	-	78	78	-	-	3.18E-02	3.30E-03
GeneMANIA	CC	GO:0031519	PcG protein complex	-	38	38	-	-	9.05E-02	1.63E-03
GeneMANIA	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	43	-	-	2.88E-02	1.84E-03
GeneMANIA	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	218	-	-	5.34E-02	9.18E-03
GeneMANIA	CC	GO:0000313	organellar ribosome	-	89	89	-	-	4.52E-01	3.78E-03
GeneMANIA	CC	GO:0099643	signal release from synapse	-	147	145	-	-	4.42E-02	6.08E-03
GeneMANIA	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	4.61E-02	1.94E-03
GeneMANIA	CC	GO:0005818	aster	-	11	11	-	-	2.66E-03	4.72E-04
GeneMANIA	CC	GO:0030018	Z disc	-	129	127	-	-	5.24E-02	5.35E-03
GeneMANIA	CC	GO:0032580	Golgi cisterna membrane	-	93	89	-	-	1.55E-01	3.78E-03
GeneMANIA	CC	GO:0097381	photoreceptor disc membrane	-	25	22	-	-	4.19E-03	9.44E-04
GeneMANIA	CC	GO:1905360	GTPase complex	-	41	40	-	-	3.40E-02	1.68E-03
GeneMANIA	CC	GO:0097540	axonemal central pair	-	161	158	-	-	3.14E-02	6.66E-03
GeneMANIA	CC	GO:0042641	actomyosin	-	77	76	-	-	4.12E-02	3.20E-03
GeneMANIA	CC	GO:0097386	glial cell projection	-	38	38	-	-	1.43E-03	1.63E-03
GeneMANIA	CC	GO:0032588	trans-Golgi network membrane	-	102	102	-	-	5.29E-02	4.30E-03
GeneMANIA	CC	GO:0070382	exocytic vesicle	-	224	222	-	-	5.80E-02	9.34E-03
GeneMANIA	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	47	-	-	2.44E-02	1.99E-03
GeneMANIA	CC	GO:0031903	microbody membrane	-	65	65	-	-	4.11E-02	2.73E-03
GeneMANIA	CC	GO:0046930	pore complex	-	26	26	-	-	1.80E-02	1.10E-03
GeneMANIA	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	1.55E-02	4.72E-04
GeneMANIA	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	1.01E-03	6.82E-04
GeneMANIA	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	1.37E-02	1.05E-03
GeneMANIA	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.52E-01	4.72E-04
GeneMANIA	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	4.55E-02	7.34E-04
GeneMANIA	CC	GO:0044298	cell body membrane	-	32	32	-	-	1.72E-02	1.36E-03
GeneMANIA	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	5.89E-02	4.72E-04
GeneMANIA	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	6.38E-04	8.92E-04
GeneMANIA	CC	GO:0045495	pole plasm	-	25	24	-	-	1.09E-01	1.05E-03
GeneMANIA	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	1.14E-01	6.29E-04
GeneMANIA	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	6.71E-02	8.39E-04
GeneMANIA	CC	GO:0010369	chromocenter	-	14	14	-	-	3.00E-03	6.29E-04
GeneMANIA	CC	GO:0002177	manchette	-	19	19	-	-	1.04E-01	8.39E-04
GeneMANIA	CC	GO:0016323	basolateral plasma membrane	-	239	238	-	-	1.96E-02	1.00E-02
GeneMANIA	CC	GO:0045009	chitosome	-	21	21	-	-	2.22E-02	8.92E-04
GeneMANIA	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	2.95E-03	5.24E-04
GeneMANIA	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	1.23E-02	1.89E-03
GeneMANIA	CC	GO:0098636	protein complex involved in cell adhesion	-	57	57	-	-	9.26E-02	2.41E-03
GeneMANIA	CC	GO:0001917	photoreceptor inner segment	-	71	69	-	-	4.71E-03	2.94E-03
GeneMANIA	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	3.15E-03	6.29E-04
GeneMANIA	CC	GO:0019897	extrinsic component of plasma membrane	-	156	154	-	-	1.89E-02	6.50E-03
GeneMANIA	CC	GO:0031594	neuromuscular junction	-	73	73	-	-	6.26E-03	3.09E-03
GeneMANIA	CC	GO:0045120	pronucleus	-	14	14	-	-	6.74E-04	6.29E-04
GeneMANIA	CC	GO:0043083	synaptic cleft	-	21	21	-	-	2.29E-02	8.92E-04
GeneMANIA	CC	GO:0000922	spindle pole	-	172	170	-	-	1.92E-02	7.13E-03
GeneMANIA	CC	GO:0120111	neuron projection cytoplasm	-	94	94	-	-	2.09E-02	3.99E-03
GeneMANIA	CC	GO:0070971	endoplasmic reticulum exit site	-	32	30	-	-	1.99E-01	1.26E-03
GeneMANIA	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	1.33E-01	5.77E-04
GeneMANIA	CC	GO:0004879	nuclear receptor activity	-	63	63	-	-	3.16E-01	2.67E-03
GeneMANIA	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	168	-	-	8.87E-03	7.08E-03
GeneMANIA	CC	GO:0000123	histone acetyltransferase complex	-	93	89	-	-	2.28E-01	3.78E-03
GeneMANIA	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	4.68E-03	5.77E-04
GeneMANIA	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	109	-	-	1.54E-01	4.62E-03
GeneMANIA	CC	GO:0048786	presynaptic active zone	-	80	80	-	-	2.12E-02	3.36E-03
GeneMANIA	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	6.41E-03	4.72E-04
GeneMANIA	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	1.45E-01	5.24E-04
GeneMANIA	CC	GO:0007034	vacuolar transport	-	168	165	-	-	8.26E-02	6.92E-03
GeneMANIA	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	3.06E-02	8.92E-04
GeneMANIA	CC	GO:0043194	axon initial segment	-	21	21	-	-	1.07E-02	8.92E-04
GeneMANIA	CC	GO:1900115	extracellular regulation of signal transduction	-	13	12	-	-	1.51E-01	5.24E-04
GeneMANIA	CC	GO:0005776	autophagosome	-	111	108	-	-	5.54E-02	4.56E-03
GeneMANIA	CC	GO:0031430	M band	-	22	22	-	-	1.45E-02	9.44E-04
GeneMANIA	CC	GO:0001931	uropod	-	13	13	-	-	3.28E-03	5.77E-04
GeneMANIA	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	88	-	-	2.63E-01	3.72E-03
GeneMANIA	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	98	-	-	3.16E-01	4.14E-03
GeneMANIA	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	2.11E-01	5.77E-04
GeneMANIA	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	2.57E-01	8.39E-04
GeneMANIA	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	28	-	-	9.26E-02	1.21E-03
GeneMANIA	CC	GO:0032994	protein-lipid complex	-	39	39	-	-	6.16E-02	1.68E-03
GeneMANIA	CC	GO:0031838	haptoglobin-hemoglobin complex	-	11	11	-	-	2.53E-01	4.72E-04
GeneMANIA	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	146	-	-	1.35E-01	6.14E-03
GeneMANIA	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	5.98E-02	5.24E-04
GeneMANIA	CC	GO:0001527	microfibril	-	13	13	-	-	5.35E-02	5.77E-04
GeneMANIA	CC	GO:0072562	blood microparticle	-	144	110	-	-	6.38E-02	4.62E-03
GeneMANIA	CC	GO:0005883	neurofilament	-	11	11	-	-	8.29E-03	4.72E-04
GeneMANIA	CC	GO:0051233	spindle midzone	-	36	36	-	-	1.12E-02	1.52E-03
GeneMANIA	CC	GO:0005811	lipid droplet	-	102	102	-	-	1.53E-02	4.30E-03
GeneMANIA	CC	GO:0045022	early endosome to late endosome transport	-	44	43	-	-	9.82E-03	1.84E-03
GeneMANIA	CC	GO:0043113	receptor clustering	-	51	51	-	-	5.53E-03	2.15E-03
GeneMANIA	CC	GO:0005940	septin ring	-	14	14	-	-	6.47E-01	6.29E-04
GeneMANIA	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	1.39E-02	4.72E-04
GeneMANIA	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	25	-	-	3.49E-02	1.05E-03
GeneMANIA	CC	GO:0044853	plasma membrane raft	-	114	114	-	-	1.73E-02	4.82E-03
GeneMANIA	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	8.23E-02	6.29E-04
GeneMANIA	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	5.64E-02	7.34E-04
GeneMANIA	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	58	-	-	4.87E-02	2.46E-03
GeneMANIA	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	1.59E-02	3.04E-03
GeneMANIA	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	1.28E-02	5.24E-04
GeneMANIA	CC	GO:0043034	costamere	-	18	18	-	-	6.06E-03	7.87E-04
GeneMANIA	CC	GO:0031904	endosome lumen	-	38	38	-	-	6.88E-02	1.63E-03
GeneMANIA	CC	GO:0060170	ciliary membrane	-	76	76	-	-	1.40E-02	3.20E-03
GeneMANIA	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	3.24E-01	5.77E-04
GeneMANIA	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	1.12E-01	5.24E-04
GeneMANIA	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	9.49E-02	1.05E-03
GeneMANIA	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	1.37E-01	6.29E-04
GeneMANIA	CC	GO:0032154	cleavage furrow	-	54	54	-	-	6.59E-03	2.31E-03
GeneMANIA	CC	GO:0005640	nuclear outer membrane	-	30	29	-	-	2.01E-03	1.26E-03
GeneMANIA	CC	GO:0005652	nuclear lamina	-	12	12	-	-	2.27E-03	5.24E-04
GeneMANIA	CC	GO:0007006	mitochondrial membrane organization	-	117	112	-	-	5.02E-02	4.72E-03
GeneMANIA	CC	GO:0001772	immunological synapse	-	44	44	-	-	1.17E-02	1.89E-03
GeneMANIA	CC	GO:0030904	retromer complex	-	12	12	-	-	6.42E-02	5.24E-04
GeneMANIA	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	1.14E-03	5.24E-04
GeneMANIA	CC	GO:0030863	cortical cytoskeleton	-	104	103	-	-	1.76E-02	4.35E-03
GeneMANIA	CC	GO:1905348	endonuclease complex	-	38	36	-	-	7.01E-02	1.52E-03
GeneMANIA	CC	GO:0005833	hemoglobin complex	-	12	12	-	-	2.68E-01	5.24E-04
GeneMANIA	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	4.65E-01	7.87E-04
GeneMANIA	CC	GO:0030315	T-tubule	-	52	52	-	-	1.30E-02	2.20E-03
GeneMANIA	CC	GO:0060076	excitatory synapse	-	64	64	-	-	1.08E-02	2.73E-03
GeneMANIA	CC	GO:0036019	endolysosome	-	29	29	-	-	2.89E-02	1.26E-03
GeneMANIA	CC	GO:0001891	phagocytic cup	-	28	28	-	-	2.99E-03	1.21E-03
GeneMANIA	CC	GO:0099086	synaptonemal structure	-	40	40	-	-	9.24E-02	1.68E-03
GeneMANIA	CC	GO:0030427	site of polarized growth	-	172	172	-	-	7.84E-03	7.24E-03
GeneMANIA	CC	GO:0044309	neuron spine	-	213	213	-	-	1.08E-02	8.97E-03
GeneMANIA	CC	GO:0030658	transport vesicle membrane	-	231	227	-	-	6.32E-02	9.54E-03
GeneMANIA	CC	GO:0000813	ESCRT I complex	-	11	11	-	-	4.22E-01	4.72E-04
GeneMANIA	CC	GO:0098918	structural constituent of synapse	-	27	26	-	-	2.48E-02	1.10E-03
GeneMANIA	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	2.55E-01	5.24E-04
GeneMANIA	CC	GO:0000940	outer kinetochore	-	17	17	-	-	5.62E-02	7.34E-04
GeneMANIA	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	1.14E-01	7.34E-04
GeneMANIA	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	1.12E-02	2.10E-03
GeneMANIA	CC	GO:0098803	respiratory chain complex	-	39	36	-	-	2.57E-01	1.52E-03
GeneMANIA	CC	GO:0097545	axonemal outer doublet	-	164	161	-	-	3.37E-02	6.77E-03
GeneMANIA	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	1.71E-02	8.39E-04
GeneMANIA	CC	GO:0070069	cytochrome complex	-	42	39	-	-	2.45E-01	1.68E-03
GeneMANIA	CC	GO:0031143	pseudopodium	-	18	18	-	-	3.96E-03	7.87E-04
GeneMANIA	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	2.35E-02	1.15E-03
GeneMANIA	CC	GO:0055037	recycling endosome	-	200	197	-	-	1.66E-02	8.29E-03
GeneMANIA	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	94	-	-	4.81E-03	3.99E-03
GeneMANIA	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	6.21E-02	5.77E-04
GeneMANIA	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	1.21E-02	5.77E-04
GeneMANIA	CC	GO:0071682	endocytic vesicle lumen	-	23	23	-	-	4.47E-03	9.96E-04
GeneMANIA	CC	GO:0030684	preribosome	-	76	74	-	-	2.04E-01	3.15E-03
GeneMANIA	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	19	-	-	6.42E-02	8.39E-04
GeneMANIA	CC	GO:1990391	DNA repair complex	-	22	22	-	-	4.27E-02	9.44E-04
GeneMANIA	CC	GO:0005775	vacuolar lumen	-	176	176	-	-	3.10E-02	7.39E-03
GeneMANIA	CC	GO:0032433	filopodium tip	-	19	19	-	-	4.17E-03	8.39E-04
GeneMANIA	CC	GO:0032982	myosin filament	-	24	24	-	-	1.37E-01	1.05E-03
GeneMANIA	CC	GO:0016327	apicolateral plasma membrane	-	23	23	-	-	9.90E-03	9.96E-04
GeneMANIA	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	1.94E-01	9.96E-04
GeneMANIA	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	6.78E-02	5.24E-04
GeneMANIA	CC	GO:0044306	neuron projection terminus	-	164	164	-	-	1.13E-02	6.92E-03
GeneMANIA	CC	GO:0034455	t-UTP complex	-	53	52	-	-	2.40E-01	2.20E-03
GeneMANIA	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	4.34E-01	7.34E-04
GeneMANIA	CC	GO:0031970	organelle envelope lumen	-	94	94	-	-	2.38E-02	3.99E-03
GeneMANIA	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.39E-02	5.77E-04
GeneMANIA	CC	GO:0120293	dynein axonemal particle	-	20	20	-	-	8.05E-03	8.39E-04
GeneMANIA	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	2.64E-03	1.05E-03
GeneMANIA	CC	GO:0043292	contractile muscle fiber	-	245	241	-	-	1.28E-01	1.01E-02
GeneMANIA	CC	GO:0018995	host cellular component	-	12	12	-	-	1.15E-03	5.24E-04
GeneMANIA	CC	GO:0034709	methylosome	-	13	13	-	-	2.37E-02	5.77E-04
GeneMANIA	CC	GO:0032426	stereocilium tip	-	21	20	-	-	4.37E-03	8.39E-04
GeneMANIA	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	1.48E-01	5.24E-04
GeneMANIA	CC	GO:0005849	mRNA cleavage factor complex	-	22	22	-	-	1.58E-01	9.44E-04
GeneMANIA	CC	GO:0000803	sex chromosome	-	32	29	-	-	5.35E-03	1.26E-03
GeneMANIA	CC	GO:0098982	GABA-ergic synapse	-	84	84	-	-	1.39E-02	3.57E-03
GeneMANIA	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	17	-	-	1.86E-01	7.34E-04
GeneMANIA	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	5.40E-02	2.67E-03
GeneMANIA	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	2.46E-01	6.29E-04
GeneMANIA	CC	GO:0000242	pericentriolar material	-	22	22	-	-	9.96E-03	9.44E-04
GeneMANIA	CC	GO:1903293	phosphatase complex	-	54	54	-	-	6.75E-02	2.31E-03
GeneMANIA	CC	GO:0097470	ribbon synapse	-	13	13	-	-	2.59E-03	5.77E-04
GeneMANIA	CC	GO:0031941	filamentous actin	-	27	27	-	-	3.84E-02	1.15E-03
GeneMANIA	CC	GO:0000786	nucleosome	-	149	143	-	-	5.77E-01	6.03E-03
GeneMANIA	CC	GO:0001533	cornified envelope	-	59	59	-	-	1.81E-01	2.52E-03
GeneMANIA	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	6.12E-03	2.31E-03
GeneMANIA	CC	GO:0030027	lamellipodium	-	202	200	-	-	2.10E-02	8.39E-03
GeneMANIA	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	3.49E-03	6.29E-04
GeneMANIA	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	26	-	-	9.38E-02	1.10E-03
GeneMANIA	CC	GO:0000800	lateral element	-	14	14	-	-	1.21E-02	6.29E-04
GeneMANIA	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	13	-	-	3.37E-03	5.77E-04
GeneMANIA	CC	GO:0060077	inhibitory synapse	-	20	20	-	-	2.34E-02	8.39E-04
GeneMANIA	CC	GO:0031209	SCAR complex	-	12	12	-	-	7.89E-02	5.24E-04
GeneMANIA	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	2.58E-01	4.72E-04
GeneMANIA	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	1.16E-01	6.82E-04
GeneMANIA	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	1.05E-01	8.92E-04
GeneMANIA	CC	GO:0002102	podosome	-	31	31	-	-	3.14E-03	1.31E-03
GeneMANIA	CC	GO:0090543	Flemming body	-	33	33	-	-	9.36E-03	1.42E-03
GeneMANIA	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	7.36E-03	2.78E-03
GeneMANIA	CC	GO:0001650	fibrillar center	-	151	150	-	-	8.06E-03	6.29E-03
GeneMANIA	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	7.11E-02	6.29E-04
GeneMANIA	CC	GO:1990204	oxidoreductase complex	-	90	84	-	-	9.21E-02	3.57E-03
GeneMANIA	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	1.28E-01	6.82E-04
GeneMANIA	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	2.10E-01	4.72E-04
GeneMANIA	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	122	-	-	7.89E-03	5.14E-03
GeneMANIA	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	1.57E-01	7.87E-04
GeneMANIA	CC	GO:0001726	ruffle	-	181	180	-	-	1.58E-02	7.55E-03
GeneMANIA	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	3.51E-01	4.72E-04
GeneMANIA	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	2.18E-02	5.77E-04
GeneMANIA	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	3.69E-02	7.87E-04
GeneMANIA	CC	GO:0043198	dendritic shaft	-	38	38	-	-	1.56E-03	1.63E-03
GeneMANIA	CC	GO:0043073	germ cell nucleus	-	67	66	-	-	9.88E-03	2.78E-03
GeneMANIA	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	22	-	-	5.82E-03	9.44E-04
GeneMANIA	CC	GO:0016592	mediator complex	-	38	38	-	-	6.55E-01	1.63E-03
GeneMANIA	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	2.42E-02	8.39E-04
GeneMANIA	CC	GO:0022626	cytosolic ribosome	-	118	113	-	-	4.86E-01	4.77E-03
GeneMANIA	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	6.72E-02	1.89E-03
GeneMANIA	CC	GO:0034451	centriolar satellite	-	120	120	-	-	1.83E-02	5.03E-03
GeneMANIA	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	1.45E-02	4.72E-04
GeneMANIA	CC	GO:0045171	intercellular bridge	-	91	90	-	-	1.33E-02	3.78E-03
GeneMANIA	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	80	-	-	1.98E-02	3.36E-03
GeneMANIA	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	2.81E-01	6.29E-04
GeneMANIA	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	2.16E-02	4.72E-04
GeneMANIA	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	1.21E-01	4.72E-04
GeneMANIA	CC	GO:0044292	dendrite terminus	-	13	13	-	-	7.21E-04	5.77E-04
GeneMANIA	CC	GO:0032039	integrator complex	-	19	18	-	-	2.24E-01	7.87E-04
GeneMANIA	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	3.89E-03	6.29E-04
GeneMANIA	CC	GO:0033268	node of Ranvier	-	16	16	-	-	1.76E-02	6.82E-04
GeneMANIA	CC	GO:0036038	MKS complex	-	13	13	-	-	2.93E-01	5.77E-04
GeneMANIA	CC	GO:0030527	structural constituent of chromatin	-	97	92	-	-	7.69E-01	3.88E-03
GeneMANIA	CC	GO:0036379	myofilament	-	26	26	-	-	1.65E-01	1.10E-03
GeneMANIA	CC	GO:0030286	dynein complex	-	210	206	-	-	8.77E-02	8.65E-03
GeneMANIA	CC	GO:0031105	septin complex	-	14	14	-	-	7.54E-01	6.29E-04
GeneMANIA	CC	GO:0097228	sperm principal piece	-	33	32	-	-	2.02E-02	1.36E-03
GeneMANIA	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	5.53E-03	5.24E-04
GeneMANIA	CC	GO:0016482	cytosolic transport	-	135	132	-	-	2.91E-02	5.56E-03
GeneMANIA	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	6.99E-02	9.96E-04
GeneMANIA	CC	GO:0005796	Golgi lumen	-	106	103	-	-	2.78E-02	4.35E-03
GeneMANIA	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	36	-	-	1.49E-01	1.52E-03
GeneMANIA	CC	GO:0034358	plasma lipoprotein particle	-	36	36	-	-	4.86E-02	1.52E-03
GeneMANIA	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	1.40E-01	1.99E-03
GeneMANIA	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	3.09E-02	1.05E-03
GeneMANIA	CC	GO:0030662	coated vesicle membrane	-	202	198	-	-	8.95E-02	8.34E-03
GeneMANIA	CC	GO:0007039	protein catabolic process in the vacuole	-	61	60	-	-	2.24E-01	2.52E-03
GeneMANIA	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	66	-	-	4.46E-01	2.78E-03
GeneMANIA	CC	GO:0090734	site of DNA damage	-	118	116	-	-	2.16E-02	4.88E-03
GeneMANIA	MF	GO:0051861	glycolipid binding	-	30	30	-	-	2.08E-03	1.26E-03
GeneMANIA	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.28E-02	4.72E-04
GeneMANIA	MF	GO:0051087	protein-folding chaperone binding	-	135	132	-	-	3.16E-02	5.56E-03
GeneMANIA	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	3.88E-01	1.15E-03
GeneMANIA	CC	GO:0015464	acetylcholine receptor activity	-	21	21	-	-	9.10E-02	8.92E-04
GeneMANIA	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	4.02E-03	5.24E-04
GeneMANIA	MF	GO:0016594	glycine binding	-	12	12	-	-	3.97E-02	5.24E-04
GeneMANIA	MF	GO:0031681	G-protein beta-subunit binding	-	22	21	-	-	5.73E-02	8.92E-04
GeneMANIA	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	6.62E-02	1.57E-03
GeneMANIA	MF	GO:0035613	RNA stem-loop binding	-	21	16	-	-	2.32E-03	6.82E-04
GeneMANIA	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	248	-	-	1.95E-01	1.04E-02
GeneMANIA	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	3.17E-02	8.39E-04
GeneMANIA	MF	GO:0033691	sialic acid binding	-	22	21	-	-	3.71E-02	8.92E-04
GeneMANIA	MF	GO:0004875	complement receptor activity	-	12	11	-	-	1.38E-02	4.72E-04
GeneMANIA	MF	GO:0048306	calcium-dependent protein binding	-	61	59	-	-	1.01E-02	2.52E-03
GeneMANIA	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	29	-	-	1.62E-01	1.26E-03
GeneMANIA	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	7.72E-02	5.77E-04
GeneMANIA	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	146	-	-	1.31E-01	6.14E-03
GeneMANIA	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	60	-	-	9.39E-02	2.52E-03
GeneMANIA	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	138	-	-	1.09E-01	5.82E-03
GeneMANIA	MF	GO:0045504	dynein heavy chain binding	-	16	16	-	-	1.29E-02	6.82E-04
GeneMANIA	MF	GO:0140457	protein demethylase activity	-	31	31	-	-	2.95E-01	1.31E-03
GeneMANIA	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	2.17E-02	9.44E-04
GeneMANIA	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	5.61E-03	6.82E-04
GeneMANIA	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	7.05E-03	6.29E-04
GeneMANIA	MF	GO:0061980	regulatory RNA binding	-	52	45	-	-	4.34E-02	1.89E-03
GeneMANIA	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	9.54E-02	1.36E-03
GeneMANIA	MF	GO:0000182	rDNA binding	-	11	11	-	-	2.78E-03	4.72E-04
GeneMANIA	MF	GO:0001671	ATPase activator activity	-	29	28	-	-	1.36E-02	1.21E-03
GeneMANIA	MF	GO:0070840	dynein complex binding	-	25	25	-	-	7.14E-03	1.05E-03
GeneMANIA	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.29E-03	1.05E-03
GeneMANIA	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.82E-03	6.82E-04
GeneMANIA	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	9.43E-02	1.47E-03
GeneMANIA	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	4.64E-02	7.87E-04
GeneMANIA	MF	GO:0005178	integrin binding	-	153	153	-	-	6.00E-02	6.45E-03
GeneMANIA	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	1.05E-03	7.34E-04
GeneMANIA	MF	GO:0005549	odorant binding	-	128	109	-	-	1.61E-02	4.62E-03
GeneMANIA	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	6.37E-02	6.29E-04
GeneMANIA	MF	GO:0008327	methyl-CpG binding	-	31	31	-	-	1.95E-01	1.31E-03
GeneMANIA	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	6.41E-01	8.39E-04
GeneMANIA	MF	GO:0048019	receptor antagonist activity	-	31	29	-	-	4.04E-01	1.26E-03
GeneMANIA	MF	GO:0005521	lamin binding	-	15	15	-	-	1.92E-03	6.29E-04
GeneMANIA	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	2.59E-03	8.39E-04
GeneMANIA	MF	GO:0140318	protein transporter activity	-	40	40	-	-	6.23E-02	1.68E-03
GeneMANIA	MF	GO:0070628	proteasome binding	-	17	17	-	-	5.37E-03	7.34E-04
GeneMANIA	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	3.70E-02	4.72E-04
GeneMANIA	MF	GO:0031432	titin binding	-	13	11	-	-	8.53E-03	4.72E-04
GeneMANIA	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.29E-03	4.72E-04
GeneMANIA	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	7.76E-03	1.57E-03
GeneMANIA	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	1.09E-01	7.34E-04
GeneMANIA	MF	GO:0002039	p53 binding	-	66	66	-	-	7.81E-03	2.78E-03
GeneMANIA	MF	GO:0005496	steroid binding	-	110	110	-	-	3.66E-02	4.62E-03
GeneMANIA	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	2.66E-02	1.15E-03
GeneMANIA	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.65E-03	4.72E-04
GeneMANIA	MF	GO:0003684	damaged DNA binding	-	89	85	-	-	4.74E-02	3.57E-03
GeneMANIA	MF	GO:0000339	RNA cap binding	-	20	19	-	-	1.06E-01	8.39E-04
GeneMANIA	MF	GO:0016500	protein-hormone receptor activity	-	21	20	-	-	1.06E-02	8.39E-04
GeneMANIA	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	135	-	-	1.60E-01	5.66E-03
GeneMANIA	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	2.02E-01	6.29E-04
GeneMANIA	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	4.22E-01	5.24E-04
GeneMANIA	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	1.08E-03	4.72E-04
GeneMANIA	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	9.89E-03	2.52E-03
GeneMANIA	MF	GO:0050811	GABA receptor binding	-	18	17	-	-	2.69E-03	7.34E-04
GeneMANIA	MF	GO:0030971	receptor tyrosine kinase binding	-	76	75	-	-	6.52E-03	3.15E-03
GeneMANIA	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	83	-	-	1.38E-01	3.51E-03
GeneMANIA	MF	GO:0140030	modification-dependent protein binding	-	179	179	-	-	5.08E-02	7.55E-03
GeneMANIA	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	4.68E-02	1.05E-03
GeneMANIA	MF	GO:0009881	photoreceptor activity	-	17	15	-	-	4.23E-01	6.29E-04
GeneMANIA	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	19	-	-	2.24E-01	8.39E-04
GeneMANIA	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	2.10E-03	5.77E-04
GeneMANIA	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	6.11E-02	6.82E-04
GeneMANIA	MF	GO:0141047	molecular tag activity	-	13	12	-	-	9.41E-03	5.24E-04
GeneMANIA	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	3.11E-02	4.72E-04
GeneMANIA	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	2.83E-02	5.24E-04
GeneMANIA	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	2.59E-03	6.29E-04
GeneMANIA	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	3.39E-02	5.24E-04
GeneMANIA	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.30E-02	6.29E-04
GeneMANIA	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	8.45E-04	6.29E-04
GeneMANIA	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	3.09E-02	6.29E-04
GeneMANIA	MF	GO:0030276	clathrin binding	-	70	69	-	-	1.40E-01	2.94E-03
GeneMANIA	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	2.31E-02	1.26E-03
GeneMANIA	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	5.61E-04	6.29E-04
GeneMANIA	MF	GO:0046790	virion binding	-	19	18	-	-	2.03E-03	7.87E-04
GeneMANIA	MF	GO:0030552	cAMP binding	-	48	47	-	-	5.19E-02	1.99E-03
GeneMANIA	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	4.15E-03	1.63E-03
GeneMANIA	MF	GO:0035173	histone kinase activity	-	17	17	-	-	1.29E-03	7.34E-04
GeneMANIA	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	3.47E-02	1.10E-03
GeneMANIA	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	7.56E-02	5.24E-04
GeneMANIA	MF	GO:0016209	antioxidant activity	-	92	88	-	-	7.46E-02	3.72E-03
GeneMANIA	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	1.81E-02	1.26E-03
GeneMANIA	MF	GO:0044325	transmembrane transporter binding	-	159	155	-	-	1.63E-02	6.50E-03
GeneMANIA	MF	GO:0048156	tau protein binding	-	43	43	-	-	5.82E-03	1.84E-03
GeneMANIA	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	5.03E-01	1.52E-03
GeneMANIA	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	5.32E-03	5.77E-04
GeneMANIA	MF	GO:0140272	exogenous protein binding	-	79	78	-	-	3.85E-03	3.30E-03
GeneMANIA	MF	GO:0030145	manganese ion binding	-	65	65	-	-	9.78E-03	2.73E-03
GeneMANIA	MF	GO:0071814	protein-lipid complex binding	-	52	47	-	-	1.24E-02	1.99E-03
GeneMANIA	MF	GO:0008066	glutamate receptor activity	-	70	70	-	-	1.03E-01	2.94E-03
GeneMANIA	MF	GO:0030553	cGMP binding	-	15	15	-	-	3.61E-02	6.29E-04
GeneMANIA	MF	GO:0017069	snRNA binding	-	54	47	-	-	5.46E-02	1.99E-03
GeneMANIA	MF	GO:0030215	semaphorin receptor binding	-	23	23	-	-	6.21E-01	9.96E-04
GeneMANIA	MF	GO:0031996	thioesterase binding	-	11	11	-	-	3.88E-03	4.72E-04
GeneMANIA	MF	GO:0031369	translation initiation factor binding	-	32	32	-	-	6.13E-02	1.36E-03
GeneMANIA	MF	GO:0019843	rRNA binding	-	69	67	-	-	3.06E-02	2.83E-03
GeneMANIA	MF	GO:0004713	protein tyrosine kinase activity	-	213	211	-	-	8.54E-02	8.86E-03
GeneMANIA	MF	GO:0061783	peptidoglycan muralytic activity	-	14	14	-	-	5.78E-01	6.29E-04
GeneMANIA	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	52	-	-	5.51E-03	2.20E-03
GeneMANIA	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.72E-02	1.05E-03
GeneMANIA	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	1.14E-03	8.39E-04
GeneMANIA	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	28	-	-	2.63E-03	1.21E-03
GeneMANIA	MF	GO:0016208	AMP binding	-	22	22	-	-	8.90E-03	9.44E-04
GeneMANIA	MF	GO:0000287	magnesium ion binding	-	225	223	-	-	3.62E-02	9.39E-03
GeneMANIA	MF	GO:0031490	chromatin DNA binding	-	120	118	-	-	1.69E-02	4.98E-03
GeneMANIA	MF	GO:0017022	myosin binding	-	73	72	-	-	8.77E-03	3.04E-03
GeneMANIA	MF	GO:0004896	cytokine receptor activity	-	93	93	-	-	7.86E-02	3.93E-03
GeneMANIA	MF	GO:0017166	vinculin binding	-	12	12	-	-	6.72E-03	5.24E-04
GeneMANIA	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	1.39E-02	7.87E-04
GeneMANIA	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	3.41E-03	5.24E-04
GeneMANIA	MF	GO:0005539	glycosaminoglycan binding	-	236	235	-	-	2.50E-02	9.86E-03
GeneMANIA	MF	GO:0140666	annealing activity	-	11	11	-	-	1.20E-02	4.72E-04
GeneMANIA	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.29E-02	6.29E-04
GeneMANIA	MF	GO:0010181	FMN binding	-	15	15	-	-	1.17E-01	6.29E-04
GeneMANIA	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	20	-	-	1.09E-01	8.39E-04
GeneMANIA	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	26	-	-	6.84E-02	1.10E-03
GeneMANIA	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	5.90E-04	7.34E-04
GeneMANIA	MF	GO:0044183	protein folding chaperone	-	67	57	-	-	3.89E-02	2.41E-03
GeneMANIA	MF	GO:0005132	type I interferon receptor binding	-	17	17	-	-	6.93E-01	7.34E-04
GeneMANIA	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	107	-	-	6.57E-02	4.51E-03
GeneMANIA	MF	GO:0003725	double-stranded RNA binding	-	72	72	-	-	6.66E-02	3.04E-03
GeneMANIA	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	3.19E-02	6.82E-04
GeneMANIA	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	2.63E-02	2.20E-03
GeneMANIA	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	8.57E-04	1.47E-03
GeneMANIA	MF	GO:0004618	phosphoglycerate kinase activity	-	89	89	-	-	3.58E-02	3.78E-03
GeneMANIA	MF	GO:0042805	actinin binding	-	36	36	-	-	1.60E-02	1.52E-03
GeneMANIA	MF	GO:0043531	ADP binding	-	38	38	-	-	2.51E-03	1.63E-03
GeneMANIA	MF	GO:0043394	proteoglycan binding	-	36	36	-	-	6.55E-03	1.52E-03
GeneMANIA	MF	GO:0005542	folic acid binding	-	13	12	-	-	1.37E-02	5.24E-04
GeneMANIA	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	1.35E-02	4.72E-04
GeneMANIA	MF	GO:0046332	SMAD binding	-	77	77	-	-	4.48E-02	3.25E-03
GeneMANIA	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.63E-03	5.77E-04
GeneMANIA	MF	GO:0001968	fibronectin binding	-	30	30	-	-	9.32E-03	1.26E-03
GeneMANIA	MF	GO:0048038	quinone binding	-	16	16	-	-	5.86E-03	6.82E-04
GeneMANIA	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	119	-	-	5.90E-02	5.03E-03
GeneMANIA	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	80	-	-	1.93E-02	3.36E-03
GeneMANIA	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	7.91E-02	7.87E-04
GeneMANIA	MF	GO:0051117	ATPase binding	-	85	84	-	-	5.71E-03	3.57E-03
GeneMANIA	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	45	-	-	1.95E-03	1.89E-03
GeneMANIA	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	3.32E-02	8.39E-04
GeneMANIA	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	7.91E-03	4.72E-04
GeneMANIA	MF	GO:0070402	NADPH binding	-	16	15	-	-	3.17E-03	6.29E-04
GeneMANIA	MF	GO:0031404	chloride ion binding	-	14	14	-	-	7.65E-02	6.29E-04
GeneMANIA	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	8.06E-03	2.57E-03
GeneMANIA	MF	GO:0036002	pre-mRNA binding	-	57	35	-	-	1.43E-02	1.47E-03
GeneMANIA	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	38	-	-	4.02E-01	1.63E-03
GeneMANIA	MF	GO:0051540	metal cluster binding	-	71	70	-	-	7.05E-02	2.94E-03
GeneMANIA	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	2.58E-03	4.72E-04
GeneMANIA	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	1.55E-02	3.88E-03
GeneMANIA	MF	GO:0019894	kinesin binding	-	45	45	-	-	9.03E-03	1.89E-03
GeneMANIA	MF	GO:0042287	MHC protein binding	-	68	60	-	-	3.12E-02	2.52E-03
GeneMANIA	MF	GO:0019003	GDP binding	-	89	87	-	-	3.06E-02	3.67E-03
GeneMANIA	MF	GO:0017171	serine hydrolase activity	-	207	198	-	-	1.72E-01	8.34E-03
GeneMANIA	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	3.10E-03	2.78E-03
GeneMANIA	MF	GO:0003774	cytoskeletal motor activity	-	117	116	-	-	3.39E-01	4.88E-03
GeneMANIA	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	2.03E-03	1.26E-03
GeneMANIA	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	1.26E-01	7.34E-04
GeneMANIA	MF	GO:0061134	peptidase regulator activity	-	224	216	-	-	1.86E-01	9.07E-03
GeneMANIA	MF	GO:0008013	beta-catenin binding	-	86	86	-	-	2.21E-02	3.62E-03
GeneMANIA	MF	GO:0051015	actin filament binding	-	208	207	-	-	7.62E-02	8.71E-03
GeneMANIA	MF	GO:0019208	phosphatase regulator activity	-	107	104	-	-	2.67E-02	4.41E-03
GeneMANIA	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	32	-	-	1.70E-01	1.36E-03
GeneMANIA	MF	GO:0043236	laminin binding	-	29	28	-	-	2.75E-03	1.21E-03
GeneMANIA	MF	GO:0030507	spectrin binding	-	26	26	-	-	7.38E-03	1.10E-03
GeneMANIA	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	1.13E-01	1.73E-03
GeneMANIA	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	112	-	-	5.99E-02	4.72E-03
GeneMANIA	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	1.28E-02	1.05E-03
GeneMANIA	MF	GO:0042393	histone binding	-	240	235	-	-	9.60E-02	9.86E-03
GeneMANIA	MF	GO:0019838	growth factor binding	-	182	180	-	-	2.90E-02	7.55E-03
GeneMANIA	MF	GO:0000149	SNARE binding	-	107	106	-	-	2.09E-01	4.46E-03
GeneMANIA	MF	GO:0003727	single-stranded RNA binding	-	90	86	-	-	1.74E-02	3.62E-03
GeneMANIA	MF	GO:0051378	serotonin binding	-	24	24	-	-	3.07E-02	1.05E-03
GeneMANIA	MF	GO:0005516	calmodulin binding	-	206	206	-	-	5.01E-02	8.65E-03
GeneMANIA	MF	GO:0019825	oxygen binding	-	40	39	-	-	9.82E-02	1.68E-03
GeneMANIA	MF	GO:0045505	dynein intermediate chain binding	-	37	37	-	-	3.89E-01	1.57E-03
GeneMANIA	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	86	-	-	1.21E-01	3.62E-03
GeneMANIA	MF	GO:0032182	ubiquitin-like protein binding	-	117	117	-	-	3.40E-02	4.93E-03
GeneMANIA	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	3.92E-02	1.52E-03
GeneMANIA	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	9.89E-03	9.44E-04
GeneMANIA	MF	GO:0043274	phospholipase binding	-	23	23	-	-	1.32E-03	9.96E-04
GeneMANIA	MF	GO:0031072	heat shock protein binding	-	128	124	-	-	3.56E-02	5.24E-03
GeneMANIA	MF	GO:0030515	snoRNA binding	-	33	33	-	-	3.37E-02	1.42E-03
GeneMANIA	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	80	-	-	3.65E-01	3.36E-03
GeneMANIA	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	23	-	-	1.99E-02	9.96E-04
GeneMANIA	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	2.07E-02	1.10E-03
GeneMANIA	MF	GO:0001530	lipopolysaccharide binding	-	38	37	-	-	1.56E-02	1.57E-03
GeneMANIA	MF	GO:0140223	general transcription initiation factor activity	-	55	52	-	-	1.76E-01	2.20E-03
GeneMANIA	MF	GO:0070403	NAD+ binding	-	16	16	-	-	1.49E-01	6.82E-04
GeneMANIA	MF	GO:0000049	tRNA binding	-	75	75	-	-	3.51E-02	3.15E-03
GeneMANIA	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	45	-	-	1.71E-02	1.89E-03
GeneMANIA	MF	GO:0015026	coreceptor activity	-	48	48	-	-	7.28E-03	2.05E-03
GeneMANIA	MF	GO:0005527	macrolide binding	-	12	12	-	-	6.37E-02	5.24E-04
GeneMANIA	MF	GO:0001653	peptide receptor activity	-	128	123	-	-	5.55E-02	5.19E-03
GeneMANIA	MF	GO:0031005	filamin binding	-	15	14	-	-	2.16E-02	6.29E-04
GeneMANIA	MF	GO:0030506	ankyrin binding	-	19	19	-	-	1.41E-02	8.39E-04
GeneMANIA	MF	GO:0006469	negative regulation of protein kinase activity	-	222	211	-	-	9.73E-03	8.86E-03
GeneMANIA	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	1.48E-03	8.39E-04
GeneMANIA	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	2.11E-03	6.29E-04
GeneMANIA	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	2.13E-02	1.31E-03
GeneMANIA	MF	GO:0051427	hormone receptor binding	-	31	31	-	-	2.07E-02	1.31E-03
GeneMANIA	MF	GO:0070851	growth factor receptor binding	-	141	140	-	-	7.51E-02	5.87E-03
GeneMANIA	MF	GO:0031210	phosphatidylcholine binding	-	32	31	-	-	1.62E-02	1.31E-03
GeneMANIA	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	1.43E-01	4.72E-04
GeneMANIA	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	41	-	-	7.71E-03	1.73E-03
GeneMANIA	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	1.96E-03	8.39E-04
GeneMANIA	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	1.11E-02	7.34E-04
GeneMANIA	MF	GO:0005506	iron ion binding	-	154	149	-	-	2.77E-01	6.29E-03
GeneMANIA	MF	GO:0003925	G protein activity	-	45	44	-	-	1.80E-02	1.89E-03
GeneMANIA	MF	GO:0038187	pattern recognition receptor activity	-	33	33	-	-	2.56E-02	1.42E-03
GeneMANIA	MF	GO:0008276	protein methyltransferase activity	-	96	95	-	-	1.64E-01	3.99E-03
GeneMANIA	MF	GO:0004396	hexokinase activity	-	16	16	-	-	2.97E-02	6.82E-04
GeneMANIA	MF	GO:0070888	E-box binding	-	59	59	-	-	6.07E-02	2.52E-03
GeneMANIA	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.13E-02	6.29E-04
GeneMANIA	MF	GO:0015399	primary active transmembrane transporter activity	-	190	188	-	-	2.83E-01	7.92E-03
GeneMANIA	MF	GO:0035254	glutamate receptor binding	-	47	47	-	-	9.04E-03	1.99E-03
GeneMANIA	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	1.20E-02	1.42E-03
GeneMANIA	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	6.57E-03	4.72E-04
GeneMANIA	MF	GO:0043021	ribonucleoprotein complex binding	-	158	157	-	-	1.60E-02	6.61E-03
GeneMANIA	MF	GO:0030170	pyridoxal phosphate binding	-	56	54	-	-	2.76E-01	2.31E-03
GeneMANIA	MF	GO:0032393	MHC class I receptor activity	-	15	15	-	-	4.48E-02	6.29E-04
GeneMANIA	MF	GO:0005112	Notch binding	-	26	26	-	-	4.06E-02	1.10E-03
GeneMANIA	MF	GO:0048185	activin binding	-	16	16	-	-	2.24E-02	6.82E-04
GeneMANIA	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	3.87E-03	1.21E-03
GeneMANIA	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	5.53E-02	4.72E-04
GeneMANIA	MF	GO:0140299	small molecule sensor activity	-	39	34	-	-	2.10E-02	1.47E-03
GeneMANIA	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	5.83E-03	9.44E-04
GeneMANIA	MF	GO:0016917	GABA receptor activity	-	23	23	-	-	9.81E-02	9.96E-04
GeneMANIA	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	1.05E-02	6.29E-04
GeneMANIA	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	26	-	-	9.09E-01	1.10E-03
GeneMANIA	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	46	-	-	3.21E-02	1.94E-03
GeneMANIA	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.39E-03	1.05E-03
GeneMANIA	MF	GO:0008527	taste receptor activity	-	28	26	-	-	4.43E-01	1.10E-03
GeneMANIA	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	9.16E-03	5.24E-04
GeneMANIA	MF	GO:0030594	neurotransmitter receptor activity	-	160	159	-	-	2.82E-01	6.71E-03
GeneMANIA	MF	GO:0034452	dynactin binding	-	12	12	-	-	3.87E-04	5.24E-04
GeneMANIA	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	1.59E-01	1.05E-03
GeneMANIA	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	1.32E-01	8.92E-04
GeneMANIA	MF	GO:0005507	copper ion binding	-	63	60	-	-	1.71E-02	2.52E-03
GeneMANIA	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	5.21E-02	9.44E-04
GeneMANIA	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	8.18E-03	4.72E-04
GeneMANIA	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.29E-02	9.44E-04
GeneMANIA	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	1.94E-01	5.24E-04
GIANT	CC	GO:0005615	extracellular space	2.10E-51	3190	2969	2712	1.09	-	-
GIANT	CC	GO:0005739	mitochondrion	9.37E-45	1671	1594	1421	1.12	-	-
GIANT	CC	GO:0005768	endosome	1.58E-34	1037	1000	882	1.13	-	-
GIANT	CC	GO:0005730	nucleolus	2.13E-34	988	955	840	1.14	-	-
GIANT	CC	GO:0005783	endoplasmic reticulum	2.24E-33	2020	1885	1718	1.10	-	-
GIANT	CC	GO:0005764	lysosome	2.37E-28	747	725	635	1.14	-	-
GIANT	CC	GO:0005794	Golgi apparatus	2.78E-28	1636	1530	1391	1.10	-	-
GIANT	CC	GO:0005815	microtubule organizing center	2.10E-15	843	790	717	1.10	-	-
GIANT	CC	GO:0005840	ribosome	3.31E-13	222	220	189	1.17	-	-
GIANT	CC	GO:0005635	nuclear envelope	3.82E-11	493	466	419	1.11	-	-
GIANT	CC	GO:0031012	extracellular matrix	1.97E-06	564	517	480	1.08	-	-
GIANT	CC	GO:0005777	peroxisome	7.52E-05	142	136	121	1.13	-	-
GIANT	CC	GO:0000228	nuclear chromosome	5.24E-04	206	192	175	1.10	-	-
GIANT	CC	GO:0005811	lipid droplet	9.38E-02	102	93	87	1.07	-	-
GIANT	CC	GO:0005929	cilium	1.03E-01	842	699	716	0.98	-	-
GIANT	BP	GO:0050877	nervous system process	1.62E-53	1527	1073	1298	0.83	-	-
GIANT	BP	GO:0012501	programmed cell death	5.03E-51	1954	1861	1662	1.12	-	-
GIANT	BP	GO:0002376	immune system process	1.46E-47	2448	2299	2082	1.10	-	-
GIANT	BP	GO:0007155	cell adhesion	7.01E-39	1444	1378	1228	1.12	-	-
GIANT	BP	GO:0016192	vesicle-mediated transport	2.93E-38	1894	1783	1610	1.11	-	-
GIANT	BP	GO:0065003	protein-containing complex assembly	7.10E-37	1648	1559	1401	1.11	-	-
GIANT	BP	GO:0048870	cell motility	5.62E-34	1659	1563	1411	1.11	-	-
GIANT	BP	GO:0003013	circulatory system process	9.64E-26	584	571	497	1.15	-	-
GIANT	BP	GO:0006954	inflammatory response	7.27E-25	820	787	697	1.13	-	-
GIANT	BP	GO:0007010	cytoskeleton organization	2.90E-24	1639	1523	1394	1.09	-	-
GIANT	BP	GO:0006886	intracellular protein transport	3.66E-24	664	643	565	1.14	-	-
GIANT	BP	GO:0006914	autophagy	7.92E-24	568	554	483	1.15	-	-
GIANT	BP	GO:0006355	regulation of DNA-templated transcription	4.86E-23	3342	3019	2842	1.06	-	-
GIANT	BP	GO:0030163	protein catabolic process	7.61E-23	990	938	842	1.11	-	-
GIANT	BP	GO:0006281	DNA repair	3.98E-21	587	568	499	1.14	-	-
GIANT	BP	GO:0003012	muscle system process	2.97E-20	425	417	361	1.15	-	-
GIANT	BP	GO:0016071	mRNA metabolic process	3.48E-20	713	682	606	1.12	-	-
GIANT	BP	GO:0006325	chromatin organization	5.45E-20	720	688	612	1.12	-	-
GIANT	BP	GO:0006629	lipid metabolic process	1.84E-18	1355	1255	1152	1.09	-	-
GIANT	BP	GO:0006091	generation of precursor metabolites and energy	2.18E-18	502	486	427	1.14	-	-
GIANT	BP	GO:0042060	wound healing	6.36E-18	431	420	366	1.15	-	-
GIANT	BP	GO:0034330	cell junction organization	1.28E-17	727	690	618	1.12	-	-
GIANT	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.31E-17	729	692	620	1.12	-	-
GIANT	BP	GO:0007005	mitochondrion organization	3.01E-17	484	468	412	1.14	-	-
GIANT	BP	GO:0042254	ribosome biogenesis	3.61E-17	297	294	253	1.16	-	-
GIANT	BP	GO:0072659	protein localization to plasma membrane	3.27E-15	284	280	241	1.16	-	-
GIANT	BP	GO:0005975	carbohydrate metabolic process	1.62E-13	551	523	469	1.12	-	-
GIANT	BP	GO:0055085	transmembrane transport	2.44E-13	1784	1617	1517	1.07	-	-
GIANT	BP	GO:0006913	nucleocytoplasmic transport	2.87E-13	326	317	277	1.14	-	-
GIANT	BP	GO:0006260	DNA replication	5.78E-13	279	273	237	1.15	-	-
GIANT	BP	GO:0140053	mitochondrial gene expression	4.38E-12	164	164	139	1.18	-	-
GIANT	BP	GO:0007163	establishment or maintenance of cell polarity	1.56E-11	227	223	193	1.16	-	-
GIANT	BP	GO:0002181	cytoplasmic translation	7.65E-10	153	152	130	1.17	-	-
GIANT	BP	GO:0032200	telomere organization	5.84E-09	186	182	158	1.15	-	-
GIANT	BP	GO:0030198	extracellular matrix organization	3.92E-08	314	298	267	1.12	-	-
GIANT	BP	GO:0007059	chromosome segregation	5.92E-08	403	378	343	1.10	-	-
GIANT	BP	GO:0098542	defense response to other organism	2.85E-07	1171	1054	996	1.06	-	-
GIANT	BP	GO:0098754	detoxification	1.29E-06	134	131	114	1.15	-	-
GIANT	BP	GO:0000910	cytokinesis	1.30E-06	186	179	158	1.13	-	-
GIANT	BP	GO:0006399	tRNA metabolic process	1.51E-06	196	188	167	1.13	-	-
GIANT	BP	GO:0006790	sulfur compound metabolic process	1.69E-06	320	300	272	1.10	-	-
GIANT	BP	GO:0003014	renal system process	4.17E-06	127	124	108	1.15	-	-
GIANT	BP	GO:0006520	amino acid metabolic process	3.04E-05	292	272	248	1.10	-	-
GIANT	BP	GO:0007040	lysosome organization	5.99E-05	107	104	91	1.14	-	-
GIANT	BP	GO:0006575	cellular modified amino acid metabolic process	7.02E-05	186	176	158	1.11	-	-
GIANT	BP	GO:0006310	DNA recombination	1.87E-04	333	306	283	1.08	-	-
GIANT	BP	GO:0006766	vitamin metabolic process	3.29E-04	107	103	91	1.13	-	-
GIANT	BP	GO:0006457	protein folding	8.55E-04	210	195	179	1.09	-	-
GIANT	BP	GO:0022600	digestive system process	1.08E-03	110	105	94	1.12	-	-
GIANT	BP	GO:0006486	protein glycosylation	4.60E-03	225	206	191	1.08	-	-
GIANT	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	2.00E-02	119	110	101	1.09	-	-
GIANT	BP	GO:0007018	microtubule-based movement	1.95E-01	640	556	544	1.02	-	-
GIANT	BP	GO:0044782	cilium organization	6.70E-01	399	343	339	1.01	-	-
GIANT	BP	GO:0140013	meiotic nuclear division	6.73E-01	279	235	237	0.99	-	-
GIANT	MF	GO:0016740	transferase activity	8.87E-53	3074	2869	2614	1.10	-	-
GIANT	MF	GO:0003723	RNA binding	2.87E-52	1679	1613	1428	1.13	-	-
GIANT	MF	GO:0140096	"catalytic activity, acting on a protein"	5.05E-41	3198	2950	2719	1.08	-	-
GIANT	MF	GO:0008092	cytoskeletal protein binding	5.60E-21	1023	964	870	1.11	-	-
GIANT	MF	GO:0140657	ATP-dependent activity	2.61E-19	729	695	620	1.12	-	-
GIANT	MF	GO:0016491	oxidoreductase activity	2.62E-19	888	839	755	1.11	-	-
GIANT	MF	GO:0140097	"catalytic activity, acting on DNA"	8.80E-17	383	374	326	1.15	-	-
GIANT	MF	GO:0003677	DNA binding	2.04E-16	2865	2575	2436	1.06	-	-
GIANT	MF	GO:0003924	GTPase activity	3.10E-15	658	623	560	1.11	-	-
GIANT	MF	GO:0008289	lipid binding	1.23E-12	836	777	711	1.09	-	-
GIANT	MF	GO:0005198	structural molecule activity	3.49E-12	798	742	679	1.09	-	-
GIANT	MF	GO:0140098	"catalytic activity, acting on RNA"	1.26E-11	417	398	355	1.12	-	-
GIANT	MF	GO:0016829	lyase activity	5.20E-11	538	506	457	1.11	-	-
GIANT	MF	GO:0140110	transcription regulator activity	1.89E-09	2033	1817	1729	1.05	-	-
GIANT	MF	GO:0140104	molecular carrier activity	5.70E-08	105	105	89	1.18	-	-
GIANT	MF	GO:0005215	transporter activity	8.35E-08	1462	1311	1243	1.05	-	-
GIANT	MF	GO:0016874	ligase activity	3.57E-07	283	268	241	1.11	-	-
GIANT	MF	GO:0045182	translation regulator activity	8.78E-07	151	147	128	1.14	-	-
GIANT	MF	GO:0009975	cyclase activity	9.59E-07	277	262	236	1.11	-	-
GIANT	MF	GO:0042393	histone binding	5.85E-06	237	224	202	1.11	-	-
GIANT	MF	GO:0016853	isomerase activity	8.09E-05	252	235	214	1.10	-	-
GIANT	MF	GO:0048018	receptor ligand activity	1.51E-03	504	453	429	1.06	-	-
GIANT	MF	GO:0003774	cytoskeletal motor activity	2.62E-02	116	107	99	1.08	-	-
GIANT	MF	GO:0038024	cargo receptor activity	2.63E-02	117	108	99	1.09	-	-
GIANT	BP	GO:0008038	neuron recognition	-	46	45	-	-	3.44E-03	2.11E-03
GIANT	BP	GO:1905145	cellular response to acetylcholine	-	33	31	-	-	1.48E-03	1.46E-03
GIANT	BP	GO:0097094	craniofacial suture morphogenesis	-	18	17	-	-	4.44E-04	8.19E-04
GIANT	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	1.68E-03	9.94E-04
GIANT	BP	GO:0051931	regulation of sensory perception	-	36	34	-	-	9.97E-04	1.64E-03
GIANT	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	24	-	-	1.69E-03	1.17E-03
GIANT	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	5.06E-04	6.43E-04
GIANT	BP	GO:0009268	response to pH	-	43	39	-	-	1.13E-02	1.87E-03
GIANT	BP	GO:0045666	positive regulation of neuron differentiation	-	91	83	-	-	3.14E-03	3.92E-03
GIANT	BP	GO:0043543	protein acylation	-	107	100	-	-	2.61E-03	4.68E-03
GIANT	MF	GO:0051349	positive regulation of lyase activity	-	41	39	-	-	1.66E-03	1.87E-03
GIANT	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	3.58E-03	7.02E-04
GIANT	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	9.84E-04	1.17E-03
GIANT	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	1.24E-03	9.36E-04
GIANT	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	132	-	-	5.54E-03	6.20E-03
GIANT	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	3.35E-03	1.99E-03
GIANT	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	35	-	-	1.48E-03	1.64E-03
GIANT	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	11	-	-	1.58E-03	5.26E-04
GIANT	BP	GO:0071806	protein transmembrane transport	-	68	66	-	-	1.05E-02	3.10E-03
GIANT	BP	GO:0022038	corpus callosum development	-	25	25	-	-	1.14E-03	1.17E-03
GIANT	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	12	-	-	2.34E-04	5.85E-04
GIANT	BP	GO:0021548	pons development	-	11	11	-	-	5.12E-04	5.26E-04
GIANT	BP	GO:0043299	leukocyte degranulation	-	82	79	-	-	7.25E-03	3.74E-03
GIANT	BP	GO:0048864	stem cell development	-	88	86	-	-	2.83E-03	4.04E-03
GIANT	BP	GO:0097384	cellular lipid biosynthetic process	-	11	11	-	-	1.87E-02	5.26E-04
GIANT	BP	GO:0009310	amine catabolic process	-	20	19	-	-	1.80E-03	9.36E-04
GIANT	BP	GO:0051651	maintenance of location in cell	-	236	221	-	-	4.97E-03	1.04E-02
GIANT	BP	GO:0033119	negative regulation of RNA splicing	-	27	25	-	-	4.37E-03	1.17E-03
GIANT	BP	GO:0014004	microglia differentiation	-	12	12	-	-	7.20E-04	5.85E-04
GIANT	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	26	-	-	1.59E-03	1.23E-03
GIANT	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	4.65E-04	7.02E-04
GIANT	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	2.25E-03	7.02E-04
GIANT	BP	GO:0046415	urate metabolic process	-	12	12	-	-	1.16E-03	5.85E-04
GIANT	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	3.67E-03	1.40E-03
GIANT	BP	GO:0006949	syncytium formation	-	66	61	-	-	2.60E-03	2.87E-03
GIANT	BP	GO:0045176	apical protein localization	-	15	14	-	-	1.83E-04	7.02E-04
GIANT	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	1.01E-02	7.02E-04
GIANT	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	57	-	-	4.76E-03	2.69E-03
GIANT	BP	GO:0030574	collagen catabolic process	-	45	44	-	-	3.34E-03	2.11E-03
GIANT	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	2.29E-03	2.16E-03
GIANT	BP	GO:0060343	trabecula formation	-	26	26	-	-	1.91E-03	1.23E-03
GIANT	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	11	-	-	1.59E-04	5.26E-04
GIANT	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	1.79E-03	1.11E-03
GIANT	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	7.90E-03	7.60E-04
GIANT	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	2.84E-03	8.77E-04
GIANT	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	3.96E-03	1.93E-03
GIANT	BP	GO:0006413	translational initiation	-	122	120	-	-	1.11E-02	5.62E-03
GIANT	BP	GO:0072176	nephric duct development	-	15	15	-	-	1.16E-03	7.02E-04
GIANT	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	8.80E-03	2.40E-03
GIANT	CC	GO:0005200	structural constituent of cytoskeleton	-	112	105	-	-	6.02E-03	4.91E-03
GIANT	BP	GO:1901298	regulation of hydrogen peroxide-mediated programmed cell death	-	13	11	-	-	4.45E-04	5.26E-04
GIANT	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	2.12E-03	2.40E-03
GIANT	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	13	-	-	7.00E-03	6.43E-04
GIANT	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	1.04E-02	1.17E-03
GIANT	BP	GO:1903036	positive regulation of response to wounding	-	76	70	-	-	3.06E-03	3.28E-03
GIANT	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	1.68E-02	9.94E-04
GIANT	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	199	-	-	5.87E-03	9.36E-03
GIANT	CC	GO:0001055	RNA polymerase II activity	-	11	11	-	-	2.32E-02	5.26E-04
GIANT	BP	GO:1903319	positive regulation of protein maturation	-	27	26	-	-	6.86E-04	1.23E-03
GIANT	BP	GO:0032528	microvillus organization	-	24	24	-	-	1.83E-03	1.17E-03
GIANT	BP	GO:0021954	central nervous system neuron development	-	85	80	-	-	2.26E-03	3.74E-03
GIANT	BP	GO:0055017	cardiac muscle tissue growth	-	92	75	-	-	6.09E-03	3.51E-03
GIANT	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	3.77E-03	1.46E-03
GIANT	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	9.56E-04	6.43E-04
GIANT	BP	GO:0048524	positive regulation of viral process	-	64	64	-	-	1.72E-03	3.04E-03
GIANT	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	11	-	-	1.20E-03	5.26E-04
GIANT	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	20	-	-	1.14E-03	9.36E-04
GIANT	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	23	-	-	1.28E-03	1.11E-03
GIANT	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	2.33E-03	8.19E-04
GIANT	BP	GO:0098661	inorganic anion transmembrane transport	-	140	131	-	-	4.23E-03	6.14E-03
GIANT	BP	GO:0006099	tricarboxylic acid cycle	-	33	33	-	-	8.59E-03	1.58E-03
GIANT	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	17	-	-	6.87E-04	8.19E-04
GIANT	BP	GO:0009612	response to mechanical stimulus	-	215	206	-	-	7.44E-03	9.65E-03
GIANT	BP	GO:0048644	muscle organ morphogenesis	-	81	77	-	-	9.65E-03	3.63E-03
GIANT	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	141	-	-	4.98E-03	6.61E-03
GIANT	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	6.49E-04	6.43E-04
GIANT	BP	GO:0071542	dopaminergic neuron differentiation	-	36	32	-	-	9.54E-03	1.52E-03
GIANT	BP	GO:0140115	export across plasma membrane	-	82	64	-	-	9.72E-03	3.04E-03
GIANT	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	11	-	-	7.90E-04	5.26E-04
GIANT	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	1.54E-03	1.81E-03
GIANT	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	11	-	-	1.83E-02	5.26E-04
GIANT	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.16E-03	5.26E-04
GIANT	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	27	-	-	1.81E-03	1.29E-03
GIANT	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	42	-	-	4.08E-03	1.99E-03
GIANT	MF	GO:0003714	transcription corepressor activity	-	190	185	-	-	9.96E-03	8.66E-03
GIANT	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	53	-	-	3.63E-03	2.52E-03
GIANT	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	9.63E-03	7.60E-04
GIANT	CC	GO:0006858	extracellular transport	-	45	37	-	-	8.30E-03	1.75E-03
GIANT	BP	GO:0006304	DNA modification	-	30	28	-	-	9.10E-03	1.35E-03
GIANT	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	2.81E-02	9.36E-04
GIANT	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	4.71E-03	2.34E-03
GIANT	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	20	-	-	1.08E-03	9.36E-04
GIANT	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	5.09E-02	7.02E-04
GIANT	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	34	-	-	1.45E-03	1.64E-03
GIANT	BP	GO:0070417	cellular response to cold	-	13	12	-	-	1.13E-03	5.85E-04
GIANT	BP	GO:0043523	regulation of neuron apoptotic process	-	218	208	-	-	4.76E-03	9.77E-03
GIANT	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	2.25E-03	1.05E-03
GIANT	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	8.53E-04	7.02E-04
GIANT	BP	GO:0044380	protein localization to cytoskeleton	-	57	56	-	-	2.18E-03	2.63E-03
GIANT	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	3.26E-03	6.43E-04
GIANT	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	9.81E-04	1.17E-03
GIANT	BP	GO:0014029	neural crest formation	-	15	14	-	-	6.40E-04	7.02E-04
GIANT	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	1.84E-03	1.11E-03
GIANT	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	41	-	-	1.88E-03	1.93E-03
GIANT	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	68	-	-	4.90E-03	3.22E-03
GIANT	BP	GO:0003188	heart valve formation	-	16	16	-	-	7.91E-02	7.60E-04
GIANT	CC	GO:0045324	late endosome to vacuole transport	-	37	35	-	-	1.62E-02	1.64E-03
GIANT	BP	GO:0043954	cellular component maintenance	-	72	67	-	-	3.79E-03	3.16E-03
GIANT	BP	GO:0050435	amyloid-beta metabolic process	-	65	52	-	-	3.01E-03	2.46E-03
GIANT	BP	GO:0014823	response to activity	-	70	66	-	-	1.91E-03	3.10E-03
GIANT	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	6.84E-04	8.77E-04
GIANT	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	1.95E-02	1.35E-03
GIANT	BP	GO:0034502	protein localization to chromosome	-	130	126	-	-	2.16E-02	5.91E-03
GIANT	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	1.25E-03	5.26E-04
GIANT	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	2.50E-04	5.26E-04
GIANT	BP	GO:0060457	negative regulation of digestive system process	-	17	15	-	-	9.99E-03	7.02E-04
GIANT	BP	GO:0019233	sensory perception of pain	-	103	99	-	-	3.13E-03	4.68E-03
GIANT	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	6.01E-02	1.05E-03
GIANT	BP	GO:0031343	positive regulation of cell killing	-	75	71	-	-	5.55E-02	3.33E-03
GIANT	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	3.41E-03	1.81E-03
GIANT	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	121	-	-	8.95E-03	5.67E-03
GIANT	BP	GO:0017148	negative regulation of translation	-	390	113	-	-	4.90E-03	5.32E-03
GIANT	BP	GO:0030220	platelet formation	-	22	22	-	-	5.64E-03	1.05E-03
GIANT	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	81	-	-	3.10E-03	3.80E-03
GIANT	MF	GO:1903624	regulation of DNA catabolic process	-	14	13	-	-	7.26E-04	6.43E-04
GIANT	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	4.39E-04	7.02E-04
GIANT	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	7.76E-04	7.02E-04
GIANT	BP	GO:1903509	liposaccharide metabolic process	-	109	104	-	-	4.57E-03	4.91E-03
GIANT	BP	GO:0009582	detection of abiotic stimulus	-	140	120	-	-	4.77E-03	5.62E-03
GIANT	BP	GO:0045683	negative regulation of epidermis development	-	13	12	-	-	4.68E-03	5.85E-04
GIANT	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	18	-	-	8.10E-04	8.77E-04
GIANT	CC	GO:0140238	presynaptic endocytosis	-	72	72	-	-	2.02E-02	3.39E-03
GIANT	BP	GO:0051236	establishment of RNA localization	-	161	154	-	-	7.54E-03	7.25E-03
GIANT	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	4.61E-03	1.17E-03
GIANT	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	16	-	-	4.14E-03	7.60E-04
GIANT	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	188	-	-	8.32E-03	8.83E-03
GIANT	BP	GO:0034067	protein localization to Golgi apparatus	-	30	28	-	-	1.04E-03	1.35E-03
GIANT	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	1.23E-03	1.52E-03
GIANT	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	1.33E-03	5.26E-04
GIANT	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	9.50E-03	8.19E-04
GIANT	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	42	-	-	1.10E-03	1.99E-03
GIANT	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	7.71E-03	1.87E-03
GIANT	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	4.07E-03	2.46E-03
GIANT	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	8.76E-03	7.60E-04
GIANT	BP	GO:0050779	RNA destabilization	-	135	95	-	-	6.70E-03	4.45E-03
GIANT	BP	GO:0006023	aminoglycan biosynthetic process	-	74	68	-	-	3.18E-03	3.22E-03
GIANT	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	67	-	-	6.04E-03	3.16E-03
GIANT	BP	GO:0010762	regulation of fibroblast migration	-	40	38	-	-	1.20E-03	1.81E-03
GIANT	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	1.70E-03	1.40E-03
GIANT	BP	GO:0035272	exocrine system development	-	46	45	-	-	9.43E-03	2.11E-03
GIANT	BP	GO:1901096	regulation of autophagosome maturation	-	17	16	-	-	9.26E-03	7.60E-04
GIANT	BP	GO:0022406	membrane docking	-	90	86	-	-	1.07E-02	4.04E-03
GIANT	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	1.30E-03	7.02E-04
GIANT	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	1.11E-03	7.60E-04
GIANT	BP	GO:0050777	negative regulation of immune response	-	196	183	-	-	7.31E-03	8.60E-03
GIANT	MF	GO:0005035	death receptor activity	-	16	16	-	-	7.23E-03	7.60E-04
GIANT	BP	GO:0002063	chondrocyte development	-	33	32	-	-	2.51E-03	1.52E-03
GIANT	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	18	-	-	4.46E-04	8.77E-04
GIANT	BP	GO:0099068	postsynapse assembly	-	40	39	-	-	5.27E-03	1.87E-03
GIANT	BP	GO:0021782	glial cell development	-	120	113	-	-	4.35E-03	5.32E-03
GIANT	BP	GO:0051782	negative regulation of cell division	-	18	17	-	-	1.88E-03	8.19E-04
GIANT	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	8.41E-04	5.26E-04
GIANT	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	83	-	-	4.20E-03	3.92E-03
GIANT	BP	GO:0001655	urogenital system development	-	66	65	-	-	7.90E-03	3.04E-03
GIANT	BP	GO:0071827	plasma lipoprotein particle organization	-	86	70	-	-	9.28E-03	3.28E-03
GIANT	BP	GO:0045494	photoreceptor cell maintenance	-	43	39	-	-	1.33E-02	1.87E-03
GIANT	BP	GO:0055088	lipid homeostasis	-	173	145	-	-	8.94E-03	6.79E-03
GIANT	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	4.13E-02	1.23E-03
GIANT	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	193	-	-	4.63E-03	9.07E-03
GIANT	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	24	-	-	1.94E-03	1.17E-03
GIANT	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	4.04E-03	1.64E-03
GIANT	BP	GO:0045667	regulation of osteoblast differentiation	-	147	121	-	-	5.21E-03	5.67E-03
GIANT	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	2.51E-03	7.60E-04
GIANT	BP	GO:0061037	negative regulation of cartilage development	-	32	29	-	-	1.55E-03	1.40E-03
GIANT	BP	GO:0045738	negative regulation of DNA repair	-	40	37	-	-	1.23E-03	1.75E-03
GIANT	BP	GO:0001704	formation of primary germ layer	-	195	183	-	-	7.27E-03	8.60E-03
GIANT	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	1.10E-03	6.43E-04
GIANT	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	1.85E-03	2.40E-03
GIANT	BP	GO:0060174	limb bud formation	-	11	11	-	-	5.15E-02	5.26E-04
GIANT	BP	GO:0048708	astrocyte differentiation	-	88	84	-	-	2.57E-03	3.98E-03
GIANT	BP	GO:0042092	type 2 immune response	-	41	41	-	-	2.13E-03	1.93E-03
GIANT	BP	GO:0048588	developmental cell growth	-	233	216	-	-	5.87E-03	1.01E-02
GIANT	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	5.34E-03	9.36E-04
GIANT	BP	GO:0021872	forebrain generation of neurons	-	52	51	-	-	2.69E-03	2.40E-03
GIANT	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	8.13E-04	1.05E-03
GIANT	BP	GO:0045023	G0 to G1 transition	-	41	38	-	-	1.53E-02	1.81E-03
GIANT	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	51	-	-	2.17E-03	2.40E-03
GIANT	BP	GO:0072488	ammonium transmembrane transport	-	12	12	-	-	1.06E-03	5.85E-04
GIANT	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	6.64E-03	1.64E-03
GIANT	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	6.94E-04	1.23E-03
GIANT	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	49	-	-	1.67E-03	2.34E-03
GIANT	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	3.11E-03	9.36E-04
GIANT	BP	GO:0015810	aspartate transmembrane transport	-	19	18	-	-	8.55E-04	8.77E-04
GIANT	BP	GO:0010232	vascular transport	-	87	84	-	-	3.49E-03	3.98E-03
GIANT	BP	GO:0021987	cerebral cortex development	-	125	121	-	-	5.79E-03	5.67E-03
GIANT	BP	GO:0008637	apoptotic mitochondrial changes	-	108	101	-	-	4.61E-03	4.74E-03
GIANT	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	34	-	-	1.05E-03	1.64E-03
GIANT	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	9.90E-03	7.02E-04
GIANT	BP	GO:0060999	positive regulation of dendritic spine development	-	35	32	-	-	1.27E-03	1.52E-03
GIANT	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	17	-	-	7.41E-04	8.19E-04
GIANT	BP	GO:2000736	regulation of stem cell differentiation	-	78	76	-	-	3.20E-03	3.57E-03
GIANT	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	2.52E-03	9.36E-04
GIANT	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	1.77E-03	9.36E-04
GIANT	BP	GO:0002064	epithelial cell development	-	210	204	-	-	6.00E-03	9.59E-03
GIANT	BP	GO:0071318	cellular response to ATP	-	18	17	-	-	5.65E-03	8.19E-04
GIANT	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	39	-	-	1.40E-03	1.87E-03
GIANT	BP	GO:2001222	regulation of neuron migration	-	46	45	-	-	1.24E-03	2.11E-03
GIANT	BP	GO:0034389	lipid droplet organization	-	38	36	-	-	6.78E-04	1.70E-03
GIANT	BP	GO:0051602	response to electrical stimulus	-	44	43	-	-	9.06E-04	2.05E-03
GIANT	BP	GO:0042177	negative regulation of protein catabolic process	-	109	103	-	-	1.91E-03	4.86E-03
GIANT	MF	GO:0038024	cargo receptor activity	-	121	108	-	-	5.20E-03	5.09E-03
GIANT	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	16	-	-	5.53E-04	7.60E-04
GIANT	BP	GO:0033120	positive regulation of RNA splicing	-	46	38	-	-	2.26E-03	1.81E-03
GIANT	BP	GO:0051445	regulation of meiotic cell cycle	-	64	54	-	-	2.43E-02	2.57E-03
GIANT	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.61E-03	5.85E-04
GIANT	BP	GO:0033619	membrane protein proteolysis	-	60	59	-	-	4.60E-03	2.81E-03
GIANT	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	1.28E-03	7.02E-04
GIANT	BP	GO:0090087	regulation of peptide transport	-	195	187	-	-	4.51E-03	8.77E-03
GIANT	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	99	-	-	2.20E-03	4.68E-03
GIANT	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	1.96E-03	1.17E-03
GIANT	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	3.51E-03	1.17E-03
GIANT	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	11	-	-	1.52E-04	5.26E-04
GIANT	BP	GO:0042537	benzene-containing compound metabolic process	-	27	26	-	-	4.23E-03	1.23E-03
GIANT	BP	GO:0099118	microtubule-based protein transport	-	14	12	-	-	1.00E-03	5.85E-04
GIANT	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	4.27E-03	7.02E-04
GIANT	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	5.82E-02	9.36E-04
GIANT	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	2.27E-03	6.43E-04
GIANT	BP	GO:0022404	molting cycle process	-	95	88	-	-	3.78E-03	4.15E-03
GIANT	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	7.91E-04	5.26E-04
GIANT	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	1.14E-03	8.19E-04
GIANT	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	1.96E-03	9.36E-04
GIANT	BP	GO:0042754	negative regulation of circadian rhythm	-	12	11	-	-	9.74E-04	5.26E-04
GIANT	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	18	-	-	5.76E-04	8.77E-04
GIANT	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	4.57E-03	1.52E-03
GIANT	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	4.03E-04	7.02E-04
GIANT	BP	GO:0008299	isoprenoid biosynthetic process	-	30	28	-	-	3.29E-03	1.35E-03
GIANT	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	228	-	-	7.99E-03	1.07E-02
GIANT	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.51E-03	1.46E-03
GIANT	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	1.61E-03	1.05E-03
GIANT	CC	GO:0098926	postsynaptic signal transduction	-	39	37	-	-	1.96E-03	1.75E-03
GIANT	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	135	-	-	6.42E-03	6.32E-03
GIANT	CC	GO:0016082	synaptic vesicle priming	-	19	18	-	-	3.79E-02	8.77E-04
GIANT	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	2.24E-03	2.22E-03
GIANT	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	138	-	-	5.31E-03	6.49E-03
GIANT	BP	GO:0034249	negative regulation of amide metabolic process	-	34	23	-	-	1.71E-03	1.11E-03
GIANT	BP	GO:0061548	ganglion development	-	17	17	-	-	1.81E-03	8.19E-04
GIANT	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	92	-	-	5.45E-03	4.33E-03
GIANT	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.37E-03	7.02E-04
GIANT	BP	GO:0042832	defense response to protozoan	-	28	25	-	-	5.37E-03	1.17E-03
GIANT	BP	GO:0048799	animal organ maturation	-	33	30	-	-	1.18E-03	1.40E-03
GIANT	BP	GO:0006925	inflammatory cell apoptotic process	-	23	21	-	-	1.58E-03	9.94E-04
GIANT	BP	GO:2000291	regulation of myoblast proliferation	-	25	17	-	-	1.02E-02	8.19E-04
GIANT	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	164	-	-	3.70E-03	7.72E-03
GIANT	BP	GO:0010269	response to selenium ion	-	11	11	-	-	6.67E-04	5.26E-04
GIANT	BP	GO:1903035	negative regulation of response to wounding	-	93	87	-	-	4.20E-03	4.09E-03
GIANT	BP	GO:0015697	quaternary ammonium group transport	-	16	15	-	-	7.98E-03	7.02E-04
GIANT	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	27	-	-	8.55E-04	1.29E-03
GIANT	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	1.52E-03	1.29E-03
GIANT	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	124	-	-	5.67E-03	5.85E-03
GIANT	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	96	-	-	6.48E-03	4.50E-03
GIANT	BP	GO:0045056	transcytosis	-	20	20	-	-	8.04E-04	9.36E-04
GIANT	BP	GO:0018342	protein prenylation	-	15	15	-	-	1.79E-03	7.02E-04
GIANT	BP	GO:0009267	cellular response to starvation	-	170	164	-	-	6.49E-03	7.72E-03
GIANT	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	4.98E-03	2.52E-03
GIANT	BP	GO:0046834	lipid phosphorylation	-	16	15	-	-	4.31E-04	7.02E-04
GIANT	CC	GO:0140239	postsynaptic endocytosis	-	23	22	-	-	1.50E-03	1.05E-03
GIANT	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	26	-	-	1.32E-03	1.23E-03
GIANT	BP	GO:0046931	pore complex assembly	-	21	21	-	-	8.19E-04	9.94E-04
GIANT	CC	GO:0032008	positive regulation of TOR signaling	-	52	50	-	-	5.95E-03	2.34E-03
GIANT	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	1.79E-02	1.58E-03
GIANT	BP	GO:0046618	xenobiotic export from cell	-	27	14	-	-	4.20E-03	7.02E-04
GIANT	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	14	-	-	5.64E-04	7.02E-04
GIANT	BP	GO:0060428	lung epithelium development	-	43	43	-	-	1.51E-03	2.05E-03
GIANT	BP	GO:0030431	sleep	-	30	29	-	-	2.05E-03	1.40E-03
GIANT	BP	GO:1903318	negative regulation of protein maturation	-	29	27	-	-	6.58E-04	1.29E-03
GIANT	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	97	-	-	2.37E-02	4.56E-03
GIANT	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	6.84E-04	8.19E-04
GIANT	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	1.60E-03	7.02E-04
GIANT	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	1.09E-03	5.85E-04
GIANT	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	8.71E-04	6.43E-04
GIANT	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	68	-	-	2.57E-03	3.22E-03
GIANT	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	65	-	-	1.90E-03	3.04E-03
GIANT	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	5.89E-04	8.19E-04
GIANT	CC	GO:0090660	cerebrospinal fluid circulation	-	15	12	-	-	8.23E-04	5.85E-04
GIANT	CC	GO:0006406	mRNA export from nucleus	-	69	66	-	-	7.40E-03	3.10E-03
GIANT	BP	GO:0009880	embryonic pattern specification	-	70	63	-	-	9.46E-03	2.98E-03
GIANT	BP	GO:0015791	polyol transmembrane transport	-	14	11	-	-	3.92E-04	5.26E-04
GIANT	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	3.32E-02	1.87E-03
GIANT	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	1.43E-03	1.17E-03
GIANT	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	1.49E-03	5.26E-04
GIANT	BP	GO:0002367	cytokine production involved in immune response	-	121	119	-	-	7.25E-03	5.62E-03
GIANT	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	3.45E-04	6.43E-04
GIANT	BP	GO:0044848	biological phase	-	211	182	-	-	1.38E-02	8.54E-03
GIANT	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	1.52E-03	5.85E-04
GIANT	BP	GO:0046660	female sex differentiation	-	125	121	-	-	3.50E-03	5.67E-03
GIANT	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	16	-	-	6.72E-04	7.60E-04
GIANT	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	40	-	-	1.66E-03	1.87E-03
GIANT	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	1.19E-02	3.28E-03
GIANT	BP	GO:0071248	cellular response to metal ion	-	201	188	-	-	5.13E-03	8.83E-03
GIANT	BP	GO:0030308	negative regulation of cell growth	-	191	184	-	-	3.66E-03	8.66E-03
GIANT	BP	GO:0097306	cellular response to alcohol	-	99	92	-	-	3.36E-03	4.33E-03
GIANT	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	122	-	-	1.66E-02	5.73E-03
GIANT	BP	GO:0010453	regulation of cell fate commitment	-	40	35	-	-	3.69E-02	1.64E-03
GIANT	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	55	-	-	2.53E-03	2.57E-03
GIANT	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	54	-	-	2.01E-03	2.57E-03
GIANT	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	4.68E-03	1.23E-03
GIANT	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	2.01E-03	1.17E-03
GIANT	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	44	-	-	1.49E-03	2.11E-03
GIANT	BP	GO:0032890	regulation of organic acid transport	-	78	75	-	-	2.05E-03	3.51E-03
GIANT	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	1.55E-03	9.36E-04
GIANT	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	21	-	-	3.88E-03	9.94E-04
GIANT	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	88	-	-	2.66E-03	4.15E-03
GIANT	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	2.03E-03	1.23E-03
GIANT	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	3.86E-03	5.26E-04
GIANT	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	51	-	-	3.20E-03	2.40E-03
GIANT	BP	GO:0051259	protein complex oligomerization	-	251	235	-	-	8.33E-03	1.10E-02
GIANT	BP	GO:0009163	nucleoside biosynthetic process	-	16	15	-	-	1.00E-02	7.02E-04
GIANT	BP	GO:0098743	cell aggregation	-	24	23	-	-	1.27E-03	1.11E-03
GIANT	BP	GO:0035112	genitalia morphogenesis	-	12	11	-	-	3.84E-04	5.26E-04
GIANT	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	1.74E-03	5.26E-04
GIANT	BP	GO:0009994	oocyte differentiation	-	57	46	-	-	6.50E-04	2.16E-03
GIANT	MF	GO:0031952	regulation of protein autophosphorylation	-	43	41	-	-	1.50E-03	1.93E-03
GIANT	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	4.55E-04	7.02E-04
GIANT	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	151	-	-	3.60E-03	7.08E-03
GIANT	BP	GO:0044319	"wound healing, spreading of cells"	-	37	34	-	-	1.37E-03	1.64E-03
GIANT	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	1.34E-03	1.35E-03
GIANT	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	1.05E-03	1.64E-03
GIANT	BP	GO:0072665	protein localization to vacuole	-	84	83	-	-	4.80E-03	3.92E-03
GIANT	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	46	-	-	7.84E-03	2.16E-03
GIANT	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	22	-	-	1.66E-03	1.05E-03
GIANT	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	71	-	-	4.56E-03	3.33E-03
GIANT	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	2.52E-03	7.60E-04
GIANT	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	9.34E-03	7.02E-04
GIANT	BP	GO:0042044	fluid transport	-	35	32	-	-	1.82E-03	1.52E-03
GIANT	BP	GO:0070633	transepithelial transport	-	35	34	-	-	8.37E-04	1.64E-03
GIANT	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	1.13E-03	6.43E-04
GIANT	BP	GO:0045661	regulation of myoblast differentiation	-	74	69	-	-	6.20E-03	3.28E-03
GIANT	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	15	-	-	1.15E-02	7.02E-04
GIANT	BP	GO:0030307	positive regulation of cell growth	-	164	155	-	-	3.67E-03	7.25E-03
GIANT	BP	GO:0034250	positive regulation of amide metabolic process	-	27	25	-	-	8.77E-04	1.17E-03
GIANT	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	2.48E-03	8.77E-04
GIANT	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	1.56E-03	6.43E-04
GIANT	BP	GO:0014812	muscle cell migration	-	110	86	-	-	3.57E-03	4.04E-03
GIANT	BP	GO:0048525	negative regulation of viral process	-	90	84	-	-	1.29E-02	3.98E-03
GIANT	BP	GO:0072044	collecting duct development	-	16	15	-	-	1.13E-03	7.02E-04
GIANT	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	13	-	-	4.31E-03	6.43E-04
GIANT	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	68	-	-	4.21E-03	3.22E-03
GIANT	BP	GO:0030238	male sex determination	-	14	14	-	-	1.22E-03	7.02E-04
GIANT	BP	GO:0051781	positive regulation of cell division	-	93	87	-	-	2.91E-03	4.09E-03
GIANT	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	2.24E-03	9.94E-04
GIANT	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	9.71E-04	5.26E-04
GIANT	BP	GO:0035524	proline transmembrane transport	-	12	11	-	-	1.75E-03	5.26E-04
GIANT	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	3.96E-02	1.11E-03
GIANT	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	22	-	-	1.44E-03	1.05E-03
GIANT	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	2.89E-03	2.22E-03
GIANT	BP	GO:0007272	ensheathment of neurons	-	146	141	-	-	4.21E-03	6.61E-03
GIANT	CC	GO:0050806	positive regulation of synaptic transmission	-	171	152	-	-	4.84E-03	7.14E-03
GIANT	BP	GO:0060021	roof of mouth development	-	91	88	-	-	5.54E-03	4.15E-03
GIANT	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	1.25E-03	1.87E-03
GIANT	BP	GO:0050819	negative regulation of coagulation	-	54	52	-	-	4.83E-03	2.46E-03
GIANT	BP	GO:0017004	cytochrome complex assembly	-	40	35	-	-	3.82E-03	1.64E-03
GIANT	BP	GO:0018410	C-terminal protein amino acid modification	-	15	12	-	-	1.12E-02	5.85E-04
GIANT	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	5.63E-02	2.92E-03
GIANT	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	1.02E-02	7.02E-04
GIANT	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	13	-	-	2.42E-04	6.43E-04
GIANT	CC	GO:0050805	negative regulation of synaptic transmission	-	55	55	-	-	9.11E-03	2.57E-03
GIANT	BP	GO:0043248	proteasome assembly	-	13	13	-	-	3.71E-03	6.43E-04
GIANT	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	57	-	-	3.00E-03	2.69E-03
GIANT	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	1.09E-03	5.26E-04
GIANT	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	84	-	-	3.32E-03	3.98E-03
GIANT	BP	GO:0016054	organic acid catabolic process	-	251	235	-	-	2.23E-02	1.10E-02
GIANT	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	5.65E-03	6.43E-04
GIANT	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	2.65E-03	1.35E-03
GIANT	BP	GO:0065005	protein-lipid complex assembly	-	29	28	-	-	2.42E-03	1.35E-03
GIANT	BP	GO:0008033	tRNA processing	-	136	127	-	-	1.47E-02	5.97E-03
GIANT	BP	GO:0046661	male sex differentiation	-	171	167	-	-	5.75E-03	7.84E-03
GIANT	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	8.54E-04	7.02E-04
GIANT	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	1.92E-03	8.19E-04
GIANT	BP	GO:0035188	hatching	-	27	21	-	-	5.38E-04	9.94E-04
GIANT	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	81	-	-	4.89E-03	3.80E-03
GIANT	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	7.56E-04	7.02E-04
GIANT	BP	GO:0090713	immunological memory process	-	18	18	-	-	7.75E-04	8.77E-04
GIANT	BP	GO:0061326	renal tubule development	-	103	102	-	-	6.15E-03	4.80E-03
GIANT	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	6.16E-03	2.57E-03
GIANT	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	1.71E-03	8.19E-04
GIANT	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	9.56E-04	9.36E-04
GIANT	BP	GO:0060325	face morphogenesis	-	31	31	-	-	1.16E-03	1.46E-03
GIANT	BP	GO:0090559	regulation of membrane permeability	-	72	61	-	-	2.62E-03	2.87E-03
GIANT	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	14	-	-	5.05E-03	7.02E-04
GIANT	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	2.01E-01	5.85E-04
GIANT	BP	GO:0031579	membrane raft organization	-	25	23	-	-	1.12E-03	1.11E-03
GIANT	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	23	-	-	1.28E-03	1.11E-03
GIANT	BP	GO:0060033	anatomical structure regression	-	16	14	-	-	8.53E-04	7.02E-04
GIANT	BP	GO:0046460	neutral lipid biosynthetic process	-	50	41	-	-	5.05E-03	1.93E-03
GIANT	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	116	-	-	8.09E-03	5.44E-03
GIANT	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	1.89E-03	5.26E-04
GIANT	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	158	-	-	4.18E-03	7.43E-03
GIANT	BP	GO:0002251	organ or tissue specific immune response	-	43	40	-	-	2.70E-02	1.87E-03
GIANT	CC	GO:0048167	regulation of synaptic plasticity	-	210	185	-	-	6.06E-03	8.66E-03
GIANT	BP	GO:1903708	positive regulation of hemopoiesis	-	184	180	-	-	1.25E-02	8.42E-03
GIANT	BP	GO:1903008	organelle disassembly	-	154	152	-	-	6.79E-03	7.14E-03
GIANT	BP	GO:0001709	cell fate determination	-	44	44	-	-	2.66E-03	2.11E-03
GIANT	BP	GO:0051873	killing by host of symbiont cells	-	28	24	-	-	9.24E-03	1.17E-03
GIANT	BP	GO:0045058	T cell selection	-	53	53	-	-	8.43E-03	2.52E-03
GIANT	CC	GO:0032387	negative regulation of intracellular transport	-	51	47	-	-	1.47E-03	2.22E-03
GIANT	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	15	-	-	2.38E-02	7.02E-04
GIANT	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	2.37E-03	3.69E-03
GIANT	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	42	-	-	3.16E-03	1.99E-03
GIANT	BP	GO:0099084	postsynaptic specialization organization	-	44	42	-	-	3.88E-03	1.99E-03
GIANT	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	6.01E-03	5.26E-04
GIANT	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	1.16E-03	7.02E-04
GIANT	BP	GO:0060384	innervation	-	27	27	-	-	1.27E-03	1.29E-03
GIANT	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	4.47E-04	5.85E-04
GIANT	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	32	-	-	5.30E-03	1.52E-03
GIANT	MF	GO:0031281	positive regulation of cyclase activity	-	40	38	-	-	1.67E-03	1.81E-03
GIANT	MF	GO:0098631	cell adhesion mediator activity	-	64	60	-	-	1.23E-02	2.81E-03
GIANT	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	1.58E-03	8.77E-04
GIANT	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	1.46E-03	5.85E-04
GIANT	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	1.80E-03	8.77E-04
GIANT	BP	GO:0071453	cellular response to oxygen levels	-	168	154	-	-	4.49E-03	7.25E-03
GIANT	BP	GO:0090399	replicative senescence	-	17	17	-	-	1.25E-03	8.19E-04
GIANT	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	12	-	-	2.35E-04	5.85E-04
GIANT	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	4.82E-03	1.40E-03
GIANT	BP	GO:0070585	protein localization to mitochondrion	-	125	123	-	-	7.24E-03	5.79E-03
GIANT	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	1.47E-03	7.02E-04
GIANT	BP	GO:0010623	programmed cell death involved in cell development	-	25	21	-	-	1.52E-03	9.94E-04
GIANT	BP	GO:0044242	cellular lipid catabolic process	-	224	206	-	-	1.21E-02	9.65E-03
GIANT	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	3.62E-04	6.43E-04
GIANT	BP	GO:0002931	response to ischemia	-	58	55	-	-	1.87E-03	2.57E-03
GIANT	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	1.23E-03	5.85E-04
GIANT	BP	GO:0014047	glutamate secretion	-	25	25	-	-	7.47E-04	1.17E-03
GIANT	BP	GO:0061005	cell differentiation involved in kidney development	-	58	58	-	-	4.50E-03	2.75E-03
GIANT	BP	GO:0030397	membrane disassembly	-	11	11	-	-	8.60E-04	5.26E-04
GIANT	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	70	-	-	5.44E-03	3.28E-03
GIANT	BP	GO:0060420	regulation of heart growth	-	74	60	-	-	5.59E-03	2.81E-03
GIANT	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	5.55E-04	7.02E-04
GIANT	BP	GO:0009755	hormone-mediated signaling pathway	-	221	208	-	-	5.31E-03	9.77E-03
GIANT	BP	GO:0022612	gland morphogenesis	-	124	121	-	-	6.90E-03	5.67E-03
GIANT	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	35	-	-	1.40E-03	1.64E-03
GIANT	MF	GO:0140416	transcription regulator inhibitor activity	-	26	25	-	-	3.19E-03	1.17E-03
GIANT	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	24	-	-	5.92E-03	1.17E-03
GIANT	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	1.31E-02	7.02E-04
GIANT	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	2.04E-03	8.19E-04
GIANT	BP	GO:1990845	adaptive thermogenesis	-	166	163	-	-	3.53E-03	7.66E-03
GIANT	BP	GO:0071320	cellular response to cAMP	-	54	54	-	-	2.58E-02	2.57E-03
GIANT	BP	GO:0015844	monoamine transport	-	88	85	-	-	3.25E-03	3.98E-03
GIANT	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	1.82E-03	1.05E-03
GIANT	BP	GO:0060039	pericardium development	-	19	18	-	-	2.15E-03	8.77E-04
GIANT	BP	GO:0071392	cellular response to estradiol stimulus	-	40	39	-	-	9.23E-04	1.87E-03
GIANT	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	1.55E-03	6.43E-04
GIANT	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	1.67E-03	9.36E-04
GIANT	BP	GO:0009451	RNA modification	-	169	156	-	-	1.45E-02	7.31E-03
GIANT	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	7.15E-03	5.26E-04
GIANT	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	39	-	-	1.65E-03	1.87E-03
GIANT	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	5.85E-03	8.19E-04
GIANT	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	108	-	-	8.17E-03	5.09E-03
GIANT	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	38	-	-	4.88E-03	1.81E-03
GIANT	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	3.67E-03	5.26E-04
GIANT	BP	GO:0015807	L-amino acid transport	-	94	83	-	-	2.61E-03	3.92E-03
GIANT	BP	GO:0032941	secretion by tissue	-	85	82	-	-	2.03E-03	3.86E-03
GIANT	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	1.16E-02	6.43E-04
GIANT	BP	GO:0046605	regulation of centrosome cycle	-	54	52	-	-	3.89E-03	2.46E-03
GIANT	BP	GO:0048753	pigment granule organization	-	40	40	-	-	5.10E-02	1.87E-03
GIANT	BP	GO:0021516	dorsal spinal cord development	-	20	17	-	-	2.44E-03	8.19E-04
GIANT	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	1.14E-03	9.36E-04
GIANT	BP	GO:0032196	transposition	-	11	11	-	-	1.10E-03	5.26E-04
GIANT	BP	GO:0003014	renal system process	-	130	126	-	-	4.47E-03	5.91E-03
GIANT	CC	GO:0070286	axonemal dynein complex assembly	-	40	29	-	-	2.67E-02	1.40E-03
GIANT	BP	GO:0045598	regulation of fat cell differentiation	-	148	127	-	-	4.58E-03	5.97E-03
GIANT	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	188	-	-	5.86E-03	8.83E-03
GIANT	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	2.32E-03	1.81E-03
GIANT	BP	GO:1901863	positive regulation of muscle tissue development	-	24	23	-	-	2.94E-03	1.11E-03
GIANT	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	220	-	-	9.71E-03	1.03E-02
GIANT	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	3.29E-04	6.43E-04
GIANT	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	6.74E-04	1.11E-03
GIANT	BP	GO:0018158	protein oxidation	-	15	15	-	-	1.39E-03	7.02E-04
GIANT	BP	GO:0039694	viral RNA genome replication	-	30	28	-	-	5.16E-03	1.35E-03
GIANT	BP	GO:0009404	toxin metabolic process	-	17	16	-	-	3.37E-03	7.60E-04
GIANT	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	5.82E-04	1.29E-03
GIANT	BP	GO:0071709	membrane assembly	-	68	61	-	-	3.22E-03	2.87E-03
GIANT	BP	GO:0008217	regulation of blood pressure	-	186	180	-	-	5.22E-03	8.42E-03
GIANT	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	5.27E-04	8.77E-04
GIANT	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	1.23E-02	7.02E-04
GIANT	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	61	-	-	1.36E-03	2.87E-03
GIANT	CC	GO:0042770	signal transduction in response to DNA damage	-	186	183	-	-	1.99E-02	8.60E-03
GIANT	BP	GO:0002200	somatic diversification of immune receptors	-	78	75	-	-	9.84E-03	3.51E-03
GIANT	BP	GO:0035315	hair cell differentiation	-	52	45	-	-	1.00E-02	2.11E-03
GIANT	BP	GO:0048645	animal organ formation	-	62	60	-	-	2.13E-02	2.81E-03
GIANT	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	156	-	-	6.18E-03	7.31E-03
GIANT	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	5.13E-02	7.02E-04
GIANT	BP	GO:0033627	cell adhesion mediated by integrin	-	87	85	-	-	5.13E-03	3.98E-03
GIANT	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	20	-	-	8.37E-03	9.36E-04
GIANT	BP	GO:0015824	proline transport	-	13	12	-	-	8.19E-04	5.85E-04
GIANT	BP	GO:0035107	appendage morphogenesis	-	147	143	-	-	8.20E-03	6.73E-03
GIANT	BP	GO:1903707	negative regulation of hemopoiesis	-	116	107	-	-	3.04E-03	5.03E-03
GIANT	BP	GO:0036342	post-anal tail morphogenesis	-	19	18	-	-	3.97E-04	8.77E-04
GIANT	CC	GO:0048208	COPII vesicle coating	-	27	26	-	-	3.46E-03	1.23E-03
GIANT	BP	GO:0030149	sphingolipid catabolic process	-	32	29	-	-	3.53E-03	1.40E-03
GIANT	BP	GO:0050994	regulation of lipid catabolic process	-	61	58	-	-	4.94E-03	2.75E-03
GIANT	BP	GO:0035988	chondrocyte proliferation	-	24	24	-	-	1.03E-03	1.17E-03
GIANT	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	28	-	-	6.66E-04	1.35E-03
GIANT	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	2.32E-04	5.26E-04
GIANT	BP	GO:0009593	detection of chemical stimulus	-	511	129	-	-	6.12E-02	6.08E-03
GIANT	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	6.19E-04	5.85E-04
GIANT	BP	GO:0045727	positive regulation of translation	-	141	138	-	-	4.99E-03	6.49E-03
GIANT	BP	GO:0036315	cellular response to sterol	-	24	20	-	-	2.73E-03	9.36E-04
GIANT	CC	GO:0032388	positive regulation of intracellular transport	-	137	131	-	-	2.60E-03	6.14E-03
GIANT	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	5.11E-03	6.43E-04
GIANT	BP	GO:0002027	regulation of heart rate	-	106	102	-	-	2.14E-02	4.80E-03
GIANT	BP	GO:0050879	multicellular organismal movement	-	118	111	-	-	5.86E-03	5.21E-03
GIANT	BP	GO:0120305	regulation of pigmentation	-	15	14	-	-	1.64E-03	7.02E-04
GIANT	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	70	-	-	3.09E-03	3.28E-03
GIANT	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	59	-	-	3.63E-03	2.81E-03
GIANT	BP	GO:0048515	spermatid differentiation	-	208	174	-	-	8.15E-03	8.19E-03
GIANT	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	7.21E-03	2.69E-03
GIANT	MF	GO:0042887	amide transmembrane transporter activity	-	33	28	-	-	7.83E-04	1.35E-03
GIANT	BP	GO:0007130	synaptonemal complex assembly	-	23	15	-	-	2.84E-03	7.02E-04
GIANT	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	34	-	-	2.88E-03	1.64E-03
GIANT	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	32	-	-	1.02E-03	1.52E-03
GIANT	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	35	-	-	8.44E-03	1.64E-03
GIANT	BP	GO:0060119	inner ear receptor cell development	-	44	37	-	-	1.77E-02	1.75E-03
GIANT	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	2.68E-03	8.77E-04
GIANT	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	1.21E-02	1.64E-03
GIANT	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	7.75E-04	1.17E-03
GIANT	BP	GO:0014854	response to inactivity	-	12	12	-	-	8.73E-04	5.85E-04
GIANT	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	240	-	-	7.86E-03	1.12E-02
GIANT	BP	GO:1900006	positive regulation of dendrite development	-	17	16	-	-	1.28E-03	7.60E-04
GIANT	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	8.76E-03	2.28E-03
GIANT	BP	GO:0010883	regulation of lipid storage	-	53	46	-	-	3.26E-03	2.16E-03
GIANT	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	9.21E-04	1.23E-03
GIANT	BP	GO:0007635	chemosensory behavior	-	20	19	-	-	5.65E-03	9.36E-04
GIANT	BP	GO:1905954	positive regulation of lipid localization	-	110	101	-	-	3.85E-03	4.74E-03
GIANT	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	8.91E-04	5.85E-04
GIANT	BP	GO:0002209	behavioral defense response	-	39	39	-	-	1.50E-03	1.87E-03
GIANT	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	7.89E-02	1.40E-03
GIANT	BP	GO:0072523	purine-containing compound catabolic process	-	146	140	-	-	6.18E-03	6.55E-03
GIANT	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	32	-	-	1.97E-03	1.52E-03
GIANT	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	26	-	-	5.74E-04	1.23E-03
GIANT	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	1.02E-03	7.60E-04
GIANT	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	93	-	-	6.14E-03	4.39E-03
GIANT	BP	GO:0007218	neuropeptide signaling pathway	-	113	98	-	-	1.01E-02	4.62E-03
GIANT	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	1.09E-03	5.85E-04
GIANT	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	163	-	-	5.09E-03	7.66E-03
GIANT	BP	GO:0031345	negative regulation of cell projection organization	-	195	186	-	-	4.99E-03	8.72E-03
GIANT	BP	GO:0048278	vesicle docking	-	64	61	-	-	1.10E-02	2.87E-03
GIANT	BP	GO:0035050	embryonic heart tube development	-	86	79	-	-	7.20E-03	3.74E-03
GIANT	BP	GO:0051593	response to folic acid	-	12	11	-	-	4.15E-04	5.26E-04
GIANT	BP	GO:0030168	platelet activation	-	135	131	-	-	7.45E-03	6.14E-03
GIANT	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	6.13E-04	7.60E-04
GIANT	CC	GO:0098810	neurotransmitter reuptake	-	35	34	-	-	4.31E-03	1.64E-03
GIANT	BP	GO:0008213	protein alkylation	-	58	51	-	-	3.66E-03	2.40E-03
GIANT	BP	GO:0009812	flavonoid metabolic process	-	14	12	-	-	8.53E-03	5.85E-04
GIANT	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	1.28E-03	6.43E-04
GIANT	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	3.81E-04	1.17E-03
GIANT	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	6.21E-04	6.43E-04
GIANT	BP	GO:0031529	ruffle organization	-	55	53	-	-	1.71E-03	2.52E-03
GIANT	BP	GO:0010842	retina layer formation	-	25	23	-	-	4.09E-04	1.11E-03
GIANT	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	82	-	-	7.40E-03	3.86E-03
GIANT	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	4.09E-03	5.26E-04
GIANT	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	71	-	-	2.65E-03	3.33E-03
GIANT	MF	GO:0170055	lipid transmembrane transporter activity	-	56	48	-	-	3.39E-03	2.28E-03
GIANT	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	31	-	-	7.08E-04	1.46E-03
GIANT	BP	GO:0035304	regulation of protein dephosphorylation	-	87	85	-	-	2.60E-03	3.98E-03
GIANT	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	224	-	-	6.49E-03	1.05E-02
GIANT	BP	GO:0099637	neurotransmitter receptor transport	-	26	25	-	-	1.21E-02	1.17E-03
GIANT	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	1.33E-03	1.64E-03
GIANT	BP	GO:0051775	response to redox state	-	13	13	-	-	2.76E-03	6.43E-04
GIANT	BP	GO:0051785	positive regulation of nuclear division	-	61	55	-	-	1.76E-03	2.57E-03
GIANT	BP	GO:0060456	positive regulation of digestive system process	-	16	15	-	-	7.47E-04	7.02E-04
GIANT	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	14	-	-	4.21E-03	7.02E-04
GIANT	BP	GO:0060749	mammary gland alveolus development	-	20	19	-	-	2.92E-03	9.36E-04
GIANT	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	4.06E-03	5.85E-04
GIANT	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	4.46E-03	2.11E-03
GIANT	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	15	-	-	1.44E-02	7.02E-04
GIANT	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	9.46E-04	8.19E-04
GIANT	BP	GO:0051299	centrosome separation	-	15	15	-	-	1.32E-03	7.02E-04
GIANT	BP	GO:0048145	regulation of fibroblast proliferation	-	87	83	-	-	2.23E-03	3.92E-03
GIANT	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	90	-	-	4.13E-02	4.21E-03
GIANT	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	1.56E-02	5.26E-04
GIANT	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	222	-	-	4.76E-03	1.04E-02
GIANT	BP	GO:0032098	regulation of appetite	-	20	19	-	-	1.31E-03	9.36E-04
GIANT	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	5.77E-04	7.02E-04
GIANT	CC	GO:0008333	endosome to lysosome transport	-	73	72	-	-	1.53E-02	3.39E-03
GIANT	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	21	-	-	1.03E-03	9.94E-04
GIANT	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	16	-	-	2.17E-04	7.60E-04
GIANT	BP	GO:0003016	respiratory system process	-	39	37	-	-	3.06E-03	1.75E-03
GIANT	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	1.28E-03	1.11E-03
GIANT	BP	GO:0045732	positive regulation of protein catabolic process	-	202	196	-	-	5.37E-03	9.18E-03
GIANT	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	68	-	-	5.07E-03	3.22E-03
GIANT	BP	GO:0007588	excretion	-	40	39	-	-	1.81E-03	1.87E-03
GIANT	BP	GO:1904018	positive regulation of vasculature development	-	185	156	-	-	7.07E-03	7.31E-03
GIANT	BP	GO:0050953	sensory perception of light stimulus	-	223	200	-	-	1.55E-02	9.36E-03
GIANT	BP	GO:0009164	nucleoside catabolic process	-	25	22	-	-	1.98E-02	1.05E-03
GIANT	BP	GO:0002357	defense response to tumor cell	-	13	11	-	-	5.03E-04	5.26E-04
GIANT	BP	GO:0009303	rRNA transcription	-	37	37	-	-	2.40E-03	1.75E-03
GIANT	BP	GO:0035601	protein deacylation	-	56	56	-	-	9.49E-03	2.63E-03
GIANT	BP	GO:0061952	midbody abscission	-	18	17	-	-	1.26E-02	8.19E-04
GIANT	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	4.04E-04	5.26E-04
GIANT	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	1.98E-03	9.36E-04
GIANT	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	31	-	-	6.93E-04	1.46E-03
GIANT	BP	GO:0071300	cellular response to retinoic acid	-	66	63	-	-	2.35E-03	2.98E-03
GIANT	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	16	-	-	8.91E-04	7.60E-04
GIANT	BP	GO:0045830	positive regulation of isotype switching	-	28	26	-	-	1.55E-03	1.23E-03
GIANT	BP	GO:0031069	hair follicle morphogenesis	-	33	28	-	-	2.90E-02	1.35E-03
GIANT	BP	GO:0046697	decidualization	-	26	26	-	-	1.55E-03	1.23E-03
GIANT	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	8.92E-04	7.02E-04
GIANT	BP	GO:0051588	regulation of neurotransmitter transport	-	99	96	-	-	1.69E-02	4.50E-03
GIANT	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	27	-	-	8.83E-03	1.29E-03
GIANT	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	3.99E-03	5.85E-04
GIANT	BP	GO:0051784	negative regulation of nuclear division	-	63	60	-	-	5.29E-03	2.81E-03
GIANT	BP	GO:0044703	multi-organism reproductive process	-	209	200	-	-	5.16E-03	9.36E-03
GIANT	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	135	-	-	3.68E-03	6.32E-03
GIANT	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	52	-	-	1.99E-03	2.46E-03
GIANT	BP	GO:0099022	vesicle tethering	-	32	32	-	-	3.70E-02	1.52E-03
GIANT	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	36	-	-	1.18E-03	1.70E-03
GIANT	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	7.87E-04	5.85E-04
GIANT	BP	GO:0048857	neural nucleus development	-	65	63	-	-	2.09E-03	2.98E-03
GIANT	BP	GO:0048663	neuron fate commitment	-	74	67	-	-	9.35E-03	3.16E-03
GIANT	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	152	-	-	4.57E-03	7.14E-03
GIANT	BP	GO:0106027	neuron projection organization	-	90	86	-	-	4.49E-03	4.04E-03
GIANT	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	127	-	-	4.39E-03	5.97E-03
GIANT	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	2.79E-03	1.64E-03
GIANT	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	5.35E-04	5.26E-04
GIANT	BP	GO:0045685	regulation of glial cell differentiation	-	77	71	-	-	3.59E-03	3.33E-03
GIANT	BP	GO:0051608	histamine transport	-	14	13	-	-	4.25E-04	6.43E-04
GIANT	BP	GO:0043414	macromolecule methylation	-	138	125	-	-	5.69E-03	5.85E-03
GIANT	BP	GO:0048521	negative regulation of behavior	-	12	11	-	-	1.74E-03	5.26E-04
GIANT	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	7.63E-04	7.60E-04
GIANT	BP	GO:0050886	endocrine process	-	93	91	-	-	2.84E-03	4.27E-03
GIANT	MF	GO:0015562	efflux transmembrane transporter activity	-	15	15	-	-	3.50E-04	7.02E-04
GIANT	BP	GO:0050951	sensory perception of temperature stimulus	-	28	26	-	-	1.27E-03	1.23E-03
GIANT	BP	GO:0045807	positive regulation of endocytosis	-	155	150	-	-	5.92E-03	7.02E-03
GIANT	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	3.43E-03	5.26E-04
GIANT	BP	GO:0002418	immune response to tumor cell	-	29	29	-	-	1.35E-02	1.40E-03
GIANT	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	59	-	-	2.01E-03	2.81E-03
GIANT	BP	GO:0048308	organelle inheritance	-	14	14	-	-	2.52E-03	7.02E-04
GIANT	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	20	-	-	1.15E-03	9.36E-04
GIANT	BP	GO:0001829	trophectodermal cell differentiation	-	19	18	-	-	5.66E-04	8.77E-04
GIANT	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	49	-	-	2.51E-03	2.34E-03
GIANT	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.63E-03	3.16E-03
GIANT	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	1.51E-04	5.85E-04
GIANT	BP	GO:0009110	vitamin biosynthetic process	-	23	23	-	-	2.16E-03	1.11E-03
GIANT	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	23	-	-	1.32E-02	1.11E-03
GIANT	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	1.40E-03	8.19E-04
GIANT	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	21	-	-	1.56E-03	9.94E-04
GIANT	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	95	-	-	2.41E-03	4.45E-03
GIANT	BP	GO:0009111	vitamin catabolic process	-	13	12	-	-	4.43E-03	5.85E-04
GIANT	MF	GO:0051100	negative regulation of binding	-	161	151	-	-	2.93E-03	7.08E-03
GIANT	BP	GO:0003151	outflow tract morphogenesis	-	81	79	-	-	6.35E-03	3.74E-03
GIANT	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	3.55E-03	2.81E-03
GIANT	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	8.46E-04	9.36E-04
GIANT	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	13	-	-	2.08E-03	6.43E-04
GIANT	BP	GO:0046504	glycerol ether biosynthetic process	-	11	11	-	-	1.86E-02	5.26E-04
GIANT	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	3.29E-03	1.58E-03
GIANT	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	3.46E-04	7.60E-04
GIANT	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	1.48E-03	6.43E-04
GIANT	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	1.29E-03	2.22E-03
GIANT	BP	GO:0046621	negative regulation of organ growth	-	39	33	-	-	9.16E-04	1.58E-03
GIANT	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	48	-	-	7.42E-02	2.28E-03
GIANT	BP	GO:0032368	regulation of lipid transport	-	149	123	-	-	3.05E-03	5.79E-03
GIANT	BP	GO:0055094	response to lipoprotein particle	-	34	30	-	-	3.16E-03	1.40E-03
GIANT	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	178	-	-	4.41E-03	8.37E-03
GIANT	BP	GO:0033002	muscle cell proliferation	-	249	204	-	-	7.49E-03	9.59E-03
GIANT	BP	GO:0043331	response to dsRNA	-	56	52	-	-	3.07E-03	2.46E-03
GIANT	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	6.65E-04	5.85E-04
GIANT	BP	GO:0051904	pigment granule transport	-	23	23	-	-	3.45E-02	1.11E-03
GIANT	BP	GO:1901679	nucleotide transmembrane transport	-	32	29	-	-	4.74E-04	1.40E-03
GIANT	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	2.06E-03	1.58E-03
GIANT	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	11	-	-	2.45E-03	5.26E-04
GIANT	BP	GO:0033363	secretory granule organization	-	63	58	-	-	1.23E-02	2.75E-03
GIANT	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	1.48E-03	1.35E-03
GIANT	BP	GO:0120009	intermembrane lipid transfer	-	52	48	-	-	1.59E-03	2.28E-03
GIANT	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	1.26E-03	7.02E-04
GIANT	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	1.32E-03	1.81E-03
GIANT	BP	GO:0033622	integrin activation	-	26	25	-	-	1.10E-03	1.17E-03
GIANT	BP	GO:0098751	bone cell development	-	18	18	-	-	9.77E-04	8.77E-04
GIANT	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	6.10E-04	9.94E-04
GIANT	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	1.88E-03	2.40E-03
GIANT	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	3.05E-03	1.40E-03
GIANT	BP	GO:0002076	osteoblast development	-	17	17	-	-	1.27E-03	8.19E-04
GIANT	BP	GO:0072164	mesonephric tubule development	-	98	97	-	-	6.30E-03	4.56E-03
GIANT	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	8.34E-04	8.19E-04
GIANT	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	103	-	-	3.82E-03	4.86E-03
GIANT	BP	GO:1903524	positive regulation of blood circulation	-	39	37	-	-	1.94E-03	1.75E-03
GIANT	BP	GO:0030901	midbrain development	-	87	84	-	-	2.71E-03	3.98E-03
GIANT	BP	GO:0048485	sympathetic nervous system development	-	22	21	-	-	1.67E-03	9.94E-04
GIANT	BP	GO:0048532	anatomical structure arrangement	-	16	15	-	-	4.73E-04	7.02E-04
GIANT	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	7.10E-04	6.43E-04
GIANT	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	66	-	-	2.29E-03	3.10E-03
GIANT	MF	GO:1901474	azole transmembrane transporter activity	-	13	12	-	-	9.68E-03	5.85E-04
GIANT	BP	GO:0002687	positive regulation of leukocyte migration	-	147	142	-	-	7.70E-03	6.67E-03
GIANT	BP	GO:0019755	one-carbon compound transport	-	28	25	-	-	3.26E-02	1.17E-03
GIANT	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	4.30E-04	6.43E-04
GIANT	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	8.14E-04	7.60E-04
GIANT	BP	GO:0110154	RNA decapping	-	19	18	-	-	3.86E-03	8.77E-04
GIANT	BP	GO:0034605	cellular response to heat	-	66	63	-	-	3.11E-03	2.98E-03
GIANT	BP	GO:0005996	monosaccharide metabolic process	-	250	236	-	-	8.26E-03	1.11E-02
GIANT	BP	GO:0033555	multicellular organismal response to stress	-	90	87	-	-	2.64E-03	4.09E-03
GIANT	BP	GO:0002262	myeloid cell homeostasis	-	172	166	-	-	4.22E-03	7.78E-03
GIANT	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	5.06E-03	1.81E-03
GIANT	BP	GO:0050688	regulation of defense response to virus	-	65	62	-	-	2.31E-02	2.92E-03
GIANT	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	21	-	-	2.48E-03	9.94E-04
GIANT	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	223	-	-	7.62E-03	1.05E-02
GIANT	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	1.96E-03	1.46E-03
GIANT	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	2.72E-03	7.02E-04
GIANT	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	33	-	-	3.60E-03	1.58E-03
GIANT	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	17	-	-	2.49E-04	8.19E-04
GIANT	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	6.97E-03	1.35E-03
GIANT	BP	GO:0022618	protein-RNA complex assembly	-	227	191	-	-	1.48E-02	8.95E-03
GIANT	BP	GO:0051147	regulation of muscle cell differentiation	-	162	130	-	-	4.80E-03	6.08E-03
GIANT	BP	GO:0090102	cochlea development	-	50	47	-	-	3.34E-03	2.22E-03
GIANT	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	1.78E-03	1.23E-03
GIANT	BP	GO:0061303	cornea development in camera-type eye	-	12	11	-	-	6.64E-04	5.26E-04
GIANT	BP	GO:0045933	positive regulation of muscle contraction	-	49	48	-	-	3.17E-03	2.28E-03
GIANT	BP	GO:0015803	branched-chain amino acid transport	-	14	12	-	-	1.26E-03	5.85E-04
GIANT	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	2.64E-03	7.60E-04
GIANT	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	33	-	-	3.09E-03	1.58E-03
GIANT	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	85	-	-	1.47E-02	3.98E-03
GIANT	BP	GO:0097264	self proteolysis	-	12	12	-	-	9.20E-04	5.85E-04
GIANT	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	1.81E-03	1.05E-03
GIANT	BP	GO:0032922	circadian regulation of gene expression	-	71	69	-	-	2.41E-03	3.28E-03
GIANT	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	55	-	-	2.84E-03	2.57E-03
GIANT	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	157	-	-	3.31E-02	7.37E-03
GIANT	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	1.57E-03	1.11E-03
GIANT	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	55	-	-	1.74E-03	2.57E-03
GIANT	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	1.93E-03	1.81E-03
GIANT	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.74E-03	5.85E-04
GIANT	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	2.28E-03	5.26E-04
GIANT	BP	GO:0140253	cell-cell fusion	-	62	58	-	-	2.27E-03	2.75E-03
GIANT	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	4.84E-04	5.85E-04
GIANT	BP	GO:0071599	otic vesicle development	-	15	14	-	-	6.79E-02	7.02E-04
GIANT	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	42	-	-	3.24E-03	1.99E-03
GIANT	BP	GO:0061635	regulation of protein complex stability	-	14	13	-	-	4.20E-04	6.43E-04
GIANT	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	59	-	-	4.86E-03	2.81E-03
GIANT	BP	GO:0001941	postsynaptic membrane organization	-	37	32	-	-	1.14E-02	1.52E-03
GIANT	BP	GO:0051293	establishment of spindle localization	-	57	53	-	-	2.24E-03	2.52E-03
GIANT	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	2.17E-04	5.85E-04
GIANT	BP	GO:0043114	regulation of vascular permeability	-	49	46	-	-	3.53E-03	2.16E-03
GIANT	BP	GO:0018126	protein hydroxylation	-	26	25	-	-	9.50E-03	1.17E-03
GIANT	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	61	-	-	1.62E-03	2.87E-03
GIANT	BP	GO:0008360	regulation of cell shape	-	139	133	-	-	5.10E-03	6.26E-03
GIANT	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	15	-	-	2.01E-03	7.02E-04
GIANT	BP	GO:0051222	positive regulation of protein transport	-	249	238	-	-	3.96E-03	1.12E-02
GIANT	CC	GO:0140632	canonical inflammasome complex assembly	-	40	37	-	-	1.93E-03	1.75E-03
GIANT	MF	GO:0034260	negative regulation of GTPase activity	-	36	34	-	-	1.28E-03	1.64E-03
GIANT	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	1.36E-03	1.05E-03
GIANT	BP	GO:0045739	positive regulation of DNA repair	-	128	122	-	-	1.18E-02	5.73E-03
GIANT	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	7.81E-04	9.36E-04
GIANT	BP	GO:0045185	maintenance of protein location	-	95	90	-	-	1.98E-03	4.21E-03
GIANT	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	12	-	-	5.64E-04	5.85E-04
GIANT	BP	GO:0003158	endothelium development	-	140	129	-	-	5.90E-03	6.08E-03
GIANT	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	1.33E-03	1.93E-03
GIANT	BP	GO:0051224	negative regulation of protein transport	-	122	105	-	-	2.61E-03	4.91E-03
GIANT	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	151	-	-	6.23E-03	7.08E-03
GIANT	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	3.99E-04	6.43E-04
GIANT	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	1.13E-03	1.46E-03
GIANT	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	6.61E-02	9.36E-04
GIANT	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	7.67E-03	2.98E-03
GIANT	BP	GO:0007405	neuroblast proliferation	-	81	74	-	-	2.36E-03	3.51E-03
GIANT	BP	GO:0009581	detection of external stimulus	-	137	117	-	-	5.18E-03	5.50E-03
GIANT	BP	GO:1990542	mitochondrial transmembrane transport	-	93	86	-	-	5.52E-03	4.04E-03
GIANT	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	1.44E-03	1.46E-03
GIANT	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	1.14E-03	5.26E-04
GIANT	BP	GO:0097186	amelogenesis	-	26	23	-	-	5.85E-04	1.11E-03
GIANT	BP	GO:0031128	developmental induction	-	26	26	-	-	2.36E-03	1.23E-03
GIANT	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	2.01E-04	7.02E-04
GIANT	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	2.21E-03	3.10E-03
GIANT	BP	GO:0021533	cell differentiation in hindbrain	-	23	22	-	-	4.42E-04	1.05E-03
GIANT	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	1.02E-03	1.46E-03
GIANT	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	2.26E-04	5.85E-04
GIANT	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	4.88E-03	2.40E-03
GIANT	BP	GO:0021517	ventral spinal cord development	-	47	43	-	-	1.51E-02	2.05E-03
GIANT	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	2.44E-03	3.51E-03
GIANT	BP	GO:0032328	alanine transport	-	19	16	-	-	3.14E-03	7.60E-04
GIANT	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	1.98E-03	7.60E-04
GIANT	BP	GO:0097722	sperm motility	-	133	99	-	-	6.59E-03	4.68E-03
GIANT	BP	GO:0051231	spindle elongation	-	14	12	-	-	8.70E-03	5.85E-04
GIANT	BP	GO:0042490	mechanoreceptor differentiation	-	67	60	-	-	2.88E-03	2.81E-03
GIANT	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	2.61E-03	1.40E-03
GIANT	BP	GO:0035148	tube formation	-	155	150	-	-	6.33E-03	7.02E-03
GIANT	BP	GO:0048520	positive regulation of behavior	-	27	26	-	-	8.46E-04	1.23E-03
GIANT	BP	GO:0098543	detection of other organism	-	19	15	-	-	1.73E-02	7.02E-04
GIANT	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	4.30E-03	2.05E-03
GIANT	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	116	-	-	3.01E-02	5.44E-03
GIANT	BP	GO:0031123	RNA 3'-end processing	-	79	77	-	-	1.35E-02	3.63E-03
GIANT	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	105	-	-	3.10E-03	4.91E-03
GIANT	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	5.94E-03	8.77E-04
GIANT	CC	GO:0007097	nuclear migration	-	24	24	-	-	2.39E-03	1.17E-03
GIANT	BP	GO:0006885	regulation of pH	-	104	100	-	-	3.84E-03	4.68E-03
GIANT	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.10E-03	7.02E-04
GIANT	BP	GO:1990840	response to lectin	-	22	20	-	-	1.73E-02	9.36E-04
GIANT	BP	GO:0071800	podosome assembly	-	19	19	-	-	1.21E-03	9.36E-04
GIANT	BP	GO:0031018	endocrine pancreas development	-	47	44	-	-	4.31E-03	2.11E-03
GIANT	BP	GO:0001708	cell fate specification	-	108	103	-	-	1.01E-02	4.86E-03
GIANT	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	68	-	-	2.66E-03	3.22E-03
GIANT	BP	GO:0030279	negative regulation of ossification	-	39	36	-	-	1.11E-03	1.70E-03
GIANT	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	13	-	-	7.89E-04	6.43E-04
GIANT	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	14	-	-	4.02E-04	7.02E-04
GIANT	BP	GO:0042440	pigment metabolic process	-	80	74	-	-	2.38E-03	3.51E-03
GIANT	BP	GO:1901606	alpha-amino acid catabolic process	-	101	92	-	-	7.13E-03	4.33E-03
GIANT	BP	GO:1901890	positive regulation of cell junction assembly	-	106	98	-	-	8.09E-03	4.62E-03
GIANT	BP	GO:0070988	demethylation	-	27	27	-	-	3.69E-03	1.29E-03
GIANT	BP	GO:1901655	cellular response to ketone	-	107	101	-	-	3.23E-03	4.74E-03
GIANT	BP	GO:0046185	aldehyde catabolic process	-	14	13	-	-	1.04E-03	6.43E-04
GIANT	BP	GO:0051255	spindle midzone assembly	-	14	12	-	-	1.57E-02	5.85E-04
GIANT	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	7.21E-02	8.19E-04
GIANT	BP	GO:0006968	cellular defense response	-	52	51	-	-	8.21E-03	2.40E-03
GIANT	BP	GO:0055006	cardiac cell development	-	93	83	-	-	3.52E-03	3.92E-03
GIANT	BP	GO:0031365	N-terminal protein amino acid modification	-	30	27	-	-	1.09E-03	1.29E-03
GIANT	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	28	-	-	2.01E-03	1.35E-03
GIANT	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	8.08E-04	5.85E-04
GIANT	BP	GO:0060004	reflex	-	63	58	-	-	1.45E-03	2.75E-03
GIANT	BP	GO:0044706	multi-multicellular organism process	-	217	207	-	-	5.35E-03	9.71E-03
GIANT	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	9.35E-04	5.85E-04
GIANT	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	138	-	-	4.97E-03	6.49E-03
GIANT	BP	GO:0006026	aminoglycan catabolic process	-	34	30	-	-	3.10E-03	1.40E-03
GIANT	BP	GO:0031294	lymphocyte costimulation	-	47	45	-	-	1.08E-02	2.11E-03
GIANT	BP	GO:0050768	negative regulation of neurogenesis	-	150	141	-	-	4.55E-03	6.61E-03
GIANT	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	91	-	-	2.55E-03	4.27E-03
GIANT	BP	GO:0090068	positive regulation of cell cycle process	-	262	236	-	-	7.46E-03	1.11E-02
GIANT	BP	GO:0043605	amide catabolic process	-	16	14	-	-	2.47E-03	7.02E-04
GIANT	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	26	-	-	1.04E-03	1.23E-03
GIANT	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	33	-	-	1.81E-03	1.58E-03
GIANT	BP	GO:1902115	regulation of organelle assembly	-	210	198	-	-	5.53E-03	9.30E-03
GIANT	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	66	-	-	2.89E-03	3.10E-03
GIANT	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	1.13E-03	7.60E-04
GIANT	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	137	-	-	2.62E-03	6.43E-03
GIANT	BP	GO:0043171	peptide catabolic process	-	19	18	-	-	7.31E-03	8.77E-04
GIANT	BP	GO:0046622	positive regulation of organ growth	-	52	43	-	-	1.73E-03	2.05E-03
GIANT	BP	GO:0051952	regulation of amine transport	-	98	93	-	-	3.56E-03	4.39E-03
GIANT	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	1.41E-03	1.11E-03
GIANT	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	19	-	-	6.20E-04	9.36E-04
GIANT	BP	GO:0015801	aromatic amino acid transport	-	13	11	-	-	3.64E-03	5.26E-04
GIANT	BP	GO:0040019	positive regulation of embryonic development	-	23	22	-	-	1.17E-02	1.05E-03
GIANT	BP	GO:0097154	GABAergic neuron differentiation	-	20	19	-	-	7.06E-03	9.36E-04
GIANT	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	15	-	-	4.18E-04	7.02E-04
GIANT	CC	GO:0032365	intracellular lipid transport	-	51	47	-	-	1.85E-03	2.22E-03
GIANT	BP	GO:0045048	protein insertion into ER membrane	-	30	29	-	-	8.78E-03	1.40E-03
GIANT	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	67	-	-	3.26E-03	3.16E-03
GIANT	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	111	-	-	4.06E-03	5.21E-03
GIANT	BP	GO:0018149	peptide cross-linking	-	28	26	-	-	5.26E-03	1.23E-03
GIANT	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	4.98E-04	1.17E-03
GIANT	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	6.86E-04	6.43E-04
GIANT	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	1.72E-04	7.02E-04
GIANT	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	2.75E-03	6.43E-04
GIANT	BP	GO:0071398	cellular response to fatty acid	-	35	33	-	-	3.68E-03	1.58E-03
GIANT	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	4.41E-03	5.26E-04
GIANT	BP	GO:0097581	lamellipodium organization	-	91	86	-	-	2.46E-03	4.04E-03
GIANT	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	30	-	-	2.78E-03	1.40E-03
GIANT	BP	GO:1903975	regulation of glial cell migration	-	20	17	-	-	8.66E-04	8.19E-04
GIANT	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	20	-	-	1.44E-03	9.36E-04
GIANT	BP	GO:0015669	gas transport	-	23	23	-	-	1.21E-01	1.11E-03
GIANT	BP	GO:0016485	protein processing	-	248	236	-	-	6.10E-03	1.11E-02
GIANT	BP	GO:0009649	entrainment of circadian clock	-	30	27	-	-	1.68E-03	1.29E-03
GIANT	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	158	-	-	8.65E-03	7.43E-03
GIANT	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	9.60E-04	1.17E-03
GIANT	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	124	-	-	5.23E-03	5.85E-03
GIANT	BP	GO:0099054	presynapse assembly	-	49	46	-	-	2.82E-03	2.16E-03
GIANT	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	1.30E-02	1.17E-03
GIANT	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	1.97E-03	1.17E-03
GIANT	BP	GO:0031348	negative regulation of defense response	-	282	236	-	-	9.05E-03	1.11E-02
GIANT	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	75	-	-	2.60E-03	3.51E-03
GIANT	BP	GO:0007606	sensory perception of chemical stimulus	-	535	141	-	-	3.79E-02	6.61E-03
GIANT	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	5.19E-03	3.22E-03
GIANT	BP	GO:0071496	cellular response to external stimulus	-	74	73	-	-	9.47E-03	3.45E-03
GIANT	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	4.65E-04	6.43E-04
GIANT	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	1.03E-03	8.19E-04
GIANT	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	3.71E-04	5.26E-04
GIANT	BP	GO:0072710	response to hydroxyurea	-	12	11	-	-	1.00E-03	5.26E-04
GIANT	BP	GO:0032094	response to food	-	37	35	-	-	1.58E-03	1.64E-03
GIANT	BP	GO:0001964	startle response	-	27	27	-	-	1.81E-03	1.29E-03
GIANT	BP	GO:0007340	acrosome reaction	-	38	29	-	-	2.58E-03	1.40E-03
GIANT	BP	GO:0046434	organophosphate catabolic process	-	232	218	-	-	7.08E-03	1.02E-02
GIANT	BP	GO:0060037	pharyngeal system development	-	29	28	-	-	2.57E-03	1.35E-03
GIANT	BP	GO:0009566	fertilization	-	205	160	-	-	3.65E-03	7.49E-03
GIANT	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	2.15E-02	2.81E-03
GIANT	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	1.21E-03	1.17E-03
GIANT	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	3.92E-03	6.43E-04
GIANT	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	1.17E-03	1.40E-03
GIANT	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	22	-	-	5.20E-04	1.05E-03
GIANT	BP	GO:0033044	regulation of chromosome organization	-	249	246	-	-	1.54E-02	1.15E-02
GIANT	BP	GO:0009309	amine biosynthetic process	-	38	37	-	-	8.25E-04	1.75E-03
GIANT	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	1.61E-02	9.36E-04
GIANT	BP	GO:0061900	glial cell activation	-	56	51	-	-	6.83E-03	2.40E-03
GIANT	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	129	-	-	6.36E-03	6.08E-03
GIANT	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	1.42E-03	6.43E-04
GIANT	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	14	-	-	1.65E-03	7.02E-04
GIANT	BP	GO:0021794	thalamus development	-	12	11	-	-	1.17E-03	5.26E-04
GIANT	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	2.10E-03	1.93E-03
GIANT	BP	GO:0035902	response to immobilization stress	-	20	18	-	-	4.03E-04	8.77E-04
GIANT	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	5.67E-04	7.02E-04
GIANT	BP	GO:0072537	fibroblast activation	-	13	13	-	-	7.82E-04	6.43E-04
GIANT	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	1.10E-03	6.43E-04
GIANT	BP	GO:0043647	inositol phosphate metabolic process	-	44	41	-	-	2.05E-03	1.93E-03
GIANT	BP	GO:0016180	snRNA processing	-	28	27	-	-	1.57E-02	1.29E-03
GIANT	BP	GO:0051303	establishment of chromosome localization	-	104	99	-	-	7.51E-03	4.68E-03
GIANT	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	1.86E-03	7.60E-04
GIANT	BP	GO:0007164	establishment of tissue polarity	-	38	37	-	-	1.53E-02	1.75E-03
GIANT	BP	GO:0097164	ammonium ion metabolic process	-	23	20	-	-	1.23E-03	9.36E-04
GIANT	BP	GO:0021515	cell differentiation in spinal cord	-	51	46	-	-	1.82E-02	2.16E-03
GIANT	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	8.24E-04	8.77E-04
GIANT	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	1.32E-03	9.94E-04
GIANT	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	1.07E-03	1.35E-03
GIANT	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	2.19E-03	8.77E-04
GIANT	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	38	-	-	7.09E-03	1.81E-03
GIANT	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	2.26E-03	1.05E-03
GIANT	BP	GO:0007566	embryo implantation	-	57	51	-	-	1.74E-03	2.40E-03
GIANT	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	1.65E-03	1.58E-03
GIANT	BP	GO:0031268	pseudopodium organization	-	17	15	-	-	1.40E-02	7.02E-04
GIANT	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	1.36E-03	1.52E-03
GIANT	BP	GO:0051017	actin filament bundle assembly	-	161	153	-	-	5.22E-03	7.20E-03
GIANT	BP	GO:1905953	negative regulation of lipid localization	-	63	40	-	-	2.31E-03	1.87E-03
GIANT	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	3.15E-04	8.77E-04
GIANT	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	5.18E-04	9.36E-04
GIANT	BP	GO:0036302	atrioventricular canal development	-	13	12	-	-	1.09E-02	5.85E-04
GIANT	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	36	-	-	1.56E-03	1.70E-03
GIANT	BP	GO:0021756	striatum development	-	21	21	-	-	2.30E-03	9.94E-04
GIANT	BP	GO:1901343	negative regulation of vasculature development	-	154	101	-	-	3.45E-03	4.74E-03
GIANT	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	145	-	-	7.02E-03	6.79E-03
GIANT	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	28	-	-	2.71E-03	1.35E-03
GIANT	BP	GO:1902414	protein localization to cell junction	-	107	102	-	-	6.38E-03	4.80E-03
GIANT	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	2.05E-03	1.05E-03
GIANT	BP	GO:0051304	chromosome separation	-	80	79	-	-	6.91E-03	3.74E-03
GIANT	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	8.46E-04	8.77E-04
GIANT	BP	GO:0048709	oligodendrocyte differentiation	-	101	97	-	-	4.59E-03	4.56E-03
GIANT	BP	GO:0045017	glycerolipid biosynthetic process	-	254	238	-	-	7.15E-03	1.12E-02
GIANT	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	4.85E-02	7.02E-04
GIANT	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	2.22E-03	1.11E-03
GIANT	BP	GO:0001776	leukocyte homeostasis	-	108	103	-	-	3.99E-03	4.86E-03
GIANT	BP	GO:0050769	positive regulation of neurogenesis	-	240	228	-	-	5.79E-03	1.07E-02
GIANT	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	4.50E-03	7.02E-04
GIANT	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	5.38E-03	3.28E-03
GIANT	BP	GO:0050866	negative regulation of cell activation	-	216	201	-	-	7.65E-03	9.42E-03
GIANT	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	1.44E-03	1.70E-03
GIANT	BP	GO:0033500	carbohydrate homeostasis	-	251	228	-	-	4.78E-03	1.07E-02
GIANT	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	30	-	-	4.74E-03	1.40E-03
GIANT	BP	GO:0038183	bile acid signaling pathway	-	12	11	-	-	3.12E-02	5.26E-04
GIANT	BP	GO:0044088	regulation of vacuole organization	-	56	55	-	-	3.94E-03	2.57E-03
GIANT	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	7.42E-04	1.11E-03
GIANT	CC	GO:0099522	cytosolic region	-	20	20	-	-	1.06E-03	9.36E-04
GIANT	CC	GO:0000791	euchromatin	-	60	58	-	-	2.01E-03	2.75E-03
GIANT	CC	GO:0030666	endocytic vesicle membrane	-	196	194	-	-	1.03E-02	9.13E-03
GIANT	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	3.64E-02	7.02E-04
GIANT	CC	GO:1990752	microtubule end	-	34	33	-	-	1.49E-03	1.58E-03
GIANT	CC	GO:0043204	perikaryon	-	156	149	-	-	5.09E-03	7.02E-03
GIANT	CC	GO:0061702	canonical inflammasome complex	-	17	15	-	-	5.51E-02	7.02E-04
GIANT	CC	GO:0098643	banded collagen fibril	-	12	11	-	-	2.77E-03	5.26E-04
GIANT	CC	GO:0097542	ciliary tip	-	48	47	-	-	1.27E-02	2.22E-03
GIANT	CC	GO:1905368	peptidase complex	-	124	121	-	-	1.67E-02	5.67E-03
GIANT	CC	GO:0000792	heterochromatin	-	98	94	-	-	6.12E-03	4.45E-03
GIANT	CC	GO:0097546	ciliary base	-	47	44	-	-	3.00E-03	2.11E-03
GIANT	CC	GO:0071819	DUBm complex	-	25	23	-	-	9.02E-02	1.11E-03
GIANT	CC	GO:0031201	SNARE complex	-	48	45	-	-	6.80E-02	2.11E-03
GIANT	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	2.26E-03	6.43E-04
GIANT	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	3.69E-03	1.87E-03
GIANT	CC	GO:0044391	ribosomal subunit	-	203	199	-	-	6.31E-02	9.36E-03
GIANT	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	7.92E-02	5.26E-04
GIANT	CC	GO:0071013	catalytic step 2 spliceosome	-	88	87	-	-	1.52E-02	4.09E-03
GIANT	CC	GO:0031907	microbody lumen	-	51	49	-	-	1.33E-02	2.34E-03
GIANT	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	5.54E-03	5.85E-04
GIANT	CC	GO:0098862	cluster of actin-based cell projections	-	162	142	-	-	6.19E-03	6.67E-03
GIANT	CC	GO:0016363	nuclear matrix	-	127	125	-	-	4.00E-03	5.85E-03
GIANT	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	4.76E-03	2.16E-03
GIANT	CC	GO:0032432	actin filament bundle	-	249	237	-	-	1.26E-02	1.11E-02
GIANT	CC	GO:0008088	axo-dendritic transport	-	78	76	-	-	1.97E-02	3.57E-03
GIANT	CC	GO:0031519	PcG protein complex	-	38	37	-	-	7.16E-03	1.75E-03
GIANT	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	38	-	-	2.07E-02	1.81E-03
GIANT	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	215	-	-	1.90E-02	1.01E-02
GIANT	CC	GO:0000313	organellar ribosome	-	89	89	-	-	2.07E-02	4.21E-03
GIANT	CC	GO:0099643	signal release from synapse	-	147	142	-	-	1.61E-02	6.67E-03
GIANT	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	45	-	-	1.58E-02	2.11E-03
GIANT	CC	GO:0005818	aster	-	11	11	-	-	5.21E-04	5.26E-04
GIANT	CC	GO:0030018	Z disc	-	129	122	-	-	2.13E-02	5.73E-03
GIANT	CC	GO:0032580	Golgi cisterna membrane	-	93	73	-	-	2.31E-02	3.45E-03
GIANT	CC	GO:0097381	photoreceptor disc membrane	-	25	19	-	-	2.49E-03	9.36E-04
GIANT	CC	GO:1905360	GTPase complex	-	41	38	-	-	3.25E-02	1.81E-03
GIANT	CC	GO:0097540	axonemal central pair	-	161	122	-	-	8.65E-03	5.73E-03
GIANT	CC	GO:0042641	actomyosin	-	77	74	-	-	6.74E-03	3.51E-03
GIANT	CC	GO:0097386	glial cell projection	-	38	36	-	-	2.13E-03	1.70E-03
GIANT	CC	GO:0032588	trans-Golgi network membrane	-	102	99	-	-	1.92E-02	4.68E-03
GIANT	CC	GO:0070382	exocytic vesicle	-	224	212	-	-	1.21E-02	9.94E-03
GIANT	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	47	-	-	7.05E-03	2.22E-03
GIANT	CC	GO:0031903	microbody membrane	-	65	65	-	-	3.19E-02	3.04E-03
GIANT	CC	GO:0046930	pore complex	-	26	26	-	-	3.21E-03	1.23E-03
GIANT	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	1.44E-02	5.26E-04
GIANT	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	15	-	-	8.11E-04	7.02E-04
GIANT	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	232	-	-	8.29E-03	1.09E-02
GIANT	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	1.24E-02	1.17E-03
GIANT	CC	GO:1990071	TRAPPII protein complex	-	12	12	-	-	1.91E-03	5.85E-04
GIANT	CC	GO:0099571	postsynaptic cytoskeleton	-	18	13	-	-	1.95E-02	6.43E-04
GIANT	CC	GO:0044298	cell body membrane	-	32	29	-	-	2.40E-03	1.40E-03
GIANT	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	5.39E-02	5.26E-04
GIANT	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	8.97E-04	9.94E-04
GIANT	CC	GO:0045495	pole plasm	-	25	18	-	-	3.11E-03	8.77E-04
GIANT	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	6.54E-03	7.02E-04
GIANT	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	4.94E-03	9.36E-04
GIANT	CC	GO:0010369	chromocenter	-	14	14	-	-	1.01E-03	7.02E-04
GIANT	CC	GO:0002177	manchette	-	19	14	-	-	9.74E-04	7.02E-04
GIANT	CC	GO:0016323	basolateral plasma membrane	-	239	223	-	-	6.55E-03	1.05E-02
GIANT	CC	GO:0045009	chitosome	-	21	21	-	-	2.35E-03	9.94E-04
GIANT	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	7.94E-04	5.85E-04
GIANT	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	4.85E-03	2.11E-03
GIANT	CC	GO:0098636	protein complex involved in cell adhesion	-	57	55	-	-	5.97E-03	2.57E-03
GIANT	CC	GO:0001917	photoreceptor inner segment	-	71	66	-	-	5.74E-03	3.10E-03
GIANT	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	5.86E-04	7.02E-04
GIANT	CC	GO:0019897	extrinsic component of plasma membrane	-	156	147	-	-	4.50E-03	6.90E-03
GIANT	CC	GO:0031594	neuromuscular junction	-	73	72	-	-	6.63E-03	3.39E-03
GIANT	CC	GO:0045120	pronucleus	-	14	13	-	-	9.65E-04	6.43E-04
GIANT	CC	GO:0043083	synaptic cleft	-	21	19	-	-	5.97E-03	9.36E-04
GIANT	CC	GO:0000922	spindle pole	-	172	165	-	-	7.58E-03	7.72E-03
GIANT	CC	GO:0120111	neuron projection cytoplasm	-	94	91	-	-	1.87E-02	4.27E-03
GIANT	CC	GO:0070971	endoplasmic reticulum exit site	-	32	27	-	-	2.56E-03	1.29E-03
GIANT	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	2.23E-03	6.43E-04
GIANT	CC	GO:0004879	nuclear receptor activity	-	63	62	-	-	3.09E-03	2.92E-03
GIANT	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	161	-	-	5.98E-03	7.55E-03
GIANT	CC	GO:0000123	histone acetyltransferase complex	-	93	86	-	-	4.49E-02	4.04E-03
GIANT	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	1.27E-03	6.43E-04
GIANT	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	104	-	-	2.29E-02	4.91E-03
GIANT	CC	GO:0048786	presynaptic active zone	-	80	77	-	-	4.40E-03	3.63E-03
GIANT	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	1.55E-04	5.26E-04
GIANT	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	3.62E-02	5.85E-04
GIANT	CC	GO:0007034	vacuolar transport	-	168	163	-	-	1.36E-02	7.66E-03
GIANT	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	1.33E-03	9.94E-04
GIANT	CC	GO:0043194	axon initial segment	-	21	20	-	-	3.93E-03	9.36E-04
GIANT	CC	GO:1900115	extracellular regulation of signal transduction	-	13	11	-	-	1.27E-03	5.26E-04
GIANT	CC	GO:0005776	autophagosome	-	111	105	-	-	8.92E-03	4.91E-03
GIANT	CC	GO:0031430	M band	-	22	18	-	-	6.98E-03	8.77E-04
GIANT	CC	GO:0001931	uropod	-	13	12	-	-	2.76E-03	5.85E-04
GIANT	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	76	-	-	2.85E-02	3.57E-03
GIANT	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	91	-	-	3.21E-02	4.27E-03
GIANT	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	1.48E-02	6.43E-04
GIANT	CC	GO:0000164	protein phosphatase type 1 complex	-	19	18	-	-	7.91E-04	8.77E-04
GIANT	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	28	-	-	4.43E-02	1.35E-03
GIANT	CC	GO:0032994	protein-lipid complex	-	39	39	-	-	8.55E-03	1.87E-03
GIANT	CC	GO:0031838	haptoglobin-hemoglobin complex	-	11	11	-	-	2.85E-01	5.26E-04
GIANT	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	151	-	-	3.74E-02	7.08E-03
GIANT	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	4.30E-03	5.85E-04
GIANT	CC	GO:0001527	microfibril	-	13	11	-	-	2.12E-03	5.26E-04
GIANT	CC	GO:0072562	blood microparticle	-	144	122	-	-	2.17E-02	5.73E-03
GIANT	CC	GO:0005883	neurofilament	-	11	11	-	-	4.52E-03	5.26E-04
GIANT	CC	GO:0051233	spindle midzone	-	36	34	-	-	4.18E-03	1.64E-03
GIANT	CC	GO:0005811	lipid droplet	-	102	93	-	-	2.37E-03	4.39E-03
GIANT	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	4.50E-03	2.11E-03
GIANT	CC	GO:0043113	receptor clustering	-	51	47	-	-	7.81E-03	2.22E-03
GIANT	CC	GO:0005940	septin ring	-	14	14	-	-	3.11E-01	7.02E-04
GIANT	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	1.20E-03	5.26E-04
GIANT	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	21	-	-	5.57E-03	9.94E-04
GIANT	CC	GO:0044853	plasma membrane raft	-	114	109	-	-	2.78E-03	5.15E-03
GIANT	CC	GO:0005881	cytoplasmic microtubule	-	256	199	-	-	8.82E-03	9.36E-03
GIANT	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	14	-	-	2.20E-03	7.02E-04
GIANT	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	4.97E-03	8.19E-04
GIANT	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	55	-	-	4.95E-03	2.57E-03
GIANT	CC	GO:0005905	clathrin-coated pit	-	73	73	-	-	4.12E-03	3.45E-03
GIANT	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	7.71E-03	5.85E-04
GIANT	CC	GO:0043034	costamere	-	18	18	-	-	2.55E-03	8.77E-04
GIANT	CC	GO:0031904	endosome lumen	-	38	38	-	-	6.50E-03	1.81E-03
GIANT	CC	GO:0060170	ciliary membrane	-	76	66	-	-	1.26E-02	3.10E-03
GIANT	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	3.66E-02	6.43E-04
GIANT	CC	GO:0000783	nuclear telomere cap complex	-	12	11	-	-	6.88E-03	5.26E-04
GIANT	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	25	-	-	4.55E-02	1.17E-03
GIANT	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	5.94E-03	7.02E-04
GIANT	CC	GO:0032154	cleavage furrow	-	54	52	-	-	1.95E-03	2.46E-03
GIANT	CC	GO:0005640	nuclear outer membrane	-	30	30	-	-	1.09E-03	1.40E-03
GIANT	CC	GO:0005652	nuclear lamina	-	12	12	-	-	1.01E-03	5.85E-04
GIANT	CC	GO:0007006	mitochondrial membrane organization	-	117	108	-	-	6.54E-03	5.09E-03
GIANT	CC	GO:0001772	immunological synapse	-	44	43	-	-	6.26E-03	2.05E-03
GIANT	CC	GO:0030904	retromer complex	-	12	12	-	-	5.31E-03	5.85E-04
GIANT	CC	GO:0030863	cortical cytoskeleton	-	104	101	-	-	4.93E-03	4.74E-03
GIANT	CC	GO:1905348	endonuclease complex	-	38	37	-	-	2.01E-02	1.75E-03
GIANT	CC	GO:0005833	hemoglobin complex	-	12	12	-	-	3.23E-01	5.85E-04
GIANT	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	3.57E-01	8.77E-04
GIANT	CC	GO:0030315	T-tubule	-	52	52	-	-	8.40E-03	2.46E-03
GIANT	CC	GO:0060076	excitatory synapse	-	64	56	-	-	1.15E-02	2.63E-03
GIANT	CC	GO:0036019	endolysosome	-	29	28	-	-	9.59E-04	1.35E-03
GIANT	CC	GO:0001891	phagocytic cup	-	28	26	-	-	1.08E-03	1.23E-03
GIANT	CC	GO:0099086	synaptonemal structure	-	40	29	-	-	2.33E-02	1.40E-03
GIANT	CC	GO:0030427	site of polarized growth	-	172	169	-	-	5.85E-03	7.96E-03
GIANT	CC	GO:0044309	neuron spine	-	213	206	-	-	8.05E-03	9.65E-03
GIANT	CC	GO:0030658	transport vesicle membrane	-	231	218	-	-	1.31E-02	1.02E-02
GIANT	CC	GO:0098918	structural constituent of synapse	-	27	22	-	-	6.91E-03	1.05E-03
GIANT	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	11	-	-	1.03E-01	5.26E-04
GIANT	CC	GO:0000940	outer kinetochore	-	17	17	-	-	6.37E-03	8.19E-04
GIANT	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	7.20E-03	8.19E-04
GIANT	CC	GO:0044232	organelle membrane contact site	-	50	49	-	-	2.25E-03	2.34E-03
GIANT	CC	GO:0098803	respiratory chain complex	-	39	32	-	-	1.81E-02	1.52E-03
GIANT	CC	GO:0097545	axonemal outer doublet	-	164	123	-	-	1.05E-02	5.79E-03
GIANT	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	18	-	-	5.29E-04	8.77E-04
GIANT	CC	GO:0070069	cytochrome complex	-	42	35	-	-	3.39E-02	1.64E-03
GIANT	CC	GO:0031143	pseudopodium	-	18	18	-	-	2.53E-03	8.77E-04
GIANT	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	25	-	-	9.91E-03	1.17E-03
GIANT	CC	GO:0055037	recycling endosome	-	200	194	-	-	4.34E-03	9.13E-03
GIANT	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	91	-	-	3.73E-03	4.27E-03
GIANT	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	3.41E-02	6.43E-04
GIANT	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	2.61E-03	6.43E-04
GIANT	CC	GO:0071682	endocytic vesicle lumen	-	23	23	-	-	4.07E-03	1.11E-03
GIANT	CC	GO:0030684	preribosome	-	76	75	-	-	1.89E-02	3.51E-03
GIANT	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	6.24E-03	8.77E-04
GIANT	CC	GO:1990391	DNA repair complex	-	22	22	-	-	3.75E-02	1.05E-03
GIANT	CC	GO:0005775	vacuolar lumen	-	176	172	-	-	1.09E-02	8.07E-03
GIANT	CC	GO:0032433	filopodium tip	-	19	19	-	-	2.59E-04	9.36E-04
GIANT	CC	GO:0032982	myosin filament	-	24	24	-	-	1.27E-02	1.17E-03
GIANT	CC	GO:0016327	apicolateral plasma membrane	-	23	22	-	-	5.89E-03	1.05E-03
GIANT	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	22	-	-	1.73E-03	1.05E-03
GIANT	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	1.21E-03	5.85E-04
GIANT	CC	GO:0044306	neuron projection terminus	-	164	159	-	-	6.26E-03	7.49E-03
GIANT	CC	GO:0034455	t-UTP complex	-	53	52	-	-	9.72E-03	2.46E-03
GIANT	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	6.67E-02	8.19E-04
GIANT	CC	GO:0031970	organelle envelope lumen	-	94	92	-	-	4.84E-03	4.33E-03
GIANT	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	9.27E-04	6.43E-04
GIANT	CC	GO:0120293	dynein axonemal particle	-	20	18	-	-	1.55E-03	8.77E-04
GIANT	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	1.08E-03	1.17E-03
GIANT	CC	GO:0043292	contractile muscle fiber	-	245	228	-	-	3.12E-02	1.07E-02
GIANT	CC	GO:0018995	host cellular component	-	12	12	-	-	7.00E-04	5.85E-04
GIANT	CC	GO:0034709	methylosome	-	13	13	-	-	7.91E-04	6.43E-04
GIANT	CC	GO:0032426	stereocilium tip	-	21	13	-	-	6.69E-02	6.43E-04
GIANT	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	2.14E-03	5.85E-04
GIANT	CC	GO:0005849	mRNA cleavage factor complex	-	22	18	-	-	2.33E-03	8.77E-04
GIANT	CC	GO:0000803	sex chromosome	-	32	29	-	-	7.23E-03	1.40E-03
GIANT	CC	GO:0098982	GABA-ergic synapse	-	84	81	-	-	5.71E-03	3.80E-03
GIANT	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	17	-	-	3.00E-03	8.19E-04
GIANT	CC	GO:0035097	histone methyltransferase complex	-	63	62	-	-	9.51E-03	2.92E-03
GIANT	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	1.38E-01	7.02E-04
GIANT	CC	GO:0000242	pericentriolar material	-	22	22	-	-	3.03E-03	1.05E-03
GIANT	CC	GO:1903293	phosphatase complex	-	54	52	-	-	5.67E-03	2.46E-03
GIANT	CC	GO:0097470	ribbon synapse	-	13	13	-	-	3.52E-03	6.43E-04
GIANT	CC	GO:0031941	filamentous actin	-	27	25	-	-	1.84E-03	1.17E-03
GIANT	CC	GO:0000786	nucleosome	-	149	137	-	-	2.15E-01	6.43E-03
GIANT	CC	GO:0001533	cornified envelope	-	59	55	-	-	3.22E-02	2.57E-03
GIANT	CC	GO:1904724	tertiary granule lumen	-	55	54	-	-	6.18E-03	2.57E-03
GIANT	CC	GO:0030027	lamellipodium	-	202	200	-	-	1.02E-02	9.36E-03
GIANT	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	14	-	-	1.55E-02	7.02E-04
GIANT	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	26	-	-	3.15E-03	1.23E-03
GIANT	CC	GO:0000800	lateral element	-	14	12	-	-	6.95E-02	5.85E-04
GIANT	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	9.78E-04	5.85E-04
GIANT	CC	GO:0060077	inhibitory synapse	-	20	19	-	-	5.50E-04	9.36E-04
GIANT	CC	GO:0031209	SCAR complex	-	12	12	-	-	1.74E-02	5.85E-04
GIANT	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	4.14E-02	7.60E-04
GIANT	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	1.13E-02	9.94E-04
GIANT	CC	GO:0002102	podosome	-	31	31	-	-	2.12E-03	1.46E-03
GIANT	CC	GO:0090543	Flemming body	-	33	30	-	-	9.68E-03	1.40E-03
GIANT	CC	GO:0016328	lateral plasma membrane	-	66	65	-	-	2.75E-03	3.04E-03
GIANT	CC	GO:0001650	fibrillar center	-	151	149	-	-	3.78E-03	7.02E-03
GIANT	CC	GO:0031332	RNAi effector complex	-	413	27	-	-	3.34E-03	1.29E-03
GIANT	CC	GO:1990204	oxidoreductase complex	-	90	81	-	-	1.54E-02	3.80E-03
GIANT	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	2.54E-02	7.60E-04
GIANT	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.58E-03	5.26E-04
GIANT	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	123	-	-	5.64E-03	5.79E-03
GIANT	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	4.75E-03	8.77E-04
GIANT	CC	GO:0001726	ruffle	-	181	177	-	-	5.80E-03	8.31E-03
GIANT	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	5.40E-03	6.43E-04
GIANT	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	6.65E-03	8.77E-04
GIANT	CC	GO:0043198	dendritic shaft	-	38	36	-	-	4.84E-03	1.70E-03
GIANT	CC	GO:0043073	germ cell nucleus	-	67	62	-	-	5.16E-03	2.92E-03
GIANT	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	2.34E-03	9.94E-04
GIANT	CC	GO:0016592	mediator complex	-	38	38	-	-	2.13E-01	1.81E-03
GIANT	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	8.02E-03	9.36E-04
GIANT	CC	GO:0022626	cytosolic ribosome	-	118	114	-	-	8.22E-02	5.38E-03
GIANT	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	2.36E-02	2.11E-03
GIANT	CC	GO:0034451	centriolar satellite	-	120	114	-	-	7.92E-03	5.38E-03
GIANT	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	3.06E-03	5.26E-04
GIANT	CC	GO:0045171	intercellular bridge	-	91	87	-	-	1.87E-03	4.09E-03
GIANT	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	81	-	-	4.93E-03	3.80E-03
GIANT	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	3.69E-02	7.02E-04
GIANT	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	6.50E-03	5.26E-04
GIANT	CC	GO:0044292	dendrite terminus	-	13	13	-	-	1.95E-04	6.43E-04
GIANT	CC	GO:0032039	integrator complex	-	19	18	-	-	1.75E-03	8.77E-04
GIANT	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	8.26E-04	7.02E-04
GIANT	CC	GO:0033268	node of Ranvier	-	16	16	-	-	1.17E-03	7.60E-04
GIANT	CC	GO:0036038	MKS complex	-	13	12	-	-	1.01E-02	5.85E-04
GIANT	CC	GO:0030527	structural constituent of chromatin	-	97	86	-	-	4.03E-01	4.04E-03
GIANT	CC	GO:0036379	myofilament	-	26	22	-	-	1.85E-02	1.05E-03
GIANT	CC	GO:0030286	dynein complex	-	210	158	-	-	8.70E-03	7.43E-03
GIANT	CC	GO:0031105	septin complex	-	14	14	-	-	2.71E-01	7.02E-04
GIANT	CC	GO:0097228	sperm principal piece	-	33	21	-	-	5.15E-02	9.94E-04
GIANT	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.86E-03	5.85E-04
GIANT	CC	GO:0016482	cytosolic transport	-	135	129	-	-	6.81E-03	6.08E-03
GIANT	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	3.55E-03	1.11E-03
GIANT	CC	GO:0005796	Golgi lumen	-	106	100	-	-	4.69E-03	4.68E-03
GIANT	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	37	-	-	8.36E-03	1.75E-03
GIANT	CC	GO:0034358	plasma lipoprotein particle	-	36	36	-	-	8.79E-03	1.70E-03
GIANT	CC	GO:0008023	transcription elongation factor complex	-	47	46	-	-	5.09E-03	2.16E-03
GIANT	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	24	-	-	7.26E-04	1.17E-03
GIANT	CC	GO:0030662	coated vesicle membrane	-	202	199	-	-	1.39E-02	9.36E-03
GIANT	CC	GO:0007039	protein catabolic process in the vacuole	-	61	59	-	-	6.76E-03	2.81E-03
GIANT	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	64	-	-	1.90E-02	3.04E-03
GIANT	CC	GO:0090734	site of DNA damage	-	118	113	-	-	8.99E-03	5.32E-03
GIANT	MF	GO:0051861	glycolipid binding	-	30	30	-	-	1.34E-03	1.40E-03
GIANT	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	7.81E-04	5.26E-04
GIANT	MF	GO:0051087	protein-folding chaperone binding	-	135	132	-	-	3.24E-03	6.20E-03
GIANT	MF	GO:0051959	dynein light intermediate chain binding	-	27	24	-	-	4.67E-03	1.17E-03
GIANT	CC	GO:0015464	acetylcholine receptor activity	-	21	20	-	-	2.53E-03	9.36E-04
GIANT	MF	GO:0042301	phosphate ion binding	-	12	11	-	-	2.70E-03	5.26E-04
GIANT	MF	GO:0016594	glycine binding	-	12	12	-	-	3.45E-02	5.85E-04
GIANT	MF	GO:0031681	G-protein beta-subunit binding	-	22	19	-	-	1.10E-03	9.36E-04
GIANT	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	35	-	-	1.31E-03	1.64E-03
GIANT	MF	GO:0035613	RNA stem-loop binding	-	21	17	-	-	5.00E-04	8.19E-04
GIANT	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	228	-	-	9.64E-03	1.07E-02
GIANT	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	1.16E-03	9.36E-04
GIANT	MF	GO:0033691	sialic acid binding	-	22	20	-	-	3.31E-03	9.36E-04
GIANT	MF	GO:0048306	calcium-dependent protein binding	-	61	60	-	-	4.92E-03	2.81E-03
GIANT	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	2.21E-03	1.35E-03
GIANT	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	1.24E-01	6.43E-04
GIANT	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	131	-	-	6.31E-03	6.14E-03
GIANT	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	56	-	-	7.05E-03	2.63E-03
GIANT	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	121	-	-	5.74E-03	5.67E-03
GIANT	MF	GO:0045504	dynein heavy chain binding	-	16	15	-	-	1.13E-03	7.02E-04
GIANT	MF	GO:0140457	protein demethylase activity	-	31	28	-	-	7.17E-03	1.35E-03
GIANT	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	1.77E-03	1.05E-03
GIANT	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	1.98E-03	7.60E-04
GIANT	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	3.90E-03	7.02E-04
GIANT	MF	GO:0061980	regulatory RNA binding	-	52	46	-	-	2.44E-02	2.16E-03
GIANT	MF	GO:0015035	protein-disulfide reductase activity	-	32	31	-	-	4.32E-03	1.46E-03
GIANT	MF	GO:0000182	rDNA binding	-	11	11	-	-	1.56E-02	5.26E-04
GIANT	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	8.64E-04	1.40E-03
GIANT	MF	GO:0070840	dynein complex binding	-	25	22	-	-	1.30E-03	1.05E-03
GIANT	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.42E-03	1.17E-03
GIANT	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	5.56E-04	7.60E-04
GIANT	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	29	-	-	1.07E-03	1.40E-03
GIANT	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	3.30E-03	8.77E-04
GIANT	MF	GO:0005178	integrin binding	-	153	153	-	-	7.19E-03	7.20E-03
GIANT	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	1.05E-03	8.19E-04
GIANT	MF	GO:0005549	odorant binding	-	128	11	-	-	2.65E-03	5.26E-04
GIANT	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.55E-04	7.02E-04
GIANT	MF	GO:0008327	methyl-CpG binding	-	31	27	-	-	1.48E-02	1.29E-03
GIANT	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	6.31E-03	9.36E-04
GIANT	MF	GO:0048019	receptor antagonist activity	-	31	18	-	-	5.33E-04	8.77E-04
GIANT	MF	GO:0005521	lamin binding	-	15	15	-	-	4.78E-04	7.02E-04
GIANT	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	2.40E-03	9.36E-04
GIANT	MF	GO:0140318	protein transporter activity	-	40	39	-	-	1.78E-03	1.87E-03
GIANT	MF	GO:0070628	proteasome binding	-	17	17	-	-	1.23E-03	8.19E-04
GIANT	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	1.41E-03	5.26E-04
GIANT	MF	GO:0031432	titin binding	-	13	13	-	-	3.34E-03	6.43E-04
GIANT	MF	GO:0046812	host cell surface binding	-	11	11	-	-	6.68E-04	5.26E-04
GIANT	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	4.28E-03	1.75E-03
GIANT	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	16	-	-	4.00E-04	7.60E-04
GIANT	MF	GO:0002039	p53 binding	-	66	66	-	-	2.69E-03	3.10E-03
GIANT	MF	GO:0005496	steroid binding	-	110	106	-	-	3.10E-03	4.97E-03
GIANT	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.00E-02	1.29E-03
GIANT	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	2.26E-04	5.26E-04
GIANT	MF	GO:0003684	damaged DNA binding	-	89	86	-	-	1.36E-02	4.04E-03
GIANT	MF	GO:0000339	RNA cap binding	-	20	18	-	-	1.64E-03	8.77E-04
GIANT	MF	GO:0016500	protein-hormone receptor activity	-	21	21	-	-	8.25E-04	9.94E-04
GIANT	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	118	-	-	1.41E-02	5.56E-03
GIANT	MF	GO:0005523	tropomyosin binding	-	15	12	-	-	2.41E-03	5.85E-04
GIANT	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	7.67E-03	5.85E-04
GIANT	MF	GO:0070063	RNA polymerase binding	-	61	59	-	-	3.45E-03	2.81E-03
GIANT	MF	GO:0008179	adenylate cyclase binding	-	11	11	-	-	1.04E-01	5.26E-04
GIANT	MF	GO:0050811	GABA receptor binding	-	18	15	-	-	1.06E-03	7.02E-04
GIANT	MF	GO:0030971	receptor tyrosine kinase binding	-	76	71	-	-	1.89E-03	3.33E-03
GIANT	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	81	-	-	6.80E-03	3.80E-03
GIANT	MF	GO:0140030	modification-dependent protein binding	-	179	175	-	-	6.30E-03	8.19E-03
GIANT	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	9.89E-04	1.17E-03
GIANT	MF	GO:0009881	photoreceptor activity	-	17	13	-	-	6.74E-04	6.43E-04
GIANT	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	17	-	-	1.43E-01	8.19E-04
GIANT	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.21E-03	6.43E-04
GIANT	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	6.86E-03	7.60E-04
GIANT	MF	GO:0141047	molecular tag activity	-	13	12	-	-	9.63E-03	5.85E-04
GIANT	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.69E-02	5.26E-04
GIANT	MF	GO:0033130	acetylcholine receptor binding	-	12	11	-	-	1.01E-01	5.26E-04
GIANT	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	4.25E-04	7.02E-04
GIANT	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	6.01E-03	5.85E-04
GIANT	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.18E-02	7.02E-04
GIANT	MF	GO:0010851	cyclase regulator activity	-	17	15	-	-	1.05E-03	7.02E-04
GIANT	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	6.43E-03	7.02E-04
GIANT	MF	GO:0030276	clathrin binding	-	70	66	-	-	7.87E-03	3.10E-03
GIANT	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	3.56E-03	1.40E-03
GIANT	MF	GO:0140311	protein sequestering activity	-	14	13	-	-	1.23E-03	6.43E-04
GIANT	MF	GO:0046790	virion binding	-	19	19	-	-	8.07E-04	9.36E-04
GIANT	MF	GO:0030552	cAMP binding	-	48	45	-	-	3.05E-02	2.11E-03
GIANT	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	1.34E-03	1.81E-03
GIANT	MF	GO:0035173	histone kinase activity	-	17	16	-	-	1.04E-03	7.60E-04
GIANT	MF	GO:0097602	cullin family protein binding	-	26	25	-	-	3.81E-03	1.17E-03
GIANT	MF	GO:0017154	semaphorin receptor activity	-	12	11	-	-	3.99E-03	5.26E-04
GIANT	MF	GO:0004984	olfactory receptor activity	-	429	66	-	-	6.54E-02	3.10E-03
GIANT	MF	GO:0016209	antioxidant activity	-	92	88	-	-	1.20E-02	4.15E-03
GIANT	MF	GO:0070325	lipoprotein particle receptor binding	-	32	29	-	-	1.81E-03	1.40E-03
GIANT	MF	GO:0044325	transmembrane transporter binding	-	159	148	-	-	5.17E-03	6.96E-03
GIANT	MF	GO:0048156	tau protein binding	-	43	43	-	-	1.61E-03	2.05E-03
GIANT	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	1.75E-03	1.70E-03
GIANT	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	1.34E-03	6.43E-04
GIANT	MF	GO:0140272	exogenous protein binding	-	79	79	-	-	2.11E-03	3.74E-03
GIANT	MF	GO:0030145	manganese ion binding	-	65	64	-	-	1.39E-03	3.04E-03
GIANT	MF	GO:0071814	protein-lipid complex binding	-	52	45	-	-	3.81E-03	2.11E-03
GIANT	MF	GO:0008066	glutamate receptor activity	-	70	64	-	-	7.44E-03	3.04E-03
GIANT	MF	GO:0030553	cGMP binding	-	15	13	-	-	3.18E-03	6.43E-04
GIANT	MF	GO:0017069	snRNA binding	-	54	46	-	-	1.08E-02	2.16E-03
GIANT	MF	GO:0030215	semaphorin receptor binding	-	23	22	-	-	2.16E-03	1.05E-03
GIANT	MF	GO:0031996	thioesterase binding	-	11	11	-	-	3.02E-03	5.26E-04
GIANT	MF	GO:0031369	translation initiation factor binding	-	32	32	-	-	1.63E-02	1.52E-03
GIANT	MF	GO:0019843	rRNA binding	-	69	68	-	-	9.13E-03	3.22E-03
GIANT	MF	GO:0004713	protein tyrosine kinase activity	-	213	207	-	-	8.28E-03	9.71E-03
GIANT	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	3.80E-03	2.40E-03
GIANT	MF	GO:0008093	cytoskeletal anchor activity	-	24	22	-	-	8.87E-04	1.05E-03
GIANT	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	1.31E-03	9.36E-04
GIANT	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	28	-	-	1.05E-03	1.35E-03
GIANT	MF	GO:0016208	AMP binding	-	22	21	-	-	1.33E-02	9.94E-04
GIANT	MF	GO:0000287	magnesium ion binding	-	225	215	-	-	4.39E-03	1.01E-02
GIANT	MF	GO:0031490	chromatin DNA binding	-	120	113	-	-	6.29E-03	5.32E-03
GIANT	MF	GO:0017022	myosin binding	-	73	71	-	-	1.94E-03	3.33E-03
GIANT	MF	GO:0004896	cytokine receptor activity	-	93	90	-	-	1.47E-02	4.21E-03
GIANT	MF	GO:0017166	vinculin binding	-	12	12	-	-	1.55E-03	5.85E-04
GIANT	MF	GO:0008301	"DNA binding, bending"	-	18	16	-	-	1.44E-03	7.60E-04
GIANT	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	1.19E-03	5.85E-04
GIANT	MF	GO:0005539	glycosaminoglycan binding	-	236	216	-	-	1.08E-02	1.01E-02
GIANT	MF	GO:0140666	annealing activity	-	11	11	-	-	7.13E-04	5.26E-04
GIANT	MF	GO:0071933	Arp2/3 complex binding	-	14	13	-	-	8.32E-04	6.43E-04
GIANT	MF	GO:0010181	FMN binding	-	15	13	-	-	2.92E-04	6.43E-04
GIANT	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	18	-	-	3.05E-03	8.77E-04
GIANT	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	21	-	-	9.17E-04	9.94E-04
GIANT	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	2.36E-04	8.19E-04
GIANT	MF	GO:0044183	protein folding chaperone	-	67	60	-	-	6.16E-03	2.81E-03
GIANT	MF	GO:0005132	type I interferon receptor binding	-	17	15	-	-	8.48E-03	7.02E-04
GIANT	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	105	-	-	7.10E-03	4.91E-03
GIANT	MF	GO:0003725	double-stranded RNA binding	-	72	70	-	-	5.85E-03	3.28E-03
GIANT	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	4.19E-02	7.60E-04
GIANT	MF	GO:0051018	protein kinase A binding	-	52	50	-	-	5.37E-03	2.34E-03
GIANT	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	2.83E-03	1.64E-03
GIANT	MF	GO:0004618	phosphoglycerate kinase activity	-	89	87	-	-	6.56E-03	4.09E-03
GIANT	MF	GO:0042805	actinin binding	-	36	36	-	-	6.12E-03	1.70E-03
GIANT	MF	GO:0043531	ADP binding	-	38	37	-	-	1.08E-03	1.75E-03
GIANT	MF	GO:0043394	proteoglycan binding	-	36	35	-	-	2.62E-03	1.64E-03
GIANT	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	2.11E-03	5.26E-04
GIANT	MF	GO:0046332	SMAD binding	-	77	75	-	-	6.86E-03	3.51E-03
GIANT	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.57E-03	6.43E-04
GIANT	MF	GO:0001968	fibronectin binding	-	30	29	-	-	2.65E-03	1.40E-03
GIANT	MF	GO:0048038	quinone binding	-	16	16	-	-	1.41E-03	7.60E-04
GIANT	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	117	-	-	9.65E-03	5.50E-03
GIANT	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	79	-	-	1.36E-03	3.74E-03
GIANT	MF	GO:0003756	protein disulfide isomerase activity	-	18	16	-	-	6.41E-03	7.60E-04
GIANT	MF	GO:0051117	ATPase binding	-	85	82	-	-	1.80E-03	3.86E-03
GIANT	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	45	-	-	1.44E-03	2.11E-03
GIANT	MF	GO:0051787	misfolded protein binding	-	20	20	-	-	3.75E-03	9.36E-04
GIANT	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	6.79E-02	5.26E-04
GIANT	MF	GO:0070402	NADPH binding	-	16	15	-	-	1.06E-03	7.02E-04
GIANT	MF	GO:0031404	chloride ion binding	-	14	13	-	-	3.38E-04	6.43E-04
GIANT	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	8.39E-03	2.87E-03
GIANT	MF	GO:0036002	pre-mRNA binding	-	57	37	-	-	1.72E-02	1.75E-03
GIANT	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	31	-	-	9.68E-04	1.46E-03
GIANT	MF	GO:0051540	metal cluster binding	-	71	67	-	-	3.91E-03	3.16E-03
GIANT	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	9.79E-04	5.26E-04
GIANT	MF	GO:0051219	phosphoprotein binding	-	92	90	-	-	6.41E-03	4.21E-03
GIANT	MF	GO:0019894	kinesin binding	-	45	44	-	-	2.27E-03	2.11E-03
GIANT	MF	GO:0042287	MHC protein binding	-	68	58	-	-	2.07E-02	2.75E-03
GIANT	MF	GO:0019003	GDP binding	-	89	89	-	-	6.20E-03	4.21E-03
GIANT	MF	GO:0017171	serine hydrolase activity	-	207	180	-	-	1.10E-02	8.42E-03
GIANT	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	1.92E-03	3.10E-03
GIANT	MF	GO:0003774	cytoskeletal motor activity	-	117	107	-	-	5.82E-03	5.03E-03
GIANT	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	2.43E-03	1.40E-03
GIANT	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	1.41E-03	8.19E-04
GIANT	MF	GO:0061134	peptidase regulator activity	-	224	189	-	-	8.78E-03	8.89E-03
GIANT	MF	GO:0008013	beta-catenin binding	-	86	85	-	-	5.10E-03	3.98E-03
GIANT	MF	GO:0051015	actin filament binding	-	208	197	-	-	9.83E-03	9.24E-03
GIANT	MF	GO:0019208	phosphatase regulator activity	-	107	98	-	-	2.15E-03	4.62E-03
GIANT	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	31	-	-	1.35E-03	1.46E-03
GIANT	MF	GO:0043236	laminin binding	-	29	27	-	-	1.80E-03	1.29E-03
GIANT	MF	GO:0030507	spectrin binding	-	26	25	-	-	7.96E-03	1.17E-03
GIANT	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	37	-	-	1.31E-03	1.75E-03
GIANT	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	110	-	-	1.24E-02	5.15E-03
GIANT	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	1.39E-03	1.17E-03
GIANT	MF	GO:0042393	histone binding	-	240	226	-	-	1.00E-02	1.06E-02
GIANT	MF	GO:0019838	growth factor binding	-	182	177	-	-	7.39E-03	8.31E-03
GIANT	MF	GO:0000149	SNARE binding	-	107	99	-	-	3.26E-02	4.68E-03
GIANT	MF	GO:0003727	single-stranded RNA binding	-	90	85	-	-	5.75E-03	3.98E-03
GIANT	MF	GO:0051378	serotonin binding	-	24	24	-	-	1.49E-03	1.17E-03
GIANT	MF	GO:0005516	calmodulin binding	-	206	194	-	-	5.26E-03	9.13E-03
GIANT	MF	GO:0019825	oxygen binding	-	40	39	-	-	2.76E-02	1.87E-03
GIANT	MF	GO:0045505	dynein intermediate chain binding	-	37	30	-	-	5.12E-03	1.40E-03
GIANT	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	85	-	-	3.41E-03	3.98E-03
GIANT	MF	GO:0032182	ubiquitin-like protein binding	-	117	114	-	-	4.17E-03	5.38E-03
GIANT	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	2.17E-02	1.70E-03
GIANT	MF	GO:0030742	GTP-dependent protein binding	-	22	21	-	-	1.27E-03	9.94E-04
GIANT	MF	GO:0043274	phospholipase binding	-	23	22	-	-	2.09E-03	1.05E-03
GIANT	MF	GO:0031072	heat shock protein binding	-	128	122	-	-	5.66E-03	5.73E-03
GIANT	MF	GO:0030515	snoRNA binding	-	33	33	-	-	3.31E-03	1.58E-03
GIANT	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	74	-	-	2.06E-03	3.51E-03
GIANT	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	21	-	-	2.40E-03	9.94E-04
GIANT	MF	GO:0001965	G-protein alpha-subunit binding	-	26	25	-	-	7.89E-04	1.17E-03
GIANT	MF	GO:0001530	lipopolysaccharide binding	-	38	30	-	-	1.69E-03	1.40E-03
GIANT	MF	GO:0140223	general transcription initiation factor activity	-	55	52	-	-	2.90E-02	2.46E-03
GIANT	MF	GO:0070403	NAD+ binding	-	16	16	-	-	6.98E-02	7.60E-04
GIANT	MF	GO:0000049	tRNA binding	-	75	71	-	-	6.92E-03	3.33E-03
GIANT	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	2.79E-03	2.11E-03
GIANT	MF	GO:0015026	coreceptor activity	-	48	45	-	-	3.95E-03	2.11E-03
GIANT	MF	GO:0005527	macrolide binding	-	12	12	-	-	2.05E-04	5.85E-04
GIANT	MF	GO:0001653	peptide receptor activity	-	128	116	-	-	5.63E-03	5.44E-03
GIANT	MF	GO:0031005	filamin binding	-	15	14	-	-	2.38E-04	7.02E-04
GIANT	MF	GO:0030506	ankyrin binding	-	19	19	-	-	5.52E-04	9.36E-04
GIANT	MF	GO:0006469	negative regulation of protein kinase activity	-	222	205	-	-	5.44E-03	9.59E-03
GIANT	MF	GO:0070182	DNA polymerase binding	-	22	21	-	-	1.59E-03	9.94E-04
GIANT	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	3.01E-04	7.02E-04
GIANT	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	3.05E-03	1.46E-03
GIANT	MF	GO:0051427	hormone receptor binding	-	31	29	-	-	8.58E-04	1.40E-03
GIANT	MF	GO:0070851	growth factor receptor binding	-	141	139	-	-	5.96E-03	6.55E-03
GIANT	MF	GO:0031210	phosphatidylcholine binding	-	32	30	-	-	1.04E-03	1.40E-03
GIANT	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	1.01E-01	5.26E-04
GIANT	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	42	-	-	2.69E-03	1.99E-03
GIANT	MF	GO:0034185	apolipoprotein binding	-	20	19	-	-	3.65E-03	9.36E-04
GIANT	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	2.58E-03	8.19E-04
GIANT	MF	GO:0005506	iron ion binding	-	154	141	-	-	5.97E-03	6.61E-03
GIANT	MF	GO:0003925	G protein activity	-	45	44	-	-	4.00E-03	2.11E-03
GIANT	MF	GO:0038187	pattern recognition receptor activity	-	33	28	-	-	1.55E-02	1.35E-03
GIANT	MF	GO:0008276	protein methyltransferase activity	-	96	86	-	-	3.96E-03	4.04E-03
GIANT	MF	GO:0004396	hexokinase activity	-	16	16	-	-	1.24E-03	7.60E-04
GIANT	MF	GO:0070888	E-box binding	-	59	54	-	-	1.09E-02	2.57E-03
GIANT	MF	GO:0039706	co-receptor binding	-	14	14	-	-	3.47E-04	7.02E-04
GIANT	MF	GO:0015399	primary active transmembrane transporter activity	-	190	176	-	-	1.61E-02	8.25E-03
GIANT	MF	GO:0035254	glutamate receptor binding	-	47	44	-	-	2.14E-03	2.11E-03
GIANT	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	1.88E-03	1.58E-03
GIANT	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	7.05E-03	5.26E-04
GIANT	MF	GO:0043021	ribonucleoprotein complex binding	-	158	156	-	-	6.40E-03	7.31E-03
GIANT	MF	GO:0030170	pyridoxal phosphate binding	-	56	52	-	-	3.88E-03	2.46E-03
GIANT	MF	GO:0032393	MHC class I receptor activity	-	15	15	-	-	1.30E-02	7.02E-04
GIANT	MF	GO:0005112	Notch binding	-	26	25	-	-	4.36E-03	1.17E-03
GIANT	MF	GO:0048185	activin binding	-	16	15	-	-	4.61E-03	7.02E-04
GIANT	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	26	-	-	1.09E-03	1.23E-03
GIANT	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	1.22E-03	5.26E-04
GIANT	MF	GO:0140299	small molecule sensor activity	-	39	34	-	-	2.04E-02	1.64E-03
GIANT	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	5.89E-04	1.05E-03
GIANT	MF	GO:0016917	GABA receptor activity	-	23	19	-	-	6.43E-03	9.36E-04
GIANT	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	4.26E-03	7.02E-04
GIANT	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	23	-	-	7.64E-04	1.11E-03
GIANT	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	46	-	-	2.33E-02	2.16E-03
GIANT	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	8.28E-04	1.17E-03
GIANT	MF	GO:0008527	taste receptor activity	-	28	15	-	-	2.28E-01	7.02E-04
GIANT	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	3.35E-03	5.85E-04
GIANT	MF	GO:0030594	neurotransmitter receptor activity	-	160	145	-	-	1.10E-02	6.79E-03
GIANT	MF	GO:0034452	dynactin binding	-	12	12	-	-	6.53E-04	5.85E-04
GIANT	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	22	-	-	5.18E-02	1.05E-03
GIANT	MF	GO:0120227	acyl-CoA binding	-	22	20	-	-	9.37E-04	9.36E-04
GIANT	MF	GO:0005507	copper ion binding	-	63	58	-	-	1.38E-03	2.75E-03
GIANT	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	4.12E-02	1.05E-03
GIANT	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	7.72E-03	5.26E-04
GIANT	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.75E-03	1.05E-03
GIANT	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	11	-	-	5.67E-04	5.26E-04
Havugimana	CC	GO:0005840	ribosome	1.52E-89	222	169	35	4.79	-	-
Havugimana	CC	GO:0005730	nucleolus	8.75E-55	988	351	157	2.24	-	-
Havugimana	CC	GO:0005739	mitochondrion	2.03E-52	1671	501	265	1.89	-	-
Havugimana	CC	GO:0005615	extracellular space	1.42E-35	3190	751	506	1.48	-	-
Havugimana	CC	GO:0000228	nuclear chromosome	2.08E-25	206	96	33	2.94	-	-
Havugimana	CC	GO:0005635	nuclear envelope	9.02E-15	493	146	78	1.87	-	-
Havugimana	CC	GO:0005764	lysosome	8.68E-09	747	178	119	1.50	-	-
Havugimana	CC	GO:0005815	microtubule organizing center	2.22E-07	843	190	134	1.42	-	-
Havugimana	CC	GO:0031012	extracellular matrix	2.25E-07	564	48	90	0.54	-	-
Havugimana	CC	GO:0005768	endosome	1.66E-04	1037	209	165	1.27	-	-
Havugimana	CC	GO:0005929	cilium	4.19E-04	842	98	134	0.73	-	-
Havugimana	CC	GO:0005777	peroxisome	3.65E-03	142	36	23	1.60	-	-
Havugimana	CC	GO:0005783	endoplasmic reticulum	1.38E-01	2020	344	321	1.07	-	-
Havugimana	CC	GO:0005811	lipid droplet	7.86E-01	102	17	16	1.05	-	-
Havugimana	CC	GO:0005794	Golgi apparatus	9.72E-01	1636	260	260	1.00	-	-
Havugimana	BP	GO:0016071	mRNA metabolic process	7.00E-91	713	338	113	2.99	-	-
Havugimana	BP	GO:0065003	protein-containing complex assembly	1.37E-75	1648	548	262	2.09	-	-
Havugimana	BP	GO:0002181	cytoplasmic translation	2.36E-66	153	120	24	4.94	-	-
Havugimana	BP	GO:0042254	ribosome biogenesis	3.45E-45	297	151	47	3.20	-	-
Havugimana	BP	GO:0006886	intracellular protein transport	2.20E-44	664	251	105	2.38	-	-
Havugimana	BP	GO:0006281	DNA repair	3.18E-44	587	231	93	2.48	-	-
Havugimana	BP	GO:0006913	nucleocytoplasmic transport	4.99E-33	326	142	52	2.74	-	-
Havugimana	BP	GO:0050877	nervous system process	9.32E-31	1527	99	242	0.41	-	-
Havugimana	BP	GO:0006091	generation of precursor metabolites and energy	4.27E-30	502	183	80	2.30	-	-
Havugimana	BP	GO:0055086	nucleobase-containing small molecule metabolic process	7.33E-30	729	237	116	2.05	-	-
Havugimana	BP	GO:0140053	mitochondrial gene expression	4.73E-29	164	88	26	3.38	-	-
Havugimana	BP	GO:0007059	chromosome segregation	1.56E-28	403	155	64	2.42	-	-
Havugimana	BP	GO:0006325	chromatin organization	6.78E-25	720	223	114	1.95	-	-
Havugimana	BP	GO:0006260	DNA replication	6.99E-24	279	114	44	2.57	-	-
Havugimana	BP	GO:0006457	protein folding	1.13E-22	210	93	33	2.79	-	-
Havugimana	BP	GO:0030163	protein catabolic process	6.76E-20	990	267	157	1.70	-	-
Havugimana	BP	GO:0032200	telomere organization	3.83E-18	186	79	30	2.68	-	-
Havugimana	BP	GO:0006399	tRNA metabolic process	1.04E-17	196	81	31	2.60	-	-
Havugimana	BP	GO:0007005	mitochondrion organization	3.81E-17	484	150	77	1.95	-	-
Havugimana	BP	GO:0006310	DNA recombination	2.76E-16	333	113	53	2.14	-	-
Havugimana	BP	GO:0006914	autophagy	6.63E-11	568	150	90	1.66	-	-
Havugimana	BP	GO:0007010	cytoskeleton organization	7.36E-09	1639	345	260	1.33	-	-
Havugimana	BP	GO:0000910	cytokinesis	2.48E-08	186	60	30	2.03	-	-
Havugimana	BP	GO:0012501	programmed cell death	3.68E-08	1954	397	310	1.28	-	-
Havugimana	BP	GO:0016192	vesicle-mediated transport	2.21E-07	1894	381	301	1.27	-	-
Havugimana	BP	GO:0006954	inflammatory response	2.52E-06	820	84	130	0.65	-	-
Havugimana	BP	GO:0006520	amino acid metabolic process	7.51E-06	292	76	46	1.64	-	-
Havugimana	BP	GO:0006629	lipid metabolic process	1.25E-05	1355	160	215	0.74	-	-
Havugimana	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	7.39E-05	119	36	19	1.91	-	-
Havugimana	BP	GO:0005975	carbohydrate metabolic process	7.27E-04	551	117	87	1.34	-	-
Havugimana	BP	GO:0003013	circulatory system process	1.03E-03	584	65	93	0.70	-	-
Havugimana	BP	GO:0007040	lysosome organization	1.28E-03	107	30	17	1.77	-	-
Havugimana	BP	GO:0072659	protein localization to plasma membrane	5.22E-03	284	63	45	1.40	-	-
Havugimana	BP	GO:0006790	sulfur compound metabolic process	6.78E-03	320	69	51	1.36	-	-
Havugimana	BP	GO:0044782	cilium organization	6.79E-03	399	44	63	0.69	-	-
Havugimana	BP	GO:0140013	meiotic nuclear division	8.06E-03	279	61	44	1.38	-	-
Havugimana	BP	GO:0007163	establishment or maintenance of cell polarity	1.35E-02	227	50	36	1.39	-	-
Havugimana	BP	GO:0006355	regulation of DNA-templated transcription	1.63E-02	3342	577	531	1.09	-	-
Havugimana	BP	GO:0055085	transmembrane transport	2.92E-02	1784	251	283	0.89	-	-
Havugimana	BP	GO:0007155	cell adhesion	2.96E-02	1444	200	229	0.87	-	-
Havugimana	BP	GO:0048870	cell motility	3.19E-02	1659	233	263	0.88	-	-
Havugimana	BP	GO:0006486	protein glycosylation	3.42E-02	225	24	36	0.67	-	-
Havugimana	BP	GO:0030198	extracellular matrix organization	7.28E-02	314	38	50	0.76	-	-
Havugimana	BP	GO:0098754	detoxification	7.46E-02	134	29	21	1.36	-	-
Havugimana	BP	GO:0042060	wound healing	9.56E-02	431	81	68	1.18	-	-
Havugimana	BP	GO:0006575	cellular modified amino acid metabolic process	1.06E-01	186	38	30	1.29	-	-
Havugimana	BP	GO:0022600	digestive system process	1.15E-01	110	11	17	0.63	-	-
Havugimana	BP	GO:0007018	microtubule-based movement	3.78E-01	640	93	102	0.92	-	-
Havugimana	BP	GO:0002376	immune system process	4.06E-01	2448	374	389	0.96	-	-
Havugimana	BP	GO:0003012	muscle system process	5.02E-01	425	62	67	0.92	-	-
Havugimana	BP	GO:0098542	defense response to other organism	5.36E-01	1171	178	186	0.96	-	-
Havugimana	BP	GO:0003014	renal system process	5.42E-01	127	17	20	0.84	-	-
Havugimana	BP	GO:0034330	cell junction organization	5.69E-01	727	121	115	1.05	-	-
Havugimana	BP	GO:0006766	vitamin metabolic process	1.00E+00	107	17	17	1.00	-	-
Havugimana	MF	GO:0003723	RNA binding	4.75E-280	1679	858	267	3.22	-	-
Havugimana	MF	GO:0140657	ATP-dependent activity	7.53E-35	729	248	116	2.14	-	-
Havugimana	MF	GO:0005198	structural molecule activity	2.03E-33	798	261	127	2.06	-	-
Havugimana	MF	GO:0140098	"catalytic activity, acting on RNA"	3.55E-26	417	154	66	2.33	-	-
Havugimana	MF	GO:0045182	translation regulator activity	4.86E-26	151	80	24	3.34	-	-
Havugimana	MF	GO:0140097	"catalytic activity, acting on DNA"	2.04E-25	383	144	61	2.37	-	-
Havugimana	MF	GO:0048018	receptor ligand activity	1.24E-24	504	11	80	0.14	-	-
Havugimana	MF	GO:0016874	ligase activity	3.11E-17	283	103	45	2.29	-	-
Havugimana	MF	GO:0140104	molecular carrier activity	2.28E-14	105	50	17	3.00	-	-
Havugimana	MF	GO:0016853	isomerase activity	2.32E-13	252	87	40	2.17	-	-
Havugimana	MF	GO:0008092	cytoskeletal protein binding	1.01E-12	1023	248	162	1.53	-	-
Havugimana	MF	GO:0042393	histone binding	2.81E-12	237	81	38	2.15	-	-
Havugimana	MF	GO:0016491	oxidoreductase activity	3.43E-09	888	207	141	1.47	-	-
Havugimana	MF	GO:0016740	transferase activity	8.59E-09	3074	597	488	1.22	-	-
Havugimana	MF	GO:0009975	cyclase activity	1.24E-04	277	22	44	0.50	-	-
Havugimana	MF	GO:0140110	transcription regulator activity	2.17E-04	2033	266	323	0.82	-	-
Havugimana	MF	GO:0140096	"catalytic activity, acting on a protein"	5.26E-03	3198	561	508	1.10	-	-
Havugimana	MF	GO:0005215	transporter activity	8.15E-03	1462	197	232	0.85	-	-
Havugimana	MF	GO:0038024	cargo receptor activity	1.51E-02	117	9	19	0.48	-	-
Havugimana	MF	GO:0003677	DNA binding	1.56E-02	2865	499	455	1.10	-	-
Havugimana	MF	GO:0003924	GTPase activity	3.89E-02	658	124	104	1.19	-	-
Havugimana	MF	GO:0008289	lipid binding	2.45E-01	836	145	133	1.09	-	-
Havugimana	MF	GO:0016829	lyase activity	8.11E-01	538	83	85	0.97	-	-
Havugimana	MF	GO:0003774	cytoskeletal motor activity	8.98E-01	116	19	18	1.03	-	-
Havugimana	BP	GO:0007346	regulation of mitotic cell cycle	-	518	163	-	-	1.88E-01	4.38E-02
Havugimana	BP	GO:0001525	angiogenesis	-	616	72	-	-	7.15E-03	1.94E-02
Havugimana	BP	GO:0043543	protein acylation	-	107	21	-	-	6.85E-02	5.68E-03
Havugimana	BP	GO:0071763	nuclear membrane organization	-	44	19	-	-	1.93E-02	5.34E-03
Havugimana	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	12	-	-	4.29E-03	3.34E-03
Havugimana	BP	GO:0071806	protein transmembrane transport	-	68	21	-	-	3.14E-02	5.68E-03
Havugimana	BP	GO:0043299	leukocyte degranulation	-	82	13	-	-	4.96E-02	3.67E-03
Havugimana	BP	GO:0051651	maintenance of location in cell	-	236	46	-	-	6.13E-03	1.24E-02
Havugimana	BP	GO:0033119	negative regulation of RNA splicing	-	27	19	-	-	3.40E-02	5.34E-03
Havugimana	CC	GO:0016197	endosomal transport	-	282	91	-	-	9.26E-02	2.44E-02
Havugimana	BP	GO:0070663	regulation of leukocyte proliferation	-	268	23	-	-	1.61E-03	6.35E-03
Havugimana	BP	GO:0045861	negative regulation of proteolysis	-	320	55	-	-	5.70E-03	1.47E-02
Havugimana	CC	GO:0006984	ER-nucleus signaling pathway	-	46	11	-	-	7.35E-03	3.01E-03
Havugimana	BP	GO:0009914	hormone transport	-	315	38	-	-	8.93E-03	1.04E-02
Havugimana	BP	GO:0140112	extracellular vesicle biogenesis	-	23	11	-	-	2.05E-02	3.01E-03
Havugimana	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	12	-	-	8.42E-02	3.34E-03
Havugimana	BP	GO:0045785	positive regulation of cell adhesion	-	482	76	-	-	9.62E-02	2.04E-02
Havugimana	BP	GO:0006413	translational initiation	-	122	68	-	-	3.42E-01	1.84E-02
Havugimana	CC	GO:0005200	structural constituent of cytoskeleton	-	112	45	-	-	1.56E-01	1.20E-02
Havugimana	BP	GO:0030865	cortical cytoskeleton organization	-	51	16	-	-	1.31E-03	4.34E-03
Havugimana	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	23	-	-	3.40E-03	6.35E-03
Havugimana	BP	GO:0002263	cell activation involved in immune response	-	304	47	-	-	9.09E-03	1.27E-02
Havugimana	BP	GO:0048524	positive regulation of viral process	-	64	27	-	-	1.46E-02	7.35E-03
Havugimana	BP	GO:0006099	tricarboxylic acid cycle	-	33	22	-	-	3.48E-02	6.01E-03
Havugimana	BP	GO:0009612	response to mechanical stimulus	-	215	29	-	-	3.91E-03	8.02E-03
Havugimana	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	16	-	-	1.50E-02	4.34E-03
Havugimana	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	13	-	-	9.81E-04	3.67E-03
Havugimana	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	13	-	-	3.85E-02	3.67E-03
Havugimana	MF	GO:0003714	transcription corepressor activity	-	190	55	-	-	9.09E-03	1.47E-02
Havugimana	BP	GO:0098609	cell-cell adhesion	-	954	118	-	-	6.92E-02	3.17E-02
Havugimana	BP	GO:0046835	carbohydrate phosphorylation	-	49	18	-	-	1.54E-01	5.01E-03
Havugimana	CC	GO:1905349	ciliary transition zone assembly	-	371	41	-	-	5.58E-02	1.10E-02
Havugimana	BP	GO:0043523	regulation of neuron apoptotic process	-	218	36	-	-	3.40E-03	9.69E-03
Havugimana	BP	GO:0044380	protein localization to cytoskeleton	-	57	18	-	-	1.28E-03	5.01E-03
Havugimana	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	17	-	-	3.90E-02	4.68E-03
Havugimana	CC	GO:0045324	late endosome to vacuole transport	-	37	17	-	-	5.77E-02	4.68E-03
Havugimana	BP	GO:0070647	protein modification by small protein conjugation or removal	-	968	208	-	-	1.36E-01	5.58E-02
Havugimana	BP	GO:0014823	response to activity	-	70	16	-	-	1.30E-03	4.34E-03
Havugimana	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	86	-	-	1.09E-02	2.30E-02
Havugimana	BP	GO:0034502	protein localization to chromosome	-	130	59	-	-	5.25E-02	1.60E-02
Havugimana	BP	GO:0048562	embryonic organ morphogenesis	-	295	23	-	-	1.59E-03	6.35E-03
Havugimana	BP	GO:0017148	negative regulation of translation	-	390	44	-	-	9.99E-03	1.20E-02
Havugimana	CC	GO:0140238	presynaptic endocytosis	-	72	15	-	-	2.67E-02	4.01E-03
Havugimana	BP	GO:0051236	establishment of RNA localization	-	161	85	-	-	3.39E-02	2.27E-02
Havugimana	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	33	-	-	5.05E-03	9.02E-03
Havugimana	BP	GO:0042246	tissue regeneration	-	496	87	-	-	1.58E-02	2.34E-02
Havugimana	MF	GO:0048018	receptor ligand activity	-	510	11	-	-	9.83E-04	3.01E-03
Havugimana	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	11	-	-	9.70E-04	3.01E-03
Havugimana	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	12	-	-	9.90E-04	3.34E-03
Havugimana	BP	GO:0050779	RNA destabilization	-	135	37	-	-	1.95E-02	1.00E-02
Havugimana	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	18	-	-	5.45E-03	5.01E-03
Havugimana	BP	GO:0061025	membrane fusion	-	532	108	-	-	7.71E-02	2.91E-02
Havugimana	BP	GO:0022406	membrane docking	-	90	30	-	-	2.07E-01	8.02E-03
Havugimana	BP	GO:0050777	negative regulation of immune response	-	196	33	-	-	2.42E-03	9.02E-03
Havugimana	BP	GO:0016053	organic acid biosynthetic process	-	335	53	-	-	1.62E-02	1.44E-02
Havugimana	BP	GO:0021782	glial cell development	-	120	20	-	-	2.09E-01	5.34E-03
Havugimana	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	22	-	-	8.85E-03	6.01E-03
Havugimana	BP	GO:0055088	lipid homeostasis	-	173	25	-	-	7.68E-03	6.68E-03
Havugimana	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	51	-	-	4.05E-03	1.37E-02
Havugimana	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	19	-	-	4.28E-02	5.34E-03
Havugimana	BP	GO:0045667	regulation of osteoblast differentiation	-	147	12	-	-	9.81E-04	3.34E-03
Havugimana	BP	GO:0050801	monoatomic ion homeostasis	-	609	93	-	-	1.75E-02	2.51E-02
Havugimana	BP	GO:0009792	embryo development ending in birth or egg hatching	-	683	129	-	-	1.87E-02	3.47E-02
Havugimana	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	45	-	-	3.20E-03	1.20E-02
Havugimana	BP	GO:0045738	negative regulation of DNA repair	-	40	15	-	-	1.29E-03	4.01E-03
Havugimana	BP	GO:0001704	formation of primary germ layer	-	195	32	-	-	2.78E-02	8.68E-03
Havugimana	BP	GO:0048588	developmental cell growth	-	233	33	-	-	5.24E-03	9.02E-03
Havugimana	BP	GO:0045023	G0 to G1 transition	-	41	21	-	-	5.68E-01	5.68E-03
Havugimana	BP	GO:0021987	cerebral cortex development	-	125	30	-	-	6.56E-03	8.02E-03
Havugimana	BP	GO:0008637	apoptotic mitochondrial changes	-	108	30	-	-	7.58E-03	8.02E-03
Havugimana	CC	GO:1902532	negative regulation of intracellular signal transduction	-	710	130	-	-	1.44E-02	3.47E-02
Havugimana	BP	GO:2000736	regulation of stem cell differentiation	-	78	32	-	-	1.35E-01	8.68E-03
Havugimana	BP	GO:0002064	epithelial cell development	-	210	35	-	-	4.94E-03	9.35E-03
Havugimana	BP	GO:0042177	negative regulation of protein catabolic process	-	109	33	-	-	4.19E-03	9.02E-03
Havugimana	BP	GO:0033120	positive regulation of RNA splicing	-	46	23	-	-	3.66E-03	6.35E-03
Havugimana	BP	GO:0051445	regulation of meiotic cell cycle	-	64	19	-	-	6.01E-01	5.34E-03
Havugimana	BP	GO:0090087	regulation of peptide transport	-	195	23	-	-	5.30E-03	6.35E-03
Havugimana	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	16	-	-	1.31E-03	4.34E-03
Havugimana	BP	GO:0007281	germ cell development	-	334	38	-	-	2.49E-03	1.04E-02
Havugimana	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	31	-	-	3.32E-03	8.35E-03
Havugimana	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	30	-	-	8.24E-03	8.02E-03
Havugimana	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	25	-	-	8.34E-03	6.68E-03
Havugimana	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	21	-	-	4.39E-02	5.68E-03
Havugimana	BP	GO:0003013	circulatory system process	-	602	65	-	-	1.07E-02	1.74E-02
Havugimana	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	28	-	-	4.62E-03	7.68E-03
Havugimana	BP	GO:1903035	negative regulation of response to wounding	-	93	11	-	-	9.79E-04	3.01E-03
Havugimana	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	57	-	-	4.64E-02	1.54E-02
Havugimana	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	23	-	-	8.06E-03	6.35E-03
Havugimana	BP	GO:0009267	cellular response to starvation	-	170	32	-	-	6.29E-03	8.68E-03
Havugimana	CC	GO:0032008	positive regulation of TOR signaling	-	52	12	-	-	8.44E-03	3.34E-03
Havugimana	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	21	-	-	2.56E-02	5.68E-03
Havugimana	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	41	-	-	1.40E-01	1.10E-02
Havugimana	BP	GO:0002521	leukocyte differentiation	-	616	90	-	-	9.50E-02	2.40E-02
Havugimana	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	11	-	-	9.97E-04	3.01E-03
Havugimana	BP	GO:0065004	protein-DNA complex assembly	-	307	117	-	-	1.49E-01	3.14E-02
Havugimana	CC	GO:0006406	mRNA export from nucleus	-	69	38	-	-	4.66E-02	1.04E-02
Havugimana	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	25	-	-	7.09E-01	6.68E-03
Havugimana	BP	GO:0002367	cytokine production involved in immune response	-	121	12	-	-	9.72E-04	3.34E-03
Havugimana	BP	GO:0044848	biological phase	-	211	32	-	-	2.42E-02	8.68E-03
Havugimana	BP	GO:0046660	female sex differentiation	-	125	15	-	-	9.01E-02	4.01E-03
Havugimana	BP	GO:0019693	ribose phosphate metabolic process	-	556	190	-	-	1.40E-01	5.08E-02
Havugimana	BP	GO:0071248	cellular response to metal ion	-	201	33	-	-	2.42E-03	9.02E-03
Havugimana	BP	GO:0030308	negative regulation of cell growth	-	191	26	-	-	5.65E-03	7.01E-03
Havugimana	BP	GO:0097306	cellular response to alcohol	-	99	15	-	-	1.26E-02	4.01E-03
Havugimana	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	53	-	-	1.23E-01	1.44E-02
Havugimana	BP	GO:0010453	regulation of cell fate commitment	-	40	12	-	-	7.15E-01	3.34E-03
Havugimana	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	133	-	-	1.52E-01	3.57E-02
Havugimana	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	11	-	-	9.91E-04	3.01E-03
Havugimana	BP	GO:0032890	regulation of organic acid transport	-	78	14	-	-	9.90E-04	4.01E-03
Havugimana	BP	GO:0098771	inorganic ion homeostasis	-	531	77	-	-	1.13E-02	2.07E-02
Havugimana	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	11	-	-	3.24E-03	3.01E-03
Havugimana	BP	GO:0051259	protein complex oligomerization	-	251	51	-	-	1.06E-02	1.37E-02
Havugimana	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	41	-	-	1.92E-02	1.10E-02
Havugimana	BP	GO:0072665	protein localization to vacuole	-	84	30	-	-	2.71E-02	8.02E-03
Havugimana	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	19	-	-	6.07E-01	5.34E-03
Havugimana	BP	GO:0006914	autophagy	-	574	150	-	-	2.37E-02	4.01E-02
Havugimana	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	25	-	-	1.34E-02	6.68E-03
Havugimana	BP	GO:0008285	negative regulation of cell population proliferation	-	787	89	-	-	6.76E-03	2.40E-02
Havugimana	BP	GO:0048858	cell projection morphogenesis	-	643	97	-	-	8.69E-03	2.61E-02
Havugimana	BP	GO:0045661	regulation of myoblast differentiation	-	74	21	-	-	4.49E-01	5.68E-03
Havugimana	BP	GO:0030307	positive regulation of cell growth	-	164	32	-	-	8.61E-03	8.68E-03
Havugimana	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	66	-	-	1.14E-02	1.77E-02
Havugimana	BP	GO:0014812	muscle cell migration	-	110	12	-	-	9.78E-04	3.34E-03
Havugimana	BP	GO:0048525	negative regulation of viral process	-	90	17	-	-	7.59E-03	4.68E-03
Havugimana	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	24	-	-	2.40E-02	6.68E-03
Havugimana	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	30	-	-	3.21E-03	8.02E-03
Havugimana	BP	GO:0018193	peptidyl-amino acid modification	-	933	151	-	-	2.59E-02	4.04E-02
Havugimana	BP	GO:0051781	positive regulation of cell division	-	93	11	-	-	1.08E-01	3.01E-03
Havugimana	BP	GO:0044770	cell cycle phase transition	-	558	185	-	-	1.28E-01	4.94E-02
Havugimana	BP	GO:0035493	SNARE complex assembly	-	23	11	-	-	1.56E-01	3.01E-03
Havugimana	BP	GO:0002696	positive regulation of leukocyte activation	-	358	58	-	-	1.25E-01	1.57E-02
Havugimana	BP	GO:0007272	ensheathment of neurons	-	146	23	-	-	2.29E-02	6.35E-03
Havugimana	CC	GO:0050806	positive regulation of synaptic transmission	-	171	17	-	-	1.28E-03	4.68E-03
Havugimana	BP	GO:0034504	protein localization to nucleus	-	312	119	-	-	6.37E-02	3.21E-02
Havugimana	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	13	-	-	1.08E-01	3.67E-03
Havugimana	BP	GO:0031647	regulation of protein stability	-	327	125	-	-	4.26E-02	3.34E-02
Havugimana	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	39	-	-	5.74E-01	1.07E-02
Havugimana	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	11	-	-	2.86E-02	3.01E-03
Havugimana	BP	GO:0016054	organic acid catabolic process	-	251	48	-	-	1.64E-02	1.30E-02
Havugimana	BP	GO:0050890	cognition	-	317	39	-	-	5.32E-03	1.07E-02
Havugimana	BP	GO:0008033	tRNA processing	-	136	48	-	-	2.05E-01	1.30E-02
Havugimana	BP	GO:0046661	male sex differentiation	-	171	19	-	-	1.32E-03	5.34E-03
Havugimana	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	20	-	-	1.79E-02	5.34E-03
Havugimana	BP	GO:1990778	protein localization to cell periphery	-	346	75	-	-	1.19E-02	2.00E-02
Havugimana	BP	GO:0001568	blood vessel development	-	790	91	-	-	8.95E-03	2.44E-02
Havugimana	BP	GO:0051258	protein polymerization	-	280	76	-	-	3.49E-02	2.04E-02
Havugimana	BP	GO:0071985	multivesicular body sorting pathway	-	56	22	-	-	3.17E-02	6.01E-03
Havugimana	BP	GO:0090559	regulation of membrane permeability	-	72	17	-	-	4.09E-03	4.68E-03
Havugimana	BP	GO:0002250	adaptive immune response	-	753	45	-	-	4.04E-03	1.20E-02
Havugimana	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	48	-	-	6.80E-03	1.30E-02
Havugimana	CC	GO:0048167	regulation of synaptic plasticity	-	210	32	-	-	8.89E-03	8.68E-03
Havugimana	BP	GO:1903708	positive regulation of hemopoiesis	-	184	36	-	-	2.34E-01	9.69E-03
Havugimana	BP	GO:1903008	organelle disassembly	-	154	48	-	-	1.40E-02	1.30E-02
Havugimana	CC	GO:0032387	negative regulation of intracellular transport	-	51	16	-	-	1.29E-03	4.34E-03
Havugimana	BP	GO:0072091	regulation of stem cell proliferation	-	91	11	-	-	9.56E-04	3.01E-03
Havugimana	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	13	-	-	3.84E-02	3.67E-03
Havugimana	BP	GO:0032535	regulation of cellular component size	-	360	76	-	-	1.18E-02	2.04E-02
Havugimana	BP	GO:0001934	positive regulation of protein phosphorylation	-	701	91	-	-	7.04E-03	2.44E-02
Havugimana	MF	GO:0098631	cell adhesion mediator activity	-	64	18	-	-	1.28E-03	5.01E-03
Havugimana	BP	GO:0046112	nucleobase biosynthetic process	-	18	13	-	-	5.90E-02	3.67E-03
Havugimana	BP	GO:0051603	proteolysis involved in protein catabolic process	-	759	220	-	-	2.58E-01	5.88E-02
Havugimana	BP	GO:0071453	cellular response to oxygen levels	-	168	33	-	-	2.21E-03	9.02E-03
Havugimana	BP	GO:0070585	protein localization to mitochondrion	-	125	59	-	-	1.62E-02	1.60E-02
Havugimana	BP	GO:0044242	cellular lipid catabolic process	-	224	36	-	-	2.14E-02	9.69E-03
Havugimana	BP	GO:0002931	response to ischemia	-	58	14	-	-	9.88E-04	4.01E-03
Havugimana	BP	GO:0043062	extracellular structure organization	-	317	38	-	-	5.89E-03	1.04E-02
Havugimana	BP	GO:0055082	intracellular chemical homeostasis	-	706	115	-	-	2.04E-02	3.07E-02
Havugimana	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	96	-	-	1.84E-02	2.57E-02
Havugimana	BP	GO:0009755	hormone-mediated signaling pathway	-	221	54	-	-	5.81E-03	1.47E-02
Havugimana	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	11	-	-	6.46E-03	3.01E-03
Havugimana	BP	GO:0044782	cilium organization	-	400	44	-	-	2.68E-02	1.20E-02
Havugimana	BP	GO:0090130	tissue migration	-	379	58	-	-	6.92E-03	1.57E-02
Havugimana	BP	GO:1990845	adaptive thermogenesis	-	166	30	-	-	2.19E-03	8.02E-03
Havugimana	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	11	-	-	2.33E-03	3.01E-03
Havugimana	BP	GO:0009314	response to radiation	-	449	101	-	-	1.66E-02	2.71E-02
Havugimana	BP	GO:0009451	RNA modification	-	169	56	-	-	9.72E-02	1.50E-02
Havugimana	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	12	-	-	5.04E-02	3.34E-03
Havugimana	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	36	-	-	2.10E-02	9.69E-03
Havugimana	BP	GO:0015807	L-amino acid transport	-	94	13	-	-	9.91E-04	3.67E-03
Havugimana	BP	GO:0032941	secretion by tissue	-	85	14	-	-	9.26E-03	4.01E-03
Havugimana	BP	GO:0046605	regulation of centrosome cycle	-	54	15	-	-	5.78E-03	4.01E-03
Havugimana	BP	GO:0003014	renal system process	-	130	17	-	-	1.31E-03	4.68E-03
Havugimana	BP	GO:0045598	regulation of fat cell differentiation	-	148	12	-	-	9.56E-04	3.34E-03
Havugimana	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	39	-	-	3.84E-03	1.07E-02
Havugimana	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	16	-	-	2.39E-01	4.34E-03
Havugimana	BP	GO:0071709	membrane assembly	-	68	18	-	-	1.76E-02	5.01E-03
Havugimana	BP	GO:0008217	regulation of blood pressure	-	186	12	-	-	8.30E-03	3.34E-03
Havugimana	CC	GO:0042770	signal transduction in response to DNA damage	-	186	56	-	-	6.32E-03	1.50E-02
Havugimana	BP	GO:0002200	somatic diversification of immune receptors	-	78	27	-	-	2.69E-02	7.35E-03
Havugimana	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	26	-	-	2.85E-02	7.01E-03
Havugimana	BP	GO:0033627	cell adhesion mediated by integrin	-	87	12	-	-	5.44E-02	3.34E-03
Havugimana	BP	GO:0035107	appendage morphogenesis	-	147	13	-	-	6.40E-03	3.67E-03
Havugimana	BP	GO:0045727	positive regulation of translation	-	141	62	-	-	1.50E-02	1.67E-02
Havugimana	CC	GO:0032388	positive regulation of intracellular transport	-	137	51	-	-	4.43E-03	1.37E-02
Havugimana	BP	GO:0002027	regulation of heart rate	-	106	12	-	-	9.89E-04	3.34E-03
Havugimana	BP	GO:0050879	multicellular organismal movement	-	118	14	-	-	9.81E-04	4.01E-03
Havugimana	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	12	-	-	3.59E-03	3.34E-03
Havugimana	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	20	-	-	8.95E-02	5.34E-03
Havugimana	BP	GO:0048515	spermatid differentiation	-	208	22	-	-	1.61E-03	6.01E-03
Havugimana	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	35	-	-	6.24E-03	9.35E-03
Havugimana	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	20	-	-	1.31E-01	5.34E-03
Havugimana	BP	GO:0072523	purine-containing compound catabolic process	-	146	44	-	-	5.54E-02	1.20E-02
Havugimana	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	33	-	-	7.73E-02	9.02E-03
Havugimana	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	12	-	-	9.93E-04	3.34E-03
Havugimana	BP	GO:0031345	negative regulation of cell projection organization	-	195	24	-	-	1.61E-03	6.68E-03
Havugimana	BP	GO:0048278	vesicle docking	-	64	21	-	-	2.78E-01	5.68E-03
Havugimana	BP	GO:0030168	platelet activation	-	135	25	-	-	8.39E-03	6.68E-03
Havugimana	BP	GO:0008284	positive regulation of cell population proliferation	-	992	114	-	-	1.38E-02	3.07E-02
Havugimana	BP	GO:0008213	protein alkylation	-	58	13	-	-	9.24E-03	3.67E-03
Havugimana	BP	GO:0002253	activation of immune response	-	529	80	-	-	3.24E-02	2.14E-02
Havugimana	BP	GO:0031529	ruffle organization	-	55	17	-	-	1.31E-03	4.68E-03
Havugimana	BP	GO:0035304	regulation of protein dephosphorylation	-	87	21	-	-	1.63E-03	5.68E-03
Havugimana	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	33	-	-	3.46E-03	9.02E-03
Havugimana	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	73	-	-	1.26E-02	1.97E-02
Havugimana	BP	GO:0051785	positive regulation of nuclear division	-	61	14	-	-	4.49E-02	4.01E-03
Havugimana	BP	GO:0044786	cell cycle DNA replication	-	45	18	-	-	2.15E-02	5.01E-03
Havugimana	BP	GO:0048145	regulation of fibroblast proliferation	-	87	20	-	-	6.28E-03	5.34E-03
Havugimana	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	62	-	-	9.16E-03	1.67E-02
Havugimana	BP	GO:0009306	protein secretion	-	376	57	-	-	1.97E-02	1.54E-02
Havugimana	CC	GO:0008333	endosome to lysosome transport	-	73	23	-	-	9.70E-02	6.35E-03
Havugimana	MF	GO:0043086	negative regulation of catalytic activity	-	717	116	-	-	8.94E-03	3.11E-02
Havugimana	BP	GO:0045732	positive regulation of protein catabolic process	-	202	51	-	-	1.67E-02	1.37E-02
Havugimana	BP	GO:0031589	cell-substrate adhesion	-	360	66	-	-	5.60E-02	1.77E-02
Havugimana	BP	GO:1904018	positive regulation of vasculature development	-	185	19	-	-	1.07E-02	5.34E-03
Havugimana	BP	GO:0010948	negative regulation of cell cycle process	-	317	83	-	-	5.40E-02	2.24E-02
Havugimana	BP	GO:0009303	rRNA transcription	-	37	24	-	-	1.44E-01	6.68E-03
Havugimana	BP	GO:0035601	protein deacylation	-	56	14	-	-	7.51E-02	4.01E-03
Havugimana	BP	GO:0071300	cellular response to retinoic acid	-	66	11	-	-	9.84E-04	3.01E-03
Havugimana	BP	GO:0048284	organelle fusion	-	456	110	-	-	7.13E-02	2.94E-02
Havugimana	BP	GO:0051588	regulation of neurotransmitter transport	-	99	21	-	-	4.87E-03	5.68E-03
Havugimana	BP	GO:0051784	negative regulation of nuclear division	-	63	26	-	-	1.03E-01	7.01E-03
Havugimana	BP	GO:0044703	multi-organism reproductive process	-	209	26	-	-	1.95E-03	7.01E-03
Havugimana	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	20	-	-	1.63E-03	5.34E-03
Havugimana	BP	GO:0048857	neural nucleus development	-	65	17	-	-	9.79E-03	4.68E-03
Havugimana	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	19	-	-	1.28E-03	5.34E-03
Havugimana	BP	GO:0106027	neuron projection organization	-	90	21	-	-	1.63E-03	5.68E-03
Havugimana	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	18	-	-	1.32E-03	5.01E-03
Havugimana	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	11	-	-	9.87E-04	3.01E-03
Havugimana	CC	GO:0043410	positive regulation of MAPK cascade	-	494	54	-	-	9.98E-03	1.47E-02
Havugimana	BP	GO:0043414	macromolecule methylation	-	138	42	-	-	2.03E-02	1.14E-02
Havugimana	BP	GO:0045807	positive regulation of endocytosis	-	155	19	-	-	3.11E-03	5.34E-03
Havugimana	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	15	-	-	4.90E-03	4.01E-03
Havugimana	BP	GO:0034394	protein localization to cell surface	-	69	15	-	-	3.94E-03	4.01E-03
Havugimana	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	12	-	-	1.76E-02	3.34E-03
Havugimana	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	14	-	-	9.93E-04	4.01E-03
Havugimana	MF	GO:0051100	negative regulation of binding	-	161	34	-	-	3.46E-03	9.35E-03
Havugimana	BP	GO:0001818	negative regulation of cytokine production	-	379	30	-	-	2.35E-02	8.02E-03
Havugimana	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	15	-	-	1.22E-02	4.01E-03
Havugimana	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	33	-	-	2.56E-01	9.02E-03
Havugimana	BP	GO:0032368	regulation of lipid transport	-	149	16	-	-	1.30E-03	4.34E-03
Havugimana	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	45	-	-	5.62E-03	1.20E-02
Havugimana	BP	GO:0033002	muscle cell proliferation	-	249	24	-	-	4.58E-03	6.68E-03
Havugimana	BP	GO:0048880	sensory system development	-	399	39	-	-	5.03E-03	1.07E-02
Havugimana	BP	GO:0043331	response to dsRNA	-	56	14	-	-	9.46E-04	4.01E-03
Havugimana	BP	GO:0033363	secretory granule organization	-	63	11	-	-	6.03E-01	3.01E-03
Havugimana	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	13	-	-	1.22E-01	3.67E-03
Havugimana	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	17	-	-	1.30E-03	4.68E-03
Havugimana	BP	GO:0030901	midbrain development	-	87	20	-	-	1.62E-03	5.34E-03
Havugimana	BP	GO:0007162	negative regulation of cell adhesion	-	310	29	-	-	6.67E-03	8.02E-03
Havugimana	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	16	-	-	1.29E-03	4.34E-03
Havugimana	BP	GO:0002687	positive regulation of leukocyte migration	-	147	17	-	-	1.32E-03	4.68E-03
Havugimana	BP	GO:0034605	cellular response to heat	-	66	27	-	-	1.27E-02	7.35E-03
Havugimana	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	30	-	-	3.22E-02	8.02E-03
Havugimana	BP	GO:0005996	monosaccharide metabolic process	-	250	66	-	-	3.94E-02	1.77E-02
Havugimana	BP	GO:0002262	myeloid cell homeostasis	-	172	43	-	-	6.69E-03	1.17E-02
Havugimana	BP	GO:0000966	RNA 5'-end processing	-	39	16	-	-	7.60E-02	4.34E-03
Havugimana	BP	GO:0050688	regulation of defense response to virus	-	65	13	-	-	9.65E-04	3.67E-03
Havugimana	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	35	-	-	7.52E-02	9.35E-03
Havugimana	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	36	-	-	4.56E-03	9.69E-03
Havugimana	BP	GO:0022618	protein-RNA complex assembly	-	227	131	-	-	1.31E-01	3.51E-02
Havugimana	BP	GO:0051147	regulation of muscle cell differentiation	-	162	24	-	-	1.63E-03	6.68E-03
Havugimana	BP	GO:0006066	alcohol metabolic process	-	374	43	-	-	7.62E-03	1.17E-02
Havugimana	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	16	-	-	7.19E-03	4.34E-03
Havugimana	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	22	-	-	1.60E-01	6.01E-03
Havugimana	BP	GO:0032922	circadian regulation of gene expression	-	71	20	-	-	1.66E-02	5.34E-03
Havugimana	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	14	-	-	8.27E-03	4.01E-03
Havugimana	BP	GO:0051293	establishment of spindle localization	-	57	19	-	-	1.12E-02	5.34E-03
Havugimana	BP	GO:0023061	signal release	-	491	67	-	-	8.74E-03	1.80E-02
Havugimana	BP	GO:0008360	regulation of cell shape	-	139	26	-	-	1.34E-02	7.01E-03
Havugimana	BP	GO:0051222	positive regulation of protein transport	-	249	56	-	-	6.28E-03	1.50E-02
Havugimana	BP	GO:0045739	positive regulation of DNA repair	-	128	60	-	-	2.82E-01	1.60E-02
Havugimana	BP	GO:0045185	maintenance of protein location	-	95	24	-	-	4.64E-03	6.68E-03
Havugimana	BP	GO:0003158	endothelium development	-	140	19	-	-	5.71E-03	5.34E-03
Havugimana	CC	GO:0072595	maintenance of protein localization in organelle	-	42	13	-	-	9.48E-04	3.67E-03
Havugimana	BP	GO:0051224	negative regulation of protein transport	-	122	20	-	-	1.63E-03	5.34E-03
Havugimana	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	14	-	-	9.85E-04	4.01E-03
Havugimana	MF	GO:0003713	transcription coactivator activity	-	281	93	-	-	8.82E-02	2.51E-02
Havugimana	BP	GO:1990542	mitochondrial transmembrane transport	-	93	35	-	-	2.96E-02	9.35E-03
Havugimana	BP	GO:0045862	positive regulation of proteolysis	-	353	74	-	-	1.72E-02	2.00E-02
Havugimana	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	12	-	-	9.91E-04	3.34E-03
Havugimana	BP	GO:0031100	animal organ regeneration	-	66	21	-	-	3.03E-03	5.68E-03
Havugimana	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	32	-	-	1.25E-01	8.68E-03
Havugimana	BP	GO:0030001	metal ion transport	-	933	95	-	-	2.44E-02	2.54E-02
Havugimana	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	11	-	-	6.81E-03	3.01E-03
Havugimana	BP	GO:0035148	tube formation	-	155	20	-	-	3.40E-02	5.34E-03
Havugimana	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	16	-	-	2.52E-01	4.34E-03
Havugimana	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	26	-	-	1.42E-02	7.01E-03
Havugimana	BP	GO:0031123	RNA 3'-end processing	-	79	41	-	-	1.57E-01	1.10E-02
Havugimana	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	15	-	-	8.44E-02	4.01E-03
Havugimana	BP	GO:0045229	external encapsulating structure organization	-	319	38	-	-	4.53E-03	1.04E-02
Havugimana	BP	GO:0006885	regulation of pH	-	104	23	-	-	2.37E-02	6.35E-03
Havugimana	BP	GO:0001667	ameboidal-type cell migration	-	495	76	-	-	9.24E-03	2.04E-02
Havugimana	BP	GO:0001708	cell fate specification	-	108	18	-	-	5.34E-01	5.01E-03
Havugimana	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	11	-	-	9.85E-04	3.01E-03
Havugimana	BP	GO:0032970	regulation of actin filament-based process	-	368	81	-	-	3.99E-02	2.17E-02
Havugimana	BP	GO:0042440	pigment metabolic process	-	80	14	-	-	9.78E-04	4.01E-03
Havugimana	BP	GO:1901606	alpha-amino acid catabolic process	-	101	14	-	-	9.87E-04	4.01E-03
Havugimana	BP	GO:0062197	cellular response to chemical stress	-	299	70	-	-	1.22E-02	1.87E-02
Havugimana	BP	GO:1901890	positive regulation of cell junction assembly	-	106	11	-	-	5.16E-03	3.01E-03
Havugimana	BP	GO:1901655	cellular response to ketone	-	107	21	-	-	7.56E-03	5.68E-03
Havugimana	MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	-	925	136	-	-	1.23E-01	3.64E-02
Havugimana	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	11	-	-	6.24E-01	3.01E-03
Havugimana	BP	GO:0055006	cardiac cell development	-	93	16	-	-	1.27E-03	4.34E-03
Havugimana	BP	GO:0060004	reflex	-	63	11	-	-	4.85E-02	3.01E-03
Havugimana	BP	GO:0044706	multi-multicellular organism process	-	217	27	-	-	1.95E-03	7.35E-03
Havugimana	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	39	-	-	5.63E-03	1.07E-02
Havugimana	BP	GO:0050768	negative regulation of neurogenesis	-	150	15	-	-	1.32E-03	4.01E-03
Havugimana	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	27	-	-	3.44E-03	7.35E-03
Havugimana	BP	GO:0090068	positive regulation of cell cycle process	-	262	85	-	-	6.54E-02	2.27E-02
Havugimana	MF	GO:0022803	passive transmembrane transporter activity	-	676	57	-	-	2.74E-02	1.54E-02
Havugimana	BP	GO:0043632	modification-dependent macromolecule catabolic process	-	642	198	-	-	1.82E-01	5.31E-02
Havugimana	BP	GO:1902115	regulation of organelle assembly	-	210	53	-	-	6.31E-03	1.44E-02
Havugimana	BP	GO:0006397	mRNA processing	-	482	245	-	-	1.35E-01	6.55E-02
Havugimana	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	41	-	-	2.04E-02	1.10E-02
Havugimana	BP	GO:0006730	one-carbon metabolic process	-	24	11	-	-	2.53E-02	3.01E-03
Havugimana	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	11	-	-	9.92E-04	3.01E-03
Havugimana	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	20	-	-	5.13E-02	5.34E-03
Havugimana	BP	GO:0097581	lamellipodium organization	-	91	28	-	-	2.46E-02	7.68E-03
Havugimana	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	78	-	-	1.05E-01	2.10E-02
Havugimana	BP	GO:0060326	cell chemotaxis	-	311	32	-	-	4.01E-03	8.68E-03
Havugimana	BP	GO:0016485	protein processing	-	248	34	-	-	1.87E-02	9.35E-03
Havugimana	BP	GO:0031348	negative regulation of defense response	-	282	38	-	-	2.81E-03	1.04E-02
Havugimana	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	15	-	-	2.23E-02	4.01E-03
Havugimana	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	16	-	-	1.33E-03	4.34E-03
Havugimana	CC	GO:0051169	nuclear transport	-	325	142	-	-	5.21E-02	3.81E-02
Havugimana	BP	GO:0071496	cellular response to external stimulus	-	74	17	-	-	1.33E-03	4.68E-03
Havugimana	BP	GO:0046434	organophosphate catabolic process	-	232	61	-	-	6.16E-02	1.64E-02
Havugimana	BP	GO:0009566	fertilization	-	205	25	-	-	3.48E-02	6.68E-03
Havugimana	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	31	-	-	1.78E-01	8.35E-03
Havugimana	BP	GO:0033044	regulation of chromosome organization	-	249	130	-	-	2.12E-01	3.47E-02
Havugimana	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	63	-	-	5.49E-03	1.70E-02
Havugimana	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	24	-	-	1.60E-03	6.68E-03
Havugimana	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	82	-	-	2.36E-02	2.20E-02
Havugimana	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	140	-	-	1.61E-01	3.74E-02
Havugimana	BP	GO:0016180	snRNA processing	-	28	16	-	-	4.10E-01	4.34E-03
Havugimana	BP	GO:0051303	establishment of chromosome localization	-	104	38	-	-	8.29E-02	1.04E-02
Havugimana	BP	GO:0031349	positive regulation of defense response	-	473	82	-	-	1.07E-02	2.20E-02
Havugimana	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	12	-	-	1.96E-02	3.34E-03
Havugimana	BP	GO:0006605	protein targeting	-	327	107	-	-	1.85E-02	2.87E-02
Havugimana	BP	GO:0061512	protein localization to cilium	-	394	42	-	-	4.99E-02	1.14E-02
Havugimana	BP	GO:0051017	actin filament bundle assembly	-	161	39	-	-	2.23E-02	1.07E-02
Havugimana	BP	GO:1901343	negative regulation of vasculature development	-	154	14	-	-	9.94E-04	4.01E-03
Havugimana	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	49	-	-	3.10E-02	1.34E-02
Havugimana	BP	GO:1902414	protein localization to cell junction	-	107	23	-	-	2.07E-03	6.35E-03
Havugimana	BP	GO:0051304	chromosome separation	-	80	40	-	-	2.09E-01	1.07E-02
Havugimana	BP	GO:0090596	sensory organ morphogenesis	-	272	23	-	-	3.41E-03	6.35E-03
Havugimana	BP	GO:0048709	oligodendrocyte differentiation	-	101	16	-	-	2.82E-01	4.34E-03
Havugimana	BP	GO:0045017	glycerolipid biosynthetic process	-	254	27	-	-	1.97E-01	7.35E-03
Havugimana	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	11	-	-	1.56E-01	3.01E-03
Havugimana	BP	GO:0001776	leukocyte homeostasis	-	108	17	-	-	6.57E-03	4.68E-03
Havugimana	BP	GO:0050769	positive regulation of neurogenesis	-	240	34	-	-	2.99E-03	9.35E-03
Havugimana	BP	GO:0050866	negative regulation of cell activation	-	216	12	-	-	9.89E-04	3.34E-03
Havugimana	BP	GO:0033500	carbohydrate homeostasis	-	251	37	-	-	3.09E-03	1.00E-02
Havugimana	BP	GO:0120035	regulation of plasma membrane bounded cell projection organization	-	647	106	-	-	1.14E-02	2.84E-02
Havugimana	BP	GO:0044088	regulation of vacuole organization	-	56	15	-	-	1.31E-03	4.01E-03
Havugimana	CC	GO:0000791	euchromatin	-	60	21	-	-	2.16E-02	5.68E-03
Havugimana	CC	GO:0030666	endocytic vesicle membrane	-	196	38	-	-	2.81E-02	1.04E-02
Havugimana	CC	GO:0098857	membrane microdomain	-	324	64	-	-	1.17E-02	1.74E-02
Havugimana	CC	GO:0030312	external encapsulating structure	-	567	48	-	-	8.71E-03	1.30E-02
Havugimana	CC	GO:0071027	nuclear RNA surveillance	-	14	11	-	-	5.04E-01	3.01E-03
Havugimana	CC	GO:0043204	perikaryon	-	156	16	-	-	3.50E-03	4.34E-03
Havugimana	CC	GO:1905368	peptidase complex	-	124	76	-	-	5.48E-01	2.04E-02
Havugimana	CC	GO:0000792	heterochromatin	-	98	34	-	-	7.81E-02	9.35E-03
Havugimana	CC	GO:0031201	SNARE complex	-	48	15	-	-	4.98E-02	4.01E-03
Havugimana	CC	GO:0016324	apical plasma membrane	-	392	47	-	-	1.82E-02	1.27E-02
Havugimana	CC	GO:0033260	nuclear DNA replication	-	40	17	-	-	2.99E-02	4.68E-03
Havugimana	CC	GO:0044391	ribosomal subunit	-	203	160	-	-	5.56E-01	4.28E-02
Havugimana	CC	GO:0071013	catalytic step 2 spliceosome	-	88	70	-	-	1.61E-01	1.87E-02
Havugimana	CC	GO:0031907	microbody lumen	-	51	15	-	-	4.86E-02	4.01E-03
Havugimana	CC	GO:0098862	cluster of actin-based cell projections	-	162	26	-	-	9.50E-03	7.01E-03
Havugimana	CC	GO:0098978	glutamatergic synapse	-	411	86	-	-	7.30E-03	2.30E-02
Havugimana	CC	GO:0016363	nuclear matrix	-	127	62	-	-	2.59E-02	1.67E-02
Havugimana	CC	GO:0031261	DNA replication preinitiation complex	-	46	29	-	-	4.73E-01	8.02E-03
Havugimana	CC	GO:0097060	synaptic membrane	-	413	30	-	-	3.96E-02	8.02E-03
Havugimana	CC	GO:0032432	actin filament bundle	-	249	66	-	-	4.06E-02	1.77E-02
Havugimana	CC	GO:0008088	axo-dendritic transport	-	78	22	-	-	6.11E-02	6.01E-03
Havugimana	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	54	-	-	1.33E-02	1.47E-02
Havugimana	CC	GO:0000313	organellar ribosome	-	89	67	-	-	4.54E-01	1.80E-02
Havugimana	CC	GO:0098791	Golgi apparatus subcompartment	-	378	67	-	-	2.11E-01	1.80E-02
Havugimana	CC	GO:0099643	signal release from synapse	-	147	31	-	-	1.21E-02	8.35E-03
Havugimana	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	16	-	-	1.31E-03	4.34E-03
Havugimana	CC	GO:0030018	Z disc	-	129	34	-	-	7.94E-02	9.35E-03
Havugimana	CC	GO:0005814	centriole	-	692	161	-	-	4.13E-02	4.31E-02
Havugimana	CC	GO:0097540	axonemal central pair	-	161	22	-	-	1.82E-02	6.01E-03
Havugimana	CC	GO:0042641	actomyosin	-	77	31	-	-	5.24E-02	8.35E-03
Havugimana	CC	GO:0032588	trans-Golgi network membrane	-	102	29	-	-	4.52E-01	8.02E-03
Havugimana	CC	GO:0070382	exocytic vesicle	-	224	42	-	-	1.82E-02	1.14E-02
Havugimana	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	14	-	-	9.76E-04	4.01E-03
Havugimana	CC	GO:0031903	microbody membrane	-	65	19	-	-	6.56E-02	5.34E-03
Havugimana	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	88	-	-	2.83E-02	2.37E-02
Havugimana	CC	GO:0070993	translation preinitiation complex	-	19	17	-	-	6.31E-01	4.68E-03
Havugimana	CC	GO:0016323	basolateral plasma membrane	-	239	34	-	-	1.78E-02	9.35E-03
Havugimana	CC	GO:0042645	mitochondrial nucleoid	-	45	19	-	-	1.37E-02	5.34E-03
Havugimana	CC	GO:1902495	transmembrane transporter complex	-	408	56	-	-	1.16E-01	1.50E-02
Havugimana	CC	GO:0019897	extrinsic component of plasma membrane	-	156	28	-	-	1.43E-01	7.68E-03
Havugimana	CC	GO:0031594	neuromuscular junction	-	73	13	-	-	9.83E-04	3.67E-03
Havugimana	CC	GO:0000793	condensed chromosome	-	274	109	-	-	1.22E-01	2.94E-02
Havugimana	CC	GO:0000922	spindle pole	-	172	53	-	-	2.69E-02	1.44E-02
Havugimana	CC	GO:0120111	neuron projection cytoplasm	-	94	27	-	-	5.12E-02	7.35E-03
Havugimana	CC	GO:0070971	endoplasmic reticulum exit site	-	32	11	-	-	2.62E-01	3.01E-03
Havugimana	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	34	-	-	1.33E-01	9.35E-03
Havugimana	CC	GO:0000123	histone acetyltransferase complex	-	93	37	-	-	2.28E-01	1.00E-02
Havugimana	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	55	-	-	1.49E-01	1.47E-02
Havugimana	CC	GO:0007034	vacuolar transport	-	168	53	-	-	3.47E-02	1.44E-02
Havugimana	CC	GO:0005776	autophagosome	-	111	23	-	-	1.58E-02	6.35E-03
Havugimana	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	49	-	-	6.65E-01	1.34E-02
Havugimana	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	54	-	-	9.67E-02	1.47E-02
Havugimana	CC	GO:0150034	distal axon	-	309	60	-	-	1.07E-02	1.60E-02
Havugimana	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	105	-	-	1.97E-01	2.81E-02
Havugimana	CC	GO:0072562	blood microparticle	-	144	24	-	-	4.84E-03	6.68E-03
Havugimana	CC	GO:0051233	spindle midzone	-	36	12	-	-	8.31E-03	3.34E-03
Havugimana	CC	GO:0005811	lipid droplet	-	102	17	-	-	3.73E-02	4.68E-03
Havugimana	CC	GO:0045022	early endosome to late endosome transport	-	44	17	-	-	1.04E-02	4.68E-03
Havugimana	CC	GO:0044853	plasma membrane raft	-	114	23	-	-	1.36E-02	6.35E-03
Havugimana	CC	GO:0005881	cytoplasmic microtubule	-	256	36	-	-	1.01E-02	9.69E-03
Havugimana	CC	GO:0008180	COP9 signalosome	-	17	11	-	-	8.00E-01	3.01E-03
Havugimana	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	19	-	-	6.70E-01	5.34E-03
Havugimana	CC	GO:0005905	clathrin-coated pit	-	73	16	-	-	1.83E-01	4.34E-03
Havugimana	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	16	-	-	2.68E-01	4.34E-03
Havugimana	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	13	-	-	8.17E-01	3.67E-03
Havugimana	CC	GO:0000139	Golgi membrane	-	646	105	-	-	2.28E-01	2.81E-02
Havugimana	CC	GO:0032154	cleavage furrow	-	54	25	-	-	1.12E-02	6.68E-03
Havugimana	CC	GO:0007006	mitochondrial membrane organization	-	117	47	-	-	3.83E-02	1.27E-02
Havugimana	CC	GO:0009897	external side of plasma membrane	-	425	30	-	-	1.79E-02	8.02E-03
Havugimana	CC	GO:0030863	cortical cytoskeleton	-	104	42	-	-	7.34E-02	1.14E-02
Havugimana	CC	GO:0030427	site of polarized growth	-	172	46	-	-	2.31E-02	1.24E-02
Havugimana	CC	GO:0044309	neuron spine	-	213	29	-	-	1.77E-02	8.02E-03
Havugimana	CC	GO:0030658	transport vesicle membrane	-	231	53	-	-	1.36E-01	1.44E-02
Havugimana	CC	GO:0034719	SMN-Sm protein complex	-	18	11	-	-	2.41E-01	3.01E-03
Havugimana	CC	GO:0044232	organelle membrane contact site	-	50	12	-	-	5.64E-03	3.34E-03
Havugimana	CC	GO:0098803	respiratory chain complex	-	39	17	-	-	6.11E-02	4.68E-03
Havugimana	CC	GO:0030667	secretory granule membrane	-	319	71	-	-	1.87E-02	1.90E-02
Havugimana	CC	GO:0097545	axonemal outer doublet	-	164	22	-	-	1.59E-03	6.01E-03
Havugimana	CC	GO:0070069	cytochrome complex	-	42	18	-	-	6.35E-02	5.01E-03
Havugimana	CC	GO:0055037	recycling endosome	-	200	38	-	-	3.60E-02	1.04E-02
Havugimana	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	19	-	-	9.12E-03	5.34E-03
Havugimana	CC	GO:0030684	preribosome	-	76	36	-	-	6.61E-02	9.69E-03
Havugimana	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	113	-	-	4.05E-02	3.04E-02
Havugimana	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	15	-	-	6.66E-01	4.01E-03
Havugimana	CC	GO:0005775	vacuolar lumen	-	176	51	-	-	8.32E-03	1.37E-02
Havugimana	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	14	-	-	5.43E-02	4.01E-03
Havugimana	CC	GO:0044306	neuron projection terminus	-	164	19	-	-	1.96E-03	5.34E-03
Havugimana	CC	GO:0034455	t-UTP complex	-	53	24	-	-	4.22E-02	6.68E-03
Havugimana	CC	GO:0005770	late endosome	-	299	66	-	-	3.90E-02	1.77E-02
Havugimana	CC	GO:0031970	organelle envelope lumen	-	94	33	-	-	3.44E-02	9.02E-03
Havugimana	CC	GO:0019866	organelle inner membrane	-	546	222	-	-	2.24E-01	5.95E-02
Havugimana	CC	GO:0098687	chromosomal region	-	397	182	-	-	9.63E-02	4.88E-02
Havugimana	CC	GO:0043292	contractile muscle fiber	-	245	69	-	-	5.08E-02	1.87E-02
Havugimana	CC	GO:0005849	mRNA cleavage factor complex	-	22	13	-	-	1.80E-01	3.67E-03
Havugimana	CC	GO:0035097	histone methyltransferase complex	-	63	40	-	-	1.15E-01	1.07E-02
Havugimana	CC	GO:0000323	lytic vacuole	-	749	178	-	-	5.34E-02	4.78E-02
Havugimana	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	11	-	-	7.17E-01	3.01E-03
Havugimana	CC	GO:1903293	phosphatase complex	-	54	17	-	-	2.74E-01	4.68E-03
Havugimana	CC	GO:0000786	nucleosome	-	149	33	-	-	2.22E-01	9.02E-03
Havugimana	CC	GO:0001533	cornified envelope	-	59	14	-	-	1.34E-01	4.01E-03
Havugimana	CC	GO:1904724	tertiary granule lumen	-	55	16	-	-	1.47E-02	4.34E-03
Havugimana	CC	GO:0030027	lamellipodium	-	202	68	-	-	1.67E-02	1.84E-02
Havugimana	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	12	-	-	2.64E-02	3.34E-03
Havugimana	CC	GO:0001056	RNA polymerase III activity	-	16	11	-	-	8.23E-01	3.01E-03
Havugimana	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	12	-	-	1.85E-01	3.34E-03
Havugimana	CC	GO:0002102	podosome	-	31	13	-	-	1.08E-02	3.67E-03
Havugimana	CC	GO:0090543	Flemming body	-	33	14	-	-	6.18E-02	4.01E-03
Havugimana	CC	GO:0016328	lateral plasma membrane	-	66	13	-	-	9.80E-04	3.67E-03
Havugimana	CC	GO:0001650	fibrillar center	-	151	57	-	-	1.65E-02	1.54E-02
Havugimana	CC	GO:1990204	oxidoreductase complex	-	90	38	-	-	1.50E-01	1.04E-02
Havugimana	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	7.52E-01	3.01E-03
Havugimana	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	77	-	-	2.88E-02	2.07E-02
Havugimana	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	14	-	-	8.86E-02	4.01E-03
Havugimana	CC	GO:0001726	ruffle	-	181	50	-	-	7.03E-03	1.34E-02
Havugimana	CC	GO:0043073	germ cell nucleus	-	67	28	-	-	1.75E-02	7.68E-03
Havugimana	CC	GO:0005788	endoplasmic reticulum lumen	-	313	48	-	-	6.16E-02	1.30E-02
Havugimana	CC	GO:0016592	mediator complex	-	38	24	-	-	6.98E-01	6.68E-03
Havugimana	CC	GO:0022626	cytosolic ribosome	-	118	94	-	-	6.39E-01	2.54E-02
Havugimana	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	14	-	-	9.00E-01	4.01E-03
Havugimana	CC	GO:0034451	centriolar satellite	-	120	23	-	-	4.04E-03	6.35E-03
Havugimana	CC	GO:0045171	intercellular bridge	-	91	21	-	-	1.58E-02	5.68E-03
Havugimana	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	26	-	-	1.16E-02	7.01E-03
Havugimana	CC	GO:0098984	neuron to neuron synapse	-	384	60	-	-	1.12E-02	1.60E-02
Havugimana	CC	GO:0030527	structural constituent of chromatin	-	97	15	-	-	4.55E-01	4.01E-03
Havugimana	CC	GO:0030286	dynein complex	-	210	35	-	-	4.49E-02	9.35E-03
Havugimana	CC	GO:0016482	cytosolic transport	-	135	44	-	-	3.10E-02	1.20E-02
Havugimana	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	12	-	-	7.30E-01	3.34E-03
Havugimana	CC	GO:0008023	transcription elongation factor complex	-	47	22	-	-	2.66E-01	6.01E-03
Havugimana	CC	GO:0030662	coated vesicle membrane	-	202	65	-	-	1.56E-01	1.74E-02
Havugimana	CC	GO:0007039	protein catabolic process in the vacuole	-	61	26	-	-	3.47E-02	7.01E-03
Havugimana	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	42	-	-	2.68E-01	1.14E-02
Havugimana	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	91	-	-	4.41E-01	2.44E-02
Havugimana	CC	GO:0005769	early endosome	-	425	100	-	-	1.57E-01	2.67E-02
Havugimana	CC	GO:0090734	site of DNA damage	-	118	51	-	-	1.38E-01	1.37E-02
Havugimana	MF	GO:0051087	protein-folding chaperone binding	-	135	45	-	-	3.20E-02	1.20E-02
Havugimana	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	53	-	-	1.25E-02	1.44E-02
Havugimana	MF	GO:0016757	glycosyltransferase activity	-	286	35	-	-	2.47E-02	9.35E-03
Havugimana	MF	GO:0048306	calcium-dependent protein binding	-	61	22	-	-	1.21E-01	6.01E-03
Havugimana	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	17	-	-	4.57E-02	4.68E-03
Havugimana	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	11	-	-	1.84E-01	3.01E-03
Havugimana	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	22	-	-	8.02E-03	6.01E-03
Havugimana	MF	GO:0051020	GTPase binding	-	311	86	-	-	2.67E-02	2.30E-02
Havugimana	MF	GO:0061980	regulatory RNA binding	-	52	14	-	-	1.54E-02	4.01E-03
Havugimana	MF	GO:0015035	protein-disulfide reductase activity	-	32	15	-	-	1.74E-02	4.01E-03
Havugimana	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	114	-	-	1.65E-02	3.07E-02
Havugimana	MF	GO:0005178	integrin binding	-	153	31	-	-	4.94E-02	8.35E-03
Havugimana	MF	GO:0008233	peptidase activity	-	998	152	-	-	1.83E-02	4.07E-02
Havugimana	MF	GO:0140318	protein transporter activity	-	40	12	-	-	1.90E-01	3.34E-03
Havugimana	MF	GO:0000217	DNA secondary structure binding	-	37	13	-	-	2.30E-02	3.67E-03
Havugimana	MF	GO:0002039	p53 binding	-	66	24	-	-	3.47E-03	6.68E-03
Havugimana	MF	GO:0005496	steroid binding	-	110	14	-	-	9.44E-03	4.01E-03
Havugimana	MF	GO:0008443	phosphofructokinase activity	-	27	14	-	-	2.72E-01	4.01E-03
Havugimana	MF	GO:0003684	damaged DNA binding	-	89	36	-	-	7.35E-02	9.69E-03
Havugimana	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	30	-	-	2.19E-02	8.02E-03
Havugimana	MF	GO:0070063	RNA polymerase binding	-	61	30	-	-	5.20E-02	8.02E-03
Havugimana	MF	GO:0030971	receptor tyrosine kinase binding	-	76	13	-	-	9.76E-04	3.67E-03
Havugimana	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	56	-	-	3.42E-01	1.50E-02
Havugimana	MF	GO:0140030	modification-dependent protein binding	-	179	48	-	-	2.71E-02	1.30E-02
Havugimana	MF	GO:0030276	clathrin binding	-	70	16	-	-	5.07E-01	4.34E-03
Havugimana	MF	GO:0003712	transcription coregulator activity	-	499	153	-	-	1.32E-01	4.11E-02
Havugimana	MF	GO:0106310	protein serine kinase activity	-	362	65	-	-	1.32E-02	1.74E-02
Havugimana	MF	GO:0016788	"hydrolase activity, acting on ester bonds"	-	936	159	-	-	5.87E-02	4.28E-02
Havugimana	MF	GO:0004857	enzyme inhibitor activity	-	395	62	-	-	1.12E-02	1.67E-02
Havugimana	MF	GO:0016209	antioxidant activity	-	92	23	-	-	3.56E-02	6.35E-03
Havugimana	MF	GO:0044325	transmembrane transporter binding	-	159	30	-	-	6.00E-02	8.02E-03
Havugimana	MF	GO:0048156	tau protein binding	-	43	17	-	-	6.17E-03	4.68E-03
Havugimana	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	14	-	-	3.21E-02	4.01E-03
Havugimana	MF	GO:0140272	exogenous protein binding	-	79	20	-	-	7.53E-03	5.34E-03
Havugimana	MF	GO:0017069	snRNA binding	-	54	33	-	-	5.57E-02	9.02E-03
Havugimana	MF	GO:0008270	zinc ion binding	-	821	129	-	-	1.97E-02	3.47E-02
Havugimana	MF	GO:0031369	translation initiation factor binding	-	32	17	-	-	3.75E-02	4.68E-03
Havugimana	MF	GO:0019843	rRNA binding	-	69	41	-	-	2.53E-02	1.10E-02
Havugimana	MF	GO:0004713	protein tyrosine kinase activity	-	213	26	-	-	1.97E-03	7.01E-03
Havugimana	MF	GO:0016779	nucleotidyltransferase activity	-	264	110	-	-	2.04E-01	2.94E-02
Havugimana	MF	GO:0000287	magnesium ion binding	-	225	65	-	-	9.23E-03	1.74E-02
Havugimana	MF	GO:0031490	chromatin DNA binding	-	120	40	-	-	6.55E-02	1.07E-02
Havugimana	MF	GO:0017022	myosin binding	-	73	14	-	-	9.67E-03	4.01E-03
Havugimana	MF	GO:0015631	tubulin binding	-	410	86	-	-	4.68E-02	2.30E-02
Havugimana	MF	GO:0019207	kinase regulator activity	-	267	48	-	-	3.99E-03	1.30E-02
Havugimana	MF	GO:0044183	protein folding chaperone	-	67	41	-	-	1.61E-01	1.10E-02
Havugimana	MF	GO:0008047	enzyme activator activity	-	697	98	-	-	1.43E-02	2.64E-02
Havugimana	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	11	-	-	9.96E-04	3.01E-03
Havugimana	MF	GO:0004674	protein serine/threonine kinase activity	-	761	129	-	-	1.99E-02	3.47E-02
Havugimana	MF	GO:0003725	double-stranded RNA binding	-	72	33	-	-	4.03E-03	9.02E-03
Havugimana	MF	GO:0004618	phosphoglycerate kinase activity	-	89	31	-	-	8.14E-02	8.35E-03
Havugimana	MF	GO:0043531	ADP binding	-	38	15	-	-	2.44E-02	4.01E-03
Havugimana	MF	GO:0046332	SMAD binding	-	77	16	-	-	1.09E-02	4.34E-03
Havugimana	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	35	-	-	1.91E-02	9.35E-03
Havugimana	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	17	-	-	3.05E-02	4.68E-03
Havugimana	MF	GO:0051117	ATPase binding	-	85	28	-	-	6.56E-03	7.68E-03
Havugimana	MF	GO:0005216	monoatomic ion channel activity	-	618	52	-	-	5.68E-02	1.40E-02
Havugimana	MF	GO:0016746	acyltransferase activity	-	895	165	-	-	2.72E-02	4.41E-02
Havugimana	MF	GO:0001098	basal transcription machinery binding	-	61	37	-	-	4.83E-02	1.00E-02
Havugimana	MF	GO:0036002	pre-mRNA binding	-	57	16	-	-	1.38E-02	4.34E-03
Havugimana	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	18	-	-	1.31E-03	5.01E-03
Havugimana	MF	GO:0051540	metal cluster binding	-	71	26	-	-	1.29E-02	7.01E-03
Havugimana	MF	GO:0051219	phosphoprotein binding	-	92	28	-	-	7.96E-03	7.68E-03
Havugimana	MF	GO:0019894	kinesin binding	-	45	13	-	-	2.01E-01	3.67E-03
Havugimana	MF	GO:0019003	GDP binding	-	89	33	-	-	3.13E-02	9.02E-03
Havugimana	MF	GO:0017171	serine hydrolase activity	-	207	12	-	-	7.42E-02	3.34E-03
Havugimana	MF	GO:0097110	scaffold protein binding	-	66	18	-	-	1.30E-03	5.01E-03
Havugimana	MF	GO:0003774	cytoskeletal motor activity	-	117	19	-	-	1.47E-01	5.34E-03
Havugimana	MF	GO:0061134	peptidase regulator activity	-	224	26	-	-	4.82E-03	7.01E-03
Havugimana	MF	GO:0008013	beta-catenin binding	-	86	19	-	-	1.12E-02	5.34E-03
Havugimana	MF	GO:0051015	actin filament binding	-	208	68	-	-	1.45E-01	1.84E-02
Havugimana	MF	GO:0019208	phosphatase regulator activity	-	107	27	-	-	7.83E-02	7.35E-03
Havugimana	MF	GO:0045860	positive regulation of protein kinase activity	-	397	53	-	-	6.39E-03	1.44E-02
Havugimana	MF	GO:0008134	transcription factor binding	-	597	186	-	-	4.26E-02	4.98E-02
Havugimana	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	28	-	-	3.79E-03	7.68E-03
Havugimana	MF	GO:0042393	histone binding	-	240	81	-	-	2.46E-02	2.17E-02
Havugimana	MF	GO:0019838	growth factor binding	-	182	22	-	-	2.37E-03	6.01E-03
Havugimana	MF	GO:0000149	SNARE binding	-	107	34	-	-	4.06E-02	9.35E-03
Havugimana	MF	GO:0003727	single-stranded RNA binding	-	90	35	-	-	2.51E-02	9.35E-03
Havugimana	MF	GO:0005516	calmodulin binding	-	206	37	-	-	1.48E-02	1.00E-02
Havugimana	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	20	-	-	4.56E-03	5.34E-03
Havugimana	MF	GO:0032182	ubiquitin-like protein binding	-	117	44	-	-	4.96E-03	1.20E-02
Havugimana	MF	GO:0019904	protein domain specific binding	-	656	173	-	-	1.85E-02	4.64E-02
Havugimana	MF	GO:0031072	heat shock protein binding	-	128	45	-	-	1.82E-02	1.20E-02
Havugimana	MF	GO:0030515	snoRNA binding	-	33	18	-	-	3.19E-02	5.01E-03
Havugimana	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	69	-	-	7.80E-02	1.87E-02
Havugimana	MF	GO:0046982	protein heterodimerization activity	-	343	76	-	-	5.81E-02	2.04E-02
Havugimana	MF	GO:0140223	general transcription initiation factor activity	-	55	33	-	-	6.57E-01	9.02E-03
Havugimana	MF	GO:0000049	tRNA binding	-	75	38	-	-	2.25E-02	1.04E-02
Havugimana	MF	GO:0006469	negative regulation of protein kinase activity	-	222	46	-	-	5.02E-03	1.24E-02
Havugimana	MF	GO:0070182	DNA polymerase binding	-	22	11	-	-	9.75E-04	3.01E-03
Havugimana	MF	GO:0070851	growth factor receptor binding	-	141	15	-	-	1.97E-02	4.01E-03
Havugimana	MF	GO:0005525	GTP binding	-	396	115	-	-	5.64E-02	3.07E-02
Havugimana	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	47	-	-	7.34E-03	1.27E-02
Havugimana	MF	GO:0042803	protein homodimerization activity	-	699	142	-	-	1.87E-02	3.81E-02
Havugimana	MF	GO:0051346	negative regulation of hydrolase activity	-	332	44	-	-	3.68E-03	1.20E-02
Havugimana	MF	GO:0003925	G protein activity	-	45	21	-	-	5.27E-02	5.68E-03
Havugimana	MF	GO:0008276	protein methyltransferase activity	-	96	19	-	-	3.45E-02	5.34E-03
Havugimana	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	112	-	-	1.29E-02	3.01E-02
Havugimana	MF	GO:0051345	positive regulation of hydrolase activity	-	535	76	-	-	1.23E-02	2.04E-02
Havugimana	MF	GO:0015399	primary active transmembrane transporter activity	-	190	74	-	-	1.21E-01	2.00E-02
Havugimana	MF	GO:0043021	ribonucleoprotein complex binding	-	158	85	-	-	2.17E-02	2.27E-02
Havugimana	MF	GO:0001664	G protein-coupled receptor binding	-	299	31	-	-	2.73E-02	8.35E-03
Havugimana	MF	GO:0140299	small molecule sensor activity	-	39	11	-	-	1.51E-01	3.01E-03
Havugimana	MF	GO:0019900	kinase binding	-	893	190	-	-	1.81E-02	5.08E-02
Havugimana	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	12	-	-	1.05E-02	3.34E-03
Havugimana	MF	GO:0005507	copper ion binding	-	63	11	-	-	9.88E-04	3.01E-03
Havugimana	MF	GO:0070034	telomerase RNA binding	-	22	12	-	-	3.05E-02	3.34E-03
Hein	CC	GO:0005730	nucleolus	2.53E-106	988	594	274	2.17	-	-
Hein	CC	GO:0005840	ribosome	8.39E-76	222	192	62	3.12	-	-
Hein	CC	GO:0005815	microtubule organizing center	1.59E-54	843	443	234	1.89	-	-
Hein	CC	GO:0005739	mitochondrion	5.86E-32	1671	676	463	1.46	-	-
Hein	CC	GO:0000228	nuclear chromosome	4.72E-29	206	134	57	2.35	-	-
Hein	CC	GO:0005635	nuclear envelope	6.62E-27	493	248	137	1.81	-	-
Hein	CC	GO:0031012	extracellular matrix	9.09E-20	564	68	156	0.43	-	-
Hein	CC	GO:0005768	endosome	9.02E-11	1037	381	288	1.32	-	-
Hein	CC	GO:0005764	lysosome	4.52E-04	747	250	207	1.21	-	-
Hein	CC	GO:0005794	Golgi apparatus	1.10E-02	1636	498	454	1.10	-	-
Hein	CC	GO:0005811	lipid droplet	2.22E-01	102	34	28	1.20	-	-
Hein	CC	GO:0005777	peroxisome	3.01E-01	142	45	39	1.14	-	-
Hein	CC	GO:0005783	endoplasmic reticulum	4.15E-01	2020	576	560	1.03	-	-
Hein	CC	GO:0005615	extracellular space	5.15E-01	3190	900	885	1.02	-	-
Hein	CC	GO:0005929	cilium	6.94E-01	842	228	233	0.98	-	-
Hein	BP	GO:0016071	mRNA metabolic process	1.23E-114	713	484	198	2.45	-	-
Hein	BP	GO:0065003	protein-containing complex assembly	1.17E-82	1648	808	457	1.77	-	-
Hein	BP	GO:0006281	DNA repair	4.12E-78	587	377	163	2.32	-	-
Hein	BP	GO:0042254	ribosome biogenesis	7.24E-77	297	235	82	2.85	-	-
Hein	BP	GO:0007059	chromosome segregation	7.53E-76	403	288	112	2.58	-	-
Hein	BP	GO:0006325	chromatin organization	1.12E-67	720	418	200	2.09	-	-
Hein	BP	GO:0007010	cytoskeleton organization	7.16E-56	1639	739	455	1.63	-	-
Hein	BP	GO:0050877	nervous system process	9.65E-55	1527	181	423	0.43	-	-
Hein	BP	GO:0002181	cytoplasmic translation	1.47E-48	153	129	42	3.04	-	-
Hein	BP	GO:0006260	DNA replication	3.34E-45	279	190	77	2.46	-	-
Hein	BP	GO:0006913	nucleocytoplasmic transport	4.10E-41	326	206	90	2.28	-	-
Hein	BP	GO:0006886	intracellular protein transport	1.39E-38	664	340	184	1.85	-	-
Hein	BP	GO:0140053	mitochondrial gene expression	4.48E-32	164	118	45	2.59	-	-
Hein	BP	GO:0032200	telomere organization	1.51E-28	186	124	52	2.40	-	-
Hein	BP	GO:0030163	protein catabolic process	1.77E-28	990	433	275	1.58	-	-
Hein	BP	GO:0006310	DNA recombination	5.70E-28	333	187	92	2.03	-	-
Hein	BP	GO:0000910	cytokinesis	3.78E-21	186	113	52	2.19	-	-
Hein	BP	GO:0006914	autophagy	1.82E-19	568	257	158	1.63	-	-
Hein	BP	GO:0016192	vesicle-mediated transport	8.32E-19	1894	693	525	1.32	-	-
Hein	BP	GO:0007163	establishment or maintenance of cell polarity	1.19E-17	227	124	63	1.97	-	-
Hein	BP	GO:0006355	regulation of DNA-templated transcription	1.60E-17	3342	1130	927	1.22	-	-
Hein	BP	GO:0006457	protein folding	6.09E-16	210	114	58	1.96	-	-
Hein	BP	GO:0055085	transmembrane transport	3.45E-14	1784	362	495	0.73	-	-
Hein	BP	GO:0012501	programmed cell death	1.32E-11	1954	671	542	1.24	-	-
Hein	BP	GO:0007005	mitochondrion organization	1.33E-10	484	199	134	1.48	-	-
Hein	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.96E-10	119	66	33	2.00	-	-
Hein	BP	GO:0006399	tRNA metabolic process	1.14E-08	196	92	54	1.69	-	-
Hein	BP	GO:0140013	meiotic nuclear division	1.68E-08	279	121	77	1.56	-	-
Hein	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.76E-08	729	271	202	1.34	-	-
Hein	BP	GO:0006091	generation of precursor metabolites and energy	3.04E-08	502	196	139	1.41	-	-
Hein	BP	GO:0003013	circulatory system process	4.66E-07	584	110	162	0.68	-	-
Hein	BP	GO:0006954	inflammatory response	5.74E-07	820	166	227	0.73	-	-
Hein	BP	GO:0072659	protein localization to plasma membrane	1.78E-06	284	116	79	1.47	-	-
Hein	BP	GO:0007018	microtubule-based movement	4.32E-06	640	230	177	1.30	-	-
Hein	BP	GO:0007040	lysosome organization	7.67E-05	107	49	30	1.65	-	-
Hein	BP	GO:0030198	extracellular matrix organization	9.80E-05	314	57	87	0.65	-	-
Hein	BP	GO:0003014	renal system process	4.42E-04	127	18	35	0.51	-	-
Hein	BP	GO:0006629	lipid metabolic process	6.62E-04	1355	322	376	0.86	-	-
Hein	BP	GO:0006486	protein glycosylation	1.21E-03	225	41	62	0.66	-	-
Hein	BP	GO:0022600	digestive system process	3.67E-03	110	17	31	0.56	-	-
Hein	BP	GO:0007155	cell adhesion	7.76E-03	1444	357	400	0.89	-	-
Hein	BP	GO:0006575	cellular modified amino acid metabolic process	1.05E-02	186	36	52	0.70	-	-
Hein	BP	GO:0034330	cell junction organization	2.79E-02	727	228	202	1.13	-	-
Hein	BP	GO:0006766	vitamin metabolic process	3.91E-02	107	20	30	0.67	-	-
Hein	BP	GO:0002376	immune system process	8.56E-02	2448	643	679	0.95	-	-
Hein	BP	GO:0044782	cilium organization	8.98E-02	399	126	111	1.14	-	-
Hein	BP	GO:0098754	detoxification	1.22E-01	134	29	37	0.78	-	-
Hein	BP	GO:0098542	defense response to other organism	1.89E-01	1171	305	325	0.94	-	-
Hein	BP	GO:0003012	muscle system process	2.08E-01	425	106	118	0.90	-	-
Hein	BP	GO:0006790	sulfur compound metabolic process	2.85E-01	320	80	89	0.90	-	-
Hein	BP	GO:0042060	wound healing	4.15E-01	431	127	120	1.06	-	-
Hein	BP	GO:0005975	carbohydrate metabolic process	5.30E-01	551	146	153	0.96	-	-
Hein	BP	GO:0006520	amino acid metabolic process	7.92E-01	292	83	81	1.03	-	-
Hein	BP	GO:0048870	cell motility	8.63E-01	1659	463	460	1.01	-	-
Hein	MF	GO:0003723	RNA binding	9.49E-295	1679	1151	466	2.47	-	-
Hein	MF	GO:0140657	ATP-dependent activity	1.24E-54	729	398	202	1.97	-	-
Hein	MF	GO:0008092	cytoskeletal protein binding	1.25E-49	1023	501	284	1.77	-	-
Hein	MF	GO:0140097	"catalytic activity, acting on DNA"	3.74E-46	383	239	106	2.25	-	-
Hein	MF	GO:0048018	receptor ligand activity	2.79E-43	504	22	140	0.16	-	-
Hein	MF	GO:0140098	"catalytic activity, acting on RNA"	2.70E-35	417	235	116	2.03	-	-
Hein	MF	GO:0042393	histone binding	7.38E-28	237	146	66	2.22	-	-
Hein	MF	GO:0005198	structural molecule activity	4.05E-21	798	343	221	1.55	-	-
Hein	MF	GO:0016740	transferase activity	2.76E-18	3074	1054	852	1.24	-	-
Hein	MF	GO:0005215	transporter activity	1.92E-13	1462	288	405	0.71	-	-
Hein	MF	GO:0003677	DNA binding	6.11E-13	2865	956	794	1.20	-	-
Hein	MF	GO:0045182	translation regulator activity	6.18E-12	151	82	42	1.96	-	-
Hein	MF	GO:0003774	cytoskeletal motor activity	4.41E-11	116	66	32	2.05	-	-
Hein	MF	GO:0016874	ligase activity	1.18E-10	283	129	78	1.64	-	-
Hein	MF	GO:0009975	cyclase activity	1.71E-09	277	35	77	0.46	-	-
Hein	MF	GO:0140104	molecular carrier activity	3.95E-09	105	58	29	1.99	-	-
Hein	MF	GO:0140096	"catalytic activity, acting on a protein"	1.47E-08	3198	1019	887	1.15	-	-
Hein	MF	GO:0016853	isomerase activity	1.35E-05	252	102	70	1.46	-	-
Hein	MF	GO:0003924	GTPase activity	1.90E-03	658	218	182	1.19	-	-
Hein	MF	GO:0016829	lyase activity	2.86E-03	538	119	149	0.80	-	-
Hein	MF	GO:0038024	cargo receptor activity	9.67E-02	117	24	32	0.74	-	-
Hein	MF	GO:0140110	transcription regulator activity	8.75E-01	2033	567	564	1.01	-	-
Hein	MF	GO:0008289	lipid binding	9.06E-01	836	230	232	0.99	-	-
Hein	MF	GO:0016491	oxidoreductase activity	1.00E+00	888	246	246	1.00	-	-
Hein	BP	GO:0008038	neuron recognition	-	46	11	-	-	5.12E-04	1.56E-03
Hein	BP	GO:0098780	response to mitochondrial depolarisation	-	21	12	-	-	3.50E-02	1.73E-03
Hein	BP	GO:0001525	angiogenesis	-	616	132	-	-	7.76E-03	1.83E-02
Hein	BP	GO:0045666	positive regulation of neuron differentiation	-	91	17	-	-	6.82E-04	2.42E-03
Hein	BP	GO:0043543	protein acylation	-	107	39	-	-	2.35E-03	5.54E-03
Hein	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	18	-	-	6.84E-04	2.59E-03
Hein	BP	GO:0071763	nuclear membrane organization	-	44	33	-	-	5.54E-03	4.67E-03
Hein	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	14	-	-	5.14E-04	2.08E-03
Hein	BP	GO:0071806	protein transmembrane transport	-	68	29	-	-	2.19E-03	4.15E-03
Hein	BP	GO:0043299	leukocyte degranulation	-	82	14	-	-	5.17E-04	2.08E-03
Hein	BP	GO:0048864	stem cell development	-	88	23	-	-	1.58E-03	3.29E-03
Hein	BP	GO:0051651	maintenance of location in cell	-	236	81	-	-	4.60E-03	1.12E-02
Hein	BP	GO:0033119	negative regulation of RNA splicing	-	27	20	-	-	8.53E-04	2.77E-03
Hein	CC	GO:0016197	endosomal transport	-	282	155	-	-	2.21E-02	2.14E-02
Hein	BP	GO:0070663	regulation of leukocyte proliferation	-	268	47	-	-	1.00E-02	6.57E-03
Hein	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	11	-	-	5.14E-04	1.56E-03
Hein	BP	GO:0006949	syncytium formation	-	66	14	-	-	9.69E-04	2.08E-03
Hein	BP	GO:0045861	negative regulation of proteolysis	-	320	78	-	-	3.91E-03	1.09E-02
Hein	CC	GO:0006984	ER-nucleus signaling pathway	-	46	17	-	-	6.78E-04	2.42E-03
Hein	BP	GO:0009914	hormone transport	-	315	64	-	-	2.18E-03	8.99E-03
Hein	BP	GO:0140112	extracellular vesicle biogenesis	-	23	14	-	-	2.23E-03	2.08E-03
Hein	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	12	-	-	1.79E-02	1.73E-03
Hein	BP	GO:0045785	positive regulation of cell adhesion	-	482	141	-	-	8.15E-03	1.95E-02
Hein	BP	GO:0085029	extracellular matrix assembly	-	42	11	-	-	9.73E-03	1.56E-03
Hein	BP	GO:0006413	translational initiation	-	122	71	-	-	5.35E-03	9.86E-03
Hein	BP	GO:1902895	positive regulation of miRNA transcription	-	51	14	-	-	7.02E-03	2.08E-03
Hein	CC	GO:0005200	structural constituent of cytoskeleton	-	112	58	-	-	1.32E-02	8.13E-03
Hein	BP	GO:0030865	cortical cytoskeleton organization	-	51	34	-	-	1.92E-03	4.84E-03
Hein	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	16	-	-	1.26E-01	2.25E-03
Hein	BP	GO:1903036	positive regulation of response to wounding	-	76	20	-	-	8.41E-04	2.77E-03
Hein	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	38	-	-	1.36E-03	5.36E-03
Hein	BP	GO:0032528	microvillus organization	-	24	11	-	-	5.15E-04	1.56E-03
Hein	BP	GO:0002263	cell activation involved in immune response	-	304	68	-	-	1.03E-02	9.51E-03
Hein	BP	GO:0021954	central nervous system neuron development	-	85	23	-	-	1.82E-03	3.29E-03
Hein	BP	GO:0055017	cardiac muscle tissue growth	-	92	23	-	-	2.45E-02	3.29E-03
Hein	BP	GO:0048524	positive regulation of viral process	-	64	37	-	-	2.16E-03	5.19E-03
Hein	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	11	-	-	5.10E-04	1.56E-03
Hein	BP	GO:0098661	inorganic anion transmembrane transport	-	140	16	-	-	6.84E-04	2.25E-03
Hein	BP	GO:0006099	tricarboxylic acid cycle	-	33	17	-	-	7.84E-02	2.42E-03
Hein	BP	GO:0009612	response to mechanical stimulus	-	215	54	-	-	5.40E-03	7.61E-03
Hein	BP	GO:0048644	muscle organ morphogenesis	-	81	19	-	-	6.80E-04	2.77E-03
Hein	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	31	-	-	2.64E-03	4.32E-03
Hein	BP	GO:0140115	export across plasma membrane	-	82	13	-	-	5.14E-04	1.90E-03
Hein	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	17	-	-	6.83E-04	2.42E-03
Hein	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	13	-	-	5.15E-04	1.90E-03
Hein	MF	GO:0003714	transcription corepressor activity	-	190	111	-	-	1.08E-02	1.54E-02
Hein	BP	GO:0098609	cell-cell adhesion	-	954	208	-	-	1.18E-02	2.89E-02
Hein	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	12	-	-	5.13E-04	1.73E-03
Hein	BP	GO:0006304	DNA modification	-	30	15	-	-	1.59E-02	2.08E-03
Hein	MF	GO:0140312	cargo adaptor activity	-	19	15	-	-	1.02E-01	2.08E-03
Hein	BP	GO:0046835	carbohydrate phosphorylation	-	49	21	-	-	8.50E-04	2.94E-03
Hein	CC	GO:1905349	ciliary transition zone assembly	-	371	118	-	-	7.45E-03	1.64E-02
Hein	BP	GO:0043523	regulation of neuron apoptotic process	-	218	59	-	-	5.27E-03	8.30E-03
Hein	BP	GO:0044380	protein localization to cytoskeleton	-	57	39	-	-	3.64E-03	5.54E-03
Hein	BP	GO:2000209	regulation of anoikis	-	25	12	-	-	1.00E-01	1.73E-03
Hein	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	17	-	-	6.83E-04	2.42E-03
Hein	CC	GO:0045324	late endosome to vacuole transport	-	37	25	-	-	1.73E-02	3.46E-03
Hein	BP	GO:0043954	cellular component maintenance	-	72	23	-	-	1.35E-03	3.29E-03
Hein	BP	GO:0050435	amyloid-beta metabolic process	-	65	23	-	-	8.45E-04	3.29E-03
Hein	BP	GO:0014823	response to activity	-	70	21	-	-	8.52E-04	2.94E-03
Hein	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	155	-	-	1.08E-02	2.14E-02
Hein	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	17	-	-	2.59E-02	2.42E-03
Hein	BP	GO:0034502	protein localization to chromosome	-	130	87	-	-	1.67E-02	1.21E-02
Hein	BP	GO:0048562	embryonic organ morphogenesis	-	295	59	-	-	4.23E-03	8.30E-03
Hein	BP	GO:0019233	sensory perception of pain	-	103	11	-	-	5.12E-04	1.56E-03
Hein	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	14	-	-	5.12E-04	2.08E-03
Hein	BP	GO:0017148	negative regulation of translation	-	390	59	-	-	1.32E-02	8.30E-03
Hein	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	15	-	-	6.81E-04	2.08E-03
Hein	BP	GO:1903509	liposaccharide metabolic process	-	109	23	-	-	1.15E-01	3.29E-03
Hein	BP	GO:0009582	detection of abiotic stimulus	-	140	19	-	-	7.95E-03	2.77E-03
Hein	CC	GO:0140238	presynaptic endocytosis	-	72	34	-	-	5.01E-03	4.84E-03
Hein	BP	GO:0051236	establishment of RNA localization	-	161	123	-	-	6.54E-02	1.71E-02
Hein	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	71	-	-	2.94E-03	9.86E-03
Hein	BP	GO:0034067	protein localization to Golgi apparatus	-	30	11	-	-	5.13E-04	1.56E-03
Hein	BP	GO:0061842	microtubule organizing center localization	-	32	23	-	-	8.41E-04	3.29E-03
Hein	BP	GO:0042246	tissue regeneration	-	496	138	-	-	7.35E-03	1.92E-02
Hein	MF	GO:0048018	receptor ligand activity	-	510	22	-	-	8.57E-04	3.11E-03
Hein	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	13	-	-	4.37E-03	1.90E-03
Hein	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	20	-	-	1.99E-02	2.77E-03
Hein	BP	GO:0050779	RNA destabilization	-	135	65	-	-	2.80E-02	8.99E-03
Hein	BP	GO:0006023	aminoglycan biosynthetic process	-	74	15	-	-	1.97E-03	2.08E-03
Hein	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	22	-	-	8.55E-04	3.11E-03
Hein	BP	GO:0061025	membrane fusion	-	532	177	-	-	2.21E-02	2.46E-02
Hein	BP	GO:0010762	regulation of fibroblast migration	-	40	17	-	-	6.86E-04	2.42E-03
Hein	BP	GO:0090311	regulation of protein deacetylation	-	29	17	-	-	5.77E-02	2.42E-03
Hein	BP	GO:0035272	exocrine system development	-	46	15	-	-	6.84E-04	2.08E-03
Hein	BP	GO:0022406	membrane docking	-	90	38	-	-	2.84E-03	5.36E-03
Hein	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	3.23E-02	2.08E-03
Hein	BP	GO:0050777	negative regulation of immune response	-	196	57	-	-	7.53E-03	7.96E-03
Hein	BP	GO:0016053	organic acid biosynthetic process	-	335	80	-	-	2.86E-03	1.11E-02
Hein	BP	GO:0021782	glial cell development	-	120	30	-	-	1.17E-03	4.15E-03
Hein	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	32	-	-	1.18E-03	4.50E-03
Hein	BP	GO:0001655	urogenital system development	-	66	11	-	-	5.14E-04	1.56E-03
Hein	BP	GO:0071827	plasma lipoprotein particle organization	-	86	17	-	-	6.84E-04	2.42E-03
Hein	BP	GO:0055088	lipid homeostasis	-	173	41	-	-	1.06E-02	5.71E-03
Hein	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	13	-	-	5.11E-04	1.90E-03
Hein	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	87	-	-	4.48E-03	1.21E-02
Hein	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	26	-	-	6.41E-03	3.63E-03
Hein	BP	GO:0045667	regulation of osteoblast differentiation	-	147	29	-	-	1.01E-03	4.15E-03
Hein	BP	GO:0050801	monoatomic ion homeostasis	-	609	131	-	-	6.39E-03	1.82E-02
Hein	BP	GO:0009792	embryo development ending in birth or egg hatching	-	683	241	-	-	1.02E-02	3.34E-02
Hein	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	97	-	-	1.26E-02	1.35E-02
Hein	BP	GO:0045738	negative regulation of DNA repair	-	40	24	-	-	8.54E-04	3.46E-03
Hein	BP	GO:0001704	formation of primary germ layer	-	195	60	-	-	4.40E-03	8.30E-03
Hein	BP	GO:0048708	astrocyte differentiation	-	88	17	-	-	6.78E-04	2.42E-03
Hein	BP	GO:0048588	developmental cell growth	-	233	65	-	-	4.20E-03	8.99E-03
Hein	CC	GO:0000963	mitochondrial RNA processing	-	20	11	-	-	5.17E-04	1.56E-03
Hein	BP	GO:0021872	forebrain generation of neurons	-	52	13	-	-	1.54E-02	1.90E-03
Hein	BP	GO:0045023	G0 to G1 transition	-	41	26	-	-	1.03E-03	3.63E-03
Hein	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	14	-	-	5.12E-04	2.08E-03
Hein	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	11	-	-	5.14E-04	1.56E-03
Hein	BP	GO:0010232	vascular transport	-	87	20	-	-	8.55E-04	2.77E-03
Hein	BP	GO:0021987	cerebral cortex development	-	125	55	-	-	2.41E-03	7.61E-03
Hein	BP	GO:0008637	apoptotic mitochondrial changes	-	108	38	-	-	1.32E-02	5.36E-03
Hein	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	13	-	-	2.86E-03	1.90E-03
Hein	BP	GO:0060999	positive regulation of dendritic spine development	-	35	15	-	-	2.84E-02	2.08E-03
Hein	CC	GO:1902532	negative regulation of intracellular signal transduction	-	710	216	-	-	9.05E-03	2.99E-02
Hein	BP	GO:2000736	regulation of stem cell differentiation	-	78	44	-	-	4.77E-03	6.23E-03
Hein	BP	GO:0002064	epithelial cell development	-	210	71	-	-	7.07E-03	9.86E-03
Hein	BP	GO:2001222	regulation of neuron migration	-	46	13	-	-	5.12E-04	1.90E-03
Hein	BP	GO:0034389	lipid droplet organization	-	38	13	-	-	5.08E-04	1.90E-03
Hein	BP	GO:0042177	negative regulation of protein catabolic process	-	109	47	-	-	2.93E-03	6.57E-03
Hein	MF	GO:0038024	cargo receptor activity	-	121	24	-	-	2.73E-03	3.46E-03
Hein	BP	GO:0033120	positive regulation of RNA splicing	-	46	26	-	-	1.01E-03	3.63E-03
Hein	BP	GO:0051445	regulation of meiotic cell cycle	-	64	24	-	-	6.22E-02	3.46E-03
Hein	BP	GO:0033619	membrane protein proteolysis	-	60	20	-	-	1.40E-03	2.77E-03
Hein	BP	GO:0090087	regulation of peptide transport	-	195	38	-	-	1.36E-03	5.36E-03
Hein	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	25	-	-	1.01E-03	3.46E-03
Hein	BP	GO:0006929	substrate-dependent cell migration	-	26	13	-	-	5.13E-04	1.90E-03
Hein	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	12	-	-	1.30E-02	1.73E-03
Hein	BP	GO:0022404	molting cycle process	-	95	27	-	-	2.27E-02	3.81E-03
Hein	BP	GO:1903358	regulation of Golgi organization	-	17	12	-	-	5.11E-04	1.73E-03
Hein	BP	GO:0007281	germ cell development	-	334	85	-	-	3.56E-03	1.18E-02
Hein	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	53	-	-	3.99E-03	7.44E-03
Hein	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	15	-	-	6.87E-04	2.08E-03
Hein	CC	GO:0098926	postsynaptic signal transduction	-	39	11	-	-	5.13E-04	1.56E-03
Hein	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	52	-	-	1.95E-03	7.27E-03
Hein	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	41	-	-	2.55E-02	5.71E-03
Hein	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	50	-	-	2.13E-02	6.92E-03
Hein	BP	GO:0003013	circulatory system process	-	602	110	-	-	8.05E-03	1.52E-02
Hein	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	61	-	-	4.36E-03	8.48E-03
Hein	BP	GO:1903035	negative regulation of response to wounding	-	93	20	-	-	4.45E-03	2.77E-03
Hein	BP	GO:0036010	protein localization to endosome	-	27	14	-	-	1.96E-01	2.08E-03
Hein	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	88	-	-	1.57E-02	1.23E-02
Hein	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	42	-	-	2.53E-03	5.88E-03
Hein	BP	GO:0009267	cellular response to starvation	-	170	71	-	-	9.75E-03	9.86E-03
Hein	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	15	-	-	6.80E-04	2.08E-03
Hein	CC	GO:0140239	postsynaptic endocytosis	-	23	11	-	-	5.13E-04	1.56E-03
Hein	BP	GO:0046931	pore complex assembly	-	21	13	-	-	8.50E-03	1.90E-03
Hein	CC	GO:0032008	positive regulation of TOR signaling	-	52	26	-	-	3.94E-02	3.63E-03
Hein	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	19	-	-	2.15E-02	2.77E-03
Hein	BP	GO:0060428	lung epithelium development	-	43	12	-	-	5.11E-04	1.73E-03
Hein	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	39	-	-	1.37E-03	5.54E-03
Hein	BP	GO:0010457	centriole-centriole cohesion	-	15	14	-	-	5.09E-04	2.08E-03
Hein	BP	GO:0002521	leukocyte differentiation	-	616	166	-	-	1.10E-02	2.30E-02
Hein	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	12	-	-	5.15E-04	1.73E-03
Hein	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	16	-	-	6.78E-04	2.25E-03
Hein	BP	GO:0065004	protein-DNA complex assembly	-	307	187	-	-	2.41E-02	2.59E-02
Hein	CC	GO:0006406	mRNA export from nucleus	-	69	58	-	-	9.09E-02	8.13E-03
Hein	BP	GO:0009880	embryonic pattern specification	-	70	15	-	-	6.84E-04	2.08E-03
Hein	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	28	-	-	1.03E-03	3.98E-03
Hein	BP	GO:0002367	cytokine production involved in immune response	-	121	22	-	-	8.51E-04	3.11E-03
Hein	BP	GO:0044848	biological phase	-	211	97	-	-	2.29E-02	1.35E-02
Hein	BP	GO:0046660	female sex differentiation	-	125	28	-	-	9.07E-03	3.98E-03
Hein	BP	GO:0019693	ribose phosphate metabolic process	-	556	220	-	-	1.52E-02	3.04E-02
Hein	BP	GO:0060411	cardiac septum morphogenesis	-	72	17	-	-	1.67E-01	2.42E-03
Hein	BP	GO:0071248	cellular response to metal ion	-	201	50	-	-	4.82E-03	6.92E-03
Hein	BP	GO:0030308	negative regulation of cell growth	-	191	48	-	-	1.70E-03	6.75E-03
Hein	BP	GO:0097306	cellular response to alcohol	-	99	25	-	-	5.26E-03	3.46E-03
Hein	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	75	-	-	7.78E-03	1.04E-02
Hein	BP	GO:0010453	regulation of cell fate commitment	-	40	14	-	-	2.41E-02	2.08E-03
Hein	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	14	-	-	5.16E-04	2.08E-03
Hein	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	163	-	-	1.07E-02	2.27E-02
Hein	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	14	-	-	5.11E-04	2.08E-03
Hein	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	12	-	-	5.17E-04	1.73E-03
Hein	BP	GO:0032890	regulation of organic acid transport	-	78	16	-	-	6.84E-04	2.25E-03
Hein	BP	GO:0098771	inorganic ion homeostasis	-	531	107	-	-	4.40E-03	1.49E-02
Hein	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	22	-	-	3.81E-03	3.11E-03
Hein	BP	GO:0051259	protein complex oligomerization	-	251	78	-	-	6.55E-03	1.09E-02
Hein	BP	GO:0009994	oocyte differentiation	-	57	18	-	-	2.46E-03	2.59E-03
Hein	MF	GO:0031952	regulation of protein autophosphorylation	-	43	11	-	-	5.11E-04	1.56E-03
Hein	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	67	-	-	8.79E-03	9.34E-03
Hein	BP	GO:0044319	"wound healing, spreading of cells"	-	37	15	-	-	1.16E-02	2.08E-03
Hein	BP	GO:0060251	regulation of glial cell proliferation	-	39	14	-	-	5.09E-04	2.08E-03
Hein	BP	GO:0072665	protein localization to vacuole	-	84	46	-	-	6.61E-03	6.40E-03
Hein	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	27	-	-	1.63E-03	3.81E-03
Hein	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	39	-	-	9.88E-03	5.54E-03
Hein	BP	GO:0008285	negative regulation of cell population proliferation	-	787	192	-	-	8.82E-03	2.66E-02
Hein	BP	GO:0048858	cell projection morphogenesis	-	643	187	-	-	1.06E-02	2.59E-02
Hein	BP	GO:0045661	regulation of myoblast differentiation	-	74	25	-	-	1.03E-03	3.46E-03
Hein	BP	GO:0030307	positive regulation of cell growth	-	164	66	-	-	2.84E-03	9.17E-03
Hein	BP	GO:0034250	positive regulation of amide metabolic process	-	27	11	-	-	5.11E-04	1.56E-03
Hein	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	116	-	-	4.45E-03	1.61E-02
Hein	BP	GO:0014812	muscle cell migration	-	110	19	-	-	6.82E-04	2.77E-03
Hein	BP	GO:0048525	negative regulation of viral process	-	90	36	-	-	3.59E-03	5.02E-03
Hein	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	42	-	-	2.20E-03	5.88E-03
Hein	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	53	-	-	2.52E-03	7.44E-03
Hein	BP	GO:0051781	positive regulation of cell division	-	93	28	-	-	1.61E-03	3.98E-03
Hein	BP	GO:0035493	SNARE complex assembly	-	23	15	-	-	1.86E-01	2.08E-03
Hein	BP	GO:0002696	positive regulation of leukocyte activation	-	358	89	-	-	3.37E-03	1.25E-02
Hein	BP	GO:0060711	labyrinthine layer development	-	47	11	-	-	5.16E-04	1.56E-03
Hein	BP	GO:0007272	ensheathment of neurons	-	146	42	-	-	2.25E-03	5.88E-03
Hein	CC	GO:0050806	positive regulation of synaptic transmission	-	171	30	-	-	3.04E-03	4.15E-03
Hein	BP	GO:0060021	roof of mouth development	-	91	15	-	-	6.84E-04	2.08E-03
Hein	BP	GO:0034504	protein localization to nucleus	-	312	174	-	-	1.15E-02	2.42E-02
Hein	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	17	-	-	6.00E-03	2.42E-03
Hein	BP	GO:0031647	regulation of protein stability	-	327	165	-	-	7.70E-03	2.28E-02
Hein	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	52	-	-	7.64E-02	7.27E-03
Hein	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	16	-	-	6.82E-04	2.25E-03
Hein	BP	GO:0016054	organic acid catabolic process	-	251	60	-	-	3.30E-03	8.30E-03
Hein	BP	GO:0050890	cognition	-	317	70	-	-	6.80E-03	9.69E-03
Hein	BP	GO:0065005	protein-lipid complex assembly	-	29	11	-	-	5.14E-04	1.56E-03
Hein	BP	GO:0008033	tRNA processing	-	136	56	-	-	4.11E-03	7.78E-03
Hein	BP	GO:0046661	male sex differentiation	-	171	45	-	-	4.56E-03	6.23E-03
Hein	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	35	-	-	4.06E-03	4.84E-03
Hein	BP	GO:1990778	protein localization to cell periphery	-	346	134	-	-	1.13E-02	1.87E-02
Hein	BP	GO:0001568	blood vessel development	-	790	177	-	-	1.18E-02	2.46E-02
Hein	BP	GO:0061326	renal tubule development	-	103	15	-	-	7.74E-03	2.08E-03
Hein	BP	GO:0051258	protein polymerization	-	280	141	-	-	1.11E-02	1.95E-02
Hein	BP	GO:0071985	multivesicular body sorting pathway	-	56	34	-	-	4.08E-03	4.84E-03
Hein	BP	GO:0090559	regulation of membrane permeability	-	72	24	-	-	2.86E-02	3.46E-03
Hein	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	21	-	-	8.49E-04	2.94E-03
Hein	BP	GO:0002250	adaptive immune response	-	753	77	-	-	5.37E-03	1.07E-02
Hein	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	80	-	-	5.67E-03	1.11E-02
Hein	CC	GO:0048167	regulation of synaptic plasticity	-	210	48	-	-	6.34E-03	6.75E-03
Hein	BP	GO:1903708	positive regulation of hemopoiesis	-	184	49	-	-	2.97E-03	6.92E-03
Hein	BP	GO:1903008	organelle disassembly	-	154	72	-	-	5.39E-03	1.00E-02
Hein	CC	GO:0032387	negative regulation of intracellular transport	-	51	22	-	-	7.99E-03	3.11E-03
Hein	BP	GO:0072091	regulation of stem cell proliferation	-	91	25	-	-	9.46E-03	3.46E-03
Hein	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	13	-	-	5.15E-04	1.90E-03
Hein	BP	GO:0032535	regulation of cellular component size	-	360	130	-	-	1.00E-02	1.80E-02
Hein	BP	GO:0001934	positive regulation of protein phosphorylation	-	701	194	-	-	8.25E-03	2.70E-02
Hein	MF	GO:0098631	cell adhesion mediator activity	-	64	24	-	-	3.32E-03	3.46E-03
Hein	BP	GO:0046112	nucleobase biosynthetic process	-	18	11	-	-	5.14E-04	1.56E-03
Hein	BP	GO:0071453	cellular response to oxygen levels	-	168	55	-	-	3.66E-03	7.61E-03
Hein	BP	GO:0070585	protein localization to mitochondrion	-	125	55	-	-	4.00E-03	7.61E-03
Hein	BP	GO:0044242	cellular lipid catabolic process	-	224	60	-	-	5.58E-03	8.30E-03
Hein	BP	GO:0002931	response to ischemia	-	58	17	-	-	6.85E-04	2.42E-03
Hein	BP	GO:0043062	extracellular structure organization	-	317	57	-	-	3.78E-03	7.96E-03
Hein	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	8.12E-02	1.73E-03
Hein	BP	GO:0061005	cell differentiation involved in kidney development	-	58	14	-	-	4.97E-03	2.08E-03
Hein	BP	GO:0055082	intracellular chemical homeostasis	-	706	165	-	-	7.75E-03	2.28E-02
Hein	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	221	-	-	1.27E-02	3.06E-02
Hein	BP	GO:0060420	regulation of heart growth	-	74	18	-	-	6.81E-04	2.59E-03
Hein	BP	GO:0009755	hormone-mediated signaling pathway	-	221	73	-	-	5.06E-03	1.02E-02
Hein	BP	GO:0022612	gland morphogenesis	-	124	29	-	-	1.01E-03	4.15E-03
Hein	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	17	-	-	6.80E-04	2.42E-03
Hein	BP	GO:0044782	cilium organization	-	400	126	-	-	9.17E-03	1.75E-02
Hein	BP	GO:0090130	tissue migration	-	379	107	-	-	5.27E-03	1.49E-02
Hein	BP	GO:1990845	adaptive thermogenesis	-	166	45	-	-	5.61E-03	6.23E-03
Hein	BP	GO:0071320	cellular response to cAMP	-	54	15	-	-	2.64E-03	2.08E-03
Hein	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	12	-	-	4.52E-03	1.73E-03
Hein	BP	GO:0071392	cellular response to estradiol stimulus	-	40	15	-	-	6.71E-04	2.08E-03
Hein	BP	GO:0009314	response to radiation	-	449	179	-	-	1.62E-02	2.49E-02
Hein	BP	GO:0009451	RNA modification	-	169	81	-	-	3.22E-02	1.12E-02
Hein	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	20	-	-	1.67E-02	2.77E-03
Hein	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	78	-	-	8.23E-03	1.09E-02
Hein	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	11	-	-	4.73E-02	1.56E-03
Hein	BP	GO:0015807	L-amino acid transport	-	94	19	-	-	6.81E-04	2.77E-03
Hein	BP	GO:0032941	secretion by tissue	-	85	19	-	-	6.81E-04	2.77E-03
Hein	BP	GO:0046605	regulation of centrosome cycle	-	54	38	-	-	4.38E-03	5.36E-03
Hein	BP	GO:0048753	pigment granule organization	-	40	16	-	-	5.69E-02	2.25E-03
Hein	BP	GO:0003014	renal system process	-	130	18	-	-	6.83E-04	2.59E-03
Hein	BP	GO:0045598	regulation of fat cell differentiation	-	148	29	-	-	9.75E-04	4.15E-03
Hein	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	63	-	-	2.78E-03	8.82E-03
Hein	BP	GO:1904646	cellular response to amyloid-beta	-	44	12	-	-	5.16E-04	1.73E-03
Hein	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	27	-	-	1.27E-02	3.81E-03
Hein	BP	GO:0039694	viral RNA genome replication	-	30	15	-	-	9.36E-03	2.08E-03
Hein	BP	GO:0071709	membrane assembly	-	68	32	-	-	2.64E-02	4.50E-03
Hein	BP	GO:0008217	regulation of blood pressure	-	186	21	-	-	6.80E-03	2.94E-03
Hein	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	16	-	-	1.34E-02	2.25E-03
Hein	CC	GO:0042770	signal transduction in response to DNA damage	-	186	109	-	-	4.90E-03	1.52E-02
Hein	BP	GO:0002200	somatic diversification of immune receptors	-	78	39	-	-	6.81E-03	5.54E-03
Hein	BP	GO:0035315	hair cell differentiation	-	52	16	-	-	8.50E-03	2.25E-03
Hein	BP	GO:0048645	animal organ formation	-	62	12	-	-	5.69E-02	1.73E-03
Hein	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	58	-	-	2.96E-02	8.13E-03
Hein	BP	GO:0033627	cell adhesion mediated by integrin	-	87	23	-	-	8.51E-04	3.29E-03
Hein	BP	GO:0035107	appendage morphogenesis	-	147	31	-	-	1.68E-03	4.32E-03
Hein	BP	GO:1903707	negative regulation of hemopoiesis	-	116	23	-	-	8.45E-04	3.29E-03
Hein	CC	GO:0048208	COPII vesicle coating	-	27	18	-	-	6.74E-04	2.59E-03
Hein	BP	GO:0030149	sphingolipid catabolic process	-	32	11	-	-	5.14E-04	1.56E-03
Hein	BP	GO:0050994	regulation of lipid catabolic process	-	61	11	-	-	5.14E-04	1.56E-03
Hein	BP	GO:0045727	positive regulation of translation	-	141	88	-	-	6.12E-03	1.23E-02
Hein	CC	GO:0032388	positive regulation of intracellular transport	-	137	65	-	-	3.77E-03	8.99E-03
Hein	BP	GO:0002027	regulation of heart rate	-	106	23	-	-	8.42E-04	3.29E-03
Hein	BP	GO:0050879	multicellular organismal movement	-	118	30	-	-	1.19E-03	4.15E-03
Hein	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	17	-	-	6.62E-02	2.42E-03
Hein	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	25	-	-	2.78E-03	3.46E-03
Hein	BP	GO:0048515	spermatid differentiation	-	208	45	-	-	1.67E-03	6.23E-03
Hein	BP	GO:0072132	mesenchyme morphogenesis	-	57	14	-	-	1.00E-01	2.08E-03
Hein	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	11	-	-	1.61E-02	1.56E-03
Hein	BP	GO:0060119	inner ear receptor cell development	-	44	12	-	-	5.13E-04	1.73E-03
Hein	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	15	-	-	6.83E-04	2.08E-03
Hein	BP	GO:1901983	regulation of protein acetylation	-	26	15	-	-	6.79E-04	2.08E-03
Hein	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	61	-	-	2.63E-03	8.48E-03
Hein	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	40	-	-	4.93E-02	5.54E-03
Hein	BP	GO:0010883	regulation of lipid storage	-	53	12	-	-	2.05E-02	1.73E-03
Hein	BP	GO:1905954	positive regulation of lipid localization	-	110	22	-	-	1.73E-02	3.11E-03
Hein	BP	GO:0072523	purine-containing compound catabolic process	-	146	49	-	-	2.14E-02	6.92E-03
Hein	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	15	-	-	1.01E-01	2.08E-03
Hein	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	16	-	-	6.76E-04	2.25E-03
Hein	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	39	-	-	1.78E-03	5.54E-03
Hein	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	14	-	-	5.08E-04	2.08E-03
Hein	BP	GO:0031345	negative regulation of cell projection organization	-	195	54	-	-	2.57E-03	7.61E-03
Hein	BP	GO:0048278	vesicle docking	-	64	25	-	-	3.16E-03	3.46E-03
Hein	BP	GO:0035050	embryonic heart tube development	-	86	23	-	-	8.48E-04	3.29E-03
Hein	BP	GO:0030168	platelet activation	-	135	39	-	-	3.68E-03	5.54E-03
Hein	BP	GO:0008284	positive regulation of cell population proliferation	-	992	248	-	-	1.32E-02	3.44E-02
Hein	BP	GO:0008213	protein alkylation	-	58	19	-	-	6.86E-04	2.77E-03
Hein	BP	GO:0002253	activation of immune response	-	529	142	-	-	6.44E-03	1.97E-02
Hein	BP	GO:0031529	ruffle organization	-	55	22	-	-	8.65E-03	3.11E-03
Hein	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	13	-	-	5.12E-04	1.90E-03
Hein	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	13	-	-	5.13E-04	1.90E-03
Hein	BP	GO:0035304	regulation of protein dephosphorylation	-	87	44	-	-	1.85E-03	6.23E-03
Hein	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	66	-	-	4.36E-03	9.17E-03
Hein	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	117	-	-	6.52E-03	1.63E-02
Hein	BP	GO:0051785	positive regulation of nuclear division	-	61	17	-	-	7.67E-03	2.42E-03
Hein	BP	GO:0044786	cell cycle DNA replication	-	45	32	-	-	1.24E-02	4.50E-03
Hein	BP	GO:0051299	centrosome separation	-	15	12	-	-	5.06E-04	1.73E-03
Hein	BP	GO:0048145	regulation of fibroblast proliferation	-	87	42	-	-	2.32E-03	5.88E-03
Hein	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	11	-	-	5.15E-04	1.56E-03
Hein	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	97	-	-	4.51E-03	1.35E-02
Hein	BP	GO:0009306	protein secretion	-	376	94	-	-	4.28E-03	1.31E-02
Hein	CC	GO:0008333	endosome to lysosome transport	-	73	44	-	-	1.58E-02	6.23E-03
Hein	MF	GO:0043086	negative regulation of catalytic activity	-	717	211	-	-	8.72E-03	2.92E-02
Hein	BP	GO:0045732	positive regulation of protein catabolic process	-	202	100	-	-	1.05E-02	1.38E-02
Hein	BP	GO:0031589	cell-substrate adhesion	-	360	123	-	-	1.70E-02	1.71E-02
Hein	BP	GO:1904018	positive regulation of vasculature development	-	185	34	-	-	1.19E-03	4.84E-03
Hein	BP	GO:0010948	negative regulation of cell cycle process	-	317	175	-	-	1.36E-02	2.42E-02
Hein	BP	GO:0050953	sensory perception of light stimulus	-	223	21	-	-	8.52E-04	2.94E-03
Hein	BP	GO:0009303	rRNA transcription	-	37	27	-	-	1.21E-02	3.81E-03
Hein	BP	GO:0035601	protein deacylation	-	56	29	-	-	2.37E-02	4.15E-03
Hein	BP	GO:0061952	midbody abscission	-	18	15	-	-	1.63E-02	2.08E-03
Hein	BP	GO:0071300	cellular response to retinoic acid	-	66	15	-	-	6.78E-04	2.08E-03
Hein	BP	GO:0045830	positive regulation of isotype switching	-	28	13	-	-	5.13E-04	1.90E-03
Hein	BP	GO:0048284	organelle fusion	-	456	166	-	-	1.63E-02	2.30E-02
Hein	BP	GO:0051588	regulation of neurotransmitter transport	-	99	26	-	-	1.69E-03	3.63E-03
Hein	BP	GO:0051784	negative regulation of nuclear division	-	63	42	-	-	1.56E-02	5.88E-03
Hein	BP	GO:0044703	multi-organism reproductive process	-	209	45	-	-	3.57E-03	6.23E-03
Hein	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	47	-	-	1.77E-03	6.57E-03
Hein	BP	GO:0099022	vesicle tethering	-	32	17	-	-	6.91E-04	2.42E-03
Hein	MF	GO:0004930	G protein-coupled receptor activity	-	873	11	-	-	5.15E-04	1.56E-03
Hein	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	13	-	-	5.13E-04	1.90E-03
Hein	BP	GO:0048857	neural nucleus development	-	65	30	-	-	2.33E-03	4.15E-03
Hein	BP	GO:0048663	neuron fate commitment	-	74	11	-	-	3.84E-02	1.56E-03
Hein	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	31	-	-	2.72E-03	4.32E-03
Hein	BP	GO:0106027	neuron projection organization	-	90	34	-	-	1.24E-02	4.84E-03
Hein	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	29	-	-	1.51E-03	4.15E-03
Hein	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	17	-	-	6.84E-04	2.42E-03
Hein	CC	GO:0043410	positive regulation of MAPK cascade	-	494	109	-	-	6.97E-03	1.52E-02
Hein	BP	GO:0045685	regulation of glial cell differentiation	-	77	13	-	-	2.15E-03	1.90E-03
Hein	BP	GO:0043414	macromolecule methylation	-	138	64	-	-	5.77E-03	8.99E-03
Hein	BP	GO:0048268	clathrin coat assembly	-	16	11	-	-	3.68E-02	1.56E-03
Hein	BP	GO:0050886	endocrine process	-	93	13	-	-	2.26E-03	1.90E-03
Hein	BP	GO:0045807	positive regulation of endocytosis	-	155	41	-	-	2.37E-03	5.71E-03
Hein	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	26	-	-	2.57E-03	3.63E-03
Hein	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	14	-	-	5.13E-04	2.08E-03
Hein	BP	GO:0034394	protein localization to cell surface	-	69	23	-	-	6.59E-03	3.29E-03
Hein	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	18	-	-	1.85E-02	2.59E-03
Hein	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	12	-	-	7.01E-03	1.73E-03
Hein	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	25	-	-	1.02E-03	3.46E-03
Hein	MF	GO:0051100	negative regulation of binding	-	161	71	-	-	3.76E-03	9.86E-03
Hein	BP	GO:0001818	negative regulation of cytokine production	-	379	58	-	-	6.70E-03	8.13E-03
Hein	BP	GO:0003151	outflow tract morphogenesis	-	81	22	-	-	1.27E-02	3.11E-03
Hein	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	27	-	-	1.32E-02	3.81E-03
Hein	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	15	-	-	5.99E-02	2.08E-03
Hein	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	43	-	-	1.97E-03	6.05E-03
Hein	BP	GO:0032368	regulation of lipid transport	-	149	34	-	-	1.07E-02	4.84E-03
Hein	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	92	-	-	8.96E-03	1.28E-02
Hein	BP	GO:0033002	muscle cell proliferation	-	249	49	-	-	8.38E-03	6.92E-03
Hein	BP	GO:0048880	sensory system development	-	399	89	-	-	5.77E-03	1.25E-02
Hein	BP	GO:0043331	response to dsRNA	-	56	20	-	-	1.11E-02	2.77E-03
Hein	BP	GO:1901679	nucleotide transmembrane transport	-	32	13	-	-	5.13E-04	1.90E-03
Hein	BP	GO:0033363	secretory granule organization	-	63	19	-	-	1.71E-02	2.77E-03
Hein	BP	GO:0120009	intermembrane lipid transfer	-	52	22	-	-	8.59E-04	3.11E-03
Hein	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	1.37E-02	2.08E-03
Hein	BP	GO:2000773	negative regulation of cellular senescence	-	25	11	-	-	5.14E-04	1.56E-03
Hein	BP	GO:0072164	mesonephric tubule development	-	98	18	-	-	6.54E-03	2.59E-03
Hein	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	30	-	-	2.32E-03	4.15E-03
Hein	BP	GO:0030901	midbrain development	-	87	36	-	-	1.62E-03	5.02E-03
Hein	BP	GO:0007162	negative regulation of cell adhesion	-	310	65	-	-	2.33E-03	8.99E-03
Hein	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	22	-	-	8.42E-04	3.11E-03
Hein	BP	GO:0002687	positive regulation of leukocyte migration	-	147	23	-	-	3.33E-02	3.29E-03
Hein	BP	GO:0034605	cellular response to heat	-	66	34	-	-	6.45E-03	4.84E-03
Hein	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	86	-	-	2.31E-02	1.19E-02
Hein	BP	GO:0005996	monosaccharide metabolic process	-	250	79	-	-	7.16E-03	1.11E-02
Hein	BP	GO:0033555	multicellular organismal response to stress	-	90	13	-	-	5.13E-04	1.90E-03
Hein	BP	GO:0002262	myeloid cell homeostasis	-	172	64	-	-	1.12E-02	8.99E-03
Hein	BP	GO:0000966	RNA 5'-end processing	-	39	30	-	-	1.18E-03	4.15E-03
Hein	BP	GO:0050688	regulation of defense response to virus	-	65	16	-	-	6.85E-04	2.25E-03
Hein	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	65	-	-	9.98E-03	8.99E-03
Hein	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	73	-	-	4.50E-03	1.02E-02
Hein	BP	GO:0022618	protein-RNA complex assembly	-	227	157	-	-	2.50E-02	2.18E-02
Hein	BP	GO:0051147	regulation of muscle cell differentiation	-	162	41	-	-	1.51E-03	5.71E-03
Hein	BP	GO:0006066	alcohol metabolic process	-	374	72	-	-	2.52E-03	1.00E-02
Hein	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	26	-	-	1.02E-03	3.63E-03
Hein	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	38	-	-	1.01E-02	5.36E-03
Hein	BP	GO:0043555	regulation of translation in response to stress	-	22	14	-	-	1.94E-03	2.08E-03
Hein	BP	GO:0032922	circadian regulation of gene expression	-	71	40	-	-	6.31E-03	5.54E-03
Hein	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	13	-	-	5.11E-04	1.90E-03
Hein	BP	GO:0140253	cell-cell fusion	-	62	14	-	-	2.48E-03	2.08E-03
Hein	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	18	-	-	6.86E-04	2.59E-03
Hein	BP	GO:0051293	establishment of spindle localization	-	57	38	-	-	4.01E-03	5.36E-03
Hein	BP	GO:0023061	signal release	-	491	109	-	-	3.98E-03	1.52E-02
Hein	BP	GO:0018126	protein hydroxylation	-	26	11	-	-	5.16E-04	1.56E-03
Hein	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	16	-	-	6.87E-04	2.25E-03
Hein	BP	GO:0008360	regulation of cell shape	-	139	60	-	-	8.37E-03	8.30E-03
Hein	BP	GO:0051222	positive regulation of protein transport	-	249	88	-	-	5.90E-03	1.23E-02
Hein	CC	GO:0140632	canonical inflammasome complex assembly	-	40	12	-	-	5.09E-04	1.73E-03
Hein	MF	GO:0034260	negative regulation of GTPase activity	-	36	14	-	-	5.16E-04	2.08E-03
Hein	BP	GO:0045739	positive regulation of DNA repair	-	128	90	-	-	4.27E-02	1.25E-02
Hein	BP	GO:0045185	maintenance of protein location	-	95	49	-	-	1.76E-03	6.92E-03
Hein	BP	GO:0003158	endothelium development	-	140	44	-	-	4.64E-03	6.23E-03
Hein	CC	GO:0072595	maintenance of protein localization in organelle	-	42	23	-	-	8.21E-04	3.29E-03
Hein	BP	GO:0051224	negative regulation of protein transport	-	122	25	-	-	1.03E-03	3.46E-03
Hein	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	42	-	-	3.01E-03	5.88E-03
Hein	MF	GO:0003713	transcription coactivator activity	-	281	158	-	-	1.28E-02	2.20E-02
Hein	BP	GO:0021885	forebrain cell migration	-	63	24	-	-	8.52E-04	3.46E-03
Hein	BP	GO:0007405	neuroblast proliferation	-	81	23	-	-	1.67E-03	3.29E-03
Hein	BP	GO:0009581	detection of external stimulus	-	137	18	-	-	2.37E-03	2.59E-03
Hein	BP	GO:1990542	mitochondrial transmembrane transport	-	93	30	-	-	1.19E-03	4.15E-03
Hein	BP	GO:0045862	positive regulation of proteolysis	-	353	136	-	-	6.80E-03	1.89E-02
Hein	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	16	-	-	2.40E-03	2.25E-03
Hein	BP	GO:0031100	animal organ regeneration	-	66	20	-	-	1.70E-03	2.77E-03
Hein	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	47	-	-	1.15E-02	6.57E-03
Hein	BP	GO:0097722	sperm motility	-	133	16	-	-	6.80E-04	2.25E-03
Hein	BP	GO:0030001	metal ion transport	-	933	149	-	-	6.47E-03	2.08E-02
Hein	BP	GO:0042490	mechanoreceptor differentiation	-	67	16	-	-	7.62E-02	2.25E-03
Hein	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	17	-	-	6.80E-04	2.42E-03
Hein	BP	GO:0035148	tube formation	-	155	55	-	-	2.68E-03	7.61E-03
Hein	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	38	-	-	1.03E-02	5.36E-03
Hein	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	39	-	-	2.90E-03	5.54E-03
Hein	BP	GO:0031123	RNA 3'-end processing	-	79	59	-	-	2.85E-02	8.30E-03
Hein	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	23	-	-	1.65E-02	3.29E-03
Hein	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	15	-	-	1.59E-02	2.08E-03
Hein	CC	GO:0007097	nuclear migration	-	24	17	-	-	6.45E-03	2.42E-03
Hein	BP	GO:0045229	external encapsulating structure organization	-	319	58	-	-	3.32E-03	8.13E-03
Hein	BP	GO:0006885	regulation of pH	-	104	32	-	-	7.94E-03	4.50E-03
Hein	BP	GO:0001667	ameboidal-type cell migration	-	495	147	-	-	7.45E-03	2.04E-02
Hein	BP	GO:0031018	endocrine pancreas development	-	47	12	-	-	5.16E-04	1.73E-03
Hein	BP	GO:0001708	cell fate specification	-	108	29	-	-	3.43E-02	4.15E-03
Hein	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	21	-	-	8.54E-04	2.94E-03
Hein	BP	GO:0032970	regulation of actin filament-based process	-	368	146	-	-	1.75E-02	2.02E-02
Hein	BP	GO:0042440	pigment metabolic process	-	80	12	-	-	5.16E-04	1.73E-03
Hein	BP	GO:1901606	alpha-amino acid catabolic process	-	101	12	-	-	5.15E-04	1.73E-03
Hein	BP	GO:0062197	cellular response to chemical stress	-	299	118	-	-	4.95E-03	1.64E-02
Hein	BP	GO:1901890	positive regulation of cell junction assembly	-	106	21	-	-	8.51E-04	2.94E-03
Hein	BP	GO:0070988	demethylation	-	27	11	-	-	5.15E-04	1.56E-03
Hein	BP	GO:1901655	cellular response to ketone	-	107	35	-	-	1.36E-03	4.84E-03
Hein	MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	-	925	177	-	-	1.37E-02	2.46E-02
Hein	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	12	-	-	5.14E-04	1.73E-03
Hein	BP	GO:0055006	cardiac cell development	-	93	22	-	-	8.19E-04	3.11E-03
Hein	BP	GO:0031365	N-terminal protein amino acid modification	-	30	12	-	-	5.16E-04	1.73E-03
Hein	BP	GO:0060004	reflex	-	63	14	-	-	5.11E-04	2.08E-03
Hein	BP	GO:0044706	multi-multicellular organism process	-	217	47	-	-	7.75E-03	6.57E-03
Hein	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	66	-	-	5.22E-03	9.17E-03
Hein	BP	GO:0050768	negative regulation of neurogenesis	-	150	37	-	-	1.65E-03	5.19E-03
Hein	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	51	-	-	6.01E-03	7.09E-03
Hein	BP	GO:0090068	positive regulation of cell cycle process	-	262	142	-	-	9.83E-03	1.97E-02
Hein	MF	GO:0022803	passive transmembrane transporter activity	-	676	89	-	-	8.32E-03	1.25E-02
Hein	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	13	-	-	5.12E-04	1.90E-03
Hein	BP	GO:1902115	regulation of organelle assembly	-	210	110	-	-	6.10E-03	1.52E-02
Hein	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	14	-	-	5.13E-04	2.08E-03
Hein	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	68	-	-	5.02E-03	9.51E-03
Hein	BP	GO:0046622	positive regulation of organ growth	-	52	11	-	-	5.73E-02	1.56E-03
Hein	CC	GO:0032365	intracellular lipid transport	-	51	22	-	-	8.57E-04	3.11E-03
Hein	BP	GO:0045048	protein insertion into ER membrane	-	30	18	-	-	7.87E-02	2.59E-03
Hein	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	19	-	-	6.77E-04	2.77E-03
Hein	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	47	-	-	7.46E-03	6.57E-03
Hein	BP	GO:0097581	lamellipodium organization	-	91	45	-	-	1.42E-02	6.23E-03
Hein	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	12	-	-	5.18E-04	1.73E-03
Hein	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	82	-	-	5.32E-03	1.14E-02
Hein	BP	GO:0060326	cell chemotaxis	-	311	59	-	-	5.32E-03	8.30E-03
Hein	BP	GO:0016485	protein processing	-	248	63	-	-	2.92E-03	8.82E-03
Hein	BP	GO:0009649	entrainment of circadian clock	-	30	15	-	-	9.01E-03	2.08E-03
Hein	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	24	-	-	8.47E-04	3.46E-03
Hein	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	22	-	-	8.56E-04	3.11E-03
Hein	BP	GO:0031348	negative regulation of defense response	-	282	73	-	-	3.21E-03	1.02E-02
Hein	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	16	-	-	3.34E-03	2.25E-03
Hein	BP	GO:0061180	mammary gland epithelium development	-	68	21	-	-	8.49E-04	2.94E-03
Hein	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	64	-	-	1.33E-02	8.99E-03
Hein	CC	GO:0051169	nuclear transport	-	325	206	-	-	4.25E-02	2.85E-02
Hein	BP	GO:0071496	cellular response to external stimulus	-	74	21	-	-	8.48E-04	2.94E-03
Hein	BP	GO:0046434	organophosphate catabolic process	-	232	71	-	-	1.14E-02	9.86E-03
Hein	BP	GO:0009566	fertilization	-	205	43	-	-	4.10E-03	6.05E-03
Hein	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	29	-	-	1.03E-03	4.15E-03
Hein	BP	GO:0033044	regulation of chromosome organization	-	249	198	-	-	2.02E-02	2.75E-02
Hein	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	120	-	-	4.31E-03	1.66E-02
Hein	BP	GO:0061900	glial cell activation	-	56	11	-	-	5.11E-04	1.56E-03
Hein	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	33	-	-	1.18E-03	4.67E-03
Hein	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	201	-	-	1.19E-02	2.78E-02
Hein	CC	GO:0140467	integrated stress response signaling	-	41	15	-	-	1.10E-02	2.08E-03
Hein	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	155	-	-	8.89E-03	2.14E-02
Hein	BP	GO:0016180	snRNA processing	-	28	25	-	-	5.89E-02	3.46E-03
Hein	BP	GO:0051303	establishment of chromosome localization	-	104	78	-	-	7.52E-03	1.09E-02
Hein	BP	GO:0051382	kinetochore assembly	-	16	15	-	-	6.85E-04	2.08E-03
Hein	BP	GO:0031349	positive regulation of defense response	-	473	131	-	-	7.11E-03	1.82E-02
Hein	BP	GO:0007164	establishment of tissue polarity	-	38	11	-	-	5.14E-04	1.56E-03
Hein	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	11	-	-	1.58E-02	1.56E-03
Hein	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	15	-	-	6.86E-04	2.08E-03
Hein	BP	GO:0006605	protein targeting	-	327	143	-	-	1.32E-02	1.99E-02
Hein	BP	GO:0007566	embryo implantation	-	57	12	-	-	5.15E-04	1.73E-03
Hein	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	13	-	-	5.16E-04	1.90E-03
Hein	BP	GO:0061512	protein localization to cilium	-	394	120	-	-	8.77E-03	1.66E-02
Hein	BP	GO:0051017	actin filament bundle assembly	-	161	67	-	-	9.99E-03	9.34E-03
Hein	BP	GO:1905953	negative regulation of lipid localization	-	63	14	-	-	3.70E-02	2.08E-03
Hein	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	20	-	-	2.53E-02	2.77E-03
Hein	BP	GO:1901343	negative regulation of vasculature development	-	154	22	-	-	8.52E-04	3.11E-03
Hein	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	74	-	-	2.88E-02	1.04E-02
Hein	BP	GO:1902414	protein localization to cell junction	-	107	38	-	-	3.27E-03	5.36E-03
Hein	BP	GO:0051304	chromosome separation	-	80	63	-	-	1.72E-02	8.82E-03
Hein	BP	GO:0090596	sensory organ morphogenesis	-	272	50	-	-	3.20E-03	6.92E-03
Hein	BP	GO:0048709	oligodendrocyte differentiation	-	101	23	-	-	1.04E-03	3.29E-03
Hein	BP	GO:0045017	glycerolipid biosynthetic process	-	254	74	-	-	4.99E-02	1.04E-02
Hein	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	2.78E-01	2.08E-03
Hein	BP	GO:0001776	leukocyte homeostasis	-	108	33	-	-	2.05E-03	4.67E-03
Hein	BP	GO:0050769	positive regulation of neurogenesis	-	240	72	-	-	6.20E-03	1.00E-02
Hein	BP	GO:0030193	regulation of blood coagulation	-	70	12	-	-	5.11E-04	1.73E-03
Hein	BP	GO:0050866	negative regulation of cell activation	-	216	38	-	-	1.34E-03	5.36E-03
Hein	BP	GO:0033500	carbohydrate homeostasis	-	251	63	-	-	1.08E-02	8.82E-03
Hein	BP	GO:0120035	regulation of plasma membrane bounded cell projection organization	-	647	218	-	-	1.15E-02	3.03E-02
Hein	BP	GO:0044088	regulation of vacuole organization	-	56	23	-	-	8.43E-04	3.29E-03
Hein	CC	GO:0051457	maintenance of protein location in nucleus	-	23	16	-	-	6.63E-04	2.25E-03
Hein	CC	GO:0099522	cytosolic region	-	20	12	-	-	1.25E-02	1.73E-03
Hein	CC	GO:0000791	euchromatin	-	60	36	-	-	6.33E-03	5.02E-03
Hein	CC	GO:0030666	endocytic vesicle membrane	-	196	58	-	-	1.14E-02	8.13E-03
Hein	CC	GO:0098857	membrane microdomain	-	324	97	-	-	3.67E-03	1.35E-02
Hein	CC	GO:0030312	external encapsulating structure	-	567	68	-	-	5.54E-03	9.51E-03
Hein	CC	GO:0071027	nuclear RNA surveillance	-	14	12	-	-	8.58E-02	1.73E-03
Hein	CC	GO:1990752	microtubule end	-	34	22	-	-	1.91E-02	3.11E-03
Hein	CC	GO:0043204	perikaryon	-	156	32	-	-	1.62E-03	4.50E-03
Hein	CC	GO:0097542	ciliary tip	-	48	17	-	-	5.41E-02	2.42E-03
Hein	CC	GO:1905368	peptidase complex	-	124	83	-	-	1.27E-01	1.16E-02
Hein	CC	GO:0000792	heterochromatin	-	98	72	-	-	8.21E-03	1.00E-02
Hein	CC	GO:0097546	ciliary base	-	47	14	-	-	3.27E-02	2.08E-03
Hein	CC	GO:0071819	DUBm complex	-	25	18	-	-	4.92E-01	2.59E-03
Hein	CC	GO:0031201	SNARE complex	-	48	23	-	-	8.57E-04	3.29E-03
Hein	CC	GO:0016324	apical plasma membrane	-	392	89	-	-	8.96E-03	1.25E-02
Hein	CC	GO:0033260	nuclear DNA replication	-	40	30	-	-	2.00E-02	4.15E-03
Hein	CC	GO:0044391	ribosomal subunit	-	203	177	-	-	1.24E-01	2.46E-02
Hein	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	5.16E-04	1.56E-03
Hein	CC	GO:0071013	catalytic step 2 spliceosome	-	88	81	-	-	7.64E-03	1.12E-02
Hein	CC	GO:0031907	microbody lumen	-	51	13	-	-	5.14E-04	1.90E-03
Hein	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	5.19E-04	1.56E-03
Hein	CC	GO:0098862	cluster of actin-based cell projections	-	162	41	-	-	1.16E-02	5.71E-03
Hein	CC	GO:0098978	glutamatergic synapse	-	411	134	-	-	7.36E-03	1.87E-02
Hein	CC	GO:0016363	nuclear matrix	-	127	89	-	-	6.11E-03	1.25E-02
Hein	CC	GO:0031261	DNA replication preinitiation complex	-	46	34	-	-	8.17E-02	4.84E-03
Hein	CC	GO:0097060	synaptic membrane	-	413	79	-	-	8.29E-03	1.11E-02
Hein	CC	GO:0032432	actin filament bundle	-	249	85	-	-	1.48E-02	1.18E-02
Hein	CC	GO:0008088	axo-dendritic transport	-	78	39	-	-	3.85E-03	5.54E-03
Hein	CC	GO:0031519	PcG protein complex	-	38	31	-	-	1.26E-01	4.32E-03
Hein	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	12	-	-	5.12E-04	1.73E-03
Hein	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	86	-	-	7.96E-03	1.19E-02
Hein	CC	GO:0000313	organellar ribosome	-	89	79	-	-	3.56E-01	1.11E-02
Hein	CC	GO:0098791	Golgi apparatus subcompartment	-	378	133	-	-	9.40E-03	1.85E-02
Hein	CC	GO:0099643	signal release from synapse	-	147	39	-	-	1.76E-03	5.54E-03
Hein	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	22	-	-	8.48E-03	3.11E-03
Hein	CC	GO:0030018	Z disc	-	129	47	-	-	8.30E-03	6.57E-03
Hein	CC	GO:0032580	Golgi cisterna membrane	-	93	23	-	-	1.35E-03	3.29E-03
Hein	CC	GO:1905360	GTPase complex	-	41	12	-	-	5.16E-04	1.73E-03
Hein	CC	GO:0097540	axonemal central pair	-	161	23	-	-	8.44E-04	3.29E-03
Hein	CC	GO:0042641	actomyosin	-	77	44	-	-	1.49E-02	6.23E-03
Hein	CC	GO:0032588	trans-Golgi network membrane	-	102	46	-	-	1.14E-02	6.40E-03
Hein	CC	GO:0070382	exocytic vesicle	-	224	63	-	-	4.22E-03	8.82E-03
Hein	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	24	-	-	8.04E-03	3.46E-03
Hein	CC	GO:0031903	microbody membrane	-	65	26	-	-	1.02E-03	3.63E-03
Hein	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	147	-	-	1.11E-02	2.04E-02
Hein	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	12	-	-	5.14E-04	1.73E-03
Hein	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	3.93E-01	1.56E-03
Hein	CC	GO:0070993	translation preinitiation complex	-	19	16	-	-	6.90E-04	2.25E-03
Hein	CC	GO:0016323	basolateral plasma membrane	-	239	58	-	-	4.63E-03	8.13E-03
Hein	CC	GO:0042645	mitochondrial nucleoid	-	45	37	-	-	1.51E-02	5.19E-03
Hein	CC	GO:1902495	transmembrane transporter complex	-	408	75	-	-	1.12E-02	1.04E-02
Hein	CC	GO:0098636	protein complex involved in cell adhesion	-	57	15	-	-	6.86E-04	2.08E-03
Hein	CC	GO:0001917	photoreceptor inner segment	-	71	15	-	-	6.81E-04	2.08E-03
Hein	CC	GO:0019897	extrinsic component of plasma membrane	-	156	56	-	-	4.92E-03	7.78E-03
Hein	CC	GO:0031594	neuromuscular junction	-	73	28	-	-	2.94E-03	3.98E-03
Hein	CC	GO:0000793	condensed chromosome	-	274	203	-	-	3.51E-02	2.82E-02
Hein	CC	GO:0000922	spindle pole	-	172	123	-	-	7.23E-03	1.71E-02
Hein	CC	GO:0120111	neuron projection cytoplasm	-	94	43	-	-	3.46E-03	6.05E-03
Hein	CC	GO:0070971	endoplasmic reticulum exit site	-	32	16	-	-	3.24E-02	2.25E-03
Hein	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	2.99E-01	1.90E-03
Hein	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	58	-	-	3.84E-03	8.13E-03
Hein	CC	GO:0000123	histone acetyltransferase complex	-	93	73	-	-	1.41E-01	1.02E-02
Hein	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	54	-	-	1.53E-02	7.61E-03
Hein	CC	GO:0048786	presynaptic active zone	-	80	24	-	-	5.06E-02	3.46E-03
Hein	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	2.42E-01	1.73E-03
Hein	CC	GO:0007034	vacuolar transport	-	168	93	-	-	2.11E-02	1.30E-02
Hein	CC	GO:0005776	autophagosome	-	111	48	-	-	2.46E-02	6.75E-03
Hein	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	61	-	-	1.19E-01	8.48E-03
Hein	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	49	-	-	1.75E-02	6.92E-03
Hein	CC	GO:0000164	protein phosphatase type 1 complex	-	19	12	-	-	2.75E-02	1.73E-03
Hein	CC	GO:0150034	distal axon	-	309	93	-	-	5.24E-03	1.30E-02
Hein	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	131	-	-	1.15E-02	1.82E-02
Hein	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	2.01E-02	1.73E-03
Hein	CC	GO:0072562	blood microparticle	-	144	43	-	-	1.51E-03	6.05E-03
Hein	CC	GO:0051233	spindle midzone	-	36	25	-	-	1.20E-03	3.46E-03
Hein	CC	GO:0005811	lipid droplet	-	102	34	-	-	3.11E-03	4.84E-03
Hein	CC	GO:0045022	early endosome to late endosome transport	-	44	32	-	-	4.86E-02	4.50E-03
Hein	CC	GO:0044853	plasma membrane raft	-	114	28	-	-	1.37E-03	3.98E-03
Hein	CC	GO:0005881	cytoplasmic microtubule	-	256	59	-	-	5.26E-03	8.30E-03
Hein	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	31	-	-	3.09E-02	4.32E-03
Hein	CC	GO:0005905	clathrin-coated pit	-	73	45	-	-	2.77E-02	6.23E-03
Hein	CC	GO:0043034	costamere	-	18	12	-	-	5.10E-04	1.73E-03
Hein	CC	GO:0031904	endosome lumen	-	38	11	-	-	1.46E-01	1.56E-03
Hein	CC	GO:0060170	ciliary membrane	-	76	11	-	-	5.12E-04	1.56E-03
Hein	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	19	-	-	9.17E-02	2.77E-03
Hein	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	14	-	-	5.17E-04	2.08E-03
Hein	CC	GO:0000139	Golgi membrane	-	646	185	-	-	1.09E-02	2.56E-02
Hein	CC	GO:0032154	cleavage furrow	-	54	32	-	-	2.55E-03	4.50E-03
Hein	CC	GO:0007006	mitochondrial membrane organization	-	117	53	-	-	1.27E-02	7.44E-03
Hein	CC	GO:0001772	immunological synapse	-	44	13	-	-	5.01E-04	1.90E-03
Hein	CC	GO:0009897	external side of plasma membrane	-	425	38	-	-	3.03E-03	5.36E-03
Hein	CC	GO:0030863	cortical cytoskeleton	-	104	55	-	-	1.46E-02	7.61E-03
Hein	CC	GO:1905348	endonuclease complex	-	38	26	-	-	4.78E-02	3.63E-03
Hein	CC	GO:0030315	T-tubule	-	52	14	-	-	5.14E-04	2.08E-03
Hein	CC	GO:0060076	excitatory synapse	-	64	18	-	-	2.20E-03	2.59E-03
Hein	CC	GO:0036019	endolysosome	-	29	12	-	-	5.78E-03	1.73E-03
Hein	CC	GO:0030427	site of polarized growth	-	172	68	-	-	5.15E-03	9.51E-03
Hein	CC	GO:0044309	neuron spine	-	213	59	-	-	4.48E-03	8.30E-03
Hein	CC	GO:0030658	transport vesicle membrane	-	231	71	-	-	2.07E-02	9.86E-03
Hein	CC	GO:0000940	outer kinetochore	-	17	16	-	-	1.11E-01	2.25E-03
Hein	CC	GO:0034719	SMN-Sm protein complex	-	18	16	-	-	2.21E-01	2.25E-03
Hein	CC	GO:0044232	organelle membrane contact site	-	50	25	-	-	4.83E-03	3.46E-03
Hein	CC	GO:0098803	respiratory chain complex	-	39	15	-	-	6.87E-04	2.08E-03
Hein	CC	GO:0030667	secretory granule membrane	-	319	90	-	-	1.03E-02	1.25E-02
Hein	CC	GO:0097545	axonemal outer doublet	-	164	23	-	-	8.43E-04	3.29E-03
Hein	CC	GO:0070069	cytochrome complex	-	42	15	-	-	6.87E-04	2.08E-03
Hein	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	14	-	-	2.20E-01	2.08E-03
Hein	CC	GO:0055037	recycling endosome	-	200	72	-	-	2.00E-02	1.00E-02
Hein	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	30	-	-	1.18E-03	4.15E-03
Hein	CC	GO:0030126	COPI vesicle coat	-	13	11	-	-	5.17E-04	1.56E-03
Hein	CC	GO:0071682	endocytic vesicle lumen	-	23	12	-	-	5.15E-04	1.73E-03
Hein	CC	GO:0030684	preribosome	-	76	63	-	-	1.39E-02	8.82E-03
Hein	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	122	-	-	6.87E-03	1.70E-02
Hein	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	17	-	-	5.00E-01	2.42E-03
Hein	CC	GO:1990391	DNA repair complex	-	22	18	-	-	4.45E-02	2.59E-03
Hein	CC	GO:0005775	vacuolar lumen	-	176	58	-	-	2.39E-03	8.13E-03
Hein	CC	GO:0032982	myosin filament	-	24	14	-	-	2.62E-02	2.08E-03
Hein	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	14	-	-	1.01E-01	2.08E-03
Hein	CC	GO:0044306	neuron projection terminus	-	164	35	-	-	2.55E-03	4.84E-03
Hein	CC	GO:0034455	t-UTP complex	-	53	42	-	-	1.04E-02	5.88E-03
Hein	CC	GO:0005770	late endosome	-	299	112	-	-	1.21E-02	1.56E-02
Hein	CC	GO:0031970	organelle envelope lumen	-	94	42	-	-	1.52E-03	5.88E-03
Hein	CC	GO:0097550	transcription preinitiation complex	-	13	11	-	-	5.17E-04	1.56E-03
Hein	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	11	-	-	5.12E-04	1.56E-03
Hein	CC	GO:0043292	contractile muscle fiber	-	245	92	-	-	1.43E-02	1.28E-02
Hein	CC	GO:0034709	methylosome	-	13	11	-	-	5.17E-04	1.56E-03
Hein	CC	GO:0005849	mRNA cleavage factor complex	-	22	17	-	-	2.20E-01	2.42E-03
Hein	CC	GO:0000803	sex chromosome	-	32	21	-	-	3.92E-03	2.94E-03
Hein	CC	GO:0098982	GABA-ergic synapse	-	84	12	-	-	3.66E-02	1.73E-03
Hein	CC	GO:0035097	histone methyltransferase complex	-	63	53	-	-	8.96E-02	7.44E-03
Hein	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	14	-	-	1.25E-01	2.08E-03
Hein	CC	GO:0000242	pericentriolar material	-	22	16	-	-	2.90E-03	2.25E-03
Hein	CC	GO:1903293	phosphatase complex	-	54	35	-	-	3.61E-02	4.84E-03
Hein	CC	GO:0031941	filamentous actin	-	27	13	-	-	5.98E-03	1.90E-03
Hein	CC	GO:0000786	nucleosome	-	149	65	-	-	4.65E-02	8.99E-03
Hein	CC	GO:0001533	cornified envelope	-	59	22	-	-	8.52E-04	3.11E-03
Hein	CC	GO:1904724	tertiary granule lumen	-	55	12	-	-	1.00E-01	1.73E-03
Hein	CC	GO:0030027	lamellipodium	-	202	105	-	-	2.09E-02	1.45E-02
Hein	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	15	-	-	3.45E-03	2.08E-03
Hein	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	3.08E-01	2.25E-03
Hein	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	17	-	-	6.84E-04	2.42E-03
Hein	CC	GO:0002102	podosome	-	31	15	-	-	6.79E-04	2.08E-03
Hein	CC	GO:0090543	Flemming body	-	33	18	-	-	4.88E-02	2.59E-03
Hein	CC	GO:0016328	lateral plasma membrane	-	66	30	-	-	6.11E-03	4.15E-03
Hein	CC	GO:0001650	fibrillar center	-	151	93	-	-	7.11E-03	1.30E-02
Hein	CC	GO:0031332	RNAi effector complex	-	413	12	-	-	2.50E-01	1.73E-03
Hein	CC	GO:1990204	oxidoreductase complex	-	90	32	-	-	1.20E-03	4.50E-03
Hein	CC	GO:0000930	gamma-tubulin complex	-	16	11	-	-	1.19E-01	1.56E-03
Hein	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	5.18E-04	1.56E-03
Hein	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	71	-	-	8.33E-03	9.86E-03
Hein	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	16	-	-	7.66E-02	2.25E-03
Hein	CC	GO:0001726	ruffle	-	181	85	-	-	6.59E-03	1.18E-02
Hein	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	13	-	-	9.41E-02	1.90E-03
Hein	CC	GO:0043198	dendritic shaft	-	38	11	-	-	5.14E-04	1.56E-03
Hein	CC	GO:0043073	germ cell nucleus	-	67	34	-	-	3.09E-03	4.84E-03
Hein	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	11	-	-	1.34E-01	1.56E-03
Hein	CC	GO:0005788	endoplasmic reticulum lumen	-	313	79	-	-	4.81E-03	1.11E-02
Hein	CC	GO:0016592	mediator complex	-	38	34	-	-	3.07E-01	4.84E-03
Hein	CC	GO:0022626	cytosolic ribosome	-	118	99	-	-	2.88E-02	1.38E-02
Hein	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	36	-	-	1.16E-01	5.02E-03
Hein	CC	GO:0034451	centriolar satellite	-	120	64	-	-	6.06E-03	8.99E-03
Hein	CC	GO:0045171	intercellular bridge	-	91	42	-	-	2.33E-03	5.88E-03
Hein	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	37	-	-	1.36E-03	5.19E-03
Hein	CC	GO:0098984	neuron to neuron synapse	-	384	120	-	-	7.84E-03	1.66E-02
Hein	CC	GO:0032039	integrator complex	-	19	15	-	-	1.55E-01	2.08E-03
Hein	CC	GO:0030527	structural constituent of chromatin	-	97	23	-	-	8.58E-04	3.29E-03
Hein	CC	GO:0030286	dynein complex	-	210	40	-	-	1.22E-02	5.54E-03
Hein	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.29E-02	1.73E-03
Hein	CC	GO:0016482	cytosolic transport	-	135	69	-	-	1.96E-02	9.69E-03
Hein	CC	GO:0005796	Golgi lumen	-	106	13	-	-	5.12E-04	1.90E-03
Hein	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	24	-	-	8.79E-02	3.46E-03
Hein	CC	GO:0008023	transcription elongation factor complex	-	47	38	-	-	1.22E-01	5.36E-03
Hein	CC	GO:0030662	coated vesicle membrane	-	202	89	-	-	2.82E-02	1.25E-02
Hein	CC	GO:0007039	protein catabolic process in the vacuole	-	61	37	-	-	1.01E-02	5.19E-03
Hein	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	44	-	-	1.54E-03	6.23E-03
Hein	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	137	-	-	1.34E-01	1.90E-02
Hein	CC	GO:0005769	early endosome	-	425	173	-	-	2.91E-02	2.40E-02
Hein	CC	GO:0090734	site of DNA damage	-	118	84	-	-	3.00E-02	1.18E-02
Hein	MF	GO:0051087	protein-folding chaperone binding	-	135	61	-	-	3.82E-03	8.48E-03
Hein	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	12	-	-	5.15E-04	1.73E-03
Hein	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	104	-	-	1.32E-02	1.45E-02
Hein	MF	GO:0016757	glycosyltransferase activity	-	286	60	-	-	4.38E-03	8.30E-03
Hein	MF	GO:0048306	calcium-dependent protein binding	-	61	19	-	-	1.13E-01	2.77E-03
Hein	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	37	-	-	6.78E-03	5.19E-03
Hein	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	11	-	-	5.16E-04	1.56E-03
Hein	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	37	-	-	2.91E-03	5.19E-03
Hein	MF	GO:0051020	GTPase binding	-	311	160	-	-	1.35E-02	2.21E-02
Hein	MF	GO:0140457	protein demethylase activity	-	31	18	-	-	6.83E-04	2.59E-03
Hein	MF	GO:0061980	regulatory RNA binding	-	52	24	-	-	7.38E-02	3.46E-03
Hein	MF	GO:0015035	protein-disulfide reductase activity	-	32	13	-	-	5.16E-04	1.90E-03
Hein	MF	GO:0001671	ATPase activator activity	-	29	16	-	-	6.14E-03	2.25E-03
Hein	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	227	-	-	1.38E-02	3.15E-02
Hein	MF	GO:0070840	dynein complex binding	-	25	13	-	-	1.37E-03	1.90E-03
Hein	MF	GO:0035035	histone acetyltransferase binding	-	24	13	-	-	5.13E-04	1.90E-03
Hein	MF	GO:0061684	chaperone-mediated autophagy	-	16	11	-	-	3.46E-03	1.56E-03
Hein	MF	GO:0003688	DNA replication origin binding	-	18	16	-	-	4.42E-02	2.25E-03
Hein	MF	GO:0005178	integrin binding	-	153	35	-	-	1.90E-03	4.84E-03
Hein	MF	GO:0070064	proline-rich region binding	-	17	11	-	-	5.15E-04	1.56E-03
Hein	MF	GO:0008327	methyl-CpG binding	-	31	16	-	-	6.84E-04	2.25E-03
Hein	MF	GO:0008233	peptidase activity	-	998	217	-	-	8.89E-03	3.01E-02
Hein	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	11	-	-	2.11E-03	1.56E-03
Hein	MF	GO:0140318	protein transporter activity	-	40	16	-	-	3.08E-03	2.25E-03
Hein	MF	GO:0070628	proteasome binding	-	17	12	-	-	8.54E-03	1.73E-03
Hein	MF	GO:0000217	DNA secondary structure binding	-	37	26	-	-	4.77E-03	3.63E-03
Hein	MF	GO:0002039	p53 binding	-	66	36	-	-	3.27E-03	5.02E-03
Hein	MF	GO:0005496	steroid binding	-	110	27	-	-	1.02E-03	3.81E-03
Hein	MF	GO:0008443	phosphofructokinase activity	-	27	14	-	-	5.12E-04	2.08E-03
Hein	MF	GO:0003684	damaged DNA binding	-	89	60	-	-	1.64E-02	8.30E-03
Hein	MF	GO:0000339	RNA cap binding	-	20	13	-	-	5.08E-04	1.90E-03
Hein	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	64	-	-	8.54E-02	8.99E-03
Hein	MF	GO:0070063	RNA polymerase binding	-	61	44	-	-	5.16E-03	6.23E-03
Hein	MF	GO:0030971	receptor tyrosine kinase binding	-	76	24	-	-	8.49E-04	3.46E-03
Hein	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	51	-	-	1.88E-03	7.09E-03
Hein	MF	GO:0140030	modification-dependent protein binding	-	179	110	-	-	5.86E-03	1.52E-02
Hein	MF	GO:0030983	mismatched DNA binding	-	14	11	-	-	6.10E-02	1.56E-03
Hein	MF	GO:0030276	clathrin binding	-	70	34	-	-	9.96E-02	4.84E-03
Hein	MF	GO:0106310	protein serine kinase activity	-	362	156	-	-	9.71E-03	2.16E-02
Hein	MF	GO:0030552	cAMP binding	-	48	15	-	-	9.15E-03	2.08E-03
Hein	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	19	-	-	1.08E-03	2.77E-03
Hein	MF	GO:0004857	enzyme inhibitor activity	-	395	117	-	-	5.60E-03	1.63E-02
Hein	MF	GO:0016209	antioxidant activity	-	92	23	-	-	5.31E-03	3.29E-03
Hein	MF	GO:0070325	lipoprotein particle receptor binding	-	32	16	-	-	8.43E-03	2.25E-03
Hein	MF	GO:0044325	transmembrane transporter binding	-	159	58	-	-	3.90E-03	8.13E-03
Hein	MF	GO:0048156	tau protein binding	-	43	33	-	-	3.41E-03	4.67E-03
Hein	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	25	-	-	1.02E-03	3.46E-03
Hein	MF	GO:0140272	exogenous protein binding	-	79	22	-	-	8.49E-04	3.11E-03
Hein	MF	GO:0030145	manganese ion binding	-	65	20	-	-	8.56E-04	2.77E-03
Hein	MF	GO:0071814	protein-lipid complex binding	-	52	15	-	-	6.81E-04	2.08E-03
Hein	MF	GO:0017069	snRNA binding	-	54	35	-	-	1.11E-02	4.84E-03
Hein	MF	GO:0031369	translation initiation factor binding	-	32	17	-	-	6.79E-03	2.42E-03
Hein	MF	GO:0019843	rRNA binding	-	69	55	-	-	8.16E-03	7.61E-03
Hein	MF	GO:0004713	protein tyrosine kinase activity	-	213	65	-	-	3.64E-03	8.99E-03
Hein	MF	GO:0016779	nucleotidyltransferase activity	-	264	156	-	-	6.67E-02	2.16E-02
Hein	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	17	-	-	9.38E-03	2.42E-03
Hein	MF	GO:0008093	cytoskeletal anchor activity	-	24	12	-	-	5.12E-04	1.73E-03
Hein	MF	GO:0070300	phosphatidic acid binding	-	20	11	-	-	5.16E-04	1.56E-03
Hein	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	11	-	-	5.16E-04	1.56E-03
Hein	MF	GO:0016208	AMP binding	-	22	12	-	-	5.17E-04	1.73E-03
Hein	MF	GO:0000287	magnesium ion binding	-	225	77	-	-	1.75E-02	1.07E-02
Hein	MF	GO:0031490	chromatin DNA binding	-	120	61	-	-	4.54E-03	8.48E-03
Hein	MF	GO:0017022	myosin binding	-	73	28	-	-	7.37E-03	3.98E-03
Hein	MF	GO:0015631	tubulin binding	-	410	222	-	-	1.22E-02	3.08E-02
Hein	MF	GO:0005539	glycosaminoglycan binding	-	236	33	-	-	1.19E-03	4.67E-03
Hein	MF	GO:0019207	kinase regulator activity	-	267	104	-	-	2.49E-02	1.45E-02
Hein	MF	GO:0044183	protein folding chaperone	-	67	40	-	-	1.17E-02	5.54E-03
Hein	MF	GO:0008047	enzyme activator activity	-	697	227	-	-	1.03E-02	3.15E-02
Hein	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	26	-	-	8.40E-03	3.63E-03
Hein	MF	GO:0003725	double-stranded RNA binding	-	72	51	-	-	3.16E-03	7.09E-03
Hein	MF	GO:0051018	protein kinase A binding	-	52	24	-	-	2.29E-02	3.46E-03
Hein	MF	GO:0071889	14-3-3 protein binding	-	34	18	-	-	6.83E-04	2.59E-03
Hein	MF	GO:0004618	phosphoglycerate kinase activity	-	89	38	-	-	1.31E-02	5.36E-03
Hein	MF	GO:0043531	ADP binding	-	38	23	-	-	4.89E-03	3.29E-03
Hein	MF	GO:0046332	SMAD binding	-	77	34	-	-	3.23E-03	4.84E-03
Hein	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	46	-	-	1.41E-02	6.40E-03
Hein	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	27	-	-	7.68E-03	3.81E-03
Hein	MF	GO:0051117	ATPase binding	-	85	36	-	-	6.17E-03	5.02E-03
Hein	MF	GO:0005216	monoatomic ion channel activity	-	618	85	-	-	6.92E-03	1.18E-02
Hein	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	13	-	-	2.16E-03	1.90E-03
Hein	MF	GO:0051787	misfolded protein binding	-	20	12	-	-	1.86E-03	1.73E-03
Hein	MF	GO:0001098	basal transcription machinery binding	-	61	41	-	-	4.14E-03	5.71E-03
Hein	MF	GO:0036002	pre-mRNA binding	-	57	25	-	-	4.55E-03	3.46E-03
Hein	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	16	-	-	6.87E-04	2.25E-03
Hein	MF	GO:0051540	metal cluster binding	-	71	31	-	-	1.19E-03	4.32E-03
Hein	MF	GO:0051219	phosphoprotein binding	-	92	41	-	-	3.12E-03	5.71E-03
Hein	MF	GO:0019894	kinesin binding	-	45	24	-	-	3.62E-03	3.46E-03
Hein	MF	GO:0019003	GDP binding	-	89	40	-	-	3.71E-02	5.54E-03
Hein	MF	GO:0017171	serine hydrolase activity	-	207	24	-	-	8.55E-04	3.46E-03
Hein	MF	GO:0097110	scaffold protein binding	-	66	33	-	-	7.20E-03	4.67E-03
Hein	MF	GO:0003774	cytoskeletal motor activity	-	117	66	-	-	7.92E-03	9.17E-03
Hein	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	18	-	-	1.19E-02	2.59E-03
Hein	MF	GO:0061134	peptidase regulator activity	-	224	42	-	-	3.62E-03	5.88E-03
Hein	MF	GO:0008013	beta-catenin binding	-	86	33	-	-	1.37E-02	4.67E-03
Hein	MF	GO:0051015	actin filament binding	-	208	109	-	-	4.51E-02	1.52E-02
Hein	MF	GO:0019208	phosphatase regulator activity	-	107	56	-	-	2.53E-02	7.78E-03
Hein	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	15	-	-	4.65E-02	2.08E-03
Hein	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	13	-	-	5.13E-04	1.90E-03
Hein	MF	GO:0045860	positive regulation of protein kinase activity	-	397	111	-	-	4.75E-03	1.54E-02
Hein	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	42	-	-	1.62E-02	5.88E-03
Hein	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	12	-	-	2.62E-02	1.73E-03
Hein	MF	GO:0042393	histone binding	-	240	146	-	-	1.14E-02	2.02E-02
Hein	MF	GO:0019838	growth factor binding	-	182	46	-	-	2.92E-03	6.40E-03
Hein	MF	GO:0000149	SNARE binding	-	107	45	-	-	1.17E-02	6.23E-03
Hein	MF	GO:0003727	single-stranded RNA binding	-	90	56	-	-	4.73E-03	7.78E-03
Hein	MF	GO:0005516	calmodulin binding	-	206	77	-	-	1.24E-02	1.07E-02
Hein	MF	GO:0045505	dynein intermediate chain binding	-	37	12	-	-	1.28E-02	1.73E-03
Hein	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	26	-	-	4.03E-03	3.63E-03
Hein	MF	GO:0032182	ubiquitin-like protein binding	-	117	56	-	-	2.45E-03	7.78E-03
Hein	MF	GO:0031072	heat shock protein binding	-	128	61	-	-	8.14E-03	8.48E-03
Hein	MF	GO:0030515	snoRNA binding	-	33	27	-	-	3.64E-02	3.81E-03
Hein	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	13	-	-	5.16E-04	1.90E-03
Hein	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	171	-	-	6.21E-03	2.37E-02
Hein	MF	GO:0046982	protein heterodimerization activity	-	343	121	-	-	1.65E-02	1.68E-02
Hein	MF	GO:0140223	general transcription initiation factor activity	-	55	37	-	-	1.08E-02	5.19E-03
Hein	MF	GO:0000049	tRNA binding	-	75	37	-	-	1.36E-03	5.19E-03
Hein	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	21	-	-	8.29E-03	2.94E-03
Hein	MF	GO:0006469	negative regulation of protein kinase activity	-	222	82	-	-	3.39E-03	1.14E-02
Hein	MF	GO:0070182	DNA polymerase binding	-	22	18	-	-	1.40E-03	2.59E-03
Hein	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	16	-	-	1.40E-02	2.25E-03
Hein	MF	GO:0070851	growth factor receptor binding	-	141	30	-	-	1.18E-03	4.15E-03
Hein	MF	GO:0031210	phosphatidylcholine binding	-	32	12	-	-	5.15E-04	1.73E-03
Hein	MF	GO:0005525	GTP binding	-	396	137	-	-	7.32E-03	1.90E-02
Hein	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	87	-	-	6.33E-03	1.21E-02
Hein	MF	GO:0042803	protein homodimerization activity	-	699	218	-	-	1.34E-02	3.03E-02
Hein	MF	GO:0051346	negative regulation of hydrolase activity	-	332	82	-	-	3.83E-03	1.14E-02
Hein	MF	GO:0005506	iron ion binding	-	154	24	-	-	2.54E-03	3.46E-03
Hein	MF	GO:0003925	G protein activity	-	45	22	-	-	1.34E-03	3.11E-03
Hein	MF	GO:0008276	protein methyltransferase activity	-	96	37	-	-	2.59E-02	5.19E-03
Hein	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	153	-	-	1.44E-02	2.13E-02
Hein	MF	GO:0051345	positive regulation of hydrolase activity	-	535	162	-	-	6.44E-03	2.25E-02
Hein	MF	GO:0070888	E-box binding	-	59	17	-	-	8.24E-03	2.42E-03
Hein	MF	GO:0015399	primary active transmembrane transporter activity	-	190	75	-	-	1.66E-02	1.04E-02
Hein	MF	GO:0035254	glutamate receptor binding	-	47	16	-	-	6.80E-04	2.25E-03
Hein	MF	GO:0050321	tau-protein kinase activity	-	36	19	-	-	2.16E-03	2.77E-03
Hein	MF	GO:0043021	ribonucleoprotein complex binding	-	158	111	-	-	6.86E-03	1.54E-02
Hein	MF	GO:0030170	pyridoxal phosphate binding	-	56	13	-	-	5.16E-04	1.90E-03
Hein	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	13	-	-	5.16E-04	1.90E-03
Hein	MF	GO:0001664	G protein-coupled receptor binding	-	299	46	-	-	4.15E-03	6.40E-03
Hein	MF	GO:0140299	small molecule sensor activity	-	39	18	-	-	2.86E-02	2.59E-03
Hein	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	14	-	-	1.28E-01	2.08E-03
Hein	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	32	-	-	2.31E-02	4.50E-03
Hein	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	11	-	-	5.15E-04	1.56E-03
Hein	MF	GO:0030594	neurotransmitter receptor activity	-	160	15	-	-	6.86E-04	2.08E-03
Hein	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	14	-	-	3.70E-02	2.08E-03
Hein	MF	GO:0005507	copper ion binding	-	63	16	-	-	5.25E-02	2.25E-03
Hein	MF	GO:0033558	protein lysine deacetylase activity	-	22	15	-	-	4.88E-03	2.08E-03
Hein	MF	GO:0070034	telomerase RNA binding	-	22	16	-	-	7.81E-02	2.25E-03
HINT	CC	GO:0005739	mitochondrion	5.87E-36	1671	1568	1407	1.11	-	-
HINT	CC	GO:0005730	nucleolus	2.64E-32	988	947	832	1.14	-	-
HINT	CC	GO:0005815	microtubule organizing center	1.13E-25	843	805	710	1.13	-	-
HINT	CC	GO:0005768	endosome	1.82E-19	1037	967	873	1.11	-	-
HINT	CC	GO:0005840	ribosome	3.01E-14	222	220	187	1.18	-	-
HINT	CC	GO:0005635	nuclear envelope	3.07E-13	493	467	415	1.13	-	-
HINT	CC	GO:0005764	lysosome	1.04E-12	747	693	629	1.10	-	-
HINT	CC	GO:0005783	endoplasmic reticulum	2.13E-12	2020	1805	1700	1.06	-	-
HINT	CC	GO:0005615	extracellular space	8.52E-12	3190	2810	2685	1.05	-	-
HINT	CC	GO:0005794	Golgi apparatus	1.23E-10	1636	1464	1377	1.06	-	-
HINT	CC	GO:0000228	nuclear chromosome	5.15E-10	206	201	173	1.16	-	-
HINT	CC	GO:0005777	peroxisome	5.50E-03	142	131	120	1.10	-	-
HINT	CC	GO:0005811	lipid droplet	9.46E-03	102	95	86	1.11	-	-
HINT	CC	GO:0031012	extracellular matrix	1.14E-01	564	461	475	0.97	-	-
HINT	CC	GO:0005929	cilium	9.23E-01	842	708	709	1.00	-	-
HINT	BP	GO:0050877	nervous system process	1.07E-99	1527	962	1285	0.75	-	-
HINT	BP	GO:0007010	cytoskeleton organization	3.38E-35	1639	1538	1380	1.11	-	-
HINT	BP	GO:0016192	vesicle-mediated transport	7.60E-35	1894	1764	1594	1.11	-	-
HINT	BP	GO:0012501	programmed cell death	3.74E-32	1954	1811	1645	1.10	-	-
HINT	BP	GO:0006355	regulation of DNA-templated transcription	2.42E-31	3342	3025	2813	1.08	-	-
HINT	BP	GO:0006281	DNA repair	4.34E-31	587	577	494	1.17	-	-
HINT	BP	GO:0006886	intracellular protein transport	2.60E-27	664	644	559	1.15	-	-
HINT	BP	GO:0030163	protein catabolic process	2.07E-26	990	939	833	1.13	-	-
HINT	BP	GO:0065003	protein-containing complex assembly	3.26E-25	1648	1523	1387	1.10	-	-
HINT	BP	GO:0006914	autophagy	2.31E-24	568	552	478	1.15	-	-
HINT	BP	GO:0016071	mRNA metabolic process	5.63E-22	713	681	600	1.13	-	-
HINT	BP	GO:0048870	cell motility	9.85E-18	1659	1511	1396	1.08	-	-
HINT	BP	GO:0002376	immune system process	1.50E-17	2448	2198	2061	1.07	-	-
HINT	BP	GO:0007005	mitochondrion organization	1.75E-17	484	466	407	1.14	-	-
HINT	BP	GO:0006260	DNA replication	4.80E-16	279	275	235	1.17	-	-
HINT	BP	GO:0006913	nucleocytoplasmic transport	1.52E-14	326	317	274	1.16	-	-
HINT	BP	GO:0072659	protein localization to plasma membrane	2.97E-14	284	278	239	1.16	-	-
HINT	BP	GO:0042254	ribosome biogenesis	3.27E-14	297	290	250	1.16	-	-
HINT	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.67E-13	729	679	614	1.11	-	-
HINT	BP	GO:0007059	chromosome segregation	1.68E-13	403	386	339	1.14	-	-
HINT	BP	GO:0006091	generation of precursor metabolites and energy	4.71E-13	502	475	423	1.12	-	-
HINT	BP	GO:0006325	chromatin organization	2.76E-12	720	668	606	1.10	-	-
HINT	BP	GO:0006310	DNA recombination	3.14E-11	333	319	280	1.14	-	-
HINT	BP	GO:0007155	cell adhesion	5.54E-11	1444	1299	1215	1.07	-	-
HINT	BP	GO:0042060	wound healing	5.15E-10	431	405	363	1.12	-	-
HINT	BP	GO:0002181	cytoplasmic translation	2.30E-09	153	151	129	1.17	-	-
HINT	BP	GO:0140053	mitochondrial gene expression	3.55E-08	164	160	138	1.16	-	-
HINT	BP	GO:0007163	establishment or maintenance of cell polarity	3.40E-07	227	216	191	1.13	-	-
HINT	BP	GO:0034330	cell junction organization	1.70E-06	727	656	612	1.07	-	-
HINT	BP	GO:0003012	muscle system process	2.13E-06	425	391	358	1.09	-	-
HINT	BP	GO:0006520	amino acid metabolic process	2.15E-06	292	273	246	1.11	-	-
HINT	BP	GO:0006457	protein folding	3.64E-06	210	199	177	1.13	-	-
HINT	BP	GO:0006399	tRNA metabolic process	4.62E-06	196	186	165	1.13	-	-
HINT	BP	GO:0098542	defense response to other organism	5.90E-05	1171	1033	986	1.05	-	-
HINT	BP	GO:0140013	meiotic nuclear division	2.52E-04	279	256	235	1.09	-	-
HINT	BP	GO:0007018	microtubule-based movement	2.65E-04	640	571	539	1.06	-	-
HINT	BP	GO:0005975	carbohydrate metabolic process	5.73E-04	551	492	464	1.06	-	-
HINT	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.47E-03	119	112	100	1.12	-	-
HINT	BP	GO:0003013	circulatory system process	1.84E-03	584	518	492	1.05	-	-
HINT	BP	GO:0000910	cytokinesis	2.33E-03	186	171	157	1.09	-	-
HINT	BP	GO:0006954	inflammatory response	2.38E-03	820	721	690	1.04	-	-
HINT	BP	GO:0044782	cilium organization	2.79E-03	399	357	336	1.06	-	-
HINT	BP	GO:0006629	lipid metabolic process	6.04E-03	1355	1176	1141	1.03	-	-
HINT	BP	GO:0006790	sulfur compound metabolic process	1.63E-02	320	285	269	1.06	-	-
HINT	BP	GO:0098754	detoxification	3.15E-02	134	122	113	1.08	-	-
HINT	BP	GO:0006486	protein glycosylation	8.08E-02	225	199	189	1.05	-	-
HINT	BP	GO:0007040	lysosome organization	8.25E-02	107	97	90	1.08	-	-
HINT	BP	GO:0003014	renal system process	8.78E-02	127	114	107	1.07	-	-
HINT	BP	GO:0006575	cellular modified amino acid metabolic process	1.57E-01	186	164	157	1.05	-	-
HINT	BP	GO:0032200	telomere organization	3.13E-01	186	162	157	1.03	-	-
HINT	BP	GO:0006766	vitamin metabolic process	3.53E-01	107	94	90	1.04	-	-
HINT	BP	GO:0030198	extracellular matrix organization	5.33E-01	314	269	264	1.02	-	-
HINT	BP	GO:0055085	transmembrane transport	5.62E-01	1784	1493	1502	0.99	-	-
HINT	BP	GO:0022600	digestive system process	1.00E+00	110	93	93	1.00	-	-
HINT	MF	GO:0003723	RNA binding	9.03E-53	1679	1605	1413	1.14	-	-
HINT	MF	GO:0016740	transferase activity	6.17E-44	3074	2828	2587	1.09	-	-
HINT	MF	GO:0008092	cytoskeletal protein binding	4.12E-27	1023	970	861	1.13	-	-
HINT	MF	GO:0140096	"catalytic activity, acting on a protein"	1.12E-25	3198	2880	2692	1.07	-	-
HINT	MF	GO:0140657	ATP-dependent activity	2.05E-20	729	693	614	1.13	-	-
HINT	MF	GO:0003677	DNA binding	2.81E-17	2865	2558	2412	1.06	-	-
HINT	MF	GO:0140097	"catalytic activity, acting on DNA"	5.65E-15	383	370	322	1.15	-	-
HINT	MF	GO:0140110	transcription regulator activity	2.93E-13	2033	1820	1711	1.06	-	-
HINT	MF	GO:0003924	GTPase activity	9.09E-13	658	614	554	1.11	-	-
HINT	MF	GO:0016491	oxidoreductase activity	3.23E-09	888	807	747	1.08	-	-
HINT	MF	GO:0042393	histone binding	2.68E-08	237	227	199	1.14	-	-
HINT	MF	GO:0140098	"catalytic activity, acting on RNA"	6.19E-08	417	388	351	1.11	-	-
HINT	MF	GO:0016874	ligase activity	6.29E-08	283	268	238	1.13	-	-
HINT	MF	GO:0045182	translation regulator activity	2.47E-07	151	147	127	1.16	-	-
HINT	MF	GO:0016853	isomerase activity	2.13E-06	252	237	212	1.12	-	-
HINT	MF	GO:0008289	lipid binding	3.02E-06	836	750	704	1.07	-	-
HINT	MF	GO:0140104	molecular carrier activity	2.83E-03	105	99	88	1.12	-	-
HINT	MF	GO:0005198	structural molecule activity	2.58E-02	798	694	672	1.03	-	-
HINT	MF	GO:0003774	cytoskeletal motor activity	3.00E-02	116	106	98	1.09	-	-
HINT	MF	GO:0005215	transporter activity	3.66E-02	1462	1202	1231	0.98	-	-
HINT	MF	GO:0009975	cyclase activity	3.76E-02	277	220	233	0.94	-	-
HINT	MF	GO:0048018	receptor ligand activity	4.77E-02	504	408	424	0.96	-	-
HINT	MF	GO:0016829	lyase activity	5.90E-01	538	458	453	1.01	-	-
HINT	MF	GO:0038024	cargo receptor activity	8.00E-01	117	100	98	1.02	-	-
HINT	BP	GO:0008038	neuron recognition	-	46	43	-	-	2.21E-03	2.16E-03
HINT	BP	GO:1905145	cellular response to acetylcholine	-	33	25	-	-	1.71E-02	1.24E-03
HINT	BP	GO:0097094	craniofacial suture morphogenesis	-	18	16	-	-	2.45E-04	8.03E-04
HINT	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	1.98E-03	1.05E-03
HINT	BP	GO:0051931	regulation of sensory perception	-	36	32	-	-	2.53E-03	1.61E-03
HINT	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	24	-	-	1.15E-03	1.24E-03
HINT	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.84E-04	6.80E-04
HINT	BP	GO:0060049	regulation of protein glycosylation	-	13	12	-	-	1.81E-04	6.18E-04
HINT	BP	GO:0009268	response to pH	-	43	34	-	-	2.17E-02	1.73E-03
HINT	BP	GO:0045666	positive regulation of neuron differentiation	-	91	75	-	-	4.03E-03	3.71E-03
HINT	BP	GO:0043543	protein acylation	-	107	100	-	-	3.60E-03	4.94E-03
HINT	MF	GO:0051349	positive regulation of lyase activity	-	41	35	-	-	1.50E-02	1.73E-03
HINT	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	7.64E-04	1.24E-03
HINT	BP	GO:0022401	negative adaptation of signaling pathway	-	21	19	-	-	4.01E-02	9.89E-04
HINT	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	109	-	-	4.39E-02	5.44E-03
HINT	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	1.42E-02	2.10E-03
HINT	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	34	-	-	1.45E-03	1.73E-03
HINT	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	12	-	-	1.48E-01	6.18E-04
HINT	BP	GO:0071806	protein transmembrane transport	-	68	67	-	-	2.37E-02	3.34E-03
HINT	BP	GO:0022038	corpus callosum development	-	25	25	-	-	2.44E-03	1.24E-03
HINT	BP	GO:0043299	leukocyte degranulation	-	82	78	-	-	1.04E-02	3.89E-03
HINT	BP	GO:0048864	stem cell development	-	88	77	-	-	7.68E-03	3.83E-03
HINT	BP	GO:0009310	amine catabolic process	-	20	15	-	-	2.43E-04	7.42E-04
HINT	BP	GO:0051651	maintenance of location in cell	-	236	212	-	-	5.09E-03	1.05E-02
HINT	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	8.78E-03	1.36E-03
HINT	BP	GO:0014004	microglia differentiation	-	12	11	-	-	2.02E-03	5.56E-04
HINT	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	28	-	-	3.66E-04	1.42E-03
HINT	BP	GO:0070663	regulation of leukocyte proliferation	-	268	249	-	-	1.76E-02	1.24E-02
HINT	BP	GO:1905962	glutamatergic neuron differentiation	-	14	13	-	-	1.84E-04	6.80E-04
HINT	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.16E-02	7.42E-04
HINT	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	2.30E-03	1.48E-03
HINT	BP	GO:0006949	syncytium formation	-	66	58	-	-	3.22E-03	2.90E-03
HINT	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.42E-04	7.42E-04
HINT	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	1.48E-02	7.42E-04
HINT	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	51	-	-	1.09E-02	2.53E-03
HINT	BP	GO:0030574	collagen catabolic process	-	45	35	-	-	1.01E-02	1.73E-03
HINT	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	4.91E-03	2.29E-03
HINT	BP	GO:0060343	trabecula formation	-	26	26	-	-	5.85E-04	1.30E-03
HINT	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	1.80E-03	1.17E-03
HINT	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	4.80E-01	8.03E-04
HINT	BP	GO:1900424	regulation of defense response to bacterium	-	21	16	-	-	2.41E-04	8.03E-04
HINT	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	8.38E-03	2.04E-03
HINT	BP	GO:0006413	translational initiation	-	122	117	-	-	3.61E-02	5.81E-03
HINT	BP	GO:0072176	nephric duct development	-	15	15	-	-	8.25E-03	7.42E-04
HINT	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	4.24E-03	2.53E-03
HINT	CC	GO:0005200	structural constituent of cytoskeleton	-	112	109	-	-	5.57E-03	5.44E-03
HINT	BP	GO:0030865	cortical cytoskeleton organization	-	51	50	-	-	1.93E-03	2.47E-03
HINT	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	1.14E-01	7.42E-04
HINT	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	24	-	-	8.39E-02	1.24E-03
HINT	BP	GO:1903036	positive regulation of response to wounding	-	76	68	-	-	3.13E-03	3.40E-03
HINT	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	2.61E-02	1.05E-03
HINT	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	189	-	-	9.96E-03	9.39E-03
HINT	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	6.43E-04	1.36E-03
HINT	BP	GO:0032528	microvillus organization	-	24	20	-	-	1.84E-03	9.89E-04
HINT	BP	GO:0021954	central nervous system neuron development	-	85	79	-	-	2.71E-03	3.95E-03
HINT	BP	GO:0055017	cardiac muscle tissue growth	-	92	72	-	-	3.26E-03	3.58E-03
HINT	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	30	-	-	2.11E-03	1.48E-03
HINT	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	11	-	-	1.83E-04	5.56E-04
HINT	BP	GO:0048524	positive regulation of viral process	-	64	63	-	-	2.00E-03	3.15E-03
HINT	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	12	-	-	1.66E-01	6.18E-04
HINT	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	16	-	-	1.61E-02	8.03E-04
HINT	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	22	-	-	4.50E-03	1.11E-03
HINT	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	2.25E-02	8.65E-04
HINT	BP	GO:0098661	inorganic anion transmembrane transport	-	140	104	-	-	4.37E-02	5.19E-03
HINT	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	2.58E-02	1.61E-03
HINT	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	5.36E-04	9.27E-04
HINT	BP	GO:0009612	response to mechanical stimulus	-	215	196	-	-	4.38E-03	9.70E-03
HINT	BP	GO:0048644	muscle organ morphogenesis	-	81	73	-	-	5.33E-03	3.65E-03
HINT	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	135	-	-	8.20E-03	6.67E-03
HINT	BP	GO:1905874	regulation of postsynaptic density organization	-	13	11	-	-	2.32E-02	5.56E-04
HINT	BP	GO:0071542	dopaminergic neuron differentiation	-	36	31	-	-	6.99E-03	1.54E-03
HINT	BP	GO:0140115	export across plasma membrane	-	82	55	-	-	2.69E-03	2.72E-03
HINT	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	5.84E-03	6.18E-04
HINT	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	1.70E-03	1.92E-03
HINT	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	27	-	-	8.04E-02	1.36E-03
HINT	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	39	-	-	7.69E-03	1.98E-03
HINT	MF	GO:0003714	transcription corepressor activity	-	190	183	-	-	7.89E-03	9.08E-03
HINT	BP	GO:0035878	nail development	-	11	11	-	-	1.82E-04	5.56E-04
HINT	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	46	-	-	1.79E-03	2.29E-03
HINT	BP	GO:0061101	neuroendocrine cell differentiation	-	16	15	-	-	6.53E-03	7.42E-04
HINT	CC	GO:0006858	extracellular transport	-	45	36	-	-	4.63E-03	1.79E-03
HINT	BP	GO:0006304	DNA modification	-	30	29	-	-	3.58E-03	1.48E-03
HINT	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	3.64E-02	9.27E-04
HINT	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	1.58E-02	2.47E-03
HINT	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	6.01E-04	9.27E-04
HINT	BP	GO:0003207	cardiac chamber formation	-	14	13	-	-	3.16E-02	6.80E-04
HINT	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	28	-	-	3.65E-04	1.42E-03
HINT	BP	GO:0070417	cellular response to cold	-	13	12	-	-	1.82E-04	6.18E-04
HINT	BP	GO:0043523	regulation of neuron apoptotic process	-	218	199	-	-	4.66E-03	9.89E-03
HINT	BP	GO:1902894	negative regulation of miRNA transcription	-	22	21	-	-	2.31E-03	1.05E-03
HINT	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	6.84E-04	7.42E-04
HINT	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	4.40E-03	2.84E-03
HINT	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	3.64E-02	6.80E-04
HINT	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	2.08E-03	1.24E-03
HINT	BP	GO:0014029	neural crest formation	-	15	15	-	-	1.37E-02	7.42E-04
HINT	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	3.68E-04	1.17E-03
HINT	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	36	-	-	1.29E-03	1.79E-03
HINT	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	66	-	-	4.65E-03	3.28E-03
HINT	BP	GO:0003188	heart valve formation	-	16	15	-	-	3.58E-03	7.42E-04
HINT	CC	GO:0045324	late endosome to vacuole transport	-	37	35	-	-	3.89E-02	1.73E-03
HINT	BP	GO:0043954	cellular component maintenance	-	72	69	-	-	1.25E-02	3.46E-03
HINT	BP	GO:0050435	amyloid-beta metabolic process	-	65	50	-	-	5.15E-03	2.47E-03
HINT	BP	GO:0014823	response to activity	-	70	63	-	-	3.40E-03	3.15E-03
HINT	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	15	-	-	2.22E-03	7.42E-04
HINT	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	4.21E-02	1.42E-03
HINT	BP	GO:0034502	protein localization to chromosome	-	130	114	-	-	5.49E-03	5.68E-03
HINT	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	1.80E-04	5.56E-04
HINT	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	2.75E-03	5.56E-04
HINT	BP	GO:0060457	negative regulation of digestive system process	-	17	15	-	-	9.84E-03	7.42E-04
HINT	BP	GO:0019233	sensory perception of pain	-	103	89	-	-	3.64E-03	4.45E-03
HINT	CC	GO:0043574	peroxisomal transport	-	22	21	-	-	1.16E-01	1.05E-03
HINT	BP	GO:0031343	positive regulation of cell killing	-	75	65	-	-	2.58E-02	3.21E-03
HINT	BP	GO:0090077	foam cell differentiation	-	39	37	-	-	1.43E-03	1.85E-03
HINT	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	100	-	-	2.26E-02	4.94E-03
HINT	BP	GO:0017148	negative regulation of translation	-	390	110	-	-	1.06E-02	5.44E-03
HINT	BP	GO:0030220	platelet formation	-	22	21	-	-	4.06E-03	1.05E-03
HINT	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	76	-	-	2.22E-02	3.77E-03
HINT	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	1.28E-02	6.18E-04
HINT	BP	GO:1901142	insulin metabolic process	-	14	12	-	-	3.15E-03	6.18E-04
HINT	BP	GO:1903509	liposaccharide metabolic process	-	109	96	-	-	3.08E-02	4.76E-03
HINT	BP	GO:0009582	detection of abiotic stimulus	-	140	107	-	-	1.58E-02	5.31E-03
HINT	BP	GO:0045683	negative regulation of epidermis development	-	13	11	-	-	1.82E-04	5.56E-04
HINT	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	13	-	-	1.85E-04	6.80E-04
HINT	CC	GO:0140238	presynaptic endocytosis	-	72	67	-	-	2.43E-02	3.34E-03
HINT	BP	GO:0051236	establishment of RNA localization	-	161	152	-	-	4.63E-02	7.54E-03
HINT	BP	GO:0042178	xenobiotic catabolic process	-	26	21	-	-	3.63E-02	1.05E-03
HINT	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	14	-	-	1.84E-04	7.42E-04
HINT	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	187	-	-	9.96E-03	9.27E-03
HINT	BP	GO:0034067	protein localization to Golgi apparatus	-	30	28	-	-	2.12E-03	1.42E-03
HINT	BP	GO:0061842	microtubule organizing center localization	-	32	31	-	-	3.25E-03	1.54E-03
HINT	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	16	-	-	2.06E-02	8.03E-04
HINT	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	40	-	-	2.91E-02	1.98E-03
HINT	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	1.13E-03	1.98E-03
HINT	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	2.27E-03	2.60E-03
HINT	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	9.06E-04	8.03E-04
HINT	BP	GO:0050779	RNA destabilization	-	135	97	-	-	3.44E-02	4.82E-03
HINT	BP	GO:0006023	aminoglycan biosynthetic process	-	74	66	-	-	9.19E-03	3.28E-03
HINT	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	66	-	-	8.18E-03	3.28E-03
HINT	BP	GO:0010762	regulation of fibroblast migration	-	40	37	-	-	3.82E-03	1.85E-03
HINT	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	5.83E-03	1.48E-03
HINT	BP	GO:0035272	exocrine system development	-	46	44	-	-	7.02E-03	2.22E-03
HINT	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	4.63E-03	8.65E-04
HINT	BP	GO:0022406	membrane docking	-	90	87	-	-	4.13E-02	4.33E-03
HINT	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	3.77E-02	7.42E-04
HINT	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	9.22E-04	8.03E-04
HINT	BP	GO:0050777	negative regulation of immune response	-	196	183	-	-	4.99E-03	9.08E-03
HINT	MF	GO:0005035	death receptor activity	-	16	16	-	-	3.26E-03	8.03E-04
HINT	BP	GO:0002063	chondrocyte development	-	33	30	-	-	1.91E-03	1.48E-03
HINT	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	16	-	-	1.48E-03	8.03E-04
HINT	BP	GO:0099068	postsynapse assembly	-	40	34	-	-	1.96E-03	1.73E-03
HINT	BP	GO:0021782	glial cell development	-	120	104	-	-	2.33E-03	5.19E-03
HINT	BP	GO:0051782	negative regulation of cell division	-	18	16	-	-	1.71E-03	8.03E-04
HINT	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	1.81E-04	5.56E-04
HINT	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	83	-	-	3.26E-03	4.14E-03
HINT	BP	GO:0001655	urogenital system development	-	66	63	-	-	3.24E-03	3.15E-03
HINT	BP	GO:0071827	plasma lipoprotein particle organization	-	86	67	-	-	2.39E-02	3.34E-03
HINT	BP	GO:0045494	photoreceptor cell maintenance	-	43	33	-	-	8.46E-03	1.67E-03
HINT	BP	GO:0055088	lipid homeostasis	-	173	145	-	-	9.81E-03	7.17E-03
HINT	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	25	-	-	1.42E-03	1.24E-03
HINT	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	189	-	-	4.58E-03	9.39E-03
HINT	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	24	-	-	6.25E-03	1.24E-03
HINT	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	7.33E-03	1.73E-03
HINT	BP	GO:0045667	regulation of osteoblast differentiation	-	147	115	-	-	2.65E-02	5.68E-03
HINT	BP	GO:2001212	regulation of vasculogenesis	-	16	15	-	-	2.60E-03	7.42E-04
HINT	BP	GO:0061037	negative regulation of cartilage development	-	32	28	-	-	3.59E-04	1.42E-03
HINT	BP	GO:0045738	negative regulation of DNA repair	-	40	38	-	-	5.80E-02	1.92E-03
HINT	BP	GO:0001704	formation of primary germ layer	-	195	182	-	-	1.34E-02	9.02E-03
HINT	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	12	-	-	5.31E-02	6.18E-04
HINT	BP	GO:0045778	positive regulation of ossification	-	51	49	-	-	3.22E-02	2.47E-03
HINT	BP	GO:0048708	astrocyte differentiation	-	88	82	-	-	2.33E-03	4.08E-03
HINT	BP	GO:0042092	type 2 immune response	-	41	41	-	-	4.35E-03	2.04E-03
HINT	BP	GO:0048588	developmental cell growth	-	233	208	-	-	4.79E-03	1.03E-02
HINT	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	1.59E-02	9.89E-04
HINT	BP	GO:0021872	forebrain generation of neurons	-	52	49	-	-	9.94E-04	2.47E-03
HINT	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	1.13E-03	1.11E-03
HINT	BP	GO:0045023	G0 to G1 transition	-	41	38	-	-	1.65E-01	1.92E-03
HINT	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	48	-	-	2.69E-02	2.41E-03
HINT	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	1.83E-04	5.56E-04
HINT	BP	GO:0034367	protein-containing complex remodeling	-	35	34	-	-	1.12E-02	1.73E-03
HINT	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	25	-	-	5.82E-04	1.24E-03
HINT	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	40	-	-	6.95E-04	1.98E-03
HINT	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	7.31E-02	9.89E-04
HINT	BP	GO:0015810	aspartate transmembrane transport	-	19	18	-	-	3.09E-03	9.27E-04
HINT	BP	GO:0010232	vascular transport	-	87	76	-	-	1.17E-02	3.77E-03
HINT	BP	GO:0021987	cerebral cortex development	-	125	120	-	-	3.92E-03	5.93E-03
HINT	BP	GO:0008637	apoptotic mitochondrial changes	-	108	99	-	-	2.19E-02	4.94E-03
HINT	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	33	-	-	5.03E-03	1.67E-03
HINT	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	4.08E-03	7.42E-04
HINT	BP	GO:0060999	positive regulation of dendritic spine development	-	35	33	-	-	4.70E-03	1.67E-03
HINT	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	8.67E-04	9.27E-04
HINT	BP	GO:2000736	regulation of stem cell differentiation	-	78	74	-	-	3.75E-03	3.71E-03
HINT	BP	GO:0060973	cell migration involved in heart development	-	21	19	-	-	2.42E-04	9.89E-04
HINT	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	19	-	-	1.76E-03	9.89E-04
HINT	BP	GO:0002064	epithelial cell development	-	210	201	-	-	4.58E-03	9.95E-03
HINT	BP	GO:0071318	cellular response to ATP	-	18	14	-	-	9.51E-04	7.42E-04
HINT	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	34	-	-	1.72E-02	1.73E-03
HINT	BP	GO:2001222	regulation of neuron migration	-	46	39	-	-	6.10E-04	1.98E-03
HINT	BP	GO:0034389	lipid droplet organization	-	38	36	-	-	7.96E-03	1.79E-03
HINT	BP	GO:0051602	response to electrical stimulus	-	44	43	-	-	6.75E-04	2.16E-03
HINT	BP	GO:0042177	negative regulation of protein catabolic process	-	109	103	-	-	2.43E-03	5.13E-03
HINT	MF	GO:0038024	cargo receptor activity	-	121	100	-	-	3.00E-02	4.94E-03
HINT	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	16	-	-	1.38E-03	8.03E-04
HINT	BP	GO:0033120	positive regulation of RNA splicing	-	46	41	-	-	3.11E-02	2.04E-03
HINT	BP	GO:0051445	regulation of meiotic cell cycle	-	64	60	-	-	7.58E-02	2.97E-03
HINT	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	7.19E-04	6.18E-04
HINT	BP	GO:0033619	membrane protein proteolysis	-	60	56	-	-	5.53E-03	2.78E-03
HINT	BP	GO:0038065	collagen-activated signaling pathway	-	15	14	-	-	2.34E-02	7.42E-04
HINT	BP	GO:0090087	regulation of peptide transport	-	195	175	-	-	6.36E-03	8.65E-03
HINT	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	95	-	-	4.45E-03	4.70E-03
HINT	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	1.02E-03	1.24E-03
HINT	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	1.18E-03	1.24E-03
HINT	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	11	-	-	1.83E-04	5.56E-04
HINT	BP	GO:0042537	benzene-containing compound metabolic process	-	27	25	-	-	2.37E-02	1.24E-03
HINT	BP	GO:0099118	microtubule-based protein transport	-	14	13	-	-	3.52E-03	6.80E-04
HINT	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	6.58E-03	7.42E-04
HINT	BP	GO:0072662	protein localization to peroxisome	-	20	19	-	-	6.05E-02	9.89E-04
HINT	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	12	-	-	1.33E-03	6.18E-04
HINT	BP	GO:0022404	molting cycle process	-	95	90	-	-	3.59E-03	4.45E-03
HINT	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	6.36E-04	5.56E-04
HINT	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	9.73E-03	8.65E-04
HINT	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	3.09E-02	9.89E-04
HINT	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	1.09E-02	6.18E-04
HINT	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	2.36E-04	8.65E-04
HINT	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	31	-	-	2.71E-03	1.54E-03
HINT	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	7.04E-03	7.42E-04
HINT	BP	GO:0008299	isoprenoid biosynthetic process	-	30	26	-	-	3.66E-04	1.30E-03
HINT	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	212	-	-	4.77E-03	1.05E-02
HINT	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	30	-	-	1.81E-03	1.48E-03
HINT	BP	GO:0034104	negative regulation of tissue remodeling	-	22	21	-	-	1.60E-03	1.05E-03
HINT	CC	GO:0098926	postsynaptic signal transduction	-	39	31	-	-	1.69E-02	1.54E-03
HINT	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	135	-	-	4.64E-03	6.67E-03
HINT	CC	GO:0016082	synaptic vesicle priming	-	19	18	-	-	2.20E-02	9.27E-04
HINT	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	46	-	-	9.23E-04	2.29E-03
HINT	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	129	-	-	1.52E-02	6.43E-03
HINT	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	3.68E-03	1.11E-03
HINT	BP	GO:0061548	ganglion development	-	17	16	-	-	2.01E-02	8.03E-04
HINT	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	96	-	-	6.05E-03	4.76E-03
HINT	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.82E-04	7.42E-04
HINT	BP	GO:0042832	defense response to protozoan	-	28	22	-	-	1.67E-03	1.11E-03
HINT	BP	GO:0048799	animal organ maturation	-	33	30	-	-	4.78E-03	1.48E-03
HINT	BP	GO:0006925	inflammatory cell apoptotic process	-	23	19	-	-	1.18E-03	9.89E-04
HINT	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	2.42E-04	8.03E-04
HINT	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	162	-	-	4.44E-03	8.03E-03
HINT	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.84E-04	5.56E-04
HINT	BP	GO:1903035	negative regulation of response to wounding	-	93	84	-	-	8.26E-03	4.20E-03
HINT	BP	GO:0015697	quaternary ammonium group transport	-	16	13	-	-	1.68E-01	6.80E-04
HINT	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	7.21E-04	1.30E-03
HINT	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	2.26E-03	1.36E-03
HINT	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	128	-	-	4.91E-02	6.36E-03
HINT	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	93	-	-	3.03E-03	4.63E-03
HINT	BP	GO:0045056	transcytosis	-	20	20	-	-	2.36E-03	9.89E-04
HINT	BP	GO:0018342	protein prenylation	-	15	15	-	-	1.74E-02	7.42E-04
HINT	BP	GO:0009267	cellular response to starvation	-	170	163	-	-	1.27E-02	8.09E-03
HINT	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	51	-	-	2.94E-03	2.53E-03
HINT	BP	GO:0046834	lipid phosphorylation	-	16	11	-	-	1.84E-04	5.56E-04
HINT	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	1.84E-03	1.17E-03
HINT	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	23	-	-	3.04E-04	1.17E-03
HINT	BP	GO:0046931	pore complex assembly	-	21	20	-	-	5.16E-03	9.89E-04
HINT	CC	GO:0032008	positive regulation of TOR signaling	-	52	49	-	-	1.03E-01	2.47E-03
HINT	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	32	-	-	6.18E-02	1.61E-03
HINT	BP	GO:0046618	xenobiotic export from cell	-	27	12	-	-	6.47E-02	6.18E-04
HINT	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	14	-	-	2.10E-02	7.42E-04
HINT	BP	GO:0060428	lung epithelium development	-	43	43	-	-	4.34E-03	2.16E-03
HINT	BP	GO:0030431	sleep	-	30	28	-	-	2.83E-02	1.42E-03
HINT	BP	GO:1903318	negative regulation of protein maturation	-	29	23	-	-	1.19E-02	1.17E-03
HINT	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	94	-	-	2.58E-01	4.70E-03
HINT	BP	GO:0071732	cellular response to nitric oxide	-	17	16	-	-	6.98E-04	8.03E-04
HINT	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	5.67E-03	7.42E-04
HINT	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	4.64E-03	5.56E-04
HINT	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.84E-04	6.80E-04
HINT	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	64	-	-	1.21E-03	3.21E-03
HINT	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	63	-	-	2.63E-03	3.15E-03
HINT	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	15	-	-	2.43E-04	7.42E-04
HINT	CC	GO:0090660	cerebrospinal fluid circulation	-	15	13	-	-	1.84E-04	6.80E-04
HINT	CC	GO:0006406	mRNA export from nucleus	-	69	67	-	-	6.71E-02	3.34E-03
HINT	BP	GO:0009880	embryonic pattern specification	-	70	67	-	-	1.83E-03	3.34E-03
HINT	BP	GO:0015791	polyol transmembrane transport	-	14	11	-	-	6.64E-03	5.56E-04
HINT	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	2.87E-01	1.98E-03
HINT	BP	GO:0043043	peptide biosynthetic process	-	25	22	-	-	8.55E-03	1.11E-03
HINT	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	1.69E-02	5.56E-04
HINT	BP	GO:0002367	cytokine production involved in immune response	-	121	116	-	-	8.71E-03	5.75E-03
HINT	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	12	-	-	1.02E-03	6.18E-04
HINT	BP	GO:0044848	biological phase	-	211	192	-	-	2.48E-02	9.52E-03
HINT	BP	GO:0002645	positive regulation of tolerance induction	-	12	11	-	-	7.93E-03	5.56E-04
HINT	BP	GO:0046660	female sex differentiation	-	125	117	-	-	4.83E-03	5.81E-03
HINT	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	16	-	-	2.38E-04	8.03E-04
HINT	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	38	-	-	1.27E-03	1.92E-03
HINT	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	1.81E-04	5.56E-04
HINT	BP	GO:0060411	cardiac septum morphogenesis	-	72	67	-	-	1.49E-02	3.34E-03
HINT	BP	GO:0071248	cellular response to metal ion	-	201	182	-	-	3.26E-03	9.02E-03
HINT	BP	GO:0030308	negative regulation of cell growth	-	191	175	-	-	6.43E-03	8.65E-03
HINT	BP	GO:0097306	cellular response to alcohol	-	99	83	-	-	7.00E-03	4.14E-03
HINT	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	118	-	-	1.83E-02	5.87E-03
HINT	BP	GO:0010453	regulation of cell fate commitment	-	40	34	-	-	1.23E-02	1.73E-03
HINT	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	57	-	-	2.96E-03	2.84E-03
HINT	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	46	-	-	1.57E-02	2.29E-03
HINT	BP	GO:0002026	regulation of the force of heart contraction	-	26	24	-	-	5.98E-03	1.24E-03
HINT	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	22	-	-	3.02E-04	1.11E-03
HINT	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	41	-	-	4.08E-03	2.04E-03
HINT	BP	GO:0032890	regulation of organic acid transport	-	78	72	-	-	1.22E-03	3.58E-03
HINT	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	3.50E-03	9.89E-04
HINT	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	3.07E-04	1.24E-03
HINT	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	87	-	-	2.38E-03	4.33E-03
HINT	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	25	-	-	3.32E-03	1.24E-03
HINT	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	1.81E-04	5.56E-04
HINT	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	49	-	-	3.21E-03	2.47E-03
HINT	BP	GO:0051259	protein complex oligomerization	-	251	232	-	-	4.85E-03	1.15E-02
HINT	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	1.28E-03	8.03E-04
HINT	BP	GO:0098743	cell aggregation	-	24	19	-	-	2.42E-04	9.89E-04
HINT	BP	GO:0035112	genitalia morphogenesis	-	12	11	-	-	1.16E-03	5.56E-04
HINT	BP	GO:0009994	oocyte differentiation	-	57	52	-	-	1.01E-03	2.60E-03
HINT	MF	GO:0031952	regulation of protein autophosphorylation	-	43	39	-	-	8.40E-04	1.98E-03
HINT	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	13	-	-	5.37E-02	6.80E-04
HINT	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	145	-	-	5.10E-03	7.17E-03
HINT	BP	GO:0044319	"wound healing, spreading of cells"	-	37	33	-	-	2.04E-03	1.67E-03
HINT	BP	GO:0033688	regulation of osteoblast proliferation	-	31	27	-	-	6.73E-04	1.36E-03
HINT	BP	GO:0060251	regulation of glial cell proliferation	-	39	33	-	-	1.01E-03	1.67E-03
HINT	BP	GO:0072665	protein localization to vacuole	-	84	79	-	-	1.24E-02	3.95E-03
HINT	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	44	-	-	5.68E-02	2.22E-03
HINT	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	21	-	-	1.30E-03	1.05E-03
HINT	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	71	-	-	5.56E-03	3.52E-03
HINT	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	1.72E-02	8.03E-04
HINT	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	1.78E-02	7.42E-04
HINT	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.84E-04	5.56E-04
HINT	BP	GO:0042044	fluid transport	-	35	32	-	-	3.22E-03	1.61E-03
HINT	BP	GO:0070633	transepithelial transport	-	35	32	-	-	3.01E-03	1.61E-03
HINT	BP	GO:0045661	regulation of myoblast differentiation	-	74	70	-	-	1.39E-02	3.46E-03
HINT	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	11	-	-	1.84E-04	5.56E-04
HINT	BP	GO:0030307	positive regulation of cell growth	-	164	151	-	-	2.75E-03	7.48E-03
HINT	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	4.88E-03	1.24E-03
HINT	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	1.13E-02	9.27E-04
HINT	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	12	-	-	1.16E-03	6.18E-04
HINT	BP	GO:0014812	muscle cell migration	-	110	83	-	-	3.01E-03	4.14E-03
HINT	BP	GO:0048525	negative regulation of viral process	-	90	85	-	-	4.73E-03	4.20E-03
HINT	BP	GO:0072044	collecting duct development	-	16	15	-	-	8.08E-03	7.42E-04
HINT	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	1.00E-01	7.42E-04
HINT	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	3.64E-03	3.46E-03
HINT	BP	GO:0030238	male sex determination	-	14	14	-	-	3.77E-03	7.42E-04
HINT	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	247	-	-	1.40E-02	1.22E-02
HINT	BP	GO:0051781	positive regulation of cell division	-	93	79	-	-	1.59E-03	3.95E-03
HINT	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	2.46E-03	1.05E-03
HINT	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	4.48E-04	5.56E-04
HINT	BP	GO:0035493	SNARE complex assembly	-	23	22	-	-	1.11E-01	1.11E-03
HINT	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	21	-	-	8.44E-04	1.05E-03
HINT	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.69E-03	2.35E-03
HINT	BP	GO:0007272	ensheathment of neurons	-	146	135	-	-	4.70E-03	6.67E-03
HINT	CC	GO:0050806	positive regulation of synaptic transmission	-	171	141	-	-	5.25E-03	6.98E-03
HINT	BP	GO:0060021	roof of mouth development	-	91	87	-	-	4.53E-03	4.33E-03
HINT	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	37	-	-	2.43E-02	1.85E-03
HINT	BP	GO:0050819	negative regulation of coagulation	-	54	51	-	-	2.72E-02	2.53E-03
HINT	BP	GO:0017004	cytochrome complex assembly	-	40	32	-	-	2.57E-02	1.61E-03
HINT	BP	GO:0018410	C-terminal protein amino acid modification	-	15	12	-	-	1.29E-02	6.18E-04
HINT	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	1.19E-01	3.09E-03
HINT	BP	GO:0097212	lysosomal membrane organization	-	15	14	-	-	1.61E-02	7.42E-04
HINT	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	12	-	-	9.35E-04	6.18E-04
HINT	CC	GO:0050805	negative regulation of synaptic transmission	-	55	49	-	-	3.36E-03	2.47E-03
HINT	BP	GO:0043248	proteasome assembly	-	13	13	-	-	2.36E-01	6.80E-04
HINT	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	58	-	-	1.78E-02	2.90E-03
HINT	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	67	-	-	2.32E-02	3.34E-03
HINT	BP	GO:0016054	organic acid catabolic process	-	251	233	-	-	1.24E-02	1.16E-02
HINT	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	9.76E-04	6.80E-04
HINT	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.46E-02	1.42E-03
HINT	BP	GO:0065005	protein-lipid complex assembly	-	29	27	-	-	2.84E-02	1.36E-03
HINT	BP	GO:0008033	tRNA processing	-	136	128	-	-	8.06E-02	6.36E-03
HINT	BP	GO:0046661	male sex differentiation	-	171	160	-	-	9.42E-03	7.91E-03
HINT	BP	GO:0072520	seminiferous tubule development	-	15	14	-	-	4.44E-04	7.42E-04
HINT	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	5.14E-03	8.65E-04
HINT	BP	GO:0035188	hatching	-	27	23	-	-	3.01E-04	1.17E-03
HINT	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	79	-	-	1.71E-03	3.95E-03
HINT	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	2.44E-04	7.42E-04
HINT	BP	GO:0090713	immunological memory process	-	18	18	-	-	3.86E-02	9.27E-04
HINT	BP	GO:0061326	renal tubule development	-	103	93	-	-	8.16E-03	4.63E-03
HINT	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	2.58E-02	2.72E-03
HINT	BP	GO:0006450	regulation of translational fidelity	-	18	16	-	-	1.60E-03	8.03E-04
HINT	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	3.58E-02	9.89E-04
HINT	BP	GO:0060325	face morphogenesis	-	31	29	-	-	5.60E-04	1.48E-03
HINT	BP	GO:0090559	regulation of membrane permeability	-	72	62	-	-	7.89E-03	3.09E-03
HINT	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	13	-	-	7.01E-02	6.80E-04
HINT	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	5.80E-02	6.18E-04
HINT	BP	GO:0031579	membrane raft organization	-	25	23	-	-	8.30E-04	1.17E-03
HINT	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	1.71E-03	1.24E-03
HINT	BP	GO:0060033	anatomical structure regression	-	16	14	-	-	1.84E-04	7.42E-04
HINT	BP	GO:0046460	neutral lipid biosynthetic process	-	50	40	-	-	1.65E-03	1.98E-03
HINT	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	122	-	-	4.52E-03	6.06E-03
HINT	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	1.84E-04	5.56E-04
HINT	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	158	-	-	4.40E-03	7.85E-03
HINT	BP	GO:0002251	organ or tissue specific immune response	-	43	32	-	-	1.46E-02	1.61E-03
HINT	CC	GO:0048167	regulation of synaptic plasticity	-	210	176	-	-	4.78E-03	8.71E-03
HINT	BP	GO:1903708	positive regulation of hemopoiesis	-	184	172	-	-	1.10E-02	8.53E-03
HINT	BP	GO:1903008	organelle disassembly	-	154	151	-	-	8.26E-03	7.48E-03
HINT	BP	GO:0001709	cell fate determination	-	44	41	-	-	5.10E-03	2.04E-03
HINT	BP	GO:0051873	killing by host of symbiont cells	-	28	25	-	-	4.45E-02	1.24E-03
HINT	BP	GO:0045058	T cell selection	-	53	53	-	-	1.25E-02	2.66E-03
HINT	CC	GO:0032387	negative regulation of intracellular transport	-	51	47	-	-	1.33E-03	2.35E-03
HINT	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	6.76E-04	9.89E-04
HINT	BP	GO:0072091	regulation of stem cell proliferation	-	91	75	-	-	3.03E-03	3.71E-03
HINT	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	39	-	-	5.51E-03	1.98E-03
HINT	BP	GO:0099084	postsynaptic specialization organization	-	44	40	-	-	8.50E-03	1.98E-03
HINT	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	8.27E-03	5.56E-04
HINT	BP	GO:0071501	cellular response to sterol depletion	-	15	14	-	-	1.20E-01	7.42E-04
HINT	BP	GO:0060384	innervation	-	27	27	-	-	4.07E-02	1.36E-03
HINT	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	2.14E-03	6.18E-04
HINT	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	28	-	-	3.67E-04	1.42E-03
HINT	MF	GO:0031281	positive regulation of cyclase activity	-	40	35	-	-	1.05E-02	1.73E-03
HINT	MF	GO:0098631	cell adhesion mediator activity	-	64	57	-	-	1.08E-02	2.84E-03
HINT	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	17	-	-	2.45E-04	8.65E-04
HINT	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	5.78E-03	6.18E-04
HINT	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	3.04E-03	9.27E-04
HINT	BP	GO:0071453	cellular response to oxygen levels	-	168	147	-	-	4.00E-03	7.29E-03
HINT	BP	GO:0090399	replicative senescence	-	17	15	-	-	4.37E-03	7.42E-04
HINT	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	12	-	-	1.83E-04	6.18E-04
HINT	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	1.39E-02	1.48E-03
HINT	BP	GO:0070585	protein localization to mitochondrion	-	125	124	-	-	9.34E-03	6.18E-03
HINT	BP	GO:0006855	xenobiotic transmembrane transport	-	14	12	-	-	2.01E-02	6.18E-04
HINT	BP	GO:0010623	programmed cell death involved in cell development	-	25	22	-	-	4.71E-03	1.11E-03
HINT	BP	GO:0044242	cellular lipid catabolic process	-	224	202	-	-	9.85E-03	1.00E-02
HINT	BP	GO:0071236	cellular response to antibiotic	-	13	12	-	-	7.39E-04	6.18E-04
HINT	BP	GO:0002931	response to ischemia	-	58	55	-	-	7.18E-03	2.72E-03
HINT	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	1.45E-02	6.18E-04
HINT	BP	GO:0014047	glutamate secretion	-	25	22	-	-	1.83E-03	1.11E-03
HINT	BP	GO:0061005	cell differentiation involved in kidney development	-	58	57	-	-	9.73E-03	2.84E-03
HINT	BP	GO:0030397	membrane disassembly	-	11	11	-	-	4.60E-04	5.56E-04
HINT	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	65	-	-	1.70E-02	3.21E-03
HINT	BP	GO:0060420	regulation of heart growth	-	74	57	-	-	2.16E-03	2.84E-03
HINT	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	13	-	-	6.72E-04	6.80E-04
HINT	BP	GO:0009755	hormone-mediated signaling pathway	-	221	198	-	-	9.13E-03	9.83E-03
HINT	BP	GO:0022612	gland morphogenesis	-	124	117	-	-	4.91E-03	5.81E-03
HINT	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	35	-	-	7.09E-04	1.73E-03
HINT	MF	GO:0140416	transcription regulator inhibitor activity	-	26	25	-	-	1.02E-03	1.24E-03
HINT	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	19	-	-	2.13E-01	9.89E-04
HINT	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	2.45E-04	7.42E-04
HINT	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	5.63E-02	8.65E-04
HINT	BP	GO:1990845	adaptive thermogenesis	-	166	155	-	-	4.79E-03	7.66E-03
HINT	BP	GO:0071320	cellular response to cAMP	-	54	50	-	-	1.53E-02	2.47E-03
HINT	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	5.80E-02	5.56E-04
HINT	BP	GO:0015844	monoamine transport	-	88	78	-	-	1.83E-02	3.89E-03
HINT	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	3.95E-03	1.11E-03
HINT	BP	GO:0060039	pericardium development	-	19	17	-	-	6.10E-04	8.65E-04
HINT	BP	GO:0071392	cellular response to estradiol stimulus	-	40	38	-	-	7.24E-04	1.92E-03
HINT	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	12	-	-	1.82E-04	6.18E-04
HINT	BP	GO:0000272	polysaccharide catabolic process	-	19	18	-	-	7.56E-03	9.27E-04
HINT	BP	GO:0009451	RNA modification	-	169	152	-	-	2.36E-02	7.54E-03
HINT	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	37	-	-	3.29E-03	1.85E-03
HINT	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	2.39E-03	8.65E-04
HINT	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	108	-	-	6.84E-03	5.38E-03
HINT	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	35	-	-	3.74E-03	1.73E-03
HINT	BP	GO:0015807	L-amino acid transport	-	94	82	-	-	6.55E-03	4.08E-03
HINT	BP	GO:0032941	secretion by tissue	-	85	77	-	-	2.32E-03	3.83E-03
HINT	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	11	-	-	3.05E-02	5.56E-04
HINT	BP	GO:0046605	regulation of centrosome cycle	-	54	52	-	-	4.96E-03	2.60E-03
HINT	BP	GO:0048753	pigment granule organization	-	40	38	-	-	9.08E-02	1.92E-03
HINT	BP	GO:0021516	dorsal spinal cord development	-	20	16	-	-	2.43E-04	8.03E-04
HINT	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	19	-	-	2.45E-04	9.89E-04
HINT	BP	GO:0003014	renal system process	-	130	117	-	-	9.17E-03	5.81E-03
HINT	CC	GO:0070286	axonemal dynein complex assembly	-	40	32	-	-	1.49E-03	1.61E-03
HINT	BP	GO:0045598	regulation of fat cell differentiation	-	148	125	-	-	3.64E-03	6.18E-03
HINT	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	184	-	-	1.31E-02	9.15E-03
HINT	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	2.39E-03	1.92E-03
HINT	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	3.89E-04	1.24E-03
HINT	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	184	-	-	7.57E-02	9.15E-03
HINT	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.77E-04	6.80E-04
HINT	BP	GO:0008340	determination of adult lifespan	-	23	22	-	-	1.09E-03	1.11E-03
HINT	BP	GO:0018158	protein oxidation	-	15	13	-	-	1.49E-02	6.80E-04
HINT	BP	GO:0039694	viral RNA genome replication	-	30	29	-	-	9.25E-03	1.48E-03
HINT	BP	GO:0009404	toxin metabolic process	-	17	14	-	-	1.84E-04	7.42E-04
HINT	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	26	-	-	5.73E-04	1.30E-03
HINT	BP	GO:0071709	membrane assembly	-	68	61	-	-	1.63E-02	3.03E-03
HINT	BP	GO:0008217	regulation of blood pressure	-	186	156	-	-	1.27E-02	7.72E-03
HINT	BP	GO:0031643	positive regulation of myelination	-	19	17	-	-	2.42E-04	8.65E-04
HINT	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	2.52E-02	7.42E-04
HINT	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	57	-	-	4.85E-03	2.84E-03
HINT	CC	GO:0042770	signal transduction in response to DNA damage	-	186	184	-	-	1.26E-02	9.15E-03
HINT	BP	GO:0002200	somatic diversification of immune receptors	-	78	78	-	-	3.54E-02	3.89E-03
HINT	BP	GO:0035315	hair cell differentiation	-	52	44	-	-	2.75E-03	2.22E-03
HINT	BP	GO:0048645	animal organ formation	-	62	59	-	-	9.36E-03	2.97E-03
HINT	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	153	-	-	4.10E-03	7.60E-03
HINT	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	11	-	-	1.81E-04	5.56E-04
HINT	BP	GO:0033627	cell adhesion mediated by integrin	-	87	82	-	-	1.02E-02	4.08E-03
HINT	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	20	-	-	3.58E-03	9.89E-04
HINT	BP	GO:0015824	proline transport	-	13	11	-	-	1.08E-02	5.56E-04
HINT	BP	GO:0035107	appendage morphogenesis	-	147	141	-	-	5.71E-03	6.98E-03
HINT	BP	GO:1903707	negative regulation of hemopoiesis	-	116	102	-	-	6.19E-03	5.07E-03
HINT	BP	GO:0036342	post-anal tail morphogenesis	-	19	16	-	-	2.43E-04	8.03E-04
HINT	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	6.62E-02	1.24E-03
HINT	BP	GO:0030149	sphingolipid catabolic process	-	32	27	-	-	2.27E-03	1.36E-03
HINT	BP	GO:0050994	regulation of lipid catabolic process	-	61	54	-	-	7.39E-04	2.72E-03
HINT	BP	GO:0035988	chondrocyte proliferation	-	24	21	-	-	2.73E-03	1.05E-03
HINT	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	28	-	-	4.74E-02	1.42E-03
HINT	BP	GO:0009593	detection of chemical stimulus	-	511	88	-	-	8.44E-03	4.39E-03
HINT	BP	GO:0060788	ectodermal placode formation	-	12	11	-	-	7.89E-04	5.56E-04
HINT	BP	GO:0045727	positive regulation of translation	-	141	136	-	-	6.01E-03	6.74E-03
HINT	BP	GO:0036315	cellular response to sterol	-	24	17	-	-	2.44E-04	8.65E-04
HINT	CC	GO:0032388	positive regulation of intracellular transport	-	137	132	-	-	2.39E-03	6.55E-03
HINT	BP	GO:0021979	hypothalamus cell differentiation	-	13	12	-	-	2.99E-03	6.18E-04
HINT	BP	GO:0002027	regulation of heart rate	-	106	87	-	-	1.77E-02	4.33E-03
HINT	BP	GO:0050879	multicellular organismal movement	-	118	102	-	-	2.19E-03	5.07E-03
HINT	BP	GO:0120305	regulation of pigmentation	-	15	12	-	-	1.12E-02	6.18E-04
HINT	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	70	-	-	2.26E-03	3.46E-03
HINT	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	55	-	-	5.76E-03	2.72E-03
HINT	BP	GO:0048515	spermatid differentiation	-	208	175	-	-	2.90E-03	8.65E-03
HINT	BP	GO:0072132	mesenchyme morphogenesis	-	57	56	-	-	1.14E-02	2.78E-03
HINT	MF	GO:0042887	amide transmembrane transporter activity	-	33	29	-	-	1.41E-03	1.48E-03
HINT	BP	GO:0007130	synaptonemal complex assembly	-	23	18	-	-	1.18E-03	9.27E-04
HINT	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	33	-	-	2.01E-03	1.67E-03
HINT	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	31	-	-	5.63E-04	1.54E-03
HINT	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	33	-	-	4.27E-04	1.67E-03
HINT	BP	GO:0060119	inner ear receptor cell development	-	44	40	-	-	1.36E-03	1.98E-03
HINT	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	1.19E-03	9.27E-04
HINT	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	32	-	-	4.30E-02	1.61E-03
HINT	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	6.75E-04	1.24E-03
HINT	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.56E-02	6.18E-04
HINT	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	235	-	-	1.38E-02	1.16E-02
HINT	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	8.85E-04	8.65E-04
HINT	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	47	-	-	6.66E-02	2.35E-03
HINT	BP	GO:0010883	regulation of lipid storage	-	53	48	-	-	3.18E-03	2.41E-03
HINT	BP	GO:0072170	metanephric tubule development	-	26	24	-	-	1.11E-02	1.24E-03
HINT	BP	GO:0007635	chemosensory behavior	-	20	16	-	-	2.40E-04	8.03E-04
HINT	BP	GO:1905954	positive regulation of lipid localization	-	110	100	-	-	5.20E-03	4.94E-03
HINT	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.79E-04	6.18E-04
HINT	BP	GO:0002209	behavioral defense response	-	39	38	-	-	1.72E-03	1.92E-03
HINT	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	27	-	-	4.83E-02	1.36E-03
HINT	BP	GO:0072523	purine-containing compound catabolic process	-	146	140	-	-	4.69E-03	6.92E-03
HINT	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	28	-	-	2.17E-03	1.42E-03
HINT	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	26	-	-	2.13E-03	1.30E-03
HINT	BP	GO:0021535	cell migration in hindbrain	-	16	15	-	-	2.42E-04	7.42E-04
HINT	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	93	-	-	6.46E-03	4.63E-03
HINT	BP	GO:0007218	neuropeptide signaling pathway	-	113	77	-	-	5.18E-02	3.83E-03
HINT	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	1.25E-02	6.18E-04
HINT	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	130	-	-	6.31E-03	6.43E-03
HINT	BP	GO:0031345	negative regulation of cell projection organization	-	195	180	-	-	8.00E-03	8.90E-03
HINT	BP	GO:0048278	vesicle docking	-	64	62	-	-	3.12E-02	3.09E-03
HINT	BP	GO:0035050	embryonic heart tube development	-	86	83	-	-	7.56E-03	4.14E-03
HINT	BP	GO:0030168	platelet activation	-	135	124	-	-	7.10E-03	6.18E-03
HINT	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	1.46E-01	8.03E-04
HINT	CC	GO:0098810	neurotransmitter reuptake	-	35	32	-	-	2.39E-02	1.61E-03
HINT	BP	GO:0008213	protein alkylation	-	58	53	-	-	5.93E-03	2.66E-03
HINT	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	5.42E-04	6.80E-04
HINT	BP	GO:0031338	regulation of vesicle fusion	-	24	23	-	-	2.15E-03	1.17E-03
HINT	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	12	-	-	1.82E-04	6.18E-04
HINT	BP	GO:0031529	ruffle organization	-	55	53	-	-	1.86E-03	2.66E-03
HINT	BP	GO:0010842	retina layer formation	-	25	23	-	-	3.06E-04	1.17E-03
HINT	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	81	-	-	7.07E-02	4.02E-03
HINT	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	4.69E-02	5.56E-04
HINT	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	68	-	-	1.10E-02	3.40E-03
HINT	MF	GO:0170055	lipid transmembrane transporter activity	-	56	46	-	-	1.58E-02	2.29E-03
HINT	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	30	-	-	7.01E-04	1.48E-03
HINT	BP	GO:0035304	regulation of protein dephosphorylation	-	87	81	-	-	1.79E-03	4.02E-03
HINT	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	216	-	-	4.52E-03	1.07E-02
HINT	BP	GO:0099637	neurotransmitter receptor transport	-	26	23	-	-	4.14E-03	1.17E-03
HINT	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	1.42E-03	1.73E-03
HINT	BP	GO:0051775	response to redox state	-	13	13	-	-	1.11E-02	6.80E-04
HINT	BP	GO:0051785	positive regulation of nuclear division	-	61	59	-	-	2.41E-03	2.97E-03
HINT	BP	GO:0060456	positive regulation of digestive system process	-	16	13	-	-	1.83E-04	6.80E-04
HINT	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	15	-	-	2.27E-03	7.42E-04
HINT	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	4.65E-04	9.89E-04
HINT	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	3.79E-02	6.18E-04
HINT	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	7.71E-03	2.22E-03
HINT	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	11	-	-	6.35E-03	5.56E-04
HINT	BP	GO:0044539	long-chain fatty acid import into cell	-	17	16	-	-	2.42E-04	8.03E-04
HINT	BP	GO:0051299	centrosome separation	-	15	14	-	-	3.56E-04	7.42E-04
HINT	BP	GO:0048145	regulation of fibroblast proliferation	-	87	83	-	-	2.22E-03	4.14E-03
HINT	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	77	-	-	9.81E-02	3.83E-03
HINT	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	1.77E-02	5.56E-04
HINT	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	220	-	-	5.60E-03	1.09E-02
HINT	BP	GO:0032098	regulation of appetite	-	20	18	-	-	2.15E-02	9.27E-04
HINT	BP	GO:0021819	layer formation in cerebral cortex	-	14	13	-	-	1.33E-03	6.80E-04
HINT	CC	GO:0008333	endosome to lysosome transport	-	73	69	-	-	1.52E-02	3.46E-03
HINT	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	20	-	-	1.45E-03	9.89E-04
HINT	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	15	-	-	6.96E-04	7.42E-04
HINT	BP	GO:0003016	respiratory system process	-	39	34	-	-	5.71E-04	1.73E-03
HINT	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	22	-	-	8.23E-03	1.11E-03
HINT	BP	GO:0045732	positive regulation of protein catabolic process	-	202	196	-	-	5.33E-03	9.70E-03
HINT	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	68	-	-	9.53E-03	3.40E-03
HINT	BP	GO:0007588	excretion	-	40	33	-	-	3.88E-02	1.67E-03
HINT	BP	GO:1904018	positive regulation of vasculature development	-	185	140	-	-	1.10E-02	6.92E-03
HINT	BP	GO:0050953	sensory perception of light stimulus	-	223	179	-	-	1.12E-02	8.90E-03
HINT	BP	GO:0009164	nucleoside catabolic process	-	25	22	-	-	3.06E-04	1.11E-03
HINT	BP	GO:0009303	rRNA transcription	-	37	36	-	-	4.02E-03	1.79E-03
HINT	BP	GO:0035601	protein deacylation	-	56	55	-	-	5.00E-03	2.72E-03
HINT	BP	GO:0061952	midbody abscission	-	18	17	-	-	2.02E-02	8.65E-04
HINT	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	4.09E-02	5.56E-04
HINT	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	18	-	-	6.94E-03	9.27E-04
HINT	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	1.10E-03	1.48E-03
HINT	BP	GO:0071300	cellular response to retinoic acid	-	66	60	-	-	2.54E-03	2.97E-03
HINT	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	12	-	-	1.84E-04	6.18E-04
HINT	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	2.89E-02	1.42E-03
HINT	BP	GO:0031069	hair follicle morphogenesis	-	33	31	-	-	7.62E-03	1.54E-03
HINT	BP	GO:0046697	decidualization	-	26	23	-	-	9.67E-04	1.17E-03
HINT	BP	GO:0008212	mineralocorticoid metabolic process	-	14	13	-	-	1.84E-04	6.80E-04
HINT	BP	GO:0051588	regulation of neurotransmitter transport	-	99	90	-	-	2.69E-03	4.45E-03
HINT	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	23	-	-	1.74E-03	1.17E-03
HINT	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	11	-	-	1.82E-04	5.56E-04
HINT	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	8.23E-03	3.15E-03
HINT	BP	GO:0044703	multi-organism reproductive process	-	209	186	-	-	5.64E-03	9.21E-03
HINT	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	132	-	-	4.51E-03	6.55E-03
HINT	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	49	-	-	1.22E-02	2.47E-03
HINT	BP	GO:0099022	vesicle tethering	-	32	31	-	-	2.59E-01	1.54E-03
HINT	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	36	-	-	7.18E-04	1.79E-03
HINT	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	1.82E-04	6.18E-04
HINT	BP	GO:0048857	neural nucleus development	-	65	57	-	-	1.04E-03	2.84E-03
HINT	BP	GO:0048663	neuron fate commitment	-	74	65	-	-	5.79E-03	3.21E-03
HINT	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	153	-	-	3.65E-03	7.60E-03
HINT	BP	GO:0106027	neuron projection organization	-	90	86	-	-	5.34E-03	4.26E-03
HINT	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	120	-	-	1.02E-02	5.93E-03
HINT	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	34	-	-	2.73E-03	1.73E-03
HINT	BP	GO:0045685	regulation of glial cell differentiation	-	77	69	-	-	2.66E-03	3.46E-03
HINT	BP	GO:0051608	histamine transport	-	14	12	-	-	1.23E-02	6.18E-04
HINT	BP	GO:0043414	macromolecule methylation	-	138	125	-	-	6.16E-03	6.18E-03
HINT	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	2.78E-02	8.03E-04
HINT	BP	GO:0050886	endocrine process	-	93	81	-	-	7.51E-03	4.02E-03
HINT	MF	GO:0015562	efflux transmembrane transporter activity	-	15	12	-	-	1.84E-04	6.18E-04
HINT	BP	GO:0050951	sensory perception of temperature stimulus	-	28	21	-	-	1.83E-02	1.05E-03
HINT	BP	GO:0045807	positive regulation of endocytosis	-	155	147	-	-	6.12E-03	7.29E-03
HINT	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	9.76E-04	5.56E-04
HINT	BP	GO:0002418	immune response to tumor cell	-	29	26	-	-	4.54E-02	1.30E-03
HINT	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	2.43E-03	2.90E-03
HINT	BP	GO:0048308	organelle inheritance	-	14	14	-	-	9.88E-04	7.42E-04
HINT	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	1.11E-03	9.27E-04
HINT	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	1.67E-03	9.89E-04
HINT	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	41	-	-	5.39E-04	2.04E-03
HINT	BP	GO:0034394	protein localization to cell surface	-	69	66	-	-	1.40E-03	3.28E-03
HINT	BP	GO:0042447	hormone catabolic process	-	12	11	-	-	1.84E-04	5.56E-04
HINT	BP	GO:0009110	vitamin biosynthetic process	-	23	20	-	-	2.99E-04	9.89E-04
HINT	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	1.08E-02	1.11E-03
HINT	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	5.50E-03	8.65E-04
HINT	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	19	-	-	1.82E-03	9.89E-04
HINT	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	89	-	-	2.33E-03	4.45E-03
HINT	MF	GO:0051100	negative regulation of binding	-	161	149	-	-	3.87E-03	7.42E-03
HINT	BP	GO:0003151	outflow tract morphogenesis	-	81	76	-	-	8.49E-03	3.77E-03
HINT	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	2.59E-03	2.97E-03
HINT	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	2.32E-03	9.89E-04
HINT	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	1.84E-04	6.18E-04
HINT	BP	GO:0061036	positive regulation of cartilage development	-	33	31	-	-	1.49E-02	1.54E-03
HINT	BP	GO:0046184	aldehyde biosynthetic process	-	16	15	-	-	2.44E-04	7.42E-04
HINT	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	2.18E-03	6.80E-04
HINT	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	46	-	-	9.62E-04	2.29E-03
HINT	BP	GO:0046621	negative regulation of organ growth	-	39	31	-	-	1.18E-03	1.54E-03
HINT	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	9.89E-02	2.47E-03
HINT	BP	GO:0032368	regulation of lipid transport	-	149	124	-	-	5.74E-03	6.18E-03
HINT	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	1.62E-02	1.48E-03
HINT	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	175	-	-	6.54E-03	8.65E-03
HINT	BP	GO:0033002	muscle cell proliferation	-	249	195	-	-	6.70E-03	9.64E-03
HINT	BP	GO:0043331	response to dsRNA	-	56	50	-	-	4.02E-02	2.47E-03
HINT	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	1.93E-02	6.18E-04
HINT	BP	GO:0051904	pigment granule transport	-	23	21	-	-	3.06E-02	1.05E-03
HINT	BP	GO:1901679	nucleotide transmembrane transport	-	32	30	-	-	7.14E-04	1.48E-03
HINT	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	2.08E-03	1.67E-03
HINT	BP	GO:0033363	secretory granule organization	-	63	61	-	-	1.51E-02	3.03E-03
HINT	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	2.19E-03	1.42E-03
HINT	BP	GO:0120009	intermembrane lipid transfer	-	52	48	-	-	3.15E-02	2.41E-03
HINT	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	2.15E-02	7.42E-04
HINT	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	36	-	-	1.50E-03	1.79E-03
HINT	BP	GO:0033622	integrin activation	-	26	24	-	-	2.38E-03	1.24E-03
HINT	BP	GO:0098751	bone cell development	-	18	16	-	-	2.40E-04	8.03E-04
HINT	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.52E-03	1.05E-03
HINT	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	50	-	-	3.59E-03	2.47E-03
HINT	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.09E-02	1.48E-03
HINT	BP	GO:0002076	osteoblast development	-	17	16	-	-	2.41E-03	8.03E-04
HINT	BP	GO:0072164	mesonephric tubule development	-	98	91	-	-	1.29E-02	4.51E-03
HINT	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	2.45E-04	8.65E-04
HINT	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	104	-	-	5.14E-03	5.19E-03
HINT	BP	GO:1903524	positive regulation of blood circulation	-	39	32	-	-	3.07E-02	1.61E-03
HINT	BP	GO:0030901	midbrain development	-	87	79	-	-	1.63E-03	3.95E-03
HINT	BP	GO:0048485	sympathetic nervous system development	-	22	20	-	-	3.59E-02	9.89E-04
HINT	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	2.25E-04	8.03E-04
HINT	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	3.76E-03	6.80E-04
HINT	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	65	-	-	4.23E-03	3.21E-03
HINT	BP	GO:0002687	positive regulation of leukocyte migration	-	147	134	-	-	5.06E-03	6.67E-03
HINT	BP	GO:0019755	one-carbon compound transport	-	28	24	-	-	2.00E-02	1.24E-03
HINT	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.81E-04	6.80E-04
HINT	BP	GO:0060856	establishment of blood-brain barrier	-	16	15	-	-	2.42E-04	7.42E-04
HINT	BP	GO:0110154	RNA decapping	-	19	18	-	-	2.63E-02	9.27E-04
HINT	BP	GO:0034605	cellular response to heat	-	66	63	-	-	2.66E-03	3.15E-03
HINT	BP	GO:0005996	monosaccharide metabolic process	-	250	231	-	-	7.77E-03	1.14E-02
HINT	BP	GO:0033555	multicellular organismal response to stress	-	90	81	-	-	3.16E-03	4.02E-03
HINT	BP	GO:0002262	myeloid cell homeostasis	-	172	161	-	-	5.67E-03	7.97E-03
HINT	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	1.63E-01	1.92E-03
HINT	BP	GO:0050688	regulation of defense response to virus	-	65	62	-	-	1.39E-02	3.09E-03
HINT	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	4.43E-03	9.89E-04
HINT	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	221	-	-	1.03E-02	1.09E-02
HINT	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	30	-	-	2.75E-03	1.48E-03
HINT	BP	GO:0061029	eyelid development in camera-type eye	-	14	13	-	-	9.21E-04	6.80E-04
HINT	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	1.64E-02	1.61E-03
HINT	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	17	-	-	2.42E-04	8.65E-04
HINT	BP	GO:0003272	endocardial cushion formation	-	28	27	-	-	2.19E-02	1.36E-03
HINT	BP	GO:0022618	protein-RNA complex assembly	-	227	189	-	-	1.98E-02	9.39E-03
HINT	BP	GO:0051147	regulation of muscle cell differentiation	-	162	131	-	-	6.59E-03	6.49E-03
HINT	BP	GO:0090102	cochlea development	-	50	45	-	-	1.15E-03	2.22E-03
HINT	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	25	-	-	1.84E-03	1.24E-03
HINT	BP	GO:0045933	positive regulation of muscle contraction	-	49	40	-	-	7.89E-03	1.98E-03
HINT	BP	GO:0015803	branched-chain amino acid transport	-	14	13	-	-	5.17E-03	6.80E-04
HINT	BP	GO:0002679	respiratory burst involved in defense response	-	16	15	-	-	2.38E-04	7.42E-04
HINT	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	32	-	-	2.43E-03	1.61E-03
HINT	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	90	-	-	8.77E-02	4.45E-03
HINT	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.83E-04	6.18E-04
HINT	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	3.92E-03	1.11E-03
HINT	BP	GO:0032922	circadian regulation of gene expression	-	71	70	-	-	6.20E-03	3.46E-03
HINT	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	37	-	-	2.26E-02	1.85E-03
HINT	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	115	-	-	3.02E-03	5.68E-03
HINT	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	12	-	-	4.02E-02	6.18E-04
HINT	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	53	-	-	4.11E-03	2.66E-03
HINT	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	1.78E-03	5.56E-04
HINT	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	1.72E-02	1.92E-03
HINT	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.80E-04	6.18E-04
HINT	BP	GO:0140253	cell-cell fusion	-	62	56	-	-	3.55E-03	2.78E-03
HINT	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	11	-	-	1.83E-04	5.56E-04
HINT	BP	GO:0071599	otic vesicle development	-	15	15	-	-	5.33E-02	7.42E-04
HINT	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	40	-	-	2.74E-02	1.98E-03
HINT	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	6.31E-04	7.42E-04
HINT	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	58	-	-	4.41E-03	2.90E-03
HINT	BP	GO:0001941	postsynaptic membrane organization	-	37	32	-	-	9.82E-03	1.61E-03
HINT	BP	GO:0051293	establishment of spindle localization	-	57	53	-	-	2.65E-03	2.66E-03
HINT	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	1.80E-04	6.18E-04
HINT	BP	GO:0043114	regulation of vascular permeability	-	49	43	-	-	5.52E-03	2.16E-03
HINT	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	7.98E-03	1.30E-03
HINT	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	61	-	-	2.20E-03	3.03E-03
HINT	BP	GO:0008360	regulation of cell shape	-	139	131	-	-	5.75E-03	6.49E-03
HINT	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	15	-	-	2.45E-04	7.42E-04
HINT	BP	GO:0051222	positive regulation of protein transport	-	249	229	-	-	9.16E-03	1.14E-02
HINT	CC	GO:0140632	canonical inflammasome complex assembly	-	40	38	-	-	2.37E-03	1.92E-03
HINT	MF	GO:0034260	negative regulation of GTPase activity	-	36	33	-	-	1.15E-03	1.67E-03
HINT	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	1.85E-02	1.11E-03
HINT	BP	GO:0045739	positive regulation of DNA repair	-	128	127	-	-	5.65E-02	6.30E-03
HINT	BP	GO:0001845	phagolysosome assembly	-	19	16	-	-	2.44E-04	8.03E-04
HINT	BP	GO:0045185	maintenance of protein location	-	95	87	-	-	1.94E-03	4.33E-03
HINT	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	12	-	-	7.14E-02	6.18E-04
HINT	BP	GO:0003158	endothelium development	-	140	125	-	-	7.90E-03	6.18E-03
HINT	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	1.83E-03	2.04E-03
HINT	BP	GO:0051224	negative regulation of protein transport	-	122	102	-	-	5.15E-03	5.07E-03
HINT	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	138	-	-	2.71E-03	6.86E-03
HINT	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	4.45E-03	6.80E-04
HINT	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	29	-	-	1.14E-03	1.48E-03
HINT	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	1.01E-01	9.89E-04
HINT	BP	GO:0021885	forebrain cell migration	-	63	60	-	-	8.55E-03	2.97E-03
HINT	BP	GO:0007405	neuroblast proliferation	-	81	74	-	-	3.81E-03	3.71E-03
HINT	BP	GO:0009581	detection of external stimulus	-	137	104	-	-	1.72E-02	5.19E-03
HINT	BP	GO:1990542	mitochondrial transmembrane transport	-	93	86	-	-	1.33E-02	4.26E-03
HINT	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	2.55E-03	1.54E-03
HINT	BP	GO:0033504	floor plate development	-	11	11	-	-	4.71E-03	5.56E-04
HINT	BP	GO:0097186	amelogenesis	-	26	20	-	-	5.18E-02	9.89E-04
HINT	BP	GO:0031128	developmental induction	-	26	25	-	-	2.93E-03	1.24E-03
HINT	BP	GO:0035672	oligopeptide transmembrane transport	-	15	13	-	-	1.84E-04	6.80E-04
HINT	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.35E-03	3.28E-03
HINT	BP	GO:0021533	cell differentiation in hindbrain	-	23	20	-	-	1.63E-02	9.89E-04
HINT	BP	GO:0045684	positive regulation of epidermis development	-	33	29	-	-	8.95E-04	1.48E-03
HINT	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	11	-	-	1.83E-04	5.56E-04
HINT	BP	GO:1900047	negative regulation of hemostasis	-	51	49	-	-	2.84E-02	2.47E-03
HINT	BP	GO:0021517	ventral spinal cord development	-	47	41	-	-	9.42E-03	2.04E-03
HINT	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	4.39E-03	3.71E-03
HINT	BP	GO:0032328	alanine transport	-	19	16	-	-	3.71E-03	8.03E-04
HINT	MF	GO:0034497	protein localization to phagophore assembly site	-	16	15	-	-	4.59E-03	7.42E-04
HINT	BP	GO:0097722	sperm motility	-	133	100	-	-	4.07E-03	4.94E-03
HINT	BP	GO:0051231	spindle elongation	-	14	13	-	-	1.32E-02	6.80E-04
HINT	BP	GO:0042490	mechanoreceptor differentiation	-	67	58	-	-	3.25E-03	2.90E-03
HINT	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	28	-	-	3.26E-03	1.42E-03
HINT	BP	GO:0035148	tube formation	-	155	146	-	-	4.74E-03	7.23E-03
HINT	BP	GO:0048520	positive regulation of behavior	-	27	25	-	-	4.57E-02	1.24E-03
HINT	BP	GO:0098543	detection of other organism	-	19	16	-	-	5.02E-02	8.03E-04
HINT	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	4.82E-03	2.16E-03
HINT	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	118	-	-	8.99E-03	5.87E-03
HINT	BP	GO:0031123	RNA 3'-end processing	-	79	76	-	-	1.05E-02	3.77E-03
HINT	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	5.31E-02	5.56E-04
HINT	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	99	-	-	2.99E-03	4.94E-03
HINT	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	7.60E-03	9.27E-04
HINT	CC	GO:0007097	nuclear migration	-	24	23	-	-	4.74E-03	1.17E-03
HINT	BP	GO:0006885	regulation of pH	-	104	85	-	-	1.38E-02	4.20E-03
HINT	BP	GO:0002467	germinal center formation	-	14	14	-	-	2.29E-03	7.42E-04
HINT	BP	GO:1990840	response to lectin	-	22	18	-	-	2.92E-03	9.27E-04
HINT	BP	GO:0071800	podosome assembly	-	19	19	-	-	5.34E-04	9.89E-04
HINT	BP	GO:0031018	endocrine pancreas development	-	47	44	-	-	1.49E-02	2.22E-03
HINT	BP	GO:0001708	cell fate specification	-	108	100	-	-	8.84E-03	4.94E-03
HINT	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	66	-	-	3.39E-03	3.28E-03
HINT	BP	GO:0030279	negative regulation of ossification	-	39	35	-	-	9.03E-03	1.73E-03
HINT	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	2.87E-03	7.42E-04
HINT	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	3.05E-03	6.18E-04
HINT	BP	GO:0042440	pigment metabolic process	-	80	67	-	-	2.86E-02	3.34E-03
HINT	BP	GO:1901606	alpha-amino acid catabolic process	-	101	93	-	-	1.02E-02	4.63E-03
HINT	BP	GO:1901890	positive regulation of cell junction assembly	-	106	86	-	-	4.98E-03	4.26E-03
HINT	BP	GO:0070988	demethylation	-	27	22	-	-	3.00E-04	1.11E-03
HINT	BP	GO:1901655	cellular response to ketone	-	107	97	-	-	4.50E-03	4.82E-03
HINT	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	1.82E-04	7.42E-04
HINT	BP	GO:0051255	spindle midzone assembly	-	14	13	-	-	1.37E-02	6.80E-04
HINT	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	2.13E-02	8.65E-04
HINT	BP	GO:0006968	cellular defense response	-	52	45	-	-	6.97E-03	2.22E-03
HINT	BP	GO:0055006	cardiac cell development	-	93	79	-	-	4.14E-03	3.95E-03
HINT	BP	GO:0031365	N-terminal protein amino acid modification	-	30	27	-	-	8.63E-03	1.36E-03
HINT	BP	GO:0035881	amacrine cell differentiation	-	12	11	-	-	1.84E-04	5.56E-04
HINT	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	27	-	-	5.01E-03	1.36E-03
HINT	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	7.12E-04	6.18E-04
HINT	BP	GO:0060004	reflex	-	63	55	-	-	1.72E-03	2.72E-03
HINT	BP	GO:0044706	multi-multicellular organism process	-	217	194	-	-	6.10E-03	9.64E-03
HINT	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	1.66E-03	6.18E-04
HINT	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	139	-	-	4.83E-03	6.92E-03
HINT	BP	GO:0006026	aminoglycan catabolic process	-	34	29	-	-	4.91E-03	1.48E-03
HINT	BP	GO:0031294	lymphocyte costimulation	-	47	44	-	-	1.35E-02	2.22E-03
HINT	BP	GO:0050768	negative regulation of neurogenesis	-	150	133	-	-	8.19E-03	6.61E-03
HINT	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	93	-	-	2.61E-03	4.63E-03
HINT	BP	GO:0090068	positive regulation of cell cycle process	-	262	238	-	-	5.75E-03	1.18E-02
HINT	BP	GO:0043605	amide catabolic process	-	16	14	-	-	1.84E-04	7.42E-04
HINT	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	21	-	-	3.01E-04	1.05E-03
HINT	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	33	-	-	1.55E-02	1.67E-03
HINT	BP	GO:1902115	regulation of organelle assembly	-	210	199	-	-	5.84E-03	9.89E-03
HINT	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	63	-	-	3.56E-03	3.15E-03
HINT	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	2.43E-04	8.03E-04
HINT	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	134	-	-	3.70E-03	6.67E-03
HINT	BP	GO:0043171	peptide catabolic process	-	19	14	-	-	1.84E-04	7.42E-04
HINT	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	7.95E-03	2.10E-03
HINT	BP	GO:0051952	regulation of amine transport	-	98	89	-	-	1.46E-02	4.45E-03
HINT	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	1.45E-02	1.17E-03
HINT	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	19	-	-	1.52E-02	9.89E-04
HINT	BP	GO:0015801	aromatic amino acid transport	-	13	11	-	-	8.91E-03	5.56E-04
HINT	BP	GO:0040019	positive regulation of embryonic development	-	23	22	-	-	7.67E-04	1.11E-03
HINT	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	3.03E-04	9.89E-04
HINT	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	2.41E-04	8.03E-04
HINT	CC	GO:0032365	intracellular lipid transport	-	51	48	-	-	1.16E-02	2.41E-03
HINT	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	2.57E-02	1.48E-03
HINT	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	65	-	-	1.06E-03	3.21E-03
HINT	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	110	-	-	7.97E-03	5.44E-03
HINT	BP	GO:0018149	peptide cross-linking	-	28	24	-	-	1.75E-03	1.24E-03
HINT	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	1.53E-03	1.24E-03
HINT	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	8.39E-04	6.80E-04
HINT	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	1.81E-04	7.42E-04
HINT	BP	GO:0061000	negative regulation of dendritic spine development	-	13	11	-	-	1.79E-04	5.56E-04
HINT	BP	GO:0071398	cellular response to fatty acid	-	35	32	-	-	3.61E-02	1.61E-03
HINT	BP	GO:0097581	lamellipodium organization	-	91	87	-	-	4.21E-03	4.33E-03
HINT	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	5.71E-02	1.48E-03
HINT	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	2.43E-04	9.27E-04
HINT	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	5.01E-03	1.05E-03
HINT	BP	GO:0015669	gas transport	-	23	21	-	-	7.09E-02	1.05E-03
HINT	BP	GO:0016485	protein processing	-	248	217	-	-	7.18E-03	1.08E-02
HINT	BP	GO:0009649	entrainment of circadian clock	-	30	27	-	-	7.54E-03	1.36E-03
HINT	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	132	-	-	2.15E-02	6.55E-03
HINT	BP	GO:1903523	negative regulation of blood circulation	-	27	22	-	-	5.88E-04	1.11E-03
HINT	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	120	-	-	1.97E-02	5.93E-03
HINT	BP	GO:0000101	sulfur amino acid transport	-	12	11	-	-	3.19E-01	5.56E-04
HINT	BP	GO:0099054	presynapse assembly	-	49	39	-	-	1.37E-02	1.98E-03
HINT	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	24	-	-	3.84E-03	1.24E-03
HINT	BP	GO:0006517	protein deglycosylation	-	26	24	-	-	6.49E-04	1.24E-03
HINT	BP	GO:0031348	negative regulation of defense response	-	282	224	-	-	6.80E-03	1.11E-02
HINT	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	73	-	-	6.50E-03	3.65E-03
HINT	BP	GO:0007606	sensory perception of chemical stimulus	-	535	98	-	-	1.62E-02	4.88E-03
HINT	BP	GO:0061180	mammary gland epithelium development	-	68	66	-	-	3.18E-03	3.28E-03
HINT	BP	GO:0071496	cellular response to external stimulus	-	74	71	-	-	5.46E-03	3.52E-03
HINT	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	12	-	-	1.83E-04	6.18E-04
HINT	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	1.13E-01	8.65E-04
HINT	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	1.79E-04	5.56E-04
HINT	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.02E-02	6.18E-04
HINT	BP	GO:0032094	response to food	-	37	35	-	-	2.57E-03	1.73E-03
HINT	BP	GO:0001964	startle response	-	27	26	-	-	4.37E-03	1.30E-03
HINT	BP	GO:0007340	acrosome reaction	-	38	29	-	-	9.70E-03	1.48E-03
HINT	BP	GO:0046434	organophosphate catabolic process	-	232	209	-	-	6.13E-03	1.04E-02
HINT	BP	GO:0060037	pharyngeal system development	-	29	27	-	-	1.42E-02	1.36E-03
HINT	BP	GO:0009566	fertilization	-	205	162	-	-	7.93E-03	8.03E-03
HINT	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	3.80E-01	2.97E-03
HINT	BP	GO:0120255	olefinic compound biosynthetic process	-	24	22	-	-	3.06E-04	1.11E-03
HINT	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	1.16E-03	6.80E-04
HINT	BP	GO:0045907	positive regulation of vasoconstriction	-	30	23	-	-	1.81E-02	1.17E-03
HINT	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	21	-	-	8.73E-04	1.05E-03
HINT	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	2.17E-02	1.23E-02
HINT	BP	GO:0009309	amine biosynthetic process	-	38	34	-	-	2.63E-02	1.73E-03
HINT	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	18	-	-	3.12E-03	9.27E-04
HINT	BP	GO:0061900	glial cell activation	-	56	47	-	-	2.36E-02	2.35E-03
HINT	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	131	-	-	1.97E-02	6.49E-03
HINT	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	12	-	-	1.81E-04	6.18E-04
HINT	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	13	-	-	1.04E-02	6.80E-04
HINT	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	8.82E-03	2.04E-03
HINT	BP	GO:0035902	response to immobilization stress	-	20	18	-	-	3.58E-04	9.27E-04
HINT	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	7.89E-04	7.42E-04
HINT	BP	GO:0072537	fibroblast activation	-	13	13	-	-	2.39E-02	6.80E-04
HINT	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	1.86E-03	6.80E-04
HINT	BP	GO:0043647	inositol phosphate metabolic process	-	44	35	-	-	4.79E-04	1.73E-03
HINT	BP	GO:0016180	snRNA processing	-	28	26	-	-	1.22E-01	1.30E-03
HINT	BP	GO:0051303	establishment of chromosome localization	-	104	100	-	-	1.20E-02	4.94E-03
HINT	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	3.00E-02	8.03E-04
HINT	BP	GO:0007164	establishment of tissue polarity	-	38	36	-	-	8.59E-04	1.79E-03
HINT	BP	GO:0097164	ammonium ion metabolic process	-	23	19	-	-	2.45E-04	9.89E-04
HINT	BP	GO:0021515	cell differentiation in spinal cord	-	51	45	-	-	1.76E-03	2.22E-03
HINT	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	17	-	-	6.84E-02	8.65E-04
HINT	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	19	-	-	3.35E-03	9.89E-04
HINT	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	7.66E-04	1.42E-03
HINT	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	2.17E-03	9.27E-04
HINT	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	36	-	-	1.31E-03	1.79E-03
HINT	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	9.54E-03	1.11E-03
HINT	BP	GO:0007566	embryo implantation	-	57	50	-	-	9.15E-04	2.47E-03
HINT	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	31	-	-	1.84E-03	1.54E-03
HINT	BP	GO:0031268	pseudopodium organization	-	17	15	-	-	2.05E-02	7.42E-04
HINT	BP	GO:0060306	regulation of membrane repolarization	-	38	29	-	-	1.31E-02	1.48E-03
HINT	BP	GO:0051017	actin filament bundle assembly	-	161	151	-	-	4.60E-03	7.48E-03
HINT	BP	GO:1905953	negative regulation of lipid localization	-	63	41	-	-	2.60E-03	2.04E-03
HINT	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	17	-	-	3.51E-03	8.65E-04
HINT	BP	GO:0021542	dentate gyrus development	-	19	18	-	-	4.85E-04	9.27E-04
HINT	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	1.82E-04	6.80E-04
HINT	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	36	-	-	3.23E-03	1.79E-03
HINT	BP	GO:0021756	striatum development	-	21	21	-	-	5.71E-03	1.05E-03
HINT	BP	GO:1901343	negative regulation of vasculature development	-	154	96	-	-	4.21E-03	4.76E-03
HINT	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	147	-	-	1.20E-02	7.29E-03
HINT	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	27	-	-	3.63E-04	1.36E-03
HINT	BP	GO:1902414	protein localization to cell junction	-	107	99	-	-	3.58E-03	4.94E-03
HINT	BP	GO:0071305	cellular response to vitamin D	-	23	19	-	-	3.59E-03	9.89E-04
HINT	BP	GO:0051304	chromosome separation	-	80	80	-	-	9.09E-03	3.95E-03
HINT	BP	GO:0090596	sensory organ morphogenesis	-	272	249	-	-	1.12E-02	1.24E-02
HINT	BP	GO:0045780	positive regulation of bone resorption	-	18	17	-	-	1.10E-03	8.65E-04
HINT	BP	GO:0048709	oligodendrocyte differentiation	-	101	92	-	-	2.21E-03	4.57E-03
HINT	BP	GO:0045017	glycerolipid biosynthetic process	-	254	230	-	-	1.54E-02	1.14E-02
HINT	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	4.11E-01	7.42E-04
HINT	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	22	-	-	1.13E-02	1.11E-03
HINT	BP	GO:0001776	leukocyte homeostasis	-	108	98	-	-	3.40E-03	4.88E-03
HINT	BP	GO:0050769	positive regulation of neurogenesis	-	240	220	-	-	7.14E-03	1.09E-02
HINT	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	3.56E-02	7.42E-04
HINT	BP	GO:0030193	regulation of blood coagulation	-	70	68	-	-	2.60E-02	3.40E-03
HINT	BP	GO:0050866	negative regulation of cell activation	-	216	192	-	-	7.03E-03	9.52E-03
HINT	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	32	-	-	1.30E-03	1.61E-03
HINT	BP	GO:0033500	carbohydrate homeostasis	-	251	215	-	-	4.91E-03	1.06E-02
HINT	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	28	-	-	2.65E-02	1.42E-03
HINT	BP	GO:0044088	regulation of vacuole organization	-	56	55	-	-	3.61E-03	2.72E-03
HINT	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	9.01E-04	1.17E-03
HINT	CC	GO:0099522	cytosolic region	-	20	20	-	-	1.35E-03	9.89E-04
HINT	CC	GO:0000791	euchromatin	-	60	56	-	-	3.95E-03	2.78E-03
HINT	CC	GO:0030666	endocytic vesicle membrane	-	196	188	-	-	1.22E-02	9.33E-03
HINT	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	3.08E-02	7.42E-04
HINT	CC	GO:1990752	microtubule end	-	34	34	-	-	2.26E-02	1.73E-03
HINT	CC	GO:0043204	perikaryon	-	156	142	-	-	2.76E-03	7.04E-03
HINT	CC	GO:0061702	canonical inflammasome complex	-	17	13	-	-	2.59E-01	6.80E-04
HINT	CC	GO:0097542	ciliary tip	-	48	47	-	-	1.63E-01	2.35E-03
HINT	CC	GO:1905368	peptidase complex	-	124	123	-	-	8.67E-02	6.12E-03
HINT	CC	GO:0000792	heterochromatin	-	98	97	-	-	1.76E-02	4.82E-03
HINT	CC	GO:0097546	ciliary base	-	47	44	-	-	9.55E-03	2.22E-03
HINT	CC	GO:0071819	DUBm complex	-	25	24	-	-	1.87E-01	1.24E-03
HINT	CC	GO:0031201	SNARE complex	-	48	47	-	-	3.47E-01	2.35E-03
HINT	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.77E-03	6.80E-04
HINT	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	6.40E-03	1.98E-03
HINT	CC	GO:0044391	ribosomal subunit	-	203	200	-	-	2.05E-01	9.89E-03
HINT	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	3.97E-02	5.56E-04
HINT	CC	GO:0071013	catalytic step 2 spliceosome	-	88	86	-	-	6.41E-02	4.26E-03
HINT	CC	GO:0031907	microbody lumen	-	51	49	-	-	1.95E-02	2.47E-03
HINT	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	3.00E-01	5.56E-04
HINT	CC	GO:0098862	cluster of actin-based cell projections	-	162	131	-	-	1.19E-02	6.49E-03
HINT	CC	GO:0016363	nuclear matrix	-	127	126	-	-	5.46E-03	6.24E-03
HINT	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	1.16E-01	2.29E-03
HINT	CC	GO:0032432	actin filament bundle	-	249	220	-	-	1.77E-02	1.09E-02
HINT	CC	GO:0008088	axo-dendritic transport	-	78	76	-	-	6.50E-03	3.77E-03
HINT	CC	GO:0031519	PcG protein complex	-	38	36	-	-	9.55E-02	1.79E-03
HINT	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	40	-	-	1.67E-02	1.98E-03
HINT	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	206	-	-	1.61E-02	1.02E-02
HINT	CC	GO:0000313	organellar ribosome	-	89	88	-	-	4.65E-01	4.39E-03
HINT	CC	GO:0099643	signal release from synapse	-	147	132	-	-	8.77E-03	6.55E-03
HINT	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	45	-	-	3.14E-02	2.22E-03
HINT	CC	GO:0005818	aster	-	11	11	-	-	1.28E-02	5.56E-04
HINT	CC	GO:0030018	Z disc	-	129	121	-	-	1.50E-02	5.99E-03
HINT	CC	GO:0032580	Golgi cisterna membrane	-	93	70	-	-	2.27E-03	3.46E-03
HINT	CC	GO:0097381	photoreceptor disc membrane	-	25	18	-	-	7.14E-03	9.27E-04
HINT	CC	GO:1905360	GTPase complex	-	41	38	-	-	5.73E-02	1.92E-03
HINT	CC	GO:0097540	axonemal central pair	-	161	126	-	-	3.58E-03	6.24E-03
HINT	CC	GO:0042641	actomyosin	-	77	74	-	-	9.14E-03	3.71E-03
HINT	CC	GO:0097386	glial cell projection	-	38	35	-	-	9.69E-04	1.73E-03
HINT	CC	GO:0032588	trans-Golgi network membrane	-	102	96	-	-	9.29E-03	4.76E-03
HINT	CC	GO:0070382	exocytic vesicle	-	224	205	-	-	2.00E-02	1.01E-02
HINT	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	46	-	-	4.68E-03	2.29E-03
HINT	CC	GO:0031903	microbody membrane	-	65	60	-	-	4.64E-02	2.97E-03
HINT	CC	GO:0046930	pore complex	-	26	26	-	-	2.55E-01	1.30E-03
HINT	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	7.68E-03	5.56E-04
HINT	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	15	-	-	1.28E-03	7.42E-04
HINT	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	238	-	-	1.36E-02	1.18E-02
HINT	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	23	-	-	5.66E-03	1.17E-03
HINT	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.46E-01	5.56E-04
HINT	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	9.07E-04	9.27E-04
HINT	CC	GO:0044298	cell body membrane	-	32	27	-	-	3.65E-04	1.36E-03
HINT	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	8.62E-02	5.56E-04
HINT	CC	GO:0051882	mitochondrial depolarization	-	21	20	-	-	5.79E-03	9.89E-04
HINT	CC	GO:0045495	pole plasm	-	25	20	-	-	7.17E-03	9.89E-04
HINT	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	2.52E-03	7.42E-04
HINT	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	1.05E-01	9.89E-04
HINT	CC	GO:0010369	chromocenter	-	14	14	-	-	3.36E-03	7.42E-04
HINT	CC	GO:0002177	manchette	-	19	15	-	-	2.69E-02	7.42E-04
HINT	CC	GO:0016323	basolateral plasma membrane	-	239	209	-	-	6.66E-03	1.04E-02
HINT	CC	GO:0045009	chitosome	-	21	19	-	-	1.07E-03	9.89E-04
HINT	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	4.38E-03	6.18E-04
HINT	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	5.61E-03	2.22E-03
HINT	CC	GO:0098636	protein complex involved in cell adhesion	-	57	53	-	-	4.87E-02	2.66E-03
HINT	CC	GO:0001917	photoreceptor inner segment	-	71	60	-	-	2.20E-03	2.97E-03
HINT	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	1.78E-03	7.42E-04
HINT	CC	GO:0019897	extrinsic component of plasma membrane	-	156	144	-	-	1.30E-02	7.17E-03
HINT	CC	GO:0031594	neuromuscular junction	-	73	66	-	-	5.38E-03	3.28E-03
HINT	CC	GO:0045120	pronucleus	-	14	14	-	-	5.37E-04	7.42E-04
HINT	CC	GO:0043083	synaptic cleft	-	21	19	-	-	5.95E-02	9.89E-04
HINT	CC	GO:0000922	spindle pole	-	172	167	-	-	6.68E-03	8.28E-03
HINT	CC	GO:0120111	neuron projection cytoplasm	-	94	89	-	-	1.25E-02	4.45E-03
HINT	CC	GO:0070971	endoplasmic reticulum exit site	-	32	26	-	-	1.62E-02	1.30E-03
HINT	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	1.15E-01	6.80E-04
HINT	CC	GO:0004879	nuclear receptor activity	-	63	62	-	-	8.21E-03	3.09E-03
HINT	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	161	-	-	9.33E-03	7.97E-03
HINT	CC	GO:0000123	histone acetyltransferase complex	-	93	91	-	-	1.26E-01	4.51E-03
HINT	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	2.80E-03	6.80E-04
HINT	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	106	-	-	1.45E-01	5.25E-03
HINT	CC	GO:0048786	presynaptic active zone	-	80	73	-	-	2.34E-03	3.65E-03
HINT	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	5.91E-02	6.18E-04
HINT	CC	GO:0007034	vacuolar transport	-	168	160	-	-	2.00E-02	7.91E-03
HINT	CC	GO:0090741	pigment granule membrane	-	21	19	-	-	2.15E-03	9.89E-04
HINT	CC	GO:0043194	axon initial segment	-	21	20	-	-	3.06E-04	9.89E-04
HINT	CC	GO:0005776	autophagosome	-	111	106	-	-	1.66E-02	5.25E-03
HINT	CC	GO:0031430	M band	-	22	20	-	-	6.15E-03	9.89E-04
HINT	CC	GO:0001931	uropod	-	13	13	-	-	8.28E-03	6.80E-04
HINT	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	1.69E-01	3.71E-03
HINT	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	95	-	-	2.57E-01	4.70E-03
HINT	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	7.75E-01	6.80E-04
HINT	CC	GO:0000164	protein phosphatase type 1 complex	-	19	17	-	-	2.78E-02	8.65E-04
HINT	CC	GO:0071203	WASH complex	-	12	11	-	-	2.77E-01	5.56E-04
HINT	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	28	-	-	1.75E-02	1.42E-03
HINT	CC	GO:0032994	protein-lipid complex	-	39	35	-	-	1.05E-02	1.73E-03
HINT	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	146	-	-	1.07E-01	7.23E-03
HINT	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	1.78E-02	6.18E-04
HINT	CC	GO:0001527	microfibril	-	13	12	-	-	7.58E-03	6.18E-04
HINT	CC	GO:0072562	blood microparticle	-	144	126	-	-	1.44E-02	6.24E-03
HINT	CC	GO:0005883	neurofilament	-	11	11	-	-	1.87E-03	5.56E-04
HINT	CC	GO:0051233	spindle midzone	-	36	34	-	-	1.89E-03	1.73E-03
HINT	CC	GO:0005811	lipid droplet	-	102	95	-	-	1.58E-02	4.70E-03
HINT	CC	GO:0045022	early endosome to late endosome transport	-	44	42	-	-	1.34E-02	2.10E-03
HINT	CC	GO:0043113	receptor clustering	-	51	47	-	-	8.34E-03	2.35E-03
HINT	CC	GO:0005940	septin ring	-	14	13	-	-	6.00E-01	6.80E-04
HINT	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	19	-	-	9.71E-02	9.89E-04
HINT	CC	GO:0044853	plasma membrane raft	-	114	108	-	-	6.99E-03	5.38E-03
HINT	CC	GO:0005881	cytoplasmic microtubule	-	256	211	-	-	5.23E-03	1.04E-02
HINT	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	14	-	-	7.56E-04	7.42E-04
HINT	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	1.74E-02	8.65E-04
HINT	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	55	-	-	2.02E-02	2.72E-03
HINT	CC	GO:0005905	clathrin-coated pit	-	73	70	-	-	3.16E-02	3.46E-03
HINT	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	6.05E-03	6.18E-04
HINT	CC	GO:0043034	costamere	-	18	16	-	-	3.12E-03	8.03E-04
HINT	CC	GO:0031904	endosome lumen	-	38	35	-	-	7.65E-03	1.73E-03
HINT	CC	GO:0060170	ciliary membrane	-	76	57	-	-	5.16E-02	2.84E-03
HINT	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	7.99E-01	6.80E-04
HINT	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	8.56E-03	6.18E-04
HINT	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	7.74E-02	1.24E-03
HINT	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	5.73E-02	7.42E-04
HINT	CC	GO:0032154	cleavage furrow	-	54	51	-	-	2.55E-03	2.53E-03
HINT	CC	GO:0005640	nuclear outer membrane	-	30	27	-	-	4.28E-04	1.36E-03
HINT	CC	GO:0005652	nuclear lamina	-	12	12	-	-	9.91E-04	6.18E-04
HINT	CC	GO:0007006	mitochondrial membrane organization	-	117	108	-	-	2.54E-02	5.38E-03
HINT	CC	GO:0001772	immunological synapse	-	44	44	-	-	8.67E-03	2.22E-03
HINT	CC	GO:0030904	retromer complex	-	12	12	-	-	4.70E-02	6.18E-04
HINT	CC	GO:0030863	cortical cytoskeleton	-	104	97	-	-	6.00E-03	4.82E-03
HINT	CC	GO:1905348	endonuclease complex	-	38	36	-	-	1.77E-01	1.79E-03
HINT	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	3.20E-01	5.56E-04
HINT	CC	GO:0030315	T-tubule	-	52	48	-	-	1.86E-03	2.41E-03
HINT	CC	GO:0060076	excitatory synapse	-	64	51	-	-	4.07E-03	2.53E-03
HINT	CC	GO:0036019	endolysosome	-	29	27	-	-	7.60E-02	1.36E-03
HINT	CC	GO:0001891	phagocytic cup	-	28	28	-	-	2.75E-03	1.42E-03
HINT	CC	GO:0099086	synaptonemal structure	-	40	37	-	-	1.49E-02	1.85E-03
HINT	CC	GO:0030427	site of polarized growth	-	172	164	-	-	4.43E-03	8.16E-03
HINT	CC	GO:0044309	neuron spine	-	213	194	-	-	7.58E-03	9.64E-03
HINT	CC	GO:0030658	transport vesicle membrane	-	231	213	-	-	1.97E-02	1.06E-02
HINT	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	2.20E-03	1.36E-03
HINT	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	3.26E-02	6.18E-04
HINT	CC	GO:0000940	outer kinetochore	-	17	17	-	-	5.17E-02	8.65E-04
HINT	CC	GO:0034719	SMN-Sm protein complex	-	18	16	-	-	1.58E-01	8.03E-04
HINT	CC	GO:0044232	organelle membrane contact site	-	50	49	-	-	8.70E-03	2.47E-03
HINT	CC	GO:0098803	respiratory chain complex	-	39	34	-	-	2.99E-01	1.73E-03
HINT	CC	GO:0097545	axonemal outer doublet	-	164	129	-	-	3.75E-03	6.43E-03
HINT	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	18	-	-	4.92E-04	9.27E-04
HINT	CC	GO:0070069	cytochrome complex	-	42	36	-	-	2.83E-01	1.79E-03
HINT	CC	GO:0031143	pseudopodium	-	18	18	-	-	6.66E-03	9.27E-04
HINT	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	25	-	-	2.32E-02	1.24E-03
HINT	CC	GO:0055037	recycling endosome	-	200	184	-	-	7.91E-03	9.15E-03
HINT	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	88	-	-	8.72E-03	4.39E-03
HINT	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	1.43E-01	6.80E-04
HINT	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	1.37E-03	6.18E-04
HINT	CC	GO:0071682	endocytic vesicle lumen	-	23	20	-	-	2.72E-03	9.89E-04
HINT	CC	GO:0030684	preribosome	-	76	73	-	-	1.68E-02	3.65E-03
HINT	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	2.23E-01	9.27E-04
HINT	CC	GO:1990391	DNA repair complex	-	22	22	-	-	1.05E-01	1.11E-03
HINT	CC	GO:0005775	vacuolar lumen	-	176	165	-	-	5.50E-03	8.16E-03
HINT	CC	GO:0032433	filopodium tip	-	19	19	-	-	7.21E-04	9.89E-04
HINT	CC	GO:0032982	myosin filament	-	24	23	-	-	1.12E-02	1.17E-03
HINT	CC	GO:0016327	apicolateral plasma membrane	-	23	22	-	-	3.09E-03	1.11E-03
HINT	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	1.26E-01	1.17E-03
HINT	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	1.82E-04	6.18E-04
HINT	CC	GO:0044306	neuron projection terminus	-	164	145	-	-	1.43E-02	7.17E-03
HINT	CC	GO:0034455	t-UTP complex	-	53	51	-	-	1.32E-02	2.53E-03
HINT	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	6.71E-01	8.65E-04
HINT	CC	GO:0031970	organelle envelope lumen	-	94	92	-	-	6.26E-03	4.57E-03
HINT	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.08E-02	6.80E-04
HINT	CC	GO:0120293	dynein axonemal particle	-	20	16	-	-	1.02E-03	8.03E-04
HINT	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	1.03E-03	1.24E-03
HINT	CC	GO:0043292	contractile muscle fiber	-	245	227	-	-	2.39E-02	1.12E-02
HINT	CC	GO:0018995	host cellular component	-	12	12	-	-	1.63E-02	6.18E-04
HINT	CC	GO:0034709	methylosome	-	13	13	-	-	3.81E-02	6.80E-04
HINT	CC	GO:0032426	stereocilium tip	-	21	17	-	-	2.43E-04	8.65E-04
HINT	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	11	-	-	6.25E-03	5.56E-04
HINT	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	8.33E-02	9.89E-04
HINT	CC	GO:0000803	sex chromosome	-	32	29	-	-	5.48E-03	1.48E-03
HINT	CC	GO:0098982	GABA-ergic synapse	-	84	72	-	-	1.09E-02	3.58E-03
HINT	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	2.26E-02	8.03E-04
HINT	CC	GO:0035097	histone methyltransferase complex	-	63	62	-	-	1.17E-01	3.09E-03
HINT	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	9.22E-02	7.42E-04
HINT	CC	GO:0000242	pericentriolar material	-	22	22	-	-	3.70E-03	1.11E-03
HINT	CC	GO:1903293	phosphatase complex	-	54	51	-	-	3.51E-02	2.53E-03
HINT	CC	GO:0097470	ribbon synapse	-	13	12	-	-	2.03E-02	6.18E-04
HINT	CC	GO:0031941	filamentous actin	-	27	25	-	-	1.79E-03	1.24E-03
HINT	CC	GO:0000786	nucleosome	-	149	101	-	-	6.23E-02	5.01E-03
HINT	CC	GO:0001533	cornified envelope	-	59	54	-	-	1.76E-02	2.72E-03
HINT	CC	GO:1904724	tertiary granule lumen	-	55	49	-	-	1.18E-03	2.47E-03
HINT	CC	GO:0030027	lamellipodium	-	202	194	-	-	7.42E-03	9.64E-03
HINT	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	5.47E-03	7.42E-04
HINT	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	25	-	-	2.99E-02	1.24E-03
HINT	CC	GO:0000800	lateral element	-	14	13	-	-	1.26E-02	6.80E-04
HINT	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	1.17E-02	6.18E-04
HINT	CC	GO:0060077	inhibitory synapse	-	20	17	-	-	2.45E-04	8.65E-04
HINT	CC	GO:0031209	SCAR complex	-	12	12	-	-	5.36E-02	6.18E-04
HINT	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	2.16E-01	8.03E-04
HINT	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	2.24E-02	1.05E-03
HINT	CC	GO:0002102	podosome	-	31	31	-	-	1.56E-03	1.54E-03
HINT	CC	GO:0090543	Flemming body	-	33	30	-	-	2.87E-03	1.48E-03
HINT	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	3.08E-03	3.28E-03
HINT	CC	GO:0001650	fibrillar center	-	151	147	-	-	3.77E-03	7.29E-03
HINT	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	6.21E-02	7.42E-04
HINT	CC	GO:1990204	oxidoreductase complex	-	90	81	-	-	1.34E-01	4.02E-03
HINT	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	1.22E-01	8.03E-04
HINT	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.65E-01	5.56E-04
HINT	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	121	-	-	3.45E-03	5.99E-03
HINT	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	3.92E-01	9.89E-04
HINT	CC	GO:0001726	ruffle	-	181	175	-	-	6.12E-03	8.65E-03
HINT	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	8.39E-03	6.80E-04
HINT	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	6.05E-02	9.27E-04
HINT	CC	GO:0043198	dendritic shaft	-	38	35	-	-	6.72E-04	1.73E-03
HINT	CC	GO:0043073	germ cell nucleus	-	67	61	-	-	2.44E-03	3.03E-03
HINT	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	7.36E-03	1.05E-03
HINT	CC	GO:0016592	mediator complex	-	38	38	-	-	7.07E-01	1.92E-03
HINT	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	4.93E-02	9.89E-04
HINT	CC	GO:0022626	cytosolic ribosome	-	118	116	-	-	2.87E-02	5.75E-03
HINT	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	1.44E-01	2.22E-03
HINT	CC	GO:0034451	centriolar satellite	-	120	115	-	-	1.41E-02	5.68E-03
HINT	CC	GO:0045171	intercellular bridge	-	91	85	-	-	2.94E-03	4.20E-03
HINT	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	75	-	-	7.42E-03	3.71E-03
HINT	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	2.19E-01	7.42E-04
HINT	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	4.37E-02	5.56E-04
HINT	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	7.22E-02	5.56E-04
HINT	CC	GO:0044292	dendrite terminus	-	13	13	-	-	9.04E-04	6.80E-04
HINT	CC	GO:0032039	integrator complex	-	19	17	-	-	4.89E-01	8.65E-04
HINT	CC	GO:0098691	dopaminergic synapse	-	15	14	-	-	9.11E-03	7.42E-04
HINT	CC	GO:0033268	node of Ranvier	-	16	16	-	-	2.45E-04	8.03E-04
HINT	CC	GO:0036038	MKS complex	-	13	13	-	-	3.69E-03	6.80E-04
HINT	CC	GO:0030527	structural constituent of chromatin	-	97	51	-	-	6.31E-02	2.53E-03
HINT	CC	GO:0036379	myofilament	-	26	24	-	-	1.21E-01	1.24E-03
HINT	CC	GO:0030286	dynein complex	-	210	170	-	-	1.19E-02	8.40E-03
HINT	CC	GO:0031105	septin complex	-	14	13	-	-	6.50E-01	6.80E-04
HINT	CC	GO:0097228	sperm principal piece	-	33	23	-	-	3.50E-03	1.17E-03
HINT	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	7.91E-03	6.18E-04
HINT	CC	GO:0016482	cytosolic transport	-	135	133	-	-	8.65E-03	6.61E-03
HINT	CC	GO:0090665	glycoprotein complex	-	23	21	-	-	6.24E-02	1.05E-03
HINT	CC	GO:0005796	Golgi lumen	-	106	88	-	-	5.15E-03	4.39E-03
HINT	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	35	-	-	5.91E-02	1.73E-03
HINT	CC	GO:0034358	plasma lipoprotein particle	-	36	32	-	-	1.17E-02	1.61E-03
HINT	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	9.81E-02	2.35E-03
HINT	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	23	-	-	1.35E-02	1.17E-03
HINT	CC	GO:0030662	coated vesicle membrane	-	202	197	-	-	2.52E-02	9.76E-03
HINT	CC	GO:0007039	protein catabolic process in the vacuole	-	61	58	-	-	3.32E-02	2.90E-03
HINT	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	66	-	-	4.38E-01	3.28E-03
HINT	CC	GO:0090734	site of DNA damage	-	118	116	-	-	4.04E-02	5.75E-03
HINT	MF	GO:0051861	glycolipid binding	-	30	30	-	-	3.71E-03	1.48E-03
HINT	MF	GO:0051087	protein-folding chaperone binding	-	135	132	-	-	6.99E-03	6.55E-03
HINT	MF	GO:0051959	dynein light intermediate chain binding	-	27	25	-	-	4.75E-03	1.24E-03
HINT	CC	GO:0015464	acetylcholine receptor activity	-	21	12	-	-	2.00E-01	6.18E-04
HINT	MF	GO:0042301	phosphate ion binding	-	12	11	-	-	3.79E-02	5.56E-04
HINT	MF	GO:0016594	glycine binding	-	12	11	-	-	3.77E-02	5.56E-04
HINT	MF	GO:0031681	G-protein beta-subunit binding	-	22	19	-	-	2.43E-04	9.89E-04
HINT	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	36	-	-	1.56E-03	1.79E-03
HINT	MF	GO:0035613	RNA stem-loop binding	-	21	16	-	-	4.11E-03	8.03E-04
HINT	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	230	-	-	7.14E-03	1.14E-02
HINT	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	18	-	-	2.42E-04	9.27E-04
HINT	MF	GO:0033691	sialic acid binding	-	22	16	-	-	4.05E-03	8.03E-04
HINT	MF	GO:0016757	glycosyltransferase activity	-	286	241	-	-	1.95E-02	1.19E-02
HINT	MF	GO:0048306	calcium-dependent protein binding	-	61	58	-	-	3.02E-02	2.90E-03
HINT	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	24	-	-	6.11E-04	1.24E-03
HINT	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	1.31E-01	6.80E-04
HINT	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	124	-	-	3.88E-03	6.18E-03
HINT	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	55	-	-	7.74E-02	2.72E-03
HINT	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	124	-	-	1.15E-02	6.18E-03
HINT	MF	GO:0045504	dynein heavy chain binding	-	16	12	-	-	6.77E-02	6.18E-04
HINT	MF	GO:0140457	protein demethylase activity	-	31	28	-	-	2.36E-02	1.42E-03
HINT	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	5.40E-03	1.11E-03
HINT	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	3.49E-03	7.42E-04
HINT	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	2.74E-02	7.42E-04
HINT	MF	GO:0061980	regulatory RNA binding	-	52	44	-	-	1.24E-02	2.22E-03
HINT	MF	GO:0015035	protein-disulfide reductase activity	-	32	31	-	-	1.49E-02	1.54E-03
HINT	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	1.45E-03	1.48E-03
HINT	MF	GO:0070840	dynein complex binding	-	25	22	-	-	1.14E-03	1.11E-03
HINT	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.69E-03	1.24E-03
HINT	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	7.14E-04	8.03E-04
HINT	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	33	-	-	1.79E-03	1.67E-03
HINT	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	2.02E-02	9.27E-04
HINT	MF	GO:0005178	integrin binding	-	153	138	-	-	2.14E-02	6.86E-03
HINT	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	8.74E-04	8.65E-04
HINT	MF	GO:0005549	odorant binding	-	128	14	-	-	1.85E-04	7.42E-04
HINT	MF	GO:0042043	neurexin family protein binding	-	14	12	-	-	1.81E-04	6.18E-04
HINT	MF	GO:0008327	methyl-CpG binding	-	31	27	-	-	2.63E-03	1.36E-03
HINT	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	1.84E-03	9.89E-04
HINT	MF	GO:0048019	receptor antagonist activity	-	31	17	-	-	1.27E-03	8.65E-04
HINT	MF	GO:0005521	lamin binding	-	15	15	-	-	5.89E-03	7.42E-04
HINT	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	4.05E-03	8.65E-04
HINT	MF	GO:0140318	protein transporter activity	-	40	40	-	-	1.45E-02	1.98E-03
HINT	MF	GO:0070628	proteasome binding	-	17	17	-	-	1.74E-03	8.65E-04
HINT	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	1.34E-03	5.56E-04
HINT	MF	GO:0031432	titin binding	-	13	11	-	-	7.30E-03	5.56E-04
HINT	MF	GO:0046812	host cell surface binding	-	11	11	-	-	5.31E-04	5.56E-04
HINT	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	7.03E-03	1.85E-03
HINT	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	15	-	-	1.76E-02	7.42E-04
HINT	MF	GO:0002039	p53 binding	-	66	65	-	-	3.42E-03	3.21E-03
HINT	MF	GO:0005496	steroid binding	-	110	101	-	-	3.41E-03	5.01E-03
HINT	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.51E-02	1.36E-03
HINT	MF	GO:0003684	damaged DNA binding	-	89	84	-	-	1.71E-02	4.20E-03
HINT	MF	GO:0000339	RNA cap binding	-	20	19	-	-	8.00E-03	9.89E-04
HINT	MF	GO:0016500	protein-hormone receptor activity	-	21	13	-	-	4.13E-03	6.80E-04
HINT	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	123	-	-	2.56E-02	6.12E-03
HINT	MF	GO:0005523	tropomyosin binding	-	15	13	-	-	1.73E-03	6.80E-04
HINT	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	4.06E-03	6.18E-04
HINT	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	4.21E-02	5.56E-04
HINT	MF	GO:0070063	RNA polymerase binding	-	61	59	-	-	5.55E-03	2.97E-03
HINT	MF	GO:0050811	GABA receptor binding	-	18	16	-	-	7.85E-04	8.03E-04
HINT	MF	GO:0030971	receptor tyrosine kinase binding	-	76	69	-	-	2.20E-03	3.46E-03
HINT	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	83	-	-	3.02E-02	4.14E-03
HINT	MF	GO:0140030	modification-dependent protein binding	-	179	176	-	-	7.58E-03	8.71E-03
HINT	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	23	-	-	8.42E-03	1.17E-03
HINT	MF	GO:0009881	photoreceptor activity	-	17	12	-	-	2.30E-03	6.18E-04
HINT	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	16	-	-	2.46E-04	8.03E-04
HINT	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	6.05E-03	6.80E-04
HINT	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	1.75E-02	8.03E-04
HINT	MF	GO:0141047	molecular tag activity	-	13	13	-	-	3.91E-04	6.80E-04
HINT	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.63E-02	5.56E-04
HINT	MF	GO:0033130	acetylcholine receptor binding	-	12	11	-	-	1.83E-04	5.56E-04
HINT	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	2.03E-03	7.42E-04
HINT	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	1.33E-02	6.18E-04
HINT	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.98E-02	7.42E-04
HINT	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	1.81E-04	7.42E-04
HINT	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.30E-02	7.42E-04
HINT	MF	GO:0030276	clathrin binding	-	70	65	-	-	2.97E-02	3.21E-03
HINT	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	4.41E-03	1.48E-03
HINT	MF	GO:0140311	protein sequestering activity	-	14	13	-	-	1.00E-03	6.80E-04
HINT	MF	GO:0046790	virion binding	-	19	19	-	-	1.98E-03	9.89E-04
HINT	MF	GO:0030552	cAMP binding	-	48	41	-	-	3.58E-02	2.04E-03
HINT	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	36	-	-	1.25E-03	1.79E-03
HINT	MF	GO:0035173	histone kinase activity	-	17	17	-	-	2.85E-03	8.65E-04
HINT	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	5.51E-03	1.30E-03
HINT	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	4.49E-02	6.18E-04
HINT	MF	GO:0004984	olfactory receptor activity	-	429	39	-	-	4.94E-04	1.98E-03
HINT	MF	GO:0016209	antioxidant activity	-	92	83	-	-	1.66E-02	4.14E-03
HINT	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	2.93E-03	1.48E-03
HINT	MF	GO:0044325	transmembrane transporter binding	-	159	142	-	-	1.14E-02	7.04E-03
HINT	MF	GO:0048156	tau protein binding	-	43	43	-	-	2.57E-03	2.16E-03
HINT	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	5.29E-03	1.79E-03
HINT	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	5.34E-03	6.80E-04
HINT	MF	GO:0140272	exogenous protein binding	-	79	78	-	-	4.47E-03	3.89E-03
HINT	MF	GO:0030145	manganese ion binding	-	65	59	-	-	7.03E-04	2.97E-03
HINT	MF	GO:0071814	protein-lipid complex binding	-	52	43	-	-	2.82E-02	2.16E-03
HINT	MF	GO:0008066	glutamate receptor activity	-	70	57	-	-	4.59E-02	2.84E-03
HINT	MF	GO:0017069	snRNA binding	-	54	46	-	-	2.35E-02	2.29E-03
HINT	MF	GO:0030215	semaphorin receptor binding	-	23	19	-	-	3.46E-02	9.89E-04
HINT	MF	GO:0031996	thioesterase binding	-	11	11	-	-	1.19E-03	5.56E-04
HINT	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	1.59E-02	1.54E-03
HINT	MF	GO:0019843	rRNA binding	-	69	68	-	-	8.59E-03	3.40E-03
HINT	MF	GO:0004713	protein tyrosine kinase activity	-	213	207	-	-	1.05E-02	1.03E-02
HINT	MF	GO:0016779	nucleotidyltransferase activity	-	264	248	-	-	1.78E-02	1.23E-02
HINT	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	50	-	-	3.01E-03	2.47E-03
HINT	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	8.31E-04	1.24E-03
HINT	MF	GO:0070300	phosphatidic acid binding	-	20	19	-	-	2.43E-04	9.89E-04
HINT	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	25	-	-	2.07E-03	1.24E-03
HINT	MF	GO:0016208	AMP binding	-	22	22	-	-	3.17E-02	1.11E-03
HINT	MF	GO:0000287	magnesium ion binding	-	225	207	-	-	4.60E-03	1.03E-02
HINT	MF	GO:0031490	chromatin DNA binding	-	120	113	-	-	5.28E-03	5.62E-03
HINT	MF	GO:0017022	myosin binding	-	73	69	-	-	7.62E-03	3.46E-03
HINT	MF	GO:0004896	cytokine receptor activity	-	93	82	-	-	2.35E-02	4.08E-03
HINT	MF	GO:0017166	vinculin binding	-	12	12	-	-	5.46E-03	6.18E-04
HINT	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	1.53E-03	9.27E-04
HINT	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	1.38E-02	6.18E-04
HINT	MF	GO:0005539	glycosaminoglycan binding	-	236	201	-	-	2.18E-02	9.95E-03
HINT	MF	GO:0140666	annealing activity	-	11	11	-	-	1.08E-03	5.56E-04
HINT	MF	GO:0071933	Arp2/3 complex binding	-	14	12	-	-	1.81E-04	6.18E-04
HINT	MF	GO:0019207	kinase regulator activity	-	267	249	-	-	7.42E-03	1.24E-02
HINT	MF	GO:0010181	FMN binding	-	15	15	-	-	2.44E-04	7.42E-04
HINT	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	14	-	-	1.84E-04	7.42E-04
HINT	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	22	-	-	2.37E-03	1.11E-03
HINT	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	2.42E-04	8.65E-04
HINT	MF	GO:0044183	protein folding chaperone	-	67	65	-	-	1.91E-03	3.21E-03
HINT	MF	GO:0005132	type I interferon receptor binding	-	17	11	-	-	2.79E-01	5.56E-04
HINT	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	105	-	-	9.28E-03	5.19E-03
HINT	MF	GO:0003725	double-stranded RNA binding	-	72	67	-	-	7.72E-03	3.34E-03
HINT	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	14	-	-	2.42E-01	7.42E-04
HINT	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	7.59E-02	2.60E-03
HINT	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.38E-03	1.73E-03
HINT	MF	GO:0004618	phosphoglycerate kinase activity	-	89	87	-	-	5.89E-03	4.33E-03
HINT	MF	GO:0042805	actinin binding	-	36	34	-	-	4.93E-03	1.73E-03
HINT	MF	GO:0043531	ADP binding	-	38	37	-	-	2.91E-03	1.85E-03
HINT	MF	GO:0043394	proteoglycan binding	-	36	30	-	-	3.66E-03	1.48E-03
HINT	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	1.70E-02	5.56E-04
HINT	MF	GO:0046332	SMAD binding	-	77	74	-	-	5.74E-03	3.71E-03
HINT	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.87E-03	6.80E-04
HINT	MF	GO:0001968	fibronectin binding	-	30	28	-	-	3.91E-03	1.42E-03
HINT	MF	GO:0048038	quinone binding	-	16	16	-	-	6.32E-03	8.03E-04
HINT	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	117	-	-	2.22E-02	5.81E-03
HINT	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	73	-	-	2.83E-03	3.65E-03
HINT	MF	GO:0003756	protein disulfide isomerase activity	-	18	17	-	-	9.11E-04	8.65E-04
HINT	MF	GO:0051117	ATPase binding	-	85	79	-	-	2.27E-03	3.95E-03
HINT	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	3.59E-03	2.29E-03
HINT	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	3.39E-03	9.89E-04
HINT	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	5.24E-03	5.56E-04
HINT	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.45E-04	7.42E-04
HINT	MF	GO:0031404	chloride ion binding	-	14	11	-	-	1.84E-04	5.56E-04
HINT	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	6.84E-03	3.03E-03
HINT	MF	GO:0036002	pre-mRNA binding	-	57	35	-	-	1.51E-02	1.73E-03
HINT	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	33	-	-	1.13E-03	1.67E-03
HINT	MF	GO:0051540	metal cluster binding	-	71	68	-	-	4.77E-03	3.40E-03
HINT	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	1.76E-03	5.56E-04
HINT	MF	GO:0051219	phosphoprotein binding	-	92	91	-	-	4.51E-03	4.51E-03
HINT	MF	GO:0019894	kinesin binding	-	45	45	-	-	7.55E-03	2.22E-03
HINT	MF	GO:0042287	MHC protein binding	-	68	52	-	-	3.26E-02	2.60E-03
HINT	MF	GO:0019003	GDP binding	-	89	86	-	-	9.11E-03	4.26E-03
HINT	MF	GO:0017171	serine hydrolase activity	-	207	155	-	-	7.41E-03	7.66E-03
HINT	MF	GO:0097110	scaffold protein binding	-	66	60	-	-	2.68E-03	2.97E-03
HINT	MF	GO:0003774	cytoskeletal motor activity	-	117	106	-	-	4.51E-03	5.25E-03
HINT	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	3.36E-03	1.48E-03
HINT	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	2.55E-03	8.65E-04
HINT	MF	GO:0061134	peptidase regulator activity	-	224	182	-	-	6.75E-03	9.02E-03
HINT	MF	GO:0008013	beta-catenin binding	-	86	82	-	-	3.24E-03	4.08E-03
HINT	MF	GO:0051015	actin filament binding	-	208	196	-	-	2.10E-02	9.70E-03
HINT	MF	GO:0019208	phosphatase regulator activity	-	107	99	-	-	1.03E-02	4.94E-03
HINT	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	30	-	-	1.01E-02	1.48E-03
HINT	MF	GO:0043236	laminin binding	-	29	27	-	-	1.17E-03	1.36E-03
HINT	MF	GO:0030507	spectrin binding	-	26	26	-	-	3.60E-04	1.30E-03
HINT	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	40	-	-	5.53E-03	1.98E-03
HINT	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	110	-	-	1.35E-02	5.44E-03
HINT	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	3.86E-03	1.24E-03
HINT	MF	GO:0042393	histone binding	-	240	228	-	-	1.44E-02	1.13E-02
HINT	MF	GO:0019838	growth factor binding	-	182	169	-	-	9.85E-03	8.40E-03
HINT	MF	GO:0000149	SNARE binding	-	107	101	-	-	7.47E-02	5.01E-03
HINT	MF	GO:0003727	single-stranded RNA binding	-	90	83	-	-	6.89E-03	4.14E-03
HINT	MF	GO:0051378	serotonin binding	-	24	12	-	-	1.85E-04	6.18E-04
HINT	MF	GO:0005516	calmodulin binding	-	206	188	-	-	6.02E-03	9.33E-03
HINT	MF	GO:0019825	oxygen binding	-	40	30	-	-	4.09E-02	1.48E-03
HINT	MF	GO:0045505	dynein intermediate chain binding	-	37	33	-	-	5.42E-03	1.67E-03
HINT	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	80	-	-	3.54E-03	3.95E-03
HINT	MF	GO:0032182	ubiquitin-like protein binding	-	117	115	-	-	7.17E-03	5.68E-03
HINT	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	1.76E-02	1.79E-03
HINT	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	5.57E-02	1.11E-03
HINT	MF	GO:0043274	phospholipase binding	-	23	19	-	-	1.85E-03	9.89E-04
HINT	MF	GO:0031072	heat shock protein binding	-	128	125	-	-	7.42E-03	6.18E-03
HINT	MF	GO:0030515	snoRNA binding	-	33	32	-	-	1.79E-02	1.61E-03
HINT	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	65	-	-	4.60E-02	3.21E-03
HINT	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	18	-	-	2.44E-04	9.27E-04
HINT	MF	GO:0001965	G-protein alpha-subunit binding	-	26	25	-	-	3.62E-04	1.24E-03
HINT	MF	GO:0001530	lipopolysaccharide binding	-	38	29	-	-	9.85E-04	1.48E-03
HINT	MF	GO:0140223	general transcription initiation factor activity	-	55	52	-	-	2.32E-01	2.60E-03
HINT	MF	GO:0070403	NAD+ binding	-	16	15	-	-	2.42E-04	7.42E-04
HINT	MF	GO:0000049	tRNA binding	-	75	67	-	-	2.18E-03	3.34E-03
HINT	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	5.11E-03	2.22E-03
HINT	MF	GO:0015026	coreceptor activity	-	48	41	-	-	1.10E-02	2.04E-03
HINT	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.80E-04	6.18E-04
HINT	MF	GO:0001653	peptide receptor activity	-	128	85	-	-	8.31E-03	4.20E-03
HINT	MF	GO:0031005	filamin binding	-	15	14	-	-	1.60E-03	7.42E-04
HINT	MF	GO:0030506	ankyrin binding	-	19	18	-	-	2.43E-04	9.27E-04
HINT	MF	GO:0006469	negative regulation of protein kinase activity	-	222	201	-	-	4.53E-03	9.95E-03
HINT	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	1.57E-03	9.89E-04
HINT	MF	GO:1901611	phosphatidylglycerol binding	-	15	14	-	-	1.83E-04	7.42E-04
HINT	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	30	-	-	5.15E-03	1.48E-03
HINT	MF	GO:0051427	hormone receptor binding	-	31	28	-	-	2.55E-03	1.42E-03
HINT	MF	GO:0070851	growth factor receptor binding	-	141	133	-	-	8.27E-03	6.61E-03
HINT	MF	GO:0031210	phosphatidylcholine binding	-	32	30	-	-	3.17E-02	1.48E-03
HINT	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	40	-	-	6.20E-03	1.98E-03
HINT	MF	GO:0034185	apolipoprotein binding	-	20	19	-	-	1.68E-03	9.89E-04
HINT	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	15	-	-	2.08E-03	7.42E-04
HINT	MF	GO:0005506	iron ion binding	-	154	119	-	-	6.09E-03	5.93E-03
HINT	MF	GO:0003925	G protein activity	-	45	43	-	-	1.10E-03	2.16E-03
HINT	MF	GO:0038187	pattern recognition receptor activity	-	33	28	-	-	5.91E-03	1.42E-03
HINT	MF	GO:0008276	protein methyltransferase activity	-	96	91	-	-	5.59E-03	4.51E-03
HINT	MF	GO:0004396	hexokinase activity	-	16	16	-	-	1.35E-01	8.03E-04
HINT	MF	GO:0070888	E-box binding	-	59	52	-	-	3.32E-02	2.60E-03
HINT	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.82E-04	7.42E-04
HINT	MF	GO:0015399	primary active transmembrane transporter activity	-	190	179	-	-	1.35E-01	8.90E-03
HINT	MF	GO:0035254	glutamate receptor binding	-	47	45	-	-	2.63E-03	2.22E-03
HINT	MF	GO:0050321	tau-protein kinase activity	-	36	31	-	-	1.38E-03	1.54E-03
HINT	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	9.05E-04	5.56E-04
HINT	MF	GO:0043021	ribonucleoprotein complex binding	-	158	155	-	-	8.43E-03	7.66E-03
HINT	MF	GO:0030170	pyridoxal phosphate binding	-	56	49	-	-	2.48E-03	2.47E-03
HINT	MF	GO:0032393	MHC class I receptor activity	-	15	11	-	-	2.29E-01	5.56E-04
HINT	MF	GO:0005112	Notch binding	-	26	20	-	-	2.18E-03	9.89E-04
HINT	MF	GO:0048185	activin binding	-	16	16	-	-	4.90E-02	8.03E-04
HINT	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	25	-	-	8.34E-04	1.24E-03
HINT	MF	GO:0001664	G protein-coupled receptor binding	-	299	247	-	-	1.11E-02	1.22E-02
HINT	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	1.82E-04	5.56E-04
HINT	MF	GO:0140299	small molecule sensor activity	-	39	33	-	-	6.73E-02	1.67E-03
HINT	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.04E-02	1.11E-03
HINT	MF	GO:0016917	GABA receptor activity	-	23	14	-	-	2.65E-01	7.42E-04
HINT	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	3.69E-03	7.42E-04
HINT	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	24	-	-	3.03E-04	1.24E-03
HINT	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	43	-	-	1.43E-02	2.16E-03
HINT	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.28E-03	1.24E-03
HINT	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	2.34E-03	6.18E-04
HINT	MF	GO:0030594	neurotransmitter receptor activity	-	160	119	-	-	3.79E-02	5.93E-03
HINT	MF	GO:0034452	dynactin binding	-	12	11	-	-	7.00E-04	5.56E-04
HINT	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	22	-	-	7.15E-03	1.11E-03
HINT	MF	GO:0120227	acyl-CoA binding	-	22	20	-	-	3.05E-04	9.89E-04
HINT	MF	GO:0005507	copper ion binding	-	63	56	-	-	7.39E-03	2.78E-03
HINT	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	5.62E-03	1.11E-03
HINT	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.60E-02	1.11E-03
HIPPIE	CC	GO:0005615	extracellular space	1.80E-35	3190	3143	3015	1.04	-	-
HIPPIE	CC	GO:0005739	mitochondrion	1.80E-18	1671	1647	1580	1.04	-	-
HIPPIE	CC	GO:0005783	endoplasmic reticulum	2.22E-14	2020	1976	1909	1.03	-	-
HIPPIE	CC	GO:0005794	Golgi apparatus	6.54E-13	1636	1603	1547	1.04	-	-
HIPPIE	CC	GO:0005768	endosome	8.54E-13	1037	1024	980	1.04	-	-
HIPPIE	CC	GO:0005730	nucleolus	1.37E-12	988	976	934	1.05	-	-
HIPPIE	CC	GO:0005815	microtubule organizing center	1.11E-11	843	834	797	1.05	-	-
HIPPIE	CC	GO:0005764	lysosome	1.08E-09	747	738	706	1.05	-	-
HIPPIE	CC	GO:0005635	nuclear envelope	4.82E-09	493	490	466	1.05	-	-
HIPPIE	CC	GO:0005840	ribosome	7.88E-06	222	222	210	1.06	-	-
HIPPIE	CC	GO:0031012	extracellular matrix	1.03E-04	564	552	533	1.04	-	-
HIPPIE	CC	GO:0000228	nuclear chromosome	1.67E-03	206	204	195	1.05	-	-
HIPPIE	CC	GO:0005777	peroxisome	5.01E-03	142	141	134	1.05	-	-
HIPPIE	CC	GO:0005929	cilium	4.34E-02	842	809	796	1.02	-	-
HIPPIE	CC	GO:0005811	lipid droplet	1.83E-01	102	100	96	1.04	-	-
HIPPIE	BP	GO:0050877	nervous system process	1.64E-81	1527	1245	1443	0.86	-	-
HIPPIE	BP	GO:0016192	vesicle-mediated transport	8.59E-24	1894	1871	1790	1.05	-	-
HIPPIE	BP	GO:0007010	cytoskeleton organization	1.59E-18	1639	1616	1549	1.04	-	-
HIPPIE	BP	GO:0048870	cell motility	1.17E-17	1659	1634	1568	1.04	-	-
HIPPIE	BP	GO:0007155	cell adhesion	2.18E-16	1444	1424	1365	1.04	-	-
HIPPIE	BP	GO:0002376	immune system process	2.80E-16	2448	2392	2314	1.03	-	-
HIPPIE	BP	GO:0012501	programmed cell death	5.93E-16	1954	1916	1847	1.04	-	-
HIPPIE	BP	GO:0065003	protein-containing complex assembly	3.59E-15	1648	1619	1558	1.04	-	-
HIPPIE	BP	GO:0006355	regulation of DNA-templated transcription	1.45E-13	3342	3242	3159	1.03	-	-
HIPPIE	BP	GO:0006281	DNA repair	1.86E-13	587	586	555	1.06	-	-
HIPPIE	BP	GO:0006886	intracellular protein transport	8.01E-13	664	661	628	1.05	-	-
HIPPIE	BP	GO:0006914	autophagy	7.77E-12	568	566	537	1.05	-	-
HIPPIE	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.14E-09	729	720	689	1.04	-	-
HIPPIE	BP	GO:0006629	lipid metabolic process	4.08E-09	1355	1324	1281	1.03	-	-
HIPPIE	BP	GO:0006325	chromatin organization	4.41E-09	720	711	681	1.04	-	-
HIPPIE	BP	GO:0030163	protein catabolic process	6.02E-09	990	972	936	1.04	-	-
HIPPIE	BP	GO:0016071	mRNA metabolic process	6.25E-09	713	704	674	1.04	-	-
HIPPIE	BP	GO:0007005	mitochondrion organization	1.09E-08	484	481	458	1.05	-	-
HIPPIE	BP	GO:0034330	cell junction organization	1.47E-08	727	717	687	1.04	-	-
HIPPIE	BP	GO:0006091	generation of precursor metabolites and energy	2.37E-08	502	498	475	1.05	-	-
HIPPIE	BP	GO:0042254	ribosome biogenesis	9.32E-08	297	297	281	1.06	-	-
HIPPIE	BP	GO:0072659	protein localization to plasma membrane	2.12E-07	284	284	268	1.06	-	-
HIPPIE	BP	GO:0003013	circulatory system process	4.04E-07	584	576	552	1.04	-	-
HIPPIE	BP	GO:0006913	nucleocytoplasmic transport	4.04E-07	326	325	308	1.05	-	-
HIPPIE	BP	GO:0007059	chromosome segregation	6.15E-07	403	400	381	1.05	-	-
HIPPIE	BP	GO:0098542	defense response to other organism	1.06E-06	1171	1141	1107	1.03	-	-
HIPPIE	BP	GO:0006954	inflammatory response	1.33E-06	820	803	775	1.04	-	-
HIPPIE	BP	GO:0042060	wound healing	4.72E-06	431	426	407	1.05	-	-
HIPPIE	BP	GO:0005975	carbohydrate metabolic process	6.13E-06	551	542	521	1.04	-	-
HIPPIE	BP	GO:0003012	muscle system process	6.74E-06	425	420	402	1.05	-	-
HIPPIE	BP	GO:0055085	transmembrane transport	8.65E-06	1784	1725	1686	1.02	-	-
HIPPIE	BP	GO:0006399	tRNA metabolic process	2.44E-05	196	196	185	1.06	-	-
HIPPIE	BP	GO:0030198	extracellular matrix organization	4.49E-05	314	311	297	1.05	-	-
HIPPIE	BP	GO:0006260	DNA replication	4.63E-05	279	277	264	1.05	-	-
HIPPIE	BP	GO:0007018	microtubule-based movement	5.86E-05	640	626	605	1.03	-	-
HIPPIE	BP	GO:0006310	DNA recombination	8.06E-05	333	329	315	1.05	-	-
HIPPIE	BP	GO:0007163	establishment or maintenance of cell polarity	8.68E-05	227	226	215	1.05	-	-
HIPPIE	BP	GO:0006790	sulfur compound metabolic process	1.60E-04	320	316	302	1.04	-	-
HIPPIE	BP	GO:0032200	telomere organization	5.38E-04	186	185	176	1.05	-	-
HIPPIE	BP	GO:0006520	amino acid metabolic process	6.17E-04	292	288	276	1.04	-	-
HIPPIE	BP	GO:0140053	mitochondrial gene expression	1.65E-03	164	163	155	1.05	-	-
HIPPIE	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.97E-03	119	119	112	1.06	-	-
HIPPIE	BP	GO:0000910	cytokinesis	3.23E-03	186	184	176	1.05	-	-
HIPPIE	BP	GO:0006575	cellular modified amino acid metabolic process	3.23E-03	186	184	176	1.05	-	-
HIPPIE	BP	GO:0140013	meiotic nuclear division	3.26E-03	279	274	264	1.04	-	-
HIPPIE	BP	GO:0002181	cytoplasmic translation	3.54E-03	153	152	145	1.05	-	-
HIPPIE	BP	GO:0044782	cilium organization	5.26E-03	399	389	377	1.03	-	-
HIPPIE	BP	GO:0006457	protein folding	5.39E-03	210	207	199	1.04	-	-
HIPPIE	BP	GO:0007040	lysosome organization	3.12E-02	107	106	101	1.05	-	-
HIPPIE	BP	GO:0022600	digestive system process	3.20E-02	110	109	104	1.05	-	-
HIPPIE	BP	GO:0003014	renal system process	4.91E-02	127	125	120	1.04	-	-
HIPPIE	BP	GO:0006766	vitamin metabolic process	1.31E-01	107	105	101	1.04	-	-
HIPPIE	BP	GO:0098754	detoxification	2.53E-01	134	130	127	1.03	-	-
HIPPIE	BP	GO:0006486	protein glycosylation	4.58E-01	225	216	213	1.02	-	-
HIPPIE	MF	GO:0003723	RNA binding	4.90E-26	1679	1665	1587	1.05	-	-
HIPPIE	MF	GO:0016740	transferase activity	1.10E-21	3074	3006	2906	1.03	-	-
HIPPIE	MF	GO:0008092	cytoskeletal protein binding	3.72E-17	1023	1016	967	1.05	-	-
HIPPIE	MF	GO:0140096	"catalytic activity, acting on a protein"	4.58E-17	3198	3114	3023	1.03	-	-
HIPPIE	MF	GO:0003677	DNA binding	7.81E-17	2865	2794	2708	1.03	-	-
HIPPIE	MF	GO:0140657	ATP-dependent activity	1.19E-11	729	723	689	1.05	-	-
HIPPIE	MF	GO:0008289	lipid binding	4.12E-10	836	825	790	1.04	-	-
HIPPIE	MF	GO:0003924	GTPase activity	1.36E-08	658	650	622	1.05	-	-
HIPPIE	MF	GO:0140110	transcription regulator activity	1.21E-07	2033	1970	1922	1.03	-	-
HIPPIE	MF	GO:0140098	"catalytic activity, acting on RNA"	2.94E-07	417	414	394	1.05	-	-
HIPPIE	MF	GO:0016491	oxidoreductase activity	3.09E-07	888	870	839	1.04	-	-
HIPPIE	MF	GO:0005198	structural molecule activity	9.84E-07	798	782	754	1.04	-	-
HIPPIE	MF	GO:0140097	"catalytic activity, acting on DNA"	1.08E-05	383	379	362	1.05	-	-
HIPPIE	MF	GO:0042393	histone binding	3.84E-05	237	236	224	1.05	-	-
HIPPIE	MF	GO:0016874	ligase activity	1.80E-04	283	280	268	1.05	-	-
HIPPIE	MF	GO:0016829	lyase activity	3.28E-04	538	526	509	1.03	-	-
HIPPIE	MF	GO:0045182	translation regulator activity	4.16E-04	151	151	143	1.06	-	-
HIPPIE	MF	GO:0048018	receptor ligand activity	4.48E-04	504	493	476	1.03	-	-
HIPPIE	MF	GO:0016853	isomerase activity	7.11E-04	252	249	238	1.05	-	-
HIPPIE	MF	GO:0005215	transporter activity	7.82E-04	1462	1409	1382	1.02	-	-
HIPPIE	MF	GO:0003774	cytoskeletal motor activity	3.08E-03	116	116	110	1.06	-	-
HIPPIE	MF	GO:0140104	molecular carrier activity	4.40E-03	105	105	99	1.06	-	-
HIPPIE	MF	GO:0009975	cyclase activity	6.10E-02	277	269	262	1.03	-	-
HIPPIE	MF	GO:0038024	cargo receptor activity	2.19E-01	117	114	111	1.03	-	-
HIPPIE	BP	GO:0008038	neuron recognition	-	46	44	-	-	2.64E-03	1.84E-03
HIPPIE	BP	GO:1905145	cellular response to acetylcholine	-	33	32	-	-	4.97E-03	1.33E-03
HIPPIE	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	1.93E-03	7.68E-04
HIPPIE	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	2.29E-03	8.71E-04
HIPPIE	BP	GO:0051931	regulation of sensory perception	-	36	36	-	-	4.28E-03	1.49E-03
HIPPIE	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	1.37E-03	1.02E-03
HIPPIE	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.49E-04	5.63E-04
HIPPIE	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	1.16E-03	5.63E-04
HIPPIE	BP	GO:0009268	response to pH	-	43	40	-	-	1.51E-02	1.64E-03
HIPPIE	BP	GO:0045666	positive regulation of neuron differentiation	-	91	87	-	-	4.97E-03	3.58E-03
HIPPIE	BP	GO:0043543	protein acylation	-	107	106	-	-	2.88E-03	4.35E-03
HIPPIE	MF	GO:0051349	positive regulation of lyase activity	-	41	39	-	-	3.79E-03	1.64E-03
HIPPIE	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	6.01E-04	6.15E-04
HIPPIE	BP	GO:0048679	regulation of axon regeneration	-	28	27	-	-	8.82E-04	1.13E-03
HIPPIE	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	3.62E-03	8.19E-04
HIPPIE	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	135	-	-	1.70E-02	5.53E-03
HIPPIE	BP	GO:0071763	nuclear membrane organization	-	44	44	-	-	9.28E-03	1.84E-03
HIPPIE	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	39	-	-	1.58E-03	1.64E-03
HIPPIE	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	12	-	-	2.16E-02	5.12E-04
HIPPIE	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	1.02E-02	2.82E-03
HIPPIE	BP	GO:0022038	corpus callosum development	-	25	25	-	-	2.17E-03	1.02E-03
HIPPIE	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	13	-	-	1.48E-04	5.63E-04
HIPPIE	BP	GO:0021548	pons development	-	11	11	-	-	1.47E-04	4.61E-04
HIPPIE	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	1.50E-04	5.12E-04
HIPPIE	BP	GO:0043299	leukocyte degranulation	-	82	81	-	-	8.31E-03	3.33E-03
HIPPIE	BP	GO:0048864	stem cell development	-	88	86	-	-	7.13E-03	3.53E-03
HIPPIE	BP	GO:0097384	cellular lipid biosynthetic process	-	11	11	-	-	4.53E-04	4.61E-04
HIPPIE	BP	GO:0009310	amine catabolic process	-	20	19	-	-	1.97E-03	8.19E-04
HIPPIE	BP	GO:0051651	maintenance of location in cell	-	236	229	-	-	7.24E-03	9.42E-03
HIPPIE	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	1.88E-03	1.13E-03
HIPPIE	BP	GO:0014004	microglia differentiation	-	12	12	-	-	7.66E-04	5.12E-04
HIPPIE	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	8.46E-04	1.28E-03
HIPPIE	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	1.50E-04	6.15E-04
HIPPIE	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.68E-03	6.15E-04
HIPPIE	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	35	-	-	1.81E-03	1.43E-03
HIPPIE	BP	GO:0006949	syncytium formation	-	66	61	-	-	3.25E-03	2.51E-03
HIPPIE	BP	GO:0045176	apical protein localization	-	15	15	-	-	3.06E-04	6.15E-04
HIPPIE	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	1.14E-02	6.15E-04
HIPPIE	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	58	-	-	1.19E-02	2.41E-03
HIPPIE	BP	GO:0030574	collagen catabolic process	-	45	45	-	-	1.43E-02	1.84E-03
HIPPIE	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	2.61E-03	1.89E-03
HIPPIE	BP	GO:0060343	trabecula formation	-	26	26	-	-	9.56E-04	1.08E-03
HIPPIE	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	18	-	-	4.73E-03	7.68E-04
HIPPIE	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.55E-03	9.73E-04
HIPPIE	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	6.83E-02	6.66E-04
HIPPIE	BP	GO:1900424	regulation of defense response to bacterium	-	21	19	-	-	1.09E-03	8.19E-04
HIPPIE	BP	GO:0085029	extracellular matrix assembly	-	42	42	-	-	2.12E-02	1.74E-03
HIPPIE	BP	GO:0006413	translational initiation	-	122	120	-	-	1.36E-02	4.92E-03
HIPPIE	BP	GO:0072176	nephric duct development	-	15	15	-	-	8.94E-04	6.15E-04
HIPPIE	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	2.44E-03	2.10E-03
HIPPIE	CC	GO:0005200	structural constituent of cytoskeleton	-	112	112	-	-	4.30E-03	4.61E-03
HIPPIE	BP	GO:1901298	regulation of hydrogen peroxide-mediated programmed cell death	-	13	13	-	-	1.27E-03	5.63E-04
HIPPIE	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	2.63E-03	2.10E-03
HIPPIE	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	1.29E-02	6.15E-04
HIPPIE	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	26	-	-	2.16E-02	1.08E-03
HIPPIE	BP	GO:1903036	positive regulation of response to wounding	-	76	75	-	-	6.75E-03	3.07E-03
HIPPIE	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	6.84E-03	8.71E-04
HIPPIE	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	221	-	-	9.44E-03	9.06E-03
HIPPIE	CC	GO:0001055	RNA polymerase II activity	-	11	11	-	-	3.49E-02	4.61E-04
HIPPIE	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.15E-03	1.13E-03
HIPPIE	BP	GO:0032528	microvillus organization	-	24	23	-	-	4.32E-03	9.73E-04
HIPPIE	BP	GO:0021954	central nervous system neuron development	-	85	85	-	-	1.61E-03	3.48E-03
HIPPIE	BP	GO:0055017	cardiac muscle tissue growth	-	92	83	-	-	4.94E-03	3.43E-03
HIPPIE	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	4.18E-03	1.28E-03
HIPPIE	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	12	-	-	7.23E-03	5.12E-04
HIPPIE	BP	GO:0048524	positive regulation of viral process	-	64	64	-	-	1.46E-03	2.66E-03
HIPPIE	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	12	-	-	1.25E-01	5.12E-04
HIPPIE	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	9.78E-03	8.71E-04
HIPPIE	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	25	-	-	2.43E-03	1.02E-03
HIPPIE	BP	GO:0001946	lymphangiogenesis	-	18	18	-	-	1.11E-03	7.68E-04
HIPPIE	BP	GO:0098661	inorganic anion transmembrane transport	-	140	132	-	-	1.01E-02	5.43E-03
HIPPIE	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	1.17E-02	1.33E-03
HIPPIE	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	1.06E-03	7.68E-04
HIPPIE	BP	GO:0009612	response to mechanical stimulus	-	215	214	-	-	4.95E-03	8.81E-03
HIPPIE	BP	GO:0043697	cell dedifferentiation	-	12	12	-	-	7.74E-04	5.12E-04
HIPPIE	BP	GO:0048644	muscle organ morphogenesis	-	81	80	-	-	4.96E-03	3.28E-03
HIPPIE	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	155	-	-	4.55E-03	6.35E-03
HIPPIE	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	5.06E-03	5.63E-04
HIPPIE	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	8.97E-03	1.43E-03
HIPPIE	BP	GO:0140115	export across plasma membrane	-	82	72	-	-	1.05E-02	2.97E-03
HIPPIE	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	1.11E-03	5.12E-04
HIPPIE	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	1.41E-03	1.59E-03
HIPPIE	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	2.82E-02	5.12E-04
HIPPIE	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	8.46E-04	4.61E-04
HIPPIE	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	28	-	-	2.63E-03	1.18E-03
HIPPIE	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	40	-	-	3.75E-03	1.64E-03
HIPPIE	MF	GO:0003714	transcription corepressor activity	-	190	189	-	-	7.10E-03	7.78E-03
HIPPIE	BP	GO:0035878	nail development	-	11	11	-	-	9.96E-03	4.61E-04
HIPPIE	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	55	-	-	6.02E-03	2.25E-03
HIPPIE	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	7.90E-03	6.66E-04
HIPPIE	CC	GO:0006858	extracellular transport	-	45	44	-	-	5.33E-03	1.84E-03
HIPPIE	BP	GO:0006304	DNA modification	-	30	30	-	-	7.47E-03	1.23E-03
HIPPIE	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	8.58E-03	8.19E-04
HIPPIE	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	4.65E-03	2.05E-03
HIPPIE	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	22	-	-	8.77E-04	9.22E-04
HIPPIE	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	1.49E-04	6.15E-04
HIPPIE	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	42	-	-	7.23E-03	1.74E-03
HIPPIE	BP	GO:0070417	cellular response to cold	-	13	13	-	-	1.34E-03	5.63E-04
HIPPIE	BP	GO:0043523	regulation of neuron apoptotic process	-	218	216	-	-	4.59E-03	8.86E-03
HIPPIE	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.30E-03	9.22E-04
HIPPIE	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	6.12E-04	6.15E-04
HIPPIE	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	4.50E-03	2.36E-03
HIPPIE	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	9.33E-02	5.63E-04
HIPPIE	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	1.60E-03	1.02E-03
HIPPIE	BP	GO:0014029	neural crest formation	-	15	15	-	-	1.36E-02	6.15E-04
HIPPIE	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	30	-	-	1.38E-03	1.23E-03
HIPPIE	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	39	-	-	3.17E-02	1.64E-03
HIPPIE	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	76	-	-	2.79E-03	3.12E-03
HIPPIE	BP	GO:0003188	heart valve formation	-	16	16	-	-	7.03E-03	6.66E-04
HIPPIE	CC	GO:0045324	late endosome to vacuole transport	-	37	37	-	-	3.84E-02	1.54E-03
HIPPIE	BP	GO:0043954	cellular component maintenance	-	72	72	-	-	7.93E-03	2.97E-03
HIPPIE	BP	GO:0050435	amyloid-beta metabolic process	-	65	59	-	-	8.77E-03	2.46E-03
HIPPIE	BP	GO:0014823	response to activity	-	70	69	-	-	3.02E-03	2.87E-03
HIPPIE	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	4.53E-02	7.68E-04
HIPPIE	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	2.07E-02	1.18E-03
HIPPIE	BP	GO:0034502	protein localization to chromosome	-	130	129	-	-	4.68E-03	5.33E-03
HIPPIE	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	5.54E-04	4.61E-04
HIPPIE	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	1.59E-03	4.61E-04
HIPPIE	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	4.69E-02	7.17E-04
HIPPIE	BP	GO:0019233	sensory perception of pain	-	103	103	-	-	2.59E-03	4.25E-03
HIPPIE	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	4.38E-02	9.22E-04
HIPPIE	BP	GO:0031343	positive regulation of cell killing	-	75	74	-	-	4.06E-02	3.07E-03
HIPPIE	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	2.36E-03	1.59E-03
HIPPIE	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	124	-	-	3.31E-02	5.12E-03
HIPPIE	BP	GO:0017148	negative regulation of translation	-	390	201	-	-	3.04E-02	8.24E-03
HIPPIE	BP	GO:0030220	platelet formation	-	22	22	-	-	1.25E-02	9.22E-04
HIPPIE	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	94	-	-	3.82E-03	3.89E-03
HIPPIE	MF	GO:1903624	regulation of DNA catabolic process	-	14	13	-	-	1.46E-04	5.63E-04
HIPPIE	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	1.42E-03	6.15E-04
HIPPIE	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	2.38E-02	6.15E-04
HIPPIE	BP	GO:1903509	liposaccharide metabolic process	-	109	107	-	-	1.40E-02	4.40E-03
HIPPIE	BP	GO:0009582	detection of abiotic stimulus	-	140	136	-	-	1.00E-02	5.58E-03
HIPPIE	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	7.27E-04	5.63E-04
HIPPIE	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	18	-	-	6.99E-04	7.68E-04
HIPPIE	CC	GO:0140238	presynaptic endocytosis	-	72	72	-	-	8.35E-03	2.97E-03
HIPPIE	BP	GO:0051236	establishment of RNA localization	-	161	158	-	-	1.04E-02	6.50E-03
HIPPIE	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	3.11E-02	1.02E-03
HIPPIE	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	1.72E-02	7.17E-04
HIPPIE	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	191	-	-	7.59E-03	7.84E-03
HIPPIE	BP	GO:0034067	protein localization to Golgi apparatus	-	30	29	-	-	1.39E-03	1.23E-03
HIPPIE	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	1.37E-03	1.33E-03
HIPPIE	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	3.03E-03	4.61E-04
HIPPIE	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	1.55E-02	7.17E-04
HIPPIE	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	50	-	-	3.69E-03	2.05E-03
HIPPIE	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	41	-	-	1.29E-03	1.69E-03
HIPPIE	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	1.66E-03	2.15E-03
HIPPIE	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	2.14E-03	6.66E-04
HIPPIE	BP	GO:0050779	RNA destabilization	-	135	115	-	-	2.74E-02	4.71E-03
HIPPIE	BP	GO:0006023	aminoglycan biosynthetic process	-	74	74	-	-	3.25E-02	3.07E-03
HIPPIE	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	5.33E-03	2.82E-03
HIPPIE	BP	GO:0010762	regulation of fibroblast migration	-	40	40	-	-	1.78E-03	1.64E-03
HIPPIE	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	3.92E-03	1.23E-03
HIPPIE	BP	GO:0035272	exocrine system development	-	46	46	-	-	2.08E-03	1.89E-03
HIPPIE	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	1.03E-02	7.17E-04
HIPPIE	BP	GO:0022406	membrane docking	-	90	90	-	-	1.42E-02	3.69E-03
HIPPIE	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	1.50E-02	6.15E-04
HIPPIE	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	17	-	-	5.21E-04	7.17E-04
HIPPIE	BP	GO:0050777	negative regulation of immune response	-	196	192	-	-	4.93E-03	7.89E-03
HIPPIE	MF	GO:0005035	death receptor activity	-	16	16	-	-	4.22E-03	6.66E-04
HIPPIE	BP	GO:0002063	chondrocyte development	-	33	32	-	-	2.26E-03	1.33E-03
HIPPIE	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	19	-	-	7.11E-04	8.19E-04
HIPPIE	BP	GO:0099068	postsynapse assembly	-	40	40	-	-	6.09E-03	1.64E-03
HIPPIE	BP	GO:0021782	glial cell development	-	120	114	-	-	1.90E-03	4.71E-03
HIPPIE	BP	GO:0051782	negative regulation of cell division	-	18	17	-	-	2.59E-03	7.17E-04
HIPPIE	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	7.12E-04	4.61E-04
HIPPIE	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	86	-	-	2.88E-03	3.53E-03
HIPPIE	BP	GO:0001655	urogenital system development	-	66	66	-	-	1.82E-03	2.71E-03
HIPPIE	BP	GO:0071827	plasma lipoprotein particle organization	-	86	78	-	-	2.30E-02	3.23E-03
HIPPIE	BP	GO:0045494	photoreceptor cell maintenance	-	43	43	-	-	1.21E-02	1.79E-03
HIPPIE	BP	GO:0055088	lipid homeostasis	-	173	163	-	-	7.48E-03	6.71E-03
HIPPIE	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	5.33E-04	1.08E-03
HIPPIE	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	196	-	-	4.74E-03	8.04E-03
HIPPIE	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	30	-	-	4.12E-02	1.23E-03
HIPPIE	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	36	-	-	2.19E-03	1.49E-03
HIPPIE	BP	GO:0045667	regulation of osteoblast differentiation	-	147	140	-	-	7.96E-03	5.74E-03
HIPPIE	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	1.88E-03	6.66E-04
HIPPIE	BP	GO:0061037	negative regulation of cartilage development	-	32	31	-	-	2.24E-03	1.28E-03
HIPPIE	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	3.67E-03	1.64E-03
HIPPIE	BP	GO:0001704	formation of primary germ layer	-	195	193	-	-	6.80E-03	7.94E-03
HIPPIE	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	8.40E-03	5.63E-04
HIPPIE	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	4.02E-03	2.10E-03
HIPPIE	BP	GO:0060174	limb bud formation	-	11	11	-	-	3.60E-03	4.61E-04
HIPPIE	BP	GO:0048708	astrocyte differentiation	-	88	86	-	-	2.63E-03	3.53E-03
HIPPIE	BP	GO:0042092	type 2 immune response	-	41	41	-	-	1.89E-03	1.69E-03
HIPPIE	BP	GO:0048588	developmental cell growth	-	233	227	-	-	4.66E-03	9.32E-03
HIPPIE	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	1.23E-02	8.19E-04
HIPPIE	BP	GO:0021872	forebrain generation of neurons	-	52	52	-	-	1.55E-03	2.15E-03
HIPPIE	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	1.74E-03	9.22E-04
HIPPIE	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	2.59E-02	1.64E-03
HIPPIE	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	52	-	-	2.05E-02	2.15E-03
HIPPIE	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	1.50E-03	4.61E-04
HIPPIE	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	2.64E-02	1.43E-03
HIPPIE	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	27	-	-	4.23E-04	1.13E-03
HIPPIE	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	50	-	-	2.14E-03	2.05E-03
HIPPIE	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	9.19E-03	8.19E-04
HIPPIE	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	8.17E-03	8.19E-04
HIPPIE	BP	GO:0010232	vascular transport	-	87	87	-	-	2.55E-03	3.58E-03
HIPPIE	BP	GO:0021987	cerebral cortex development	-	125	121	-	-	2.44E-03	4.97E-03
HIPPIE	BP	GO:0008637	apoptotic mitochondrial changes	-	108	107	-	-	6.02E-03	4.40E-03
HIPPIE	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	36	-	-	1.22E-02	1.49E-03
HIPPIE	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	3.07E-03	6.15E-04
HIPPIE	BP	GO:0060999	positive regulation of dendritic spine development	-	35	34	-	-	1.28E-03	1.43E-03
HIPPIE	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	1.31E-03	7.68E-04
HIPPIE	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	5.54E-03	3.18E-03
HIPPIE	BP	GO:0060973	cell migration involved in heart development	-	21	21	-	-	1.39E-03	8.71E-04
HIPPIE	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	2.36E-03	8.19E-04
HIPPIE	BP	GO:0002064	epithelial cell development	-	210	208	-	-	5.06E-03	8.55E-03
HIPPIE	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	3.39E-04	7.68E-04
HIPPIE	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	40	-	-	7.92E-03	1.64E-03
HIPPIE	BP	GO:2001222	regulation of neuron migration	-	46	45	-	-	5.22E-03	1.84E-03
HIPPIE	BP	GO:0034389	lipid droplet organization	-	38	37	-	-	2.83E-03	1.54E-03
HIPPIE	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	6.03E-04	1.84E-03
HIPPIE	BP	GO:0042177	negative regulation of protein catabolic process	-	109	108	-	-	1.59E-03	4.46E-03
HIPPIE	MF	GO:0038024	cargo receptor activity	-	121	115	-	-	8.23E-03	4.71E-03
HIPPIE	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	18	-	-	2.68E-03	7.68E-04
HIPPIE	BP	GO:0033120	positive regulation of RNA splicing	-	46	45	-	-	2.57E-02	1.84E-03
HIPPIE	BP	GO:0051445	regulation of meiotic cell cycle	-	64	62	-	-	1.58E-02	2.56E-03
HIPPIE	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.47E-04	5.12E-04
HIPPIE	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	5.62E-03	2.46E-03
HIPPIE	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	1.06E-02	6.15E-04
HIPPIE	BP	GO:0090087	regulation of peptide transport	-	195	191	-	-	7.84E-03	7.84E-03
HIPPIE	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	100	-	-	4.25E-03	4.10E-03
HIPPIE	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	8.59E-04	1.02E-03
HIPPIE	BP	GO:0006929	substrate-dependent cell migration	-	26	26	-	-	7.98E-04	1.08E-03
HIPPIE	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	6.78E-03	6.15E-04
HIPPIE	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	3.65E-02	1.13E-03
HIPPIE	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	3.94E-03	6.15E-04
HIPPIE	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	1.22E-03	6.15E-04
HIPPIE	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	2.66E-02	8.19E-04
HIPPIE	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	9.99E-03	5.63E-04
HIPPIE	BP	GO:0022404	molting cycle process	-	95	95	-	-	2.17E-03	3.89E-03
HIPPIE	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	12	-	-	2.81E-04	5.12E-04
HIPPIE	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	2.26E-03	7.17E-04
HIPPIE	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	4.89E-03	8.19E-04
HIPPIE	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	1.59E-03	5.12E-04
HIPPIE	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	19	-	-	5.90E-04	8.19E-04
HIPPIE	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	33	-	-	3.85E-03	1.38E-03
HIPPIE	BP	GO:0017014	protein nitrosylation	-	17	16	-	-	4.69E-03	6.66E-04
HIPPIE	BP	GO:0008299	isoprenoid biosynthetic process	-	30	30	-	-	1.98E-03	1.23E-03
HIPPIE	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	239	-	-	1.52E-02	9.83E-03
HIPPIE	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	2.06E-03	1.28E-03
HIPPIE	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	1.54E-03	9.22E-04
HIPPIE	CC	GO:0098926	postsynaptic signal transduction	-	39	38	-	-	6.52E-03	1.59E-03
HIPPIE	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	139	-	-	3.04E-03	5.74E-03
HIPPIE	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	8.09E-03	8.19E-04
HIPPIE	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	1.57E-03	1.95E-03
HIPPIE	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	159	-	-	5.65E-03	6.56E-03
HIPPIE	BP	GO:0034249	negative regulation of amide metabolic process	-	34	28	-	-	1.35E-03	1.18E-03
HIPPIE	BP	GO:0061548	ganglion development	-	17	17	-	-	1.59E-02	7.17E-04
HIPPIE	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	102	-	-	6.60E-03	4.20E-03
HIPPIE	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.39E-02	6.15E-04
HIPPIE	BP	GO:0042832	defense response to protozoan	-	28	26	-	-	4.35E-02	1.08E-03
HIPPIE	BP	GO:0048799	animal organ maturation	-	33	32	-	-	3.78E-03	1.33E-03
HIPPIE	BP	GO:0006925	inflammatory cell apoptotic process	-	23	21	-	-	1.37E-03	8.71E-04
HIPPIE	BP	GO:2000291	regulation of myoblast proliferation	-	25	20	-	-	8.52E-04	8.19E-04
HIPPIE	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	182	-	-	4.33E-03	7.48E-03
HIPPIE	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.50E-04	4.61E-04
HIPPIE	BP	GO:1903035	negative regulation of response to wounding	-	93	91	-	-	9.77E-03	3.74E-03
HIPPIE	BP	GO:0015697	quaternary ammonium group transport	-	16	15	-	-	5.70E-03	6.15E-04
HIPPIE	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	35	-	-	9.17E-04	1.43E-03
HIPPIE	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	2.27E-03	1.13E-03
HIPPIE	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	150	-	-	3.03E-02	6.15E-03
HIPPIE	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	97	-	-	2.79E-03	3.99E-03
HIPPIE	BP	GO:0045056	transcytosis	-	20	20	-	-	1.28E-03	8.19E-04
HIPPIE	BP	GO:0018342	protein prenylation	-	15	15	-	-	3.01E-03	6.15E-04
HIPPIE	BP	GO:0009267	cellular response to starvation	-	170	169	-	-	5.54E-03	6.96E-03
HIPPIE	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	5.15E-03	4.61E-04
HIPPIE	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	56	-	-	4.62E-03	2.30E-03
HIPPIE	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	1.13E-02	6.66E-04
HIPPIE	BP	GO:0007343	egg activation	-	11	11	-	-	4.42E-02	4.61E-04
HIPPIE	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	1.60E-03	9.73E-04
HIPPIE	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	26	-	-	1.43E-02	1.08E-03
HIPPIE	BP	GO:0046931	pore complex assembly	-	21	21	-	-	2.46E-03	8.71E-04
HIPPIE	CC	GO:0032008	positive regulation of TOR signaling	-	52	52	-	-	1.93E-02	2.15E-03
HIPPIE	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	2.12E-02	1.38E-03
HIPPIE	BP	GO:0046618	xenobiotic export from cell	-	27	18	-	-	8.11E-03	7.68E-04
HIPPIE	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	15	-	-	7.85E-04	6.15E-04
HIPPIE	BP	GO:0060428	lung epithelium development	-	43	43	-	-	1.70E-03	1.79E-03
HIPPIE	BP	GO:0030431	sleep	-	30	30	-	-	1.08E-02	1.23E-03
HIPPIE	BP	GO:1903318	negative regulation of protein maturation	-	29	29	-	-	1.37E-02	1.23E-03
HIPPIE	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	99	-	-	1.64E-01	4.10E-03
HIPPIE	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	4.18E-04	7.17E-04
HIPPIE	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	3.00E-03	6.15E-04
HIPPIE	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	3.43E-03	5.12E-04
HIPPIE	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.47E-04	5.63E-04
HIPPIE	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	73	-	-	1.12E-02	3.02E-03
HIPPIE	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	79	-	-	1.74E-03	3.28E-03
HIPPIE	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	1.11E-03	7.17E-04
HIPPIE	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	1.51E-04	6.15E-04
HIPPIE	CC	GO:0006406	mRNA export from nucleus	-	69	69	-	-	1.49E-02	2.87E-03
HIPPIE	BP	GO:0009880	embryonic pattern specification	-	70	70	-	-	5.02E-03	2.87E-03
HIPPIE	BP	GO:0015791	polyol transmembrane transport	-	14	13	-	-	3.02E-03	5.63E-04
HIPPIE	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	1.20E-01	1.64E-03
HIPPIE	BP	GO:0043043	peptide biosynthetic process	-	25	25	-	-	2.21E-02	1.02E-03
HIPPIE	BP	GO:0034105	positive regulation of tissue remodeling	-	23	22	-	-	5.68E-04	9.22E-04
HIPPIE	BP	GO:0002367	cytokine production involved in immune response	-	121	120	-	-	4.53E-03	4.92E-03
HIPPIE	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	15	-	-	5.96E-04	6.15E-04
HIPPIE	BP	GO:0044848	biological phase	-	211	207	-	-	1.26E-02	8.50E-03
HIPPIE	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	1.22E-02	5.12E-04
HIPPIE	BP	GO:0046660	female sex differentiation	-	125	124	-	-	6.45E-03	5.12E-03
HIPPIE	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	1.31E-03	7.17E-04
HIPPIE	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	45	-	-	7.58E-04	1.84E-03
HIPPIE	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	1.47E-04	4.61E-04
HIPPIE	BP	GO:0060411	cardiac septum morphogenesis	-	72	72	-	-	5.08E-03	2.97E-03
HIPPIE	BP	GO:0071248	cellular response to metal ion	-	201	198	-	-	3.34E-03	8.14E-03
HIPPIE	BP	GO:0030308	negative regulation of cell growth	-	191	189	-	-	4.43E-03	7.78E-03
HIPPIE	BP	GO:0097306	cellular response to alcohol	-	99	95	-	-	3.82E-03	3.89E-03
HIPPIE	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	127	-	-	2.86E-02	5.22E-03
HIPPIE	BP	GO:0010453	regulation of cell fate commitment	-	40	38	-	-	9.57E-03	1.59E-03
HIPPIE	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	58	-	-	2.35E-03	2.41E-03
HIPPIE	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	56	-	-	1.74E-03	2.30E-03
HIPPIE	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	2.64E-03	1.08E-03
HIPPIE	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	3.87E-02	1.02E-03
HIPPIE	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	45	-	-	9.68E-03	1.84E-03
HIPPIE	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	4.55E-03	3.18E-03
HIPPIE	BP	GO:0071498	cellular response to fluid shear stress	-	21	20	-	-	6.75E-04	8.19E-04
HIPPIE	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	1.36E-03	1.02E-03
HIPPIE	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	95	-	-	2.45E-03	3.89E-03
HIPPIE	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	2.61E-03	1.08E-03
HIPPIE	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	2.24E-03	4.61E-04
HIPPIE	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	53	-	-	4.21E-03	2.20E-03
HIPPIE	BP	GO:0051259	protein complex oligomerization	-	251	248	-	-	5.48E-03	1.02E-02
HIPPIE	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	3.02E-03	6.66E-04
HIPPIE	BP	GO:0098743	cell aggregation	-	24	24	-	-	8.00E-04	1.02E-03
HIPPIE	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	3.95E-04	5.12E-04
HIPPIE	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	5.53E-03	4.61E-04
HIPPIE	BP	GO:0009994	oocyte differentiation	-	57	54	-	-	2.37E-03	2.25E-03
HIPPIE	MF	GO:0031952	regulation of protein autophosphorylation	-	43	43	-	-	8.97E-04	1.79E-03
HIPPIE	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	3.06E-04	6.15E-04
HIPPIE	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	159	-	-	4.94E-03	6.56E-03
HIPPIE	BP	GO:0044319	"wound healing, spreading of cells"	-	37	36	-	-	3.63E-03	1.49E-03
HIPPIE	BP	GO:0033688	regulation of osteoblast proliferation	-	31	30	-	-	1.71E-03	1.23E-03
HIPPIE	BP	GO:0060251	regulation of glial cell proliferation	-	39	38	-	-	6.25E-04	1.59E-03
HIPPIE	BP	GO:0072665	protein localization to vacuole	-	84	84	-	-	5.99E-03	3.48E-03
HIPPIE	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	46	-	-	2.00E-02	1.89E-03
HIPPIE	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	25	-	-	1.45E-03	1.02E-03
HIPPIE	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	74	-	-	5.30E-03	3.07E-03
HIPPIE	BP	GO:0042953	lipoprotein transport	-	20	17	-	-	5.56E-03	7.17E-04
HIPPIE	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	7.19E-03	6.15E-04
HIPPIE	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.50E-04	4.61E-04
HIPPIE	BP	GO:0042044	fluid transport	-	35	34	-	-	1.25E-03	1.43E-03
HIPPIE	BP	GO:0070633	transepithelial transport	-	35	34	-	-	2.90E-03	1.43E-03
HIPPIE	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	1.29E-02	5.63E-04
HIPPIE	BP	GO:0045661	regulation of myoblast differentiation	-	74	74	-	-	7.31E-03	3.07E-03
HIPPIE	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	14	-	-	9.74E-04	6.15E-04
HIPPIE	BP	GO:0030307	positive regulation of cell growth	-	164	161	-	-	3.04E-03	6.61E-03
HIPPIE	BP	GO:0034250	positive regulation of amide metabolic process	-	27	27	-	-	2.05E-03	1.13E-03
HIPPIE	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	20	-	-	2.68E-03	8.19E-04
HIPPIE	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	16	-	-	1.39E-03	6.66E-04
HIPPIE	BP	GO:0014812	muscle cell migration	-	110	95	-	-	2.47E-03	3.89E-03
HIPPIE	BP	GO:0048525	negative regulation of viral process	-	90	90	-	-	2.40E-03	3.69E-03
HIPPIE	BP	GO:0072044	collecting duct development	-	16	16	-	-	5.50E-04	6.66E-04
HIPPIE	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	9.05E-03	6.15E-04
HIPPIE	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	73	-	-	3.02E-03	3.02E-03
HIPPIE	BP	GO:0030238	male sex determination	-	14	14	-	-	7.72E-03	6.15E-04
HIPPIE	BP	GO:0051781	positive regulation of cell division	-	93	93	-	-	2.26E-03	3.84E-03
HIPPIE	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	6.93E-03	8.71E-04
HIPPIE	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	1.19E-03	4.61E-04
HIPPIE	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	1.61E-02	9.73E-04
HIPPIE	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	22	-	-	7.86E-04	9.22E-04
HIPPIE	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.27E-03	1.95E-03
HIPPIE	BP	GO:0007272	ensheathment of neurons	-	146	142	-	-	3.55E-03	5.84E-03
HIPPIE	CC	GO:0050806	positive regulation of synaptic transmission	-	171	152	-	-	3.42E-03	6.25E-03
HIPPIE	BP	GO:0060021	roof of mouth development	-	91	91	-	-	4.76E-03	3.74E-03
HIPPIE	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	40	-	-	5.84E-03	1.64E-03
HIPPIE	BP	GO:0050819	negative regulation of coagulation	-	54	54	-	-	3.46E-02	2.25E-03
HIPPIE	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	4.85E-03	4.61E-04
HIPPIE	BP	GO:0017004	cytochrome complex assembly	-	40	38	-	-	6.09E-02	1.59E-03
HIPPIE	BP	GO:0018410	C-terminal protein amino acid modification	-	15	15	-	-	1.06E-02	6.15E-04
HIPPIE	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	5.01E-02	2.56E-03
HIPPIE	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	1.89E-02	6.15E-04
HIPPIE	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	15	-	-	1.06E-03	6.15E-04
HIPPIE	CC	GO:0050805	negative regulation of synaptic transmission	-	55	54	-	-	4.71E-03	2.25E-03
HIPPIE	BP	GO:0043248	proteasome assembly	-	13	13	-	-	1.35E-02	5.63E-04
HIPPIE	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	59	-	-	1.51E-03	2.46E-03
HIPPIE	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	1.35E-02	4.61E-04
HIPPIE	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	82	-	-	1.67E-02	3.38E-03
HIPPIE	BP	GO:0016054	organic acid catabolic process	-	251	245	-	-	1.54E-02	1.00E-02
HIPPIE	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	5.33E-04	5.63E-04
HIPPIE	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	3.20E-02	1.18E-03
HIPPIE	BP	GO:0065005	protein-lipid complex assembly	-	29	29	-	-	1.15E-02	1.23E-03
HIPPIE	BP	GO:0008033	tRNA processing	-	136	135	-	-	3.13E-02	5.53E-03
HIPPIE	BP	GO:0046661	male sex differentiation	-	171	170	-	-	5.78E-03	6.96E-03
HIPPIE	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	4.37E-04	6.15E-04
HIPPIE	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	18	-	-	2.50E-03	7.68E-04
HIPPIE	BP	GO:0035188	hatching	-	27	27	-	-	3.43E-04	1.13E-03
HIPPIE	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	88	-	-	2.06E-03	3.64E-03
HIPPIE	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	1.98E-04	6.15E-04
HIPPIE	BP	GO:0090713	immunological memory process	-	18	18	-	-	4.89E-02	7.68E-04
HIPPIE	BP	GO:0061326	renal tubule development	-	103	103	-	-	2.69E-03	4.25E-03
HIPPIE	BP	GO:0071985	multivesicular body sorting pathway	-	56	55	-	-	2.40E-02	2.25E-03
HIPPIE	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	9.83E-04	7.17E-04
HIPPIE	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	1.17E-03	8.19E-04
HIPPIE	BP	GO:0060325	face morphogenesis	-	31	31	-	-	9.30E-04	1.28E-03
HIPPIE	BP	GO:0090559	regulation of membrane permeability	-	72	70	-	-	2.76E-03	2.87E-03
HIPPIE	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	14	-	-	2.47E-03	6.15E-04
HIPPIE	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	5.08E-03	5.12E-04
HIPPIE	BP	GO:0031579	membrane raft organization	-	25	25	-	-	1.24E-03	1.02E-03
HIPPIE	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	6.63E-04	1.02E-03
HIPPIE	BP	GO:0060033	anatomical structure regression	-	16	16	-	-	4.22E-03	6.66E-04
HIPPIE	BP	GO:0046460	neutral lipid biosynthetic process	-	50	49	-	-	1.06E-02	2.05E-03
HIPPIE	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	149	-	-	1.21E-02	6.15E-03
HIPPIE	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	7.83E-03	4.61E-04
HIPPIE	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	162	-	-	3.37E-03	6.66E-03
HIPPIE	BP	GO:0002251	organ or tissue specific immune response	-	43	42	-	-	1.12E-02	1.74E-03
HIPPIE	CC	GO:0048167	regulation of synaptic plasticity	-	210	193	-	-	6.06E-03	7.94E-03
HIPPIE	BP	GO:1903708	positive regulation of hemopoiesis	-	184	181	-	-	6.58E-03	7.43E-03
HIPPIE	BP	GO:1903008	organelle disassembly	-	154	154	-	-	6.05E-03	6.35E-03
HIPPIE	BP	GO:0001709	cell fate determination	-	44	43	-	-	3.17E-03	1.79E-03
HIPPIE	BP	GO:0051873	killing by host of symbiont cells	-	28	28	-	-	7.08E-03	1.18E-03
HIPPIE	BP	GO:0045058	T cell selection	-	53	53	-	-	1.48E-02	2.20E-03
HIPPIE	CC	GO:0032387	negative regulation of intracellular transport	-	51	50	-	-	1.08E-03	2.05E-03
HIPPIE	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	1.54E-03	8.19E-04
HIPPIE	BP	GO:0072091	regulation of stem cell proliferation	-	91	83	-	-	2.01E-03	3.43E-03
HIPPIE	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	40	-	-	3.06E-03	1.64E-03
HIPPIE	BP	GO:0099084	postsynaptic specialization organization	-	44	44	-	-	5.28E-03	1.84E-03
HIPPIE	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	6.53E-03	4.61E-04
HIPPIE	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	1.20E-02	6.15E-04
HIPPIE	BP	GO:0060384	innervation	-	27	27	-	-	5.61E-03	1.13E-03
HIPPIE	BP	GO:2000774	positive regulation of cellular senescence	-	19	17	-	-	3.56E-04	7.17E-04
HIPPIE	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	35	-	-	7.33E-04	1.43E-03
HIPPIE	MF	GO:0031281	positive regulation of cyclase activity	-	40	38	-	-	3.08E-03	1.59E-03
HIPPIE	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	5.31E-03	2.61E-03
HIPPIE	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	1.98E-04	7.68E-04
HIPPIE	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	3.33E-02	5.12E-04
HIPPIE	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	2.40E-03	7.68E-04
HIPPIE	BP	GO:0071453	cellular response to oxygen levels	-	168	161	-	-	4.02E-03	6.61E-03
HIPPIE	BP	GO:0090399	replicative senescence	-	17	17	-	-	1.45E-03	7.17E-04
HIPPIE	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	8.15E-02	6.15E-04
HIPPIE	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	7.14E-03	1.23E-03
HIPPIE	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	6.29E-03	5.12E-03
HIPPIE	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	1.26E-02	6.15E-04
HIPPIE	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	1.25E-03	1.02E-03
HIPPIE	BP	GO:0044242	cellular lipid catabolic process	-	224	220	-	-	1.09E-02	9.01E-03
HIPPIE	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	3.11E-04	5.63E-04
HIPPIE	BP	GO:0002931	response to ischemia	-	58	56	-	-	3.00E-03	2.30E-03
HIPPIE	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	1.34E-02	5.12E-04
HIPPIE	BP	GO:0014047	glutamate secretion	-	25	25	-	-	1.45E-02	1.02E-03
HIPPIE	BP	GO:0061005	cell differentiation involved in kidney development	-	58	56	-	-	2.33E-03	2.30E-03
HIPPIE	BP	GO:0030397	membrane disassembly	-	11	11	-	-	6.32E-04	4.61E-04
HIPPIE	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	76	-	-	7.84E-03	3.12E-03
HIPPIE	BP	GO:0060420	regulation of heart growth	-	74	67	-	-	4.96E-03	2.77E-03
HIPPIE	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	7.86E-04	6.15E-04
HIPPIE	BP	GO:0009755	hormone-mediated signaling pathway	-	221	219	-	-	8.38E-03	9.01E-03
HIPPIE	BP	GO:0022612	gland morphogenesis	-	124	124	-	-	3.76E-03	5.12E-03
HIPPIE	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	35	-	-	7.38E-04	1.43E-03
HIPPIE	MF	GO:0140416	transcription regulator inhibitor activity	-	26	26	-	-	1.98E-03	1.08E-03
HIPPIE	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	26	-	-	1.68E-01	1.08E-03
HIPPIE	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	3.32E-03	6.15E-04
HIPPIE	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	2.48E-02	7.17E-04
HIPPIE	BP	GO:1990845	adaptive thermogenesis	-	166	165	-	-	4.79E-03	6.76E-03
HIPPIE	BP	GO:0071320	cellular response to cAMP	-	54	54	-	-	1.84E-03	2.25E-03
HIPPIE	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	1.99E-02	4.61E-04
HIPPIE	BP	GO:0015844	monoamine transport	-	88	88	-	-	2.02E-02	3.64E-03
HIPPIE	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	5.88E-03	9.22E-04
HIPPIE	BP	GO:0060039	pericardium development	-	19	19	-	-	5.95E-04	8.19E-04
HIPPIE	BP	GO:0071392	cellular response to estradiol stimulus	-	40	40	-	-	1.06E-03	1.64E-03
HIPPIE	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	16	-	-	6.95E-03	6.66E-04
HIPPIE	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	1.28E-02	8.19E-04
HIPPIE	BP	GO:0009451	RNA modification	-	169	165	-	-	9.99E-03	6.76E-03
HIPPIE	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	2.63E-01	4.61E-04
HIPPIE	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	40	-	-	1.86E-03	1.64E-03
HIPPIE	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	8.09E-04	7.17E-04
HIPPIE	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	112	-	-	5.23E-03	4.61E-03
HIPPIE	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	43	-	-	3.96E-03	1.79E-03
HIPPIE	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	2.79E-02	4.61E-04
HIPPIE	BP	GO:0015807	L-amino acid transport	-	94	89	-	-	4.52E-03	3.69E-03
HIPPIE	BP	GO:0032941	secretion by tissue	-	85	84	-	-	2.22E-03	3.48E-03
HIPPIE	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	2.67E-03	5.63E-04
HIPPIE	BP	GO:0046605	regulation of centrosome cycle	-	54	53	-	-	4.47E-03	2.20E-03
HIPPIE	BP	GO:0048753	pigment granule organization	-	40	40	-	-	3.53E-02	1.64E-03
HIPPIE	BP	GO:0021516	dorsal spinal cord development	-	20	19	-	-	5.21E-03	8.19E-04
HIPPIE	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	7.12E-02	8.19E-04
HIPPIE	BP	GO:0032196	transposition	-	11	11	-	-	7.45E-04	4.61E-04
HIPPIE	BP	GO:0003014	renal system process	-	130	128	-	-	4.88E-03	5.27E-03
HIPPIE	CC	GO:0070286	axonemal dynein complex assembly	-	40	40	-	-	3.38E-03	1.64E-03
HIPPIE	BP	GO:0045598	regulation of fat cell differentiation	-	148	141	-	-	4.13E-03	5.79E-03
HIPPIE	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	197	-	-	7.94E-03	8.09E-03
HIPPIE	BP	GO:1904646	cellular response to amyloid-beta	-	44	43	-	-	1.41E-03	1.79E-03
HIPPIE	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	1.15E-03	1.02E-03
HIPPIE	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	228	-	-	6.23E-02	9.37E-03
HIPPIE	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.41E-04	5.63E-04
HIPPIE	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	5.20E-04	9.73E-04
HIPPIE	BP	GO:0018158	protein oxidation	-	15	14	-	-	1.16E-03	6.15E-04
HIPPIE	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	2.17E-03	1.23E-03
HIPPIE	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	4.00E-03	7.17E-04
HIPPIE	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	28	-	-	8.78E-04	1.18E-03
HIPPIE	BP	GO:0071709	membrane assembly	-	68	67	-	-	7.29E-03	2.77E-03
HIPPIE	BP	GO:0008217	regulation of blood pressure	-	186	183	-	-	1.41E-02	7.53E-03
HIPPIE	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	1.70E-03	7.68E-04
HIPPIE	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	2.40E-02	6.15E-04
HIPPIE	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	62	-	-	2.86E-03	2.56E-03
HIPPIE	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	9.22E-03	7.63E-03
HIPPIE	BP	GO:0002200	somatic diversification of immune receptors	-	78	77	-	-	5.26E-03	3.18E-03
HIPPIE	BP	GO:0035315	hair cell differentiation	-	52	51	-	-	3.03E-03	2.10E-03
HIPPIE	BP	GO:0048645	animal organ formation	-	62	62	-	-	2.28E-03	2.56E-03
HIPPIE	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	163	-	-	7.03E-03	6.71E-03
HIPPIE	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	15	-	-	3.38E-02	6.15E-04
HIPPIE	BP	GO:0033627	cell adhesion mediated by integrin	-	87	87	-	-	1.22E-02	3.58E-03
HIPPIE	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	1.46E-02	8.71E-04
HIPPIE	BP	GO:0015824	proline transport	-	13	11	-	-	2.32E-03	4.61E-04
HIPPIE	BP	GO:0035107	appendage morphogenesis	-	147	147	-	-	4.80E-03	6.04E-03
HIPPIE	BP	GO:1903707	negative regulation of hemopoiesis	-	116	114	-	-	2.42E-03	4.71E-03
HIPPIE	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	1.41E-03	8.19E-04
HIPPIE	CC	GO:0048208	COPII vesicle coating	-	27	26	-	-	2.40E-02	1.08E-03
HIPPIE	BP	GO:0030149	sphingolipid catabolic process	-	32	32	-	-	1.64E-03	1.33E-03
HIPPIE	BP	GO:0050994	regulation of lipid catabolic process	-	61	59	-	-	4.87E-03	2.46E-03
HIPPIE	BP	GO:0035988	chondrocyte proliferation	-	24	24	-	-	1.56E-03	1.02E-03
HIPPIE	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	8.98E-03	1.23E-03
HIPPIE	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	1.48E-03	4.61E-04
HIPPIE	BP	GO:0009593	detection of chemical stimulus	-	511	229	-	-	6.53E-03	9.42E-03
HIPPIE	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	1.40E-03	5.12E-04
HIPPIE	BP	GO:0045727	positive regulation of translation	-	141	140	-	-	3.71E-03	5.74E-03
HIPPIE	BP	GO:0036315	cellular response to sterol	-	24	21	-	-	9.16E-03	8.71E-04
HIPPIE	CC	GO:0032388	positive regulation of intracellular transport	-	137	134	-	-	2.15E-03	5.53E-03
HIPPIE	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	7.78E-04	5.63E-04
HIPPIE	BP	GO:0002027	regulation of heart rate	-	106	102	-	-	1.51E-02	4.20E-03
HIPPIE	BP	GO:0050879	multicellular organismal movement	-	118	116	-	-	1.71E-03	4.76E-03
HIPPIE	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	1.24E-03	6.15E-04
HIPPIE	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	77	-	-	2.35E-03	3.18E-03
HIPPIE	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	62	-	-	2.78E-03	2.56E-03
HIPPIE	BP	GO:0048515	spermatid differentiation	-	208	195	-	-	4.39E-03	7.99E-03
HIPPIE	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	3.20E-03	2.36E-03
HIPPIE	MF	GO:0042887	amide transmembrane transporter activity	-	33	32	-	-	1.00E-03	1.33E-03
HIPPIE	BP	GO:0007130	synaptonemal complex assembly	-	23	23	-	-	5.13E-02	9.73E-04
HIPPIE	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	34	-	-	5.21E-03	1.43E-03
HIPPIE	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	34	-	-	9.56E-04	1.43E-03
HIPPIE	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	36	-	-	3.21E-02	1.49E-03
HIPPIE	BP	GO:0060119	inner ear receptor cell development	-	44	43	-	-	3.45E-03	1.79E-03
HIPPIE	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	3.93E-03	7.68E-04
HIPPIE	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	2.49E-02	1.43E-03
HIPPIE	BP	GO:1901983	regulation of protein acetylation	-	26	26	-	-	8.81E-04	1.08E-03
HIPPIE	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.05E-03	5.12E-04
HIPPIE	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	248	-	-	7.60E-03	1.02E-02
HIPPIE	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	5.96E-04	7.17E-04
HIPPIE	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	1.77E-02	2.00E-03
HIPPIE	BP	GO:0010883	regulation of lipid storage	-	53	52	-	-	4.06E-03	2.15E-03
HIPPIE	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	3.00E-03	1.08E-03
HIPPIE	BP	GO:0007635	chemosensory behavior	-	20	20	-	-	7.39E-04	8.19E-04
HIPPIE	BP	GO:1905954	positive regulation of lipid localization	-	110	110	-	-	7.86E-03	4.51E-03
HIPPIE	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	4.78E-04	5.12E-04
HIPPIE	BP	GO:0002209	behavioral defense response	-	39	39	-	-	6.25E-03	1.64E-03
HIPPIE	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	30	-	-	5.03E-02	1.23E-03
HIPPIE	BP	GO:0072523	purine-containing compound catabolic process	-	146	144	-	-	3.21E-03	5.94E-03
HIPPIE	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	34	-	-	3.42E-03	1.43E-03
HIPPIE	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	27	-	-	9.79E-04	1.13E-03
HIPPIE	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	1.96E-04	6.66E-04
HIPPIE	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	95	-	-	2.75E-03	3.89E-03
HIPPIE	BP	GO:0007218	neuropeptide signaling pathway	-	113	105	-	-	5.94E-02	4.30E-03
HIPPIE	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	13	-	-	1.90E-03	5.63E-04
HIPPIE	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	163	-	-	1.52E-02	6.71E-03
HIPPIE	BP	GO:0031345	negative regulation of cell projection organization	-	195	188	-	-	5.66E-03	7.73E-03
HIPPIE	BP	GO:0048278	vesicle docking	-	64	64	-	-	1.14E-02	2.66E-03
HIPPIE	BP	GO:0035050	embryonic heart tube development	-	86	85	-	-	3.48E-03	3.48E-03
HIPPIE	BP	GO:0051593	response to folic acid	-	12	11	-	-	1.50E-04	4.61E-04
HIPPIE	BP	GO:0030168	platelet activation	-	135	133	-	-	8.16E-03	5.48E-03
HIPPIE	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	3.14E-02	6.66E-04
HIPPIE	CC	GO:0098810	neurotransmitter reuptake	-	35	35	-	-	5.33E-03	1.43E-03
HIPPIE	BP	GO:0008213	protein alkylation	-	58	56	-	-	6.04E-03	2.30E-03
HIPPIE	BP	GO:0009812	flavonoid metabolic process	-	14	14	-	-	1.48E-01	6.15E-04
HIPPIE	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	2.26E-03	5.63E-04
HIPPIE	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	3.17E-02	1.02E-03
HIPPIE	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	3.18E-04	5.63E-04
HIPPIE	BP	GO:0031529	ruffle organization	-	55	55	-	-	2.90E-03	2.25E-03
HIPPIE	BP	GO:0010842	retina layer formation	-	25	25	-	-	1.05E-03	1.02E-03
HIPPIE	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	93	-	-	4.31E-02	3.84E-03
HIPPIE	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	13	-	-	2.14E-02	5.63E-04
HIPPIE	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	70	-	-	1.00E-02	2.87E-03
HIPPIE	MF	GO:0170055	lipid transmembrane transporter activity	-	56	55	-	-	8.87E-03	2.25E-03
HIPPIE	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	35	-	-	1.71E-03	1.43E-03
HIPPIE	BP	GO:0035304	regulation of protein dephosphorylation	-	87	86	-	-	2.13E-03	3.53E-03
HIPPIE	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	231	-	-	4.74E-03	9.47E-03
HIPPIE	BP	GO:0099637	neurotransmitter receptor transport	-	26	26	-	-	9.58E-04	1.08E-03
HIPPIE	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	38	-	-	1.47E-03	1.59E-03
HIPPIE	BP	GO:0051775	response to redox state	-	13	13	-	-	3.74E-03	5.63E-04
HIPPIE	BP	GO:0051785	positive regulation of nuclear division	-	61	60	-	-	2.72E-03	2.46E-03
HIPPIE	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	1.47E-02	6.66E-04
HIPPIE	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	2.46E-03	6.66E-04
HIPPIE	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	1.32E-03	8.19E-04
HIPPIE	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	4.52E-03	5.12E-04
HIPPIE	BP	GO:0044786	cell cycle DNA replication	-	45	45	-	-	6.78E-03	1.84E-03
HIPPIE	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	15	-	-	3.51E-03	6.15E-04
HIPPIE	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	1.17E-03	7.17E-04
HIPPIE	BP	GO:0051299	centrosome separation	-	15	15	-	-	1.43E-03	6.15E-04
HIPPIE	BP	GO:0048145	regulation of fibroblast proliferation	-	87	85	-	-	2.03E-03	3.48E-03
HIPPIE	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	90	-	-	3.29E-01	3.69E-03
HIPPIE	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	2.44E-03	4.61E-04
HIPPIE	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	231	-	-	4.04E-03	9.47E-03
HIPPIE	BP	GO:0032098	regulation of appetite	-	20	20	-	-	3.71E-02	8.19E-04
HIPPIE	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	1.08E-02	6.15E-04
HIPPIE	CC	GO:0008333	endosome to lysosome transport	-	73	73	-	-	1.51E-02	3.02E-03
HIPPIE	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	23	-	-	3.44E-02	9.73E-04
HIPPIE	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	17	-	-	1.33E-02	7.17E-04
HIPPIE	BP	GO:0003016	respiratory system process	-	39	38	-	-	8.24E-04	1.59E-03
HIPPIE	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	9.66E-03	9.73E-04
HIPPIE	BP	GO:0045732	positive regulation of protein catabolic process	-	202	200	-	-	4.43E-03	8.19E-03
HIPPIE	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	72	-	-	3.58E-03	2.97E-03
HIPPIE	BP	GO:0007588	excretion	-	40	40	-	-	5.37E-03	1.64E-03
HIPPIE	BP	GO:1904018	positive regulation of vasculature development	-	185	174	-	-	5.85E-03	7.17E-03
HIPPIE	BP	GO:0050953	sensory perception of light stimulus	-	223	219	-	-	3.48E-02	9.01E-03
HIPPIE	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	5.01E-02	1.02E-03
HIPPIE	BP	GO:0002357	defense response to tumor cell	-	13	12	-	-	4.12E-04	5.12E-04
HIPPIE	BP	GO:0009303	rRNA transcription	-	37	37	-	-	4.34E-03	1.54E-03
HIPPIE	BP	GO:0035601	protein deacylation	-	56	56	-	-	3.20E-03	2.30E-03
HIPPIE	BP	GO:0061952	midbody abscission	-	18	18	-	-	1.66E-02	7.68E-04
HIPPIE	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	6.30E-04	4.61E-04
HIPPIE	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	21	-	-	1.45E-03	8.71E-04
HIPPIE	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	36	-	-	1.23E-03	1.49E-03
HIPPIE	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	3.31E-03	2.66E-03
HIPPIE	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	16	-	-	3.86E-03	6.66E-04
HIPPIE	BP	GO:0045830	positive regulation of isotype switching	-	28	27	-	-	4.09E-03	1.13E-03
HIPPIE	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	1.26E-03	1.38E-03
HIPPIE	BP	GO:0046697	decidualization	-	26	26	-	-	3.43E-03	1.08E-03
HIPPIE	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	1.49E-04	6.15E-04
HIPPIE	BP	GO:0051588	regulation of neurotransmitter transport	-	99	99	-	-	3.82E-03	4.10E-03
HIPPIE	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	32	-	-	5.67E-02	1.33E-03
HIPPIE	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	1.02E-03	5.12E-04
HIPPIE	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	5.70E-03	2.61E-03
HIPPIE	BP	GO:0044703	multi-organism reproductive process	-	209	206	-	-	5.89E-03	8.45E-03
HIPPIE	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	140	-	-	1.16E-02	5.74E-03
HIPPIE	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	2.62E-03	4.61E-04
HIPPIE	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	53	-	-	7.12E-03	2.20E-03
HIPPIE	BP	GO:0099022	vesicle tethering	-	32	32	-	-	8.34E-02	1.33E-03
HIPPIE	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	38	-	-	1.20E-03	1.59E-03
HIPPIE	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	2.37E-03	5.12E-04
HIPPIE	BP	GO:0048857	neural nucleus development	-	65	65	-	-	5.78E-03	2.66E-03
HIPPIE	BP	GO:0048663	neuron fate commitment	-	74	72	-	-	7.79E-03	2.97E-03
HIPPIE	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	174	-	-	4.85E-03	7.17E-03
HIPPIE	BP	GO:0106027	neuron projection organization	-	90	89	-	-	2.47E-03	3.69E-03
HIPPIE	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	133	-	-	1.05E-02	5.48E-03
HIPPIE	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	38	-	-	1.88E-03	1.59E-03
HIPPIE	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	9.53E-04	4.61E-04
HIPPIE	BP	GO:0045685	regulation of glial cell differentiation	-	77	75	-	-	4.46E-03	3.07E-03
HIPPIE	BP	GO:0051608	histamine transport	-	14	14	-	-	7.48E-04	6.15E-04
HIPPIE	BP	GO:0043414	macromolecule methylation	-	138	134	-	-	1.44E-02	5.53E-03
HIPPIE	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	7.92E-03	5.12E-04
HIPPIE	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	2.78E-02	6.66E-04
HIPPIE	BP	GO:0050886	endocrine process	-	93	92	-	-	1.75E-02	3.79E-03
HIPPIE	MF	GO:0015562	efflux transmembrane transporter activity	-	15	14	-	-	5.22E-04	6.15E-04
HIPPIE	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	1.47E-03	1.18E-03
HIPPIE	BP	GO:0045807	positive regulation of endocytosis	-	155	153	-	-	6.12E-03	6.30E-03
HIPPIE	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	5.00E-04	4.61E-04
HIPPIE	BP	GO:0002418	immune response to tumor cell	-	29	29	-	-	7.03E-03	1.23E-03
HIPPIE	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	62	-	-	1.75E-03	2.56E-03
HIPPIE	BP	GO:0048308	organelle inheritance	-	14	14	-	-	1.37E-03	6.15E-04
HIPPIE	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	22	-	-	7.98E-04	9.22E-04
HIPPIE	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	1.31E-03	8.19E-04
HIPPIE	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	51	-	-	1.73E-03	2.10E-03
HIPPIE	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.48E-03	2.77E-03
HIPPIE	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	1.48E-04	5.12E-04
HIPPIE	BP	GO:0009110	vitamin biosynthetic process	-	23	22	-	-	1.34E-03	9.22E-04
HIPPIE	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	23	-	-	2.02E-03	9.73E-04
HIPPIE	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	3.38E-03	7.17E-04
HIPPIE	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	21	-	-	3.26E-03	8.71E-04
HIPPIE	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	103	-	-	3.22E-03	4.25E-03
HIPPIE	BP	GO:0009111	vitamin catabolic process	-	13	12	-	-	1.57E-02	5.12E-04
HIPPIE	MF	GO:0051100	negative regulation of binding	-	161	159	-	-	3.05E-03	6.56E-03
HIPPIE	BP	GO:0003151	outflow tract morphogenesis	-	81	81	-	-	4.72E-03	3.33E-03
HIPPIE	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	1.59E-03	2.46E-03
HIPPIE	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	1.33E-03	8.19E-04
HIPPIE	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	13	-	-	2.66E-04	5.63E-04
HIPPIE	BP	GO:0046504	glycerol ether biosynthetic process	-	11	11	-	-	1.10E-03	4.61E-04
HIPPIE	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	2.27E-02	1.38E-03
HIPPIE	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	2.85E-02	6.66E-04
HIPPIE	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	2.44E-04	5.63E-04
HIPPIE	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	2.43E-03	1.95E-03
HIPPIE	BP	GO:0046621	negative regulation of organ growth	-	39	36	-	-	1.38E-03	1.49E-03
HIPPIE	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	8.00E-02	2.05E-03
HIPPIE	BP	GO:0032368	regulation of lipid transport	-	149	141	-	-	5.22E-03	5.79E-03
HIPPIE	BP	GO:0055094	response to lipoprotein particle	-	34	32	-	-	3.57E-03	1.33E-03
HIPPIE	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	181	-	-	5.80E-03	7.43E-03
HIPPIE	BP	GO:0033002	muscle cell proliferation	-	249	221	-	-	5.76E-03	9.06E-03
HIPPIE	BP	GO:0043331	response to dsRNA	-	56	55	-	-	1.07E-02	2.25E-03
HIPPIE	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	2.61E-03	5.12E-04
HIPPIE	BP	GO:0051904	pigment granule transport	-	23	23	-	-	1.70E-02	9.73E-04
HIPPIE	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	2.99E-03	1.33E-03
HIPPIE	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	34	-	-	1.19E-03	1.43E-03
HIPPIE	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	11	-	-	1.81E-02	4.61E-04
HIPPIE	BP	GO:0033363	secretory granule organization	-	63	62	-	-	6.77E-03	2.56E-03
HIPPIE	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	7.18E-04	1.18E-03
HIPPIE	BP	GO:0120009	intermembrane lipid transfer	-	52	52	-	-	3.25E-02	2.15E-03
HIPPIE	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	2.87E-03	6.15E-04
HIPPIE	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	2.27E-03	1.59E-03
HIPPIE	BP	GO:0097250	mitochondrial respirasome assembly	-	11	11	-	-	1.44E-02	4.61E-04
HIPPIE	BP	GO:0033622	integrin activation	-	26	26	-	-	2.34E-03	1.08E-03
HIPPIE	BP	GO:0098751	bone cell development	-	18	16	-	-	3.57E-04	6.66E-04
HIPPIE	BP	GO:2000773	negative regulation of cellular senescence	-	25	23	-	-	1.57E-03	9.73E-04
HIPPIE	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	1.41E-03	2.10E-03
HIPPIE	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.57E-02	1.23E-03
HIPPIE	BP	GO:0002076	osteoblast development	-	17	17	-	-	2.03E-03	7.17E-04
HIPPIE	BP	GO:0072164	mesonephric tubule development	-	98	98	-	-	5.56E-03	4.05E-03
HIPPIE	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	1.97E-04	7.17E-04
HIPPIE	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	114	-	-	3.77E-03	4.71E-03
HIPPIE	BP	GO:1903524	positive regulation of blood circulation	-	39	38	-	-	2.22E-03	1.59E-03
HIPPIE	BP	GO:0030901	midbrain development	-	87	87	-	-	2.74E-03	3.58E-03
HIPPIE	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	1.11E-02	9.22E-04
HIPPIE	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	1.83E-03	6.66E-04
HIPPIE	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	14	-	-	1.19E-03	6.15E-04
HIPPIE	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	68	-	-	1.78E-03	2.82E-03
HIPPIE	MF	GO:1901474	azole transmembrane transporter activity	-	13	12	-	-	2.25E-03	5.12E-04
HIPPIE	BP	GO:0002687	positive regulation of leukocyte migration	-	147	146	-	-	6.96E-03	5.99E-03
HIPPIE	BP	GO:0019755	one-carbon compound transport	-	28	27	-	-	2.86E-02	1.13E-03
HIPPIE	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.44E-04	5.63E-04
HIPPIE	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	3.81E-03	6.66E-04
HIPPIE	BP	GO:0110154	RNA decapping	-	19	19	-	-	3.89E-02	8.19E-04
HIPPIE	BP	GO:0034605	cellular response to heat	-	66	66	-	-	2.23E-03	2.71E-03
HIPPIE	BP	GO:0005996	monosaccharide metabolic process	-	250	242	-	-	6.67E-03	9.93E-03
HIPPIE	BP	GO:0033555	multicellular organismal response to stress	-	90	90	-	-	5.80E-03	3.69E-03
HIPPIE	BP	GO:0002262	myeloid cell homeostasis	-	172	170	-	-	3.87E-03	6.96E-03
HIPPIE	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	7.69E-02	1.59E-03
HIPPIE	BP	GO:0050688	regulation of defense response to virus	-	65	64	-	-	3.77E-03	2.66E-03
HIPPIE	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	27	-	-	1.18E-03	1.13E-03
HIPPIE	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	227	-	-	1.31E-02	9.32E-03
HIPPIE	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	7.15E-04	1.28E-03
HIPPIE	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	8.39E-04	6.15E-04
HIPPIE	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	35	-	-	7.02E-03	1.43E-03
HIPPIE	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	20	-	-	4.32E-03	8.19E-04
HIPPIE	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	1.11E-02	1.18E-03
HIPPIE	BP	GO:0022618	protein-RNA complex assembly	-	227	207	-	-	2.08E-02	8.50E-03
HIPPIE	BP	GO:0051147	regulation of muscle cell differentiation	-	162	154	-	-	8.22E-03	6.35E-03
HIPPIE	BP	GO:0014745	negative regulation of muscle adaptation	-	11	11	-	-	7.36E-04	4.61E-04
HIPPIE	BP	GO:0090102	cochlea development	-	50	48	-	-	1.36E-03	2.00E-03
HIPPIE	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	2.16E-03	1.08E-03
HIPPIE	BP	GO:0061303	cornea development in camera-type eye	-	12	12	-	-	1.50E-04	5.12E-04
HIPPIE	BP	GO:0045933	positive regulation of muscle contraction	-	49	49	-	-	3.33E-03	2.05E-03
HIPPIE	BP	GO:0015803	branched-chain amino acid transport	-	14	13	-	-	5.13E-02	5.63E-04
HIPPIE	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	1.17E-03	6.66E-04
HIPPIE	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	35	-	-	3.53E-03	1.43E-03
HIPPIE	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	93	-	-	6.40E-02	3.84E-03
HIPPIE	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.49E-04	5.12E-04
HIPPIE	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	1.35E-03	9.22E-04
HIPPIE	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	5.99E-03	2.92E-03
HIPPIE	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	56	-	-	1.99E-02	2.30E-03
HIPPIE	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	3.18E-02	9.73E-04
HIPPIE	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	57	-	-	4.72E-03	2.36E-03
HIPPIE	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	5.03E-04	4.61E-04
HIPPIE	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	3.97E-03	1.59E-03
HIPPIE	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.47E-04	5.12E-04
HIPPIE	BP	GO:0140253	cell-cell fusion	-	62	58	-	-	2.26E-03	2.41E-03
HIPPIE	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	2.23E-03	5.12E-04
HIPPIE	BP	GO:0071599	otic vesicle development	-	15	15	-	-	5.52E-04	6.15E-04
HIPPIE	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	43	-	-	1.01E-01	1.79E-03
HIPPIE	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	1.80E-03	6.15E-04
HIPPIE	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	4.50E-03	2.46E-03
HIPPIE	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	3.32E-02	1.49E-03
HIPPIE	BP	GO:0051293	establishment of spindle localization	-	57	56	-	-	2.11E-03	2.30E-03
HIPPIE	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	3.58E-04	5.63E-04
HIPPIE	BP	GO:0043114	regulation of vascular permeability	-	49	46	-	-	3.84E-03	1.89E-03
HIPPIE	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	2.29E-03	1.08E-03
HIPPIE	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	65	-	-	1.67E-03	2.66E-03
HIPPIE	BP	GO:0008360	regulation of cell shape	-	139	137	-	-	6.60E-03	5.63E-03
HIPPIE	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	8.76E-03	6.66E-04
HIPPIE	BP	GO:0051222	positive regulation of protein transport	-	249	242	-	-	4.81E-03	9.93E-03
HIPPIE	CC	GO:0140632	canonical inflammasome complex assembly	-	40	40	-	-	1.10E-02	1.64E-03
HIPPIE	MF	GO:0034260	negative regulation of GTPase activity	-	36	34	-	-	7.68E-04	1.43E-03
HIPPIE	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	4.08E-03	9.22E-04
HIPPIE	BP	GO:0045739	positive regulation of DNA repair	-	128	126	-	-	1.65E-02	5.17E-03
HIPPIE	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	3.40E-03	8.19E-04
HIPPIE	BP	GO:0045185	maintenance of protein location	-	95	90	-	-	1.71E-03	3.69E-03
HIPPIE	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	5.38E-03	5.63E-04
HIPPIE	BP	GO:0003158	endothelium development	-	140	133	-	-	8.67E-03	5.48E-03
HIPPIE	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	1.67E-03	1.69E-03
HIPPIE	BP	GO:0051224	negative regulation of protein transport	-	122	118	-	-	3.40E-03	4.87E-03
HIPPIE	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	157	-	-	3.31E-03	6.45E-03
HIPPIE	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	4.11E-03	5.63E-04
HIPPIE	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	1.68E-02	1.28E-03
HIPPIE	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	19	-	-	4.76E-02	8.19E-04
HIPPIE	BP	GO:0021885	forebrain cell migration	-	63	62	-	-	3.20E-03	2.56E-03
HIPPIE	BP	GO:0007405	neuroblast proliferation	-	81	79	-	-	1.83E-03	3.28E-03
HIPPIE	BP	GO:0009581	detection of external stimulus	-	137	133	-	-	5.99E-03	5.48E-03
HIPPIE	BP	GO:1990542	mitochondrial transmembrane transport	-	93	92	-	-	1.64E-02	3.79E-03
HIPPIE	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	32	-	-	3.13E-03	1.33E-03
HIPPIE	BP	GO:0033504	floor plate development	-	11	11	-	-	6.61E-03	4.61E-04
HIPPIE	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	3.21E-03	4.61E-04
HIPPIE	BP	GO:0097186	amelogenesis	-	26	26	-	-	3.27E-02	1.08E-03
HIPPIE	BP	GO:0070572	positive regulation of neuron projection regeneration	-	13	12	-	-	6.12E-04	5.12E-04
HIPPIE	BP	GO:0031128	developmental induction	-	26	26	-	-	1.43E-03	1.08E-03
HIPPIE	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	1.63E-03	6.15E-04
HIPPIE	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.00E-03	2.71E-03
HIPPIE	BP	GO:0021533	cell differentiation in hindbrain	-	23	23	-	-	1.62E-03	9.73E-04
HIPPIE	BP	GO:0045684	positive regulation of epidermis development	-	33	33	-	-	1.45E-03	1.38E-03
HIPPIE	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	1.95E-03	5.12E-04
HIPPIE	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	3.36E-02	2.10E-03
HIPPIE	BP	GO:0021517	ventral spinal cord development	-	47	46	-	-	5.02E-03	1.89E-03
HIPPIE	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	2.27E-03	3.07E-03
HIPPIE	BP	GO:0032328	alanine transport	-	19	17	-	-	2.31E-03	7.17E-04
HIPPIE	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	2.77E-03	6.66E-04
HIPPIE	BP	GO:0097722	sperm motility	-	133	123	-	-	4.62E-03	5.07E-03
HIPPIE	BP	GO:0051231	spindle elongation	-	14	14	-	-	7.47E-03	6.15E-04
HIPPIE	BP	GO:0042490	mechanoreceptor differentiation	-	67	66	-	-	4.95E-03	2.71E-03
HIPPIE	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.49E-03	1.23E-03
HIPPIE	BP	GO:0035148	tube formation	-	155	154	-	-	4.41E-03	6.35E-03
HIPPIE	BP	GO:0048520	positive regulation of behavior	-	27	26	-	-	3.39E-02	1.08E-03
HIPPIE	BP	GO:0098543	detection of other organism	-	19	17	-	-	5.53E-02	7.17E-04
HIPPIE	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	4.77E-03	1.79E-03
HIPPIE	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	123	-	-	4.73E-03	5.07E-03
HIPPIE	BP	GO:0031123	RNA 3'-end processing	-	79	78	-	-	7.36E-03	3.23E-03
HIPPIE	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	16	-	-	2.49E-03	6.66E-04
HIPPIE	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	112	-	-	6.15E-03	4.61E-03
HIPPIE	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	3.94E-03	7.68E-04
HIPPIE	CC	GO:0007097	nuclear migration	-	24	24	-	-	2.16E-03	1.02E-03
HIPPIE	BP	GO:0006885	regulation of pH	-	104	99	-	-	9.26E-03	4.10E-03
HIPPIE	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.03E-03	6.15E-04
HIPPIE	BP	GO:1990840	response to lectin	-	22	20	-	-	1.86E-03	8.19E-04
HIPPIE	BP	GO:0071800	podosome assembly	-	19	19	-	-	5.74E-04	8.19E-04
HIPPIE	BP	GO:0031018	endocrine pancreas development	-	47	46	-	-	5.17E-03	1.89E-03
HIPPIE	BP	GO:0001708	cell fate specification	-	108	106	-	-	7.76E-03	4.35E-03
HIPPIE	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	87	-	-	7.66E-03	3.58E-03
HIPPIE	BP	GO:0060354	negative regulation of cell adhesion molecule production	-	15	11	-	-	1.49E-04	4.61E-04
HIPPIE	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	1.14E-02	1.54E-03
HIPPIE	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	20	-	-	5.95E-03	8.19E-04
HIPPIE	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	16	-	-	7.24E-04	6.66E-04
HIPPIE	BP	GO:0032966	negative regulation of collagen biosynthetic process	-	13	12	-	-	1.48E-04	5.12E-04
HIPPIE	BP	GO:0042440	pigment metabolic process	-	80	79	-	-	2.63E-02	3.28E-03
HIPPIE	BP	GO:1901606	alpha-amino acid catabolic process	-	101	99	-	-	6.14E-03	4.10E-03
HIPPIE	BP	GO:1901890	positive regulation of cell junction assembly	-	106	103	-	-	5.95E-03	4.25E-03
HIPPIE	BP	GO:0070988	demethylation	-	27	27	-	-	4.22E-02	1.13E-03
HIPPIE	BP	GO:1901655	cellular response to ketone	-	107	106	-	-	3.73E-03	4.35E-03
HIPPIE	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	1.15E-03	6.15E-04
HIPPIE	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	5.12E-03	6.15E-04
HIPPIE	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	6.57E-03	7.17E-04
HIPPIE	BP	GO:0006968	cellular defense response	-	52	52	-	-	4.19E-03	2.15E-03
HIPPIE	BP	GO:0055006	cardiac cell development	-	93	88	-	-	2.50E-03	3.64E-03
HIPPIE	BP	GO:0031365	N-terminal protein amino acid modification	-	30	29	-	-	5.03E-03	1.23E-03
HIPPIE	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	1.52E-04	5.12E-04
HIPPIE	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	28	-	-	1.86E-03	1.18E-03
HIPPIE	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	13	-	-	3.08E-04	5.63E-04
HIPPIE	BP	GO:0060004	reflex	-	63	62	-	-	8.69E-03	2.56E-03
HIPPIE	BP	GO:0044706	multi-multicellular organism process	-	217	214	-	-	7.54E-03	8.81E-03
HIPPIE	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	1.99E-03	5.12E-04
HIPPIE	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	138	-	-	3.63E-03	5.68E-03
HIPPIE	BP	GO:0006026	aminoglycan catabolic process	-	34	33	-	-	1.89E-03	1.38E-03
HIPPIE	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	6.42E-03	1.89E-03
HIPPIE	BP	GO:0050768	negative regulation of neurogenesis	-	150	145	-	-	3.47E-03	5.94E-03
HIPPIE	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	95	-	-	1.76E-03	3.89E-03
HIPPIE	BP	GO:0042118	endothelial cell activation	-	11	11	-	-	3.57E-03	4.61E-04
HIPPIE	BP	GO:0043605	amide catabolic process	-	16	16	-	-	2.42E-02	6.66E-04
HIPPIE	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	5.72E-03	1.13E-03
HIPPIE	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	2.58E-02	1.43E-03
HIPPIE	BP	GO:1902115	regulation of organelle assembly	-	210	206	-	-	4.69E-03	8.45E-03
HIPPIE	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	75	-	-	2.33E-03	3.07E-03
HIPPIE	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	1.58E-03	6.66E-04
HIPPIE	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	145	-	-	3.86E-03	5.94E-03
HIPPIE	BP	GO:0043171	peptide catabolic process	-	19	19	-	-	4.45E-04	8.19E-04
HIPPIE	BP	GO:0046622	positive regulation of organ growth	-	52	48	-	-	1.81E-03	2.00E-03
HIPPIE	BP	GO:0051952	regulation of amine transport	-	98	98	-	-	1.21E-02	4.05E-03
HIPPIE	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	3.31E-03	9.73E-04
HIPPIE	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	6.67E-03	8.19E-04
HIPPIE	BP	GO:0015801	aromatic amino acid transport	-	13	11	-	-	5.72E-03	4.61E-04
HIPPIE	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	2.23E-03	9.73E-04
HIPPIE	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	8.23E-04	8.19E-04
HIPPIE	BP	GO:1903242	regulation of cardiac muscle hypertrophy in response to stress	-	18	17	-	-	2.68E-03	7.17E-04
HIPPIE	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	1.94E-04	6.66E-04
HIPPIE	CC	GO:0032365	intracellular lipid transport	-	51	51	-	-	1.53E-02	2.10E-03
HIPPIE	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	2.21E-02	1.23E-03
HIPPIE	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	80	-	-	2.39E-03	3.28E-03
HIPPIE	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	116	-	-	2.61E-03	4.76E-03
HIPPIE	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	2.83E-02	1.18E-03
HIPPIE	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	29	-	-	5.92E-04	1.23E-03
HIPPIE	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	1.09E-03	5.63E-04
HIPPIE	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	2.18E-04	6.15E-04
HIPPIE	BP	GO:0061000	negative regulation of dendritic spine development	-	13	12	-	-	1.40E-04	5.12E-04
HIPPIE	BP	GO:0071398	cellular response to fatty acid	-	35	35	-	-	1.27E-03	1.43E-03
HIPPIE	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	2.94E-02	4.61E-04
HIPPIE	BP	GO:0097581	lamellipodium organization	-	91	90	-	-	5.52E-03	3.69E-03
HIPPIE	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	30	-	-	1.11E-02	1.23E-03
HIPPIE	BP	GO:1903975	regulation of glial cell migration	-	20	20	-	-	1.24E-03	8.19E-04
HIPPIE	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	2.75E-03	8.71E-04
HIPPIE	BP	GO:0015669	gas transport	-	23	23	-	-	4.71E-02	9.73E-04
HIPPIE	BP	GO:0016485	protein processing	-	248	245	-	-	8.48E-03	1.00E-02
HIPPIE	BP	GO:0009649	entrainment of circadian clock	-	30	30	-	-	2.96E-03	1.23E-03
HIPPIE	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	167	-	-	2.55E-02	6.86E-03
HIPPIE	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	1.52E-03	1.02E-03
HIPPIE	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	135	-	-	1.53E-02	5.53E-03
HIPPIE	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	5.65E-03	5.12E-04
HIPPIE	BP	GO:0099054	presynapse assembly	-	49	48	-	-	3.10E-03	2.00E-03
HIPPIE	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	2.21E-01	5.12E-04
HIPPIE	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	27	-	-	1.71E-03	1.13E-03
HIPPIE	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	3.80E-03	1.02E-03
HIPPIE	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	79	-	-	3.21E-03	3.28E-03
HIPPIE	BP	GO:0007606	sensory perception of chemical stimulus	-	535	248	-	-	1.53E-02	1.02E-02
HIPPIE	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	3.03E-03	2.82E-03
HIPPIE	BP	GO:0071496	cellular response to external stimulus	-	74	74	-	-	5.72E-03	3.07E-03
HIPPIE	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	16	-	-	1.37E-02	6.66E-04
HIPPIE	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	3.66E-02	7.17E-04
HIPPIE	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	13	-	-	1.30E-03	5.63E-04
HIPPIE	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.57E-02	5.12E-04
HIPPIE	BP	GO:0032094	response to food	-	37	37	-	-	4.64E-03	1.54E-03
HIPPIE	BP	GO:0001964	startle response	-	27	27	-	-	3.50E-03	1.13E-03
HIPPIE	BP	GO:0007340	acrosome reaction	-	38	35	-	-	6.75E-03	1.43E-03
HIPPIE	BP	GO:0046434	organophosphate catabolic process	-	232	228	-	-	5.05E-03	9.37E-03
HIPPIE	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	1.67E-02	1.23E-03
HIPPIE	BP	GO:0009566	fertilization	-	205	193	-	-	8.60E-03	7.94E-03
HIPPIE	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	2.58E-01	2.46E-03
HIPPIE	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	2.25E-02	1.02E-03
HIPPIE	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	3.80E-03	5.63E-04
HIPPIE	BP	GO:0045907	positive regulation of vasoconstriction	-	30	30	-	-	8.80E-03	1.23E-03
HIPPIE	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	23	-	-	1.39E-03	9.73E-04
HIPPIE	BP	GO:0033044	regulation of chromosome organization	-	249	249	-	-	1.14E-02	1.02E-02
HIPPIE	BP	GO:0009309	amine biosynthetic process	-	38	36	-	-	2.90E-02	1.49E-03
HIPPIE	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	20	-	-	2.43E-04	8.19E-04
HIPPIE	BP	GO:0061900	glial cell activation	-	56	54	-	-	1.43E-03	2.25E-03
HIPPIE	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	133	-	-	1.28E-02	5.48E-03
HIPPIE	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	4.18E-02	5.63E-04
HIPPIE	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	4.93E-03	6.15E-04
HIPPIE	BP	GO:0021794	thalamus development	-	12	12	-	-	1.50E-04	5.12E-04
HIPPIE	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	9.74E-03	1.69E-03
HIPPIE	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	2.38E-04	8.19E-04
HIPPIE	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	5.39E-04	6.15E-04
HIPPIE	BP	GO:0072537	fibroblast activation	-	13	13	-	-	1.01E-03	5.63E-04
HIPPIE	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	2.08E-03	5.63E-04
HIPPIE	BP	GO:0043647	inositol phosphate metabolic process	-	44	43	-	-	1.32E-02	1.79E-03
HIPPIE	BP	GO:0016180	snRNA processing	-	28	27	-	-	8.06E-02	1.13E-03
HIPPIE	BP	GO:0051303	establishment of chromosome localization	-	104	104	-	-	5.67E-03	4.30E-03
HIPPIE	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	6.10E-03	6.66E-04
HIPPIE	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	5.10E-03	1.59E-03
HIPPIE	BP	GO:0097164	ammonium ion metabolic process	-	23	23	-	-	1.21E-02	9.73E-04
HIPPIE	BP	GO:0021515	cell differentiation in spinal cord	-	51	51	-	-	4.62E-03	2.10E-03
HIPPIE	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	6.04E-04	7.68E-04
HIPPIE	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	5.56E-03	8.71E-04
HIPPIE	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	1.04E-03	1.18E-03
HIPPIE	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.66E-03	7.68E-04
HIPPIE	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	38	-	-	7.10E-03	1.59E-03
HIPPIE	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	7.50E-03	9.22E-04
HIPPIE	BP	GO:0007566	embryo implantation	-	57	56	-	-	2.03E-03	2.30E-03
HIPPIE	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	34	-	-	6.94E-03	1.43E-03
HIPPIE	BP	GO:0031268	pseudopodium organization	-	17	15	-	-	3.81E-03	6.15E-04
HIPPIE	BP	GO:0060306	regulation of membrane repolarization	-	38	33	-	-	1.46E-02	1.38E-03
HIPPIE	BP	GO:0051017	actin filament bundle assembly	-	161	159	-	-	5.74E-03	6.56E-03
HIPPIE	BP	GO:1905953	negative regulation of lipid localization	-	63	54	-	-	2.34E-03	2.25E-03
HIPPIE	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	21	-	-	6.21E-04	8.71E-04
HIPPIE	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	2.83E-04	8.19E-04
HIPPIE	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	2.67E-04	5.63E-04
HIPPIE	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	36	-	-	2.74E-03	1.49E-03
HIPPIE	BP	GO:0021756	striatum development	-	21	21	-	-	1.67E-03	8.71E-04
HIPPIE	BP	GO:1901343	negative regulation of vasculature development	-	154	131	-	-	2.07E-03	5.38E-03
HIPPIE	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	149	-	-	1.06E-02	6.15E-03
HIPPIE	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	30	-	-	1.25E-03	1.23E-03
HIPPIE	BP	GO:1902414	protein localization to cell junction	-	107	106	-	-	3.62E-03	4.35E-03
HIPPIE	BP	GO:0071305	cellular response to vitamin D	-	23	23	-	-	6.79E-02	9.73E-04
HIPPIE	BP	GO:0051304	chromosome separation	-	80	80	-	-	7.32E-03	3.28E-03
HIPPIE	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	4.65E-03	7.68E-04
HIPPIE	BP	GO:0048709	oligodendrocyte differentiation	-	101	100	-	-	3.13E-03	4.10E-03
HIPPIE	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	1.19E-01	6.15E-04
HIPPIE	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	24	-	-	4.91E-03	1.02E-03
HIPPIE	BP	GO:0001776	leukocyte homeostasis	-	108	103	-	-	2.90E-03	4.25E-03
HIPPIE	BP	GO:0014744	positive regulation of muscle adaptation	-	14	12	-	-	1.51E-04	5.12E-04
HIPPIE	BP	GO:0050769	positive regulation of neurogenesis	-	240	237	-	-	5.58E-03	9.73E-03
HIPPIE	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	1.76E-02	6.15E-04
HIPPIE	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	1.98E-02	2.87E-03
HIPPIE	BP	GO:0050866	negative regulation of cell activation	-	216	209	-	-	5.33E-03	8.60E-03
HIPPIE	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	9.68E-04	1.49E-03
HIPPIE	BP	GO:0033500	carbohydrate homeostasis	-	251	236	-	-	4.83E-03	9.68E-03
HIPPIE	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	31	-	-	1.11E-02	1.28E-03
HIPPIE	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	2.40E-02	5.12E-04
HIPPIE	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	3.43E-03	2.30E-03
HIPPIE	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	3.25E-03	9.73E-04
HIPPIE	CC	GO:0099522	cytosolic region	-	20	20	-	-	7.07E-04	8.19E-04
HIPPIE	CC	GO:0000791	euchromatin	-	60	60	-	-	2.76E-03	2.46E-03
HIPPIE	CC	GO:0030666	endocytic vesicle membrane	-	196	194	-	-	1.05E-02	7.99E-03
HIPPIE	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	2.56E-02	6.15E-04
HIPPIE	CC	GO:1990752	microtubule end	-	34	34	-	-	1.26E-02	1.43E-03
HIPPIE	CC	GO:0043204	perikaryon	-	156	155	-	-	3.24E-03	6.35E-03
HIPPIE	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	1.26E-01	7.17E-04
HIPPIE	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	9.63E-02	5.12E-04
HIPPIE	CC	GO:0097542	ciliary tip	-	48	48	-	-	6.37E-02	2.00E-03
HIPPIE	CC	GO:1905368	peptidase complex	-	124	122	-	-	2.09E-02	5.02E-03
HIPPIE	CC	GO:0000792	heterochromatin	-	98	98	-	-	5.71E-03	4.05E-03
HIPPIE	CC	GO:0097546	ciliary base	-	47	44	-	-	3.11E-03	1.84E-03
HIPPIE	CC	GO:0071819	DUBm complex	-	25	24	-	-	8.69E-02	1.02E-03
HIPPIE	CC	GO:0031201	SNARE complex	-	48	48	-	-	1.32E-01	2.00E-03
HIPPIE	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	2.71E-03	5.63E-04
HIPPIE	CC	GO:0000815	ESCRT III complex	-	11	11	-	-	1.27E-02	4.61E-04
HIPPIE	CC	GO:0033260	nuclear DNA replication	-	40	40	-	-	6.09E-03	1.64E-03
HIPPIE	CC	GO:0044391	ribosomal subunit	-	203	203	-	-	9.02E-02	8.35E-03
HIPPIE	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	2.24E-02	4.61E-04
HIPPIE	CC	GO:0071013	catalytic step 2 spliceosome	-	88	88	-	-	1.75E-02	3.64E-03
HIPPIE	CC	GO:0031907	microbody lumen	-	51	51	-	-	7.03E-02	2.10E-03
HIPPIE	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	1.57E-01	5.12E-04
HIPPIE	CC	GO:0098862	cluster of actin-based cell projections	-	162	155	-	-	1.81E-02	6.35E-03
HIPPIE	CC	GO:0016363	nuclear matrix	-	127	127	-	-	3.61E-03	5.22E-03
HIPPIE	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	2.35E-02	1.89E-03
HIPPIE	CC	GO:0032432	actin filament bundle	-	249	242	-	-	9.82E-03	9.93E-03
HIPPIE	CC	GO:0008088	axo-dendritic transport	-	78	78	-	-	4.30E-03	3.23E-03
HIPPIE	CC	GO:0031519	PcG protein complex	-	38	38	-	-	2.49E-02	1.59E-03
HIPPIE	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	40	-	-	3.17E-02	1.64E-03
HIPPIE	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	220	-	-	1.46E-02	9.01E-03
HIPPIE	CC	GO:0000313	organellar ribosome	-	89	89	-	-	1.48E-01	3.69E-03
HIPPIE	CC	GO:0099643	signal release from synapse	-	147	147	-	-	9.78E-03	6.04E-03
HIPPIE	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	1.08E-02	1.89E-03
HIPPIE	CC	GO:0005818	aster	-	11	11	-	-	8.37E-03	4.61E-04
HIPPIE	CC	GO:0030018	Z disc	-	129	129	-	-	1.12E-02	5.33E-03
HIPPIE	CC	GO:0032580	Golgi cisterna membrane	-	93	84	-	-	1.04E-02	3.48E-03
HIPPIE	CC	GO:0097381	photoreceptor disc membrane	-	25	23	-	-	7.46E-02	9.73E-04
HIPPIE	CC	GO:1905360	GTPase complex	-	41	39	-	-	3.07E-02	1.64E-03
HIPPIE	CC	GO:0097540	axonemal central pair	-	161	152	-	-	4.35E-03	6.25E-03
HIPPIE	CC	GO:0042641	actomyosin	-	77	77	-	-	5.73E-03	3.18E-03
HIPPIE	CC	GO:0097386	glial cell projection	-	38	36	-	-	1.05E-03	1.49E-03
HIPPIE	CC	GO:0032588	trans-Golgi network membrane	-	102	102	-	-	8.45E-03	4.20E-03
HIPPIE	CC	GO:0070382	exocytic vesicle	-	224	223	-	-	9.04E-03	9.17E-03
HIPPIE	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	46	-	-	1.85E-02	1.89E-03
HIPPIE	CC	GO:0031903	microbody membrane	-	65	65	-	-	5.38E-02	2.66E-03
HIPPIE	CC	GO:0046930	pore complex	-	26	26	-	-	1.67E-02	1.08E-03
HIPPIE	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	6.82E-03	4.61E-04
HIPPIE	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	6.51E-04	6.66E-04
HIPPIE	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	6.04E-03	1.02E-03
HIPPIE	CC	GO:1990071	TRAPPII protein complex	-	12	12	-	-	8.09E-02	5.12E-04
HIPPIE	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	2.16E-03	7.68E-04
HIPPIE	CC	GO:0044298	cell body membrane	-	32	32	-	-	3.14E-02	1.33E-03
HIPPIE	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	5.58E-02	4.61E-04
HIPPIE	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	9.24E-04	8.71E-04
HIPPIE	CC	GO:0045495	pole plasm	-	25	25	-	-	2.75E-03	1.02E-03
HIPPIE	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	5.99E-03	6.15E-04
HIPPIE	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	2.66E-02	8.19E-04
HIPPIE	CC	GO:0010369	chromocenter	-	14	14	-	-	2.01E-03	6.15E-04
HIPPIE	CC	GO:0002177	manchette	-	19	17	-	-	2.32E-02	7.17E-04
HIPPIE	CC	GO:0016323	basolateral plasma membrane	-	239	236	-	-	7.31E-03	9.68E-03
HIPPIE	CC	GO:0045009	chitosome	-	21	21	-	-	5.99E-02	8.71E-04
HIPPIE	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	9.93E-04	5.12E-04
HIPPIE	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	4.87E-03	1.84E-03
HIPPIE	CC	GO:0098636	protein complex involved in cell adhesion	-	57	55	-	-	2.70E-02	2.25E-03
HIPPIE	CC	GO:0001917	photoreceptor inner segment	-	71	69	-	-	4.12E-03	2.87E-03
HIPPIE	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	9.15E-04	6.15E-04
HIPPIE	CC	GO:0019897	extrinsic component of plasma membrane	-	156	153	-	-	1.34E-02	6.30E-03
HIPPIE	CC	GO:0031594	neuromuscular junction	-	73	73	-	-	2.00E-03	3.02E-03
HIPPIE	CC	GO:0045120	pronucleus	-	14	14	-	-	4.37E-04	6.15E-04
HIPPIE	CC	GO:0043083	synaptic cleft	-	21	21	-	-	7.52E-02	8.71E-04
HIPPIE	CC	GO:0000922	spindle pole	-	172	172	-	-	6.69E-03	7.07E-03
HIPPIE	CC	GO:0120111	neuron projection cytoplasm	-	94	94	-	-	4.95E-03	3.89E-03
HIPPIE	CC	GO:0070971	endoplasmic reticulum exit site	-	32	29	-	-	2.66E-02	1.23E-03
HIPPIE	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	4.14E-02	5.63E-04
HIPPIE	CC	GO:0004879	nuclear receptor activity	-	63	63	-	-	1.03E-02	2.61E-03
HIPPIE	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	169	-	-	7.86E-03	6.96E-03
HIPPIE	CC	GO:0000123	histone acetyltransferase complex	-	93	92	-	-	4.74E-02	3.79E-03
HIPPIE	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	1.95E-03	5.63E-04
HIPPIE	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	111	-	-	7.75E-02	4.56E-03
HIPPIE	CC	GO:0048786	presynaptic active zone	-	80	80	-	-	3.78E-03	3.28E-03
HIPPIE	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	1.49E-04	4.61E-04
HIPPIE	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	4.47E-02	5.12E-04
HIPPIE	CC	GO:0007034	vacuolar transport	-	168	167	-	-	1.12E-02	6.86E-03
HIPPIE	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	4.47E-02	8.71E-04
HIPPIE	CC	GO:0043194	axon initial segment	-	21	20	-	-	1.86E-02	8.19E-04
HIPPIE	CC	GO:1900115	extracellular regulation of signal transduction	-	13	11	-	-	9.86E-03	4.61E-04
HIPPIE	CC	GO:0005776	autophagosome	-	111	110	-	-	1.33E-02	4.51E-03
HIPPIE	CC	GO:0031430	M band	-	22	22	-	-	1.38E-03	9.22E-04
HIPPIE	CC	GO:0001931	uropod	-	13	13	-	-	6.68E-03	5.63E-04
HIPPIE	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	78	-	-	7.74E-02	3.23E-03
HIPPIE	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	98	-	-	1.48E-01	4.05E-03
HIPPIE	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	2.43E-01	5.63E-04
HIPPIE	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	1.11E-02	8.19E-04
HIPPIE	CC	GO:0071203	WASH complex	-	12	12	-	-	1.83E-01	5.12E-04
HIPPIE	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	2.92E-02	1.23E-03
HIPPIE	CC	GO:0032994	protein-lipid complex	-	39	36	-	-	4.36E-02	1.49E-03
HIPPIE	CC	GO:0031838	haptoglobin-hemoglobin complex	-	11	11	-	-	1.82E-01	4.61E-04
HIPPIE	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	162	-	-	4.83E-02	6.66E-03
HIPPIE	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	7.53E-03	5.12E-04
HIPPIE	CC	GO:0001527	microfibril	-	13	13	-	-	1.13E-01	5.63E-04
HIPPIE	CC	GO:0072562	blood microparticle	-	144	140	-	-	8.33E-03	5.74E-03
HIPPIE	CC	GO:0005883	neurofilament	-	11	11	-	-	2.65E-03	4.61E-04
HIPPIE	CC	GO:0051233	spindle midzone	-	36	36	-	-	1.46E-03	1.49E-03
HIPPIE	CC	GO:0005811	lipid droplet	-	102	100	-	-	1.34E-02	4.10E-03
HIPPIE	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	6.81E-03	1.84E-03
HIPPIE	CC	GO:0043113	receptor clustering	-	51	50	-	-	5.32E-03	2.05E-03
HIPPIE	CC	GO:0005940	septin ring	-	14	14	-	-	1.80E-01	6.15E-04
HIPPIE	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	3.59E-02	4.61E-04
HIPPIE	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	23	-	-	4.03E-02	9.73E-04
HIPPIE	CC	GO:0044853	plasma membrane raft	-	114	114	-	-	4.79E-03	4.71E-03
HIPPIE	CC	GO:0005881	cytoplasmic microtubule	-	256	242	-	-	6.61E-03	9.93E-03
HIPPIE	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	2.09E-03	6.15E-04
HIPPIE	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	1.12E-02	7.17E-04
HIPPIE	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	58	-	-	7.39E-03	2.41E-03
HIPPIE	CC	GO:0005905	clathrin-coated pit	-	73	73	-	-	1.12E-02	3.02E-03
HIPPIE	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	5.42E-02	5.12E-04
HIPPIE	CC	GO:0043034	costamere	-	18	18	-	-	1.75E-03	7.68E-04
HIPPIE	CC	GO:0031904	endosome lumen	-	38	38	-	-	4.53E-03	1.59E-03
HIPPIE	CC	GO:0060170	ciliary membrane	-	76	71	-	-	1.20E-02	2.92E-03
HIPPIE	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	5.36E-01	5.63E-04
HIPPIE	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	6.87E-03	5.12E-04
HIPPIE	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	30	-	-	3.97E-02	1.23E-03
HIPPIE	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	1.55E-02	6.15E-04
HIPPIE	CC	GO:0032154	cleavage furrow	-	54	54	-	-	2.61E-03	2.25E-03
HIPPIE	CC	GO:0005640	nuclear outer membrane	-	30	30	-	-	3.13E-03	1.23E-03
HIPPIE	CC	GO:0005652	nuclear lamina	-	12	12	-	-	1.82E-03	5.12E-04
HIPPIE	CC	GO:0007006	mitochondrial membrane organization	-	117	116	-	-	9.32E-03	4.76E-03
HIPPIE	CC	GO:0001772	immunological synapse	-	44	44	-	-	5.10E-03	1.84E-03
HIPPIE	CC	GO:0030904	retromer complex	-	12	12	-	-	8.50E-03	5.12E-04
HIPPIE	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	3.34E-02	5.12E-04
HIPPIE	CC	GO:0030863	cortical cytoskeleton	-	104	103	-	-	6.84E-03	4.25E-03
HIPPIE	CC	GO:1905348	endonuclease complex	-	38	37	-	-	2.98E-02	1.54E-03
HIPPIE	CC	GO:0005833	hemoglobin complex	-	12	12	-	-	1.47E-01	5.12E-04
HIPPIE	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	1.10E-03	7.68E-04
HIPPIE	CC	GO:0030315	T-tubule	-	52	52	-	-	1.45E-02	2.15E-03
HIPPIE	CC	GO:0060076	excitatory synapse	-	64	61	-	-	3.00E-02	2.51E-03
HIPPIE	CC	GO:0036019	endolysosome	-	29	29	-	-	1.28E-02	1.23E-03
HIPPIE	CC	GO:0001891	phagocytic cup	-	28	28	-	-	2.54E-03	1.18E-03
HIPPIE	CC	GO:0099086	synaptonemal structure	-	40	38	-	-	8.45E-03	1.59E-03
HIPPIE	CC	GO:0030427	site of polarized growth	-	172	172	-	-	3.84E-03	7.07E-03
HIPPIE	CC	GO:0044309	neuron spine	-	213	212	-	-	5.83E-03	8.71E-03
HIPPIE	CC	GO:0030658	transport vesicle membrane	-	231	229	-	-	1.55E-02	9.42E-03
HIPPIE	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	2.72E-03	1.13E-03
HIPPIE	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.24E-01	5.12E-04
HIPPIE	CC	GO:0000940	outer kinetochore	-	17	17	-	-	5.00E-02	7.17E-04
HIPPIE	CC	GO:0034719	SMN-Sm protein complex	-	18	18	-	-	2.58E-02	7.68E-04
HIPPIE	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	6.20E-03	2.05E-03
HIPPIE	CC	GO:0098803	respiratory chain complex	-	39	37	-	-	1.95E-01	1.54E-03
HIPPIE	CC	GO:0097545	axonemal outer doublet	-	164	155	-	-	2.98E-03	6.35E-03
HIPPIE	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	6.53E-03	8.19E-04
HIPPIE	CC	GO:0070069	cytochrome complex	-	42	40	-	-	2.18E-01	1.64E-03
HIPPIE	CC	GO:0031143	pseudopodium	-	18	18	-	-	2.72E-03	7.68E-04
HIPPIE	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	6.74E-03	1.13E-03
HIPPIE	CC	GO:0055037	recycling endosome	-	200	198	-	-	8.74E-03	8.14E-03
HIPPIE	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	94	-	-	3.52E-03	3.89E-03
HIPPIE	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	1.77E-02	5.63E-04
HIPPIE	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	5.55E-04	5.63E-04
HIPPIE	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	1.83E-03	9.22E-04
HIPPIE	CC	GO:0030684	preribosome	-	76	75	-	-	1.24E-02	3.07E-03
HIPPIE	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	19	-	-	7.22E-02	8.19E-04
HIPPIE	CC	GO:1990391	DNA repair complex	-	22	22	-	-	9.36E-03	9.22E-04
HIPPIE	CC	GO:0005775	vacuolar lumen	-	176	175	-	-	7.14E-03	7.17E-03
HIPPIE	CC	GO:0032433	filopodium tip	-	19	19	-	-	5.52E-04	8.19E-04
HIPPIE	CC	GO:0032982	myosin filament	-	24	24	-	-	1.10E-02	1.02E-03
HIPPIE	CC	GO:0016327	apicolateral plasma membrane	-	23	23	-	-	1.81E-03	9.73E-04
HIPPIE	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	5.55E-02	9.73E-04
HIPPIE	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	8.16E-03	5.12E-04
HIPPIE	CC	GO:0044306	neuron projection terminus	-	164	163	-	-	7.21E-03	6.71E-03
HIPPIE	CC	GO:0034455	t-UTP complex	-	53	52	-	-	6.41E-03	2.15E-03
HIPPIE	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	3.84E-01	7.17E-04
HIPPIE	CC	GO:0031970	organelle envelope lumen	-	94	94	-	-	5.14E-03	3.89E-03
HIPPIE	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	6.36E-03	5.63E-04
HIPPIE	CC	GO:0120293	dynein axonemal particle	-	20	20	-	-	1.97E-03	8.19E-04
HIPPIE	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	1.06E-03	1.02E-03
HIPPIE	CC	GO:0043292	contractile muscle fiber	-	245	243	-	-	1.59E-02	9.99E-03
HIPPIE	CC	GO:0018995	host cellular component	-	12	12	-	-	4.26E-03	5.12E-04
HIPPIE	CC	GO:0034709	methylosome	-	13	12	-	-	6.79E-03	5.12E-04
HIPPIE	CC	GO:0032426	stereocilium tip	-	21	20	-	-	1.62E-03	8.19E-04
HIPPIE	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	1.28E-02	5.12E-04
HIPPIE	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	6.97E-02	8.19E-04
HIPPIE	CC	GO:0000803	sex chromosome	-	32	31	-	-	2.78E-03	1.28E-03
HIPPIE	CC	GO:0098982	GABA-ergic synapse	-	84	84	-	-	1.22E-02	3.48E-03
HIPPIE	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	17	-	-	1.37E-02	7.17E-04
HIPPIE	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	2.62E-02	2.61E-03
HIPPIE	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	5.11E-02	6.15E-04
HIPPIE	CC	GO:0000242	pericentriolar material	-	22	22	-	-	4.20E-03	9.22E-04
HIPPIE	CC	GO:1903293	phosphatase complex	-	54	53	-	-	1.80E-02	2.20E-03
HIPPIE	CC	GO:0097470	ribbon synapse	-	13	13	-	-	1.02E-03	5.63E-04
HIPPIE	CC	GO:0031941	filamentous actin	-	27	27	-	-	1.32E-03	1.13E-03
HIPPIE	CC	GO:0000786	nucleosome	-	149	144	-	-	1.36E-02	5.94E-03
HIPPIE	CC	GO:0001533	cornified envelope	-	59	59	-	-	1.09E-02	2.46E-03
HIPPIE	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	2.99E-03	2.25E-03
HIPPIE	CC	GO:0030027	lamellipodium	-	202	201	-	-	8.98E-03	8.24E-03
HIPPIE	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	1.82E-03	6.15E-04
HIPPIE	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	26	-	-	2.57E-02	1.08E-03
HIPPIE	CC	GO:0000800	lateral element	-	14	13	-	-	1.13E-02	5.63E-04
HIPPIE	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	2.03E-03	5.12E-04
HIPPIE	CC	GO:0060077	inhibitory synapse	-	20	20	-	-	2.32E-02	8.19E-04
HIPPIE	CC	GO:0031209	SCAR complex	-	12	12	-	-	1.25E-01	5.12E-04
HIPPIE	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	5.71E-02	4.61E-04
HIPPIE	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	8.66E-02	6.66E-04
HIPPIE	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	22	-	-	1.62E-02	9.22E-04
HIPPIE	CC	GO:0002102	podosome	-	31	31	-	-	2.49E-03	1.28E-03
HIPPIE	CC	GO:0090543	Flemming body	-	33	33	-	-	2.48E-03	1.38E-03
HIPPIE	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	3.13E-03	2.71E-03
HIPPIE	CC	GO:0001650	fibrillar center	-	151	151	-	-	3.25E-03	6.20E-03
HIPPIE	CC	GO:0031332	RNAi effector complex	-	413	130	-	-	4.72E-02	5.33E-03
HIPPIE	CC	GO:1990204	oxidoreductase complex	-	90	88	-	-	9.04E-02	3.64E-03
HIPPIE	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	4.07E-02	6.66E-04
HIPPIE	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.29E-02	4.61E-04
HIPPIE	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	3.26E-03	5.12E-03
HIPPIE	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	3.80E-02	8.19E-04
HIPPIE	CC	GO:0001726	ruffle	-	181	181	-	-	5.47E-03	7.43E-03
HIPPIE	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	5.63E-02	4.61E-04
HIPPIE	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	3.29E-03	5.63E-04
HIPPIE	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	2.56E-02	7.68E-04
HIPPIE	CC	GO:0043198	dendritic shaft	-	38	38	-	-	8.06E-04	1.59E-03
HIPPIE	CC	GO:0043073	germ cell nucleus	-	67	65	-	-	2.75E-03	2.66E-03
HIPPIE	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	1.96E-03	8.71E-04
HIPPIE	CC	GO:0016592	mediator complex	-	38	38	-	-	4.38E-01	1.59E-03
HIPPIE	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	2.11E-02	8.19E-04
HIPPIE	CC	GO:0022626	cytosolic ribosome	-	118	118	-	-	4.45E-02	4.87E-03
HIPPIE	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	2.05E-02	1.84E-03
HIPPIE	CC	GO:0034451	centriolar satellite	-	120	117	-	-	1.58E-02	4.81E-03
HIPPIE	CC	GO:0045171	intercellular bridge	-	91	91	-	-	4.25E-03	3.74E-03
HIPPIE	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	81	-	-	5.13E-03	3.33E-03
HIPPIE	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	7.63E-02	6.15E-04
HIPPIE	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	3.57E-03	4.61E-04
HIPPIE	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	4.03E-03	4.61E-04
HIPPIE	CC	GO:0044292	dendrite terminus	-	13	13	-	-	9.13E-04	5.63E-04
HIPPIE	CC	GO:0032039	integrator complex	-	19	18	-	-	3.08E-01	7.68E-04
HIPPIE	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	8.33E-04	6.15E-04
HIPPIE	CC	GO:0033268	node of Ranvier	-	16	16	-	-	4.64E-02	6.66E-04
HIPPIE	CC	GO:0036038	MKS complex	-	13	13	-	-	7.66E-02	5.63E-04
HIPPIE	CC	GO:0030527	structural constituent of chromatin	-	97	92	-	-	6.05E-03	3.79E-03
HIPPIE	CC	GO:0036379	myofilament	-	26	25	-	-	6.88E-02	1.02E-03
HIPPIE	CC	GO:0030286	dynein complex	-	210	199	-	-	7.41E-03	8.19E-03
HIPPIE	CC	GO:0031105	septin complex	-	14	14	-	-	1.96E-01	6.15E-04
HIPPIE	CC	GO:0097228	sperm principal piece	-	33	29	-	-	9.37E-03	1.23E-03
HIPPIE	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	4.98E-03	5.12E-04
HIPPIE	CC	GO:0016482	cytosolic transport	-	135	135	-	-	8.99E-03	5.53E-03
HIPPIE	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	2.93E-02	9.73E-04
HIPPIE	CC	GO:0005796	Golgi lumen	-	106	103	-	-	4.12E-03	4.25E-03
HIPPIE	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	37	-	-	4.14E-02	1.54E-03
HIPPIE	CC	GO:0034358	plasma lipoprotein particle	-	36	33	-	-	3.38E-02	1.38E-03
HIPPIE	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	6.48E-02	1.95E-03
HIPPIE	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	3.74E-03	1.02E-03
HIPPIE	CC	GO:0030662	coated vesicle membrane	-	202	201	-	-	1.74E-02	8.24E-03
HIPPIE	CC	GO:0007039	protein catabolic process in the vacuole	-	61	60	-	-	1.48E-02	2.46E-03
HIPPIE	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	67	-	-	1.59E-01	2.77E-03
HIPPIE	CC	GO:0090734	site of DNA damage	-	118	116	-	-	1.17E-02	4.76E-03
HIPPIE	MF	GO:0051861	glycolipid binding	-	30	30	-	-	1.77E-03	1.23E-03
HIPPIE	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.49E-04	4.61E-04
HIPPIE	MF	GO:0051087	protein-folding chaperone binding	-	135	134	-	-	4.59E-03	5.53E-03
HIPPIE	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	2.53E-03	1.13E-03
HIPPIE	CC	GO:0015464	acetylcholine receptor activity	-	21	21	-	-	1.11E-01	8.71E-04
HIPPIE	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	1.47E-04	5.12E-04
HIPPIE	MF	GO:0016594	glycine binding	-	12	12	-	-	1.10E-01	5.12E-04
HIPPIE	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	1.56E-03	8.19E-04
HIPPIE	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	1.75E-03	1.54E-03
HIPPIE	MF	GO:0035613	RNA stem-loop binding	-	21	17	-	-	1.19E-03	7.17E-04
HIPPIE	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	244	-	-	7.56E-03	1.00E-02
HIPPIE	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	1.31E-03	8.19E-04
HIPPIE	MF	GO:0033691	sialic acid binding	-	22	22	-	-	5.63E-02	9.22E-04
HIPPIE	MF	GO:0048306	calcium-dependent protein binding	-	61	61	-	-	7.48E-03	2.51E-03
HIPPIE	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	2.59E-02	1.18E-03
HIPPIE	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	2.06E-02	5.63E-04
HIPPIE	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	145	-	-	5.40E-03	5.94E-03
HIPPIE	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	59	-	-	5.94E-02	2.46E-03
HIPPIE	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	136	-	-	6.80E-03	5.58E-03
HIPPIE	MF	GO:0045504	dynein heavy chain binding	-	16	16	-	-	8.31E-02	6.66E-04
HIPPIE	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	1.11E-02	1.23E-03
HIPPIE	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	2.10E-03	9.22E-04
HIPPIE	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	1.70E-03	6.66E-04
HIPPIE	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	4.86E-03	6.15E-04
HIPPIE	MF	GO:0061980	regulatory RNA binding	-	52	49	-	-	3.26E-03	2.05E-03
HIPPIE	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	9.50E-03	1.33E-03
HIPPIE	MF	GO:0000182	rDNA binding	-	11	11	-	-	3.94E-03	4.61E-04
HIPPIE	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	7.80E-04	1.23E-03
HIPPIE	MF	GO:0070840	dynein complex binding	-	25	24	-	-	1.21E-03	1.02E-03
HIPPIE	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.19E-03	1.02E-03
HIPPIE	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.08E-03	6.66E-04
HIPPIE	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	1.52E-03	1.43E-03
HIPPIE	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	6.61E-03	7.68E-04
HIPPIE	MF	GO:0005178	integrin binding	-	153	152	-	-	1.92E-02	6.25E-03
HIPPIE	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	8.58E-04	7.17E-04
HIPPIE	MF	GO:0005549	odorant binding	-	128	45	-	-	1.94E-02	1.84E-03
HIPPIE	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.07E-02	6.15E-04
HIPPIE	MF	GO:0008327	methyl-CpG binding	-	31	28	-	-	3.57E-03	1.18E-03
HIPPIE	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	1.47E-03	8.19E-04
HIPPIE	MF	GO:0048019	receptor antagonist activity	-	31	20	-	-	3.60E-04	8.19E-04
HIPPIE	MF	GO:0005521	lamin binding	-	15	15	-	-	1.95E-03	6.15E-04
HIPPIE	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	1.96E-03	8.19E-04
HIPPIE	MF	GO:0140318	protein transporter activity	-	40	40	-	-	1.53E-02	1.64E-03
HIPPIE	MF	GO:0070628	proteasome binding	-	17	17	-	-	1.89E-03	7.17E-04
HIPPIE	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	1.28E-03	4.61E-04
HIPPIE	MF	GO:0031432	titin binding	-	13	13	-	-	2.98E-03	5.63E-04
HIPPIE	MF	GO:0046812	host cell surface binding	-	11	11	-	-	4.80E-03	4.61E-04
HIPPIE	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	3.43E-03	1.54E-03
HIPPIE	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	1.87E-03	7.17E-04
HIPPIE	MF	GO:0002039	p53 binding	-	66	66	-	-	2.27E-03	2.71E-03
HIPPIE	MF	GO:0005496	steroid binding	-	110	108	-	-	7.09E-03	4.46E-03
HIPPIE	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.16E-02	1.13E-03
HIPPIE	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.48E-04	4.61E-04
HIPPIE	MF	GO:0003684	damaged DNA binding	-	89	88	-	-	1.19E-02	3.64E-03
HIPPIE	MF	GO:0000339	RNA cap binding	-	20	19	-	-	4.99E-03	8.19E-04
HIPPIE	MF	GO:0016500	protein-hormone receptor activity	-	21	21	-	-	2.02E-03	8.71E-04
HIPPIE	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	129	-	-	1.21E-02	5.33E-03
HIPPIE	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	2.57E-03	6.15E-04
HIPPIE	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	1.19E-03	5.12E-04
HIPPIE	MF	GO:1900121	negative regulation of receptor binding	-	13	12	-	-	1.23E-03	5.12E-04
HIPPIE	MF	GO:0070063	RNA polymerase binding	-	61	61	-	-	4.34E-03	2.51E-03
HIPPIE	MF	GO:0008179	adenylate cyclase binding	-	11	11	-	-	1.48E-02	4.61E-04
HIPPIE	MF	GO:0050811	GABA receptor binding	-	18	17	-	-	2.36E-02	7.17E-04
HIPPIE	MF	GO:0030971	receptor tyrosine kinase binding	-	76	76	-	-	3.02E-03	3.12E-03
HIPPIE	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	84	-	-	1.18E-02	3.48E-03
HIPPIE	MF	GO:0140030	modification-dependent protein binding	-	179	179	-	-	4.89E-03	7.37E-03
HIPPIE	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	1.96E-03	1.02E-03
HIPPIE	MF	GO:0009881	photoreceptor activity	-	17	16	-	-	7.05E-04	6.66E-04
HIPPIE	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	18	-	-	1.36E-02	7.68E-04
HIPPIE	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.63E-03	5.63E-04
HIPPIE	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	9.24E-03	6.66E-04
HIPPIE	MF	GO:0141047	molecular tag activity	-	13	12	-	-	7.09E-04	5.12E-04
HIPPIE	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.18E-02	4.61E-04
HIPPIE	MF	GO:0033130	acetylcholine receptor binding	-	12	11	-	-	1.49E-04	4.61E-04
HIPPIE	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	9.03E-04	6.15E-04
HIPPIE	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	6.50E-03	5.12E-04
HIPPIE	MF	GO:0044548	S100 protein binding	-	14	14	-	-	5.31E-03	6.15E-04
HIPPIE	MF	GO:0010851	cyclase regulator activity	-	17	16	-	-	2.87E-03	6.66E-04
HIPPIE	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.29E-02	6.15E-04
HIPPIE	MF	GO:0030276	clathrin binding	-	70	70	-	-	2.98E-02	2.87E-03
HIPPIE	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	2.50E-03	1.23E-03
HIPPIE	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	4.27E-04	6.15E-04
HIPPIE	MF	GO:0046790	virion binding	-	19	19	-	-	2.53E-03	8.19E-04
HIPPIE	MF	GO:0030552	cAMP binding	-	48	46	-	-	9.92E-03	1.89E-03
HIPPIE	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	40	-	-	1.04E-03	1.64E-03
HIPPIE	MF	GO:0035173	histone kinase activity	-	17	17	-	-	6.73E-04	7.17E-04
HIPPIE	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	7.29E-03	1.08E-03
HIPPIE	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	1.41E-02	5.12E-04
HIPPIE	MF	GO:0004984	olfactory receptor activity	-	429	159	-	-	2.38E-02	6.56E-03
HIPPIE	MF	GO:0016209	antioxidant activity	-	92	89	-	-	1.49E-02	3.69E-03
HIPPIE	MF	GO:0070325	lipoprotein particle receptor binding	-	32	31	-	-	2.50E-03	1.28E-03
HIPPIE	MF	GO:0044325	transmembrane transporter binding	-	159	157	-	-	7.20E-03	6.45E-03
HIPPIE	MF	GO:0048156	tau protein binding	-	43	43	-	-	2.28E-03	1.79E-03
HIPPIE	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	2.93E-03	1.49E-03
HIPPIE	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	3.20E-03	5.63E-04
HIPPIE	MF	GO:0140272	exogenous protein binding	-	79	79	-	-	3.41E-03	3.28E-03
HIPPIE	MF	GO:0030145	manganese ion binding	-	65	64	-	-	1.72E-03	2.66E-03
HIPPIE	MF	GO:0071814	protein-lipid complex binding	-	52	49	-	-	4.18E-03	2.05E-03
HIPPIE	MF	GO:0008066	glutamate receptor activity	-	70	69	-	-	7.02E-03	2.87E-03
HIPPIE	MF	GO:0030553	cGMP binding	-	15	14	-	-	7.12E-03	6.15E-04
HIPPIE	MF	GO:0017069	snRNA binding	-	54	52	-	-	2.01E-02	2.15E-03
HIPPIE	MF	GO:0030215	semaphorin receptor binding	-	23	22	-	-	1.37E-01	9.22E-04
HIPPIE	MF	GO:0031996	thioesterase binding	-	11	11	-	-	7.42E-04	4.61E-04
HIPPIE	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	9.65E-03	1.28E-03
HIPPIE	MF	GO:0019843	rRNA binding	-	69	69	-	-	1.13E-02	2.87E-03
HIPPIE	MF	GO:0004713	protein tyrosine kinase activity	-	213	212	-	-	1.25E-02	8.71E-03
HIPPIE	MF	GO:0061783	peptidoglycan muralytic activity	-	14	11	-	-	1.51E-04	4.61E-04
HIPPIE	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	4.53E-03	2.10E-03
HIPPIE	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.01E-03	1.02E-03
HIPPIE	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	1.14E-03	8.19E-04
HIPPIE	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	29	-	-	8.53E-04	1.23E-03
HIPPIE	MF	GO:0016208	AMP binding	-	22	22	-	-	2.91E-03	9.22E-04
HIPPIE	MF	GO:0000287	magnesium ion binding	-	225	221	-	-	5.23E-03	9.06E-03
HIPPIE	MF	GO:0031490	chromatin DNA binding	-	120	118	-	-	5.62E-03	4.87E-03
HIPPIE	MF	GO:0017022	myosin binding	-	73	73	-	-	3.87E-03	3.02E-03
HIPPIE	MF	GO:0004896	cytokine receptor activity	-	93	92	-	-	1.02E-02	3.79E-03
HIPPIE	MF	GO:0017166	vinculin binding	-	12	12	-	-	7.81E-03	5.12E-04
HIPPIE	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	2.43E-03	7.68E-04
HIPPIE	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	1.32E-03	5.12E-04
HIPPIE	MF	GO:0005539	glycosaminoglycan binding	-	236	228	-	-	1.39E-02	9.37E-03
HIPPIE	MF	GO:0140666	annealing activity	-	11	11	-	-	5.71E-04	4.61E-04
HIPPIE	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	4.32E-03	6.15E-04
HIPPIE	MF	GO:0010181	FMN binding	-	15	15	-	-	3.04E-03	6.15E-04
HIPPIE	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	20	-	-	5.36E-02	8.19E-04
HIPPIE	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	25	-	-	1.10E-03	1.02E-03
HIPPIE	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	8.38E-04	7.17E-04
HIPPIE	MF	GO:0044183	protein folding chaperone	-	67	67	-	-	1.90E-03	2.77E-03
HIPPIE	MF	GO:0005132	type I interferon receptor binding	-	17	16	-	-	4.47E-01	6.66E-04
HIPPIE	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	8.55E-03	4.46E-03
HIPPIE	MF	GO:0003725	double-stranded RNA binding	-	72	71	-	-	2.84E-03	2.92E-03
HIPPIE	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	9.06E-02	6.66E-04
HIPPIE	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	1.13E-02	2.15E-03
HIPPIE	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.14E-03	1.43E-03
HIPPIE	MF	GO:0004618	phosphoglycerate kinase activity	-	89	89	-	-	2.83E-03	3.69E-03
HIPPIE	MF	GO:0042805	actinin binding	-	36	36	-	-	2.92E-03	1.49E-03
HIPPIE	MF	GO:0043531	ADP binding	-	38	38	-	-	8.42E-04	1.59E-03
HIPPIE	MF	GO:0043394	proteoglycan binding	-	36	35	-	-	5.97E-03	1.43E-03
HIPPIE	MF	GO:0005542	folic acid binding	-	13	11	-	-	1.17E-01	4.61E-04
HIPPIE	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	6.09E-03	4.61E-04
HIPPIE	MF	GO:0046332	SMAD binding	-	77	77	-	-	1.25E-02	3.18E-03
HIPPIE	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.99E-03	5.63E-04
HIPPIE	MF	GO:0001968	fibronectin binding	-	30	30	-	-	3.69E-03	1.23E-03
HIPPIE	MF	GO:0048038	quinone binding	-	16	16	-	-	1.93E-02	6.66E-04
HIPPIE	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	121	-	-	1.73E-02	4.97E-03
HIPPIE	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	81	-	-	2.79E-03	3.33E-03
HIPPIE	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	2.00E-03	7.68E-04
HIPPIE	MF	GO:0051117	ATPase binding	-	85	84	-	-	3.21E-03	3.48E-03
HIPPIE	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	2.32E-03	1.89E-03
HIPPIE	MF	GO:0051787	misfolded protein binding	-	20	20	-	-	2.15E-03	8.19E-04
HIPPIE	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	2.43E-03	4.61E-04
HIPPIE	MF	GO:0070402	NADPH binding	-	16	15	-	-	1.98E-04	6.15E-04
HIPPIE	MF	GO:0031404	chloride ion binding	-	14	14	-	-	1.51E-04	6.15E-04
HIPPIE	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	3.66E-03	2.51E-03
HIPPIE	MF	GO:0036002	pre-mRNA binding	-	57	43	-	-	3.61E-03	1.79E-03
HIPPIE	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	36	-	-	2.01E-02	1.49E-03
HIPPIE	MF	GO:0051540	metal cluster binding	-	71	71	-	-	5.17E-03	2.92E-03
HIPPIE	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	8.35E-04	4.61E-04
HIPPIE	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	4.66E-03	3.79E-03
HIPPIE	MF	GO:0019894	kinesin binding	-	45	45	-	-	2.40E-03	1.84E-03
HIPPIE	MF	GO:0042287	MHC protein binding	-	68	60	-	-	1.40E-02	2.46E-03
HIPPIE	MF	GO:0019003	GDP binding	-	89	89	-	-	7.78E-03	3.69E-03
HIPPIE	MF	GO:0017171	serine hydrolase activity	-	207	198	-	-	1.62E-02	8.14E-03
HIPPIE	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	3.20E-03	2.71E-03
HIPPIE	MF	GO:0003774	cytoskeletal motor activity	-	117	116	-	-	4.26E-03	4.76E-03
HIPPIE	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.36E-03	1.23E-03
HIPPIE	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	5.14E-03	7.17E-04
HIPPIE	MF	GO:0061134	peptidase regulator activity	-	224	216	-	-	1.13E-02	8.86E-03
HIPPIE	MF	GO:0008013	beta-catenin binding	-	86	85	-	-	6.63E-03	3.48E-03
HIPPIE	MF	GO:0051015	actin filament binding	-	208	208	-	-	1.27E-02	8.55E-03
HIPPIE	MF	GO:0019208	phosphatase regulator activity	-	107	104	-	-	5.65E-03	4.30E-03
HIPPIE	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	32	-	-	5.12E-03	1.33E-03
HIPPIE	MF	GO:0043236	laminin binding	-	29	29	-	-	2.05E-03	1.23E-03
HIPPIE	MF	GO:0030507	spectrin binding	-	26	26	-	-	5.13E-03	1.08E-03
HIPPIE	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	1.91E-03	1.69E-03
HIPPIE	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	114	-	-	1.08E-02	4.71E-03
HIPPIE	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	2.49E-03	1.02E-03
HIPPIE	MF	GO:0042393	histone binding	-	240	238	-	-	1.28E-02	9.78E-03
HIPPIE	MF	GO:0019838	growth factor binding	-	182	180	-	-	1.05E-02	7.37E-03
HIPPIE	MF	GO:0000149	SNARE binding	-	107	107	-	-	3.36E-02	4.40E-03
HIPPIE	MF	GO:0003727	single-stranded RNA binding	-	90	88	-	-	3.32E-03	3.64E-03
HIPPIE	MF	GO:0051378	serotonin binding	-	24	24	-	-	3.47E-02	1.02E-03
HIPPIE	MF	GO:0005516	calmodulin binding	-	206	204	-	-	5.71E-03	8.40E-03
HIPPIE	MF	GO:0019825	oxygen binding	-	40	38	-	-	1.55E-02	1.59E-03
HIPPIE	MF	GO:0045505	dynein intermediate chain binding	-	37	37	-	-	4.14E-03	1.54E-03
HIPPIE	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	85	-	-	5.02E-03	3.48E-03
HIPPIE	MF	GO:0032182	ubiquitin-like protein binding	-	117	116	-	-	4.76E-03	4.76E-03
HIPPIE	MF	GO:0023023	MHC protein complex binding	-	36	35	-	-	4.09E-02	1.43E-03
HIPPIE	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	2.33E-03	9.22E-04
HIPPIE	MF	GO:0043274	phospholipase binding	-	23	22	-	-	1.33E-03	9.22E-04
HIPPIE	MF	GO:0031072	heat shock protein binding	-	128	127	-	-	1.21E-02	5.22E-03
HIPPIE	MF	GO:0030515	snoRNA binding	-	33	33	-	-	2.39E-03	1.38E-03
HIPPIE	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	80	-	-	4.22E-02	3.28E-03
HIPPIE	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	21	-	-	1.52E-03	8.71E-04
HIPPIE	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	4.82E-04	1.08E-03
HIPPIE	MF	GO:0001530	lipopolysaccharide binding	-	38	37	-	-	2.00E-02	1.54E-03
HIPPIE	MF	GO:0140223	general transcription initiation factor activity	-	55	54	-	-	9.20E-02	2.25E-03
HIPPIE	MF	GO:0070403	NAD+ binding	-	16	16	-	-	1.76E-03	6.66E-04
HIPPIE	MF	GO:0000049	tRNA binding	-	75	73	-	-	5.02E-03	3.02E-03
HIPPIE	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	45	-	-	3.06E-03	1.84E-03
HIPPIE	MF	GO:0015026	coreceptor activity	-	48	47	-	-	5.85E-03	1.95E-03
HIPPIE	MF	GO:0005527	macrolide binding	-	12	12	-	-	3.88E-04	5.12E-04
HIPPIE	MF	GO:0001653	peptide receptor activity	-	128	119	-	-	1.51E-02	4.92E-03
HIPPIE	MF	GO:0031005	filamin binding	-	15	14	-	-	5.47E-03	6.15E-04
HIPPIE	MF	GO:0030506	ankyrin binding	-	19	19	-	-	2.05E-03	8.19E-04
HIPPIE	MF	GO:0006469	negative regulation of protein kinase activity	-	222	217	-	-	3.76E-03	8.91E-03
HIPPIE	MF	GO:0070182	DNA polymerase binding	-	22	22	-	-	8.66E-04	9.22E-04
HIPPIE	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	6.06E-04	6.15E-04
HIPPIE	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	5.04E-03	1.28E-03
HIPPIE	MF	GO:0051427	hormone receptor binding	-	31	31	-	-	7.31E-03	1.28E-03
HIPPIE	MF	GO:0070851	growth factor receptor binding	-	141	141	-	-	7.10E-03	5.79E-03
HIPPIE	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	3.45E-03	1.33E-03
HIPPIE	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	1.32E-02	4.61E-04
HIPPIE	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	43	-	-	3.08E-03	1.79E-03
HIPPIE	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	5.49E-03	8.19E-04
HIPPIE	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	3.41E-03	7.17E-04
HIPPIE	MF	GO:0005506	iron ion binding	-	154	147	-	-	1.79E-02	6.04E-03
HIPPIE	MF	GO:0003925	G protein activity	-	45	44	-	-	4.56E-03	1.84E-03
HIPPIE	MF	GO:0038187	pattern recognition receptor activity	-	33	31	-	-	2.62E-03	1.28E-03
HIPPIE	MF	GO:0008276	protein methyltransferase activity	-	96	93	-	-	3.06E-03	3.84E-03
HIPPIE	MF	GO:0004396	hexokinase activity	-	16	16	-	-	2.64E-02	6.66E-04
HIPPIE	MF	GO:0070888	E-box binding	-	59	58	-	-	4.66E-02	2.41E-03
HIPPIE	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.50E-03	6.15E-04
HIPPIE	MF	GO:0015399	primary active transmembrane transporter activity	-	190	186	-	-	7.63E-02	7.63E-03
HIPPIE	MF	GO:0035254	glutamate receptor binding	-	47	46	-	-	1.63E-03	1.89E-03
HIPPIE	MF	GO:0050321	tau-protein kinase activity	-	36	35	-	-	2.55E-03	1.43E-03
HIPPIE	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	3.03E-03	4.61E-04
HIPPIE	MF	GO:0043021	ribonucleoprotein complex binding	-	158	158	-	-	5.31E-03	6.50E-03
HIPPIE	MF	GO:0030170	pyridoxal phosphate binding	-	56	54	-	-	4.94E-03	2.25E-03
HIPPIE	MF	GO:0032393	MHC class I receptor activity	-	15	14	-	-	5.34E-02	6.15E-04
HIPPIE	MF	GO:0005112	Notch binding	-	26	25	-	-	1.50E-02	1.02E-03
HIPPIE	MF	GO:0048185	activin binding	-	16	16	-	-	2.28E-02	6.66E-04
HIPPIE	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	9.05E-04	1.18E-03
HIPPIE	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	2.48E-03	4.61E-04
HIPPIE	MF	GO:0140299	small molecule sensor activity	-	39	37	-	-	1.59E-02	1.54E-03
HIPPIE	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	4.89E-03	9.22E-04
HIPPIE	MF	GO:0016917	GABA receptor activity	-	23	21	-	-	2.50E-01	8.71E-04
HIPPIE	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	2.94E-03	6.15E-04
HIPPIE	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	26	-	-	3.94E-04	1.08E-03
HIPPIE	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	46	-	-	8.06E-03	1.89E-03
HIPPIE	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.18E-03	1.02E-03
HIPPIE	MF	GO:0008527	taste receptor activity	-	28	17	-	-	1.43E-01	7.17E-04
HIPPIE	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	2.92E-03	5.12E-04
HIPPIE	MF	GO:0030594	neurotransmitter receptor activity	-	160	156	-	-	1.75E-02	6.40E-03
HIPPIE	MF	GO:0034452	dynactin binding	-	12	12	-	-	4.36E-04	5.12E-04
HIPPIE	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	1.04E-01	1.02E-03
HIPPIE	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	5.32E-03	8.71E-04
HIPPIE	MF	GO:0005507	copper ion binding	-	63	60	-	-	5.66E-03	2.46E-03
HIPPIE	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	2.55E-03	9.22E-04
HIPPIE	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	5.14E-03	4.61E-04
HIPPIE	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	5.87E-03	9.22E-04
HIPPIE	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	6.42E-03	5.12E-04
HPRD	CC	GO:0005615	extracellular space	2.22E-106	3190	2143	1584	1.35	-	-
HPRD	CC	GO:0005730	nucleolus	3.05E-31	988	667	491	1.36	-	-
HPRD	CC	GO:0005768	endosome	2.71E-27	1037	683	515	1.33	-	-
HPRD	CC	GO:0005815	microtubule organizing center	1.32E-20	843	550	419	1.31	-	-
HPRD	CC	GO:0005794	Golgi apparatus	1.25E-16	1636	972	812	1.20	-	-
HPRD	CC	GO:0005635	nuclear envelope	2.77E-12	493	321	245	1.31	-	-
HPRD	CC	GO:0000228	nuclear chromosome	4.51E-12	206	151	102	1.48	-	-
HPRD	CC	GO:0031012	extracellular matrix	7.79E-12	564	360	280	1.29	-	-
HPRD	CC	GO:0005764	lysosome	8.03E-10	747	453	371	1.22	-	-
HPRD	CC	GO:0005783	endoplasmic reticulum	6.04E-06	2020	1099	1003	1.10	-	-
HPRD	CC	GO:0005840	ribosome	6.82E-02	222	124	110	1.12	-	-
HPRD	CC	GO:0005777	peroxisome	9.17E-02	142	81	71	1.15	-	-
HPRD	CC	GO:0005811	lipid droplet	3.73E-01	102	46	51	0.91	-	-
HPRD	CC	GO:0005739	mitochondrion	6.63E-01	1671	821	830	0.99	-	-
HPRD	CC	GO:0005929	cilium	8.88E-01	842	416	418	1.00	-	-
HPRD	BP	GO:0012501	programmed cell death	3.92E-152	1954	1507	970	1.55	-	-
HPRD	BP	GO:0002376	immune system process	2.58E-125	2448	1757	1215	1.45	-	-
HPRD	BP	GO:0007155	cell adhesion	6.75E-105	1444	1105	717	1.54	-	-
HPRD	BP	GO:0048870	cell motility	2.46E-86	1659	1201	824	1.46	-	-
HPRD	BP	GO:0006355	regulation of DNA-templated transcription	1.22E-79	3342	2152	1659	1.30	-	-
HPRD	BP	GO:0006954	inflammatory response	5.95E-69	820	646	407	1.59	-	-
HPRD	BP	GO:0042060	wound healing	1.93E-61	431	375	214	1.75	-	-
HPRD	BP	GO:0034330	cell junction organization	1.57E-60	727	572	361	1.58	-	-
HPRD	BP	GO:0016192	vesicle-mediated transport	5.19E-59	1894	1272	940	1.35	-	-
HPRD	BP	GO:0065003	protein-containing complex assembly	6.29E-55	1648	1118	818	1.37	-	-
HPRD	BP	GO:0003012	muscle system process	2.93E-48	425	354	211	1.68	-	-
HPRD	BP	GO:0006886	intracellular protein transport	1.08E-47	664	509	330	1.54	-	-
HPRD	BP	GO:0003013	circulatory system process	1.57E-46	584	456	290	1.57	-	-
HPRD	BP	GO:0007010	cytoskeleton organization	6.84E-41	1639	1071	814	1.32	-	-
HPRD	BP	GO:0030163	protein catabolic process	7.65E-39	990	689	492	1.40	-	-
HPRD	BP	GO:0098542	defense response to other organism	6.47E-38	1171	793	581	1.36	-	-
HPRD	BP	GO:0006281	DNA repair	9.17E-31	587	427	291	1.47	-	-
HPRD	BP	GO:0006913	nucleocytoplasmic transport	2.01E-29	326	260	162	1.61	-	-
HPRD	BP	GO:0016071	mRNA metabolic process	2.64E-25	713	489	354	1.38	-	-
HPRD	BP	GO:0006914	autophagy	1.20E-24	568	401	282	1.42	-	-
HPRD	BP	GO:0007163	establishment or maintenance of cell polarity	6.58E-21	227	181	113	1.61	-	-
HPRD	BP	GO:0072659	protein localization to plasma membrane	6.81E-20	284	216	141	1.53	-	-
HPRD	BP	GO:0006325	chromatin organization	7.04E-20	720	477	357	1.33	-	-
HPRD	BP	GO:0006260	DNA replication	5.47E-17	279	207	139	1.49	-	-
HPRD	BP	GO:0007059	chromosome segregation	2.08E-16	403	281	200	1.40	-	-
HPRD	BP	GO:0000910	cytokinesis	2.42E-11	186	137	92	1.48	-	-
HPRD	BP	GO:0032200	telomere organization	6.93E-11	186	136	92	1.47	-	-
HPRD	BP	GO:0006457	protein folding	1.44E-10	210	150	104	1.44	-	-
HPRD	BP	GO:0002181	cytoplasmic translation	1.64E-10	153	115	76	1.51	-	-
HPRD	BP	GO:0006310	DNA recombination	4.96E-09	333	218	165	1.32	-	-
HPRD	BP	GO:0030198	extracellular matrix organization	9.94E-09	314	206	156	1.32	-	-
HPRD	BP	GO:0003014	renal system process	8.74E-08	127	93	63	1.47	-	-
HPRD	BP	GO:0022600	digestive system process	1.36E-07	110	82	55	1.50	-	-
HPRD	BP	GO:0005975	carbohydrate metabolic process	3.17E-05	551	322	274	1.18	-	-
HPRD	BP	GO:0140053	mitochondrial gene expression	3.93E-05	164	55	81	0.68	-	-
HPRD	BP	GO:0006091	generation of precursor metabolites and energy	5.45E-05	502	294	249	1.18	-	-
HPRD	BP	GO:0006486	protein glycosylation	7.01E-05	225	82	112	0.73	-	-
HPRD	BP	GO:0055085	transmembrane transport	2.77E-04	1784	959	886	1.08	-	-
HPRD	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.20E-03	119	77	59	1.30	-	-
HPRD	BP	GO:0006790	sulfur compound metabolic process	2.75E-03	320	132	159	0.83	-	-
HPRD	BP	GO:0098754	detoxification	5.34E-03	134	83	67	1.25	-	-
HPRD	BP	GO:0140013	meiotic nuclear division	5.43E-03	279	162	139	1.17	-	-
HPRD	BP	GO:0042254	ribosome biogenesis	5.96E-03	297	171	147	1.16	-	-
HPRD	BP	GO:0007005	mitochondrion organization	1.13E-02	484	268	240	1.12	-	-
HPRD	BP	GO:0050877	nervous system process	2.49E-02	1527	716	758	0.94	-	-
HPRD	BP	GO:0006399	tRNA metabolic process	4.42E-02	196	83	97	0.85	-	-
HPRD	BP	GO:0007040	lysosome organization	6.50E-02	107	63	53	1.19	-	-
HPRD	BP	GO:0044782	cilium organization	1.06E-01	399	182	198	0.92	-	-
HPRD	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.31E-01	729	382	362	1.06	-	-
HPRD	BP	GO:0007018	microtubule-based movement	1.48E-01	640	336	318	1.06	-	-
HPRD	BP	GO:0006520	amino acid metabolic process	3.16E-01	292	136	145	0.94	-	-
HPRD	BP	GO:0006766	vitamin metabolic process	5.62E-01	107	50	53	0.94	-	-
HPRD	BP	GO:0006575	cellular modified amino acid metabolic process	7.68E-01	186	90	92	0.97	-	-
HPRD	BP	GO:0006629	lipid metabolic process	9.78E-01	1355	672	673	1.00	-	-
HPRD	MF	GO:0140096	"catalytic activity, acting on a protein"	3.65E-106	3198	2147	1588	1.35	-	-
HPRD	MF	GO:0008092	cytoskeletal protein binding	9.03E-60	1023	757	508	1.49	-	-
HPRD	MF	GO:0016740	transferase activity	5.21E-59	3074	1935	1526	1.27	-	-
HPRD	MF	GO:0140110	transcription regulator activity	1.60E-51	2033	1329	1009	1.32	-	-
HPRD	MF	GO:0003677	DNA binding	3.30E-42	2865	1757	1422	1.24	-	-
HPRD	MF	GO:0003723	RNA binding	1.24E-35	1679	1076	834	1.29	-	-
HPRD	MF	GO:0140097	"catalytic activity, acting on DNA"	2.29E-25	383	289	190	1.52	-	-
HPRD	MF	GO:0048018	receptor ligand activity	1.38E-24	504	362	250	1.45	-	-
HPRD	MF	GO:0003924	GTPase activity	4.42E-24	658	453	327	1.39	-	-
HPRD	MF	GO:0009975	cyclase activity	4.32E-19	277	210	138	1.53	-	-
HPRD	MF	GO:0016829	lyase activity	1.31E-18	538	367	267	1.37	-	-
HPRD	MF	GO:0008289	lipid binding	1.16E-14	836	524	415	1.26	-	-
HPRD	MF	GO:0140657	ATP-dependent activity	5.00E-12	729	453	362	1.25	-	-
HPRD	MF	GO:0005198	structural molecule activity	1.09E-11	798	490	396	1.24	-	-
HPRD	MF	GO:0045182	translation regulator activity	9.45E-09	151	110	75	1.47	-	-
HPRD	MF	GO:0042393	histone binding	2.71E-07	237	157	118	1.33	-	-
HPRD	MF	GO:0016853	isomerase activity	1.67E-06	252	163	125	1.30	-	-
HPRD	MF	GO:0140104	molecular carrier activity	1.14E-04	105	72	52	1.38	-	-
HPRD	MF	GO:0038024	cargo receptor activity	2.64E-04	117	78	58	1.34	-	-
HPRD	MF	GO:0003774	cytoskeletal motor activity	4.00E-02	116	69	58	1.20	-	-
HPRD	MF	GO:0005215	transporter activity	9.66E-02	1462	695	726	0.96	-	-
HPRD	MF	GO:0016491	oxidoreductase activity	2.86E-01	888	425	441	0.96	-	-
HPRD	MF	GO:0016874	ligase activity	4.02E-01	283	148	141	1.05	-	-
HPRD	MF	GO:0140098	"catalytic activity, acting on RNA"	6.21E-01	417	202	207	0.98	-	-
HPRD	BP	GO:0008038	neuron recognition	-	46	37	-	-	3.83E-03	3.19E-03
HPRD	BP	GO:1905145	cellular response to acetylcholine	-	33	28	-	-	6.00E-03	2.44E-03
HPRD	BP	GO:0097094	craniofacial suture morphogenesis	-	18	14	-	-	3.16E-04	1.27E-03
HPRD	BP	GO:0098780	response to mitochondrial depolarisation	-	21	15	-	-	4.83E-02	1.27E-03
HPRD	BP	GO:0051931	regulation of sensory perception	-	36	26	-	-	1.30E-02	2.23E-03
HPRD	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	22	-	-	6.75E-04	1.91E-03
HPRD	BP	GO:0009268	response to pH	-	43	28	-	-	1.51E-02	2.44E-03
HPRD	BP	GO:0045666	positive regulation of neuron differentiation	-	91	61	-	-	3.65E-03	5.20E-03
HPRD	BP	GO:0043543	protein acylation	-	107	62	-	-	4.59E-03	5.31E-03
HPRD	MF	GO:0051349	positive regulation of lyase activity	-	41	35	-	-	6.95E-03	2.97E-03
HPRD	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	12	-	-	1.97E-02	1.06E-03
HPRD	BP	GO:0048679	regulation of axon regeneration	-	28	22	-	-	1.25E-03	1.91E-03
HPRD	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	2.94E-02	1.70E-03
HPRD	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	67	-	-	5.32E-03	5.73E-03
HPRD	BP	GO:0071763	nuclear membrane organization	-	44	34	-	-	7.26E-02	2.97E-03
HPRD	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	28	-	-	6.79E-03	2.44E-03
HPRD	BP	GO:0071806	protein transmembrane transport	-	68	50	-	-	1.64E-01	4.25E-03
HPRD	BP	GO:0022038	corpus callosum development	-	25	20	-	-	1.66E-02	1.70E-03
HPRD	BP	GO:0021548	pons development	-	11	11	-	-	3.14E-04	9.56E-04
HPRD	BP	GO:0043299	leukocyte degranulation	-	82	69	-	-	2.63E-02	5.95E-03
HPRD	BP	GO:0048864	stem cell development	-	88	67	-	-	2.07E-02	5.73E-03
HPRD	BP	GO:0051651	maintenance of location in cell	-	236	181	-	-	1.61E-02	1.54E-02
HPRD	BP	GO:0033119	negative regulation of RNA splicing	-	27	22	-	-	4.06E-02	1.91E-03
HPRD	CC	GO:0016197	endosomal transport	-	282	184	-	-	4.48E-02	1.57E-02
HPRD	BP	GO:0070663	regulation of leukocyte proliferation	-	268	229	-	-	1.84E-02	1.95E-02
HPRD	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	28	-	-	5.76E-03	2.44E-03
HPRD	BP	GO:0006949	syncytium formation	-	66	49	-	-	4.69E-03	4.25E-03
HPRD	BP	GO:0045176	apical protein localization	-	15	13	-	-	3.14E-04	1.17E-03
HPRD	BP	GO:0045861	negative regulation of proteolysis	-	320	219	-	-	1.18E-02	1.87E-02
HPRD	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	21	-	-	6.36E-03	1.80E-03
HPRD	BP	GO:0030574	collagen catabolic process	-	45	35	-	-	1.11E-02	2.97E-03
HPRD	CC	GO:0006984	ER-nucleus signaling pathway	-	46	39	-	-	4.51E-02	3.40E-03
HPRD	BP	GO:0060343	trabecula formation	-	26	22	-	-	3.24E-03	1.91E-03
HPRD	BP	GO:0009914	hormone transport	-	315	248	-	-	1.48E-02	2.11E-02
HPRD	BP	GO:0140112	extracellular vesicle biogenesis	-	23	17	-	-	2.51E-02	1.49E-03
HPRD	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	13	-	-	2.03E-01	1.17E-03
HPRD	BP	GO:1900424	regulation of defense response to bacterium	-	21	13	-	-	8.51E-02	1.17E-03
HPRD	BP	GO:0085029	extracellular matrix assembly	-	42	32	-	-	2.79E-03	2.76E-03
HPRD	BP	GO:0006413	translational initiation	-	122	94	-	-	1.10E-01	8.07E-03
HPRD	BP	GO:0072176	nephric duct development	-	15	11	-	-	1.69E-02	9.56E-04
HPRD	BP	GO:1902895	positive regulation of miRNA transcription	-	51	49	-	-	5.06E-03	4.25E-03
HPRD	CC	GO:0005200	structural constituent of cytoskeleton	-	112	88	-	-	2.32E-02	7.54E-03
HPRD	BP	GO:0030865	cortical cytoskeleton organization	-	51	43	-	-	4.69E-03	3.72E-03
HPRD	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	13	-	-	5.55E-02	1.17E-03
HPRD	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	21	-	-	1.26E-01	1.80E-03
HPRD	BP	GO:1903036	positive regulation of response to wounding	-	76	63	-	-	1.21E-02	5.41E-03
HPRD	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	101	-	-	3.36E-02	8.60E-03
HPRD	BP	GO:1903319	positive regulation of protein maturation	-	27	19	-	-	4.70E-03	1.70E-03
HPRD	BP	GO:0032528	microvillus organization	-	24	17	-	-	4.32E-03	1.49E-03
HPRD	BP	GO:0002263	cell activation involved in immune response	-	304	236	-	-	2.40E-02	2.01E-02
HPRD	BP	GO:0021954	central nervous system neuron development	-	85	59	-	-	3.80E-03	5.10E-03
HPRD	BP	GO:0055017	cardiac muscle tissue growth	-	92	64	-	-	1.38E-02	5.52E-03
HPRD	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	28	-	-	3.44E-03	2.44E-03
HPRD	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	12	-	-	3.15E-04	1.06E-03
HPRD	BP	GO:0048524	positive regulation of viral process	-	64	53	-	-	4.19E-03	4.57E-03
HPRD	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	19	-	-	8.86E-03	1.70E-03
HPRD	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	21	-	-	7.33E-03	1.80E-03
HPRD	BP	GO:0001946	lymphangiogenesis	-	18	13	-	-	1.22E-02	1.17E-03
HPRD	BP	GO:0098661	inorganic anion transmembrane transport	-	140	67	-	-	3.72E-03	5.73E-03
HPRD	BP	GO:0006099	tricarboxylic acid cycle	-	33	23	-	-	1.12E-01	2.02E-03
HPRD	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	16	-	-	2.93E-03	1.38E-03
HPRD	BP	GO:0009612	response to mechanical stimulus	-	215	171	-	-	9.08E-03	1.45E-02
HPRD	BP	GO:0048644	muscle organ morphogenesis	-	81	61	-	-	1.12E-02	5.20E-03
HPRD	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	131	-	-	1.08E-02	1.11E-02
HPRD	BP	GO:0071542	dopaminergic neuron differentiation	-	36	26	-	-	1.55E-02	2.23E-03
HPRD	BP	GO:0140115	export across plasma membrane	-	82	40	-	-	3.24E-02	3.40E-03
HPRD	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	11	-	-	1.77E-02	9.56E-04
HPRD	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	29	-	-	2.38E-03	2.55E-03
HPRD	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	11	-	-	1.08E-01	9.56E-04
HPRD	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	26	-	-	1.90E-02	2.23E-03
HPRD	MF	GO:0003714	transcription corepressor activity	-	190	161	-	-	1.59E-02	1.37E-02
HPRD	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	45	-	-	1.30E-02	3.82E-03
HPRD	BP	GO:0061101	neuroendocrine cell differentiation	-	16	14	-	-	7.65E-03	1.27E-03
HPRD	CC	GO:0006858	extracellular transport	-	45	17	-	-	4.93E-02	1.49E-03
HPRD	BP	GO:0006304	DNA modification	-	30	23	-	-	6.23E-02	2.02E-03
HPRD	MF	GO:0140312	cargo adaptor activity	-	19	17	-	-	1.41E-01	1.49E-03
HPRD	BP	GO:0046835	carbohydrate phosphorylation	-	49	28	-	-	1.44E-02	2.44E-03
HPRD	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	13	-	-	1.55E-03	1.17E-03
HPRD	CC	GO:1905349	ciliary transition zone assembly	-	371	172	-	-	2.34E-02	1.47E-02
HPRD	BP	GO:0003207	cardiac chamber formation	-	14	12	-	-	6.33E-02	1.06E-03
HPRD	BP	GO:0070417	cellular response to cold	-	13	11	-	-	3.46E-02	9.56E-04
HPRD	BP	GO:0043523	regulation of neuron apoptotic process	-	218	172	-	-	1.50E-02	1.47E-02
HPRD	BP	GO:1902894	negative regulation of miRNA transcription	-	22	21	-	-	3.96E-03	1.80E-03
HPRD	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	11	-	-	3.17E-03	9.56E-04
HPRD	BP	GO:0044380	protein localization to cytoskeleton	-	57	40	-	-	1.11E-02	3.40E-03
HPRD	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	3.62E-02	1.17E-03
HPRD	BP	GO:2000209	regulation of anoikis	-	25	22	-	-	1.47E-03	1.91E-03
HPRD	BP	GO:0014029	neural crest formation	-	15	13	-	-	2.44E-02	1.17E-03
HPRD	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	17	-	-	2.98E-03	1.49E-03
HPRD	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	27	-	-	3.59E-02	2.34E-03
HPRD	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	61	-	-	2.81E-03	5.20E-03
HPRD	BP	GO:0003188	heart valve formation	-	16	12	-	-	3.11E-04	1.06E-03
HPRD	CC	GO:0045324	late endosome to vacuole transport	-	37	31	-	-	2.11E-01	2.65E-03
HPRD	BP	GO:0043954	cellular component maintenance	-	72	61	-	-	8.65E-03	5.20E-03
HPRD	BP	GO:0050435	amyloid-beta metabolic process	-	65	46	-	-	6.87E-02	3.93E-03
HPRD	BP	GO:0014823	response to activity	-	70	54	-	-	7.26E-03	4.67E-03
HPRD	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	17	-	-	2.31E-02	1.49E-03
HPRD	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	21	-	-	4.81E-02	1.80E-03
HPRD	BP	GO:0034502	protein localization to chromosome	-	130	91	-	-	1.64E-02	7.75E-03
HPRD	BP	GO:0048562	embryonic organ morphogenesis	-	295	203	-	-	1.61E-02	1.73E-02
HPRD	BP	GO:0060457	negative regulation of digestive system process	-	17	14	-	-	9.70E-02	1.27E-03
HPRD	BP	GO:0019233	sensory perception of pain	-	103	79	-	-	5.86E-03	6.79E-03
HPRD	CC	GO:0043574	peroxisomal transport	-	22	21	-	-	5.01E-01	1.80E-03
HPRD	BP	GO:0031343	positive regulation of cell killing	-	75	64	-	-	1.00E-01	5.52E-03
HPRD	BP	GO:0090077	foam cell differentiation	-	39	31	-	-	2.13E-03	2.65E-03
HPRD	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	89	-	-	5.29E-02	7.64E-03
HPRD	BP	GO:0017148	negative regulation of translation	-	390	84	-	-	6.72E-03	7.22E-03
HPRD	BP	GO:0030220	platelet formation	-	22	20	-	-	2.15E-02	1.70E-03
HPRD	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	67	-	-	1.13E-02	5.73E-03
HPRD	MF	GO:1903624	regulation of DNA catabolic process	-	14	11	-	-	1.69E-02	9.56E-04
HPRD	BP	GO:1901142	insulin metabolic process	-	14	11	-	-	3.16E-04	9.56E-04
HPRD	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	12	-	-	5.24E-02	1.06E-03
HPRD	BP	GO:1903509	liposaccharide metabolic process	-	109	50	-	-	1.84E-01	4.25E-03
HPRD	BP	GO:0009582	detection of abiotic stimulus	-	140	88	-	-	1.40E-02	7.54E-03
HPRD	BP	GO:0045683	negative regulation of epidermis development	-	13	11	-	-	4.41E-03	9.56E-04
HPRD	CC	GO:0140238	presynaptic endocytosis	-	72	61	-	-	2.05E-02	5.20E-03
HPRD	BP	GO:0051236	establishment of RNA localization	-	161	120	-	-	1.34E-01	1.02E-02
HPRD	BP	GO:0042178	xenobiotic catabolic process	-	26	13	-	-	1.20E-01	1.17E-03
HPRD	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	152	-	-	2.45E-02	1.30E-02
HPRD	BP	GO:0034067	protein localization to Golgi apparatus	-	30	19	-	-	4.21E-04	1.70E-03
HPRD	BP	GO:0061842	microtubule organizing center localization	-	32	27	-	-	3.74E-03	2.34E-03
HPRD	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	1.97E-02	9.56E-04
HPRD	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	15	-	-	2.72E-02	1.27E-03
HPRD	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	20	-	-	8.38E-02	1.70E-03
HPRD	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	27	-	-	3.60E-03	2.34E-03
HPRD	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	44	-	-	3.07E-02	3.82E-03
HPRD	BP	GO:0050779	RNA destabilization	-	135	61	-	-	7.09E-02	5.20E-03
HPRD	BP	GO:0006023	aminoglycan biosynthetic process	-	74	24	-	-	3.43E-02	2.12E-03
HPRD	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	41	-	-	6.64E-03	3.50E-03
HPRD	BP	GO:0010762	regulation of fibroblast migration	-	40	31	-	-	1.12E-02	2.65E-03
HPRD	BP	GO:0090311	regulation of protein deacetylation	-	29	23	-	-	1.31E-02	2.02E-03
HPRD	BP	GO:0035272	exocrine system development	-	46	40	-	-	3.73E-03	3.40E-03
HPRD	BP	GO:0022406	membrane docking	-	90	71	-	-	3.45E-02	6.05E-03
HPRD	BP	GO:0006999	nuclear pore organization	-	15	11	-	-	5.43E-01	9.56E-04
HPRD	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	11	-	-	1.86E-03	9.56E-04
HPRD	BP	GO:0050777	negative regulation of immune response	-	196	142	-	-	1.96E-02	1.21E-02
HPRD	BP	GO:0016053	organic acid biosynthetic process	-	335	172	-	-	3.29E-02	1.47E-02
HPRD	MF	GO:0005035	death receptor activity	-	16	16	-	-	1.19E-02	1.38E-03
HPRD	BP	GO:0002063	chondrocyte development	-	33	23	-	-	2.95E-03	2.02E-03
HPRD	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	13	-	-	2.57E-03	1.17E-03
HPRD	BP	GO:0099068	postsynapse assembly	-	40	33	-	-	8.18E-03	2.87E-03
HPRD	BP	GO:0021782	glial cell development	-	120	88	-	-	4.61E-03	7.54E-03
HPRD	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	56	-	-	3.56E-03	4.78E-03
HPRD	BP	GO:0001655	urogenital system development	-	66	55	-	-	3.94E-03	4.67E-03
HPRD	BP	GO:0071827	plasma lipoprotein particle organization	-	86	52	-	-	4.90E-02	4.46E-03
HPRD	BP	GO:0045494	photoreceptor cell maintenance	-	43	24	-	-	8.14E-02	2.12E-03
HPRD	BP	GO:0055088	lipid homeostasis	-	173	98	-	-	1.81E-02	8.39E-03
HPRD	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	22	-	-	1.01E-03	1.91E-03
HPRD	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	157	-	-	7.11E-03	1.34E-02
HPRD	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	15	-	-	1.59E-01	1.27E-03
HPRD	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	26	-	-	8.12E-03	2.23E-03
HPRD	BP	GO:0045667	regulation of osteoblast differentiation	-	147	103	-	-	1.04E-02	8.81E-03
HPRD	BP	GO:2001212	regulation of vasculogenesis	-	16	14	-	-	7.87E-03	1.27E-03
HPRD	BP	GO:0061037	negative regulation of cartilage development	-	32	22	-	-	1.39E-03	1.91E-03
HPRD	BP	GO:0045738	negative regulation of DNA repair	-	40	24	-	-	5.11E-04	2.12E-03
HPRD	BP	GO:0001704	formation of primary germ layer	-	195	151	-	-	9.19E-03	1.28E-02
HPRD	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	1.43E-02	1.17E-03
HPRD	BP	GO:0045778	positive regulation of ossification	-	51	43	-	-	4.13E-03	3.72E-03
HPRD	BP	GO:0060174	limb bud formation	-	11	11	-	-	1.61E-02	9.56E-04
HPRD	BP	GO:0048708	astrocyte differentiation	-	88	71	-	-	5.72E-03	6.05E-03
HPRD	BP	GO:0042092	type 2 immune response	-	41	36	-	-	1.39E-02	3.08E-03
HPRD	BP	GO:0048588	developmental cell growth	-	233	173	-	-	7.43E-03	1.48E-02
HPRD	BP	GO:0021872	forebrain generation of neurons	-	52	36	-	-	4.29E-03	3.08E-03
HPRD	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	16	-	-	1.14E-02	1.38E-03
HPRD	BP	GO:0045023	G0 to G1 transition	-	41	33	-	-	3.29E-02	2.87E-03
HPRD	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	42	-	-	2.11E-02	3.61E-03
HPRD	BP	GO:0034367	protein-containing complex remodeling	-	35	28	-	-	6.03E-02	2.44E-03
HPRD	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	2.10E-03	2.23E-03
HPRD	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	13	-	-	3.17E-04	1.17E-03
HPRD	BP	GO:0015810	aspartate transmembrane transport	-	19	11	-	-	3.18E-04	9.56E-04
HPRD	BP	GO:0010232	vascular transport	-	87	51	-	-	2.51E-03	4.35E-03
HPRD	BP	GO:0021987	cerebral cortex development	-	125	95	-	-	7.43E-03	8.07E-03
HPRD	BP	GO:0008637	apoptotic mitochondrial changes	-	108	82	-	-	8.16E-02	7.01E-03
HPRD	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	27	-	-	6.86E-03	2.34E-03
HPRD	BP	GO:0060999	positive regulation of dendritic spine development	-	35	29	-	-	7.19E-03	2.55E-03
HPRD	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	14	-	-	3.00E-03	1.27E-03
HPRD	BP	GO:2000736	regulation of stem cell differentiation	-	78	59	-	-	8.05E-03	5.10E-03
HPRD	BP	GO:0060973	cell migration involved in heart development	-	21	15	-	-	1.82E-03	1.27E-03
HPRD	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	17	-	-	2.41E-03	1.49E-03
HPRD	BP	GO:0002064	epithelial cell development	-	210	161	-	-	8.85E-03	1.37E-02
HPRD	BP	GO:0071318	cellular response to ATP	-	18	14	-	-	3.16E-04	1.27E-03
HPRD	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	31	-	-	1.21E-02	2.65E-03
HPRD	BP	GO:2001222	regulation of neuron migration	-	46	29	-	-	6.25E-04	2.55E-03
HPRD	BP	GO:0034389	lipid droplet organization	-	38	21	-	-	1.12E-02	1.80E-03
HPRD	BP	GO:0051602	response to electrical stimulus	-	44	40	-	-	9.16E-04	3.40E-03
HPRD	BP	GO:0042177	negative regulation of protein catabolic process	-	109	82	-	-	2.72E-03	7.01E-03
HPRD	MF	GO:0038024	cargo receptor activity	-	121	78	-	-	7.76E-03	6.69E-03
HPRD	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	15	-	-	1.35E-03	1.27E-03
HPRD	BP	GO:0033120	positive regulation of RNA splicing	-	46	31	-	-	5.28E-03	2.65E-03
HPRD	BP	GO:0051445	regulation of meiotic cell cycle	-	64	41	-	-	8.13E-02	3.50E-03
HPRD	BP	GO:0033619	membrane protein proteolysis	-	60	51	-	-	3.67E-02	4.35E-03
HPRD	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	8.19E-03	1.27E-03
HPRD	BP	GO:0090087	regulation of peptide transport	-	195	150	-	-	1.43E-02	1.27E-02
HPRD	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	79	-	-	1.13E-02	6.79E-03
HPRD	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	20	-	-	5.19E-04	1.70E-03
HPRD	BP	GO:0006929	substrate-dependent cell migration	-	26	22	-	-	3.43E-03	1.91E-03
HPRD	BP	GO:0042537	benzene-containing compound metabolic process	-	27	12	-	-	1.50E-01	1.06E-03
HPRD	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	12	-	-	8.80E-03	1.06E-03
HPRD	BP	GO:0072662	protein localization to peroxisome	-	20	19	-	-	3.60E-01	1.70E-03
HPRD	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	11	-	-	7.10E-03	9.56E-04
HPRD	BP	GO:0022404	molting cycle process	-	95	69	-	-	3.17E-03	5.95E-03
HPRD	BP	GO:1903358	regulation of Golgi organization	-	17	15	-	-	2.51E-03	1.27E-03
HPRD	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	18	-	-	6.63E-03	1.59E-03
HPRD	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	14	-	-	2.45E-03	1.27E-03
HPRD	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	28	-	-	1.85E-03	2.44E-03
HPRD	BP	GO:0017014	protein nitrosylation	-	17	13	-	-	2.35E-02	1.17E-03
HPRD	BP	GO:0007281	germ cell development	-	334	179	-	-	8.86E-03	1.53E-02
HPRD	BP	GO:0008299	isoprenoid biosynthetic process	-	30	11	-	-	3.18E-04	9.56E-04
HPRD	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	146	-	-	3.25E-02	1.24E-02
HPRD	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	28	-	-	2.56E-03	2.44E-03
HPRD	BP	GO:0034104	negative regulation of tissue remodeling	-	22	17	-	-	4.18E-04	1.49E-03
HPRD	CC	GO:0098926	postsynaptic signal transduction	-	39	33	-	-	2.47E-03	2.87E-03
HPRD	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	97	-	-	3.73E-03	8.28E-03
HPRD	CC	GO:0016082	synaptic vesicle priming	-	19	15	-	-	2.96E-02	1.27E-03
HPRD	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	42	-	-	2.78E-03	3.61E-03
HPRD	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	110	-	-	2.61E-02	9.34E-03
HPRD	BP	GO:0034249	negative regulation of amide metabolic process	-	34	19	-	-	2.28E-03	1.70E-03
HPRD	BP	GO:0061548	ganglion development	-	17	14	-	-	1.12E-02	1.27E-03
HPRD	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	82	-	-	1.17E-02	7.01E-03
HPRD	BP	GO:0042832	defense response to protozoan	-	28	19	-	-	1.92E-03	1.70E-03
HPRD	BP	GO:0048799	animal organ maturation	-	33	24	-	-	7.20E-03	2.12E-03
HPRD	BP	GO:0006925	inflammatory cell apoptotic process	-	23	18	-	-	1.83E-03	1.59E-03
HPRD	BP	GO:2000291	regulation of myoblast proliferation	-	25	14	-	-	3.11E-04	1.27E-03
HPRD	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	141	-	-	1.89E-02	1.20E-02
HPRD	BP	GO:1903035	negative regulation of response to wounding	-	93	78	-	-	1.59E-02	6.69E-03
HPRD	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	25	-	-	1.64E-03	2.12E-03
HPRD	BP	GO:0036010	protein localization to endosome	-	27	20	-	-	3.61E-03	1.70E-03
HPRD	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	83	-	-	3.63E-02	7.11E-03
HPRD	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	71	-	-	9.61E-03	6.05E-03
HPRD	BP	GO:0045056	transcytosis	-	20	18	-	-	2.51E-03	1.59E-03
HPRD	BP	GO:0009267	cellular response to starvation	-	170	119	-	-	1.83E-02	1.02E-02
HPRD	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	47	-	-	6.95E-03	4.03E-03
HPRD	CC	GO:0140239	postsynaptic endocytosis	-	23	21	-	-	1.31E-02	1.80E-03
HPRD	BP	GO:0046931	pore complex assembly	-	21	14	-	-	1.85E-02	1.27E-03
HPRD	CC	GO:0032008	positive regulation of TOR signaling	-	52	30	-	-	1.34E-02	2.55E-03
HPRD	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	21	-	-	2.18E-01	1.80E-03
HPRD	BP	GO:0060428	lung epithelium development	-	43	39	-	-	4.12E-03	3.40E-03
HPRD	BP	GO:0030431	sleep	-	30	27	-	-	3.01E-02	2.34E-03
HPRD	BP	GO:1903318	negative regulation of protein maturation	-	29	20	-	-	1.23E-02	1.70E-03
HPRD	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	25	-	-	2.86E-02	2.12E-03
HPRD	BP	GO:0071732	cellular response to nitric oxide	-	17	16	-	-	1.94E-03	1.38E-03
HPRD	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	1.15E-02	9.56E-04
HPRD	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	26	-	-	8.33E-02	2.23E-03
HPRD	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	60	-	-	3.86E-03	5.10E-03
HPRD	BP	GO:0065004	protein-DNA complex assembly	-	307	217	-	-	9.74E-02	1.85E-02
HPRD	CC	GO:0006406	mRNA export from nucleus	-	69	57	-	-	1.57E-01	4.88E-03
HPRD	BP	GO:0009880	embryonic pattern specification	-	70	45	-	-	4.56E-03	3.82E-03
HPRD	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	39	-	-	4.44E-01	3.40E-03
HPRD	BP	GO:0043043	peptide biosynthetic process	-	25	17	-	-	4.21E-04	1.49E-03
HPRD	BP	GO:0002367	cytokine production involved in immune response	-	121	103	-	-	1.72E-02	8.81E-03
HPRD	BP	GO:0044848	biological phase	-	211	135	-	-	5.43E-02	1.15E-02
HPRD	BP	GO:0002645	positive regulation of tolerance induction	-	12	11	-	-	1.27E-02	9.56E-04
HPRD	BP	GO:0046660	female sex differentiation	-	125	104	-	-	1.66E-02	8.92E-03
HPRD	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	12	-	-	8.49E-03	1.06E-03
HPRD	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	38	-	-	1.59E-02	3.29E-03
HPRD	BP	GO:0060411	cardiac septum morphogenesis	-	72	61	-	-	2.48E-02	5.20E-03
HPRD	BP	GO:0071248	cellular response to metal ion	-	201	152	-	-	1.09E-02	1.30E-02
HPRD	BP	GO:0030308	negative regulation of cell growth	-	191	138	-	-	9.59E-03	1.18E-02
HPRD	BP	GO:0097306	cellular response to alcohol	-	99	75	-	-	6.37E-03	6.37E-03
HPRD	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	81	-	-	6.61E-02	6.90E-03
HPRD	BP	GO:0010453	regulation of cell fate commitment	-	40	31	-	-	5.80E-02	2.65E-03
HPRD	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	41	-	-	6.16E-03	3.50E-03
HPRD	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	17	-	-	4.23E-04	1.49E-03
HPRD	BP	GO:0002026	regulation of the force of heart contraction	-	26	24	-	-	4.75E-03	2.12E-03
HPRD	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	16	-	-	1.47E-01	1.38E-03
HPRD	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	24	-	-	1.65E-03	2.12E-03
HPRD	BP	GO:0032890	regulation of organic acid transport	-	78	64	-	-	4.83E-03	5.52E-03
HPRD	BP	GO:0071498	cellular response to fluid shear stress	-	21	18	-	-	1.60E-03	1.59E-03
HPRD	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	74	-	-	4.65E-03	6.37E-03
HPRD	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	21	-	-	2.52E-03	1.80E-03
HPRD	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	42	-	-	4.38E-03	3.61E-03
HPRD	BP	GO:0051259	protein complex oligomerization	-	251	160	-	-	2.03E-02	1.36E-02
HPRD	BP	GO:0098743	cell aggregation	-	24	21	-	-	3.21E-03	1.80E-03
HPRD	BP	GO:0009994	oocyte differentiation	-	57	32	-	-	4.13E-03	2.76E-03
HPRD	MF	GO:0031952	regulation of protein autophosphorylation	-	43	38	-	-	2.19E-03	3.29E-03
HPRD	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	1.22E-02	1.27E-03
HPRD	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	118	-	-	7.05E-03	1.01E-02
HPRD	BP	GO:0044319	"wound healing, spreading of cells"	-	37	32	-	-	2.34E-03	2.76E-03
HPRD	BP	GO:0033688	regulation of osteoblast proliferation	-	31	24	-	-	2.24E-03	2.12E-03
HPRD	BP	GO:0060251	regulation of glial cell proliferation	-	39	34	-	-	1.25E-03	2.97E-03
HPRD	BP	GO:0072665	protein localization to vacuole	-	84	59	-	-	4.12E-02	5.10E-03
HPRD	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	42	-	-	1.31E-01	3.61E-03
HPRD	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	18	-	-	6.68E-03	1.59E-03
HPRD	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	57	-	-	1.72E-02	4.88E-03
HPRD	BP	GO:0042953	lipoprotein transport	-	20	11	-	-	3.11E-04	9.56E-04
HPRD	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	11	-	-	1.57E-01	9.56E-04
HPRD	BP	GO:0042044	fluid transport	-	35	22	-	-	1.33E-02	1.91E-03
HPRD	BP	GO:0070633	transepithelial transport	-	35	24	-	-	5.07E-03	2.12E-03
HPRD	BP	GO:0045661	regulation of myoblast differentiation	-	74	61	-	-	9.94E-03	5.20E-03
HPRD	BP	GO:0030307	positive regulation of cell growth	-	164	128	-	-	9.28E-03	1.09E-02
HPRD	BP	GO:0034250	positive regulation of amide metabolic process	-	27	21	-	-	1.03E-02	1.80E-03
HPRD	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	13	-	-	3.15E-04	1.17E-03
HPRD	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	5.94E-03	1.17E-03
HPRD	BP	GO:0014812	muscle cell migration	-	110	73	-	-	6.53E-03	6.26E-03
HPRD	BP	GO:0048525	negative regulation of viral process	-	90	62	-	-	1.03E-02	5.31E-03
HPRD	BP	GO:0072044	collecting duct development	-	16	13	-	-	7.35E-03	1.17E-03
HPRD	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	53	-	-	3.70E-02	4.57E-03
HPRD	BP	GO:0030238	male sex determination	-	14	13	-	-	1.88E-02	1.17E-03
HPRD	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	124	-	-	2.48E-02	1.06E-02
HPRD	BP	GO:0051781	positive regulation of cell division	-	93	74	-	-	8.73E-03	6.37E-03
HPRD	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	16	-	-	8.12E-03	1.38E-03
HPRD	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	2.15E-03	9.56E-04
HPRD	BP	GO:0035493	SNARE complex assembly	-	23	22	-	-	6.10E-02	1.91E-03
HPRD	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	17	-	-	4.18E-04	1.49E-03
HPRD	BP	GO:0060711	labyrinthine layer development	-	47	39	-	-	2.34E-03	3.40E-03
HPRD	BP	GO:0007272	ensheathment of neurons	-	146	110	-	-	5.79E-03	9.34E-03
HPRD	CC	GO:0050806	positive regulation of synaptic transmission	-	171	124	-	-	8.04E-03	1.06E-02
HPRD	BP	GO:0060021	roof of mouth development	-	91	64	-	-	6.35E-03	5.52E-03
HPRD	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	32	-	-	1.03E-02	2.76E-03
HPRD	BP	GO:0050819	negative regulation of coagulation	-	54	49	-	-	3.71E-02	4.25E-03
HPRD	BP	GO:0031647	regulation of protein stability	-	327	246	-	-	1.11E-02	2.09E-02
HPRD	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	3.97E-03	9.56E-04
HPRD	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	61	-	-	2.40E-01	5.20E-03
HPRD	BP	GO:0097212	lysosomal membrane organization	-	15	11	-	-	4.02E-02	9.56E-04
HPRD	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	12	-	-	2.36E-03	1.06E-03
HPRD	CC	GO:0050805	negative regulation of synaptic transmission	-	55	46	-	-	3.79E-03	3.93E-03
HPRD	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	41	-	-	1.88E-03	3.50E-03
HPRD	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	3.17E-04	9.56E-04
HPRD	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	75	-	-	3.18E-02	6.37E-03
HPRD	BP	GO:0016054	organic acid catabolic process	-	251	112	-	-	3.93E-02	9.56E-03
HPRD	BP	GO:0050890	cognition	-	317	235	-	-	8.59E-03	2.00E-02
HPRD	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	11	-	-	3.15E-04	9.56E-04
HPRD	BP	GO:1900048	positive regulation of hemostasis	-	28	25	-	-	4.28E-02	2.12E-03
HPRD	BP	GO:0065005	protein-lipid complex assembly	-	29	18	-	-	5.68E-03	1.59E-03
HPRD	BP	GO:0008033	tRNA processing	-	136	53	-	-	2.09E-01	4.57E-03
HPRD	BP	GO:0046661	male sex differentiation	-	171	128	-	-	1.04E-02	1.09E-02
HPRD	BP	GO:0072520	seminiferous tubule development	-	15	11	-	-	1.54E-03	9.56E-04
HPRD	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	15	-	-	3.67E-03	1.27E-03
HPRD	BP	GO:0035188	hatching	-	27	13	-	-	3.16E-04	1.17E-03
HPRD	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	67	-	-	4.70E-03	5.73E-03
HPRD	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	12	-	-	3.13E-04	1.06E-03
HPRD	BP	GO:0090713	immunological memory process	-	18	14	-	-	1.20E-01	1.27E-03
HPRD	BP	GO:0061326	renal tubule development	-	103	80	-	-	6.79E-03	6.79E-03
HPRD	BP	GO:0051258	protein polymerization	-	280	203	-	-	1.50E-02	1.73E-02
HPRD	BP	GO:0071985	multivesicular body sorting pathway	-	56	46	-	-	1.31E-01	3.93E-03
HPRD	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	15	-	-	4.60E-03	1.27E-03
HPRD	BP	GO:0060325	face morphogenesis	-	31	22	-	-	1.23E-02	1.91E-03
HPRD	BP	GO:0090559	regulation of membrane permeability	-	72	50	-	-	8.65E-03	4.25E-03
HPRD	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	13	-	-	3.15E-04	1.17E-03
HPRD	BP	GO:0043482	cellular pigment accumulation	-	12	11	-	-	3.17E-04	9.56E-04
HPRD	BP	GO:0031579	membrane raft organization	-	25	14	-	-	2.73E-03	1.27E-03
HPRD	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	21	-	-	2.04E-03	1.80E-03
HPRD	BP	GO:0060033	anatomical structure regression	-	16	13	-	-	1.77E-02	1.17E-03
HPRD	BP	GO:0046460	neutral lipid biosynthetic process	-	50	20	-	-	2.97E-03	1.70E-03
HPRD	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	53	-	-	6.68E-02	4.57E-03
HPRD	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	126	-	-	5.86E-03	1.07E-02
HPRD	BP	GO:0002251	organ or tissue specific immune response	-	43	28	-	-	2.03E-02	2.44E-03
HPRD	CC	GO:0048167	regulation of synaptic plasticity	-	210	150	-	-	9.89E-03	1.27E-02
HPRD	BP	GO:1903708	positive regulation of hemopoiesis	-	184	153	-	-	2.22E-02	1.31E-02
HPRD	BP	GO:1903008	organelle disassembly	-	154	101	-	-	2.97E-02	8.60E-03
HPRD	BP	GO:0001709	cell fate determination	-	44	35	-	-	4.07E-03	2.97E-03
HPRD	BP	GO:0051873	killing by host of symbiont cells	-	28	21	-	-	7.66E-03	1.80E-03
HPRD	BP	GO:0045058	T cell selection	-	53	49	-	-	3.74E-02	4.25E-03
HPRD	CC	GO:0032387	negative regulation of intracellular transport	-	51	38	-	-	2.65E-03	3.29E-03
HPRD	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	12	-	-	3.40E-03	1.06E-03
HPRD	BP	GO:0072091	regulation of stem cell proliferation	-	91	61	-	-	3.02E-03	5.20E-03
HPRD	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	26	-	-	1.80E-02	2.23E-03
HPRD	BP	GO:0099084	postsynaptic specialization organization	-	44	36	-	-	2.23E-02	3.08E-03
HPRD	BP	GO:0060384	innervation	-	27	17	-	-	2.29E-02	1.49E-03
HPRD	MF	GO:0031281	positive regulation of cyclase activity	-	40	36	-	-	6.34E-03	3.08E-03
HPRD	MF	GO:0098631	cell adhesion mediator activity	-	64	53	-	-	2.00E-02	4.57E-03
HPRD	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	13	-	-	3.17E-04	1.17E-03
HPRD	BP	GO:0046112	nucleobase biosynthetic process	-	18	14	-	-	3.17E-04	1.27E-03
HPRD	BP	GO:0071453	cellular response to oxygen levels	-	168	123	-	-	9.76E-03	1.05E-02
HPRD	BP	GO:0090399	replicative senescence	-	17	13	-	-	4.92E-03	1.17E-03
HPRD	BP	GO:0031342	negative regulation of cell killing	-	29	25	-	-	5.28E-02	2.12E-03
HPRD	BP	GO:0070585	protein localization to mitochondrion	-	125	82	-	-	6.21E-02	7.01E-03
HPRD	BP	GO:0010623	programmed cell death involved in cell development	-	25	19	-	-	2.39E-03	1.70E-03
HPRD	BP	GO:0044242	cellular lipid catabolic process	-	224	99	-	-	5.40E-02	8.49E-03
HPRD	BP	GO:0071236	cellular response to antibiotic	-	13	12	-	-	1.09E-03	1.06E-03
HPRD	BP	GO:0002931	response to ischemia	-	58	46	-	-	1.17E-02	3.93E-03
HPRD	BP	GO:0043062	extracellular structure organization	-	317	206	-	-	3.24E-02	1.75E-02
HPRD	BP	GO:0014047	glutamate secretion	-	25	23	-	-	5.88E-03	2.02E-03
HPRD	BP	GO:0061005	cell differentiation involved in kidney development	-	58	47	-	-	8.91E-03	4.03E-03
HPRD	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	57	-	-	2.10E-02	4.88E-03
HPRD	BP	GO:0060420	regulation of heart growth	-	74	52	-	-	8.28E-03	4.46E-03
HPRD	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	11	-	-	3.14E-04	9.56E-04
HPRD	BP	GO:0009755	hormone-mediated signaling pathway	-	221	179	-	-	3.28E-02	1.53E-02
HPRD	BP	GO:0022612	gland morphogenesis	-	124	111	-	-	8.53E-03	9.45E-03
HPRD	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	24	-	-	1.10E-03	2.12E-03
HPRD	MF	GO:0140416	transcription regulator inhibitor activity	-	26	22	-	-	2.50E-03	1.91E-03
HPRD	BP	GO:0044782	cilium organization	-	400	182	-	-	2.60E-02	1.55E-02
HPRD	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	19	-	-	1.29E-02	1.70E-03
HPRD	BP	GO:0048935	peripheral nervous system neuron development	-	15	13	-	-	2.25E-02	1.17E-03
HPRD	BP	GO:0110096	cellular response to aldehyde	-	17	11	-	-	1.57E-01	9.56E-04
HPRD	BP	GO:1990845	adaptive thermogenesis	-	166	127	-	-	8.68E-03	1.08E-02
HPRD	BP	GO:0071320	cellular response to cAMP	-	54	43	-	-	3.80E-02	3.72E-03
HPRD	BP	GO:0015844	monoamine transport	-	88	70	-	-	2.32E-02	5.95E-03
HPRD	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	15	-	-	5.03E-03	1.27E-03
HPRD	BP	GO:0060039	pericardium development	-	19	14	-	-	4.81E-03	1.27E-03
HPRD	BP	GO:0071392	cellular response to estradiol stimulus	-	40	35	-	-	5.60E-03	2.97E-03
HPRD	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	1.39E-02	1.17E-03
HPRD	BP	GO:0000272	polysaccharide catabolic process	-	19	15	-	-	1.18E-02	1.27E-03
HPRD	BP	GO:0009451	RNA modification	-	169	63	-	-	2.78E-02	5.41E-03
HPRD	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	1.89E-01	9.56E-04
HPRD	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	28	-	-	1.73E-03	2.44E-03
HPRD	BP	GO:1903729	regulation of plasma membrane organization	-	17	14	-	-	4.53E-03	1.27E-03
HPRD	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	81	-	-	1.46E-02	6.90E-03
HPRD	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	33	-	-	7.18E-03	2.87E-03
HPRD	BP	GO:0015807	L-amino acid transport	-	94	42	-	-	5.24E-02	3.61E-03
HPRD	BP	GO:0032941	secretion by tissue	-	85	73	-	-	5.01E-03	6.26E-03
HPRD	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	2.14E-02	1.17E-03
HPRD	BP	GO:0046605	regulation of centrosome cycle	-	54	39	-	-	9.33E-03	3.40E-03
HPRD	BP	GO:0048753	pigment granule organization	-	40	35	-	-	8.01E-02	2.97E-03
HPRD	BP	GO:0021516	dorsal spinal cord development	-	20	12	-	-	1.46E-02	1.06E-03
HPRD	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	18	-	-	2.44E-02	1.59E-03
HPRD	BP	GO:0003014	renal system process	-	130	93	-	-	7.76E-03	7.96E-03
HPRD	BP	GO:0045598	regulation of fat cell differentiation	-	148	97	-	-	1.74E-02	8.28E-03
HPRD	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	172	-	-	1.92E-02	1.47E-02
HPRD	BP	GO:1904646	cellular response to amyloid-beta	-	44	35	-	-	4.42E-03	2.97E-03
HPRD	BP	GO:1901863	positive regulation of muscle tissue development	-	24	21	-	-	1.54E-03	1.80E-03
HPRD	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	177	-	-	9.07E-02	1.51E-02
HPRD	BP	GO:0008340	determination of adult lifespan	-	23	14	-	-	3.72E-03	1.27E-03
HPRD	BP	GO:0039694	viral RNA genome replication	-	30	22	-	-	3.23E-02	1.91E-03
HPRD	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	21	-	-	6.62E-03	1.80E-03
HPRD	BP	GO:0071709	membrane assembly	-	68	48	-	-	6.79E-02	4.14E-03
HPRD	BP	GO:0008217	regulation of blood pressure	-	186	152	-	-	4.06E-02	1.30E-02
HPRD	BP	GO:0031643	positive regulation of myelination	-	19	15	-	-	3.52E-03	1.27E-03
HPRD	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	52	-	-	2.99E-03	4.46E-03
HPRD	CC	GO:0042770	signal transduction in response to DNA damage	-	186	150	-	-	3.24E-02	1.27E-02
HPRD	BP	GO:0002200	somatic diversification of immune receptors	-	78	65	-	-	4.41E-02	5.52E-03
HPRD	BP	GO:0035315	hair cell differentiation	-	52	34	-	-	5.90E-03	2.97E-03
HPRD	BP	GO:0048645	animal organ formation	-	62	51	-	-	8.35E-03	4.35E-03
HPRD	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	122	-	-	1.33E-02	1.04E-02
HPRD	BP	GO:0033627	cell adhesion mediated by integrin	-	87	75	-	-	3.74E-02	6.37E-03
HPRD	BP	GO:0035107	appendage morphogenesis	-	147	105	-	-	9.36E-03	8.92E-03
HPRD	BP	GO:1903707	negative regulation of hemopoiesis	-	116	82	-	-	5.40E-03	7.01E-03
HPRD	BP	GO:0036342	post-anal tail morphogenesis	-	19	13	-	-	3.16E-04	1.17E-03
HPRD	CC	GO:0048208	COPII vesicle coating	-	27	20	-	-	8.91E-02	1.70E-03
HPRD	BP	GO:0030149	sphingolipid catabolic process	-	32	14	-	-	7.84E-02	1.27E-03
HPRD	BP	GO:0050994	regulation of lipid catabolic process	-	61	45	-	-	1.48E-02	3.82E-03
HPRD	BP	GO:0035988	chondrocyte proliferation	-	24	19	-	-	4.16E-04	1.70E-03
HPRD	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	24	-	-	1.51E-02	2.12E-03
HPRD	BP	GO:0009593	detection of chemical stimulus	-	511	35	-	-	4.85E-03	2.97E-03
HPRD	BP	GO:0045727	positive regulation of translation	-	141	91	-	-	1.51E-02	7.75E-03
HPRD	BP	GO:0036315	cellular response to sterol	-	24	15	-	-	4.35E-03	1.27E-03
HPRD	CC	GO:0032388	positive regulation of intracellular transport	-	137	104	-	-	3.67E-03	8.92E-03
HPRD	BP	GO:0002027	regulation of heart rate	-	106	84	-	-	2.28E-02	7.22E-03
HPRD	BP	GO:0050879	multicellular organismal movement	-	118	83	-	-	1.00E-02	7.11E-03
HPRD	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	64	-	-	3.06E-03	5.52E-03
HPRD	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	48	-	-	7.71E-03	4.14E-03
HPRD	BP	GO:0048515	spermatid differentiation	-	208	100	-	-	1.62E-02	8.49E-03
HPRD	BP	GO:0072132	mesenchyme morphogenesis	-	57	49	-	-	2.11E-02	4.25E-03
HPRD	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	25	-	-	3.58E-03	2.12E-03
HPRD	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	26	-	-	9.17E-04	2.23E-03
HPRD	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	21	-	-	1.65E-01	1.80E-03
HPRD	BP	GO:0060119	inner ear receptor cell development	-	44	26	-	-	7.19E-02	2.23E-03
HPRD	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	14	-	-	7.15E-03	1.27E-03
HPRD	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	29	-	-	7.78E-02	2.55E-03
HPRD	BP	GO:1901983	regulation of protein acetylation	-	26	17	-	-	6.77E-04	1.49E-03
HPRD	BP	GO:0014854	response to inactivity	-	12	11	-	-	3.15E-04	9.56E-04
HPRD	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	220	-	-	1.43E-02	1.87E-02
HPRD	BP	GO:1900006	positive regulation of dendrite development	-	17	13	-	-	1.45E-03	1.17E-03
HPRD	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	39	-	-	1.07E-01	3.40E-03
HPRD	BP	GO:0010883	regulation of lipid storage	-	53	38	-	-	4.09E-03	3.29E-03
HPRD	BP	GO:0072170	metanephric tubule development	-	26	23	-	-	4.71E-03	2.02E-03
HPRD	BP	GO:0007635	chemosensory behavior	-	20	12	-	-	8.46E-03	1.06E-03
HPRD	BP	GO:1905954	positive regulation of lipid localization	-	110	76	-	-	1.50E-02	6.48E-03
HPRD	BP	GO:0002209	behavioral defense response	-	39	29	-	-	1.99E-03	2.55E-03
HPRD	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	20	-	-	1.75E-01	1.70E-03
HPRD	BP	GO:0072523	purine-containing compound catabolic process	-	146	94	-	-	1.94E-02	8.07E-03
HPRD	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	30	-	-	9.31E-03	2.55E-03
HPRD	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	21	-	-	1.27E-03	1.80E-03
HPRD	BP	GO:0021535	cell migration in hindbrain	-	16	13	-	-	3.14E-04	1.17E-03
HPRD	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	73	-	-	7.54E-03	6.26E-03
HPRD	BP	GO:0007218	neuropeptide signaling pathway	-	113	81	-	-	1.74E-01	6.90E-03
HPRD	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	1.84E-01	1.06E-03
HPRD	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	142	-	-	1.50E-02	1.21E-02
HPRD	BP	GO:0031345	negative regulation of cell projection organization	-	195	147	-	-	1.17E-02	1.25E-02
HPRD	BP	GO:0048278	vesicle docking	-	64	52	-	-	3.25E-02	4.46E-03
HPRD	BP	GO:0035050	embryonic heart tube development	-	86	59	-	-	1.25E-02	5.10E-03
HPRD	BP	GO:0030168	platelet activation	-	135	122	-	-	1.55E-02	1.04E-02
HPRD	CC	GO:0098810	neurotransmitter reuptake	-	35	25	-	-	7.06E-03	2.12E-03
HPRD	BP	GO:0008213	protein alkylation	-	58	28	-	-	1.49E-02	2.44E-03
HPRD	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	8.23E-03	1.17E-03
HPRD	BP	GO:0031338	regulation of vesicle fusion	-	24	22	-	-	5.04E-03	1.91E-03
HPRD	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	6.29E-03	1.17E-03
HPRD	BP	GO:0031529	ruffle organization	-	55	40	-	-	4.82E-03	3.40E-03
HPRD	BP	GO:0010842	retina layer formation	-	25	12	-	-	3.16E-04	1.06E-03
HPRD	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	62	-	-	3.48E-02	5.31E-03
HPRD	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	52	-	-	1.57E-02	4.46E-03
HPRD	MF	GO:0170055	lipid transmembrane transporter activity	-	56	25	-	-	1.47E-01	2.12E-03
HPRD	BP	GO:0035304	regulation of protein dephosphorylation	-	87	62	-	-	2.80E-03	5.31E-03
HPRD	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	177	-	-	2.15E-02	1.51E-02
HPRD	BP	GO:0099637	neurotransmitter receptor transport	-	26	18	-	-	1.14E-03	1.59E-03
HPRD	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	29	-	-	5.79E-03	2.55E-03
HPRD	BP	GO:0051775	response to redox state	-	13	11	-	-	9.21E-02	9.56E-04
HPRD	BP	GO:0051785	positive regulation of nuclear division	-	61	48	-	-	4.22E-03	4.14E-03
HPRD	BP	GO:0060456	positive regulation of digestive system process	-	16	12	-	-	4.14E-03	1.06E-03
HPRD	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	11	-	-	8.76E-02	9.56E-04
HPRD	BP	GO:0060749	mammary gland alveolus development	-	20	18	-	-	3.50E-03	1.59E-03
HPRD	BP	GO:0044786	cell cycle DNA replication	-	45	33	-	-	2.33E-02	2.87E-03
HPRD	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	14	-	-	3.02E-02	1.27E-03
HPRD	BP	GO:0044539	long-chain fatty acid import into cell	-	17	11	-	-	3.86E-03	9.56E-04
HPRD	BP	GO:0051299	centrosome separation	-	15	12	-	-	1.06E-02	1.06E-03
HPRD	BP	GO:0048145	regulation of fibroblast proliferation	-	87	72	-	-	7.34E-03	6.16E-03
HPRD	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	78	-	-	2.42E-01	6.69E-03
HPRD	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	190	-	-	8.41E-03	1.61E-02
HPRD	BP	GO:0032098	regulation of appetite	-	20	16	-	-	4.96E-02	1.38E-03
HPRD	BP	GO:0021819	layer formation in cerebral cortex	-	14	11	-	-	8.77E-03	9.56E-04
HPRD	CC	GO:0008333	endosome to lysosome transport	-	73	56	-	-	1.37E-01	4.78E-03
HPRD	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	17	-	-	1.63E-02	1.49E-03
HPRD	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	11	-	-	9.36E-03	9.56E-04
HPRD	BP	GO:0003016	respiratory system process	-	39	22	-	-	5.22E-04	1.91E-03
HPRD	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	19	-	-	1.26E-02	1.70E-03
HPRD	BP	GO:0045732	positive regulation of protein catabolic process	-	202	167	-	-	1.49E-02	1.42E-02
HPRD	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	34	-	-	2.44E-02	2.97E-03
HPRD	BP	GO:0007588	excretion	-	40	31	-	-	9.74E-03	2.65E-03
HPRD	BP	GO:1904018	positive regulation of vasculature development	-	185	127	-	-	8.92E-03	1.08E-02
HPRD	BP	GO:0010948	negative regulation of cell cycle process	-	317	221	-	-	4.16E-02	1.88E-02
HPRD	BP	GO:0050953	sensory perception of light stimulus	-	223	129	-	-	1.24E-01	1.10E-02
HPRD	BP	GO:0009164	nucleoside catabolic process	-	25	13	-	-	1.89E-01	1.17E-03
HPRD	BP	GO:0009303	rRNA transcription	-	37	33	-	-	6.50E-02	2.87E-03
HPRD	BP	GO:0035601	protein deacylation	-	56	39	-	-	9.47E-03	3.40E-03
HPRD	BP	GO:0061952	midbody abscission	-	18	16	-	-	2.42E-01	1.38E-03
HPRD	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	16	-	-	3.20E-03	1.38E-03
HPRD	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	27	-	-	1.22E-03	2.34E-03
HPRD	BP	GO:0071300	cellular response to retinoic acid	-	66	48	-	-	4.08E-03	4.14E-03
HPRD	BP	GO:0045830	positive regulation of isotype switching	-	28	21	-	-	3.02E-03	1.80E-03
HPRD	BP	GO:0031069	hair follicle morphogenesis	-	33	25	-	-	4.86E-03	2.12E-03
HPRD	BP	GO:0046697	decidualization	-	26	20	-	-	5.76E-03	1.70E-03
HPRD	BP	GO:0008212	mineralocorticoid metabolic process	-	14	12	-	-	1.10E-01	1.06E-03
HPRD	BP	GO:0051588	regulation of neurotransmitter transport	-	99	73	-	-	6.45E-03	6.26E-03
HPRD	BP	GO:0051784	negative regulation of nuclear division	-	63	49	-	-	6.58E-02	4.25E-03
HPRD	BP	GO:0044703	multi-organism reproductive process	-	209	164	-	-	8.88E-03	1.40E-02
HPRD	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	117	-	-	6.56E-03	9.98E-03
HPRD	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	41	-	-	4.83E-03	3.50E-03
HPRD	BP	GO:0099022	vesicle tethering	-	32	15	-	-	2.11E-01	1.27E-03
HPRD	MF	GO:0004930	G protein-coupled receptor activity	-	873	247	-	-	1.62E-02	2.10E-02
HPRD	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	22	-	-	2.01E-03	1.91E-03
HPRD	BP	GO:0048857	neural nucleus development	-	65	49	-	-	1.85E-03	4.25E-03
HPRD	BP	GO:0048663	neuron fate commitment	-	74	55	-	-	7.30E-03	4.67E-03
HPRD	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	104	-	-	1.52E-02	8.92E-03
HPRD	BP	GO:0106027	neuron projection organization	-	90	78	-	-	8.92E-03	6.69E-03
HPRD	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	108	-	-	2.31E-02	9.24E-03
HPRD	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	30	-	-	3.16E-03	2.55E-03
HPRD	BP	GO:0045685	regulation of glial cell differentiation	-	77	59	-	-	8.07E-03	5.10E-03
HPRD	BP	GO:0051608	histamine transport	-	14	11	-	-	6.92E-03	9.56E-04
HPRD	BP	GO:0043414	macromolecule methylation	-	138	57	-	-	1.96E-02	4.88E-03
HPRD	BP	GO:0048268	clathrin coat assembly	-	16	13	-	-	5.00E-02	1.17E-03
HPRD	BP	GO:0050886	endocrine process	-	93	78	-	-	3.47E-02	6.69E-03
HPRD	BP	GO:0050951	sensory perception of temperature stimulus	-	28	19	-	-	1.67E-02	1.70E-03
HPRD	BP	GO:0045807	positive regulation of endocytosis	-	155	127	-	-	1.71E-02	1.08E-02
HPRD	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	2.66E-02	9.56E-04
HPRD	BP	GO:0002418	immune response to tumor cell	-	29	20	-	-	3.74E-03	1.70E-03
HPRD	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	53	-	-	5.39E-03	4.57E-03
HPRD	BP	GO:0048308	organelle inheritance	-	14	14	-	-	1.19E-01	1.27E-03
HPRD	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	13	-	-	1.64E-03	1.17E-03
HPRD	BP	GO:0001829	trophectodermal cell differentiation	-	19	16	-	-	3.95E-02	1.38E-03
HPRD	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	12	-	-	3.17E-04	1.06E-03
HPRD	BP	GO:0034394	protein localization to cell surface	-	69	51	-	-	2.31E-03	4.35E-03
HPRD	BP	GO:0009110	vitamin biosynthetic process	-	23	13	-	-	9.71E-03	1.17E-03
HPRD	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	19	-	-	2.22E-02	1.70E-03
HPRD	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	14	-	-	1.64E-03	1.27E-03
HPRD	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	18	-	-	3.93E-03	1.59E-03
HPRD	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	84	-	-	3.70E-03	7.22E-03
HPRD	MF	GO:0051100	negative regulation of binding	-	161	133	-	-	6.40E-03	1.14E-02
HPRD	BP	GO:0001818	negative regulation of cytokine production	-	379	231	-	-	1.70E-02	1.96E-02
HPRD	BP	GO:0003151	outflow tract morphogenesis	-	81	72	-	-	1.87E-02	6.16E-03
HPRD	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	51	-	-	2.55E-02	4.35E-03
HPRD	BP	GO:0055093	response to hyperoxia	-	20	19	-	-	1.22E-03	1.70E-03
HPRD	BP	GO:0061036	positive regulation of cartilage development	-	33	26	-	-	8.76E-03	2.23E-03
HPRD	BP	GO:0046184	aldehyde biosynthetic process	-	16	12	-	-	4.94E-02	1.06E-03
HPRD	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	35	-	-	1.43E-03	2.97E-03
HPRD	BP	GO:0046621	negative regulation of organ growth	-	39	28	-	-	4.22E-02	2.44E-03
HPRD	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	45	-	-	1.41E-01	3.82E-03
HPRD	BP	GO:0032368	regulation of lipid transport	-	149	97	-	-	1.22E-02	8.28E-03
HPRD	BP	GO:0055094	response to lipoprotein particle	-	34	24	-	-	3.55E-03	2.12E-03
HPRD	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	147	-	-	8.00E-03	1.25E-02
HPRD	BP	GO:0033002	muscle cell proliferation	-	249	181	-	-	1.06E-02	1.54E-02
HPRD	BP	GO:0043331	response to dsRNA	-	56	36	-	-	6.98E-03	3.08E-03
HPRD	BP	GO:0033327	Leydig cell differentiation	-	12	11	-	-	1.04E-02	9.56E-04
HPRD	BP	GO:0051904	pigment granule transport	-	23	19	-	-	2.10E-02	1.70E-03
HPRD	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	31	-	-	1.51E-03	2.65E-03
HPRD	BP	GO:0033363	secretory granule organization	-	63	45	-	-	6.44E-02	3.82E-03
HPRD	BP	GO:0060479	lung cell differentiation	-	28	26	-	-	4.35E-03	2.23E-03
HPRD	BP	GO:0120009	intermembrane lipid transfer	-	52	27	-	-	6.99E-02	2.34E-03
HPRD	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	11	-	-	7.41E-02	9.56E-04
HPRD	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	35	-	-	2.20E-03	2.97E-03
HPRD	BP	GO:0033622	integrin activation	-	26	21	-	-	5.60E-02	1.80E-03
HPRD	BP	GO:0098751	bone cell development	-	18	12	-	-	1.73E-03	1.06E-03
HPRD	BP	GO:2000773	negative regulation of cellular senescence	-	25	20	-	-	3.87E-03	1.70E-03
HPRD	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	43	-	-	4.17E-03	3.72E-03
HPRD	BP	GO:0050820	positive regulation of coagulation	-	30	26	-	-	4.28E-02	2.23E-03
HPRD	BP	GO:0002076	osteoblast development	-	17	16	-	-	7.76E-03	1.38E-03
HPRD	BP	GO:0072164	mesonephric tubule development	-	98	79	-	-	8.24E-03	6.79E-03
HPRD	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	11	-	-	3.16E-04	9.56E-04
HPRD	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	86	-	-	8.15E-03	7.33E-03
HPRD	BP	GO:1903524	positive regulation of blood circulation	-	39	34	-	-	5.73E-03	2.97E-03
HPRD	BP	GO:0030901	midbrain development	-	87	66	-	-	2.03E-02	5.63E-03
HPRD	BP	GO:0048485	sympathetic nervous system development	-	22	21	-	-	7.02E-03	1.80E-03
HPRD	BP	GO:0007162	negative regulation of cell adhesion	-	310	227	-	-	1.21E-02	1.93E-02
HPRD	BP	GO:0048532	anatomical structure arrangement	-	16	15	-	-	8.12E-03	1.27E-03
HPRD	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	12	-	-	4.75E-03	1.06E-03
HPRD	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	56	-	-	4.84E-03	4.78E-03
HPRD	BP	GO:0002687	positive regulation of leukocyte migration	-	147	125	-	-	9.04E-03	1.06E-02
HPRD	BP	GO:0019755	one-carbon compound transport	-	28	15	-	-	2.10E-01	1.27E-03
HPRD	BP	GO:0060856	establishment of blood-brain barrier	-	16	11	-	-	3.14E-04	9.56E-04
HPRD	BP	GO:0110154	RNA decapping	-	19	11	-	-	1.64E-02	9.56E-04
HPRD	BP	GO:0034605	cellular response to heat	-	66	52	-	-	5.45E-03	4.46E-03
HPRD	BP	GO:0005996	monosaccharide metabolic process	-	250	159	-	-	2.86E-02	1.36E-02
HPRD	BP	GO:0033555	multicellular organismal response to stress	-	90	66	-	-	5.56E-03	5.63E-03
HPRD	BP	GO:0002262	myeloid cell homeostasis	-	172	132	-	-	7.46E-03	1.13E-02
HPRD	BP	GO:0000966	RNA 5'-end processing	-	39	29	-	-	2.97E-01	2.55E-03
HPRD	BP	GO:0050688	regulation of defense response to virus	-	65	49	-	-	4.64E-02	4.25E-03
HPRD	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	19	-	-	2.58E-03	1.70E-03
HPRD	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	205	-	-	2.91E-02	1.74E-02
HPRD	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	26	-	-	3.92E-03	2.23E-03
HPRD	BP	GO:0061029	eyelid development in camera-type eye	-	14	12	-	-	1.01E-03	1.06E-03
HPRD	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	27	-	-	1.33E-02	2.34E-03
HPRD	BP	GO:0003272	endocardial cushion formation	-	28	23	-	-	1.25E-02	2.02E-03
HPRD	BP	GO:0022618	protein-RNA complex assembly	-	227	145	-	-	7.88E-02	1.23E-02
HPRD	BP	GO:0051147	regulation of muscle cell differentiation	-	162	107	-	-	5.52E-03	9.13E-03
HPRD	BP	GO:0006066	alcohol metabolic process	-	374	196	-	-	4.09E-02	1.67E-02
HPRD	BP	GO:0090102	cochlea development	-	50	35	-	-	1.43E-03	2.97E-03
HPRD	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	25	-	-	2.54E-03	2.12E-03
HPRD	BP	GO:0045933	positive regulation of muscle contraction	-	49	44	-	-	5.95E-03	3.82E-03
HPRD	BP	GO:0002679	respiratory burst involved in defense response	-	16	12	-	-	3.14E-04	1.06E-03
HPRD	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	24	-	-	3.83E-03	2.12E-03
HPRD	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	53	-	-	8.58E-02	4.57E-03
HPRD	BP	GO:0043555	regulation of translation in response to stress	-	22	21	-	-	1.71E-02	1.80E-03
HPRD	BP	GO:0032922	circadian regulation of gene expression	-	71	60	-	-	4.68E-02	5.10E-03
HPRD	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	50	-	-	2.22E-02	4.25E-03
HPRD	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	53	-	-	1.03E-02	4.57E-03
HPRD	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	19	-	-	3.66E-02	1.70E-03
HPRD	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	46	-	-	8.31E-03	3.93E-03
HPRD	BP	GO:0038179	neurotrophin signaling pathway	-	38	36	-	-	4.30E-02	3.08E-03
HPRD	BP	GO:0140253	cell-cell fusion	-	62	46	-	-	7.95E-03	3.93E-03
HPRD	BP	GO:0071599	otic vesicle development	-	15	12	-	-	3.52E-02	1.06E-03
HPRD	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	36	-	-	9.08E-02	3.08E-03
HPRD	BP	GO:0061635	regulation of protein complex stability	-	14	11	-	-	3.15E-04	9.56E-04
HPRD	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	35	-	-	6.89E-03	2.97E-03
HPRD	BP	GO:0001941	postsynaptic membrane organization	-	37	30	-	-	6.34E-02	2.55E-03
HPRD	BP	GO:0051293	establishment of spindle localization	-	57	41	-	-	7.24E-03	3.50E-03
HPRD	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	5.86E-02	1.06E-03
HPRD	BP	GO:0043114	regulation of vascular permeability	-	49	38	-	-	1.05E-02	3.29E-03
HPRD	BP	GO:0018126	protein hydroxylation	-	26	14	-	-	5.61E-02	1.27E-03
HPRD	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	49	-	-	4.07E-03	4.25E-03
HPRD	BP	GO:0008360	regulation of cell shape	-	139	111	-	-	9.73E-03	9.45E-03
HPRD	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	12	-	-	1.14E-02	1.06E-03
HPRD	BP	GO:0051222	positive regulation of protein transport	-	249	194	-	-	7.58E-03	1.66E-02
HPRD	CC	GO:0140632	canonical inflammasome complex assembly	-	40	30	-	-	3.37E-02	2.55E-03
HPRD	MF	GO:0034260	negative regulation of GTPase activity	-	36	27	-	-	2.45E-03	2.34E-03
HPRD	BP	GO:0045932	negative regulation of muscle contraction	-	24	19	-	-	1.89E-02	1.70E-03
HPRD	BP	GO:0045739	positive regulation of DNA repair	-	128	93	-	-	2.49E-02	7.96E-03
HPRD	BP	GO:0001845	phagolysosome assembly	-	19	12	-	-	2.03E-02	1.06E-03
HPRD	BP	GO:0045185	maintenance of protein location	-	95	75	-	-	3.64E-03	6.37E-03
HPRD	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	12	-	-	1.51E-02	1.06E-03
HPRD	BP	GO:0003158	endothelium development	-	140	97	-	-	8.22E-03	8.28E-03
HPRD	CC	GO:0072595	maintenance of protein localization in organelle	-	42	34	-	-	2.18E-03	2.97E-03
HPRD	BP	GO:0051224	negative regulation of protein transport	-	122	83	-	-	9.12E-03	7.11E-03
HPRD	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	112	-	-	6.88E-03	9.56E-03
HPRD	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	1.40E-02	1.17E-03
HPRD	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	25	-	-	2.99E-02	2.12E-03
HPRD	MF	GO:0003713	transcription coactivator activity	-	281	233	-	-	1.36E-02	1.99E-02
HPRD	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	18	-	-	1.15E-01	1.59E-03
HPRD	BP	GO:0021885	forebrain cell migration	-	63	49	-	-	8.51E-03	4.25E-03
HPRD	BP	GO:0007405	neuroblast proliferation	-	81	64	-	-	4.75E-03	5.52E-03
HPRD	BP	GO:0009581	detection of external stimulus	-	137	84	-	-	1.30E-02	7.22E-03
HPRD	BP	GO:1990542	mitochondrial transmembrane transport	-	93	36	-	-	4.95E-02	3.08E-03
HPRD	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	26	-	-	1.43E-02	2.23E-03
HPRD	BP	GO:0097186	amelogenesis	-	26	13	-	-	3.16E-04	1.17E-03
HPRD	BP	GO:0031128	developmental induction	-	26	23	-	-	2.24E-03	2.02E-03
HPRD	BP	GO:0031100	animal organ regeneration	-	66	57	-	-	7.64E-03	4.88E-03
HPRD	BP	GO:0021533	cell differentiation in hindbrain	-	23	16	-	-	4.36E-03	1.38E-03
HPRD	BP	GO:0045684	positive regulation of epidermis development	-	33	23	-	-	7.97E-04	2.02E-03
HPRD	BP	GO:1900047	negative regulation of hemostasis	-	51	48	-	-	3.52E-02	4.14E-03
HPRD	BP	GO:0021517	ventral spinal cord development	-	47	35	-	-	6.52E-02	2.97E-03
HPRD	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	65	-	-	2.39E-02	5.52E-03
HPRD	BP	GO:0097722	sperm motility	-	133	47	-	-	7.40E-02	4.03E-03
HPRD	BP	GO:0051231	spindle elongation	-	14	12	-	-	1.49E-01	1.06E-03
HPRD	BP	GO:0042490	mechanoreceptor differentiation	-	67	43	-	-	8.76E-03	3.72E-03
HPRD	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	25	-	-	4.64E-02	2.12E-03
HPRD	BP	GO:0035148	tube formation	-	155	125	-	-	1.36E-02	1.06E-02
HPRD	BP	GO:0048520	positive regulation of behavior	-	27	22	-	-	1.19E-01	1.91E-03
HPRD	BP	GO:0098543	detection of other organism	-	19	12	-	-	3.48E-02	1.06E-03
HPRD	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	35	-	-	4.83E-02	2.97E-03
HPRD	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	90	-	-	2.45E-02	7.64E-03
HPRD	BP	GO:0031123	RNA 3'-end processing	-	79	48	-	-	5.83E-02	4.14E-03
HPRD	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	89	-	-	4.47E-03	7.64E-03
HPRD	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	14	-	-	1.77E-01	1.27E-03
HPRD	CC	GO:0007097	nuclear migration	-	24	18	-	-	7.06E-03	1.59E-03
HPRD	BP	GO:0045229	external encapsulating structure organization	-	319	208	-	-	3.62E-02	1.77E-02
HPRD	BP	GO:0006885	regulation of pH	-	104	55	-	-	1.68E-02	4.67E-03
HPRD	BP	GO:0002467	germinal center formation	-	14	11	-	-	3.03E-03	9.56E-04
HPRD	BP	GO:1990840	response to lectin	-	22	19	-	-	4.80E-03	1.70E-03
HPRD	BP	GO:0071800	podosome assembly	-	19	15	-	-	6.80E-03	1.27E-03
HPRD	BP	GO:0031018	endocrine pancreas development	-	47	39	-	-	6.06E-03	3.40E-03
HPRD	BP	GO:0001708	cell fate specification	-	108	82	-	-	4.40E-02	7.01E-03
HPRD	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	55	-	-	5.84E-03	4.67E-03
HPRD	BP	GO:0030279	negative regulation of ossification	-	39	32	-	-	9.51E-03	2.76E-03
HPRD	BP	GO:0042440	pigment metabolic process	-	80	40	-	-	1.35E-02	3.40E-03
HPRD	BP	GO:1901606	alpha-amino acid catabolic process	-	101	43	-	-	1.95E-02	3.72E-03
HPRD	BP	GO:0062197	cellular response to chemical stress	-	299	225	-	-	1.27E-02	1.91E-02
HPRD	BP	GO:1901890	positive regulation of cell junction assembly	-	106	80	-	-	1.56E-02	6.79E-03
HPRD	BP	GO:1901655	cellular response to ketone	-	107	86	-	-	1.44E-02	7.33E-03
HPRD	BP	GO:0051255	spindle midzone assembly	-	14	11	-	-	6.17E-02	9.56E-04
HPRD	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	12	-	-	7.17E-02	1.06E-03
HPRD	BP	GO:0006968	cellular defense response	-	52	44	-	-	1.26E-02	3.82E-03
HPRD	BP	GO:0055006	cardiac cell development	-	93	66	-	-	1.22E-02	5.63E-03
HPRD	BP	GO:0031365	N-terminal protein amino acid modification	-	30	16	-	-	4.59E-03	1.38E-03
HPRD	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	26	-	-	6.44E-03	2.23E-03
HPRD	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	1.63E-03	1.06E-03
HPRD	BP	GO:0060004	reflex	-	63	46	-	-	1.13E-02	3.93E-03
HPRD	BP	GO:0044706	multi-multicellular organism process	-	217	169	-	-	1.35E-02	1.44E-02
HPRD	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	9.05E-03	1.06E-03
HPRD	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	113	-	-	6.59E-03	9.66E-03
HPRD	BP	GO:0006026	aminoglycan catabolic process	-	34	12	-	-	1.99E-03	1.06E-03
HPRD	BP	GO:0031294	lymphocyte costimulation	-	47	41	-	-	1.16E-02	3.50E-03
HPRD	BP	GO:0050768	negative regulation of neurogenesis	-	150	118	-	-	5.92E-03	1.01E-02
HPRD	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	71	-	-	3.14E-03	6.05E-03
HPRD	BP	GO:0090068	positive regulation of cell cycle process	-	262	191	-	-	2.25E-02	1.62E-02
HPRD	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	22	-	-	2.74E-02	1.91E-03
HPRD	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	25	-	-	1.41E-01	2.12E-03
HPRD	BP	GO:1902115	regulation of organelle assembly	-	210	156	-	-	6.58E-03	1.33E-02
HPRD	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	57	-	-	1.10E-02	4.88E-03
HPRD	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	105	-	-	5.29E-03	8.92E-03
HPRD	BP	GO:0043171	peptide catabolic process	-	19	13	-	-	3.18E-04	1.17E-03
HPRD	BP	GO:0046622	positive regulation of organ growth	-	52	37	-	-	2.89E-03	3.19E-03
HPRD	BP	GO:0051952	regulation of amine transport	-	98	79	-	-	9.03E-03	6.79E-03
HPRD	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	15	-	-	1.11E-02	1.27E-03
HPRD	BP	GO:0040019	positive regulation of embryonic development	-	23	15	-	-	8.34E-03	1.27E-03
HPRD	BP	GO:0097154	GABAergic neuron differentiation	-	20	13	-	-	3.16E-04	1.17E-03
HPRD	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	14	-	-	3.14E-04	1.27E-03
HPRD	CC	GO:0032365	intracellular lipid transport	-	51	28	-	-	3.32E-02	2.44E-03
HPRD	BP	GO:0045048	protein insertion into ER membrane	-	30	15	-	-	2.09E-01	1.27E-03
HPRD	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	52	-	-	9.48E-03	4.46E-03
HPRD	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	85	-	-	1.86E-02	7.22E-03
HPRD	BP	GO:0018149	peptide cross-linking	-	28	21	-	-	6.34E-02	1.80E-03
HPRD	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	20	-	-	1.01E-03	1.70E-03
HPRD	BP	GO:0061000	negative regulation of dendritic spine development	-	13	11	-	-	3.14E-04	9.56E-04
HPRD	BP	GO:0071398	cellular response to fatty acid	-	35	25	-	-	1.02E-03	2.12E-03
HPRD	BP	GO:0097581	lamellipodium organization	-	91	74	-	-	3.17E-02	6.37E-03
HPRD	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	13	-	-	1.32E-01	1.17E-03
HPRD	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	125	-	-	3.11E-02	1.06E-02
HPRD	BP	GO:0060326	cell chemotaxis	-	311	243	-	-	2.60E-02	2.07E-02
HPRD	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	1.34E-01	1.59E-03
HPRD	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	13	-	-	6.85E-02	1.17E-03
HPRD	BP	GO:0015669	gas transport	-	23	14	-	-	1.56E-01	1.27E-03
HPRD	BP	GO:0016485	protein processing	-	248	175	-	-	2.34E-02	1.49E-02
HPRD	BP	GO:0009649	entrainment of circadian clock	-	30	22	-	-	1.67E-02	1.91E-03
HPRD	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	135	-	-	4.90E-02	1.15E-02
HPRD	BP	GO:1903523	negative regulation of blood circulation	-	27	21	-	-	4.01E-03	1.80E-03
HPRD	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	71	-	-	4.04E-02	6.05E-03
HPRD	BP	GO:0099054	presynapse assembly	-	49	32	-	-	4.47E-03	2.76E-03
HPRD	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	22	-	-	8.70E-03	1.91E-03
HPRD	BP	GO:0006517	protein deglycosylation	-	26	15	-	-	4.24E-04	1.27E-03
HPRD	BP	GO:0031348	negative regulation of defense response	-	282	187	-	-	1.00E-02	1.59E-02
HPRD	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	64	-	-	4.26E-03	5.52E-03
HPRD	BP	GO:0007606	sensory perception of chemical stimulus	-	535	43	-	-	4.50E-02	3.72E-03
HPRD	BP	GO:0061180	mammary gland epithelium development	-	68	59	-	-	3.98E-03	5.10E-03
HPRD	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	180	-	-	2.45E-02	1.53E-02
HPRD	BP	GO:0071496	cellular response to external stimulus	-	74	65	-	-	9.94E-03	5.52E-03
HPRD	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	11	-	-	3.16E-04	9.56E-04
HPRD	BP	GO:0042753	positive regulation of circadian rhythm	-	18	16	-	-	7.03E-02	1.38E-03
HPRD	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	3.07E-04	9.56E-04
HPRD	BP	GO:0032094	response to food	-	37	27	-	-	8.61E-03	2.34E-03
HPRD	BP	GO:0001964	startle response	-	27	21	-	-	4.53E-03	1.80E-03
HPRD	BP	GO:0007340	acrosome reaction	-	38	22	-	-	2.76E-02	1.91E-03
HPRD	BP	GO:0046434	organophosphate catabolic process	-	232	145	-	-	1.06E-02	1.23E-02
HPRD	BP	GO:0060037	pharyngeal system development	-	29	25	-	-	1.85E-02	2.12E-03
HPRD	BP	GO:0009566	fertilization	-	205	101	-	-	3.33E-02	8.60E-03
HPRD	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	16	-	-	1.34E-01	1.38E-03
HPRD	BP	GO:0120255	olefinic compound biosynthetic process	-	24	17	-	-	3.09E-02	1.49E-03
HPRD	BP	GO:0045907	positive regulation of vasoconstriction	-	30	24	-	-	2.22E-02	2.12E-03
HPRD	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	17	-	-	1.29E-02	1.49E-03
HPRD	BP	GO:0033044	regulation of chromosome organization	-	249	200	-	-	4.98E-02	1.70E-02
HPRD	BP	GO:0009309	amine biosynthetic process	-	38	23	-	-	1.09E-01	2.02E-03
HPRD	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	13	-	-	6.17E-03	1.17E-03
HPRD	BP	GO:0061900	glial cell activation	-	56	48	-	-	9.39E-03	4.14E-03
HPRD	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	111	-	-	1.87E-02	9.45E-03
HPRD	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	11	-	-	2.68E-02	9.56E-04
HPRD	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	13	-	-	8.14E-03	1.17E-03
HPRD	CC	GO:0140467	integrated stress response signaling	-	41	37	-	-	5.65E-02	3.19E-03
HPRD	BP	GO:0035902	response to immobilization stress	-	20	18	-	-	4.17E-04	1.59E-03
HPRD	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	185	-	-	3.71E-02	1.57E-02
HPRD	BP	GO:0035821	modulation of process of another organism	-	14	13	-	-	3.12E-04	1.17E-03
HPRD	BP	GO:0090235	regulation of metaphase plate congression	-	13	12	-	-	1.28E-01	1.06E-03
HPRD	BP	GO:0043647	inositol phosphate metabolic process	-	44	31	-	-	1.53E-02	2.65E-03
HPRD	BP	GO:0016180	snRNA processing	-	28	16	-	-	7.31E-02	1.38E-03
HPRD	BP	GO:0051303	establishment of chromosome localization	-	104	78	-	-	4.30E-02	6.69E-03
HPRD	BP	GO:0051382	kinetochore assembly	-	16	14	-	-	3.17E-04	1.27E-03
HPRD	BP	GO:0007164	establishment of tissue polarity	-	38	29	-	-	1.48E-02	2.55E-03
HPRD	BP	GO:0021515	cell differentiation in spinal cord	-	51	36	-	-	5.11E-02	3.08E-03
HPRD	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	16	-	-	3.43E-03	1.38E-03
HPRD	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	17	-	-	8.76E-03	1.49E-03
HPRD	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	23	-	-	1.03E-03	2.02E-03
HPRD	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	16	-	-	1.14E-03	1.38E-03
HPRD	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	25	-	-	1.71E-02	2.12E-03
HPRD	BP	GO:0006605	protein targeting	-	327	217	-	-	2.49E-02	1.85E-02
HPRD	BP	GO:0061318	renal filtration cell differentiation	-	22	16	-	-	1.10E-02	1.38E-03
HPRD	BP	GO:0007566	embryo implantation	-	57	42	-	-	5.35E-03	3.61E-03
HPRD	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	27	-	-	2.25E-03	2.34E-03
HPRD	BP	GO:0031268	pseudopodium organization	-	17	14	-	-	3.52E-02	1.27E-03
HPRD	BP	GO:0061512	protein localization to cilium	-	394	187	-	-	4.07E-02	1.59E-02
HPRD	BP	GO:0060306	regulation of membrane repolarization	-	38	26	-	-	9.58E-02	2.23E-03
HPRD	BP	GO:0051017	actin filament bundle assembly	-	161	125	-	-	7.11E-03	1.06E-02
HPRD	BP	GO:1905953	negative regulation of lipid localization	-	63	38	-	-	2.25E-03	3.29E-03
HPRD	BP	GO:0021542	dentate gyrus development	-	19	15	-	-	2.34E-03	1.27E-03
HPRD	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	27	-	-	4.76E-02	2.34E-03
HPRD	BP	GO:0021756	striatum development	-	21	16	-	-	3.92E-02	1.38E-03
HPRD	BP	GO:1901343	negative regulation of vasculature development	-	154	80	-	-	4.98E-03	6.79E-03
HPRD	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	104	-	-	2.31E-02	8.92E-03
HPRD	BP	GO:1902414	protein localization to cell junction	-	107	84	-	-	6.28E-03	7.22E-03
HPRD	BP	GO:0071305	cellular response to vitamin D	-	23	16	-	-	5.85E-02	1.38E-03
HPRD	BP	GO:0051304	chromosome separation	-	80	67	-	-	6.63E-02	5.73E-03
HPRD	BP	GO:0090596	sensory organ morphogenesis	-	272	191	-	-	1.03E-02	1.62E-02
HPRD	BP	GO:0045780	positive regulation of bone resorption	-	18	14	-	-	4.88E-03	1.27E-03
HPRD	BP	GO:0048709	oligodendrocyte differentiation	-	101	79	-	-	6.64E-03	6.79E-03
HPRD	BP	GO:0045017	glycerolipid biosynthetic process	-	254	141	-	-	2.69E-02	1.20E-02
HPRD	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	11	-	-	2.28E-02	9.56E-04
HPRD	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	19	-	-	4.42E-02	1.70E-03
HPRD	BP	GO:0001776	leukocyte homeostasis	-	108	83	-	-	4.75E-03	7.11E-03
HPRD	BP	GO:0050769	positive regulation of neurogenesis	-	240	196	-	-	9.09E-03	1.67E-02
HPRD	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	12	-	-	3.47E-01	1.06E-03
HPRD	BP	GO:0030193	regulation of blood coagulation	-	70	63	-	-	3.48E-02	5.41E-03
HPRD	BP	GO:0050866	negative regulation of cell activation	-	216	163	-	-	1.53E-02	1.39E-02
HPRD	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	26	-	-	4.73E-03	2.23E-03
HPRD	BP	GO:0033500	carbohydrate homeostasis	-	251	181	-	-	8.35E-03	1.54E-02
HPRD	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	28	-	-	1.29E-02	2.44E-03
HPRD	BP	GO:0044088	regulation of vacuole organization	-	56	40	-	-	9.53E-03	3.40E-03
HPRD	CC	GO:0051457	maintenance of protein location in nucleus	-	23	20	-	-	4.54E-03	1.70E-03
HPRD	CC	GO:0099522	cytosolic region	-	20	18	-	-	1.42E-03	1.59E-03
HPRD	CC	GO:0000791	euchromatin	-	60	45	-	-	5.45E-03	3.82E-03
HPRD	CC	GO:0030666	endocytic vesicle membrane	-	196	162	-	-	3.23E-02	1.38E-02
HPRD	CC	GO:0071027	nuclear RNA surveillance	-	14	12	-	-	6.95E-02	1.06E-03
HPRD	CC	GO:1990752	microtubule end	-	34	22	-	-	2.12E-02	1.91E-03
HPRD	CC	GO:0043204	perikaryon	-	156	111	-	-	8.59E-03	9.45E-03
HPRD	CC	GO:0061702	canonical inflammasome complex	-	17	12	-	-	3.10E-01	1.06E-03
HPRD	CC	GO:0097542	ciliary tip	-	48	28	-	-	4.49E-02	2.44E-03
HPRD	CC	GO:1905368	peptidase complex	-	124	101	-	-	7.39E-02	8.60E-03
HPRD	CC	GO:0000792	heterochromatin	-	98	77	-	-	3.04E-02	6.58E-03
HPRD	CC	GO:0097546	ciliary base	-	47	31	-	-	3.30E-03	2.65E-03
HPRD	CC	GO:0071819	DUBm complex	-	25	18	-	-	4.90E-02	1.59E-03
HPRD	CC	GO:0031201	SNARE complex	-	48	40	-	-	2.66E-01	3.40E-03
HPRD	CC	GO:0016324	apical plasma membrane	-	392	248	-	-	2.98E-02	2.11E-02
HPRD	CC	GO:0005677	chromatin silencing complex	-	13	12	-	-	1.01E-01	1.06E-03
HPRD	CC	GO:0033260	nuclear DNA replication	-	40	30	-	-	2.45E-02	2.55E-03
HPRD	CC	GO:0044391	ribosomal subunit	-	203	108	-	-	3.39E-02	9.24E-03
HPRD	CC	GO:0071013	catalytic step 2 spliceosome	-	88	69	-	-	3.62E-02	5.95E-03
HPRD	CC	GO:0031907	microbody lumen	-	51	28	-	-	8.31E-02	2.44E-03
HPRD	CC	GO:0098862	cluster of actin-based cell projections	-	162	101	-	-	2.78E-02	8.60E-03
HPRD	CC	GO:0016363	nuclear matrix	-	127	113	-	-	1.89E-02	9.66E-03
HPRD	CC	GO:0031261	DNA replication preinitiation complex	-	46	36	-	-	8.88E-02	3.08E-03
HPRD	CC	GO:0032432	actin filament bundle	-	249	179	-	-	1.40E-02	1.53E-02
HPRD	CC	GO:0008088	axo-dendritic transport	-	78	66	-	-	4.04E-02	5.63E-03
HPRD	CC	GO:0031519	PcG protein complex	-	38	27	-	-	5.52E-02	2.34E-03
HPRD	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	28	-	-	2.54E-01	2.44E-03
HPRD	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	180	-	-	3.69E-02	1.53E-02
HPRD	CC	GO:0000313	organellar ribosome	-	89	26	-	-	6.35E-04	2.23E-03
HPRD	CC	GO:0098791	Golgi apparatus subcompartment	-	378	213	-	-	5.14E-02	1.82E-02
HPRD	CC	GO:0099643	signal release from synapse	-	147	114	-	-	4.42E-02	9.77E-03
HPRD	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	30	-	-	5.37E-02	2.55E-03
HPRD	CC	GO:0030018	Z disc	-	129	108	-	-	4.47E-02	9.24E-03
HPRD	CC	GO:0032580	Golgi cisterna membrane	-	93	29	-	-	5.31E-03	2.55E-03
HPRD	CC	GO:0097381	photoreceptor disc membrane	-	25	16	-	-	2.18E-01	1.38E-03
HPRD	CC	GO:1905360	GTPase complex	-	41	35	-	-	1.09E-01	2.97E-03
HPRD	CC	GO:0097540	axonemal central pair	-	161	66	-	-	6.81E-03	5.63E-03
HPRD	CC	GO:0042641	actomyosin	-	77	61	-	-	2.98E-02	5.20E-03
HPRD	CC	GO:0097386	glial cell projection	-	38	26	-	-	4.58E-03	2.23E-03
HPRD	CC	GO:0032588	trans-Golgi network membrane	-	102	62	-	-	1.03E-01	5.31E-03
HPRD	CC	GO:0070382	exocytic vesicle	-	224	163	-	-	2.65E-02	1.39E-02
HPRD	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	22	-	-	2.41E-02	1.91E-03
HPRD	CC	GO:0031903	microbody membrane	-	65	46	-	-	2.04E-01	3.93E-03
HPRD	CC	GO:0046930	pore complex	-	26	21	-	-	1.48E-01	1.80E-03
HPRD	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	2.12E-02	9.56E-04
HPRD	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	12	-	-	1.92E-03	1.06E-03
HPRD	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	175	-	-	3.92E-02	1.49E-02
HPRD	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	13	-	-	3.16E-04	1.17E-03
HPRD	CC	GO:0099571	postsynaptic cytoskeleton	-	18	11	-	-	1.55E-02	9.56E-04
HPRD	CC	GO:0044298	cell body membrane	-	32	24	-	-	5.25E-04	2.12E-03
HPRD	CC	GO:0051882	mitochondrial depolarization	-	21	16	-	-	1.34E-03	1.38E-03
HPRD	CC	GO:0070993	translation preinitiation complex	-	19	17	-	-	4.22E-01	1.49E-03
HPRD	CC	GO:0010369	chromocenter	-	14	13	-	-	3.21E-02	1.17E-03
HPRD	CC	GO:0016323	basolateral plasma membrane	-	239	146	-	-	1.70E-02	1.24E-02
HPRD	CC	GO:0045009	chitosome	-	21	12	-	-	6.70E-02	1.06E-03
HPRD	CC	GO:0042405	nuclear inclusion body	-	12	11	-	-	5.20E-03	9.56E-04
HPRD	CC	GO:0042645	mitochondrial nucleoid	-	45	29	-	-	1.09E-01	2.55E-03
HPRD	CC	GO:1902495	transmembrane transporter complex	-	408	232	-	-	1.03E-01	1.97E-02
HPRD	CC	GO:0098636	protein complex involved in cell adhesion	-	57	50	-	-	4.37E-02	4.25E-03
HPRD	CC	GO:0001917	photoreceptor inner segment	-	71	42	-	-	3.26E-02	3.61E-03
HPRD	CC	GO:0098845	postsynaptic endosome	-	14	11	-	-	1.43E-03	9.56E-04
HPRD	CC	GO:0019897	extrinsic component of plasma membrane	-	156	128	-	-	3.53E-02	1.09E-02
HPRD	CC	GO:0031594	neuromuscular junction	-	73	64	-	-	1.32E-02	5.52E-03
HPRD	CC	GO:0000793	condensed chromosome	-	274	205	-	-	6.06E-02	1.74E-02
HPRD	CC	GO:0043083	synaptic cleft	-	21	14	-	-	1.03E-02	1.27E-03
HPRD	CC	GO:0000922	spindle pole	-	172	121	-	-	7.38E-03	1.03E-02
HPRD	CC	GO:0120111	neuron projection cytoplasm	-	94	79	-	-	2.28E-02	6.79E-03
HPRD	CC	GO:0070971	endoplasmic reticulum exit site	-	32	18	-	-	1.11E-01	1.59E-03
HPRD	CC	GO:0005736	RNA polymerase I complex	-	13	11	-	-	3.41E-01	9.56E-04
HPRD	CC	GO:0004879	nuclear receptor activity	-	63	55	-	-	1.77E-02	4.67E-03
HPRD	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	142	-	-	1.87E-02	1.21E-02
HPRD	CC	GO:0000123	histone acetyltransferase complex	-	93	62	-	-	4.28E-02	5.31E-03
HPRD	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	43	-	-	6.79E-02	3.72E-03
HPRD	CC	GO:0048786	presynaptic active zone	-	80	67	-	-	2.63E-02	5.73E-03
HPRD	CC	GO:0007034	vacuolar transport	-	168	121	-	-	8.49E-02	1.03E-02
HPRD	CC	GO:0090741	pigment granule membrane	-	21	12	-	-	3.17E-04	1.06E-03
HPRD	CC	GO:0043194	axon initial segment	-	21	18	-	-	2.76E-02	1.59E-03
HPRD	CC	GO:0005776	autophagosome	-	111	72	-	-	2.91E-02	6.16E-03
HPRD	CC	GO:0031430	M band	-	22	14	-	-	4.55E-02	1.27E-03
HPRD	CC	GO:0001931	uropod	-	13	12	-	-	3.07E-02	1.06E-03
HPRD	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	67	-	-	3.21E-01	5.73E-03
HPRD	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	38	-	-	7.20E-02	3.29E-03
HPRD	CC	GO:0030677	ribonuclease P complex	-	14	11	-	-	9.00E-01	9.56E-04
HPRD	CC	GO:0000164	protein phosphatase type 1 complex	-	19	14	-	-	3.35E-02	1.27E-03
HPRD	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	23	-	-	5.69E-02	2.02E-03
HPRD	CC	GO:0032994	protein-lipid complex	-	39	32	-	-	1.71E-01	2.76E-03
HPRD	CC	GO:0150034	distal axon	-	309	249	-	-	1.06E-02	2.12E-02
HPRD	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	112	-	-	5.04E-02	9.56E-03
HPRD	CC	GO:0072562	blood microparticle	-	144	101	-	-	5.41E-02	8.60E-03
HPRD	CC	GO:0005883	neurofilament	-	11	11	-	-	9.82E-03	9.56E-04
HPRD	CC	GO:0051233	spindle midzone	-	36	29	-	-	1.28E-02	2.55E-03
HPRD	CC	GO:0005811	lipid droplet	-	102	46	-	-	2.61E-02	3.93E-03
HPRD	CC	GO:0045022	early endosome to late endosome transport	-	44	32	-	-	1.67E-02	2.76E-03
HPRD	CC	GO:0043113	receptor clustering	-	51	44	-	-	1.07E-02	3.82E-03
HPRD	CC	GO:0044853	plasma membrane raft	-	114	96	-	-	8.24E-03	8.17E-03
HPRD	CC	GO:0005881	cytoplasmic microtubule	-	256	116	-	-	8.05E-03	9.87E-03
HPRD	CC	GO:0008180	COP9 signalosome	-	17	14	-	-	5.28E-02	1.27E-03
HPRD	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	42	-	-	1.88E-01	3.61E-03
HPRD	CC	GO:0005905	clathrin-coated pit	-	73	63	-	-	2.66E-02	5.41E-03
HPRD	CC	GO:0043034	costamere	-	18	16	-	-	9.37E-03	1.38E-03
HPRD	CC	GO:0031904	endosome lumen	-	38	31	-	-	2.41E-02	2.65E-03
HPRD	CC	GO:0060170	ciliary membrane	-	76	38	-	-	3.50E-02	3.29E-03
HPRD	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	11	-	-	5.67E-01	9.56E-04
HPRD	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	18	-	-	2.89E-01	1.59E-03
HPRD	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	14	-	-	4.86E-01	1.27E-03
HPRD	CC	GO:0032154	cleavage furrow	-	54	39	-	-	1.33E-02	3.40E-03
HPRD	CC	GO:0005640	nuclear outer membrane	-	30	20	-	-	1.03E-02	1.70E-03
HPRD	CC	GO:0007006	mitochondrial membrane organization	-	117	73	-	-	5.39E-02	6.26E-03
HPRD	CC	GO:0001772	immunological synapse	-	44	37	-	-	6.98E-03	3.19E-03
HPRD	CC	GO:0030863	cortical cytoskeleton	-	104	83	-	-	1.61E-02	7.11E-03
HPRD	CC	GO:1905348	endonuclease complex	-	38	28	-	-	4.80E-01	2.44E-03
HPRD	CC	GO:0030315	T-tubule	-	52	38	-	-	1.92E-02	3.29E-03
HPRD	CC	GO:0060076	excitatory synapse	-	64	47	-	-	1.08E-02	4.03E-03
HPRD	CC	GO:0036019	endolysosome	-	29	21	-	-	3.20E-02	1.80E-03
HPRD	CC	GO:0001891	phagocytic cup	-	28	20	-	-	7.20E-03	1.70E-03
HPRD	CC	GO:0099086	synaptonemal structure	-	40	20	-	-	6.93E-02	1.70E-03
HPRD	CC	GO:0030427	site of polarized growth	-	172	139	-	-	6.31E-03	1.19E-02
HPRD	CC	GO:0044309	neuron spine	-	213	180	-	-	1.34E-02	1.53E-02
HPRD	CC	GO:0030658	transport vesicle membrane	-	231	167	-	-	4.47E-02	1.42E-02
HPRD	CC	GO:0098918	structural constituent of synapse	-	27	20	-	-	1.09E-02	1.70E-03
HPRD	CC	GO:0000940	outer kinetochore	-	17	14	-	-	4.63E-02	1.27E-03
HPRD	CC	GO:0034719	SMN-Sm protein complex	-	18	15	-	-	3.63E-01	1.27E-03
HPRD	CC	GO:0044232	organelle membrane contact site	-	50	20	-	-	2.17E-02	1.70E-03
HPRD	CC	GO:0098803	respiratory chain complex	-	39	13	-	-	1.93E-01	1.17E-03
HPRD	CC	GO:0030667	secretory granule membrane	-	319	206	-	-	1.22E-02	1.75E-02
HPRD	CC	GO:0097545	axonemal outer doublet	-	164	67	-	-	5.42E-03	5.73E-03
HPRD	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	11	-	-	3.61E-03	9.56E-04
HPRD	CC	GO:0070069	cytochrome complex	-	42	13	-	-	6.70E-02	1.17E-03
HPRD	CC	GO:0031143	pseudopodium	-	18	17	-	-	1.29E-02	1.49E-03
HPRD	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	22	-	-	3.34E-02	1.91E-03
HPRD	CC	GO:0055037	recycling endosome	-	200	133	-	-	3.26E-02	1.14E-02
HPRD	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	82	-	-	6.81E-03	7.01E-03
HPRD	CC	GO:0071682	endocytic vesicle lumen	-	23	19	-	-	1.75E-02	1.70E-03
HPRD	CC	GO:0030684	preribosome	-	76	40	-	-	2.69E-02	3.40E-03
HPRD	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	17	-	-	2.10E-01	1.49E-03
HPRD	CC	GO:1990391	DNA repair complex	-	22	21	-	-	1.02E-01	1.80E-03
HPRD	CC	GO:0005775	vacuolar lumen	-	176	120	-	-	3.01E-02	1.02E-02
HPRD	CC	GO:0032433	filopodium tip	-	19	15	-	-	8.94E-03	1.27E-03
HPRD	CC	GO:0032982	myosin filament	-	24	19	-	-	1.65E-01	1.70E-03
HPRD	CC	GO:0016327	apicolateral plasma membrane	-	23	19	-	-	2.79E-02	1.70E-03
HPRD	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	12	-	-	3.51E-01	1.06E-03
HPRD	CC	GO:0044306	neuron projection terminus	-	164	133	-	-	1.08E-02	1.14E-02
HPRD	CC	GO:0034455	t-UTP complex	-	53	30	-	-	9.69E-02	2.55E-03
HPRD	CC	GO:0005770	late endosome	-	299	179	-	-	4.08E-02	1.53E-02
HPRD	CC	GO:0031970	organelle envelope lumen	-	94	52	-	-	7.61E-03	4.46E-03
HPRD	CC	GO:0019866	organelle inner membrane	-	546	191	-	-	2.58E-02	1.62E-02
HPRD	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	20	-	-	9.53E-03	1.70E-03
HPRD	CC	GO:0043292	contractile muscle fiber	-	245	191	-	-	6.27E-02	1.62E-02
HPRD	CC	GO:0034709	methylosome	-	13	12	-	-	1.14E-01	1.06E-03
HPRD	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	11	-	-	1.81E-02	9.56E-04
HPRD	CC	GO:0005849	mRNA cleavage factor complex	-	22	14	-	-	2.04E-01	1.27E-03
HPRD	CC	GO:0000803	sex chromosome	-	32	19	-	-	1.44E-02	1.70E-03
HPRD	CC	GO:0098982	GABA-ergic synapse	-	84	59	-	-	1.11E-02	5.10E-03
HPRD	CC	GO:0035097	histone methyltransferase complex	-	63	46	-	-	6.80E-02	3.93E-03
HPRD	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	13	-	-	2.62E-01	1.17E-03
HPRD	CC	GO:0000242	pericentriolar material	-	22	16	-	-	2.95E-02	1.38E-03
HPRD	CC	GO:1903293	phosphatase complex	-	54	42	-	-	3.82E-02	3.61E-03
HPRD	CC	GO:0097470	ribbon synapse	-	13	12	-	-	3.13E-03	1.06E-03
HPRD	CC	GO:0031941	filamentous actin	-	27	20	-	-	5.14E-02	1.70E-03
HPRD	CC	GO:0000786	nucleosome	-	149	72	-	-	1.90E-02	6.16E-03
HPRD	CC	GO:0001533	cornified envelope	-	59	41	-	-	2.83E-01	3.50E-03
HPRD	CC	GO:1904724	tertiary granule lumen	-	55	41	-	-	1.32E-02	3.50E-03
HPRD	CC	GO:0030027	lamellipodium	-	202	175	-	-	2.65E-02	1.49E-02
HPRD	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	11	-	-	2.28E-02	9.56E-04
HPRD	CC	GO:0060077	inhibitory synapse	-	20	12	-	-	1.46E-02	1.06E-03
HPRD	CC	GO:0031209	SCAR complex	-	12	11	-	-	2.87E-01	9.56E-04
HPRD	CC	GO:0001056	RNA polymerase III activity	-	16	14	-	-	4.47E-01	1.27E-03
HPRD	CC	GO:0002102	podosome	-	31	24	-	-	8.25E-03	2.12E-03
HPRD	CC	GO:0090543	Flemming body	-	33	25	-	-	2.18E-02	2.12E-03
HPRD	CC	GO:0016328	lateral plasma membrane	-	66	55	-	-	1.09E-02	4.67E-03
HPRD	CC	GO:0001650	fibrillar center	-	151	119	-	-	4.97E-03	1.02E-02
HPRD	CC	GO:0031332	RNAi effector complex	-	413	12	-	-	2.75E-01	1.06E-03
HPRD	CC	GO:1990204	oxidoreductase complex	-	90	47	-	-	1.26E-01	4.03E-03
HPRD	CC	GO:0000930	gamma-tubulin complex	-	16	11	-	-	3.37E-02	9.56E-04
HPRD	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	103	-	-	7.55E-03	8.81E-03
HPRD	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	11	-	-	1.34E-01	9.56E-04
HPRD	CC	GO:0001726	ruffle	-	181	146	-	-	1.62E-02	1.24E-02
HPRD	CC	GO:1990909	Wnt signalosome	-	13	11	-	-	3.36E-02	9.56E-04
HPRD	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	15	-	-	3.02E-01	1.27E-03
HPRD	CC	GO:0043198	dendritic shaft	-	38	32	-	-	2.68E-03	2.76E-03
HPRD	CC	GO:0043073	germ cell nucleus	-	67	45	-	-	6.18E-03	3.82E-03
HPRD	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	13	-	-	5.89E-02	1.17E-03
HPRD	CC	GO:0005788	endoplasmic reticulum lumen	-	313	222	-	-	2.35E-02	1.89E-02
HPRD	CC	GO:0016592	mediator complex	-	38	35	-	-	4.10E-01	2.97E-03
HPRD	CC	GO:0034045	phagophore assembly site membrane	-	19	12	-	-	1.41E-01	1.06E-03
HPRD	CC	GO:0022626	cytosolic ribosome	-	118	85	-	-	3.51E-02	7.22E-03
HPRD	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	34	-	-	1.63E-01	2.97E-03
HPRD	CC	GO:0034451	centriolar satellite	-	120	80	-	-	3.46E-03	6.79E-03
HPRD	CC	GO:0045171	intercellular bridge	-	91	61	-	-	1.90E-02	5.20E-03
HPRD	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	47	-	-	4.96E-02	4.03E-03
HPRD	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	6.23E-02	9.56E-04
HPRD	CC	GO:0098691	dopaminergic synapse	-	15	11	-	-	1.21E-02	9.56E-04
HPRD	CC	GO:0033268	node of Ranvier	-	16	14	-	-	1.15E-01	1.27E-03
HPRD	CC	GO:0030527	structural constituent of chromatin	-	97	37	-	-	2.28E-03	3.19E-03
HPRD	CC	GO:0036379	myofilament	-	26	19	-	-	2.43E-01	1.70E-03
HPRD	CC	GO:0030286	dynein complex	-	210	90	-	-	1.30E-02	7.64E-03
HPRD	CC	GO:0097228	sperm principal piece	-	33	13	-	-	6.47E-02	1.17E-03
HPRD	CC	GO:0044615	nuclear pore nuclear basket	-	12	11	-	-	7.73E-02	9.56E-04
HPRD	CC	GO:0016482	cytosolic transport	-	135	79	-	-	3.73E-02	6.79E-03
HPRD	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	4.10E-01	2.02E-03
HPRD	CC	GO:0005796	Golgi lumen	-	106	79	-	-	1.27E-02	6.79E-03
HPRD	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	27	-	-	1.94E-01	2.34E-03
HPRD	CC	GO:0034358	plasma lipoprotein particle	-	36	29	-	-	1.72E-01	2.55E-03
HPRD	CC	GO:0008023	transcription elongation factor complex	-	47	37	-	-	4.88E-02	3.19E-03
HPRD	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	14	-	-	3.15E-04	1.27E-03
HPRD	CC	GO:0030662	coated vesicle membrane	-	202	166	-	-	8.99E-02	1.41E-02
HPRD	CC	GO:0007039	protein catabolic process in the vacuole	-	61	44	-	-	1.50E-01	3.82E-03
HPRD	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	25	-	-	4.71E-02	2.12E-03
HPRD	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	239	-	-	9.37E-02	2.04E-02
HPRD	CC	GO:0090734	site of DNA damage	-	118	76	-	-	1.75E-02	6.48E-03
HPRD	MF	GO:0051861	glycolipid binding	-	30	21	-	-	1.95E-02	1.80E-03
HPRD	MF	GO:0051087	protein-folding chaperone binding	-	135	102	-	-	1.09E-02	8.71E-03
HPRD	MF	GO:0051959	dynein light intermediate chain binding	-	27	12	-	-	1.02E-02	1.06E-03
HPRD	CC	GO:0015464	acetylcholine receptor activity	-	21	18	-	-	2.76E-01	1.59E-03
HPRD	MF	GO:0031681	G-protein beta-subunit binding	-	22	19	-	-	4.22E-04	1.70E-03
HPRD	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	22	-	-	5.18E-04	1.91E-03
HPRD	MF	GO:0035613	RNA stem-loop binding	-	21	11	-	-	3.17E-04	9.56E-04
HPRD	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	101	-	-	1.80E-02	8.60E-03
HPRD	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	16	-	-	4.14E-03	1.38E-03
HPRD	MF	GO:0033691	sialic acid binding	-	22	19	-	-	3.58E-03	1.70E-03
HPRD	MF	GO:0016757	glycosyltransferase activity	-	286	103	-	-	1.62E-02	8.81E-03
HPRD	MF	GO:0048306	calcium-dependent protein binding	-	61	54	-	-	1.81E-02	4.67E-03
HPRD	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	14	-	-	1.74E-02	1.27E-03
HPRD	MF	GO:0035325	Toll-like receptor binding	-	13	12	-	-	5.81E-02	1.06E-03
HPRD	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	77	-	-	1.06E-02	6.58E-03
HPRD	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	34	-	-	3.74E-02	2.97E-03
HPRD	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	65	-	-	3.39E-02	5.52E-03
HPRD	MF	GO:0051020	GTPase binding	-	311	245	-	-	1.52E-02	2.08E-02
HPRD	MF	GO:0140457	protein demethylase activity	-	31	14	-	-	3.18E-04	1.27E-03
HPRD	MF	GO:0005158	insulin receptor binding	-	22	21	-	-	1.03E-02	1.80E-03
HPRD	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	3.99E-03	1.27E-03
HPRD	MF	GO:0061980	regulatory RNA binding	-	52	33	-	-	1.15E-01	2.87E-03
HPRD	MF	GO:0015035	protein-disulfide reductase activity	-	32	21	-	-	7.34E-02	1.80E-03
HPRD	MF	GO:0001671	ATPase activator activity	-	29	24	-	-	5.23E-04	2.12E-03
HPRD	MF	GO:0070840	dynein complex binding	-	25	17	-	-	4.31E-03	1.49E-03
HPRD	MF	GO:0035035	histone acetyltransferase binding	-	24	21	-	-	3.01E-03	1.80E-03
HPRD	MF	GO:0061684	chaperone-mediated autophagy	-	16	14	-	-	3.29E-03	1.27E-03
HPRD	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	20	-	-	1.78E-02	1.70E-03
HPRD	MF	GO:0003688	DNA replication origin binding	-	18	17	-	-	2.35E-01	1.49E-03
HPRD	MF	GO:0005178	integrin binding	-	153	136	-	-	4.27E-02	1.16E-02
HPRD	MF	GO:0070064	proline-rich region binding	-	17	16	-	-	2.62E-03	1.38E-03
HPRD	MF	GO:0042043	neurexin family protein binding	-	14	12	-	-	3.16E-04	1.06E-03
HPRD	MF	GO:0008327	methyl-CpG binding	-	31	19	-	-	7.74E-02	1.70E-03
HPRD	MF	GO:0031418	L-ascorbic acid binding	-	20	11	-	-	3.18E-04	9.56E-04
HPRD	MF	GO:0048019	receptor antagonist activity	-	31	13	-	-	3.16E-04	1.17E-03
HPRD	MF	GO:0005521	lamin binding	-	15	13	-	-	7.57E-03	1.17E-03
HPRD	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	18	-	-	4.73E-03	1.59E-03
HPRD	MF	GO:0140318	protein transporter activity	-	40	28	-	-	1.75E-01	2.44E-03
HPRD	MF	GO:0070628	proteasome binding	-	17	13	-	-	4.62E-02	1.17E-03
HPRD	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	8.53E-03	9.56E-04
HPRD	MF	GO:0031432	titin binding	-	13	13	-	-	6.61E-03	1.17E-03
HPRD	MF	GO:0000217	DNA secondary structure binding	-	37	29	-	-	1.24E-02	2.55E-03
HPRD	MF	GO:0002039	p53 binding	-	66	60	-	-	5.98E-03	5.10E-03
HPRD	MF	GO:0005496	steroid binding	-	110	63	-	-	2.92E-02	5.41E-03
HPRD	MF	GO:0008443	phosphofructokinase activity	-	27	20	-	-	9.73E-03	1.70E-03
HPRD	MF	GO:0003684	damaged DNA binding	-	89	76	-	-	8.21E-02	6.48E-03
HPRD	MF	GO:0000339	RNA cap binding	-	20	15	-	-	2.60E-02	1.27E-03
HPRD	MF	GO:0016500	protein-hormone receptor activity	-	21	15	-	-	1.57E-02	1.27E-03
HPRD	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	103	-	-	3.20E-02	8.81E-03
HPRD	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	4.38E-03	9.56E-04
HPRD	MF	GO:0070063	RNA polymerase binding	-	61	47	-	-	1.04E-02	4.03E-03
HPRD	MF	GO:0008179	adenylate cyclase binding	-	11	11	-	-	3.44E-02	9.56E-04
HPRD	MF	GO:0050811	GABA receptor binding	-	18	13	-	-	2.41E-02	1.17E-03
HPRD	MF	GO:0030971	receptor tyrosine kinase binding	-	76	68	-	-	5.92E-03	5.84E-03
HPRD	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	60	-	-	1.54E-01	5.10E-03
HPRD	MF	GO:0140030	modification-dependent protein binding	-	179	124	-	-	1.15E-02	1.06E-02
HPRD	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	11	-	-	3.18E-04	9.56E-04
HPRD	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	2.54E-03	1.17E-03
HPRD	MF	GO:0042813	Wnt receptor activity	-	16	14	-	-	3.91E-02	1.27E-03
HPRD	MF	GO:0141047	molecular tag activity	-	13	12	-	-	3.12E-04	1.06E-03
HPRD	MF	GO:1990226	histone methyltransferase binding	-	15	12	-	-	5.33E-03	1.06E-03
HPRD	MF	GO:0035497	cAMP response element binding	-	12	11	-	-	1.20E-01	9.56E-04
HPRD	MF	GO:0044548	S100 protein binding	-	14	14	-	-	7.10E-02	1.27E-03
HPRD	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	3.77E-03	1.27E-03
HPRD	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.89E-01	1.27E-03
HPRD	MF	GO:0030276	clathrin binding	-	70	58	-	-	9.17E-02	4.99E-03
HPRD	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	9.17E-03	2.55E-03
HPRD	MF	GO:0140311	protein sequestering activity	-	14	12	-	-	3.10E-04	1.06E-03
HPRD	MF	GO:0046790	virion binding	-	19	17	-	-	4.18E-04	1.49E-03
HPRD	MF	GO:0030552	cAMP binding	-	48	39	-	-	5.76E-02	3.40E-03
HPRD	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	31	-	-	2.17E-03	2.65E-03
HPRD	MF	GO:0035173	histone kinase activity	-	17	15	-	-	4.06E-04	1.27E-03
HPRD	MF	GO:0097602	cullin family protein binding	-	26	13	-	-	2.57E-03	1.17E-03
HPRD	MF	GO:0017154	semaphorin receptor activity	-	12	11	-	-	1.66E-02	9.56E-04
HPRD	MF	GO:0016209	antioxidant activity	-	92	59	-	-	6.33E-02	5.10E-03
HPRD	MF	GO:0070325	lipoprotein particle receptor binding	-	32	28	-	-	6.44E-03	2.44E-03
HPRD	MF	GO:0044325	transmembrane transporter binding	-	159	127	-	-	8.18E-03	1.08E-02
HPRD	MF	GO:0048156	tau protein binding	-	43	41	-	-	4.86E-03	3.50E-03
HPRD	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	25	-	-	7.15E-03	2.12E-03
HPRD	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	4.98E-03	1.17E-03
HPRD	MF	GO:0140272	exogenous protein binding	-	79	67	-	-	6.05E-03	5.73E-03
HPRD	MF	GO:0030145	manganese ion binding	-	65	31	-	-	8.75E-03	2.65E-03
HPRD	MF	GO:0071814	protein-lipid complex binding	-	52	40	-	-	2.39E-02	3.40E-03
HPRD	MF	GO:0008066	glutamate receptor activity	-	70	54	-	-	3.70E-02	4.67E-03
HPRD	MF	GO:0017069	snRNA binding	-	54	36	-	-	1.86E-02	3.08E-03
HPRD	MF	GO:0030215	semaphorin receptor binding	-	23	16	-	-	3.41E-02	1.38E-03
HPRD	MF	GO:0031996	thioesterase binding	-	11	11	-	-	2.57E-03	9.56E-04
HPRD	MF	GO:0031369	translation initiation factor binding	-	32	26	-	-	4.21E-02	2.23E-03
HPRD	MF	GO:0019843	rRNA binding	-	69	39	-	-	2.07E-03	3.40E-03
HPRD	MF	GO:0004713	protein tyrosine kinase activity	-	213	188	-	-	2.53E-02	1.60E-02
HPRD	MF	GO:0016779	nucleotidyltransferase activity	-	264	179	-	-	4.84E-02	1.53E-02
HPRD	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	50	-	-	6.84E-03	4.25E-03
HPRD	MF	GO:0008093	cytoskeletal anchor activity	-	24	19	-	-	4.28E-03	1.70E-03
HPRD	MF	GO:0070300	phosphatidic acid binding	-	20	12	-	-	3.17E-04	1.06E-03
HPRD	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	18	-	-	2.45E-03	1.59E-03
HPRD	MF	GO:0016208	AMP binding	-	22	15	-	-	1.94E-01	1.27E-03
HPRD	MF	GO:0000287	magnesium ion binding	-	225	143	-	-	1.41E-02	1.22E-02
HPRD	MF	GO:0031490	chromatin DNA binding	-	120	90	-	-	1.44E-02	7.64E-03
HPRD	MF	GO:0017022	myosin binding	-	73	52	-	-	2.61E-03	4.46E-03
HPRD	MF	GO:0004896	cytokine receptor activity	-	93	83	-	-	1.76E-02	7.11E-03
HPRD	MF	GO:0017166	vinculin binding	-	12	11	-	-	1.53E-02	9.56E-04
HPRD	MF	GO:0008301	"DNA binding, bending"	-	18	13	-	-	1.33E-03	1.17E-03
HPRD	MF	GO:1990459	transferrin receptor binding	-	12	11	-	-	2.17E-02	9.56E-04
HPRD	MF	GO:0005539	glycosaminoglycan binding	-	236	162	-	-	4.52E-02	1.38E-02
HPRD	MF	GO:0071933	Arp2/3 complex binding	-	14	12	-	-	3.16E-04	1.06E-03
HPRD	MF	GO:0019207	kinase regulator activity	-	267	217	-	-	1.33E-02	1.85E-02
HPRD	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	15	-	-	1.30E-02	1.27E-03
HPRD	MF	GO:0031420	alkali metal ion binding	-	17	11	-	-	3.16E-04	9.56E-04
HPRD	MF	GO:0044183	protein folding chaperone	-	67	45	-	-	5.21E-03	3.82E-03
HPRD	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	98	-	-	1.91E-02	8.39E-03
HPRD	MF	GO:0003725	double-stranded RNA binding	-	72	48	-	-	1.84E-02	4.14E-03
HPRD	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	15	-	-	6.22E-02	1.27E-03
HPRD	MF	GO:0051018	protein kinase A binding	-	52	43	-	-	8.09E-02	3.72E-03
HPRD	MF	GO:0071889	14-3-3 protein binding	-	34	26	-	-	2.70E-03	2.23E-03
HPRD	MF	GO:0004618	phosphoglycerate kinase activity	-	89	71	-	-	1.41E-02	6.05E-03
HPRD	MF	GO:0042805	actinin binding	-	36	29	-	-	1.39E-03	2.55E-03
HPRD	MF	GO:0043531	ADP binding	-	38	32	-	-	8.50E-03	2.76E-03
HPRD	MF	GO:0043394	proteoglycan binding	-	36	29	-	-	1.42E-02	2.55E-03
HPRD	MF	GO:0046332	SMAD binding	-	77	71	-	-	1.03E-02	6.05E-03
HPRD	MF	GO:0043560	insulin receptor substrate binding	-	13	12	-	-	7.68E-03	1.06E-03
HPRD	MF	GO:0001968	fibronectin binding	-	30	25	-	-	8.06E-03	2.12E-03
HPRD	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	80	-	-	3.70E-02	6.79E-03
HPRD	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	55	-	-	3.75E-03	4.67E-03
HPRD	MF	GO:0003756	protein disulfide isomerase activity	-	18	15	-	-	4.22E-04	1.27E-03
HPRD	MF	GO:0051117	ATPase binding	-	85	67	-	-	4.01E-03	5.73E-03
HPRD	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	41	-	-	3.57E-03	3.50E-03
HPRD	MF	GO:0051787	misfolded protein binding	-	20	16	-	-	1.08E-02	1.38E-03
HPRD	MF	GO:0070402	NADPH binding	-	16	11	-	-	3.18E-04	9.56E-04
HPRD	MF	GO:0031404	chloride ion binding	-	14	11	-	-	3.18E-04	9.56E-04
HPRD	MF	GO:0001098	basal transcription machinery binding	-	61	52	-	-	2.81E-02	4.46E-03
HPRD	MF	GO:0036002	pre-mRNA binding	-	57	26	-	-	7.64E-03	2.23E-03
HPRD	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	24	-	-	3.19E-03	2.12E-03
HPRD	MF	GO:0051540	metal cluster binding	-	71	34	-	-	1.16E-02	2.97E-03
HPRD	MF	GO:0051219	phosphoprotein binding	-	92	84	-	-	8.98E-03	7.22E-03
HPRD	MF	GO:0019894	kinesin binding	-	45	37	-	-	2.25E-02	3.19E-03
HPRD	MF	GO:0042287	MHC protein binding	-	68	45	-	-	2.53E-02	3.82E-03
HPRD	MF	GO:0019003	GDP binding	-	89	76	-	-	1.75E-02	6.48E-03
HPRD	MF	GO:0017171	serine hydrolase activity	-	207	112	-	-	1.72E-02	9.56E-03
HPRD	MF	GO:0097110	scaffold protein binding	-	66	64	-	-	6.08E-03	5.52E-03
HPRD	MF	GO:0003774	cytoskeletal motor activity	-	117	69	-	-	1.58E-02	5.95E-03
HPRD	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	26	-	-	1.44E-02	2.23E-03
HPRD	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	2.26E-02	1.49E-03
HPRD	MF	GO:0061134	peptidase regulator activity	-	224	144	-	-	3.36E-02	1.23E-02
HPRD	MF	GO:0008013	beta-catenin binding	-	86	71	-	-	7.02E-03	6.05E-03
HPRD	MF	GO:0051015	actin filament binding	-	208	159	-	-	2.36E-02	1.36E-02
HPRD	MF	GO:0019208	phosphatase regulator activity	-	107	75	-	-	6.47E-03	6.37E-03
HPRD	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	20	-	-	3.53E-02	1.70E-03
HPRD	MF	GO:0043236	laminin binding	-	29	23	-	-	6.48E-03	2.02E-03
HPRD	MF	GO:0030507	spectrin binding	-	26	22	-	-	2.22E-02	1.91E-03
HPRD	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	24	-	-	8.05E-03	2.12E-03
HPRD	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	72	-	-	5.41E-02	6.16E-03
HPRD	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	23	-	-	1.36E-03	2.02E-03
HPRD	MF	GO:0042393	histone binding	-	240	158	-	-	1.01E-02	1.35E-02
HPRD	MF	GO:0019838	growth factor binding	-	182	159	-	-	1.75E-02	1.36E-02
HPRD	MF	GO:0000149	SNARE binding	-	107	83	-	-	1.61E-01	7.11E-03
HPRD	MF	GO:0003727	single-stranded RNA binding	-	90	57	-	-	6.19E-03	4.88E-03
HPRD	MF	GO:0051378	serotonin binding	-	24	20	-	-	6.26E-02	1.70E-03
HPRD	MF	GO:0005516	calmodulin binding	-	206	163	-	-	1.18E-02	1.39E-02
HPRD	MF	GO:0019825	oxygen binding	-	40	23	-	-	4.53E-02	2.02E-03
HPRD	MF	GO:0045505	dynein intermediate chain binding	-	37	15	-	-	4.17E-04	1.27E-03
HPRD	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	45	-	-	1.05E-03	3.82E-03
HPRD	MF	GO:0032182	ubiquitin-like protein binding	-	117	92	-	-	7.48E-03	7.86E-03
HPRD	MF	GO:0023023	MHC protein complex binding	-	36	32	-	-	1.85E-01	2.76E-03
HPRD	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	9.24E-03	1.91E-03
HPRD	MF	GO:0043274	phospholipase binding	-	23	19	-	-	3.31E-03	1.70E-03
HPRD	MF	GO:0031072	heat shock protein binding	-	128	97	-	-	2.54E-02	8.28E-03
HPRD	MF	GO:0030515	snoRNA binding	-	33	20	-	-	2.50E-03	1.70E-03
HPRD	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	24	-	-	1.63E-02	2.12E-03
HPRD	MF	GO:0001965	G-protein alpha-subunit binding	-	26	22	-	-	5.24E-04	1.91E-03
HPRD	MF	GO:0001530	lipopolysaccharide binding	-	38	23	-	-	5.57E-02	2.02E-03
HPRD	MF	GO:0046982	protein heterodimerization activity	-	343	245	-	-	3.40E-02	2.08E-02
HPRD	MF	GO:0140223	general transcription initiation factor activity	-	55	49	-	-	4.27E-01	4.25E-03
HPRD	MF	GO:0000049	tRNA binding	-	75	33	-	-	3.77E-03	2.87E-03
HPRD	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	41	-	-	7.56E-03	3.50E-03
HPRD	MF	GO:0015026	coreceptor activity	-	48	39	-	-	1.17E-02	3.40E-03
HPRD	MF	GO:0005527	macrolide binding	-	12	11	-	-	1.35E-02	9.56E-04
HPRD	MF	GO:0001653	peptide receptor activity	-	128	102	-	-	1.87E-02	8.71E-03
HPRD	MF	GO:0031005	filamin binding	-	15	11	-	-	3.12E-04	9.56E-04
HPRD	MF	GO:0030506	ankyrin binding	-	19	16	-	-	4.33E-03	1.38E-03
HPRD	MF	GO:0006469	negative regulation of protein kinase activity	-	222	184	-	-	5.90E-03	1.57E-02
HPRD	MF	GO:0070182	DNA polymerase binding	-	22	14	-	-	2.24E-02	1.27E-03
HPRD	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	26	-	-	1.03E-02	2.23E-03
HPRD	MF	GO:0051427	hormone receptor binding	-	31	30	-	-	1.24E-02	2.55E-03
HPRD	MF	GO:0070851	growth factor receptor binding	-	141	127	-	-	1.59E-02	1.08E-02
HPRD	MF	GO:0031210	phosphatidylcholine binding	-	32	24	-	-	3.50E-02	2.12E-03
HPRD	MF	GO:0005525	GTP binding	-	396	248	-	-	1.04E-02	2.11E-02
HPRD	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	38	-	-	6.41E-03	3.29E-03
HPRD	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	225	-	-	1.77E-02	1.91E-02
HPRD	MF	GO:0034185	apolipoprotein binding	-	20	19	-	-	6.10E-03	1.70E-03
HPRD	MF	GO:0051346	negative regulation of hydrolase activity	-	332	229	-	-	1.04E-02	1.95E-02
HPRD	MF	GO:0005506	iron ion binding	-	154	60	-	-	2.56E-02	5.10E-03
HPRD	MF	GO:0003925	G protein activity	-	45	37	-	-	1.23E-03	3.19E-03
HPRD	MF	GO:0038187	pattern recognition receptor activity	-	33	21	-	-	7.69E-02	1.80E-03
HPRD	MF	GO:0008276	protein methyltransferase activity	-	96	46	-	-	7.82E-03	3.93E-03
HPRD	MF	GO:0070888	E-box binding	-	59	44	-	-	4.77E-02	3.82E-03
HPRD	MF	GO:0015399	primary active transmembrane transporter activity	-	190	95	-	-	4.40E-02	8.07E-03
HPRD	MF	GO:0035254	glutamate receptor binding	-	47	37	-	-	3.22E-03	3.19E-03
HPRD	MF	GO:0050321	tau-protein kinase activity	-	36	32	-	-	1.15E-02	2.76E-03
HPRD	MF	GO:0043021	ribonucleoprotein complex binding	-	158	106	-	-	1.78E-02	9.02E-03
HPRD	MF	GO:0030170	pyridoxal phosphate binding	-	56	26	-	-	2.50E-02	2.23E-03
HPRD	MF	GO:0005112	Notch binding	-	26	18	-	-	4.29E-02	1.59E-03
HPRD	MF	GO:0048185	activin binding	-	16	16	-	-	8.62E-03	1.38E-03
HPRD	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	14	-	-	9.20E-03	1.27E-03
HPRD	MF	GO:0001664	G protein-coupled receptor binding	-	299	231	-	-	1.49E-02	1.96E-02
HPRD	MF	GO:0140299	small molecule sensor activity	-	39	25	-	-	9.34E-02	2.12E-03
HPRD	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	19	-	-	8.42E-03	1.70E-03
HPRD	MF	GO:0016917	GABA receptor activity	-	23	14	-	-	2.79E-02	1.27E-03
HPRD	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	13	-	-	5.35E-02	1.17E-03
HPRD	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	31	-	-	7.30E-03	2.65E-03
HPRD	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	23	-	-	1.59E-03	2.02E-03
HPRD	MF	GO:0030594	neurotransmitter receptor activity	-	160	114	-	-	5.86E-02	9.77E-03
HPRD	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	21	-	-	6.43E-02	1.80E-03
HPRD	MF	GO:0005507	copper ion binding	-	63	40	-	-	7.81E-03	3.40E-03
HPRD	MF	GO:0033558	protein lysine deacetylase activity	-	22	19	-	-	2.62E-02	1.70E-03
HPRD	MF	GO:0070034	telomerase RNA binding	-	22	16	-	-	8.11E-02	1.38E-03
HumanNet	CC	GO:0005739	mitochondrion	7.36E-31	1671	1601	1470	1.09	-	-
HumanNet	MF	GO:0000049	tRNA binding	-	75	75	-	-	1.20E-01	3.23E-03
HumanNet	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	17	-	-	2.69E-01	7.53E-04
HumanNet	BP	GO:0000098	sulfur amino acid catabolic process	-	11	11	-	-	1.21E-01	4.84E-04
HumanNet	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	5.12E-02	5.38E-04
HumanNet	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	6.32E-02	4.84E-04
HumanNet	CC	GO:0000123	histone acetyltransferase complex	-	93	89	-	-	4.05E-01	3.87E-03
HumanNet	MF	GO:0000149	SNARE binding	-	107	105	-	-	2.52E-01	4.52E-03
HumanNet	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	43	-	-	2.36E-01	1.88E-03
HumanNet	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	1.64E-01	8.61E-04
HumanNet	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	7.71E-02	6.45E-04
HumanNet	MF	GO:0000182	rDNA binding	-	11	11	-	-	1.12E-02	4.84E-04
HumanNet	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	2.43E-02	1.61E-03
HumanNet	CC	GO:0000228	nuclear chromosome	1.11E-02	206	205	199	1.03	-	-
HumanNet	CC	GO:0000242	pericentriolar material	-	22	22	-	-	2.11E-02	9.68E-04
HumanNet	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	1.00E-01	8.61E-04
HumanNet	MF	GO:0000287	magnesium ion binding	-	225	223	-	-	4.27E-02	9.63E-03
HumanNet	CC	GO:0000313	organellar ribosome	-	89	89	-	-	5.67E-01	3.87E-03
HumanNet	MF	GO:0000339	RNA cap binding	-	20	20	-	-	6.49E-02	8.61E-04
HumanNet	CC	GO:0000783	nuclear telomere cap complex	-	12	11	-	-	7.72E-02	4.84E-04
HumanNet	CC	GO:0000786	nucleosome	-	149	139	-	-	6.37E-01	6.02E-03
HumanNet	CC	GO:0000791	euchromatin	-	60	60	-	-	7.20E-03	2.58E-03
HumanNet	CC	GO:0000792	heterochromatin	-	98	96	-	-	5.41E-02	4.14E-03
HumanNet	CC	GO:0000800	lateral element	-	14	14	-	-	3.70E-02	6.45E-04
HumanNet	CC	GO:0000803	sex chromosome	-	32	29	-	-	1.51E-02	1.29E-03
HumanNet	CC	GO:0000813	ESCRT I complex	-	11	11	-	-	4.99E-01	4.84E-04
HumanNet	BP	GO:0000910	cytokinesis	8.38E-01	186	181	180	1.01	-	-
HumanNet	CC	GO:0000922	spindle pole	-	172	168	-	-	3.35E-02	7.26E-03
HumanNet	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	4.95E-01	6.99E-04
HumanNet	CC	GO:0000940	outer kinetochore	-	17	17	-	-	1.67E-01	7.53E-04
HumanNet	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	47	-	-	1.14E-01	2.04E-03
HumanNet	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	2.38E-01	8.61E-04
HumanNet	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	1.71E-01	1.67E-03
HumanNet	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	18	-	-	2.28E-02	8.07E-04
HumanNet	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	1.76E-01	5.38E-04
HumanNet	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	1.52E-01	6.99E-04
HumanNet	MF	GO:0001098	basal transcription machinery binding	-	61	60	-	-	5.29E-02	2.58E-03
HumanNet	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	2.45E-02	6.45E-04
HumanNet	CC	GO:0001527	microfibril	-	13	13	-	-	2.08E-01	5.92E-04
HumanNet	MF	GO:0001530	lipopolysaccharide binding	-	38	36	-	-	8.80E-03	1.56E-03
HumanNet	CC	GO:0001533	cornified envelope	-	59	59	-	-	2.36E-01	2.58E-03
HumanNet	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	154	-	-	1.00E-01	6.67E-03
HumanNet	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	9.87E-03	4.84E-04
HumanNet	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	20	-	-	1.76E-01	8.61E-04
HumanNet	CC	GO:0001650	fibrillar center	-	151	150	-	-	1.18E-02	6.45E-03
HumanNet	MF	GO:0001653	peptide receptor activity	-	128	124	-	-	1.44E-01	5.38E-03
HumanNet	BP	GO:0001655	urogenital system development	-	66	65	-	-	1.87E-02	2.80E-03
HumanNet	MF	GO:0001671	ATPase activator activity	-	29	27	-	-	7.30E-02	1.18E-03
HumanNet	BP	GO:0001704	formation of primary germ layer	-	195	187	-	-	5.94E-02	8.07E-03
HumanNet	BP	GO:0001708	cell fate specification	-	108	107	-	-	7.29E-02	4.63E-03
HumanNet	BP	GO:0001709	cell fate determination	-	44	42	-	-	1.90E-02	1.83E-03
HumanNet	CC	GO:0001726	ruffle	-	181	180	-	-	2.93E-02	7.75E-03
HumanNet	CC	GO:0001772	immunological synapse	-	44	44	-	-	1.26E-02	1.94E-03
HumanNet	BP	GO:0001776	leukocyte homeostasis	-	108	107	-	-	6.96E-03	4.63E-03
HumanNet	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	2.03E-03	8.61E-04
HumanNet	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.23E-03	6.45E-04
HumanNet	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	1.91E-02	8.61E-04
HumanNet	CC	GO:0001891	phagocytic cup	-	28	28	-	-	4.89E-03	1.24E-03
HumanNet	CC	GO:0001917	photoreceptor inner segment	-	71	69	-	-	5.93E-02	3.01E-03
HumanNet	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	5.12E-04	5.38E-04
HumanNet	CC	GO:0001931	uropod	-	13	13	-	-	1.52E-02	5.92E-04
HumanNet	BP	GO:0001941	postsynaptic membrane organization	-	37	35	-	-	2.13E-02	1.51E-03
HumanNet	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	1.31E-01	7.53E-04
HumanNet	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	68	-	-	4.90E-03	2.96E-03
HumanNet	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	58	-	-	2.06E-02	2.53E-03
HumanNet	BP	GO:0001964	startle response	-	27	27	-	-	8.73E-03	1.18E-03
HumanNet	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	2.91E-02	1.13E-03
HumanNet	MF	GO:0001968	fibronectin binding	-	30	30	-	-	1.89E-02	1.29E-03
HumanNet	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	13	-	-	1.10E-03	5.92E-04
HumanNet	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	1.45E-02	1.13E-03
HumanNet	BP	GO:0002027	regulation of heart rate	-	106	101	-	-	1.35E-01	4.36E-03
HumanNet	MF	GO:0002039	p53 binding	-	66	65	-	-	1.10E-02	2.80E-03
HumanNet	BP	GO:0002063	chondrocyte development	-	33	31	-	-	9.71E-03	1.34E-03
HumanNet	BP	GO:0002064	epithelial cell development	-	210	207	-	-	1.96E-02	8.93E-03
HumanNet	BP	GO:0002076	osteoblast development	-	17	17	-	-	9.24E-03	7.53E-04
HumanNet	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	1.73E-03	5.38E-04
HumanNet	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	1.62E-02	9.14E-04
HumanNet	CC	GO:0002102	podosome	-	31	31	-	-	3.99E-03	1.34E-03
HumanNet	CC	GO:0002177	manchette	-	19	19	-	-	2.68E-02	8.61E-04
HumanNet	BP	GO:0002181	cytoplasmic translation	1.81E-01	153	151	148	1.02	-	-
HumanNet	BP	GO:0002200	somatic diversification of immune receptors	-	78	77	-	-	5.88E-02	3.33E-03
HumanNet	BP	GO:0002209	behavioral defense response	-	39	38	-	-	1.88E-03	1.67E-03
HumanNet	BP	GO:0002251	organ or tissue specific immune response	-	43	41	-	-	2.05E-02	1.78E-03
HumanNet	BP	GO:0002262	myeloid cell homeostasis	-	172	168	-	-	2.04E-02	7.26E-03
HumanNet	BP	GO:0002357	defense response to tumor cell	-	13	12	-	-	5.30E-04	5.38E-04
HumanNet	BP	GO:0002367	cytokine production involved in immune response	-	121	120	-	-	2.89E-02	5.16E-03
HumanNet	BP	GO:0002376	immune system process	2.72E-09	2448	2410	2364	1.02	-	-
HumanNet	BP	GO:0002418	immune response to tumor cell	-	29	26	-	-	2.29E-02	1.13E-03
HumanNet	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	74	-	-	9.67E-03	3.23E-03
HumanNet	BP	GO:0002467	germinal center formation	-	14	14	-	-	3.35E-03	6.45E-04
HumanNet	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	18	-	-	3.24E-02	8.07E-04
HumanNet	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	81	-	-	1.44E-02	3.50E-03
HumanNet	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	6.29E-03	5.38E-04
HumanNet	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	1.24E-03	6.99E-04
HumanNet	BP	GO:0002687	positive regulation of leukocyte migration	-	147	146	-	-	4.64E-02	6.29E-03
HumanNet	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	4.55E-03	2.04E-03
HumanNet	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	132	-	-	2.43E-02	5.70E-03
HumanNet	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	1.38E-03	5.38E-04
HumanNet	BP	GO:0002931	response to ischemia	-	58	57	-	-	3.92E-03	2.47E-03
HumanNet	BP	GO:0003012	muscle system process	6.40E-03	425	420	410	1.02	-	-
HumanNet	BP	GO:0003013	circulatory system process	2.28E-05	584	580	564	1.03	-	-
HumanNet	BP	GO:0003014	renal system process	1.36E-01	127	126	123	1.03	-	-
HumanNet	BP	GO:0003014	renal system process	-	130	126	-	-	1.70E-02	5.43E-03
HumanNet	BP	GO:0003016	respiratory system process	-	39	39	-	-	9.88E-04	1.72E-03
HumanNet	BP	GO:0003151	outflow tract morphogenesis	-	81	77	-	-	5.14E-02	3.33E-03
HumanNet	BP	GO:0003158	endothelium development	-	140	128	-	-	4.63E-02	5.54E-03
HumanNet	BP	GO:0003188	heart valve formation	-	16	16	-	-	1.09E-02	6.99E-04
HumanNet	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	5.62E-02	6.45E-04
HumanNet	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	3.12E-02	1.24E-03
HumanNet	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	4.57E-03	1.02E-03
HumanNet	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	1.01E-01	5.38E-04
HumanNet	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	15	-	-	5.14E-02	6.45E-04
HumanNet	MF	GO:0003677	DNA binding	1.40E-04	2865	2800	2767	1.01	-	-
HumanNet	MF	GO:0003684	damaged DNA binding	-	89	83	-	-	1.35E-01	3.60E-03
HumanNet	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	1.76E-01	8.07E-04
HumanNet	MF	GO:0003714	transcription corepressor activity	-	190	187	-	-	6.33E-02	8.07E-03
HumanNet	MF	GO:0003723	RNA binding	1.64E-05	1679	1650	1622	1.02	-	-
HumanNet	MF	GO:0003725	double-stranded RNA binding	-	72	72	-	-	7.93E-02	3.12E-03
HumanNet	MF	GO:0003727	single-stranded RNA binding	-	90	84	-	-	3.36E-02	3.66E-03
HumanNet	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	37	-	-	4.80E-01	1.61E-03
HumanNet	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	9.32E-02	8.07E-04
HumanNet	MF	GO:0003774	cytoskeletal motor activity	1.93E-01	116	115	112	1.03	-	-
HumanNet	MF	GO:0003774	cytoskeletal motor activity	-	117	115	-	-	3.80E-01	4.95E-03
HumanNet	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	26	-	-	1.98E-01	1.13E-03
HumanNet	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	5.95E-02	5.38E-04
HumanNet	MF	GO:0003924	GTPase activity	1.45E-03	658	649	635	1.02	-	-
HumanNet	MF	GO:0003925	G protein activity	-	45	44	-	-	1.34E-01	1.94E-03
HumanNet	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	1.13E-01	5.38E-04
HumanNet	MF	GO:0004396	hexokinase activity	-	16	16	-	-	2.29E-02	6.99E-04
HumanNet	MF	GO:0004618	phosphoglycerate kinase activity	-	89	88	-	-	9.00E-02	3.82E-03
HumanNet	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	19	-	-	9.23E-02	8.61E-04
HumanNet	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	45	-	-	6.18E-02	1.94E-03
HumanNet	MF	GO:0004713	protein tyrosine kinase activity	-	213	211	-	-	2.11E-01	9.09E-03
HumanNet	MF	GO:0004875	complement receptor activity	-	12	11	-	-	2.06E-02	4.84E-04
HumanNet	CC	GO:0004879	nuclear receptor activity	-	63	59	-	-	3.31E-01	2.58E-03
HumanNet	MF	GO:0004896	cytokine receptor activity	-	93	93	-	-	1.85E-01	4.03E-03
HumanNet	MF	GO:0005035	death receptor activity	-	16	16	-	-	5.61E-02	6.99E-04
HumanNet	MF	GO:0005112	Notch binding	-	26	26	-	-	8.19E-02	1.13E-03
HumanNet	MF	GO:0005132	type I interferon receptor binding	-	17	17	-	-	5.79E-02	7.53E-04
HumanNet	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	7.80E-02	9.68E-04
HumanNet	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	9.24E-03	6.99E-04
HumanNet	MF	GO:0005178	integrin binding	-	153	153	-	-	1.99E-01	6.62E-03
HumanNet	MF	GO:0005198	structural molecule activity	7.23E-02	798	780	771	1.01	-	-
HumanNet	CC	GO:0005200	structural constituent of cytoskeleton	-	112	111	-	-	1.37E-01	4.79E-03
HumanNet	MF	GO:0005215	transporter activity	5.00E-01	1462	1417	1412	1.00	-	-
HumanNet	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	19	-	-	6.19E-02	8.61E-04
HumanNet	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	223	-	-	1.82E-01	9.63E-03
HumanNet	MF	GO:0005496	steroid binding	-	110	109	-	-	1.13E-01	4.73E-03
HumanNet	MF	GO:0005506	iron ion binding	-	154	150	-	-	3.18E-01	6.45E-03
HumanNet	MF	GO:0005507	copper ion binding	-	63	58	-	-	2.22E-02	2.53E-03
HumanNet	MF	GO:0005516	calmodulin binding	-	206	202	-	-	2.79E-02	8.71E-03
HumanNet	MF	GO:0005521	lamin binding	-	15	14	-	-	3.09E-02	6.45E-04
HumanNet	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	1.64E-01	6.45E-04
HumanNet	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.45E-01	5.38E-04
HumanNet	MF	GO:0005539	glycosaminoglycan binding	-	236	232	-	-	5.01E-02	1.00E-02
HumanNet	MF	GO:0005542	folic acid binding	-	13	12	-	-	2.50E-01	5.38E-04
HumanNet	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	81	-	-	2.37E-02	3.50E-03
HumanNet	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	40	-	-	7.77E-03	1.72E-03
HumanNet	MF	GO:0005549	odorant binding	-	128	97	-	-	1.19E-01	4.20E-03
HumanNet	CC	GO:0005615	extracellular space	2.10E-10	3190	3136	3081	1.02	-	-
HumanNet	CC	GO:0005635	nuclear envelope	3.81E-01	493	480	476	1.01	-	-
HumanNet	CC	GO:0005640	nuclear outer membrane	-	30	30	-	-	3.12E-02	1.29E-03
HumanNet	CC	GO:0005652	nuclear lamina	-	12	12	-	-	8.20E-03	5.38E-04
HumanNet	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	5.45E-03	5.92E-04
HumanNet	CC	GO:0005730	nucleolus	1.15E-02	988	968	954	1.01	-	-
HumanNet	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	1.43E-01	1.08E-03
HumanNet	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	1.75E-01	5.92E-04
HumanNet	CC	GO:0005739	mitochondrion	2.00E-02	1671	1630	1614	1.01	-	-
HumanNet	CC	GO:0005764	lysosome	5.04E-02	747	731	721	1.01	-	-
HumanNet	CC	GO:0005768	endosome	5.63E-04	1037	1020	1001	1.02	-	-
HumanNet	CC	GO:0005775	vacuolar lumen	-	176	174	-	-	1.47E-01	7.53E-03
HumanNet	CC	GO:0005776	autophagosome	-	111	105	-	-	1.17E-01	4.52E-03
HumanNet	CC	GO:0005777	peroxisome	9.78E-02	142	141	137	1.03	-	-
HumanNet	CC	GO:0005783	endoplasmic reticulum	5.05E-06	2020	1984	1951	1.02	-	-
HumanNet	CC	GO:0005794	Golgi apparatus	3.51E-04	1636	1604	1580	1.02	-	-
HumanNet	CC	GO:0005796	Golgi lumen	-	106	102	-	-	3.70E-02	4.41E-03
HumanNet	CC	GO:0005811	lipid droplet	2.69E-01	102	101	99	1.03	-	-
HumanNet	CC	GO:0005811	lipid droplet	-	102	101	-	-	6.99E-02	4.36E-03
HumanNet	CC	GO:0005815	microtubule organizing center	4.81E-03	843	828	814	1.02	-	-
HumanNet	CC	GO:0005818	aster	-	11	11	-	-	2.61E-02	4.84E-04
HumanNet	CC	GO:0005833	hemoglobin complex	-	12	12	-	-	2.03E-01	5.38E-04
HumanNet	CC	GO:0005840	ribosome	3.79E-02	222	220	214	1.03	-	-
HumanNet	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	1.94E-01	8.61E-04
HumanNet	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	5.16E-01	6.45E-04
HumanNet	CC	GO:0005881	cytoplasmic microtubule	-	256	245	-	-	6.55E-02	1.05E-02
HumanNet	CC	GO:0005883	neurofilament	-	11	11	-	-	4.64E-03	4.84E-04
HumanNet	CC	GO:0005905	clathrin-coated pit	-	73	73	-	-	1.37E-01	3.17E-03
HumanNet	CC	GO:0005929	cilium	5.60E-01	842	817	813	1.00	-	-
HumanNet	CC	GO:0005940	septin ring	-	14	12	-	-	8.90E-01	5.38E-04
HumanNet	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	26	-	-	2.37E-01	1.13E-03
HumanNet	BP	GO:0005975	carbohydrate metabolic process	6.03E-03	551	543	532	1.02	-	-
HumanNet	BP	GO:0005996	monosaccharide metabolic process	-	250	242	-	-	1.30E-01	1.04E-02
HumanNet	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	4.94E-02	5.38E-04
HumanNet	BP	GO:0006023	aminoglycan biosynthetic process	-	74	73	-	-	3.24E-01	3.17E-03
HumanNet	BP	GO:0006026	aminoglycan catabolic process	-	34	34	-	-	2.86E-01	1.51E-03
HumanNet	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	2.07E-01	6.45E-04
HumanNet	BP	GO:0006091	generation of precursor metabolites and energy	2.14E-01	502	480	485	0.99	-	-
HumanNet	BP	GO:0006099	tricarboxylic acid cycle	-	33	33	-	-	1.67E-01	1.45E-03
HumanNet	BP	GO:0006260	DNA replication	7.01E-03	279	277	269	1.03	-	-
HumanNet	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	1.04E-01	7.53E-04
HumanNet	BP	GO:0006281	DNA repair	1.07E-01	587	574	567	1.01	-	-
HumanNet	BP	GO:0006304	DNA modification	-	30	29	-	-	1.19E-01	1.29E-03
HumanNet	BP	GO:0006310	DNA recombination	4.77E-02	333	328	322	1.02	-	-
HumanNet	BP	GO:0006325	chromatin organization	3.42E-04	720	711	695	1.02	-	-
HumanNet	BP	GO:0006355	regulation of DNA-templated transcription	1.23E-04	3342	3263	3228	1.01	-	-
HumanNet	BP	GO:0006399	tRNA metabolic process	2.24E-03	196	196	189	1.04	-	-
HumanNet	CC	GO:0006406	mRNA export from nucleus	-	69	69	-	-	2.10E-01	3.01E-03
HumanNet	BP	GO:0006413	translational initiation	-	122	121	-	-	3.45E-01	5.22E-03
HumanNet	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	3.42E-02	7.53E-04
HumanNet	BP	GO:0006457	protein folding	3.35E-01	210	206	203	1.02	-	-
HumanNet	MF	GO:0006469	negative regulation of protein kinase activity	-	222	209	-	-	1.36E-02	9.04E-03
HumanNet	BP	GO:0006486	protein glycosylation	8.53E-01	225	217	217	1.00	-	-
HumanNet	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	3.14E-01	9.14E-04
HumanNet	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	1.95E-01	1.08E-03
HumanNet	BP	GO:0006520	amino acid metabolic process	1.41E-01	292	287	282	1.02	-	-
HumanNet	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	4.48E-03	5.38E-04
HumanNet	BP	GO:0006575	cellular modified amino acid metabolic process	9.97E-02	186	184	180	1.02	-	-
HumanNet	BP	GO:0006629	lipid metabolic process	3.11E-03	1355	1327	1309	1.01	-	-
HumanNet	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	1.05E-02	8.61E-04
HumanNet	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	1.67E-01	1.02E-03
HumanNet	BP	GO:0006766	vitamin metabolic process	5.44E-02	107	107	103	1.04	-	-
HumanNet	BP	GO:0006790	sulfur compound metabolic process	2.83E-02	320	316	309	1.02	-	-
HumanNet	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	1.24E-02	6.45E-04
HumanNet	CC	GO:0006858	extracellular transport	-	45	45	-	-	4.49E-02	1.94E-03
HumanNet	BP	GO:0006885	regulation of pH	-	104	101	-	-	1.19E-01	4.36E-03
HumanNet	BP	GO:0006886	intracellular protein transport	1.82E-04	664	657	641	1.02	-	-
HumanNet	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	128	-	-	2.60E-01	5.54E-03
HumanNet	BP	GO:0006913	nucleocytoplasmic transport	2.08E-02	326	322	315	1.02	-	-
HumanNet	BP	GO:0006914	autophagy	1.47E-03	568	561	549	1.02	-	-
HumanNet	BP	GO:0006925	inflammatory cell apoptotic process	-	23	22	-	-	2.16E-03	9.68E-04
HumanNet	BP	GO:0006929	substrate-dependent cell migration	-	26	26	-	-	2.98E-03	1.13E-03
HumanNet	BP	GO:0006949	syncytium formation	-	66	64	-	-	1.42E-02	2.80E-03
HumanNet	BP	GO:0006954	inflammatory response	7.96E-06	820	812	792	1.03	-	-
HumanNet	BP	GO:0006968	cellular defense response	-	52	51	-	-	2.49E-02	2.21E-03
HumanNet	CC	GO:0006984	ER-nucleus signaling pathway	-	46	45	-	-	5.70E-02	1.94E-03
HumanNet	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	1.41E-01	6.45E-04
HumanNet	BP	GO:0007005	mitochondrion organization	6.12E-01	484	470	467	1.01	-	-
HumanNet	CC	GO:0007006	mitochondrial membrane organization	-	117	109	-	-	1.29E-01	4.73E-03
HumanNet	BP	GO:0007010	cytoskeleton organization	1.79E-05	1639	1611	1583	1.02	-	-
HumanNet	BP	GO:0007018	microtubule-based movement	2.63E-02	640	628	618	1.02	-	-
HumanNet	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.54E-04	4.84E-04
HumanNet	CC	GO:0007034	vacuolar transport	-	168	163	-	-	1.76E-01	7.05E-03
HumanNet	CC	GO:0007039	protein catabolic process in the vacuole	-	61	58	-	-	3.26E-01	2.53E-03
HumanNet	BP	GO:0007040	lysosome organization	7.87E-01	107	103	103	1.00	-	-
HumanNet	BP	GO:0007059	chromosome segregation	5.78E-01	403	392	389	1.01	-	-
HumanNet	CC	GO:0007097	nuclear migration	-	24	24	-	-	1.08E-01	1.08E-03
HumanNet	BP	GO:0007130	synaptonemal complex assembly	-	23	23	-	-	1.25E-01	1.02E-03
HumanNet	BP	GO:0007155	cell adhesion	1.64E-08	1444	1428	1395	1.02	-	-
HumanNet	BP	GO:0007163	establishment or maintenance of cell polarity	9.50E-02	227	224	219	1.02	-	-
HumanNet	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	3.95E-02	1.67E-03
HumanNet	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	9.39E-02	4.84E-04
HumanNet	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	55	-	-	1.05E-01	2.37E-03
HumanNet	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	231	-	-	2.06E-01	9.95E-03
HumanNet	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	87	-	-	7.91E-02	3.77E-03
HumanNet	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	165	-	-	6.77E-02	7.10E-03
HumanNet	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	3.92E-02	1.18E-03
HumanNet	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	40	-	-	3.25E-02	1.72E-03
HumanNet	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	1.31E-02	9.14E-04
HumanNet	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	28	-	-	1.53E-01	1.24E-03
HumanNet	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	2.83E-02	6.45E-04
HumanNet	BP	GO:0007218	neuropeptide signaling pathway	-	113	110	-	-	1.84E-01	4.73E-03
HumanNet	BP	GO:0007272	ensheathment of neurons	-	146	144	-	-	4.43E-02	6.24E-03
HumanNet	BP	GO:0007340	acrosome reaction	-	38	38	-	-	1.02E-02	1.67E-03
HumanNet	BP	GO:0007343	egg activation	-	11	11	-	-	2.44E-02	4.84E-04
HumanNet	BP	GO:0007405	neuroblast proliferation	-	81	80	-	-	2.00E-02	3.44E-03
HumanNet	BP	GO:0007566	embryo implantation	-	57	54	-	-	2.68E-03	2.37E-03
HumanNet	BP	GO:0007588	excretion	-	40	39	-	-	1.32E-02	1.72E-03
HumanNet	BP	GO:0007635	chemosensory behavior	-	20	20	-	-	2.62E-03	8.61E-04
HumanNet	MF	GO:0008013	beta-catenin binding	-	86	86	-	-	4.33E-02	3.71E-03
HumanNet	CC	GO:0008023	transcription elongation factor complex	-	47	45	-	-	3.52E-01	1.94E-03
HumanNet	BP	GO:0008033	tRNA processing	-	136	135	-	-	5.55E-01	5.81E-03
HumanNet	BP	GO:0008038	neuron recognition	-	46	45	-	-	6.76E-02	1.94E-03
HumanNet	MF	GO:0008066	glutamate receptor activity	-	70	68	-	-	1.50E-01	2.96E-03
HumanNet	CC	GO:0008088	axo-dendritic transport	-	78	78	-	-	6.75E-02	3.39E-03
HumanNet	MF	GO:0008092	cytoskeletal protein binding	5.40E-06	1023	1011	988	1.02	-	-
HumanNet	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	6.16E-03	1.08E-03
HumanNet	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	83	-	-	4.62E-01	3.60E-03
HumanNet	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	3.62E-01	7.53E-04
HumanNet	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	7.77E-03	6.45E-04
HumanNet	BP	GO:0008213	protein alkylation	-	58	57	-	-	1.82E-01	2.47E-03
HumanNet	BP	GO:0008217	regulation of blood pressure	-	186	180	-	-	6.45E-02	7.75E-03
HumanNet	CC	GO:0008250	oligosaccharyltransferase complex	-	14	12	-	-	3.40E-01	5.38E-04
HumanNet	MF	GO:0008276	protein methyltransferase activity	-	96	94	-	-	2.55E-01	4.09E-03
HumanNet	MF	GO:0008289	lipid binding	1.23E-03	836	823	807	1.02	-	-
HumanNet	BP	GO:0008299	isoprenoid biosynthetic process	-	30	29	-	-	9.43E-02	1.29E-03
HumanNet	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	3.64E-02	8.07E-04
HumanNet	MF	GO:0008327	methyl-CpG binding	-	31	30	-	-	1.79E-01	1.29E-03
HumanNet	CC	GO:0008333	endosome to lysosome transport	-	73	70	-	-	8.98E-02	3.01E-03
HumanNet	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	2.10E-03	1.02E-03
HumanNet	BP	GO:0008360	regulation of cell shape	-	139	135	-	-	6.00E-02	5.81E-03
HumanNet	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.01E-01	1.18E-03
HumanNet	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	140	-	-	1.62E-01	6.02E-03
HumanNet	MF	GO:0008527	taste receptor activity	-	28	26	-	-	6.43E-02	1.13E-03
HumanNet	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	9.35E-02	1.88E-03
HumanNet	BP	GO:0008637	apoptotic mitochondrial changes	-	108	102	-	-	7.54E-02	4.41E-03
HumanNet	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	117	-	-	1.15E-01	5.06E-03
HumanNet	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	4.11E-01	1.08E-03
HumanNet	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	20	-	-	2.65E-01	8.61E-04
HumanNet	BP	GO:0009110	vitamin biosynthetic process	-	23	23	-	-	6.58E-03	1.02E-03
HumanNet	BP	GO:0009111	vitamin catabolic process	-	13	13	-	-	6.20E-02	5.92E-04
HumanNet	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	3.55E-02	6.99E-04
HumanNet	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	1.81E-01	1.08E-03
HumanNet	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	3.30E-01	8.61E-04
HumanNet	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	41	-	-	1.02E-01	1.78E-03
HumanNet	BP	GO:0009267	cellular response to starvation	-	170	168	-	-	5.01E-02	7.26E-03
HumanNet	BP	GO:0009268	response to pH	-	43	43	-	-	3.62E-02	1.88E-03
HumanNet	BP	GO:0009303	rRNA transcription	-	37	37	-	-	3.44E-02	1.61E-03
HumanNet	BP	GO:0009309	amine biosynthetic process	-	38	37	-	-	1.20E-01	1.61E-03
HumanNet	BP	GO:0009310	amine catabolic process	-	20	18	-	-	2.64E-02	8.07E-04
HumanNet	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	1.30E-02	7.53E-04
HumanNet	BP	GO:0009451	RNA modification	-	169	165	-	-	4.48E-01	7.10E-03
HumanNet	BP	GO:0009566	fertilization	-	205	200	-	-	5.56E-02	8.61E-03
HumanNet	BP	GO:0009581	detection of external stimulus	-	137	135	-	-	1.06E-01	5.81E-03
HumanNet	BP	GO:0009582	detection of abiotic stimulus	-	140	138	-	-	1.11E-01	5.97E-03
HumanNet	BP	GO:0009612	response to mechanical stimulus	-	215	210	-	-	1.97E-02	9.04E-03
HumanNet	BP	GO:0009649	entrainment of circadian clock	-	30	29	-	-	2.21E-02	1.29E-03
HumanNet	BP	GO:0009755	hormone-mediated signaling pathway	-	221	218	-	-	6.29E-02	9.41E-03
HumanNet	BP	GO:0009812	flavonoid metabolic process	-	14	14	-	-	2.12E-02	6.45E-04
HumanNet	BP	GO:0009880	embryonic pattern specification	-	70	69	-	-	2.05E-02	3.01E-03
HumanNet	MF	GO:0009881	photoreceptor activity	-	17	16	-	-	1.44E-01	6.99E-04
HumanNet	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	166	-	-	9.50E-02	7.15E-03
HumanNet	MF	GO:0009975	cyclase activity	3.16E-01	277	271	268	1.01	-	-
HumanNet	BP	GO:0009994	oocyte differentiation	-	57	56	-	-	3.87E-02	2.42E-03
HumanNet	MF	GO:0010181	FMN binding	-	15	15	-	-	5.78E-03	6.45E-04
HumanNet	BP	GO:0010232	vascular transport	-	87	87	-	-	1.11E-01	3.77E-03
HumanNet	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	2.35E-02	5.38E-04
HumanNet	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	52	-	-	8.12E-02	2.26E-03
HumanNet	BP	GO:0010269	response to selenium ion	-	11	11	-	-	2.18E-01	4.84E-04
HumanNet	CC	GO:0010369	chromocenter	-	14	14	-	-	2.63E-03	6.45E-04
HumanNet	BP	GO:0010453	regulation of cell fate commitment	-	40	35	-	-	5.68E-02	1.51E-03
HumanNet	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	9.42E-02	6.45E-04
HumanNet	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	1.95E-02	1.34E-03
HumanNet	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	1.08E-02	8.07E-04
HumanNet	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	22	-	-	1.28E-03	9.68E-04
HumanNet	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	2.75E-02	5.38E-04
HumanNet	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	1.64E-03	7.53E-04
HumanNet	BP	GO:0010623	programmed cell death involved in cell development	-	25	25	-	-	3.33E-03	1.08E-03
HumanNet	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	68	-	-	6.06E-03	2.96E-03
HumanNet	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.30E-03	5.92E-04
HumanNet	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	15	-	-	2.04E-02	6.45E-04
HumanNet	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	62	-	-	5.44E-03	2.69E-03
HumanNet	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	4.40E-02	2.31E-03
HumanNet	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	1.57E-02	1.51E-03
HumanNet	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	11	-	-	1.09E-03	4.84E-04
HumanNet	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	29	-	-	1.32E-02	1.29E-03
HumanNet	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	5.93E-03	1.72E-03
HumanNet	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	43	-	-	1.89E-03	1.88E-03
HumanNet	BP	GO:0010842	retina layer formation	-	25	24	-	-	2.73E-03	1.08E-03
HumanNet	MF	GO:0010851	cyclase regulator activity	-	17	16	-	-	1.74E-02	6.99E-04
HumanNet	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	23	-	-	2.23E-02	1.02E-03
HumanNet	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	13	-	-	6.64E-02	5.92E-04
HumanNet	BP	GO:0010883	regulation of lipid storage	-	53	48	-	-	5.32E-02	2.10E-03
HumanNet	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	122	-	-	7.06E-02	5.27E-03
HumanNet	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	1.65E-01	4.84E-04
HumanNet	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	2.76E-02	4.84E-04
HumanNet	BP	GO:0012501	programmed cell death	9.75E-10	1954	1929	1887	1.02	-	-
HumanNet	BP	GO:0014004	microglia differentiation	-	12	11	-	-	1.96E-03	4.84E-04
HumanNet	BP	GO:0014029	neural crest formation	-	15	15	-	-	2.90E-02	6.45E-04
HumanNet	BP	GO:0014047	glutamate secretion	-	25	25	-	-	8.11E-03	1.08E-03
HumanNet	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	2.22E-03	1.29E-03
HumanNet	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	1.55E-03	1.13E-03
HumanNet	BP	GO:0014812	muscle cell migration	-	110	83	-	-	9.46E-03	3.60E-03
HumanNet	BP	GO:0014823	response to activity	-	70	68	-	-	7.76E-03	2.96E-03
HumanNet	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.85E-03	5.38E-04
HumanNet	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	16	-	-	3.49E-02	6.99E-04
HumanNet	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	12	-	-	9.13E-03	5.38E-04
HumanNet	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	64	-	-	6.34E-03	2.80E-03
HumanNet	MF	GO:0015026	coreceptor activity	-	48	48	-	-	1.83E-02	2.10E-03
HumanNet	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	1.26E-01	1.40E-03
HumanNet	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	75	-	-	1.35E-01	3.23E-03
HumanNet	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	40	-	-	1.80E-01	1.72E-03
HumanNet	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	138	-	-	1.73E-01	5.97E-03
HumanNet	MF	GO:0015399	primary active transmembrane transporter activity	-	190	172	-	-	9.25E-02	7.42E-03
HumanNet	CC	GO:0015464	acetylcholine receptor activity	-	21	21	-	-	9.46E-02	9.14E-04
HumanNet	MF	GO:0015562	efflux transmembrane transporter activity	-	15	15	-	-	7.85E-03	6.45E-04
HumanNet	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	32	-	-	7.27E-02	1.40E-03
HumanNet	BP	GO:0015669	gas transport	-	23	23	-	-	1.35E-01	1.02E-03
HumanNet	BP	GO:0015697	quaternary ammonium group transport	-	16	16	-	-	1.67E-02	6.99E-04
HumanNet	BP	GO:0015791	polyol transmembrane transport	-	14	12	-	-	1.29E-01	5.38E-04
HumanNet	BP	GO:0015801	aromatic amino acid transport	-	13	13	-	-	4.05E-02	5.92E-04
HumanNet	BP	GO:0015803	branched-chain amino acid transport	-	14	14	-	-	2.19E-02	6.45E-04
HumanNet	BP	GO:0015807	L-amino acid transport	-	94	92	-	-	2.27E-01	3.98E-03
HumanNet	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	1.46E-02	8.61E-04
HumanNet	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	6.67E-03	8.07E-04
HumanNet	BP	GO:0015824	proline transport	-	13	13	-	-	3.74E-02	5.92E-04
HumanNet	BP	GO:0015844	monoamine transport	-	88	87	-	-	1.22E-01	3.77E-03
HumanNet	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	50	-	-	6.08E-02	2.15E-03
HumanNet	BP	GO:0016054	organic acid catabolic process	-	251	245	-	-	1.72E-01	1.05E-02
HumanNet	BP	GO:0016071	mRNA metabolic process	2.69E-02	713	699	689	1.02	-	-
HumanNet	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	1.02E-01	8.61E-04
HumanNet	BP	GO:0016180	snRNA processing	-	28	26	-	-	1.43E-01	1.13E-03
HumanNet	BP	GO:0016192	vesicle-mediated transport	2.66E-06	1894	1862	1829	1.02	-	-
HumanNet	MF	GO:0016208	AMP binding	-	22	22	-	-	7.73E-03	9.68E-04
HumanNet	MF	GO:0016209	antioxidant activity	-	92	88	-	-	1.44E-01	3.82E-03
HumanNet	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	39	-	-	4.29E-01	1.72E-03
HumanNet	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.87E-01	5.38E-04
HumanNet	CC	GO:0016323	basolateral plasma membrane	-	239	235	-	-	4.99E-02	1.01E-02
HumanNet	CC	GO:0016327	apicolateral plasma membrane	-	23	23	-	-	4.57E-02	1.02E-03
HumanNet	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	1.18E-02	2.85E-03
HumanNet	CC	GO:0016363	nuclear matrix	-	127	126	-	-	2.23E-02	5.43E-03
HumanNet	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	1.13E-03	4.84E-04
HumanNet	CC	GO:0016482	cytosolic transport	-	135	132	-	-	6.40E-02	5.70E-03
HumanNet	BP	GO:0016485	protein processing	-	248	244	-	-	5.77E-02	1.05E-02
HumanNet	MF	GO:0016491	oxidoreductase activity	1.00E+00	888	858	858	1.00	-	-
HumanNet	MF	GO:0016500	protein-hormone receptor activity	-	21	19	-	-	1.26E-02	8.61E-04
HumanNet	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	22	-	-	2.96E-02	9.68E-04
HumanNet	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	1.20E-02	6.45E-04
HumanNet	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	5.34E-01	3.23E-03
HumanNet	CC	GO:0016592	mediator complex	-	38	36	-	-	8.72E-01	1.56E-03
HumanNet	MF	GO:0016594	glycine binding	-	12	12	-	-	3.84E-02	5.38E-04
HumanNet	MF	GO:0016740	transferase activity	4.00E-07	3074	3013	2969	1.01	-	-
HumanNet	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	245	-	-	3.68E-01	1.05E-02
HumanNet	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	1.19E-01	4.84E-04
HumanNet	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	58	-	-	8.94E-02	2.53E-03
HumanNet	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	29	-	-	6.90E-02	1.29E-03
HumanNet	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	35	-	-	2.00E-01	1.51E-03
HumanNet	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	2.36E-02	1.08E-03
HumanNet	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	78	-	-	3.52E-01	3.39E-03
HumanNet	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	141	-	-	2.21E-01	6.08E-03
HumanNet	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	137	-	-	1.19E-01	5.92E-03
HumanNet	MF	GO:0016829	lyase activity	4.04E-02	538	528	520	1.02	-	-
HumanNet	MF	GO:0016853	isomerase activity	1.17E-01	252	248	243	1.02	-	-
HumanNet	MF	GO:0016874	ligase activity	7.41E-01	283	275	273	1.01	-	-
HumanNet	MF	GO:0016917	GABA receptor activity	-	23	23	-	-	2.16E-01	1.02E-03
HumanNet	BP	GO:0017004	cytochrome complex assembly	-	40	38	-	-	8.98E-02	1.67E-03
HumanNet	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	6.96E-03	6.45E-04
HumanNet	MF	GO:0017022	myosin binding	-	73	73	-	-	2.52E-02	3.17E-03
HumanNet	MF	GO:0017069	snRNA binding	-	54	46	-	-	9.39E-02	1.99E-03
HumanNet	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	3.33E-01	4.84E-04
HumanNet	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	1.89E-01	7.53E-04
HumanNet	BP	GO:0017148	negative regulation of translation	-	390	116	-	-	3.95E-02	5.00E-03
HumanNet	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	1.68E-01	5.38E-04
HumanNet	MF	GO:0017166	vinculin binding	-	12	12	-	-	1.45E-02	5.38E-04
HumanNet	MF	GO:0017171	serine hydrolase activity	-	207	194	-	-	4.86E-01	8.39E-03
HumanNet	BP	GO:0018126	protein hydroxylation	-	26	25	-	-	1.80E-01	1.08E-03
HumanNet	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	1.47E-01	1.24E-03
HumanNet	BP	GO:0018158	protein oxidation	-	15	15	-	-	3.16E-02	6.45E-04
HumanNet	BP	GO:0018342	protein prenylation	-	15	15	-	-	9.74E-02	6.45E-04
HumanNet	BP	GO:0018410	C-terminal protein amino acid modification	-	15	14	-	-	1.14E-01	6.45E-04
HumanNet	CC	GO:0018995	host cellular component	-	12	12	-	-	1.29E-02	5.38E-04
HumanNet	MF	GO:0019003	GDP binding	-	89	87	-	-	1.07E-01	3.77E-03
HumanNet	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	3.68E-01	7.53E-04
HumanNet	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	1.55E-01	4.68E-03
HumanNet	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	42	-	-	1.57E-01	1.83E-03
HumanNet	MF	GO:0019208	phosphatase regulator activity	-	107	104	-	-	1.53E-01	4.52E-03
HumanNet	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	1.19E-02	4.84E-04
HumanNet	BP	GO:0019233	sensory perception of pain	-	103	103	-	-	3.01E-02	4.46E-03
HumanNet	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	41	-	-	9.40E-02	1.78E-03
HumanNet	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	26	-	-	9.07E-01	1.13E-03
HumanNet	BP	GO:0019755	one-carbon compound transport	-	28	26	-	-	4.35E-02	1.13E-03
HumanNet	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	8.27E-02	4.84E-04
HumanNet	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	110	-	-	1.46E-01	4.73E-03
HumanNet	MF	GO:0019825	oxygen binding	-	40	39	-	-	5.71E-02	1.72E-03
HumanNet	MF	GO:0019838	growth factor binding	-	182	181	-	-	6.15E-02	7.80E-03
HumanNet	MF	GO:0019843	rRNA binding	-	69	68	-	-	4.59E-02	2.96E-03
HumanNet	MF	GO:0019894	kinesin binding	-	45	45	-	-	5.56E-02	1.94E-03
HumanNet	CC	GO:0019897	extrinsic component of plasma membrane	-	156	153	-	-	1.56E-01	6.62E-03
HumanNet	BP	GO:0021515	cell differentiation in spinal cord	-	51	51	-	-	6.21E-02	2.21E-03
HumanNet	BP	GO:0021516	dorsal spinal cord development	-	20	20	-	-	6.75E-03	8.61E-04
HumanNet	BP	GO:0021517	ventral spinal cord development	-	47	47	-	-	3.93E-02	2.04E-03
HumanNet	BP	GO:0021533	cell differentiation in hindbrain	-	23	23	-	-	1.95E-03	1.02E-03
HumanNet	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	1.01E-03	6.99E-04
HumanNet	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	5.14E-03	8.61E-04
HumanNet	BP	GO:0021548	pons development	-	11	11	-	-	1.06E-01	4.84E-04
HumanNet	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	4.10E-03	4.84E-04
HumanNet	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.37E-03	5.38E-04
HumanNet	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	15	-	-	3.51E-03	6.45E-04
HumanNet	BP	GO:0021756	striatum development	-	21	20	-	-	1.42E-03	8.61E-04
HumanNet	BP	GO:0021782	glial cell development	-	120	116	-	-	1.55E-02	5.00E-03
HumanNet	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	3.55E-02	6.99E-04
HumanNet	BP	GO:0021794	thalamus development	-	12	12	-	-	1.63E-03	5.38E-04
HumanNet	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	1.04E-01	6.45E-04
HumanNet	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	7.86E-04	6.45E-04
HumanNet	BP	GO:0021872	forebrain generation of neurons	-	52	51	-	-	2.37E-02	2.21E-03
HumanNet	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	1.74E-02	2.74E-03
HumanNet	BP	GO:0021954	central nervous system neuron development	-	85	84	-	-	9.38E-03	3.66E-03
HumanNet	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	4.19E-02	5.92E-04
HumanNet	BP	GO:0021987	cerebral cortex development	-	125	124	-	-	2.88E-02	5.38E-03
HumanNet	BP	GO:0022038	corpus callosum development	-	25	25	-	-	1.66E-03	1.08E-03
HumanNet	BP	GO:0022401	negative adaptation of signaling pathway	-	21	21	-	-	4.62E-02	9.14E-04
HumanNet	BP	GO:0022404	molting cycle process	-	95	94	-	-	2.32E-02	4.09E-03
HumanNet	BP	GO:0022406	membrane docking	-	90	88	-	-	1.09E-01	3.82E-03
HumanNet	BP	GO:0022600	digestive system process	7.91E-01	110	106	106	1.00	-	-
HumanNet	BP	GO:0022612	gland morphogenesis	-	124	124	-	-	1.74E-02	5.38E-03
HumanNet	BP	GO:0022618	protein-RNA complex assembly	-	227	189	-	-	1.80E-01	8.18E-03
HumanNet	CC	GO:0022626	cytosolic ribosome	-	118	112	-	-	6.16E-01	4.84E-03
HumanNet	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	5.80E-02	1.51E-03
HumanNet	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	22	-	-	2.85E-02	9.68E-04
HumanNet	MF	GO:0023023	MHC protein complex binding	-	36	34	-	-	2.19E-02	1.51E-03
HumanNet	CC	GO:0030018	Z disc	-	129	128	-	-	8.45E-02	5.54E-03
HumanNet	CC	GO:0030027	lamellipodium	-	202	200	-	-	4.20E-02	8.61E-03
HumanNet	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	37	-	-	2.31E-01	1.61E-03
HumanNet	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	3.25E-01	5.92E-04
HumanNet	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	2.23E-01	8.07E-04
HumanNet	MF	GO:0030145	manganese ion binding	-	65	64	-	-	1.02E-02	2.80E-03
HumanNet	BP	GO:0030149	sphingolipid catabolic process	-	32	30	-	-	1.12E-01	1.29E-03
HumanNet	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	2.14E-02	2.21E-03
HumanNet	BP	GO:0030163	protein catabolic process	4.82E-02	990	967	956	1.01	-	-
HumanNet	BP	GO:0030168	platelet activation	-	135	135	-	-	3.84E-02	5.81E-03
HumanNet	MF	GO:0030170	pyridoxal phosphate binding	-	56	55	-	-	1.90E-01	2.37E-03
HumanNet	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	138	-	-	1.79E-02	5.97E-03
HumanNet	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	163	-	-	6.45E-02	7.05E-03
HumanNet	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	6.72E-02	3.01E-03
HumanNet	BP	GO:0030198	extracellular matrix organization	8.27E-02	314	309	303	1.02	-	-
HumanNet	MF	GO:0030215	semaphorin receptor binding	-	23	23	-	-	7.73E-01	1.02E-03
HumanNet	BP	GO:0030220	platelet formation	-	22	22	-	-	5.97E-03	9.68E-04
HumanNet	BP	GO:0030238	male sex determination	-	14	14	-	-	3.13E-02	6.45E-04
HumanNet	MF	GO:0030276	clathrin binding	-	70	69	-	-	1.66E-01	3.01E-03
HumanNet	BP	GO:0030279	negative regulation of ossification	-	39	36	-	-	1.34E-02	1.56E-03
HumanNet	CC	GO:0030286	dynein complex	-	210	202	-	-	1.52E-01	8.71E-03
HumanNet	BP	GO:0030307	positive regulation of cell growth	-	164	157	-	-	7.60E-03	6.78E-03
HumanNet	BP	GO:0030308	negative regulation of cell growth	-	191	186	-	-	8.70E-02	8.01E-03
HumanNet	CC	GO:0030315	T-tubule	-	52	52	-	-	6.52E-02	2.26E-03
HumanNet	BP	GO:0030397	membrane disassembly	-	11	11	-	-	1.15E-02	4.84E-04
HumanNet	CC	GO:0030427	site of polarized growth	-	172	172	-	-	1.63E-02	7.42E-03
HumanNet	BP	GO:0030431	sleep	-	30	30	-	-	1.83E-02	1.29E-03
HumanNet	MF	GO:0030506	ankyrin binding	-	19	19	-	-	2.31E-02	8.61E-04
HumanNet	MF	GO:0030507	spectrin binding	-	26	26	-	-	2.33E-02	1.13E-03
HumanNet	MF	GO:0030515	snoRNA binding	-	33	33	-	-	1.21E-01	1.45E-03
HumanNet	CC	GO:0030527	structural constituent of chromatin	-	97	88	-	-	7.99E-01	3.82E-03
HumanNet	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	147	-	-	5.35E-01	6.35E-03
HumanNet	MF	GO:0030552	cAMP binding	-	48	46	-	-	9.67E-02	1.99E-03
HumanNet	MF	GO:0030553	cGMP binding	-	15	14	-	-	5.93E-02	6.45E-04
HumanNet	BP	GO:0030574	collagen catabolic process	-	45	45	-	-	3.16E-01	1.94E-03
HumanNet	MF	GO:0030594	neurotransmitter receptor activity	-	160	158	-	-	4.96E-01	6.83E-03
HumanNet	CC	GO:0030658	transport vesicle membrane	-	231	225	-	-	1.08E-01	9.68E-03
HumanNet	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	58	-	-	1.21E-01	2.53E-03
HumanNet	CC	GO:0030662	coated vesicle membrane	-	202	193	-	-	1.72E-01	8.34E-03
HumanNet	CC	GO:0030666	endocytic vesicle membrane	-	196	189	-	-	3.92E-02	8.18E-03
HumanNet	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	3.28E-01	5.92E-04
HumanNet	CC	GO:0030684	preribosome	-	76	71	-	-	2.56E-01	3.07E-03
HumanNet	MF	GO:0030742	GTP-dependent protein binding	-	22	21	-	-	3.30E-02	9.14E-04
HumanNet	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	18	-	-	9.28E-04	8.07E-04
HumanNet	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	51	-	-	6.06E-03	2.21E-03
HumanNet	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	150	-	-	1.94E-02	6.45E-03
HumanNet	CC	GO:0030863	cortical cytoskeleton	-	104	103	-	-	4.26E-02	4.46E-03
HumanNet	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	2.42E-02	2.21E-03
HumanNet	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	3.37E-02	4.84E-04
HumanNet	BP	GO:0030901	midbrain development	-	87	85	-	-	1.32E-02	3.66E-03
HumanNet	CC	GO:0030904	retromer complex	-	12	12	-	-	1.72E-01	5.38E-04
HumanNet	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	7.25E-04	4.84E-04
HumanNet	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	1.63E-03	5.92E-04
HumanNet	MF	GO:0030971	receptor tyrosine kinase binding	-	76	75	-	-	5.06E-02	3.23E-03
HumanNet	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	2.60E-02	6.45E-04
HumanNet	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	8.92E-02	7.53E-04
HumanNet	MF	GO:0031005	filamin binding	-	15	13	-	-	2.24E-03	5.92E-04
HumanNet	CC	GO:0031012	extracellular matrix	5.84E-02	564	553	545	1.02	-	-
HumanNet	BP	GO:0031018	endocrine pancreas development	-	47	46	-	-	4.65E-02	1.99E-03
HumanNet	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	4.45E-01	119	117	115	1.02	-	-
HumanNet	BP	GO:0031069	hair follicle morphogenesis	-	33	32	-	-	1.23E-02	1.40E-03
HumanNet	MF	GO:0031072	heat shock protein binding	-	128	122	-	-	5.82E-02	5.27E-03
HumanNet	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	2.88E-01	5.38E-04
HumanNet	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	2.50E-03	2.85E-03
HumanNet	CC	GO:0031105	septin complex	-	14	12	-	-	8.73E-01	5.38E-04
HumanNet	BP	GO:0031123	RNA 3'-end processing	-	79	76	-	-	5.83E-02	3.28E-03
HumanNet	BP	GO:0031128	developmental induction	-	26	26	-	-	1.68E-02	1.13E-03
HumanNet	CC	GO:0031143	pseudopodium	-	18	18	-	-	3.93E-03	8.07E-04
HumanNet	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	3.35E-01	1.29E-03
HumanNet	CC	GO:0031201	SNARE complex	-	48	48	-	-	6.16E-01	2.10E-03
HumanNet	CC	GO:0031209	SCAR complex	-	12	11	-	-	2.09E-01	4.84E-04
HumanNet	MF	GO:0031210	phosphatidylcholine binding	-	32	30	-	-	8.16E-02	1.29E-03
HumanNet	CC	GO:0031261	DNA replication preinitiation complex	-	46	45	-	-	1.32E-01	1.94E-03
HumanNet	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	2.90E-01	6.99E-04
HumanNet	MF	GO:0031281	positive regulation of cyclase activity	-	40	36	-	-	2.00E-02	1.56E-03
HumanNet	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	2.24E-02	1.99E-03
HumanNet	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	111	-	-	7.51E-03	4.79E-03
HumanNet	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	1.52E-01	6.45E-04
HumanNet	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	143	-	-	5.00E-02	6.19E-03
HumanNet	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	193	-	-	1.55E-02	8.34E-03
HumanNet	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	4.95E-02	1.08E-03
HumanNet	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	9.85E-03	1.29E-03
HumanNet	BP	GO:0031343	positive regulation of cell killing	-	75	73	-	-	1.19E-01	3.17E-03
HumanNet	BP	GO:0031345	negative regulation of cell projection organization	-	195	188	-	-	8.92E-02	8.12E-03
HumanNet	BP	GO:0031348	negative regulation of defense response	-	282	241	-	-	1.36E-02	1.04E-02
HumanNet	BP	GO:0031365	N-terminal protein amino acid modification	-	30	30	-	-	1.84E-01	1.29E-03
HumanNet	MF	GO:0031369	translation initiation factor binding	-	32	32	-	-	7.94E-02	1.40E-03
HumanNet	MF	GO:0031404	chloride ion binding	-	14	14	-	-	1.33E-02	6.45E-04
HumanNet	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	3.84E-01	8.61E-04
HumanNet	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	9.85E-04	7.53E-04
HumanNet	CC	GO:0031430	M band	-	22	22	-	-	5.24E-02	9.68E-04
HumanNet	MF	GO:0031432	titin binding	-	13	13	-	-	3.56E-02	5.92E-04
HumanNet	MF	GO:0031490	chromatin DNA binding	-	120	117	-	-	4.06E-02	5.06E-03
HumanNet	CC	GO:0031519	PcG protein complex	-	38	36	-	-	4.28E-01	1.56E-03
HumanNet	BP	GO:0031529	ruffle organization	-	55	55	-	-	9.12E-03	2.37E-03
HumanNet	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	2.48E-01	5.38E-04
HumanNet	BP	GO:0031579	membrane raft organization	-	25	24	-	-	9.56E-04	1.08E-03
HumanNet	CC	GO:0031594	neuromuscular junction	-	73	73	-	-	2.72E-02	3.17E-03
HumanNet	BP	GO:0031643	positive regulation of myelination	-	19	19	-	-	1.44E-03	8.61E-04
HumanNet	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	14	-	-	1.96E-03	6.45E-04
HumanNet	MF	GO:0031681	G-protein beta-subunit binding	-	22	21	-	-	4.04E-01	9.14E-04
HumanNet	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.92E-01	9.68E-04
HumanNet	CC	GO:0031838	haptoglobin-hemoglobin complex	-	11	11	-	-	1.09E-01	4.84E-04
HumanNet	CC	GO:0031903	microbody membrane	-	65	65	-	-	2.67E-01	2.80E-03
HumanNet	CC	GO:0031904	endosome lumen	-	38	37	-	-	2.39E-02	1.61E-03
HumanNet	CC	GO:0031907	microbody lumen	-	51	50	-	-	2.88E-01	2.15E-03
HumanNet	CC	GO:0031941	filamentous actin	-	27	27	-	-	2.73E-02	1.18E-03
HumanNet	MF	GO:0031952	regulation of protein autophosphorylation	-	43	43	-	-	3.86E-03	1.88E-03
HumanNet	CC	GO:0031970	organelle envelope lumen	-	94	92	-	-	9.92E-02	3.98E-03
HumanNet	CC	GO:0032008	positive regulation of TOR signaling	-	52	51	-	-	1.11E-01	2.21E-03
HumanNet	CC	GO:0032039	integrator complex	-	19	18	-	-	2.51E-01	8.07E-04
HumanNet	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	22	-	-	2.73E-02	9.68E-04
HumanNet	BP	GO:0032094	response to food	-	37	37	-	-	8.85E-03	1.61E-03
HumanNet	BP	GO:0032098	regulation of appetite	-	20	20	-	-	1.91E-02	8.61E-04
HumanNet	CC	GO:0032154	cleavage furrow	-	54	53	-	-	1.28E-02	2.31E-03
HumanNet	MF	GO:0032182	ubiquitin-like protein binding	-	117	116	-	-	7.37E-02	5.00E-03
HumanNet	BP	GO:0032196	transposition	-	11	11	-	-	7.37E-03	4.84E-04
HumanNet	BP	GO:0032200	telomere organization	9.97E-02	186	184	180	1.02	-	-
HumanNet	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	4.27E-03	6.45E-04
HumanNet	BP	GO:0032328	alanine transport	-	19	19	-	-	4.08E-02	8.61E-04
HumanNet	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	52	-	-	3.25E-02	2.26E-03
HumanNet	CC	GO:0032365	intracellular lipid transport	-	51	48	-	-	2.02E-02	2.10E-03
HumanNet	BP	GO:0032368	regulation of lipid transport	-	149	127	-	-	1.50E-02	5.49E-03
HumanNet	CC	GO:0032387	negative regulation of intracellular transport	-	51	49	-	-	6.45E-03	2.15E-03
HumanNet	CC	GO:0032388	positive regulation of intracellular transport	-	137	134	-	-	3.69E-03	5.81E-03
HumanNet	MF	GO:0032393	MHC class I receptor activity	-	15	12	-	-	1.39E-01	5.38E-04
HumanNet	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.08E-02	4.84E-04
HumanNet	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	70	-	-	1.56E-02	3.01E-03
HumanNet	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	107	-	-	2.93E-02	4.63E-03
HumanNet	CC	GO:0032426	stereocilium tip	-	21	20	-	-	8.12E-02	8.61E-04
HumanNet	CC	GO:0032432	actin filament bundle	-	249	246	-	-	5.80E-02	1.06E-02
HumanNet	CC	GO:0032433	filopodium tip	-	19	19	-	-	4.03E-03	8.61E-04
HumanNet	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	24	-	-	2.82E-03	1.08E-03
HumanNet	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	2.01E-01	1.99E-03
HumanNet	BP	GO:0032528	microvillus organization	-	24	24	-	-	8.57E-03	1.08E-03
HumanNet	CC	GO:0032580	Golgi cisterna membrane	-	93	86	-	-	2.14E-01	3.71E-03
HumanNet	CC	GO:0032588	trans-Golgi network membrane	-	102	99	-	-	1.37E-01	4.30E-03
HumanNet	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	15	-	-	8.57E-03	6.45E-04
HumanNet	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	7.05E-04	9.68E-04
HumanNet	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	20	-	-	2.93E-02	8.61E-04
HumanNet	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	6.01E-03	5.92E-04
HumanNet	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	1.46E-01	8.07E-04
HumanNet	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	2.67E-02	4.84E-04
HumanNet	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	28	-	-	4.37E-03	1.24E-03
HumanNet	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	8.28E-02	1.51E-03
HumanNet	BP	GO:0032890	regulation of organic acid transport	-	78	76	-	-	7.75E-03	3.28E-03
HumanNet	BP	GO:0032922	circadian regulation of gene expression	-	71	70	-	-	7.35E-02	3.01E-03
HumanNet	BP	GO:0032941	secretion by tissue	-	85	80	-	-	6.63E-03	3.44E-03
HumanNet	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	4.65E-03	1.13E-03
HumanNet	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	47	-	-	3.81E-01	2.04E-03
HumanNet	CC	GO:0032982	myosin filament	-	24	23	-	-	9.28E-02	1.02E-03
HumanNet	CC	GO:0032994	protein-lipid complex	-	39	38	-	-	2.68E-01	1.67E-03
HumanNet	BP	GO:0033002	muscle cell proliferation	-	249	201	-	-	2.26E-02	8.66E-03
HumanNet	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	1.48E-01	5.92E-04
HumanNet	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	43	-	-	5.42E-02	1.88E-03
HumanNet	BP	GO:0033044	regulation of chromosome organization	-	249	247	-	-	9.19E-02	1.07E-02
HumanNet	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	92	-	-	1.60E-01	3.98E-03
HumanNet	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	78	-	-	6.48E-02	3.39E-03
HumanNet	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	3.61E-02	1.18E-03
HumanNet	BP	GO:0033120	positive regulation of RNA splicing	-	46	44	-	-	4.51E-02	1.94E-03
HumanNet	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	1.03E-01	5.38E-04
HumanNet	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	141	-	-	1.19E-02	6.08E-03
HumanNet	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	2.80E-03	5.38E-04
HumanNet	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	21	-	-	1.62E-01	9.14E-04
HumanNet	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	1.68E-01	8.07E-04
HumanNet	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	2.62E-02	1.72E-03
HumanNet	CC	GO:0033268	node of Ranvier	-	16	16	-	-	4.08E-02	6.99E-04
HumanNet	CC	GO:0033270	paranode region of axon	-	11	11	-	-	7.92E-04	4.84E-04
HumanNet	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	6.99E-03	5.38E-04
HumanNet	BP	GO:0033363	secretory granule organization	-	63	62	-	-	1.04E-01	2.69E-03
HumanNet	BP	GO:0033500	carbohydrate homeostasis	-	251	234	-	-	3.24E-02	1.01E-02
HumanNet	BP	GO:0033504	floor plate development	-	11	11	-	-	1.61E-03	4.84E-04
HumanNet	BP	GO:0033555	multicellular organismal response to stress	-	90	89	-	-	1.03E-02	3.87E-03
HumanNet	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	1.08E-01	9.68E-04
HumanNet	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	1.56E-02	8.61E-04
HumanNet	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	24	-	-	7.22E-02	1.08E-03
HumanNet	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	8.85E-02	2.58E-03
HumanNet	BP	GO:0033622	integrin activation	-	26	26	-	-	1.70E-02	1.13E-03
HumanNet	BP	GO:0033627	cell adhesion mediated by integrin	-	87	87	-	-	2.60E-01	3.77E-03
HumanNet	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	7.57E-03	1.24E-03
HumanNet	MF	GO:0033691	sialic acid binding	-	22	20	-	-	2.80E-01	8.61E-04
HumanNet	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	8.36E-02	8.61E-04
HumanNet	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	5.86E-02	4.84E-04
HumanNet	BP	GO:0034067	protein localization to Golgi apparatus	-	30	30	-	-	2.21E-02	1.29E-03
HumanNet	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	2.74E-02	5.38E-04
HumanNet	BP	GO:0034104	negative regulation of tissue remodeling	-	22	21	-	-	2.60E-02	9.14E-04
HumanNet	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	3.38E-03	4.84E-04
HumanNet	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	19	-	-	2.26E-03	8.61E-04
HumanNet	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	7.41E-02	8.61E-04
HumanNet	BP	GO:0034249	negative regulation of amide metabolic process	-	34	23	-	-	5.14E-03	1.02E-03
HumanNet	BP	GO:0034250	positive regulation of amide metabolic process	-	27	26	-	-	1.07E-03	1.13E-03
HumanNet	MF	GO:0034260	negative regulation of GTPase activity	-	36	33	-	-	2.16E-03	1.45E-03
HumanNet	BP	GO:0034330	cell junction organization	2.36E-03	727	716	702	1.02	-	-
HumanNet	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	2.40E-03	4.84E-04
HumanNet	CC	GO:0034358	plasma lipoprotein particle	-	36	35	-	-	2.56E-01	1.51E-03
HumanNet	BP	GO:0034367	protein-containing complex remodeling	-	35	34	-	-	4.43E-02	1.51E-03
HumanNet	BP	GO:0034389	lipid droplet organization	-	38	37	-	-	4.36E-02	1.61E-03
HumanNet	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	3.86E-03	2.90E-03
HumanNet	CC	GO:0034451	centriolar satellite	-	120	119	-	-	7.57E-02	5.16E-03
HumanNet	MF	GO:0034452	dynactin binding	-	12	12	-	-	5.96E-03	5.38E-04
HumanNet	CC	GO:0034455	t-UTP complex	-	53	48	-	-	2.24E-01	2.10E-03
HumanNet	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	7.14E-02	6.99E-04
HumanNet	BP	GO:0034502	protein localization to chromosome	-	130	128	-	-	4.05E-02	5.54E-03
HumanNet	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	9.25E-02	5.38E-04
HumanNet	BP	GO:0034605	cellular response to heat	-	66	61	-	-	1.27E-02	2.64E-03
HumanNet	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	15	-	-	6.06E-02	6.45E-04
HumanNet	CC	GO:0034709	methylosome	-	13	13	-	-	1.35E-01	5.92E-04
HumanNet	CC	GO:0034719	SMN-Sm protein complex	-	18	16	-	-	2.10E-01	6.99E-04
HumanNet	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	3.08E-02	5.92E-04
HumanNet	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	4.80E-01	4.84E-04
HumanNet	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	2.73E-03	1.08E-03
HumanNet	BP	GO:0035050	embryonic heart tube development	-	86	85	-	-	2.72E-02	3.66E-03
HumanNet	CC	GO:0035097	histone methyltransferase complex	-	63	62	-	-	1.91E-01	2.69E-03
HumanNet	BP	GO:0035107	appendage morphogenesis	-	147	145	-	-	5.30E-02	6.24E-03
HumanNet	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	3.16E-04	5.38E-04
HumanNet	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	1.21E-01	4.84E-04
HumanNet	BP	GO:0035148	tube formation	-	155	154	-	-	3.32E-02	6.67E-03
HumanNet	MF	GO:0035173	histone kinase activity	-	17	17	-	-	7.58E-03	7.53E-04
HumanNet	BP	GO:0035188	hatching	-	27	27	-	-	9.20E-04	1.18E-03
HumanNet	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	8.15E-03	5.92E-04
HumanNet	MF	GO:0035254	glutamate receptor binding	-	47	45	-	-	8.91E-03	1.94E-03
HumanNet	BP	GO:0035272	exocrine system development	-	46	46	-	-	1.34E-02	1.99E-03
HumanNet	BP	GO:0035304	regulation of protein dephosphorylation	-	87	86	-	-	2.46E-02	3.71E-03
HumanNet	BP	GO:0035315	hair cell differentiation	-	52	52	-	-	6.38E-02	2.26E-03
HumanNet	MF	GO:0035325	Toll-like receptor binding	-	13	12	-	-	4.66E-02	5.38E-04
HumanNet	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	13	-	-	4.72E-02	5.92E-04
HumanNet	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	5.88E-02	1.02E-03
HumanNet	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	1.59E-01	5.38E-04
HumanNet	BP	GO:0035524	proline transmembrane transport	-	12	12	-	-	1.01E-02	5.38E-04
HumanNet	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	7.36E-03	5.38E-04
HumanNet	BP	GO:0035601	protein deacylation	-	56	56	-	-	1.30E-01	2.42E-03
HumanNet	MF	GO:0035613	RNA stem-loop binding	-	21	16	-	-	2.39E-02	6.99E-04
HumanNet	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	3.99E-03	6.45E-04
HumanNet	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	9.64E-03	4.84E-04
HumanNet	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	12	-	-	9.60E-03	5.38E-04
HumanNet	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	2.72E-03	6.45E-04
HumanNet	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	2.06E-02	6.45E-04
HumanNet	BP	GO:0035878	nail development	-	11	11	-	-	9.34E-03	4.84E-04
HumanNet	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	3.24E-02	5.38E-04
HumanNet	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	9.51E-04	8.61E-04
HumanNet	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	95	-	-	5.81E-02	4.09E-03
HumanNet	BP	GO:0035988	chondrocyte proliferation	-	24	23	-	-	6.45E-03	1.02E-03
HumanNet	MF	GO:0036002	pre-mRNA binding	-	57	35	-	-	4.29E-02	1.51E-03
HumanNet	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	2.82E-02	1.18E-03
HumanNet	CC	GO:0036019	endolysosome	-	29	29	-	-	3.54E-02	1.29E-03
HumanNet	CC	GO:0036038	MKS complex	-	13	13	-	-	7.15E-02	5.92E-04
HumanNet	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	1.53E-02	5.92E-04
HumanNet	BP	GO:0036315	cellular response to sterol	-	24	21	-	-	1.19E-02	9.14E-04
HumanNet	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	1.17E-02	8.61E-04
HumanNet	CC	GO:0036379	myofilament	-	26	25	-	-	2.63E-01	1.08E-03
HumanNet	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	3.17E-03	4.84E-04
HumanNet	MF	GO:0038024	cargo receptor activity	4.44E-01	117	115	113	1.02	-	-
HumanNet	MF	GO:0038024	cargo receptor activity	-	121	115	-	-	9.14E-02	4.95E-03
HumanNet	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	2.69E-02	6.45E-04
HumanNet	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	14	-	-	1.33E-03	6.45E-04
HumanNet	BP	GO:0038179	neurotrophin signaling pathway	-	38	37	-	-	1.58E-02	1.61E-03
HumanNet	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	4.45E-02	5.38E-04
HumanNet	MF	GO:0038187	pattern recognition receptor activity	-	33	33	-	-	3.49E-02	1.45E-03
HumanNet	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	86	-	-	9.59E-03	3.71E-03
HumanNet	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	3.86E-02	1.29E-03
HumanNet	MF	GO:0039706	co-receptor binding	-	14	14	-	-	4.43E-02	6.45E-04
HumanNet	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	11	-	-	3.10E-04	4.84E-04
HumanNet	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	1.21E-02	1.34E-03
HumanNet	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	2.30E-03	1.02E-03
HumanNet	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	4.75E-03	8.07E-04
HumanNet	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	5.12E-02	6.45E-04
HumanNet	BP	GO:0042044	fluid transport	-	35	33	-	-	7.83E-02	1.45E-03
HumanNet	BP	GO:0042060	wound healing	3.96E-04	431	428	416	1.03	-	-
HumanNet	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	6.34E-03	8.61E-04
HumanNet	BP	GO:0042092	type 2 immune response	-	41	41	-	-	1.88E-02	1.78E-03
HumanNet	BP	GO:0042177	negative regulation of protein catabolic process	-	109	105	-	-	9.85E-03	4.52E-03
HumanNet	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	4.88E-02	1.08E-03
HumanNet	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	8.42E-03	6.45E-04
HumanNet	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	30	-	-	2.54E-02	1.29E-03
HumanNet	BP	GO:0042254	ribosome biogenesis	2.56E-01	297	291	287	1.01	-	-
HumanNet	MF	GO:0042287	MHC protein binding	-	68	54	-	-	6.17E-02	2.37E-03
HumanNet	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	9.56E-04	5.38E-04
HumanNet	MF	GO:0042393	histone binding	7.01E-02	237	234	229	1.02	-	-
HumanNet	MF	GO:0042393	histone binding	-	240	234	-	-	1.08E-01	1.01E-02
HumanNet	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	44	-	-	2.53E-02	1.94E-03
HumanNet	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	6.13E-03	5.38E-04
HumanNet	BP	GO:0042440	pigment metabolic process	-	80	78	-	-	1.35E-01	3.39E-03
HumanNet	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	2.73E-02	5.38E-04
HumanNet	BP	GO:0042490	mechanoreceptor differentiation	-	67	67	-	-	9.41E-02	2.90E-03
HumanNet	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	1.99E-01	1.18E-03
HumanNet	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.01E-01	6.45E-04
HumanNet	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	8.00E-03	4.84E-04
HumanNet	CC	GO:0042641	actomyosin	-	77	77	-	-	7.43E-02	3.33E-03
HumanNet	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	7.13E-02	1.94E-03
HumanNet	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	30	-	-	7.51E-02	1.29E-03
HumanNet	BP	GO:0042753	positive regulation of circadian rhythm	-	18	18	-	-	1.46E-02	8.07E-04
HumanNet	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	3.34E-02	5.38E-04
HumanNet	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	6.55E-02	8.01E-03
HumanNet	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	84	-	-	1.43E-01	3.66E-03
HumanNet	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	55	-	-	1.08E-01	2.37E-03
HumanNet	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	44	-	-	4.93E-02	1.94E-03
HumanNet	MF	GO:0042805	actinin binding	-	36	36	-	-	8.44E-02	1.56E-03
HumanNet	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	4.40E-02	6.99E-04
HumanNet	BP	GO:0042832	defense response to protozoan	-	28	26	-	-	8.96E-03	1.13E-03
HumanNet	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	2.53E-02	1.34E-03
HumanNet	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	27	-	-	3.27E-02	1.18E-03
HumanNet	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	4.32E-03	6.99E-04
HumanNet	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	3.68E-02	6.45E-04
HumanNet	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	4.34E-03	1.67E-03
HumanNet	MF	GO:0043021	ribonucleoprotein complex binding	-	158	152	-	-	3.24E-02	6.56E-03
HumanNet	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	40	-	-	4.71E-02	1.72E-03
HumanNet	CC	GO:0043034	costamere	-	18	18	-	-	1.12E-02	8.07E-04
HumanNet	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	5.70E-02	1.08E-03
HumanNet	CC	GO:0043073	germ cell nucleus	-	67	66	-	-	1.56E-02	2.85E-03
HumanNet	CC	GO:0043083	synaptic cleft	-	21	21	-	-	3.22E-02	9.14E-04
HumanNet	BP	GO:0043101	purine-containing compound salvage	-	15	14	-	-	2.30E-01	6.45E-04
HumanNet	CC	GO:0043113	receptor clustering	-	51	49	-	-	8.14E-03	2.15E-03
HumanNet	BP	GO:0043114	regulation of vascular permeability	-	49	48	-	-	6.74E-03	2.10E-03
HumanNet	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	191	-	-	8.91E-02	8.23E-03
HumanNet	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	4.06E-02	6.45E-04
HumanNet	BP	GO:0043171	peptide catabolic process	-	19	17	-	-	2.66E-01	7.53E-04
HumanNet	CC	GO:0043194	axon initial segment	-	21	21	-	-	9.62E-02	9.14E-04
HumanNet	CC	GO:0043198	dendritic shaft	-	38	38	-	-	3.69E-03	1.67E-03
HumanNet	CC	GO:0043204	perikaryon	-	156	156	-	-	6.77E-03	6.72E-03
HumanNet	CC	GO:0043220	Schmidt-Lanterman incisure	-	11	11	-	-	3.54E-03	4.84E-04
HumanNet	MF	GO:0043236	laminin binding	-	29	28	-	-	7.66E-03	1.24E-03
HumanNet	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	1.33E-01	5.92E-04
HumanNet	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	33	-	-	6.56E-03	1.45E-03
HumanNet	BP	GO:0043248	proteasome assembly	-	13	13	-	-	3.54E-02	5.92E-04
HumanNet	MF	GO:0043274	phospholipase binding	-	23	23	-	-	3.52E-03	1.02E-03
HumanNet	CC	GO:0043292	contractile muscle fiber	-	245	242	-	-	2.58E-01	1.04E-02
HumanNet	BP	GO:0043299	leukocyte degranulation	-	82	82	-	-	2.34E-02	3.55E-03
HumanNet	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	29	-	-	5.34E-03	1.29E-03
HumanNet	BP	GO:0043331	response to dsRNA	-	56	56	-	-	3.37E-02	2.42E-03
HumanNet	MF	GO:0043394	proteoglycan binding	-	36	36	-	-	1.03E-02	1.56E-03
HumanNet	BP	GO:0043414	macromolecule methylation	-	138	133	-	-	2.20E-01	5.76E-03
HumanNet	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	169	-	-	1.34E-02	7.32E-03
HumanNet	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	59	-	-	6.19E-03	2.58E-03
HumanNet	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	4.44E-02	5.38E-04
HumanNet	BP	GO:0043523	regulation of neuron apoptotic process	-	218	212	-	-	1.51E-02	9.14E-03
HumanNet	MF	GO:0043531	ADP binding	-	38	37	-	-	1.35E-03	1.61E-03
HumanNet	BP	GO:0043543	protein acylation	-	107	104	-	-	2.34E-01	4.52E-03
HumanNet	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	7.69E-02	1.34E-03
HumanNet	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	2.23E-02	9.68E-04
HumanNet	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	8.79E-03	5.92E-04
HumanNet	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	5.01E-02	5.92E-04
HumanNet	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	7.78E-02	9.68E-04
HumanNet	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	7.29E-03	1.08E-03
HumanNet	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	1.62E-03	5.38E-04
HumanNet	BP	GO:0043605	amide catabolic process	-	16	16	-	-	3.64E-02	6.99E-04
HumanNet	BP	GO:0043647	inositol phosphate metabolic process	-	44	44	-	-	3.06E-01	1.94E-03
HumanNet	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	60	-	-	2.06E-02	2.58E-03
HumanNet	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	14	-	-	1.43E-02	6.45E-04
HumanNet	BP	GO:0043954	cellular component maintenance	-	72	70	-	-	1.57E-02	3.01E-03
HumanNet	BP	GO:0044088	regulation of vacuole organization	-	56	54	-	-	1.17E-02	2.37E-03
HumanNet	MF	GO:0044183	protein folding chaperone	-	67	57	-	-	5.70E-02	2.47E-03
HumanNet	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	1.61E-02	4.84E-04
HumanNet	CC	GO:0044232	organelle membrane contact site	-	50	49	-	-	5.25E-02	2.15E-03
HumanNet	BP	GO:0044242	cellular lipid catabolic process	-	224	219	-	-	9.26E-02	9.47E-03
HumanNet	CC	GO:0044292	dendrite terminus	-	13	13	-	-	2.02E-03	5.92E-04
HumanNet	CC	GO:0044298	cell body membrane	-	32	32	-	-	5.10E-03	1.40E-03
HumanNet	CC	GO:0044306	neuron projection terminus	-	164	164	-	-	3.81E-02	7.10E-03
HumanNet	CC	GO:0044309	neuron spine	-	213	212	-	-	2.87E-02	9.14E-03
HumanNet	BP	GO:0044319	"wound healing, spreading of cells"	-	37	34	-	-	1.01E-02	1.51E-03
HumanNet	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	1.91E-01	1.08E-03
HumanNet	MF	GO:0044325	transmembrane transporter binding	-	159	156	-	-	3.41E-02	6.72E-03
HumanNet	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	3.14E-02	2.47E-03
HumanNet	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	1.16E-01	1.61E-03
HumanNet	CC	GO:0044391	ribosomal subunit	-	203	197	-	-	5.74E-01	8.50E-03
HumanNet	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	4.86E-03	7.53E-04
HumanNet	MF	GO:0044548	S100 protein binding	-	14	14	-	-	3.03E-02	6.45E-04
HumanNet	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.79E-02	5.38E-04
HumanNet	BP	GO:0044703	multi-organism reproductive process	-	209	201	-	-	1.97E-02	8.66E-03
HumanNet	BP	GO:0044706	multi-multicellular organism process	-	217	208	-	-	1.89E-02	8.98E-03
HumanNet	BP	GO:0044782	cilium organization	4.02E-01	399	389	385	1.01	-	-
HumanNet	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	2.85E-02	1.94E-03
HumanNet	BP	GO:0044848	biological phase	-	211	207	-	-	1.99E-01	8.93E-03
HumanNet	CC	GO:0044853	plasma membrane raft	-	114	113	-	-	1.63E-02	4.89E-03
HumanNet	CC	GO:0045009	chitosome	-	21	21	-	-	5.64E-02	9.14E-04
HumanNet	BP	GO:0045017	glycerolipid biosynthetic process	-	254	244	-	-	3.08E-01	1.05E-02
HumanNet	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	8.17E-04	5.92E-04
HumanNet	CC	GO:0045022	early endosome to late endosome transport	-	44	43	-	-	4.06E-02	1.88E-03
HumanNet	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	2.05E-01	1.72E-03
HumanNet	BP	GO:0045048	protein insertion into ER membrane	-	30	29	-	-	6.10E-01	1.29E-03
HumanNet	BP	GO:0045056	transcytosis	-	20	20	-	-	6.87E-03	8.61E-04
HumanNet	BP	GO:0045058	T cell selection	-	53	52	-	-	3.25E-02	2.26E-03
HumanNet	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	92	-	-	4.16E-01	3.98E-03
HumanNet	CC	GO:0045120	pronucleus	-	14	14	-	-	9.05E-04	6.45E-04
HumanNet	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	1.41E-02	5.38E-04
HumanNet	CC	GO:0045171	intercellular bridge	-	91	86	-	-	2.36E-02	3.71E-03
HumanNet	BP	GO:0045176	apical protein localization	-	15	15	-	-	1.80E-02	6.45E-04
HumanNet	MF	GO:0045182	translation regulator activity	1.09E-02	151	151	146	1.04	-	-
HumanNet	BP	GO:0045185	maintenance of protein location	-	95	92	-	-	1.89E-02	3.98E-03
HumanNet	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	18	-	-	2.79E-01	8.07E-04
HumanNet	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	7.14E-03	5.92E-04
HumanNet	CC	GO:0045324	late endosome to vacuole transport	-	37	35	-	-	5.59E-01	1.51E-03
HumanNet	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	2.06E-02	6.45E-04
HumanNet	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	37	-	-	5.42E-03	1.61E-03
HumanNet	BP	GO:0045494	photoreceptor cell maintenance	-	43	43	-	-	6.24E-02	1.88E-03
HumanNet	CC	GO:0045495	pole plasm	-	25	24	-	-	2.78E-01	1.08E-03
HumanNet	MF	GO:0045504	dynein heavy chain binding	-	16	15	-	-	1.81E-01	6.45E-04
HumanNet	MF	GO:0045505	dynein intermediate chain binding	-	37	36	-	-	2.14E-01	1.56E-03
HumanNet	BP	GO:0045598	regulation of fat cell differentiation	-	148	132	-	-	1.32E-02	5.70E-03
HumanNet	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	18	-	-	1.98E-03	8.07E-04
HumanNet	BP	GO:0045661	regulation of myoblast differentiation	-	74	72	-	-	4.63E-02	3.12E-03
HumanNet	BP	GO:0045666	positive regulation of neuron differentiation	-	91	87	-	-	1.47E-02	3.77E-03
HumanNet	BP	GO:0045667	regulation of osteoblast differentiation	-	147	125	-	-	4.62E-02	5.38E-03
HumanNet	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	2.12E-03	5.92E-04
HumanNet	BP	GO:0045684	positive regulation of epidermis development	-	33	32	-	-	3.32E-03	1.40E-03
HumanNet	BP	GO:0045685	regulation of glial cell differentiation	-	77	74	-	-	1.10E-02	3.23E-03
HumanNet	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	8.66E-03	8.07E-04
HumanNet	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	18	-	-	1.10E-02	8.07E-04
HumanNet	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	1.12E-02	8.61E-04
HumanNet	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	21	-	-	1.99E-03	9.14E-04
HumanNet	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	3.04E-02	6.45E-04
HumanNet	BP	GO:0045727	positive regulation of translation	-	141	137	-	-	2.94E-02	5.92E-03
HumanNet	BP	GO:0045732	positive regulation of protein catabolic process	-	202	198	-	-	2.55E-02	8.55E-03
HumanNet	BP	GO:0045738	negative regulation of DNA repair	-	40	38	-	-	3.56E-02	1.67E-03
HumanNet	BP	GO:0045739	positive regulation of DNA repair	-	128	125	-	-	2.10E-01	5.38E-03
HumanNet	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	57	-	-	1.63E-02	2.47E-03
HumanNet	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	33	-	-	1.17E-03	1.45E-03
HumanNet	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	1.06E-02	1.56E-03
HumanNet	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	43	-	-	2.09E-02	1.88E-03
HumanNet	BP	GO:0045778	positive regulation of ossification	-	51	50	-	-	1.46E-02	2.15E-03
HumanNet	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	2.74E-03	8.07E-04
HumanNet	BP	GO:0045807	positive regulation of endocytosis	-	155	152	-	-	1.27E-02	6.56E-03
HumanNet	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	110	-	-	6.46E-02	4.73E-03
HumanNet	BP	GO:0045830	positive regulation of isotype switching	-	28	27	-	-	1.99E-02	1.18E-03
HumanNet	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	7.42E-02	6.99E-04
HumanNet	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	36	-	-	6.12E-02	1.56E-03
HumanNet	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	37	-	-	1.35E-02	1.61E-03
HumanNet	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	1.11E-02	1.29E-03
HumanNet	BP	GO:0045932	negative regulation of muscle contraction	-	24	20	-	-	3.88E-03	8.61E-04
HumanNet	BP	GO:0045933	positive regulation of muscle contraction	-	49	47	-	-	7.73E-03	2.04E-03
HumanNet	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	34	-	-	2.53E-02	1.51E-03
HumanNet	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	7.04E-03	8.07E-04
HumanNet	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	4.48E-02	8.07E-04
HumanNet	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	5.21E-03	6.99E-04
HumanNet	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	6.60E-03	6.45E-04
HumanNet	MF	GO:0046332	SMAD binding	-	77	76	-	-	1.09E-01	3.28E-03
HumanNet	BP	GO:0046415	urate metabolic process	-	12	12	-	-	1.80E-02	5.38E-04
HumanNet	BP	GO:0046434	organophosphate catabolic process	-	232	228	-	-	1.03E-01	9.84E-03
HumanNet	BP	GO:0046460	neutral lipid biosynthetic process	-	50	46	-	-	2.19E-01	1.99E-03
HumanNet	BP	GO:0046504	glycerol ether biosynthetic process	-	11	11	-	-	1.22E-01	4.84E-04
HumanNet	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	3.65E-02	2.37E-03
HumanNet	BP	GO:0046618	xenobiotic export from cell	-	27	14	-	-	1.35E-02	6.45E-04
HumanNet	BP	GO:0046621	negative regulation of organ growth	-	39	32	-	-	1.28E-02	1.40E-03
HumanNet	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	1.46E-02	1.83E-03
HumanNet	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	6.88E-03	1.51E-03
HumanNet	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	3.15E-03	1.08E-03
HumanNet	BP	GO:0046660	female sex differentiation	-	125	125	-	-	2.54E-02	5.38E-03
HumanNet	BP	GO:0046661	male sex differentiation	-	171	169	-	-	7.58E-02	7.32E-03
HumanNet	BP	GO:0046697	decidualization	-	26	25	-	-	2.24E-03	1.08E-03
HumanNet	MF	GO:0046790	virion binding	-	19	18	-	-	3.52E-03	8.07E-04
HumanNet	MF	GO:0046812	host cell surface binding	-	11	11	-	-	3.04E-03	4.84E-04
HumanNet	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	2.54E-01	6.99E-04
HumanNet	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	9.44E-02	2.15E-03
HumanNet	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	3.25E-02	1.29E-03
HumanNet	CC	GO:0046930	pore complex	-	26	26	-	-	2.82E-02	1.13E-03
HumanNet	BP	GO:0046931	pore complex assembly	-	21	21	-	-	3.82E-02	9.14E-04
HumanNet	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	6.52E-03	4.84E-04
HumanNet	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	1.27E-02	6.99E-04
HumanNet	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	3.90E-02	1.45E-03
HumanNet	MF	GO:0048018	receptor ligand activity	8.07E-02	504	494	487	1.01	-	-
HumanNet	MF	GO:0048019	receptor antagonist activity	-	31	26	-	-	2.49E-01	1.13E-03
HumanNet	MF	GO:0048038	quinone binding	-	16	15	-	-	2.43E-02	6.45E-04
HumanNet	BP	GO:0048145	regulation of fibroblast proliferation	-	87	83	-	-	6.12E-03	3.60E-03
HumanNet	MF	GO:0048156	tau protein binding	-	43	43	-	-	8.11E-03	1.88E-03
HumanNet	CC	GO:0048167	regulation of synaptic plasticity	-	210	191	-	-	2.72E-02	8.23E-03
HumanNet	MF	GO:0048185	activin binding	-	16	16	-	-	1.47E-01	6.99E-04
HumanNet	CC	GO:0048208	COPII vesicle coating	-	27	26	-	-	8.95E-02	1.13E-03
HumanNet	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	1.66E-01	6.99E-04
HumanNet	BP	GO:0048278	vesicle docking	-	64	63	-	-	1.13E-01	2.74E-03
HumanNet	MF	GO:0048306	calcium-dependent protein binding	-	61	61	-	-	5.51E-02	2.64E-03
HumanNet	BP	GO:0048308	organelle inheritance	-	14	13	-	-	1.23E-03	5.92E-04
HumanNet	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	3.18E-02	4.84E-04
HumanNet	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	2.11E-02	9.68E-04
HumanNet	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	1.13E-02	4.84E-04
HumanNet	BP	GO:0048515	spermatid differentiation	-	208	203	-	-	5.50E-02	8.77E-03
HumanNet	BP	GO:0048520	positive regulation of behavior	-	27	27	-	-	2.94E-02	1.18E-03
HumanNet	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	1.28E-02	5.38E-04
HumanNet	BP	GO:0048524	positive regulation of viral process	-	64	63	-	-	2.73E-03	2.74E-03
HumanNet	BP	GO:0048525	negative regulation of viral process	-	90	87	-	-	6.39E-02	3.77E-03
HumanNet	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	1.84E-02	6.99E-04
HumanNet	BP	GO:0048588	developmental cell growth	-	233	222	-	-	7.29E-02	9.57E-03
HumanNet	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	2.78E-02	3.39E-03
HumanNet	BP	GO:0048645	animal organ formation	-	62	61	-	-	3.02E-02	2.64E-03
HumanNet	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	138	-	-	1.67E-02	5.97E-03
HumanNet	BP	GO:0048663	neuron fate commitment	-	74	74	-	-	8.35E-02	3.23E-03
HumanNet	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.26E-03	1.08E-03
HumanNet	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	7.99E-03	3.66E-03
HumanNet	BP	GO:0048709	oligodendrocyte differentiation	-	101	99	-	-	4.59E-02	4.30E-03
HumanNet	BP	GO:0048753	pigment granule organization	-	40	40	-	-	2.73E-01	1.72E-03
HumanNet	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	9.41E-04	4.84E-04
HumanNet	CC	GO:0048786	presynaptic active zone	-	80	79	-	-	5.75E-02	3.44E-03
HumanNet	BP	GO:0048799	animal organ maturation	-	33	30	-	-	1.75E-03	1.29E-03
HumanNet	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	5.60E-03	5.92E-04
HumanNet	BP	GO:0048857	neural nucleus development	-	65	64	-	-	4.82E-03	2.80E-03
HumanNet	BP	GO:0048864	stem cell development	-	88	88	-	-	2.32E-01	3.82E-03
HumanNet	BP	GO:0048870	cell motility	1.70E-08	1659	1638	1602	1.02	-	-
HumanNet	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	6.17E-03	6.45E-04
HumanNet	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	1.06E-02	1.45E-03
HumanNet	BP	GO:0050435	amyloid-beta metabolic process	-	65	52	-	-	4.08E-02	2.26E-03
HumanNet	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	83	-	-	2.82E-02	3.60E-03
HumanNet	BP	GO:0050688	regulation of defense response to virus	-	65	64	-	-	2.83E-02	2.80E-03
HumanNet	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	241	-	-	3.67E-02	1.04E-02
HumanNet	BP	GO:0050768	negative regulation of neurogenesis	-	150	146	-	-	1.27E-01	6.29E-03
HumanNet	BP	GO:0050769	positive regulation of neurogenesis	-	240	234	-	-	2.69E-02	1.01E-02
HumanNet	BP	GO:0050777	negative regulation of immune response	-	196	188	-	-	2.04E-02	8.12E-03
HumanNet	BP	GO:0050779	RNA destabilization	-	135	98	-	-	1.83E-01	4.25E-03
HumanNet	CC	GO:0050805	negative regulation of synaptic transmission	-	55	54	-	-	8.86E-03	2.37E-03
HumanNet	CC	GO:0050806	positive regulation of synaptic transmission	-	171	153	-	-	2.07E-02	6.62E-03
HumanNet	MF	GO:0050811	GABA receptor binding	-	18	17	-	-	2.38E-03	7.53E-04
HumanNet	BP	GO:0050819	negative regulation of coagulation	-	54	53	-	-	1.17E-01	2.31E-03
HumanNet	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.67E-02	1.29E-03
HumanNet	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	39	-	-	1.66E-02	1.72E-03
HumanNet	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	3.46E-03	1.08E-03
HumanNet	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	1.75E-02	1.40E-03
HumanNet	BP	GO:0050866	negative regulation of cell activation	-	216	206	-	-	2.31E-02	8.88E-03
HumanNet	BP	GO:0050877	nervous system process	2.35E-10	1527	1427	1475	0.97	-	-
HumanNet	BP	GO:0050879	multicellular organismal movement	-	118	117	-	-	1.95E-02	5.06E-03
HumanNet	BP	GO:0050886	endocrine process	-	93	92	-	-	3.72E-02	3.98E-03
HumanNet	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	8.04E-02	6.45E-04
HumanNet	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	2.82E-02	1.24E-03
HumanNet	BP	GO:0050953	sensory perception of light stimulus	-	223	215	-	-	2.78E-01	9.25E-03
HumanNet	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	174	-	-	1.56E-01	7.53E-03
HumanNet	BP	GO:0050994	regulation of lipid catabolic process	-	61	60	-	-	1.70E-02	2.58E-03
HumanNet	MF	GO:0051015	actin filament binding	-	208	207	-	-	1.25E-01	8.93E-03
HumanNet	BP	GO:0051017	actin filament bundle assembly	-	161	153	-	-	2.04E-02	6.62E-03
HumanNet	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	1.80E-01	2.26E-03
HumanNet	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	67	-	-	3.10E-02	2.90E-03
HumanNet	MF	GO:0051087	protein-folding chaperone binding	-	135	130	-	-	5.26E-02	5.59E-03
HumanNet	MF	GO:0051100	negative regulation of binding	-	161	155	-	-	4.61E-03	6.67E-03
HumanNet	MF	GO:0051117	ATPase binding	-	85	82	-	-	1.05E-02	3.55E-03
HumanNet	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	9.24E-03	9.68E-04
HumanNet	BP	GO:0051147	regulation of muscle cell differentiation	-	162	136	-	-	1.74E-02	5.86E-03
HumanNet	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	38	-	-	1.06E-01	1.67E-03
HumanNet	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	3.51E-02	3.98E-03
HumanNet	BP	GO:0051222	positive regulation of protein transport	-	249	241	-	-	1.17E-02	1.04E-02
HumanNet	BP	GO:0051224	negative regulation of protein transport	-	122	106	-	-	8.59E-03	4.57E-03
HumanNet	BP	GO:0051231	spindle elongation	-	14	13	-	-	1.51E-02	5.92E-04
HumanNet	CC	GO:0051233	spindle midzone	-	36	35	-	-	1.37E-02	1.51E-03
HumanNet	BP	GO:0051236	establishment of RNA localization	-	161	158	-	-	2.69E-01	6.83E-03
HumanNet	BP	GO:0051255	spindle midzone assembly	-	14	13	-	-	1.12E-02	5.92E-04
HumanNet	BP	GO:0051259	protein complex oligomerization	-	251	248	-	-	1.60E-01	1.07E-02
HumanNet	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	132	-	-	2.80E-02	5.70E-03
HumanNet	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	2.59E-02	5.92E-04
HumanNet	BP	GO:0051293	establishment of spindle localization	-	57	55	-	-	2.22E-02	2.37E-03
HumanNet	BP	GO:0051299	centrosome separation	-	15	15	-	-	3.58E-03	6.45E-04
HumanNet	BP	GO:0051303	establishment of chromosome localization	-	104	99	-	-	7.20E-02	4.30E-03
HumanNet	BP	GO:0051304	chromosome separation	-	80	79	-	-	6.73E-02	3.44E-03
HumanNet	MF	GO:0051349	positive regulation of lyase activity	-	41	37	-	-	1.82E-02	1.61E-03
HumanNet	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	60	-	-	6.11E-03	2.58E-03
HumanNet	MF	GO:0051378	serotonin binding	-	24	24	-	-	5.20E-02	1.08E-03
HumanNet	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	1.09E-01	6.99E-04
HumanNet	MF	GO:0051427	hormone receptor binding	-	31	31	-	-	7.39E-02	1.34E-03
HumanNet	BP	GO:0051445	regulation of meiotic cell cycle	-	64	62	-	-	6.32E-02	2.69E-03
HumanNet	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	6.14E-03	1.02E-03
HumanNet	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	5.42E-03	5.92E-04
HumanNet	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	154	-	-	5.05E-02	6.67E-03
HumanNet	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	180	-	-	3.12E-02	7.75E-03
HumanNet	MF	GO:0051540	metal cluster binding	-	71	67	-	-	7.56E-02	2.90E-03
HumanNet	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	24	-	-	3.42E-01	1.08E-03
HumanNet	BP	GO:0051588	regulation of neurotransmitter transport	-	99	97	-	-	2.87E-02	4.20E-03
HumanNet	BP	GO:0051593	response to folic acid	-	12	11	-	-	3.66E-02	4.84E-04
HumanNet	BP	GO:0051602	response to electrical stimulus	-	44	43	-	-	1.43E-03	1.88E-03
HumanNet	BP	GO:0051608	histamine transport	-	14	14	-	-	2.92E-03	6.45E-04
HumanNet	BP	GO:0051651	maintenance of location in cell	-	236	230	-	-	2.06E-02	9.90E-03
HumanNet	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	54	-	-	3.47E-02	2.37E-03
HumanNet	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	5.17E-03	8.07E-04
HumanNet	BP	GO:0051775	response to redox state	-	13	13	-	-	3.23E-02	5.92E-04
HumanNet	BP	GO:0051781	positive regulation of cell division	-	93	90	-	-	3.85E-02	3.87E-03
HumanNet	BP	GO:0051782	negative regulation of cell division	-	18	17	-	-	8.55E-03	7.53E-04
HumanNet	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	4.28E-02	2.74E-03
HumanNet	BP	GO:0051785	positive regulation of nuclear division	-	61	59	-	-	8.58E-03	2.58E-03
HumanNet	MF	GO:0051787	misfolded protein binding	-	20	20	-	-	5.93E-02	8.61E-04
HumanNet	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.52E-03	5.38E-04
HumanNet	MF	GO:0051861	glycolipid binding	-	30	28	-	-	9.15E-03	1.24E-03
HumanNet	BP	GO:0051873	killing by host of symbiont cells	-	28	26	-	-	1.16E-02	1.13E-03
HumanNet	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	7.23E-04	9.14E-04
HumanNet	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	107	-	-	1.12E-02	4.63E-03
HumanNet	BP	GO:0051904	pigment granule transport	-	23	23	-	-	6.67E-02	1.02E-03
HumanNet	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	4.67E-02	5.92E-04
HumanNet	BP	GO:0051931	regulation of sensory perception	-	36	36	-	-	2.32E-02	1.56E-03
HumanNet	BP	GO:0051952	regulation of amine transport	-	98	97	-	-	1.14E-01	4.20E-03
HumanNet	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	1.81E-01	1.18E-03
HumanNet	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	4.95E-02	4.84E-04
HumanNet	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	1.91E-01	1.08E-03
HumanNet	BP	GO:0055006	cardiac cell development	-	93	81	-	-	1.75E-02	3.50E-03
HumanNet	BP	GO:0055017	cardiac muscle tissue growth	-	92	73	-	-	1.39E-02	3.17E-03
HumanNet	CC	GO:0055037	recycling endosome	-	200	195	-	-	6.50E-02	8.39E-03
HumanNet	BP	GO:0055085	transmembrane transport	7.51E-02	1784	1736	1723	1.01	-	-
HumanNet	BP	GO:0055086	nucleobase-containing small molecule metabolic process	7.56E-01	729	706	704	1.00	-	-
HumanNet	BP	GO:0055088	lipid homeostasis	-	173	155	-	-	1.01E-01	6.67E-03
HumanNet	BP	GO:0055093	response to hyperoxia	-	20	18	-	-	2.63E-03	8.07E-04
HumanNet	BP	GO:0055094	response to lipoprotein particle	-	34	28	-	-	6.56E-03	1.24E-03
HumanNet	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	5.30E-03	1.29E-03
HumanNet	BP	GO:0060004	reflex	-	63	61	-	-	6.94E-03	2.64E-03
HumanNet	BP	GO:0060021	roof of mouth development	-	91	91	-	-	3.22E-02	3.93E-03
HumanNet	BP	GO:0060033	anatomical structure regression	-	16	16	-	-	4.54E-03	6.99E-04
HumanNet	BP	GO:0060037	pharyngeal system development	-	29	28	-	-	2.34E-02	1.24E-03
HumanNet	BP	GO:0060039	pericardium development	-	19	18	-	-	7.44E-03	8.07E-04
HumanNet	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	37	-	-	1.51E-02	1.61E-03
HumanNet	BP	GO:0060049	regulation of protein glycosylation	-	13	12	-	-	2.04E-03	5.38E-04
HumanNet	CC	GO:0060076	excitatory synapse	-	64	64	-	-	1.80E-02	2.80E-03
HumanNet	CC	GO:0060077	inhibitory synapse	-	20	20	-	-	4.59E-03	8.61E-04
HumanNet	BP	GO:0060119	inner ear receptor cell development	-	44	44	-	-	1.10E-01	1.94E-03
HumanNet	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	24	-	-	1.68E-02	1.08E-03
HumanNet	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	17	-	-	1.11E-02	7.53E-04
HumanNet	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	3.24E-03	8.07E-04
HumanNet	CC	GO:0060170	ciliary membrane	-	76	73	-	-	3.44E-02	3.17E-03
HumanNet	BP	GO:0060174	limb bud formation	-	11	11	-	-	4.58E-03	4.84E-04
HumanNet	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	3.18E-03	1.51E-03
HumanNet	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	58	-	-	4.05E-01	2.53E-03
HumanNet	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	1.40E-01	1.40E-03
HumanNet	BP	GO:0060325	face morphogenesis	-	31	31	-	-	2.50E-03	1.34E-03
HumanNet	BP	GO:0060343	trabecula formation	-	26	26	-	-	2.91E-03	1.13E-03
HumanNet	BP	GO:0060384	innervation	-	27	27	-	-	2.19E-03	1.18E-03
HumanNet	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	1.13E-02	8.61E-04
HumanNet	BP	GO:0060411	cardiac septum morphogenesis	-	72	69	-	-	3.64E-02	3.01E-03
HumanNet	BP	GO:0060420	regulation of heart growth	-	74	59	-	-	9.59E-03	2.58E-03
HumanNet	BP	GO:0060428	lung epithelium development	-	43	43	-	-	5.21E-03	1.88E-03
HumanNet	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	4.04E-03	4.84E-04
HumanNet	BP	GO:0060456	positive regulation of digestive system process	-	16	15	-	-	2.54E-03	6.45E-04
HumanNet	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	2.29E-03	7.53E-04
HumanNet	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	4.40E-03	1.24E-03
HumanNet	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	233	-	-	7.03E-02	1.01E-02
HumanNet	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	2.69E-03	1.13E-03
HumanNet	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	50	-	-	1.63E-02	2.15E-03
HumanNet	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	3.59E-03	1.08E-03
HumanNet	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.15E-02	2.04E-03
HumanNet	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	8.42E-03	6.45E-04
HumanNet	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	1.00E-02	8.61E-04
HumanNet	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	2.23E-03	5.38E-04
HumanNet	BP	GO:0060856	establishment of blood-brain barrier	-	16	15	-	-	4.78E-03	6.45E-04
HumanNet	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	3.74E-03	4.84E-04
HumanNet	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	4.12E-03	8.07E-04
HumanNet	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	5.05E-03	8.61E-04
HumanNet	BP	GO:0060999	positive regulation of dendritic spine development	-	35	32	-	-	7.85E-03	1.40E-03
HumanNet	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	1.49E-04	5.92E-04
HumanNet	BP	GO:0061005	cell differentiation involved in kidney development	-	58	58	-	-	5.29E-02	2.53E-03
HumanNet	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	1.49E-03	6.45E-04
HumanNet	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	3.97E-02	1.45E-03
HumanNet	BP	GO:0061037	negative regulation of cartilage development	-	32	29	-	-	1.04E-02	1.29E-03
HumanNet	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	1.18E-02	6.99E-04
HumanNet	MF	GO:0061134	peptidase regulator activity	-	224	212	-	-	2.51E-01	9.14E-03
HumanNet	BP	GO:0061180	mammary gland epithelium development	-	68	66	-	-	1.23E-02	2.85E-03
HumanNet	BP	GO:0061303	cornea development in camera-type eye	-	12	12	-	-	8.23E-03	5.38E-04
HumanNet	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	2.41E-02	7.53E-04
HumanNet	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	3.84E-02	9.68E-04
HumanNet	BP	GO:0061326	renal tubule development	-	103	102	-	-	1.25E-01	4.41E-03
HumanNet	BP	GO:0061548	ganglion development	-	17	17	-	-	6.87E-03	7.53E-04
HumanNet	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	9.47E-04	6.45E-04
HumanNet	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	6.50E-02	8.07E-04
HumanNet	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	4.15E-03	6.99E-04
HumanNet	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	1.19E-01	7.53E-04
HumanNet	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	45	-	-	1.31E-01	1.94E-03
HumanNet	MF	GO:0061783	peptidoglycan muralytic activity	-	14	12	-	-	1.85E-01	5.38E-04
HumanNet	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	1.19E-02	1.40E-03
HumanNet	BP	GO:0061900	glial cell activation	-	56	52	-	-	1.10E-02	2.26E-03
HumanNet	BP	GO:0061952	midbody abscission	-	18	16	-	-	2.12E-01	6.99E-04
HumanNet	MF	GO:0061980	regulatory RNA binding	-	52	45	-	-	5.37E-02	1.94E-03
HumanNet	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	5.31E-02	1.29E-03
HumanNet	BP	GO:0065003	protein-containing complex assembly	5.71E-01	1648	1596	1592	1.00	-	-
HumanNet	BP	GO:0065005	protein-lipid complex assembly	-	29	27	-	-	2.90E-02	1.18E-03
HumanNet	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	3.91E-02	9.68E-04
HumanNet	MF	GO:0070063	RNA polymerase binding	-	61	59	-	-	4.87E-02	2.58E-03
HumanNet	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	1.48E-03	7.53E-04
HumanNet	CC	GO:0070069	cytochrome complex	-	42	34	-	-	1.34E-01	1.51E-03
HumanNet	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	15	-	-	1.29E-02	6.45E-04
HumanNet	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	89	-	-	4.66E-01	3.87E-03
HumanNet	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	26	-	-	2.34E-03	1.13E-03
HumanNet	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	52	-	-	1.54E-02	2.26E-03
HumanNet	MF	GO:0070182	DNA polymerase binding	-	22	19	-	-	2.90E-03	8.61E-04
HumanNet	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	1.78E-01	4.84E-04
HumanNet	CC	GO:0070286	axonemal dynein complex assembly	-	40	40	-	-	1.82E-01	1.72E-03
HumanNet	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	1.75E-02	8.61E-04
HumanNet	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	4.51E-03	8.61E-04
HumanNet	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	1.98E-02	1.29E-03
HumanNet	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	1.25E-03	4.84E-04
HumanNet	CC	GO:0070382	exocytic vesicle	-	224	220	-	-	8.79E-02	9.47E-03
HumanNet	MF	GO:0070402	NADPH binding	-	16	15	-	-	1.59E-02	6.45E-04
HumanNet	MF	GO:0070403	NAD+ binding	-	16	16	-	-	2.60E-02	6.99E-04
HumanNet	BP	GO:0070417	cellular response to cold	-	13	13	-	-	3.24E-03	5.92E-04
HumanNet	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	7.54E-03	5.92E-04
HumanNet	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.74E-03	5.92E-04
HumanNet	BP	GO:0070585	protein localization to mitochondrion	-	125	122	-	-	1.99E-01	5.27E-03
HumanNet	MF	GO:0070628	proteasome binding	-	17	17	-	-	7.08E-03	7.53E-04
HumanNet	BP	GO:0070633	transepithelial transport	-	35	35	-	-	8.67E-03	1.51E-03
HumanNet	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	2.98E-02	6.99E-04
HumanNet	MF	GO:0070840	dynein complex binding	-	25	25	-	-	3.00E-03	1.08E-03
HumanNet	MF	GO:0070851	growth factor receptor binding	-	141	139	-	-	1.44E-01	6.02E-03
HumanNet	BP	GO:0070857	regulation of bile acid biosynthetic process	-	12	11	-	-	9.64E-03	4.84E-04
HumanNet	MF	GO:0070888	E-box binding	-	59	59	-	-	7.94E-02	2.58E-03
HumanNet	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	1.64E-02	6.99E-04
HumanNet	CC	GO:0070971	endoplasmic reticulum exit site	-	32	31	-	-	3.60E-01	1.34E-03
HumanNet	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	68	-	-	1.35E-01	2.96E-03
HumanNet	BP	GO:0070988	demethylation	-	27	27	-	-	4.48E-02	1.18E-03
HumanNet	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	4.22E-01	8.61E-04
HumanNet	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	2.00E-02	5.38E-04
HumanNet	CC	GO:0071013	catalytic step 2 spliceosome	-	88	87	-	-	2.33E-01	3.77E-03
HumanNet	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	7.21E-02	6.45E-04
HumanNet	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	1.29E-02	4.84E-04
HumanNet	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	7.15E-04	5.92E-04
HumanNet	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	6.79E-02	8.07E-04
HumanNet	BP	GO:0071248	cellular response to metal ion	-	201	198	-	-	6.96E-02	8.55E-03
HumanNet	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	2.88E-02	2.80E-03
HumanNet	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	1.27E-02	9.68E-04
HumanNet	BP	GO:0071318	cellular response to ATP	-	18	17	-	-	2.05E-02	7.53E-04
HumanNet	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	4.56E-03	2.31E-03
HumanNet	BP	GO:0071392	cellular response to estradiol stimulus	-	40	40	-	-	4.90E-03	1.72E-03
HumanNet	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	6.82E-03	1.51E-03
HumanNet	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	31	-	-	1.19E-02	1.34E-03
HumanNet	BP	GO:0071453	cellular response to oxygen levels	-	168	153	-	-	2.12E-02	6.62E-03
HumanNet	BP	GO:0071496	cellular response to external stimulus	-	74	70	-	-	1.67E-02	3.01E-03
HumanNet	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	3.39E-03	8.61E-04
HumanNet	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	1.17E-01	6.45E-04
HumanNet	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	44	-	-	5.87E-01	1.94E-03
HumanNet	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	3.59E-02	1.51E-03
HumanNet	BP	GO:0071599	otic vesicle development	-	15	15	-	-	8.17E-03	6.45E-04
HumanNet	CC	GO:0071682	endocytic vesicle lumen	-	23	23	-	-	1.22E-02	1.02E-03
HumanNet	BP	GO:0071709	membrane assembly	-	68	65	-	-	5.68E-02	2.80E-03
HumanNet	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	4.51E-04	7.53E-04
HumanNet	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	7.61E-02	1.83E-03
HumanNet	BP	GO:0071800	podosome assembly	-	19	19	-	-	2.12E-03	8.61E-04
HumanNet	BP	GO:0071806	protein transmembrane transport	-	68	67	-	-	1.27E-01	2.90E-03
HumanNet	MF	GO:0071814	protein-lipid complex binding	-	52	45	-	-	5.92E-02	1.94E-03
HumanNet	CC	GO:0071819	DUBm complex	-	25	23	-	-	4.46E-01	1.02E-03
HumanNet	BP	GO:0071827	plasma lipoprotein particle organization	-	86	69	-	-	1.28E-01	3.01E-03
HumanNet	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	62	-	-	2.19E-02	2.69E-03
HumanNet	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	2.75E-04	4.84E-04
HumanNet	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	28	-	-	1.69E-02	1.24E-03
HumanNet	MF	GO:0071889	14-3-3 protein binding	-	34	33	-	-	5.80E-03	1.45E-03
HumanNet	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.46E-02	6.45E-04
HumanNet	BP	GO:0071985	multivesicular body sorting pathway	-	56	53	-	-	4.39E-01	2.31E-03
HumanNet	BP	GO:0072044	collecting duct development	-	16	16	-	-	1.46E-02	6.99E-04
HumanNet	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	1.32E-02	3.39E-03
HumanNet	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	4.16E-02	2.47E-03
HumanNet	BP	GO:0072164	mesonephric tubule development	-	98	97	-	-	8.86E-02	4.20E-03
HumanNet	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	1.85E-02	1.13E-03
HumanNet	BP	GO:0072176	nephric duct development	-	15	15	-	-	6.86E-02	6.45E-04
HumanNet	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	29	-	-	1.83E-02	1.29E-03
HumanNet	CC	GO:0072379	ER membrane insertion complex	-	14	13	-	-	5.17E-01	5.92E-04
HumanNet	BP	GO:0072488	ammonium transmembrane transport	-	12	12	-	-	4.96E-02	5.38E-04
HumanNet	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	8.39E-04	6.45E-04
HumanNet	BP	GO:0072523	purine-containing compound catabolic process	-	146	145	-	-	1.20E-01	6.24E-03
HumanNet	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	3.75E-01	1.34E-03
HumanNet	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	95	-	-	9.18E-02	4.09E-03
HumanNet	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	36	-	-	2.13E-01	1.56E-03
HumanNet	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	30	-	-	4.12E-02	1.29E-03
HumanNet	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	15	-	-	8.89E-03	6.45E-04
HumanNet	BP	GO:0072537	fibroblast activation	-	13	13	-	-	1.88E-03	5.92E-04
HumanNet	CC	GO:0072562	blood microparticle	-	144	112	-	-	1.48E-01	4.84E-03
HumanNet	CC	GO:0072595	maintenance of protein localization in organelle	-	42	42	-	-	3.32E-03	1.83E-03
HumanNet	BP	GO:0072659	protein localization to plasma membrane	7.31E-03	284	282	274	1.03	-	-
HumanNet	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	8.02E-02	8.61E-04
HumanNet	BP	GO:0072665	protein localization to vacuole	-	84	82	-	-	9.22E-02	3.55E-03
HumanNet	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.46E-02	5.38E-04
HumanNet	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	1.28E-03	6.45E-04
HumanNet	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	4.85E-03	1.24E-03
HumanNet	BP	GO:0085029	extracellular matrix assembly	-	42	38	-	-	2.12E-02	1.67E-03
HumanNet	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	1.91E-01	1.51E-03
HumanNet	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	8.73E-04	5.92E-04
HumanNet	BP	GO:0090068	positive regulation of cell cycle process	-	262	247	-	-	2.68E-02	1.07E-02
HumanNet	BP	GO:0090077	foam cell differentiation	-	39	35	-	-	1.20E-02	1.51E-03
HumanNet	BP	GO:0090087	regulation of peptide transport	-	195	193	-	-	2.67E-02	8.34E-03
HumanNet	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	142	-	-	9.53E-02	6.13E-03
HumanNet	BP	GO:0090102	cochlea development	-	50	50	-	-	6.57E-03	2.15E-03
HumanNet	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	4.59E-01	6.45E-04
HumanNet	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	20	-	-	5.87E-02	8.61E-04
HumanNet	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	31	-	-	1.63E-01	1.34E-03
HumanNet	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	2.41E-03	5.92E-04
HumanNet	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	9.44E-03	4.84E-04
HumanNet	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	17	-	-	1.51E-02	7.53E-04
HumanNet	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	2.49E-03	5.92E-04
HumanNet	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	2.05E-01	1.29E-03
HumanNet	BP	GO:0090399	replicative senescence	-	17	16	-	-	9.24E-03	6.99E-04
HumanNet	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	34	-	-	4.66E-02	1.51E-03
HumanNet	CC	GO:0090543	Flemming body	-	33	33	-	-	3.20E-02	1.45E-03
HumanNet	BP	GO:0090559	regulation of membrane permeability	-	72	64	-	-	3.17E-02	2.80E-03
HumanNet	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	14	-	-	1.03E-02	6.45E-04
HumanNet	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	248	-	-	3.38E-01	1.07E-02
HumanNet	CC	GO:0090660	cerebrospinal fluid circulation	-	15	15	-	-	3.15E-03	6.45E-04
HumanNet	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	1.00E-01	1.02E-03
HumanNet	BP	GO:0090713	immunological memory process	-	18	18	-	-	1.52E-03	8.07E-04
HumanNet	CC	GO:0090734	site of DNA damage	-	118	116	-	-	7.30E-02	5.00E-03
HumanNet	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	8.28E-02	9.14E-04
HumanNet	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	3.10E-03	8.61E-04
HumanNet	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	3.65E-03	8.07E-04
HumanNet	MF	GO:0097110	scaffold protein binding	-	66	65	-	-	5.75E-03	2.80E-03
HumanNet	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	190	-	-	6.59E-02	8.18E-03
HumanNet	BP	GO:0097154	GABAergic neuron differentiation	-	20	19	-	-	1.86E-02	8.61E-04
HumanNet	BP	GO:0097164	ammonium ion metabolic process	-	23	23	-	-	1.46E-02	1.02E-03
HumanNet	BP	GO:0097186	amelogenesis	-	26	26	-	-	1.10E-01	1.13E-03
HumanNet	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	222	-	-	6.34E-02	9.57E-03
HumanNet	BP	GO:0097212	lysosomal membrane organization	-	15	13	-	-	2.11E-01	5.92E-04
HumanNet	CC	GO:0097228	sperm principal piece	-	33	32	-	-	7.16E-02	1.40E-03
HumanNet	BP	GO:0097264	self proteolysis	-	12	12	-	-	2.08E-02	5.38E-04
HumanNet	BP	GO:0097306	cellular response to alcohol	-	99	95	-	-	5.67E-03	4.09E-03
HumanNet	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	1.25E-03	4.84E-04
HumanNet	CC	GO:0097381	photoreceptor disc membrane	-	25	23	-	-	1.85E-01	1.02E-03
HumanNet	BP	GO:0097384	cellular lipid biosynthetic process	-	11	11	-	-	1.23E-01	4.84E-04
HumanNet	CC	GO:0097386	glial cell projection	-	38	38	-	-	4.22E-03	1.67E-03
HumanNet	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	2.26E-01	6.99E-04
HumanNet	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	13	-	-	2.68E-03	5.92E-04
HumanNet	CC	GO:0097470	ribbon synapse	-	13	13	-	-	3.57E-03	5.92E-04
HumanNet	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	129	-	-	1.93E-01	5.59E-03
HumanNet	CC	GO:0097540	axonemal central pair	-	161	154	-	-	6.98E-02	6.67E-03
HumanNet	CC	GO:0097542	ciliary tip	-	48	48	-	-	1.63E-01	2.10E-03
HumanNet	CC	GO:0097545	axonemal outer doublet	-	164	157	-	-	7.68E-02	6.78E-03
HumanNet	CC	GO:0097546	ciliary base	-	47	45	-	-	2.62E-02	1.94E-03
HumanNet	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	5.49E-02	5.92E-04
HumanNet	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	4.46E-02	3.87E-03
HumanNet	MF	GO:0097602	cullin family protein binding	-	26	25	-	-	1.10E-01	1.08E-03
HumanNet	BP	GO:0097722	sperm motility	-	133	129	-	-	6.04E-02	5.59E-03
HumanNet	BP	GO:0098542	defense response to other organism	5.99E-03	1171	1147	1131	1.01	-	-
HumanNet	BP	GO:0098543	detection of other organism	-	19	19	-	-	4.31E-02	8.61E-04
HumanNet	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	26	-	-	4.05E-02	1.13E-03
HumanNet	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	6.25E-02	6.45E-04
HumanNet	MF	GO:0098631	cell adhesion mediator activity	-	64	62	-	-	6.85E-02	2.69E-03
HumanNet	CC	GO:0098636	protein complex involved in cell adhesion	-	57	57	-	-	4.31E-01	2.47E-03
HumanNet	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	4.64E-02	5.38E-04
HumanNet	BP	GO:0098661	inorganic anion transmembrane transport	-	140	136	-	-	1.51E-01	5.86E-03
HumanNet	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	4.23E-02	1.02E-03
HumanNet	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	94	-	-	1.43E-02	4.09E-03
HumanNet	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	3.60E-03	6.45E-04
HumanNet	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	7.34E-04	4.84E-04
HumanNet	BP	GO:0098743	cell aggregation	-	24	24	-	-	6.02E-03	1.08E-03
HumanNet	BP	GO:0098751	bone cell development	-	18	18	-	-	9.40E-04	8.07E-04
HumanNet	BP	GO:0098754	detoxification	3.35E-01	134	132	129	1.02	-	-
HumanNet	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	2.95E-02	9.14E-04
HumanNet	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	3.70E-01	1.02E-03
HumanNet	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	101	-	-	2.86E-01	4.36E-03
HumanNet	CC	GO:0098803	respiratory chain complex	-	39	31	-	-	1.29E-01	1.34E-03
HumanNet	CC	GO:0098810	neurotransmitter reuptake	-	35	35	-	-	3.72E-02	1.51E-03
HumanNet	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	4.10E-03	6.45E-04
HumanNet	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	14	-	-	2.19E-02	6.45E-04
HumanNet	CC	GO:0098862	cluster of actin-based cell projections	-	162	160	-	-	1.01E-01	6.89E-03
HumanNet	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	146	-	-	5.58E-02	6.29E-03
HumanNet	CC	GO:0098918	structural constituent of synapse	-	27	26	-	-	2.92E-02	1.13E-03
HumanNet	CC	GO:0098926	postsynaptic signal transduction	-	39	39	-	-	2.02E-02	1.72E-03
HumanNet	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	1.13E-02	4.84E-04
HumanNet	CC	GO:0098982	GABA-ergic synapse	-	84	84	-	-	4.85E-02	3.66E-03
HumanNet	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	219	-	-	1.14E-01	9.47E-03
HumanNet	BP	GO:0099022	vesicle tethering	-	32	32	-	-	2.70E-01	1.40E-03
HumanNet	BP	GO:0099054	presynapse assembly	-	49	48	-	-	6.09E-02	2.10E-03
HumanNet	BP	GO:0099068	postsynapse assembly	-	40	39	-	-	1.62E-02	1.72E-03
HumanNet	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	87	-	-	2.08E-02	3.77E-03
HumanNet	BP	GO:0099084	postsynaptic specialization organization	-	44	43	-	-	2.49E-02	1.88E-03
HumanNet	CC	GO:0099086	synaptonemal structure	-	40	40	-	-	2.10E-01	1.72E-03
HumanNet	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	9.71E-03	6.99E-04
HumanNet	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	3.41E-03	6.45E-04
HumanNet	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	2.88E-04	6.99E-04
HumanNet	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	1.84E-02	8.61E-04
HumanNet	CC	GO:0099522	cytosolic region	-	20	20	-	-	1.47E-03	8.61E-04
HumanNet	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	165	-	-	2.01E-01	7.10E-03
HumanNet	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	3.72E-01	5.38E-04
HumanNet	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	2.28E-02	7.53E-04
HumanNet	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	127	-	-	1.03E-01	5.49E-03
HumanNet	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	25	-	-	8.13E-03	1.08E-03
HumanNet	BP	GO:0099637	neurotransmitter receptor transport	-	26	26	-	-	2.13E-02	1.13E-03
HumanNet	CC	GO:0099643	signal release from synapse	-	147	145	-	-	1.40E-01	6.24E-03
HumanNet	BP	GO:0106027	neuron projection organization	-	90	87	-	-	8.05E-03	3.77E-03
HumanNet	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	5.69E-01	4.84E-04
HumanNet	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	8.90E-03	7.53E-04
HumanNet	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	1.63E-02	1.08E-03
HumanNet	BP	GO:0110154	RNA decapping	-	19	18	-	-	5.45E-02	8.07E-04
HumanNet	BP	GO:0120009	intermembrane lipid transfer	-	52	51	-	-	1.12E-01	2.21E-03
HumanNet	CC	GO:0120111	neuron projection cytoplasm	-	94	94	-	-	3.91E-02	4.09E-03
HumanNet	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	99	-	-	2.60E-02	4.30E-03
HumanNet	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	46	-	-	2.00E-03	1.99E-03
HumanNet	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	9.40E-02	9.14E-04
HumanNet	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	2.05E-02	1.08E-03
HumanNet	CC	GO:0120293	dynein axonemal particle	-	20	19	-	-	4.00E-02	8.61E-04
HumanNet	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	5.55E-03	6.45E-04
HumanNet	BP	GO:0140013	meiotic nuclear division	7.40E-01	279	271	269	1.01	-	-
HumanNet	MF	GO:0140030	modification-dependent protein binding	-	179	178	-	-	4.63E-02	7.69E-03
HumanNet	BP	GO:0140053	mitochondrial gene expression	7.50E-03	164	164	158	1.04	-	-
HumanNet	MF	GO:0140096	"catalytic activity, acting on a protein"	1.84E-05	3198	3127	3088	1.01	-	-
HumanNet	MF	GO:0140097	"catalytic activity, acting on DNA"	3.18E-01	383	374	370	1.01	-	-
HumanNet	MF	GO:0140098	"catalytic activity, acting on RNA"	1.98E-02	417	411	403	1.02	-	-
HumanNet	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	22	-	-	1.25E-01	9.68E-04
HumanNet	MF	GO:0140104	molecular carrier activity	1.00E+00	105	102	101	1.01	-	-
HumanNet	MF	GO:0140110	transcription regulator activity	6.09E-02	2033	1978	1963	1.01	-	-
HumanNet	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.03E-02	1.02E-03
HumanNet	BP	GO:0140115	export across plasma membrane	-	82	67	-	-	8.75E-02	2.90E-03
HumanNet	MF	GO:0140223	general transcription initiation factor activity	-	55	51	-	-	4.01E-01	2.21E-03
HumanNet	CC	GO:0140238	presynaptic endocytosis	-	72	72	-	-	4.19E-02	3.12E-03
HumanNet	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	2.38E-02	1.02E-03
HumanNet	BP	GO:0140253	cell-cell fusion	-	62	61	-	-	2.24E-02	2.64E-03
HumanNet	MF	GO:0140272	exogenous protein binding	-	79	79	-	-	2.49E-02	3.44E-03
HumanNet	MF	GO:0140299	small molecule sensor activity	-	39	35	-	-	1.90E-02	1.51E-03
HumanNet	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	2.91E-03	6.45E-04
HumanNet	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	4.03E-02	8.61E-04
HumanNet	MF	GO:0140318	protein transporter activity	-	40	39	-	-	4.51E-02	1.72E-03
HumanNet	MF	GO:0140416	transcription regulator inhibitor activity	-	26	25	-	-	6.51E-03	1.08E-03
HumanNet	MF	GO:0140457	protein demethylase activity	-	31	30	-	-	3.76E-01	1.29E-03
HumanNet	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	1.03E-01	1.78E-03
HumanNet	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	3.92E-03	5.92E-04
HumanNet	CC	GO:0140632	canonical inflammasome complex assembly	-	40	38	-	-	3.61E-02	1.67E-03
HumanNet	MF	GO:0140657	ATP-dependent activity	2.16E-02	729	715	704	1.02	-	-
HumanNet	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	34	-	-	6.92E-01	1.51E-03
HumanNet	MF	GO:0140666	annealing activity	-	11	11	-	-	1.03E-02	4.84E-04
HumanNet	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	71	-	-	3.05E-02	3.07E-03
HumanNet	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	4.40E-02	7.53E-04
HumanNet	MF	GO:0141047	molecular tag activity	-	13	12	-	-	3.26E-02	5.38E-04
HumanNet	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	93	-	-	5.63E-02	4.03E-03
HumanNet	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	20	-	-	3.88E-03	8.61E-04
HumanNet	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	36	-	-	1.17E-02	1.56E-03
HumanNet	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	2.04E-03	1.34E-03
HumanNet	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	1.54E-01	2.58E-03
HumanNet	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	69	-	-	8.90E-02	3.01E-03
HumanNet	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	6.13E-03	7.53E-04
HumanNet	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	1.20E-02	7.53E-04
HumanNet	MF	GO:0170055	lipid transmembrane transporter activity	-	56	55	-	-	3.81E-02	2.37E-03
HumanNet	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	3.56E-03	7.53E-04
HumanNet	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	8.79E-02	2.21E-03
HumanNet	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.43E-02	1.24E-03
HumanNet	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	9.29E-03	5.92E-04
HumanNet	CC	GO:1900115	extracellular regulation of signal transduction	-	13	12	-	-	4.69E-02	5.38E-04
HumanNet	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	12	-	-	1.71E-01	5.38E-04
HumanNet	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	24	-	-	3.04E-01	1.08E-03
HumanNet	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	8.03E-04	4.84E-04
HumanNet	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	1.16E-03	5.38E-04
HumanNet	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	3.51E-02	8.07E-04
HumanNet	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	2.76E-04	4.84E-04
HumanNet	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	22	-	-	8.08E-04	9.68E-04
HumanNet	BP	GO:1901096	regulation of autophagosome maturation	-	17	16	-	-	1.82E-02	6.99E-04
HumanNet	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	34	-	-	4.91E-03	1.51E-03
HumanNet	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	2.03E-02	6.45E-04
HumanNet	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	32	-	-	6.03E-03	1.40E-03
HumanNet	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	25	-	-	1.38E-03	1.08E-03
HumanNet	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	68	-	-	1.03E-02	2.96E-03
HumanNet	BP	GO:1901343	negative regulation of vasculature development	-	154	101	-	-	1.01E-02	4.36E-03
HumanNet	MF	GO:1901474	azole transmembrane transporter activity	-	13	13	-	-	8.29E-03	5.92E-04
HumanNet	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	49	-	-	4.16E-02	2.15E-03
HumanNet	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	38	-	-	1.94E-03	1.67E-03
HumanNet	BP	GO:1901606	alpha-amino acid catabolic process	-	101	96	-	-	1.51E-01	4.14E-03
HumanNet	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	1.78E-01	2.96E-03
HumanNet	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	2.34E-03	6.45E-04
HumanNet	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	58	-	-	1.90E-02	2.53E-03
HumanNet	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	238	-	-	1.93E-01	1.03E-02
HumanNet	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	50	-	-	3.34E-02	2.15E-03
HumanNet	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.92E-02	4.84E-04
HumanNet	BP	GO:1901655	cellular response to ketone	-	107	106	-	-	7.87E-03	4.57E-03
HumanNet	BP	GO:1901679	nucleotide transmembrane transport	-	32	30	-	-	9.21E-02	1.29E-03
HumanNet	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	56	-	-	5.32E-02	2.42E-03
HumanNet	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	1.22E-03	6.45E-04
HumanNet	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	4.70E-03	1.29E-03
HumanNet	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	2.99E-03	5.92E-04
HumanNet	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.08E-03	5.92E-04
HumanNet	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	7.25E-03	1.08E-03
HumanNet	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	94	-	-	2.71E-03	4.09E-03
HumanNet	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	137	-	-	1.93E-02	5.92E-03
HumanNet	BP	GO:1901890	positive regulation of cell junction assembly	-	106	104	-	-	5.02E-02	4.52E-03
HumanNet	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	8.49E-03	8.07E-04
HumanNet	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	2.21E-03	1.08E-03
HumanNet	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	30	-	-	6.47E-03	1.29E-03
HumanNet	BP	GO:1902115	regulation of organelle assembly	-	210	206	-	-	2.48E-02	8.88E-03
HumanNet	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	71	-	-	3.59E-02	3.07E-03
HumanNet	BP	GO:1902414	protein localization to cell junction	-	107	106	-	-	1.88E-02	4.57E-03
HumanNet	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	3.00E-01	1.08E-03
HumanNet	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	2.10E-01	2.10E-03
HumanNet	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	35	-	-	1.92E-02	1.51E-03
HumanNet	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.11E-02	9.68E-04
HumanNet	BP	GO:1902895	positive regulation of miRNA transcription	-	51	50	-	-	1.93E-02	2.15E-03
HumanNet	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	1.36E-02	5.92E-04
HumanNet	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	21	-	-	8.57E-03	9.14E-04
HumanNet	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	24	-	-	1.37E-03	1.08E-03
HumanNet	BP	GO:1903008	organelle disassembly	-	154	147	-	-	6.69E-02	6.35E-03
HumanNet	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	1.03E-01	4.84E-04
HumanNet	BP	GO:1903035	negative regulation of response to wounding	-	93	86	-	-	4.49E-02	3.71E-03
HumanNet	BP	GO:1903036	positive regulation of response to wounding	-	76	70	-	-	8.41E-03	3.01E-03
HumanNet	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	25	-	-	2.71E-03	1.08E-03
HumanNet	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	6.45E-03	4.84E-04
HumanNet	CC	GO:1903293	phosphatase complex	-	54	53	-	-	2.30E-01	2.31E-03
HumanNet	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	133	-	-	1.36E-01	5.76E-03
HumanNet	BP	GO:1903318	negative regulation of protein maturation	-	29	29	-	-	4.10E-03	1.29E-03
HumanNet	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.73E-03	1.18E-03
HumanNet	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	3.60E-03	7.53E-04
HumanNet	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	4.80E-03	1.13E-03
HumanNet	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	15	-	-	1.32E-03	6.45E-04
HumanNet	BP	GO:1903509	liposaccharide metabolic process	-	109	107	-	-	4.45E-01	4.63E-03
HumanNet	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	2.95E-01	1.24E-03
HumanNet	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	1.12E-03	1.08E-03
HumanNet	BP	GO:1903524	positive regulation of blood circulation	-	39	38	-	-	1.05E-02	1.67E-03
HumanNet	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	39	-	-	1.06E-02	1.72E-03
HumanNet	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	2.25E-02	5.38E-04
HumanNet	BP	GO:1903707	negative regulation of hemopoiesis	-	116	109	-	-	7.15E-03	4.73E-03
HumanNet	BP	GO:1903708	positive regulation of hemopoiesis	-	184	181	-	-	3.26E-02	7.80E-03
HumanNet	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	5.39E-03	7.53E-04
HumanNet	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	32	-	-	5.58E-03	1.40E-03
HumanNet	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	7.14E-04	5.38E-04
HumanNet	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	5.10E-03	8.07E-04
HumanNet	BP	GO:1904018	positive regulation of vasculature development	-	185	158	-	-	2.69E-02	6.83E-03
HumanNet	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	102	-	-	1.48E-01	4.41E-03
HumanNet	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	95	-	-	5.50E-03	4.09E-03
HumanNet	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	18	-	-	5.90E-02	8.07E-04
HumanNet	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	1.20E-01	4.84E-04
HumanNet	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	1.84E-03	4.84E-04
HumanNet	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	6.44E-01	6.45E-04
HumanNet	BP	GO:1904646	cellular response to amyloid-beta	-	44	37	-	-	5.27E-03	1.61E-03
HumanNet	CC	GO:1904724	tertiary granule lumen	-	55	54	-	-	8.76E-03	2.37E-03
HumanNet	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	2.21E-02	5.38E-03
HumanNet	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	2.09E-02	6.45E-04
HumanNet	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	1.65E-03	1.08E-03
HumanNet	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	50	-	-	3.93E-02	2.15E-03
HumanNet	BP	GO:1905145	cellular response to acetylcholine	-	33	33	-	-	1.66E-02	1.45E-03
HumanNet	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	6.66E-03	5.92E-04
HumanNet	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	2.88E-03	4.84E-04
HumanNet	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	2.04E-02	5.92E-04
HumanNet	CC	GO:1905348	endonuclease complex	-	38	36	-	-	2.36E-01	1.56E-03
HumanNet	CC	GO:1905360	GTPase complex	-	41	40	-	-	4.81E-01	1.72E-03
HumanNet	CC	GO:1905368	peptidase complex	-	124	119	-	-	4.26E-01	5.16E-03
HumanNet	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	9.56E-03	5.92E-04
HumanNet	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	5.59E-02	5.38E-04
HumanNet	BP	GO:1905953	negative regulation of lipid localization	-	63	41	-	-	6.35E-03	1.78E-03
HumanNet	BP	GO:1905954	positive regulation of lipid localization	-	110	105	-	-	4.47E-02	4.52E-03
HumanNet	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	1.01E-03	6.45E-04
HumanNet	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	12	-	-	3.82E-01	5.38E-04
HumanNet	CC	GO:1990071	TRAPPII protein complex	-	12	12	-	-	3.09E-01	5.38E-04
HumanNet	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	3.62E-01	5.38E-04
HumanNet	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	4.77E-02	5.38E-04
HumanNet	CC	GO:1990204	oxidoreductase complex	-	90	79	-	-	8.17E-02	3.44E-03
HumanNet	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	5.81E-03	6.45E-04
HumanNet	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	2.34E-01	6.99E-04
HumanNet	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	8.04E-02	4.84E-04
HumanNet	CC	GO:1990391	DNA repair complex	-	22	22	-	-	5.00E-02	9.68E-04
HumanNet	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	32	-	-	1.57E-01	1.40E-03
HumanNet	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	5.99E-03	5.38E-04
HumanNet	BP	GO:1990542	mitochondrial transmembrane transport	-	93	91	-	-	1.87E-01	3.93E-03
HumanNet	CC	GO:1990752	microtubule end	-	34	33	-	-	1.24E-01	1.45E-03
HumanNet	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	74	-	-	5.51E-02	3.23E-03
HumanNet	BP	GO:1990840	response to lectin	-	22	21	-	-	1.03E-02	9.14E-04
HumanNet	BP	GO:1990845	adaptive thermogenesis	-	166	163	-	-	2.19E-02	7.05E-03
HumanNet	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	2.07E-02	5.92E-04
HumanNet	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	158	-	-	2.16E-02	6.83E-03
HumanNet	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	7.13E-03	7.53E-04
HumanNet	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	96	-	-	2.25E-02	4.14E-03
HumanNet	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	2.28E-03	1.08E-03
HumanNet	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	18	-	-	5.85E-03	8.07E-04
HumanNet	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	6.45E-03	1.18E-03
HumanNet	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	43	-	-	2.34E-02	1.88E-03
HumanNet	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	36	-	-	1.73E-02	1.56E-03
HumanNet	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	2.31E-03	6.99E-04
HumanNet	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	29	-	-	2.47E-02	1.29E-03
HumanNet	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	73	-	-	1.04E-02	3.17E-03
HumanNet	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.98E-03	1.08E-03
HumanNet	BP	GO:2000736	regulation of stem cell differentiation	-	78	76	-	-	2.26E-02	3.28E-03
HumanNet	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	2.22E-03	9.14E-04
HumanNet	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	5.31E-04	5.38E-04
HumanNet	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	7.69E-03	4.84E-04
HumanNet	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	1.37E-03	8.61E-04
HumanNet	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	3.84E-02	5.92E-04
HumanNet	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	2.24E-02	5.92E-04
HumanNet	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	75	-	-	2.57E-02	3.23E-03
HumanNet	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	3.45E-03	6.99E-04
HumanNet	BP	GO:2001222	regulation of neuron migration	-	46	46	-	-	5.10E-03	1.99E-03
HumanNet	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	226	-	-	1.56E-02	9.74E-03
HumanNet	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	59	-	-	1.58E-02	2.58E-03
huMAP	CC	GO:0005739	mitochondrion	4.00E-68	1671	1489	1208	1.23	-	-
huMAP	CC	GO:0005730	nucleolus	6.96E-56	988	908	714	1.27	-	-
huMAP	CC	GO:0005815	microtubule organizing center	1.74E-37	843	758	610	1.24	-	-
huMAP	CC	GO:0005840	ribosome	2.87E-24	222	217	161	1.35	-	-
huMAP	CC	GO:0005768	endosome	3.53E-18	1037	866	750	1.15	-	-
huMAP	CC	GO:0005794	Golgi apparatus	9.16E-16	1636	1318	1183	1.11	-	-
huMAP	CC	GO:0005635	nuclear envelope	1.16E-13	493	425	356	1.19	-	-
huMAP	CC	GO:0005764	lysosome	2.71E-13	747	624	540	1.16	-	-
huMAP	CC	GO:0005615	extracellular space	8.38E-13	3190	2469	2307	1.07	-	-
huMAP	CC	GO:0005783	endoplasmic reticulum	8.45E-12	2020	1588	1461	1.09	-	-
huMAP	CC	GO:0000228	nuclear chromosome	1.06E-07	206	181	149	1.22	-	-
huMAP	CC	GO:0005777	peroxisome	6.49E-05	142	123	103	1.20	-	-
huMAP	CC	GO:0005929	cilium	1.40E-03	842	649	609	1.07	-	-
huMAP	CC	GO:0005811	lipid droplet	2.57E-03	102	87	74	1.18	-	-
huMAP	CC	GO:0031012	extracellular matrix	4.17E-01	564	399	408	0.98	-	-
huMAP	BP	GO:0050877	nervous system process	9.26E-85	1527	760	1104	0.69	-	-
huMAP	BP	GO:0007010	cytoskeleton organization	1.54E-49	1639	1425	1185	1.20	-	-
huMAP	BP	GO:0016071	mRNA metabolic process	9.72E-45	713	662	516	1.28	-	-
huMAP	BP	GO:0065003	protein-containing complex assembly	1.09E-43	1648	1418	1192	1.19	-	-
huMAP	BP	GO:0042254	ribosome biogenesis	2.15E-37	297	294	215	1.37	-	-
huMAP	BP	GO:0006281	DNA repair	5.35E-37	587	545	424	1.28	-	-
huMAP	BP	GO:0016192	vesicle-mediated transport	2.89E-36	1894	1591	1369	1.16	-	-
huMAP	BP	GO:0006886	intracellular protein transport	3.34E-31	664	600	480	1.25	-	-
huMAP	BP	GO:0006914	autophagy	7.70E-31	568	520	411	1.27	-	-
huMAP	BP	GO:0030163	protein catabolic process	1.18E-25	990	851	716	1.19	-	-
huMAP	BP	GO:0007005	mitochondrion organization	2.03E-24	484	440	350	1.26	-	-
huMAP	BP	GO:0140053	mitochondrial gene expression	6.33E-22	164	163	119	1.37	-	-
huMAP	BP	GO:0007059	chromosome segregation	2.33E-20	403	366	291	1.26	-	-
huMAP	BP	GO:0006913	nucleocytoplasmic transport	2.64E-20	326	302	236	1.28	-	-
huMAP	BP	GO:0006325	chromatin organization	1.33E-19	720	621	521	1.19	-	-
huMAP	BP	GO:0055086	nucleobase-containing small molecule metabolic process	3.36E-19	729	627	527	1.19	-	-
huMAP	BP	GO:0006260	DNA replication	1.29E-18	279	260	202	1.29	-	-
huMAP	BP	GO:0006399	tRNA metabolic process	8.17E-18	196	188	142	1.33	-	-
huMAP	BP	GO:0002181	cytoplasmic translation	1.58E-16	153	149	111	1.35	-	-
huMAP	BP	GO:0006091	generation of precursor metabolites and energy	1.87E-14	502	434	363	1.20	-	-
huMAP	BP	GO:0007018	microtubule-based movement	2.73E-14	640	543	463	1.17	-	-
huMAP	BP	GO:0006520	amino acid metabolic process	9.20E-14	292	263	211	1.25	-	-
huMAP	BP	GO:0005975	carbohydrate metabolic process	2.68E-11	551	464	398	1.16	-	-
huMAP	BP	GO:0006457	protein folding	2.97E-11	210	191	152	1.26	-	-
huMAP	BP	GO:0012501	programmed cell death	1.07E-09	1954	1525	1413	1.08	-	-
huMAP	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.80E-09	119	112	86	1.30	-	-
huMAP	BP	GO:0044782	cilium organization	2.12E-09	399	339	289	1.18	-	-
huMAP	BP	GO:0000910	cytokinesis	7.42E-09	186	167	134	1.24	-	-
huMAP	BP	GO:0006310	DNA recombination	9.55E-09	333	285	241	1.18	-	-
huMAP	BP	GO:0006629	lipid metabolic process	1.32E-08	1355	1068	980	1.09	-	-
huMAP	BP	GO:0007163	establishment or maintenance of cell polarity	3.41E-08	227	199	164	1.21	-	-
huMAP	BP	GO:0006790	sulfur compound metabolic process	6.94E-08	320	272	231	1.18	-	-
huMAP	BP	GO:0072659	protein localization to plasma membrane	1.28E-06	284	240	205	1.17	-	-
huMAP	BP	GO:0032200	telomere organization	1.06E-05	186	160	134	1.19	-	-
huMAP	BP	GO:0034330	cell junction organization	6.89E-05	727	572	526	1.09	-	-
huMAP	BP	GO:0055085	transmembrane transport	1.92E-04	1784	1222	1290	0.95	-	-
huMAP	BP	GO:0006954	inflammatory response	1.05E-03	820	551	593	0.93	-	-
huMAP	BP	GO:0007040	lysosome organization	1.05E-03	107	92	77	1.19	-	-
huMAP	BP	GO:0098754	detoxification	1.31E-03	134	113	97	1.17	-	-
huMAP	BP	GO:0006575	cellular modified amino acid metabolic process	1.72E-03	186	153	134	1.14	-	-
huMAP	BP	GO:0006355	regulation of DNA-templated transcription	3.99E-03	3342	2484	2416	1.03	-	-
huMAP	BP	GO:0042060	wound healing	1.04E-02	431	335	312	1.07	-	-
huMAP	BP	GO:0006486	protein glycosylation	1.34E-02	225	179	163	1.10	-	-
huMAP	BP	GO:0003013	circulatory system process	1.88E-02	584	397	422	0.94	-	-
huMAP	BP	GO:0006766	vitamin metabolic process	2.24E-02	107	88	77	1.14	-	-
huMAP	BP	GO:0022600	digestive system process	3.19E-02	110	69	80	0.87	-	-
huMAP	BP	GO:0007155	cell adhesion	5.38E-02	1444	1076	1044	1.03	-	-
huMAP	BP	GO:0140013	meiotic nuclear division	7.95E-02	279	215	202	1.07	-	-
huMAP	BP	GO:0048870	cell motility	8.46E-02	1659	1230	1200	1.03	-	-
huMAP	BP	GO:0003014	renal system process	1.95E-01	127	85	92	0.93	-	-
huMAP	BP	GO:0098542	defense response to other organism	3.63E-01	1171	833	847	0.98	-	-
huMAP	BP	GO:0002376	immune system process	5.29E-01	2448	1757	1770	0.99	-	-
huMAP	BP	GO:0003012	muscle system process	8.26E-01	425	310	307	1.01	-	-
huMAP	BP	GO:0030198	extracellular matrix organization	1.00E+00	314	227	227	1.00	-	-
huMAP	MF	GO:0003723	RNA binding	1.49E-119	1679	1574	1214	1.30	-	-
huMAP	MF	GO:0016740	transferase activity	7.68E-60	3074	2577	2223	1.16	-	-
huMAP	MF	GO:0008092	cytoskeletal protein binding	1.13E-39	1023	909	740	1.23	-	-
huMAP	MF	GO:0140657	ATP-dependent activity	7.29E-38	729	665	527	1.26	-	-
huMAP	MF	GO:0140098	"catalytic activity, acting on RNA"	2.22E-33	417	396	302	1.31	-	-
huMAP	MF	GO:0140096	"catalytic activity, acting on a protein"	3.00E-30	3198	2569	2312	1.11	-	-
huMAP	MF	GO:0048018	receptor ligand activity	1.32E-25	504	255	364	0.70	-	-
huMAP	MF	GO:0140097	"catalytic activity, acting on DNA"	1.99E-19	383	348	277	1.26	-	-
huMAP	MF	GO:0016491	oxidoreductase activity	2.54E-19	888	753	642	1.17	-	-
huMAP	MF	GO:0009975	cyclase activity	1.76E-15	277	138	200	0.69	-	-
huMAP	MF	GO:0016874	ligase activity	5.96E-14	283	256	205	1.25	-	-
huMAP	MF	GO:0016853	isomerase activity	8.79E-14	252	230	182	1.26	-	-
huMAP	MF	GO:0042393	histone binding	3.74E-11	237	213	171	1.24	-	-
huMAP	MF	GO:0003774	cytoskeletal motor activity	8.63E-10	116	110	84	1.31	-	-
huMAP	MF	GO:0140104	molecular carrier activity	2.12E-09	105	100	76	1.32	-	-
huMAP	MF	GO:0045182	translation regulator activity	2.19E-09	151	139	109	1.27	-	-
huMAP	MF	GO:0003924	GTPase activity	4.04E-09	658	540	476	1.13	-	-
huMAP	MF	GO:0005198	structural molecule activity	7.58E-07	798	637	577	1.10	-	-
huMAP	MF	GO:0005215	transporter activity	4.63E-04	1462	999	1057	0.95	-	-
huMAP	MF	GO:0008289	lipid binding	2.31E-03	836	643	604	1.06	-	-
huMAP	MF	GO:0140110	transcription regulator activity	1.26E-02	2033	1422	1470	0.97	-	-
huMAP	MF	GO:0016829	lyase activity	9.67E-02	538	372	389	0.96	-	-
huMAP	MF	GO:0003677	DNA binding	5.25E-01	2865	2086	2072	1.01	-	-
huMAP	MF	GO:0038024	cargo receptor activity	8.36E-01	117	86	85	1.02	-	-
huMAP	BP	GO:0008038	neuron recognition	-	46	38	-	-	1.12E-03	2.23E-03
huMAP	BP	GO:1905145	cellular response to acetylcholine	-	33	21	-	-	1.69E-03	1.22E-03
huMAP	BP	GO:0097094	craniofacial suture morphogenesis	-	18	11	-	-	2.05E-04	6.48E-04
huMAP	BP	GO:0098780	response to mitochondrial depolarisation	-	21	19	-	-	1.45E-03	1.15E-03
huMAP	BP	GO:0051931	regulation of sensory perception	-	36	18	-	-	2.64E-04	1.08E-03
huMAP	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	14	-	-	2.06E-04	8.64E-04
huMAP	BP	GO:0009268	response to pH	-	43	27	-	-	1.26E-03	1.58E-03
huMAP	BP	GO:0045666	positive regulation of neuron differentiation	-	91	57	-	-	3.25E-03	3.31E-03
huMAP	BP	GO:0043543	protein acylation	-	107	89	-	-	5.15E-03	5.18E-03
huMAP	MF	GO:0051349	positive regulation of lyase activity	-	41	19	-	-	1.12E-03	1.15E-03
huMAP	BP	GO:0048679	regulation of axon regeneration	-	28	20	-	-	1.94E-03	1.15E-03
huMAP	BP	GO:0022401	negative adaptation of signaling pathway	-	21	17	-	-	3.71E-02	1.01E-03
huMAP	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	86	-	-	4.62E-02	4.97E-03
huMAP	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	5.95E-03	2.45E-03
huMAP	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	31	-	-	1.85E-03	1.80E-03
huMAP	BP	GO:0071806	protein transmembrane transport	-	68	61	-	-	1.56E-03	3.53E-03
huMAP	BP	GO:0022038	corpus callosum development	-	25	22	-	-	9.76E-04	1.30E-03
huMAP	BP	GO:0043299	leukocyte degranulation	-	82	51	-	-	2.48E-03	2.95E-03
huMAP	BP	GO:0048864	stem cell development	-	88	61	-	-	2.02E-03	3.53E-03
huMAP	BP	GO:0009310	amine catabolic process	-	20	14	-	-	1.23E-03	8.64E-04
huMAP	BP	GO:0051651	maintenance of location in cell	-	236	178	-	-	2.86E-03	1.03E-02
huMAP	BP	GO:0033119	negative regulation of RNA splicing	-	27	26	-	-	1.43E-03	1.51E-03
huMAP	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	26	-	-	7.65E-04	1.51E-03
huMAP	BP	GO:0070663	regulation of leukocyte proliferation	-	268	181	-	-	3.57E-03	1.04E-02
huMAP	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	3.86E-03	8.64E-04
huMAP	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	27	-	-	1.18E-03	1.58E-03
huMAP	BP	GO:0006949	syncytium formation	-	66	39	-	-	7.73E-04	2.30E-03
huMAP	BP	GO:0045176	apical protein localization	-	15	12	-	-	3.17E-04	7.20E-04
huMAP	BP	GO:0045861	negative regulation of proteolysis	-	320	235	-	-	5.66E-03	1.35E-02
huMAP	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	2.75E-03	8.64E-04
huMAP	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	41	-	-	3.46E-02	2.37E-03
huMAP	BP	GO:0030574	collagen catabolic process	-	45	30	-	-	1.49E-02	1.73E-03
huMAP	CC	GO:0006984	ER-nucleus signaling pathway	-	46	44	-	-	1.06E-03	2.59E-03
huMAP	BP	GO:0060343	trabecula formation	-	26	19	-	-	9.33E-03	1.15E-03
huMAP	BP	GO:0009914	hormone transport	-	315	220	-	-	4.94E-03	1.27E-02
huMAP	BP	GO:0140112	extracellular vesicle biogenesis	-	23	21	-	-	2.19E-03	1.22E-03
huMAP	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	4.32E-02	9.36E-04
huMAP	BP	GO:1900424	regulation of defense response to bacterium	-	21	17	-	-	9.73E-04	1.01E-03
huMAP	BP	GO:0085029	extracellular matrix assembly	-	42	31	-	-	2.38E-03	1.80E-03
huMAP	BP	GO:0006413	translational initiation	-	122	111	-	-	3.94E-03	6.40E-03
huMAP	BP	GO:0072176	nephric duct development	-	15	11	-	-	3.56E-03	6.48E-04
huMAP	BP	GO:1902895	positive regulation of miRNA transcription	-	51	38	-	-	1.52E-03	2.23E-03
huMAP	CC	GO:0005200	structural constituent of cytoskeleton	-	112	105	-	-	2.58E-03	6.04E-03
huMAP	BP	GO:0030865	cortical cytoskeleton organization	-	51	50	-	-	2.13E-03	2.88E-03
huMAP	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	22	-	-	2.04E-02	1.30E-03
huMAP	BP	GO:1903036	positive regulation of response to wounding	-	76	56	-	-	2.90E-03	3.24E-03
huMAP	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	20	-	-	2.30E-02	1.15E-03
huMAP	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	153	-	-	9.34E-03	8.85E-03
huMAP	BP	GO:1903319	positive regulation of protein maturation	-	27	20	-	-	8.86E-04	1.15E-03
huMAP	BP	GO:0032528	microvillus organization	-	24	23	-	-	2.89E-03	1.37E-03
huMAP	BP	GO:0002263	cell activation involved in immune response	-	304	215	-	-	1.58E-02	1.24E-02
huMAP	BP	GO:0021954	central nervous system neuron development	-	85	67	-	-	1.12E-03	3.89E-03
huMAP	BP	GO:0055017	cardiac muscle tissue growth	-	92	63	-	-	3.17E-03	3.67E-03
huMAP	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	21	-	-	9.99E-04	1.22E-03
huMAP	BP	GO:0048524	positive regulation of viral process	-	64	59	-	-	1.07E-03	3.45E-03
huMAP	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	15	-	-	2.72E-03	8.64E-04
huMAP	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	20	-	-	1.85E-03	1.15E-03
huMAP	BP	GO:0001946	lymphangiogenesis	-	18	14	-	-	1.02E-03	8.64E-04
huMAP	BP	GO:0098661	inorganic anion transmembrane transport	-	140	81	-	-	4.27E-02	4.68E-03
huMAP	BP	GO:0006099	tricarboxylic acid cycle	-	33	30	-	-	2.99E-03	1.73E-03
huMAP	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	17	-	-	5.72E-03	1.01E-03
huMAP	BP	GO:0009612	response to mechanical stimulus	-	215	152	-	-	1.04E-02	8.78E-03
huMAP	BP	GO:0048644	muscle organ morphogenesis	-	81	60	-	-	8.63E-03	3.45E-03
huMAP	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	109	-	-	3.07E-03	6.33E-03
huMAP	BP	GO:0071542	dopaminergic neuron differentiation	-	36	25	-	-	2.26E-03	1.44E-03
huMAP	BP	GO:0140115	export across plasma membrane	-	82	45	-	-	2.12E-03	2.59E-03
huMAP	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	34	-	-	8.93E-04	2.01E-03
huMAP	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	19	-	-	2.98E-03	1.15E-03
huMAP	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	37	-	-	3.04E-03	2.16E-03
huMAP	MF	GO:0003714	transcription corepressor activity	-	190	174	-	-	1.16E-02	1.01E-02
huMAP	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	41	-	-	1.07E-02	2.37E-03
huMAP	CC	GO:0006858	extracellular transport	-	45	37	-	-	1.09E-02	2.16E-03
huMAP	BP	GO:0006304	DNA modification	-	30	24	-	-	1.32E-03	1.44E-03
huMAP	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	3.49E-02	1.15E-03
huMAP	BP	GO:0046835	carbohydrate phosphorylation	-	49	48	-	-	6.36E-03	2.81E-03
huMAP	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	1.28E-03	1.08E-03
huMAP	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	21	-	-	2.39E-02	1.22E-03
huMAP	BP	GO:0070417	cellular response to cold	-	13	12	-	-	6.72E-04	7.20E-04
huMAP	BP	GO:0043523	regulation of neuron apoptotic process	-	218	164	-	-	3.51E-03	9.50E-03
huMAP	BP	GO:1902894	negative regulation of miRNA transcription	-	22	19	-	-	3.49E-04	1.15E-03
huMAP	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	12	-	-	4.02E-04	7.20E-04
huMAP	BP	GO:0044380	protein localization to cytoskeleton	-	57	53	-	-	2.94E-03	3.09E-03
huMAP	BP	GO:2000209	regulation of anoikis	-	25	20	-	-	2.05E-03	1.15E-03
huMAP	BP	GO:0014029	neural crest formation	-	15	11	-	-	3.06E-04	6.48E-04
huMAP	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	20	-	-	3.13E-04	1.15E-03
huMAP	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	27	-	-	8.76E-04	1.58E-03
huMAP	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	51	-	-	1.79E-03	2.95E-03
huMAP	BP	GO:0003188	heart valve formation	-	16	13	-	-	3.63E-02	7.92E-04
huMAP	CC	GO:0045324	late endosome to vacuole transport	-	37	32	-	-	3.68E-02	1.87E-03
huMAP	BP	GO:0043954	cellular component maintenance	-	72	55	-	-	1.16E-03	3.17E-03
huMAP	BP	GO:0050435	amyloid-beta metabolic process	-	65	41	-	-	2.91E-03	2.37E-03
huMAP	BP	GO:0014823	response to activity	-	70	52	-	-	1.87E-03	3.02E-03
huMAP	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	11	-	-	1.84E-02	6.48E-04
huMAP	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	26	-	-	9.63E-04	1.51E-03
huMAP	BP	GO:0034502	protein localization to chromosome	-	130	112	-	-	3.85E-03	6.48E-03
huMAP	BP	GO:0048562	embryonic organ morphogenesis	-	295	213	-	-	5.92E-03	1.23E-02
huMAP	BP	GO:0019233	sensory perception of pain	-	103	52	-	-	8.97E-03	3.02E-03
huMAP	CC	GO:0043574	peroxisomal transport	-	22	20	-	-	4.08E-03	1.15E-03
huMAP	BP	GO:0031343	positive regulation of cell killing	-	75	44	-	-	9.25E-03	2.59E-03
huMAP	BP	GO:0090077	foam cell differentiation	-	39	28	-	-	3.74E-04	1.66E-03
huMAP	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	79	-	-	4.99E-03	4.61E-03
huMAP	BP	GO:0017148	negative regulation of translation	-	390	102	-	-	2.14E-03	5.90E-03
huMAP	BP	GO:0030220	platelet formation	-	22	18	-	-	7.18E-04	1.08E-03
huMAP	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	65	-	-	1.13E-03	3.74E-03
huMAP	MF	GO:1903624	regulation of DNA catabolic process	-	14	11	-	-	3.78E-04	6.48E-04
huMAP	BP	GO:1903509	liposaccharide metabolic process	-	109	87	-	-	6.56E-03	5.04E-03
huMAP	BP	GO:0009582	detection of abiotic stimulus	-	140	74	-	-	2.53E-03	4.32E-03
huMAP	CC	GO:0140238	presynaptic endocytosis	-	72	69	-	-	5.19E-03	4.03E-03
huMAP	BP	GO:0051236	establishment of RNA localization	-	161	151	-	-	8.79E-03	8.71E-03
huMAP	BP	GO:0042178	xenobiotic catabolic process	-	26	20	-	-	3.18E-02	1.15E-03
huMAP	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	16	-	-	4.02E-03	9.36E-04
huMAP	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	162	-	-	5.67E-03	9.36E-03
huMAP	BP	GO:0034067	protein localization to Golgi apparatus	-	30	27	-	-	1.94E-03	1.58E-03
huMAP	BP	GO:0061842	microtubule organizing center localization	-	32	29	-	-	2.16E-03	1.73E-03
huMAP	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	12	-	-	6.36E-03	7.20E-04
huMAP	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	25	-	-	3.82E-04	1.44E-03
huMAP	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	35	-	-	1.02E-03	2.01E-03
huMAP	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	46	-	-	1.64E-03	2.66E-03
huMAP	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	1.08E-03	9.36E-04
huMAP	BP	GO:0050779	RNA destabilization	-	135	96	-	-	3.71E-03	5.54E-03
huMAP	BP	GO:0006023	aminoglycan biosynthetic process	-	74	57	-	-	1.24E-02	3.31E-03
huMAP	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	2.21E-03	3.96E-03
huMAP	BP	GO:0010762	regulation of fibroblast migration	-	40	35	-	-	4.36E-03	2.01E-03
huMAP	BP	GO:0090311	regulation of protein deacetylation	-	29	27	-	-	1.06E-02	1.58E-03
huMAP	BP	GO:0035272	exocrine system development	-	46	35	-	-	1.92E-03	2.01E-03
huMAP	BP	GO:1901096	regulation of autophagosome maturation	-	17	14	-	-	2.82E-04	8.64E-04
huMAP	BP	GO:0022406	membrane docking	-	90	81	-	-	1.79E-02	4.68E-03
huMAP	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	3.00E-03	8.64E-04
huMAP	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	15	-	-	1.32E-03	8.64E-04
huMAP	BP	GO:0050777	negative regulation of immune response	-	196	145	-	-	2.89E-03	8.35E-03
huMAP	BP	GO:0002063	chondrocyte development	-	33	25	-	-	1.35E-03	1.44E-03
huMAP	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	12	-	-	6.81E-04	7.20E-04
huMAP	BP	GO:0099068	postsynapse assembly	-	40	31	-	-	3.54E-02	1.80E-03
huMAP	BP	GO:0021782	glial cell development	-	120	85	-	-	1.66E-03	4.89E-03
huMAP	BP	GO:0051782	negative regulation of cell division	-	18	14	-	-	1.23E-02	8.64E-04
huMAP	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	70	-	-	1.68E-03	4.03E-03
huMAP	BP	GO:0001655	urogenital system development	-	66	52	-	-	8.14E-04	3.02E-03
huMAP	BP	GO:0071827	plasma lipoprotein particle organization	-	86	55	-	-	2.22E-03	3.17E-03
huMAP	BP	GO:0045494	photoreceptor cell maintenance	-	43	37	-	-	7.66E-03	2.16E-03
huMAP	BP	GO:0055088	lipid homeostasis	-	173	125	-	-	4.01E-03	7.20E-03
huMAP	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	24	-	-	3.58E-04	1.44E-03
huMAP	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	166	-	-	4.59E-03	9.57E-03
huMAP	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	18	-	-	5.18E-03	1.08E-03
huMAP	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	32	-	-	2.52E-03	1.87E-03
huMAP	BP	GO:0045667	regulation of osteoblast differentiation	-	147	91	-	-	4.48E-03	5.25E-03
huMAP	BP	GO:2001212	regulation of vasculogenesis	-	16	11	-	-	2.93E-02	6.48E-04
huMAP	BP	GO:0061037	negative regulation of cartilage development	-	32	18	-	-	2.89E-02	1.08E-03
huMAP	BP	GO:0045738	negative regulation of DNA repair	-	40	36	-	-	1.14E-03	2.09E-03
huMAP	BP	GO:0001704	formation of primary germ layer	-	195	146	-	-	7.31E-03	8.42E-03
huMAP	BP	GO:0045778	positive regulation of ossification	-	51	39	-	-	3.76E-02	2.30E-03
huMAP	BP	GO:0048708	astrocyte differentiation	-	88	56	-	-	2.13E-03	3.24E-03
huMAP	BP	GO:0042092	type 2 immune response	-	41	30	-	-	5.53E-04	1.73E-03
huMAP	BP	GO:0048588	developmental cell growth	-	233	177	-	-	4.44E-03	1.02E-02
huMAP	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	3.68E-03	1.15E-03
huMAP	BP	GO:0021872	forebrain generation of neurons	-	52	39	-	-	7.35E-04	2.30E-03
huMAP	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	18	-	-	3.82E-04	1.08E-03
huMAP	BP	GO:0045023	G0 to G1 transition	-	41	35	-	-	3.39E-02	2.01E-03
huMAP	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	33	-	-	7.11E-03	1.94E-03
huMAP	BP	GO:0034367	protein-containing complex remodeling	-	35	26	-	-	3.82E-03	1.51E-03
huMAP	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	22	-	-	1.17E-03	1.30E-03
huMAP	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	36	-	-	3.91E-03	2.09E-03
huMAP	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	2.64E-02	1.15E-03
huMAP	BP	GO:0015810	aspartate transmembrane transport	-	19	15	-	-	3.71E-03	8.64E-04
huMAP	BP	GO:0010232	vascular transport	-	87	62	-	-	7.38E-03	3.60E-03
huMAP	BP	GO:0021987	cerebral cortex development	-	125	99	-	-	2.80E-03	5.76E-03
huMAP	BP	GO:0008637	apoptotic mitochondrial changes	-	108	86	-	-	7.12E-03	4.97E-03
huMAP	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	27	-	-	1.10E-03	1.58E-03
huMAP	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.26E-03	8.64E-04
huMAP	BP	GO:0060999	positive regulation of dendritic spine development	-	35	30	-	-	7.40E-04	1.73E-03
huMAP	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	16	-	-	7.01E-04	9.36E-04
huMAP	BP	GO:2000736	regulation of stem cell differentiation	-	78	66	-	-	2.59E-03	3.81E-03
huMAP	BP	GO:0060973	cell migration involved in heart development	-	21	13	-	-	1.92E-04	7.92E-04
huMAP	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	12	-	-	2.33E-04	7.20E-04
huMAP	BP	GO:0002064	epithelial cell development	-	210	166	-	-	4.54E-03	9.57E-03
huMAP	BP	GO:0071318	cellular response to ATP	-	18	12	-	-	2.42E-04	7.20E-04
huMAP	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	30	-	-	6.02E-03	1.73E-03
huMAP	BP	GO:2001222	regulation of neuron migration	-	46	34	-	-	1.21E-02	2.01E-03
huMAP	BP	GO:0034389	lipid droplet organization	-	38	32	-	-	1.27E-03	1.87E-03
huMAP	BP	GO:0051602	response to electrical stimulus	-	44	35	-	-	1.24E-03	2.01E-03
huMAP	BP	GO:0042177	negative regulation of protein catabolic process	-	109	91	-	-	1.70E-03	5.25E-03
huMAP	MF	GO:0038024	cargo receptor activity	-	121	86	-	-	3.63E-03	4.97E-03
huMAP	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	13	-	-	6.43E-04	7.92E-04
huMAP	BP	GO:0033120	positive regulation of RNA splicing	-	46	36	-	-	9.99E-04	2.09E-03
huMAP	BP	GO:0051445	regulation of meiotic cell cycle	-	64	51	-	-	2.08E-02	2.95E-03
huMAP	BP	GO:0033619	membrane protein proteolysis	-	60	51	-	-	2.00E-03	2.95E-03
huMAP	BP	GO:0038065	collagen-activated signaling pathway	-	15	12	-	-	1.44E-02	7.20E-04
huMAP	BP	GO:0090087	regulation of peptide transport	-	195	136	-	-	3.07E-03	7.84E-03
huMAP	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	69	-	-	1.39E-03	4.03E-03
huMAP	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	17	-	-	8.16E-04	1.01E-03
huMAP	BP	GO:0006929	substrate-dependent cell migration	-	26	24	-	-	1.03E-03	1.44E-03
huMAP	BP	GO:0042537	benzene-containing compound metabolic process	-	27	24	-	-	7.48E-03	1.44E-03
huMAP	BP	GO:0099118	microtubule-based protein transport	-	14	12	-	-	1.60E-03	7.20E-04
huMAP	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	14	-	-	1.04E-03	8.64E-04
huMAP	BP	GO:0072662	protein localization to peroxisome	-	20	19	-	-	1.50E-03	1.15E-03
huMAP	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	11	-	-	3.69E-03	6.48E-04
huMAP	BP	GO:0022404	molting cycle process	-	95	77	-	-	2.73E-03	4.46E-03
huMAP	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	2.83E-03	1.01E-03
huMAP	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	15	-	-	8.39E-03	8.64E-04
huMAP	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	14	-	-	1.03E-03	8.64E-04
huMAP	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	23	-	-	8.28E-04	1.37E-03
huMAP	BP	GO:0017014	protein nitrosylation	-	17	11	-	-	6.76E-04	6.48E-04
huMAP	BP	GO:0007281	germ cell development	-	334	215	-	-	5.40E-03	1.24E-02
huMAP	BP	GO:0008299	isoprenoid biosynthetic process	-	30	28	-	-	5.84E-03	1.66E-03
huMAP	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	181	-	-	4.62E-03	1.04E-02
huMAP	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	26	-	-	5.45E-04	1.51E-03
huMAP	BP	GO:0034104	negative regulation of tissue remodeling	-	22	13	-	-	1.98E-04	7.92E-04
huMAP	CC	GO:0098926	postsynaptic signal transduction	-	39	25	-	-	1.02E-03	1.44E-03
huMAP	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	116	-	-	2.95E-03	6.69E-03
huMAP	CC	GO:0016082	synaptic vesicle priming	-	19	17	-	-	1.45E-02	1.01E-03
huMAP	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	38	-	-	2.35E-03	2.23E-03
huMAP	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	110	-	-	4.73E-03	6.33E-03
huMAP	BP	GO:0034249	negative regulation of amide metabolic process	-	34	17	-	-	2.66E-03	1.01E-03
huMAP	BP	GO:0061548	ganglion development	-	17	11	-	-	2.00E-04	6.48E-04
huMAP	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	84	-	-	2.49E-02	4.89E-03
huMAP	BP	GO:0042182	ketone catabolic process	-	14	13	-	-	4.09E-02	7.92E-04
huMAP	BP	GO:0042832	defense response to protozoan	-	28	14	-	-	1.07E-01	8.64E-04
huMAP	BP	GO:0048799	animal organ maturation	-	33	22	-	-	3.22E-04	1.30E-03
huMAP	BP	GO:0006925	inflammatory cell apoptotic process	-	23	18	-	-	2.39E-04	1.08E-03
huMAP	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	130	-	-	3.41E-03	7.48E-03
huMAP	BP	GO:1903035	negative regulation of response to wounding	-	93	63	-	-	3.34E-03	3.67E-03
huMAP	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	19	-	-	6.45E-04	1.15E-03
huMAP	BP	GO:0036010	protein localization to endosome	-	27	23	-	-	1.69E-03	1.37E-03
huMAP	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	121	-	-	3.93E-03	6.98E-03
huMAP	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	87	-	-	1.78E-03	5.04E-03
huMAP	BP	GO:0045056	transcytosis	-	20	16	-	-	5.72E-04	9.36E-04
huMAP	BP	GO:0018342	protein prenylation	-	15	14	-	-	1.01E-02	8.64E-04
huMAP	BP	GO:0009267	cellular response to starvation	-	170	144	-	-	5.74E-03	8.35E-03
huMAP	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	43	-	-	1.82E-03	2.52E-03
huMAP	BP	GO:0046834	lipid phosphorylation	-	16	13	-	-	5.74E-04	7.92E-04
huMAP	CC	GO:0140239	postsynaptic endocytosis	-	23	18	-	-	1.93E-03	1.08E-03
huMAP	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	22	-	-	2.38E-03	1.30E-03
huMAP	BP	GO:0046931	pore complex assembly	-	21	18	-	-	6.76E-04	1.08E-03
huMAP	CC	GO:0032008	positive regulation of TOR signaling	-	52	45	-	-	2.11E-02	2.59E-03
huMAP	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	30	-	-	4.75E-03	1.73E-03
huMAP	BP	GO:0046618	xenobiotic export from cell	-	27	13	-	-	2.97E-03	7.92E-04
huMAP	BP	GO:0060428	lung epithelium development	-	43	34	-	-	8.35E-04	2.01E-03
huMAP	BP	GO:0030431	sleep	-	30	15	-	-	3.96E-04	8.64E-04
huMAP	BP	GO:1903318	negative regulation of protein maturation	-	29	20	-	-	2.83E-03	1.15E-03
huMAP	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	96	-	-	9.87E-02	5.54E-03
huMAP	BP	GO:0071732	cellular response to nitric oxide	-	17	14	-	-	4.17E-04	8.64E-04
huMAP	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	3.44E-03	8.64E-04
huMAP	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	2.03E-04	6.48E-04
huMAP	BP	GO:1905155	positive regulation of membrane invagination	-	13	12	-	-	4.35E-04	7.20E-04
huMAP	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	51	-	-	9.10E-03	2.95E-03
huMAP	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	54	-	-	1.02E-03	3.17E-03
huMAP	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	16	-	-	4.95E-04	9.36E-04
huMAP	BP	GO:0065004	protein-DNA complex assembly	-	307	248	-	-	1.68E-02	1.43E-02
huMAP	CC	GO:0090660	cerebrospinal fluid circulation	-	15	11	-	-	2.10E-04	6.48E-04
huMAP	CC	GO:0006406	mRNA export from nucleus	-	69	66	-	-	1.24E-02	3.81E-03
huMAP	BP	GO:0009880	embryonic pattern specification	-	70	52	-	-	8.68E-03	3.02E-03
huMAP	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	39	-	-	1.36E-01	2.30E-03
huMAP	BP	GO:0043043	peptide biosynthetic process	-	25	20	-	-	1.47E-03	1.15E-03
huMAP	BP	GO:0002367	cytokine production involved in immune response	-	121	85	-	-	3.66E-03	4.89E-03
huMAP	BP	GO:0044848	biological phase	-	211	166	-	-	7.35E-03	9.57E-03
huMAP	BP	GO:0046660	female sex differentiation	-	125	91	-	-	1.72E-03	5.25E-03
huMAP	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	15	-	-	6.81E-04	8.64E-04
huMAP	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	35	-	-	1.54E-03	2.01E-03
huMAP	BP	GO:0060411	cardiac septum morphogenesis	-	72	59	-	-	7.08E-03	3.45E-03
huMAP	BP	GO:0071248	cellular response to metal ion	-	201	148	-	-	4.24E-03	8.56E-03
huMAP	BP	GO:0030308	negative regulation of cell growth	-	191	143	-	-	2.78E-03	8.28E-03
huMAP	BP	GO:0097306	cellular response to alcohol	-	99	66	-	-	3.31E-03	3.81E-03
huMAP	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	121	-	-	1.58E-02	6.98E-03
huMAP	BP	GO:0010453	regulation of cell fate commitment	-	40	28	-	-	1.39E-03	1.66E-03
huMAP	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	43	-	-	8.90E-04	2.52E-03
huMAP	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	39	-	-	4.34E-03	2.30E-03
huMAP	BP	GO:0002026	regulation of the force of heart contraction	-	26	20	-	-	7.90E-03	1.15E-03
huMAP	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	14	-	-	7.62E-03	8.64E-04
huMAP	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	42	-	-	1.89E-03	2.45E-03
huMAP	BP	GO:0032890	regulation of organic acid transport	-	78	54	-	-	1.04E-03	3.17E-03
huMAP	BP	GO:0071498	cellular response to fluid shear stress	-	21	17	-	-	3.77E-03	1.01E-03
huMAP	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	19	-	-	1.81E-03	1.15E-03
huMAP	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	65	-	-	1.23E-02	3.74E-03
huMAP	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	20	-	-	4.60E-04	1.15E-03
huMAP	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	37	-	-	1.27E-02	2.16E-03
huMAP	BP	GO:0051259	protein complex oligomerization	-	251	206	-	-	5.02E-03	1.19E-02
huMAP	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	6.80E-04	9.36E-04
huMAP	BP	GO:0098743	cell aggregation	-	24	13	-	-	2.09E-02	7.92E-04
huMAP	BP	GO:0009994	oocyte differentiation	-	57	39	-	-	7.67E-04	2.30E-03
huMAP	MF	GO:0031952	regulation of protein autophosphorylation	-	43	32	-	-	1.01E-03	1.87E-03
huMAP	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	11	-	-	2.06E-04	6.48E-04
huMAP	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	142	-	-	2.52E-03	8.20E-03
huMAP	BP	GO:0044319	"wound healing, spreading of cells"	-	37	30	-	-	1.40E-03	1.73E-03
huMAP	BP	GO:0033688	regulation of osteoblast proliferation	-	31	19	-	-	2.53E-04	1.15E-03
huMAP	BP	GO:0060251	regulation of glial cell proliferation	-	39	28	-	-	1.06E-02	1.66E-03
huMAP	BP	GO:0072665	protein localization to vacuole	-	84	75	-	-	6.59E-03	4.32E-03
huMAP	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	41	-	-	3.46E-02	2.37E-03
huMAP	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	19	-	-	2.47E-03	1.15E-03
huMAP	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	65	-	-	1.91E-03	3.74E-03
huMAP	BP	GO:0042953	lipoprotein transport	-	20	15	-	-	9.01E-04	8.64E-04
huMAP	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	2.08E-02	8.64E-04
huMAP	BP	GO:0042044	fluid transport	-	35	14	-	-	2.62E-03	8.64E-04
huMAP	BP	GO:0070633	transepithelial transport	-	35	21	-	-	1.97E-03	1.22E-03
huMAP	BP	GO:0045661	regulation of myoblast differentiation	-	74	58	-	-	1.02E-02	3.38E-03
huMAP	BP	GO:0030307	positive regulation of cell growth	-	164	128	-	-	2.66E-03	7.41E-03
huMAP	BP	GO:0034250	positive regulation of amide metabolic process	-	27	23	-	-	4.62E-03	1.37E-03
huMAP	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	249	-	-	5.42E-03	1.44E-02
huMAP	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	14	-	-	1.10E-02	8.64E-04
huMAP	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	12	-	-	8.43E-04	7.20E-04
huMAP	BP	GO:0014812	muscle cell migration	-	110	68	-	-	1.64E-03	3.96E-03
huMAP	BP	GO:0048525	negative regulation of viral process	-	90	78	-	-	2.96E-03	4.53E-03
huMAP	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	13	-	-	4.32E-02	7.92E-04
huMAP	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	64	-	-	1.84E-03	3.74E-03
huMAP	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	206	-	-	1.17E-02	1.19E-02
huMAP	BP	GO:0051781	positive regulation of cell division	-	93	63	-	-	1.59E-03	3.67E-03
huMAP	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	17	-	-	1.59E-03	1.01E-03
huMAP	BP	GO:0035493	SNARE complex assembly	-	23	21	-	-	8.66E-02	1.22E-03
huMAP	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	17	-	-	9.27E-04	1.01E-03
huMAP	BP	GO:0060711	labyrinthine layer development	-	47	38	-	-	3.17E-03	2.23E-03
huMAP	BP	GO:0007272	ensheathment of neurons	-	146	108	-	-	3.53E-03	6.26E-03
huMAP	CC	GO:0050806	positive regulation of synaptic transmission	-	171	112	-	-	4.21E-03	6.48E-03
huMAP	BP	GO:0060021	roof of mouth development	-	91	69	-	-	4.44E-03	4.03E-03
huMAP	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	31	-	-	2.39E-03	1.80E-03
huMAP	BP	GO:0050819	negative regulation of coagulation	-	54	37	-	-	1.68E-03	2.16E-03
huMAP	BP	GO:0017004	cytochrome complex assembly	-	40	37	-	-	4.74E-03	2.16E-03
huMAP	BP	GO:0018410	C-terminal protein amino acid modification	-	15	13	-	-	7.25E-02	7.92E-04
huMAP	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	59	-	-	2.03E-01	3.45E-03
huMAP	BP	GO:0097212	lysosomal membrane organization	-	15	13	-	-	2.78E-02	7.92E-04
huMAP	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	12	-	-	1.06E-03	7.20E-04
huMAP	CC	GO:0050805	negative regulation of synaptic transmission	-	55	34	-	-	5.79E-04	2.01E-03
huMAP	BP	GO:0043248	proteasome assembly	-	13	13	-	-	2.47E-02	7.92E-04
huMAP	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	48	-	-	1.12E-02	2.81E-03
huMAP	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	40	-	-	2.21E-03	2.30E-03
huMAP	BP	GO:0016054	organic acid catabolic process	-	251	221	-	-	1.34E-02	1.27E-02
huMAP	BP	GO:0050890	cognition	-	317	232	-	-	4.59E-03	1.34E-02
huMAP	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	12	-	-	2.09E-04	7.20E-04
huMAP	BP	GO:1900048	positive regulation of hemostasis	-	28	23	-	-	1.39E-03	1.37E-03
huMAP	BP	GO:0065005	protein-lipid complex assembly	-	29	23	-	-	1.03E-02	1.37E-03
huMAP	BP	GO:0008033	tRNA processing	-	136	130	-	-	8.87E-03	7.48E-03
huMAP	BP	GO:0046661	male sex differentiation	-	171	121	-	-	3.50E-03	6.98E-03
huMAP	BP	GO:0072520	seminiferous tubule development	-	15	11	-	-	2.61E-04	6.48E-04
huMAP	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	13	-	-	1.43E-02	7.92E-04
huMAP	BP	GO:0035188	hatching	-	27	18	-	-	6.49E-04	1.08E-03
huMAP	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	68	-	-	3.01E-03	3.96E-03
huMAP	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	12	-	-	1.95E-04	7.20E-04
huMAP	BP	GO:0090713	immunological memory process	-	18	14	-	-	2.06E-04	8.64E-04
huMAP	BP	GO:0061326	renal tubule development	-	103	65	-	-	2.55E-03	3.74E-03
huMAP	BP	GO:0051258	protein polymerization	-	280	241	-	-	5.43E-03	1.39E-02
huMAP	BP	GO:0071985	multivesicular body sorting pathway	-	56	51	-	-	2.31E-02	2.95E-03
huMAP	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	2.88E-03	1.01E-03
huMAP	BP	GO:0060325	face morphogenesis	-	31	23	-	-	8.21E-04	1.37E-03
huMAP	BP	GO:0090559	regulation of membrane permeability	-	72	56	-	-	5.34E-03	3.24E-03
huMAP	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	2.26E-02	7.20E-04
huMAP	BP	GO:0031579	membrane raft organization	-	25	20	-	-	1.08E-03	1.15E-03
huMAP	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	22	-	-	5.12E-04	1.30E-03
huMAP	BP	GO:0046460	neutral lipid biosynthetic process	-	50	38	-	-	3.11E-02	2.23E-03
huMAP	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	111	-	-	6.99E-03	6.40E-03
huMAP	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	144	-	-	2.59E-03	8.35E-03
huMAP	BP	GO:0002251	organ or tissue specific immune response	-	43	26	-	-	3.49E-03	1.51E-03
huMAP	CC	GO:0048167	regulation of synaptic plasticity	-	210	140	-	-	4.43E-03	8.06E-03
huMAP	BP	GO:1903708	positive regulation of hemopoiesis	-	184	133	-	-	5.83E-03	7.70E-03
huMAP	BP	GO:1903008	organelle disassembly	-	154	143	-	-	6.95E-03	8.28E-03
huMAP	BP	GO:0001709	cell fate determination	-	44	23	-	-	3.24E-04	1.37E-03
huMAP	BP	GO:0051873	killing by host of symbiont cells	-	28	19	-	-	8.55E-02	1.15E-03
huMAP	BP	GO:0045058	T cell selection	-	53	36	-	-	4.89E-04	2.09E-03
huMAP	CC	GO:0032387	negative regulation of intracellular transport	-	51	42	-	-	9.08E-04	2.45E-03
huMAP	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	4.69E-04	1.15E-03
huMAP	BP	GO:0072091	regulation of stem cell proliferation	-	91	62	-	-	1.45E-03	3.60E-03
huMAP	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	37	-	-	2.89E-03	2.16E-03
huMAP	BP	GO:0099084	postsynaptic specialization organization	-	44	33	-	-	6.25E-03	1.94E-03
huMAP	BP	GO:0071501	cellular response to sterol depletion	-	15	13	-	-	6.47E-04	7.92E-04
huMAP	BP	GO:0060384	innervation	-	27	22	-	-	1.79E-03	1.30E-03
huMAP	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	25	-	-	1.42E-03	1.44E-03
huMAP	MF	GO:0031281	positive regulation of cyclase activity	-	40	18	-	-	4.06E-04	1.08E-03
huMAP	MF	GO:0098631	cell adhesion mediator activity	-	64	57	-	-	1.96E-02	3.31E-03
huMAP	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	11	-	-	2.03E-04	6.48E-04
huMAP	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	7.38E-04	1.08E-03
huMAP	BP	GO:0071453	cellular response to oxygen levels	-	168	124	-	-	2.52E-03	7.20E-03
huMAP	BP	GO:0090399	replicative senescence	-	17	15	-	-	9.95E-04	8.64E-04
huMAP	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	11	-	-	1.38E-03	6.48E-04
huMAP	BP	GO:0031342	negative regulation of cell killing	-	29	18	-	-	2.05E-03	1.08E-03
huMAP	BP	GO:0070585	protein localization to mitochondrion	-	125	114	-	-	2.25E-03	6.62E-03
huMAP	BP	GO:0006855	xenobiotic transmembrane transport	-	14	12	-	-	6.56E-04	7.20E-04
huMAP	BP	GO:0010623	programmed cell death involved in cell development	-	25	19	-	-	1.09E-02	1.15E-03
huMAP	BP	GO:0044242	cellular lipid catabolic process	-	224	187	-	-	8.09E-03	1.08E-02
huMAP	BP	GO:0071236	cellular response to antibiotic	-	13	12	-	-	2.69E-04	7.20E-04
huMAP	BP	GO:0002931	response to ischemia	-	58	44	-	-	1.14E-03	2.59E-03
huMAP	BP	GO:0043062	extracellular structure organization	-	317	227	-	-	1.61E-02	1.31E-02
huMAP	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	3.47E-02	7.20E-04
huMAP	BP	GO:0014047	glutamate secretion	-	25	13	-	-	6.41E-04	7.92E-04
huMAP	BP	GO:0061005	cell differentiation involved in kidney development	-	58	38	-	-	1.30E-03	2.23E-03
huMAP	BP	GO:0030397	membrane disassembly	-	11	11	-	-	3.87E-03	6.48E-04
huMAP	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	50	-	-	5.11E-03	2.88E-03
huMAP	BP	GO:0060420	regulation of heart growth	-	74	50	-	-	9.64E-03	2.88E-03
huMAP	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	11	-	-	2.08E-04	6.48E-04
huMAP	BP	GO:0009755	hormone-mediated signaling pathway	-	221	163	-	-	5.51E-03	9.43E-03
huMAP	BP	GO:0022612	gland morphogenesis	-	124	88	-	-	4.15E-03	5.11E-03
huMAP	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	31	-	-	1.68E-03	1.80E-03
huMAP	MF	GO:0140416	transcription regulator inhibitor activity	-	26	19	-	-	1.89E-02	1.15E-03
huMAP	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	20	-	-	3.01E-02	1.15E-03
huMAP	BP	GO:0110096	cellular response to aldehyde	-	17	14	-	-	1.29E-03	8.64E-04
huMAP	BP	GO:1990845	adaptive thermogenesis	-	166	121	-	-	2.18E-03	6.98E-03
huMAP	BP	GO:0071320	cellular response to cAMP	-	54	37	-	-	7.02E-04	2.16E-03
huMAP	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	1.91E-02	6.48E-04
huMAP	BP	GO:0015844	monoamine transport	-	88	50	-	-	4.66E-02	2.88E-03
huMAP	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	19	-	-	7.62E-04	1.15E-03
huMAP	BP	GO:0060039	pericardium development	-	19	13	-	-	1.20E-02	7.92E-04
huMAP	BP	GO:0071392	cellular response to estradiol stimulus	-	40	28	-	-	6.97E-04	1.66E-03
huMAP	BP	GO:0000272	polysaccharide catabolic process	-	19	17	-	-	1.38E-02	1.01E-03
huMAP	BP	GO:0009451	RNA modification	-	169	156	-	-	5.78E-03	9.00E-03
huMAP	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	35	-	-	9.86E-04	2.01E-03
huMAP	BP	GO:1903729	regulation of plasma membrane organization	-	17	16	-	-	6.12E-03	9.36E-04
huMAP	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	101	-	-	4.10E-03	5.83E-03
huMAP	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	33	-	-	1.91E-02	1.94E-03
huMAP	BP	GO:0015807	L-amino acid transport	-	94	67	-	-	3.45E-03	3.89E-03
huMAP	BP	GO:0032941	secretion by tissue	-	85	59	-	-	2.55E-03	3.45E-03
huMAP	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	11	-	-	5.83E-04	6.48E-04
huMAP	BP	GO:0046605	regulation of centrosome cycle	-	54	49	-	-	5.39E-03	2.88E-03
huMAP	BP	GO:0048753	pigment granule organization	-	40	37	-	-	2.87E-02	2.16E-03
huMAP	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	13	-	-	2.04E-04	7.92E-04
huMAP	BP	GO:0003014	renal system process	-	130	87	-	-	1.41E-02	5.04E-03
huMAP	CC	GO:0070286	axonemal dynein complex assembly	-	40	32	-	-	1.92E-03	1.87E-03
huMAP	BP	GO:0045598	regulation of fat cell differentiation	-	148	101	-	-	3.09E-03	5.83E-03
huMAP	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	157	-	-	3.61E-03	9.07E-03
huMAP	BP	GO:1904646	cellular response to amyloid-beta	-	44	32	-	-	9.03E-04	1.87E-03
huMAP	BP	GO:1901863	positive regulation of muscle tissue development	-	24	18	-	-	3.57E-03	1.08E-03
huMAP	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	110	-	-	6.11E-03	6.33E-03
huMAP	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	12	-	-	7.97E-04	7.20E-04
huMAP	BP	GO:0008340	determination of adult lifespan	-	23	21	-	-	7.42E-04	1.22E-03
huMAP	BP	GO:0018158	protein oxidation	-	15	13	-	-	1.50E-03	7.92E-04
huMAP	BP	GO:0039694	viral RNA genome replication	-	30	26	-	-	9.01E-04	1.51E-03
huMAP	BP	GO:0009404	toxin metabolic process	-	17	15	-	-	7.12E-04	8.64E-04
huMAP	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	22	-	-	9.25E-03	1.30E-03
huMAP	BP	GO:0071709	membrane assembly	-	68	61	-	-	9.08E-03	3.53E-03
huMAP	BP	GO:0008217	regulation of blood pressure	-	186	109	-	-	3.74E-03	6.33E-03
huMAP	BP	GO:0031643	positive regulation of myelination	-	19	14	-	-	1.91E-04	8.64E-04
huMAP	BP	GO:0043101	purine-containing compound salvage	-	15	13	-	-	2.76E-03	7.92E-04
huMAP	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	50	-	-	1.38E-03	2.88E-03
huMAP	CC	GO:0042770	signal transduction in response to DNA damage	-	186	167	-	-	6.19E-03	9.64E-03
huMAP	BP	GO:0002200	somatic diversification of immune receptors	-	78	62	-	-	6.13E-03	3.60E-03
huMAP	BP	GO:0035315	hair cell differentiation	-	52	39	-	-	2.03E-03	2.30E-03
huMAP	BP	GO:0048645	animal organ formation	-	62	43	-	-	2.40E-03	2.52E-03
huMAP	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	123	-	-	4.03E-03	7.12E-03
huMAP	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	12	-	-	2.06E-04	7.20E-04
huMAP	BP	GO:0033627	cell adhesion mediated by integrin	-	87	70	-	-	4.99E-03	4.03E-03
huMAP	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	1.12E-02	1.22E-03
huMAP	BP	GO:0035107	appendage morphogenesis	-	147	118	-	-	3.74E-03	6.84E-03
huMAP	BP	GO:1903707	negative regulation of hemopoiesis	-	116	71	-	-	1.29E-03	4.10E-03
huMAP	BP	GO:0036342	post-anal tail morphogenesis	-	19	17	-	-	6.58E-04	1.01E-03
huMAP	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	4.61E-02	1.44E-03
huMAP	BP	GO:0030149	sphingolipid catabolic process	-	32	25	-	-	8.80E-04	1.44E-03
huMAP	BP	GO:0050994	regulation of lipid catabolic process	-	61	43	-	-	4.43E-03	2.52E-03
huMAP	BP	GO:0035988	chondrocyte proliferation	-	24	17	-	-	2.66E-04	1.01E-03
huMAP	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	15	-	-	4.74E-02	8.64E-04
huMAP	BP	GO:0009593	detection of chemical stimulus	-	511	58	-	-	5.73E-03	3.38E-03
huMAP	BP	GO:0060788	ectodermal placode formation	-	12	11	-	-	2.64E-04	6.48E-04
huMAP	BP	GO:0045727	positive regulation of translation	-	141	125	-	-	2.49E-03	7.20E-03
huMAP	BP	GO:0036315	cellular response to sterol	-	24	12	-	-	1.29E-02	7.20E-04
huMAP	CC	GO:0032388	positive regulation of intracellular transport	-	137	118	-	-	2.78E-03	6.84E-03
huMAP	BP	GO:0002027	regulation of heart rate	-	106	69	-	-	1.60E-03	4.03E-03
huMAP	BP	GO:0050879	multicellular organismal movement	-	118	85	-	-	2.34E-03	4.89E-03
huMAP	BP	GO:0120305	regulation of pigmentation	-	15	11	-	-	3.50E-02	6.48E-04
huMAP	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	52	-	-	1.59E-03	3.02E-03
huMAP	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	50	-	-	2.24E-03	2.88E-03
huMAP	BP	GO:0048515	spermatid differentiation	-	208	134	-	-	3.94E-03	7.77E-03
huMAP	BP	GO:0072132	mesenchyme morphogenesis	-	57	46	-	-	1.06E-02	2.66E-03
huMAP	MF	GO:0042887	amide transmembrane transporter activity	-	33	23	-	-	1.95E-03	1.37E-03
huMAP	BP	GO:0007130	synaptonemal complex assembly	-	23	12	-	-	1.94E-04	7.20E-04
huMAP	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	28	-	-	2.89E-03	1.66E-03
huMAP	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	21	-	-	1.00E-03	1.22E-03
huMAP	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	29	-	-	1.13E-03	1.73E-03
huMAP	BP	GO:0060119	inner ear receptor cell development	-	44	35	-	-	9.25E-04	2.01E-03
huMAP	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	17	-	-	1.38E-03	1.01E-03
huMAP	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	23	-	-	2.37E-03	1.37E-03
huMAP	BP	GO:1901983	regulation of protein acetylation	-	26	22	-	-	5.88E-04	1.30E-03
huMAP	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	178	-	-	5.20E-03	1.03E-02
huMAP	BP	GO:1900006	positive regulation of dendrite development	-	17	15	-	-	4.21E-03	8.64E-04
huMAP	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	46	-	-	1.67E-02	2.66E-03
huMAP	BP	GO:0010883	regulation of lipid storage	-	53	41	-	-	1.05E-03	2.37E-03
huMAP	BP	GO:0072170	metanephric tubule development	-	26	11	-	-	1.07E-03	6.48E-04
huMAP	BP	GO:1905954	positive regulation of lipid localization	-	110	81	-	-	4.55E-03	4.68E-03
huMAP	BP	GO:0002209	behavioral defense response	-	39	32	-	-	4.45E-04	1.87E-03
huMAP	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	26	-	-	6.95E-03	1.51E-03
huMAP	BP	GO:0072523	purine-containing compound catabolic process	-	146	132	-	-	5.12E-03	7.63E-03
huMAP	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	30	-	-	3.57E-02	1.73E-03
huMAP	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	24	-	-	9.70E-04	1.44E-03
huMAP	BP	GO:0021535	cell migration in hindbrain	-	16	11	-	-	2.03E-04	6.48E-04
huMAP	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	88	-	-	5.97E-03	5.11E-03
huMAP	BP	GO:0007218	neuropeptide signaling pathway	-	113	42	-	-	1.48E-03	2.45E-03
huMAP	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	92	-	-	3.69E-03	5.33E-03
huMAP	BP	GO:0031345	negative regulation of cell projection organization	-	195	146	-	-	4.31E-03	8.42E-03
huMAP	BP	GO:0048278	vesicle docking	-	64	57	-	-	2.52E-02	3.31E-03
huMAP	BP	GO:0035050	embryonic heart tube development	-	86	68	-	-	3.87E-03	3.96E-03
huMAP	BP	GO:0030168	platelet activation	-	135	94	-	-	1.94E-03	5.47E-03
huMAP	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	17	-	-	1.03E-03	1.01E-03
huMAP	CC	GO:0098810	neurotransmitter reuptake	-	35	17	-	-	1.26E-03	1.01E-03
huMAP	BP	GO:0008213	protein alkylation	-	58	49	-	-	2.57E-03	2.88E-03
huMAP	BP	GO:0031338	regulation of vesicle fusion	-	24	23	-	-	1.79E-02	1.37E-03
huMAP	BP	GO:0031529	ruffle organization	-	55	47	-	-	9.89E-04	2.73E-03
huMAP	BP	GO:0010842	retina layer formation	-	25	18	-	-	5.97E-04	1.08E-03
huMAP	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	52	-	-	3.59E-02	3.02E-03
huMAP	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	51	-	-	4.23E-03	2.95E-03
huMAP	MF	GO:0170055	lipid transmembrane transporter activity	-	56	38	-	-	5.16E-03	2.23E-03
huMAP	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	30	-	-	2.64E-03	1.73E-03
huMAP	BP	GO:0035304	regulation of protein dephosphorylation	-	87	74	-	-	1.56E-03	4.32E-03
huMAP	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	185	-	-	5.07E-03	1.07E-02
huMAP	BP	GO:0099637	neurotransmitter receptor transport	-	26	19	-	-	7.32E-04	1.15E-03
huMAP	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	23	-	-	3.37E-04	1.37E-03
huMAP	BP	GO:0051775	response to redox state	-	13	13	-	-	6.55E-02	7.92E-04
huMAP	BP	GO:0051785	positive regulation of nuclear division	-	61	41	-	-	1.37E-03	2.37E-03
huMAP	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	13	-	-	9.46E-04	7.92E-04
huMAP	BP	GO:0060749	mammary gland alveolus development	-	20	14	-	-	1.94E-04	8.64E-04
huMAP	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	4.57E-03	7.20E-04
huMAP	BP	GO:0044786	cell cycle DNA replication	-	45	43	-	-	5.34E-03	2.52E-03
huMAP	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	11	-	-	5.17E-04	6.48E-04
huMAP	BP	GO:0044539	long-chain fatty acid import into cell	-	17	16	-	-	7.28E-04	9.36E-04
huMAP	BP	GO:0051299	centrosome separation	-	15	15	-	-	6.25E-04	8.64E-04
huMAP	BP	GO:0048145	regulation of fibroblast proliferation	-	87	73	-	-	1.92E-03	4.25E-03
huMAP	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	31	-	-	7.70E-04	1.80E-03
huMAP	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	6.13E-03	6.48E-04
huMAP	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	188	-	-	4.15E-03	1.09E-02
huMAP	BP	GO:0021819	layer formation in cerebral cortex	-	14	11	-	-	1.29E-03	6.48E-04
huMAP	CC	GO:0008333	endosome to lysosome transport	-	73	66	-	-	1.01E-02	3.81E-03
huMAP	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	17	-	-	4.36E-04	1.01E-03
huMAP	BP	GO:0003016	respiratory system process	-	39	29	-	-	1.58E-03	1.73E-03
huMAP	BP	GO:0045732	positive regulation of protein catabolic process	-	202	178	-	-	3.57E-03	1.03E-02
huMAP	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	63	-	-	1.45E-02	3.67E-03
huMAP	BP	GO:0007588	excretion	-	40	24	-	-	3.25E-04	1.44E-03
huMAP	BP	GO:1904018	positive regulation of vasculature development	-	185	114	-	-	2.09E-03	6.62E-03
huMAP	BP	GO:0050953	sensory perception of light stimulus	-	223	146	-	-	3.46E-03	8.42E-03
huMAP	BP	GO:0009164	nucleoside catabolic process	-	25	20	-	-	6.93E-03	1.15E-03
huMAP	BP	GO:0009303	rRNA transcription	-	37	35	-	-	1.93E-03	2.01E-03
huMAP	BP	GO:0035601	protein deacylation	-	56	50	-	-	4.79E-03	2.88E-03
huMAP	BP	GO:0061952	midbody abscission	-	18	17	-	-	2.14E-02	1.01E-03
huMAP	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	17	-	-	7.86E-03	1.01E-03
huMAP	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	26	-	-	4.35E-04	1.51E-03
huMAP	BP	GO:0071300	cellular response to retinoic acid	-	66	48	-	-	5.54E-03	2.81E-03
huMAP	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	13	-	-	2.08E-04	7.92E-04
huMAP	BP	GO:0045830	positive regulation of isotype switching	-	28	18	-	-	7.62E-04	1.08E-03
huMAP	BP	GO:0031069	hair follicle morphogenesis	-	33	22	-	-	3.09E-04	1.30E-03
huMAP	BP	GO:0046697	decidualization	-	26	16	-	-	4.24E-04	9.36E-04
huMAP	BP	GO:0051588	regulation of neurotransmitter transport	-	99	81	-	-	4.72E-03	4.68E-03
huMAP	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	25	-	-	2.09E-02	1.44E-03
huMAP	BP	GO:0051784	negative regulation of nuclear division	-	63	57	-	-	3.54E-03	3.31E-03
huMAP	BP	GO:0044703	multi-organism reproductive process	-	209	142	-	-	8.39E-03	8.20E-03
huMAP	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	116	-	-	2.25E-02	6.69E-03
huMAP	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	37	-	-	2.33E-02	2.16E-03
huMAP	BP	GO:0099022	vesicle tethering	-	32	31	-	-	1.03E-01	1.80E-03
huMAP	MF	GO:0004930	G protein-coupled receptor activity	-	873	173	-	-	6.07E-03	1.00E-02
huMAP	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	30	-	-	1.02E-03	1.73E-03
huMAP	BP	GO:1903867	extraembryonic membrane development	-	12	11	-	-	7.71E-04	6.48E-04
huMAP	BP	GO:0048857	neural nucleus development	-	65	51	-	-	1.20E-03	2.95E-03
huMAP	BP	GO:0048663	neuron fate commitment	-	74	42	-	-	7.55E-03	2.45E-03
huMAP	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	118	-	-	4.00E-03	6.84E-03
huMAP	BP	GO:0106027	neuron projection organization	-	90	78	-	-	2.10E-03	4.53E-03
huMAP	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	91	-	-	2.89E-03	5.25E-03
huMAP	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	30	-	-	1.56E-03	1.73E-03
huMAP	BP	GO:0045685	regulation of glial cell differentiation	-	77	45	-	-	2.04E-03	2.59E-03
huMAP	BP	GO:0043414	macromolecule methylation	-	138	125	-	-	4.26E-03	7.20E-03
huMAP	BP	GO:0048268	clathrin coat assembly	-	16	14	-	-	7.98E-03	8.64E-04
huMAP	BP	GO:0050886	endocrine process	-	93	60	-	-	8.32E-04	3.45E-03
huMAP	MF	GO:0015562	efflux transmembrane transporter activity	-	15	13	-	-	2.60E-03	7.92E-04
huMAP	BP	GO:0050951	sensory perception of temperature stimulus	-	28	12	-	-	2.06E-04	7.20E-04
huMAP	BP	GO:0045807	positive regulation of endocytosis	-	155	124	-	-	5.13E-03	7.20E-03
huMAP	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	6.42E-04	6.48E-04
huMAP	BP	GO:0002418	immune response to tumor cell	-	29	18	-	-	5.92E-04	1.08E-03
huMAP	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	53	-	-	3.06E-03	3.09E-03
huMAP	BP	GO:0048308	organelle inheritance	-	14	13	-	-	3.79E-03	7.92E-04
huMAP	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	9.43E-04	1.08E-03
huMAP	BP	GO:0001829	trophectodermal cell differentiation	-	19	15	-	-	3.28E-03	8.64E-04
huMAP	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	42	-	-	3.64E-03	2.45E-03
huMAP	BP	GO:0034394	protein localization to cell surface	-	69	57	-	-	1.75E-03	3.31E-03
huMAP	BP	GO:0009110	vitamin biosynthetic process	-	23	16	-	-	7.77E-03	9.36E-04
huMAP	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	21	-	-	1.00E-03	1.22E-03
huMAP	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	1.30E-02	1.01E-03
huMAP	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	15	-	-	1.78E-03	8.64E-04
huMAP	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	72	-	-	1.58E-03	4.17E-03
huMAP	MF	GO:0051100	negative regulation of binding	-	161	128	-	-	4.23E-03	7.41E-03
huMAP	BP	GO:0001818	negative regulation of cytokine production	-	379	206	-	-	4.01E-03	1.19E-02
huMAP	BP	GO:0003151	outflow tract morphogenesis	-	81	62	-	-	3.42E-03	3.60E-03
huMAP	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	54	-	-	1.25E-03	3.17E-03
huMAP	BP	GO:0055093	response to hyperoxia	-	20	19	-	-	7.45E-04	1.15E-03
huMAP	BP	GO:0061036	positive regulation of cartilage development	-	33	24	-	-	2.52E-02	1.44E-03
huMAP	BP	GO:0046184	aldehyde biosynthetic process	-	16	12	-	-	2.68E-04	7.20E-04
huMAP	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	40	-	-	1.68E-03	2.30E-03
huMAP	BP	GO:0046621	negative regulation of organ growth	-	39	27	-	-	1.19E-03	1.58E-03
huMAP	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	1.33E-01	2.88E-03
huMAP	BP	GO:0032368	regulation of lipid transport	-	149	102	-	-	4.92E-03	5.90E-03
huMAP	BP	GO:0055094	response to lipoprotein particle	-	34	23	-	-	3.31E-04	1.37E-03
huMAP	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	156	-	-	4.15E-03	9.00E-03
huMAP	BP	GO:0033002	muscle cell proliferation	-	249	161	-	-	4.24E-03	9.28E-03
huMAP	BP	GO:0043331	response to dsRNA	-	56	52	-	-	6.74E-02	3.02E-03
huMAP	BP	GO:0051904	pigment granule transport	-	23	21	-	-	5.97E-03	1.22E-03
huMAP	BP	GO:1901679	nucleotide transmembrane transport	-	32	31	-	-	3.32E-03	1.80E-03
huMAP	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	26	-	-	1.64E-02	1.51E-03
huMAP	BP	GO:0033363	secretory granule organization	-	63	47	-	-	9.38E-03	2.73E-03
huMAP	BP	GO:0060479	lung cell differentiation	-	28	23	-	-	8.37E-04	1.37E-03
huMAP	BP	GO:0120009	intermembrane lipid transfer	-	52	43	-	-	3.06E-02	2.52E-03
huMAP	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	6.06E-04	8.64E-04
huMAP	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	27	-	-	9.39E-04	1.58E-03
huMAP	BP	GO:0033622	integrin activation	-	26	19	-	-	5.76E-03	1.15E-03
huMAP	BP	GO:0098751	bone cell development	-	18	14	-	-	4.97E-04	8.64E-04
huMAP	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.94E-03	1.22E-03
huMAP	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	36	-	-	1.01E-03	2.09E-03
huMAP	BP	GO:0050820	positive regulation of coagulation	-	30	25	-	-	1.21E-03	1.44E-03
huMAP	BP	GO:0002076	osteoblast development	-	17	12	-	-	1.93E-04	7.20E-04
huMAP	BP	GO:0072164	mesonephric tubule development	-	98	72	-	-	3.84E-03	4.17E-03
huMAP	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	15	-	-	2.74E-04	8.64E-04
huMAP	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	71	-	-	2.12E-03	4.10E-03
huMAP	BP	GO:1903524	positive regulation of blood circulation	-	39	22	-	-	4.86E-04	1.30E-03
huMAP	BP	GO:0030901	midbrain development	-	87	66	-	-	1.09E-03	3.81E-03
huMAP	BP	GO:0048485	sympathetic nervous system development	-	22	11	-	-	2.01E-04	6.48E-04
huMAP	BP	GO:0007162	negative regulation of cell adhesion	-	310	208	-	-	4.67E-03	1.20E-02
huMAP	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	47	-	-	1.94E-03	2.73E-03
huMAP	BP	GO:0002687	positive regulation of leukocyte migration	-	147	95	-	-	2.09E-03	5.47E-03
huMAP	BP	GO:0019755	one-carbon compound transport	-	28	12	-	-	3.20E-03	7.20E-04
huMAP	BP	GO:1901862	negative regulation of muscle tissue development	-	13	11	-	-	2.29E-03	6.48E-04
huMAP	BP	GO:0110154	RNA decapping	-	19	17	-	-	1.33E-03	1.01E-03
huMAP	BP	GO:0034605	cellular response to heat	-	66	57	-	-	8.81E-03	3.31E-03
huMAP	BP	GO:0005996	monosaccharide metabolic process	-	250	212	-	-	6.70E-03	1.22E-02
huMAP	BP	GO:0033555	multicellular organismal response to stress	-	90	60	-	-	1.99E-03	3.45E-03
huMAP	BP	GO:0002262	myeloid cell homeostasis	-	172	140	-	-	2.67E-03	8.06E-03
huMAP	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	3.25E-02	2.23E-03
huMAP	BP	GO:0050688	regulation of defense response to virus	-	65	50	-	-	1.22E-03	2.88E-03
huMAP	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	232	-	-	1.16E-02	1.34E-02
huMAP	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	15	-	-	2.84E-03	8.64E-04
huMAP	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	177	-	-	4.99E-03	1.02E-02
huMAP	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	23	-	-	2.11E-03	1.37E-03
huMAP	BP	GO:0061029	eyelid development in camera-type eye	-	14	12	-	-	4.96E-04	7.20E-04
huMAP	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	25	-	-	4.97E-04	1.44E-03
huMAP	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	12	-	-	6.01E-04	7.20E-04
huMAP	BP	GO:0003272	endocardial cushion formation	-	28	21	-	-	1.36E-02	1.22E-03
huMAP	BP	GO:0022618	protein-RNA complex assembly	-	227	190	-	-	9.60E-03	1.09E-02
huMAP	BP	GO:0051147	regulation of muscle cell differentiation	-	162	104	-	-	3.62E-03	6.04E-03
huMAP	BP	GO:0090102	cochlea development	-	50	32	-	-	1.57E-03	1.87E-03
huMAP	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	18	-	-	4.19E-03	1.08E-03
huMAP	BP	GO:0045933	positive regulation of muscle contraction	-	49	27	-	-	1.70E-03	1.58E-03
huMAP	BP	GO:0002679	respiratory burst involved in defense response	-	16	13	-	-	2.63E-04	7.92E-04
huMAP	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	32	-	-	1.88E-03	1.87E-03
huMAP	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	85	-	-	9.76E-02	4.89E-03
huMAP	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	5.85E-04	1.30E-03
huMAP	BP	GO:0032922	circadian regulation of gene expression	-	71	62	-	-	1.55E-02	3.60E-03
huMAP	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	19	-	-	2.78E-04	1.15E-03
huMAP	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	73	-	-	2.62E-03	4.25E-03
huMAP	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	44	-	-	4.84E-03	2.59E-03
huMAP	BP	GO:0038179	neurotrophin signaling pathway	-	38	29	-	-	1.32E-03	1.73E-03
huMAP	BP	GO:0140253	cell-cell fusion	-	62	36	-	-	9.11E-04	2.09E-03
huMAP	BP	GO:0071599	otic vesicle development	-	15	12	-	-	7.33E-03	7.20E-04
huMAP	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	30	-	-	5.84E-03	1.73E-03
huMAP	BP	GO:0061635	regulation of protein complex stability	-	14	13	-	-	4.01E-04	7.92E-04
huMAP	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	3.26E-03	3.45E-03
huMAP	BP	GO:0001941	postsynaptic membrane organization	-	37	31	-	-	4.36E-02	1.80E-03
huMAP	BP	GO:0051293	establishment of spindle localization	-	57	51	-	-	2.43E-03	2.95E-03
huMAP	BP	GO:0043114	regulation of vascular permeability	-	49	31	-	-	9.63E-04	1.80E-03
huMAP	BP	GO:0018126	protein hydroxylation	-	26	25	-	-	4.35E-03	1.44E-03
huMAP	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	48	-	-	1.52E-03	2.81E-03
huMAP	BP	GO:0008360	regulation of cell shape	-	139	111	-	-	4.11E-03	6.40E-03
huMAP	BP	GO:0051222	positive regulation of protein transport	-	249	195	-	-	4.04E-03	1.12E-02
huMAP	CC	GO:0140632	canonical inflammasome complex assembly	-	40	31	-	-	1.09E-03	1.80E-03
huMAP	MF	GO:0034260	negative regulation of GTPase activity	-	36	29	-	-	5.34E-04	1.73E-03
huMAP	BP	GO:0045932	negative regulation of muscle contraction	-	24	15	-	-	1.39E-03	8.64E-04
huMAP	BP	GO:0045739	positive regulation of DNA repair	-	128	122	-	-	3.15E-02	7.05E-03
huMAP	BP	GO:0001845	phagolysosome assembly	-	19	13	-	-	1.54E-03	7.92E-04
huMAP	BP	GO:0045185	maintenance of protein location	-	95	79	-	-	1.29E-03	4.61E-03
huMAP	BP	GO:0003158	endothelium development	-	140	95	-	-	4.39E-03	5.47E-03
huMAP	CC	GO:0072595	maintenance of protein localization in organelle	-	42	38	-	-	7.18E-04	2.23E-03
huMAP	BP	GO:0051224	negative regulation of protein transport	-	122	87	-	-	2.48E-03	5.04E-03
huMAP	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	100	-	-	3.61E-03	5.76E-03
huMAP	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	6.63E-04	7.92E-04
huMAP	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	22	-	-	8.75E-04	1.30E-03
huMAP	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	15	-	-	3.99E-03	8.64E-04
huMAP	BP	GO:0021885	forebrain cell migration	-	63	45	-	-	3.42E-03	2.59E-03
huMAP	BP	GO:0007405	neuroblast proliferation	-	81	57	-	-	1.58E-03	3.31E-03
huMAP	BP	GO:0009581	detection of external stimulus	-	137	73	-	-	3.15E-03	4.25E-03
huMAP	BP	GO:1990542	mitochondrial transmembrane transport	-	93	87	-	-	6.30E-03	5.04E-03
huMAP	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	29	-	-	6.04E-03	1.73E-03
huMAP	BP	GO:0097186	amelogenesis	-	26	14	-	-	2.60E-03	8.64E-04
huMAP	BP	GO:0031128	developmental induction	-	26	21	-	-	3.21E-04	1.22E-03
huMAP	BP	GO:0035672	oligopeptide transmembrane transport	-	15	12	-	-	7.15E-04	7.20E-04
huMAP	BP	GO:0031100	animal organ regeneration	-	66	53	-	-	1.01E-03	3.09E-03
huMAP	BP	GO:0021533	cell differentiation in hindbrain	-	23	14	-	-	2.24E-03	8.64E-04
huMAP	BP	GO:0045684	positive regulation of epidermis development	-	33	23	-	-	5.84E-04	1.37E-03
huMAP	BP	GO:1900047	negative regulation of hemostasis	-	51	36	-	-	4.87E-03	2.09E-03
huMAP	BP	GO:0021517	ventral spinal cord development	-	47	30	-	-	1.84E-02	1.73E-03
huMAP	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	71	-	-	1.66E-03	4.10E-03
huMAP	BP	GO:0032328	alanine transport	-	19	13	-	-	1.91E-03	7.92E-04
huMAP	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	6.75E-04	9.36E-04
huMAP	BP	GO:0097722	sperm motility	-	133	93	-	-	5.62E-03	5.40E-03
huMAP	BP	GO:0051231	spindle elongation	-	14	14	-	-	4.46E-03	8.64E-04
huMAP	BP	GO:0042490	mechanoreceptor differentiation	-	67	51	-	-	2.06E-03	2.95E-03
huMAP	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	26	-	-	8.60E-04	1.51E-03
huMAP	BP	GO:0035148	tube formation	-	155	126	-	-	2.37E-03	7.27E-03
huMAP	BP	GO:0048520	positive regulation of behavior	-	27	13	-	-	1.92E-04	7.92E-04
huMAP	BP	GO:0098543	detection of other organism	-	19	12	-	-	6.19E-02	7.20E-04
huMAP	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	42	-	-	3.43E-03	2.45E-03
huMAP	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	97	-	-	2.70E-03	5.61E-03
huMAP	BP	GO:0031123	RNA 3'-end processing	-	79	75	-	-	3.77E-03	4.32E-03
huMAP	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	80	-	-	1.97E-03	4.61E-03
huMAP	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	2.35E-03	1.08E-03
huMAP	CC	GO:0007097	nuclear migration	-	24	21	-	-	1.72E-03	1.22E-03
huMAP	BP	GO:0045229	external encapsulating structure organization	-	319	230	-	-	1.54E-02	1.32E-02
huMAP	BP	GO:0006885	regulation of pH	-	104	82	-	-	1.01E-02	4.75E-03
huMAP	BP	GO:0002467	germinal center formation	-	14	12	-	-	1.95E-04	7.20E-04
huMAP	BP	GO:1990840	response to lectin	-	22	13	-	-	8.82E-04	7.92E-04
huMAP	BP	GO:0071800	podosome assembly	-	19	17	-	-	5.60E-04	1.01E-03
huMAP	BP	GO:0031018	endocrine pancreas development	-	47	31	-	-	1.35E-03	1.80E-03
huMAP	BP	GO:0001708	cell fate specification	-	108	70	-	-	2.63E-03	4.03E-03
huMAP	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	57	-	-	2.64E-03	3.31E-03
huMAP	BP	GO:0030279	negative regulation of ossification	-	39	24	-	-	1.37E-03	1.44E-03
huMAP	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	3.21E-02	8.64E-04
huMAP	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	11	-	-	4.71E-04	6.48E-04
huMAP	BP	GO:0042440	pigment metabolic process	-	80	60	-	-	5.18E-03	3.45E-03
huMAP	BP	GO:1901606	alpha-amino acid catabolic process	-	101	88	-	-	1.23E-02	5.11E-03
huMAP	BP	GO:1901890	positive regulation of cell junction assembly	-	106	69	-	-	4.41E-03	4.03E-03
huMAP	BP	GO:0070988	demethylation	-	27	23	-	-	1.41E-02	1.37E-03
huMAP	BP	GO:1901655	cellular response to ketone	-	107	82	-	-	2.32E-03	4.75E-03
huMAP	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	8.84E-04	8.64E-04
huMAP	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	2.03E-03	8.64E-04
huMAP	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	3.28E-03	1.01E-03
huMAP	BP	GO:0006968	cellular defense response	-	52	28	-	-	4.28E-04	1.66E-03
huMAP	BP	GO:0055006	cardiac cell development	-	93	72	-	-	1.53E-03	4.17E-03
huMAP	BP	GO:0031365	N-terminal protein amino acid modification	-	30	27	-	-	8.20E-03	1.58E-03
huMAP	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	21	-	-	1.13E-02	1.22E-03
huMAP	BP	GO:0060004	reflex	-	63	44	-	-	2.06E-03	2.59E-03
huMAP	BP	GO:0044706	multi-multicellular organism process	-	217	148	-	-	8.45E-03	8.56E-03
huMAP	BP	GO:0043589	skin morphogenesis	-	12	11	-	-	1.41E-03	6.48E-04
huMAP	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	125	-	-	2.51E-03	7.20E-03
huMAP	BP	GO:0006026	aminoglycan catabolic process	-	34	28	-	-	5.80E-03	1.66E-03
huMAP	BP	GO:0031294	lymphocyte costimulation	-	47	28	-	-	5.48E-03	1.66E-03
huMAP	BP	GO:0050768	negative regulation of neurogenesis	-	150	101	-	-	3.36E-03	5.83E-03
huMAP	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	86	-	-	1.57E-03	4.97E-03
huMAP	BP	GO:0090068	positive regulation of cell cycle process	-	262	211	-	-	4.93E-03	1.22E-02
huMAP	BP	GO:0043605	amide catabolic process	-	16	15	-	-	9.96E-04	8.64E-04
huMAP	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	19	-	-	2.60E-04	1.15E-03
huMAP	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	29	-	-	1.37E-03	1.73E-03
huMAP	BP	GO:1902115	regulation of organelle assembly	-	210	189	-	-	4.65E-03	1.09E-02
huMAP	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	50	-	-	8.65E-04	2.88E-03
huMAP	BP	GO:0047484	regulation of response to osmotic stress	-	16	12	-	-	7.57E-04	7.20E-04
huMAP	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	123	-	-	1.95E-03	7.12E-03
huMAP	BP	GO:0043171	peptide catabolic process	-	19	13	-	-	1.91E-04	7.92E-04
huMAP	BP	GO:0046622	positive regulation of organ growth	-	52	32	-	-	1.35E-03	1.87E-03
huMAP	BP	GO:0051952	regulation of amine transport	-	98	57	-	-	1.40E-02	3.31E-03
huMAP	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	1.57E-03	1.37E-03
huMAP	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	18	-	-	3.51E-02	1.08E-03
huMAP	BP	GO:0040019	positive regulation of embryonic development	-	23	17	-	-	5.90E-04	1.01E-03
huMAP	BP	GO:0097154	GABAergic neuron differentiation	-	20	11	-	-	2.10E-04	6.48E-04
huMAP	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	12	-	-	5.08E-04	7.20E-04
huMAP	CC	GO:0032365	intracellular lipid transport	-	51	43	-	-	2.82E-02	2.52E-03
huMAP	BP	GO:0045048	protein insertion into ER membrane	-	30	28	-	-	1.41E-02	1.66E-03
huMAP	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	53	-	-	1.14E-03	3.09E-03
huMAP	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	97	-	-	5.13E-03	5.61E-03
huMAP	BP	GO:0018149	peptide cross-linking	-	28	23	-	-	2.79E-02	1.37E-03
huMAP	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	20	-	-	4.51E-04	1.15E-03
huMAP	MF	GO:0140537	transcription regulator activator activity	-	13	12	-	-	1.12E-03	7.20E-04
huMAP	BP	GO:0021859	pyramidal neuron differentiation	-	14	13	-	-	1.91E-04	7.92E-04
huMAP	BP	GO:0061000	negative regulation of dendritic spine development	-	13	11	-	-	1.96E-04	6.48E-04
huMAP	BP	GO:0071398	cellular response to fatty acid	-	35	26	-	-	3.67E-02	1.51E-03
huMAP	BP	GO:0097581	lamellipodium organization	-	91	80	-	-	3.90E-03	4.61E-03
huMAP	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	4.26E-02	1.73E-03
huMAP	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	227	-	-	3.41E-02	1.31E-02
huMAP	BP	GO:0060326	cell chemotaxis	-	311	186	-	-	3.52E-03	1.07E-02
huMAP	BP	GO:1903975	regulation of glial cell migration	-	20	13	-	-	1.92E-04	7.92E-04
huMAP	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	19	-	-	2.90E-04	1.15E-03
huMAP	BP	GO:0015669	gas transport	-	23	17	-	-	8.30E-03	1.01E-03
huMAP	BP	GO:0016485	protein processing	-	248	193	-	-	4.65E-03	1.12E-02
huMAP	BP	GO:0009649	entrainment of circadian clock	-	30	26	-	-	4.40E-02	1.51E-03
huMAP	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	108	-	-	8.05E-03	6.26E-03
huMAP	BP	GO:1903523	negative regulation of blood circulation	-	27	16	-	-	3.48E-04	9.36E-04
huMAP	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	87	-	-	4.54E-03	5.04E-03
huMAP	BP	GO:0099054	presynapse assembly	-	49	38	-	-	3.07E-02	2.23E-03
huMAP	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	19	-	-	1.71E-03	1.15E-03
huMAP	BP	GO:0006517	protein deglycosylation	-	26	23	-	-	7.68E-04	1.37E-03
huMAP	BP	GO:0031348	negative regulation of defense response	-	282	187	-	-	3.83E-03	1.08E-02
huMAP	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	56	-	-	1.41E-03	3.24E-03
huMAP	BP	GO:0007606	sensory perception of chemical stimulus	-	535	71	-	-	6.43E-03	4.10E-03
huMAP	BP	GO:0061180	mammary gland epithelium development	-	68	52	-	-	2.45E-03	3.02E-03
huMAP	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	207	-	-	1.21E-02	1.19E-02
huMAP	BP	GO:0071496	cellular response to external stimulus	-	74	52	-	-	2.61E-03	3.02E-03
huMAP	BP	GO:0042753	positive regulation of circadian rhythm	-	18	12	-	-	6.65E-03	7.20E-04
huMAP	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	4.83E-03	7.20E-04
huMAP	BP	GO:0032094	response to food	-	37	24	-	-	6.99E-04	1.44E-03
huMAP	BP	GO:0001964	startle response	-	27	16	-	-	3.90E-04	9.36E-04
huMAP	BP	GO:0007340	acrosome reaction	-	38	22	-	-	4.67E-04	1.30E-03
huMAP	BP	GO:0046434	organophosphate catabolic process	-	232	200	-	-	6.41E-03	1.15E-02
huMAP	BP	GO:0060037	pharyngeal system development	-	29	19	-	-	7.34E-03	1.15E-03
huMAP	BP	GO:0009566	fertilization	-	205	127	-	-	2.23E-03	7.34E-03
huMAP	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	58	-	-	1.45E-01	3.38E-03
huMAP	BP	GO:0120255	olefinic compound biosynthetic process	-	24	16	-	-	2.77E-04	9.36E-04
huMAP	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	2.82E-03	7.92E-04
huMAP	BP	GO:0045907	positive regulation of vasoconstriction	-	30	15	-	-	4.27E-03	8.64E-04
huMAP	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	15	-	-	2.17E-03	8.64E-04
huMAP	BP	GO:0033044	regulation of chromosome organization	-	249	238	-	-	9.73E-03	1.37E-02
huMAP	BP	GO:0009309	amine biosynthetic process	-	38	27	-	-	2.44E-02	1.58E-03
huMAP	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	17	-	-	5.45E-04	1.01E-03
huMAP	BP	GO:0061900	glial cell activation	-	56	31	-	-	8.65E-04	1.80E-03
huMAP	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	91	-	-	4.12E-03	5.25E-03
huMAP	CC	GO:0140467	integrated stress response signaling	-	41	35	-	-	3.02E-03	2.01E-03
huMAP	BP	GO:0035902	response to immobilization stress	-	20	15	-	-	2.50E-04	8.64E-04
huMAP	BP	GO:0072537	fibroblast activation	-	13	12	-	-	1.62E-03	7.20E-04
huMAP	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	7.35E-04	7.92E-04
huMAP	BP	GO:0043647	inositol phosphate metabolic process	-	44	33	-	-	1.22E-02	1.94E-03
huMAP	BP	GO:0016180	snRNA processing	-	28	26	-	-	3.77E-02	1.51E-03
huMAP	BP	GO:0051303	establishment of chromosome localization	-	104	95	-	-	3.49E-03	5.47E-03
huMAP	BP	GO:0051382	kinetochore assembly	-	16	15	-	-	1.13E-01	8.64E-04
huMAP	BP	GO:0007164	establishment of tissue polarity	-	38	33	-	-	3.70E-03	1.94E-03
huMAP	BP	GO:0097164	ammonium ion metabolic process	-	23	17	-	-	5.61E-04	1.01E-03
huMAP	BP	GO:0021515	cell differentiation in spinal cord	-	51	32	-	-	2.85E-02	1.87E-03
huMAP	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	20	-	-	3.54E-02	1.15E-03
huMAP	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	24	-	-	4.19E-04	1.44E-03
huMAP	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	12	-	-	9.24E-04	7.20E-04
huMAP	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	34	-	-	3.69E-03	2.01E-03
huMAP	BP	GO:0061318	renal filtration cell differentiation	-	22	15	-	-	1.12E-03	8.64E-04
huMAP	BP	GO:0007566	embryo implantation	-	57	41	-	-	1.05E-03	2.37E-03
huMAP	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	24	-	-	2.65E-03	1.44E-03
huMAP	BP	GO:0060306	regulation of membrane repolarization	-	38	20	-	-	6.45E-04	1.15E-03
huMAP	BP	GO:0051017	actin filament bundle assembly	-	161	141	-	-	3.27E-03	8.13E-03
huMAP	BP	GO:1905953	negative regulation of lipid localization	-	63	34	-	-	1.92E-03	2.01E-03
huMAP	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	14	-	-	2.16E-04	8.64E-04
huMAP	BP	GO:0021542	dentate gyrus development	-	19	14	-	-	5.39E-04	8.64E-04
huMAP	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	34	-	-	8.17E-03	2.01E-03
huMAP	BP	GO:0021756	striatum development	-	21	20	-	-	1.05E-03	1.15E-03
huMAP	BP	GO:1901343	negative regulation of vasculature development	-	154	73	-	-	1.48E-03	4.25E-03
huMAP	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	137	-	-	6.24E-03	7.92E-03
huMAP	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	23	-	-	2.67E-03	1.37E-03
huMAP	BP	GO:1902414	protein localization to cell junction	-	107	88	-	-	2.85E-03	5.11E-03
huMAP	BP	GO:0071305	cellular response to vitamin D	-	23	14	-	-	1.17E-03	8.64E-04
huMAP	BP	GO:0051304	chromosome separation	-	80	76	-	-	5.53E-03	4.39E-03
huMAP	BP	GO:0090596	sensory organ morphogenesis	-	272	196	-	-	4.23E-03	1.13E-02
huMAP	BP	GO:0045780	positive regulation of bone resorption	-	18	11	-	-	3.44E-03	6.48E-04
huMAP	BP	GO:0048709	oligodendrocyte differentiation	-	101	67	-	-	1.17E-02	3.89E-03
huMAP	BP	GO:0045017	glycerolipid biosynthetic process	-	254	214	-	-	1.02E-02	1.24E-02
huMAP	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	9.30E-02	8.64E-04
huMAP	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	20	-	-	9.18E-04	1.15E-03
huMAP	BP	GO:0001776	leukocyte homeostasis	-	108	82	-	-	5.10E-03	4.75E-03
huMAP	BP	GO:0050769	positive regulation of neurogenesis	-	240	181	-	-	4.86E-03	1.04E-02
huMAP	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	2.46E-03	8.64E-04
huMAP	BP	GO:0030193	regulation of blood coagulation	-	70	53	-	-	3.49E-03	3.09E-03
huMAP	BP	GO:0050866	negative regulation of cell activation	-	216	139	-	-	3.33E-03	8.06E-03
huMAP	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	27	-	-	4.92E-02	1.58E-03
huMAP	BP	GO:0033500	carbohydrate homeostasis	-	251	177	-	-	3.69E-03	1.02E-02
huMAP	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	23	-	-	9.82E-03	1.37E-03
huMAP	BP	GO:0044088	regulation of vacuole organization	-	56	51	-	-	8.63E-03	2.95E-03
huMAP	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	5.34E-04	1.37E-03
huMAP	CC	GO:0099522	cytosolic region	-	20	19	-	-	9.60E-04	1.15E-03
huMAP	CC	GO:0000791	euchromatin	-	60	51	-	-	1.54E-03	2.95E-03
huMAP	CC	GO:0030666	endocytic vesicle membrane	-	196	163	-	-	1.02E-02	9.43E-03
huMAP	CC	GO:0098857	membrane microdomain	-	324	248	-	-	6.72E-03	1.43E-02
huMAP	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	2.47E-03	8.64E-04
huMAP	CC	GO:1990752	microtubule end	-	34	30	-	-	6.66E-03	1.73E-03
huMAP	CC	GO:0043204	perikaryon	-	156	117	-	-	2.77E-03	6.76E-03
huMAP	CC	GO:0061702	canonical inflammasome complex	-	17	13	-	-	1.29E-02	7.92E-04
huMAP	CC	GO:0097542	ciliary tip	-	48	47	-	-	2.70E-02	2.73E-03
huMAP	CC	GO:1905368	peptidase complex	-	124	117	-	-	2.87E-02	6.76E-03
huMAP	CC	GO:0000792	heterochromatin	-	98	93	-	-	6.55E-03	5.40E-03
huMAP	CC	GO:0097546	ciliary base	-	47	41	-	-	6.49E-03	2.37E-03
huMAP	CC	GO:0071819	DUBm complex	-	25	24	-	-	4.73E-02	1.44E-03
huMAP	CC	GO:0031201	SNARE complex	-	48	47	-	-	1.27E-01	2.73E-03
huMAP	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	9.61E-04	7.92E-04
huMAP	CC	GO:0033260	nuclear DNA replication	-	40	38	-	-	2.67E-03	2.23E-03
huMAP	CC	GO:0044391	ribosomal subunit	-	203	196	-	-	1.04E-01	1.13E-02
huMAP	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	5.79E-03	6.48E-04
huMAP	CC	GO:0071013	catalytic step 2 spliceosome	-	88	88	-	-	6.51E-03	5.11E-03
huMAP	CC	GO:0031907	microbody lumen	-	51	45	-	-	1.64E-02	2.59E-03
huMAP	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	1.92E-01	6.48E-04
huMAP	CC	GO:0098862	cluster of actin-based cell projections	-	162	120	-	-	2.60E-03	6.91E-03
huMAP	CC	GO:0016363	nuclear matrix	-	127	120	-	-	3.01E-03	6.91E-03
huMAP	CC	GO:0031261	DNA replication preinitiation complex	-	46	44	-	-	1.73E-02	2.59E-03
huMAP	CC	GO:0032432	actin filament bundle	-	249	197	-	-	5.45E-03	1.14E-02
huMAP	CC	GO:0008088	axo-dendritic transport	-	78	73	-	-	1.54E-02	4.25E-03
huMAP	CC	GO:0031519	PcG protein complex	-	38	37	-	-	3.26E-02	2.16E-03
huMAP	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	35	-	-	2.06E-03	2.01E-03
huMAP	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	196	-	-	1.05E-02	1.13E-02
huMAP	CC	GO:0000313	organellar ribosome	-	89	89	-	-	3.66E-01	5.18E-03
huMAP	CC	GO:0099643	signal release from synapse	-	147	123	-	-	1.42E-02	7.12E-03
huMAP	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	43	-	-	1.39E-03	2.52E-03
huMAP	CC	GO:0030018	Z disc	-	129	112	-	-	3.00E-03	6.48E-03
huMAP	CC	GO:0032580	Golgi cisterna membrane	-	93	62	-	-	9.00E-03	3.60E-03
huMAP	CC	GO:1905360	GTPase complex	-	41	36	-	-	1.39E-01	2.09E-03
huMAP	CC	GO:0097540	axonemal central pair	-	161	110	-	-	5.95E-03	6.33E-03
huMAP	CC	GO:0042641	actomyosin	-	77	71	-	-	3.63E-03	4.10E-03
huMAP	CC	GO:0097386	glial cell projection	-	38	29	-	-	4.23E-04	1.73E-03
huMAP	CC	GO:0032588	trans-Golgi network membrane	-	102	88	-	-	1.67E-02	5.11E-03
huMAP	CC	GO:0070382	exocytic vesicle	-	224	185	-	-	2.06E-02	1.07E-02
huMAP	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	47	-	-	5.91E-03	2.73E-03
huMAP	CC	GO:0031903	microbody membrane	-	65	57	-	-	4.59E-03	3.31E-03
huMAP	CC	GO:0046930	pore complex	-	26	22	-	-	3.48E-03	1.30E-03
huMAP	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	12	-	-	1.43E-03	7.20E-04
huMAP	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	230	-	-	4.78E-03	1.32E-02
huMAP	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	22	-	-	5.63E-04	1.30E-03
huMAP	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.98E-01	6.48E-04
huMAP	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	1.70E-03	1.01E-03
huMAP	CC	GO:0044298	cell body membrane	-	32	22	-	-	3.85E-03	1.30E-03
huMAP	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	5.87E-02	6.48E-04
huMAP	CC	GO:0051882	mitochondrial depolarization	-	21	17	-	-	4.56E-04	1.01E-03
huMAP	CC	GO:0045495	pole plasm	-	25	21	-	-	2.05E-02	1.22E-03
huMAP	CC	GO:0072379	ER membrane insertion complex	-	14	13	-	-	7.74E-03	7.92E-04
huMAP	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	1.30E-02	1.15E-03
huMAP	CC	GO:0010369	chromocenter	-	14	13	-	-	2.75E-03	7.92E-04
huMAP	CC	GO:0002177	manchette	-	19	12	-	-	4.81E-04	7.20E-04
huMAP	CC	GO:0016323	basolateral plasma membrane	-	239	158	-	-	6.90E-03	9.14E-03
huMAP	CC	GO:0045009	chitosome	-	21	18	-	-	7.18E-03	1.08E-03
huMAP	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	3.07E-03	7.20E-04
huMAP	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	1.41E-03	2.59E-03
huMAP	CC	GO:0098636	protein complex involved in cell adhesion	-	57	40	-	-	6.52E-03	2.30E-03
huMAP	CC	GO:0001917	photoreceptor inner segment	-	71	57	-	-	1.87E-03	3.31E-03
huMAP	CC	GO:0098845	postsynaptic endosome	-	14	12	-	-	2.22E-03	7.20E-04
huMAP	CC	GO:0019897	extrinsic component of plasma membrane	-	156	131	-	-	2.91E-02	7.56E-03
huMAP	CC	GO:0031594	neuromuscular junction	-	73	63	-	-	1.43E-03	3.67E-03
huMAP	CC	GO:0000793	condensed chromosome	-	274	247	-	-	1.58E-02	1.42E-02
huMAP	CC	GO:0045120	pronucleus	-	14	12	-	-	2.82E-04	7.20E-04
huMAP	CC	GO:0043083	synaptic cleft	-	21	14	-	-	6.36E-04	8.64E-04
huMAP	CC	GO:0000922	spindle pole	-	172	161	-	-	5.38E-03	9.28E-03
huMAP	CC	GO:0120111	neuron projection cytoplasm	-	94	87	-	-	8.66E-03	5.04E-03
huMAP	CC	GO:0070971	endoplasmic reticulum exit site	-	32	29	-	-	1.66E-02	1.73E-03
huMAP	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	9.93E-02	7.92E-04
huMAP	CC	GO:0004879	nuclear receptor activity	-	63	50	-	-	7.08E-02	2.88E-03
huMAP	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	145	-	-	1.60E-02	8.35E-03
huMAP	CC	GO:0000123	histone acetyltransferase complex	-	93	91	-	-	4.89E-02	5.25E-03
huMAP	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	1.17E-03	7.92E-04
huMAP	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	96	-	-	1.20E-02	5.54E-03
huMAP	CC	GO:0048786	presynaptic active zone	-	80	64	-	-	2.94E-03	3.74E-03
huMAP	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	9.51E-02	7.20E-04
huMAP	CC	GO:0007034	vacuolar transport	-	168	148	-	-	9.92E-03	8.56E-03
huMAP	CC	GO:0090741	pigment granule membrane	-	21	18	-	-	8.68E-03	1.08E-03
huMAP	CC	GO:0043194	axon initial segment	-	21	13	-	-	7.88E-04	7.92E-04
huMAP	CC	GO:0005776	autophagosome	-	111	98	-	-	1.31E-02	5.69E-03
huMAP	CC	GO:0031430	M band	-	22	17	-	-	4.10E-04	1.01E-03
huMAP	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	5.27E-02	4.32E-03
huMAP	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	83	-	-	6.87E-02	4.82E-03
huMAP	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	1.35E-01	7.92E-04
huMAP	CC	GO:0000164	protein phosphatase type 1 complex	-	19	16	-	-	1.40E-02	9.36E-04
huMAP	CC	GO:0071203	WASH complex	-	12	12	-	-	1.81E-02	7.20E-04
huMAP	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	26	-	-	1.92E-03	1.51E-03
huMAP	CC	GO:0032994	protein-lipid complex	-	39	27	-	-	9.03E-03	1.58E-03
huMAP	CC	GO:0150034	distal axon	-	309	242	-	-	6.85E-03	1.40E-02
huMAP	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	148	-	-	2.00E-02	8.56E-03
huMAP	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	1.08E-02	7.20E-04
huMAP	CC	GO:0072562	blood microparticle	-	144	108	-	-	3.95E-02	6.26E-03
huMAP	CC	GO:0051233	spindle midzone	-	36	35	-	-	1.40E-03	2.01E-03
huMAP	CC	GO:0005811	lipid droplet	-	102	87	-	-	2.54E-03	5.04E-03
huMAP	CC	GO:0045022	early endosome to late endosome transport	-	44	43	-	-	5.85E-03	2.52E-03
huMAP	CC	GO:0043113	receptor clustering	-	51	41	-	-	1.29E-03	2.37E-03
huMAP	CC	GO:0005940	septin ring	-	14	14	-	-	1.77E-01	8.64E-04
huMAP	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	22	-	-	7.10E-04	1.30E-03
huMAP	CC	GO:0044853	plasma membrane raft	-	114	88	-	-	3.48E-03	5.11E-03
huMAP	CC	GO:0005881	cytoplasmic microtubule	-	256	183	-	-	6.63E-03	1.06E-02
huMAP	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	14	-	-	7.06E-04	8.64E-04
huMAP	CC	GO:0008180	COP9 signalosome	-	17	15	-	-	3.95E-02	8.64E-04
huMAP	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	50	-	-	6.80E-03	2.88E-03
huMAP	CC	GO:0005905	clathrin-coated pit	-	73	66	-	-	8.83E-03	3.81E-03
huMAP	CC	GO:0099569	presynaptic cytoskeleton	-	12	11	-	-	1.95E-04	6.48E-04
huMAP	CC	GO:0043034	costamere	-	18	18	-	-	9.28E-04	1.08E-03
huMAP	CC	GO:0031904	endosome lumen	-	38	28	-	-	1.56E-02	1.66E-03
huMAP	CC	GO:0060170	ciliary membrane	-	76	51	-	-	2.67E-02	2.95E-03
huMAP	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	7.57E-02	7.20E-04
huMAP	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	6.08E-03	1.44E-03
huMAP	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	2.42E-02	8.64E-04
huMAP	CC	GO:0032154	cleavage furrow	-	54	49	-	-	5.25E-03	2.88E-03
huMAP	CC	GO:0005640	nuclear outer membrane	-	30	23	-	-	8.52E-04	1.37E-03
huMAP	CC	GO:0005652	nuclear lamina	-	12	11	-	-	1.25E-03	6.48E-04
huMAP	CC	GO:0007006	mitochondrial membrane organization	-	117	101	-	-	4.36E-03	5.83E-03
huMAP	CC	GO:0001772	immunological synapse	-	44	34	-	-	1.17E-03	2.01E-03
huMAP	CC	GO:0030904	retromer complex	-	12	12	-	-	1.31E-02	7.20E-04
huMAP	CC	GO:0009897	external side of plasma membrane	-	425	222	-	-	2.38E-02	1.28E-02
huMAP	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	11	-	-	7.09E-03	6.48E-04
huMAP	CC	GO:0030863	cortical cytoskeleton	-	104	91	-	-	1.58E-03	5.25E-03
huMAP	CC	GO:1905348	endonuclease complex	-	38	35	-	-	3.59E-02	2.01E-03
huMAP	CC	GO:0030315	T-tubule	-	52	43	-	-	2.53E-03	2.52E-03
huMAP	CC	GO:0060076	excitatory synapse	-	64	45	-	-	1.18E-02	2.59E-03
huMAP	CC	GO:0036019	endolysosome	-	29	24	-	-	8.48E-04	1.44E-03
huMAP	CC	GO:0001891	phagocytic cup	-	28	21	-	-	1.56E-03	1.22E-03
huMAP	CC	GO:0099086	synaptonemal structure	-	40	25	-	-	3.71E-03	1.44E-03
huMAP	CC	GO:0030427	site of polarized growth	-	172	150	-	-	4.48E-03	8.64E-03
huMAP	CC	GO:0044309	neuron spine	-	213	166	-	-	3.79E-03	9.57E-03
huMAP	CC	GO:0030658	transport vesicle membrane	-	231	192	-	-	1.38E-02	1.11E-02
huMAP	CC	GO:0098918	structural constituent of synapse	-	27	25	-	-	1.07E-03	1.44E-03
huMAP	CC	GO:0000940	outer kinetochore	-	17	17	-	-	2.89E-02	1.01E-03
huMAP	CC	GO:0034719	SMN-Sm protein complex	-	18	18	-	-	1.94E-02	1.08E-03
huMAP	CC	GO:0044232	organelle membrane contact site	-	50	43	-	-	1.93E-03	2.52E-03
huMAP	CC	GO:0098803	respiratory chain complex	-	39	28	-	-	9.82E-02	1.66E-03
huMAP	CC	GO:0097545	axonemal outer doublet	-	164	111	-	-	4.82E-03	6.40E-03
huMAP	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	17	-	-	1.25E-03	1.01E-03
huMAP	CC	GO:0070069	cytochrome complex	-	42	30	-	-	6.51E-02	1.73E-03
huMAP	CC	GO:0031143	pseudopodium	-	18	17	-	-	2.64E-03	1.01E-03
huMAP	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	22	-	-	5.91E-02	1.30E-03
huMAP	CC	GO:0055037	recycling endosome	-	200	174	-	-	7.65E-03	1.01E-02
huMAP	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	76	-	-	3.68E-03	4.39E-03
huMAP	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	4.80E-03	7.92E-04
huMAP	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	7.69E-04	7.20E-04
huMAP	CC	GO:0071682	endocytic vesicle lumen	-	23	19	-	-	8.24E-04	1.15E-03
huMAP	CC	GO:0030684	preribosome	-	76	75	-	-	1.71E-02	4.32E-03
huMAP	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	19	-	-	8.73E-02	1.15E-03
huMAP	CC	GO:1990391	DNA repair complex	-	22	22	-	-	2.64E-02	1.30E-03
huMAP	CC	GO:0005775	vacuolar lumen	-	176	161	-	-	5.54E-03	9.28E-03
huMAP	CC	GO:0032433	filopodium tip	-	19	18	-	-	1.56E-03	1.08E-03
huMAP	CC	GO:0032982	myosin filament	-	24	20	-	-	6.35E-02	1.15E-03
huMAP	CC	GO:0016327	apicolateral plasma membrane	-	23	15	-	-	1.57E-03	8.64E-04
huMAP	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	19	-	-	5.97E-03	1.15E-03
huMAP	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	5.47E-04	7.20E-04
huMAP	CC	GO:0044306	neuron projection terminus	-	164	117	-	-	4.55E-03	6.76E-03
huMAP	CC	GO:0034455	t-UTP complex	-	53	52	-	-	1.82E-02	3.02E-03
huMAP	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	7.66E-02	1.01E-03
huMAP	CC	GO:0031970	organelle envelope lumen	-	94	88	-	-	9.77E-03	5.11E-03
huMAP	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	4.45E-03	7.92E-04
huMAP	CC	GO:0120293	dynein axonemal particle	-	20	19	-	-	1.31E-03	1.15E-03
huMAP	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	24	-	-	2.27E-03	1.44E-03
huMAP	CC	GO:0043292	contractile muscle fiber	-	245	212	-	-	1.03E-02	1.22E-02
huMAP	CC	GO:0018995	host cellular component	-	12	12	-	-	1.83E-03	7.20E-04
huMAP	CC	GO:0034709	methylosome	-	13	12	-	-	2.55E-03	7.20E-04
huMAP	CC	GO:0032426	stereocilium tip	-	21	15	-	-	9.65E-03	8.64E-04
huMAP	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	5.25E-04	7.20E-04
huMAP	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	1.60E-02	1.15E-03
huMAP	CC	GO:0000803	sex chromosome	-	32	27	-	-	1.98E-03	1.58E-03
huMAP	CC	GO:0098982	GABA-ergic synapse	-	84	60	-	-	7.60E-03	3.45E-03
huMAP	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	8.26E-03	9.36E-04
huMAP	CC	GO:0035097	histone methyltransferase complex	-	63	59	-	-	1.35E-02	3.45E-03
huMAP	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	3.05E-03	8.64E-04
huMAP	CC	GO:0000242	pericentriolar material	-	22	21	-	-	1.09E-03	1.22E-03
huMAP	CC	GO:1903293	phosphatase complex	-	54	49	-	-	1.49E-02	2.88E-03
huMAP	CC	GO:0097470	ribbon synapse	-	13	13	-	-	5.40E-04	7.92E-04
huMAP	CC	GO:0031941	filamentous actin	-	27	25	-	-	1.47E-03	1.44E-03
huMAP	CC	GO:0000786	nucleosome	-	149	103	-	-	2.09E-02	5.97E-03
huMAP	CC	GO:0001533	cornified envelope	-	59	54	-	-	1.26E-02	3.17E-03
huMAP	CC	GO:1904724	tertiary granule lumen	-	55	48	-	-	1.29E-02	2.81E-03
huMAP	CC	GO:0030027	lamellipodium	-	202	181	-	-	6.20E-03	1.04E-02
huMAP	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	14	-	-	2.34E-02	8.64E-04
huMAP	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	23	-	-	2.20E-02	1.37E-03
huMAP	CC	GO:0000800	lateral element	-	14	11	-	-	3.47E-02	6.48E-04
huMAP	CC	GO:0060077	inhibitory synapse	-	20	17	-	-	1.65E-01	1.01E-03
huMAP	CC	GO:0031209	SCAR complex	-	12	11	-	-	6.92E-02	6.48E-04
huMAP	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	1.05E-01	9.36E-04
huMAP	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	1.34E-02	1.22E-03
huMAP	CC	GO:0002102	podosome	-	31	31	-	-	4.86E-03	1.80E-03
huMAP	CC	GO:0090543	Flemming body	-	33	29	-	-	3.10E-03	1.73E-03
huMAP	CC	GO:0016328	lateral plasma membrane	-	66	53	-	-	2.04E-03	3.09E-03
huMAP	CC	GO:0001650	fibrillar center	-	151	142	-	-	3.45E-03	8.20E-03
huMAP	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	2.34E-03	8.64E-04
huMAP	CC	GO:1990204	oxidoreductase complex	-	90	70	-	-	1.11E-02	4.03E-03
huMAP	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	2.12E-01	9.36E-04
huMAP	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	5.88E-03	6.48E-04
huMAP	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	119	-	-	2.05E-03	6.91E-03
huMAP	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	2.79E-02	1.15E-03
huMAP	CC	GO:0001726	ruffle	-	181	162	-	-	7.55E-03	9.36E-03
huMAP	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	5.85E-03	7.92E-04
huMAP	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	17	-	-	2.32E-02	1.01E-03
huMAP	CC	GO:0043198	dendritic shaft	-	38	27	-	-	7.64E-04	1.58E-03
huMAP	CC	GO:0043073	germ cell nucleus	-	67	51	-	-	2.26E-03	2.95E-03
huMAP	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	20	-	-	3.38E-03	1.15E-03
huMAP	CC	GO:0016592	mediator complex	-	38	37	-	-	3.21E-01	2.16E-03
huMAP	CC	GO:0034045	phagophore assembly site membrane	-	19	18	-	-	2.64E-03	1.08E-03
huMAP	CC	GO:0022626	cytosolic ribosome	-	118	111	-	-	2.70E-02	6.40E-03
huMAP	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	43	-	-	4.30E-02	2.52E-03
huMAP	CC	GO:0034451	centriolar satellite	-	120	106	-	-	1.33E-02	6.12E-03
huMAP	CC	GO:0045171	intercellular bridge	-	91	82	-	-	2.77E-03	4.75E-03
huMAP	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	69	-	-	4.38E-03	4.03E-03
huMAP	CC	GO:0008250	oligosaccharyltransferase complex	-	14	13	-	-	3.13E-03	7.92E-04
huMAP	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	3.55E-03	6.48E-04
huMAP	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	3.98E-02	6.48E-04
huMAP	CC	GO:0044292	dendrite terminus	-	13	13	-	-	5.10E-04	7.92E-04
huMAP	CC	GO:0032039	integrator complex	-	19	17	-	-	2.39E-01	1.01E-03
huMAP	CC	GO:0033268	node of Ranvier	-	16	12	-	-	4.94E-04	7.20E-04
huMAP	CC	GO:0036038	MKS complex	-	13	13	-	-	2.34E-02	7.92E-04
huMAP	CC	GO:0030527	structural constituent of chromatin	-	97	57	-	-	1.51E-02	3.31E-03
huMAP	CC	GO:0036379	myofilament	-	26	19	-	-	8.38E-02	1.15E-03
huMAP	CC	GO:0030286	dynein complex	-	210	152	-	-	9.33E-03	8.78E-03
huMAP	CC	GO:0031105	septin complex	-	14	14	-	-	2.14E-01	8.64E-04
huMAP	CC	GO:0097228	sperm principal piece	-	33	17	-	-	1.54E-03	1.01E-03
huMAP	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.18E-03	7.20E-04
huMAP	CC	GO:0016482	cytosolic transport	-	135	123	-	-	9.67E-03	7.12E-03
huMAP	CC	GO:0090665	glycoprotein complex	-	23	18	-	-	5.47E-02	1.08E-03
huMAP	CC	GO:0005796	Golgi lumen	-	106	72	-	-	1.34E-02	4.17E-03
huMAP	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	34	-	-	5.22E-02	2.01E-03
huMAP	CC	GO:0034358	plasma lipoprotein particle	-	36	24	-	-	1.17E-02	1.44E-03
huMAP	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	1.84E-02	2.73E-03
huMAP	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	23	-	-	3.93E-03	1.37E-03
huMAP	CC	GO:0030662	coated vesicle membrane	-	202	169	-	-	1.14E-02	9.79E-03
huMAP	CC	GO:0007039	protein catabolic process in the vacuole	-	61	56	-	-	1.66E-02	3.24E-03
huMAP	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	60	-	-	7.70E-02	3.45E-03
huMAP	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	225	-	-	8.21E-02	1.30E-02
huMAP	CC	GO:0090734	site of DNA damage	-	118	113	-	-	1.14E-02	6.55E-03
huMAP	MF	GO:0051861	glycolipid binding	-	30	22	-	-	1.72E-03	1.30E-03
huMAP	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	2.47E-04	6.48E-04
huMAP	MF	GO:0051087	protein-folding chaperone binding	-	135	121	-	-	2.14E-03	6.98E-03
huMAP	MF	GO:0051959	dynein light intermediate chain binding	-	27	25	-	-	3.84E-03	1.44E-03
huMAP	MF	GO:0042301	phosphate ion binding	-	12	11	-	-	2.78E-03	6.48E-04
huMAP	MF	GO:0031681	G-protein beta-subunit binding	-	22	16	-	-	2.05E-02	9.36E-04
huMAP	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	29	-	-	7.18E-04	1.73E-03
huMAP	MF	GO:0035613	RNA stem-loop binding	-	21	15	-	-	6.95E-04	8.64E-04
huMAP	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	217	-	-	5.10E-03	1.25E-02
huMAP	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	11	-	-	2.07E-04	6.48E-04
huMAP	MF	GO:0033691	sialic acid binding	-	22	13	-	-	2.11E-04	7.92E-04
huMAP	MF	GO:0016757	glycosyltransferase activity	-	286	223	-	-	1.47E-02	1.29E-02
huMAP	MF	GO:0048306	calcium-dependent protein binding	-	61	53	-	-	2.07E-03	3.09E-03
huMAP	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	27	-	-	1.05E-03	1.58E-03
huMAP	MF	GO:0035325	Toll-like receptor binding	-	13	12	-	-	4.41E-03	7.20E-04
huMAP	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	113	-	-	2.88E-03	6.55E-03
huMAP	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	58	-	-	1.39E-02	3.38E-03
huMAP	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	112	-	-	3.95E-03	6.48E-03
huMAP	MF	GO:0045504	dynein heavy chain binding	-	16	15	-	-	1.20E-02	8.64E-04
huMAP	MF	GO:0140457	protein demethylase activity	-	31	25	-	-	2.45E-03	1.44E-03
huMAP	MF	GO:0005158	insulin receptor binding	-	22	20	-	-	1.59E-03	1.15E-03
huMAP	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	13	-	-	6.30E-04	7.92E-04
huMAP	MF	GO:0016530	metallochaperone activity	-	14	13	-	-	3.67E-04	7.92E-04
huMAP	MF	GO:0061980	regulatory RNA binding	-	52	43	-	-	1.31E-03	2.52E-03
huMAP	MF	GO:0015035	protein-disulfide reductase activity	-	32	29	-	-	4.98E-04	1.73E-03
huMAP	MF	GO:0001671	ATPase activator activity	-	29	24	-	-	1.18E-03	1.44E-03
huMAP	MF	GO:0070840	dynein complex binding	-	25	20	-	-	1.04E-03	1.15E-03
huMAP	MF	GO:0035035	histone acetyltransferase binding	-	24	22	-	-	5.02E-04	1.30E-03
huMAP	MF	GO:0061684	chaperone-mediated autophagy	-	16	15	-	-	4.36E-04	8.64E-04
huMAP	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	31	-	-	2.39E-03	1.80E-03
huMAP	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	1.29E-03	1.08E-03
huMAP	MF	GO:0005178	integrin binding	-	153	117	-	-	4.00E-03	6.76E-03
huMAP	MF	GO:0070064	proline-rich region binding	-	17	16	-	-	1.23E-03	9.36E-04
huMAP	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	2.99E-01	8.64E-04
huMAP	MF	GO:0008327	methyl-CpG binding	-	31	24	-	-	1.29E-03	1.44E-03
huMAP	MF	GO:0031418	L-ascorbic acid binding	-	20	18	-	-	2.42E-03	1.08E-03
huMAP	MF	GO:0048019	receptor antagonist activity	-	31	11	-	-	2.07E-04	6.48E-04
huMAP	MF	GO:0005521	lamin binding	-	15	13	-	-	3.87E-04	7.92E-04
huMAP	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	1.48E-03	1.01E-03
huMAP	MF	GO:0140318	protein transporter activity	-	40	36	-	-	4.66E-03	2.09E-03
huMAP	MF	GO:0070628	proteasome binding	-	17	15	-	-	1.69E-03	8.64E-04
huMAP	MF	GO:0000217	DNA secondary structure binding	-	37	35	-	-	2.25E-03	2.01E-03
huMAP	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	13	-	-	1.93E-04	7.92E-04
huMAP	MF	GO:0002039	p53 binding	-	66	61	-	-	1.99E-03	3.53E-03
huMAP	MF	GO:0005496	steroid binding	-	110	77	-	-	5.20E-03	4.46E-03
huMAP	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	8.83E-03	1.58E-03
huMAP	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	2.03E-04	6.48E-04
huMAP	MF	GO:0003684	damaged DNA binding	-	89	81	-	-	4.37E-03	4.68E-03
huMAP	MF	GO:0000339	RNA cap binding	-	20	18	-	-	9.37E-03	1.08E-03
huMAP	MF	GO:0016500	protein-hormone receptor activity	-	21	11	-	-	2.07E-04	6.48E-04
huMAP	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	111	-	-	2.27E-02	6.40E-03
huMAP	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	11	-	-	2.15E-03	6.48E-04
huMAP	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	8.74E-03	3.45E-03
huMAP	MF	GO:0050811	GABA receptor binding	-	18	15	-	-	1.51E-02	8.64E-04
huMAP	MF	GO:0030971	receptor tyrosine kinase binding	-	76	60	-	-	8.78E-03	3.45E-03
huMAP	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	82	-	-	5.92E-03	4.75E-03
huMAP	MF	GO:0140030	modification-dependent protein binding	-	179	168	-	-	5.65E-03	9.72E-03
huMAP	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	20	-	-	2.76E-03	1.15E-03
huMAP	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	13	-	-	1.62E-02	7.92E-04
huMAP	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	8.35E-03	7.92E-04
huMAP	MF	GO:0042813	Wnt receptor activity	-	16	14	-	-	9.21E-03	8.64E-04
huMAP	MF	GO:0141047	molecular tag activity	-	13	12	-	-	7.44E-04	7.20E-04
huMAP	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	2.51E-03	6.48E-04
huMAP	MF	GO:1990226	histone methyltransferase binding	-	15	13	-	-	1.19E-03	7.92E-04
huMAP	MF	GO:0044548	S100 protein binding	-	14	12	-	-	4.77E-04	7.20E-04
huMAP	MF	GO:0030983	mismatched DNA binding	-	14	13	-	-	2.06E-03	7.92E-04
huMAP	MF	GO:0030276	clathrin binding	-	70	60	-	-	2.16E-02	3.45E-03
huMAP	MF	GO:0046875	ephrin receptor binding	-	29	25	-	-	2.20E-03	1.44E-03
huMAP	MF	GO:0046790	virion binding	-	19	17	-	-	9.96E-04	1.01E-03
huMAP	MF	GO:0030552	cAMP binding	-	48	32	-	-	2.24E-02	1.87E-03
huMAP	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	34	-	-	2.09E-03	2.01E-03
huMAP	MF	GO:0035173	histone kinase activity	-	17	15	-	-	2.48E-03	8.64E-04
huMAP	MF	GO:0097602	cullin family protein binding	-	26	24	-	-	2.88E-03	1.44E-03
huMAP	MF	GO:0004984	olfactory receptor activity	-	429	19	-	-	2.82E-04	1.15E-03
huMAP	MF	GO:0016209	antioxidant activity	-	92	75	-	-	3.60E-03	4.32E-03
huMAP	MF	GO:0070325	lipoprotein particle receptor binding	-	32	28	-	-	1.47E-03	1.66E-03
huMAP	MF	GO:0044325	transmembrane transporter binding	-	159	125	-	-	3.36E-03	7.20E-03
huMAP	MF	GO:0048156	tau protein binding	-	43	42	-	-	1.10E-03	2.45E-03
huMAP	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	35	-	-	4.65E-03	2.01E-03
huMAP	MF	GO:0045295	gamma-catenin binding	-	13	12	-	-	9.65E-03	7.20E-04
huMAP	MF	GO:0140272	exogenous protein binding	-	79	57	-	-	2.31E-03	3.31E-03
huMAP	MF	GO:0030145	manganese ion binding	-	65	58	-	-	2.63E-03	3.38E-03
huMAP	MF	GO:0071814	protein-lipid complex binding	-	52	37	-	-	2.04E-03	2.16E-03
huMAP	MF	GO:0008066	glutamate receptor activity	-	70	41	-	-	1.22E-02	2.37E-03
huMAP	MF	GO:0017069	snRNA binding	-	54	47	-	-	9.08E-03	2.73E-03
huMAP	MF	GO:0030215	semaphorin receptor binding	-	23	13	-	-	7.14E-03	7.92E-04
huMAP	MF	GO:0031369	translation initiation factor binding	-	32	28	-	-	2.24E-03	1.66E-03
huMAP	MF	GO:0019843	rRNA binding	-	69	67	-	-	5.30E-03	3.89E-03
huMAP	MF	GO:0004713	protein tyrosine kinase activity	-	213	171	-	-	1.08E-02	9.86E-03
huMAP	MF	GO:0016779	nucleotidyltransferase activity	-	264	239	-	-	6.51E-03	1.38E-02
huMAP	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	44	-	-	2.41E-03	2.59E-03
huMAP	MF	GO:0008093	cytoskeletal anchor activity	-	24	22	-	-	4.64E-03	1.30E-03
huMAP	MF	GO:0070300	phosphatidic acid binding	-	20	17	-	-	3.64E-04	1.01E-03
huMAP	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	23	-	-	4.49E-04	1.37E-03
huMAP	MF	GO:0016208	AMP binding	-	22	22	-	-	6.93E-03	1.30E-03
huMAP	MF	GO:0000287	magnesium ion binding	-	225	204	-	-	4.00E-03	1.18E-02
huMAP	MF	GO:0031490	chromatin DNA binding	-	120	104	-	-	2.97E-03	6.04E-03
huMAP	MF	GO:0017022	myosin binding	-	73	61	-	-	5.82E-03	3.53E-03
huMAP	MF	GO:0004896	cytokine receptor activity	-	93	49	-	-	1.43E-03	2.88E-03
huMAP	MF	GO:0017166	vinculin binding	-	12	12	-	-	2.96E-04	7.20E-04
huMAP	MF	GO:0008301	"DNA binding, bending"	-	18	14	-	-	2.27E-03	8.64E-04
huMAP	MF	GO:1990459	transferrin receptor binding	-	12	11	-	-	3.14E-03	6.48E-04
huMAP	MF	GO:0005539	glycosaminoglycan binding	-	236	154	-	-	1.49E-02	8.92E-03
huMAP	MF	GO:0140666	annealing activity	-	11	11	-	-	2.66E-04	6.48E-04
huMAP	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.50E-03	8.64E-04
huMAP	MF	GO:0019207	kinase regulator activity	-	267	221	-	-	9.52E-03	1.27E-02
huMAP	MF	GO:0010181	FMN binding	-	15	13	-	-	5.16E-04	7.92E-04
huMAP	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	11	-	-	2.12E-04	6.48E-04
huMAP	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	19	-	-	1.40E-02	1.15E-03
huMAP	MF	GO:0031420	alkali metal ion binding	-	17	15	-	-	4.51E-04	8.64E-04
huMAP	MF	GO:0044183	protein folding chaperone	-	67	62	-	-	1.06E-03	3.60E-03
huMAP	MF	GO:0005132	type I interferon receptor binding	-	17	16	-	-	3.95E-01	9.36E-04
huMAP	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	84	-	-	2.12E-02	4.89E-03
huMAP	MF	GO:0003725	double-stranded RNA binding	-	72	64	-	-	1.15E-03	3.74E-03
huMAP	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	11	-	-	1.16E-03	6.48E-04
huMAP	MF	GO:0051018	protein kinase A binding	-	52	45	-	-	3.62E-02	2.59E-03
huMAP	MF	GO:0071889	14-3-3 protein binding	-	34	32	-	-	1.10E-03	1.87E-03
huMAP	MF	GO:0004618	phosphoglycerate kinase activity	-	89	82	-	-	6.45E-03	4.75E-03
huMAP	MF	GO:0042805	actinin binding	-	36	28	-	-	2.35E-03	1.66E-03
huMAP	MF	GO:0043531	ADP binding	-	38	37	-	-	7.83E-04	2.16E-03
huMAP	MF	GO:0043394	proteoglycan binding	-	36	27	-	-	1.42E-03	1.58E-03
huMAP	MF	GO:0046332	SMAD binding	-	77	67	-	-	1.33E-02	3.89E-03
huMAP	MF	GO:0043560	insulin receptor substrate binding	-	13	11	-	-	1.36E-03	6.48E-04
huMAP	MF	GO:0001968	fibronectin binding	-	30	23	-	-	8.07E-04	1.37E-03
huMAP	MF	GO:0048038	quinone binding	-	16	13	-	-	2.58E-03	7.92E-04
huMAP	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	110	-	-	7.30E-03	6.33E-03
huMAP	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	65	-	-	2.77E-03	3.74E-03
huMAP	MF	GO:0003756	protein disulfide isomerase activity	-	18	15	-	-	2.90E-04	8.64E-04
huMAP	MF	GO:0051117	ATPase binding	-	85	71	-	-	1.86E-03	4.10E-03
huMAP	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	27	-	-	2.11E-03	1.58E-03
huMAP	MF	GO:0051787	misfolded protein binding	-	20	18	-	-	4.07E-04	1.08E-03
huMAP	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	4.66E-04	6.48E-04
huMAP	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.27E-03	8.64E-04
huMAP	MF	GO:0031404	chloride ion binding	-	14	11	-	-	2.05E-04	6.48E-04
huMAP	MF	GO:0001098	basal transcription machinery binding	-	61	60	-	-	5.24E-03	3.45E-03
huMAP	MF	GO:0036002	pre-mRNA binding	-	57	34	-	-	1.69E-03	2.01E-03
huMAP	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	35	-	-	3.26E-03	2.01E-03
huMAP	MF	GO:0051540	metal cluster binding	-	71	66	-	-	1.83E-03	3.81E-03
huMAP	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	5.46E-03	6.48E-04
huMAP	MF	GO:0051219	phosphoprotein binding	-	92	83	-	-	5.62E-03	4.82E-03
huMAP	MF	GO:0019894	kinesin binding	-	45	42	-	-	1.51E-03	2.45E-03
huMAP	MF	GO:0042287	MHC protein binding	-	68	40	-	-	2.10E-02	2.30E-03
huMAP	MF	GO:0019003	GDP binding	-	89	86	-	-	2.34E-02	4.97E-03
huMAP	MF	GO:0017171	serine hydrolase activity	-	207	137	-	-	6.43E-03	7.92E-03
huMAP	MF	GO:0097110	scaffold protein binding	-	66	55	-	-	1.86E-03	3.17E-03
huMAP	MF	GO:0003774	cytoskeletal motor activity	-	117	110	-	-	2.05E-02	6.33E-03
huMAP	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	28	-	-	2.09E-03	1.66E-03
huMAP	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	12	-	-	6.23E-03	7.20E-04
huMAP	MF	GO:0061134	peptidase regulator activity	-	224	159	-	-	8.48E-03	9.21E-03
huMAP	MF	GO:0008013	beta-catenin binding	-	86	71	-	-	4.01E-03	4.10E-03
huMAP	MF	GO:0051015	actin filament binding	-	208	195	-	-	7.34E-03	1.12E-02
huMAP	MF	GO:0019208	phosphatase regulator activity	-	107	88	-	-	1.18E-02	5.11E-03
huMAP	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	28	-	-	4.42E-03	1.66E-03
huMAP	MF	GO:0043236	laminin binding	-	29	25	-	-	1.39E-03	1.44E-03
huMAP	MF	GO:0030507	spectrin binding	-	26	25	-	-	1.36E-03	1.44E-03
huMAP	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	38	-	-	2.72E-03	2.23E-03
huMAP	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	104	-	-	8.77E-03	6.04E-03
huMAP	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	22	-	-	6.75E-02	1.30E-03
huMAP	MF	GO:0042393	histone binding	-	240	213	-	-	1.56E-02	1.23E-02
huMAP	MF	GO:0019838	growth factor binding	-	182	133	-	-	7.92E-03	7.70E-03
huMAP	MF	GO:0000149	SNARE binding	-	107	93	-	-	6.49E-02	5.40E-03
huMAP	MF	GO:0003727	single-stranded RNA binding	-	90	80	-	-	2.52E-03	4.61E-03
huMAP	MF	GO:0005516	calmodulin binding	-	206	169	-	-	7.84E-03	9.79E-03
huMAP	MF	GO:0019825	oxygen binding	-	40	35	-	-	1.77E-02	2.01E-03
huMAP	MF	GO:0045505	dynein intermediate chain binding	-	37	31	-	-	8.08E-03	1.80E-03
huMAP	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	78	-	-	1.94E-03	4.53E-03
huMAP	MF	GO:0032182	ubiquitin-like protein binding	-	117	113	-	-	4.36E-03	6.55E-03
huMAP	MF	GO:0023023	MHC protein complex binding	-	36	26	-	-	1.97E-03	1.51E-03
huMAP	MF	GO:0030742	GTP-dependent protein binding	-	22	20	-	-	3.60E-03	1.15E-03
huMAP	MF	GO:0043274	phospholipase binding	-	23	19	-	-	8.40E-04	1.15E-03
huMAP	MF	GO:0031072	heat shock protein binding	-	128	121	-	-	2.34E-03	6.98E-03
huMAP	MF	GO:0030515	snoRNA binding	-	33	32	-	-	4.67E-03	1.87E-03
huMAP	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	61	-	-	2.40E-02	3.53E-03
huMAP	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	20	-	-	5.89E-03	1.15E-03
huMAP	MF	GO:0001965	G-protein alpha-subunit binding	-	26	23	-	-	5.57E-03	1.37E-03
huMAP	MF	GO:0001530	lipopolysaccharide binding	-	38	19	-	-	3.62E-04	1.15E-03
huMAP	MF	GO:0046982	protein heterodimerization activity	-	343	247	-	-	1.06E-02	1.42E-02
huMAP	MF	GO:0140223	general transcription initiation factor activity	-	55	51	-	-	9.17E-02	2.95E-03
huMAP	MF	GO:0070403	NAD+ binding	-	16	15	-	-	4.11E-04	8.64E-04
huMAP	MF	GO:0000049	tRNA binding	-	75	71	-	-	2.14E-03	4.10E-03
huMAP	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	42	-	-	2.54E-03	2.45E-03
huMAP	MF	GO:0015026	coreceptor activity	-	48	25	-	-	2.69E-03	1.44E-03
huMAP	MF	GO:0005527	macrolide binding	-	12	12	-	-	8.73E-04	7.20E-04
huMAP	MF	GO:0001653	peptide receptor activity	-	128	39	-	-	2.31E-03	2.30E-03
huMAP	MF	GO:0031005	filamin binding	-	15	11	-	-	5.59E-04	6.48E-04
huMAP	MF	GO:0030506	ankyrin binding	-	19	15	-	-	2.70E-03	8.64E-04
huMAP	MF	GO:0006469	negative regulation of protein kinase activity	-	222	173	-	-	4.85E-03	1.00E-02
huMAP	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	4.41E-04	1.15E-03
huMAP	MF	GO:1901611	phosphatidylglycerol binding	-	15	13	-	-	4.51E-04	7.92E-04
huMAP	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	26	-	-	2.28E-03	1.51E-03
huMAP	MF	GO:0051427	hormone receptor binding	-	31	19	-	-	8.83E-03	1.15E-03
huMAP	MF	GO:0070851	growth factor receptor binding	-	141	95	-	-	2.50E-03	5.47E-03
huMAP	MF	GO:0031210	phosphatidylcholine binding	-	32	25	-	-	7.66E-03	1.44E-03
huMAP	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	34	-	-	2.05E-03	2.01E-03
huMAP	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	212	-	-	4.21E-03	1.22E-02
huMAP	MF	GO:0034185	apolipoprotein binding	-	20	16	-	-	4.47E-04	9.36E-04
huMAP	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	16	-	-	1.79E-03	9.36E-04
huMAP	MF	GO:0051346	negative regulation of hydrolase activity	-	332	241	-	-	6.34E-03	1.39E-02
huMAP	MF	GO:0005506	iron ion binding	-	154	120	-	-	2.05E-02	6.91E-03
huMAP	MF	GO:0003925	G protein activity	-	45	40	-	-	1.30E-02	2.30E-03
huMAP	MF	GO:0038187	pattern recognition receptor activity	-	33	19	-	-	4.19E-04	1.15E-03
huMAP	MF	GO:0008276	protein methyltransferase activity	-	96	85	-	-	3.58E-03	4.89E-03
huMAP	MF	GO:0004396	hexokinase activity	-	16	15	-	-	7.28E-02	8.64E-04
huMAP	MF	GO:0070888	E-box binding	-	59	33	-	-	3.34E-02	1.94E-03
huMAP	MF	GO:0039706	co-receptor binding	-	14	11	-	-	2.10E-04	6.48E-04
huMAP	MF	GO:0015399	primary active transmembrane transporter activity	-	190	157	-	-	4.51E-02	9.07E-03
huMAP	MF	GO:0035254	glutamate receptor binding	-	47	36	-	-	7.21E-04	2.09E-03
huMAP	MF	GO:0050321	tau-protein kinase activity	-	36	31	-	-	2.23E-03	1.80E-03
huMAP	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	1.06E-03	6.48E-04
huMAP	MF	GO:0043021	ribonucleoprotein complex binding	-	158	154	-	-	2.61E-03	8.92E-03
huMAP	MF	GO:0030170	pyridoxal phosphate binding	-	56	52	-	-	7.35E-03	3.02E-03
huMAP	MF	GO:0032393	MHC class I receptor activity	-	15	11	-	-	3.22E-01	6.48E-04
huMAP	MF	GO:0005112	Notch binding	-	26	16	-	-	2.24E-03	9.36E-04
huMAP	MF	GO:0048185	activin binding	-	16	11	-	-	7.59E-02	6.48E-04
huMAP	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	25	-	-	1.12E-03	1.44E-03
huMAP	MF	GO:0001664	G protein-coupled receptor binding	-	299	175	-	-	4.80E-03	1.01E-02
huMAP	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	9.28E-04	6.48E-04
huMAP	MF	GO:0140299	small molecule sensor activity	-	39	31	-	-	3.20E-03	1.80E-03
huMAP	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	19	-	-	1.53E-02	1.15E-03
huMAP	MF	GO:0016917	GABA receptor activity	-	23	14	-	-	6.33E-02	8.64E-04
huMAP	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	1.74E-02	8.64E-04
huMAP	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	19	-	-	6.29E-03	1.15E-03
huMAP	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	41	-	-	1.85E-02	2.37E-03
huMAP	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	19	-	-	6.96E-04	1.15E-03
huMAP	MF	GO:0003916	DNA topoisomerase activity	-	12	11	-	-	3.30E-04	6.48E-04
huMAP	MF	GO:0030594	neurotransmitter receptor activity	-	160	91	-	-	1.15E-02	5.25E-03
huMAP	MF	GO:0034452	dynactin binding	-	12	12	-	-	3.99E-03	7.20E-04
huMAP	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	22	-	-	7.21E-03	1.30E-03
huMAP	MF	GO:0120227	acyl-CoA binding	-	22	20	-	-	6.73E-04	1.15E-03
huMAP	MF	GO:0005507	copper ion binding	-	63	47	-	-	2.37E-03	2.73E-03
huMAP	MF	GO:0033558	protein lysine deacetylase activity	-	22	20	-	-	2.48E-03	1.15E-03
huMAP	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.65E-03	1.30E-03
HuRI	CC	GO:0031012	extracellular matrix	2.90E-15	564	177	268	0.66	-	-
HuRI	CC	GO:0005730	nucleolus	1.55E-07	988	550	470	1.17	-	-
HuRI	CC	GO:0005815	microtubule organizing center	2.17E-06	843	468	401	1.17	-	-
HuRI	CC	GO:0005635	nuclear envelope	4.26E-04	493	273	234	1.17	-	-
HuRI	CC	GO:0005768	endosome	1.71E-03	1037	542	493	1.10	-	-
HuRI	CC	GO:0005615	extracellular space	3.51E-03	3190	1441	1516	0.95	-	-
HuRI	CC	GO:0000228	nuclear chromosome	2.48E-02	206	114	98	1.16	-	-
HuRI	CC	GO:0005811	lipid droplet	3.73E-01	102	53	48	1.09	-	-
HuRI	CC	GO:0005929	cilium	5.25E-01	842	391	400	0.98	-	-
HuRI	CC	GO:0005794	Golgi apparatus	5.34E-01	1636	765	777	0.98	-	-
HuRI	CC	GO:0005764	lysosome	6.54E-01	747	361	355	1.02	-	-
HuRI	CC	GO:0005777	peroxisome	9.33E-01	142	68	67	1.01	-	-
HuRI	CC	GO:0005783	endoplasmic reticulum	9.44E-01	2020	958	960	1.00	-	-
HuRI	CC	GO:0005840	ribosome	9.46E-01	222	106	106	1.00	-	-
HuRI	CC	GO:0005739	mitochondrion	1.00E+00	1671	794	794	1.00	-	-
HuRI	BP	GO:0050877	nervous system process	2.32E-43	1527	471	726	0.65	-	-
HuRI	BP	GO:0006355	regulation of DNA-templated transcription	1.43E-17	3342	1812	1588	1.14	-	-
HuRI	BP	GO:0006886	intracellular protein transport	2.42E-11	664	400	316	1.27	-	-
HuRI	BP	GO:0016071	mRNA metabolic process	1.09E-08	713	414	339	1.22	-	-
HuRI	BP	GO:0065003	protein-containing complex assembly	1.10E-08	1648	894	783	1.14	-	-
HuRI	BP	GO:0006914	autophagy	5.35E-08	568	334	270	1.24	-	-
HuRI	BP	GO:0016192	vesicle-mediated transport	1.04E-07	1894	1010	900	1.12	-	-
HuRI	BP	GO:0030198	extracellular matrix organization	1.48E-06	314	107	149	0.72	-	-
HuRI	BP	GO:0030163	protein catabolic process	1.74E-06	990	544	470	1.16	-	-
HuRI	BP	GO:0006325	chromatin organization	3.97E-06	720	403	342	1.18	-	-
HuRI	BP	GO:0006629	lipid metabolic process	6.13E-06	1355	564	644	0.88	-	-
HuRI	BP	GO:0072659	protein localization to plasma membrane	3.32E-05	284	170	135	1.26	-	-
HuRI	BP	GO:0055085	transmembrane transport	1.11E-04	1784	770	848	0.91	-	-
HuRI	BP	GO:0005975	carbohydrate metabolic process	1.13E-04	551	217	262	0.83	-	-
HuRI	BP	GO:0006954	inflammatory response	1.28E-04	820	336	390	0.86	-	-
HuRI	BP	GO:0006486	protein glycosylation	1.63E-04	225	79	107	0.74	-	-
HuRI	BP	GO:0007010	cytoskeleton organization	2.36E-04	1639	850	779	1.09	-	-
HuRI	BP	GO:0006913	nucleocytoplasmic transport	2.65E-04	326	188	155	1.21	-	-
HuRI	BP	GO:0007155	cell adhesion	5.45E-04	1444	623	686	0.91	-	-
HuRI	BP	GO:0012501	programmed cell death	6.75E-04	1954	1000	929	1.08	-	-
HuRI	BP	GO:0006790	sulfur compound metabolic process	1.55E-03	320	124	152	0.82	-	-
HuRI	BP	GO:0006281	DNA repair	1.62E-03	587	317	279	1.14	-	-
HuRI	BP	GO:0003013	circulatory system process	3.67E-03	584	243	278	0.88	-	-
HuRI	BP	GO:0000910	cytokinesis	3.97E-03	186	108	88	1.22	-	-
HuRI	BP	GO:0032200	telomere organization	3.97E-03	186	108	88	1.22	-	-
HuRI	BP	GO:0006457	protein folding	1.81E-02	210	117	100	1.17	-	-
HuRI	BP	GO:0007059	chromosome segregation	5.52E-02	403	211	192	1.10	-	-
HuRI	BP	GO:0007005	mitochondrion organization	5.86E-02	484	251	230	1.09	-	-
HuRI	BP	GO:0098542	defense response to other organism	6.09E-02	1171	588	557	1.06	-	-
HuRI	BP	GO:0002376	immune system process	7.16E-02	2448	1205	1163	1.04	-	-
HuRI	BP	GO:0007040	lysosome organization	8.08E-02	107	60	51	1.18	-	-
HuRI	BP	GO:0042254	ribosome biogenesis	1.14E-01	297	155	141	1.10	-	-
HuRI	BP	GO:0044782	cilium organization	1.56E-01	399	204	190	1.08	-	-
HuRI	BP	GO:0006310	DNA recombination	1.66E-01	333	171	158	1.08	-	-
HuRI	BP	GO:0006520	amino acid metabolic process	1.74E-01	292	127	139	0.92	-	-
HuRI	BP	GO:0007163	establishment or maintenance of cell polarity	1.82E-01	227	118	108	1.09	-	-
HuRI	BP	GO:0140053	mitochondrial gene expression	1.82E-01	164	69	78	0.89	-	-
HuRI	BP	GO:0034330	cell junction organization	1.98E-01	727	328	345	0.95	-	-
HuRI	BP	GO:0006260	DNA replication	3.34E-01	279	141	133	1.06	-	-
HuRI	BP	GO:0006091	generation of precursor metabolites and energy	3.90E-01	502	229	239	0.96	-	-
HuRI	BP	GO:0007018	microtubule-based movement	4.44E-01	640	314	304	1.03	-	-
HuRI	BP	GO:0098754	detoxification	4.88E-01	134	68	64	1.07	-	-
HuRI	BP	GO:0042060	wound healing	5.26E-01	431	198	205	0.97	-	-
HuRI	BP	GO:0006575	cellular modified amino acid metabolic process	5.55E-01	186	84	88	0.95	-	-
HuRI	BP	GO:0006399	tRNA metabolic process	5.66E-01	196	89	93	0.96	-	-
HuRI	BP	GO:0003014	renal system process	5.93E-01	127	57	60	0.94	-	-
HuRI	BP	GO:0006766	vitamin metabolic process	6.28E-01	107	48	51	0.94	-	-
HuRI	BP	GO:0140013	meiotic nuclear division	6.29E-01	279	137	133	1.03	-	-
HuRI	BP	GO:0048870	cell motility	6.43E-01	1659	779	788	0.99	-	-
HuRI	BP	GO:0002181	cytoplasmic translation	7.45E-01	153	75	73	1.03	-	-
HuRI	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	7.83E-01	119	55	57	0.97	-	-
HuRI	BP	GO:0003012	muscle system process	8.83E-01	425	200	202	0.99	-	-
HuRI	BP	GO:0022600	digestive system process	9.24E-01	110	53	52	1.01	-	-
HuRI	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.00E+00	729	346	346	1.00	-	-
HuRI	MF	GO:0003677	DNA binding	4.39E-13	2865	1540	1362	1.13	-	-
HuRI	MF	GO:0140110	transcription regulator activity	7.23E-12	2033	1112	966	1.15	-	-
HuRI	MF	GO:0009975	cyclase activity	1.45E-06	277	92	132	0.70	-	-
HuRI	MF	GO:0005215	transporter activity	3.04E-06	1462	609	695	0.88	-	-
HuRI	MF	GO:0003723	RNA binding	5.71E-06	1679	887	798	1.11	-	-
HuRI	MF	GO:0003774	cytoskeletal motor activity	3.37E-05	116	33	55	0.60	-	-
HuRI	MF	GO:0140104	molecular carrier activity	1.80E-04	105	69	50	1.38	-	-
HuRI	MF	GO:0008092	cytoskeletal protein binding	9.06E-04	1023	538	486	1.11	-	-
HuRI	MF	GO:0016491	oxidoreductase activity	1.21E-03	888	375	422	0.89	-	-
HuRI	MF	GO:0048018	receptor ligand activity	1.32E-03	504	204	240	0.85	-	-
HuRI	MF	GO:0016829	lyase activity	9.72E-03	538	226	256	0.88	-	-
HuRI	MF	GO:0140657	ATP-dependent activity	1.54E-02	729	314	346	0.91	-	-
HuRI	MF	GO:0045182	translation regulator activity	2.18E-02	151	86	72	1.20	-	-
HuRI	MF	GO:0003924	GTPase activity	3.88E-02	658	339	313	1.08	-	-
HuRI	MF	GO:0016740	transferase activity	7.55E-02	3074	1506	1461	1.03	-	-
HuRI	MF	GO:0016853	isomerase activity	9.87E-02	252	133	120	1.11	-	-
HuRI	MF	GO:0140098	"catalytic activity, acting on RNA"	1.13E-01	417	182	198	0.92	-	-
HuRI	MF	GO:0038024	cargo receptor activity	1.65E-01	117	48	56	0.86	-	-
HuRI	MF	GO:0140096	"catalytic activity, acting on a protein"	2.06E-01	3198	1487	1520	0.98	-	-
HuRI	MF	GO:0008289	lipid binding	2.15E-01	836	415	397	1.04	-	-
HuRI	MF	GO:0016874	ligase activity	5.10E-01	283	140	134	1.04	-	-
HuRI	MF	GO:0042393	histone binding	6.01E-01	237	117	113	1.04	-	-
HuRI	MF	GO:0140097	"catalytic activity, acting on DNA"	8.77E-01	383	180	182	0.99	-	-
HuRI	MF	GO:0005198	structural molecule activity	8.85E-01	798	377	379	0.99	-	-
HuRI	BP	GO:0008038	neuron recognition	-	46	22	-	-	5.50E-04	2.00E-03
HuRI	BP	GO:1905145	cellular response to acetylcholine	-	33	12	-	-	3.31E-04	1.11E-03
HuRI	BP	GO:0098780	response to mitochondrial depolarisation	-	21	12	-	-	1.97E-02	1.11E-03
HuRI	BP	GO:0051931	regulation of sensory perception	-	36	19	-	-	4.37E-04	1.78E-03
HuRI	BP	GO:0001525	angiogenesis	-	616	238	-	-	5.91E-03	2.12E-02
HuRI	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	11	-	-	3.30E-04	1.00E-03
HuRI	BP	GO:0009268	response to pH	-	43	15	-	-	1.34E-01	1.33E-03
HuRI	BP	GO:0045666	positive regulation of neuron differentiation	-	91	43	-	-	5.31E-02	3.89E-03
HuRI	BP	GO:0043543	protein acylation	-	107	56	-	-	1.88E-03	5.00E-03
HuRI	MF	GO:0051349	positive regulation of lyase activity	-	41	14	-	-	3.31E-04	1.33E-03
HuRI	BP	GO:0048679	regulation of axon regeneration	-	28	17	-	-	4.40E-04	1.56E-03
HuRI	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	53	-	-	1.86E-03	4.78E-03
HuRI	BP	GO:0071763	nuclear membrane organization	-	44	28	-	-	2.87E-02	2.56E-03
HuRI	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	23	-	-	2.98E-03	2.11E-03
HuRI	BP	GO:0071806	protein transmembrane transport	-	68	34	-	-	3.12E-03	3.11E-03
HuRI	BP	GO:0022038	corpus callosum development	-	25	13	-	-	3.32E-04	1.22E-03
HuRI	BP	GO:0043299	leukocyte degranulation	-	82	39	-	-	2.36E-03	3.56E-03
HuRI	BP	GO:0048864	stem cell development	-	88	31	-	-	2.78E-03	2.78E-03
HuRI	BP	GO:0051651	maintenance of location in cell	-	236	108	-	-	3.92E-03	9.67E-03
HuRI	BP	GO:0033119	negative regulation of RNA splicing	-	27	21	-	-	2.44E-02	1.89E-03
HuRI	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	16	-	-	4.42E-04	1.44E-03
HuRI	CC	GO:0016197	endosomal transport	-	282	174	-	-	2.22E-02	1.56E-02
HuRI	BP	GO:0070663	regulation of leukocyte proliferation	-	268	127	-	-	5.10E-03	1.13E-02
HuRI	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	16	-	-	8.53E-03	1.44E-03
HuRI	BP	GO:0006949	syncytium formation	-	66	30	-	-	7.56E-04	2.67E-03
HuRI	BP	GO:0045861	negative regulation of proteolysis	-	320	127	-	-	3.85E-03	1.13E-02
HuRI	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	22	-	-	2.43E-02	2.00E-03
HuRI	BP	GO:0030574	collagen catabolic process	-	45	11	-	-	3.29E-04	1.00E-03
HuRI	CC	GO:0006984	ER-nucleus signaling pathway	-	46	25	-	-	9.95E-04	2.22E-03
HuRI	BP	GO:0060343	trabecula formation	-	26	14	-	-	3.26E-04	1.33E-03
HuRI	BP	GO:0009914	hormone transport	-	315	139	-	-	4.64E-03	1.24E-02
HuRI	BP	GO:0140112	extracellular vesicle biogenesis	-	23	16	-	-	6.98E-03	1.44E-03
HuRI	BP	GO:0045785	positive regulation of cell adhesion	-	482	229	-	-	1.19E-02	2.04E-02
HuRI	BP	GO:0085029	extracellular matrix assembly	-	42	19	-	-	4.34E-04	1.78E-03
HuRI	BP	GO:0006413	translational initiation	-	122	66	-	-	2.15E-02	5.89E-03
HuRI	BP	GO:1902895	positive regulation of miRNA transcription	-	51	27	-	-	5.35E-03	2.44E-03
HuRI	CC	GO:0005200	structural constituent of cytoskeleton	-	112	48	-	-	3.34E-02	4.33E-03
HuRI	BP	GO:0030865	cortical cytoskeleton organization	-	51	24	-	-	5.51E-04	2.22E-03
HuRI	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	13	-	-	3.31E-04	1.22E-03
HuRI	BP	GO:1903036	positive regulation of response to wounding	-	76	37	-	-	2.95E-03	3.33E-03
HuRI	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	86	-	-	2.31E-02	7.67E-03
HuRI	BP	GO:1903319	positive regulation of protein maturation	-	27	13	-	-	3.32E-04	1.22E-03
HuRI	BP	GO:0002263	cell activation involved in immune response	-	304	144	-	-	4.56E-03	1.29E-02
HuRI	BP	GO:0021954	central nervous system neuron development	-	85	30	-	-	1.34E-03	2.67E-03
HuRI	BP	GO:0055017	cardiac muscle tissue growth	-	92	32	-	-	7.60E-04	2.89E-03
HuRI	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	18	-	-	6.92E-03	1.67E-03
HuRI	BP	GO:0048524	positive regulation of viral process	-	64	38	-	-	2.75E-03	3.44E-03
HuRI	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	12	-	-	3.31E-04	1.11E-03
HuRI	BP	GO:0098661	inorganic anion transmembrane transport	-	140	52	-	-	1.57E-03	4.67E-03
HuRI	BP	GO:0009612	response to mechanical stimulus	-	215	91	-	-	3.27E-03	8.11E-03
HuRI	BP	GO:0048644	muscle organ morphogenesis	-	81	33	-	-	1.25E-02	3.00E-03
HuRI	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	63	-	-	7.22E-03	5.67E-03
HuRI	BP	GO:0071542	dopaminergic neuron differentiation	-	36	12	-	-	3.31E-04	1.11E-03
HuRI	BP	GO:0140115	export across plasma membrane	-	82	26	-	-	6.58E-04	2.33E-03
HuRI	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	26	-	-	2.77E-02	2.33E-03
HuRI	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	21	-	-	5.50E-04	1.89E-03
HuRI	MF	GO:0003714	transcription corepressor activity	-	190	118	-	-	3.99E-03	1.06E-02
HuRI	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	21	-	-	5.47E-04	1.89E-03
HuRI	CC	GO:0006858	extracellular transport	-	45	22	-	-	1.01E-02	2.00E-03
HuRI	BP	GO:0006304	DNA modification	-	30	14	-	-	3.29E-04	1.33E-03
HuRI	MF	GO:0140312	cargo adaptor activity	-	19	14	-	-	2.15E-02	1.33E-03
HuRI	BP	GO:0046835	carbohydrate phosphorylation	-	49	29	-	-	5.06E-02	2.67E-03
HuRI	CC	GO:1905349	ciliary transition zone assembly	-	371	188	-	-	8.68E-03	1.68E-02
HuRI	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	17	-	-	4.35E-04	1.56E-03
HuRI	BP	GO:0043523	regulation of neuron apoptotic process	-	218	95	-	-	2.42E-03	8.44E-03
HuRI	BP	GO:0044380	protein localization to cytoskeleton	-	57	33	-	-	4.88E-03	3.00E-03
HuRI	BP	GO:2000209	regulation of anoikis	-	25	12	-	-	8.53E-04	1.11E-03
HuRI	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	15	-	-	4.37E-04	1.33E-03
HuRI	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	14	-	-	3.19E-04	1.33E-03
HuRI	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	40	-	-	2.83E-02	3.56E-03
HuRI	CC	GO:0045324	late endosome to vacuole transport	-	37	34	-	-	2.95E-02	3.11E-03
HuRI	BP	GO:0043954	cellular component maintenance	-	72	29	-	-	1.93E-03	2.67E-03
HuRI	BP	GO:0050435	amyloid-beta metabolic process	-	65	26	-	-	1.22E-02	2.33E-03
HuRI	BP	GO:0014823	response to activity	-	70	30	-	-	1.31E-03	2.67E-03
HuRI	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	237	-	-	8.80E-03	2.11E-02
HuRI	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	19	-	-	9.44E-02	1.78E-03
HuRI	BP	GO:0034502	protein localization to chromosome	-	130	84	-	-	1.06E-02	7.55E-03
HuRI	BP	GO:0048562	embryonic organ morphogenesis	-	295	144	-	-	6.30E-03	1.29E-02
HuRI	BP	GO:0019233	sensory perception of pain	-	103	45	-	-	1.06E-03	4.00E-03
HuRI	BP	GO:0031343	positive regulation of cell killing	-	75	29	-	-	6.53E-04	2.67E-03
HuRI	BP	GO:0090077	foam cell differentiation	-	39	22	-	-	4.87E-03	2.00E-03
HuRI	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	42	-	-	4.06E-02	3.78E-03
HuRI	BP	GO:0017148	negative regulation of translation	-	390	58	-	-	9.73E-03	5.22E-03
HuRI	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	43	-	-	1.62E-03	3.89E-03
HuRI	BP	GO:1903509	liposaccharide metabolic process	-	109	32	-	-	7.65E-04	2.89E-03
HuRI	BP	GO:0009582	detection of abiotic stimulus	-	140	46	-	-	1.07E-03	4.11E-03
HuRI	CC	GO:0140238	presynaptic endocytosis	-	72	35	-	-	8.42E-03	3.11E-03
HuRI	BP	GO:0051236	establishment of RNA localization	-	161	86	-	-	3.10E-02	7.67E-03
HuRI	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	112	-	-	1.46E-02	1.00E-02
HuRI	BP	GO:0034067	protein localization to Golgi apparatus	-	30	15	-	-	5.99E-03	1.33E-03
HuRI	BP	GO:0061842	microtubule organizing center localization	-	32	17	-	-	4.55E-02	1.56E-03
HuRI	BP	GO:0042246	tissue regeneration	-	496	226	-	-	6.81E-03	2.01E-02
HuRI	MF	GO:0048018	receptor ligand activity	-	510	205	-	-	1.01E-02	1.82E-02
HuRI	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	23	-	-	5.35E-04	2.11E-03
HuRI	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	26	-	-	8.29E-04	2.33E-03
HuRI	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	31	-	-	1.70E-03	2.78E-03
HuRI	BP	GO:0050779	RNA destabilization	-	135	45	-	-	5.26E-02	4.00E-03
HuRI	BP	GO:0006023	aminoglycan biosynthetic process	-	74	14	-	-	3.32E-04	1.33E-03
HuRI	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	31	-	-	2.35E-03	2.78E-03
HuRI	BP	GO:0010762	regulation of fibroblast migration	-	40	18	-	-	2.85E-03	1.67E-03
HuRI	BP	GO:0090311	regulation of protein deacetylation	-	29	19	-	-	7.81E-03	1.78E-03
HuRI	BP	GO:0035272	exocrine system development	-	46	21	-	-	5.45E-04	1.89E-03
HuRI	BP	GO:0022406	membrane docking	-	90	63	-	-	2.33E-02	5.67E-03
HuRI	BP	GO:0050777	negative regulation of immune response	-	196	93	-	-	4.06E-03	8.33E-03
HuRI	BP	GO:0016053	organic acid biosynthetic process	-	335	154	-	-	1.44E-02	1.38E-02
HuRI	BP	GO:0021782	glial cell development	-	120	54	-	-	3.42E-03	4.89E-03
HuRI	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	40	-	-	8.98E-03	3.56E-03
HuRI	BP	GO:0001655	urogenital system development	-	66	34	-	-	3.41E-03	3.11E-03
HuRI	BP	GO:0071827	plasma lipoprotein particle organization	-	86	34	-	-	7.55E-04	3.11E-03
HuRI	BP	GO:0045494	photoreceptor cell maintenance	-	43	11	-	-	3.31E-04	1.00E-03
HuRI	BP	GO:0055088	lipid homeostasis	-	173	76	-	-	1.84E-03	6.78E-03
HuRI	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	16	-	-	4.37E-04	1.44E-03
HuRI	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	100	-	-	3.83E-03	8.89E-03
HuRI	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	15	-	-	4.32E-04	1.33E-03
HuRI	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	16	-	-	1.46E-02	1.44E-03
HuRI	BP	GO:0045667	regulation of osteoblast differentiation	-	147	58	-	-	1.65E-03	5.22E-03
HuRI	BP	GO:0061037	negative regulation of cartilage development	-	32	16	-	-	4.42E-04	1.44E-03
HuRI	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	168	-	-	6.39E-03	1.50E-02
HuRI	BP	GO:0045738	negative regulation of DNA repair	-	40	16	-	-	8.60E-04	1.44E-03
HuRI	BP	GO:0001704	formation of primary germ layer	-	195	85	-	-	6.67E-03	7.55E-03
HuRI	BP	GO:0045778	positive regulation of ossification	-	51	25	-	-	6.55E-04	2.22E-03
HuRI	BP	GO:0048708	astrocyte differentiation	-	88	38	-	-	1.26E-03	3.44E-03
HuRI	BP	GO:0042092	type 2 immune response	-	41	21	-	-	5.47E-04	1.89E-03
HuRI	BP	GO:0048588	developmental cell growth	-	233	97	-	-	2.36E-03	8.67E-03
HuRI	BP	GO:0021872	forebrain generation of neurons	-	52	16	-	-	4.35E-04	1.44E-03
HuRI	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	15	-	-	4.37E-04	1.33E-03
HuRI	BP	GO:0045023	G0 to G1 transition	-	41	25	-	-	1.30E-02	2.22E-03
HuRI	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	24	-	-	5.42E-04	2.22E-03
HuRI	BP	GO:0034367	protein-containing complex remodeling	-	35	19	-	-	2.89E-03	1.78E-03
HuRI	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	16	-	-	4.35E-04	1.44E-03
HuRI	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	23	-	-	5.48E-04	2.11E-03
HuRI	BP	GO:0010232	vascular transport	-	87	35	-	-	8.72E-04	3.11E-03
HuRI	BP	GO:0021987	cerebral cortex development	-	125	63	-	-	1.52E-03	5.67E-03
HuRI	BP	GO:0008637	apoptotic mitochondrial changes	-	108	64	-	-	1.11E-02	5.78E-03
HuRI	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	20	-	-	9.05E-03	1.78E-03
HuRI	BP	GO:0060999	positive regulation of dendritic spine development	-	35	12	-	-	8.36E-02	1.11E-03
HuRI	BP	GO:2000736	regulation of stem cell differentiation	-	78	37	-	-	1.63E-02	3.33E-03
HuRI	BP	GO:0002064	epithelial cell development	-	210	101	-	-	3.56E-03	9.00E-03
HuRI	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	21	-	-	6.45E-02	1.89E-03
HuRI	BP	GO:2001222	regulation of neuron migration	-	46	15	-	-	2.93E-03	1.33E-03
HuRI	BP	GO:0034389	lipid droplet organization	-	38	23	-	-	5.38E-04	2.11E-03
HuRI	BP	GO:0051602	response to electrical stimulus	-	44	21	-	-	5.44E-04	1.89E-03
HuRI	BP	GO:0042177	negative regulation of protein catabolic process	-	109	61	-	-	2.19E-03	5.44E-03
HuRI	MF	GO:0038024	cargo receptor activity	-	121	48	-	-	1.33E-02	4.33E-03
HuRI	BP	GO:0033120	positive regulation of RNA splicing	-	46	34	-	-	2.73E-02	3.11E-03
HuRI	BP	GO:0051445	regulation of meiotic cell cycle	-	64	32	-	-	1.57E-02	2.89E-03
HuRI	BP	GO:0033619	membrane protein proteolysis	-	60	22	-	-	5.47E-04	2.00E-03
HuRI	BP	GO:0090087	regulation of peptide transport	-	195	86	-	-	4.40E-03	7.67E-03
HuRI	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	50	-	-	2.20E-03	4.44E-03
HuRI	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	17	-	-	8.66E-04	1.56E-03
HuRI	BP	GO:0006929	substrate-dependent cell migration	-	26	12	-	-	3.23E-04	1.11E-03
HuRI	BP	GO:0042537	benzene-containing compound metabolic process	-	27	14	-	-	5.03E-02	1.33E-03
HuRI	BP	GO:0072662	protein localization to peroxisome	-	20	12	-	-	2.56E-02	1.11E-03
HuRI	BP	GO:0022404	molting cycle process	-	95	44	-	-	2.03E-03	4.00E-03
HuRI	BP	GO:1903358	regulation of Golgi organization	-	17	13	-	-	3.28E-04	1.22E-03
HuRI	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	19	-	-	1.52E-02	1.78E-03
HuRI	BP	GO:0007281	germ cell development	-	334	173	-	-	4.60E-03	1.54E-02
HuRI	BP	GO:0008299	isoprenoid biosynthetic process	-	30	14	-	-	3.32E-04	1.33E-03
HuRI	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	102	-	-	3.20E-03	9.11E-03
HuRI	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	21	-	-	5.49E-04	1.89E-03
HuRI	BP	GO:0034104	negative regulation of tissue remodeling	-	22	14	-	-	3.31E-04	1.33E-03
HuRI	CC	GO:0098926	postsynaptic signal transduction	-	39	16	-	-	4.41E-04	1.44E-03
HuRI	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	73	-	-	2.71E-03	6.55E-03
HuRI	CC	GO:0016082	synaptic vesicle priming	-	19	12	-	-	3.33E-02	1.11E-03
HuRI	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	21	-	-	1.96E-03	1.89E-03
HuRI	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	63	-	-	1.90E-03	5.67E-03
HuRI	BP	GO:0034249	negative regulation of amide metabolic process	-	34	14	-	-	2.14E-03	1.33E-03
HuRI	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	55	-	-	1.27E-02	4.89E-03
HuRI	BP	GO:0042832	defense response to protozoan	-	28	14	-	-	3.28E-04	1.33E-03
HuRI	BP	GO:0048799	animal organ maturation	-	33	13	-	-	3.23E-04	1.22E-03
HuRI	BP	GO:0006925	inflammatory cell apoptotic process	-	23	12	-	-	3.32E-04	1.11E-03
HuRI	BP	GO:0003013	circulatory system process	-	602	244	-	-	6.20E-03	2.18E-02
HuRI	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	93	-	-	3.63E-03	8.33E-03
HuRI	BP	GO:1903035	negative regulation of response to wounding	-	93	38	-	-	8.65E-04	3.44E-03
HuRI	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	16	-	-	4.37E-04	1.44E-03
HuRI	BP	GO:0036010	protein localization to endosome	-	27	15	-	-	4.41E-04	1.33E-03
HuRI	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	77	-	-	3.04E-02	6.89E-03
HuRI	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	63	-	-	3.38E-03	5.67E-03
HuRI	BP	GO:0045056	transcytosis	-	20	13	-	-	3.33E-04	1.22E-03
HuRI	BP	GO:0009267	cellular response to starvation	-	170	83	-	-	3.35E-03	7.44E-03
HuRI	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	22	-	-	5.33E-04	2.00E-03
HuRI	CC	GO:0140239	postsynaptic endocytosis	-	23	12	-	-	1.19E-03	1.11E-03
HuRI	CC	GO:0032008	positive regulation of TOR signaling	-	52	23	-	-	2.08E-02	2.11E-03
HuRI	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	18	-	-	4.42E-04	1.67E-03
HuRI	BP	GO:0060428	lung epithelium development	-	43	24	-	-	2.73E-03	2.22E-03
HuRI	BP	GO:0030431	sleep	-	30	11	-	-	3.31E-04	1.00E-03
HuRI	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	44	-	-	4.38E-03	4.00E-03
HuRI	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	33	-	-	2.33E-02	3.00E-03
HuRI	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	30	-	-	7.55E-04	2.67E-03
HuRI	BP	GO:0065004	protein-DNA complex assembly	-	307	176	-	-	6.07E-02	1.57E-02
HuRI	CC	GO:0006406	mRNA export from nucleus	-	69	43	-	-	8.35E-02	3.89E-03
HuRI	BP	GO:0009880	embryonic pattern specification	-	70	34	-	-	1.32E-03	3.11E-03
HuRI	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	25	-	-	9.59E-02	2.22E-03
HuRI	BP	GO:0043043	peptide biosynthetic process	-	25	13	-	-	3.29E-04	1.22E-03
HuRI	BP	GO:0002367	cytokine production involved in immune response	-	121	50	-	-	5.34E-03	4.44E-03
HuRI	BP	GO:0044848	biological phase	-	211	102	-	-	9.64E-03	9.11E-03
HuRI	BP	GO:0046660	female sex differentiation	-	125	58	-	-	1.68E-02	5.22E-03
HuRI	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	22	-	-	5.43E-04	2.00E-03
HuRI	BP	GO:0060411	cardiac septum morphogenesis	-	72	24	-	-	5.49E-04	2.22E-03
HuRI	BP	GO:0071248	cellular response to metal ion	-	201	104	-	-	2.79E-03	9.33E-03
HuRI	BP	GO:0030308	negative regulation of cell growth	-	191	88	-	-	2.36E-03	7.89E-03
HuRI	BP	GO:0097306	cellular response to alcohol	-	99	34	-	-	1.55E-03	3.11E-03
HuRI	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	78	-	-	2.38E-02	7.00E-03
HuRI	BP	GO:0010453	regulation of cell fate commitment	-	40	13	-	-	6.84E-03	1.22E-03
HuRI	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	28	-	-	4.47E-03	2.56E-03
HuRI	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	20	-	-	5.50E-04	1.78E-03
HuRI	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	24	-	-	2.05E-02	2.22E-03
HuRI	BP	GO:0032890	regulation of organic acid transport	-	78	42	-	-	2.76E-03	3.78E-03
HuRI	BP	GO:0098771	inorganic ion homeostasis	-	531	230	-	-	8.10E-03	2.04E-02
HuRI	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	15	-	-	4.43E-04	1.33E-03
HuRI	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	42	-	-	1.68E-03	3.78E-03
HuRI	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	20	-	-	5.46E-04	1.78E-03
HuRI	BP	GO:0051259	protein complex oligomerization	-	251	135	-	-	8.34E-03	1.20E-02
HuRI	BP	GO:0009994	oocyte differentiation	-	57	20	-	-	5.46E-04	1.78E-03
HuRI	MF	GO:0031952	regulation of protein autophosphorylation	-	43	23	-	-	5.50E-04	2.11E-03
HuRI	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	68	-	-	2.25E-03	6.11E-03
HuRI	BP	GO:0044319	"wound healing, spreading of cells"	-	37	14	-	-	3.31E-04	1.33E-03
HuRI	BP	GO:0033688	regulation of osteoblast proliferation	-	31	15	-	-	4.41E-04	1.33E-03
HuRI	BP	GO:0060251	regulation of glial cell proliferation	-	39	13	-	-	3.29E-04	1.22E-03
HuRI	BP	GO:0072665	protein localization to vacuole	-	84	47	-	-	1.41E-02	4.22E-03
HuRI	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	26	-	-	7.59E-03	2.33E-03
HuRI	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	42	-	-	1.42E-03	3.78E-03
HuRI	BP	GO:0042044	fluid transport	-	35	22	-	-	1.84E-03	2.00E-03
HuRI	BP	GO:0070633	transepithelial transport	-	35	18	-	-	2.15E-03	1.67E-03
HuRI	BP	GO:0045661	regulation of myoblast differentiation	-	74	47	-	-	1.17E-02	4.22E-03
HuRI	BP	GO:0030307	positive regulation of cell growth	-	164	79	-	-	2.11E-03	7.11E-03
HuRI	BP	GO:0034250	positive regulation of amide metabolic process	-	27	13	-	-	3.31E-04	1.22E-03
HuRI	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	148	-	-	4.08E-03	1.32E-02
HuRI	BP	GO:0014812	muscle cell migration	-	110	45	-	-	1.08E-03	4.00E-03
HuRI	BP	GO:0048525	negative regulation of viral process	-	90	55	-	-	1.44E-03	4.89E-03
HuRI	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	42	-	-	4.09E-03	3.78E-03
HuRI	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	114	-	-	9.48E-03	1.02E-02
HuRI	BP	GO:0051781	positive regulation of cell division	-	93	37	-	-	8.72E-04	3.33E-03
HuRI	BP	GO:0035493	SNARE complex assembly	-	23	14	-	-	4.06E-02	1.33E-03
HuRI	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	13	-	-	3.31E-04	1.22E-03
HuRI	BP	GO:0002696	positive regulation of leukocyte activation	-	358	166	-	-	5.58E-03	1.48E-02
HuRI	BP	GO:0060711	labyrinthine layer development	-	47	26	-	-	6.54E-04	2.33E-03
HuRI	BP	GO:0007272	ensheathment of neurons	-	146	68	-	-	5.09E-03	6.11E-03
HuRI	CC	GO:0050806	positive regulation of synaptic transmission	-	171	73	-	-	5.27E-03	6.55E-03
HuRI	BP	GO:0060021	roof of mouth development	-	91	39	-	-	1.65E-03	3.56E-03
HuRI	BP	GO:0034504	protein localization to nucleus	-	312	181	-	-	1.23E-02	1.61E-02
HuRI	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	18	-	-	4.40E-04	1.67E-03
HuRI	BP	GO:0050819	negative regulation of coagulation	-	54	23	-	-	5.49E-04	2.11E-03
HuRI	BP	GO:0031647	regulation of protein stability	-	327	196	-	-	1.20E-02	1.74E-02
HuRI	BP	GO:0017004	cytochrome complex assembly	-	40	17	-	-	1.35E-02	1.56E-03
HuRI	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	33	-	-	1.88E-02	3.00E-03
HuRI	BP	GO:0097212	lysosomal membrane organization	-	15	12	-	-	3.51E-02	1.11E-03
HuRI	CC	GO:0050805	negative regulation of synaptic transmission	-	55	21	-	-	9.13E-04	1.89E-03
HuRI	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	33	-	-	1.21E-03	3.00E-03
HuRI	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	27	-	-	6.52E-04	2.44E-03
HuRI	BP	GO:0016054	organic acid catabolic process	-	251	108	-	-	3.75E-03	9.67E-03
HuRI	BP	GO:0050890	cognition	-	317	135	-	-	5.28E-03	1.20E-02
HuRI	BP	GO:1900048	positive regulation of hemostasis	-	28	12	-	-	3.30E-04	1.11E-03
HuRI	BP	GO:0065005	protein-lipid complex assembly	-	29	11	-	-	3.30E-04	1.00E-03
HuRI	BP	GO:0008033	tRNA processing	-	136	62	-	-	4.94E-02	5.55E-03
HuRI	BP	GO:0046661	male sex differentiation	-	171	77	-	-	3.02E-03	6.89E-03
HuRI	BP	GO:0035188	hatching	-	27	15	-	-	4.38E-04	1.33E-03
HuRI	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	42	-	-	1.24E-03	3.78E-03
HuRI	BP	GO:1990778	protein localization to cell periphery	-	346	198	-	-	6.69E-03	1.77E-02
HuRI	BP	GO:0061326	renal tubule development	-	103	40	-	-	9.72E-04	3.56E-03
HuRI	BP	GO:0051258	protein polymerization	-	280	139	-	-	7.23E-03	1.24E-02
HuRI	BP	GO:0071985	multivesicular body sorting pathway	-	56	48	-	-	2.44E-02	4.33E-03
HuRI	BP	GO:0060325	face morphogenesis	-	31	16	-	-	4.35E-04	1.44E-03
HuRI	BP	GO:0090559	regulation of membrane permeability	-	72	41	-	-	1.08E-02	3.67E-03
HuRI	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	15	-	-	4.42E-04	1.33E-03
HuRI	BP	GO:0046460	neutral lipid biosynthetic process	-	50	14	-	-	3.29E-04	1.33E-03
HuRI	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	67	-	-	1.96E-03	6.00E-03
HuRI	BP	GO:0002250	adaptive immune response	-	753	212	-	-	5.37E-03	1.89E-02
HuRI	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	93	-	-	2.79E-03	8.33E-03
HuRI	BP	GO:0002251	organ or tissue specific immune response	-	43	23	-	-	3.21E-03	2.11E-03
HuRI	CC	GO:0048167	regulation of synaptic plasticity	-	210	92	-	-	2.70E-03	8.22E-03
HuRI	BP	GO:1903708	positive regulation of hemopoiesis	-	184	93	-	-	4.71E-03	8.33E-03
HuRI	BP	GO:1903008	organelle disassembly	-	154	85	-	-	1.62E-02	7.55E-03
HuRI	BP	GO:0001709	cell fate determination	-	44	20	-	-	5.41E-04	1.78E-03
HuRI	BP	GO:0051873	killing by host of symbiont cells	-	28	14	-	-	3.32E-04	1.33E-03
HuRI	BP	GO:0045058	T cell selection	-	53	26	-	-	8.97E-03	2.33E-03
HuRI	CC	GO:0032387	negative regulation of intracellular transport	-	51	31	-	-	2.83E-03	2.78E-03
HuRI	BP	GO:0072091	regulation of stem cell proliferation	-	91	39	-	-	8.70E-04	3.56E-03
HuRI	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	21	-	-	1.37E-02	1.89E-03
HuRI	BP	GO:0099084	postsynaptic specialization organization	-	44	11	-	-	3.30E-04	1.00E-03
HuRI	BP	GO:0032535	regulation of cellular component size	-	360	156	-	-	5.35E-03	1.39E-02
HuRI	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	12	-	-	3.32E-04	1.11E-03
HuRI	MF	GO:0031281	positive regulation of cyclase activity	-	40	15	-	-	4.43E-04	1.33E-03
HuRI	MF	GO:0098631	cell adhesion mediator activity	-	64	33	-	-	5.53E-03	3.00E-03
HuRI	BP	GO:0071453	cellular response to oxygen levels	-	168	72	-	-	2.91E-03	6.44E-03
HuRI	BP	GO:0031342	negative regulation of cell killing	-	29	12	-	-	3.30E-04	1.11E-03
HuRI	BP	GO:0070585	protein localization to mitochondrion	-	125	71	-	-	3.12E-03	6.33E-03
HuRI	BP	GO:0044242	cellular lipid catabolic process	-	224	88	-	-	4.70E-03	7.89E-03
HuRI	BP	GO:0002931	response to ischemia	-	58	27	-	-	2.02E-03	2.44E-03
HuRI	BP	GO:0043062	extracellular structure organization	-	317	108	-	-	6.43E-03	9.67E-03
HuRI	BP	GO:0014047	glutamate secretion	-	25	11	-	-	3.31E-04	1.00E-03
HuRI	BP	GO:0061005	cell differentiation involved in kidney development	-	58	28	-	-	6.56E-04	2.56E-03
HuRI	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	24	-	-	8.21E-04	2.22E-03
HuRI	BP	GO:0060420	regulation of heart growth	-	74	24	-	-	5.47E-04	2.22E-03
HuRI	BP	GO:0009755	hormone-mediated signaling pathway	-	221	118	-	-	9.79E-03	1.06E-02
HuRI	BP	GO:0022612	gland morphogenesis	-	124	47	-	-	1.07E-03	4.22E-03
HuRI	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	16	-	-	3.76E-03	1.44E-03
HuRI	MF	GO:0140416	transcription regulator inhibitor activity	-	26	16	-	-	4.26E-04	1.44E-03
HuRI	BP	GO:0044782	cilium organization	-	400	204	-	-	9.32E-03	1.82E-02
HuRI	BP	GO:0090130	tissue migration	-	379	142	-	-	4.72E-03	1.27E-02
HuRI	BP	GO:1990845	adaptive thermogenesis	-	166	82	-	-	2.46E-03	7.33E-03
HuRI	BP	GO:0071320	cellular response to cAMP	-	54	24	-	-	1.24E-03	2.22E-03
HuRI	BP	GO:0015844	monoamine transport	-	88	41	-	-	6.73E-03	3.67E-03
HuRI	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	15	-	-	3.93E-02	1.33E-03
HuRI	BP	GO:0071392	cellular response to estradiol stimulus	-	40	20	-	-	2.01E-03	1.78E-03
HuRI	BP	GO:0009314	response to radiation	-	449	217	-	-	7.81E-03	1.93E-02
HuRI	BP	GO:0000272	polysaccharide catabolic process	-	19	13	-	-	2.12E-01	1.22E-03
HuRI	BP	GO:0009451	RNA modification	-	169	77	-	-	4.47E-02	6.89E-03
HuRI	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	18	-	-	3.44E-03	1.67E-03
HuRI	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	62	-	-	1.79E-03	5.55E-03
HuRI	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	16	-	-	4.40E-04	1.44E-03
HuRI	BP	GO:0015807	L-amino acid transport	-	94	43	-	-	3.04E-02	3.89E-03
HuRI	BP	GO:0032941	secretion by tissue	-	85	43	-	-	1.56E-03	3.89E-03
HuRI	BP	GO:0046605	regulation of centrosome cycle	-	54	29	-	-	5.94E-03	2.67E-03
HuRI	BP	GO:0048753	pigment granule organization	-	40	20	-	-	2.93E-02	1.78E-03
HuRI	BP	GO:0003014	renal system process	-	130	57	-	-	2.57E-03	5.11E-03
HuRI	CC	GO:0070286	axonemal dynein complex assembly	-	40	14	-	-	5.07E-03	1.33E-03
HuRI	BP	GO:0045598	regulation of fat cell differentiation	-	148	75	-	-	2.61E-02	6.67E-03
HuRI	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	107	-	-	3.28E-03	9.55E-03
HuRI	BP	GO:1904646	cellular response to amyloid-beta	-	44	15	-	-	4.40E-04	1.33E-03
HuRI	BP	GO:1901863	positive regulation of muscle tissue development	-	24	13	-	-	3.28E-04	1.22E-03
HuRI	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	72	-	-	2.92E-03	6.44E-03
HuRI	BP	GO:0039694	viral RNA genome replication	-	30	15	-	-	1.09E-02	1.33E-03
HuRI	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	16	-	-	6.87E-02	1.44E-03
HuRI	BP	GO:0071709	membrane assembly	-	68	35	-	-	1.85E-02	3.11E-03
HuRI	BP	GO:0008217	regulation of blood pressure	-	186	69	-	-	3.78E-03	6.22E-03
HuRI	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	27	-	-	6.60E-04	2.44E-03
HuRI	CC	GO:0042770	signal transduction in response to DNA damage	-	186	107	-	-	1.00E-02	9.55E-03
HuRI	BP	GO:0002200	somatic diversification of immune receptors	-	78	40	-	-	7.04E-03	3.56E-03
HuRI	BP	GO:0035315	hair cell differentiation	-	52	19	-	-	3.32E-03	1.78E-03
HuRI	BP	GO:0048645	animal organ formation	-	62	30	-	-	1.79E-02	2.67E-03
HuRI	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	79	-	-	2.65E-03	7.11E-03
HuRI	BP	GO:0033627	cell adhesion mediated by integrin	-	87	37	-	-	1.24E-03	3.33E-03
HuRI	BP	GO:0035107	appendage morphogenesis	-	147	58	-	-	1.44E-03	5.22E-03
HuRI	BP	GO:1903707	negative regulation of hemopoiesis	-	116	53	-	-	2.96E-02	4.78E-03
HuRI	CC	GO:0048208	COPII vesicle coating	-	27	18	-	-	4.06E-02	1.67E-03
HuRI	BP	GO:0050994	regulation of lipid catabolic process	-	61	34	-	-	9.56E-03	3.11E-03
HuRI	BP	GO:0009593	detection of chemical stimulus	-	511	47	-	-	6.97E-03	4.22E-03
HuRI	BP	GO:0045727	positive regulation of translation	-	141	62	-	-	4.29E-03	5.55E-03
HuRI	CC	GO:0032388	positive regulation of intracellular transport	-	137	78	-	-	2.57E-03	7.00E-03
HuRI	BP	GO:0002027	regulation of heart rate	-	106	42	-	-	2.51E-03	3.78E-03
HuRI	BP	GO:0050879	multicellular organismal movement	-	118	56	-	-	7.91E-03	5.00E-03
HuRI	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	34	-	-	1.40E-03	3.11E-03
HuRI	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	29	-	-	6.54E-04	2.67E-03
HuRI	BP	GO:0048515	spermatid differentiation	-	208	111	-	-	3.71E-03	9.89E-03
HuRI	BP	GO:0072132	mesenchyme morphogenesis	-	57	27	-	-	6.55E-04	2.44E-03
HuRI	MF	GO:0042887	amide transmembrane transporter activity	-	33	14	-	-	5.25E-03	1.33E-03
HuRI	BP	GO:0007130	synaptonemal complex assembly	-	23	12	-	-	1.78E-03	1.11E-03
HuRI	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	18	-	-	3.12E-03	1.67E-03
HuRI	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	14	-	-	3.29E-04	1.33E-03
HuRI	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	15	-	-	4.41E-04	1.33E-03
HuRI	BP	GO:0060119	inner ear receptor cell development	-	44	15	-	-	5.64E-03	1.33E-03
HuRI	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	17	-	-	4.37E-04	1.56E-03
HuRI	BP	GO:1901983	regulation of protein acetylation	-	26	12	-	-	1.26E-03	1.11E-03
HuRI	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	111	-	-	1.09E-02	9.89E-03
HuRI	BP	GO:1900006	positive regulation of dendrite development	-	17	14	-	-	3.31E-04	1.33E-03
HuRI	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	30	-	-	2.11E-03	2.67E-03
HuRI	BP	GO:0010883	regulation of lipid storage	-	53	28	-	-	1.78E-02	2.56E-03
HuRI	BP	GO:0072170	metanephric tubule development	-	26	11	-	-	3.29E-04	1.00E-03
HuRI	BP	GO:1905954	positive regulation of lipid localization	-	110	56	-	-	1.30E-03	5.00E-03
HuRI	BP	GO:0002209	behavioral defense response	-	39	16	-	-	4.42E-04	1.44E-03
HuRI	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	14	-	-	5.70E-01	1.33E-03
HuRI	BP	GO:0072523	purine-containing compound catabolic process	-	146	79	-	-	3.98E-03	7.11E-03
HuRI	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	12	-	-	7.46E-04	1.11E-03
HuRI	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	14	-	-	3.31E-04	1.33E-03
HuRI	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	52	-	-	7.04E-03	4.67E-03
HuRI	BP	GO:0007218	neuropeptide signaling pathway	-	113	41	-	-	9.86E-04	3.67E-03
HuRI	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	60	-	-	1.41E-03	5.33E-03
HuRI	BP	GO:0031345	negative regulation of cell projection organization	-	195	86	-	-	4.83E-03	7.67E-03
HuRI	BP	GO:0048278	vesicle docking	-	64	48	-	-	2.54E-02	4.33E-03
HuRI	BP	GO:0035050	embryonic heart tube development	-	86	38	-	-	8.49E-03	3.44E-03
HuRI	BP	GO:0030168	platelet activation	-	135	54	-	-	2.36E-03	4.89E-03
HuRI	CC	GO:0098810	neurotransmitter reuptake	-	35	14	-	-	3.30E-04	1.33E-03
HuRI	BP	GO:0008213	protein alkylation	-	58	33	-	-	3.61E-03	3.00E-03
HuRI	BP	GO:0031338	regulation of vesicle fusion	-	24	13	-	-	3.32E-04	1.22E-03
HuRI	BP	GO:0002253	activation of immune response	-	529	245	-	-	8.89E-03	2.18E-02
HuRI	BP	GO:0031529	ruffle organization	-	55	24	-	-	4.29E-03	2.22E-03
HuRI	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	41	-	-	1.16E-03	3.67E-03
HuRI	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	31	-	-	2.56E-03	2.78E-03
HuRI	MF	GO:0170055	lipid transmembrane transporter activity	-	56	19	-	-	4.35E-04	1.78E-03
HuRI	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	12	-	-	3.32E-04	1.11E-03
HuRI	BP	GO:0035304	regulation of protein dephosphorylation	-	87	39	-	-	2.28E-03	3.56E-03
HuRI	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	105	-	-	2.65E-03	9.33E-03
HuRI	BP	GO:0099637	neurotransmitter receptor transport	-	26	14	-	-	3.28E-04	1.33E-03
HuRI	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	22	-	-	1.37E-03	2.00E-03
HuRI	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	194	-	-	8.46E-03	1.73E-02
HuRI	BP	GO:0051785	positive regulation of nuclear division	-	61	32	-	-	7.58E-04	2.89E-03
HuRI	BP	GO:0060456	positive regulation of digestive system process	-	16	11	-	-	3.28E-04	1.00E-03
HuRI	BP	GO:0060749	mammary gland alveolus development	-	20	14	-	-	3.32E-04	1.33E-03
HuRI	BP	GO:0044786	cell cycle DNA replication	-	45	19	-	-	3.53E-02	1.78E-03
HuRI	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	12	-	-	3.31E-04	1.11E-03
HuRI	BP	GO:0048145	regulation of fibroblast proliferation	-	87	48	-	-	5.75E-03	4.33E-03
HuRI	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	34	-	-	7.68E-04	3.11E-03
HuRI	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	128	-	-	5.89E-03	1.14E-02
HuRI	BP	GO:0032098	regulation of appetite	-	20	14	-	-	3.30E-04	1.33E-03
HuRI	BP	GO:0009306	protein secretion	-	376	158	-	-	5.82E-03	1.41E-02
HuRI	CC	GO:0008333	endosome to lysosome transport	-	73	43	-	-	1.12E-02	3.89E-03
HuRI	BP	GO:0003016	respiratory system process	-	39	17	-	-	4.35E-04	1.56E-03
HuRI	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	13	-	-	1.76E-03	1.22E-03
HuRI	BP	GO:0045732	positive regulation of protein catabolic process	-	202	108	-	-	6.01E-03	9.67E-03
HuRI	BP	GO:0031589	cell-substrate adhesion	-	360	166	-	-	7.83E-03	1.48E-02
HuRI	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	30	-	-	3.32E-03	2.67E-03
HuRI	BP	GO:0007588	excretion	-	40	18	-	-	4.42E-04	1.67E-03
HuRI	BP	GO:1904018	positive regulation of vasculature development	-	185	61	-	-	1.58E-03	5.44E-03
HuRI	BP	GO:0010948	negative regulation of cell cycle process	-	317	161	-	-	1.12E-02	1.43E-02
HuRI	BP	GO:0050953	sensory perception of light stimulus	-	223	91	-	-	5.68E-03	8.11E-03
HuRI	BP	GO:0009164	nucleoside catabolic process	-	25	12	-	-	3.32E-04	1.11E-03
HuRI	BP	GO:0009303	rRNA transcription	-	37	16	-	-	4.42E-04	1.44E-03
HuRI	BP	GO:0035601	protein deacylation	-	56	31	-	-	2.62E-03	2.78E-03
HuRI	BP	GO:0061952	midbody abscission	-	18	16	-	-	2.19E-01	1.44E-03
HuRI	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	17	-	-	8.25E-03	1.56E-03
HuRI	BP	GO:0071300	cellular response to retinoic acid	-	66	28	-	-	1.02E-02	2.56E-03
HuRI	BP	GO:0045830	positive regulation of isotype switching	-	28	13	-	-	3.28E-04	1.22E-03
HuRI	BP	GO:0031069	hair follicle morphogenesis	-	33	15	-	-	5.28E-03	1.33E-03
HuRI	BP	GO:0046697	decidualization	-	26	11	-	-	3.31E-04	1.00E-03
HuRI	BP	GO:0051588	regulation of neurotransmitter transport	-	99	48	-	-	7.32E-03	4.33E-03
HuRI	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	12	-	-	3.31E-04	1.11E-03
HuRI	BP	GO:0051784	negative regulation of nuclear division	-	63	36	-	-	1.35E-02	3.22E-03
HuRI	BP	GO:0044703	multi-organism reproductive process	-	209	88	-	-	5.89E-03	7.89E-03
HuRI	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	76	-	-	4.24E-03	6.78E-03
HuRI	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	24	-	-	5.47E-04	2.22E-03
HuRI	BP	GO:0099022	vesicle tethering	-	32	22	-	-	1.12E-01	2.00E-03
HuRI	MF	GO:0004930	G protein-coupled receptor activity	-	873	138	-	-	3.39E-03	1.23E-02
HuRI	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	13	-	-	3.24E-04	1.22E-03
HuRI	BP	GO:0048857	neural nucleus development	-	65	33	-	-	7.60E-04	3.00E-03
HuRI	BP	GO:0048663	neuron fate commitment	-	74	36	-	-	1.04E-02	3.22E-03
HuRI	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	78	-	-	4.83E-03	7.00E-03
HuRI	BP	GO:0106027	neuron projection organization	-	90	36	-	-	1.08E-03	3.22E-03
HuRI	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	59	-	-	2.74E-03	5.33E-03
HuRI	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	18	-	-	4.37E-04	1.67E-03
HuRI	CC	GO:0043410	positive regulation of MAPK cascade	-	494	211	-	-	5.93E-03	1.88E-02
HuRI	BP	GO:0045685	regulation of glial cell differentiation	-	77	28	-	-	2.58E-03	2.56E-03
HuRI	BP	GO:0043414	macromolecule methylation	-	138	78	-	-	1.20E-02	7.00E-03
HuRI	BP	GO:0050886	endocrine process	-	93	44	-	-	9.74E-04	4.00E-03
HuRI	BP	GO:0045807	positive regulation of endocytosis	-	155	68	-	-	1.70E-03	6.11E-03
HuRI	BP	GO:0002418	immune response to tumor cell	-	29	13	-	-	3.29E-04	1.22E-03
HuRI	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	35	-	-	8.57E-04	3.11E-03
HuRI	BP	GO:0048308	organelle inheritance	-	14	12	-	-	2.91E-03	1.11E-03
HuRI	BP	GO:0001829	trophectodermal cell differentiation	-	19	14	-	-	4.18E-02	1.33E-03
HuRI	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	19	-	-	4.39E-04	1.78E-03
HuRI	BP	GO:0034394	protein localization to cell surface	-	69	39	-	-	1.65E-03	3.56E-03
HuRI	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	14	-	-	1.10E-01	1.33E-03
HuRI	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	12	-	-	3.31E-04	1.11E-03
HuRI	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	11	-	-	2.13E-03	1.00E-03
HuRI	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	52	-	-	1.19E-03	4.67E-03
HuRI	MF	GO:0051100	negative regulation of binding	-	161	91	-	-	3.26E-03	8.11E-03
HuRI	BP	GO:0001818	negative regulation of cytokine production	-	379	138	-	-	4.81E-03	1.23E-02
HuRI	BP	GO:0003151	outflow tract morphogenesis	-	81	36	-	-	6.02E-03	3.22E-03
HuRI	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	36	-	-	3.62E-03	3.22E-03
HuRI	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	26	-	-	6.52E-04	2.33E-03
HuRI	BP	GO:0046621	negative regulation of organ growth	-	39	12	-	-	5.74E-02	1.11E-03
HuRI	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	31	-	-	9.20E-03	2.78E-03
HuRI	BP	GO:0032368	regulation of lipid transport	-	149	69	-	-	1.50E-03	6.22E-03
HuRI	BP	GO:0055094	response to lipoprotein particle	-	34	15	-	-	4.39E-04	1.33E-03
HuRI	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	96	-	-	7.26E-03	8.55E-03
HuRI	BP	GO:0033002	muscle cell proliferation	-	249	96	-	-	4.52E-03	8.55E-03
HuRI	BP	GO:0048880	sensory system development	-	399	176	-	-	6.10E-03	1.57E-02
HuRI	BP	GO:0043331	response to dsRNA	-	56	32	-	-	7.65E-04	2.89E-03
HuRI	BP	GO:0051904	pigment granule transport	-	23	14	-	-	2.20E-02	1.33E-03
HuRI	BP	GO:1901679	nucleotide transmembrane transport	-	32	11	-	-	3.32E-04	1.00E-03
HuRI	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	18	-	-	5.36E-03	1.67E-03
HuRI	BP	GO:0033363	secretory granule organization	-	63	33	-	-	6.65E-03	3.00E-03
HuRI	BP	GO:0060479	lung cell differentiation	-	28	17	-	-	4.07E-03	1.56E-03
HuRI	BP	GO:0120009	intermembrane lipid transfer	-	52	23	-	-	5.49E-04	2.11E-03
HuRI	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	13	-	-	2.04E-01	1.22E-03
HuRI	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	16	-	-	4.39E-04	1.44E-03
HuRI	BP	GO:0033622	integrin activation	-	26	11	-	-	3.33E-04	1.00E-03
HuRI	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	27	-	-	6.55E-04	2.44E-03
HuRI	BP	GO:0050820	positive regulation of coagulation	-	30	14	-	-	3.30E-04	1.33E-03
HuRI	BP	GO:0072164	mesonephric tubule development	-	98	42	-	-	1.63E-02	3.78E-03
HuRI	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	55	-	-	1.29E-03	4.89E-03
HuRI	BP	GO:0030901	midbrain development	-	87	38	-	-	8.55E-04	3.44E-03
HuRI	BP	GO:0007162	negative regulation of cell adhesion	-	310	139	-	-	7.23E-03	1.24E-02
HuRI	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	35	-	-	3.82E-03	3.11E-03
HuRI	BP	GO:0002687	positive regulation of leukocyte migration	-	147	75	-	-	3.53E-03	6.67E-03
HuRI	BP	GO:0019755	one-carbon compound transport	-	28	22	-	-	1.40E-01	2.00E-03
HuRI	BP	GO:0110154	RNA decapping	-	19	12	-	-	5.33E-02	1.11E-03
HuRI	BP	GO:0034605	cellular response to heat	-	66	29	-	-	2.52E-02	2.67E-03
HuRI	BP	GO:0005996	monosaccharide metabolic process	-	250	112	-	-	5.38E-03	1.00E-02
HuRI	BP	GO:0033555	multicellular organismal response to stress	-	90	32	-	-	7.64E-04	2.89E-03
HuRI	BP	GO:0002262	myeloid cell homeostasis	-	172	89	-	-	1.25E-02	8.00E-03
HuRI	BP	GO:0000966	RNA 5'-end processing	-	39	24	-	-	1.76E-01	2.22E-03
HuRI	BP	GO:0050688	regulation of defense response to virus	-	65	34	-	-	7.64E-04	3.11E-03
HuRI	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	159	-	-	8.05E-03	1.42E-02
HuRI	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	12	-	-	9.00E-03	1.11E-03
HuRI	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	126	-	-	1.71E-02	1.12E-02
HuRI	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	17	-	-	4.39E-04	1.56E-03
HuRI	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	12	-	-	3.31E-04	1.11E-03
HuRI	BP	GO:0003272	endocardial cushion formation	-	28	15	-	-	4.39E-04	1.33E-03
HuRI	BP	GO:0022618	protein-RNA complex assembly	-	227	126	-	-	3.21E-02	1.12E-02
HuRI	BP	GO:0051147	regulation of muscle cell differentiation	-	162	69	-	-	5.88E-03	6.22E-03
HuRI	BP	GO:0006066	alcohol metabolic process	-	374	144	-	-	6.52E-03	1.29E-02
HuRI	BP	GO:0090102	cochlea development	-	50	21	-	-	5.28E-02	1.89E-03
HuRI	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	13	-	-	3.31E-04	1.22E-03
HuRI	BP	GO:0045933	positive regulation of muscle contraction	-	49	16	-	-	4.40E-04	1.44E-03
HuRI	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	65	-	-	2.01E-01	5.78E-03
HuRI	BP	GO:0043555	regulation of translation in response to stress	-	22	11	-	-	3.27E-04	1.00E-03
HuRI	BP	GO:0032922	circadian regulation of gene expression	-	71	43	-	-	1.67E-02	3.89E-03
HuRI	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	16	-	-	2.91E-03	1.44E-03
HuRI	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	54	-	-	1.72E-03	4.89E-03
HuRI	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	22	-	-	9.65E-04	2.00E-03
HuRI	BP	GO:0038179	neurotrophin signaling pathway	-	38	25	-	-	1.38E-03	2.22E-03
HuRI	BP	GO:0140253	cell-cell fusion	-	62	28	-	-	9.84E-04	2.56E-03
HuRI	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	13	-	-	3.31E-04	1.22E-03
HuRI	BP	GO:0061635	regulation of protein complex stability	-	14	11	-	-	3.30E-04	1.00E-03
HuRI	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	27	-	-	6.60E-04	2.44E-03
HuRI	BP	GO:0001941	postsynaptic membrane organization	-	37	14	-	-	3.30E-04	1.33E-03
HuRI	BP	GO:0051293	establishment of spindle localization	-	57	32	-	-	3.41E-03	2.89E-03
HuRI	BP	GO:0023061	signal release	-	491	226	-	-	8.84E-03	2.01E-02
HuRI	BP	GO:0043114	regulation of vascular permeability	-	49	14	-	-	3.29E-04	1.33E-03
HuRI	BP	GO:0018126	protein hydroxylation	-	26	13	-	-	3.08E-02	1.22E-03
HuRI	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	26	-	-	6.61E-04	2.33E-03
HuRI	BP	GO:0008360	regulation of cell shape	-	139	67	-	-	2.02E-03	6.00E-03
HuRI	BP	GO:0051222	positive regulation of protein transport	-	249	120	-	-	4.47E-03	1.07E-02
HuRI	CC	GO:0140632	canonical inflammasome complex assembly	-	40	13	-	-	3.32E-04	1.22E-03
HuRI	MF	GO:0034260	negative regulation of GTPase activity	-	36	19	-	-	3.84E-03	1.78E-03
HuRI	BP	GO:0045739	positive regulation of DNA repair	-	128	73	-	-	1.34E-02	6.55E-03
HuRI	BP	GO:0001845	phagolysosome assembly	-	19	11	-	-	3.33E-04	1.00E-03
HuRI	BP	GO:0045185	maintenance of protein location	-	95	52	-	-	2.35E-03	4.67E-03
HuRI	BP	GO:0003158	endothelium development	-	140	59	-	-	2.25E-03	5.33E-03
HuRI	CC	GO:0072595	maintenance of protein localization in organelle	-	42	22	-	-	4.06E-03	2.00E-03
HuRI	BP	GO:0051224	negative regulation of protein transport	-	122	57	-	-	2.64E-03	5.11E-03
HuRI	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	79	-	-	3.07E-03	7.11E-03
HuRI	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	15	-	-	4.42E-04	1.33E-03
HuRI	MF	GO:0003713	transcription coactivator activity	-	281	156	-	-	5.83E-03	1.39E-02
HuRI	BP	GO:0021885	forebrain cell migration	-	63	28	-	-	9.49E-04	2.56E-03
HuRI	BP	GO:0007405	neuroblast proliferation	-	81	37	-	-	8.60E-04	3.33E-03
HuRI	BP	GO:0009581	detection of external stimulus	-	137	44	-	-	1.13E-03	4.00E-03
HuRI	BP	GO:1990542	mitochondrial transmembrane transport	-	93	39	-	-	3.18E-02	3.56E-03
HuRI	BP	GO:0045862	positive regulation of proteolysis	-	353	190	-	-	1.13E-02	1.69E-02
HuRI	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	20	-	-	1.37E-02	1.78E-03
HuRI	BP	GO:0097186	amelogenesis	-	26	12	-	-	3.31E-04	1.11E-03
HuRI	BP	GO:0031100	animal organ regeneration	-	66	29	-	-	6.55E-04	2.67E-03
HuRI	BP	GO:0045684	positive regulation of epidermis development	-	33	16	-	-	4.40E-04	1.44E-03
HuRI	BP	GO:1900047	negative regulation of hemostasis	-	51	23	-	-	5.49E-04	2.11E-03
HuRI	BP	GO:0021517	ventral spinal cord development	-	47	25	-	-	6.39E-04	2.22E-03
HuRI	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	45	-	-	2.43E-02	4.00E-03
HuRI	BP	GO:0097722	sperm motility	-	133	56	-	-	5.04E-03	5.00E-03
HuRI	BP	GO:0042490	mechanoreceptor differentiation	-	67	21	-	-	2.98E-03	1.89E-03
HuRI	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	18	-	-	4.41E-04	1.67E-03
HuRI	BP	GO:0035148	tube formation	-	155	72	-	-	2.29E-03	6.44E-03
HuRI	BP	GO:0048520	positive regulation of behavior	-	27	14	-	-	3.31E-04	1.33E-03
HuRI	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	20	-	-	4.09E-02	1.78E-03
HuRI	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	64	-	-	6.02E-03	5.78E-03
HuRI	BP	GO:0031123	RNA 3'-end processing	-	79	38	-	-	3.78E-03	3.44E-03
HuRI	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	60	-	-	4.08E-03	5.33E-03
HuRI	CC	GO:0007097	nuclear migration	-	24	14	-	-	4.56E-03	1.33E-03
HuRI	BP	GO:0045229	external encapsulating structure organization	-	319	108	-	-	3.21E-03	9.67E-03
HuRI	BP	GO:0006885	regulation of pH	-	104	48	-	-	7.11E-03	4.33E-03
HuRI	BP	GO:0001667	ameboidal-type cell migration	-	495	187	-	-	6.06E-03	1.67E-02
HuRI	BP	GO:0031018	endocrine pancreas development	-	47	17	-	-	3.09E-02	1.56E-03
HuRI	BP	GO:0001708	cell fate specification	-	108	49	-	-	1.01E-02	4.44E-03
HuRI	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	38	-	-	2.10E-03	3.44E-03
HuRI	BP	GO:0030279	negative regulation of ossification	-	39	19	-	-	4.41E-04	1.78E-03
HuRI	BP	GO:0032970	regulation of actin filament-based process	-	368	171	-	-	7.72E-03	1.52E-02
HuRI	BP	GO:0042440	pigment metabolic process	-	80	28	-	-	3.13E-03	2.56E-03
HuRI	BP	GO:1901606	alpha-amino acid catabolic process	-	101	42	-	-	1.57E-02	3.78E-03
HuRI	BP	GO:0062197	cellular response to chemical stress	-	299	144	-	-	4.50E-03	1.29E-02
HuRI	BP	GO:1901890	positive regulation of cell junction assembly	-	106	42	-	-	1.40E-03	3.78E-03
HuRI	BP	GO:1901655	cellular response to ketone	-	107	44	-	-	1.75E-03	4.00E-03
HuRI	BP	GO:0006968	cellular defense response	-	52	27	-	-	4.72E-03	2.44E-03
HuRI	BP	GO:0055006	cardiac cell development	-	93	36	-	-	1.18E-03	3.22E-03
HuRI	BP	GO:0031365	N-terminal protein amino acid modification	-	30	16	-	-	4.41E-04	1.44E-03
HuRI	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	16	-	-	4.40E-04	1.44E-03
HuRI	BP	GO:0060004	reflex	-	63	31	-	-	7.70E-04	2.78E-03
HuRI	BP	GO:0044706	multi-multicellular organism process	-	217	94	-	-	4.81E-03	8.44E-03
HuRI	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	90	-	-	4.90E-03	8.00E-03
HuRI	BP	GO:0006026	aminoglycan catabolic process	-	34	13	-	-	3.31E-04	1.22E-03
HuRI	BP	GO:0031294	lymphocyte costimulation	-	47	18	-	-	4.38E-04	1.67E-03
HuRI	BP	GO:0050768	negative regulation of neurogenesis	-	150	58	-	-	1.27E-03	5.22E-03
HuRI	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	63	-	-	2.02E-03	5.67E-03
HuRI	BP	GO:0090068	positive regulation of cell cycle process	-	262	126	-	-	6.26E-03	1.12E-02
HuRI	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	16	-	-	2.35E-02	1.44E-03
HuRI	BP	GO:1902115	regulation of organelle assembly	-	210	123	-	-	3.48E-03	1.10E-02
HuRI	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	31	-	-	7.59E-04	2.78E-03
HuRI	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	63	-	-	2.35E-03	5.67E-03
HuRI	BP	GO:0046622	positive regulation of organ growth	-	52	17	-	-	4.38E-04	1.56E-03
HuRI	BP	GO:0051952	regulation of amine transport	-	98	49	-	-	1.39E-03	4.44E-03
HuRI	BP	GO:0006730	one-carbon metabolic process	-	24	15	-	-	4.03E-02	1.33E-03
HuRI	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	11	-	-	8.60E-03	1.00E-03
HuRI	CC	GO:0032365	intracellular lipid transport	-	51	23	-	-	5.44E-04	2.11E-03
HuRI	BP	GO:0045048	protein insertion into ER membrane	-	30	20	-	-	1.99E-02	1.78E-03
HuRI	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	29	-	-	7.83E-03	2.67E-03
HuRI	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	56	-	-	6.33E-03	5.00E-03
HuRI	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	16	-	-	4.28E-04	1.44E-03
HuRI	BP	GO:0071398	cellular response to fatty acid	-	35	16	-	-	4.34E-04	1.44E-03
HuRI	BP	GO:0097581	lamellipodium organization	-	91	46	-	-	5.31E-03	4.11E-03
HuRI	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	23	-	-	6.68E-02	2.11E-03
HuRI	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	128	-	-	1.12E-02	1.14E-02
HuRI	BP	GO:0060326	cell chemotaxis	-	311	141	-	-	4.55E-03	1.26E-02
HuRI	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	12	-	-	3.26E-04	1.11E-03
HuRI	BP	GO:0015669	gas transport	-	23	20	-	-	2.32E-01	1.78E-03
HuRI	BP	GO:0016485	protein processing	-	248	94	-	-	7.98E-03	8.44E-03
HuRI	BP	GO:0009649	entrainment of circadian clock	-	30	17	-	-	2.27E-03	1.56E-03
HuRI	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	51	-	-	1.36E-03	4.56E-03
HuRI	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	55	-	-	2.57E-02	4.89E-03
HuRI	BP	GO:0099054	presynapse assembly	-	49	16	-	-	4.33E-04	1.44E-03
HuRI	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	13	-	-	3.30E-04	1.22E-03
HuRI	BP	GO:0031348	negative regulation of defense response	-	282	117	-	-	4.74E-03	1.04E-02
HuRI	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	36	-	-	1.36E-03	3.22E-03
HuRI	BP	GO:0007606	sensory perception of chemical stimulus	-	535	44	-	-	7.32E-03	4.00E-03
HuRI	BP	GO:0061180	mammary gland epithelium development	-	68	29	-	-	1.70E-03	2.67E-03
HuRI	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	186	-	-	6.53E-03	1.66E-02
HuRI	CC	GO:0051169	nuclear transport	-	325	186	-	-	2.30E-02	1.66E-02
HuRI	BP	GO:0071496	cellular response to external stimulus	-	74	33	-	-	4.03E-03	3.00E-03
HuRI	BP	GO:0032094	response to food	-	37	18	-	-	4.39E-04	1.67E-03
HuRI	BP	GO:0007340	acrosome reaction	-	38	20	-	-	5.47E-04	1.78E-03
HuRI	BP	GO:0046434	organophosphate catabolic process	-	232	109	-	-	5.27E-03	9.78E-03
HuRI	BP	GO:0060037	pharyngeal system development	-	29	13	-	-	3.32E-04	1.22E-03
HuRI	BP	GO:0009566	fertilization	-	205	88	-	-	3.28E-03	7.89E-03
HuRI	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	26	-	-	1.09E-01	2.33E-03
HuRI	BP	GO:0033044	regulation of chromosome organization	-	249	135	-	-	8.40E-03	1.20E-02
HuRI	BP	GO:0009309	amine biosynthetic process	-	38	19	-	-	2.45E-02	1.78E-03
HuRI	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	172	-	-	6.31E-03	1.53E-02
HuRI	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	11	-	-	3.31E-04	1.00E-03
HuRI	BP	GO:0061900	glial cell activation	-	56	22	-	-	5.46E-04	2.00E-03
HuRI	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	55	-	-	2.61E-03	4.89E-03
HuRI	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	11	-	-	3.31E-04	1.00E-03
HuRI	CC	GO:0140467	integrated stress response signaling	-	41	26	-	-	5.21E-03	2.33E-03
HuRI	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	176	-	-	2.26E-02	1.57E-02
HuRI	BP	GO:0043647	inositol phosphate metabolic process	-	44	20	-	-	5.52E-04	1.78E-03
HuRI	BP	GO:0016180	snRNA processing	-	28	15	-	-	3.02E-03	1.33E-03
HuRI	BP	GO:0051303	establishment of chromosome localization	-	104	63	-	-	6.58E-03	5.67E-03
HuRI	BP	GO:0031349	positive regulation of defense response	-	473	205	-	-	7.73E-03	1.82E-02
HuRI	BP	GO:0007164	establishment of tissue polarity	-	38	13	-	-	3.08E-03	1.22E-03
HuRI	BP	GO:0021515	cell differentiation in spinal cord	-	51	24	-	-	5.37E-04	2.22E-03
HuRI	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	14	-	-	3.26E-04	1.33E-03
HuRI	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	15	-	-	5.60E-02	1.33E-03
HuRI	BP	GO:0006605	protein targeting	-	327	182	-	-	6.28E-03	1.62E-02
HuRI	BP	GO:0007566	embryo implantation	-	57	30	-	-	1.49E-03	2.67E-03
HuRI	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	14	-	-	3.32E-04	1.33E-03
HuRI	BP	GO:0061512	protein localization to cilium	-	394	200	-	-	1.45E-02	1.78E-02
HuRI	BP	GO:0060306	regulation of membrane repolarization	-	38	17	-	-	4.40E-04	1.56E-03
HuRI	BP	GO:0051017	actin filament bundle assembly	-	161	88	-	-	4.69E-03	7.89E-03
HuRI	BP	GO:1905953	negative regulation of lipid localization	-	63	27	-	-	6.52E-04	2.44E-03
HuRI	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	16	-	-	1.25E-01	1.44E-03
HuRI	BP	GO:0021756	striatum development	-	21	11	-	-	3.32E-04	1.00E-03
HuRI	BP	GO:1901343	negative regulation of vasculature development	-	154	46	-	-	1.84E-03	4.11E-03
HuRI	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	91	-	-	7.86E-03	8.11E-03
HuRI	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	12	-	-	3.31E-04	1.11E-03
HuRI	BP	GO:1902414	protein localization to cell junction	-	107	44	-	-	3.85E-03	4.00E-03
HuRI	BP	GO:0051304	chromosome separation	-	80	43	-	-	6.94E-03	3.89E-03
HuRI	BP	GO:0090596	sensory organ morphogenesis	-	272	109	-	-	4.29E-03	9.78E-03
HuRI	BP	GO:0048709	oligodendrocyte differentiation	-	101	40	-	-	9.65E-04	3.56E-03
HuRI	BP	GO:0045017	glycerolipid biosynthetic process	-	254	106	-	-	2.73E-02	9.44E-03
HuRI	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	12	-	-	4.78E-02	1.11E-03
HuRI	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	11	-	-	2.14E-03	1.00E-03
HuRI	BP	GO:0001776	leukocyte homeostasis	-	108	56	-	-	1.28E-03	5.00E-03
HuRI	BP	GO:0050769	positive regulation of neurogenesis	-	240	92	-	-	2.35E-03	8.22E-03
HuRI	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	12	-	-	9.31E-02	1.11E-03
HuRI	BP	GO:0030193	regulation of blood coagulation	-	70	29	-	-	6.55E-04	2.67E-03
HuRI	BP	GO:0050866	negative regulation of cell activation	-	216	101	-	-	6.34E-03	9.00E-03
HuRI	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	23	-	-	2.12E-03	2.11E-03
HuRI	BP	GO:0033500	carbohydrate homeostasis	-	251	112	-	-	5.04E-03	1.00E-02
HuRI	BP	GO:0044088	regulation of vacuole organization	-	56	36	-	-	9.19E-03	3.22E-03
HuRI	CC	GO:0051457	maintenance of protein location in nucleus	-	23	12	-	-	8.11E-03	1.11E-03
HuRI	CC	GO:0000791	euchromatin	-	60	31	-	-	7.59E-04	2.78E-03
HuRI	CC	GO:0030666	endocytic vesicle membrane	-	196	99	-	-	3.25E-03	8.89E-03
HuRI	CC	GO:0098857	membrane microdomain	-	324	139	-	-	8.89E-03	1.24E-02
HuRI	CC	GO:0030312	external encapsulating structure	-	567	177	-	-	5.11E-03	1.58E-02
HuRI	CC	GO:1990752	microtubule end	-	34	19	-	-	7.85E-03	1.78E-03
HuRI	CC	GO:0043204	perikaryon	-	156	78	-	-	2.11E-03	7.00E-03
HuRI	CC	GO:0097542	ciliary tip	-	48	23	-	-	1.09E-02	2.11E-03
HuRI	CC	GO:1905368	peptidase complex	-	124	78	-	-	5.24E-02	7.00E-03
HuRI	CC	GO:0000792	heterochromatin	-	98	47	-	-	1.23E-02	4.22E-03
HuRI	CC	GO:0097546	ciliary base	-	47	29	-	-	4.46E-03	2.67E-03
HuRI	CC	GO:0071819	DUBm complex	-	25	12	-	-	1.53E-01	1.11E-03
HuRI	CC	GO:0031201	SNARE complex	-	48	37	-	-	1.05E-01	3.33E-03
HuRI	CC	GO:0016324	apical plasma membrane	-	392	163	-	-	1.36E-02	1.46E-02
HuRI	CC	GO:0033260	nuclear DNA replication	-	40	16	-	-	1.69E-02	1.44E-03
HuRI	CC	GO:0044391	ribosomal subunit	-	203	94	-	-	1.09E-02	8.44E-03
HuRI	CC	GO:0071013	catalytic step 2 spliceosome	-	88	58	-	-	2.15E-02	5.22E-03
HuRI	CC	GO:0031907	microbody lumen	-	51	22	-	-	3.83E-03	2.00E-03
HuRI	CC	GO:0098862	cluster of actin-based cell projections	-	162	67	-	-	6.21E-03	6.00E-03
HuRI	CC	GO:0098978	glutamatergic synapse	-	411	179	-	-	1.03E-02	1.60E-02
HuRI	CC	GO:0016363	nuclear matrix	-	127	76	-	-	4.64E-03	6.78E-03
HuRI	CC	GO:0031261	DNA replication preinitiation complex	-	46	23	-	-	8.45E-02	2.11E-03
HuRI	CC	GO:0097060	synaptic membrane	-	413	135	-	-	5.83E-03	1.20E-02
HuRI	CC	GO:0032432	actin filament bundle	-	249	128	-	-	7.31E-03	1.14E-02
HuRI	CC	GO:0008088	axo-dendritic transport	-	78	40	-	-	7.32E-03	3.56E-03
HuRI	CC	GO:0031519	PcG protein complex	-	38	28	-	-	1.43E-01	2.56E-03
HuRI	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	27	-	-	4.02E-03	2.44E-03
HuRI	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	117	-	-	1.45E-02	1.04E-02
HuRI	CC	GO:0000313	organellar ribosome	-	89	38	-	-	2.52E-02	3.44E-03
HuRI	CC	GO:0098791	Golgi apparatus subcompartment	-	378	172	-	-	6.57E-03	1.53E-02
HuRI	CC	GO:0099643	signal release from synapse	-	147	75	-	-	1.14E-02	6.67E-03
HuRI	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	30	-	-	5.14E-02	2.67E-03
HuRI	CC	GO:0030018	Z disc	-	129	78	-	-	5.94E-03	7.00E-03
HuRI	CC	GO:0032580	Golgi cisterna membrane	-	93	33	-	-	7.42E-04	3.00E-03
HuRI	CC	GO:1905360	GTPase complex	-	41	19	-	-	4.17E-02	1.78E-03
HuRI	CC	GO:0097540	axonemal central pair	-	161	82	-	-	1.27E-02	7.33E-03
HuRI	CC	GO:0042641	actomyosin	-	77	49	-	-	6.34E-03	4.44E-03
HuRI	CC	GO:0097386	glial cell projection	-	38	21	-	-	5.47E-04	1.89E-03
HuRI	CC	GO:0032588	trans-Golgi network membrane	-	102	55	-	-	1.14E-02	4.89E-03
HuRI	CC	GO:0070382	exocytic vesicle	-	224	125	-	-	9.24E-03	1.11E-02
HuRI	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	18	-	-	4.39E-04	1.67E-03
HuRI	CC	GO:0031903	microbody membrane	-	65	29	-	-	4.46E-02	2.67E-03
HuRI	CC	GO:0046930	pore complex	-	26	13	-	-	3.30E-04	1.22E-03
HuRI	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	138	-	-	1.28E-02	1.23E-02
HuRI	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	11	-	-	8.80E-03	1.00E-03
HuRI	CC	GO:0051882	mitochondrial depolarization	-	21	11	-	-	3.32E-04	1.00E-03
HuRI	CC	GO:0070993	translation preinitiation complex	-	19	15	-	-	8.09E-02	1.33E-03
HuRI	CC	GO:0010369	chromocenter	-	14	11	-	-	3.28E-04	1.00E-03
HuRI	CC	GO:0002177	manchette	-	19	11	-	-	7.25E-02	1.00E-03
HuRI	CC	GO:0016323	basolateral plasma membrane	-	239	97	-	-	4.19E-03	8.67E-03
HuRI	CC	GO:0042645	mitochondrial nucleoid	-	45	15	-	-	4.42E-04	1.33E-03
HuRI	CC	GO:1902495	transmembrane transporter complex	-	408	155	-	-	9.31E-03	1.38E-02
HuRI	CC	GO:0098636	protein complex involved in cell adhesion	-	57	16	-	-	4.37E-04	1.44E-03
HuRI	CC	GO:0001917	photoreceptor inner segment	-	71	27	-	-	6.50E-04	2.44E-03
HuRI	CC	GO:0098845	postsynaptic endosome	-	14	11	-	-	1.70E-03	1.00E-03
HuRI	CC	GO:0019897	extrinsic component of plasma membrane	-	156	74	-	-	3.74E-03	6.67E-03
HuRI	CC	GO:0031594	neuromuscular junction	-	73	35	-	-	4.00E-03	3.11E-03
HuRI	CC	GO:0000793	condensed chromosome	-	274	145	-	-	7.03E-03	1.29E-02
HuRI	CC	GO:0000922	spindle pole	-	172	104	-	-	4.06E-03	9.33E-03
HuRI	CC	GO:0120111	neuron projection cytoplasm	-	94	46	-	-	5.34E-03	4.11E-03
HuRI	CC	GO:0070971	endoplasmic reticulum exit site	-	32	17	-	-	8.42E-02	1.56E-03
HuRI	CC	GO:0004879	nuclear receptor activity	-	63	38	-	-	3.92E-02	3.44E-03
HuRI	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	96	-	-	1.21E-02	8.55E-03
HuRI	CC	GO:0000123	histone acetyltransferase complex	-	93	52	-	-	5.80E-02	4.67E-03
HuRI	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	50	-	-	3.88E-02	4.44E-03
HuRI	CC	GO:0048786	presynaptic active zone	-	80	32	-	-	4.70E-03	2.89E-03
HuRI	CC	GO:0007034	vacuolar transport	-	168	98	-	-	2.17E-02	8.78E-03
HuRI	CC	GO:0005776	autophagosome	-	111	69	-	-	1.90E-02	6.22E-03
HuRI	CC	GO:0031430	M band	-	22	11	-	-	3.31E-04	1.00E-03
HuRI	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	47	-	-	1.06E-01	4.22E-03
HuRI	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	43	-	-	1.19E-02	3.89E-03
HuRI	CC	GO:0032994	protein-lipid complex	-	39	19	-	-	4.41E-04	1.78E-03
HuRI	CC	GO:0150034	distal axon	-	309	142	-	-	5.48E-03	1.27E-02
HuRI	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	107	-	-	4.19E-02	9.55E-03
HuRI	CC	GO:0071012	catalytic step 1 spliceosome	-	12	11	-	-	3.09E-02	1.00E-03
HuRI	CC	GO:0072562	blood microparticle	-	144	53	-	-	6.71E-03	4.78E-03
HuRI	CC	GO:0051233	spindle midzone	-	36	19	-	-	5.43E-03	1.78E-03
HuRI	CC	GO:0005811	lipid droplet	-	102	53	-	-	4.09E-03	4.78E-03
HuRI	CC	GO:0045022	early endosome to late endosome transport	-	44	25	-	-	2.29E-02	2.22E-03
HuRI	CC	GO:0043113	receptor clustering	-	51	24	-	-	1.15E-03	2.22E-03
HuRI	CC	GO:0005940	septin ring	-	14	11	-	-	6.50E-01	1.00E-03
HuRI	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	11	-	-	3.32E-04	1.00E-03
HuRI	CC	GO:0044853	plasma membrane raft	-	114	50	-	-	3.01E-03	4.44E-03
HuRI	CC	GO:0005881	cytoplasmic microtubule	-	256	131	-	-	9.91E-03	1.17E-02
HuRI	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	11	-	-	3.31E-04	1.00E-03
HuRI	CC	GO:0008180	COP9 signalosome	-	17	13	-	-	4.35E-02	1.22E-03
HuRI	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	29	-	-	1.02E-02	2.67E-03
HuRI	CC	GO:0005905	clathrin-coated pit	-	73	36	-	-	1.24E-02	3.22E-03
HuRI	CC	GO:0031904	endosome lumen	-	38	18	-	-	4.41E-04	1.67E-03
HuRI	CC	GO:0060170	ciliary membrane	-	76	26	-	-	4.92E-02	2.33E-03
HuRI	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	14	-	-	2.55E-01	1.33E-03
HuRI	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	13	-	-	7.25E-02	1.22E-03
HuRI	CC	GO:0032154	cleavage furrow	-	54	26	-	-	1.58E-03	2.33E-03
HuRI	CC	GO:0005640	nuclear outer membrane	-	30	11	-	-	1.66E-03	1.00E-03
HuRI	CC	GO:0007006	mitochondrial membrane organization	-	117	65	-	-	9.61E-03	5.78E-03
HuRI	CC	GO:0001772	immunological synapse	-	44	25	-	-	3.77E-03	2.22E-03
HuRI	CC	GO:0030904	retromer complex	-	12	11	-	-	2.09E-01	1.00E-03
HuRI	CC	GO:0009897	external side of plasma membrane	-	425	136	-	-	8.17E-03	1.21E-02
HuRI	CC	GO:0030863	cortical cytoskeleton	-	104	44	-	-	9.13E-03	4.00E-03
HuRI	CC	GO:1905348	endonuclease complex	-	38	17	-	-	8.40E-02	1.56E-03
HuRI	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	6.85E-01	1.00E-03
HuRI	CC	GO:0061638	CENP-A containing chromatin	-	18	17	-	-	4.45E-04	1.56E-03
HuRI	CC	GO:0030315	T-tubule	-	52	25	-	-	6.60E-04	2.22E-03
HuRI	CC	GO:0060076	excitatory synapse	-	64	19	-	-	4.39E-04	1.78E-03
HuRI	CC	GO:0001891	phagocytic cup	-	28	17	-	-	1.63E-02	1.56E-03
HuRI	CC	GO:0099086	synaptonemal structure	-	40	23	-	-	2.96E-03	2.11E-03
HuRI	CC	GO:0030427	site of polarized growth	-	172	86	-	-	5.30E-03	7.67E-03
HuRI	CC	GO:0044309	neuron spine	-	213	96	-	-	7.98E-03	8.55E-03
HuRI	CC	GO:0030658	transport vesicle membrane	-	231	127	-	-	1.11E-02	1.13E-02
HuRI	CC	GO:0000940	outer kinetochore	-	17	12	-	-	3.18E-01	1.11E-03
HuRI	CC	GO:0034719	SMN-Sm protein complex	-	18	15	-	-	1.31E-01	1.33E-03
HuRI	CC	GO:0044232	organelle membrane contact site	-	50	28	-	-	1.22E-03	2.56E-03
HuRI	CC	GO:0098803	respiratory chain complex	-	39	14	-	-	3.32E-04	1.33E-03
HuRI	CC	GO:0030667	secretory granule membrane	-	319	154	-	-	6.35E-03	1.38E-02
HuRI	CC	GO:0097545	axonemal outer doublet	-	164	84	-	-	1.28E-02	7.55E-03
HuRI	CC	GO:0070069	cytochrome complex	-	42	14	-	-	3.32E-04	1.33E-03
HuRI	CC	GO:0031143	pseudopodium	-	18	14	-	-	1.71E-02	1.33E-03
HuRI	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	16	-	-	1.77E-01	1.44E-03
HuRI	CC	GO:0055037	recycling endosome	-	200	99	-	-	2.56E-02	8.89E-03
HuRI	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	39	-	-	5.13E-03	3.56E-03
HuRI	CC	GO:0030684	preribosome	-	76	42	-	-	5.64E-03	3.78E-03
HuRI	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	164	-	-	8.87E-03	1.47E-02
HuRI	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	13	-	-	6.03E-02	1.22E-03
HuRI	CC	GO:1990391	DNA repair complex	-	22	12	-	-	1.32E-01	1.11E-03
HuRI	CC	GO:0005775	vacuolar lumen	-	176	73	-	-	1.68E-03	6.55E-03
HuRI	CC	GO:0016327	apicolateral plasma membrane	-	23	14	-	-	1.45E-03	1.33E-03
HuRI	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	12	-	-	1.05E-01	1.11E-03
HuRI	CC	GO:0044306	neuron projection terminus	-	164	69	-	-	6.09E-03	6.22E-03
HuRI	CC	GO:0034455	t-UTP complex	-	53	27	-	-	6.60E-04	2.44E-03
HuRI	CC	GO:0005770	late endosome	-	299	166	-	-	1.16E-02	1.48E-02
HuRI	CC	GO:0031970	organelle envelope lumen	-	94	46	-	-	2.23E-03	4.11E-03
HuRI	CC	GO:0019866	organelle inner membrane	-	546	230	-	-	1.93E-02	2.04E-02
HuRI	CC	GO:0098687	chromosomal region	-	397	228	-	-	1.42E-02	2.03E-02
HuRI	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	17	-	-	4.38E-04	1.56E-03
HuRI	CC	GO:0043292	contractile muscle fiber	-	245	140	-	-	8.76E-03	1.24E-02
HuRI	CC	GO:0018995	host cellular component	-	12	11	-	-	3.30E-04	1.00E-03
HuRI	CC	GO:0034709	methylosome	-	13	12	-	-	2.12E-01	1.11E-03
HuRI	CC	GO:0000803	sex chromosome	-	32	20	-	-	1.00E-02	1.78E-03
HuRI	CC	GO:0098982	GABA-ergic synapse	-	84	24	-	-	8.54E-03	2.22E-03
HuRI	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	14	-	-	5.93E-02	1.33E-03
HuRI	CC	GO:0035097	histone methyltransferase complex	-	63	32	-	-	1.83E-02	2.89E-03
HuRI	CC	GO:1903293	phosphatase complex	-	54	25	-	-	6.31E-02	2.22E-03
HuRI	CC	GO:0031941	filamentous actin	-	27	14	-	-	3.31E-04	1.33E-03
HuRI	CC	GO:0000786	nucleosome	-	149	86	-	-	1.61E-02	7.67E-03
HuRI	CC	GO:0001533	cornified envelope	-	59	24	-	-	3.26E-03	2.22E-03
HuRI	CC	GO:1904724	tertiary granule lumen	-	55	21	-	-	1.96E-02	1.89E-03
HuRI	CC	GO:0030027	lamellipodium	-	202	101	-	-	8.62E-03	9.00E-03
HuRI	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	15	-	-	4.38E-04	1.33E-03
HuRI	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	12	-	-	2.45E-01	1.11E-03
HuRI	CC	GO:0002102	podosome	-	31	15	-	-	2.98E-03	1.33E-03
HuRI	CC	GO:0090543	Flemming body	-	33	19	-	-	2.25E-02	1.78E-03
HuRI	CC	GO:0016328	lateral plasma membrane	-	66	32	-	-	2.32E-03	2.89E-03
HuRI	CC	GO:0001650	fibrillar center	-	151	82	-	-	3.80E-03	7.33E-03
HuRI	CC	GO:1990204	oxidoreductase complex	-	90	40	-	-	1.94E-02	3.56E-03
HuRI	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	70	-	-	4.12E-03	6.22E-03
HuRI	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	14	-	-	5.00E-01	1.33E-03
HuRI	CC	GO:0001726	ruffle	-	181	95	-	-	8.72E-03	8.44E-03
HuRI	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	11	-	-	4.51E-02	1.00E-03
HuRI	CC	GO:0043198	dendritic shaft	-	38	19	-	-	2.56E-03	1.78E-03
HuRI	CC	GO:0043073	germ cell nucleus	-	67	29	-	-	6.43E-04	2.67E-03
HuRI	CC	GO:0005788	endoplasmic reticulum lumen	-	313	127	-	-	4.50E-03	1.13E-02
HuRI	CC	GO:0016592	mediator complex	-	38	20	-	-	1.35E-02	1.78E-03
HuRI	CC	GO:0022626	cytosolic ribosome	-	118	59	-	-	1.49E-02	5.33E-03
HuRI	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	30	-	-	1.83E-01	2.67E-03
HuRI	CC	GO:0034451	centriolar satellite	-	120	70	-	-	3.49E-03	6.22E-03
HuRI	CC	GO:0045171	intercellular bridge	-	91	44	-	-	3.10E-02	4.00E-03
HuRI	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	45	-	-	2.93E-03	4.00E-03
HuRI	CC	GO:0098984	neuron to neuron synapse	-	384	165	-	-	1.02E-02	1.47E-02
HuRI	CC	GO:0030527	structural constituent of chromatin	-	97	57	-	-	3.63E-02	5.11E-03
HuRI	CC	GO:0036379	myofilament	-	26	17	-	-	1.27E-01	1.56E-03
HuRI	CC	GO:0030286	dynein complex	-	210	112	-	-	2.06E-02	1.00E-02
HuRI	CC	GO:0031105	septin complex	-	14	11	-	-	8.30E-01	1.00E-03
HuRI	CC	GO:0097228	sperm principal piece	-	33	12	-	-	3.28E-04	1.11E-03
HuRI	CC	GO:0016482	cytosolic transport	-	135	79	-	-	2.44E-02	7.11E-03
HuRI	CC	GO:0005796	Golgi lumen	-	106	37	-	-	2.83E-02	3.33E-03
HuRI	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	21	-	-	1.91E-02	1.89E-03
HuRI	CC	GO:0034358	plasma lipoprotein particle	-	36	17	-	-	1.98E-02	1.56E-03
HuRI	CC	GO:0008023	transcription elongation factor complex	-	47	28	-	-	7.37E-02	2.56E-03
HuRI	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	12	-	-	9.64E-04	1.11E-03
HuRI	CC	GO:0030662	coated vesicle membrane	-	202	118	-	-	1.36E-02	1.06E-02
HuRI	CC	GO:0007039	protein catabolic process in the vacuole	-	61	45	-	-	1.58E-02	4.00E-03
HuRI	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	31	-	-	9.72E-02	2.78E-03
HuRI	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	158	-	-	5.82E-02	1.41E-02
HuRI	CC	GO:0005769	early endosome	-	425	215	-	-	1.33E-02	1.91E-02
HuRI	CC	GO:0090734	site of DNA damage	-	118	60	-	-	5.08E-03	5.33E-03
HuRI	MF	GO:0051861	glycolipid binding	-	30	13	-	-	3.32E-04	1.22E-03
HuRI	MF	GO:0051087	protein-folding chaperone binding	-	135	63	-	-	3.46E-03	5.67E-03
HuRI	MF	GO:0031681	G-protein beta-subunit binding	-	22	13	-	-	3.30E-04	1.22E-03
HuRI	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	25	-	-	1.07E-03	2.22E-03
HuRI	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	129	-	-	2.49E-02	1.16E-02
HuRI	MF	GO:0016757	glycosyltransferase activity	-	286	88	-	-	2.03E-02	7.89E-03
HuRI	MF	GO:0048306	calcium-dependent protein binding	-	61	41	-	-	1.12E-02	3.67E-03
HuRI	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	40	-	-	1.91E-03	3.56E-03
HuRI	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	38	-	-	1.06E-01	3.44E-03
HuRI	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	64	-	-	1.02E-02	5.78E-03
HuRI	MF	GO:0051020	GTPase binding	-	311	157	-	-	5.19E-03	1.40E-02
HuRI	MF	GO:0005158	insulin receptor binding	-	22	15	-	-	4.42E-04	1.33E-03
HuRI	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	12	-	-	3.32E-04	1.11E-03
HuRI	MF	GO:0061980	regulatory RNA binding	-	52	19	-	-	6.92E-03	1.78E-03
HuRI	MF	GO:0015035	protein-disulfide reductase activity	-	32	16	-	-	4.39E-04	1.44E-03
HuRI	MF	GO:0001671	ATPase activator activity	-	29	14	-	-	3.33E-04	1.33E-03
HuRI	MF	GO:0035035	histone acetyltransferase binding	-	24	13	-	-	3.26E-04	1.22E-03
HuRI	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	18	-	-	5.52E-03	1.67E-03
HuRI	MF	GO:0003688	DNA replication origin binding	-	18	11	-	-	3.32E-04	1.00E-03
HuRI	MF	GO:0005178	integrin binding	-	153	63	-	-	2.59E-03	5.67E-03
HuRI	MF	GO:0070064	proline-rich region binding	-	17	11	-	-	1.08E-02	1.00E-03
HuRI	MF	GO:0008327	methyl-CpG binding	-	31	15	-	-	4.37E-04	1.33E-03
HuRI	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	13	-	-	3.29E-04	1.22E-03
HuRI	MF	GO:0140318	protein transporter activity	-	40	19	-	-	1.51E-02	1.78E-03
HuRI	MF	GO:0070628	proteasome binding	-	17	14	-	-	1.21E-02	1.33E-03
HuRI	MF	GO:0000217	DNA secondary structure binding	-	37	20	-	-	2.30E-02	1.78E-03
HuRI	MF	GO:0002039	p53 binding	-	66	40	-	-	1.11E-03	3.56E-03
HuRI	MF	GO:0005496	steroid binding	-	110	54	-	-	7.04E-03	4.89E-03
HuRI	MF	GO:0008443	phosphofructokinase activity	-	27	17	-	-	5.88E-02	1.56E-03
HuRI	MF	GO:0003684	damaged DNA binding	-	89	44	-	-	3.36E-02	4.00E-03
HuRI	MF	GO:0000339	RNA cap binding	-	20	12	-	-	3.30E-04	1.11E-03
HuRI	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	69	-	-	5.22E-02	6.22E-03
HuRI	MF	GO:0070063	RNA polymerase binding	-	61	28	-	-	1.71E-02	2.56E-03
HuRI	MF	GO:0030971	receptor tyrosine kinase binding	-	76	40	-	-	4.01E-02	3.56E-03
HuRI	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	48	-	-	4.02E-02	4.33E-03
HuRI	MF	GO:0140030	modification-dependent protein binding	-	179	92	-	-	5.10E-03	8.22E-03
HuRI	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	11	-	-	3.31E-04	1.00E-03
HuRI	MF	GO:0035497	cAMP response element binding	-	12	11	-	-	6.86E-03	1.00E-03
HuRI	MF	GO:0010851	cyclase regulator activity	-	17	11	-	-	3.31E-04	1.00E-03
HuRI	MF	GO:0030276	clathrin binding	-	70	44	-	-	5.11E-03	4.00E-03
HuRI	MF	GO:0046875	ephrin receptor binding	-	29	19	-	-	4.21E-04	1.78E-03
HuRI	MF	GO:0106310	protein serine kinase activity	-	362	163	-	-	5.82E-03	1.46E-02
HuRI	MF	GO:0030552	cAMP binding	-	48	22	-	-	4.06E-02	2.00E-03
HuRI	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	20	-	-	5.48E-04	1.78E-03
HuRI	MF	GO:0004857	enzyme inhibitor activity	-	395	181	-	-	4.65E-03	1.61E-02
HuRI	MF	GO:0097602	cullin family protein binding	-	26	15	-	-	4.36E-04	1.33E-03
HuRI	MF	GO:0004984	olfactory receptor activity	-	429	21	-	-	5.55E-04	1.89E-03
HuRI	MF	GO:0016209	antioxidant activity	-	92	45	-	-	1.28E-01	4.00E-03
HuRI	MF	GO:0070325	lipoprotein particle receptor binding	-	32	17	-	-	4.37E-04	1.56E-03
HuRI	MF	GO:0044325	transmembrane transporter binding	-	159	89	-	-	2.79E-03	8.00E-03
HuRI	MF	GO:0048156	tau protein binding	-	43	23	-	-	5.45E-04	2.11E-03
HuRI	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	14	-	-	3.31E-04	1.33E-03
HuRI	MF	GO:0140272	exogenous protein binding	-	79	42	-	-	1.85E-03	3.78E-03
HuRI	MF	GO:0030145	manganese ion binding	-	65	23	-	-	5.45E-04	2.11E-03
HuRI	MF	GO:0071814	protein-lipid complex binding	-	52	19	-	-	4.34E-04	1.78E-03
HuRI	MF	GO:0008066	glutamate receptor activity	-	70	19	-	-	4.38E-04	1.78E-03
HuRI	MF	GO:0017069	snRNA binding	-	54	29	-	-	3.59E-02	2.67E-03
HuRI	MF	GO:0031369	translation initiation factor binding	-	32	23	-	-	1.66E-02	2.11E-03
HuRI	MF	GO:0019843	rRNA binding	-	69	38	-	-	8.77E-04	3.44E-03
HuRI	MF	GO:0004713	protein tyrosine kinase activity	-	213	98	-	-	6.88E-03	8.78E-03
HuRI	MF	GO:0016779	nucleotidyltransferase activity	-	264	134	-	-	2.84E-02	1.20E-02
HuRI	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	37	-	-	5.00E-03	3.33E-03
HuRI	MF	GO:0008093	cytoskeletal anchor activity	-	24	18	-	-	1.07E-03	1.67E-03
HuRI	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	15	-	-	4.39E-04	1.33E-03
HuRI	MF	GO:0016208	AMP binding	-	22	19	-	-	1.02E-02	1.78E-03
HuRI	MF	GO:0000287	magnesium ion binding	-	225	105	-	-	1.22E-02	9.33E-03
HuRI	MF	GO:0031490	chromatin DNA binding	-	120	62	-	-	2.96E-03	5.55E-03
HuRI	MF	GO:0017022	myosin binding	-	73	38	-	-	1.08E-02	3.44E-03
HuRI	MF	GO:0004896	cytokine receptor activity	-	93	34	-	-	7.68E-04	3.11E-03
HuRI	MF	GO:0008301	"DNA binding, bending"	-	18	11	-	-	3.30E-04	1.00E-03
HuRI	MF	GO:0015631	tubulin binding	-	410	209	-	-	6.78E-03	1.87E-02
HuRI	MF	GO:0005539	glycosaminoglycan binding	-	236	75	-	-	1.73E-03	6.67E-03
HuRI	MF	GO:0019207	kinase regulator activity	-	267	157	-	-	7.02E-03	1.40E-02
HuRI	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	13	-	-	6.75E-03	1.22E-03
HuRI	MF	GO:0044183	protein folding chaperone	-	67	36	-	-	5.84E-03	3.22E-03
HuRI	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	38	-	-	5.06E-03	3.44E-03
HuRI	MF	GO:0003725	double-stranded RNA binding	-	72	33	-	-	4.57E-02	3.00E-03
HuRI	MF	GO:0051018	protein kinase A binding	-	52	27	-	-	8.78E-02	2.44E-03
HuRI	MF	GO:0071889	14-3-3 protein binding	-	34	16	-	-	4.39E-04	1.44E-03
HuRI	MF	GO:0004618	phosphoglycerate kinase activity	-	89	50	-	-	8.34E-03	4.44E-03
HuRI	MF	GO:0042805	actinin binding	-	36	20	-	-	1.10E-02	1.78E-03
HuRI	MF	GO:0043531	ADP binding	-	38	14	-	-	1.46E-02	1.33E-03
HuRI	MF	GO:0046332	SMAD binding	-	77	35	-	-	3.61E-02	3.11E-03
HuRI	MF	GO:0001968	fibronectin binding	-	30	11	-	-	3.29E-04	1.00E-03
HuRI	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	76	-	-	9.20E-03	6.78E-03
HuRI	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	41	-	-	9.60E-04	3.67E-03
HuRI	MF	GO:0051117	ATPase binding	-	85	52	-	-	5.03E-03	4.67E-03
HuRI	MF	GO:0005216	monoatomic ion channel activity	-	618	225	-	-	1.36E-02	2.00E-02
HuRI	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	18	-	-	4.41E-04	1.67E-03
HuRI	MF	GO:0001098	basal transcription machinery binding	-	61	32	-	-	1.09E-02	2.89E-03
HuRI	MF	GO:0036002	pre-mRNA binding	-	57	23	-	-	3.73E-03	2.11E-03
HuRI	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	23	-	-	1.39E-03	2.11E-03
HuRI	MF	GO:0051540	metal cluster binding	-	71	35	-	-	8.74E-03	3.11E-03
HuRI	MF	GO:0051219	phosphoprotein binding	-	92	60	-	-	4.56E-03	5.33E-03
HuRI	MF	GO:0019894	kinesin binding	-	45	27	-	-	1.42E-02	2.44E-03
HuRI	MF	GO:0042287	MHC protein binding	-	68	26	-	-	1.95E-02	2.33E-03
HuRI	MF	GO:0019003	GDP binding	-	89	59	-	-	6.36E-03	5.33E-03
HuRI	MF	GO:0017171	serine hydrolase activity	-	207	51	-	-	5.74E-03	4.56E-03
HuRI	MF	GO:0097110	scaffold protein binding	-	66	30	-	-	1.35E-03	2.67E-03
HuRI	MF	GO:0003774	cytoskeletal motor activity	-	117	33	-	-	4.25E-03	3.00E-03
HuRI	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	21	-	-	7.06E-03	1.89E-03
HuRI	MF	GO:0061134	peptidase regulator activity	-	224	83	-	-	4.64E-03	7.44E-03
HuRI	MF	GO:0008013	beta-catenin binding	-	86	40	-	-	1.45E-03	3.56E-03
HuRI	MF	GO:0051015	actin filament binding	-	208	90	-	-	1.98E-02	8.00E-03
HuRI	MF	GO:0019208	phosphatase regulator activity	-	107	47	-	-	8.50E-03	4.22E-03
HuRI	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	12	-	-	3.32E-04	1.11E-03
HuRI	MF	GO:0030507	spectrin binding	-	26	15	-	-	4.42E-04	1.33E-03
HuRI	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	19	-	-	4.10E-03	1.78E-03
HuRI	MF	GO:0045860	positive regulation of protein kinase activity	-	397	176	-	-	1.19E-02	1.57E-02
HuRI	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	70	-	-	2.72E-02	6.22E-03
HuRI	MF	GO:0042393	histone binding	-	240	117	-	-	5.66E-03	1.04E-02
HuRI	MF	GO:0019838	growth factor binding	-	182	68	-	-	2.67E-03	6.11E-03
HuRI	MF	GO:0000149	SNARE binding	-	107	68	-	-	3.44E-02	6.11E-03
HuRI	MF	GO:0003727	single-stranded RNA binding	-	90	42	-	-	8.96E-03	3.78E-03
HuRI	MF	GO:0005516	calmodulin binding	-	206	77	-	-	7.57E-03	6.89E-03
HuRI	MF	GO:0019825	oxygen binding	-	40	18	-	-	3.31E-01	1.67E-03
HuRI	MF	GO:0045505	dynein intermediate chain binding	-	37	14	-	-	7.07E-03	1.33E-03
HuRI	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	35	-	-	8.73E-04	3.11E-03
HuRI	MF	GO:0032182	ubiquitin-like protein binding	-	117	76	-	-	5.51E-03	6.78E-03
HuRI	MF	GO:0023023	MHC protein complex binding	-	36	16	-	-	4.38E-04	1.44E-03
HuRI	MF	GO:0030742	GTP-dependent protein binding	-	22	12	-	-	3.31E-04	1.11E-03
HuRI	MF	GO:0043274	phospholipase binding	-	23	12	-	-	3.30E-04	1.11E-03
HuRI	MF	GO:0031072	heat shock protein binding	-	128	62	-	-	7.10E-03	5.55E-03
HuRI	MF	GO:0030515	snoRNA binding	-	33	19	-	-	2.61E-02	1.78E-03
HuRI	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	28	-	-	1.49E-01	2.56E-03
HuRI	MF	GO:0001965	G-protein alpha-subunit binding	-	26	13	-	-	3.29E-04	1.22E-03
HuRI	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	232	-	-	1.27E-02	2.07E-02
HuRI	MF	GO:0001530	lipopolysaccharide binding	-	38	12	-	-	3.27E-04	1.11E-03
HuRI	MF	GO:0046982	protein heterodimerization activity	-	343	187	-	-	2.23E-02	1.67E-02
HuRI	MF	GO:0140223	general transcription initiation factor activity	-	55	31	-	-	5.85E-02	2.78E-03
HuRI	MF	GO:0000049	tRNA binding	-	75	25	-	-	6.61E-04	2.22E-03
HuRI	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	27	-	-	1.00E-02	2.44E-03
HuRI	MF	GO:0015026	coreceptor activity	-	48	12	-	-	3.32E-04	1.11E-03
HuRI	MF	GO:0001653	peptide receptor activity	-	128	37	-	-	8.66E-04	3.33E-03
HuRI	MF	GO:0031005	filamin binding	-	15	11	-	-	2.88E-02	1.00E-03
HuRI	MF	GO:0006469	negative regulation of protein kinase activity	-	222	113	-	-	4.66E-03	1.01E-02
HuRI	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	18	-	-	4.40E-04	1.67E-03
HuRI	MF	GO:0051427	hormone receptor binding	-	31	13	-	-	3.32E-04	1.22E-03
HuRI	MF	GO:0070851	growth factor receptor binding	-	141	74	-	-	3.53E-03	6.67E-03
HuRI	MF	GO:0031210	phosphatidylcholine binding	-	32	13	-	-	1.62E-02	1.22E-03
HuRI	MF	GO:0005525	GTP binding	-	396	203	-	-	1.35E-02	1.81E-02
HuRI	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	22	-	-	2.28E-03	2.00E-03
HuRI	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	137	-	-	6.27E-03	1.22E-02
HuRI	MF	GO:0051346	negative regulation of hydrolase activity	-	332	131	-	-	3.86E-03	1.17E-02
HuRI	MF	GO:0005506	iron ion binding	-	154	59	-	-	1.82E-03	5.33E-03
HuRI	MF	GO:0003925	G protein activity	-	45	32	-	-	7.74E-04	2.89E-03
HuRI	MF	GO:0038187	pattern recognition receptor activity	-	33	11	-	-	3.31E-04	1.00E-03
HuRI	MF	GO:0008276	protein methyltransferase activity	-	96	53	-	-	5.18E-03	4.78E-03
HuRI	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	210	-	-	9.56E-03	1.87E-02
HuRI	MF	GO:0070888	E-box binding	-	59	40	-	-	8.36E-02	3.56E-03
HuRI	MF	GO:0015399	primary active transmembrane transporter activity	-	190	70	-	-	9.30E-03	6.22E-03
HuRI	MF	GO:0035254	glutamate receptor binding	-	47	26	-	-	2.00E-03	2.33E-03
HuRI	MF	GO:0050321	tau-protein kinase activity	-	36	19	-	-	4.38E-04	1.78E-03
HuRI	MF	GO:0043021	ribonucleoprotein complex binding	-	158	92	-	-	2.27E-03	8.22E-03
HuRI	MF	GO:0030170	pyridoxal phosphate binding	-	56	26	-	-	3.72E-02	2.33E-03
HuRI	MF	GO:0005112	Notch binding	-	26	11	-	-	1.50E-03	1.00E-03
HuRI	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	14	-	-	3.31E-04	1.33E-03
HuRI	MF	GO:0001664	G protein-coupled receptor binding	-	299	133	-	-	3.47E-03	1.19E-02
HuRI	MF	GO:0140299	small molecule sensor activity	-	39	15	-	-	6.45E-03	1.33E-03
HuRI	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	14	-	-	3.30E-04	1.33E-03
HuRI	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	23	-	-	5.44E-03	2.11E-03
HuRI	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	13	-	-	1.41E-03	1.22E-03
HuRI	MF	GO:0030594	neurotransmitter receptor activity	-	160	40	-	-	1.37E-03	3.56E-03
HuRI	MF	GO:0120227	acyl-CoA binding	-	22	12	-	-	3.32E-04	1.11E-03
HuRI	MF	GO:0005507	copper ion binding	-	63	23	-	-	5.52E-04	2.11E-03
HuRI	MF	GO:0070034	telomerase RNA binding	-	22	11	-	-	1.34E-01	1.00E-03
IID	CC	GO:0005739	mitochondrion	2.49E-16	1671	1653	1596	1.04	-	-
IID	CC	GO:0005615	extracellular space	9.56E-12	3190	3115	3047	1.02	-	-
IID	CC	GO:0005730	nucleolus	6.87E-11	988	979	944	1.04	-	-
IID	CC	GO:0005815	microtubule organizing center	6.82E-10	843	836	805	1.04	-	-
IID	CC	GO:0005783	endoplasmic reticulum	8.19E-10	2020	1979	1929	1.03	-	-
IID	CC	GO:0005764	lysosome	4.15E-09	747	741	714	1.04	-	-
IID	CC	GO:0005794	Golgi apparatus	6.44E-09	1636	1605	1563	1.03	-	-
IID	CC	GO:0005768	endosome	1.18E-08	1037	1023	991	1.03	-	-
IID	CC	GO:0031012	extracellular matrix	2.30E-07	564	560	539	1.04	-	-
IID	CC	GO:0005635	nuclear envelope	8.24E-04	493	485	471	1.03	-	-
IID	CC	GO:0005840	ribosome	8.40E-04	222	221	212	1.04	-	-
IID	CC	GO:0000228	nuclear chromosome	9.73E-03	206	204	197	1.04	-	-
IID	CC	GO:0005777	peroxisome	2.27E-02	142	141	136	1.04	-	-
IID	CC	GO:0005929	cilium	4.93E-02	842	816	804	1.01	-	-
IID	CC	GO:0005811	lipid droplet	9.28E-02	102	101	97	1.04	-	-
IID	BP	GO:0016192	vesicle-mediated transport	1.68E-17	1894	1872	1809	1.03	-	-
IID	BP	GO:0050877	nervous system process	3.37E-16	1527	1388	1459	0.95	-	-
IID	BP	GO:0007010	cytoskeleton organization	1.09E-15	1639	1621	1566	1.04	-	-
IID	BP	GO:0007155	cell adhesion	3.10E-15	1444	1430	1379	1.04	-	-
IID	BP	GO:0048870	cell motility	4.31E-13	1659	1636	1585	1.03	-	-
IID	BP	GO:0055085	transmembrane transport	9.24E-12	1784	1755	1704	1.03	-	-
IID	BP	GO:0012501	programmed cell death	1.94E-11	1954	1919	1866	1.03	-	-
IID	BP	GO:0006629	lipid metabolic process	1.32E-10	1355	1336	1294	1.03	-	-
IID	BP	GO:0006886	intracellular protein transport	2.79E-09	664	660	634	1.04	-	-
IID	BP	GO:0006281	DNA repair	1.12E-08	587	584	561	1.04	-	-
IID	BP	GO:0002376	immune system process	3.15E-08	2448	2388	2338	1.02	-	-
IID	BP	GO:0034330	cell junction organization	6.67E-08	727	720	694	1.04	-	-
IID	BP	GO:0003013	circulatory system process	7.51E-08	584	580	558	1.04	-	-
IID	BP	GO:0006355	regulation of DNA-templated transcription	1.30E-07	3342	3247	3192	1.02	-	-
IID	BP	GO:0006954	inflammatory response	1.49E-07	820	810	783	1.03	-	-
IID	BP	GO:0006914	autophagy	1.55E-07	568	564	543	1.04	-	-
IID	BP	GO:0055086	nucleobase-containing small molecule metabolic process	9.33E-07	729	720	696	1.03	-	-
IID	BP	GO:0007005	mitochondrion organization	9.68E-07	484	481	462	1.04	-	-
IID	BP	GO:0032200	telomere organization	3.17E-06	186	162	178	0.91	-	-
IID	BP	GO:0072659	protein localization to plasma membrane	3.63E-06	284	284	271	1.05	-	-
IID	BP	GO:0016071	mRNA metabolic process	5.01E-06	713	703	681	1.03	-	-
IID	BP	GO:0030198	extracellular matrix organization	1.31E-05	314	313	300	1.04	-	-
IID	BP	GO:0006091	generation of precursor metabolites and energy	1.43E-05	502	497	479	1.04	-	-
IID	BP	GO:0030163	protein catabolic process	3.54E-05	990	970	946	1.03	-	-
IID	BP	GO:0005975	carbohydrate metabolic process	3.61E-05	551	544	526	1.03	-	-
IID	BP	GO:0003012	muscle system process	4.30E-05	425	421	406	1.04	-	-
IID	BP	GO:0042060	wound healing	4.52E-05	431	427	412	1.04	-	-
IID	BP	GO:0006260	DNA replication	5.95E-05	279	278	266	1.04	-	-
IID	BP	GO:0007059	chromosome segregation	1.24E-04	403	399	385	1.04	-	-
IID	BP	GO:0007018	microtubule-based movement	1.92E-04	640	629	611	1.03	-	-
IID	BP	GO:0042254	ribosome biogenesis	3.02E-04	297	295	284	1.04	-	-
IID	BP	GO:0006913	nucleocytoplasmic transport	3.76E-04	326	323	311	1.04	-	-
IID	BP	GO:0006310	DNA recombination	3.98E-04	333	330	318	1.04	-	-
IID	BP	GO:0007163	establishment or maintenance of cell polarity	5.65E-04	227	226	217	1.04	-	-
IID	BP	GO:0140053	mitochondrial gene expression	9.38E-04	164	164	157	1.05	-	-
IID	BP	GO:0006520	amino acid metabolic process	1.47E-03	292	289	279	1.04	-	-
IID	BP	GO:0006399	tRNA metabolic process	2.56E-03	196	195	187	1.04	-	-
IID	BP	GO:0140013	meiotic nuclear division	3.01E-03	279	276	266	1.04	-	-
IID	BP	GO:0003014	renal system process	4.57E-03	127	127	121	1.05	-	-
IID	BP	GO:0006790	sulfur compound metabolic process	6.18E-03	320	315	306	1.03	-	-
IID	BP	GO:0022600	digestive system process	1.02E-02	110	110	105	1.05	-	-
IID	BP	GO:0044782	cilium organization	1.36E-02	399	391	381	1.03	-	-
IID	BP	GO:0006766	vitamin metabolic process	1.58E-02	107	107	102	1.05	-	-
IID	BP	GO:0002181	cytoplasmic translation	1.61E-02	153	152	146	1.04	-	-
IID	BP	GO:0006575	cellular modified amino acid metabolic process	1.88E-02	186	184	178	1.04	-	-
IID	BP	GO:0098754	detoxification	3.27E-02	134	133	128	1.04	-	-
IID	BP	GO:0098542	defense response to other organism	3.42E-02	1171	1133	1119	1.01	-	-
IID	BP	GO:0006486	protein glycosylation	4.98E-02	225	221	215	1.03	-	-
IID	BP	GO:0006325	chromatin organization	5.34E-02	720	677	688	0.98	-	-
IID	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	6.90E-02	119	118	114	1.04	-	-
IID	BP	GO:0007040	lysosome organization	9.50E-02	107	106	102	1.04	-	-
IID	BP	GO:0065003	protein-containing complex assembly	1.51E-01	1648	1586	1574	1.01	-	-
IID	BP	GO:0006457	protein folding	1.77E-01	210	205	201	1.02	-	-
IID	BP	GO:0000910	cytokinesis	2.87E-01	186	181	178	1.02	-	-
IID	MF	GO:0140096	"catalytic activity, acting on a protein"	1.22E-15	3198	3133	3055	1.03	-	-
IID	MF	GO:0016740	transferase activity	4.24E-15	3074	3012	2936	1.03	-	-
IID	MF	GO:0008092	cytoskeletal protein binding	4.59E-13	1023	1016	977	1.04	-	-
IID	MF	GO:0003723	RNA binding	6.44E-10	1679	1649	1604	1.03	-	-
IID	MF	GO:0140657	ATP-dependent activity	1.42E-09	729	724	696	1.04	-	-
IID	MF	GO:0016491	oxidoreductase activity	3.22E-09	888	879	848	1.04	-	-
IID	MF	GO:0005215	transporter activity	7.45E-08	1462	1434	1396	1.03	-	-
IID	MF	GO:0008289	lipid binding	3.17E-07	836	825	799	1.03	-	-
IID	MF	GO:0140098	"catalytic activity, acting on RNA"	1.75E-06	417	415	398	1.04	-	-
IID	MF	GO:0016829	lyase activity	3.65E-06	538	533	514	1.04	-	-
IID	MF	GO:0140110	transcription regulator activity	8.82E-06	2033	1979	1942	1.02	-	-
IID	MF	GO:0140097	"catalytic activity, acting on DNA"	2.37E-04	383	379	366	1.04	-	-
IID	MF	GO:0003924	GTPase activity	3.40E-04	658	646	629	1.03	-	-
IID	MF	GO:0016874	ligase activity	4.09E-04	283	281	270	1.04	-	-
IID	MF	GO:0045182	translation regulator activity	2.19E-03	151	151	144	1.05	-	-
IID	MF	GO:0005198	structural molecule activity	2.79E-03	798	744	762	0.98	-	-
IID	MF	GO:0009975	cyclase activity	2.94E-03	277	274	265	1.04	-	-
IID	MF	GO:0016853	isomerase activity	5.51E-03	252	249	241	1.03	-	-
IID	MF	GO:0003774	cytoskeletal motor activity	1.07E-02	116	116	111	1.05	-	-
IID	MF	GO:0038024	cargo receptor activity	1.08E-02	117	117	112	1.05	-	-
IID	MF	GO:0003677	DNA binding	1.61E-02	2865	2761	2737	1.01	-	-
IID	MF	GO:0140104	molecular carrier activity	9.37E-02	105	104	100	1.04	-	-
IID	MF	GO:0048018	receptor ligand activity	1.02E-01	504	489	481	1.02	-	-
IID	MF	GO:0042393	histone binding	3.40E-01	237	230	226	1.02	-	-
IID	BP	GO:0008038	neuron recognition	-	46	46	-	-	5.63E-03	1.98E-03
IID	BP	GO:1905145	cellular response to acetylcholine	-	33	32	-	-	6.65E-03	1.39E-03
IID	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	1.48E-03	8.01E-04
IID	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	3.26E-03	9.08E-04
IID	BP	GO:0051931	regulation of sensory perception	-	36	36	-	-	4.76E-03	1.55E-03
IID	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	4.06E-03	1.07E-03
IID	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	6.76E-03	5.88E-04
IID	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	1.89E-03	5.88E-04
IID	BP	GO:0009268	response to pH	-	43	43	-	-	1.53E-02	1.87E-03
IID	BP	GO:0045666	positive regulation of neuron differentiation	-	91	87	-	-	5.40E-03	3.74E-03
IID	BP	GO:0043543	protein acylation	-	107	103	-	-	7.01E-03	4.43E-03
IID	MF	GO:0051349	positive regulation of lyase activity	-	41	40	-	-	5.70E-03	1.71E-03
IID	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	4.58E-03	6.41E-04
IID	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	2.15E-03	1.07E-03
IID	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	2.29E-03	8.55E-04
IID	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	139	-	-	1.17E-01	5.98E-03
IID	BP	GO:0071763	nuclear membrane organization	-	44	44	-	-	1.32E-02	1.92E-03
IID	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	34	-	-	3.97E-03	1.50E-03
IID	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	12	-	-	1.95E-02	5.34E-04
IID	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	1.83E-02	2.94E-03
IID	BP	GO:0022038	corpus callosum development	-	25	25	-	-	1.81E-03	1.07E-03
IID	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	14	-	-	1.67E-03	6.41E-04
IID	BP	GO:0021548	pons development	-	11	11	-	-	3.13E-03	4.81E-04
IID	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	4.56E-03	5.34E-04
IID	BP	GO:0043299	leukocyte degranulation	-	82	81	-	-	6.10E-03	3.47E-03
IID	BP	GO:0048864	stem cell development	-	88	88	-	-	6.17E-02	3.79E-03
IID	BP	GO:0009310	amine catabolic process	-	20	17	-	-	7.28E-02	7.48E-04
IID	BP	GO:0051651	maintenance of location in cell	-	236	225	-	-	1.73E-02	9.62E-03
IID	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	4.70E-03	1.18E-03
IID	BP	GO:0014004	microglia differentiation	-	12	12	-	-	7.82E-04	5.34E-04
IID	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	9.04E-02	1.34E-03
IID	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	1.09E-03	6.41E-04
IID	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.41E-03	6.41E-04
IID	BP	GO:0046415	urate metabolic process	-	12	12	-	-	9.89E-03	5.34E-04
IID	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	2.74E-03	1.28E-03
IID	BP	GO:0006949	syncytium formation	-	66	61	-	-	3.52E-03	2.62E-03
IID	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.35E-03	6.41E-04
IID	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	1.78E-02	6.41E-04
IID	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	57	-	-	3.93E-02	2.46E-03
IID	BP	GO:0030574	collagen catabolic process	-	45	45	-	-	3.07E-01	1.92E-03
IID	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	9.12E-03	1.98E-03
IID	BP	GO:0060343	trabecula formation	-	26	26	-	-	3.66E-03	1.12E-03
IID	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	1.68E-03	5.34E-04
IID	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.57E-03	1.02E-03
IID	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	4.17E-02	6.95E-04
IID	BP	GO:1900424	regulation of defense response to bacterium	-	21	19	-	-	1.64E-03	8.55E-04
IID	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	3.51E-02	1.76E-03
IID	BP	GO:0006413	translational initiation	-	122	120	-	-	4.20E-02	5.13E-03
IID	BP	GO:0072176	nephric duct development	-	15	15	-	-	4.20E-03	6.41E-04
IID	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	4.17E-03	2.19E-03
IID	CC	GO:0005200	structural constituent of cytoskeleton	-	112	112	-	-	1.33E-02	4.81E-03
IID	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	5.09E-03	2.19E-03
IID	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	5.87E-02	6.41E-04
IID	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	3.74E-02	1.07E-03
IID	BP	GO:1903036	positive regulation of response to wounding	-	76	70	-	-	6.33E-03	2.99E-03
IID	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	9.62E-02	9.08E-04
IID	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	226	-	-	4.26E-02	9.67E-03
IID	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	7.51E-04	1.18E-03
IID	BP	GO:0032528	microvillus organization	-	24	24	-	-	1.70E-03	1.07E-03
IID	BP	GO:0021954	central nervous system neuron development	-	85	85	-	-	4.06E-03	3.63E-03
IID	BP	GO:0055017	cardiac muscle tissue growth	-	92	75	-	-	4.22E-03	3.21E-03
IID	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	1.13E-02	1.34E-03
IID	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	4.28E-03	5.88E-04
IID	BP	GO:0048524	positive regulation of viral process	-	64	63	-	-	1.94E-03	2.72E-03
IID	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	14	-	-	2.28E-02	6.41E-04
IID	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	1.07E-02	9.08E-04
IID	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	23	-	-	1.15E-03	1.02E-03
IID	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	2.65E-02	7.48E-04
IID	BP	GO:0098661	inorganic anion transmembrane transport	-	140	137	-	-	1.15E-01	5.88E-03
IID	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	1.16E-01	1.39E-03
IID	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	1.32E-03	8.01E-04
IID	BP	GO:0009612	response to mechanical stimulus	-	215	214	-	-	7.32E-03	9.19E-03
IID	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	1.10E-02	3.37E-03
IID	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	140	-	-	6.74E-03	5.98E-03
IID	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	5.10E-03	5.88E-04
IID	BP	GO:0071542	dopaminergic neuron differentiation	-	36	36	-	-	1.20E-02	1.55E-03
IID	BP	GO:0140115	export across plasma membrane	-	82	65	-	-	1.67E-02	2.78E-03
IID	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	1.66E-03	5.34E-04
IID	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	6.25E-03	1.66E-03
IID	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	1.96E-02	5.34E-04
IID	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.56E-03	4.81E-04
IID	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	29	-	-	4.04E-03	1.28E-03
IID	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	42	-	-	5.65E-02	1.82E-03
IID	MF	GO:0003714	transcription corepressor activity	-	190	186	-	-	1.49E-02	7.96E-03
IID	BP	GO:0035878	nail development	-	11	11	-	-	1.66E-03	4.81E-04
IID	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	55	-	-	8.40E-03	2.35E-03
IID	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	4.73E-03	6.95E-04
IID	CC	GO:0006858	extracellular transport	-	45	44	-	-	2.20E-02	1.92E-03
IID	BP	GO:0006304	DNA modification	-	30	30	-	-	4.55E-02	1.28E-03
IID	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	6.91E-02	8.01E-04
IID	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	3.25E-02	2.14E-03
IID	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	8.25E-04	8.01E-04
IID	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	1.05E-02	6.41E-04
IID	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	40	-	-	1.33E-01	1.71E-03
IID	BP	GO:0070417	cellular response to cold	-	13	13	-	-	2.38E-02	5.88E-04
IID	BP	GO:0043523	regulation of neuron apoptotic process	-	218	212	-	-	5.45E-03	9.08E-03
IID	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.29E-03	9.62E-04
IID	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	1.23E-03	6.41E-04
IID	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	4.71E-03	2.46E-03
IID	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	2.62E-02	5.88E-04
IID	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	1.11E-03	1.07E-03
IID	BP	GO:0014029	neural crest formation	-	15	15	-	-	1.01E-02	6.41E-04
IID	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	1.97E-03	1.02E-03
IID	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	41	-	-	1.83E-02	1.76E-03
IID	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	68	-	-	2.64E-03	2.94E-03
IID	BP	GO:0003188	heart valve formation	-	16	16	-	-	2.38E-02	6.95E-04
IID	CC	GO:0045324	late endosome to vacuole transport	-	37	37	-	-	7.33E-02	1.60E-03
IID	BP	GO:0043954	cellular component maintenance	-	72	71	-	-	3.89E-03	3.05E-03
IID	BP	GO:0050435	amyloid-beta metabolic process	-	65	52	-	-	2.28E-02	2.24E-03
IID	BP	GO:0014823	response to activity	-	70	69	-	-	2.09E-03	2.99E-03
IID	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	2.71E-02	8.01E-04
IID	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	6.63E-02	1.23E-03
IID	BP	GO:0034502	protein localization to chromosome	-	130	114	-	-	7.82E-03	4.92E-03
IID	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	2.82E-03	4.81E-04
IID	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	1.61E-03	4.81E-04
IID	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	2.87E-03	7.48E-04
IID	BP	GO:0019233	sensory perception of pain	-	103	103	-	-	1.05E-02	4.43E-03
IID	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	1.02E-01	9.62E-04
IID	BP	GO:0031343	positive regulation of cell killing	-	75	74	-	-	7.91E-02	3.21E-03
IID	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	9.04E-03	1.66E-03
IID	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	127	-	-	7.57E-02	5.45E-03
IID	BP	GO:0017148	negative regulation of translation	-	390	115	-	-	1.39E-02	4.92E-03
IID	BP	GO:0030220	platelet formation	-	22	22	-	-	1.41E-02	9.62E-04
IID	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	81	-	-	4.30E-03	3.47E-03
IID	MF	GO:1903624	regulation of DNA catabolic process	-	14	13	-	-	4.22E-03	5.88E-04
IID	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	8.72E-03	6.41E-04
IID	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	8.91E-02	6.41E-04
IID	BP	GO:1903509	liposaccharide metabolic process	-	109	109	-	-	1.30E-01	4.70E-03
IID	BP	GO:0009582	detection of abiotic stimulus	-	140	137	-	-	2.98E-02	5.88E-03
IID	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	3.71E-03	5.88E-04
IID	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	19	-	-	5.44E-02	8.55E-04
IID	CC	GO:0140238	presynaptic endocytosis	-	72	71	-	-	1.10E-02	3.05E-03
IID	BP	GO:0051236	establishment of RNA localization	-	161	157	-	-	4.98E-02	6.73E-03
IID	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	4.57E-02	1.07E-03
IID	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	3.38E-02	7.48E-04
IID	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	192	-	-	1.50E-02	8.23E-03
IID	BP	GO:0034067	protein localization to Golgi apparatus	-	30	29	-	-	3.38E-03	1.28E-03
IID	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	2.52E-03	1.39E-03
IID	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	1.41E-02	4.81E-04
IID	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	5.87E-03	7.48E-04
IID	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	50	-	-	2.97E-02	2.14E-03
IID	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	39	-	-	1.52E-03	1.71E-03
IID	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	1.77E-03	2.24E-03
IID	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	8.26E-03	6.95E-04
IID	BP	GO:0050779	RNA destabilization	-	135	101	-	-	2.92E-02	4.33E-03
IID	BP	GO:0006023	aminoglycan biosynthetic process	-	74	74	-	-	9.86E-02	3.21E-03
IID	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	6.88E-02	2.94E-03
IID	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	1.39E-03	1.71E-03
IID	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	7.27E-03	1.28E-03
IID	BP	GO:0035272	exocrine system development	-	46	46	-	-	5.20E-03	1.98E-03
IID	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	8.02E-03	7.48E-04
IID	BP	GO:0022406	membrane docking	-	90	89	-	-	2.78E-02	3.85E-03
IID	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	2.06E-02	6.41E-04
IID	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	1.54E-03	6.95E-04
IID	BP	GO:0050777	negative regulation of immune response	-	196	190	-	-	8.57E-03	8.12E-03
IID	MF	GO:0005035	death receptor activity	-	16	15	-	-	2.27E-02	6.41E-04
IID	BP	GO:0002063	chondrocyte development	-	33	32	-	-	4.12E-03	1.39E-03
IID	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	2.47E-03	7.48E-04
IID	BP	GO:0099068	postsynapse assembly	-	40	40	-	-	1.25E-02	1.71E-03
IID	BP	GO:0021782	glial cell development	-	120	115	-	-	3.81E-03	4.92E-03
IID	BP	GO:0051782	negative regulation of cell division	-	18	16	-	-	1.89E-03	6.95E-04
IID	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	1.18E-03	4.81E-04
IID	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	87	-	-	5.48E-03	3.74E-03
IID	BP	GO:0001655	urogenital system development	-	66	66	-	-	7.75E-03	2.83E-03
IID	BP	GO:0071827	plasma lipoprotein particle organization	-	86	71	-	-	4.32E-02	3.05E-03
IID	BP	GO:0045494	photoreceptor cell maintenance	-	43	43	-	-	2.47E-02	1.87E-03
IID	BP	GO:0055088	lipid homeostasis	-	173	154	-	-	2.73E-02	6.62E-03
IID	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	1.84E-03	1.12E-03
IID	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	195	-	-	6.90E-03	8.33E-03
IID	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	29	-	-	2.02E-02	1.28E-03
IID	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	4.36E-03	1.50E-03
IID	BP	GO:0045667	regulation of osteoblast differentiation	-	147	125	-	-	1.18E-02	5.34E-03
IID	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	6.75E-03	6.95E-04
IID	BP	GO:0061037	negative regulation of cartilage development	-	32	30	-	-	4.71E-03	1.28E-03
IID	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	9.85E-03	1.71E-03
IID	BP	GO:0001704	formation of primary germ layer	-	195	189	-	-	1.57E-02	8.12E-03
IID	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	6.32E-03	5.88E-04
IID	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	6.09E-03	2.19E-03
IID	BP	GO:0060174	limb bud formation	-	11	11	-	-	5.52E-03	4.81E-04
IID	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	2.51E-03	3.63E-03
IID	BP	GO:0042092	type 2 immune response	-	41	41	-	-	6.33E-03	1.76E-03
IID	BP	GO:0048588	developmental cell growth	-	233	225	-	-	1.62E-02	9.62E-03
IID	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	2.40E-02	8.55E-04
IID	BP	GO:0021872	forebrain generation of neurons	-	52	52	-	-	3.65E-03	2.24E-03
IID	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	5.85E-04	9.62E-04
IID	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	6.12E-02	1.71E-03
IID	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	50	-	-	3.64E-02	2.14E-03
IID	BP	GO:0072488	ammonium transmembrane transport	-	12	12	-	-	1.32E-01	5.34E-04
IID	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	4.77E-02	1.50E-03
IID	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	1.15E-03	1.12E-03
IID	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	50	-	-	6.61E-02	2.14E-03
IID	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	5.36E-02	8.55E-04
IID	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	6.04E-02	8.55E-04
IID	BP	GO:0010232	vascular transport	-	87	87	-	-	2.34E-02	3.74E-03
IID	BP	GO:0021987	cerebral cortex development	-	125	124	-	-	4.40E-03	5.34E-03
IID	BP	GO:0008637	apoptotic mitochondrial changes	-	108	101	-	-	1.33E-02	4.33E-03
IID	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	3.88E-02	1.50E-03
IID	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.15E-01	6.41E-04
IID	BP	GO:0060999	positive regulation of dendritic spine development	-	35	34	-	-	2.17E-03	1.50E-03
IID	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	3.92E-03	8.01E-04
IID	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	3.55E-03	3.31E-03
IID	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	2.81E-03	8.55E-04
IID	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	4.51E-03	8.55E-04
IID	BP	GO:0002064	epithelial cell development	-	210	208	-	-	7.23E-03	8.92E-03
IID	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	2.15E-03	8.01E-04
IID	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	40	-	-	9.20E-03	1.71E-03
IID	BP	GO:2001222	regulation of neuron migration	-	46	45	-	-	2.68E-02	1.92E-03
IID	BP	GO:0034389	lipid droplet organization	-	38	37	-	-	4.85E-03	1.60E-03
IID	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	9.00E-04	1.92E-03
IID	BP	GO:0042177	negative regulation of protein catabolic process	-	109	106	-	-	2.27E-03	4.54E-03
IID	MF	GO:0038024	cargo receptor activity	-	121	117	-	-	1.92E-02	5.02E-03
IID	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	18	-	-	2.18E-03	8.01E-04
IID	BP	GO:0033120	positive regulation of RNA splicing	-	46	44	-	-	1.30E-02	1.92E-03
IID	BP	GO:0051445	regulation of meiotic cell cycle	-	64	63	-	-	3.28E-02	2.72E-03
IID	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.50E-03	5.34E-04
IID	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	1.54E-02	2.56E-03
IID	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	1.73E-02	6.41E-04
IID	BP	GO:0090087	regulation of peptide transport	-	195	193	-	-	1.06E-02	8.28E-03
IID	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	101	-	-	5.29E-03	4.33E-03
IID	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	1.13E-03	1.07E-03
IID	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	1.66E-03	1.07E-03
IID	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	4.80E-03	6.41E-04
IID	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	5.17E-02	1.18E-03
IID	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	1.29E-03	6.41E-04
IID	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	2.17E-03	6.41E-04
IID	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	8.72E-02	8.55E-04
IID	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	3.32E-03	5.88E-04
IID	BP	GO:0022404	molting cycle process	-	95	95	-	-	6.04E-03	4.06E-03
IID	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	3.95E-04	4.81E-04
IID	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	1.45E-03	7.48E-04
IID	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	3.46E-03	8.55E-04
IID	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	3.23E-03	5.34E-04
IID	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	18	-	-	1.39E-03	8.01E-04
IID	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	3.33E-03	1.39E-03
IID	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	5.61E-03	6.41E-04
IID	BP	GO:0008299	isoprenoid biosynthetic process	-	30	30	-	-	1.35E-01	1.28E-03
IID	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	238	-	-	2.96E-02	1.02E-02
IID	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.23E-03	1.34E-03
IID	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	4.52E-03	9.62E-04
IID	CC	GO:0098926	postsynaptic signal transduction	-	39	38	-	-	4.55E-03	1.66E-03
IID	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	140	-	-	5.05E-03	5.98E-03
IID	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	1.14E-02	8.55E-04
IID	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	2.37E-03	2.03E-03
IID	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	143	-	-	1.74E-02	6.14E-03
IID	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	3.31E-03	9.62E-04
IID	BP	GO:0061548	ganglion development	-	17	17	-	-	4.25E-03	7.48E-04
IID	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	101	-	-	1.88E-02	4.33E-03
IID	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.17E-02	6.41E-04
IID	BP	GO:0042832	defense response to protozoan	-	28	25	-	-	2.82E-02	1.07E-03
IID	BP	GO:0048799	animal organ maturation	-	33	32	-	-	2.90E-03	1.39E-03
IID	BP	GO:0006925	inflammatory cell apoptotic process	-	23	22	-	-	1.42E-03	9.62E-04
IID	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	2.20E-03	6.95E-04
IID	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	171	-	-	6.90E-03	7.32E-03
IID	BP	GO:0010269	response to selenium ion	-	11	11	-	-	8.20E-04	4.81E-04
IID	BP	GO:1903035	negative regulation of response to wounding	-	93	88	-	-	1.10E-02	3.79E-03
IID	BP	GO:0015697	quaternary ammonium group transport	-	16	16	-	-	2.09E-02	6.95E-04
IID	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	1.49E-03	1.12E-03
IID	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	2.20E-03	1.18E-03
IID	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	136	-	-	3.03E-02	5.82E-03
IID	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	96	-	-	5.20E-03	4.11E-03
IID	BP	GO:0045056	transcytosis	-	20	20	-	-	1.23E-03	8.55E-04
IID	BP	GO:0018342	protein prenylation	-	15	15	-	-	5.15E-02	6.41E-04
IID	BP	GO:0009267	cellular response to starvation	-	170	169	-	-	1.56E-02	7.27E-03
IID	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	2.57E-03	4.81E-04
IID	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	5.48E-03	2.30E-03
IID	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	4.04E-01	6.95E-04
IID	BP	GO:0007343	egg activation	-	11	11	-	-	4.44E-02	4.81E-04
IID	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	2.42E-03	1.02E-03
IID	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	27	-	-	1.03E-01	1.18E-03
IID	BP	GO:0046931	pore complex assembly	-	21	20	-	-	5.81E-03	8.55E-04
IID	CC	GO:0032008	positive regulation of TOR signaling	-	52	51	-	-	5.06E-02	2.19E-03
IID	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	2.92E-02	1.44E-03
IID	BP	GO:0046618	xenobiotic export from cell	-	27	14	-	-	3.40E-02	6.41E-04
IID	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	15	-	-	4.86E-03	6.41E-04
IID	BP	GO:0060428	lung epithelium development	-	43	43	-	-	1.52E-03	1.87E-03
IID	BP	GO:0030431	sleep	-	30	30	-	-	9.62E-03	1.28E-03
IID	BP	GO:1903318	negative regulation of protein maturation	-	29	29	-	-	3.78E-03	1.28E-03
IID	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	100	-	-	1.70E-01	4.27E-03
IID	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	3.97E-04	7.48E-04
IID	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	5.07E-03	6.41E-04
IID	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	2.74E-03	5.34E-04
IID	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	3.88E-04	5.88E-04
IID	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	76	-	-	4.50E-02	3.26E-03
IID	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	2.00E-03	2.78E-03
IID	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	8.33E-03	7.48E-04
IID	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	1.70E-03	6.41E-04
IID	CC	GO:0006406	mRNA export from nucleus	-	69	68	-	-	3.65E-02	2.94E-03
IID	BP	GO:0009880	embryonic pattern specification	-	70	70	-	-	1.29E-02	2.99E-03
IID	BP	GO:0015791	polyol transmembrane transport	-	14	13	-	-	2.93E-01	5.88E-04
IID	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	1.31E-01	1.71E-03
IID	BP	GO:0043043	peptide biosynthetic process	-	25	25	-	-	6.18E-02	1.07E-03
IID	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	8.07E-03	4.81E-04
IID	BP	GO:0002367	cytokine production involved in immune response	-	121	121	-	-	9.50E-03	5.18E-03
IID	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	1.18E-03	5.88E-04
IID	BP	GO:0044848	biological phase	-	211	208	-	-	3.49E-02	8.92E-03
IID	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	3.75E-03	5.34E-04
IID	BP	GO:0046660	female sex differentiation	-	125	124	-	-	7.07E-03	5.34E-03
IID	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	1.16E-03	7.48E-04
IID	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	41	-	-	7.33E-04	1.76E-03
IID	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	6.07E-04	4.81E-04
IID	BP	GO:0060411	cardiac septum morphogenesis	-	72	71	-	-	1.08E-02	3.05E-03
IID	BP	GO:0071248	cellular response to metal ion	-	201	199	-	-	1.38E-02	8.55E-03
IID	BP	GO:0030308	negative regulation of cell growth	-	191	187	-	-	2.35E-02	8.01E-03
IID	BP	GO:0097306	cellular response to alcohol	-	99	93	-	-	4.21E-03	4.01E-03
IID	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	126	-	-	6.95E-02	5.40E-03
IID	BP	GO:0010453	regulation of cell fate commitment	-	40	36	-	-	4.23E-03	1.55E-03
IID	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	57	-	-	4.76E-03	2.46E-03
IID	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	57	-	-	5.33E-02	2.46E-03
IID	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	5.13E-03	1.12E-03
IID	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	1.75E-02	1.07E-03
IID	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	44	-	-	4.40E-02	1.92E-03
IID	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	4.47E-03	3.31E-03
IID	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	1.07E-03	8.55E-04
IID	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	1.44E-01	1.07E-03
IID	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	96	-	-	4.04E-03	4.11E-03
IID	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	1.69E-03	1.12E-03
IID	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	8.12E-04	4.81E-04
IID	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	53	-	-	1.18E-02	2.30E-03
IID	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	4.08E-02	6.95E-04
IID	BP	GO:0098743	cell aggregation	-	24	24	-	-	1.42E-02	1.07E-03
IID	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	1.64E-03	5.34E-04
IID	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	8.20E-03	4.81E-04
IID	BP	GO:0009994	oocyte differentiation	-	57	56	-	-	4.01E-03	2.40E-03
IID	MF	GO:0031952	regulation of protein autophosphorylation	-	43	41	-	-	2.71E-03	1.76E-03
IID	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	2.37E-03	6.41E-04
IID	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	157	-	-	1.31E-02	6.73E-03
IID	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	3.80E-03	1.50E-03
IID	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	1.75E-03	1.23E-03
IID	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	1.17E-03	1.50E-03
IID	BP	GO:0072665	protein localization to vacuole	-	84	84	-	-	1.04E-02	3.63E-03
IID	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	46	-	-	1.25E-02	1.98E-03
IID	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	25	-	-	3.12E-03	1.07E-03
IID	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	74	-	-	9.79E-03	3.21E-03
IID	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	1.01E-02	6.95E-04
IID	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	7.60E-03	6.41E-04
IID	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.50E-04	4.81E-04
IID	BP	GO:0042044	fluid transport	-	35	34	-	-	4.17E-02	1.50E-03
IID	BP	GO:0070633	transepithelial transport	-	35	35	-	-	6.89E-03	1.50E-03
IID	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	6.81E-02	5.88E-04
IID	BP	GO:0045661	regulation of myoblast differentiation	-	74	73	-	-	1.18E-02	3.15E-03
IID	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	15	-	-	1.17E-01	6.41E-04
IID	BP	GO:0030307	positive regulation of cell growth	-	164	159	-	-	3.97E-03	6.84E-03
IID	BP	GO:0034250	positive regulation of amide metabolic process	-	27	25	-	-	1.12E-03	1.07E-03
IID	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	6.07E-03	8.01E-04
IID	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	1.15E-03	5.88E-04
IID	BP	GO:0014812	muscle cell migration	-	110	85	-	-	4.00E-03	3.63E-03
IID	BP	GO:0048525	negative regulation of viral process	-	90	88	-	-	7.95E-03	3.79E-03
IID	BP	GO:0072044	collecting duct development	-	16	16	-	-	9.83E-04	6.95E-04
IID	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	9.04E-02	6.41E-04
IID	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	9.27E-03	2.99E-03
IID	BP	GO:0030238	male sex determination	-	14	14	-	-	1.42E-02	6.41E-04
IID	BP	GO:0051781	positive regulation of cell division	-	93	91	-	-	9.07E-03	3.90E-03
IID	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	1.87E-03	9.08E-04
IID	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	7.18E-04	4.81E-04
IID	BP	GO:0035524	proline transmembrane transport	-	12	12	-	-	7.90E-02	5.34E-04
IID	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	3.97E-02	1.02E-03
IID	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	21	-	-	2.27E-03	9.08E-04
IID	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	5.55E-03	2.03E-03
IID	BP	GO:0070857	regulation of bile acid biosynthetic process	-	12	11	-	-	1.75E-02	4.81E-04
IID	BP	GO:0007272	ensheathment of neurons	-	146	144	-	-	8.98E-03	6.20E-03
IID	CC	GO:0050806	positive regulation of synaptic transmission	-	171	152	-	-	5.90E-03	6.52E-03
IID	BP	GO:0060021	roof of mouth development	-	91	91	-	-	1.24E-02	3.90E-03
IID	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	6.83E-03	1.71E-03
IID	BP	GO:0050819	negative regulation of coagulation	-	54	53	-	-	3.00E-02	2.30E-03
IID	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	2.08E-03	4.81E-04
IID	BP	GO:0017004	cytochrome complex assembly	-	40	39	-	-	1.21E-01	1.71E-03
IID	BP	GO:0018410	C-terminal protein amino acid modification	-	15	15	-	-	1.52E-01	6.41E-04
IID	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	6.86E-02	2.67E-03
IID	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	2.79E-02	6.41E-04
IID	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	14	-	-	1.95E-03	6.41E-04
IID	CC	GO:0050805	negative regulation of synaptic transmission	-	55	55	-	-	4.95E-03	2.35E-03
IID	BP	GO:0043248	proteasome assembly	-	13	13	-	-	2.10E-02	5.88E-04
IID	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	59	-	-	5.43E-03	2.56E-03
IID	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	6.27E-03	4.81E-04
IID	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	86	-	-	5.22E-02	3.69E-03
IID	BP	GO:0016054	organic acid catabolic process	-	251	247	-	-	9.08E-02	1.06E-02
IID	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	7.66E-04	5.88E-04
IID	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.48E-02	1.23E-03
IID	BP	GO:0065005	protein-lipid complex assembly	-	29	28	-	-	1.41E-02	1.23E-03
IID	BP	GO:0008033	tRNA processing	-	136	135	-	-	7.04E-02	5.77E-03
IID	BP	GO:0046661	male sex differentiation	-	171	170	-	-	1.15E-02	7.27E-03
IID	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	6.52E-04	6.41E-04
IID	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	3.14E-03	7.48E-04
IID	BP	GO:0035188	hatching	-	27	27	-	-	4.49E-04	1.18E-03
IID	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	88	-	-	4.75E-03	3.79E-03
IID	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	9.10E-04	6.41E-04
IID	BP	GO:0090713	immunological memory process	-	18	18	-	-	2.45E-03	8.01E-04
IID	BP	GO:0061326	renal tubule development	-	103	103	-	-	9.71E-03	4.43E-03
IID	BP	GO:0071985	multivesicular body sorting pathway	-	56	55	-	-	4.94E-02	2.35E-03
IID	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	2.22E-02	7.48E-04
IID	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	8.21E-04	8.55E-04
IID	BP	GO:0060325	face morphogenesis	-	31	31	-	-	6.88E-03	1.34E-03
IID	BP	GO:0090559	regulation of membrane permeability	-	72	63	-	-	1.29E-02	2.72E-03
IID	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	14	-	-	6.18E-03	6.41E-04
IID	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	1.21E-02	5.34E-04
IID	BP	GO:0031579	membrane raft organization	-	25	24	-	-	1.25E-03	1.07E-03
IID	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	7.35E-04	1.07E-03
IID	BP	GO:0060033	anatomical structure regression	-	16	16	-	-	4.88E-03	6.95E-04
IID	BP	GO:0046460	neutral lipid biosynthetic process	-	50	45	-	-	4.53E-02	1.92E-03
IID	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	152	-	-	2.02E-02	6.52E-03
IID	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	5.08E-03	4.81E-04
IID	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	161	-	-	4.95E-03	6.89E-03
IID	BP	GO:0002251	organ or tissue specific immune response	-	43	36	-	-	1.62E-02	1.55E-03
IID	CC	GO:0048167	regulation of synaptic plasticity	-	210	192	-	-	8.91E-03	8.23E-03
IID	BP	GO:1903708	positive regulation of hemopoiesis	-	184	180	-	-	1.24E-02	7.69E-03
IID	BP	GO:1903008	organelle disassembly	-	154	154	-	-	1.41E-02	6.62E-03
IID	BP	GO:0001709	cell fate determination	-	44	44	-	-	8.61E-03	1.92E-03
IID	BP	GO:0051873	killing by host of symbiont cells	-	28	26	-	-	9.32E-03	1.12E-03
IID	BP	GO:0045058	T cell selection	-	53	53	-	-	1.07E-02	2.30E-03
IID	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	2.04E-03	2.08E-03
IID	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	3.63E-03	8.55E-04
IID	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	4.64E-03	3.37E-03
IID	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	42	-	-	6.56E-02	1.82E-03
IID	BP	GO:0099084	postsynaptic specialization organization	-	44	44	-	-	8.20E-03	1.92E-03
IID	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	4.53E-03	4.81E-04
IID	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	2.65E-02	6.41E-04
IID	BP	GO:0060384	innervation	-	27	27	-	-	6.13E-03	1.18E-03
IID	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	1.41E-03	5.34E-04
IID	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	35	-	-	2.44E-02	1.50E-03
IID	MF	GO:0031281	positive regulation of cyclase activity	-	40	39	-	-	6.19E-03	1.71E-03
IID	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	7.93E-03	2.72E-03
IID	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	1.36E-02	8.01E-04
IID	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	2.50E-02	5.34E-04
IID	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	1.77E-02	8.01E-04
IID	BP	GO:0071453	cellular response to oxygen levels	-	168	154	-	-	4.59E-03	6.62E-03
IID	BP	GO:0090399	replicative senescence	-	17	16	-	-	5.32E-03	6.95E-04
IID	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	1.49E-02	6.41E-04
IID	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	5.66E-03	1.28E-03
IID	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	1.05E-02	5.34E-03
IID	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	6.28E-02	6.41E-04
IID	BP	GO:0010623	programmed cell death involved in cell development	-	25	25	-	-	1.42E-03	1.07E-03
IID	BP	GO:0044242	cellular lipid catabolic process	-	224	220	-	-	6.00E-02	9.40E-03
IID	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	1.34E-03	5.88E-04
IID	BP	GO:0002931	response to ischemia	-	58	57	-	-	2.86E-03	2.46E-03
IID	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	8.60E-03	5.34E-04
IID	BP	GO:0014047	glutamate secretion	-	25	25	-	-	8.67E-03	1.07E-03
IID	BP	GO:0061005	cell differentiation involved in kidney development	-	58	58	-	-	4.04E-03	2.51E-03
IID	BP	GO:0030397	membrane disassembly	-	11	11	-	-	4.96E-04	4.81E-04
IID	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	76	-	-	2.51E-02	3.26E-03
IID	BP	GO:0060420	regulation of heart growth	-	74	60	-	-	3.69E-03	2.56E-03
IID	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	1.12E-03	6.41E-04
IID	BP	GO:0009755	hormone-mediated signaling pathway	-	221	218	-	-	1.52E-02	9.35E-03
IID	BP	GO:0022612	gland morphogenesis	-	124	124	-	-	7.77E-03	5.34E-03
IID	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	36	-	-	2.14E-03	1.55E-03
IID	MF	GO:0140416	transcription regulator inhibitor activity	-	26	24	-	-	1.56E-03	1.07E-03
IID	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	28	-	-	1.53E-01	1.23E-03
IID	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	3.68E-03	6.41E-04
IID	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	1.82E-02	7.48E-04
IID	BP	GO:1990845	adaptive thermogenesis	-	166	166	-	-	5.38E-03	7.11E-03
IID	BP	GO:0071320	cellular response to cAMP	-	54	54	-	-	1.90E-03	2.35E-03
IID	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	1.27E-02	4.81E-04
IID	BP	GO:0015844	monoamine transport	-	88	88	-	-	2.98E-02	3.79E-03
IID	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	1.10E-02	9.62E-04
IID	BP	GO:0060039	pericardium development	-	19	19	-	-	1.01E-03	8.55E-04
IID	BP	GO:0071392	cellular response to estradiol stimulus	-	40	40	-	-	1.31E-03	1.71E-03
IID	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	9.98E-04	5.88E-04
IID	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	1.29E-02	8.55E-04
IID	BP	GO:0009451	RNA modification	-	169	167	-	-	7.97E-02	7.16E-03
IID	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	2.02E-01	4.81E-04
IID	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	40	-	-	1.97E-03	1.71E-03
IID	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	8.46E-04	7.48E-04
IID	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	110	-	-	1.02E-02	4.70E-03
IID	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	38	-	-	4.26E-03	1.66E-03
IID	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	1.51E-01	4.81E-04
IID	BP	GO:0015807	L-amino acid transport	-	94	93	-	-	5.45E-02	4.01E-03
IID	BP	GO:0032941	secretion by tissue	-	85	84	-	-	3.59E-03	3.63E-03
IID	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	11	-	-	1.31E-02	4.81E-04
IID	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	4.56E-03	2.35E-03
IID	BP	GO:0048753	pigment granule organization	-	40	40	-	-	1.42E-01	1.71E-03
IID	BP	GO:0021516	dorsal spinal cord development	-	20	20	-	-	7.66E-03	8.55E-04
IID	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	1.74E-02	8.55E-04
IID	BP	GO:0032196	transposition	-	11	11	-	-	1.48E-03	4.81E-04
IID	BP	GO:0003014	renal system process	-	130	130	-	-	6.72E-03	5.56E-03
IID	CC	GO:0070286	axonemal dynein complex assembly	-	40	39	-	-	2.38E-02	1.71E-03
IID	BP	GO:0045598	regulation of fat cell differentiation	-	148	132	-	-	4.82E-03	5.66E-03
IID	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	195	-	-	1.69E-02	8.33E-03
IID	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	1.06E-03	1.66E-03
IID	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	2.14E-03	1.07E-03
IID	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	232	-	-	1.11E-01	9.94E-03
IID	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	4.15E-04	5.88E-04
IID	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	1.80E-03	1.02E-03
IID	BP	GO:0018158	protein oxidation	-	15	14	-	-	7.02E-03	6.41E-04
IID	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	9.80E-03	1.28E-03
IID	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	4.55E-02	7.48E-04
IID	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	1.67E-03	1.18E-03
IID	BP	GO:0071709	membrane assembly	-	68	67	-	-	1.58E-02	2.88E-03
IID	BP	GO:0008217	regulation of blood pressure	-	186	182	-	-	2.10E-02	7.80E-03
IID	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	4.68E-04	8.01E-04
IID	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	5.13E-02	6.41E-04
IID	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	62	-	-	7.79E-03	2.67E-03
IID	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	2.17E-02	7.96E-03
IID	BP	GO:0002200	somatic diversification of immune receptors	-	78	78	-	-	1.39E-02	3.37E-03
IID	BP	GO:0035315	hair cell differentiation	-	52	50	-	-	4.02E-03	2.14E-03
IID	BP	GO:0048645	animal organ formation	-	62	61	-	-	7.51E-03	2.62E-03
IID	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	161	-	-	1.09E-02	6.89E-03
IID	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	2.28E-03	6.41E-04
IID	BP	GO:0033627	cell adhesion mediated by integrin	-	87	87	-	-	3.03E-02	3.74E-03
IID	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	7.83E-02	9.08E-04
IID	BP	GO:0015824	proline transport	-	13	13	-	-	7.81E-02	5.88E-04
IID	BP	GO:0035107	appendage morphogenesis	-	147	146	-	-	1.77E-02	6.25E-03
IID	BP	GO:1903707	negative regulation of hemopoiesis	-	116	108	-	-	5.83E-03	4.65E-03
IID	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	4.25E-03	8.55E-04
IID	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	4.34E-02	1.07E-03
IID	BP	GO:0030149	sphingolipid catabolic process	-	32	31	-	-	4.14E-02	1.34E-03
IID	BP	GO:0050994	regulation of lipid catabolic process	-	61	60	-	-	8.43E-03	2.56E-03
IID	BP	GO:0035988	chondrocyte proliferation	-	24	23	-	-	1.54E-03	1.02E-03
IID	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	9.82E-03	1.28E-03
IID	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	3.91E-02	4.81E-04
IID	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	1.62E-03	5.34E-04
IID	BP	GO:0045727	positive regulation of translation	-	141	138	-	-	7.04E-03	5.93E-03
IID	BP	GO:0036315	cellular response to sterol	-	24	20	-	-	4.81E-03	8.55E-04
IID	CC	GO:0032388	positive regulation of intracellular transport	-	137	135	-	-	2.39E-03	5.77E-03
IID	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	1.04E-01	5.88E-04
IID	BP	GO:0002027	regulation of heart rate	-	106	99	-	-	1.13E-02	4.27E-03
IID	BP	GO:0050879	multicellular organismal movement	-	118	116	-	-	4.69E-03	4.97E-03
IID	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	3.25E-03	6.41E-04
IID	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	75	-	-	4.76E-03	3.21E-03
IID	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	61	-	-	4.18E-03	2.62E-03
IID	BP	GO:0048515	spermatid differentiation	-	208	200	-	-	1.05E-02	8.55E-03
IID	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	4.31E-03	2.46E-03
IID	MF	GO:0042887	amide transmembrane transporter activity	-	33	32	-	-	2.11E-02	1.39E-03
IID	BP	GO:0007130	synaptonemal complex assembly	-	23	22	-	-	5.91E-02	9.62E-04
IID	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	35	-	-	3.34E-03	1.50E-03
IID	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	34	-	-	7.07E-04	1.50E-03
IID	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	37	-	-	1.13E-01	1.60E-03
IID	BP	GO:0060119	inner ear receptor cell development	-	44	43	-	-	5.82E-03	1.87E-03
IID	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	2.97E-03	8.01E-04
IID	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	2.72E-02	1.50E-03
IID	BP	GO:1901983	regulation of protein acetylation	-	26	23	-	-	1.11E-03	1.02E-03
IID	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.34E-03	5.34E-04
IID	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	243	-	-	1.56E-02	1.04E-02
IID	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	1.38E-03	7.48E-04
IID	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	3.45E-02	2.08E-03
IID	BP	GO:0010883	regulation of lipid storage	-	53	49	-	-	1.04E-02	2.14E-03
IID	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	3.13E-03	1.12E-03
IID	BP	GO:0007635	chemosensory behavior	-	20	20	-	-	1.24E-02	8.55E-04
IID	BP	GO:1905954	positive regulation of lipid localization	-	110	106	-	-	1.41E-02	4.54E-03
IID	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	6.10E-03	5.34E-04
IID	BP	GO:0002209	behavioral defense response	-	39	39	-	-	3.49E-03	1.71E-03
IID	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	1.48E-01	1.28E-03
IID	BP	GO:0072523	purine-containing compound catabolic process	-	146	144	-	-	1.29E-02	6.20E-03
IID	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	32	-	-	2.79E-03	1.39E-03
IID	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	27	-	-	1.21E-03	1.18E-03
IID	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	1.12E-03	6.95E-04
IID	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	95	-	-	8.04E-03	4.06E-03
IID	BP	GO:0007218	neuropeptide signaling pathway	-	113	108	-	-	7.64E-02	4.65E-03
IID	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	3.02E-03	5.34E-04
IID	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	165	-	-	2.95E-02	7.05E-03
IID	BP	GO:0031345	negative regulation of cell projection organization	-	195	189	-	-	2.12E-02	8.12E-03
IID	BP	GO:0048278	vesicle docking	-	64	64	-	-	3.50E-02	2.78E-03
IID	BP	GO:0035050	embryonic heart tube development	-	86	85	-	-	7.05E-03	3.63E-03
IID	BP	GO:0051593	response to folic acid	-	12	11	-	-	1.43E-02	4.81E-04
IID	BP	GO:0030168	platelet activation	-	135	133	-	-	1.35E-02	5.72E-03
IID	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	1.24E-01	6.95E-04
IID	CC	GO:0098810	neurotransmitter reuptake	-	35	35	-	-	2.26E-02	1.50E-03
IID	BP	GO:0008213	protein alkylation	-	58	57	-	-	4.20E-02	2.46E-03
IID	BP	GO:0009812	flavonoid metabolic process	-	14	13	-	-	1.98E-01	5.88E-04
IID	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	4.48E-03	5.88E-04
IID	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	8.17E-03	1.07E-03
IID	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.49E-03	5.88E-04
IID	BP	GO:0031529	ruffle organization	-	55	54	-	-	3.81E-03	2.35E-03
IID	BP	GO:0010842	retina layer formation	-	25	25	-	-	3.47E-03	1.07E-03
IID	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	93	-	-	6.84E-02	4.01E-03
IID	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	1.51E-04	4.81E-04
IID	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	71	-	-	9.30E-03	3.05E-03
IID	MF	GO:0170055	lipid transmembrane transporter activity	-	56	55	-	-	3.57E-02	2.35E-03
IID	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	34	-	-	6.59E-03	1.50E-03
IID	BP	GO:0035304	regulation of protein dephosphorylation	-	87	84	-	-	2.80E-03	3.63E-03
IID	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	234	-	-	3.14E-02	1.00E-02
IID	BP	GO:0099637	neurotransmitter receptor transport	-	26	26	-	-	3.24E-03	1.12E-03
IID	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	1.46E-03	1.50E-03
IID	BP	GO:0051775	response to redox state	-	13	13	-	-	4.07E-03	5.88E-04
IID	BP	GO:0051785	positive regulation of nuclear division	-	61	60	-	-	4.89E-03	2.56E-03
IID	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	5.65E-03	6.95E-04
IID	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	1.75E-02	6.95E-04
IID	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	2.12E-03	8.55E-04
IID	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	3.46E-02	5.34E-04
IID	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	1.20E-02	1.92E-03
IID	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	13	-	-	5.31E-03	5.88E-04
IID	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	7.31E-02	7.48E-04
IID	BP	GO:0051299	centrosome separation	-	15	15	-	-	3.30E-03	6.41E-04
IID	BP	GO:0048145	regulation of fibroblast proliferation	-	87	85	-	-	2.25E-03	3.63E-03
IID	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	89	-	-	2.69E-01	3.85E-03
IID	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	9.83E-03	4.81E-04
IID	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	224	-	-	5.53E-03	9.62E-03
IID	BP	GO:0032098	regulation of appetite	-	20	20	-	-	1.80E-02	8.55E-04
IID	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	7.19E-03	6.41E-04
IID	CC	GO:0008333	endosome to lysosome transport	-	73	73	-	-	2.08E-02	3.15E-03
IID	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	22	-	-	4.77E-03	9.62E-04
IID	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	16	-	-	2.19E-03	6.95E-04
IID	BP	GO:0003016	respiratory system process	-	39	38	-	-	1.18E-03	1.66E-03
IID	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	1.89E-03	1.02E-03
IID	BP	GO:0045732	positive regulation of protein catabolic process	-	202	200	-	-	7.28E-03	8.55E-03
IID	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	72	-	-	8.14E-02	3.10E-03
IID	BP	GO:0007588	excretion	-	40	40	-	-	6.40E-03	1.71E-03
IID	BP	GO:1904018	positive regulation of vasculature development	-	185	158	-	-	8.06E-03	6.78E-03
IID	BP	GO:0050953	sensory perception of light stimulus	-	223	219	-	-	6.76E-02	9.40E-03
IID	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	1.07E-01	1.07E-03
IID	BP	GO:0002357	defense response to tumor cell	-	13	12	-	-	7.55E-04	5.34E-04
IID	BP	GO:0009303	rRNA transcription	-	37	37	-	-	2.00E-02	1.60E-03
IID	BP	GO:0035601	protein deacylation	-	56	56	-	-	5.07E-03	2.40E-03
IID	BP	GO:0061952	midbody abscission	-	18	18	-	-	2.56E-02	8.01E-04
IID	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	8.72E-04	4.81E-04
IID	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	8.18E-04	8.55E-04
IID	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	9.69E-04	1.28E-03
IID	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	1.66E-02	2.78E-03
IID	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	16	-	-	9.83E-03	6.95E-04
IID	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	8.01E-03	1.23E-03
IID	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	5.16E-03	1.44E-03
IID	BP	GO:0046697	decidualization	-	26	26	-	-	7.31E-03	1.12E-03
IID	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	4.53E-03	6.41E-04
IID	BP	GO:0051588	regulation of neurotransmitter transport	-	99	99	-	-	7.88E-03	4.27E-03
IID	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	32	-	-	2.11E-01	1.39E-03
IID	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	3.83E-03	5.34E-04
IID	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	1.25E-02	2.72E-03
IID	BP	GO:0044703	multi-organism reproductive process	-	209	203	-	-	1.48E-02	8.71E-03
IID	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	139	-	-	6.66E-03	5.98E-03
IID	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	53	-	-	6.35E-03	2.30E-03
IID	BP	GO:0099022	vesicle tethering	-	32	31	-	-	1.27E-01	1.34E-03
IID	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	38	-	-	1.91E-03	1.66E-03
IID	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	2.37E-04	5.34E-04
IID	BP	GO:0048857	neural nucleus development	-	65	62	-	-	2.12E-03	2.67E-03
IID	BP	GO:0048663	neuron fate commitment	-	74	74	-	-	1.63E-02	3.21E-03
IID	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	175	-	-	1.05E-02	7.48E-03
IID	BP	GO:0106027	neuron projection organization	-	90	87	-	-	2.85E-03	3.74E-03
IID	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	129	-	-	1.59E-02	5.56E-03
IID	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	3.46E-03	1.50E-03
IID	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	1.19E-03	4.81E-04
IID	BP	GO:0045685	regulation of glial cell differentiation	-	77	74	-	-	8.50E-03	3.21E-03
IID	BP	GO:0051608	histamine transport	-	14	14	-	-	7.25E-03	6.41E-04
IID	BP	GO:0043414	macromolecule methylation	-	138	135	-	-	4.33E-02	5.77E-03
IID	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	6.52E-03	5.34E-04
IID	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	2.48E-02	6.95E-04
IID	BP	GO:0050886	endocrine process	-	93	93	-	-	1.01E-02	4.01E-03
IID	MF	GO:0015562	efflux transmembrane transporter activity	-	15	15	-	-	4.00E-02	6.41E-04
IID	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	3.00E-03	1.23E-03
IID	BP	GO:0045807	positive regulation of endocytosis	-	155	150	-	-	7.61E-03	6.41E-03
IID	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	2.78E-03	4.81E-04
IID	BP	GO:0002418	immune response to tumor cell	-	29	29	-	-	8.75E-03	1.28E-03
IID	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	59	-	-	3.13E-03	2.56E-03
IID	BP	GO:0048308	organelle inheritance	-	14	14	-	-	1.18E-03	6.41E-04
IID	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	1.85E-03	8.01E-04
IID	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	5.30E-03	8.55E-04
IID	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	52	-	-	6.20E-02	2.24E-03
IID	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.84E-03	2.88E-03
IID	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	8.39E-03	5.34E-04
IID	BP	GO:0009110	vitamin biosynthetic process	-	23	23	-	-	2.40E-02	1.02E-03
IID	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	3.09E-03	9.62E-04
IID	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	3.65E-03	7.48E-04
IID	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	22	-	-	2.04E-03	9.62E-04
IID	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	96	-	-	2.80E-03	4.11E-03
IID	BP	GO:0009111	vitamin catabolic process	-	13	13	-	-	6.45E-02	5.88E-04
IID	MF	GO:0051100	negative regulation of binding	-	161	157	-	-	3.19E-03	6.73E-03
IID	BP	GO:0003151	outflow tract morphogenesis	-	81	79	-	-	8.22E-03	3.42E-03
IID	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	2.01E-03	2.56E-03
IID	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	7.31E-04	8.55E-04
IID	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	2.07E-03	5.34E-04
IID	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	1.63E-02	1.44E-03
IID	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	4.15E-03	6.95E-04
IID	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	5.23E-04	5.88E-04
IID	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	1.35E-03	2.03E-03
IID	BP	GO:0046621	negative regulation of organ growth	-	39	33	-	-	3.10E-03	1.44E-03
IID	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	1.10E-01	2.14E-03
IID	BP	GO:0032368	regulation of lipid transport	-	149	129	-	-	9.40E-03	5.56E-03
IID	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	2.16E-03	1.28E-03
IID	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	180	-	-	8.71E-03	7.69E-03
IID	BP	GO:0033002	muscle cell proliferation	-	249	203	-	-	8.73E-03	8.71E-03
IID	BP	GO:0043331	response to dsRNA	-	56	55	-	-	3.23E-02	2.35E-03
IID	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	2.65E-03	5.34E-04
IID	BP	GO:0051904	pigment granule transport	-	23	23	-	-	2.08E-02	1.02E-03
IID	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	1.40E-02	1.39E-03
IID	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	1.74E-03	1.44E-03
IID	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	12	-	-	1.74E-02	5.34E-04
IID	BP	GO:0033363	secretory granule organization	-	63	63	-	-	3.73E-02	2.72E-03
IID	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	1.64E-03	1.23E-03
IID	BP	GO:0120009	intermembrane lipid transfer	-	52	51	-	-	5.62E-02	2.19E-03
IID	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	5.07E-03	6.41E-04
IID	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	1.79E-03	1.66E-03
IID	BP	GO:0097250	mitochondrial respirasome assembly	-	11	11	-	-	7.07E-03	4.81E-04
IID	BP	GO:0033622	integrin activation	-	26	26	-	-	2.29E-03	1.12E-03
IID	BP	GO:0098751	bone cell development	-	18	18	-	-	8.33E-04	8.01E-04
IID	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.37E-03	9.08E-04
IID	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	3.49E-03	2.19E-03
IID	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.41E-02	1.28E-03
IID	BP	GO:0002076	osteoblast development	-	17	17	-	-	1.65E-03	7.48E-04
IID	BP	GO:0072164	mesonephric tubule development	-	98	98	-	-	1.25E-02	4.22E-03
IID	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	8.18E-04	7.48E-04
IID	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	106	-	-	4.01E-03	4.54E-03
IID	BP	GO:1903524	positive regulation of blood circulation	-	39	36	-	-	7.46E-03	1.55E-03
IID	BP	GO:0030901	midbrain development	-	87	84	-	-	4.44E-03	3.63E-03
IID	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	7.69E-03	9.62E-04
IID	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	2.15E-03	6.95E-04
IID	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	5.48E-03	5.88E-04
IID	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	68	-	-	2.83E-03	2.94E-03
IID	MF	GO:1901474	azole transmembrane transporter activity	-	13	13	-	-	4.69E-02	5.88E-04
IID	BP	GO:0002687	positive regulation of leukocyte migration	-	147	147	-	-	1.05E-02	6.30E-03
IID	BP	GO:0019755	one-carbon compound transport	-	28	26	-	-	9.54E-02	1.12E-03
IID	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.28E-03	5.88E-04
IID	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	3.73E-03	6.95E-04
IID	BP	GO:0110154	RNA decapping	-	19	19	-	-	1.79E-02	8.55E-04
IID	BP	GO:0034605	cellular response to heat	-	66	65	-	-	2.32E-03	2.78E-03
IID	BP	GO:0005996	monosaccharide metabolic process	-	250	245	-	-	2.92E-02	1.05E-02
IID	BP	GO:0033555	multicellular organismal response to stress	-	90	89	-	-	8.46E-03	3.85E-03
IID	BP	GO:0002262	myeloid cell homeostasis	-	172	168	-	-	6.40E-03	7.21E-03
IID	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	5.43E-02	1.66E-03
IID	BP	GO:0050688	regulation of defense response to virus	-	65	63	-	-	5.66E-03	2.72E-03
IID	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	4.11E-03	8.55E-04
IID	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	223	-	-	1.32E-02	9.56E-03
IID	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	2.22E-03	1.34E-03
IID	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	4.24E-04	6.41E-04
IID	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	3.16E-03	1.39E-03
IID	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	18	-	-	3.02E-03	8.01E-04
IID	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	4.47E-03	1.23E-03
IID	BP	GO:0022618	protein-RNA complex assembly	-	227	190	-	-	4.16E-02	8.12E-03
IID	BP	GO:0051147	regulation of muscle cell differentiation	-	162	135	-	-	1.04E-02	5.77E-03
IID	BP	GO:0090102	cochlea development	-	50	50	-	-	3.82E-03	2.14E-03
IID	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	2.79E-03	1.12E-03
IID	BP	GO:0061303	cornea development in camera-type eye	-	12	12	-	-	1.66E-02	5.34E-04
IID	BP	GO:0045933	positive regulation of muscle contraction	-	49	47	-	-	7.62E-03	2.03E-03
IID	BP	GO:0015803	branched-chain amino acid transport	-	14	14	-	-	3.82E-02	6.41E-04
IID	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	8.80E-04	6.95E-04
IID	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	35	-	-	3.86E-03	1.50E-03
IID	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	92	-	-	8.09E-02	3.95E-03
IID	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.88E-03	5.34E-04
IID	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	2.11E-03	9.62E-04
IID	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	1.11E-02	3.05E-03
IID	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	55	-	-	1.66E-01	2.35E-03
IID	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	8.33E-02	1.02E-03
IID	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	57	-	-	4.11E-03	2.46E-03
IID	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	6.67E-04	4.81E-04
IID	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	4.06E-03	1.66E-03
IID	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	7.06E-04	5.34E-04
IID	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	1.90E-03	4.81E-04
IID	BP	GO:0140253	cell-cell fusion	-	62	58	-	-	3.19E-03	2.51E-03
IID	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	5.05E-04	5.34E-04
IID	BP	GO:0071599	otic vesicle development	-	15	15	-	-	2.19E-03	6.41E-04
IID	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	44	-	-	4.00E-01	1.92E-03
IID	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	5.54E-03	6.41E-04
IID	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	4.26E-02	2.56E-03
IID	BP	GO:0001941	postsynaptic membrane organization	-	37	37	-	-	2.56E-02	1.60E-03
IID	BP	GO:0051293	establishment of spindle localization	-	57	56	-	-	6.15E-03	2.40E-03
IID	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	1.81E-03	5.88E-04
IID	BP	GO:0043114	regulation of vascular permeability	-	49	48	-	-	5.29E-03	2.08E-03
IID	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	5.67E-03	1.12E-03
IID	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	67	-	-	7.44E-03	2.88E-03
IID	BP	GO:0008360	regulation of cell shape	-	139	135	-	-	1.81E-02	5.77E-03
IID	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	3.25E-03	6.95E-04
IID	BP	GO:0051222	positive regulation of protein transport	-	249	243	-	-	5.12E-03	1.04E-02
IID	CC	GO:0140632	canonical inflammasome complex assembly	-	40	40	-	-	1.02E-02	1.71E-03
IID	MF	GO:0034260	negative regulation of GTPase activity	-	36	33	-	-	1.14E-03	1.44E-03
IID	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	3.18E-03	9.62E-04
IID	BP	GO:0045739	positive regulation of DNA repair	-	128	127	-	-	2.73E-02	5.45E-03
IID	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	2.02E-03	8.55E-04
IID	BP	GO:0045185	maintenance of protein location	-	95	91	-	-	3.11E-03	3.90E-03
IID	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	1.22E-02	5.88E-04
IID	BP	GO:0003158	endothelium development	-	140	129	-	-	8.34E-03	5.56E-03
IID	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	3.02E-03	1.76E-03
IID	BP	GO:0051224	negative regulation of protein transport	-	122	106	-	-	3.81E-03	4.54E-03
IID	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	150	-	-	7.24E-03	6.41E-03
IID	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	5.47E-03	5.88E-04
IID	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	1.02E-02	1.34E-03
IID	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	1.37E-01	8.55E-04
IID	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	4.92E-03	2.72E-03
IID	BP	GO:0007405	neuroblast proliferation	-	81	80	-	-	4.88E-03	3.42E-03
IID	BP	GO:0009581	detection of external stimulus	-	137	134	-	-	2.74E-02	5.77E-03
IID	BP	GO:1990542	mitochondrial transmembrane transport	-	93	92	-	-	3.22E-02	3.95E-03
IID	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	32	-	-	3.39E-03	1.39E-03
IID	BP	GO:0033504	floor plate development	-	11	11	-	-	5.87E-03	4.81E-04
IID	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	1.74E-03	4.81E-04
IID	BP	GO:0097186	amelogenesis	-	26	26	-	-	2.10E-02	1.12E-03
IID	BP	GO:0031128	developmental induction	-	26	26	-	-	6.22E-03	1.12E-03
IID	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	1.76E-02	6.41E-04
IID	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.80E-03	2.83E-03
IID	BP	GO:0021533	cell differentiation in hindbrain	-	23	23	-	-	5.61E-03	1.02E-03
IID	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	1.76E-03	1.34E-03
IID	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	1.68E-02	5.34E-04
IID	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	3.39E-02	2.19E-03
IID	BP	GO:0021517	ventral spinal cord development	-	47	47	-	-	2.24E-02	2.03E-03
IID	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	2.99E-03	3.21E-03
IID	BP	GO:0032328	alanine transport	-	19	19	-	-	1.02E-02	8.55E-04
IID	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	7.57E-03	6.95E-04
IID	BP	GO:0097722	sperm motility	-	133	126	-	-	2.05E-02	5.40E-03
IID	BP	GO:0051231	spindle elongation	-	14	14	-	-	3.11E-03	6.41E-04
IID	BP	GO:0042490	mechanoreceptor differentiation	-	67	65	-	-	7.68E-03	2.78E-03
IID	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.87E-03	1.28E-03
IID	BP	GO:0035148	tube formation	-	155	154	-	-	9.61E-03	6.62E-03
IID	BP	GO:0048520	positive regulation of behavior	-	27	26	-	-	2.76E-02	1.12E-03
IID	BP	GO:0098543	detection of other organism	-	19	19	-	-	5.70E-02	8.55E-04
IID	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	7.45E-03	1.87E-03
IID	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	124	-	-	1.26E-02	5.34E-03
IID	BP	GO:0031123	RNA 3'-end processing	-	79	78	-	-	1.58E-02	3.37E-03
IID	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	2.12E-02	4.81E-04
IID	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	108	-	-	6.14E-03	4.65E-03
IID	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	2.23E-03	8.01E-04
IID	CC	GO:0007097	nuclear migration	-	24	24	-	-	2.69E-02	1.07E-03
IID	BP	GO:0006885	regulation of pH	-	104	102	-	-	3.39E-02	4.38E-03
IID	BP	GO:0002467	germinal center formation	-	14	14	-	-	6.09E-03	6.41E-04
IID	BP	GO:1990840	response to lectin	-	22	21	-	-	1.15E-02	9.08E-04
IID	BP	GO:0071800	podosome assembly	-	19	19	-	-	1.90E-03	8.55E-04
IID	BP	GO:0031018	endocrine pancreas development	-	47	46	-	-	8.41E-03	1.98E-03
IID	BP	GO:0001708	cell fate specification	-	108	107	-	-	1.65E-02	4.59E-03
IID	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	67	-	-	1.37E-02	2.88E-03
IID	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	2.08E-02	1.60E-03
IID	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	7.71E-03	6.41E-04
IID	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	13	-	-	9.14E-04	5.88E-04
IID	BP	GO:0042440	pigment metabolic process	-	80	79	-	-	4.99E-02	3.42E-03
IID	BP	GO:1901606	alpha-amino acid catabolic process	-	101	99	-	-	9.41E-02	4.27E-03
IID	BP	GO:1901890	positive regulation of cell junction assembly	-	106	105	-	-	7.98E-03	4.49E-03
IID	BP	GO:0070988	demethylation	-	27	27	-	-	2.50E-02	1.18E-03
IID	BP	GO:1901655	cellular response to ketone	-	107	105	-	-	4.14E-03	4.49E-03
IID	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	2.96E-02	6.41E-04
IID	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	1.85E-03	6.41E-04
IID	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	2.58E-02	7.48E-04
IID	BP	GO:0006968	cellular defense response	-	52	52	-	-	4.98E-02	2.24E-03
IID	BP	GO:0055006	cardiac cell development	-	93	84	-	-	5.19E-03	3.63E-03
IID	BP	GO:0031365	N-terminal protein amino acid modification	-	30	29	-	-	2.47E-02	1.28E-03
IID	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	1.69E-02	5.34E-04
IID	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	28	-	-	2.86E-03	1.23E-03
IID	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	3.33E-04	5.34E-04
IID	BP	GO:0060004	reflex	-	63	62	-	-	5.55E-03	2.67E-03
IID	BP	GO:0044706	multi-multicellular organism process	-	217	211	-	-	1.30E-02	9.03E-03
IID	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	2.09E-03	5.34E-04
IID	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	138	-	-	5.91E-03	5.93E-03
IID	BP	GO:0006026	aminoglycan catabolic process	-	34	34	-	-	1.65E-01	1.50E-03
IID	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	7.54E-03	1.98E-03
IID	BP	GO:0050768	negative regulation of neurogenesis	-	150	146	-	-	2.74E-02	6.25E-03
IID	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	93	-	-	2.24E-03	4.01E-03
IID	BP	GO:0090068	positive regulation of cell cycle process	-	262	248	-	-	8.34E-03	1.06E-02
IID	BP	GO:0043605	amide catabolic process	-	16	16	-	-	6.23E-02	6.95E-04
IID	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	1.40E-01	1.18E-03
IID	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	1.84E-02	1.50E-03
IID	BP	GO:1902115	regulation of organelle assembly	-	210	207	-	-	7.05E-03	8.87E-03
IID	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	65	-	-	3.04E-03	2.78E-03
IID	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	3.09E-04	6.95E-04
IID	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	143	-	-	7.96E-03	6.14E-03
IID	BP	GO:0043171	peptide catabolic process	-	19	18	-	-	1.62E-02	8.01E-04
IID	BP	GO:0046622	positive regulation of organ growth	-	52	43	-	-	3.41E-03	1.87E-03
IID	BP	GO:0051952	regulation of amine transport	-	98	98	-	-	2.46E-02	4.22E-03
IID	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	3.86E-02	1.02E-03
IID	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	6.87E-03	8.55E-04
IID	BP	GO:0015801	aromatic amino acid transport	-	13	13	-	-	1.19E-02	5.88E-04
IID	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	2.18E-03	1.02E-03
IID	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	3.86E-03	8.55E-04
IID	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	6.43E-04	6.95E-04
IID	CC	GO:0032365	intracellular lipid transport	-	51	49	-	-	1.81E-02	2.14E-03
IID	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	2.09E-02	1.28E-03
IID	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	69	-	-	5.85E-03	2.99E-03
IID	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	113	-	-	3.90E-03	4.86E-03
IID	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	1.42E-01	1.23E-03
IID	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	8.56E-04	1.07E-03
IID	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	1.06E-03	5.88E-04
IID	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	5.09E-04	6.41E-04
IID	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	5.69E-04	5.88E-04
IID	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	8.10E-03	1.50E-03
IID	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	5.51E-03	4.81E-04
IID	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	7.93E-03	3.85E-03
IID	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	3.55E-02	1.28E-03
IID	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	1.96E-03	8.01E-04
IID	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	2.71E-03	9.08E-04
IID	BP	GO:0015669	gas transport	-	23	22	-	-	1.82E-01	9.62E-04
IID	BP	GO:0016485	protein processing	-	248	244	-	-	1.78E-02	1.05E-02
IID	BP	GO:0009649	entrainment of circadian clock	-	30	30	-	-	5.67E-03	1.28E-03
IID	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	166	-	-	4.77E-02	7.11E-03
IID	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	9.12E-04	1.07E-03
IID	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	140	-	-	5.73E-02	5.98E-03
IID	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	7.00E-02	5.34E-04
IID	BP	GO:0099054	presynapse assembly	-	49	48	-	-	3.68E-03	2.08E-03
IID	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	6.71E-02	5.34E-04
IID	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	2.91E-03	1.07E-03
IID	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	2.05E-02	1.07E-03
IID	BP	GO:0031348	negative regulation of defense response	-	282	243	-	-	7.63E-03	1.04E-02
IID	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	76	-	-	4.34E-03	3.26E-03
IID	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	3.74E-03	2.94E-03
IID	BP	GO:0071496	cellular response to external stimulus	-	74	73	-	-	6.48E-03	3.15E-03
IID	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	3.17E-03	5.88E-04
IID	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	7.82E-03	7.48E-04
IID	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	4.94E-04	4.81E-04
IID	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.54E-02	5.34E-04
IID	BP	GO:0032094	response to food	-	37	37	-	-	1.04E-02	1.60E-03
IID	BP	GO:0001964	startle response	-	27	27	-	-	5.89E-03	1.18E-03
IID	BP	GO:0007340	acrosome reaction	-	38	37	-	-	3.12E-02	1.60E-03
IID	BP	GO:0046434	organophosphate catabolic process	-	232	228	-	-	2.61E-02	9.78E-03
IID	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	2.72E-02	1.28E-03
IID	BP	GO:0009566	fertilization	-	205	198	-	-	2.11E-02	8.49E-03
IID	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	2.31E-01	2.56E-03
IID	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	1.68E-02	1.07E-03
IID	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	3.16E-03	5.88E-04
IID	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	6.41E-03	1.28E-03
IID	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	23	-	-	1.57E-03	1.02E-03
IID	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	2.25E-02	1.06E-02
IID	BP	GO:0009309	amine biosynthetic process	-	38	37	-	-	5.86E-02	1.60E-03
IID	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	5.73E-04	8.55E-04
IID	BP	GO:0061900	glial cell activation	-	56	52	-	-	2.14E-03	2.24E-03
IID	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	133	-	-	1.01E-02	5.72E-03
IID	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	2.97E-02	5.88E-04
IID	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	2.15E-02	6.41E-04
IID	BP	GO:0021794	thalamus development	-	12	12	-	-	1.23E-03	5.34E-04
IID	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	1.14E-02	1.76E-03
IID	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	1.62E-03	8.55E-04
IID	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	1.46E-03	6.41E-04
IID	BP	GO:0072537	fibroblast activation	-	13	13	-	-	1.59E-03	5.88E-04
IID	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	1.42E-03	5.88E-04
IID	BP	GO:0043647	inositol phosphate metabolic process	-	44	43	-	-	1.39E-02	1.87E-03
IID	BP	GO:0016180	snRNA processing	-	28	27	-	-	1.86E-01	1.18E-03
IID	BP	GO:0051303	establishment of chromosome localization	-	104	103	-	-	1.40E-02	4.43E-03
IID	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	1.18E-02	6.95E-04
IID	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	3.02E-02	1.66E-03
IID	BP	GO:0097164	ammonium ion metabolic process	-	23	23	-	-	5.74E-02	1.02E-03
IID	BP	GO:0021515	cell differentiation in spinal cord	-	51	51	-	-	3.43E-02	2.19E-03
IID	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	3.46E-03	8.01E-04
IID	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	1.60E-03	9.08E-04
IID	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	2.20E-03	1.23E-03
IID	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.65E-03	8.01E-04
IID	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	37	-	-	2.35E-02	1.60E-03
IID	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	1.46E-03	9.62E-04
IID	BP	GO:0007566	embryo implantation	-	57	53	-	-	3.16E-03	2.30E-03
IID	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	8.29E-03	1.44E-03
IID	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	1.10E-01	6.95E-04
IID	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	1.52E-02	1.39E-03
IID	BP	GO:0051017	actin filament bundle assembly	-	161	157	-	-	1.10E-02	6.73E-03
IID	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	4.29E-03	1.82E-03
IID	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	4.09E-03	8.01E-04
IID	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	2.64E-03	8.55E-04
IID	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	2.84E-03	5.88E-04
IID	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	37	-	-	4.39E-03	1.60E-03
IID	BP	GO:0021756	striatum development	-	21	21	-	-	2.46E-03	9.08E-04
IID	BP	GO:1901343	negative regulation of vasculature development	-	154	102	-	-	4.67E-03	4.38E-03
IID	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	149	-	-	1.90E-02	6.41E-03
IID	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	31	-	-	5.04E-02	1.34E-03
IID	BP	GO:1902414	protein localization to cell junction	-	107	106	-	-	7.59E-03	4.54E-03
IID	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	6.51E-03	9.62E-04
IID	BP	GO:0051304	chromosome separation	-	80	80	-	-	1.81E-02	3.42E-03
IID	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	2.60E-03	8.01E-04
IID	BP	GO:0048709	oligodendrocyte differentiation	-	101	100	-	-	7.12E-03	4.27E-03
IID	BP	GO:0045017	glycerolipid biosynthetic process	-	254	248	-	-	4.50E-02	1.06E-02
IID	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	2.29E-01	6.41E-04
IID	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	24	-	-	7.83E-03	1.07E-03
IID	BP	GO:0001776	leukocyte homeostasis	-	108	106	-	-	5.11E-03	4.54E-03
IID	BP	GO:0050769	positive regulation of neurogenesis	-	240	235	-	-	1.04E-02	1.00E-02
IID	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	3.82E-02	6.41E-04
IID	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	2.55E-02	2.99E-03
IID	BP	GO:0050866	negative regulation of cell activation	-	216	206	-	-	1.26E-02	8.82E-03
IID	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	1.46E-03	1.55E-03
IID	BP	GO:0033500	carbohydrate homeostasis	-	251	234	-	-	7.39E-03	1.00E-02
IID	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	30	-	-	6.60E-03	1.28E-03
IID	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	2.56E-03	5.34E-04
IID	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	4.09E-03	2.40E-03
IID	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	6.07E-03	1.02E-03
IID	CC	GO:0099522	cytosolic region	-	20	20	-	-	7.69E-04	8.55E-04
IID	CC	GO:0000791	euchromatin	-	60	59	-	-	3.30E-03	2.56E-03
IID	CC	GO:0030666	endocytic vesicle membrane	-	196	195	-	-	1.33E-02	8.33E-03
IID	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	4.04E-02	6.41E-04
IID	CC	GO:1990752	microtubule end	-	34	34	-	-	9.06E-03	1.50E-03
IID	CC	GO:0043204	perikaryon	-	156	154	-	-	4.00E-03	6.62E-03
IID	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	6.31E-02	7.48E-04
IID	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	8.74E-03	5.34E-04
IID	CC	GO:0097542	ciliary tip	-	48	48	-	-	1.06E-01	2.08E-03
IID	CC	GO:1905368	peptidase complex	-	124	122	-	-	5.11E-02	5.24E-03
IID	CC	GO:0000792	heterochromatin	-	98	97	-	-	1.13E-02	4.17E-03
IID	CC	GO:0097546	ciliary base	-	47	44	-	-	7.40E-03	1.92E-03
IID	CC	GO:0071819	DUBm complex	-	25	24	-	-	1.34E-01	1.07E-03
IID	CC	GO:0031201	SNARE complex	-	48	48	-	-	2.34E-01	2.08E-03
IID	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	2.74E-03	5.88E-04
IID	CC	GO:0000815	ESCRT III complex	-	11	11	-	-	3.39E-02	4.81E-04
IID	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	1.03E-02	1.71E-03
IID	CC	GO:0044391	ribosomal subunit	-	203	202	-	-	2.12E-01	8.65E-03
IID	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	3.65E-02	4.81E-04
IID	CC	GO:0071013	catalytic step 2 spliceosome	-	88	87	-	-	4.07E-02	3.74E-03
IID	CC	GO:0031907	microbody lumen	-	51	51	-	-	5.59E-02	2.19E-03
IID	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.42E-01	4.81E-04
IID	CC	GO:0098862	cluster of actin-based cell projections	-	162	158	-	-	1.45E-02	6.78E-03
IID	CC	GO:0016363	nuclear matrix	-	127	127	-	-	5.46E-03	5.45E-03
IID	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	4.82E-02	1.98E-03
IID	CC	GO:0032432	actin filament bundle	-	249	246	-	-	1.65E-02	1.05E-02
IID	CC	GO:0008088	axo-dendritic transport	-	78	78	-	-	6.69E-03	3.37E-03
IID	CC	GO:0031519	PcG protein complex	-	38	38	-	-	3.85E-02	1.66E-03
IID	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	41	-	-	1.80E-02	1.76E-03
IID	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	219	-	-	3.23E-02	9.40E-03
IID	CC	GO:0000313	organellar ribosome	-	89	89	-	-	2.40E-01	3.85E-03
IID	CC	GO:0099643	signal release from synapse	-	147	147	-	-	2.29E-02	6.30E-03
IID	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	2.80E-02	1.98E-03
IID	CC	GO:0005818	aster	-	11	11	-	-	6.60E-03	4.81E-04
IID	CC	GO:0030018	Z disc	-	129	126	-	-	1.88E-02	5.40E-03
IID	CC	GO:0032580	Golgi cisterna membrane	-	93	85	-	-	4.84E-02	3.63E-03
IID	CC	GO:0097381	photoreceptor disc membrane	-	25	22	-	-	6.31E-02	9.62E-04
IID	CC	GO:1905360	GTPase complex	-	41	39	-	-	1.49E-01	1.71E-03
IID	CC	GO:0097540	axonemal central pair	-	161	153	-	-	4.27E-02	6.57E-03
IID	CC	GO:0042641	actomyosin	-	77	76	-	-	1.23E-02	3.26E-03
IID	CC	GO:0097386	glial cell projection	-	38	38	-	-	1.40E-03	1.66E-03
IID	CC	GO:0032588	trans-Golgi network membrane	-	102	102	-	-	1.50E-02	4.38E-03
IID	CC	GO:0070382	exocytic vesicle	-	224	223	-	-	2.10E-02	9.56E-03
IID	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	47	-	-	2.85E-02	2.03E-03
IID	CC	GO:0031903	microbody membrane	-	65	65	-	-	1.23E-01	2.78E-03
IID	CC	GO:0046930	pore complex	-	26	26	-	-	2.07E-02	1.12E-03
IID	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	4.57E-03	4.81E-04
IID	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	1.69E-03	6.95E-04
IID	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	249	-	-	2.49E-02	1.07E-02
IID	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	7.61E-03	1.07E-03
IID	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.55E-01	4.81E-04
IID	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	3.94E-03	8.01E-04
IID	CC	GO:0044298	cell body membrane	-	32	32	-	-	8.08E-03	1.39E-03
IID	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	1.55E-02	4.81E-04
IID	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	7.98E-04	9.08E-04
IID	CC	GO:0045495	pole plasm	-	25	25	-	-	2.98E-02	1.07E-03
IID	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	5.89E-03	6.41E-04
IID	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	4.45E-02	8.55E-04
IID	CC	GO:0010369	chromocenter	-	14	14	-	-	1.79E-03	6.41E-04
IID	CC	GO:0002177	manchette	-	19	18	-	-	2.71E-02	8.01E-04
IID	CC	GO:0016323	basolateral plasma membrane	-	239	238	-	-	1.41E-02	1.02E-02
IID	CC	GO:0045009	chitosome	-	21	21	-	-	4.75E-02	9.08E-04
IID	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	1.37E-03	5.34E-04
IID	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	1.09E-02	1.92E-03
IID	CC	GO:0098636	protein complex involved in cell adhesion	-	57	56	-	-	5.24E-02	2.40E-03
IID	CC	GO:0001917	photoreceptor inner segment	-	71	70	-	-	1.27E-02	2.99E-03
IID	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	1.18E-03	6.41E-04
IID	CC	GO:0019897	extrinsic component of plasma membrane	-	156	153	-	-	2.62E-02	6.57E-03
IID	CC	GO:0031594	neuromuscular junction	-	73	73	-	-	3.21E-03	3.15E-03
IID	CC	GO:0045120	pronucleus	-	14	14	-	-	4.81E-04	6.41E-04
IID	CC	GO:0043083	synaptic cleft	-	21	21	-	-	7.41E-02	9.08E-04
IID	CC	GO:0000922	spindle pole	-	172	169	-	-	1.56E-02	7.27E-03
IID	CC	GO:0120111	neuron projection cytoplasm	-	94	94	-	-	8.11E-03	4.06E-03
IID	CC	GO:0070971	endoplasmic reticulum exit site	-	32	29	-	-	1.23E-01	1.28E-03
IID	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	5.85E-02	5.88E-04
IID	CC	GO:0004879	nuclear receptor activity	-	63	63	-	-	5.88E-02	2.72E-03
IID	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	168	-	-	1.91E-02	7.21E-03
IID	CC	GO:0000123	histone acetyltransferase complex	-	93	92	-	-	1.08E-01	3.95E-03
IID	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	5.38E-03	5.88E-04
IID	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	112	-	-	1.48E-01	4.81E-03
IID	CC	GO:0048786	presynaptic active zone	-	80	80	-	-	7.51E-03	3.42E-03
IID	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	5.21E-03	4.81E-04
IID	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	7.54E-02	5.34E-04
IID	CC	GO:0007034	vacuolar transport	-	168	166	-	-	3.02E-02	7.11E-03
IID	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	2.55E-02	9.08E-04
IID	CC	GO:0043194	axon initial segment	-	21	21	-	-	7.47E-03	9.08E-04
IID	CC	GO:1900115	extracellular regulation of signal transduction	-	13	12	-	-	3.02E-03	5.34E-04
IID	CC	GO:0005776	autophagosome	-	111	110	-	-	3.12E-02	4.70E-03
IID	CC	GO:0031430	M band	-	22	22	-	-	1.02E-02	9.62E-04
IID	CC	GO:0001931	uropod	-	13	13	-	-	9.87E-03	5.88E-04
IID	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	76	-	-	1.43E-01	3.26E-03
IID	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	100	-	-	2.26E-01	4.27E-03
IID	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	1.98E-01	5.88E-04
IID	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	2.17E-02	8.55E-04
IID	CC	GO:0071203	WASH complex	-	12	12	-	-	1.89E-01	5.34E-04
IID	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	5.84E-02	1.28E-03
IID	CC	GO:0032994	protein-lipid complex	-	39	39	-	-	7.88E-02	1.71E-03
IID	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	147	-	-	8.22E-02	6.30E-03
IID	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	9.24E-03	5.34E-04
IID	CC	GO:0001527	microfibril	-	13	13	-	-	5.61E-02	5.88E-04
IID	CC	GO:0072562	blood microparticle	-	144	138	-	-	2.75E-02	5.93E-03
IID	CC	GO:0005883	neurofilament	-	11	11	-	-	3.47E-03	4.81E-04
IID	CC	GO:0051233	spindle midzone	-	36	35	-	-	5.26E-03	1.50E-03
IID	CC	GO:0005811	lipid droplet	-	102	101	-	-	2.31E-02	4.33E-03
IID	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	1.14E-02	1.92E-03
IID	CC	GO:0043113	receptor clustering	-	51	51	-	-	4.60E-03	2.19E-03
IID	CC	GO:0005940	septin ring	-	14	13	-	-	4.32E-01	5.88E-04
IID	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	7.99E-03	4.81E-04
IID	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	24	-	-	4.80E-02	1.07E-03
IID	CC	GO:0044853	plasma membrane raft	-	114	113	-	-	5.90E-03	4.86E-03
IID	CC	GO:0005881	cytoplasmic microtubule	-	256	245	-	-	2.08E-02	1.05E-02
IID	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	2.23E-03	6.41E-04
IID	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	2.56E-02	7.48E-04
IID	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	58	-	-	3.24E-02	2.51E-03
IID	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	1.43E-02	3.10E-03
IID	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	3.08E-02	5.34E-04
IID	CC	GO:0043034	costamere	-	18	18	-	-	6.78E-03	8.01E-04
IID	CC	GO:0031904	endosome lumen	-	38	38	-	-	1.69E-02	1.66E-03
IID	CC	GO:0060170	ciliary membrane	-	76	74	-	-	1.60E-02	3.21E-03
IID	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	3.68E-01	5.88E-04
IID	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	1.63E-02	5.34E-04
IID	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	5.86E-02	1.07E-03
IID	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	2.36E-02	6.41E-04
IID	CC	GO:0032154	cleavage furrow	-	54	53	-	-	4.29E-03	2.30E-03
IID	CC	GO:0005640	nuclear outer membrane	-	30	29	-	-	4.66E-03	1.28E-03
IID	CC	GO:0005652	nuclear lamina	-	12	12	-	-	2.54E-03	5.34E-04
IID	CC	GO:0007006	mitochondrial membrane organization	-	117	110	-	-	2.27E-02	4.70E-03
IID	CC	GO:0001772	immunological synapse	-	44	44	-	-	5.43E-03	1.92E-03
IID	CC	GO:0030904	retromer complex	-	12	12	-	-	3.52E-02	5.34E-04
IID	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	8.15E-03	5.34E-04
IID	CC	GO:0030863	cortical cytoskeleton	-	104	102	-	-	1.11E-02	4.38E-03
IID	CC	GO:1905348	endonuclease complex	-	38	36	-	-	3.96E-02	1.55E-03
IID	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	3.24E-01	4.81E-04
IID	CC	GO:0030315	T-tubule	-	52	52	-	-	1.29E-02	2.24E-03
IID	CC	GO:0060076	excitatory synapse	-	64	64	-	-	1.62E-02	2.78E-03
IID	CC	GO:0036019	endolysosome	-	29	29	-	-	2.63E-02	1.28E-03
IID	CC	GO:0001891	phagocytic cup	-	28	28	-	-	4.10E-03	1.23E-03
IID	CC	GO:0099086	synaptonemal structure	-	40	39	-	-	2.29E-02	1.71E-03
IID	CC	GO:0030427	site of polarized growth	-	172	172	-	-	5.17E-03	7.37E-03
IID	CC	GO:0044309	neuron spine	-	213	213	-	-	9.87E-03	9.14E-03
IID	CC	GO:0030658	transport vesicle membrane	-	231	229	-	-	3.67E-02	9.83E-03
IID	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	4.53E-03	1.18E-03
IID	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.64E-01	5.34E-04
IID	CC	GO:0000940	outer kinetochore	-	17	17	-	-	3.25E-02	7.48E-04
IID	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	5.06E-02	7.48E-04
IID	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	8.52E-03	2.14E-03
IID	CC	GO:0098803	respiratory chain complex	-	39	38	-	-	1.53E-01	1.66E-03
IID	CC	GO:0097545	axonemal outer doublet	-	164	156	-	-	3.79E-02	6.68E-03
IID	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	4.05E-04	8.55E-04
IID	CC	GO:0070069	cytochrome complex	-	42	41	-	-	1.40E-01	1.76E-03
IID	CC	GO:0031143	pseudopodium	-	18	18	-	-	4.88E-03	8.01E-04
IID	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	1.05E-01	1.18E-03
IID	CC	GO:0055037	recycling endosome	-	200	197	-	-	1.11E-02	8.44E-03
IID	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	94	-	-	5.39E-03	4.06E-03
IID	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	8.07E-02	5.88E-04
IID	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	6.11E-04	5.88E-04
IID	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	2.23E-03	9.62E-04
IID	CC	GO:0030684	preribosome	-	76	73	-	-	1.11E-01	3.15E-03
IID	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	1.37E-01	8.01E-04
IID	CC	GO:1990391	DNA repair complex	-	22	22	-	-	5.86E-03	9.62E-04
IID	CC	GO:0005775	vacuolar lumen	-	176	175	-	-	1.27E-02	7.48E-03
IID	CC	GO:0032433	filopodium tip	-	19	19	-	-	6.04E-04	8.55E-04
IID	CC	GO:0032982	myosin filament	-	24	24	-	-	5.76E-02	1.07E-03
IID	CC	GO:0016327	apicolateral plasma membrane	-	23	23	-	-	1.55E-02	1.02E-03
IID	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	4.56E-02	1.02E-03
IID	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	2.76E-03	5.34E-04
IID	CC	GO:0044306	neuron projection terminus	-	164	164	-	-	9.78E-03	7.05E-03
IID	CC	GO:0034455	t-UTP complex	-	53	51	-	-	9.65E-02	2.19E-03
IID	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	6.57E-01	7.48E-04
IID	CC	GO:0031970	organelle envelope lumen	-	94	93	-	-	9.08E-03	4.01E-03
IID	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	2.12E-02	5.88E-04
IID	CC	GO:0120293	dynein axonemal particle	-	20	20	-	-	1.89E-02	8.55E-04
IID	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	9.28E-04	1.07E-03
IID	CC	GO:0043292	contractile muscle fiber	-	245	239	-	-	5.18E-02	1.03E-02
IID	CC	GO:0018995	host cellular component	-	12	12	-	-	1.20E-03	5.34E-04
IID	CC	GO:0034709	methylosome	-	13	13	-	-	7.20E-03	5.88E-04
IID	CC	GO:0032426	stereocilium tip	-	21	20	-	-	2.82E-03	8.55E-04
IID	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	4.57E-02	5.34E-04
IID	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	9.99E-02	8.55E-04
IID	CC	GO:0000803	sex chromosome	-	32	29	-	-	3.11E-03	1.28E-03
IID	CC	GO:0098982	GABA-ergic synapse	-	84	84	-	-	1.76E-02	3.63E-03
IID	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	3.89E-02	6.95E-04
IID	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	3.40E-02	2.72E-03
IID	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	1.61E-01	6.41E-04
IID	CC	GO:0000242	pericentriolar material	-	22	22	-	-	7.49E-03	9.62E-04
IID	CC	GO:1903293	phosphatase complex	-	54	53	-	-	3.64E-02	2.30E-03
IID	CC	GO:0097470	ribbon synapse	-	13	13	-	-	2.22E-03	5.88E-04
IID	CC	GO:0031941	filamentous actin	-	27	27	-	-	2.28E-02	1.18E-03
IID	CC	GO:0000786	nucleosome	-	149	107	-	-	4.54E-02	4.59E-03
IID	CC	GO:0001533	cornified envelope	-	59	59	-	-	4.80E-02	2.56E-03
IID	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	5.63E-03	2.35E-03
IID	CC	GO:0030027	lamellipodium	-	202	201	-	-	1.08E-02	8.60E-03
IID	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	3.32E-03	6.41E-04
IID	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	26	-	-	2.11E-01	1.12E-03
IID	CC	GO:0000800	lateral element	-	14	14	-	-	7.28E-03	6.41E-04
IID	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	8.09E-03	5.34E-04
IID	CC	GO:0060077	inhibitory synapse	-	20	20	-	-	2.46E-02	8.55E-04
IID	CC	GO:0031209	SCAR complex	-	12	12	-	-	2.56E-02	5.34E-04
IID	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	2.17E-01	4.81E-04
IID	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	1.74E-01	6.95E-04
IID	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	22	-	-	2.00E-01	9.62E-04
IID	CC	GO:0002102	podosome	-	31	31	-	-	3.49E-03	1.34E-03
IID	CC	GO:0090543	Flemming body	-	33	32	-	-	3.31E-03	1.39E-03
IID	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	9.64E-03	2.83E-03
IID	CC	GO:0001650	fibrillar center	-	151	151	-	-	4.76E-03	6.46E-03
IID	CC	GO:0031332	RNAi effector complex	-	413	17	-	-	1.27E-02	7.48E-04
IID	CC	GO:1990204	oxidoreductase complex	-	90	89	-	-	6.96E-02	3.85E-03
IID	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	1.65E-01	6.95E-04
IID	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	4.04E-02	4.81E-04
IID	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	122	-	-	4.11E-03	5.24E-03
IID	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	4.79E-02	8.55E-04
IID	CC	GO:0001726	ruffle	-	181	180	-	-	1.19E-02	7.69E-03
IID	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	2.39E-01	4.81E-04
IID	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	3.10E-03	5.88E-04
IID	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	7.63E-02	8.01E-04
IID	CC	GO:0043198	dendritic shaft	-	38	38	-	-	9.27E-04	1.66E-03
IID	CC	GO:0043073	germ cell nucleus	-	67	66	-	-	4.27E-03	2.83E-03
IID	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	22	-	-	5.64E-03	9.62E-04
IID	CC	GO:0016592	mediator complex	-	38	38	-	-	3.64E-01	1.66E-03
IID	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	3.26E-02	8.55E-04
IID	CC	GO:0022626	cytosolic ribosome	-	118	117	-	-	1.93E-01	5.02E-03
IID	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	3.63E-02	1.92E-03
IID	CC	GO:0034451	centriolar satellite	-	120	118	-	-	1.77E-02	5.08E-03
IID	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	2.45E-02	4.81E-04
IID	CC	GO:0045171	intercellular bridge	-	91	91	-	-	3.55E-03	3.90E-03
IID	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	81	-	-	1.53E-02	3.47E-03
IID	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	1.39E-01	6.41E-04
IID	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.73E-02	4.81E-04
IID	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	1.27E-01	4.81E-04
IID	CC	GO:0044292	dendrite terminus	-	13	13	-	-	2.05E-03	5.88E-04
IID	CC	GO:0032039	integrator complex	-	19	18	-	-	5.98E-01	8.01E-04
IID	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	4.40E-03	6.41E-04
IID	CC	GO:0033268	node of Ranvier	-	16	16	-	-	6.62E-03	6.95E-04
IID	CC	GO:0036038	MKS complex	-	13	13	-	-	3.24E-02	5.88E-04
IID	CC	GO:0030527	structural constituent of chromatin	-	97	55	-	-	4.83E-02	2.35E-03
IID	CC	GO:0036379	myofilament	-	26	25	-	-	5.50E-02	1.07E-03
IID	CC	GO:0030286	dynein complex	-	210	200	-	-	5.75E-02	8.55E-03
IID	CC	GO:0031105	septin complex	-	14	13	-	-	3.88E-01	5.88E-04
IID	CC	GO:0097228	sperm principal piece	-	33	31	-	-	5.98E-02	1.34E-03
IID	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	5.59E-03	5.34E-04
IID	CC	GO:0016482	cytosolic transport	-	135	135	-	-	1.37E-02	5.77E-03
IID	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	6.59E-02	1.02E-03
IID	CC	GO:0005796	Golgi lumen	-	106	102	-	-	1.11E-02	4.38E-03
IID	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	36	-	-	1.99E-01	1.55E-03
IID	CC	GO:0034358	plasma lipoprotein particle	-	36	36	-	-	1.05E-01	1.55E-03
IID	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	6.10E-02	2.03E-03
IID	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	8.08E-03	1.07E-03
IID	CC	GO:0030662	coated vesicle membrane	-	202	200	-	-	3.46E-02	8.55E-03
IID	CC	GO:0007039	protein catabolic process in the vacuole	-	61	60	-	-	3.81E-02	2.56E-03
IID	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	67	-	-	2.02E-01	2.88E-03
IID	CC	GO:0090734	site of DNA damage	-	118	117	-	-	1.85E-02	5.02E-03
IID	MF	GO:0051861	glycolipid binding	-	30	30	-	-	2.27E-03	1.28E-03
IID	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	6.69E-03	4.81E-04
IID	MF	GO:0051087	protein-folding chaperone binding	-	135	134	-	-	8.42E-03	5.77E-03
IID	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	2.53E-02	1.18E-03
IID	CC	GO:0015464	acetylcholine receptor activity	-	21	20	-	-	4.03E-02	8.55E-04
IID	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	5.07E-03	5.34E-04
IID	MF	GO:0016594	glycine binding	-	12	12	-	-	2.60E-02	5.34E-04
IID	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	1.01E-01	8.55E-04
IID	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	3.10E-03	1.60E-03
IID	MF	GO:0035613	RNA stem-loop binding	-	21	18	-	-	1.56E-03	8.01E-04
IID	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	247	-	-	3.38E-02	1.06E-02
IID	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	7.40E-03	8.55E-04
IID	MF	GO:0033691	sialic acid binding	-	22	22	-	-	3.47E-02	9.62E-04
IID	MF	GO:0048306	calcium-dependent protein binding	-	61	59	-	-	6.78E-03	2.56E-03
IID	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	1.13E-01	1.23E-03
IID	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	1.65E-02	5.88E-04
IID	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	144	-	-	8.27E-02	6.20E-03
IID	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	59	-	-	9.60E-02	2.56E-03
IID	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	137	-	-	3.78E-02	5.88E-03
IID	MF	GO:0045504	dynein heavy chain binding	-	16	16	-	-	3.53E-02	6.95E-04
IID	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	3.96E-02	1.28E-03
IID	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	2.38E-03	9.62E-04
IID	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	1.33E-03	6.95E-04
IID	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	1.89E-02	6.41E-04
IID	MF	GO:0061980	regulatory RNA binding	-	52	45	-	-	3.15E-02	1.92E-03
IID	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	6.65E-02	1.39E-03
IID	MF	GO:0000182	rDNA binding	-	11	11	-	-	6.66E-03	4.81E-04
IID	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	3.00E-03	1.28E-03
IID	MF	GO:0070840	dynein complex binding	-	25	25	-	-	1.11E-03	1.07E-03
IID	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.79E-03	1.07E-03
IID	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.25E-03	6.95E-04
IID	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	35	-	-	1.48E-02	1.50E-03
IID	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	1.31E-02	8.01E-04
IID	MF	GO:0005178	integrin binding	-	153	153	-	-	6.13E-02	6.57E-03
IID	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	9.20E-04	7.48E-04
IID	MF	GO:0005549	odorant binding	-	128	89	-	-	7.55E-02	3.85E-03
IID	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	3.46E-02	6.41E-04
IID	MF	GO:0008327	methyl-CpG binding	-	31	28	-	-	6.11E-03	1.23E-03
IID	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	5.12E-03	8.55E-04
IID	MF	GO:0048019	receptor antagonist activity	-	31	20	-	-	1.00E-02	8.55E-04
IID	MF	GO:0005521	lamin binding	-	15	15	-	-	3.41E-03	6.41E-04
IID	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	18	-	-	2.15E-03	8.01E-04
IID	MF	GO:0140318	protein transporter activity	-	40	40	-	-	3.11E-02	1.71E-03
IID	MF	GO:0070628	proteasome binding	-	17	17	-	-	3.36E-03	7.48E-04
IID	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	2.85E-03	4.81E-04
IID	MF	GO:0031432	titin binding	-	13	11	-	-	1.61E-02	4.81E-04
IID	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.26E-03	4.81E-04
IID	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	9.86E-03	1.60E-03
IID	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	2.58E-01	7.48E-04
IID	MF	GO:0002039	p53 binding	-	66	66	-	-	3.45E-03	2.83E-03
IID	MF	GO:0005496	steroid binding	-	110	109	-	-	1.56E-02	4.70E-03
IID	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	4.42E-02	1.18E-03
IID	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	5.84E-04	4.81E-04
IID	MF	GO:0003684	damaged DNA binding	-	89	87	-	-	3.10E-02	3.74E-03
IID	MF	GO:0000339	RNA cap binding	-	20	20	-	-	1.65E-02	8.55E-04
IID	MF	GO:0016500	protein-hormone receptor activity	-	21	21	-	-	5.15E-03	9.08E-04
IID	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	128	-	-	2.87E-02	5.50E-03
IID	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	4.05E-03	6.41E-04
IID	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	2.27E-03	5.34E-04
IID	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	1.11E-03	4.81E-04
IID	MF	GO:0070063	RNA polymerase binding	-	61	61	-	-	4.35E-03	2.62E-03
IID	MF	GO:0050811	GABA receptor binding	-	18	18	-	-	2.02E-02	8.01E-04
IID	MF	GO:0030971	receptor tyrosine kinase binding	-	76	76	-	-	7.91E-03	3.26E-03
IID	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	84	-	-	5.45E-02	3.63E-03
IID	MF	GO:0140030	modification-dependent protein binding	-	179	177	-	-	1.15E-02	7.59E-03
IID	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	4.47E-02	1.07E-03
IID	MF	GO:0009881	photoreceptor activity	-	17	15	-	-	1.48E-01	6.41E-04
IID	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	19	-	-	2.87E-01	8.55E-04
IID	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.19E-03	5.88E-04
IID	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	2.39E-02	6.95E-04
IID	MF	GO:0141047	molecular tag activity	-	13	13	-	-	1.39E-03	5.88E-04
IID	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.32E-02	4.81E-04
IID	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	1.49E-02	5.34E-04
IID	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	1.81E-03	6.41E-04
IID	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	8.88E-03	5.34E-04
IID	MF	GO:0044548	S100 protein binding	-	14	14	-	-	8.77E-03	6.41E-04
IID	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	3.40E-02	6.41E-04
IID	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.52E-02	6.41E-04
IID	MF	GO:0030276	clathrin binding	-	70	69	-	-	4.03E-02	2.99E-03
IID	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	6.89E-03	1.28E-03
IID	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	4.57E-04	6.41E-04
IID	MF	GO:0046790	virion binding	-	19	19	-	-	1.05E-03	8.55E-04
IID	MF	GO:0030552	cAMP binding	-	48	46	-	-	1.64E-02	1.98E-03
IID	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	5.31E-03	1.66E-03
IID	MF	GO:0035173	histone kinase activity	-	17	17	-	-	2.20E-03	7.48E-04
IID	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	1.48E-02	1.12E-03
IID	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	2.37E-02	5.34E-04
IID	MF	GO:0016209	antioxidant activity	-	92	88	-	-	1.07E-01	3.79E-03
IID	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	6.05E-03	1.28E-03
IID	MF	GO:0044325	transmembrane transporter binding	-	159	154	-	-	6.95E-03	6.62E-03
IID	MF	GO:0048156	tau protein binding	-	43	43	-	-	3.13E-03	1.87E-03
IID	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	1.96E-02	1.55E-03
IID	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	5.35E-03	5.88E-04
IID	MF	GO:0140272	exogenous protein binding	-	79	78	-	-	5.96E-03	3.37E-03
IID	MF	GO:0030145	manganese ion binding	-	65	64	-	-	4.10E-03	2.78E-03
IID	MF	GO:0071814	protein-lipid complex binding	-	52	47	-	-	1.12E-02	2.03E-03
IID	MF	GO:0008066	glutamate receptor activity	-	70	70	-	-	3.65E-02	2.99E-03
IID	MF	GO:0030553	cGMP binding	-	15	15	-	-	5.96E-02	6.41E-04
IID	MF	GO:0017069	snRNA binding	-	54	47	-	-	1.43E-02	2.03E-03
IID	MF	GO:0030215	semaphorin receptor binding	-	23	23	-	-	4.29E-01	1.02E-03
IID	MF	GO:0031996	thioesterase binding	-	11	11	-	-	9.31E-04	4.81E-04
IID	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	1.72E-02	1.34E-03
IID	MF	GO:0019843	rRNA binding	-	69	68	-	-	1.86E-02	2.94E-03
IID	MF	GO:0004713	protein tyrosine kinase activity	-	213	212	-	-	3.24E-02	9.08E-03
IID	MF	GO:0061783	peptidoglycan muralytic activity	-	14	13	-	-	6.67E-01	5.88E-04
IID	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	52	-	-	5.17E-03	2.24E-03
IID	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.15E-03	1.07E-03
IID	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	6.52E-04	8.55E-04
IID	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	28	-	-	1.66E-03	1.23E-03
IID	MF	GO:0016208	AMP binding	-	22	22	-	-	8.66E-03	9.62E-04
IID	MF	GO:0000287	magnesium ion binding	-	225	224	-	-	2.24E-02	9.62E-03
IID	MF	GO:0031490	chromatin DNA binding	-	120	117	-	-	6.35E-03	5.02E-03
IID	MF	GO:0017022	myosin binding	-	73	72	-	-	6.00E-03	3.10E-03
IID	MF	GO:0004896	cytokine receptor activity	-	93	93	-	-	4.74E-02	4.01E-03
IID	MF	GO:0017166	vinculin binding	-	12	12	-	-	1.16E-02	5.34E-04
IID	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	2.93E-03	8.01E-04
IID	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	6.30E-03	5.34E-04
IID	MF	GO:0005539	glycosaminoglycan binding	-	236	233	-	-	2.03E-02	9.99E-03
IID	MF	GO:0140666	annealing activity	-	11	11	-	-	1.82E-03	4.81E-04
IID	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	5.97E-04	6.41E-04
IID	MF	GO:0010181	FMN binding	-	15	15	-	-	8.04E-03	6.41E-04
IID	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	20	-	-	1.90E-02	8.55E-04
IID	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	26	-	-	1.77E-01	1.12E-03
IID	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	1.41E-03	7.48E-04
IID	MF	GO:0044183	protein folding chaperone	-	67	65	-	-	4.23E-03	2.78E-03
IID	MF	GO:0005132	type I interferon receptor binding	-	17	16	-	-	2.83E-01	6.95E-04
IID	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	2.24E-02	4.65E-03
IID	MF	GO:0003725	double-stranded RNA binding	-	72	72	-	-	7.97E-03	3.10E-03
IID	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	1.27E-02	6.95E-04
IID	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	2.43E-02	2.24E-03
IID	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.44E-03	1.50E-03
IID	MF	GO:0004618	phosphoglycerate kinase activity	-	89	89	-	-	8.09E-03	3.85E-03
IID	MF	GO:0042805	actinin binding	-	36	36	-	-	6.91E-03	1.55E-03
IID	MF	GO:0043531	ADP binding	-	38	38	-	-	2.39E-03	1.66E-03
IID	MF	GO:0043394	proteoglycan binding	-	36	36	-	-	3.88E-03	1.55E-03
IID	MF	GO:0005542	folic acid binding	-	13	11	-	-	1.69E-01	4.81E-04
IID	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	4.99E-03	4.81E-04
IID	MF	GO:0046332	SMAD binding	-	77	77	-	-	1.90E-02	3.31E-03
IID	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.46E-03	5.88E-04
IID	MF	GO:0001968	fibronectin binding	-	30	30	-	-	5.08E-03	1.28E-03
IID	MF	GO:0048038	quinone binding	-	16	16	-	-	4.53E-02	6.95E-04
IID	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	121	-	-	2.46E-02	5.18E-03
IID	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	81	-	-	6.79E-03	3.47E-03
IID	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	3.02E-02	8.01E-04
IID	MF	GO:0051117	ATPase binding	-	85	83	-	-	4.17E-03	3.58E-03
IID	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	4.62E-03	1.98E-03
IID	MF	GO:0051787	misfolded protein binding	-	20	18	-	-	4.63E-03	8.01E-04
IID	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	1.41E-03	4.81E-04
IID	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.49E-03	6.41E-04
IID	MF	GO:0031404	chloride ion binding	-	14	12	-	-	2.09E-03	5.34E-04
IID	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	6.29E-03	2.62E-03
IID	MF	GO:0036002	pre-mRNA binding	-	57	36	-	-	8.55E-03	1.55E-03
IID	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	37	-	-	1.87E-01	1.60E-03
IID	MF	GO:0051540	metal cluster binding	-	71	70	-	-	1.59E-02	2.99E-03
IID	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	8.08E-04	4.81E-04
IID	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	6.13E-03	3.95E-03
IID	MF	GO:0019894	kinesin binding	-	45	45	-	-	6.08E-03	1.92E-03
IID	MF	GO:0042287	MHC protein binding	-	68	63	-	-	3.11E-02	2.72E-03
IID	MF	GO:0019003	GDP binding	-	89	88	-	-	3.49E-02	3.79E-03
IID	MF	GO:0017171	serine hydrolase activity	-	207	200	-	-	2.22E-01	8.55E-03
IID	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	2.64E-03	2.83E-03
IID	MF	GO:0003774	cytoskeletal motor activity	-	117	117	-	-	5.82E-02	5.02E-03
IID	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.30E-03	1.28E-03
IID	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	4.80E-02	7.48E-04
IID	MF	GO:0061134	peptidase regulator activity	-	224	214	-	-	6.77E-02	9.19E-03
IID	MF	GO:0008013	beta-catenin binding	-	86	86	-	-	1.11E-02	3.69E-03
IID	MF	GO:0051015	actin filament binding	-	208	207	-	-	3.86E-02	8.87E-03
IID	MF	GO:0019208	phosphatase regulator activity	-	107	103	-	-	3.33E-02	4.43E-03
IID	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	32	-	-	9.33E-02	1.39E-03
IID	MF	GO:0043236	laminin binding	-	29	28	-	-	3.26E-03	1.23E-03
IID	MF	GO:0030507	spectrin binding	-	26	26	-	-	4.68E-03	1.12E-03
IID	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	42	-	-	2.42E-02	1.82E-03
IID	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	114	-	-	2.93E-02	4.92E-03
IID	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	4.92E-03	1.07E-03
IID	MF	GO:0042393	histone binding	-	240	233	-	-	3.91E-02	9.99E-03
IID	MF	GO:0019838	growth factor binding	-	182	181	-	-	1.77E-02	7.75E-03
IID	MF	GO:0000149	SNARE binding	-	107	107	-	-	8.70E-02	4.59E-03
IID	MF	GO:0003727	single-stranded RNA binding	-	90	86	-	-	9.86E-03	3.69E-03
IID	MF	GO:0051378	serotonin binding	-	24	24	-	-	5.90E-02	1.07E-03
IID	MF	GO:0005516	calmodulin binding	-	206	204	-	-	1.48E-02	8.76E-03
IID	MF	GO:0019825	oxygen binding	-	40	38	-	-	9.92E-02	1.66E-03
IID	MF	GO:0045505	dynein intermediate chain binding	-	37	37	-	-	1.34E-02	1.60E-03
IID	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	86	-	-	3.96E-02	3.69E-03
IID	MF	GO:0032182	ubiquitin-like protein binding	-	117	116	-	-	9.05E-03	4.97E-03
IID	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	2.96E-02	1.55E-03
IID	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	3.86E-03	9.62E-04
IID	MF	GO:0043274	phospholipase binding	-	23	23	-	-	1.04E-03	1.02E-03
IID	MF	GO:0031072	heat shock protein binding	-	128	126	-	-	1.24E-02	5.40E-03
IID	MF	GO:0030515	snoRNA binding	-	33	33	-	-	2.60E-02	1.44E-03
IID	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	76	-	-	2.52E-01	3.26E-03
IID	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	22	-	-	1.44E-01	9.62E-04
IID	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	9.91E-03	1.12E-03
IID	MF	GO:0001530	lipopolysaccharide binding	-	38	35	-	-	7.02E-03	1.50E-03
IID	MF	GO:0140223	general transcription initiation factor activity	-	55	54	-	-	1.12E-01	2.35E-03
IID	MF	GO:0070403	NAD+ binding	-	16	16	-	-	1.37E-02	6.95E-04
IID	MF	GO:0000049	tRNA binding	-	75	74	-	-	2.43E-02	3.21E-03
IID	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	9.46E-03	1.92E-03
IID	MF	GO:0015026	coreceptor activity	-	48	47	-	-	1.88E-02	2.03E-03
IID	MF	GO:0005527	macrolide binding	-	12	12	-	-	3.06E-02	5.34E-04
IID	MF	GO:0001653	peptide receptor activity	-	128	121	-	-	6.39E-02	5.18E-03
IID	MF	GO:0031005	filamin binding	-	15	14	-	-	4.00E-03	6.41E-04
IID	MF	GO:0030506	ankyrin binding	-	19	19	-	-	1.89E-03	8.55E-04
IID	MF	GO:0006469	negative regulation of protein kinase activity	-	222	210	-	-	7.14E-03	8.98E-03
IID	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	1.40E-03	8.55E-04
IID	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	5.20E-04	6.41E-04
IID	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	5.61E-03	1.34E-03
IID	MF	GO:0051427	hormone receptor binding	-	31	31	-	-	1.38E-02	1.34E-03
IID	MF	GO:0070851	growth factor receptor binding	-	141	141	-	-	3.12E-02	6.04E-03
IID	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	2.09E-02	1.39E-03
IID	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	43	-	-	1.00E-02	1.87E-03
IID	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	6.01E-03	8.55E-04
IID	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	3.12E-03	7.48E-04
IID	MF	GO:0005506	iron ion binding	-	154	151	-	-	2.70E-01	6.46E-03
IID	MF	GO:0003925	G protein activity	-	45	45	-	-	1.65E-02	1.92E-03
IID	MF	GO:0038187	pattern recognition receptor activity	-	33	33	-	-	4.15E-02	1.44E-03
IID	MF	GO:0008276	protein methyltransferase activity	-	96	95	-	-	1.31E-02	4.06E-03
IID	MF	GO:0004396	hexokinase activity	-	16	16	-	-	6.43E-02	6.95E-04
IID	MF	GO:0070888	E-box binding	-	59	58	-	-	3.93E-02	2.51E-03
IID	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.70E-02	6.41E-04
IID	MF	GO:0015399	primary active transmembrane transporter activity	-	190	188	-	-	1.56E-01	8.07E-03
IID	MF	GO:0035254	glutamate receptor binding	-	47	47	-	-	2.57E-03	2.03E-03
IID	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	5.45E-03	1.44E-03
IID	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	1.92E-03	4.81E-04
IID	MF	GO:0043021	ribonucleoprotein complex binding	-	158	157	-	-	9.39E-03	6.73E-03
IID	MF	GO:0030170	pyridoxal phosphate binding	-	56	53	-	-	1.27E-01	2.30E-03
IID	MF	GO:0032393	MHC class I receptor activity	-	15	15	-	-	6.56E-02	6.41E-04
IID	MF	GO:0005112	Notch binding	-	26	25	-	-	8.14E-03	1.07E-03
IID	MF	GO:0048185	activin binding	-	16	16	-	-	1.22E-02	6.95E-04
IID	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	8.54E-03	1.23E-03
IID	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	3.47E-03	4.81E-04
IID	MF	GO:0140299	small molecule sensor activity	-	39	37	-	-	3.95E-02	1.60E-03
IID	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.70E-02	9.62E-04
IID	MF	GO:0016917	GABA receptor activity	-	23	23	-	-	3.37E-01	1.02E-03
IID	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	1.12E-02	6.41E-04
IID	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	26	-	-	1.78E-03	1.12E-03
IID	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	44	-	-	1.75E-02	1.92E-03
IID	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.41E-03	1.07E-03
IID	MF	GO:0008527	taste receptor activity	-	28	23	-	-	4.09E-01	1.02E-03
IID	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	2.93E-02	5.34E-04
IID	MF	GO:0030594	neurotransmitter receptor activity	-	160	158	-	-	2.07E-01	6.78E-03
IID	MF	GO:0034452	dynactin binding	-	12	12	-	-	1.07E-03	5.34E-04
IID	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	5.01E-02	1.07E-03
IID	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	1.23E-01	9.08E-04
IID	MF	GO:0005507	copper ion binding	-	63	60	-	-	1.26E-02	2.56E-03
IID	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	1.41E-02	9.62E-04
IID	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	1.97E-03	4.81E-04
IID	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.54E-02	9.62E-04
IID	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	1.20E-01	5.34E-04
InBio	CC	GO:0005739	mitochondrion	5.27E-28	1671	1621	1510	1.07	-	-
InBio	CC	GO:0005730	nucleolus	1.37E-20	988	965	893	1.08	-	-
InBio	CC	GO:0005768	endosome	1.49E-18	1037	1008	937	1.08	-	-
InBio	CC	GO:0005783	endoplasmic reticulum	2.71E-18	2020	1926	1825	1.06	-	-
InBio	CC	GO:0005615	extracellular space	1.79E-13	3190	2989	2882	1.04	-	-
InBio	CC	GO:0005764	lysosome	6.83E-13	747	725	675	1.07	-	-
InBio	CC	GO:0005794	Golgi apparatus	1.28E-10	1636	1547	1478	1.05	-	-
InBio	CC	GO:0005815	microtubule organizing center	5.51E-10	843	809	762	1.06	-	-
InBio	CC	GO:0005635	nuclear envelope	9.61E-10	493	480	445	1.08	-	-
InBio	CC	GO:0005840	ribosome	6.82E-09	222	221	201	1.10	-	-
InBio	CC	GO:0000228	nuclear chromosome	7.23E-05	206	201	186	1.08	-	-
InBio	CC	GO:0005811	lipid droplet	3.83E-03	102	100	92	1.09	-	-
InBio	CC	GO:0005777	peroxisome	2.24E-02	142	136	128	1.06	-	-
InBio	CC	GO:0031012	extracellular matrix	3.56E-02	564	524	510	1.03	-	-
InBio	CC	GO:0005929	cilium	9.05E-01	842	760	761	1.00	-	-
InBio	BP	GO:0006355	regulation of DNA-templated transcription	1.22E-29	3342	3182	3019	1.05	-	-
InBio	BP	GO:0016192	vesicle-mediated transport	8.04E-27	1894	1828	1711	1.07	-	-
InBio	BP	GO:0012501	programmed cell death	2.77E-26	1954	1883	1765	1.07	-	-
InBio	BP	GO:0007010	cytoskeleton organization	2.34E-20	1639	1576	1481	1.06	-	-
InBio	BP	GO:0048870	cell motility	4.35E-19	1659	1592	1499	1.06	-	-
InBio	BP	GO:0006886	intracellular protein transport	4.69E-19	664	655	600	1.09	-	-
InBio	BP	GO:0006914	autophagy	5.59E-17	568	561	513	1.09	-	-
InBio	BP	GO:0006281	DNA repair	6.72E-16	587	578	530	1.09	-	-
InBio	BP	GO:0030163	protein catabolic process	2.71E-14	990	956	894	1.07	-	-
InBio	BP	GO:0007155	cell adhesion	1.52E-13	1444	1378	1305	1.06	-	-
InBio	BP	GO:0016071	mRNA metabolic process	9.35E-12	713	691	644	1.07	-	-
InBio	BP	GO:0055086	nucleobase-containing small molecule metabolic process	9.99E-12	729	706	659	1.07	-	-
InBio	BP	GO:0006091	generation of precursor metabolites and energy	3.24E-11	502	491	454	1.08	-	-
InBio	BP	GO:0042060	wound healing	8.66E-11	431	423	389	1.09	-	-
InBio	BP	GO:0006629	lipid metabolic process	1.20E-10	1355	1287	1224	1.05	-	-
InBio	BP	GO:0007005	mitochondrion organization	1.27E-10	484	473	437	1.08	-	-
InBio	BP	GO:0065003	protein-containing complex assembly	1.47E-10	1648	1558	1489	1.05	-	-
InBio	BP	GO:0072659	protein localization to plasma membrane	2.00E-10	284	282	257	1.10	-	-
InBio	BP	GO:0042254	ribosome biogenesis	5.91E-10	297	294	268	1.10	-	-
InBio	BP	GO:0003013	circulatory system process	8.63E-10	584	566	528	1.07	-	-
InBio	BP	GO:0002376	immune system process	3.14E-09	2448	2289	2212	1.04	-	-
InBio	BP	GO:0006913	nucleocytoplasmic transport	3.49E-09	326	321	295	1.09	-	-
InBio	BP	GO:0006260	DNA replication	4.16E-09	279	276	252	1.10	-	-
InBio	BP	GO:0006520	amino acid metabolic process	1.00E-08	292	288	264	1.09	-	-
InBio	BP	GO:0006954	inflammatory response	3.02E-08	820	783	741	1.06	-	-
InBio	BP	GO:0007163	establishment or maintenance of cell polarity	4.79E-08	227	225	205	1.10	-	-
InBio	BP	GO:0005975	carbohydrate metabolic process	6.86E-08	551	531	498	1.07	-	-
InBio	BP	GO:0140053	mitochondrial gene expression	8.17E-08	164	164	148	1.11	-	-
InBio	BP	GO:0003012	muscle system process	6.94E-07	425	411	384	1.07	-	-
InBio	BP	GO:0007059	chromosome segregation	8.75E-07	403	390	364	1.07	-	-
InBio	BP	GO:0006399	tRNA metabolic process	1.09E-06	196	194	177	1.10	-	-
InBio	BP	GO:0034330	cell junction organization	2.61E-06	727	691	657	1.05	-	-
InBio	BP	GO:0002181	cytoplasmic translation	5.84E-06	153	152	138	1.10	-	-
InBio	BP	GO:0006310	DNA recombination	1.31E-05	333	322	301	1.07	-	-
InBio	BP	GO:0007018	microtubule-based movement	2.24E-04	640	604	578	1.04	-	-
InBio	BP	GO:0006790	sulfur compound metabolic process	2.53E-04	320	307	289	1.06	-	-
InBio	BP	GO:0006766	vitamin metabolic process	4.21E-04	107	106	97	1.10	-	-
InBio	BP	GO:0055085	transmembrane transport	7.39E-04	1784	1651	1612	1.02	-	-
InBio	BP	GO:0050877	nervous system process	8.07E-04	1527	1416	1380	1.03	-	-
InBio	BP	GO:0000910	cytokinesis	1.10E-03	186	180	168	1.07	-	-
InBio	BP	GO:0022600	digestive system process	1.86E-03	110	108	99	1.09	-	-
InBio	BP	GO:0003014	renal system process	2.27E-03	127	124	115	1.08	-	-
InBio	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	4.52E-03	119	116	108	1.08	-	-
InBio	BP	GO:0006325	chromatin organization	4.57E-03	720	672	650	1.03	-	-
InBio	BP	GO:0044782	cilium organization	5.98E-03	399	376	360	1.04	-	-
InBio	BP	GO:0007040	lysosome organization	1.26E-02	107	104	97	1.08	-	-
InBio	BP	GO:0006457	protein folding	1.31E-02	210	200	190	1.05	-	-
InBio	BP	GO:0030198	extracellular matrix organization	2.65E-02	314	295	284	1.04	-	-
InBio	BP	GO:0098754	detoxification	3.92E-02	134	128	121	1.06	-	-
InBio	BP	GO:0140013	meiotic nuclear division	4.09E-02	279	262	252	1.04	-	-
InBio	BP	GO:0032200	telomere organization	8.11E-02	186	161	168	0.96	-	-
InBio	BP	GO:0006486	protein glycosylation	1.40E-01	225	210	203	1.03	-	-
InBio	BP	GO:0006575	cellular modified amino acid metabolic process	1.68E-01	186	174	168	1.04	-	-
InBio	BP	GO:0098542	defense response to other organism	5.07E-01	1171	1065	1058	1.01	-	-
InBio	MF	GO:0016740	transferase activity	2.17E-42	3074	2962	2777	1.07	-	-
InBio	MF	GO:0003723	RNA binding	1.35E-26	1679	1626	1517	1.07	-	-
InBio	MF	GO:0008092	cytoskeletal protein binding	5.01E-17	1023	992	924	1.07	-	-
InBio	MF	GO:0140096	"catalytic activity, acting on a protein"	2.01E-16	3198	3008	2889	1.04	-	-
InBio	MF	GO:0140657	ATP-dependent activity	4.09E-16	729	713	659	1.08	-	-
InBio	MF	GO:0016491	oxidoreductase activity	1.04E-14	888	861	802	1.07	-	-
InBio	MF	GO:0003677	DNA binding	1.08E-14	2865	2695	2588	1.04	-	-
InBio	MF	GO:0140110	transcription regulator activity	1.58E-14	2033	1927	1837	1.05	-	-
InBio	MF	GO:0140098	"catalytic activity, acting on RNA"	2.46E-10	417	409	377	1.09	-	-
InBio	MF	GO:0140097	"catalytic activity, acting on DNA"	7.62E-10	383	376	346	1.09	-	-
InBio	MF	GO:0003924	GTPase activity	1.19E-08	658	633	594	1.06	-	-
InBio	MF	GO:0008289	lipid binding	5.88E-08	836	797	755	1.06	-	-
InBio	MF	GO:0016829	lyase activity	1.23E-06	538	516	486	1.06	-	-
InBio	MF	GO:0045182	translation regulator activity	5.68E-06	151	150	136	1.10	-	-
InBio	MF	GO:0016874	ligase activity	1.04E-05	283	275	256	1.08	-	-
InBio	MF	GO:0016853	isomerase activity	3.50E-04	252	243	228	1.07	-	-
InBio	MF	GO:0042393	histone binding	1.18E-03	237	228	214	1.06	-	-
InBio	MF	GO:0140104	molecular carrier activity	1.23E-02	105	102	95	1.08	-	-
InBio	MF	GO:0009975	cyclase activity	1.36E-02	277	262	250	1.05	-	-
InBio	MF	GO:0003774	cytoskeletal motor activity	5.64E-02	116	111	105	1.06	-	-
InBio	MF	GO:0038024	cargo receptor activity	2.09E-01	117	110	106	1.04	-	-
InBio	MF	GO:0005215	transporter activity	2.31E-01	1462	1334	1321	1.01	-	-
InBio	MF	GO:0048018	receptor ligand activity	5.41E-01	504	460	455	1.01	-	-
InBio	MF	GO:0005198	structural molecule activity	9.51E-01	798	722	721	1.00	-	-
InBio	BP	GO:0008038	neuron recognition	-	46	46	-	-	2.13E-03	2.13E-03
InBio	BP	GO:1905145	cellular response to acetylcholine	-	33	31	-	-	6.03E-03	1.44E-03
InBio	BP	GO:0097094	craniofacial suture morphogenesis	-	18	17	-	-	2.53E-03	8.04E-04
InBio	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	6.58E-03	9.77E-04
InBio	BP	GO:0051931	regulation of sensory perception	-	36	32	-	-	4.36E-03	1.49E-03
InBio	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	3.11E-03	1.15E-03
InBio	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.68E-04	6.32E-04
InBio	BP	GO:0009268	response to pH	-	43	41	-	-	2.29E-02	1.90E-03
InBio	BP	GO:0045666	positive regulation of neuron differentiation	-	91	84	-	-	5.65E-03	3.91E-03
InBio	BP	GO:0043543	protein acylation	-	107	102	-	-	3.78E-03	4.71E-03
InBio	MF	GO:0051349	positive regulation of lyase activity	-	41	39	-	-	1.51E-02	1.84E-03
InBio	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	3.81E-03	6.89E-04
InBio	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.26E-03	1.15E-03
InBio	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	6.55E-03	9.19E-04
InBio	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	133	-	-	7.83E-02	6.15E-03
InBio	BP	GO:0071763	nuclear membrane organization	-	44	43	-	-	2.48E-02	2.01E-03
InBio	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	34	-	-	2.84E-03	1.61E-03
InBio	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	3.71E-02	3.16E-03
InBio	BP	GO:0022038	corpus callosum development	-	25	25	-	-	2.64E-03	1.15E-03
InBio	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	11	-	-	1.65E-03	5.17E-04
InBio	BP	GO:0021548	pons development	-	11	11	-	-	5.54E-04	5.17E-04
InBio	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	8.22E-03	5.74E-04
InBio	BP	GO:0043299	leukocyte degranulation	-	82	79	-	-	6.17E-03	3.68E-03
InBio	BP	GO:0048864	stem cell development	-	88	87	-	-	2.94E-03	4.02E-03
InBio	BP	GO:0009310	amine catabolic process	-	20	16	-	-	6.01E-03	7.47E-04
InBio	BP	GO:0051651	maintenance of location in cell	-	236	222	-	-	9.29E-03	1.02E-02
InBio	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	5.04E-03	1.26E-03
InBio	BP	GO:0014004	microglia differentiation	-	12	12	-	-	7.67E-04	5.74E-04
InBio	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	29	-	-	2.30E-03	1.38E-03
InBio	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	2.63E-03	6.89E-04
InBio	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.93E-03	6.89E-04
InBio	BP	GO:0046415	urate metabolic process	-	12	11	-	-	1.70E-04	5.17E-04
InBio	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	4.46E-03	1.38E-03
InBio	BP	GO:0006949	syncytium formation	-	66	60	-	-	7.98E-03	2.76E-03
InBio	BP	GO:0045176	apical protein localization	-	15	15	-	-	3.73E-04	6.89E-04
InBio	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	2.00E-02	6.89E-04
InBio	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	57	-	-	1.79E-02	2.64E-03
InBio	BP	GO:0030574	collagen catabolic process	-	45	41	-	-	2.94E-02	1.90E-03
InBio	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	1.34E-02	2.13E-03
InBio	BP	GO:0060343	trabecula formation	-	26	26	-	-	1.40E-03	1.21E-03
InBio	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	11	-	-	1.67E-04	5.17E-04
InBio	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	1.94E-03	1.09E-03
InBio	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	3.82E-02	7.47E-04
InBio	BP	GO:1900424	regulation of defense response to bacterium	-	21	19	-	-	2.07E-02	9.19E-04
InBio	BP	GO:0085029	extracellular matrix assembly	-	42	40	-	-	1.68E-02	1.84E-03
InBio	BP	GO:0006413	translational initiation	-	122	120	-	-	1.81E-02	5.52E-03
InBio	BP	GO:0072176	nephric duct development	-	15	15	-	-	3.37E-03	6.89E-04
InBio	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	3.54E-03	2.36E-03
InBio	CC	GO:0005200	structural constituent of cytoskeleton	-	112	109	-	-	5.79E-03	5.06E-03
InBio	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	3.05E-03	2.36E-03
InBio	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	2.72E-02	6.89E-04
InBio	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	5.50E-02	1.15E-03
InBio	BP	GO:1903036	positive regulation of response to wounding	-	76	69	-	-	8.18E-03	3.22E-03
InBio	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	3.00E-02	9.77E-04
InBio	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	207	-	-	1.21E-02	9.54E-03
InBio	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.80E-03	1.26E-03
InBio	BP	GO:0032528	microvillus organization	-	24	24	-	-	1.32E-02	1.15E-03
InBio	BP	GO:0021954	central nervous system neuron development	-	85	83	-	-	2.48E-03	3.85E-03
InBio	BP	GO:0055017	cardiac muscle tissue growth	-	92	74	-	-	3.71E-03	3.45E-03
InBio	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	30	-	-	6.19E-03	1.38E-03
InBio	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	3.96E-03	6.32E-04
InBio	BP	GO:0048524	positive regulation of viral process	-	64	62	-	-	1.69E-03	2.87E-03
InBio	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	13	-	-	1.41E-02	6.32E-04
InBio	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	2.78E-03	9.77E-04
InBio	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	22	-	-	2.43E-03	1.03E-03
InBio	BP	GO:0001946	lymphangiogenesis	-	18	16	-	-	1.27E-02	7.47E-04
InBio	BP	GO:0098661	inorganic anion transmembrane transport	-	140	131	-	-	9.32E-02	6.03E-03
InBio	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	1.69E-02	1.49E-03
InBio	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	1.49E-03	8.62E-04
InBio	BP	GO:0009612	response to mechanical stimulus	-	215	205	-	-	5.53E-03	9.42E-03
InBio	BP	GO:0048644	muscle organ morphogenesis	-	81	77	-	-	1.24E-02	3.56E-03
InBio	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	139	-	-	7.34E-03	6.43E-03
InBio	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	2.68E-02	6.32E-04
InBio	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	5.35E-03	1.61E-03
InBio	BP	GO:0140115	export across plasma membrane	-	82	60	-	-	4.77E-02	2.76E-03
InBio	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	3.57E-03	5.74E-04
InBio	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	3.35E-03	1.78E-03
InBio	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	4.87E-03	5.74E-04
InBio	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.68E-04	5.17E-04
InBio	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	28	-	-	1.85E-02	1.32E-03
InBio	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	41	-	-	1.11E-02	1.90E-03
InBio	MF	GO:0003714	transcription corepressor activity	-	190	184	-	-	1.13E-02	8.50E-03
InBio	BP	GO:0035878	nail development	-	11	11	-	-	8.55E-03	5.17E-04
InBio	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	54	-	-	5.18E-03	2.53E-03
InBio	BP	GO:0061101	neuroendocrine cell differentiation	-	16	15	-	-	7.12E-04	6.89E-04
InBio	CC	GO:0006858	extracellular transport	-	45	44	-	-	2.98E-02	2.07E-03
InBio	BP	GO:0006304	DNA modification	-	30	29	-	-	3.15E-03	1.38E-03
InBio	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	2.11E-02	8.62E-04
InBio	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	2.44E-03	2.30E-03
InBio	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	1.35E-03	8.62E-04
InBio	BP	GO:0003207	cardiac chamber formation	-	14	13	-	-	1.41E-02	6.32E-04
InBio	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	32	-	-	3.81E-04	1.49E-03
InBio	BP	GO:0070417	cellular response to cold	-	13	13	-	-	1.48E-02	6.32E-04
InBio	BP	GO:0043523	regulation of neuron apoptotic process	-	218	210	-	-	1.22E-02	9.65E-03
InBio	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	3.01E-03	1.03E-03
InBio	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	2.53E-03	6.89E-04
InBio	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	5.30E-03	2.64E-03
InBio	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	4.30E-02	6.32E-04
InBio	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	2.97E-03	1.15E-03
InBio	BP	GO:0014029	neural crest formation	-	15	15	-	-	1.37E-02	6.89E-04
InBio	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	1.99E-03	1.09E-03
InBio	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	39	-	-	5.83E-03	1.84E-03
InBio	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	68	-	-	2.35E-03	3.16E-03
InBio	BP	GO:0003188	heart valve formation	-	16	16	-	-	4.65E-02	7.47E-04
InBio	CC	GO:0045324	late endosome to vacuole transport	-	37	36	-	-	2.03E-01	1.67E-03
InBio	BP	GO:0043954	cellular component maintenance	-	72	67	-	-	5.25E-03	3.10E-03
InBio	BP	GO:0050435	amyloid-beta metabolic process	-	65	51	-	-	1.15E-02	2.36E-03
InBio	BP	GO:0014823	response to activity	-	70	67	-	-	2.32E-03	3.10E-03
InBio	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	17	-	-	2.56E-02	8.04E-04
InBio	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	1.03E-01	1.32E-03
InBio	BP	GO:0034502	protein localization to chromosome	-	130	114	-	-	9.42E-03	5.29E-03
InBio	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	2.79E-03	5.17E-04
InBio	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	4.74E-03	5.17E-04
InBio	BP	GO:0060457	negative regulation of digestive system process	-	17	16	-	-	2.36E-02	7.47E-04
InBio	BP	GO:0019233	sensory perception of pain	-	103	95	-	-	5.08E-03	4.37E-03
InBio	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	9.86E-02	1.03E-03
InBio	BP	GO:0031343	positive regulation of cell killing	-	75	70	-	-	3.61E-02	3.22E-03
InBio	BP	GO:0090077	foam cell differentiation	-	39	37	-	-	5.83E-03	1.72E-03
InBio	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	121	-	-	2.17E-02	5.57E-03
InBio	BP	GO:0017148	negative regulation of translation	-	390	112	-	-	9.73E-03	5.17E-03
InBio	BP	GO:0030220	platelet formation	-	22	22	-	-	1.43E-02	1.03E-03
InBio	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	78	-	-	8.76E-03	3.62E-03
InBio	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	3.49E-03	5.74E-04
InBio	BP	GO:1901142	insulin metabolic process	-	14	13	-	-	1.40E-03	6.32E-04
InBio	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	1.35E-02	6.89E-04
InBio	BP	GO:1903509	liposaccharide metabolic process	-	109	104	-	-	3.08E-02	4.83E-03
InBio	BP	GO:0009582	detection of abiotic stimulus	-	140	121	-	-	6.94E-03	5.57E-03
InBio	BP	GO:0045683	negative regulation of epidermis development	-	13	12	-	-	2.68E-03	5.74E-04
InBio	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	15	-	-	1.67E-02	6.89E-04
InBio	CC	GO:0140238	presynaptic endocytosis	-	72	71	-	-	1.15E-02	3.27E-03
InBio	BP	GO:0051236	establishment of RNA localization	-	161	153	-	-	5.10E-02	7.07E-03
InBio	BP	GO:0042178	xenobiotic catabolic process	-	26	24	-	-	6.27E-02	1.15E-03
InBio	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	1.25E-02	8.04E-04
InBio	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	192	-	-	1.70E-02	8.85E-03
InBio	BP	GO:0034067	protein localization to Golgi apparatus	-	30	28	-	-	5.44E-03	1.32E-03
InBio	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	3.52E-03	1.49E-03
InBio	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	6.00E-03	5.17E-04
InBio	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	6.53E-03	8.04E-04
InBio	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	43	-	-	5.06E-04	2.01E-03
InBio	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	39	-	-	3.03E-03	1.84E-03
InBio	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	2.95E-03	2.41E-03
InBio	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	7.86E-04	7.47E-04
InBio	BP	GO:0050779	RNA destabilization	-	135	99	-	-	3.64E-02	4.60E-03
InBio	BP	GO:0006023	aminoglycan biosynthetic process	-	74	74	-	-	1.94E-02	3.45E-03
InBio	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	3.42E-03	3.16E-03
InBio	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	2.26E-03	1.84E-03
InBio	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	1.74E-02	1.38E-03
InBio	BP	GO:0035272	exocrine system development	-	46	46	-	-	3.51E-03	2.13E-03
InBio	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	8.62E-03	8.04E-04
InBio	BP	GO:0022406	membrane docking	-	90	87	-	-	3.47E-02	4.02E-03
InBio	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	1.17E-02	6.89E-04
InBio	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	1.84E-03	7.47E-04
InBio	BP	GO:0050777	negative regulation of immune response	-	196	185	-	-	6.28E-03	8.50E-03
InBio	MF	GO:0005035	death receptor activity	-	16	15	-	-	1.13E-02	6.89E-04
InBio	BP	GO:0002063	chondrocyte development	-	33	32	-	-	3.48E-03	1.49E-03
InBio	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	2.25E-03	8.04E-04
InBio	BP	GO:0099068	postsynapse assembly	-	40	40	-	-	1.06E-02	1.84E-03
InBio	BP	GO:0021782	glial cell development	-	120	114	-	-	2.91E-03	5.29E-03
InBio	BP	GO:0051782	negative regulation of cell division	-	18	16	-	-	1.10E-03	7.47E-04
InBio	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	1.63E-04	5.17E-04
InBio	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	82	-	-	9.64E-03	3.79E-03
InBio	BP	GO:0001655	urogenital system development	-	66	66	-	-	2.57E-03	3.04E-03
InBio	BP	GO:0071827	plasma lipoprotein particle organization	-	86	68	-	-	6.36E-02	3.16E-03
InBio	BP	GO:0045494	photoreceptor cell maintenance	-	43	42	-	-	2.43E-02	1.95E-03
InBio	BP	GO:0055088	lipid homeostasis	-	173	153	-	-	2.21E-02	7.07E-03
InBio	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	1.34E-03	1.21E-03
InBio	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	191	-	-	4.98E-03	8.79E-03
InBio	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	27	-	-	4.87E-02	1.26E-03
InBio	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	2.95E-03	1.61E-03
InBio	BP	GO:0045667	regulation of osteoblast differentiation	-	147	124	-	-	8.55E-03	5.74E-03
InBio	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	3.39E-03	7.47E-04
InBio	BP	GO:0061037	negative regulation of cartilage development	-	32	29	-	-	5.69E-03	1.38E-03
InBio	BP	GO:0045738	negative regulation of DNA repair	-	40	38	-	-	5.44E-03	1.78E-03
InBio	BP	GO:0001704	formation of primary germ layer	-	195	186	-	-	6.85E-03	8.56E-03
InBio	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	1.52E-02	6.32E-04
InBio	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	4.49E-03	2.36E-03
InBio	BP	GO:0060174	limb bud formation	-	11	11	-	-	8.55E-04	5.17E-04
InBio	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	2.84E-03	3.91E-03
InBio	BP	GO:0042092	type 2 immune response	-	41	41	-	-	4.36E-03	1.90E-03
InBio	BP	GO:0048588	developmental cell growth	-	233	220	-	-	8.87E-03	1.01E-02
InBio	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	8.97E-03	9.19E-04
InBio	BP	GO:0021872	forebrain generation of neurons	-	52	50	-	-	3.40E-03	2.30E-03
InBio	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	1.81E-03	1.03E-03
InBio	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	1.25E-01	1.84E-03
InBio	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	50	-	-	2.78E-02	2.30E-03
InBio	BP	GO:0034367	protein-containing complex remodeling	-	35	33	-	-	7.20E-02	1.55E-03
InBio	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	1.05E-03	1.21E-03
InBio	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	44	-	-	7.46E-03	2.07E-03
InBio	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	2.41E-02	9.19E-04
InBio	BP	GO:0015810	aspartate transmembrane transport	-	19	18	-	-	6.65E-02	8.62E-04
InBio	BP	GO:0010232	vascular transport	-	87	81	-	-	3.80E-03	3.73E-03
InBio	BP	GO:0021987	cerebral cortex development	-	125	123	-	-	4.40E-03	5.69E-03
InBio	BP	GO:0008637	apoptotic mitochondrial changes	-	108	101	-	-	2.49E-02	4.65E-03
InBio	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	3.12E-03	1.61E-03
InBio	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.40E-03	6.89E-04
InBio	BP	GO:0060999	positive regulation of dendritic spine development	-	35	34	-	-	5.73E-03	1.61E-03
InBio	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	1.54E-03	8.62E-04
InBio	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	3.60E-03	3.56E-03
InBio	BP	GO:0060973	cell migration involved in heart development	-	21	19	-	-	2.25E-03	9.19E-04
InBio	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	5.55E-03	9.19E-04
InBio	BP	GO:0002064	epithelial cell development	-	210	204	-	-	6.08E-03	9.42E-03
InBio	BP	GO:0071318	cellular response to ATP	-	18	17	-	-	7.29E-04	8.04E-04
InBio	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	38	-	-	1.14E-02	1.78E-03
InBio	BP	GO:2001222	regulation of neuron migration	-	46	44	-	-	9.61E-03	2.07E-03
InBio	BP	GO:0034389	lipid droplet organization	-	38	36	-	-	2.00E-03	1.67E-03
InBio	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	8.52E-04	2.07E-03
InBio	BP	GO:0042177	negative regulation of protein catabolic process	-	109	106	-	-	2.28E-03	4.88E-03
InBio	MF	GO:0038024	cargo receptor activity	-	121	110	-	-	2.25E-02	5.06E-03
InBio	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	17	-	-	1.89E-03	8.04E-04
InBio	BP	GO:0033120	positive regulation of RNA splicing	-	46	38	-	-	2.83E-03	1.78E-03
InBio	BP	GO:0051445	regulation of meiotic cell cycle	-	64	62	-	-	4.60E-02	2.87E-03
InBio	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.29E-03	5.74E-04
InBio	BP	GO:0033619	membrane protein proteolysis	-	60	59	-	-	3.73E-03	2.76E-03
InBio	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	9.04E-03	6.89E-04
InBio	BP	GO:0090087	regulation of peptide transport	-	195	190	-	-	5.91E-03	8.73E-03
InBio	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	100	-	-	5.69E-03	4.60E-03
InBio	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	1.90E-03	1.15E-03
InBio	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	1.16E-03	1.15E-03
InBio	BP	GO:0042537	benzene-containing compound metabolic process	-	27	25	-	-	1.93E-02	1.15E-03
InBio	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	1.29E-03	6.89E-04
InBio	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	6.13E-03	6.89E-04
InBio	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	1.04E-01	9.19E-04
InBio	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	2.84E-02	6.32E-04
InBio	BP	GO:0022404	molting cycle process	-	95	93	-	-	3.51E-03	4.31E-03
InBio	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	4.68E-04	5.17E-04
InBio	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	3.31E-03	8.04E-04
InBio	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	3.13E-03	9.19E-04
InBio	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	5.73E-03	5.74E-04
InBio	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	1.51E-03	8.04E-04
InBio	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	9.52E-03	1.49E-03
InBio	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	1.05E-02	6.89E-04
InBio	BP	GO:0008299	isoprenoid biosynthetic process	-	30	29	-	-	6.42E-03	1.38E-03
InBio	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	232	-	-	1.63E-02	1.07E-02
InBio	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.81E-03	1.44E-03
InBio	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	1.62E-03	1.03E-03
InBio	CC	GO:0098926	postsynaptic signal transduction	-	39	37	-	-	2.21E-03	1.72E-03
InBio	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	138	-	-	6.15E-03	6.38E-03
InBio	CC	GO:0016082	synaptic vesicle priming	-	19	18	-	-	2.02E-02	8.62E-04
InBio	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	1.86E-03	2.18E-03
InBio	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	141	-	-	1.51E-02	6.49E-03
InBio	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	2.70E-03	1.03E-03
InBio	BP	GO:0061548	ganglion development	-	17	17	-	-	1.68E-02	8.04E-04
InBio	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	94	-	-	4.98E-03	4.37E-03
InBio	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	5.08E-03	6.89E-04
InBio	BP	GO:0042832	defense response to protozoan	-	28	24	-	-	4.89E-03	1.15E-03
InBio	BP	GO:0048799	animal organ maturation	-	33	31	-	-	2.84E-03	1.44E-03
InBio	BP	GO:0006925	inflammatory cell apoptotic process	-	23	22	-	-	1.70E-03	1.03E-03
InBio	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	2.28E-03	7.47E-04
InBio	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	169	-	-	4.42E-03	7.81E-03
InBio	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.68E-04	5.17E-04
InBio	BP	GO:1903035	negative regulation of response to wounding	-	93	87	-	-	1.05E-02	4.02E-03
InBio	BP	GO:0015697	quaternary ammonium group transport	-	16	15	-	-	2.28E-04	6.89E-04
InBio	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	1.12E-03	1.21E-03
InBio	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	4.72E-03	1.26E-03
InBio	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	128	-	-	3.89E-02	5.92E-03
InBio	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	94	-	-	5.20E-03	4.37E-03
InBio	BP	GO:0045056	transcytosis	-	20	19	-	-	1.58E-03	9.19E-04
InBio	BP	GO:0018342	protein prenylation	-	15	15	-	-	9.24E-02	6.89E-04
InBio	BP	GO:0009267	cellular response to starvation	-	170	165	-	-	8.08E-03	7.58E-03
InBio	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	9.87E-03	2.47E-03
InBio	BP	GO:0046834	lipid phosphorylation	-	16	15	-	-	2.27E-04	6.89E-04
InBio	BP	GO:0007343	egg activation	-	11	11	-	-	4.09E-02	5.17E-04
InBio	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	2.43E-03	1.09E-03
InBio	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	25	-	-	3.39E-04	1.15E-03
InBio	BP	GO:0046931	pore complex assembly	-	21	21	-	-	5.51E-02	9.77E-04
InBio	CC	GO:0032008	positive regulation of TOR signaling	-	52	50	-	-	6.19E-02	2.30E-03
InBio	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	32	-	-	4.19E-02	1.49E-03
InBio	BP	GO:0046618	xenobiotic export from cell	-	27	13	-	-	1.07E-02	6.32E-04
InBio	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	15	-	-	1.20E-02	6.89E-04
InBio	BP	GO:0060428	lung epithelium development	-	43	43	-	-	3.01E-03	2.01E-03
InBio	BP	GO:0030431	sleep	-	30	29	-	-	4.52E-03	1.38E-03
InBio	BP	GO:1903318	negative regulation of protein maturation	-	29	28	-	-	2.51E-03	1.32E-03
InBio	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	96	-	-	3.39E-01	4.42E-03
InBio	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	6.06E-04	8.04E-04
InBio	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	1.89E-03	6.89E-04
InBio	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	3.23E-03	5.74E-04
InBio	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	3.79E-04	6.32E-04
InBio	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	70	-	-	1.38E-02	3.22E-03
InBio	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	2.56E-03	2.99E-03
InBio	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	2.47E-03	8.04E-04
InBio	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	1.71E-04	6.89E-04
InBio	CC	GO:0006406	mRNA export from nucleus	-	69	67	-	-	2.46E-02	3.10E-03
InBio	BP	GO:0009880	embryonic pattern specification	-	70	66	-	-	2.98E-03	3.04E-03
InBio	BP	GO:0015791	polyol transmembrane transport	-	14	11	-	-	1.72E-04	5.17E-04
InBio	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	2.97E-02	1.84E-03
InBio	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	6.03E-04	1.15E-03
InBio	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	1.13E-03	5.17E-04
InBio	BP	GO:0002367	cytokine production involved in immune response	-	121	119	-	-	9.44E-03	5.52E-03
InBio	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	3.37E-04	6.32E-04
InBio	BP	GO:0044848	biological phase	-	211	198	-	-	2.05E-02	9.13E-03
InBio	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	6.83E-03	5.74E-04
InBio	BP	GO:0046660	female sex differentiation	-	125	121	-	-	6.00E-03	5.57E-03
InBio	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	6.24E-04	8.04E-04
InBio	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	41	-	-	1.66E-03	1.90E-03
InBio	BP	GO:0060411	cardiac septum morphogenesis	-	72	71	-	-	9.13E-03	3.27E-03
InBio	BP	GO:0071248	cellular response to metal ion	-	201	194	-	-	3.64E-03	8.96E-03
InBio	BP	GO:0030308	negative regulation of cell growth	-	191	181	-	-	4.91E-03	8.33E-03
InBio	BP	GO:0097306	cellular response to alcohol	-	99	92	-	-	4.48E-03	4.25E-03
InBio	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	124	-	-	4.82E-02	5.74E-03
InBio	BP	GO:0010453	regulation of cell fate commitment	-	40	35	-	-	1.21E-02	1.61E-03
InBio	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	56	-	-	5.95E-03	2.59E-03
InBio	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	52	-	-	2.51E-03	2.41E-03
InBio	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	7.89E-03	1.21E-03
InBio	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	2.24E-03	1.15E-03
InBio	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	43	-	-	1.17E-03	2.01E-03
InBio	BP	GO:0032890	regulation of organic acid transport	-	78	76	-	-	3.25E-03	3.50E-03
InBio	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	1.06E-03	9.19E-04
InBio	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	23	-	-	4.50E-03	1.09E-03
InBio	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	93	-	-	5.77E-03	4.31E-03
InBio	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	3.85E-03	1.21E-03
InBio	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	2.19E-03	5.17E-04
InBio	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	52	-	-	3.31E-03	2.41E-03
InBio	BP	GO:0051259	protein complex oligomerization	-	251	243	-	-	4.84E-03	1.12E-02
InBio	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	1.60E-03	7.47E-04
InBio	BP	GO:0098743	cell aggregation	-	24	22	-	-	3.62E-03	1.03E-03
InBio	BP	GO:0035112	genitalia morphogenesis	-	12	11	-	-	1.64E-04	5.17E-04
InBio	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	3.13E-03	5.17E-04
InBio	BP	GO:0009994	oocyte differentiation	-	57	50	-	-	1.11E-03	2.30E-03
InBio	MF	GO:0031952	regulation of protein autophosphorylation	-	43	41	-	-	2.80E-03	1.90E-03
InBio	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	1.91E-02	6.89E-04
InBio	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	152	-	-	8.00E-03	7.01E-03
InBio	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	6.24E-03	1.61E-03
InBio	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	2.35E-03	1.32E-03
InBio	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	1.17E-03	1.61E-03
InBio	BP	GO:0072665	protein localization to vacuole	-	84	84	-	-	1.59E-02	3.91E-03
InBio	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	46	-	-	5.02E-03	2.13E-03
InBio	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	24	-	-	7.25E-03	1.15E-03
InBio	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	72	-	-	3.78E-03	3.33E-03
InBio	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	2.67E-03	7.47E-04
InBio	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	1.09E-02	6.89E-04
InBio	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.67E-04	5.17E-04
InBio	BP	GO:0042044	fluid transport	-	35	31	-	-	4.23E-03	1.44E-03
InBio	BP	GO:0070633	transepithelial transport	-	35	33	-	-	1.25E-02	1.55E-03
InBio	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	7.65E-03	6.32E-04
InBio	BP	GO:0045661	regulation of myoblast differentiation	-	74	73	-	-	1.05E-02	3.39E-03
InBio	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	11	-	-	1.72E-04	5.17E-04
InBio	BP	GO:0030307	positive regulation of cell growth	-	164	156	-	-	3.42E-03	7.18E-03
InBio	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	9.54E-04	1.15E-03
InBio	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	5.35E-03	8.62E-04
InBio	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	1.72E-03	6.32E-04
InBio	BP	GO:0014812	muscle cell migration	-	110	84	-	-	3.99E-03	3.91E-03
InBio	BP	GO:0048525	negative regulation of viral process	-	90	88	-	-	4.93E-03	4.08E-03
InBio	BP	GO:0072044	collecting duct development	-	16	16	-	-	1.26E-03	7.47E-04
InBio	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	3.25E-02	6.89E-04
InBio	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	6.57E-03	3.22E-03
InBio	BP	GO:0030238	male sex determination	-	14	14	-	-	2.00E-03	6.89E-04
InBio	BP	GO:0051781	positive regulation of cell division	-	93	90	-	-	5.45E-03	4.14E-03
InBio	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	19	-	-	1.40E-02	9.19E-04
InBio	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	3.70E-03	5.17E-04
InBio	BP	GO:0035524	proline transmembrane transport	-	12	12	-	-	2.28E-02	5.74E-04
InBio	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	3.03E-02	1.09E-03
InBio	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	21	-	-	1.78E-03	9.77E-04
InBio	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.74E-03	2.18E-03
InBio	BP	GO:0007272	ensheathment of neurons	-	146	142	-	-	7.47E-03	6.55E-03
InBio	CC	GO:0050806	positive regulation of synaptic transmission	-	171	150	-	-	6.23E-03	6.89E-03
InBio	BP	GO:0060021	roof of mouth development	-	91	91	-	-	6.52E-03	4.19E-03
InBio	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	2.38E-03	1.84E-03
InBio	BP	GO:0050819	negative regulation of coagulation	-	54	53	-	-	3.23E-02	2.47E-03
InBio	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	6.74E-03	5.17E-04
InBio	BP	GO:0017004	cytochrome complex assembly	-	40	36	-	-	1.49E-01	1.67E-03
InBio	BP	GO:0018410	C-terminal protein amino acid modification	-	15	12	-	-	2.16E-02	5.74E-04
InBio	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	1.47E-02	2.87E-03
InBio	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	4.79E-02	6.89E-04
InBio	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	13	-	-	1.61E-03	6.32E-04
InBio	CC	GO:0050805	negative regulation of synaptic transmission	-	55	55	-	-	1.98E-02	2.53E-03
InBio	BP	GO:0043248	proteasome assembly	-	13	13	-	-	6.96E-02	6.32E-04
InBio	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	60	-	-	5.72E-03	2.76E-03
InBio	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	5.24E-04	5.17E-04
InBio	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	86	-	-	2.42E-02	3.96E-03
InBio	BP	GO:0016054	organic acid catabolic process	-	251	244	-	-	1.64E-02	1.13E-02
InBio	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	12	-	-	2.34E-03	5.74E-04
InBio	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	2.44E-02	1.32E-03
InBio	BP	GO:0065005	protein-lipid complex assembly	-	29	26	-	-	2.14E-02	1.21E-03
InBio	BP	GO:0008033	tRNA processing	-	136	135	-	-	3.93E-02	6.20E-03
InBio	BP	GO:0046661	male sex differentiation	-	171	164	-	-	8.13E-03	7.58E-03
InBio	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	6.33E-04	6.89E-04
InBio	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	2.53E-03	8.04E-04
InBio	BP	GO:0035188	hatching	-	27	25	-	-	4.03E-04	1.15E-03
InBio	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	85	-	-	4.37E-03	3.91E-03
InBio	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	2.23E-04	6.89E-04
InBio	BP	GO:0090713	immunological memory process	-	18	18	-	-	3.59E-02	8.62E-04
InBio	BP	GO:0061326	renal tubule development	-	103	102	-	-	4.39E-03	4.71E-03
InBio	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	9.41E-02	2.53E-03
InBio	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	1.97E-03	8.04E-04
InBio	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	5.73E-04	9.19E-04
InBio	BP	GO:0060325	face morphogenesis	-	31	30	-	-	1.39E-03	1.38E-03
InBio	BP	GO:0090559	regulation of membrane permeability	-	72	62	-	-	8.23E-03	2.87E-03
InBio	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	13	-	-	3.89E-02	6.32E-04
InBio	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	1.58E-02	5.74E-04
InBio	BP	GO:0031579	membrane raft organization	-	25	24	-	-	1.95E-03	1.15E-03
InBio	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	1.38E-03	1.15E-03
InBio	BP	GO:0060033	anatomical structure regression	-	16	15	-	-	1.45E-03	6.89E-04
InBio	BP	GO:0046460	neutral lipid biosynthetic process	-	50	45	-	-	1.10E-02	2.07E-03
InBio	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	139	-	-	1.28E-02	6.43E-03
InBio	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	1.28E-02	5.17E-04
InBio	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	159	-	-	3.15E-03	7.35E-03
InBio	BP	GO:0002251	organ or tissue specific immune response	-	43	35	-	-	1.98E-02	1.61E-03
InBio	CC	GO:0048167	regulation of synaptic plasticity	-	210	184	-	-	7.82E-03	8.50E-03
InBio	BP	GO:1903708	positive regulation of hemopoiesis	-	184	177	-	-	1.03E-02	8.16E-03
InBio	BP	GO:1903008	organelle disassembly	-	154	152	-	-	8.22E-03	7.01E-03
InBio	BP	GO:0001709	cell fate determination	-	44	42	-	-	2.60E-03	1.95E-03
InBio	BP	GO:0051873	killing by host of symbiont cells	-	28	26	-	-	4.36E-04	1.21E-03
InBio	BP	GO:0045058	T cell selection	-	53	53	-	-	1.65E-02	2.47E-03
InBio	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	3.31E-03	2.24E-03
InBio	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	1.29E-03	9.19E-04
InBio	BP	GO:0072091	regulation of stem cell proliferation	-	91	77	-	-	2.53E-03	3.56E-03
InBio	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	41	-	-	8.99E-03	1.90E-03
InBio	BP	GO:0099084	postsynaptic specialization organization	-	44	44	-	-	9.53E-03	2.07E-03
InBio	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	2.80E-03	5.17E-04
InBio	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	5.35E-02	6.89E-04
InBio	BP	GO:0060384	innervation	-	27	27	-	-	8.91E-04	1.26E-03
InBio	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	9.61E-03	5.74E-04
InBio	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	32	-	-	1.15E-02	1.49E-03
InBio	MF	GO:0031281	positive regulation of cyclase activity	-	40	38	-	-	9.82E-03	1.78E-03
InBio	MF	GO:0098631	cell adhesion mediator activity	-	64	62	-	-	9.72E-03	2.87E-03
InBio	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	3.02E-03	8.62E-04
InBio	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	7.62E-02	5.74E-04
InBio	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	1.22E-03	8.62E-04
InBio	BP	GO:0071453	cellular response to oxygen levels	-	168	152	-	-	3.98E-03	7.01E-03
InBio	BP	GO:0090399	replicative senescence	-	17	15	-	-	1.81E-03	6.89E-04
InBio	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	11	-	-	1.25E-03	5.17E-04
InBio	BP	GO:0031342	negative regulation of cell killing	-	29	28	-	-	9.95E-03	1.32E-03
InBio	BP	GO:0070585	protein localization to mitochondrion	-	125	123	-	-	2.06E-02	5.69E-03
InBio	BP	GO:0006855	xenobiotic transmembrane transport	-	14	12	-	-	5.24E-02	5.74E-04
InBio	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	2.41E-03	1.15E-03
InBio	BP	GO:0044242	cellular lipid catabolic process	-	224	215	-	-	1.49E-02	9.88E-03
InBio	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	3.33E-04	6.32E-04
InBio	BP	GO:0002931	response to ischemia	-	58	56	-	-	2.66E-02	2.59E-03
InBio	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	1.03E-02	5.74E-04
InBio	BP	GO:0014047	glutamate secretion	-	25	25	-	-	3.06E-03	1.15E-03
InBio	BP	GO:0061005	cell differentiation involved in kidney development	-	58	58	-	-	2.66E-03	2.70E-03
InBio	BP	GO:0030397	membrane disassembly	-	11	11	-	-	2.72E-03	5.17E-04
InBio	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	72	-	-	2.49E-02	3.33E-03
InBio	BP	GO:0060420	regulation of heart growth	-	74	59	-	-	3.14E-03	2.76E-03
InBio	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	7.24E-04	6.89E-04
InBio	BP	GO:0009755	hormone-mediated signaling pathway	-	221	215	-	-	1.14E-02	9.88E-03
InBio	BP	GO:0022612	gland morphogenesis	-	124	124	-	-	4.95E-03	5.74E-03
InBio	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	36	-	-	1.11E-03	1.67E-03
InBio	MF	GO:0140416	transcription regulator inhibitor activity	-	26	24	-	-	1.12E-03	1.15E-03
InBio	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	25	-	-	1.49E-01	1.15E-03
InBio	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	7.18E-03	6.89E-04
InBio	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	3.43E-02	8.04E-04
InBio	BP	GO:1990845	adaptive thermogenesis	-	166	165	-	-	5.69E-03	7.58E-03
InBio	BP	GO:0071320	cellular response to cAMP	-	54	51	-	-	5.24E-03	2.36E-03
InBio	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	1.12E-02	5.17E-04
InBio	BP	GO:0015844	monoamine transport	-	88	86	-	-	2.66E-02	3.96E-03
InBio	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	21	-	-	6.09E-03	9.77E-04
InBio	BP	GO:0060039	pericardium development	-	19	19	-	-	7.79E-04	9.19E-04
InBio	BP	GO:0071392	cellular response to estradiol stimulus	-	40	39	-	-	1.61E-03	1.84E-03
InBio	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	4.37E-03	6.32E-04
InBio	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	5.03E-03	9.19E-04
InBio	BP	GO:0009451	RNA modification	-	169	166	-	-	1.91E-02	7.64E-03
InBio	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	40	-	-	2.05E-03	1.84E-03
InBio	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	3.24E-03	8.04E-04
InBio	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	108	-	-	7.94E-03	5.00E-03
InBio	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	38	-	-	3.63E-03	1.78E-03
InBio	BP	GO:0015807	L-amino acid transport	-	94	91	-	-	2.37E-02	4.19E-03
InBio	BP	GO:0032941	secretion by tissue	-	85	83	-	-	2.52E-03	3.85E-03
InBio	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	11	-	-	1.54E-02	5.17E-04
InBio	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	3.54E-03	2.53E-03
InBio	BP	GO:0048753	pigment granule organization	-	40	40	-	-	4.39E-02	1.84E-03
InBio	BP	GO:0021516	dorsal spinal cord development	-	20	20	-	-	4.97E-03	9.19E-04
InBio	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	3.02E-03	9.19E-04
InBio	BP	GO:0032196	transposition	-	11	11	-	-	3.16E-03	5.17E-04
InBio	BP	GO:0003014	renal system process	-	130	127	-	-	5.15E-03	5.86E-03
InBio	CC	GO:0070286	axonemal dynein complex assembly	-	40	37	-	-	4.66E-02	1.72E-03
InBio	BP	GO:0045598	regulation of fat cell differentiation	-	148	129	-	-	5.16E-03	5.97E-03
InBio	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	189	-	-	1.11E-02	8.73E-03
InBio	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	1.64E-03	1.78E-03
InBio	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	3.34E-03	1.15E-03
InBio	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	223	-	-	7.98E-02	1.03E-02
InBio	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.62E-04	6.32E-04
InBio	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	1.11E-03	1.09E-03
InBio	BP	GO:0018158	protein oxidation	-	15	15	-	-	3.05E-03	6.89E-04
InBio	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	5.32E-03	1.38E-03
InBio	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	7.42E-02	8.04E-04
InBio	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	26	-	-	1.75E-03	1.21E-03
InBio	BP	GO:0071709	membrane assembly	-	68	66	-	-	1.45E-02	3.04E-03
InBio	BP	GO:0008217	regulation of blood pressure	-	186	179	-	-	1.91E-02	8.27E-03
InBio	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	8.24E-04	8.62E-04
InBio	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	3.23E-03	6.89E-04
InBio	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	61	-	-	2.03E-03	2.81E-03
InBio	CC	GO:0042770	signal transduction in response to DNA damage	-	186	183	-	-	1.28E-02	8.44E-03
InBio	BP	GO:0002200	somatic diversification of immune receptors	-	78	77	-	-	8.50E-03	3.56E-03
InBio	BP	GO:0035315	hair cell differentiation	-	52	46	-	-	5.99E-03	2.13E-03
InBio	BP	GO:0048645	animal organ formation	-	62	60	-	-	3.23E-03	2.76E-03
InBio	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	157	-	-	8.99E-03	7.24E-03
InBio	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	13	-	-	5.49E-02	6.32E-04
InBio	BP	GO:0033627	cell adhesion mediated by integrin	-	87	85	-	-	1.46E-02	3.91E-03
InBio	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	1.06E-02	9.77E-04
InBio	BP	GO:0015824	proline transport	-	13	13	-	-	1.59E-01	6.32E-04
InBio	BP	GO:0035107	appendage morphogenesis	-	147	146	-	-	9.42E-03	6.72E-03
InBio	BP	GO:1903707	negative regulation of hemopoiesis	-	116	106	-	-	3.34E-03	4.88E-03
InBio	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	3.70E-03	9.19E-04
InBio	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	2.01E-02	1.15E-03
InBio	BP	GO:0030149	sphingolipid catabolic process	-	32	30	-	-	8.23E-04	1.38E-03
InBio	BP	GO:0050994	regulation of lipid catabolic process	-	61	58	-	-	7.71E-03	2.70E-03
InBio	BP	GO:0035988	chondrocyte proliferation	-	24	22	-	-	2.40E-03	1.03E-03
InBio	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	6.40E-03	1.38E-03
InBio	BP	GO:0060788	ectodermal placode formation	-	12	11	-	-	1.32E-03	5.17E-04
InBio	BP	GO:0045727	positive regulation of translation	-	141	138	-	-	4.35E-03	6.38E-03
InBio	BP	GO:0036315	cellular response to sterol	-	24	20	-	-	3.48E-03	9.19E-04
InBio	CC	GO:0032388	positive regulation of intracellular transport	-	137	132	-	-	2.62E-03	6.09E-03
InBio	BP	GO:0021979	hypothalamus cell differentiation	-	13	12	-	-	6.10E-03	5.74E-04
InBio	BP	GO:0002027	regulation of heart rate	-	106	99	-	-	1.95E-02	4.60E-03
InBio	BP	GO:0050879	multicellular organismal movement	-	118	108	-	-	3.89E-03	5.00E-03
InBio	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	6.14E-03	6.89E-04
InBio	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	74	-	-	2.48E-03	3.45E-03
InBio	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	61	-	-	1.92E-02	2.81E-03
InBio	BP	GO:0048515	spermatid differentiation	-	208	191	-	-	9.73E-03	8.79E-03
InBio	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	3.79E-03	2.64E-03
InBio	MF	GO:0042887	amide transmembrane transporter activity	-	33	28	-	-	1.30E-02	1.32E-03
InBio	BP	GO:0007130	synaptonemal complex assembly	-	23	20	-	-	4.90E-02	9.19E-04
InBio	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	35	-	-	1.53E-02	1.61E-03
InBio	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	33	-	-	2.56E-03	1.55E-03
InBio	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	35	-	-	9.50E-02	1.61E-03
InBio	BP	GO:0060119	inner ear receptor cell development	-	44	38	-	-	1.45E-02	1.78E-03
InBio	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	7.79E-03	8.62E-04
InBio	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	4.42E-02	1.61E-03
InBio	BP	GO:1901983	regulation of protein acetylation	-	26	23	-	-	8.41E-04	1.09E-03
InBio	BP	GO:0014854	response to inactivity	-	12	11	-	-	2.91E-03	5.17E-04
InBio	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	241	-	-	1.22E-02	1.11E-02
InBio	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	1.59E-03	8.04E-04
InBio	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	4.76E-02	2.24E-03
InBio	BP	GO:0010883	regulation of lipid storage	-	53	49	-	-	7.14E-03	2.30E-03
InBio	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	9.67E-03	1.21E-03
InBio	BP	GO:0007635	chemosensory behavior	-	20	18	-	-	2.21E-04	8.62E-04
InBio	BP	GO:1905954	positive regulation of lipid localization	-	110	105	-	-	8.46E-03	4.83E-03
InBio	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	5.77E-04	5.74E-04
InBio	BP	GO:0002209	behavioral defense response	-	39	39	-	-	1.13E-03	1.84E-03
InBio	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	28	-	-	7.29E-02	1.32E-03
InBio	BP	GO:0072523	purine-containing compound catabolic process	-	146	143	-	-	3.34E-03	6.61E-03
InBio	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	32	-	-	5.05E-03	1.49E-03
InBio	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	27	-	-	2.52E-03	1.26E-03
InBio	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	1.29E-03	7.47E-04
InBio	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	94	-	-	3.53E-03	4.37E-03
InBio	BP	GO:0007218	neuropeptide signaling pathway	-	113	105	-	-	5.67E-02	4.83E-03
InBio	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	4.67E-03	5.74E-04
InBio	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	162	-	-	2.48E-02	7.47E-03
InBio	BP	GO:0031345	negative regulation of cell projection organization	-	195	187	-	-	1.02E-02	8.62E-03
InBio	BP	GO:0048278	vesicle docking	-	64	63	-	-	3.25E-02	2.93E-03
InBio	BP	GO:0035050	embryonic heart tube development	-	86	83	-	-	1.16E-02	3.85E-03
InBio	BP	GO:0030168	platelet activation	-	135	131	-	-	8.86E-03	6.03E-03
InBio	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	6.01E-02	7.47E-04
InBio	CC	GO:0098810	neurotransmitter reuptake	-	35	34	-	-	5.74E-03	1.61E-03
InBio	BP	GO:0008213	protein alkylation	-	58	54	-	-	4.79E-03	2.53E-03
InBio	BP	GO:0009812	flavonoid metabolic process	-	14	13	-	-	9.79E-02	6.32E-04
InBio	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	8.86E-04	6.32E-04
InBio	BP	GO:0031338	regulation of vesicle fusion	-	24	23	-	-	1.23E-02	1.09E-03
InBio	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.99E-03	6.32E-04
InBio	BP	GO:0031529	ruffle organization	-	55	54	-	-	2.61E-03	2.53E-03
InBio	BP	GO:0010842	retina layer formation	-	25	25	-	-	1.17E-02	1.15E-03
InBio	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	83	-	-	4.92E-02	3.85E-03
InBio	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	3.09E-02	5.17E-04
InBio	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	71	-	-	1.12E-02	3.27E-03
InBio	MF	GO:0170055	lipid transmembrane transporter activity	-	56	49	-	-	1.92E-02	2.30E-03
InBio	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	31	-	-	7.38E-03	1.44E-03
InBio	BP	GO:0035304	regulation of protein dephosphorylation	-	87	82	-	-	2.21E-03	3.79E-03
InBio	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	229	-	-	7.05E-03	1.06E-02
InBio	BP	GO:0099637	neurotransmitter receptor transport	-	26	26	-	-	4.34E-03	1.21E-03
InBio	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	2.39E-03	1.61E-03
InBio	BP	GO:0051775	response to redox state	-	13	13	-	-	9.02E-03	6.32E-04
InBio	BP	GO:0051785	positive regulation of nuclear division	-	61	59	-	-	3.26E-03	2.76E-03
InBio	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	2.54E-03	7.47E-04
InBio	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	1.10E-03	7.47E-04
InBio	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	1.69E-03	9.19E-04
InBio	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	2.42E-03	5.74E-04
InBio	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	8.73E-03	2.07E-03
InBio	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	13	-	-	3.17E-02	6.32E-04
InBio	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	3.74E-03	8.04E-04
InBio	BP	GO:0051299	centrosome separation	-	15	15	-	-	1.04E-03	6.89E-04
InBio	BP	GO:0048145	regulation of fibroblast proliferation	-	87	84	-	-	2.38E-03	3.91E-03
InBio	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	86	-	-	1.03E-01	3.96E-03
InBio	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	5.37E-03	5.17E-04
InBio	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	223	-	-	5.63E-03	1.03E-02
InBio	BP	GO:0032098	regulation of appetite	-	20	19	-	-	1.04E-02	9.19E-04
InBio	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	1.43E-02	6.89E-04
InBio	CC	GO:0008333	endosome to lysosome transport	-	73	72	-	-	2.43E-02	3.33E-03
InBio	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	22	-	-	2.84E-03	1.03E-03
InBio	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	15	-	-	1.73E-03	6.89E-04
InBio	BP	GO:0003016	respiratory system process	-	39	38	-	-	8.24E-04	1.78E-03
InBio	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	3.98E-03	1.09E-03
InBio	BP	GO:0045732	positive regulation of protein catabolic process	-	202	200	-	-	4.36E-03	9.19E-03
InBio	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	70	-	-	6.12E-03	3.22E-03
InBio	BP	GO:0007588	excretion	-	40	39	-	-	7.87E-03	1.84E-03
InBio	BP	GO:1904018	positive regulation of vasculature development	-	185	156	-	-	1.50E-02	7.18E-03
InBio	BP	GO:0050953	sensory perception of light stimulus	-	223	203	-	-	8.75E-02	9.36E-03
InBio	BP	GO:0009164	nucleoside catabolic process	-	25	24	-	-	9.67E-02	1.15E-03
InBio	BP	GO:0002357	defense response to tumor cell	-	13	11	-	-	1.45E-03	5.17E-04
InBio	BP	GO:0009303	rRNA transcription	-	37	37	-	-	1.18E-02	1.72E-03
InBio	BP	GO:0035601	protein deacylation	-	56	56	-	-	5.52E-03	2.59E-03
InBio	BP	GO:0061952	midbody abscission	-	18	17	-	-	6.23E-02	8.04E-04
InBio	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	1.15E-03	5.17E-04
InBio	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	1.25E-03	9.19E-04
InBio	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	29	-	-	9.26E-03	1.38E-03
InBio	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	4.41E-03	2.99E-03
InBio	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	14	-	-	1.70E-04	6.89E-04
InBio	BP	GO:0045830	positive regulation of isotype switching	-	28	27	-	-	8.17E-03	1.26E-03
InBio	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	8.39E-04	1.55E-03
InBio	BP	GO:0046697	decidualization	-	26	25	-	-	9.78E-04	1.15E-03
InBio	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	2.22E-03	6.89E-04
InBio	BP	GO:0051588	regulation of neurotransmitter transport	-	99	93	-	-	7.21E-03	4.31E-03
InBio	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	26	-	-	3.39E-04	1.21E-03
InBio	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	1.68E-04	5.74E-04
InBio	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	1.40E-02	2.93E-03
InBio	BP	GO:0044703	multi-organism reproductive process	-	209	196	-	-	9.82E-03	9.02E-03
InBio	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	138	-	-	6.83E-03	6.38E-03
InBio	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	1.00E-02	5.17E-04
InBio	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	52	-	-	4.30E-03	2.41E-03
InBio	BP	GO:0099022	vesicle tethering	-	32	31	-	-	1.04E-01	1.44E-03
InBio	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	38	-	-	1.79E-02	1.78E-03
InBio	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	5.94E-03	5.74E-04
InBio	BP	GO:0048857	neural nucleus development	-	65	62	-	-	2.12E-03	2.87E-03
InBio	BP	GO:0048663	neuron fate commitment	-	74	69	-	-	6.31E-03	3.22E-03
InBio	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	156	-	-	1.24E-02	7.18E-03
InBio	BP	GO:0106027	neuron projection organization	-	90	87	-	-	3.26E-03	4.02E-03
InBio	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	128	-	-	2.09E-02	5.92E-03
InBio	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	3.44E-03	1.61E-03
InBio	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	1.65E-04	5.17E-04
InBio	BP	GO:0045685	regulation of glial cell differentiation	-	77	74	-	-	6.95E-03	3.45E-03
InBio	BP	GO:0051608	histamine transport	-	14	13	-	-	1.76E-03	6.32E-04
InBio	BP	GO:0043414	macromolecule methylation	-	138	131	-	-	6.14E-03	6.03E-03
InBio	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	2.80E-03	5.74E-04
InBio	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	2.59E-02	7.47E-04
InBio	BP	GO:0050886	endocrine process	-	93	93	-	-	7.48E-03	4.31E-03
InBio	MF	GO:0015562	efflux transmembrane transporter activity	-	15	14	-	-	1.69E-04	6.89E-04
InBio	BP	GO:0050951	sensory perception of temperature stimulus	-	28	26	-	-	7.81E-04	1.21E-03
InBio	BP	GO:0045807	positive regulation of endocytosis	-	155	149	-	-	1.53E-02	6.89E-03
InBio	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	2.97E-03	5.17E-04
InBio	BP	GO:0002418	immune response to tumor cell	-	29	25	-	-	1.98E-02	1.15E-03
InBio	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	4.86E-03	2.70E-03
InBio	BP	GO:0048308	organelle inheritance	-	14	14	-	-	1.48E-03	6.89E-04
InBio	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	1.22E-03	8.62E-04
InBio	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	1.13E-03	9.19E-04
InBio	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	43	-	-	5.68E-03	2.01E-03
InBio	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	2.01E-03	3.10E-03
InBio	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	1.69E-04	5.74E-04
InBio	BP	GO:0009110	vitamin biosynthetic process	-	23	23	-	-	3.26E-03	1.09E-03
InBio	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	4.31E-03	1.03E-03
InBio	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	5.02E-03	8.04E-04
InBio	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	21	-	-	8.49E-04	9.77E-04
InBio	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	94	-	-	5.38E-03	4.37E-03
InBio	BP	GO:0009111	vitamin catabolic process	-	13	13	-	-	3.71E-02	6.32E-04
InBio	MF	GO:0051100	negative regulation of binding	-	161	155	-	-	3.00E-03	7.12E-03
InBio	BP	GO:0003151	outflow tract morphogenesis	-	81	79	-	-	6.29E-03	3.68E-03
InBio	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	2.14E-03	2.76E-03
InBio	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	1.44E-03	9.19E-04
InBio	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	1.68E-04	5.74E-04
InBio	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	2.04E-02	1.55E-03
InBio	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	9.23E-04	7.47E-04
InBio	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	2.97E-04	6.32E-04
InBio	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	1.82E-03	2.18E-03
InBio	BP	GO:0046621	negative regulation of organ growth	-	39	32	-	-	2.68E-03	1.49E-03
InBio	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	48	-	-	6.42E-02	2.24E-03
InBio	BP	GO:0032368	regulation of lipid transport	-	149	128	-	-	7.19E-03	5.92E-03
InBio	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	9.55E-03	1.38E-03
InBio	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	178	-	-	5.73E-03	8.22E-03
InBio	BP	GO:0033002	muscle cell proliferation	-	249	202	-	-	6.97E-03	9.31E-03
InBio	BP	GO:0043331	response to dsRNA	-	56	53	-	-	4.62E-02	2.47E-03
InBio	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	2.55E-03	5.74E-04
InBio	BP	GO:0051904	pigment granule transport	-	23	23	-	-	2.10E-02	1.09E-03
InBio	BP	GO:1901679	nucleotide transmembrane transport	-	32	30	-	-	1.20E-02	1.38E-03
InBio	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	32	-	-	1.71E-03	1.49E-03
InBio	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	12	-	-	1.98E-02	5.74E-04
InBio	BP	GO:0033363	secretory granule organization	-	63	61	-	-	1.33E-02	2.81E-03
InBio	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	3.55E-03	1.32E-03
InBio	BP	GO:0120009	intermembrane lipid transfer	-	52	49	-	-	1.57E-02	2.30E-03
InBio	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	3.05E-03	6.89E-04
InBio	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	1.84E-03	1.78E-03
InBio	BP	GO:0033622	integrin activation	-	26	26	-	-	7.01E-03	1.21E-03
InBio	BP	GO:0098751	bone cell development	-	18	18	-	-	1.10E-03	8.62E-04
InBio	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	6.44E-04	9.77E-04
InBio	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	2.00E-03	2.36E-03
InBio	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.27E-02	1.38E-03
InBio	BP	GO:0002076	osteoblast development	-	17	17	-	-	3.98E-03	8.04E-04
InBio	BP	GO:0072164	mesonephric tubule development	-	98	97	-	-	8.11E-03	4.48E-03
InBio	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	2.22E-04	8.04E-04
InBio	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	104	-	-	3.58E-03	4.83E-03
InBio	BP	GO:1903524	positive regulation of blood circulation	-	39	36	-	-	2.84E-03	1.67E-03
InBio	BP	GO:0030901	midbrain development	-	87	83	-	-	4.12E-03	3.85E-03
InBio	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	1.12E-02	1.03E-03
InBio	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	9.27E-03	7.47E-04
InBio	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	4.69E-03	6.32E-04
InBio	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	66	-	-	3.12E-03	3.04E-03
InBio	BP	GO:0002687	positive regulation of leukocyte migration	-	147	141	-	-	5.56E-03	6.49E-03
InBio	BP	GO:0019755	one-carbon compound transport	-	28	22	-	-	4.76E-02	1.03E-03
InBio	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	5.38E-04	6.32E-04
InBio	BP	GO:0060856	establishment of blood-brain barrier	-	16	15	-	-	2.04E-02	6.89E-04
InBio	BP	GO:0110154	RNA decapping	-	19	18	-	-	4.16E-02	8.62E-04
InBio	BP	GO:0034605	cellular response to heat	-	66	63	-	-	1.34E-03	2.93E-03
InBio	BP	GO:0005996	monosaccharide metabolic process	-	250	239	-	-	7.99E-03	1.10E-02
InBio	BP	GO:0033555	multicellular organismal response to stress	-	90	88	-	-	4.23E-03	4.08E-03
InBio	BP	GO:0002262	myeloid cell homeostasis	-	172	167	-	-	6.17E-03	7.70E-03
InBio	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	2.90E-02	1.78E-03
InBio	BP	GO:0050688	regulation of defense response to virus	-	65	64	-	-	7.45E-03	2.99E-03
InBio	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	2.70E-03	9.19E-04
InBio	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	222	-	-	1.01E-02	1.02E-02
InBio	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	2.88E-03	1.44E-03
InBio	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	5.26E-04	6.89E-04
InBio	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	9.68E-03	1.49E-03
InBio	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	18	-	-	2.17E-04	8.62E-04
InBio	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	1.38E-02	1.32E-03
InBio	BP	GO:0022618	protein-RNA complex assembly	-	227	189	-	-	2.60E-02	8.73E-03
InBio	BP	GO:0051147	regulation of muscle cell differentiation	-	162	132	-	-	7.36E-03	6.09E-03
InBio	BP	GO:0090102	cochlea development	-	50	49	-	-	4.52E-03	2.30E-03
InBio	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	2.08E-03	1.21E-03
InBio	BP	GO:0061303	cornea development in camera-type eye	-	12	12	-	-	1.70E-04	5.74E-04
InBio	BP	GO:0045933	positive regulation of muscle contraction	-	49	47	-	-	7.98E-03	2.18E-03
InBio	BP	GO:0015803	branched-chain amino acid transport	-	14	14	-	-	4.22E-02	6.89E-04
InBio	BP	GO:0002679	respiratory burst involved in defense response	-	16	15	-	-	2.18E-04	6.89E-04
InBio	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	33	-	-	4.31E-03	1.55E-03
InBio	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	91	-	-	2.43E-02	4.19E-03
InBio	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.40E-02	5.74E-04
InBio	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	4.88E-03	1.03E-03
InBio	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	1.43E-02	3.27E-03
InBio	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	56	-	-	2.48E-02	2.59E-03
InBio	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	1.02E-02	1.09E-03
InBio	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	56	-	-	7.49E-03	2.59E-03
InBio	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	1.51E-03	5.17E-04
InBio	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	6.79E-03	1.78E-03
InBio	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.62E-04	5.74E-04
InBio	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	1.60E-04	5.17E-04
InBio	BP	GO:0140253	cell-cell fusion	-	62	57	-	-	8.24E-03	2.64E-03
InBio	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	1.24E-03	5.74E-04
InBio	BP	GO:0071599	otic vesicle development	-	15	15	-	-	3.25E-03	6.89E-04
InBio	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	44	-	-	2.62E-01	2.07E-03
InBio	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	8.93E-04	6.89E-04
InBio	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	5.12E-03	2.76E-03
InBio	BP	GO:0001941	postsynaptic membrane organization	-	37	33	-	-	7.71E-03	1.55E-03
InBio	BP	GO:0051293	establishment of spindle localization	-	57	56	-	-	8.65E-03	2.59E-03
InBio	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	1.58E-04	6.32E-04
InBio	BP	GO:0043114	regulation of vascular permeability	-	49	46	-	-	6.36E-03	2.13E-03
InBio	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	9.21E-03	1.21E-03
InBio	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	64	-	-	3.97E-03	2.99E-03
InBio	BP	GO:0008360	regulation of cell shape	-	139	134	-	-	1.03E-02	6.20E-03
InBio	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	1.55E-02	7.47E-04
InBio	BP	GO:0051222	positive regulation of protein transport	-	249	242	-	-	5.30E-03	1.11E-02
InBio	CC	GO:0140632	canonical inflammasome complex assembly	-	40	38	-	-	2.56E-02	1.78E-03
InBio	MF	GO:0034260	negative regulation of GTPase activity	-	36	33	-	-	1.78E-03	1.55E-03
InBio	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	3.62E-03	1.03E-03
InBio	BP	GO:0045739	positive regulation of DNA repair	-	128	126	-	-	5.49E-02	5.80E-03
InBio	BP	GO:0001845	phagolysosome assembly	-	19	18	-	-	2.08E-03	8.62E-04
InBio	BP	GO:0045185	maintenance of protein location	-	95	89	-	-	2.74E-03	4.14E-03
InBio	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	3.44E-03	6.32E-04
InBio	BP	GO:0003158	endothelium development	-	140	127	-	-	7.97E-03	5.86E-03
InBio	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	2.02E-03	1.90E-03
InBio	BP	GO:0051224	negative regulation of protein transport	-	122	106	-	-	3.79E-03	4.88E-03
InBio	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	146	-	-	4.01E-03	6.72E-03
InBio	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	5.15E-03	6.32E-04
InBio	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	2.54E-03	1.44E-03
InBio	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	2.31E-01	9.19E-04
InBio	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	2.91E-03	2.93E-03
InBio	BP	GO:0007405	neuroblast proliferation	-	81	77	-	-	7.73E-03	3.56E-03
InBio	BP	GO:0009581	detection of external stimulus	-	137	118	-	-	9.66E-03	5.46E-03
InBio	BP	GO:1990542	mitochondrial transmembrane transport	-	93	91	-	-	3.92E-02	4.19E-03
InBio	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	4.52E-03	1.44E-03
InBio	BP	GO:0033504	floor plate development	-	11	11	-	-	1.69E-04	5.17E-04
InBio	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	1.65E-04	5.17E-04
InBio	BP	GO:0097186	amelogenesis	-	26	22	-	-	3.50E-04	1.03E-03
InBio	BP	GO:0031128	developmental induction	-	26	26	-	-	7.52E-03	1.21E-03
InBio	BP	GO:0035672	oligopeptide transmembrane transport	-	15	14	-	-	3.10E-02	6.89E-04
InBio	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.95E-03	3.04E-03
InBio	BP	GO:0021533	cell differentiation in hindbrain	-	23	23	-	-	6.24E-03	1.09E-03
InBio	BP	GO:0045684	positive regulation of epidermis development	-	33	29	-	-	9.02E-04	1.38E-03
InBio	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	6.32E-03	5.74E-04
InBio	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	3.40E-02	2.36E-03
InBio	BP	GO:0021517	ventral spinal cord development	-	47	44	-	-	6.59E-03	2.07E-03
InBio	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	73	-	-	3.01E-03	3.39E-03
InBio	BP	GO:0032328	alanine transport	-	19	19	-	-	1.68E-02	9.19E-04
InBio	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	6.26E-03	7.47E-04
InBio	BP	GO:0097722	sperm motility	-	133	116	-	-	1.38E-02	5.34E-03
InBio	BP	GO:0051231	spindle elongation	-	14	14	-	-	4.81E-03	6.89E-04
InBio	BP	GO:0042490	mechanoreceptor differentiation	-	67	60	-	-	1.84E-02	2.76E-03
InBio	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	28	-	-	1.56E-03	1.32E-03
InBio	BP	GO:0035148	tube formation	-	155	153	-	-	6.07E-03	7.07E-03
InBio	BP	GO:0048520	positive regulation of behavior	-	27	27	-	-	5.36E-03	1.26E-03
InBio	BP	GO:0098543	detection of other organism	-	19	18	-	-	3.20E-02	8.62E-04
InBio	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	1.13E-02	2.01E-03
InBio	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	120	-	-	1.41E-02	5.52E-03
InBio	BP	GO:0031123	RNA 3'-end processing	-	79	77	-	-	2.71E-02	3.56E-03
InBio	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	1.25E-02	5.17E-04
InBio	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	105	-	-	8.00E-03	4.83E-03
InBio	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	7.19E-03	8.62E-04
InBio	CC	GO:0007097	nuclear migration	-	24	24	-	-	6.11E-03	1.15E-03
InBio	BP	GO:0006885	regulation of pH	-	104	98	-	-	1.56E-02	4.54E-03
InBio	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.55E-03	6.89E-04
InBio	BP	GO:1990840	response to lectin	-	22	20	-	-	3.88E-02	9.19E-04
InBio	BP	GO:0071800	podosome assembly	-	19	19	-	-	5.16E-04	9.19E-04
InBio	BP	GO:0031018	endocrine pancreas development	-	47	46	-	-	1.82E-03	2.13E-03
InBio	BP	GO:0001708	cell fate specification	-	108	104	-	-	1.23E-02	4.83E-03
InBio	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	67	-	-	4.01E-03	3.10E-03
InBio	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	8.17E-03	1.72E-03
InBio	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	3.59E-04	6.89E-04
InBio	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	2.49E-03	5.74E-04
InBio	BP	GO:0042440	pigment metabolic process	-	80	77	-	-	1.61E-02	3.56E-03
InBio	BP	GO:1901606	alpha-amino acid catabolic process	-	101	97	-	-	9.00E-03	4.48E-03
InBio	BP	GO:1901890	positive regulation of cell junction assembly	-	106	97	-	-	1.16E-02	4.48E-03
InBio	BP	GO:0070988	demethylation	-	27	26	-	-	1.82E-02	1.21E-03
InBio	BP	GO:1901655	cellular response to ketone	-	107	104	-	-	4.04E-03	4.83E-03
InBio	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	3.65E-04	6.89E-04
InBio	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	6.00E-03	6.89E-04
InBio	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	4.79E-02	8.04E-04
InBio	BP	GO:0006968	cellular defense response	-	52	52	-	-	1.43E-02	2.41E-03
InBio	BP	GO:0055006	cardiac cell development	-	93	81	-	-	8.05E-03	3.73E-03
InBio	BP	GO:0031365	N-terminal protein amino acid modification	-	30	30	-	-	1.24E-02	1.38E-03
InBio	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	1.00E-02	5.74E-04
InBio	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	28	-	-	1.36E-03	1.32E-03
InBio	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	7.50E-04	5.74E-04
InBio	BP	GO:0060004	reflex	-	63	60	-	-	2.77E-03	2.76E-03
InBio	BP	GO:0044706	multi-multicellular organism process	-	217	204	-	-	9.99E-03	9.42E-03
InBio	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	2.65E-03	5.74E-04
InBio	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	138	-	-	5.90E-03	6.38E-03
InBio	BP	GO:0006026	aminoglycan catabolic process	-	34	30	-	-	1.72E-02	1.38E-03
InBio	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	2.75E-02	2.13E-03
InBio	BP	GO:0050768	negative regulation of neurogenesis	-	150	146	-	-	7.12E-03	6.72E-03
InBio	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	92	-	-	1.73E-03	4.25E-03
InBio	BP	GO:0090068	positive regulation of cell cycle process	-	262	245	-	-	5.61E-03	1.13E-02
InBio	BP	GO:0043605	amide catabolic process	-	16	16	-	-	1.20E-03	7.47E-04
InBio	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	26	-	-	6.71E-03	1.21E-03
InBio	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	33	-	-	2.13E-02	1.55E-03
InBio	BP	GO:1902115	regulation of organelle assembly	-	210	202	-	-	8.93E-03	9.31E-03
InBio	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	64	-	-	2.99E-03	2.99E-03
InBio	BP	GO:0047484	regulation of response to osmotic stress	-	16	15	-	-	9.43E-04	6.89E-04
InBio	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	140	-	-	5.39E-03	6.43E-03
InBio	BP	GO:0043171	peptide catabolic process	-	19	18	-	-	4.82E-02	8.62E-04
InBio	BP	GO:0046622	positive regulation of organ growth	-	52	43	-	-	1.89E-03	2.01E-03
InBio	BP	GO:0051952	regulation of amine transport	-	98	98	-	-	1.55E-02	4.54E-03
InBio	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	2.35E-03	1.09E-03
InBio	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	1.44E-02	9.19E-04
InBio	BP	GO:0015801	aromatic amino acid transport	-	13	13	-	-	3.29E-02	6.32E-04
InBio	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	3.73E-02	1.09E-03
InBio	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	2.41E-02	9.19E-04
InBio	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	9.21E-04	7.47E-04
InBio	CC	GO:0032365	intracellular lipid transport	-	51	47	-	-	9.00E-03	2.18E-03
InBio	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	6.62E-02	1.38E-03
InBio	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	68	-	-	3.13E-03	3.16E-03
InBio	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	111	-	-	3.76E-03	5.11E-03
InBio	BP	GO:0018149	peptide cross-linking	-	28	26	-	-	1.02E-01	1.21E-03
InBio	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	23	-	-	1.18E-03	1.09E-03
InBio	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	1.19E-03	6.32E-04
InBio	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	1.64E-04	6.89E-04
InBio	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	7.09E-04	6.32E-04
InBio	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	2.10E-03	1.61E-03
InBio	BP	GO:0097581	lamellipodium organization	-	91	87	-	-	6.05E-03	4.02E-03
InBio	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	2.85E-02	1.38E-03
InBio	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	4.76E-02	8.62E-04
InBio	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	1.80E-02	9.77E-04
InBio	BP	GO:0015669	gas transport	-	23	21	-	-	8.26E-02	9.77E-04
InBio	BP	GO:0016485	protein processing	-	248	241	-	-	1.22E-02	1.11E-02
InBio	BP	GO:0009649	entrainment of circadian clock	-	30	28	-	-	5.19E-03	1.32E-03
InBio	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	155	-	-	3.08E-02	7.12E-03
InBio	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	1.85E-03	1.15E-03
InBio	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	132	-	-	1.77E-02	6.09E-03
InBio	BP	GO:0000101	sulfur amino acid transport	-	12	11	-	-	7.83E-02	5.17E-04
InBio	BP	GO:0099054	presynapse assembly	-	49	43	-	-	1.44E-03	2.01E-03
InBio	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	5.08E-03	1.15E-03
InBio	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	5.11E-03	1.15E-03
InBio	BP	GO:0031348	negative regulation of defense response	-	282	235	-	-	5.85E-03	1.08E-02
InBio	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	76	-	-	3.64E-03	3.50E-03
InBio	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	2.92E-03	3.16E-03
InBio	BP	GO:0071496	cellular response to external stimulus	-	74	74	-	-	5.12E-03	3.45E-03
InBio	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	2.28E-02	6.32E-04
InBio	BP	GO:0042753	positive regulation of circadian rhythm	-	18	18	-	-	3.45E-03	8.62E-04
InBio	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	7.85E-04	5.17E-04
InBio	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.10E-02	5.74E-04
InBio	BP	GO:0032094	response to food	-	37	36	-	-	1.99E-03	1.67E-03
InBio	BP	GO:0001964	startle response	-	27	27	-	-	6.21E-03	1.26E-03
InBio	BP	GO:0007340	acrosome reaction	-	38	34	-	-	2.77E-02	1.61E-03
InBio	BP	GO:0046434	organophosphate catabolic process	-	232	222	-	-	4.41E-03	1.02E-02
InBio	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	3.50E-03	1.38E-03
InBio	BP	GO:0009566	fertilization	-	205	179	-	-	2.56E-02	8.27E-03
InBio	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	4.85E-01	2.76E-03
InBio	BP	GO:0120255	olefinic compound biosynthetic process	-	24	23	-	-	3.16E-03	1.09E-03
InBio	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	2.77E-03	6.32E-04
InBio	BP	GO:0045907	positive regulation of vasoconstriction	-	30	28	-	-	6.64E-03	1.32E-03
InBio	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	22	-	-	9.60E-04	1.03E-03
InBio	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	1.70E-02	1.14E-02
InBio	BP	GO:0009309	amine biosynthetic process	-	38	35	-	-	4.09E-02	1.61E-03
InBio	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	2.16E-03	9.19E-04
InBio	BP	GO:0061900	glial cell activation	-	56	51	-	-	2.44E-03	2.36E-03
InBio	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	132	-	-	1.06E-02	6.09E-03
InBio	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	1.77E-03	6.32E-04
InBio	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	8.34E-03	6.89E-04
InBio	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	1.29E-02	1.90E-03
InBio	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	1.45E-03	9.19E-04
InBio	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	8.75E-04	6.89E-04
InBio	BP	GO:0072537	fibroblast activation	-	13	13	-	-	8.11E-03	6.32E-04
InBio	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	1.89E-03	6.32E-04
InBio	BP	GO:0043647	inositol phosphate metabolic process	-	44	43	-	-	3.45E-03	2.01E-03
InBio	BP	GO:0016180	snRNA processing	-	28	26	-	-	6.45E-02	1.21E-03
InBio	BP	GO:0051303	establishment of chromosome localization	-	104	100	-	-	1.56E-02	4.60E-03
InBio	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	2.79E-02	7.47E-04
InBio	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	8.03E-03	1.78E-03
InBio	BP	GO:0097164	ammonium ion metabolic process	-	23	20	-	-	2.72E-04	9.19E-04
InBio	BP	GO:0021515	cell differentiation in spinal cord	-	51	49	-	-	5.64E-03	2.30E-03
InBio	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	4.62E-03	8.62E-04
InBio	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	1.78E-02	9.77E-04
InBio	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	2.28E-03	1.32E-03
InBio	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	4.93E-03	8.62E-04
InBio	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	36	-	-	1.51E-03	1.67E-03
InBio	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	2.89E-03	1.03E-03
InBio	BP	GO:0007566	embryo implantation	-	57	51	-	-	2.55E-03	2.36E-03
InBio	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	4.71E-03	1.55E-03
InBio	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	3.47E-02	7.47E-04
InBio	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	5.50E-02	1.49E-03
InBio	BP	GO:0051017	actin filament bundle assembly	-	161	153	-	-	6.78E-03	7.07E-03
InBio	BP	GO:1905953	negative regulation of lipid localization	-	63	41	-	-	3.08E-03	1.90E-03
InBio	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	3.26E-03	8.62E-04
InBio	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	9.20E-04	9.19E-04
InBio	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	3.99E-03	6.32E-04
InBio	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	37	-	-	5.35E-03	1.72E-03
InBio	BP	GO:0021756	striatum development	-	21	21	-	-	4.94E-03	9.77E-04
InBio	BP	GO:1901343	negative regulation of vasculature development	-	154	99	-	-	4.53E-03	4.60E-03
InBio	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	147	-	-	2.39E-02	6.78E-03
InBio	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	27	-	-	5.45E-03	1.26E-03
InBio	BP	GO:1902414	protein localization to cell junction	-	107	105	-	-	7.80E-03	4.83E-03
InBio	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	5.02E-03	1.03E-03
InBio	BP	GO:0051304	chromosome separation	-	80	80	-	-	1.67E-02	3.68E-03
InBio	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	3.36E-03	8.62E-04
InBio	BP	GO:0048709	oligodendrocyte differentiation	-	101	100	-	-	4.77E-03	4.60E-03
InBio	BP	GO:0045017	glycerolipid biosynthetic process	-	254	245	-	-	1.50E-02	1.13E-02
InBio	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	1.84E-01	6.89E-04
InBio	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	5.23E-03	1.09E-03
InBio	BP	GO:0001776	leukocyte homeostasis	-	108	104	-	-	4.38E-03	4.83E-03
InBio	BP	GO:0050769	positive regulation of neurogenesis	-	240	230	-	-	6.78E-03	1.06E-02
InBio	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	3.78E-02	6.89E-04
InBio	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	3.06E-02	3.22E-03
InBio	BP	GO:0050866	negative regulation of cell activation	-	216	197	-	-	8.11E-03	9.08E-03
InBio	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	34	-	-	2.20E-03	1.61E-03
InBio	BP	GO:0033500	carbohydrate homeostasis	-	251	233	-	-	5.28E-03	1.07E-02
InBio	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	29	-	-	6.49E-03	1.38E-03
InBio	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	5.64E-02	5.74E-04
InBio	BP	GO:0044088	regulation of vacuole organization	-	56	55	-	-	9.80E-03	2.53E-03
InBio	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	1.61E-03	1.09E-03
InBio	CC	GO:0099522	cytosolic region	-	20	20	-	-	1.60E-03	9.19E-04
InBio	CC	GO:0000791	euchromatin	-	60	59	-	-	3.27E-03	2.76E-03
InBio	CC	GO:0030666	endocytic vesicle membrane	-	196	193	-	-	1.11E-02	8.90E-03
InBio	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	2.49E-02	6.89E-04
InBio	CC	GO:1990752	microtubule end	-	34	34	-	-	1.46E-02	1.61E-03
InBio	CC	GO:0043204	perikaryon	-	156	151	-	-	4.26E-03	6.95E-03
InBio	CC	GO:0061702	canonical inflammasome complex	-	17	16	-	-	1.03E-01	7.47E-04
InBio	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	2.23E-02	5.74E-04
InBio	CC	GO:0097542	ciliary tip	-	48	48	-	-	3.60E-01	2.24E-03
InBio	CC	GO:1905368	peptidase complex	-	124	122	-	-	7.36E-02	5.63E-03
InBio	CC	GO:0000792	heterochromatin	-	98	97	-	-	9.67E-03	4.48E-03
InBio	CC	GO:0097546	ciliary base	-	47	45	-	-	5.77E-03	2.07E-03
InBio	CC	GO:0071819	DUBm complex	-	25	24	-	-	2.53E-01	1.15E-03
InBio	CC	GO:0031201	SNARE complex	-	48	46	-	-	1.53E-01	2.13E-03
InBio	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.67E-03	6.32E-04
InBio	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	8.54E-03	1.84E-03
InBio	CC	GO:0044391	ribosomal subunit	-	203	201	-	-	2.65E-01	9.25E-03
InBio	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	4.34E-02	5.17E-04
InBio	CC	GO:0071013	catalytic step 2 spliceosome	-	88	86	-	-	5.90E-02	3.96E-03
InBio	CC	GO:0031907	microbody lumen	-	51	50	-	-	7.89E-02	2.30E-03
InBio	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.02E-01	5.17E-04
InBio	CC	GO:0098862	cluster of actin-based cell projections	-	162	144	-	-	2.94E-02	6.66E-03
InBio	CC	GO:0016363	nuclear matrix	-	127	127	-	-	6.18E-03	5.86E-03
InBio	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	5.97E-02	2.13E-03
InBio	CC	GO:0032432	actin filament bundle	-	249	234	-	-	2.03E-02	1.08E-02
InBio	CC	GO:0008088	axo-dendritic transport	-	78	77	-	-	1.14E-02	3.56E-03
InBio	CC	GO:0031519	PcG protein complex	-	38	38	-	-	2.57E-02	1.78E-03
InBio	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	39	-	-	1.29E-01	1.84E-03
InBio	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	214	-	-	3.15E-02	9.88E-03
InBio	CC	GO:0000313	organellar ribosome	-	89	89	-	-	5.27E-01	4.14E-03
InBio	CC	GO:0099643	signal release from synapse	-	147	139	-	-	1.89E-02	6.43E-03
InBio	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	45	-	-	5.08E-02	2.07E-03
InBio	CC	GO:0005818	aster	-	11	11	-	-	3.63E-02	5.17E-04
InBio	CC	GO:0030018	Z disc	-	129	125	-	-	3.35E-02	5.74E-03
InBio	CC	GO:0032580	Golgi cisterna membrane	-	93	77	-	-	3.31E-03	3.56E-03
InBio	CC	GO:0097381	photoreceptor disc membrane	-	25	19	-	-	2.38E-03	9.19E-04
InBio	CC	GO:1905360	GTPase complex	-	41	39	-	-	5.53E-03	1.84E-03
InBio	CC	GO:0097540	axonemal central pair	-	161	138	-	-	7.22E-03	6.38E-03
InBio	CC	GO:0042641	actomyosin	-	77	75	-	-	9.11E-03	3.45E-03
InBio	CC	GO:0097386	glial cell projection	-	38	38	-	-	9.71E-04	1.78E-03
InBio	CC	GO:0032588	trans-Golgi network membrane	-	102	98	-	-	4.14E-02	4.54E-03
InBio	CC	GO:0070382	exocytic vesicle	-	224	216	-	-	1.50E-02	9.94E-03
InBio	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	47	-	-	6.52E-03	2.18E-03
InBio	CC	GO:0031903	microbody membrane	-	65	64	-	-	7.09E-02	2.99E-03
InBio	CC	GO:0046930	pore complex	-	26	26	-	-	1.55E-01	1.21E-03
InBio	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	8.47E-03	5.17E-04
InBio	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	1.12E-03	7.47E-04
InBio	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	243	-	-	2.20E-02	1.12E-02
InBio	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	1.88E-02	1.15E-03
InBio	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	6.24E-02	5.17E-04
InBio	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	1.51E-03	8.62E-04
InBio	CC	GO:0044298	cell body membrane	-	32	32	-	-	3.55E-03	1.49E-03
InBio	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	3.87E-02	5.17E-04
InBio	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	1.35E-03	9.77E-04
InBio	CC	GO:0045495	pole plasm	-	25	22	-	-	2.10E-01	1.03E-03
InBio	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	3.93E-03	6.89E-04
InBio	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	5.76E-02	9.19E-04
InBio	CC	GO:0010369	chromocenter	-	14	14	-	-	1.91E-03	6.89E-04
InBio	CC	GO:0002177	manchette	-	19	16	-	-	2.21E-04	7.47E-04
InBio	CC	GO:0016323	basolateral plasma membrane	-	239	222	-	-	7.26E-03	1.02E-02
InBio	CC	GO:0045009	chitosome	-	21	21	-	-	3.08E-02	9.77E-04
InBio	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	1.32E-03	5.74E-04
InBio	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	6.30E-03	2.07E-03
InBio	CC	GO:0098636	protein complex involved in cell adhesion	-	57	56	-	-	3.77E-02	2.59E-03
InBio	CC	GO:0001917	photoreceptor inner segment	-	71	66	-	-	2.41E-02	3.04E-03
InBio	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	5.32E-03	6.89E-04
InBio	CC	GO:0019897	extrinsic component of plasma membrane	-	156	148	-	-	1.72E-02	6.84E-03
InBio	CC	GO:0031594	neuromuscular junction	-	73	71	-	-	2.76E-03	3.27E-03
InBio	CC	GO:0045120	pronucleus	-	14	13	-	-	2.98E-04	6.32E-04
InBio	CC	GO:0043083	synaptic cleft	-	21	20	-	-	1.27E-01	9.19E-04
InBio	CC	GO:0000922	spindle pole	-	172	169	-	-	8.86E-03	7.81E-03
InBio	CC	GO:0120111	neuron projection cytoplasm	-	94	93	-	-	7.87E-03	4.31E-03
InBio	CC	GO:0070971	endoplasmic reticulum exit site	-	32	27	-	-	9.23E-03	1.26E-03
InBio	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	6.47E-02	6.32E-04
InBio	CC	GO:0004879	nuclear receptor activity	-	63	62	-	-	4.02E-03	2.87E-03
InBio	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	162	-	-	5.64E-03	7.47E-03
InBio	CC	GO:0000123	histone acetyltransferase complex	-	93	91	-	-	8.22E-02	4.19E-03
InBio	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	1.13E-02	6.32E-04
InBio	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	108	-	-	2.75E-01	5.00E-03
InBio	CC	GO:0048786	presynaptic active zone	-	80	77	-	-	1.01E-02	3.56E-03
InBio	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	4.11E-02	5.74E-04
InBio	CC	GO:0007034	vacuolar transport	-	168	163	-	-	4.45E-02	7.53E-03
InBio	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	3.01E-02	9.77E-04
InBio	CC	GO:0043194	axon initial segment	-	21	20	-	-	4.91E-02	9.19E-04
InBio	CC	GO:1900115	extracellular regulation of signal transduction	-	13	12	-	-	3.21E-02	5.74E-04
InBio	CC	GO:0005776	autophagosome	-	111	109	-	-	2.53E-02	5.06E-03
InBio	CC	GO:0031430	M band	-	22	19	-	-	3.71E-03	9.19E-04
InBio	CC	GO:0001931	uropod	-	13	13	-	-	8.36E-03	6.32E-04
InBio	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	4.12E-02	3.45E-03
InBio	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	96	-	-	2.96E-01	4.42E-03
InBio	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	1.40E-01	6.32E-04
InBio	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	2.43E-02	9.19E-04
InBio	CC	GO:0071203	WASH complex	-	12	11	-	-	4.24E-01	5.17E-04
InBio	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	28	-	-	1.82E-02	1.32E-03
InBio	CC	GO:0032994	protein-lipid complex	-	39	39	-	-	1.93E-01	1.84E-03
InBio	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	146	-	-	1.41E-01	6.72E-03
InBio	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	1.16E-02	5.74E-04
InBio	CC	GO:0001527	microfibril	-	13	12	-	-	4.05E-01	5.74E-04
InBio	CC	GO:0072562	blood microparticle	-	144	136	-	-	2.19E-02	6.26E-03
InBio	CC	GO:0005883	neurofilament	-	11	11	-	-	1.08E-02	5.17E-04
InBio	CC	GO:0051233	spindle midzone	-	36	36	-	-	2.48E-03	1.67E-03
InBio	CC	GO:0005811	lipid droplet	-	102	100	-	-	1.58E-02	4.60E-03
InBio	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	6.12E-03	2.07E-03
InBio	CC	GO:0043113	receptor clustering	-	51	47	-	-	4.80E-03	2.18E-03
InBio	CC	GO:0005940	septin ring	-	14	13	-	-	5.27E-01	6.32E-04
InBio	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	4.14E-02	5.17E-04
InBio	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	22	-	-	2.02E-01	1.03E-03
InBio	CC	GO:0044853	plasma membrane raft	-	114	110	-	-	6.61E-03	5.06E-03
InBio	CC	GO:0005881	cytoplasmic microtubule	-	256	221	-	-	7.95E-03	1.02E-02
InBio	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	14	-	-	5.04E-04	6.89E-04
InBio	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	1.14E-02	8.04E-04
InBio	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	56	-	-	1.03E-02	2.59E-03
InBio	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	1.38E-02	3.33E-03
InBio	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	6.58E-02	5.74E-04
InBio	CC	GO:0043034	costamere	-	18	17	-	-	6.09E-03	8.04E-04
InBio	CC	GO:0031904	endosome lumen	-	38	38	-	-	2.81E-02	1.78E-03
InBio	CC	GO:0060170	ciliary membrane	-	76	73	-	-	4.97E-02	3.39E-03
InBio	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	1.97E-01	6.32E-04
InBio	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	9.27E-03	5.74E-04
InBio	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	9.79E-02	1.15E-03
InBio	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	2.71E-02	6.89E-04
InBio	CC	GO:0032154	cleavage furrow	-	54	53	-	-	5.45E-03	2.47E-03
InBio	CC	GO:0005640	nuclear outer membrane	-	30	29	-	-	1.56E-03	1.38E-03
InBio	CC	GO:0005652	nuclear lamina	-	12	11	-	-	9.20E-04	5.17E-04
InBio	CC	GO:0007006	mitochondrial membrane organization	-	117	109	-	-	2.90E-02	5.06E-03
InBio	CC	GO:0001772	immunological synapse	-	44	43	-	-	1.04E-02	2.01E-03
InBio	CC	GO:0030904	retromer complex	-	12	12	-	-	6.14E-02	5.74E-04
InBio	CC	GO:0030863	cortical cytoskeleton	-	104	101	-	-	1.16E-02	4.65E-03
InBio	CC	GO:1905348	endonuclease complex	-	38	36	-	-	4.51E-02	1.67E-03
InBio	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	2.22E-01	5.17E-04
InBio	CC	GO:0030315	T-tubule	-	52	51	-	-	4.86E-02	2.36E-03
InBio	CC	GO:0060076	excitatory synapse	-	64	60	-	-	1.23E-02	2.76E-03
InBio	CC	GO:0036019	endolysosome	-	29	29	-	-	2.90E-02	1.38E-03
InBio	CC	GO:0001891	phagocytic cup	-	28	28	-	-	8.18E-03	1.32E-03
InBio	CC	GO:0099086	synaptonemal structure	-	40	37	-	-	5.91E-02	1.72E-03
InBio	CC	GO:0030427	site of polarized growth	-	172	169	-	-	4.38E-03	7.81E-03
InBio	CC	GO:0044309	neuron spine	-	213	208	-	-	7.86E-03	9.59E-03
InBio	CC	GO:0030658	transport vesicle membrane	-	231	221	-	-	4.18E-02	1.02E-02
InBio	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	3.12E-03	1.26E-03
InBio	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	6.32E-02	5.74E-04
InBio	CC	GO:0000940	outer kinetochore	-	17	17	-	-	4.01E-02	8.04E-04
InBio	CC	GO:0034719	SMN-Sm protein complex	-	18	16	-	-	1.19E-01	7.47E-04
InBio	CC	GO:0044232	organelle membrane contact site	-	50	49	-	-	1.63E-02	2.30E-03
InBio	CC	GO:0098803	respiratory chain complex	-	39	35	-	-	5.10E-01	1.61E-03
InBio	CC	GO:0097545	axonemal outer doublet	-	164	141	-	-	9.02E-03	6.49E-03
InBio	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	4.68E-03	9.19E-04
InBio	CC	GO:0070069	cytochrome complex	-	42	38	-	-	4.65E-01	1.78E-03
InBio	CC	GO:0031143	pseudopodium	-	18	18	-	-	6.62E-03	8.62E-04
InBio	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	6.35E-02	1.26E-03
InBio	CC	GO:0055037	recycling endosome	-	200	193	-	-	6.67E-03	8.90E-03
InBio	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	93	-	-	1.91E-02	4.31E-03
InBio	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	1.26E-02	6.32E-04
InBio	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	1.40E-03	5.74E-04
InBio	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	2.67E-03	1.03E-03
InBio	CC	GO:0030684	preribosome	-	76	73	-	-	1.30E-01	3.39E-03
InBio	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	1.88E-02	8.62E-04
InBio	CC	GO:1990391	DNA repair complex	-	22	22	-	-	2.24E-02	1.03E-03
InBio	CC	GO:0005775	vacuolar lumen	-	176	172	-	-	5.69E-03	7.93E-03
InBio	CC	GO:0032433	filopodium tip	-	19	19	-	-	2.64E-03	9.19E-04
InBio	CC	GO:0032982	myosin filament	-	24	24	-	-	8.34E-03	1.15E-03
InBio	CC	GO:0016327	apicolateral plasma membrane	-	23	21	-	-	6.06E-02	9.77E-04
InBio	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	3.80E-01	1.09E-03
InBio	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	1.20E-02	5.74E-04
InBio	CC	GO:0044306	neuron projection terminus	-	164	159	-	-	1.22E-02	7.35E-03
InBio	CC	GO:0034455	t-UTP complex	-	53	51	-	-	1.45E-01	2.36E-03
InBio	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	2.28E-01	8.04E-04
InBio	CC	GO:0031970	organelle envelope lumen	-	94	91	-	-	4.72E-03	4.19E-03
InBio	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.22E-02	6.32E-04
InBio	CC	GO:0120293	dynein axonemal particle	-	20	19	-	-	4.28E-03	9.19E-04
InBio	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	8.28E-04	1.15E-03
InBio	CC	GO:0043292	contractile muscle fiber	-	245	232	-	-	8.02E-02	1.07E-02
InBio	CC	GO:0018995	host cellular component	-	12	12	-	-	9.48E-03	5.74E-04
InBio	CC	GO:0034709	methylosome	-	13	12	-	-	1.31E-02	5.74E-04
InBio	CC	GO:0032426	stereocilium tip	-	21	15	-	-	2.24E-04	6.89E-04
InBio	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	4.78E-03	5.74E-04
InBio	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	1.05E-01	9.19E-04
InBio	CC	GO:0000803	sex chromosome	-	32	29	-	-	2.73E-03	1.38E-03
InBio	CC	GO:0098982	GABA-ergic synapse	-	84	80	-	-	3.61E-02	3.68E-03
InBio	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	4.41E-02	7.47E-04
InBio	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	9.09E-03	2.93E-03
InBio	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	9.18E-02	6.89E-04
InBio	CC	GO:0000242	pericentriolar material	-	22	22	-	-	3.89E-03	1.03E-03
InBio	CC	GO:1903293	phosphatase complex	-	54	53	-	-	1.88E-02	2.47E-03
InBio	CC	GO:0097470	ribbon synapse	-	13	12	-	-	1.47E-03	5.74E-04
InBio	CC	GO:0031941	filamentous actin	-	27	26	-	-	2.25E-03	1.21E-03
InBio	CC	GO:0000786	nucleosome	-	149	102	-	-	2.34E-02	4.71E-03
InBio	CC	GO:0001533	cornified envelope	-	59	58	-	-	5.13E-02	2.70E-03
InBio	CC	GO:1904724	tertiary granule lumen	-	55	54	-	-	3.10E-03	2.53E-03
InBio	CC	GO:0030027	lamellipodium	-	202	198	-	-	8.89E-03	9.13E-03
InBio	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	1.96E-03	6.89E-04
InBio	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	26	-	-	2.26E-01	1.21E-03
InBio	CC	GO:0000800	lateral element	-	14	14	-	-	9.31E-03	6.89E-04
InBio	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	5.34E-03	5.74E-04
InBio	CC	GO:0060077	inhibitory synapse	-	20	19	-	-	1.82E-02	9.19E-04
InBio	CC	GO:0031209	SCAR complex	-	12	12	-	-	7.14E-02	5.74E-04
InBio	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	5.19E-02	7.47E-04
InBio	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	22	-	-	2.65E-01	1.03E-03
InBio	CC	GO:0002102	podosome	-	31	31	-	-	2.03E-03	1.44E-03
InBio	CC	GO:0090543	Flemming body	-	33	33	-	-	9.72E-03	1.55E-03
InBio	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	9.29E-03	3.04E-03
InBio	CC	GO:0001650	fibrillar center	-	151	148	-	-	4.17E-03	6.84E-03
InBio	CC	GO:0031332	RNAi effector complex	-	413	16	-	-	1.38E-02	7.47E-04
InBio	CC	GO:1990204	oxidoreductase complex	-	90	84	-	-	2.62E-01	3.91E-03
InBio	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	4.11E-02	7.47E-04
InBio	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	3.75E-01	5.17E-04
InBio	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	122	-	-	3.65E-03	5.63E-03
InBio	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	1.69E-02	9.19E-04
InBio	CC	GO:0001726	ruffle	-	181	178	-	-	8.71E-03	8.22E-03
InBio	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	8.32E-03	6.32E-04
InBio	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	17	-	-	4.76E-02	8.04E-04
InBio	CC	GO:0043198	dendritic shaft	-	38	38	-	-	9.89E-04	1.78E-03
InBio	CC	GO:0043073	germ cell nucleus	-	67	63	-	-	2.82E-03	2.93E-03
InBio	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	22	-	-	3.49E-03	1.03E-03
InBio	CC	GO:0016592	mediator complex	-	38	38	-	-	2.59E-01	1.78E-03
InBio	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	2.12E-02	9.19E-04
InBio	CC	GO:0022626	cytosolic ribosome	-	118	116	-	-	8.51E-02	5.34E-03
InBio	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	3.03E-02	2.07E-03
InBio	CC	GO:0034451	centriolar satellite	-	120	115	-	-	1.57E-02	5.29E-03
InBio	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	5.78E-03	5.17E-04
InBio	CC	GO:0045171	intercellular bridge	-	91	88	-	-	2.87E-03	4.08E-03
InBio	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	79	-	-	6.68E-02	3.68E-03
InBio	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	2.68E-01	6.89E-04
InBio	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.95E-02	5.17E-04
InBio	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	6.30E-02	5.17E-04
InBio	CC	GO:0044292	dendrite terminus	-	13	13	-	-	7.30E-04	6.32E-04
InBio	CC	GO:0032039	integrator complex	-	19	17	-	-	1.70E-01	8.04E-04
InBio	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	1.63E-02	6.89E-04
InBio	CC	GO:0033268	node of Ranvier	-	16	16	-	-	2.23E-02	7.47E-04
InBio	CC	GO:0036038	MKS complex	-	13	13	-	-	5.99E-03	6.32E-04
InBio	CC	GO:0030527	structural constituent of chromatin	-	97	51	-	-	7.03E-03	2.36E-03
InBio	CC	GO:0036379	myofilament	-	26	24	-	-	6.96E-02	1.15E-03
InBio	CC	GO:0030286	dynein complex	-	210	182	-	-	1.05E-02	8.39E-03
InBio	CC	GO:0031105	septin complex	-	14	13	-	-	4.84E-01	6.32E-04
InBio	CC	GO:0097228	sperm principal piece	-	33	26	-	-	7.00E-02	1.21E-03
InBio	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	9.06E-03	5.74E-04
InBio	CC	GO:0016482	cytosolic transport	-	135	133	-	-	2.97E-02	6.15E-03
InBio	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	1.60E-01	1.09E-03
InBio	CC	GO:0005796	Golgi lumen	-	106	103	-	-	3.45E-03	4.77E-03
InBio	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	35	-	-	5.76E-02	1.61E-03
InBio	CC	GO:0034358	plasma lipoprotein particle	-	36	36	-	-	1.94E-01	1.67E-03
InBio	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	1.32E-01	2.18E-03
InBio	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	1.44E-02	1.15E-03
InBio	CC	GO:0030662	coated vesicle membrane	-	202	196	-	-	7.38E-02	9.02E-03
InBio	CC	GO:0007039	protein catabolic process in the vacuole	-	61	59	-	-	1.15E-01	2.76E-03
InBio	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	66	-	-	2.96E-01	3.04E-03
InBio	CC	GO:0090734	site of DNA damage	-	118	116	-	-	1.19E-02	5.34E-03
InBio	MF	GO:0051861	glycolipid binding	-	30	30	-	-	4.15E-03	1.38E-03
InBio	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.68E-04	5.17E-04
InBio	MF	GO:0051087	protein-folding chaperone binding	-	135	133	-	-	6.51E-03	6.15E-03
InBio	MF	GO:0051959	dynein light intermediate chain binding	-	27	25	-	-	2.41E-03	1.15E-03
InBio	CC	GO:0015464	acetylcholine receptor activity	-	21	20	-	-	2.15E-01	9.19E-04
InBio	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	1.65E-04	5.74E-04
InBio	MF	GO:0016594	glycine binding	-	12	12	-	-	8.09E-02	5.74E-04
InBio	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	1.17E-03	9.19E-04
InBio	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	36	-	-	2.58E-03	1.67E-03
InBio	MF	GO:0035613	RNA stem-loop binding	-	21	17	-	-	1.82E-03	8.04E-04
InBio	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	238	-	-	9.77E-03	1.10E-02
InBio	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	19	-	-	1.69E-03	9.19E-04
InBio	MF	GO:0033691	sialic acid binding	-	22	21	-	-	2.84E-04	9.77E-04
InBio	MF	GO:0048306	calcium-dependent protein binding	-	61	58	-	-	9.98E-03	2.70E-03
InBio	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	2.81E-03	1.32E-03
InBio	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	2.13E-01	6.32E-04
InBio	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	135	-	-	7.11E-03	6.20E-03
InBio	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	59	-	-	1.80E-01	2.76E-03
InBio	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	132	-	-	8.66E-03	6.09E-03
InBio	MF	GO:0045504	dynein heavy chain binding	-	16	15	-	-	2.24E-02	6.89E-04
InBio	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	2.44E-03	1.38E-03
InBio	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	7.88E-03	1.03E-03
InBio	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	2.93E-03	6.89E-04
InBio	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	1.86E-02	6.89E-04
InBio	MF	GO:0061980	regulatory RNA binding	-	52	44	-	-	5.83E-03	2.07E-03
InBio	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	1.74E-02	1.49E-03
InBio	MF	GO:0000182	rDNA binding	-	11	11	-	-	1.87E-03	5.17E-04
InBio	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	1.28E-02	1.38E-03
InBio	MF	GO:0070840	dynein complex binding	-	25	24	-	-	1.19E-03	1.15E-03
InBio	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.28E-03	1.15E-03
InBio	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.02E-03	7.47E-04
InBio	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	1.36E-03	1.61E-03
InBio	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	1.03E-02	8.62E-04
InBio	MF	GO:0005178	integrin binding	-	153	149	-	-	3.22E-02	6.89E-03
InBio	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	7.82E-04	8.04E-04
InBio	MF	GO:0005549	odorant binding	-	128	112	-	-	1.34E-02	5.17E-03
InBio	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	4.71E-03	6.89E-04
InBio	MF	GO:0008327	methyl-CpG binding	-	31	27	-	-	1.07E-02	1.26E-03
InBio	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	3.00E-03	9.19E-04
InBio	MF	GO:0048019	receptor antagonist activity	-	31	18	-	-	1.94E-03	8.62E-04
InBio	MF	GO:0005521	lamin binding	-	15	15	-	-	4.57E-03	6.89E-04
InBio	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	9.32E-04	8.04E-04
InBio	MF	GO:0140318	protein transporter activity	-	40	40	-	-	2.37E-02	1.84E-03
InBio	MF	GO:0070628	proteasome binding	-	17	17	-	-	5.40E-03	8.04E-04
InBio	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	2.18E-03	5.17E-04
InBio	MF	GO:0031432	titin binding	-	13	11	-	-	5.49E-03	5.17E-04
InBio	MF	GO:0046812	host cell surface binding	-	11	11	-	-	2.53E-03	5.17E-04
InBio	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	9.12E-03	1.72E-03
InBio	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	3.02E-02	8.04E-04
InBio	MF	GO:0002039	p53 binding	-	66	66	-	-	3.20E-03	3.04E-03
InBio	MF	GO:0005496	steroid binding	-	110	103	-	-	8.90E-03	4.77E-03
InBio	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	2.71E-03	1.26E-03
InBio	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	2.35E-03	5.17E-04
InBio	MF	GO:0003684	damaged DNA binding	-	89	84	-	-	2.34E-02	3.91E-03
InBio	MF	GO:0000339	RNA cap binding	-	20	20	-	-	1.22E-02	9.19E-04
InBio	MF	GO:0016500	protein-hormone receptor activity	-	21	20	-	-	2.29E-02	9.19E-04
InBio	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	121	-	-	1.45E-02	5.57E-03
InBio	MF	GO:0005523	tropomyosin binding	-	15	13	-	-	1.93E-03	6.32E-04
InBio	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	1.29E-02	5.74E-04
InBio	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	5.69E-03	5.17E-04
InBio	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	4.34E-03	2.76E-03
InBio	MF	GO:0050811	GABA receptor binding	-	18	16	-	-	5.08E-03	7.47E-04
InBio	MF	GO:0030971	receptor tyrosine kinase binding	-	76	73	-	-	7.11E-03	3.39E-03
InBio	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	83	-	-	2.06E-02	3.85E-03
InBio	MF	GO:0140030	modification-dependent protein binding	-	179	175	-	-	6.07E-03	8.04E-03
InBio	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	7.70E-02	1.15E-03
InBio	MF	GO:0009881	photoreceptor activity	-	17	13	-	-	3.41E-02	6.32E-04
InBio	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	18	-	-	2.28E-04	8.62E-04
InBio	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	4.05E-03	6.32E-04
InBio	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	2.73E-02	7.47E-04
InBio	MF	GO:0141047	molecular tag activity	-	13	12	-	-	2.48E-04	5.74E-04
InBio	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.41E-02	5.17E-04
InBio	MF	GO:0033130	acetylcholine receptor binding	-	12	11	-	-	3.62E-04	5.17E-04
InBio	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	6.93E-04	6.89E-04
InBio	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	2.92E-03	5.74E-04
InBio	MF	GO:0044548	S100 protein binding	-	14	14	-	-	3.84E-02	6.89E-04
InBio	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.48E-02	6.89E-04
InBio	MF	GO:0030276	clathrin binding	-	70	67	-	-	3.81E-02	3.10E-03
InBio	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	7.97E-03	1.38E-03
InBio	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	8.08E-04	6.89E-04
InBio	MF	GO:0046790	virion binding	-	19	19	-	-	4.93E-03	9.19E-04
InBio	MF	GO:0030552	cAMP binding	-	48	45	-	-	1.17E-02	2.07E-03
InBio	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	37	-	-	7.01E-04	1.72E-03
InBio	MF	GO:0035173	histone kinase activity	-	17	17	-	-	1.21E-03	8.04E-04
InBio	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	1.02E-02	1.21E-03
InBio	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	4.33E-02	5.74E-04
InBio	MF	GO:0016209	antioxidant activity	-	92	86	-	-	4.55E-02	3.96E-03
InBio	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	9.28E-03	1.38E-03
InBio	MF	GO:0044325	transmembrane transporter binding	-	159	151	-	-	1.10E-02	6.95E-03
InBio	MF	GO:0048156	tau protein binding	-	43	43	-	-	2.79E-03	2.01E-03
InBio	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	1.83E-02	1.67E-03
InBio	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	3.01E-03	6.32E-04
InBio	MF	GO:0140272	exogenous protein binding	-	79	77	-	-	4.11E-03	3.56E-03
InBio	MF	GO:0030145	manganese ion binding	-	65	62	-	-	1.29E-03	2.87E-03
InBio	MF	GO:0071814	protein-lipid complex binding	-	52	46	-	-	1.34E-02	2.13E-03
InBio	MF	GO:0008066	glutamate receptor activity	-	70	66	-	-	1.79E-02	3.04E-03
InBio	MF	GO:0030553	cGMP binding	-	15	14	-	-	8.28E-02	6.89E-04
InBio	MF	GO:0017069	snRNA binding	-	54	47	-	-	2.59E-02	2.18E-03
InBio	MF	GO:0030215	semaphorin receptor binding	-	23	23	-	-	1.15E-02	1.09E-03
InBio	MF	GO:0031996	thioesterase binding	-	11	11	-	-	1.22E-03	5.17E-04
InBio	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	5.24E-03	1.44E-03
InBio	MF	GO:0019843	rRNA binding	-	69	68	-	-	9.87E-03	3.16E-03
InBio	MF	GO:0004713	protein tyrosine kinase activity	-	213	210	-	-	1.32E-02	9.65E-03
InBio	MF	GO:0061783	peptidoglycan muralytic activity	-	14	11	-	-	1.71E-04	5.17E-04
InBio	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	52	-	-	2.43E-03	2.41E-03
InBio	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.23E-03	1.15E-03
InBio	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	1.05E-03	9.19E-04
InBio	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	27	-	-	6.92E-03	1.26E-03
InBio	MF	GO:0016208	AMP binding	-	22	22	-	-	3.83E-03	1.03E-03
InBio	MF	GO:0000287	magnesium ion binding	-	225	221	-	-	6.48E-03	1.02E-02
InBio	MF	GO:0031490	chromatin DNA binding	-	120	115	-	-	9.01E-03	5.29E-03
InBio	MF	GO:0017022	myosin binding	-	73	71	-	-	9.33E-03	3.27E-03
InBio	MF	GO:0004896	cytokine receptor activity	-	93	88	-	-	3.78E-02	4.08E-03
InBio	MF	GO:0017166	vinculin binding	-	12	12	-	-	3.61E-03	5.74E-04
InBio	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	5.79E-03	8.62E-04
InBio	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	3.53E-03	5.74E-04
InBio	MF	GO:0005539	glycosaminoglycan binding	-	236	220	-	-	2.30E-02	1.01E-02
InBio	MF	GO:0140666	annealing activity	-	11	11	-	-	2.39E-03	5.17E-04
InBio	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	5.00E-03	6.89E-04
InBio	MF	GO:0010181	FMN binding	-	15	15	-	-	2.24E-04	6.89E-04
InBio	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	15	-	-	1.49E-01	6.89E-04
InBio	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	24	-	-	1.34E-03	1.15E-03
InBio	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	2.17E-04	8.04E-04
InBio	MF	GO:0044183	protein folding chaperone	-	67	61	-	-	1.90E-03	2.81E-03
InBio	MF	GO:0005132	type I interferon receptor binding	-	17	15	-	-	5.80E-01	6.89E-04
InBio	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	107	-	-	9.84E-03	4.94E-03
InBio	MF	GO:0003725	double-stranded RNA binding	-	72	72	-	-	1.05E-02	3.33E-03
InBio	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	1.24E-01	7.47E-04
InBio	MF	GO:0051018	protein kinase A binding	-	52	51	-	-	2.18E-02	2.36E-03
InBio	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.47E-03	1.61E-03
InBio	MF	GO:0004618	phosphoglycerate kinase activity	-	89	88	-	-	3.32E-03	4.08E-03
InBio	MF	GO:0042805	actinin binding	-	36	35	-	-	2.48E-03	1.61E-03
InBio	MF	GO:0043531	ADP binding	-	38	38	-	-	1.40E-03	1.78E-03
InBio	MF	GO:0043394	proteoglycan binding	-	36	36	-	-	6.02E-03	1.67E-03
InBio	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	1.34E-02	5.17E-04
InBio	MF	GO:0046332	SMAD binding	-	77	77	-	-	9.57E-03	3.56E-03
InBio	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.87E-03	6.32E-04
InBio	MF	GO:0001968	fibronectin binding	-	30	30	-	-	5.83E-03	1.38E-03
InBio	MF	GO:0048038	quinone binding	-	16	16	-	-	1.38E-02	7.47E-04
InBio	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	120	-	-	2.37E-02	5.52E-03
InBio	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	78	-	-	4.75E-03	3.62E-03
InBio	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	3.92E-03	8.62E-04
InBio	MF	GO:0051117	ATPase binding	-	85	83	-	-	4.33E-03	3.85E-03
InBio	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	45	-	-	1.61E-03	2.07E-03
InBio	MF	GO:0051787	misfolded protein binding	-	20	18	-	-	5.88E-03	8.62E-04
InBio	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	9.35E-03	5.17E-04
InBio	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.26E-04	6.89E-04
InBio	MF	GO:0031404	chloride ion binding	-	14	12	-	-	1.70E-04	5.74E-04
InBio	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	3.70E-03	2.81E-03
InBio	MF	GO:0036002	pre-mRNA binding	-	57	36	-	-	6.20E-03	1.67E-03
InBio	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	33	-	-	1.80E-03	1.55E-03
InBio	MF	GO:0051540	metal cluster binding	-	71	70	-	-	1.22E-02	3.22E-03
InBio	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	1.58E-03	5.17E-04
InBio	MF	GO:0051219	phosphoprotein binding	-	92	91	-	-	4.00E-03	4.19E-03
InBio	MF	GO:0019894	kinesin binding	-	45	44	-	-	3.51E-03	2.07E-03
InBio	MF	GO:0042287	MHC protein binding	-	68	60	-	-	3.57E-02	2.76E-03
InBio	MF	GO:0019003	GDP binding	-	89	85	-	-	8.27E-03	3.91E-03
InBio	MF	GO:0017171	serine hydrolase activity	-	207	176	-	-	3.01E-02	8.10E-03
InBio	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	2.83E-03	3.04E-03
InBio	MF	GO:0003774	cytoskeletal motor activity	-	117	111	-	-	5.48E-03	5.11E-03
InBio	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.74E-03	1.38E-03
InBio	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	1.14E-02	8.04E-04
InBio	MF	GO:0061134	peptidase regulator activity	-	224	194	-	-	5.14E-03	8.96E-03
InBio	MF	GO:0008013	beta-catenin binding	-	86	85	-	-	9.86E-03	3.91E-03
InBio	MF	GO:0051015	actin filament binding	-	208	202	-	-	2.24E-02	9.31E-03
InBio	MF	GO:0019208	phosphatase regulator activity	-	107	100	-	-	7.96E-03	4.60E-03
InBio	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	30	-	-	3.90E-03	1.38E-03
InBio	MF	GO:0043236	laminin binding	-	29	28	-	-	3.12E-03	1.32E-03
InBio	MF	GO:0030507	spectrin binding	-	26	26	-	-	4.28E-02	1.21E-03
InBio	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	2.15E-03	1.90E-03
InBio	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	113	-	-	1.66E-02	5.23E-03
InBio	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	8.26E-02	1.15E-03
InBio	MF	GO:0042393	histone binding	-	240	229	-	-	9.81E-03	1.06E-02
InBio	MF	GO:0019838	growth factor binding	-	182	178	-	-	1.47E-02	8.22E-03
InBio	MF	GO:0000149	SNARE binding	-	107	102	-	-	6.79E-02	4.71E-03
InBio	MF	GO:0003727	single-stranded RNA binding	-	90	86	-	-	6.61E-03	3.96E-03
InBio	MF	GO:0051378	serotonin binding	-	24	24	-	-	8.88E-03	1.15E-03
InBio	MF	GO:0005516	calmodulin binding	-	206	200	-	-	9.44E-03	9.19E-03
InBio	MF	GO:0019825	oxygen binding	-	40	37	-	-	3.98E-02	1.72E-03
InBio	MF	GO:0045505	dynein intermediate chain binding	-	37	34	-	-	1.09E-02	1.61E-03
InBio	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	85	-	-	3.19E-02	3.91E-03
InBio	MF	GO:0032182	ubiquitin-like protein binding	-	117	115	-	-	7.71E-03	5.29E-03
InBio	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	8.05E-02	1.67E-03
InBio	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	1.11E-02	1.03E-03
InBio	MF	GO:0043274	phospholipase binding	-	23	22	-	-	5.99E-03	1.03E-03
InBio	MF	GO:0031072	heat shock protein binding	-	128	125	-	-	8.13E-03	5.74E-03
InBio	MF	GO:0030515	snoRNA binding	-	33	33	-	-	2.35E-02	1.55E-03
InBio	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	76	-	-	5.85E-01	3.50E-03
InBio	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	21	-	-	9.24E-04	9.77E-04
InBio	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	8.19E-04	1.21E-03
InBio	MF	GO:0001530	lipopolysaccharide binding	-	38	30	-	-	3.97E-03	1.38E-03
InBio	MF	GO:0140223	general transcription initiation factor activity	-	55	51	-	-	2.77E-02	2.36E-03
InBio	MF	GO:0070403	NAD+ binding	-	16	16	-	-	3.45E-03	7.47E-04
InBio	MF	GO:0000049	tRNA binding	-	75	73	-	-	5.51E-03	3.39E-03
InBio	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	4.10E-03	2.07E-03
InBio	MF	GO:0015026	coreceptor activity	-	48	46	-	-	5.69E-03	2.13E-03
InBio	MF	GO:0005527	macrolide binding	-	12	12	-	-	7.83E-04	5.74E-04
InBio	MF	GO:0001653	peptide receptor activity	-	128	120	-	-	6.66E-02	5.52E-03
InBio	MF	GO:0031005	filamin binding	-	15	14	-	-	1.36E-03	6.89E-04
InBio	MF	GO:0030506	ankyrin binding	-	19	18	-	-	2.41E-02	8.62E-04
InBio	MF	GO:0006469	negative regulation of protein kinase activity	-	222	207	-	-	5.17E-03	9.54E-03
InBio	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	1.01E-03	9.19E-04
InBio	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	1.58E-03	6.89E-04
InBio	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	5.81E-03	1.44E-03
InBio	MF	GO:0051427	hormone receptor binding	-	31	30	-	-	1.57E-02	1.38E-03
InBio	MF	GO:0070851	growth factor receptor binding	-	141	139	-	-	2.16E-02	6.43E-03
InBio	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	4.01E-02	1.49E-03
InBio	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	42	-	-	7.17E-03	1.95E-03
InBio	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	2.80E-03	9.19E-04
InBio	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	4.80E-04	8.04E-04
InBio	MF	GO:0005506	iron ion binding	-	154	147	-	-	3.56E-01	6.78E-03
InBio	MF	GO:0003925	G protein activity	-	45	43	-	-	3.67E-03	2.01E-03
InBio	MF	GO:0038187	pattern recognition receptor activity	-	33	32	-	-	1.60E-02	1.49E-03
InBio	MF	GO:0008276	protein methyltransferase activity	-	96	92	-	-	5.45E-03	4.25E-03
InBio	MF	GO:0004396	hexokinase activity	-	16	16	-	-	1.83E-02	7.47E-04
InBio	MF	GO:0070888	E-box binding	-	59	54	-	-	1.67E-02	2.53E-03
InBio	MF	GO:0039706	co-receptor binding	-	14	13	-	-	6.25E-03	6.32E-04
InBio	MF	GO:0015399	primary active transmembrane transporter activity	-	190	185	-	-	1.15E-01	8.50E-03
InBio	MF	GO:0035254	glutamate receptor binding	-	47	44	-	-	3.11E-03	2.07E-03
InBio	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	3.66E-03	1.55E-03
InBio	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	3.93E-03	5.17E-04
InBio	MF	GO:0043021	ribonucleoprotein complex binding	-	158	155	-	-	6.83E-03	7.12E-03
InBio	MF	GO:0030170	pyridoxal phosphate binding	-	56	53	-	-	3.11E-03	2.47E-03
InBio	MF	GO:0032393	MHC class I receptor activity	-	15	13	-	-	2.69E-02	6.32E-04
InBio	MF	GO:0005112	Notch binding	-	26	25	-	-	1.39E-02	1.15E-03
InBio	MF	GO:0048185	activin binding	-	16	16	-	-	2.27E-02	7.47E-04
InBio	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	27	-	-	1.03E-02	1.26E-03
InBio	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	2.17E-03	5.17E-04
InBio	MF	GO:0140299	small molecule sensor activity	-	39	33	-	-	8.47E-03	1.55E-03
InBio	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	6.00E-03	1.03E-03
InBio	MF	GO:0016917	GABA receptor activity	-	23	20	-	-	4.18E-01	9.19E-04
InBio	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	3.83E-03	6.89E-04
InBio	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	24	-	-	6.14E-04	1.15E-03
InBio	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	44	-	-	4.45E-03	2.07E-03
InBio	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.55E-03	1.15E-03
InBio	MF	GO:0008527	taste receptor activity	-	28	26	-	-	3.42E-01	1.21E-03
InBio	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	7.49E-03	5.74E-04
InBio	MF	GO:0030594	neurotransmitter receptor activity	-	160	150	-	-	4.77E-02	6.89E-03
InBio	MF	GO:0034452	dynactin binding	-	12	12	-	-	1.45E-03	5.74E-04
InBio	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	9.14E-02	1.15E-03
InBio	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	1.00E-02	9.77E-04
InBio	MF	GO:0005507	copper ion binding	-	63	61	-	-	5.26E-03	2.81E-03
InBio	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	3.20E-03	1.03E-03
InBio	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.60E-02	1.03E-03
InBio	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	11	-	-	2.18E-02	5.17E-04
InnateDB	MF	GO:0000049	tRNA binding	-	75	70	-	-	9.40E-03	3.63E-03
InnateDB	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	2.57E-04	8.43E-04
InnateDB	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	4.46E-02	5.84E-04
InnateDB	CC	GO:0000123	histone acetyltransferase complex	-	93	86	-	-	8.53E-02	4.47E-03
InnateDB	MF	GO:0000149	SNARE binding	-	107	97	-	-	7.95E-02	5.06E-03
InnateDB	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	8.68E-02	2.33E-03
InnateDB	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	2.04E-02	1.04E-03
InnateDB	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	3.16E-01	7.78E-04
InnateDB	MF	GO:0000182	rDNA binding	-	11	11	-	-	9.26E-03	5.84E-04
InnateDB	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	9.64E-03	1.95E-03
InnateDB	CC	GO:0000228	nuclear chromosome	5.44E-08	206	193	165	1.17	-	-
InnateDB	CC	GO:0000242	pericentriolar material	-	22	22	-	-	9.47E-03	1.17E-03
InnateDB	BP	GO:0000272	polysaccharide catabolic process	-	19	18	-	-	7.72E-03	9.73E-04
InnateDB	MF	GO:0000287	magnesium ion binding	-	225	211	-	-	4.33E-03	1.10E-02
InnateDB	CC	GO:0000313	organellar ribosome	-	89	89	-	-	3.36E-01	4.67E-03
InnateDB	MF	GO:0000339	RNA cap binding	-	20	18	-	-	1.36E-02	9.73E-04
InnateDB	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	8.14E-03	6.49E-04
InnateDB	CC	GO:0000786	nucleosome	-	149	126	-	-	4.35E-02	6.55E-03
InnateDB	CC	GO:0000791	euchromatin	-	60	57	-	-	3.55E-03	2.98E-03
InnateDB	CC	GO:0000792	heterochromatin	-	98	97	-	-	6.68E-03	5.06E-03
InnateDB	CC	GO:0000800	lateral element	-	14	12	-	-	1.19E-02	6.49E-04
InnateDB	CC	GO:0000803	sex chromosome	-	32	30	-	-	3.55E-03	1.56E-03
InnateDB	BP	GO:0000910	cytokinesis	1.70E-06	186	173	149	1.16	-	-
InnateDB	CC	GO:0000922	spindle pole	-	172	167	-	-	1.35E-02	8.69E-03
InnateDB	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	1.10E-01	8.43E-04
InnateDB	CC	GO:0000940	outer kinetochore	-	17	17	-	-	1.31E-01	9.08E-04
InnateDB	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	45	-	-	3.40E-02	2.33E-03
InnateDB	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	3.22E-04	1.04E-03
InnateDB	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	1.60E-01	2.01E-03
InnateDB	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	2.47E-03	1.04E-03
InnateDB	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	1.58E-02	6.49E-04
InnateDB	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	8.80E-02	8.43E-04
InnateDB	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	5.78E-03	3.18E-03
InnateDB	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	9.97E-03	7.78E-04
InnateDB	MF	GO:0001530	lipopolysaccharide binding	-	38	29	-	-	4.66E-03	1.56E-03
InnateDB	CC	GO:0001533	cornified envelope	-	59	55	-	-	5.05E-02	2.85E-03
InnateDB	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	110	-	-	6.81E-03	5.71E-03
InnateDB	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	12	-	-	1.94E-04	6.49E-04
InnateDB	CC	GO:0001650	fibrillar center	-	151	147	-	-	3.41E-03	7.65E-03
InnateDB	MF	GO:0001653	peptide receptor activity	-	128	99	-	-	2.34E-02	5.19E-03
InnateDB	BP	GO:0001655	urogenital system development	-	66	64	-	-	3.09E-03	3.37E-03
InnateDB	MF	GO:0001671	ATPase activator activity	-	29	26	-	-	3.79E-04	1.36E-03
InnateDB	BP	GO:0001704	formation of primary germ layer	-	195	178	-	-	1.03E-02	9.27E-03
InnateDB	BP	GO:0001708	cell fate specification	-	108	97	-	-	7.56E-03	5.06E-03
InnateDB	BP	GO:0001709	cell fate determination	-	44	39	-	-	4.82E-03	2.08E-03
InnateDB	CC	GO:0001726	ruffle	-	181	175	-	-	8.55E-03	9.08E-03
InnateDB	CC	GO:0001772	immunological synapse	-	44	42	-	-	5.76E-03	2.20E-03
InnateDB	BP	GO:0001776	leukocyte homeostasis	-	108	99	-	-	3.68E-03	5.19E-03
InnateDB	BP	GO:0001829	trophectodermal cell differentiation	-	19	17	-	-	9.35E-04	9.08E-04
InnateDB	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.09E-02	7.78E-04
InnateDB	BP	GO:0001845	phagolysosome assembly	-	19	18	-	-	3.95E-03	9.73E-04
InnateDB	CC	GO:0001891	phagocytic cup	-	28	25	-	-	3.46E-03	1.30E-03
InnateDB	CC	GO:0001917	photoreceptor inner segment	-	71	58	-	-	1.94E-02	3.05E-03
InnateDB	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.21E-02	6.49E-04
InnateDB	CC	GO:0001931	uropod	-	13	13	-	-	6.21E-02	7.13E-04
InnateDB	BP	GO:0001941	postsynaptic membrane organization	-	37	32	-	-	2.64E-02	1.69E-03
InnateDB	BP	GO:0001946	lymphangiogenesis	-	18	16	-	-	7.43E-03	8.43E-04
InnateDB	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	75	-	-	3.88E-03	3.89E-03
InnateDB	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	55	-	-	5.18E-03	2.85E-03
InnateDB	BP	GO:0001964	startle response	-	27	26	-	-	2.44E-03	1.36E-03
InnateDB	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	3.83E-04	1.36E-03
InnateDB	MF	GO:0001968	fibronectin binding	-	30	29	-	-	6.78E-03	1.56E-03
InnateDB	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	12	-	-	2.57E-02	6.49E-04
InnateDB	BP	GO:0002026	regulation of the force of heart contraction	-	26	25	-	-	4.37E-03	1.30E-03
InnateDB	BP	GO:0002027	regulation of heart rate	-	106	96	-	-	3.26E-02	4.99E-03
InnateDB	MF	GO:0002039	p53 binding	-	66	65	-	-	3.35E-03	3.37E-03
InnateDB	BP	GO:0002063	chondrocyte development	-	33	30	-	-	2.91E-03	1.56E-03
InnateDB	BP	GO:0002064	epithelial cell development	-	210	196	-	-	6.06E-03	1.02E-02
InnateDB	BP	GO:0002076	osteoblast development	-	17	16	-	-	6.56E-03	8.43E-04
InnateDB	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	19	-	-	1.23E-03	1.04E-03
InnateDB	CC	GO:0002102	podosome	-	31	31	-	-	4.23E-03	1.62E-03
InnateDB	CC	GO:0002177	manchette	-	19	15	-	-	2.57E-04	7.78E-04
InnateDB	BP	GO:0002181	cytoplasmic translation	2.45E-12	153	151	123	1.23	-	-
InnateDB	BP	GO:0002200	somatic diversification of immune receptors	-	78	77	-	-	5.19E-03	4.02E-03
InnateDB	BP	GO:0002209	behavioral defense response	-	39	38	-	-	1.43E-03	2.01E-03
InnateDB	BP	GO:0002251	organ or tissue specific immune response	-	43	37	-	-	1.68E-03	1.95E-03
InnateDB	BP	GO:0002262	myeloid cell homeostasis	-	172	163	-	-	6.45E-03	8.50E-03
InnateDB	BP	GO:0002367	cytokine production involved in immune response	-	121	115	-	-	1.30E-02	5.97E-03
InnateDB	BP	GO:0002376	immune system process	1.20E-44	2448	2204	1963	1.12	-	-
InnateDB	BP	GO:0002418	immune response to tumor cell	-	29	24	-	-	5.24E-03	1.30E-03
InnateDB	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	70	-	-	2.99E-03	3.63E-03
InnateDB	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.75E-03	7.78E-04
InnateDB	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	18	-	-	9.16E-02	9.73E-04
InnateDB	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	83	-	-	1.03E-02	4.35E-03
InnateDB	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	6.27E-03	6.49E-04
InnateDB	BP	GO:0002679	respiratory burst involved in defense response	-	16	15	-	-	3.05E-03	7.78E-04
InnateDB	BP	GO:0002687	positive regulation of leukocyte migration	-	147	140	-	-	4.53E-03	7.26E-03
InnateDB	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	45	-	-	1.19E-03	2.33E-03
InnateDB	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	128	-	-	7.85E-03	6.68E-03
InnateDB	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	11	-	-	6.06E-02	5.84E-04
InnateDB	BP	GO:0002931	response to ischemia	-	58	51	-	-	3.18E-03	2.66E-03
InnateDB	BP	GO:0003012	muscle system process	1.67E-11	425	391	341	1.15	-	-
InnateDB	BP	GO:0003013	circulatory system process	5.42E-14	584	534	468	1.14	-	-
InnateDB	BP	GO:0003014	renal system process	7.56E-04	127	116	102	1.14	-	-
InnateDB	BP	GO:0003014	renal system process	-	130	119	-	-	4.67E-03	6.23E-03
InnateDB	BP	GO:0003016	respiratory system process	-	39	34	-	-	4.34E-04	1.82E-03
InnateDB	BP	GO:0003151	outflow tract morphogenesis	-	81	79	-	-	9.59E-03	4.15E-03
InnateDB	BP	GO:0003158	endothelium development	-	140	124	-	-	7.62E-03	6.49E-03
InnateDB	BP	GO:0003188	heart valve formation	-	16	16	-	-	1.91E-02	8.43E-04
InnateDB	BP	GO:0003207	cardiac chamber formation	-	14	13	-	-	2.10E-03	7.13E-04
InnateDB	BP	GO:0003272	endocardial cushion formation	-	28	27	-	-	7.93E-03	1.43E-03
InnateDB	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	25	-	-	6.48E-03	1.30E-03
InnateDB	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	11	-	-	1.89E-04	5.84E-04
InnateDB	MF	GO:0003677	DNA binding	1.72E-39	2865	2542	2297	1.11	-	-
InnateDB	MF	GO:0003684	damaged DNA binding	-	89	84	-	-	1.95E-02	4.41E-03
InnateDB	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	7.39E-02	9.73E-04
InnateDB	MF	GO:0003714	transcription corepressor activity	-	190	183	-	-	1.11E-02	9.53E-03
InnateDB	MF	GO:0003723	RNA binding	1.34E-83	1679	1608	1346	1.19	-	-
InnateDB	MF	GO:0003725	double-stranded RNA binding	-	72	68	-	-	8.13E-03	3.57E-03
InnateDB	MF	GO:0003727	single-stranded RNA binding	-	90	85	-	-	7.11E-03	4.41E-03
InnateDB	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	31	-	-	4.37E-04	1.62E-03
InnateDB	MF	GO:0003756	protein disulfide isomerase activity	-	18	17	-	-	4.14E-03	9.08E-04
InnateDB	MF	GO:0003774	cytoskeletal motor activity	1.46E-03	116	106	93	1.14	-	-
InnateDB	MF	GO:0003774	cytoskeletal motor activity	-	117	106	-	-	7.82E-03	5.51E-03
InnateDB	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	21	-	-	3.48E-03	1.10E-03
InnateDB	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	1.11E-02	6.49E-04
InnateDB	MF	GO:0003924	GTPase activity	4.01E-18	658	607	528	1.15	-	-
InnateDB	MF	GO:0003925	G protein activity	-	45	39	-	-	4.24E-03	2.08E-03
InnateDB	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	11	-	-	4.33E-02	5.84E-04
InnateDB	MF	GO:0004396	hexokinase activity	-	16	16	-	-	4.45E-02	8.43E-04
InnateDB	MF	GO:0004618	phosphoglycerate kinase activity	-	89	86	-	-	3.66E-03	4.47E-03
InnateDB	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	13	-	-	1.94E-04	7.13E-04
InnateDB	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	43	-	-	5.28E-03	2.27E-03
InnateDB	MF	GO:0004713	protein tyrosine kinase activity	-	213	205	-	-	1.79E-02	1.06E-02
InnateDB	CC	GO:0004879	nuclear receptor activity	-	63	60	-	-	4.15E-03	3.11E-03
InnateDB	MF	GO:0004896	cytokine receptor activity	-	93	85	-	-	1.62E-02	4.41E-03
InnateDB	MF	GO:0004984	olfactory receptor activity	-	429	25	-	-	3.89E-04	1.30E-03
InnateDB	MF	GO:0005035	death receptor activity	-	16	16	-	-	3.37E-03	8.43E-04
InnateDB	MF	GO:0005112	Notch binding	-	26	21	-	-	2.50E-03	1.10E-03
InnateDB	MF	GO:0005132	type I interferon receptor binding	-	17	12	-	-	1.94E-04	6.49E-04
InnateDB	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	5.93E-03	1.17E-03
InnateDB	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	4.20E-03	7.78E-04
InnateDB	MF	GO:0005178	integrin binding	-	153	144	-	-	3.78E-02	7.52E-03
InnateDB	MF	GO:0005198	structural molecule activity	7.23E-13	798	714	640	1.12	-	-
InnateDB	CC	GO:0005200	structural constituent of cytoskeleton	-	112	107	-	-	1.21E-02	5.58E-03
InnateDB	MF	GO:0005215	transporter activity	6.57E-01	1462	1166	1172	0.99	-	-
InnateDB	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	11	-	-	1.94E-04	5.84E-04
InnateDB	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	169	-	-	1.78E-02	8.82E-03
InnateDB	MF	GO:0005496	steroid binding	-	110	95	-	-	2.26E-02	4.93E-03
InnateDB	MF	GO:0005506	iron ion binding	-	154	136	-	-	4.43E-03	7.07E-03
InnateDB	MF	GO:0005507	copper ion binding	-	63	53	-	-	3.68E-03	2.79E-03
InnateDB	MF	GO:0005516	calmodulin binding	-	206	187	-	-	7.49E-03	9.73E-03
InnateDB	MF	GO:0005521	lamin binding	-	15	15	-	-	5.19E-03	7.78E-04
InnateDB	MF	GO:0005523	tropomyosin binding	-	15	12	-	-	1.93E-04	6.49E-04
InnateDB	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.90E-04	6.49E-04
InnateDB	MF	GO:0005539	glycosaminoglycan binding	-	236	202	-	-	1.04E-02	1.05E-02
InnateDB	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	74	-	-	2.03E-03	3.89E-03
InnateDB	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	6.31E-03	2.01E-03
InnateDB	CC	GO:0005615	extracellular space	2.55E-35	3190	2801	2558	1.10	-	-
InnateDB	CC	GO:0005635	nuclear envelope	1.14E-17	493	462	395	1.17	-	-
InnateDB	CC	GO:0005640	nuclear outer membrane	-	30	26	-	-	3.06E-03	1.36E-03
InnateDB	CC	GO:0005652	nuclear lamina	-	12	11	-	-	2.27E-03	5.84E-04
InnateDB	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	8.66E-03	7.13E-04
InnateDB	CC	GO:0005730	nucleolus	2.87E-48	988	946	792	1.19	-	-
InnateDB	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	23	-	-	2.27E-01	1.23E-03
InnateDB	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	1.89E-02	7.13E-04
InnateDB	CC	GO:0005739	mitochondrion	5.56E-41	1671	1531	1340	1.14	-	-
InnateDB	CC	GO:0005764	lysosome	1.84E-16	747	680	599	1.14	-	-
InnateDB	CC	GO:0005768	endosome	5.78E-32	1037	964	832	1.16	-	-
InnateDB	CC	GO:0005775	vacuolar lumen	-	176	166	-	-	5.22E-03	8.63E-03
InnateDB	CC	GO:0005776	autophagosome	-	111	100	-	-	3.45E-02	5.19E-03
InnateDB	CC	GO:0005777	peroxisome	1.17E-04	142	131	114	1.15	-	-
InnateDB	CC	GO:0005783	endoplasmic reticulum	2.07E-21	2020	1773	1620	1.09	-	-
InnateDB	CC	GO:0005794	Golgi apparatus	3.92E-11	1636	1410	1312	1.07	-	-
InnateDB	CC	GO:0005796	Golgi lumen	-	106	92	-	-	3.76E-03	4.80E-03
InnateDB	CC	GO:0005811	lipid droplet	8.64E-03	102	92	82	1.12	-	-
InnateDB	CC	GO:0005811	lipid droplet	-	102	92	-	-	2.43E-02	4.80E-03
InnateDB	CC	GO:0005815	microtubule organizing center	2.45E-27	843	786	676	1.16	-	-
InnateDB	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	2.47E-01	5.84E-04
InnateDB	CC	GO:0005840	ribosome	8.26E-19	222	220	178	1.24	-	-
InnateDB	CC	GO:0005849	mRNA cleavage factor complex	-	22	18	-	-	7.77E-02	9.73E-04
InnateDB	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	5.47E-02	7.78E-04
InnateDB	CC	GO:0005881	cytoplasmic microtubule	-	256	192	-	-	4.11E-03	9.99E-03
InnateDB	CC	GO:0005883	neurofilament	-	11	11	-	-	2.18E-02	5.84E-04
InnateDB	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	7.87E-03	3.76E-03
InnateDB	CC	GO:0005929	cilium	1.33E-01	842	658	675	0.97	-	-
InnateDB	CC	GO:0005940	septin ring	-	14	12	-	-	2.46E-01	6.49E-04
InnateDB	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	26	-	-	2.72E-02	1.36E-03
InnateDB	BP	GO:0005975	carbohydrate metabolic process	9.37E-07	551	485	442	1.10	-	-
InnateDB	BP	GO:0005996	monosaccharide metabolic process	-	250	231	-	-	7.71E-03	1.20E-02
InnateDB	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	1.13E-02	6.49E-04
InnateDB	BP	GO:0006023	aminoglycan biosynthetic process	-	74	57	-	-	1.23E-02	2.98E-03
InnateDB	BP	GO:0006026	aminoglycan catabolic process	-	34	27	-	-	1.21E-01	1.43E-03
InnateDB	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	12	-	-	1.09E-01	6.49E-04
InnateDB	BP	GO:0006091	generation of precursor metabolites and energy	4.59E-16	502	467	403	1.16	-	-
InnateDB	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	3.75E-02	1.69E-03
InnateDB	BP	GO:0006260	DNA replication	2.57E-16	279	270	224	1.21	-	-
InnateDB	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	16	-	-	1.69E-01	8.43E-04
InnateDB	BP	GO:0006281	DNA repair	1.20E-33	587	568	471	1.21	-	-
InnateDB	BP	GO:0006304	DNA modification	-	30	28	-	-	7.28E-03	1.49E-03
InnateDB	BP	GO:0006310	DNA recombination	1.31E-11	333	311	267	1.16	-	-
InnateDB	BP	GO:0006325	chromatin organization	3.75E-31	720	684	577	1.18	-	-
InnateDB	BP	GO:0006355	regulation of DNA-templated transcription	4.15E-55	3342	2988	2680	1.12	-	-
InnateDB	BP	GO:0006399	tRNA metabolic process	1.04E-07	196	184	157	1.17	-	-
InnateDB	CC	GO:0006406	mRNA export from nucleus	-	69	65	-	-	9.31E-02	3.37E-03
InnateDB	BP	GO:0006413	translational initiation	-	122	118	-	-	3.24E-02	6.16E-03
InnateDB	BP	GO:0006450	regulation of translational fidelity	-	18	16	-	-	6.40E-03	8.43E-04
InnateDB	BP	GO:0006457	protein folding	1.09E-05	210	192	168	1.14	-	-
InnateDB	MF	GO:0006469	negative regulation of protein kinase activity	-	222	205	-	-	5.22E-03	1.06E-02
InnateDB	BP	GO:0006486	protein glycosylation	9.33E-01	225	180	180	1.00	-	-
InnateDB	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	20	-	-	3.23E-04	1.04E-03
InnateDB	BP	GO:0006517	protein deglycosylation	-	26	24	-	-	5.14E-03	1.30E-03
InnateDB	BP	GO:0006520	amino acid metabolic process	2.59E-06	292	264	234	1.13	-	-
InnateDB	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	1.92E-04	6.49E-04
InnateDB	BP	GO:0006575	cellular modified amino acid metabolic process	5.18E-01	186	153	149	1.03	-	-
InnateDB	BP	GO:0006629	lipid metabolic process	5.76E-08	1355	1161	1087	1.07	-	-
InnateDB	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	19	-	-	1.31E-03	1.04E-03
InnateDB	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	2.08E-02	1.23E-03
InnateDB	BP	GO:0006766	vitamin metabolic process	1.35E-05	107	102	86	1.19	-	-
InnateDB	BP	GO:0006790	sulfur compound metabolic process	8.32E-01	320	255	257	0.99	-	-
InnateDB	BP	GO:0006855	xenobiotic transmembrane transport	-	14	11	-	-	2.06E-02	5.84E-04
InnateDB	CC	GO:0006858	extracellular transport	-	45	38	-	-	3.00E-03	2.01E-03
InnateDB	BP	GO:0006885	regulation of pH	-	104	92	-	-	8.95E-03	4.80E-03
InnateDB	BP	GO:0006886	intracellular protein transport	2.88E-33	664	637	532	1.20	-	-
InnateDB	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	120	-	-	9.92E-02	6.23E-03
InnateDB	BP	GO:0006913	nucleocytoplasmic transport	1.97E-20	326	317	261	1.21	-	-
InnateDB	BP	GO:0006914	autophagy	8.69E-26	568	541	455	1.19	-	-
InnateDB	BP	GO:0006925	inflammatory cell apoptotic process	-	23	20	-	-	7.66E-04	1.04E-03
InnateDB	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	1.88E-03	1.30E-03
InnateDB	BP	GO:0006949	syncytium formation	-	66	58	-	-	9.91E-03	3.05E-03
InnateDB	BP	GO:0006954	inflammatory response	8.59E-16	820	741	658	1.13	-	-
InnateDB	BP	GO:0006968	cellular defense response	-	52	50	-	-	6.44E-03	2.59E-03
InnateDB	CC	GO:0006984	ER-nucleus signaling pathway	-	46	45	-	-	8.31E-03	2.33E-03
InnateDB	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	3.38E-02	7.78E-04
InnateDB	BP	GO:0007005	mitochondrion organization	4.66E-17	484	453	388	1.17	-	-
InnateDB	CC	GO:0007006	mitochondrial membrane organization	-	117	105	-	-	1.39E-02	5.45E-03
InnateDB	BP	GO:0007010	cytoskeleton organization	3.65E-34	1639	1488	1314	1.13	-	-
InnateDB	BP	GO:0007018	microtubule-based movement	3.84E-02	640	534	513	1.04	-	-
InnateDB	CC	GO:0007034	vacuolar transport	-	168	155	-	-	3.44E-02	8.04E-03
InnateDB	CC	GO:0007039	protein catabolic process in the vacuole	-	61	58	-	-	4.78E-02	3.05E-03
InnateDB	BP	GO:0007040	lysosome organization	2.11E-03	107	98	86	1.14	-	-
InnateDB	BP	GO:0007059	chromosome segregation	1.03E-13	403	376	323	1.16	-	-
InnateDB	CC	GO:0007097	nuclear migration	-	24	23	-	-	5.61E-03	1.23E-03
InnateDB	BP	GO:0007130	synaptonemal complex assembly	-	23	15	-	-	2.54E-04	7.78E-04
InnateDB	BP	GO:0007155	cell adhesion	2.86E-31	1444	1314	1158	1.13	-	-
InnateDB	BP	GO:0007163	establishment or maintenance of cell polarity	5.08E-13	227	219	182	1.20	-	-
InnateDB	BP	GO:0007164	establishment of tissue polarity	-	38	35	-	-	1.36E-02	1.82E-03
InnateDB	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	52	-	-	9.80E-03	2.72E-03
InnateDB	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	199	-	-	4.72E-02	1.04E-02
InnateDB	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	71	-	-	6.14E-03	3.70E-03
InnateDB	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	146	-	-	9.63E-03	7.59E-03
InnateDB	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	25	-	-	8.43E-03	1.30E-03
InnateDB	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	40	-	-	9.27E-03	2.08E-03
InnateDB	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	20	-	-	7.44E-03	1.04E-03
InnateDB	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	21	-	-	1.38E-02	1.10E-03
InnateDB	BP	GO:0007218	neuropeptide signaling pathway	-	113	79	-	-	6.51E-02	4.15E-03
InnateDB	BP	GO:0007272	ensheathment of neurons	-	146	138	-	-	5.13E-03	7.20E-03
InnateDB	BP	GO:0007340	acrosome reaction	-	38	29	-	-	3.11E-02	1.56E-03
InnateDB	BP	GO:0007405	neuroblast proliferation	-	81	69	-	-	2.98E-03	3.63E-03
InnateDB	BP	GO:0007566	embryo implantation	-	57	51	-	-	1.27E-03	2.66E-03
InnateDB	BP	GO:0007588	excretion	-	40	36	-	-	7.27E-03	1.88E-03
InnateDB	BP	GO:0007606	sensory perception of chemical stimulus	-	535	82	-	-	3.86E-02	4.28E-03
InnateDB	BP	GO:0007635	chemosensory behavior	-	20	16	-	-	3.33E-03	8.43E-04
InnateDB	MF	GO:0008013	beta-catenin binding	-	86	84	-	-	6.67E-03	4.41E-03
InnateDB	CC	GO:0008023	transcription elongation factor complex	-	47	46	-	-	1.24E-01	2.40E-03
InnateDB	BP	GO:0008033	tRNA processing	-	136	126	-	-	8.80E-02	6.55E-03
InnateDB	BP	GO:0008038	neuron recognition	-	46	44	-	-	9.05E-04	2.33E-03
InnateDB	MF	GO:0008066	glutamate receptor activity	-	70	55	-	-	1.11E-02	2.85E-03
InnateDB	CC	GO:0008088	axo-dendritic transport	-	78	76	-	-	3.00E-02	3.96E-03
InnateDB	MF	GO:0008092	cytoskeletal protein binding	6.87E-34	1023	955	820	1.16	-	-
InnateDB	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.67E-03	1.30E-03
InnateDB	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	81	-	-	2.69E-02	4.22E-03
InnateDB	MF	GO:0008179	adenylate cyclase binding	-	11	11	-	-	4.17E-02	5.84E-04
InnateDB	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	5.05E-03	9.08E-04
InnateDB	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	1.60E-03	7.78E-04
InnateDB	BP	GO:0008213	protein alkylation	-	58	52	-	-	4.74E-03	2.72E-03
InnateDB	BP	GO:0008217	regulation of blood pressure	-	186	167	-	-	1.17E-02	8.69E-03
InnateDB	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	2.12E-01	7.78E-04
InnateDB	MF	GO:0008276	protein methyltransferase activity	-	96	88	-	-	5.17E-03	4.60E-03
InnateDB	MF	GO:0008289	lipid binding	4.09E-14	836	750	670	1.12	-	-
InnateDB	BP	GO:0008299	isoprenoid biosynthetic process	-	30	28	-	-	3.86E-04	1.49E-03
InnateDB	MF	GO:0008301	"DNA binding, bending"	-	18	16	-	-	1.88E-03	8.43E-04
InnateDB	MF	GO:0008327	methyl-CpG binding	-	31	27	-	-	1.00E-02	1.43E-03
InnateDB	CC	GO:0008333	endosome to lysosome transport	-	73	67	-	-	4.84E-02	3.50E-03
InnateDB	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	1.03E-03	1.23E-03
InnateDB	BP	GO:0008360	regulation of cell shape	-	139	130	-	-	1.07E-02	6.74E-03
InnateDB	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.20E-02	1.43E-03
InnateDB	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	108	-	-	5.45E-03	5.64E-03
InnateDB	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	227	-	-	8.90E-03	1.18E-02
InnateDB	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	1.17E-02	2.27E-03
InnateDB	BP	GO:0008637	apoptotic mitochondrial changes	-	108	98	-	-	1.63E-02	5.12E-03
InnateDB	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	111	-	-	3.26E-02	5.77E-03
InnateDB	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	20	-	-	5.03E-02	1.04E-03
InnateDB	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	20	-	-	1.42E-02	1.04E-03
InnateDB	BP	GO:0009110	vitamin biosynthetic process	-	23	23	-	-	1.74E-03	1.23E-03
InnateDB	BP	GO:0009111	vitamin catabolic process	-	13	12	-	-	1.94E-04	6.49E-04
InnateDB	BP	GO:0009163	nucleoside biosynthetic process	-	16	14	-	-	6.02E-03	7.78E-04
InnateDB	BP	GO:0009164	nucleoside catabolic process	-	25	21	-	-	5.75E-02	1.10E-03
InnateDB	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	17	-	-	3.67E-02	9.08E-04
InnateDB	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	38	-	-	6.49E-03	2.01E-03
InnateDB	BP	GO:0009267	cellular response to starvation	-	170	158	-	-	6.01E-03	8.24E-03
InnateDB	BP	GO:0009268	response to pH	-	43	36	-	-	2.54E-02	1.88E-03
InnateDB	BP	GO:0009303	rRNA transcription	-	37	37	-	-	1.93E-02	1.95E-03
InnateDB	BP	GO:0009309	amine biosynthetic process	-	38	33	-	-	2.57E-03	1.75E-03
InnateDB	BP	GO:0009310	amine catabolic process	-	20	17	-	-	2.57E-04	9.08E-04
InnateDB	BP	GO:0009404	toxin metabolic process	-	17	15	-	-	2.58E-04	7.78E-04
InnateDB	BP	GO:0009451	RNA modification	-	169	152	-	-	1.77E-02	7.91E-03
InnateDB	BP	GO:0009566	fertilization	-	205	153	-	-	8.31E-03	7.98E-03
InnateDB	BP	GO:0009581	detection of external stimulus	-	137	102	-	-	1.72E-02	5.32E-03
InnateDB	BP	GO:0009582	detection of abiotic stimulus	-	140	105	-	-	1.72E-02	5.45E-03
InnateDB	BP	GO:0009593	detection of chemical stimulus	-	511	73	-	-	2.64E-02	3.83E-03
InnateDB	BP	GO:0009612	response to mechanical stimulus	-	215	198	-	-	7.08E-03	1.03E-02
InnateDB	BP	GO:0009649	entrainment of circadian clock	-	30	27	-	-	5.84E-03	1.43E-03
InnateDB	BP	GO:0009755	hormone-mediated signaling pathway	-	221	203	-	-	1.02E-02	1.06E-02
InnateDB	BP	GO:0009880	embryonic pattern specification	-	70	57	-	-	6.33E-03	2.98E-03
InnateDB	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	161	-	-	3.53E-02	8.37E-03
InnateDB	MF	GO:0009975	cyclase activity	2.26E-02	277	237	222	1.07	-	-
InnateDB	BP	GO:0009994	oocyte differentiation	-	57	49	-	-	2.31E-03	2.59E-03
InnateDB	MF	GO:0010181	FMN binding	-	15	14	-	-	1.91E-04	7.78E-04
InnateDB	BP	GO:0010232	vascular transport	-	87	75	-	-	1.82E-03	3.89E-03
InnateDB	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	11	-	-	3.95E-03	5.84E-04
InnateDB	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	58	-	-	1.50E-01	3.05E-03
InnateDB	CC	GO:0010369	chromocenter	-	14	14	-	-	2.61E-03	7.78E-04
InnateDB	BP	GO:0010453	regulation of cell fate commitment	-	40	33	-	-	4.99E-02	1.75E-03
InnateDB	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	1.97E-03	7.78E-04
InnateDB	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	2.36E-03	1.62E-03
InnateDB	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	16	-	-	3.45E-03	8.43E-04
InnateDB	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	21	-	-	2.74E-03	1.10E-03
InnateDB	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	1.92E-04	6.49E-04
InnateDB	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	9.81E-04	9.08E-04
InnateDB	BP	GO:0010623	programmed cell death involved in cell development	-	25	22	-	-	1.92E-03	1.17E-03
InnateDB	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	77	-	-	6.58E-03	4.02E-03
InnateDB	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	12	-	-	1.89E-04	6.49E-04
InnateDB	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	15	-	-	1.50E-01	7.78E-04
InnateDB	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	67	-	-	2.34E-03	3.50E-03
InnateDB	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	6.21E-03	2.79E-03
InnateDB	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	36	-	-	2.09E-03	1.88E-03
InnateDB	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	1.75E-03	6.49E-04
InnateDB	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	30	-	-	8.75E-03	1.56E-03
InnateDB	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	4.00E-03	2.08E-03
InnateDB	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	41	-	-	1.04E-03	2.14E-03
InnateDB	BP	GO:0010842	retina layer formation	-	25	23	-	-	3.20E-04	1.23E-03
InnateDB	MF	GO:0010851	cyclase regulator activity	-	17	12	-	-	1.32E-03	6.49E-04
InnateDB	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	4.33E-03	1.30E-03
InnateDB	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	12	-	-	1.15E-01	6.49E-04
InnateDB	BP	GO:0010883	regulation of lipid storage	-	53	47	-	-	6.98E-03	2.46E-03
InnateDB	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	114	-	-	2.31E-02	5.97E-03
InnateDB	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	16	-	-	5.64E-02	8.43E-04
InnateDB	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	8.33E-03	5.84E-04
InnateDB	BP	GO:0012501	programmed cell death	2.21E-66	1954	1825	1567	1.16	-	-
InnateDB	BP	GO:0014004	microglia differentiation	-	12	12	-	-	4.46E-04	6.49E-04
InnateDB	BP	GO:0014029	neural crest formation	-	15	15	-	-	1.64E-02	7.78E-04
InnateDB	BP	GO:0014047	glutamate secretion	-	25	24	-	-	1.04E-03	1.30E-03
InnateDB	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	33	-	-	6.94E-03	1.75E-03
InnateDB	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	27	-	-	1.22E-03	1.43E-03
InnateDB	BP	GO:0014812	muscle cell migration	-	110	85	-	-	4.15E-03	4.41E-03
InnateDB	BP	GO:0014823	response to activity	-	70	62	-	-	2.46E-03	3.24E-03
InnateDB	BP	GO:0014854	response to inactivity	-	12	11	-	-	9.68E-03	5.84E-04
InnateDB	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	2.56E-04	7.78E-04
InnateDB	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	12	-	-	8.74E-03	6.49E-04
InnateDB	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	66	-	-	5.26E-03	3.44E-03
InnateDB	MF	GO:0015026	coreceptor activity	-	48	44	-	-	2.51E-02	2.33E-03
InnateDB	MF	GO:0015035	protein-disulfide reductase activity	-	32	31	-	-	4.18E-02	1.62E-03
InnateDB	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	51	-	-	2.03E-02	2.66E-03
InnateDB	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	30	-	-	4.51E-04	1.56E-03
InnateDB	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	98	-	-	8.90E-03	5.12E-03
InnateDB	MF	GO:0015399	primary active transmembrane transporter activity	-	190	173	-	-	2.40E-02	9.01E-03
InnateDB	CC	GO:0015464	acetylcholine receptor activity	-	21	16	-	-	1.78E-01	8.43E-04
InnateDB	MF	GO:0015562	efflux transmembrane transporter activity	-	15	13	-	-	1.93E-04	7.13E-04
InnateDB	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	27	-	-	3.83E-04	1.43E-03
InnateDB	BP	GO:0015669	gas transport	-	23	21	-	-	2.37E-02	1.10E-03
InnateDB	BP	GO:0015697	quaternary ammonium group transport	-	16	13	-	-	1.94E-04	7.13E-04
InnateDB	BP	GO:0015803	branched-chain amino acid transport	-	14	12	-	-	8.16E-03	6.49E-04
InnateDB	BP	GO:0015807	L-amino acid transport	-	94	70	-	-	1.91E-02	3.63E-03
InnateDB	BP	GO:0015810	aspartate transmembrane transport	-	19	18	-	-	2.58E-04	9.73E-04
InnateDB	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	16	-	-	2.57E-04	8.43E-04
InnateDB	BP	GO:0015844	monoamine transport	-	88	80	-	-	1.33E-02	4.15E-03
InnateDB	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	38	-	-	5.09E-04	2.01E-03
InnateDB	BP	GO:0016054	organic acid catabolic process	-	251	226	-	-	3.13E-02	1.17E-02
InnateDB	BP	GO:0016071	mRNA metabolic process	2.28E-29	713	675	572	1.18	-	-
InnateDB	CC	GO:0016082	synaptic vesicle priming	-	19	18	-	-	3.45E-02	9.73E-04
InnateDB	BP	GO:0016180	snRNA processing	-	28	26	-	-	2.43E-01	1.36E-03
InnateDB	BP	GO:0016192	vesicle-mediated transport	2.36E-40	1894	1721	1519	1.13	-	-
InnateDB	MF	GO:0016208	AMP binding	-	22	21	-	-	1.87E-02	1.10E-03
InnateDB	MF	GO:0016209	antioxidant activity	-	92	81	-	-	7.93E-03	4.22E-03
InnateDB	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	39	-	-	3.39E-01	2.08E-03
InnateDB	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	11	-	-	1.63E-01	5.84E-04
InnateDB	CC	GO:0016323	basolateral plasma membrane	-	239	213	-	-	7.18E-03	1.11E-02
InnateDB	CC	GO:0016327	apicolateral plasma membrane	-	23	21	-	-	1.77E-03	1.10E-03
InnateDB	CC	GO:0016328	lateral plasma membrane	-	66	64	-	-	6.83E-03	3.37E-03
InnateDB	CC	GO:0016363	nuclear matrix	-	127	127	-	-	9.78E-03	6.61E-03
InnateDB	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	2.36E-03	5.84E-04
InnateDB	CC	GO:0016482	cytosolic transport	-	135	130	-	-	2.91E-02	6.74E-03
InnateDB	BP	GO:0016485	protein processing	-	248	224	-	-	1.50E-02	1.17E-02
InnateDB	MF	GO:0016491	oxidoreductase activity	4.59E-18	888	805	712	1.13	-	-
InnateDB	MF	GO:0016500	protein-hormone receptor activity	-	21	17	-	-	6.60E-03	9.08E-04
InnateDB	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	8.09E-03	1.23E-03
InnateDB	MF	GO:0016530	metallochaperone activity	-	14	13	-	-	3.15E-02	7.13E-04
InnateDB	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	8.40E-02	3.89E-03
InnateDB	CC	GO:0016592	mediator complex	-	38	37	-	-	4.04E-01	1.95E-03
InnateDB	MF	GO:0016740	transferase activity	1.18E-64	3074	2785	2465	1.13	-	-
InnateDB	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	224	-	-	6.97E-03	1.17E-02
InnateDB	MF	GO:0016757	glycosyltransferase activity	-	286	221	-	-	9.38E-03	1.15E-02
InnateDB	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	52	-	-	3.57E-02	2.72E-03
InnateDB	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	26	-	-	3.59E-02	1.36E-03
InnateDB	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	33	-	-	5.05E-03	1.75E-03
InnateDB	MF	GO:0016779	nucleotidyltransferase activity	-	264	248	-	-	1.42E-02	1.29E-02
InnateDB	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	21	-	-	3.14E-02	1.10E-03
InnateDB	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	58	-	-	3.15E-03	3.05E-03
InnateDB	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	125	-	-	6.17E-03	6.49E-03
InnateDB	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	119	-	-	5.68E-03	6.23E-03
InnateDB	MF	GO:0016829	lyase activity	3.64E-06	538	472	431	1.09	-	-
InnateDB	MF	GO:0016853	isomerase activity	2.57E-08	252	234	202	1.16	-	-
InnateDB	MF	GO:0016874	ligase activity	7.88E-06	283	255	227	1.12	-	-
InnateDB	MF	GO:0016917	GABA receptor activity	-	23	15	-	-	1.81E-02	7.78E-04
InnateDB	BP	GO:0017004	cytochrome complex assembly	-	40	33	-	-	1.22E-01	1.75E-03
InnateDB	BP	GO:0017014	protein nitrosylation	-	17	17	-	-	4.03E-03	9.08E-04
InnateDB	MF	GO:0017022	myosin binding	-	73	70	-	-	3.27E-03	3.63E-03
InnateDB	MF	GO:0017069	snRNA binding	-	54	51	-	-	3.00E-02	2.66E-03
InnateDB	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	4.63E-01	5.84E-04
InnateDB	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	13	-	-	1.94E-04	7.13E-04
InnateDB	BP	GO:0017148	negative regulation of translation	-	390	163	-	-	9.47E-03	8.50E-03
InnateDB	MF	GO:0017154	semaphorin receptor activity	-	12	11	-	-	7.35E-03	5.84E-04
InnateDB	MF	GO:0017166	vinculin binding	-	12	12	-	-	3.44E-03	6.49E-04
InnateDB	MF	GO:0017171	serine hydrolase activity	-	207	153	-	-	1.73E-02	7.98E-03
InnateDB	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	8.38E-03	1.36E-03
InnateDB	BP	GO:0018149	peptide cross-linking	-	28	26	-	-	3.10E-02	1.36E-03
InnateDB	BP	GO:0018158	protein oxidation	-	15	15	-	-	2.29E-03	7.78E-04
InnateDB	BP	GO:0018342	protein prenylation	-	15	15	-	-	5.29E-03	7.78E-04
InnateDB	BP	GO:0018410	C-terminal protein amino acid modification	-	15	11	-	-	1.51E-02	5.84E-04
InnateDB	CC	GO:0018995	host cellular component	-	12	12	-	-	1.05E-02	6.49E-04
InnateDB	MF	GO:0019003	GDP binding	-	89	86	-	-	1.06E-02	4.47E-03
InnateDB	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	2.57E-04	9.08E-04
InnateDB	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	105	-	-	1.83E-02	5.45E-03
InnateDB	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	40	-	-	2.23E-03	2.08E-03
InnateDB	MF	GO:0019208	phosphatase regulator activity	-	107	100	-	-	5.06E-03	5.19E-03
InnateDB	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	8.46E-03	5.84E-04
InnateDB	BP	GO:0019233	sensory perception of pain	-	103	92	-	-	5.75E-03	4.80E-03
InnateDB	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	38	-	-	4.42E-03	2.01E-03
InnateDB	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	18	-	-	2.57E-04	9.73E-04
InnateDB	BP	GO:0019755	one-carbon compound transport	-	28	21	-	-	2.73E-02	1.10E-03
InnateDB	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	104	-	-	2.64E-02	5.45E-03
InnateDB	MF	GO:0019825	oxygen binding	-	40	35	-	-	4.86E-03	1.82E-03
InnateDB	MF	GO:0019838	growth factor binding	-	182	172	-	-	9.69E-03	8.95E-03
InnateDB	MF	GO:0019843	rRNA binding	-	69	67	-	-	8.92E-03	3.50E-03
InnateDB	MF	GO:0019894	kinesin binding	-	45	41	-	-	8.13E-03	2.14E-03
InnateDB	CC	GO:0019897	extrinsic component of plasma membrane	-	156	148	-	-	6.33E-02	7.72E-03
InnateDB	BP	GO:0021515	cell differentiation in spinal cord	-	51	40	-	-	1.82E-02	2.08E-03
InnateDB	BP	GO:0021516	dorsal spinal cord development	-	20	13	-	-	8.67E-02	7.13E-04
InnateDB	BP	GO:0021517	ventral spinal cord development	-	47	40	-	-	1.61E-02	2.08E-03
InnateDB	BP	GO:0021533	cell differentiation in hindbrain	-	23	20	-	-	2.51E-03	1.04E-03
InnateDB	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	2.57E-04	8.43E-04
InnateDB	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	1.84E-03	1.04E-03
InnateDB	BP	GO:0021548	pons development	-	11	11	-	-	9.43E-04	5.84E-04
InnateDB	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.90E-04	6.49E-04
InnateDB	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	13	-	-	1.93E-04	7.13E-04
InnateDB	BP	GO:0021756	striatum development	-	21	21	-	-	4.09E-03	1.10E-03
InnateDB	BP	GO:0021782	glial cell development	-	120	113	-	-	4.68E-03	5.90E-03
InnateDB	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	15	-	-	1.65E-02	7.78E-04
InnateDB	BP	GO:0021794	thalamus development	-	12	11	-	-	1.94E-04	5.84E-04
InnateDB	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	5.29E-03	7.78E-04
InnateDB	BP	GO:0021859	pyramidal neuron differentiation	-	14	13	-	-	1.91E-04	7.13E-04
InnateDB	BP	GO:0021872	forebrain generation of neurons	-	52	48	-	-	1.98E-03	2.53E-03
InnateDB	BP	GO:0021885	forebrain cell migration	-	63	61	-	-	4.74E-03	3.18E-03
InnateDB	BP	GO:0021954	central nervous system neuron development	-	85	76	-	-	2.11E-03	3.96E-03
InnateDB	BP	GO:0021979	hypothalamus cell differentiation	-	13	11	-	-	1.91E-04	5.84E-04
InnateDB	BP	GO:0021987	cerebral cortex development	-	125	118	-	-	4.68E-03	6.16E-03
InnateDB	BP	GO:0022038	corpus callosum development	-	25	25	-	-	6.76E-03	1.30E-03
InnateDB	BP	GO:0022401	negative adaptation of signaling pathway	-	21	19	-	-	1.03E-02	1.04E-03
InnateDB	BP	GO:0022404	molting cycle process	-	95	83	-	-	2.54E-03	4.35E-03
InnateDB	BP	GO:0022406	membrane docking	-	90	84	-	-	5.36E-02	4.41E-03
InnateDB	BP	GO:0022600	digestive system process	3.26E-05	110	104	88	1.18	-	-
InnateDB	BP	GO:0022612	gland morphogenesis	-	124	121	-	-	4.90E-03	6.29E-03
InnateDB	BP	GO:0022618	protein-RNA complex assembly	-	227	193	-	-	3.28E-02	1.01E-02
InnateDB	CC	GO:0022626	cytosolic ribosome	-	118	112	-	-	4.42E-01	5.84E-03
InnateDB	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	245	-	-	3.05E-02	1.27E-02
InnateDB	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	31	-	-	5.32E-02	1.62E-03
InnateDB	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	19	-	-	6.80E-04	1.04E-03
InnateDB	MF	GO:0023023	MHC protein complex binding	-	36	34	-	-	6.90E-02	1.82E-03
InnateDB	CC	GO:0030018	Z disc	-	129	127	-	-	1.88E-02	6.61E-03
InnateDB	CC	GO:0030027	lamellipodium	-	202	196	-	-	1.10E-02	1.02E-02
InnateDB	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	35	-	-	1.43E-01	1.82E-03
InnateDB	CC	GO:0030126	COPI vesicle coat	-	13	12	-	-	1.34E-01	6.49E-04
InnateDB	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	16	-	-	1.55E-01	8.43E-04
InnateDB	MF	GO:0030145	manganese ion binding	-	65	54	-	-	8.57E-04	2.85E-03
InnateDB	BP	GO:0030149	sphingolipid catabolic process	-	32	30	-	-	1.78E-02	1.56E-03
InnateDB	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	52	-	-	5.28E-03	2.72E-03
InnateDB	BP	GO:0030163	protein catabolic process	1.09E-36	990	931	794	1.17	-	-
InnateDB	BP	GO:0030168	platelet activation	-	135	128	-	-	8.57E-03	6.68E-03
InnateDB	MF	GO:0030170	pyridoxal phosphate binding	-	56	51	-	-	3.92E-03	2.66E-03
InnateDB	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	131	-	-	1.43E-02	6.81E-03
InnateDB	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	151	-	-	6.53E-03	7.85E-03
InnateDB	BP	GO:0030193	regulation of blood coagulation	-	70	67	-	-	1.62E-02	3.50E-03
InnateDB	BP	GO:0030198	extracellular matrix organization	5.89E-04	314	275	252	1.09	-	-
InnateDB	MF	GO:0030215	semaphorin receptor binding	-	23	19	-	-	5.67E-02	1.04E-03
InnateDB	BP	GO:0030220	platelet formation	-	22	22	-	-	2.96E-03	1.17E-03
InnateDB	BP	GO:0030238	male sex determination	-	14	14	-	-	6.81E-03	7.78E-04
InnateDB	MF	GO:0030276	clathrin binding	-	70	67	-	-	4.35E-02	3.50E-03
InnateDB	BP	GO:0030279	negative regulation of ossification	-	39	35	-	-	1.63E-02	1.82E-03
InnateDB	CC	GO:0030286	dynein complex	-	210	157	-	-	4.23E-03	8.17E-03
InnateDB	BP	GO:0030307	positive regulation of cell growth	-	164	155	-	-	3.26E-03	8.04E-03
InnateDB	BP	GO:0030308	negative regulation of cell growth	-	191	179	-	-	3.30E-03	9.34E-03
InnateDB	CC	GO:0030315	T-tubule	-	52	46	-	-	6.20E-02	2.40E-03
InnateDB	BP	GO:0030397	membrane disassembly	-	11	11	-	-	1.48E-03	5.84E-04
InnateDB	CC	GO:0030427	site of polarized growth	-	172	158	-	-	4.18E-03	8.24E-03
InnateDB	BP	GO:0030431	sleep	-	30	28	-	-	3.96E-02	1.49E-03
InnateDB	MF	GO:0030506	ankyrin binding	-	19	18	-	-	2.27E-03	9.73E-04
InnateDB	MF	GO:0030507	spectrin binding	-	26	24	-	-	1.79E-02	1.30E-03
InnateDB	MF	GO:0030515	snoRNA binding	-	33	32	-	-	1.24E-02	1.69E-03
InnateDB	CC	GO:0030527	structural constituent of chromatin	-	97	75	-	-	1.11E-02	3.89E-03
InnateDB	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	152	-	-	8.85E-02	7.91E-03
InnateDB	MF	GO:0030552	cAMP binding	-	48	44	-	-	3.44E-02	2.33E-03
InnateDB	MF	GO:0030553	cGMP binding	-	15	11	-	-	3.91E-02	5.84E-04
InnateDB	BP	GO:0030574	collagen catabolic process	-	45	35	-	-	3.22E-03	1.82E-03
InnateDB	MF	GO:0030594	neurotransmitter receptor activity	-	160	120	-	-	2.04E-02	6.23E-03
InnateDB	CC	GO:0030658	transport vesicle membrane	-	231	202	-	-	2.10E-02	1.05E-02
InnateDB	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	51	-	-	1.68E-02	2.66E-03
InnateDB	CC	GO:0030662	coated vesicle membrane	-	202	187	-	-	2.46E-02	9.73E-03
InnateDB	CC	GO:0030666	endocytic vesicle membrane	-	196	184	-	-	1.17E-02	9.60E-03
InnateDB	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	6.17E-01	7.13E-04
InnateDB	CC	GO:0030684	preribosome	-	76	73	-	-	2.33E-02	3.83E-03
InnateDB	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	7.81E-03	1.17E-03
InnateDB	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	6.58E-04	1.04E-03
InnateDB	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	50	-	-	2.34E-03	2.59E-03
InnateDB	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	143	-	-	4.46E-03	7.46E-03
InnateDB	CC	GO:0030863	cortical cytoskeleton	-	104	98	-	-	6.25E-03	5.12E-03
InnateDB	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	3.12E-03	2.66E-03
InnateDB	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	1.66E-02	5.84E-04
InnateDB	BP	GO:0030901	midbrain development	-	87	85	-	-	2.58E-03	4.41E-03
InnateDB	CC	GO:0030904	retromer complex	-	12	12	-	-	1.00E-01	6.49E-04
InnateDB	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	12	-	-	8.07E-04	6.49E-04
InnateDB	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	14	-	-	1.01E-03	7.78E-04
InnateDB	MF	GO:0030971	receptor tyrosine kinase binding	-	76	71	-	-	2.91E-03	3.70E-03
InnateDB	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	4.05E-02	7.78E-04
InnateDB	CC	GO:0030992	intraciliary transport particle B	-	17	16	-	-	2.80E-01	8.43E-04
InnateDB	MF	GO:0031005	filamin binding	-	15	13	-	-	1.91E-04	7.13E-04
InnateDB	CC	GO:0031012	extracellular matrix	2.18E-01	564	464	452	1.03	-	-
InnateDB	BP	GO:0031018	endocrine pancreas development	-	47	43	-	-	1.92E-03	2.27E-03
InnateDB	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	7.59E-06	119	113	95	1.18	-	-
InnateDB	BP	GO:0031069	hair follicle morphogenesis	-	33	28	-	-	1.86E-03	1.49E-03
InnateDB	MF	GO:0031072	heat shock protein binding	-	128	123	-	-	1.16E-02	6.42E-03
InnateDB	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	2.25E-02	6.49E-04
InnateDB	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	2.06E-03	3.44E-03
InnateDB	CC	GO:0031105	septin complex	-	14	12	-	-	3.74E-01	6.49E-04
InnateDB	BP	GO:0031123	RNA 3'-end processing	-	79	74	-	-	5.04E-02	3.89E-03
InnateDB	BP	GO:0031128	developmental induction	-	26	26	-	-	2.29E-03	1.36E-03
InnateDB	CC	GO:0031143	pseudopodium	-	18	18	-	-	1.07E-02	9.73E-04
InnateDB	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	2.54E-02	1.56E-03
InnateDB	CC	GO:0031201	SNARE complex	-	48	46	-	-	3.09E-01	2.40E-03
InnateDB	CC	GO:0031209	SCAR complex	-	12	12	-	-	5.29E-02	6.49E-04
InnateDB	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	4.77E-02	1.69E-03
InnateDB	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	4.98E-02	2.40E-03
InnateDB	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	4.22E-02	8.43E-04
InnateDB	MF	GO:0031281	positive regulation of cyclase activity	-	40	37	-	-	1.89E-03	1.95E-03
InnateDB	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	1.25E-02	2.40E-03
InnateDB	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	108	-	-	5.24E-03	5.64E-03
InnateDB	CC	GO:0031332	RNAi effector complex	-	413	76	-	-	5.88E-03	3.96E-03
InnateDB	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	132	-	-	4.92E-03	6.87E-03
InnateDB	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	189	-	-	5.37E-03	9.86E-03
InnateDB	BP	GO:0031338	regulation of vesicle fusion	-	24	23	-	-	9.25E-04	1.23E-03
InnateDB	BP	GO:0031342	negative regulation of cell killing	-	29	28	-	-	1.64E-02	1.49E-03
InnateDB	BP	GO:0031343	positive regulation of cell killing	-	75	67	-	-	4.19E-02	3.50E-03
InnateDB	BP	GO:0031345	negative regulation of cell projection organization	-	195	179	-	-	6.81E-03	9.34E-03
InnateDB	BP	GO:0031348	negative regulation of defense response	-	282	227	-	-	6.56E-03	1.18E-02
InnateDB	BP	GO:0031365	N-terminal protein amino acid modification	-	30	26	-	-	3.18E-02	1.36E-03
InnateDB	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	1.23E-02	1.62E-03
InnateDB	MF	GO:0031404	chloride ion binding	-	14	12	-	-	1.94E-04	6.49E-04
InnateDB	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	9.28E-03	1.04E-03
InnateDB	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	8.29E-04	9.08E-04
InnateDB	CC	GO:0031430	M band	-	22	16	-	-	2.45E-02	8.43E-04
InnateDB	MF	GO:0031432	titin binding	-	13	13	-	-	1.31E-02	7.13E-04
InnateDB	MF	GO:0031490	chromatin DNA binding	-	120	111	-	-	7.56E-03	5.77E-03
InnateDB	CC	GO:0031519	PcG protein complex	-	38	36	-	-	5.89E-02	1.88E-03
InnateDB	BP	GO:0031529	ruffle organization	-	55	52	-	-	1.60E-03	2.72E-03
InnateDB	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	2.96E-02	6.49E-04
InnateDB	BP	GO:0031579	membrane raft organization	-	25	23	-	-	2.37E-03	1.23E-03
InnateDB	CC	GO:0031594	neuromuscular junction	-	73	69	-	-	5.11E-03	3.63E-03
InnateDB	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	2.55E-04	9.73E-04
InnateDB	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	4.78E-03	1.04E-03
InnateDB	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	6.23E-03	1.17E-03
InnateDB	CC	GO:0031903	microbody membrane	-	65	61	-	-	1.52E-01	3.18E-03
InnateDB	CC	GO:0031904	endosome lumen	-	38	37	-	-	3.09E-03	1.95E-03
InnateDB	CC	GO:0031907	microbody lumen	-	51	50	-	-	1.95E-01	2.59E-03
InnateDB	CC	GO:0031941	filamentous actin	-	27	24	-	-	3.18E-04	1.30E-03
InnateDB	MF	GO:0031952	regulation of protein autophosphorylation	-	43	43	-	-	1.56E-03	2.27E-03
InnateDB	CC	GO:0031970	organelle envelope lumen	-	94	90	-	-	2.60E-03	4.67E-03
InnateDB	MF	GO:0031996	thioesterase binding	-	11	11	-	-	2.20E-03	5.84E-04
InnateDB	CC	GO:0032008	positive regulation of TOR signaling	-	52	48	-	-	2.00E-02	2.53E-03
InnateDB	CC	GO:0032039	integrator complex	-	19	17	-	-	7.10E-01	9.08E-04
InnateDB	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	7.61E-03	1.10E-03
InnateDB	BP	GO:0032094	response to food	-	37	34	-	-	9.34E-04	1.82E-03
InnateDB	BP	GO:0032098	regulation of appetite	-	20	18	-	-	1.33E-02	9.73E-04
InnateDB	CC	GO:0032154	cleavage furrow	-	54	50	-	-	7.11E-03	2.59E-03
InnateDB	MF	GO:0032182	ubiquitin-like protein binding	-	117	115	-	-	6.15E-03	5.97E-03
InnateDB	BP	GO:0032200	telomere organization	2.81E-11	186	180	149	1.21	-	-
InnateDB	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	1.03E-02	7.78E-04
InnateDB	BP	GO:0032328	alanine transport	-	19	13	-	-	2.02E-02	7.13E-04
InnateDB	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	47	-	-	3.92E-03	2.46E-03
InnateDB	CC	GO:0032365	intracellular lipid transport	-	51	46	-	-	5.33E-02	2.40E-03
InnateDB	BP	GO:0032368	regulation of lipid transport	-	149	127	-	-	1.36E-02	6.61E-03
InnateDB	CC	GO:0032387	negative regulation of intracellular transport	-	51	47	-	-	2.58E-03	2.46E-03
InnateDB	CC	GO:0032388	positive regulation of intracellular transport	-	137	131	-	-	2.29E-03	6.81E-03
InnateDB	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	9.41E-03	5.84E-04
InnateDB	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	71	-	-	4.15E-03	3.70E-03
InnateDB	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	103	-	-	5.31E-03	5.38E-03
InnateDB	CC	GO:0032426	stereocilium tip	-	21	12	-	-	2.00E-02	6.49E-04
InnateDB	CC	GO:0032432	actin filament bundle	-	249	225	-	-	2.62E-02	1.17E-02
InnateDB	CC	GO:0032433	filopodium tip	-	19	19	-	-	2.10E-03	1.04E-03
InnateDB	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	1.08E-03	1.30E-03
InnateDB	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	44	-	-	2.83E-02	2.33E-03
InnateDB	BP	GO:0032528	microvillus organization	-	24	22	-	-	1.40E-02	1.17E-03
InnateDB	CC	GO:0032580	Golgi cisterna membrane	-	93	66	-	-	1.65E-03	3.44E-03
InnateDB	CC	GO:0032588	trans-Golgi network membrane	-	102	93	-	-	6.60E-02	4.86E-03
InnateDB	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	13	-	-	1.21E-01	7.13E-04
InnateDB	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	21	-	-	1.98E-03	1.10E-03
InnateDB	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	6.30E-03	1.17E-03
InnateDB	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.88E-04	7.13E-04
InnateDB	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	1.92E-01	9.73E-04
InnateDB	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	1.93E-04	5.84E-04
InnateDB	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	26	-	-	1.73E-03	1.36E-03
InnateDB	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	1.41E-02	1.82E-03
InnateDB	BP	GO:0032890	regulation of organic acid transport	-	78	72	-	-	1.91E-03	3.76E-03
InnateDB	BP	GO:0032922	circadian regulation of gene expression	-	71	69	-	-	5.75E-03	3.63E-03
InnateDB	BP	GO:0032941	secretion by tissue	-	85	81	-	-	2.50E-03	4.22E-03
InnateDB	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	1.80E-03	1.36E-03
InnateDB	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	48	-	-	1.17E-01	2.53E-03
InnateDB	CC	GO:0032982	myosin filament	-	24	23	-	-	1.41E-03	1.23E-03
InnateDB	CC	GO:0032994	protein-lipid complex	-	39	38	-	-	7.14E-02	2.01E-03
InnateDB	BP	GO:0033002	muscle cell proliferation	-	249	210	-	-	1.01E-02	1.09E-02
InnateDB	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	1.93E-04	7.13E-04
InnateDB	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	36	-	-	1.58E-01	1.88E-03
InnateDB	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	2.88E-02	1.29E-02
InnateDB	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	90	-	-	1.49E-01	4.67E-03
InnateDB	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	73	-	-	1.91E-02	3.83E-03
InnateDB	BP	GO:0033119	negative regulation of RNA splicing	-	27	26	-	-	7.50E-03	1.36E-03
InnateDB	BP	GO:0033120	positive regulation of RNA splicing	-	46	37	-	-	1.73E-03	1.95E-03
InnateDB	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	134	-	-	3.75E-03	7.00E-03
InnateDB	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	11	-	-	2.70E-03	5.84E-04
InnateDB	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	23	-	-	1.41E-02	1.23E-03
InnateDB	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	8.01E-02	9.73E-04
InnateDB	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	6.67E-03	2.08E-03
InnateDB	CC	GO:0033268	node of Ranvier	-	16	15	-	-	7.18E-02	7.78E-04
InnateDB	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	8.98E-03	6.49E-04
InnateDB	BP	GO:0033363	secretory granule organization	-	63	54	-	-	1.23E-02	2.85E-03
InnateDB	BP	GO:0033500	carbohydrate homeostasis	-	251	222	-	-	4.59E-03	1.15E-02
InnateDB	BP	GO:0033555	multicellular organismal response to stress	-	90	81	-	-	3.19E-03	4.22E-03
InnateDB	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	3.28E-03	1.17E-03
InnateDB	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	16	-	-	1.10E-03	8.43E-04
InnateDB	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	20	-	-	7.11E-02	1.04E-03
InnateDB	BP	GO:0033619	membrane protein proteolysis	-	60	57	-	-	2.19E-02	2.98E-03
InnateDB	BP	GO:0033622	integrin activation	-	26	25	-	-	1.25E-02	1.30E-03
InnateDB	BP	GO:0033627	cell adhesion mediated by integrin	-	87	84	-	-	1.76E-02	4.41E-03
InnateDB	BP	GO:0033688	regulation of osteoblast proliferation	-	31	27	-	-	3.82E-03	1.43E-03
InnateDB	MF	GO:0033691	sialic acid binding	-	22	17	-	-	2.58E-04	9.08E-04
InnateDB	CC	GO:0034045	phagophore assembly site membrane	-	19	18	-	-	7.93E-02	9.73E-04
InnateDB	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	2.20E-03	5.84E-04
InnateDB	BP	GO:0034067	protein localization to Golgi apparatus	-	30	28	-	-	2.76E-03	1.49E-03
InnateDB	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	2.11E-02	6.49E-04
InnateDB	BP	GO:0034104	negative regulation of tissue remodeling	-	22	20	-	-	2.35E-03	1.04E-03
InnateDB	BP	GO:0034105	positive regulation of tissue remodeling	-	23	13	-	-	7.14E-03	7.13E-04
InnateDB	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	16	-	-	1.79E-03	8.43E-04
InnateDB	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	7.46E-03	1.04E-03
InnateDB	BP	GO:0034249	negative regulation of amide metabolic process	-	34	24	-	-	1.02E-03	1.30E-03
InnateDB	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	1.84E-03	1.30E-03
InnateDB	MF	GO:0034260	negative regulation of GTPase activity	-	36	32	-	-	2.18E-03	1.69E-03
InnateDB	BP	GO:0034330	cell junction organization	6.06E-15	727	659	583	1.13	-	-
InnateDB	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	2.35E-03	5.84E-04
InnateDB	CC	GO:0034358	plasma lipoprotein particle	-	36	35	-	-	6.70E-02	1.82E-03
InnateDB	BP	GO:0034367	protein-containing complex remodeling	-	35	32	-	-	3.65E-02	1.69E-03
InnateDB	BP	GO:0034389	lipid droplet organization	-	38	35	-	-	2.27E-03	1.82E-03
InnateDB	BP	GO:0034394	protein localization to cell surface	-	69	65	-	-	2.71E-03	3.37E-03
InnateDB	CC	GO:0034451	centriolar satellite	-	120	111	-	-	9.08E-03	5.77E-03
InnateDB	MF	GO:0034452	dynactin binding	-	12	11	-	-	3.07E-03	5.84E-04
InnateDB	CC	GO:0034455	t-UTP complex	-	53	50	-	-	2.14E-02	2.59E-03
InnateDB	MF	GO:0034497	protein localization to phagophore assembly site	-	16	15	-	-	3.45E-03	7.78E-04
InnateDB	BP	GO:0034502	protein localization to chromosome	-	130	124	-	-	7.49E-03	6.49E-03
InnateDB	BP	GO:0034605	cellular response to heat	-	66	58	-	-	1.64E-03	3.05E-03
InnateDB	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	14	-	-	1.94E-04	7.78E-04
InnateDB	CC	GO:0034709	methylosome	-	13	12	-	-	2.40E-02	6.49E-04
InnateDB	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	3.57E-01	9.08E-04
InnateDB	CC	GO:0034982	mitochondrial protein processing	-	13	12	-	-	1.91E-04	6.49E-04
InnateDB	MF	GO:0035035	histone acetyltransferase binding	-	24	23	-	-	8.72E-04	1.23E-03
InnateDB	BP	GO:0035050	embryonic heart tube development	-	86	73	-	-	8.39E-03	3.83E-03
InnateDB	CC	GO:0035097	histone methyltransferase complex	-	63	60	-	-	2.31E-02	3.11E-03
InnateDB	BP	GO:0035107	appendage morphogenesis	-	147	140	-	-	7.10E-03	7.26E-03
InnateDB	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	7.35E-02	5.84E-04
InnateDB	BP	GO:0035148	tube formation	-	155	148	-	-	7.40E-03	7.72E-03
InnateDB	MF	GO:0035173	histone kinase activity	-	17	17	-	-	5.98E-04	9.08E-04
InnateDB	BP	GO:0035188	hatching	-	27	20	-	-	3.19E-04	1.04E-03
InnateDB	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	7.79E-04	6.49E-04
InnateDB	MF	GO:0035254	glutamate receptor binding	-	47	43	-	-	3.10E-03	2.27E-03
InnateDB	BP	GO:0035272	exocrine system development	-	46	45	-	-	2.32E-03	2.33E-03
InnateDB	BP	GO:0035304	regulation of protein dephosphorylation	-	87	83	-	-	2.28E-03	4.35E-03
InnateDB	BP	GO:0035315	hair cell differentiation	-	52	41	-	-	5.54E-03	2.14E-03
InnateDB	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	3.12E-02	7.13E-04
InnateDB	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	7.43E-03	6.49E-04
InnateDB	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	3.55E-02	1.23E-03
InnateDB	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	2.04E-03	6.49E-04
InnateDB	BP	GO:0035601	protein deacylation	-	56	54	-	-	4.46E-03	2.85E-03
InnateDB	MF	GO:0035613	RNA stem-loop binding	-	21	16	-	-	1.76E-03	8.43E-04
InnateDB	BP	GO:0035672	oligopeptide transmembrane transport	-	15	13	-	-	7.71E-02	7.13E-04
InnateDB	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.94E-04	5.84E-04
InnateDB	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	2.62E-02	7.13E-04
InnateDB	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	1.87E-04	7.78E-04
InnateDB	BP	GO:0035902	response to immobilization stress	-	20	18	-	-	2.50E-04	9.73E-04
InnateDB	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	96	-	-	4.73E-03	4.99E-03
InnateDB	BP	GO:0035988	chondrocyte proliferation	-	24	22	-	-	3.94E-03	1.17E-03
InnateDB	MF	GO:0036002	pre-mRNA binding	-	57	37	-	-	5.65E-03	1.95E-03
InnateDB	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	5.95E-03	1.43E-03
InnateDB	CC	GO:0036019	endolysosome	-	29	28	-	-	8.76E-03	1.49E-03
InnateDB	CC	GO:0036038	MKS complex	-	13	11	-	-	1.94E-04	5.84E-04
InnateDB	BP	GO:0036302	atrioventricular canal development	-	13	12	-	-	2.13E-03	6.49E-04
InnateDB	BP	GO:0036315	cellular response to sterol	-	24	19	-	-	3.67E-03	1.04E-03
InnateDB	BP	GO:0036342	post-anal tail morphogenesis	-	19	18	-	-	2.54E-04	9.73E-04
InnateDB	CC	GO:0036379	myofilament	-	26	21	-	-	6.33E-02	1.10E-03
InnateDB	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	235	-	-	1.63E-02	1.22E-02
InnateDB	MF	GO:0038024	cargo receptor activity	2.47E-01	117	99	94	1.06	-	-
InnateDB	MF	GO:0038024	cargo receptor activity	-	121	101	-	-	6.88E-03	5.25E-03
InnateDB	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	1.19E-02	7.78E-04
InnateDB	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	14	-	-	3.03E-03	7.78E-04
InnateDB	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	8.18E-03	2.01E-03
InnateDB	BP	GO:0038183	bile acid signaling pathway	-	12	11	-	-	1.53E-02	5.84E-04
InnateDB	MF	GO:0038187	pattern recognition receptor activity	-	33	30	-	-	3.22E-02	1.56E-03
InnateDB	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	79	-	-	5.31E-03	4.15E-03
InnateDB	BP	GO:0039694	viral RNA genome replication	-	30	29	-	-	8.97E-03	1.56E-03
InnateDB	MF	GO:0039706	co-receptor binding	-	14	13	-	-	7.68E-03	7.13E-04
InnateDB	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	1.91E-04	6.49E-04
InnateDB	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	29	-	-	7.16E-03	1.56E-03
InnateDB	BP	GO:0040019	positive regulation of embryonic development	-	23	22	-	-	4.93E-02	1.17E-03
InnateDB	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	20	-	-	8.92E-03	1.04E-03
InnateDB	MF	GO:0042043	neurexin family protein binding	-	14	13	-	-	1.19E-02	7.13E-04
InnateDB	BP	GO:0042044	fluid transport	-	35	30	-	-	2.96E-03	1.56E-03
InnateDB	BP	GO:0042060	wound healing	2.33E-22	431	414	346	1.20	-	-
InnateDB	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	5.57E-03	1.04E-03
InnateDB	BP	GO:0042092	type 2 immune response	-	41	40	-	-	3.47E-03	2.08E-03
InnateDB	BP	GO:0042177	negative regulation of protein catabolic process	-	109	101	-	-	2.45E-03	5.25E-03
InnateDB	BP	GO:0042178	xenobiotic catabolic process	-	26	23	-	-	5.64E-02	1.23E-03
InnateDB	BP	GO:0042182	ketone catabolic process	-	14	13	-	-	1.93E-04	7.13E-04
InnateDB	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	21	-	-	3.23E-04	1.10E-03
InnateDB	BP	GO:0042254	ribosome biogenesis	7.78E-20	297	290	238	1.22	-	-
InnateDB	MF	GO:0042287	MHC protein binding	-	68	51	-	-	3.31E-02	2.66E-03
InnateDB	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	1.90E-04	6.49E-04
InnateDB	MF	GO:0042393	histone binding	1.91E-11	237	226	190	1.19	-	-
InnateDB	MF	GO:0042393	histone binding	-	240	226	-	-	1.26E-02	1.17E-02
InnateDB	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	42	-	-	2.07E-03	2.20E-03
InnateDB	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	3.03E-03	6.49E-04
InnateDB	BP	GO:0042440	pigment metabolic process	-	80	69	-	-	1.58E-03	3.63E-03
InnateDB	BP	GO:0042447	hormone catabolic process	-	12	11	-	-	1.92E-04	5.84E-04
InnateDB	BP	GO:0042490	mechanoreceptor differentiation	-	67	55	-	-	2.42E-02	2.85E-03
InnateDB	BP	GO:0042537	benzene-containing compound metabolic process	-	27	20	-	-	3.76E-02	1.04E-03
InnateDB	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.62E-03	7.78E-04
InnateDB	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	2.22E-02	5.84E-04
InnateDB	CC	GO:0042641	actomyosin	-	77	74	-	-	7.93E-03	3.89E-03
InnateDB	CC	GO:0042645	mitochondrial nucleoid	-	45	43	-	-	1.52E-02	2.27E-03
InnateDB	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	27	-	-	1.78E-02	1.43E-03
InnateDB	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	3.25E-02	9.08E-04
InnateDB	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	1.14E-02	6.49E-04
InnateDB	CC	GO:0042770	signal transduction in response to DNA damage	-	186	184	-	-	1.27E-02	9.60E-03
InnateDB	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	93	-	-	1.29E-01	4.86E-03
InnateDB	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	65	-	-	1.29E-01	3.37E-03
InnateDB	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	44	-	-	1.50E-02	2.33E-03
InnateDB	MF	GO:0042805	actinin binding	-	36	34	-	-	1.73E-03	1.82E-03
InnateDB	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	1.23E-02	8.43E-04
InnateDB	BP	GO:0042832	defense response to protozoan	-	28	24	-	-	2.41E-03	1.30E-03
InnateDB	MF	GO:0042887	amide transmembrane transporter activity	-	33	23	-	-	4.03E-02	1.23E-03
InnateDB	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	22	-	-	3.21E-04	1.17E-03
InnateDB	BP	GO:0042953	lipoprotein transport	-	20	18	-	-	2.36E-03	9.73E-04
InnateDB	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	15	-	-	2.16E-03	7.78E-04
InnateDB	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	37	-	-	2.81E-03	1.95E-03
InnateDB	MF	GO:0043021	ribonucleoprotein complex binding	-	158	155	-	-	5.78E-03	8.04E-03
InnateDB	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	41	-	-	3.71E-03	2.14E-03
InnateDB	CC	GO:0043034	costamere	-	18	17	-	-	8.38E-03	9.08E-04
InnateDB	BP	GO:0043043	peptide biosynthetic process	-	25	21	-	-	4.98E-03	1.10E-03
InnateDB	CC	GO:0043073	germ cell nucleus	-	67	61	-	-	3.21E-03	3.18E-03
InnateDB	CC	GO:0043083	synaptic cleft	-	21	15	-	-	2.58E-04	7.78E-04
InnateDB	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	3.83E-02	7.78E-04
InnateDB	CC	GO:0043113	receptor clustering	-	51	47	-	-	1.99E-02	2.46E-03
InnateDB	BP	GO:0043114	regulation of vascular permeability	-	49	45	-	-	7.44E-03	2.33E-03
InnateDB	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	189	-	-	1.76E-02	9.86E-03
InnateDB	BP	GO:0043144	sno(s)RNA processing	-	14	13	-	-	1.93E-02	7.13E-04
InnateDB	BP	GO:0043171	peptide catabolic process	-	19	16	-	-	7.76E-03	8.43E-04
InnateDB	CC	GO:0043194	axon initial segment	-	21	20	-	-	8.20E-02	1.04E-03
InnateDB	CC	GO:0043198	dendritic shaft	-	38	31	-	-	1.45E-03	1.62E-03
InnateDB	CC	GO:0043204	perikaryon	-	156	141	-	-	2.65E-03	7.33E-03
InnateDB	MF	GO:0043236	laminin binding	-	29	27	-	-	9.39E-03	1.43E-03
InnateDB	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	6.42E-01	7.13E-04
InnateDB	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	35	-	-	1.05E-03	1.82E-03
InnateDB	BP	GO:0043248	proteasome assembly	-	13	13	-	-	2.79E-02	7.13E-04
InnateDB	MF	GO:0043274	phospholipase binding	-	23	22	-	-	1.98E-03	1.17E-03
InnateDB	CC	GO:0043292	contractile muscle fiber	-	245	229	-	-	3.09E-02	1.19E-02
InnateDB	BP	GO:0043299	leukocyte degranulation	-	82	76	-	-	9.62E-03	3.96E-03
InnateDB	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	28	-	-	7.52E-03	1.49E-03
InnateDB	BP	GO:0043331	response to dsRNA	-	56	50	-	-	4.90E-03	2.59E-03
InnateDB	MF	GO:0043394	proteoglycan binding	-	36	34	-	-	4.41E-03	1.82E-03
InnateDB	BP	GO:0043414	macromolecule methylation	-	138	122	-	-	7.06E-03	6.36E-03
InnateDB	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	171	-	-	4.95E-03	8.88E-03
InnateDB	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	58	-	-	2.23E-03	3.05E-03
InnateDB	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	1.20E-01	6.49E-04
InnateDB	BP	GO:0043523	regulation of neuron apoptotic process	-	218	207	-	-	1.27E-02	1.08E-02
InnateDB	MF	GO:0043531	ADP binding	-	38	37	-	-	2.58E-03	1.95E-03
InnateDB	BP	GO:0043543	protein acylation	-	107	91	-	-	5.50E-03	4.73E-03
InnateDB	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	30	-	-	9.25E-03	1.56E-03
InnateDB	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	4.66E-03	1.17E-03
InnateDB	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	7.11E-03	7.13E-04
InnateDB	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	12	-	-	8.12E-02	6.49E-04
InnateDB	CC	GO:0043574	peroxisomal transport	-	22	21	-	-	1.55E-01	1.10E-03
InnateDB	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	22	-	-	4.74E-02	1.17E-03
InnateDB	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	5.48E-03	6.49E-04
InnateDB	BP	GO:0043605	amide catabolic process	-	16	13	-	-	1.94E-04	7.13E-04
InnateDB	BP	GO:0043647	inositol phosphate metabolic process	-	44	39	-	-	9.82E-03	2.08E-03
InnateDB	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	56	-	-	6.46E-03	2.92E-03
InnateDB	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	11	-	-	7.33E-02	5.84E-04
InnateDB	BP	GO:0043954	cellular component maintenance	-	72	63	-	-	5.38E-03	3.31E-03
InnateDB	BP	GO:0044088	regulation of vacuole organization	-	56	53	-	-	7.45E-03	2.79E-03
InnateDB	MF	GO:0044183	protein folding chaperone	-	67	58	-	-	2.32E-03	3.05E-03
InnateDB	CC	GO:0044232	organelle membrane contact site	-	50	48	-	-	9.06E-03	2.53E-03
InnateDB	BP	GO:0044242	cellular lipid catabolic process	-	224	202	-	-	1.65E-02	1.05E-02
InnateDB	CC	GO:0044292	dendrite terminus	-	13	12	-	-	7.03E-04	6.49E-04
InnateDB	CC	GO:0044298	cell body membrane	-	32	29	-	-	2.65E-02	1.56E-03
InnateDB	CC	GO:0044306	neuron projection terminus	-	164	145	-	-	8.71E-03	7.52E-03
InnateDB	CC	GO:0044309	neuron spine	-	213	199	-	-	7.71E-03	1.04E-02
InnateDB	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	8.61E-03	1.82E-03
InnateDB	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	23	-	-	7.72E-03	1.23E-03
InnateDB	MF	GO:0044325	transmembrane transporter binding	-	159	150	-	-	8.30E-03	7.78E-03
InnateDB	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	3.75E-03	2.98E-03
InnateDB	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	36	-	-	1.24E-03	1.88E-03
InnateDB	CC	GO:0044391	ribosomal subunit	-	203	197	-	-	3.69E-01	1.02E-02
InnateDB	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	7.74E-04	9.08E-04
InnateDB	MF	GO:0044548	S100 protein binding	-	14	14	-	-	4.32E-02	7.78E-04
InnateDB	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	2.59E-02	6.49E-04
InnateDB	BP	GO:0044703	multi-organism reproductive process	-	209	194	-	-	6.15E-03	1.01E-02
InnateDB	BP	GO:0044706	multi-multicellular organism process	-	217	203	-	-	6.14E-03	1.06E-02
InnateDB	BP	GO:0044782	cilium organization	4.85E-01	399	326	320	1.02	-	-
InnateDB	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	8.65E-03	2.33E-03
InnateDB	BP	GO:0044848	biological phase	-	211	187	-	-	1.39E-02	9.73E-03
InnateDB	CC	GO:0044853	plasma membrane raft	-	114	110	-	-	6.75E-03	5.71E-03
InnateDB	CC	GO:0045009	chitosome	-	21	19	-	-	2.57E-04	1.04E-03
InnateDB	BP	GO:0045017	glycerolipid biosynthetic process	-	254	227	-	-	1.81E-02	1.18E-02
InnateDB	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	16	-	-	8.22E-04	8.43E-04
InnateDB	CC	GO:0045022	early endosome to late endosome transport	-	44	41	-	-	1.30E-02	2.14E-03
InnateDB	BP	GO:0045023	G0 to G1 transition	-	41	38	-	-	1.46E-01	2.01E-03
InnateDB	BP	GO:0045048	protein insertion into ER membrane	-	30	29	-	-	1.42E-02	1.56E-03
InnateDB	BP	GO:0045056	transcytosis	-	20	19	-	-	3.26E-03	1.04E-03
InnateDB	BP	GO:0045058	T cell selection	-	53	52	-	-	1.65E-02	2.72E-03
InnateDB	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	90	-	-	9.89E-03	4.67E-03
InnateDB	CC	GO:0045120	pronucleus	-	14	11	-	-	7.71E-04	5.84E-04
InnateDB	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	5.68E-03	5.84E-04
InnateDB	CC	GO:0045171	intercellular bridge	-	91	84	-	-	6.95E-03	4.41E-03
InnateDB	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.54E-04	7.78E-04
InnateDB	MF	GO:0045182	translation regulator activity	4.37E-10	151	147	121	1.21	-	-
InnateDB	BP	GO:0045185	maintenance of protein location	-	95	87	-	-	2.69E-03	4.54E-03
InnateDB	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	20	-	-	3.40E-02	1.04E-03
InnateDB	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	7.37E-03	7.13E-04
InnateDB	CC	GO:0045324	late endosome to vacuole transport	-	37	34	-	-	8.43E-02	1.82E-03
InnateDB	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	6.88E-03	7.78E-04
InnateDB	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	1.46E-03	2.01E-03
InnateDB	BP	GO:0045494	photoreceptor cell maintenance	-	43	37	-	-	3.29E-02	1.95E-03
InnateDB	CC	GO:0045495	pole plasm	-	25	19	-	-	3.50E-03	1.04E-03
InnateDB	MF	GO:0045504	dynein heavy chain binding	-	16	14	-	-	5.11E-02	7.78E-04
InnateDB	MF	GO:0045505	dynein intermediate chain binding	-	37	29	-	-	1.74E-03	1.56E-03
InnateDB	BP	GO:0045598	regulation of fat cell differentiation	-	148	118	-	-	3.90E-03	6.16E-03
InnateDB	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	19	-	-	8.11E-04	1.04E-03
InnateDB	BP	GO:0045661	regulation of myoblast differentiation	-	74	70	-	-	1.47E-02	3.63E-03
InnateDB	BP	GO:0045666	positive regulation of neuron differentiation	-	91	78	-	-	2.58E-03	4.09E-03
InnateDB	BP	GO:0045667	regulation of osteoblast differentiation	-	147	123	-	-	9.56E-03	6.42E-03
InnateDB	BP	GO:0045683	negative regulation of epidermis development	-	13	11	-	-	3.60E-03	5.84E-04
InnateDB	BP	GO:0045684	positive regulation of epidermis development	-	33	29	-	-	1.18E-03	1.56E-03
InnateDB	BP	GO:0045685	regulation of glial cell differentiation	-	77	68	-	-	2.87E-03	3.57E-03
InnateDB	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	19	-	-	2.43E-03	1.04E-03
InnateDB	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	15	-	-	2.49E-04	7.78E-04
InnateDB	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	1.36E-03	1.04E-03
InnateDB	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	22	-	-	5.83E-03	1.17E-03
InnateDB	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	6.95E-03	7.78E-04
InnateDB	BP	GO:0045727	positive regulation of translation	-	141	136	-	-	6.82E-03	7.07E-03
InnateDB	BP	GO:0045732	positive regulation of protein catabolic process	-	202	198	-	-	4.91E-03	1.03E-02
InnateDB	BP	GO:0045738	negative regulation of DNA repair	-	40	38	-	-	1.74E-03	2.01E-03
InnateDB	BP	GO:0045739	positive regulation of DNA repair	-	128	121	-	-	1.01E-01	6.29E-03
InnateDB	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	55	-	-	5.30E-03	2.85E-03
InnateDB	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	32	-	-	1.31E-03	1.69E-03
InnateDB	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	33	-	-	2.41E-03	1.75E-03
InnateDB	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	36	-	-	6.18E-03	1.88E-03
InnateDB	BP	GO:0045778	positive regulation of ossification	-	51	47	-	-	5.38E-03	2.46E-03
InnateDB	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	2.23E-03	9.73E-04
InnateDB	BP	GO:0045807	positive regulation of endocytosis	-	155	148	-	-	7.28E-03	7.72E-03
InnateDB	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	108	-	-	6.97E-03	5.64E-03
InnateDB	BP	GO:0045830	positive regulation of isotype switching	-	28	27	-	-	9.20E-04	1.43E-03
InnateDB	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	15	-	-	2.64E-03	7.78E-04
InnateDB	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	33	-	-	4.17E-03	1.75E-03
InnateDB	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	35	-	-	1.40E-03	1.82E-03
InnateDB	BP	GO:0045907	positive regulation of vasoconstriction	-	30	28	-	-	3.87E-03	1.49E-03
InnateDB	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	5.33E-03	1.17E-03
InnateDB	BP	GO:0045933	positive regulation of muscle contraction	-	49	42	-	-	1.26E-03	2.20E-03
InnateDB	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	32	-	-	4.32E-03	1.69E-03
InnateDB	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	1.83E-02	9.73E-04
InnateDB	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	6.65E-03	9.73E-04
InnateDB	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	1.15E-02	8.43E-04
InnateDB	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	1.93E-04	7.78E-04
InnateDB	MF	GO:0046332	SMAD binding	-	77	75	-	-	1.03E-02	3.89E-03
InnateDB	BP	GO:0046415	urate metabolic process	-	12	11	-	-	1.94E-04	5.84E-04
InnateDB	BP	GO:0046434	organophosphate catabolic process	-	232	211	-	-	4.60E-03	1.10E-02
InnateDB	BP	GO:0046460	neutral lipid biosynthetic process	-	50	40	-	-	8.55E-03	2.08E-03
InnateDB	BP	GO:0046504	glycerol ether biosynthetic process	-	11	11	-	-	2.10E-02	5.84E-04
InnateDB	BP	GO:0046605	regulation of centrosome cycle	-	54	53	-	-	7.42E-03	2.79E-03
InnateDB	BP	GO:0046618	xenobiotic export from cell	-	27	12	-	-	4.45E-03	6.49E-04
InnateDB	BP	GO:0046621	negative regulation of organ growth	-	39	36	-	-	1.10E-03	1.88E-03
InnateDB	BP	GO:0046622	positive regulation of organ growth	-	52	43	-	-	5.35E-03	2.27E-03
InnateDB	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	34	-	-	3.34E-03	1.82E-03
InnateDB	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	23	-	-	1.55E-03	1.23E-03
InnateDB	BP	GO:0046660	female sex differentiation	-	125	119	-	-	1.18E-02	6.23E-03
InnateDB	BP	GO:0046661	male sex differentiation	-	171	160	-	-	7.16E-03	8.30E-03
InnateDB	BP	GO:0046697	decidualization	-	26	25	-	-	1.73E-03	1.30E-03
InnateDB	MF	GO:0046790	virion binding	-	19	17	-	-	3.98E-03	9.08E-04
InnateDB	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.89E-04	5.84E-04
InnateDB	BP	GO:0046834	lipid phosphorylation	-	16	14	-	-	6.21E-02	7.78E-04
InnateDB	BP	GO:0046835	carbohydrate phosphorylation	-	49	48	-	-	1.54E-02	2.53E-03
InnateDB	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	1.15E-02	1.56E-03
InnateDB	CC	GO:0046930	pore complex	-	26	25	-	-	1.13E-01	1.30E-03
InnateDB	BP	GO:0046931	pore complex assembly	-	21	20	-	-	2.20E-03	1.04E-03
InnateDB	BP	GO:0047484	regulation of response to osmotic stress	-	16	15	-	-	2.54E-04	7.78E-04
InnateDB	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	32	-	-	2.84E-03	1.69E-03
InnateDB	MF	GO:0048018	receptor ligand activity	6.92E-01	504	408	404	1.01	-	-
InnateDB	MF	GO:0048019	receptor antagonist activity	-	31	17	-	-	2.56E-04	9.08E-04
InnateDB	MF	GO:0048038	quinone binding	-	16	14	-	-	1.33E-02	7.78E-04
InnateDB	BP	GO:0048145	regulation of fibroblast proliferation	-	87	81	-	-	2.94E-03	4.22E-03
InnateDB	MF	GO:0048156	tau protein binding	-	43	43	-	-	3.32E-03	2.27E-03
InnateDB	CC	GO:0048167	regulation of synaptic plasticity	-	210	177	-	-	4.84E-03	9.21E-03
InnateDB	MF	GO:0048185	activin binding	-	16	16	-	-	1.99E-02	8.43E-04
InnateDB	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	4.53E-02	1.30E-03
InnateDB	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	4.45E-02	8.43E-04
InnateDB	BP	GO:0048278	vesicle docking	-	64	59	-	-	2.33E-02	3.11E-03
InnateDB	MF	GO:0048306	calcium-dependent protein binding	-	61	60	-	-	1.46E-02	3.11E-03
InnateDB	BP	GO:0048308	organelle inheritance	-	14	14	-	-	2.35E-03	7.78E-04
InnateDB	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	1.94E-04	5.84E-04
InnateDB	BP	GO:0048485	sympathetic nervous system development	-	22	21	-	-	6.46E-03	1.10E-03
InnateDB	BP	GO:0048515	spermatid differentiation	-	208	158	-	-	3.13E-03	8.24E-03
InnateDB	BP	GO:0048520	positive regulation of behavior	-	27	24	-	-	4.85E-04	1.30E-03
InnateDB	BP	GO:0048524	positive regulation of viral process	-	64	61	-	-	1.95E-03	3.18E-03
InnateDB	BP	GO:0048525	negative regulation of viral process	-	90	87	-	-	5.30E-03	4.54E-03
InnateDB	BP	GO:0048532	anatomical structure arrangement	-	16	15	-	-	1.12E-02	7.78E-04
InnateDB	BP	GO:0048588	developmental cell growth	-	233	211	-	-	4.69E-03	1.10E-02
InnateDB	BP	GO:0048644	muscle organ morphogenesis	-	81	77	-	-	7.77E-03	4.02E-03
InnateDB	BP	GO:0048645	animal organ formation	-	62	59	-	-	6.03E-03	3.11E-03
InnateDB	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	145	-	-	9.98E-03	7.52E-03
InnateDB	BP	GO:0048663	neuron fate commitment	-	74	59	-	-	4.87E-03	3.11E-03
InnateDB	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.69E-03	1.30E-03
InnateDB	BP	GO:0048708	astrocyte differentiation	-	88	83	-	-	2.28E-03	4.35E-03
InnateDB	BP	GO:0048709	oligodendrocyte differentiation	-	101	92	-	-	3.28E-03	4.80E-03
InnateDB	BP	GO:0048753	pigment granule organization	-	40	38	-	-	1.42E-01	2.01E-03
InnateDB	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	1.90E-04	5.84E-04
InnateDB	CC	GO:0048786	presynaptic active zone	-	80	74	-	-	6.33E-03	3.89E-03
InnateDB	BP	GO:0048799	animal organ maturation	-	33	28	-	-	5.56E-03	1.49E-03
InnateDB	BP	GO:0048853	forebrain morphogenesis	-	13	11	-	-	1.89E-04	5.84E-04
InnateDB	BP	GO:0048857	neural nucleus development	-	65	63	-	-	3.08E-03	3.31E-03
InnateDB	BP	GO:0048864	stem cell development	-	88	84	-	-	4.81E-03	4.41E-03
InnateDB	BP	GO:0048870	cell motility	3.77E-36	1659	1510	1330	1.14	-	-
InnateDB	BP	GO:0048935	peripheral nervous system neuron development	-	15	14	-	-	3.92E-02	7.78E-04
InnateDB	MF	GO:0050321	tau-protein kinase activity	-	36	34	-	-	1.55E-03	1.82E-03
InnateDB	BP	GO:0050435	amyloid-beta metabolic process	-	65	51	-	-	1.65E-02	2.66E-03
InnateDB	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	78	-	-	2.12E-03	4.09E-03
InnateDB	BP	GO:0050688	regulation of defense response to virus	-	65	61	-	-	2.25E-02	3.18E-03
InnateDB	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	239	-	-	8.68E-03	1.25E-02
InnateDB	BP	GO:0050768	negative regulation of neurogenesis	-	150	135	-	-	3.07E-03	7.00E-03
InnateDB	BP	GO:0050769	positive regulation of neurogenesis	-	240	225	-	-	5.00E-03	1.17E-02
InnateDB	BP	GO:0050777	negative regulation of immune response	-	196	178	-	-	1.17E-02	9.27E-03
InnateDB	BP	GO:0050779	RNA destabilization	-	135	108	-	-	6.34E-02	5.64E-03
InnateDB	CC	GO:0050805	negative regulation of synaptic transmission	-	55	51	-	-	1.43E-02	2.66E-03
InnateDB	CC	GO:0050806	positive regulation of synaptic transmission	-	171	137	-	-	3.50E-03	7.13E-03
InnateDB	MF	GO:0050811	GABA receptor binding	-	18	14	-	-	1.10E-02	7.78E-04
InnateDB	BP	GO:0050819	negative regulation of coagulation	-	54	50	-	-	3.16E-02	2.59E-03
InnateDB	BP	GO:0050820	positive regulation of coagulation	-	30	29	-	-	1.31E-02	1.56E-03
InnateDB	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	37	-	-	3.91E-03	1.95E-03
InnateDB	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	24	-	-	3.62E-03	1.30E-03
InnateDB	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	30	-	-	1.10E-02	1.56E-03
InnateDB	BP	GO:0050866	negative regulation of cell activation	-	216	196	-	-	8.58E-03	1.02E-02
InnateDB	BP	GO:0050877	nervous system process	2.53E-73	1527	932	1224	0.76	-	-
InnateDB	BP	GO:0050879	multicellular organismal movement	-	118	102	-	-	4.53E-03	5.32E-03
InnateDB	BP	GO:0050886	endocrine process	-	93	83	-	-	7.08E-03	4.35E-03
InnateDB	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	99	-	-	2.36E-02	5.19E-03
InnateDB	BP	GO:0050951	sensory perception of temperature stimulus	-	28	25	-	-	2.84E-03	1.30E-03
InnateDB	BP	GO:0050953	sensory perception of light stimulus	-	223	177	-	-	5.45E-02	9.21E-03
InnateDB	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	145	-	-	8.77E-03	7.52E-03
InnateDB	BP	GO:0050994	regulation of lipid catabolic process	-	61	56	-	-	5.44E-03	2.92E-03
InnateDB	MF	GO:0051015	actin filament binding	-	208	195	-	-	1.27E-02	1.01E-02
InnateDB	BP	GO:0051017	actin filament bundle assembly	-	161	145	-	-	5.51E-03	7.52E-03
InnateDB	MF	GO:0051018	protein kinase A binding	-	52	48	-	-	3.21E-02	2.53E-03
InnateDB	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	57	-	-	2.38E-03	2.98E-03
InnateDB	MF	GO:0051087	protein-folding chaperone binding	-	135	125	-	-	5.43E-03	6.49E-03
InnateDB	MF	GO:0051100	negative regulation of binding	-	161	153	-	-	3.41E-03	7.98E-03
InnateDB	MF	GO:0051117	ATPase binding	-	85	79	-	-	4.62E-03	4.15E-03
InnateDB	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	5.98E-03	1.17E-03
InnateDB	BP	GO:0051147	regulation of muscle cell differentiation	-	162	135	-	-	4.34E-03	7.00E-03
InnateDB	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	35	-	-	7.77E-03	1.82E-03
InnateDB	MF	GO:0051219	phosphoprotein binding	-	92	89	-	-	5.47E-03	4.67E-03
InnateDB	BP	GO:0051222	positive regulation of protein transport	-	249	231	-	-	5.38E-03	1.20E-02
InnateDB	BP	GO:0051224	negative regulation of protein transport	-	122	108	-	-	2.98E-03	5.64E-03
InnateDB	BP	GO:0051231	spindle elongation	-	14	13	-	-	2.33E-02	7.13E-04
InnateDB	CC	GO:0051233	spindle midzone	-	36	34	-	-	2.98E-03	1.82E-03
InnateDB	BP	GO:0051236	establishment of RNA localization	-	161	147	-	-	6.23E-02	7.65E-03
InnateDB	BP	GO:0051255	spindle midzone assembly	-	14	13	-	-	4.44E-02	7.13E-04
InnateDB	BP	GO:0051259	protein complex oligomerization	-	251	229	-	-	1.92E-02	1.19E-02
InnateDB	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	123	-	-	1.84E-02	6.42E-03
InnateDB	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	2.16E-02	7.13E-04
InnateDB	BP	GO:0051293	establishment of spindle localization	-	57	51	-	-	2.72E-03	2.66E-03
InnateDB	BP	GO:0051299	centrosome separation	-	15	14	-	-	1.80E-03	7.78E-04
InnateDB	BP	GO:0051303	establishment of chromosome localization	-	104	98	-	-	8.02E-03	5.12E-03
InnateDB	BP	GO:0051304	chromosome separation	-	80	80	-	-	1.39E-02	4.15E-03
InnateDB	MF	GO:0051349	positive regulation of lyase activity	-	41	37	-	-	1.03E-03	1.95E-03
InnateDB	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	58	-	-	1.69E-03	3.05E-03
InnateDB	MF	GO:0051378	serotonin binding	-	24	20	-	-	4.36E-02	1.04E-03
InnateDB	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	8.61E-02	8.43E-04
InnateDB	MF	GO:0051427	hormone receptor binding	-	31	27	-	-	1.04E-03	1.43E-03
InnateDB	BP	GO:0051445	regulation of meiotic cell cycle	-	64	56	-	-	7.07E-02	2.92E-03
InnateDB	CC	GO:0051457	maintenance of protein location in nucleus	-	23	22	-	-	5.69E-03	1.17E-03
InnateDB	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.88E-03	7.13E-04
InnateDB	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	147	-	-	5.74E-03	7.65E-03
InnateDB	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	175	-	-	7.81E-03	9.08E-03
InnateDB	MF	GO:0051540	metal cluster binding	-	71	67	-	-	1.13E-02	3.50E-03
InnateDB	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	22	-	-	5.59E-03	1.17E-03
InnateDB	BP	GO:0051588	regulation of neurotransmitter transport	-	99	85	-	-	9.33E-03	4.41E-03
InnateDB	BP	GO:0051602	response to electrical stimulus	-	44	43	-	-	1.06E-03	2.27E-03
InnateDB	BP	GO:0051608	histamine transport	-	14	12	-	-	4.09E-03	6.49E-04
InnateDB	BP	GO:0051651	maintenance of location in cell	-	236	215	-	-	8.70E-03	1.12E-02
InnateDB	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	52	-	-	6.23E-03	2.72E-03
InnateDB	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	2.66E-03	9.73E-04
InnateDB	BP	GO:0051775	response to redox state	-	13	13	-	-	1.60E-02	7.13E-04
InnateDB	BP	GO:0051781	positive regulation of cell division	-	93	84	-	-	4.25E-03	4.41E-03
InnateDB	BP	GO:0051782	negative regulation of cell division	-	18	15	-	-	2.12E-03	7.78E-04
InnateDB	BP	GO:0051784	negative regulation of nuclear division	-	63	61	-	-	1.58E-02	3.18E-03
InnateDB	BP	GO:0051785	positive regulation of nuclear division	-	61	56	-	-	4.05E-03	2.92E-03
InnateDB	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	5.19E-03	1.04E-03
InnateDB	BP	GO:0051798	positive regulation of hair follicle development	-	12	11	-	-	2.40E-03	5.84E-04
InnateDB	MF	GO:0051861	glycolipid binding	-	30	28	-	-	5.22E-03	1.49E-03
InnateDB	BP	GO:0051873	killing by host of symbiont cells	-	28	25	-	-	4.47E-03	1.30E-03
InnateDB	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	1.52E-03	1.10E-03
InnateDB	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	107	-	-	5.03E-03	5.58E-03
InnateDB	BP	GO:0051904	pigment granule transport	-	23	22	-	-	3.73E-02	1.17E-03
InnateDB	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	4.38E-02	7.13E-04
InnateDB	BP	GO:0051931	regulation of sensory perception	-	36	30	-	-	1.21E-02	1.56E-03
InnateDB	BP	GO:0051952	regulation of amine transport	-	98	88	-	-	9.17E-03	4.60E-03
InnateDB	MF	GO:0051959	dynein light intermediate chain binding	-	27	24	-	-	4.55E-02	1.30E-03
InnateDB	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	2.34E-02	1.30E-03
InnateDB	BP	GO:0055006	cardiac cell development	-	93	81	-	-	2.79E-03	4.22E-03
InnateDB	BP	GO:0055017	cardiac muscle tissue growth	-	92	77	-	-	4.87E-03	4.02E-03
InnateDB	CC	GO:0055037	recycling endosome	-	200	183	-	-	7.85E-03	9.53E-03
InnateDB	BP	GO:0055085	transmembrane transport	6.55E-02	1784	1460	1431	1.02	-	-
InnateDB	BP	GO:0055086	nucleobase-containing small molecule metabolic process	6.16E-15	729	661	585	1.13	-	-
InnateDB	BP	GO:0055088	lipid homeostasis	-	173	144	-	-	7.95E-03	7.52E-03
InnateDB	BP	GO:0055093	response to hyperoxia	-	20	19	-	-	1.37E-03	1.04E-03
InnateDB	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	5.18E-03	1.56E-03
InnateDB	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	2.48E-03	1.56E-03
InnateDB	BP	GO:0060004	reflex	-	63	57	-	-	5.11E-03	2.98E-03
InnateDB	BP	GO:0060021	roof of mouth development	-	91	85	-	-	8.69E-03	4.41E-03
InnateDB	BP	GO:0060033	anatomical structure regression	-	16	14	-	-	3.76E-03	7.78E-04
InnateDB	BP	GO:0060037	pharyngeal system development	-	29	27	-	-	8.26E-03	1.43E-03
InnateDB	BP	GO:0060039	pericardium development	-	19	16	-	-	1.69E-03	8.43E-04
InnateDB	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	41	-	-	5.06E-03	2.14E-03
InnateDB	CC	GO:0060076	excitatory synapse	-	64	51	-	-	1.20E-02	2.66E-03
InnateDB	CC	GO:0060077	inhibitory synapse	-	20	15	-	-	2.47E-02	7.78E-04
InnateDB	BP	GO:0060119	inner ear receptor cell development	-	44	35	-	-	3.19E-02	1.82E-03
InnateDB	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	2.74E-03	1.23E-03
InnateDB	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	2.57E-03	9.73E-04
InnateDB	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	19	-	-	6.14E-04	1.04E-03
InnateDB	CC	GO:0060170	ciliary membrane	-	76	59	-	-	4.07E-02	3.11E-03
InnateDB	BP	GO:0060174	limb bud formation	-	11	11	-	-	1.68E-02	5.84E-04
InnateDB	BP	GO:0060251	regulation of glial cell proliferation	-	39	36	-	-	9.52E-04	1.88E-03
InnateDB	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	61	-	-	8.25E-02	3.18E-03
InnateDB	BP	GO:0060306	regulation of membrane repolarization	-	38	30	-	-	1.35E-02	1.56E-03
InnateDB	BP	GO:0060325	face morphogenesis	-	31	30	-	-	1.47E-03	1.56E-03
InnateDB	BP	GO:0060343	trabecula formation	-	26	24	-	-	2.35E-03	1.30E-03
InnateDB	BP	GO:0060384	innervation	-	27	27	-	-	1.50E-02	1.43E-03
InnateDB	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	18	-	-	1.04E-02	9.73E-04
InnateDB	BP	GO:0060411	cardiac septum morphogenesis	-	72	69	-	-	8.08E-03	3.63E-03
InnateDB	BP	GO:0060420	regulation of heart growth	-	74	63	-	-	2.77E-03	3.31E-03
InnateDB	BP	GO:0060428	lung epithelium development	-	43	43	-	-	1.29E-03	2.27E-03
InnateDB	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	4.21E-03	5.84E-04
InnateDB	BP	GO:0060456	positive regulation of digestive system process	-	16	15	-	-	2.57E-04	7.78E-04
InnateDB	BP	GO:0060457	negative regulation of digestive system process	-	17	14	-	-	2.12E-02	7.78E-04
InnateDB	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	1.50E-03	1.49E-03
InnateDB	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	216	-	-	8.58E-03	1.12E-02
InnateDB	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	2.67E-03	1.36E-03
InnateDB	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	3.20E-03	2.66E-03
InnateDB	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	2.64E-03	1.30E-03
InnateDB	BP	GO:0060711	labyrinthine layer development	-	47	45	-	-	1.30E-03	2.33E-03
InnateDB	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	13	-	-	3.75E-03	7.13E-04
InnateDB	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	2.47E-03	1.04E-03
InnateDB	BP	GO:0060856	establishment of blood-brain barrier	-	16	15	-	-	9.10E-03	7.78E-04
InnateDB	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	1.93E-04	5.84E-04
InnateDB	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	19	-	-	5.30E-04	1.04E-03
InnateDB	BP	GO:0060973	cell migration involved in heart development	-	21	17	-	-	3.04E-03	9.08E-04
InnateDB	BP	GO:0060999	positive regulation of dendritic spine development	-	35	34	-	-	1.50E-03	1.82E-03
InnateDB	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	9.67E-04	7.13E-04
InnateDB	BP	GO:0061005	cell differentiation involved in kidney development	-	58	57	-	-	4.85E-03	2.98E-03
InnateDB	BP	GO:0061029	eyelid development in camera-type eye	-	14	13	-	-	1.07E-03	7.13E-04
InnateDB	BP	GO:0061036	positive regulation of cartilage development	-	33	31	-	-	1.88E-02	1.62E-03
InnateDB	BP	GO:0061037	negative regulation of cartilage development	-	32	27	-	-	9.15E-04	1.43E-03
InnateDB	BP	GO:0061101	neuroendocrine cell differentiation	-	16	15	-	-	6.69E-03	7.78E-04
InnateDB	MF	GO:0061134	peptidase regulator activity	-	224	183	-	-	5.79E-03	9.53E-03
InnateDB	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	3.32E-03	3.57E-03
InnateDB	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	15	-	-	1.41E-02	7.78E-04
InnateDB	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	3.97E-02	1.17E-03
InnateDB	BP	GO:0061326	renal tubule development	-	103	98	-	-	4.03E-03	5.12E-03
InnateDB	BP	GO:0061548	ganglion development	-	17	17	-	-	2.36E-02	9.08E-04
InnateDB	BP	GO:0061635	regulation of protein complex stability	-	14	13	-	-	8.04E-04	7.13E-04
InnateDB	CC	GO:0061638	CENP-A containing chromatin	-	18	15	-	-	4.72E-03	7.78E-04
InnateDB	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.47E-03	8.43E-04
InnateDB	CC	GO:0061702	canonical inflammasome complex	-	17	15	-	-	2.03E-01	7.78E-04
InnateDB	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	43	-	-	9.25E-03	2.27E-03
InnateDB	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	7.94E-03	1.69E-03
InnateDB	BP	GO:0061900	glial cell activation	-	56	51	-	-	2.39E-03	2.66E-03
InnateDB	BP	GO:0061952	midbody abscission	-	18	17	-	-	1.21E-01	9.08E-04
InnateDB	MF	GO:0061980	regulatory RNA binding	-	52	45	-	-	1.30E-02	2.33E-03
InnateDB	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	6.09E-03	1.56E-03
InnateDB	BP	GO:0065003	protein-containing complex assembly	3.22E-46	1648	1522	1321	1.15	-	-
InnateDB	BP	GO:0065005	protein-lipid complex assembly	-	29	26	-	-	1.36E-02	1.36E-03
InnateDB	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.31E-02	1.17E-03
InnateDB	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	3.67E-03	3.11E-03
InnateDB	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	6.02E-04	9.08E-04
InnateDB	CC	GO:0070069	cytochrome complex	-	42	33	-	-	3.87E-02	1.75E-03
InnateDB	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	8.35E-03	8.43E-04
InnateDB	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	83	-	-	1.83E-01	4.35E-03
InnateDB	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	26	-	-	2.66E-03	1.36E-03
InnateDB	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	45	-	-	5.31E-03	2.33E-03
InnateDB	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	7.95E-04	1.04E-03
InnateDB	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	3.97E-03	5.84E-04
InnateDB	CC	GO:0070286	axonemal dynein complex assembly	-	40	26	-	-	3.88E-04	1.36E-03
InnateDB	MF	GO:0070300	phosphatidic acid binding	-	20	18	-	-	2.08E-03	9.73E-04
InnateDB	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	1.18E-02	1.04E-03
InnateDB	MF	GO:0070325	lipoprotein particle receptor binding	-	32	31	-	-	6.31E-03	1.62E-03
InnateDB	CC	GO:0070382	exocytic vesicle	-	224	202	-	-	8.99E-03	1.05E-02
InnateDB	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.58E-04	7.78E-04
InnateDB	MF	GO:0070403	NAD+ binding	-	16	15	-	-	9.48E-04	7.78E-04
InnateDB	BP	GO:0070417	cellular response to cold	-	13	12	-	-	5.95E-03	6.49E-04
InnateDB	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	12	-	-	9.97E-03	6.49E-04
InnateDB	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.93E-04	7.13E-04
InnateDB	BP	GO:0070585	protein localization to mitochondrion	-	125	118	-	-	5.77E-03	6.16E-03
InnateDB	MF	GO:0070628	proteasome binding	-	17	17	-	-	3.30E-03	9.08E-04
InnateDB	BP	GO:0070633	transepithelial transport	-	35	33	-	-	1.27E-02	1.75E-03
InnateDB	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	2.03E-01	8.43E-04
InnateDB	MF	GO:0070840	dynein complex binding	-	25	22	-	-	3.39E-03	1.17E-03
InnateDB	MF	GO:0070851	growth factor receptor binding	-	141	135	-	-	5.74E-03	7.00E-03
InnateDB	MF	GO:0070888	E-box binding	-	59	53	-	-	1.04E-02	2.79E-03
InnateDB	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	6.47E-04	8.43E-04
InnateDB	CC	GO:0070971	endoplasmic reticulum exit site	-	32	27	-	-	9.72E-03	1.43E-03
InnateDB	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	67	-	-	6.88E-03	3.50E-03
InnateDB	BP	GO:0070988	demethylation	-	27	26	-	-	6.15E-03	1.36E-03
InnateDB	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	3.06E-01	1.04E-03
InnateDB	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	2.22E-02	6.49E-04
InnateDB	CC	GO:0071013	catalytic step 2 spliceosome	-	88	87	-	-	5.13E-02	4.54E-03
InnateDB	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	4.67E-02	7.78E-04
InnateDB	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	5.78E-02	5.84E-04
InnateDB	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	3.66E-04	7.13E-04
InnateDB	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	17	-	-	1.45E-03	9.08E-04
InnateDB	BP	GO:0071248	cellular response to metal ion	-	201	182	-	-	3.53E-03	9.47E-03
InnateDB	BP	GO:0071300	cellular response to retinoic acid	-	66	61	-	-	2.70E-03	3.18E-03
InnateDB	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	1.89E-03	1.17E-03
InnateDB	BP	GO:0071318	cellular response to ATP	-	18	14	-	-	1.92E-04	7.78E-04
InnateDB	BP	GO:0071320	cellular response to cAMP	-	54	52	-	-	2.20E-02	2.72E-03
InnateDB	BP	GO:0071392	cellular response to estradiol stimulus	-	40	38	-	-	8.40E-03	2.01E-03
InnateDB	BP	GO:0071398	cellular response to fatty acid	-	35	32	-	-	9.93E-04	1.69E-03
InnateDB	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	6.04E-03	1.69E-03
InnateDB	BP	GO:0071453	cellular response to oxygen levels	-	168	150	-	-	5.62E-03	7.78E-03
InnateDB	BP	GO:0071496	cellular response to external stimulus	-	74	74	-	-	4.78E-03	3.89E-03
InnateDB	BP	GO:0071498	cellular response to fluid shear stress	-	21	20	-	-	2.40E-03	1.04E-03
InnateDB	BP	GO:0071501	cellular response to sterol depletion	-	15	14	-	-	7.06E-02	7.78E-04
InnateDB	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	39	-	-	8.38E-02	2.08E-03
InnateDB	BP	GO:0071542	dopaminergic neuron differentiation	-	36	32	-	-	8.83E-03	1.69E-03
InnateDB	BP	GO:0071599	otic vesicle development	-	15	15	-	-	2.59E-02	7.78E-04
InnateDB	CC	GO:0071682	endocytic vesicle lumen	-	23	23	-	-	4.25E-03	1.23E-03
InnateDB	BP	GO:0071709	membrane assembly	-	68	61	-	-	2.21E-02	3.18E-03
InnateDB	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	1.05E-03	9.08E-04
InnateDB	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	3.99E-02	2.20E-03
InnateDB	BP	GO:0071800	podosome assembly	-	19	19	-	-	8.25E-04	1.04E-03
InnateDB	BP	GO:0071806	protein transmembrane transport	-	68	64	-	-	2.15E-02	3.37E-03
InnateDB	MF	GO:0071814	protein-lipid complex binding	-	52	46	-	-	2.43E-02	2.40E-03
InnateDB	CC	GO:0071819	DUBm complex	-	25	22	-	-	1.47E-01	1.17E-03
InnateDB	BP	GO:0071827	plasma lipoprotein particle organization	-	86	72	-	-	3.37E-02	3.76E-03
InnateDB	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	58	-	-	1.43E-03	3.05E-03
InnateDB	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	2.43E-03	5.84E-04
InnateDB	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	4.09E-03	1.56E-03
InnateDB	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.52E-03	1.82E-03
InnateDB	MF	GO:0071933	Arp2/3 complex binding	-	14	13	-	-	1.93E-04	7.13E-04
InnateDB	BP	GO:0071985	multivesicular body sorting pathway	-	56	52	-	-	5.53E-02	2.72E-03
InnateDB	BP	GO:0072044	collecting duct development	-	16	15	-	-	2.56E-04	7.78E-04
InnateDB	BP	GO:0072091	regulation of stem cell proliferation	-	91	76	-	-	2.19E-03	3.96E-03
InnateDB	BP	GO:0072132	mesenchyme morphogenesis	-	57	56	-	-	4.74E-03	2.92E-03
InnateDB	BP	GO:0072164	mesonephric tubule development	-	98	92	-	-	1.43E-02	4.80E-03
InnateDB	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	1.02E-03	1.36E-03
InnateDB	BP	GO:0072176	nephric duct development	-	15	15	-	-	1.72E-02	7.78E-04
InnateDB	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	24	-	-	3.22E-04	1.30E-03
InnateDB	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	9.83E-03	7.78E-04
InnateDB	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	5.59E-04	7.78E-04
InnateDB	BP	GO:0072523	purine-containing compound catabolic process	-	146	135	-	-	3.66E-03	7.00E-03
InnateDB	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	24	-	-	3.22E-04	1.30E-03
InnateDB	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	92	-	-	2.81E-03	4.80E-03
InnateDB	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	32	-	-	8.38E-03	1.69E-03
InnateDB	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	25	-	-	3.85E-04	1.30E-03
InnateDB	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	11	-	-	1.94E-04	5.84E-04
InnateDB	BP	GO:0072537	fibroblast activation	-	13	13	-	-	2.03E-02	7.13E-04
InnateDB	CC	GO:0072562	blood microparticle	-	144	124	-	-	1.45E-02	6.49E-03
InnateDB	CC	GO:0072595	maintenance of protein localization in organelle	-	42	40	-	-	2.30E-03	2.08E-03
InnateDB	BP	GO:0072659	protein localization to plasma membrane	5.73E-13	284	270	228	1.19	-	-
InnateDB	BP	GO:0072662	protein localization to peroxisome	-	20	19	-	-	1.25E-01	1.04E-03
InnateDB	BP	GO:0072665	protein localization to vacuole	-	84	76	-	-	1.25E-02	3.96E-03
InnateDB	BP	GO:0072710	response to hydroxyurea	-	12	11	-	-	1.50E-02	5.84E-04
InnateDB	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	13	-	-	4.73E-03	7.13E-04
InnateDB	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	26	-	-	3.83E-04	1.36E-03
InnateDB	BP	GO:0085029	extracellular matrix assembly	-	42	39	-	-	4.75E-03	2.08E-03
InnateDB	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	33	-	-	1.03E-01	1.75E-03
InnateDB	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	1.88E-03	7.13E-04
InnateDB	BP	GO:0090068	positive regulation of cell cycle process	-	262	235	-	-	6.55E-03	1.22E-02
InnateDB	BP	GO:0090077	foam cell differentiation	-	39	37	-	-	4.95E-03	1.95E-03
InnateDB	BP	GO:0090087	regulation of peptide transport	-	195	177	-	-	4.02E-03	9.21E-03
InnateDB	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	137	-	-	7.18E-03	7.13E-03
InnateDB	BP	GO:0090102	cochlea development	-	50	44	-	-	3.73E-03	2.33E-03
InnateDB	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	7.41E-02	7.78E-04
InnateDB	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	2.28E-02	1.10E-03
InnateDB	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	30	-	-	1.41E-02	1.56E-03
InnateDB	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	1.93E-04	7.13E-04
InnateDB	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	3.05E-03	5.84E-04
InnateDB	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	2.54E-04	9.73E-04
InnateDB	BP	GO:0090235	regulation of metaphase plate congression	-	13	12	-	-	7.90E-03	6.49E-04
InnateDB	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	2.69E-02	1.56E-03
InnateDB	BP	GO:0090399	replicative senescence	-	17	14	-	-	2.09E-03	7.78E-04
InnateDB	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	28	-	-	3.87E-04	1.49E-03
InnateDB	CC	GO:0090543	Flemming body	-	33	31	-	-	1.08E-02	1.62E-03
InnateDB	BP	GO:0090559	regulation of membrane permeability	-	72	60	-	-	6.15E-03	3.11E-03
InnateDB	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	13	-	-	1.87E-03	7.13E-04
InnateDB	BP	GO:0090596	sensory organ morphogenesis	-	272	236	-	-	7.68E-03	1.23E-02
InnateDB	CC	GO:0090660	cerebrospinal fluid circulation	-	15	11	-	-	1.94E-04	5.84E-04
InnateDB	CC	GO:0090665	glycoprotein complex	-	23	22	-	-	5.41E-02	1.17E-03
InnateDB	BP	GO:0090713	immunological memory process	-	18	17	-	-	9.47E-02	9.08E-04
InnateDB	CC	GO:0090734	site of DNA damage	-	118	115	-	-	1.02E-02	5.97E-03
InnateDB	CC	GO:0090741	pigment granule membrane	-	21	19	-	-	2.57E-04	1.04E-03
InnateDB	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	18	-	-	4.56E-04	9.73E-04
InnateDB	BP	GO:0097094	craniofacial suture morphogenesis	-	18	16	-	-	3.34E-03	8.43E-04
InnateDB	MF	GO:0097110	scaffold protein binding	-	66	65	-	-	2.96E-03	3.37E-03
InnateDB	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	188	-	-	9.08E-03	9.79E-03
InnateDB	BP	GO:0097154	GABAergic neuron differentiation	-	20	18	-	-	2.57E-04	9.73E-04
InnateDB	BP	GO:0097164	ammonium ion metabolic process	-	23	19	-	-	2.58E-04	1.04E-03
InnateDB	BP	GO:0097186	amelogenesis	-	26	19	-	-	6.67E-04	1.04E-03
InnateDB	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	222	-	-	1.01E-02	1.15E-02
InnateDB	BP	GO:0097212	lysosomal membrane organization	-	15	14	-	-	6.28E-02	7.78E-04
InnateDB	CC	GO:0097228	sperm principal piece	-	33	20	-	-	1.87E-02	1.04E-03
InnateDB	BP	GO:0097264	self proteolysis	-	12	11	-	-	1.92E-04	5.84E-04
InnateDB	BP	GO:0097306	cellular response to alcohol	-	99	87	-	-	2.99E-03	4.54E-03
InnateDB	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	9.11E-04	5.84E-04
InnateDB	CC	GO:0097381	photoreceptor disc membrane	-	25	15	-	-	9.63E-03	7.78E-04
InnateDB	BP	GO:0097384	cellular lipid biosynthetic process	-	11	11	-	-	1.93E-04	5.84E-04
InnateDB	CC	GO:0097386	glial cell projection	-	38	35	-	-	9.12E-04	1.82E-03
InnateDB	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	9.48E-02	8.43E-04
InnateDB	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	3.23E-03	6.49E-04
InnateDB	CC	GO:0097470	ribbon synapse	-	13	13	-	-	1.18E-03	7.13E-04
InnateDB	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	118	-	-	1.46E-02	6.16E-03
InnateDB	CC	GO:0097540	axonemal central pair	-	161	120	-	-	2.57E-03	6.23E-03
InnateDB	CC	GO:0097542	ciliary tip	-	48	47	-	-	2.15E-02	2.46E-03
InnateDB	CC	GO:0097545	axonemal outer doublet	-	164	121	-	-	2.30E-03	6.29E-03
InnateDB	CC	GO:0097546	ciliary base	-	47	42	-	-	4.61E-03	2.20E-03
InnateDB	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	7.53E-04	7.13E-04
InnateDB	BP	GO:0097581	lamellipodium organization	-	91	85	-	-	7.36E-03	4.41E-03
InnateDB	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	5.89E-03	1.36E-03
InnateDB	BP	GO:0097722	sperm motility	-	133	92	-	-	8.01E-03	4.80E-03
InnateDB	BP	GO:0098542	defense response to other organism	1.50E-12	1171	1028	939	1.09	-	-
InnateDB	BP	GO:0098543	detection of other organism	-	19	17	-	-	5.45E-02	9.08E-04
InnateDB	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	24	-	-	2.02E-02	1.30E-03
InnateDB	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	13	-	-	7.66E-03	7.13E-04
InnateDB	MF	GO:0098631	cell adhesion mediator activity	-	64	58	-	-	1.27E-02	3.05E-03
InnateDB	CC	GO:0098636	protein complex involved in cell adhesion	-	57	54	-	-	3.00E-02	2.85E-03
InnateDB	CC	GO:0098643	banded collagen fibril	-	12	11	-	-	3.04E-03	5.84E-04
InnateDB	BP	GO:0098661	inorganic anion transmembrane transport	-	140	107	-	-	8.48E-03	5.58E-03
InnateDB	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	20	-	-	4.78E-02	1.04E-03
InnateDB	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	88	-	-	2.00E-02	4.60E-03
InnateDB	CC	GO:0098691	dopaminergic synapse	-	15	13	-	-	4.86E-03	7.13E-04
InnateDB	BP	GO:0098743	cell aggregation	-	24	22	-	-	1.08E-03	1.17E-03
InnateDB	BP	GO:0098751	bone cell development	-	18	16	-	-	1.89E-03	8.43E-04
InnateDB	BP	GO:0098754	detoxification	2.18E-02	134	118	107	1.10	-	-
InnateDB	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	2.71E-03	1.10E-03
InnateDB	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	21	-	-	1.22E-01	1.10E-03
InnateDB	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	99	-	-	5.11E-02	5.19E-03
InnateDB	CC	GO:0098803	respiratory chain complex	-	39	31	-	-	1.66E-02	1.62E-03
InnateDB	CC	GO:0098810	neurotransmitter reuptake	-	35	31	-	-	7.68E-03	1.62E-03
InnateDB	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	7.81E-03	7.78E-04
InnateDB	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	3.54E-03	7.78E-04
InnateDB	CC	GO:0098862	cluster of actin-based cell projections	-	162	135	-	-	1.70E-02	7.00E-03
InnateDB	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	141	-	-	2.10E-02	7.33E-03
InnateDB	CC	GO:0098918	structural constituent of synapse	-	27	25	-	-	4.50E-03	1.30E-03
InnateDB	CC	GO:0098926	postsynaptic signal transduction	-	39	33	-	-	2.50E-03	1.75E-03
InnateDB	CC	GO:0098982	GABA-ergic synapse	-	84	71	-	-	1.33E-03	3.70E-03
InnateDB	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	207	-	-	2.39E-02	1.08E-02
InnateDB	BP	GO:0099022	vesicle tethering	-	32	31	-	-	3.14E-01	1.62E-03
InnateDB	BP	GO:0099054	presynapse assembly	-	49	38	-	-	1.44E-03	2.01E-03
InnateDB	BP	GO:0099068	postsynapse assembly	-	40	35	-	-	1.36E-02	1.82E-03
InnateDB	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	75	-	-	4.97E-03	3.89E-03
InnateDB	BP	GO:0099084	postsynaptic specialization organization	-	44	40	-	-	1.50E-02	2.08E-03
InnateDB	CC	GO:0099086	synaptonemal structure	-	40	30	-	-	1.37E-02	1.56E-03
InnateDB	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	1.19E-03	8.43E-04
InnateDB	BP	GO:0099118	microtubule-based protein transport	-	14	13	-	-	6.89E-03	7.13E-04
InnateDB	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	15	-	-	2.57E-04	7.78E-04
InnateDB	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	18	-	-	1.48E-03	9.73E-04
InnateDB	CC	GO:0099522	cytosolic region	-	20	20	-	-	5.86E-04	1.04E-03
InnateDB	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	137	-	-	1.29E-02	7.13E-03
InnateDB	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	4.37E-02	6.49E-04
InnateDB	CC	GO:0099571	postsynaptic cytoskeleton	-	18	16	-	-	1.54E-02	8.43E-04
InnateDB	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	110	-	-	2.10E-02	5.71E-03
InnateDB	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	19	-	-	1.30E-02	1.04E-03
InnateDB	BP	GO:0099637	neurotransmitter receptor transport	-	26	22	-	-	3.06E-03	1.17E-03
InnateDB	CC	GO:0099643	signal release from synapse	-	147	128	-	-	1.47E-02	6.68E-03
InnateDB	BP	GO:0106027	neuron projection organization	-	90	88	-	-	2.31E-03	4.60E-03
InnateDB	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	5.56E-03	9.08E-04
InnateDB	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	3.03E-03	1.30E-03
InnateDB	BP	GO:0110154	RNA decapping	-	19	16	-	-	5.23E-02	8.43E-04
InnateDB	BP	GO:0120009	intermembrane lipid transfer	-	52	47	-	-	6.36E-03	2.46E-03
InnateDB	CC	GO:0120111	neuron projection cytoplasm	-	94	91	-	-	1.91E-02	4.73E-03
InnateDB	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	97	-	-	2.59E-03	5.06E-03
InnateDB	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	45	-	-	2.08E-03	2.33E-03
InnateDB	MF	GO:0120227	acyl-CoA binding	-	22	20	-	-	9.09E-03	1.04E-03
InnateDB	BP	GO:0120255	olefinic compound biosynthetic process	-	24	21	-	-	1.55E-03	1.10E-03
InnateDB	CC	GO:0120293	dynein axonemal particle	-	20	17	-	-	1.11E-03	9.08E-04
InnateDB	BP	GO:0120305	regulation of pigmentation	-	15	13	-	-	6.12E-03	7.13E-04
InnateDB	BP	GO:0140013	meiotic nuclear division	1.90E-02	279	239	224	1.07	-	-
InnateDB	MF	GO:0140030	modification-dependent protein binding	-	179	173	-	-	6.66E-03	9.01E-03
InnateDB	BP	GO:0140053	mitochondrial gene expression	2.94E-13	164	162	132	1.23	-	-
InnateDB	MF	GO:0140096	"catalytic activity, acting on a protein"	8.16E-54	3198	2863	2564	1.12	-	-
InnateDB	MF	GO:0140097	"catalytic activity, acting on DNA"	1.77E-22	383	371	307	1.21	-	-
InnateDB	MF	GO:0140098	"catalytic activity, acting on RNA"	6.52E-13	417	387	334	1.16	-	-
InnateDB	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	15	-	-	2.59E-04	7.78E-04
InnateDB	MF	GO:0140104	molecular carrier activity	3.21E-06	105	101	84	1.20	-	-
InnateDB	MF	GO:0140110	transcription regulator activity	3.32E-25	2033	1797	1630	1.10	-	-
InnateDB	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.88E-03	1.23E-03
InnateDB	BP	GO:0140115	export across plasma membrane	-	82	58	-	-	2.81E-02	3.05E-03
InnateDB	MF	GO:0140223	general transcription initiation factor activity	-	55	50	-	-	3.54E-01	2.59E-03
InnateDB	CC	GO:0140238	presynaptic endocytosis	-	72	70	-	-	8.43E-03	3.63E-03
InnateDB	CC	GO:0140239	postsynaptic endocytosis	-	23	22	-	-	8.26E-03	1.17E-03
InnateDB	BP	GO:0140253	cell-cell fusion	-	62	55	-	-	1.76E-02	2.85E-03
InnateDB	MF	GO:0140272	exogenous protein binding	-	79	74	-	-	3.81E-03	3.89E-03
InnateDB	MF	GO:0140299	small molecule sensor activity	-	39	31	-	-	4.38E-02	1.62E-03
InnateDB	MF	GO:0140311	protein sequestering activity	-	14	12	-	-	5.08E-04	6.49E-04
InnateDB	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	3.39E-02	1.04E-03
InnateDB	MF	GO:0140318	protein transporter activity	-	40	39	-	-	2.69E-02	2.08E-03
InnateDB	MF	GO:0140416	transcription regulator inhibitor activity	-	26	25	-	-	2.01E-03	1.30E-03
InnateDB	MF	GO:0140457	protein demethylase activity	-	31	28	-	-	1.31E-03	1.49E-03
InnateDB	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	9.75E-03	2.14E-03
InnateDB	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	9.93E-04	7.13E-04
InnateDB	CC	GO:0140632	canonical inflammasome complex assembly	-	40	35	-	-	2.25E-02	1.82E-03
InnateDB	MF	GO:0140657	ATP-dependent activity	4.07E-26	729	684	585	1.17	-	-
InnateDB	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	8.14E-03	1.88E-03
InnateDB	MF	GO:0140666	annealing activity	-	11	11	-	-	3.48E-03	5.84E-04
InnateDB	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	69	-	-	8.34E-03	3.63E-03
InnateDB	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	5.55E-03	9.08E-04
InnateDB	MF	GO:0141047	molecular tag activity	-	13	12	-	-	2.50E-04	6.49E-04
InnateDB	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	81	-	-	2.55E-02	4.22E-03
InnateDB	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	19	-	-	4.81E-02	1.04E-03
InnateDB	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	4.89E-03	1.82E-03
InnateDB	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	3.48E-03	1.62E-03
InnateDB	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	57	-	-	2.50E-03	2.98E-03
InnateDB	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	65	-	-	1.36E-02	3.37E-03
InnateDB	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	3.36E-02	9.08E-04
InnateDB	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	16	-	-	2.58E-04	8.43E-04
InnateDB	MF	GO:0170055	lipid transmembrane transporter activity	-	56	45	-	-	1.57E-02	2.33E-03
InnateDB	BP	GO:1900006	positive regulation of dendrite development	-	17	16	-	-	3.16E-03	8.43E-04
InnateDB	BP	GO:1900047	negative regulation of hemostasis	-	51	49	-	-	2.72E-02	2.59E-03
InnateDB	BP	GO:1900048	positive regulation of hemostasis	-	28	27	-	-	2.70E-02	1.43E-03
InnateDB	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	5.96E-03	7.13E-04
InnateDB	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	16	-	-	2.87E-03	8.43E-04
InnateDB	MF	GO:1900121	negative regulation of receptor binding	-	13	12	-	-	3.03E-03	6.49E-04
InnateDB	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	5.25E-04	6.49E-04
InnateDB	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	4.96E-02	9.73E-04
InnateDB	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	13	-	-	7.17E-03	7.13E-04
InnateDB	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	21	-	-	2.25E-03	1.10E-03
InnateDB	BP	GO:1901096	regulation of autophagosome maturation	-	17	16	-	-	4.78E-03	8.43E-04
InnateDB	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	34	-	-	1.37E-03	1.82E-03
InnateDB	BP	GO:1901142	insulin metabolic process	-	14	12	-	-	6.72E-03	6.49E-04
InnateDB	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	5.65E-03	1.62E-03
InnateDB	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	25	-	-	1.49E-03	1.30E-03
InnateDB	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	66	-	-	2.10E-03	3.44E-03
InnateDB	BP	GO:1901343	negative regulation of vasculature development	-	154	103	-	-	1.26E-02	5.38E-03
InnateDB	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	39	-	-	5.11E-04	2.08E-03
InnateDB	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	39	-	-	3.88E-03	2.08E-03
InnateDB	BP	GO:1901606	alpha-amino acid catabolic process	-	101	89	-	-	1.32E-02	4.67E-03
InnateDB	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	64	-	-	1.60E-03	3.37E-03
InnateDB	MF	GO:1901611	phosphatidylglycerol binding	-	15	14	-	-	2.68E-03	7.78E-04
InnateDB	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	53	-	-	7.00E-04	2.79E-03
InnateDB	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	225	-	-	1.59E-02	1.17E-02
InnateDB	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	39	-	-	5.15E-04	2.08E-03
InnateDB	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.93E-04	5.84E-04
InnateDB	BP	GO:1901655	cellular response to ketone	-	107	101	-	-	3.18E-03	5.25E-03
InnateDB	BP	GO:1901679	nucleotide transmembrane transport	-	32	27	-	-	3.83E-04	1.43E-03
InnateDB	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	45	-	-	6.40E-04	2.33E-03
InnateDB	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	3.30E-04	7.78E-04
InnateDB	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	28	-	-	1.81E-03	1.49E-03
InnateDB	BP	GO:1901857	positive regulation of cellular respiration	-	13	12	-	-	1.96E-03	6.49E-04
InnateDB	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.91E-04	7.13E-04
InnateDB	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	9.99E-04	1.30E-03
InnateDB	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	92	-	-	2.41E-03	4.80E-03
InnateDB	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	138	-	-	4.48E-03	7.20E-03
InnateDB	BP	GO:1901890	positive regulation of cell junction assembly	-	106	90	-	-	4.59E-03	4.67E-03
InnateDB	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	2.46E-02	9.73E-04
InnateDB	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	1.12E-03	1.30E-03
InnateDB	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	23	-	-	6.08E-03	1.23E-03
InnateDB	BP	GO:1902115	regulation of organelle assembly	-	210	193	-	-	6.78E-03	1.01E-02
InnateDB	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	69	-	-	4.43E-03	3.63E-03
InnateDB	BP	GO:1902414	protein localization to cell junction	-	107	97	-	-	8.81E-03	5.06E-03
InnateDB	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	26	-	-	2.74E-02	1.36E-03
InnateDB	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	2.89E-02	2.53E-03
InnateDB	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	33	-	-	1.30E-03	1.75E-03
InnateDB	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.97E-03	1.17E-03
InnateDB	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	2.98E-03	2.66E-03
InnateDB	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	15	-	-	1.25E-03	7.78E-04
InnateDB	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	22	-	-	1.18E-03	1.17E-03
InnateDB	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	22	-	-	2.18E-03	1.17E-03
InnateDB	BP	GO:1903008	organelle disassembly	-	154	148	-	-	1.08E-02	7.72E-03
InnateDB	BP	GO:1903035	negative regulation of response to wounding	-	93	86	-	-	1.06E-02	4.47E-03
InnateDB	BP	GO:1903036	positive regulation of response to wounding	-	76	68	-	-	8.83E-03	3.57E-03
InnateDB	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	2.87E-03	1.49E-03
InnateDB	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	2.47E-02	5.84E-04
InnateDB	BP	GO:1903242	regulation of cardiac muscle hypertrophy in response to stress	-	18	12	-	-	2.28E-02	6.49E-04
InnateDB	CC	GO:1903293	phosphatase complex	-	54	52	-	-	2.86E-02	2.72E-03
InnateDB	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	136	-	-	3.50E-02	7.07E-03
InnateDB	BP	GO:1903318	negative regulation of protein maturation	-	29	27	-	-	7.85E-03	1.43E-03
InnateDB	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.25E-03	1.43E-03
InnateDB	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	7.38E-03	9.08E-04
InnateDB	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	25	-	-	2.00E-03	1.30E-03
InnateDB	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	14	-	-	1.89E-04	7.78E-04
InnateDB	BP	GO:1903509	liposaccharide metabolic process	-	109	88	-	-	6.25E-02	4.60E-03
InnateDB	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	5.11E-02	1.49E-03
InnateDB	BP	GO:1903523	negative regulation of blood circulation	-	27	25	-	-	3.70E-03	1.30E-03
InnateDB	BP	GO:1903524	positive regulation of blood circulation	-	39	34	-	-	8.29E-04	1.82E-03
InnateDB	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	41	-	-	2.86E-03	2.14E-03
InnateDB	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	3.05E-03	6.49E-04
InnateDB	BP	GO:1903707	negative regulation of hemopoiesis	-	116	102	-	-	3.32E-03	5.32E-03
InnateDB	BP	GO:1903708	positive regulation of hemopoiesis	-	184	176	-	-	9.89E-03	9.14E-03
InnateDB	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	3.29E-03	9.08E-04
InnateDB	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	32	-	-	3.31E-02	1.69E-03
InnateDB	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	3.30E-03	6.49E-04
InnateDB	BP	GO:1903975	regulation of glial cell migration	-	20	17	-	-	4.41E-03	9.08E-04
InnateDB	BP	GO:1904018	positive regulation of vasculature development	-	185	160	-	-	1.41E-02	8.30E-03
InnateDB	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	92	-	-	5.35E-03	4.80E-03
InnateDB	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	95	-	-	2.85E-03	4.93E-03
InnateDB	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	15	-	-	2.19E-03	7.78E-04
InnateDB	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	3.76E-02	5.84E-04
InnateDB	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	5.83E-01	7.78E-04
InnateDB	BP	GO:1904646	cellular response to amyloid-beta	-	44	40	-	-	9.23E-04	2.08E-03
InnateDB	CC	GO:1904724	tertiary granule lumen	-	55	54	-	-	2.33E-03	2.85E-03
InnateDB	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	123	-	-	5.06E-03	6.42E-03
InnateDB	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	9.03E-02	7.78E-04
InnateDB	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	28	-	-	1.79E-03	1.49E-03
InnateDB	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	50	-	-	1.70E-02	2.59E-03
InnateDB	BP	GO:1905145	cellular response to acetylcholine	-	33	27	-	-	4.14E-03	1.43E-03
InnateDB	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.93E-04	7.13E-04
InnateDB	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	12	-	-	1.84E-04	6.49E-04
InnateDB	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	14	-	-	6.24E-03	7.78E-04
InnateDB	CC	GO:1905348	endonuclease complex	-	38	36	-	-	1.44E-01	1.88E-03
InnateDB	CC	GO:1905360	GTPase complex	-	41	39	-	-	1.75E-01	2.08E-03
InnateDB	CC	GO:1905368	peptidase complex	-	124	117	-	-	9.12E-02	6.10E-03
InnateDB	BP	GO:1905874	regulation of postsynaptic density organization	-	13	11	-	-	1.19E-02	5.84E-04
InnateDB	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	1.09E-02	6.49E-04
InnateDB	BP	GO:1905953	negative regulation of lipid localization	-	63	44	-	-	2.65E-03	2.33E-03
InnateDB	BP	GO:1905954	positive regulation of lipid localization	-	110	100	-	-	7.05E-03	5.19E-03
InnateDB	BP	GO:1905962	glutamatergic neuron differentiation	-	14	12	-	-	1.93E-04	6.49E-04
InnateDB	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	4.94E-02	5.84E-04
InnateDB	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	2.18E-01	5.84E-04
InnateDB	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.94E-01	5.84E-04
InnateDB	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	11	-	-	2.02E-03	5.84E-04
InnateDB	CC	GO:1990204	oxidoreductase complex	-	90	78	-	-	2.71E-02	4.09E-03
InnateDB	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	7.80E-04	7.78E-04
InnateDB	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	17	-	-	7.30E-02	9.08E-04
InnateDB	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	1.65E-03	5.84E-04
InnateDB	CC	GO:1990391	DNA repair complex	-	22	22	-	-	1.31E-02	1.17E-03
InnateDB	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	31	-	-	4.95E-03	1.62E-03
InnateDB	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	2.02E-03	6.49E-04
InnateDB	BP	GO:1990542	mitochondrial transmembrane transport	-	93	80	-	-	4.08E-02	4.15E-03
InnateDB	CC	GO:1990752	microtubule end	-	34	34	-	-	2.83E-02	1.82E-03
InnateDB	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	64	-	-	2.67E-02	3.37E-03
InnateDB	BP	GO:1990840	response to lectin	-	22	20	-	-	4.96E-03	1.04E-03
InnateDB	BP	GO:1990845	adaptive thermogenesis	-	166	159	-	-	4.54E-03	8.30E-03
InnateDB	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	3.57E-03	7.13E-04
InnateDB	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	156	-	-	3.77E-03	8.11E-03
InnateDB	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	5.92E-03	9.08E-04
InnateDB	BP	GO:2000169	regulation of peptidyl-cysteine S-nitrosylation	-	11	11	-	-	3.52E-03	5.84E-04
InnateDB	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	84	-	-	4.26E-03	4.41E-03
InnateDB	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	3.31E-03	1.30E-03
InnateDB	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	6.70E-04	9.08E-04
InnateDB	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	29	-	-	7.04E-04	1.56E-03
InnateDB	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	45	-	-	2.35E-03	2.33E-03
InnateDB	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	37	-	-	1.45E-02	1.95E-03
InnateDB	BP	GO:2000291	regulation of myoblast proliferation	-	25	19	-	-	1.87E-03	1.04E-03
InnateDB	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	31	-	-	1.26E-02	1.62E-03
InnateDB	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	73	-	-	1.96E-02	3.83E-03
InnateDB	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	2.17E-03	1.30E-03
InnateDB	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	5.51E-03	4.02E-03
InnateDB	BP	GO:2000773	negative regulation of cellular senescence	-	25	20	-	-	9.25E-04	1.04E-03
InnateDB	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	1.54E-03	6.49E-04
InnateDB	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	6.02E-04	1.04E-03
InnateDB	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	1.06E-02	7.13E-04
InnateDB	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	1.68E-03	7.13E-04
InnateDB	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	79	-	-	2.82E-03	4.15E-03
InnateDB	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	8.04E-03	8.43E-04
InnateDB	BP	GO:2001222	regulation of neuron migration	-	46	41	-	-	1.11E-03	2.14E-03
InnateDB	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	223	-	-	5.95E-03	1.16E-02
InnateDB	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	59	-	-	2.40E-03	3.11E-03
IntAct	CC	GO:0005739	mitochondrion	1.00E-34	1671	1616	1483	1.09	-	-
IntAct	CC	GO:0005815	microtubule organizing center	1.20E-25	843	827	748	1.11	-	-
IntAct	CC	GO:0005730	nucleolus	2.45E-25	988	963	877	1.10	-	-
IntAct	CC	GO:0005615	extracellular space	2.90E-23	3190	2984	2831	1.05	-	-
IntAct	CC	GO:0005768	endosome	3.05E-18	1037	997	920	1.08	-	-
IntAct	CC	GO:0005783	endoplasmic reticulum	1.11E-16	2020	1897	1793	1.06	-	-
IntAct	CC	GO:0005764	lysosome	2.31E-15	747	722	663	1.09	-	-
IntAct	CC	GO:0005794	Golgi apparatus	1.78E-10	1636	1526	1452	1.05	-	-
IntAct	CC	GO:0005635	nuclear envelope	3.12E-10	493	476	438	1.09	-	-
IntAct	CC	GO:0005840	ribosome	2.51E-09	222	220	197	1.12	-	-
IntAct	CC	GO:0000228	nuclear chromosome	8.24E-05	206	199	183	1.09	-	-
IntAct	CC	GO:0005777	peroxisome	4.31E-04	142	138	126	1.09	-	-
IntAct	CC	GO:0005811	lipid droplet	4.02E-02	102	97	91	1.07	-	-
IntAct	CC	GO:0005929	cilium	8.35E-02	842	763	747	1.02	-	-
IntAct	CC	GO:0031012	extracellular matrix	1.76E-01	564	511	501	1.02	-	-
IntAct	BP	GO:0050877	nervous system process	6.78E-105	1527	1058	1355	0.78	-	-
IntAct	BP	GO:0016192	vesicle-mediated transport	1.32E-41	1894	1835	1681	1.09	-	-
IntAct	BP	GO:0007010	cytoskeleton organization	2.55E-33	1639	1584	1455	1.09	-	-
IntAct	BP	GO:0006355	regulation of DNA-templated transcription	2.55E-27	3342	3135	2966	1.06	-	-
IntAct	BP	GO:0012501	programmed cell death	1.72E-25	1954	1860	1734	1.07	-	-
IntAct	BP	GO:0048870	cell motility	6.46E-22	1659	1580	1473	1.07	-	-
IntAct	BP	GO:0006914	autophagy	6.35E-21	568	561	504	1.11	-	-
IntAct	BP	GO:0006886	intracellular protein transport	7.58E-21	664	652	589	1.11	-	-
IntAct	BP	GO:0006281	DNA repair	7.79E-21	587	579	521	1.11	-	-
IntAct	BP	GO:0007155	cell adhesion	6.08E-19	1444	1375	1282	1.07	-	-
IntAct	BP	GO:0030163	protein catabolic process	1.44E-17	990	952	879	1.08	-	-
IntAct	BP	GO:0016071	mRNA metabolic process	3.67E-17	713	693	633	1.10	-	-
IntAct	BP	GO:0065003	protein-containing complex assembly	9.41E-17	1648	1557	1463	1.06	-	-
IntAct	BP	GO:0002376	immune system process	4.00E-16	2448	2285	2173	1.05	-	-
IntAct	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.25E-14	729	704	647	1.09	-	-
IntAct	BP	GO:0007005	mitochondrion organization	1.76E-14	484	474	430	1.10	-	-
IntAct	BP	GO:0006091	generation of precursor metabolites and energy	9.57E-14	502	490	446	1.10	-	-
IntAct	BP	GO:0007059	chromosome segregation	1.39E-11	403	394	358	1.10	-	-
IntAct	BP	GO:0034330	cell junction organization	1.77E-11	727	696	645	1.08	-	-
IntAct	BP	GO:0072659	protein localization to plasma membrane	3.09E-11	284	281	252	1.11	-	-
IntAct	BP	GO:0042254	ribosome biogenesis	5.30E-11	297	293	264	1.11	-	-
IntAct	BP	GO:0006913	nucleocytoplasmic transport	1.34E-10	326	320	289	1.11	-	-
IntAct	BP	GO:0042060	wound healing	1.66E-09	431	417	383	1.09	-	-
IntAct	BP	GO:0006260	DNA replication	2.59E-09	279	274	248	1.11	-	-
IntAct	BP	GO:0007018	microtubule-based movement	3.33E-08	640	608	568	1.07	-	-
IntAct	BP	GO:0006520	amino acid metabolic process	1.09E-07	292	284	259	1.10	-	-
IntAct	BP	GO:0003012	muscle system process	3.37E-07	425	407	377	1.08	-	-
IntAct	BP	GO:0007163	establishment or maintenance of cell polarity	6.75E-07	227	222	201	1.10	-	-
IntAct	BP	GO:0006310	DNA recombination	6.85E-07	333	321	296	1.09	-	-
IntAct	BP	GO:0006629	lipid metabolic process	1.06E-06	1355	1255	1203	1.04	-	-
IntAct	BP	GO:0140053	mitochondrial gene expression	1.28E-06	164	162	146	1.11	-	-
IntAct	BP	GO:0006954	inflammatory response	1.64E-05	820	764	728	1.05	-	-
IntAct	BP	GO:0044782	cilium organization	1.86E-05	399	379	354	1.07	-	-
IntAct	BP	GO:0002181	cytoplasmic translation	2.77E-05	153	150	136	1.10	-	-
IntAct	BP	GO:0005975	carbohydrate metabolic process	5.00E-05	551	517	489	1.06	-	-
IntAct	BP	GO:0006399	tRNA metabolic process	5.32E-05	196	190	174	1.09	-	-
IntAct	BP	GO:0098542	defense response to other organism	8.72E-05	1171	1079	1039	1.04	-	-
IntAct	BP	GO:0006790	sulfur compound metabolic process	1.55E-04	320	304	284	1.07	-	-
IntAct	BP	GO:0006325	chromatin organization	1.82E-04	720	669	639	1.05	-	-
IntAct	BP	GO:0003013	circulatory system process	3.98E-04	584	544	518	1.05	-	-
IntAct	BP	GO:0006457	protein folding	5.81E-04	210	201	186	1.08	-	-
IntAct	BP	GO:0055085	transmembrane transport	9.21E-04	1784	1625	1583	1.03	-	-
IntAct	BP	GO:0000910	cytokinesis	3.33E-03	186	177	165	1.07	-	-
IntAct	BP	GO:0006486	protein glycosylation	7.55E-03	225	212	200	1.06	-	-
IntAct	BP	GO:0140013	meiotic nuclear division	9.57E-03	279	261	248	1.05	-	-
IntAct	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.23E-02	119	114	106	1.08	-	-
IntAct	BP	GO:0030198	extracellular matrix organization	1.47E-02	314	292	279	1.05	-	-
IntAct	BP	GO:0003014	renal system process	1.59E-02	127	121	113	1.07	-	-
IntAct	BP	GO:0098754	detoxification	2.69E-02	134	127	119	1.07	-	-
IntAct	BP	GO:0007040	lysosome organization	3.02E-02	107	102	95	1.07	-	-
IntAct	BP	GO:0006766	vitamin metabolic process	6.53E-02	107	101	95	1.06	-	-
IntAct	BP	GO:0006575	cellular modified amino acid metabolic process	7.87E-02	186	173	165	1.05	-	-
IntAct	BP	GO:0022600	digestive system process	2.26E-01	110	102	98	1.04	-	-
IntAct	BP	GO:0032200	telomere organization	4.83E-01	186	162	165	0.98	-	-
IntAct	MF	GO:0016740	transferase activity	2.21E-37	3074	2917	2728	1.07	-	-
IntAct	MF	GO:0003723	RNA binding	2.21E-34	1679	1623	1490	1.09	-	-
IntAct	MF	GO:0140096	"catalytic activity, acting on a protein"	2.09E-28	3198	3007	2839	1.06	-	-
IntAct	MF	GO:0008092	cytoskeletal protein binding	2.58E-28	1023	1000	908	1.10	-	-
IntAct	MF	GO:0140657	ATP-dependent activity	8.89E-18	729	709	647	1.10	-	-
IntAct	MF	GO:0003677	DNA binding	5.68E-14	2865	2655	2543	1.04	-	-
IntAct	MF	GO:0140110	transcription regulator activity	6.61E-11	2033	1888	1804	1.05	-	-
IntAct	MF	GO:0016491	oxidoreductase activity	6.79E-11	888	843	788	1.07	-	-
IntAct	MF	GO:0003924	GTPase activity	1.43E-10	658	630	584	1.08	-	-
IntAct	MF	GO:0140097	"catalytic activity, acting on DNA"	9.93E-09	383	371	340	1.09	-	-
IntAct	MF	GO:0140098	"catalytic activity, acting on RNA"	2.60E-08	417	402	370	1.09	-	-
IntAct	MF	GO:0016874	ligase activity	6.26E-08	283	276	251	1.10	-	-
IntAct	MF	GO:0016853	isomerase activity	3.00E-07	252	246	224	1.10	-	-
IntAct	MF	GO:0008289	lipid binding	5.50E-07	836	784	742	1.06	-	-
IntAct	MF	GO:0045182	translation regulator activity	6.21E-06	151	149	134	1.11	-	-
IntAct	MF	GO:0042393	histone binding	1.73E-04	237	227	210	1.08	-	-
IntAct	MF	GO:0140104	molecular carrier activity	8.70E-04	105	103	93	1.11	-	-
IntAct	MF	GO:0016829	lyase activity	3.16E-02	538	493	478	1.03	-	-
IntAct	MF	GO:0003774	cytoskeletal motor activity	3.78E-02	116	110	103	1.07	-	-
IntAct	MF	GO:0038024	cargo receptor activity	7.72E-02	117	110	104	1.06	-	-
IntAct	MF	GO:0005215	transporter activity	1.01E-01	1462	1317	1298	1.01	-	-
IntAct	MF	GO:0048018	receptor ligand activity	5.20E-01	504	443	447	0.99	-	-
IntAct	MF	GO:0009975	cyclase activity	5.65E-01	277	243	246	0.99	-	-
IntAct	MF	GO:0005198	structural molecule activity	5.67E-01	798	714	708	1.01	-	-
IntAct	BP	GO:0008038	neuron recognition	-	46	44	-	-	7.91E-03	2.09E-03
IntAct	BP	GO:1905145	cellular response to acetylcholine	-	33	31	-	-	2.36E-03	1.45E-03
IntAct	BP	GO:0097094	craniofacial suture morphogenesis	-	18	17	-	-	2.28E-04	8.14E-04
IntAct	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	2.29E-03	9.89E-04
IntAct	BP	GO:0051931	regulation of sensory perception	-	36	35	-	-	5.89E-03	1.63E-03
IntAct	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	3.81E-03	1.16E-03
IntAct	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.71E-04	6.40E-04
IntAct	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	6.04E-03	6.40E-04
IntAct	BP	GO:0009268	response to pH	-	43	37	-	-	5.90E-02	1.74E-03
IntAct	BP	GO:0045666	positive regulation of neuron differentiation	-	91	81	-	-	4.97E-03	3.78E-03
IntAct	BP	GO:0043543	protein acylation	-	107	101	-	-	3.46E-03	4.71E-03
IntAct	MF	GO:0051349	positive regulation of lyase activity	-	41	36	-	-	6.08E-03	1.69E-03
IntAct	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	11	-	-	6.02E-04	5.23E-04
IntAct	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.06E-03	1.16E-03
IntAct	BP	GO:0022401	negative adaptation of signaling pathway	-	21	19	-	-	8.82E-03	9.31E-04
IntAct	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	126	-	-	1.27E-02	5.87E-03
IntAct	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	2.23E-02	1.98E-03
IntAct	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	34	-	-	3.37E-03	1.63E-03
IntAct	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	11	-	-	2.53E-02	5.23E-04
IntAct	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	1.00E-02	3.20E-03
IntAct	BP	GO:0022038	corpus callosum development	-	25	25	-	-	4.72E-03	1.16E-03
IntAct	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	11	-	-	1.72E-04	5.23E-04
IntAct	BP	GO:0021548	pons development	-	11	11	-	-	1.70E-04	5.23E-04
IntAct	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	11	-	-	1.73E-04	5.23E-04
IntAct	BP	GO:0043299	leukocyte degranulation	-	82	80	-	-	6.36E-03	3.72E-03
IntAct	BP	GO:0048864	stem cell development	-	88	81	-	-	3.16E-03	3.78E-03
IntAct	BP	GO:0009310	amine catabolic process	-	20	16	-	-	3.44E-03	7.56E-04
IntAct	BP	GO:0051651	maintenance of location in cell	-	236	217	-	-	5.90E-03	1.01E-02
IntAct	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	4.29E-03	1.28E-03
IntAct	BP	GO:0014004	microglia differentiation	-	12	12	-	-	2.67E-03	5.82E-04
IntAct	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	30	-	-	4.00E-04	1.40E-03
IntAct	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	1.72E-04	6.98E-04
IntAct	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.37E-03	6.98E-04
IntAct	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	3.42E-03	1.40E-03
IntAct	BP	GO:0006949	syncytium formation	-	66	60	-	-	1.44E-03	2.79E-03
IntAct	BP	GO:0045176	apical protein localization	-	15	14	-	-	1.68E-04	6.98E-04
IntAct	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	3.69E-02	6.98E-04
IntAct	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	52	-	-	2.14E-02	2.44E-03
IntAct	BP	GO:0030574	collagen catabolic process	-	45	36	-	-	5.84E-03	1.69E-03
IntAct	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	2.64E-03	2.15E-03
IntAct	BP	GO:0060343	trabecula formation	-	26	25	-	-	9.85E-04	1.16E-03
IntAct	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	11	-	-	1.71E-04	5.23E-04
IntAct	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	1.44E-03	1.11E-03
IntAct	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	8.13E-02	7.56E-04
IntAct	BP	GO:1900424	regulation of defense response to bacterium	-	21	19	-	-	2.23E-04	9.31E-04
IntAct	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	4.31E-02	1.92E-03
IntAct	BP	GO:0006413	translational initiation	-	122	119	-	-	1.34E-02	5.58E-03
IntAct	BP	GO:0072176	nephric duct development	-	15	14	-	-	4.28E-03	6.98E-04
IntAct	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	3.49E-03	2.38E-03
IntAct	CC	GO:0005200	structural constituent of cytoskeleton	-	112	110	-	-	4.74E-03	5.12E-03
IntAct	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	2.03E-03	2.38E-03
IntAct	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	6.29E-02	6.98E-04
IntAct	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	6.94E-02	1.16E-03
IntAct	BP	GO:1903036	positive regulation of response to wounding	-	76	69	-	-	3.45E-03	3.26E-03
IntAct	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	2.65E-02	9.89E-04
IntAct	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	206	-	-	8.99E-03	9.60E-03
IntAct	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.07E-03	1.28E-03
IntAct	BP	GO:0032528	microvillus organization	-	24	22	-	-	7.56E-03	1.05E-03
IntAct	BP	GO:0021954	central nervous system neuron development	-	85	82	-	-	1.99E-03	3.84E-03
IntAct	BP	GO:0055017	cardiac muscle tissue growth	-	92	73	-	-	1.84E-03	3.43E-03
IntAct	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	30	-	-	1.11E-03	1.40E-03
IntAct	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	12	-	-	1.71E-04	5.82E-04
IntAct	BP	GO:0048524	positive regulation of viral process	-	64	63	-	-	1.42E-03	2.97E-03
IntAct	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	13	-	-	1.10E-01	6.40E-04
IntAct	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	20	-	-	1.51E-03	9.31E-04
IntAct	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	22	-	-	4.03E-03	1.05E-03
IntAct	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	1.23E-02	8.14E-04
IntAct	BP	GO:0098661	inorganic anion transmembrane transport	-	140	125	-	-	2.75E-02	5.82E-03
IntAct	BP	GO:0006099	tricarboxylic acid cycle	-	33	33	-	-	8.31E-03	1.57E-03
IntAct	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	3.56E-04	8.72E-04
IntAct	BP	GO:0009612	response to mechanical stimulus	-	215	209	-	-	4.25E-03	9.77E-03
IntAct	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	2.37E-03	3.66E-03
IntAct	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	136	-	-	4.30E-03	6.34E-03
IntAct	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	7.01E-03	6.40E-04
IntAct	BP	GO:0071542	dopaminergic neuron differentiation	-	36	32	-	-	3.82E-03	1.51E-03
IntAct	BP	GO:0140115	export across plasma membrane	-	82	60	-	-	2.41E-03	2.79E-03
IntAct	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	3.53E-03	5.82E-04
IntAct	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	37	-	-	7.34E-04	1.74E-03
IntAct	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	11	-	-	1.46E-02	5.23E-04
IntAct	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	7.86E-04	5.23E-04
IntAct	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	26	-	-	4.98E-02	1.22E-03
IntAct	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	39	-	-	7.55E-03	1.86E-03
IntAct	MF	GO:0003714	transcription corepressor activity	-	190	186	-	-	7.14E-03	8.67E-03
IntAct	BP	GO:0035878	nail development	-	11	11	-	-	5.97E-03	5.23E-04
IntAct	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	55	-	-	2.82E-03	2.56E-03
IntAct	BP	GO:0061101	neuroendocrine cell differentiation	-	16	15	-	-	3.47E-03	6.98E-04
IntAct	CC	GO:0006858	extracellular transport	-	45	42	-	-	4.34E-03	1.98E-03
IntAct	BP	GO:0006304	DNA modification	-	30	29	-	-	1.67E-02	1.40E-03
IntAct	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	3.00E-02	8.72E-04
IntAct	BP	GO:0046835	carbohydrate phosphorylation	-	49	48	-	-	2.50E-02	2.27E-03
IntAct	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	1.34E-03	8.72E-04
IntAct	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	1.92E-02	6.98E-04
IntAct	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	36	-	-	4.73E-03	1.69E-03
IntAct	BP	GO:0070417	cellular response to cold	-	13	13	-	-	1.71E-04	6.40E-04
IntAct	BP	GO:0043523	regulation of neuron apoptotic process	-	218	207	-	-	5.47E-03	9.65E-03
IntAct	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.56E-03	1.05E-03
IntAct	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	1.67E-04	6.98E-04
IntAct	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	3.14E-03	2.68E-03
IntAct	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	3.23E-02	6.40E-04
IntAct	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	3.18E-03	1.16E-03
IntAct	BP	GO:0014029	neural crest formation	-	15	15	-	-	4.06E-03	6.98E-04
IntAct	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	7.45E-03	1.11E-03
IntAct	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	36	-	-	6.61E-04	1.69E-03
IntAct	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	66	-	-	2.06E-03	3.08E-03
IntAct	BP	GO:0003188	heart valve formation	-	16	16	-	-	2.57E-03	7.56E-04
IntAct	CC	GO:0045324	late endosome to vacuole transport	-	37	36	-	-	7.18E-02	1.69E-03
IntAct	BP	GO:0043954	cellular component maintenance	-	72	69	-	-	3.18E-03	3.26E-03
IntAct	BP	GO:0050435	amyloid-beta metabolic process	-	65	51	-	-	3.62E-03	2.38E-03
IntAct	BP	GO:0014823	response to activity	-	70	66	-	-	2.50E-03	3.08E-03
IntAct	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	16	-	-	2.10E-03	7.56E-04
IntAct	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	1.89E-02	1.34E-03
IntAct	BP	GO:0034502	protein localization to chromosome	-	130	114	-	-	6.19E-03	5.35E-03
IntAct	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	6.27E-04	5.23E-04
IntAct	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	2.95E-02	8.14E-04
IntAct	BP	GO:0019233	sensory perception of pain	-	103	97	-	-	2.01E-03	4.54E-03
IntAct	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	1.21E-01	1.05E-03
IntAct	BP	GO:0031343	positive regulation of cell killing	-	75	72	-	-	6.78E-02	3.37E-03
IntAct	BP	GO:0090077	foam cell differentiation	-	39	37	-	-	1.84E-03	1.74E-03
IntAct	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	113	-	-	2.39E-02	5.29E-03
IntAct	BP	GO:0017148	negative regulation of translation	-	390	113	-	-	1.04E-02	5.29E-03
IntAct	BP	GO:0030220	platelet formation	-	22	22	-	-	5.17E-03	1.05E-03
IntAct	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	79	-	-	5.41E-03	3.72E-03
IntAct	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	2.73E-03	5.82E-04
IntAct	BP	GO:1901142	insulin metabolic process	-	14	13	-	-	3.35E-03	6.40E-04
IntAct	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	11	-	-	4.03E-02	5.23E-04
IntAct	BP	GO:1903509	liposaccharide metabolic process	-	109	103	-	-	4.71E-02	4.83E-03
IntAct	BP	GO:0009582	detection of abiotic stimulus	-	140	117	-	-	7.10E-03	5.47E-03
IntAct	BP	GO:0045683	negative regulation of epidermis development	-	13	11	-	-	1.71E-04	5.23E-04
IntAct	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	16	-	-	2.31E-04	7.56E-04
IntAct	CC	GO:0140238	presynaptic endocytosis	-	72	70	-	-	7.37E-03	3.26E-03
IntAct	BP	GO:0051236	establishment of RNA localization	-	161	155	-	-	3.56E-02	7.21E-03
IntAct	BP	GO:0042178	xenobiotic catabolic process	-	26	24	-	-	7.64E-02	1.16E-03
IntAct	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	2.30E-04	8.14E-04
IntAct	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	190	-	-	9.18E-03	8.84E-03
IntAct	BP	GO:0034067	protein localization to Golgi apparatus	-	30	27	-	-	1.48E-03	1.28E-03
IntAct	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	2.72E-03	1.51E-03
IntAct	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	1.72E-04	5.23E-04
IntAct	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	5.72E-03	8.14E-04
IntAct	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	45	-	-	1.24E-03	2.09E-03
IntAct	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	8.68E-04	1.86E-03
IntAct	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	3.10E-03	2.44E-03
IntAct	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	2.66E-03	7.56E-04
IntAct	BP	GO:0050779	RNA destabilization	-	135	99	-	-	2.67E-02	4.65E-03
IntAct	BP	GO:0006023	aminoglycan biosynthetic process	-	74	69	-	-	3.62E-02	3.26E-03
IntAct	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	7.45E-03	3.20E-03
IntAct	BP	GO:0010762	regulation of fibroblast migration	-	40	38	-	-	1.21E-03	1.80E-03
IntAct	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	3.87E-03	1.40E-03
IntAct	BP	GO:0035272	exocrine system development	-	46	45	-	-	1.93E-03	2.09E-03
IntAct	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	7.62E-03	8.14E-04
IntAct	BP	GO:0022406	membrane docking	-	90	89	-	-	1.34E-02	4.19E-03
IntAct	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	3.56E-02	6.98E-04
IntAct	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	1.58E-03	7.56E-04
IntAct	BP	GO:0050777	negative regulation of immune response	-	196	186	-	-	5.34E-03	8.67E-03
IntAct	MF	GO:0005035	death receptor activity	-	16	16	-	-	1.44E-03	7.56E-04
IntAct	BP	GO:0002063	chondrocyte development	-	33	31	-	-	9.71E-04	1.45E-03
IntAct	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	16	-	-	1.38E-03	7.56E-04
IntAct	BP	GO:0099068	postsynapse assembly	-	40	38	-	-	3.53E-03	1.80E-03
IntAct	BP	GO:0021782	glial cell development	-	120	107	-	-	2.08E-03	5.00E-03
IntAct	BP	GO:0051782	negative regulation of cell division	-	18	16	-	-	1.49E-02	7.56E-04
IntAct	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	5.23E-04	5.23E-04
IntAct	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	86	-	-	2.78E-03	4.01E-03
IntAct	BP	GO:0001655	urogenital system development	-	66	64	-	-	2.65E-03	3.02E-03
IntAct	BP	GO:0071827	plasma lipoprotein particle organization	-	86	68	-	-	1.15E-02	3.20E-03
IntAct	BP	GO:0045494	photoreceptor cell maintenance	-	43	40	-	-	1.36E-02	1.86E-03
IntAct	BP	GO:0055088	lipid homeostasis	-	173	150	-	-	7.02E-03	6.98E-03
IntAct	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	2.59E-03	1.22E-03
IntAct	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	194	-	-	4.18E-03	9.07E-03
IntAct	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	25	-	-	1.84E-03	1.16E-03
IntAct	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	8.27E-03	1.63E-03
IntAct	BP	GO:0045667	regulation of osteoblast differentiation	-	147	119	-	-	1.06E-02	5.58E-03
IntAct	BP	GO:2001212	regulation of vasculogenesis	-	16	15	-	-	1.03E-02	6.98E-04
IntAct	BP	GO:0061037	negative regulation of cartilage development	-	32	29	-	-	1.37E-03	1.40E-03
IntAct	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	4.97E-03	1.86E-03
IntAct	BP	GO:0001704	formation of primary germ layer	-	195	184	-	-	6.67E-03	8.61E-03
IntAct	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	9.07E-03	6.40E-04
IntAct	BP	GO:0045778	positive regulation of ossification	-	51	50	-	-	3.57E-03	2.33E-03
IntAct	BP	GO:0060174	limb bud formation	-	11	11	-	-	7.61E-03	5.23E-04
IntAct	BP	GO:0048708	astrocyte differentiation	-	88	83	-	-	2.41E-03	3.90E-03
IntAct	BP	GO:0042092	type 2 immune response	-	41	41	-	-	4.33E-03	1.92E-03
IntAct	BP	GO:0048588	developmental cell growth	-	233	217	-	-	4.93E-03	1.01E-02
IntAct	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	5.54E-02	9.31E-04
IntAct	BP	GO:0021872	forebrain generation of neurons	-	52	50	-	-	6.96E-04	2.33E-03
IntAct	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	7.40E-04	1.05E-03
IntAct	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	8.67E-02	1.86E-03
IntAct	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	47	-	-	1.06E-02	2.21E-03
IntAct	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	1.72E-04	5.23E-04
IntAct	BP	GO:0034367	protein-containing complex remodeling	-	35	34	-	-	1.03E-02	1.63E-03
IntAct	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	25	-	-	4.88E-04	1.16E-03
IntAct	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	45	-	-	4.80E-03	2.09E-03
IntAct	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	7.52E-02	9.31E-04
IntAct	BP	GO:0015810	aspartate transmembrane transport	-	19	18	-	-	2.65E-02	8.72E-04
IntAct	BP	GO:0010232	vascular transport	-	87	81	-	-	1.25E-03	3.78E-03
IntAct	BP	GO:0021987	cerebral cortex development	-	125	121	-	-	3.03E-03	5.64E-03
IntAct	BP	GO:0008637	apoptotic mitochondrial changes	-	108	99	-	-	9.13E-03	4.65E-03
IntAct	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	7.68E-03	1.63E-03
IntAct	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	2.41E-03	6.98E-04
IntAct	BP	GO:0060999	positive regulation of dendritic spine development	-	35	34	-	-	4.10E-03	1.63E-03
IntAct	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	17	-	-	7.95E-04	8.14E-04
IntAct	BP	GO:2000736	regulation of stem cell differentiation	-	78	75	-	-	4.09E-03	3.49E-03
IntAct	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	2.21E-03	9.31E-04
IntAct	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	19	-	-	1.36E-03	9.31E-04
IntAct	BP	GO:0002064	epithelial cell development	-	210	204	-	-	4.93E-03	9.54E-03
IntAct	BP	GO:0071318	cellular response to ATP	-	18	16	-	-	2.26E-04	7.56E-04
IntAct	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	38	-	-	3.75E-03	1.80E-03
IntAct	BP	GO:2001222	regulation of neuron migration	-	46	42	-	-	2.75E-02	1.98E-03
IntAct	BP	GO:0034389	lipid droplet organization	-	38	37	-	-	7.54E-03	1.74E-03
IntAct	BP	GO:0051602	response to electrical stimulus	-	44	43	-	-	6.13E-04	2.04E-03
IntAct	BP	GO:0042177	negative regulation of protein catabolic process	-	109	104	-	-	2.23E-03	4.89E-03
IntAct	MF	GO:0038024	cargo receptor activity	-	121	110	-	-	1.92E-02	5.12E-03
IntAct	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	16	-	-	2.90E-03	7.56E-04
IntAct	BP	GO:0033120	positive regulation of RNA splicing	-	46	42	-	-	2.17E-02	1.98E-03
IntAct	BP	GO:0051445	regulation of meiotic cell cycle	-	64	59	-	-	6.34E-02	2.79E-03
IntAct	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.19E-03	5.82E-04
IntAct	BP	GO:0033619	membrane protein proteolysis	-	60	59	-	-	5.75E-03	2.79E-03
IntAct	BP	GO:0038065	collagen-activated signaling pathway	-	15	14	-	-	9.23E-03	6.98E-04
IntAct	BP	GO:0090087	regulation of peptide transport	-	195	182	-	-	1.00E-02	8.49E-03
IntAct	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	98	-	-	2.52E-03	4.59E-03
IntAct	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	1.59E-03	1.16E-03
IntAct	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	8.90E-04	1.16E-03
IntAct	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	14	-	-	3.35E-02	6.98E-04
IntAct	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	2.90E-02	1.28E-03
IntAct	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	2.02E-03	6.98E-04
IntAct	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	4.47E-04	6.98E-04
IntAct	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	6.82E-02	9.31E-04
IntAct	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	1.70E-04	6.40E-04
IntAct	BP	GO:0022404	molting cycle process	-	95	93	-	-	1.97E-03	4.36E-03
IntAct	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	5.70E-04	5.23E-04
IntAct	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	4.00E-03	8.14E-04
IntAct	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	1.78E-02	9.31E-04
IntAct	BP	GO:0042754	negative regulation of circadian rhythm	-	12	11	-	-	2.14E-03	5.23E-04
IntAct	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	9.96E-04	8.14E-04
IntAct	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	3.08E-03	1.51E-03
IntAct	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	2.13E-02	6.98E-04
IntAct	BP	GO:0008299	isoprenoid biosynthetic process	-	30	30	-	-	2.49E-02	1.40E-03
IntAct	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	225	-	-	1.25E-02	1.05E-02
IntAct	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.37E-03	1.45E-03
IntAct	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	8.94E-04	1.05E-03
IntAct	CC	GO:0098926	postsynaptic signal transduction	-	39	37	-	-	6.12E-04	1.74E-03
IntAct	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	137	-	-	3.60E-03	6.40E-03
IntAct	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	3.29E-02	9.31E-04
IntAct	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	7.89E-04	2.21E-03
IntAct	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	133	-	-	9.91E-03	6.22E-03
IntAct	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	1.56E-03	1.05E-03
IntAct	BP	GO:0061548	ganglion development	-	17	16	-	-	6.41E-03	7.56E-04
IntAct	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	97	-	-	5.05E-03	4.54E-03
IntAct	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	6.41E-03	6.98E-04
IntAct	BP	GO:0042832	defense response to protozoan	-	28	24	-	-	3.41E-02	1.16E-03
IntAct	BP	GO:0048799	animal organ maturation	-	33	32	-	-	9.50E-04	1.51E-03
IntAct	BP	GO:0006925	inflammatory cell apoptotic process	-	23	21	-	-	1.10E-03	9.89E-04
IntAct	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	1.09E-03	7.56E-04
IntAct	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	167	-	-	5.51E-03	7.79E-03
IntAct	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.73E-04	5.23E-04
IntAct	BP	GO:1903035	negative regulation of response to wounding	-	93	88	-	-	5.41E-03	4.13E-03
IntAct	BP	GO:0015697	quaternary ammonium group transport	-	16	14	-	-	1.73E-04	6.98E-04
IntAct	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	4.42E-04	1.22E-03
IntAct	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	2.26E-03	1.28E-03
IntAct	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	131	-	-	2.34E-02	6.11E-03
IntAct	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	96	-	-	2.82E-03	4.48E-03
IntAct	BP	GO:0045056	transcytosis	-	20	20	-	-	1.61E-03	9.31E-04
IntAct	BP	GO:0018342	protein prenylation	-	15	15	-	-	1.23E-02	6.98E-04
IntAct	BP	GO:0009267	cellular response to starvation	-	170	168	-	-	9.34E-03	7.85E-03
IntAct	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	7.16E-03	2.50E-03
IntAct	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	2.30E-04	7.56E-04
IntAct	BP	GO:0007343	egg activation	-	11	11	-	-	1.11E-01	5.23E-04
IntAct	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	2.48E-03	1.11E-03
IntAct	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	24	-	-	2.85E-04	1.16E-03
IntAct	BP	GO:0046931	pore complex assembly	-	21	20	-	-	3.27E-03	9.31E-04
IntAct	CC	GO:0032008	positive regulation of TOR signaling	-	52	50	-	-	6.43E-02	2.33E-03
IntAct	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	3.89E-02	1.57E-03
IntAct	BP	GO:0046618	xenobiotic export from cell	-	27	12	-	-	1.72E-04	5.82E-04
IntAct	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	14	-	-	1.71E-04	6.98E-04
IntAct	BP	GO:0060428	lung epithelium development	-	43	43	-	-	2.93E-03	2.04E-03
IntAct	BP	GO:0030431	sleep	-	30	28	-	-	9.25E-03	1.34E-03
IntAct	BP	GO:1903318	negative regulation of protein maturation	-	29	28	-	-	2.78E-03	1.34E-03
IntAct	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	97	-	-	1.96E-01	4.54E-03
IntAct	BP	GO:0071732	cellular response to nitric oxide	-	17	16	-	-	4.48E-04	7.56E-04
IntAct	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	1.13E-02	6.98E-04
IntAct	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	1.69E-04	5.82E-04
IntAct	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.71E-04	6.40E-04
IntAct	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	67	-	-	1.78E-03	3.14E-03
IntAct	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	3.47E-03	3.02E-03
IntAct	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	16	-	-	3.73E-03	7.56E-04
IntAct	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	1.72E-04	6.98E-04
IntAct	CC	GO:0006406	mRNA export from nucleus	-	69	67	-	-	3.81E-02	3.14E-03
IntAct	BP	GO:0009880	embryonic pattern specification	-	70	70	-	-	2.01E-03	3.26E-03
IntAct	BP	GO:0015791	polyol transmembrane transport	-	14	12	-	-	3.97E-03	5.82E-04
IntAct	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	39	-	-	2.45E-01	1.86E-03
IntAct	BP	GO:0043043	peptide biosynthetic process	-	25	25	-	-	3.46E-02	1.16E-03
IntAct	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	3.48E-02	5.23E-04
IntAct	BP	GO:0002367	cytokine production involved in immune response	-	121	119	-	-	6.59E-03	5.58E-03
IntAct	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	12	-	-	4.18E-04	5.82E-04
IntAct	BP	GO:0044848	biological phase	-	211	197	-	-	1.95E-02	9.19E-03
IntAct	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	3.02E-03	5.82E-04
IntAct	BP	GO:0046660	female sex differentiation	-	125	118	-	-	3.69E-03	5.53E-03
IntAct	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	3.25E-04	8.14E-04
IntAct	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	41	-	-	7.37E-04	1.92E-03
IntAct	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	1.69E-04	5.23E-04
IntAct	BP	GO:0060411	cardiac septum morphogenesis	-	72	69	-	-	4.02E-03	3.26E-03
IntAct	BP	GO:0071248	cellular response to metal ion	-	201	193	-	-	6.62E-03	9.01E-03
IntAct	BP	GO:0030308	negative regulation of cell growth	-	191	182	-	-	3.50E-03	8.49E-03
IntAct	BP	GO:0097306	cellular response to alcohol	-	99	91	-	-	3.12E-03	4.25E-03
IntAct	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	126	-	-	2.20E-02	5.87E-03
IntAct	BP	GO:0010453	regulation of cell fate commitment	-	40	34	-	-	2.66E-02	1.63E-03
IntAct	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	57	-	-	2.23E-03	2.68E-03
IntAct	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	53	-	-	2.44E-02	2.50E-03
IntAct	BP	GO:0002026	regulation of the force of heart contraction	-	26	24	-	-	7.50E-04	1.16E-03
IntAct	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	22	-	-	3.03E-03	1.05E-03
IntAct	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	44	-	-	1.26E-02	2.09E-03
IntAct	BP	GO:0032890	regulation of organic acid transport	-	78	75	-	-	2.42E-03	3.49E-03
IntAct	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	9.05E-04	9.31E-04
IntAct	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	2.88E-04	1.16E-03
IntAct	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	92	-	-	2.30E-03	4.30E-03
IntAct	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	25	-	-	1.36E-03	1.16E-03
IntAct	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	3.28E-03	5.23E-04
IntAct	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	50	-	-	2.87E-03	2.33E-03
IntAct	BP	GO:0051259	protein complex oligomerization	-	251	241	-	-	1.03E-02	1.12E-02
IntAct	BP	GO:0009163	nucleoside biosynthetic process	-	16	15	-	-	1.23E-03	6.98E-04
IntAct	BP	GO:0098743	cell aggregation	-	24	23	-	-	4.78E-04	1.11E-03
IntAct	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	1.85E-03	5.82E-04
IntAct	BP	GO:0009994	oocyte differentiation	-	57	53	-	-	1.54E-03	2.50E-03
IntAct	MF	GO:0031952	regulation of protein autophosphorylation	-	43	42	-	-	1.30E-03	1.98E-03
IntAct	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	2.12E-02	6.98E-04
IntAct	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	148	-	-	5.48E-03	6.92E-03
IntAct	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	6.50E-03	1.63E-03
IntAct	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	1.29E-03	1.34E-03
IntAct	BP	GO:0060251	regulation of glial cell proliferation	-	39	34	-	-	8.11E-04	1.63E-03
IntAct	BP	GO:0072665	protein localization to vacuole	-	84	82	-	-	4.66E-03	3.84E-03
IntAct	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	45	-	-	3.35E-02	2.09E-03
IntAct	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	23	-	-	2.09E-03	1.11E-03
IntAct	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	73	-	-	5.07E-03	3.43E-03
IntAct	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	1.13E-02	7.56E-04
IntAct	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	5.73E-03	6.98E-04
IntAct	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.72E-04	5.23E-04
IntAct	BP	GO:0042044	fluid transport	-	35	33	-	-	1.54E-03	1.57E-03
IntAct	BP	GO:0070633	transepithelial transport	-	35	35	-	-	3.97E-03	1.63E-03
IntAct	BP	GO:0033015	tetrapyrrole catabolic process	-	13	11	-	-	1.72E-04	5.23E-04
IntAct	BP	GO:0045661	regulation of myoblast differentiation	-	74	72	-	-	1.46E-02	3.37E-03
IntAct	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	13	-	-	1.73E-04	6.40E-04
IntAct	BP	GO:0030307	positive regulation of cell growth	-	164	154	-	-	3.55E-03	7.21E-03
IntAct	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	1.40E-03	1.16E-03
IntAct	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	4.95E-04	8.72E-04
IntAct	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	1.26E-03	6.40E-04
IntAct	BP	GO:0014812	muscle cell migration	-	110	84	-	-	2.80E-03	3.95E-03
IntAct	BP	GO:0048525	negative regulation of viral process	-	90	86	-	-	3.51E-03	4.01E-03
IntAct	BP	GO:0072044	collecting duct development	-	16	16	-	-	3.38E-02	7.56E-04
IntAct	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	3.86E-02	6.98E-04
IntAct	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	2.33E-03	3.26E-03
IntAct	BP	GO:0030238	male sex determination	-	14	14	-	-	1.56E-03	6.98E-04
IntAct	BP	GO:0051781	positive regulation of cell division	-	93	85	-	-	4.45E-03	3.95E-03
IntAct	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	7.88E-03	9.89E-04
IntAct	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	2.54E-03	5.23E-04
IntAct	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	6.04E-02	1.11E-03
IntAct	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	21	-	-	9.12E-04	9.89E-04
IntAct	BP	GO:0060711	labyrinthine layer development	-	47	46	-	-	1.14E-03	2.15E-03
IntAct	BP	GO:0007272	ensheathment of neurons	-	146	137	-	-	4.14E-03	6.40E-03
IntAct	CC	GO:0050806	positive regulation of synaptic transmission	-	171	145	-	-	4.04E-03	6.75E-03
IntAct	BP	GO:0060021	roof of mouth development	-	91	89	-	-	3.77E-03	4.19E-03
IntAct	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	38	-	-	1.12E-03	1.80E-03
IntAct	BP	GO:0050819	negative regulation of coagulation	-	54	52	-	-	1.07E-02	2.44E-03
IntAct	BP	GO:0017004	cytochrome complex assembly	-	40	37	-	-	6.97E-02	1.74E-03
IntAct	BP	GO:0018410	C-terminal protein amino acid modification	-	15	13	-	-	1.38E-02	6.40E-04
IntAct	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	1.26E-01	2.91E-03
IntAct	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	5.34E-02	6.98E-04
IntAct	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	13	-	-	2.44E-03	6.40E-04
IntAct	CC	GO:0050805	negative regulation of synaptic transmission	-	55	53	-	-	4.56E-03	2.50E-03
IntAct	BP	GO:0043248	proteasome assembly	-	13	13	-	-	3.52E-02	6.40E-04
IntAct	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	57	-	-	2.17E-03	2.68E-03
IntAct	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	1.73E-04	5.23E-04
IntAct	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	75	-	-	2.62E-03	3.49E-03
IntAct	BP	GO:0016054	organic acid catabolic process	-	251	239	-	-	1.08E-02	1.12E-02
IntAct	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	6.51E-04	6.40E-04
IntAct	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.48E-02	1.34E-03
IntAct	BP	GO:0065005	protein-lipid complex assembly	-	29	27	-	-	1.02E-02	1.28E-03
IntAct	BP	GO:0008033	tRNA processing	-	136	132	-	-	1.03E-01	6.16E-03
IntAct	BP	GO:0046661	male sex differentiation	-	171	164	-	-	3.66E-03	7.68E-03
IntAct	BP	GO:0072520	seminiferous tubule development	-	15	14	-	-	1.67E-04	6.98E-04
IntAct	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	5.72E-03	8.14E-04
IntAct	BP	GO:0035188	hatching	-	27	24	-	-	2.79E-04	1.16E-03
IntAct	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	84	-	-	2.31E-03	3.95E-03
IntAct	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	2.29E-04	6.98E-04
IntAct	BP	GO:0090713	immunological memory process	-	18	18	-	-	4.43E-02	8.72E-04
IntAct	BP	GO:0061326	renal tubule development	-	103	96	-	-	2.74E-03	4.48E-03
IntAct	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	2.57E-02	2.56E-03
IntAct	BP	GO:0006450	regulation of translational fidelity	-	18	16	-	-	8.63E-04	7.56E-04
IntAct	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	2.34E-02	9.31E-04
IntAct	BP	GO:0060325	face morphogenesis	-	31	30	-	-	9.41E-04	1.40E-03
IntAct	BP	GO:0090559	regulation of membrane permeability	-	72	63	-	-	9.43E-03	2.97E-03
IntAct	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	13	-	-	1.00E-01	6.40E-04
IntAct	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	5.21E-02	5.82E-04
IntAct	BP	GO:0031579	membrane raft organization	-	25	24	-	-	1.48E-03	1.16E-03
IntAct	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	2.05E-03	1.16E-03
IntAct	BP	GO:0060033	anatomical structure regression	-	16	15	-	-	2.80E-03	6.98E-04
IntAct	BP	GO:0046460	neutral lipid biosynthetic process	-	50	44	-	-	4.41E-03	2.09E-03
IntAct	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	139	-	-	4.54E-03	6.51E-03
IntAct	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	1.73E-04	5.23E-04
IntAct	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	161	-	-	3.36E-03	7.50E-03
IntAct	BP	GO:0002251	organ or tissue specific immune response	-	43	34	-	-	1.68E-03	1.63E-03
IntAct	CC	GO:0048167	regulation of synaptic plasticity	-	210	187	-	-	5.25E-03	8.72E-03
IntAct	BP	GO:1903708	positive regulation of hemopoiesis	-	184	175	-	-	1.48E-02	8.14E-03
IntAct	BP	GO:1903008	organelle disassembly	-	154	153	-	-	7.02E-03	7.15E-03
IntAct	BP	GO:0001709	cell fate determination	-	44	41	-	-	5.76E-04	1.92E-03
IntAct	BP	GO:0051873	killing by host of symbiont cells	-	28	25	-	-	1.46E-02	1.16E-03
IntAct	BP	GO:0045058	T cell selection	-	53	53	-	-	4.67E-02	2.50E-03
IntAct	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	1.33E-03	2.27E-03
IntAct	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	1.87E-03	9.31E-04
IntAct	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	2.31E-03	3.66E-03
IntAct	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	39	-	-	4.44E-03	1.86E-03
IntAct	BP	GO:0099084	postsynaptic specialization organization	-	44	42	-	-	2.69E-03	1.98E-03
IntAct	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	4.32E-03	5.23E-04
IntAct	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	7.28E-03	6.98E-04
IntAct	BP	GO:0060384	innervation	-	27	27	-	-	7.62E-03	1.28E-03
IntAct	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	1.16E-03	5.82E-04
IntAct	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	34	-	-	3.57E-03	1.63E-03
IntAct	MF	GO:0031281	positive regulation of cyclase activity	-	40	36	-	-	8.35E-04	1.69E-03
IntAct	MF	GO:0098631	cell adhesion mediator activity	-	64	61	-	-	2.27E-03	2.85E-03
IntAct	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	2.30E-04	8.72E-04
IntAct	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	1.95E-02	5.82E-04
IntAct	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	4.26E-03	8.72E-04
IntAct	BP	GO:0071453	cellular response to oxygen levels	-	168	151	-	-	3.35E-03	7.04E-03
IntAct	BP	GO:0090399	replicative senescence	-	17	16	-	-	1.28E-03	7.56E-04
IntAct	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	13	-	-	1.72E-04	6.40E-04
IntAct	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	2.17E-02	1.40E-03
IntAct	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	7.03E-03	5.82E-03
IntAct	BP	GO:0006855	xenobiotic transmembrane transport	-	14	13	-	-	1.27E-02	6.40E-04
IntAct	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	2.68E-03	1.16E-03
IntAct	BP	GO:0044242	cellular lipid catabolic process	-	224	210	-	-	7.26E-03	9.77E-03
IntAct	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	4.68E-04	6.40E-04
IntAct	BP	GO:0002931	response to ischemia	-	58	56	-	-	4.10E-03	2.62E-03
IntAct	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	1.90E-02	5.82E-04
IntAct	BP	GO:0014047	glutamate secretion	-	25	23	-	-	3.82E-03	1.11E-03
IntAct	BP	GO:0061005	cell differentiation involved in kidney development	-	58	56	-	-	9.94E-03	2.62E-03
IntAct	BP	GO:0030397	membrane disassembly	-	11	11	-	-	4.19E-04	5.23E-04
IntAct	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	69	-	-	5.42E-03	3.26E-03
IntAct	BP	GO:0060420	regulation of heart growth	-	74	58	-	-	6.07E-03	2.73E-03
IntAct	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	1.60E-04	6.98E-04
IntAct	BP	GO:0009755	hormone-mediated signaling pathway	-	221	205	-	-	1.51E-02	9.54E-03
IntAct	BP	GO:0022612	gland morphogenesis	-	124	121	-	-	3.56E-03	5.64E-03
IntAct	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	35	-	-	6.32E-04	1.63E-03
IntAct	MF	GO:0140416	transcription regulator inhibitor activity	-	26	24	-	-	7.42E-04	1.16E-03
IntAct	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	24	-	-	1.40E-01	1.16E-03
IntAct	BP	GO:0048935	peripheral nervous system neuron development	-	15	14	-	-	1.72E-04	6.98E-04
IntAct	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	1.04E-01	8.14E-04
IntAct	BP	GO:1990845	adaptive thermogenesis	-	166	160	-	-	3.40E-03	7.44E-03
IntAct	BP	GO:0071320	cellular response to cAMP	-	54	52	-	-	1.50E-03	2.44E-03
IntAct	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	6.33E-02	5.23E-04
IntAct	BP	GO:0015844	monoamine transport	-	88	85	-	-	3.13E-02	3.95E-03
IntAct	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	3.16E-03	1.05E-03
IntAct	BP	GO:0060039	pericardium development	-	19	19	-	-	7.21E-04	9.31E-04
IntAct	BP	GO:0071392	cellular response to estradiol stimulus	-	40	39	-	-	1.07E-03	1.86E-03
IntAct	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	12	-	-	1.96E-02	5.82E-04
IntAct	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	1.21E-02	9.31E-04
IntAct	BP	GO:0009451	RNA modification	-	169	158	-	-	1.97E-02	7.39E-03
IntAct	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	39	-	-	2.44E-03	1.86E-03
IntAct	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	1.11E-03	8.14E-04
IntAct	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	110	-	-	4.80E-03	5.12E-03
IntAct	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	36	-	-	8.74E-03	1.69E-03
IntAct	BP	GO:0015807	L-amino acid transport	-	94	85	-	-	6.41E-03	3.95E-03
IntAct	BP	GO:0032941	secretion by tissue	-	85	82	-	-	1.90E-03	3.84E-03
IntAct	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	12	-	-	6.25E-03	5.82E-04
IntAct	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	6.34E-03	2.56E-03
IntAct	BP	GO:0048753	pigment granule organization	-	40	39	-	-	5.69E-02	1.86E-03
IntAct	BP	GO:0021516	dorsal spinal cord development	-	20	15	-	-	2.27E-04	6.98E-04
IntAct	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	17	-	-	2.29E-04	8.14E-04
IntAct	BP	GO:0032196	transposition	-	11	11	-	-	1.70E-04	5.23E-04
IntAct	BP	GO:0003014	renal system process	-	130	124	-	-	3.15E-03	5.82E-03
IntAct	CC	GO:0070286	axonemal dynein complex assembly	-	40	36	-	-	4.49E-03	1.69E-03
IntAct	BP	GO:0045598	regulation of fat cell differentiation	-	148	126	-	-	3.45E-03	5.87E-03
IntAct	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	187	-	-	5.24E-03	8.72E-03
IntAct	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	2.49E-03	1.80E-03
IntAct	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	2.76E-04	1.16E-03
IntAct	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	202	-	-	3.62E-02	9.42E-03
IntAct	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.66E-04	6.40E-04
IntAct	BP	GO:0008340	determination of adult lifespan	-	23	21	-	-	6.40E-04	9.89E-04
IntAct	BP	GO:0018158	protein oxidation	-	15	14	-	-	1.71E-04	6.98E-04
IntAct	BP	GO:0039694	viral RNA genome replication	-	30	29	-	-	4.58E-03	1.40E-03
IntAct	BP	GO:0009404	toxin metabolic process	-	17	16	-	-	2.30E-04	7.56E-04
IntAct	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	8.27E-04	1.28E-03
IntAct	BP	GO:0071709	membrane assembly	-	68	64	-	-	1.75E-02	3.02E-03
IntAct	BP	GO:0008217	regulation of blood pressure	-	186	166	-	-	8.06E-03	7.74E-03
IntAct	BP	GO:0031643	positive regulation of myelination	-	19	17	-	-	9.15E-04	8.14E-04
IntAct	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	4.52E-02	6.98E-04
IntAct	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	58	-	-	3.46E-03	2.73E-03
IntAct	CC	GO:0042770	signal transduction in response to DNA damage	-	186	185	-	-	9.27E-03	8.61E-03
IntAct	BP	GO:0002200	somatic diversification of immune receptors	-	78	76	-	-	7.12E-03	3.55E-03
IntAct	BP	GO:0035315	hair cell differentiation	-	52	47	-	-	4.42E-03	2.21E-03
IntAct	BP	GO:0048645	animal organ formation	-	62	61	-	-	3.97E-03	2.85E-03
IntAct	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	158	-	-	6.46E-03	7.39E-03
IntAct	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	5.02E-02	6.98E-04
IntAct	BP	GO:0033627	cell adhesion mediated by integrin	-	87	84	-	-	6.85E-03	3.95E-03
IntAct	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	1.86E-02	9.89E-04
IntAct	BP	GO:0015824	proline transport	-	13	11	-	-	4.39E-03	5.23E-04
IntAct	BP	GO:0035107	appendage morphogenesis	-	147	144	-	-	7.25E-03	6.75E-03
IntAct	BP	GO:1903707	negative regulation of hemopoiesis	-	116	105	-	-	3.80E-03	4.89E-03
IntAct	BP	GO:0036342	post-anal tail morphogenesis	-	19	18	-	-	2.25E-04	8.72E-04
IntAct	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	2.43E-02	1.16E-03
IntAct	BP	GO:0030149	sphingolipid catabolic process	-	32	30	-	-	1.49E-03	1.40E-03
IntAct	BP	GO:0050994	regulation of lipid catabolic process	-	61	56	-	-	5.23E-03	2.62E-03
IntAct	BP	GO:0035988	chondrocyte proliferation	-	24	21	-	-	8.64E-04	9.89E-04
IntAct	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	5.18E-03	1.40E-03
IntAct	BP	GO:0009593	detection of chemical stimulus	-	511	117	-	-	7.13E-03	5.47E-03
IntAct	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	2.59E-03	5.82E-04
IntAct	BP	GO:0045727	positive regulation of translation	-	141	138	-	-	4.85E-03	6.46E-03
IntAct	BP	GO:0036315	cellular response to sterol	-	24	18	-	-	4.88E-03	8.72E-04
IntAct	CC	GO:0032388	positive regulation of intracellular transport	-	137	135	-	-	2.15E-03	6.28E-03
IntAct	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	1.71E-04	6.40E-04
IntAct	BP	GO:0002027	regulation of heart rate	-	106	90	-	-	9.81E-03	4.19E-03
IntAct	BP	GO:0050879	multicellular organismal movement	-	118	108	-	-	2.46E-03	5.06E-03
IntAct	BP	GO:0120305	regulation of pigmentation	-	15	13	-	-	7.25E-03	6.40E-04
IntAct	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	72	-	-	2.13E-03	3.37E-03
IntAct	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	59	-	-	3.17E-03	2.79E-03
IntAct	BP	GO:0048515	spermatid differentiation	-	208	188	-	-	3.12E-03	8.78E-03
IntAct	BP	GO:0072132	mesenchyme morphogenesis	-	57	56	-	-	5.83E-03	2.62E-03
IntAct	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	2.61E-03	1.45E-03
IntAct	BP	GO:0007130	synaptonemal complex assembly	-	23	19	-	-	1.08E-03	9.31E-04
IntAct	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	33	-	-	7.38E-03	1.57E-03
IntAct	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	31	-	-	8.40E-04	1.45E-03
IntAct	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	33	-	-	7.98E-03	1.57E-03
IntAct	BP	GO:0060119	inner ear receptor cell development	-	44	41	-	-	2.94E-03	1.92E-03
IntAct	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	6.10E-03	8.72E-04
IntAct	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	32	-	-	1.01E-02	1.51E-03
IntAct	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	6.92E-04	1.16E-03
IntAct	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.11E-03	5.82E-04
IntAct	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	238	-	-	8.87E-03	1.11E-02
IntAct	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	7.49E-04	8.14E-04
IntAct	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	47	-	-	4.41E-02	2.21E-03
IntAct	BP	GO:0010883	regulation of lipid storage	-	53	48	-	-	2.95E-03	2.27E-03
IntAct	BP	GO:0072170	metanephric tubule development	-	26	24	-	-	2.63E-03	1.16E-03
IntAct	BP	GO:0007635	chemosensory behavior	-	20	18	-	-	6.29E-04	8.72E-04
IntAct	BP	GO:1905954	positive regulation of lipid localization	-	110	104	-	-	7.85E-03	4.89E-03
IntAct	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.67E-04	5.82E-04
IntAct	BP	GO:0002209	behavioral defense response	-	39	38	-	-	2.07E-03	1.80E-03
IntAct	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	28	-	-	8.12E-02	1.34E-03
IntAct	BP	GO:0072523	purine-containing compound catabolic process	-	146	140	-	-	6.82E-03	6.51E-03
IntAct	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	30	-	-	1.57E-03	1.40E-03
IntAct	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	26	-	-	2.55E-03	1.22E-03
IntAct	BP	GO:0021535	cell migration in hindbrain	-	16	15	-	-	8.26E-03	6.98E-04
IntAct	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	94	-	-	4.64E-03	4.42E-03
IntAct	BP	GO:0007218	neuropeptide signaling pathway	-	113	90	-	-	3.31E-02	4.19E-03
IntAct	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	5.03E-03	5.82E-04
IntAct	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	150	-	-	4.73E-03	6.98E-03
IntAct	BP	GO:0031345	negative regulation of cell projection organization	-	195	186	-	-	4.16E-03	8.67E-03
IntAct	BP	GO:0048278	vesicle docking	-	64	64	-	-	1.79E-02	3.02E-03
IntAct	BP	GO:0035050	embryonic heart tube development	-	86	84	-	-	2.67E-03	3.95E-03
IntAct	BP	GO:0030168	platelet activation	-	135	129	-	-	7.30E-03	6.05E-03
IntAct	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	1.93E-02	7.56E-04
IntAct	CC	GO:0098810	neurotransmitter reuptake	-	35	34	-	-	2.78E-03	1.63E-03
IntAct	BP	GO:0008213	protein alkylation	-	58	53	-	-	3.83E-03	2.50E-03
IntAct	BP	GO:0009812	flavonoid metabolic process	-	14	13	-	-	1.80E-01	6.40E-04
IntAct	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	5.23E-03	6.40E-04
IntAct	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	2.39E-02	1.16E-03
IntAct	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	3.15E-04	6.40E-04
IntAct	BP	GO:0031529	ruffle organization	-	55	53	-	-	3.04E-03	2.50E-03
IntAct	BP	GO:0010842	retina layer formation	-	25	24	-	-	3.15E-03	1.16E-03
IntAct	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	84	-	-	2.81E-02	3.95E-03
IntAct	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	4.68E-02	5.23E-04
IntAct	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	69	-	-	3.49E-03	3.26E-03
IntAct	MF	GO:0170055	lipid transmembrane transporter activity	-	56	52	-	-	1.14E-02	2.44E-03
IntAct	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	33	-	-	1.01E-03	1.57E-03
IntAct	BP	GO:0035304	regulation of protein dephosphorylation	-	87	84	-	-	1.70E-03	3.95E-03
IntAct	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	225	-	-	4.18E-03	1.05E-02
IntAct	BP	GO:0099637	neurotransmitter receptor transport	-	26	25	-	-	1.68E-03	1.16E-03
IntAct	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	34	-	-	2.37E-03	1.63E-03
IntAct	BP	GO:0051775	response to redox state	-	13	13	-	-	6.85E-03	6.40E-04
IntAct	BP	GO:0051785	positive regulation of nuclear division	-	61	59	-	-	3.57E-03	2.79E-03
IntAct	BP	GO:0060456	positive regulation of digestive system process	-	16	15	-	-	2.61E-03	6.98E-04
IntAct	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	15	-	-	3.24E-03	6.98E-04
IntAct	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	1.14E-03	9.31E-04
IntAct	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	3.82E-02	5.82E-04
IntAct	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	1.64E-02	2.09E-03
IntAct	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	14	-	-	3.56E-04	6.98E-04
IntAct	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	1.94E-03	8.14E-04
IntAct	BP	GO:0051299	centrosome separation	-	15	15	-	-	8.52E-04	6.98E-04
IntAct	BP	GO:0048145	regulation of fibroblast proliferation	-	87	84	-	-	2.03E-03	3.95E-03
IntAct	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	86	-	-	1.83E-01	4.01E-03
IntAct	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	2.00E-02	5.23E-04
IntAct	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	219	-	-	3.77E-03	1.02E-02
IntAct	BP	GO:0032098	regulation of appetite	-	20	20	-	-	7.28E-03	9.31E-04
IntAct	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	2.11E-03	6.98E-04
IntAct	CC	GO:0008333	endosome to lysosome transport	-	73	71	-	-	2.26E-02	3.32E-03
IntAct	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	21	-	-	3.53E-02	9.89E-04
IntAct	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	15	-	-	1.42E-02	6.98E-04
IntAct	BP	GO:0003016	respiratory system process	-	39	37	-	-	1.00E-03	1.74E-03
IntAct	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	7.64E-03	1.11E-03
IntAct	BP	GO:0045732	positive regulation of protein catabolic process	-	202	197	-	-	4.46E-03	9.19E-03
IntAct	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	71	-	-	1.26E-02	3.32E-03
IntAct	BP	GO:0007588	excretion	-	40	38	-	-	3.88E-03	1.80E-03
IntAct	BP	GO:1904018	positive regulation of vasculature development	-	185	151	-	-	1.28E-02	7.04E-03
IntAct	BP	GO:0050953	sensory perception of light stimulus	-	223	193	-	-	1.15E-02	9.01E-03
IntAct	BP	GO:0009164	nucleoside catabolic process	-	25	21	-	-	7.68E-02	9.89E-04
IntAct	BP	GO:0002357	defense response to tumor cell	-	13	11	-	-	1.69E-04	5.23E-04
IntAct	BP	GO:0009303	rRNA transcription	-	37	37	-	-	1.00E-02	1.74E-03
IntAct	BP	GO:0035601	protein deacylation	-	56	55	-	-	3.34E-03	2.56E-03
IntAct	BP	GO:0061952	midbody abscission	-	18	17	-	-	1.31E-01	8.14E-04
IntAct	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	2.76E-03	5.23E-04
IntAct	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	3.39E-03	9.31E-04
IntAct	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	8.09E-03	1.40E-03
IntAct	BP	GO:0071300	cellular response to retinoic acid	-	66	63	-	-	3.46E-03	2.97E-03
IntAct	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	14	-	-	1.72E-04	6.98E-04
IntAct	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	3.62E-03	1.34E-03
IntAct	BP	GO:0031069	hair follicle morphogenesis	-	33	32	-	-	5.67E-03	1.51E-03
IntAct	BP	GO:0046697	decidualization	-	26	25	-	-	5.28E-04	1.16E-03
IntAct	BP	GO:0008212	mineralocorticoid metabolic process	-	14	12	-	-	1.73E-04	5.82E-04
IntAct	BP	GO:0051588	regulation of neurotransmitter transport	-	99	97	-	-	2.63E-03	4.54E-03
IntAct	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	28	-	-	1.34E-02	1.34E-03
IntAct	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	11	-	-	2.83E-03	5.23E-04
IntAct	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	1.17E-02	2.97E-03
IntAct	BP	GO:0044703	multi-organism reproductive process	-	209	193	-	-	5.04E-03	9.01E-03
IntAct	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	137	-	-	7.44E-03	6.40E-03
IntAct	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	50	-	-	2.33E-03	2.33E-03
IntAct	BP	GO:0099022	vesicle tethering	-	32	31	-	-	1.52E-01	1.45E-03
IntAct	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	36	-	-	1.06E-03	1.69E-03
IntAct	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	8.45E-03	5.82E-04
IntAct	BP	GO:0048857	neural nucleus development	-	65	61	-	-	1.52E-03	2.85E-03
IntAct	BP	GO:0048663	neuron fate commitment	-	74	66	-	-	8.08E-03	3.08E-03
IntAct	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	160	-	-	5.24E-03	7.44E-03
IntAct	BP	GO:0106027	neuron projection organization	-	90	87	-	-	4.18E-03	4.07E-03
IntAct	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	125	-	-	7.85E-03	5.82E-03
IntAct	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	1.59E-03	1.63E-03
IntAct	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	2.40E-03	5.23E-04
IntAct	BP	GO:0045685	regulation of glial cell differentiation	-	77	70	-	-	5.08E-03	3.26E-03
IntAct	BP	GO:0051608	histamine transport	-	14	13	-	-	1.32E-03	6.40E-04
IntAct	BP	GO:0043414	macromolecule methylation	-	138	129	-	-	8.09E-03	6.05E-03
IntAct	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	2.72E-02	5.82E-04
IntAct	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	3.63E-02	7.56E-04
IntAct	BP	GO:0050886	endocrine process	-	93	85	-	-	3.25E-03	3.95E-03
IntAct	MF	GO:0015562	efflux transmembrane transporter activity	-	15	13	-	-	1.73E-04	6.40E-04
IntAct	BP	GO:0050951	sensory perception of temperature stimulus	-	28	25	-	-	8.31E-04	1.16E-03
IntAct	BP	GO:0045807	positive regulation of endocytosis	-	155	148	-	-	5.39E-03	6.92E-03
IntAct	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	4.05E-04	5.23E-04
IntAct	BP	GO:0002418	immune response to tumor cell	-	29	27	-	-	1.74E-02	1.28E-03
IntAct	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	57	-	-	2.29E-03	2.68E-03
IntAct	BP	GO:0048308	organelle inheritance	-	14	14	-	-	1.67E-03	6.98E-04
IntAct	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	1.20E-03	8.72E-04
IntAct	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	5.18E-04	9.31E-04
IntAct	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	46	-	-	4.55E-03	2.15E-03
IntAct	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.20E-03	3.14E-03
IntAct	BP	GO:0009110	vitamin biosynthetic process	-	23	21	-	-	2.82E-04	9.89E-04
IntAct	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	4.53E-03	1.05E-03
IntAct	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	4.14E-03	8.14E-04
IntAct	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	21	-	-	1.60E-03	9.89E-04
IntAct	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	91	-	-	1.58E-03	4.25E-03
IntAct	MF	GO:0051100	negative regulation of binding	-	161	155	-	-	2.99E-03	7.21E-03
IntAct	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	3.15E-03	3.66E-03
IntAct	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	3.11E-03	2.79E-03
IntAct	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	4.26E-04	9.31E-04
IntAct	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	11	-	-	1.71E-04	5.23E-04
IntAct	BP	GO:0061036	positive regulation of cartilage development	-	33	30	-	-	9.74E-03	1.40E-03
IntAct	BP	GO:0046184	aldehyde biosynthetic process	-	16	14	-	-	1.72E-04	6.98E-04
IntAct	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	1.71E-04	6.40E-04
IntAct	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	3.51E-03	2.21E-03
IntAct	BP	GO:0046621	negative regulation of organ growth	-	39	31	-	-	7.93E-04	1.45E-03
IntAct	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	1.46E-01	2.33E-03
IntAct	BP	GO:0032368	regulation of lipid transport	-	149	128	-	-	7.14E-03	5.99E-03
IntAct	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	3.55E-03	1.40E-03
IntAct	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	177	-	-	5.35E-03	8.26E-03
IntAct	BP	GO:0033002	muscle cell proliferation	-	249	197	-	-	5.52E-03	9.19E-03
IntAct	BP	GO:0043331	response to dsRNA	-	56	54	-	-	5.98E-02	2.56E-03
IntAct	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	4.16E-02	5.82E-04
IntAct	BP	GO:0051904	pigment granule transport	-	23	22	-	-	3.48E-02	1.05E-03
IntAct	BP	GO:1901679	nucleotide transmembrane transport	-	32	31	-	-	5.52E-03	1.45E-03
IntAct	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	8.18E-04	1.57E-03
IntAct	BP	GO:0033363	secretory granule organization	-	63	59	-	-	1.17E-02	2.79E-03
IntAct	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	1.73E-03	1.34E-03
IntAct	BP	GO:0120009	intermembrane lipid transfer	-	52	49	-	-	3.82E-02	2.33E-03
IntAct	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	6.79E-03	6.98E-04
IntAct	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	36	-	-	2.52E-03	1.69E-03
IntAct	BP	GO:0033622	integrin activation	-	26	26	-	-	5.24E-03	1.22E-03
IntAct	BP	GO:0098751	bone cell development	-	18	16	-	-	2.24E-04	7.56E-04
IntAct	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.19E-03	9.89E-04
IntAct	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	3.65E-03	2.38E-03
IntAct	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	8.23E-03	1.40E-03
IntAct	BP	GO:0002076	osteoblast development	-	17	17	-	-	2.48E-02	8.14E-04
IntAct	BP	GO:0072164	mesonephric tubule development	-	98	92	-	-	3.19E-03	4.30E-03
IntAct	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	16	-	-	2.29E-04	7.56E-04
IntAct	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	104	-	-	5.63E-03	4.89E-03
IntAct	BP	GO:1903524	positive regulation of blood circulation	-	39	31	-	-	5.89E-04	1.45E-03
IntAct	BP	GO:0030901	midbrain development	-	87	82	-	-	3.32E-03	3.84E-03
IntAct	BP	GO:0048485	sympathetic nervous system development	-	22	21	-	-	8.05E-04	9.89E-04
IntAct	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	2.24E-04	7.56E-04
IntAct	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	2.55E-03	6.40E-04
IntAct	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	66	-	-	2.35E-03	3.08E-03
IntAct	MF	GO:1901474	azole transmembrane transporter activity	-	13	11	-	-	2.60E-03	5.23E-04
IntAct	BP	GO:0002687	positive regulation of leukocyte migration	-	147	142	-	-	1.12E-02	6.63E-03
IntAct	BP	GO:0019755	one-carbon compound transport	-	28	25	-	-	1.33E-02	1.16E-03
IntAct	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.69E-04	6.40E-04
IntAct	BP	GO:0060856	establishment of blood-brain barrier	-	16	15	-	-	1.07E-02	6.98E-04
IntAct	BP	GO:0110154	RNA decapping	-	19	19	-	-	5.50E-02	9.31E-04
IntAct	BP	GO:0034605	cellular response to heat	-	66	65	-	-	1.47E-03	3.02E-03
IntAct	BP	GO:0005996	monosaccharide metabolic process	-	250	237	-	-	7.24E-03	1.11E-02
IntAct	BP	GO:0033555	multicellular organismal response to stress	-	90	85	-	-	1.69E-03	3.95E-03
IntAct	BP	GO:0002262	myeloid cell homeostasis	-	172	165	-	-	4.25E-03	7.68E-03
IntAct	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	1.03E-01	1.80E-03
IntAct	BP	GO:0050688	regulation of defense response to virus	-	65	63	-	-	1.57E-02	2.97E-03
IntAct	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	2.04E-03	9.31E-04
IntAct	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	221	-	-	7.36E-03	1.03E-02
IntAct	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	9.48E-04	1.45E-03
IntAct	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	5.73E-04	6.98E-04
IntAct	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	7.98E-03	1.51E-03
IntAct	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	17	-	-	4.12E-03	8.14E-04
IntAct	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	1.98E-02	1.34E-03
IntAct	BP	GO:0022618	protein-RNA complex assembly	-	227	190	-	-	2.87E-02	8.84E-03
IntAct	BP	GO:0051147	regulation of muscle cell differentiation	-	162	133	-	-	3.35E-03	6.22E-03
IntAct	BP	GO:0090102	cochlea development	-	50	48	-	-	1.01E-03	2.27E-03
IntAct	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	1.94E-03	1.22E-03
IntAct	BP	GO:0045933	positive regulation of muscle contraction	-	49	42	-	-	4.17E-03	1.98E-03
IntAct	BP	GO:0015803	branched-chain amino acid transport	-	14	12	-	-	2.93E-03	5.82E-04
IntAct	BP	GO:0002679	respiratory burst involved in defense response	-	16	15	-	-	2.24E-04	6.98E-04
IntAct	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	35	-	-	3.66E-03	1.63E-03
IntAct	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	90	-	-	5.83E-02	4.19E-03
IntAct	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.71E-04	5.82E-04
IntAct	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	1.58E-03	1.05E-03
IntAct	BP	GO:0032922	circadian regulation of gene expression	-	71	70	-	-	5.88E-03	3.26E-03
IntAct	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	49	-	-	8.69E-03	2.33E-03
IntAct	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	150	-	-	5.54E-03	6.98E-03
IntAct	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	19	-	-	1.62E-02	9.31E-04
IntAct	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	56	-	-	4.54E-03	2.62E-03
IntAct	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	1.99E-03	5.23E-04
IntAct	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	9.00E-03	1.80E-03
IntAct	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.69E-04	5.82E-04
IntAct	BP	GO:0140253	cell-cell fusion	-	62	57	-	-	2.36E-03	2.68E-03
IntAct	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	1.72E-04	5.82E-04
IntAct	BP	GO:0071599	otic vesicle development	-	15	15	-	-	8.17E-03	6.98E-04
IntAct	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	42	-	-	4.75E-02	1.98E-03
IntAct	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	1.20E-03	6.98E-04
IntAct	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	5.98E-03	2.79E-03
IntAct	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	7.26E-03	1.69E-03
IntAct	BP	GO:0051293	establishment of spindle localization	-	57	56	-	-	3.29E-03	2.62E-03
IntAct	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	1.67E-04	5.82E-04
IntAct	BP	GO:0043114	regulation of vascular permeability	-	49	42	-	-	3.18E-03	1.98E-03
IntAct	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	4.67E-03	1.22E-03
IntAct	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	61	-	-	1.66E-03	2.85E-03
IntAct	BP	GO:0008360	regulation of cell shape	-	139	135	-	-	8.61E-03	6.28E-03
IntAct	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	2.29E-04	7.56E-04
IntAct	BP	GO:0051222	positive regulation of protein transport	-	249	237	-	-	4.20E-03	1.11E-02
IntAct	CC	GO:0140632	canonical inflammasome complex assembly	-	40	39	-	-	1.05E-02	1.86E-03
IntAct	MF	GO:0034260	negative regulation of GTPase activity	-	36	32	-	-	7.54E-04	1.51E-03
IntAct	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	1.30E-02	1.05E-03
IntAct	BP	GO:0045739	positive regulation of DNA repair	-	128	127	-	-	4.54E-02	5.93E-03
IntAct	BP	GO:0001845	phagolysosome assembly	-	19	17	-	-	3.70E-03	8.14E-04
IntAct	BP	GO:0045185	maintenance of protein location	-	95	88	-	-	2.83E-03	4.13E-03
IntAct	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	12	-	-	2.51E-02	5.82E-04
IntAct	BP	GO:0003158	endothelium development	-	140	126	-	-	6.23E-03	5.87E-03
IntAct	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	2.04E-03	1.92E-03
IntAct	BP	GO:0051224	negative regulation of protein transport	-	122	104	-	-	4.80E-03	4.89E-03
IntAct	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	137	-	-	2.62E-03	6.40E-03
IntAct	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	4.61E-03	6.40E-04
IntAct	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	29	-	-	1.43E-03	1.40E-03
IntAct	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	9.47E-02	9.31E-04
IntAct	BP	GO:0021885	forebrain cell migration	-	63	62	-	-	4.64E-03	2.91E-03
IntAct	BP	GO:0007405	neuroblast proliferation	-	81	77	-	-	2.94E-03	3.61E-03
IntAct	BP	GO:0009581	detection of external stimulus	-	137	114	-	-	1.62E-02	5.35E-03
IntAct	BP	GO:1990542	mitochondrial transmembrane transport	-	93	90	-	-	2.34E-02	4.19E-03
IntAct	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	1.86E-03	1.45E-03
IntAct	BP	GO:0033504	floor plate development	-	11	11	-	-	4.73E-04	5.23E-04
IntAct	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	5.18E-03	5.23E-04
IntAct	BP	GO:0097186	amelogenesis	-	26	21	-	-	5.33E-02	9.89E-04
IntAct	BP	GO:0031128	developmental induction	-	26	26	-	-	4.64E-03	1.22E-03
IntAct	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	8.02E-03	6.98E-04
IntAct	BP	GO:0031100	animal organ regeneration	-	66	65	-	-	9.52E-04	3.02E-03
IntAct	BP	GO:0021533	cell differentiation in hindbrain	-	23	21	-	-	8.92E-04	9.89E-04
IntAct	BP	GO:0045684	positive regulation of epidermis development	-	33	29	-	-	7.98E-04	1.40E-03
IntAct	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	1.72E-04	5.82E-04
IntAct	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	1.67E-02	2.38E-03
IntAct	BP	GO:0021517	ventral spinal cord development	-	47	42	-	-	2.72E-03	1.98E-03
IntAct	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	3.34E-03	3.49E-03
IntAct	BP	GO:0032328	alanine transport	-	19	17	-	-	2.60E-03	8.14E-04
IntAct	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	1.87E-03	7.56E-04
IntAct	BP	GO:0097722	sperm motility	-	133	115	-	-	3.07E-03	5.35E-03
IntAct	BP	GO:0051231	spindle elongation	-	14	14	-	-	2.39E-02	6.98E-04
IntAct	BP	GO:0042490	mechanoreceptor differentiation	-	67	62	-	-	6.22E-03	2.91E-03
IntAct	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	2.43E-03	1.40E-03
IntAct	BP	GO:0035148	tube formation	-	155	148	-	-	4.33E-03	6.92E-03
IntAct	BP	GO:0048520	positive regulation of behavior	-	27	25	-	-	8.10E-03	1.16E-03
IntAct	BP	GO:0098543	detection of other organism	-	19	17	-	-	2.73E-03	8.14E-04
IntAct	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	1.02E-02	2.04E-03
IntAct	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	118	-	-	1.40E-02	5.53E-03
IntAct	BP	GO:0031123	RNA 3'-end processing	-	79	77	-	-	2.66E-02	3.61E-03
IntAct	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	105	-	-	2.93E-03	4.89E-03
IntAct	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	1.38E-02	8.72E-04
IntAct	CC	GO:0007097	nuclear migration	-	24	23	-	-	1.91E-02	1.11E-03
IntAct	BP	GO:0006885	regulation of pH	-	104	95	-	-	5.40E-03	4.42E-03
IntAct	BP	GO:0002467	germinal center formation	-	14	14	-	-	2.57E-03	6.98E-04
IntAct	BP	GO:1990840	response to lectin	-	22	19	-	-	1.44E-02	9.31E-04
IntAct	BP	GO:0071800	podosome assembly	-	19	19	-	-	4.37E-04	9.31E-04
IntAct	BP	GO:0031018	endocrine pancreas development	-	47	43	-	-	4.84E-03	2.04E-03
IntAct	BP	GO:0001708	cell fate specification	-	108	102	-	-	7.55E-03	4.77E-03
IntAct	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	66	-	-	1.05E-02	3.08E-03
IntAct	BP	GO:0030279	negative regulation of ossification	-	39	36	-	-	5.73E-03	1.69E-03
IntAct	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	3.04E-03	6.98E-04
IntAct	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	13	-	-	4.90E-03	6.40E-04
IntAct	BP	GO:0042440	pigment metabolic process	-	80	75	-	-	3.91E-02	3.49E-03
IntAct	BP	GO:1901606	alpha-amino acid catabolic process	-	101	98	-	-	1.36E-02	4.59E-03
IntAct	BP	GO:1901890	positive regulation of cell junction assembly	-	106	97	-	-	3.00E-03	4.54E-03
IntAct	BP	GO:0070988	demethylation	-	27	25	-	-	2.82E-02	1.16E-03
IntAct	BP	GO:1901655	cellular response to ketone	-	107	104	-	-	2.80E-03	4.89E-03
IntAct	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	1.71E-04	6.98E-04
IntAct	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	1.62E-02	6.98E-04
IntAct	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	4.29E-02	8.14E-04
IntAct	BP	GO:0006968	cellular defense response	-	52	50	-	-	1.26E-02	2.33E-03
IntAct	BP	GO:0055006	cardiac cell development	-	93	83	-	-	3.26E-03	3.90E-03
IntAct	BP	GO:0031365	N-terminal protein amino acid modification	-	30	28	-	-	3.71E-02	1.34E-03
IntAct	BP	GO:0035881	amacrine cell differentiation	-	12	11	-	-	1.73E-04	5.23E-04
IntAct	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	27	-	-	1.49E-03	1.28E-03
IntAct	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	4.76E-04	5.82E-04
IntAct	BP	GO:0060004	reflex	-	63	59	-	-	3.91E-03	2.79E-03
IntAct	BP	GO:0044706	multi-multicellular organism process	-	217	202	-	-	4.84E-03	9.42E-03
IntAct	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	4.75E-03	5.82E-04
IntAct	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	139	-	-	4.22E-03	6.51E-03
IntAct	BP	GO:0006026	aminoglycan catabolic process	-	34	32	-	-	2.63E-03	1.51E-03
IntAct	BP	GO:0031294	lymphocyte costimulation	-	47	43	-	-	1.09E-02	2.04E-03
IntAct	BP	GO:0050768	negative regulation of neurogenesis	-	150	138	-	-	2.52E-03	6.46E-03
IntAct	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	93	-	-	2.05E-03	4.36E-03
IntAct	BP	GO:0090068	positive regulation of cell cycle process	-	262	241	-	-	7.39E-03	1.12E-02
IntAct	BP	GO:0043605	amide catabolic process	-	16	16	-	-	1.77E-03	7.56E-04
IntAct	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	3.38E-04	1.28E-03
IntAct	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	1.40E-02	1.63E-03
IntAct	BP	GO:1902115	regulation of organelle assembly	-	210	207	-	-	5.91E-03	9.65E-03
IntAct	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	64	-	-	2.22E-03	3.02E-03
IntAct	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	7.29E-04	7.56E-04
IntAct	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	138	-	-	4.12E-03	6.46E-03
IntAct	BP	GO:0043171	peptide catabolic process	-	19	17	-	-	2.29E-04	8.14E-04
IntAct	BP	GO:0046622	positive regulation of organ growth	-	52	41	-	-	1.58E-03	1.92E-03
IntAct	BP	GO:0051952	regulation of amine transport	-	98	94	-	-	1.87E-02	4.42E-03
IntAct	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	8.99E-03	1.11E-03
IntAct	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	19	-	-	1.04E-02	9.31E-04
IntAct	BP	GO:0015801	aromatic amino acid transport	-	13	11	-	-	5.97E-03	5.23E-04
IntAct	BP	GO:0040019	positive regulation of embryonic development	-	23	22	-	-	2.32E-02	1.05E-03
IntAct	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	2.82E-04	9.31E-04
IntAct	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	2.25E-04	7.56E-04
IntAct	CC	GO:0032365	intracellular lipid transport	-	51	49	-	-	4.43E-02	2.33E-03
IntAct	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	5.81E-02	1.40E-03
IntAct	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	68	-	-	2.58E-03	3.20E-03
IntAct	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	112	-	-	3.24E-03	5.23E-03
IntAct	BP	GO:0018149	peptide cross-linking	-	28	27	-	-	1.83E-03	1.28E-03
IntAct	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	5.30E-04	1.16E-03
IntAct	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	5.31E-04	6.40E-04
IntAct	BP	GO:0021859	pyramidal neuron differentiation	-	14	13	-	-	3.00E-04	6.40E-04
IntAct	BP	GO:0061000	negative regulation of dendritic spine development	-	13	12	-	-	1.69E-04	5.82E-04
IntAct	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	2.83E-02	1.63E-03
IntAct	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	6.51E-03	4.19E-03
IntAct	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	3.27E-02	1.40E-03
IntAct	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	1.40E-02	8.72E-04
IntAct	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	2.23E-03	9.89E-04
IntAct	BP	GO:0015669	gas transport	-	23	22	-	-	1.15E-01	1.05E-03
IntAct	BP	GO:0016485	protein processing	-	248	236	-	-	9.12E-03	1.10E-02
IntAct	BP	GO:0009649	entrainment of circadian clock	-	30	28	-	-	4.10E-03	1.34E-03
IntAct	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	151	-	-	1.33E-02	7.04E-03
IntAct	BP	GO:1903523	negative regulation of blood circulation	-	27	23	-	-	1.23E-03	1.11E-03
IntAct	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	125	-	-	5.90E-03	5.82E-03
IntAct	BP	GO:0000101	sulfur amino acid transport	-	12	11	-	-	1.91E-01	5.23E-04
IntAct	BP	GO:0099054	presynapse assembly	-	49	43	-	-	3.06E-03	2.04E-03
IntAct	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	24	-	-	6.36E-03	1.16E-03
IntAct	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	1.90E-03	1.16E-03
IntAct	BP	GO:0031348	negative regulation of defense response	-	282	237	-	-	5.15E-03	1.11E-02
IntAct	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	74	-	-	5.10E-03	3.49E-03
IntAct	BP	GO:0007606	sensory perception of chemical stimulus	-	535	133	-	-	1.82E-02	6.22E-03
IntAct	BP	GO:0061180	mammary gland epithelium development	-	68	67	-	-	3.11E-03	3.14E-03
IntAct	BP	GO:0071496	cellular response to external stimulus	-	74	72	-	-	3.31E-03	3.37E-03
IntAct	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	1.71E-04	6.40E-04
IntAct	BP	GO:0042753	positive regulation of circadian rhythm	-	18	16	-	-	3.38E-03	7.56E-04
IntAct	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	1.28E-03	5.23E-04
IntAct	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.41E-02	5.82E-04
IntAct	BP	GO:0032094	response to food	-	37	35	-	-	1.91E-03	1.63E-03
IntAct	BP	GO:0001964	startle response	-	27	26	-	-	6.51E-03	1.22E-03
IntAct	BP	GO:0007340	acrosome reaction	-	38	33	-	-	5.06E-02	1.57E-03
IntAct	BP	GO:0046434	organophosphate catabolic process	-	232	219	-	-	6.38E-03	1.02E-02
IntAct	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	5.33E-02	1.40E-03
IntAct	BP	GO:0009566	fertilization	-	205	176	-	-	6.07E-03	8.20E-03
IntAct	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	59	-	-	3.14E-01	2.79E-03
IntAct	BP	GO:0120255	olefinic compound biosynthetic process	-	24	21	-	-	2.86E-04	9.89E-04
IntAct	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	3.49E-03	6.40E-04
IntAct	BP	GO:0045907	positive regulation of vasoconstriction	-	30	27	-	-	1.85E-03	1.28E-03
IntAct	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	21	-	-	2.59E-03	9.89E-04
IntAct	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	1.36E-02	1.16E-02
IntAct	BP	GO:0009309	amine biosynthetic process	-	38	35	-	-	2.08E-02	1.63E-03
IntAct	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	6.75E-04	9.31E-04
IntAct	BP	GO:0061900	glial cell activation	-	56	50	-	-	2.40E-03	2.33E-03
IntAct	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	133	-	-	1.57E-02	6.22E-03
IntAct	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	11	-	-	5.28E-03	5.23E-04
IntAct	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	6.16E-03	6.98E-04
IntAct	BP	GO:0021794	thalamus development	-	12	11	-	-	1.72E-04	5.23E-04
IntAct	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	1.88E-02	1.92E-03
IntAct	BP	GO:0035902	response to immobilization stress	-	20	19	-	-	2.24E-04	9.31E-04
IntAct	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	3.38E-03	6.98E-04
IntAct	BP	GO:0072537	fibroblast activation	-	13	13	-	-	1.77E-02	6.40E-04
IntAct	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	2.36E-03	6.40E-04
IntAct	BP	GO:0043647	inositol phosphate metabolic process	-	44	40	-	-	3.03E-03	1.86E-03
IntAct	BP	GO:0016180	snRNA processing	-	28	27	-	-	1.21E-01	1.28E-03
IntAct	BP	GO:0051303	establishment of chromosome localization	-	104	102	-	-	1.13E-02	4.77E-03
IntAct	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	4.49E-02	7.56E-04
IntAct	BP	GO:0007164	establishment of tissue polarity	-	38	37	-	-	5.37E-03	1.74E-03
IntAct	BP	GO:0097164	ammonium ion metabolic process	-	23	22	-	-	2.87E-04	1.05E-03
IntAct	BP	GO:0021515	cell differentiation in spinal cord	-	51	45	-	-	7.22E-03	2.09E-03
IntAct	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	2.26E-04	8.72E-04
IntAct	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	20	-	-	1.51E-03	9.31E-04
IntAct	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	1.43E-03	1.34E-03
IntAct	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	9.94E-04	8.72E-04
IntAct	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	36	-	-	4.99E-02	1.69E-03
IntAct	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	2.62E-02	1.05E-03
IntAct	BP	GO:0007566	embryo implantation	-	57	51	-	-	1.05E-03	2.38E-03
IntAct	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	7.24E-04	1.57E-03
IntAct	BP	GO:0031268	pseudopodium organization	-	17	17	-	-	3.92E-02	8.14E-04
IntAct	BP	GO:0060306	regulation of membrane repolarization	-	38	29	-	-	7.95E-03	1.40E-03
IntAct	BP	GO:0051017	actin filament bundle assembly	-	161	152	-	-	5.13E-03	7.10E-03
IntAct	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	1.63E-03	1.98E-03
IntAct	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	17	-	-	2.97E-03	8.14E-04
IntAct	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	2.20E-04	9.31E-04
IntAct	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	1.68E-04	6.40E-04
IntAct	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	34	-	-	3.04E-03	1.63E-03
IntAct	BP	GO:0021756	striatum development	-	21	21	-	-	1.08E-03	9.89E-04
IntAct	BP	GO:1901343	negative regulation of vasculature development	-	154	99	-	-	3.34E-03	4.65E-03
IntAct	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	148	-	-	1.18E-02	6.92E-03
IntAct	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	28	-	-	6.57E-03	1.34E-03
IntAct	BP	GO:1902414	protein localization to cell junction	-	107	104	-	-	3.16E-03	4.89E-03
IntAct	BP	GO:0071305	cellular response to vitamin D	-	23	21	-	-	3.99E-03	9.89E-04
IntAct	BP	GO:0051304	chromosome separation	-	80	80	-	-	8.08E-03	3.72E-03
IntAct	BP	GO:0045780	positive regulation of bone resorption	-	18	17	-	-	4.23E-03	8.14E-04
IntAct	BP	GO:0048709	oligodendrocyte differentiation	-	101	94	-	-	1.77E-03	4.42E-03
IntAct	BP	GO:0045017	glycerolipid biosynthetic process	-	254	244	-	-	1.95E-02	1.14E-02
IntAct	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	2.83E-01	6.98E-04
IntAct	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	9.11E-03	1.11E-03
IntAct	BP	GO:0001776	leukocyte homeostasis	-	108	99	-	-	4.04E-03	4.65E-03
IntAct	BP	GO:0050769	positive regulation of neurogenesis	-	240	228	-	-	8.70E-03	1.06E-02
IntAct	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	1.41E-02	6.98E-04
IntAct	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	1.06E-02	3.26E-03
IntAct	BP	GO:0050866	negative regulation of cell activation	-	216	201	-	-	6.07E-03	9.36E-03
IntAct	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	35	-	-	1.30E-03	1.63E-03
IntAct	BP	GO:0033500	carbohydrate homeostasis	-	251	221	-	-	3.86E-03	1.03E-02
IntAct	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	30	-	-	1.46E-02	1.40E-03
IntAct	BP	GO:0038183	bile acid signaling pathway	-	12	11	-	-	1.31E-02	5.23E-04
IntAct	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	2.02E-03	2.62E-03
IntAct	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	2.14E-03	1.11E-03
IntAct	CC	GO:0099522	cytosolic region	-	20	20	-	-	6.82E-04	9.31E-04
IntAct	CC	GO:0000791	euchromatin	-	60	56	-	-	2.46E-03	2.62E-03
IntAct	CC	GO:0030666	endocytic vesicle membrane	-	196	189	-	-	1.06E-02	8.84E-03
IntAct	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.12E-01	6.98E-04
IntAct	CC	GO:1990752	microtubule end	-	34	34	-	-	1.27E-02	1.63E-03
IntAct	CC	GO:0043204	perikaryon	-	156	151	-	-	3.29E-03	7.04E-03
IntAct	CC	GO:0061702	canonical inflammasome complex	-	17	15	-	-	8.97E-02	6.98E-04
IntAct	CC	GO:0097542	ciliary tip	-	48	48	-	-	1.71E-01	2.27E-03
IntAct	CC	GO:1905368	peptidase complex	-	124	122	-	-	7.09E-02	5.70E-03
IntAct	CC	GO:0000792	heterochromatin	-	98	97	-	-	5.64E-03	4.54E-03
IntAct	CC	GO:0097546	ciliary base	-	47	44	-	-	5.92E-03	2.09E-03
IntAct	CC	GO:0071819	DUBm complex	-	25	24	-	-	2.39E-01	1.16E-03
IntAct	CC	GO:0031201	SNARE complex	-	48	48	-	-	2.21E-01	2.27E-03
IntAct	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.18E-03	6.40E-04
IntAct	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	1.06E-02	1.86E-03
IntAct	CC	GO:0044391	ribosomal subunit	-	203	201	-	-	1.03E-01	9.36E-03
IntAct	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	12	-	-	3.74E-02	5.82E-04
IntAct	CC	GO:0071013	catalytic step 2 spliceosome	-	88	88	-	-	4.44E-02	4.13E-03
IntAct	CC	GO:0031907	microbody lumen	-	51	49	-	-	3.62E-02	2.33E-03
IntAct	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.63E-01	5.23E-04
IntAct	CC	GO:0098862	cluster of actin-based cell projections	-	162	149	-	-	1.25E-02	6.98E-03
IntAct	CC	GO:0016363	nuclear matrix	-	127	126	-	-	4.63E-03	5.87E-03
IntAct	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	7.59E-02	2.15E-03
IntAct	CC	GO:0032432	actin filament bundle	-	249	233	-	-	1.46E-02	1.09E-02
IntAct	CC	GO:0008088	axo-dendritic transport	-	78	78	-	-	2.07E-02	3.66E-03
IntAct	CC	GO:0031519	PcG protein complex	-	38	38	-	-	2.57E-02	1.80E-03
IntAct	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	40	-	-	6.24E-03	1.86E-03
IntAct	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	218	-	-	1.44E-02	1.02E-02
IntAct	CC	GO:0000313	organellar ribosome	-	89	89	-	-	3.14E-01	4.19E-03
IntAct	CC	GO:0099643	signal release from synapse	-	147	142	-	-	1.34E-02	6.63E-03
IntAct	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	9.90E-03	2.15E-03
IntAct	CC	GO:0005818	aster	-	11	11	-	-	1.52E-02	5.23E-04
IntAct	CC	GO:0030018	Z disc	-	129	123	-	-	1.00E-02	5.76E-03
IntAct	CC	GO:0032580	Golgi cisterna membrane	-	93	76	-	-	5.72E-03	3.55E-03
IntAct	CC	GO:0097381	photoreceptor disc membrane	-	25	20	-	-	1.60E-02	9.31E-04
IntAct	CC	GO:1905360	GTPase complex	-	41	38	-	-	4.88E-02	1.80E-03
IntAct	CC	GO:0097540	axonemal central pair	-	161	136	-	-	2.59E-03	6.34E-03
IntAct	CC	GO:0042641	actomyosin	-	77	73	-	-	6.27E-03	3.43E-03
IntAct	CC	GO:0097386	glial cell projection	-	38	37	-	-	3.55E-03	1.74E-03
IntAct	CC	GO:0032588	trans-Golgi network membrane	-	102	98	-	-	1.66E-02	4.59E-03
IntAct	CC	GO:0070382	exocytic vesicle	-	224	219	-	-	1.62E-02	1.02E-02
IntAct	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	46	-	-	2.20E-02	2.15E-03
IntAct	CC	GO:0031903	microbody membrane	-	65	64	-	-	7.16E-02	3.02E-03
IntAct	CC	GO:0046930	pore complex	-	26	26	-	-	4.53E-02	1.22E-03
IntAct	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	4.14E-03	5.23E-04
IntAct	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	8.37E-04	7.56E-04
IntAct	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	244	-	-	1.72E-02	1.14E-02
IntAct	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	4.01E-03	1.16E-03
IntAct	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.17E-01	5.23E-04
IntAct	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	1.92E-03	8.14E-04
IntAct	CC	GO:0044298	cell body membrane	-	32	29	-	-	2.70E-02	1.40E-03
IntAct	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	1.17E-01	5.23E-04
IntAct	CC	GO:0051882	mitochondrial depolarization	-	21	20	-	-	2.70E-03	9.31E-04
IntAct	CC	GO:0045495	pole plasm	-	25	21	-	-	3.51E-03	9.89E-04
IntAct	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	2.57E-03	6.98E-04
IntAct	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	1.41E-01	9.31E-04
IntAct	CC	GO:0010369	chromocenter	-	14	14	-	-	5.28E-03	6.98E-04
IntAct	CC	GO:0002177	manchette	-	19	17	-	-	1.69E-02	8.14E-04
IntAct	CC	GO:0016323	basolateral plasma membrane	-	239	227	-	-	1.23E-02	1.06E-02
IntAct	CC	GO:0045009	chitosome	-	21	21	-	-	3.01E-02	9.89E-04
IntAct	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	3.27E-03	5.82E-04
IntAct	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	6.64E-03	2.09E-03
IntAct	CC	GO:0098636	protein complex involved in cell adhesion	-	57	54	-	-	2.26E-02	2.56E-03
IntAct	CC	GO:0001917	photoreceptor inner segment	-	71	66	-	-	7.70E-03	3.08E-03
IntAct	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	2.50E-03	6.98E-04
IntAct	CC	GO:0019897	extrinsic component of plasma membrane	-	156	150	-	-	9.09E-03	6.98E-03
IntAct	CC	GO:0031594	neuromuscular junction	-	73	70	-	-	2.13E-03	3.26E-03
IntAct	CC	GO:0045120	pronucleus	-	14	14	-	-	5.12E-04	6.98E-04
IntAct	CC	GO:0043083	synaptic cleft	-	21	19	-	-	5.66E-03	9.31E-04
IntAct	CC	GO:0000922	spindle pole	-	172	170	-	-	8.31E-03	7.91E-03
IntAct	CC	GO:0120111	neuron projection cytoplasm	-	94	92	-	-	1.67E-02	4.30E-03
IntAct	CC	GO:0070971	endoplasmic reticulum exit site	-	32	29	-	-	6.85E-02	1.40E-03
IntAct	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	6.58E-02	6.40E-04
IntAct	CC	GO:0004879	nuclear receptor activity	-	63	60	-	-	8.21E-03	2.79E-03
IntAct	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	162	-	-	8.71E-03	7.56E-03
IntAct	CC	GO:0000123	histone acetyltransferase complex	-	93	90	-	-	8.59E-02	4.19E-03
IntAct	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	2.26E-03	6.40E-04
IntAct	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	108	-	-	5.28E-02	5.06E-03
IntAct	CC	GO:0048786	presynaptic active zone	-	80	77	-	-	2.36E-03	3.61E-03
IntAct	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	6.88E-02	5.82E-04
IntAct	CC	GO:0007034	vacuolar transport	-	168	163	-	-	1.68E-02	7.62E-03
IntAct	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	2.77E-02	9.89E-04
IntAct	CC	GO:0043194	axon initial segment	-	21	19	-	-	2.29E-04	9.31E-04
IntAct	CC	GO:0005776	autophagosome	-	111	107	-	-	1.02E-02	5.00E-03
IntAct	CC	GO:0031430	M band	-	22	21	-	-	2.25E-03	9.89E-04
IntAct	CC	GO:0001931	uropod	-	13	13	-	-	1.40E-03	6.40E-04
IntAct	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	76	-	-	1.98E-01	3.55E-03
IntAct	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	96	-	-	1.37E-01	4.48E-03
IntAct	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	5.62E-01	6.40E-04
IntAct	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	2.05E-02	9.31E-04
IntAct	CC	GO:0071203	WASH complex	-	12	12	-	-	2.09E-01	5.82E-04
IntAct	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	2.73E-02	1.40E-03
IntAct	CC	GO:0032994	protein-lipid complex	-	39	37	-	-	1.37E-02	1.74E-03
IntAct	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	148	-	-	7.93E-02	6.92E-03
IntAct	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	1.26E-02	5.82E-04
IntAct	CC	GO:0001527	microfibril	-	13	12	-	-	1.08E-01	5.82E-04
IntAct	CC	GO:0072562	blood microparticle	-	144	133	-	-	1.23E-02	6.22E-03
IntAct	CC	GO:0005883	neurofilament	-	11	11	-	-	9.28E-03	5.23E-04
IntAct	CC	GO:0051233	spindle midzone	-	36	35	-	-	6.23E-03	1.63E-03
IntAct	CC	GO:0005811	lipid droplet	-	102	97	-	-	8.09E-03	4.54E-03
IntAct	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	5.90E-03	2.09E-03
IntAct	CC	GO:0043113	receptor clustering	-	51	50	-	-	4.02E-03	2.33E-03
IntAct	CC	GO:0005940	septin ring	-	14	13	-	-	3.56E-01	6.40E-04
IntAct	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	2.58E-02	5.23E-04
IntAct	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	22	-	-	1.36E-01	1.05E-03
IntAct	CC	GO:0044853	plasma membrane raft	-	114	112	-	-	3.77E-03	5.23E-03
IntAct	CC	GO:0005881	cytoplasmic microtubule	-	256	223	-	-	5.75E-03	1.04E-02
IntAct	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	2.21E-03	6.98E-04
IntAct	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	1.25E-02	8.14E-04
IntAct	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	55	-	-	6.75E-03	2.56E-03
IntAct	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	1.30E-02	3.37E-03
IntAct	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	1.70E-04	5.82E-04
IntAct	CC	GO:0043034	costamere	-	18	17	-	-	3.26E-03	8.14E-04
IntAct	CC	GO:0031904	endosome lumen	-	38	36	-	-	1.38E-02	1.69E-03
IntAct	CC	GO:0060170	ciliary membrane	-	76	63	-	-	7.12E-03	2.97E-03
IntAct	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	5.71E-01	6.40E-04
IntAct	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	8.73E-03	5.82E-04
IntAct	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	6.35E-02	1.16E-03
IntAct	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	6.44E-02	6.98E-04
IntAct	CC	GO:0032154	cleavage furrow	-	54	52	-	-	3.92E-03	2.44E-03
IntAct	CC	GO:0005640	nuclear outer membrane	-	30	27	-	-	2.16E-02	1.28E-03
IntAct	CC	GO:0005652	nuclear lamina	-	12	12	-	-	9.99E-04	5.82E-04
IntAct	CC	GO:0007006	mitochondrial membrane organization	-	117	110	-	-	2.76E-02	5.12E-03
IntAct	CC	GO:0001772	immunological synapse	-	44	44	-	-	7.26E-03	2.09E-03
IntAct	CC	GO:0030904	retromer complex	-	12	12	-	-	2.02E-02	5.82E-04
IntAct	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	8.40E-03	5.82E-04
IntAct	CC	GO:0030863	cortical cytoskeleton	-	104	100	-	-	6.90E-03	4.65E-03
IntAct	CC	GO:1905348	endonuclease complex	-	38	36	-	-	1.05E-01	1.69E-03
IntAct	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	2.96E-01	5.23E-04
IntAct	CC	GO:0030315	T-tubule	-	52	51	-	-	7.65E-03	2.38E-03
IntAct	CC	GO:0060076	excitatory synapse	-	64	61	-	-	5.37E-03	2.85E-03
IntAct	CC	GO:0036019	endolysosome	-	29	29	-	-	1.99E-02	1.40E-03
IntAct	CC	GO:0001891	phagocytic cup	-	28	28	-	-	2.19E-03	1.34E-03
IntAct	CC	GO:0099086	synaptonemal structure	-	40	36	-	-	3.51E-03	1.69E-03
IntAct	CC	GO:0030427	site of polarized growth	-	172	171	-	-	4.38E-03	7.97E-03
IntAct	CC	GO:0044309	neuron spine	-	213	204	-	-	6.44E-03	9.54E-03
IntAct	CC	GO:0030658	transport vesicle membrane	-	231	226	-	-	1.43E-02	1.05E-02
IntAct	CC	GO:0098918	structural constituent of synapse	-	27	26	-	-	1.84E-03	1.22E-03
IntAct	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	6.16E-02	5.82E-04
IntAct	CC	GO:0000940	outer kinetochore	-	17	17	-	-	7.60E-02	8.14E-04
IntAct	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	2.06E-01	8.14E-04
IntAct	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	1.56E-02	2.33E-03
IntAct	CC	GO:0098803	respiratory chain complex	-	39	35	-	-	1.45E-01	1.63E-03
IntAct	CC	GO:0097545	axonemal outer doublet	-	164	139	-	-	3.22E-03	6.51E-03
IntAct	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	18	-	-	3.79E-04	8.72E-04
IntAct	CC	GO:0070069	cytochrome complex	-	42	38	-	-	1.32E-01	1.80E-03
IntAct	CC	GO:0031143	pseudopodium	-	18	18	-	-	1.96E-03	8.72E-04
IntAct	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	26	-	-	2.33E-02	1.22E-03
IntAct	CC	GO:0055037	recycling endosome	-	200	192	-	-	1.13E-02	8.96E-03
IntAct	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	91	-	-	5.79E-03	4.25E-03
IntAct	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	2.44E-02	6.40E-04
IntAct	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	1.21E-03	6.40E-04
IntAct	CC	GO:0071682	endocytic vesicle lumen	-	23	20	-	-	1.81E-03	9.31E-04
IntAct	CC	GO:0030684	preribosome	-	76	73	-	-	2.37E-02	3.43E-03
IntAct	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	19	-	-	3.13E-01	9.31E-04
IntAct	CC	GO:1990391	DNA repair complex	-	22	22	-	-	3.26E-02	1.05E-03
IntAct	CC	GO:0005775	vacuolar lumen	-	176	171	-	-	4.19E-03	7.97E-03
IntAct	CC	GO:0032433	filopodium tip	-	19	19	-	-	5.45E-03	9.31E-04
IntAct	CC	GO:0032982	myosin filament	-	24	24	-	-	1.01E-02	1.16E-03
IntAct	CC	GO:0016327	apicolateral plasma membrane	-	23	22	-	-	1.41E-03	1.05E-03
IntAct	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	9.22E-02	1.11E-03
IntAct	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	11	-	-	5.86E-03	5.23E-04
IntAct	CC	GO:0044306	neuron projection terminus	-	164	155	-	-	4.21E-03	7.21E-03
IntAct	CC	GO:0034455	t-UTP complex	-	53	51	-	-	1.52E-02	2.38E-03
IntAct	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	6.85E-01	8.14E-04
IntAct	CC	GO:0031970	organelle envelope lumen	-	94	92	-	-	9.81E-03	4.30E-03
IntAct	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.97E-02	6.40E-04
IntAct	CC	GO:0120293	dynein axonemal particle	-	20	17	-	-	1.67E-03	8.14E-04
IntAct	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	1.78E-03	1.16E-03
IntAct	CC	GO:0043292	contractile muscle fiber	-	245	233	-	-	1.58E-02	1.09E-02
IntAct	CC	GO:0018995	host cellular component	-	12	12	-	-	4.60E-03	5.82E-04
IntAct	CC	GO:0034709	methylosome	-	13	13	-	-	2.76E-02	6.40E-04
IntAct	CC	GO:0032426	stereocilium tip	-	21	18	-	-	1.18E-03	8.72E-04
IntAct	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	5.80E-03	5.82E-04
IntAct	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	1.19E-01	9.31E-04
IntAct	CC	GO:0000803	sex chromosome	-	32	29	-	-	1.78E-03	1.40E-03
IntAct	CC	GO:0098982	GABA-ergic synapse	-	84	77	-	-	1.12E-02	3.61E-03
IntAct	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	5.62E-02	7.56E-04
IntAct	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	5.81E-02	2.97E-03
IntAct	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	3.13E-01	6.98E-04
IntAct	CC	GO:0000242	pericentriolar material	-	22	22	-	-	3.54E-03	1.05E-03
IntAct	CC	GO:1903293	phosphatase complex	-	54	53	-	-	2.45E-02	2.50E-03
IntAct	CC	GO:0097470	ribbon synapse	-	13	13	-	-	5.04E-03	6.40E-04
IntAct	CC	GO:0031941	filamentous actin	-	27	25	-	-	1.60E-03	1.16E-03
IntAct	CC	GO:0000786	nucleosome	-	149	103	-	-	1.53E-02	4.83E-03
IntAct	CC	GO:0001533	cornified envelope	-	59	56	-	-	1.86E-03	2.62E-03
IntAct	CC	GO:1904724	tertiary granule lumen	-	55	53	-	-	1.80E-03	2.50E-03
IntAct	CC	GO:0030027	lamellipodium	-	202	199	-	-	7.88E-03	9.31E-03
IntAct	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	5.14E-03	6.98E-04
IntAct	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	25	-	-	4.16E-02	1.16E-03
IntAct	CC	GO:0000800	lateral element	-	14	14	-	-	1.37E-02	6.98E-04
IntAct	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	6.96E-03	5.82E-04
IntAct	CC	GO:0060077	inhibitory synapse	-	20	19	-	-	5.18E-02	9.31E-04
IntAct	CC	GO:0031209	SCAR complex	-	12	12	-	-	4.42E-02	5.82E-04
IntAct	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	1.73E-01	7.56E-04
IntAct	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	3.73E-02	9.89E-04
IntAct	CC	GO:0002102	podosome	-	31	31	-	-	2.31E-03	1.45E-03
IntAct	CC	GO:0090543	Flemming body	-	33	32	-	-	1.58E-02	1.51E-03
IntAct	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	3.65E-03	3.08E-03
IntAct	CC	GO:0001650	fibrillar center	-	151	148	-	-	3.66E-03	6.92E-03
IntAct	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	1.70E-02	6.98E-04
IntAct	CC	GO:1990204	oxidoreductase complex	-	90	85	-	-	7.90E-02	3.95E-03
IntAct	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	1.47E-01	7.56E-04
IntAct	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	3.18E-01	5.23E-04
IntAct	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	3.19E-03	5.82E-03
IntAct	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	1.03E-01	9.31E-04
IntAct	CC	GO:0001726	ruffle	-	181	181	-	-	7.43E-03	8.43E-03
IntAct	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	4.16E-03	6.40E-04
IntAct	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	7.77E-02	8.72E-04
IntAct	CC	GO:0043198	dendritic shaft	-	38	36	-	-	9.91E-04	1.69E-03
IntAct	CC	GO:0043073	germ cell nucleus	-	67	62	-	-	1.79E-03	2.91E-03
IntAct	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	6.57E-03	9.89E-04
IntAct	CC	GO:0016592	mediator complex	-	38	38	-	-	5.21E-01	1.80E-03
IntAct	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	3.21E-02	9.31E-04
IntAct	CC	GO:0022626	cytosolic ribosome	-	118	116	-	-	2.33E-02	5.41E-03
IntAct	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	1.09E-01	2.09E-03
IntAct	CC	GO:0034451	centriolar satellite	-	120	116	-	-	1.31E-02	5.41E-03
IntAct	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	2.96E-02	5.23E-04
IntAct	CC	GO:0045171	intercellular bridge	-	91	90	-	-	1.55E-02	4.19E-03
IntAct	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	81	-	-	8.32E-03	3.78E-03
IntAct	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	2.53E-02	6.98E-04
IntAct	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	3.57E-02	5.23E-04
IntAct	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	4.48E-02	5.23E-04
IntAct	CC	GO:0044292	dendrite terminus	-	13	13	-	-	1.34E-03	6.40E-04
IntAct	CC	GO:0032039	integrator complex	-	19	18	-	-	2.61E-01	8.72E-04
IntAct	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	3.60E-03	6.98E-04
IntAct	CC	GO:0033268	node of Ranvier	-	16	15	-	-	2.29E-04	6.98E-04
IntAct	CC	GO:0036038	MKS complex	-	13	13	-	-	6.70E-03	6.40E-04
IntAct	CC	GO:0030527	structural constituent of chromatin	-	97	52	-	-	7.42E-03	2.44E-03
IntAct	CC	GO:0036379	myofilament	-	26	24	-	-	4.09E-02	1.16E-03
IntAct	CC	GO:0030286	dynein complex	-	210	181	-	-	7.56E-03	8.43E-03
IntAct	CC	GO:0031105	septin complex	-	14	13	-	-	4.51E-01	6.40E-04
IntAct	CC	GO:0097228	sperm principal piece	-	33	26	-	-	3.61E-03	1.22E-03
IntAct	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.52E-02	5.82E-04
IntAct	CC	GO:0016482	cytosolic transport	-	135	134	-	-	8.54E-03	6.28E-03
IntAct	CC	GO:0090665	glycoprotein complex	-	23	22	-	-	3.40E-02	1.05E-03
IntAct	CC	GO:0005796	Golgi lumen	-	106	91	-	-	7.46E-03	4.25E-03
IntAct	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	36	-	-	9.54E-02	1.69E-03
IntAct	CC	GO:0034358	plasma lipoprotein particle	-	36	34	-	-	2.29E-02	1.63E-03
IntAct	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	1.21E-01	2.21E-03
IntAct	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	24	-	-	6.59E-03	1.16E-03
IntAct	CC	GO:0030662	coated vesicle membrane	-	202	199	-	-	1.36E-02	9.31E-03
IntAct	CC	GO:0007039	protein catabolic process in the vacuole	-	61	59	-	-	1.78E-02	2.79E-03
IntAct	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	66	-	-	1.80E-01	3.08E-03
IntAct	CC	GO:0090734	site of DNA damage	-	118	116	-	-	1.78E-02	5.41E-03
IntAct	MF	GO:0051861	glycolipid binding	-	30	30	-	-	4.22E-03	1.40E-03
IntAct	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.73E-04	5.23E-04
IntAct	MF	GO:0051087	protein-folding chaperone binding	-	135	132	-	-	3.20E-03	6.16E-03
IntAct	MF	GO:0051959	dynein light intermediate chain binding	-	27	26	-	-	3.17E-03	1.22E-03
IntAct	CC	GO:0015464	acetylcholine receptor activity	-	21	16	-	-	2.56E-02	7.56E-04
IntAct	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	4.33E-03	5.82E-04
IntAct	MF	GO:0031681	G-protein beta-subunit binding	-	22	19	-	-	2.26E-04	9.31E-04
IntAct	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	1.33E-03	1.74E-03
IntAct	MF	GO:0035613	RNA stem-loop binding	-	21	18	-	-	9.94E-04	8.72E-04
IntAct	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	236	-	-	7.17E-03	1.10E-02
IntAct	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	19	-	-	4.14E-04	9.31E-04
IntAct	MF	GO:0033691	sialic acid binding	-	22	21	-	-	2.34E-02	9.89E-04
IntAct	MF	GO:0048306	calcium-dependent protein binding	-	61	59	-	-	7.49E-03	2.79E-03
IntAct	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	8.68E-03	1.34E-03
IntAct	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	9.10E-02	6.40E-04
IntAct	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	138	-	-	5.23E-03	6.46E-03
IntAct	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	59	-	-	4.77E-02	2.79E-03
IntAct	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	127	-	-	1.11E-02	5.93E-03
IntAct	MF	GO:0045504	dynein heavy chain binding	-	16	12	-	-	4.52E-02	5.82E-04
IntAct	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	4.33E-02	1.40E-03
IntAct	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	4.33E-03	1.05E-03
IntAct	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	1.69E-03	6.98E-04
IntAct	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	6.77E-02	6.98E-04
IntAct	MF	GO:0061980	regulatory RNA binding	-	52	44	-	-	7.54E-03	2.09E-03
IntAct	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	7.22E-03	1.51E-03
IntAct	MF	GO:0000182	rDNA binding	-	11	11	-	-	5.79E-03	5.23E-04
IntAct	MF	GO:0001671	ATPase activator activity	-	29	28	-	-	1.04E-03	1.34E-03
IntAct	MF	GO:0070840	dynein complex binding	-	25	24	-	-	1.13E-03	1.16E-03
IntAct	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	6.91E-04	1.16E-03
IntAct	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	9.51E-04	7.56E-04
IntAct	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	1.89E-03	1.63E-03
IntAct	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	2.41E-02	8.72E-04
IntAct	MF	GO:0005178	integrin binding	-	153	148	-	-	3.28E-02	6.92E-03
IntAct	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	8.45E-04	8.14E-04
IntAct	MF	GO:0005549	odorant binding	-	128	23	-	-	2.90E-04	1.11E-03
IntAct	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	2.84E-02	6.98E-04
IntAct	MF	GO:0008327	methyl-CpG binding	-	31	28	-	-	2.04E-03	1.34E-03
IntAct	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	1.68E-03	9.31E-04
IntAct	MF	GO:0048019	receptor antagonist activity	-	31	17	-	-	4.00E-04	8.14E-04
IntAct	MF	GO:0005521	lamin binding	-	15	15	-	-	3.74E-03	6.98E-04
IntAct	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	3.66E-03	8.14E-04
IntAct	MF	GO:0140318	protein transporter activity	-	40	40	-	-	2.04E-02	1.86E-03
IntAct	MF	GO:0070628	proteasome binding	-	17	17	-	-	3.17E-03	8.14E-04
IntAct	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	6.71E-03	5.23E-04
IntAct	MF	GO:0031432	titin binding	-	13	12	-	-	6.43E-03	5.82E-04
IntAct	MF	GO:0046812	host cell surface binding	-	11	11	-	-	3.85E-03	5.23E-04
IntAct	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	4.44E-03	1.74E-03
IntAct	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	2.31E-04	8.14E-04
IntAct	MF	GO:0002039	p53 binding	-	66	66	-	-	2.10E-03	3.08E-03
IntAct	MF	GO:0005496	steroid binding	-	110	102	-	-	4.29E-03	4.77E-03
IntAct	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	2.29E-02	1.28E-03
IntAct	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.72E-04	5.23E-04
IntAct	MF	GO:0003684	damaged DNA binding	-	89	85	-	-	1.38E-02	3.95E-03
IntAct	MF	GO:0000339	RNA cap binding	-	20	19	-	-	1.46E-02	9.31E-04
IntAct	MF	GO:0016500	protein-hormone receptor activity	-	21	15	-	-	1.22E-03	6.98E-04
IntAct	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	124	-	-	2.49E-02	5.82E-03
IntAct	MF	GO:0005523	tropomyosin binding	-	15	14	-	-	6.61E-03	6.98E-04
IntAct	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	8.49E-04	5.82E-04
IntAct	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	1.35E-02	5.23E-04
IntAct	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	4.30E-03	2.79E-03
IntAct	MF	GO:0008179	adenylate cyclase binding	-	11	11	-	-	7.24E-03	5.23E-04
IntAct	MF	GO:0050811	GABA receptor binding	-	18	16	-	-	1.01E-03	7.56E-04
IntAct	MF	GO:0030971	receptor tyrosine kinase binding	-	76	72	-	-	2.82E-03	3.37E-03
IntAct	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	83	-	-	2.63E-02	3.90E-03
IntAct	MF	GO:0140030	modification-dependent protein binding	-	179	175	-	-	5.76E-03	8.14E-03
IntAct	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	2.98E-02	1.16E-03
IntAct	MF	GO:0009881	photoreceptor activity	-	17	12	-	-	2.21E-03	5.82E-04
IntAct	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	17	-	-	2.78E-02	8.14E-04
IntAct	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	5.30E-04	6.40E-04
IntAct	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	2.29E-04	7.56E-04
IntAct	MF	GO:0141047	molecular tag activity	-	13	13	-	-	9.16E-04	6.40E-04
IntAct	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	4.59E-03	5.23E-04
IntAct	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	1.73E-04	5.82E-04
IntAct	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	6.54E-04	6.98E-04
IntAct	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	2.63E-03	5.82E-04
IntAct	MF	GO:0044548	S100 protein binding	-	14	14	-	-	4.86E-03	6.98E-04
IntAct	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	1.70E-04	6.98E-04
IntAct	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	6.43E-03	6.98E-04
IntAct	MF	GO:0030276	clathrin binding	-	70	68	-	-	3.20E-02	3.20E-03
IntAct	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	5.11E-03	1.40E-03
IntAct	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	3.40E-04	6.98E-04
IntAct	MF	GO:0046790	virion binding	-	19	18	-	-	2.59E-03	8.72E-04
IntAct	MF	GO:0030552	cAMP binding	-	48	41	-	-	5.98E-03	1.92E-03
IntAct	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	37	-	-	1.08E-03	1.74E-03
IntAct	MF	GO:0035173	histone kinase activity	-	17	17	-	-	8.91E-04	8.14E-04
IntAct	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	6.49E-03	1.22E-03
IntAct	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	8.67E-03	5.82E-04
IntAct	MF	GO:0004984	olfactory receptor activity	-	429	66	-	-	8.13E-04	3.08E-03
IntAct	MF	GO:0016209	antioxidant activity	-	92	85	-	-	1.11E-02	3.95E-03
IntAct	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	2.91E-03	1.40E-03
IntAct	MF	GO:0044325	transmembrane transporter binding	-	159	150	-	-	4.49E-03	6.98E-03
IntAct	MF	GO:0048156	tau protein binding	-	43	43	-	-	1.93E-03	2.04E-03
IntAct	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	2.13E-02	1.69E-03
IntAct	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	3.17E-03	6.40E-04
IntAct	MF	GO:0140272	exogenous protein binding	-	79	78	-	-	4.72E-03	3.66E-03
IntAct	MF	GO:0030145	manganese ion binding	-	65	64	-	-	1.90E-03	3.02E-03
IntAct	MF	GO:0071814	protein-lipid complex binding	-	52	46	-	-	2.21E-03	2.15E-03
IntAct	MF	GO:0008066	glutamate receptor activity	-	70	61	-	-	6.54E-03	2.85E-03
IntAct	MF	GO:0017069	snRNA binding	-	54	46	-	-	1.98E-02	2.15E-03
IntAct	MF	GO:0030215	semaphorin receptor binding	-	23	21	-	-	1.54E-02	9.89E-04
IntAct	MF	GO:0031996	thioesterase binding	-	11	11	-	-	1.26E-03	5.23E-04
IntAct	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	8.22E-03	1.45E-03
IntAct	MF	GO:0019843	rRNA binding	-	69	67	-	-	7.57E-03	3.14E-03
IntAct	MF	GO:0004713	protein tyrosine kinase activity	-	213	210	-	-	8.67E-03	9.77E-03
IntAct	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	3.28E-03	2.38E-03
IntAct	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.17E-03	1.16E-03
IntAct	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	2.83E-04	9.31E-04
IntAct	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	26	-	-	1.67E-03	1.22E-03
IntAct	MF	GO:0016208	AMP binding	-	22	22	-	-	6.84E-03	1.05E-03
IntAct	MF	GO:0000287	magnesium ion binding	-	225	217	-	-	5.97E-03	1.01E-02
IntAct	MF	GO:0031490	chromatin DNA binding	-	120	116	-	-	4.80E-03	5.41E-03
IntAct	MF	GO:0017022	myosin binding	-	73	71	-	-	5.31E-03	3.32E-03
IntAct	MF	GO:0004896	cytokine receptor activity	-	93	86	-	-	1.71E-02	4.01E-03
IntAct	MF	GO:0017166	vinculin binding	-	12	12	-	-	4.44E-03	5.82E-04
IntAct	MF	GO:0008301	"DNA binding, bending"	-	18	17	-	-	3.09E-03	8.14E-04
IntAct	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	2.05E-02	5.82E-04
IntAct	MF	GO:0005539	glycosaminoglycan binding	-	236	215	-	-	1.78E-02	1.00E-02
IntAct	MF	GO:0140666	annealing activity	-	11	11	-	-	1.71E-03	5.23E-04
IntAct	MF	GO:0071933	Arp2/3 complex binding	-	14	13	-	-	1.69E-04	6.40E-04
IntAct	MF	GO:0010181	FMN binding	-	15	15	-	-	2.29E-04	6.98E-04
IntAct	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	18	-	-	2.27E-04	8.72E-04
IntAct	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	24	-	-	2.83E-04	1.16E-03
IntAct	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	2.25E-04	8.14E-04
IntAct	MF	GO:0044183	protein folding chaperone	-	67	65	-	-	2.02E-03	3.02E-03
IntAct	MF	GO:0005132	type I interferon receptor binding	-	17	15	-	-	5.41E-01	6.98E-04
IntAct	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	107	-	-	5.70E-03	5.00E-03
IntAct	MF	GO:0003725	double-stranded RNA binding	-	72	68	-	-	8.49E-03	3.20E-03
IntAct	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	4.34E-02	7.56E-04
IntAct	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	1.41E-02	2.44E-03
IntAct	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.67E-03	1.63E-03
IntAct	MF	GO:0004618	phosphoglycerate kinase activity	-	89	88	-	-	7.37E-03	4.13E-03
IntAct	MF	GO:0042805	actinin binding	-	36	35	-	-	5.93E-03	1.63E-03
IntAct	MF	GO:0043531	ADP binding	-	38	38	-	-	2.00E-03	1.80E-03
IntAct	MF	GO:0043394	proteoglycan binding	-	36	33	-	-	4.70E-03	1.57E-03
IntAct	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	2.48E-02	5.23E-04
IntAct	MF	GO:0046332	SMAD binding	-	77	76	-	-	8.11E-03	3.55E-03
IntAct	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.63E-03	6.40E-04
IntAct	MF	GO:0001968	fibronectin binding	-	30	30	-	-	5.23E-03	1.40E-03
IntAct	MF	GO:0048038	quinone binding	-	16	16	-	-	4.02E-02	7.56E-04
IntAct	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	120	-	-	1.91E-02	5.58E-03
IntAct	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	78	-	-	2.92E-03	3.66E-03
IntAct	MF	GO:0003756	protein disulfide isomerase activity	-	18	17	-	-	1.54E-03	8.14E-04
IntAct	MF	GO:0051117	ATPase binding	-	85	82	-	-	2.61E-03	3.84E-03
IntAct	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	3.06E-03	2.15E-03
IntAct	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	1.58E-03	9.31E-04
IntAct	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	2.22E-03	5.23E-04
IntAct	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.30E-04	6.98E-04
IntAct	MF	GO:0031404	chloride ion binding	-	14	12	-	-	1.73E-04	5.82E-04
IntAct	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	6.13E-03	2.85E-03
IntAct	MF	GO:0036002	pre-mRNA binding	-	57	36	-	-	1.06E-02	1.69E-03
IntAct	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	36	-	-	7.70E-03	1.69E-03
IntAct	MF	GO:0051540	metal cluster binding	-	71	69	-	-	6.26E-03	3.26E-03
IntAct	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	1.98E-03	5.23E-04
IntAct	MF	GO:0051219	phosphoprotein binding	-	92	91	-	-	3.06E-03	4.25E-03
IntAct	MF	GO:0019894	kinesin binding	-	45	44	-	-	2.93E-03	2.09E-03
IntAct	MF	GO:0042287	MHC protein binding	-	68	56	-	-	3.77E-02	2.62E-03
IntAct	MF	GO:0019003	GDP binding	-	89	89	-	-	1.26E-02	4.19E-03
IntAct	MF	GO:0017171	serine hydrolase activity	-	207	175	-	-	1.48E-02	8.14E-03
IntAct	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	2.65E-03	3.08E-03
IntAct	MF	GO:0003774	cytoskeletal motor activity	-	117	111	-	-	4.76E-03	5.18E-03
IntAct	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.99E-03	1.40E-03
IntAct	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	2.76E-03	8.14E-04
IntAct	MF	GO:0061134	peptidase regulator activity	-	224	197	-	-	6.16E-03	9.19E-03
IntAct	MF	GO:0008013	beta-catenin binding	-	86	85	-	-	5.70E-03	3.95E-03
IntAct	MF	GO:0051015	actin filament binding	-	208	203	-	-	2.07E-02	9.48E-03
IntAct	MF	GO:0019208	phosphatase regulator activity	-	107	102	-	-	7.78E-03	4.77E-03
IntAct	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	30	-	-	9.26E-04	1.40E-03
IntAct	MF	GO:0043236	laminin binding	-	29	27	-	-	1.97E-03	1.28E-03
IntAct	MF	GO:0030507	spectrin binding	-	26	26	-	-	1.77E-03	1.22E-03
IntAct	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	4.02E-03	1.92E-03
IntAct	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	113	-	-	9.52E-03	5.29E-03
IntAct	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	3.23E-03	1.16E-03
IntAct	MF	GO:0042393	histone binding	-	240	229	-	-	1.09E-02	1.07E-02
IntAct	MF	GO:0019838	growth factor binding	-	182	177	-	-	6.41E-03	8.26E-03
IntAct	MF	GO:0000149	SNARE binding	-	107	104	-	-	3.88E-02	4.89E-03
IntAct	MF	GO:0003727	single-stranded RNA binding	-	90	84	-	-	4.42E-03	3.95E-03
IntAct	MF	GO:0051378	serotonin binding	-	24	20	-	-	1.01E-02	9.31E-04
IntAct	MF	GO:0005516	calmodulin binding	-	206	198	-	-	6.37E-03	9.25E-03
IntAct	MF	GO:0019825	oxygen binding	-	40	36	-	-	4.80E-02	1.69E-03
IntAct	MF	GO:0045505	dynein intermediate chain binding	-	37	35	-	-	5.49E-03	1.63E-03
IntAct	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	85	-	-	2.62E-03	3.95E-03
IntAct	MF	GO:0032182	ubiquitin-like protein binding	-	117	115	-	-	6.95E-03	5.35E-03
IntAct	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	3.16E-02	1.69E-03
IntAct	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	2.82E-03	1.05E-03
IntAct	MF	GO:0043274	phospholipase binding	-	23	22	-	-	1.63E-03	1.05E-03
IntAct	MF	GO:0031072	heat shock protein binding	-	128	125	-	-	3.93E-03	5.82E-03
IntAct	MF	GO:0030515	snoRNA binding	-	33	33	-	-	1.02E-02	1.57E-03
IntAct	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	68	-	-	2.45E-02	3.20E-03
IntAct	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	20	-	-	2.88E-04	9.31E-04
IntAct	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	3.33E-04	1.22E-03
IntAct	MF	GO:0001530	lipopolysaccharide binding	-	38	32	-	-	3.02E-03	1.51E-03
IntAct	MF	GO:0140223	general transcription initiation factor activity	-	55	53	-	-	1.46E-01	2.50E-03
IntAct	MF	GO:0070403	NAD+ binding	-	16	15	-	-	2.41E-03	6.98E-04
IntAct	MF	GO:0000049	tRNA binding	-	75	70	-	-	1.52E-02	3.26E-03
IntAct	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	45	-	-	4.00E-03	2.09E-03
IntAct	MF	GO:0015026	coreceptor activity	-	48	43	-	-	9.44E-03	2.04E-03
IntAct	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.50E-03	5.82E-04
IntAct	MF	GO:0001653	peptide receptor activity	-	128	104	-	-	1.13E-02	4.89E-03
IntAct	MF	GO:0031005	filamin binding	-	15	14	-	-	5.17E-03	6.98E-04
IntAct	MF	GO:0030506	ankyrin binding	-	19	19	-	-	1.23E-03	9.31E-04
IntAct	MF	GO:0006469	negative regulation of protein kinase activity	-	222	208	-	-	3.74E-03	9.71E-03
IntAct	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	2.60E-03	9.31E-04
IntAct	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	9.26E-04	6.98E-04
IntAct	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	6.53E-03	1.45E-03
IntAct	MF	GO:0051427	hormone receptor binding	-	31	29	-	-	8.21E-03	1.40E-03
IntAct	MF	GO:0070851	growth factor receptor binding	-	141	136	-	-	6.50E-03	6.34E-03
IntAct	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	1.32E-03	1.51E-03
IntAct	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	42	-	-	5.19E-03	1.98E-03
IntAct	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	3.85E-04	9.31E-04
IntAct	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	5.41E-03	8.14E-04
IntAct	MF	GO:0005506	iron ion binding	-	154	136	-	-	2.03E-02	6.34E-03
IntAct	MF	GO:0003925	G protein activity	-	45	44	-	-	3.26E-03	2.09E-03
IntAct	MF	GO:0038187	pattern recognition receptor activity	-	33	29	-	-	1.60E-02	1.40E-03
IntAct	MF	GO:0008276	protein methyltransferase activity	-	96	91	-	-	4.77E-03	4.25E-03
IntAct	MF	GO:0004396	hexokinase activity	-	16	16	-	-	1.78E-01	7.56E-04
IntAct	MF	GO:0070888	E-box binding	-	59	54	-	-	2.20E-02	2.56E-03
IntAct	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.60E-04	6.98E-04
IntAct	MF	GO:0015399	primary active transmembrane transporter activity	-	190	186	-	-	3.92E-02	8.67E-03
IntAct	MF	GO:0035254	glutamate receptor binding	-	47	46	-	-	1.73E-03	2.15E-03
IntAct	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	7.56E-03	1.57E-03
IntAct	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	2.89E-03	5.23E-04
IntAct	MF	GO:0043021	ribonucleoprotein complex binding	-	158	156	-	-	5.29E-03	7.27E-03
IntAct	MF	GO:0030170	pyridoxal phosphate binding	-	56	52	-	-	1.10E-02	2.44E-03
IntAct	MF	GO:0032393	MHC class I receptor activity	-	15	13	-	-	3.24E-01	6.40E-04
IntAct	MF	GO:0005112	Notch binding	-	26	24	-	-	2.25E-03	1.16E-03
IntAct	MF	GO:0048185	activin binding	-	16	16	-	-	4.82E-02	7.56E-04
IntAct	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	26	-	-	8.04E-04	1.22E-03
IntAct	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	3.04E-03	5.23E-04
IntAct	MF	GO:0140299	small molecule sensor activity	-	39	34	-	-	7.85E-03	1.63E-03
IntAct	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.58E-02	1.05E-03
IntAct	MF	GO:0016917	GABA receptor activity	-	23	18	-	-	2.60E-01	8.72E-04
IntAct	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	3.80E-03	6.98E-04
IntAct	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	24	-	-	4.91E-04	1.16E-03
IntAct	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	43	-	-	1.95E-02	2.04E-03
IntAct	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	9.27E-04	1.16E-03
IntAct	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	2.12E-03	5.82E-04
IntAct	MF	GO:0030594	neurotransmitter receptor activity	-	160	139	-	-	2.05E-02	6.51E-03
IntAct	MF	GO:0034452	dynactin binding	-	12	12	-	-	4.76E-04	5.82E-04
IntAct	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	23	-	-	3.22E-03	1.11E-03
IntAct	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	2.82E-04	9.89E-04
IntAct	MF	GO:0005507	copper ion binding	-	63	60	-	-	5.40E-03	2.79E-03
IntAct	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	5.17E-03	1.05E-03
IntAct	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.05E-02	1.05E-03
IntAct	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	2.81E-04	5.82E-04
iRefIndex	CC	GO:0005815	microtubule organizing center	1.13E-04	843	796	766	1.04	-	-
iRefIndex	CC	GO:0005739	mitochondrion	2.89E-03	1671	1551	1518	1.02	-	-
iRefIndex	CC	GO:0005615	extracellular space	5.75E-03	3190	2938	2897	1.01	-	-
iRefIndex	CC	GO:0005783	endoplasmic reticulum	7.95E-03	2020	1867	1835	1.02	-	-
iRefIndex	CC	GO:0005794	Golgi apparatus	1.54E-02	1636	1513	1486	1.02	-	-
iRefIndex	CC	GO:0005635	nuclear envelope	3.93E-02	493	461	448	1.03	-	-
iRefIndex	CC	GO:0031012	extracellular matrix	4.51E-02	564	526	512	1.03	-	-
iRefIndex	CC	GO:0005730	nucleolus	6.15E-02	988	914	897	1.02	-	-
iRefIndex	CC	GO:0005768	endosome	9.68E-02	1037	957	942	1.02	-	-
iRefIndex	CC	GO:0005929	cilium	1.12E-01	842	778	765	1.02	-	-
iRefIndex	CC	GO:0000228	nuclear chromosome	1.81E-01	206	193	187	1.03	-	-
iRefIndex	CC	GO:0005777	peroxisome	1.87E-01	142	134	129	1.04	-	-
iRefIndex	CC	GO:0005840	ribosome	2.91E-01	222	197	202	0.98	-	-
iRefIndex	CC	GO:0005764	lysosome	4.38E-01	747	685	678	1.01	-	-
iRefIndex	CC	GO:0005811	lipid droplet	1.00E+00	102	93	93	1.00	-	-
iRefIndex	BP	GO:0007010	cytoskeleton organization	1.20E-10	1639	1556	1489	1.05	-	-
iRefIndex	BP	GO:0012501	programmed cell death	3.26E-07	1954	1834	1775	1.03	-	-
iRefIndex	BP	GO:0048870	cell motility	1.13E-06	1659	1559	1507	1.03	-	-
iRefIndex	BP	GO:0034330	cell junction organization	2.06E-06	727	694	660	1.05	-	-
iRefIndex	BP	GO:0050877	nervous system process	2.21E-06	1527	1436	1387	1.04	-	-
iRefIndex	BP	GO:0006091	generation of precursor metabolites and energy	2.08E-05	502	481	456	1.05	-	-
iRefIndex	BP	GO:0007155	cell adhesion	4.35E-05	1444	1353	1312	1.03	-	-
iRefIndex	BP	GO:0002376	immune system process	1.08E-04	2448	2274	2223	1.02	-	-
iRefIndex	BP	GO:0003013	circulatory system process	5.89E-04	584	553	530	1.04	-	-
iRefIndex	BP	GO:0032200	telomere organization	1.20E-03	186	155	169	0.92	-	-
iRefIndex	BP	GO:0006281	DNA repair	1.72E-03	587	554	533	1.04	-	-
iRefIndex	BP	GO:0006629	lipid metabolic process	2.44E-03	1355	1261	1231	1.02	-	-
iRefIndex	BP	GO:0003012	muscle system process	2.80E-03	425	403	386	1.04	-	-
iRefIndex	BP	GO:0055086	nucleobase-containing small molecule metabolic process	3.18E-03	729	684	662	1.03	-	-
iRefIndex	BP	GO:0016192	vesicle-mediated transport	3.26E-03	1894	1755	1720	1.02	-	-
iRefIndex	BP	GO:0016071	mRNA metabolic process	3.55E-03	713	669	648	1.03	-	-
iRefIndex	BP	GO:0006310	DNA recombination	3.86E-03	333	317	302	1.05	-	-
iRefIndex	BP	GO:0072659	protein localization to plasma membrane	4.91E-03	284	271	258	1.05	-	-
iRefIndex	BP	GO:0006954	inflammatory response	5.27E-03	820	767	745	1.03	-	-
iRefIndex	BP	GO:0030163	protein catabolic process	6.52E-03	990	923	899	1.03	-	-
iRefIndex	BP	GO:0007005	mitochondrion organization	8.22E-03	484	456	440	1.04	-	-
iRefIndex	BP	GO:0006325	chromatin organization	1.48E-02	720	635	654	0.97	-	-
iRefIndex	BP	GO:0007018	microtubule-based movement	1.78E-02	640	598	581	1.03	-	-
iRefIndex	BP	GO:0006520	amino acid metabolic process	2.44E-02	292	276	265	1.04	-	-
iRefIndex	BP	GO:0098542	defense response to other organism	2.45E-02	1171	1085	1064	1.02	-	-
iRefIndex	BP	GO:0005975	carbohydrate metabolic process	2.95E-02	551	515	500	1.03	-	-
iRefIndex	BP	GO:0140013	meiotic nuclear division	4.64E-02	279	263	253	1.04	-	-
iRefIndex	BP	GO:0006355	regulation of DNA-templated transcription	5.11E-02	3342	3065	3035	1.01	-	-
iRefIndex	BP	GO:0006914	autophagy	5.47E-02	568	529	516	1.03	-	-
iRefIndex	BP	GO:0006575	cellular modified amino acid metabolic process	7.37E-02	186	176	169	1.04	-	-
iRefIndex	BP	GO:0006913	nucleocytoplasmic transport	1.46E-01	326	304	296	1.03	-	-
iRefIndex	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.49E-01	119	113	108	1.05	-	-
iRefIndex	BP	GO:0006790	sulfur compound metabolic process	1.71E-01	320	298	291	1.03	-	-
iRefIndex	BP	GO:0042060	wound healing	1.76E-01	431	400	391	1.02	-	-
iRefIndex	BP	GO:0007059	chromosome segregation	1.90E-01	403	374	366	1.02	-	-
iRefIndex	BP	GO:0030198	extracellular matrix organization	2.00E-01	314	292	285	1.02	-	-
iRefIndex	BP	GO:0006486	protein glycosylation	2.02E-01	225	199	204	0.97	-	-
iRefIndex	BP	GO:0006457	protein folding	2.30E-01	210	196	191	1.03	-	-
iRefIndex	BP	GO:0098754	detoxification	2.30E-01	134	126	122	1.04	-	-
iRefIndex	BP	GO:0006766	vitamin metabolic process	2.40E-01	107	101	97	1.04	-	-
iRefIndex	BP	GO:0022600	digestive system process	2.43E-01	110	104	100	1.04	-	-
iRefIndex	BP	GO:0002181	cytoplasmic translation	2.60E-01	153	135	139	0.97	-	-
iRefIndex	BP	GO:0055085	transmembrane transport	2.62E-01	1784	1634	1620	1.01	-	-
iRefIndex	BP	GO:0044782	cilium organization	2.92E-01	399	369	362	1.02	-	-
iRefIndex	BP	GO:0006260	DNA replication	2.95E-01	279	259	253	1.02	-	-
iRefIndex	BP	GO:0003014	renal system process	3.52E-01	127	119	115	1.03	-	-
iRefIndex	BP	GO:0006399	tRNA metabolic process	3.84E-01	196	182	178	1.02	-	-
iRefIndex	BP	GO:0007163	establishment or maintenance of cell polarity	4.20E-01	227	210	206	1.02	-	-
iRefIndex	BP	GO:0065003	protein-containing complex assembly	4.47E-01	1648	1506	1497	1.01	-	-
iRefIndex	BP	GO:0000910	cytokinesis	6.09E-01	186	167	169	0.99	-	-
iRefIndex	BP	GO:0140053	mitochondrial gene expression	6.84E-01	164	151	149	1.01	-	-
iRefIndex	BP	GO:0006886	intracellular protein transport	8.38E-01	664	605	603	1.00	-	-
iRefIndex	BP	GO:0007040	lysosome organization	1.00E+00	107	98	97	1.01	-	-
iRefIndex	BP	GO:0042254	ribosome biogenesis	1.00E+00	297	270	270	1.00	-	-
iRefIndex	MF	GO:0008092	cytoskeletal protein binding	9.14E-05	1023	963	929	1.04	-	-
iRefIndex	MF	GO:0140096	"catalytic activity, acting on a protein"	1.23E-04	3198	2961	2905	1.02	-	-
iRefIndex	MF	GO:0016740	transferase activity	7.09E-04	3074	2841	2792	1.02	-	-
iRefIndex	MF	GO:0008289	lipid binding	7.23E-04	836	786	759	1.04	-	-
iRefIndex	MF	GO:0005198	structural molecule activity	8.62E-04	798	697	725	0.96	-	-
iRefIndex	MF	GO:0003723	RNA binding	1.20E-03	1679	1561	1525	1.02	-	-
iRefIndex	MF	GO:0016491	oxidoreductase activity	1.26E-03	888	833	807	1.03	-	-
iRefIndex	MF	GO:0140097	"catalytic activity, acting on DNA"	5.35E-03	383	363	348	1.04	-	-
iRefIndex	MF	GO:0048018	receptor ligand activity	1.52E-02	504	473	458	1.03	-	-
iRefIndex	MF	GO:0140657	ATP-dependent activity	1.83E-02	729	680	662	1.03	-	-
iRefIndex	MF	GO:0140098	"catalytic activity, acting on RNA"	2.04E-02	417	392	379	1.03	-	-
iRefIndex	MF	GO:0016874	ligase activity	3.76E-02	283	267	257	1.04	-	-
iRefIndex	MF	GO:0016829	lyase activity	6.84E-02	538	501	489	1.03	-	-
iRefIndex	MF	GO:0003774	cytoskeletal motor activity	7.46E-02	116	111	105	1.05	-	-
iRefIndex	MF	GO:0140110	transcription regulator activity	1.66E-01	2033	1864	1847	1.01	-	-
iRefIndex	MF	GO:0016853	isomerase activity	4.41E-01	252	233	229	1.02	-	-
iRefIndex	MF	GO:0005215	transporter activity	4.79E-01	1462	1336	1328	1.01	-	-
iRefIndex	MF	GO:0045182	translation regulator activity	4.81E-01	151	140	137	1.02	-	-
iRefIndex	MF	GO:0140104	molecular carrier activity	4.96E-01	105	98	95	1.03	-	-
iRefIndex	MF	GO:0038024	cargo receptor activity	5.18E-01	117	109	106	1.03	-	-
iRefIndex	MF	GO:0009975	cyclase activity	5.30E-01	277	255	252	1.01	-	-
iRefIndex	MF	GO:0042393	histone binding	7.34E-01	237	214	215	0.99	-	-
iRefIndex	MF	GO:0003924	GTPase activity	8.36E-01	658	600	598	1.00	-	-
iRefIndex	MF	GO:0003677	DNA binding	9.44E-01	2865	2601	2602	1.00	-	-
iRefIndex	BP	GO:0008038	neuron recognition	-	46	43	-	-	3.07E-03	1.98E-03
iRefIndex	BP	GO:1905145	cellular response to acetylcholine	-	33	30	-	-	2.38E-03	1.36E-03
iRefIndex	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	1.43E-03	8.49E-04
iRefIndex	BP	GO:0098780	response to mitochondrial depolarisation	-	21	18	-	-	1.13E-03	8.49E-04
iRefIndex	BP	GO:0051931	regulation of sensory perception	-	36	34	-	-	2.50E-03	1.58E-03
iRefIndex	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	6.27E-03	1.13E-03
iRefIndex	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	12	-	-	2.92E-03	5.66E-04
iRefIndex	BP	GO:0060049	regulation of protein glycosylation	-	13	12	-	-	7.75E-04	5.66E-04
iRefIndex	BP	GO:0009268	response to pH	-	43	42	-	-	1.14E-02	1.92E-03
iRefIndex	BP	GO:0045666	positive regulation of neuron differentiation	-	91	85	-	-	4.60E-03	3.85E-03
iRefIndex	BP	GO:0043543	protein acylation	-	107	100	-	-	4.31E-03	4.53E-03
iRefIndex	MF	GO:0051349	positive regulation of lyase activity	-	41	38	-	-	1.05E-02	1.75E-03
iRefIndex	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	13	-	-	4.77E-03	6.22E-04
iRefIndex	BP	GO:0048679	regulation of axon regeneration	-	28	23	-	-	9.87E-04	1.08E-03
iRefIndex	BP	GO:0022401	negative adaptation of signaling pathway	-	21	19	-	-	3.84E-03	9.05E-04
iRefIndex	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	125	-	-	4.91E-02	5.66E-03
iRefIndex	BP	GO:0071763	nuclear membrane organization	-	44	40	-	-	2.41E-02	1.81E-03
iRefIndex	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	33	-	-	3.14E-03	1.53E-03
iRefIndex	BP	GO:0071806	protein transmembrane transport	-	68	64	-	-	1.61E-02	2.94E-03
iRefIndex	BP	GO:0022038	corpus callosum development	-	25	24	-	-	3.52E-03	1.13E-03
iRefIndex	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	13	-	-	1.27E-02	6.22E-04
iRefIndex	BP	GO:0021548	pons development	-	11	11	-	-	1.64E-04	5.09E-04
iRefIndex	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	3.67E-02	5.66E-04
iRefIndex	BP	GO:0043299	leukocyte degranulation	-	82	76	-	-	9.87E-03	3.45E-03
iRefIndex	BP	GO:0048864	stem cell development	-	88	82	-	-	7.25E-03	3.73E-03
iRefIndex	BP	GO:0009310	amine catabolic process	-	20	17	-	-	1.99E-03	7.92E-04
iRefIndex	BP	GO:0051651	maintenance of location in cell	-	236	217	-	-	8.44E-03	9.85E-03
iRefIndex	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	5.18E-03	1.24E-03
iRefIndex	BP	GO:0014004	microglia differentiation	-	12	12	-	-	1.09E-03	5.66E-04
iRefIndex	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	29	-	-	1.52E-01	1.36E-03
iRefIndex	BP	GO:0070663	regulation of leukocyte proliferation	-	268	244	-	-	1.32E-02	1.11E-02
iRefIndex	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	8.85E-03	6.79E-04
iRefIndex	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	2.56E-03	6.79E-04
iRefIndex	BP	GO:0046415	urate metabolic process	-	12	11	-	-	1.67E-04	5.09E-04
iRefIndex	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	29	-	-	1.56E-03	1.36E-03
iRefIndex	BP	GO:0006949	syncytium formation	-	66	58	-	-	2.81E-03	2.66E-03
iRefIndex	BP	GO:0045176	apical protein localization	-	15	14	-	-	5.54E-04	6.79E-04
iRefIndex	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	2.92E-02	6.79E-04
iRefIndex	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	53	-	-	7.46E-03	2.43E-03
iRefIndex	BP	GO:0030574	collagen catabolic process	-	45	41	-	-	1.75E-02	1.87E-03
iRefIndex	CC	GO:0006984	ER-nucleus signaling pathway	-	46	43	-	-	8.19E-03	1.98E-03
iRefIndex	BP	GO:0060343	trabecula formation	-	26	25	-	-	1.28E-03	1.13E-03
iRefIndex	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	11	-	-	1.65E-04	5.09E-04
iRefIndex	BP	GO:0140112	extracellular vesicle biogenesis	-	23	20	-	-	8.84E-04	9.05E-04
iRefIndex	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	14	-	-	6.67E-02	6.79E-04
iRefIndex	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	7.83E-03	8.49E-04
iRefIndex	BP	GO:0085029	extracellular matrix assembly	-	42	37	-	-	1.81E-02	1.70E-03
iRefIndex	BP	GO:0006413	translational initiation	-	122	115	-	-	2.51E-02	5.21E-03
iRefIndex	BP	GO:0072176	nephric duct development	-	15	15	-	-	2.10E-03	6.79E-04
iRefIndex	BP	GO:1902895	positive regulation of miRNA transcription	-	51	49	-	-	2.84E-03	2.26E-03
iRefIndex	CC	GO:0005200	structural constituent of cytoskeleton	-	112	109	-	-	6.14E-03	4.98E-03
iRefIndex	BP	GO:0030865	cortical cytoskeleton organization	-	51	47	-	-	2.27E-03	2.15E-03
iRefIndex	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	8.20E-02	6.79E-04
iRefIndex	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	2.32E-02	1.13E-03
iRefIndex	BP	GO:1903036	positive regulation of response to wounding	-	76	63	-	-	6.61E-03	2.89E-03
iRefIndex	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	1.36E-01	9.62E-04
iRefIndex	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	204	-	-	1.72E-02	9.28E-03
iRefIndex	BP	GO:1903319	positive regulation of protein maturation	-	27	25	-	-	1.17E-03	1.13E-03
iRefIndex	BP	GO:0032528	microvillus organization	-	24	23	-	-	1.60E-02	1.08E-03
iRefIndex	BP	GO:0021954	central nervous system neuron development	-	85	80	-	-	2.23E-03	3.62E-03
iRefIndex	BP	GO:0055017	cardiac muscle tissue growth	-	92	70	-	-	3.97E-03	3.17E-03
iRefIndex	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	30	-	-	6.38E-03	1.36E-03
iRefIndex	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	3.91E-03	6.22E-04
iRefIndex	BP	GO:0048524	positive regulation of viral process	-	64	56	-	-	1.41E-03	2.55E-03
iRefIndex	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	14	-	-	1.22E-02	6.79E-04
iRefIndex	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	19	-	-	2.74E-03	9.05E-04
iRefIndex	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	22	-	-	1.20E-03	1.02E-03
iRefIndex	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	1.11E-02	7.92E-04
iRefIndex	BP	GO:0098661	inorganic anion transmembrane transport	-	140	119	-	-	5.95E-02	5.43E-03
iRefIndex	BP	GO:0006099	tricarboxylic acid cycle	-	33	30	-	-	2.34E-02	1.36E-03
iRefIndex	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	1.38E-03	8.49E-04
iRefIndex	BP	GO:0009612	response to mechanical stimulus	-	215	204	-	-	5.03E-03	9.28E-03
iRefIndex	BP	GO:0048644	muscle organ morphogenesis	-	81	77	-	-	9.47E-03	3.51E-03
iRefIndex	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	134	-	-	6.30E-03	6.11E-03
iRefIndex	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	4.14E-02	6.22E-04
iRefIndex	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	7.56E-03	1.58E-03
iRefIndex	BP	GO:0140115	export across plasma membrane	-	82	63	-	-	3.24E-02	2.89E-03
iRefIndex	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	36	-	-	2.38E-03	1.64E-03
iRefIndex	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	9.90E-04	5.09E-04
iRefIndex	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	28	-	-	3.77E-03	1.30E-03
iRefIndex	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	39	-	-	2.89E-02	1.81E-03
iRefIndex	MF	GO:0003714	transcription corepressor activity	-	190	179	-	-	8.89E-03	8.15E-03
iRefIndex	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	53	-	-	6.71E-03	2.43E-03
iRefIndex	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	4.45E-03	7.36E-04
iRefIndex	CC	GO:0006858	extracellular transport	-	45	44	-	-	2.05E-02	2.04E-03
iRefIndex	BP	GO:0006304	DNA modification	-	30	29	-	-	5.97E-03	1.36E-03
iRefIndex	MF	GO:0140312	cargo adaptor activity	-	19	15	-	-	1.21E-02	6.79E-04
iRefIndex	BP	GO:0046835	carbohydrate phosphorylation	-	49	46	-	-	5.44E-03	2.09E-03
iRefIndex	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	19	-	-	6.39E-04	9.05E-04
iRefIndex	BP	GO:0003207	cardiac chamber formation	-	14	13	-	-	4.52E-03	6.22E-04
iRefIndex	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	37	-	-	9.12E-03	1.70E-03
iRefIndex	BP	GO:0070417	cellular response to cold	-	13	13	-	-	4.39E-03	6.22E-04
iRefIndex	BP	GO:0043523	regulation of neuron apoptotic process	-	218	203	-	-	6.38E-03	9.22E-03
iRefIndex	BP	GO:1902894	negative regulation of miRNA transcription	-	22	21	-	-	1.61E-03	9.62E-04
iRefIndex	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	11	-	-	8.99E-04	5.09E-04
iRefIndex	BP	GO:0044380	protein localization to cytoskeleton	-	57	55	-	-	5.54E-03	2.49E-03
iRefIndex	BP	GO:0051918	negative regulation of fibrinolysis	-	13	12	-	-	4.78E-02	5.66E-04
iRefIndex	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	2.18E-03	1.13E-03
iRefIndex	BP	GO:0014029	neural crest formation	-	15	14	-	-	3.75E-03	6.79E-04
iRefIndex	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	2.19E-03	1.08E-03
iRefIndex	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	40	-	-	1.49E-02	1.81E-03
iRefIndex	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	65	-	-	3.02E-03	2.94E-03
iRefIndex	BP	GO:0003188	heart valve formation	-	16	16	-	-	8.29E-03	7.36E-04
iRefIndex	CC	GO:0045324	late endosome to vacuole transport	-	37	31	-	-	1.04E-01	1.41E-03
iRefIndex	BP	GO:0043954	cellular component maintenance	-	72	67	-	-	7.86E-03	3.06E-03
iRefIndex	BP	GO:0050435	amyloid-beta metabolic process	-	65	51	-	-	4.95E-03	2.32E-03
iRefIndex	BP	GO:0014823	response to activity	-	70	67	-	-	2.11E-03	3.06E-03
iRefIndex	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	4.50E-02	8.49E-04
iRefIndex	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	27	-	-	2.25E-02	1.24E-03
iRefIndex	BP	GO:0034502	protein localization to chromosome	-	130	106	-	-	7.75E-03	4.81E-03
iRefIndex	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	5.66E-04	5.09E-04
iRefIndex	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	1.57E-03	5.09E-04
iRefIndex	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	1.25E-02	7.92E-04
iRefIndex	BP	GO:0019233	sensory perception of pain	-	103	98	-	-	3.12E-03	4.47E-03
iRefIndex	CC	GO:0043574	peroxisomal transport	-	22	21	-	-	1.05E-01	9.62E-04
iRefIndex	BP	GO:0031343	positive regulation of cell killing	-	75	70	-	-	2.34E-02	3.17E-03
iRefIndex	BP	GO:0090077	foam cell differentiation	-	39	37	-	-	2.49E-03	1.70E-03
iRefIndex	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	114	-	-	3.28E-02	5.21E-03
iRefIndex	BP	GO:0017148	negative regulation of translation	-	390	113	-	-	1.35E-02	5.15E-03
iRefIndex	BP	GO:0030220	platelet formation	-	22	20	-	-	3.63E-02	9.05E-04
iRefIndex	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	78	-	-	3.25E-03	3.57E-03
iRefIndex	MF	GO:1903624	regulation of DNA catabolic process	-	14	13	-	-	1.60E-03	6.22E-04
iRefIndex	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	9.99E-04	6.79E-04
iRefIndex	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	2.08E-02	6.79E-04
iRefIndex	BP	GO:1903509	liposaccharide metabolic process	-	109	101	-	-	7.11E-02	4.58E-03
iRefIndex	BP	GO:0009582	detection of abiotic stimulus	-	140	132	-	-	1.04E-02	6.00E-03
iRefIndex	BP	GO:0045683	negative regulation of epidermis development	-	13	12	-	-	3.41E-03	5.66E-04
iRefIndex	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	16	-	-	3.33E-02	7.36E-04
iRefIndex	CC	GO:0140238	presynaptic endocytosis	-	72	68	-	-	5.54E-03	3.11E-03
iRefIndex	BP	GO:0051236	establishment of RNA localization	-	161	149	-	-	3.39E-02	6.79E-03
iRefIndex	BP	GO:0042178	xenobiotic catabolic process	-	26	24	-	-	4.73E-02	1.13E-03
iRefIndex	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	16	-	-	3.76E-02	7.36E-04
iRefIndex	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	181	-	-	1.11E-02	8.21E-03
iRefIndex	BP	GO:0034067	protein localization to Golgi apparatus	-	30	28	-	-	2.23E-03	1.30E-03
iRefIndex	BP	GO:0061842	microtubule organizing center localization	-	32	31	-	-	2.26E-03	1.41E-03
iRefIndex	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	3.38E-03	5.09E-04
iRefIndex	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	1.72E-02	7.92E-04
iRefIndex	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	46	-	-	3.59E-02	2.09E-03
iRefIndex	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	39	-	-	8.97E-04	1.81E-03
iRefIndex	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	50	-	-	4.03E-03	2.26E-03
iRefIndex	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	15	-	-	3.76E-03	6.79E-04
iRefIndex	BP	GO:0050779	RNA destabilization	-	135	96	-	-	4.87E-02	4.36E-03
iRefIndex	BP	GO:0006023	aminoglycan biosynthetic process	-	74	71	-	-	6.78E-02	3.23E-03
iRefIndex	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	64	-	-	1.55E-02	2.94E-03
iRefIndex	BP	GO:0010762	regulation of fibroblast migration	-	40	35	-	-	2.86E-03	1.58E-03
iRefIndex	BP	GO:0090311	regulation of protein deacetylation	-	29	28	-	-	4.43E-03	1.30E-03
iRefIndex	BP	GO:0035272	exocrine system development	-	46	45	-	-	3.63E-03	2.04E-03
iRefIndex	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	5.27E-03	7.92E-04
iRefIndex	BP	GO:0022406	membrane docking	-	90	80	-	-	1.61E-02	3.62E-03
iRefIndex	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	5.65E-02	6.79E-04
iRefIndex	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	17	-	-	8.87E-04	7.92E-04
iRefIndex	BP	GO:0050777	negative regulation of immune response	-	196	175	-	-	1.09E-02	7.92E-03
iRefIndex	MF	GO:0005035	death receptor activity	-	16	16	-	-	6.18E-03	7.36E-04
iRefIndex	BP	GO:0002063	chondrocyte development	-	33	31	-	-	5.12E-03	1.41E-03
iRefIndex	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	1.69E-03	7.92E-04
iRefIndex	BP	GO:0099068	postsynapse assembly	-	40	40	-	-	1.43E-02	1.81E-03
iRefIndex	BP	GO:0021782	glial cell development	-	120	108	-	-	2.44E-03	4.92E-03
iRefIndex	BP	GO:0051782	negative regulation of cell division	-	18	15	-	-	6.94E-02	6.79E-04
iRefIndex	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	85	-	-	4.12E-03	3.85E-03
iRefIndex	BP	GO:0001655	urogenital system development	-	66	65	-	-	2.34E-03	2.94E-03
iRefIndex	BP	GO:0071827	plasma lipoprotein particle organization	-	86	67	-	-	2.94E-02	3.06E-03
iRefIndex	BP	GO:0045494	photoreceptor cell maintenance	-	43	41	-	-	2.49E-02	1.87E-03
iRefIndex	BP	GO:0055088	lipid homeostasis	-	173	151	-	-	1.78E-02	6.85E-03
iRefIndex	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	7.15E-04	1.19E-03
iRefIndex	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	190	-	-	4.55E-03	8.60E-03
iRefIndex	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	29	-	-	4.92E-02	1.36E-03
iRefIndex	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	32	-	-	2.16E-03	1.47E-03
iRefIndex	BP	GO:0045667	regulation of osteoblast differentiation	-	147	121	-	-	1.15E-02	5.49E-03
iRefIndex	BP	GO:2001212	regulation of vasculogenesis	-	16	14	-	-	2.78E-03	6.79E-04
iRefIndex	BP	GO:0061037	negative regulation of cartilage development	-	32	29	-	-	1.95E-03	1.36E-03
iRefIndex	BP	GO:0045738	negative regulation of DNA repair	-	40	37	-	-	3.40E-02	1.70E-03
iRefIndex	BP	GO:0001704	formation of primary germ layer	-	195	181	-	-	8.07E-03	8.21E-03
iRefIndex	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	12	-	-	1.93E-02	5.66E-04
iRefIndex	BP	GO:0045778	positive regulation of ossification	-	51	50	-	-	6.72E-03	2.26E-03
iRefIndex	BP	GO:0060174	limb bud formation	-	11	11	-	-	1.27E-03	5.09E-04
iRefIndex	BP	GO:0048708	astrocyte differentiation	-	88	83	-	-	2.39E-03	3.79E-03
iRefIndex	BP	GO:0042092	type 2 immune response	-	41	40	-	-	3.20E-03	1.81E-03
iRefIndex	BP	GO:0048588	developmental cell growth	-	233	210	-	-	4.45E-03	9.51E-03
iRefIndex	CC	GO:0000963	mitochondrial RNA processing	-	20	19	-	-	1.50E-02	9.05E-04
iRefIndex	BP	GO:0021872	forebrain generation of neurons	-	52	50	-	-	1.31E-03	2.26E-03
iRefIndex	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	20	-	-	1.26E-03	9.05E-04
iRefIndex	BP	GO:0045023	G0 to G1 transition	-	41	38	-	-	3.49E-02	1.75E-03
iRefIndex	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	49	-	-	1.95E-02	2.26E-03
iRefIndex	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	2.19E-03	5.09E-04
iRefIndex	BP	GO:0034367	protein-containing complex remodeling	-	35	33	-	-	8.92E-02	1.53E-03
iRefIndex	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	24	-	-	3.95E-04	1.13E-03
iRefIndex	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	45	-	-	1.37E-03	2.04E-03
iRefIndex	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	18	-	-	8.99E-02	8.49E-04
iRefIndex	BP	GO:0015810	aspartate transmembrane transport	-	19	16	-	-	1.15E-02	7.36E-04
iRefIndex	BP	GO:0010232	vascular transport	-	87	82	-	-	5.30E-03	3.73E-03
iRefIndex	BP	GO:0021987	cerebral cortex development	-	125	123	-	-	4.38E-03	5.60E-03
iRefIndex	BP	GO:0008637	apoptotic mitochondrial changes	-	108	98	-	-	1.16E-02	4.47E-03
iRefIndex	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	34	-	-	1.41E-02	1.58E-03
iRefIndex	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.21E-02	6.79E-04
iRefIndex	BP	GO:0060999	positive regulation of dendritic spine development	-	35	33	-	-	1.84E-03	1.53E-03
iRefIndex	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	17	-	-	3.06E-03	7.92E-04
iRefIndex	BP	GO:2000736	regulation of stem cell differentiation	-	78	71	-	-	3.12E-03	3.23E-03
iRefIndex	BP	GO:0060973	cell migration involved in heart development	-	21	18	-	-	3.12E-03	8.49E-04
iRefIndex	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	1.13E-03	9.05E-04
iRefIndex	BP	GO:0002064	epithelial cell development	-	210	202	-	-	5.31E-03	9.17E-03
iRefIndex	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	8.83E-04	8.49E-04
iRefIndex	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	39	-	-	1.10E-02	1.81E-03
iRefIndex	BP	GO:2001222	regulation of neuron migration	-	46	45	-	-	2.52E-02	2.04E-03
iRefIndex	BP	GO:0034389	lipid droplet organization	-	38	36	-	-	2.59E-03	1.64E-03
iRefIndex	BP	GO:0051602	response to electrical stimulus	-	44	41	-	-	6.98E-04	1.87E-03
iRefIndex	BP	GO:0042177	negative regulation of protein catabolic process	-	109	97	-	-	1.96E-03	4.41E-03
iRefIndex	MF	GO:0038024	cargo receptor activity	-	121	109	-	-	6.12E-03	4.98E-03
iRefIndex	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	17	-	-	1.41E-03	7.92E-04
iRefIndex	BP	GO:0033120	positive regulation of RNA splicing	-	46	44	-	-	2.93E-02	2.04E-03
iRefIndex	BP	GO:0051445	regulation of meiotic cell cycle	-	64	61	-	-	3.42E-02	2.77E-03
iRefIndex	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.73E-03	5.66E-04
iRefIndex	BP	GO:0033619	membrane protein proteolysis	-	60	57	-	-	6.28E-03	2.60E-03
iRefIndex	BP	GO:0038065	collagen-activated signaling pathway	-	15	12	-	-	1.20E-02	5.66E-04
iRefIndex	BP	GO:0090087	regulation of peptide transport	-	195	180	-	-	7.01E-03	8.15E-03
iRefIndex	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	95	-	-	3.41E-03	4.30E-03
iRefIndex	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	24	-	-	1.89E-03	1.13E-03
iRefIndex	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	1.62E-03	1.13E-03
iRefIndex	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	3.06E-02	6.79E-04
iRefIndex	BP	GO:0042537	benzene-containing compound metabolic process	-	27	26	-	-	1.10E-01	1.19E-03
iRefIndex	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	1.60E-03	6.79E-04
iRefIndex	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	6.24E-03	6.79E-04
iRefIndex	BP	GO:0072662	protein localization to peroxisome	-	20	19	-	-	2.84E-02	9.05E-04
iRefIndex	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	12	-	-	1.83E-02	5.66E-04
iRefIndex	BP	GO:0022404	molting cycle process	-	95	92	-	-	2.17E-03	4.19E-03
iRefIndex	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	2.38E-04	5.09E-04
iRefIndex	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	1.03E-03	7.92E-04
iRefIndex	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	16	-	-	7.49E-03	7.36E-04
iRefIndex	BP	GO:0042754	negative regulation of circadian rhythm	-	12	11	-	-	2.62E-03	5.09E-04
iRefIndex	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	1.17E-03	7.92E-04
iRefIndex	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	6.12E-03	1.47E-03
iRefIndex	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	6.92E-03	6.79E-04
iRefIndex	BP	GO:0008299	isoprenoid biosynthetic process	-	30	29	-	-	2.98E-02	1.36E-03
iRefIndex	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	223	-	-	2.23E-02	1.01E-02
iRefIndex	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.44E-03	1.41E-03
iRefIndex	BP	GO:0034104	negative regulation of tissue remodeling	-	22	21	-	-	9.31E-04	9.62E-04
iRefIndex	CC	GO:0098926	postsynaptic signal transduction	-	39	36	-	-	2.02E-03	1.64E-03
iRefIndex	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	136	-	-	1.25E-02	6.17E-03
iRefIndex	CC	GO:0016082	synaptic vesicle priming	-	19	18	-	-	2.03E-02	8.49E-04
iRefIndex	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	44	-	-	1.47E-03	2.04E-03
iRefIndex	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	136	-	-	8.14E-03	6.17E-03
iRefIndex	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	1.15E-03	1.02E-03
iRefIndex	BP	GO:0061548	ganglion development	-	17	17	-	-	1.17E-02	7.92E-04
iRefIndex	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	93	-	-	7.97E-03	4.24E-03
iRefIndex	BP	GO:0042182	ketone catabolic process	-	14	12	-	-	2.95E-03	5.66E-04
iRefIndex	BP	GO:0042832	defense response to protozoan	-	28	24	-	-	2.87E-02	1.13E-03
iRefIndex	BP	GO:0048799	animal organ maturation	-	33	32	-	-	7.23E-03	1.47E-03
iRefIndex	BP	GO:0006925	inflammatory cell apoptotic process	-	23	21	-	-	1.03E-03	9.62E-04
iRefIndex	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	5.57E-04	7.36E-04
iRefIndex	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	159	-	-	6.90E-03	7.24E-03
iRefIndex	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.66E-04	5.09E-04
iRefIndex	BP	GO:1903035	negative regulation of response to wounding	-	93	84	-	-	9.22E-03	3.85E-03
iRefIndex	BP	GO:0015697	quaternary ammonium group transport	-	16	14	-	-	3.28E-03	6.79E-04
iRefIndex	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	25	-	-	1.56E-03	1.13E-03
iRefIndex	BP	GO:0036010	protein localization to endosome	-	27	25	-	-	2.17E-03	1.13E-03
iRefIndex	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	129	-	-	3.76E-02	5.89E-03
iRefIndex	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	94	-	-	3.17E-03	4.30E-03
iRefIndex	BP	GO:0045056	transcytosis	-	20	17	-	-	6.57E-04	7.92E-04
iRefIndex	BP	GO:0018342	protein prenylation	-	15	15	-	-	2.48E-02	6.79E-04
iRefIndex	BP	GO:0009267	cellular response to starvation	-	170	158	-	-	1.30E-02	7.19E-03
iRefIndex	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	5.47E-02	5.09E-04
iRefIndex	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	51	-	-	9.17E-03	2.32E-03
iRefIndex	BP	GO:0046834	lipid phosphorylation	-	16	15	-	-	1.63E-02	6.79E-04
iRefIndex	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	1.43E-03	1.08E-03
iRefIndex	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	22	-	-	2.48E-02	1.02E-03
iRefIndex	BP	GO:0046931	pore complex assembly	-	21	19	-	-	5.26E-02	9.05E-04
iRefIndex	CC	GO:0032008	positive regulation of TOR signaling	-	52	50	-	-	3.03E-02	2.26E-03
iRefIndex	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	30	-	-	1.27E-01	1.36E-03
iRefIndex	BP	GO:0046618	xenobiotic export from cell	-	27	12	-	-	1.44E-02	5.66E-04
iRefIndex	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	14	-	-	1.62E-03	6.79E-04
iRefIndex	BP	GO:0060428	lung epithelium development	-	43	42	-	-	3.89E-03	1.92E-03
iRefIndex	BP	GO:0030431	sleep	-	30	28	-	-	5.00E-03	1.30E-03
iRefIndex	BP	GO:1903318	negative regulation of protein maturation	-	29	26	-	-	1.04E-02	1.19E-03
iRefIndex	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	93	-	-	1.05E-01	4.24E-03
iRefIndex	BP	GO:0071732	cellular response to nitric oxide	-	17	16	-	-	3.20E-04	7.36E-04
iRefIndex	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	1.79E-02	6.79E-04
iRefIndex	BP	GO:1905155	positive regulation of membrane invagination	-	13	12	-	-	3.55E-03	5.66E-04
iRefIndex	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	65	-	-	1.13E-02	2.94E-03
iRefIndex	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	2.26E-03	2.94E-03
iRefIndex	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	15	-	-	7.24E-03	6.79E-04
iRefIndex	BP	GO:0065004	protein-DNA complex assembly	-	307	241	-	-	1.59E-02	1.09E-02
iRefIndex	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	1.68E-04	6.79E-04
iRefIndex	CC	GO:0006406	mRNA export from nucleus	-	69	66	-	-	3.79E-02	3.00E-03
iRefIndex	BP	GO:0009880	embryonic pattern specification	-	70	66	-	-	3.60E-03	3.00E-03
iRefIndex	BP	GO:0015791	polyol transmembrane transport	-	14	12	-	-	1.52E-02	5.66E-04
iRefIndex	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	35	-	-	2.05E-01	1.58E-03
iRefIndex	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	1.93E-02	1.13E-03
iRefIndex	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	1.49E-02	5.09E-04
iRefIndex	BP	GO:0002367	cytokine production involved in immune response	-	121	116	-	-	7.37E-03	5.26E-03
iRefIndex	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	1.63E-04	6.22E-04
iRefIndex	BP	GO:0044848	biological phase	-	211	197	-	-	2.48E-02	8.94E-03
iRefIndex	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	3.53E-03	5.66E-04
iRefIndex	BP	GO:0046660	female sex differentiation	-	125	121	-	-	7.72E-03	5.49E-03
iRefIndex	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	5.39E-04	7.92E-04
iRefIndex	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	37	-	-	8.41E-04	1.70E-03
iRefIndex	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	1.63E-04	5.09E-04
iRefIndex	BP	GO:0060411	cardiac septum morphogenesis	-	72	68	-	-	8.90E-03	3.11E-03
iRefIndex	BP	GO:0071248	cellular response to metal ion	-	201	184	-	-	3.44E-03	8.38E-03
iRefIndex	BP	GO:0030308	negative regulation of cell growth	-	191	175	-	-	5.33E-03	7.92E-03
iRefIndex	BP	GO:0097306	cellular response to alcohol	-	99	90	-	-	2.35E-03	4.07E-03
iRefIndex	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	124	-	-	2.83E-02	5.66E-03
iRefIndex	BP	GO:0010453	regulation of cell fate commitment	-	40	34	-	-	2.10E-02	1.58E-03
iRefIndex	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	57	-	-	2.46E-03	2.60E-03
iRefIndex	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	50	-	-	8.99E-03	2.26E-03
iRefIndex	BP	GO:0002026	regulation of the force of heart contraction	-	26	25	-	-	2.30E-03	1.13E-03
iRefIndex	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	1.80E-03	1.13E-03
iRefIndex	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	43	-	-	2.73E-02	1.98E-03
iRefIndex	BP	GO:0032890	regulation of organic acid transport	-	78	72	-	-	4.42E-03	3.28E-03
iRefIndex	BP	GO:0071498	cellular response to fluid shear stress	-	21	18	-	-	5.45E-04	8.49E-04
iRefIndex	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	23	-	-	4.59E-01	1.08E-03
iRefIndex	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	88	-	-	5.40E-03	4.02E-03
iRefIndex	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	24	-	-	1.65E-03	1.13E-03
iRefIndex	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	2.42E-03	5.09E-04
iRefIndex	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	52	-	-	4.04E-03	2.38E-03
iRefIndex	BP	GO:0051259	protein complex oligomerization	-	251	239	-	-	7.97E-03	1.09E-02
iRefIndex	BP	GO:0009163	nucleoside biosynthetic process	-	16	15	-	-	1.28E-02	6.79E-04
iRefIndex	BP	GO:0098743	cell aggregation	-	24	22	-	-	1.76E-03	1.02E-03
iRefIndex	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	4.35E-04	5.66E-04
iRefIndex	BP	GO:0009994	oocyte differentiation	-	57	55	-	-	3.94E-03	2.49E-03
iRefIndex	MF	GO:0031952	regulation of protein autophosphorylation	-	43	40	-	-	1.88E-03	1.81E-03
iRefIndex	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	13	-	-	7.97E-04	6.22E-04
iRefIndex	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	145	-	-	5.35E-03	6.56E-03
iRefIndex	BP	GO:0044319	"wound healing, spreading of cells"	-	37	32	-	-	4.54E-03	1.47E-03
iRefIndex	BP	GO:0033688	regulation of osteoblast proliferation	-	31	27	-	-	4.03E-03	1.24E-03
iRefIndex	BP	GO:0060251	regulation of glial cell proliferation	-	39	33	-	-	1.12E-03	1.53E-03
iRefIndex	BP	GO:0072665	protein localization to vacuole	-	84	76	-	-	6.42E-03	3.45E-03
iRefIndex	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	44	-	-	2.10E-02	2.04E-03
iRefIndex	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	24	-	-	2.19E-03	1.13E-03
iRefIndex	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	71	-	-	1.13E-02	3.23E-03
iRefIndex	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	5.73E-03	7.36E-04
iRefIndex	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	8.78E-03	6.79E-04
iRefIndex	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.62E-04	5.09E-04
iRefIndex	BP	GO:0042044	fluid transport	-	35	32	-	-	4.52E-03	1.47E-03
iRefIndex	BP	GO:0070633	transepithelial transport	-	35	33	-	-	2.71E-03	1.53E-03
iRefIndex	BP	GO:0033015	tetrapyrrole catabolic process	-	13	12	-	-	2.66E-02	5.66E-04
iRefIndex	BP	GO:0045661	regulation of myoblast differentiation	-	74	70	-	-	1.02E-02	3.17E-03
iRefIndex	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	14	-	-	1.19E-03	6.79E-04
iRefIndex	BP	GO:0030307	positive regulation of cell growth	-	164	150	-	-	3.19E-03	6.79E-03
iRefIndex	BP	GO:0034250	positive regulation of amide metabolic process	-	27	23	-	-	4.68E-04	1.08E-03
iRefIndex	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	17	-	-	5.67E-04	7.92E-04
iRefIndex	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	14	-	-	6.79E-04	6.79E-04
iRefIndex	BP	GO:0014812	muscle cell migration	-	110	79	-	-	3.16E-03	3.62E-03
iRefIndex	BP	GO:0048525	negative regulation of viral process	-	90	86	-	-	4.93E-03	3.90E-03
iRefIndex	BP	GO:0072044	collecting duct development	-	16	16	-	-	6.42E-03	7.36E-04
iRefIndex	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	1.86E-01	6.79E-04
iRefIndex	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	67	-	-	4.18E-03	3.06E-03
iRefIndex	BP	GO:0030238	male sex determination	-	14	14	-	-	8.75E-03	6.79E-04
iRefIndex	BP	GO:0051781	positive regulation of cell division	-	93	85	-	-	4.14E-03	3.85E-03
iRefIndex	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	5.55E-03	9.62E-04
iRefIndex	BP	GO:0035493	SNARE complex assembly	-	23	22	-	-	2.10E-02	1.02E-03
iRefIndex	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	20	-	-	1.13E-03	9.05E-04
iRefIndex	BP	GO:0060711	labyrinthine layer development	-	47	46	-	-	2.05E-03	2.09E-03
iRefIndex	BP	GO:0007272	ensheathment of neurons	-	146	135	-	-	3.67E-03	6.11E-03
iRefIndex	CC	GO:0050806	positive regulation of synaptic transmission	-	171	143	-	-	4.55E-03	6.51E-03
iRefIndex	BP	GO:0060021	roof of mouth development	-	91	86	-	-	4.79E-03	3.90E-03
iRefIndex	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	37	-	-	1.62E-03	1.70E-03
iRefIndex	BP	GO:0050819	negative regulation of coagulation	-	54	50	-	-	2.43E-02	2.26E-03
iRefIndex	BP	GO:0017004	cytochrome complex assembly	-	40	36	-	-	1.32E-01	1.64E-03
iRefIndex	BP	GO:0018410	C-terminal protein amino acid modification	-	15	14	-	-	9.27E-03	6.79E-04
iRefIndex	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	57	-	-	5.98E-02	2.60E-03
iRefIndex	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	5.80E-02	6.79E-04
iRefIndex	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	12	-	-	2.92E-04	5.66E-04
iRefIndex	CC	GO:0050805	negative regulation of synaptic transmission	-	55	47	-	-	2.92E-03	2.15E-03
iRefIndex	BP	GO:0043248	proteasome assembly	-	13	13	-	-	2.93E-02	6.22E-04
iRefIndex	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	54	-	-	2.04E-03	2.49E-03
iRefIndex	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	80	-	-	1.43E-02	3.62E-03
iRefIndex	BP	GO:0016054	organic acid catabolic process	-	251	233	-	-	5.23E-02	1.06E-02
iRefIndex	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	7.25E-04	6.22E-04
iRefIndex	BP	GO:1900048	positive regulation of hemostasis	-	28	26	-	-	1.57E-02	1.19E-03
iRefIndex	BP	GO:0065005	protein-lipid complex assembly	-	29	26	-	-	1.73E-02	1.19E-03
iRefIndex	BP	GO:0008033	tRNA processing	-	136	123	-	-	6.58E-02	5.60E-03
iRefIndex	BP	GO:0046661	male sex differentiation	-	171	165	-	-	9.26E-03	7.47E-03
iRefIndex	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	1.60E-03	6.79E-04
iRefIndex	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	16	-	-	3.62E-03	7.36E-04
iRefIndex	BP	GO:0035188	hatching	-	27	23	-	-	3.18E-04	1.08E-03
iRefIndex	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	85	-	-	3.11E-03	3.85E-03
iRefIndex	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	2.19E-04	6.79E-04
iRefIndex	BP	GO:0090713	immunological memory process	-	18	17	-	-	8.36E-02	7.92E-04
iRefIndex	BP	GO:0061326	renal tubule development	-	103	100	-	-	8.49E-03	4.53E-03
iRefIndex	BP	GO:0071985	multivesicular body sorting pathway	-	56	48	-	-	5.89E-02	2.21E-03
iRefIndex	BP	GO:0006450	regulation of translational fidelity	-	18	16	-	-	2.34E-03	7.36E-04
iRefIndex	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	1.48E-03	9.05E-04
iRefIndex	BP	GO:0060325	face morphogenesis	-	31	27	-	-	7.06E-04	1.24E-03
iRefIndex	BP	GO:0090559	regulation of membrane permeability	-	72	61	-	-	6.01E-03	2.77E-03
iRefIndex	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	12	-	-	2.82E-02	5.66E-04
iRefIndex	BP	GO:0031579	membrane raft organization	-	25	24	-	-	1.19E-03	1.13E-03
iRefIndex	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	1.55E-03	1.13E-03
iRefIndex	BP	GO:0060033	anatomical structure regression	-	16	15	-	-	2.36E-02	6.79E-04
iRefIndex	BP	GO:0046460	neutral lipid biosynthetic process	-	50	47	-	-	2.63E-02	2.15E-03
iRefIndex	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	146	-	-	1.41E-02	6.62E-03
iRefIndex	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	9.42E-03	5.09E-04
iRefIndex	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	150	-	-	3.61E-03	6.79E-03
iRefIndex	BP	GO:0002251	organ or tissue specific immune response	-	43	33	-	-	1.20E-02	1.53E-03
iRefIndex	CC	GO:0048167	regulation of synaptic plasticity	-	210	175	-	-	7.39E-03	7.92E-03
iRefIndex	BP	GO:1903708	positive regulation of hemopoiesis	-	184	171	-	-	8.23E-03	7.75E-03
iRefIndex	BP	GO:1903008	organelle disassembly	-	154	145	-	-	9.02E-03	6.56E-03
iRefIndex	BP	GO:0001709	cell fate determination	-	44	40	-	-	2.16E-03	1.81E-03
iRefIndex	BP	GO:0051873	killing by host of symbiont cells	-	28	26	-	-	2.41E-02	1.19E-03
iRefIndex	BP	GO:0045058	T cell selection	-	53	48	-	-	3.13E-02	2.21E-03
iRefIndex	CC	GO:0032387	negative regulation of intracellular transport	-	51	45	-	-	1.14E-03	2.04E-03
iRefIndex	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	1.29E-03	9.05E-04
iRefIndex	BP	GO:0072091	regulation of stem cell proliferation	-	91	74	-	-	3.12E-03	3.40E-03
iRefIndex	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	39	-	-	1.82E-02	1.81E-03
iRefIndex	BP	GO:0099084	postsynaptic specialization organization	-	44	44	-	-	5.04E-03	2.04E-03
iRefIndex	BP	GO:0071501	cellular response to sterol depletion	-	15	13	-	-	9.91E-02	6.22E-04
iRefIndex	BP	GO:0060384	innervation	-	27	25	-	-	4.89E-03	1.13E-03
iRefIndex	BP	GO:2000774	positive regulation of cellular senescence	-	19	11	-	-	1.07E-03	5.09E-04
iRefIndex	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	33	-	-	4.12E-03	1.53E-03
iRefIndex	MF	GO:0031281	positive regulation of cyclase activity	-	40	37	-	-	8.82E-03	1.70E-03
iRefIndex	MF	GO:0098631	cell adhesion mediator activity	-	64	60	-	-	3.65E-03	2.72E-03
iRefIndex	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	16	-	-	4.02E-03	7.36E-04
iRefIndex	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	3.95E-02	5.66E-04
iRefIndex	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	1.51E-02	8.49E-04
iRefIndex	BP	GO:0071453	cellular response to oxygen levels	-	168	148	-	-	4.92E-03	6.73E-03
iRefIndex	BP	GO:0090399	replicative senescence	-	17	14	-	-	8.43E-04	6.79E-04
iRefIndex	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	4.73E-02	6.79E-04
iRefIndex	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	1.59E-02	1.36E-03
iRefIndex	BP	GO:0070585	protein localization to mitochondrion	-	125	113	-	-	5.52E-02	5.15E-03
iRefIndex	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	9.96E-04	6.79E-04
iRefIndex	BP	GO:0010623	programmed cell death involved in cell development	-	25	22	-	-	6.34E-04	1.02E-03
iRefIndex	BP	GO:0044242	cellular lipid catabolic process	-	224	205	-	-	1.93E-02	9.28E-03
iRefIndex	BP	GO:0071236	cellular response to antibiotic	-	13	12	-	-	2.79E-04	5.66E-04
iRefIndex	BP	GO:0002931	response to ischemia	-	58	55	-	-	3.71E-03	2.49E-03
iRefIndex	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	11	-	-	3.17E-02	5.09E-04
iRefIndex	BP	GO:0014047	glutamate secretion	-	25	24	-	-	2.70E-03	1.13E-03
iRefIndex	BP	GO:0061005	cell differentiation involved in kidney development	-	58	57	-	-	2.95E-03	2.60E-03
iRefIndex	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	73	-	-	3.05E-02	3.34E-03
iRefIndex	BP	GO:0060420	regulation of heart growth	-	74	55	-	-	3.41E-03	2.49E-03
iRefIndex	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	1.48E-03	6.79E-04
iRefIndex	BP	GO:0009755	hormone-mediated signaling pathway	-	221	207	-	-	1.26E-02	9.39E-03
iRefIndex	BP	GO:0022612	gland morphogenesis	-	124	121	-	-	3.81E-03	5.49E-03
iRefIndex	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	36	-	-	9.35E-04	1.64E-03
iRefIndex	MF	GO:0140416	transcription regulator inhibitor activity	-	26	24	-	-	3.81E-03	1.13E-03
iRefIndex	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	25	-	-	2.65E-01	1.13E-03
iRefIndex	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	2.66E-03	6.79E-04
iRefIndex	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	1.57E-02	7.92E-04
iRefIndex	BP	GO:1990845	adaptive thermogenesis	-	166	158	-	-	5.09E-03	7.19E-03
iRefIndex	BP	GO:0071320	cellular response to cAMP	-	54	48	-	-	2.40E-03	2.21E-03
iRefIndex	BP	GO:0015844	monoamine transport	-	88	78	-	-	5.52E-03	3.57E-03
iRefIndex	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	4.60E-03	1.02E-03
iRefIndex	BP	GO:0060039	pericardium development	-	19	18	-	-	1.34E-03	8.49E-04
iRefIndex	BP	GO:0071392	cellular response to estradiol stimulus	-	40	40	-	-	3.45E-03	1.81E-03
iRefIndex	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	7.12E-03	6.22E-04
iRefIndex	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	1.29E-02	9.05E-04
iRefIndex	BP	GO:0009451	RNA modification	-	169	153	-	-	2.13E-02	6.96E-03
iRefIndex	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	2.13E-01	5.09E-04
iRefIndex	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	37	-	-	1.76E-03	1.70E-03
iRefIndex	BP	GO:1903729	regulation of plasma membrane organization	-	17	15	-	-	1.76E-03	6.79E-04
iRefIndex	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	106	-	-	7.51E-03	4.81E-03
iRefIndex	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	35	-	-	5.34E-03	1.58E-03
iRefIndex	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	1.68E-04	5.09E-04
iRefIndex	BP	GO:0015807	L-amino acid transport	-	94	79	-	-	7.80E-03	3.62E-03
iRefIndex	BP	GO:0032941	secretion by tissue	-	85	81	-	-	3.58E-03	3.68E-03
iRefIndex	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	1.70E-02	6.22E-04
iRefIndex	BP	GO:0046605	regulation of centrosome cycle	-	54	50	-	-	4.74E-03	2.26E-03
iRefIndex	BP	GO:0048753	pigment granule organization	-	40	35	-	-	1.41E-01	1.58E-03
iRefIndex	BP	GO:0021516	dorsal spinal cord development	-	20	18	-	-	3.33E-03	8.49E-04
iRefIndex	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	19	-	-	4.77E-02	9.05E-04
iRefIndex	BP	GO:0032196	transposition	-	11	11	-	-	2.43E-02	5.09E-04
iRefIndex	BP	GO:0003014	renal system process	-	130	122	-	-	5.33E-03	5.55E-03
iRefIndex	CC	GO:0070286	axonemal dynein complex assembly	-	40	37	-	-	3.31E-02	1.70E-03
iRefIndex	BP	GO:0045598	regulation of fat cell differentiation	-	148	129	-	-	4.88E-03	5.89E-03
iRefIndex	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	185	-	-	1.08E-02	8.38E-03
iRefIndex	BP	GO:1904646	cellular response to amyloid-beta	-	44	36	-	-	1.73E-03	1.64E-03
iRefIndex	BP	GO:1901863	positive regulation of muscle tissue development	-	24	23	-	-	1.40E-03	1.08E-03
iRefIndex	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	215	-	-	5.97E-02	9.73E-03
iRefIndex	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.57E-04	6.22E-04
iRefIndex	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	9.42E-04	1.08E-03
iRefIndex	BP	GO:0018158	protein oxidation	-	15	12	-	-	1.06E-03	5.66E-04
iRefIndex	BP	GO:0039694	viral RNA genome replication	-	30	29	-	-	4.88E-03	1.36E-03
iRefIndex	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	4.96E-03	7.92E-04
iRefIndex	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	26	-	-	1.19E-03	1.19E-03
iRefIndex	BP	GO:0071709	membrane assembly	-	68	61	-	-	2.72E-02	2.77E-03
iRefIndex	BP	GO:0008217	regulation of blood pressure	-	186	173	-	-	2.16E-02	7.87E-03
iRefIndex	BP	GO:0031643	positive regulation of myelination	-	19	17	-	-	2.17E-04	7.92E-04
iRefIndex	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	2.68E-01	6.79E-04
iRefIndex	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	60	-	-	5.06E-03	2.72E-03
iRefIndex	CC	GO:0042770	signal transduction in response to DNA damage	-	186	181	-	-	1.20E-02	8.21E-03
iRefIndex	BP	GO:0002200	somatic diversification of immune receptors	-	78	75	-	-	2.19E-02	3.40E-03
iRefIndex	BP	GO:0035315	hair cell differentiation	-	52	51	-	-	1.13E-02	2.32E-03
iRefIndex	BP	GO:0048645	animal organ formation	-	62	58	-	-	5.02E-03	2.66E-03
iRefIndex	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	145	-	-	5.94E-03	6.56E-03
iRefIndex	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	1.01E-01	6.79E-04
iRefIndex	BP	GO:0033627	cell adhesion mediated by integrin	-	87	83	-	-	1.07E-02	3.79E-03
iRefIndex	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	20	-	-	1.25E-01	9.05E-04
iRefIndex	BP	GO:0015824	proline transport	-	13	11	-	-	7.97E-04	5.09E-04
iRefIndex	BP	GO:0035107	appendage morphogenesis	-	147	142	-	-	5.40E-03	6.45E-03
iRefIndex	BP	GO:1903707	negative regulation of hemopoiesis	-	116	103	-	-	3.52E-03	4.70E-03
iRefIndex	BP	GO:0036342	post-anal tail morphogenesis	-	19	18	-	-	1.02E-03	8.49E-04
iRefIndex	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	1.43E-02	1.13E-03
iRefIndex	BP	GO:0030149	sphingolipid catabolic process	-	32	30	-	-	1.24E-02	1.36E-03
iRefIndex	BP	GO:0050994	regulation of lipid catabolic process	-	61	56	-	-	3.88E-03	2.55E-03
iRefIndex	BP	GO:0035988	chondrocyte proliferation	-	24	21	-	-	1.16E-02	9.62E-04
iRefIndex	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	27	-	-	6.79E-03	1.24E-03
iRefIndex	BP	GO:0045727	positive regulation of translation	-	141	133	-	-	5.66E-03	6.06E-03
iRefIndex	BP	GO:0036315	cellular response to sterol	-	24	20	-	-	4.15E-03	9.05E-04
iRefIndex	CC	GO:0032388	positive regulation of intracellular transport	-	137	128	-	-	2.27E-03	5.83E-03
iRefIndex	BP	GO:0021979	hypothalamus cell differentiation	-	13	12	-	-	1.54E-03	5.66E-04
iRefIndex	BP	GO:0002027	regulation of heart rate	-	106	97	-	-	3.94E-02	4.41E-03
iRefIndex	BP	GO:0050879	multicellular organismal movement	-	118	111	-	-	3.39E-03	5.04E-03
iRefIndex	BP	GO:0120305	regulation of pigmentation	-	15	14	-	-	5.51E-03	6.79E-04
iRefIndex	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	69	-	-	2.36E-03	3.17E-03
iRefIndex	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	59	-	-	2.07E-02	2.72E-03
iRefIndex	BP	GO:0048515	spermatid differentiation	-	208	186	-	-	7.51E-03	8.43E-03
iRefIndex	BP	GO:0072132	mesenchyme morphogenesis	-	57	55	-	-	7.68E-03	2.49E-03
iRefIndex	MF	GO:0042887	amide transmembrane transporter activity	-	33	30	-	-	5.88E-03	1.36E-03
iRefIndex	BP	GO:0007130	synaptonemal complex assembly	-	23	22	-	-	1.19E-01	1.02E-03
iRefIndex	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	33	-	-	4.14E-03	1.53E-03
iRefIndex	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	31	-	-	8.31E-04	1.41E-03
iRefIndex	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	34	-	-	1.70E-02	1.58E-03
iRefIndex	BP	GO:0060119	inner ear receptor cell development	-	44	43	-	-	1.41E-02	1.98E-03
iRefIndex	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	7.16E-02	8.49E-04
iRefIndex	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	34	-	-	9.40E-02	1.58E-03
iRefIndex	BP	GO:1901983	regulation of protein acetylation	-	26	22	-	-	8.24E-04	1.02E-03
iRefIndex	BP	GO:0014854	response to inactivity	-	12	11	-	-	1.04E-03	5.09E-04
iRefIndex	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	235	-	-	9.05E-03	1.06E-02
iRefIndex	BP	GO:1900006	positive regulation of dendrite development	-	17	16	-	-	1.00E-02	7.36E-04
iRefIndex	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	2.44E-02	2.21E-03
iRefIndex	BP	GO:0010883	regulation of lipid storage	-	53	47	-	-	3.60E-03	2.15E-03
iRefIndex	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	3.46E-03	1.19E-03
iRefIndex	BP	GO:0007635	chemosensory behavior	-	20	19	-	-	3.71E-04	9.05E-04
iRefIndex	BP	GO:1905954	positive regulation of lipid localization	-	110	100	-	-	1.76E-02	4.53E-03
iRefIndex	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.39E-03	5.66E-04
iRefIndex	BP	GO:0002209	behavioral defense response	-	39	39	-	-	1.39E-03	1.81E-03
iRefIndex	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	3.00E-02	1.36E-03
iRefIndex	BP	GO:0072523	purine-containing compound catabolic process	-	146	138	-	-	7.68E-03	6.28E-03
iRefIndex	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	30	-	-	1.22E-02	1.36E-03
iRefIndex	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	23	-	-	6.52E-03	1.08E-03
iRefIndex	BP	GO:0021535	cell migration in hindbrain	-	16	15	-	-	9.35E-04	6.79E-04
iRefIndex	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	90	-	-	7.86E-03	4.07E-03
iRefIndex	BP	GO:0007218	neuropeptide signaling pathway	-	113	107	-	-	3.90E-02	4.87E-03
iRefIndex	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	11	-	-	5.93E-03	5.09E-04
iRefIndex	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	157	-	-	2.48E-02	7.13E-03
iRefIndex	BP	GO:0031345	negative regulation of cell projection organization	-	195	177	-	-	7.10E-03	8.04E-03
iRefIndex	BP	GO:0048278	vesicle docking	-	64	56	-	-	1.95E-02	2.55E-03
iRefIndex	BP	GO:0035050	embryonic heart tube development	-	86	79	-	-	7.87E-03	3.62E-03
iRefIndex	BP	GO:0030168	platelet activation	-	135	123	-	-	6.85E-03	5.60E-03
iRefIndex	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	7.73E-02	7.36E-04
iRefIndex	CC	GO:0098810	neurotransmitter reuptake	-	35	30	-	-	2.52E-03	1.36E-03
iRefIndex	BP	GO:0008213	protein alkylation	-	58	52	-	-	3.84E-03	2.38E-03
iRefIndex	BP	GO:0009812	flavonoid metabolic process	-	14	13	-	-	2.14E-01	6.22E-04
iRefIndex	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	12	-	-	6.88E-04	5.66E-04
iRefIndex	BP	GO:0031338	regulation of vesicle fusion	-	24	22	-	-	1.65E-02	1.02E-03
iRefIndex	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	12	-	-	4.34E-04	5.66E-04
iRefIndex	BP	GO:0031529	ruffle organization	-	55	49	-	-	1.85E-03	2.26E-03
iRefIndex	BP	GO:0010842	retina layer formation	-	25	24	-	-	2.71E-04	1.13E-03
iRefIndex	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	87	-	-	5.97E-02	3.96E-03
iRefIndex	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	3.46E-02	5.09E-04
iRefIndex	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	68	-	-	2.04E-02	3.11E-03
iRefIndex	MF	GO:0170055	lipid transmembrane transporter activity	-	56	53	-	-	2.66E-02	2.43E-03
iRefIndex	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	33	-	-	5.19E-04	1.53E-03
iRefIndex	BP	GO:0035304	regulation of protein dephosphorylation	-	87	81	-	-	2.92E-03	3.68E-03
iRefIndex	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	219	-	-	4.45E-03	9.96E-03
iRefIndex	BP	GO:0099637	neurotransmitter receptor transport	-	26	24	-	-	1.46E-03	1.13E-03
iRefIndex	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	32	-	-	2.99E-03	1.47E-03
iRefIndex	BP	GO:0051775	response to redox state	-	13	13	-	-	4.64E-03	6.22E-04
iRefIndex	BP	GO:0051785	positive regulation of nuclear division	-	61	57	-	-	2.15E-03	2.60E-03
iRefIndex	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	2.16E-03	7.36E-04
iRefIndex	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	3.80E-03	7.36E-04
iRefIndex	BP	GO:0060749	mammary gland alveolus development	-	20	19	-	-	1.07E-03	9.05E-04
iRefIndex	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	11	-	-	6.86E-03	5.09E-04
iRefIndex	BP	GO:0044786	cell cycle DNA replication	-	45	43	-	-	1.07E-02	1.98E-03
iRefIndex	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	14	-	-	8.81E-03	6.79E-04
iRefIndex	BP	GO:0044539	long-chain fatty acid import into cell	-	17	16	-	-	2.53E-03	7.36E-04
iRefIndex	BP	GO:0051299	centrosome separation	-	15	13	-	-	1.86E-03	6.22E-04
iRefIndex	BP	GO:0048145	regulation of fibroblast proliferation	-	87	81	-	-	3.12E-03	3.68E-03
iRefIndex	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	84	-	-	9.90E-02	3.85E-03
iRefIndex	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	6.57E-03	5.09E-04
iRefIndex	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	220	-	-	4.56E-03	9.96E-03
iRefIndex	BP	GO:0032098	regulation of appetite	-	20	20	-	-	1.37E-02	9.05E-04
iRefIndex	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	1.26E-02	6.79E-04
iRefIndex	CC	GO:0008333	endosome to lysosome transport	-	73	66	-	-	2.02E-02	3.00E-03
iRefIndex	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	22	-	-	2.53E-02	1.02E-03
iRefIndex	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	16	-	-	1.19E-03	7.36E-04
iRefIndex	BP	GO:0003016	respiratory system process	-	39	37	-	-	1.22E-03	1.70E-03
iRefIndex	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	22	-	-	5.91E-03	1.02E-03
iRefIndex	BP	GO:0045732	positive regulation of protein catabolic process	-	202	193	-	-	6.61E-03	8.77E-03
iRefIndex	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	67	-	-	2.26E-02	3.06E-03
iRefIndex	BP	GO:0007588	excretion	-	40	38	-	-	5.40E-03	1.75E-03
iRefIndex	BP	GO:1904018	positive regulation of vasculature development	-	185	152	-	-	6.98E-03	6.90E-03
iRefIndex	BP	GO:0050953	sensory perception of light stimulus	-	223	211	-	-	6.84E-02	9.56E-03
iRefIndex	BP	GO:0009164	nucleoside catabolic process	-	25	23	-	-	1.32E-01	1.08E-03
iRefIndex	BP	GO:0002357	defense response to tumor cell	-	13	11	-	-	1.12E-03	5.09E-04
iRefIndex	BP	GO:0009303	rRNA transcription	-	37	35	-	-	1.50E-02	1.58E-03
iRefIndex	BP	GO:0035601	protein deacylation	-	56	54	-	-	5.74E-03	2.49E-03
iRefIndex	BP	GO:0061952	midbody abscission	-	18	15	-	-	3.86E-02	6.79E-04
iRefIndex	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	2.73E-03	9.05E-04
iRefIndex	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	28	-	-	1.73E-03	1.30E-03
iRefIndex	BP	GO:0071300	cellular response to retinoic acid	-	66	64	-	-	1.30E-02	2.94E-03
iRefIndex	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	14	-	-	5.98E-03	6.79E-04
iRefIndex	BP	GO:0045830	positive regulation of isotype switching	-	28	27	-	-	4.19E-02	1.24E-03
iRefIndex	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	3.69E-03	1.53E-03
iRefIndex	BP	GO:0046697	decidualization	-	26	23	-	-	5.97E-04	1.08E-03
iRefIndex	BP	GO:0008212	mineralocorticoid metabolic process	-	14	13	-	-	6.68E-02	6.22E-04
iRefIndex	BP	GO:0051588	regulation of neurotransmitter transport	-	99	92	-	-	3.38E-03	4.19E-03
iRefIndex	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	30	-	-	4.55E-02	1.36E-03
iRefIndex	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	5.76E-04	5.66E-04
iRefIndex	BP	GO:0051784	negative regulation of nuclear division	-	63	61	-	-	1.37E-02	2.77E-03
iRefIndex	BP	GO:0044703	multi-organism reproductive process	-	209	189	-	-	8.87E-03	8.60E-03
iRefIndex	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	132	-	-	4.23E-03	6.00E-03
iRefIndex	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	3.39E-01	5.09E-04
iRefIndex	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	51	-	-	1.06E-02	2.32E-03
iRefIndex	BP	GO:0099022	vesicle tethering	-	32	28	-	-	1.05E-01	1.30E-03
iRefIndex	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	37	-	-	3.23E-03	1.70E-03
iRefIndex	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	1.62E-04	5.66E-04
iRefIndex	BP	GO:0048857	neural nucleus development	-	65	61	-	-	1.64E-03	2.77E-03
iRefIndex	BP	GO:0048663	neuron fate commitment	-	74	71	-	-	8.02E-03	3.23E-03
iRefIndex	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	166	-	-	6.74E-03	7.53E-03
iRefIndex	BP	GO:0106027	neuron projection organization	-	90	82	-	-	4.47E-03	3.73E-03
iRefIndex	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	126	-	-	1.27E-02	5.72E-03
iRefIndex	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	33	-	-	1.97E-03	1.53E-03
iRefIndex	BP	GO:0045685	regulation of glial cell differentiation	-	77	69	-	-	4.26E-03	3.17E-03
iRefIndex	BP	GO:0051608	histamine transport	-	14	12	-	-	1.73E-03	5.66E-04
iRefIndex	BP	GO:0043414	macromolecule methylation	-	138	127	-	-	5.30E-03	5.77E-03
iRefIndex	BP	GO:0048521	negative regulation of behavior	-	12	11	-	-	3.78E-03	5.09E-04
iRefIndex	BP	GO:0048268	clathrin coat assembly	-	16	15	-	-	3.87E-02	6.79E-04
iRefIndex	BP	GO:0050886	endocrine process	-	93	87	-	-	1.99E-02	3.96E-03
iRefIndex	MF	GO:0015562	efflux transmembrane transporter activity	-	15	12	-	-	4.98E-03	5.66E-04
iRefIndex	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	1.50E-03	1.30E-03
iRefIndex	BP	GO:0045807	positive regulation of endocytosis	-	155	138	-	-	6.88E-03	6.28E-03
iRefIndex	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	6.93E-04	5.09E-04
iRefIndex	BP	GO:0002418	immune response to tumor cell	-	29	25	-	-	1.37E-02	1.13E-03
iRefIndex	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	56	-	-	2.70E-03	2.55E-03
iRefIndex	BP	GO:0048308	organelle inheritance	-	14	14	-	-	6.96E-03	6.79E-04
iRefIndex	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	19	-	-	9.34E-04	9.05E-04
iRefIndex	BP	GO:0001829	trophectodermal cell differentiation	-	19	17	-	-	7.30E-04	7.92E-04
iRefIndex	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	49	-	-	1.39E-03	2.26E-03
iRefIndex	BP	GO:0034394	protein localization to cell surface	-	69	66	-	-	1.94E-03	3.00E-03
iRefIndex	BP	GO:0009110	vitamin biosynthetic process	-	23	22	-	-	4.30E-03	1.02E-03
iRefIndex	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	20	-	-	2.68E-03	9.05E-04
iRefIndex	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	15	-	-	1.11E-03	6.79E-04
iRefIndex	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	19	-	-	6.79E-03	9.05E-04
iRefIndex	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	89	-	-	2.45E-03	4.07E-03
iRefIndex	MF	GO:0051100	negative regulation of binding	-	161	145	-	-	3.90E-03	6.56E-03
iRefIndex	BP	GO:0003151	outflow tract morphogenesis	-	81	73	-	-	7.75E-03	3.34E-03
iRefIndex	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	56	-	-	2.81E-03	2.55E-03
iRefIndex	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	1.29E-03	9.05E-04
iRefIndex	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	5.02E-04	5.66E-04
iRefIndex	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	2.65E-02	1.53E-03
iRefIndex	BP	GO:0046184	aldehyde biosynthetic process	-	16	15	-	-	5.62E-02	6.79E-04
iRefIndex	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	4.68E-03	6.22E-04
iRefIndex	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	45	-	-	3.58E-03	2.04E-03
iRefIndex	BP	GO:0046621	negative regulation of organ growth	-	39	29	-	-	2.90E-03	1.36E-03
iRefIndex	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	47	-	-	8.85E-02	2.15E-03
iRefIndex	BP	GO:0032368	regulation of lipid transport	-	149	120	-	-	7.25E-03	5.43E-03
iRefIndex	BP	GO:0055094	response to lipoprotein particle	-	34	27	-	-	4.40E-03	1.24E-03
iRefIndex	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	177	-	-	5.81E-03	8.04E-03
iRefIndex	BP	GO:0033002	muscle cell proliferation	-	249	193	-	-	6.43E-03	8.77E-03
iRefIndex	BP	GO:0043331	response to dsRNA	-	56	53	-	-	1.69E-02	2.43E-03
iRefIndex	BP	GO:0033327	Leydig cell differentiation	-	12	11	-	-	5.12E-03	5.09E-04
iRefIndex	BP	GO:0051904	pigment granule transport	-	23	21	-	-	4.04E-02	9.62E-04
iRefIndex	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	1.44E-03	1.47E-03
iRefIndex	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	34	-	-	1.99E-03	1.58E-03
iRefIndex	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	11	-	-	2.16E-02	5.09E-04
iRefIndex	BP	GO:0033363	secretory granule organization	-	63	52	-	-	4.32E-02	2.38E-03
iRefIndex	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	2.16E-03	1.30E-03
iRefIndex	BP	GO:0120009	intermembrane lipid transfer	-	52	51	-	-	7.23E-02	2.32E-03
iRefIndex	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	4.36E-03	6.79E-04
iRefIndex	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	37	-	-	1.95E-03	1.70E-03
iRefIndex	BP	GO:0033622	integrin activation	-	26	25	-	-	3.00E-03	1.13E-03
iRefIndex	BP	GO:0098751	bone cell development	-	18	18	-	-	1.48E-02	8.49E-04
iRefIndex	BP	GO:2000773	negative regulation of cellular senescence	-	25	19	-	-	6.94E-04	9.05E-04
iRefIndex	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	2.70E-03	2.32E-03
iRefIndex	BP	GO:0050820	positive regulation of coagulation	-	30	28	-	-	1.83E-02	1.30E-03
iRefIndex	BP	GO:0002076	osteoblast development	-	17	15	-	-	2.79E-03	6.79E-04
iRefIndex	BP	GO:0072164	mesonephric tubule development	-	98	95	-	-	6.90E-03	4.30E-03
iRefIndex	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	16	-	-	2.21E-04	7.36E-04
iRefIndex	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	102	-	-	3.68E-03	4.64E-03
iRefIndex	BP	GO:1903524	positive regulation of blood circulation	-	39	33	-	-	3.17E-03	1.53E-03
iRefIndex	BP	GO:0030901	midbrain development	-	87	82	-	-	2.97E-03	3.73E-03
iRefIndex	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	8.73E-03	1.02E-03
iRefIndex	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	2.69E-03	7.36E-04
iRefIndex	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	2.47E-03	6.22E-04
iRefIndex	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	66	-	-	2.93E-03	3.00E-03
iRefIndex	MF	GO:1901474	azole transmembrane transporter activity	-	13	12	-	-	4.79E-03	5.66E-04
iRefIndex	BP	GO:0002687	positive regulation of leukocyte migration	-	147	136	-	-	5.14E-03	6.17E-03
iRefIndex	BP	GO:0019755	one-carbon compound transport	-	28	25	-	-	1.76E-02	1.13E-03
iRefIndex	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	6.82E-04	6.22E-04
iRefIndex	BP	GO:0060856	establishment of blood-brain barrier	-	16	15	-	-	1.94E-03	6.79E-04
iRefIndex	BP	GO:0110154	RNA decapping	-	19	19	-	-	5.17E-02	9.05E-04
iRefIndex	BP	GO:0034605	cellular response to heat	-	66	64	-	-	2.46E-03	2.94E-03
iRefIndex	BP	GO:0005996	monosaccharide metabolic process	-	250	231	-	-	8.69E-03	1.05E-02
iRefIndex	BP	GO:0033555	multicellular organismal response to stress	-	90	89	-	-	3.03E-03	4.07E-03
iRefIndex	BP	GO:0002262	myeloid cell homeostasis	-	172	161	-	-	4.50E-03	7.30E-03
iRefIndex	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	7.07E-02	1.75E-03
iRefIndex	BP	GO:0050688	regulation of defense response to virus	-	65	61	-	-	9.50E-03	2.77E-03
iRefIndex	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	1.52E-03	9.05E-04
iRefIndex	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	217	-	-	8.88E-03	9.85E-03
iRefIndex	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	30	-	-	1.94E-03	1.36E-03
iRefIndex	BP	GO:0061029	eyelid development in camera-type eye	-	14	12	-	-	3.46E-04	5.66E-04
iRefIndex	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	30	-	-	6.27E-03	1.36E-03
iRefIndex	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	18	-	-	1.87E-03	8.49E-04
iRefIndex	BP	GO:0003272	endocardial cushion formation	-	28	26	-	-	2.52E-02	1.19E-03
iRefIndex	BP	GO:0022618	protein-RNA complex assembly	-	227	177	-	-	2.85E-02	8.04E-03
iRefIndex	BP	GO:0051147	regulation of muscle cell differentiation	-	162	131	-	-	1.08E-02	5.94E-03
iRefIndex	BP	GO:0090102	cochlea development	-	50	47	-	-	2.78E-03	2.15E-03
iRefIndex	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	2.89E-03	1.19E-03
iRefIndex	BP	GO:0045933	positive regulation of muscle contraction	-	49	43	-	-	3.58E-03	1.98E-03
iRefIndex	BP	GO:0015803	branched-chain amino acid transport	-	14	12	-	-	7.48E-02	5.66E-04
iRefIndex	BP	GO:0002679	respiratory burst involved in defense response	-	16	15	-	-	4.97E-04	6.79E-04
iRefIndex	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	34	-	-	4.38E-03	1.58E-03
iRefIndex	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	90	-	-	5.99E-02	4.07E-03
iRefIndex	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.65E-04	5.66E-04
iRefIndex	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	4.06E-03	1.02E-03
iRefIndex	BP	GO:0032922	circadian regulation of gene expression	-	71	67	-	-	1.17E-02	3.06E-03
iRefIndex	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	52	-	-	2.06E-02	2.38E-03
iRefIndex	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	21	-	-	7.43E-03	9.62E-04
iRefIndex	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	54	-	-	5.06E-03	2.49E-03
iRefIndex	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	1.23E-03	5.09E-04
iRefIndex	BP	GO:0038179	neurotrophin signaling pathway	-	38	33	-	-	6.69E-03	1.53E-03
iRefIndex	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.64E-04	5.66E-04
iRefIndex	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	1.62E-04	5.09E-04
iRefIndex	BP	GO:0140253	cell-cell fusion	-	62	55	-	-	4.28E-03	2.49E-03
iRefIndex	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	11	-	-	1.53E-03	5.09E-04
iRefIndex	BP	GO:0071599	otic vesicle development	-	15	14	-	-	4.56E-03	6.79E-04
iRefIndex	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	44	-	-	8.31E-02	2.04E-03
iRefIndex	BP	GO:0061635	regulation of protein complex stability	-	14	13	-	-	1.46E-03	6.22E-04
iRefIndex	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	57	-	-	1.36E-02	2.60E-03
iRefIndex	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	9.57E-03	1.64E-03
iRefIndex	BP	GO:0051293	establishment of spindle localization	-	57	53	-	-	3.97E-03	2.43E-03
iRefIndex	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	1.59E-04	5.66E-04
iRefIndex	BP	GO:0043114	regulation of vascular permeability	-	49	45	-	-	4.51E-03	2.04E-03
iRefIndex	BP	GO:0018126	protein hydroxylation	-	26	25	-	-	1.38E-02	1.13E-03
iRefIndex	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	63	-	-	2.17E-03	2.89E-03
iRefIndex	BP	GO:0008360	regulation of cell shape	-	139	130	-	-	1.07E-02	5.89E-03
iRefIndex	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	6.70E-03	7.36E-04
iRefIndex	BP	GO:0051222	positive regulation of protein transport	-	249	233	-	-	5.39E-03	1.06E-02
iRefIndex	CC	GO:0140632	canonical inflammasome complex assembly	-	40	40	-	-	1.09E-02	1.81E-03
iRefIndex	MF	GO:0034260	negative regulation of GTPase activity	-	36	30	-	-	9.08E-04	1.36E-03
iRefIndex	BP	GO:0045932	negative regulation of muscle contraction	-	24	20	-	-	6.97E-03	9.05E-04
iRefIndex	BP	GO:0045739	positive regulation of DNA repair	-	128	121	-	-	4.21E-02	5.49E-03
iRefIndex	BP	GO:0001845	phagolysosome assembly	-	19	17	-	-	3.43E-02	7.92E-04
iRefIndex	BP	GO:0045185	maintenance of protein location	-	95	82	-	-	2.36E-03	3.73E-03
iRefIndex	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	12	-	-	3.00E-03	5.66E-04
iRefIndex	BP	GO:0003158	endothelium development	-	140	126	-	-	1.63E-02	5.72E-03
iRefIndex	CC	GO:0072595	maintenance of protein localization in organelle	-	42	38	-	-	1.41E-03	1.75E-03
iRefIndex	BP	GO:0051224	negative regulation of protein transport	-	122	98	-	-	2.40E-03	4.47E-03
iRefIndex	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	138	-	-	3.16E-03	6.28E-03
iRefIndex	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	12	-	-	3.21E-03	5.66E-04
iRefIndex	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	30	-	-	1.45E-03	1.36E-03
iRefIndex	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	1.92E-02	9.05E-04
iRefIndex	BP	GO:0021885	forebrain cell migration	-	63	60	-	-	6.39E-03	2.72E-03
iRefIndex	BP	GO:0007405	neuroblast proliferation	-	81	72	-	-	3.99E-03	3.28E-03
iRefIndex	BP	GO:0009581	detection of external stimulus	-	137	129	-	-	6.09E-03	5.89E-03
iRefIndex	BP	GO:1990542	mitochondrial transmembrane transport	-	93	83	-	-	2.94E-02	3.79E-03
iRefIndex	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	29	-	-	2.88E-03	1.36E-03
iRefIndex	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	3.22E-03	5.09E-04
iRefIndex	BP	GO:0097186	amelogenesis	-	26	23	-	-	7.54E-02	1.08E-03
iRefIndex	BP	GO:0031128	developmental induction	-	26	26	-	-	1.40E-02	1.19E-03
iRefIndex	BP	GO:0035672	oligopeptide transmembrane transport	-	15	14	-	-	3.01E-03	6.79E-04
iRefIndex	BP	GO:0031100	animal organ regeneration	-	66	63	-	-	1.16E-03	2.89E-03
iRefIndex	BP	GO:0021533	cell differentiation in hindbrain	-	23	22	-	-	3.73E-02	1.02E-03
iRefIndex	BP	GO:0045684	positive regulation of epidermis development	-	33	30	-	-	1.52E-03	1.36E-03
iRefIndex	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	11	-	-	2.40E-03	5.09E-04
iRefIndex	BP	GO:1900047	negative regulation of hemostasis	-	51	48	-	-	2.76E-02	2.21E-03
iRefIndex	BP	GO:0021517	ventral spinal cord development	-	47	44	-	-	1.67E-02	2.04E-03
iRefIndex	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	3.19E-03	3.40E-03
iRefIndex	BP	GO:0032328	alanine transport	-	19	16	-	-	3.62E-02	7.36E-04
iRefIndex	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	1.66E-03	7.36E-04
iRefIndex	BP	GO:0097722	sperm motility	-	133	121	-	-	2.01E-02	5.49E-03
iRefIndex	BP	GO:0051231	spindle elongation	-	14	13	-	-	5.22E-03	6.22E-04
iRefIndex	BP	GO:0042490	mechanoreceptor differentiation	-	67	65	-	-	1.59E-02	2.94E-03
iRefIndex	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	28	-	-	1.47E-02	1.30E-03
iRefIndex	BP	GO:0035148	tube formation	-	155	146	-	-	5.49E-03	6.62E-03
iRefIndex	BP	GO:0048520	positive regulation of behavior	-	27	27	-	-	7.59E-03	1.24E-03
iRefIndex	BP	GO:0098543	detection of other organism	-	19	19	-	-	5.30E-02	9.05E-04
iRefIndex	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	39	-	-	1.41E-02	1.81E-03
iRefIndex	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	118	-	-	1.60E-02	5.38E-03
iRefIndex	BP	GO:0031123	RNA 3'-end processing	-	79	72	-	-	1.64E-02	3.28E-03
iRefIndex	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	106	-	-	5.29E-03	4.81E-03
iRefIndex	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	3.46E-03	8.49E-04
iRefIndex	CC	GO:0007097	nuclear migration	-	24	23	-	-	2.10E-03	1.08E-03
iRefIndex	BP	GO:0006885	regulation of pH	-	104	92	-	-	1.57E-02	4.19E-03
iRefIndex	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.63E-04	6.79E-04
iRefIndex	BP	GO:1990840	response to lectin	-	22	19	-	-	2.71E-03	9.05E-04
iRefIndex	BP	GO:0071800	podosome assembly	-	19	18	-	-	1.10E-03	8.49E-04
iRefIndex	BP	GO:0031018	endocrine pancreas development	-	47	42	-	-	6.14E-03	1.92E-03
iRefIndex	BP	GO:0001708	cell fate specification	-	108	103	-	-	1.07E-02	4.70E-03
iRefIndex	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	66	-	-	3.64E-03	3.00E-03
iRefIndex	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	1.96E-03	1.70E-03
iRefIndex	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	2.25E-02	6.79E-04
iRefIndex	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	11	-	-	2.96E-03	5.09E-04
iRefIndex	BP	GO:0042440	pigment metabolic process	-	80	74	-	-	5.06E-02	3.40E-03
iRefIndex	BP	GO:1901606	alpha-amino acid catabolic process	-	101	93	-	-	6.49E-02	4.24E-03
iRefIndex	BP	GO:1901890	positive regulation of cell junction assembly	-	106	101	-	-	7.61E-03	4.58E-03
iRefIndex	BP	GO:0070988	demethylation	-	27	26	-	-	4.07E-03	1.19E-03
iRefIndex	BP	GO:1901655	cellular response to ketone	-	107	97	-	-	2.00E-03	4.41E-03
iRefIndex	BP	GO:0046185	aldehyde catabolic process	-	14	13	-	-	3.13E-03	6.22E-04
iRefIndex	BP	GO:0051255	spindle midzone assembly	-	14	13	-	-	2.88E-03	6.22E-04
iRefIndex	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	16	-	-	2.41E-02	7.36E-04
iRefIndex	BP	GO:0006968	cellular defense response	-	52	49	-	-	4.94E-03	2.26E-03
iRefIndex	BP	GO:0055006	cardiac cell development	-	93	77	-	-	3.19E-03	3.51E-03
iRefIndex	BP	GO:0031365	N-terminal protein amino acid modification	-	30	27	-	-	9.21E-03	1.24E-03
iRefIndex	BP	GO:0035881	amacrine cell differentiation	-	12	11	-	-	1.68E-04	5.09E-04
iRefIndex	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	28	-	-	1.72E-03	1.30E-03
iRefIndex	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	11	-	-	3.99E-04	5.09E-04
iRefIndex	BP	GO:0060004	reflex	-	63	61	-	-	5.56E-03	2.77E-03
iRefIndex	BP	GO:0044706	multi-multicellular organism process	-	217	198	-	-	6.24E-03	9.00E-03
iRefIndex	BP	GO:0043589	skin morphogenesis	-	12	11	-	-	1.34E-03	5.09E-04
iRefIndex	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	133	-	-	4.03E-03	6.06E-03
iRefIndex	BP	GO:0006026	aminoglycan catabolic process	-	34	32	-	-	7.16E-02	1.47E-03
iRefIndex	BP	GO:0031294	lymphocyte costimulation	-	47	44	-	-	2.69E-02	2.04E-03
iRefIndex	BP	GO:0050768	negative regulation of neurogenesis	-	150	138	-	-	5.75E-03	6.28E-03
iRefIndex	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	90	-	-	2.51E-03	4.07E-03
iRefIndex	BP	GO:0090068	positive regulation of cell cycle process	-	262	230	-	-	6.13E-03	1.04E-02
iRefIndex	BP	GO:0043605	amide catabolic process	-	16	15	-	-	1.41E-01	6.79E-04
iRefIndex	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	24	-	-	6.77E-03	1.13E-03
iRefIndex	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	31	-	-	3.43E-02	1.41E-03
iRefIndex	BP	GO:1902115	regulation of organelle assembly	-	210	193	-	-	5.58E-03	8.77E-03
iRefIndex	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	60	-	-	2.15E-03	2.72E-03
iRefIndex	BP	GO:0047484	regulation of response to osmotic stress	-	16	14	-	-	3.93E-03	6.79E-04
iRefIndex	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	135	-	-	4.10E-03	6.11E-03
iRefIndex	BP	GO:0043171	peptide catabolic process	-	19	16	-	-	1.36E-03	7.36E-04
iRefIndex	BP	GO:0046622	positive regulation of organ growth	-	52	41	-	-	1.80E-03	1.87E-03
iRefIndex	BP	GO:0051952	regulation of amine transport	-	98	89	-	-	5.10E-03	4.07E-03
iRefIndex	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	1.41E-02	1.08E-03
iRefIndex	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	18	-	-	5.85E-03	8.49E-04
iRefIndex	BP	GO:0015801	aromatic amino acid transport	-	13	11	-	-	4.01E-03	5.09E-04
iRefIndex	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	5.95E-02	1.08E-03
iRefIndex	BP	GO:0097154	GABAergic neuron differentiation	-	20	18	-	-	9.71E-04	8.49E-04
iRefIndex	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	4.12E-04	7.36E-04
iRefIndex	CC	GO:0032365	intracellular lipid transport	-	51	47	-	-	1.96E-02	2.15E-03
iRefIndex	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	1.51E-02	1.36E-03
iRefIndex	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	64	-	-	3.53E-03	2.94E-03
iRefIndex	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	107	-	-	2.67E-03	4.87E-03
iRefIndex	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	6.11E-02	1.30E-03
iRefIndex	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	24	-	-	7.82E-04	1.13E-03
iRefIndex	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	1.70E-03	6.22E-04
iRefIndex	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	4.12E-04	6.79E-04
iRefIndex	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	1.59E-04	6.22E-04
iRefIndex	BP	GO:0071398	cellular response to fatty acid	-	35	33	-	-	4.47E-03	1.53E-03
iRefIndex	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	1.96E-02	5.09E-04
iRefIndex	BP	GO:0097581	lamellipodium organization	-	91	82	-	-	5.90E-03	3.73E-03
iRefIndex	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	4.18E-02	1.36E-03
iRefIndex	BP	GO:1903975	regulation of glial cell migration	-	20	15	-	-	1.65E-02	6.79E-04
iRefIndex	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	20	-	-	6.25E-03	9.05E-04
iRefIndex	BP	GO:0015669	gas transport	-	23	22	-	-	4.43E-02	1.02E-03
iRefIndex	BP	GO:0016485	protein processing	-	248	233	-	-	1.14E-02	1.06E-02
iRefIndex	BP	GO:0009649	entrainment of circadian clock	-	30	30	-	-	4.78E-03	1.36E-03
iRefIndex	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	157	-	-	4.11E-02	7.13E-03
iRefIndex	BP	GO:1903523	negative regulation of blood circulation	-	27	23	-	-	1.33E-03	1.08E-03
iRefIndex	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	127	-	-	2.32E-02	5.77E-03
iRefIndex	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	1.53E-01	5.66E-04
iRefIndex	BP	GO:0099054	presynapse assembly	-	49	46	-	-	4.37E-03	2.09E-03
iRefIndex	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	1.18E-01	5.66E-04
iRefIndex	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	22	-	-	1.26E-03	1.02E-03
iRefIndex	BP	GO:0006517	protein deglycosylation	-	26	24	-	-	1.15E-02	1.13E-03
iRefIndex	BP	GO:0031348	negative regulation of defense response	-	282	221	-	-	4.86E-03	1.00E-02
iRefIndex	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	72	-	-	3.57E-03	3.28E-03
iRefIndex	BP	GO:0061180	mammary gland epithelium development	-	68	65	-	-	2.75E-03	2.94E-03
iRefIndex	BP	GO:0071496	cellular response to external stimulus	-	74	71	-	-	5.25E-03	3.23E-03
iRefIndex	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	12	-	-	2.57E-02	5.66E-04
iRefIndex	BP	GO:0042753	positive regulation of circadian rhythm	-	18	18	-	-	4.15E-03	8.49E-04
iRefIndex	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.08E-01	5.66E-04
iRefIndex	BP	GO:0032094	response to food	-	37	37	-	-	6.33E-03	1.70E-03
iRefIndex	BP	GO:0001964	startle response	-	27	26	-	-	3.74E-03	1.19E-03
iRefIndex	BP	GO:0007340	acrosome reaction	-	38	35	-	-	2.75E-02	1.58E-03
iRefIndex	BP	GO:0046434	organophosphate catabolic process	-	232	215	-	-	8.78E-03	9.73E-03
iRefIndex	BP	GO:0060037	pharyngeal system development	-	29	27	-	-	1.19E-02	1.24E-03
iRefIndex	BP	GO:0009566	fertilization	-	205	180	-	-	4.31E-02	8.15E-03
iRefIndex	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	56	-	-	1.18E-01	2.55E-03
iRefIndex	BP	GO:0120255	olefinic compound biosynthetic process	-	24	22	-	-	3.49E-02	1.02E-03
iRefIndex	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	12	-	-	6.32E-03	5.66E-04
iRefIndex	BP	GO:0045907	positive regulation of vasoconstriction	-	30	28	-	-	7.84E-03	1.30E-03
iRefIndex	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	22	-	-	1.84E-03	1.02E-03
iRefIndex	BP	GO:0033044	regulation of chromosome organization	-	249	239	-	-	1.54E-02	1.09E-02
iRefIndex	BP	GO:0009309	amine biosynthetic process	-	38	36	-	-	9.97E-02	1.64E-03
iRefIndex	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	7.16E-03	9.05E-04
iRefIndex	BP	GO:0061900	glial cell activation	-	56	51	-	-	2.27E-03	2.32E-03
iRefIndex	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	129	-	-	2.01E-02	5.89E-03
iRefIndex	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	12	-	-	5.45E-04	5.66E-04
iRefIndex	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	7.22E-03	6.79E-04
iRefIndex	CC	GO:0140467	integrated stress response signaling	-	41	40	-	-	1.59E-02	1.81E-03
iRefIndex	BP	GO:0035902	response to immobilization stress	-	20	18	-	-	2.14E-04	8.49E-04
iRefIndex	BP	GO:0035821	modulation of process of another organism	-	14	13	-	-	3.47E-04	6.22E-04
iRefIndex	BP	GO:0072537	fibroblast activation	-	13	12	-	-	1.03E-02	5.66E-04
iRefIndex	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	1.55E-03	6.22E-04
iRefIndex	BP	GO:0043647	inositol phosphate metabolic process	-	44	41	-	-	5.83E-02	1.87E-03
iRefIndex	BP	GO:0016180	snRNA processing	-	28	26	-	-	7.24E-02	1.19E-03
iRefIndex	BP	GO:0051303	establishment of chromosome localization	-	104	92	-	-	1.36E-02	4.19E-03
iRefIndex	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	1.14E-02	7.36E-04
iRefIndex	BP	GO:0007164	establishment of tissue polarity	-	38	35	-	-	5.63E-03	1.58E-03
iRefIndex	BP	GO:0097164	ammonium ion metabolic process	-	23	22	-	-	3.15E-02	1.02E-03
iRefIndex	BP	GO:0021515	cell differentiation in spinal cord	-	51	49	-	-	9.34E-03	2.26E-03
iRefIndex	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	7.96E-04	8.49E-04
iRefIndex	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	5.72E-03	9.62E-04
iRefIndex	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	25	-	-	3.31E-03	1.13E-03
iRefIndex	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	17	-	-	4.35E-03	7.92E-04
iRefIndex	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	35	-	-	6.03E-03	1.58E-03
iRefIndex	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	4.45E-03	1.02E-03
iRefIndex	BP	GO:0007566	embryo implantation	-	57	50	-	-	1.98E-03	2.26E-03
iRefIndex	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	32	-	-	1.18E-03	1.47E-03
iRefIndex	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	6.69E-02	7.36E-04
iRefIndex	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	8.10E-02	1.47E-03
iRefIndex	BP	GO:0051017	actin filament bundle assembly	-	161	151	-	-	5.26E-03	6.85E-03
iRefIndex	BP	GO:1905953	negative regulation of lipid localization	-	63	40	-	-	4.68E-03	1.81E-03
iRefIndex	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	17	-	-	1.57E-03	7.92E-04
iRefIndex	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	4.47E-04	9.05E-04
iRefIndex	BP	GO:0036302	atrioventricular canal development	-	13	11	-	-	3.58E-03	5.09E-04
iRefIndex	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	34	-	-	2.06E-03	1.58E-03
iRefIndex	BP	GO:0021756	striatum development	-	21	20	-	-	7.24E-03	9.05E-04
iRefIndex	BP	GO:1901343	negative regulation of vasculature development	-	154	96	-	-	2.69E-03	4.36E-03
iRefIndex	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	137	-	-	1.87E-02	6.22E-03
iRefIndex	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	30	-	-	1.74E-03	1.36E-03
iRefIndex	BP	GO:1902414	protein localization to cell junction	-	107	103	-	-	4.59E-03	4.70E-03
iRefIndex	BP	GO:0071305	cellular response to vitamin D	-	23	20	-	-	2.68E-02	9.05E-04
iRefIndex	BP	GO:0051304	chromosome separation	-	80	77	-	-	1.19E-02	3.51E-03
iRefIndex	BP	GO:0045780	positive regulation of bone resorption	-	18	16	-	-	2.35E-03	7.36E-04
iRefIndex	BP	GO:0048709	oligodendrocyte differentiation	-	101	94	-	-	3.51E-03	4.30E-03
iRefIndex	BP	GO:0045017	glycerolipid biosynthetic process	-	254	234	-	-	1.08E-01	1.06E-02
iRefIndex	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	13	-	-	1.85E-01	6.22E-04
iRefIndex	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	21	-	-	5.64E-03	9.62E-04
iRefIndex	BP	GO:0001776	leukocyte homeostasis	-	108	94	-	-	2.64E-03	4.30E-03
iRefIndex	BP	GO:0050769	positive regulation of neurogenesis	-	240	222	-	-	6.56E-03	1.01E-02
iRefIndex	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	6.33E-02	6.79E-04
iRefIndex	BP	GO:0030193	regulation of blood coagulation	-	70	65	-	-	2.01E-02	2.94E-03
iRefIndex	BP	GO:0050866	negative regulation of cell activation	-	216	194	-	-	5.74E-03	8.83E-03
iRefIndex	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	34	-	-	1.01E-03	1.58E-03
iRefIndex	BP	GO:0033500	carbohydrate homeostasis	-	251	223	-	-	6.76E-03	1.01E-02
iRefIndex	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	30	-	-	7.22E-03	1.36E-03
iRefIndex	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	3.91E-02	5.66E-04
iRefIndex	BP	GO:0044088	regulation of vacuole organization	-	56	52	-	-	4.48E-03	2.38E-03
iRefIndex	CC	GO:0051457	maintenance of protein location in nucleus	-	23	20	-	-	1.99E-03	9.05E-04
iRefIndex	CC	GO:0099522	cytosolic region	-	20	19	-	-	7.22E-04	9.05E-04
iRefIndex	CC	GO:0000791	euchromatin	-	60	59	-	-	2.30E-02	2.72E-03
iRefIndex	CC	GO:0030666	endocytic vesicle membrane	-	196	181	-	-	1.63E-02	8.21E-03
iRefIndex	CC	GO:0071027	nuclear RNA surveillance	-	14	12	-	-	4.76E-02	5.66E-04
iRefIndex	CC	GO:1990752	microtubule end	-	34	34	-	-	2.05E-02	1.58E-03
iRefIndex	CC	GO:0043204	perikaryon	-	156	149	-	-	3.57E-03	6.79E-03
iRefIndex	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	8.33E-02	7.92E-04
iRefIndex	CC	GO:0098643	banded collagen fibril	-	12	11	-	-	2.40E-02	5.09E-04
iRefIndex	CC	GO:0097542	ciliary tip	-	48	48	-	-	7.82E-02	2.21E-03
iRefIndex	CC	GO:1905368	peptidase complex	-	124	116	-	-	4.76E-02	5.26E-03
iRefIndex	CC	GO:0000792	heterochromatin	-	98	93	-	-	1.05E-02	4.24E-03
iRefIndex	CC	GO:0097546	ciliary base	-	47	43	-	-	3.82E-03	1.98E-03
iRefIndex	CC	GO:0071819	DUBm complex	-	25	21	-	-	1.46E-01	9.62E-04
iRefIndex	CC	GO:0031201	SNARE complex	-	48	47	-	-	1.42E-01	2.15E-03
iRefIndex	CC	GO:0005677	chromatin silencing complex	-	13	12	-	-	3.46E-03	5.66E-04
iRefIndex	CC	GO:0033260	nuclear DNA replication	-	40	38	-	-	8.71E-03	1.75E-03
iRefIndex	CC	GO:0044391	ribosomal subunit	-	203	177	-	-	9.99E-02	8.04E-03
iRefIndex	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	2.94E-02	5.09E-04
iRefIndex	CC	GO:0071013	catalytic step 2 spliceosome	-	88	79	-	-	6.68E-02	3.62E-03
iRefIndex	CC	GO:0031907	microbody lumen	-	51	51	-	-	1.02E-01	2.32E-03
iRefIndex	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	1.49E-01	5.09E-04
iRefIndex	CC	GO:0098862	cluster of actin-based cell projections	-	162	146	-	-	3.56E-02	6.62E-03
iRefIndex	CC	GO:0016363	nuclear matrix	-	127	120	-	-	4.00E-03	5.43E-03
iRefIndex	CC	GO:0031261	DNA replication preinitiation complex	-	46	44	-	-	5.10E-02	2.04E-03
iRefIndex	CC	GO:0032432	actin filament bundle	-	249	229	-	-	2.00E-02	1.04E-02
iRefIndex	CC	GO:0008088	axo-dendritic transport	-	78	73	-	-	5.29E-03	3.34E-03
iRefIndex	CC	GO:0031519	PcG protein complex	-	38	35	-	-	4.48E-02	1.58E-03
iRefIndex	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	41	-	-	4.76E-02	1.87E-03
iRefIndex	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	208	-	-	1.74E-02	9.45E-03
iRefIndex	CC	GO:0000313	organellar ribosome	-	89	80	-	-	1.50E-01	3.62E-03
iRefIndex	CC	GO:0099643	signal release from synapse	-	147	138	-	-	1.19E-02	6.28E-03
iRefIndex	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	45	-	-	1.17E-02	2.04E-03
iRefIndex	CC	GO:0005818	aster	-	11	11	-	-	4.41E-02	5.09E-04
iRefIndex	CC	GO:0030018	Z disc	-	129	124	-	-	2.07E-02	5.66E-03
iRefIndex	CC	GO:0032580	Golgi cisterna membrane	-	93	75	-	-	5.71E-03	3.40E-03
iRefIndex	CC	GO:0097381	photoreceptor disc membrane	-	25	21	-	-	4.01E-03	9.62E-04
iRefIndex	CC	GO:1905360	GTPase complex	-	41	36	-	-	4.83E-03	1.64E-03
iRefIndex	CC	GO:0097540	axonemal central pair	-	161	145	-	-	1.00E-02	6.56E-03
iRefIndex	CC	GO:0042641	actomyosin	-	77	72	-	-	6.81E-03	3.28E-03
iRefIndex	CC	GO:0097386	glial cell projection	-	38	35	-	-	8.14E-04	1.58E-03
iRefIndex	CC	GO:0032588	trans-Golgi network membrane	-	102	94	-	-	1.15E-02	4.30E-03
iRefIndex	CC	GO:0070382	exocytic vesicle	-	224	206	-	-	1.24E-02	9.34E-03
iRefIndex	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	46	-	-	1.99E-02	2.09E-03
iRefIndex	CC	GO:0031903	microbody membrane	-	65	61	-	-	3.67E-02	2.77E-03
iRefIndex	CC	GO:0046930	pore complex	-	26	24	-	-	8.81E-02	1.13E-03
iRefIndex	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	3.14E-03	7.36E-04
iRefIndex	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	236	-	-	3.43E-02	1.07E-02
iRefIndex	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	23	-	-	1.22E-02	1.08E-03
iRefIndex	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	9.20E-02	5.09E-04
iRefIndex	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	3.07E-03	8.49E-04
iRefIndex	CC	GO:0044298	cell body membrane	-	32	31	-	-	5.36E-03	1.41E-03
iRefIndex	CC	GO:0051882	mitochondrial depolarization	-	21	20	-	-	2.62E-03	9.05E-04
iRefIndex	CC	GO:0045495	pole plasm	-	25	20	-	-	2.76E-03	9.05E-04
iRefIndex	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	6.85E-03	6.79E-04
iRefIndex	CC	GO:0070993	translation preinitiation complex	-	19	18	-	-	1.11E-01	8.49E-04
iRefIndex	CC	GO:0010369	chromocenter	-	14	12	-	-	2.08E-03	5.66E-04
iRefIndex	CC	GO:0002177	manchette	-	19	17	-	-	1.45E-02	7.92E-04
iRefIndex	CC	GO:0016323	basolateral plasma membrane	-	239	218	-	-	8.46E-03	9.90E-03
iRefIndex	CC	GO:0045009	chitosome	-	21	20	-	-	4.12E-02	9.05E-04
iRefIndex	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	2.99E-03	5.66E-04
iRefIndex	CC	GO:0042645	mitochondrial nucleoid	-	45	43	-	-	1.06E-02	1.98E-03
iRefIndex	CC	GO:0098636	protein complex involved in cell adhesion	-	57	55	-	-	2.82E-02	2.49E-03
iRefIndex	CC	GO:0001917	photoreceptor inner segment	-	71	67	-	-	3.13E-03	3.06E-03
iRefIndex	CC	GO:0019897	extrinsic component of plasma membrane	-	156	142	-	-	6.84E-03	6.45E-03
iRefIndex	CC	GO:0031594	neuromuscular junction	-	73	70	-	-	2.59E-03	3.17E-03
iRefIndex	CC	GO:0045120	pronucleus	-	14	14	-	-	6.00E-04	6.79E-04
iRefIndex	CC	GO:0043083	synaptic cleft	-	21	21	-	-	2.11E-02	9.62E-04
iRefIndex	CC	GO:0000922	spindle pole	-	172	158	-	-	7.25E-03	7.19E-03
iRefIndex	CC	GO:0120111	neuron projection cytoplasm	-	94	87	-	-	5.55E-03	3.96E-03
iRefIndex	CC	GO:0070971	endoplasmic reticulum exit site	-	32	29	-	-	5.13E-02	1.36E-03
iRefIndex	CC	GO:0005736	RNA polymerase I complex	-	13	12	-	-	4.74E-02	5.66E-04
iRefIndex	CC	GO:0004879	nuclear receptor activity	-	63	62	-	-	1.25E-02	2.83E-03
iRefIndex	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	152	-	-	4.81E-03	6.90E-03
iRefIndex	CC	GO:0000123	histone acetyltransferase complex	-	93	86	-	-	7.57E-02	3.90E-03
iRefIndex	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	2.12E-03	6.22E-04
iRefIndex	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	105	-	-	1.29E-01	4.75E-03
iRefIndex	CC	GO:0048786	presynaptic active zone	-	80	79	-	-	8.09E-03	3.62E-03
iRefIndex	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	1.35E-02	5.09E-04
iRefIndex	CC	GO:0001054	RNA polymerase I activity	-	12	11	-	-	3.28E-02	5.09E-04
iRefIndex	CC	GO:0007034	vacuolar transport	-	168	154	-	-	1.80E-02	7.02E-03
iRefIndex	CC	GO:0090741	pigment granule membrane	-	21	20	-	-	3.99E-02	9.05E-04
iRefIndex	CC	GO:0043194	axon initial segment	-	21	20	-	-	5.81E-02	9.05E-04
iRefIndex	CC	GO:1900115	extracellular regulation of signal transduction	-	13	11	-	-	1.35E-02	5.09E-04
iRefIndex	CC	GO:0005776	autophagosome	-	111	106	-	-	2.08E-02	4.81E-03
iRefIndex	CC	GO:0031430	M band	-	22	22	-	-	2.13E-03	1.02E-03
iRefIndex	CC	GO:0001931	uropod	-	13	11	-	-	1.30E-02	5.09E-04
iRefIndex	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	67	-	-	1.26E-01	3.06E-03
iRefIndex	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	93	-	-	1.77E-01	4.24E-03
iRefIndex	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	3.73E-01	6.22E-04
iRefIndex	CC	GO:0000164	protein phosphatase type 1 complex	-	19	18	-	-	2.28E-02	8.49E-04
iRefIndex	CC	GO:0071203	WASH complex	-	12	11	-	-	2.76E-02	5.09E-04
iRefIndex	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	7.62E-03	1.36E-03
iRefIndex	CC	GO:0032994	protein-lipid complex	-	39	38	-	-	7.14E-02	1.75E-03
iRefIndex	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	137	-	-	7.75E-02	6.22E-03
iRefIndex	CC	GO:0071012	catalytic step 1 spliceosome	-	12	11	-	-	5.85E-03	5.09E-04
iRefIndex	CC	GO:0001527	microfibril	-	13	13	-	-	2.03E-01	6.22E-04
iRefIndex	CC	GO:0072562	blood microparticle	-	144	134	-	-	2.07E-02	6.11E-03
iRefIndex	CC	GO:0005883	neurofilament	-	11	11	-	-	3.22E-03	5.09E-04
iRefIndex	CC	GO:0051233	spindle midzone	-	36	32	-	-	2.57E-03	1.47E-03
iRefIndex	CC	GO:0005811	lipid droplet	-	102	93	-	-	1.34E-02	4.24E-03
iRefIndex	CC	GO:0045022	early endosome to late endosome transport	-	44	39	-	-	6.73E-03	1.81E-03
iRefIndex	CC	GO:0043113	receptor clustering	-	51	47	-	-	4.36E-03	2.15E-03
iRefIndex	CC	GO:0005940	septin ring	-	14	13	-	-	2.63E-01	6.22E-04
iRefIndex	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	21	-	-	1.31E-01	9.62E-04
iRefIndex	CC	GO:0044853	plasma membrane raft	-	114	107	-	-	6.01E-03	4.87E-03
iRefIndex	CC	GO:0005881	cytoplasmic microtubule	-	256	234	-	-	9.00E-03	1.06E-02
iRefIndex	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	14	-	-	5.65E-04	6.79E-04
iRefIndex	CC	GO:0008180	COP9 signalosome	-	17	16	-	-	2.30E-02	7.36E-04
iRefIndex	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	52	-	-	1.28E-02	2.38E-03
iRefIndex	CC	GO:0005905	clathrin-coated pit	-	73	69	-	-	8.92E-03	3.17E-03
iRefIndex	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	4.40E-02	5.66E-04
iRefIndex	CC	GO:0043034	costamere	-	18	18	-	-	4.76E-03	8.49E-04
iRefIndex	CC	GO:0031904	endosome lumen	-	38	34	-	-	5.27E-03	1.58E-03
iRefIndex	CC	GO:0060170	ciliary membrane	-	76	69	-	-	1.94E-02	3.17E-03
iRefIndex	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	3.19E-01	6.22E-04
iRefIndex	CC	GO:0000783	nuclear telomere cap complex	-	12	11	-	-	1.05E-02	5.09E-04
iRefIndex	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	7.52E-02	1.13E-03
iRefIndex	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	14	-	-	4.78E-02	6.79E-04
iRefIndex	CC	GO:0032154	cleavage furrow	-	54	49	-	-	4.78E-03	2.26E-03
iRefIndex	CC	GO:0005640	nuclear outer membrane	-	30	27	-	-	3.29E-03	1.24E-03
iRefIndex	CC	GO:0005652	nuclear lamina	-	12	11	-	-	8.69E-03	5.09E-04
iRefIndex	CC	GO:0007006	mitochondrial membrane organization	-	117	105	-	-	4.62E-02	4.75E-03
iRefIndex	CC	GO:0001772	immunological synapse	-	44	40	-	-	4.87E-03	1.81E-03
iRefIndex	CC	GO:0030904	retromer complex	-	12	11	-	-	3.96E-02	5.09E-04
iRefIndex	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	4.57E-02	5.66E-04
iRefIndex	CC	GO:0030863	cortical cytoskeleton	-	104	100	-	-	8.23E-03	4.53E-03
iRefIndex	CC	GO:1905348	endonuclease complex	-	38	34	-	-	8.61E-02	1.58E-03
iRefIndex	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	1.20E-01	5.09E-04
iRefIndex	CC	GO:0030315	T-tubule	-	52	52	-	-	1.51E-02	2.38E-03
iRefIndex	CC	GO:0060076	excitatory synapse	-	64	59	-	-	2.10E-02	2.72E-03
iRefIndex	CC	GO:0036019	endolysosome	-	29	27	-	-	1.91E-02	1.24E-03
iRefIndex	CC	GO:0001891	phagocytic cup	-	28	26	-	-	9.37E-04	1.19E-03
iRefIndex	CC	GO:0099086	synaptonemal structure	-	40	37	-	-	2.43E-02	1.70E-03
iRefIndex	CC	GO:0030427	site of polarized growth	-	172	170	-	-	5.01E-03	7.70E-03
iRefIndex	CC	GO:0044309	neuron spine	-	213	203	-	-	8.27E-03	9.22E-03
iRefIndex	CC	GO:0030658	transport vesicle membrane	-	231	211	-	-	2.10E-02	9.56E-03
iRefIndex	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	4.40E-03	1.24E-03
iRefIndex	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.51E-01	5.66E-04
iRefIndex	CC	GO:0000940	outer kinetochore	-	17	16	-	-	2.49E-02	7.36E-04
iRefIndex	CC	GO:0034719	SMN-Sm protein complex	-	18	16	-	-	4.69E-02	7.36E-04
iRefIndex	CC	GO:0044232	organelle membrane contact site	-	50	46	-	-	5.75E-03	2.09E-03
iRefIndex	CC	GO:0098803	respiratory chain complex	-	39	34	-	-	1.70E-01	1.58E-03
iRefIndex	CC	GO:0097545	axonemal outer doublet	-	164	147	-	-	8.02E-03	6.68E-03
iRefIndex	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	18	-	-	3.48E-02	8.49E-04
iRefIndex	CC	GO:0070069	cytochrome complex	-	42	37	-	-	1.88E-01	1.70E-03
iRefIndex	CC	GO:0031143	pseudopodium	-	18	18	-	-	5.25E-03	8.49E-04
iRefIndex	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	24	-	-	5.59E-02	1.13E-03
iRefIndex	CC	GO:0055037	recycling endosome	-	200	182	-	-	9.16E-03	8.26E-03
iRefIndex	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	91	-	-	3.65E-03	4.13E-03
iRefIndex	CC	GO:0030126	COPI vesicle coat	-	13	12	-	-	1.16E-01	5.66E-04
iRefIndex	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	5.55E-03	6.22E-04
iRefIndex	CC	GO:0071682	endocytic vesicle lumen	-	23	21	-	-	2.40E-03	9.62E-04
iRefIndex	CC	GO:0030684	preribosome	-	76	73	-	-	2.85E-02	3.34E-03
iRefIndex	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	3.53E-02	8.49E-04
iRefIndex	CC	GO:1990391	DNA repair complex	-	22	20	-	-	1.44E-02	9.05E-04
iRefIndex	CC	GO:0005775	vacuolar lumen	-	176	164	-	-	1.29E-02	7.47E-03
iRefIndex	CC	GO:0032433	filopodium tip	-	19	19	-	-	2.54E-03	9.05E-04
iRefIndex	CC	GO:0032982	myosin filament	-	24	23	-	-	1.78E-02	1.08E-03
iRefIndex	CC	GO:0016327	apicolateral plasma membrane	-	23	22	-	-	3.52E-03	1.02E-03
iRefIndex	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	22	-	-	1.60E-01	1.02E-03
iRefIndex	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	9.71E-03	5.66E-04
iRefIndex	CC	GO:0044306	neuron projection terminus	-	164	158	-	-	8.51E-03	7.19E-03
iRefIndex	CC	GO:0034455	t-UTP complex	-	53	52	-	-	2.38E-02	2.38E-03
iRefIndex	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	4.64E-01	7.92E-04
iRefIndex	CC	GO:0031970	organelle envelope lumen	-	94	87	-	-	5.74E-03	3.96E-03
iRefIndex	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.46E-02	6.22E-04
iRefIndex	CC	GO:0120293	dynein axonemal particle	-	20	18	-	-	6.30E-03	8.49E-04
iRefIndex	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	26	-	-	8.36E-04	1.19E-03
iRefIndex	CC	GO:0043292	contractile muscle fiber	-	245	230	-	-	5.19E-02	1.04E-02
iRefIndex	CC	GO:0018995	host cellular component	-	12	11	-	-	7.18E-03	5.09E-04
iRefIndex	CC	GO:0034709	methylosome	-	13	12	-	-	5.86E-03	5.66E-04
iRefIndex	CC	GO:0032426	stereocilium tip	-	21	20	-	-	6.49E-03	9.05E-04
iRefIndex	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	11	-	-	7.37E-03	5.09E-04
iRefIndex	CC	GO:0005849	mRNA cleavage factor complex	-	22	17	-	-	1.05E-01	7.92E-04
iRefIndex	CC	GO:0000803	sex chromosome	-	32	27	-	-	3.06E-03	1.24E-03
iRefIndex	CC	GO:0098982	GABA-ergic synapse	-	84	79	-	-	3.24E-02	3.62E-03
iRefIndex	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	3.38E-02	7.36E-04
iRefIndex	CC	GO:0035097	histone methyltransferase complex	-	63	60	-	-	4.14E-02	2.72E-03
iRefIndex	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	14	-	-	5.80E-02	6.79E-04
iRefIndex	CC	GO:0000242	pericentriolar material	-	22	22	-	-	5.19E-03	1.02E-03
iRefIndex	CC	GO:1903293	phosphatase complex	-	54	50	-	-	2.17E-02	2.26E-03
iRefIndex	CC	GO:0097470	ribbon synapse	-	13	13	-	-	2.95E-03	6.22E-04
iRefIndex	CC	GO:0031941	filamentous actin	-	27	27	-	-	2.12E-03	1.24E-03
iRefIndex	CC	GO:0000786	nucleosome	-	149	101	-	-	1.93E-02	4.58E-03
iRefIndex	CC	GO:0001533	cornified envelope	-	59	59	-	-	1.25E-02	2.72E-03
iRefIndex	CC	GO:1904724	tertiary granule lumen	-	55	51	-	-	4.11E-03	2.32E-03
iRefIndex	CC	GO:0030027	lamellipodium	-	202	192	-	-	1.06E-02	8.71E-03
iRefIndex	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	14	-	-	2.39E-03	6.79E-04
iRefIndex	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	24	-	-	7.40E-02	1.13E-03
iRefIndex	CC	GO:0000800	lateral element	-	14	14	-	-	1.41E-02	6.79E-04
iRefIndex	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	3.15E-03	5.66E-04
iRefIndex	CC	GO:0060077	inhibitory synapse	-	20	19	-	-	8.95E-03	9.05E-04
iRefIndex	CC	GO:0031209	SCAR complex	-	12	12	-	-	3.46E-02	5.66E-04
iRefIndex	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	3.67E-02	5.09E-04
iRefIndex	CC	GO:0001056	RNA polymerase III activity	-	16	15	-	-	1.19E-01	6.79E-04
iRefIndex	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	2.03E-02	9.62E-04
iRefIndex	CC	GO:0002102	podosome	-	31	29	-	-	3.73E-03	1.36E-03
iRefIndex	CC	GO:0090543	Flemming body	-	33	27	-	-	4.57E-03	1.24E-03
iRefIndex	CC	GO:0016328	lateral plasma membrane	-	66	62	-	-	5.60E-03	2.83E-03
iRefIndex	CC	GO:0001650	fibrillar center	-	151	140	-	-	4.32E-03	6.34E-03
iRefIndex	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	4.20E-02	6.79E-04
iRefIndex	CC	GO:1990204	oxidoreductase complex	-	90	82	-	-	5.92E-02	3.73E-03
iRefIndex	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	6.31E-02	7.36E-04
iRefIndex	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.47E-01	5.09E-04
iRefIndex	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	116	-	-	3.96E-03	5.26E-03
iRefIndex	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	17	-	-	3.27E-02	7.92E-04
iRefIndex	CC	GO:0001726	ruffle	-	181	171	-	-	8.20E-03	7.75E-03
iRefIndex	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	1.03E-02	5.09E-04
iRefIndex	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	1.22E-02	6.22E-04
iRefIndex	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	16	-	-	3.11E-02	7.36E-04
iRefIndex	CC	GO:0043198	dendritic shaft	-	38	37	-	-	1.10E-03	1.70E-03
iRefIndex	CC	GO:0043073	germ cell nucleus	-	67	63	-	-	5.06E-03	2.89E-03
iRefIndex	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	20	-	-	5.85E-03	9.05E-04
iRefIndex	CC	GO:0016592	mediator complex	-	38	36	-	-	3.50E-01	1.64E-03
iRefIndex	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	3.55E-02	9.05E-04
iRefIndex	CC	GO:0022626	cytosolic ribosome	-	118	101	-	-	7.36E-02	4.58E-03
iRefIndex	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	41	-	-	3.25E-02	1.87E-03
iRefIndex	CC	GO:0034451	centriolar satellite	-	120	106	-	-	2.26E-02	4.81E-03
iRefIndex	CC	GO:0045171	intercellular bridge	-	91	83	-	-	4.96E-03	3.79E-03
iRefIndex	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	75	-	-	4.60E-03	3.40E-03
iRefIndex	CC	GO:0008250	oligosaccharyltransferase complex	-	14	13	-	-	1.41E-01	6.22E-04
iRefIndex	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	4.88E-02	5.09E-04
iRefIndex	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	2.75E-02	5.09E-04
iRefIndex	CC	GO:0044292	dendrite terminus	-	13	13	-	-	9.89E-04	6.22E-04
iRefIndex	CC	GO:0032039	integrator complex	-	19	18	-	-	1.47E-01	8.49E-04
iRefIndex	CC	GO:0098691	dopaminergic synapse	-	15	14	-	-	4.44E-03	6.79E-04
iRefIndex	CC	GO:0033268	node of Ranvier	-	16	15	-	-	3.95E-02	6.79E-04
iRefIndex	CC	GO:0036038	MKS complex	-	13	13	-	-	1.05E-01	6.22E-04
iRefIndex	CC	GO:0030527	structural constituent of chromatin	-	97	50	-	-	8.93E-03	2.26E-03
iRefIndex	CC	GO:0036379	myofilament	-	26	25	-	-	8.22E-02	1.13E-03
iRefIndex	CC	GO:0030286	dynein complex	-	210	191	-	-	1.96E-02	8.66E-03
iRefIndex	CC	GO:0031105	septin complex	-	14	13	-	-	2.98E-01	6.22E-04
iRefIndex	CC	GO:0097228	sperm principal piece	-	33	28	-	-	4.07E-02	1.30E-03
iRefIndex	CC	GO:0044615	nuclear pore nuclear basket	-	12	11	-	-	9.34E-03	5.09E-04
iRefIndex	CC	GO:0016482	cytosolic transport	-	135	130	-	-	1.23E-02	5.89E-03
iRefIndex	CC	GO:0090665	glycoprotein complex	-	23	22	-	-	3.43E-02	1.02E-03
iRefIndex	CC	GO:0005796	Golgi lumen	-	106	101	-	-	7.05E-03	4.58E-03
iRefIndex	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	30	-	-	5.69E-02	1.36E-03
iRefIndex	CC	GO:0034358	plasma lipoprotein particle	-	36	35	-	-	8.67E-02	1.58E-03
iRefIndex	CC	GO:0008023	transcription elongation factor complex	-	47	45	-	-	1.16E-01	2.04E-03
iRefIndex	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	23	-	-	1.73E-02	1.08E-03
iRefIndex	CC	GO:0030662	coated vesicle membrane	-	202	187	-	-	2.82E-02	8.49E-03
iRefIndex	CC	GO:0007039	protein catabolic process in the vacuole	-	61	50	-	-	3.92E-02	2.26E-03
iRefIndex	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	64	-	-	2.62E-01	2.94E-03
iRefIndex	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	237	-	-	5.66E-02	1.08E-02
iRefIndex	CC	GO:0090734	site of DNA damage	-	118	111	-	-	1.84E-02	5.04E-03
iRefIndex	MF	GO:0051861	glycolipid binding	-	30	29	-	-	4.52E-03	1.36E-03
iRefIndex	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.64E-04	5.09E-04
iRefIndex	MF	GO:0051087	protein-folding chaperone binding	-	135	124	-	-	4.56E-03	5.66E-03
iRefIndex	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	2.55E-03	1.24E-03
iRefIndex	CC	GO:0015464	acetylcholine receptor activity	-	21	18	-	-	7.45E-02	8.49E-04
iRefIndex	MF	GO:0042301	phosphate ion binding	-	12	11	-	-	1.49E-02	5.09E-04
iRefIndex	MF	GO:0016594	glycine binding	-	12	12	-	-	4.12E-02	5.66E-04
iRefIndex	MF	GO:0031681	G-protein beta-subunit binding	-	22	18	-	-	3.64E-04	8.49E-04
iRefIndex	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	36	-	-	2.17E-03	1.64E-03
iRefIndex	MF	GO:0035613	RNA stem-loop binding	-	21	15	-	-	9.28E-03	6.79E-04
iRefIndex	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	234	-	-	8.42E-03	1.06E-02
iRefIndex	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	19	-	-	1.15E-03	9.05E-04
iRefIndex	MF	GO:0033691	sialic acid binding	-	22	22	-	-	1.56E-02	1.02E-03
iRefIndex	MF	GO:0048306	calcium-dependent protein binding	-	61	56	-	-	2.29E-02	2.55E-03
iRefIndex	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	25	-	-	2.00E-02	1.13E-03
iRefIndex	MF	GO:0035325	Toll-like receptor binding	-	13	12	-	-	4.21E-02	5.66E-04
iRefIndex	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	138	-	-	9.11E-03	6.28E-03
iRefIndex	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	57	-	-	6.15E-02	2.60E-03
iRefIndex	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	128	-	-	1.19E-02	5.83E-03
iRefIndex	MF	GO:0045504	dynein heavy chain binding	-	16	15	-	-	2.76E-02	6.79E-04
iRefIndex	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	1.05E-02	1.36E-03
iRefIndex	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	5.15E-03	1.02E-03
iRefIndex	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	14	-	-	2.01E-03	6.79E-04
iRefIndex	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	2.26E-02	6.79E-04
iRefIndex	MF	GO:0061980	regulatory RNA binding	-	52	44	-	-	1.09E-02	2.04E-03
iRefIndex	MF	GO:0015035	protein-disulfide reductase activity	-	32	31	-	-	7.32E-03	1.41E-03
iRefIndex	MF	GO:0000182	rDNA binding	-	11	11	-	-	9.66E-03	5.09E-04
iRefIndex	MF	GO:0001671	ATPase activator activity	-	29	28	-	-	2.50E-03	1.30E-03
iRefIndex	MF	GO:0070840	dynein complex binding	-	25	21	-	-	1.98E-03	9.62E-04
iRefIndex	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.40E-03	1.13E-03
iRefIndex	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.12E-03	7.36E-04
iRefIndex	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	31	-	-	4.16E-03	1.41E-03
iRefIndex	MF	GO:0003688	DNA replication origin binding	-	18	16	-	-	1.42E-02	7.36E-04
iRefIndex	MF	GO:0005178	integrin binding	-	153	138	-	-	4.46E-02	6.28E-03
iRefIndex	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	9.37E-04	7.92E-04
iRefIndex	MF	GO:0005549	odorant binding	-	128	113	-	-	1.30E-03	5.15E-03
iRefIndex	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	7.83E-03	6.79E-04
iRefIndex	MF	GO:0008327	methyl-CpG binding	-	31	27	-	-	9.35E-03	1.24E-03
iRefIndex	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	4.90E-03	9.05E-04
iRefIndex	MF	GO:0048019	receptor antagonist activity	-	31	17	-	-	1.48E-03	7.92E-04
iRefIndex	MF	GO:0005521	lamin binding	-	15	15	-	-	2.28E-03	6.79E-04
iRefIndex	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	2.27E-03	7.92E-04
iRefIndex	MF	GO:0140318	protein transporter activity	-	40	37	-	-	4.75E-02	1.70E-03
iRefIndex	MF	GO:0070628	proteasome binding	-	17	16	-	-	3.53E-03	7.36E-04
iRefIndex	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	1.90E-03	5.09E-04
iRefIndex	MF	GO:0031432	titin binding	-	13	12	-	-	6.00E-03	5.66E-04
iRefIndex	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.58E-02	5.09E-04
iRefIndex	MF	GO:0000217	DNA secondary structure binding	-	37	36	-	-	5.26E-03	1.64E-03
iRefIndex	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	14	-	-	1.67E-04	6.79E-04
iRefIndex	MF	GO:0002039	p53 binding	-	66	64	-	-	3.15E-03	2.94E-03
iRefIndex	MF	GO:0005496	steroid binding	-	110	107	-	-	1.53E-02	4.87E-03
iRefIndex	MF	GO:0008443	phosphofructokinase activity	-	27	26	-	-	1.91E-02	1.19E-03
iRefIndex	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	3.66E-03	5.09E-04
iRefIndex	MF	GO:0003684	damaged DNA binding	-	89	78	-	-	3.60E-02	3.57E-03
iRefIndex	MF	GO:0000339	RNA cap binding	-	20	19	-	-	2.34E-02	9.05E-04
iRefIndex	MF	GO:0016500	protein-hormone receptor activity	-	21	20	-	-	2.53E-03	9.05E-04
iRefIndex	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	118	-	-	3.40E-02	5.38E-03
iRefIndex	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	5.05E-03	6.79E-04
iRefIndex	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	6.70E-03	5.66E-04
iRefIndex	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	3.18E-03	5.09E-04
iRefIndex	MF	GO:0070063	RNA polymerase binding	-	61	59	-	-	7.93E-03	2.72E-03
iRefIndex	MF	GO:0050811	GABA receptor binding	-	18	16	-	-	1.67E-02	7.36E-04
iRefIndex	MF	GO:0030971	receptor tyrosine kinase binding	-	76	72	-	-	2.77E-03	3.28E-03
iRefIndex	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	77	-	-	3.72E-02	3.51E-03
iRefIndex	MF	GO:0140030	modification-dependent protein binding	-	179	167	-	-	5.48E-03	7.58E-03
iRefIndex	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	22	-	-	7.57E-02	1.02E-03
iRefIndex	MF	GO:0009881	photoreceptor activity	-	17	15	-	-	6.27E-02	6.79E-04
iRefIndex	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	17	-	-	1.12E-03	7.92E-04
iRefIndex	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.36E-03	6.22E-04
iRefIndex	MF	GO:0042813	Wnt receptor activity	-	16	15	-	-	1.64E-02	6.79E-04
iRefIndex	MF	GO:0141047	molecular tag activity	-	13	12	-	-	7.31E-04	5.66E-04
iRefIndex	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	2.81E-02	5.09E-04
iRefIndex	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	1.64E-04	5.66E-04
iRefIndex	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	1.47E-03	6.79E-04
iRefIndex	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	4.78E-03	5.66E-04
iRefIndex	MF	GO:0044548	S100 protein binding	-	14	14	-	-	6.22E-03	6.79E-04
iRefIndex	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	5.53E-04	6.79E-04
iRefIndex	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	2.48E-02	6.79E-04
iRefIndex	MF	GO:0030276	clathrin binding	-	70	61	-	-	1.78E-02	2.77E-03
iRefIndex	MF	GO:0046875	ephrin receptor binding	-	29	28	-	-	2.40E-03	1.30E-03
iRefIndex	MF	GO:0140311	protein sequestering activity	-	14	13	-	-	1.55E-04	6.22E-04
iRefIndex	MF	GO:0046790	virion binding	-	19	18	-	-	7.62E-03	8.49E-04
iRefIndex	MF	GO:0030552	cAMP binding	-	48	44	-	-	1.43E-02	2.04E-03
iRefIndex	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	1.49E-03	1.75E-03
iRefIndex	MF	GO:0035173	histone kinase activity	-	17	17	-	-	1.07E-03	7.92E-04
iRefIndex	MF	GO:0097602	cullin family protein binding	-	26	25	-	-	9.02E-03	1.13E-03
iRefIndex	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	1.42E-02	5.66E-04
iRefIndex	MF	GO:0016209	antioxidant activity	-	92	85	-	-	1.48E-02	3.85E-03
iRefIndex	MF	GO:0070325	lipoprotein particle receptor binding	-	32	27	-	-	6.01E-03	1.24E-03
iRefIndex	MF	GO:0044325	transmembrane transporter binding	-	159	152	-	-	8.41E-03	6.90E-03
iRefIndex	MF	GO:0048156	tau protein binding	-	43	39	-	-	2.78E-03	1.81E-03
iRefIndex	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	35	-	-	8.95E-03	1.58E-03
iRefIndex	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	1.87E-03	6.22E-04
iRefIndex	MF	GO:0140272	exogenous protein binding	-	79	74	-	-	5.92E-03	3.40E-03
iRefIndex	MF	GO:0030145	manganese ion binding	-	65	61	-	-	1.58E-03	2.77E-03
iRefIndex	MF	GO:0071814	protein-lipid complex binding	-	52	46	-	-	1.15E-02	2.09E-03
iRefIndex	MF	GO:0008066	glutamate receptor activity	-	70	69	-	-	1.49E-02	3.17E-03
iRefIndex	MF	GO:0030553	cGMP binding	-	15	15	-	-	4.66E-02	6.79E-04
iRefIndex	MF	GO:0017069	snRNA binding	-	54	47	-	-	1.93E-02	2.15E-03
iRefIndex	MF	GO:0030215	semaphorin receptor binding	-	23	23	-	-	1.47E-01	1.08E-03
iRefIndex	MF	GO:0031369	translation initiation factor binding	-	32	29	-	-	8.13E-03	1.36E-03
iRefIndex	MF	GO:0019843	rRNA binding	-	69	61	-	-	1.31E-02	2.77E-03
iRefIndex	MF	GO:0004713	protein tyrosine kinase activity	-	213	203	-	-	1.03E-02	9.22E-03
iRefIndex	MF	GO:0061783	peptidoglycan muralytic activity	-	14	12	-	-	1.07E-01	5.66E-04
iRefIndex	MF	GO:0016779	nucleotidyltransferase activity	-	264	245	-	-	1.18E-02	1.11E-02
iRefIndex	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	48	-	-	2.22E-03	2.21E-03
iRefIndex	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	2.25E-03	1.13E-03
iRefIndex	MF	GO:0070300	phosphatidic acid binding	-	20	19	-	-	8.08E-04	9.05E-04
iRefIndex	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	29	-	-	2.11E-03	1.36E-03
iRefIndex	MF	GO:0016208	AMP binding	-	22	21	-	-	3.97E-02	9.62E-04
iRefIndex	MF	GO:0000287	magnesium ion binding	-	225	209	-	-	4.90E-03	9.51E-03
iRefIndex	MF	GO:0031490	chromatin DNA binding	-	120	110	-	-	6.65E-03	4.98E-03
iRefIndex	MF	GO:0017022	myosin binding	-	73	64	-	-	6.45E-03	2.94E-03
iRefIndex	MF	GO:0004896	cytokine receptor activity	-	93	89	-	-	1.96E-02	4.07E-03
iRefIndex	MF	GO:0017166	vinculin binding	-	12	12	-	-	1.01E-02	5.66E-04
iRefIndex	MF	GO:0008301	"DNA binding, bending"	-	18	17	-	-	1.22E-02	7.92E-04
iRefIndex	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	3.82E-03	5.66E-04
iRefIndex	MF	GO:0005539	glycosaminoglycan binding	-	236	211	-	-	1.85E-02	9.56E-03
iRefIndex	MF	GO:0071933	Arp2/3 complex binding	-	14	12	-	-	4.55E-03	5.66E-04
iRefIndex	MF	GO:0019207	kinase regulator activity	-	267	244	-	-	6.68E-03	1.11E-02
iRefIndex	MF	GO:0010181	FMN binding	-	15	14	-	-	1.56E-03	6.79E-04
iRefIndex	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	20	-	-	6.32E-03	9.05E-04
iRefIndex	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	24	-	-	1.64E-03	1.13E-03
iRefIndex	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	6.78E-04	7.92E-04
iRefIndex	MF	GO:0044183	protein folding chaperone	-	67	62	-	-	3.49E-03	2.83E-03
iRefIndex	MF	GO:0005132	type I interferon receptor binding	-	17	17	-	-	1.33E-01	7.92E-04
iRefIndex	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	106	-	-	1.03E-02	4.81E-03
iRefIndex	MF	GO:0003725	double-stranded RNA binding	-	72	66	-	-	1.00E-02	3.00E-03
iRefIndex	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	3.64E-02	7.36E-04
iRefIndex	MF	GO:0051018	protein kinase A binding	-	52	48	-	-	1.84E-02	2.21E-03
iRefIndex	MF	GO:0071889	14-3-3 protein binding	-	34	31	-	-	2.31E-03	1.41E-03
iRefIndex	MF	GO:0004618	phosphoglycerate kinase activity	-	89	84	-	-	6.29E-03	3.85E-03
iRefIndex	MF	GO:0042805	actinin binding	-	36	36	-	-	6.39E-03	1.64E-03
iRefIndex	MF	GO:0043531	ADP binding	-	38	37	-	-	2.97E-03	1.70E-03
iRefIndex	MF	GO:0043394	proteoglycan binding	-	36	32	-	-	6.04E-03	1.47E-03
iRefIndex	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	8.22E-03	5.09E-04
iRefIndex	MF	GO:0046332	SMAD binding	-	77	75	-	-	4.30E-02	3.40E-03
iRefIndex	MF	GO:0043560	insulin receptor substrate binding	-	13	12	-	-	2.05E-03	5.66E-04
iRefIndex	MF	GO:0001968	fibronectin binding	-	30	28	-	-	4.10E-03	1.30E-03
iRefIndex	MF	GO:0048038	quinone binding	-	16	15	-	-	1.87E-02	6.79E-04
iRefIndex	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	114	-	-	1.93E-02	5.21E-03
iRefIndex	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	78	-	-	5.06E-03	3.57E-03
iRefIndex	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	3.18E-03	8.49E-04
iRefIndex	MF	GO:0051117	ATPase binding	-	85	79	-	-	2.86E-03	3.62E-03
iRefIndex	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	45	-	-	1.65E-03	2.04E-03
iRefIndex	MF	GO:0051787	misfolded protein binding	-	20	18	-	-	1.82E-03	8.49E-04
iRefIndex	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	6.08E-03	5.09E-04
iRefIndex	MF	GO:0070402	NADPH binding	-	16	13	-	-	1.65E-04	6.22E-04
iRefIndex	MF	GO:0031404	chloride ion binding	-	14	11	-	-	1.67E-04	5.09E-04
iRefIndex	MF	GO:0001098	basal transcription machinery binding	-	61	57	-	-	5.76E-03	2.60E-03
iRefIndex	MF	GO:0036002	pre-mRNA binding	-	57	36	-	-	1.22E-02	1.64E-03
iRefIndex	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	32	-	-	1.39E-02	1.47E-03
iRefIndex	MF	GO:0051540	metal cluster binding	-	71	68	-	-	1.31E-02	3.11E-03
iRefIndex	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	1.96E-03	5.09E-04
iRefIndex	MF	GO:0051219	phosphoprotein binding	-	92	89	-	-	4.43E-03	4.07E-03
iRefIndex	MF	GO:0019894	kinesin binding	-	45	45	-	-	3.72E-03	2.04E-03
iRefIndex	MF	GO:0042287	MHC protein binding	-	68	61	-	-	2.11E-02	2.77E-03
iRefIndex	MF	GO:0019003	GDP binding	-	89	68	-	-	6.17E-03	3.11E-03
iRefIndex	MF	GO:0017171	serine hydrolase activity	-	207	186	-	-	1.55E-02	8.43E-03
iRefIndex	MF	GO:0097110	scaffold protein binding	-	66	61	-	-	3.31E-03	2.77E-03
iRefIndex	MF	GO:0003774	cytoskeletal motor activity	-	117	111	-	-	8.71E-03	5.04E-03
iRefIndex	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	28	-	-	1.25E-03	1.30E-03
iRefIndex	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	2.66E-02	7.92E-04
iRefIndex	MF	GO:0061134	peptidase regulator activity	-	224	199	-	-	1.22E-02	9.05E-03
iRefIndex	MF	GO:0008013	beta-catenin binding	-	86	81	-	-	1.64E-02	3.68E-03
iRefIndex	MF	GO:0051015	actin filament binding	-	208	198	-	-	1.36E-02	9.00E-03
iRefIndex	MF	GO:0019208	phosphatase regulator activity	-	107	99	-	-	9.02E-03	4.53E-03
iRefIndex	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	31	-	-	7.92E-03	1.41E-03
iRefIndex	MF	GO:0043236	laminin binding	-	29	28	-	-	3.08E-03	1.30E-03
iRefIndex	MF	GO:0030507	spectrin binding	-	26	26	-	-	9.40E-03	1.19E-03
iRefIndex	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	39	-	-	5.85E-03	1.81E-03
iRefIndex	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	108	-	-	3.05E-02	4.92E-03
iRefIndex	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	22	-	-	2.17E-03	1.02E-03
iRefIndex	MF	GO:0042393	histone binding	-	240	216	-	-	1.42E-02	9.79E-03
iRefIndex	MF	GO:0019838	growth factor binding	-	182	176	-	-	1.26E-02	7.98E-03
iRefIndex	MF	GO:0000149	SNARE binding	-	107	99	-	-	4.65E-02	4.53E-03
iRefIndex	MF	GO:0003727	single-stranded RNA binding	-	90	78	-	-	5.22E-03	3.57E-03
iRefIndex	MF	GO:0051378	serotonin binding	-	24	22	-	-	6.11E-03	1.02E-03
iRefIndex	MF	GO:0005516	calmodulin binding	-	206	194	-	-	8.36E-03	8.83E-03
iRefIndex	MF	GO:0019825	oxygen binding	-	40	36	-	-	1.64E-02	1.64E-03
iRefIndex	MF	GO:0045505	dynein intermediate chain binding	-	37	37	-	-	5.23E-03	1.70E-03
iRefIndex	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	80	-	-	1.11E-02	3.62E-03
iRefIndex	MF	GO:0032182	ubiquitin-like protein binding	-	117	110	-	-	4.93E-03	4.98E-03
iRefIndex	MF	GO:0023023	MHC protein complex binding	-	36	35	-	-	1.09E-02	1.58E-03
iRefIndex	MF	GO:0030742	GTP-dependent protein binding	-	22	19	-	-	1.86E-02	9.05E-04
iRefIndex	MF	GO:0043274	phospholipase binding	-	23	21	-	-	1.01E-03	9.62E-04
iRefIndex	MF	GO:0031072	heat shock protein binding	-	128	117	-	-	5.99E-03	5.32E-03
iRefIndex	MF	GO:0030515	snoRNA binding	-	33	33	-	-	1.01E-02	1.53E-03
iRefIndex	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	71	-	-	2.73E-02	3.23E-03
iRefIndex	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	20	-	-	4.32E-03	9.05E-04
iRefIndex	MF	GO:0001965	G-protein alpha-subunit binding	-	26	23	-	-	9.96E-04	1.08E-03
iRefIndex	MF	GO:0001530	lipopolysaccharide binding	-	38	34	-	-	8.66E-03	1.58E-03
iRefIndex	MF	GO:0140223	general transcription initiation factor activity	-	55	48	-	-	1.34E-01	2.21E-03
iRefIndex	MF	GO:0070403	NAD+ binding	-	16	16	-	-	1.21E-02	7.36E-04
iRefIndex	MF	GO:0000049	tRNA binding	-	75	70	-	-	1.74E-02	3.17E-03
iRefIndex	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	43	-	-	3.36E-03	1.98E-03
iRefIndex	MF	GO:0015026	coreceptor activity	-	48	46	-	-	5.89E-03	2.09E-03
iRefIndex	MF	GO:0005527	macrolide binding	-	12	11	-	-	1.49E-03	5.09E-04
iRefIndex	MF	GO:0001653	peptide receptor activity	-	128	116	-	-	3.09E-02	5.26E-03
iRefIndex	MF	GO:0031005	filamin binding	-	15	14	-	-	3.49E-03	6.79E-04
iRefIndex	MF	GO:0030506	ankyrin binding	-	19	19	-	-	1.00E-02	9.05E-04
iRefIndex	MF	GO:0006469	negative regulation of protein kinase activity	-	222	196	-	-	4.40E-03	8.88E-03
iRefIndex	MF	GO:0070182	DNA polymerase binding	-	22	19	-	-	1.26E-03	9.05E-04
iRefIndex	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	7.18E-04	6.79E-04
iRefIndex	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	30	-	-	8.10E-03	1.36E-03
iRefIndex	MF	GO:0051427	hormone receptor binding	-	31	29	-	-	1.59E-02	1.36E-03
iRefIndex	MF	GO:0070851	growth factor receptor binding	-	141	139	-	-	1.84E-02	6.34E-03
iRefIndex	MF	GO:0031210	phosphatidylcholine binding	-	32	28	-	-	1.90E-02	1.30E-03
iRefIndex	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	2.62E-02	5.09E-04
iRefIndex	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	41	-	-	4.28E-03	1.87E-03
iRefIndex	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	4.00E-03	9.05E-04
iRefIndex	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	5.42E-03	7.92E-04
iRefIndex	MF	GO:0005506	iron ion binding	-	154	139	-	-	1.73E-02	6.34E-03
iRefIndex	MF	GO:0003925	G protein activity	-	45	34	-	-	4.18E-03	1.58E-03
iRefIndex	MF	GO:0034987	immunoglobulin receptor binding	-	11	11	-	-	1.49E-03	5.09E-04
iRefIndex	MF	GO:0038187	pattern recognition receptor activity	-	33	33	-	-	2.32E-02	1.53E-03
iRefIndex	MF	GO:0008276	protein methyltransferase activity	-	96	90	-	-	5.00E-03	4.07E-03
iRefIndex	MF	GO:0004396	hexokinase activity	-	16	14	-	-	2.96E-03	6.79E-04
iRefIndex	MF	GO:0070888	E-box binding	-	59	56	-	-	5.92E-02	2.55E-03
iRefIndex	MF	GO:0039706	co-receptor binding	-	14	14	-	-	6.01E-03	6.79E-04
iRefIndex	MF	GO:0015399	primary active transmembrane transporter activity	-	190	173	-	-	9.38E-02	7.87E-03
iRefIndex	MF	GO:0035254	glutamate receptor binding	-	47	45	-	-	2.93E-03	2.04E-03
iRefIndex	MF	GO:0050321	tau-protein kinase activity	-	36	30	-	-	2.33E-03	1.36E-03
iRefIndex	MF	GO:0043021	ribonucleoprotein complex binding	-	158	149	-	-	6.10E-03	6.79E-03
iRefIndex	MF	GO:0030170	pyridoxal phosphate binding	-	56	48	-	-	8.39E-03	2.21E-03
iRefIndex	MF	GO:0032393	MHC class I receptor activity	-	15	14	-	-	1.68E-04	6.79E-04
iRefIndex	MF	GO:0005112	Notch binding	-	26	25	-	-	1.01E-02	1.13E-03
iRefIndex	MF	GO:0048185	activin binding	-	16	15	-	-	5.08E-02	6.79E-04
iRefIndex	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	27	-	-	8.50E-03	1.24E-03
iRefIndex	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	3.57E-03	5.09E-04
iRefIndex	MF	GO:0140299	small molecule sensor activity	-	39	32	-	-	2.84E-02	1.47E-03
iRefIndex	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	20	-	-	3.16E-03	9.05E-04
iRefIndex	MF	GO:0016917	GABA receptor activity	-	23	19	-	-	5.21E-01	9.05E-04
iRefIndex	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	3.75E-03	6.79E-04
iRefIndex	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	24	-	-	1.17E-03	1.13E-03
iRefIndex	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	43	-	-	1.20E-02	1.98E-03
iRefIndex	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	23	-	-	8.01E-04	1.08E-03
iRefIndex	MF	GO:0008527	taste receptor activity	-	28	26	-	-	4.32E-02	1.19E-03
iRefIndex	MF	GO:0003916	DNA topoisomerase activity	-	12	11	-	-	5.53E-03	5.09E-04
iRefIndex	MF	GO:0030594	neurotransmitter receptor activity	-	160	151	-	-	6.19E-02	6.85E-03
iRefIndex	MF	GO:0034452	dynactin binding	-	12	12	-	-	6.74E-04	5.66E-04
iRefIndex	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	23	-	-	1.38E-01	1.08E-03
iRefIndex	MF	GO:0120227	acyl-CoA binding	-	22	18	-	-	2.62E-03	8.49E-04
iRefIndex	MF	GO:0005507	copper ion binding	-	63	60	-	-	6.83E-03	2.72E-03
iRefIndex	MF	GO:0033558	protein lysine deacetylase activity	-	22	20	-	-	5.12E-03	9.05E-04
iRefIndex	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	2.15E-02	5.09E-04
iRefIndex	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.59E-02	1.02E-03
iRefIndex	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	11	-	-	5.93E-02	5.09E-04
MatrixDB	CC	GO:0005615	extracellular space	2.32E-85	3190	2413	1934	1.25	-	-
MatrixDB	CC	GO:0005730	nucleolus	1.07E-63	988	836	599	1.40	-	-
MatrixDB	CC	GO:0005739	mitochondrion	1.41E-49	1671	1286	1013	1.27	-	-
MatrixDB	CC	GO:0005815	microtubule organizing center	2.46E-44	843	695	511	1.36	-	-
MatrixDB	CC	GO:0005840	ribosome	2.41E-36	222	214	135	1.59	-	-
MatrixDB	CC	GO:0005768	endosome	1.35E-21	1037	771	629	1.23	-	-
MatrixDB	CC	GO:0031012	extracellular matrix	2.51E-21	564	446	342	1.30	-	-
MatrixDB	CC	GO:0005635	nuclear envelope	1.02E-15	493	382	299	1.28	-	-
MatrixDB	CC	GO:0000228	nuclear chromosome	1.24E-12	206	172	125	1.38	-	-
MatrixDB	CC	GO:0005764	lysosome	1.89E-10	747	535	453	1.18	-	-
MatrixDB	CC	GO:0005783	endoplasmic reticulum	3.76E-08	2020	1338	1224	1.09	-	-
MatrixDB	CC	GO:0005794	Golgi apparatus	4.00E-05	1636	1069	992	1.08	-	-
MatrixDB	CC	GO:0005777	peroxisome	5.73E-03	142	102	86	1.19	-	-
MatrixDB	CC	GO:0005811	lipid droplet	8.40E-01	102	63	62	1.02	-	-
MatrixDB	CC	GO:0005929	cilium	8.85E-01	842	508	510	1.00	-	-
MatrixDB	BP	GO:0065003	protein-containing complex assembly	2.55E-82	1648	1346	999	1.35	-	-
MatrixDB	BP	GO:0012501	programmed cell death	5.08E-75	1954	1545	1184	1.30	-	-
MatrixDB	BP	GO:0007010	cytoskeleton organization	4.73E-71	1639	1316	993	1.32	-	-
MatrixDB	BP	GO:0016071	mRNA metabolic process	4.53E-56	713	620	432	1.43	-	-
MatrixDB	BP	GO:0050877	nervous system process	1.01E-52	1527	642	926	0.69	-	-
MatrixDB	BP	GO:0006281	DNA repair	2.25E-51	587	518	356	1.46	-	-
MatrixDB	BP	GO:0016192	vesicle-mediated transport	2.98E-50	1894	1440	1148	1.25	-	-
MatrixDB	BP	GO:0048870	cell motility	1.19E-46	1659	1270	1006	1.26	-	-
MatrixDB	BP	GO:0030163	protein catabolic process	9.25E-46	990	803	600	1.34	-	-
MatrixDB	BP	GO:0002376	immune system process	3.36E-43	2448	1788	1484	1.21	-	-
MatrixDB	BP	GO:0006914	autophagy	8.98E-40	568	486	344	1.41	-	-
MatrixDB	BP	GO:0006325	chromatin organization	1.11E-35	720	589	436	1.35	-	-
MatrixDB	BP	GO:0007155	cell adhesion	1.72E-35	1444	1091	875	1.25	-	-
MatrixDB	BP	GO:0042254	ribosome biogenesis	5.99E-34	297	272	180	1.51	-	-
MatrixDB	BP	GO:0007059	chromosome segregation	6.37E-31	403	349	244	1.43	-	-
MatrixDB	BP	GO:0006886	intracellular protein transport	1.92E-30	664	538	402	1.34	-	-
MatrixDB	BP	GO:0042060	wound healing	1.95E-30	431	369	261	1.41	-	-
MatrixDB	BP	GO:0006913	nucleocytoplasmic transport	4.36E-25	326	282	198	1.43	-	-
MatrixDB	BP	GO:0007005	mitochondrion organization	2.84E-24	484	396	293	1.35	-	-
MatrixDB	BP	GO:0002181	cytoplasmic translation	8.52E-24	153	146	93	1.57	-	-
MatrixDB	BP	GO:0140053	mitochondrial gene expression	9.15E-23	164	154	99	1.55	-	-
MatrixDB	BP	GO:0006954	inflammatory response	3.01E-22	820	626	497	1.26	-	-
MatrixDB	BP	GO:0006355	regulation of DNA-templated transcription	7.93E-20	3342	2257	2026	1.11	-	-
MatrixDB	BP	GO:0006091	generation of precursor metabolites and energy	5.01E-19	502	397	304	1.30	-	-
MatrixDB	BP	GO:0006260	DNA replication	1.75E-18	279	236	169	1.40	-	-
MatrixDB	BP	GO:0034330	cell junction organization	6.48E-18	727	549	441	1.25	-	-
MatrixDB	BP	GO:0006457	protein folding	8.72E-17	210	182	127	1.43	-	-
MatrixDB	BP	GO:0098542	defense response to other organism	9.25E-17	1171	842	710	1.19	-	-
MatrixDB	BP	GO:0007163	establishment or maintenance of cell polarity	2.43E-16	227	194	138	1.41	-	-
MatrixDB	BP	GO:0006310	DNA recombination	8.14E-16	333	270	202	1.34	-	-
MatrixDB	BP	GO:0055086	nucleobase-containing small molecule metabolic process	3.58E-13	729	534	442	1.21	-	-
MatrixDB	BP	GO:0030198	extracellular matrix organization	3.42E-12	314	248	190	1.30	-	-
MatrixDB	BP	GO:0072659	protein localization to plasma membrane	3.59E-12	284	227	172	1.32	-	-
MatrixDB	BP	GO:0032200	telomere organization	1.95E-10	186	153	113	1.36	-	-
MatrixDB	BP	GO:0055085	transmembrane transport	9.24E-10	1784	960	1081	0.89	-	-
MatrixDB	BP	GO:0000910	cytokinesis	5.91E-09	186	150	113	1.33	-	-
MatrixDB	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	4.25E-08	119	100	72	1.39	-	-
MatrixDB	BP	GO:0007018	microtubule-based movement	3.81E-07	640	449	388	1.16	-	-
MatrixDB	BP	GO:0006399	tRNA metabolic process	3.00E-06	196	150	119	1.26	-	-
MatrixDB	BP	GO:0003012	muscle system process	3.61E-06	425	303	258	1.18	-	-
MatrixDB	BP	GO:0006486	protein glycosylation	3.63E-06	225	102	136	0.75	-	-
MatrixDB	BP	GO:0003013	circulatory system process	1.49E-04	584	398	354	1.12	-	-
MatrixDB	BP	GO:0007040	lysosome organization	6.67E-04	107	82	65	1.26	-	-
MatrixDB	BP	GO:0044782	cilium organization	8.96E-04	399	274	242	1.13	-	-
MatrixDB	BP	GO:0140013	meiotic nuclear division	1.30E-03	279	195	169	1.15	-	-
MatrixDB	BP	GO:0006520	amino acid metabolic process	1.66E-03	292	203	177	1.15	-	-
MatrixDB	BP	GO:0098754	detoxification	3.26E-03	134	98	81	1.21	-	-
MatrixDB	BP	GO:0005975	carbohydrate metabolic process	4.18E-02	551	357	334	1.07	-	-
MatrixDB	BP	GO:0006575	cellular modified amino acid metabolic process	7.02E-02	186	125	113	1.11	-	-
MatrixDB	BP	GO:0022600	digestive system process	1.17E-01	110	75	67	1.12	-	-
MatrixDB	BP	GO:0006766	vitamin metabolic process	6.93E-01	107	67	65	1.03	-	-
MatrixDB	BP	GO:0003014	renal system process	7.85E-01	127	79	77	1.03	-	-
MatrixDB	BP	GO:0006790	sulfur compound metabolic process	8.63E-01	320	196	194	1.01	-	-
MatrixDB	BP	GO:0006629	lipid metabolic process	8.85E-01	1355	824	821	1.00	-	-
MatrixDB	MF	GO:0003723	RNA binding	8.58E-149	1679	1478	1018	1.45	-	-
MatrixDB	MF	GO:0140096	"catalytic activity, acting on a protein"	2.63E-87	3198	2424	1938	1.25	-	-
MatrixDB	MF	GO:0016740	transferase activity	1.89E-51	3074	2230	1863	1.20	-	-
MatrixDB	MF	GO:0008092	cytoskeletal protein binding	2.48E-51	1023	838	620	1.35	-	-
MatrixDB	MF	GO:0140657	ATP-dependent activity	7.86E-37	729	598	442	1.35	-	-
MatrixDB	MF	GO:0005198	structural molecule activity	1.77E-27	798	625	484	1.29	-	-
MatrixDB	MF	GO:0140097	"catalytic activity, acting on DNA"	4.11E-21	383	317	232	1.37	-	-
MatrixDB	MF	GO:0016874	ligase activity	5.72E-18	283	238	172	1.39	-	-
MatrixDB	MF	GO:0005215	transporter activity	4.86E-17	1462	734	886	0.83	-	-
MatrixDB	MF	GO:0042393	histone binding	3.76E-16	237	201	144	1.40	-	-
MatrixDB	MF	GO:0140098	"catalytic activity, acting on RNA"	4.91E-16	417	330	253	1.31	-	-
MatrixDB	MF	GO:0003924	GTPase activity	2.91E-11	658	479	399	1.20	-	-
MatrixDB	MF	GO:0016853	isomerase activity	3.45E-09	252	197	153	1.29	-	-
MatrixDB	MF	GO:0003774	cytoskeletal motor activity	2.87E-08	116	98	70	1.39	-	-
MatrixDB	MF	GO:0140104	molecular carrier activity	1.01E-07	105	89	64	1.40	-	-
MatrixDB	MF	GO:0045182	translation regulator activity	3.64E-07	151	121	92	1.32	-	-
MatrixDB	MF	GO:0008289	lipid binding	2.00E-06	836	572	507	1.13	-	-
MatrixDB	MF	GO:0003677	DNA binding	2.92E-06	2865	1849	1737	1.06	-	-
MatrixDB	MF	GO:0016491	oxidoreductase activity	8.98E-06	888	601	538	1.12	-	-
MatrixDB	MF	GO:0009975	cyclase activity	4.03E-04	277	139	168	0.83	-	-
MatrixDB	MF	GO:0048018	receptor ligand activity	2.64E-03	504	338	305	1.11	-	-
MatrixDB	MF	GO:0038024	cargo receptor activity	4.24E-03	117	86	71	1.21	-	-
MatrixDB	MF	GO:0140110	transcription regulator activity	2.24E-02	2033	1280	1232	1.04	-	-
MatrixDB	MF	GO:0016829	lyase activity	3.71E-01	538	316	326	0.97	-	-
MatrixDB	BP	GO:0008038	neuron recognition	-	46	38	-	-	4.58E-03	2.68E-03
MatrixDB	BP	GO:1905145	cellular response to acetylcholine	-	33	24	-	-	4.28E-04	1.73E-03
MatrixDB	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	1.27E-02	1.47E-03
MatrixDB	BP	GO:0051931	regulation of sensory perception	-	36	22	-	-	2.71E-02	1.55E-03
MatrixDB	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	18	-	-	3.42E-04	1.30E-03
MatrixDB	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	11	-	-	2.58E-04	7.77E-04
MatrixDB	BP	GO:0009268	response to pH	-	43	20	-	-	4.28E-04	1.38E-03
MatrixDB	BP	GO:0045666	positive regulation of neuron differentiation	-	91	52	-	-	1.67E-03	3.63E-03
MatrixDB	BP	GO:0043543	protein acylation	-	107	62	-	-	2.15E-03	4.32E-03
MatrixDB	MF	GO:0051349	positive regulation of lyase activity	-	41	24	-	-	1.06E-02	1.73E-03
MatrixDB	BP	GO:0048679	regulation of axon regeneration	-	28	21	-	-	6.53E-03	1.47E-03
MatrixDB	BP	GO:0022401	negative adaptation of signaling pathway	-	21	18	-	-	1.32E-02	1.30E-03
MatrixDB	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	54	-	-	6.82E-03	3.80E-03
MatrixDB	BP	GO:0071763	nuclear membrane organization	-	44	41	-	-	3.65E-03	2.85E-03
MatrixDB	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	27	-	-	1.80E-03	1.90E-03
MatrixDB	BP	GO:0071806	protein transmembrane transport	-	68	56	-	-	1.28E-02	3.89E-03
MatrixDB	BP	GO:0022038	corpus callosum development	-	25	17	-	-	3.38E-04	1.21E-03
MatrixDB	BP	GO:0043299	leukocyte degranulation	-	82	60	-	-	4.60E-03	4.15E-03
MatrixDB	BP	GO:0048864	stem cell development	-	88	64	-	-	6.33E-03	4.49E-03
MatrixDB	BP	GO:0009310	amine catabolic process	-	20	11	-	-	2.59E-04	7.77E-04
MatrixDB	BP	GO:0051651	maintenance of location in cell	-	236	178	-	-	1.26E-02	1.24E-02
MatrixDB	BP	GO:0033119	negative regulation of RNA splicing	-	27	25	-	-	1.63E-03	1.73E-03
MatrixDB	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	20	-	-	4.31E-04	1.38E-03
MatrixDB	CC	GO:0016197	endosomal transport	-	282	242	-	-	1.26E-02	1.68E-02
MatrixDB	BP	GO:0070663	regulation of leukocyte proliferation	-	268	216	-	-	2.79E-02	1.49E-02
MatrixDB	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	27	-	-	2.22E-02	1.90E-03
MatrixDB	BP	GO:0006949	syncytium formation	-	66	47	-	-	3.07E-02	3.28E-03
MatrixDB	BP	GO:0045176	apical protein localization	-	15	12	-	-	2.56E-04	8.64E-04
MatrixDB	BP	GO:0045861	negative regulation of proteolysis	-	320	228	-	-	5.34E-03	1.58E-02
MatrixDB	BP	GO:0043144	sno(s)RNA processing	-	14	13	-	-	2.58E-02	9.50E-04
MatrixDB	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	32	-	-	5.99E-04	2.25E-03
MatrixDB	BP	GO:0030574	collagen catabolic process	-	45	33	-	-	1.05E-03	2.33E-03
MatrixDB	CC	GO:0006984	ER-nucleus signaling pathway	-	46	39	-	-	1.47E-03	2.76E-03
MatrixDB	BP	GO:0060343	trabecula formation	-	26	19	-	-	3.43E-04	1.38E-03
MatrixDB	BP	GO:0009914	hormone transport	-	315	218	-	-	1.15E-02	1.51E-02
MatrixDB	BP	GO:0140112	extracellular vesicle biogenesis	-	23	19	-	-	1.65E-03	1.38E-03
MatrixDB	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	15	-	-	3.48E-02	1.04E-03
MatrixDB	BP	GO:1900424	regulation of defense response to bacterium	-	21	13	-	-	2.57E-04	9.50E-04
MatrixDB	BP	GO:0085029	extracellular matrix assembly	-	42	33	-	-	2.59E-03	2.33E-03
MatrixDB	BP	GO:0006413	translational initiation	-	122	105	-	-	9.59E-03	7.26E-03
MatrixDB	BP	GO:0072176	nephric duct development	-	15	11	-	-	2.58E-04	7.77E-04
MatrixDB	BP	GO:1902895	positive regulation of miRNA transcription	-	51	47	-	-	1.59E-03	3.28E-03
MatrixDB	CC	GO:0005200	structural constituent of cytoskeleton	-	112	99	-	-	4.85E-03	6.91E-03
MatrixDB	BP	GO:0030865	cortical cytoskeleton organization	-	51	49	-	-	2.74E-03	3.45E-03
MatrixDB	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	11	-	-	2.58E-04	7.77E-04
MatrixDB	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	23	-	-	6.73E-02	1.64E-03
MatrixDB	BP	GO:1903036	positive regulation of response to wounding	-	76	62	-	-	6.29E-03	4.32E-03
MatrixDB	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	13	-	-	2.59E-04	9.50E-04
MatrixDB	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	95	-	-	3.30E-03	6.56E-03
MatrixDB	BP	GO:1903319	positive regulation of protein maturation	-	27	21	-	-	1.04E-03	1.47E-03
MatrixDB	BP	GO:0032528	microvillus organization	-	24	18	-	-	2.65E-03	1.30E-03
MatrixDB	BP	GO:0002263	cell activation involved in immune response	-	304	218	-	-	1.03E-02	1.51E-02
MatrixDB	BP	GO:0021954	central nervous system neuron development	-	85	64	-	-	1.80E-03	4.49E-03
MatrixDB	BP	GO:0055017	cardiac muscle tissue growth	-	92	62	-	-	2.33E-03	4.32E-03
MatrixDB	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	27	-	-	1.57E-03	1.90E-03
MatrixDB	BP	GO:0048524	positive regulation of viral process	-	64	54	-	-	1.97E-03	3.80E-03
MatrixDB	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	16	-	-	3.44E-04	1.12E-03
MatrixDB	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	20	-	-	2.00E-02	1.38E-03
MatrixDB	BP	GO:0001946	lymphangiogenesis	-	18	15	-	-	3.53E-02	1.04E-03
MatrixDB	BP	GO:0098661	inorganic anion transmembrane transport	-	140	51	-	-	9.34E-04	3.54E-03
MatrixDB	BP	GO:0006099	tricarboxylic acid cycle	-	33	31	-	-	1.24E-03	2.16E-03
MatrixDB	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	16	-	-	3.41E-04	1.12E-03
MatrixDB	BP	GO:0009612	response to mechanical stimulus	-	215	166	-	-	4.59E-03	1.15E-02
MatrixDB	BP	GO:0048644	muscle organ morphogenesis	-	81	58	-	-	4.62E-03	4.06E-03
MatrixDB	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	120	-	-	5.81E-03	8.29E-03
MatrixDB	BP	GO:0071542	dopaminergic neuron differentiation	-	36	22	-	-	8.00E-03	1.55E-03
MatrixDB	BP	GO:0140115	export across plasma membrane	-	82	35	-	-	9.48E-03	2.42E-03
MatrixDB	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	11	-	-	5.19E-03	7.77E-04
MatrixDB	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	32	-	-	5.94E-04	2.25E-03
MatrixDB	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	14	-	-	2.58E-04	1.04E-03
MatrixDB	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	27	-	-	5.15E-04	1.90E-03
MatrixDB	MF	GO:0003714	transcription corepressor activity	-	190	165	-	-	9.96E-03	1.14E-02
MatrixDB	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	33	-	-	5.89E-04	2.33E-03
MatrixDB	BP	GO:0061101	neuroendocrine cell differentiation	-	16	11	-	-	2.74E-03	7.77E-04
MatrixDB	CC	GO:0006858	extracellular transport	-	45	26	-	-	7.89E-03	1.81E-03
MatrixDB	BP	GO:0006304	DNA modification	-	30	22	-	-	8.58E-03	1.55E-03
MatrixDB	MF	GO:0140312	cargo adaptor activity	-	19	17	-	-	2.09E-02	1.21E-03
MatrixDB	BP	GO:0046835	carbohydrate phosphorylation	-	49	41	-	-	2.22E-03	2.85E-03
MatrixDB	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	16	-	-	3.38E-04	1.12E-03
MatrixDB	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	12	-	-	2.58E-04	8.64E-04
MatrixDB	BP	GO:0043523	regulation of neuron apoptotic process	-	218	177	-	-	5.74E-03	1.23E-02
MatrixDB	BP	GO:1902894	negative regulation of miRNA transcription	-	22	20	-	-	2.40E-03	1.38E-03
MatrixDB	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	12	-	-	2.56E-04	8.64E-04
MatrixDB	BP	GO:0044380	protein localization to cytoskeleton	-	57	54	-	-	6.23E-03	3.80E-03
MatrixDB	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	3.88E-02	9.50E-04
MatrixDB	BP	GO:2000209	regulation of anoikis	-	25	20	-	-	4.21E-04	1.38E-03
MatrixDB	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	19	-	-	3.35E-04	1.38E-03
MatrixDB	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	26	-	-	5.71E-04	1.81E-03
MatrixDB	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	52	-	-	1.25E-03	3.63E-03
MatrixDB	CC	GO:0045324	late endosome to vacuole transport	-	37	29	-	-	2.63E-02	2.07E-03
MatrixDB	BP	GO:0043954	cellular component maintenance	-	72	59	-	-	2.14E-03	4.15E-03
MatrixDB	BP	GO:0050435	amyloid-beta metabolic process	-	65	45	-	-	4.79E-03	3.11E-03
MatrixDB	BP	GO:0014823	response to activity	-	70	55	-	-	2.98E-03	3.80E-03
MatrixDB	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	12	-	-	2.57E-04	8.64E-04
MatrixDB	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	24	-	-	1.64E-02	1.73E-03
MatrixDB	BP	GO:0034502	protein localization to chromosome	-	130	108	-	-	8.55E-03	7.51E-03
MatrixDB	BP	GO:0048562	embryonic organ morphogenesis	-	295	186	-	-	9.21E-03	1.29E-02
MatrixDB	BP	GO:0060457	negative regulation of digestive system process	-	17	11	-	-	2.59E-04	7.77E-04
MatrixDB	BP	GO:0019233	sensory perception of pain	-	103	68	-	-	2.80E-03	4.75E-03
MatrixDB	CC	GO:0043574	peroxisomal transport	-	22	17	-	-	3.76E-01	1.21E-03
MatrixDB	BP	GO:0031343	positive regulation of cell killing	-	75	57	-	-	1.03E-01	3.97E-03
MatrixDB	BP	GO:0090077	foam cell differentiation	-	39	34	-	-	1.24E-03	2.42E-03
MatrixDB	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	62	-	-	3.33E-03	4.32E-03
MatrixDB	BP	GO:0017148	negative regulation of translation	-	390	96	-	-	1.31E-02	6.65E-03
MatrixDB	BP	GO:0030220	platelet formation	-	22	20	-	-	8.23E-03	1.38E-03
MatrixDB	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	69	-	-	5.53E-03	4.84E-03
MatrixDB	BP	GO:1903509	liposaccharide metabolic process	-	109	53	-	-	2.03E-03	3.71E-03
MatrixDB	BP	GO:0009582	detection of abiotic stimulus	-	140	64	-	-	5.41E-03	4.49E-03
MatrixDB	CC	GO:0140238	presynaptic endocytosis	-	72	57	-	-	2.14E-03	3.97E-03
MatrixDB	BP	GO:0051236	establishment of RNA localization	-	161	139	-	-	5.00E-02	9.67E-03
MatrixDB	BP	GO:0042178	xenobiotic catabolic process	-	26	11	-	-	2.59E-04	7.77E-04
MatrixDB	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	11	-	-	2.58E-04	7.77E-04
MatrixDB	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	163	-	-	1.74E-02	1.13E-02
MatrixDB	BP	GO:0034067	protein localization to Golgi apparatus	-	30	21	-	-	4.26E-04	1.47E-03
MatrixDB	BP	GO:0061842	microtubule organizing center localization	-	32	28	-	-	2.61E-03	1.99E-03
MatrixDB	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	11	-	-	3.00E-03	7.77E-04
MatrixDB	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	14	-	-	2.58E-04	1.04E-03
MatrixDB	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	31	-	-	1.37E-03	2.16E-03
MatrixDB	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	43	-	-	7.21E-03	3.02E-03
MatrixDB	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	14	-	-	2.57E-04	1.04E-03
MatrixDB	BP	GO:0050779	RNA destabilization	-	135	89	-	-	2.60E-02	6.22E-03
MatrixDB	BP	GO:0006023	aminoglycan biosynthetic process	-	74	34	-	-	9.52E-04	2.42E-03
MatrixDB	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	48	-	-	1.44E-03	3.37E-03
MatrixDB	BP	GO:0010762	regulation of fibroblast migration	-	40	31	-	-	1.38E-03	2.16E-03
MatrixDB	BP	GO:0090311	regulation of protein deacetylation	-	29	24	-	-	2.11E-02	1.73E-03
MatrixDB	BP	GO:0035272	exocrine system development	-	46	37	-	-	3.14E-03	2.59E-03
MatrixDB	BP	GO:1901096	regulation of autophagosome maturation	-	17	16	-	-	6.15E-03	1.12E-03
MatrixDB	BP	GO:0022406	membrane docking	-	90	78	-	-	7.83E-03	5.44E-03
MatrixDB	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	4.46E-02	1.04E-03
MatrixDB	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	14	-	-	2.54E-04	1.04E-03
MatrixDB	BP	GO:0050777	negative regulation of immune response	-	196	157	-	-	6.07E-03	1.09E-02
MatrixDB	BP	GO:0016053	organic acid biosynthetic process	-	335	211	-	-	6.54E-03	1.46E-02
MatrixDB	MF	GO:0005035	death receptor activity	-	16	15	-	-	4.24E-03	1.04E-03
MatrixDB	BP	GO:0002063	chondrocyte development	-	33	26	-	-	4.95E-03	1.81E-03
MatrixDB	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	11	-	-	2.55E-04	7.77E-04
MatrixDB	BP	GO:0099068	postsynapse assembly	-	40	27	-	-	5.10E-04	1.90E-03
MatrixDB	BP	GO:0021782	glial cell development	-	120	83	-	-	3.74E-03	5.79E-03
MatrixDB	BP	GO:0051782	negative regulation of cell division	-	18	12	-	-	2.17E-03	8.64E-04
MatrixDB	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	66	-	-	4.17E-03	4.58E-03
MatrixDB	BP	GO:0001655	urogenital system development	-	66	51	-	-	2.09E-03	3.54E-03
MatrixDB	BP	GO:0071827	plasma lipoprotein particle organization	-	86	60	-	-	5.58E-02	4.15E-03
MatrixDB	BP	GO:0045494	photoreceptor cell maintenance	-	43	26	-	-	9.14E-03	1.81E-03
MatrixDB	BP	GO:0055088	lipid homeostasis	-	173	113	-	-	1.59E-02	7.86E-03
MatrixDB	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	22	-	-	1.23E-03	1.55E-03
MatrixDB	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	177	-	-	6.04E-03	1.23E-02
MatrixDB	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	14	-	-	2.59E-04	1.04E-03
MatrixDB	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	33	-	-	8.20E-03	2.33E-03
MatrixDB	BP	GO:0045667	regulation of osteoblast differentiation	-	147	96	-	-	6.43E-03	6.65E-03
MatrixDB	BP	GO:2001212	regulation of vasculogenesis	-	16	12	-	-	2.54E-04	8.64E-04
MatrixDB	BP	GO:0061037	negative regulation of cartilage development	-	32	25	-	-	4.92E-03	1.73E-03
MatrixDB	BP	GO:0045738	negative regulation of DNA repair	-	40	35	-	-	2.03E-03	2.42E-03
MatrixDB	BP	GO:0001704	formation of primary germ layer	-	195	143	-	-	5.74E-03	9.93E-03
MatrixDB	BP	GO:0045778	positive regulation of ossification	-	51	40	-	-	5.61E-03	2.76E-03
MatrixDB	BP	GO:0048708	astrocyte differentiation	-	88	72	-	-	5.00E-03	5.01E-03
MatrixDB	BP	GO:0042092	type 2 immune response	-	41	30	-	-	4.82E-03	2.07E-03
MatrixDB	BP	GO:0048588	developmental cell growth	-	233	176	-	-	5.18E-03	1.22E-02
MatrixDB	CC	GO:0000963	mitochondrial RNA processing	-	20	18	-	-	2.37E-02	1.30E-03
MatrixDB	BP	GO:0021872	forebrain generation of neurons	-	52	36	-	-	1.09E-03	2.50E-03
MatrixDB	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	15	-	-	3.39E-04	1.04E-03
MatrixDB	BP	GO:0045023	G0 to G1 transition	-	41	36	-	-	1.35E-01	2.50E-03
MatrixDB	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	42	-	-	1.57E-02	2.94E-03
MatrixDB	BP	GO:0034367	protein-containing complex remodeling	-	35	31	-	-	2.80E-02	2.16E-03
MatrixDB	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	22	-	-	4.23E-04	1.55E-03
MatrixDB	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	24	-	-	4.27E-04	1.73E-03
MatrixDB	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	11	-	-	2.59E-04	7.77E-04
MatrixDB	BP	GO:0015810	aspartate transmembrane transport	-	19	13	-	-	2.57E-04	9.50E-04
MatrixDB	BP	GO:0010232	vascular transport	-	87	52	-	-	1.33E-03	3.63E-03
MatrixDB	BP	GO:0021987	cerebral cortex development	-	125	96	-	-	1.32E-02	6.65E-03
MatrixDB	BP	GO:0008637	apoptotic mitochondrial changes	-	108	83	-	-	2.13E-03	5.79E-03
MatrixDB	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	31	-	-	4.16E-03	2.16E-03
MatrixDB	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	12	-	-	2.58E-04	8.64E-04
MatrixDB	BP	GO:0060999	positive regulation of dendritic spine development	-	35	28	-	-	1.04E-02	1.99E-03
MatrixDB	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	13	-	-	1.37E-03	9.50E-04
MatrixDB	BP	GO:2000736	regulation of stem cell differentiation	-	78	62	-	-	3.56E-03	4.32E-03
MatrixDB	BP	GO:0060973	cell migration involved in heart development	-	21	15	-	-	1.64E-02	1.04E-03
MatrixDB	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	13	-	-	2.57E-04	9.50E-04
MatrixDB	BP	GO:0002064	epithelial cell development	-	210	166	-	-	4.86E-03	1.15E-02
MatrixDB	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	29	-	-	2.01E-03	2.07E-03
MatrixDB	BP	GO:2001222	regulation of neuron migration	-	46	29	-	-	1.19E-02	2.07E-03
MatrixDB	BP	GO:0034389	lipid droplet organization	-	38	24	-	-	9.30E-04	1.73E-03
MatrixDB	BP	GO:0051602	response to electrical stimulus	-	44	33	-	-	5.87E-04	2.33E-03
MatrixDB	BP	GO:0042177	negative regulation of protein catabolic process	-	109	90	-	-	2.36E-03	6.22E-03
MatrixDB	MF	GO:0038024	cargo receptor activity	-	121	86	-	-	2.16E-02	5.96E-03
MatrixDB	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	12	-	-	3.36E-02	8.64E-04
MatrixDB	BP	GO:0033120	positive regulation of RNA splicing	-	46	35	-	-	6.99E-03	2.42E-03
MatrixDB	BP	GO:0051445	regulation of meiotic cell cycle	-	64	45	-	-	2.14E-02	3.11E-03
MatrixDB	BP	GO:0033619	membrane protein proteolysis	-	60	53	-	-	3.06E-03	3.71E-03
MatrixDB	BP	GO:0038065	collagen-activated signaling pathway	-	15	13	-	-	1.27E-02	9.50E-04
MatrixDB	BP	GO:0090087	regulation of peptide transport	-	195	133	-	-	4.40E-03	9.24E-03
MatrixDB	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	76	-	-	4.14E-03	5.27E-03
MatrixDB	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	18	-	-	3.38E-04	1.30E-03
MatrixDB	BP	GO:0006929	substrate-dependent cell migration	-	26	23	-	-	1.44E-03	1.64E-03
MatrixDB	BP	GO:0042537	benzene-containing compound metabolic process	-	27	14	-	-	2.59E-04	1.04E-03
MatrixDB	BP	GO:0099118	microtubule-based protein transport	-	14	11	-	-	1.50E-03	7.77E-04
MatrixDB	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	13	-	-	1.34E-03	9.50E-04
MatrixDB	BP	GO:0072662	protein localization to peroxisome	-	20	16	-	-	3.84E-01	1.12E-03
MatrixDB	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	2.53E-04	9.50E-04
MatrixDB	BP	GO:0022404	molting cycle process	-	95	78	-	-	3.37E-03	5.44E-03
MatrixDB	BP	GO:1903358	regulation of Golgi organization	-	17	16	-	-	2.57E-03	1.12E-03
MatrixDB	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	18	-	-	1.30E-02	1.30E-03
MatrixDB	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	15	-	-	3.40E-04	1.04E-03
MatrixDB	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	26	-	-	1.93E-02	1.81E-03
MatrixDB	BP	GO:0017014	protein nitrosylation	-	17	14	-	-	1.68E-02	1.04E-03
MatrixDB	BP	GO:0007281	germ cell development	-	334	205	-	-	4.84E-03	1.42E-02
MatrixDB	BP	GO:0008299	isoprenoid biosynthetic process	-	30	21	-	-	4.29E-04	1.47E-03
MatrixDB	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	148	-	-	3.78E-03	1.03E-02
MatrixDB	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	3.58E-03	2.16E-03
MatrixDB	BP	GO:0034104	negative regulation of tissue remodeling	-	22	18	-	-	3.44E-04	1.30E-03
MatrixDB	CC	GO:0098926	postsynaptic signal transduction	-	39	29	-	-	5.03E-04	2.07E-03
MatrixDB	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	116	-	-	3.55E-03	8.03E-03
MatrixDB	CC	GO:0016082	synaptic vesicle priming	-	19	17	-	-	2.09E-02	1.21E-03
MatrixDB	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	39	-	-	8.37E-04	2.76E-03
MatrixDB	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	100	-	-	1.30E-02	6.91E-03
MatrixDB	BP	GO:0034249	negative regulation of amide metabolic process	-	34	21	-	-	1.87E-03	1.47E-03
MatrixDB	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	81	-	-	2.97E-03	5.61E-03
MatrixDB	BP	GO:0042832	defense response to protozoan	-	28	14	-	-	2.57E-04	1.04E-03
MatrixDB	BP	GO:0048799	animal organ maturation	-	33	27	-	-	5.09E-04	1.90E-03
MatrixDB	BP	GO:0006925	inflammatory cell apoptotic process	-	23	16	-	-	3.37E-04	1.12E-03
MatrixDB	BP	GO:2000291	regulation of myoblast proliferation	-	25	14	-	-	2.54E-04	1.04E-03
MatrixDB	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	133	-	-	4.08E-03	9.24E-03
MatrixDB	BP	GO:1903035	negative regulation of response to wounding	-	93	78	-	-	8.01E-03	5.44E-03
MatrixDB	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	22	-	-	4.22E-04	1.55E-03
MatrixDB	BP	GO:0036010	protein localization to endosome	-	27	23	-	-	9.88E-03	1.64E-03
MatrixDB	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	116	-	-	2.01E-02	8.03E-03
MatrixDB	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	76	-	-	2.23E-03	5.27E-03
MatrixDB	BP	GO:0045056	transcytosis	-	20	18	-	-	2.12E-03	1.30E-03
MatrixDB	BP	GO:0018342	protein prenylation	-	15	11	-	-	2.58E-04	7.77E-04
MatrixDB	BP	GO:0009267	cellular response to starvation	-	170	135	-	-	4.87E-03	9.33E-03
MatrixDB	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	46	-	-	6.01E-03	3.20E-03
MatrixDB	BP	GO:0046834	lipid phosphorylation	-	16	12	-	-	2.57E-04	8.64E-04
MatrixDB	CC	GO:0140239	postsynaptic endocytosis	-	23	16	-	-	1.29E-02	1.12E-03
MatrixDB	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	14	-	-	2.58E-04	1.04E-03
MatrixDB	BP	GO:0046931	pore complex assembly	-	21	19	-	-	2.29E-03	1.38E-03
MatrixDB	CC	GO:0032008	positive regulation of TOR signaling	-	52	45	-	-	1.15E-02	3.11E-03
MatrixDB	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	28	-	-	3.02E-03	1.99E-03
MatrixDB	BP	GO:0060428	lung epithelium development	-	43	33	-	-	3.09E-03	2.33E-03
MatrixDB	BP	GO:0030431	sleep	-	30	20	-	-	4.28E-04	1.38E-03
MatrixDB	BP	GO:1903318	negative regulation of protein maturation	-	29	20	-	-	3.43E-03	1.38E-03
MatrixDB	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	79	-	-	8.23E-02	5.53E-03
MatrixDB	BP	GO:0071732	cellular response to nitric oxide	-	17	15	-	-	1.26E-03	1.04E-03
MatrixDB	BP	GO:0010457	centriole-centriole cohesion	-	15	14	-	-	2.82E-02	1.04E-03
MatrixDB	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	2.58E-04	9.50E-04
MatrixDB	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	30	-	-	1.91E-03	2.07E-03
MatrixDB	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	61	-	-	4.43E-03	4.23E-03
MatrixDB	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	11	-	-	2.55E-04	7.77E-04
MatrixDB	BP	GO:0065004	protein-DNA complex assembly	-	307	237	-	-	1.29E-02	1.64E-02
MatrixDB	CC	GO:0006406	mRNA export from nucleus	-	69	61	-	-	5.21E-02	4.23E-03
MatrixDB	BP	GO:0009880	embryonic pattern specification	-	70	45	-	-	1.04E-02	3.11E-03
MatrixDB	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	35	-	-	6.87E-04	2.42E-03
MatrixDB	BP	GO:0043043	peptide biosynthetic process	-	25	18	-	-	3.44E-04	1.30E-03
MatrixDB	BP	GO:0002367	cytokine production involved in immune response	-	121	103	-	-	6.09E-03	7.17E-03
MatrixDB	BP	GO:0044848	biological phase	-	211	153	-	-	8.00E-03	1.06E-02
MatrixDB	BP	GO:0002645	positive regulation of tolerance induction	-	12	11	-	-	3.94E-03	7.77E-04
MatrixDB	BP	GO:0046660	female sex differentiation	-	125	94	-	-	3.04E-03	6.56E-03
MatrixDB	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	13	-	-	2.55E-04	9.50E-04
MatrixDB	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	30	-	-	1.25E-03	2.07E-03
MatrixDB	BP	GO:0060411	cardiac septum morphogenesis	-	72	50	-	-	5.28E-03	3.45E-03
MatrixDB	BP	GO:0071248	cellular response to metal ion	-	201	138	-	-	3.40E-03	9.59E-03
MatrixDB	BP	GO:0030308	negative regulation of cell growth	-	191	155	-	-	3.14E-03	1.07E-02
MatrixDB	BP	GO:0097306	cellular response to alcohol	-	99	61	-	-	1.94E-03	4.23E-03
MatrixDB	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	105	-	-	8.53E-03	7.26E-03
MatrixDB	BP	GO:0010453	regulation of cell fate commitment	-	40	28	-	-	4.82E-02	1.99E-03
MatrixDB	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	50	-	-	1.40E-02	3.45E-03
MatrixDB	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	26	-	-	5.13E-04	1.81E-03
MatrixDB	BP	GO:0002026	regulation of the force of heart contraction	-	26	21	-	-	4.25E-04	1.47E-03
MatrixDB	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	13	-	-	2.58E-04	9.50E-04
MatrixDB	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	35	-	-	1.59E-03	2.42E-03
MatrixDB	BP	GO:0032890	regulation of organic acid transport	-	78	56	-	-	1.66E-03	3.89E-03
MatrixDB	BP	GO:0071498	cellular response to fluid shear stress	-	21	14	-	-	2.56E-04	1.04E-03
MatrixDB	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	68	-	-	3.80E-03	4.75E-03
MatrixDB	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	22	-	-	2.02E-03	1.55E-03
MatrixDB	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	41	-	-	5.21E-03	2.85E-03
MatrixDB	BP	GO:0051259	protein complex oligomerization	-	251	177	-	-	3.77E-03	1.23E-02
MatrixDB	BP	GO:0009163	nucleoside biosynthetic process	-	16	12	-	-	2.58E-04	8.64E-04
MatrixDB	BP	GO:0098743	cell aggregation	-	24	12	-	-	2.57E-04	8.64E-04
MatrixDB	BP	GO:0009994	oocyte differentiation	-	57	40	-	-	9.93E-04	2.76E-03
MatrixDB	MF	GO:0031952	regulation of protein autophosphorylation	-	43	40	-	-	9.74E-04	2.76E-03
MatrixDB	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	132	-	-	5.36E-03	9.16E-03
MatrixDB	BP	GO:0044319	"wound healing, spreading of cells"	-	37	34	-	-	8.80E-03	2.42E-03
MatrixDB	BP	GO:0033688	regulation of osteoblast proliferation	-	31	25	-	-	8.95E-03	1.73E-03
MatrixDB	BP	GO:0060251	regulation of glial cell proliferation	-	39	30	-	-	7.69E-04	2.07E-03
MatrixDB	BP	GO:0072665	protein localization to vacuole	-	84	58	-	-	1.65E-03	4.06E-03
MatrixDB	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	43	-	-	3.52E-03	3.02E-03
MatrixDB	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	16	-	-	8.48E-03	1.12E-03
MatrixDB	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	54	-	-	2.73E-03	3.80E-03
MatrixDB	BP	GO:0042953	lipoprotein transport	-	20	14	-	-	2.57E-04	1.04E-03
MatrixDB	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	13	-	-	8.68E-03	9.50E-04
MatrixDB	BP	GO:0042044	fluid transport	-	35	14	-	-	2.02E-02	1.04E-03
MatrixDB	BP	GO:0070633	transepithelial transport	-	35	22	-	-	1.23E-02	1.55E-03
MatrixDB	BP	GO:0045661	regulation of myoblast differentiation	-	74	56	-	-	3.74E-02	3.89E-03
MatrixDB	BP	GO:0030307	positive regulation of cell growth	-	164	123	-	-	3.29E-03	8.55E-03
MatrixDB	BP	GO:0034250	positive regulation of amide metabolic process	-	27	20	-	-	1.49E-02	1.38E-03
MatrixDB	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	235	-	-	8.74E-03	1.62E-02
MatrixDB	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	15	-	-	3.44E-04	1.04E-03
MatrixDB	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	12	-	-	2.56E-04	8.64E-04
MatrixDB	BP	GO:0014812	muscle cell migration	-	110	69	-	-	9.70E-03	4.84E-03
MatrixDB	BP	GO:0048525	negative regulation of viral process	-	90	69	-	-	5.95E-03	4.84E-03
MatrixDB	BP	GO:0072044	collecting duct development	-	16	11	-	-	4.21E-02	7.77E-04
MatrixDB	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	60	-	-	2.39E-03	4.15E-03
MatrixDB	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	127	-	-	3.67E-03	8.81E-03
MatrixDB	BP	GO:0051781	positive regulation of cell division	-	93	70	-	-	3.95E-03	4.84E-03
MatrixDB	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	18	-	-	1.94E-02	1.30E-03
MatrixDB	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	2.56E-04	7.77E-04
MatrixDB	BP	GO:0035493	SNARE complex assembly	-	23	20	-	-	7.46E-02	1.38E-03
MatrixDB	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	15	-	-	3.40E-04	1.04E-03
MatrixDB	BP	GO:0060711	labyrinthine layer development	-	47	37	-	-	1.86E-03	2.59E-03
MatrixDB	BP	GO:0007272	ensheathment of neurons	-	146	99	-	-	1.08E-02	6.91E-03
MatrixDB	CC	GO:0050806	positive regulation of synaptic transmission	-	171	105	-	-	3.94E-03	7.26E-03
MatrixDB	BP	GO:0060021	roof of mouth development	-	91	64	-	-	2.39E-02	4.49E-03
MatrixDB	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	29	-	-	6.53E-04	2.07E-03
MatrixDB	BP	GO:0050819	negative regulation of coagulation	-	54	46	-	-	1.94E-02	3.20E-03
MatrixDB	BP	GO:0017004	cytochrome complex assembly	-	40	28	-	-	5.80E-02	1.99E-03
MatrixDB	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	59	-	-	7.72E-02	4.15E-03
MatrixDB	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	3.07E-02	1.04E-03
MatrixDB	CC	GO:0050805	negative regulation of synaptic transmission	-	55	33	-	-	1.90E-03	2.33E-03
MatrixDB	BP	GO:0043248	proteasome assembly	-	13	13	-	-	4.31E-03	9.50E-04
MatrixDB	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	42	-	-	1.04E-02	2.94E-03
MatrixDB	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	41	-	-	1.45E-03	2.85E-03
MatrixDB	BP	GO:0016054	organic acid catabolic process	-	251	160	-	-	3.64E-03	1.11E-02
MatrixDB	BP	GO:0050890	cognition	-	317	208	-	-	5.80E-03	1.44E-02
MatrixDB	BP	GO:1900048	positive regulation of hemostasis	-	28	25	-	-	2.91E-02	1.73E-03
MatrixDB	BP	GO:0065005	protein-lipid complex assembly	-	29	24	-	-	1.86E-02	1.73E-03
MatrixDB	BP	GO:0008033	tRNA processing	-	136	95	-	-	4.63E-02	6.56E-03
MatrixDB	BP	GO:0046661	male sex differentiation	-	171	124	-	-	2.92E-03	8.64E-03
MatrixDB	BP	GO:0072520	seminiferous tubule development	-	15	13	-	-	2.55E-04	9.50E-04
MatrixDB	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	14	-	-	1.12E-03	1.04E-03
MatrixDB	BP	GO:0035188	hatching	-	27	15	-	-	3.38E-04	1.04E-03
MatrixDB	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	61	-	-	3.88E-03	4.23E-03
MatrixDB	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	13	-	-	2.58E-04	9.50E-04
MatrixDB	BP	GO:0090713	immunological memory process	-	18	15	-	-	2.10E-01	1.04E-03
MatrixDB	BP	GO:0061326	renal tubule development	-	103	69	-	-	2.19E-03	4.84E-03
MatrixDB	BP	GO:0051258	protein polymerization	-	280	239	-	-	1.09E-02	1.66E-02
MatrixDB	BP	GO:0071985	multivesicular body sorting pathway	-	56	45	-	-	8.93E-03	3.11E-03
MatrixDB	BP	GO:0006450	regulation of translational fidelity	-	18	15	-	-	3.43E-04	1.04E-03
MatrixDB	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	17	-	-	3.40E-04	1.21E-03
MatrixDB	BP	GO:0060325	face morphogenesis	-	31	23	-	-	4.27E-04	1.64E-03
MatrixDB	BP	GO:0090559	regulation of membrane permeability	-	72	53	-	-	1.78E-03	3.71E-03
MatrixDB	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	12	-	-	1.04E-01	8.64E-04
MatrixDB	BP	GO:0043482	cellular pigment accumulation	-	12	11	-	-	1.74E-01	7.77E-04
MatrixDB	BP	GO:0031579	membrane raft organization	-	25	22	-	-	1.95E-03	1.55E-03
MatrixDB	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	22	-	-	4.25E-04	1.55E-03
MatrixDB	BP	GO:0060033	anatomical structure regression	-	16	13	-	-	2.58E-04	9.50E-04
MatrixDB	BP	GO:0046460	neutral lipid biosynthetic process	-	50	29	-	-	5.09E-04	2.07E-03
MatrixDB	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	76	-	-	1.35E-03	5.27E-03
MatrixDB	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	137	-	-	6.93E-03	9.50E-03
MatrixDB	BP	GO:0002251	organ or tissue specific immune response	-	43	25	-	-	1.31E-03	1.73E-03
MatrixDB	CC	GO:0048167	regulation of synaptic plasticity	-	210	134	-	-	3.98E-03	9.33E-03
MatrixDB	BP	GO:1903708	positive regulation of hemopoiesis	-	184	149	-	-	1.73E-02	1.04E-02
MatrixDB	BP	GO:1903008	organelle disassembly	-	154	140	-	-	7.80E-03	9.67E-03
MatrixDB	BP	GO:0001709	cell fate determination	-	44	24	-	-	4.23E-04	1.73E-03
MatrixDB	BP	GO:0051873	killing by host of symbiont cells	-	28	21	-	-	3.08E-03	1.47E-03
MatrixDB	BP	GO:0045058	T cell selection	-	53	44	-	-	8.36E-02	3.11E-03
MatrixDB	CC	GO:0032387	negative regulation of intracellular transport	-	51	41	-	-	1.85E-03	2.85E-03
MatrixDB	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	18	-	-	5.28E-04	1.30E-03
MatrixDB	BP	GO:0072091	regulation of stem cell proliferation	-	91	60	-	-	2.30E-03	4.15E-03
MatrixDB	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	27	-	-	5.15E-04	1.90E-03
MatrixDB	BP	GO:0099084	postsynaptic specialization organization	-	44	32	-	-	3.12E-03	2.25E-03
MatrixDB	BP	GO:0071501	cellular response to sterol depletion	-	15	12	-	-	2.86E-02	8.64E-04
MatrixDB	BP	GO:0060384	innervation	-	27	18	-	-	3.88E-02	1.30E-03
MatrixDB	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	13	-	-	2.58E-04	9.50E-04
MatrixDB	MF	GO:0031281	positive regulation of cyclase activity	-	40	24	-	-	8.19E-03	1.73E-03
MatrixDB	MF	GO:0098631	cell adhesion mediator activity	-	64	51	-	-	4.46E-03	3.54E-03
MatrixDB	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	11	-	-	2.58E-04	7.77E-04
MatrixDB	BP	GO:0046112	nucleobase biosynthetic process	-	18	17	-	-	3.41E-04	1.21E-03
MatrixDB	BP	GO:0071453	cellular response to oxygen levels	-	168	125	-	-	8.10E-03	8.64E-03
MatrixDB	BP	GO:0090399	replicative senescence	-	17	16	-	-	2.16E-03	1.12E-03
MatrixDB	BP	GO:0031342	negative regulation of cell killing	-	29	23	-	-	9.24E-03	1.64E-03
MatrixDB	BP	GO:0070585	protein localization to mitochondrion	-	125	106	-	-	4.44E-03	7.34E-03
MatrixDB	BP	GO:0010623	programmed cell death involved in cell development	-	25	21	-	-	1.68E-03	1.47E-03
MatrixDB	BP	GO:0044242	cellular lipid catabolic process	-	224	148	-	-	1.22E-02	1.03E-02
MatrixDB	BP	GO:0071236	cellular response to antibiotic	-	13	12	-	-	1.35E-03	8.64E-04
MatrixDB	BP	GO:0002931	response to ischemia	-	58	46	-	-	1.08E-02	3.20E-03
MatrixDB	BP	GO:0043062	extracellular structure organization	-	317	249	-	-	9.73E-03	1.73E-02
MatrixDB	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	11	-	-	2.57E-04	7.77E-04
MatrixDB	BP	GO:0014047	glutamate secretion	-	25	15	-	-	3.42E-04	1.04E-03
MatrixDB	BP	GO:0061005	cell differentiation involved in kidney development	-	58	48	-	-	3.30E-03	3.37E-03
MatrixDB	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	39	-	-	5.62E-03	2.76E-03
MatrixDB	BP	GO:0060420	regulation of heart growth	-	74	49	-	-	2.78E-03	3.45E-03
MatrixDB	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	13	-	-	2.47E-04	9.50E-04
MatrixDB	BP	GO:0009755	hormone-mediated signaling pathway	-	221	153	-	-	8.27E-03	1.06E-02
MatrixDB	BP	GO:0022612	gland morphogenesis	-	124	104	-	-	4.13E-03	7.26E-03
MatrixDB	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	32	-	-	5.90E-04	2.25E-03
MatrixDB	MF	GO:0140416	transcription regulator inhibitor activity	-	26	18	-	-	3.41E-04	1.30E-03
MatrixDB	BP	GO:0110096	cellular response to aldehyde	-	17	11	-	-	2.54E-04	7.77E-04
MatrixDB	BP	GO:1990845	adaptive thermogenesis	-	166	126	-	-	4.80E-03	8.72E-03
MatrixDB	BP	GO:0071320	cellular response to cAMP	-	54	33	-	-	8.66E-04	2.33E-03
MatrixDB	BP	GO:0015844	monoamine transport	-	88	48	-	-	1.21E-02	3.37E-03
MatrixDB	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	17	-	-	1.80E-03	1.21E-03
MatrixDB	BP	GO:0060039	pericardium development	-	19	13	-	-	8.06E-04	9.50E-04
MatrixDB	BP	GO:0071392	cellular response to estradiol stimulus	-	40	28	-	-	2.12E-03	1.99E-03
MatrixDB	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	11	-	-	1.44E-03	7.77E-04
MatrixDB	BP	GO:0000272	polysaccharide catabolic process	-	19	17	-	-	5.14E-03	1.21E-03
MatrixDB	BP	GO:0009451	RNA modification	-	169	116	-	-	1.40E-02	8.03E-03
MatrixDB	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	36	-	-	1.59E-03	2.50E-03
MatrixDB	BP	GO:1903729	regulation of plasma membrane organization	-	17	14	-	-	2.28E-03	1.04E-03
MatrixDB	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	98	-	-	4.67E-03	6.82E-03
MatrixDB	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	31	-	-	4.13E-03	2.16E-03
MatrixDB	BP	GO:0015807	L-amino acid transport	-	94	50	-	-	1.62E-03	3.45E-03
MatrixDB	BP	GO:0032941	secretion by tissue	-	85	65	-	-	3.20E-03	4.49E-03
MatrixDB	BP	GO:0046605	regulation of centrosome cycle	-	54	47	-	-	6.19E-03	3.28E-03
MatrixDB	BP	GO:0048753	pigment granule organization	-	40	30	-	-	1.71E-01	2.07E-03
MatrixDB	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	13	-	-	2.57E-04	9.50E-04
MatrixDB	BP	GO:0003014	renal system process	-	130	82	-	-	6.77E-03	5.70E-03
MatrixDB	CC	GO:0070286	axonemal dynein complex assembly	-	40	19	-	-	3.45E-04	1.38E-03
MatrixDB	BP	GO:0045598	regulation of fat cell differentiation	-	148	102	-	-	2.03E-03	7.08E-03
MatrixDB	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	161	-	-	1.26E-02	1.11E-02
MatrixDB	BP	GO:1904646	cellular response to amyloid-beta	-	44	37	-	-	4.88E-03	2.59E-03
MatrixDB	BP	GO:1901863	positive regulation of muscle tissue development	-	24	19	-	-	3.39E-04	1.38E-03
MatrixDB	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	111	-	-	3.61E-02	7.69E-03
MatrixDB	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	12	-	-	2.56E-04	8.64E-04
MatrixDB	BP	GO:0008340	determination of adult lifespan	-	23	16	-	-	8.47E-04	1.12E-03
MatrixDB	BP	GO:0018158	protein oxidation	-	15	13	-	-	2.56E-04	9.50E-04
MatrixDB	BP	GO:0039694	viral RNA genome replication	-	30	27	-	-	9.33E-03	1.90E-03
MatrixDB	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	20	-	-	4.28E-04	1.38E-03
MatrixDB	BP	GO:0071709	membrane assembly	-	68	58	-	-	6.01E-03	4.06E-03
MatrixDB	BP	GO:0008217	regulation of blood pressure	-	186	117	-	-	3.99E-03	8.12E-03
MatrixDB	BP	GO:0031643	positive regulation of myelination	-	19	13	-	-	1.35E-03	9.50E-04
MatrixDB	BP	GO:0043101	purine-containing compound salvage	-	15	13	-	-	2.58E-04	9.50E-04
MatrixDB	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	52	-	-	3.65E-03	3.63E-03
MatrixDB	CC	GO:0042770	signal transduction in response to DNA damage	-	186	167	-	-	1.05E-02	1.16E-02
MatrixDB	BP	GO:0002200	somatic diversification of immune receptors	-	78	66	-	-	2.60E-03	4.58E-03
MatrixDB	BP	GO:0035315	hair cell differentiation	-	52	33	-	-	1.03E-02	2.33E-03
MatrixDB	BP	GO:0048645	animal organ formation	-	62	49	-	-	4.63E-03	3.45E-03
MatrixDB	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	130	-	-	7.63E-03	8.98E-03
MatrixDB	BP	GO:0033627	cell adhesion mediated by integrin	-	87	70	-	-	4.28E-03	4.84E-03
MatrixDB	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	18	-	-	1.82E-03	1.30E-03
MatrixDB	BP	GO:0035107	appendage morphogenesis	-	147	109	-	-	6.53E-03	7.60E-03
MatrixDB	BP	GO:1903707	negative regulation of hemopoiesis	-	116	81	-	-	2.57E-03	5.61E-03
MatrixDB	BP	GO:0036342	post-anal tail morphogenesis	-	19	14	-	-	2.55E-04	1.04E-03
MatrixDB	CC	GO:0048208	COPII vesicle coating	-	27	24	-	-	4.23E-04	1.73E-03
MatrixDB	BP	GO:0030149	sphingolipid catabolic process	-	32	24	-	-	1.59E-03	1.73E-03
MatrixDB	BP	GO:0050994	regulation of lipid catabolic process	-	61	40	-	-	1.72E-03	2.76E-03
MatrixDB	BP	GO:0035988	chondrocyte proliferation	-	24	18	-	-	5.78E-03	1.30E-03
MatrixDB	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	16	-	-	3.44E-04	1.12E-03
MatrixDB	BP	GO:0009593	detection of chemical stimulus	-	511	45	-	-	1.07E-02	3.11E-03
MatrixDB	BP	GO:0045727	positive regulation of translation	-	141	114	-	-	5.14E-03	7.95E-03
MatrixDB	BP	GO:0036315	cellular response to sterol	-	24	11	-	-	2.58E-04	7.77E-04
MatrixDB	CC	GO:0032388	positive regulation of intracellular transport	-	137	107	-	-	2.98E-03	7.43E-03
MatrixDB	BP	GO:0002027	regulation of heart rate	-	106	64	-	-	6.54E-03	4.49E-03
MatrixDB	BP	GO:0050879	multicellular organismal movement	-	118	73	-	-	5.51E-03	5.10E-03
MatrixDB	BP	GO:0120305	regulation of pigmentation	-	15	11	-	-	7.38E-03	7.77E-04
MatrixDB	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	55	-	-	3.16E-03	3.80E-03
MatrixDB	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	44	-	-	1.98E-03	3.11E-03
MatrixDB	BP	GO:0048515	spermatid differentiation	-	208	119	-	-	4.84E-03	8.29E-03
MatrixDB	BP	GO:0072132	mesenchyme morphogenesis	-	57	45	-	-	4.54E-03	3.11E-03
MatrixDB	MF	GO:0042887	amide transmembrane transporter activity	-	33	12	-	-	2.58E-04	8.64E-04
MatrixDB	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	29	-	-	4.69E-03	2.07E-03
MatrixDB	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	25	-	-	4.96E-04	1.73E-03
MatrixDB	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	20	-	-	4.30E-04	1.38E-03
MatrixDB	BP	GO:0060119	inner ear receptor cell development	-	44	27	-	-	4.80E-03	1.90E-03
MatrixDB	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	3.41E-04	1.30E-03
MatrixDB	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	18	-	-	3.39E-04	1.30E-03
MatrixDB	BP	GO:1901983	regulation of protein acetylation	-	26	20	-	-	4.17E-04	1.38E-03
MatrixDB	BP	GO:0014854	response to inactivity	-	12	11	-	-	2.57E-04	7.77E-04
MatrixDB	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	219	-	-	1.21E-02	1.52E-02
MatrixDB	BP	GO:1900006	positive regulation of dendrite development	-	17	12	-	-	2.54E-04	8.64E-04
MatrixDB	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	43	-	-	4.91E-02	3.02E-03
MatrixDB	BP	GO:0010883	regulation of lipid storage	-	53	39	-	-	1.51E-03	2.76E-03
MatrixDB	BP	GO:0072170	metanephric tubule development	-	26	17	-	-	3.42E-04	1.21E-03
MatrixDB	BP	GO:1905954	positive regulation of lipid localization	-	110	80	-	-	2.24E-03	5.53E-03
MatrixDB	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	2.55E-04	8.64E-04
MatrixDB	BP	GO:0002209	behavioral defense response	-	39	26	-	-	5.05E-04	1.81E-03
MatrixDB	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	22	-	-	1.48E-02	1.55E-03
MatrixDB	BP	GO:0072523	purine-containing compound catabolic process	-	146	107	-	-	4.48E-03	7.43E-03
MatrixDB	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	27	-	-	1.17E-03	1.90E-03
MatrixDB	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	26	-	-	5.07E-04	1.81E-03
MatrixDB	BP	GO:0021535	cell migration in hindbrain	-	16	13	-	-	2.58E-04	9.50E-04
MatrixDB	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	78	-	-	4.74E-03	5.44E-03
MatrixDB	BP	GO:0007218	neuropeptide signaling pathway	-	113	44	-	-	1.28E-02	3.11E-03
MatrixDB	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	2.57E-04	8.64E-04
MatrixDB	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	104	-	-	7.75E-03	7.26E-03
MatrixDB	BP	GO:0031345	negative regulation of cell projection organization	-	195	155	-	-	4.85E-03	1.07E-02
MatrixDB	BP	GO:0048278	vesicle docking	-	64	55	-	-	2.67E-02	3.80E-03
MatrixDB	BP	GO:0035050	embryonic heart tube development	-	86	67	-	-	4.46E-03	4.66E-03
MatrixDB	BP	GO:0030168	platelet activation	-	135	116	-	-	5.23E-03	8.03E-03
MatrixDB	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	13	-	-	2.58E-04	9.50E-04
MatrixDB	CC	GO:0098810	neurotransmitter reuptake	-	35	14	-	-	4.23E-02	1.04E-03
MatrixDB	BP	GO:0008213	protein alkylation	-	58	35	-	-	2.53E-03	2.42E-03
MatrixDB	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	2.56E-04	9.50E-04
MatrixDB	BP	GO:0031338	regulation of vesicle fusion	-	24	18	-	-	3.38E-04	1.30E-03
MatrixDB	BP	GO:0031529	ruffle organization	-	55	45	-	-	6.30E-03	3.11E-03
MatrixDB	BP	GO:0010842	retina layer formation	-	25	18	-	-	2.77E-02	1.30E-03
MatrixDB	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	59	-	-	5.11E-03	4.15E-03
MatrixDB	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	53	-	-	1.10E-02	3.71E-03
MatrixDB	MF	GO:0170055	lipid transmembrane transporter activity	-	56	22	-	-	4.29E-04	1.55E-03
MatrixDB	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	20	-	-	4.27E-04	1.38E-03
MatrixDB	BP	GO:0035304	regulation of protein dephosphorylation	-	87	71	-	-	2.26E-03	4.92E-03
MatrixDB	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	179	-	-	4.54E-03	1.24E-02
MatrixDB	BP	GO:0099637	neurotransmitter receptor transport	-	26	18	-	-	3.39E-04	1.30E-03
MatrixDB	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	21	-	-	1.70E-03	1.47E-03
MatrixDB	BP	GO:0051775	response to redox state	-	13	12	-	-	2.59E-04	8.64E-04
MatrixDB	BP	GO:0051785	positive regulation of nuclear division	-	61	46	-	-	7.42E-03	3.20E-03
MatrixDB	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	13	-	-	1.27E-02	9.50E-04
MatrixDB	BP	GO:0060749	mammary gland alveolus development	-	20	18	-	-	2.65E-03	1.30E-03
MatrixDB	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	11	-	-	1.24E-02	7.77E-04
MatrixDB	BP	GO:0044786	cell cycle DNA replication	-	45	36	-	-	3.13E-03	2.50E-03
MatrixDB	BP	GO:0044539	long-chain fatty acid import into cell	-	17	14	-	-	1.27E-02	1.04E-03
MatrixDB	BP	GO:0051299	centrosome separation	-	15	15	-	-	1.83E-03	1.04E-03
MatrixDB	BP	GO:0048145	regulation of fibroblast proliferation	-	87	78	-	-	1.56E-02	5.44E-03
MatrixDB	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	76	-	-	2.05E-01	5.27E-03
MatrixDB	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	194	-	-	5.06E-03	1.35E-02
MatrixDB	BP	GO:0032098	regulation of appetite	-	20	12	-	-	2.59E-04	8.64E-04
MatrixDB	BP	GO:0021819	layer formation in cerebral cortex	-	14	11	-	-	1.45E-02	7.77E-04
MatrixDB	CC	GO:0008333	endosome to lysosome transport	-	73	57	-	-	1.82E-02	3.97E-03
MatrixDB	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	17	-	-	3.43E-04	1.21E-03
MatrixDB	BP	GO:0003016	respiratory system process	-	39	24	-	-	9.06E-04	1.73E-03
MatrixDB	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	18	-	-	3.67E-03	1.30E-03
MatrixDB	BP	GO:0045732	positive regulation of protein catabolic process	-	202	171	-	-	6.79E-03	1.18E-02
MatrixDB	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	42	-	-	3.04E-03	2.94E-03
MatrixDB	BP	GO:0007588	excretion	-	40	25	-	-	3.02E-02	1.73E-03
MatrixDB	BP	GO:1904018	positive regulation of vasculature development	-	185	132	-	-	1.39E-02	9.16E-03
MatrixDB	BP	GO:0050953	sensory perception of light stimulus	-	223	105	-	-	8.18E-03	7.26E-03
MatrixDB	BP	GO:0009164	nucleoside catabolic process	-	25	13	-	-	2.58E-04	9.50E-04
MatrixDB	BP	GO:0009303	rRNA transcription	-	37	34	-	-	7.89E-04	2.42E-03
MatrixDB	BP	GO:0035601	protein deacylation	-	56	48	-	-	6.59E-03	3.37E-03
MatrixDB	BP	GO:0061952	midbody abscission	-	18	17	-	-	5.67E-02	1.21E-03
MatrixDB	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	15	-	-	2.66E-03	1.04E-03
MatrixDB	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	26	-	-	9.17E-04	1.81E-03
MatrixDB	BP	GO:0071300	cellular response to retinoic acid	-	66	50	-	-	3.01E-03	3.45E-03
MatrixDB	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	11	-	-	2.59E-04	7.77E-04
MatrixDB	BP	GO:0045830	positive regulation of isotype switching	-	28	24	-	-	1.57E-03	1.73E-03
MatrixDB	BP	GO:0031069	hair follicle morphogenesis	-	33	28	-	-	1.51E-03	1.99E-03
MatrixDB	BP	GO:0046697	decidualization	-	26	21	-	-	8.36E-04	1.47E-03
MatrixDB	BP	GO:0051588	regulation of neurotransmitter transport	-	99	69	-	-	1.73E-03	4.84E-03
MatrixDB	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	15	-	-	3.45E-04	1.04E-03
MatrixDB	BP	GO:0051784	negative regulation of nuclear division	-	63	57	-	-	1.29E-02	3.97E-03
MatrixDB	BP	GO:0044703	multi-organism reproductive process	-	209	153	-	-	5.12E-03	1.06E-02
MatrixDB	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	109	-	-	5.66E-03	7.60E-03
MatrixDB	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	43	-	-	7.93E-03	3.02E-03
MatrixDB	BP	GO:0099022	vesicle tethering	-	32	28	-	-	4.36E-02	1.99E-03
MatrixDB	MF	GO:0004930	G protein-coupled receptor activity	-	873	159	-	-	9.22E-03	1.11E-02
MatrixDB	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	28	-	-	1.37E-03	1.99E-03
MatrixDB	BP	GO:0048857	neural nucleus development	-	65	47	-	-	1.29E-03	3.28E-03
MatrixDB	BP	GO:0048663	neuron fate commitment	-	74	39	-	-	2.14E-03	2.76E-03
MatrixDB	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	108	-	-	6.13E-03	7.51E-03
MatrixDB	BP	GO:0106027	neuron projection organization	-	90	75	-	-	2.59E-03	5.18E-03
MatrixDB	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	96	-	-	1.81E-02	6.65E-03
MatrixDB	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	34	-	-	4.37E-03	2.42E-03
MatrixDB	BP	GO:0045685	regulation of glial cell differentiation	-	77	55	-	-	2.88E-03	3.80E-03
MatrixDB	BP	GO:0043414	macromolecule methylation	-	138	93	-	-	6.19E-03	6.48E-03
MatrixDB	BP	GO:0048268	clathrin coat assembly	-	16	15	-	-	3.53E-02	1.04E-03
MatrixDB	BP	GO:0050886	endocrine process	-	93	63	-	-	6.68E-03	4.40E-03
MatrixDB	BP	GO:0050951	sensory perception of temperature stimulus	-	28	15	-	-	3.39E-04	1.04E-03
MatrixDB	BP	GO:0045807	positive regulation of endocytosis	-	155	138	-	-	4.73E-03	9.59E-03
MatrixDB	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	2.54E-04	7.77E-04
MatrixDB	BP	GO:0002418	immune response to tumor cell	-	29	22	-	-	1.39E-02	1.55E-03
MatrixDB	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	52	-	-	1.48E-03	3.63E-03
MatrixDB	BP	GO:0048308	organelle inheritance	-	14	13	-	-	1.68E-03	9.50E-04
MatrixDB	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	16	-	-	3.37E-04	1.12E-03
MatrixDB	BP	GO:0001829	trophectodermal cell differentiation	-	19	12	-	-	3.70E-03	8.64E-04
MatrixDB	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	24	-	-	4.26E-04	1.73E-03
MatrixDB	BP	GO:0034394	protein localization to cell surface	-	69	58	-	-	1.18E-03	4.06E-03
MatrixDB	BP	GO:0009110	vitamin biosynthetic process	-	23	16	-	-	3.36E-04	1.12E-03
MatrixDB	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	21	-	-	4.17E-04	1.47E-03
MatrixDB	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	13	-	-	4.62E-03	9.50E-04
MatrixDB	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	12	-	-	1.61E-03	8.64E-04
MatrixDB	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	78	-	-	2.89E-03	5.44E-03
MatrixDB	MF	GO:0051100	negative regulation of binding	-	161	132	-	-	2.97E-03	9.16E-03
MatrixDB	BP	GO:0001818	negative regulation of cytokine production	-	379	227	-	-	9.20E-03	1.57E-02
MatrixDB	BP	GO:0003151	outflow tract morphogenesis	-	81	61	-	-	3.45E-03	4.23E-03
MatrixDB	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	51	-	-	6.66E-03	3.54E-03
MatrixDB	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	1.08E-03	1.38E-03
MatrixDB	BP	GO:0061036	positive regulation of cartilage development	-	33	25	-	-	1.64E-02	1.73E-03
MatrixDB	BP	GO:0046184	aldehyde biosynthetic process	-	16	13	-	-	2.57E-04	9.50E-04
MatrixDB	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	38	-	-	9.09E-04	2.68E-03
MatrixDB	BP	GO:0046621	negative regulation of organ growth	-	39	25	-	-	5.07E-04	1.73E-03
MatrixDB	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	47	-	-	1.03E-01	3.28E-03
MatrixDB	BP	GO:0032368	regulation of lipid transport	-	149	101	-	-	5.10E-03	7.00E-03
MatrixDB	BP	GO:0055094	response to lipoprotein particle	-	34	26	-	-	7.28E-03	1.81E-03
MatrixDB	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	157	-	-	5.39E-03	1.09E-02
MatrixDB	BP	GO:0033002	muscle cell proliferation	-	249	172	-	-	6.09E-03	1.19E-02
MatrixDB	BP	GO:0043331	response to dsRNA	-	56	40	-	-	2.50E-03	2.76E-03
MatrixDB	BP	GO:0051904	pigment granule transport	-	23	20	-	-	5.66E-02	1.38E-03
MatrixDB	BP	GO:1901679	nucleotide transmembrane transport	-	32	20	-	-	4.27E-04	1.38E-03
MatrixDB	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	29	-	-	5.23E-03	2.07E-03
MatrixDB	BP	GO:0033363	secretory granule organization	-	63	45	-	-	5.21E-02	3.11E-03
MatrixDB	BP	GO:0060479	lung cell differentiation	-	28	20	-	-	8.66E-04	1.38E-03
MatrixDB	BP	GO:0120009	intermembrane lipid transfer	-	52	39	-	-	3.75E-03	2.76E-03
MatrixDB	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	5.66E-03	1.04E-03
MatrixDB	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	33	-	-	1.54E-03	2.33E-03
MatrixDB	BP	GO:0033622	integrin activation	-	26	24	-	-	3.05E-03	1.73E-03
MatrixDB	BP	GO:0098751	bone cell development	-	18	14	-	-	2.53E-04	1.04E-03
MatrixDB	BP	GO:2000773	negative regulation of cellular senescence	-	25	20	-	-	7.00E-04	1.38E-03
MatrixDB	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	42	-	-	2.75E-03	2.94E-03
MatrixDB	BP	GO:0050820	positive regulation of coagulation	-	30	27	-	-	2.72E-02	1.90E-03
MatrixDB	BP	GO:0002076	osteoblast development	-	17	12	-	-	2.57E-04	8.64E-04
MatrixDB	BP	GO:0072164	mesonephric tubule development	-	98	75	-	-	3.93E-03	5.18E-03
MatrixDB	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	12	-	-	2.57E-04	8.64E-04
MatrixDB	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	89	-	-	5.46E-03	6.22E-03
MatrixDB	BP	GO:1903524	positive regulation of blood circulation	-	39	24	-	-	4.21E-04	1.73E-03
MatrixDB	BP	GO:0030901	midbrain development	-	87	67	-	-	3.47E-03	4.66E-03
MatrixDB	BP	GO:0048485	sympathetic nervous system development	-	22	12	-	-	2.56E-04	8.64E-04
MatrixDB	BP	GO:0007162	negative regulation of cell adhesion	-	310	233	-	-	8.58E-03	1.62E-02
MatrixDB	BP	GO:0048532	anatomical structure arrangement	-	16	11	-	-	2.55E-04	7.77E-04
MatrixDB	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	12	-	-	4.09E-03	8.64E-04
MatrixDB	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	61	-	-	3.41E-03	4.23E-03
MatrixDB	BP	GO:0002687	positive regulation of leukocyte migration	-	147	124	-	-	1.37E-02	8.64E-03
MatrixDB	BP	GO:1901862	negative regulation of muscle tissue development	-	13	11	-	-	2.56E-04	7.77E-04
MatrixDB	BP	GO:0060856	establishment of blood-brain barrier	-	16	13	-	-	3.20E-02	9.50E-04
MatrixDB	BP	GO:0110154	RNA decapping	-	19	18	-	-	3.44E-04	1.30E-03
MatrixDB	BP	GO:0034605	cellular response to heat	-	66	57	-	-	1.72E-03	3.97E-03
MatrixDB	BP	GO:0005996	monosaccharide metabolic process	-	250	181	-	-	5.41E-03	1.25E-02
MatrixDB	BP	GO:0033555	multicellular organismal response to stress	-	90	56	-	-	1.51E-03	3.89E-03
MatrixDB	BP	GO:0002262	myeloid cell homeostasis	-	172	138	-	-	3.06E-03	9.59E-03
MatrixDB	BP	GO:0000966	RNA 5'-end processing	-	39	37	-	-	2.03E-02	2.59E-03
MatrixDB	BP	GO:0050688	regulation of defense response to virus	-	65	54	-	-	6.30E-02	3.80E-03
MatrixDB	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	239	-	-	3.44E-02	1.66E-02
MatrixDB	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	19	-	-	3.44E-03	1.38E-03
MatrixDB	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	195	-	-	7.92E-03	1.35E-02
MatrixDB	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	26	-	-	9.82E-04	1.81E-03
MatrixDB	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	27	-	-	1.28E-02	1.90E-03
MatrixDB	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	15	-	-	3.38E-04	1.04E-03
MatrixDB	BP	GO:0003272	endocardial cushion formation	-	28	20	-	-	1.55E-02	1.38E-03
MatrixDB	BP	GO:0022618	protein-RNA complex assembly	-	227	183	-	-	1.30E-02	1.27E-02
MatrixDB	BP	GO:0051147	regulation of muscle cell differentiation	-	162	106	-	-	2.69E-03	7.34E-03
MatrixDB	BP	GO:0006066	alcohol metabolic process	-	374	231	-	-	5.97E-03	1.60E-02
MatrixDB	BP	GO:0090102	cochlea development	-	50	28	-	-	1.59E-03	1.99E-03
MatrixDB	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	23	-	-	4.19E-04	1.64E-03
MatrixDB	BP	GO:0045933	positive regulation of muscle contraction	-	49	32	-	-	5.86E-04	2.25E-03
MatrixDB	BP	GO:0002679	respiratory burst involved in defense response	-	16	12	-	-	2.57E-04	8.64E-04
MatrixDB	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	30	-	-	7.83E-04	2.07E-03
MatrixDB	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	77	-	-	2.38E-02	5.35E-03
MatrixDB	BP	GO:0097264	self proteolysis	-	12	12	-	-	2.58E-04	8.64E-04
MatrixDB	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	5.79E-03	1.55E-03
MatrixDB	BP	GO:0032922	circadian regulation of gene expression	-	71	59	-	-	3.61E-03	4.15E-03
MatrixDB	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	28	-	-	5.12E-04	1.99E-03
MatrixDB	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	61	-	-	1.08E-03	4.23E-03
MatrixDB	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	14	-	-	2.59E-04	1.04E-03
MatrixDB	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	45	-	-	1.87E-02	3.11E-03
MatrixDB	BP	GO:0038179	neurotrophin signaling pathway	-	38	37	-	-	4.69E-03	2.59E-03
MatrixDB	BP	GO:0021670	lateral ventricle development	-	12	11	-	-	2.55E-04	7.77E-04
MatrixDB	BP	GO:0140253	cell-cell fusion	-	62	45	-	-	1.15E-02	3.11E-03
MatrixDB	BP	GO:0071599	otic vesicle development	-	15	11	-	-	2.61E-02	7.77E-04
MatrixDB	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	33	-	-	6.33E-02	2.33E-03
MatrixDB	BP	GO:0061635	regulation of protein complex stability	-	14	12	-	-	1.51E-03	8.64E-04
MatrixDB	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	43	-	-	7.64E-04	3.02E-03
MatrixDB	BP	GO:0001941	postsynaptic membrane organization	-	37	25	-	-	5.13E-04	1.73E-03
MatrixDB	BP	GO:0051293	establishment of spindle localization	-	57	48	-	-	3.51E-03	3.37E-03
MatrixDB	BP	GO:0043114	regulation of vascular permeability	-	49	35	-	-	6.91E-03	2.42E-03
MatrixDB	BP	GO:0018126	protein hydroxylation	-	26	23	-	-	3.06E-03	1.64E-03
MatrixDB	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	46	-	-	2.60E-03	3.20E-03
MatrixDB	BP	GO:0008360	regulation of cell shape	-	139	114	-	-	4.87E-03	7.95E-03
MatrixDB	BP	GO:0051222	positive regulation of protein transport	-	249	189	-	-	5.30E-03	1.31E-02
MatrixDB	CC	GO:0140632	canonical inflammasome complex assembly	-	40	33	-	-	2.06E-02	2.33E-03
MatrixDB	MF	GO:0034260	negative regulation of GTPase activity	-	36	27	-	-	5.89E-04	1.90E-03
MatrixDB	BP	GO:0045932	negative regulation of muscle contraction	-	24	19	-	-	1.76E-02	1.38E-03
MatrixDB	BP	GO:0045739	positive regulation of DNA repair	-	128	118	-	-	4.52E-02	8.21E-03
MatrixDB	BP	GO:0001845	phagolysosome assembly	-	19	14	-	-	2.56E-04	1.04E-03
MatrixDB	BP	GO:0045185	maintenance of protein location	-	95	78	-	-	1.93E-03	5.44E-03
MatrixDB	BP	GO:0003158	endothelium development	-	140	101	-	-	1.62E-02	7.00E-03
MatrixDB	CC	GO:0072595	maintenance of protein localization in organelle	-	42	37	-	-	7.52E-04	2.59E-03
MatrixDB	BP	GO:0051224	negative regulation of protein transport	-	122	80	-	-	3.77E-03	5.53E-03
MatrixDB	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	107	-	-	2.21E-03	7.43E-03
MatrixDB	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	11	-	-	2.56E-04	7.77E-04
MatrixDB	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	25	-	-	1.20E-03	1.73E-03
MatrixDB	MF	GO:0003713	transcription coactivator activity	-	281	233	-	-	9.83E-03	1.62E-02
MatrixDB	BP	GO:0021885	forebrain cell migration	-	63	47	-	-	2.79E-03	3.28E-03
MatrixDB	BP	GO:0007405	neuroblast proliferation	-	81	58	-	-	3.54E-03	4.06E-03
MatrixDB	BP	GO:0009581	detection of external stimulus	-	137	62	-	-	4.10E-03	4.32E-03
MatrixDB	BP	GO:1990542	mitochondrial transmembrane transport	-	93	58	-	-	3.92E-03	4.06E-03
MatrixDB	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	27	-	-	1.88E-03	1.90E-03
MatrixDB	BP	GO:0097186	amelogenesis	-	26	17	-	-	1.24E-02	1.21E-03
MatrixDB	BP	GO:0031128	developmental induction	-	26	20	-	-	4.28E-04	1.38E-03
MatrixDB	BP	GO:0031100	animal organ regeneration	-	66	56	-	-	4.32E-03	3.89E-03
MatrixDB	BP	GO:0021533	cell differentiation in hindbrain	-	23	14	-	-	2.58E-04	1.04E-03
MatrixDB	BP	GO:0045684	positive regulation of epidermis development	-	33	21	-	-	4.19E-04	1.47E-03
MatrixDB	BP	GO:1900047	negative regulation of hemostasis	-	51	45	-	-	2.02E-02	3.11E-03
MatrixDB	BP	GO:0021517	ventral spinal cord development	-	47	24	-	-	4.23E-04	1.73E-03
MatrixDB	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	63	-	-	3.08E-03	4.40E-03
MatrixDB	MF	GO:0034497	protein localization to phagophore assembly site	-	16	14	-	-	2.58E-04	1.04E-03
MatrixDB	BP	GO:0097722	sperm motility	-	133	62	-	-	1.10E-03	4.32E-03
MatrixDB	BP	GO:0051231	spindle elongation	-	14	12	-	-	4.08E-02	8.64E-04
MatrixDB	BP	GO:0042490	mechanoreceptor differentiation	-	67	43	-	-	7.88E-03	3.02E-03
MatrixDB	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	26	-	-	1.70E-02	1.81E-03
MatrixDB	BP	GO:0035148	tube formation	-	155	119	-	-	4.79E-03	8.29E-03
MatrixDB	BP	GO:0048520	positive regulation of behavior	-	27	15	-	-	5.48E-03	1.04E-03
MatrixDB	BP	GO:0098543	detection of other organism	-	19	15	-	-	3.43E-04	1.04E-03
MatrixDB	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	1.23E-02	3.02E-03
MatrixDB	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	95	-	-	1.56E-02	6.56E-03
MatrixDB	BP	GO:0031123	RNA 3'-end processing	-	79	73	-	-	2.89E-02	5.10E-03
MatrixDB	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	72	-	-	3.17E-03	5.01E-03
MatrixDB	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	17	-	-	1.93E-02	1.21E-03
MatrixDB	CC	GO:0007097	nuclear migration	-	24	22	-	-	1.81E-03	1.55E-03
MatrixDB	BP	GO:0006885	regulation of pH	-	104	60	-	-	2.60E-03	4.15E-03
MatrixDB	BP	GO:0002467	germinal center formation	-	14	11	-	-	2.57E-04	7.77E-04
MatrixDB	BP	GO:1990840	response to lectin	-	22	16	-	-	3.40E-04	1.12E-03
MatrixDB	BP	GO:0071800	podosome assembly	-	19	18	-	-	3.40E-04	1.30E-03
MatrixDB	BP	GO:0031018	endocrine pancreas development	-	47	34	-	-	1.51E-03	2.42E-03
MatrixDB	BP	GO:0001708	cell fate specification	-	108	67	-	-	1.84E-02	4.66E-03
MatrixDB	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	58	-	-	2.55E-03	4.06E-03
MatrixDB	BP	GO:0030279	negative regulation of ossification	-	39	31	-	-	1.79E-02	2.16E-03
MatrixDB	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	11	-	-	2.53E-04	7.77E-04
MatrixDB	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	1.42E-03	8.64E-04
MatrixDB	BP	GO:0042440	pigment metabolic process	-	80	39	-	-	6.78E-04	2.76E-03
MatrixDB	BP	GO:1901606	alpha-amino acid catabolic process	-	101	61	-	-	3.03E-03	4.23E-03
MatrixDB	BP	GO:0062197	cellular response to chemical stress	-	299	245	-	-	6.86E-03	1.69E-02
MatrixDB	BP	GO:1901890	positive regulation of cell junction assembly	-	106	71	-	-	3.35E-03	4.92E-03
MatrixDB	BP	GO:0070988	demethylation	-	27	17	-	-	3.42E-04	1.21E-03
MatrixDB	BP	GO:1901655	cellular response to ketone	-	107	75	-	-	3.79E-03	5.18E-03
MatrixDB	BP	GO:0051255	spindle midzone assembly	-	14	11	-	-	2.09E-02	7.77E-04
MatrixDB	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	12	-	-	2.57E-04	8.64E-04
MatrixDB	BP	GO:0006968	cellular defense response	-	52	37	-	-	2.21E-03	2.59E-03
MatrixDB	BP	GO:0055006	cardiac cell development	-	93	71	-	-	3.03E-03	4.92E-03
MatrixDB	BP	GO:0031365	N-terminal protein amino acid modification	-	30	17	-	-	3.43E-04	1.21E-03
MatrixDB	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	25	-	-	9.94E-04	1.73E-03
MatrixDB	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	11	-	-	3.48E-03	7.77E-04
MatrixDB	BP	GO:0060004	reflex	-	63	46	-	-	2.84E-03	3.20E-03
MatrixDB	BP	GO:0044706	multi-multicellular organism process	-	217	160	-	-	5.45E-03	1.11E-02
MatrixDB	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	6.40E-03	8.64E-04
MatrixDB	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	125	-	-	4.53E-03	8.64E-03
MatrixDB	BP	GO:0006026	aminoglycan catabolic process	-	34	25	-	-	7.51E-03	1.73E-03
MatrixDB	BP	GO:0031294	lymphocyte costimulation	-	47	37	-	-	1.79E-02	2.59E-03
MatrixDB	BP	GO:0050768	negative regulation of neurogenesis	-	150	116	-	-	3.10E-03	8.03E-03
MatrixDB	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	82	-	-	2.66E-03	5.70E-03
MatrixDB	BP	GO:0090068	positive regulation of cell cycle process	-	262	210	-	-	7.61E-03	1.45E-02
MatrixDB	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	22	-	-	4.30E-04	1.55E-03
MatrixDB	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	29	-	-	4.34E-02	2.07E-03
MatrixDB	BP	GO:1902115	regulation of organelle assembly	-	210	177	-	-	6.25E-03	1.23E-02
MatrixDB	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	52	-	-	9.94E-03	3.63E-03
MatrixDB	BP	GO:0047484	regulation of response to osmotic stress	-	16	14	-	-	2.56E-04	1.04E-03
MatrixDB	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	122	-	-	4.13E-03	8.46E-03
MatrixDB	BP	GO:0043171	peptide catabolic process	-	19	14	-	-	2.56E-04	1.04E-03
MatrixDB	BP	GO:0046622	positive regulation of organ growth	-	52	34	-	-	1.47E-03	2.42E-03
MatrixDB	BP	GO:0051952	regulation of amine transport	-	98	54	-	-	1.58E-03	3.80E-03
MatrixDB	BP	GO:0006730	one-carbon metabolic process	-	24	20	-	-	1.24E-03	1.38E-03
MatrixDB	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	17	-	-	3.42E-04	1.21E-03
MatrixDB	BP	GO:0040019	positive regulation of embryonic development	-	23	13	-	-	2.56E-04	9.50E-04
MatrixDB	BP	GO:0097154	GABAergic neuron differentiation	-	20	11	-	-	2.59E-04	7.77E-04
MatrixDB	CC	GO:0032365	intracellular lipid transport	-	51	38	-	-	1.72E-02	2.68E-03
MatrixDB	BP	GO:0045048	protein insertion into ER membrane	-	30	24	-	-	1.54E-02	1.73E-03
MatrixDB	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	59	-	-	1.89E-03	4.15E-03
MatrixDB	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	96	-	-	3.13E-03	6.65E-03
MatrixDB	BP	GO:0018149	peptide cross-linking	-	28	23	-	-	2.02E-03	1.64E-03
MatrixDB	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	19	-	-	6.60E-04	1.38E-03
MatrixDB	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	1.33E-03	9.50E-04
MatrixDB	BP	GO:0021859	pyramidal neuron differentiation	-	14	12	-	-	2.54E-04	8.64E-04
MatrixDB	BP	GO:0071398	cellular response to fatty acid	-	35	23	-	-	9.10E-04	1.64E-03
MatrixDB	BP	GO:0097581	lamellipodium organization	-	91	77	-	-	7.69E-03	5.35E-03
MatrixDB	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	24	-	-	6.04E-03	1.73E-03
MatrixDB	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	165	-	-	9.43E-03	1.14E-02
MatrixDB	BP	GO:0060326	cell chemotaxis	-	311	245	-	-	7.44E-02	1.69E-02
MatrixDB	BP	GO:1903975	regulation of glial cell migration	-	20	16	-	-	1.13E-02	1.12E-03
MatrixDB	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	19	-	-	4.03E-03	1.38E-03
MatrixDB	BP	GO:0015669	gas transport	-	23	12	-	-	8.35E-02	8.64E-04
MatrixDB	BP	GO:0016485	protein processing	-	248	186	-	-	8.65E-03	1.29E-02
MatrixDB	BP	GO:0009649	entrainment of circadian clock	-	30	24	-	-	1.58E-03	1.73E-03
MatrixDB	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	87	-	-	2.47E-03	6.05E-03
MatrixDB	BP	GO:1903523	negative regulation of blood circulation	-	27	20	-	-	2.69E-03	1.38E-03
MatrixDB	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	60	-	-	3.13E-03	4.15E-03
MatrixDB	BP	GO:0099054	presynapse assembly	-	49	34	-	-	7.57E-04	2.42E-03
MatrixDB	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	21	-	-	1.26E-03	1.47E-03
MatrixDB	BP	GO:0006517	protein deglycosylation	-	26	17	-	-	3.42E-04	1.21E-03
MatrixDB	BP	GO:0031348	negative regulation of defense response	-	282	198	-	-	5.27E-03	1.37E-02
MatrixDB	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	63	-	-	1.77E-03	4.40E-03
MatrixDB	BP	GO:0007606	sensory perception of chemical stimulus	-	535	52	-	-	9.42E-04	3.63E-03
MatrixDB	BP	GO:0061180	mammary gland epithelium development	-	68	58	-	-	2.69E-03	4.06E-03
MatrixDB	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	172	-	-	1.42E-02	1.19E-02
MatrixDB	BP	GO:0071496	cellular response to external stimulus	-	74	65	-	-	6.30E-03	4.49E-03
MatrixDB	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	11	-	-	2.58E-04	7.77E-04
MatrixDB	BP	GO:0042753	positive regulation of circadian rhythm	-	18	14	-	-	3.63E-03	1.04E-03
MatrixDB	BP	GO:0032094	response to food	-	37	28	-	-	5.12E-04	1.99E-03
MatrixDB	BP	GO:0001964	startle response	-	27	16	-	-	3.37E-04	1.12E-03
MatrixDB	BP	GO:0007340	acrosome reaction	-	38	15	-	-	3.45E-04	1.04E-03
MatrixDB	BP	GO:0046434	organophosphate catabolic process	-	232	160	-	-	4.83E-03	1.11E-02
MatrixDB	BP	GO:0060037	pharyngeal system development	-	29	21	-	-	3.15E-02	1.47E-03
MatrixDB	BP	GO:0009566	fertilization	-	205	101	-	-	4.95E-03	7.00E-03
MatrixDB	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	52	-	-	1.02E-01	3.63E-03
MatrixDB	BP	GO:0120255	olefinic compound biosynthetic process	-	24	13	-	-	2.58E-04	9.50E-04
MatrixDB	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	12	-	-	2.57E-04	8.64E-04
MatrixDB	BP	GO:0045907	positive regulation of vasoconstriction	-	30	16	-	-	3.34E-03	1.12E-03
MatrixDB	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	17	-	-	3.46E-02	1.21E-03
MatrixDB	BP	GO:0033044	regulation of chromosome organization	-	249	238	-	-	1.87E-02	1.65E-02
MatrixDB	BP	GO:0009309	amine biosynthetic process	-	38	21	-	-	5.30E-02	1.47E-03
MatrixDB	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	14	-	-	2.57E-04	1.04E-03
MatrixDB	BP	GO:0061900	glial cell activation	-	56	45	-	-	4.26E-03	3.11E-03
MatrixDB	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	116	-	-	8.51E-03	8.03E-03
MatrixDB	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	13	-	-	9.33E-03	9.50E-04
MatrixDB	CC	GO:0140467	integrated stress response signaling	-	41	33	-	-	7.65E-04	2.33E-03
MatrixDB	BP	GO:0035902	response to immobilization stress	-	20	16	-	-	3.43E-04	1.12E-03
MatrixDB	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	3.41E-03	1.04E-03
MatrixDB	BP	GO:0090235	regulation of metaphase plate congression	-	13	12	-	-	4.60E-02	8.64E-04
MatrixDB	BP	GO:0043647	inositol phosphate metabolic process	-	44	27	-	-	4.09E-03	1.90E-03
MatrixDB	BP	GO:0016180	snRNA processing	-	28	26	-	-	1.04E-01	1.81E-03
MatrixDB	BP	GO:0051303	establishment of chromosome localization	-	104	94	-	-	7.66E-03	6.56E-03
MatrixDB	BP	GO:0051382	kinetochore assembly	-	16	15	-	-	9.33E-03	1.04E-03
MatrixDB	BP	GO:0007164	establishment of tissue polarity	-	38	30	-	-	1.35E-03	2.07E-03
MatrixDB	BP	GO:0021515	cell differentiation in spinal cord	-	51	23	-	-	1.38E-02	1.64E-03
MatrixDB	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	14	-	-	2.58E-04	1.04E-03
MatrixDB	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	14	-	-	1.17E-02	1.04E-03
MatrixDB	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	26	-	-	1.00E-03	1.81E-03
MatrixDB	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.31E-03	1.30E-03
MatrixDB	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	28	-	-	6.76E-03	1.99E-03
MatrixDB	BP	GO:0006605	protein targeting	-	327	247	-	-	6.12E-03	1.71E-02
MatrixDB	BP	GO:0061318	renal filtration cell differentiation	-	22	20	-	-	2.08E-03	1.38E-03
MatrixDB	BP	GO:0007566	embryo implantation	-	57	44	-	-	1.83E-03	3.11E-03
MatrixDB	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	26	-	-	3.03E-03	1.81E-03
MatrixDB	BP	GO:0031268	pseudopodium organization	-	17	12	-	-	2.88E-02	8.64E-04
MatrixDB	BP	GO:0060306	regulation of membrane repolarization	-	38	22	-	-	1.19E-03	1.55E-03
MatrixDB	BP	GO:0051017	actin filament bundle assembly	-	161	133	-	-	4.86E-03	9.24E-03
MatrixDB	BP	GO:1905953	negative regulation of lipid localization	-	63	36	-	-	2.83E-03	2.50E-03
MatrixDB	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	14	-	-	2.53E-04	1.04E-03
MatrixDB	BP	GO:0021542	dentate gyrus development	-	19	12	-	-	2.52E-04	8.64E-04
MatrixDB	BP	GO:0036302	atrioventricular canal development	-	13	11	-	-	2.56E-04	7.77E-04
MatrixDB	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	31	-	-	1.51E-03	2.16E-03
MatrixDB	BP	GO:0021756	striatum development	-	21	18	-	-	3.33E-04	1.30E-03
MatrixDB	BP	GO:1901343	negative regulation of vasculature development	-	154	79	-	-	2.28E-03	5.53E-03
MatrixDB	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	129	-	-	1.15E-02	8.98E-03
MatrixDB	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	16	-	-	3.42E-04	1.12E-03
MatrixDB	BP	GO:1902414	protein localization to cell junction	-	107	83	-	-	4.50E-03	5.79E-03
MatrixDB	BP	GO:0071305	cellular response to vitamin D	-	23	15	-	-	3.31E-04	1.04E-03
MatrixDB	BP	GO:0051304	chromosome separation	-	80	76	-	-	7.46E-03	5.27E-03
MatrixDB	BP	GO:0090596	sensory organ morphogenesis	-	272	175	-	-	7.70E-03	1.21E-02
MatrixDB	BP	GO:0045780	positive regulation of bone resorption	-	18	14	-	-	6.68E-03	1.04E-03
MatrixDB	BP	GO:0048709	oligodendrocyte differentiation	-	101	63	-	-	1.52E-03	4.40E-03
MatrixDB	BP	GO:0045017	glycerolipid biosynthetic process	-	254	168	-	-	3.82E-03	1.17E-02
MatrixDB	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	4.95E-01	1.04E-03
MatrixDB	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	21	-	-	3.22E-03	1.47E-03
MatrixDB	BP	GO:0001776	leukocyte homeostasis	-	108	87	-	-	1.66E-02	6.05E-03
MatrixDB	BP	GO:0050769	positive regulation of neurogenesis	-	240	191	-	-	5.22E-03	1.32E-02
MatrixDB	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	13	-	-	2.57E-04	9.50E-04
MatrixDB	BP	GO:0030193	regulation of blood coagulation	-	70	61	-	-	1.49E-02	4.23E-03
MatrixDB	BP	GO:0050866	negative regulation of cell activation	-	216	165	-	-	6.70E-03	1.14E-02
MatrixDB	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	24	-	-	6.29E-04	1.73E-03
MatrixDB	BP	GO:0033500	carbohydrate homeostasis	-	251	178	-	-	4.68E-03	1.24E-02
MatrixDB	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	25	-	-	5.13E-04	1.73E-03
MatrixDB	BP	GO:0044088	regulation of vacuole organization	-	56	46	-	-	3.17E-03	3.20E-03
MatrixDB	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	7.27E-04	1.64E-03
MatrixDB	CC	GO:0099522	cytosolic region	-	20	19	-	-	4.02E-03	1.38E-03
MatrixDB	CC	GO:0000791	euchromatin	-	60	47	-	-	2.16E-03	3.28E-03
MatrixDB	CC	GO:0030666	endocytic vesicle membrane	-	196	146	-	-	1.10E-02	1.01E-02
MatrixDB	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.23E-01	1.04E-03
MatrixDB	CC	GO:1990752	microtubule end	-	34	32	-	-	2.50E-02	2.25E-03
MatrixDB	CC	GO:0043204	perikaryon	-	156	99	-	-	2.54E-03	6.91E-03
MatrixDB	CC	GO:0061702	canonical inflammasome complex	-	17	13	-	-	5.63E-02	9.50E-04
MatrixDB	CC	GO:0097542	ciliary tip	-	48	43	-	-	1.05E-01	3.02E-03
MatrixDB	CC	GO:1905368	peptidase complex	-	124	114	-	-	9.69E-02	7.95E-03
MatrixDB	CC	GO:0000792	heterochromatin	-	98	91	-	-	6.29E-03	6.31E-03
MatrixDB	CC	GO:0097546	ciliary base	-	47	35	-	-	1.73E-02	2.42E-03
MatrixDB	CC	GO:0071819	DUBm complex	-	25	23	-	-	2.19E-01	1.64E-03
MatrixDB	CC	GO:0031201	SNARE complex	-	48	42	-	-	9.52E-02	2.94E-03
MatrixDB	CC	GO:0016324	apical plasma membrane	-	392	228	-	-	8.11E-03	1.58E-02
MatrixDB	CC	GO:0005677	chromatin silencing complex	-	13	12	-	-	5.02E-03	8.64E-04
MatrixDB	CC	GO:0033260	nuclear DNA replication	-	40	33	-	-	1.49E-03	2.33E-03
MatrixDB	CC	GO:0044391	ribosomal subunit	-	203	197	-	-	8.47E-02	1.36E-02
MatrixDB	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	4.13E-02	7.77E-04
MatrixDB	CC	GO:0071013	catalytic step 2 spliceosome	-	88	86	-	-	1.36E-02	5.96E-03
MatrixDB	CC	GO:0031907	microbody lumen	-	51	35	-	-	5.84E-02	2.42E-03
MatrixDB	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.59E-04	7.77E-04
MatrixDB	CC	GO:0098862	cluster of actin-based cell projections	-	162	102	-	-	5.08E-03	7.08E-03
MatrixDB	CC	GO:0016363	nuclear matrix	-	127	118	-	-	6.00E-03	8.21E-03
MatrixDB	CC	GO:0031261	DNA replication preinitiation complex	-	46	38	-	-	7.31E-03	2.68E-03
MatrixDB	CC	GO:0097060	synaptic membrane	-	413	235	-	-	1.20E-02	1.62E-02
MatrixDB	CC	GO:0032432	actin filament bundle	-	249	187	-	-	9.07E-03	1.30E-02
MatrixDB	CC	GO:0008088	axo-dendritic transport	-	78	69	-	-	2.98E-02	4.84E-03
MatrixDB	CC	GO:0031519	PcG protein complex	-	38	37	-	-	6.43E-02	2.59E-03
MatrixDB	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	29	-	-	3.74E-03	2.07E-03
MatrixDB	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	164	-	-	7.12E-03	1.14E-02
MatrixDB	CC	GO:0000313	organellar ribosome	-	89	86	-	-	2.58E-01	5.96E-03
MatrixDB	CC	GO:0098791	Golgi apparatus subcompartment	-	378	234	-	-	1.59E-02	1.62E-02
MatrixDB	CC	GO:0099643	signal release from synapse	-	147	104	-	-	4.40E-03	7.26E-03
MatrixDB	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	36	-	-	6.89E-03	2.50E-03
MatrixDB	CC	GO:0030018	Z disc	-	129	108	-	-	1.73E-02	7.51E-03
MatrixDB	CC	GO:0032580	Golgi cisterna membrane	-	93	45	-	-	1.98E-03	3.11E-03
MatrixDB	CC	GO:1905360	GTPase complex	-	41	26	-	-	5.15E-04	1.81E-03
MatrixDB	CC	GO:0097540	axonemal central pair	-	161	66	-	-	1.86E-03	4.58E-03
MatrixDB	CC	GO:0042641	actomyosin	-	77	72	-	-	4.10E-03	5.01E-03
MatrixDB	CC	GO:0097386	glial cell projection	-	38	25	-	-	4.82E-03	1.73E-03
MatrixDB	CC	GO:0032588	trans-Golgi network membrane	-	102	68	-	-	1.01E-02	4.75E-03
MatrixDB	CC	GO:0070382	exocytic vesicle	-	224	152	-	-	6.77E-03	1.05E-02
MatrixDB	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	41	-	-	1.46E-02	2.85E-03
MatrixDB	CC	GO:0031903	microbody membrane	-	65	49	-	-	6.16E-02	3.45E-03
MatrixDB	CC	GO:0046930	pore complex	-	26	17	-	-	1.23E-03	1.21E-03
MatrixDB	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	7.02E-02	7.77E-04
MatrixDB	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	13	-	-	2.55E-04	9.50E-04
MatrixDB	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	211	-	-	1.09E-02	1.46E-02
MatrixDB	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	19	-	-	3.31E-03	1.38E-03
MatrixDB	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	2.59E-04	7.77E-04
MatrixDB	CC	GO:0099571	postsynaptic cytoskeleton	-	18	16	-	-	8.07E-04	1.12E-03
MatrixDB	CC	GO:0044298	cell body membrane	-	32	15	-	-	3.44E-04	1.04E-03
MatrixDB	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	1.57E-01	7.77E-04
MatrixDB	CC	GO:0051882	mitochondrial depolarization	-	21	18	-	-	1.17E-03	1.30E-03
MatrixDB	CC	GO:0045495	pole plasm	-	25	14	-	-	2.56E-04	1.04E-03
MatrixDB	CC	GO:0072379	ER membrane insertion complex	-	14	12	-	-	6.07E-03	8.64E-04
MatrixDB	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	1.22E-01	1.38E-03
MatrixDB	CC	GO:0010369	chromocenter	-	14	14	-	-	2.68E-03	1.04E-03
MatrixDB	CC	GO:0016323	basolateral plasma membrane	-	239	140	-	-	4.55E-03	9.67E-03
MatrixDB	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	1.66E-02	8.64E-04
MatrixDB	CC	GO:0042645	mitochondrial nucleoid	-	45	43	-	-	3.51E-03	3.02E-03
MatrixDB	CC	GO:1902495	transmembrane transporter complex	-	408	198	-	-	8.03E-03	1.37E-02
MatrixDB	CC	GO:0098636	protein complex involved in cell adhesion	-	57	45	-	-	9.59E-03	3.11E-03
MatrixDB	CC	GO:0001917	photoreceptor inner segment	-	71	45	-	-	2.18E-02	3.11E-03
MatrixDB	CC	GO:0098845	postsynaptic endosome	-	14	11	-	-	2.55E-04	7.77E-04
MatrixDB	CC	GO:0019897	extrinsic component of plasma membrane	-	156	119	-	-	4.06E-03	8.29E-03
MatrixDB	CC	GO:0031594	neuromuscular junction	-	73	59	-	-	2.37E-03	4.15E-03
MatrixDB	CC	GO:0000793	condensed chromosome	-	274	241	-	-	2.56E-02	1.67E-02
MatrixDB	CC	GO:0045120	pronucleus	-	14	11	-	-	2.54E-04	7.77E-04
MatrixDB	CC	GO:0043083	synaptic cleft	-	21	13	-	-	4.02E-02	9.50E-04
MatrixDB	CC	GO:0000922	spindle pole	-	172	153	-	-	9.09E-03	1.06E-02
MatrixDB	CC	GO:0120111	neuron projection cytoplasm	-	94	76	-	-	5.13E-02	5.27E-03
MatrixDB	CC	GO:0070971	endoplasmic reticulum exit site	-	32	23	-	-	2.31E-03	1.64E-03
MatrixDB	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	2.58E-04	9.50E-04
MatrixDB	CC	GO:0004879	nuclear receptor activity	-	63	45	-	-	4.93E-03	3.11E-03
MatrixDB	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	138	-	-	5.26E-03	9.59E-03
MatrixDB	CC	GO:0000123	histone acetyltransferase complex	-	93	87	-	-	1.11E-01	6.05E-03
MatrixDB	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	90	-	-	2.09E-02	6.22E-03
MatrixDB	CC	GO:0048786	presynaptic active zone	-	80	58	-	-	1.60E-03	4.06E-03
MatrixDB	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	2.58E-04	8.64E-04
MatrixDB	CC	GO:0007034	vacuolar transport	-	168	135	-	-	6.82E-03	9.33E-03
MatrixDB	CC	GO:0043194	axon initial segment	-	21	14	-	-	2.58E-04	1.04E-03
MatrixDB	CC	GO:0005776	autophagosome	-	111	99	-	-	5.80E-03	6.91E-03
MatrixDB	CC	GO:0031430	M band	-	22	16	-	-	5.32E-03	1.12E-03
MatrixDB	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	72	-	-	4.47E-02	5.01E-03
MatrixDB	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	85	-	-	2.20E-02	5.87E-03
MatrixDB	CC	GO:0030677	ribonuclease P complex	-	14	12	-	-	2.40E-01	8.64E-04
MatrixDB	CC	GO:0000164	protein phosphatase type 1 complex	-	19	18	-	-	5.70E-02	1.30E-03
MatrixDB	CC	GO:0071203	WASH complex	-	12	11	-	-	4.41E-03	7.77E-04
MatrixDB	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	18	-	-	1.16E-02	1.30E-03
MatrixDB	CC	GO:0032994	protein-lipid complex	-	39	30	-	-	8.32E-02	2.07E-03
MatrixDB	CC	GO:0150034	distal axon	-	309	222	-	-	7.00E-03	1.54E-02
MatrixDB	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	144	-	-	1.70E-02	1.00E-02
MatrixDB	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	4.38E-02	8.64E-04
MatrixDB	CC	GO:0001527	microfibril	-	13	11	-	-	6.49E-02	7.77E-04
MatrixDB	CC	GO:0072562	blood microparticle	-	144	116	-	-	6.93E-03	8.03E-03
MatrixDB	CC	GO:0051233	spindle midzone	-	36	32	-	-	3.50E-03	2.25E-03
MatrixDB	CC	GO:0005811	lipid droplet	-	102	63	-	-	5.46E-03	4.40E-03
MatrixDB	CC	GO:0045022	early endosome to late endosome transport	-	44	41	-	-	4.86E-03	2.85E-03
MatrixDB	CC	GO:0043113	receptor clustering	-	51	40	-	-	2.74E-03	2.76E-03
MatrixDB	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	16	-	-	8.11E-02	1.12E-03
MatrixDB	CC	GO:0044853	plasma membrane raft	-	114	91	-	-	3.79E-03	6.31E-03
MatrixDB	CC	GO:0005881	cytoplasmic microtubule	-	256	129	-	-	4.42E-03	8.98E-03
MatrixDB	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	12	-	-	2.56E-04	8.64E-04
MatrixDB	CC	GO:0008180	COP9 signalosome	-	17	14	-	-	2.73E-03	1.04E-03
MatrixDB	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	39	-	-	1.87E-03	2.76E-03
MatrixDB	CC	GO:0005905	clathrin-coated pit	-	73	64	-	-	6.80E-03	4.49E-03
MatrixDB	CC	GO:0043034	costamere	-	18	16	-	-	2.36E-02	1.12E-03
MatrixDB	CC	GO:0031904	endosome lumen	-	38	33	-	-	7.72E-03	2.33E-03
MatrixDB	CC	GO:0060170	ciliary membrane	-	76	35	-	-	2.43E-03	2.42E-03
MatrixDB	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	2.59E-04	9.50E-04
MatrixDB	CC	GO:0000783	nuclear telomere cap complex	-	12	11	-	-	6.80E-03	7.77E-04
MatrixDB	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	6.22E-02	1.73E-03
MatrixDB	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	1.53E-01	1.04E-03
MatrixDB	CC	GO:0032154	cleavage furrow	-	54	46	-	-	5.67E-03	3.20E-03
MatrixDB	CC	GO:0005640	nuclear outer membrane	-	30	20	-	-	4.26E-04	1.38E-03
MatrixDB	CC	GO:0007006	mitochondrial membrane organization	-	117	92	-	-	6.30E-03	6.39E-03
MatrixDB	CC	GO:0001772	immunological synapse	-	44	38	-	-	4.31E-03	2.68E-03
MatrixDB	CC	GO:0030904	retromer complex	-	12	12	-	-	4.24E-02	8.64E-04
MatrixDB	CC	GO:0030863	cortical cytoskeleton	-	104	87	-	-	4.77E-03	6.05E-03
MatrixDB	CC	GO:1905348	endonuclease complex	-	38	34	-	-	4.01E-02	2.42E-03
MatrixDB	CC	GO:0030315	T-tubule	-	52	37	-	-	1.30E-02	2.59E-03
MatrixDB	CC	GO:0060076	excitatory synapse	-	64	36	-	-	1.56E-03	2.50E-03
MatrixDB	CC	GO:0036019	endolysosome	-	29	25	-	-	6.15E-03	1.73E-03
MatrixDB	CC	GO:0001891	phagocytic cup	-	28	21	-	-	4.78E-03	1.47E-03
MatrixDB	CC	GO:0099086	synaptonemal structure	-	40	22	-	-	1.42E-03	1.55E-03
MatrixDB	CC	GO:0030427	site of polarized growth	-	172	138	-	-	4.24E-03	9.59E-03
MatrixDB	CC	GO:0044309	neuron spine	-	213	153	-	-	4.97E-03	1.06E-02
MatrixDB	CC	GO:0030658	transport vesicle membrane	-	231	153	-	-	8.49E-03	1.06E-02
MatrixDB	CC	GO:0098918	structural constituent of synapse	-	27	26	-	-	1.13E-03	1.81E-03
MatrixDB	CC	GO:0000940	outer kinetochore	-	17	17	-	-	9.15E-02	1.21E-03
MatrixDB	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	1.32E-01	1.21E-03
MatrixDB	CC	GO:0044232	organelle membrane contact site	-	50	40	-	-	3.88E-03	2.76E-03
MatrixDB	CC	GO:0098803	respiratory chain complex	-	39	31	-	-	6.58E-03	2.16E-03
MatrixDB	CC	GO:0030667	secretory granule membrane	-	319	235	-	-	8.31E-03	1.62E-02
MatrixDB	CC	GO:0097545	axonemal outer doublet	-	164	68	-	-	1.96E-03	4.75E-03
MatrixDB	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	13	-	-	2.57E-04	9.50E-04
MatrixDB	CC	GO:0070069	cytochrome complex	-	42	33	-	-	5.92E-03	2.33E-03
MatrixDB	CC	GO:0031143	pseudopodium	-	18	17	-	-	1.06E-02	1.21E-03
MatrixDB	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	23	-	-	2.87E-02	1.64E-03
MatrixDB	CC	GO:0055037	recycling endosome	-	200	150	-	-	1.49E-02	1.04E-02
MatrixDB	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	77	-	-	6.63E-03	5.35E-03
MatrixDB	CC	GO:0035253	ciliary rootlet	-	13	11	-	-	7.79E-03	7.77E-04
MatrixDB	CC	GO:0071682	endocytic vesicle lumen	-	23	19	-	-	3.07E-03	1.38E-03
MatrixDB	CC	GO:0030684	preribosome	-	76	72	-	-	3.71E-02	5.01E-03
MatrixDB	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	1.66E-01	1.30E-03
MatrixDB	CC	GO:1990391	DNA repair complex	-	22	20	-	-	1.80E-02	1.38E-03
MatrixDB	CC	GO:0005775	vacuolar lumen	-	176	147	-	-	9.87E-03	1.02E-02
MatrixDB	CC	GO:0032433	filopodium tip	-	19	16	-	-	1.17E-02	1.12E-03
MatrixDB	CC	GO:0032982	myosin filament	-	24	24	-	-	2.08E-02	1.73E-03
MatrixDB	CC	GO:0016327	apicolateral plasma membrane	-	23	17	-	-	5.51E-03	1.21E-03
MatrixDB	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	19	-	-	5.79E-03	1.38E-03
MatrixDB	CC	GO:0044306	neuron projection terminus	-	164	110	-	-	9.32E-03	7.60E-03
MatrixDB	CC	GO:0034455	t-UTP complex	-	53	50	-	-	1.97E-02	3.45E-03
MatrixDB	CC	GO:0005770	late endosome	-	299	215	-	-	1.28E-02	1.49E-02
MatrixDB	CC	GO:0030992	intraciliary transport particle B	-	17	16	-	-	3.15E-01	1.12E-03
MatrixDB	CC	GO:0031970	organelle envelope lumen	-	94	78	-	-	7.54E-03	5.44E-03
MatrixDB	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	2.58E-04	9.50E-04
MatrixDB	CC	GO:0120293	dynein axonemal particle	-	20	13	-	-	9.61E-04	9.50E-04
MatrixDB	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	23	-	-	2.01E-03	1.64E-03
MatrixDB	CC	GO:0043292	contractile muscle fiber	-	245	192	-	-	2.23E-02	1.33E-02
MatrixDB	CC	GO:0018995	host cellular component	-	12	11	-	-	7.58E-03	7.77E-04
MatrixDB	CC	GO:0034709	methylosome	-	13	12	-	-	1.79E-02	8.64E-04
MatrixDB	CC	GO:0032426	stereocilium tip	-	21	12	-	-	2.58E-04	8.64E-04
MatrixDB	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	7.68E-02	8.64E-04
MatrixDB	CC	GO:0005849	mRNA cleavage factor complex	-	22	18	-	-	2.64E-01	1.30E-03
MatrixDB	CC	GO:0000803	sex chromosome	-	32	27	-	-	2.79E-03	1.90E-03
MatrixDB	CC	GO:0098982	GABA-ergic synapse	-	84	47	-	-	1.64E-03	3.28E-03
MatrixDB	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	14	-	-	3.47E-02	1.04E-03
MatrixDB	CC	GO:0035097	histone methyltransferase complex	-	63	60	-	-	5.26E-02	4.15E-03
MatrixDB	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	3.96E-01	1.04E-03
MatrixDB	CC	GO:0000242	pericentriolar material	-	22	20	-	-	8.73E-03	1.38E-03
MatrixDB	CC	GO:1903293	phosphatase complex	-	54	49	-	-	4.20E-02	3.45E-03
MatrixDB	CC	GO:0097470	ribbon synapse	-	13	11	-	-	1.85E-03	7.77E-04
MatrixDB	CC	GO:0031941	filamentous actin	-	27	23	-	-	1.86E-03	1.64E-03
MatrixDB	CC	GO:0000786	nucleosome	-	149	91	-	-	9.83E-03	6.31E-03
MatrixDB	CC	GO:0001533	cornified envelope	-	59	49	-	-	1.07E-03	3.45E-03
MatrixDB	CC	GO:1904724	tertiary granule lumen	-	55	50	-	-	2.57E-03	3.45E-03
MatrixDB	CC	GO:0030027	lamellipodium	-	202	175	-	-	8.96E-03	1.21E-02
MatrixDB	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	14	-	-	5.85E-03	1.04E-03
MatrixDB	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	19	-	-	5.04E-03	1.38E-03
MatrixDB	CC	GO:0000800	lateral element	-	14	11	-	-	5.91E-03	7.77E-04
MatrixDB	CC	GO:0060077	inhibitory synapse	-	20	11	-	-	2.59E-04	7.77E-04
MatrixDB	CC	GO:0031209	SCAR complex	-	12	11	-	-	6.08E-02	7.77E-04
MatrixDB	CC	GO:0001056	RNA polymerase III activity	-	16	15	-	-	3.44E-04	1.04E-03
MatrixDB	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	18	-	-	2.89E-03	1.30E-03
MatrixDB	CC	GO:0002102	podosome	-	31	28	-	-	8.33E-03	1.99E-03
MatrixDB	CC	GO:0090543	Flemming body	-	33	29	-	-	1.54E-02	2.07E-03
MatrixDB	CC	GO:0016328	lateral plasma membrane	-	66	54	-	-	7.41E-03	3.80E-03
MatrixDB	CC	GO:0001650	fibrillar center	-	151	128	-	-	4.15E-03	8.90E-03
MatrixDB	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	1.61E-02	1.04E-03
MatrixDB	CC	GO:1990204	oxidoreductase complex	-	90	66	-	-	3.74E-03	4.58E-03
MatrixDB	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	3.78E-02	1.12E-03
MatrixDB	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	7.37E-02	7.77E-04
MatrixDB	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	119	-	-	2.82E-03	8.29E-03
MatrixDB	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	1.76E-02	1.30E-03
MatrixDB	CC	GO:0001726	ruffle	-	181	156	-	-	6.50E-03	1.08E-02
MatrixDB	CC	GO:1990909	Wnt signalosome	-	13	12	-	-	3.76E-03	8.64E-04
MatrixDB	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	14	-	-	5.69E-03	1.04E-03
MatrixDB	CC	GO:0043198	dendritic shaft	-	38	24	-	-	2.26E-03	1.73E-03
MatrixDB	CC	GO:0043073	germ cell nucleus	-	67	49	-	-	2.84E-03	3.45E-03
MatrixDB	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	17	-	-	7.56E-03	1.21E-03
MatrixDB	CC	GO:0016592	mediator complex	-	38	37	-	-	4.23E-01	2.59E-03
MatrixDB	CC	GO:0034045	phagophore assembly site membrane	-	19	18	-	-	5.58E-02	1.30E-03
MatrixDB	CC	GO:0022626	cytosolic ribosome	-	118	114	-	-	1.96E-02	7.95E-03
MatrixDB	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	43	-	-	9.54E-02	3.02E-03
MatrixDB	CC	GO:0034451	centriolar satellite	-	120	101	-	-	2.54E-02	7.00E-03
MatrixDB	CC	GO:0045171	intercellular bridge	-	91	71	-	-	2.88E-03	4.92E-03
MatrixDB	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	62	-	-	8.71E-03	4.32E-03
MatrixDB	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	3.30E-02	7.77E-04
MatrixDB	CC	GO:0044292	dendrite terminus	-	13	12	-	-	1.44E-03	8.64E-04
MatrixDB	CC	GO:0032039	integrator complex	-	19	18	-	-	2.60E-01	1.30E-03
MatrixDB	CC	GO:0033268	node of Ranvier	-	16	12	-	-	2.57E-04	8.64E-04
MatrixDB	CC	GO:0036038	MKS complex	-	13	11	-	-	6.54E-03	7.77E-04
MatrixDB	CC	GO:0030527	structural constituent of chromatin	-	97	46	-	-	6.95E-03	3.20E-03
MatrixDB	CC	GO:0036379	myofilament	-	26	16	-	-	3.43E-04	1.12E-03
MatrixDB	CC	GO:0030286	dynein complex	-	210	99	-	-	2.89E-02	6.91E-03
MatrixDB	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	2.08E-02	8.64E-04
MatrixDB	CC	GO:0016482	cytosolic transport	-	135	115	-	-	4.76E-03	7.95E-03
MatrixDB	CC	GO:0090665	glycoprotein complex	-	23	16	-	-	1.63E-01	1.12E-03
MatrixDB	CC	GO:0005796	Golgi lumen	-	106	78	-	-	3.79E-03	5.44E-03
MatrixDB	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	27	-	-	3.10E-02	1.90E-03
MatrixDB	CC	GO:0034358	plasma lipoprotein particle	-	36	28	-	-	4.76E-02	1.99E-03
MatrixDB	CC	GO:0008023	transcription elongation factor complex	-	47	45	-	-	4.31E-02	3.11E-03
MatrixDB	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	18	-	-	5.21E-03	1.30E-03
MatrixDB	CC	GO:0030662	coated vesicle membrane	-	202	156	-	-	1.59E-02	1.08E-02
MatrixDB	CC	GO:0007039	protein catabolic process in the vacuole	-	61	48	-	-	8.42E-03	3.37E-03
MatrixDB	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	59	-	-	3.87E-02	4.15E-03
MatrixDB	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	217	-	-	4.27E-02	1.50E-02
MatrixDB	CC	GO:0090734	site of DNA damage	-	118	110	-	-	2.04E-02	7.60E-03
MatrixDB	MF	GO:0051861	glycolipid binding	-	30	24	-	-	4.27E-04	1.73E-03
MatrixDB	MF	GO:0051087	protein-folding chaperone binding	-	135	117	-	-	4.37E-03	8.12E-03
MatrixDB	MF	GO:0051959	dynein light intermediate chain binding	-	27	20	-	-	4.28E-04	1.38E-03
MatrixDB	CC	GO:0015464	acetylcholine receptor activity	-	21	13	-	-	2.59E-04	9.50E-04
MatrixDB	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	25	-	-	5.06E-04	1.73E-03
MatrixDB	MF	GO:0035613	RNA stem-loop binding	-	21	14	-	-	5.12E-03	1.04E-03
MatrixDB	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	158	-	-	5.30E-03	1.10E-02
MatrixDB	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	12	-	-	2.57E-04	8.64E-04
MatrixDB	MF	GO:0033691	sialic acid binding	-	22	16	-	-	3.45E-04	1.12E-03
MatrixDB	MF	GO:0016757	glycosyltransferase activity	-	286	131	-	-	3.37E-03	9.07E-03
MatrixDB	MF	GO:0048306	calcium-dependent protein binding	-	61	49	-	-	3.94E-03	3.45E-03
MatrixDB	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	14	-	-	2.57E-04	1.04E-03
MatrixDB	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	4.06E-03	9.50E-04
MatrixDB	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	98	-	-	2.49E-03	6.82E-03
MatrixDB	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	42	-	-	7.65E-04	2.94E-03
MatrixDB	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	92	-	-	4.36E-03	6.39E-03
MatrixDB	MF	GO:0140457	protein demethylase activity	-	31	24	-	-	4.26E-04	1.73E-03
MatrixDB	MF	GO:0005158	insulin receptor binding	-	22	20	-	-	5.32E-03	1.38E-03
MatrixDB	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	8.89E-03	1.04E-03
MatrixDB	MF	GO:0061980	regulatory RNA binding	-	52	38	-	-	1.46E-02	2.68E-03
MatrixDB	MF	GO:0015035	protein-disulfide reductase activity	-	32	30	-	-	8.55E-03	2.07E-03
MatrixDB	MF	GO:0001671	ATPase activator activity	-	29	24	-	-	2.22E-03	1.73E-03
MatrixDB	MF	GO:0070840	dynein complex binding	-	25	19	-	-	1.81E-03	1.38E-03
MatrixDB	MF	GO:0035035	histone acetyltransferase binding	-	24	21	-	-	4.24E-04	1.47E-03
MatrixDB	MF	GO:0061684	chaperone-mediated autophagy	-	16	15	-	-	2.68E-03	1.04E-03
MatrixDB	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	27	-	-	5.08E-04	1.90E-03
MatrixDB	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	3.33E-04	1.30E-03
MatrixDB	MF	GO:0005178	integrin binding	-	153	128	-	-	2.40E-02	8.90E-03
MatrixDB	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	3.40E-04	1.21E-03
MatrixDB	MF	GO:0008327	methyl-CpG binding	-	31	21	-	-	1.98E-03	1.47E-03
MatrixDB	MF	GO:0031418	L-ascorbic acid binding	-	20	17	-	-	1.52E-03	1.21E-03
MatrixDB	MF	GO:0048019	receptor antagonist activity	-	31	15	-	-	1.55E-03	1.04E-03
MatrixDB	MF	GO:0005521	lamin binding	-	15	14	-	-	4.10E-03	1.04E-03
MatrixDB	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	8.90E-04	1.21E-03
MatrixDB	MF	GO:0140318	protein transporter activity	-	40	33	-	-	5.07E-02	2.33E-03
MatrixDB	MF	GO:0070628	proteasome binding	-	17	15	-	-	7.93E-03	1.04E-03
MatrixDB	MF	GO:0046812	host cell surface binding	-	11	11	-	-	2.48E-04	7.77E-04
MatrixDB	MF	GO:0000217	DNA secondary structure binding	-	37	35	-	-	4.40E-03	2.42E-03
MatrixDB	MF	GO:0002039	p53 binding	-	66	60	-	-	2.37E-03	4.15E-03
MatrixDB	MF	GO:0005496	steroid binding	-	110	69	-	-	2.72E-03	4.84E-03
MatrixDB	MF	GO:0008443	phosphofructokinase activity	-	27	24	-	-	1.51E-03	1.73E-03
MatrixDB	MF	GO:0003684	damaged DNA binding	-	89	79	-	-	1.06E-02	5.53E-03
MatrixDB	MF	GO:0000339	RNA cap binding	-	20	18	-	-	2.05E-03	1.30E-03
MatrixDB	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	105	-	-	2.26E-02	7.26E-03
MatrixDB	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	2.57E-04	7.77E-04
MatrixDB	MF	GO:0070063	RNA polymerase binding	-	61	57	-	-	4.76E-03	3.97E-03
MatrixDB	MF	GO:0050811	GABA receptor binding	-	18	12	-	-	9.88E-04	8.64E-04
MatrixDB	MF	GO:0030971	receptor tyrosine kinase binding	-	76	63	-	-	4.26E-03	4.40E-03
MatrixDB	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	76	-	-	7.63E-03	5.27E-03
MatrixDB	MF	GO:0140030	modification-dependent protein binding	-	179	155	-	-	5.76E-03	1.07E-02
MatrixDB	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	14	-	-	2.58E-04	1.04E-03
MatrixDB	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	2.55E-04	9.50E-04
MatrixDB	MF	GO:0042813	Wnt receptor activity	-	16	12	-	-	2.58E-04	8.64E-04
MatrixDB	MF	GO:0141047	molecular tag activity	-	13	12	-	-	1.29E-03	8.64E-04
MatrixDB	MF	GO:1990226	histone methyltransferase binding	-	15	11	-	-	3.94E-03	7.77E-04
MatrixDB	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.86E-02	1.04E-03
MatrixDB	MF	GO:0030983	mismatched DNA binding	-	14	13	-	-	7.37E-03	9.50E-04
MatrixDB	MF	GO:0030276	clathrin binding	-	70	50	-	-	4.61E-03	3.45E-03
MatrixDB	MF	GO:0046875	ephrin receptor binding	-	29	27	-	-	4.50E-02	1.90E-03
MatrixDB	MF	GO:0046790	virion binding	-	19	18	-	-	3.28E-04	1.30E-03
MatrixDB	MF	GO:0030552	cAMP binding	-	48	30	-	-	1.05E-02	2.07E-03
MatrixDB	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	30	-	-	8.65E-04	2.07E-03
MatrixDB	MF	GO:0035173	histone kinase activity	-	17	17	-	-	1.30E-03	1.21E-03
MatrixDB	MF	GO:0097602	cullin family protein binding	-	26	22	-	-	1.86E-03	1.55E-03
MatrixDB	MF	GO:0004984	olfactory receptor activity	-	429	15	-	-	3.46E-04	1.04E-03
MatrixDB	MF	GO:0016209	antioxidant activity	-	92	66	-	-	3.91E-03	4.58E-03
MatrixDB	MF	GO:0070325	lipoprotein particle receptor binding	-	32	29	-	-	5.35E-03	2.07E-03
MatrixDB	MF	GO:0044325	transmembrane transporter binding	-	159	106	-	-	5.26E-03	7.34E-03
MatrixDB	MF	GO:0048156	tau protein binding	-	43	42	-	-	2.31E-03	2.94E-03
MatrixDB	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	35	-	-	2.94E-03	2.42E-03
MatrixDB	MF	GO:0045295	gamma-catenin binding	-	13	12	-	-	2.41E-03	8.64E-04
MatrixDB	MF	GO:0140272	exogenous protein binding	-	79	65	-	-	4.83E-03	4.49E-03
MatrixDB	MF	GO:0030145	manganese ion binding	-	65	44	-	-	1.09E-03	3.11E-03
MatrixDB	MF	GO:0071814	protein-lipid complex binding	-	52	43	-	-	5.14E-03	3.02E-03
MatrixDB	MF	GO:0008066	glutamate receptor activity	-	70	29	-	-	3.86E-03	2.07E-03
MatrixDB	MF	GO:0017069	snRNA binding	-	54	44	-	-	1.47E-02	3.11E-03
MatrixDB	MF	GO:0030215	semaphorin receptor binding	-	23	14	-	-	2.13E-02	1.04E-03
MatrixDB	MF	GO:0031996	thioesterase binding	-	11	11	-	-	2.55E-04	7.77E-04
MatrixDB	MF	GO:0031369	translation initiation factor binding	-	32	26	-	-	1.51E-02	1.81E-03
MatrixDB	MF	GO:0019843	rRNA binding	-	69	65	-	-	4.91E-03	4.49E-03
MatrixDB	MF	GO:0004713	protein tyrosine kinase activity	-	213	193	-	-	1.74E-02	1.34E-02
MatrixDB	MF	GO:0016779	nucleotidyltransferase activity	-	264	204	-	-	5.57E-03	1.42E-02
MatrixDB	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	47	-	-	2.97E-03	3.28E-03
MatrixDB	MF	GO:0008093	cytoskeletal anchor activity	-	24	22	-	-	8.74E-04	1.55E-03
MatrixDB	MF	GO:0070300	phosphatidic acid binding	-	20	16	-	-	3.43E-04	1.12E-03
MatrixDB	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	20	-	-	4.29E-04	1.38E-03
MatrixDB	MF	GO:0016208	AMP binding	-	22	18	-	-	3.97E-02	1.30E-03
MatrixDB	MF	GO:0000287	magnesium ion binding	-	225	174	-	-	5.09E-03	1.21E-02
MatrixDB	MF	GO:0031490	chromatin DNA binding	-	120	100	-	-	4.70E-03	6.91E-03
MatrixDB	MF	GO:0017022	myosin binding	-	73	61	-	-	7.23E-03	4.23E-03
MatrixDB	MF	GO:0004896	cytokine receptor activity	-	93	66	-	-	1.21E-02	4.58E-03
MatrixDB	MF	GO:0017166	vinculin binding	-	12	11	-	-	6.56E-02	7.77E-04
MatrixDB	MF	GO:0008301	"DNA binding, bending"	-	18	15	-	-	4.34E-03	1.04E-03
MatrixDB	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	2.39E-02	8.64E-04
MatrixDB	MF	GO:0005539	glycosaminoglycan binding	-	236	182	-	-	1.20E-02	1.26E-02
MatrixDB	MF	GO:0140666	annealing activity	-	11	11	-	-	1.80E-02	7.77E-04
MatrixDB	MF	GO:0071933	Arp2/3 complex binding	-	14	11	-	-	2.58E-04	7.77E-04
MatrixDB	MF	GO:0019207	kinase regulator activity	-	267	223	-	-	9.08E-03	1.55E-02
MatrixDB	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	18	-	-	3.42E-04	1.30E-03
MatrixDB	MF	GO:0031420	alkali metal ion binding	-	17	14	-	-	2.54E-04	1.04E-03
MatrixDB	MF	GO:0044183	protein folding chaperone	-	67	59	-	-	2.76E-03	4.15E-03
MatrixDB	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	96	-	-	6.63E-03	6.65E-03
MatrixDB	MF	GO:0003725	double-stranded RNA binding	-	72	64	-	-	2.02E-02	4.49E-03
MatrixDB	MF	GO:0051018	protein kinase A binding	-	52	38	-	-	3.78E-02	2.68E-03
MatrixDB	MF	GO:0071889	14-3-3 protein binding	-	34	31	-	-	1.07E-03	2.16E-03
MatrixDB	MF	GO:0004618	phosphoglycerate kinase activity	-	89	74	-	-	6.06E-03	5.18E-03
MatrixDB	MF	GO:0042805	actinin binding	-	36	31	-	-	1.04E-03	2.16E-03
MatrixDB	MF	GO:0043531	ADP binding	-	38	30	-	-	2.17E-03	2.07E-03
MatrixDB	MF	GO:0043394	proteoglycan binding	-	36	31	-	-	1.64E-03	2.16E-03
MatrixDB	MF	GO:0046332	SMAD binding	-	77	67	-	-	3.21E-03	4.66E-03
MatrixDB	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	4.94E-03	9.50E-04
MatrixDB	MF	GO:0001968	fibronectin binding	-	30	29	-	-	5.01E-03	2.07E-03
MatrixDB	MF	GO:0048038	quinone binding	-	16	13	-	-	1.44E-02	9.50E-04
MatrixDB	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	105	-	-	1.10E-02	7.26E-03
MatrixDB	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	62	-	-	2.42E-03	4.32E-03
MatrixDB	MF	GO:0003756	protein disulfide isomerase activity	-	18	17	-	-	3.97E-03	1.21E-03
MatrixDB	MF	GO:0051117	ATPase binding	-	85	63	-	-	2.23E-03	4.40E-03
MatrixDB	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	33	-	-	2.86E-03	2.33E-03
MatrixDB	MF	GO:0051787	misfolded protein binding	-	20	16	-	-	3.15E-03	1.12E-03
MatrixDB	MF	GO:0070402	NADPH binding	-	16	11	-	-	2.58E-04	7.77E-04
MatrixDB	MF	GO:0001098	basal transcription machinery binding	-	61	58	-	-	5.14E-03	4.06E-03
MatrixDB	MF	GO:0036002	pre-mRNA binding	-	57	29	-	-	1.78E-03	2.07E-03
MatrixDB	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	29	-	-	8.49E-04	2.07E-03
MatrixDB	MF	GO:0051540	metal cluster binding	-	71	52	-	-	9.29E-04	3.63E-03
MatrixDB	MF	GO:0051219	phosphoprotein binding	-	92	87	-	-	3.55E-03	6.05E-03
MatrixDB	MF	GO:0019894	kinesin binding	-	45	40	-	-	2.42E-03	2.76E-03
MatrixDB	MF	GO:0042287	MHC protein binding	-	68	32	-	-	2.11E-03	2.25E-03
MatrixDB	MF	GO:0019003	GDP binding	-	89	67	-	-	1.09E-02	4.66E-03
MatrixDB	MF	GO:0017171	serine hydrolase activity	-	207	122	-	-	3.81E-03	8.46E-03
MatrixDB	MF	GO:0097110	scaffold protein binding	-	66	58	-	-	2.77E-03	4.06E-03
MatrixDB	MF	GO:0003774	cytoskeletal motor activity	-	117	98	-	-	6.69E-03	6.82E-03
MatrixDB	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.94E-03	2.07E-03
MatrixDB	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	16	-	-	3.60E-03	1.12E-03
MatrixDB	MF	GO:0061134	peptidase regulator activity	-	224	156	-	-	3.62E-03	1.08E-02
MatrixDB	MF	GO:0008013	beta-catenin binding	-	86	69	-	-	4.56E-03	4.84E-03
MatrixDB	MF	GO:0051015	actin filament binding	-	208	175	-	-	2.22E-02	1.21E-02
MatrixDB	MF	GO:0019208	phosphatase regulator activity	-	107	79	-	-	8.47E-03	5.53E-03
MatrixDB	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	26	-	-	3.17E-03	1.81E-03
MatrixDB	MF	GO:0043236	laminin binding	-	29	25	-	-	6.89E-03	1.73E-03
MatrixDB	MF	GO:0030507	spectrin binding	-	26	22	-	-	4.27E-04	1.55E-03
MatrixDB	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	33	-	-	5.92E-04	2.33E-03
MatrixDB	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	99	-	-	1.34E-02	6.91E-03
MatrixDB	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	1.48E-02	1.73E-03
MatrixDB	MF	GO:0042393	histone binding	-	240	202	-	-	1.16E-02	1.40E-02
MatrixDB	MF	GO:0019838	growth factor binding	-	182	157	-	-	8.08E-03	1.09E-02
MatrixDB	MF	GO:0000149	SNARE binding	-	107	79	-	-	9.65E-03	5.53E-03
MatrixDB	MF	GO:0003727	single-stranded RNA binding	-	90	78	-	-	6.46E-03	5.44E-03
MatrixDB	MF	GO:0051378	serotonin binding	-	24	13	-	-	2.59E-04	9.50E-04
MatrixDB	MF	GO:0005516	calmodulin binding	-	206	162	-	-	8.57E-03	1.12E-02
MatrixDB	MF	GO:0019825	oxygen binding	-	40	23	-	-	2.33E-03	1.64E-03
MatrixDB	MF	GO:0045505	dynein intermediate chain binding	-	37	27	-	-	5.46E-02	1.90E-03
MatrixDB	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	55	-	-	2.61E-03	3.80E-03
MatrixDB	MF	GO:0032182	ubiquitin-like protein binding	-	117	104	-	-	5.10E-03	7.26E-03
MatrixDB	MF	GO:0023023	MHC protein complex binding	-	36	19	-	-	1.05E-03	1.38E-03
MatrixDB	MF	GO:0030742	GTP-dependent protein binding	-	22	20	-	-	4.23E-04	1.38E-03
MatrixDB	MF	GO:0043274	phospholipase binding	-	23	20	-	-	4.26E-04	1.38E-03
MatrixDB	MF	GO:0031072	heat shock protein binding	-	128	105	-	-	5.73E-03	7.26E-03
MatrixDB	MF	GO:0030515	snoRNA binding	-	33	30	-	-	5.92E-03	2.07E-03
MatrixDB	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	35	-	-	5.79E-03	2.42E-03
MatrixDB	MF	GO:0001965	G-protein alpha-subunit binding	-	26	21	-	-	4.29E-04	1.47E-03
MatrixDB	MF	GO:0001530	lipopolysaccharide binding	-	38	25	-	-	3.56E-03	1.73E-03
MatrixDB	MF	GO:0046982	protein heterodimerization activity	-	343	232	-	-	7.24E-03	1.61E-02
MatrixDB	MF	GO:0140223	general transcription initiation factor activity	-	55	46	-	-	8.56E-04	3.20E-03
MatrixDB	MF	GO:0070403	NAD+ binding	-	16	12	-	-	5.06E-03	8.64E-04
MatrixDB	MF	GO:0000049	tRNA binding	-	75	59	-	-	1.73E-02	4.15E-03
MatrixDB	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	43	-	-	8.96E-03	3.02E-03
MatrixDB	MF	GO:0015026	coreceptor activity	-	48	35	-	-	7.87E-03	2.42E-03
MatrixDB	MF	GO:0005527	macrolide binding	-	12	11	-	-	2.53E-04	7.77E-04
MatrixDB	MF	GO:0001653	peptide receptor activity	-	128	50	-	-	1.13E-02	3.45E-03
MatrixDB	MF	GO:0031005	filamin binding	-	15	14	-	-	7.38E-03	1.04E-03
MatrixDB	MF	GO:0030506	ankyrin binding	-	19	14	-	-	2.55E-04	1.04E-03
MatrixDB	MF	GO:0006469	negative regulation of protein kinase activity	-	222	184	-	-	4.08E-03	1.28E-02
MatrixDB	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	9.36E-04	1.38E-03
MatrixDB	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	28	-	-	2.28E-03	1.99E-03
MatrixDB	MF	GO:0051427	hormone receptor binding	-	31	22	-	-	4.25E-04	1.55E-03
MatrixDB	MF	GO:0070851	growth factor receptor binding	-	141	119	-	-	7.26E-03	8.29E-03
MatrixDB	MF	GO:0031210	phosphatidylcholine binding	-	32	25	-	-	5.08E-04	1.73E-03
MatrixDB	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	36	-	-	1.92E-03	2.50E-03
MatrixDB	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	216	-	-	7.44E-03	1.49E-02
MatrixDB	MF	GO:0034185	apolipoprotein binding	-	20	19	-	-	1.11E-03	1.38E-03
MatrixDB	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	11	-	-	3.31E-03	7.77E-04
MatrixDB	MF	GO:0051346	negative regulation of hydrolase activity	-	332	237	-	-	5.21E-03	1.64E-02
MatrixDB	MF	GO:0005506	iron ion binding	-	154	80	-	-	2.12E-03	5.53E-03
MatrixDB	MF	GO:0003925	G protein activity	-	45	36	-	-	9.09E-04	2.50E-03
MatrixDB	MF	GO:0038187	pattern recognition receptor activity	-	33	25	-	-	1.21E-02	1.73E-03
MatrixDB	MF	GO:0008276	protein methyltransferase activity	-	96	61	-	-	6.20E-03	4.23E-03
MatrixDB	MF	GO:0004396	hexokinase activity	-	16	13	-	-	2.57E-04	9.50E-04
MatrixDB	MF	GO:0070888	E-box binding	-	59	31	-	-	1.17E-03	2.16E-03
MatrixDB	MF	GO:0039706	co-receptor binding	-	14	12	-	-	2.50E-04	8.64E-04
MatrixDB	MF	GO:0015399	primary active transmembrane transporter activity	-	190	138	-	-	1.64E-02	9.59E-03
MatrixDB	MF	GO:0035254	glutamate receptor binding	-	47	38	-	-	1.03E-03	2.68E-03
MatrixDB	MF	GO:0050321	tau-protein kinase activity	-	36	30	-	-	1.64E-03	2.07E-03
MatrixDB	MF	GO:0043021	ribonucleoprotein complex binding	-	158	144	-	-	5.11E-03	1.00E-02
MatrixDB	MF	GO:0030170	pyridoxal phosphate binding	-	56	35	-	-	1.43E-03	2.42E-03
MatrixDB	MF	GO:0005112	Notch binding	-	26	17	-	-	2.35E-03	1.21E-03
MatrixDB	MF	GO:0048185	activin binding	-	16	15	-	-	3.78E-02	1.04E-03
MatrixDB	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	20	-	-	4.29E-04	1.38E-03
MatrixDB	MF	GO:0001664	G protein-coupled receptor binding	-	299	204	-	-	5.92E-02	1.42E-02
MatrixDB	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	6.76E-03	7.77E-04
MatrixDB	MF	GO:0140299	small molecule sensor activity	-	39	29	-	-	1.95E-03	2.07E-03
MatrixDB	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	16	-	-	3.43E-04	1.12E-03
MatrixDB	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	4.10E-03	1.04E-03
MatrixDB	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	40	-	-	3.02E-02	2.76E-03
MatrixDB	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	19	-	-	3.35E-04	1.38E-03
MatrixDB	MF	GO:0003916	DNA topoisomerase activity	-	12	11	-	-	1.28E-02	7.77E-04
MatrixDB	MF	GO:0030594	neurotransmitter receptor activity	-	160	69	-	-	7.81E-03	4.84E-03
MatrixDB	MF	GO:0034452	dynactin binding	-	12	12	-	-	7.05E-04	8.64E-04
MatrixDB	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	19	-	-	3.43E-04	1.38E-03
MatrixDB	MF	GO:0120227	acyl-CoA binding	-	22	15	-	-	3.40E-04	1.04E-03
MatrixDB	MF	GO:0005507	copper ion binding	-	63	47	-	-	3.44E-03	3.28E-03
MatrixDB	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	1.43E-02	1.55E-03
MatrixDB	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	2.60E-03	1.55E-03
Mentha	CC	GO:0005739	mitochondrion	5.93E-34	1671	1609	1474	1.09	-	-
Mentha	CC	GO:0005730	nucleolus	4.53E-29	988	965	871	1.11	-	-
Mentha	CC	GO:0005615	extracellular space	1.53E-20	3190	2960	2813	1.05	-	-
Mentha	CC	GO:0005815	microtubule organizing center	1.78E-18	843	814	743	1.09	-	-
Mentha	CC	GO:0005768	endosome	1.08E-17	1037	992	915	1.08	-	-
Mentha	CC	GO:0005783	endoplasmic reticulum	9.18E-16	2020	1885	1782	1.06	-	-
Mentha	CC	GO:0005764	lysosome	3.65E-15	747	719	659	1.09	-	-
Mentha	CC	GO:0005840	ribosome	3.50E-11	222	221	196	1.13	-	-
Mentha	CC	GO:0005635	nuclear envelope	3.90E-11	493	476	435	1.09	-	-
Mentha	CC	GO:0005794	Golgi apparatus	7.26E-10	1636	1516	1443	1.05	-	-
Mentha	CC	GO:0000228	nuclear chromosome	3.13E-07	206	202	182	1.11	-	-
Mentha	CC	GO:0005777	peroxisome	2.05E-04	142	138	125	1.10	-	-
Mentha	CC	GO:0005811	lipid droplet	2.98E-02	102	97	90	1.08	-	-
Mentha	CC	GO:0031012	extracellular matrix	4.26E-01	564	504	497	1.01	-	-
Mentha	CC	GO:0005929	cilium	7.43E-01	842	746	743	1.00	-	-
Mentha	BP	GO:0050877	nervous system process	3.11E-97	1527	1057	1347	0.78	-	-
Mentha	BP	GO:0016192	vesicle-mediated transport	1.60E-36	1894	1820	1670	1.09	-	-
Mentha	BP	GO:0012501	programmed cell death	2.73E-35	1954	1873	1723	1.09	-	-
Mentha	BP	GO:0006355	regulation of DNA-templated transcription	1.52E-29	3342	3127	2947	1.06	-	-
Mentha	BP	GO:0006914	autophagy	2.15E-23	568	562	501	1.12	-	-
Mentha	BP	GO:0048870	cell motility	5.87E-23	1659	1576	1463	1.08	-	-
Mentha	BP	GO:0007010	cytoskeleton organization	8.21E-23	1639	1557	1445	1.08	-	-
Mentha	BP	GO:0006886	intracellular protein transport	1.38E-21	664	651	586	1.11	-	-
Mentha	BP	GO:0006281	DNA repair	2.26E-21	587	578	518	1.12	-	-
Mentha	BP	GO:0002376	immune system process	5.68E-21	2448	2290	2159	1.06	-	-
Mentha	BP	GO:0030163	protein catabolic process	1.44E-20	990	954	873	1.09	-	-
Mentha	BP	GO:0007155	cell adhesion	5.04E-18	1444	1367	1274	1.07	-	-
Mentha	BP	GO:0065003	protein-containing complex assembly	3.90E-17	1648	1551	1453	1.07	-	-
Mentha	BP	GO:0055086	nucleobase-containing small molecule metabolic process	8.28E-17	729	705	643	1.10	-	-
Mentha	BP	GO:0016071	mRNA metabolic process	1.02E-16	713	690	629	1.10	-	-
Mentha	BP	GO:0007005	mitochondrion organization	2.46E-16	484	475	427	1.11	-	-
Mentha	BP	GO:0006091	generation of precursor metabolites and energy	4.59E-12	502	486	443	1.10	-	-
Mentha	BP	GO:0042254	ribosome biogenesis	1.00E-11	297	293	262	1.12	-	-
Mentha	BP	GO:0006913	nucleocytoplasmic transport	2.76E-11	326	320	288	1.11	-	-
Mentha	BP	GO:0072659	protein localization to plasma membrane	4.82E-11	284	280	250	1.12	-	-
Mentha	BP	GO:0006260	DNA replication	6.92E-11	279	275	246	1.12	-	-
Mentha	BP	GO:0007059	chromosome segregation	2.08E-10	403	391	355	1.10	-	-
Mentha	BP	GO:0003012	muscle system process	4.89E-09	425	409	375	1.09	-	-
Mentha	BP	GO:0034330	cell junction organization	1.42E-08	727	686	641	1.07	-	-
Mentha	BP	GO:0006520	amino acid metabolic process	2.48E-08	292	284	258	1.10	-	-
Mentha	BP	GO:0140053	mitochondrial gene expression	3.58E-08	164	163	145	1.13	-	-
Mentha	BP	GO:0042060	wound healing	3.71E-08	431	413	380	1.09	-	-
Mentha	BP	GO:0006954	inflammatory response	6.60E-08	820	769	723	1.06	-	-
Mentha	BP	GO:0003013	circulatory system process	7.36E-08	584	553	515	1.07	-	-
Mentha	BP	GO:0007163	establishment or maintenance of cell polarity	2.14E-07	227	222	200	1.11	-	-
Mentha	BP	GO:0006629	lipid metabolic process	9.11E-07	1355	1249	1195	1.05	-	-
Mentha	BP	GO:0002181	cytoplasmic translation	1.77E-06	153	151	135	1.12	-	-
Mentha	BP	GO:0006310	DNA recombination	1.84E-06	333	319	294	1.09	-	-
Mentha	BP	GO:0006457	protein folding	4.48E-06	210	204	185	1.10	-	-
Mentha	BP	GO:0005975	carbohydrate metabolic process	4.53E-06	551	518	486	1.07	-	-
Mentha	BP	GO:0006325	chromatin organization	7.05E-06	720	671	635	1.06	-	-
Mentha	BP	GO:0007018	microtubule-based movement	8.85E-06	640	598	564	1.06	-	-
Mentha	BP	GO:0006399	tRNA metabolic process	1.79E-05	196	190	173	1.10	-	-
Mentha	BP	GO:0098542	defense response to other organism	4.53E-05	1171	1075	1033	1.04	-	-
Mentha	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	4.95E-04	119	116	105	1.11	-	-
Mentha	BP	GO:0003014	renal system process	8.20E-04	127	123	112	1.10	-	-
Mentha	BP	GO:0140013	meiotic nuclear division	9.78E-04	279	263	246	1.07	-	-
Mentha	BP	GO:0006790	sulfur compound metabolic process	1.15E-03	320	300	282	1.06	-	-
Mentha	BP	GO:0007040	lysosome organization	1.42E-03	107	104	94	1.10	-	-
Mentha	BP	GO:0055085	transmembrane transport	2.61E-03	1784	1612	1573	1.02	-	-
Mentha	BP	GO:0044782	cilium organization	3.59E-03	399	370	352	1.05	-	-
Mentha	BP	GO:0000910	cytokinesis	4.09E-03	186	176	164	1.07	-	-
Mentha	BP	GO:0006486	protein glycosylation	4.78E-02	225	208	198	1.05	-	-
Mentha	BP	GO:0006766	vitamin metabolic process	4.93E-02	107	101	94	1.07	-	-
Mentha	BP	GO:0006575	cellular modified amino acid metabolic process	6.81E-02	186	172	164	1.05	-	-
Mentha	BP	GO:0030198	extracellular matrix organization	7.78E-02	314	287	277	1.04	-	-
Mentha	BP	GO:0098754	detoxification	2.27E-01	134	123	118	1.04	-	-
Mentha	BP	GO:0022600	digestive system process	2.99E-01	110	101	97	1.04	-	-
Mentha	BP	GO:0032200	telomere organization	4.92E-01	186	161	164	0.98	-	-
Mentha	MF	GO:0016740	transferase activity	1.31E-44	3074	2921	2711	1.08	-	-
Mentha	MF	GO:0003723	RNA binding	3.23E-37	1679	1622	1481	1.10	-	-
Mentha	MF	GO:0140096	"catalytic activity, acting on a protein"	1.54E-30	3198	2999	2820	1.06	-	-
Mentha	MF	GO:0008092	cytoskeletal protein binding	3.53E-20	1023	984	902	1.09	-	-
Mentha	MF	GO:0140657	ATP-dependent activity	2.65E-17	729	706	643	1.10	-	-
Mentha	MF	GO:0003677	DNA binding	2.80E-16	2865	2651	2527	1.05	-	-
Mentha	MF	GO:0003924	GTPase activity	7.14E-14	658	634	580	1.09	-	-
Mentha	MF	GO:0140110	transcription regulator activity	1.74E-12	2033	1885	1793	1.05	-	-
Mentha	MF	GO:0140097	"catalytic activity, acting on DNA"	1.21E-11	383	374	338	1.11	-	-
Mentha	MF	GO:0140098	"catalytic activity, acting on RNA"	5.17E-11	417	405	368	1.10	-	-
Mentha	MF	GO:0016491	oxidoreductase activity	4.99E-10	888	837	783	1.07	-	-
Mentha	MF	GO:0008289	lipid binding	4.70E-08	836	784	737	1.06	-	-
Mentha	MF	GO:0016874	ligase activity	7.18E-08	283	275	250	1.10	-	-
Mentha	MF	GO:0016853	isomerase activity	1.62E-06	252	244	222	1.10	-	-
Mentha	MF	GO:0042393	histone binding	6.10E-06	237	229	209	1.10	-	-
Mentha	MF	GO:0045182	translation regulator activity	1.07E-04	151	147	133	1.10	-	-
Mentha	MF	GO:0016829	lyase activity	1.80E-04	538	501	474	1.06	-	-
Mentha	MF	GO:0140104	molecular carrier activity	3.74E-04	105	103	93	1.11	-	-
Mentha	MF	GO:0038024	cargo receptor activity	2.09E-02	117	111	103	1.08	-	-
Mentha	MF	GO:0003774	cytoskeletal motor activity	2.88E-02	116	110	102	1.08	-	-
Mentha	MF	GO:0048018	receptor ligand activity	2.07E-01	504	454	444	1.02	-	-
Mentha	MF	GO:0009975	cyclase activity	3.47E-01	277	250	244	1.02	-	-
Mentha	MF	GO:0005215	transporter activity	3.53E-01	1462	1301	1289	1.01	-	-
Mentha	MF	GO:0005198	structural molecule activity	4.00E-01	798	712	704	1.01	-	-
Mentha	BP	GO:0008038	neuron recognition	-	46	44	-	-	1.32E-03	2.12E-03
Mentha	BP	GO:1905145	cellular response to acetylcholine	-	33	29	-	-	2.51E-03	1.41E-03
Mentha	BP	GO:0097094	craniofacial suture morphogenesis	-	18	17	-	-	2.33E-03	8.23E-04
Mentha	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	3.22E-03	9.99E-04
Mentha	BP	GO:0051931	regulation of sensory perception	-	36	34	-	-	8.05E-03	1.65E-03
Mentha	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	2.83E-03	1.18E-03
Mentha	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.74E-04	6.47E-04
Mentha	BP	GO:0060049	regulation of protein glycosylation	-	13	12	-	-	1.71E-04	5.88E-04
Mentha	BP	GO:0009268	response to pH	-	43	39	-	-	5.99E-02	1.88E-03
Mentha	BP	GO:0045666	positive regulation of neuron differentiation	-	91	83	-	-	3.94E-03	3.94E-03
Mentha	BP	GO:0043543	protein acylation	-	107	101	-	-	3.07E-03	4.76E-03
Mentha	MF	GO:0051349	positive regulation of lyase activity	-	41	37	-	-	2.16E-03	1.76E-03
Mentha	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	13	-	-	1.41E-02	6.47E-04
Mentha	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.19E-03	1.18E-03
Mentha	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	2.64E-03	9.40E-04
Mentha	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	119	-	-	1.66E-02	5.64E-03
Mentha	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	2.67E-02	2.00E-03
Mentha	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	35	-	-	4.31E-03	1.65E-03
Mentha	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	2.33E-02	3.23E-03
Mentha	BP	GO:0022038	corpus callosum development	-	25	25	-	-	4.90E-03	1.18E-03
Mentha	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	11	-	-	1.73E-04	5.29E-04
Mentha	BP	GO:0021548	pons development	-	11	11	-	-	1.72E-04	5.29E-04
Mentha	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	11	-	-	1.75E-04	5.29E-04
Mentha	BP	GO:0043299	leukocyte degranulation	-	82	78	-	-	9.09E-03	3.70E-03
Mentha	BP	GO:0048864	stem cell development	-	88	83	-	-	7.26E-03	3.94E-03
Mentha	BP	GO:0009310	amine catabolic process	-	20	17	-	-	4.67E-03	8.23E-04
Mentha	BP	GO:0051651	maintenance of location in cell	-	236	216	-	-	8.79E-03	1.02E-02
Mentha	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	5.90E-03	1.29E-03
Mentha	BP	GO:0014004	microglia differentiation	-	12	12	-	-	9.45E-04	5.88E-04
Mentha	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	1.17E-03	1.47E-03
Mentha	BP	GO:1905962	glutamatergic neuron differentiation	-	14	13	-	-	1.74E-04	6.47E-04
Mentha	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.17E-03	7.05E-04
Mentha	BP	GO:0046415	urate metabolic process	-	12	11	-	-	1.75E-04	5.29E-04
Mentha	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	3.79E-03	1.41E-03
Mentha	BP	GO:0006949	syncytium formation	-	66	59	-	-	9.15E-03	2.82E-03
Mentha	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.26E-04	7.05E-04
Mentha	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	5.03E-03	7.05E-04
Mentha	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	52	-	-	7.96E-03	2.47E-03
Mentha	BP	GO:0030574	collagen catabolic process	-	45	39	-	-	4.39E-03	1.88E-03
Mentha	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	4.55E-03	2.17E-03
Mentha	BP	GO:0060343	trabecula formation	-	26	26	-	-	1.39E-03	1.23E-03
Mentha	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.36E-03	1.12E-03
Mentha	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	8.03E-02	7.64E-04
Mentha	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	4.96E-03	8.82E-04
Mentha	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	1.66E-02	1.94E-03
Mentha	BP	GO:0006413	translational initiation	-	122	118	-	-	2.64E-02	5.58E-03
Mentha	BP	GO:0072176	nephric duct development	-	15	15	-	-	3.42E-03	7.05E-04
Mentha	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	4.13E-03	2.41E-03
Mentha	CC	GO:0005200	structural constituent of cytoskeleton	-	112	108	-	-	7.22E-03	5.11E-03
Mentha	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	3.71E-03	2.41E-03
Mentha	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	2.57E-02	7.05E-04
Mentha	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	4.47E-02	1.18E-03
Mentha	BP	GO:1903036	positive regulation of response to wounding	-	76	67	-	-	6.76E-03	3.17E-03
Mentha	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	1.25E-02	9.99E-04
Mentha	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	206	-	-	1.48E-02	9.70E-03
Mentha	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	6.93E-04	1.29E-03
Mentha	BP	GO:0032528	microvillus organization	-	24	21	-	-	8.48E-03	9.99E-04
Mentha	BP	GO:0021954	central nervous system neuron development	-	85	82	-	-	1.78E-03	3.88E-03
Mentha	BP	GO:0055017	cardiac muscle tissue growth	-	92	73	-	-	4.96E-03	3.47E-03
Mentha	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	30	-	-	3.11E-03	1.41E-03
Mentha	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	12	-	-	3.44E-03	5.88E-04
Mentha	BP	GO:0048524	positive regulation of viral process	-	64	63	-	-	1.54E-03	3.00E-03
Mentha	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	12	-	-	9.17E-02	5.88E-04
Mentha	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	19	-	-	4.43E-03	9.40E-04
Mentha	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	22	-	-	3.83E-03	1.06E-03
Mentha	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	1.74E-02	8.23E-04
Mentha	BP	GO:0098661	inorganic anion transmembrane transport	-	140	117	-	-	1.30E-02	5.52E-03
Mentha	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	3.04E-02	1.53E-03
Mentha	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	7.93E-04	8.82E-04
Mentha	BP	GO:0009612	response to mechanical stimulus	-	215	205	-	-	5.56E-03	9.64E-03
Mentha	BP	GO:0048644	muscle organ morphogenesis	-	81	77	-	-	6.41E-03	3.64E-03
Mentha	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	138	-	-	5.33E-03	6.52E-03
Mentha	BP	GO:1905874	regulation of postsynaptic density organization	-	13	12	-	-	5.04E-03	5.88E-04
Mentha	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	9.26E-03	1.65E-03
Mentha	BP	GO:0140115	export across plasma membrane	-	82	60	-	-	2.49E-02	2.82E-03
Mentha	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	1.33E-03	5.88E-04
Mentha	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	1.71E-03	1.82E-03
Mentha	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	2.13E-01	5.88E-04
Mentha	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.75E-04	5.29E-04
Mentha	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	28	-	-	9.59E-04	1.35E-03
Mentha	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	40	-	-	4.11E-03	1.88E-03
Mentha	MF	GO:0003714	transcription corepressor activity	-	190	186	-	-	1.05E-02	8.76E-03
Mentha	BP	GO:0035878	nail development	-	11	11	-	-	1.45E-02	5.29E-04
Mentha	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	53	-	-	8.98E-03	2.53E-03
Mentha	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	2.12E-03	7.64E-04
Mentha	CC	GO:0006858	extracellular transport	-	45	41	-	-	3.09E-03	1.94E-03
Mentha	BP	GO:0006304	DNA modification	-	30	29	-	-	8.39E-03	1.41E-03
Mentha	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	7.19E-02	8.82E-04
Mentha	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	1.54E-02	2.35E-03
Mentha	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	4.09E-04	8.82E-04
Mentha	BP	GO:0003207	cardiac chamber formation	-	14	13	-	-	1.95E-03	6.47E-04
Mentha	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	35	-	-	6.35E-03	1.65E-03
Mentha	BP	GO:0070417	cellular response to cold	-	13	13	-	-	2.26E-03	6.47E-04
Mentha	BP	GO:0043523	regulation of neuron apoptotic process	-	218	210	-	-	7.85E-03	9.87E-03
Mentha	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.80E-03	1.06E-03
Mentha	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	1.03E-03	7.05E-04
Mentha	BP	GO:0044380	protein localization to cytoskeleton	-	57	56	-	-	4.79E-03	2.64E-03
Mentha	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	5.00E-02	6.47E-04
Mentha	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	3.51E-03	1.18E-03
Mentha	BP	GO:0014029	neural crest formation	-	15	15	-	-	2.50E-02	7.05E-04
Mentha	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	9.74E-03	1.12E-03
Mentha	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	36	-	-	2.05E-03	1.70E-03
Mentha	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	68	-	-	2.70E-03	3.23E-03
Mentha	BP	GO:0003188	heart valve formation	-	16	16	-	-	1.22E-02	7.64E-04
Mentha	CC	GO:0045324	late endosome to vacuole transport	-	37	36	-	-	7.35E-02	1.70E-03
Mentha	BP	GO:0043954	cellular component maintenance	-	72	67	-	-	4.92E-03	3.17E-03
Mentha	BP	GO:0050435	amyloid-beta metabolic process	-	65	51	-	-	3.29E-02	2.41E-03
Mentha	BP	GO:0014823	response to activity	-	70	67	-	-	1.74E-03	3.17E-03
Mentha	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	17	-	-	2.12E-03	8.23E-04
Mentha	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	4.96E-02	1.35E-03
Mentha	BP	GO:0034502	protein localization to chromosome	-	130	114	-	-	6.88E-03	5.41E-03
Mentha	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	1.66E-04	5.29E-04
Mentha	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	9.09E-03	5.29E-04
Mentha	BP	GO:0060457	negative regulation of digestive system process	-	17	14	-	-	3.41E-02	7.05E-04
Mentha	BP	GO:0019233	sensory perception of pain	-	103	97	-	-	2.99E-03	4.58E-03
Mentha	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	1.27E-01	1.06E-03
Mentha	BP	GO:0031343	positive regulation of cell killing	-	75	69	-	-	9.14E-02	3.29E-03
Mentha	BP	GO:0090077	foam cell differentiation	-	39	37	-	-	1.87E-03	1.76E-03
Mentha	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	118	-	-	2.56E-02	5.58E-03
Mentha	BP	GO:0017148	negative regulation of translation	-	390	112	-	-	9.40E-03	5.29E-03
Mentha	BP	GO:0030220	platelet formation	-	22	22	-	-	2.25E-02	1.06E-03
Mentha	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	79	-	-	5.85E-03	3.76E-03
Mentha	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	6.17E-04	5.88E-04
Mentha	BP	GO:1901142	insulin metabolic process	-	14	12	-	-	2.28E-03	5.88E-04
Mentha	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	13	-	-	4.46E-02	6.47E-04
Mentha	BP	GO:1903509	liposaccharide metabolic process	-	109	102	-	-	3.24E-02	4.82E-03
Mentha	BP	GO:0009582	detection of abiotic stimulus	-	140	118	-	-	1.01E-02	5.58E-03
Mentha	BP	GO:0045683	negative regulation of epidermis development	-	13	12	-	-	9.28E-03	5.88E-04
Mentha	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	15	-	-	2.34E-04	7.05E-04
Mentha	CC	GO:0140238	presynaptic endocytosis	-	72	70	-	-	1.21E-02	3.29E-03
Mentha	BP	GO:0051236	establishment of RNA localization	-	161	154	-	-	3.72E-02	7.29E-03
Mentha	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	3.13E-02	1.18E-03
Mentha	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	9.15E-03	8.23E-04
Mentha	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	190	-	-	1.48E-02	8.93E-03
Mentha	BP	GO:0034067	protein localization to Golgi apparatus	-	30	29	-	-	2.34E-03	1.41E-03
Mentha	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	1.39E-03	1.53E-03
Mentha	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	3.02E-03	5.29E-04
Mentha	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	16	-	-	9.93E-03	7.64E-04
Mentha	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	46	-	-	7.87E-03	2.17E-03
Mentha	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	1.66E-03	1.88E-03
Mentha	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	1.83E-03	2.47E-03
Mentha	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	2.75E-03	7.64E-04
Mentha	BP	GO:0050779	RNA destabilization	-	135	99	-	-	2.78E-02	4.70E-03
Mentha	BP	GO:0006023	aminoglycan biosynthetic process	-	74	68	-	-	1.39E-02	3.23E-03
Mentha	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	67	-	-	8.46E-03	3.17E-03
Mentha	BP	GO:0010762	regulation of fibroblast migration	-	40	38	-	-	3.42E-03	1.82E-03
Mentha	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	1.83E-02	1.41E-03
Mentha	BP	GO:0035272	exocrine system development	-	46	46	-	-	2.00E-03	2.17E-03
Mentha	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	1.40E-02	8.23E-04
Mentha	BP	GO:0022406	membrane docking	-	90	88	-	-	2.33E-02	4.17E-03
Mentha	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	4.32E-02	7.05E-04
Mentha	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	4.70E-04	7.64E-04
Mentha	BP	GO:0050777	negative regulation of immune response	-	196	185	-	-	4.99E-03	8.70E-03
Mentha	MF	GO:0005035	death receptor activity	-	16	16	-	-	1.51E-03	7.64E-04
Mentha	BP	GO:0002063	chondrocyte development	-	33	31	-	-	5.83E-03	1.47E-03
Mentha	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	1.11E-03	8.23E-04
Mentha	BP	GO:0099068	postsynapse assembly	-	40	37	-	-	1.20E-02	1.76E-03
Mentha	BP	GO:0021782	glial cell development	-	120	111	-	-	2.46E-03	5.23E-03
Mentha	BP	GO:0051782	negative regulation of cell division	-	18	16	-	-	6.00E-03	7.64E-04
Mentha	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	9.29E-04	5.29E-04
Mentha	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	84	-	-	1.04E-02	4.00E-03
Mentha	BP	GO:0001655	urogenital system development	-	66	65	-	-	3.18E-03	3.06E-03
Mentha	BP	GO:0071827	plasma lipoprotein particle organization	-	86	69	-	-	1.29E-02	3.29E-03
Mentha	BP	GO:0045494	photoreceptor cell maintenance	-	43	41	-	-	1.51E-02	1.94E-03
Mentha	BP	GO:0055088	lipid homeostasis	-	173	148	-	-	5.17E-03	6.99E-03
Mentha	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	25	-	-	1.81E-03	1.18E-03
Mentha	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	192	-	-	5.25E-03	9.05E-03
Mentha	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	26	-	-	1.84E-02	1.23E-03
Mentha	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	4.60E-03	1.65E-03
Mentha	BP	GO:0045667	regulation of osteoblast differentiation	-	147	121	-	-	2.05E-02	5.70E-03
Mentha	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	2.36E-03	7.64E-04
Mentha	BP	GO:0061037	negative regulation of cartilage development	-	32	28	-	-	8.90E-04	1.35E-03
Mentha	BP	GO:0045738	negative regulation of DNA repair	-	40	38	-	-	1.28E-03	1.82E-03
Mentha	BP	GO:0001704	formation of primary germ layer	-	195	184	-	-	6.84E-03	8.70E-03
Mentha	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	2.66E-02	6.47E-04
Mentha	BP	GO:0045778	positive regulation of ossification	-	51	49	-	-	1.23E-02	2.35E-03
Mentha	BP	GO:0060174	limb bud formation	-	11	11	-	-	6.79E-03	5.29E-04
Mentha	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	3.85E-03	4.00E-03
Mentha	BP	GO:0042092	type 2 immune response	-	41	41	-	-	5.34E-03	1.94E-03
Mentha	BP	GO:0048588	developmental cell growth	-	233	218	-	-	4.31E-03	1.03E-02
Mentha	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	4.24E-02	9.40E-04
Mentha	BP	GO:0021872	forebrain generation of neurons	-	52	49	-	-	1.64E-03	2.35E-03
Mentha	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	1.76E-03	1.06E-03
Mentha	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	1.14E-01	1.88E-03
Mentha	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	49	-	-	2.67E-02	2.35E-03
Mentha	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	1.74E-04	5.29E-04
Mentha	BP	GO:0034367	protein-containing complex remodeling	-	35	34	-	-	1.61E-02	1.65E-03
Mentha	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	25	-	-	5.92E-04	1.18E-03
Mentha	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	43	-	-	9.03E-03	2.06E-03
Mentha	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	3.56E-02	9.40E-04
Mentha	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	6.89E-03	9.40E-04
Mentha	BP	GO:0010232	vascular transport	-	87	83	-	-	1.68E-03	3.94E-03
Mentha	BP	GO:0021987	cerebral cortex development	-	125	120	-	-	3.70E-03	5.64E-03
Mentha	BP	GO:0008637	apoptotic mitochondrial changes	-	108	101	-	-	3.26E-02	4.76E-03
Mentha	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	2.43E-02	1.65E-03
Mentha	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	4.54E-03	7.05E-04
Mentha	BP	GO:0060999	positive regulation of dendritic spine development	-	35	33	-	-	1.73E-02	1.59E-03
Mentha	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	17	-	-	9.05E-04	8.23E-04
Mentha	BP	GO:2000736	regulation of stem cell differentiation	-	78	76	-	-	5.71E-03	3.59E-03
Mentha	BP	GO:0060973	cell migration involved in heart development	-	21	19	-	-	5.19E-03	9.40E-04
Mentha	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	8.93E-04	9.40E-04
Mentha	BP	GO:0002064	epithelial cell development	-	210	206	-	-	6.35E-03	9.70E-03
Mentha	BP	GO:0071318	cellular response to ATP	-	18	15	-	-	6.00E-04	7.05E-04
Mentha	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	39	-	-	3.34E-03	1.88E-03
Mentha	BP	GO:2001222	regulation of neuron migration	-	46	41	-	-	6.06E-04	1.94E-03
Mentha	BP	GO:0034389	lipid droplet organization	-	38	37	-	-	1.60E-03	1.76E-03
Mentha	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	8.17E-04	2.12E-03
Mentha	BP	GO:0042177	negative regulation of protein catabolic process	-	109	106	-	-	2.12E-03	5.00E-03
Mentha	MF	GO:0038024	cargo receptor activity	-	121	111	-	-	1.89E-02	5.23E-03
Mentha	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	17	-	-	6.37E-03	8.23E-04
Mentha	BP	GO:0033120	positive regulation of RNA splicing	-	46	42	-	-	8.84E-03	2.00E-03
Mentha	BP	GO:0051445	regulation of meiotic cell cycle	-	64	62	-	-	6.92E-02	2.94E-03
Mentha	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.14E-03	5.88E-04
Mentha	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	9.68E-03	2.82E-03
Mentha	BP	GO:0038065	collagen-activated signaling pathway	-	15	14	-	-	5.08E-03	7.05E-04
Mentha	BP	GO:0090087	regulation of peptide transport	-	195	181	-	-	7.07E-03	8.52E-03
Mentha	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	98	-	-	3.73E-03	4.64E-03
Mentha	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	2.15E-03	1.18E-03
Mentha	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	1.10E-03	1.18E-03
Mentha	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	3.10E-02	1.29E-03
Mentha	BP	GO:0099118	microtubule-based protein transport	-	14	13	-	-	1.20E-02	6.47E-04
Mentha	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	5.24E-03	7.05E-04
Mentha	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	1.06E-01	9.40E-04
Mentha	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	1.14E-03	6.47E-04
Mentha	BP	GO:0022404	molting cycle process	-	95	94	-	-	2.53E-03	4.47E-03
Mentha	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	4.81E-04	5.29E-04
Mentha	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	6.54E-03	8.23E-04
Mentha	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	8.58E-03	9.40E-04
Mentha	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	8.52E-03	5.88E-04
Mentha	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	9.83E-04	8.23E-04
Mentha	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	2.73E-03	1.53E-03
Mentha	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	1.24E-02	7.05E-04
Mentha	BP	GO:0008299	isoprenoid biosynthetic process	-	30	28	-	-	1.05E-02	1.35E-03
Mentha	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	225	-	-	5.82E-03	1.06E-02
Mentha	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	2.50E-03	1.47E-03
Mentha	BP	GO:0034104	negative regulation of tissue remodeling	-	22	21	-	-	1.75E-03	9.99E-04
Mentha	CC	GO:0098926	postsynaptic signal transduction	-	39	35	-	-	2.32E-03	1.65E-03
Mentha	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	137	-	-	4.14E-03	6.47E-03
Mentha	CC	GO:0016082	synaptic vesicle priming	-	19	18	-	-	3.34E-02	8.82E-04
Mentha	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	1.16E-03	2.23E-03
Mentha	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	138	-	-	1.41E-02	6.52E-03
Mentha	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	8.86E-04	1.06E-03
Mentha	BP	GO:0061548	ganglion development	-	17	17	-	-	1.19E-02	8.23E-04
Mentha	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	96	-	-	5.51E-03	4.53E-03
Mentha	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.21E-03	7.05E-04
Mentha	BP	GO:0042832	defense response to protozoan	-	28	23	-	-	6.27E-02	1.12E-03
Mentha	BP	GO:0048799	animal organ maturation	-	33	31	-	-	1.64E-03	1.47E-03
Mentha	BP	GO:0006925	inflammatory cell apoptotic process	-	23	20	-	-	1.02E-03	9.40E-04
Mentha	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	4.68E-04	7.64E-04
Mentha	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	166	-	-	5.64E-03	7.82E-03
Mentha	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.74E-04	5.29E-04
Mentha	BP	GO:1903035	negative regulation of response to wounding	-	93	86	-	-	9.02E-03	4.06E-03
Mentha	BP	GO:0015697	quaternary ammonium group transport	-	16	14	-	-	5.64E-02	7.05E-04
Mentha	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	1.59E-03	1.23E-03
Mentha	BP	GO:0036010	protein localization to endosome	-	27	26	-	-	2.73E-03	1.23E-03
Mentha	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	131	-	-	3.27E-02	6.17E-03
Mentha	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	96	-	-	3.63E-03	4.53E-03
Mentha	BP	GO:0045056	transcytosis	-	20	19	-	-	2.01E-03	9.40E-04
Mentha	BP	GO:0018342	protein prenylation	-	15	15	-	-	1.34E-02	7.05E-04
Mentha	BP	GO:0009267	cellular response to starvation	-	170	168	-	-	1.00E-02	7.93E-03
Mentha	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	1.21E-02	5.29E-04
Mentha	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	7.73E-03	2.53E-03
Mentha	BP	GO:0046834	lipid phosphorylation	-	16	15	-	-	3.58E-02	7.05E-04
Mentha	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	3.25E-03	1.12E-03
Mentha	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	22	-	-	2.88E-04	1.06E-03
Mentha	BP	GO:0046931	pore complex assembly	-	21	20	-	-	6.33E-03	9.40E-04
Mentha	CC	GO:0032008	positive regulation of TOR signaling	-	52	50	-	-	6.60E-02	2.35E-03
Mentha	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	1.52E-02	1.59E-03
Mentha	BP	GO:0046618	xenobiotic export from cell	-	27	12	-	-	9.00E-03	5.88E-04
Mentha	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	13	-	-	1.02E-02	6.47E-04
Mentha	BP	GO:0060428	lung epithelium development	-	43	43	-	-	2.58E-03	2.06E-03
Mentha	BP	GO:0030431	sleep	-	30	28	-	-	2.86E-02	1.35E-03
Mentha	BP	GO:1903318	negative regulation of protein maturation	-	29	27	-	-	2.49E-03	1.29E-03
Mentha	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	97	-	-	2.16E-01	4.58E-03
Mentha	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	6.55E-04	8.23E-04
Mentha	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	1.86E-02	7.05E-04
Mentha	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	1.89E-02	5.29E-04
Mentha	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.74E-04	6.47E-04
Mentha	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	66	-	-	5.00E-03	3.12E-03
Mentha	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	1.74E-03	3.06E-03
Mentha	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	5.68E-04	8.23E-04
Mentha	CC	GO:0090660	cerebrospinal fluid circulation	-	15	13	-	-	1.75E-04	6.47E-04
Mentha	CC	GO:0006406	mRNA export from nucleus	-	69	67	-	-	3.08E-02	3.17E-03
Mentha	BP	GO:0009880	embryonic pattern specification	-	70	66	-	-	2.37E-03	3.12E-03
Mentha	BP	GO:0015791	polyol transmembrane transport	-	14	12	-	-	5.25E-03	5.88E-04
Mentha	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	3.63E-01	1.88E-03
Mentha	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	2.86E-03	1.18E-03
Mentha	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	2.24E-02	5.29E-04
Mentha	BP	GO:0002367	cytokine production involved in immune response	-	121	120	-	-	9.55E-03	5.64E-03
Mentha	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	12	-	-	1.29E-03	5.88E-04
Mentha	BP	GO:0044848	biological phase	-	211	198	-	-	1.39E-02	9.35E-03
Mentha	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	4.53E-03	5.88E-04
Mentha	BP	GO:0046660	female sex differentiation	-	125	123	-	-	6.63E-03	5.82E-03
Mentha	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	4.39E-04	8.23E-04
Mentha	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	41	-	-	8.82E-04	1.94E-03
Mentha	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	1.01E-02	3.29E-03
Mentha	BP	GO:0071248	cellular response to metal ion	-	201	192	-	-	3.85E-03	9.05E-03
Mentha	BP	GO:0030308	negative regulation of cell growth	-	191	182	-	-	4.48E-03	8.58E-03
Mentha	BP	GO:0097306	cellular response to alcohol	-	99	89	-	-	4.29E-03	4.23E-03
Mentha	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	125	-	-	4.44E-02	5.88E-03
Mentha	BP	GO:0010453	regulation of cell fate commitment	-	40	34	-	-	3.46E-02	1.65E-03
Mentha	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	57	-	-	4.16E-03	2.70E-03
Mentha	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	50	-	-	7.78E-04	2.35E-03
Mentha	BP	GO:0002026	regulation of the force of heart contraction	-	26	25	-	-	1.17E-03	1.18E-03
Mentha	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	3.15E-02	1.18E-03
Mentha	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	43	-	-	4.23E-03	2.06E-03
Mentha	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	5.46E-03	3.64E-03
Mentha	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	1.53E-03	9.40E-04
Mentha	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	23	-	-	1.46E-02	1.12E-03
Mentha	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	92	-	-	2.86E-03	4.35E-03
Mentha	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	2.79E-03	1.23E-03
Mentha	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	2.14E-03	5.29E-04
Mentha	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	51	-	-	3.58E-03	2.41E-03
Mentha	BP	GO:0051259	protein complex oligomerization	-	251	239	-	-	8.11E-03	1.13E-02
Mentha	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	4.80E-03	7.64E-04
Mentha	BP	GO:0098743	cell aggregation	-	24	23	-	-	3.27E-03	1.12E-03
Mentha	BP	GO:0035112	genitalia morphogenesis	-	12	11	-	-	1.70E-04	5.29E-04
Mentha	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	1.75E-04	5.29E-04
Mentha	BP	GO:0009994	oocyte differentiation	-	57	54	-	-	2.42E-03	2.59E-03
Mentha	MF	GO:0031952	regulation of protein autophosphorylation	-	43	41	-	-	7.96E-04	1.94E-03
Mentha	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	2.42E-02	7.05E-04
Mentha	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	148	-	-	6.30E-03	6.99E-03
Mentha	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	4.73E-03	1.65E-03
Mentha	BP	GO:0033688	regulation of osteoblast proliferation	-	31	27	-	-	2.13E-03	1.29E-03
Mentha	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	7.76E-04	1.65E-03
Mentha	BP	GO:0072665	protein localization to vacuole	-	84	83	-	-	7.69E-03	3.94E-03
Mentha	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	45	-	-	3.42E-02	2.12E-03
Mentha	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	22	-	-	1.28E-02	1.06E-03
Mentha	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	71	-	-	3.68E-03	3.35E-03
Mentha	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	8.84E-03	7.64E-04
Mentha	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	2.15E-03	7.05E-04
Mentha	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.74E-04	5.29E-04
Mentha	BP	GO:0042044	fluid transport	-	35	32	-	-	4.84E-03	1.53E-03
Mentha	BP	GO:0070633	transepithelial transport	-	35	33	-	-	4.80E-03	1.59E-03
Mentha	BP	GO:0033015	tetrapyrrole catabolic process	-	13	12	-	-	1.74E-04	5.88E-04
Mentha	BP	GO:0045661	regulation of myoblast differentiation	-	74	73	-	-	9.26E-03	3.47E-03
Mentha	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	11	-	-	1.75E-04	5.29E-04
Mentha	BP	GO:0030307	positive regulation of cell growth	-	164	155	-	-	3.49E-03	7.29E-03
Mentha	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	1.31E-03	1.18E-03
Mentha	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	3.42E-03	8.82E-04
Mentha	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	1.85E-03	6.47E-04
Mentha	BP	GO:0014812	muscle cell migration	-	110	83	-	-	3.34E-03	3.94E-03
Mentha	BP	GO:0048525	negative regulation of viral process	-	90	86	-	-	4.94E-03	4.06E-03
Mentha	BP	GO:0072044	collecting duct development	-	16	16	-	-	2.29E-04	7.64E-04
Mentha	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	1.17E-01	7.05E-04
Mentha	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	4.01E-03	3.29E-03
Mentha	BP	GO:0030238	male sex determination	-	14	14	-	-	8.40E-03	7.05E-04
Mentha	BP	GO:0051781	positive regulation of cell division	-	93	85	-	-	4.76E-03	4.00E-03
Mentha	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	2.43E-02	9.99E-04
Mentha	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	2.12E-03	5.29E-04
Mentha	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	5.14E-02	1.12E-03
Mentha	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	22	-	-	1.24E-03	1.06E-03
Mentha	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.14E-03	2.23E-03
Mentha	BP	GO:0007272	ensheathment of neurons	-	146	138	-	-	3.65E-03	6.52E-03
Mentha	CC	GO:0050806	positive regulation of synaptic transmission	-	171	144	-	-	4.88E-03	6.82E-03
Mentha	BP	GO:0060021	roof of mouth development	-	91	90	-	-	4.61E-03	4.23E-03
Mentha	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	3.36E-03	1.88E-03
Mentha	BP	GO:0050819	negative regulation of coagulation	-	54	51	-	-	2.26E-02	2.41E-03
Mentha	BP	GO:0017004	cytochrome complex assembly	-	40	37	-	-	6.03E-02	1.76E-03
Mentha	BP	GO:0018410	C-terminal protein amino acid modification	-	15	12	-	-	1.82E-02	5.88E-04
Mentha	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	9.16E-02	2.94E-03
Mentha	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	1.02E-01	7.05E-04
Mentha	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	13	-	-	7.89E-04	6.47E-04
Mentha	CC	GO:0050805	negative regulation of synaptic transmission	-	55	52	-	-	1.06E-02	2.47E-03
Mentha	BP	GO:0043248	proteasome assembly	-	13	13	-	-	1.80E-02	6.47E-04
Mentha	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	58	-	-	9.13E-03	2.76E-03
Mentha	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	1.98E-02	5.29E-04
Mentha	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	74	-	-	4.50E-03	3.53E-03
Mentha	BP	GO:0016054	organic acid catabolic process	-	251	238	-	-	1.84E-02	1.12E-02
Mentha	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	2.36E-03	6.47E-04
Mentha	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	3.11E-02	1.35E-03
Mentha	BP	GO:0065005	protein-lipid complex assembly	-	29	28	-	-	1.19E-02	1.35E-03
Mentha	BP	GO:0008033	tRNA processing	-	136	131	-	-	5.13E-02	6.17E-03
Mentha	BP	GO:0046661	male sex differentiation	-	171	166	-	-	6.29E-03	7.82E-03
Mentha	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	6.12E-04	7.05E-04
Mentha	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	4.20E-03	8.23E-04
Mentha	BP	GO:0035188	hatching	-	27	22	-	-	5.27E-04	1.06E-03
Mentha	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	83	-	-	2.16E-03	3.94E-03
Mentha	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	2.31E-04	7.05E-04
Mentha	BP	GO:0090713	immunological memory process	-	18	18	-	-	5.40E-02	8.82E-04
Mentha	BP	GO:0061326	renal tubule development	-	103	101	-	-	5.11E-03	4.76E-03
Mentha	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	3.94E-02	2.59E-03
Mentha	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	1.50E-03	8.23E-04
Mentha	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	2.79E-03	9.40E-04
Mentha	BP	GO:0060325	face morphogenesis	-	31	30	-	-	1.44E-03	1.41E-03
Mentha	BP	GO:0090559	regulation of membrane permeability	-	72	63	-	-	7.83E-03	3.00E-03
Mentha	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	13	-	-	6.82E-02	6.47E-04
Mentha	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	4.13E-02	5.88E-04
Mentha	BP	GO:0031579	membrane raft organization	-	25	24	-	-	3.54E-03	1.18E-03
Mentha	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	1.48E-03	1.18E-03
Mentha	BP	GO:0060033	anatomical structure regression	-	16	15	-	-	2.52E-03	7.05E-04
Mentha	BP	GO:0046460	neutral lipid biosynthetic process	-	50	44	-	-	6.93E-03	2.12E-03
Mentha	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	138	-	-	1.73E-02	6.52E-03
Mentha	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	1.74E-04	5.29E-04
Mentha	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	159	-	-	3.78E-03	7.52E-03
Mentha	BP	GO:0002251	organ or tissue specific immune response	-	43	34	-	-	2.30E-03	1.65E-03
Mentha	CC	GO:0048167	regulation of synaptic plasticity	-	210	181	-	-	6.13E-03	8.52E-03
Mentha	BP	GO:1903708	positive regulation of hemopoiesis	-	184	175	-	-	1.32E-02	8.23E-03
Mentha	BP	GO:1903008	organelle disassembly	-	154	152	-	-	8.56E-03	7.17E-03
Mentha	BP	GO:0001709	cell fate determination	-	44	42	-	-	2.99E-03	2.00E-03
Mentha	BP	GO:0051873	killing by host of symbiont cells	-	28	25	-	-	5.63E-02	1.18E-03
Mentha	BP	GO:0045058	T cell selection	-	53	53	-	-	5.37E-02	2.53E-03
Mentha	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	1.81E-03	2.29E-03
Mentha	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	1.55E-03	9.40E-04
Mentha	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	1.86E-03	3.70E-03
Mentha	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	40	-	-	8.41E-03	1.88E-03
Mentha	BP	GO:0099084	postsynaptic specialization organization	-	44	41	-	-	7.17E-03	1.94E-03
Mentha	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	8.35E-03	5.29E-04
Mentha	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	2.64E-02	7.05E-04
Mentha	BP	GO:0060384	innervation	-	27	27	-	-	1.85E-02	1.29E-03
Mentha	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	2.37E-03	5.88E-04
Mentha	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	32	-	-	9.33E-03	1.53E-03
Mentha	MF	GO:0031281	positive regulation of cyclase activity	-	40	37	-	-	1.61E-03	1.76E-03
Mentha	MF	GO:0098631	cell adhesion mediator activity	-	64	61	-	-	1.16E-02	2.88E-03
Mentha	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	17	-	-	2.32E-04	8.23E-04
Mentha	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	4.15E-03	5.88E-04
Mentha	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	6.82E-03	8.82E-04
Mentha	BP	GO:0071453	cellular response to oxygen levels	-	168	149	-	-	4.18E-03	7.05E-03
Mentha	BP	GO:0090399	replicative senescence	-	17	16	-	-	1.91E-03	7.64E-04
Mentha	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	12	-	-	1.74E-04	5.88E-04
Mentha	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	1.34E-02	1.41E-03
Mentha	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	7.82E-03	5.88E-03
Mentha	BP	GO:0006855	xenobiotic transmembrane transport	-	14	12	-	-	4.16E-02	5.88E-04
Mentha	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	3.95E-03	1.18E-03
Mentha	BP	GO:0044242	cellular lipid catabolic process	-	224	210	-	-	1.16E-02	9.87E-03
Mentha	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	4.46E-04	6.47E-04
Mentha	BP	GO:0002931	response to ischemia	-	58	55	-	-	4.05E-03	2.59E-03
Mentha	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	1.17E-02	5.88E-04
Mentha	BP	GO:0014047	glutamate secretion	-	25	25	-	-	1.98E-02	1.18E-03
Mentha	BP	GO:0061005	cell differentiation involved in kidney development	-	58	57	-	-	6.55E-03	2.70E-03
Mentha	BP	GO:0030397	membrane disassembly	-	11	11	-	-	6.49E-04	5.29E-04
Mentha	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	71	-	-	1.92E-02	3.35E-03
Mentha	BP	GO:0060420	regulation of heart growth	-	74	58	-	-	2.19E-03	2.76E-03
Mentha	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	6.48E-04	7.05E-04
Mentha	BP	GO:0009755	hormone-mediated signaling pathway	-	221	207	-	-	9.81E-03	9.76E-03
Mentha	BP	GO:0022612	gland morphogenesis	-	124	121	-	-	4.63E-03	5.70E-03
Mentha	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	35	-	-	1.04E-03	1.65E-03
Mentha	MF	GO:0140416	transcription regulator inhibitor activity	-	26	25	-	-	2.33E-03	1.18E-03
Mentha	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	23	-	-	1.02E-01	1.12E-03
Mentha	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	6.76E-03	7.05E-04
Mentha	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	2.29E-02	8.23E-04
Mentha	BP	GO:1990845	adaptive thermogenesis	-	166	161	-	-	5.32E-03	7.58E-03
Mentha	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	2.98E-03	2.53E-03
Mentha	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	4.60E-02	5.29E-04
Mentha	BP	GO:0015844	monoamine transport	-	88	84	-	-	3.03E-02	4.00E-03
Mentha	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	23	-	-	3.58E-03	1.12E-03
Mentha	BP	GO:0060039	pericardium development	-	19	18	-	-	8.39E-04	8.82E-04
Mentha	BP	GO:0071392	cellular response to estradiol stimulus	-	40	38	-	-	8.86E-04	1.82E-03
Mentha	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	12	-	-	2.80E-03	5.88E-04
Mentha	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	7.23E-03	9.40E-04
Mentha	BP	GO:0009451	RNA modification	-	169	159	-	-	2.44E-02	7.52E-03
Mentha	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	2.38E-01	5.29E-04
Mentha	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	38	-	-	3.57E-03	1.82E-03
Mentha	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	2.63E-03	8.23E-04
Mentha	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	109	-	-	7.38E-03	5.17E-03
Mentha	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	36	-	-	1.53E-02	1.70E-03
Mentha	BP	GO:0015807	L-amino acid transport	-	94	84	-	-	9.22E-03	4.00E-03
Mentha	BP	GO:0032941	secretion by tissue	-	85	81	-	-	3.15E-03	3.82E-03
Mentha	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	11	-	-	7.10E-03	5.29E-04
Mentha	BP	GO:0046605	regulation of centrosome cycle	-	54	53	-	-	5.11E-03	2.53E-03
Mentha	BP	GO:0048753	pigment granule organization	-	40	39	-	-	7.48E-02	1.88E-03
Mentha	BP	GO:0021516	dorsal spinal cord development	-	20	16	-	-	1.84E-02	7.64E-04
Mentha	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	18	-	-	2.31E-04	8.82E-04
Mentha	BP	GO:0032196	transposition	-	11	11	-	-	1.45E-03	5.29E-04
Mentha	BP	GO:0003014	renal system process	-	130	126	-	-	7.78E-03	5.94E-03
Mentha	CC	GO:0070286	axonemal dynein complex assembly	-	40	36	-	-	1.18E-02	1.70E-03
Mentha	BP	GO:0045598	regulation of fat cell differentiation	-	148	126	-	-	4.40E-03	5.94E-03
Mentha	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	189	-	-	8.67E-03	8.93E-03
Mentha	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	1.15E-03	1.82E-03
Mentha	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	1.14E-03	1.18E-03
Mentha	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	210	-	-	4.57E-02	9.87E-03
Mentha	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.67E-04	6.47E-04
Mentha	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	1.31E-03	1.12E-03
Mentha	BP	GO:0018158	protein oxidation	-	15	14	-	-	2.06E-03	7.05E-04
Mentha	BP	GO:0039694	viral RNA genome replication	-	30	29	-	-	4.04E-03	1.41E-03
Mentha	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	2.32E-04	8.23E-04
Mentha	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	2.10E-03	1.29E-03
Mentha	BP	GO:0071709	membrane assembly	-	68	64	-	-	1.84E-02	3.06E-03
Mentha	BP	GO:0008217	regulation of blood pressure	-	186	172	-	-	1.05E-02	8.11E-03
Mentha	BP	GO:0031643	positive regulation of myelination	-	19	17	-	-	2.29E-04	8.23E-04
Mentha	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	3.68E-02	7.05E-04
Mentha	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	59	-	-	3.23E-03	2.82E-03
Mentha	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	1.65E-02	8.76E-03
Mentha	BP	GO:0002200	somatic diversification of immune receptors	-	78	77	-	-	5.00E-03	3.64E-03
Mentha	BP	GO:0035315	hair cell differentiation	-	52	46	-	-	4.77E-03	2.17E-03
Mentha	BP	GO:0048645	animal organ formation	-	62	60	-	-	4.29E-03	2.82E-03
Mentha	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	158	-	-	8.59E-03	7.46E-03
Mentha	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	2.63E-02	7.05E-04
Mentha	BP	GO:0033627	cell adhesion mediated by integrin	-	87	86	-	-	1.54E-02	4.06E-03
Mentha	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	3.87E-02	9.99E-04
Mentha	BP	GO:0035107	appendage morphogenesis	-	147	144	-	-	5.08E-03	6.82E-03
Mentha	BP	GO:1903707	negative regulation of hemopoiesis	-	116	104	-	-	3.64E-03	4.94E-03
Mentha	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	2.27E-04	9.40E-04
Mentha	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	2.82E-02	1.18E-03
Mentha	BP	GO:0030149	sphingolipid catabolic process	-	32	30	-	-	2.73E-03	1.41E-03
Mentha	BP	GO:0050994	regulation of lipid catabolic process	-	61	58	-	-	1.35E-03	2.76E-03
Mentha	BP	GO:0035988	chondrocyte proliferation	-	24	23	-	-	3.11E-03	1.12E-03
Mentha	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	1.16E-02	1.41E-03
Mentha	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	1.32E-03	5.29E-04
Mentha	BP	GO:0009593	detection of chemical stimulus	-	511	118	-	-	1.50E-02	5.58E-03
Mentha	BP	GO:0060788	ectodermal placode formation	-	12	11	-	-	1.90E-03	5.29E-04
Mentha	BP	GO:0045727	positive regulation of translation	-	141	135	-	-	4.34E-03	6.35E-03
Mentha	BP	GO:0036315	cellular response to sterol	-	24	18	-	-	1.17E-02	8.82E-04
Mentha	CC	GO:0032388	positive regulation of intracellular transport	-	137	134	-	-	2.24E-03	6.35E-03
Mentha	BP	GO:0021979	hypothalamus cell differentiation	-	13	12	-	-	2.19E-03	5.88E-04
Mentha	BP	GO:0002027	regulation of heart rate	-	106	95	-	-	3.24E-02	4.47E-03
Mentha	BP	GO:0050879	multicellular organismal movement	-	118	111	-	-	2.20E-03	5.23E-03
Mentha	BP	GO:0120305	regulation of pigmentation	-	15	14	-	-	4.43E-03	7.05E-04
Mentha	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	73	-	-	2.45E-03	3.47E-03
Mentha	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	61	-	-	2.52E-03	2.88E-03
Mentha	BP	GO:0048515	spermatid differentiation	-	208	182	-	-	5.55E-03	8.58E-03
Mentha	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	5.86E-03	2.70E-03
Mentha	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	2.06E-03	1.47E-03
Mentha	BP	GO:0007130	synaptonemal complex assembly	-	23	20	-	-	1.80E-03	9.40E-04
Mentha	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	34	-	-	7.30E-03	1.65E-03
Mentha	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	31	-	-	1.28E-03	1.47E-03
Mentha	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	35	-	-	3.16E-02	1.65E-03
Mentha	BP	GO:0060119	inner ear receptor cell development	-	44	39	-	-	3.44E-03	1.88E-03
Mentha	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	5.34E-03	8.82E-04
Mentha	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	33	-	-	6.07E-02	1.59E-03
Mentha	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	8.81E-04	1.18E-03
Mentha	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.84E-03	5.88E-04
Mentha	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	241	-	-	9.07E-03	1.13E-02
Mentha	BP	GO:1900006	positive regulation of dendrite development	-	17	16	-	-	1.18E-03	7.64E-04
Mentha	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	4.31E-02	2.29E-03
Mentha	BP	GO:0010883	regulation of lipid storage	-	53	49	-	-	1.91E-03	2.35E-03
Mentha	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	4.50E-03	1.23E-03
Mentha	BP	GO:0007635	chemosensory behavior	-	20	18	-	-	1.46E-03	8.82E-04
Mentha	BP	GO:1905954	positive regulation of lipid localization	-	110	104	-	-	4.91E-03	4.94E-03
Mentha	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	4.39E-04	5.88E-04
Mentha	BP	GO:0002209	behavioral defense response	-	39	39	-	-	8.65E-04	1.88E-03
Mentha	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	26	-	-	7.06E-02	1.23E-03
Mentha	BP	GO:0072523	purine-containing compound catabolic process	-	146	143	-	-	4.50E-03	6.76E-03
Mentha	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	31	-	-	1.15E-02	1.47E-03
Mentha	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	26	-	-	1.82E-03	1.23E-03
Mentha	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	2.29E-04	7.64E-04
Mentha	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	94	-	-	4.64E-03	4.47E-03
Mentha	BP	GO:0007218	neuropeptide signaling pathway	-	113	94	-	-	3.81E-02	4.47E-03
Mentha	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	5.35E-03	5.88E-04
Mentha	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	153	-	-	1.32E-02	7.23E-03
Mentha	BP	GO:0031345	negative regulation of cell projection organization	-	195	184	-	-	6.25E-03	8.70E-03
Mentha	BP	GO:0048278	vesicle docking	-	64	63	-	-	2.83E-02	3.00E-03
Mentha	BP	GO:0035050	embryonic heart tube development	-	86	83	-	-	7.23E-03	3.94E-03
Mentha	BP	GO:0030168	platelet activation	-	135	130	-	-	1.88E-02	6.11E-03
Mentha	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	3.82E-02	7.64E-04
Mentha	CC	GO:0098810	neurotransmitter reuptake	-	35	33	-	-	9.08E-03	1.59E-03
Mentha	BP	GO:0008213	protein alkylation	-	58	53	-	-	5.27E-03	2.53E-03
Mentha	BP	GO:0009812	flavonoid metabolic process	-	14	11	-	-	2.22E-01	5.29E-04
Mentha	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	5.10E-03	6.47E-04
Mentha	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	1.88E-02	1.18E-03
Mentha	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.70E-04	6.47E-04
Mentha	BP	GO:0031529	ruffle organization	-	55	53	-	-	2.89E-03	2.53E-03
Mentha	BP	GO:0010842	retina layer formation	-	25	25	-	-	4.22E-03	1.18E-03
Mentha	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	85	-	-	3.38E-02	4.00E-03
Mentha	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	3.49E-02	5.29E-04
Mentha	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	68	-	-	6.36E-03	3.23E-03
Mentha	MF	GO:0170055	lipid transmembrane transporter activity	-	56	51	-	-	5.19E-03	2.41E-03
Mentha	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	31	-	-	3.66E-03	1.47E-03
Mentha	BP	GO:0035304	regulation of protein dephosphorylation	-	87	83	-	-	2.24E-03	3.94E-03
Mentha	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	225	-	-	3.83E-03	1.06E-02
Mentha	BP	GO:0099637	neurotransmitter receptor transport	-	26	25	-	-	2.44E-03	1.18E-03
Mentha	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	3.01E-03	1.65E-03
Mentha	BP	GO:0051775	response to redox state	-	13	13	-	-	1.07E-02	6.47E-04
Mentha	BP	GO:0051785	positive regulation of nuclear division	-	61	60	-	-	2.69E-03	2.82E-03
Mentha	BP	GO:0060456	positive regulation of digestive system process	-	16	15	-	-	2.64E-03	7.05E-04
Mentha	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	15	-	-	2.77E-03	7.05E-04
Mentha	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	2.18E-03	9.40E-04
Mentha	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	1.96E-02	5.88E-04
Mentha	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	8.76E-03	2.12E-03
Mentha	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	12	-	-	8.15E-03	5.88E-04
Mentha	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	1.52E-03	8.23E-04
Mentha	BP	GO:0051299	centrosome separation	-	15	15	-	-	1.39E-03	7.05E-04
Mentha	BP	GO:0048145	regulation of fibroblast proliferation	-	87	84	-	-	2.29E-03	4.00E-03
Mentha	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	86	-	-	2.89E-01	4.06E-03
Mentha	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	2.49E-02	5.29E-04
Mentha	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	223	-	-	5.31E-03	1.05E-02
Mentha	BP	GO:0032098	regulation of appetite	-	20	19	-	-	7.62E-03	9.40E-04
Mentha	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	1.88E-03	7.05E-04
Mentha	CC	GO:0008333	endosome to lysosome transport	-	73	72	-	-	3.35E-02	3.41E-03
Mentha	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	21	-	-	2.62E-02	9.99E-04
Mentha	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	15	-	-	1.23E-02	7.05E-04
Mentha	BP	GO:0003016	respiratory system process	-	39	37	-	-	5.08E-04	1.76E-03
Mentha	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	2.88E-02	1.12E-03
Mentha	BP	GO:0045732	positive regulation of protein catabolic process	-	202	200	-	-	4.96E-03	9.40E-03
Mentha	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	69	-	-	9.80E-03	3.29E-03
Mentha	BP	GO:0007588	excretion	-	40	39	-	-	1.53E-02	1.88E-03
Mentha	BP	GO:1904018	positive regulation of vasculature development	-	185	153	-	-	9.48E-03	7.23E-03
Mentha	BP	GO:0050953	sensory perception of light stimulus	-	223	198	-	-	2.16E-02	9.35E-03
Mentha	BP	GO:0009164	nucleoside catabolic process	-	25	24	-	-	5.53E-02	1.18E-03
Mentha	BP	GO:0009303	rRNA transcription	-	37	37	-	-	1.10E-02	1.76E-03
Mentha	BP	GO:0035601	protein deacylation	-	56	54	-	-	6.24E-03	2.59E-03
Mentha	BP	GO:0061952	midbody abscission	-	18	17	-	-	2.21E-01	8.23E-04
Mentha	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	1.02E-03	5.29E-04
Mentha	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	2.09E-03	9.40E-04
Mentha	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	4.90E-03	1.41E-03
Mentha	BP	GO:0071300	cellular response to retinoic acid	-	66	64	-	-	1.03E-02	3.06E-03
Mentha	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	15	-	-	2.32E-04	7.05E-04
Mentha	BP	GO:0045830	positive regulation of isotype switching	-	28	27	-	-	8.31E-04	1.29E-03
Mentha	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	1.94E-03	1.59E-03
Mentha	BP	GO:0046697	decidualization	-	26	24	-	-	8.52E-04	1.18E-03
Mentha	BP	GO:0008212	mineralocorticoid metabolic process	-	14	12	-	-	1.74E-04	5.88E-04
Mentha	BP	GO:0051588	regulation of neurotransmitter transport	-	99	93	-	-	4.81E-03	4.41E-03
Mentha	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	28	-	-	3.47E-04	1.35E-03
Mentha	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	1.97E-03	5.88E-04
Mentha	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	9.99E-03	3.00E-03
Mentha	BP	GO:0044703	multi-organism reproductive process	-	209	195	-	-	9.84E-03	9.17E-03
Mentha	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	138	-	-	9.01E-03	6.52E-03
Mentha	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	51	-	-	1.04E-02	2.41E-03
Mentha	BP	GO:0099022	vesicle tethering	-	32	31	-	-	1.53E-01	1.47E-03
Mentha	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	36	-	-	1.14E-03	1.70E-03
Mentha	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	4.24E-03	5.88E-04
Mentha	BP	GO:0048857	neural nucleus development	-	65	62	-	-	4.13E-03	2.94E-03
Mentha	BP	GO:0048663	neuron fate commitment	-	74	68	-	-	2.11E-02	3.23E-03
Mentha	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	157	-	-	4.49E-03	7.41E-03
Mentha	BP	GO:0106027	neuron projection organization	-	90	86	-	-	2.67E-03	4.06E-03
Mentha	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	124	-	-	1.95E-02	5.88E-03
Mentha	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	4.54E-03	1.65E-03
Mentha	BP	GO:0045685	regulation of glial cell differentiation	-	77	71	-	-	6.55E-03	3.35E-03
Mentha	BP	GO:0051608	histamine transport	-	14	12	-	-	3.07E-03	5.88E-04
Mentha	BP	GO:0043414	macromolecule methylation	-	138	129	-	-	8.06E-03	6.11E-03
Mentha	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	7.76E-02	7.64E-04
Mentha	BP	GO:0050886	endocrine process	-	93	88	-	-	2.15E-02	4.17E-03
Mentha	MF	GO:0015562	efflux transmembrane transporter activity	-	15	13	-	-	1.74E-04	6.47E-04
Mentha	BP	GO:0050951	sensory perception of temperature stimulus	-	28	26	-	-	1.23E-03	1.23E-03
Mentha	BP	GO:0045807	positive regulation of endocytosis	-	155	148	-	-	7.80E-03	6.99E-03
Mentha	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	1.21E-03	5.29E-04
Mentha	BP	GO:0002418	immune response to tumor cell	-	29	25	-	-	1.41E-02	1.18E-03
Mentha	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	4.78E-03	2.76E-03
Mentha	BP	GO:0048308	organelle inheritance	-	14	14	-	-	2.32E-03	7.05E-04
Mentha	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	8.43E-04	8.82E-04
Mentha	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	9.08E-04	9.40E-04
Mentha	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	44	-	-	8.37E-03	2.12E-03
Mentha	BP	GO:0034394	protein localization to cell surface	-	69	65	-	-	1.71E-03	3.06E-03
Mentha	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	1.73E-04	5.88E-04
Mentha	BP	GO:0009110	vitamin biosynthetic process	-	23	21	-	-	2.82E-04	9.99E-04
Mentha	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	5.73E-03	1.06E-03
Mentha	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	6.00E-03	8.23E-04
Mentha	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	20	-	-	1.86E-03	9.40E-04
Mentha	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	91	-	-	2.97E-03	4.29E-03
Mentha	MF	GO:0051100	negative regulation of binding	-	161	155	-	-	3.39E-03	7.29E-03
Mentha	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	6.11E-03	3.70E-03
Mentha	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	2.54E-03	2.82E-03
Mentha	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	1.37E-03	9.40E-04
Mentha	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	1.72E-04	5.88E-04
Mentha	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	1.67E-02	1.59E-03
Mentha	BP	GO:0046184	aldehyde biosynthetic process	-	16	14	-	-	9.02E-04	7.05E-04
Mentha	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	3.27E-04	6.47E-04
Mentha	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	46	-	-	5.27E-03	2.17E-03
Mentha	BP	GO:0046621	negative regulation of organ growth	-	39	31	-	-	3.20E-03	1.47E-03
Mentha	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	1.29E-01	2.35E-03
Mentha	BP	GO:0032368	regulation of lipid transport	-	149	127	-	-	3.36E-03	6.00E-03
Mentha	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	1.18E-02	1.41E-03
Mentha	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	175	-	-	7.28E-03	8.23E-03
Mentha	BP	GO:0033002	muscle cell proliferation	-	249	199	-	-	7.60E-03	9.40E-03
Mentha	BP	GO:0043331	response to dsRNA	-	56	54	-	-	2.82E-02	2.59E-03
Mentha	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	8.03E-03	5.88E-04
Mentha	BP	GO:0051904	pigment granule transport	-	23	22	-	-	3.82E-02	1.06E-03
Mentha	BP	GO:1901679	nucleotide transmembrane transport	-	32	31	-	-	2.03E-03	1.47E-03
Mentha	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	1.35E-03	1.59E-03
Mentha	BP	GO:0033363	secretory granule organization	-	63	59	-	-	1.86E-02	2.82E-03
Mentha	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	9.84E-04	1.35E-03
Mentha	BP	GO:0120009	intermembrane lipid transfer	-	52	48	-	-	1.27E-02	2.29E-03
Mentha	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	6.55E-03	7.05E-04
Mentha	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	2.86E-03	1.82E-03
Mentha	BP	GO:0033622	integrin activation	-	26	26	-	-	8.83E-03	1.23E-03
Mentha	BP	GO:0098751	bone cell development	-	18	16	-	-	8.49E-04	7.64E-04
Mentha	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	9.42E-04	9.99E-04
Mentha	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	1.97E-03	2.41E-03
Mentha	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.70E-02	1.41E-03
Mentha	BP	GO:0002076	osteoblast development	-	17	17	-	-	1.53E-02	8.23E-04
Mentha	BP	GO:0072164	mesonephric tubule development	-	98	96	-	-	6.33E-03	4.53E-03
Mentha	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	2.30E-04	8.23E-04
Mentha	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	104	-	-	3.93E-03	4.94E-03
Mentha	BP	GO:1903524	positive regulation of blood circulation	-	39	35	-	-	5.19E-04	1.65E-03
Mentha	BP	GO:0030901	midbrain development	-	87	82	-	-	2.78E-03	3.88E-03
Mentha	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	1.40E-02	1.06E-03
Mentha	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	2.25E-04	7.64E-04
Mentha	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	2.88E-03	6.47E-04
Mentha	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	67	-	-	2.01E-03	3.17E-03
Mentha	BP	GO:0002687	positive regulation of leukocyte migration	-	147	142	-	-	3.66E-03	6.70E-03
Mentha	BP	GO:0019755	one-carbon compound transport	-	28	25	-	-	1.89E-02	1.18E-03
Mentha	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.70E-04	6.47E-04
Mentha	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	1.11E-02	7.64E-04
Mentha	BP	GO:0110154	RNA decapping	-	19	18	-	-	3.15E-02	8.82E-04
Mentha	BP	GO:0034605	cellular response to heat	-	66	65	-	-	1.91E-03	3.06E-03
Mentha	BP	GO:0005996	monosaccharide metabolic process	-	250	238	-	-	1.09E-02	1.12E-02
Mentha	BP	GO:0033555	multicellular organismal response to stress	-	90	87	-	-	2.90E-03	4.11E-03
Mentha	BP	GO:0002262	myeloid cell homeostasis	-	172	167	-	-	4.84E-03	7.88E-03
Mentha	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	1.10E-01	1.82E-03
Mentha	BP	GO:0050688	regulation of defense response to virus	-	65	63	-	-	1.83E-02	3.00E-03
Mentha	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	2.38E-03	9.40E-04
Mentha	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	222	-	-	1.53E-02	1.05E-02
Mentha	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	9.89E-04	1.47E-03
Mentha	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	4.57E-04	7.05E-04
Mentha	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	6.85E-03	1.53E-03
Mentha	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	17	-	-	7.97E-04	8.23E-04
Mentha	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	4.24E-02	1.35E-03
Mentha	BP	GO:0022618	protein-RNA complex assembly	-	227	189	-	-	2.52E-02	8.93E-03
Mentha	BP	GO:0051147	regulation of muscle cell differentiation	-	162	130	-	-	5.24E-03	6.11E-03
Mentha	BP	GO:0090102	cochlea development	-	50	47	-	-	1.32E-03	2.23E-03
Mentha	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	1.97E-03	1.23E-03
Mentha	BP	GO:0061303	cornea development in camera-type eye	-	12	11	-	-	1.75E-04	5.29E-04
Mentha	BP	GO:0045933	positive regulation of muscle contraction	-	49	43	-	-	1.43E-03	2.06E-03
Mentha	BP	GO:0015803	branched-chain amino acid transport	-	14	13	-	-	1.10E-02	6.47E-04
Mentha	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	2.28E-04	7.64E-04
Mentha	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	34	-	-	6.12E-03	1.65E-03
Mentha	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	91	-	-	1.08E-01	4.29E-03
Mentha	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.73E-04	5.88E-04
Mentha	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	4.74E-03	1.06E-03
Mentha	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	6.10E-03	3.35E-03
Mentha	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	50	-	-	2.63E-02	2.35E-03
Mentha	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	146	-	-	1.55E-02	6.88E-03
Mentha	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	18	-	-	1.34E-01	8.82E-04
Mentha	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	56	-	-	5.58E-03	2.64E-03
Mentha	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	3.28E-03	5.29E-04
Mentha	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	6.20E-03	1.82E-03
Mentha	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.70E-04	5.88E-04
Mentha	BP	GO:0140253	cell-cell fusion	-	62	56	-	-	9.83E-03	2.64E-03
Mentha	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	1.72E-04	5.88E-04
Mentha	BP	GO:0071599	otic vesicle development	-	15	15	-	-	8.56E-03	7.05E-04
Mentha	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	41	-	-	6.59E-02	1.94E-03
Mentha	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	1.20E-03	7.05E-04
Mentha	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	59	-	-	4.64E-03	2.82E-03
Mentha	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	2.39E-02	1.70E-03
Mentha	BP	GO:0051293	establishment of spindle localization	-	57	56	-	-	4.00E-03	2.64E-03
Mentha	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	1.66E-04	5.88E-04
Mentha	BP	GO:0043114	regulation of vascular permeability	-	49	44	-	-	8.11E-03	2.12E-03
Mentha	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	3.10E-03	1.23E-03
Mentha	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	62	-	-	1.94E-03	2.94E-03
Mentha	BP	GO:0008360	regulation of cell shape	-	139	133	-	-	9.85E-03	6.29E-03
Mentha	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	2.31E-04	7.64E-04
Mentha	BP	GO:0051222	positive regulation of protein transport	-	249	237	-	-	4.85E-03	1.12E-02
Mentha	CC	GO:0140632	canonical inflammasome complex assembly	-	40	38	-	-	1.04E-02	1.82E-03
Mentha	MF	GO:0034260	negative regulation of GTPase activity	-	36	32	-	-	6.67E-04	1.53E-03
Mentha	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	7.55E-03	1.06E-03
Mentha	BP	GO:0045739	positive regulation of DNA repair	-	128	125	-	-	4.92E-02	5.88E-03
Mentha	BP	GO:0001845	phagolysosome assembly	-	19	18	-	-	5.10E-03	8.82E-04
Mentha	BP	GO:0045185	maintenance of protein location	-	95	88	-	-	2.09E-03	4.17E-03
Mentha	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	12	-	-	1.74E-01	5.88E-04
Mentha	BP	GO:0003158	endothelium development	-	140	127	-	-	8.16E-03	6.00E-03
Mentha	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	3.09E-03	1.94E-03
Mentha	BP	GO:0051224	negative regulation of protein transport	-	122	104	-	-	4.43E-03	4.94E-03
Mentha	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	144	-	-	4.27E-03	6.82E-03
Mentha	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	3.63E-03	6.47E-04
Mentha	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	30	-	-	1.91E-02	1.41E-03
Mentha	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	7.00E-02	9.40E-04
Mentha	BP	GO:0021885	forebrain cell migration	-	63	61	-	-	2.79E-03	2.88E-03
Mentha	BP	GO:0007405	neuroblast proliferation	-	81	76	-	-	3.83E-03	3.59E-03
Mentha	BP	GO:0009581	detection of external stimulus	-	137	115	-	-	1.84E-02	5.41E-03
Mentha	BP	GO:1990542	mitochondrial transmembrane transport	-	93	91	-	-	3.46E-02	4.29E-03
Mentha	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	3.79E-03	1.47E-03
Mentha	BP	GO:0033504	floor plate development	-	11	11	-	-	4.91E-03	5.29E-04
Mentha	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	1.92E-03	5.29E-04
Mentha	BP	GO:0097186	amelogenesis	-	26	23	-	-	1.02E-01	1.12E-03
Mentha	BP	GO:0031128	developmental induction	-	26	26	-	-	2.27E-03	1.23E-03
Mentha	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	2.32E-04	7.05E-04
Mentha	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.49E-03	3.12E-03
Mentha	BP	GO:0021533	cell differentiation in hindbrain	-	23	20	-	-	3.96E-03	9.40E-04
Mentha	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	1.00E-03	1.47E-03
Mentha	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	1.60E-03	5.88E-04
Mentha	BP	GO:1900047	negative regulation of hemostasis	-	51	50	-	-	2.36E-02	2.35E-03
Mentha	BP	GO:0021517	ventral spinal cord development	-	47	43	-	-	1.52E-02	2.06E-03
Mentha	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	3.18E-03	3.53E-03
Mentha	BP	GO:0032328	alanine transport	-	19	16	-	-	5.43E-03	7.64E-04
Mentha	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	2.47E-03	7.64E-04
Mentha	BP	GO:0097722	sperm motility	-	133	115	-	-	7.16E-03	5.41E-03
Mentha	BP	GO:0051231	spindle elongation	-	14	13	-	-	9.12E-03	6.47E-04
Mentha	BP	GO:0042490	mechanoreceptor differentiation	-	67	60	-	-	4.52E-03	2.82E-03
Mentha	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.50E-03	1.41E-03
Mentha	BP	GO:0035148	tube formation	-	155	151	-	-	4.79E-03	7.11E-03
Mentha	BP	GO:0048520	positive regulation of behavior	-	27	25	-	-	3.32E-02	1.18E-03
Mentha	BP	GO:0098543	detection of other organism	-	19	17	-	-	5.71E-02	8.23E-04
Mentha	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	9.34E-03	2.06E-03
Mentha	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	118	-	-	8.33E-03	5.58E-03
Mentha	BP	GO:0031123	RNA 3'-end processing	-	79	76	-	-	4.11E-02	3.59E-03
Mentha	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	1.71E-02	5.29E-04
Mentha	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	106	-	-	4.75E-03	5.00E-03
Mentha	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	1.75E-02	8.82E-04
Mentha	CC	GO:0007097	nuclear migration	-	24	23	-	-	2.78E-03	1.12E-03
Mentha	BP	GO:0006885	regulation of pH	-	104	97	-	-	1.59E-02	4.58E-03
Mentha	BP	GO:0002467	germinal center formation	-	14	14	-	-	9.73E-04	7.05E-04
Mentha	BP	GO:1990840	response to lectin	-	22	19	-	-	1.05E-02	9.40E-04
Mentha	BP	GO:0071800	podosome assembly	-	19	19	-	-	9.26E-04	9.40E-04
Mentha	BP	GO:0031018	endocrine pancreas development	-	47	45	-	-	4.23E-03	2.12E-03
Mentha	BP	GO:0001708	cell fate specification	-	108	102	-	-	6.74E-03	4.82E-03
Mentha	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	67	-	-	6.07E-03	3.17E-03
Mentha	BP	GO:0030279	negative regulation of ossification	-	39	36	-	-	1.72E-02	1.70E-03
Mentha	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	2.03E-02	7.05E-04
Mentha	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	2.85E-03	5.88E-04
Mentha	BP	GO:0042440	pigment metabolic process	-	80	75	-	-	2.36E-02	3.53E-03
Mentha	BP	GO:1901606	alpha-amino acid catabolic process	-	101	96	-	-	1.39E-02	4.53E-03
Mentha	BP	GO:1901890	positive regulation of cell junction assembly	-	106	93	-	-	7.23E-03	4.41E-03
Mentha	BP	GO:0070988	demethylation	-	27	25	-	-	3.44E-02	1.18E-03
Mentha	BP	GO:1901655	cellular response to ketone	-	107	102	-	-	5.81E-03	4.82E-03
Mentha	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	2.63E-03	7.05E-04
Mentha	BP	GO:0051255	spindle midzone assembly	-	14	13	-	-	1.78E-02	6.47E-04
Mentha	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	5.34E-02	8.23E-04
Mentha	BP	GO:0006968	cellular defense response	-	52	50	-	-	4.18E-03	2.35E-03
Mentha	BP	GO:0055006	cardiac cell development	-	93	81	-	-	2.95E-03	3.82E-03
Mentha	BP	GO:0031365	N-terminal protein amino acid modification	-	30	28	-	-	2.09E-03	1.35E-03
Mentha	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	1.75E-04	5.88E-04
Mentha	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	27	-	-	1.71E-03	1.29E-03
Mentha	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	4.72E-04	5.88E-04
Mentha	BP	GO:0060004	reflex	-	63	59	-	-	1.23E-02	2.82E-03
Mentha	BP	GO:0044706	multi-multicellular organism process	-	217	204	-	-	9.92E-03	9.64E-03
Mentha	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	4.02E-03	5.88E-04
Mentha	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	139	-	-	4.48E-03	6.58E-03
Mentha	BP	GO:0006026	aminoglycan catabolic process	-	34	32	-	-	2.50E-03	1.53E-03
Mentha	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	2.53E-02	2.17E-03
Mentha	BP	GO:0050768	negative regulation of neurogenesis	-	150	141	-	-	4.07E-03	6.64E-03
Mentha	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	94	-	-	2.18E-03	4.47E-03
Mentha	BP	GO:0090068	positive regulation of cell cycle process	-	262	242	-	-	6.03E-03	1.14E-02
Mentha	BP	GO:0043605	amide catabolic process	-	16	16	-	-	3.43E-02	7.64E-04
Mentha	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	26	-	-	2.84E-03	1.23E-03
Mentha	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	33	-	-	1.94E-02	1.59E-03
Mentha	BP	GO:1902115	regulation of organelle assembly	-	210	200	-	-	5.91E-03	9.40E-03
Mentha	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	63	-	-	2.36E-03	3.00E-03
Mentha	BP	GO:0047484	regulation of response to osmotic stress	-	16	15	-	-	2.29E-04	7.05E-04
Mentha	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	136	-	-	5.06E-03	6.41E-03
Mentha	BP	GO:0043171	peptide catabolic process	-	19	16	-	-	2.31E-04	7.64E-04
Mentha	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	1.36E-03	2.00E-03
Mentha	BP	GO:0051952	regulation of amine transport	-	98	96	-	-	1.50E-02	4.53E-03
Mentha	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	1.05E-02	1.12E-03
Mentha	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	9.50E-03	9.40E-04
Mentha	BP	GO:0015801	aromatic amino acid transport	-	13	11	-	-	1.01E-03	5.29E-04
Mentha	BP	GO:0040019	positive regulation of embryonic development	-	23	22	-	-	7.20E-03	1.06E-03
Mentha	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	2.89E-04	9.40E-04
Mentha	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	2.27E-04	7.64E-04
Mentha	CC	GO:0032365	intracellular lipid transport	-	51	47	-	-	6.66E-03	2.23E-03
Mentha	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	2.87E-02	1.41E-03
Mentha	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	67	-	-	1.69E-03	3.17E-03
Mentha	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	113	-	-	3.25E-03	5.35E-03
Mentha	BP	GO:0018149	peptide cross-linking	-	28	27	-	-	9.18E-02	1.29E-03
Mentha	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	1.07E-03	1.18E-03
Mentha	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	8.27E-04	6.47E-04
Mentha	BP	GO:0021859	pyramidal neuron differentiation	-	14	13	-	-	1.70E-04	6.47E-04
Mentha	BP	GO:0061000	negative regulation of dendritic spine development	-	13	12	-	-	1.68E-04	5.88E-04
Mentha	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	1.87E-02	1.65E-03
Mentha	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	5.71E-03	4.23E-03
Mentha	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	1.47E-02	1.41E-03
Mentha	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	9.57E-03	8.82E-04
Mentha	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	4.27E-03	9.99E-04
Mentha	BP	GO:0015669	gas transport	-	23	22	-	-	2.91E-02	1.06E-03
Mentha	BP	GO:0016485	protein processing	-	248	234	-	-	9.83E-03	1.10E-02
Mentha	BP	GO:0009649	entrainment of circadian clock	-	30	28	-	-	4.92E-03	1.35E-03
Mentha	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	153	-	-	1.31E-02	7.23E-03
Mentha	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	1.61E-03	1.18E-03
Mentha	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	124	-	-	1.55E-02	5.88E-03
Mentha	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	2.25E-02	5.88E-04
Mentha	BP	GO:0099054	presynapse assembly	-	49	43	-	-	1.20E-03	2.06E-03
Mentha	BP	GO:0003353	positive regulation of cilium movement	-	12	11	-	-	2.04E-01	5.29E-04
Mentha	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	5.57E-03	1.18E-03
Mentha	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	1.12E-03	1.18E-03
Mentha	BP	GO:0031348	negative regulation of defense response	-	282	233	-	-	5.88E-03	1.10E-02
Mentha	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	76	-	-	4.75E-03	3.59E-03
Mentha	BP	GO:0007606	sensory perception of chemical stimulus	-	535	130	-	-	2.56E-02	6.11E-03
Mentha	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	3.22E-03	3.23E-03
Mentha	BP	GO:0071496	cellular response to external stimulus	-	74	72	-	-	4.57E-03	3.41E-03
Mentha	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	1.89E-02	6.47E-04
Mentha	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	4.23E-02	8.23E-04
Mentha	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	3.49E-04	5.29E-04
Mentha	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	4.31E-03	5.88E-04
Mentha	BP	GO:0032094	response to food	-	37	36	-	-	1.05E-03	1.70E-03
Mentha	BP	GO:0001964	startle response	-	27	27	-	-	4.79E-03	1.29E-03
Mentha	BP	GO:0007340	acrosome reaction	-	38	32	-	-	1.49E-03	1.53E-03
Mentha	BP	GO:0046434	organophosphate catabolic process	-	232	224	-	-	4.83E-03	1.06E-02
Mentha	BP	GO:0060037	pharyngeal system development	-	29	28	-	-	2.35E-02	1.35E-03
Mentha	BP	GO:0009566	fertilization	-	205	171	-	-	5.85E-03	8.05E-03
Mentha	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	59	-	-	2.74E-01	2.82E-03
Mentha	BP	GO:0120255	olefinic compound biosynthetic process	-	24	22	-	-	2.88E-04	1.06E-03
Mentha	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	9.58E-04	6.47E-04
Mentha	BP	GO:0045907	positive regulation of vasoconstriction	-	30	26	-	-	5.95E-03	1.23E-03
Mentha	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	22	-	-	5.47E-02	1.06E-03
Mentha	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	2.33E-02	1.17E-02
Mentha	BP	GO:0009309	amine biosynthetic process	-	38	35	-	-	3.04E-02	1.65E-03
Mentha	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	5.61E-04	9.40E-04
Mentha	BP	GO:0061900	glial cell activation	-	56	52	-	-	2.49E-03	2.47E-03
Mentha	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	132	-	-	8.91E-03	6.23E-03
Mentha	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	12	-	-	1.73E-04	5.88E-04
Mentha	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	4.11E-03	7.05E-04
Mentha	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	1.34E-02	1.94E-03
Mentha	BP	GO:0035902	response to immobilization stress	-	20	19	-	-	2.25E-04	9.40E-04
Mentha	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	3.37E-04	7.05E-04
Mentha	BP	GO:0072537	fibroblast activation	-	13	13	-	-	5.35E-03	6.47E-04
Mentha	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	5.74E-03	6.47E-04
Mentha	BP	GO:0043647	inositol phosphate metabolic process	-	44	42	-	-	1.53E-03	2.00E-03
Mentha	BP	GO:0016180	snRNA processing	-	28	26	-	-	2.05E-01	1.23E-03
Mentha	BP	GO:0051303	establishment of chromosome localization	-	104	101	-	-	9.28E-03	4.76E-03
Mentha	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	3.04E-02	7.64E-04
Mentha	BP	GO:0007164	establishment of tissue polarity	-	38	37	-	-	4.37E-03	1.76E-03
Mentha	BP	GO:0097164	ammonium ion metabolic process	-	23	22	-	-	2.90E-04	1.06E-03
Mentha	BP	GO:0021515	cell differentiation in spinal cord	-	51	46	-	-	5.67E-03	2.17E-03
Mentha	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	4.90E-03	8.82E-04
Mentha	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	2.10E-03	9.99E-04
Mentha	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	8.06E-04	1.35E-03
Mentha	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	3.43E-03	8.82E-04
Mentha	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	35	-	-	1.23E-02	1.65E-03
Mentha	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	1.62E-03	1.06E-03
Mentha	BP	GO:0007566	embryo implantation	-	57	52	-	-	1.68E-03	2.47E-03
Mentha	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	32	-	-	1.40E-03	1.53E-03
Mentha	BP	GO:0031268	pseudopodium organization	-	17	15	-	-	6.19E-02	7.05E-04
Mentha	BP	GO:0060306	regulation of membrane repolarization	-	38	30	-	-	6.06E-03	1.41E-03
Mentha	BP	GO:0051017	actin filament bundle assembly	-	161	151	-	-	5.69E-03	7.11E-03
Mentha	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	1.70E-03	2.00E-03
Mentha	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	17	-	-	8.47E-04	8.23E-04
Mentha	BP	GO:0021542	dentate gyrus development	-	19	18	-	-	4.06E-04	8.82E-04
Mentha	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	2.52E-03	6.47E-04
Mentha	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	36	-	-	2.99E-03	1.70E-03
Mentha	BP	GO:0021756	striatum development	-	21	21	-	-	1.88E-03	9.99E-04
Mentha	BP	GO:1901343	negative regulation of vasculature development	-	154	99	-	-	4.96E-03	4.70E-03
Mentha	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	149	-	-	1.32E-02	7.05E-03
Mentha	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	28	-	-	6.62E-04	1.35E-03
Mentha	BP	GO:1902414	protein localization to cell junction	-	107	103	-	-	7.29E-03	4.88E-03
Mentha	BP	GO:0071305	cellular response to vitamin D	-	23	21	-	-	1.81E-03	9.99E-04
Mentha	BP	GO:0051304	chromosome separation	-	80	80	-	-	1.04E-02	3.76E-03
Mentha	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	2.18E-03	8.82E-04
Mentha	BP	GO:0048709	oligodendrocyte differentiation	-	101	97	-	-	2.28E-03	4.58E-03
Mentha	BP	GO:0045017	glycerolipid biosynthetic process	-	254	241	-	-	1.35E-02	1.13E-02
Mentha	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	3.45E-01	7.05E-04
Mentha	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	7.99E-03	1.12E-03
Mentha	BP	GO:0001776	leukocyte homeostasis	-	108	100	-	-	2.68E-03	4.70E-03
Mentha	BP	GO:0050769	positive regulation of neurogenesis	-	240	227	-	-	6.23E-03	1.07E-02
Mentha	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	3.27E-02	7.05E-04
Mentha	BP	GO:0030193	regulation of blood coagulation	-	70	69	-	-	1.47E-02	3.29E-03
Mentha	BP	GO:0050866	negative regulation of cell activation	-	216	199	-	-	5.83E-03	9.40E-03
Mentha	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	35	-	-	1.58E-03	1.65E-03
Mentha	BP	GO:0033500	carbohydrate homeostasis	-	251	222	-	-	4.95E-03	1.05E-02
Mentha	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	29	-	-	1.33E-02	1.41E-03
Mentha	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	4.41E-03	2.64E-03
Mentha	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	3.28E-03	1.12E-03
Mentha	CC	GO:0099522	cytosolic region	-	20	20	-	-	9.12E-04	9.40E-04
Mentha	CC	GO:0000791	euchromatin	-	60	58	-	-	4.22E-03	2.76E-03
Mentha	CC	GO:0030666	endocytic vesicle membrane	-	196	192	-	-	9.57E-03	9.05E-03
Mentha	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	5.43E-02	7.05E-04
Mentha	CC	GO:1990752	microtubule end	-	34	34	-	-	1.57E-02	1.65E-03
Mentha	CC	GO:0043204	perikaryon	-	156	148	-	-	2.65E-03	6.99E-03
Mentha	CC	GO:0061702	canonical inflammasome complex	-	17	16	-	-	6.33E-02	7.64E-04
Mentha	CC	GO:0097542	ciliary tip	-	48	47	-	-	1.32E-01	2.23E-03
Mentha	CC	GO:1905368	peptidase complex	-	124	121	-	-	7.90E-02	5.70E-03
Mentha	CC	GO:0000792	heterochromatin	-	98	97	-	-	9.97E-03	4.58E-03
Mentha	CC	GO:0097546	ciliary base	-	47	43	-	-	9.17E-03	2.06E-03
Mentha	CC	GO:0071819	DUBm complex	-	25	23	-	-	2.70E-01	1.12E-03
Mentha	CC	GO:0031201	SNARE complex	-	48	48	-	-	2.85E-01	2.29E-03
Mentha	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.53E-03	6.47E-04
Mentha	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	7.96E-03	1.88E-03
Mentha	CC	GO:0044391	ribosomal subunit	-	203	201	-	-	3.37E-01	9.46E-03
Mentha	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	4.43E-02	5.29E-04
Mentha	CC	GO:0071013	catalytic step 2 spliceosome	-	88	86	-	-	6.55E-02	4.06E-03
Mentha	CC	GO:0031907	microbody lumen	-	51	51	-	-	9.17E-02	2.41E-03
Mentha	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	2.12E-01	5.29E-04
Mentha	CC	GO:0098862	cluster of actin-based cell projections	-	162	141	-	-	2.36E-02	6.64E-03
Mentha	CC	GO:0016363	nuclear matrix	-	127	127	-	-	5.64E-03	6.00E-03
Mentha	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	4.10E-02	2.17E-03
Mentha	CC	GO:0032432	actin filament bundle	-	249	229	-	-	1.44E-02	1.08E-02
Mentha	CC	GO:0008088	axo-dendritic transport	-	78	77	-	-	6.77E-03	3.64E-03
Mentha	CC	GO:0031519	PcG protein complex	-	38	38	-	-	5.65E-02	1.82E-03
Mentha	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	40	-	-	3.51E-02	1.88E-03
Mentha	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	215	-	-	1.86E-02	1.01E-02
Mentha	CC	GO:0000313	organellar ribosome	-	89	89	-	-	3.64E-01	4.23E-03
Mentha	CC	GO:0099643	signal release from synapse	-	147	139	-	-	8.34E-03	6.58E-03
Mentha	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	2.42E-02	2.17E-03
Mentha	CC	GO:0030018	Z disc	-	129	124	-	-	1.29E-02	5.88E-03
Mentha	CC	GO:0032580	Golgi cisterna membrane	-	93	73	-	-	4.62E-03	3.47E-03
Mentha	CC	GO:0097381	photoreceptor disc membrane	-	25	20	-	-	1.27E-02	9.40E-04
Mentha	CC	GO:1905360	GTPase complex	-	41	39	-	-	8.07E-02	1.88E-03
Mentha	CC	GO:0097540	axonemal central pair	-	161	137	-	-	6.36E-03	6.47E-03
Mentha	CC	GO:0042641	actomyosin	-	77	74	-	-	8.15E-03	3.53E-03
Mentha	CC	GO:0097386	glial cell projection	-	38	36	-	-	9.07E-04	1.70E-03
Mentha	CC	GO:0032588	trans-Golgi network membrane	-	102	99	-	-	8.37E-03	4.70E-03
Mentha	CC	GO:0070382	exocytic vesicle	-	224	214	-	-	1.09E-02	1.01E-02
Mentha	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	46	-	-	3.16E-02	2.17E-03
Mentha	CC	GO:0031903	microbody membrane	-	65	64	-	-	8.82E-02	3.06E-03
Mentha	CC	GO:0046930	pore complex	-	26	26	-	-	4.78E-02	1.23E-03
Mentha	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	1.38E-02	5.29E-04
Mentha	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	1.34E-03	7.64E-04
Mentha	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	242	-	-	1.12E-02	1.14E-02
Mentha	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	5.73E-03	1.18E-03
Mentha	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.12E-01	5.29E-04
Mentha	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	5.58E-03	8.23E-04
Mentha	CC	GO:0044298	cell body membrane	-	32	32	-	-	1.32E-02	1.53E-03
Mentha	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	4.54E-02	5.29E-04
Mentha	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	1.68E-03	9.99E-04
Mentha	CC	GO:0045495	pole plasm	-	25	22	-	-	8.45E-04	1.06E-03
Mentha	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	2.14E-03	7.05E-04
Mentha	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	1.34E-01	9.40E-04
Mentha	CC	GO:0010369	chromocenter	-	14	14	-	-	1.02E-03	7.05E-04
Mentha	CC	GO:0002177	manchette	-	19	15	-	-	2.29E-04	7.05E-04
Mentha	CC	GO:0016323	basolateral plasma membrane	-	239	225	-	-	8.62E-03	1.06E-02
Mentha	CC	GO:0045009	chitosome	-	21	21	-	-	5.94E-02	9.99E-04
Mentha	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	2.05E-03	5.88E-04
Mentha	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	5.94E-03	2.12E-03
Mentha	CC	GO:0098636	protein complex involved in cell adhesion	-	57	54	-	-	2.04E-02	2.59E-03
Mentha	CC	GO:0001917	photoreceptor inner segment	-	71	66	-	-	8.13E-03	3.12E-03
Mentha	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	1.11E-03	7.05E-04
Mentha	CC	GO:0019897	extrinsic component of plasma membrane	-	156	150	-	-	2.31E-02	7.05E-03
Mentha	CC	GO:0031594	neuromuscular junction	-	73	72	-	-	2.98E-03	3.41E-03
Mentha	CC	GO:0045120	pronucleus	-	14	14	-	-	3.04E-04	7.05E-04
Mentha	CC	GO:0043083	synaptic cleft	-	21	18	-	-	7.00E-03	8.82E-04
Mentha	CC	GO:0000922	spindle pole	-	172	167	-	-	6.89E-03	7.88E-03
Mentha	CC	GO:0120111	neuron projection cytoplasm	-	94	91	-	-	1.22E-02	4.29E-03
Mentha	CC	GO:0070971	endoplasmic reticulum exit site	-	32	28	-	-	7.95E-02	1.35E-03
Mentha	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	9.52E-02	6.47E-04
Mentha	CC	GO:0004879	nuclear receptor activity	-	63	61	-	-	1.15E-02	2.88E-03
Mentha	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	164	-	-	1.38E-02	7.76E-03
Mentha	CC	GO:0000123	histone acetyltransferase complex	-	93	89	-	-	8.78E-02	4.23E-03
Mentha	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	3.49E-03	6.47E-04
Mentha	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	106	-	-	1.32E-01	5.00E-03
Mentha	CC	GO:0048786	presynaptic active zone	-	80	76	-	-	6.25E-03	3.59E-03
Mentha	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	6.15E-02	5.88E-04
Mentha	CC	GO:0007034	vacuolar transport	-	168	164	-	-	2.74E-02	7.76E-03
Mentha	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	5.88E-02	9.99E-04
Mentha	CC	GO:0043194	axon initial segment	-	21	20	-	-	8.99E-02	9.40E-04
Mentha	CC	GO:0005776	autophagosome	-	111	107	-	-	1.82E-02	5.05E-03
Mentha	CC	GO:0031430	M band	-	22	20	-	-	8.82E-04	9.40E-04
Mentha	CC	GO:0001931	uropod	-	13	13	-	-	2.27E-02	6.47E-04
Mentha	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	2.31E-01	3.53E-03
Mentha	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	93	-	-	2.07E-01	4.41E-03
Mentha	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	4.49E-01	6.47E-04
Mentha	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	4.32E-02	9.40E-04
Mentha	CC	GO:0071203	WASH complex	-	12	12	-	-	1.36E-01	5.88E-04
Mentha	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	2.28E-02	1.41E-03
Mentha	CC	GO:0032994	protein-lipid complex	-	39	37	-	-	4.64E-02	1.76E-03
Mentha	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	146	-	-	1.03E-01	6.88E-03
Mentha	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	1.09E-02	5.88E-04
Mentha	CC	GO:0001527	microfibril	-	13	12	-	-	1.81E-02	5.88E-04
Mentha	CC	GO:0072562	blood microparticle	-	144	128	-	-	2.64E-02	6.05E-03
Mentha	CC	GO:0005883	neurofilament	-	11	11	-	-	1.30E-02	5.29E-04
Mentha	CC	GO:0051233	spindle midzone	-	36	34	-	-	2.29E-03	1.65E-03
Mentha	CC	GO:0005811	lipid droplet	-	102	97	-	-	1.41E-02	4.58E-03
Mentha	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	7.89E-03	2.12E-03
Mentha	CC	GO:0043113	receptor clustering	-	51	50	-	-	7.59E-03	2.35E-03
Mentha	CC	GO:0005940	septin ring	-	14	13	-	-	6.82E-01	6.47E-04
Mentha	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	3.50E-02	5.29E-04
Mentha	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	22	-	-	6.87E-02	1.06E-03
Mentha	CC	GO:0044853	plasma membrane raft	-	114	112	-	-	6.77E-03	5.29E-03
Mentha	CC	GO:0005881	cytoplasmic microtubule	-	256	220	-	-	7.18E-03	1.03E-02
Mentha	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	2.03E-03	7.05E-04
Mentha	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	9.89E-03	8.23E-04
Mentha	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	57	-	-	1.73E-02	2.70E-03
Mentha	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	1.34E-02	3.41E-03
Mentha	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	5.77E-02	5.88E-04
Mentha	CC	GO:0043034	costamere	-	18	18	-	-	8.05E-03	8.82E-04
Mentha	CC	GO:0031904	endosome lumen	-	38	36	-	-	5.38E-03	1.70E-03
Mentha	CC	GO:0060170	ciliary membrane	-	76	66	-	-	1.54E-02	3.12E-03
Mentha	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	4.92E-01	6.47E-04
Mentha	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	7.83E-03	5.88E-04
Mentha	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	6.76E-02	1.18E-03
Mentha	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	9.04E-02	7.05E-04
Mentha	CC	GO:0032154	cleavage furrow	-	54	52	-	-	5.55E-03	2.47E-03
Mentha	CC	GO:0005640	nuclear outer membrane	-	30	27	-	-	2.20E-03	1.29E-03
Mentha	CC	GO:0005652	nuclear lamina	-	12	12	-	-	1.19E-03	5.88E-04
Mentha	CC	GO:0007006	mitochondrial membrane organization	-	117	110	-	-	1.75E-02	5.17E-03
Mentha	CC	GO:0001772	immunological synapse	-	44	42	-	-	4.28E-03	2.00E-03
Mentha	CC	GO:0030904	retromer complex	-	12	12	-	-	3.31E-02	5.88E-04
Mentha	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	9.94E-03	5.88E-04
Mentha	CC	GO:0030863	cortical cytoskeleton	-	104	99	-	-	7.57E-03	4.70E-03
Mentha	CC	GO:1905348	endonuclease complex	-	38	36	-	-	1.11E-01	1.70E-03
Mentha	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	2.36E-01	5.29E-04
Mentha	CC	GO:0030315	T-tubule	-	52	50	-	-	3.95E-02	2.35E-03
Mentha	CC	GO:0060076	excitatory synapse	-	64	58	-	-	1.44E-02	2.76E-03
Mentha	CC	GO:0036019	endolysosome	-	29	29	-	-	3.34E-02	1.41E-03
Mentha	CC	GO:0001891	phagocytic cup	-	28	28	-	-	3.29E-03	1.35E-03
Mentha	CC	GO:0099086	synaptonemal structure	-	40	38	-	-	1.09E-02	1.82E-03
Mentha	CC	GO:0030427	site of polarized growth	-	172	170	-	-	4.09E-03	7.99E-03
Mentha	CC	GO:0044309	neuron spine	-	213	203	-	-	7.58E-03	9.58E-03
Mentha	CC	GO:0030658	transport vesicle membrane	-	231	221	-	-	1.79E-02	1.04E-02
Mentha	CC	GO:0098918	structural constituent of synapse	-	27	26	-	-	5.31E-03	1.23E-03
Mentha	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.00E-01	5.88E-04
Mentha	CC	GO:0000940	outer kinetochore	-	17	17	-	-	9.88E-02	8.23E-04
Mentha	CC	GO:0034719	SMN-Sm protein complex	-	18	16	-	-	1.65E-01	7.64E-04
Mentha	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	1.61E-02	2.35E-03
Mentha	CC	GO:0098803	respiratory chain complex	-	39	33	-	-	2.45E-01	1.59E-03
Mentha	CC	GO:0097545	axonemal outer doublet	-	164	140	-	-	6.35E-03	6.58E-03
Mentha	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	18	-	-	3.98E-04	8.82E-04
Mentha	CC	GO:0070069	cytochrome complex	-	42	36	-	-	2.51E-01	1.70E-03
Mentha	CC	GO:0031143	pseudopodium	-	18	18	-	-	4.89E-03	8.82E-04
Mentha	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	25	-	-	6.24E-02	1.18E-03
Mentha	CC	GO:0055037	recycling endosome	-	200	186	-	-	6.36E-03	8.76E-03
Mentha	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	91	-	-	7.11E-03	4.29E-03
Mentha	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	1.71E-01	6.47E-04
Mentha	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	1.33E-03	5.88E-04
Mentha	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	2.03E-03	1.06E-03
Mentha	CC	GO:0030684	preribosome	-	76	73	-	-	4.95E-02	3.47E-03
Mentha	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	2.74E-01	8.82E-04
Mentha	CC	GO:1990391	DNA repair complex	-	22	22	-	-	3.31E-02	1.06E-03
Mentha	CC	GO:0005775	vacuolar lumen	-	176	170	-	-	5.70E-03	7.99E-03
Mentha	CC	GO:0032433	filopodium tip	-	19	19	-	-	2.41E-03	9.40E-04
Mentha	CC	GO:0032982	myosin filament	-	24	24	-	-	9.01E-03	1.18E-03
Mentha	CC	GO:0016327	apicolateral plasma membrane	-	23	22	-	-	1.81E-03	1.06E-03
Mentha	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	1.16E-01	1.12E-03
Mentha	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	11	-	-	2.46E-02	5.29E-04
Mentha	CC	GO:0044306	neuron projection terminus	-	164	156	-	-	1.07E-02	7.35E-03
Mentha	CC	GO:0034455	t-UTP complex	-	53	51	-	-	4.08E-02	2.41E-03
Mentha	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	7.14E-01	8.23E-04
Mentha	CC	GO:0031970	organelle envelope lumen	-	94	92	-	-	5.12E-03	4.35E-03
Mentha	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.06E-02	6.47E-04
Mentha	CC	GO:0120293	dynein axonemal particle	-	20	18	-	-	3.73E-03	8.82E-04
Mentha	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	8.57E-04	1.18E-03
Mentha	CC	GO:0043292	contractile muscle fiber	-	245	233	-	-	2.83E-02	1.10E-02
Mentha	CC	GO:0018995	host cellular component	-	12	12	-	-	7.14E-03	5.88E-04
Mentha	CC	GO:0034709	methylosome	-	13	12	-	-	1.79E-02	5.88E-04
Mentha	CC	GO:0032426	stereocilium tip	-	21	14	-	-	1.74E-04	7.05E-04
Mentha	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	5.02E-02	5.88E-04
Mentha	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	1.81E-01	9.40E-04
Mentha	CC	GO:0000803	sex chromosome	-	32	29	-	-	2.58E-03	1.41E-03
Mentha	CC	GO:0098982	GABA-ergic synapse	-	84	77	-	-	8.28E-03	3.64E-03
Mentha	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	4.11E-02	7.64E-04
Mentha	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	3.70E-02	3.00E-03
Mentha	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	1.93E-01	7.05E-04
Mentha	CC	GO:0000242	pericentriolar material	-	22	22	-	-	6.30E-03	1.06E-03
Mentha	CC	GO:1903293	phosphatase complex	-	54	53	-	-	2.37E-02	2.53E-03
Mentha	CC	GO:0097470	ribbon synapse	-	13	13	-	-	5.73E-03	6.47E-04
Mentha	CC	GO:0031941	filamentous actin	-	27	24	-	-	2.63E-03	1.18E-03
Mentha	CC	GO:0000786	nucleosome	-	149	103	-	-	3.71E-02	4.88E-03
Mentha	CC	GO:0001533	cornified envelope	-	59	56	-	-	4.42E-02	2.64E-03
Mentha	CC	GO:1904724	tertiary granule lumen	-	55	54	-	-	4.02E-03	2.59E-03
Mentha	CC	GO:0030027	lamellipodium	-	202	201	-	-	8.57E-03	9.46E-03
Mentha	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	3.84E-03	7.05E-04
Mentha	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	25	-	-	2.97E-02	1.18E-03
Mentha	CC	GO:0000800	lateral element	-	14	14	-	-	2.52E-02	7.05E-04
Mentha	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	4.80E-03	5.88E-04
Mentha	CC	GO:0060077	inhibitory synapse	-	20	19	-	-	2.57E-02	9.40E-04
Mentha	CC	GO:0031209	SCAR complex	-	12	12	-	-	9.58E-02	5.88E-04
Mentha	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	2.50E-01	7.64E-04
Mentha	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	6.53E-02	9.99E-04
Mentha	CC	GO:0002102	podosome	-	31	31	-	-	1.40E-03	1.47E-03
Mentha	CC	GO:0090543	Flemming body	-	33	32	-	-	1.33E-02	1.53E-03
Mentha	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	4.54E-03	3.12E-03
Mentha	CC	GO:0001650	fibrillar center	-	151	150	-	-	4.45E-03	7.05E-03
Mentha	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	1.18E-02	7.05E-04
Mentha	CC	GO:1990204	oxidoreductase complex	-	90	80	-	-	9.88E-02	3.76E-03
Mentha	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	7.31E-02	7.64E-04
Mentha	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.93E-01	5.29E-04
Mentha	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	4.04E-03	5.88E-03
Mentha	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	1.32E-01	9.40E-04
Mentha	CC	GO:0001726	ruffle	-	181	180	-	-	7.50E-03	8.46E-03
Mentha	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	4.70E-03	6.47E-04
Mentha	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	1.01E-01	8.82E-04
Mentha	CC	GO:0043198	dendritic shaft	-	38	37	-	-	8.12E-04	1.76E-03
Mentha	CC	GO:0043073	germ cell nucleus	-	67	63	-	-	2.50E-03	3.00E-03
Mentha	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	1.55E-02	9.99E-04
Mentha	CC	GO:0016592	mediator complex	-	38	38	-	-	6.28E-01	1.82E-03
Mentha	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	2.29E-02	9.40E-04
Mentha	CC	GO:0022626	cytosolic ribosome	-	118	116	-	-	2.41E-01	5.47E-03
Mentha	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	5.58E-02	2.12E-03
Mentha	CC	GO:0034451	centriolar satellite	-	120	117	-	-	1.58E-02	5.52E-03
Mentha	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	4.77E-02	5.29E-04
Mentha	CC	GO:0045171	intercellular bridge	-	91	88	-	-	1.68E-02	4.17E-03
Mentha	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	80	-	-	9.41E-03	3.76E-03
Mentha	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	2.63E-01	7.05E-04
Mentha	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.62E-02	5.29E-04
Mentha	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	4.99E-02	5.29E-04
Mentha	CC	GO:0044292	dendrite terminus	-	13	13	-	-	1.07E-03	6.47E-04
Mentha	CC	GO:0032039	integrator complex	-	19	17	-	-	7.04E-01	8.23E-04
Mentha	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	9.77E-03	7.05E-04
Mentha	CC	GO:0033268	node of Ranvier	-	16	16	-	-	3.65E-02	7.64E-04
Mentha	CC	GO:0036038	MKS complex	-	13	13	-	-	7.59E-03	6.47E-04
Mentha	CC	GO:0030527	structural constituent of chromatin	-	97	53	-	-	1.22E-02	2.53E-03
Mentha	CC	GO:0036379	myofilament	-	26	23	-	-	2.33E-02	1.12E-03
Mentha	CC	GO:0030286	dynein complex	-	210	180	-	-	1.12E-02	8.46E-03
Mentha	CC	GO:0031105	septin complex	-	14	13	-	-	5.73E-01	6.47E-04
Mentha	CC	GO:0097228	sperm principal piece	-	33	25	-	-	5.67E-02	1.18E-03
Mentha	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	8.53E-03	5.88E-04
Mentha	CC	GO:0016482	cytosolic transport	-	135	134	-	-	1.18E-02	6.35E-03
Mentha	CC	GO:0090665	glycoprotein complex	-	23	22	-	-	4.44E-02	1.06E-03
Mentha	CC	GO:0005796	Golgi lumen	-	106	94	-	-	4.71E-03	4.47E-03
Mentha	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	35	-	-	9.42E-02	1.65E-03
Mentha	CC	GO:0034358	plasma lipoprotein particle	-	36	34	-	-	3.91E-02	1.65E-03
Mentha	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	7.33E-02	2.23E-03
Mentha	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	24	-	-	8.19E-03	1.18E-03
Mentha	CC	GO:0030662	coated vesicle membrane	-	202	197	-	-	1.99E-02	9.29E-03
Mentha	CC	GO:0007039	protein catabolic process in the vacuole	-	61	59	-	-	3.64E-02	2.82E-03
Mentha	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	66	-	-	2.69E-01	3.12E-03
Mentha	CC	GO:0090734	site of DNA damage	-	118	116	-	-	1.34E-02	5.47E-03
Mentha	MF	GO:0051861	glycolipid binding	-	30	29	-	-	4.72E-03	1.41E-03
Mentha	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.73E-04	5.29E-04
Mentha	MF	GO:0051087	protein-folding chaperone binding	-	135	134	-	-	6.83E-03	6.35E-03
Mentha	MF	GO:0051959	dynein light intermediate chain binding	-	27	25	-	-	2.29E-03	1.18E-03
Mentha	CC	GO:0015464	acetylcholine receptor activity	-	21	17	-	-	3.03E-01	8.23E-04
Mentha	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	1.52E-02	5.88E-04
Mentha	MF	GO:0016594	glycine binding	-	12	12	-	-	5.97E-02	5.88E-04
Mentha	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	2.05E-03	9.40E-04
Mentha	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	1.07E-03	1.76E-03
Mentha	MF	GO:0035613	RNA stem-loop binding	-	21	17	-	-	7.92E-04	8.23E-04
Mentha	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	238	-	-	8.90E-03	1.12E-02
Mentha	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	19	-	-	5.68E-04	9.40E-04
Mentha	MF	GO:0033691	sialic acid binding	-	22	20	-	-	4.70E-03	9.40E-04
Mentha	MF	GO:0048306	calcium-dependent protein binding	-	61	58	-	-	3.44E-02	2.76E-03
Mentha	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	1.74E-02	1.35E-03
Mentha	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	1.26E-01	6.47E-04
Mentha	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	135	-	-	1.09E-02	6.35E-03
Mentha	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	58	-	-	6.73E-02	2.76E-03
Mentha	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	130	-	-	1.25E-02	6.11E-03
Mentha	MF	GO:0045504	dynein heavy chain binding	-	16	15	-	-	1.29E-01	7.05E-04
Mentha	MF	GO:0140457	protein demethylase activity	-	31	28	-	-	1.70E-03	1.35E-03
Mentha	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	4.59E-03	1.06E-03
Mentha	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	2.42E-03	7.05E-04
Mentha	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	3.03E-02	7.05E-04
Mentha	MF	GO:0061980	regulatory RNA binding	-	52	45	-	-	5.04E-03	2.12E-03
Mentha	MF	GO:0015035	protein-disulfide reductase activity	-	32	31	-	-	1.67E-02	1.47E-03
Mentha	MF	GO:0000182	rDNA binding	-	11	11	-	-	3.48E-03	5.29E-04
Mentha	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	8.04E-04	1.41E-03
Mentha	MF	GO:0070840	dynein complex binding	-	25	23	-	-	2.31E-03	1.12E-03
Mentha	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.03E-03	1.18E-03
Mentha	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.40E-03	7.64E-04
Mentha	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	8.11E-04	1.65E-03
Mentha	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	1.10E-02	8.82E-04
Mentha	MF	GO:0005178	integrin binding	-	153	149	-	-	2.71E-02	7.05E-03
Mentha	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	4.63E-04	8.23E-04
Mentha	MF	GO:0005549	odorant binding	-	128	18	-	-	9.36E-02	8.82E-04
Mentha	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.12E-02	7.05E-04
Mentha	MF	GO:0008327	methyl-CpG binding	-	31	28	-	-	8.64E-03	1.35E-03
Mentha	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	1.94E-03	9.40E-04
Mentha	MF	GO:0048019	receptor antagonist activity	-	31	19	-	-	6.28E-04	9.40E-04
Mentha	MF	GO:0005521	lamin binding	-	15	15	-	-	6.10E-03	7.05E-04
Mentha	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	4.64E-03	8.23E-04
Mentha	MF	GO:0140318	protein transporter activity	-	40	39	-	-	2.12E-02	1.88E-03
Mentha	MF	GO:0070628	proteasome binding	-	17	17	-	-	6.86E-03	8.23E-04
Mentha	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	3.65E-03	5.29E-04
Mentha	MF	GO:0031432	titin binding	-	13	11	-	-	9.72E-03	5.29E-04
Mentha	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.83E-03	5.29E-04
Mentha	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	5.66E-03	1.76E-03
Mentha	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	9.12E-03	8.23E-04
Mentha	MF	GO:0002039	p53 binding	-	66	66	-	-	3.81E-03	3.12E-03
Mentha	MF	GO:0005496	steroid binding	-	110	101	-	-	7.20E-03	4.76E-03
Mentha	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.68E-02	1.29E-03
Mentha	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.73E-04	5.29E-04
Mentha	MF	GO:0003684	damaged DNA binding	-	89	85	-	-	2.19E-02	4.00E-03
Mentha	MF	GO:0000339	RNA cap binding	-	20	19	-	-	1.33E-02	9.40E-04
Mentha	MF	GO:0016500	protein-hormone receptor activity	-	21	17	-	-	4.14E-03	8.23E-04
Mentha	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	123	-	-	1.11E-02	5.82E-03
Mentha	MF	GO:0005523	tropomyosin binding	-	15	12	-	-	4.53E-03	5.88E-04
Mentha	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	2.43E-03	5.88E-04
Mentha	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	1.55E-02	5.29E-04
Mentha	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	1.03E-02	2.82E-03
Mentha	MF	GO:0050811	GABA receptor binding	-	18	16	-	-	1.14E-03	7.64E-04
Mentha	MF	GO:0030971	receptor tyrosine kinase binding	-	76	69	-	-	3.10E-03	3.29E-03
Mentha	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	83	-	-	3.63E-02	3.94E-03
Mentha	MF	GO:0140030	modification-dependent protein binding	-	179	175	-	-	6.29E-03	8.23E-03
Mentha	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	23	-	-	4.62E-03	1.12E-03
Mentha	MF	GO:0009881	photoreceptor activity	-	17	12	-	-	6.28E-04	5.88E-04
Mentha	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	17	-	-	2.88E-02	8.23E-04
Mentha	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.12E-03	6.47E-04
Mentha	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	1.80E-02	7.64E-04
Mentha	MF	GO:0141047	molecular tag activity	-	13	13	-	-	6.33E-04	6.47E-04
Mentha	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.68E-02	5.29E-04
Mentha	MF	GO:0033130	acetylcholine receptor binding	-	12	11	-	-	1.74E-04	5.29E-04
Mentha	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	1.22E-03	7.05E-04
Mentha	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	9.39E-03	5.88E-04
Mentha	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.21E-02	7.05E-04
Mentha	MF	GO:0010851	cyclase regulator activity	-	17	13	-	-	1.47E-03	6.47E-04
Mentha	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	2.07E-02	7.05E-04
Mentha	MF	GO:0030276	clathrin binding	-	70	68	-	-	3.91E-02	3.23E-03
Mentha	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	3.49E-03	1.41E-03
Mentha	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	8.85E-04	7.05E-04
Mentha	MF	GO:0046790	virion binding	-	19	18	-	-	5.44E-04	8.82E-04
Mentha	MF	GO:0030552	cAMP binding	-	48	45	-	-	1.98E-02	2.12E-03
Mentha	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	4.23E-03	1.82E-03
Mentha	MF	GO:0035173	histone kinase activity	-	17	17	-	-	6.29E-04	8.23E-04
Mentha	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	1.29E-02	1.23E-03
Mentha	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	4.68E-03	5.88E-04
Mentha	MF	GO:0004984	olfactory receptor activity	-	429	60	-	-	7.61E-04	2.82E-03
Mentha	MF	GO:0016209	antioxidant activity	-	92	82	-	-	1.10E-02	3.88E-03
Mentha	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	3.12E-03	1.41E-03
Mentha	MF	GO:0044325	transmembrane transporter binding	-	159	148	-	-	8.69E-03	6.99E-03
Mentha	MF	GO:0048156	tau protein binding	-	43	43	-	-	2.42E-03	2.06E-03
Mentha	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	2.65E-02	1.70E-03
Mentha	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	2.34E-03	6.47E-04
Mentha	MF	GO:0140272	exogenous protein binding	-	79	79	-	-	4.67E-03	3.76E-03
Mentha	MF	GO:0030145	manganese ion binding	-	65	62	-	-	2.00E-03	2.94E-03
Mentha	MF	GO:0071814	protein-lipid complex binding	-	52	45	-	-	5.39E-03	2.12E-03
Mentha	MF	GO:0008066	glutamate receptor activity	-	70	65	-	-	6.77E-03	3.06E-03
Mentha	MF	GO:0030553	cGMP binding	-	15	11	-	-	1.87E-02	5.29E-04
Mentha	MF	GO:0017069	snRNA binding	-	54	47	-	-	1.91E-02	2.23E-03
Mentha	MF	GO:0030215	semaphorin receptor binding	-	23	20	-	-	2.35E-02	9.40E-04
Mentha	MF	GO:0031996	thioesterase binding	-	11	11	-	-	1.15E-03	5.29E-04
Mentha	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	9.35E-03	1.47E-03
Mentha	MF	GO:0019843	rRNA binding	-	69	68	-	-	2.12E-02	3.23E-03
Mentha	MF	GO:0004713	protein tyrosine kinase activity	-	213	210	-	-	1.07E-02	9.87E-03
Mentha	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	4.44E-03	2.41E-03
Mentha	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.24E-03	1.18E-03
Mentha	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	1.12E-03	9.40E-04
Mentha	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	28	-	-	3.59E-03	1.35E-03
Mentha	MF	GO:0016208	AMP binding	-	22	22	-	-	1.37E-02	1.06E-03
Mentha	MF	GO:0000287	magnesium ion binding	-	225	215	-	-	6.97E-03	1.01E-02
Mentha	MF	GO:0031490	chromatin DNA binding	-	120	115	-	-	8.85E-03	5.41E-03
Mentha	MF	GO:0017022	myosin binding	-	73	71	-	-	8.61E-03	3.35E-03
Mentha	MF	GO:0004896	cytokine receptor activity	-	93	87	-	-	1.06E-02	4.11E-03
Mentha	MF	GO:0017166	vinculin binding	-	12	12	-	-	5.06E-03	5.88E-04
Mentha	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	2.92E-03	8.82E-04
Mentha	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	2.75E-02	5.88E-04
Mentha	MF	GO:0005539	glycosaminoglycan binding	-	236	216	-	-	9.53E-03	1.02E-02
Mentha	MF	GO:0140666	annealing activity	-	11	11	-	-	3.39E-03	5.29E-04
Mentha	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.71E-04	7.05E-04
Mentha	MF	GO:0010181	FMN binding	-	15	15	-	-	2.30E-04	7.05E-04
Mentha	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	15	-	-	2.33E-04	7.05E-04
Mentha	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	23	-	-	2.84E-04	1.12E-03
Mentha	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	5.11E-04	8.23E-04
Mentha	MF	GO:0044183	protein folding chaperone	-	67	64	-	-	2.57E-03	3.06E-03
Mentha	MF	GO:0005132	type I interferon receptor binding	-	17	15	-	-	2.22E-01	7.05E-04
Mentha	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	6.35E-03	5.11E-03
Mentha	MF	GO:0003725	double-stranded RNA binding	-	72	70	-	-	7.71E-03	3.29E-03
Mentha	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	2.75E-01	7.64E-04
Mentha	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	2.77E-02	2.47E-03
Mentha	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.42E-03	1.65E-03
Mentha	MF	GO:0004618	phosphoglycerate kinase activity	-	89	88	-	-	6.43E-03	4.17E-03
Mentha	MF	GO:0042805	actinin binding	-	36	35	-	-	3.52E-03	1.65E-03
Mentha	MF	GO:0043531	ADP binding	-	38	38	-	-	1.87E-03	1.82E-03
Mentha	MF	GO:0043394	proteoglycan binding	-	36	33	-	-	3.55E-03	1.59E-03
Mentha	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	2.14E-02	5.29E-04
Mentha	MF	GO:0046332	SMAD binding	-	77	76	-	-	1.24E-02	3.59E-03
Mentha	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.37E-03	6.47E-04
Mentha	MF	GO:0001968	fibronectin binding	-	30	29	-	-	5.27E-03	1.41E-03
Mentha	MF	GO:0048038	quinone binding	-	16	16	-	-	4.54E-03	7.64E-04
Mentha	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	120	-	-	1.39E-02	5.64E-03
Mentha	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	80	-	-	3.91E-03	3.76E-03
Mentha	MF	GO:0003756	protein disulfide isomerase activity	-	18	17	-	-	1.76E-03	8.23E-04
Mentha	MF	GO:0051117	ATPase binding	-	85	82	-	-	3.20E-03	3.88E-03
Mentha	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	2.81E-03	2.17E-03
Mentha	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	3.33E-03	9.40E-04
Mentha	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	1.41E-02	5.29E-04
Mentha	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.32E-04	7.05E-04
Mentha	MF	GO:0031404	chloride ion binding	-	14	12	-	-	1.75E-04	5.88E-04
Mentha	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	5.59E-03	2.88E-03
Mentha	MF	GO:0036002	pre-mRNA binding	-	57	36	-	-	6.84E-03	1.70E-03
Mentha	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	35	-	-	1.59E-02	1.65E-03
Mentha	MF	GO:0051540	metal cluster binding	-	71	69	-	-	7.17E-03	3.29E-03
Mentha	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	8.46E-04	5.29E-04
Mentha	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	4.25E-03	4.35E-03
Mentha	MF	GO:0019894	kinesin binding	-	45	44	-	-	5.76E-03	2.12E-03
Mentha	MF	GO:0042287	MHC protein binding	-	68	56	-	-	3.74E-02	2.64E-03
Mentha	MF	GO:0019003	GDP binding	-	89	88	-	-	1.32E-02	4.17E-03
Mentha	MF	GO:0017171	serine hydrolase activity	-	207	180	-	-	1.02E-02	8.46E-03
Mentha	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	2.88E-03	3.12E-03
Mentha	MF	GO:0003774	cytoskeletal motor activity	-	117	110	-	-	6.60E-03	5.17E-03
Mentha	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.56E-03	1.41E-03
Mentha	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	1.71E-03	8.23E-04
Mentha	MF	GO:0061134	peptidase regulator activity	-	224	194	-	-	4.93E-03	9.17E-03
Mentha	MF	GO:0008013	beta-catenin binding	-	86	85	-	-	1.15E-02	4.00E-03
Mentha	MF	GO:0051015	actin filament binding	-	208	201	-	-	2.37E-02	9.46E-03
Mentha	MF	GO:0019208	phosphatase regulator activity	-	107	100	-	-	7.60E-03	4.70E-03
Mentha	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	31	-	-	5.22E-03	1.47E-03
Mentha	MF	GO:0043236	laminin binding	-	29	28	-	-	3.02E-03	1.35E-03
Mentha	MF	GO:0030507	spectrin binding	-	26	26	-	-	5.87E-03	1.23E-03
Mentha	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	2.15E-03	1.94E-03
Mentha	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	113	-	-	1.37E-02	5.35E-03
Mentha	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	4.41E-03	1.18E-03
Mentha	MF	GO:0042393	histone binding	-	240	230	-	-	1.41E-02	1.08E-02
Mentha	MF	GO:0019838	growth factor binding	-	182	177	-	-	7.96E-03	8.35E-03
Mentha	MF	GO:0000149	SNARE binding	-	107	104	-	-	6.87E-02	4.94E-03
Mentha	MF	GO:0003727	single-stranded RNA binding	-	90	84	-	-	6.56E-03	4.00E-03
Mentha	MF	GO:0051378	serotonin binding	-	24	19	-	-	6.47E-02	9.40E-04
Mentha	MF	GO:0005516	calmodulin binding	-	206	196	-	-	1.04E-02	9.23E-03
Mentha	MF	GO:0019825	oxygen binding	-	40	35	-	-	4.08E-02	1.65E-03
Mentha	MF	GO:0045505	dynein intermediate chain binding	-	37	34	-	-	4.33E-03	1.65E-03
Mentha	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	84	-	-	2.34E-03	4.00E-03
Mentha	MF	GO:0032182	ubiquitin-like protein binding	-	117	115	-	-	6.21E-03	5.41E-03
Mentha	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	3.06E-02	1.70E-03
Mentha	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	1.79E-02	1.06E-03
Mentha	MF	GO:0043274	phospholipase binding	-	23	22	-	-	1.94E-03	1.06E-03
Mentha	MF	GO:0031072	heat shock protein binding	-	128	127	-	-	1.17E-02	6.00E-03
Mentha	MF	GO:0030515	snoRNA binding	-	33	33	-	-	9.65E-03	1.59E-03
Mentha	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	66	-	-	1.98E-02	3.12E-03
Mentha	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	20	-	-	5.15E-03	9.40E-04
Mentha	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	3.40E-04	1.23E-03
Mentha	MF	GO:0001530	lipopolysaccharide binding	-	38	30	-	-	9.64E-03	1.41E-03
Mentha	MF	GO:0140223	general transcription initiation factor activity	-	55	52	-	-	2.71E-01	2.47E-03
Mentha	MF	GO:0070403	NAD+ binding	-	16	16	-	-	2.49E-03	7.64E-04
Mentha	MF	GO:0000049	tRNA binding	-	75	72	-	-	1.31E-02	3.41E-03
Mentha	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	5.56E-03	2.12E-03
Mentha	MF	GO:0015026	coreceptor activity	-	48	45	-	-	1.19E-02	2.12E-03
Mentha	MF	GO:0005527	macrolide binding	-	12	12	-	-	4.95E-04	5.88E-04
Mentha	MF	GO:0001653	peptide receptor activity	-	128	107	-	-	1.75E-02	5.05E-03
Mentha	MF	GO:0031005	filamin binding	-	15	14	-	-	3.79E-03	7.05E-04
Mentha	MF	GO:0030506	ankyrin binding	-	19	19	-	-	3.03E-04	9.40E-04
Mentha	MF	GO:0006469	negative regulation of protein kinase activity	-	222	207	-	-	4.32E-03	9.76E-03
Mentha	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	1.04E-03	9.40E-04
Mentha	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	1.05E-03	7.05E-04
Mentha	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	1.00E-02	1.47E-03
Mentha	MF	GO:0051427	hormone receptor binding	-	31	29	-	-	4.35E-03	1.41E-03
Mentha	MF	GO:0070851	growth factor receptor binding	-	141	139	-	-	5.72E-03	6.58E-03
Mentha	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	8.25E-03	1.53E-03
Mentha	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	42	-	-	7.00E-03	2.00E-03
Mentha	MF	GO:0034185	apolipoprotein binding	-	20	19	-	-	3.80E-03	9.40E-04
Mentha	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	16	-	-	4.08E-03	7.64E-04
Mentha	MF	GO:0005506	iron ion binding	-	154	136	-	-	2.52E-02	6.41E-03
Mentha	MF	GO:0003925	G protein activity	-	45	44	-	-	5.63E-03	2.12E-03
Mentha	MF	GO:0038187	pattern recognition receptor activity	-	33	30	-	-	1.59E-02	1.41E-03
Mentha	MF	GO:0008276	protein methyltransferase activity	-	96	91	-	-	5.99E-03	4.29E-03
Mentha	MF	GO:0004396	hexokinase activity	-	16	16	-	-	8.31E-02	7.64E-04
Mentha	MF	GO:0070888	E-box binding	-	59	56	-	-	1.81E-02	2.64E-03
Mentha	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.71E-04	7.05E-04
Mentha	MF	GO:0015399	primary active transmembrane transporter activity	-	190	181	-	-	7.35E-02	8.52E-03
Mentha	MF	GO:0035254	glutamate receptor binding	-	47	46	-	-	2.38E-03	2.17E-03
Mentha	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	4.31E-03	1.59E-03
Mentha	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	3.16E-03	5.29E-04
Mentha	MF	GO:0043021	ribonucleoprotein complex binding	-	158	155	-	-	5.77E-03	7.29E-03
Mentha	MF	GO:0030170	pyridoxal phosphate binding	-	56	51	-	-	4.42E-03	2.41E-03
Mentha	MF	GO:0032393	MHC class I receptor activity	-	15	13	-	-	1.25E-01	6.47E-04
Mentha	MF	GO:0005112	Notch binding	-	26	24	-	-	3.40E-03	1.18E-03
Mentha	MF	GO:0048185	activin binding	-	16	16	-	-	4.74E-02	7.64E-04
Mentha	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	7.41E-04	1.35E-03
Mentha	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	4.77E-03	5.29E-04
Mentha	MF	GO:0140299	small molecule sensor activity	-	39	33	-	-	1.09E-02	1.59E-03
Mentha	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.08E-02	1.06E-03
Mentha	MF	GO:0016917	GABA receptor activity	-	23	18	-	-	1.81E-01	8.82E-04
Mentha	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	2.44E-03	7.05E-04
Mentha	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	24	-	-	2.87E-04	1.18E-03
Mentha	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	44	-	-	1.08E-02	2.12E-03
Mentha	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.22E-03	1.18E-03
Mentha	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	7.27E-03	5.88E-04
Mentha	MF	GO:0030594	neurotransmitter receptor activity	-	160	141	-	-	2.29E-02	6.64E-03
Mentha	MF	GO:0034452	dynactin binding	-	12	12	-	-	1.32E-03	5.88E-04
Mentha	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	22	-	-	7.11E-02	1.06E-03
Mentha	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	3.27E-03	9.99E-04
Mentha	MF	GO:0005507	copper ion binding	-	63	59	-	-	4.65E-03	2.82E-03
Mentha	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	3.85E-03	1.06E-03
Mentha	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.83E-02	1.06E-03
Mentha	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	11	-	-	3.37E-02	5.29E-04
MINT	CC	GO:0005730	nucleolus	9.36E-75	988	756	482	1.57	-	-
MINT	CC	GO:0005739	mitochondrion	4.78E-47	1671	1095	816	1.34	-	-
MINT	CC	GO:0005840	ribosome	1.21E-43	222	204	108	1.88	-	-
MINT	CC	GO:0005815	microtubule organizing center	1.23E-31	843	576	411	1.40	-	-
MINT	CC	GO:0005768	endosome	1.88E-23	1037	662	506	1.31	-	-
MINT	CC	GO:0000228	nuclear chromosome	8.05E-22	206	167	101	1.66	-	-
MINT	CC	GO:0005635	nuclear envelope	7.21E-19	493	337	241	1.40	-	-
MINT	CC	GO:0005615	extracellular space	4.76E-16	3190	1766	1557	1.13	-	-
MINT	CC	GO:0005764	lysosome	2.95E-08	747	439	365	1.20	-	-
MINT	CC	GO:0005783	endoplasmic reticulum	1.05E-06	2020	1090	986	1.11	-	-
MINT	CC	GO:0005794	Golgi apparatus	8.34E-06	1636	885	799	1.11	-	-
MINT	CC	GO:0031012	extracellular matrix	1.14E-03	564	237	275	0.86	-	-
MINT	CC	GO:0005929	cilium	1.12E-01	842	388	411	0.94	-	-
MINT	CC	GO:0005811	lipid droplet	3.21E-01	102	55	50	1.10	-	-
MINT	CC	GO:0005777	peroxisome	4.49E-01	142	74	69	1.07	-	-
MINT	BP	GO:0065003	protein-containing complex assembly	1.51E-82	1648	1173	804	1.46	-	-
MINT	BP	GO:0012501	programmed cell death	4.15E-75	1954	1334	954	1.40	-	-
MINT	BP	GO:0016071	mRNA metabolic process	8.15E-69	713	571	348	1.64	-	-
MINT	BP	GO:0006325	chromatin organization	1.71E-66	720	572	351	1.63	-	-
MINT	BP	GO:0006281	DNA repair	2.47E-55	587	468	287	1.63	-	-
MINT	BP	GO:0030163	protein catabolic process	1.68E-54	990	718	483	1.49	-	-
MINT	BP	GO:0007010	cytoskeleton organization	6.56E-53	1639	1094	800	1.37	-	-
MINT	BP	GO:0006355	regulation of DNA-templated transcription	3.92E-45	3342	2000	1631	1.23	-	-
MINT	BP	GO:0007059	chromosome segregation	7.72E-42	403	327	197	1.66	-	-
MINT	BP	GO:0006886	intracellular protein transport	1.72E-41	664	492	324	1.52	-	-
MINT	BP	GO:0006914	autophagy	1.20E-37	568	425	277	1.53	-	-
MINT	BP	GO:0016192	vesicle-mediated transport	1.58E-37	1894	1188	924	1.29	-	-
MINT	BP	GO:0006913	nucleocytoplasmic transport	2.92E-34	326	265	159	1.67	-	-
MINT	BP	GO:0042254	ribosome biogenesis	1.16E-33	297	245	145	1.69	-	-
MINT	BP	GO:0006260	DNA replication	2.84E-30	279	228	136	1.67	-	-
MINT	BP	GO:0050877	nervous system process	3.97E-29	1527	537	745	0.72	-	-
MINT	BP	GO:0002181	cytoplasmic translation	9.77E-29	153	139	75	1.86	-	-
MINT	BP	GO:0007005	mitochondrion organization	1.63E-24	484	346	236	1.46	-	-
MINT	BP	GO:0140053	mitochondrial gene expression	1.52E-23	164	141	80	1.76	-	-
MINT	BP	GO:0034330	cell junction organization	1.85E-23	727	486	355	1.37	-	-
MINT	BP	GO:0048870	cell motility	3.51E-22	1659	998	810	1.23	-	-
MINT	BP	GO:0002376	immune system process	8.62E-20	2448	1405	1195	1.18	-	-
MINT	BP	GO:0006310	DNA recombination	1.83E-19	333	243	163	1.49	-	-
MINT	BP	GO:0007163	establishment or maintenance of cell polarity	1.87E-19	227	177	111	1.60	-	-
MINT	BP	GO:0007155	cell adhesion	1.95E-17	1444	860	705	1.22	-	-
MINT	BP	GO:0072659	protein localization to plasma membrane	3.27E-16	284	206	139	1.49	-	-
MINT	BP	GO:0042060	wound healing	5.87E-16	431	293	210	1.39	-	-
MINT	BP	GO:0006091	generation of precursor metabolites and energy	5.91E-16	502	334	245	1.36	-	-
MINT	BP	GO:0000910	cytokinesis	1.62E-15	186	144	91	1.59	-	-
MINT	BP	GO:0006457	protein folding	1.17E-11	210	151	103	1.47	-	-
MINT	BP	GO:0032200	telomere organization	2.25E-09	186	131	91	1.44	-	-
MINT	BP	GO:0055086	nucleobase-containing small molecule metabolic process	3.35E-09	729	434	356	1.22	-	-
MINT	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	9.05E-08	119	87	58	1.50	-	-
MINT	BP	GO:0006486	protein glycosylation	1.57E-06	225	74	110	0.67	-	-
MINT	BP	GO:0003012	muscle system process	2.24E-06	425	256	207	1.23	-	-
MINT	BP	GO:0098542	defense response to other organism	3.24E-06	1171	649	572	1.14	-	-
MINT	BP	GO:0003013	circulatory system process	4.36E-05	584	334	285	1.17	-	-
MINT	BP	GO:0140013	meiotic nuclear division	4.92E-05	279	170	136	1.25	-	-
MINT	BP	GO:0006954	inflammatory response	2.31E-04	820	452	400	1.13	-	-
MINT	BP	GO:0006399	tRNA metabolic process	9.12E-04	196	119	96	1.24	-	-
MINT	BP	GO:0006520	amino acid metabolic process	2.10E-03	292	169	143	1.19	-	-
MINT	BP	GO:0007040	lysosome organization	2.51E-03	107	68	52	1.30	-	-
MINT	BP	GO:0007018	microtubule-based movement	1.41E-02	640	343	312	1.10	-	-
MINT	BP	GO:0006629	lipid metabolic process	6.26E-02	1355	628	661	0.95	-	-
MINT	BP	GO:0005975	carbohydrate metabolic process	8.37E-02	551	289	269	1.07	-	-
MINT	BP	GO:0006790	sulfur compound metabolic process	3.10E-01	320	147	156	0.94	-	-
MINT	BP	GO:0098754	detoxification	4.36E-01	134	70	65	1.07	-	-
MINT	BP	GO:0006766	vitamin metabolic process	4.39E-01	107	48	52	0.92	-	-
MINT	BP	GO:0044782	cilium organization	4.79E-01	399	202	195	1.04	-	-
MINT	BP	GO:0003014	renal system process	5.33E-01	127	58	62	0.94	-	-
MINT	BP	GO:0030198	extracellular matrix organization	6.09E-01	314	158	153	1.03	-	-
MINT	BP	GO:0055085	transmembrane transport	7.84E-01	1784	865	871	0.99	-	-
MINT	BP	GO:0022600	digestive system process	8.48E-01	110	55	54	1.02	-	-
MINT	BP	GO:0006575	cellular modified amino acid metabolic process	1.00E+00	186	91	91	1.00	-	-
MINT	MF	GO:0003723	RNA binding	3.59E-178	1679	1359	820	1.66	-	-
MINT	MF	GO:0140096	"catalytic activity, acting on a protein"	1.48E-72	3198	2023	1561	1.30	-	-
MINT	MF	GO:0008092	cytoskeletal protein binding	7.45E-52	1023	732	499	1.47	-	-
MINT	MF	GO:0016740	transferase activity	2.73E-47	3074	1866	1500	1.24	-	-
MINT	MF	GO:0140657	ATP-dependent activity	2.45E-39	729	527	356	1.48	-	-
MINT	MF	GO:0042393	histone binding	5.32E-32	237	202	116	1.75	-	-
MINT	MF	GO:0140097	"catalytic activity, acting on DNA"	2.18E-26	383	288	187	1.54	-	-
MINT	MF	GO:0005198	structural molecule activity	2.95E-23	798	526	390	1.35	-	-
MINT	MF	GO:0003677	DNA binding	5.23E-22	2865	1636	1398	1.17	-	-
MINT	MF	GO:0045182	translation regulator activity	4.48E-16	151	122	74	1.66	-	-
MINT	MF	GO:0140098	"catalytic activity, acting on RNA"	1.04E-15	417	284	204	1.40	-	-
MINT	MF	GO:0048018	receptor ligand activity	1.92E-14	504	162	246	0.66	-	-
MINT	MF	GO:0016874	ligase activity	1.87E-13	283	199	138	1.44	-	-
MINT	MF	GO:0140110	transcription regulator activity	2.78E-11	2033	1134	992	1.14	-	-
MINT	MF	GO:0003924	GTPase activity	2.81E-07	658	386	321	1.20	-	-
MINT	MF	GO:0016853	isomerase activity	4.38E-07	252	163	123	1.33	-	-
MINT	MF	GO:0140104	molecular carrier activity	3.02E-06	105	75	51	1.46	-	-
MINT	MF	GO:0008289	lipid binding	1.30E-05	836	470	408	1.15	-	-
MINT	MF	GO:0003774	cytoskeletal motor activity	1.70E-04	116	77	57	1.36	-	-
MINT	MF	GO:0016491	oxidoreductase activity	2.31E-04	888	487	433	1.12	-	-
MINT	MF	GO:0005215	transporter activity	2.07E-03	1462	657	714	0.92	-	-
MINT	MF	GO:0009975	cyclase activity	5.45E-01	277	130	135	0.96	-	-
MINT	MF	GO:0016829	lyase activity	6.00E-01	538	269	263	1.02	-	-
MINT	MF	GO:0038024	cargo receptor activity	6.43E-01	117	60	57	1.05	-	-
MINT	BP	GO:0008038	neuron recognition	-	46	28	-	-	6.12E-04	2.48E-03
MINT	BP	GO:1905145	cellular response to acetylcholine	-	33	18	-	-	2.48E-03	1.62E-03
MINT	BP	GO:0098780	response to mitochondrial depolarisation	-	21	20	-	-	1.87E-02	1.73E-03
MINT	BP	GO:0051931	regulation of sensory perception	-	36	19	-	-	7.62E-03	1.73E-03
MINT	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	11	-	-	1.70E-03	9.72E-04
MINT	BP	GO:0009268	response to pH	-	43	17	-	-	3.19E-02	1.51E-03
MINT	BP	GO:0045666	positive regulation of neuron differentiation	-	91	48	-	-	3.06E-03	4.21E-03
MINT	BP	GO:0043543	protein acylation	-	107	63	-	-	1.17E-02	5.51E-03
MINT	MF	GO:0051349	positive regulation of lyase activity	-	41	23	-	-	5.01E-03	2.05E-03
MINT	BP	GO:0048679	regulation of axon regeneration	-	28	18	-	-	4.76E-03	1.62E-03
MINT	BP	GO:0022401	negative adaptation of signaling pathway	-	21	13	-	-	3.19E-04	1.19E-03
MINT	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	54	-	-	2.40E-03	4.75E-03
MINT	BP	GO:0071763	nuclear membrane organization	-	44	39	-	-	8.46E-04	3.46E-03
MINT	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	29	-	-	1.06E-03	2.59E-03
MINT	BP	GO:0071806	protein transmembrane transport	-	68	46	-	-	2.89E-02	4.00E-03
MINT	BP	GO:0022038	corpus callosum development	-	25	19	-	-	4.30E-04	1.73E-03
MINT	BP	GO:0043299	leukocyte degranulation	-	82	57	-	-	2.17E-03	4.97E-03
MINT	BP	GO:0048864	stem cell development	-	88	50	-	-	3.14E-03	4.32E-03
MINT	BP	GO:0009310	amine catabolic process	-	20	13	-	-	3.23E-04	1.19E-03
MINT	BP	GO:0051651	maintenance of location in cell	-	236	160	-	-	8.57E-03	1.38E-02
MINT	BP	GO:0033119	negative regulation of RNA splicing	-	27	24	-	-	4.11E-03	2.16E-03
MINT	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	15	-	-	4.31E-04	1.30E-03
MINT	CC	GO:0016197	endosomal transport	-	282	209	-	-	2.00E-02	1.81E-02
MINT	BP	GO:0070663	regulation of leukocyte proliferation	-	268	153	-	-	6.25E-03	1.33E-02
MINT	BP	GO:0001833	inner cell mass cell proliferation	-	14	13	-	-	8.53E-03	1.19E-03
MINT	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	27	-	-	1.48E-02	2.38E-03
MINT	BP	GO:0006949	syncytium formation	-	66	43	-	-	1.21E-02	3.78E-03
MINT	BP	GO:0045176	apical protein localization	-	15	11	-	-	3.22E-04	9.72E-04
MINT	BP	GO:0045861	negative regulation of proteolysis	-	320	185	-	-	5.38E-03	1.60E-02
MINT	BP	GO:0043144	sno(s)RNA processing	-	14	12	-	-	5.41E-02	1.08E-03
MINT	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	21	-	-	5.37E-04	1.84E-03
MINT	BP	GO:0030574	collagen catabolic process	-	45	21	-	-	2.85E-03	1.84E-03
MINT	CC	GO:0006984	ER-nucleus signaling pathway	-	46	38	-	-	2.80E-03	3.35E-03
MINT	BP	GO:0060343	trabecula formation	-	26	15	-	-	4.30E-04	1.30E-03
MINT	BP	GO:0009914	hormone transport	-	315	184	-	-	5.32E-03	1.60E-02
MINT	BP	GO:0140112	extracellular vesicle biogenesis	-	23	18	-	-	2.15E-02	1.62E-03
MINT	BP	GO:1900424	regulation of defense response to bacterium	-	21	12	-	-	3.21E-04	1.08E-03
MINT	BP	GO:0085029	extracellular matrix assembly	-	42	26	-	-	6.33E-04	2.27E-03
MINT	BP	GO:0006413	translational initiation	-	122	102	-	-	2.72E-02	8.86E-03
MINT	BP	GO:1902895	positive regulation of miRNA transcription	-	51	44	-	-	2.10E-03	3.89E-03
MINT	CC	GO:0005200	structural constituent of cytoskeleton	-	112	95	-	-	9.41E-03	8.21E-03
MINT	BP	GO:0030865	cortical cytoskeleton organization	-	51	46	-	-	5.53E-03	4.00E-03
MINT	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	21	-	-	8.13E-02	1.84E-03
MINT	BP	GO:1903036	positive regulation of response to wounding	-	76	41	-	-	1.02E-02	3.56E-03
MINT	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	93	-	-	5.63E-03	8.10E-03
MINT	BP	GO:1903319	positive regulation of protein maturation	-	27	15	-	-	4.25E-04	1.30E-03
MINT	BP	GO:0032528	microvillus organization	-	24	17	-	-	2.95E-03	1.51E-03
MINT	BP	GO:0002263	cell activation involved in immune response	-	304	190	-	-	8.83E-03	1.64E-02
MINT	BP	GO:0021954	central nervous system neuron development	-	85	59	-	-	1.99E-03	5.18E-03
MINT	BP	GO:0055017	cardiac muscle tissue growth	-	92	55	-	-	2.29E-03	4.75E-03
MINT	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	18	-	-	2.23E-03	1.62E-03
MINT	BP	GO:0048524	positive regulation of viral process	-	64	55	-	-	2.55E-03	4.75E-03
MINT	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	14	-	-	1.95E-03	1.30E-03
MINT	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	17	-	-	4.27E-04	1.51E-03
MINT	BP	GO:0001946	lymphangiogenesis	-	18	12	-	-	3.21E-04	1.08E-03
MINT	BP	GO:0098661	inorganic anion transmembrane transport	-	140	51	-	-	1.22E-02	4.43E-03
MINT	BP	GO:0006099	tricarboxylic acid cycle	-	33	27	-	-	3.30E-02	2.38E-03
MINT	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	16	-	-	1.07E-03	1.40E-03
MINT	BP	GO:0009612	response to mechanical stimulus	-	215	137	-	-	5.77E-03	1.19E-02
MINT	BP	GO:0048644	muscle organ morphogenesis	-	81	49	-	-	7.23E-03	4.32E-03
MINT	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	104	-	-	3.54E-03	9.07E-03
MINT	BP	GO:0071542	dopaminergic neuron differentiation	-	36	16	-	-	1.89E-03	1.40E-03
MINT	BP	GO:0140115	export across plasma membrane	-	82	29	-	-	8.39E-03	2.59E-03
MINT	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	23	-	-	5.34E-04	2.05E-03
MINT	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	15	-	-	4.31E-04	1.30E-03
MINT	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	21	-	-	5.39E-04	1.84E-03
MINT	MF	GO:0003714	transcription corepressor activity	-	190	155	-	-	7.64E-03	1.34E-02
MINT	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	31	-	-	1.71E-03	2.70E-03
MINT	CC	GO:0006858	extracellular transport	-	45	16	-	-	4.30E-04	1.40E-03
MINT	BP	GO:0006304	DNA modification	-	30	15	-	-	1.42E-02	1.30E-03
MINT	MF	GO:0140312	cargo adaptor activity	-	19	14	-	-	3.23E-04	1.30E-03
MINT	BP	GO:0046835	carbohydrate phosphorylation	-	49	31	-	-	1.30E-03	2.70E-03
MINT	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	13	-	-	5.13E-03	1.19E-03
MINT	CC	GO:1905349	ciliary transition zone assembly	-	371	188	-	-	9.97E-03	1.63E-02
MINT	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	13	-	-	3.24E-04	1.19E-03
MINT	BP	GO:0043523	regulation of neuron apoptotic process	-	218	150	-	-	6.05E-03	1.30E-02
MINT	BP	GO:1902894	negative regulation of miRNA transcription	-	22	19	-	-	3.39E-03	1.73E-03
MINT	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	12	-	-	3.23E-04	1.08E-03
MINT	BP	GO:0044380	protein localization to cytoskeleton	-	57	47	-	-	1.71E-03	4.10E-03
MINT	BP	GO:2000209	regulation of anoikis	-	25	19	-	-	1.76E-03	1.73E-03
MINT	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	16	-	-	4.24E-04	1.40E-03
MINT	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	22	-	-	2.32E-03	1.94E-03
MINT	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	50	-	-	3.12E-03	4.32E-03
MINT	CC	GO:0045324	late endosome to vacuole transport	-	37	31	-	-	1.19E-02	2.70E-03
MINT	BP	GO:0043954	cellular component maintenance	-	72	50	-	-	5.48E-03	4.32E-03
MINT	BP	GO:0050435	amyloid-beta metabolic process	-	65	38	-	-	1.17E-02	3.35E-03
MINT	BP	GO:0014823	response to activity	-	70	47	-	-	1.04E-02	4.10E-03
MINT	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	23	-	-	8.17E-02	2.05E-03
MINT	BP	GO:0034502	protein localization to chromosome	-	130	96	-	-	7.73E-03	8.32E-03
MINT	BP	GO:0048562	embryonic organ morphogenesis	-	295	162	-	-	8.69E-03	1.40E-02
MINT	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	3.22E-04	9.72E-04
MINT	BP	GO:0019233	sensory perception of pain	-	103	55	-	-	3.77E-03	4.75E-03
MINT	CC	GO:0043574	peroxisomal transport	-	22	16	-	-	4.88E-01	1.40E-03
MINT	BP	GO:0031343	positive regulation of cell killing	-	75	37	-	-	1.10E-02	3.24E-03
MINT	BP	GO:0090077	foam cell differentiation	-	39	25	-	-	2.63E-03	2.16E-03
MINT	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	57	-	-	8.62E-03	4.97E-03
MINT	BP	GO:0017148	negative regulation of translation	-	390	88	-	-	6.06E-03	7.67E-03
MINT	BP	GO:0030220	platelet formation	-	22	17	-	-	1.08E-02	1.51E-03
MINT	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	49	-	-	4.56E-03	4.32E-03
MINT	BP	GO:1903509	liposaccharide metabolic process	-	109	34	-	-	7.52E-04	3.02E-03
MINT	BP	GO:0009582	detection of abiotic stimulus	-	140	51	-	-	3.62E-02	4.43E-03
MINT	CC	GO:0140238	presynaptic endocytosis	-	72	53	-	-	4.64E-03	4.64E-03
MINT	BP	GO:0051236	establishment of RNA localization	-	161	133	-	-	7.28E-02	1.16E-02
MINT	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	142	-	-	4.40E-02	1.23E-02
MINT	BP	GO:0034067	protein localization to Golgi apparatus	-	30	20	-	-	5.38E-04	1.73E-03
MINT	BP	GO:0061842	microtubule organizing center localization	-	32	26	-	-	1.90E-03	2.27E-03
MINT	MF	GO:0048018	receptor ligand activity	-	510	162	-	-	1.82E-02	1.40E-02
MINT	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	16	-	-	1.00E-01	1.40E-03
MINT	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	33	-	-	1.40E-03	2.92E-03
MINT	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	39	-	-	2.71E-03	3.46E-03
MINT	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	14	-	-	3.23E-04	1.30E-03
MINT	BP	GO:0050779	RNA destabilization	-	135	73	-	-	2.83E-02	6.37E-03
MINT	BP	GO:0006023	aminoglycan biosynthetic process	-	74	21	-	-	5.25E-04	1.84E-03
MINT	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	47	-	-	1.07E-03	4.10E-03
MINT	BP	GO:0010762	regulation of fibroblast migration	-	40	29	-	-	1.14E-03	2.59E-03
MINT	BP	GO:0090311	regulation of protein deacetylation	-	29	26	-	-	1.34E-01	2.27E-03
MINT	BP	GO:0035272	exocrine system development	-	46	24	-	-	8.54E-04	2.16E-03
MINT	BP	GO:0022406	membrane docking	-	90	68	-	-	7.34E-03	5.94E-03
MINT	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	2.41E-03	1.30E-03
MINT	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	12	-	-	6.21E-03	1.08E-03
MINT	BP	GO:0050777	negative regulation of immune response	-	196	130	-	-	1.22E-02	1.12E-02
MINT	BP	GO:0016053	organic acid biosynthetic process	-	335	157	-	-	4.38E-03	1.36E-02
MINT	BP	GO:0002063	chondrocyte development	-	33	15	-	-	4.26E-04	1.30E-03
MINT	BP	GO:0099068	postsynapse assembly	-	40	26	-	-	6.31E-04	2.27E-03
MINT	BP	GO:0021782	glial cell development	-	120	73	-	-	3.68E-03	6.37E-03
MINT	BP	GO:0051782	negative regulation of cell division	-	18	11	-	-	1.50E-01	9.72E-04
MINT	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	54	-	-	3.86E-03	4.75E-03
MINT	BP	GO:0001655	urogenital system development	-	66	45	-	-	1.94E-03	3.89E-03
MINT	BP	GO:0071827	plasma lipoprotein particle organization	-	86	42	-	-	1.25E-02	3.67E-03
MINT	BP	GO:0045494	photoreceptor cell maintenance	-	43	17	-	-	6.71E-02	1.51E-03
MINT	BP	GO:0055088	lipid homeostasis	-	173	90	-	-	2.61E-02	7.78E-03
MINT	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	22	-	-	2.37E-03	1.94E-03
MINT	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	152	-	-	6.81E-03	1.32E-02
MINT	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	12	-	-	3.23E-04	1.08E-03
MINT	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	29	-	-	1.11E-02	2.59E-03
MINT	BP	GO:0045667	regulation of osteoblast differentiation	-	147	82	-	-	6.21E-03	7.13E-03
MINT	BP	GO:0061037	negative regulation of cartilage development	-	32	15	-	-	4.27E-04	1.30E-03
MINT	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	241	-	-	6.10E-03	2.08E-02
MINT	BP	GO:0045738	negative regulation of DNA repair	-	40	32	-	-	3.92E-03	2.81E-03
MINT	BP	GO:0001704	formation of primary germ layer	-	195	131	-	-	4.51E-03	1.13E-02
MINT	BP	GO:0045778	positive regulation of ossification	-	51	35	-	-	7.13E-03	3.02E-03
MINT	BP	GO:0048708	astrocyte differentiation	-	88	62	-	-	5.15E-03	5.40E-03
MINT	BP	GO:0042092	type 2 immune response	-	41	28	-	-	6.91E-03	2.48E-03
MINT	BP	GO:0048588	developmental cell growth	-	233	142	-	-	5.31E-03	1.23E-02
MINT	CC	GO:0000963	mitochondrial RNA processing	-	20	15	-	-	4.32E-04	1.30E-03
MINT	BP	GO:0021872	forebrain generation of neurons	-	52	33	-	-	7.25E-04	2.92E-03
MINT	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	16	-	-	4.18E-04	1.40E-03
MINT	BP	GO:0045023	G0 to G1 transition	-	41	36	-	-	2.08E-01	3.13E-03
MINT	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	27	-	-	2.54E-02	2.38E-03
MINT	BP	GO:0034367	protein-containing complex remodeling	-	35	19	-	-	1.14E-03	1.73E-03
MINT	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	19	-	-	4.22E-04	1.73E-03
MINT	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	24	-	-	5.88E-02	2.16E-03
MINT	BP	GO:0015810	aspartate transmembrane transport	-	19	11	-	-	3.23E-04	9.72E-04
MINT	BP	GO:0010232	vascular transport	-	87	49	-	-	1.07E-03	4.32E-03
MINT	BP	GO:0021987	cerebral cortex development	-	125	88	-	-	4.33E-03	7.67E-03
MINT	BP	GO:0008637	apoptotic mitochondrial changes	-	108	79	-	-	5.75E-03	6.91E-03
MINT	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	24	-	-	3.53E-03	2.16E-03
MINT	BP	GO:0060999	positive regulation of dendritic spine development	-	35	23	-	-	2.86E-03	2.05E-03
MINT	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	13	-	-	3.20E-04	1.19E-03
MINT	BP	GO:2000736	regulation of stem cell differentiation	-	78	57	-	-	8.20E-03	4.97E-03
MINT	BP	GO:0060973	cell migration involved in heart development	-	21	11	-	-	3.18E-04	9.72E-04
MINT	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	13	-	-	3.22E-04	1.19E-03
MINT	BP	GO:0002064	epithelial cell development	-	210	143	-	-	4.90E-03	1.24E-02
MINT	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	27	-	-	2.16E-02	2.38E-03
MINT	BP	GO:2001222	regulation of neuron migration	-	46	24	-	-	3.48E-03	2.16E-03
MINT	BP	GO:0034389	lipid droplet organization	-	38	24	-	-	5.33E-04	2.16E-03
MINT	BP	GO:0051602	response to electrical stimulus	-	44	33	-	-	1.10E-03	2.92E-03
MINT	BP	GO:0042177	negative regulation of protein catabolic process	-	109	87	-	-	3.21E-03	7.56E-03
MINT	MF	GO:0038024	cargo receptor activity	-	121	60	-	-	8.78E-03	5.18E-03
MINT	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	12	-	-	3.36E-03	1.08E-03
MINT	BP	GO:0033120	positive regulation of RNA splicing	-	46	36	-	-	4.13E-03	3.13E-03
MINT	BP	GO:0051445	regulation of meiotic cell cycle	-	64	37	-	-	5.20E-03	3.24E-03
MINT	BP	GO:0033619	membrane protein proteolysis	-	60	44	-	-	1.36E-02	3.89E-03
MINT	BP	GO:0038065	collagen-activated signaling pathway	-	15	11	-	-	2.35E-02	9.72E-04
MINT	BP	GO:0090087	regulation of peptide transport	-	195	111	-	-	3.70E-03	9.61E-03
MINT	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	68	-	-	2.03E-03	5.94E-03
MINT	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	23	-	-	3.07E-02	2.05E-03
MINT	BP	GO:0006929	substrate-dependent cell migration	-	26	18	-	-	4.27E-04	1.62E-03
MINT	BP	GO:0099118	microtubule-based protein transport	-	14	11	-	-	3.22E-04	9.72E-04
MINT	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	13	-	-	1.87E-03	1.19E-03
MINT	BP	GO:0072662	protein localization to peroxisome	-	20	15	-	-	3.22E-01	1.30E-03
MINT	BP	GO:0022404	molting cycle process	-	95	53	-	-	2.03E-03	4.64E-03
MINT	BP	GO:1903358	regulation of Golgi organization	-	17	16	-	-	2.00E-03	1.40E-03
MINT	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	16	-	-	1.93E-02	1.40E-03
MINT	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	14	-	-	3.11E-04	1.30E-03
MINT	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	26	-	-	1.89E-03	2.27E-03
MINT	BP	GO:0017014	protein nitrosylation	-	17	12	-	-	3.47E-03	1.08E-03
MINT	BP	GO:0007281	germ cell development	-	334	166	-	-	4.60E-03	1.44E-02
MINT	BP	GO:0008299	isoprenoid biosynthetic process	-	30	11	-	-	3.24E-04	9.72E-04
MINT	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	120	-	-	3.59E-03	1.04E-02
MINT	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	27	-	-	5.74E-03	2.38E-03
MINT	CC	GO:0098926	postsynaptic signal transduction	-	39	21	-	-	1.91E-03	1.84E-03
MINT	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	100	-	-	3.35E-03	8.64E-03
MINT	CC	GO:0016082	synaptic vesicle priming	-	19	15	-	-	1.18E-01	1.30E-03
MINT	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	31	-	-	7.44E-04	2.70E-03
MINT	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	98	-	-	1.42E-02	8.53E-03
MINT	BP	GO:0034249	negative regulation of amide metabolic process	-	34	16	-	-	4.28E-04	1.40E-03
MINT	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	76	-	-	5.74E-03	6.59E-03
MINT	BP	GO:0042832	defense response to protozoan	-	28	11	-	-	3.12E-04	9.72E-04
MINT	BP	GO:0048799	animal organ maturation	-	33	15	-	-	4.27E-04	1.30E-03
MINT	BP	GO:0006925	inflammatory cell apoptotic process	-	23	16	-	-	4.27E-04	1.40E-03
MINT	BP	GO:2000291	regulation of myoblast proliferation	-	25	13	-	-	3.21E-04	1.19E-03
MINT	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	124	-	-	5.52E-03	1.08E-02
MINT	BP	GO:1903035	negative regulation of response to wounding	-	93	55	-	-	6.44E-03	4.75E-03
MINT	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	17	-	-	1.38E-03	1.51E-03
MINT	BP	GO:0036010	protein localization to endosome	-	27	23	-	-	5.33E-04	2.05E-03
MINT	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	99	-	-	2.36E-02	8.64E-03
MINT	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	69	-	-	3.82E-03	6.05E-03
MINT	BP	GO:0045056	transcytosis	-	20	17	-	-	4.25E-04	1.51E-03
MINT	BP	GO:0009267	cellular response to starvation	-	170	122	-	-	8.00E-03	1.06E-02
MINT	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	40	-	-	5.47E-03	3.46E-03
MINT	CC	GO:0140239	postsynaptic endocytosis	-	23	18	-	-	9.78E-03	1.62E-03
MINT	BP	GO:0046931	pore complex assembly	-	21	17	-	-	4.20E-04	1.51E-03
MINT	CC	GO:0032008	positive regulation of TOR signaling	-	52	38	-	-	2.49E-03	3.35E-03
MINT	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	25	-	-	2.95E-03	2.16E-03
MINT	BP	GO:0060428	lung epithelium development	-	43	29	-	-	2.41E-03	2.59E-03
MINT	BP	GO:0030431	sleep	-	30	19	-	-	3.53E-03	1.73E-03
MINT	BP	GO:1903318	negative regulation of protein maturation	-	29	17	-	-	1.56E-01	1.51E-03
MINT	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	68	-	-	2.51E-01	5.94E-03
MINT	BP	GO:0071732	cellular response to nitric oxide	-	17	13	-	-	3.19E-04	1.19E-03
MINT	BP	GO:0010457	centriole-centriole cohesion	-	15	11	-	-	1.35E-02	9.72E-04
MINT	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	28	-	-	6.47E-04	2.48E-03
MINT	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	49	-	-	2.99E-03	4.32E-03
MINT	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	12	-	-	3.23E-04	1.08E-03
MINT	BP	GO:0065004	protein-DNA complex assembly	-	307	213	-	-	4.04E-02	1.85E-02
MINT	CC	GO:0006406	mRNA export from nucleus	-	69	60	-	-	9.30E-02	5.18E-03
MINT	BP	GO:0009880	embryonic pattern specification	-	70	40	-	-	2.20E-03	3.46E-03
MINT	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	32	-	-	2.63E-01	2.81E-03
MINT	BP	GO:0043043	peptide biosynthetic process	-	25	14	-	-	1.42E-02	1.30E-03
MINT	BP	GO:0002367	cytokine production involved in immune response	-	121	80	-	-	1.36E-02	6.91E-03
MINT	BP	GO:0044848	biological phase	-	211	137	-	-	1.86E-02	1.19E-02
MINT	BP	GO:0046660	female sex differentiation	-	125	82	-	-	3.96E-03	7.13E-03
MINT	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	12	-	-	3.21E-04	1.08E-03
MINT	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	29	-	-	1.52E-03	2.59E-03
MINT	BP	GO:0060411	cardiac septum morphogenesis	-	72	51	-	-	2.42E-03	4.43E-03
MINT	BP	GO:0071248	cellular response to metal ion	-	201	121	-	-	7.29E-03	1.05E-02
MINT	BP	GO:0030308	negative regulation of cell growth	-	191	121	-	-	3.33E-03	1.05E-02
MINT	BP	GO:0097306	cellular response to alcohol	-	99	56	-	-	2.12E-03	4.86E-03
MINT	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	93	-	-	5.07E-02	8.10E-03
MINT	BP	GO:0010453	regulation of cell fate commitment	-	40	22	-	-	2.23E-02	1.94E-03
MINT	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	37	-	-	1.40E-02	3.24E-03
MINT	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	25	-	-	6.46E-04	2.16E-03
MINT	BP	GO:0002026	regulation of the force of heart contraction	-	26	19	-	-	4.28E-04	1.73E-03
MINT	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	12	-	-	3.22E-04	1.08E-03
MINT	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	29	-	-	5.05E-03	2.59E-03
MINT	BP	GO:0032890	regulation of organic acid transport	-	78	41	-	-	9.49E-04	3.56E-03
MINT	BP	GO:0071498	cellular response to fluid shear stress	-	21	17	-	-	5.54E-03	1.51E-03
MINT	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	58	-	-	2.23E-03	5.08E-03
MINT	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	15	-	-	4.40E-03	1.30E-03
MINT	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	31	-	-	4.79E-03	2.70E-03
MINT	BP	GO:0051259	protein complex oligomerization	-	251	153	-	-	4.27E-03	1.33E-02
MINT	BP	GO:0098743	cell aggregation	-	24	15	-	-	4.30E-04	1.30E-03
MINT	BP	GO:0009994	oocyte differentiation	-	57	31	-	-	7.80E-03	2.70E-03
MINT	MF	GO:0031952	regulation of protein autophosphorylation	-	43	29	-	-	1.59E-03	2.59E-03
MINT	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	106	-	-	4.41E-03	9.18E-03
MINT	BP	GO:0044319	"wound healing, spreading of cells"	-	37	28	-	-	8.62E-03	2.48E-03
MINT	BP	GO:0033688	regulation of osteoblast proliferation	-	31	20	-	-	2.45E-03	1.73E-03
MINT	BP	GO:0060251	regulation of glial cell proliferation	-	39	26	-	-	1.26E-03	2.27E-03
MINT	BP	GO:0072665	protein localization to vacuole	-	84	52	-	-	6.37E-03	4.54E-03
MINT	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	38	-	-	2.21E-02	3.35E-03
MINT	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	14	-	-	1.55E-03	1.30E-03
MINT	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	48	-	-	6.29E-03	4.21E-03
MINT	BP	GO:0070633	transepithelial transport	-	35	19	-	-	1.05E-02	1.73E-03
MINT	BP	GO:0045661	regulation of myoblast differentiation	-	74	50	-	-	2.66E-02	4.32E-03
MINT	BP	GO:0030307	positive regulation of cell growth	-	164	106	-	-	3.25E-03	9.18E-03
MINT	BP	GO:0034250	positive regulation of amide metabolic process	-	27	19	-	-	4.26E-04	1.73E-03
MINT	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	218	-	-	8.16E-03	1.89E-02
MINT	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	13	-	-	3.22E-04	1.19E-03
MINT	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	11	-	-	1.25E-03	9.72E-04
MINT	BP	GO:0014812	muscle cell migration	-	110	65	-	-	9.03E-03	5.62E-03
MINT	BP	GO:0048525	negative regulation of viral process	-	90	55	-	-	2.79E-03	4.75E-03
MINT	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	60	-	-	5.40E-03	5.18E-03
MINT	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	128	-	-	5.21E-03	1.11E-02
MINT	BP	GO:0051781	positive regulation of cell division	-	93	55	-	-	4.22E-03	4.75E-03
MINT	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	15	-	-	3.99E-03	1.30E-03
MINT	BP	GO:0035493	SNARE complex assembly	-	23	21	-	-	2.82E-02	1.84E-03
MINT	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	17	-	-	1.47E-03	1.51E-03
MINT	BP	GO:0002696	positive regulation of leukocyte activation	-	358	229	-	-	2.56E-02	1.99E-02
MINT	BP	GO:0060711	labyrinthine layer development	-	47	34	-	-	1.36E-03	3.02E-03
MINT	BP	GO:0007272	ensheathment of neurons	-	146	89	-	-	6.59E-03	7.78E-03
MINT	CC	GO:0050806	positive regulation of synaptic transmission	-	171	98	-	-	5.62E-03	8.53E-03
MINT	BP	GO:0060021	roof of mouth development	-	91	57	-	-	8.72E-03	4.97E-03
MINT	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	27	-	-	6.30E-04	2.38E-03
MINT	BP	GO:0050819	negative regulation of coagulation	-	54	29	-	-	1.46E-02	2.59E-03
MINT	BP	GO:0017004	cytochrome complex assembly	-	40	18	-	-	4.31E-04	1.62E-03
MINT	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	56	-	-	9.17E-02	4.86E-03
MINT	BP	GO:0097212	lysosomal membrane organization	-	15	14	-	-	3.24E-04	1.30E-03
MINT	CC	GO:0050805	negative regulation of synaptic transmission	-	55	29	-	-	4.47E-03	2.59E-03
MINT	BP	GO:0043248	proteasome assembly	-	13	12	-	-	1.84E-02	1.08E-03
MINT	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	36	-	-	8.52E-04	3.13E-03
MINT	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	40	-	-	3.02E-03	3.46E-03
MINT	BP	GO:0016054	organic acid catabolic process	-	251	120	-	-	2.66E-03	1.04E-02
MINT	BP	GO:0050890	cognition	-	317	194	-	-	9.53E-03	1.68E-02
MINT	BP	GO:1900048	positive regulation of hemostasis	-	28	12	-	-	1.00E-01	1.08E-03
MINT	BP	GO:0065005	protein-lipid complex assembly	-	29	20	-	-	5.36E-04	1.73E-03
MINT	BP	GO:0008033	tRNA processing	-	136	69	-	-	1.49E-03	6.05E-03
MINT	BP	GO:0046661	male sex differentiation	-	171	99	-	-	3.52E-03	8.64E-03
MINT	BP	GO:0072520	seminiferous tubule development	-	15	12	-	-	3.15E-04	1.08E-03
MINT	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	12	-	-	1.04E-03	1.08E-03
MINT	BP	GO:0035188	hatching	-	27	14	-	-	3.20E-04	1.30E-03
MINT	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	62	-	-	4.43E-03	5.40E-03
MINT	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	12	-	-	3.23E-04	1.08E-03
MINT	BP	GO:1990778	protein localization to cell periphery	-	346	245	-	-	1.01E-02	2.12E-02
MINT	BP	GO:0061326	renal tubule development	-	103	53	-	-	5.03E-03	4.64E-03
MINT	BP	GO:0051258	protein polymerization	-	280	197	-	-	1.71E-02	1.71E-02
MINT	BP	GO:0071985	multivesicular body sorting pathway	-	56	44	-	-	1.26E-02	3.89E-03
MINT	BP	GO:0006450	regulation of translational fidelity	-	18	15	-	-	4.30E-04	1.30E-03
MINT	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	14	-	-	3.22E-04	1.30E-03
MINT	BP	GO:0060325	face morphogenesis	-	31	19	-	-	4.27E-04	1.73E-03
MINT	BP	GO:0090559	regulation of membrane permeability	-	72	51	-	-	4.68E-03	4.43E-03
MINT	BP	GO:0031579	membrane raft organization	-	25	19	-	-	4.28E-04	1.73E-03
MINT	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	19	-	-	1.61E-03	1.73E-03
MINT	BP	GO:0046460	neutral lipid biosynthetic process	-	50	26	-	-	6.34E-04	2.27E-03
MINT	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	45	-	-	1.07E-03	3.89E-03
MINT	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	136	-	-	4.37E-03	1.18E-02
MINT	BP	GO:0002251	organ or tissue specific immune response	-	43	15	-	-	4.23E-04	1.30E-03
MINT	CC	GO:0048167	regulation of synaptic plasticity	-	210	125	-	-	9.05E-03	1.08E-02
MINT	BP	GO:1903708	positive regulation of hemopoiesis	-	184	115	-	-	1.75E-02	9.94E-03
MINT	BP	GO:1903008	organelle disassembly	-	154	120	-	-	7.52E-03	1.04E-02
MINT	BP	GO:0001709	cell fate determination	-	44	21	-	-	5.30E-04	1.84E-03
MINT	BP	GO:0051873	killing by host of symbiont cells	-	28	16	-	-	4.27E-04	1.40E-03
MINT	BP	GO:0045058	T cell selection	-	53	36	-	-	4.40E-03	3.13E-03
MINT	CC	GO:0032387	negative regulation of intracellular transport	-	51	39	-	-	2.87E-03	3.46E-03
MINT	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	2.64E-03	1.73E-03
MINT	BP	GO:0072091	regulation of stem cell proliferation	-	91	52	-	-	1.98E-03	4.54E-03
MINT	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	21	-	-	5.39E-04	1.84E-03
MINT	BP	GO:0099084	postsynaptic specialization organization	-	44	28	-	-	2.03E-02	2.48E-03
MINT	BP	GO:0032535	regulation of cellular component size	-	360	223	-	-	7.73E-03	1.93E-02
MINT	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	14	-	-	3.24E-04	1.30E-03
MINT	MF	GO:0031281	positive regulation of cyclase activity	-	40	23	-	-	5.48E-03	2.05E-03
MINT	MF	GO:0098631	cell adhesion mediator activity	-	64	41	-	-	2.03E-03	3.56E-03
MINT	BP	GO:0046112	nucleobase biosynthetic process	-	18	15	-	-	4.30E-04	1.30E-03
MINT	BP	GO:0071453	cellular response to oxygen levels	-	168	112	-	-	4.28E-03	9.72E-03
MINT	BP	GO:0090399	replicative senescence	-	17	12	-	-	1.79E-03	1.08E-03
MINT	BP	GO:0031342	negative regulation of cell killing	-	29	20	-	-	1.72E-02	1.73E-03
MINT	BP	GO:0070585	protein localization to mitochondrion	-	125	100	-	-	1.43E-02	8.64E-03
MINT	BP	GO:0010623	programmed cell death involved in cell development	-	25	16	-	-	4.24E-03	1.40E-03
MINT	BP	GO:0044242	cellular lipid catabolic process	-	224	111	-	-	4.38E-03	9.61E-03
MINT	BP	GO:0071236	cellular response to antibiotic	-	13	11	-	-	2.63E-03	9.72E-04
MINT	BP	GO:0002931	response to ischemia	-	58	36	-	-	1.31E-03	3.13E-03
MINT	BP	GO:0043062	extracellular structure organization	-	317	158	-	-	1.54E-02	1.37E-02
MINT	BP	GO:0014047	glutamate secretion	-	25	12	-	-	3.22E-04	1.08E-03
MINT	BP	GO:0061005	cell differentiation involved in kidney development	-	58	35	-	-	5.49E-03	3.02E-03
MINT	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	43	-	-	3.99E-03	3.78E-03
MINT	BP	GO:0060420	regulation of heart growth	-	74	44	-	-	2.04E-03	3.89E-03
MINT	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	11	-	-	3.08E-04	9.72E-04
MINT	BP	GO:0009755	hormone-mediated signaling pathway	-	221	148	-	-	1.59E-02	1.29E-02
MINT	BP	GO:0022612	gland morphogenesis	-	124	84	-	-	3.17E-03	7.34E-03
MINT	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	30	-	-	7.37E-04	2.59E-03
MINT	MF	GO:0140416	transcription regulator inhibitor activity	-	26	19	-	-	4.26E-04	1.73E-03
MINT	BP	GO:0044782	cilium organization	-	400	202	-	-	9.95E-03	1.75E-02
MINT	BP	GO:0110096	cellular response to aldehyde	-	17	12	-	-	3.22E-04	1.08E-03
MINT	BP	GO:0090130	tissue migration	-	379	224	-	-	6.49E-03	1.94E-02
MINT	BP	GO:1990845	adaptive thermogenesis	-	166	109	-	-	1.31E-02	9.50E-03
MINT	BP	GO:0071320	cellular response to cAMP	-	54	30	-	-	1.88E-03	2.59E-03
MINT	BP	GO:0015844	monoamine transport	-	88	44	-	-	1.01E-02	3.89E-03
MINT	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	17	-	-	1.85E-03	1.51E-03
MINT	BP	GO:0060039	pericardium development	-	19	11	-	-	3.16E-04	9.72E-04
MINT	BP	GO:0071392	cellular response to estradiol stimulus	-	40	27	-	-	9.48E-04	2.38E-03
MINT	BP	GO:0000272	polysaccharide catabolic process	-	19	13	-	-	1.77E-02	1.19E-03
MINT	BP	GO:0009451	RNA modification	-	169	85	-	-	4.83E-03	7.34E-03
MINT	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	29	-	-	9.21E-04	2.59E-03
MINT	BP	GO:1903729	regulation of plasma membrane organization	-	17	14	-	-	3.21E-04	1.30E-03
MINT	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	91	-	-	7.39E-03	7.88E-03
MINT	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	28	-	-	2.21E-03	2.48E-03
MINT	BP	GO:0015807	L-amino acid transport	-	94	43	-	-	9.63E-04	3.78E-03
MINT	BP	GO:0032941	secretion by tissue	-	85	54	-	-	4.90E-03	4.75E-03
MINT	BP	GO:0046605	regulation of centrosome cycle	-	54	41	-	-	7.16E-03	3.56E-03
MINT	BP	GO:0048753	pigment granule organization	-	40	22	-	-	5.38E-04	1.94E-03
MINT	BP	GO:0003014	renal system process	-	130	60	-	-	2.59E-03	5.18E-03
MINT	CC	GO:0070286	axonemal dynein complex assembly	-	40	11	-	-	3.24E-04	9.72E-04
MINT	BP	GO:0045598	regulation of fat cell differentiation	-	148	87	-	-	3.07E-03	7.56E-03
MINT	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	152	-	-	1.18E-02	1.32E-02
MINT	BP	GO:1904646	cellular response to amyloid-beta	-	44	27	-	-	2.53E-03	2.38E-03
MINT	BP	GO:1901863	positive regulation of muscle tissue development	-	24	18	-	-	4.23E-04	1.62E-03
MINT	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	108	-	-	1.70E-02	9.40E-03
MINT	BP	GO:0008340	determination of adult lifespan	-	23	12	-	-	1.63E-03	1.08E-03
MINT	BP	GO:0018158	protein oxidation	-	15	11	-	-	3.23E-04	9.72E-04
MINT	BP	GO:0039694	viral RNA genome replication	-	30	21	-	-	4.94E-03	1.84E-03
MINT	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	20	-	-	5.33E-04	1.73E-03
MINT	BP	GO:0071709	membrane assembly	-	68	49	-	-	1.40E-03	4.32E-03
MINT	BP	GO:0008217	regulation of blood pressure	-	186	85	-	-	2.00E-03	7.34E-03
MINT	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	41	-	-	3.33E-03	3.56E-03
MINT	CC	GO:0042770	signal transduction in response to DNA damage	-	186	156	-	-	9.18E-03	1.35E-02
MINT	BP	GO:0002200	somatic diversification of immune receptors	-	78	61	-	-	4.49E-03	5.29E-03
MINT	BP	GO:0035315	hair cell differentiation	-	52	26	-	-	1.89E-03	2.27E-03
MINT	BP	GO:0048645	animal organ formation	-	62	42	-	-	3.15E-03	3.67E-03
MINT	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	115	-	-	1.36E-02	9.94E-03
MINT	BP	GO:0033627	cell adhesion mediated by integrin	-	87	59	-	-	3.91E-02	5.18E-03
MINT	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	14	-	-	3.23E-04	1.30E-03
MINT	BP	GO:0035107	appendage morphogenesis	-	147	87	-	-	3.79E-03	7.56E-03
MINT	BP	GO:1903707	negative regulation of hemopoiesis	-	116	65	-	-	8.54E-03	5.62E-03
MINT	CC	GO:0048208	COPII vesicle coating	-	27	17	-	-	3.51E-02	1.51E-03
MINT	BP	GO:0030149	sphingolipid catabolic process	-	32	14	-	-	3.23E-04	1.30E-03
MINT	BP	GO:0050994	regulation of lipid catabolic process	-	61	31	-	-	7.43E-04	2.70E-03
MINT	BP	GO:0035988	chondrocyte proliferation	-	24	14	-	-	2.68E-03	1.30E-03
MINT	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	21	-	-	1.98E-03	1.84E-03
MINT	BP	GO:0009593	detection of chemical stimulus	-	511	29	-	-	3.39E-02	2.59E-03
MINT	BP	GO:0045727	positive regulation of translation	-	141	109	-	-	5.82E-03	9.50E-03
MINT	BP	GO:0036315	cellular response to sterol	-	24	11	-	-	3.23E-04	9.72E-04
MINT	CC	GO:0032388	positive regulation of intracellular transport	-	137	104	-	-	3.11E-03	9.07E-03
MINT	BP	GO:0002027	regulation of heart rate	-	106	51	-	-	4.10E-03	4.43E-03
MINT	BP	GO:0050879	multicellular organismal movement	-	118	68	-	-	3.62E-03	5.94E-03
MINT	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	52	-	-	2.73E-03	4.54E-03
MINT	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	42	-	-	1.07E-03	3.67E-03
MINT	BP	GO:0048515	spermatid differentiation	-	208	96	-	-	2.67E-03	8.32E-03
MINT	BP	GO:0072132	mesenchyme morphogenesis	-	57	44	-	-	5.09E-03	3.89E-03
MINT	MF	GO:0042887	amide transmembrane transporter activity	-	33	13	-	-	3.24E-04	1.19E-03
MINT	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	24	-	-	8.94E-03	2.16E-03
MINT	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	24	-	-	5.30E-04	2.16E-03
MINT	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	14	-	-	3.23E-04	1.30E-03
MINT	BP	GO:0060119	inner ear receptor cell development	-	44	22	-	-	3.62E-02	1.94E-03
MINT	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	16	-	-	3.56E-03	1.40E-03
MINT	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	17	-	-	4.29E-04	1.51E-03
MINT	BP	GO:1901983	regulation of protein acetylation	-	26	17	-	-	2.49E-03	1.51E-03
MINT	BP	GO:0014854	response to inactivity	-	12	11	-	-	3.17E-04	9.72E-04
MINT	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	155	-	-	1.12E-02	1.34E-02
MINT	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	45	-	-	7.15E-02	3.89E-03
MINT	BP	GO:0010883	regulation of lipid storage	-	53	37	-	-	1.30E-03	3.24E-03
MINT	BP	GO:0072170	metanephric tubule development	-	26	13	-	-	1.10E-02	1.19E-03
MINT	BP	GO:1905954	positive regulation of lipid localization	-	110	59	-	-	1.71E-03	5.18E-03
MINT	BP	GO:0002209	behavioral defense response	-	39	21	-	-	2.27E-03	1.84E-03
MINT	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	14	-	-	5.03E-02	1.30E-03
MINT	BP	GO:0072523	purine-containing compound catabolic process	-	146	87	-	-	4.21E-03	7.56E-03
MINT	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	27	-	-	2.54E-03	2.38E-03
MINT	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	20	-	-	5.32E-04	1.73E-03
MINT	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	68	-	-	3.75E-03	5.94E-03
MINT	BP	GO:0007218	neuropeptide signaling pathway	-	113	37	-	-	4.94E-03	3.24E-03
MINT	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	75	-	-	4.75E-03	6.48E-03
MINT	BP	GO:0031345	negative regulation of cell projection organization	-	195	125	-	-	4.75E-03	1.08E-02
MINT	BP	GO:0048278	vesicle docking	-	64	47	-	-	5.71E-03	4.10E-03
MINT	BP	GO:0035050	embryonic heart tube development	-	86	49	-	-	4.50E-03	4.32E-03
MINT	BP	GO:0030168	platelet activation	-	135	87	-	-	7.04E-03	7.56E-03
MINT	CC	GO:0098810	neurotransmitter reuptake	-	35	19	-	-	3.48E-03	1.73E-03
MINT	BP	GO:0008213	protein alkylation	-	58	35	-	-	5.75E-03	3.02E-03
MINT	BP	GO:0031338	regulation of vesicle fusion	-	24	16	-	-	4.29E-04	1.40E-03
MINT	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	11	-	-	3.20E-04	9.72E-04
MINT	BP	GO:0031529	ruffle organization	-	55	44	-	-	1.19E-03	3.89E-03
MINT	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	39	-	-	1.07E-02	3.46E-03
MINT	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	42	-	-	2.40E-03	3.67E-03
MINT	MF	GO:0170055	lipid transmembrane transporter activity	-	56	20	-	-	5.39E-04	1.73E-03
MINT	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	18	-	-	4.30E-04	1.62E-03
MINT	BP	GO:0035304	regulation of protein dephosphorylation	-	87	65	-	-	2.33E-03	5.62E-03
MINT	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	142	-	-	5.12E-03	1.23E-02
MINT	BP	GO:0099637	neurotransmitter receptor transport	-	26	16	-	-	7.41E-03	1.40E-03
MINT	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	22	-	-	1.22E-03	1.94E-03
MINT	BP	GO:0051785	positive regulation of nuclear division	-	61	37	-	-	1.32E-03	3.24E-03
MINT	BP	GO:0060749	mammary gland alveolus development	-	20	19	-	-	4.10E-04	1.73E-03
MINT	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	11	-	-	3.22E-04	9.72E-04
MINT	BP	GO:0044786	cell cycle DNA replication	-	45	39	-	-	3.90E-02	3.46E-03
MINT	BP	GO:0044539	long-chain fatty acid import into cell	-	17	13	-	-	3.20E-04	1.19E-03
MINT	BP	GO:0051299	centrosome separation	-	15	12	-	-	3.21E-04	1.08E-03
MINT	BP	GO:0048145	regulation of fibroblast proliferation	-	87	61	-	-	2.03E-03	5.29E-03
MINT	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	44	-	-	4.82E-03	3.89E-03
MINT	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	180	-	-	5.10E-03	1.56E-02
MINT	BP	GO:0021819	layer formation in cerebral cortex	-	14	11	-	-	7.53E-02	9.72E-04
MINT	BP	GO:0009306	protein secretion	-	376	207	-	-	5.68E-03	1.79E-02
MINT	CC	GO:0008333	endosome to lysosome transport	-	73	49	-	-	5.07E-03	4.32E-03
MINT	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	11	-	-	3.22E-04	9.72E-04
MINT	BP	GO:0003016	respiratory system process	-	39	23	-	-	5.14E-04	2.05E-03
MINT	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	14	-	-	1.21E-02	1.30E-03
MINT	BP	GO:0045732	positive regulation of protein catabolic process	-	202	156	-	-	6.01E-03	1.35E-02
MINT	BP	GO:0031589	cell-substrate adhesion	-	360	238	-	-	1.20E-02	2.06E-02
MINT	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	35	-	-	8.59E-04	3.02E-03
MINT	BP	GO:0007588	excretion	-	40	18	-	-	2.92E-03	1.62E-03
MINT	BP	GO:1904018	positive regulation of vasculature development	-	185	96	-	-	5.25E-03	8.32E-03
MINT	BP	GO:0010948	negative regulation of cell cycle process	-	317	232	-	-	1.60E-02	2.01E-02
MINT	BP	GO:0050953	sensory perception of light stimulus	-	223	76	-	-	6.88E-02	6.59E-03
MINT	BP	GO:0009303	rRNA transcription	-	37	30	-	-	1.65E-03	2.59E-03
MINT	BP	GO:0035601	protein deacylation	-	56	41	-	-	8.40E-02	3.56E-03
MINT	BP	GO:0061952	midbody abscission	-	18	16	-	-	2.48E-02	1.40E-03
MINT	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	15	-	-	4.23E-04	1.30E-03
MINT	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	24	-	-	7.59E-04	2.16E-03
MINT	BP	GO:0071300	cellular response to retinoic acid	-	66	39	-	-	1.03E-03	3.46E-03
MINT	BP	GO:0045830	positive regulation of isotype switching	-	28	21	-	-	3.43E-03	1.84E-03
MINT	BP	GO:0031069	hair follicle morphogenesis	-	33	17	-	-	6.21E-04	1.51E-03
MINT	BP	GO:0046697	decidualization	-	26	17	-	-	1.88E-03	1.51E-03
MINT	BP	GO:0051588	regulation of neurotransmitter transport	-	99	60	-	-	2.45E-03	5.18E-03
MINT	BP	GO:0051784	negative regulation of nuclear division	-	63	48	-	-	1.40E-02	4.21E-03
MINT	BP	GO:0044703	multi-organism reproductive process	-	209	119	-	-	3.51E-03	1.04E-02
MINT	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	92	-	-	3.88E-03	7.99E-03
MINT	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	36	-	-	2.00E-03	3.13E-03
MINT	BP	GO:0099022	vesicle tethering	-	32	22	-	-	1.42E-01	1.94E-03
MINT	MF	GO:0004930	G protein-coupled receptor activity	-	873	151	-	-	7.86E-03	1.31E-02
MINT	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	18	-	-	3.02E-03	1.62E-03
MINT	BP	GO:1903867	extraembryonic membrane development	-	12	11	-	-	1.00E-01	9.72E-04
MINT	BP	GO:0048857	neural nucleus development	-	65	46	-	-	2.18E-03	4.00E-03
MINT	BP	GO:0048663	neuron fate commitment	-	74	32	-	-	4.99E-03	2.81E-03
MINT	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	84	-	-	4.79E-03	7.34E-03
MINT	BP	GO:0106027	neuron projection organization	-	90	74	-	-	5.35E-03	6.48E-03
MINT	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	84	-	-	4.02E-03	7.34E-03
MINT	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	31	-	-	1.23E-03	2.70E-03
MINT	BP	GO:0045685	regulation of glial cell differentiation	-	77	52	-	-	3.30E-03	4.54E-03
MINT	BP	GO:0043414	macromolecule methylation	-	138	78	-	-	5.02E-03	6.80E-03
MINT	BP	GO:0048268	clathrin coat assembly	-	16	14	-	-	3.23E-04	1.30E-03
MINT	BP	GO:0050886	endocrine process	-	93	46	-	-	1.09E-03	4.00E-03
MINT	BP	GO:0050951	sensory perception of temperature stimulus	-	28	13	-	-	3.23E-04	1.19E-03
MINT	BP	GO:0045807	positive regulation of endocytosis	-	155	109	-	-	7.04E-03	9.50E-03
MINT	BP	GO:0002418	immune response to tumor cell	-	29	13	-	-	3.19E-04	1.19E-03
MINT	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	48	-	-	2.48E-03	4.21E-03
MINT	BP	GO:0048308	organelle inheritance	-	14	13	-	-	1.59E-03	1.19E-03
MINT	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	13	-	-	5.45E-03	1.19E-03
MINT	BP	GO:0001829	trophectodermal cell differentiation	-	19	16	-	-	1.53E-02	1.40E-03
MINT	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	24	-	-	1.30E-02	2.16E-03
MINT	BP	GO:0034394	protein localization to cell surface	-	69	52	-	-	2.32E-03	4.54E-03
MINT	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	20	-	-	2.82E-02	1.73E-03
MINT	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	4.18E-04	1.51E-03
MINT	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	11	-	-	3.18E-04	9.72E-04
MINT	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	68	-	-	5.18E-03	5.94E-03
MINT	MF	GO:0051100	negative regulation of binding	-	161	124	-	-	3.19E-03	1.08E-02
MINT	BP	GO:0001818	negative regulation of cytokine production	-	379	165	-	-	7.00E-03	1.43E-02
MINT	BP	GO:0003151	outflow tract morphogenesis	-	81	54	-	-	4.73E-03	4.75E-03
MINT	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	47	-	-	3.87E-03	4.10E-03
MINT	BP	GO:0055093	response to hyperoxia	-	20	16	-	-	4.26E-04	1.40E-03
MINT	BP	GO:0061036	positive regulation of cartilage development	-	33	21	-	-	6.48E-02	1.84E-03
MINT	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	30	-	-	9.32E-04	2.59E-03
MINT	BP	GO:0046621	negative regulation of organ growth	-	39	27	-	-	1.67E-03	2.38E-03
MINT	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	44	-	-	1.08E-01	3.89E-03
MINT	BP	GO:0032368	regulation of lipid transport	-	149	79	-	-	4.22E-03	6.91E-03
MINT	BP	GO:0055094	response to lipoprotein particle	-	34	25	-	-	9.80E-03	2.16E-03
MINT	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	132	-	-	1.10E-02	1.14E-02
MINT	BP	GO:0033002	muscle cell proliferation	-	249	151	-	-	1.18E-02	1.31E-02
MINT	BP	GO:0048880	sensory system development	-	399	231	-	-	1.66E-02	2.00E-02
MINT	BP	GO:0043331	response to dsRNA	-	56	30	-	-	1.58E-03	2.59E-03
MINT	BP	GO:0051904	pigment granule transport	-	23	12	-	-	1.00E-01	1.08E-03
MINT	BP	GO:1901679	nucleotide transmembrane transport	-	32	16	-	-	4.30E-04	1.40E-03
MINT	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	21	-	-	4.07E-03	1.84E-03
MINT	BP	GO:0033363	secretory granule organization	-	63	29	-	-	8.48E-03	2.59E-03
MINT	BP	GO:0060479	lung cell differentiation	-	28	20	-	-	1.57E-03	1.73E-03
MINT	BP	GO:0120009	intermembrane lipid transfer	-	52	26	-	-	8.06E-02	2.27E-03
MINT	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	13	-	-	3.22E-04	1.19E-03
MINT	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	25	-	-	6.29E-04	2.16E-03
MINT	BP	GO:0033622	integrin activation	-	26	16	-	-	4.25E-04	1.40E-03
MINT	BP	GO:0098751	bone cell development	-	18	12	-	-	3.18E-04	1.08E-03
MINT	BP	GO:2000773	negative regulation of cellular senescence	-	25	19	-	-	1.24E-03	1.73E-03
MINT	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	26	-	-	1.22E-03	2.27E-03
MINT	BP	GO:0050820	positive regulation of coagulation	-	30	14	-	-	9.84E-02	1.30E-03
MINT	BP	GO:0072164	mesonephric tubule development	-	98	60	-	-	5.79E-03	5.18E-03
MINT	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	69	-	-	3.46E-03	6.05E-03
MINT	BP	GO:1903524	positive regulation of blood circulation	-	39	17	-	-	4.27E-04	1.51E-03
MINT	BP	GO:0030901	midbrain development	-	87	57	-	-	1.70E-03	4.97E-03
MINT	BP	GO:0007162	negative regulation of cell adhesion	-	310	185	-	-	8.75E-03	1.60E-02
MINT	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	43	-	-	1.10E-02	3.78E-03
MINT	BP	GO:0002687	positive regulation of leukocyte migration	-	147	82	-	-	2.78E-03	7.13E-03
MINT	BP	GO:0110154	RNA decapping	-	19	13	-	-	2.19E-02	1.19E-03
MINT	BP	GO:0034605	cellular response to heat	-	66	52	-	-	5.20E-03	4.54E-03
MINT	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	240	-	-	1.75E-02	2.07E-02
MINT	BP	GO:0005996	monosaccharide metabolic process	-	250	156	-	-	4.91E-03	1.35E-02
MINT	BP	GO:0033555	multicellular organismal response to stress	-	90	44	-	-	2.02E-03	3.89E-03
MINT	BP	GO:0002262	myeloid cell homeostasis	-	172	125	-	-	3.66E-03	1.08E-02
MINT	BP	GO:0000966	RNA 5'-end processing	-	39	27	-	-	5.48E-02	2.38E-03
MINT	BP	GO:0050688	regulation of defense response to virus	-	65	40	-	-	6.08E-03	3.46E-03
MINT	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	211	-	-	2.18E-02	1.83E-02
MINT	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	16	-	-	4.28E-04	1.40E-03
MINT	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	173	-	-	1.58E-02	1.50E-02
MINT	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	22	-	-	1.46E-02	1.94E-03
MINT	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	28	-	-	1.85E-02	2.48E-03
MINT	BP	GO:0003272	endocardial cushion formation	-	28	21	-	-	1.19E-03	1.84E-03
MINT	BP	GO:0022618	protein-RNA complex assembly	-	227	175	-	-	6.10E-02	1.51E-02
MINT	BP	GO:0051147	regulation of muscle cell differentiation	-	162	96	-	-	1.01E-02	8.32E-03
MINT	BP	GO:0006066	alcohol metabolic process	-	374	168	-	-	6.27E-03	1.46E-02
MINT	BP	GO:0090102	cochlea development	-	50	27	-	-	6.36E-04	2.38E-03
MINT	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	21	-	-	4.09E-03	1.84E-03
MINT	BP	GO:0045933	positive regulation of muscle contraction	-	49	26	-	-	6.36E-04	2.27E-03
MINT	BP	GO:0002679	respiratory burst involved in defense response	-	16	12	-	-	3.21E-04	1.08E-03
MINT	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	28	-	-	3.98E-03	2.48E-03
MINT	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	55	-	-	7.37E-03	4.75E-03
MINT	BP	GO:0043555	regulation of translation in response to stress	-	22	19	-	-	2.79E-02	1.73E-03
MINT	BP	GO:0032922	circadian regulation of gene expression	-	71	57	-	-	3.29E-03	4.97E-03
MINT	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	29	-	-	1.69E-03	2.59E-03
MINT	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	44	-	-	4.26E-02	3.89E-03
MINT	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	12	-	-	3.20E-04	1.08E-03
MINT	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	38	-	-	1.11E-03	3.35E-03
MINT	BP	GO:0038179	neurotrophin signaling pathway	-	38	29	-	-	4.11E-03	2.59E-03
MINT	BP	GO:0140253	cell-cell fusion	-	62	40	-	-	1.20E-02	3.46E-03
MINT	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	22	-	-	1.63E-01	1.94E-03
MINT	BP	GO:0061635	regulation of protein complex stability	-	14	11	-	-	3.21E-04	9.72E-04
MINT	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	40	-	-	9.68E-04	3.46E-03
MINT	BP	GO:0001941	postsynaptic membrane organization	-	37	23	-	-	1.74E-03	2.05E-03
MINT	BP	GO:0051293	establishment of spindle localization	-	57	40	-	-	3.61E-03	3.46E-03
MINT	BP	GO:0043114	regulation of vascular permeability	-	49	33	-	-	5.42E-03	2.92E-03
MINT	BP	GO:0018126	protein hydroxylation	-	26	21	-	-	1.36E-02	1.84E-03
MINT	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	41	-	-	1.55E-03	3.56E-03
MINT	BP	GO:0008360	regulation of cell shape	-	139	94	-	-	2.40E-02	8.21E-03
MINT	BP	GO:0051222	positive regulation of protein transport	-	249	166	-	-	4.24E-03	1.44E-02
MINT	CC	GO:0140632	canonical inflammasome complex assembly	-	40	24	-	-	2.44E-02	2.16E-03
MINT	MF	GO:0034260	negative regulation of GTPase activity	-	36	23	-	-	7.80E-04	2.05E-03
MINT	BP	GO:0045932	negative regulation of muscle contraction	-	24	15	-	-	4.25E-04	1.30E-03
MINT	BP	GO:0045739	positive regulation of DNA repair	-	128	110	-	-	5.67E-02	9.50E-03
MINT	BP	GO:0045185	maintenance of protein location	-	95	73	-	-	3.04E-03	6.37E-03
MINT	BP	GO:0003158	endothelium development	-	140	85	-	-	5.18E-03	7.34E-03
MINT	CC	GO:0072595	maintenance of protein localization in organelle	-	42	36	-	-	8.44E-04	3.13E-03
MINT	BP	GO:0051224	negative regulation of protein transport	-	122	67	-	-	4.14E-03	5.83E-03
MINT	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	87	-	-	4.18E-03	7.56E-03
MINT	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	3.03E-03	1.19E-03
MINT	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	18	-	-	2.11E-03	1.62E-03
MINT	MF	GO:0003713	transcription coactivator activity	-	281	212	-	-	1.14E-02	1.84E-02
MINT	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	14	-	-	2.38E-01	1.30E-03
MINT	BP	GO:0021885	forebrain cell migration	-	63	44	-	-	3.20E-03	3.89E-03
MINT	BP	GO:0007405	neuroblast proliferation	-	81	47	-	-	1.69E-03	4.10E-03
MINT	BP	GO:0009581	detection of external stimulus	-	137	50	-	-	3.41E-02	4.32E-03
MINT	BP	GO:1990542	mitochondrial transmembrane transport	-	93	53	-	-	1.77E-03	4.64E-03
MINT	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	28	-	-	2.74E-03	2.48E-03
MINT	BP	GO:0097186	amelogenesis	-	26	11	-	-	3.09E-04	9.72E-04
MINT	BP	GO:0031128	developmental induction	-	26	13	-	-	1.84E-03	1.19E-03
MINT	BP	GO:0031100	animal organ regeneration	-	66	49	-	-	4.51E-03	4.32E-03
MINT	BP	GO:0045684	positive regulation of epidermis development	-	33	18	-	-	4.19E-04	1.62E-03
MINT	BP	GO:1900047	negative regulation of hemostasis	-	51	28	-	-	9.07E-03	2.48E-03
MINT	BP	GO:0021517	ventral spinal cord development	-	47	15	-	-	4.30E-04	1.30E-03
MINT	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	57	-	-	2.52E-03	4.97E-03
MINT	MF	GO:0034497	protein localization to phagophore assembly site	-	16	12	-	-	6.55E-03	1.08E-03
MINT	BP	GO:0097722	sperm motility	-	133	38	-	-	8.59E-04	3.35E-03
MINT	BP	GO:0051231	spindle elongation	-	14	11	-	-	9.48E-02	9.72E-04
MINT	BP	GO:0042490	mechanoreceptor differentiation	-	67	32	-	-	1.01E-03	2.81E-03
MINT	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	23	-	-	2.83E-03	2.05E-03
MINT	BP	GO:0035148	tube formation	-	155	102	-	-	2.93E-03	8.86E-03
MINT	BP	GO:0048520	positive regulation of behavior	-	27	12	-	-	3.21E-04	1.08E-03
MINT	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	40	-	-	2.42E-02	3.46E-03
MINT	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	80	-	-	1.34E-02	6.91E-03
MINT	BP	GO:0031123	RNA 3'-end processing	-	79	67	-	-	1.06E-02	5.83E-03
MINT	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	62	-	-	2.56E-03	5.40E-03
MINT	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	16	-	-	4.29E-02	1.40E-03
MINT	CC	GO:0007097	nuclear migration	-	24	17	-	-	6.96E-03	1.51E-03
MINT	BP	GO:0045229	external encapsulating structure organization	-	319	161	-	-	7.12E-03	1.39E-02
MINT	BP	GO:0006885	regulation of pH	-	104	54	-	-	1.65E-03	4.75E-03
MINT	BP	GO:1990840	response to lectin	-	22	15	-	-	5.56E-03	1.30E-03
MINT	BP	GO:0071800	podosome assembly	-	19	15	-	-	3.45E-03	1.30E-03
MINT	BP	GO:0031018	endocrine pancreas development	-	47	29	-	-	1.14E-03	2.59E-03
MINT	BP	GO:0001708	cell fate specification	-	108	60	-	-	7.18E-03	5.18E-03
MINT	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	48	-	-	2.14E-03	4.21E-03
MINT	BP	GO:0030279	negative regulation of ossification	-	39	25	-	-	9.89E-04	2.16E-03
MINT	BP	GO:0032970	regulation of actin filament-based process	-	368	238	-	-	1.26E-02	2.06E-02
MINT	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	11	-	-	3.19E-04	9.72E-04
MINT	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	11	-	-	1.92E-02	9.72E-04
MINT	BP	GO:0042440	pigment metabolic process	-	80	40	-	-	9.62E-04	3.46E-03
MINT	BP	GO:1901606	alpha-amino acid catabolic process	-	101	46	-	-	1.07E-03	4.00E-03
MINT	BP	GO:0062197	cellular response to chemical stress	-	299	210	-	-	7.69E-03	1.81E-02
MINT	BP	GO:1901890	positive regulation of cell junction assembly	-	106	57	-	-	2.74E-03	4.97E-03
MINT	BP	GO:0070988	demethylation	-	27	16	-	-	4.21E-04	1.40E-03
MINT	BP	GO:1901655	cellular response to ketone	-	107	71	-	-	2.40E-03	6.16E-03
MINT	BP	GO:0051255	spindle midzone assembly	-	14	11	-	-	4.03E-02	9.72E-04
MINT	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	15	-	-	4.30E-04	1.30E-03
MINT	BP	GO:0006968	cellular defense response	-	52	26	-	-	2.41E-03	2.27E-03
MINT	BP	GO:0055006	cardiac cell development	-	93	58	-	-	3.84E-03	5.08E-03
MINT	BP	GO:0031365	N-terminal protein amino acid modification	-	30	18	-	-	2.91E-03	1.62E-03
MINT	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	21	-	-	1.41E-03	1.84E-03
MINT	BP	GO:0060004	reflex	-	63	38	-	-	1.84E-03	3.35E-03
MINT	BP	GO:0044706	multi-multicellular organism process	-	217	123	-	-	3.61E-03	1.07E-02
MINT	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	3.23E-04	1.08E-03
MINT	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	118	-	-	5.75E-03	1.03E-02
MINT	BP	GO:0006026	aminoglycan catabolic process	-	34	14	-	-	3.22E-04	1.30E-03
MINT	BP	GO:0031294	lymphocyte costimulation	-	47	28	-	-	4.61E-03	2.48E-03
MINT	BP	GO:0050768	negative regulation of neurogenesis	-	150	97	-	-	2.28E-03	8.42E-03
MINT	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	77	-	-	3.17E-03	6.70E-03
MINT	BP	GO:0090068	positive regulation of cell cycle process	-	262	189	-	-	1.42E-02	1.64E-02
MINT	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	12	-	-	3.21E-04	1.08E-03
MINT	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	24	-	-	2.30E-02	2.16E-03
MINT	BP	GO:1902115	regulation of organelle assembly	-	210	157	-	-	1.58E-02	1.36E-02
MINT	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	49	-	-	5.42E-03	4.32E-03
MINT	BP	GO:0047484	regulation of response to osmotic stress	-	16	13	-	-	3.22E-04	1.19E-03
MINT	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	99	-	-	2.84E-03	8.64E-03
MINT	BP	GO:0046622	positive regulation of organ growth	-	52	27	-	-	9.55E-04	2.38E-03
MINT	BP	GO:0051952	regulation of amine transport	-	98	47	-	-	4.83E-03	4.10E-03
MINT	BP	GO:0006730	one-carbon metabolic process	-	24	16	-	-	4.31E-04	1.40E-03
MINT	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	12	-	-	3.12E-02	1.08E-03
MINT	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	12	-	-	3.21E-04	1.08E-03
MINT	CC	GO:0032365	intracellular lipid transport	-	51	33	-	-	4.25E-03	2.92E-03
MINT	BP	GO:0045048	protein insertion into ER membrane	-	30	22	-	-	1.68E-02	1.94E-03
MINT	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	47	-	-	1.05E-03	4.10E-03
MINT	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	87	-	-	3.72E-03	7.56E-03
MINT	BP	GO:0018149	peptide cross-linking	-	28	19	-	-	4.29E-04	1.73E-03
MINT	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	20	-	-	5.30E-04	1.73E-03
MINT	MF	GO:0140537	transcription regulator activator activity	-	13	12	-	-	3.15E-04	1.08E-03
MINT	BP	GO:0021859	pyramidal neuron differentiation	-	14	11	-	-	3.16E-04	9.72E-04
MINT	BP	GO:0071398	cellular response to fatty acid	-	35	22	-	-	5.29E-04	1.94E-03
MINT	BP	GO:0097581	lamellipodium organization	-	91	66	-	-	6.10E-03	5.72E-03
MINT	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	19	-	-	2.80E-02	1.73E-03
MINT	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	167	-	-	8.07E-02	1.45E-02
MINT	BP	GO:0060326	cell chemotaxis	-	311	174	-	-	8.21E-03	1.51E-02
MINT	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	19	-	-	3.84E-02	1.73E-03
MINT	BP	GO:0016485	protein processing	-	248	135	-	-	6.79E-03	1.17E-02
MINT	BP	GO:0009649	entrainment of circadian clock	-	30	19	-	-	1.80E-03	1.73E-03
MINT	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	81	-	-	1.47E-02	7.02E-03
MINT	BP	GO:1903523	negative regulation of blood circulation	-	27	15	-	-	4.14E-03	1.30E-03
MINT	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	63	-	-	4.94E-03	5.51E-03
MINT	BP	GO:0099054	presynapse assembly	-	49	27	-	-	6.37E-04	2.38E-03
MINT	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	18	-	-	1.42E-02	1.62E-03
MINT	BP	GO:0006517	protein deglycosylation	-	26	16	-	-	4.31E-04	1.40E-03
MINT	BP	GO:0031348	negative regulation of defense response	-	282	168	-	-	5.10E-03	1.46E-02
MINT	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	52	-	-	4.02E-03	4.54E-03
MINT	BP	GO:0007606	sensory perception of chemical stimulus	-	535	29	-	-	1.39E-02	2.59E-03
MINT	BP	GO:0061180	mammary gland epithelium development	-	68	56	-	-	1.79E-03	4.86E-03
MINT	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	153	-	-	5.81E-03	1.33E-02
MINT	BP	GO:0071496	cellular response to external stimulus	-	74	49	-	-	4.81E-03	4.32E-03
MINT	BP	GO:0042753	positive regulation of circadian rhythm	-	18	11	-	-	8.53E-03	9.72E-04
MINT	BP	GO:0032094	response to food	-	37	19	-	-	1.43E-03	1.73E-03
MINT	BP	GO:0001964	startle response	-	27	20	-	-	2.62E-02	1.73E-03
MINT	BP	GO:0046434	organophosphate catabolic process	-	232	128	-	-	5.52E-03	1.11E-02
MINT	BP	GO:0060037	pharyngeal system development	-	29	18	-	-	6.86E-03	1.62E-03
MINT	BP	GO:0009566	fertilization	-	205	81	-	-	6.68E-03	7.02E-03
MINT	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	51	-	-	3.19E-01	4.43E-03
MINT	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	11	-	-	3.23E-04	9.72E-04
MINT	BP	GO:0045907	positive regulation of vasoconstriction	-	30	16	-	-	4.26E-04	1.40E-03
MINT	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	12	-	-	1.20E-02	1.08E-03
MINT	BP	GO:0033044	regulation of chromosome organization	-	249	206	-	-	3.59E-02	1.78E-02
MINT	BP	GO:0009309	amine biosynthetic process	-	38	18	-	-	4.27E-04	1.62E-03
MINT	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	243	-	-	7.12E-03	2.11E-02
MINT	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	11	-	-	9.80E-03	9.72E-04
MINT	BP	GO:0061900	glial cell activation	-	56	38	-	-	6.53E-03	3.35E-03
MINT	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	94	-	-	7.08E-03	8.21E-03
MINT	CC	GO:0140467	integrated stress response signaling	-	41	32	-	-	2.66E-03	2.81E-03
MINT	BP	GO:0035902	response to immobilization stress	-	20	11	-	-	3.21E-04	9.72E-04
MINT	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	241	-	-	8.44E-02	2.08E-02
MINT	BP	GO:0090235	regulation of metaphase plate congression	-	13	12	-	-	2.80E-02	1.08E-03
MINT	BP	GO:0043647	inositol phosphate metabolic process	-	44	23	-	-	4.52E-03	2.05E-03
MINT	BP	GO:0016180	snRNA processing	-	28	25	-	-	1.02E-01	2.16E-03
MINT	BP	GO:0051303	establishment of chromosome localization	-	104	88	-	-	7.74E-03	7.67E-03
MINT	BP	GO:0051382	kinetochore assembly	-	16	11	-	-	1.36E-02	9.72E-04
MINT	BP	GO:0007164	establishment of tissue polarity	-	38	25	-	-	2.54E-02	2.16E-03
MINT	BP	GO:0021515	cell differentiation in spinal cord	-	51	17	-	-	4.26E-04	1.51E-03
MINT	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	18	-	-	4.97E-03	1.62E-03
MINT	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	22	-	-	3.06E-03	1.94E-03
MINT	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	15	-	-	2.85E-03	1.30E-03
MINT	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	27	-	-	2.09E-03	2.38E-03
MINT	BP	GO:0006605	protein targeting	-	327	230	-	-	1.17E-02	1.99E-02
MINT	BP	GO:0061318	renal filtration cell differentiation	-	22	13	-	-	3.21E-04	1.19E-03
MINT	BP	GO:0007566	embryo implantation	-	57	36	-	-	1.29E-03	3.13E-03
MINT	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	24	-	-	1.09E-02	2.16E-03
MINT	BP	GO:0061512	protein localization to cilium	-	394	199	-	-	1.95E-02	1.73E-02
MINT	BP	GO:0060306	regulation of membrane repolarization	-	38	18	-	-	1.45E-02	1.62E-03
MINT	BP	GO:0051017	actin filament bundle assembly	-	161	114	-	-	5.98E-03	9.94E-03
MINT	BP	GO:1905953	negative regulation of lipid localization	-	63	33	-	-	2.50E-03	2.92E-03
MINT	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	13	-	-	3.22E-04	1.19E-03
MINT	BP	GO:0021542	dentate gyrus development	-	19	13	-	-	1.03E-03	1.19E-03
MINT	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	24	-	-	4.58E-03	2.16E-03
MINT	BP	GO:0021756	striatum development	-	21	16	-	-	1.16E-03	1.40E-03
MINT	BP	GO:1901343	negative regulation of vasculature development	-	154	63	-	-	1.53E-03	5.51E-03
MINT	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	108	-	-	1.83E-02	9.40E-03
MINT	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	11	-	-	3.23E-04	9.72E-04
MINT	BP	GO:1902414	protein localization to cell junction	-	107	76	-	-	2.03E-02	6.59E-03
MINT	BP	GO:0071305	cellular response to vitamin D	-	23	11	-	-	4.95E-04	9.72E-04
MINT	BP	GO:0051304	chromosome separation	-	80	65	-	-	1.83E-02	5.62E-03
MINT	BP	GO:0090596	sensory organ morphogenesis	-	272	146	-	-	5.27E-03	1.26E-02
MINT	BP	GO:0045780	positive regulation of bone resorption	-	18	13	-	-	3.19E-04	1.19E-03
MINT	BP	GO:0048709	oligodendrocyte differentiation	-	101	67	-	-	2.45E-03	5.83E-03
MINT	BP	GO:0045017	glycerolipid biosynthetic process	-	254	154	-	-	5.50E-03	1.34E-02
MINT	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	14	-	-	3.82E-01	1.30E-03
MINT	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	17	-	-	3.19E-02	1.51E-03
MINT	BP	GO:0001776	leukocyte homeostasis	-	108	74	-	-	2.80E-03	6.48E-03
MINT	BP	GO:0050769	positive regulation of neurogenesis	-	240	148	-	-	3.82E-03	1.29E-02
MINT	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	14	-	-	2.00E-01	1.30E-03
MINT	BP	GO:0030193	regulation of blood coagulation	-	70	38	-	-	4.92E-03	3.35E-03
MINT	BP	GO:0050866	negative regulation of cell activation	-	216	123	-	-	1.23E-02	1.07E-02
MINT	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	22	-	-	1.37E-03	1.94E-03
MINT	BP	GO:0033500	carbohydrate homeostasis	-	251	158	-	-	4.03E-03	1.37E-02
MINT	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	20	-	-	6.98E-03	1.73E-03
MINT	BP	GO:0044088	regulation of vacuole organization	-	56	42	-	-	6.15E-03	3.67E-03
MINT	CC	GO:0051457	maintenance of protein location in nucleus	-	23	21	-	-	5.32E-04	1.84E-03
MINT	CC	GO:0099522	cytosolic region	-	20	18	-	-	4.27E-04	1.62E-03
MINT	CC	GO:0000791	euchromatin	-	60	45	-	-	2.46E-03	3.89E-03
MINT	CC	GO:0030666	endocytic vesicle membrane	-	196	144	-	-	1.11E-02	1.25E-02
MINT	CC	GO:0098857	membrane microdomain	-	324	229	-	-	1.40E-02	1.99E-02
MINT	CC	GO:0030312	external encapsulating structure	-	567	238	-	-	2.23E-02	2.06E-02
MINT	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.12E-01	1.30E-03
MINT	CC	GO:1990752	microtubule end	-	34	27	-	-	2.02E-02	2.38E-03
MINT	CC	GO:0043204	perikaryon	-	156	89	-	-	4.14E-03	7.78E-03
MINT	CC	GO:0097542	ciliary tip	-	48	34	-	-	2.39E-02	3.02E-03
MINT	CC	GO:1905368	peptidase complex	-	124	104	-	-	4.57E-02	9.07E-03
MINT	CC	GO:0000792	heterochromatin	-	98	90	-	-	1.07E-02	7.78E-03
MINT	CC	GO:0097546	ciliary base	-	47	31	-	-	6.78E-03	2.70E-03
MINT	CC	GO:0071819	DUBm complex	-	25	23	-	-	3.77E-01	2.05E-03
MINT	CC	GO:0031201	SNARE complex	-	48	41	-	-	2.26E-01	3.56E-03
MINT	CC	GO:0016324	apical plasma membrane	-	392	192	-	-	8.54E-03	1.66E-02
MINT	CC	GO:0005677	chromatin silencing complex	-	13	12	-	-	3.31E-03	1.08E-03
MINT	CC	GO:0033260	nuclear DNA replication	-	40	34	-	-	4.45E-02	3.02E-03
MINT	CC	GO:0044391	ribosomal subunit	-	203	187	-	-	3.68E-02	1.62E-02
MINT	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	9.02E-02	9.72E-04
MINT	CC	GO:0071013	catalytic step 2 spliceosome	-	88	88	-	-	2.21E-02	7.67E-03
MINT	CC	GO:0031907	microbody lumen	-	51	25	-	-	6.43E-04	2.16E-03
MINT	CC	GO:0098862	cluster of actin-based cell projections	-	162	86	-	-	2.85E-03	7.45E-03
MINT	CC	GO:0016363	nuclear matrix	-	127	114	-	-	9.50E-03	9.94E-03
MINT	CC	GO:0031261	DNA replication preinitiation complex	-	46	39	-	-	1.28E-01	3.46E-03
MINT	CC	GO:0097060	synaptic membrane	-	413	218	-	-	1.92E-02	1.89E-02
MINT	CC	GO:0032432	actin filament bundle	-	249	154	-	-	1.02E-02	1.34E-02
MINT	CC	GO:0008088	axo-dendritic transport	-	78	61	-	-	2.74E-03	5.29E-03
MINT	CC	GO:0031519	PcG protein complex	-	38	36	-	-	1.71E-01	3.13E-03
MINT	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	24	-	-	7.87E-03	2.16E-03
MINT	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	147	-	-	1.77E-02	1.27E-02
MINT	CC	GO:0000313	organellar ribosome	-	89	82	-	-	7.61E-02	7.13E-03
MINT	CC	GO:0098791	Golgi apparatus subcompartment	-	378	203	-	-	4.58E-02	1.76E-02
MINT	CC	GO:0099643	signal release from synapse	-	147	93	-	-	7.82E-03	8.10E-03
MINT	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	34	-	-	9.47E-02	3.02E-03
MINT	CC	GO:0030018	Z disc	-	129	91	-	-	1.89E-02	7.88E-03
MINT	CC	GO:0032580	Golgi cisterna membrane	-	93	34	-	-	7.48E-03	3.02E-03
MINT	CC	GO:1905360	GTPase complex	-	41	22	-	-	1.93E-02	1.94E-03
MINT	CC	GO:0097540	axonemal central pair	-	161	59	-	-	1.49E-03	5.18E-03
MINT	CC	GO:0042641	actomyosin	-	77	57	-	-	1.27E-03	4.97E-03
MINT	CC	GO:0097386	glial cell projection	-	38	20	-	-	5.27E-04	1.73E-03
MINT	CC	GO:0032588	trans-Golgi network membrane	-	102	64	-	-	7.87E-02	5.62E-03
MINT	CC	GO:0070382	exocytic vesicle	-	224	132	-	-	7.97E-03	1.14E-02
MINT	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	39	-	-	8.60E-04	3.46E-03
MINT	CC	GO:0031903	microbody membrane	-	65	36	-	-	3.28E-01	3.13E-03
MINT	CC	GO:0046930	pore complex	-	26	17	-	-	2.29E-03	1.51E-03
MINT	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	1.33E-02	9.72E-04
MINT	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	13	-	-	8.80E-03	1.19E-03
MINT	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	187	-	-	1.94E-02	1.62E-02
MINT	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	17	-	-	4.29E-04	1.51E-03
MINT	CC	GO:0099571	postsynaptic cytoskeleton	-	18	14	-	-	2.25E-02	1.30E-03
MINT	CC	GO:0044298	cell body membrane	-	32	13	-	-	3.23E-04	1.19E-03
MINT	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	1.72E-01	9.72E-04
MINT	CC	GO:0051882	mitochondrial depolarization	-	21	14	-	-	1.03E-03	1.30E-03
MINT	CC	GO:0045495	pole plasm	-	25	14	-	-	1.46E-02	1.30E-03
MINT	CC	GO:0072379	ER membrane insertion complex	-	14	12	-	-	3.23E-04	1.08E-03
MINT	CC	GO:0070993	translation preinitiation complex	-	19	18	-	-	9.72E-02	1.62E-03
MINT	CC	GO:0010369	chromocenter	-	14	11	-	-	3.49E-03	9.72E-04
MINT	CC	GO:0016323	basolateral plasma membrane	-	239	136	-	-	7.66E-03	1.18E-02
MINT	CC	GO:0045009	chitosome	-	21	13	-	-	2.53E-02	1.19E-03
MINT	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	6.46E-02	1.08E-03
MINT	CC	GO:0042645	mitochondrial nucleoid	-	45	40	-	-	1.99E-02	3.46E-03
MINT	CC	GO:1902495	transmembrane transporter complex	-	408	163	-	-	1.72E-02	1.41E-02
MINT	CC	GO:0098636	protein complex involved in cell adhesion	-	57	36	-	-	2.31E-02	3.13E-03
MINT	CC	GO:0001917	photoreceptor inner segment	-	71	32	-	-	1.74E-02	2.81E-03
MINT	CC	GO:0098845	postsynaptic endosome	-	14	12	-	-	2.08E-02	1.08E-03
MINT	CC	GO:0019897	extrinsic component of plasma membrane	-	156	100	-	-	4.49E-03	8.64E-03
MINT	CC	GO:0031594	neuromuscular junction	-	73	45	-	-	6.64E-03	3.89E-03
MINT	CC	GO:0000793	condensed chromosome	-	274	227	-	-	5.89E-02	1.97E-02
MINT	CC	GO:0045120	pronucleus	-	14	13	-	-	3.19E-04	1.19E-03
MINT	CC	GO:0000922	spindle pole	-	172	134	-	-	7.61E-03	1.17E-02
MINT	CC	GO:0120111	neuron projection cytoplasm	-	94	70	-	-	2.92E-03	6.05E-03
MINT	CC	GO:0070971	endoplasmic reticulum exit site	-	32	21	-	-	1.61E-02	1.84E-03
MINT	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	2.46E-01	1.19E-03
MINT	CC	GO:0004879	nuclear receptor activity	-	63	44	-	-	1.90E-02	3.89E-03
MINT	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	123	-	-	6.21E-03	1.07E-02
MINT	CC	GO:0000123	histone acetyltransferase complex	-	93	88	-	-	1.64E-01	7.67E-03
MINT	CC	GO:0034982	mitochondrial protein processing	-	13	11	-	-	2.62E-03	9.72E-04
MINT	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	77	-	-	1.63E-02	6.70E-03
MINT	CC	GO:0048786	presynaptic active zone	-	80	51	-	-	1.69E-03	4.43E-03
MINT	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	1.48E-01	1.08E-03
MINT	CC	GO:0007034	vacuolar transport	-	168	117	-	-	9.39E-03	1.02E-02
MINT	CC	GO:0090741	pigment granule membrane	-	21	13	-	-	3.24E-04	1.19E-03
MINT	CC	GO:0043194	axon initial segment	-	21	13	-	-	3.23E-04	1.19E-03
MINT	CC	GO:0005776	autophagosome	-	111	79	-	-	5.21E-02	6.91E-03
MINT	CC	GO:0031430	M band	-	22	13	-	-	3.22E-04	1.19E-03
MINT	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	68	-	-	1.48E-01	5.94E-03
MINT	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	76	-	-	2.52E-01	6.59E-03
MINT	CC	GO:0000164	protein phosphatase type 1 complex	-	19	16	-	-	3.37E-02	1.40E-03
MINT	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	22	-	-	8.60E-02	1.94E-03
MINT	CC	GO:0032994	protein-lipid complex	-	39	18	-	-	3.87E-02	1.62E-03
MINT	CC	GO:0150034	distal axon	-	309	196	-	-	6.49E-03	1.70E-02
MINT	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	144	-	-	6.66E-02	1.25E-02
MINT	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	1.74E-02	1.08E-03
MINT	CC	GO:0072562	blood microparticle	-	144	80	-	-	5.56E-03	6.91E-03
MINT	CC	GO:0051233	spindle midzone	-	36	29	-	-	2.01E-03	2.59E-03
MINT	CC	GO:0005811	lipid droplet	-	102	55	-	-	3.43E-03	4.75E-03
MINT	CC	GO:0045022	early endosome to late endosome transport	-	44	32	-	-	1.35E-02	2.81E-03
MINT	CC	GO:0043113	receptor clustering	-	51	37	-	-	4.21E-03	3.24E-03
MINT	CC	GO:0044853	plasma membrane raft	-	114	77	-	-	8.35E-03	6.70E-03
MINT	CC	GO:0005881	cytoplasmic microtubule	-	256	113	-	-	4.04E-03	9.83E-03
MINT	CC	GO:0008180	COP9 signalosome	-	17	15	-	-	4.32E-02	1.30E-03
MINT	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	36	-	-	6.26E-03	3.13E-03
MINT	CC	GO:0005905	clathrin-coated pit	-	73	53	-	-	2.40E-02	4.64E-03
MINT	CC	GO:0043034	costamere	-	18	16	-	-	1.63E-03	1.40E-03
MINT	CC	GO:0031904	endosome lumen	-	38	20	-	-	6.98E-03	1.73E-03
MINT	CC	GO:0060170	ciliary membrane	-	76	28	-	-	1.42E-03	2.48E-03
MINT	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	12	-	-	9.00E-01	1.08E-03
MINT	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	17	-	-	4.30E-04	1.51E-03
MINT	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	14	-	-	1.05E-01	1.30E-03
MINT	CC	GO:0032154	cleavage furrow	-	54	43	-	-	9.81E-03	3.78E-03
MINT	CC	GO:0005640	nuclear outer membrane	-	30	18	-	-	4.29E-04	1.62E-03
MINT	CC	GO:0005652	nuclear lamina	-	12	11	-	-	3.02E-03	9.72E-04
MINT	CC	GO:0007006	mitochondrial membrane organization	-	117	88	-	-	8.01E-03	7.67E-03
MINT	CC	GO:0001772	immunological synapse	-	44	36	-	-	8.83E-03	3.13E-03
MINT	CC	GO:0030904	retromer complex	-	12	12	-	-	2.88E-01	1.08E-03
MINT	CC	GO:0009897	external side of plasma membrane	-	425	182	-	-	1.87E-02	1.58E-02
MINT	CC	GO:0030863	cortical cytoskeleton	-	104	81	-	-	1.64E-02	7.02E-03
MINT	CC	GO:1905348	endonuclease complex	-	38	28	-	-	1.00E-01	2.48E-03
MINT	CC	GO:0030315	T-tubule	-	52	32	-	-	1.15E-03	2.81E-03
MINT	CC	GO:0060076	excitatory synapse	-	64	32	-	-	9.75E-04	2.81E-03
MINT	CC	GO:0036019	endolysosome	-	29	22	-	-	1.37E-02	1.94E-03
MINT	CC	GO:0001891	phagocytic cup	-	28	20	-	-	5.35E-04	1.73E-03
MINT	CC	GO:0099086	synaptonemal structure	-	40	21	-	-	3.89E-02	1.84E-03
MINT	CC	GO:0030427	site of polarized growth	-	172	131	-	-	5.34E-03	1.13E-02
MINT	CC	GO:0044309	neuron spine	-	213	142	-	-	7.37E-03	1.23E-02
MINT	CC	GO:0030658	transport vesicle membrane	-	231	144	-	-	5.92E-03	1.25E-02
MINT	CC	GO:0098918	structural constituent of synapse	-	27	23	-	-	2.29E-03	2.05E-03
MINT	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	11	-	-	1.15E-01	9.72E-04
MINT	CC	GO:0000940	outer kinetochore	-	17	16	-	-	1.43E-01	1.40E-03
MINT	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	2.80E-01	1.51E-03
MINT	CC	GO:0044232	organelle membrane contact site	-	50	38	-	-	4.42E-03	3.35E-03
MINT	CC	GO:0098803	respiratory chain complex	-	39	23	-	-	5.38E-04	2.05E-03
MINT	CC	GO:0030667	secretory granule membrane	-	319	179	-	-	1.09E-02	1.56E-02
MINT	CC	GO:0097545	axonemal outer doublet	-	164	62	-	-	1.80E-03	5.40E-03
MINT	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	12	-	-	3.20E-04	1.08E-03
MINT	CC	GO:0070069	cytochrome complex	-	42	25	-	-	6.46E-04	2.16E-03
MINT	CC	GO:0031143	pseudopodium	-	18	15	-	-	4.25E-04	1.30E-03
MINT	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	24	-	-	9.68E-03	2.16E-03
MINT	CC	GO:0055037	recycling endosome	-	200	133	-	-	1.45E-02	1.16E-02
MINT	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	73	-	-	6.43E-03	6.37E-03
MINT	CC	GO:0035253	ciliary rootlet	-	13	11	-	-	3.22E-04	9.72E-04
MINT	CC	GO:0071682	endocytic vesicle lumen	-	23	18	-	-	4.90E-02	1.62E-03
MINT	CC	GO:0030684	preribosome	-	76	61	-	-	4.29E-03	5.29E-03
MINT	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	216	-	-	7.63E-03	1.87E-02
MINT	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	17	-	-	2.27E-01	1.51E-03
MINT	CC	GO:1990391	DNA repair complex	-	22	19	-	-	5.97E-03	1.73E-03
MINT	CC	GO:0005775	vacuolar lumen	-	176	101	-	-	2.64E-03	8.75E-03
MINT	CC	GO:0032433	filopodium tip	-	19	15	-	-	4.92E-03	1.30E-03
MINT	CC	GO:0032982	myosin filament	-	24	17	-	-	4.31E-04	1.51E-03
MINT	CC	GO:0016327	apicolateral plasma membrane	-	23	13	-	-	1.29E-03	1.19E-03
MINT	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	15	-	-	1.25E-01	1.30E-03
MINT	CC	GO:0044306	neuron projection terminus	-	164	86	-	-	2.87E-03	7.45E-03
MINT	CC	GO:0034455	t-UTP complex	-	53	45	-	-	5.92E-03	3.89E-03
MINT	CC	GO:0005770	late endosome	-	299	183	-	-	1.60E-02	1.59E-02
MINT	CC	GO:0031970	organelle envelope lumen	-	94	64	-	-	8.73E-03	5.62E-03
MINT	CC	GO:0097550	transcription preinitiation complex	-	13	11	-	-	6.49E-02	9.72E-04
MINT	CC	GO:0120293	dynein axonemal particle	-	20	11	-	-	3.21E-04	9.72E-04
MINT	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	23	-	-	6.78E-03	2.05E-03
MINT	CC	GO:0043292	contractile muscle fiber	-	245	163	-	-	1.08E-02	1.41E-02
MINT	CC	GO:0034709	methylosome	-	13	12	-	-	2.39E-02	1.08E-03
MINT	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	11	-	-	1.23E-02	9.72E-04
MINT	CC	GO:0005849	mRNA cleavage factor complex	-	22	17	-	-	8.81E-02	1.51E-03
MINT	CC	GO:0000803	sex chromosome	-	32	27	-	-	5.00E-03	2.38E-03
MINT	CC	GO:0098982	GABA-ergic synapse	-	84	43	-	-	3.42E-03	3.78E-03
MINT	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	12	-	-	9.08E-02	1.08E-03
MINT	CC	GO:0035097	histone methyltransferase complex	-	63	58	-	-	1.28E-01	5.08E-03
MINT	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	4.82E-01	1.30E-03
MINT	CC	GO:0000242	pericentriolar material	-	22	16	-	-	4.29E-04	1.40E-03
MINT	CC	GO:1903293	phosphatase complex	-	54	48	-	-	3.90E-02	4.21E-03
MINT	CC	GO:0031941	filamentous actin	-	27	19	-	-	4.29E-04	1.73E-03
MINT	CC	GO:0000786	nucleosome	-	149	86	-	-	2.70E-02	7.45E-03
MINT	CC	GO:0001533	cornified envelope	-	59	46	-	-	1.07E-03	4.00E-03
MINT	CC	GO:1904724	tertiary granule lumen	-	55	34	-	-	7.45E-04	3.02E-03
MINT	CC	GO:0030027	lamellipodium	-	202	166	-	-	1.17E-02	1.44E-02
MINT	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	14	-	-	6.99E-02	1.30E-03
MINT	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	18	-	-	6.71E-02	1.62E-03
MINT	CC	GO:0000800	lateral element	-	14	11	-	-	1.32E-01	9.72E-04
MINT	CC	GO:0060077	inhibitory synapse	-	20	12	-	-	3.23E-04	1.08E-03
MINT	CC	GO:0031209	SCAR complex	-	12	11	-	-	3.83E-01	9.72E-04
MINT	CC	GO:0001056	RNA polymerase III activity	-	16	15	-	-	2.73E-01	1.30E-03
MINT	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	14	-	-	3.23E-04	1.30E-03
MINT	CC	GO:0002102	podosome	-	31	25	-	-	7.86E-03	2.16E-03
MINT	CC	GO:0090543	Flemming body	-	33	29	-	-	5.29E-03	2.59E-03
MINT	CC	GO:0016328	lateral plasma membrane	-	66	47	-	-	4.69E-03	4.10E-03
MINT	CC	GO:0001650	fibrillar center	-	151	115	-	-	4.87E-03	9.94E-03
MINT	CC	GO:0031332	RNAi effector complex	-	413	14	-	-	1.63E-02	1.30E-03
MINT	CC	GO:1990204	oxidoreductase complex	-	90	59	-	-	3.50E-02	5.18E-03
MINT	CC	GO:0000930	gamma-tubulin complex	-	16	12	-	-	1.74E-01	1.08E-03
MINT	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.99E-02	9.72E-04
MINT	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	97	-	-	3.23E-03	8.42E-03
MINT	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	13	-	-	2.00E-01	1.19E-03
MINT	CC	GO:0001726	ruffle	-	181	146	-	-	8.90E-03	1.26E-02
MINT	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	13	-	-	4.03E-02	1.19E-03
MINT	CC	GO:0043198	dendritic shaft	-	38	23	-	-	1.91E-03	2.05E-03
MINT	CC	GO:0043073	germ cell nucleus	-	67	49	-	-	3.10E-03	4.32E-03
MINT	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	17	-	-	1.62E-02	1.51E-03
MINT	CC	GO:0005788	endoplasmic reticulum lumen	-	313	171	-	-	2.38E-02	1.48E-02
MINT	CC	GO:0016592	mediator complex	-	38	35	-	-	2.78E-01	3.02E-03
MINT	CC	GO:0034045	phagophore assembly site membrane	-	19	13	-	-	1.19E-01	1.19E-03
MINT	CC	GO:0022626	cytosolic ribosome	-	118	109	-	-	1.52E-02	9.50E-03
MINT	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	38	-	-	1.42E-01	3.35E-03
MINT	CC	GO:0034451	centriolar satellite	-	120	81	-	-	4.15E-03	7.02E-03
MINT	CC	GO:0045171	intercellular bridge	-	91	63	-	-	5.42E-03	5.51E-03
MINT	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	58	-	-	9.10E-03	5.08E-03
MINT	CC	GO:0044292	dendrite terminus	-	13	11	-	-	3.19E-04	9.72E-04
MINT	CC	GO:0032039	integrator complex	-	19	15	-	-	1.81E-01	1.30E-03
MINT	CC	GO:0030527	structural constituent of chromatin	-	97	42	-	-	2.27E-03	3.67E-03
MINT	CC	GO:0036379	myofilament	-	26	14	-	-	4.07E-03	1.30E-03
MINT	CC	GO:0030286	dynein complex	-	210	83	-	-	1.56E-02	7.24E-03
MINT	CC	GO:0044615	nuclear pore nuclear basket	-	12	11	-	-	2.08E-02	9.72E-04
MINT	CC	GO:0016482	cytosolic transport	-	135	99	-	-	1.53E-02	8.64E-03
MINT	CC	GO:0090665	glycoprotein complex	-	23	18	-	-	1.44E-01	1.62E-03
MINT	CC	GO:0005796	Golgi lumen	-	106	43	-	-	1.23E-02	3.78E-03
MINT	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	21	-	-	5.38E-04	1.84E-03
MINT	CC	GO:0034358	plasma lipoprotein particle	-	36	15	-	-	5.38E-02	1.30E-03
MINT	CC	GO:0008023	transcription elongation factor complex	-	47	41	-	-	4.10E-02	3.56E-03
MINT	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	17	-	-	1.62E-03	1.51E-03
MINT	CC	GO:0030662	coated vesicle membrane	-	202	149	-	-	5.32E-03	1.30E-02
MINT	CC	GO:0007039	protein catabolic process in the vacuole	-	61	50	-	-	1.58E-02	4.32E-03
MINT	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	58	-	-	3.98E-01	5.08E-03
MINT	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	209	-	-	4.61E-02	1.81E-02
MINT	CC	GO:0090734	site of DNA damage	-	118	95	-	-	1.48E-02	8.21E-03
MINT	MF	GO:0051861	glycolipid binding	-	30	11	-	-	3.23E-04	9.72E-04
MINT	MF	GO:0051087	protein-folding chaperone binding	-	135	102	-	-	4.01E-03	8.86E-03
MINT	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	29	-	-	4.63E-03	2.59E-03
MINT	MF	GO:0035613	RNA stem-loop binding	-	21	13	-	-	1.99E-03	1.19E-03
MINT	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	149	-	-	5.83E-03	1.30E-02
MINT	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	13	-	-	2.74E-03	1.19E-03
MINT	MF	GO:0016757	glycosyltransferase activity	-	286	88	-	-	4.54E-03	7.67E-03
MINT	MF	GO:0048306	calcium-dependent protein binding	-	61	46	-	-	6.36E-03	4.00E-03
MINT	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	12	-	-	3.65E-02	1.08E-03
MINT	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	63	-	-	7.17E-03	5.51E-03
MINT	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	28	-	-	5.66E-02	2.48E-03
MINT	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	63	-	-	2.20E-02	5.51E-03
MINT	MF	GO:0051020	GTPase binding	-	311	221	-	-	9.28E-03	1.91E-02
MINT	MF	GO:0140457	protein demethylase activity	-	31	28	-	-	4.18E-03	2.48E-03
MINT	MF	GO:0005158	insulin receptor binding	-	22	19	-	-	6.63E-03	1.73E-03
MINT	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	13	-	-	1.17E-03	1.19E-03
MINT	MF	GO:0061980	regulatory RNA binding	-	52	35	-	-	3.05E-02	3.02E-03
MINT	MF	GO:0015035	protein-disulfide reductase activity	-	32	24	-	-	1.22E-01	2.16E-03
MINT	MF	GO:0001671	ATPase activator activity	-	29	21	-	-	5.37E-04	1.84E-03
MINT	MF	GO:0070840	dynein complex binding	-	25	20	-	-	5.27E-04	1.73E-03
MINT	MF	GO:0035035	histone acetyltransferase binding	-	24	19	-	-	2.35E-03	1.73E-03
MINT	MF	GO:0061684	chaperone-mediated autophagy	-	16	14	-	-	2.87E-03	1.30E-03
MINT	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	20	-	-	5.35E-04	1.73E-03
MINT	MF	GO:0003688	DNA replication origin binding	-	18	16	-	-	3.73E-03	1.40E-03
MINT	MF	GO:0005178	integrin binding	-	153	96	-	-	9.43E-03	8.32E-03
MINT	MF	GO:0070064	proline-rich region binding	-	17	15	-	-	3.96E-03	1.30E-03
MINT	MF	GO:0008327	methyl-CpG binding	-	31	22	-	-	2.65E-03	1.94E-03
MINT	MF	GO:0031418	L-ascorbic acid binding	-	20	11	-	-	3.23E-04	9.72E-04
MINT	MF	GO:0005521	lamin binding	-	15	13	-	-	3.20E-04	1.19E-03
MINT	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	16	-	-	2.46E-02	1.40E-03
MINT	MF	GO:0140318	protein transporter activity	-	40	29	-	-	9.74E-03	2.59E-03
MINT	MF	GO:0070628	proteasome binding	-	17	17	-	-	1.22E-02	1.51E-03
MINT	MF	GO:0000217	DNA secondary structure binding	-	37	31	-	-	1.10E-02	2.70E-03
MINT	MF	GO:0002039	p53 binding	-	66	56	-	-	3.40E-03	4.86E-03
MINT	MF	GO:0005496	steroid binding	-	110	57	-	-	5.73E-03	4.97E-03
MINT	MF	GO:0008443	phosphofructokinase activity	-	27	22	-	-	1.13E-03	1.94E-03
MINT	MF	GO:0003684	damaged DNA binding	-	89	72	-	-	2.51E-02	6.26E-03
MINT	MF	GO:0000339	RNA cap binding	-	20	17	-	-	1.67E-02	1.51E-03
MINT	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	98	-	-	3.64E-02	8.53E-03
MINT	MF	GO:0070063	RNA polymerase binding	-	61	52	-	-	4.51E-03	4.54E-03
MINT	MF	GO:0050811	GABA receptor binding	-	18	12	-	-	3.20E-04	1.08E-03
MINT	MF	GO:0030971	receptor tyrosine kinase binding	-	76	56	-	-	6.77E-03	4.86E-03
MINT	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	74	-	-	2.26E-02	6.48E-03
MINT	MF	GO:0140030	modification-dependent protein binding	-	179	153	-	-	8.40E-03	1.33E-02
MINT	MF	GO:0032794	GTPase activating protein binding	-	13	12	-	-	3.21E-04	1.08E-03
MINT	MF	GO:0141047	molecular tag activity	-	13	11	-	-	2.08E-03	9.72E-04
MINT	MF	GO:1990226	histone methyltransferase binding	-	15	12	-	-	6.37E-03	1.08E-03
MINT	MF	GO:0035497	cAMP response element binding	-	12	11	-	-	2.21E-03	9.72E-04
MINT	MF	GO:0044548	S100 protein binding	-	14	14	-	-	2.87E-02	1.30E-03
MINT	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	3.25E-02	1.30E-03
MINT	MF	GO:0030276	clathrin binding	-	70	47	-	-	1.34E-02	4.10E-03
MINT	MF	GO:0046875	ephrin receptor binding	-	29	25	-	-	4.57E-03	2.16E-03
MINT	MF	GO:0046790	virion binding	-	19	15	-	-	4.26E-04	1.30E-03
MINT	MF	GO:0030552	cAMP binding	-	48	20	-	-	2.99E-03	1.73E-03
MINT	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	30	-	-	7.42E-04	2.59E-03
MINT	MF	GO:0004857	enzyme inhibitor activity	-	395	224	-	-	6.13E-03	1.94E-02
MINT	MF	GO:0035173	histone kinase activity	-	17	15	-	-	4.27E-04	1.30E-03
MINT	MF	GO:0097602	cullin family protein binding	-	26	21	-	-	7.69E-03	1.84E-03
MINT	MF	GO:0016209	antioxidant activity	-	92	43	-	-	1.06E-02	3.78E-03
MINT	MF	GO:0070325	lipoprotein particle receptor binding	-	32	27	-	-	6.91E-03	2.38E-03
MINT	MF	GO:0044325	transmembrane transporter binding	-	159	107	-	-	7.90E-03	9.29E-03
MINT	MF	GO:0048156	tau protein binding	-	43	39	-	-	2.42E-03	3.46E-03
MINT	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	32	-	-	1.44E-03	2.81E-03
MINT	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	2.17E-03	1.19E-03
MINT	MF	GO:0140272	exogenous protein binding	-	79	59	-	-	5.12E-03	5.18E-03
MINT	MF	GO:0030145	manganese ion binding	-	65	41	-	-	1.26E-03	3.56E-03
MINT	MF	GO:0071814	protein-lipid complex binding	-	52	30	-	-	1.03E-02	2.59E-03
MINT	MF	GO:0008066	glutamate receptor activity	-	70	34	-	-	5.85E-03	3.02E-03
MINT	MF	GO:0017069	snRNA binding	-	54	42	-	-	1.04E-01	3.67E-03
MINT	MF	GO:0031369	translation initiation factor binding	-	32	27	-	-	1.12E-02	2.38E-03
MINT	MF	GO:0019843	rRNA binding	-	69	61	-	-	2.04E-03	5.29E-03
MINT	MF	GO:0004713	protein tyrosine kinase activity	-	213	169	-	-	2.51E-02	1.47E-02
MINT	MF	GO:0016779	nucleotidyltransferase activity	-	264	181	-	-	1.87E-02	1.57E-02
MINT	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	48	-	-	3.05E-02	4.21E-03
MINT	MF	GO:0008093	cytoskeletal anchor activity	-	24	18	-	-	4.27E-04	1.62E-03
MINT	MF	GO:0070300	phosphatidic acid binding	-	20	11	-	-	3.23E-04	9.72E-04
MINT	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	20	-	-	5.34E-04	1.73E-03
MINT	MF	GO:0016208	AMP binding	-	22	17	-	-	4.86E-02	1.51E-03
MINT	MF	GO:0000287	magnesium ion binding	-	225	155	-	-	4.48E-03	1.34E-02
MINT	MF	GO:0031490	chromatin DNA binding	-	120	100	-	-	1.32E-02	8.64E-03
MINT	MF	GO:0017022	myosin binding	-	73	48	-	-	8.40E-03	4.21E-03
MINT	MF	GO:0004896	cytokine receptor activity	-	93	45	-	-	3.09E-03	3.89E-03
MINT	MF	GO:0008301	"DNA binding, bending"	-	18	14	-	-	9.50E-04	1.30E-03
MINT	MF	GO:0005539	glycosaminoglycan binding	-	236	113	-	-	7.69E-03	9.83E-03
MINT	MF	GO:0019207	kinase regulator activity	-	267	195	-	-	7.57E-03	1.68E-02
MINT	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	12	-	-	3.23E-04	1.08E-03
MINT	MF	GO:0031420	alkali metal ion binding	-	17	11	-	-	3.22E-04	9.72E-04
MINT	MF	GO:0044183	protein folding chaperone	-	67	53	-	-	1.92E-03	4.64E-03
MINT	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	90	-	-	7.36E-03	7.78E-03
MINT	MF	GO:0003725	double-stranded RNA binding	-	72	56	-	-	3.23E-02	4.86E-03
MINT	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	11	-	-	1.50E-01	9.72E-04
MINT	MF	GO:0051018	protein kinase A binding	-	52	34	-	-	7.59E-03	3.02E-03
MINT	MF	GO:0071889	14-3-3 protein binding	-	34	27	-	-	1.48E-03	2.38E-03
MINT	MF	GO:0004618	phosphoglycerate kinase activity	-	89	64	-	-	4.42E-03	5.62E-03
MINT	MF	GO:0042805	actinin binding	-	36	23	-	-	1.14E-03	2.05E-03
MINT	MF	GO:0043531	ADP binding	-	38	33	-	-	1.95E-03	2.92E-03
MINT	MF	GO:0043394	proteoglycan binding	-	36	24	-	-	5.07E-03	2.16E-03
MINT	MF	GO:0046332	SMAD binding	-	77	63	-	-	2.97E-03	5.51E-03
MINT	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.56E-03	1.19E-03
MINT	MF	GO:0001968	fibronectin binding	-	30	18	-	-	1.95E-02	1.62E-03
MINT	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	89	-	-	3.70E-02	7.78E-03
MINT	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	52	-	-	1.17E-03	4.54E-03
MINT	MF	GO:0003756	protein disulfide isomerase activity	-	18	13	-	-	7.49E-03	1.19E-03
MINT	MF	GO:0051117	ATPase binding	-	85	64	-	-	3.36E-03	5.62E-03
MINT	MF	GO:0005216	monoatomic ion channel activity	-	618	243	-	-	1.37E-02	2.11E-02
MINT	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	33	-	-	8.93E-04	2.92E-03
MINT	MF	GO:0051787	misfolded protein binding	-	20	12	-	-	4.43E-03	1.08E-03
MINT	MF	GO:0001098	basal transcription machinery binding	-	61	54	-	-	4.61E-03	4.75E-03
MINT	MF	GO:0036002	pre-mRNA binding	-	57	28	-	-	1.37E-02	2.48E-03
MINT	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	24	-	-	5.35E-04	2.16E-03
MINT	MF	GO:0051540	metal cluster binding	-	71	40	-	-	1.30E-02	3.46E-03
MINT	MF	GO:0051219	phosphoprotein binding	-	92	81	-	-	7.25E-03	7.02E-03
MINT	MF	GO:0019894	kinesin binding	-	45	33	-	-	7.34E-04	2.92E-03
MINT	MF	GO:0042287	MHC protein binding	-	68	26	-	-	1.30E-01	2.27E-03
MINT	MF	GO:0019003	GDP binding	-	89	65	-	-	4.13E-03	5.62E-03
MINT	MF	GO:0017171	serine hydrolase activity	-	207	73	-	-	4.20E-03	6.37E-03
MINT	MF	GO:0097110	scaffold protein binding	-	66	56	-	-	3.53E-03	4.86E-03
MINT	MF	GO:0003774	cytoskeletal motor activity	-	117	77	-	-	3.87E-03	6.70E-03
MINT	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	26	-	-	3.96E-03	2.27E-03
MINT	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	1.30E-03	1.51E-03
MINT	MF	GO:0061134	peptidase regulator activity	-	224	107	-	-	9.69E-03	9.29E-03
MINT	MF	GO:0008013	beta-catenin binding	-	86	74	-	-	7.10E-03	6.48E-03
MINT	MF	GO:0051015	actin filament binding	-	208	154	-	-	1.88E-02	1.34E-02
MINT	MF	GO:0019208	phosphatase regulator activity	-	107	79	-	-	3.92E-03	6.91E-03
MINT	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	21	-	-	2.54E-03	1.84E-03
MINT	MF	GO:0043236	laminin binding	-	29	21	-	-	5.37E-04	1.84E-03
MINT	MF	GO:0030507	spectrin binding	-	26	20	-	-	4.38E-02	1.73E-03
MINT	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	27	-	-	9.48E-04	2.38E-03
MINT	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	82	-	-	4.02E-02	7.13E-03
MINT	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	20	-	-	5.58E-03	1.73E-03
MINT	MF	GO:0042393	histone binding	-	240	203	-	-	1.31E-02	1.76E-02
MINT	MF	GO:0019838	growth factor binding	-	182	130	-	-	5.88E-03	1.12E-02
MINT	MF	GO:0000149	SNARE binding	-	107	77	-	-	5.50E-02	6.70E-03
MINT	MF	GO:0003727	single-stranded RNA binding	-	90	61	-	-	6.14E-03	5.29E-03
MINT	MF	GO:0051378	serotonin binding	-	24	12	-	-	3.20E-04	1.08E-03
MINT	MF	GO:0005516	calmodulin binding	-	206	135	-	-	3.94E-03	1.17E-02
MINT	MF	GO:0019825	oxygen binding	-	40	14	-	-	2.03E-02	1.30E-03
MINT	MF	GO:0045505	dynein intermediate chain binding	-	37	15	-	-	4.29E-04	1.30E-03
MINT	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	48	-	-	1.34E-03	4.21E-03
MINT	MF	GO:0032182	ubiquitin-like protein binding	-	117	103	-	-	8.06E-03	8.96E-03
MINT	MF	GO:0023023	MHC protein complex binding	-	36	24	-	-	1.17E-01	2.16E-03
MINT	MF	GO:0030742	GTP-dependent protein binding	-	22	14	-	-	3.22E-04	1.30E-03
MINT	MF	GO:0043274	phospholipase binding	-	23	19	-	-	5.33E-03	1.73E-03
MINT	MF	GO:0031072	heat shock protein binding	-	128	100	-	-	3.85E-03	8.64E-03
MINT	MF	GO:0030515	snoRNA binding	-	33	31	-	-	7.52E-04	2.70E-03
MINT	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	24	-	-	5.36E-04	2.16E-03
MINT	MF	GO:0001965	G-protein alpha-subunit binding	-	26	19	-	-	4.24E-04	1.73E-03
MINT	MF	GO:0001530	lipopolysaccharide binding	-	38	17	-	-	1.84E-02	1.51E-03
MINT	MF	GO:0046982	protein heterodimerization activity	-	343	202	-	-	1.09E-02	1.75E-02
MINT	MF	GO:0140223	general transcription initiation factor activity	-	55	40	-	-	1.35E-01	3.46E-03
MINT	MF	GO:0000049	tRNA binding	-	75	51	-	-	1.18E-03	4.43E-03
MINT	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	37	-	-	1.16E-02	3.24E-03
MINT	MF	GO:0015026	coreceptor activity	-	48	24	-	-	8.70E-03	2.16E-03
MINT	MF	GO:0005527	macrolide binding	-	12	11	-	-	3.22E-04	9.72E-04
MINT	MF	GO:0001653	peptide receptor activity	-	128	51	-	-	6.37E-03	4.43E-03
MINT	MF	GO:0030506	ankyrin binding	-	19	11	-	-	3.21E-04	9.72E-04
MINT	MF	GO:0006469	negative regulation of protein kinase activity	-	222	168	-	-	4.41E-03	1.46E-02
MINT	MF	GO:0070182	DNA polymerase binding	-	22	18	-	-	9.70E-04	1.62E-03
MINT	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	24	-	-	8.04E-03	2.16E-03
MINT	MF	GO:0051427	hormone receptor binding	-	31	15	-	-	4.28E-04	1.30E-03
MINT	MF	GO:0070851	growth factor receptor binding	-	141	85	-	-	9.78E-03	7.34E-03
MINT	MF	GO:0031210	phosphatidylcholine binding	-	32	19	-	-	4.29E-04	1.73E-03
MINT	MF	GO:0005525	GTP binding	-	396	238	-	-	8.68E-03	2.06E-02
MINT	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	30	-	-	7.24E-03	2.59E-03
MINT	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	180	-	-	2.98E-02	1.56E-02
MINT	MF	GO:0034185	apolipoprotein binding	-	20	11	-	-	3.20E-04	9.72E-04
MINT	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	12	-	-	2.92E-03	1.08E-03
MINT	MF	GO:0051346	negative regulation of hydrolase activity	-	332	185	-	-	4.74E-03	1.60E-02
MINT	MF	GO:0005506	iron ion binding	-	154	61	-	-	5.66E-03	5.29E-03
MINT	MF	GO:0003925	G protein activity	-	45	30	-	-	3.07E-03	2.59E-03
MINT	MF	GO:0038187	pattern recognition receptor activity	-	33	16	-	-	4.30E-04	1.40E-03
MINT	MF	GO:0008276	protein methyltransferase activity	-	96	68	-	-	9.23E-03	5.94E-03
MINT	MF	GO:0004396	hexokinase activity	-	16	12	-	-	3.23E-04	1.08E-03
MINT	MF	GO:0070888	E-box binding	-	59	32	-	-	3.86E-02	2.81E-03
MINT	MF	GO:0015399	primary active transmembrane transporter activity	-	190	123	-	-	6.69E-02	1.07E-02
MINT	MF	GO:0035254	glutamate receptor binding	-	47	35	-	-	1.42E-03	3.02E-03
MINT	MF	GO:0050321	tau-protein kinase activity	-	36	26	-	-	1.31E-03	2.27E-03
MINT	MF	GO:0043021	ribonucleoprotein complex binding	-	158	134	-	-	6.61E-03	1.17E-02
MINT	MF	GO:0030170	pyridoxal phosphate binding	-	56	29	-	-	6.44E-04	2.59E-03
MINT	MF	GO:0005112	Notch binding	-	26	14	-	-	2.21E-03	1.30E-03
MINT	MF	GO:0048185	activin binding	-	16	13	-	-	3.22E-04	1.19E-03
MINT	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	16	-	-	4.31E-04	1.40E-03
MINT	MF	GO:0001664	G protein-coupled receptor binding	-	299	141	-	-	9.00E-03	1.22E-02
MINT	MF	GO:0140299	small molecule sensor activity	-	39	28	-	-	8.07E-02	2.48E-03
MINT	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	16	-	-	4.31E-04	1.40E-03
MINT	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	11	-	-	7.80E-03	9.72E-04
MINT	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	12	-	-	3.24E-04	1.08E-03
MINT	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	39	-	-	3.32E-02	3.46E-03
MINT	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	16	-	-	2.18E-03	1.40E-03
MINT	MF	GO:0030594	neurotransmitter receptor activity	-	160	70	-	-	2.65E-02	6.05E-03
MINT	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	18	-	-	1.90E-03	1.62E-03
MINT	MF	GO:0120227	acyl-CoA binding	-	22	14	-	-	3.23E-04	1.30E-03
MINT	MF	GO:0005507	copper ion binding	-	63	32	-	-	1.65E-02	2.81E-03
MINT	MF	GO:0033558	protein lysine deacetylase activity	-	22	17	-	-	1.36E-02	1.51E-03
MINT	MF	GO:0070034	telomerase RNA binding	-	22	18	-	-	6.03E-03	1.62E-03
MultiNet	CC	GO:0005730	nucleolus	9.06E-56	988	894	694	1.29	-	-
MultiNet	CC	GO:0005739	mitochondrion	1.25E-39	1671	1397	1174	1.19	-	-
MultiNet	CC	GO:0005840	ribosome	1.32E-24	222	215	156	1.38	-	-
MultiNet	CC	GO:0005615	extracellular space	2.08E-21	3190	2460	2240	1.10	-	-
MultiNet	CC	GO:0005768	endosome	2.15E-20	1037	855	728	1.17	-	-
MultiNet	CC	GO:0005815	microtubule organizing center	2.61E-16	843	694	592	1.17	-	-
MultiNet	CC	GO:0005635	nuclear envelope	9.68E-16	493	422	346	1.22	-	-
MultiNet	CC	GO:0005783	endoplasmic reticulum	1.84E-12	2020	1553	1419	1.09	-	-
MultiNet	CC	GO:0005764	lysosome	2.94E-12	747	607	525	1.16	-	-
MultiNet	CC	GO:0005794	Golgi apparatus	3.11E-10	1636	1258	1149	1.09	-	-
MultiNet	CC	GO:0000228	nuclear chromosome	2.19E-09	206	181	145	1.25	-	-
MultiNet	CC	GO:0005777	peroxisome	5.95E-04	142	118	100	1.18	-	-
MultiNet	CC	GO:0031012	extracellular matrix	1.31E-02	564	369	396	0.93	-	-
MultiNet	CC	GO:0005929	cilium	4.49E-02	842	565	591	0.96	-	-
MultiNet	CC	GO:0005811	lipid droplet	4.99E-02	102	81	72	1.13	-	-
MultiNet	BP	GO:0012501	programmed cell death	2.12E-86	1954	1722	1372	1.25	-	-
MultiNet	BP	GO:0006355	regulation of DNA-templated transcription	6.66E-84	3342	2792	2347	1.19	-	-
MultiNet	BP	GO:0050877	nervous system process	1.99E-51	1527	804	1072	0.75	-	-
MultiNet	BP	GO:0002376	immune system process	4.79E-50	2448	2020	1719	1.17	-	-
MultiNet	BP	GO:0065003	protein-containing complex assembly	1.50E-47	1648	1400	1157	1.21	-	-
MultiNet	BP	GO:0030163	protein catabolic process	2.34E-41	990	870	695	1.25	-	-
MultiNet	BP	GO:0006325	chromatin organization	2.15E-40	720	651	506	1.29	-	-
MultiNet	BP	GO:0006281	DNA repair	8.28E-40	587	541	412	1.31	-	-
MultiNet	BP	GO:0016071	mRNA metabolic process	5.31E-36	713	638	501	1.27	-	-
MultiNet	BP	GO:0006914	autophagy	3.06E-32	568	514	399	1.29	-	-
MultiNet	BP	GO:0006886	intracellular protein transport	1.03E-31	664	591	466	1.27	-	-
MultiNet	BP	GO:0042254	ribosome biogenesis	7.16E-29	297	284	209	1.36	-	-
MultiNet	BP	GO:0016192	vesicle-mediated transport	2.74E-28	1894	1531	1330	1.15	-	-
MultiNet	BP	GO:0048870	cell motility	2.14E-26	1659	1347	1165	1.16	-	-
MultiNet	BP	GO:0042060	wound healing	6.47E-24	431	389	303	1.29	-	-
MultiNet	BP	GO:0006913	nucleocytoplasmic transport	1.45E-23	326	302	229	1.32	-	-
MultiNet	BP	GO:0006260	DNA replication	3.53E-22	279	261	196	1.33	-	-
MultiNet	BP	GO:0007155	cell adhesion	2.40E-21	1444	1167	1014	1.15	-	-
MultiNet	BP	GO:0032200	telomere organization	1.33E-20	186	180	131	1.38	-	-
MultiNet	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.91E-19	729	615	512	1.20	-	-
MultiNet	BP	GO:0007010	cytoskeleton organization	2.93E-19	1639	1305	1151	1.13	-	-
MultiNet	BP	GO:0006091	generation of precursor metabolites and energy	6.66E-18	502	434	353	1.23	-	-
MultiNet	BP	GO:0007059	chromosome segregation	1.23E-16	403	353	283	1.25	-	-
MultiNet	BP	GO:0034330	cell junction organization	1.20E-15	727	603	511	1.18	-	-
MultiNet	BP	GO:0006954	inflammatory response	1.87E-14	820	670	576	1.16	-	-
MultiNet	BP	GO:0007005	mitochondrion organization	3.42E-14	484	411	340	1.21	-	-
MultiNet	BP	GO:0140053	mitochondrial gene expression	5.19E-14	164	154	115	1.34	-	-
MultiNet	BP	GO:0002181	cytoplasmic translation	2.13E-13	153	144	107	1.34	-	-
MultiNet	BP	GO:0006310	DNA recombination	4.42E-13	333	290	234	1.24	-	-
MultiNet	BP	GO:0007163	establishment or maintenance of cell polarity	2.11E-11	227	202	159	1.27	-	-
MultiNet	BP	GO:0003013	circulatory system process	3.21E-10	584	476	410	1.16	-	-
MultiNet	BP	GO:0003012	muscle system process	9.94E-10	425	353	298	1.18	-	-
MultiNet	BP	GO:0006629	lipid metabolic process	4.31E-09	1355	1045	952	1.10	-	-
MultiNet	BP	GO:0098542	defense response to other organism	1.27E-08	1171	907	822	1.10	-	-
MultiNet	BP	GO:0072659	protein localization to plasma membrane	2.89E-08	284	240	199	1.20	-	-
MultiNet	BP	GO:0006520	amino acid metabolic process	3.14E-08	292	246	205	1.20	-	-
MultiNet	BP	GO:0000910	cytokinesis	7.11E-08	186	162	131	1.24	-	-
MultiNet	BP	GO:0005975	carbohydrate metabolic process	1.37E-07	551	441	387	1.14	-	-
MultiNet	BP	GO:0006457	protein folding	1.83E-07	210	180	147	1.22	-	-
MultiNet	BP	GO:0006399	tRNA metabolic process	1.30E-06	196	167	138	1.21	-	-
MultiNet	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.24E-05	119	104	84	1.24	-	-
MultiNet	BP	GO:0098754	detoxification	1.17E-03	134	111	94	1.18	-	-
MultiNet	BP	GO:0006575	cellular modified amino acid metabolic process	7.72E-03	186	147	131	1.13	-	-
MultiNet	BP	GO:0140013	meiotic nuclear division	8.20E-03	279	216	196	1.10	-	-
MultiNet	BP	GO:0006766	vitamin metabolic process	1.08E-02	107	87	75	1.16	-	-
MultiNet	BP	GO:0007040	lysosome organization	1.08E-02	107	87	75	1.16	-	-
MultiNet	BP	GO:0022600	digestive system process	2.75E-02	110	88	77	1.14	-	-
MultiNet	BP	GO:0006486	protein glycosylation	3.31E-02	225	143	158	0.90	-	-
MultiNet	BP	GO:0003014	renal system process	6.38E-02	127	99	89	1.11	-	-
MultiNet	BP	GO:0055085	transmembrane transport	1.21E-01	1784	1224	1253	0.98	-	-
MultiNet	BP	GO:0006790	sulfur compound metabolic process	1.75E-01	320	236	225	1.05	-	-
MultiNet	BP	GO:0044782	cilium organization	2.23E-01	399	269	280	0.96	-	-
MultiNet	BP	GO:0007018	microtubule-based movement	4.82E-01	640	458	449	1.02	-	-
MultiNet	BP	GO:0030198	extracellular matrix organization	1.00E+00	314	221	221	1.00	-	-
MultiNet	MF	GO:0003723	RNA binding	2.61E-95	1679	1517	1179	1.29	-	-
MultiNet	MF	GO:0016740	transferase activity	2.59E-83	3074	2586	2159	1.20	-	-
MultiNet	MF	GO:0003677	DNA binding	1.71E-78	2865	2414	2012	1.20	-	-
MultiNet	MF	GO:0140110	transcription regulator activity	2.41E-55	2033	1717	1428	1.20	-	-
MultiNet	MF	GO:0140096	"catalytic activity, acting on a protein"	1.76E-52	3198	2593	2246	1.15	-	-
MultiNet	MF	GO:0140097	"catalytic activity, acting on DNA"	3.81E-24	383	350	269	1.30	-	-
MultiNet	MF	GO:0008092	cytoskeletal protein binding	6.13E-21	1023	846	718	1.18	-	-
MultiNet	MF	GO:0140657	ATP-dependent activity	6.34E-19	729	614	512	1.20	-	-
MultiNet	MF	GO:0140098	"catalytic activity, acting on RNA"	5.24E-18	417	367	293	1.25	-	-
MultiNet	MF	GO:0016491	oxidoreductase activity	4.84E-15	888	724	624	1.16	-	-
MultiNet	MF	GO:0008289	lipid binding	1.87E-10	836	667	587	1.14	-	-
MultiNet	MF	GO:0045182	translation regulator activity	1.62E-09	151	137	106	1.29	-	-
MultiNet	MF	GO:0016853	isomerase activity	9.19E-09	252	216	177	1.22	-	-
MultiNet	MF	GO:0005198	structural molecule activity	1.08E-08	798	631	560	1.13	-	-
MultiNet	MF	GO:0042393	histone binding	1.14E-08	237	204	166	1.23	-	-
MultiNet	MF	GO:0003924	GTPase activity	3.17E-08	658	524	462	1.13	-	-
MultiNet	MF	GO:0140104	molecular carrier activity	4.04E-08	105	97	74	1.32	-	-
MultiNet	MF	GO:0016874	ligase activity	3.89E-06	283	233	199	1.17	-	-
MultiNet	MF	GO:0016829	lyase activity	1.59E-05	538	422	378	1.12	-	-
MultiNet	MF	GO:0005215	transporter activity	2.01E-05	1462	954	1027	0.93	-	-
MultiNet	MF	GO:0003774	cytoskeletal motor activity	1.53E-01	116	89	81	1.09	-	-
MultiNet	MF	GO:0048018	receptor ligand activity	1.99E-01	504	341	354	0.96	-	-
MultiNet	MF	GO:0009975	cyclase activity	3.54E-01	277	202	195	1.04	-	-
MultiNet	MF	GO:0038024	cargo receptor activity	9.19E-01	117	83	82	1.01	-	-
MultiNet	BP	GO:0008038	neuron recognition	-	46	33	-	-	4.13E-03	1.93E-03
MultiNet	BP	GO:1905145	cellular response to acetylcholine	-	33	25	-	-	4.05E-03	1.43E-03
MultiNet	BP	GO:0097094	craniofacial suture morphogenesis	-	18	15	-	-	2.32E-02	8.59E-04
MultiNet	BP	GO:0098780	response to mitochondrial depolarisation	-	21	18	-	-	6.63E-03	1.07E-03
MultiNet	BP	GO:0051931	regulation of sensory perception	-	36	25	-	-	1.96E-02	1.43E-03
MultiNet	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	24	-	-	1.01E-02	1.43E-03
MultiNet	BP	GO:0060049	regulation of protein glycosylation	-	13	11	-	-	2.14E-04	6.44E-04
MultiNet	BP	GO:0009268	response to pH	-	43	33	-	-	1.17E-02	1.93E-03
MultiNet	BP	GO:0045666	positive regulation of neuron differentiation	-	91	78	-	-	1.72E-03	4.51E-03
MultiNet	BP	GO:0043543	protein acylation	-	107	87	-	-	3.54E-03	5.01E-03
MultiNet	MF	GO:0051349	positive regulation of lyase activity	-	41	34	-	-	3.91E-03	2.00E-03
MultiNet	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	13	-	-	2.14E-04	7.87E-04
MultiNet	BP	GO:0048679	regulation of axon regeneration	-	28	21	-	-	2.11E-03	1.22E-03
MultiNet	BP	GO:0022401	negative adaptation of signaling pathway	-	21	16	-	-	1.70E-03	9.31E-04
MultiNet	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	79	-	-	8.87E-03	4.58E-03
MultiNet	BP	GO:0071763	nuclear membrane organization	-	44	40	-	-	5.06E-03	2.29E-03
MultiNet	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	33	-	-	1.01E-02	1.93E-03
MultiNet	BP	GO:0071806	protein transmembrane transport	-	68	61	-	-	8.70E-02	3.51E-03
MultiNet	BP	GO:0022038	corpus callosum development	-	25	21	-	-	5.53E-03	1.22E-03
MultiNet	BP	GO:0021548	pons development	-	11	11	-	-	2.12E-04	6.44E-04
MultiNet	BP	GO:0043299	leukocyte degranulation	-	82	70	-	-	4.30E-03	4.01E-03
MultiNet	BP	GO:0048864	stem cell development	-	88	71	-	-	1.87E-03	4.08E-03
MultiNet	BP	GO:0009310	amine catabolic process	-	20	13	-	-	9.56E-02	7.87E-04
MultiNet	BP	GO:0051651	maintenance of location in cell	-	236	197	-	-	1.34E-02	1.13E-02
MultiNet	BP	GO:0033119	negative regulation of RNA splicing	-	27	25	-	-	4.03E-02	1.43E-03
MultiNet	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	24	-	-	2.13E-01	1.43E-03
MultiNet	CC	GO:0016197	endosomal transport	-	282	235	-	-	2.31E-02	1.35E-02
MultiNet	BP	GO:0070663	regulation of leukocyte proliferation	-	268	238	-	-	1.61E-02	1.37E-02
MultiNet	BP	GO:1905962	glutamatergic neuron differentiation	-	14	11	-	-	2.13E-04	6.44E-04
MultiNet	BP	GO:0001833	inner cell mass cell proliferation	-	14	13	-	-	6.44E-04	7.87E-04
MultiNet	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	29	-	-	4.16E-03	1.72E-03
MultiNet	BP	GO:0006949	syncytium formation	-	66	51	-	-	5.81E-03	2.94E-03
MultiNet	BP	GO:0045176	apical protein localization	-	15	11	-	-	2.13E-04	6.44E-04
MultiNet	BP	GO:0045861	negative regulation of proteolysis	-	320	231	-	-	8.21E-03	1.32E-02
MultiNet	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	8.20E-03	8.59E-04
MultiNet	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	42	-	-	3.45E-02	2.43E-03
MultiNet	BP	GO:0030574	collagen catabolic process	-	45	28	-	-	3.18E-03	1.65E-03
MultiNet	CC	GO:0006984	ER-nucleus signaling pathway	-	46	45	-	-	5.21E-03	2.58E-03
MultiNet	BP	GO:0060343	trabecula formation	-	26	21	-	-	7.67E-04	1.22E-03
MultiNet	BP	GO:0140112	extracellular vesicle biogenesis	-	23	21	-	-	4.27E-03	1.22E-03
MultiNet	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	14	-	-	1.17E-01	8.59E-04
MultiNet	BP	GO:1900424	regulation of defense response to bacterium	-	21	15	-	-	8.60E-02	8.59E-04
MultiNet	BP	GO:0085029	extracellular matrix assembly	-	42	35	-	-	1.15E-02	2.00E-03
MultiNet	BP	GO:0006413	translational initiation	-	122	114	-	-	6.09E-02	6.59E-03
MultiNet	BP	GO:0072176	nephric duct development	-	15	14	-	-	4.02E-02	8.59E-04
MultiNet	BP	GO:1902895	positive regulation of miRNA transcription	-	51	49	-	-	1.29E-03	2.86E-03
MultiNet	CC	GO:0005200	structural constituent of cytoskeleton	-	112	100	-	-	1.95E-02	5.73E-03
MultiNet	BP	GO:0030865	cortical cytoskeleton organization	-	51	48	-	-	3.45E-03	2.79E-03
MultiNet	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	11	-	-	7.96E-03	6.44E-04
MultiNet	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	23	-	-	5.01E-02	1.36E-03
MultiNet	BP	GO:1903036	positive regulation of response to wounding	-	76	61	-	-	6.25E-03	3.51E-03
MultiNet	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	20	-	-	1.02E-02	1.15E-03
MultiNet	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	147	-	-	2.40E-02	8.45E-03
MultiNet	CC	GO:0001055	RNA polymerase II activity	-	11	11	-	-	2.33E-02	6.44E-04
MultiNet	BP	GO:1903319	positive regulation of protein maturation	-	27	23	-	-	1.68E-03	1.36E-03
MultiNet	BP	GO:0032528	microvillus organization	-	24	19	-	-	1.44E-03	1.15E-03
MultiNet	BP	GO:0021954	central nervous system neuron development	-	85	70	-	-	2.18E-03	4.01E-03
MultiNet	BP	GO:0055017	cardiac muscle tissue growth	-	92	66	-	-	3.57E-03	3.79E-03
MultiNet	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	2.95E-03	1.79E-03
MultiNet	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	6.03E-03	7.87E-04
MultiNet	BP	GO:0048524	positive regulation of viral process	-	64	60	-	-	3.55E-03	3.44E-03
MultiNet	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	17	-	-	8.60E-03	1.00E-03
MultiNet	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	21	-	-	4.23E-03	1.22E-03
MultiNet	BP	GO:0001946	lymphangiogenesis	-	18	16	-	-	4.98E-02	9.31E-04
MultiNet	BP	GO:0098661	inorganic anion transmembrane transport	-	140	80	-	-	3.33E-03	4.58E-03
MultiNet	BP	GO:0006099	tricarboxylic acid cycle	-	33	31	-	-	1.31E-01	1.79E-03
MultiNet	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	4.11E-03	1.07E-03
MultiNet	BP	GO:0009612	response to mechanical stimulus	-	215	184	-	-	6.30E-03	1.06E-02
MultiNet	BP	GO:0048644	muscle organ morphogenesis	-	81	74	-	-	1.79E-02	4.30E-03
MultiNet	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	126	-	-	4.41E-03	7.23E-03
MultiNet	BP	GO:0071542	dopaminergic neuron differentiation	-	36	32	-	-	1.86E-03	1.86E-03
MultiNet	BP	GO:0140115	export across plasma membrane	-	82	42	-	-	1.28E-02	2.43E-03
MultiNet	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	2.81E-03	7.16E-04
MultiNet	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	35	-	-	9.01E-04	2.00E-03
MultiNet	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	11	-	-	6.92E-02	6.44E-04
MultiNet	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	17	-	-	2.86E-04	1.00E-03
MultiNet	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	41	-	-	1.44E-01	2.36E-03
MultiNet	MF	GO:0003714	transcription corepressor activity	-	190	173	-	-	8.48E-03	9.95E-03
MultiNet	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	46	-	-	2.85E-02	2.65E-03
MultiNet	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	1.09E-03	9.31E-04
MultiNet	CC	GO:0006858	extracellular transport	-	45	30	-	-	1.15E-03	1.72E-03
MultiNet	BP	GO:0006304	DNA modification	-	30	27	-	-	6.09E-02	1.57E-03
MultiNet	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	9.77E-02	1.15E-03
MultiNet	BP	GO:0046835	carbohydrate phosphorylation	-	49	45	-	-	4.63E-02	2.58E-03
MultiNet	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	8.35E-04	1.07E-03
MultiNet	BP	GO:0003207	cardiac chamber formation	-	14	12	-	-	8.25E-03	7.16E-04
MultiNet	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	22	-	-	3.57E-04	1.29E-03
MultiNet	BP	GO:0043523	regulation of neuron apoptotic process	-	218	192	-	-	5.55E-03	1.10E-02
MultiNet	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	8.61E-04	1.29E-03
MultiNet	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	12	-	-	7.40E-03	7.16E-04
MultiNet	BP	GO:0044380	protein localization to cytoskeleton	-	57	52	-	-	5.31E-03	3.01E-03
MultiNet	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	5.35E-03	7.87E-04
MultiNet	BP	GO:2000209	regulation of anoikis	-	25	22	-	-	1.81E-03	1.29E-03
MultiNet	BP	GO:0014029	neural crest formation	-	15	14	-	-	1.16E-02	8.59E-04
MultiNet	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	20	-	-	2.18E-03	1.15E-03
MultiNet	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	33	-	-	4.64E-03	1.93E-03
MultiNet	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	59	-	-	3.52E-03	3.44E-03
MultiNet	BP	GO:0003188	heart valve formation	-	16	16	-	-	6.77E-02	9.31E-04
MultiNet	CC	GO:0045324	late endosome to vacuole transport	-	37	32	-	-	8.39E-02	1.86E-03
MultiNet	BP	GO:0043954	cellular component maintenance	-	72	58	-	-	6.15E-03	3.36E-03
MultiNet	BP	GO:0050435	amyloid-beta metabolic process	-	65	47	-	-	2.04E-02	2.72E-03
MultiNet	BP	GO:0014823	response to activity	-	70	61	-	-	3.61E-03	3.51E-03
MultiNet	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	13	-	-	3.70E-03	7.87E-04
MultiNet	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	8.34E-02	1.65E-03
MultiNet	BP	GO:0034502	protein localization to chromosome	-	130	125	-	-	3.23E-03	7.16E-03
MultiNet	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	2.01E-04	6.44E-04
MultiNet	BP	GO:0048562	embryonic organ morphogenesis	-	295	249	-	-	8.08E-03	1.43E-02
MultiNet	BP	GO:0060457	negative regulation of digestive system process	-	17	13	-	-	9.11E-02	7.87E-04
MultiNet	BP	GO:0019233	sensory perception of pain	-	103	80	-	-	5.50E-03	4.58E-03
MultiNet	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	4.64E-01	1.29E-03
MultiNet	BP	GO:0031343	positive regulation of cell killing	-	75	55	-	-	2.88E-02	3.15E-03
MultiNet	BP	GO:0090077	foam cell differentiation	-	39	36	-	-	3.34E-03	2.08E-03
MultiNet	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	89	-	-	1.15E-02	5.15E-03
MultiNet	BP	GO:0017148	negative regulation of translation	-	390	105	-	-	7.26E-03	6.01E-03
MultiNet	BP	GO:0030220	platelet formation	-	22	21	-	-	2.72E-03	1.22E-03
MultiNet	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	68	-	-	4.25E-03	3.94E-03
MultiNet	MF	GO:1903624	regulation of DNA catabolic process	-	14	13	-	-	6.84E-03	7.87E-04
MultiNet	BP	GO:1901142	insulin metabolic process	-	14	12	-	-	2.87E-02	7.16E-04
MultiNet	BP	GO:1903509	liposaccharide metabolic process	-	109	74	-	-	1.16E-01	4.30E-03
MultiNet	BP	GO:0009582	detection of abiotic stimulus	-	140	94	-	-	4.73E-03	5.44E-03
MultiNet	CC	GO:0140238	presynaptic endocytosis	-	72	66	-	-	9.47E-03	3.79E-03
MultiNet	BP	GO:0051236	establishment of RNA localization	-	161	144	-	-	3.60E-02	8.30E-03
MultiNet	BP	GO:0042178	xenobiotic catabolic process	-	26	22	-	-	3.70E-02	1.29E-03
MultiNet	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	14	-	-	2.51E-02	8.59E-04
MultiNet	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	168	-	-	1.77E-02	9.66E-03
MultiNet	BP	GO:0034067	protein localization to Golgi apparatus	-	30	25	-	-	3.82E-03	1.43E-03
MultiNet	BP	GO:0061842	microtubule organizing center localization	-	32	28	-	-	2.14E-03	1.65E-03
MultiNet	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	15	-	-	1.07E-02	8.59E-04
MultiNet	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	28	-	-	4.28E-04	1.65E-03
MultiNet	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	39	-	-	2.05E-03	2.29E-03
MultiNet	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	48	-	-	2.53E-03	2.79E-03
MultiNet	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	14	-	-	2.14E-04	8.59E-04
MultiNet	BP	GO:0050779	RNA destabilization	-	135	90	-	-	3.41E-02	5.15E-03
MultiNet	BP	GO:0006023	aminoglycan biosynthetic process	-	74	47	-	-	1.17E-02	2.72E-03
MultiNet	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	60	-	-	4.37E-02	3.44E-03
MultiNet	BP	GO:0010762	regulation of fibroblast migration	-	40	36	-	-	7.52E-03	2.08E-03
MultiNet	BP	GO:0090311	regulation of protein deacetylation	-	29	26	-	-	6.24E-03	1.50E-03
MultiNet	BP	GO:0035272	exocrine system development	-	46	40	-	-	9.80E-03	2.29E-03
MultiNet	BP	GO:1901096	regulation of autophagosome maturation	-	17	15	-	-	4.99E-03	8.59E-04
MultiNet	BP	GO:0022406	membrane docking	-	90	78	-	-	6.00E-02	4.51E-03
MultiNet	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	5.22E-02	8.59E-04
MultiNet	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	8.90E-04	9.31E-04
MultiNet	BP	GO:0050777	negative regulation of immune response	-	196	159	-	-	1.25E-02	9.16E-03
MultiNet	MF	GO:0005035	death receptor activity	-	16	16	-	-	7.43E-03	9.31E-04
MultiNet	BP	GO:0002063	chondrocyte development	-	33	24	-	-	2.90E-03	1.43E-03
MultiNet	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	16	-	-	1.51E-03	9.31E-04
MultiNet	BP	GO:0099068	postsynapse assembly	-	40	33	-	-	1.98E-02	1.93E-03
MultiNet	BP	GO:0021782	glial cell development	-	120	102	-	-	4.54E-03	5.87E-03
MultiNet	BP	GO:0051782	negative regulation of cell division	-	18	15	-	-	2.69E-04	8.59E-04
MultiNet	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	9.45E-04	6.44E-04
MultiNet	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	71	-	-	4.54E-03	4.08E-03
MultiNet	BP	GO:0001655	urogenital system development	-	66	62	-	-	2.11E-03	3.58E-03
MultiNet	BP	GO:0071827	plasma lipoprotein particle organization	-	86	67	-	-	6.46E-02	3.87E-03
MultiNet	BP	GO:0045494	photoreceptor cell maintenance	-	43	28	-	-	1.55E-02	1.65E-03
MultiNet	BP	GO:0055088	lipid homeostasis	-	173	129	-	-	5.34E-03	7.45E-03
MultiNet	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	23	-	-	8.63E-03	1.36E-03
MultiNet	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	173	-	-	5.17E-03	9.95E-03
MultiNet	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	20	-	-	3.57E-04	1.15E-03
MultiNet	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	31	-	-	1.32E-03	1.79E-03
MultiNet	BP	GO:0045667	regulation of osteoblast differentiation	-	147	106	-	-	1.57E-02	6.08E-03
MultiNet	BP	GO:2001212	regulation of vasculogenesis	-	16	15	-	-	1.42E-02	8.59E-04
MultiNet	BP	GO:0061037	negative regulation of cartilage development	-	32	25	-	-	7.87E-04	1.43E-03
MultiNet	BP	GO:0045738	negative regulation of DNA repair	-	40	34	-	-	1.10E-03	2.00E-03
MultiNet	BP	GO:0001704	formation of primary germ layer	-	195	168	-	-	7.99E-03	9.66E-03
MultiNet	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	3.80E-02	7.87E-04
MultiNet	BP	GO:0045778	positive regulation of ossification	-	51	45	-	-	1.41E-02	2.58E-03
MultiNet	BP	GO:0048708	astrocyte differentiation	-	88	81	-	-	1.98E-03	4.65E-03
MultiNet	BP	GO:0042092	type 2 immune response	-	41	34	-	-	2.93E-03	2.00E-03
MultiNet	BP	GO:0048588	developmental cell growth	-	233	189	-	-	3.93E-03	1.09E-02
MultiNet	CC	GO:0000963	mitochondrial RNA processing	-	20	17	-	-	2.80E-04	1.00E-03
MultiNet	BP	GO:0021872	forebrain generation of neurons	-	52	46	-	-	1.00E-03	2.65E-03
MultiNet	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	20	-	-	1.35E-02	1.15E-03
MultiNet	BP	GO:0045023	G0 to G1 transition	-	41	38	-	-	4.46E-02	2.22E-03
MultiNet	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	47	-	-	3.07E-02	2.72E-03
MultiNet	BP	GO:0034367	protein-containing complex remodeling	-	35	32	-	-	7.44E-02	1.86E-03
MultiNet	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	25	-	-	2.11E-02	1.43E-03
MultiNet	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	38	-	-	5.69E-04	2.22E-03
MultiNet	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	17	-	-	1.71E-01	1.00E-03
MultiNet	BP	GO:0015810	aspartate transmembrane transport	-	19	15	-	-	2.86E-04	8.59E-04
MultiNet	BP	GO:0010232	vascular transport	-	87	57	-	-	1.44E-03	3.29E-03
MultiNet	BP	GO:0021987	cerebral cortex development	-	125	113	-	-	7.30E-03	6.51E-03
MultiNet	BP	GO:0008637	apoptotic mitochondrial changes	-	108	97	-	-	3.19E-02	5.58E-03
MultiNet	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	33	-	-	2.56E-03	1.93E-03
MultiNet	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	7.41E-02	8.59E-04
MultiNet	BP	GO:0060999	positive regulation of dendritic spine development	-	35	28	-	-	3.03E-03	1.65E-03
MultiNet	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	17	-	-	2.78E-04	1.00E-03
MultiNet	BP	GO:2000736	regulation of stem cell differentiation	-	78	70	-	-	3.39E-03	4.01E-03
MultiNet	BP	GO:0060973	cell migration involved in heart development	-	21	16	-	-	2.30E-03	9.31E-04
MultiNet	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	18	-	-	2.10E-03	1.07E-03
MultiNet	BP	GO:0002064	epithelial cell development	-	210	186	-	-	1.75E-02	1.07E-02
MultiNet	BP	GO:0071318	cellular response to ATP	-	18	13	-	-	2.06E-04	7.87E-04
MultiNet	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	31	-	-	7.70E-03	1.79E-03
MultiNet	BP	GO:2001222	regulation of neuron migration	-	46	38	-	-	6.18E-04	2.22E-03
MultiNet	BP	GO:0034389	lipid droplet organization	-	38	33	-	-	9.20E-04	1.93E-03
MultiNet	BP	GO:0051602	response to electrical stimulus	-	44	37	-	-	7.45E-04	2.15E-03
MultiNet	BP	GO:0042177	negative regulation of protein catabolic process	-	109	97	-	-	2.27E-03	5.58E-03
MultiNet	MF	GO:0038024	cargo receptor activity	-	121	83	-	-	5.34E-03	4.80E-03
MultiNet	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	20	-	-	3.09E-03	1.15E-03
MultiNet	BP	GO:0033120	positive regulation of RNA splicing	-	46	36	-	-	3.83E-03	2.08E-03
MultiNet	BP	GO:0051445	regulation of meiotic cell cycle	-	64	54	-	-	2.42E-02	3.15E-03
MultiNet	BP	GO:0033619	membrane protein proteolysis	-	60	54	-	-	6.44E-02	3.15E-03
MultiNet	BP	GO:0038065	collagen-activated signaling pathway	-	15	11	-	-	7.02E-02	6.44E-04
MultiNet	BP	GO:0090087	regulation of peptide transport	-	195	164	-	-	4.31E-03	9.45E-03
MultiNet	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	92	-	-	2.70E-03	5.30E-03
MultiNet	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	24	-	-	6.25E-04	1.43E-03
MultiNet	BP	GO:0006929	substrate-dependent cell migration	-	26	23	-	-	1.69E-03	1.36E-03
MultiNet	BP	GO:0042537	benzene-containing compound metabolic process	-	27	23	-	-	1.37E-01	1.36E-03
MultiNet	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	14	-	-	1.25E-01	8.59E-04
MultiNet	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	4.45E-01	1.15E-03
MultiNet	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	3.71E-03	7.87E-04
MultiNet	BP	GO:0022404	molting cycle process	-	95	81	-	-	5.05E-03	4.65E-03
MultiNet	BP	GO:1903358	regulation of Golgi organization	-	17	15	-	-	2.59E-03	8.59E-04
MultiNet	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	1.46E-02	1.15E-03
MultiNet	BP	GO:0042754	negative regulation of circadian rhythm	-	12	11	-	-	3.11E-02	6.44E-04
MultiNet	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	8.29E-04	1.00E-03
MultiNet	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	30	-	-	1.13E-03	1.72E-03
MultiNet	BP	GO:0017014	protein nitrosylation	-	17	14	-	-	2.33E-02	8.59E-04
MultiNet	BP	GO:0007281	germ cell development	-	334	238	-	-	3.98E-03	1.37E-02
MultiNet	BP	GO:0008299	isoprenoid biosynthetic process	-	30	25	-	-	1.04E-01	1.43E-03
MultiNet	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	209	-	-	2.69E-02	1.20E-02
MultiNet	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	30	-	-	2.51E-03	1.72E-03
MultiNet	BP	GO:0034104	negative regulation of tissue remodeling	-	22	13	-	-	2.08E-03	7.87E-04
MultiNet	CC	GO:0098926	postsynaptic signal transduction	-	39	31	-	-	2.69E-03	1.79E-03
MultiNet	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	121	-	-	4.10E-03	6.94E-03
MultiNet	CC	GO:0016082	synaptic vesicle priming	-	19	16	-	-	4.34E-02	9.31E-04
MultiNet	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	43	-	-	2.64E-03	2.51E-03
MultiNet	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	118	-	-	8.60E-03	6.80E-03
MultiNet	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	1.32E-03	1.29E-03
MultiNet	BP	GO:0061548	ganglion development	-	17	15	-	-	3.33E-03	8.59E-04
MultiNet	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	87	-	-	7.41E-03	5.01E-03
MultiNet	BP	GO:0042832	defense response to protozoan	-	28	19	-	-	1.07E-03	1.15E-03
MultiNet	BP	GO:0048799	animal organ maturation	-	33	25	-	-	4.72E-03	1.43E-03
MultiNet	BP	GO:0006925	inflammatory cell apoptotic process	-	23	20	-	-	1.42E-03	1.15E-03
MultiNet	BP	GO:2000291	regulation of myoblast proliferation	-	25	15	-	-	2.81E-04	8.59E-04
MultiNet	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	152	-	-	3.83E-03	8.73E-03
MultiNet	BP	GO:0010269	response to selenium ion	-	11	11	-	-	2.13E-04	6.44E-04
MultiNet	BP	GO:1903035	negative regulation of response to wounding	-	93	82	-	-	1.04E-02	4.72E-03
MultiNet	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	22	-	-	1.92E-03	1.29E-03
MultiNet	BP	GO:0036010	protein localization to endosome	-	27	25	-	-	4.40E-03	1.43E-03
MultiNet	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	117	-	-	2.10E-02	6.73E-03
MultiNet	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	90	-	-	1.74E-02	5.15E-03
MultiNet	BP	GO:0045056	transcytosis	-	20	19	-	-	2.01E-03	1.15E-03
MultiNet	BP	GO:0018342	protein prenylation	-	15	13	-	-	2.14E-04	7.87E-04
MultiNet	BP	GO:0009267	cellular response to starvation	-	170	155	-	-	5.45E-03	8.88E-03
MultiNet	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	51	-	-	8.03E-03	2.94E-03
MultiNet	BP	GO:0046834	lipid phosphorylation	-	16	14	-	-	2.18E-03	8.59E-04
MultiNet	CC	GO:0140239	postsynaptic endocytosis	-	23	20	-	-	1.69E-03	1.15E-03
MultiNet	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	14	-	-	2.14E-04	8.59E-04
MultiNet	BP	GO:0046931	pore complex assembly	-	21	18	-	-	2.82E-04	1.07E-03
MultiNet	CC	GO:0032008	positive regulation of TOR signaling	-	52	45	-	-	2.48E-02	2.58E-03
MultiNet	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	31	-	-	1.96E-02	1.79E-03
MultiNet	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	11	-	-	2.14E-04	6.44E-04
MultiNet	BP	GO:0060428	lung epithelium development	-	43	42	-	-	3.13E-03	2.43E-03
MultiNet	BP	GO:0030431	sleep	-	30	23	-	-	6.06E-03	1.36E-03
MultiNet	BP	GO:1903318	negative regulation of protein maturation	-	29	24	-	-	1.07E-02	1.43E-03
MultiNet	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	75	-	-	2.60E-02	4.30E-03
MultiNet	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	7.57E-04	1.00E-03
MultiNet	BP	GO:0010457	centriole-centriole cohesion	-	15	12	-	-	2.71E-03	7.16E-04
MultiNet	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	3.15E-02	6.44E-04
MultiNet	BP	GO:1905155	positive regulation of membrane invagination	-	13	11	-	-	1.55E-03	6.44E-04
MultiNet	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	46	-	-	2.54E-02	2.65E-03
MultiNet	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	62	-	-	2.91E-03	3.58E-03
MultiNet	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	2.84E-02	1.00E-03
MultiNet	CC	GO:0006406	mRNA export from nucleus	-	69	62	-	-	4.15E-02	3.58E-03
MultiNet	BP	GO:0009880	embryonic pattern specification	-	70	55	-	-	6.44E-03	3.15E-03
MultiNet	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	1.04E-01	2.29E-03
MultiNet	BP	GO:0043043	peptide biosynthetic process	-	25	21	-	-	9.63E-03	1.22E-03
MultiNet	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	2.24E-02	6.44E-04
MultiNet	BP	GO:0002367	cytokine production involved in immune response	-	121	104	-	-	9.98E-03	6.01E-03
MultiNet	BP	GO:0044848	biological phase	-	211	163	-	-	1.45E-02	9.38E-03
MultiNet	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	7.09E-03	7.16E-04
MultiNet	BP	GO:0046660	female sex differentiation	-	125	114	-	-	6.86E-03	6.59E-03
MultiNet	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	14	-	-	3.07E-04	8.59E-04
MultiNet	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	37	-	-	6.25E-03	2.15E-03
MultiNet	BP	GO:0060411	cardiac septum morphogenesis	-	72	66	-	-	8.90E-03	3.79E-03
MultiNet	BP	GO:0071248	cellular response to metal ion	-	201	171	-	-	3.39E-03	9.81E-03
MultiNet	BP	GO:0030308	negative regulation of cell growth	-	191	157	-	-	2.87E-03	9.02E-03
MultiNet	BP	GO:0097306	cellular response to alcohol	-	99	81	-	-	1.99E-03	4.65E-03
MultiNet	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	111	-	-	7.85E-02	6.37E-03
MultiNet	BP	GO:0010453	regulation of cell fate commitment	-	40	31	-	-	2.50E-02	1.79E-03
MultiNet	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	51	-	-	8.39E-03	2.94E-03
MultiNet	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	35	-	-	5.70E-04	2.00E-03
MultiNet	BP	GO:0002026	regulation of the force of heart contraction	-	26	22	-	-	6.18E-03	1.29E-03
MultiNet	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	21	-	-	7.00E-03	1.22E-03
MultiNet	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	41	-	-	5.97E-02	2.36E-03
MultiNet	BP	GO:0032890	regulation of organic acid transport	-	78	65	-	-	1.53E-03	3.72E-03
MultiNet	BP	GO:0071498	cellular response to fluid shear stress	-	21	18	-	-	8.07E-04	1.07E-03
MultiNet	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	21	-	-	3.32E-01	1.22E-03
MultiNet	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	90	-	-	4.69E-03	5.15E-03
MultiNet	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	24	-	-	6.57E-04	1.43E-03
MultiNet	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	3.34E-03	6.44E-04
MultiNet	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	45	-	-	5.83E-03	2.58E-03
MultiNet	BP	GO:0051259	protein complex oligomerization	-	251	210	-	-	1.75E-02	1.20E-02
MultiNet	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	4.94E-02	9.31E-04
MultiNet	BP	GO:0098743	cell aggregation	-	24	18	-	-	3.05E-03	1.07E-03
MultiNet	BP	GO:0009994	oocyte differentiation	-	57	45	-	-	1.47E-03	2.58E-03
MultiNet	MF	GO:0031952	regulation of protein autophosphorylation	-	43	39	-	-	1.26E-03	2.29E-03
MultiNet	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	122	-	-	5.09E-03	7.02E-03
MultiNet	BP	GO:0044319	"wound healing, spreading of cells"	-	37	32	-	-	3.68E-03	1.86E-03
MultiNet	BP	GO:0033688	regulation of osteoblast proliferation	-	31	24	-	-	2.37E-03	1.43E-03
MultiNet	BP	GO:0060251	regulation of glial cell proliferation	-	39	33	-	-	6.20E-04	1.93E-03
MultiNet	BP	GO:0072665	protein localization to vacuole	-	84	74	-	-	1.44E-02	4.30E-03
MultiNet	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	45	-	-	6.40E-03	2.58E-03
MultiNet	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	21	-	-	7.90E-03	1.22E-03
MultiNet	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	66	-	-	2.82E-03	3.79E-03
MultiNet	BP	GO:0042953	lipoprotein transport	-	20	15	-	-	2.81E-04	8.59E-04
MultiNet	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	9.51E-03	8.59E-04
MultiNet	BP	GO:0042044	fluid transport	-	35	27	-	-	1.45E-02	1.57E-03
MultiNet	BP	GO:0070633	transepithelial transport	-	35	26	-	-	2.93E-03	1.50E-03
MultiNet	BP	GO:0045661	regulation of myoblast differentiation	-	74	67	-	-	6.69E-03	3.87E-03
MultiNet	BP	GO:0030307	positive regulation of cell growth	-	164	142	-	-	4.01E-03	8.16E-03
MultiNet	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	8.46E-04	1.43E-03
MultiNet	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	15	-	-	2.84E-04	8.59E-04
MultiNet	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	2.32E-02	7.87E-04
MultiNet	BP	GO:0014812	muscle cell migration	-	110	76	-	-	5.75E-03	4.37E-03
MultiNet	BP	GO:0048525	negative regulation of viral process	-	90	83	-	-	9.18E-03	4.80E-03
MultiNet	BP	GO:0072044	collecting duct development	-	16	15	-	-	1.74E-02	8.59E-04
MultiNet	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	11	-	-	6.11E-01	6.44E-04
MultiNet	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	65	-	-	6.91E-03	3.72E-03
MultiNet	BP	GO:0030238	male sex determination	-	14	13	-	-	4.85E-02	7.87E-04
MultiNet	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	196	-	-	2.50E-02	1.12E-02
MultiNet	BP	GO:0051781	positive regulation of cell division	-	93	75	-	-	2.67E-03	4.30E-03
MultiNet	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	19	-	-	3.42E-03	1.15E-03
MultiNet	BP	GO:0035493	SNARE complex assembly	-	23	22	-	-	4.34E-02	1.29E-03
MultiNet	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	20	-	-	3.51E-04	1.15E-03
MultiNet	BP	GO:0060711	labyrinthine layer development	-	47	40	-	-	9.18E-04	2.29E-03
MultiNet	BP	GO:0007272	ensheathment of neurons	-	146	126	-	-	7.40E-03	7.23E-03
MultiNet	CC	GO:0050806	positive regulation of synaptic transmission	-	171	133	-	-	8.21E-03	7.66E-03
MultiNet	BP	GO:0060021	roof of mouth development	-	91	84	-	-	4.82E-03	4.87E-03
MultiNet	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	31	-	-	4.79E-03	1.79E-03
MultiNet	BP	GO:0050819	negative regulation of coagulation	-	54	51	-	-	2.36E-02	2.94E-03
MultiNet	BP	GO:0017004	cytochrome complex assembly	-	40	27	-	-	6.71E-02	1.57E-03
MultiNet	BP	GO:0018410	C-terminal protein amino acid modification	-	15	11	-	-	6.71E-02	6.44E-04
MultiNet	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	61	-	-	9.76E-02	3.51E-03
MultiNet	BP	GO:0097212	lysosomal membrane organization	-	15	11	-	-	2.14E-04	6.44E-04
MultiNet	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	14	-	-	2.11E-04	8.59E-04
MultiNet	CC	GO:0050805	negative regulation of synaptic transmission	-	55	48	-	-	6.56E-03	2.79E-03
MultiNet	BP	GO:0043248	proteasome assembly	-	13	12	-	-	1.01E-02	7.16E-04
MultiNet	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	48	-	-	1.59E-03	2.79E-03
MultiNet	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	63	-	-	2.42E-03	3.65E-03
MultiNet	BP	GO:0016054	organic acid catabolic process	-	251	212	-	-	8.07E-02	1.22E-02
MultiNet	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	12	-	-	6.25E-03	7.16E-04
MultiNet	BP	GO:1900048	positive regulation of hemostasis	-	28	25	-	-	2.43E-02	1.43E-03
MultiNet	BP	GO:0065005	protein-lipid complex assembly	-	29	27	-	-	1.55E-02	1.57E-03
MultiNet	BP	GO:0008033	tRNA processing	-	136	119	-	-	1.04E-01	6.87E-03
MultiNet	BP	GO:0046661	male sex differentiation	-	171	154	-	-	6.63E-03	8.88E-03
MultiNet	BP	GO:0072520	seminiferous tubule development	-	15	14	-	-	1.06E-03	8.59E-04
MultiNet	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	16	-	-	1.98E-02	9.31E-04
MultiNet	BP	GO:0035188	hatching	-	27	14	-	-	2.09E-04	8.59E-04
MultiNet	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	73	-	-	5.03E-03	4.22E-03
MultiNet	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	14	-	-	2.07E-04	8.59E-04
MultiNet	BP	GO:0090713	immunological memory process	-	18	15	-	-	8.31E-02	8.59E-04
MultiNet	BP	GO:0061326	renal tubule development	-	103	95	-	-	1.28E-02	5.44E-03
MultiNet	BP	GO:0051258	protein polymerization	-	280	227	-	-	1.08E-02	1.30E-02
MultiNet	BP	GO:0071985	multivesicular body sorting pathway	-	56	47	-	-	5.74E-02	2.72E-03
MultiNet	BP	GO:0006450	regulation of translational fidelity	-	18	15	-	-	2.85E-04	8.59E-04
MultiNet	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	15	-	-	3.83E-03	8.59E-04
MultiNet	BP	GO:0060325	face morphogenesis	-	31	28	-	-	2.02E-03	1.65E-03
MultiNet	BP	GO:0090559	regulation of membrane permeability	-	72	57	-	-	8.38E-03	3.29E-03
MultiNet	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	13	-	-	6.24E-02	7.87E-04
MultiNet	BP	GO:0031579	membrane raft organization	-	25	21	-	-	5.82E-03	1.22E-03
MultiNet	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	21	-	-	1.68E-03	1.22E-03
MultiNet	BP	GO:0060033	anatomical structure regression	-	16	14	-	-	4.59E-03	8.59E-04
MultiNet	BP	GO:0046460	neutral lipid biosynthetic process	-	50	35	-	-	6.08E-03	2.00E-03
MultiNet	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	87	-	-	1.34E-02	5.01E-03
MultiNet	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	144	-	-	4.67E-03	8.30E-03
MultiNet	BP	GO:0002251	organ or tissue specific immune response	-	43	29	-	-	1.02E-02	1.72E-03
MultiNet	CC	GO:0048167	regulation of synaptic plasticity	-	210	162	-	-	6.27E-03	9.31E-03
MultiNet	BP	GO:1903708	positive regulation of hemopoiesis	-	184	172	-	-	5.33E-03	9.88E-03
MultiNet	BP	GO:1903008	organelle disassembly	-	154	136	-	-	1.00E-02	7.80E-03
MultiNet	BP	GO:0001709	cell fate determination	-	44	38	-	-	1.97E-03	2.22E-03
MultiNet	BP	GO:0051873	killing by host of symbiont cells	-	28	21	-	-	3.55E-04	1.22E-03
MultiNet	BP	GO:0045058	T cell selection	-	53	50	-	-	2.51E-02	2.86E-03
MultiNet	CC	GO:0032387	negative regulation of intracellular transport	-	51	45	-	-	2.04E-03	2.58E-03
MultiNet	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	18	-	-	1.93E-02	1.07E-03
MultiNet	BP	GO:0072091	regulation of stem cell proliferation	-	91	74	-	-	2.11E-03	4.30E-03
MultiNet	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	41	-	-	9.65E-02	2.36E-03
MultiNet	BP	GO:0099084	postsynaptic specialization organization	-	44	37	-	-	1.86E-02	2.15E-03
MultiNet	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	1.63E-02	6.44E-04
MultiNet	BP	GO:0071501	cellular response to sterol depletion	-	15	14	-	-	2.71E-02	8.59E-04
MultiNet	BP	GO:0060384	innervation	-	27	25	-	-	7.48E-04	1.43E-03
MultiNet	BP	GO:2000774	positive regulation of cellular senescence	-	19	11	-	-	3.53E-02	6.44E-04
MultiNet	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	19	-	-	2.86E-04	1.15E-03
MultiNet	MF	GO:0031281	positive regulation of cyclase activity	-	40	34	-	-	1.08E-03	2.00E-03
MultiNet	MF	GO:0098631	cell adhesion mediator activity	-	64	52	-	-	3.51E-02	3.01E-03
MultiNet	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	11	-	-	2.14E-04	6.44E-04
MultiNet	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	1.29E-01	1.07E-03
MultiNet	BP	GO:0071453	cellular response to oxygen levels	-	168	137	-	-	4.44E-03	7.87E-03
MultiNet	BP	GO:0090399	replicative senescence	-	17	14	-	-	1.62E-03	8.59E-04
MultiNet	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	11	-	-	2.14E-04	6.44E-04
MultiNet	BP	GO:0031342	negative regulation of cell killing	-	29	28	-	-	2.43E-02	1.65E-03
MultiNet	BP	GO:0070585	protein localization to mitochondrion	-	125	115	-	-	7.30E-03	6.59E-03
MultiNet	BP	GO:0010623	programmed cell death involved in cell development	-	25	20	-	-	1.70E-02	1.15E-03
MultiNet	BP	GO:0044242	cellular lipid catabolic process	-	224	176	-	-	4.67E-02	1.01E-02
MultiNet	BP	GO:0071236	cellular response to antibiotic	-	13	12	-	-	1.43E-03	7.16E-04
MultiNet	BP	GO:0002931	response to ischemia	-	58	47	-	-	1.83E-03	2.72E-03
MultiNet	BP	GO:0043062	extracellular structure organization	-	317	222	-	-	1.47E-02	1.27E-02
MultiNet	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	2.12E-04	7.16E-04
MultiNet	BP	GO:0014047	glutamate secretion	-	25	22	-	-	1.33E-03	1.29E-03
MultiNet	BP	GO:0061005	cell differentiation involved in kidney development	-	58	55	-	-	3.69E-03	3.15E-03
MultiNet	BP	GO:0030397	membrane disassembly	-	11	11	-	-	2.59E-03	6.44E-04
MultiNet	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	60	-	-	6.76E-02	3.44E-03
MultiNet	BP	GO:0060420	regulation of heart growth	-	74	54	-	-	2.04E-03	3.15E-03
MultiNet	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	12	-	-	4.86E-04	7.16E-04
MultiNet	BP	GO:0009755	hormone-mediated signaling pathway	-	221	190	-	-	6.95E-03	1.09E-02
MultiNet	BP	GO:0022612	gland morphogenesis	-	124	117	-	-	4.74E-03	6.73E-03
MultiNet	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	29	-	-	4.22E-04	1.72E-03
MultiNet	MF	GO:0140416	transcription regulator inhibitor activity	-	26	24	-	-	1.10E-03	1.43E-03
MultiNet	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	18	-	-	4.02E-02	1.07E-03
MultiNet	BP	GO:0048935	peripheral nervous system neuron development	-	15	14	-	-	2.05E-02	8.59E-04
MultiNet	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	4.65E-03	1.00E-03
MultiNet	BP	GO:1990845	adaptive thermogenesis	-	166	148	-	-	3.88E-03	8.52E-03
MultiNet	BP	GO:0071320	cellular response to cAMP	-	54	50	-	-	3.27E-02	2.86E-03
MultiNet	BP	GO:0015844	monoamine transport	-	88	72	-	-	4.09E-03	4.15E-03
MultiNet	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	19	-	-	2.55E-03	1.15E-03
MultiNet	BP	GO:0060039	pericardium development	-	19	19	-	-	3.40E-03	1.15E-03
MultiNet	BP	GO:0071392	cellular response to estradiol stimulus	-	40	37	-	-	2.11E-03	2.15E-03
MultiNet	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	2.07E-03	7.87E-04
MultiNet	BP	GO:0000272	polysaccharide catabolic process	-	19	18	-	-	2.47E-02	1.07E-03
MultiNet	BP	GO:0009451	RNA modification	-	169	147	-	-	3.22E-02	8.45E-03
MultiNet	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	36	-	-	1.16E-03	2.08E-03
MultiNet	BP	GO:1903729	regulation of plasma membrane organization	-	17	14	-	-	8.58E-03	8.59E-04
MultiNet	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	104	-	-	5.73E-03	6.01E-03
MultiNet	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	34	-	-	5.38E-03	2.00E-03
MultiNet	BP	GO:0015807	L-amino acid transport	-	94	59	-	-	5.57E-03	3.44E-03
MultiNet	BP	GO:0032941	secretion by tissue	-	85	74	-	-	2.37E-03	4.30E-03
MultiNet	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	8.55E-02	7.87E-04
MultiNet	BP	GO:0046605	regulation of centrosome cycle	-	54	46	-	-	1.79E-03	2.65E-03
MultiNet	BP	GO:0048753	pigment granule organization	-	40	36	-	-	1.32E-01	2.08E-03
MultiNet	BP	GO:0021516	dorsal spinal cord development	-	20	17	-	-	1.65E-03	1.00E-03
MultiNet	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	16	-	-	2.74E-04	9.31E-04
MultiNet	BP	GO:0003014	renal system process	-	130	101	-	-	3.15E-03	5.80E-03
MultiNet	CC	GO:0070286	axonemal dynein complex assembly	-	40	19	-	-	2.86E-04	1.15E-03
MultiNet	BP	GO:0045598	regulation of fat cell differentiation	-	148	109	-	-	3.08E-03	6.30E-03
MultiNet	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	184	-	-	1.18E-02	1.06E-02
MultiNet	BP	GO:1904646	cellular response to amyloid-beta	-	44	31	-	-	1.26E-03	1.79E-03
MultiNet	BP	GO:1901863	positive regulation of muscle tissue development	-	24	22	-	-	2.00E-03	1.29E-03
MultiNet	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	168	-	-	3.96E-02	9.66E-03
MultiNet	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	11	-	-	2.12E-04	6.44E-04
MultiNet	BP	GO:0008340	determination of adult lifespan	-	23	21	-	-	2.74E-03	1.22E-03
MultiNet	BP	GO:0018158	protein oxidation	-	15	13	-	-	2.14E-04	7.87E-04
MultiNet	BP	GO:0039694	viral RNA genome replication	-	30	27	-	-	9.39E-03	1.57E-03
MultiNet	BP	GO:0009404	toxin metabolic process	-	17	13	-	-	4.19E-02	7.87E-04
MultiNet	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	25	-	-	2.69E-03	1.43E-03
MultiNet	BP	GO:0071709	membrane assembly	-	68	55	-	-	7.65E-03	3.15E-03
MultiNet	BP	GO:0008217	regulation of blood pressure	-	186	150	-	-	1.22E-02	8.59E-03
MultiNet	BP	GO:0031643	positive regulation of myelination	-	19	15	-	-	2.80E-04	8.59E-04
MultiNet	BP	GO:0043101	purine-containing compound salvage	-	15	14	-	-	2.94E-02	8.59E-04
MultiNet	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	53	-	-	7.38E-04	3.08E-03
MultiNet	CC	GO:0042770	signal transduction in response to DNA damage	-	186	175	-	-	1.25E-02	1.00E-02
MultiNet	BP	GO:0002200	somatic diversification of immune receptors	-	78	75	-	-	6.93E-03	4.30E-03
MultiNet	BP	GO:0035315	hair cell differentiation	-	52	35	-	-	1.45E-02	2.00E-03
MultiNet	BP	GO:0048645	animal organ formation	-	62	56	-	-	8.30E-03	3.22E-03
MultiNet	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	132	-	-	6.17E-03	7.59E-03
MultiNet	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	13	-	-	7.53E-04	7.87E-04
MultiNet	BP	GO:0033627	cell adhesion mediated by integrin	-	87	81	-	-	1.88E-02	4.65E-03
MultiNet	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	20	-	-	1.52E-01	1.15E-03
MultiNet	BP	GO:0035107	appendage morphogenesis	-	147	131	-	-	1.21E-02	7.52E-03
MultiNet	BP	GO:1903707	negative regulation of hemopoiesis	-	116	91	-	-	1.91E-03	5.23E-03
MultiNet	BP	GO:0036342	post-anal tail morphogenesis	-	19	18	-	-	2.79E-04	1.07E-03
MultiNet	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	1.56E-02	1.43E-03
MultiNet	BP	GO:0030149	sphingolipid catabolic process	-	32	26	-	-	8.14E-02	1.50E-03
MultiNet	BP	GO:0050994	regulation of lipid catabolic process	-	61	51	-	-	6.86E-03	2.94E-03
MultiNet	BP	GO:0035988	chondrocyte proliferation	-	24	21	-	-	1.73E-03	1.22E-03
MultiNet	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	27	-	-	3.86E-03	1.57E-03
MultiNet	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	1.18E-02	6.44E-04
MultiNet	BP	GO:0009593	detection of chemical stimulus	-	511	54	-	-	3.91E-02	3.15E-03
MultiNet	BP	GO:0060788	ectodermal placode formation	-	12	11	-	-	3.41E-03	6.44E-04
MultiNet	BP	GO:0045727	positive regulation of translation	-	141	127	-	-	5.06E-03	7.30E-03
MultiNet	BP	GO:0036315	cellular response to sterol	-	24	18	-	-	1.94E-02	1.07E-03
MultiNet	CC	GO:0032388	positive regulation of intracellular transport	-	137	123	-	-	2.84E-03	7.09E-03
MultiNet	BP	GO:0002027	regulation of heart rate	-	106	83	-	-	4.23E-02	4.80E-03
MultiNet	BP	GO:0050879	multicellular organismal movement	-	118	92	-	-	7.25E-03	5.30E-03
MultiNet	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	66	-	-	1.68E-03	3.79E-03
MultiNet	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	47	-	-	1.54E-03	2.72E-03
MultiNet	BP	GO:0048515	spermatid differentiation	-	208	140	-	-	4.55E-03	8.02E-03
MultiNet	BP	GO:0072132	mesenchyme morphogenesis	-	57	54	-	-	2.83E-03	3.15E-03
MultiNet	MF	GO:0042887	amide transmembrane transporter activity	-	33	19	-	-	2.86E-04	1.15E-03
MultiNet	BP	GO:0007130	synaptonemal complex assembly	-	23	12	-	-	2.11E-04	7.16E-04
MultiNet	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	34	-	-	3.31E-03	2.00E-03
MultiNet	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	23	-	-	3.49E-04	1.36E-03
MultiNet	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	33	-	-	1.94E-01	1.93E-03
MultiNet	BP	GO:0060119	inner ear receptor cell development	-	44	29	-	-	2.97E-02	1.72E-03
MultiNet	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	17	-	-	2.05E-03	1.00E-03
MultiNet	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	26	-	-	1.61E-01	1.50E-03
MultiNet	BP	GO:1901983	regulation of protein acetylation	-	26	23	-	-	1.18E-03	1.36E-03
MultiNet	BP	GO:0014854	response to inactivity	-	12	12	-	-	2.41E-02	7.16E-04
MultiNet	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	224	-	-	1.49E-02	1.29E-02
MultiNet	BP	GO:1900006	positive regulation of dendrite development	-	17	14	-	-	2.42E-03	8.59E-04
MultiNet	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	44	-	-	2.41E-02	2.58E-03
MultiNet	BP	GO:0010883	regulation of lipid storage	-	53	43	-	-	1.84E-03	2.51E-03
MultiNet	BP	GO:0072170	metanephric tubule development	-	26	24	-	-	4.28E-03	1.43E-03
MultiNet	BP	GO:0007635	chemosensory behavior	-	20	15	-	-	2.83E-04	8.59E-04
MultiNet	BP	GO:1905954	positive regulation of lipid localization	-	110	85	-	-	5.65E-03	4.87E-03
MultiNet	BP	GO:0002209	behavioral defense response	-	39	34	-	-	5.65E-04	2.00E-03
MultiNet	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	21	-	-	1.92E-02	1.22E-03
MultiNet	BP	GO:0072523	purine-containing compound catabolic process	-	146	129	-	-	2.32E-02	7.45E-03
MultiNet	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	30	-	-	6.37E-03	1.72E-03
MultiNet	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	25	-	-	2.42E-03	1.43E-03
MultiNet	BP	GO:0021535	cell migration in hindbrain	-	16	12	-	-	2.13E-04	7.16E-04
MultiNet	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	88	-	-	1.94E-02	5.08E-03
MultiNet	BP	GO:0007218	neuropeptide signaling pathway	-	113	67	-	-	5.97E-02	3.87E-03
MultiNet	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	128	-	-	9.72E-03	7.37E-03
MultiNet	BP	GO:0031345	negative regulation of cell projection organization	-	195	160	-	-	6.37E-03	9.16E-03
MultiNet	BP	GO:0048278	vesicle docking	-	64	56	-	-	3.17E-02	3.22E-03
MultiNet	BP	GO:0035050	embryonic heart tube development	-	86	70	-	-	3.37E-03	4.01E-03
MultiNet	BP	GO:0030168	platelet activation	-	135	124	-	-	7.34E-03	7.16E-03
MultiNet	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	11	-	-	5.21E-02	6.44E-04
MultiNet	CC	GO:0098810	neurotransmitter reuptake	-	35	23	-	-	1.67E-03	1.36E-03
MultiNet	BP	GO:0008213	protein alkylation	-	58	48	-	-	3.42E-03	2.79E-03
MultiNet	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	1.04E-03	7.87E-04
MultiNet	BP	GO:0031338	regulation of vesicle fusion	-	24	23	-	-	3.54E-04	1.36E-03
MultiNet	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	11	-	-	2.12E-04	6.44E-04
MultiNet	BP	GO:0031529	ruffle organization	-	55	47	-	-	1.73E-03	2.72E-03
MultiNet	BP	GO:0010842	retina layer formation	-	25	19	-	-	2.81E-04	1.15E-03
MultiNet	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	59	-	-	2.40E-02	3.44E-03
MultiNet	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	62	-	-	4.51E-03	3.58E-03
MultiNet	MF	GO:0170055	lipid transmembrane transporter activity	-	56	34	-	-	1.99E-02	2.00E-03
MultiNet	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	26	-	-	4.27E-04	1.50E-03
MultiNet	BP	GO:0035304	regulation of protein dephosphorylation	-	87	77	-	-	2.86E-03	4.44E-03
MultiNet	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	199	-	-	4.82E-03	1.15E-02
MultiNet	BP	GO:0099637	neurotransmitter receptor transport	-	26	20	-	-	1.59E-02	1.15E-03
MultiNet	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	31	-	-	1.64E-03	1.79E-03
MultiNet	BP	GO:0051775	response to redox state	-	13	13	-	-	1.72E-02	7.87E-04
MultiNet	BP	GO:0051785	positive regulation of nuclear division	-	61	55	-	-	4.87E-03	3.15E-03
MultiNet	BP	GO:0060456	positive regulation of digestive system process	-	16	13	-	-	2.14E-04	7.87E-04
MultiNet	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	15	-	-	7.19E-02	8.59E-04
MultiNet	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	1.89E-03	1.15E-03
MultiNet	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	8.91E-02	7.16E-04
MultiNet	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	7.16E-03	2.58E-03
MultiNet	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	15	-	-	2.36E-02	8.59E-04
MultiNet	BP	GO:0044539	long-chain fatty acid import into cell	-	17	16	-	-	4.69E-03	9.31E-04
MultiNet	BP	GO:0051299	centrosome separation	-	15	14	-	-	2.09E-04	8.59E-04
MultiNet	BP	GO:0048145	regulation of fibroblast proliferation	-	87	76	-	-	2.61E-03	4.37E-03
MultiNet	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	69	-	-	2.68E-01	4.01E-03
MultiNet	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	220	-	-	6.94E-03	1.26E-02
MultiNet	BP	GO:0032098	regulation of appetite	-	20	15	-	-	1.62E-02	8.59E-04
MultiNet	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	4.53E-03	8.59E-04
MultiNet	CC	GO:0008333	endosome to lysosome transport	-	73	65	-	-	1.93E-02	3.72E-03
MultiNet	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	19	-	-	4.38E-03	1.15E-03
MultiNet	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	13	-	-	3.83E-03	7.87E-04
MultiNet	BP	GO:0003016	respiratory system process	-	39	32	-	-	4.74E-04	1.86E-03
MultiNet	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	20	-	-	4.17E-03	1.15E-03
MultiNet	BP	GO:0045732	positive regulation of protein catabolic process	-	202	181	-	-	1.27E-02	1.04E-02
MultiNet	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	67	-	-	5.81E-02	3.87E-03
MultiNet	BP	GO:0007588	excretion	-	40	30	-	-	6.34E-03	1.72E-03
MultiNet	BP	GO:1904018	positive regulation of vasculature development	-	185	135	-	-	1.20E-02	7.73E-03
MultiNet	BP	GO:0050953	sensory perception of light stimulus	-	223	149	-	-	2.75E-02	8.59E-03
MultiNet	BP	GO:0009164	nucleoside catabolic process	-	25	22	-	-	2.47E-01	1.29E-03
MultiNet	BP	GO:0009303	rRNA transcription	-	37	35	-	-	5.15E-03	2.00E-03
MultiNet	BP	GO:0035601	protein deacylation	-	56	50	-	-	3.58E-03	2.86E-03
MultiNet	BP	GO:0061952	midbody abscission	-	18	16	-	-	5.26E-02	9.31E-04
MultiNet	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	9.73E-04	1.15E-03
MultiNet	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	27	-	-	8.48E-04	1.57E-03
MultiNet	BP	GO:0071300	cellular response to retinoic acid	-	66	56	-	-	1.77E-03	3.22E-03
MultiNet	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	13	-	-	1.26E-01	7.87E-04
MultiNet	BP	GO:0045830	positive regulation of isotype switching	-	28	26	-	-	9.99E-04	1.50E-03
MultiNet	BP	GO:0031069	hair follicle morphogenesis	-	33	30	-	-	3.21E-03	1.72E-03
MultiNet	BP	GO:0046697	decidualization	-	26	22	-	-	1.83E-03	1.29E-03
MultiNet	BP	GO:0008212	mineralocorticoid metabolic process	-	14	11	-	-	9.68E-04	6.44E-04
MultiNet	BP	GO:0051588	regulation of neurotransmitter transport	-	99	80	-	-	1.35E-02	4.58E-03
MultiNet	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	20	-	-	3.63E-02	1.15E-03
MultiNet	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	11	-	-	2.10E-04	6.44E-04
MultiNet	BP	GO:0051784	negative regulation of nuclear division	-	63	58	-	-	2.89E-03	3.36E-03
MultiNet	BP	GO:0044703	multi-organism reproductive process	-	209	173	-	-	4.80E-03	9.95E-03
MultiNet	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	117	-	-	6.66E-03	6.73E-03
MultiNet	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	44	-	-	3.97E-03	2.58E-03
MultiNet	BP	GO:0099022	vesicle tethering	-	32	29	-	-	8.78E-02	1.72E-03
MultiNet	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	32	-	-	5.38E-04	1.86E-03
MultiNet	BP	GO:1903867	extraembryonic membrane development	-	12	11	-	-	2.13E-04	6.44E-04
MultiNet	BP	GO:0048857	neural nucleus development	-	65	59	-	-	4.05E-03	3.44E-03
MultiNet	BP	GO:0048663	neuron fate commitment	-	74	70	-	-	3.59E-03	4.01E-03
MultiNet	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	132	-	-	4.74E-03	7.59E-03
MultiNet	BP	GO:0106027	neuron projection organization	-	90	80	-	-	7.81E-03	4.58E-03
MultiNet	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	115	-	-	2.43E-02	6.59E-03
MultiNet	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	32	-	-	2.37E-03	1.86E-03
MultiNet	BP	GO:0045685	regulation of glial cell differentiation	-	77	64	-	-	2.70E-03	3.72E-03
MultiNet	BP	GO:0043414	macromolecule methylation	-	138	116	-	-	4.61E-03	6.66E-03
MultiNet	BP	GO:0048268	clathrin coat assembly	-	16	14	-	-	1.18E-01	8.59E-04
MultiNet	BP	GO:0050886	endocrine process	-	93	76	-	-	6.22E-03	4.37E-03
MultiNet	BP	GO:0050951	sensory perception of temperature stimulus	-	28	22	-	-	3.55E-04	1.29E-03
MultiNet	BP	GO:0045807	positive regulation of endocytosis	-	155	130	-	-	6.90E-03	7.45E-03
MultiNet	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	2.02E-02	6.44E-04
MultiNet	BP	GO:0002418	immune response to tumor cell	-	29	24	-	-	3.66E-02	1.43E-03
MultiNet	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	56	-	-	4.00E-03	3.22E-03
MultiNet	BP	GO:0048308	organelle inheritance	-	14	14	-	-	1.86E-03	8.59E-04
MultiNet	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	5.10E-04	1.07E-03
MultiNet	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	1.18E-03	1.15E-03
MultiNet	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	38	-	-	5.69E-04	2.22E-03
MultiNet	BP	GO:0034394	protein localization to cell surface	-	69	63	-	-	3.30E-03	3.65E-03
MultiNet	BP	GO:0042447	hormone catabolic process	-	12	11	-	-	2.13E-04	6.44E-04
MultiNet	BP	GO:0009110	vitamin biosynthetic process	-	23	21	-	-	4.42E-03	1.22E-03
MultiNet	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	23	-	-	5.08E-03	1.36E-03
MultiNet	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	9.58E-04	1.00E-03
MultiNet	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	19	-	-	1.16E-03	1.15E-03
MultiNet	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	86	-	-	2.88E-03	4.94E-03
MultiNet	MF	GO:0051100	negative regulation of binding	-	161	141	-	-	3.91E-03	8.09E-03
MultiNet	BP	GO:0001818	negative regulation of cytokine production	-	379	243	-	-	6.68E-03	1.40E-02
MultiNet	BP	GO:0003151	outflow tract morphogenesis	-	81	73	-	-	9.52E-03	4.22E-03
MultiNet	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	56	-	-	2.22E-03	3.22E-03
MultiNet	BP	GO:0055093	response to hyperoxia	-	20	19	-	-	2.18E-03	1.15E-03
MultiNet	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	11	-	-	2.11E-04	6.44E-04
MultiNet	BP	GO:0061036	positive regulation of cartilage development	-	33	30	-	-	2.40E-02	1.72E-03
MultiNet	BP	GO:0046184	aldehyde biosynthetic process	-	16	13	-	-	1.06E-03	7.87E-04
MultiNet	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	7.23E-03	7.87E-04
MultiNet	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	41	-	-	1.73E-03	2.36E-03
MultiNet	BP	GO:0046621	negative regulation of organ growth	-	39	29	-	-	4.61E-04	1.72E-03
MultiNet	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	47	-	-	1.23E-01	2.72E-03
MultiNet	BP	GO:0032368	regulation of lipid transport	-	149	111	-	-	7.51E-03	6.37E-03
MultiNet	BP	GO:0055094	response to lipoprotein particle	-	34	27	-	-	2.33E-02	1.57E-03
MultiNet	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	156	-	-	6.87E-03	8.95E-03
MultiNet	BP	GO:0033002	muscle cell proliferation	-	249	181	-	-	5.49E-03	1.04E-02
MultiNet	BP	GO:0043331	response to dsRNA	-	56	40	-	-	1.47E-03	2.29E-03
MultiNet	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	8.25E-03	7.16E-04
MultiNet	BP	GO:0051904	pigment granule transport	-	23	18	-	-	1.80E-02	1.07E-03
MultiNet	BP	GO:1901679	nucleotide transmembrane transport	-	32	24	-	-	3.56E-04	1.43E-03
MultiNet	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	1.73E-03	1.93E-03
MultiNet	BP	GO:0033363	secretory granule organization	-	63	57	-	-	1.54E-02	3.29E-03
MultiNet	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	1.34E-03	1.65E-03
MultiNet	BP	GO:0120009	intermembrane lipid transfer	-	52	43	-	-	4.80E-02	2.51E-03
MultiNet	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	9.09E-03	8.59E-04
MultiNet	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	35	-	-	1.61E-03	2.00E-03
MultiNet	BP	GO:0033622	integrin activation	-	26	22	-	-	4.05E-02	1.29E-03
MultiNet	BP	GO:0098751	bone cell development	-	18	14	-	-	6.84E-03	8.59E-04
MultiNet	BP	GO:2000773	negative regulation of cellular senescence	-	25	22	-	-	1.19E-03	1.29E-03
MultiNet	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	47	-	-	4.04E-03	2.72E-03
MultiNet	BP	GO:0050820	positive regulation of coagulation	-	30	27	-	-	1.68E-02	1.57E-03
MultiNet	BP	GO:0002076	osteoblast development	-	17	15	-	-	3.06E-03	8.59E-04
MultiNet	BP	GO:0072164	mesonephric tubule development	-	98	91	-	-	1.05E-02	5.23E-03
MultiNet	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	15	-	-	1.44E-03	8.59E-04
MultiNet	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	96	-	-	1.03E-02	5.51E-03
MultiNet	BP	GO:1903524	positive regulation of blood circulation	-	39	28	-	-	4.21E-04	1.65E-03
MultiNet	BP	GO:0030901	midbrain development	-	87	79	-	-	1.88E-03	4.58E-03
MultiNet	BP	GO:0048485	sympathetic nervous system development	-	22	19	-	-	3.42E-03	1.15E-03
MultiNet	BP	GO:0007162	negative regulation of cell adhesion	-	310	249	-	-	7.45E-03	1.43E-02
MultiNet	BP	GO:0048532	anatomical structure arrangement	-	16	13	-	-	2.10E-04	7.87E-04
MultiNet	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	12	-	-	1.37E-03	7.16E-04
MultiNet	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	62	-	-	4.56E-03	3.58E-03
MultiNet	BP	GO:0002687	positive regulation of leukocyte migration	-	147	120	-	-	6.12E-03	6.87E-03
MultiNet	BP	GO:0019755	one-carbon compound transport	-	28	18	-	-	2.85E-04	1.07E-03
MultiNet	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	2.13E-04	7.87E-04
MultiNet	BP	GO:0060856	establishment of blood-brain barrier	-	16	13	-	-	2.12E-04	7.87E-04
MultiNet	BP	GO:0110154	RNA decapping	-	19	16	-	-	2.84E-02	9.31E-04
MultiNet	BP	GO:0034605	cellular response to heat	-	66	58	-	-	2.73E-03	3.36E-03
MultiNet	BP	GO:0005996	monosaccharide metabolic process	-	250	218	-	-	3.32E-02	1.25E-02
MultiNet	BP	GO:0033555	multicellular organismal response to stress	-	90	70	-	-	2.72E-03	4.01E-03
MultiNet	BP	GO:0002262	myeloid cell homeostasis	-	172	165	-	-	4.53E-03	9.45E-03
MultiNet	BP	GO:0000966	RNA 5'-end processing	-	39	37	-	-	1.66E-01	2.15E-03
MultiNet	BP	GO:0050688	regulation of defense response to virus	-	65	58	-	-	2.62E-02	3.36E-03
MultiNet	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	3.51E-04	1.15E-03
MultiNet	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	217	-	-	2.15E-02	1.25E-02
MultiNet	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	8.34E-04	1.79E-03
MultiNet	BP	GO:0061029	eyelid development in camera-type eye	-	14	13	-	-	4.56E-04	7.87E-04
MultiNet	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	29	-	-	3.62E-03	1.72E-03
MultiNet	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	14	-	-	2.10E-04	8.59E-04
MultiNet	BP	GO:0003272	endocardial cushion formation	-	28	26	-	-	3.96E-02	1.50E-03
MultiNet	BP	GO:0022618	protein-RNA complex assembly	-	227	181	-	-	5.04E-02	1.04E-02
MultiNet	BP	GO:0051147	regulation of muscle cell differentiation	-	162	117	-	-	6.10E-03	6.73E-03
MultiNet	BP	GO:0090102	cochlea development	-	50	40	-	-	1.68E-03	2.29E-03
MultiNet	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	25	-	-	1.84E-03	1.43E-03
MultiNet	BP	GO:0045933	positive regulation of muscle contraction	-	49	39	-	-	8.80E-04	2.29E-03
MultiNet	BP	GO:0002679	respiratory burst involved in defense response	-	16	13	-	-	2.14E-03	7.87E-04
MultiNet	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	31	-	-	2.16E-03	1.79E-03
MultiNet	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	78	-	-	3.16E-02	4.51E-03
MultiNet	BP	GO:0097264	self proteolysis	-	12	11	-	-	2.14E-04	6.44E-04
MultiNet	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	5.99E-03	1.29E-03
MultiNet	BP	GO:0032922	circadian regulation of gene expression	-	71	65	-	-	4.35E-03	3.72E-03
MultiNet	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	41	-	-	3.76E-02	2.36E-03
MultiNet	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	78	-	-	7.83E-03	4.51E-03
MultiNet	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	15	-	-	1.22E-01	8.59E-04
MultiNet	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	44	-	-	1.67E-03	2.58E-03
MultiNet	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	3.49E-03	6.44E-04
MultiNet	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	3.28E-02	2.22E-03
MultiNet	BP	GO:0140253	cell-cell fusion	-	62	48	-	-	6.33E-03	2.79E-03
MultiNet	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	2.14E-04	7.16E-04
MultiNet	BP	GO:0071599	otic vesicle development	-	15	14	-	-	9.11E-02	8.59E-04
MultiNet	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	32	-	-	4.52E-03	1.86E-03
MultiNet	BP	GO:0061635	regulation of protein complex stability	-	14	13	-	-	2.12E-04	7.87E-04
MultiNet	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	52	-	-	3.80E-02	3.01E-03
MultiNet	BP	GO:0001941	postsynaptic membrane organization	-	37	31	-	-	6.46E-02	1.79E-03
MultiNet	BP	GO:0051293	establishment of spindle localization	-	57	49	-	-	2.16E-03	2.86E-03
MultiNet	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	2.11E-04	7.16E-04
MultiNet	BP	GO:0043114	regulation of vascular permeability	-	49	42	-	-	8.89E-03	2.43E-03
MultiNet	BP	GO:0018126	protein hydroxylation	-	26	23	-	-	5.85E-02	1.36E-03
MultiNet	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	50	-	-	2.62E-03	2.86E-03
MultiNet	BP	GO:0008360	regulation of cell shape	-	139	118	-	-	6.16E-03	6.80E-03
MultiNet	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	13	-	-	2.11E-04	7.87E-04
MultiNet	BP	GO:0051222	positive regulation of protein transport	-	249	222	-	-	4.94E-03	1.27E-02
MultiNet	CC	GO:0140632	canonical inflammasome complex assembly	-	40	32	-	-	8.76E-03	1.86E-03
MultiNet	MF	GO:0034260	negative regulation of GTPase activity	-	36	30	-	-	4.94E-04	1.72E-03
MultiNet	BP	GO:0045932	negative regulation of muscle contraction	-	24	19	-	-	1.45E-03	1.15E-03
MultiNet	BP	GO:0045739	positive regulation of DNA repair	-	128	119	-	-	5.26E-02	6.87E-03
MultiNet	BP	GO:0001845	phagolysosome assembly	-	19	15	-	-	5.17E-02	8.59E-04
MultiNet	BP	GO:0045185	maintenance of protein location	-	95	81	-	-	3.64E-03	4.65E-03
MultiNet	BP	GO:0003158	endothelium development	-	140	112	-	-	1.77E-02	6.44E-03
MultiNet	CC	GO:0072595	maintenance of protein localization in organelle	-	42	38	-	-	4.13E-03	2.22E-03
MultiNet	BP	GO:0051224	negative regulation of protein transport	-	122	97	-	-	3.56E-03	5.58E-03
MultiNet	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	134	-	-	3.49E-03	7.73E-03
MultiNet	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	2.56E-03	7.87E-04
MultiNet	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	26	-	-	2.07E-03	1.50E-03
MultiNet	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	17	-	-	5.53E-02	1.00E-03
MultiNet	BP	GO:0021885	forebrain cell migration	-	63	58	-	-	4.93E-03	3.36E-03
MultiNet	BP	GO:0007405	neuroblast proliferation	-	81	76	-	-	4.31E-03	4.37E-03
MultiNet	BP	GO:0009581	detection of external stimulus	-	137	92	-	-	1.21E-02	5.30E-03
MultiNet	BP	GO:1990542	mitochondrial transmembrane transport	-	93	72	-	-	3.88E-02	4.15E-03
MultiNet	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	32	-	-	3.54E-03	1.86E-03
MultiNet	BP	GO:0097186	amelogenesis	-	26	12	-	-	2.13E-04	7.16E-04
MultiNet	BP	GO:0031128	developmental induction	-	26	25	-	-	8.13E-03	1.43E-03
MultiNet	BP	GO:0031100	animal organ regeneration	-	66	64	-	-	2.18E-03	3.72E-03
MultiNet	BP	GO:0021533	cell differentiation in hindbrain	-	23	19	-	-	1.06E-03	1.15E-03
MultiNet	BP	GO:0045684	positive regulation of epidermis development	-	33	29	-	-	8.43E-04	1.72E-03
MultiNet	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	11	-	-	2.24E-02	6.44E-04
MultiNet	BP	GO:1900047	negative regulation of hemostasis	-	51	50	-	-	4.00E-02	2.86E-03
MultiNet	BP	GO:0021517	ventral spinal cord development	-	47	42	-	-	3.10E-02	2.43E-03
MultiNet	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	71	-	-	4.39E-03	4.08E-03
MultiNet	BP	GO:0032328	alanine transport	-	19	11	-	-	8.71E-02	6.44E-04
MultiNet	MF	GO:0034497	protein localization to phagophore assembly site	-	16	14	-	-	2.11E-04	8.59E-04
MultiNet	BP	GO:0097722	sperm motility	-	133	77	-	-	1.09E-02	4.44E-03
MultiNet	BP	GO:0051231	spindle elongation	-	14	13	-	-	4.21E-02	7.87E-04
MultiNet	BP	GO:0042490	mechanoreceptor differentiation	-	67	46	-	-	3.74E-02	2.65E-03
MultiNet	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	25	-	-	1.21E-03	1.43E-03
MultiNet	BP	GO:0035148	tube formation	-	155	141	-	-	1.17E-02	8.09E-03
MultiNet	BP	GO:0048520	positive regulation of behavior	-	27	19	-	-	2.80E-04	1.15E-03
MultiNet	BP	GO:0098543	detection of other organism	-	19	13	-	-	6.98E-02	7.87E-04
MultiNet	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	42	-	-	9.64E-03	2.43E-03
MultiNet	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	105	-	-	2.58E-02	6.01E-03
MultiNet	BP	GO:0031123	RNA 3'-end processing	-	79	71	-	-	6.26E-02	4.08E-03
MultiNet	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	2.11E-02	6.44E-04
MultiNet	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	93	-	-	5.18E-03	5.37E-03
MultiNet	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	17	-	-	4.57E-02	1.00E-03
MultiNet	CC	GO:0007097	nuclear migration	-	24	20	-	-	9.31E-03	1.15E-03
MultiNet	BP	GO:0045229	external encapsulating structure organization	-	319	224	-	-	1.58E-02	1.29E-02
MultiNet	BP	GO:0006885	regulation of pH	-	104	76	-	-	2.09E-02	4.37E-03
MultiNet	BP	GO:0002467	germinal center formation	-	14	13	-	-	8.16E-04	7.87E-04
MultiNet	BP	GO:1990840	response to lectin	-	22	18	-	-	1.37E-02	1.07E-03
MultiNet	BP	GO:0071800	podosome assembly	-	19	18	-	-	1.74E-03	1.07E-03
MultiNet	BP	GO:0031018	endocrine pancreas development	-	47	44	-	-	2.93E-03	2.58E-03
MultiNet	BP	GO:0001708	cell fate specification	-	108	101	-	-	1.88E-02	5.80E-03
MultiNet	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	61	-	-	3.36E-03	3.51E-03
MultiNet	BP	GO:0030279	negative regulation of ossification	-	39	30	-	-	3.28E-03	1.72E-03
MultiNet	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	13	-	-	3.84E-03	7.87E-04
MultiNet	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	13	-	-	2.35E-03	7.87E-04
MultiNet	BP	GO:0042440	pigment metabolic process	-	80	67	-	-	8.44E-02	3.87E-03
MultiNet	BP	GO:1901606	alpha-amino acid catabolic process	-	101	89	-	-	6.57E-02	5.15E-03
MultiNet	BP	GO:1901890	positive regulation of cell junction assembly	-	106	85	-	-	1.46E-02	4.87E-03
MultiNet	BP	GO:0070988	demethylation	-	27	22	-	-	1.79E-03	1.29E-03
MultiNet	BP	GO:1901655	cellular response to ketone	-	107	92	-	-	2.16E-03	5.30E-03
MultiNet	BP	GO:0046185	aldehyde catabolic process	-	14	13	-	-	5.20E-03	7.87E-04
MultiNet	BP	GO:0051255	spindle midzone assembly	-	14	13	-	-	2.93E-02	7.87E-04
MultiNet	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	15	-	-	1.17E-01	8.59E-04
MultiNet	BP	GO:0006968	cellular defense response	-	52	44	-	-	7.35E-03	2.58E-03
MultiNet	BP	GO:0055006	cardiac cell development	-	93	71	-	-	2.95E-03	4.08E-03
MultiNet	BP	GO:0031365	N-terminal protein amino acid modification	-	30	26	-	-	1.39E-03	1.50E-03
MultiNet	BP	GO:0035881	amacrine cell differentiation	-	12	11	-	-	2.13E-04	6.44E-04
MultiNet	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	22	-	-	4.99E-04	1.29E-03
MultiNet	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	2.09E-04	7.16E-04
MultiNet	BP	GO:0060004	reflex	-	63	52	-	-	1.04E-03	3.01E-03
MultiNet	BP	GO:0044706	multi-multicellular organism process	-	217	179	-	-	5.83E-03	1.03E-02
MultiNet	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	1.35E-03	7.16E-04
MultiNet	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	129	-	-	6.38E-03	7.45E-03
MultiNet	BP	GO:0006026	aminoglycan catabolic process	-	34	22	-	-	3.55E-04	1.29E-03
MultiNet	BP	GO:0031294	lymphocyte costimulation	-	47	44	-	-	8.23E-03	2.58E-03
MultiNet	BP	GO:0050768	negative regulation of neurogenesis	-	150	122	-	-	3.27E-03	7.02E-03
MultiNet	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	90	-	-	3.00E-03	5.15E-03
MultiNet	BP	GO:0090068	positive regulation of cell cycle process	-	262	226	-	-	7.24E-03	1.30E-02
MultiNet	BP	GO:0043605	amide catabolic process	-	16	14	-	-	1.97E-01	8.59E-04
MultiNet	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	21	-	-	3.37E-02	1.22E-03
MultiNet	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	30	-	-	5.16E-02	1.72E-03
MultiNet	BP	GO:1902115	regulation of organelle assembly	-	210	180	-	-	5.16E-03	1.03E-02
MultiNet	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	59	-	-	3.71E-03	3.44E-03
MultiNet	BP	GO:0047484	regulation of response to osmotic stress	-	16	14	-	-	2.13E-04	8.59E-04
MultiNet	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	115	-	-	3.66E-03	6.59E-03
MultiNet	BP	GO:0043171	peptide catabolic process	-	19	13	-	-	2.13E-04	7.87E-04
MultiNet	BP	GO:0046622	positive regulation of organ growth	-	52	40	-	-	1.78E-03	2.29E-03
MultiNet	BP	GO:0051952	regulation of amine transport	-	98	79	-	-	5.70E-03	4.58E-03
MultiNet	BP	GO:0006730	one-carbon metabolic process	-	24	22	-	-	2.53E-01	1.29E-03
MultiNet	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	19	-	-	1.72E-03	1.15E-03
MultiNet	BP	GO:0040019	positive regulation of embryonic development	-	23	17	-	-	2.95E-03	1.00E-03
MultiNet	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	3.48E-04	1.15E-03
MultiNet	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	14	-	-	2.13E-04	8.59E-04
MultiNet	CC	GO:0032365	intracellular lipid transport	-	51	46	-	-	3.10E-02	2.65E-03
MultiNet	BP	GO:0045048	protein insertion into ER membrane	-	30	25	-	-	3.93E-02	1.43E-03
MultiNet	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	59	-	-	4.51E-03	3.44E-03
MultiNet	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	103	-	-	5.15E-03	5.94E-03
MultiNet	BP	GO:0018149	peptide cross-linking	-	28	21	-	-	2.78E-01	1.22E-03
MultiNet	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	19	-	-	1.17E-03	1.15E-03
MultiNet	MF	GO:0140537	transcription regulator activator activity	-	13	11	-	-	9.25E-04	6.44E-04
MultiNet	BP	GO:0061000	negative regulation of dendritic spine development	-	13	11	-	-	2.09E-04	6.44E-04
MultiNet	BP	GO:0071398	cellular response to fatty acid	-	35	31	-	-	1.48E-03	1.79E-03
MultiNet	BP	GO:0097581	lamellipodium organization	-	91	77	-	-	5.44E-03	4.44E-03
MultiNet	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	26	-	-	5.32E-02	1.50E-03
MultiNet	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	195	-	-	3.29E-02	1.12E-02
MultiNet	BP	GO:0060326	cell chemotaxis	-	311	236	-	-	1.24E-02	1.35E-02
MultiNet	BP	GO:1903975	regulation of glial cell migration	-	20	14	-	-	8.35E-02	8.59E-04
MultiNet	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	17	-	-	7.39E-03	1.00E-03
MultiNet	BP	GO:0015669	gas transport	-	23	15	-	-	1.89E-02	8.59E-04
MultiNet	BP	GO:0016485	protein processing	-	248	197	-	-	1.53E-02	1.13E-02
MultiNet	BP	GO:0009649	entrainment of circadian clock	-	30	26	-	-	4.19E-02	1.50E-03
MultiNet	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	119	-	-	3.91E-02	6.87E-03
MultiNet	BP	GO:1903523	negative regulation of blood circulation	-	27	20	-	-	3.70E-03	1.15E-03
MultiNet	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	93	-	-	3.29E-02	5.37E-03
MultiNet	BP	GO:0099054	presynapse assembly	-	49	35	-	-	1.05E-02	2.00E-03
MultiNet	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	22	-	-	6.26E-03	1.29E-03
MultiNet	BP	GO:0006517	protein deglycosylation	-	26	21	-	-	4.73E-03	1.22E-03
MultiNet	BP	GO:0031348	negative regulation of defense response	-	282	202	-	-	8.04E-03	1.16E-02
MultiNet	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	71	-	-	4.13E-03	4.08E-03
MultiNet	BP	GO:0007606	sensory perception of chemical stimulus	-	535	63	-	-	1.70E-02	3.65E-03
MultiNet	BP	GO:0061180	mammary gland epithelium development	-	68	65	-	-	1.87E-03	3.72E-03
MultiNet	BP	GO:0071496	cellular response to external stimulus	-	74	68	-	-	7.55E-03	3.94E-03
MultiNet	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	2.13E-04	7.87E-04
MultiNet	BP	GO:0042753	positive regulation of circadian rhythm	-	18	13	-	-	4.50E-03	7.87E-04
MultiNet	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	2.09E-04	6.44E-04
MultiNet	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	1.15E-02	7.16E-04
MultiNet	BP	GO:0032094	response to food	-	37	29	-	-	6.69E-03	1.72E-03
MultiNet	BP	GO:0001964	startle response	-	27	23	-	-	4.58E-03	1.36E-03
MultiNet	BP	GO:0007340	acrosome reaction	-	38	22	-	-	7.75E-03	1.29E-03
MultiNet	BP	GO:0046434	organophosphate catabolic process	-	232	200	-	-	2.53E-02	1.15E-02
MultiNet	BP	GO:0060037	pharyngeal system development	-	29	26	-	-	3.07E-02	1.50E-03
MultiNet	BP	GO:0009566	fertilization	-	205	124	-	-	1.06E-02	7.16E-03
MultiNet	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	47	-	-	6.57E-02	2.72E-03
MultiNet	BP	GO:0120255	olefinic compound biosynthetic process	-	24	19	-	-	5.57E-04	1.15E-03
MultiNet	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	2.14E-04	7.87E-04
MultiNet	BP	GO:0045907	positive regulation of vasoconstriction	-	30	26	-	-	5.95E-03	1.50E-03
MultiNet	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	20	-	-	6.36E-03	1.15E-03
MultiNet	BP	GO:0033044	regulation of chromosome organization	-	249	242	-	-	2.14E-02	1.39E-02
MultiNet	BP	GO:0009309	amine biosynthetic process	-	38	33	-	-	6.09E-02	1.93E-03
MultiNet	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	16	-	-	2.47E-03	9.31E-04
MultiNet	BP	GO:0061900	glial cell activation	-	56	47	-	-	6.07E-03	2.72E-03
MultiNet	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	119	-	-	8.87E-03	6.87E-03
MultiNet	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	14	-	-	8.15E-03	8.59E-04
MultiNet	BP	GO:0021794	thalamus development	-	12	11	-	-	2.14E-04	6.44E-04
MultiNet	CC	GO:0140467	integrated stress response signaling	-	41	40	-	-	2.27E-03	2.29E-03
MultiNet	BP	GO:0035902	response to immobilization stress	-	20	19	-	-	2.69E-04	1.15E-03
MultiNet	BP	GO:0035821	modulation of process of another organism	-	14	12	-	-	2.10E-04	7.16E-04
MultiNet	BP	GO:0072537	fibroblast activation	-	13	12	-	-	2.12E-04	7.16E-04
MultiNet	BP	GO:0090235	regulation of metaphase plate congression	-	13	12	-	-	2.42E-02	7.16E-04
MultiNet	BP	GO:0043647	inositol phosphate metabolic process	-	44	37	-	-	2.48E-02	2.15E-03
MultiNet	BP	GO:0016180	snRNA processing	-	28	24	-	-	2.78E-01	1.43E-03
MultiNet	BP	GO:0051303	establishment of chromosome localization	-	104	91	-	-	8.22E-03	5.23E-03
MultiNet	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	2.90E-02	9.31E-04
MultiNet	BP	GO:0007164	establishment of tissue polarity	-	38	34	-	-	1.88E-02	2.00E-03
MultiNet	BP	GO:0097164	ammonium ion metabolic process	-	23	19	-	-	1.14E-02	1.15E-03
MultiNet	BP	GO:0021515	cell differentiation in spinal cord	-	51	46	-	-	3.24E-03	2.65E-03
MultiNet	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	16	-	-	2.84E-04	9.31E-04
MultiNet	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	17	-	-	1.09E-03	1.00E-03
MultiNet	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	24	-	-	1.32E-03	1.43E-03
MultiNet	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	17	-	-	9.38E-04	1.00E-03
MultiNet	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	34	-	-	1.83E-02	2.00E-03
MultiNet	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	2.60E-02	1.29E-03
MultiNet	BP	GO:0007566	embryo implantation	-	57	47	-	-	1.27E-03	2.72E-03
MultiNet	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	30	-	-	2.82E-03	1.72E-03
MultiNet	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	1.54E-02	9.31E-04
MultiNet	BP	GO:0060306	regulation of membrane repolarization	-	38	28	-	-	5.12E-02	1.65E-03
MultiNet	BP	GO:0051017	actin filament bundle assembly	-	161	132	-	-	4.95E-03	7.59E-03
MultiNet	BP	GO:1905953	negative regulation of lipid localization	-	63	40	-	-	1.56E-03	2.29E-03
MultiNet	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	2.76E-04	1.07E-03
MultiNet	BP	GO:0021542	dentate gyrus development	-	19	17	-	-	3.44E-03	1.00E-03
MultiNet	BP	GO:0036302	atrioventricular canal development	-	13	12	-	-	6.08E-03	7.16E-04
MultiNet	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	34	-	-	3.76E-03	2.00E-03
MultiNet	BP	GO:0021756	striatum development	-	21	20	-	-	8.04E-03	1.15E-03
MultiNet	BP	GO:1901343	negative regulation of vasculature development	-	154	79	-	-	1.73E-02	4.58E-03
MultiNet	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	125	-	-	1.68E-02	7.16E-03
MultiNet	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	20	-	-	3.57E-04	1.15E-03
MultiNet	BP	GO:1902414	protein localization to cell junction	-	107	96	-	-	2.05E-02	5.51E-03
MultiNet	BP	GO:0071305	cellular response to vitamin D	-	23	17	-	-	3.09E-03	1.00E-03
MultiNet	BP	GO:0051304	chromosome separation	-	80	79	-	-	7.23E-03	4.58E-03
MultiNet	BP	GO:0090596	sensory organ morphogenesis	-	272	222	-	-	4.79E-03	1.27E-02
MultiNet	BP	GO:0045780	positive regulation of bone resorption	-	18	15	-	-	4.37E-03	8.59E-04
MultiNet	BP	GO:0048709	oligodendrocyte differentiation	-	101	84	-	-	4.94E-03	4.87E-03
MultiNet	BP	GO:0045017	glycerolipid biosynthetic process	-	254	211	-	-	6.38E-02	1.21E-02
MultiNet	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	5.25E-01	8.59E-04
MultiNet	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	21	-	-	3.79E-03	1.22E-03
MultiNet	BP	GO:0001776	leukocyte homeostasis	-	108	96	-	-	4.76E-03	5.51E-03
MultiNet	BP	GO:0050769	positive regulation of neurogenesis	-	240	209	-	-	4.81E-03	1.20E-02
MultiNet	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	13	-	-	2.78E-01	7.87E-04
MultiNet	BP	GO:0030193	regulation of blood coagulation	-	70	65	-	-	2.83E-02	3.72E-03
MultiNet	BP	GO:0050866	negative regulation of cell activation	-	216	174	-	-	4.86E-03	1.00E-02
MultiNet	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	32	-	-	2.33E-03	1.86E-03
MultiNet	BP	GO:0033500	carbohydrate homeostasis	-	251	199	-	-	3.83E-03	1.15E-02
MultiNet	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	27	-	-	1.80E-02	1.57E-03
MultiNet	BP	GO:0044088	regulation of vacuole organization	-	56	48	-	-	3.83E-03	2.79E-03
MultiNet	CC	GO:0051457	maintenance of protein location in nucleus	-	23	21	-	-	1.13E-02	1.22E-03
MultiNet	CC	GO:0099522	cytosolic region	-	20	20	-	-	5.07E-04	1.15E-03
MultiNet	CC	GO:0000791	euchromatin	-	60	53	-	-	2.29E-03	3.08E-03
MultiNet	CC	GO:0030666	endocytic vesicle membrane	-	196	166	-	-	1.14E-02	9.52E-03
MultiNet	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.69E-02	8.59E-04
MultiNet	CC	GO:1990752	microtubule end	-	34	28	-	-	9.94E-02	1.65E-03
MultiNet	CC	GO:0043204	perikaryon	-	156	122	-	-	4.21E-03	7.02E-03
MultiNet	CC	GO:0061702	canonical inflammasome complex	-	17	15	-	-	1.43E-01	8.59E-04
MultiNet	CC	GO:0097542	ciliary tip	-	48	39	-	-	1.89E-02	2.29E-03
MultiNet	CC	GO:1905368	peptidase complex	-	124	116	-	-	1.37E-01	6.66E-03
MultiNet	CC	GO:0000792	heterochromatin	-	98	93	-	-	6.50E-03	5.37E-03
MultiNet	CC	GO:0097546	ciliary base	-	47	35	-	-	6.27E-03	2.00E-03
MultiNet	CC	GO:0071819	DUBm complex	-	25	23	-	-	2.60E-01	1.36E-03
MultiNet	CC	GO:0031201	SNARE complex	-	48	44	-	-	3.13E-01	2.58E-03
MultiNet	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.16E-03	7.87E-04
MultiNet	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	6.52E-03	2.29E-03
MultiNet	CC	GO:0044391	ribosomal subunit	-	203	194	-	-	5.11E-02	1.12E-02
MultiNet	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	4.25E-02	6.44E-04
MultiNet	CC	GO:0071013	catalytic step 2 spliceosome	-	88	83	-	-	4.90E-02	4.80E-03
MultiNet	CC	GO:0031907	microbody lumen	-	51	41	-	-	2.71E-02	2.36E-03
MultiNet	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	2.75E-01	7.16E-04
MultiNet	CC	GO:0098862	cluster of actin-based cell projections	-	162	117	-	-	1.02E-02	6.73E-03
MultiNet	CC	GO:0016363	nuclear matrix	-	127	122	-	-	4.08E-03	7.02E-03
MultiNet	CC	GO:0031261	DNA replication preinitiation complex	-	46	43	-	-	7.57E-02	2.51E-03
MultiNet	CC	GO:0032432	actin filament bundle	-	249	195	-	-	7.51E-03	1.12E-02
MultiNet	CC	GO:0008088	axo-dendritic transport	-	78	71	-	-	3.19E-02	4.08E-03
MultiNet	CC	GO:0031519	PcG protein complex	-	38	35	-	-	5.74E-02	2.00E-03
MultiNet	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	36	-	-	1.41E-01	2.08E-03
MultiNet	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	190	-	-	4.28E-02	1.09E-02
MultiNet	CC	GO:0000313	organellar ribosome	-	89	89	-	-	9.42E-02	5.15E-03
MultiNet	CC	GO:0099643	signal release from synapse	-	147	122	-	-	3.88E-02	7.02E-03
MultiNet	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	43	-	-	6.80E-02	2.51E-03
MultiNet	CC	GO:0030018	Z disc	-	129	116	-	-	4.26E-02	6.66E-03
MultiNet	CC	GO:0032580	Golgi cisterna membrane	-	93	47	-	-	9.68E-03	2.72E-03
MultiNet	CC	GO:0097381	photoreceptor disc membrane	-	25	13	-	-	7.61E-03	7.87E-04
MultiNet	CC	GO:1905360	GTPase complex	-	41	35	-	-	1.68E-01	2.00E-03
MultiNet	CC	GO:0097540	axonemal central pair	-	161	92	-	-	4.17E-03	5.30E-03
MultiNet	CC	GO:0042641	actomyosin	-	77	65	-	-	9.10E-03	3.72E-03
MultiNet	CC	GO:0097386	glial cell projection	-	38	29	-	-	6.22E-04	1.72E-03
MultiNet	CC	GO:0032588	trans-Golgi network membrane	-	102	83	-	-	4.86E-02	4.80E-03
MultiNet	CC	GO:0070382	exocytic vesicle	-	224	181	-	-	2.25E-02	1.04E-02
MultiNet	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	41	-	-	3.21E-02	2.36E-03
MultiNet	CC	GO:0031903	microbody membrane	-	65	61	-	-	2.87E-01	3.51E-03
MultiNet	CC	GO:0046930	pore complex	-	26	24	-	-	7.48E-02	1.43E-03
MultiNet	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	1.31E-02	6.44E-04
MultiNet	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	1.42E-03	9.31E-04
MultiNet	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	222	-	-	1.66E-02	1.27E-02
MultiNet	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	23	-	-	2.61E-02	1.36E-03
MultiNet	CC	GO:1990071	TRAPPII protein complex	-	12	12	-	-	9.19E-02	7.16E-04
MultiNet	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	1.34E-02	1.00E-03
MultiNet	CC	GO:0044298	cell body membrane	-	32	23	-	-	7.01E-03	1.36E-03
MultiNet	CC	GO:0051882	mitochondrial depolarization	-	21	20	-	-	1.02E-03	1.15E-03
MultiNet	CC	GO:0045495	pole plasm	-	25	18	-	-	3.91E-03	1.07E-03
MultiNet	CC	GO:0072379	ER membrane insertion complex	-	14	12	-	-	5.82E-02	7.16E-04
MultiNet	CC	GO:0070993	translation preinitiation complex	-	19	18	-	-	3.90E-01	1.07E-03
MultiNet	CC	GO:0010369	chromocenter	-	14	14	-	-	1.40E-02	8.59E-04
MultiNet	CC	GO:0016323	basolateral plasma membrane	-	239	179	-	-	8.21E-03	1.03E-02
MultiNet	CC	GO:0045009	chitosome	-	21	17	-	-	5.31E-02	1.00E-03
MultiNet	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	2.09E-02	7.16E-04
MultiNet	CC	GO:0042645	mitochondrial nucleoid	-	45	43	-	-	3.82E-02	2.51E-03
MultiNet	CC	GO:0098636	protein complex involved in cell adhesion	-	57	54	-	-	4.74E-02	3.15E-03
MultiNet	CC	GO:0001917	photoreceptor inner segment	-	71	49	-	-	1.46E-02	2.86E-03
MultiNet	CC	GO:0098845	postsynaptic endosome	-	14	12	-	-	2.13E-04	7.16E-04
MultiNet	CC	GO:0019897	extrinsic component of plasma membrane	-	156	131	-	-	5.42E-02	7.52E-03
MultiNet	CC	GO:0031594	neuromuscular junction	-	73	62	-	-	1.11E-02	3.58E-03
MultiNet	CC	GO:0000793	condensed chromosome	-	274	240	-	-	2.50E-02	1.37E-02
MultiNet	CC	GO:0045120	pronucleus	-	14	11	-	-	2.07E-04	6.44E-04
MultiNet	CC	GO:0043083	synaptic cleft	-	21	15	-	-	2.86E-04	8.59E-04
MultiNet	CC	GO:0000922	spindle pole	-	172	155	-	-	4.20E-03	8.88E-03
MultiNet	CC	GO:0120111	neuron projection cytoplasm	-	94	83	-	-	2.66E-02	4.80E-03
MultiNet	CC	GO:0070971	endoplasmic reticulum exit site	-	32	21	-	-	5.18E-02	1.22E-03
MultiNet	CC	GO:0005736	RNA polymerase I complex	-	13	12	-	-	1.64E-01	7.16E-04
MultiNet	CC	GO:0004879	nuclear receptor activity	-	63	61	-	-	1.38E-02	3.51E-03
MultiNet	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	148	-	-	2.26E-02	8.52E-03
MultiNet	CC	GO:0000123	histone acetyltransferase complex	-	93	87	-	-	5.48E-02	5.01E-03
MultiNet	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	2.14E-04	7.87E-04
MultiNet	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	85	-	-	3.27E-02	4.87E-03
MultiNet	CC	GO:0048786	presynaptic active zone	-	80	69	-	-	4.18E-02	4.01E-03
MultiNet	CC	GO:0001054	RNA polymerase I activity	-	12	11	-	-	4.47E-02	6.44E-04
MultiNet	CC	GO:0007034	vacuolar transport	-	168	147	-	-	2.73E-02	8.45E-03
MultiNet	CC	GO:0090741	pigment granule membrane	-	21	17	-	-	6.46E-02	1.00E-03
MultiNet	CC	GO:0043194	axon initial segment	-	21	20	-	-	6.73E-02	1.15E-03
MultiNet	CC	GO:0005776	autophagosome	-	111	98	-	-	1.81E-02	5.66E-03
MultiNet	CC	GO:0031430	M band	-	22	16	-	-	1.44E-02	9.31E-04
MultiNet	CC	GO:0001931	uropod	-	13	13	-	-	2.49E-02	7.87E-04
MultiNet	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	73	-	-	9.98E-02	4.22E-03
MultiNet	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	78	-	-	3.02E-02	4.51E-03
MultiNet	CC	GO:0030677	ribonuclease P complex	-	14	14	-	-	7.00E-01	8.59E-04
MultiNet	CC	GO:0000164	protein phosphatase type 1 complex	-	19	17	-	-	6.76E-02	1.00E-03
MultiNet	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	25	-	-	3.28E-03	1.43E-03
MultiNet	CC	GO:0032994	protein-lipid complex	-	39	36	-	-	5.05E-02	2.08E-03
MultiNet	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	144	-	-	7.55E-02	8.30E-03
MultiNet	CC	GO:0071012	catalytic step 1 spliceosome	-	12	11	-	-	5.02E-02	6.44E-04
MultiNet	CC	GO:0072562	blood microparticle	-	144	107	-	-	1.88E-02	6.16E-03
MultiNet	CC	GO:0005883	neurofilament	-	11	11	-	-	1.02E-01	6.44E-04
MultiNet	CC	GO:0051233	spindle midzone	-	36	32	-	-	1.50E-02	1.86E-03
MultiNet	CC	GO:0005811	lipid droplet	-	102	81	-	-	2.09E-03	4.65E-03
MultiNet	CC	GO:0045022	early endosome to late endosome transport	-	44	40	-	-	2.83E-02	2.29E-03
MultiNet	CC	GO:0043113	receptor clustering	-	51	47	-	-	2.36E-02	2.72E-03
MultiNet	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	17	-	-	2.86E-04	1.00E-03
MultiNet	CC	GO:0044853	plasma membrane raft	-	114	97	-	-	9.07E-03	5.58E-03
MultiNet	CC	GO:0005881	cytoplasmic microtubule	-	256	158	-	-	4.75E-03	9.09E-03
MultiNet	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	13	-	-	2.14E-04	7.87E-04
MultiNet	CC	GO:0008180	COP9 signalosome	-	17	16	-	-	4.68E-02	9.31E-04
MultiNet	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	49	-	-	5.84E-02	2.86E-03
MultiNet	CC	GO:0005905	clathrin-coated pit	-	73	67	-	-	1.54E-02	3.87E-03
MultiNet	CC	GO:0099569	presynaptic cytoskeleton	-	12	11	-	-	3.46E-02	6.44E-04
MultiNet	CC	GO:0043034	costamere	-	18	17	-	-	2.67E-03	1.00E-03
MultiNet	CC	GO:0031904	endosome lumen	-	38	32	-	-	1.56E-02	1.86E-03
MultiNet	CC	GO:0060170	ciliary membrane	-	76	48	-	-	1.39E-02	2.79E-03
MultiNet	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	12	-	-	3.86E-01	7.16E-04
MultiNet	CC	GO:0000783	nuclear telomere cap complex	-	12	11	-	-	5.73E-02	6.44E-04
MultiNet	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	27	-	-	2.59E-01	1.57E-03
MultiNet	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	14	-	-	3.75E-01	8.59E-04
MultiNet	CC	GO:0032154	cleavage furrow	-	54	47	-	-	8.25E-03	2.72E-03
MultiNet	CC	GO:0005640	nuclear outer membrane	-	30	27	-	-	8.14E-03	1.57E-03
MultiNet	CC	GO:0005652	nuclear lamina	-	12	12	-	-	2.30E-03	7.16E-04
MultiNet	CC	GO:0007006	mitochondrial membrane organization	-	117	102	-	-	1.36E-02	5.87E-03
MultiNet	CC	GO:0001772	immunological synapse	-	44	43	-	-	5.47E-03	2.51E-03
MultiNet	CC	GO:0030904	retromer complex	-	12	11	-	-	1.89E-01	6.44E-04
MultiNet	CC	GO:0030863	cortical cytoskeleton	-	104	95	-	-	7.90E-03	5.44E-03
MultiNet	CC	GO:1905348	endonuclease complex	-	38	37	-	-	1.78E-01	2.15E-03
MultiNet	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	2.83E-04	1.07E-03
MultiNet	CC	GO:0030315	T-tubule	-	52	39	-	-	7.31E-02	2.29E-03
MultiNet	CC	GO:0060076	excitatory synapse	-	64	44	-	-	1.69E-02	2.58E-03
MultiNet	CC	GO:0036019	endolysosome	-	29	27	-	-	2.06E-03	1.57E-03
MultiNet	CC	GO:0001891	phagocytic cup	-	28	20	-	-	1.05E-02	1.15E-03
MultiNet	CC	GO:0099086	synaptonemal structure	-	40	25	-	-	3.03E-02	1.43E-03
MultiNet	CC	GO:0030427	site of polarized growth	-	172	148	-	-	1.09E-02	8.52E-03
MultiNet	CC	GO:0044309	neuron spine	-	213	177	-	-	1.48E-02	1.02E-02
MultiNet	CC	GO:0030658	transport vesicle membrane	-	231	185	-	-	2.80E-02	1.06E-02
MultiNet	CC	GO:0098918	structural constituent of synapse	-	27	26	-	-	5.33E-03	1.50E-03
MultiNet	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	11	-	-	1.16E-01	6.44E-04
MultiNet	CC	GO:0000940	outer kinetochore	-	17	17	-	-	7.18E-02	1.00E-03
MultiNet	CC	GO:0034719	SMN-Sm protein complex	-	18	16	-	-	3.31E-01	9.31E-04
MultiNet	CC	GO:0044232	organelle membrane contact site	-	50	39	-	-	4.72E-03	2.29E-03
MultiNet	CC	GO:0098803	respiratory chain complex	-	39	25	-	-	1.19E-02	1.43E-03
MultiNet	CC	GO:0030667	secretory granule membrane	-	319	243	-	-	1.01E-02	1.40E-02
MultiNet	CC	GO:0097545	axonemal outer doublet	-	164	93	-	-	1.66E-03	5.37E-03
MultiNet	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	14	-	-	8.91E-04	8.59E-04
MultiNet	CC	GO:0070069	cytochrome complex	-	42	28	-	-	4.91E-02	1.65E-03
MultiNet	CC	GO:0031143	pseudopodium	-	18	18	-	-	3.20E-02	1.07E-03
MultiNet	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	26	-	-	2.69E-02	1.50E-03
MultiNet	CC	GO:0055037	recycling endosome	-	200	168	-	-	3.19E-02	9.66E-03
MultiNet	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	82	-	-	1.81E-02	4.72E-03
MultiNet	CC	GO:0030126	COPI vesicle coat	-	13	12	-	-	2.99E-01	7.16E-04
MultiNet	CC	GO:0035253	ciliary rootlet	-	13	11	-	-	1.63E-02	6.44E-04
MultiNet	CC	GO:0071682	endocytic vesicle lumen	-	23	21	-	-	7.68E-03	1.22E-03
MultiNet	CC	GO:0030684	preribosome	-	76	73	-	-	2.05E-02	4.22E-03
MultiNet	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	17	-	-	9.46E-02	1.00E-03
MultiNet	CC	GO:1990391	DNA repair complex	-	22	22	-	-	2.83E-02	1.29E-03
MultiNet	CC	GO:0005775	vacuolar lumen	-	176	143	-	-	6.53E-03	8.23E-03
MultiNet	CC	GO:0032433	filopodium tip	-	19	16	-	-	4.11E-03	9.31E-04
MultiNet	CC	GO:0032982	myosin filament	-	24	19	-	-	2.85E-04	1.15E-03
MultiNet	CC	GO:0016327	apicolateral plasma membrane	-	23	21	-	-	8.61E-03	1.22E-03
MultiNet	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	18	-	-	3.12E-02	1.07E-03
MultiNet	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	11	-	-	2.13E-04	6.44E-04
MultiNet	CC	GO:0044306	neuron projection terminus	-	164	135	-	-	5.94E-03	7.73E-03
MultiNet	CC	GO:0034455	t-UTP complex	-	53	50	-	-	2.66E-02	2.86E-03
MultiNet	CC	GO:0005770	late endosome	-	299	237	-	-	1.63E-02	1.36E-02
MultiNet	CC	GO:0030992	intraciliary transport particle B	-	17	11	-	-	2.14E-04	6.44E-04
MultiNet	CC	GO:0031970	organelle envelope lumen	-	94	85	-	-	5.66E-03	4.87E-03
MultiNet	CC	GO:0097550	transcription preinitiation complex	-	13	11	-	-	1.80E-03	6.44E-04
MultiNet	CC	GO:0120293	dynein axonemal particle	-	20	13	-	-	6.88E-04	7.87E-04
MultiNet	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	23	-	-	3.80E-03	1.36E-03
MultiNet	CC	GO:0043292	contractile muscle fiber	-	245	207	-	-	5.70E-02	1.19E-02
MultiNet	CC	GO:0018995	host cellular component	-	12	11	-	-	1.20E-01	6.44E-04
MultiNet	CC	GO:0034709	methylosome	-	13	12	-	-	8.25E-02	7.16E-04
MultiNet	CC	GO:0032426	stereocilium tip	-	21	12	-	-	7.35E-02	7.16E-04
MultiNet	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	2.17E-02	7.16E-04
MultiNet	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	9.80E-02	1.15E-03
MultiNet	CC	GO:0000803	sex chromosome	-	32	28	-	-	2.03E-03	1.65E-03
MultiNet	CC	GO:0098982	GABA-ergic synapse	-	84	58	-	-	1.89E-03	3.36E-03
MultiNet	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	14	-	-	5.20E-03	8.59E-04
MultiNet	CC	GO:0035097	histone methyltransferase complex	-	63	60	-	-	9.72E-03	3.44E-03
MultiNet	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	4.95E-02	8.59E-04
MultiNet	CC	GO:0000242	pericentriolar material	-	22	19	-	-	9.16E-03	1.15E-03
MultiNet	CC	GO:1903293	phosphatase complex	-	54	48	-	-	6.77E-02	2.79E-03
MultiNet	CC	GO:0097470	ribbon synapse	-	13	12	-	-	1.13E-03	7.16E-04
MultiNet	CC	GO:0031941	filamentous actin	-	27	21	-	-	3.52E-04	1.22E-03
MultiNet	CC	GO:0000786	nucleosome	-	149	129	-	-	2.10E-02	7.45E-03
MultiNet	CC	GO:0001533	cornified envelope	-	59	43	-	-	3.30E-01	2.51E-03
MultiNet	CC	GO:1904724	tertiary granule lumen	-	55	44	-	-	1.23E-02	2.58E-03
MultiNet	CC	GO:0030027	lamellipodium	-	202	181	-	-	2.20E-02	1.04E-02
MultiNet	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	14	-	-	1.10E-03	8.59E-04
MultiNet	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	19	-	-	2.86E-04	1.15E-03
MultiNet	CC	GO:0000800	lateral element	-	14	12	-	-	1.41E-02	7.16E-04
MultiNet	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	11	-	-	2.13E-04	6.44E-04
MultiNet	CC	GO:0060077	inhibitory synapse	-	20	16	-	-	4.31E-03	9.31E-04
MultiNet	CC	GO:0031209	SCAR complex	-	12	11	-	-	1.81E-02	6.44E-04
MultiNet	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	5.69E-02	9.31E-04
MultiNet	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	16	-	-	2.85E-04	9.31E-04
MultiNet	CC	GO:0002102	podosome	-	31	27	-	-	3.14E-03	1.57E-03
MultiNet	CC	GO:0090543	Flemming body	-	33	29	-	-	3.35E-03	1.72E-03
MultiNet	CC	GO:0016328	lateral plasma membrane	-	66	58	-	-	8.51E-03	3.36E-03
MultiNet	CC	GO:0001650	fibrillar center	-	151	140	-	-	2.90E-03	8.02E-03
MultiNet	CC	GO:0031332	RNAi effector complex	-	413	19	-	-	2.69E-02	1.15E-03
MultiNet	CC	GO:1990204	oxidoreductase complex	-	90	66	-	-	2.38E-02	3.79E-03
MultiNet	CC	GO:0000930	gamma-tubulin complex	-	16	15	-	-	4.07E-03	8.59E-04
MultiNet	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	114	-	-	1.08E-02	6.59E-03
MultiNet	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	14	-	-	4.60E-02	8.59E-04
MultiNet	CC	GO:0001726	ruffle	-	181	162	-	-	1.49E-02	9.31E-03
MultiNet	CC	GO:1990909	Wnt signalosome	-	13	11	-	-	1.11E-02	6.44E-04
MultiNet	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	17	-	-	9.41E-02	1.00E-03
MultiNet	CC	GO:0043198	dendritic shaft	-	38	28	-	-	1.41E-03	1.65E-03
MultiNet	CC	GO:0043073	germ cell nucleus	-	67	58	-	-	1.67E-03	3.36E-03
MultiNet	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	20	-	-	1.03E-03	1.15E-03
MultiNet	CC	GO:0005788	endoplasmic reticulum lumen	-	313	242	-	-	2.02E-02	1.39E-02
MultiNet	CC	GO:0016592	mediator complex	-	38	37	-	-	4.12E-01	2.15E-03
MultiNet	CC	GO:0034045	phagophore assembly site membrane	-	19	18	-	-	9.26E-02	1.07E-03
MultiNet	CC	GO:0022626	cytosolic ribosome	-	118	109	-	-	2.48E-02	6.30E-03
MultiNet	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	41	-	-	1.25E-01	2.36E-03
MultiNet	CC	GO:0034451	centriolar satellite	-	120	101	-	-	4.80E-03	5.80E-03
MultiNet	CC	GO:0045171	intercellular bridge	-	91	77	-	-	2.22E-03	4.44E-03
MultiNet	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	61	-	-	4.86E-02	3.51E-03
MultiNet	CC	GO:0008250	oligosaccharyltransferase complex	-	14	11	-	-	2.14E-04	6.44E-04
MultiNet	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.42E-01	6.44E-04
MultiNet	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	2.14E-04	6.44E-04
MultiNet	CC	GO:0044292	dendrite terminus	-	13	12	-	-	5.05E-03	7.16E-04
MultiNet	CC	GO:0032039	integrator complex	-	19	16	-	-	6.06E-01	9.31E-04
MultiNet	CC	GO:0033268	node of Ranvier	-	16	15	-	-	7.90E-02	8.59E-04
MultiNet	CC	GO:0030527	structural constituent of chromatin	-	97	81	-	-	3.91E-03	4.65E-03
MultiNet	CC	GO:0036379	myofilament	-	26	17	-	-	6.46E-02	1.00E-03
MultiNet	CC	GO:0030286	dynein complex	-	210	127	-	-	8.70E-03	7.30E-03
MultiNet	CC	GO:0097228	sperm principal piece	-	33	18	-	-	5.80E-02	1.07E-03
MultiNet	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	2.87E-02	7.16E-04
MultiNet	CC	GO:0016482	cytosolic transport	-	135	112	-	-	1.21E-02	6.44E-03
MultiNet	CC	GO:0090665	glycoprotein complex	-	23	19	-	-	7.56E-02	1.15E-03
MultiNet	CC	GO:0005796	Golgi lumen	-	106	76	-	-	1.99E-02	4.37E-03
MultiNet	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	34	-	-	6.88E-02	2.00E-03
MultiNet	CC	GO:0034358	plasma lipoprotein particle	-	36	33	-	-	7.90E-02	1.93E-03
MultiNet	CC	GO:0008023	transcription elongation factor complex	-	47	45	-	-	9.76E-02	2.58E-03
MultiNet	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	19	-	-	1.42E-03	1.15E-03
MultiNet	CC	GO:0030662	coated vesicle membrane	-	202	177	-	-	2.72E-02	1.02E-02
MultiNet	CC	GO:0007039	protein catabolic process in the vacuole	-	61	48	-	-	6.19E-02	2.79E-03
MultiNet	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	57	-	-	4.84E-02	3.29E-03
MultiNet	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	247	-	-	1.91E-02	1.42E-02
MultiNet	CC	GO:0090734	site of DNA damage	-	118	110	-	-	1.18E-02	6.30E-03
MultiNet	MF	GO:0051861	glycolipid binding	-	30	23	-	-	1.84E-03	1.36E-03
MultiNet	MF	GO:0051087	protein-folding chaperone binding	-	135	119	-	-	7.28E-03	6.87E-03
MultiNet	MF	GO:0051959	dynein light intermediate chain binding	-	27	16	-	-	2.01E-02	9.31E-04
MultiNet	CC	GO:0015464	acetylcholine receptor activity	-	21	12	-	-	2.34E-01	7.16E-04
MultiNet	MF	GO:0016594	glycine binding	-	12	12	-	-	1.79E-01	7.16E-04
MultiNet	MF	GO:0031681	G-protein beta-subunit binding	-	22	18	-	-	2.85E-04	1.07E-03
MultiNet	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	33	-	-	7.01E-04	1.93E-03
MultiNet	MF	GO:0035613	RNA stem-loop binding	-	21	14	-	-	2.10E-04	8.59E-04
MultiNet	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	207	-	-	9.75E-03	1.19E-02
MultiNet	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	16	-	-	2.82E-04	9.31E-04
MultiNet	MF	GO:0033691	sialic acid binding	-	22	17	-	-	1.12E-02	1.00E-03
MultiNet	MF	GO:0016757	glycosyltransferase activity	-	286	179	-	-	1.23E-02	1.03E-02
MultiNet	MF	GO:0048306	calcium-dependent protein binding	-	61	59	-	-	3.66E-02	3.44E-03
MultiNet	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	24	-	-	1.25E-02	1.43E-03
MultiNet	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	6.49E-02	7.87E-04
MultiNet	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	105	-	-	1.76E-02	6.01E-03
MultiNet	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	55	-	-	2.73E-02	3.15E-03
MultiNet	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	115	-	-	6.19E-02	6.59E-03
MultiNet	MF	GO:0045504	dynein heavy chain binding	-	16	12	-	-	2.14E-04	7.16E-04
MultiNet	MF	GO:0140457	protein demethylase activity	-	31	27	-	-	3.00E-03	1.57E-03
MultiNet	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	1.35E-02	1.29E-03
MultiNet	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	5.19E-03	8.59E-04
MultiNet	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	1.34E-01	8.59E-04
MultiNet	MF	GO:0061980	regulatory RNA binding	-	52	43	-	-	4.64E-02	2.51E-03
MultiNet	MF	GO:0015035	protein-disulfide reductase activity	-	32	30	-	-	1.23E-02	1.72E-03
MultiNet	MF	GO:0001671	ATPase activator activity	-	29	26	-	-	4.24E-04	1.50E-03
MultiNet	MF	GO:0070840	dynein complex binding	-	25	21	-	-	3.00E-03	1.22E-03
MultiNet	MF	GO:0035035	histone acetyltransferase binding	-	24	23	-	-	1.21E-03	1.36E-03
MultiNet	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.93E-03	9.31E-04
MultiNet	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	30	-	-	2.82E-02	1.72E-03
MultiNet	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	4.16E-02	1.07E-03
MultiNet	MF	GO:0005178	integrin binding	-	153	136	-	-	3.04E-02	7.80E-03
MultiNet	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	8.09E-04	1.00E-03
MultiNet	MF	GO:0042043	neurexin family protein binding	-	14	12	-	-	2.14E-04	7.16E-04
MultiNet	MF	GO:0008327	methyl-CpG binding	-	31	22	-	-	1.06E-02	1.29E-03
MultiNet	MF	GO:0031418	L-ascorbic acid binding	-	20	18	-	-	9.47E-03	1.07E-03
MultiNet	MF	GO:0048019	receptor antagonist activity	-	31	16	-	-	2.84E-04	9.31E-04
MultiNet	MF	GO:0005521	lamin binding	-	15	14	-	-	1.12E-02	8.59E-04
MultiNet	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	1.07E-03	1.15E-03
MultiNet	MF	GO:0140318	protein transporter activity	-	40	36	-	-	2.09E-02	2.08E-03
MultiNet	MF	GO:0070628	proteasome binding	-	17	15	-	-	4.15E-03	8.59E-04
MultiNet	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	1.60E-03	6.44E-04
MultiNet	MF	GO:0031432	titin binding	-	13	13	-	-	3.94E-03	7.87E-04
MultiNet	MF	GO:0000217	DNA secondary structure binding	-	37	33	-	-	2.06E-02	1.93E-03
MultiNet	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	15	-	-	2.86E-02	8.59E-04
MultiNet	MF	GO:0002039	p53 binding	-	66	64	-	-	2.28E-03	3.72E-03
MultiNet	MF	GO:0005496	steroid binding	-	110	92	-	-	1.24E-02	5.30E-03
MultiNet	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	8.45E-02	1.57E-03
MultiNet	MF	GO:0003684	damaged DNA binding	-	89	84	-	-	1.48E-02	4.87E-03
MultiNet	MF	GO:0000339	RNA cap binding	-	20	18	-	-	2.80E-02	1.07E-03
MultiNet	MF	GO:0016500	protein-hormone receptor activity	-	21	13	-	-	7.34E-03	7.87E-04
MultiNet	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	110	-	-	2.40E-02	6.30E-03
MultiNet	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	2.14E-04	6.44E-04
MultiNet	MF	GO:0070063	RNA polymerase binding	-	61	58	-	-	6.13E-03	3.36E-03
MultiNet	MF	GO:0050811	GABA receptor binding	-	18	15	-	-	1.38E-02	8.59E-04
MultiNet	MF	GO:0030971	receptor tyrosine kinase binding	-	76	70	-	-	3.59E-03	4.01E-03
MultiNet	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	76	-	-	5.21E-02	4.37E-03
MultiNet	MF	GO:0140030	modification-dependent protein binding	-	179	154	-	-	4.24E-03	8.88E-03
MultiNet	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	19	-	-	1.30E-02	1.15E-03
MultiNet	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.20E-03	7.87E-04
MultiNet	MF	GO:0042813	Wnt receptor activity	-	16	15	-	-	3.90E-03	8.59E-04
MultiNet	MF	GO:0141047	molecular tag activity	-	13	13	-	-	5.87E-04	7.87E-04
MultiNet	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	9.16E-04	8.59E-04
MultiNet	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	4.43E-03	7.16E-04
MultiNet	MF	GO:0044548	S100 protein binding	-	14	14	-	-	6.24E-02	8.59E-04
MultiNet	MF	GO:0010851	cyclase regulator activity	-	17	13	-	-	4.27E-03	7.87E-04
MultiNet	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	3.13E-02	8.59E-04
MultiNet	MF	GO:0030276	clathrin binding	-	70	61	-	-	5.02E-02	3.51E-03
MultiNet	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	6.95E-03	1.72E-03
MultiNet	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	7.29E-04	8.59E-04
MultiNet	MF	GO:0046790	virion binding	-	19	16	-	-	3.94E-02	9.31E-04
MultiNet	MF	GO:0030552	cAMP binding	-	48	40	-	-	5.70E-02	2.29E-03
MultiNet	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	36	-	-	2.05E-03	2.08E-03
MultiNet	MF	GO:0035173	histone kinase activity	-	17	17	-	-	4.24E-04	1.00E-03
MultiNet	MF	GO:0097602	cullin family protein binding	-	26	23	-	-	1.77E-02	1.36E-03
MultiNet	MF	GO:0016209	antioxidant activity	-	92	76	-	-	4.65E-02	4.37E-03
MultiNet	MF	GO:0070325	lipoprotein particle receptor binding	-	32	29	-	-	3.95E-03	1.72E-03
MultiNet	MF	GO:0044325	transmembrane transporter binding	-	159	133	-	-	8.15E-03	7.66E-03
MultiNet	MF	GO:0048156	tau protein binding	-	43	43	-	-	4.52E-03	2.51E-03
MultiNet	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	35	-	-	2.73E-03	2.00E-03
MultiNet	MF	GO:0045295	gamma-catenin binding	-	13	12	-	-	7.13E-03	7.16E-04
MultiNet	MF	GO:0140272	exogenous protein binding	-	79	70	-	-	8.98E-03	4.01E-03
MultiNet	MF	GO:0030145	manganese ion binding	-	65	47	-	-	3.97E-03	2.72E-03
MultiNet	MF	GO:0071814	protein-lipid complex binding	-	52	37	-	-	3.53E-02	2.15E-03
MultiNet	MF	GO:0008066	glutamate receptor activity	-	70	53	-	-	7.02E-02	3.08E-03
MultiNet	MF	GO:0030553	cGMP binding	-	15	11	-	-	2.14E-04	6.44E-04
MultiNet	MF	GO:0017069	snRNA binding	-	54	48	-	-	2.77E-02	2.79E-03
MultiNet	MF	GO:0030215	semaphorin receptor binding	-	23	15	-	-	4.47E-02	8.59E-04
MultiNet	MF	GO:0031996	thioesterase binding	-	11	11	-	-	2.12E-03	6.44E-04
MultiNet	MF	GO:0031369	translation initiation factor binding	-	32	29	-	-	5.21E-02	1.72E-03
MultiNet	MF	GO:0019843	rRNA binding	-	69	64	-	-	3.81E-03	3.72E-03
MultiNet	MF	GO:0004713	protein tyrosine kinase activity	-	213	196	-	-	1.41E-02	1.12E-02
MultiNet	MF	GO:0016779	nucleotidyltransferase activity	-	264	237	-	-	1.42E-02	1.36E-02
MultiNet	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	50	-	-	7.56E-03	2.86E-03
MultiNet	MF	GO:0008093	cytoskeletal anchor activity	-	24	21	-	-	4.76E-03	1.22E-03
MultiNet	MF	GO:0070300	phosphatidic acid binding	-	20	16	-	-	3.53E-03	9.31E-04
MultiNet	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	25	-	-	3.51E-02	1.43E-03
MultiNet	MF	GO:0016208	AMP binding	-	22	20	-	-	1.69E-02	1.15E-03
MultiNet	MF	GO:0000287	magnesium ion binding	-	225	193	-	-	7.10E-03	1.11E-02
MultiNet	MF	GO:0031490	chromatin DNA binding	-	120	110	-	-	5.14E-03	6.30E-03
MultiNet	MF	GO:0017022	myosin binding	-	73	62	-	-	5.77E-03	3.58E-03
MultiNet	MF	GO:0004896	cytokine receptor activity	-	93	76	-	-	8.85E-03	4.37E-03
MultiNet	MF	GO:0017166	vinculin binding	-	12	12	-	-	5.29E-03	7.16E-04
MultiNet	MF	GO:0008301	"DNA binding, bending"	-	18	16	-	-	2.81E-04	9.31E-04
MultiNet	MF	GO:1990459	transferrin receptor binding	-	12	11	-	-	5.76E-03	6.44E-04
MultiNet	MF	GO:0005539	glycosaminoglycan binding	-	236	164	-	-	1.47E-02	9.45E-03
MultiNet	MF	GO:0140666	annealing activity	-	11	11	-	-	1.44E-03	6.44E-04
MultiNet	MF	GO:0071933	Arp2/3 complex binding	-	14	11	-	-	2.14E-04	6.44E-04
MultiNet	MF	GO:0019207	kinase regulator activity	-	267	245	-	-	9.83E-03	1.40E-02
MultiNet	MF	GO:0010181	FMN binding	-	15	12	-	-	1.10E-02	7.16E-04
MultiNet	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	16	-	-	2.83E-04	9.31E-04
MultiNet	MF	GO:0031420	alkali metal ion binding	-	17	13	-	-	2.11E-04	7.87E-04
MultiNet	MF	GO:0044183	protein folding chaperone	-	67	57	-	-	3.19E-03	3.29E-03
MultiNet	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	104	-	-	1.44E-02	6.01E-03
MultiNet	MF	GO:0003725	double-stranded RNA binding	-	72	66	-	-	7.92E-03	3.79E-03
MultiNet	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	2.44E-01	9.31E-04
MultiNet	MF	GO:0051018	protein kinase A binding	-	52	47	-	-	7.89E-02	2.72E-03
MultiNet	MF	GO:0071889	14-3-3 protein binding	-	34	32	-	-	3.27E-03	1.86E-03
MultiNet	MF	GO:0004618	phosphoglycerate kinase activity	-	89	82	-	-	8.92E-03	4.72E-03
MultiNet	MF	GO:0042805	actinin binding	-	36	32	-	-	1.05E-03	1.86E-03
MultiNet	MF	GO:0043531	ADP binding	-	38	37	-	-	2.70E-03	2.15E-03
MultiNet	MF	GO:0043394	proteoglycan binding	-	36	27	-	-	8.29E-03	1.57E-03
MultiNet	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	3.97E-03	6.44E-04
MultiNet	MF	GO:0046332	SMAD binding	-	77	74	-	-	6.40E-03	4.30E-03
MultiNet	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.58E-03	7.87E-04
MultiNet	MF	GO:0001968	fibronectin binding	-	30	29	-	-	9.39E-03	1.72E-03
MultiNet	MF	GO:0048038	quinone binding	-	16	13	-	-	1.53E-02	7.87E-04
MultiNet	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	107	-	-	3.17E-02	6.16E-03
MultiNet	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	70	-	-	1.14E-03	4.01E-03
MultiNet	MF	GO:0003756	protein disulfide isomerase activity	-	18	16	-	-	2.85E-04	9.31E-04
MultiNet	MF	GO:0051117	ATPase binding	-	85	74	-	-	4.55E-03	4.30E-03
MultiNet	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	42	-	-	3.51E-03	2.43E-03
MultiNet	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	1.04E-02	1.15E-03
MultiNet	MF	GO:0070402	NADPH binding	-	16	13	-	-	2.13E-04	7.87E-04
MultiNet	MF	GO:0031404	chloride ion binding	-	14	12	-	-	2.14E-04	7.16E-04
MultiNet	MF	GO:0001098	basal transcription machinery binding	-	61	59	-	-	3.93E-03	3.44E-03
MultiNet	MF	GO:0036002	pre-mRNA binding	-	57	37	-	-	3.68E-03	2.15E-03
MultiNet	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	28	-	-	4.22E-04	1.65E-03
MultiNet	MF	GO:0051540	metal cluster binding	-	71	61	-	-	4.08E-03	3.51E-03
MultiNet	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	1.49E-03	6.44E-04
MultiNet	MF	GO:0051219	phosphoprotein binding	-	92	90	-	-	6.78E-03	5.15E-03
MultiNet	MF	GO:0019894	kinesin binding	-	45	40	-	-	7.84E-03	2.29E-03
MultiNet	MF	GO:0042287	MHC protein binding	-	68	46	-	-	1.80E-02	2.65E-03
MultiNet	MF	GO:0019003	GDP binding	-	89	78	-	-	1.68E-02	4.51E-03
MultiNet	MF	GO:0017171	serine hydrolase activity	-	207	114	-	-	6.09E-03	6.59E-03
MultiNet	MF	GO:0097110	scaffold protein binding	-	66	62	-	-	5.81E-03	3.58E-03
MultiNet	MF	GO:0003774	cytoskeletal motor activity	-	117	89	-	-	1.20E-02	5.15E-03
MultiNet	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	28	-	-	5.14E-03	1.65E-03
MultiNet	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	16	-	-	2.84E-04	9.31E-04
MultiNet	MF	GO:0061134	peptidase regulator activity	-	224	142	-	-	1.90E-02	8.16E-03
MultiNet	MF	GO:0008013	beta-catenin binding	-	86	76	-	-	4.94E-03	4.37E-03
MultiNet	MF	GO:0051015	actin filament binding	-	208	168	-	-	1.38E-02	9.66E-03
MultiNet	MF	GO:0019208	phosphatase regulator activity	-	107	87	-	-	7.54E-03	5.01E-03
MultiNet	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	27	-	-	4.06E-03	1.57E-03
MultiNet	MF	GO:0043236	laminin binding	-	29	26	-	-	8.27E-03	1.50E-03
MultiNet	MF	GO:0030507	spectrin binding	-	26	20	-	-	1.62E-02	1.15E-03
MultiNet	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	38	-	-	2.40E-02	2.22E-03
MultiNet	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	99	-	-	2.07E-02	5.73E-03
MultiNet	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	9.26E-04	1.43E-03
MultiNet	MF	GO:0042393	histone binding	-	240	205	-	-	6.56E-03	1.17E-02
MultiNet	MF	GO:0019838	growth factor binding	-	182	163	-	-	2.13E-02	9.38E-03
MultiNet	MF	GO:0000149	SNARE binding	-	107	93	-	-	2.33E-01	5.37E-03
MultiNet	MF	GO:0003727	single-stranded RNA binding	-	90	75	-	-	5.35E-03	4.30E-03
MultiNet	MF	GO:0051378	serotonin binding	-	24	15	-	-	7.49E-02	8.59E-04
MultiNet	MF	GO:0005516	calmodulin binding	-	206	177	-	-	6.41E-03	1.02E-02
MultiNet	MF	GO:0019825	oxygen binding	-	40	29	-	-	2.04E-03	1.72E-03
MultiNet	MF	GO:0045505	dynein intermediate chain binding	-	37	23	-	-	3.53E-04	1.36E-03
MultiNet	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	67	-	-	5.08E-03	3.87E-03
MultiNet	MF	GO:0032182	ubiquitin-like protein binding	-	117	112	-	-	7.58E-03	6.44E-03
MultiNet	MF	GO:0023023	MHC protein complex binding	-	36	32	-	-	4.31E-02	1.86E-03
MultiNet	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	1.78E-03	1.29E-03
MultiNet	MF	GO:0043274	phospholipase binding	-	23	19	-	-	2.14E-03	1.15E-03
MultiNet	MF	GO:0031072	heat shock protein binding	-	128	116	-	-	8.26E-03	6.66E-03
MultiNet	MF	GO:0030515	snoRNA binding	-	33	30	-	-	5.26E-03	1.72E-03
MultiNet	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	52	-	-	3.72E-03	3.01E-03
MultiNet	MF	GO:0001965	G-protein alpha-subunit binding	-	26	21	-	-	3.55E-04	1.22E-03
MultiNet	MF	GO:0001530	lipopolysaccharide binding	-	38	23	-	-	3.66E-02	1.36E-03
MultiNet	MF	GO:0140223	general transcription initiation factor activity	-	55	51	-	-	1.14E-01	2.94E-03
MultiNet	MF	GO:0070403	NAD+ binding	-	16	14	-	-	4.81E-03	8.59E-04
MultiNet	MF	GO:0000049	tRNA binding	-	75	65	-	-	4.61E-03	3.72E-03
MultiNet	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	45	-	-	3.20E-03	2.58E-03
MultiNet	MF	GO:0015026	coreceptor activity	-	48	39	-	-	1.56E-02	2.29E-03
MultiNet	MF	GO:0005527	macrolide binding	-	12	12	-	-	2.14E-04	7.16E-04
MultiNet	MF	GO:0001653	peptide receptor activity	-	128	89	-	-	2.63E-02	5.15E-03
MultiNet	MF	GO:0031005	filamin binding	-	15	11	-	-	2.12E-04	6.44E-04
MultiNet	MF	GO:0030506	ankyrin binding	-	19	18	-	-	2.84E-04	1.07E-03
MultiNet	MF	GO:0006469	negative regulation of protein kinase activity	-	222	201	-	-	7.02E-03	1.15E-02
MultiNet	MF	GO:0070182	DNA polymerase binding	-	22	22	-	-	1.34E-03	1.29E-03
MultiNet	MF	GO:1901611	phosphatidylglycerol binding	-	15	12	-	-	9.29E-03	7.16E-04
MultiNet	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	27	-	-	2.51E-02	1.57E-03
MultiNet	MF	GO:0051427	hormone receptor binding	-	31	24	-	-	1.48E-03	1.43E-03
MultiNet	MF	GO:0070851	growth factor receptor binding	-	141	119	-	-	1.13E-02	6.87E-03
MultiNet	MF	GO:0031210	phosphatidylcholine binding	-	32	25	-	-	6.81E-03	1.43E-03
MultiNet	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	40	-	-	4.33E-03	2.29E-03
MultiNet	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	246	-	-	8.29E-03	1.41E-02
MultiNet	MF	GO:0034185	apolipoprotein binding	-	20	19	-	-	6.36E-03	1.15E-03
MultiNet	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	16	-	-	2.83E-04	9.31E-04
MultiNet	MF	GO:0051346	negative regulation of hydrolase activity	-	332	234	-	-	6.04E-03	1.35E-02
MultiNet	MF	GO:0005506	iron ion binding	-	154	116	-	-	1.63E-02	6.66E-03
MultiNet	MF	GO:0003925	G protein activity	-	45	36	-	-	4.13E-03	2.08E-03
MultiNet	MF	GO:0038187	pattern recognition receptor activity	-	33	24	-	-	7.03E-02	1.43E-03
MultiNet	MF	GO:0008276	protein methyltransferase activity	-	96	80	-	-	1.92E-02	4.58E-03
MultiNet	MF	GO:0004396	hexokinase activity	-	16	13	-	-	5.73E-02	7.87E-04
MultiNet	MF	GO:0070888	E-box binding	-	59	55	-	-	1.72E-03	3.15E-03
MultiNet	MF	GO:0039706	co-receptor binding	-	14	11	-	-	3.63E-02	6.44E-04
MultiNet	MF	GO:0015399	primary active transmembrane transporter activity	-	190	137	-	-	2.37E-02	7.87E-03
MultiNet	MF	GO:0035254	glutamate receptor binding	-	47	40	-	-	3.70E-03	2.29E-03
MultiNet	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	3.46E-03	1.93E-03
MultiNet	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	2.62E-02	6.44E-04
MultiNet	MF	GO:0043021	ribonucleoprotein complex binding	-	158	146	-	-	7.60E-03	8.38E-03
MultiNet	MF	GO:0030170	pyridoxal phosphate binding	-	56	47	-	-	2.01E-02	2.72E-03
MultiNet	MF	GO:0005112	Notch binding	-	26	20	-	-	1.67E-02	1.15E-03
MultiNet	MF	GO:0048185	activin binding	-	16	16	-	-	5.69E-02	9.31E-04
MultiNet	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	24	-	-	2.72E-02	1.43E-03
MultiNet	MF	GO:0001664	G protein-coupled receptor binding	-	299	229	-	-	7.83E-03	1.32E-02
MultiNet	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	2.14E-04	6.44E-04
MultiNet	MF	GO:0140299	small molecule sensor activity	-	39	31	-	-	6.56E-02	1.79E-03
MultiNet	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	20	-	-	2.30E-03	1.15E-03
MultiNet	MF	GO:0016917	GABA receptor activity	-	23	12	-	-	3.35E-02	7.16E-04
MultiNet	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	14	-	-	6.76E-03	8.59E-04
MultiNet	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	18	-	-	2.84E-04	1.07E-03
MultiNet	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	39	-	-	4.60E-03	2.29E-03
MultiNet	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	24	-	-	9.52E-04	1.43E-03
MultiNet	MF	GO:0030594	neurotransmitter receptor activity	-	160	106	-	-	6.11E-02	6.08E-03
MultiNet	MF	GO:0034452	dynactin binding	-	12	11	-	-	2.11E-04	6.44E-04
MultiNet	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	1.35E-01	1.43E-03
MultiNet	MF	GO:0120227	acyl-CoA binding	-	22	19	-	-	2.55E-02	1.15E-03
MultiNet	MF	GO:0005507	copper ion binding	-	63	52	-	-	2.11E-02	3.01E-03
MultiNet	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	5.40E-03	1.29E-03
MultiNet	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	9.83E-02	1.29E-03
MultiNet	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	11	-	-	4.88E-03	6.44E-04
PathwayCommons	CC	GO:0005615	extracellular space	2.27E-14	3190	3136	3067	1.02	-	-
PathwayCommons	CC	GO:0005783	endoplasmic reticulum	6.26E-11	2020	1990	1942	1.02	-	-
PathwayCommons	CC	GO:0005768	endosome	7.45E-11	1037	1030	997	1.03	-	-
PathwayCommons	CC	GO:0005815	microtubule organizing center	6.71E-08	843	836	810	1.03	-	-
PathwayCommons	CC	GO:0005764	lysosome	2.94E-07	747	741	718	1.03	-	-
PathwayCommons	CC	GO:0005794	Golgi apparatus	1.56E-05	1636	1603	1573	1.02	-	-
PathwayCommons	CC	GO:0005635	nuclear envelope	4.41E-05	493	489	474	1.03	-	-
PathwayCommons	CC	GO:0005739	mitochondrion	6.12E-05	1671	1635	1606	1.02	-	-
PathwayCommons	CC	GO:0031012	extracellular matrix	3.30E-04	564	557	542	1.03	-	-
PathwayCommons	CC	GO:0005730	nucleolus	6.41E-04	988	969	950	1.02	-	-
PathwayCommons	CC	GO:0005840	ribosome	2.55E-03	222	221	213	1.04	-	-
PathwayCommons	CC	GO:0000228	nuclear chromosome	2.68E-02	206	204	198	1.03	-	-
PathwayCommons	CC	GO:0005811	lipid droplet	3.50E-02	102	102	98	1.04	-	-
PathwayCommons	CC	GO:0005777	peroxisome	3.81E-01	142	139	137	1.02	-	-
PathwayCommons	CC	GO:0005929	cilium	8.55E-01	842	811	809	1.00	-	-
PathwayCommons	BP	GO:0016192	vesicle-mediated transport	5.43E-14	1894	1873	1821	1.03	-	-
PathwayCommons	BP	GO:0007155	cell adhesion	9.29E-11	1444	1428	1388	1.03	-	-
PathwayCommons	BP	GO:0030163	protein catabolic process	3.16E-10	990	983	952	1.03	-	-
PathwayCommons	BP	GO:0048870	cell motility	8.53E-10	1659	1636	1595	1.03	-	-
PathwayCommons	BP	GO:0006629	lipid metabolic process	5.07E-09	1355	1338	1303	1.03	-	-
PathwayCommons	BP	GO:0002376	immune system process	7.79E-09	2448	2401	2353	1.02	-	-
PathwayCommons	BP	GO:0012501	programmed cell death	8.76E-09	1954	1921	1878	1.02	-	-
PathwayCommons	BP	GO:0007010	cytoskeleton organization	4.15E-08	1639	1613	1576	1.02	-	-
PathwayCommons	BP	GO:0006281	DNA repair	4.34E-08	587	585	564	1.04	-	-
PathwayCommons	BP	GO:0006886	intracellular protein transport	9.22E-07	664	659	638	1.03	-	-
PathwayCommons	BP	GO:0005975	carbohydrate metabolic process	1.44E-06	551	548	530	1.03	-	-
PathwayCommons	BP	GO:0006355	regulation of DNA-templated transcription	3.06E-06	3342	3258	3213	1.01	-	-
PathwayCommons	BP	GO:0034330	cell junction organization	8.01E-06	727	719	699	1.03	-	-
PathwayCommons	BP	GO:0003013	circulatory system process	9.92E-06	584	579	561	1.03	-	-
PathwayCommons	BP	GO:0050877	nervous system process	1.60E-05	1527	1497	1468	1.02	-	-
PathwayCommons	BP	GO:0016071	mRNA metabolic process	4.16E-05	713	704	685	1.03	-	-
PathwayCommons	BP	GO:0006954	inflammatory response	5.98E-05	820	808	788	1.03	-	-
PathwayCommons	BP	GO:0042060	wound healing	6.83E-05	431	428	414	1.03	-	-
PathwayCommons	BP	GO:0006914	autophagy	8.72E-05	568	562	546	1.03	-	-
PathwayCommons	BP	GO:0003012	muscle system process	9.98E-05	425	422	409	1.03	-	-
PathwayCommons	BP	GO:0006260	DNA replication	4.17E-04	279	278	268	1.04	-	-
PathwayCommons	BP	GO:0055085	transmembrane transport	4.73E-04	1784	1741	1715	1.02	-	-
PathwayCommons	BP	GO:0030198	extracellular matrix organization	5.94E-04	314	312	302	1.03	-	-
PathwayCommons	BP	GO:0007059	chromosome segregation	9.17E-04	403	399	387	1.03	-	-
PathwayCommons	BP	GO:0065003	protein-containing complex assembly	1.01E-03	1648	1608	1584	1.01	-	-
PathwayCommons	BP	GO:0032200	telomere organization	1.55E-03	186	186	179	1.04	-	-
PathwayCommons	BP	GO:0072659	protein localization to plasma membrane	1.71E-03	284	282	273	1.03	-	-
PathwayCommons	BP	GO:0006913	nucleocytoplasmic transport	2.09E-03	326	323	313	1.03	-	-
PathwayCommons	BP	GO:0007163	establishment or maintenance of cell polarity	2.62E-03	227	226	218	1.04	-	-
PathwayCommons	BP	GO:0006790	sulfur compound metabolic process	2.98E-03	320	317	308	1.03	-	-
PathwayCommons	BP	GO:0006310	DNA recombination	6.07E-03	333	329	320	1.03	-	-
PathwayCommons	BP	GO:0007018	microtubule-based movement	6.29E-03	640	628	615	1.02	-	-
PathwayCommons	BP	GO:0007005	mitochondrion organization	1.64E-02	484	475	465	1.02	-	-
PathwayCommons	BP	GO:0042254	ribosome biogenesis	2.12E-02	297	293	286	1.03	-	-
PathwayCommons	BP	GO:0098542	defense response to other organism	2.31E-02	1171	1140	1126	1.01	-	-
PathwayCommons	BP	GO:0006766	vitamin metabolic process	3.74E-02	107	107	103	1.04	-	-
PathwayCommons	BP	GO:0006575	cellular modified amino acid metabolic process	5.22E-02	186	184	179	1.03	-	-
PathwayCommons	BP	GO:0006325	chromatin organization	6.01E-02	720	702	692	1.01	-	-
PathwayCommons	BP	GO:0098754	detoxification	6.72E-02	134	133	129	1.03	-	-
PathwayCommons	BP	GO:0006457	protein folding	6.97E-02	210	207	202	1.03	-	-
PathwayCommons	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	9.38E-02	119	118	114	1.03	-	-
PathwayCommons	BP	GO:0003014	renal system process	9.84E-02	127	126	122	1.03	-	-
PathwayCommons	BP	GO:0022600	digestive system process	1.34E-01	110	109	106	1.03	-	-
PathwayCommons	BP	GO:0002181	cytoplasmic translation	1.35E-01	153	151	147	1.03	-	-
PathwayCommons	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.71E-01	729	708	701	1.01	-	-
PathwayCommons	BP	GO:0044782	cilium organization	1.88E-01	399	389	384	1.01	-	-
PathwayCommons	BP	GO:0140053	mitochondrial gene expression	2.22E-01	164	161	158	1.02	-	-
PathwayCommons	BP	GO:0140013	meiotic nuclear division	2.75E-01	279	272	268	1.01	-	-
PathwayCommons	BP	GO:0007040	lysosome organization	4.46E-01	107	105	103	1.02	-	-
PathwayCommons	BP	GO:0006486	protein glycosylation	4.84E-01	225	219	216	1.01	-	-
PathwayCommons	BP	GO:0006091	generation of precursor metabolites and energy	6.40E-01	502	485	483	1.01	-	-
PathwayCommons	BP	GO:0006399	tRNA metabolic process	8.51E-01	196	188	188	1.00	-	-
PathwayCommons	BP	GO:0006520	amino acid metabolic process	8.78E-01	292	282	281	1.00	-	-
PathwayCommons	BP	GO:0000910	cytokinesis	1.00E+00	186	179	179	1.00	-	-
PathwayCommons	MF	GO:0008092	cytoskeletal protein binding	1.72E-11	1023	1017	983	1.03	-	-
PathwayCommons	MF	GO:0003723	RNA binding	4.55E-10	1679	1656	1614	1.03	-	-
PathwayCommons	MF	GO:0003677	DNA binding	2.69E-08	2865	2804	2754	1.02	-	-
PathwayCommons	MF	GO:0016740	transferase activity	2.74E-07	3074	3003	2955	1.02	-	-
PathwayCommons	MF	GO:0140657	ATP-dependent activity	4.02E-07	729	723	701	1.03	-	-
PathwayCommons	MF	GO:0140096	"catalytic activity, acting on a protein"	9.32E-07	3198	3121	3074	1.02	-	-
PathwayCommons	MF	GO:0008289	lipid binding	5.21E-06	836	826	804	1.03	-	-
PathwayCommons	MF	GO:0140097	"catalytic activity, acting on DNA"	3.95E-04	383	380	368	1.03	-	-
PathwayCommons	MF	GO:0140110	transcription regulator activity	1.22E-03	2033	1980	1954	1.01	-	-
PathwayCommons	MF	GO:0016491	oxidoreductase activity	2.31E-03	888	870	854	1.02	-	-
PathwayCommons	MF	GO:0016829	lyase activity	4.38E-03	538	529	517	1.02	-	-
PathwayCommons	MF	GO:0045182	translation regulator activity	4.73E-03	151	151	145	1.04	-	-
PathwayCommons	MF	GO:0005215	transporter activity	1.32E-02	1462	1423	1405	1.01	-	-
PathwayCommons	MF	GO:0016853	isomerase activity	2.03E-02	252	249	242	1.03	-	-
PathwayCommons	MF	GO:0009975	cyclase activity	3.88E-02	277	273	266	1.03	-	-
PathwayCommons	MF	GO:0140098	"catalytic activity, acting on RNA"	7.12E-02	417	408	401	1.02	-	-
PathwayCommons	MF	GO:0042393	histone binding	8.83E-02	237	233	228	1.02	-	-
PathwayCommons	MF	GO:0003924	GTPase activity	9.83E-02	658	641	633	1.01	-	-
PathwayCommons	MF	GO:0003774	cytoskeletal motor activity	1.39E-01	116	115	112	1.03	-	-
PathwayCommons	MF	GO:0048018	receptor ligand activity	1.58E-01	504	491	485	1.01	-	-
PathwayCommons	MF	GO:0005198	structural molecule activity	1.59E-01	798	775	767	1.01	-	-
PathwayCommons	MF	GO:0140104	molecular carrier activity	1.95E-01	105	104	101	1.03	-	-
PathwayCommons	MF	GO:0038024	cargo receptor activity	3.32E-01	117	115	112	1.02	-	-
PathwayCommons	MF	GO:0016874	ligase activity	5.32E-01	283	270	272	0.99	-	-
PathwayCommons	BP	GO:0008038	neuron recognition	-	46	46	-	-	2.16E-03	1.94E-03
PathwayCommons	BP	GO:1905145	cellular response to acetylcholine	-	33	33	-	-	4.90E-03	1.42E-03
PathwayCommons	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	1.07E-02	7.88E-04
PathwayCommons	BP	GO:0098780	response to mitochondrial depolarisation	-	21	20	-	-	8.07E-03	8.41E-04
PathwayCommons	BP	GO:0051931	regulation of sensory perception	-	36	33	-	-	2.09E-03	1.42E-03
PathwayCommons	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	4.28E-03	1.05E-03
PathwayCommons	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	5.06E-04	5.78E-04
PathwayCommons	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	1.51E-04	5.78E-04
PathwayCommons	BP	GO:0009268	response to pH	-	43	42	-	-	2.77E-03	1.79E-03
PathwayCommons	BP	GO:0045666	positive regulation of neuron differentiation	-	91	86	-	-	3.17E-03	3.62E-03
PathwayCommons	BP	GO:0043543	protein acylation	-	107	104	-	-	4.67E-03	4.41E-03
PathwayCommons	MF	GO:0051349	positive regulation of lyase activity	-	41	40	-	-	2.42E-03	1.68E-03
PathwayCommons	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	7.22E-04	6.30E-04
PathwayCommons	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.28E-03	1.05E-03
PathwayCommons	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	4.00E-03	8.41E-04
PathwayCommons	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	142	-	-	3.03E-01	5.99E-03
PathwayCommons	BP	GO:0071763	nuclear membrane organization	-	44	43	-	-	3.34E-02	1.84E-03
PathwayCommons	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	35	-	-	2.05E-03	1.47E-03
PathwayCommons	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	11	-	-	1.47E-02	4.73E-04
PathwayCommons	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	4.05E-02	2.89E-03
PathwayCommons	BP	GO:0022038	corpus callosum development	-	25	25	-	-	2.18E-03	1.05E-03
PathwayCommons	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	12	-	-	1.06E-02	5.25E-04
PathwayCommons	BP	GO:0021548	pons development	-	11	11	-	-	3.06E-04	4.73E-04
PathwayCommons	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	11	-	-	4.62E-03	4.73E-04
PathwayCommons	BP	GO:0043299	leukocyte degranulation	-	82	82	-	-	3.25E-03	3.47E-03
PathwayCommons	BP	GO:0048864	stem cell development	-	88	88	-	-	3.07E-03	3.73E-03
PathwayCommons	BP	GO:0009310	amine catabolic process	-	20	18	-	-	1.60E-02	7.88E-04
PathwayCommons	BP	GO:0051651	maintenance of location in cell	-	236	228	-	-	9.40E-03	9.61E-03
PathwayCommons	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	2.58E-03	1.16E-03
PathwayCommons	BP	GO:0014004	microglia differentiation	-	12	11	-	-	4.97E-04	4.73E-04
PathwayCommons	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	4.91E-02	1.31E-03
PathwayCommons	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	8.73E-04	6.30E-04
PathwayCommons	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	3.70E-03	6.30E-04
PathwayCommons	BP	GO:0046415	urate metabolic process	-	12	12	-	-	5.61E-03	5.25E-04
PathwayCommons	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	3.96E-03	1.26E-03
PathwayCommons	BP	GO:0006949	syncytium formation	-	66	62	-	-	1.85E-03	2.63E-03
PathwayCommons	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.87E-04	6.30E-04
PathwayCommons	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	1.18E-02	6.30E-04
PathwayCommons	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	58	-	-	1.98E-02	2.47E-03
PathwayCommons	BP	GO:0030574	collagen catabolic process	-	45	45	-	-	1.55E-02	1.89E-03
PathwayCommons	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	4.93E-03	1.94E-03
PathwayCommons	BP	GO:0060343	trabecula formation	-	26	26	-	-	1.35E-03	1.10E-03
PathwayCommons	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	1.48E-04	5.25E-04
PathwayCommons	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.86E-03	9.98E-04
PathwayCommons	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	3.43E-02	6.83E-04
PathwayCommons	BP	GO:1900424	regulation of defense response to bacterium	-	21	19	-	-	1.96E-03	8.41E-04
PathwayCommons	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	2.42E-03	1.73E-03
PathwayCommons	BP	GO:0006413	translational initiation	-	122	121	-	-	3.09E-02	5.10E-03
PathwayCommons	BP	GO:0072176	nephric duct development	-	15	15	-	-	1.58E-03	6.30E-04
PathwayCommons	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	1.16E-03	2.15E-03
PathwayCommons	CC	GO:0005200	structural constituent of cytoskeleton	-	112	111	-	-	6.87E-03	4.68E-03
PathwayCommons	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	3.23E-03	2.15E-03
PathwayCommons	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	8.78E-03	6.30E-04
PathwayCommons	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	4.94E-02	1.05E-03
PathwayCommons	BP	GO:1903036	positive regulation of response to wounding	-	76	70	-	-	6.24E-03	2.94E-03
PathwayCommons	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	1.75E-01	8.93E-04
PathwayCommons	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	222	-	-	2.61E-02	9.35E-03
PathwayCommons	CC	GO:0001055	RNA polymerase II activity	-	11	11	-	-	2.29E-03	4.73E-04
PathwayCommons	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	9.99E-04	1.16E-03
PathwayCommons	BP	GO:0032528	microvillus organization	-	24	23	-	-	6.22E-03	9.98E-04
PathwayCommons	BP	GO:0021954	central nervous system neuron development	-	85	85	-	-	1.90E-03	3.57E-03
PathwayCommons	BP	GO:0055017	cardiac muscle tissue growth	-	92	75	-	-	1.45E-03	3.15E-03
PathwayCommons	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	3.20E-03	1.31E-03
PathwayCommons	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	2.01E-04	5.78E-04
PathwayCommons	BP	GO:0048524	positive regulation of viral process	-	64	63	-	-	1.48E-03	2.68E-03
PathwayCommons	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	14	-	-	5.38E-03	6.30E-04
PathwayCommons	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	7.25E-03	8.93E-04
PathwayCommons	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	24	-	-	1.14E-03	1.05E-03
PathwayCommons	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	2.47E-03	7.35E-04
PathwayCommons	BP	GO:0098661	inorganic anion transmembrane transport	-	140	140	-	-	2.45E-01	5.88E-03
PathwayCommons	BP	GO:0006099	tricarboxylic acid cycle	-	33	33	-	-	1.41E-02	1.42E-03
PathwayCommons	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	5.29E-04	7.88E-04
PathwayCommons	BP	GO:0009612	response to mechanical stimulus	-	215	214	-	-	5.29E-03	9.04E-03
PathwayCommons	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	1.78E-03	3.31E-03
PathwayCommons	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	139	-	-	4.00E-03	5.88E-03
PathwayCommons	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	8.07E-02	5.78E-04
PathwayCommons	BP	GO:0071542	dopaminergic neuron differentiation	-	36	36	-	-	6.43E-03	1.52E-03
PathwayCommons	BP	GO:0140115	export across plasma membrane	-	82	67	-	-	1.24E-02	2.84E-03
PathwayCommons	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	8.44E-04	5.25E-04
PathwayCommons	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	2.39E-03	1.63E-03
PathwayCommons	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	2.12E-03	5.25E-04
PathwayCommons	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.53E-04	4.73E-04
PathwayCommons	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	29	-	-	4.87E-03	1.26E-03
PathwayCommons	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	42	-	-	3.12E-02	1.79E-03
PathwayCommons	MF	GO:0003714	transcription corepressor activity	-	190	188	-	-	7.96E-03	7.93E-03
PathwayCommons	BP	GO:0035878	nail development	-	11	11	-	-	1.57E-03	4.73E-04
PathwayCommons	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	54	-	-	2.03E-02	2.31E-03
PathwayCommons	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	8.29E-04	6.83E-04
PathwayCommons	CC	GO:0006858	extracellular transport	-	45	43	-	-	1.34E-02	1.84E-03
PathwayCommons	BP	GO:0006304	DNA modification	-	30	30	-	-	3.98E-03	1.26E-03
PathwayCommons	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	2.13E-02	8.41E-04
PathwayCommons	BP	GO:0046835	carbohydrate phosphorylation	-	49	48	-	-	1.61E-02	2.05E-03
PathwayCommons	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	6.61E-04	7.88E-04
PathwayCommons	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	1.00E-02	6.30E-04
PathwayCommons	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	41	-	-	1.36E-02	1.73E-03
PathwayCommons	BP	GO:0070417	cellular response to cold	-	13	13	-	-	1.50E-03	5.78E-04
PathwayCommons	BP	GO:0043523	regulation of neuron apoptotic process	-	218	211	-	-	5.33E-03	8.88E-03
PathwayCommons	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	4.72E-04	9.46E-04
PathwayCommons	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	1.34E-03	6.30E-04
PathwayCommons	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	7.87E-03	2.42E-03
PathwayCommons	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	3.90E-02	5.78E-04
PathwayCommons	BP	GO:2000209	regulation of anoikis	-	25	24	-	-	1.43E-03	1.05E-03
PathwayCommons	BP	GO:0014029	neural crest formation	-	15	15	-	-	5.27E-03	6.30E-04
PathwayCommons	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	9.40E-04	9.98E-04
PathwayCommons	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	41	-	-	7.13E-03	1.73E-03
PathwayCommons	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	69	-	-	3.48E-03	2.94E-03
PathwayCommons	BP	GO:0003188	heart valve formation	-	16	16	-	-	1.58E-03	6.83E-04
PathwayCommons	CC	GO:0045324	late endosome to vacuole transport	-	37	36	-	-	1.44E-01	1.52E-03
PathwayCommons	BP	GO:0043954	cellular component maintenance	-	72	70	-	-	6.90E-03	2.94E-03
PathwayCommons	BP	GO:0050435	amyloid-beta metabolic process	-	65	53	-	-	4.42E-03	2.26E-03
PathwayCommons	BP	GO:0014823	response to activity	-	70	69	-	-	1.71E-03	2.94E-03
PathwayCommons	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	1.63E-03	7.88E-04
PathwayCommons	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	5.92E-02	1.21E-03
PathwayCommons	BP	GO:0034502	protein localization to chromosome	-	130	128	-	-	6.98E-03	5.41E-03
PathwayCommons	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	2.55E-04	4.73E-04
PathwayCommons	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	4.48E-03	4.73E-04
PathwayCommons	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	5.12E-03	7.35E-04
PathwayCommons	BP	GO:0019233	sensory perception of pain	-	103	100	-	-	3.87E-03	4.20E-03
PathwayCommons	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	1.38E-01	9.46E-04
PathwayCommons	BP	GO:0031343	positive regulation of cell killing	-	75	74	-	-	2.96E-02	3.15E-03
PathwayCommons	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	1.52E-03	1.63E-03
PathwayCommons	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	127	-	-	3.90E-02	5.36E-03
PathwayCommons	BP	GO:0017148	negative regulation of translation	-	390	116	-	-	8.95E-03	4.89E-03
PathwayCommons	BP	GO:0030220	platelet formation	-	22	22	-	-	3.05E-03	9.46E-04
PathwayCommons	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	81	-	-	2.23E-03	3.41E-03
PathwayCommons	MF	GO:1903624	regulation of DNA catabolic process	-	14	13	-	-	1.30E-03	5.78E-04
PathwayCommons	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	3.33E-03	6.30E-04
PathwayCommons	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	4.42E-03	6.30E-04
PathwayCommons	BP	GO:1903509	liposaccharide metabolic process	-	109	106	-	-	8.55E-02	4.47E-03
PathwayCommons	BP	GO:0009582	detection of abiotic stimulus	-	140	134	-	-	1.18E-02	5.67E-03
PathwayCommons	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	1.05E-03	5.78E-04
PathwayCommons	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	19	-	-	7.99E-03	8.41E-04
PathwayCommons	CC	GO:0140238	presynaptic endocytosis	-	72	72	-	-	1.83E-02	3.05E-03
PathwayCommons	BP	GO:0051236	establishment of RNA localization	-	161	156	-	-	4.68E-02	6.57E-03
PathwayCommons	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	2.38E-02	1.05E-03
PathwayCommons	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	2.03E-02	7.35E-04
PathwayCommons	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	192	-	-	1.52E-02	8.09E-03
PathwayCommons	BP	GO:0034067	protein localization to Golgi apparatus	-	30	29	-	-	1.58E-02	1.26E-03
PathwayCommons	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	2.17E-03	1.37E-03
PathwayCommons	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	2.80E-03	4.73E-04
PathwayCommons	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	1.50E-02	7.35E-04
PathwayCommons	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	49	-	-	6.12E-03	2.10E-03
PathwayCommons	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	1.78E-03	1.68E-03
PathwayCommons	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	1.12E-03	2.21E-03
PathwayCommons	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	8.95E-03	6.83E-04
PathwayCommons	BP	GO:0050779	RNA destabilization	-	135	100	-	-	4.33E-02	4.20E-03
PathwayCommons	BP	GO:0006023	aminoglycan biosynthetic process	-	74	74	-	-	1.99E-02	3.15E-03
PathwayCommons	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	2.30E-02	2.89E-03
PathwayCommons	BP	GO:0010762	regulation of fibroblast migration	-	40	38	-	-	1.43E-03	1.63E-03
PathwayCommons	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	1.65E-02	1.26E-03
PathwayCommons	BP	GO:0035272	exocrine system development	-	46	46	-	-	1.21E-03	1.94E-03
PathwayCommons	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	1.85E-02	7.35E-04
PathwayCommons	BP	GO:0022406	membrane docking	-	90	90	-	-	2.57E-02	3.78E-03
PathwayCommons	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	1.77E-02	6.30E-04
PathwayCommons	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	4.56E-04	6.83E-04
PathwayCommons	BP	GO:0050777	negative regulation of immune response	-	196	188	-	-	3.90E-03	7.93E-03
PathwayCommons	MF	GO:0005035	death receptor activity	-	16	16	-	-	1.80E-03	6.83E-04
PathwayCommons	BP	GO:0002063	chondrocyte development	-	33	32	-	-	2.39E-03	1.37E-03
PathwayCommons	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	8.96E-04	7.35E-04
PathwayCommons	BP	GO:0099068	postsynapse assembly	-	40	40	-	-	2.70E-02	1.68E-03
PathwayCommons	BP	GO:0021782	glial cell development	-	120	115	-	-	2.01E-03	4.83E-03
PathwayCommons	BP	GO:0051782	negative regulation of cell division	-	18	17	-	-	3.73E-03	7.35E-04
PathwayCommons	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	6.05E-04	4.73E-04
PathwayCommons	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	88	-	-	4.07E-03	3.73E-03
PathwayCommons	BP	GO:0001655	urogenital system development	-	66	66	-	-	1.00E-03	2.78E-03
PathwayCommons	BP	GO:0071827	plasma lipoprotein particle organization	-	86	71	-	-	1.42E-02	2.99E-03
PathwayCommons	BP	GO:0045494	photoreceptor cell maintenance	-	43	42	-	-	1.27E-02	1.79E-03
PathwayCommons	BP	GO:0055088	lipid homeostasis	-	173	152	-	-	8.02E-03	6.41E-03
PathwayCommons	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	1.24E-03	1.10E-03
PathwayCommons	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	196	-	-	4.77E-03	8.25E-03
PathwayCommons	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	30	-	-	3.47E-02	1.26E-03
PathwayCommons	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	34	-	-	1.49E-03	1.47E-03
PathwayCommons	BP	GO:0045667	regulation of osteoblast differentiation	-	147	124	-	-	3.35E-03	5.25E-03
PathwayCommons	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	2.77E-03	6.83E-04
PathwayCommons	BP	GO:0061037	negative regulation of cartilage development	-	32	30	-	-	1.11E-03	1.26E-03
PathwayCommons	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	1.60E-02	1.68E-03
PathwayCommons	BP	GO:0001704	formation of primary germ layer	-	195	188	-	-	4.28E-03	7.93E-03
PathwayCommons	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	7.41E-03	5.78E-04
PathwayCommons	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	2.59E-03	2.15E-03
PathwayCommons	BP	GO:0060174	limb bud formation	-	11	11	-	-	5.99E-04	4.73E-04
PathwayCommons	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	1.53E-03	3.57E-03
PathwayCommons	BP	GO:0042092	type 2 immune response	-	41	41	-	-	1.37E-03	1.73E-03
PathwayCommons	BP	GO:0048588	developmental cell growth	-	233	224	-	-	4.52E-03	9.46E-03
PathwayCommons	CC	GO:0000963	mitochondrial RNA processing	-	20	19	-	-	3.04E-02	8.41E-04
PathwayCommons	BP	GO:0021872	forebrain generation of neurons	-	52	52	-	-	1.95E-03	2.21E-03
PathwayCommons	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	8.12E-04	9.46E-04
PathwayCommons	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	6.12E-02	1.68E-03
PathwayCommons	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	51	-	-	3.22E-02	2.15E-03
PathwayCommons	BP	GO:0072488	ammonium transmembrane transport	-	12	12	-	-	4.57E-03	5.25E-04
PathwayCommons	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	1.76E-02	1.47E-03
PathwayCommons	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	7.05E-04	1.10E-03
PathwayCommons	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	51	-	-	8.42E-03	2.15E-03
PathwayCommons	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	18	-	-	7.55E-02	7.88E-04
PathwayCommons	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	4.33E-02	8.41E-04
PathwayCommons	BP	GO:0010232	vascular transport	-	87	86	-	-	1.27E-02	3.62E-03
PathwayCommons	BP	GO:0021987	cerebral cortex development	-	125	123	-	-	6.32E-03	5.20E-03
PathwayCommons	BP	GO:0008637	apoptotic mitochondrial changes	-	108	102	-	-	8.92E-03	4.31E-03
PathwayCommons	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	2.72E-03	1.47E-03
PathwayCommons	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.93E-02	6.30E-04
PathwayCommons	BP	GO:0060999	positive regulation of dendritic spine development	-	35	34	-	-	3.43E-03	1.47E-03
PathwayCommons	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	7.47E-04	7.88E-04
PathwayCommons	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	2.80E-03	3.26E-03
PathwayCommons	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	9.04E-04	8.41E-04
PathwayCommons	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	1.30E-03	8.41E-04
PathwayCommons	BP	GO:0002064	epithelial cell development	-	210	208	-	-	4.20E-03	8.77E-03
PathwayCommons	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	1.26E-03	7.88E-04
PathwayCommons	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	40	-	-	5.51E-03	1.68E-03
PathwayCommons	BP	GO:2001222	regulation of neuron migration	-	46	45	-	-	2.91E-02	1.89E-03
PathwayCommons	BP	GO:0034389	lipid droplet organization	-	38	37	-	-	2.23E-03	1.58E-03
PathwayCommons	BP	GO:0051602	response to electrical stimulus	-	44	42	-	-	7.87E-04	1.79E-03
PathwayCommons	BP	GO:0042177	negative regulation of protein catabolic process	-	109	108	-	-	2.17E-03	4.57E-03
PathwayCommons	MF	GO:0038024	cargo receptor activity	-	121	115	-	-	6.68E-03	4.83E-03
PathwayCommons	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	18	-	-	1.14E-03	7.88E-04
PathwayCommons	BP	GO:0033120	positive regulation of RNA splicing	-	46	44	-	-	7.08E-03	1.89E-03
PathwayCommons	BP	GO:0051445	regulation of meiotic cell cycle	-	64	63	-	-	1.73E-02	2.68E-03
PathwayCommons	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	4.45E-04	5.25E-04
PathwayCommons	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	3.01E-03	2.52E-03
PathwayCommons	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	7.21E-03	6.30E-04
PathwayCommons	BP	GO:0090087	regulation of peptide transport	-	195	193	-	-	4.15E-03	8.14E-03
PathwayCommons	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	101	-	-	3.51E-03	4.26E-03
PathwayCommons	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	1.47E-03	1.05E-03
PathwayCommons	BP	GO:0006929	substrate-dependent cell migration	-	26	26	-	-	1.88E-03	1.10E-03
PathwayCommons	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	14	-	-	1.99E-02	6.30E-04
PathwayCommons	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	8.58E-02	1.16E-03
PathwayCommons	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	2.81E-03	6.30E-04
PathwayCommons	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	2.02E-03	6.30E-04
PathwayCommons	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	2.02E-01	8.41E-04
PathwayCommons	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	3.02E-02	5.78E-04
PathwayCommons	BP	GO:0022404	molting cycle process	-	95	95	-	-	2.43E-03	3.99E-03
PathwayCommons	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	1.27E-03	7.35E-04
PathwayCommons	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	1.82E-03	8.41E-04
PathwayCommons	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	1.86E-03	5.25E-04
PathwayCommons	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	18	-	-	6.08E-04	7.88E-04
PathwayCommons	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	2.99E-03	1.37E-03
PathwayCommons	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	3.13E-03	6.30E-04
PathwayCommons	BP	GO:0008299	isoprenoid biosynthetic process	-	30	29	-	-	1.45E-01	1.26E-03
PathwayCommons	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	236	-	-	2.38E-02	9.93E-03
PathwayCommons	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.25E-03	1.31E-03
PathwayCommons	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	3.56E-03	9.46E-04
PathwayCommons	CC	GO:0098926	postsynaptic signal transduction	-	39	39	-	-	1.30E-02	1.68E-03
PathwayCommons	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	139	-	-	3.71E-03	5.88E-03
PathwayCommons	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	5.87E-02	8.41E-04
PathwayCommons	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	1.45E-03	2.00E-03
PathwayCommons	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	143	-	-	4.71E-03	6.04E-03
PathwayCommons	BP	GO:0034249	negative regulation of amide metabolic process	-	34	23	-	-	1.72E-03	9.98E-04
PathwayCommons	BP	GO:0061548	ganglion development	-	17	17	-	-	5.72E-03	7.35E-04
PathwayCommons	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	99	-	-	4.32E-03	4.20E-03
PathwayCommons	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	4.29E-03	6.30E-04
PathwayCommons	BP	GO:0042832	defense response to protozoan	-	28	27	-	-	4.56E-02	1.16E-03
PathwayCommons	BP	GO:0048799	animal organ maturation	-	33	32	-	-	2.10E-03	1.37E-03
PathwayCommons	BP	GO:0006925	inflammatory cell apoptotic process	-	23	22	-	-	8.10E-04	9.46E-04
PathwayCommons	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	7.88E-04	6.83E-04
PathwayCommons	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	170	-	-	5.00E-03	7.14E-03
PathwayCommons	BP	GO:0010269	response to selenium ion	-	11	11	-	-	6.45E-04	4.73E-04
PathwayCommons	BP	GO:1903035	negative regulation of response to wounding	-	93	87	-	-	9.36E-03	3.68E-03
PathwayCommons	BP	GO:0015697	quaternary ammonium group transport	-	16	16	-	-	4.25E-03	6.83E-04
PathwayCommons	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	26	-	-	1.07E-03	1.10E-03
PathwayCommons	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	2.43E-03	1.16E-03
PathwayCommons	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	134	-	-	4.15E-02	5.67E-03
PathwayCommons	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	96	-	-	4.11E-03	4.05E-03
PathwayCommons	BP	GO:0045056	transcytosis	-	20	20	-	-	3.31E-03	8.41E-04
PathwayCommons	BP	GO:0018342	protein prenylation	-	15	15	-	-	7.37E-03	6.30E-04
PathwayCommons	BP	GO:0009267	cellular response to starvation	-	170	167	-	-	8.76E-03	7.04E-03
PathwayCommons	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	5.11E-03	4.73E-04
PathwayCommons	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	1.99E-03	2.26E-03
PathwayCommons	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	1.03E-03	6.83E-04
PathwayCommons	BP	GO:0007343	egg activation	-	11	11	-	-	4.51E-02	4.73E-04
PathwayCommons	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	2.12E-03	9.98E-04
PathwayCommons	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	27	-	-	2.90E-03	1.16E-03
PathwayCommons	BP	GO:0046931	pore complex assembly	-	21	21	-	-	5.98E-03	8.93E-04
PathwayCommons	CC	GO:0032008	positive regulation of TOR signaling	-	52	51	-	-	2.22E-02	2.15E-03
PathwayCommons	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	5.90E-02	1.42E-03
PathwayCommons	BP	GO:0046618	xenobiotic export from cell	-	27	14	-	-	2.66E-03	6.30E-04
PathwayCommons	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	14	-	-	1.70E-03	6.30E-04
PathwayCommons	BP	GO:0060428	lung epithelium development	-	43	43	-	-	9.67E-04	1.84E-03
PathwayCommons	BP	GO:0030431	sleep	-	30	30	-	-	5.12E-03	1.26E-03
PathwayCommons	BP	GO:1903318	negative regulation of protein maturation	-	29	29	-	-	6.51E-03	1.26E-03
PathwayCommons	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	95	-	-	3.25E-01	3.99E-03
PathwayCommons	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	4.13E-04	7.35E-04
PathwayCommons	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	2.37E-03	6.30E-04
PathwayCommons	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	1.63E-02	5.25E-04
PathwayCommons	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	6.81E-04	5.78E-04
PathwayCommons	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	75	-	-	3.70E-02	3.15E-03
PathwayCommons	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	1.81E-03	2.73E-03
PathwayCommons	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	3.77E-03	7.35E-04
PathwayCommons	CC	GO:0090660	cerebrospinal fluid circulation	-	15	13	-	-	1.56E-04	5.78E-04
PathwayCommons	CC	GO:0006406	mRNA export from nucleus	-	69	68	-	-	4.50E-02	2.89E-03
PathwayCommons	BP	GO:0009880	embryonic pattern specification	-	70	70	-	-	8.74E-03	2.94E-03
PathwayCommons	BP	GO:0015791	polyol transmembrane transport	-	14	12	-	-	8.01E-03	5.25E-04
PathwayCommons	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	1.43E-01	1.68E-03
PathwayCommons	BP	GO:0043043	peptide biosynthetic process	-	25	25	-	-	1.26E-02	1.05E-03
PathwayCommons	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	4.47E-03	4.73E-04
PathwayCommons	BP	GO:0002367	cytokine production involved in immune response	-	121	121	-	-	5.18E-03	5.10E-03
PathwayCommons	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	4.58E-04	5.78E-04
PathwayCommons	BP	GO:0044848	biological phase	-	211	206	-	-	2.41E-02	8.67E-03
PathwayCommons	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	7.06E-03	5.25E-04
PathwayCommons	BP	GO:0046660	female sex differentiation	-	125	124	-	-	4.37E-03	5.25E-03
PathwayCommons	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	18	-	-	2.52E-04	7.88E-04
PathwayCommons	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	43	-	-	1.10E-03	1.84E-03
PathwayCommons	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	3.57E-04	4.73E-04
PathwayCommons	BP	GO:0060411	cardiac septum morphogenesis	-	72	71	-	-	3.36E-03	2.99E-03
PathwayCommons	BP	GO:0071248	cellular response to metal ion	-	201	199	-	-	3.80E-03	8.41E-03
PathwayCommons	BP	GO:0030308	negative regulation of cell growth	-	191	186	-	-	3.30E-03	7.83E-03
PathwayCommons	BP	GO:0097306	cellular response to alcohol	-	99	94	-	-	2.39E-03	3.99E-03
PathwayCommons	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	130	-	-	7.51E-02	5.46E-03
PathwayCommons	BP	GO:0010453	regulation of cell fate commitment	-	40	36	-	-	4.38E-03	1.52E-03
PathwayCommons	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	58	-	-	2.88E-03	2.47E-03
PathwayCommons	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	57	-	-	1.14E-02	2.42E-03
PathwayCommons	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	1.70E-03	1.10E-03
PathwayCommons	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	5.52E-03	1.05E-03
PathwayCommons	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	45	-	-	1.60E-02	1.89E-03
PathwayCommons	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	2.31E-03	3.26E-03
PathwayCommons	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	2.88E-03	8.41E-04
PathwayCommons	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	2.01E-01	1.05E-03
PathwayCommons	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	94	-	-	2.11E-03	3.99E-03
PathwayCommons	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	1.15E-03	1.10E-03
PathwayCommons	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	8.05E-04	4.73E-04
PathwayCommons	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	53	-	-	3.43E-03	2.26E-03
PathwayCommons	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	1.46E-02	6.83E-04
PathwayCommons	BP	GO:0098743	cell aggregation	-	24	23	-	-	2.78E-03	9.98E-04
PathwayCommons	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	1.04E-03	5.25E-04
PathwayCommons	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	1.31E-03	4.73E-04
PathwayCommons	BP	GO:0009994	oocyte differentiation	-	57	56	-	-	1.03E-03	2.36E-03
PathwayCommons	MF	GO:0031952	regulation of protein autophosphorylation	-	43	43	-	-	7.98E-04	1.84E-03
PathwayCommons	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	1.91E-03	6.30E-04
PathwayCommons	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	154	-	-	5.50E-03	6.51E-03
PathwayCommons	BP	GO:0044319	"wound healing, spreading of cells"	-	37	36	-	-	3.18E-03	1.52E-03
PathwayCommons	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	1.86E-03	1.21E-03
PathwayCommons	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	8.03E-04	1.47E-03
PathwayCommons	BP	GO:0072665	protein localization to vacuole	-	84	84	-	-	8.69E-03	3.57E-03
PathwayCommons	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	46	-	-	4.44E-03	1.94E-03
PathwayCommons	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	25	-	-	4.83E-03	1.05E-03
PathwayCommons	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	74	-	-	5.23E-03	3.15E-03
PathwayCommons	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	3.69E-03	6.83E-04
PathwayCommons	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	1.36E-02	6.30E-04
PathwayCommons	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.50E-04	4.73E-04
PathwayCommons	BP	GO:0042044	fluid transport	-	35	33	-	-	1.54E-03	1.42E-03
PathwayCommons	BP	GO:0070633	transepithelial transport	-	35	35	-	-	3.26E-03	1.47E-03
PathwayCommons	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	5.50E-03	5.78E-04
PathwayCommons	BP	GO:0045661	regulation of myoblast differentiation	-	74	73	-	-	6.00E-03	3.10E-03
PathwayCommons	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	15	-	-	4.63E-03	6.30E-04
PathwayCommons	BP	GO:0030307	positive regulation of cell growth	-	164	159	-	-	2.71E-03	6.72E-03
PathwayCommons	BP	GO:0034250	positive regulation of amide metabolic process	-	27	26	-	-	7.93E-04	1.10E-03
PathwayCommons	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	9.24E-04	7.88E-04
PathwayCommons	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	14	-	-	7.04E-04	6.30E-04
PathwayCommons	BP	GO:0014812	muscle cell migration	-	110	83	-	-	3.59E-03	3.52E-03
PathwayCommons	BP	GO:0048525	negative regulation of viral process	-	90	88	-	-	2.68E-03	3.73E-03
PathwayCommons	BP	GO:0072044	collecting duct development	-	16	16	-	-	5.32E-04	6.83E-04
PathwayCommons	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	1.58E-01	6.30E-04
PathwayCommons	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	5.82E-03	2.94E-03
PathwayCommons	BP	GO:0030238	male sex determination	-	14	14	-	-	1.21E-03	6.30E-04
PathwayCommons	BP	GO:0051781	positive regulation of cell division	-	93	92	-	-	3.29E-03	3.89E-03
PathwayCommons	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	5.12E-03	8.93E-04
PathwayCommons	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	6.11E-04	4.73E-04
PathwayCommons	BP	GO:0035524	proline transmembrane transport	-	12	12	-	-	2.18E-02	5.25E-04
PathwayCommons	BP	GO:0035493	SNARE complex assembly	-	23	22	-	-	8.96E-02	9.46E-04
PathwayCommons	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	22	-	-	2.36E-03	9.46E-04
PathwayCommons	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.46E-03	2.00E-03
PathwayCommons	BP	GO:0007272	ensheathment of neurons	-	146	144	-	-	3.41E-03	6.09E-03
PathwayCommons	CC	GO:0050806	positive regulation of synaptic transmission	-	171	153	-	-	3.07E-03	6.46E-03
PathwayCommons	BP	GO:0060021	roof of mouth development	-	91	91	-	-	3.52E-03	3.84E-03
PathwayCommons	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	3.11E-03	1.68E-03
PathwayCommons	BP	GO:0050819	negative regulation of coagulation	-	54	53	-	-	2.69E-02	2.26E-03
PathwayCommons	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	4.84E-03	4.73E-04
PathwayCommons	BP	GO:0017004	cytochrome complex assembly	-	40	38	-	-	1.18E-01	1.63E-03
PathwayCommons	BP	GO:0018410	C-terminal protein amino acid modification	-	15	15	-	-	4.15E-03	6.30E-04
PathwayCommons	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	3.41E-02	2.63E-03
PathwayCommons	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	8.63E-02	6.30E-04
PathwayCommons	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	14	-	-	2.94E-03	6.30E-04
PathwayCommons	CC	GO:0050805	negative regulation of synaptic transmission	-	55	55	-	-	3.22E-03	2.31E-03
PathwayCommons	BP	GO:0043248	proteasome assembly	-	13	13	-	-	2.60E-02	5.78E-04
PathwayCommons	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	59	-	-	4.48E-03	2.52E-03
PathwayCommons	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	4.11E-03	4.73E-04
PathwayCommons	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	87	-	-	1.58E-02	3.68E-03
PathwayCommons	BP	GO:0016054	organic acid catabolic process	-	251	248	-	-	6.94E-02	1.05E-02
PathwayCommons	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	3.40E-03	5.78E-04
PathwayCommons	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.35E-02	1.21E-03
PathwayCommons	BP	GO:0065005	protein-lipid complex assembly	-	29	28	-	-	8.02E-03	1.21E-03
PathwayCommons	BP	GO:0008033	tRNA processing	-	136	132	-	-	4.97E-02	5.57E-03
PathwayCommons	BP	GO:0046661	male sex differentiation	-	171	167	-	-	4.33E-03	7.04E-03
PathwayCommons	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	5.08E-04	6.30E-04
PathwayCommons	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	1.53E-03	7.35E-04
PathwayCommons	BP	GO:0035188	hatching	-	27	27	-	-	3.68E-04	1.16E-03
PathwayCommons	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	87	-	-	3.98E-03	3.68E-03
PathwayCommons	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	5.28E-04	6.30E-04
PathwayCommons	BP	GO:0090713	immunological memory process	-	18	18	-	-	9.53E-03	7.88E-04
PathwayCommons	BP	GO:0061326	renal tubule development	-	103	103	-	-	2.43E-03	4.36E-03
PathwayCommons	BP	GO:0071985	multivesicular body sorting pathway	-	56	55	-	-	1.16E-01	2.31E-03
PathwayCommons	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	1.16E-03	7.35E-04
PathwayCommons	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	19	-	-	6.34E-04	8.41E-04
PathwayCommons	BP	GO:0060325	face morphogenesis	-	31	31	-	-	9.73E-04	1.31E-03
PathwayCommons	BP	GO:0090559	regulation of membrane permeability	-	72	64	-	-	4.20E-03	2.73E-03
PathwayCommons	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	14	-	-	6.30E-03	6.30E-04
PathwayCommons	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	4.80E-02	5.25E-04
PathwayCommons	BP	GO:0031579	membrane raft organization	-	25	24	-	-	1.33E-03	1.05E-03
PathwayCommons	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	25	-	-	6.36E-04	1.05E-03
PathwayCommons	BP	GO:0060033	anatomical structure regression	-	16	16	-	-	1.64E-03	6.83E-04
PathwayCommons	BP	GO:0046460	neutral lipid biosynthetic process	-	50	47	-	-	1.53E-02	2.00E-03
PathwayCommons	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	154	-	-	8.98E-03	6.51E-03
PathwayCommons	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	8.59E-03	4.73E-04
PathwayCommons	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	161	-	-	3.40E-03	6.78E-03
PathwayCommons	BP	GO:0002251	organ or tissue specific immune response	-	43	42	-	-	1.37E-02	1.79E-03
PathwayCommons	CC	GO:0048167	regulation of synaptic plasticity	-	210	191	-	-	4.22E-03	8.04E-03
PathwayCommons	BP	GO:1903708	positive regulation of hemopoiesis	-	184	180	-	-	5.07E-03	7.57E-03
PathwayCommons	BP	GO:1903008	organelle disassembly	-	154	153	-	-	1.65E-02	6.46E-03
PathwayCommons	BP	GO:0001709	cell fate determination	-	44	44	-	-	1.85E-03	1.89E-03
PathwayCommons	BP	GO:0051873	killing by host of symbiont cells	-	28	28	-	-	3.06E-03	1.21E-03
PathwayCommons	BP	GO:0045058	T cell selection	-	53	53	-	-	4.91E-03	2.26E-03
PathwayCommons	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	2.24E-03	2.05E-03
PathwayCommons	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	1.03E-03	8.41E-04
PathwayCommons	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	2.15E-03	3.31E-03
PathwayCommons	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	42	-	-	3.44E-02	1.79E-03
PathwayCommons	BP	GO:0099084	postsynaptic specialization organization	-	44	44	-	-	9.33E-03	1.89E-03
PathwayCommons	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	3.75E-03	4.73E-04
PathwayCommons	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	1.56E-02	6.30E-04
PathwayCommons	BP	GO:0060384	innervation	-	27	27	-	-	9.14E-03	1.16E-03
PathwayCommons	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	3.28E-03	5.25E-04
PathwayCommons	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	35	-	-	2.58E-03	1.47E-03
PathwayCommons	MF	GO:0031281	positive regulation of cyclase activity	-	40	39	-	-	2.30E-03	1.68E-03
PathwayCommons	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	4.75E-03	2.68E-03
PathwayCommons	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	17	-	-	7.17E-03	7.35E-04
PathwayCommons	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	1.61E-03	5.25E-04
PathwayCommons	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	5.07E-03	7.88E-04
PathwayCommons	BP	GO:0071453	cellular response to oxygen levels	-	168	154	-	-	3.23E-03	6.51E-03
PathwayCommons	BP	GO:0090399	replicative senescence	-	17	16	-	-	1.10E-03	6.83E-04
PathwayCommons	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	1.04E-01	6.30E-04
PathwayCommons	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	2.92E-03	1.26E-03
PathwayCommons	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	1.59E-02	5.25E-03
PathwayCommons	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	1.15E-02	6.30E-04
PathwayCommons	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	1.02E-03	1.05E-03
PathwayCommons	BP	GO:0044242	cellular lipid catabolic process	-	224	222	-	-	3.84E-02	9.35E-03
PathwayCommons	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	4.70E-04	5.78E-04
PathwayCommons	BP	GO:0002931	response to ischemia	-	58	57	-	-	2.88E-03	2.42E-03
PathwayCommons	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	1.18E-02	5.25E-04
PathwayCommons	BP	GO:0014047	glutamate secretion	-	25	25	-	-	1.91E-03	1.05E-03
PathwayCommons	BP	GO:0061005	cell differentiation involved in kidney development	-	58	58	-	-	2.29E-03	2.47E-03
PathwayCommons	BP	GO:0030397	membrane disassembly	-	11	11	-	-	2.49E-03	4.73E-04
PathwayCommons	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	75	-	-	1.78E-02	3.15E-03
PathwayCommons	BP	GO:0060420	regulation of heart growth	-	74	60	-	-	1.27E-03	2.52E-03
PathwayCommons	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	4.83E-04	6.30E-04
PathwayCommons	BP	GO:0009755	hormone-mediated signaling pathway	-	221	219	-	-	6.71E-03	9.25E-03
PathwayCommons	BP	GO:0022612	gland morphogenesis	-	124	123	-	-	2.04E-03	5.20E-03
PathwayCommons	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	34	-	-	7.79E-04	1.47E-03
PathwayCommons	MF	GO:0140416	transcription regulator inhibitor activity	-	26	26	-	-	8.10E-04	1.10E-03
PathwayCommons	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	27	-	-	2.03E-01	1.16E-03
PathwayCommons	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	3.65E-03	6.30E-04
PathwayCommons	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	7.07E-03	7.35E-04
PathwayCommons	BP	GO:1990845	adaptive thermogenesis	-	166	166	-	-	4.51E-03	6.99E-03
PathwayCommons	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	1.28E-03	2.26E-03
PathwayCommons	BP	GO:0015844	monoamine transport	-	88	88	-	-	1.06E-02	3.73E-03
PathwayCommons	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	9.20E-03	9.46E-04
PathwayCommons	BP	GO:0060039	pericardium development	-	19	19	-	-	1.17E-03	8.41E-04
PathwayCommons	BP	GO:0071392	cellular response to estradiol stimulus	-	40	40	-	-	5.96E-04	1.68E-03
PathwayCommons	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	6.73E-04	5.78E-04
PathwayCommons	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	3.45E-03	8.41E-04
PathwayCommons	BP	GO:0009451	RNA modification	-	169	164	-	-	2.31E-02	6.93E-03
PathwayCommons	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	9.12E-02	4.73E-04
PathwayCommons	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	40	-	-	1.50E-03	1.68E-03
PathwayCommons	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	1.47E-03	7.35E-04
PathwayCommons	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	109	-	-	5.90E-03	4.62E-03
PathwayCommons	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	38	-	-	1.57E-03	1.63E-03
PathwayCommons	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	1.42E-02	4.73E-04
PathwayCommons	BP	GO:0015807	L-amino acid transport	-	94	92	-	-	2.11E-02	3.89E-03
PathwayCommons	BP	GO:0032941	secretion by tissue	-	85	83	-	-	2.22E-03	3.52E-03
PathwayCommons	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	2.98E-03	5.78E-04
PathwayCommons	BP	GO:0046605	regulation of centrosome cycle	-	54	53	-	-	8.15E-03	2.26E-03
PathwayCommons	BP	GO:0048753	pigment granule organization	-	40	40	-	-	1.94E-01	1.68E-03
PathwayCommons	BP	GO:0021516	dorsal spinal cord development	-	20	18	-	-	9.57E-04	7.88E-04
PathwayCommons	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	4.14E-03	8.41E-04
PathwayCommons	BP	GO:0032196	transposition	-	11	11	-	-	6.02E-04	4.73E-04
PathwayCommons	BP	GO:0003014	renal system process	-	130	129	-	-	4.34E-03	5.46E-03
PathwayCommons	CC	GO:0070286	axonemal dynein complex assembly	-	40	40	-	-	1.52E-02	1.68E-03
PathwayCommons	BP	GO:0045598	regulation of fat cell differentiation	-	148	133	-	-	3.82E-03	5.62E-03
PathwayCommons	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	193	-	-	9.49E-03	8.14E-03
PathwayCommons	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	1.16E-03	1.63E-03
PathwayCommons	BP	GO:1901863	positive regulation of muscle tissue development	-	24	23	-	-	1.43E-03	9.98E-04
PathwayCommons	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	230	-	-	2.97E-02	9.67E-03
PathwayCommons	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	12	-	-	1.43E-04	5.25E-04
PathwayCommons	BP	GO:0008340	determination of adult lifespan	-	23	22	-	-	6.91E-04	9.46E-04
PathwayCommons	BP	GO:0018158	protein oxidation	-	15	15	-	-	3.21E-03	6.30E-04
PathwayCommons	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	9.97E-04	1.26E-03
PathwayCommons	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	9.89E-03	7.35E-04
PathwayCommons	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	1.54E-03	1.16E-03
PathwayCommons	BP	GO:0071709	membrane assembly	-	68	66	-	-	2.04E-02	2.78E-03
PathwayCommons	BP	GO:0008217	regulation of blood pressure	-	186	182	-	-	1.04E-02	7.67E-03
PathwayCommons	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	1.15E-03	7.88E-04
PathwayCommons	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	6.66E-03	6.30E-04
PathwayCommons	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	62	-	-	2.72E-03	2.63E-03
PathwayCommons	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	1.31E-02	7.83E-03
PathwayCommons	BP	GO:0002200	somatic diversification of immune receptors	-	78	78	-	-	2.51E-03	3.31E-03
PathwayCommons	BP	GO:0035315	hair cell differentiation	-	52	50	-	-	5.27E-03	2.10E-03
PathwayCommons	BP	GO:0048645	animal organ formation	-	62	61	-	-	1.40E-03	2.57E-03
PathwayCommons	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	161	-	-	5.87E-03	6.78E-03
PathwayCommons	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	2.83E-03	6.30E-04
PathwayCommons	BP	GO:0033627	cell adhesion mediated by integrin	-	87	86	-	-	1.54E-02	3.62E-03
PathwayCommons	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	3.34E-02	8.93E-04
PathwayCommons	BP	GO:0015824	proline transport	-	13	13	-	-	1.48E-02	5.78E-04
PathwayCommons	BP	GO:0035107	appendage morphogenesis	-	147	146	-	-	3.94E-03	6.15E-03
PathwayCommons	BP	GO:1903707	negative regulation of hemopoiesis	-	116	109	-	-	2.22E-03	4.62E-03
PathwayCommons	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	1.63E-03	8.41E-04
PathwayCommons	CC	GO:0048208	COPII vesicle coating	-	27	26	-	-	3.80E-02	1.10E-03
PathwayCommons	BP	GO:0030149	sphingolipid catabolic process	-	32	31	-	-	1.31E-01	1.31E-03
PathwayCommons	BP	GO:0050994	regulation of lipid catabolic process	-	61	60	-	-	1.76E-03	2.52E-03
PathwayCommons	BP	GO:0035988	chondrocyte proliferation	-	24	22	-	-	1.02E-03	9.46E-04
PathwayCommons	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	2.58E-03	1.26E-03
PathwayCommons	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	1.98E-03	4.73E-04
PathwayCommons	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	1.72E-03	5.25E-04
PathwayCommons	BP	GO:0045727	positive regulation of translation	-	141	138	-	-	5.25E-03	5.83E-03
PathwayCommons	BP	GO:0036315	cellular response to sterol	-	24	20	-	-	3.54E-03	8.41E-04
PathwayCommons	CC	GO:0032388	positive regulation of intracellular transport	-	137	134	-	-	1.80E-03	5.67E-03
PathwayCommons	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	8.11E-03	5.78E-04
PathwayCommons	BP	GO:0002027	regulation of heart rate	-	106	101	-	-	6.18E-03	4.26E-03
PathwayCommons	BP	GO:0050879	multicellular organismal movement	-	118	115	-	-	3.75E-03	4.83E-03
PathwayCommons	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	2.38E-03	6.30E-04
PathwayCommons	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	75	-	-	5.50E-03	3.15E-03
PathwayCommons	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	61	-	-	1.84E-03	2.57E-03
PathwayCommons	BP	GO:0048515	spermatid differentiation	-	208	199	-	-	5.30E-03	8.41E-03
PathwayCommons	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	1.33E-03	2.42E-03
PathwayCommons	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	3.67E-03	1.31E-03
PathwayCommons	BP	GO:0007130	synaptonemal complex assembly	-	23	21	-	-	5.37E-02	8.93E-04
PathwayCommons	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	36	-	-	8.71E-03	1.52E-03
PathwayCommons	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	34	-	-	1.45E-03	1.47E-03
PathwayCommons	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	37	-	-	4.15E-02	1.58E-03
PathwayCommons	BP	GO:0060119	inner ear receptor cell development	-	44	41	-	-	8.43E-03	1.73E-03
PathwayCommons	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	3.35E-03	7.88E-04
PathwayCommons	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	4.99E-03	1.47E-03
PathwayCommons	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	1.55E-03	1.05E-03
PathwayCommons	BP	GO:0014854	response to inactivity	-	12	12	-	-	2.28E-03	5.25E-04
PathwayCommons	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	243	-	-	1.26E-02	1.02E-02
PathwayCommons	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	1.42E-03	7.35E-04
PathwayCommons	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	8.96E-02	2.05E-03
PathwayCommons	BP	GO:0010883	regulation of lipid storage	-	53	49	-	-	2.32E-03	2.10E-03
PathwayCommons	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	1.50E-03	1.10E-03
PathwayCommons	BP	GO:0007635	chemosensory behavior	-	20	20	-	-	5.64E-04	8.41E-04
PathwayCommons	BP	GO:1905954	positive regulation of lipid localization	-	110	106	-	-	8.75E-03	4.47E-03
PathwayCommons	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	4.50E-04	5.25E-04
PathwayCommons	BP	GO:0002209	behavioral defense response	-	39	39	-	-	1.22E-03	1.68E-03
PathwayCommons	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	6.21E-02	1.26E-03
PathwayCommons	BP	GO:0072523	purine-containing compound catabolic process	-	146	145	-	-	6.77E-03	6.09E-03
PathwayCommons	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	32	-	-	4.48E-03	1.37E-03
PathwayCommons	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	28	-	-	1.91E-03	1.21E-03
PathwayCommons	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	6.68E-04	6.83E-04
PathwayCommons	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	95	-	-	3.85E-03	3.99E-03
PathwayCommons	BP	GO:0007218	neuropeptide signaling pathway	-	113	108	-	-	1.66E-02	4.57E-03
PathwayCommons	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	7.53E-03	5.25E-04
PathwayCommons	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	167	-	-	7.94E-03	7.04E-03
PathwayCommons	BP	GO:0031345	negative regulation of cell projection organization	-	195	189	-	-	6.68E-03	7.99E-03
PathwayCommons	BP	GO:0048278	vesicle docking	-	64	64	-	-	2.54E-02	2.73E-03
PathwayCommons	BP	GO:0035050	embryonic heart tube development	-	86	85	-	-	5.55E-03	3.57E-03
PathwayCommons	BP	GO:0051593	response to folic acid	-	12	11	-	-	2.48E-02	4.73E-04
PathwayCommons	BP	GO:0030168	platelet activation	-	135	133	-	-	6.80E-03	5.62E-03
PathwayCommons	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	4.46E-02	6.83E-04
PathwayCommons	CC	GO:0098810	neurotransmitter reuptake	-	35	35	-	-	8.36E-03	1.47E-03
PathwayCommons	BP	GO:0008213	protein alkylation	-	58	54	-	-	5.80E-03	2.31E-03
PathwayCommons	BP	GO:0009812	flavonoid metabolic process	-	14	14	-	-	1.16E-02	6.30E-04
PathwayCommons	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	1.15E-03	5.78E-04
PathwayCommons	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	3.21E-02	1.05E-03
PathwayCommons	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.13E-03	5.78E-04
PathwayCommons	BP	GO:0031529	ruffle organization	-	55	55	-	-	2.75E-03	2.31E-03
PathwayCommons	BP	GO:0010842	retina layer formation	-	25	25	-	-	1.48E-03	1.05E-03
PathwayCommons	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	94	-	-	2.15E-02	3.99E-03
PathwayCommons	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	1.43E-03	4.73E-04
PathwayCommons	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	71	-	-	9.64E-03	2.99E-03
PathwayCommons	MF	GO:0170055	lipid transmembrane transporter activity	-	56	55	-	-	1.71E-02	2.31E-03
PathwayCommons	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	35	-	-	2.59E-03	1.47E-03
PathwayCommons	BP	GO:0035304	regulation of protein dephosphorylation	-	87	85	-	-	1.86E-03	3.57E-03
PathwayCommons	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	233	-	-	4.58E-03	9.82E-03
PathwayCommons	BP	GO:0099637	neurotransmitter receptor transport	-	26	25	-	-	2.93E-03	1.05E-03
PathwayCommons	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	7.36E-04	1.47E-03
PathwayCommons	BP	GO:0051775	response to redox state	-	13	13	-	-	3.26E-03	5.78E-04
PathwayCommons	BP	GO:0051785	positive regulation of nuclear division	-	61	60	-	-	1.57E-03	2.52E-03
PathwayCommons	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	3.27E-03	6.83E-04
PathwayCommons	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	5.08E-03	6.83E-04
PathwayCommons	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	6.43E-04	8.41E-04
PathwayCommons	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	2.57E-02	5.25E-04
PathwayCommons	BP	GO:0044786	cell cycle DNA replication	-	45	45	-	-	1.16E-02	1.89E-03
PathwayCommons	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	15	-	-	1.89E-03	6.30E-04
PathwayCommons	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	1.54E-03	7.35E-04
PathwayCommons	BP	GO:0051299	centrosome separation	-	15	15	-	-	2.15E-03	6.30E-04
PathwayCommons	BP	GO:0048145	regulation of fibroblast proliferation	-	87	85	-	-	1.46E-03	3.57E-03
PathwayCommons	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	91	-	-	1.22E-01	3.84E-03
PathwayCommons	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	1.43E-02	4.73E-04
PathwayCommons	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	225	-	-	3.33E-03	9.46E-03
PathwayCommons	BP	GO:0032098	regulation of appetite	-	20	20	-	-	3.24E-03	8.41E-04
PathwayCommons	BP	GO:0021819	layer formation in cerebral cortex	-	14	13	-	-	8.55E-03	5.78E-04
PathwayCommons	CC	GO:0008333	endosome to lysosome transport	-	73	73	-	-	4.68E-02	3.10E-03
PathwayCommons	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	22	-	-	3.05E-03	9.46E-04
PathwayCommons	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	16	-	-	8.37E-04	6.83E-04
PathwayCommons	BP	GO:0003016	respiratory system process	-	39	38	-	-	4.86E-04	1.63E-03
PathwayCommons	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	8.37E-04	9.98E-04
PathwayCommons	BP	GO:0045732	positive regulation of protein catabolic process	-	202	200	-	-	5.15E-03	8.41E-03
PathwayCommons	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	72	-	-	9.48E-02	3.05E-03
PathwayCommons	BP	GO:0007588	excretion	-	40	39	-	-	3.55E-03	1.68E-03
PathwayCommons	BP	GO:1904018	positive regulation of vasculature development	-	185	159	-	-	4.64E-03	6.72E-03
PathwayCommons	BP	GO:0050953	sensory perception of light stimulus	-	223	218	-	-	3.86E-02	9.19E-03
PathwayCommons	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	1.16E-02	1.05E-03
PathwayCommons	BP	GO:0002357	defense response to tumor cell	-	13	12	-	-	1.17E-03	5.25E-04
PathwayCommons	BP	GO:0009303	rRNA transcription	-	37	37	-	-	6.04E-03	1.58E-03
PathwayCommons	BP	GO:0035601	protein deacylation	-	56	56	-	-	6.54E-03	2.36E-03
PathwayCommons	BP	GO:0061952	midbody abscission	-	18	17	-	-	1.16E-01	7.35E-04
PathwayCommons	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	4.31E-04	4.73E-04
PathwayCommons	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	5.30E-04	8.41E-04
PathwayCommons	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	1.57E-03	1.26E-03
PathwayCommons	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	2.54E-03	2.73E-03
PathwayCommons	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	16	-	-	1.20E-02	6.83E-04
PathwayCommons	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	2.73E-03	1.21E-03
PathwayCommons	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	1.60E-03	1.42E-03
PathwayCommons	BP	GO:0046697	decidualization	-	26	26	-	-	1.33E-03	1.10E-03
PathwayCommons	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	5.07E-03	6.30E-04
PathwayCommons	BP	GO:0051588	regulation of neurotransmitter transport	-	99	97	-	-	4.51E-03	4.10E-03
PathwayCommons	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	31	-	-	1.62E-02	1.31E-03
PathwayCommons	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	3.20E-04	5.25E-04
PathwayCommons	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	2.18E-02	2.68E-03
PathwayCommons	BP	GO:0044703	multi-organism reproductive process	-	209	203	-	-	5.50E-03	8.56E-03
PathwayCommons	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	140	-	-	3.24E-03	5.88E-03
PathwayCommons	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	1.83E-01	4.73E-04
PathwayCommons	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	53	-	-	4.12E-03	2.26E-03
PathwayCommons	BP	GO:0099022	vesicle tethering	-	32	32	-	-	8.64E-02	1.37E-03
PathwayCommons	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	38	-	-	1.83E-03	1.63E-03
PathwayCommons	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	5.62E-03	5.25E-04
PathwayCommons	BP	GO:0048857	neural nucleus development	-	65	65	-	-	1.35E-03	2.73E-03
PathwayCommons	BP	GO:0048663	neuron fate commitment	-	74	72	-	-	4.04E-03	3.05E-03
PathwayCommons	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	171	-	-	5.74E-03	7.20E-03
PathwayCommons	BP	GO:0106027	neuron projection organization	-	90	88	-	-	2.14E-03	3.73E-03
PathwayCommons	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	131	-	-	9.82E-03	5.52E-03
PathwayCommons	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	1.50E-03	1.47E-03
PathwayCommons	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	6.25E-04	4.73E-04
PathwayCommons	BP	GO:0045685	regulation of glial cell differentiation	-	77	74	-	-	1.59E-03	3.15E-03
PathwayCommons	BP	GO:0051608	histamine transport	-	14	14	-	-	3.59E-03	6.30E-04
PathwayCommons	BP	GO:0043414	macromolecule methylation	-	138	132	-	-	6.99E-03	5.57E-03
PathwayCommons	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	9.75E-04	5.25E-04
PathwayCommons	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	1.40E-02	6.83E-04
PathwayCommons	BP	GO:0050886	endocrine process	-	93	92	-	-	9.70E-03	3.89E-03
PathwayCommons	MF	GO:0015562	efflux transmembrane transporter activity	-	15	15	-	-	1.53E-03	6.30E-04
PathwayCommons	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	2.34E-03	1.21E-03
PathwayCommons	BP	GO:0045807	positive regulation of endocytosis	-	155	151	-	-	7.10E-03	6.36E-03
PathwayCommons	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	1.15E-03	4.73E-04
PathwayCommons	BP	GO:0002418	immune response to tumor cell	-	29	27	-	-	2.06E-03	1.16E-03
PathwayCommons	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	1.97E-03	2.47E-03
PathwayCommons	BP	GO:0048308	organelle inheritance	-	14	14	-	-	2.48E-03	6.30E-04
PathwayCommons	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	6.09E-04	7.88E-04
PathwayCommons	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	1.05E-03	8.41E-04
PathwayCommons	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	52	-	-	6.93E-03	2.21E-03
PathwayCommons	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.45E-03	2.84E-03
PathwayCommons	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	2.99E-03	5.25E-04
PathwayCommons	BP	GO:0009110	vitamin biosynthetic process	-	23	23	-	-	2.83E-03	9.98E-04
PathwayCommons	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	2.76E-03	9.46E-04
PathwayCommons	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	5.69E-03	7.35E-04
PathwayCommons	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	22	-	-	8.44E-04	9.46E-04
PathwayCommons	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	97	-	-	1.94E-03	4.10E-03
PathwayCommons	BP	GO:0009111	vitamin catabolic process	-	13	13	-	-	1.64E-02	5.78E-04
PathwayCommons	MF	GO:0051100	negative regulation of binding	-	161	156	-	-	1.98E-03	6.57E-03
PathwayCommons	BP	GO:0003151	outflow tract morphogenesis	-	81	79	-	-	2.42E-03	3.36E-03
PathwayCommons	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	1.18E-03	2.52E-03
PathwayCommons	BP	GO:0055093	response to hyperoxia	-	20	19	-	-	1.54E-03	8.41E-04
PathwayCommons	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	2.61E-04	5.25E-04
PathwayCommons	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	5.64E-03	1.42E-03
PathwayCommons	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	2.66E-03	6.83E-04
PathwayCommons	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	5.99E-03	5.78E-04
PathwayCommons	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	1.15E-03	2.00E-03
PathwayCommons	BP	GO:0046621	negative regulation of organ growth	-	39	33	-	-	6.34E-04	1.42E-03
PathwayCommons	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	1.11E-01	2.10E-03
PathwayCommons	BP	GO:0032368	regulation of lipid transport	-	149	129	-	-	5.13E-03	5.46E-03
PathwayCommons	BP	GO:0055094	response to lipoprotein particle	-	34	30	-	-	3.69E-03	1.26E-03
PathwayCommons	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	180	-	-	5.90E-03	7.57E-03
PathwayCommons	BP	GO:0033002	muscle cell proliferation	-	249	201	-	-	4.08E-03	8.46E-03
PathwayCommons	BP	GO:0043331	response to dsRNA	-	56	56	-	-	5.50E-03	2.36E-03
PathwayCommons	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	5.44E-04	5.25E-04
PathwayCommons	BP	GO:0051904	pigment granule transport	-	23	23	-	-	5.97E-02	9.98E-04
PathwayCommons	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	1.00E-02	1.37E-03
PathwayCommons	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	34	-	-	1.06E-03	1.47E-03
PathwayCommons	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	12	-	-	1.90E-02	5.25E-04
PathwayCommons	BP	GO:0033363	secretory granule organization	-	63	63	-	-	2.18E-02	2.68E-03
PathwayCommons	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	6.36E-04	1.21E-03
PathwayCommons	BP	GO:0120009	intermembrane lipid transfer	-	52	51	-	-	2.31E-02	2.15E-03
PathwayCommons	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	9.77E-03	6.30E-04
PathwayCommons	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	1.95E-03	1.63E-03
PathwayCommons	BP	GO:0097250	mitochondrial respirasome assembly	-	11	11	-	-	6.68E-02	4.73E-04
PathwayCommons	BP	GO:0033622	integrin activation	-	26	26	-	-	8.86E-03	1.10E-03
PathwayCommons	BP	GO:0098751	bone cell development	-	18	18	-	-	2.78E-02	7.88E-04
PathwayCommons	BP	GO:2000773	negative regulation of cellular senescence	-	25	22	-	-	2.27E-03	9.46E-04
PathwayCommons	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	1.16E-03	2.15E-03
PathwayCommons	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.45E-02	1.26E-03
PathwayCommons	BP	GO:0002076	osteoblast development	-	17	17	-	-	1.90E-03	7.35E-04
PathwayCommons	BP	GO:0072164	mesonephric tubule development	-	98	98	-	-	5.61E-03	4.15E-03
PathwayCommons	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	4.87E-04	7.35E-04
PathwayCommons	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	107	-	-	2.14E-03	4.52E-03
PathwayCommons	BP	GO:1903524	positive regulation of blood circulation	-	39	36	-	-	2.51E-03	1.52E-03
PathwayCommons	BP	GO:0030901	midbrain development	-	87	87	-	-	2.42E-03	3.68E-03
PathwayCommons	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	5.05E-03	9.46E-04
PathwayCommons	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	2.83E-03	6.83E-04
PathwayCommons	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	6.56E-04	5.78E-04
PathwayCommons	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	68	-	-	2.35E-03	2.89E-03
PathwayCommons	MF	GO:1901474	azole transmembrane transporter activity	-	13	13	-	-	1.05E-01	5.78E-04
PathwayCommons	BP	GO:0002687	positive regulation of leukocyte migration	-	147	146	-	-	7.80E-03	6.15E-03
PathwayCommons	BP	GO:0019755	one-carbon compound transport	-	28	25	-	-	2.11E-02	1.05E-03
PathwayCommons	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	2.77E-04	5.78E-04
PathwayCommons	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	1.26E-03	6.83E-04
PathwayCommons	BP	GO:0110154	RNA decapping	-	19	19	-	-	3.46E-02	8.41E-04
PathwayCommons	BP	GO:0034605	cellular response to heat	-	66	66	-	-	2.10E-03	2.78E-03
PathwayCommons	BP	GO:0005996	monosaccharide metabolic process	-	250	247	-	-	1.25E-02	1.04E-02
PathwayCommons	BP	GO:0033555	multicellular organismal response to stress	-	90	89	-	-	2.68E-03	3.78E-03
PathwayCommons	BP	GO:0002262	myeloid cell homeostasis	-	172	169	-	-	3.54E-03	7.14E-03
PathwayCommons	BP	GO:0000966	RNA 5'-end processing	-	39	37	-	-	5.55E-02	1.58E-03
PathwayCommons	BP	GO:0050688	regulation of defense response to virus	-	65	64	-	-	5.22E-03	2.73E-03
PathwayCommons	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	21	-	-	2.12E-03	8.93E-04
PathwayCommons	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	225	-	-	7.25E-03	9.46E-03
PathwayCommons	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	7.91E-04	1.31E-03
PathwayCommons	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	3.52E-04	6.30E-04
PathwayCommons	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	33	-	-	4.68E-03	1.42E-03
PathwayCommons	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	18	-	-	2.94E-04	7.88E-04
PathwayCommons	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	1.33E-03	1.21E-03
PathwayCommons	BP	GO:0022618	protein-RNA complex assembly	-	227	195	-	-	3.22E-02	8.20E-03
PathwayCommons	BP	GO:0051147	regulation of muscle cell differentiation	-	162	134	-	-	2.81E-03	5.67E-03
PathwayCommons	BP	GO:0090102	cochlea development	-	50	50	-	-	1.92E-03	2.10E-03
PathwayCommons	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	8.21E-04	1.10E-03
PathwayCommons	BP	GO:0061303	cornea development in camera-type eye	-	12	12	-	-	1.52E-04	5.25E-04
PathwayCommons	BP	GO:0045933	positive regulation of muscle contraction	-	49	47	-	-	2.68E-03	2.00E-03
PathwayCommons	BP	GO:0015803	branched-chain amino acid transport	-	14	14	-	-	1.46E-02	6.30E-04
PathwayCommons	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	3.74E-04	6.83E-04
PathwayCommons	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	35	-	-	5.49E-03	1.47E-03
PathwayCommons	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	92	-	-	2.09E-01	3.89E-03
PathwayCommons	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.52E-04	5.25E-04
PathwayCommons	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	1.19E-03	9.46E-04
PathwayCommons	BP	GO:0032922	circadian regulation of gene expression	-	71	70	-	-	5.49E-03	2.94E-03
PathwayCommons	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	56	-	-	5.60E-03	2.36E-03
PathwayCommons	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	7.25E-03	9.98E-04
PathwayCommons	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	57	-	-	4.18E-03	2.42E-03
PathwayCommons	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	1.04E-03	4.73E-04
PathwayCommons	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	5.07E-03	1.63E-03
PathwayCommons	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.46E-04	5.25E-04
PathwayCommons	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	3.90E-04	4.73E-04
PathwayCommons	BP	GO:0140253	cell-cell fusion	-	62	58	-	-	2.22E-03	2.47E-03
PathwayCommons	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	2.10E-03	5.25E-04
PathwayCommons	BP	GO:0071599	otic vesicle development	-	15	15	-	-	1.51E-03	6.30E-04
PathwayCommons	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	44	-	-	9.66E-02	1.89E-03
PathwayCommons	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	6.08E-03	6.30E-04
PathwayCommons	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	2.52E-02	2.52E-03
PathwayCommons	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	2.65E-02	1.52E-03
PathwayCommons	BP	GO:0051293	establishment of spindle localization	-	57	57	-	-	7.47E-03	2.42E-03
PathwayCommons	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	3.13E-04	5.78E-04
PathwayCommons	BP	GO:0043114	regulation of vascular permeability	-	49	46	-	-	1.73E-03	1.94E-03
PathwayCommons	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	3.88E-03	1.10E-03
PathwayCommons	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	66	-	-	2.76E-03	2.78E-03
PathwayCommons	BP	GO:0008360	regulation of cell shape	-	139	133	-	-	9.40E-03	5.62E-03
PathwayCommons	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	8.16E-03	6.83E-04
PathwayCommons	BP	GO:0051222	positive regulation of protein transport	-	249	244	-	-	3.83E-03	1.03E-02
PathwayCommons	CC	GO:0140632	canonical inflammasome complex assembly	-	40	40	-	-	2.68E-02	1.68E-03
PathwayCommons	MF	GO:0034260	negative regulation of GTPase activity	-	36	33	-	-	1.71E-03	1.42E-03
PathwayCommons	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	3.43E-03	9.46E-04
PathwayCommons	BP	GO:0045739	positive regulation of DNA repair	-	128	127	-	-	1.98E-02	5.36E-03
PathwayCommons	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	3.04E-03	8.41E-04
PathwayCommons	BP	GO:0045185	maintenance of protein location	-	95	92	-	-	2.21E-03	3.89E-03
PathwayCommons	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	1.45E-03	5.78E-04
PathwayCommons	BP	GO:0003158	endothelium development	-	140	129	-	-	4.81E-03	5.46E-03
PathwayCommons	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	1.84E-03	1.73E-03
PathwayCommons	BP	GO:0051224	negative regulation of protein transport	-	122	105	-	-	2.70E-03	4.41E-03
PathwayCommons	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	150	-	-	4.43E-03	6.30E-03
PathwayCommons	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	6.04E-03	5.78E-04
PathwayCommons	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	2.08E-03	1.31E-03
PathwayCommons	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	1.69E-01	8.41E-04
PathwayCommons	BP	GO:0021885	forebrain cell migration	-	63	62	-	-	5.47E-03	2.63E-03
PathwayCommons	BP	GO:0007405	neuroblast proliferation	-	81	78	-	-	1.84E-03	3.31E-03
PathwayCommons	BP	GO:0009581	detection of external stimulus	-	137	131	-	-	1.20E-02	5.52E-03
PathwayCommons	BP	GO:1990542	mitochondrial transmembrane transport	-	93	92	-	-	3.98E-02	3.89E-03
PathwayCommons	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	32	-	-	2.76E-03	1.37E-03
PathwayCommons	BP	GO:0033504	floor plate development	-	11	11	-	-	6.40E-03	4.73E-04
PathwayCommons	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	6.15E-04	4.73E-04
PathwayCommons	BP	GO:0097186	amelogenesis	-	26	26	-	-	5.60E-03	1.10E-03
PathwayCommons	BP	GO:0031128	developmental induction	-	26	26	-	-	2.15E-03	1.10E-03
PathwayCommons	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	1.54E-03	6.30E-04
PathwayCommons	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.97E-03	2.78E-03
PathwayCommons	BP	GO:0021533	cell differentiation in hindbrain	-	23	23	-	-	1.47E-03	9.98E-04
PathwayCommons	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	9.60E-04	1.31E-03
PathwayCommons	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	2.79E-03	5.25E-04
PathwayCommons	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	2.06E-02	2.15E-03
PathwayCommons	BP	GO:0021517	ventral spinal cord development	-	47	44	-	-	1.75E-02	1.89E-03
PathwayCommons	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	3.85E-03	3.15E-03
PathwayCommons	BP	GO:0032328	alanine transport	-	19	19	-	-	1.39E-02	8.41E-04
PathwayCommons	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	2.28E-03	6.83E-04
PathwayCommons	BP	GO:0097722	sperm motility	-	133	129	-	-	7.37E-03	5.46E-03
PathwayCommons	BP	GO:0051231	spindle elongation	-	14	14	-	-	7.03E-03	6.30E-04
PathwayCommons	BP	GO:0042490	mechanoreceptor differentiation	-	67	64	-	-	8.47E-03	2.73E-03
PathwayCommons	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.16E-03	1.26E-03
PathwayCommons	BP	GO:0035148	tube formation	-	155	154	-	-	3.40E-03	6.51E-03
PathwayCommons	BP	GO:0048520	positive regulation of behavior	-	27	27	-	-	1.11E-02	1.16E-03
PathwayCommons	BP	GO:0098543	detection of other organism	-	19	19	-	-	6.52E-03	8.41E-04
PathwayCommons	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	1.39E-02	1.84E-03
PathwayCommons	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	124	-	-	6.09E-03	5.25E-03
PathwayCommons	BP	GO:0031123	RNA 3'-end processing	-	79	78	-	-	1.26E-02	3.31E-03
PathwayCommons	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	6.67E-03	4.73E-04
PathwayCommons	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	110	-	-	6.87E-03	4.62E-03
PathwayCommons	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	1.16E-02	7.88E-04
PathwayCommons	CC	GO:0007097	nuclear migration	-	24	23	-	-	6.52E-03	9.98E-04
PathwayCommons	BP	GO:0006885	regulation of pH	-	104	104	-	-	1.74E-02	4.41E-03
PathwayCommons	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.37E-03	6.30E-04
PathwayCommons	BP	GO:1990840	response to lectin	-	22	21	-	-	5.28E-02	8.93E-04
PathwayCommons	BP	GO:0071800	podosome assembly	-	19	19	-	-	9.13E-04	8.41E-04
PathwayCommons	BP	GO:0031018	endocrine pancreas development	-	47	46	-	-	2.21E-03	1.94E-03
PathwayCommons	BP	GO:0001708	cell fate specification	-	108	106	-	-	6.12E-03	4.47E-03
PathwayCommons	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	68	-	-	2.05E-03	2.89E-03
PathwayCommons	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	1.06E-03	1.58E-03
PathwayCommons	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	2.75E-02	6.30E-04
PathwayCommons	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	2.09E-03	5.25E-04
PathwayCommons	BP	GO:0042440	pigment metabolic process	-	80	78	-	-	7.98E-03	3.31E-03
PathwayCommons	BP	GO:1901606	alpha-amino acid catabolic process	-	101	99	-	-	6.41E-02	4.20E-03
PathwayCommons	BP	GO:1901890	positive regulation of cell junction assembly	-	106	102	-	-	4.52E-03	4.31E-03
PathwayCommons	BP	GO:0070988	demethylation	-	27	27	-	-	8.92E-03	1.16E-03
PathwayCommons	BP	GO:1901655	cellular response to ketone	-	107	105	-	-	1.94E-03	4.41E-03
PathwayCommons	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	3.04E-03	6.30E-04
PathwayCommons	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	9.29E-03	6.30E-04
PathwayCommons	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	8.19E-02	7.35E-04
PathwayCommons	BP	GO:0006968	cellular defense response	-	52	52	-	-	1.15E-02	2.21E-03
PathwayCommons	BP	GO:0055006	cardiac cell development	-	93	84	-	-	2.19E-03	3.57E-03
PathwayCommons	BP	GO:0031365	N-terminal protein amino acid modification	-	30	29	-	-	1.45E-02	1.26E-03
PathwayCommons	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	8.02E-04	5.25E-04
PathwayCommons	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	28	-	-	9.56E-04	1.21E-03
PathwayCommons	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	3.00E-04	5.25E-04
PathwayCommons	BP	GO:0060004	reflex	-	63	61	-	-	2.96E-03	2.57E-03
PathwayCommons	BP	GO:0044706	multi-multicellular organism process	-	217	211	-	-	5.93E-03	8.88E-03
PathwayCommons	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	1.80E-03	5.25E-04
PathwayCommons	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	139	-	-	6.10E-03	5.88E-03
PathwayCommons	BP	GO:0006026	aminoglycan catabolic process	-	34	33	-	-	3.88E-03	1.42E-03
PathwayCommons	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	4.74E-03	1.94E-03
PathwayCommons	BP	GO:0050768	negative regulation of neurogenesis	-	150	146	-	-	2.99E-03	6.15E-03
PathwayCommons	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	95	-	-	1.94E-03	3.99E-03
PathwayCommons	BP	GO:0090068	positive regulation of cell cycle process	-	262	249	-	-	6.35E-03	1.05E-02
PathwayCommons	BP	GO:0043605	amide catabolic process	-	16	16	-	-	7.50E-02	6.83E-04
PathwayCommons	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	1.66E-03	1.16E-03
PathwayCommons	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	2.35E-02	1.47E-03
PathwayCommons	BP	GO:1902115	regulation of organelle assembly	-	210	205	-	-	8.53E-03	8.62E-03
PathwayCommons	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	64	-	-	2.19E-03	2.73E-03
PathwayCommons	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	3.80E-03	6.83E-04
PathwayCommons	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	142	-	-	4.56E-03	5.99E-03
PathwayCommons	BP	GO:0043171	peptide catabolic process	-	19	18	-	-	4.80E-03	7.88E-04
PathwayCommons	BP	GO:0046622	positive regulation of organ growth	-	52	43	-	-	1.70E-03	1.84E-03
PathwayCommons	BP	GO:0051952	regulation of amine transport	-	98	98	-	-	9.74E-03	4.15E-03
PathwayCommons	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	1.19E-02	9.98E-04
PathwayCommons	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	9.21E-03	8.41E-04
PathwayCommons	BP	GO:0015801	aromatic amino acid transport	-	13	13	-	-	6.87E-02	5.78E-04
PathwayCommons	BP	GO:0040019	positive regulation of embryonic development	-	23	22	-	-	5.97E-02	9.46E-04
PathwayCommons	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	1.45E-03	8.41E-04
PathwayCommons	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	3.08E-04	6.83E-04
PathwayCommons	CC	GO:0032365	intracellular lipid transport	-	51	49	-	-	2.13E-02	2.10E-03
PathwayCommons	BP	GO:0045048	protein insertion into ER membrane	-	30	29	-	-	4.14E-02	1.26E-03
PathwayCommons	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	69	-	-	2.02E-03	2.94E-03
PathwayCommons	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	113	-	-	3.03E-03	4.78E-03
PathwayCommons	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	4.73E-02	1.21E-03
PathwayCommons	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	7.46E-04	1.05E-03
PathwayCommons	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	3.79E-04	5.78E-04
PathwayCommons	BP	GO:0021859	pyramidal neuron differentiation	-	14	13	-	-	1.41E-04	5.78E-04
PathwayCommons	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	5.92E-04	5.78E-04
PathwayCommons	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	9.83E-04	1.47E-03
PathwayCommons	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	4.21E-03	4.73E-04
PathwayCommons	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	6.96E-03	3.78E-03
PathwayCommons	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	30	-	-	5.09E-02	1.26E-03
PathwayCommons	BP	GO:1903975	regulation of glial cell migration	-	20	17	-	-	1.40E-03	7.35E-04
PathwayCommons	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	1.10E-02	8.93E-04
PathwayCommons	BP	GO:0015669	gas transport	-	23	22	-	-	5.35E-02	9.46E-04
PathwayCommons	BP	GO:0016485	protein processing	-	248	247	-	-	1.07E-02	1.04E-02
PathwayCommons	BP	GO:0009649	entrainment of circadian clock	-	30	29	-	-	4.26E-03	1.26E-03
PathwayCommons	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	164	-	-	2.14E-02	6.93E-03
PathwayCommons	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	9.40E-04	1.05E-03
PathwayCommons	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	136	-	-	1.71E-02	5.73E-03
PathwayCommons	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	7.88E-03	5.25E-04
PathwayCommons	BP	GO:0099054	presynapse assembly	-	49	48	-	-	4.74E-03	2.05E-03
PathwayCommons	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	1.13E-01	5.25E-04
PathwayCommons	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	3.99E-03	1.05E-03
PathwayCommons	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	2.69E-03	1.05E-03
PathwayCommons	BP	GO:0031348	negative regulation of defense response	-	282	239	-	-	3.70E-03	1.01E-02
PathwayCommons	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	76	-	-	5.96E-03	3.20E-03
PathwayCommons	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	1.54E-03	2.89E-03
PathwayCommons	BP	GO:0071496	cellular response to external stimulus	-	74	74	-	-	4.19E-03	3.15E-03
PathwayCommons	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	3.96E-03	5.78E-04
PathwayCommons	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	1.59E-03	7.35E-04
PathwayCommons	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	6.01E-04	4.73E-04
PathwayCommons	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	2.96E-03	5.25E-04
PathwayCommons	BP	GO:0032094	response to food	-	37	37	-	-	2.06E-03	1.58E-03
PathwayCommons	BP	GO:0001964	startle response	-	27	27	-	-	8.92E-04	1.16E-03
PathwayCommons	BP	GO:0007340	acrosome reaction	-	38	35	-	-	2.45E-02	1.47E-03
PathwayCommons	BP	GO:0046434	organophosphate catabolic process	-	232	230	-	-	1.51E-02	9.67E-03
PathwayCommons	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	1.26E-03	1.26E-03
PathwayCommons	BP	GO:0009566	fertilization	-	205	193	-	-	2.21E-02	8.14E-03
PathwayCommons	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	55	-	-	4.95E-01	2.31E-03
PathwayCommons	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	2.73E-03	1.05E-03
PathwayCommons	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	5.48E-03	5.78E-04
PathwayCommons	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	3.40E-03	1.26E-03
PathwayCommons	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	23	-	-	1.17E-03	9.98E-04
PathwayCommons	BP	GO:0033044	regulation of chromosome organization	-	249	249	-	-	1.50E-02	1.05E-02
PathwayCommons	BP	GO:0009309	amine biosynthetic process	-	38	37	-	-	1.97E-02	1.58E-03
PathwayCommons	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	3.47E-04	8.41E-04
PathwayCommons	BP	GO:0061900	glial cell activation	-	56	51	-	-	1.51E-03	2.15E-03
PathwayCommons	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	133	-	-	5.22E-03	5.62E-03
PathwayCommons	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	2.24E-03	5.78E-04
PathwayCommons	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	7.15E-04	6.30E-04
PathwayCommons	BP	GO:0021794	thalamus development	-	12	12	-	-	6.45E-04	5.25E-04
PathwayCommons	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	3.81E-03	1.73E-03
PathwayCommons	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	3.52E-04	8.41E-04
PathwayCommons	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	1.16E-03	6.30E-04
PathwayCommons	BP	GO:0072537	fibroblast activation	-	13	13	-	-	5.09E-04	5.78E-04
PathwayCommons	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	2.10E-03	5.78E-04
PathwayCommons	BP	GO:0043647	inositol phosphate metabolic process	-	44	44	-	-	1.62E-01	1.89E-03
PathwayCommons	BP	GO:0016180	snRNA processing	-	28	27	-	-	6.80E-02	1.16E-03
PathwayCommons	BP	GO:0051303	establishment of chromosome localization	-	104	102	-	-	2.23E-02	4.31E-03
PathwayCommons	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	8.98E-03	6.83E-04
PathwayCommons	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	7.25E-03	1.63E-03
PathwayCommons	BP	GO:0097164	ammonium ion metabolic process	-	23	23	-	-	2.78E-03	9.98E-04
PathwayCommons	BP	GO:0021515	cell differentiation in spinal cord	-	51	49	-	-	8.32E-03	2.10E-03
PathwayCommons	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	4.60E-04	7.88E-04
PathwayCommons	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	2.52E-03	8.93E-04
PathwayCommons	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	8.09E-04	1.21E-03
PathwayCommons	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.34E-03	7.88E-04
PathwayCommons	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	38	-	-	3.90E-02	1.63E-03
PathwayCommons	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	1.90E-03	9.46E-04
PathwayCommons	BP	GO:0007566	embryo implantation	-	57	52	-	-	1.46E-03	2.21E-03
PathwayCommons	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	5.23E-03	1.42E-03
PathwayCommons	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	7.94E-02	6.83E-04
PathwayCommons	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	8.07E-03	1.37E-03
PathwayCommons	BP	GO:0051017	actin filament bundle assembly	-	161	156	-	-	8.30E-03	6.57E-03
PathwayCommons	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	1.63E-03	1.79E-03
PathwayCommons	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	3.27E-03	7.88E-04
PathwayCommons	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	6.07E-04	8.41E-04
PathwayCommons	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	1.46E-03	5.78E-04
PathwayCommons	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	36	-	-	2.84E-03	1.52E-03
PathwayCommons	BP	GO:0021756	striatum development	-	21	21	-	-	5.24E-03	8.93E-04
PathwayCommons	BP	GO:1901343	negative regulation of vasculature development	-	154	99	-	-	1.08E-02	4.20E-03
PathwayCommons	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	148	-	-	2.75E-02	6.25E-03
PathwayCommons	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	31	-	-	5.05E-03	1.31E-03
PathwayCommons	BP	GO:1902414	protein localization to cell junction	-	107	106	-	-	4.80E-03	4.47E-03
PathwayCommons	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	2.42E-03	9.46E-04
PathwayCommons	BP	GO:0051304	chromosome separation	-	80	80	-	-	2.51E-02	3.36E-03
PathwayCommons	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	1.51E-03	7.88E-04
PathwayCommons	BP	GO:0048709	oligodendrocyte differentiation	-	101	100	-	-	3.24E-03	4.20E-03
PathwayCommons	BP	GO:0045017	glycerolipid biosynthetic process	-	254	249	-	-	6.04E-02	1.05E-02
PathwayCommons	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	7.76E-02	6.30E-04
PathwayCommons	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	24	-	-	6.03E-03	1.05E-03
PathwayCommons	BP	GO:0001776	leukocyte homeostasis	-	108	108	-	-	2.35E-03	4.57E-03
PathwayCommons	BP	GO:0050769	positive regulation of neurogenesis	-	240	235	-	-	5.46E-03	9.88E-03
PathwayCommons	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	2.16E-02	6.30E-04
PathwayCommons	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	2.61E-02	2.94E-03
PathwayCommons	BP	GO:0050866	negative regulation of cell activation	-	216	206	-	-	5.74E-03	8.67E-03
PathwayCommons	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	35	-	-	2.12E-03	1.47E-03
PathwayCommons	BP	GO:0033500	carbohydrate homeostasis	-	251	234	-	-	4.13E-03	9.88E-03
PathwayCommons	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	31	-	-	7.03E-03	1.31E-03
PathwayCommons	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	2.56E-03	5.25E-04
PathwayCommons	BP	GO:0044088	regulation of vacuole organization	-	56	55	-	-	6.04E-03	2.31E-03
PathwayCommons	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	2.04E-03	9.98E-04
PathwayCommons	CC	GO:0099522	cytosolic region	-	20	20	-	-	7.47E-04	8.41E-04
PathwayCommons	CC	GO:0000791	euchromatin	-	60	60	-	-	1.27E-03	2.52E-03
PathwayCommons	CC	GO:0030666	endocytic vesicle membrane	-	196	196	-	-	1.45E-02	8.25E-03
PathwayCommons	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	3.54E-02	6.30E-04
PathwayCommons	CC	GO:1990752	microtubule end	-	34	34	-	-	9.41E-03	1.47E-03
PathwayCommons	CC	GO:0043204	perikaryon	-	156	156	-	-	2.69E-03	6.57E-03
PathwayCommons	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	6.50E-02	7.35E-04
PathwayCommons	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	1.45E-02	5.25E-04
PathwayCommons	CC	GO:0097542	ciliary tip	-	48	48	-	-	2.36E-01	2.05E-03
PathwayCommons	CC	GO:1905368	peptidase complex	-	124	121	-	-	3.24E-02	5.10E-03
PathwayCommons	CC	GO:0000792	heterochromatin	-	98	97	-	-	6.12E-03	4.10E-03
PathwayCommons	CC	GO:0097546	ciliary base	-	47	42	-	-	1.15E-02	1.79E-03
PathwayCommons	CC	GO:0071819	DUBm complex	-	25	23	-	-	1.59E-01	9.98E-04
PathwayCommons	CC	GO:0031201	SNARE complex	-	48	48	-	-	1.30E-01	2.05E-03
PathwayCommons	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	1.40E-03	5.78E-04
PathwayCommons	CC	GO:0033260	nuclear DNA replication	-	40	40	-	-	1.34E-02	1.68E-03
PathwayCommons	CC	GO:0044391	ribosomal subunit	-	203	202	-	-	2.35E-01	8.51E-03
PathwayCommons	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	3.67E-02	4.73E-04
PathwayCommons	CC	GO:0071013	catalytic step 2 spliceosome	-	88	87	-	-	1.19E-01	3.68E-03
PathwayCommons	CC	GO:0031907	microbody lumen	-	51	51	-	-	8.33E-02	2.15E-03
PathwayCommons	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	1.82E-01	5.25E-04
PathwayCommons	CC	GO:0098862	cluster of actin-based cell projections	-	162	156	-	-	1.44E-02	6.57E-03
PathwayCommons	CC	GO:0016363	nuclear matrix	-	127	127	-	-	4.05E-03	5.36E-03
PathwayCommons	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	5.74E-02	1.94E-03
PathwayCommons	CC	GO:0032432	actin filament bundle	-	249	243	-	-	9.79E-03	1.02E-02
PathwayCommons	CC	GO:0008088	axo-dendritic transport	-	78	78	-	-	1.54E-02	3.31E-03
PathwayCommons	CC	GO:0031519	PcG protein complex	-	38	38	-	-	3.63E-02	1.63E-03
PathwayCommons	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	40	-	-	9.02E-03	1.68E-03
PathwayCommons	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	218	-	-	3.00E-02	9.19E-03
PathwayCommons	CC	GO:0000313	organellar ribosome	-	89	89	-	-	5.07E-01	3.78E-03
PathwayCommons	CC	GO:0099643	signal release from synapse	-	147	145	-	-	1.54E-02	6.09E-03
PathwayCommons	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	3.18E-02	1.94E-03
PathwayCommons	CC	GO:0005818	aster	-	11	11	-	-	6.12E-03	4.73E-04
PathwayCommons	CC	GO:0030018	Z disc	-	129	129	-	-	1.05E-02	5.46E-03
PathwayCommons	CC	GO:0032580	Golgi cisterna membrane	-	93	82	-	-	5.34E-02	3.47E-03
PathwayCommons	CC	GO:0097381	photoreceptor disc membrane	-	25	22	-	-	9.77E-02	9.46E-04
PathwayCommons	CC	GO:1905360	GTPase complex	-	41	39	-	-	2.90E-03	1.68E-03
PathwayCommons	CC	GO:0097540	axonemal central pair	-	161	148	-	-	4.24E-03	6.25E-03
PathwayCommons	CC	GO:0042641	actomyosin	-	77	76	-	-	7.96E-03	3.20E-03
PathwayCommons	CC	GO:0097386	glial cell projection	-	38	38	-	-	1.41E-03	1.63E-03
PathwayCommons	CC	GO:0032588	trans-Golgi network membrane	-	102	102	-	-	4.21E-02	4.31E-03
PathwayCommons	CC	GO:0070382	exocytic vesicle	-	224	220	-	-	1.70E-02	9.25E-03
PathwayCommons	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	45	-	-	1.29E-02	1.89E-03
PathwayCommons	CC	GO:0031903	microbody membrane	-	65	64	-	-	7.08E-02	2.73E-03
PathwayCommons	CC	GO:0046930	pore complex	-	26	26	-	-	5.20E-02	1.10E-03
PathwayCommons	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	1.17E-02	4.73E-04
PathwayCommons	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	6.84E-04	6.83E-04
PathwayCommons	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	1.04E-02	1.05E-03
PathwayCommons	CC	GO:1990071	TRAPPII protein complex	-	12	12	-	-	1.01E-01	5.25E-04
PathwayCommons	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	1.41E-03	7.88E-04
PathwayCommons	CC	GO:0044298	cell body membrane	-	32	32	-	-	9.74E-03	1.37E-03
PathwayCommons	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	1.32E-02	4.73E-04
PathwayCommons	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	5.02E-04	8.93E-04
PathwayCommons	CC	GO:0045495	pole plasm	-	25	24	-	-	1.24E-01	1.05E-03
PathwayCommons	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	6.87E-03	6.30E-04
PathwayCommons	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	9.54E-02	8.41E-04
PathwayCommons	CC	GO:0010369	chromocenter	-	14	14	-	-	1.39E-03	6.30E-04
PathwayCommons	CC	GO:0002177	manchette	-	19	17	-	-	4.80E-02	7.35E-04
PathwayCommons	CC	GO:0016323	basolateral plasma membrane	-	239	237	-	-	9.24E-03	9.98E-03
PathwayCommons	CC	GO:0045009	chitosome	-	21	21	-	-	5.98E-02	8.93E-04
PathwayCommons	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	2.22E-03	5.25E-04
PathwayCommons	CC	GO:0042645	mitochondrial nucleoid	-	45	44	-	-	7.53E-03	1.89E-03
PathwayCommons	CC	GO:0098636	protein complex involved in cell adhesion	-	57	56	-	-	4.46E-02	2.36E-03
PathwayCommons	CC	GO:0001917	photoreceptor inner segment	-	71	68	-	-	6.35E-03	2.89E-03
PathwayCommons	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	3.17E-03	6.30E-04
PathwayCommons	CC	GO:0019897	extrinsic component of plasma membrane	-	156	154	-	-	5.14E-03	6.51E-03
PathwayCommons	CC	GO:0031594	neuromuscular junction	-	73	73	-	-	3.92E-03	3.10E-03
PathwayCommons	CC	GO:0045120	pronucleus	-	14	14	-	-	3.40E-04	6.30E-04
PathwayCommons	CC	GO:0043083	synaptic cleft	-	21	21	-	-	3.08E-03	8.93E-04
PathwayCommons	CC	GO:0000922	spindle pole	-	172	171	-	-	1.33E-02	7.20E-03
PathwayCommons	CC	GO:0120111	neuron projection cytoplasm	-	94	94	-	-	1.41E-02	3.99E-03
PathwayCommons	CC	GO:0070971	endoplasmic reticulum exit site	-	32	31	-	-	6.26E-02	1.31E-03
PathwayCommons	CC	GO:0005736	RNA polymerase I complex	-	13	12	-	-	1.23E-02	5.25E-04
PathwayCommons	CC	GO:0004879	nuclear receptor activity	-	63	63	-	-	2.00E-03	2.68E-03
PathwayCommons	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	168	-	-	5.06E-03	7.09E-03
PathwayCommons	CC	GO:0000123	histone acetyltransferase complex	-	93	91	-	-	6.68E-02	3.84E-03
PathwayCommons	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	5.55E-03	5.78E-04
PathwayCommons	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	104	-	-	1.60E-01	4.41E-03
PathwayCommons	CC	GO:0048786	presynaptic active zone	-	80	80	-	-	1.06E-02	3.36E-03
PathwayCommons	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	6.02E-03	4.73E-04
PathwayCommons	CC	GO:0001054	RNA polymerase I activity	-	12	11	-	-	1.08E-02	4.73E-04
PathwayCommons	CC	GO:0007034	vacuolar transport	-	168	166	-	-	4.36E-02	6.99E-03
PathwayCommons	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	8.81E-02	8.93E-04
PathwayCommons	CC	GO:0043194	axon initial segment	-	21	21	-	-	6.93E-02	8.93E-04
PathwayCommons	CC	GO:1900115	extracellular regulation of signal transduction	-	13	12	-	-	2.04E-02	5.25E-04
PathwayCommons	CC	GO:0005776	autophagosome	-	111	109	-	-	3.43E-02	4.62E-03
PathwayCommons	CC	GO:0031430	M band	-	22	22	-	-	2.41E-03	9.46E-04
PathwayCommons	CC	GO:0001931	uropod	-	13	13	-	-	1.23E-02	5.78E-04
PathwayCommons	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	78	-	-	1.10E-01	3.31E-03
PathwayCommons	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	88	-	-	1.81E-01	3.73E-03
PathwayCommons	CC	GO:0030677	ribonuclease P complex	-	14	12	-	-	2.04E-01	5.25E-04
PathwayCommons	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	7.49E-02	8.41E-04
PathwayCommons	CC	GO:0071203	WASH complex	-	12	12	-	-	2.41E-01	5.25E-04
PathwayCommons	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	1.38E-02	1.26E-03
PathwayCommons	CC	GO:0032994	protein-lipid complex	-	39	39	-	-	6.12E-02	1.68E-03
PathwayCommons	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	150	-	-	1.68E-01	6.30E-03
PathwayCommons	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	9.34E-03	5.25E-04
PathwayCommons	CC	GO:0001527	microfibril	-	13	13	-	-	1.30E-01	5.78E-04
PathwayCommons	CC	GO:0072562	blood microparticle	-	144	140	-	-	1.24E-02	5.88E-03
PathwayCommons	CC	GO:0005883	neurofilament	-	11	11	-	-	7.44E-03	4.73E-04
PathwayCommons	CC	GO:0051233	spindle midzone	-	36	36	-	-	7.34E-03	1.52E-03
PathwayCommons	CC	GO:0005811	lipid droplet	-	102	102	-	-	7.24E-03	4.31E-03
PathwayCommons	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	7.95E-03	1.89E-03
PathwayCommons	CC	GO:0043113	receptor clustering	-	51	50	-	-	3.43E-03	2.10E-03
PathwayCommons	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	2.68E-02	4.73E-04
PathwayCommons	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	24	-	-	8.27E-02	1.05E-03
PathwayCommons	CC	GO:0044853	plasma membrane raft	-	114	113	-	-	4.68E-03	4.78E-03
PathwayCommons	CC	GO:0005881	cytoplasmic microtubule	-	256	237	-	-	4.31E-03	9.98E-03
PathwayCommons	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	2.15E-03	6.30E-04
PathwayCommons	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	1.72E-02	7.35E-04
PathwayCommons	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	58	-	-	1.24E-02	2.47E-03
PathwayCommons	CC	GO:0005905	clathrin-coated pit	-	73	73	-	-	1.50E-02	3.10E-03
PathwayCommons	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	4.20E-02	5.25E-04
PathwayCommons	CC	GO:0043034	costamere	-	18	18	-	-	3.39E-03	7.88E-04
PathwayCommons	CC	GO:0031904	endosome lumen	-	38	38	-	-	8.23E-03	1.63E-03
PathwayCommons	CC	GO:0060170	ciliary membrane	-	76	74	-	-	2.56E-02	3.15E-03
PathwayCommons	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	1.83E-01	5.78E-04
PathwayCommons	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	4.28E-02	5.25E-04
PathwayCommons	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	27	-	-	1.21E-01	1.16E-03
PathwayCommons	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	4.27E-02	6.30E-04
PathwayCommons	CC	GO:0032154	cleavage furrow	-	54	51	-	-	4.67E-03	2.15E-03
PathwayCommons	CC	GO:0005640	nuclear outer membrane	-	30	30	-	-	1.42E-03	1.26E-03
PathwayCommons	CC	GO:0005652	nuclear lamina	-	12	12	-	-	2.38E-03	5.25E-04
PathwayCommons	CC	GO:0007006	mitochondrial membrane organization	-	117	110	-	-	3.53E-02	4.62E-03
PathwayCommons	CC	GO:0001772	immunological synapse	-	44	44	-	-	4.13E-03	1.89E-03
PathwayCommons	CC	GO:0030904	retromer complex	-	12	12	-	-	4.46E-02	5.25E-04
PathwayCommons	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	1.74E-02	5.25E-04
PathwayCommons	CC	GO:0030863	cortical cytoskeleton	-	104	103	-	-	8.38E-03	4.36E-03
PathwayCommons	CC	GO:1905348	endonuclease complex	-	38	35	-	-	6.86E-02	1.47E-03
PathwayCommons	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	2.04E-01	4.73E-04
PathwayCommons	CC	GO:0061638	CENP-A containing chromatin	-	18	18	-	-	1.72E-03	7.88E-04
PathwayCommons	CC	GO:0030315	T-tubule	-	52	52	-	-	9.53E-03	2.21E-03
PathwayCommons	CC	GO:0060076	excitatory synapse	-	64	63	-	-	8.97E-03	2.68E-03
PathwayCommons	CC	GO:0036019	endolysosome	-	29	29	-	-	1.41E-02	1.26E-03
PathwayCommons	CC	GO:0001891	phagocytic cup	-	28	28	-	-	2.35E-03	1.21E-03
PathwayCommons	CC	GO:0099086	synaptonemal structure	-	40	38	-	-	4.26E-02	1.63E-03
PathwayCommons	CC	GO:0030427	site of polarized growth	-	172	171	-	-	4.64E-03	7.20E-03
PathwayCommons	CC	GO:0044309	neuron spine	-	213	211	-	-	6.70E-03	8.88E-03
PathwayCommons	CC	GO:0030658	transport vesicle membrane	-	231	229	-	-	2.77E-02	9.67E-03
PathwayCommons	CC	GO:0000813	ESCRT I complex	-	11	11	-	-	1.16E-01	4.73E-04
PathwayCommons	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	4.24E-03	1.16E-03
PathwayCommons	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.09E-01	5.25E-04
PathwayCommons	CC	GO:0000940	outer kinetochore	-	17	17	-	-	4.48E-02	7.35E-04
PathwayCommons	CC	GO:0034719	SMN-Sm protein complex	-	18	18	-	-	5.06E-02	7.88E-04
PathwayCommons	CC	GO:0044232	organelle membrane contact site	-	50	49	-	-	7.14E-03	2.10E-03
PathwayCommons	CC	GO:0098803	respiratory chain complex	-	39	34	-	-	4.89E-01	1.47E-03
PathwayCommons	CC	GO:0097545	axonemal outer doublet	-	164	151	-	-	3.07E-03	6.36E-03
PathwayCommons	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	1.55E-03	8.41E-04
PathwayCommons	CC	GO:0070069	cytochrome complex	-	42	37	-	-	4.81E-01	1.58E-03
PathwayCommons	CC	GO:0031143	pseudopodium	-	18	18	-	-	3.90E-03	7.88E-04
PathwayCommons	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	4.80E-03	1.16E-03
PathwayCommons	CC	GO:0055037	recycling endosome	-	200	199	-	-	8.18E-03	8.41E-03
PathwayCommons	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	93	-	-	4.75E-03	3.94E-03
PathwayCommons	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	1.14E-02	5.78E-04
PathwayCommons	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	1.73E-03	5.25E-04
PathwayCommons	CC	GO:0071682	endocytic vesicle lumen	-	23	23	-	-	1.34E-03	9.98E-04
PathwayCommons	CC	GO:0030684	preribosome	-	76	73	-	-	1.34E-01	3.10E-03
PathwayCommons	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	19	-	-	6.36E-02	8.41E-04
PathwayCommons	CC	GO:1990391	DNA repair complex	-	22	22	-	-	1.20E-02	9.46E-04
PathwayCommons	CC	GO:0005775	vacuolar lumen	-	176	174	-	-	1.48E-02	7.35E-03
PathwayCommons	CC	GO:0032433	filopodium tip	-	19	18	-	-	9.82E-04	7.88E-04
PathwayCommons	CC	GO:0032982	myosin filament	-	24	24	-	-	6.84E-03	1.05E-03
PathwayCommons	CC	GO:0016327	apicolateral plasma membrane	-	23	23	-	-	9.21E-04	9.98E-04
PathwayCommons	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	22	-	-	1.21E-01	9.46E-04
PathwayCommons	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	5.24E-03	5.25E-04
PathwayCommons	CC	GO:0044306	neuron projection terminus	-	164	163	-	-	7.52E-03	6.88E-03
PathwayCommons	CC	GO:0034455	t-UTP complex	-	53	50	-	-	1.43E-01	2.10E-03
PathwayCommons	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	2.04E-01	7.35E-04
PathwayCommons	CC	GO:0031970	organelle envelope lumen	-	94	94	-	-	1.23E-02	3.99E-03
PathwayCommons	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	7.27E-03	5.78E-04
PathwayCommons	CC	GO:0120293	dynein axonemal particle	-	20	18	-	-	9.40E-03	7.88E-04
PathwayCommons	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	1.36E-03	1.05E-03
PathwayCommons	CC	GO:0043292	contractile muscle fiber	-	245	244	-	-	1.97E-02	1.03E-02
PathwayCommons	CC	GO:0018995	host cellular component	-	12	12	-	-	2.36E-03	5.25E-04
PathwayCommons	CC	GO:0034709	methylosome	-	13	13	-	-	6.21E-03	5.78E-04
PathwayCommons	CC	GO:0032426	stereocilium tip	-	21	18	-	-	1.31E-03	7.88E-04
PathwayCommons	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	1.41E-02	5.25E-04
PathwayCommons	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	8.96E-02	8.41E-04
PathwayCommons	CC	GO:0000803	sex chromosome	-	32	29	-	-	2.77E-03	1.26E-03
PathwayCommons	CC	GO:0098982	GABA-ergic synapse	-	84	83	-	-	4.42E-02	3.52E-03
PathwayCommons	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	17	-	-	3.81E-02	7.35E-04
PathwayCommons	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	4.42E-02	2.68E-03
PathwayCommons	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	9.76E-02	6.30E-04
PathwayCommons	CC	GO:0000242	pericentriolar material	-	22	22	-	-	4.50E-03	9.46E-04
PathwayCommons	CC	GO:1903293	phosphatase complex	-	54	54	-	-	1.78E-02	2.31E-03
PathwayCommons	CC	GO:0097470	ribbon synapse	-	13	13	-	-	2.63E-03	5.78E-04
PathwayCommons	CC	GO:0031941	filamentous actin	-	27	27	-	-	3.87E-03	1.16E-03
PathwayCommons	CC	GO:0000786	nucleosome	-	149	141	-	-	2.47E-02	5.94E-03
PathwayCommons	CC	GO:0001533	cornified envelope	-	59	59	-	-	7.37E-02	2.52E-03
PathwayCommons	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	3.71E-03	2.31E-03
PathwayCommons	CC	GO:0030027	lamellipodium	-	202	200	-	-	1.03E-02	8.41E-03
PathwayCommons	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	9.76E-04	6.30E-04
PathwayCommons	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	23	-	-	5.96E-02	9.98E-04
PathwayCommons	CC	GO:0000800	lateral element	-	14	14	-	-	5.43E-03	6.30E-04
PathwayCommons	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	2.91E-03	5.25E-04
PathwayCommons	CC	GO:0060077	inhibitory synapse	-	20	19	-	-	1.34E-02	8.41E-04
PathwayCommons	CC	GO:0031209	SCAR complex	-	12	12	-	-	9.59E-03	5.25E-04
PathwayCommons	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	1.26E-01	6.83E-04
PathwayCommons	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	19	-	-	1.69E-01	8.41E-04
PathwayCommons	CC	GO:0002102	podosome	-	31	31	-	-	1.57E-03	1.31E-03
PathwayCommons	CC	GO:0090543	Flemming body	-	33	33	-	-	1.23E-02	1.42E-03
PathwayCommons	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	3.13E-03	2.78E-03
PathwayCommons	CC	GO:0001650	fibrillar center	-	151	150	-	-	3.12E-03	6.30E-03
PathwayCommons	CC	GO:0031332	RNAi effector complex	-	413	17	-	-	1.58E-02	7.35E-04
PathwayCommons	CC	GO:1990204	oxidoreductase complex	-	90	83	-	-	2.00E-01	3.52E-03
PathwayCommons	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	3.06E-02	6.83E-04
PathwayCommons	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	124	-	-	3.16E-03	5.25E-03
PathwayCommons	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	1.88E-02	8.41E-04
PathwayCommons	CC	GO:0001726	ruffle	-	181	180	-	-	7.65E-03	7.57E-03
PathwayCommons	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	4.38E-03	5.78E-04
PathwayCommons	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	4.53E-02	7.88E-04
PathwayCommons	CC	GO:0043198	dendritic shaft	-	38	38	-	-	7.89E-04	1.63E-03
PathwayCommons	CC	GO:0043073	germ cell nucleus	-	67	65	-	-	3.22E-03	2.73E-03
PathwayCommons	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	22	-	-	2.10E-03	9.46E-04
PathwayCommons	CC	GO:0016592	mediator complex	-	38	38	-	-	2.83E-01	1.63E-03
PathwayCommons	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	3.25E-02	8.41E-04
PathwayCommons	CC	GO:0022626	cytosolic ribosome	-	118	117	-	-	9.53E-02	4.94E-03
PathwayCommons	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	2.32E-02	1.89E-03
PathwayCommons	CC	GO:0034451	centriolar satellite	-	120	119	-	-	2.02E-02	5.04E-03
PathwayCommons	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	6.80E-02	4.73E-04
PathwayCommons	CC	GO:0045171	intercellular bridge	-	91	89	-	-	2.41E-03	3.78E-03
PathwayCommons	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	81	-	-	1.03E-02	3.41E-03
PathwayCommons	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	8.85E-02	6.30E-04
PathwayCommons	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	3.41E-02	4.73E-04
PathwayCommons	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	1.14E-02	4.73E-04
PathwayCommons	CC	GO:0044292	dendrite terminus	-	13	13	-	-	1.10E-03	5.78E-04
PathwayCommons	CC	GO:0032039	integrator complex	-	19	18	-	-	1.51E-01	7.88E-04
PathwayCommons	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	1.68E-03	6.30E-04
PathwayCommons	CC	GO:0033268	node of Ranvier	-	16	16	-	-	3.09E-02	6.83E-04
PathwayCommons	CC	GO:0036038	MKS complex	-	13	13	-	-	1.81E-02	5.78E-04
PathwayCommons	CC	GO:0030527	structural constituent of chromatin	-	97	89	-	-	9.25E-03	3.78E-03
PathwayCommons	CC	GO:0036379	myofilament	-	26	25	-	-	1.25E-02	1.05E-03
PathwayCommons	CC	GO:0030286	dynein complex	-	210	195	-	-	1.08E-02	8.20E-03
PathwayCommons	CC	GO:0097228	sperm principal piece	-	33	30	-	-	3.21E-02	1.26E-03
PathwayCommons	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	8.27E-03	5.25E-04
PathwayCommons	CC	GO:0016482	cytosolic transport	-	135	133	-	-	4.13E-02	5.62E-03
PathwayCommons	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	1.85E-01	9.98E-04
PathwayCommons	CC	GO:0005796	Golgi lumen	-	106	106	-	-	3.95E-03	4.47E-03
PathwayCommons	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	37	-	-	8.33E-02	1.58E-03
PathwayCommons	CC	GO:0034358	plasma lipoprotein particle	-	36	36	-	-	6.36E-02	1.52E-03
PathwayCommons	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	1.56E-01	2.00E-03
PathwayCommons	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	3.84E-02	1.05E-03
PathwayCommons	CC	GO:0030662	coated vesicle membrane	-	202	201	-	-	3.56E-02	8.46E-03
PathwayCommons	CC	GO:0007039	protein catabolic process in the vacuole	-	61	59	-	-	1.11E-01	2.52E-03
PathwayCommons	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	57	-	-	1.70E-01	2.42E-03
PathwayCommons	CC	GO:0090734	site of DNA damage	-	118	117	-	-	1.55E-02	4.94E-03
PathwayCommons	MF	GO:0051861	glycolipid binding	-	30	30	-	-	3.68E-03	1.26E-03
PathwayCommons	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.49E-04	4.73E-04
PathwayCommons	MF	GO:0051087	protein-folding chaperone binding	-	135	135	-	-	6.00E-03	5.67E-03
PathwayCommons	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	5.53E-03	1.16E-03
PathwayCommons	CC	GO:0015464	acetylcholine receptor activity	-	21	21	-	-	1.35E-02	8.93E-04
PathwayCommons	MF	GO:0042301	phosphate ion binding	-	12	11	-	-	8.14E-04	4.73E-04
PathwayCommons	MF	GO:0016594	glycine binding	-	12	12	-	-	2.65E-02	5.25E-04
PathwayCommons	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	1.80E-03	8.41E-04
PathwayCommons	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	7.61E-04	1.58E-03
PathwayCommons	MF	GO:0035613	RNA stem-loop binding	-	21	18	-	-	8.85E-04	7.88E-04
PathwayCommons	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	245	-	-	1.91E-02	1.03E-02
PathwayCommons	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	1.08E-02	8.41E-04
PathwayCommons	MF	GO:0033691	sialic acid binding	-	22	22	-	-	1.79E-02	9.46E-04
PathwayCommons	MF	GO:0004875	complement receptor activity	-	12	11	-	-	7.39E-03	4.73E-04
PathwayCommons	MF	GO:0048306	calcium-dependent protein binding	-	61	61	-	-	7.68E-03	2.57E-03
PathwayCommons	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	28	-	-	3.38E-02	1.21E-03
PathwayCommons	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	5.60E-02	5.78E-04
PathwayCommons	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	143	-	-	4.38E-02	6.04E-03
PathwayCommons	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	60	-	-	2.92E-02	2.52E-03
PathwayCommons	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	136	-	-	1.75E-02	5.73E-03
PathwayCommons	MF	GO:0045504	dynein heavy chain binding	-	16	16	-	-	7.46E-02	6.83E-04
PathwayCommons	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	1.42E-03	1.26E-03
PathwayCommons	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	1.08E-03	9.46E-04
PathwayCommons	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	7.89E-04	6.83E-04
PathwayCommons	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	1.42E-02	6.30E-04
PathwayCommons	MF	GO:0061980	regulatory RNA binding	-	52	46	-	-	7.21E-03	1.94E-03
PathwayCommons	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	1.32E-02	1.37E-03
PathwayCommons	MF	GO:0000182	rDNA binding	-	11	11	-	-	1.20E-02	4.73E-04
PathwayCommons	MF	GO:0001671	ATPase activator activity	-	29	29	-	-	1.20E-03	1.26E-03
PathwayCommons	MF	GO:0070840	dynein complex binding	-	25	24	-	-	1.85E-03	1.05E-03
PathwayCommons	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	7.85E-04	1.05E-03
PathwayCommons	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	2.25E-03	6.83E-04
PathwayCommons	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	35	-	-	7.33E-03	1.47E-03
PathwayCommons	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	2.00E-02	7.88E-04
PathwayCommons	MF	GO:0005178	integrin binding	-	153	151	-	-	3.73E-02	6.36E-03
PathwayCommons	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	5.08E-04	7.35E-04
PathwayCommons	MF	GO:0005549	odorant binding	-	128	125	-	-	9.52E-03	5.25E-03
PathwayCommons	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.07E-02	6.30E-04
PathwayCommons	MF	GO:0008327	methyl-CpG binding	-	31	28	-	-	3.73E-03	1.21E-03
PathwayCommons	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	2.51E-03	8.41E-04
PathwayCommons	MF	GO:0048019	receptor antagonist activity	-	31	20	-	-	3.45E-04	8.41E-04
PathwayCommons	MF	GO:0005521	lamin binding	-	15	15	-	-	1.82E-03	6.30E-04
PathwayCommons	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	6.52E-04	8.41E-04
PathwayCommons	MF	GO:0140318	protein transporter activity	-	40	40	-	-	3.19E-02	1.68E-03
PathwayCommons	MF	GO:0070628	proteasome binding	-	17	17	-	-	1.12E-02	7.35E-04
PathwayCommons	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	4.85E-04	4.73E-04
PathwayCommons	MF	GO:0031432	titin binding	-	13	13	-	-	2.51E-03	5.78E-04
PathwayCommons	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.44E-03	4.73E-04
PathwayCommons	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	4.80E-03	1.58E-03
PathwayCommons	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	1.02E-03	7.35E-04
PathwayCommons	MF	GO:0002039	p53 binding	-	66	66	-	-	2.45E-03	2.78E-03
PathwayCommons	MF	GO:0005496	steroid binding	-	110	109	-	-	1.33E-02	4.62E-03
PathwayCommons	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.73E-02	1.16E-03
PathwayCommons	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.51E-04	4.73E-04
PathwayCommons	MF	GO:0003684	damaged DNA binding	-	89	86	-	-	3.16E-02	3.62E-03
PathwayCommons	MF	GO:0000339	RNA cap binding	-	20	19	-	-	3.59E-02	8.41E-04
PathwayCommons	MF	GO:0016500	protein-hormone receptor activity	-	21	20	-	-	2.25E-03	8.41E-04
PathwayCommons	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	125	-	-	1.13E-02	5.25E-03
PathwayCommons	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	3.60E-03	6.30E-04
PathwayCommons	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	1.37E-03	5.25E-04
PathwayCommons	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	2.94E-04	4.73E-04
PathwayCommons	MF	GO:0070063	RNA polymerase binding	-	61	61	-	-	4.81E-03	2.57E-03
PathwayCommons	MF	GO:0008179	adenylate cyclase binding	-	11	11	-	-	8.50E-03	4.73E-04
PathwayCommons	MF	GO:0050811	GABA receptor binding	-	18	17	-	-	8.96E-03	7.35E-04
PathwayCommons	MF	GO:0030971	receptor tyrosine kinase binding	-	76	75	-	-	6.96E-03	3.15E-03
PathwayCommons	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	84	-	-	4.63E-02	3.57E-03
PathwayCommons	MF	GO:0140030	modification-dependent protein binding	-	179	179	-	-	5.85E-03	7.57E-03
PathwayCommons	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	2.91E-02	1.05E-03
PathwayCommons	MF	GO:0009881	photoreceptor activity	-	17	15	-	-	4.96E-02	6.30E-04
PathwayCommons	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	19	-	-	5.82E-03	8.41E-04
PathwayCommons	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	7.86E-04	5.78E-04
PathwayCommons	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	3.34E-03	6.83E-04
PathwayCommons	MF	GO:0141047	molecular tag activity	-	13	13	-	-	8.87E-04	5.78E-04
PathwayCommons	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	2.83E-02	4.73E-04
PathwayCommons	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	7.77E-04	5.25E-04
PathwayCommons	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	1.03E-03	6.30E-04
PathwayCommons	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	1.38E-03	5.25E-04
PathwayCommons	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.21E-02	6.30E-04
PathwayCommons	MF	GO:0010851	cyclase regulator activity	-	17	16	-	-	1.11E-03	6.83E-04
PathwayCommons	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	4.13E-02	6.30E-04
PathwayCommons	MF	GO:0030276	clathrin binding	-	70	70	-	-	3.15E-02	2.94E-03
PathwayCommons	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	5.31E-03	1.26E-03
PathwayCommons	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	6.98E-04	6.30E-04
PathwayCommons	MF	GO:0046790	virion binding	-	19	19	-	-	5.71E-04	8.41E-04
PathwayCommons	MF	GO:0030552	cAMP binding	-	48	47	-	-	1.34E-02	2.00E-03
PathwayCommons	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	39	-	-	1.02E-03	1.68E-03
PathwayCommons	MF	GO:0035173	histone kinase activity	-	17	17	-	-	6.40E-04	7.35E-04
PathwayCommons	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	9.63E-03	1.10E-03
PathwayCommons	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	2.14E-02	5.25E-04
PathwayCommons	MF	GO:0016209	antioxidant activity	-	92	88	-	-	2.96E-02	3.73E-03
PathwayCommons	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	5.56E-03	1.26E-03
PathwayCommons	MF	GO:0044325	transmembrane transporter binding	-	159	155	-	-	8.06E-03	6.51E-03
PathwayCommons	MF	GO:0048156	tau protein binding	-	43	43	-	-	3.23E-03	1.84E-03
PathwayCommons	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	1.51E-02	1.52E-03
PathwayCommons	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	1.17E-03	5.78E-04
PathwayCommons	MF	GO:0140272	exogenous protein binding	-	79	79	-	-	3.60E-03	3.36E-03
PathwayCommons	MF	GO:0030145	manganese ion binding	-	65	65	-	-	4.13E-03	2.73E-03
PathwayCommons	MF	GO:0071814	protein-lipid complex binding	-	52	47	-	-	1.20E-02	2.00E-03
PathwayCommons	MF	GO:0008066	glutamate receptor activity	-	70	68	-	-	2.08E-02	2.89E-03
PathwayCommons	MF	GO:0030553	cGMP binding	-	15	15	-	-	3.95E-02	6.30E-04
PathwayCommons	MF	GO:0017069	snRNA binding	-	54	49	-	-	1.56E-02	2.10E-03
PathwayCommons	MF	GO:0030215	semaphorin receptor binding	-	23	23	-	-	1.13E-02	9.98E-04
PathwayCommons	MF	GO:0031996	thioesterase binding	-	11	11	-	-	1.02E-03	4.73E-04
PathwayCommons	MF	GO:0031369	translation initiation factor binding	-	32	32	-	-	9.65E-03	1.37E-03
PathwayCommons	MF	GO:0019843	rRNA binding	-	69	69	-	-	1.63E-02	2.94E-03
PathwayCommons	MF	GO:0004713	protein tyrosine kinase activity	-	213	211	-	-	9.86E-03	8.88E-03
PathwayCommons	MF	GO:0061783	peptidoglycan muralytic activity	-	14	12	-	-	5.27E-03	5.25E-04
PathwayCommons	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	2.55E-03	2.15E-03
PathwayCommons	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.44E-03	1.05E-03
PathwayCommons	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	4.07E-04	8.41E-04
PathwayCommons	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	29	-	-	1.43E-03	1.26E-03
PathwayCommons	MF	GO:0016208	AMP binding	-	22	22	-	-	4.07E-03	9.46E-04
PathwayCommons	MF	GO:0000287	magnesium ion binding	-	225	223	-	-	7.11E-03	9.40E-03
PathwayCommons	MF	GO:0031490	chromatin DNA binding	-	120	117	-	-	3.37E-03	4.94E-03
PathwayCommons	MF	GO:0017022	myosin binding	-	73	72	-	-	6.18E-03	3.05E-03
PathwayCommons	MF	GO:0004896	cytokine receptor activity	-	93	93	-	-	5.22E-02	3.94E-03
PathwayCommons	MF	GO:0017166	vinculin binding	-	12	12	-	-	6.17E-03	5.25E-04
PathwayCommons	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	7.60E-04	7.88E-04
PathwayCommons	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	5.22E-03	5.25E-04
PathwayCommons	MF	GO:0005539	glycosaminoglycan binding	-	236	229	-	-	9.94E-03	9.67E-03
PathwayCommons	MF	GO:0140666	annealing activity	-	11	11	-	-	8.04E-04	4.73E-04
PathwayCommons	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	9.09E-04	6.30E-04
PathwayCommons	MF	GO:0010181	FMN binding	-	15	15	-	-	1.13E-03	6.30E-04
PathwayCommons	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	20	-	-	1.32E-03	8.41E-04
PathwayCommons	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	25	-	-	1.19E-03	1.05E-03
PathwayCommons	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	2.03E-03	7.35E-04
PathwayCommons	MF	GO:0044183	protein folding chaperone	-	67	65	-	-	4.71E-03	2.73E-03
PathwayCommons	MF	GO:0005132	type I interferon receptor binding	-	17	17	-	-	9.08E-03	7.35E-04
PathwayCommons	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	4.87E-03	4.57E-03
PathwayCommons	MF	GO:0003725	double-stranded RNA binding	-	72	71	-	-	5.92E-03	2.99E-03
PathwayCommons	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	2.90E-03	6.83E-04
PathwayCommons	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	2.80E-02	2.21E-03
PathwayCommons	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.19E-03	1.47E-03
PathwayCommons	MF	GO:0004618	phosphoglycerate kinase activity	-	89	89	-	-	3.44E-03	3.78E-03
PathwayCommons	MF	GO:0042805	actinin binding	-	36	36	-	-	3.40E-03	1.52E-03
PathwayCommons	MF	GO:0043531	ADP binding	-	38	38	-	-	1.09E-03	1.63E-03
PathwayCommons	MF	GO:0043394	proteoglycan binding	-	36	36	-	-	3.93E-03	1.52E-03
PathwayCommons	MF	GO:0005542	folic acid binding	-	13	11	-	-	6.89E-02	4.73E-04
PathwayCommons	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	6.36E-03	4.73E-04
PathwayCommons	MF	GO:0046332	SMAD binding	-	77	77	-	-	6.52E-03	3.26E-03
PathwayCommons	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.03E-03	5.78E-04
PathwayCommons	MF	GO:0001968	fibronectin binding	-	30	30	-	-	2.17E-03	1.26E-03
PathwayCommons	MF	GO:0048038	quinone binding	-	16	15	-	-	1.80E-03	6.30E-04
PathwayCommons	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	120	-	-	1.98E-02	5.04E-03
PathwayCommons	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	82	-	-	3.77E-03	3.47E-03
PathwayCommons	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	3.58E-03	7.88E-04
PathwayCommons	MF	GO:0051117	ATPase binding	-	85	84	-	-	2.47E-03	3.57E-03
PathwayCommons	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	1.56E-03	1.94E-03
PathwayCommons	MF	GO:0051787	misfolded protein binding	-	20	20	-	-	4.80E-03	8.41E-04
PathwayCommons	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	3.66E-03	4.73E-04
PathwayCommons	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.31E-02	6.30E-04
PathwayCommons	MF	GO:0031404	chloride ion binding	-	14	14	-	-	1.43E-02	6.30E-04
PathwayCommons	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	2.51E-03	2.57E-03
PathwayCommons	MF	GO:0036002	pre-mRNA binding	-	57	38	-	-	2.85E-03	1.63E-03
PathwayCommons	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	37	-	-	2.29E-02	1.58E-03
PathwayCommons	MF	GO:0051540	metal cluster binding	-	71	71	-	-	1.41E-02	2.99E-03
PathwayCommons	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	4.64E-04	4.73E-04
PathwayCommons	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	4.62E-03	3.89E-03
PathwayCommons	MF	GO:0019894	kinesin binding	-	45	45	-	-	7.99E-03	1.89E-03
PathwayCommons	MF	GO:0042287	MHC protein binding	-	68	63	-	-	4.81E-02	2.68E-03
PathwayCommons	MF	GO:0019003	GDP binding	-	89	88	-	-	9.78E-03	3.73E-03
PathwayCommons	MF	GO:0017171	serine hydrolase activity	-	207	197	-	-	3.57E-02	8.30E-03
PathwayCommons	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	3.68E-03	2.78E-03
PathwayCommons	MF	GO:0003774	cytoskeletal motor activity	-	117	116	-	-	7.06E-03	4.89E-03
PathwayCommons	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.96E-03	1.26E-03
PathwayCommons	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	1.58E-03	7.35E-04
PathwayCommons	MF	GO:0061134	peptidase regulator activity	-	224	211	-	-	1.52E-02	8.88E-03
PathwayCommons	MF	GO:0008013	beta-catenin binding	-	86	85	-	-	3.51E-03	3.57E-03
PathwayCommons	MF	GO:0051015	actin filament binding	-	208	206	-	-	1.63E-02	8.67E-03
PathwayCommons	MF	GO:0019208	phosphatase regulator activity	-	107	106	-	-	1.01E-02	4.47E-03
PathwayCommons	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	32	-	-	1.38E-03	1.37E-03
PathwayCommons	MF	GO:0043236	laminin binding	-	29	28	-	-	3.62E-03	1.21E-03
PathwayCommons	MF	GO:0030507	spectrin binding	-	26	26	-	-	5.97E-03	1.10E-03
PathwayCommons	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	42	-	-	1.04E-02	1.79E-03
PathwayCommons	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	113	-	-	2.44E-02	4.78E-03
PathwayCommons	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	1.84E-03	1.05E-03
PathwayCommons	MF	GO:0042393	histone binding	-	240	236	-	-	1.01E-02	9.93E-03
PathwayCommons	MF	GO:0019838	growth factor binding	-	182	181	-	-	7.45E-03	7.62E-03
PathwayCommons	MF	GO:0000149	SNARE binding	-	107	107	-	-	6.42E-02	4.52E-03
PathwayCommons	MF	GO:0003727	single-stranded RNA binding	-	90	84	-	-	5.21E-03	3.57E-03
PathwayCommons	MF	GO:0051378	serotonin binding	-	24	24	-	-	8.00E-03	1.05E-03
PathwayCommons	MF	GO:0005516	calmodulin binding	-	206	204	-	-	9.35E-03	8.62E-03
PathwayCommons	MF	GO:0019825	oxygen binding	-	40	38	-	-	4.51E-02	1.63E-03
PathwayCommons	MF	GO:0045505	dynein intermediate chain binding	-	37	36	-	-	1.04E-02	1.52E-03
PathwayCommons	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	86	-	-	1.44E-02	3.62E-03
PathwayCommons	MF	GO:0032182	ubiquitin-like protein binding	-	117	117	-	-	6.46E-03	4.94E-03
PathwayCommons	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	9.66E-02	1.52E-03
PathwayCommons	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	2.71E-03	9.46E-04
PathwayCommons	MF	GO:0043274	phospholipase binding	-	23	23	-	-	2.10E-02	9.98E-04
PathwayCommons	MF	GO:0031072	heat shock protein binding	-	128	128	-	-	1.15E-02	5.41E-03
PathwayCommons	MF	GO:0030515	snoRNA binding	-	33	33	-	-	2.55E-02	1.42E-03
PathwayCommons	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	81	-	-	3.78E-02	3.41E-03
PathwayCommons	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	22	-	-	6.28E-02	9.46E-04
PathwayCommons	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	6.37E-04	1.10E-03
PathwayCommons	MF	GO:0001530	lipopolysaccharide binding	-	38	33	-	-	4.03E-02	1.42E-03
PathwayCommons	MF	GO:0140223	general transcription initiation factor activity	-	55	54	-	-	1.22E-01	2.31E-03
PathwayCommons	MF	GO:0070403	NAD+ binding	-	16	16	-	-	5.28E-03	6.83E-04
PathwayCommons	MF	GO:0000049	tRNA binding	-	75	72	-	-	9.16E-03	3.05E-03
PathwayCommons	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	5.71E-03	1.89E-03
PathwayCommons	MF	GO:0015026	coreceptor activity	-	48	47	-	-	6.97E-03	2.00E-03
PathwayCommons	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.91E-03	5.25E-04
PathwayCommons	MF	GO:0001653	peptide receptor activity	-	128	123	-	-	4.70E-03	5.20E-03
PathwayCommons	MF	GO:0031005	filamin binding	-	15	14	-	-	1.54E-03	6.30E-04
PathwayCommons	MF	GO:0030506	ankyrin binding	-	19	19	-	-	5.06E-03	8.41E-04
PathwayCommons	MF	GO:0006469	negative regulation of protein kinase activity	-	222	207	-	-	4.67E-03	8.72E-03
PathwayCommons	MF	GO:0070182	DNA polymerase binding	-	22	21	-	-	1.09E-03	8.93E-04
PathwayCommons	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	4.38E-04	6.30E-04
PathwayCommons	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	5.31E-03	1.31E-03
PathwayCommons	MF	GO:0051427	hormone receptor binding	-	31	31	-	-	8.47E-03	1.31E-03
PathwayCommons	MF	GO:0070851	growth factor receptor binding	-	141	140	-	-	1.37E-02	5.88E-03
PathwayCommons	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	8.76E-03	1.37E-03
PathwayCommons	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	1.45E-01	4.73E-04
PathwayCommons	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	43	-	-	9.43E-03	1.84E-03
PathwayCommons	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	4.52E-03	8.41E-04
PathwayCommons	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	5.65E-03	7.35E-04
PathwayCommons	MF	GO:0005506	iron ion binding	-	154	152	-	-	1.93E-02	6.41E-03
PathwayCommons	MF	GO:0003925	G protein activity	-	45	44	-	-	4.00E-03	1.89E-03
PathwayCommons	MF	GO:0038187	pattern recognition receptor activity	-	33	33	-	-	4.18E-03	1.42E-03
PathwayCommons	MF	GO:0008276	protein methyltransferase activity	-	96	92	-	-	5.27E-03	3.89E-03
PathwayCommons	MF	GO:0004396	hexokinase activity	-	16	16	-	-	1.42E-02	6.83E-04
PathwayCommons	MF	GO:0070888	E-box binding	-	59	58	-	-	1.06E-02	2.47E-03
PathwayCommons	MF	GO:0039706	co-receptor binding	-	14	14	-	-	3.71E-03	6.30E-04
PathwayCommons	MF	GO:0015399	primary active transmembrane transporter activity	-	190	175	-	-	4.80E-02	7.35E-03
PathwayCommons	MF	GO:0035254	glutamate receptor binding	-	47	44	-	-	3.01E-03	1.89E-03
PathwayCommons	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	2.38E-03	1.42E-03
PathwayCommons	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	2.70E-03	4.73E-04
PathwayCommons	MF	GO:0043021	ribonucleoprotein complex binding	-	158	157	-	-	6.71E-03	6.62E-03
PathwayCommons	MF	GO:0030170	pyridoxal phosphate binding	-	56	52	-	-	2.53E-02	2.21E-03
PathwayCommons	MF	GO:0032393	MHC class I receptor activity	-	15	15	-	-	5.51E-02	6.30E-04
PathwayCommons	MF	GO:0005112	Notch binding	-	26	24	-	-	1.24E-02	1.05E-03
PathwayCommons	MF	GO:0048185	activin binding	-	16	16	-	-	2.45E-02	6.83E-04
PathwayCommons	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	1.35E-03	1.21E-03
PathwayCommons	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	1.90E-03	4.73E-04
PathwayCommons	MF	GO:0140299	small molecule sensor activity	-	39	36	-	-	9.40E-03	1.52E-03
PathwayCommons	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.87E-03	9.46E-04
PathwayCommons	MF	GO:0016917	GABA receptor activity	-	23	22	-	-	5.80E-01	9.46E-04
PathwayCommons	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	2.78E-03	6.30E-04
PathwayCommons	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	25	-	-	3.03E-04	1.05E-03
PathwayCommons	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	46	-	-	5.55E-03	1.94E-03
PathwayCommons	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	24	-	-	6.60E-04	1.05E-03
PathwayCommons	MF	GO:0008527	taste receptor activity	-	28	26	-	-	6.69E-02	1.10E-03
PathwayCommons	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	8.67E-03	5.25E-04
PathwayCommons	MF	GO:0030594	neurotransmitter receptor activity	-	160	157	-	-	2.57E-02	6.62E-03
PathwayCommons	MF	GO:0034452	dynactin binding	-	12	12	-	-	2.59E-03	5.25E-04
PathwayCommons	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	1.54E-02	1.05E-03
PathwayCommons	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	1.31E-02	8.93E-04
PathwayCommons	MF	GO:0005507	copper ion binding	-	63	60	-	-	7.07E-03	2.52E-03
PathwayCommons	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	2.67E-03	9.46E-04
PathwayCommons	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	2.96E-03	4.73E-04
PathwayCommons	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	2.16E-02	9.46E-04
PathwayCommons	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	5.94E-04	5.25E-04
PhosphoSitePlus	BP	GO:0008038	neuron recognition	-	46	13	-	-	1.00E-03	3.69E-03
PhosphoSitePlus	BP	GO:1905145	cellular response to acetylcholine	-	33	13	-	-	1.61E-02	3.69E-03
PhosphoSitePlus	BP	GO:0098780	response to mitochondrial depolarisation	-	21	16	-	-	1.08E-02	4.36E-03
PhosphoSitePlus	BP	GO:0001525	angiogenesis	-	616	194	-	-	2.52E-02	5.23E-02
PhosphoSitePlus	BP	GO:0009268	response to pH	-	43	11	-	-	7.11E-03	3.02E-03
PhosphoSitePlus	BP	GO:0045666	positive regulation of neuron differentiation	-	91	23	-	-	1.66E-03	6.37E-03
PhosphoSitePlus	BP	GO:0043543	protein acylation	-	107	32	-	-	5.79E-03	8.71E-03
PhosphoSitePlus	MF	GO:0051349	positive regulation of lyase activity	-	41	17	-	-	1.33E-03	4.69E-03
PhosphoSitePlus	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	23	-	-	1.67E-03	6.37E-03
PhosphoSitePlus	BP	GO:0071763	nuclear membrane organization	-	44	20	-	-	2.35E-03	5.36E-03
PhosphoSitePlus	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	15	-	-	3.88E-03	4.02E-03
PhosphoSitePlus	BP	GO:0071806	protein transmembrane transport	-	68	12	-	-	5.09E-02	3.35E-03
PhosphoSitePlus	BP	GO:0043299	leukocyte degranulation	-	82	30	-	-	4.84E-02	8.04E-03
PhosphoSitePlus	BP	GO:0048864	stem cell development	-	88	24	-	-	1.08E-02	6.70E-03
PhosphoSitePlus	BP	GO:0051651	maintenance of location in cell	-	236	88	-	-	1.10E-02	2.38E-02
PhosphoSitePlus	BP	GO:0033119	negative regulation of RNA splicing	-	27	11	-	-	9.98E-04	3.02E-03
PhosphoSitePlus	CC	GO:0016197	endosomal transport	-	282	61	-	-	6.34E-03	1.64E-02
PhosphoSitePlus	BP	GO:0070663	regulation of leukocyte proliferation	-	268	94	-	-	1.04E-02	2.55E-02
PhosphoSitePlus	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	18	-	-	1.31E-03	5.03E-03
PhosphoSitePlus	BP	GO:0006949	syncytium formation	-	66	17	-	-	3.19E-03	4.69E-03
PhosphoSitePlus	BP	GO:0045861	negative regulation of proteolysis	-	320	80	-	-	8.28E-03	2.14E-02
PhosphoSitePlus	CC	GO:0006984	ER-nucleus signaling pathway	-	46	20	-	-	3.33E-03	5.36E-03
PhosphoSitePlus	BP	GO:0009914	hormone transport	-	315	112	-	-	1.14E-02	3.02E-02
PhosphoSitePlus	BP	GO:0045785	positive regulation of cell adhesion	-	482	168	-	-	1.84E-02	4.52E-02
PhosphoSitePlus	BP	GO:0006413	translational initiation	-	122	47	-	-	1.54E-02	1.27E-02
PhosphoSitePlus	BP	GO:1902895	positive regulation of miRNA transcription	-	51	37	-	-	3.23E-03	1.01E-02
PhosphoSitePlus	CC	GO:0005200	structural constituent of cytoskeleton	-	112	37	-	-	2.67E-03	1.01E-02
PhosphoSitePlus	BP	GO:0030865	cortical cytoskeleton organization	-	51	24	-	-	7.03E-03	6.70E-03
PhosphoSitePlus	BP	GO:1903036	positive regulation of response to wounding	-	76	34	-	-	5.18E-03	9.38E-03
PhosphoSitePlus	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	33	-	-	5.16E-03	9.05E-03
PhosphoSitePlus	BP	GO:0032528	microvillus organization	-	24	11	-	-	2.34E-02	3.02E-03
PhosphoSitePlus	BP	GO:0002263	cell activation involved in immune response	-	304	104	-	-	1.67E-02	2.81E-02
PhosphoSitePlus	BP	GO:0021954	central nervous system neuron development	-	85	28	-	-	5.44E-03	7.71E-03
PhosphoSitePlus	BP	GO:0055017	cardiac muscle tissue growth	-	92	39	-	-	5.74E-03	1.07E-02
PhosphoSitePlus	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	12	-	-	9.85E-04	3.35E-03
PhosphoSitePlus	BP	GO:0048524	positive regulation of viral process	-	64	26	-	-	1.99E-03	7.04E-03
PhosphoSitePlus	BP	GO:0098661	inorganic anion transmembrane transport	-	140	22	-	-	1.67E-03	6.03E-03
PhosphoSitePlus	BP	GO:0009612	response to mechanical stimulus	-	215	92	-	-	8.77E-03	2.48E-02
PhosphoSitePlus	BP	GO:0048644	muscle organ morphogenesis	-	81	31	-	-	4.72E-02	8.38E-03
PhosphoSitePlus	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	64	-	-	1.68E-02	1.74E-02
PhosphoSitePlus	BP	GO:0140115	export across plasma membrane	-	82	22	-	-	1.67E-03	6.03E-03
PhosphoSitePlus	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	13	-	-	1.00E-03	3.69E-03
PhosphoSitePlus	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	MF	GO:0003714	transcription corepressor activity	-	190	75	-	-	1.16E-02	2.01E-02
PhosphoSitePlus	BP	GO:0098609	cell-cell adhesion	-	954	247	-	-	3.24E-02	6.63E-02
PhosphoSitePlus	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	15	-	-	1.32E-03	4.02E-03
PhosphoSitePlus	BP	GO:0046835	carbohydrate phosphorylation	-	49	23	-	-	3.31E-03	6.37E-03
PhosphoSitePlus	CC	GO:1905349	ciliary transition zone assembly	-	371	63	-	-	1.42E-02	1.71E-02
PhosphoSitePlus	BP	GO:0043523	regulation of neuron apoptotic process	-	218	99	-	-	8.74E-03	2.68E-02
PhosphoSitePlus	BP	GO:1902894	negative regulation of miRNA transcription	-	22	16	-	-	1.32E-03	4.36E-03
PhosphoSitePlus	BP	GO:0044380	protein localization to cytoskeleton	-	57	30	-	-	7.36E-03	8.04E-03
PhosphoSitePlus	BP	GO:2000209	regulation of anoikis	-	25	18	-	-	2.86E-03	5.03E-03
PhosphoSitePlus	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	11	-	-	9.96E-04	3.02E-03
PhosphoSitePlus	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	14	-	-	2.18E-03	4.02E-03
PhosphoSitePlus	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	26	-	-	1.97E-03	7.04E-03
PhosphoSitePlus	BP	GO:0043954	cellular component maintenance	-	72	25	-	-	4.85E-03	6.70E-03
PhosphoSitePlus	BP	GO:0050435	amyloid-beta metabolic process	-	65	23	-	-	1.16E-02	6.37E-03
PhosphoSitePlus	BP	GO:0014823	response to activity	-	70	23	-	-	1.88E-03	6.37E-03
PhosphoSitePlus	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	178	-	-	1.86E-02	4.79E-02
PhosphoSitePlus	BP	GO:0034502	protein localization to chromosome	-	130	57	-	-	2.05E-02	1.54E-02
PhosphoSitePlus	BP	GO:0048562	embryonic organ morphogenesis	-	295	75	-	-	8.81E-03	2.01E-02
PhosphoSitePlus	BP	GO:0019233	sensory perception of pain	-	103	29	-	-	5.49E-03	8.04E-03
PhosphoSitePlus	BP	GO:0031343	positive regulation of cell killing	-	75	12	-	-	9.70E-04	3.35E-03
PhosphoSitePlus	BP	GO:0090077	foam cell differentiation	-	39	14	-	-	9.83E-04	4.02E-03
PhosphoSitePlus	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	37	-	-	6.30E-03	1.01E-02
PhosphoSitePlus	BP	GO:0017148	negative regulation of translation	-	390	44	-	-	3.15E-02	1.21E-02
PhosphoSitePlus	BP	GO:0030220	platelet formation	-	22	13	-	-	6.12E-03	3.69E-03
PhosphoSitePlus	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	34	-	-	5.28E-03	9.38E-03
PhosphoSitePlus	BP	GO:0009582	detection of abiotic stimulus	-	140	34	-	-	5.90E-03	9.38E-03
PhosphoSitePlus	CC	GO:0140238	presynaptic endocytosis	-	72	27	-	-	2.17E-02	7.37E-03
PhosphoSitePlus	BP	GO:0051236	establishment of RNA localization	-	161	52	-	-	4.82E-03	1.41E-02
PhosphoSitePlus	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	78	-	-	1.29E-02	2.11E-02
PhosphoSitePlus	BP	GO:0061842	microtubule organizing center localization	-	32	17	-	-	6.82E-03	4.69E-03
PhosphoSitePlus	BP	GO:0042246	tissue regeneration	-	496	173	-	-	2.37E-02	4.66E-02
PhosphoSitePlus	MF	GO:0048018	receptor ligand activity	-	510	22	-	-	1.67E-03	6.03E-03
PhosphoSitePlus	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	16	-	-	1.32E-03	4.36E-03
PhosphoSitePlus	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	30	-	-	3.80E-03	8.04E-03
PhosphoSitePlus	BP	GO:0050779	RNA destabilization	-	135	30	-	-	2.31E-03	8.04E-03
PhosphoSitePlus	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	14	-	-	1.00E-03	4.02E-03
PhosphoSitePlus	BP	GO:0061025	membrane fusion	-	532	150	-	-	2.55E-02	4.02E-02
PhosphoSitePlus	BP	GO:0010762	regulation of fibroblast migration	-	40	21	-	-	5.74E-03	5.70E-03
PhosphoSitePlus	BP	GO:0090311	regulation of protein deacetylation	-	29	14	-	-	6.00E-03	4.02E-03
PhosphoSitePlus	BP	GO:0035272	exocrine system development	-	46	11	-	-	9.81E-04	3.02E-03
PhosphoSitePlus	BP	GO:0022406	membrane docking	-	90	24	-	-	6.76E-03	6.70E-03
PhosphoSitePlus	BP	GO:0050777	negative regulation of immune response	-	196	63	-	-	5.43E-03	1.71E-02
PhosphoSitePlus	BP	GO:0016053	organic acid biosynthetic process	-	335	63	-	-	2.36E-02	1.71E-02
PhosphoSitePlus	BP	GO:0002063	chondrocyte development	-	33	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	BP	GO:0021782	glial cell development	-	120	39	-	-	4.48E-03	1.07E-02
PhosphoSitePlus	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	33	-	-	8.14E-03	9.05E-03
PhosphoSitePlus	BP	GO:0001655	urogenital system development	-	66	28	-	-	3.86E-03	7.71E-03
PhosphoSitePlus	BP	GO:0071827	plasma lipoprotein particle organization	-	86	14	-	-	5.44E-03	4.02E-03
PhosphoSitePlus	BP	GO:0055088	lipid homeostasis	-	173	35	-	-	3.33E-02	9.38E-03
PhosphoSitePlus	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	99	-	-	9.30E-03	2.68E-02
PhosphoSitePlus	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	19	-	-	3.51E-03	5.36E-03
PhosphoSitePlus	BP	GO:0045667	regulation of osteoblast differentiation	-	147	49	-	-	6.18E-03	1.34E-02
PhosphoSitePlus	BP	GO:0050801	monoatomic ion homeostasis	-	609	166	-	-	2.29E-02	4.46E-02
PhosphoSitePlus	BP	GO:0009792	embryo development ending in birth or egg hatching	-	683	224	-	-	1.72E-02	6.03E-02
PhosphoSitePlus	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	155	-	-	1.75E-02	4.15E-02
PhosphoSitePlus	BP	GO:0045738	negative regulation of DNA repair	-	40	18	-	-	6.19E-03	5.03E-03
PhosphoSitePlus	BP	GO:0001704	formation of primary germ layer	-	195	62	-	-	6.14E-03	1.68E-02
PhosphoSitePlus	BP	GO:0045778	positive regulation of ossification	-	51	13	-	-	9.94E-04	3.69E-03
PhosphoSitePlus	BP	GO:0048708	astrocyte differentiation	-	88	37	-	-	4.04E-03	1.01E-02
PhosphoSitePlus	BP	GO:0042092	type 2 immune response	-	41	13	-	-	9.88E-04	3.69E-03
PhosphoSitePlus	BP	GO:0048588	developmental cell growth	-	233	68	-	-	7.12E-03	1.84E-02
PhosphoSitePlus	BP	GO:0021872	forebrain generation of neurons	-	52	14	-	-	1.00E-03	4.02E-03
PhosphoSitePlus	BP	GO:0045023	G0 to G1 transition	-	41	15	-	-	6.83E-03	4.02E-03
PhosphoSitePlus	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	13	-	-	1.25E-02	3.69E-03
PhosphoSitePlus	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	BP	GO:0010232	vascular transport	-	87	17	-	-	1.33E-03	4.69E-03
PhosphoSitePlus	BP	GO:0021987	cerebral cortex development	-	125	50	-	-	6.96E-03	1.34E-02
PhosphoSitePlus	BP	GO:0008637	apoptotic mitochondrial changes	-	108	45	-	-	5.12E-03	1.21E-02
PhosphoSitePlus	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	16	-	-	2.62E-03	4.36E-03
PhosphoSitePlus	BP	GO:0060999	positive regulation of dendritic spine development	-	35	14	-	-	9.92E-04	4.02E-03
PhosphoSitePlus	BP	GO:2000736	regulation of stem cell differentiation	-	78	36	-	-	6.67E-03	9.72E-03
PhosphoSitePlus	BP	GO:0002064	epithelial cell development	-	210	82	-	-	9.11E-03	2.21E-02
PhosphoSitePlus	BP	GO:2001222	regulation of neuron migration	-	46	12	-	-	9.73E-04	3.35E-03
PhosphoSitePlus	BP	GO:0034389	lipid droplet organization	-	38	11	-	-	9.62E-04	3.02E-03
PhosphoSitePlus	BP	GO:0051602	response to electrical stimulus	-	44	18	-	-	2.17E-03	5.03E-03
PhosphoSitePlus	BP	GO:0042177	negative regulation of protein catabolic process	-	109	44	-	-	3.20E-03	1.21E-02
PhosphoSitePlus	MF	GO:0038024	cargo receptor activity	-	121	22	-	-	1.66E-03	6.03E-03
PhosphoSitePlus	BP	GO:0033120	positive regulation of RNA splicing	-	46	19	-	-	1.24E-02	5.36E-03
PhosphoSitePlus	BP	GO:0051445	regulation of meiotic cell cycle	-	64	27	-	-	1.98E-03	7.37E-03
PhosphoSitePlus	BP	GO:0033619	membrane protein proteolysis	-	60	14	-	-	9.80E-04	4.02E-03
PhosphoSitePlus	BP	GO:0090087	regulation of peptide transport	-	195	68	-	-	9.47E-03	1.84E-02
PhosphoSitePlus	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	37	-	-	1.12E-02	1.01E-02
PhosphoSitePlus	BP	GO:0006929	substrate-dependent cell migration	-	26	11	-	-	7.75E-02	3.02E-03
PhosphoSitePlus	BP	GO:0022404	molting cycle process	-	95	29	-	-	6.40E-03	8.04E-03
PhosphoSitePlus	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	13	-	-	9.98E-04	3.69E-03
PhosphoSitePlus	BP	GO:0007281	germ cell development	-	334	67	-	-	5.46E-03	1.81E-02
PhosphoSitePlus	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	69	-	-	2.00E-02	1.88E-02
PhosphoSitePlus	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	14	-	-	9.52E-04	4.02E-03
PhosphoSitePlus	CC	GO:0098926	postsynaptic signal transduction	-	39	16	-	-	1.79E-02	4.36E-03
PhosphoSitePlus	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	53	-	-	5.24E-03	1.44E-02
PhosphoSitePlus	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	11	-	-	9.97E-04	3.02E-03
PhosphoSitePlus	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	36	-	-	7.92E-03	9.72E-03
PhosphoSitePlus	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	51	-	-	5.13E-03	1.37E-02
PhosphoSitePlus	BP	GO:0003013	circulatory system process	-	602	183	-	-	2.98E-02	4.92E-02
PhosphoSitePlus	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	78	-	-	1.36E-02	2.11E-02
PhosphoSitePlus	BP	GO:1903035	negative regulation of response to wounding	-	93	24	-	-	1.61E-03	6.70E-03
PhosphoSitePlus	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	12	-	-	2.40E-03	3.35E-03
PhosphoSitePlus	BP	GO:0036010	protein localization to endosome	-	27	11	-	-	3.71E-02	3.02E-03
PhosphoSitePlus	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	44	-	-	4.87E-03	1.21E-02
PhosphoSitePlus	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	35	-	-	7.94E-03	9.38E-03
PhosphoSitePlus	BP	GO:0009267	cellular response to starvation	-	170	79	-	-	8.67E-03	2.14E-02
PhosphoSitePlus	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	25	-	-	1.20E-02	6.70E-03
PhosphoSitePlus	CC	GO:0032008	positive regulation of TOR signaling	-	52	23	-	-	2.74E-03	6.37E-03
PhosphoSitePlus	BP	GO:0060428	lung epithelium development	-	43	19	-	-	6.58E-03	5.36E-03
PhosphoSitePlus	BP	GO:0071732	cellular response to nitric oxide	-	17	12	-	-	6.01E-03	3.35E-03
PhosphoSitePlus	BP	GO:0002521	leukocyte differentiation	-	616	231	-	-	2.26E-02	6.20E-02
PhosphoSitePlus	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	35	-	-	5.02E-03	9.38E-03
PhosphoSitePlus	BP	GO:0065004	protein-DNA complex assembly	-	307	102	-	-	1.97E-02	2.75E-02
PhosphoSitePlus	CC	GO:0006406	mRNA export from nucleus	-	69	27	-	-	2.01E-03	7.37E-03
PhosphoSitePlus	BP	GO:0009880	embryonic pattern specification	-	70	14	-	-	5.69E-03	4.02E-03
PhosphoSitePlus	BP	GO:0002367	cytokine production involved in immune response	-	121	42	-	-	5.13E-03	1.14E-02
PhosphoSitePlus	BP	GO:0044848	biological phase	-	211	83	-	-	1.50E-02	2.24E-02
PhosphoSitePlus	BP	GO:0046660	female sex differentiation	-	125	43	-	-	4.21E-03	1.17E-02
PhosphoSitePlus	BP	GO:0019693	ribose phosphate metabolic process	-	556	135	-	-	2.79E-02	3.62E-02
PhosphoSitePlus	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	19	-	-	3.10E-03	5.36E-03
PhosphoSitePlus	BP	GO:0060411	cardiac septum morphogenesis	-	72	25	-	-	3.63E-02	6.70E-03
PhosphoSitePlus	BP	GO:0071248	cellular response to metal ion	-	201	91	-	-	1.20E-02	2.45E-02
PhosphoSitePlus	BP	GO:0030308	negative regulation of cell growth	-	191	66	-	-	9.81E-03	1.78E-02
PhosphoSitePlus	BP	GO:0097306	cellular response to alcohol	-	99	35	-	-	3.18E-03	9.38E-03
PhosphoSitePlus	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	20	-	-	1.65E-03	5.36E-03
PhosphoSitePlus	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	22	-	-	2.00E-02	6.03E-03
PhosphoSitePlus	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	159	-	-	3.59E-02	4.29E-02
PhosphoSitePlus	BP	GO:0002026	regulation of the force of heart contraction	-	26	11	-	-	9.90E-04	3.02E-03
PhosphoSitePlus	BP	GO:0032890	regulation of organic acid transport	-	78	20	-	-	3.81E-03	5.36E-03
PhosphoSitePlus	BP	GO:0071498	cellular response to fluid shear stress	-	21	15	-	-	1.68E-02	4.02E-03
PhosphoSitePlus	BP	GO:0098771	inorganic ion homeostasis	-	531	149	-	-	2.80E-02	4.02E-02
PhosphoSitePlus	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	32	-	-	8.08E-03	8.71E-03
PhosphoSitePlus	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	16	-	-	1.32E-03	4.36E-03
PhosphoSitePlus	BP	GO:0051259	protein complex oligomerization	-	251	89	-	-	5.91E-03	2.41E-02
PhosphoSitePlus	BP	GO:0009994	oocyte differentiation	-	57	21	-	-	1.77E-03	5.70E-03
PhosphoSitePlus	MF	GO:0031952	regulation of protein autophosphorylation	-	43	19	-	-	2.00E-03	5.36E-03
PhosphoSitePlus	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	67	-	-	5.70E-03	1.81E-02
PhosphoSitePlus	BP	GO:0044319	"wound healing, spreading of cells"	-	37	19	-	-	1.31E-03	5.36E-03
PhosphoSitePlus	BP	GO:0033688	regulation of osteoblast proliferation	-	31	13	-	-	9.66E-04	3.69E-03
PhosphoSitePlus	BP	GO:0060251	regulation of glial cell proliferation	-	39	15	-	-	1.29E-03	4.02E-03
PhosphoSitePlus	BP	GO:0072665	protein localization to vacuole	-	84	18	-	-	3.46E-02	5.03E-03
PhosphoSitePlus	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	24	-	-	4.33E-02	6.70E-03
PhosphoSitePlus	BP	GO:0006914	autophagy	-	574	214	-	-	2.76E-02	5.76E-02
PhosphoSitePlus	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	28	-	-	5.38E-03	7.71E-03
PhosphoSitePlus	BP	GO:0070633	transepithelial transport	-	35	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	BP	GO:0048858	cell projection morphogenesis	-	643	206	-	-	2.06E-02	5.53E-02
PhosphoSitePlus	BP	GO:0045661	regulation of myoblast differentiation	-	74	27	-	-	5.47E-03	7.37E-03
PhosphoSitePlus	BP	GO:0030307	positive regulation of cell growth	-	164	54	-	-	4.51E-03	1.47E-02
PhosphoSitePlus	BP	GO:0034250	positive regulation of amide metabolic process	-	27	11	-	-	3.82E-03	3.02E-03
PhosphoSitePlus	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	144	-	-	1.41E-02	3.89E-02
PhosphoSitePlus	BP	GO:0014812	muscle cell migration	-	110	40	-	-	5.96E-03	1.07E-02
PhosphoSitePlus	BP	GO:0048525	negative regulation of viral process	-	90	27	-	-	7.65E-03	7.37E-03
PhosphoSitePlus	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	15	-	-	1.68E-02	4.02E-03
PhosphoSitePlus	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	42	-	-	7.54E-03	1.14E-02
PhosphoSitePlus	BP	GO:0051781	positive regulation of cell division	-	93	34	-	-	6.64E-03	9.38E-03
PhosphoSitePlus	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	13	-	-	5.06E-03	3.69E-03
PhosphoSitePlus	BP	GO:0002696	positive regulation of leukocyte activation	-	358	124	-	-	2.38E-02	3.35E-02
PhosphoSitePlus	BP	GO:0060711	labyrinthine layer development	-	47	16	-	-	2.51E-03	4.36E-03
PhosphoSitePlus	BP	GO:0007272	ensheathment of neurons	-	146	37	-	-	5.08E-03	1.01E-02
PhosphoSitePlus	CC	GO:0050806	positive regulation of synaptic transmission	-	171	50	-	-	4.33E-03	1.34E-02
PhosphoSitePlus	BP	GO:0060021	roof of mouth development	-	91	23	-	-	2.59E-02	6.37E-03
PhosphoSitePlus	BP	GO:0034504	protein localization to nucleus	-	312	140	-	-	1.29E-02	3.75E-02
PhosphoSitePlus	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	14	-	-	9.34E-04	4.02E-03
PhosphoSitePlus	BP	GO:0050819	negative regulation of coagulation	-	54	12	-	-	9.70E-04	3.35E-03
PhosphoSitePlus	BP	GO:0031647	regulation of protein stability	-	327	118	-	-	9.97E-03	3.18E-02
PhosphoSitePlus	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	14	-	-	1.46E-01	4.02E-03
PhosphoSitePlus	CC	GO:0050805	negative regulation of synaptic transmission	-	55	15	-	-	1.32E-03	4.02E-03
PhosphoSitePlus	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	22	-	-	9.19E-03	6.03E-03
PhosphoSitePlus	BP	GO:0016054	organic acid catabolic process	-	251	30	-	-	8.05E-03	8.04E-03
PhosphoSitePlus	BP	GO:0050890	cognition	-	317	103	-	-	8.85E-03	2.78E-02
PhosphoSitePlus	BP	GO:0008033	tRNA processing	-	136	15	-	-	1.25E-02	4.02E-03
PhosphoSitePlus	BP	GO:0046661	male sex differentiation	-	171	50	-	-	8.79E-03	1.34E-02
PhosphoSitePlus	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	27	-	-	7.93E-03	7.37E-03
PhosphoSitePlus	BP	GO:1990778	protein localization to cell periphery	-	346	117	-	-	1.10E-02	3.15E-02
PhosphoSitePlus	BP	GO:0001568	blood vessel development	-	790	248	-	-	3.07E-02	6.67E-02
PhosphoSitePlus	BP	GO:0061326	renal tubule development	-	103	33	-	-	2.30E-03	9.05E-03
PhosphoSitePlus	BP	GO:0051258	protein polymerization	-	280	119	-	-	1.25E-02	3.22E-02
PhosphoSitePlus	BP	GO:0090559	regulation of membrane permeability	-	72	28	-	-	3.22E-03	7.71E-03
PhosphoSitePlus	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	12	-	-	7.65E-03	3.35E-03
PhosphoSitePlus	BP	GO:0002250	adaptive immune response	-	753	133	-	-	1.79E-02	3.58E-02
PhosphoSitePlus	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	69	-	-	5.65E-03	1.88E-02
PhosphoSitePlus	CC	GO:0048167	regulation of synaptic plasticity	-	210	70	-	-	7.52E-03	1.88E-02
PhosphoSitePlus	BP	GO:1903708	positive regulation of hemopoiesis	-	184	66	-	-	6.76E-03	1.78E-02
PhosphoSitePlus	BP	GO:1903008	organelle disassembly	-	154	78	-	-	1.49E-02	2.11E-02
PhosphoSitePlus	BP	GO:0001709	cell fate determination	-	44	12	-	-	9.93E-04	3.35E-03
PhosphoSitePlus	BP	GO:0045058	T cell selection	-	53	30	-	-	4.59E-03	8.04E-03
PhosphoSitePlus	CC	GO:0032387	negative regulation of intracellular transport	-	51	19	-	-	3.34E-03	5.36E-03
PhosphoSitePlus	BP	GO:0072091	regulation of stem cell proliferation	-	91	35	-	-	3.79E-03	9.38E-03
PhosphoSitePlus	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	BP	GO:0032535	regulation of cellular component size	-	360	126	-	-	1.18E-02	3.38E-02
PhosphoSitePlus	MF	GO:0031281	positive regulation of cyclase activity	-	40	17	-	-	2.05E-03	4.69E-03
PhosphoSitePlus	MF	GO:0098631	cell adhesion mediator activity	-	64	22	-	-	1.66E-03	6.03E-03
PhosphoSitePlus	BP	GO:0051603	proteolysis involved in protein catabolic process	-	759	222	-	-	1.97E-02	5.96E-02
PhosphoSitePlus	BP	GO:0071453	cellular response to oxygen levels	-	168	85	-	-	7.96E-03	2.28E-02
PhosphoSitePlus	BP	GO:0070585	protein localization to mitochondrion	-	125	36	-	-	5.35E-03	9.72E-03
PhosphoSitePlus	BP	GO:0010623	programmed cell death involved in cell development	-	25	11	-	-	1.34E-02	3.02E-03
PhosphoSitePlus	BP	GO:0044242	cellular lipid catabolic process	-	224	33	-	-	8.52E-03	9.05E-03
PhosphoSitePlus	BP	GO:0002931	response to ischemia	-	58	26	-	-	2.91E-03	7.04E-03
PhosphoSitePlus	BP	GO:0043062	extracellular structure organization	-	317	56	-	-	4.75E-03	1.51E-02
PhosphoSitePlus	BP	GO:0061005	cell differentiation involved in kidney development	-	58	17	-	-	1.32E-03	4.69E-03
PhosphoSitePlus	BP	GO:0055082	intracellular chemical homeostasis	-	706	205	-	-	2.09E-02	5.49E-02
PhosphoSitePlus	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	161	-	-	1.92E-02	4.32E-02
PhosphoSitePlus	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	22	-	-	7.58E-03	6.03E-03
PhosphoSitePlus	BP	GO:0060420	regulation of heart growth	-	74	31	-	-	4.87E-03	8.38E-03
PhosphoSitePlus	BP	GO:0009755	hormone-mediated signaling pathway	-	221	87	-	-	8.76E-03	2.35E-02
PhosphoSitePlus	BP	GO:0022612	gland morphogenesis	-	124	49	-	-	4.33E-03	1.34E-02
PhosphoSitePlus	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	13	-	-	9.96E-04	3.69E-03
PhosphoSitePlus	MF	GO:0140416	transcription regulator inhibitor activity	-	26	14	-	-	1.00E-03	4.02E-03
PhosphoSitePlus	BP	GO:0044782	cilium organization	-	400	67	-	-	2.17E-02	1.81E-02
PhosphoSitePlus	BP	GO:0090130	tissue migration	-	379	132	-	-	1.60E-02	3.55E-02
PhosphoSitePlus	BP	GO:1990845	adaptive thermogenesis	-	166	65	-	-	1.22E-02	1.74E-02
PhosphoSitePlus	BP	GO:0071320	cellular response to cAMP	-	54	26	-	-	1.99E-03	7.04E-03
PhosphoSitePlus	BP	GO:0015844	monoamine transport	-	88	25	-	-	9.27E-03	6.70E-03
PhosphoSitePlus	BP	GO:0071392	cellular response to estradiol stimulus	-	40	18	-	-	9.52E-03	5.03E-03
PhosphoSitePlus	BP	GO:0009314	response to radiation	-	449	206	-	-	2.71E-02	5.53E-02
PhosphoSitePlus	BP	GO:0009451	RNA modification	-	169	21	-	-	7.99E-03	5.70E-03
PhosphoSitePlus	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	23	-	-	1.59E-03	6.37E-03
PhosphoSitePlus	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	51	-	-	6.89E-03	1.37E-02
PhosphoSitePlus	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	21	-	-	5.13E-03	5.70E-03
PhosphoSitePlus	BP	GO:0015807	L-amino acid transport	-	94	13	-	-	1.00E-03	3.69E-03
PhosphoSitePlus	BP	GO:0032941	secretion by tissue	-	85	34	-	-	4.85E-03	9.38E-03
PhosphoSitePlus	BP	GO:0046605	regulation of centrosome cycle	-	54	27	-	-	1.51E-02	7.37E-03
PhosphoSitePlus	BP	GO:0003014	renal system process	-	130	35	-	-	8.63E-03	9.38E-03
PhosphoSitePlus	BP	GO:0045598	regulation of fat cell differentiation	-	148	57	-	-	6.14E-03	1.54E-02
PhosphoSitePlus	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	96	-	-	9.37E-03	2.58E-02
PhosphoSitePlus	BP	GO:1904646	cellular response to amyloid-beta	-	44	23	-	-	6.85E-03	6.37E-03
PhosphoSitePlus	BP	GO:1901863	positive regulation of muscle tissue development	-	24	12	-	-	9.52E-04	3.35E-03
PhosphoSitePlus	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	49	-	-	8.19E-03	1.34E-02
PhosphoSitePlus	BP	GO:0039694	viral RNA genome replication	-	30	16	-	-	1.34E-03	4.36E-03
PhosphoSitePlus	BP	GO:0071709	membrane assembly	-	68	22	-	-	1.67E-03	6.03E-03
PhosphoSitePlus	BP	GO:0008217	regulation of blood pressure	-	186	42	-	-	7.08E-03	1.14E-02
PhosphoSitePlus	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	23	-	-	4.97E-03	6.37E-03
PhosphoSitePlus	CC	GO:0042770	signal transduction in response to DNA damage	-	186	110	-	-	2.16E-02	2.95E-02
PhosphoSitePlus	BP	GO:0002200	somatic diversification of immune receptors	-	78	34	-	-	1.66E-02	9.38E-03
PhosphoSitePlus	BP	GO:0035315	hair cell differentiation	-	52	15	-	-	1.33E-03	4.02E-03
PhosphoSitePlus	BP	GO:0048645	animal organ formation	-	62	25	-	-	5.21E-03	6.70E-03
PhosphoSitePlus	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	65	-	-	7.09E-03	1.74E-02
PhosphoSitePlus	BP	GO:0033627	cell adhesion mediated by integrin	-	87	33	-	-	6.18E-03	9.05E-03
PhosphoSitePlus	BP	GO:0035107	appendage morphogenesis	-	147	35	-	-	6.12E-03	9.38E-03
PhosphoSitePlus	BP	GO:1903707	negative regulation of hemopoiesis	-	116	34	-	-	8.87E-03	9.38E-03
PhosphoSitePlus	BP	GO:0050994	regulation of lipid catabolic process	-	61	18	-	-	2.56E-03	5.03E-03
PhosphoSitePlus	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	14	-	-	9.90E-04	4.02E-03
PhosphoSitePlus	BP	GO:0009593	detection of chemical stimulus	-	511	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	BP	GO:0045727	positive regulation of translation	-	141	50	-	-	8.12E-03	1.34E-02
PhosphoSitePlus	CC	GO:0032388	positive regulation of intracellular transport	-	137	63	-	-	5.94E-03	1.71E-02
PhosphoSitePlus	BP	GO:0002027	regulation of heart rate	-	106	41	-	-	6.20E-02	1.11E-02
PhosphoSitePlus	BP	GO:0050879	multicellular organismal movement	-	118	28	-	-	2.86E-03	7.71E-03
PhosphoSitePlus	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	26	-	-	4.81E-03	7.04E-03
PhosphoSitePlus	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	26	-	-	2.98E-03	7.04E-03
PhosphoSitePlus	BP	GO:0048515	spermatid differentiation	-	208	29	-	-	3.60E-03	8.04E-03
PhosphoSitePlus	BP	GO:0072132	mesenchyme morphogenesis	-	57	25	-	-	5.76E-02	6.70E-03
PhosphoSitePlus	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	14	-	-	5.39E-03	4.02E-03
PhosphoSitePlus	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	11	-	-	2.17E-02	3.02E-03
PhosphoSitePlus	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	15	-	-	1.34E-03	4.02E-03
PhosphoSitePlus	BP	GO:1901983	regulation of protein acetylation	-	26	15	-	-	5.61E-03	4.02E-03
PhosphoSitePlus	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	83	-	-	1.28E-02	2.24E-02
PhosphoSitePlus	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	19	-	-	1.33E-03	5.36E-03
PhosphoSitePlus	BP	GO:0010883	regulation of lipid storage	-	53	20	-	-	7.09E-03	5.36E-03
PhosphoSitePlus	BP	GO:0072170	metanephric tubule development	-	26	12	-	-	9.93E-04	3.35E-03
PhosphoSitePlus	BP	GO:1905954	positive regulation of lipid localization	-	110	27	-	-	4.38E-03	7.37E-03
PhosphoSitePlus	BP	GO:0002209	behavioral defense response	-	39	14	-	-	9.88E-04	4.02E-03
PhosphoSitePlus	BP	GO:0072523	purine-containing compound catabolic process	-	146	56	-	-	7.10E-03	1.51E-02
PhosphoSitePlus	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	18	-	-	6.77E-03	5.03E-03
PhosphoSitePlus	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	16	-	-	3.86E-03	4.36E-03
PhosphoSitePlus	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	45	-	-	5.45E-03	1.21E-02
PhosphoSitePlus	BP	GO:0007218	neuropeptide signaling pathway	-	113	18	-	-	1.33E-03	5.03E-03
PhosphoSitePlus	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	50	-	-	5.76E-03	1.34E-02
PhosphoSitePlus	BP	GO:0031345	negative regulation of cell projection organization	-	195	63	-	-	9.01E-03	1.71E-02
PhosphoSitePlus	BP	GO:0048278	vesicle docking	-	64	15	-	-	1.34E-03	4.02E-03
PhosphoSitePlus	BP	GO:0035050	embryonic heart tube development	-	86	26	-	-	1.43E-02	7.04E-03
PhosphoSitePlus	BP	GO:0030168	platelet activation	-	135	51	-	-	8.42E-03	1.37E-02
PhosphoSitePlus	CC	GO:0098810	neurotransmitter reuptake	-	35	11	-	-	9.97E-04	3.02E-03
PhosphoSitePlus	BP	GO:0031338	regulation of vesicle fusion	-	24	11	-	-	4.92E-02	3.02E-03
PhosphoSitePlus	BP	GO:0002253	activation of immune response	-	529	194	-	-	3.13E-02	5.23E-02
PhosphoSitePlus	BP	GO:0031529	ruffle organization	-	55	17	-	-	1.31E-03	4.69E-03
PhosphoSitePlus	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	16	-	-	3.07E-02	4.36E-03
PhosphoSitePlus	BP	GO:0035304	regulation of protein dephosphorylation	-	87	47	-	-	6.58E-03	1.27E-02
PhosphoSitePlus	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	66	-	-	5.77E-03	1.78E-02
PhosphoSitePlus	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	11	-	-	9.98E-04	3.02E-03
PhosphoSitePlus	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	148	-	-	1.88E-02	3.99E-02
PhosphoSitePlus	BP	GO:0051785	positive regulation of nuclear division	-	61	21	-	-	4.04E-03	5.70E-03
PhosphoSitePlus	BP	GO:0044786	cell cycle DNA replication	-	45	25	-	-	2.69E-02	6.70E-03
PhosphoSitePlus	BP	GO:0051299	centrosome separation	-	15	11	-	-	4.96E-03	3.02E-03
PhosphoSitePlus	BP	GO:0048145	regulation of fibroblast proliferation	-	87	44	-	-	9.09E-03	1.21E-02
PhosphoSitePlus	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	13	-	-	4.77E-03	3.69E-03
PhosphoSitePlus	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	109	-	-	1.07E-02	2.95E-02
PhosphoSitePlus	BP	GO:0009306	protein secretion	-	376	106	-	-	1.27E-02	2.85E-02
PhosphoSitePlus	CC	GO:0008333	endosome to lysosome transport	-	73	15	-	-	1.33E-03	4.02E-03
PhosphoSitePlus	MF	GO:0043086	negative regulation of catalytic activity	-	717	233	-	-	2.02E-02	6.26E-02
PhosphoSitePlus	BP	GO:0045732	positive regulation of protein catabolic process	-	202	79	-	-	9.52E-03	2.14E-02
PhosphoSitePlus	BP	GO:0031589	cell-substrate adhesion	-	360	130	-	-	1.42E-02	3.48E-02
PhosphoSitePlus	BP	GO:1904018	positive regulation of vasculature development	-	185	70	-	-	9.78E-03	1.88E-02
PhosphoSitePlus	BP	GO:0010948	negative regulation of cell cycle process	-	317	158	-	-	2.64E-02	4.25E-02
PhosphoSitePlus	BP	GO:0050953	sensory perception of light stimulus	-	223	19	-	-	1.34E-03	5.36E-03
PhosphoSitePlus	BP	GO:0009303	rRNA transcription	-	37	16	-	-	1.30E-03	4.36E-03
PhosphoSitePlus	BP	GO:0035601	protein deacylation	-	56	27	-	-	5.94E-03	7.37E-03
PhosphoSitePlus	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	13	-	-	5.19E-03	3.69E-03
PhosphoSitePlus	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	15	-	-	1.26E-02	4.02E-03
PhosphoSitePlus	BP	GO:0071300	cellular response to retinoic acid	-	66	23	-	-	2.24E-03	6.37E-03
PhosphoSitePlus	BP	GO:0046697	decidualization	-	26	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	BP	GO:0048284	organelle fusion	-	456	141	-	-	1.50E-02	3.79E-02
PhosphoSitePlus	BP	GO:0051588	regulation of neurotransmitter transport	-	99	30	-	-	3.98E-03	8.04E-03
PhosphoSitePlus	BP	GO:0051784	negative regulation of nuclear division	-	63	34	-	-	2.52E-02	9.38E-03
PhosphoSitePlus	BP	GO:0044703	multi-organism reproductive process	-	209	57	-	-	4.30E-03	1.54E-02
PhosphoSitePlus	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	63	-	-	5.12E-03	1.71E-02
PhosphoSitePlus	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	13	-	-	9.92E-04	3.69E-03
PhosphoSitePlus	MF	GO:0004930	G protein-coupled receptor activity	-	873	54	-	-	3.68E-03	1.47E-02
PhosphoSitePlus	BP	GO:0048857	neural nucleus development	-	65	25	-	-	2.00E-03	6.70E-03
PhosphoSitePlus	BP	GO:0048663	neuron fate commitment	-	74	20	-	-	1.66E-03	5.36E-03
PhosphoSitePlus	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	41	-	-	7.59E-03	1.11E-02
PhosphoSitePlus	BP	GO:0106027	neuron projection organization	-	90	41	-	-	1.05E-02	1.11E-02
PhosphoSitePlus	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	52	-	-	1.34E-02	1.41E-02
PhosphoSitePlus	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	24	-	-	5.51E-03	6.70E-03
PhosphoSitePlus	CC	GO:0043410	positive regulation of MAPK cascade	-	494	191	-	-	2.00E-02	5.13E-02
PhosphoSitePlus	BP	GO:0045685	regulation of glial cell differentiation	-	77	22	-	-	4.67E-03	6.03E-03
PhosphoSitePlus	BP	GO:0043414	macromolecule methylation	-	138	14	-	-	9.37E-04	4.02E-03
PhosphoSitePlus	BP	GO:0050886	endocrine process	-	93	33	-	-	2.33E-03	9.05E-03
PhosphoSitePlus	BP	GO:0050951	sensory perception of temperature stimulus	-	28	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	BP	GO:0045807	positive regulation of endocytosis	-	155	52	-	-	1.02E-02	1.41E-02
PhosphoSitePlus	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	35	-	-	2.59E-03	9.38E-03
PhosphoSitePlus	BP	GO:0048308	organelle inheritance	-	14	12	-	-	4.29E-03	3.35E-03
PhosphoSitePlus	BP	GO:0034394	protein localization to cell surface	-	69	17	-	-	5.65E-03	4.69E-03
PhosphoSitePlus	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	14	-	-	1.00E-03	4.02E-03
PhosphoSitePlus	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	12	-	-	3.19E-03	3.35E-03
PhosphoSitePlus	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	44	-	-	5.49E-03	1.21E-02
PhosphoSitePlus	MF	GO:0051100	negative regulation of binding	-	161	73	-	-	5.78E-03	1.98E-02
PhosphoSitePlus	BP	GO:0001818	negative regulation of cytokine production	-	379	87	-	-	1.19E-02	2.35E-02
PhosphoSitePlus	BP	GO:0003151	outflow tract morphogenesis	-	81	29	-	-	5.60E-03	8.04E-03
PhosphoSitePlus	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	33	-	-	3.66E-03	9.05E-03
PhosphoSitePlus	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	21	-	-	1.65E-03	5.70E-03
PhosphoSitePlus	BP	GO:0046621	negative regulation of organ growth	-	39	18	-	-	2.35E-02	5.03E-03
PhosphoSitePlus	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	14	-	-	1.14E-02	4.02E-03
PhosphoSitePlus	BP	GO:0032368	regulation of lipid transport	-	149	36	-	-	5.82E-03	9.72E-03
PhosphoSitePlus	BP	GO:0055094	response to lipoprotein particle	-	34	14	-	-	9.29E-04	4.02E-03
PhosphoSitePlus	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	83	-	-	1.08E-02	2.24E-02
PhosphoSitePlus	BP	GO:0033002	muscle cell proliferation	-	249	95	-	-	2.26E-02	2.55E-02
PhosphoSitePlus	BP	GO:0048880	sensory system development	-	399	112	-	-	9.09E-03	3.02E-02
PhosphoSitePlus	BP	GO:0043331	response to dsRNA	-	56	25	-	-	5.95E-03	6.70E-03
PhosphoSitePlus	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	18	-	-	6.98E-03	5.03E-03
PhosphoSitePlus	BP	GO:0060479	lung cell differentiation	-	28	13	-	-	9.85E-04	3.69E-03
PhosphoSitePlus	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	18	-	-	2.85E-03	5.03E-03
PhosphoSitePlus	BP	GO:0033622	integrin activation	-	26	11	-	-	9.33E-04	3.02E-03
PhosphoSitePlus	BP	GO:2000773	negative regulation of cellular senescence	-	25	16	-	-	1.28E-03	4.36E-03
PhosphoSitePlus	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	16	-	-	3.69E-03	4.36E-03
PhosphoSitePlus	BP	GO:0072164	mesonephric tubule development	-	98	32	-	-	4.68E-03	8.71E-03
PhosphoSitePlus	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	42	-	-	5.80E-03	1.14E-02
PhosphoSitePlus	BP	GO:1903524	positive regulation of blood circulation	-	39	13	-	-	9.92E-04	3.69E-03
PhosphoSitePlus	BP	GO:0030901	midbrain development	-	87	30	-	-	6.82E-03	8.04E-03
PhosphoSitePlus	BP	GO:0007162	negative regulation of cell adhesion	-	310	97	-	-	8.92E-03	2.61E-02
PhosphoSitePlus	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	27	-	-	4.71E-03	7.37E-03
PhosphoSitePlus	BP	GO:0002687	positive regulation of leukocyte migration	-	147	41	-	-	5.59E-03	1.11E-02
PhosphoSitePlus	BP	GO:0034605	cellular response to heat	-	66	34	-	-	3.70E-03	9.38E-03
PhosphoSitePlus	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	149	-	-	9.94E-03	4.02E-02
PhosphoSitePlus	BP	GO:0005996	monosaccharide metabolic process	-	250	84	-	-	4.28E-02	2.28E-02
PhosphoSitePlus	BP	GO:0033555	multicellular organismal response to stress	-	90	29	-	-	2.18E-03	8.04E-03
PhosphoSitePlus	BP	GO:0002262	myeloid cell homeostasis	-	172	76	-	-	8.33E-03	2.04E-02
PhosphoSitePlus	BP	GO:0050688	regulation of defense response to virus	-	65	21	-	-	1.66E-03	5.70E-03
PhosphoSitePlus	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	130	-	-	2.70E-02	3.48E-02
PhosphoSitePlus	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	105	-	-	1.42E-02	2.81E-02
PhosphoSitePlus	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	12	-	-	1.69E-02	3.35E-03
PhosphoSitePlus	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	15	-	-	1.24E-03	4.02E-03
PhosphoSitePlus	BP	GO:0003272	endocardial cushion formation	-	28	11	-	-	1.17E-01	3.02E-03
PhosphoSitePlus	BP	GO:0022618	protein-RNA complex assembly	-	227	54	-	-	6.08E-03	1.47E-02
PhosphoSitePlus	BP	GO:0051147	regulation of muscle cell differentiation	-	162	65	-	-	1.61E-02	1.74E-02
PhosphoSitePlus	BP	GO:0006066	alcohol metabolic process	-	374	70	-	-	2.11E-02	1.88E-02
PhosphoSitePlus	BP	GO:0090102	cochlea development	-	50	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	13	-	-	1.00E-03	3.69E-03
PhosphoSitePlus	BP	GO:0045933	positive regulation of muscle contraction	-	49	18	-	-	1.33E-03	5.03E-03
PhosphoSitePlus	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	17	-	-	1.31E-03	4.69E-03
PhosphoSitePlus	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	19	-	-	1.31E-03	5.36E-03
PhosphoSitePlus	BP	GO:0043555	regulation of translation in response to stress	-	22	14	-	-	4.35E-02	4.02E-03
PhosphoSitePlus	BP	GO:0032922	circadian regulation of gene expression	-	71	45	-	-	6.53E-03	1.21E-02
PhosphoSitePlus	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	19	-	-	7.76E-03	5.36E-03
PhosphoSitePlus	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	20	-	-	4.94E-02	5.36E-03
PhosphoSitePlus	BP	GO:0038179	neurotrophin signaling pathway	-	38	17	-	-	7.32E-03	4.69E-03
PhosphoSitePlus	BP	GO:0140253	cell-cell fusion	-	62	16	-	-	1.29E-03	4.36E-03
PhosphoSitePlus	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	11	-	-	9.97E-04	3.02E-03
PhosphoSitePlus	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	BP	GO:0051293	establishment of spindle localization	-	57	30	-	-	4.75E-03	8.04E-03
PhosphoSitePlus	BP	GO:0023061	signal release	-	491	159	-	-	1.78E-02	4.29E-02
PhosphoSitePlus	BP	GO:0043114	regulation of vascular permeability	-	49	19	-	-	7.87E-03	5.36E-03
PhosphoSitePlus	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	22	-	-	5.47E-03	6.03E-03
PhosphoSitePlus	BP	GO:0008360	regulation of cell shape	-	139	49	-	-	1.07E-02	1.34E-02
PhosphoSitePlus	BP	GO:0051222	positive regulation of protein transport	-	249	91	-	-	1.27E-02	2.45E-02
PhosphoSitePlus	CC	GO:0140632	canonical inflammasome complex assembly	-	40	21	-	-	5.97E-03	5.70E-03
PhosphoSitePlus	MF	GO:0034260	negative regulation of GTPase activity	-	36	12	-	-	1.15E-02	3.35E-03
PhosphoSitePlus	BP	GO:0045739	positive regulation of DNA repair	-	128	46	-	-	7.54E-03	1.24E-02
PhosphoSitePlus	BP	GO:0045185	maintenance of protein location	-	95	39	-	-	3.45E-03	1.07E-02
PhosphoSitePlus	BP	GO:0003158	endothelium development	-	140	49	-	-	6.41E-03	1.34E-02
PhosphoSitePlus	CC	GO:0072595	maintenance of protein localization in organelle	-	42	19	-	-	3.09E-03	5.36E-03
PhosphoSitePlus	BP	GO:0051224	negative regulation of protein transport	-	122	35	-	-	1.65E-02	9.38E-03
PhosphoSitePlus	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	57	-	-	5.53E-03	1.54E-02
PhosphoSitePlus	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	14	-	-	9.94E-04	4.02E-03
PhosphoSitePlus	MF	GO:0003713	transcription coactivator activity	-	281	102	-	-	9.42E-03	2.75E-02
PhosphoSitePlus	BP	GO:0021885	forebrain cell migration	-	63	26	-	-	9.25E-03	7.04E-03
PhosphoSitePlus	BP	GO:0007405	neuroblast proliferation	-	81	30	-	-	2.71E-02	8.04E-03
PhosphoSitePlus	BP	GO:0009581	detection of external stimulus	-	137	33	-	-	7.33E-03	9.05E-03
PhosphoSitePlus	BP	GO:0045862	positive regulation of proteolysis	-	353	148	-	-	1.21E-02	3.99E-02
PhosphoSitePlus	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	17	-	-	1.75E-02	4.69E-03
PhosphoSitePlus	BP	GO:0031100	animal organ regeneration	-	66	33	-	-	2.90E-03	9.05E-03
PhosphoSitePlus	BP	GO:0045684	positive regulation of epidermis development	-	33	11	-	-	9.96E-04	3.02E-03
PhosphoSitePlus	BP	GO:1900047	negative regulation of hemostasis	-	51	12	-	-	9.71E-04	3.35E-03
PhosphoSitePlus	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	41	-	-	4.02E-03	1.11E-02
PhosphoSitePlus	BP	GO:0051231	spindle elongation	-	14	11	-	-	2.57E-02	3.02E-03
PhosphoSitePlus	BP	GO:0030001	metal ion transport	-	933	232	-	-	3.65E-02	6.23E-02
PhosphoSitePlus	BP	GO:0042490	mechanoreceptor differentiation	-	67	14	-	-	9.99E-04	4.02E-03
PhosphoSitePlus	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	12	-	-	4.56E-03	3.35E-03
PhosphoSitePlus	BP	GO:0035148	tube formation	-	155	54	-	-	4.90E-03	1.47E-02
PhosphoSitePlus	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	33	-	-	1.85E-02	9.05E-03
PhosphoSitePlus	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	32	-	-	1.04E-02	8.71E-03
PhosphoSitePlus	BP	GO:0031123	RNA 3'-end processing	-	79	16	-	-	1.33E-03	4.36E-03
PhosphoSitePlus	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	28	-	-	4.66E-03	7.71E-03
PhosphoSitePlus	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	14	-	-	5.19E-03	4.02E-03
PhosphoSitePlus	CC	GO:0007097	nuclear migration	-	24	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	BP	GO:0045229	external encapsulating structure organization	-	319	55	-	-	6.38E-03	1.47E-02
PhosphoSitePlus	BP	GO:0006885	regulation of pH	-	104	21	-	-	2.88E-03	5.70E-03
PhosphoSitePlus	BP	GO:0001667	ameboidal-type cell migration	-	495	169	-	-	2.21E-02	4.56E-02
PhosphoSitePlus	BP	GO:1990840	response to lectin	-	22	13	-	-	3.11E-03	3.69E-03
PhosphoSitePlus	BP	GO:0071800	podosome assembly	-	19	11	-	-	8.23E-03	3.02E-03
PhosphoSitePlus	BP	GO:0031018	endocrine pancreas development	-	47	18	-	-	6.56E-03	5.03E-03
PhosphoSitePlus	BP	GO:0001708	cell fate specification	-	108	31	-	-	2.31E-03	8.38E-03
PhosphoSitePlus	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	28	-	-	1.98E-03	7.71E-03
PhosphoSitePlus	BP	GO:0030279	negative regulation of ossification	-	39	13	-	-	9.96E-04	3.69E-03
PhosphoSitePlus	BP	GO:0032970	regulation of actin filament-based process	-	368	149	-	-	1.70E-02	4.02E-02
PhosphoSitePlus	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	11	-	-	8.51E-03	3.02E-03
PhosphoSitePlus	BP	GO:0042440	pigment metabolic process	-	80	17	-	-	1.34E-03	4.69E-03
PhosphoSitePlus	BP	GO:0062197	cellular response to chemical stress	-	299	159	-	-	1.53E-02	4.29E-02
PhosphoSitePlus	BP	GO:1901890	positive regulation of cell junction assembly	-	106	29	-	-	3.06E-03	8.04E-03
PhosphoSitePlus	BP	GO:1901655	cellular response to ketone	-	107	47	-	-	8.98E-03	1.27E-02
PhosphoSitePlus	MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	-	925	185	-	-	3.48E-02	4.96E-02
PhosphoSitePlus	BP	GO:0051255	spindle midzone assembly	-	14	11	-	-	1.42E-01	3.02E-03
PhosphoSitePlus	BP	GO:0006968	cellular defense response	-	52	16	-	-	1.32E-03	4.36E-03
PhosphoSitePlus	BP	GO:0055006	cardiac cell development	-	93	34	-	-	2.74E-03	9.38E-03
PhosphoSitePlus	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	11	-	-	1.03E-02	3.02E-03
PhosphoSitePlus	BP	GO:0060004	reflex	-	63	24	-	-	1.66E-03	6.70E-03
PhosphoSitePlus	BP	GO:0044706	multi-multicellular organism process	-	217	57	-	-	4.63E-03	1.54E-02
PhosphoSitePlus	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	61	-	-	7.05E-03	1.64E-02
PhosphoSitePlus	BP	GO:0031294	lymphocyte costimulation	-	47	19	-	-	6.68E-03	5.36E-03
PhosphoSitePlus	BP	GO:0050768	negative regulation of neurogenesis	-	150	39	-	-	3.73E-03	1.07E-02
PhosphoSitePlus	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	40	-	-	4.33E-03	1.07E-02
PhosphoSitePlus	BP	GO:0090068	positive regulation of cell cycle process	-	262	123	-	-	1.92E-02	3.32E-02
PhosphoSitePlus	MF	GO:0022803	passive transmembrane transporter activity	-	676	147	-	-	3.58E-02	3.95E-02
PhosphoSitePlus	BP	GO:0043632	modification-dependent macromolecule catabolic process	-	642	197	-	-	1.98E-02	5.29E-02
PhosphoSitePlus	BP	GO:1902115	regulation of organelle assembly	-	210	88	-	-	8.30E-03	2.38E-02
PhosphoSitePlus	BP	GO:0006397	mRNA processing	-	482	126	-	-	1.08E-02	3.38E-02
PhosphoSitePlus	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	31	-	-	5.01E-03	8.38E-03
PhosphoSitePlus	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	60	-	-	7.54E-03	1.61E-02
PhosphoSitePlus	BP	GO:0046622	positive regulation of organ growth	-	52	20	-	-	3.16E-03	5.36E-03
PhosphoSitePlus	BP	GO:0051952	regulation of amine transport	-	98	20	-	-	1.76E-02	5.36E-03
PhosphoSitePlus	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	19	-	-	1.33E-03	5.36E-03
PhosphoSitePlus	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	47	-	-	6.19E-03	1.27E-02
PhosphoSitePlus	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	11	-	-	9.98E-04	3.02E-03
PhosphoSitePlus	BP	GO:0071398	cellular response to fatty acid	-	35	12	-	-	3.26E-03	3.35E-03
PhosphoSitePlus	BP	GO:0097581	lamellipodium organization	-	91	40	-	-	8.62E-03	1.07E-02
PhosphoSitePlus	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	39	-	-	2.68E-03	1.07E-02
PhosphoSitePlus	BP	GO:0060326	cell chemotaxis	-	311	88	-	-	1.05E-02	2.38E-02
PhosphoSitePlus	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	12	-	-	1.54E-02	3.35E-03
PhosphoSitePlus	BP	GO:0016485	protein processing	-	248	61	-	-	5.94E-03	1.64E-02
PhosphoSitePlus	BP	GO:0009649	entrainment of circadian clock	-	30	15	-	-	1.32E-03	4.02E-03
PhosphoSitePlus	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	41	-	-	4.80E-03	1.11E-02
PhosphoSitePlus	BP	GO:1903523	negative regulation of blood circulation	-	27	12	-	-	9.88E-04	3.35E-03
PhosphoSitePlus	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	24	-	-	4.06E-03	6.70E-03
PhosphoSitePlus	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	13	-	-	3.68E-03	3.69E-03
PhosphoSitePlus	BP	GO:0031348	negative regulation of defense response	-	282	94	-	-	7.17E-03	2.55E-02
PhosphoSitePlus	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	30	-	-	5.56E-03	8.04E-03
PhosphoSitePlus	BP	GO:0007606	sensory perception of chemical stimulus	-	535	13	-	-	1.00E-03	3.69E-03
PhosphoSitePlus	BP	GO:0061180	mammary gland epithelium development	-	68	38	-	-	4.47E-03	1.04E-02
PhosphoSitePlus	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	76	-	-	5.27E-03	2.04E-02
PhosphoSitePlus	CC	GO:0051169	nuclear transport	-	325	143	-	-	1.37E-02	3.85E-02
PhosphoSitePlus	BP	GO:0071496	cellular response to external stimulus	-	74	37	-	-	3.36E-03	1.01E-02
PhosphoSitePlus	BP	GO:0032094	response to food	-	37	11	-	-	4.89E-03	3.02E-03
PhosphoSitePlus	BP	GO:0001964	startle response	-	27	11	-	-	9.98E-04	3.02E-03
PhosphoSitePlus	BP	GO:0046434	organophosphate catabolic process	-	232	74	-	-	9.33E-03	2.01E-02
PhosphoSitePlus	BP	GO:0009566	fertilization	-	205	34	-	-	4.02E-03	9.38E-03
PhosphoSitePlus	BP	GO:0045907	positive regulation of vasoconstriction	-	30	13	-	-	1.30E-02	3.69E-03
PhosphoSitePlus	BP	GO:0033044	regulation of chromosome organization	-	249	133	-	-	2.92E-02	3.58E-02
PhosphoSitePlus	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	141	-	-	1.23E-02	3.79E-02
PhosphoSitePlus	BP	GO:0061900	glial cell activation	-	56	19	-	-	6.60E-03	5.36E-03
PhosphoSitePlus	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	46	-	-	4.88E-03	1.24E-02
PhosphoSitePlus	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	105	-	-	1.33E-02	2.81E-02
PhosphoSitePlus	CC	GO:0140467	integrated stress response signaling	-	41	21	-	-	8.49E-02	5.70E-03
PhosphoSitePlus	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	81	-	-	3.32E-02	2.18E-02
PhosphoSitePlus	BP	GO:0090235	regulation of metaphase plate congression	-	13	11	-	-	7.94E-03	3.02E-03
PhosphoSitePlus	BP	GO:0043647	inositol phosphate metabolic process	-	44	11	-	-	2.74E-02	3.02E-03
PhosphoSitePlus	BP	GO:0051303	establishment of chromosome localization	-	104	57	-	-	1.38E-02	1.54E-02
PhosphoSitePlus	BP	GO:0031349	positive regulation of defense response	-	473	159	-	-	2.30E-02	4.29E-02
PhosphoSitePlus	BP	GO:0007164	establishment of tissue polarity	-	38	11	-	-	9.98E-04	3.02E-03
PhosphoSitePlus	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	11	-	-	9.37E-03	3.02E-03
PhosphoSitePlus	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	17	-	-	3.37E-03	4.69E-03
PhosphoSitePlus	BP	GO:0006605	protein targeting	-	327	73	-	-	8.48E-03	1.98E-02
PhosphoSitePlus	BP	GO:0007566	embryo implantation	-	57	18	-	-	1.33E-03	5.03E-03
PhosphoSitePlus	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	14	-	-	7.70E-03	4.02E-03
PhosphoSitePlus	BP	GO:0061512	protein localization to cilium	-	394	68	-	-	1.10E-02	1.84E-02
PhosphoSitePlus	BP	GO:0060306	regulation of membrane repolarization	-	38	13	-	-	1.00E-03	3.69E-03
PhosphoSitePlus	BP	GO:0051017	actin filament bundle assembly	-	161	76	-	-	1.49E-02	2.04E-02
PhosphoSitePlus	BP	GO:1905953	negative regulation of lipid localization	-	63	16	-	-	2.80E-03	4.36E-03
PhosphoSitePlus	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	15	-	-	1.98E-03	4.02E-03
PhosphoSitePlus	BP	GO:1901343	negative regulation of vasculature development	-	154	34	-	-	2.28E-03	9.38E-03
PhosphoSitePlus	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	31	-	-	2.33E-03	8.38E-03
PhosphoSitePlus	BP	GO:1902414	protein localization to cell junction	-	107	33	-	-	3.12E-03	9.05E-03
PhosphoSitePlus	BP	GO:0051304	chromosome separation	-	80	46	-	-	1.52E-02	1.24E-02
PhosphoSitePlus	BP	GO:0090596	sensory organ morphogenesis	-	272	68	-	-	6.78E-03	1.84E-02
PhosphoSitePlus	BP	GO:0048709	oligodendrocyte differentiation	-	101	28	-	-	5.94E-03	7.71E-03
PhosphoSitePlus	BP	GO:0045017	glycerolipid biosynthetic process	-	254	53	-	-	4.14E-03	1.44E-02
PhosphoSitePlus	BP	GO:0001776	leukocyte homeostasis	-	108	39	-	-	4.01E-03	1.07E-02
PhosphoSitePlus	BP	GO:0050769	positive regulation of neurogenesis	-	240	88	-	-	7.57E-03	2.38E-02
PhosphoSitePlus	BP	GO:0030193	regulation of blood coagulation	-	70	21	-	-	4.06E-03	5.70E-03
PhosphoSitePlus	BP	GO:0050866	negative regulation of cell activation	-	216	68	-	-	6.40E-03	1.84E-02
PhosphoSitePlus	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	11	-	-	4.96E-03	3.02E-03
PhosphoSitePlus	BP	GO:0033500	carbohydrate homeostasis	-	251	99	-	-	1.12E-02	2.68E-02
PhosphoSitePlus	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	11	-	-	6.37E-03	3.02E-03
PhosphoSitePlus	BP	GO:0120035	regulation of plasma membrane bounded cell projection organization	-	647	226	-	-	2.37E-02	6.06E-02
PhosphoSitePlus	BP	GO:0044088	regulation of vacuole organization	-	56	20	-	-	5.39E-03	5.36E-03
PhosphoSitePlus	CC	GO:0051457	maintenance of protein location in nucleus	-	23	11	-	-	9.77E-04	3.02E-03
PhosphoSitePlus	CC	GO:0000791	euchromatin	-	60	29	-	-	1.96E-03	8.04E-03
PhosphoSitePlus	CC	GO:0030666	endocytic vesicle membrane	-	196	52	-	-	5.79E-03	1.41E-02
PhosphoSitePlus	CC	GO:0098857	membrane microdomain	-	324	148	-	-	2.26E-02	3.99E-02
PhosphoSitePlus	CC	GO:0030312	external encapsulating structure	-	567	41	-	-	2.99E-03	1.11E-02
PhosphoSitePlus	CC	GO:1990752	microtubule end	-	34	19	-	-	1.34E-03	5.36E-03
PhosphoSitePlus	CC	GO:0043204	perikaryon	-	156	40	-	-	6.51E-03	1.07E-02
PhosphoSitePlus	CC	GO:0097542	ciliary tip	-	48	11	-	-	9.84E-03	3.02E-03
PhosphoSitePlus	CC	GO:1905368	peptidase complex	-	124	22	-	-	1.67E-03	6.03E-03
PhosphoSitePlus	CC	GO:0000792	heterochromatin	-	98	47	-	-	3.31E-03	1.27E-02
PhosphoSitePlus	CC	GO:0097546	ciliary base	-	47	12	-	-	1.12E-02	3.35E-03
PhosphoSitePlus	CC	GO:0016324	apical plasma membrane	-	392	92	-	-	2.23E-02	2.48E-02
PhosphoSitePlus	CC	GO:0033260	nuclear DNA replication	-	40	23	-	-	2.74E-02	6.37E-03
PhosphoSitePlus	CC	GO:0044391	ribosomal subunit	-	203	28	-	-	2.00E-03	7.71E-03
PhosphoSitePlus	CC	GO:0071013	catalytic step 2 spliceosome	-	88	24	-	-	1.67E-03	6.70E-03
PhosphoSitePlus	CC	GO:0098862	cluster of actin-based cell projections	-	162	33	-	-	5.10E-03	9.05E-03
PhosphoSitePlus	CC	GO:0098978	glutamatergic synapse	-	411	144	-	-	1.30E-02	3.89E-02
PhosphoSitePlus	CC	GO:0016363	nuclear matrix	-	127	57	-	-	6.94E-03	1.54E-02
PhosphoSitePlus	CC	GO:0031261	DNA replication preinitiation complex	-	46	17	-	-	1.34E-03	4.69E-03
PhosphoSitePlus	CC	GO:0031966	mitochondrial membrane	-	746	123	-	-	1.48E-02	3.32E-02
PhosphoSitePlus	CC	GO:0097060	synaptic membrane	-	413	86	-	-	9.91E-03	2.31E-02
PhosphoSitePlus	CC	GO:0032432	actin filament bundle	-	249	78	-	-	1.02E-02	2.11E-02
PhosphoSitePlus	CC	GO:0008088	axo-dendritic transport	-	78	22	-	-	1.65E-03	6.03E-03
PhosphoSitePlus	CC	GO:0031519	PcG protein complex	-	38	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	12	-	-	5.68E-02	3.35E-03
PhosphoSitePlus	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	68	-	-	1.60E-02	1.84E-02
PhosphoSitePlus	CC	GO:0098791	Golgi apparatus subcompartment	-	378	56	-	-	1.66E-02	1.51E-02
PhosphoSitePlus	CC	GO:0099643	signal release from synapse	-	147	44	-	-	8.45E-03	1.21E-02
PhosphoSitePlus	CC	GO:0030018	Z disc	-	129	46	-	-	4.29E-03	1.24E-02
PhosphoSitePlus	CC	GO:0005814	centriole	-	692	226	-	-	3.59E-02	6.06E-02
PhosphoSitePlus	CC	GO:0097540	axonemal central pair	-	161	23	-	-	5.27E-03	6.37E-03
PhosphoSitePlus	CC	GO:0042641	actomyosin	-	77	35	-	-	1.93E-02	9.38E-03
PhosphoSitePlus	CC	GO:0097386	glial cell projection	-	38	14	-	-	3.23E-03	4.02E-03
PhosphoSitePlus	CC	GO:0070382	exocytic vesicle	-	224	58	-	-	2.37E-02	1.57E-02
PhosphoSitePlus	CC	GO:0031903	microbody membrane	-	65	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	84	-	-	8.53E-03	2.28E-02
PhosphoSitePlus	CC	GO:0016323	basolateral plasma membrane	-	239	64	-	-	1.03E-02	1.74E-02
PhosphoSitePlus	CC	GO:0042645	mitochondrial nucleoid	-	45	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	CC	GO:1902495	transmembrane transporter complex	-	408	72	-	-	1.40E-02	1.94E-02
PhosphoSitePlus	CC	GO:0098636	protein complex involved in cell adhesion	-	57	12	-	-	9.89E-04	3.35E-03
PhosphoSitePlus	CC	GO:0019897	extrinsic component of plasma membrane	-	156	60	-	-	2.42E-02	1.61E-02
PhosphoSitePlus	CC	GO:0031594	neuromuscular junction	-	73	26	-	-	5.49E-03	7.04E-03
PhosphoSitePlus	CC	GO:0000793	condensed chromosome	-	274	117	-	-	2.66E-02	3.15E-02
PhosphoSitePlus	CC	GO:0000922	spindle pole	-	172	73	-	-	1.68E-02	1.98E-02
PhosphoSitePlus	CC	GO:0120111	neuron projection cytoplasm	-	94	33	-	-	1.21E-02	9.05E-03
PhosphoSitePlus	CC	GO:0004879	nuclear receptor activity	-	63	35	-	-	2.64E-03	9.38E-03
PhosphoSitePlus	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	69	-	-	1.19E-02	1.88E-02
PhosphoSitePlus	CC	GO:0000123	histone acetyltransferase complex	-	93	21	-	-	1.65E-03	5.70E-03
PhosphoSitePlus	CC	GO:0048786	presynaptic active zone	-	80	17	-	-	1.32E-03	4.69E-03
PhosphoSitePlus	CC	GO:0007034	vacuolar transport	-	168	33	-	-	6.22E-03	9.05E-03
PhosphoSitePlus	CC	GO:0005776	autophagosome	-	111	41	-	-	1.93E-02	1.11E-02
PhosphoSitePlus	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	13	-	-	1.30E-01	3.69E-03
PhosphoSitePlus	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	18	-	-	1.68E-02	5.03E-03
PhosphoSitePlus	CC	GO:0150034	distal axon	-	309	105	-	-	1.45E-02	2.81E-02
PhosphoSitePlus	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	37	-	-	2.68E-03	1.01E-02
PhosphoSitePlus	CC	GO:0072562	blood microparticle	-	144	19	-	-	1.33E-03	5.36E-03
PhosphoSitePlus	CC	GO:0051233	spindle midzone	-	36	24	-	-	2.34E-02	6.70E-03
PhosphoSitePlus	CC	GO:0005811	lipid droplet	-	102	22	-	-	1.67E-03	6.03E-03
PhosphoSitePlus	CC	GO:0045022	early endosome to late endosome transport	-	44	20	-	-	2.55E-03	5.36E-03
PhosphoSitePlus	CC	GO:0043113	receptor clustering	-	51	15	-	-	1.30E-03	4.02E-03
PhosphoSitePlus	CC	GO:0044853	plasma membrane raft	-	114	50	-	-	5.33E-03	1.34E-02
PhosphoSitePlus	CC	GO:0005881	cytoplasmic microtubule	-	256	45	-	-	4.67E-03	1.21E-02
PhosphoSitePlus	CC	GO:0005905	clathrin-coated pit	-	73	24	-	-	4.49E-02	6.70E-03
PhosphoSitePlus	CC	GO:0060170	ciliary membrane	-	76	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	CC	GO:0000139	Golgi membrane	-	646	101	-	-	1.11E-02	2.71E-02
PhosphoSitePlus	CC	GO:0032154	cleavage furrow	-	54	31	-	-	2.31E-03	8.38E-03
PhosphoSitePlus	CC	GO:0007006	mitochondrial membrane organization	-	117	35	-	-	1.31E-02	9.38E-03
PhosphoSitePlus	CC	GO:0001772	immunological synapse	-	44	25	-	-	1.03E-02	6.70E-03
PhosphoSitePlus	CC	GO:0009897	external side of plasma membrane	-	425	70	-	-	5.00E-03	1.88E-02
PhosphoSitePlus	CC	GO:0030863	cortical cytoskeleton	-	104	46	-	-	5.06E-03	1.24E-02
PhosphoSitePlus	CC	GO:0030315	T-tubule	-	52	18	-	-	1.33E-03	5.03E-03
PhosphoSitePlus	CC	GO:0060076	excitatory synapse	-	64	14	-	-	1.00E-03	4.02E-03
PhosphoSitePlus	CC	GO:0001891	phagocytic cup	-	28	12	-	-	1.00E-03	3.35E-03
PhosphoSitePlus	CC	GO:0030427	site of polarized growth	-	172	67	-	-	8.18E-03	1.81E-02
PhosphoSitePlus	CC	GO:0044309	neuron spine	-	213	67	-	-	9.81E-03	1.81E-02
PhosphoSitePlus	CC	GO:0030658	transport vesicle membrane	-	231	40	-	-	1.35E-02	1.07E-02
PhosphoSitePlus	CC	GO:0030667	secretory granule membrane	-	319	68	-	-	4.69E-03	1.84E-02
PhosphoSitePlus	CC	GO:0097545	axonemal outer doublet	-	164	23	-	-	6.52E-03	6.37E-03
PhosphoSitePlus	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	13	-	-	1.91E-02	3.69E-03
PhosphoSitePlus	CC	GO:0055037	recycling endosome	-	200	41	-	-	5.39E-03	1.11E-02
PhosphoSitePlus	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	35	-	-	4.93E-03	9.38E-03
PhosphoSitePlus	CC	GO:0030684	preribosome	-	76	14	-	-	1.34E-02	4.02E-03
PhosphoSitePlus	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	68	-	-	4.90E-03	1.84E-02
PhosphoSitePlus	CC	GO:1990391	DNA repair complex	-	22	14	-	-	2.09E-02	4.02E-03
PhosphoSitePlus	CC	GO:0005775	vacuolar lumen	-	176	29	-	-	7.34E-03	8.04E-03
PhosphoSitePlus	CC	GO:0016327	apicolateral plasma membrane	-	23	11	-	-	9.91E-04	3.02E-03
PhosphoSitePlus	CC	GO:0044306	neuron projection terminus	-	164	46	-	-	5.76E-03	1.24E-02
PhosphoSitePlus	CC	GO:0005770	late endosome	-	299	56	-	-	5.28E-03	1.51E-02
PhosphoSitePlus	CC	GO:0031970	organelle envelope lumen	-	94	29	-	-	2.80E-03	8.04E-03
PhosphoSitePlus	CC	GO:0019866	organelle inner membrane	-	546	60	-	-	6.22E-03	1.61E-02
PhosphoSitePlus	CC	GO:0098687	chromosomal region	-	397	178	-	-	3.93E-02	4.79E-02
PhosphoSitePlus	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	11	-	-	9.97E-04	3.02E-03
PhosphoSitePlus	CC	GO:0043292	contractile muscle fiber	-	245	77	-	-	8.34E-03	2.08E-02
PhosphoSitePlus	CC	GO:0098982	GABA-ergic synapse	-	84	15	-	-	1.34E-03	4.02E-03
PhosphoSitePlus	CC	GO:0035097	histone methyltransferase complex	-	63	23	-	-	6.83E-02	6.37E-03
PhosphoSitePlus	CC	GO:0000323	lytic vacuole	-	749	128	-	-	1.31E-02	3.45E-02
PhosphoSitePlus	CC	GO:1903293	phosphatase complex	-	54	15	-	-	1.33E-03	4.02E-03
PhosphoSitePlus	CC	GO:0000786	nucleosome	-	149	37	-	-	2.65E-03	1.01E-02
PhosphoSitePlus	CC	GO:0030027	lamellipodium	-	202	92	-	-	1.04E-02	2.48E-02
PhosphoSitePlus	CC	GO:0002102	podosome	-	31	15	-	-	1.42E-02	4.02E-03
PhosphoSitePlus	CC	GO:0090543	Flemming body	-	33	13	-	-	1.00E-03	3.69E-03
PhosphoSitePlus	CC	GO:0016328	lateral plasma membrane	-	66	30	-	-	2.31E-03	8.04E-03
PhosphoSitePlus	CC	GO:0001650	fibrillar center	-	151	42	-	-	2.94E-03	1.14E-02
PhosphoSitePlus	CC	GO:1990204	oxidoreductase complex	-	90	20	-	-	1.66E-03	5.36E-03
PhosphoSitePlus	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	38	-	-	2.70E-03	1.04E-02
PhosphoSitePlus	CC	GO:0001726	ruffle	-	181	84	-	-	1.21E-02	2.28E-02
PhosphoSitePlus	CC	GO:0043073	germ cell nucleus	-	67	29	-	-	6.09E-03	8.04E-03
PhosphoSitePlus	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	11	-	-	9.91E-04	3.02E-03
PhosphoSitePlus	CC	GO:0005788	endoplasmic reticulum lumen	-	313	42	-	-	1.96E-02	1.14E-02
PhosphoSitePlus	CC	GO:0022626	cytosolic ribosome	-	118	25	-	-	2.00E-03	6.70E-03
PhosphoSitePlus	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	20	-	-	1.67E-03	5.36E-03
PhosphoSitePlus	CC	GO:0034451	centriolar satellite	-	120	33	-	-	1.11E-02	9.05E-03
PhosphoSitePlus	CC	GO:0045171	intercellular bridge	-	91	26	-	-	1.99E-03	7.04E-03
PhosphoSitePlus	CC	GO:0098984	neuron to neuron synapse	-	384	127	-	-	1.27E-02	3.42E-02
PhosphoSitePlus	CC	GO:0030527	structural constituent of chromatin	-	97	24	-	-	1.66E-03	6.70E-03
PhosphoSitePlus	CC	GO:0030286	dynein complex	-	210	29	-	-	8.05E-03	8.04E-03
PhosphoSitePlus	CC	GO:0016482	cytosolic transport	-	135	25	-	-	1.13E-02	6.70E-03
PhosphoSitePlus	CC	GO:0008023	transcription elongation factor complex	-	47	18	-	-	8.69E-03	5.03E-03
PhosphoSitePlus	CC	GO:0030662	coated vesicle membrane	-	202	37	-	-	7.74E-03	1.01E-02
PhosphoSitePlus	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	11	-	-	1.01E-03	3.02E-03
PhosphoSitePlus	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	98	-	-	2.22E-02	2.65E-02
PhosphoSitePlus	CC	GO:0005769	early endosome	-	425	100	-	-	9.50E-03	2.68E-02
PhosphoSitePlus	CC	GO:0090734	site of DNA damage	-	118	52	-	-	3.65E-03	1.41E-02
PhosphoSitePlus	MF	GO:0051087	protein-folding chaperone binding	-	135	48	-	-	4.32E-03	1.31E-02
PhosphoSitePlus	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	MF	GO:0140640	"catalytic activity, acting on a nucleic acid"	-	762	196	-	-	1.57E-02	5.26E-02
PhosphoSitePlus	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	37	-	-	2.65E-03	1.01E-02
PhosphoSitePlus	MF	GO:0016757	glycosyltransferase activity	-	286	23	-	-	4.85E-03	6.37E-03
PhosphoSitePlus	MF	GO:0048306	calcium-dependent protein binding	-	61	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	32	-	-	2.33E-03	8.71E-03
PhosphoSitePlus	MF	GO:0051020	GTPase binding	-	311	121	-	-	2.40E-02	3.25E-02
PhosphoSitePlus	MF	GO:0005158	insulin receptor binding	-	22	11	-	-	6.17E-03	3.02E-03
PhosphoSitePlus	MF	GO:0061980	regulatory RNA binding	-	52	17	-	-	1.33E-03	4.69E-03
PhosphoSitePlus	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	161	-	-	1.72E-02	4.32E-02
PhosphoSitePlus	MF	GO:0035035	histone acetyltransferase binding	-	24	15	-	-	1.33E-03	4.02E-03
PhosphoSitePlus	MF	GO:0005178	integrin binding	-	153	42	-	-	1.18E-02	1.14E-02
PhosphoSitePlus	MF	GO:0070064	proline-rich region binding	-	17	11	-	-	4.49E-03	3.02E-03
PhosphoSitePlus	MF	GO:0008233	peptidase activity	-	998	204	-	-	1.90E-02	5.49E-02
PhosphoSitePlus	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	11	-	-	6.76E-02	3.02E-03
PhosphoSitePlus	MF	GO:0000217	DNA secondary structure binding	-	37	19	-	-	3.27E-03	5.36E-03
PhosphoSitePlus	MF	GO:0002039	p53 binding	-	66	41	-	-	4.77E-03	1.11E-02
PhosphoSitePlus	MF	GO:0005496	steroid binding	-	110	27	-	-	1.99E-03	7.37E-03
PhosphoSitePlus	MF	GO:0008443	phosphofructokinase activity	-	27	16	-	-	3.36E-03	4.36E-03
PhosphoSitePlus	MF	GO:0003684	damaged DNA binding	-	89	41	-	-	3.00E-03	1.11E-02
PhosphoSitePlus	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	73	-	-	7.51E-03	1.98E-02
PhosphoSitePlus	MF	GO:0070063	RNA polymerase binding	-	61	23	-	-	1.65E-03	6.37E-03
PhosphoSitePlus	MF	GO:0030971	receptor tyrosine kinase binding	-	76	33	-	-	2.28E-03	9.05E-03
PhosphoSitePlus	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	24	-	-	4.13E-03	6.70E-03
PhosphoSitePlus	MF	GO:0140030	modification-dependent protein binding	-	179	62	-	-	1.08E-02	1.68E-02
PhosphoSitePlus	MF	GO:0030276	clathrin binding	-	70	17	-	-	3.85E-02	4.69E-03
PhosphoSitePlus	MF	GO:0003712	transcription coregulator activity	-	499	171	-	-	1.61E-02	4.59E-02
PhosphoSitePlus	MF	GO:0046875	ephrin receptor binding	-	29	17	-	-	7.09E-03	4.69E-03
PhosphoSitePlus	MF	GO:0016788	"hydrolase activity, acting on ester bonds"	-	936	227	-	-	1.75E-02	6.10E-02
PhosphoSitePlus	MF	GO:0030552	cAMP binding	-	48	22	-	-	5.88E-03	6.03E-03
PhosphoSitePlus	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	17	-	-	4.08E-03	4.69E-03
PhosphoSitePlus	MF	GO:0004857	enzyme inhibitor activity	-	395	116	-	-	1.05E-02	3.12E-02
PhosphoSitePlus	MF	GO:0035173	histone kinase activity	-	17	16	-	-	1.44E-03	4.36E-03
PhosphoSitePlus	MF	GO:0016209	antioxidant activity	-	92	21	-	-	1.66E-03	5.70E-03
PhosphoSitePlus	MF	GO:0044325	transmembrane transporter binding	-	159	67	-	-	7.43E-03	1.81E-02
PhosphoSitePlus	MF	GO:0048156	tau protein binding	-	43	35	-	-	5.44E-03	9.38E-03
PhosphoSitePlus	MF	GO:0140272	exogenous protein binding	-	79	26	-	-	2.17E-03	7.04E-03
PhosphoSitePlus	MF	GO:0030145	manganese ion binding	-	65	14	-	-	2.80E-03	4.02E-03
PhosphoSitePlus	MF	GO:0071814	protein-lipid complex binding	-	52	11	-	-	9.90E-04	3.02E-03
PhosphoSitePlus	MF	GO:0008066	glutamate receptor activity	-	70	18	-	-	6.58E-03	5.03E-03
PhosphoSitePlus	MF	GO:0008270	zinc ion binding	-	821	185	-	-	1.42E-02	4.96E-02
PhosphoSitePlus	MF	GO:0031369	translation initiation factor binding	-	32	15	-	-	1.34E-03	4.02E-03
PhosphoSitePlus	MF	GO:0019843	rRNA binding	-	69	11	-	-	9.97E-04	3.02E-03
PhosphoSitePlus	MF	GO:0004713	protein tyrosine kinase activity	-	213	135	-	-	1.58E-02	3.62E-02
PhosphoSitePlus	MF	GO:0016779	nucleotidyltransferase activity	-	264	74	-	-	6.49E-03	2.01E-02
PhosphoSitePlus	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	23	-	-	1.65E-03	6.37E-03
PhosphoSitePlus	MF	GO:0016208	AMP binding	-	22	12	-	-	2.38E-03	3.35E-03
PhosphoSitePlus	MF	GO:0000287	magnesium ion binding	-	225	85	-	-	1.17E-02	2.28E-02
PhosphoSitePlus	MF	GO:0031490	chromatin DNA binding	-	120	53	-	-	3.63E-03	1.44E-02
PhosphoSitePlus	MF	GO:0017022	myosin binding	-	73	27	-	-	1.99E-03	7.37E-03
PhosphoSitePlus	MF	GO:0004896	cytokine receptor activity	-	93	16	-	-	1.34E-03	4.36E-03
PhosphoSitePlus	MF	GO:0015631	tubulin binding	-	410	153	-	-	1.80E-02	4.12E-02
PhosphoSitePlus	MF	GO:0005539	glycosaminoglycan binding	-	236	25	-	-	1.03E-02	6.70E-03
PhosphoSitePlus	MF	GO:0019207	kinase regulator activity	-	267	122	-	-	2.32E-02	3.28E-02
PhosphoSitePlus	MF	GO:0044183	protein folding chaperone	-	67	16	-	-	1.33E-03	4.36E-03
PhosphoSitePlus	MF	GO:0008047	enzyme activator activity	-	697	237	-	-	2.35E-02	6.37E-02
PhosphoSitePlus	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	55	-	-	8.44E-03	1.47E-02
PhosphoSitePlus	MF	GO:0003725	double-stranded RNA binding	-	72	23	-	-	1.65E-03	6.37E-03
PhosphoSitePlus	MF	GO:0051018	protein kinase A binding	-	52	27	-	-	1.13E-02	7.37E-03
PhosphoSitePlus	MF	GO:0071889	14-3-3 protein binding	-	34	21	-	-	2.50E-03	5.70E-03
PhosphoSitePlus	MF	GO:0004618	phosphoglycerate kinase activity	-	89	44	-	-	5.58E-03	1.21E-02
PhosphoSitePlus	MF	GO:0042805	actinin binding	-	36	15	-	-	1.33E-03	4.02E-03
PhosphoSitePlus	MF	GO:0043531	ADP binding	-	38	15	-	-	1.33E-03	4.02E-03
PhosphoSitePlus	MF	GO:0046332	SMAD binding	-	77	41	-	-	4.89E-02	1.11E-02
PhosphoSitePlus	MF	GO:0043560	insulin receptor substrate binding	-	13	11	-	-	3.82E-03	3.02E-03
PhosphoSitePlus	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	46	-	-	4.99E-02	1.24E-02
PhosphoSitePlus	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	20	-	-	1.67E-03	5.36E-03
PhosphoSitePlus	MF	GO:0051117	ATPase binding	-	85	33	-	-	3.98E-03	9.05E-03
PhosphoSitePlus	MF	GO:0005216	monoatomic ion channel activity	-	618	134	-	-	2.45E-02	3.62E-02
PhosphoSitePlus	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	16	-	-	1.24E-02	4.36E-03
PhosphoSitePlus	MF	GO:0016746	acyltransferase activity	-	895	205	-	-	1.83E-02	5.49E-02
PhosphoSitePlus	MF	GO:0001098	basal transcription machinery binding	-	61	23	-	-	7.98E-02	6.37E-03
PhosphoSitePlus	MF	GO:0036002	pre-mRNA binding	-	57	15	-	-	1.33E-03	4.02E-03
PhosphoSitePlus	MF	GO:0051540	metal cluster binding	-	71	15	-	-	1.34E-03	4.02E-03
PhosphoSitePlus	MF	GO:0051219	phosphoprotein binding	-	92	55	-	-	5.62E-03	1.47E-02
PhosphoSitePlus	MF	GO:0019894	kinesin binding	-	45	15	-	-	1.33E-03	4.02E-03
PhosphoSitePlus	MF	GO:0019003	GDP binding	-	89	34	-	-	2.34E-03	9.38E-03
PhosphoSitePlus	MF	GO:0017171	serine hydrolase activity	-	207	13	-	-	1.00E-03	3.69E-03
PhosphoSitePlus	MF	GO:0097110	scaffold protein binding	-	66	41	-	-	7.09E-03	1.11E-02
PhosphoSitePlus	MF	GO:0003774	cytoskeletal motor activity	-	117	22	-	-	1.67E-03	6.03E-03
PhosphoSitePlus	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	13	-	-	9.98E-04	3.69E-03
PhosphoSitePlus	MF	GO:0061134	peptidase regulator activity	-	224	32	-	-	3.54E-03	8.71E-03
PhosphoSitePlus	MF	GO:0008013	beta-catenin binding	-	86	42	-	-	4.46E-03	1.14E-02
PhosphoSitePlus	MF	GO:0051015	actin filament binding	-	208	72	-	-	7.19E-03	1.94E-02
PhosphoSitePlus	MF	GO:0019208	phosphatase regulator activity	-	107	42	-	-	8.75E-03	1.14E-02
PhosphoSitePlus	MF	GO:0045860	positive regulation of protein kinase activity	-	397	171	-	-	1.58E-02	4.59E-02
PhosphoSitePlus	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	46	-	-	2.34E-02	1.24E-02
PhosphoSitePlus	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	23	-	-	2.16E-03	6.37E-03
PhosphoSitePlus	MF	GO:0042393	histone binding	-	240	83	-	-	1.10E-02	2.24E-02
PhosphoSitePlus	MF	GO:0019838	growth factor binding	-	182	59	-	-	1.85E-02	1.61E-02
PhosphoSitePlus	MF	GO:0000149	SNARE binding	-	107	27	-	-	4.89E-03	7.37E-03
PhosphoSitePlus	MF	GO:0003727	single-stranded RNA binding	-	90	29	-	-	2.00E-03	8.04E-03
PhosphoSitePlus	MF	GO:0005516	calmodulin binding	-	206	92	-	-	1.08E-02	2.48E-02
PhosphoSitePlus	MF	GO:0005198	structural molecule activity	-	823	144	-	-	9.95E-03	3.89E-02
PhosphoSitePlus	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	16	-	-	1.33E-03	4.36E-03
PhosphoSitePlus	MF	GO:0032182	ubiquitin-like protein binding	-	117	42	-	-	2.96E-03	1.14E-02
PhosphoSitePlus	MF	GO:0043274	phospholipase binding	-	23	13	-	-	2.61E-03	3.69E-03
PhosphoSitePlus	MF	GO:0031072	heat shock protein binding	-	128	54	-	-	5.66E-03	1.47E-02
PhosphoSitePlus	MF	GO:0001965	G-protein alpha-subunit binding	-	26	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	145	-	-	1.21E-02	3.89E-02
PhosphoSitePlus	MF	GO:0046982	protein heterodimerization activity	-	343	106	-	-	1.55E-02	2.85E-02
PhosphoSitePlus	MF	GO:0000049	tRNA binding	-	75	16	-	-	1.35E-01	4.36E-03
PhosphoSitePlus	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	39	-	-	3.21E-03	1.07E-02
PhosphoSitePlus	MF	GO:0015026	coreceptor activity	-	48	16	-	-	1.34E-03	4.36E-03
PhosphoSitePlus	MF	GO:0001653	peptide receptor activity	-	128	23	-	-	1.68E-03	6.37E-03
PhosphoSitePlus	MF	GO:0030506	ankyrin binding	-	19	11	-	-	1.00E-03	3.02E-03
PhosphoSitePlus	MF	GO:0006469	negative regulation of protein kinase activity	-	222	101	-	-	9.64E-03	2.71E-02
PhosphoSitePlus	MF	GO:0070182	DNA polymerase binding	-	22	15	-	-	1.33E-03	4.02E-03
PhosphoSitePlus	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	23	-	-	1.13E-02	6.37E-03
PhosphoSitePlus	MF	GO:0070851	growth factor receptor binding	-	141	40	-	-	1.38E-02	1.07E-02
PhosphoSitePlus	MF	GO:0005525	GTP binding	-	396	100	-	-	1.54E-02	2.68E-02
PhosphoSitePlus	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	14	-	-	2.14E-02	4.02E-03
PhosphoSitePlus	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	116	-	-	1.68E-02	3.12E-02
PhosphoSitePlus	MF	GO:0042803	protein homodimerization activity	-	699	228	-	-	1.85E-02	6.13E-02
PhosphoSitePlus	MF	GO:0051346	negative regulation of hydrolase activity	-	332	82	-	-	8.88E-03	2.21E-02
PhosphoSitePlus	MF	GO:0005506	iron ion binding	-	154	23	-	-	1.66E-03	6.37E-03
PhosphoSitePlus	MF	GO:0003925	G protein activity	-	45	19	-	-	1.34E-03	5.36E-03
PhosphoSitePlus	MF	GO:0008276	protein methyltransferase activity	-	96	16	-	-	1.34E-03	4.36E-03
PhosphoSitePlus	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	144	-	-	1.53E-02	3.89E-02
PhosphoSitePlus	MF	GO:0051345	positive regulation of hydrolase activity	-	535	193	-	-	2.11E-02	5.19E-02
PhosphoSitePlus	MF	GO:0070888	E-box binding	-	59	23	-	-	1.66E-03	6.37E-03
PhosphoSitePlus	MF	GO:0015399	primary active transmembrane transporter activity	-	190	25	-	-	2.01E-03	6.70E-03
PhosphoSitePlus	MF	GO:0035254	glutamate receptor binding	-	47	18	-	-	8.47E-03	5.03E-03
PhosphoSitePlus	MF	GO:0050321	tau-protein kinase activity	-	36	26	-	-	3.84E-03	7.04E-03
PhosphoSitePlus	MF	GO:0043021	ribonucleoprotein complex binding	-	158	37	-	-	3.91E-03	1.01E-02
PhosphoSitePlus	MF	GO:0001664	G protein-coupled receptor binding	-	299	54	-	-	5.76E-03	1.47E-02
PhosphoSitePlus	MF	GO:0140299	small molecule sensor activity	-	39	14	-	-	1.00E-03	4.02E-03
PhosphoSitePlus	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	11	-	-	9.97E-04	3.02E-03
PhosphoSitePlus	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	17	-	-	1.33E-03	4.69E-03
PhosphoSitePlus	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	12	-	-	9.91E-04	3.35E-03
PhosphoSitePlus	MF	GO:0030594	neurotransmitter receptor activity	-	160	30	-	-	7.12E-03	8.04E-03
PhosphoSitePlus	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	14	-	-	9.58E-04	4.02E-03
PhosphoSitePlus	MF	GO:0005507	copper ion binding	-	63	11	-	-	9.90E-04	3.02E-03
PhosphoSitePlus	MF	GO:0033558	protein lysine deacetylase activity	-	22	14	-	-	9.96E-04	4.02E-03
PhosphoSitePlus	CC	GO:0005815	microtubule organizing center	1.80E-37	843	281	134	2.10	-	-
PhosphoSitePlus	CC	GO:0005730	nucleolus	1.31E-28	988	292	157	1.86	-	-
PhosphoSitePlus	CC	GO:0000228	nuclear chromosome	5.96E-14	206	77	33	2.35	-	-
PhosphoSitePlus	CC	GO:0005768	endosome	9.80E-12	1037	247	165	1.50	-	-
PhosphoSitePlus	CC	GO:0005635	nuclear envelope	4.34E-10	493	132	78	1.68	-	-
PhosphoSitePlus	CC	GO:0031012	extracellular matrix	6.14E-10	564	41	90	0.46	-	-
PhosphoSitePlus	CC	GO:0005739	mitochondrion	3.50E-08	1671	347	266	1.31	-	-
PhosphoSitePlus	CC	GO:0005794	Golgi apparatus	3.95E-05	1636	320	260	1.23	-	-
PhosphoSitePlus	CC	GO:0005929	cilium	2.33E-02	842	158	134	1.18	-	-
PhosphoSitePlus	CC	GO:0005615	extracellular space	8.41E-02	3190	540	507	1.06	-	-
PhosphoSitePlus	CC	GO:0005811	lipid droplet	1.34E-01	102	22	16	1.36	-	-
PhosphoSitePlus	CC	GO:0005783	endoplasmic reticulum	2.60E-01	2020	339	321	1.06	-	-
PhosphoSitePlus	CC	GO:0005777	peroxisome	3.01E-01	142	27	23	1.20	-	-
PhosphoSitePlus	CC	GO:0005764	lysosome	3.58E-01	747	128	119	1.08	-	-
PhosphoSitePlus	CC	GO:0005840	ribosome	1.00E+00	222	35	35	0.99	-	-
PhosphoSitePlus	BP	GO:0012501	programmed cell death	5.68E-153	1954	761	311	2.45	-	-
PhosphoSitePlus	BP	GO:0006355	regulation of DNA-templated transcription	9.94E-73	3342	897	531	1.69	-	-
PhosphoSitePlus	BP	GO:0002376	immune system process	2.48E-67	2448	703	389	1.81	-	-
PhosphoSitePlus	BP	GO:0007010	cytoskeleton organization	5.46E-66	1639	526	261	2.02	-	-
PhosphoSitePlus	BP	GO:0065003	protein-containing complex assembly	4.52E-65	1648	526	262	2.01	-	-
PhosphoSitePlus	BP	GO:0048870	cell motility	4.84E-57	1659	510	264	1.93	-	-
PhosphoSitePlus	BP	GO:0007059	chromosome segregation	2.25E-45	403	183	64	2.86	-	-
PhosphoSitePlus	BP	GO:0006325	chromatin organization	3.62E-42	720	261	115	2.28	-	-
PhosphoSitePlus	BP	GO:0006281	DNA repair	1.19E-38	587	221	93	2.37	-	-
PhosphoSitePlus	BP	GO:0006914	autophagy	1.76E-37	568	214	90	2.37	-	-
PhosphoSitePlus	BP	GO:0006913	nucleocytoplasmic transport	3.24E-34	326	144	52	2.78	-	-
PhosphoSitePlus	BP	GO:0007155	cell adhesion	1.50E-30	1444	394	230	1.72	-	-
PhosphoSitePlus	BP	GO:0006260	DNA replication	6.34E-30	279	124	44	2.79	-	-
PhosphoSitePlus	BP	GO:0007163	establishment or maintenance of cell polarity	2.51E-29	227	108	36	2.99	-	-
PhosphoSitePlus	BP	GO:0006954	inflammatory response	3.02E-28	820	254	130	1.95	-	-
PhosphoSitePlus	BP	GO:0030163	protein catabolic process	4.31E-28	990	291	157	1.85	-	-
PhosphoSitePlus	BP	GO:0042060	wound healing	2.58E-26	431	158	69	2.31	-	-
PhosphoSitePlus	BP	GO:0034330	cell junction organization	7.39E-26	727	227	116	1.96	-	-
PhosphoSitePlus	BP	GO:0003012	muscle system process	1.39E-23	425	151	68	2.23	-	-
PhosphoSitePlus	BP	GO:0003013	circulatory system process	3.39E-21	584	183	93	1.97	-	-
PhosphoSitePlus	BP	GO:0032200	telomere organization	1.36E-20	186	83	30	2.81	-	-
PhosphoSitePlus	BP	GO:0016071	mRNA metabolic process	1.60E-20	713	210	113	1.85	-	-
PhosphoSitePlus	BP	GO:0098542	defense response to other organism	2.18E-20	1171	306	186	1.64	-	-
PhosphoSitePlus	BP	GO:0016192	vesicle-mediated transport	1.73E-19	1894	444	301	1.47	-	-
PhosphoSitePlus	BP	GO:0000910	cytokinesis	2.51E-19	186	81	30	2.74	-	-
PhosphoSitePlus	BP	GO:0006310	DNA recombination	4.14E-18	333	117	53	2.21	-	-
PhosphoSitePlus	BP	GO:0072659	protein localization to plasma membrane	4.02E-16	284	101	45	2.24	-	-
PhosphoSitePlus	BP	GO:0006091	generation of precursor metabolites and energy	1.01E-14	502	148	80	1.85	-	-
PhosphoSitePlus	BP	GO:0007005	mitochondrion organization	1.17E-13	484	141	77	1.83	-	-
PhosphoSitePlus	BP	GO:0006886	intracellular protein transport	3.71E-13	664	178	106	1.69	-	-
PhosphoSitePlus	BP	GO:0140013	meiotic nuclear division	2.55E-11	279	89	44	2.01	-	-
PhosphoSitePlus	BP	GO:0005975	carbohydrate metabolic process	2.45E-10	551	145	88	1.65	-	-
PhosphoSitePlus	BP	GO:0006486	protein glycosylation	1.05E-09	225	7	36	0.20	-	-
PhosphoSitePlus	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.08E-07	729	169	116	1.46	-	-
PhosphoSitePlus	BP	GO:0055085	transmembrane transport	4.22E-06	1784	353	284	1.24	-	-
PhosphoSitePlus	BP	GO:0002181	cytoplasmic translation	1.05E-05	153	46	24	1.89	-	-
PhosphoSitePlus	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	3.88E-05	119	37	19	1.96	-	-
PhosphoSitePlus	BP	GO:0140053	mitochondrial gene expression	5.46E-04	164	11	26	0.42	-	-
PhosphoSitePlus	BP	GO:0003014	renal system process	8.65E-04	127	35	20	1.73	-	-
PhosphoSitePlus	BP	GO:0098754	detoxification	2.74E-03	134	35	21	1.64	-	-
PhosphoSitePlus	BP	GO:0022600	digestive system process	8.68E-03	110	28	17	1.60	-	-
PhosphoSitePlus	BP	GO:0006629	lipid metabolic process	2.52E-02	1355	245	215	1.14	-	-
PhosphoSitePlus	BP	GO:0007018	microtubule-based movement	4.77E-02	640	120	102	1.18	-	-
PhosphoSitePlus	BP	GO:0006457	protein folding	7.15E-02	210	43	33	1.29	-	-
PhosphoSitePlus	BP	GO:0006399	tRNA metabolic process	1.16E-01	196	23	31	0.74	-	-
PhosphoSitePlus	BP	GO:0006520	amino acid metabolic process	2.26E-01	292	54	46	1.16	-	-
PhosphoSitePlus	BP	GO:0030198	extracellular matrix organization	4.36E-01	314	55	50	1.10	-	-
PhosphoSitePlus	BP	GO:0006766	vitamin metabolic process	5.08E-01	107	14	17	0.82	-	-
PhosphoSitePlus	BP	GO:0050877	nervous system process	5.35E-01	1527	234	243	0.96	-	-
PhosphoSitePlus	BP	GO:0044782	cilium organization	6.28E-01	399	67	63	1.06	-	-
PhosphoSitePlus	BP	GO:0006575	cellular modified amino acid metabolic process	7.63E-01	186	31	30	1.05	-	-
PhosphoSitePlus	BP	GO:0006790	sulfur compound metabolic process	8.17E-01	320	49	51	0.96	-	-
PhosphoSitePlus	BP	GO:0007040	lysosome organization	1.00E+00	107	17	17	1.00	-	-
PhosphoSitePlus	BP	GO:0042254	ribosome biogenesis	1.00E+00	297	47	47	1.00	-	-
PhosphoSitePlus	MF	GO:0140096	"catalytic activity, acting on a protein"	4.27E-140	3198	1020	509	2.01	-	-
PhosphoSitePlus	MF	GO:0016740	transferase activity	2.69E-120	3074	954	489	1.95	-	-
PhosphoSitePlus	MF	GO:0008092	cytoskeletal protein binding	4.30E-64	1023	378	163	2.32	-	-
PhosphoSitePlus	MF	GO:0003677	DNA binding	1.99E-61	2865	772	456	1.69	-	-
PhosphoSitePlus	MF	GO:0140110	transcription regulator activity	1.48E-46	2033	562	323	1.74	-	-
PhosphoSitePlus	MF	GO:0003723	RNA binding	1.92E-35	1679	457	267	1.71	-	-
PhosphoSitePlus	MF	GO:0140097	"catalytic activity, acting on DNA"	2.80E-30	383	153	61	2.51	-	-
PhosphoSitePlus	MF	GO:0003924	GTPase activity	6.05E-17	658	188	105	1.80	-	-
PhosphoSitePlus	MF	GO:0048018	receptor ligand activity	2.96E-16	504	22	80	0.27	-	-
PhosphoSitePlus	MF	GO:0042393	histone binding	5.52E-13	237	83	38	2.20	-	-
PhosphoSitePlus	MF	GO:0140657	ATP-dependent activity	6.02E-12	729	187	116	1.61	-	-
PhosphoSitePlus	MF	GO:0008289	lipid binding	8.77E-12	836	208	133	1.56	-	-
PhosphoSitePlus	MF	GO:0016874	ligase activity	2.67E-07	283	79	45	1.76	-	-
PhosphoSitePlus	MF	GO:0016829	lyase activity	3.07E-07	538	131	86	1.53	-	-
PhosphoSitePlus	MF	GO:0016853	isomerase activity	7.66E-06	252	68	40	1.70	-	-
PhosphoSitePlus	MF	GO:0045182	translation regulator activity	7.82E-05	151	43	24	1.79	-	-
PhosphoSitePlus	MF	GO:0016491	oxidoreductase activity	8.27E-04	888	178	141	1.26	-	-
PhosphoSitePlus	MF	GO:0009975	cyclase activity	8.96E-04	277	65	44	1.48	-	-
PhosphoSitePlus	MF	GO:0140104	molecular carrier activity	1.07E-01	105	23	17	1.38	-	-
PhosphoSitePlus	MF	GO:0005198	structural molecule activity	1.13E-01	798	143	127	1.13	-	-
PhosphoSitePlus	MF	GO:0005215	transporter activity	2.80E-01	1462	247	233	1.06	-	-
PhosphoSitePlus	MF	GO:0003774	cytoskeletal motor activity	3.72E-01	116	22	18	1.19	-	-
PhosphoSitePlus	MF	GO:0038024	cargo receptor activity	3.75E-01	117	22	19	1.18	-	-
PhosphoSitePlus	MF	GO:0140098	"catalytic activity, acting on RNA"	8.92E-01	417	67	66	1.01	-	-
PID2	CC	GO:0005615	extracellular space	3.64E-48	3190	701	430	1.63	-	-
PID2	CC	GO:0005768	endosome	2.25E-22	1037	253	140	1.81	-	-
PID2	CC	GO:0031012	extracellular matrix	1.09E-16	564	149	76	1.96	-	-
PID2	CC	GO:0005815	microtubule organizing center	1.33E-13	843	191	114	1.68	-	-
PID2	CC	GO:0005794	Golgi apparatus	5.64E-12	1636	316	221	1.43	-	-
PID2	CC	GO:0000228	nuclear chromosome	2.51E-08	206	58	28	2.09	-	-
PID2	CC	GO:0005730	nucleolus	9.49E-08	988	192	133	1.44	-	-
PID2	CC	GO:0005764	lysosome	6.75E-06	747	144	101	1.43	-	-
PID2	CC	GO:0005635	nuclear envelope	2.30E-05	493	100	66	1.50	-	-
PID2	CC	GO:0005783	endoplasmic reticulum	3.42E-05	2020	334	272	1.23	-	-
PID2	CC	GO:0005840	ribosome	4.03E-03	222	16	30	0.53	-	-
PID2	CC	GO:0005777	peroxisome	9.29E-03	142	9	19	0.47	-	-
PID2	CC	GO:0005739	mitochondrion	5.56E-02	1671	251	225	1.11	-	-
PID2	CC	GO:0005811	lipid droplet	1.44E-01	102	19	14	1.38	-	-
PID2	CC	GO:0005929	cilium	7.18E-01	842	117	114	1.03	-	-
PID2	BP	GO:0012501	programmed cell death	6.88E-219	1954	784	263	2.98	-	-
PID2	BP	GO:0002376	immune system process	5.12E-147	2448	783	330	2.37	-	-
PID2	BP	GO:0048870	cell motility	2.63E-142	1659	610	224	2.73	-	-
PID2	BP	GO:0007155	cell adhesion	4.93E-120	1444	528	195	2.71	-	-
PID2	BP	GO:0006355	regulation of DNA-templated transcription	1.42E-106	3342	873	451	1.94	-	-
PID2	BP	GO:0006954	inflammatory response	3.40E-79	820	321	111	2.90	-	-
PID2	BP	GO:0042060	wound healing	2.26E-57	431	192	58	3.30	-	-
PID2	BP	GO:0034330	cell junction organization	5.51E-57	727	264	98	2.69	-	-
PID2	BP	GO:0007010	cytoskeleton organization	9.30E-41	1639	413	221	1.87	-	-
PID2	BP	GO:0098542	defense response to other organism	2.29E-39	1171	322	158	2.04	-	-
PID2	BP	GO:0016192	vesicle-mediated transport	2.72E-34	1894	440	255	1.72	-	-
PID2	BP	GO:0003013	circulatory system process	9.58E-30	584	183	79	2.32	-	-
PID2	BP	GO:0065003	protein-containing complex assembly	2.53E-28	1648	379	222	1.71	-	-
PID2	BP	GO:0006281	DNA repair	3.37E-26	587	176	79	2.22	-	-
PID2	BP	GO:0007163	establishment or maintenance of cell polarity	5.82E-23	227	90	31	2.94	-	-
PID2	BP	GO:0003012	muscle system process	2.77E-21	425	132	57	2.30	-	-
PID2	BP	GO:0006914	autophagy	1.31E-18	568	155	77	2.02	-	-
PID2	BP	GO:0030163	protein catabolic process	3.02E-18	990	232	133	1.74	-	-
PID2	BP	GO:0006913	nucleocytoplasmic transport	1.80E-16	326	101	44	2.30	-	-
PID2	BP	GO:0006260	DNA replication	4.76E-16	279	90	38	2.39	-	-
PID2	BP	GO:0000910	cytokinesis	1.49E-15	186	68	25	2.71	-	-
PID2	BP	GO:0032200	telomere organization	7.45E-14	186	65	25	2.59	-	-
PID2	BP	GO:0072659	protein localization to plasma membrane	1.19E-13	284	86	38	2.25	-	-
PID2	BP	GO:0006310	DNA recombination	9.47E-13	333	94	45	2.09	-	-
PID2	BP	GO:0007059	chromosome segregation	1.73E-12	403	107	54	1.97	-	-
PID2	BP	GO:0030198	extracellular matrix organization	2.72E-12	314	89	42	2.10	-	-
PID2	BP	GO:0006886	intracellular protein transport	5.07E-12	664	154	90	1.72	-	-
PID2	BP	GO:0005975	carbohydrate metabolic process	1.67E-11	551	132	74	1.78	-	-
PID2	BP	GO:0006325	chromatin organization	3.43E-11	720	161	97	1.66	-	-
PID2	BP	GO:0007005	mitochondrion organization	4.79E-09	484	112	65	1.72	-	-
PID2	BP	GO:0006399	tRNA metabolic process	4.88E-09	196	3	26	0.11	-	-
PID2	BP	GO:0006629	lipid metabolic process	1.44E-07	1355	249	183	1.36	-	-
PID2	BP	GO:0006091	generation of precursor metabolites and energy	1.87E-07	502	110	68	1.63	-	-
PID2	BP	GO:0006486	protein glycosylation	1.91E-07	225	7	30	0.23	-	-
PID2	BP	GO:0140013	meiotic nuclear division	2.09E-06	279	67	38	1.78	-	-
PID2	BP	GO:0140053	mitochondrial gene expression	8.84E-06	164	5	22	0.23	-	-
PID2	BP	GO:0098754	detoxification	1.93E-04	134	34	18	1.88	-	-
PID2	BP	GO:0003014	renal system process	1.97E-04	127	33	17	1.93	-	-
PID2	BP	GO:0022600	digestive system process	6.65E-04	110	28	15	1.89	-	-
PID2	BP	GO:0050877	nervous system process	2.27E-03	1527	246	206	1.19	-	-
PID2	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	6.43E-03	119	27	16	1.68	-	-
PID2	BP	GO:0055085	transmembrane transport	7.00E-03	1784	278	241	1.16	-	-
PID2	BP	GO:0006520	amino acid metabolic process	7.17E-03	292	24	39	0.61	-	-
PID2	BP	GO:0042254	ribosome biogenesis	7.87E-03	297	25	40	0.62	-	-
PID2	BP	GO:0006790	sulfur compound metabolic process	1.04E-02	320	28	43	0.65	-	-
PID2	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.48E-02	729	121	98	1.23	-	-
PID2	BP	GO:0044782	cilium organization	4.50E-02	399	40	54	0.74	-	-
PID2	BP	GO:0006766	vitamin metabolic process	4.51E-02	107	22	14	1.52	-	-
PID2	BP	GO:0006457	protein folding	5.34E-02	210	38	28	1.34	-	-
PID2	BP	GO:0007040	lysosome organization	1.54E-01	107	9	14	0.62	-	-
PID2	BP	GO:0002181	cytoplasmic translation	3.41E-01	153	16	21	0.78	-	-
PID2	BP	GO:0007018	microtubule-based movement	5.96E-01	640	81	86	0.94	-	-
PID2	BP	GO:0016071	mRNA metabolic process	7.80E-01	713	93	96	0.97	-	-
PID2	BP	GO:0006575	cellular modified amino acid metabolic process	9.14E-01	186	24	25	0.96	-	-
PID2	MF	GO:0140096	"catalytic activity, acting on a protein"	8.09E-115	3198	865	431	2.01	-	-
PID2	MF	GO:0016740	transferase activity	3.17E-93	3074	797	414	1.92	-	-
PID2	MF	GO:0140110	transcription regulator activity	1.08E-73	2033	564	274	2.06	-	-
PID2	MF	GO:0003677	DNA binding	3.38E-59	2865	678	386	1.76	-	-
PID2	MF	GO:0003924	GTPase activity	1.51E-30	658	200	89	2.25	-	-
PID2	MF	GO:0048018	receptor ligand activity	7.43E-26	504	158	68	2.32	-	-
PID2	MF	GO:0140097	"catalytic activity, acting on DNA"	4.86E-25	383	130	52	2.52	-	-
PID2	MF	GO:0008092	cytoskeletal protein binding	5.95E-24	1023	255	138	1.85	-	-
PID2	MF	GO:0008289	lipid binding	1.65E-18	836	205	113	1.82	-	-
PID2	MF	GO:0016829	lyase activity	3.13E-13	538	135	73	1.86	-	-
PID2	MF	GO:0009975	cyclase activity	1.08E-10	277	78	37	2.09	-	-
PID2	MF	GO:0016853	isomerase activity	3.48E-07	252	64	34	1.88	-	-
PID2	MF	GO:0140098	"catalytic activity, acting on RNA"	9.63E-07	417	25	56	0.44	-	-
PID2	MF	GO:0005215	transporter activity	9.07E-05	1462	149	197	0.76	-	-
PID2	MF	GO:0016491	oxidoreductase activity	1.25E-03	888	153	120	1.28	-	-
PID2	MF	GO:0140657	ATP-dependent activity	3.99E-03	729	125	98	1.27	-	-
PID2	MF	GO:0042393	histone binding	7.03E-03	237	47	32	1.47	-	-
PID2	MF	GO:0005198	structural molecule activity	1.10E-02	798	132	108	1.23	-	-
PID2	MF	GO:0038024	cargo receptor activity	2.99E-02	117	24	16	1.52	-	-
PID2	MF	GO:0140104	molecular carrier activity	1.13E-01	105	20	14	1.41	-	-
PID2	MF	GO:0045182	translation regulator activity	4.01E-01	151	24	20	1.18	-	-
PID2	MF	GO:0016874	ligase activity	4.30E-01	283	33	38	0.86	-	-
PID2	MF	GO:0003723	RNA binding	4.54E-01	1679	216	226	0.95	-	-
PID2	MF	GO:0003774	cytoskeletal motor activity	4.96E-01	116	18	16	1.15	-	-
PID2	BP	GO:0008038	neuron recognition	-	46	20	-	-	1.21E-02	6.29E-03
PID2	BP	GO:1905145	cellular response to acetylcholine	-	33	12	-	-	5.80E-02	3.93E-03
PID2	BP	GO:0007346	regulation of mitotic cell cycle	-	518	208	-	-	8.28E-02	6.57E-02
PID2	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	13	-	-	3.47E-03	4.33E-03
PID2	BP	GO:0045666	positive regulation of neuron differentiation	-	91	37	-	-	8.43E-03	1.18E-02
PID2	BP	GO:0043543	protein acylation	-	107	25	-	-	1.66E-02	7.86E-03
PID2	MF	GO:0051349	positive regulation of lyase activity	-	41	16	-	-	2.10E-02	5.11E-03
PID2	BP	GO:0048679	regulation of axon regeneration	-	28	11	-	-	3.18E-03	3.54E-03
PID2	BP	GO:0071763	nuclear membrane organization	-	44	12	-	-	2.01E-03	3.93E-03
PID2	BP	GO:0071806	protein transmembrane transport	-	68	12	-	-	1.37E-02	3.93E-03
PID2	BP	GO:0043299	leukocyte degranulation	-	82	39	-	-	2.78E-02	1.26E-02
PID2	BP	GO:0048864	stem cell development	-	88	40	-	-	1.27E-02	1.26E-02
PID2	BP	GO:0051651	maintenance of location in cell	-	236	77	-	-	1.98E-02	2.44E-02
PID2	CC	GO:0016197	endosomal transport	-	282	54	-	-	7.97E-02	1.73E-02
PID2	BP	GO:0070663	regulation of leukocyte proliferation	-	268	132	-	-	3.08E-02	4.17E-02
PID2	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	19	-	-	8.14E-03	6.29E-03
PID2	BP	GO:0006949	syncytium formation	-	66	22	-	-	1.11E-02	7.08E-03
PID2	BP	GO:0045861	negative regulation of proteolysis	-	320	85	-	-	1.41E-02	2.67E-02
PID2	BP	GO:0030574	collagen catabolic process	-	45	13	-	-	2.05E-02	4.33E-03
PID2	CC	GO:0006984	ER-nucleus signaling pathway	-	46	18	-	-	8.73E-03	5.90E-03
PID2	BP	GO:0060343	trabecula formation	-	26	14	-	-	4.22E-03	4.72E-03
PID2	BP	GO:0009914	hormone transport	-	315	112	-	-	5.87E-02	3.54E-02
PID2	BP	GO:0140112	extracellular vesicle biogenesis	-	23	15	-	-	1.48E-01	4.72E-03
PID2	BP	GO:0045785	positive regulation of cell adhesion	-	482	234	-	-	3.90E-02	7.39E-02
PID2	BP	GO:0085029	extracellular matrix assembly	-	42	11	-	-	8.46E-03	3.54E-03
PID2	BP	GO:0006413	translational initiation	-	122	23	-	-	5.30E-02	7.47E-03
PID2	BP	GO:1902895	positive regulation of miRNA transcription	-	51	43	-	-	5.91E-03	1.38E-02
PID2	CC	GO:0005200	structural constituent of cytoskeleton	-	112	31	-	-	3.79E-01	9.83E-03
PID2	BP	GO:0030865	cortical cytoskeleton organization	-	51	21	-	-	4.87E-03	6.69E-03
PID2	BP	GO:1903036	positive regulation of response to wounding	-	76	29	-	-	9.68E-03	9.44E-03
PID2	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	27	-	-	3.36E-02	8.65E-03
PID2	BP	GO:0002263	cell activation involved in immune response	-	304	139	-	-	4.80E-02	4.40E-02
PID2	BP	GO:0021954	central nervous system neuron development	-	85	30	-	-	1.08E-02	9.44E-03
PID2	BP	GO:0055017	cardiac muscle tissue growth	-	92	42	-	-	9.55E-03	1.34E-02
PID2	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	20	-	-	2.71E-02	6.29E-03
PID2	BP	GO:0048524	positive regulation of viral process	-	64	21	-	-	5.62E-03	6.69E-03
PID2	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	16	-	-	4.00E-03	5.11E-03
PID2	BP	GO:0009612	response to mechanical stimulus	-	215	100	-	-	1.37E-02	3.15E-02
PID2	BP	GO:0048644	muscle organ morphogenesis	-	81	41	-	-	2.14E-02	1.30E-02
PID2	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	96	-	-	1.18E-02	3.03E-02
PID2	BP	GO:0071542	dopaminergic neuron differentiation	-	36	16	-	-	6.66E-03	5.11E-03
PID2	BP	GO:0140115	export across plasma membrane	-	82	14	-	-	9.02E-03	4.72E-03
PID2	MF	GO:0003714	transcription corepressor activity	-	190	75	-	-	4.30E-02	2.36E-02
PID2	BP	GO:0046835	carbohydrate phosphorylation	-	49	17	-	-	8.57E-02	5.51E-03
PID2	CC	GO:1905349	ciliary transition zone assembly	-	371	38	-	-	2.61E-02	1.22E-02
PID2	BP	GO:0043523	regulation of neuron apoptotic process	-	218	113	-	-	1.41E-02	3.58E-02
PID2	BP	GO:1902894	negative regulation of miRNA transcription	-	22	18	-	-	7.74E-03	5.90E-03
PID2	BP	GO:0044380	protein localization to cytoskeleton	-	57	13	-	-	1.18E-02	4.33E-03
PID2	BP	GO:2000209	regulation of anoikis	-	25	14	-	-	2.34E-03	4.72E-03
PID2	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	11	-	-	8.51E-03	3.54E-03
PID2	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	22	-	-	1.33E-02	7.08E-03
PID2	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	23	-	-	5.44E-02	7.47E-03
PID2	BP	GO:0070647	protein modification by small protein conjugation or removal	-	968	204	-	-	1.04E-01	6.45E-02
PID2	BP	GO:0043954	cellular component maintenance	-	72	30	-	-	7.41E-03	9.44E-03
PID2	BP	GO:0050435	amyloid-beta metabolic process	-	65	26	-	-	6.79E-02	8.26E-03
PID2	BP	GO:0014823	response to activity	-	70	35	-	-	9.41E-03	1.10E-02
PID2	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	213	-	-	7.57E-02	6.72E-02
PID2	BP	GO:0034502	protein localization to chromosome	-	130	32	-	-	3.42E-02	1.02E-02
PID2	BP	GO:0048562	embryonic organ morphogenesis	-	295	92	-	-	2.47E-02	2.91E-02
PID2	BP	GO:0019233	sensory perception of pain	-	103	29	-	-	1.13E-02	9.44E-03
PID2	BP	GO:0031343	positive regulation of cell killing	-	75	29	-	-	5.68E-02	9.44E-03
PID2	BP	GO:0090077	foam cell differentiation	-	39	23	-	-	2.02E-02	7.47E-03
PID2	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	19	-	-	8.15E-02	6.29E-03
PID2	BP	GO:0017148	negative regulation of translation	-	390	28	-	-	1.01E-02	9.04E-03
PID2	BP	GO:0030220	platelet formation	-	22	12	-	-	3.96E-03	3.93E-03
PID2	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	35	-	-	1.04E-02	1.10E-02
PID2	BP	GO:0009582	detection of abiotic stimulus	-	140	35	-	-	7.78E-02	1.10E-02
PID2	CC	GO:0140238	presynaptic endocytosis	-	72	26	-	-	6.36E-02	8.26E-03
PID2	BP	GO:0051236	establishment of RNA localization	-	161	25	-	-	1.27E-01	7.86E-03
PID2	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	79	-	-	6.25E-02	2.52E-02
PID2	BP	GO:0042246	tissue regeneration	-	496	209	-	-	4.56E-02	6.61E-02
PID2	MF	GO:0048018	receptor ligand activity	-	510	158	-	-	6.86E-02	4.99E-02
PID2	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	11	-	-	3.32E-02	3.54E-03
PID2	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	15	-	-	6.35E-03	4.72E-03
PID2	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	25	-	-	1.76E-02	7.86E-03
PID2	BP	GO:0050779	RNA destabilization	-	135	15	-	-	4.66E-03	4.72E-03
PID2	BP	GO:0061025	membrane fusion	-	532	138	-	-	1.11E-01	4.36E-02
PID2	BP	GO:0010762	regulation of fibroblast migration	-	40	21	-	-	5.72E-03	6.69E-03
PID2	BP	GO:0035272	exocrine system development	-	46	25	-	-	4.66E-02	7.86E-03
PID2	BP	GO:0022406	membrane docking	-	90	27	-	-	3.35E-01	8.65E-03
PID2	BP	GO:0050777	negative regulation of immune response	-	196	65	-	-	2.82E-02	2.04E-02
PID2	BP	GO:0016053	organic acid biosynthetic process	-	335	45	-	-	6.72E-02	1.42E-02
PID2	BP	GO:0099068	postsynapse assembly	-	40	14	-	-	3.10E-03	4.72E-03
PID2	BP	GO:0021782	glial cell development	-	120	50	-	-	9.84E-03	1.57E-02
PID2	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	25	-	-	1.41E-02	7.86E-03
PID2	BP	GO:0001655	urogenital system development	-	66	38	-	-	7.00E-03	1.22E-02
PID2	BP	GO:0071827	plasma lipoprotein particle organization	-	86	24	-	-	4.00E-02	7.86E-03
PID2	BP	GO:0055088	lipid homeostasis	-	173	36	-	-	3.94E-02	1.14E-02
PID2	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	99	-	-	1.30E-02	3.15E-02
PID2	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	14	-	-	2.81E-03	4.72E-03
PID2	BP	GO:0045667	regulation of osteoblast differentiation	-	147	68	-	-	7.05E-02	2.16E-02
PID2	BP	GO:0050801	monoatomic ion homeostasis	-	609	145	-	-	2.56E-02	4.56E-02
PID2	BP	GO:0009792	embryo development ending in birth or egg hatching	-	683	239	-	-	3.93E-02	7.55E-02
PID2	BP	GO:0061037	negative regulation of cartilage development	-	32	14	-	-	8.75E-03	4.72E-03
PID2	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	197	-	-	3.88E-02	6.21E-02
PID2	BP	GO:0001704	formation of primary germ layer	-	195	92	-	-	2.37E-02	2.91E-02
PID2	BP	GO:0045778	positive regulation of ossification	-	51	24	-	-	3.65E-02	7.86E-03
PID2	BP	GO:0048708	astrocyte differentiation	-	88	48	-	-	7.01E-03	1.53E-02
PID2	BP	GO:0042092	type 2 immune response	-	41	22	-	-	1.36E-02	7.08E-03
PID2	BP	GO:0048588	developmental cell growth	-	233	92	-	-	1.55E-02	2.91E-02
PID2	BP	GO:0021872	forebrain generation of neurons	-	52	21	-	-	4.76E-03	6.69E-03
PID2	BP	GO:0045023	G0 to G1 transition	-	41	16	-	-	5.71E-02	5.11E-03
PID2	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	30	-	-	1.14E-02	9.44E-03
PID2	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	13	-	-	8.10E-03	4.33E-03
PID2	BP	GO:0010232	vascular transport	-	87	13	-	-	1.67E-02	4.33E-03
PID2	BP	GO:0021987	cerebral cortex development	-	125	50	-	-	2.60E-02	1.57E-02
PID2	BP	GO:0008637	apoptotic mitochondrial changes	-	108	44	-	-	4.16E-02	1.42E-02
PID2	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	22	-	-	9.34E-03	7.08E-03
PID2	BP	GO:0060999	positive regulation of dendritic spine development	-	35	13	-	-	9.36E-03	4.33E-03
PID2	CC	GO:1902532	negative regulation of intracellular signal transduction	-	710	237	-	-	3.11E-02	7.47E-02
PID2	BP	GO:2000736	regulation of stem cell differentiation	-	78	36	-	-	6.84E-02	1.14E-02
PID2	BP	GO:0060973	cell migration involved in heart development	-	21	12	-	-	4.38E-03	3.93E-03
PID2	BP	GO:0002064	epithelial cell development	-	210	102	-	-	1.53E-02	3.22E-02
PID2	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	17	-	-	1.86E-02	5.51E-03
PID2	BP	GO:2001222	regulation of neuron migration	-	46	12	-	-	1.04E-03	3.93E-03
PID2	BP	GO:0051602	response to electrical stimulus	-	44	16	-	-	2.41E-03	5.11E-03
PID2	BP	GO:0042177	negative regulation of protein catabolic process	-	109	36	-	-	6.34E-03	1.14E-02
PID2	MF	GO:0038024	cargo receptor activity	-	121	24	-	-	1.30E-02	7.86E-03
PID2	BP	GO:0051445	regulation of meiotic cell cycle	-	64	13	-	-	6.79E-02	4.33E-03
PID2	BP	GO:0033619	membrane protein proteolysis	-	60	25	-	-	5.93E-02	7.86E-03
PID2	BP	GO:0090087	regulation of peptide transport	-	195	74	-	-	7.18E-02	2.36E-02
PID2	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	40	-	-	8.33E-03	1.26E-02
PID2	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	11	-	-	2.69E-02	3.54E-03
PID2	BP	GO:0006929	substrate-dependent cell migration	-	26	18	-	-	1.55E-02	5.90E-03
PID2	BP	GO:0022404	molting cycle process	-	95	37	-	-	5.16E-03	1.18E-02
PID2	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	14	-	-	2.65E-02	4.72E-03
PID2	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	16	-	-	1.40E-02	5.11E-03
PID2	BP	GO:0007281	germ cell development	-	334	64	-	-	7.82E-03	2.04E-02
PID2	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	55	-	-	3.34E-02	1.73E-02
PID2	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	19	-	-	6.94E-03	6.29E-03
PID2	CC	GO:0098926	postsynaptic signal transduction	-	39	17	-	-	2.04E-02	5.51E-03
PID2	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	55	-	-	1.77E-02	1.73E-02
PID2	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	23	-	-	5.02E-03	7.47E-03
PID2	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	64	-	-	2.82E-02	2.04E-02
PID2	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	46	-	-	1.48E-02	1.45E-02
PID2	BP	GO:0042832	defense response to protozoan	-	28	14	-	-	6.14E-02	4.72E-03
PID2	BP	GO:0003013	circulatory system process	-	602	184	-	-	3.48E-02	5.82E-02
PID2	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	72	-	-	1.11E-02	2.28E-02
PID2	BP	GO:1903035	negative regulation of response to wounding	-	93	42	-	-	3.64E-02	1.34E-02
PID2	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	16	-	-	1.40E-02	5.11E-03
PID2	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	18	-	-	1.53E-02	5.90E-03
PID2	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	30	-	-	1.11E-02	9.44E-03
PID2	BP	GO:0045056	transcytosis	-	20	11	-	-	9.01E-03	3.54E-03
PID2	BP	GO:0009267	cellular response to starvation	-	170	55	-	-	2.66E-02	1.73E-02
PID2	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	33	-	-	1.34E-02	1.06E-02
PID2	CC	GO:0032008	positive regulation of TOR signaling	-	52	14	-	-	1.24E-01	4.72E-03
PID2	BP	GO:0060428	lung epithelium development	-	43	23	-	-	4.83E-03	7.47E-03
PID2	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	42	-	-	8.83E-03	1.34E-02
PID2	BP	GO:0065004	protein-DNA complex assembly	-	307	68	-	-	5.40E-02	2.16E-02
PID2	BP	GO:0009880	embryonic pattern specification	-	70	29	-	-	2.91E-02	9.44E-03
PID2	BP	GO:0002367	cytokine production involved in immune response	-	121	54	-	-	2.09E-02	1.73E-02
PID2	BP	GO:0044848	biological phase	-	211	68	-	-	4.89E-02	2.16E-02
PID2	BP	GO:0046660	female sex differentiation	-	125	61	-	-	8.18E-03	1.93E-02
PID2	BP	GO:0019693	ribose phosphate metabolic process	-	556	104	-	-	8.72E-02	3.30E-02
PID2	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	25	-	-	6.00E-03	7.86E-03
PID2	BP	GO:0060411	cardiac septum morphogenesis	-	72	44	-	-	2.60E-02	1.42E-02
PID2	BP	GO:0071248	cellular response to metal ion	-	201	80	-	-	1.22E-02	2.52E-02
PID2	BP	GO:0030308	negative regulation of cell growth	-	191	71	-	-	1.13E-02	2.24E-02
PID2	BP	GO:0097306	cellular response to alcohol	-	99	46	-	-	2.79E-02	1.45E-02
PID2	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	13	-	-	3.15E-01	4.33E-03
PID2	BP	GO:0010453	regulation of cell fate commitment	-	40	27	-	-	1.01E-01	8.65E-03
PID2	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	24	-	-	6.67E-03	7.86E-03
PID2	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	81	-	-	4.94E-02	2.56E-02
PID2	BP	GO:0032890	regulation of organic acid transport	-	78	23	-	-	4.08E-03	7.47E-03
PID2	BP	GO:0071498	cellular response to fluid shear stress	-	21	11	-	-	4.39E-03	3.54E-03
PID2	BP	GO:0098771	inorganic ion homeostasis	-	531	136	-	-	2.54E-02	4.29E-02
PID2	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	43	-	-	1.10E-02	1.38E-02
PID2	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	15	-	-	1.46E-02	4.72E-03
PID2	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	20	-	-	4.29E-02	6.29E-03
PID2	BP	GO:0051259	protein complex oligomerization	-	251	44	-	-	6.16E-03	1.42E-02
PID2	BP	GO:0009994	oocyte differentiation	-	57	17	-	-	2.37E-03	5.51E-03
PID2	MF	GO:0031952	regulation of protein autophosphorylation	-	43	24	-	-	5.65E-02	7.86E-03
PID2	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	46	-	-	4.69E-03	1.45E-02
PID2	BP	GO:0044319	"wound healing, spreading of cells"	-	37	19	-	-	2.91E-03	6.29E-03
PID2	BP	GO:0033688	regulation of osteoblast proliferation	-	31	18	-	-	2.50E-03	5.90E-03
PID2	BP	GO:0060251	regulation of glial cell proliferation	-	39	24	-	-	2.37E-03	7.86E-03
PID2	BP	GO:0072665	protein localization to vacuole	-	84	20	-	-	4.86E-02	6.29E-03
PID2	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	24	-	-	7.90E-02	7.86E-03
PID2	BP	GO:0006914	autophagy	-	574	155	-	-	5.49E-02	4.88E-02
PID2	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	15	-	-	3.15E-03	4.72E-03
PID2	BP	GO:0048858	cell projection morphogenesis	-	643	249	-	-	7.26E-02	7.86E-02
PID2	BP	GO:0045661	regulation of myoblast differentiation	-	74	37	-	-	1.68E-02	1.18E-02
PID2	BP	GO:0030307	positive regulation of cell growth	-	164	74	-	-	1.17E-02	2.36E-02
PID2	BP	GO:0034250	positive regulation of amide metabolic process	-	27	15	-	-	2.92E-03	4.72E-03
PID2	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	160	-	-	3.17E-02	5.03E-02
PID2	BP	GO:0014812	muscle cell migration	-	110	48	-	-	1.25E-02	1.53E-02
PID2	BP	GO:0048525	negative regulation of viral process	-	90	13	-	-	2.07E-03	4.33E-03
PID2	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	31	-	-	4.73E-02	9.83E-03
PID2	BP	GO:0051781	positive regulation of cell division	-	93	54	-	-	1.66E-02	1.73E-02
PID2	BP	GO:0044770	cell cycle phase transition	-	558	204	-	-	1.02E-01	6.45E-02
PID2	BP	GO:0002696	positive regulation of leukocyte activation	-	358	173	-	-	3.80E-02	5.47E-02
PID2	BP	GO:0060711	labyrinthine layer development	-	47	24	-	-	6.35E-03	7.86E-03
PID2	BP	GO:0007272	ensheathment of neurons	-	146	43	-	-	6.91E-03	1.38E-02
PID2	CC	GO:0050806	positive regulation of synaptic transmission	-	171	55	-	-	6.18E-02	1.73E-02
PID2	BP	GO:0060021	roof of mouth development	-	91	42	-	-	1.18E-02	1.34E-02
PID2	BP	GO:0034504	protein localization to nucleus	-	312	115	-	-	1.97E-02	3.62E-02
PID2	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	16	-	-	2.31E-02	5.11E-03
PID2	BP	GO:0050819	negative regulation of coagulation	-	54	28	-	-	4.53E-02	9.04E-03
PID2	BP	GO:0031647	regulation of protein stability	-	327	105	-	-	1.46E-02	3.30E-02
PID2	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	16	-	-	1.04E-02	5.11E-03
PID2	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	12	-	-	3.55E-02	3.93E-03
PID2	CC	GO:0050805	negative regulation of synaptic transmission	-	55	15	-	-	1.41E-03	4.72E-03
PID2	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	18	-	-	1.13E-02	5.90E-03
PID2	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	26	-	-	9.48E-02	8.26E-03
PID2	BP	GO:0016054	organic acid catabolic process	-	251	25	-	-	3.17E-02	7.86E-03
PID2	BP	GO:0050890	cognition	-	317	104	-	-	1.68E-02	3.30E-02
PID2	BP	GO:1900048	positive regulation of hemostasis	-	28	12	-	-	1.70E-02	3.93E-03
PID2	BP	GO:0046661	male sex differentiation	-	171	71	-	-	1.27E-02	2.24E-02
PID2	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	29	-	-	1.76E-02	9.44E-03
PID2	BP	GO:1990778	protein localization to cell periphery	-	346	100	-	-	1.53E-02	3.15E-02
PID2	BP	GO:0061326	renal tubule development	-	103	44	-	-	1.19E-02	1.42E-02
PID2	BP	GO:0051258	protein polymerization	-	280	92	-	-	1.93E-02	2.91E-02
PID2	BP	GO:0060325	face morphogenesis	-	31	14	-	-	1.67E-03	4.72E-03
PID2	BP	GO:0090559	regulation of membrane permeability	-	72	26	-	-	2.67E-02	8.26E-03
PID2	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	15	-	-	5.80E-03	4.72E-03
PID2	BP	GO:0060033	anatomical structure regression	-	16	11	-	-	5.73E-02	3.54E-03
PID2	BP	GO:0046460	neutral lipid biosynthetic process	-	50	16	-	-	2.02E-02	5.11E-03
PID2	BP	GO:0002250	adaptive immune response	-	753	177	-	-	1.24E-01	5.58E-02
PID2	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	66	-	-	2.31E-02	2.08E-02
PID2	CC	GO:0048167	regulation of synaptic plasticity	-	210	76	-	-	2.73E-02	2.40E-02
PID2	BP	GO:1903708	positive regulation of hemopoiesis	-	184	100	-	-	1.92E-02	3.15E-02
PID2	BP	GO:1903008	organelle disassembly	-	154	43	-	-	1.83E-02	1.38E-02
PID2	BP	GO:0001709	cell fate determination	-	44	23	-	-	9.23E-03	7.47E-03
PID2	BP	GO:0045058	T cell selection	-	53	36	-	-	1.43E-02	1.14E-02
PID2	CC	GO:0032387	negative regulation of intracellular transport	-	51	17	-	-	1.46E-02	5.51E-03
PID2	BP	GO:0072091	regulation of stem cell proliferation	-	91	39	-	-	6.16E-03	1.26E-02
PID2	BP	GO:0099084	postsynaptic specialization organization	-	44	17	-	-	3.03E-03	5.51E-03
PID2	BP	GO:0060384	innervation	-	27	13	-	-	6.81E-03	4.33E-03
PID2	BP	GO:0032535	regulation of cellular component size	-	360	126	-	-	3.65E-02	3.97E-02
PID2	MF	GO:0031281	positive regulation of cyclase activity	-	40	17	-	-	1.19E-02	5.51E-03
PID2	MF	GO:0098631	cell adhesion mediator activity	-	64	19	-	-	1.52E-02	6.29E-03
PID2	BP	GO:0051603	proteolysis involved in protein catabolic process	-	759	158	-	-	5.75E-02	4.99E-02
PID2	BP	GO:0071453	cellular response to oxygen levels	-	168	90	-	-	1.93E-02	2.83E-02
PID2	BP	GO:0090399	replicative senescence	-	17	11	-	-	3.57E-03	3.54E-03
PID2	BP	GO:0070585	protein localization to mitochondrion	-	125	27	-	-	7.11E-02	8.65E-03
PID2	BP	GO:0010623	programmed cell death involved in cell development	-	25	14	-	-	2.75E-03	4.72E-03
PID2	BP	GO:0044242	cellular lipid catabolic process	-	224	41	-	-	3.13E-02	1.30E-02
PID2	BP	GO:0002931	response to ischemia	-	58	31	-	-	9.26E-03	9.83E-03
PID2	BP	GO:0043062	extracellular structure organization	-	317	89	-	-	7.09E-02	2.83E-02
PID2	BP	GO:0061005	cell differentiation involved in kidney development	-	58	30	-	-	1.31E-02	9.44E-03
PID2	BP	GO:0055082	intracellular chemical homeostasis	-	706	184	-	-	2.72E-02	5.82E-02
PID2	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	151	-	-	3.03E-02	4.76E-02
PID2	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	24	-	-	2.67E-02	7.86E-03
PID2	BP	GO:0060420	regulation of heart growth	-	74	33	-	-	8.31E-03	1.06E-02
PID2	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	11	-	-	7.70E-03	3.54E-03
PID2	BP	GO:0009755	hormone-mediated signaling pathway	-	221	99	-	-	4.63E-02	3.15E-02
PID2	BP	GO:0022612	gland morphogenesis	-	124	81	-	-	1.77E-02	2.56E-02
PID2	MF	GO:0140416	transcription regulator inhibitor activity	-	26	13	-	-	2.07E-03	4.33E-03
PID2	BP	GO:0044782	cilium organization	-	400	40	-	-	1.12E-02	1.26E-02
PID2	BP	GO:0090130	tissue migration	-	379	155	-	-	2.57E-02	4.88E-02
PID2	BP	GO:1990845	adaptive thermogenesis	-	166	66	-	-	1.34E-02	2.08E-02
PID2	BP	GO:0071320	cellular response to cAMP	-	54	14	-	-	7.17E-03	4.72E-03
PID2	BP	GO:0015844	monoamine transport	-	88	16	-	-	7.18E-02	5.11E-03
PID2	BP	GO:0071392	cellular response to estradiol stimulus	-	40	23	-	-	1.74E-02	7.47E-03
PID2	BP	GO:0009314	response to radiation	-	449	198	-	-	5.04E-02	6.25E-02
PID2	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	19	-	-	5.86E-03	6.29E-03
PID2	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	32	-	-	5.68E-02	1.02E-02
PID2	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	24	-	-	8.78E-03	7.86E-03
PID2	BP	GO:0015807	L-amino acid transport	-	94	12	-	-	1.42E-03	3.93E-03
PID2	BP	GO:0032941	secretion by tissue	-	85	32	-	-	2.00E-02	1.02E-02
PID2	BP	GO:0046605	regulation of centrosome cycle	-	54	15	-	-	6.58E-03	4.72E-03
PID2	BP	GO:0003014	renal system process	-	130	34	-	-	2.43E-02	1.10E-02
PID2	BP	GO:0045598	regulation of fat cell differentiation	-	148	57	-	-	1.06E-02	1.81E-02
PID2	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	93	-	-	2.63E-02	2.95E-02
PID2	BP	GO:1904646	cellular response to amyloid-beta	-	44	28	-	-	9.72E-03	9.04E-03
PID2	BP	GO:1901863	positive regulation of muscle tissue development	-	24	17	-	-	1.15E-02	5.51E-03
PID2	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	62	-	-	8.41E-02	1.97E-02
PID2	BP	GO:0071709	membrane assembly	-	68	16	-	-	5.03E-02	5.11E-03
PID2	BP	GO:0008217	regulation of blood pressure	-	186	58	-	-	1.30E-02	1.85E-02
PID2	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	32	-	-	1.55E-02	1.02E-02
PID2	CC	GO:0042770	signal transduction in response to DNA damage	-	186	91	-	-	8.49E-02	2.87E-02
PID2	BP	GO:0002200	somatic diversification of immune receptors	-	78	36	-	-	7.33E-02	1.14E-02
PID2	BP	GO:0035315	hair cell differentiation	-	52	15	-	-	1.36E-02	4.72E-03
PID2	BP	GO:0048645	animal organ formation	-	62	34	-	-	7.24E-03	1.10E-02
PID2	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	72	-	-	3.31E-02	2.28E-02
PID2	BP	GO:0033627	cell adhesion mediated by integrin	-	87	53	-	-	8.86E-02	1.69E-02
PID2	BP	GO:0035107	appendage morphogenesis	-	147	52	-	-	4.11E-02	1.65E-02
PID2	BP	GO:1903707	negative regulation of hemopoiesis	-	116	50	-	-	9.50E-03	1.57E-02
PID2	BP	GO:0050994	regulation of lipid catabolic process	-	61	21	-	-	2.06E-02	6.69E-03
PID2	BP	GO:0009593	detection of chemical stimulus	-	511	20	-	-	3.50E-02	6.29E-03
PID2	BP	GO:0045727	positive regulation of translation	-	141	30	-	-	4.36E-03	9.44E-03
PID2	CC	GO:0032388	positive regulation of intracellular transport	-	137	47	-	-	6.52E-03	1.49E-02
PID2	BP	GO:0002027	regulation of heart rate	-	106	31	-	-	5.87E-02	9.83E-03
PID2	BP	GO:0050879	multicellular organismal movement	-	118	25	-	-	3.87E-03	7.86E-03
PID2	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	39	-	-	1.20E-02	1.26E-02
PID2	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	27	-	-	9.33E-03	8.65E-03
PID2	BP	GO:0048515	spermatid differentiation	-	208	21	-	-	4.15E-03	6.69E-03
PID2	BP	GO:0072132	mesenchyme morphogenesis	-	57	34	-	-	8.18E-03	1.10E-02
PID2	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	16	-	-	4.97E-02	5.11E-03
PID2	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	11	-	-	2.01E-03	3.54E-03
PID2	BP	GO:1901983	regulation of protein acetylation	-	26	11	-	-	3.22E-03	3.54E-03
PID2	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	142	-	-	3.93E-02	4.48E-02
PID2	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	16	-	-	2.11E-02	5.11E-03
PID2	BP	GO:0010883	regulation of lipid storage	-	53	25	-	-	4.85E-02	7.86E-03
PID2	BP	GO:1905954	positive regulation of lipid localization	-	110	34	-	-	1.18E-02	1.10E-02
PID2	BP	GO:0072523	purine-containing compound catabolic process	-	146	42	-	-	1.29E-01	1.34E-02
PID2	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	21	-	-	1.45E-02	6.69E-03
PID2	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	13	-	-	6.27E-03	4.33E-03
PID2	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	39	-	-	1.17E-01	1.26E-02
PID2	BP	GO:0007218	neuropeptide signaling pathway	-	113	12	-	-	8.92E-02	3.93E-03
PID2	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	60	-	-	2.82E-02	1.89E-02
PID2	BP	GO:0031345	negative regulation of cell projection organization	-	195	76	-	-	2.06E-02	2.40E-02
PID2	BP	GO:0048278	vesicle docking	-	64	19	-	-	4.29E-01	6.29E-03
PID2	BP	GO:0035050	embryonic heart tube development	-	86	34	-	-	1.43E-02	1.10E-02
PID2	BP	GO:0030168	platelet activation	-	135	62	-	-	2.63E-02	1.97E-02
PID2	BP	GO:0002253	activation of immune response	-	529	199	-	-	9.27E-02	6.29E-02
PID2	BP	GO:0031529	ruffle organization	-	55	18	-	-	4.11E-03	5.90E-03
PID2	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	19	-	-	1.05E-02	6.29E-03
PID2	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	20	-	-	2.21E-02	6.29E-03
PID2	BP	GO:0035304	regulation of protein dephosphorylation	-	87	38	-	-	5.43E-03	1.22E-02
PID2	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	100	-	-	1.79E-02	3.15E-02
PID2	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	16	-	-	1.05E-02	5.11E-03
PID2	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	146	-	-	4.46E-02	4.60E-02
PID2	BP	GO:0051785	positive regulation of nuclear division	-	61	30	-	-	1.69E-02	9.44E-03
PID2	BP	GO:0060749	mammary gland alveolus development	-	20	15	-	-	6.59E-03	4.72E-03
PID2	BP	GO:0044786	cell cycle DNA replication	-	45	19	-	-	2.13E-02	6.29E-03
PID2	BP	GO:0048145	regulation of fibroblast proliferation	-	87	53	-	-	3.34E-02	1.69E-02
PID2	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	30	-	-	1.87E-01	9.44E-03
PID2	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	118	-	-	1.34E-02	3.74E-02
PID2	BP	GO:0009306	protein secretion	-	376	119	-	-	4.31E-02	3.78E-02
PID2	MF	GO:0043086	negative regulation of catalytic activity	-	717	232	-	-	2.56E-02	7.31E-02
PID2	BP	GO:0045732	positive regulation of protein catabolic process	-	202	75	-	-	2.56E-02	2.36E-02
PID2	BP	GO:0031589	cell-substrate adhesion	-	360	175	-	-	7.54E-02	5.51E-02
PID2	BP	GO:1904018	positive regulation of vasculature development	-	185	87	-	-	4.61E-02	2.75E-02
PID2	BP	GO:0010948	negative regulation of cell cycle process	-	317	120	-	-	9.44E-02	3.78E-02
PID2	BP	GO:0050953	sensory perception of light stimulus	-	223	44	-	-	5.02E-01	1.42E-02
PID2	BP	GO:0035601	protein deacylation	-	56	22	-	-	2.56E-02	7.08E-03
PID2	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	12	-	-	3.89E-03	3.93E-03
PID2	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	12	-	-	3.79E-03	3.93E-03
PID2	BP	GO:0071300	cellular response to retinoic acid	-	66	27	-	-	6.95E-02	8.65E-03
PID2	BP	GO:0045830	positive regulation of isotype switching	-	28	13	-	-	7.70E-03	4.33E-03
PID2	BP	GO:0031069	hair follicle morphogenesis	-	33	14	-	-	2.52E-03	4.72E-03
PID2	BP	GO:0046697	decidualization	-	26	13	-	-	7.44E-03	4.33E-03
PID2	BP	GO:0048284	organelle fusion	-	456	124	-	-	1.44E-01	3.93E-02
PID2	BP	GO:0051588	regulation of neurotransmitter transport	-	99	29	-	-	7.64E-02	9.44E-03
PID2	BP	GO:0051784	negative regulation of nuclear division	-	63	26	-	-	8.80E-02	8.26E-03
PID2	BP	GO:0044703	multi-organism reproductive process	-	209	74	-	-	1.16E-02	2.36E-02
PID2	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	66	-	-	1.03E-02	2.08E-02
PID2	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	25	-	-	3.83E-02	7.86E-03
PID2	MF	GO:0004930	G protein-coupled receptor activity	-	873	63	-	-	5.75E-02	2.01E-02
PID2	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	11	-	-	3.79E-02	3.54E-03
PID2	BP	GO:0048857	neural nucleus development	-	65	21	-	-	5.75E-03	6.69E-03
PID2	BP	GO:0048663	neuron fate commitment	-	74	33	-	-	1.60E-02	1.06E-02
PID2	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	35	-	-	2.58E-02	1.10E-02
PID2	BP	GO:0106027	neuron projection organization	-	90	40	-	-	1.53E-02	1.26E-02
PID2	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	49	-	-	1.66E-02	1.57E-02
PID2	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	19	-	-	5.66E-03	6.29E-03
PID2	BP	GO:0045685	regulation of glial cell differentiation	-	77	37	-	-	1.02E-02	1.18E-02
PID2	BP	GO:0043414	macromolecule methylation	-	138	11	-	-	1.08E-01	3.54E-03
PID2	BP	GO:0050886	endocrine process	-	93	35	-	-	4.06E-02	1.10E-02
PID2	BP	GO:0045807	positive regulation of endocytosis	-	155	73	-	-	1.13E-02	2.32E-02
PID2	BP	GO:0002418	immune response to tumor cell	-	29	11	-	-	2.68E-02	3.54E-03
PID2	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	30	-	-	7.71E-03	9.44E-03
PID2	BP	GO:0034394	protein localization to cell surface	-	69	24	-	-	1.07E-02	7.86E-03
PID2	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	59	-	-	1.06E-02	1.89E-02
PID2	MF	GO:0051100	negative regulation of binding	-	161	62	-	-	9.36E-03	1.97E-02
PID2	BP	GO:0001818	negative regulation of cytokine production	-	379	107	-	-	1.56E-02	3.38E-02
PID2	BP	GO:0003151	outflow tract morphogenesis	-	81	48	-	-	2.77E-02	1.53E-02
PID2	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	28	-	-	1.65E-02	9.04E-03
PID2	BP	GO:0055093	response to hyperoxia	-	20	12	-	-	8.67E-03	3.93E-03
PID2	BP	GO:0061036	positive regulation of cartilage development	-	33	14	-	-	3.51E-02	4.72E-03
PID2	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	24	-	-	2.91E-03	7.86E-03
PID2	BP	GO:0046621	negative regulation of organ growth	-	39	12	-	-	2.09E-03	3.93E-03
PID2	BP	GO:0032368	regulation of lipid transport	-	149	49	-	-	9.61E-03	1.57E-02
PID2	BP	GO:0055094	response to lipoprotein particle	-	34	19	-	-	5.51E-03	6.29E-03
PID2	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	83	-	-	2.14E-02	2.63E-02
PID2	BP	GO:0033002	muscle cell proliferation	-	249	131	-	-	1.52E-02	4.13E-02
PID2	BP	GO:0048880	sensory system development	-	399	146	-	-	3.23E-02	4.60E-02
PID2	BP	GO:0043331	response to dsRNA	-	56	18	-	-	1.74E-02	5.90E-03
PID2	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	23	-	-	3.94E-03	7.47E-03
PID2	BP	GO:0060479	lung cell differentiation	-	28	15	-	-	3.43E-03	4.72E-03
PID2	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	22	-	-	5.61E-03	7.08E-03
PID2	BP	GO:2000773	negative regulation of cellular senescence	-	25	16	-	-	7.44E-03	5.11E-03
PID2	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	26	-	-	8.08E-03	8.26E-03
PID2	BP	GO:0050820	positive regulation of coagulation	-	30	13	-	-	1.74E-02	4.33E-03
PID2	BP	GO:0072164	mesonephric tubule development	-	98	50	-	-	1.48E-02	1.57E-02
PID2	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	56	-	-	1.17E-02	1.77E-02
PID2	BP	GO:1903524	positive regulation of blood circulation	-	39	13	-	-	4.08E-02	4.33E-03
PID2	BP	GO:0030901	midbrain development	-	87	32	-	-	6.80E-03	1.02E-02
PID2	BP	GO:0007162	negative regulation of cell adhesion	-	310	129	-	-	2.27E-02	4.09E-02
PID2	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	32	-	-	7.09E-03	1.02E-02
PID2	BP	GO:0002687	positive regulation of leukocyte migration	-	147	73	-	-	1.37E-02	2.32E-02
PID2	BP	GO:0034605	cellular response to heat	-	66	34	-	-	4.72E-03	1.10E-02
PID2	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	146	-	-	2.95E-02	4.60E-02
PID2	BP	GO:0005996	monosaccharide metabolic process	-	250	80	-	-	3.77E-02	2.52E-02
PID2	BP	GO:0033555	multicellular organismal response to stress	-	90	24	-	-	6.01E-03	7.86E-03
PID2	BP	GO:0002262	myeloid cell homeostasis	-	172	76	-	-	1.83E-02	2.40E-02
PID2	BP	GO:0050688	regulation of defense response to virus	-	65	16	-	-	1.53E-02	5.11E-03
PID2	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	151	-	-	7.61E-02	4.76E-02
PID2	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	144	-	-	5.90E-02	4.56E-02
PID2	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	22	-	-	5.11E-03	7.08E-03
PID2	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	20	-	-	1.10E-02	6.29E-03
PID2	BP	GO:0003272	endocardial cushion formation	-	28	16	-	-	2.20E-02	5.11E-03
PID2	BP	GO:0022618	protein-RNA complex assembly	-	227	19	-	-	1.54E-02	6.29E-03
PID2	BP	GO:0051147	regulation of muscle cell differentiation	-	162	76	-	-	1.57E-02	2.40E-02
PID2	BP	GO:0006066	alcohol metabolic process	-	374	71	-	-	6.59E-02	2.24E-02
PID2	BP	GO:0090102	cochlea development	-	50	17	-	-	7.67E-03	5.51E-03
PID2	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	16	-	-	5.74E-03	5.11E-03
PID2	BP	GO:0045933	positive regulation of muscle contraction	-	49	18	-	-	5.38E-03	5.90E-03
PID2	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	18	-	-	2.04E-02	5.90E-03
PID2	BP	GO:0043555	regulation of translation in response to stress	-	22	11	-	-	2.28E-02	3.54E-03
PID2	BP	GO:0032922	circadian regulation of gene expression	-	71	38	-	-	1.90E-01	1.22E-02
PID2	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	19	-	-	9.53E-03	6.29E-03
PID2	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	22	-	-	2.04E-02	7.08E-03
PID2	BP	GO:0038179	neurotrophin signaling pathway	-	38	28	-	-	6.02E-02	9.04E-03
PID2	BP	GO:0140253	cell-cell fusion	-	62	21	-	-	1.50E-02	6.69E-03
PID2	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	16	-	-	1.31E-01	5.11E-03
PID2	BP	GO:0001941	postsynaptic membrane organization	-	37	11	-	-	4.64E-03	3.54E-03
PID2	BP	GO:0051293	establishment of spindle localization	-	57	20	-	-	5.42E-02	6.29E-03
PID2	BP	GO:0023061	signal release	-	491	158	-	-	7.17E-02	4.99E-02
PID2	BP	GO:0043114	regulation of vascular permeability	-	49	23	-	-	6.31E-02	7.47E-03
PID2	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	40	-	-	1.43E-02	1.26E-02
PID2	BP	GO:0008360	regulation of cell shape	-	139	53	-	-	1.33E-02	1.69E-02
PID2	BP	GO:0051222	positive regulation of protein transport	-	249	97	-	-	1.10E-02	3.07E-02
PID2	CC	GO:0140632	canonical inflammasome complex assembly	-	40	15	-	-	1.52E-02	4.72E-03
PID2	MF	GO:0034260	negative regulation of GTPase activity	-	36	11	-	-	4.24E-02	3.54E-03
PID2	BP	GO:0045739	positive regulation of DNA repair	-	128	41	-	-	4.10E-02	1.30E-02
PID2	BP	GO:0045185	maintenance of protein location	-	95	29	-	-	5.52E-03	9.44E-03
PID2	BP	GO:0003158	endothelium development	-	140	72	-	-	2.20E-02	2.28E-02
PID2	CC	GO:0072595	maintenance of protein localization in organelle	-	42	15	-	-	2.01E-02	4.72E-03
PID2	BP	GO:0051224	negative regulation of protein transport	-	122	36	-	-	3.06E-02	1.14E-02
PID2	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	75	-	-	1.38E-02	2.36E-02
PID2	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	12	-	-	1.68E-03	3.93E-03
PID2	MF	GO:0003713	transcription coactivator activity	-	281	100	-	-	3.94E-02	3.15E-02
PID2	BP	GO:0021885	forebrain cell migration	-	63	27	-	-	4.78E-02	8.65E-03
PID2	BP	GO:0007405	neuroblast proliferation	-	81	39	-	-	7.90E-03	1.26E-02
PID2	BP	GO:0009581	detection of external stimulus	-	137	35	-	-	8.83E-02	1.10E-02
PID2	BP	GO:0045862	positive regulation of proteolysis	-	353	142	-	-	3.31E-02	4.48E-02
PID2	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	13	-	-	6.84E-02	4.33E-03
PID2	BP	GO:0031128	developmental induction	-	26	13	-	-	4.27E-03	4.33E-03
PID2	BP	GO:0031100	animal organ regeneration	-	66	35	-	-	4.38E-03	1.10E-02
PID2	BP	GO:0045684	positive regulation of epidermis development	-	33	14	-	-	3.52E-03	4.72E-03
PID2	BP	GO:1900047	negative regulation of hemostasis	-	51	28	-	-	6.02E-02	9.04E-03
PID2	BP	GO:0021517	ventral spinal cord development	-	47	16	-	-	4.38E-02	5.11E-03
PID2	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	41	-	-	1.29E-02	1.30E-02
PID2	BP	GO:0030001	metal ion transport	-	933	178	-	-	3.66E-02	5.62E-02
PID2	BP	GO:0042490	mechanoreceptor differentiation	-	67	20	-	-	1.53E-02	6.29E-03
PID2	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	12	-	-	8.77E-03	3.93E-03
PID2	BP	GO:0035148	tube formation	-	155	64	-	-	1.89E-02	2.04E-02
PID2	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	23	-	-	7.04E-02	7.47E-03
PID2	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	33	-	-	8.48E-03	1.06E-02
PID2	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	29	-	-	6.96E-02	9.44E-03
PID2	CC	GO:0007097	nuclear migration	-	24	12	-	-	1.03E-01	3.93E-03
PID2	BP	GO:0045229	external encapsulating structure organization	-	319	89	-	-	6.87E-02	2.83E-02
PID2	BP	GO:0006885	regulation of pH	-	104	16	-	-	9.80E-03	5.11E-03
PID2	BP	GO:0001667	ameboidal-type cell migration	-	495	203	-	-	3.72E-02	6.41E-02
PID2	BP	GO:1990840	response to lectin	-	22	13	-	-	3.82E-03	4.33E-03
PID2	BP	GO:0071800	podosome assembly	-	19	12	-	-	1.40E-02	3.93E-03
PID2	BP	GO:0031018	endocrine pancreas development	-	47	24	-	-	6.89E-03	7.86E-03
PID2	BP	GO:0001708	cell fate specification	-	108	51	-	-	6.47E-02	1.61E-02
PID2	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	37	-	-	8.86E-03	1.18E-02
PID2	BP	GO:0030279	negative regulation of ossification	-	39	20	-	-	1.46E-02	6.29E-03
PID2	BP	GO:0032970	regulation of actin filament-based process	-	368	130	-	-	4.43E-02	4.09E-02
PID2	BP	GO:0042440	pigment metabolic process	-	80	15	-	-	1.44E-02	4.72E-03
PID2	BP	GO:0062197	cellular response to chemical stress	-	299	131	-	-	1.73E-02	4.13E-02
PID2	BP	GO:1901890	positive regulation of cell junction assembly	-	106	33	-	-	2.17E-02	1.06E-02
PID2	BP	GO:1901655	cellular response to ketone	-	107	51	-	-	2.36E-02	1.61E-02
PID2	MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	-	925	89	-	-	1.78E-02	2.83E-02
PID2	BP	GO:0006968	cellular defense response	-	52	20	-	-	7.41E-03	6.29E-03
PID2	BP	GO:0055006	cardiac cell development	-	93	33	-	-	4.88E-03	1.06E-02
PID2	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	15	-	-	9.90E-03	4.72E-03
PID2	BP	GO:0060004	reflex	-	63	23	-	-	3.22E-02	7.47E-03
PID2	BP	GO:0044706	multi-multicellular organism process	-	217	74	-	-	1.30E-02	2.36E-02
PID2	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	63	-	-	3.41E-02	2.01E-02
PID2	BP	GO:0031294	lymphocyte costimulation	-	47	23	-	-	9.49E-03	7.47E-03
PID2	BP	GO:0050768	negative regulation of neurogenesis	-	150	73	-	-	1.10E-02	2.32E-02
PID2	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	34	-	-	8.30E-03	1.10E-02
PID2	BP	GO:0090068	positive regulation of cell cycle process	-	262	103	-	-	6.16E-02	3.26E-02
PID2	MF	GO:0022803	passive transmembrane transporter activity	-	676	89	-	-	3.18E-02	2.83E-02
PID2	BP	GO:0043632	modification-dependent macromolecule catabolic process	-	642	139	-	-	5.39E-02	4.40E-02
PID2	BP	GO:1902115	regulation of organelle assembly	-	210	54	-	-	9.06E-03	1.73E-02
PID2	BP	GO:0006397	mRNA processing	-	482	29	-	-	1.61E-02	9.44E-03
PID2	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	41	-	-	1.10E-02	1.30E-02
PID2	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	43	-	-	5.84E-03	1.38E-02
PID2	BP	GO:0046622	positive regulation of organ growth	-	52	25	-	-	4.78E-03	7.86E-03
PID2	BP	GO:0051952	regulation of amine transport	-	98	18	-	-	3.82E-02	5.90E-03
PID2	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	27	-	-	1.45E-02	8.65E-03
PID2	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	38	-	-	8.04E-02	1.22E-02
PID2	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	16	-	-	1.17E-02	5.11E-03
PID2	BP	GO:0071398	cellular response to fatty acid	-	35	16	-	-	2.27E-03	5.11E-03
PID2	BP	GO:0097581	lamellipodium organization	-	91	46	-	-	6.60E-02	1.45E-02
PID2	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	19	-	-	2.16E-02	6.29E-03
PID2	BP	GO:0060326	cell chemotaxis	-	311	137	-	-	5.41E-02	4.33E-02
PID2	BP	GO:0016485	protein processing	-	248	69	-	-	4.97E-02	2.20E-02
PID2	BP	GO:0009649	entrainment of circadian clock	-	30	15	-	-	3.63E-02	4.72E-03
PID2	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	34	-	-	2.55E-02	1.10E-02
PID2	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	21	-	-	1.67E-02	6.69E-03
PID2	BP	GO:0099054	presynapse assembly	-	49	17	-	-	9.19E-03	5.51E-03
PID2	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	11	-	-	1.16E-02	3.54E-03
PID2	BP	GO:0031348	negative regulation of defense response	-	282	87	-	-	1.13E-02	2.75E-02
PID2	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	34	-	-	7.64E-03	1.10E-02
PID2	BP	GO:0007606	sensory perception of chemical stimulus	-	535	12	-	-	4.48E-03	3.93E-03
PID2	BP	GO:0061180	mammary gland epithelium development	-	68	47	-	-	6.62E-03	1.49E-02
PID2	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	74	-	-	1.40E-02	2.36E-02
PID2	CC	GO:0051169	nuclear transport	-	325	100	-	-	5.88E-02	3.15E-02
PID2	BP	GO:0071496	cellular response to external stimulus	-	74	43	-	-	1.28E-02	1.38E-02
PID2	BP	GO:0046434	organophosphate catabolic process	-	232	57	-	-	8.12E-02	1.81E-02
PID2	BP	GO:0060037	pharyngeal system development	-	29	15	-	-	2.29E-02	4.72E-03
PID2	BP	GO:0009566	fertilization	-	205	28	-	-	4.43E-03	9.04E-03
PID2	BP	GO:0045907	positive regulation of vasoconstriction	-	30	11	-	-	1.01E-02	3.54E-03
PID2	BP	GO:0033044	regulation of chromosome organization	-	249	95	-	-	7.41E-02	2.99E-02
PID2	BP	GO:0009309	amine biosynthetic process	-	38	11	-	-	1.40E-01	3.54E-03
PID2	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	144	-	-	1.89E-02	4.56E-02
PID2	BP	GO:0061900	glial cell activation	-	56	31	-	-	9.05E-03	9.83E-03
PID2	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	58	-	-	1.77E-02	1.85E-02
PID2	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	72	-	-	2.13E-02	2.28E-02
PID2	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	11	-	-	1.14E-02	3.54E-03
PID2	CC	GO:0140467	integrated stress response signaling	-	41	18	-	-	1.05E-02	5.90E-03
PID2	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	57	-	-	5.84E-02	1.81E-02
PID2	BP	GO:0051303	establishment of chromosome localization	-	104	39	-	-	4.59E-02	1.26E-02
PID2	BP	GO:0031349	positive regulation of defense response	-	473	170	-	-	1.03E-01	5.35E-02
PID2	BP	GO:0007164	establishment of tissue polarity	-	38	15	-	-	2.40E-02	4.72E-03
PID2	BP	GO:0021515	cell differentiation in spinal cord	-	51	13	-	-	2.40E-02	4.33E-03
PID2	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	12	-	-	5.86E-03	3.93E-03
PID2	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	11	-	-	3.15E-03	3.54E-03
PID2	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	13	-	-	5.59E-03	4.33E-03
PID2	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	13	-	-	7.90E-03	4.33E-03
PID2	BP	GO:0006605	protein targeting	-	327	60	-	-	1.74E-02	1.89E-02
PID2	BP	GO:0061318	renal filtration cell differentiation	-	22	11	-	-	3.31E-02	3.54E-03
PID2	BP	GO:0007566	embryo implantation	-	57	23	-	-	3.61E-03	7.47E-03
PID2	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	18	-	-	3.23E-02	5.90E-03
PID2	BP	GO:0061512	protein localization to cilium	-	394	39	-	-	1.66E-02	1.26E-02
PID2	BP	GO:0051017	actin filament bundle assembly	-	161	67	-	-	1.69E-02	2.12E-02
PID2	BP	GO:1905953	negative regulation of lipid localization	-	63	27	-	-	1.26E-02	8.65E-03
PID2	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	16	-	-	2.28E-02	5.11E-03
PID2	BP	GO:1901343	negative regulation of vasculature development	-	154	49	-	-	1.47E-02	1.57E-02
PID2	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	30	-	-	1.47E-01	9.44E-03
PID2	BP	GO:1902414	protein localization to cell junction	-	107	39	-	-	1.97E-02	1.26E-02
PID2	BP	GO:0071305	cellular response to vitamin D	-	23	14	-	-	9.90E-03	4.72E-03
PID2	BP	GO:0051304	chromosome separation	-	80	32	-	-	1.92E-01	1.02E-02
PID2	BP	GO:0090596	sensory organ morphogenesis	-	272	100	-	-	2.44E-02	3.15E-02
PID2	BP	GO:0048709	oligodendrocyte differentiation	-	101	39	-	-	6.73E-03	1.26E-02
PID2	BP	GO:0045017	glycerolipid biosynthetic process	-	254	55	-	-	1.49E-02	1.73E-02
PID2	BP	GO:0001776	leukocyte homeostasis	-	108	51	-	-	7.71E-03	1.61E-02
PID2	BP	GO:0050769	positive regulation of neurogenesis	-	240	107	-	-	1.54E-02	3.38E-02
PID2	BP	GO:0030193	regulation of blood coagulation	-	70	35	-	-	3.05E-02	1.10E-02
PID2	BP	GO:0050866	negative regulation of cell activation	-	216	84	-	-	1.69E-02	2.67E-02
PID2	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	15	-	-	1.29E-02	4.72E-03
PID2	BP	GO:0033500	carbohydrate homeostasis	-	251	94	-	-	3.71E-02	2.99E-02
PID2	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	15	-	-	4.13E-02	4.72E-03
PID2	BP	GO:0120035	regulation of plasma membrane bounded cell projection organization	-	647	229	-	-	6.09E-02	7.24E-02
PID2	CC	GO:0099522	cytosolic region	-	20	12	-	-	1.63E-02	3.93E-03
PID2	CC	GO:0000791	euchromatin	-	60	21	-	-	3.67E-03	6.69E-03
PID2	CC	GO:0030666	endocytic vesicle membrane	-	196	68	-	-	6.10E-02	2.16E-02
PID2	CC	GO:0098857	membrane microdomain	-	324	157	-	-	3.05E-02	4.95E-02
PID2	CC	GO:0030312	external encapsulating structure	-	567	149	-	-	1.84E-01	4.72E-02
PID2	CC	GO:0043204	perikaryon	-	156	35	-	-	1.35E-02	1.10E-02
PID2	CC	GO:1905368	peptidase complex	-	124	23	-	-	1.49E-01	7.47E-03
PID2	CC	GO:0000792	heterochromatin	-	98	29	-	-	4.58E-02	9.44E-03
PID2	CC	GO:0016324	apical plasma membrane	-	392	68	-	-	1.33E-02	2.16E-02
PID2	CC	GO:0033260	nuclear DNA replication	-	40	16	-	-	3.02E-02	5.11E-03
PID2	CC	GO:0044391	ribosomal subunit	-	203	11	-	-	2.01E-01	3.54E-03
PID2	CC	GO:0098862	cluster of actin-based cell projections	-	162	22	-	-	1.65E-02	7.08E-03
PID2	CC	GO:0098978	glutamatergic synapse	-	411	144	-	-	2.41E-02	4.56E-02
PID2	CC	GO:0016363	nuclear matrix	-	127	46	-	-	2.12E-02	1.45E-02
PID2	CC	GO:0031261	DNA replication preinitiation complex	-	46	15	-	-	2.81E-01	4.72E-03
PID2	CC	GO:0031966	mitochondrial membrane	-	746	89	-	-	2.34E-02	2.83E-02
PID2	CC	GO:0097060	synaptic membrane	-	413	91	-	-	7.52E-02	2.87E-02
PID2	CC	GO:0032432	actin filament bundle	-	249	57	-	-	1.70E-02	1.81E-02
PID2	CC	GO:0008088	axo-dendritic transport	-	78	21	-	-	1.40E-02	6.69E-03
PID2	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	65	-	-	1.19E-01	2.04E-02
PID2	CC	GO:0098791	Golgi apparatus subcompartment	-	378	47	-	-	3.93E-02	1.49E-02
PID2	CC	GO:0099643	signal release from synapse	-	147	38	-	-	1.24E-01	1.22E-02
PID2	CC	GO:0030018	Z disc	-	129	36	-	-	5.80E-02	1.14E-02
PID2	CC	GO:0005814	centriole	-	692	161	-	-	5.67E-02	5.07E-02
PID2	CC	GO:0097381	photoreceptor disc membrane	-	25	13	-	-	7.13E-01	4.33E-03
PID2	CC	GO:1905360	GTPase complex	-	41	20	-	-	1.70E-01	6.29E-03
PID2	CC	GO:0097540	axonemal central pair	-	161	16	-	-	1.97E-02	5.11E-03
PID2	CC	GO:0042641	actomyosin	-	77	23	-	-	1.26E-02	7.47E-03
PID2	CC	GO:0032588	trans-Golgi network membrane	-	102	12	-	-	2.53E-02	3.93E-03
PID2	CC	GO:0070382	exocytic vesicle	-	224	42	-	-	4.72E-02	1.34E-02
PID2	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	41	-	-	5.14E-03	1.30E-02
PID2	CC	GO:0016323	basolateral plasma membrane	-	239	49	-	-	1.39E-02	1.57E-02
PID2	CC	GO:1902495	transmembrane transporter complex	-	408	32	-	-	7.25E-02	1.02E-02
PID2	CC	GO:0098636	protein complex involved in cell adhesion	-	57	42	-	-	1.27E-01	1.34E-02
PID2	CC	GO:0001917	photoreceptor inner segment	-	71	15	-	-	1.15E-01	4.72E-03
PID2	CC	GO:0019897	extrinsic component of plasma membrane	-	156	65	-	-	2.17E-02	2.04E-02
PID2	CC	GO:0031594	neuromuscular junction	-	73	34	-	-	1.98E-02	1.10E-02
PID2	CC	GO:0000793	condensed chromosome	-	274	85	-	-	1.37E-01	2.67E-02
PID2	CC	GO:0000922	spindle pole	-	172	57	-	-	6.41E-02	1.81E-02
PID2	CC	GO:0120111	neuron projection cytoplasm	-	94	23	-	-	2.21E-02	7.47E-03
PID2	CC	GO:0004879	nuclear receptor activity	-	63	34	-	-	1.56E-01	1.10E-02
PID2	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	74	-	-	2.35E-02	2.36E-02
PID2	CC	GO:0000123	histone acetyltransferase complex	-	93	21	-	-	1.14E-01	6.69E-03
PID2	CC	GO:0048786	presynaptic active zone	-	80	19	-	-	3.36E-02	6.29E-03
PID2	CC	GO:0007034	vacuolar transport	-	168	26	-	-	7.22E-02	8.26E-03
PID2	CC	GO:0005776	autophagosome	-	111	17	-	-	6.86E-02	5.51E-03
PID2	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	13	-	-	3.51E-01	4.33E-03
PID2	CC	GO:0032994	protein-lipid complex	-	39	11	-	-	2.88E-01	3.54E-03
PID2	CC	GO:0150034	distal axon	-	309	100	-	-	4.14E-02	3.15E-02
PID2	CC	GO:0072562	blood microparticle	-	144	40	-	-	7.66E-02	1.26E-02
PID2	CC	GO:0051233	spindle midzone	-	36	15	-	-	2.33E-02	4.72E-03
PID2	CC	GO:0005811	lipid droplet	-	102	19	-	-	3.97E-03	6.29E-03
PID2	CC	GO:0045022	early endosome to late endosome transport	-	44	14	-	-	1.09E-02	4.72E-03
PID2	CC	GO:0043113	receptor clustering	-	51	21	-	-	2.84E-02	6.69E-03
PID2	CC	GO:0044853	plasma membrane raft	-	114	55	-	-	9.55E-03	1.73E-02
PID2	CC	GO:0005881	cytoplasmic microtubule	-	256	32	-	-	1.70E-02	1.02E-02
PID2	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	12	-	-	3.79E-02	3.93E-03
PID2	CC	GO:0005905	clathrin-coated pit	-	73	31	-	-	5.30E-02	9.83E-03
PID2	CC	GO:0031904	endosome lumen	-	38	17	-	-	1.36E-02	5.51E-03
PID2	CC	GO:0060170	ciliary membrane	-	76	17	-	-	1.84E-01	5.51E-03
PID2	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	11	-	-	8.83E-01	3.54E-03
PID2	CC	GO:0000139	Golgi membrane	-	646	94	-	-	4.48E-02	2.99E-02
PID2	CC	GO:0032154	cleavage furrow	-	54	24	-	-	6.99E-02	7.86E-03
PID2	CC	GO:0007006	mitochondrial membrane organization	-	117	26	-	-	1.65E-02	8.26E-03
PID2	CC	GO:0001772	immunological synapse	-	44	21	-	-	6.34E-02	6.69E-03
PID2	CC	GO:0009897	external side of plasma membrane	-	425	135	-	-	5.47E-02	4.25E-02
PID2	CC	GO:0030863	cortical cytoskeleton	-	104	31	-	-	5.81E-02	9.83E-03
PID2	CC	GO:0060076	excitatory synapse	-	64	15	-	-	5.29E-02	4.72E-03
PID2	CC	GO:0030427	site of polarized growth	-	172	68	-	-	3.45E-02	2.16E-02
PID2	CC	GO:0044309	neuron spine	-	213	72	-	-	1.27E-02	2.28E-02
PID2	CC	GO:0030658	transport vesicle membrane	-	231	36	-	-	4.65E-02	1.14E-02
PID2	CC	GO:0030667	secretory granule membrane	-	319	66	-	-	1.85E-02	2.08E-02
PID2	CC	GO:0097545	axonemal outer doublet	-	164	16	-	-	1.75E-02	5.11E-03
PID2	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	13	-	-	2.41E-02	4.33E-03
PID2	CC	GO:0055037	recycling endosome	-	200	36	-	-	1.10E-02	1.14E-02
PID2	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	40	-	-	8.80E-03	1.26E-02
PID2	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	104	-	-	3.20E-02	3.30E-02
PID2	CC	GO:1990391	DNA repair complex	-	22	15	-	-	3.04E-01	4.72E-03
PID2	CC	GO:0005775	vacuolar lumen	-	176	44	-	-	2.83E-02	1.42E-02
PID2	CC	GO:0044306	neuron projection terminus	-	164	38	-	-	2.37E-02	1.22E-02
PID2	CC	GO:0005770	late endosome	-	299	59	-	-	3.21E-02	1.89E-02
PID2	CC	GO:0031970	organelle envelope lumen	-	94	12	-	-	1.11E-02	3.93E-03
PID2	CC	GO:0019866	organelle inner membrane	-	546	38	-	-	6.82E-03	1.22E-02
PID2	CC	GO:0098687	chromosomal region	-	397	134	-	-	1.33E-01	4.25E-02
PID2	CC	GO:0043292	contractile muscle fiber	-	245	61	-	-	4.83E-02	1.93E-02
PID2	CC	GO:0098982	GABA-ergic synapse	-	84	15	-	-	1.77E-02	4.72E-03
PID2	CC	GO:0035097	histone methyltransferase complex	-	63	17	-	-	7.20E-03	5.51E-03
PID2	CC	GO:0000323	lytic vacuole	-	749	144	-	-	4.93E-02	4.56E-02
PID2	CC	GO:1903293	phosphatase complex	-	54	22	-	-	1.36E-01	7.08E-03
PID2	CC	GO:0000786	nucleosome	-	149	12	-	-	5.51E-02	3.93E-03
PID2	CC	GO:0001533	cornified envelope	-	59	12	-	-	1.44E-02	3.93E-03
PID2	CC	GO:1904724	tertiary granule lumen	-	55	12	-	-	6.75E-03	3.93E-03
PID2	CC	GO:0030027	lamellipodium	-	202	89	-	-	6.80E-02	2.83E-02
PID2	CC	GO:0002102	podosome	-	31	12	-	-	7.83E-02	3.93E-03
PID2	CC	GO:0090543	Flemming body	-	33	14	-	-	1.01E-01	4.72E-03
PID2	CC	GO:0016328	lateral plasma membrane	-	66	21	-	-	3.55E-02	6.69E-03
PID2	CC	GO:0001650	fibrillar center	-	151	35	-	-	7.67E-03	1.10E-02
PID2	CC	GO:1990204	oxidoreductase complex	-	90	15	-	-	4.27E-01	4.72E-03
PID2	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	38	-	-	6.77E-03	1.22E-02
PID2	CC	GO:0001726	ruffle	-	181	76	-	-	2.56E-02	2.40E-02
PID2	CC	GO:1990909	Wnt signalosome	-	13	11	-	-	2.54E-02	3.54E-03
PID2	CC	GO:0043073	germ cell nucleus	-	67	25	-	-	5.63E-03	7.86E-03
PID2	CC	GO:0005788	endoplasmic reticulum lumen	-	313	105	-	-	4.58E-02	3.30E-02
PID2	CC	GO:0034451	centriolar satellite	-	120	23	-	-	2.34E-02	7.47E-03
PID2	CC	GO:0045171	intercellular bridge	-	91	19	-	-	1.66E-02	6.29E-03
PID2	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	13	-	-	1.26E-02	4.33E-03
PID2	CC	GO:0098984	neuron to neuron synapse	-	384	103	-	-	1.97E-02	3.26E-02
PID2	CC	GO:0030286	dynein complex	-	210	19	-	-	7.08E-03	6.29E-03
PID2	CC	GO:0016604	nuclear body	-	847	181	-	-	3.75E-02	5.70E-02
PID2	CC	GO:0016482	cytosolic transport	-	135	21	-	-	8.22E-02	6.69E-03
PID2	CC	GO:0005796	Golgi lumen	-	106	38	-	-	3.26E-02	1.22E-02
PID2	CC	GO:0030662	coated vesicle membrane	-	202	54	-	-	6.84E-02	1.73E-02
PID2	CC	GO:0007039	protein catabolic process in the vacuole	-	61	15	-	-	1.75E-01	4.72E-03
PID2	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	123	-	-	4.42E-02	3.89E-02
PID2	CC	GO:0005769	early endosome	-	425	106	-	-	3.15E-02	3.34E-02
PID2	CC	GO:0090734	site of DNA damage	-	118	37	-	-	7.02E-02	1.18E-02
PID2	MF	GO:0051087	protein-folding chaperone binding	-	135	40	-	-	8.65E-03	1.26E-02
PID2	MF	GO:0140640	"catalytic activity, acting on a nucleic acid"	-	762	142	-	-	1.24E-01	4.48E-02
PID2	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	29	-	-	8.70E-02	9.44E-03
PID2	MF	GO:0016757	glycosyltransferase activity	-	286	19	-	-	3.00E-02	6.29E-03
PID2	MF	GO:0048306	calcium-dependent protein binding	-	61	13	-	-	1.41E-01	4.33E-03
PID2	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	19	-	-	5.58E-02	6.29E-03
PID2	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	26	-	-	5.07E-02	8.26E-03
PID2	MF	GO:0051020	GTPase binding	-	311	102	-	-	5.24E-02	3.22E-02
PID2	MF	GO:0005158	insulin receptor binding	-	22	15	-	-	8.15E-02	4.72E-03
PID2	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	13	-	-	9.83E-03	4.33E-03
PID2	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	124	-	-	4.59E-02	3.93E-02
PID2	MF	GO:0035035	histone acetyltransferase binding	-	24	14	-	-	2.35E-03	4.72E-03
PID2	MF	GO:0005178	integrin binding	-	153	89	-	-	2.32E-01	2.83E-02
PID2	MF	GO:0070064	proline-rich region binding	-	17	11	-	-	2.11E-03	3.54E-03
PID2	MF	GO:0008233	peptidase activity	-	998	198	-	-	4.98E-02	6.25E-02
PID2	MF	GO:0000217	DNA secondary structure binding	-	37	14	-	-	1.31E-02	4.72E-03
PID2	MF	GO:0002039	p53 binding	-	66	42	-	-	1.40E-02	1.34E-02
PID2	MF	GO:0005496	steroid binding	-	110	19	-	-	7.10E-03	6.29E-03
PID2	MF	GO:0008443	phosphofructokinase activity	-	27	11	-	-	1.03E-01	3.54E-03
PID2	MF	GO:0003684	damaged DNA binding	-	89	35	-	-	5.61E-02	1.10E-02
PID2	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	52	-	-	4.02E-02	1.65E-02
PID2	MF	GO:0070063	RNA polymerase binding	-	61	12	-	-	3.91E-03	3.93E-03
PID2	MF	GO:0030971	receptor tyrosine kinase binding	-	76	43	-	-	2.16E-02	1.38E-02
PID2	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	11	-	-	2.06E-01	3.54E-03
PID2	MF	GO:0140030	modification-dependent protein binding	-	179	33	-	-	1.28E-02	1.06E-02
PID2	MF	GO:0042813	Wnt receptor activity	-	16	13	-	-	8.06E-02	4.33E-03
PID2	MF	GO:0030276	clathrin binding	-	70	17	-	-	2.24E-01	5.51E-03
PID2	MF	GO:0003712	transcription coregulator activity	-	499	168	-	-	6.70E-02	5.31E-02
PID2	MF	GO:0046875	ephrin receptor binding	-	29	24	-	-	1.77E-02	7.86E-03
PID2	MF	GO:0106310	protein serine kinase activity	-	362	153	-	-	6.66E-02	4.84E-02
PID2	MF	GO:0016788	"hydrolase activity, acting on ester bonds"	-	936	227	-	-	4.28E-02	7.16E-02
PID2	MF	GO:0030552	cAMP binding	-	48	12	-	-	2.24E-01	3.93E-03
PID2	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	19	-	-	2.93E-03	6.29E-03
PID2	MF	GO:0004857	enzyme inhibitor activity	-	395	94	-	-	1.20E-02	2.99E-02
PID2	MF	GO:0016209	antioxidant activity	-	92	20	-	-	6.23E-03	6.29E-03
PID2	MF	GO:0070325	lipoprotein particle receptor binding	-	32	17	-	-	3.96E-02	5.51E-03
PID2	MF	GO:0044325	transmembrane transporter binding	-	159	45	-	-	3.85E-02	1.42E-02
PID2	MF	GO:0048156	tau protein binding	-	43	29	-	-	2.72E-02	9.44E-03
PID2	MF	GO:0140272	exogenous protein binding	-	79	35	-	-	2.64E-02	1.10E-02
PID2	MF	GO:0030145	manganese ion binding	-	65	14	-	-	6.85E-03	4.72E-03
PID2	MF	GO:0071814	protein-lipid complex binding	-	52	15	-	-	8.81E-03	4.72E-03
PID2	MF	GO:0008066	glutamate receptor activity	-	70	18	-	-	2.58E-02	5.90E-03
PID2	MF	GO:0008270	zinc ion binding	-	821	162	-	-	3.60E-02	5.11E-02
PID2	MF	GO:0004713	protein tyrosine kinase activity	-	213	123	-	-	5.73E-02	3.89E-02
PID2	MF	GO:0016779	nucleotidyltransferase activity	-	264	61	-	-	1.06E-01	1.93E-02
PID2	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	32	-	-	6.06E-02	1.02E-02
PID2	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	11	-	-	5.51E-02	3.54E-03
PID2	MF	GO:0000287	magnesium ion binding	-	225	54	-	-	2.45E-02	1.73E-02
PID2	MF	GO:0031490	chromatin DNA binding	-	120	50	-	-	2.25E-02	1.57E-02
PID2	MF	GO:0017022	myosin binding	-	73	19	-	-	7.42E-03	6.29E-03
PID2	MF	GO:0004896	cytokine receptor activity	-	93	40	-	-	5.75E-02	1.26E-02
PID2	MF	GO:0015631	tubulin binding	-	410	100	-	-	5.53E-02	3.15E-02
PID2	MF	GO:0005539	glycosaminoglycan binding	-	236	68	-	-	3.14E-02	2.16E-02
PID2	MF	GO:0019207	kinase regulator activity	-	267	128	-	-	3.03E-02	4.05E-02
PID2	MF	GO:0044183	protein folding chaperone	-	67	16	-	-	1.30E-02	5.11E-03
PID2	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	73	-	-	7.92E-02	2.32E-02
PID2	MF	GO:0003725	double-stranded RNA binding	-	72	18	-	-	1.71E-02	5.90E-03
PID2	MF	GO:0051018	protein kinase A binding	-	52	19	-	-	1.98E-01	6.29E-03
PID2	MF	GO:0071889	14-3-3 protein binding	-	34	20	-	-	3.88E-03	6.29E-03
PID2	MF	GO:0004618	phosphoglycerate kinase activity	-	89	39	-	-	1.11E-01	1.26E-02
PID2	MF	GO:0043531	ADP binding	-	38	11	-	-	6.66E-03	3.54E-03
PID2	MF	GO:0043394	proteoglycan binding	-	36	15	-	-	2.68E-02	4.72E-03
PID2	MF	GO:0046332	SMAD binding	-	77	52	-	-	1.21E-01	1.65E-02
PID2	MF	GO:0001968	fibronectin binding	-	30	13	-	-	1.28E-02	4.33E-03
PID2	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	22	-	-	7.81E-02	7.08E-03
PID2	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	17	-	-	1.49E-03	5.51E-03
PID2	MF	GO:0051117	ATPase binding	-	85	26	-	-	5.39E-03	8.26E-03
PID2	MF	GO:0005216	monoatomic ion channel activity	-	618	80	-	-	4.13E-02	2.52E-02
PID2	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	29	-	-	4.56E-02	9.44E-03
PID2	MF	GO:0016746	acyltransferase activity	-	895	165	-	-	4.44E-02	5.19E-02
PID2	MF	GO:0051219	phosphoprotein binding	-	92	56	-	-	1.54E-02	1.77E-02
PID2	MF	GO:0019894	kinesin binding	-	45	12	-	-	1.72E-01	3.93E-03
PID2	MF	GO:0019003	GDP binding	-	89	31	-	-	2.05E-02	9.83E-03
PID2	MF	GO:0017171	serine hydrolase activity	-	207	30	-	-	6.93E-02	9.44E-03
PID2	MF	GO:0097110	scaffold protein binding	-	66	36	-	-	1.00E-02	1.14E-02
PID2	MF	GO:0003774	cytoskeletal motor activity	-	117	18	-	-	1.53E-03	5.90E-03
PID2	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	13	-	-	1.53E-01	4.33E-03
PID2	MF	GO:0061134	peptidase regulator activity	-	224	45	-	-	1.65E-02	1.42E-02
PID2	MF	GO:0008013	beta-catenin binding	-	86	50	-	-	2.74E-02	1.57E-02
PID2	MF	GO:0051015	actin filament binding	-	208	39	-	-	1.74E-01	1.26E-02
PID2	MF	GO:0019208	phosphatase regulator activity	-	107	29	-	-	6.35E-03	9.44E-03
PID2	MF	GO:0043236	laminin binding	-	29	15	-	-	2.92E-02	4.72E-03
PID2	MF	GO:0045860	positive regulation of protein kinase activity	-	397	214	-	-	4.32E-02	6.76E-02
PID2	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	21	-	-	2.67E-02	6.69E-03
PID2	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	19	-	-	3.91E-02	6.29E-03
PID2	MF	GO:0042393	histone binding	-	240	47	-	-	2.64E-02	1.49E-02
PID2	MF	GO:0019838	growth factor binding	-	182	103	-	-	5.39E-02	3.26E-02
PID2	MF	GO:0000149	SNARE binding	-	107	20	-	-	2.08E-01	6.29E-03
PID2	MF	GO:0005516	calmodulin binding	-	206	65	-	-	1.58E-02	2.04E-02
PID2	MF	GO:0019825	oxygen binding	-	40	11	-	-	4.70E-03	3.54E-03
PID2	MF	GO:0005198	structural molecule activity	-	823	132	-	-	2.19E-01	4.17E-02
PID2	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	12	-	-	1.65E-03	3.93E-03
PID2	MF	GO:0032182	ubiquitin-like protein binding	-	117	35	-	-	5.23E-02	1.10E-02
PID2	MF	GO:0023023	MHC protein complex binding	-	36	11	-	-	5.65E-02	3.54E-03
PID2	MF	GO:0043274	phospholipase binding	-	23	15	-	-	5.67E-03	4.72E-03
PID2	MF	GO:0031072	heat shock protein binding	-	128	49	-	-	1.56E-02	1.57E-02
PID2	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	163	-	-	5.21E-02	5.15E-02
PID2	MF	GO:0046982	protein heterodimerization activity	-	343	104	-	-	2.23E-02	3.30E-02
PID2	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	27	-	-	9.81E-03	8.65E-03
PID2	MF	GO:0015026	coreceptor activity	-	48	30	-	-	1.50E-02	9.44E-03
PID2	MF	GO:0001653	peptide receptor activity	-	128	22	-	-	1.87E-01	7.08E-03
PID2	MF	GO:0006469	negative regulation of protein kinase activity	-	222	94	-	-	1.14E-02	2.99E-02
PID2	MF	GO:0070182	DNA polymerase binding	-	22	12	-	-	1.31E-02	3.93E-03
PID2	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	16	-	-	1.10E-02	5.11E-03
PID2	MF	GO:0070851	growth factor receptor binding	-	141	84	-	-	5.20E-02	2.67E-02
PID2	MF	GO:0005525	GTP binding	-	396	81	-	-	2.07E-02	2.56E-02
PID2	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	16	-	-	1.02E-02	5.11E-03
PID2	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	148	-	-	3.17E-02	4.68E-02
PID2	MF	GO:0042803	protein homodimerization activity	-	699	195	-	-	2.62E-02	6.13E-02
PID2	MF	GO:0051346	negative regulation of hydrolase activity	-	332	87	-	-	1.44E-02	2.75E-02
PID2	MF	GO:0005506	iron ion binding	-	154	17	-	-	2.72E-02	5.51E-03
PID2	MF	GO:0003925	G protein activity	-	45	21	-	-	8.92E-03	6.69E-03
PID2	MF	GO:0008276	protein methyltransferase activity	-	96	13	-	-	2.29E-01	4.33E-03
PID2	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	141	-	-	2.30E-02	4.44E-02
PID2	MF	GO:0051345	positive regulation of hydrolase activity	-	535	225	-	-	4.03E-02	7.08E-02
PID2	MF	GO:0070888	E-box binding	-	59	30	-	-	2.65E-02	9.44E-03
PID2	MF	GO:0015399	primary active transmembrane transporter activity	-	190	16	-	-	1.51E-01	5.11E-03
PID2	MF	GO:0035254	glutamate receptor binding	-	47	18	-	-	6.84E-03	5.90E-03
PID2	MF	GO:0050321	tau-protein kinase activity	-	36	22	-	-	1.13E-02	7.08E-03
PID2	MF	GO:0043021	ribonucleoprotein complex binding	-	158	24	-	-	5.79E-03	7.86E-03
PID2	MF	GO:0005112	Notch binding	-	26	13	-	-	7.56E-02	4.33E-03
PID2	MF	GO:0048185	activin binding	-	16	13	-	-	3.17E-01	4.33E-03
PID2	MF	GO:0001664	G protein-coupled receptor binding	-	299	99	-	-	5.55E-02	3.15E-02
PID2	MF	GO:0140299	small molecule sensor activity	-	39	11	-	-	1.31E-01	3.54E-03
PID2	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	15	-	-	8.98E-03	4.72E-03
PID2	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	15	-	-	7.01E-03	4.72E-03
PID2	MF	GO:0030594	neurotransmitter receptor activity	-	160	21	-	-	2.94E-02	6.69E-03
PID2	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	12	-	-	8.19E-02	3.93E-03
PID2	MF	GO:0033558	protein lysine deacetylase activity	-	22	15	-	-	1.18E-01	4.72E-03
PIPs	CC	GO:0005615	extracellular space	2.76E-79	3190	1345	896	1.50	-	-
PIPs	CC	GO:0005730	nucleolus	3.97E-31	988	444	277	1.60	-	-
PIPs	CC	GO:0005768	endosome	2.56E-19	1037	422	291	1.45	-	-
PIPs	CC	GO:0031012	extracellular matrix	1.04E-14	564	243	158	1.53	-	-
PIPs	CC	GO:0000228	nuclear chromosome	3.22E-08	206	95	58	1.64	-	-
PIPs	CC	GO:0005635	nuclear envelope	8.28E-08	493	193	138	1.39	-	-
PIPs	CC	GO:0005764	lysosome	7.09E-07	747	271	210	1.29	-	-
PIPs	CC	GO:0005794	Golgi apparatus	3.48E-06	1636	541	459	1.18	-	-
PIPs	CC	GO:0005840	ribosome	1.11E-05	222	93	62	1.49	-	-
PIPs	CC	GO:0005739	mitochondrion	5.55E-04	1671	409	469	0.87	-	-
PIPs	CC	GO:0005929	cilium	4.15E-03	842	200	236	0.85	-	-
PIPs	CC	GO:0005777	peroxisome	1.11E-01	142	31	40	0.78	-	-
PIPs	CC	GO:0005783	endoplasmic reticulum	1.35E-01	2020	596	567	1.05	-	-
PIPs	CC	GO:0005815	microtubule organizing center	1.58E-01	843	255	237	1.08	-	-
PIPs	CC	GO:0005811	lipid droplet	6.59E-01	102	26	29	0.91	-	-
PIPs	BP	GO:0002376	immune system process	2.12E-104	2448	1156	687	1.68	-	-
PIPs	BP	GO:0012501	programmed cell death	6.48E-102	1954	971	549	1.77	-	-
PIPs	BP	GO:0006355	regulation of DNA-templated transcription	7.96E-75	3342	1382	938	1.47	-	-
PIPs	BP	GO:0007155	cell adhesion	2.58E-71	1444	713	405	1.76	-	-
PIPs	BP	GO:0006954	inflammatory response	1.59E-63	820	455	230	1.98	-	-
PIPs	BP	GO:0048870	cell motility	3.19E-54	1659	748	466	1.61	-	-
PIPs	BP	GO:0065003	protein-containing complex assembly	1.34E-50	1648	734	463	1.59	-	-
PIPs	BP	GO:0042060	wound healing	1.41E-44	431	259	121	2.14	-	-
PIPs	BP	GO:0098542	defense response to other organism	7.52E-34	1171	517	329	1.57	-	-
PIPs	BP	GO:0016071	mRNA metabolic process	2.75E-31	713	344	200	1.72	-	-
PIPs	BP	GO:0006886	intracellular protein transport	3.23E-30	664	323	186	1.73	-	-
PIPs	BP	GO:0016192	vesicle-mediated transport	1.63E-27	1894	739	532	1.39	-	-
PIPs	BP	GO:0034330	cell junction organization	3.20E-26	727	336	204	1.65	-	-
PIPs	BP	GO:0003013	circulatory system process	5.17E-25	584	280	164	1.71	-	-
PIPs	BP	GO:0003012	muscle system process	2.96E-22	425	213	119	1.79	-	-
PIPs	BP	GO:0030163	protein catabolic process	6.67E-21	990	412	278	1.48	-	-
PIPs	BP	GO:0006913	nucleocytoplasmic transport	3.92E-20	326	170	92	1.86	-	-
PIPs	BP	GO:0006281	DNA repair	7.32E-20	587	267	165	1.62	-	-
PIPs	BP	GO:0002181	cytoplasmic translation	9.93E-18	153	94	43	2.19	-	-
PIPs	BP	GO:0006260	DNA replication	8.47E-17	279	144	78	1.84	-	-
PIPs	BP	GO:0006914	autophagy	2.99E-12	568	236	159	1.48	-	-
PIPs	BP	GO:0007163	establishment or maintenance of cell polarity	4.99E-12	227	113	64	1.77	-	-
PIPs	BP	GO:0032200	telomere organization	1.09E-11	186	96	52	1.84	-	-
PIPs	BP	GO:0042254	ribosome biogenesis	1.60E-11	297	138	83	1.66	-	-
PIPs	BP	GO:0006325	chromatin organization	5.91E-11	720	282	202	1.40	-	-
PIPs	BP	GO:0006310	DNA recombination	1.16E-09	333	145	93	1.55	-	-
PIPs	BP	GO:0072659	protein localization to plasma membrane	4.71E-09	284	126	80	1.58	-	-
PIPs	BP	GO:0007010	cytoskeleton organization	8.34E-08	1639	555	460	1.21	-	-
PIPs	BP	GO:0022600	digestive system process	1.66E-07	110	57	31	1.85	-	-
PIPs	BP	GO:0006486	protein glycosylation	1.89E-07	225	30	63	0.47	-	-
PIPs	BP	GO:0044782	cilium organization	4.74E-07	399	69	112	0.62	-	-
PIPs	BP	GO:0140053	mitochondrial gene expression	1.22E-06	164	20	46	0.43	-	-
PIPs	BP	GO:0055085	transmembrane transport	1.22E-06	1784	590	501	1.18	-	-
PIPs	BP	GO:0030198	extracellular matrix organization	1.25E-06	314	128	88	1.45	-	-
PIPs	BP	GO:0000910	cytokinesis	3.42E-06	186	82	52	1.57	-	-
PIPs	BP	GO:0007059	chromosome segregation	5.20E-06	403	155	113	1.37	-	-
PIPs	BP	GO:0007018	microtubule-based movement	8.88E-06	640	131	180	0.73	-	-
PIPs	BP	GO:0006457	protein folding	1.84E-05	210	88	59	1.49	-	-
PIPs	BP	GO:0003014	renal system process	2.51E-05	127	58	36	1.63	-	-
PIPs	BP	GO:0006790	sulfur compound metabolic process	1.07E-03	320	64	90	0.71	-	-
PIPs	BP	GO:0140013	meiotic nuclear division	1.97E-03	279	102	78	1.30	-	-
PIPs	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	2.04E-03	119	49	33	1.47	-	-
PIPs	BP	GO:0006575	cellular modified amino acid metabolic process	2.34E-03	186	34	52	0.65	-	-
PIPs	BP	GO:0006520	amino acid metabolic process	2.46E-03	292	59	82	0.72	-	-
PIPs	BP	GO:0005975	carbohydrate metabolic process	1.23E-02	551	181	155	1.17	-	-
PIPs	BP	GO:0006091	generation of precursor metabolites and energy	8.71E-02	502	158	141	1.12	-	-
PIPs	BP	GO:0006766	vitamin metabolic process	1.60E-01	107	23	30	0.77	-	-
PIPs	BP	GO:0007005	mitochondrion organization	2.19E-01	484	148	136	1.09	-	-
PIPs	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.23E-01	729	190	205	0.93	-	-
PIPs	BP	GO:0006399	tRNA metabolic process	3.79E-01	196	49	55	0.89	-	-
PIPs	BP	GO:0098754	detoxification	5.01E-01	134	41	38	1.09	-	-
PIPs	BP	GO:0006629	lipid metabolic process	5.30E-01	1355	370	380	0.97	-	-
PIPs	BP	GO:0050877	nervous system process	6.56E-01	1527	421	429	0.98	-	-
PIPs	BP	GO:0007040	lysosome organization	6.67E-01	107	32	30	1.07	-	-
PIPs	MF	GO:0140096	"catalytic activity, acting on a protein"	3.84E-84	3198	1362	898	1.52	-	-
PIPs	MF	GO:0003677	DNA binding	1.44E-64	2865	1192	804	1.48	-	-
PIPs	MF	GO:0003723	RNA binding	2.85E-56	1679	761	471	1.61	-	-
PIPs	MF	GO:0140110	transcription regulator activity	8.45E-41	2033	835	571	1.46	-	-
PIPs	MF	GO:0016740	transferase activity	4.65E-38	3074	1164	863	1.35	-	-
PIPs	MF	GO:0009975	cyclase activity	3.81E-23	277	156	78	2.01	-	-
PIPs	MF	GO:0140097	"catalytic activity, acting on DNA"	8.22E-23	383	198	108	1.84	-	-
PIPs	MF	GO:0008092	cytoskeletal protein binding	3.60E-17	1023	409	287	1.42	-	-
PIPs	MF	GO:0003924	GTPase activity	1.60E-16	658	282	185	1.53	-	-
PIPs	MF	GO:0016829	lyase activity	1.77E-14	538	233	151	1.54	-	-
PIPs	MF	GO:0140657	ATP-dependent activity	6.76E-14	729	297	205	1.45	-	-
PIPs	MF	GO:0008289	lipid binding	9.99E-12	836	324	235	1.38	-	-
PIPs	MF	GO:0005198	structural molecule activity	2.81E-10	798	305	224	1.36	-	-
PIPs	MF	GO:0048018	receptor ligand activity	8.24E-09	504	201	141	1.42	-	-
PIPs	MF	GO:0045182	translation regulator activity	4.81E-08	151	74	42	1.75	-	-
PIPs	MF	GO:0042393	histone binding	8.56E-07	237	102	67	1.53	-	-
PIPs	MF	GO:0140104	molecular carrier activity	3.26E-06	105	52	29	1.76	-	-
PIPs	MF	GO:0038024	cargo receptor activity	6.23E-04	117	50	33	1.52	-	-
PIPs	MF	GO:0140098	"catalytic activity, acting on RNA"	1.36E-03	417	147	117	1.26	-	-
PIPs	MF	GO:0016853	isomerase activity	3.71E-03	252	92	71	1.30	-	-
PIPs	MF	GO:0016491	oxidoreductase activity	2.64E-02	888	220	249	0.88	-	-
PIPs	MF	GO:0016874	ligase activity	2.57E-01	283	88	79	1.11	-	-
PIPs	MF	GO:0003774	cytoskeletal motor activity	3.00E-01	116	27	33	0.83	-	-
PIPs	MF	GO:0005215	transporter activity	6.94E-01	1462	417	410	1.02	-	-
PIPs	BP	GO:0008038	neuron recognition	-	46	30	-	-	1.96E-02	4.51E-03
PIPs	BP	GO:1905145	cellular response to acetylcholine	-	33	21	-	-	5.38E-03	3.19E-03
PIPs	BP	GO:0051931	regulation of sensory perception	-	36	21	-	-	8.94E-03	3.19E-03
PIPs	BP	GO:0007346	regulation of mitotic cell cycle	-	518	243	-	-	3.64E-02	3.66E-02
PIPs	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	15	-	-	9.15E-03	2.25E-03
PIPs	BP	GO:0009268	response to pH	-	43	16	-	-	7.27E-04	2.44E-03
PIPs	BP	GO:0045666	positive regulation of neuron differentiation	-	91	48	-	-	3.81E-02	7.32E-03
PIPs	BP	GO:0043543	protein acylation	-	107	34	-	-	9.54E-03	5.26E-03
PIPs	MF	GO:0051349	positive regulation of lyase activity	-	41	26	-	-	2.92E-02	3.94E-03
PIPs	BP	GO:0048679	regulation of axon regeneration	-	28	13	-	-	3.91E-03	2.07E-03
PIPs	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	38	-	-	9.62E-02	5.82E-03
PIPs	BP	GO:0071763	nuclear membrane organization	-	44	23	-	-	1.92E-01	3.57E-03
PIPs	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	15	-	-	1.76E-02	2.25E-03
PIPs	BP	GO:0071806	protein transmembrane transport	-	68	35	-	-	1.76E-01	5.26E-03
PIPs	BP	GO:0022038	corpus callosum development	-	25	13	-	-	1.56E-03	2.07E-03
PIPs	BP	GO:0043299	leukocyte degranulation	-	82	52	-	-	7.31E-03	7.89E-03
PIPs	BP	GO:0048864	stem cell development	-	88	38	-	-	3.70E-03	5.82E-03
PIPs	BP	GO:0051651	maintenance of location in cell	-	236	110	-	-	2.62E-02	1.65E-02
PIPs	BP	GO:0033119	negative regulation of RNA splicing	-	27	15	-	-	1.65E-02	2.25E-03
PIPs	CC	GO:0016197	endosomal transport	-	282	106	-	-	3.68E-02	1.60E-02
PIPs	BP	GO:0070663	regulation of leukocyte proliferation	-	268	161	-	-	1.48E-02	2.42E-02
PIPs	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	16	-	-	1.28E-02	2.44E-03
PIPs	BP	GO:0006949	syncytium formation	-	66	32	-	-	1.27E-03	4.88E-03
PIPs	BP	GO:0045861	negative regulation of proteolysis	-	320	149	-	-	2.14E-02	2.25E-02
PIPs	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	12	-	-	2.00E-01	1.88E-03
PIPs	BP	GO:0030574	collagen catabolic process	-	45	23	-	-	1.14E-01	3.57E-03
PIPs	CC	GO:0006984	ER-nucleus signaling pathway	-	46	22	-	-	5.96E-03	3.38E-03
PIPs	BP	GO:0060343	trabecula formation	-	26	13	-	-	2.71E-03	2.07E-03
PIPs	BP	GO:0009914	hormone transport	-	315	149	-	-	1.20E-02	2.25E-02
PIPs	BP	GO:0140112	extracellular vesicle biogenesis	-	23	15	-	-	2.32E-02	2.25E-03
PIPs	BP	GO:0085029	extracellular matrix assembly	-	42	13	-	-	5.29E-04	2.07E-03
PIPs	BP	GO:0006413	translational initiation	-	122	73	-	-	8.21E-02	1.11E-02
PIPs	BP	GO:1902895	positive regulation of miRNA transcription	-	51	38	-	-	7.07E-03	5.82E-03
PIPs	CC	GO:0005200	structural constituent of cytoskeleton	-	112	46	-	-	3.93E-02	6.95E-03
PIPs	BP	GO:0030865	cortical cytoskeleton organization	-	51	34	-	-	6.95E-03	5.26E-03
PIPs	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	12	-	-	1.07E-01	1.88E-03
PIPs	BP	GO:1903036	positive regulation of response to wounding	-	76	45	-	-	9.58E-03	6.76E-03
PIPs	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	51	-	-	4.67E-02	7.70E-03
PIPs	BP	GO:1903319	positive regulation of protein maturation	-	27	14	-	-	8.95E-03	2.25E-03
PIPs	BP	GO:0032528	microvillus organization	-	24	13	-	-	5.53E-04	2.07E-03
PIPs	BP	GO:0002263	cell activation involved in immune response	-	304	171	-	-	1.70E-02	2.57E-02
PIPs	BP	GO:0021954	central nervous system neuron development	-	85	38	-	-	4.34E-03	5.82E-03
PIPs	BP	GO:0055017	cardiac muscle tissue growth	-	92	40	-	-	3.09E-03	6.01E-03
PIPs	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	23	-	-	1.74E-03	3.57E-03
PIPs	BP	GO:0048524	positive regulation of viral process	-	64	35	-	-	2.50E-03	5.26E-03
PIPs	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	15	-	-	1.41E-02	2.25E-03
PIPs	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	20	-	-	2.28E-03	3.00E-03
PIPs	BP	GO:0098661	inorganic anion transmembrane transport	-	140	36	-	-	1.14E-01	5.44E-03
PIPs	BP	GO:0006099	tricarboxylic acid cycle	-	33	15	-	-	1.71E-01	2.25E-03
PIPs	BP	GO:0009612	response to mechanical stimulus	-	215	127	-	-	9.85E-03	1.92E-02
PIPs	BP	GO:0048644	muscle organ morphogenesis	-	81	35	-	-	1.56E-02	5.26E-03
PIPs	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	94	-	-	7.88E-03	1.43E-02
PIPs	BP	GO:0071542	dopaminergic neuron differentiation	-	36	14	-	-	3.39E-03	2.25E-03
PIPs	BP	GO:0140115	export across plasma membrane	-	82	22	-	-	1.75E-02	3.38E-03
PIPs	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	13	-	-	1.79E-02	2.07E-03
PIPs	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	11	-	-	5.15E-02	1.69E-03
PIPs	MF	GO:0003714	transcription corepressor activity	-	190	88	-	-	1.47E-02	1.33E-02
PIPs	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	23	-	-	9.28E-04	3.57E-03
PIPs	BP	GO:0006304	DNA modification	-	30	11	-	-	2.20E-02	1.69E-03
PIPs	MF	GO:0140312	cargo adaptor activity	-	19	11	-	-	4.07E-01	1.69E-03
PIPs	BP	GO:0046835	carbohydrate phosphorylation	-	49	16	-	-	7.37E-04	2.44E-03
PIPs	CC	GO:1905349	ciliary transition zone assembly	-	371	65	-	-	1.32E-02	9.76E-03
PIPs	BP	GO:0043523	regulation of neuron apoptotic process	-	218	117	-	-	1.83E-02	1.76E-02
PIPs	BP	GO:1902894	negative regulation of miRNA transcription	-	22	15	-	-	1.91E-03	2.25E-03
PIPs	BP	GO:0044380	protein localization to cytoskeleton	-	57	16	-	-	9.11E-03	2.44E-03
PIPs	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	1.08E-02	2.07E-03
PIPs	BP	GO:2000209	regulation of anoikis	-	25	16	-	-	8.38E-03	2.44E-03
PIPs	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	13	-	-	1.29E-03	2.07E-03
PIPs	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	18	-	-	2.80E-02	2.82E-03
PIPs	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	39	-	-	4.28E-02	6.01E-03
PIPs	CC	GO:0045324	late endosome to vacuole transport	-	37	19	-	-	3.46E-01	3.00E-03
PIPs	BP	GO:0043954	cellular component maintenance	-	72	33	-	-	3.09E-03	5.07E-03
PIPs	BP	GO:0050435	amyloid-beta metabolic process	-	65	33	-	-	5.52E-03	5.07E-03
PIPs	BP	GO:0014823	response to activity	-	70	41	-	-	5.57E-03	6.20E-03
PIPs	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	11	-	-	1.34E-01	1.69E-03
PIPs	BP	GO:0034502	protein localization to chromosome	-	130	54	-	-	6.12E-03	8.26E-03
PIPs	BP	GO:0048562	embryonic organ morphogenesis	-	295	121	-	-	2.21E-02	1.82E-02
PIPs	BP	GO:0019233	sensory perception of pain	-	103	53	-	-	1.01E-02	8.07E-03
PIPs	CC	GO:0043574	peroxisomal transport	-	22	14	-	-	2.13E-01	2.25E-03
PIPs	BP	GO:0031343	positive regulation of cell killing	-	75	44	-	-	1.36E-01	6.76E-03
PIPs	BP	GO:0090077	foam cell differentiation	-	39	26	-	-	2.21E-03	3.94E-03
PIPs	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	56	-	-	1.03E-01	8.45E-03
PIPs	BP	GO:0017148	negative regulation of translation	-	390	48	-	-	8.23E-03	7.32E-03
PIPs	BP	GO:0030220	platelet formation	-	22	17	-	-	1.09E-02	2.63E-03
PIPs	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	42	-	-	4.52E-03	6.38E-03
PIPs	BP	GO:1903509	liposaccharide metabolic process	-	109	18	-	-	1.66E-01	2.82E-03
PIPs	BP	GO:0009582	detection of abiotic stimulus	-	140	55	-	-	3.24E-02	8.26E-03
PIPs	CC	GO:0140238	presynaptic endocytosis	-	72	42	-	-	3.20E-02	6.38E-03
PIPs	BP	GO:0051236	establishment of RNA localization	-	161	72	-	-	5.09E-02	1.09E-02
PIPs	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	100	-	-	3.22E-02	1.50E-02
PIPs	BP	GO:0034067	protein localization to Golgi apparatus	-	30	12	-	-	5.60E-04	1.88E-03
PIPs	BP	GO:0061842	microtubule organizing center localization	-	32	13	-	-	5.49E-04	2.07E-03
PIPs	MF	GO:0048018	receptor ligand activity	-	510	201	-	-	6.86E-02	3.02E-02
PIPs	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	13	-	-	3.44E-03	2.07E-03
PIPs	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	32	-	-	6.33E-03	4.88E-03
PIPs	BP	GO:0050779	RNA destabilization	-	135	38	-	-	4.78E-02	5.82E-03
PIPs	BP	GO:0006023	aminoglycan biosynthetic process	-	74	14	-	-	3.59E-03	2.25E-03
PIPs	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	14	-	-	5.59E-04	2.25E-03
PIPs	BP	GO:0061025	membrane fusion	-	532	243	-	-	1.43E-01	3.66E-02
PIPs	BP	GO:0010762	regulation of fibroblast migration	-	40	25	-	-	6.83E-03	3.76E-03
PIPs	BP	GO:0090311	regulation of protein deacetylation	-	29	18	-	-	1.08E-02	2.82E-03
PIPs	BP	GO:0035272	exocrine system development	-	46	22	-	-	7.24E-03	3.38E-03
PIPs	BP	GO:0022406	membrane docking	-	90	55	-	-	6.10E-02	8.26E-03
PIPs	BP	GO:0050777	negative regulation of immune response	-	196	106	-	-	9.90E-03	1.60E-02
PIPs	BP	GO:0016053	organic acid biosynthetic process	-	335	83	-	-	1.13E-02	1.26E-02
PIPs	MF	GO:0005035	death receptor activity	-	16	13	-	-	9.86E-02	2.07E-03
PIPs	BP	GO:0002063	chondrocyte development	-	33	13	-	-	3.46E-03	2.07E-03
PIPs	BP	GO:0099068	postsynapse assembly	-	40	16	-	-	2.22E-03	2.44E-03
PIPs	BP	GO:0021782	glial cell development	-	120	70	-	-	8.30E-03	1.05E-02
PIPs	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	37	-	-	2.80E-02	5.63E-03
PIPs	BP	GO:0001655	urogenital system development	-	66	38	-	-	1.35E-02	5.82E-03
PIPs	BP	GO:0071827	plasma lipoprotein particle organization	-	86	35	-	-	8.94E-03	5.26E-03
PIPs	BP	GO:0055088	lipid homeostasis	-	173	55	-	-	9.59E-03	8.26E-03
PIPs	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	14	-	-	3.50E-03	2.25E-03
PIPs	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	108	-	-	1.24E-02	1.63E-02
PIPs	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	16	-	-	3.19E-03	2.44E-03
PIPs	BP	GO:0045667	regulation of osteoblast differentiation	-	147	67	-	-	3.70E-02	1.01E-02
PIPs	BP	GO:0061037	negative regulation of cartilage development	-	32	16	-	-	1.37E-02	2.44E-03
PIPs	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	192	-	-	1.40E-02	2.89E-02
PIPs	BP	GO:0045738	negative regulation of DNA repair	-	40	14	-	-	5.37E-04	2.25E-03
PIPs	BP	GO:0001704	formation of primary germ layer	-	195	106	-	-	1.32E-02	1.60E-02
PIPs	BP	GO:0045778	positive regulation of ossification	-	51	29	-	-	7.15E-02	4.51E-03
PIPs	BP	GO:0048708	astrocyte differentiation	-	88	61	-	-	4.19E-03	9.20E-03
PIPs	BP	GO:0042092	type 2 immune response	-	41	23	-	-	4.02E-03	3.57E-03
PIPs	BP	GO:0048588	developmental cell growth	-	233	106	-	-	2.42E-02	1.60E-02
PIPs	BP	GO:0021872	forebrain generation of neurons	-	52	13	-	-	5.33E-04	2.07E-03
PIPs	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	12	-	-	1.40E-02	1.88E-03
PIPs	BP	GO:0045023	G0 to G1 transition	-	41	22	-	-	6.18E-02	3.38E-03
PIPs	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	31	-	-	1.18E-02	4.69E-03
PIPs	BP	GO:0034367	protein-containing complex remodeling	-	35	20	-	-	1.99E-02	3.00E-03
PIPs	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	13	-	-	1.16E-03	2.07E-03
PIPs	BP	GO:0010232	vascular transport	-	87	24	-	-	3.34E-03	3.76E-03
PIPs	BP	GO:0021987	cerebral cortex development	-	125	61	-	-	6.39E-03	9.20E-03
PIPs	BP	GO:0008637	apoptotic mitochondrial changes	-	108	52	-	-	1.20E-01	7.89E-03
PIPs	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	15	-	-	2.54E-03	2.25E-03
PIPs	BP	GO:0060999	positive regulation of dendritic spine development	-	35	15	-	-	2.75E-03	2.25E-03
PIPs	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	12	-	-	5.05E-02	1.88E-03
PIPs	BP	GO:2000736	regulation of stem cell differentiation	-	78	42	-	-	3.60E-02	6.38E-03
PIPs	BP	GO:0002064	epithelial cell development	-	210	96	-	-	7.07E-03	1.45E-02
PIPs	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	22	-	-	1.16E-03	3.38E-03
PIPs	BP	GO:2001222	regulation of neuron migration	-	46	13	-	-	5.41E-04	2.07E-03
PIPs	BP	GO:0034389	lipid droplet organization	-	38	11	-	-	5.45E-04	1.69E-03
PIPs	BP	GO:0051602	response to electrical stimulus	-	44	26	-	-	1.08E-03	3.94E-03
PIPs	BP	GO:0042177	negative regulation of protein catabolic process	-	109	45	-	-	4.38E-03	6.76E-03
PIPs	MF	GO:0038024	cargo receptor activity	-	121	50	-	-	1.48E-02	7.51E-03
PIPs	BP	GO:0033120	positive regulation of RNA splicing	-	46	24	-	-	6.89E-03	3.76E-03
PIPs	BP	GO:0051445	regulation of meiotic cell cycle	-	64	30	-	-	8.78E-02	4.51E-03
PIPs	BP	GO:0033619	membrane protein proteolysis	-	60	30	-	-	8.25E-03	4.51E-03
PIPs	BP	GO:0090087	regulation of peptide transport	-	195	95	-	-	5.63E-03	1.43E-02
PIPs	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	51	-	-	5.24E-03	7.70E-03
PIPs	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	12	-	-	2.08E-03	1.88E-03
PIPs	BP	GO:0006929	substrate-dependent cell migration	-	26	19	-	-	1.01E-03	3.00E-03
PIPs	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	11	-	-	5.43E-04	1.69E-03
PIPs	BP	GO:0072662	protein localization to peroxisome	-	20	11	-	-	3.97E-01	1.69E-03
PIPs	BP	GO:0022404	molting cycle process	-	95	37	-	-	6.22E-03	5.63E-03
PIPs	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	14	-	-	9.30E-02	2.25E-03
PIPs	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	17	-	-	4.31E-03	2.63E-03
PIPs	BP	GO:0017014	protein nitrosylation	-	17	11	-	-	5.55E-04	1.69E-03
PIPs	BP	GO:0007281	germ cell development	-	334	91	-	-	1.10E-02	1.37E-02
PIPs	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	74	-	-	1.26E-02	1.13E-02
PIPs	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	21	-	-	2.34E-03	3.19E-03
PIPs	BP	GO:0034104	negative regulation of tissue remodeling	-	22	11	-	-	2.39E-03	1.69E-03
PIPs	CC	GO:0098926	postsynaptic signal transduction	-	39	24	-	-	5.20E-03	3.76E-03
PIPs	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	61	-	-	4.84E-03	9.20E-03
PIPs	CC	GO:0016082	synaptic vesicle priming	-	19	13	-	-	3.46E-02	2.07E-03
PIPs	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	27	-	-	2.09E-02	4.13E-03
PIPs	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	62	-	-	4.82E-03	9.39E-03
PIPs	BP	GO:0034249	negative regulation of amide metabolic process	-	34	13	-	-	5.54E-04	2.07E-03
PIPs	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	57	-	-	1.39E-02	8.64E-03
PIPs	BP	GO:0048799	animal organ maturation	-	33	13	-	-	4.36E-03	2.07E-03
PIPs	BP	GO:0006925	inflammatory cell apoptotic process	-	23	16	-	-	7.34E-04	2.44E-03
PIPs	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	78	-	-	5.19E-03	1.18E-02
PIPs	BP	GO:1903035	negative regulation of response to wounding	-	93	55	-	-	1.31E-02	8.26E-03
PIPs	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	17	-	-	7.10E-03	2.63E-03
PIPs	BP	GO:0036010	protein localization to endosome	-	27	13	-	-	9.61E-03	2.07E-03
PIPs	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	56	-	-	5.81E-02	8.45E-03
PIPs	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	41	-	-	1.38E-02	6.20E-03
PIPs	BP	GO:0045056	transcytosis	-	20	13	-	-	7.03E-03	2.07E-03
PIPs	BP	GO:0009267	cellular response to starvation	-	170	77	-	-	1.53E-02	1.16E-02
PIPs	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	32	-	-	1.38E-02	4.88E-03
PIPs	CC	GO:0140239	postsynaptic endocytosis	-	23	16	-	-	1.12E-01	2.44E-03
PIPs	CC	GO:0032008	positive regulation of TOR signaling	-	52	17	-	-	9.40E-02	2.63E-03
PIPs	BP	GO:0060428	lung epithelium development	-	43	25	-	-	6.27E-03	3.76E-03
PIPs	BP	GO:0030431	sleep	-	30	18	-	-	3.25E-03	2.82E-03
PIPs	BP	GO:1903318	negative regulation of protein maturation	-	29	15	-	-	1.23E-02	2.25E-03
PIPs	BP	GO:0071732	cellular response to nitric oxide	-	17	13	-	-	1.83E-03	2.07E-03
PIPs	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	42	-	-	5.01E-03	6.38E-03
PIPs	BP	GO:0065004	protein-DNA complex assembly	-	307	144	-	-	6.72E-02	2.18E-02
PIPs	CC	GO:0006406	mRNA export from nucleus	-	69	37	-	-	3.64E-02	5.63E-03
PIPs	BP	GO:0009880	embryonic pattern specification	-	70	23	-	-	1.58E-03	3.57E-03
PIPs	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	30	-	-	2.94E-01	4.51E-03
PIPs	BP	GO:0002367	cytokine production involved in immune response	-	121	72	-	-	1.22E-02	1.09E-02
PIPs	BP	GO:0044848	biological phase	-	211	76	-	-	2.32E-02	1.15E-02
PIPs	BP	GO:0046660	female sex differentiation	-	125	72	-	-	1.94E-02	1.09E-02
PIPs	BP	GO:0019693	ribose phosphate metabolic process	-	556	157	-	-	7.19E-02	2.37E-02
PIPs	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	22	-	-	1.43E-03	3.38E-03
PIPs	BP	GO:0060411	cardiac septum morphogenesis	-	72	34	-	-	2.80E-02	5.26E-03
PIPs	BP	GO:0071248	cellular response to metal ion	-	201	99	-	-	6.74E-03	1.50E-02
PIPs	BP	GO:0030308	negative regulation of cell growth	-	191	81	-	-	3.99E-03	1.22E-02
PIPs	BP	GO:0097306	cellular response to alcohol	-	99	50	-	-	3.61E-03	7.51E-03
PIPs	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	60	-	-	1.04E-01	9.01E-03
PIPs	BP	GO:0010453	regulation of cell fate commitment	-	40	19	-	-	4.38E-02	3.00E-03
PIPs	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	27	-	-	4.80E-03	4.13E-03
PIPs	BP	GO:0002026	regulation of the force of heart contraction	-	26	16	-	-	7.32E-04	2.44E-03
PIPs	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	12	-	-	9.05E-02	1.88E-03
PIPs	BP	GO:0032890	regulation of organic acid transport	-	78	37	-	-	1.72E-02	5.63E-03
PIPs	BP	GO:0071498	cellular response to fluid shear stress	-	21	14	-	-	3.21E-03	2.25E-03
PIPs	BP	GO:0098771	inorganic ion homeostasis	-	531	236	-	-	2.72E-02	3.55E-02
PIPs	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	40	-	-	2.86E-03	6.01E-03
PIPs	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	13	-	-	1.42E-02	2.07E-03
PIPs	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	27	-	-	1.33E-02	4.13E-03
PIPs	BP	GO:0051259	protein complex oligomerization	-	251	105	-	-	5.01E-02	1.58E-02
PIPs	BP	GO:0098743	cell aggregation	-	24	14	-	-	5.51E-04	2.25E-03
PIPs	BP	GO:0009994	oocyte differentiation	-	57	27	-	-	2.41E-03	4.13E-03
PIPs	MF	GO:0031952	regulation of protein autophosphorylation	-	43	25	-	-	2.16E-03	3.76E-03
PIPs	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	67	-	-	1.53E-02	1.01E-02
PIPs	BP	GO:0044319	"wound healing, spreading of cells"	-	37	21	-	-	9.17E-04	3.19E-03
PIPs	BP	GO:0033688	regulation of osteoblast proliferation	-	31	19	-	-	1.43E-03	3.00E-03
PIPs	BP	GO:0060251	regulation of glial cell proliferation	-	39	21	-	-	1.64E-03	3.19E-03
PIPs	BP	GO:0072665	protein localization to vacuole	-	84	37	-	-	2.33E-02	5.63E-03
PIPs	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	31	-	-	8.65E-02	4.69E-03
PIPs	BP	GO:0006914	autophagy	-	574	237	-	-	9.01E-02	3.57E-02
PIPs	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	34	-	-	2.26E-02	5.26E-03
PIPs	BP	GO:0042044	fluid transport	-	35	12	-	-	5.55E-04	1.88E-03
PIPs	BP	GO:0070633	transepithelial transport	-	35	15	-	-	1.40E-03	2.25E-03
PIPs	BP	GO:0045661	regulation of myoblast differentiation	-	74	40	-	-	3.45E-02	6.01E-03
PIPs	BP	GO:0030307	positive regulation of cell growth	-	164	80	-	-	1.06E-02	1.20E-02
PIPs	BP	GO:0034250	positive regulation of amide metabolic process	-	27	18	-	-	1.47E-03	2.82E-03
PIPs	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	181	-	-	1.38E-02	2.72E-02
PIPs	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	11	-	-	4.52E-03	1.69E-03
PIPs	BP	GO:0014812	muscle cell migration	-	110	53	-	-	6.70E-03	8.07E-03
PIPs	BP	GO:0048525	negative regulation of viral process	-	90	32	-	-	3.40E-03	4.88E-03
PIPs	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	25	-	-	6.51E-02	3.76E-03
PIPs	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	67	-	-	2.81E-02	1.01E-02
PIPs	BP	GO:0051781	positive regulation of cell division	-	93	46	-	-	1.63E-02	6.95E-03
PIPs	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	12	-	-	1.51E-02	1.88E-03
PIPs	BP	GO:0035493	SNARE complex assembly	-	23	14	-	-	2.64E-01	2.25E-03
PIPs	BP	GO:0002696	positive regulation of leukocyte activation	-	358	212	-	-	2.45E-02	3.19E-02
PIPs	BP	GO:0060711	labyrinthine layer development	-	47	22	-	-	2.98E-03	3.38E-03
PIPs	BP	GO:0007272	ensheathment of neurons	-	146	72	-	-	7.16E-03	1.09E-02
PIPs	CC	GO:0050806	positive regulation of synaptic transmission	-	171	72	-	-	9.08E-03	1.09E-02
PIPs	BP	GO:0060021	roof of mouth development	-	91	41	-	-	3.78E-03	6.20E-03
PIPs	BP	GO:0034504	protein localization to nucleus	-	312	171	-	-	1.79E-02	2.57E-02
PIPs	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	26	-	-	5.27E-02	3.94E-03
PIPs	BP	GO:0050819	negative regulation of coagulation	-	54	40	-	-	1.65E-02	6.01E-03
PIPs	BP	GO:0031647	regulation of protein stability	-	327	149	-	-	1.48E-02	2.25E-02
PIPs	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	26	-	-	1.21E-01	3.94E-03
PIPs	CC	GO:0050805	negative regulation of synaptic transmission	-	55	27	-	-	3.14E-02	4.13E-03
PIPs	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	24	-	-	3.33E-03	3.76E-03
PIPs	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	55	-	-	2.38E-02	8.26E-03
PIPs	BP	GO:0016054	organic acid catabolic process	-	251	48	-	-	2.12E-02	7.32E-03
PIPs	BP	GO:0050890	cognition	-	317	138	-	-	8.21E-03	2.08E-02
PIPs	BP	GO:1900048	positive regulation of hemostasis	-	28	22	-	-	1.14E-02	3.38E-03
PIPs	BP	GO:0065005	protein-lipid complex assembly	-	29	12	-	-	1.18E-02	1.88E-03
PIPs	BP	GO:0008033	tRNA processing	-	136	22	-	-	5.00E-02	3.38E-03
PIPs	BP	GO:0046661	male sex differentiation	-	171	86	-	-	2.06E-02	1.30E-02
PIPs	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	40	-	-	3.58E-02	6.01E-03
PIPs	BP	GO:1990778	protein localization to cell periphery	-	346	146	-	-	1.39E-02	2.20E-02
PIPs	BP	GO:0061326	renal tubule development	-	103	51	-	-	1.36E-02	7.70E-03
PIPs	BP	GO:0051258	protein polymerization	-	280	123	-	-	1.62E-02	1.86E-02
PIPs	BP	GO:0071985	multivesicular body sorting pathway	-	56	24	-	-	2.53E-01	3.76E-03
PIPs	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	13	-	-	2.91E-02	2.07E-03
PIPs	BP	GO:0060325	face morphogenesis	-	31	16	-	-	4.29E-02	2.44E-03
PIPs	BP	GO:0090559	regulation of membrane permeability	-	72	28	-	-	3.12E-02	4.32E-03
PIPs	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	14	-	-	2.08E-03	2.25E-03
PIPs	BP	GO:0046460	neutral lipid biosynthetic process	-	50	12	-	-	5.53E-04	1.88E-03
PIPs	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	17	-	-	7.43E-04	2.63E-03
PIPs	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	76	-	-	7.49E-03	1.15E-02
PIPs	BP	GO:0002251	organ or tissue specific immune response	-	43	18	-	-	1.10E-02	2.82E-03
PIPs	CC	GO:0048167	regulation of synaptic plasticity	-	210	91	-	-	1.75E-02	1.37E-02
PIPs	BP	GO:1903708	positive regulation of hemopoiesis	-	184	101	-	-	1.63E-02	1.52E-02
PIPs	BP	GO:1903008	organelle disassembly	-	154	62	-	-	6.66E-02	9.39E-03
PIPs	BP	GO:0001709	cell fate determination	-	44	23	-	-	1.96E-02	3.57E-03
PIPs	BP	GO:0051873	killing by host of symbiont cells	-	28	17	-	-	9.36E-02	2.63E-03
PIPs	BP	GO:0045058	T cell selection	-	53	36	-	-	3.84E-03	5.44E-03
PIPs	CC	GO:0032387	negative regulation of intracellular transport	-	51	22	-	-	4.35E-03	3.38E-03
PIPs	BP	GO:0072091	regulation of stem cell proliferation	-	91	37	-	-	2.34E-02	5.63E-03
PIPs	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	11	-	-	6.17E-02	1.69E-03
PIPs	BP	GO:0099084	postsynaptic specialization organization	-	44	24	-	-	7.17E-03	3.76E-03
PIPs	BP	GO:0060384	innervation	-	27	12	-	-	5.46E-04	1.88E-03
PIPs	BP	GO:0032535	regulation of cellular component size	-	360	151	-	-	1.74E-02	2.27E-02
PIPs	MF	GO:0031281	positive regulation of cyclase activity	-	40	27	-	-	2.41E-02	4.13E-03
PIPs	MF	GO:0098631	cell adhesion mediator activity	-	64	36	-	-	8.45E-03	5.44E-03
PIPs	BP	GO:0071453	cellular response to oxygen levels	-	168	77	-	-	7.40E-03	1.16E-02
PIPs	BP	GO:0090399	replicative senescence	-	17	12	-	-	4.00E-03	1.88E-03
PIPs	BP	GO:0031342	negative regulation of cell killing	-	29	22	-	-	1.37E-02	3.38E-03
PIPs	BP	GO:0070585	protein localization to mitochondrion	-	125	47	-	-	1.03E-01	7.13E-03
PIPs	BP	GO:0010623	programmed cell death involved in cell development	-	25	17	-	-	1.81E-02	2.63E-03
PIPs	BP	GO:0044242	cellular lipid catabolic process	-	224	56	-	-	5.18E-02	8.45E-03
PIPs	BP	GO:0002931	response to ischemia	-	58	29	-	-	5.15E-03	4.51E-03
PIPs	BP	GO:0043062	extracellular structure organization	-	317	128	-	-	3.88E-02	1.93E-02
PIPs	BP	GO:0014047	glutamate secretion	-	25	13	-	-	5.52E-04	2.07E-03
PIPs	BP	GO:0061005	cell differentiation involved in kidney development	-	58	31	-	-	8.51E-03	4.69E-03
PIPs	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	207	-	-	1.69E-02	3.12E-02
PIPs	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	40	-	-	4.77E-02	6.01E-03
PIPs	BP	GO:0060420	regulation of heart growth	-	74	33	-	-	2.34E-03	5.07E-03
PIPs	BP	GO:0009755	hormone-mediated signaling pathway	-	221	114	-	-	1.94E-02	1.73E-02
PIPs	BP	GO:0022612	gland morphogenesis	-	124	70	-	-	1.31E-02	1.05E-02
PIPs	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	19	-	-	4.67E-03	3.00E-03
PIPs	MF	GO:0140416	transcription regulator inhibitor activity	-	26	12	-	-	2.02E-02	1.88E-03
PIPs	BP	GO:0044782	cilium organization	-	400	69	-	-	8.95E-03	1.05E-02
PIPs	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	13	-	-	1.61E-01	2.07E-03
PIPs	BP	GO:0090130	tissue migration	-	379	181	-	-	1.13E-02	2.72E-02
PIPs	BP	GO:1990845	adaptive thermogenesis	-	166	81	-	-	6.12E-03	1.22E-02
PIPs	BP	GO:0071320	cellular response to cAMP	-	54	29	-	-	2.39E-02	4.51E-03
PIPs	BP	GO:0015844	monoamine transport	-	88	44	-	-	6.16E-03	6.76E-03
PIPs	BP	GO:0071392	cellular response to estradiol stimulus	-	40	22	-	-	2.31E-03	3.38E-03
PIPs	BP	GO:0009314	response to radiation	-	449	233	-	-	2.05E-02	3.51E-02
PIPs	BP	GO:0009451	RNA modification	-	169	40	-	-	6.67E-02	6.01E-03
PIPs	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	21	-	-	1.48E-03	3.19E-03
PIPs	BP	GO:1903729	regulation of plasma membrane organization	-	17	12	-	-	3.73E-03	1.88E-03
PIPs	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	50	-	-	1.32E-02	7.51E-03
PIPs	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	20	-	-	2.31E-03	3.00E-03
PIPs	BP	GO:0015807	L-amino acid transport	-	94	14	-	-	6.88E-03	2.25E-03
PIPs	BP	GO:0032941	secretion by tissue	-	85	46	-	-	3.95E-03	6.95E-03
PIPs	BP	GO:0046605	regulation of centrosome cycle	-	54	24	-	-	7.32E-02	3.76E-03
PIPs	BP	GO:0048753	pigment granule organization	-	40	15	-	-	1.04E-01	2.25E-03
PIPs	BP	GO:0003014	renal system process	-	130	60	-	-	1.92E-02	9.01E-03
PIPs	BP	GO:0045598	regulation of fat cell differentiation	-	148	70	-	-	8.53E-03	1.05E-02
PIPs	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	113	-	-	2.36E-02	1.71E-02
PIPs	BP	GO:1904646	cellular response to amyloid-beta	-	44	28	-	-	4.42E-03	4.32E-03
PIPs	BP	GO:1901863	positive regulation of muscle tissue development	-	24	17	-	-	6.23E-03	2.63E-03
PIPs	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	132	-	-	8.82E-02	1.99E-02
PIPs	BP	GO:0039694	viral RNA genome replication	-	30	12	-	-	3.37E-03	1.88E-03
PIPs	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	16	-	-	1.27E-02	2.44E-03
PIPs	BP	GO:0071709	membrane assembly	-	68	30	-	-	1.41E-01	4.51E-03
PIPs	BP	GO:0008217	regulation of blood pressure	-	186	91	-	-	2.90E-02	1.37E-02
PIPs	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	37	-	-	3.64E-02	5.63E-03
PIPs	CC	GO:0042770	signal transduction in response to DNA damage	-	186	97	-	-	1.01E-02	1.46E-02
PIPs	BP	GO:0002200	somatic diversification of immune receptors	-	78	46	-	-	1.32E-02	6.95E-03
PIPs	BP	GO:0035315	hair cell differentiation	-	52	17	-	-	7.25E-03	2.63E-03
PIPs	BP	GO:0048645	animal organ formation	-	62	27	-	-	7.51E-03	4.13E-03
PIPs	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	63	-	-	9.61E-03	9.58E-03
PIPs	BP	GO:0033627	cell adhesion mediated by integrin	-	87	50	-	-	8.11E-03	7.51E-03
PIPs	BP	GO:0035107	appendage morphogenesis	-	147	65	-	-	1.19E-02	9.76E-03
PIPs	BP	GO:1903707	negative regulation of hemopoiesis	-	116	62	-	-	6.57E-03	9.39E-03
PIPs	CC	GO:0048208	COPII vesicle coating	-	27	12	-	-	4.45E-01	1.88E-03
PIPs	BP	GO:0050994	regulation of lipid catabolic process	-	61	32	-	-	1.59E-02	4.88E-03
PIPs	BP	GO:0035988	chondrocyte proliferation	-	24	12	-	-	1.34E-02	1.88E-03
PIPs	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	18	-	-	1.46E-02	2.82E-03
PIPs	BP	GO:0009593	detection of chemical stimulus	-	511	43	-	-	6.26E-03	6.57E-03
PIPs	BP	GO:0045727	positive regulation of translation	-	141	65	-	-	1.55E-02	9.76E-03
PIPs	CC	GO:0032388	positive regulation of intracellular transport	-	137	68	-	-	4.28E-03	1.03E-02
PIPs	BP	GO:0002027	regulation of heart rate	-	106	51	-	-	5.26E-02	7.70E-03
PIPs	BP	GO:0050879	multicellular organismal movement	-	118	49	-	-	3.68E-02	7.51E-03
PIPs	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	46	-	-	4.08E-03	6.95E-03
PIPs	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	39	-	-	5.13E-03	6.01E-03
PIPs	BP	GO:0048515	spermatid differentiation	-	208	40	-	-	1.12E-02	6.01E-03
PIPs	BP	GO:0072132	mesenchyme morphogenesis	-	57	35	-	-	7.17E-03	5.26E-03
PIPs	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	14	-	-	1.59E-02	2.25E-03
PIPs	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	20	-	-	8.33E-03	3.00E-03
PIPs	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	12	-	-	5.51E-04	1.88E-03
PIPs	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	21	-	-	5.46E-02	3.19E-03
PIPs	BP	GO:1901983	regulation of protein acetylation	-	26	12	-	-	5.41E-04	1.88E-03
PIPs	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	155	-	-	1.84E-02	2.33E-02
PIPs	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	26	-	-	1.99E-02	3.94E-03
PIPs	BP	GO:0010883	regulation of lipid storage	-	53	25	-	-	1.74E-03	3.76E-03
PIPs	BP	GO:0072170	metanephric tubule development	-	26	19	-	-	7.36E-03	3.00E-03
PIPs	BP	GO:1905954	positive regulation of lipid localization	-	110	47	-	-	6.47E-03	7.13E-03
PIPs	BP	GO:0002209	behavioral defense response	-	39	22	-	-	1.30E-03	3.38E-03
PIPs	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	11	-	-	8.38E-02	1.69E-03
PIPs	BP	GO:0072523	purine-containing compound catabolic process	-	146	54	-	-	4.33E-03	8.26E-03
PIPs	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	18	-	-	3.68E-03	2.82E-03
PIPs	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	11	-	-	2.72E-03	1.69E-03
PIPs	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	46	-	-	6.68E-03	6.95E-03
PIPs	BP	GO:0007218	neuropeptide signaling pathway	-	113	34	-	-	8.42E-02	5.26E-03
PIPs	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	93	-	-	2.47E-02	1.41E-02
PIPs	BP	GO:0031345	negative regulation of cell projection organization	-	195	85	-	-	5.11E-03	1.28E-02
PIPs	BP	GO:0048278	vesicle docking	-	64	39	-	-	8.09E-02	6.01E-03
PIPs	BP	GO:0035050	embryonic heart tube development	-	86	27	-	-	4.77E-03	4.13E-03
PIPs	BP	GO:0030168	platelet activation	-	135	90	-	-	7.08E-03	1.35E-02
PIPs	CC	GO:0098810	neurotransmitter reuptake	-	35	12	-	-	5.53E-04	1.88E-03
PIPs	BP	GO:0031338	regulation of vesicle fusion	-	24	13	-	-	5.55E-04	2.07E-03
PIPs	BP	GO:0031529	ruffle organization	-	55	26	-	-	2.51E-03	3.94E-03
PIPs	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	46	-	-	3.35E-02	6.95E-03
PIPs	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	30	-	-	3.22E-03	4.51E-03
PIPs	MF	GO:0170055	lipid transmembrane transporter activity	-	56	16	-	-	9.64E-02	2.44E-03
PIPs	BP	GO:0035304	regulation of protein dephosphorylation	-	87	48	-	-	5.15E-03	7.32E-03
PIPs	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	110	-	-	7.33E-03	1.65E-02
PIPs	BP	GO:0099637	neurotransmitter receptor transport	-	26	12	-	-	9.28E-03	1.88E-03
PIPs	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	17	-	-	1.71E-03	2.63E-03
PIPs	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	215	-	-	2.09E-02	3.23E-02
PIPs	BP	GO:0051785	positive regulation of nuclear division	-	61	31	-	-	1.58E-02	4.69E-03
PIPs	BP	GO:0060749	mammary gland alveolus development	-	20	15	-	-	1.30E-02	2.25E-03
PIPs	BP	GO:0044786	cell cycle DNA replication	-	45	26	-	-	6.65E-02	3.94E-03
PIPs	BP	GO:0048145	regulation of fibroblast proliferation	-	87	43	-	-	3.39E-03	6.57E-03
PIPs	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	59	-	-	3.54E-02	9.01E-03
PIPs	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	127	-	-	2.34E-02	1.92E-02
PIPs	BP	GO:0009306	protein secretion	-	376	157	-	-	9.06E-03	2.37E-02
PIPs	CC	GO:0008333	endosome to lysosome transport	-	73	31	-	-	2.24E-01	4.69E-03
PIPs	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	13	-	-	1.51E-02	2.07E-03
PIPs	BP	GO:0003016	respiratory system process	-	39	12	-	-	5.52E-04	1.88E-03
PIPs	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	13	-	-	9.19E-03	2.07E-03
PIPs	BP	GO:0045732	positive regulation of protein catabolic process	-	202	102	-	-	1.31E-02	1.54E-02
PIPs	BP	GO:0031589	cell-substrate adhesion	-	360	191	-	-	2.14E-02	2.87E-02
PIPs	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	15	-	-	3.92E-02	2.25E-03
PIPs	BP	GO:0007588	excretion	-	40	22	-	-	8.89E-02	3.38E-03
PIPs	BP	GO:1904018	positive regulation of vasculature development	-	185	91	-	-	5.73E-03	1.37E-02
PIPs	BP	GO:0010948	negative regulation of cell cycle process	-	317	137	-	-	1.88E-02	2.07E-02
PIPs	BP	GO:0050953	sensory perception of light stimulus	-	223	60	-	-	1.29E-02	9.01E-03
PIPs	BP	GO:0009303	rRNA transcription	-	37	17	-	-	7.30E-04	2.63E-03
PIPs	BP	GO:0035601	protein deacylation	-	56	26	-	-	8.48E-03	3.94E-03
PIPs	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	11	-	-	8.61E-03	1.69E-03
PIPs	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	20	-	-	1.75E-03	3.00E-03
PIPs	BP	GO:0071300	cellular response to retinoic acid	-	66	34	-	-	2.21E-03	5.26E-03
PIPs	BP	GO:0045830	positive regulation of isotype switching	-	28	15	-	-	1.56E-03	2.25E-03
PIPs	BP	GO:0046697	decidualization	-	26	14	-	-	5.45E-04	2.25E-03
PIPs	BP	GO:0048284	organelle fusion	-	456	220	-	-	1.67E-01	3.30E-02
PIPs	BP	GO:0051588	regulation of neurotransmitter transport	-	99	40	-	-	5.46E-03	6.01E-03
PIPs	BP	GO:0051784	negative regulation of nuclear division	-	63	31	-	-	4.28E-03	4.69E-03
PIPs	BP	GO:0044703	multi-organism reproductive process	-	209	103	-	-	8.51E-03	1.56E-02
PIPs	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	74	-	-	6.11E-03	1.13E-02
PIPs	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	26	-	-	6.96E-02	3.94E-03
PIPs	MF	GO:0004930	G protein-coupled receptor activity	-	873	190	-	-	1.25E-01	2.85E-02
PIPs	BP	GO:0048857	neural nucleus development	-	65	32	-	-	2.05E-03	4.88E-03
PIPs	BP	GO:0048663	neuron fate commitment	-	74	32	-	-	1.61E-02	4.88E-03
PIPs	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	56	-	-	2.22E-02	8.45E-03
PIPs	BP	GO:0106027	neuron projection organization	-	90	45	-	-	5.27E-03	6.76E-03
PIPs	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	73	-	-	5.77E-03	1.11E-02
PIPs	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	24	-	-	4.96E-03	3.76E-03
PIPs	BP	GO:0045685	regulation of glial cell differentiation	-	77	47	-	-	5.29E-03	7.13E-03
PIPs	BP	GO:0043414	macromolecule methylation	-	138	29	-	-	4.88E-02	4.51E-03
PIPs	BP	GO:0050886	endocrine process	-	93	51	-	-	2.85E-02	7.70E-03
PIPs	BP	GO:0050951	sensory perception of temperature stimulus	-	28	15	-	-	5.32E-03	2.25E-03
PIPs	BP	GO:0045807	positive regulation of endocytosis	-	155	97	-	-	1.15E-02	1.46E-02
PIPs	BP	GO:0002418	immune response to tumor cell	-	29	16	-	-	7.26E-04	2.44E-03
PIPs	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	37	-	-	7.36E-03	5.63E-03
PIPs	BP	GO:0001829	trophectodermal cell differentiation	-	19	14	-	-	1.30E-02	2.25E-03
PIPs	BP	GO:0034394	protein localization to cell surface	-	69	34	-	-	1.42E-02	5.26E-03
PIPs	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	66	-	-	3.80E-03	9.95E-03
PIPs	MF	GO:0051100	negative regulation of binding	-	161	84	-	-	5.29E-03	1.28E-02
PIPs	BP	GO:0001818	negative regulation of cytokine production	-	379	151	-	-	1.00E-02	2.27E-02
PIPs	BP	GO:0003151	outflow tract morphogenesis	-	81	38	-	-	1.04E-02	5.82E-03
PIPs	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	37	-	-	4.76E-03	5.63E-03
PIPs	BP	GO:0055093	response to hyperoxia	-	20	14	-	-	2.84E-03	2.25E-03
PIPs	BP	GO:0061036	positive regulation of cartilage development	-	33	16	-	-	2.41E-02	2.44E-03
PIPs	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	23	-	-	9.19E-04	3.57E-03
PIPs	BP	GO:0046621	negative regulation of organ growth	-	39	22	-	-	1.60E-03	3.38E-03
PIPs	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	14	-	-	5.13E-02	2.25E-03
PIPs	BP	GO:0032368	regulation of lipid transport	-	149	62	-	-	6.19E-03	9.39E-03
PIPs	BP	GO:0055094	response to lipoprotein particle	-	34	19	-	-	1.08E-02	3.00E-03
PIPs	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	95	-	-	8.51E-03	1.43E-02
PIPs	BP	GO:0033002	muscle cell proliferation	-	249	126	-	-	1.00E-02	1.90E-02
PIPs	BP	GO:0048880	sensory system development	-	399	162	-	-	1.79E-02	2.44E-02
PIPs	BP	GO:0043331	response to dsRNA	-	56	22	-	-	6.99E-03	3.38E-03
PIPs	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	22	-	-	3.45E-02	3.38E-03
PIPs	BP	GO:0033363	secretory granule organization	-	63	21	-	-	4.79E-02	3.19E-03
PIPs	BP	GO:0060479	lung cell differentiation	-	28	18	-	-	7.37E-04	2.82E-03
PIPs	BP	GO:0120009	intermembrane lipid transfer	-	52	11	-	-	5.72E-02	1.69E-03
PIPs	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	13	-	-	1.85E-01	2.07E-03
PIPs	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	24	-	-	3.25E-03	3.76E-03
PIPs	BP	GO:0033622	integrin activation	-	26	13	-	-	5.49E-04	2.07E-03
PIPs	BP	GO:2000773	negative regulation of cellular senescence	-	25	13	-	-	5.44E-04	2.07E-03
PIPs	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	29	-	-	1.40E-02	4.51E-03
PIPs	BP	GO:0050820	positive regulation of coagulation	-	30	23	-	-	1.14E-02	3.57E-03
PIPs	BP	GO:0002076	osteoblast development	-	17	11	-	-	5.37E-04	1.69E-03
PIPs	BP	GO:0072164	mesonephric tubule development	-	98	53	-	-	1.09E-02	8.07E-03
PIPs	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	59	-	-	5.24E-03	9.01E-03
PIPs	BP	GO:1903524	positive regulation of blood circulation	-	39	16	-	-	7.67E-02	2.44E-03
PIPs	BP	GO:0030901	midbrain development	-	87	39	-	-	2.06E-03	6.01E-03
PIPs	BP	GO:0007162	negative regulation of cell adhesion	-	310	146	-	-	1.20E-02	2.20E-02
PIPs	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	12	-	-	6.71E-03	1.88E-03
PIPs	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	45	-	-	6.92E-03	6.76E-03
PIPs	BP	GO:0002687	positive regulation of leukocyte migration	-	147	88	-	-	1.58E-02	1.33E-02
PIPs	BP	GO:0034605	cellular response to heat	-	66	39	-	-	5.16E-03	6.01E-03
PIPs	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	223	-	-	6.51E-02	3.36E-02
PIPs	BP	GO:0005996	monosaccharide metabolic process	-	250	93	-	-	5.84E-02	1.41E-02
PIPs	BP	GO:0033555	multicellular organismal response to stress	-	90	45	-	-	2.15E-03	6.76E-03
PIPs	BP	GO:0002262	myeloid cell homeostasis	-	172	96	-	-	1.67E-02	1.45E-02
PIPs	BP	GO:0000966	RNA 5'-end processing	-	39	17	-	-	1.52E-02	2.63E-03
PIPs	BP	GO:0050688	regulation of defense response to virus	-	65	21	-	-	2.71E-03	3.19E-03
PIPs	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	182	-	-	2.31E-02	2.74E-02
PIPs	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	14	-	-	1.05E-02	2.25E-03
PIPs	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	154	-	-	3.67E-02	2.33E-02
PIPs	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	19	-	-	2.55E-03	3.00E-03
PIPs	BP	GO:0061029	eyelid development in camera-type eye	-	14	12	-	-	5.45E-03	1.88E-03
PIPs	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	20	-	-	7.13E-03	3.00E-03
PIPs	BP	GO:0003272	endocardial cushion formation	-	28	14	-	-	1.25E-02	2.25E-03
PIPs	BP	GO:0022618	protein-RNA complex assembly	-	227	112	-	-	6.23E-02	1.69E-02
PIPs	BP	GO:0051147	regulation of muscle cell differentiation	-	162	77	-	-	7.40E-03	1.16E-02
PIPs	BP	GO:0006066	alcohol metabolic process	-	374	105	-	-	1.81E-02	1.58E-02
PIPs	BP	GO:0090102	cochlea development	-	50	21	-	-	2.62E-03	3.19E-03
PIPs	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	19	-	-	3.06E-03	3.00E-03
PIPs	BP	GO:0045933	positive regulation of muscle contraction	-	49	28	-	-	5.79E-03	4.32E-03
PIPs	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	20	-	-	8.97E-04	3.00E-03
PIPs	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	18	-	-	3.19E-02	2.82E-03
PIPs	BP	GO:0043555	regulation of translation in response to stress	-	22	13	-	-	1.60E-03	2.07E-03
PIPs	BP	GO:0032922	circadian regulation of gene expression	-	71	42	-	-	5.75E-03	6.38E-03
PIPs	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	40	-	-	4.71E-02	6.01E-03
PIPs	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	49	-	-	4.02E-02	7.51E-03
PIPs	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	15	-	-	2.90E-02	2.25E-03
PIPs	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	33	-	-	7.15E-03	5.07E-03
PIPs	BP	GO:0038179	neurotrophin signaling pathway	-	38	18	-	-	2.84E-03	2.82E-03
PIPs	BP	GO:0140253	cell-cell fusion	-	62	30	-	-	2.24E-03	4.51E-03
PIPs	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	16	-	-	2.62E-03	2.44E-03
PIPs	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	12	-	-	5.61E-04	1.88E-03
PIPs	BP	GO:0001941	postsynaptic membrane organization	-	37	11	-	-	5.38E-04	1.69E-03
PIPs	BP	GO:0051293	establishment of spindle localization	-	57	26	-	-	1.30E-03	3.94E-03
PIPs	BP	GO:0023061	signal release	-	491	226	-	-	2.07E-02	3.40E-02
PIPs	BP	GO:0043114	regulation of vascular permeability	-	49	29	-	-	1.60E-03	4.51E-03
PIPs	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	32	-	-	3.19E-03	4.88E-03
PIPs	BP	GO:0008360	regulation of cell shape	-	139	67	-	-	7.07E-03	1.01E-02
PIPs	BP	GO:0051222	positive regulation of protein transport	-	249	118	-	-	7.28E-03	1.78E-02
PIPs	CC	GO:0140632	canonical inflammasome complex assembly	-	40	23	-	-	2.38E-02	3.57E-03
PIPs	MF	GO:0034260	negative regulation of GTPase activity	-	36	12	-	-	5.57E-04	1.88E-03
PIPs	BP	GO:0045932	negative regulation of muscle contraction	-	24	14	-	-	6.47E-03	2.25E-03
PIPs	BP	GO:0045739	positive regulation of DNA repair	-	128	50	-	-	3.96E-02	7.51E-03
PIPs	BP	GO:0045185	maintenance of protein location	-	95	43	-	-	4.85E-03	6.57E-03
PIPs	BP	GO:0003158	endothelium development	-	140	67	-	-	6.43E-03	1.01E-02
PIPs	CC	GO:0072595	maintenance of protein localization in organelle	-	42	15	-	-	7.32E-04	2.25E-03
PIPs	BP	GO:0051224	negative regulation of protein transport	-	122	50	-	-	2.46E-03	7.51E-03
PIPs	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	84	-	-	1.30E-02	1.28E-02
PIPs	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	17	-	-	2.07E-03	2.63E-03
PIPs	MF	GO:0003713	transcription coactivator activity	-	281	120	-	-	2.23E-02	1.80E-02
PIPs	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	15	-	-	3.54E-02	2.25E-03
PIPs	BP	GO:0021885	forebrain cell migration	-	63	32	-	-	2.10E-02	4.88E-03
PIPs	BP	GO:0007405	neuroblast proliferation	-	81	32	-	-	4.64E-03	4.88E-03
PIPs	BP	GO:0009581	detection of external stimulus	-	137	53	-	-	4.11E-02	8.07E-03
PIPs	BP	GO:1990542	mitochondrial transmembrane transport	-	93	19	-	-	2.69E-01	3.00E-03
PIPs	BP	GO:0045862	positive regulation of proteolysis	-	353	180	-	-	2.27E-02	2.70E-02
PIPs	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	17	-	-	1.07E-02	2.63E-03
PIPs	BP	GO:0031128	developmental induction	-	26	14	-	-	5.53E-04	2.25E-03
PIPs	BP	GO:0031100	animal organ regeneration	-	66	32	-	-	2.79E-03	4.88E-03
PIPs	BP	GO:1900047	negative regulation of hemostasis	-	51	40	-	-	1.62E-02	6.01E-03
PIPs	BP	GO:0021517	ventral spinal cord development	-	47	15	-	-	7.43E-04	2.25E-03
PIPs	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	54	-	-	2.60E-02	8.26E-03
PIPs	BP	GO:0097722	sperm motility	-	133	16	-	-	7.44E-04	2.44E-03
PIPs	BP	GO:0042490	mechanoreceptor differentiation	-	67	17	-	-	6.06E-03	2.63E-03
PIPs	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	12	-	-	1.92E-03	1.88E-03
PIPs	BP	GO:0035148	tube formation	-	155	75	-	-	1.57E-02	1.13E-02
PIPs	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	20	-	-	6.04E-03	3.00E-03
PIPs	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	54	-	-	2.88E-02	8.26E-03
PIPs	BP	GO:0031123	RNA 3'-end processing	-	79	31	-	-	5.09E-02	4.69E-03
PIPs	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	49	-	-	2.95E-02	7.51E-03
PIPs	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	11	-	-	5.58E-04	1.69E-03
PIPs	CC	GO:0007097	nuclear migration	-	24	12	-	-	1.60E-02	1.88E-03
PIPs	BP	GO:0045229	external encapsulating structure organization	-	319	128	-	-	4.38E-02	1.93E-02
PIPs	BP	GO:0006885	regulation of pH	-	104	39	-	-	3.04E-02	6.01E-03
PIPs	BP	GO:0001667	ameboidal-type cell migration	-	495	232	-	-	1.77E-02	3.49E-02
PIPs	BP	GO:1990840	response to lectin	-	22	14	-	-	2.97E-03	2.25E-03
PIPs	BP	GO:0071800	podosome assembly	-	19	13	-	-	2.06E-03	2.07E-03
PIPs	BP	GO:0031018	endocrine pancreas development	-	47	29	-	-	3.32E-03	4.51E-03
PIPs	BP	GO:0001708	cell fate specification	-	108	49	-	-	1.05E-02	7.51E-03
PIPs	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	39	-	-	3.52E-03	6.01E-03
PIPs	BP	GO:0030279	negative regulation of ossification	-	39	19	-	-	4.46E-03	3.00E-03
PIPs	BP	GO:0032970	regulation of actin filament-based process	-	368	171	-	-	2.33E-02	2.57E-02
PIPs	BP	GO:0042440	pigment metabolic process	-	80	16	-	-	3.02E-03	2.44E-03
PIPs	BP	GO:1901606	alpha-amino acid catabolic process	-	101	16	-	-	7.39E-03	2.44E-03
PIPs	BP	GO:0062197	cellular response to chemical stress	-	299	141	-	-	9.47E-03	2.12E-02
PIPs	BP	GO:1901890	positive regulation of cell junction assembly	-	106	40	-	-	4.14E-03	6.01E-03
PIPs	BP	GO:1901655	cellular response to ketone	-	107	63	-	-	4.15E-03	9.58E-03
PIPs	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	11	-	-	1.98E-01	1.69E-03
PIPs	BP	GO:0006968	cellular defense response	-	52	36	-	-	2.59E-03	5.44E-03
PIPs	BP	GO:0055006	cardiac cell development	-	93	39	-	-	1.11E-02	6.01E-03
PIPs	BP	GO:0031365	N-terminal protein amino acid modification	-	30	12	-	-	2.26E-02	1.88E-03
PIPs	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	17	-	-	3.34E-03	2.63E-03
PIPs	BP	GO:0060004	reflex	-	63	29	-	-	2.84E-03	4.51E-03
PIPs	BP	GO:0044706	multi-multicellular organism process	-	217	105	-	-	7.65E-03	1.58E-02
PIPs	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	66	-	-	1.97E-02	9.95E-03
PIPs	BP	GO:0031294	lymphocyte costimulation	-	47	33	-	-	3.43E-03	5.07E-03
PIPs	BP	GO:0050768	negative regulation of neurogenesis	-	150	67	-	-	4.89E-03	1.01E-02
PIPs	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	41	-	-	4.13E-03	6.20E-03
PIPs	BP	GO:0090068	positive regulation of cell cycle process	-	262	131	-	-	2.36E-02	1.97E-02
PIPs	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	15	-	-	1.80E-02	2.25E-03
PIPs	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	16	-	-	8.22E-02	2.44E-03
PIPs	BP	GO:1902115	regulation of organelle assembly	-	210	88	-	-	2.93E-02	1.33E-02
PIPs	BP	GO:0006397	mRNA processing	-	482	219	-	-	1.00E-01	3.30E-02
PIPs	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	40	-	-	3.29E-03	6.01E-03
PIPs	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	64	-	-	1.28E-02	9.76E-03
PIPs	BP	GO:0046622	positive regulation of organ growth	-	52	19	-	-	2.44E-03	3.00E-03
PIPs	BP	GO:0051952	regulation of amine transport	-	98	46	-	-	1.97E-02	6.95E-03
PIPs	BP	GO:0040019	positive regulation of embryonic development	-	23	11	-	-	5.52E-04	1.69E-03
PIPs	CC	GO:0032365	intracellular lipid transport	-	51	14	-	-	4.77E-02	2.25E-03
PIPs	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	36	-	-	4.13E-03	5.44E-03
PIPs	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	51	-	-	5.11E-02	7.70E-03
PIPs	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	13	-	-	6.50E-03	2.07E-03
PIPs	BP	GO:0071398	cellular response to fatty acid	-	35	17	-	-	2.28E-03	2.63E-03
PIPs	BP	GO:0097581	lamellipodium organization	-	91	50	-	-	6.61E-03	7.51E-03
PIPs	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	55	-	-	7.38E-02	8.26E-03
PIPs	BP	GO:0060326	cell chemotaxis	-	311	167	-	-	2.82E-02	2.52E-02
PIPs	BP	GO:1903975	regulation of glial cell migration	-	20	11	-	-	6.90E-02	1.69E-03
PIPs	BP	GO:0016485	protein processing	-	248	115	-	-	1.65E-02	1.73E-02
PIPs	BP	GO:0009649	entrainment of circadian clock	-	30	14	-	-	5.48E-04	2.25E-03
PIPs	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	78	-	-	1.13E-01	1.18E-02
PIPs	BP	GO:1903523	negative regulation of blood circulation	-	27	13	-	-	1.43E-03	2.07E-03
PIPs	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	34	-	-	4.62E-02	5.26E-03
PIPs	BP	GO:0099054	presynapse assembly	-	49	21	-	-	9.10E-04	3.19E-03
PIPs	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	15	-	-	3.52E-03	2.25E-03
PIPs	BP	GO:0031348	negative regulation of defense response	-	282	134	-	-	8.69E-03	2.03E-02
PIPs	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	41	-	-	8.83E-03	6.20E-03
PIPs	BP	GO:0007606	sensory perception of chemical stimulus	-	535	42	-	-	3.86E-03	6.38E-03
PIPs	BP	GO:0061180	mammary gland epithelium development	-	68	42	-	-	5.36E-03	6.38E-03
PIPs	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	135	-	-	3.16E-02	2.03E-02
PIPs	CC	GO:0051169	nuclear transport	-	325	169	-	-	4.98E-02	2.55E-02
PIPs	BP	GO:0071496	cellular response to external stimulus	-	74	51	-	-	1.29E-02	7.70E-03
PIPs	BP	GO:0032094	response to food	-	37	15	-	-	7.24E-04	2.25E-03
PIPs	BP	GO:0001964	startle response	-	27	16	-	-	2.43E-03	2.44E-03
PIPs	BP	GO:0007340	acrosome reaction	-	38	15	-	-	7.02E-03	2.25E-03
PIPs	BP	GO:0046434	organophosphate catabolic process	-	232	80	-	-	6.25E-03	1.20E-02
PIPs	BP	GO:0060037	pharyngeal system development	-	29	21	-	-	2.98E-02	3.19E-03
PIPs	BP	GO:0009566	fertilization	-	205	56	-	-	8.40E-03	8.45E-03
PIPs	BP	GO:0045907	positive regulation of vasoconstriction	-	30	20	-	-	7.33E-03	3.00E-03
PIPs	BP	GO:0033044	regulation of chromosome organization	-	249	132	-	-	2.51E-02	1.99E-02
PIPs	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	173	-	-	1.77E-02	2.61E-02
PIPs	BP	GO:0061900	glial cell activation	-	56	42	-	-	6.04E-03	6.38E-03
PIPs	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	75	-	-	9.80E-03	1.13E-02
PIPs	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	115	-	-	5.83E-02	1.73E-02
PIPs	CC	GO:0140467	integrated stress response signaling	-	41	25	-	-	2.35E-02	3.76E-03
PIPs	BP	GO:0035902	response to immobilization stress	-	20	13	-	-	5.39E-04	2.07E-03
PIPs	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	98	-	-	7.55E-02	1.48E-02
PIPs	BP	GO:0035821	modulation of process of another organism	-	14	11	-	-	5.28E-04	1.69E-03
PIPs	BP	GO:0043647	inositol phosphate metabolic process	-	44	15	-	-	7.24E-04	2.25E-03
PIPs	BP	GO:0051303	establishment of chromosome localization	-	104	44	-	-	9.98E-02	6.76E-03
PIPs	BP	GO:0031349	positive regulation of defense response	-	473	238	-	-	4.17E-02	3.59E-02
PIPs	BP	GO:0021515	cell differentiation in spinal cord	-	51	17	-	-	7.37E-04	2.63E-03
PIPs	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	12	-	-	1.28E-02	1.88E-03
PIPs	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	14	-	-	2.70E-03	2.25E-03
PIPs	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	14	-	-	7.66E-03	2.25E-03
PIPs	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	11	-	-	5.54E-04	1.69E-03
PIPs	BP	GO:0006605	protein targeting	-	327	123	-	-	4.59E-02	1.86E-02
PIPs	BP	GO:0007566	embryo implantation	-	57	31	-	-	4.66E-03	4.69E-03
PIPs	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	20	-	-	1.37E-02	3.00E-03
PIPs	BP	GO:0061512	protein localization to cilium	-	394	68	-	-	9.49E-03	1.03E-02
PIPs	BP	GO:0060306	regulation of membrane repolarization	-	38	18	-	-	2.17E-02	2.82E-03
PIPs	BP	GO:0051017	actin filament bundle assembly	-	161	80	-	-	6.13E-03	1.20E-02
PIPs	BP	GO:1905953	negative regulation of lipid localization	-	63	26	-	-	2.88E-03	3.94E-03
PIPs	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	19	-	-	7.26E-04	3.00E-03
PIPs	BP	GO:1901343	negative regulation of vasculature development	-	154	50	-	-	5.83E-03	7.51E-03
PIPs	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	56	-	-	1.91E-02	8.45E-03
PIPs	BP	GO:1902414	protein localization to cell junction	-	107	44	-	-	4.62E-03	6.76E-03
PIPs	BP	GO:0071305	cellular response to vitamin D	-	23	12	-	-	1.99E-02	1.88E-03
PIPs	BP	GO:0051304	chromosome separation	-	80	41	-	-	2.92E-02	6.20E-03
PIPs	BP	GO:0090596	sensory organ morphogenesis	-	272	115	-	-	2.17E-02	1.73E-02
PIPs	BP	GO:0045780	positive regulation of bone resorption	-	18	11	-	-	4.97E-03	1.69E-03
PIPs	BP	GO:0048709	oligodendrocyte differentiation	-	101	56	-	-	3.98E-03	8.45E-03
PIPs	BP	GO:0045017	glycerolipid biosynthetic process	-	254	77	-	-	4.02E-02	1.16E-02
PIPs	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	15	-	-	9.52E-02	2.25E-03
PIPs	BP	GO:0001776	leukocyte homeostasis	-	108	59	-	-	5.67E-03	9.01E-03
PIPs	BP	GO:0050769	positive regulation of neurogenesis	-	240	123	-	-	6.85E-03	1.86E-02
PIPs	BP	GO:0030193	regulation of blood coagulation	-	70	53	-	-	1.48E-02	8.07E-03
PIPs	BP	GO:0050866	negative regulation of cell activation	-	216	111	-	-	7.43E-03	1.67E-02
PIPs	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	17	-	-	7.33E-04	2.63E-03
PIPs	BP	GO:0033500	carbohydrate homeostasis	-	251	114	-	-	1.04E-02	1.73E-02
PIPs	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	17	-	-	4.20E-03	2.63E-03
PIPs	BP	GO:0044088	regulation of vacuole organization	-	56	20	-	-	4.84E-03	3.00E-03
PIPs	CC	GO:0099522	cytosolic region	-	20	12	-	-	3.98E-03	1.88E-03
PIPs	CC	GO:0000791	euchromatin	-	60	33	-	-	1.01E-02	5.07E-03
PIPs	CC	GO:0030666	endocytic vesicle membrane	-	196	113	-	-	2.69E-02	1.71E-02
PIPs	CC	GO:0098857	membrane microdomain	-	324	178	-	-	1.60E-02	2.68E-02
PIPs	CC	GO:0030312	external encapsulating structure	-	567	243	-	-	1.17E-01	3.66E-02
PIPs	CC	GO:1990752	microtubule end	-	34	11	-	-	1.33E-02	1.69E-03
PIPs	CC	GO:0043204	perikaryon	-	156	60	-	-	4.25E-03	9.01E-03
PIPs	CC	GO:0061702	canonical inflammasome complex	-	17	11	-	-	1.12E-01	1.69E-03
PIPs	CC	GO:1905368	peptidase complex	-	124	81	-	-	1.83E-01	1.22E-02
PIPs	CC	GO:0000792	heterochromatin	-	98	54	-	-	1.64E-02	8.26E-03
PIPs	CC	GO:0097546	ciliary base	-	47	17	-	-	7.49E-02	2.63E-03
PIPs	CC	GO:0071819	DUBm complex	-	25	12	-	-	2.28E-02	1.88E-03
PIPs	CC	GO:0031201	SNARE complex	-	48	32	-	-	4.11E-01	4.88E-03
PIPs	CC	GO:0016324	apical plasma membrane	-	392	134	-	-	1.74E-02	2.03E-02
PIPs	CC	GO:0033260	nuclear DNA replication	-	40	25	-	-	5.12E-02	3.76E-03
PIPs	CC	GO:0044391	ribosomal subunit	-	203	82	-	-	8.93E-02	1.24E-02
PIPs	CC	GO:0071013	catalytic step 2 spliceosome	-	88	56	-	-	6.35E-02	8.45E-03
PIPs	CC	GO:0098862	cluster of actin-based cell projections	-	162	52	-	-	2.78E-03	7.89E-03
PIPs	CC	GO:0098978	glutamatergic synapse	-	411	207	-	-	2.34E-02	3.12E-02
PIPs	CC	GO:0016363	nuclear matrix	-	127	68	-	-	3.26E-02	1.03E-02
PIPs	CC	GO:0031261	DNA replication preinitiation complex	-	46	30	-	-	1.15E-01	4.51E-03
PIPs	CC	GO:0031966	mitochondrial membrane	-	746	142	-	-	1.48E-01	2.14E-02
PIPs	CC	GO:0097060	synaptic membrane	-	413	185	-	-	7.26E-02	2.78E-02
PIPs	CC	GO:0032432	actin filament bundle	-	249	99	-	-	1.15E-02	1.50E-02
PIPs	CC	GO:0008088	axo-dendritic transport	-	78	32	-	-	1.70E-01	4.88E-03
PIPs	CC	GO:0031519	PcG protein complex	-	38	17	-	-	6.45E-03	2.63E-03
PIPs	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	14	-	-	5.81E-02	2.25E-03
PIPs	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	108	-	-	4.83E-02	1.63E-02
PIPs	CC	GO:0000313	organellar ribosome	-	89	11	-	-	3.67E-01	1.69E-03
PIPs	CC	GO:0098791	Golgi apparatus subcompartment	-	378	103	-	-	2.69E-02	1.56E-02
PIPs	CC	GO:0099643	signal release from synapse	-	147	63	-	-	3.10E-02	9.58E-03
PIPs	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	16	-	-	7.43E-04	2.44E-03
PIPs	CC	GO:0030018	Z disc	-	129	64	-	-	7.31E-02	9.76E-03
PIPs	CC	GO:0032580	Golgi cisterna membrane	-	93	12	-	-	5.62E-04	1.88E-03
PIPs	CC	GO:0005814	centriole	-	692	205	-	-	2.33E-02	3.08E-02
PIPs	CC	GO:1905360	GTPase complex	-	41	32	-	-	2.43E-01	4.88E-03
PIPs	CC	GO:0097540	axonemal central pair	-	161	28	-	-	3.86E-03	4.32E-03
PIPs	CC	GO:0042641	actomyosin	-	77	35	-	-	2.64E-02	5.26E-03
PIPs	CC	GO:0097386	glial cell projection	-	38	16	-	-	3.20E-03	2.44E-03
PIPs	CC	GO:0032588	trans-Golgi network membrane	-	102	34	-	-	5.40E-02	5.26E-03
PIPs	CC	GO:0070382	exocytic vesicle	-	224	90	-	-	5.50E-02	1.35E-02
PIPs	CC	GO:0031903	microbody membrane	-	65	18	-	-	1.83E-01	2.82E-03
PIPs	CC	GO:0046930	pore complex	-	26	14	-	-	2.80E-02	2.25E-03
PIPs	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	107	-	-	3.15E-02	1.61E-02
PIPs	CC	GO:0044298	cell body membrane	-	32	12	-	-	5.05E-03	1.88E-03
PIPs	CC	GO:0070993	translation preinitiation complex	-	19	15	-	-	7.82E-02	2.25E-03
PIPs	CC	GO:0016323	basolateral plasma membrane	-	239	82	-	-	1.49E-02	1.24E-02
PIPs	CC	GO:0042645	mitochondrial nucleoid	-	45	13	-	-	5.61E-04	2.07E-03
PIPs	CC	GO:1902495	transmembrane transporter complex	-	408	157	-	-	3.11E-01	2.37E-02
PIPs	CC	GO:0098636	protein complex involved in cell adhesion	-	57	34	-	-	3.92E-03	5.26E-03
PIPs	CC	GO:0001917	photoreceptor inner segment	-	71	21	-	-	7.32E-03	3.19E-03
PIPs	CC	GO:0019897	extrinsic component of plasma membrane	-	156	98	-	-	5.45E-02	1.48E-02
PIPs	CC	GO:0031594	neuromuscular junction	-	73	37	-	-	5.32E-03	5.63E-03
PIPs	CC	GO:0000793	condensed chromosome	-	274	118	-	-	5.02E-02	1.78E-02
PIPs	CC	GO:0000922	spindle pole	-	172	64	-	-	4.55E-02	9.76E-03
PIPs	CC	GO:0120111	neuron projection cytoplasm	-	94	40	-	-	1.36E-01	6.01E-03
PIPs	CC	GO:0070971	endoplasmic reticulum exit site	-	32	12	-	-	1.46E-01	1.88E-03
PIPs	CC	GO:0004879	nuclear receptor activity	-	63	39	-	-	1.18E-01	6.01E-03
PIPs	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	104	-	-	4.24E-02	1.58E-02
PIPs	CC	GO:0000123	histone acetyltransferase complex	-	93	36	-	-	3.72E-02	5.44E-03
PIPs	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	27	-	-	4.33E-01	4.13E-03
PIPs	CC	GO:0048786	presynaptic active zone	-	80	39	-	-	5.32E-02	6.01E-03
PIPs	CC	GO:0007034	vacuolar transport	-	168	68	-	-	1.10E-01	1.03E-02
PIPs	CC	GO:0043194	axon initial segment	-	21	12	-	-	1.30E-02	1.88E-03
PIPs	CC	GO:0005776	autophagosome	-	111	39	-	-	7.97E-02	6.01E-03
PIPs	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	55	-	-	2.28E-01	8.26E-03
PIPs	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	19	-	-	2.91E-02	3.00E-03
PIPs	CC	GO:0032994	protein-lipid complex	-	39	23	-	-	3.63E-02	3.57E-03
PIPs	CC	GO:0150034	distal axon	-	309	141	-	-	1.39E-02	2.12E-02
PIPs	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	89	-	-	1.08E-01	1.35E-02
PIPs	CC	GO:0072562	blood microparticle	-	144	85	-	-	2.23E-02	1.28E-02
PIPs	CC	GO:0051233	spindle midzone	-	36	14	-	-	2.36E-03	2.25E-03
PIPs	CC	GO:0005811	lipid droplet	-	102	26	-	-	1.09E-03	3.94E-03
PIPs	CC	GO:0045022	early endosome to late endosome transport	-	44	27	-	-	3.59E-03	4.13E-03
PIPs	CC	GO:0043113	receptor clustering	-	51	24	-	-	8.89E-04	3.76E-03
PIPs	CC	GO:0044853	plasma membrane raft	-	114	59	-	-	6.04E-03	9.01E-03
PIPs	CC	GO:0005881	cytoplasmic microtubule	-	256	48	-	-	1.41E-02	7.32E-03
PIPs	CC	GO:0008180	COP9 signalosome	-	17	13	-	-	5.14E-01	2.07E-03
PIPs	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	29	-	-	2.14E-01	4.51E-03
PIPs	CC	GO:0005905	clathrin-coated pit	-	73	36	-	-	9.55E-02	5.44E-03
PIPs	CC	GO:0031904	endosome lumen	-	38	14	-	-	9.38E-03	2.25E-03
PIPs	CC	GO:0060170	ciliary membrane	-	76	26	-	-	7.65E-03	3.94E-03
PIPs	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	12	-	-	5.21E-02	1.88E-03
PIPs	CC	GO:0000139	Golgi membrane	-	646	189	-	-	4.25E-02	2.85E-02
PIPs	CC	GO:0032154	cleavage furrow	-	54	30	-	-	1.28E-03	4.51E-03
PIPs	CC	GO:0007006	mitochondrial membrane organization	-	117	37	-	-	3.58E-02	5.63E-03
PIPs	CC	GO:0001772	immunological synapse	-	44	31	-	-	3.28E-03	4.69E-03
PIPs	CC	GO:0009897	external side of plasma membrane	-	425	196	-	-	6.23E-02	2.95E-02
PIPs	CC	GO:0030863	cortical cytoskeleton	-	104	51	-	-	9.27E-03	7.70E-03
PIPs	CC	GO:0030315	T-tubule	-	52	23	-	-	4.46E-03	3.57E-03
PIPs	CC	GO:0060076	excitatory synapse	-	64	25	-	-	4.26E-02	3.76E-03
PIPs	CC	GO:0036019	endolysosome	-	29	17	-	-	2.52E-01	2.63E-03
PIPs	CC	GO:0001891	phagocytic cup	-	28	11	-	-	5.50E-04	1.69E-03
PIPs	CC	GO:0030427	site of polarized growth	-	172	79	-	-	1.02E-02	1.20E-02
PIPs	CC	GO:0044309	neuron spine	-	213	106	-	-	1.89E-02	1.60E-02
PIPs	CC	GO:0030658	transport vesicle membrane	-	231	100	-	-	6.19E-02	1.50E-02
PIPs	CC	GO:0098918	structural constituent of synapse	-	27	13	-	-	5.06E-03	2.07E-03
PIPs	CC	GO:0034719	SMN-Sm protein complex	-	18	11	-	-	5.83E-02	1.69E-03
PIPs	CC	GO:0030667	secretory granule membrane	-	319	134	-	-	1.62E-02	2.03E-02
PIPs	CC	GO:0097545	axonemal outer doublet	-	164	28	-	-	2.18E-03	4.32E-03
PIPs	CC	GO:0031143	pseudopodium	-	18	13	-	-	2.04E-02	2.07E-03
PIPs	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	18	-	-	5.42E-02	2.82E-03
PIPs	CC	GO:0055037	recycling endosome	-	200	83	-	-	2.89E-02	1.26E-02
PIPs	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	53	-	-	4.85E-03	8.07E-03
PIPs	CC	GO:0071682	endocytic vesicle lumen	-	23	14	-	-	3.40E-03	2.25E-03
PIPs	CC	GO:0030684	preribosome	-	76	42	-	-	2.71E-01	6.38E-03
PIPs	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	172	-	-	2.42E-02	2.59E-02
PIPs	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	13	-	-	2.89E-01	2.07E-03
PIPs	CC	GO:1990391	DNA repair complex	-	22	13	-	-	4.31E-03	2.07E-03
PIPs	CC	GO:0005775	vacuolar lumen	-	176	66	-	-	1.57E-02	9.95E-03
PIPs	CC	GO:0044306	neuron projection terminus	-	164	75	-	-	6.95E-03	1.13E-02
PIPs	CC	GO:0034455	t-UTP complex	-	53	29	-	-	2.35E-01	4.51E-03
PIPs	CC	GO:0005770	late endosome	-	299	105	-	-	5.56E-02	1.58E-02
PIPs	CC	GO:0031970	organelle envelope lumen	-	94	26	-	-	1.01E-02	3.94E-03
PIPs	CC	GO:0019866	organelle inner membrane	-	546	87	-	-	1.27E-01	1.31E-02
PIPs	CC	GO:0098687	chromosomal region	-	397	198	-	-	3.88E-02	2.99E-02
PIPs	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	11	-	-	1.40E-02	1.69E-03
PIPs	CC	GO:0043292	contractile muscle fiber	-	245	111	-	-	5.54E-02	1.67E-02
PIPs	CC	GO:0005849	mRNA cleavage factor complex	-	22	14	-	-	2.25E-01	2.25E-03
PIPs	CC	GO:0000803	sex chromosome	-	32	12	-	-	5.29E-03	1.88E-03
PIPs	CC	GO:0098982	GABA-ergic synapse	-	84	35	-	-	1.10E-01	5.26E-03
PIPs	CC	GO:0035097	histone methyltransferase complex	-	63	26	-	-	1.80E-02	3.94E-03
PIPs	CC	GO:1903293	phosphatase complex	-	54	24	-	-	1.06E-01	3.76E-03
PIPs	CC	GO:0000786	nucleosome	-	149	49	-	-	1.04E-01	7.51E-03
PIPs	CC	GO:0001533	cornified envelope	-	59	18	-	-	2.67E-02	2.82E-03
PIPs	CC	GO:1904724	tertiary granule lumen	-	55	24	-	-	3.57E-03	3.76E-03
PIPs	CC	GO:0030027	lamellipodium	-	202	123	-	-	1.65E-02	1.86E-02
PIPs	CC	GO:0001056	RNA polymerase III activity	-	16	14	-	-	4.97E-01	2.25E-03
PIPs	CC	GO:0002102	podosome	-	31	15	-	-	1.07E-02	2.25E-03
PIPs	CC	GO:0090543	Flemming body	-	33	13	-	-	1.25E-01	2.07E-03
PIPs	CC	GO:0016328	lateral plasma membrane	-	66	28	-	-	9.14E-03	4.32E-03
PIPs	CC	GO:0001650	fibrillar center	-	151	78	-	-	4.36E-03	1.18E-02
PIPs	CC	GO:1990204	oxidoreductase complex	-	90	27	-	-	1.55E-01	4.13E-03
PIPs	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	73	-	-	1.70E-02	1.11E-02
PIPs	CC	GO:0001726	ruffle	-	181	104	-	-	9.41E-03	1.58E-02
PIPs	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	11	-	-	3.24E-01	1.69E-03
PIPs	CC	GO:0043198	dendritic shaft	-	38	18	-	-	7.26E-04	2.82E-03
PIPs	CC	GO:0043073	germ cell nucleus	-	67	34	-	-	7.85E-03	5.26E-03
PIPs	CC	GO:0005788	endoplasmic reticulum lumen	-	313	121	-	-	2.47E-02	1.82E-02
PIPs	CC	GO:0022626	cytosolic ribosome	-	118	70	-	-	7.45E-02	1.05E-02
PIPs	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	21	-	-	1.12E-01	3.19E-03
PIPs	CC	GO:0034451	centriolar satellite	-	120	33	-	-	2.37E-03	5.07E-03
PIPs	CC	GO:0045171	intercellular bridge	-	91	27	-	-	1.31E-02	4.13E-03
PIPs	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	32	-	-	1.72E-02	4.88E-03
PIPs	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.77E-01	1.69E-03
PIPs	CC	GO:0098984	neuron to neuron synapse	-	384	189	-	-	1.73E-02	2.85E-02
PIPs	CC	GO:0030527	structural constituent of chromatin	-	97	37	-	-	1.32E-01	5.63E-03
PIPs	CC	GO:0030286	dynein complex	-	210	36	-	-	3.18E-03	5.44E-03
PIPs	CC	GO:0016482	cytosolic transport	-	135	41	-	-	2.13E-02	6.20E-03
PIPs	CC	GO:0005796	Golgi lumen	-	106	40	-	-	9.26E-03	6.01E-03
PIPs	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	17	-	-	3.61E-01	2.63E-03
PIPs	CC	GO:0034358	plasma lipoprotein particle	-	36	22	-	-	3.72E-02	3.38E-03
PIPs	CC	GO:0008023	transcription elongation factor complex	-	47	20	-	-	8.86E-03	3.00E-03
PIPs	CC	GO:0030662	coated vesicle membrane	-	202	116	-	-	8.18E-02	1.75E-02
PIPs	CC	GO:0007039	protein catabolic process in the vacuole	-	61	28	-	-	2.74E-01	4.32E-03
PIPs	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	156	-	-	6.20E-02	2.35E-02
PIPs	CC	GO:0005769	early endosome	-	425	190	-	-	3.56E-02	2.85E-02
PIPs	CC	GO:0090734	site of DNA damage	-	118	54	-	-	1.14E-02	8.26E-03
PIPs	MF	GO:0051861	glycolipid binding	-	30	14	-	-	1.59E-02	2.25E-03
PIPs	MF	GO:0051087	protein-folding chaperone binding	-	135	65	-	-	3.28E-02	9.76E-03
PIPs	CC	GO:0015464	acetylcholine receptor activity	-	21	13	-	-	1.43E-01	2.07E-03
PIPs	MF	GO:0031681	G-protein beta-subunit binding	-	22	14	-	-	5.19E-03	2.25E-03
PIPs	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	13	-	-	5.56E-04	2.07E-03
PIPs	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	48	-	-	1.21E-02	7.32E-03
PIPs	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	11	-	-	6.41E-02	1.69E-03
PIPs	MF	GO:0033691	sialic acid binding	-	22	14	-	-	7.93E-02	2.25E-03
PIPs	MF	GO:0016757	glycosyltransferase activity	-	286	40	-	-	7.34E-02	6.01E-03
PIPs	MF	GO:0048306	calcium-dependent protein binding	-	61	33	-	-	4.94E-03	5.07E-03
PIPs	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	33	-	-	2.14E-02	5.07E-03
PIPs	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	25	-	-	2.05E-02	3.76E-03
PIPs	MF	GO:0051020	GTPase binding	-	311	128	-	-	2.45E-02	1.93E-02
PIPs	MF	GO:0140457	protein demethylase activity	-	31	11	-	-	5.61E-04	1.69E-03
PIPs	MF	GO:0005158	insulin receptor binding	-	22	14	-	-	2.17E-02	2.25E-03
PIPs	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	11	-	-	4.45E-03	1.69E-03
PIPs	MF	GO:0061980	regulatory RNA binding	-	52	19	-	-	7.34E-04	3.00E-03
PIPs	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	206	-	-	8.24E-02	3.10E-02
PIPs	MF	GO:0035035	histone acetyltransferase binding	-	24	11	-	-	3.07E-03	1.69E-03
PIPs	MF	GO:0061684	chaperone-mediated autophagy	-	16	12	-	-	2.40E-02	1.88E-03
PIPs	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	12	-	-	7.17E-03	1.88E-03
PIPs	MF	GO:0003688	DNA replication origin binding	-	18	15	-	-	7.45E-02	2.25E-03
PIPs	MF	GO:0005178	integrin binding	-	153	88	-	-	1.44E-02	1.33E-02
PIPs	MF	GO:0070064	proline-rich region binding	-	17	11	-	-	1.09E-03	1.69E-03
PIPs	MF	GO:0008327	methyl-CpG binding	-	31	12	-	-	3.96E-03	1.88E-03
PIPs	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	15	-	-	7.24E-03	2.25E-03
PIPs	MF	GO:0140318	protein transporter activity	-	40	18	-	-	4.96E-02	2.82E-03
PIPs	MF	GO:0000217	DNA secondary structure binding	-	37	25	-	-	3.63E-03	3.76E-03
PIPs	MF	GO:0002039	p53 binding	-	66	38	-	-	2.96E-03	5.82E-03
PIPs	MF	GO:0005496	steroid binding	-	110	33	-	-	1.11E-02	5.07E-03
PIPs	MF	GO:0008443	phosphofructokinase activity	-	27	12	-	-	2.92E-02	1.88E-03
PIPs	MF	GO:0003684	damaged DNA binding	-	89	55	-	-	5.69E-02	8.26E-03
PIPs	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	71	-	-	2.81E-02	1.07E-02
PIPs	MF	GO:0070063	RNA polymerase binding	-	61	33	-	-	2.61E-03	5.07E-03
PIPs	MF	GO:0030971	receptor tyrosine kinase binding	-	76	47	-	-	8.97E-03	7.13E-03
PIPs	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	52	-	-	5.08E-02	7.89E-03
PIPs	MF	GO:0140030	modification-dependent protein binding	-	179	69	-	-	1.03E-02	1.05E-02
PIPs	MF	GO:0044548	S100 protein binding	-	14	11	-	-	2.55E-02	1.69E-03
PIPs	MF	GO:0030276	clathrin binding	-	70	33	-	-	2.06E-01	5.07E-03
PIPs	MF	GO:0003712	transcription coregulator activity	-	499	207	-	-	2.67E-02	3.12E-02
PIPs	MF	GO:0046875	ephrin receptor binding	-	29	28	-	-	7.62E-03	4.32E-03
PIPs	MF	GO:0106310	protein serine kinase activity	-	362	222	-	-	2.31E-02	3.34E-02
PIPs	MF	GO:0030552	cAMP binding	-	48	29	-	-	8.12E-02	4.51E-03
PIPs	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	17	-	-	9.59E-03	2.63E-03
PIPs	MF	GO:0004857	enzyme inhibitor activity	-	395	177	-	-	1.74E-02	2.67E-02
PIPs	MF	GO:0035173	histone kinase activity	-	17	13	-	-	5.75E-03	2.07E-03
PIPs	MF	GO:0004984	olfactory receptor activity	-	429	15	-	-	7.50E-04	2.25E-03
PIPs	MF	GO:0016209	antioxidant activity	-	92	27	-	-	6.76E-02	4.13E-03
PIPs	MF	GO:0070325	lipoprotein particle receptor binding	-	32	22	-	-	1.44E-02	3.38E-03
PIPs	MF	GO:0044325	transmembrane transporter binding	-	159	80	-	-	1.02E-02	1.20E-02
PIPs	MF	GO:0048156	tau protein binding	-	43	32	-	-	3.01E-03	4.88E-03
PIPs	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	14	-	-	4.45E-02	2.25E-03
PIPs	MF	GO:0045295	gamma-catenin binding	-	13	11	-	-	4.33E-02	1.69E-03
PIPs	MF	GO:0140272	exogenous protein binding	-	79	42	-	-	3.97E-03	6.38E-03
PIPs	MF	GO:0030145	manganese ion binding	-	65	18	-	-	1.81E-03	2.82E-03
PIPs	MF	GO:0071814	protein-lipid complex binding	-	52	24	-	-	1.46E-02	3.76E-03
PIPs	MF	GO:0008066	glutamate receptor activity	-	70	36	-	-	3.39E-02	5.44E-03
PIPs	MF	GO:0017069	snRNA binding	-	54	25	-	-	3.13E-02	3.76E-03
PIPs	MF	GO:0031369	translation initiation factor binding	-	32	21	-	-	1.39E-02	3.19E-03
PIPs	MF	GO:0019843	rRNA binding	-	69	27	-	-	1.71E-02	4.13E-03
PIPs	MF	GO:0004713	protein tyrosine kinase activity	-	213	156	-	-	3.15E-02	2.35E-02
PIPs	MF	GO:0016779	nucleotidyltransferase activity	-	264	123	-	-	4.99E-02	1.86E-02
PIPs	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	39	-	-	5.09E-03	6.01E-03
PIPs	MF	GO:0008093	cytoskeletal anchor activity	-	24	12	-	-	1.69E-03	1.88E-03
PIPs	MF	GO:0016208	AMP binding	-	22	14	-	-	1.63E-01	2.25E-03
PIPs	MF	GO:0000287	magnesium ion binding	-	225	90	-	-	2.24E-02	1.35E-02
PIPs	MF	GO:0031490	chromatin DNA binding	-	120	66	-	-	3.72E-02	9.95E-03
PIPs	MF	GO:0017022	myosin binding	-	73	25	-	-	5.67E-03	3.76E-03
PIPs	MF	GO:0004896	cytokine receptor activity	-	93	64	-	-	8.63E-03	9.76E-03
PIPs	MF	GO:0008301	"DNA binding, bending"	-	18	11	-	-	5.57E-04	1.69E-03
PIPs	MF	GO:0015631	tubulin binding	-	410	136	-	-	2.62E-02	2.05E-02
PIPs	MF	GO:0005539	glycosaminoglycan binding	-	236	117	-	-	1.49E-02	1.76E-02
PIPs	MF	GO:0019207	kinase regulator activity	-	267	145	-	-	1.83E-02	2.18E-02
PIPs	MF	GO:0044183	protein folding chaperone	-	67	31	-	-	1.92E-02	4.69E-03
PIPs	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	88	-	-	6.63E-02	1.33E-02
PIPs	MF	GO:0003725	double-stranded RNA binding	-	72	27	-	-	2.93E-03	4.13E-03
PIPs	MF	GO:0051018	protein kinase A binding	-	52	24	-	-	2.18E-02	3.76E-03
PIPs	MF	GO:0071889	14-3-3 protein binding	-	34	22	-	-	1.48E-03	3.38E-03
PIPs	MF	GO:0004618	phosphoglycerate kinase activity	-	89	46	-	-	7.00E-03	6.95E-03
PIPs	MF	GO:0042805	actinin binding	-	36	18	-	-	3.37E-03	2.82E-03
PIPs	MF	GO:0043531	ADP binding	-	38	24	-	-	1.02E-02	3.76E-03
PIPs	MF	GO:0043394	proteoglycan binding	-	36	25	-	-	2.48E-02	3.76E-03
PIPs	MF	GO:0046332	SMAD binding	-	77	48	-	-	1.49E-02	7.32E-03
PIPs	MF	GO:0043560	insulin receptor substrate binding	-	13	11	-	-	3.35E-03	1.69E-03
PIPs	MF	GO:0001968	fibronectin binding	-	30	19	-	-	3.30E-02	3.00E-03
PIPs	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	45	-	-	8.17E-02	6.76E-03
PIPs	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	28	-	-	4.36E-03	4.32E-03
PIPs	MF	GO:0051117	ATPase binding	-	85	36	-	-	1.27E-02	5.44E-03
PIPs	MF	GO:0005216	monoatomic ion channel activity	-	618	244	-	-	2.07E-01	3.68E-02
PIPs	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	34	-	-	4.47E-03	5.26E-03
PIPs	MF	GO:0001098	basal transcription machinery binding	-	61	38	-	-	6.76E-02	5.82E-03
PIPs	MF	GO:0036002	pre-mRNA binding	-	57	18	-	-	1.30E-02	2.82E-03
PIPs	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	14	-	-	1.69E-02	2.25E-03
PIPs	MF	GO:0051540	metal cluster binding	-	71	24	-	-	2.13E-02	3.76E-03
PIPs	MF	GO:0051219	phosphoprotein binding	-	92	71	-	-	8.77E-03	1.07E-02
PIPs	MF	GO:0019894	kinesin binding	-	45	15	-	-	1.47E-02	2.25E-03
PIPs	MF	GO:0042287	MHC protein binding	-	68	35	-	-	5.83E-02	5.26E-03
PIPs	MF	GO:0019003	GDP binding	-	89	44	-	-	3.83E-02	6.76E-03
PIPs	MF	GO:0017171	serine hydrolase activity	-	207	105	-	-	1.23E-01	1.58E-02
PIPs	MF	GO:0097110	scaffold protein binding	-	66	48	-	-	3.60E-03	7.32E-03
PIPs	MF	GO:0003774	cytoskeletal motor activity	-	117	27	-	-	5.31E-02	4.13E-03
PIPs	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	16	-	-	6.95E-02	2.44E-03
PIPs	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	13	-	-	5.36E-03	2.07E-03
PIPs	MF	GO:0061134	peptidase regulator activity	-	224	106	-	-	2.90E-02	1.60E-02
PIPs	MF	GO:0008013	beta-catenin binding	-	86	45	-	-	9.42E-03	6.76E-03
PIPs	MF	GO:0051015	actin filament binding	-	208	91	-	-	4.96E-02	1.37E-02
PIPs	MF	GO:0019208	phosphatase regulator activity	-	107	43	-	-	1.84E-02	6.57E-03
PIPs	MF	GO:0043236	laminin binding	-	29	13	-	-	5.55E-04	2.07E-03
PIPs	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	14	-	-	1.06E-02	2.25E-03
PIPs	MF	GO:0045860	positive regulation of protein kinase activity	-	397	222	-	-	1.94E-02	3.34E-02
PIPs	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	40	-	-	1.85E-01	6.01E-03
PIPs	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	22	-	-	8.92E-03	3.38E-03
PIPs	MF	GO:0042393	histone binding	-	240	102	-	-	1.39E-02	1.54E-02
PIPs	MF	GO:0019838	growth factor binding	-	182	120	-	-	2.18E-02	1.80E-02
PIPs	MF	GO:0000149	SNARE binding	-	107	55	-	-	2.73E-01	8.26E-03
PIPs	MF	GO:0003727	single-stranded RNA binding	-	90	43	-	-	1.44E-02	6.57E-03
PIPs	MF	GO:0051378	serotonin binding	-	24	15	-	-	2.74E-02	2.25E-03
PIPs	MF	GO:0005516	calmodulin binding	-	206	101	-	-	2.53E-02	1.52E-02
PIPs	MF	GO:0019825	oxygen binding	-	40	13	-	-	1.10E-01	2.07E-03
PIPs	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	12	-	-	3.42E-02	1.88E-03
PIPs	MF	GO:0032182	ubiquitin-like protein binding	-	117	52	-	-	1.92E-02	7.89E-03
PIPs	MF	GO:0023023	MHC protein complex binding	-	36	28	-	-	5.63E-02	4.32E-03
PIPs	MF	GO:0030742	GTP-dependent protein binding	-	22	11	-	-	1.88E-03	1.69E-03
PIPs	MF	GO:0043274	phospholipase binding	-	23	14	-	-	1.27E-03	2.25E-03
PIPs	MF	GO:0031072	heat shock protein binding	-	128	60	-	-	2.26E-02	9.01E-03
PIPs	MF	GO:0030515	snoRNA binding	-	33	20	-	-	1.49E-01	3.00E-03
PIPs	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	13	-	-	6.91E-02	2.07E-03
PIPs	MF	GO:0001965	G-protein alpha-subunit binding	-	26	16	-	-	1.10E-02	2.44E-03
PIPs	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	171	-	-	2.17E-02	2.57E-02
PIPs	MF	GO:0001530	lipopolysaccharide binding	-	38	20	-	-	1.02E-02	3.00E-03
PIPs	MF	GO:0046982	protein heterodimerization activity	-	343	163	-	-	5.43E-02	2.46E-02
PIPs	MF	GO:0140223	general transcription initiation factor activity	-	55	36	-	-	2.21E-01	5.44E-03
PIPs	MF	GO:0000049	tRNA binding	-	75	20	-	-	2.03E-02	3.00E-03
PIPs	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	38	-	-	7.90E-03	5.82E-03
PIPs	MF	GO:0015026	coreceptor activity	-	48	27	-	-	1.74E-03	4.13E-03
PIPs	MF	GO:0001653	peptide receptor activity	-	128	57	-	-	6.41E-02	8.64E-03
PIPs	MF	GO:0030506	ankyrin binding	-	19	12	-	-	5.55E-04	1.88E-03
PIPs	MF	GO:0006469	negative regulation of protein kinase activity	-	222	121	-	-	2.03E-02	1.82E-02
PIPs	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	20	-	-	7.05E-03	3.00E-03
PIPs	MF	GO:0051427	hormone receptor binding	-	31	19	-	-	1.98E-03	3.00E-03
PIPs	MF	GO:0070851	growth factor receptor binding	-	141	77	-	-	1.77E-02	1.16E-02
PIPs	MF	GO:0031210	phosphatidylcholine binding	-	32	15	-	-	1.78E-02	2.25E-03
PIPs	MF	GO:0005525	GTP binding	-	396	155	-	-	3.49E-02	2.33E-02
PIPs	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	28	-	-	3.75E-02	4.32E-03
PIPs	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	153	-	-	2.08E-02	2.31E-02
PIPs	MF	GO:0034185	apolipoprotein binding	-	20	11	-	-	2.63E-03	1.69E-03
PIPs	MF	GO:0051346	negative regulation of hydrolase activity	-	332	154	-	-	1.83E-02	2.33E-02
PIPs	MF	GO:0005506	iron ion binding	-	154	36	-	-	7.51E-02	5.44E-03
PIPs	MF	GO:0003925	G protein activity	-	45	26	-	-	2.18E-03	3.94E-03
PIPs	MF	GO:0038187	pattern recognition receptor activity	-	33	19	-	-	2.17E-02	3.00E-03
PIPs	MF	GO:0008276	protein methyltransferase activity	-	96	15	-	-	7.42E-04	2.25E-03
PIPs	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	174	-	-	1.44E-02	2.63E-02
PIPs	MF	GO:0070888	E-box binding	-	59	43	-	-	7.86E-02	6.57E-03
PIPs	MF	GO:0015399	primary active transmembrane transporter activity	-	190	53	-	-	1.46E-01	8.07E-03
PIPs	MF	GO:0035254	glutamate receptor binding	-	47	23	-	-	2.38E-03	3.57E-03
PIPs	MF	GO:0050321	tau-protein kinase activity	-	36	25	-	-	1.97E-03	3.76E-03
PIPs	MF	GO:0043021	ribonucleoprotein complex binding	-	158	71	-	-	1.34E-02	1.07E-02
PIPs	MF	GO:0048185	activin binding	-	16	13	-	-	5.88E-02	2.07E-03
PIPs	MF	GO:0001664	G protein-coupled receptor binding	-	299	136	-	-	3.95E-02	2.05E-02
PIPs	MF	GO:0140299	small molecule sensor activity	-	39	16	-	-	1.98E-02	2.44E-03
PIPs	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	19	-	-	2.08E-02	3.00E-03
PIPs	MF	GO:0016917	GABA receptor activity	-	23	11	-	-	3.09E-01	1.69E-03
PIPs	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	12	-	-	1.28E-02	1.88E-03
PIPs	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	23	-	-	1.36E-02	3.57E-03
PIPs	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	15	-	-	7.24E-04	2.25E-03
PIPs	MF	GO:0030594	neurotransmitter receptor activity	-	160	79	-	-	1.71E-01	1.20E-02
PIPs	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	11	-	-	5.54E-04	1.69E-03
PIPs	MF	GO:0005507	copper ion binding	-	63	20	-	-	1.27E-01	3.00E-03
PIPs	MF	GO:0033558	protein lysine deacetylase activity	-	22	11	-	-	3.76E-02	1.69E-03
PIPs	MF	GO:0070034	telomerase RNA binding	-	22	13	-	-	1.68E-02	2.07E-03
PrePPI	CC	GO:0005730	nucleolus	2.81E-13	988	505	394	1.28	-	-
PrePPI	CC	GO:0005615	extracellular space	4.14E-12	3190	1449	1273	1.14	-	-
PrePPI	CC	GO:0005768	endosome	1.79E-09	1037	507	414	1.22	-	-
PrePPI	CC	GO:0005739	mitochondrion	6.96E-09	1671	557	667	0.84	-	-
PrePPI	CC	GO:0005815	microtubule organizing center	1.14E-07	843	411	336	1.22	-	-
PrePPI	CC	GO:0000228	nuclear chromosome	9.50E-07	206	117	82	1.42	-	-
PrePPI	CC	GO:0005794	Golgi apparatus	3.35E-03	1636	709	653	1.09	-	-
PrePPI	CC	GO:0031012	extracellular matrix	9.96E-03	564	255	225	1.13	-	-
PrePPI	CC	GO:0005635	nuclear envelope	1.98E-02	493	222	197	1.13	-	-
PrePPI	CC	GO:0005783	endoplasmic reticulum	3.12E-01	2020	785	806	0.97	-	-
PrePPI	CC	GO:0005929	cilium	4.29E-01	842	325	336	0.97	-	-
PrePPI	CC	GO:0005764	lysosome	5.17E-01	747	307	298	1.03	-	-
PrePPI	CC	GO:0005777	peroxisome	7.31E-01	142	59	57	1.04	-	-
PrePPI	CC	GO:0005811	lipid droplet	7.62E-01	102	39	41	0.96	-	-
PrePPI	CC	GO:0005840	ribosome	7.83E-01	222	91	89	1.03	-	-
PrePPI	BP	GO:0006355	regulation of DNA-templated transcription	3.25E-208	3342	2132	1334	1.60	-	-
PrePPI	BP	GO:0012501	programmed cell death	9.76E-63	1954	1127	780	1.44	-	-
PrePPI	BP	GO:0048870	cell motility	2.34E-52	1659	956	662	1.44	-	-
PrePPI	BP	GO:0007155	cell adhesion	1.17E-47	1444	839	576	1.46	-	-
PrePPI	BP	GO:0034330	cell junction organization	1.14E-42	727	470	290	1.62	-	-
PrePPI	BP	GO:0050877	nervous system process	2.03E-40	1527	857	610	1.41	-	-
PrePPI	BP	GO:0002376	immune system process	8.58E-36	2448	1262	977	1.29	-	-
PrePPI	BP	GO:0007010	cytoskeleton organization	1.58E-32	1639	882	654	1.35	-	-
PrePPI	BP	GO:0016192	vesicle-mediated transport	1.16E-29	1894	987	756	1.31	-	-
PrePPI	BP	GO:0006886	intracellular protein transport	8.14E-27	664	400	265	1.51	-	-
PrePPI	BP	GO:0065003	protein-containing complex assembly	3.52E-26	1648	861	658	1.31	-	-
PrePPI	BP	GO:0030163	protein catabolic process	5.71E-25	990	552	395	1.40	-	-
PrePPI	BP	GO:0042060	wound healing	1.63E-23	431	274	172	1.59	-	-
PrePPI	BP	GO:0003012	muscle system process	8.65E-22	425	267	170	1.57	-	-
PrePPI	BP	GO:0007163	establishment or maintenance of cell polarity	3.00E-21	227	161	91	1.78	-	-
PrePPI	BP	GO:0016071	mRNA metabolic process	9.93E-20	713	403	285	1.42	-	-
PrePPI	BP	GO:0006913	nucleocytoplasmic transport	8.75E-19	326	209	130	1.61	-	-
PrePPI	BP	GO:0003013	circulatory system process	3.48E-15	584	326	233	1.40	-	-
PrePPI	BP	GO:0006954	inflammatory response	1.81E-14	820	434	327	1.33	-	-
PrePPI	BP	GO:0006325	chromatin organization	2.64E-14	720	387	287	1.35	-	-
PrePPI	BP	GO:0006914	autophagy	3.30E-12	568	308	227	1.36	-	-
PrePPI	BP	GO:0007059	chromosome segregation	1.07E-11	403	228	161	1.42	-	-
PrePPI	BP	GO:0006281	DNA repair	5.90E-11	587	312	234	1.33	-	-
PrePPI	BP	GO:0072659	protein localization to plasma membrane	2.98E-10	284	166	113	1.46	-	-
PrePPI	BP	GO:0006260	DNA replication	1.66E-09	279	161	111	1.45	-	-
PrePPI	BP	GO:0006486	protein glycosylation	3.73E-09	225	48	90	0.53	-	-
PrePPI	BP	GO:0000910	cytokinesis	2.58E-08	186	112	74	1.51	-	-
PrePPI	BP	GO:0002181	cytoplasmic translation	4.31E-08	153	95	61	1.56	-	-
PrePPI	BP	GO:0006790	sulfur compound metabolic process	1.37E-07	320	83	128	0.65	-	-
PrePPI	BP	GO:0032200	telomere organization	5.50E-07	186	108	74	1.45	-	-
PrePPI	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	3.00E-06	119	73	48	1.54	-	-
PrePPI	BP	GO:0140053	mitochondrial gene expression	6.22E-06	164	38	65	0.58	-	-
PrePPI	BP	GO:0006310	DNA recombination	1.29E-05	333	172	133	1.29	-	-
PrePPI	BP	GO:0098542	defense response to other organism	1.31E-04	1171	530	467	1.13	-	-
PrePPI	BP	GO:0030198	extracellular matrix organization	1.91E-04	314	158	125	1.26	-	-
PrePPI	BP	GO:0006457	protein folding	4.88E-04	210	109	84	1.30	-	-
PrePPI	BP	GO:0003014	renal system process	5.28E-04	127	70	51	1.38	-	-
PrePPI	BP	GO:0006766	vitamin metabolic process	9.91E-04	107	26	43	0.61	-	-
PrePPI	BP	GO:0006575	cellular modified amino acid metabolic process	2.52E-03	186	54	74	0.73	-	-
PrePPI	BP	GO:0140013	meiotic nuclear division	4.52E-03	279	135	111	1.21	-	-
PrePPI	BP	GO:0022600	digestive system process	8.08E-03	110	58	44	1.32	-	-
PrePPI	BP	GO:0006520	amino acid metabolic process	9.55E-03	292	95	117	0.82	-	-
PrePPI	BP	GO:0042254	ribosome biogenesis	2.31E-02	297	138	119	1.16	-	-
PrePPI	BP	GO:0006399	tRNA metabolic process	3.99E-02	196	64	78	0.82	-	-
PrePPI	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.53E-01	729	272	291	0.93	-	-
PrePPI	BP	GO:0006629	lipid metabolic process	1.76E-01	1355	517	541	0.96	-	-
PrePPI	BP	GO:0006091	generation of precursor metabolites and energy	2.88E-01	502	212	200	1.06	-	-
PrePPI	BP	GO:0055085	transmembrane transport	3.74E-01	1784	730	712	1.03	-	-
PrePPI	BP	GO:0005975	carbohydrate metabolic process	5.37E-01	551	227	220	1.03	-	-
PrePPI	BP	GO:0007018	microtubule-based movement	6.52E-01	640	261	255	1.02	-	-
PrePPI	BP	GO:0098754	detoxification	6.59E-01	134	56	53	1.05	-	-
PrePPI	BP	GO:0044782	cilium organization	6.80E-01	399	155	159	0.97	-	-
PrePPI	BP	GO:0007005	mitochondrion organization	8.88E-01	484	195	193	1.01	-	-
PrePPI	BP	GO:0007040	lysosome organization	1.00E+00	107	43	43	1.01	-	-
PrePPI	MF	GO:0003677	DNA binding	5.76E-192	2865	1864	1144	1.63	-	-
PrePPI	MF	GO:0140110	transcription regulator activity	4.57E-151	2033	1363	812	1.68	-	-
PrePPI	MF	GO:0140096	"catalytic activity, acting on a protein"	5.37E-65	3198	1710	1277	1.34	-	-
PrePPI	MF	GO:0003924	GTPase activity	4.03E-48	658	445	263	1.69	-	-
PrePPI	MF	GO:0016740	transferase activity	7.49E-29	3074	1506	1227	1.23	-	-
PrePPI	MF	GO:0008092	cytoskeletal protein binding	3.12E-26	1023	572	408	1.40	-	-
PrePPI	MF	GO:0003723	RNA binding	2.30E-21	1679	854	670	1.27	-	-
PrePPI	MF	GO:0140097	"catalytic activity, acting on DNA"	6.06E-11	383	216	153	1.41	-	-
PrePPI	MF	GO:0009975	cyclase activity	3.01E-08	277	156	111	1.41	-	-
PrePPI	MF	GO:0045182	translation regulator activity	1.02E-06	151	90	60	1.49	-	-
PrePPI	MF	GO:0140657	ATP-dependent activity	1.63E-06	729	354	291	1.22	-	-
PrePPI	MF	GO:0042393	histone binding	6.74E-06	237	129	95	1.36	-	-
PrePPI	MF	GO:0005215	transporter activity	1.83E-05	1462	507	584	0.87	-	-
PrePPI	MF	GO:0008289	lipid binding	5.92E-05	836	390	334	1.17	-	-
PrePPI	MF	GO:0005198	structural molecule activity	2.91E-04	798	368	319	1.16	-	-
PrePPI	MF	GO:0016829	lyase activity	7.93E-04	538	253	215	1.18	-	-
PrePPI	MF	GO:0140104	molecular carrier activity	2.11E-02	105	54	42	1.29	-	-
PrePPI	MF	GO:0003774	cytoskeletal motor activity	2.87E-02	116	58	46	1.25	-	-
PrePPI	MF	GO:0016874	ligase activity	4.34E-02	283	130	113	1.15	-	-
PrePPI	MF	GO:0140098	"catalytic activity, acting on RNA"	1.57E-01	417	152	166	0.91	-	-
PrePPI	MF	GO:0038024	cargo receptor activity	1.85E-01	117	54	47	1.16	-	-
PrePPI	MF	GO:0016853	isomerase activity	1.95E-01	252	111	101	1.10	-	-
PrePPI	MF	GO:0016491	oxidoreductase activity	2.33E-01	888	337	354	0.95	-	-
PrePPI	MF	GO:0048018	receptor ligand activity	5.49E-01	504	208	201	1.03	-	-
PrePPI	BP	GO:0008038	neuron recognition	-	46	33	-	-	5.26E-03	3.52E-03
PrePPI	BP	GO:1905145	cellular response to acetylcholine	-	33	23	-	-	6.48E-04	2.48E-03
PrePPI	BP	GO:0098780	response to mitochondrial depolarisation	-	21	18	-	-	5.20E-04	1.96E-03
PrePPI	BP	GO:0051931	regulation of sensory perception	-	36	18	-	-	5.08E-02	1.96E-03
PrePPI	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	19	-	-	6.68E-03	2.09E-03
PrePPI	BP	GO:0009268	response to pH	-	43	19	-	-	5.21E-04	2.09E-03
PrePPI	BP	GO:0045666	positive regulation of neuron differentiation	-	91	54	-	-	3.83E-03	5.74E-03
PrePPI	BP	GO:0043543	protein acylation	-	107	46	-	-	2.51E-03	4.83E-03
PrePPI	MF	GO:0051349	positive regulation of lyase activity	-	41	26	-	-	7.78E-04	2.74E-03
PrePPI	BP	GO:0048679	regulation of axon regeneration	-	28	15	-	-	5.19E-04	1.57E-03
PrePPI	BP	GO:0022401	negative adaptation of signaling pathway	-	21	15	-	-	5.20E-04	1.57E-03
PrePPI	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	44	-	-	6.44E-02	4.70E-03
PrePPI	BP	GO:0071763	nuclear membrane organization	-	44	22	-	-	3.82E-03	2.35E-03
PrePPI	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	17	-	-	5.19E-04	1.83E-03
PrePPI	BP	GO:0071806	protein transmembrane transport	-	68	37	-	-	1.58E-02	3.92E-03
PrePPI	BP	GO:0022038	corpus callosum development	-	25	16	-	-	2.64E-02	1.70E-03
PrePPI	BP	GO:0043299	leukocyte degranulation	-	82	50	-	-	2.86E-03	5.22E-03
PrePPI	BP	GO:0048864	stem cell development	-	88	60	-	-	3.21E-03	6.26E-03
PrePPI	BP	GO:0051651	maintenance of location in cell	-	236	130	-	-	9.98E-03	1.36E-02
PrePPI	BP	GO:0033119	negative regulation of RNA splicing	-	27	20	-	-	2.94E-02	2.09E-03
PrePPI	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	11	-	-	3.91E-04	1.17E-03
PrePPI	CC	GO:0016197	endosomal transport	-	282	150	-	-	9.44E-03	1.57E-02
PrePPI	BP	GO:0070663	regulation of leukocyte proliferation	-	268	164	-	-	9.37E-03	1.72E-02
PrePPI	BP	GO:1905962	glutamatergic neuron differentiation	-	14	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0001833	inner cell mass cell proliferation	-	14	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	23	-	-	6.47E-04	2.48E-03
PrePPI	BP	GO:0006949	syncytium formation	-	66	39	-	-	4.46E-03	4.18E-03
PrePPI	BP	GO:0045861	negative regulation of proteolysis	-	320	150	-	-	8.24E-03	1.57E-02
PrePPI	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	19	-	-	5.21E-04	2.09E-03
PrePPI	BP	GO:0030574	collagen catabolic process	-	45	24	-	-	8.77E-02	2.61E-03
PrePPI	CC	GO:0006984	ER-nucleus signaling pathway	-	46	26	-	-	7.74E-04	2.74E-03
PrePPI	BP	GO:0060343	trabecula formation	-	26	20	-	-	6.50E-04	2.09E-03
PrePPI	BP	GO:0009914	hormone transport	-	315	188	-	-	3.34E-02	1.97E-02
PrePPI	BP	GO:0140112	extracellular vesicle biogenesis	-	23	15	-	-	5.20E-04	1.57E-03
PrePPI	BP	GO:0085029	extracellular matrix assembly	-	42	24	-	-	6.48E-04	2.61E-03
PrePPI	BP	GO:0006413	translational initiation	-	122	71	-	-	3.13E-02	7.44E-03
PrePPI	BP	GO:0072176	nephric duct development	-	15	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:1902895	positive regulation of miRNA transcription	-	51	44	-	-	1.63E-03	4.70E-03
PrePPI	CC	GO:0005200	structural constituent of cytoskeleton	-	112	72	-	-	2.02E-02	7.57E-03
PrePPI	BP	GO:0030865	cortical cytoskeleton organization	-	51	38	-	-	1.03E-03	4.05E-03
PrePPI	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:1903036	positive regulation of response to wounding	-	76	48	-	-	5.13E-03	5.09E-03
PrePPI	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	78	-	-	1.01E-02	8.22E-03
PrePPI	BP	GO:1903319	positive regulation of protein maturation	-	27	14	-	-	3.90E-04	1.57E-03
PrePPI	BP	GO:0032528	microvillus organization	-	24	17	-	-	5.19E-04	1.83E-03
PrePPI	BP	GO:0002263	cell activation involved in immune response	-	304	174	-	-	9.20E-03	1.83E-02
PrePPI	BP	GO:0021954	central nervous system neuron development	-	85	55	-	-	4.42E-03	5.74E-03
PrePPI	BP	GO:0055017	cardiac muscle tissue growth	-	92	53	-	-	1.73E-03	5.61E-03
PrePPI	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	24	-	-	6.47E-04	2.61E-03
PrePPI	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:0048524	positive regulation of viral process	-	64	44	-	-	3.66E-03	4.70E-03
PrePPI	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	18	-	-	5.20E-04	1.96E-03
PrePPI	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	15	-	-	5.19E-04	1.57E-03
PrePPI	BP	GO:0001946	lymphangiogenesis	-	18	14	-	-	3.89E-04	1.57E-03
PrePPI	BP	GO:0098661	inorganic anion transmembrane transport	-	140	47	-	-	6.58E-02	4.96E-03
PrePPI	BP	GO:0006099	tricarboxylic acid cycle	-	33	13	-	-	2.04E-02	1.44E-03
PrePPI	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	12	-	-	1.83E-02	1.31E-03
PrePPI	BP	GO:0009612	response to mechanical stimulus	-	215	134	-	-	1.12E-02	1.41E-02
PrePPI	BP	GO:0048644	muscle organ morphogenesis	-	81	58	-	-	4.38E-03	6.13E-03
PrePPI	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	103	-	-	5.11E-03	1.08E-02
PrePPI	BP	GO:0071542	dopaminergic neuron differentiation	-	36	27	-	-	7.76E-04	2.87E-03
PrePPI	BP	GO:0140115	export across plasma membrane	-	82	26	-	-	9.04E-03	2.74E-03
PrePPI	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	21	-	-	2.74E-03	2.22E-03
PrePPI	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	12	-	-	3.91E-04	1.31E-03
PrePPI	MF	GO:0003714	transcription corepressor activity	-	190	107	-	-	4.12E-03	1.12E-02
PrePPI	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	28	-	-	7.77E-04	3.00E-03
PrePPI	BP	GO:0061101	neuroendocrine cell differentiation	-	16	14	-	-	3.90E-04	1.57E-03
PrePPI	CC	GO:0006858	extracellular transport	-	45	17	-	-	5.21E-04	1.83E-03
PrePPI	MF	GO:0140312	cargo adaptor activity	-	19	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:0046835	carbohydrate phosphorylation	-	49	23	-	-	2.03E-02	2.48E-03
PrePPI	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	14	-	-	7.51E-03	1.57E-03
PrePPI	CC	GO:1905349	ciliary transition zone assembly	-	371	142	-	-	4.34E-03	1.49E-02
PrePPI	BP	GO:0003207	cardiac chamber formation	-	14	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0043523	regulation of neuron apoptotic process	-	218	149	-	-	5.64E-03	1.57E-02
PrePPI	BP	GO:1902894	negative regulation of miRNA transcription	-	22	19	-	-	5.17E-04	2.09E-03
PrePPI	BP	GO:0044380	protein localization to cytoskeleton	-	57	26	-	-	7.74E-04	2.74E-03
PrePPI	BP	GO:0051918	negative regulation of fibrinolysis	-	13	11	-	-	2.22E-02	1.17E-03
PrePPI	BP	GO:2000209	regulation of anoikis	-	25	17	-	-	1.47E-03	1.83E-03
PrePPI	BP	GO:0014029	neural crest formation	-	15	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	19	-	-	5.19E-04	2.09E-03
PrePPI	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	24	-	-	4.48E-03	2.61E-03
PrePPI	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	40	-	-	4.97E-03	4.18E-03
PrePPI	CC	GO:0045324	late endosome to vacuole transport	-	37	14	-	-	3.91E-04	1.57E-03
PrePPI	BP	GO:0043954	cellular component maintenance	-	72	45	-	-	1.29E-03	4.70E-03
PrePPI	BP	GO:0050435	amyloid-beta metabolic process	-	65	34	-	-	1.80E-03	3.65E-03
PrePPI	BP	GO:0014823	response to activity	-	70	45	-	-	1.85E-03	4.70E-03
PrePPI	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	14	-	-	3.90E-04	1.57E-03
PrePPI	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	16	-	-	5.21E-04	1.70E-03
PrePPI	BP	GO:0034502	protein localization to chromosome	-	130	73	-	-	4.46E-03	7.70E-03
PrePPI	BP	GO:0048562	embryonic organ morphogenesis	-	295	201	-	-	1.52E-02	2.10E-02
PrePPI	BP	GO:0019233	sensory perception of pain	-	103	63	-	-	6.38E-03	6.66E-03
PrePPI	CC	GO:0043574	peroxisomal transport	-	22	16	-	-	6.41E-02	1.70E-03
PrePPI	BP	GO:0031343	positive regulation of cell killing	-	75	42	-	-	5.21E-03	4.44E-03
PrePPI	BP	GO:0090077	foam cell differentiation	-	39	29	-	-	7.73E-04	3.13E-03
PrePPI	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	53	-	-	1.20E-02	5.61E-03
PrePPI	BP	GO:0017148	negative regulation of translation	-	390	62	-	-	5.66E-03	6.53E-03
PrePPI	BP	GO:0030220	platelet formation	-	22	15	-	-	5.22E-03	1.57E-03
PrePPI	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	44	-	-	1.43E-03	4.70E-03
PrePPI	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	12	-	-	1.00E-01	1.31E-03
PrePPI	BP	GO:1903509	liposaccharide metabolic process	-	109	27	-	-	3.68E-02	2.87E-03
PrePPI	BP	GO:0009582	detection of abiotic stimulus	-	140	68	-	-	3.31E-03	7.18E-03
PrePPI	CC	GO:0140238	presynaptic endocytosis	-	72	44	-	-	6.27E-03	4.70E-03
PrePPI	BP	GO:0051236	establishment of RNA localization	-	161	91	-	-	7.90E-02	9.53E-03
PrePPI	BP	GO:0042178	xenobiotic catabolic process	-	26	13	-	-	2.04E-02	1.44E-03
PrePPI	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	119	-	-	9.61E-03	1.25E-02
PrePPI	BP	GO:0034067	protein localization to Golgi apparatus	-	30	14	-	-	3.90E-04	1.57E-03
PrePPI	BP	GO:0061842	microtubule organizing center localization	-	32	20	-	-	4.43E-03	2.09E-03
PrePPI	MF	GO:0048018	receptor ligand activity	-	510	208	-	-	3.72E-02	2.18E-02
PrePPI	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	12	-	-	5.03E-02	1.31E-03
PrePPI	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	24	-	-	6.47E-04	2.61E-03
PrePPI	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	35	-	-	2.72E-03	3.65E-03
PrePPI	BP	GO:0050779	RNA destabilization	-	135	49	-	-	9.40E-03	5.22E-03
PrePPI	BP	GO:0006023	aminoglycan biosynthetic process	-	74	21	-	-	9.58E-03	2.22E-03
PrePPI	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	25	-	-	4.36E-02	2.61E-03
PrePPI	BP	GO:0010762	regulation of fibroblast migration	-	40	29	-	-	4.03E-03	3.13E-03
PrePPI	BP	GO:0090311	regulation of protein deacetylation	-	29	20	-	-	6.49E-04	2.09E-03
PrePPI	BP	GO:0035272	exocrine system development	-	46	31	-	-	2.93E-03	3.26E-03
PrePPI	BP	GO:0022406	membrane docking	-	90	58	-	-	6.10E-03	6.13E-03
PrePPI	BP	GO:0006999	nuclear pore organization	-	15	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	12	-	-	1.53E-02	1.31E-03
PrePPI	BP	GO:0050777	negative regulation of immune response	-	196	105	-	-	4.15E-03	1.10E-02
PrePPI	BP	GO:0016053	organic acid biosynthetic process	-	335	119	-	-	2.17E-02	1.25E-02
PrePPI	BP	GO:0002063	chondrocyte development	-	33	19	-	-	5.19E-04	2.09E-03
PrePPI	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0099068	postsynapse assembly	-	40	26	-	-	7.89E-03	2.74E-03
PrePPI	BP	GO:0021782	glial cell development	-	120	74	-	-	4.38E-03	7.83E-03
PrePPI	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	37	-	-	1.03E-03	3.92E-03
PrePPI	BP	GO:0001655	urogenital system development	-	66	52	-	-	9.48E-03	5.48E-03
PrePPI	BP	GO:0071827	plasma lipoprotein particle organization	-	86	39	-	-	8.06E-03	4.18E-03
PrePPI	BP	GO:0045494	photoreceptor cell maintenance	-	43	20	-	-	6.51E-04	2.09E-03
PrePPI	BP	GO:0055088	lipid homeostasis	-	173	73	-	-	4.66E-03	7.70E-03
PrePPI	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	16	-	-	3.07E-03	1.70E-03
PrePPI	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	139	-	-	4.54E-03	1.46E-02
PrePPI	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	25	-	-	7.78E-04	2.61E-03
PrePPI	BP	GO:0045667	regulation of osteoblast differentiation	-	147	80	-	-	6.38E-03	8.35E-03
PrePPI	BP	GO:0061037	negative regulation of cartilage development	-	32	21	-	-	2.10E-03	2.22E-03
PrePPI	BP	GO:0045738	negative regulation of DNA repair	-	40	18	-	-	5.20E-04	1.96E-03
PrePPI	BP	GO:0001704	formation of primary germ layer	-	195	137	-	-	6.06E-03	1.44E-02
PrePPI	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0045778	positive regulation of ossification	-	51	36	-	-	1.75E-02	3.78E-03
PrePPI	BP	GO:0048708	astrocyte differentiation	-	88	62	-	-	4.68E-03	6.53E-03
PrePPI	BP	GO:0042092	type 2 immune response	-	41	27	-	-	2.59E-03	2.87E-03
PrePPI	BP	GO:0048588	developmental cell growth	-	233	137	-	-	5.02E-03	1.44E-02
PrePPI	BP	GO:0021872	forebrain generation of neurons	-	52	37	-	-	1.03E-03	3.92E-03
PrePPI	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:0045023	G0 to G1 transition	-	41	29	-	-	7.79E-04	3.13E-03
PrePPI	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	33	-	-	1.44E-03	3.52E-03
PrePPI	BP	GO:0034367	protein-containing complex remodeling	-	35	20	-	-	3.70E-02	2.09E-03
PrePPI	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	17	-	-	5.20E-04	1.83E-03
PrePPI	BP	GO:0010232	vascular transport	-	87	27	-	-	7.81E-04	2.87E-03
PrePPI	BP	GO:0021987	cerebral cortex development	-	125	80	-	-	2.90E-03	8.35E-03
PrePPI	BP	GO:0008637	apoptotic mitochondrial changes	-	108	52	-	-	2.60E-03	5.48E-03
PrePPI	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	23	-	-	6.44E-04	2.48E-03
PrePPI	BP	GO:0060999	positive regulation of dendritic spine development	-	35	22	-	-	6.49E-04	2.35E-03
PrePPI	BP	GO:2000736	regulation of stem cell differentiation	-	78	48	-	-	3.20E-03	5.09E-03
PrePPI	BP	GO:0060973	cell migration involved in heart development	-	21	16	-	-	5.19E-04	1.70E-03
PrePPI	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0002064	epithelial cell development	-	210	138	-	-	6.11E-03	1.45E-02
PrePPI	BP	GO:0071318	cellular response to ATP	-	18	13	-	-	3.91E-04	1.44E-03
PrePPI	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	24	-	-	1.56E-02	2.61E-03
PrePPI	BP	GO:2001222	regulation of neuron migration	-	46	29	-	-	7.77E-04	3.13E-03
PrePPI	BP	GO:0034389	lipid droplet organization	-	38	16	-	-	4.73E-03	1.70E-03
PrePPI	BP	GO:0051602	response to electrical stimulus	-	44	30	-	-	7.18E-03	3.13E-03
PrePPI	BP	GO:0042177	negative regulation of protein catabolic process	-	109	66	-	-	2.63E-03	6.92E-03
PrePPI	MF	GO:0038024	cargo receptor activity	-	121	54	-	-	1.09E-02	5.74E-03
PrePPI	BP	GO:0033120	positive regulation of RNA splicing	-	46	31	-	-	2.04E-03	3.26E-03
PrePPI	BP	GO:0051445	regulation of meiotic cell cycle	-	64	40	-	-	4.16E-03	4.18E-03
PrePPI	BP	GO:0033619	membrane protein proteolysis	-	60	38	-	-	7.11E-03	4.05E-03
PrePPI	BP	GO:0090087	regulation of peptide transport	-	195	118	-	-	4.93E-03	1.24E-02
PrePPI	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	59	-	-	3.88E-03	6.26E-03
PrePPI	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	17	-	-	5.20E-04	1.83E-03
PrePPI	BP	GO:0006929	substrate-dependent cell migration	-	26	21	-	-	2.55E-03	2.22E-03
PrePPI	BP	GO:0072662	protein localization to peroxisome	-	20	14	-	-	6.53E-02	1.57E-03
PrePPI	BP	GO:0022404	molting cycle process	-	95	64	-	-	3.35E-03	6.79E-03
PrePPI	BP	GO:1903358	regulation of Golgi organization	-	17	12	-	-	3.90E-04	1.31E-03
PrePPI	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	17	-	-	2.81E-03	1.83E-03
PrePPI	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	12	-	-	1.61E-02	1.31E-03
PrePPI	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	18	-	-	5.20E-04	1.96E-03
PrePPI	BP	GO:0007281	germ cell development	-	334	148	-	-	1.42E-02	1.55E-02
PrePPI	BP	GO:0008299	isoprenoid biosynthetic process	-	30	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	103	-	-	7.73E-03	1.08E-02
PrePPI	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	25	-	-	2.18E-03	2.61E-03
PrePPI	BP	GO:0034104	negative regulation of tissue remodeling	-	22	15	-	-	4.20E-03	1.57E-03
PrePPI	CC	GO:0098926	postsynaptic signal transduction	-	39	28	-	-	7.74E-04	3.00E-03
PrePPI	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	87	-	-	3.98E-03	9.14E-03
PrePPI	CC	GO:0016082	synaptic vesicle priming	-	19	15	-	-	1.72E-02	1.57E-03
PrePPI	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	27	-	-	7.79E-04	2.87E-03
PrePPI	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	79	-	-	4.42E-03	8.35E-03
PrePPI	BP	GO:0034249	negative regulation of amide metabolic process	-	34	15	-	-	5.20E-04	1.57E-03
PrePPI	BP	GO:0061548	ganglion development	-	17	11	-	-	3.90E-04	1.17E-03
PrePPI	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	68	-	-	3.91E-03	7.18E-03
PrePPI	BP	GO:0042832	defense response to protozoan	-	28	13	-	-	3.61E-02	1.44E-03
PrePPI	BP	GO:0048799	animal organ maturation	-	33	15	-	-	5.21E-04	1.57E-03
PrePPI	BP	GO:0006925	inflammatory cell apoptotic process	-	23	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:2000291	regulation of myoblast proliferation	-	25	13	-	-	3.89E-04	1.44E-03
PrePPI	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	113	-	-	4.63E-03	1.19E-02
PrePPI	BP	GO:1903035	negative regulation of response to wounding	-	93	53	-	-	9.62E-03	5.61E-03
PrePPI	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	20	-	-	6.48E-04	2.09E-03
PrePPI	BP	GO:0036010	protein localization to endosome	-	27	15	-	-	5.19E-04	1.57E-03
PrePPI	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	76	-	-	1.50E-02	7.96E-03
PrePPI	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	48	-	-	4.64E-03	5.09E-03
PrePPI	BP	GO:0045056	transcytosis	-	20	13	-	-	3.89E-04	1.44E-03
PrePPI	BP	GO:0009267	cellular response to starvation	-	170	96	-	-	9.99E-03	1.00E-02
PrePPI	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	43	-	-	1.88E-03	4.57E-03
PrePPI	CC	GO:0140239	postsynaptic endocytosis	-	23	15	-	-	5.19E-04	1.57E-03
PrePPI	BP	GO:0046931	pore complex assembly	-	21	12	-	-	3.91E-04	1.31E-03
PrePPI	CC	GO:0032008	positive regulation of TOR signaling	-	52	26	-	-	7.80E-04	2.74E-03
PrePPI	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	13	-	-	2.22E-02	1.44E-03
PrePPI	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0060428	lung epithelium development	-	43	27	-	-	8.45E-03	2.87E-03
PrePPI	BP	GO:0030431	sleep	-	30	21	-	-	7.27E-03	2.22E-03
PrePPI	BP	GO:1903318	negative regulation of protein maturation	-	29	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	13	-	-	1.00E-01	1.44E-03
PrePPI	BP	GO:0071732	cellular response to nitric oxide	-	17	13	-	-	3.89E-04	1.44E-03
PrePPI	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	48	-	-	4.61E-03	5.09E-03
PrePPI	BP	GO:0065004	protein-DNA complex assembly	-	307	162	-	-	1.48E-02	1.70E-02
PrePPI	CC	GO:0006406	mRNA export from nucleus	-	69	38	-	-	1.87E-02	4.05E-03
PrePPI	BP	GO:0009880	embryonic pattern specification	-	70	44	-	-	3.54E-03	4.70E-03
PrePPI	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	25	-	-	3.92E-02	2.61E-03
PrePPI	BP	GO:0002367	cytokine production involved in immune response	-	121	73	-	-	6.64E-03	7.70E-03
PrePPI	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	11	-	-	8.56E-03	1.17E-03
PrePPI	BP	GO:0044848	biological phase	-	211	109	-	-	6.81E-03	1.15E-02
PrePPI	BP	GO:0046660	female sex differentiation	-	125	81	-	-	5.79E-03	8.48E-03
PrePPI	BP	GO:0019693	ribose phosphate metabolic process	-	556	224	-	-	3.23E-02	2.35E-02
PrePPI	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	28	-	-	7.03E-03	3.00E-03
PrePPI	BP	GO:0060411	cardiac septum morphogenesis	-	72	56	-	-	8.14E-03	5.87E-03
PrePPI	BP	GO:0071248	cellular response to metal ion	-	201	110	-	-	5.18E-03	1.15E-02
PrePPI	BP	GO:0030308	negative regulation of cell growth	-	191	110	-	-	4.24E-03	1.15E-02
PrePPI	BP	GO:0097306	cellular response to alcohol	-	99	51	-	-	2.97E-03	5.35E-03
PrePPI	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	63	-	-	9.72E-03	6.66E-03
PrePPI	BP	GO:0010453	regulation of cell fate commitment	-	40	21	-	-	7.08E-03	2.22E-03
PrePPI	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	29	-	-	1.35E-03	3.13E-03
PrePPI	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	16	-	-	4.05E-02	1.70E-03
PrePPI	BP	GO:0002026	regulation of the force of heart contraction	-	26	20	-	-	5.95E-02	2.09E-03
PrePPI	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	14	-	-	3.90E-04	1.57E-03
PrePPI	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	12	-	-	2.26E-02	1.31E-03
PrePPI	BP	GO:0032890	regulation of organic acid transport	-	78	49	-	-	1.68E-03	5.22E-03
PrePPI	BP	GO:0071498	cellular response to fluid shear stress	-	21	17	-	-	5.17E-04	1.83E-03
PrePPI	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	67	-	-	3.92E-03	7.05E-03
PrePPI	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	17	-	-	5.19E-04	1.83E-03
PrePPI	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	34	-	-	9.00E-04	3.65E-03
PrePPI	BP	GO:0051259	protein complex oligomerization	-	251	113	-	-	1.91E-02	1.19E-02
PrePPI	BP	GO:0098743	cell aggregation	-	24	16	-	-	4.14E-03	1.70E-03
PrePPI	BP	GO:0009994	oocyte differentiation	-	57	32	-	-	3.02E-03	3.39E-03
PrePPI	MF	GO:0031952	regulation of protein autophosphorylation	-	43	31	-	-	9.06E-04	3.26E-03
PrePPI	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	97	-	-	5.36E-03	1.02E-02
PrePPI	BP	GO:0044319	"wound healing, spreading of cells"	-	37	25	-	-	7.77E-04	2.61E-03
PrePPI	BP	GO:0033688	regulation of osteoblast proliferation	-	31	18	-	-	5.19E-04	1.96E-03
PrePPI	BP	GO:0060251	regulation of glial cell proliferation	-	39	29	-	-	7.74E-04	3.13E-03
PrePPI	BP	GO:0072665	protein localization to vacuole	-	84	44	-	-	3.16E-03	4.70E-03
PrePPI	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	32	-	-	1.20E-03	3.39E-03
PrePPI	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	15	-	-	5.19E-04	1.57E-03
PrePPI	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	35	-	-	1.25E-02	3.65E-03
PrePPI	BP	GO:0042044	fluid transport	-	35	13	-	-	3.91E-04	1.44E-03
PrePPI	BP	GO:0070633	transepithelial transport	-	35	18	-	-	5.21E-04	1.96E-03
PrePPI	BP	GO:0045661	regulation of myoblast differentiation	-	74	45	-	-	1.29E-03	4.70E-03
PrePPI	BP	GO:0030307	positive regulation of cell growth	-	164	95	-	-	1.37E-02	9.92E-03
PrePPI	BP	GO:0034250	positive regulation of amide metabolic process	-	27	18	-	-	5.19E-04	1.96E-03
PrePPI	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	199	-	-	8.88E-03	2.09E-02
PrePPI	BP	GO:0014812	muscle cell migration	-	110	61	-	-	3.85E-03	6.40E-03
PrePPI	BP	GO:0048525	negative regulation of viral process	-	90	36	-	-	3.23E-03	3.78E-03
PrePPI	BP	GO:0072044	collecting duct development	-	16	12	-	-	4.45E-03	1.31E-03
PrePPI	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	37	-	-	6.00E-03	3.92E-03
PrePPI	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	91	-	-	1.72E-02	9.53E-03
PrePPI	BP	GO:0051781	positive regulation of cell division	-	93	66	-	-	4.48E-03	6.92E-03
PrePPI	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	13	-	-	3.07E-03	1.44E-03
PrePPI	BP	GO:0002696	positive regulation of leukocyte activation	-	358	230	-	-	1.48E-02	2.40E-02
PrePPI	BP	GO:0060711	labyrinthine layer development	-	47	36	-	-	4.45E-03	3.78E-03
PrePPI	BP	GO:0007272	ensheathment of neurons	-	146	82	-	-	5.51E-03	8.61E-03
PrePPI	CC	GO:0050806	positive regulation of synaptic transmission	-	171	97	-	-	4.57E-03	1.02E-02
PrePPI	BP	GO:0060021	roof of mouth development	-	91	64	-	-	4.51E-03	6.79E-03
PrePPI	BP	GO:0034504	protein localization to nucleus	-	312	201	-	-	9.50E-03	2.10E-02
PrePPI	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	29	-	-	6.61E-03	3.13E-03
PrePPI	BP	GO:0050819	negative regulation of coagulation	-	54	36	-	-	7.79E-03	3.78E-03
PrePPI	BP	GO:0031647	regulation of protein stability	-	327	184	-	-	1.06E-02	1.93E-02
PrePPI	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	36	-	-	1.26E-02	3.78E-03
PrePPI	CC	GO:0050805	negative regulation of synaptic transmission	-	55	40	-	-	8.22E-03	4.18E-03
PrePPI	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	24	-	-	2.30E-03	2.61E-03
PrePPI	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	64	-	-	3.55E-02	6.79E-03
PrePPI	BP	GO:0016054	organic acid catabolic process	-	251	69	-	-	2.16E-02	7.31E-03
PrePPI	BP	GO:0050890	cognition	-	317	190	-	-	8.59E-03	1.98E-02
PrePPI	BP	GO:1900048	positive regulation of hemostasis	-	28	19	-	-	9.44E-03	2.09E-03
PrePPI	BP	GO:0065005	protein-lipid complex assembly	-	29	16	-	-	5.20E-04	1.70E-03
PrePPI	BP	GO:0008033	tRNA processing	-	136	42	-	-	7.95E-02	4.44E-03
PrePPI	BP	GO:0046661	male sex differentiation	-	171	110	-	-	6.02E-03	1.15E-02
PrePPI	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	16	-	-	5.18E-04	1.70E-03
PrePPI	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	53	-	-	1.66E-03	5.61E-03
PrePPI	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	11	-	-	3.89E-04	1.17E-03
PrePPI	BP	GO:1990778	protein localization to cell periphery	-	346	201	-	-	6.71E-03	2.10E-02
PrePPI	BP	GO:0090713	immunological memory process	-	18	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0061326	renal tubule development	-	103	72	-	-	3.03E-03	7.57E-03
PrePPI	BP	GO:0051258	protein polymerization	-	280	172	-	-	8.10E-03	1.80E-02
PrePPI	BP	GO:0071985	multivesicular body sorting pathway	-	56	24	-	-	2.93E-03	2.61E-03
PrePPI	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	16	-	-	5.20E-04	1.70E-03
PrePPI	BP	GO:0060325	face morphogenesis	-	31	24	-	-	8.85E-03	2.61E-03
PrePPI	BP	GO:0090559	regulation of membrane permeability	-	72	29	-	-	7.76E-04	3.13E-03
PrePPI	BP	GO:0031579	membrane raft organization	-	25	14	-	-	3.90E-04	1.57E-03
PrePPI	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	18	-	-	1.24E-03	1.96E-03
PrePPI	BP	GO:0060033	anatomical structure regression	-	16	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:0046460	neutral lipid biosynthetic process	-	50	15	-	-	4.39E-03	1.57E-03
PrePPI	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	38	-	-	1.04E-03	4.05E-03
PrePPI	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	108	-	-	4.47E-03	1.14E-02
PrePPI	BP	GO:0002251	organ or tissue specific immune response	-	43	14	-	-	3.91E-04	1.57E-03
PrePPI	CC	GO:0048167	regulation of synaptic plasticity	-	210	129	-	-	1.37E-02	1.36E-02
PrePPI	BP	GO:1903708	positive regulation of hemopoiesis	-	184	120	-	-	4.79E-03	1.25E-02
PrePPI	BP	GO:1903008	organelle disassembly	-	154	88	-	-	4.14E-03	9.27E-03
PrePPI	BP	GO:0001709	cell fate determination	-	44	37	-	-	2.79E-03	3.92E-03
PrePPI	BP	GO:0051873	killing by host of symbiont cells	-	28	12	-	-	3.02E-02	1.31E-03
PrePPI	BP	GO:0045058	T cell selection	-	53	38	-	-	1.54E-03	4.05E-03
PrePPI	CC	GO:0032387	negative regulation of intracellular transport	-	51	32	-	-	4.68E-03	3.39E-03
PrePPI	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	13	-	-	2.29E-02	1.44E-03
PrePPI	BP	GO:0072091	regulation of stem cell proliferation	-	91	52	-	-	1.41E-03	5.48E-03
PrePPI	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	12	-	-	3.91E-04	1.31E-03
PrePPI	BP	GO:0099084	postsynaptic specialization organization	-	44	32	-	-	7.50E-03	3.39E-03
PrePPI	BP	GO:0060384	innervation	-	27	20	-	-	6.50E-04	2.09E-03
PrePPI	BP	GO:0032535	regulation of cellular component size	-	360	218	-	-	8.60E-03	2.28E-02
PrePPI	MF	GO:0031281	positive regulation of cyclase activity	-	40	27	-	-	2.32E-03	2.87E-03
PrePPI	MF	GO:0098631	cell adhesion mediator activity	-	64	38	-	-	5.32E-03	4.05E-03
PrePPI	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:0071453	cellular response to oxygen levels	-	168	96	-	-	3.42E-03	1.00E-02
PrePPI	BP	GO:0090399	replicative senescence	-	17	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:0031342	negative regulation of cell killing	-	29	17	-	-	5.20E-04	1.83E-03
PrePPI	BP	GO:0070585	protein localization to mitochondrion	-	125	70	-	-	1.40E-02	7.31E-03
PrePPI	BP	GO:0010623	programmed cell death involved in cell development	-	25	18	-	-	5.19E-04	1.96E-03
PrePPI	BP	GO:0044242	cellular lipid catabolic process	-	224	79	-	-	3.17E-02	8.35E-03
PrePPI	BP	GO:0002931	response to ischemia	-	58	41	-	-	2.46E-03	4.31E-03
PrePPI	BP	GO:0043062	extracellular structure organization	-	317	159	-	-	1.74E-02	1.67E-02
PrePPI	BP	GO:0014047	glutamate secretion	-	25	19	-	-	5.20E-04	2.09E-03
PrePPI	BP	GO:0061005	cell differentiation involved in kidney development	-	58	43	-	-	1.67E-03	4.57E-03
PrePPI	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	47	-	-	1.29E-03	4.96E-03
PrePPI	BP	GO:0060420	regulation of heart growth	-	74	43	-	-	1.16E-03	4.57E-03
PrePPI	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0009755	hormone-mediated signaling pathway	-	221	146	-	-	1.17E-02	1.53E-02
PrePPI	BP	GO:0022612	gland morphogenesis	-	124	94	-	-	6.52E-03	9.92E-03
PrePPI	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	20	-	-	6.50E-04	2.09E-03
PrePPI	MF	GO:0140416	transcription regulator inhibitor activity	-	26	13	-	-	3.91E-04	1.44E-03
PrePPI	BP	GO:0044782	cilium organization	-	400	155	-	-	5.40E-03	1.62E-02
PrePPI	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	13	-	-	3.91E-04	1.44E-03
PrePPI	BP	GO:0048935	peripheral nervous system neuron development	-	15	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0090130	tissue migration	-	379	223	-	-	1.13E-02	2.34E-02
PrePPI	BP	GO:1990845	adaptive thermogenesis	-	166	91	-	-	4.25E-03	9.53E-03
PrePPI	BP	GO:0071320	cellular response to cAMP	-	54	27	-	-	7.78E-04	2.87E-03
PrePPI	BP	GO:0015844	monoamine transport	-	88	59	-	-	4.00E-03	6.26E-03
PrePPI	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:0060039	pericardium development	-	19	16	-	-	4.73E-03	1.70E-03
PrePPI	BP	GO:0071392	cellular response to estradiol stimulus	-	40	26	-	-	7.76E-04	2.74E-03
PrePPI	BP	GO:0009451	RNA modification	-	169	56	-	-	3.56E-02	5.87E-03
PrePPI	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	26	-	-	7.76E-04	2.74E-03
PrePPI	BP	GO:1903729	regulation of plasma membrane organization	-	17	14	-	-	3.89E-04	1.57E-03
PrePPI	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	67	-	-	6.40E-03	7.05E-03
PrePPI	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	30	-	-	9.04E-04	3.13E-03
PrePPI	BP	GO:0015807	L-amino acid transport	-	94	30	-	-	1.06E-02	3.13E-03
PrePPI	BP	GO:0032941	secretion by tissue	-	85	50	-	-	3.02E-03	5.22E-03
PrePPI	BP	GO:0046605	regulation of centrosome cycle	-	54	27	-	-	7.77E-04	2.87E-03
PrePPI	BP	GO:0048753	pigment granule organization	-	40	20	-	-	6.49E-04	2.09E-03
PrePPI	BP	GO:0021516	dorsal spinal cord development	-	20	16	-	-	1.38E-02	1.70E-03
PrePPI	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	12	-	-	3.91E-04	1.31E-03
PrePPI	BP	GO:0003014	renal system process	-	130	72	-	-	4.98E-03	7.57E-03
PrePPI	CC	GO:0070286	axonemal dynein complex assembly	-	40	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0045598	regulation of fat cell differentiation	-	148	80	-	-	4.02E-03	8.35E-03
PrePPI	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	115	-	-	4.78E-03	1.20E-02
PrePPI	BP	GO:1904646	cellular response to amyloid-beta	-	44	29	-	-	1.37E-03	3.13E-03
PrePPI	BP	GO:1901863	positive regulation of muscle tissue development	-	24	17	-	-	5.18E-04	1.83E-03
PrePPI	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	131	-	-	3.59E-02	1.37E-02
PrePPI	BP	GO:0008340	determination of adult lifespan	-	23	15	-	-	5.19E-04	1.57E-03
PrePPI	BP	GO:0039694	viral RNA genome replication	-	30	15	-	-	5.21E-04	1.57E-03
PrePPI	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	18	-	-	5.18E-04	1.96E-03
PrePPI	BP	GO:0071709	membrane assembly	-	68	34	-	-	1.24E-02	3.65E-03
PrePPI	BP	GO:0008217	regulation of blood pressure	-	186	113	-	-	8.32E-03	1.19E-02
PrePPI	BP	GO:0031643	positive regulation of myelination	-	19	13	-	-	3.90E-04	1.44E-03
PrePPI	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	38	-	-	2.86E-03	4.05E-03
PrePPI	CC	GO:0042770	signal transduction in response to DNA damage	-	186	124	-	-	6.77E-03	1.31E-02
PrePPI	BP	GO:0002200	somatic diversification of immune receptors	-	78	52	-	-	1.16E-02	5.48E-03
PrePPI	BP	GO:0035315	hair cell differentiation	-	52	34	-	-	2.20E-03	3.65E-03
PrePPI	BP	GO:0048645	animal organ formation	-	62	52	-	-	2.06E-03	5.48E-03
PrePPI	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	92	-	-	5.28E-03	9.66E-03
PrePPI	BP	GO:0033627	cell adhesion mediated by integrin	-	87	59	-	-	1.01E-02	6.26E-03
PrePPI	BP	GO:0035107	appendage morphogenesis	-	147	109	-	-	7.36E-03	1.15E-02
PrePPI	BP	GO:1903707	negative regulation of hemopoiesis	-	116	68	-	-	2.81E-03	7.18E-03
PrePPI	BP	GO:0036342	post-anal tail morphogenesis	-	19	13	-	-	3.90E-04	1.44E-03
PrePPI	CC	GO:0048208	COPII vesicle coating	-	27	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:0030149	sphingolipid catabolic process	-	32	12	-	-	6.31E-02	1.31E-03
PrePPI	BP	GO:0050994	regulation of lipid catabolic process	-	61	37	-	-	9.18E-03	3.92E-03
PrePPI	BP	GO:0035988	chondrocyte proliferation	-	24	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	20	-	-	6.49E-04	2.09E-03
PrePPI	BP	GO:0045727	positive regulation of translation	-	141	80	-	-	1.04E-02	8.35E-03
PrePPI	CC	GO:0032388	positive regulation of intracellular transport	-	137	89	-	-	3.32E-03	9.40E-03
PrePPI	BP	GO:0021979	hypothalamus cell differentiation	-	13	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0002027	regulation of heart rate	-	106	56	-	-	5.13E-03	5.87E-03
PrePPI	BP	GO:0050879	multicellular organismal movement	-	118	74	-	-	2.91E-02	7.83E-03
PrePPI	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	44	-	-	1.16E-03	4.70E-03
PrePPI	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	43	-	-	4.94E-03	4.57E-03
PrePPI	BP	GO:0048515	spermatid differentiation	-	208	73	-	-	4.19E-03	7.70E-03
PrePPI	BP	GO:0072132	mesenchyme morphogenesis	-	57	48	-	-	1.69E-03	5.09E-03
PrePPI	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	20	-	-	6.47E-04	2.09E-03
PrePPI	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	19	-	-	2.09E-03	2.09E-03
PrePPI	BP	GO:0060119	inner ear receptor cell development	-	44	22	-	-	6.49E-04	2.35E-03
PrePPI	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	16	-	-	5.87E-02	1.70E-03
PrePPI	BP	GO:1901983	regulation of protein acetylation	-	26	17	-	-	3.86E-03	1.83E-03
PrePPI	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	172	-	-	6.88E-03	1.80E-02
PrePPI	BP	GO:1900006	positive regulation of dendrite development	-	17	13	-	-	3.91E-04	1.44E-03
PrePPI	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	25	-	-	7.78E-04	2.61E-03
PrePPI	BP	GO:0010883	regulation of lipid storage	-	53	31	-	-	3.29E-03	3.26E-03
PrePPI	BP	GO:0072170	metanephric tubule development	-	26	17	-	-	5.19E-04	1.83E-03
PrePPI	BP	GO:0007635	chemosensory behavior	-	20	14	-	-	3.91E-04	1.57E-03
PrePPI	BP	GO:1905954	positive regulation of lipid localization	-	110	57	-	-	3.27E-03	6.00E-03
PrePPI	BP	GO:0002209	behavioral defense response	-	39	25	-	-	7.78E-04	2.61E-03
PrePPI	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	13	-	-	8.06E-03	1.44E-03
PrePPI	BP	GO:0072523	purine-containing compound catabolic process	-	146	74	-	-	8.21E-03	7.83E-03
PrePPI	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	24	-	-	6.47E-04	2.61E-03
PrePPI	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	20	-	-	6.48E-04	2.09E-03
PrePPI	BP	GO:0021535	cell migration in hindbrain	-	16	13	-	-	3.91E-04	1.44E-03
PrePPI	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	52	-	-	8.14E-03	5.48E-03
PrePPI	BP	GO:0007218	neuropeptide signaling pathway	-	113	47	-	-	2.20E-02	4.96E-03
PrePPI	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	109	-	-	1.15E-02	1.15E-02
PrePPI	BP	GO:0031345	negative regulation of cell projection organization	-	195	116	-	-	4.47E-03	1.21E-02
PrePPI	BP	GO:0048278	vesicle docking	-	64	44	-	-	5.60E-03	4.70E-03
PrePPI	BP	GO:0035050	embryonic heart tube development	-	86	57	-	-	5.00E-03	6.00E-03
PrePPI	BP	GO:0030168	platelet activation	-	135	89	-	-	4.83E-03	9.40E-03
PrePPI	CC	GO:0098810	neurotransmitter reuptake	-	35	18	-	-	5.19E-04	1.96E-03
PrePPI	BP	GO:0008213	protein alkylation	-	58	24	-	-	1.86E-02	2.61E-03
PrePPI	BP	GO:0031338	regulation of vesicle fusion	-	24	20	-	-	6.50E-04	2.09E-03
PrePPI	BP	GO:0031529	ruffle organization	-	55	33	-	-	9.03E-04	3.52E-03
PrePPI	BP	GO:0010842	retina layer formation	-	25	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	39	-	-	1.36E-02	4.18E-03
PrePPI	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	32	-	-	4.68E-03	3.39E-03
PrePPI	MF	GO:0170055	lipid transmembrane transporter activity	-	56	15	-	-	3.27E-02	1.57E-03
PrePPI	BP	GO:0035304	regulation of protein dephosphorylation	-	87	50	-	-	2.82E-03	5.22E-03
PrePPI	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	146	-	-	6.77E-03	1.53E-02
PrePPI	BP	GO:0099637	neurotransmitter receptor transport	-	26	16	-	-	5.20E-04	1.70E-03
PrePPI	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	24	-	-	3.73E-03	2.61E-03
PrePPI	BP	GO:0051785	positive regulation of nuclear division	-	61	48	-	-	3.01E-03	5.09E-03
PrePPI	BP	GO:0060749	mammary gland alveolus development	-	20	16	-	-	5.19E-04	1.70E-03
PrePPI	BP	GO:0044786	cell cycle DNA replication	-	45	26	-	-	2.55E-03	2.74E-03
PrePPI	BP	GO:0044539	long-chain fatty acid import into cell	-	17	12	-	-	1.72E-02	1.31E-03
PrePPI	BP	GO:0048145	regulation of fibroblast proliferation	-	87	59	-	-	2.14E-03	6.26E-03
PrePPI	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	40	-	-	7.43E-02	4.18E-03
PrePPI	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	143	-	-	5.13E-03	1.50E-02
PrePPI	BP	GO:0009306	protein secretion	-	376	211	-	-	1.26E-02	2.21E-02
PrePPI	CC	GO:0008333	endosome to lysosome transport	-	73	38	-	-	1.04E-03	4.05E-03
PrePPI	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	15	-	-	5.20E-04	1.57E-03
PrePPI	BP	GO:0003016	respiratory system process	-	39	26	-	-	7.75E-04	2.74E-03
PrePPI	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	13	-	-	3.91E-04	1.44E-03
PrePPI	BP	GO:0045732	positive regulation of protein catabolic process	-	202	136	-	-	5.01E-03	1.42E-02
PrePPI	BP	GO:0031589	cell-substrate adhesion	-	360	223	-	-	1.63E-02	2.34E-02
PrePPI	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	21	-	-	1.81E-02	2.22E-03
PrePPI	BP	GO:0007588	excretion	-	40	28	-	-	7.79E-04	3.00E-03
PrePPI	BP	GO:1904018	positive regulation of vasculature development	-	185	106	-	-	6.20E-03	1.11E-02
PrePPI	BP	GO:0010948	negative regulation of cell cycle process	-	317	193	-	-	9.90E-03	2.02E-02
PrePPI	BP	GO:0050953	sensory perception of light stimulus	-	223	103	-	-	7.32E-03	1.08E-02
PrePPI	BP	GO:0009303	rRNA transcription	-	37	19	-	-	1.30E-02	2.09E-03
PrePPI	BP	GO:0035601	protein deacylation	-	56	33	-	-	1.32E-03	3.52E-03
PrePPI	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	13	-	-	3.89E-04	1.44E-03
PrePPI	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	20	-	-	6.48E-04	2.09E-03
PrePPI	BP	GO:0071300	cellular response to retinoic acid	-	66	46	-	-	4.59E-03	4.83E-03
PrePPI	BP	GO:0045830	positive regulation of isotype switching	-	28	17	-	-	2.59E-02	1.83E-03
PrePPI	BP	GO:0031069	hair follicle morphogenesis	-	33	21	-	-	6.48E-04	2.22E-03
PrePPI	BP	GO:0046697	decidualization	-	26	20	-	-	6.49E-04	2.09E-03
PrePPI	BP	GO:0008212	mineralocorticoid metabolic process	-	14	12	-	-	3.91E-04	1.31E-03
PrePPI	BP	GO:0051588	regulation of neurotransmitter transport	-	99	64	-	-	2.27E-02	6.79E-03
PrePPI	BP	GO:0051784	negative regulation of nuclear division	-	63	42	-	-	3.82E-03	4.44E-03
PrePPI	BP	GO:0044703	multi-organism reproductive process	-	209	124	-	-	7.53E-03	1.31E-02
PrePPI	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	88	-	-	5.44E-03	9.27E-03
PrePPI	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	34	-	-	1.08E-02	3.65E-03
PrePPI	BP	GO:0099022	vesicle tethering	-	32	12	-	-	3.91E-04	1.31E-03
PrePPI	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	22	-	-	6.51E-04	2.35E-03
PrePPI	BP	GO:0048857	neural nucleus development	-	65	39	-	-	1.02E-03	4.18E-03
PrePPI	BP	GO:0048663	neuron fate commitment	-	74	54	-	-	3.15E-03	5.74E-03
PrePPI	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	100	-	-	1.46E-02	1.04E-02
PrePPI	BP	GO:0106027	neuron projection organization	-	90	60	-	-	1.83E-03	6.26E-03
PrePPI	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	80	-	-	2.86E-03	8.35E-03
PrePPI	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	28	-	-	4.51E-03	3.00E-03
PrePPI	BP	GO:0045685	regulation of glial cell differentiation	-	77	52	-	-	5.78E-03	5.48E-03
PrePPI	BP	GO:0043414	macromolecule methylation	-	138	55	-	-	6.25E-03	5.74E-03
PrePPI	BP	GO:0050886	endocrine process	-	93	58	-	-	3.08E-03	6.13E-03
PrePPI	BP	GO:0050951	sensory perception of temperature stimulus	-	28	16	-	-	5.84E-03	1.70E-03
PrePPI	BP	GO:0045807	positive regulation of endocytosis	-	155	105	-	-	5.65E-03	1.10E-02
PrePPI	BP	GO:0002418	immune response to tumor cell	-	29	14	-	-	3.90E-04	1.57E-03
PrePPI	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	40	-	-	1.16E-03	4.18E-03
PrePPI	BP	GO:0048308	organelle inheritance	-	14	11	-	-	3.87E-04	1.17E-03
PrePPI	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	14	-	-	7.51E-03	1.57E-03
PrePPI	BP	GO:0001829	trophectodermal cell differentiation	-	19	14	-	-	3.90E-04	1.57E-03
PrePPI	BP	GO:0034394	protein localization to cell surface	-	69	39	-	-	1.94E-03	4.18E-03
PrePPI	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	15	-	-	5.21E-04	1.57E-03
PrePPI	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	17	-	-	5.19E-04	1.83E-03
PrePPI	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	72	-	-	5.91E-03	7.57E-03
PrePPI	MF	GO:0051100	negative regulation of binding	-	161	111	-	-	4.54E-03	1.16E-02
PrePPI	BP	GO:0001818	negative regulation of cytokine production	-	379	156	-	-	1.62E-02	1.63E-02
PrePPI	BP	GO:0003151	outflow tract morphogenesis	-	81	61	-	-	5.53E-03	6.40E-03
PrePPI	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	40	-	-	2.48E-03	4.18E-03
PrePPI	BP	GO:0055093	response to hyperoxia	-	20	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:0061036	positive regulation of cartilage development	-	33	22	-	-	6.48E-04	2.35E-03
PrePPI	BP	GO:0046184	aldehyde biosynthetic process	-	16	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	26	-	-	4.11E-03	2.74E-03
PrePPI	BP	GO:0046621	negative regulation of organ growth	-	39	21	-	-	4.34E-03	2.22E-03
PrePPI	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	22	-	-	1.27E-02	2.35E-03
PrePPI	BP	GO:0032368	regulation of lipid transport	-	149	76	-	-	2.56E-03	7.96E-03
PrePPI	BP	GO:0055094	response to lipoprotein particle	-	34	21	-	-	2.19E-03	2.22E-03
PrePPI	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	130	-	-	5.41E-03	1.36E-02
PrePPI	BP	GO:0033002	muscle cell proliferation	-	249	149	-	-	5.78E-03	1.57E-02
PrePPI	BP	GO:0048880	sensory system development	-	399	242	-	-	1.34E-02	2.53E-02
PrePPI	BP	GO:0043331	response to dsRNA	-	56	22	-	-	6.47E-04	2.35E-03
PrePPI	BP	GO:0051904	pigment granule transport	-	23	15	-	-	5.20E-04	1.57E-03
PrePPI	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	23	-	-	6.48E-04	2.48E-03
PrePPI	BP	GO:0033363	secretory granule organization	-	63	28	-	-	8.69E-03	3.00E-03
PrePPI	BP	GO:0060479	lung cell differentiation	-	28	17	-	-	1.55E-02	1.83E-03
PrePPI	BP	GO:0120009	intermembrane lipid transfer	-	52	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	33	-	-	1.66E-03	3.52E-03
PrePPI	BP	GO:0033622	integrin activation	-	26	19	-	-	1.68E-03	2.09E-03
PrePPI	BP	GO:2000773	negative regulation of cellular senescence	-	25	16	-	-	5.18E-04	1.70E-03
PrePPI	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	38	-	-	4.11E-03	4.05E-03
PrePPI	BP	GO:0050820	positive regulation of coagulation	-	30	21	-	-	6.32E-03	2.22E-03
PrePPI	BP	GO:0072164	mesonephric tubule development	-	98	78	-	-	5.39E-03	8.22E-03
PrePPI	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	12	-	-	3.91E-04	1.31E-03
PrePPI	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	72	-	-	4.30E-03	7.57E-03
PrePPI	BP	GO:1903524	positive regulation of blood circulation	-	39	24	-	-	6.48E-04	2.61E-03
PrePPI	BP	GO:0030901	midbrain development	-	87	55	-	-	2.02E-03	5.74E-03
PrePPI	BP	GO:0048485	sympathetic nervous system development	-	22	17	-	-	1.71E-02	1.83E-03
PrePPI	BP	GO:0007162	negative regulation of cell adhesion	-	310	179	-	-	6.75E-03	1.88E-02
PrePPI	BP	GO:0048532	anatomical structure arrangement	-	16	14	-	-	4.81E-03	1.57E-03
PrePPI	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	41	-	-	3.16E-03	4.31E-03
PrePPI	BP	GO:0002687	positive regulation of leukocyte migration	-	147	95	-	-	7.19E-03	9.92E-03
PrePPI	BP	GO:0034605	cellular response to heat	-	66	45	-	-	2.71E-03	4.70E-03
PrePPI	BP	GO:0005996	monosaccharide metabolic process	-	250	119	-	-	9.27E-03	1.25E-02
PrePPI	BP	GO:0033555	multicellular organismal response to stress	-	90	55	-	-	4.07E-03	5.74E-03
PrePPI	BP	GO:0002262	myeloid cell homeostasis	-	172	109	-	-	4.34E-03	1.15E-02
PrePPI	BP	GO:0000966	RNA 5'-end processing	-	39	22	-	-	6.51E-04	2.35E-03
PrePPI	BP	GO:0050688	regulation of defense response to virus	-	65	28	-	-	5.87E-03	3.00E-03
PrePPI	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	190	-	-	1.33E-02	1.98E-02
PrePPI	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	14	-	-	3.91E-04	1.57E-03
PrePPI	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	149	-	-	7.08E-03	1.57E-02
PrePPI	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	27	-	-	7.74E-04	2.87E-03
PrePPI	BP	GO:0061029	eyelid development in camera-type eye	-	14	11	-	-	3.89E-04	1.17E-03
PrePPI	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	23	-	-	1.50E-03	2.48E-03
PrePPI	BP	GO:0003272	endocardial cushion formation	-	28	26	-	-	7.76E-04	2.74E-03
PrePPI	BP	GO:0022618	protein-RNA complex assembly	-	227	123	-	-	2.00E-02	1.29E-02
PrePPI	BP	GO:0051147	regulation of muscle cell differentiation	-	162	87	-	-	2.96E-03	9.14E-03
PrePPI	BP	GO:0006066	alcohol metabolic process	-	374	144	-	-	2.31E-02	1.51E-02
PrePPI	BP	GO:0090102	cochlea development	-	50	34	-	-	2.14E-03	3.65E-03
PrePPI	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	24	-	-	6.48E-04	2.61E-03
PrePPI	BP	GO:0045933	positive regulation of muscle contraction	-	49	32	-	-	9.08E-04	3.39E-03
PrePPI	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	21	-	-	2.40E-03	2.22E-03
PrePPI	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	44	-	-	1.22E-01	4.70E-03
PrePPI	BP	GO:0043555	regulation of translation in response to stress	-	22	16	-	-	8.93E-03	1.70E-03
PrePPI	BP	GO:0032922	circadian regulation of gene expression	-	71	47	-	-	5.74E-03	4.96E-03
PrePPI	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	39	-	-	1.92E-03	4.18E-03
PrePPI	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	16	-	-	5.21E-04	1.70E-03
PrePPI	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	40	-	-	1.81E-03	4.18E-03
PrePPI	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	3.88E-04	1.17E-03
PrePPI	BP	GO:0038179	neurotrophin signaling pathway	-	38	30	-	-	1.16E-02	3.13E-03
PrePPI	BP	GO:0140253	cell-cell fusion	-	62	37	-	-	4.19E-03	3.92E-03
PrePPI	BP	GO:0071599	otic vesicle development	-	15	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	28	-	-	8.18E-03	3.00E-03
PrePPI	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	21	-	-	7.22E-02	2.22E-03
PrePPI	BP	GO:0001941	postsynaptic membrane organization	-	37	23	-	-	1.80E-02	2.48E-03
PrePPI	BP	GO:0051293	establishment of spindle localization	-	57	39	-	-	1.04E-03	4.18E-03
PrePPI	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	4.91E-03	1.44E-03
PrePPI	BP	GO:0043114	regulation of vascular permeability	-	49	32	-	-	9.06E-04	3.39E-03
PrePPI	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	45	-	-	1.84E-03	4.70E-03
PrePPI	BP	GO:0008360	regulation of cell shape	-	139	93	-	-	7.44E-03	9.79E-03
PrePPI	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0051222	positive regulation of protein transport	-	249	153	-	-	5.97E-03	1.61E-02
PrePPI	CC	GO:0140632	canonical inflammasome complex assembly	-	40	19	-	-	5.19E-04	2.09E-03
PrePPI	MF	GO:0034260	negative regulation of GTPase activity	-	36	22	-	-	1.80E-03	2.35E-03
PrePPI	BP	GO:0045932	negative regulation of muscle contraction	-	24	16	-	-	5.20E-04	1.70E-03
PrePPI	BP	GO:0045739	positive regulation of DNA repair	-	128	70	-	-	5.94E-03	7.31E-03
PrePPI	BP	GO:0001845	phagolysosome assembly	-	19	12	-	-	3.91E-04	1.31E-03
PrePPI	BP	GO:0045185	maintenance of protein location	-	95	52	-	-	3.54E-03	5.48E-03
PrePPI	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0003158	endothelium development	-	140	82	-	-	2.63E-03	8.61E-03
PrePPI	CC	GO:0072595	maintenance of protein localization in organelle	-	42	25	-	-	7.77E-04	2.61E-03
PrePPI	BP	GO:0051224	negative regulation of protein transport	-	122	65	-	-	2.34E-03	6.79E-03
PrePPI	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	106	-	-	5.44E-03	1.11E-02
PrePPI	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	27	-	-	7.75E-04	2.87E-03
PrePPI	MF	GO:0003713	transcription coactivator activity	-	281	164	-	-	8.17E-03	1.72E-02
PrePPI	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	12	-	-	5.99E-02	1.31E-03
PrePPI	BP	GO:0021885	forebrain cell migration	-	63	44	-	-	1.63E-03	4.70E-03
PrePPI	BP	GO:0007405	neuroblast proliferation	-	81	56	-	-	2.06E-03	5.87E-03
PrePPI	BP	GO:0009581	detection of external stimulus	-	137	66	-	-	3.77E-03	6.92E-03
PrePPI	BP	GO:1990542	mitochondrial transmembrane transport	-	93	22	-	-	2.17E-02	2.35E-03
PrePPI	BP	GO:0045862	positive regulation of proteolysis	-	353	208	-	-	6.86E-03	2.18E-02
PrePPI	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	21	-	-	1.95E-03	2.22E-03
PrePPI	BP	GO:0031128	developmental induction	-	26	22	-	-	6.47E-04	2.35E-03
PrePPI	BP	GO:0031100	animal organ regeneration	-	66	44	-	-	3.85E-03	4.70E-03
PrePPI	BP	GO:0021533	cell differentiation in hindbrain	-	23	17	-	-	5.20E-04	1.83E-03
PrePPI	BP	GO:0045684	positive regulation of epidermis development	-	33	20	-	-	6.45E-04	2.09E-03
PrePPI	BP	GO:1900047	negative regulation of hemostasis	-	51	34	-	-	1.37E-02	3.65E-03
PrePPI	BP	GO:0021517	ventral spinal cord development	-	47	30	-	-	9.08E-04	3.13E-03
PrePPI	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	56	-	-	1.89E-03	5.87E-03
PrePPI	BP	GO:0097722	sperm motility	-	133	32	-	-	9.11E-04	3.39E-03
PrePPI	BP	GO:0051231	spindle elongation	-	14	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:0042490	mechanoreceptor differentiation	-	67	38	-	-	2.36E-03	4.05E-03
PrePPI	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	19	-	-	5.19E-04	2.09E-03
PrePPI	BP	GO:0035148	tube formation	-	155	112	-	-	3.39E-03	1.17E-02
PrePPI	BP	GO:0048520	positive regulation of behavior	-	27	13	-	-	3.90E-04	1.44E-03
PrePPI	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	34	-	-	9.04E-04	3.65E-03
PrePPI	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	74	-	-	2.84E-03	7.83E-03
PrePPI	BP	GO:0031123	RNA 3'-end processing	-	79	42	-	-	1.08E-02	4.44E-03
PrePPI	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	63	-	-	5.19E-03	6.66E-03
PrePPI	CC	GO:0007097	nuclear migration	-	24	15	-	-	6.81E-03	1.57E-03
PrePPI	BP	GO:0045229	external encapsulating structure organization	-	319	160	-	-	2.08E-02	1.67E-02
PrePPI	BP	GO:0006885	regulation of pH	-	104	38	-	-	1.74E-03	4.05E-03
PrePPI	BP	GO:0002467	germinal center formation	-	14	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:1990840	response to lectin	-	22	16	-	-	1.37E-03	1.70E-03
PrePPI	BP	GO:0071800	podosome assembly	-	19	15	-	-	5.19E-04	1.57E-03
PrePPI	BP	GO:0031018	endocrine pancreas development	-	47	36	-	-	2.38E-03	3.78E-03
PrePPI	BP	GO:0001708	cell fate specification	-	108	80	-	-	4.14E-03	8.35E-03
PrePPI	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	50	-	-	5.10E-03	5.22E-03
PrePPI	BP	GO:0030279	negative regulation of ossification	-	39	18	-	-	5.18E-04	1.96E-03
PrePPI	BP	GO:0032970	regulation of actin filament-based process	-	368	225	-	-	9.75E-03	2.35E-02
PrePPI	BP	GO:0042440	pigment metabolic process	-	80	31	-	-	9.10E-04	3.26E-03
PrePPI	BP	GO:1901606	alpha-amino acid catabolic process	-	101	26	-	-	7.17E-02	2.74E-03
PrePPI	BP	GO:0062197	cellular response to chemical stress	-	299	175	-	-	6.30E-03	1.83E-02
PrePPI	BP	GO:1901890	positive regulation of cell junction assembly	-	106	69	-	-	1.10E-02	7.31E-03
PrePPI	BP	GO:1901655	cellular response to ketone	-	107	60	-	-	1.66E-03	6.26E-03
PrePPI	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0006968	cellular defense response	-	52	26	-	-	1.42E-02	2.74E-03
PrePPI	BP	GO:0055006	cardiac cell development	-	93	63	-	-	2.73E-03	6.66E-03
PrePPI	BP	GO:0031365	N-terminal protein amino acid modification	-	30	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	17	-	-	5.18E-04	1.83E-03
PrePPI	BP	GO:0060004	reflex	-	63	39	-	-	3.72E-03	4.18E-03
PrePPI	BP	GO:0044706	multi-multicellular organism process	-	217	125	-	-	6.23E-03	1.31E-02
PrePPI	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	82	-	-	3.30E-03	8.61E-03
PrePPI	BP	GO:0031294	lymphocyte costimulation	-	47	33	-	-	6.45E-03	3.52E-03
PrePPI	BP	GO:0050768	negative regulation of neurogenesis	-	150	95	-	-	3.72E-03	9.92E-03
PrePPI	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	58	-	-	3.57E-03	6.13E-03
PrePPI	BP	GO:0090068	positive regulation of cell cycle process	-	262	169	-	-	6.79E-03	1.77E-02
PrePPI	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	20	-	-	6.49E-04	2.09E-03
PrePPI	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	16	-	-	3.60E-02	1.70E-03
PrePPI	BP	GO:1902115	regulation of organelle assembly	-	210	119	-	-	5.27E-03	1.25E-02
PrePPI	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	48	-	-	2.92E-03	5.09E-03
PrePPI	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	84	-	-	3.51E-03	8.87E-03
PrePPI	BP	GO:0046622	positive regulation of organ growth	-	52	31	-	-	2.17E-03	3.26E-03
PrePPI	BP	GO:0051952	regulation of amine transport	-	98	61	-	-	7.11E-03	6.40E-03
PrePPI	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	11	-	-	1.10E-02	1.17E-03
PrePPI	BP	GO:0040019	positive regulation of embryonic development	-	23	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0097154	GABAergic neuron differentiation	-	20	17	-	-	5.19E-04	1.83E-03
PrePPI	CC	GO:0032365	intracellular lipid transport	-	51	17	-	-	5.21E-04	1.83E-03
PrePPI	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	34	-	-	2.41E-03	3.65E-03
PrePPI	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	72	-	-	2.95E-03	7.57E-03
PrePPI	BP	GO:0018149	peptide cross-linking	-	28	12	-	-	3.91E-04	1.31E-03
PrePPI	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	18	-	-	5.17E-04	1.96E-03
PrePPI	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	3.90E-04	1.44E-03
PrePPI	BP	GO:0071398	cellular response to fatty acid	-	35	19	-	-	5.18E-04	2.09E-03
PrePPI	BP	GO:0097581	lamellipodium organization	-	91	58	-	-	3.01E-03	6.13E-03
PrePPI	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	83	-	-	2.64E-02	8.74E-03
PrePPI	BP	GO:0060326	cell chemotaxis	-	311	166	-	-	9.43E-03	1.74E-02
PrePPI	BP	GO:1903975	regulation of glial cell migration	-	20	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	13	-	-	8.06E-03	1.44E-03
PrePPI	BP	GO:0016485	protein processing	-	248	130	-	-	4.16E-03	1.36E-02
PrePPI	BP	GO:0009649	entrainment of circadian clock	-	30	17	-	-	5.20E-04	1.83E-03
PrePPI	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	110	-	-	9.78E-03	1.15E-02
PrePPI	BP	GO:1903523	negative regulation of blood circulation	-	27	16	-	-	5.19E-04	1.70E-03
PrePPI	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	58	-	-	7.77E-03	6.13E-03
PrePPI	BP	GO:0099054	presynapse assembly	-	49	26	-	-	7.78E-04	2.74E-03
PrePPI	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	19	-	-	5.20E-04	2.09E-03
PrePPI	BP	GO:0006517	protein deglycosylation	-	26	14	-	-	3.91E-04	1.57E-03
PrePPI	BP	GO:0031348	negative regulation of defense response	-	282	137	-	-	6.88E-03	1.44E-02
PrePPI	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	49	-	-	1.65E-03	5.22E-03
PrePPI	BP	GO:0061180	mammary gland epithelium development	-	68	55	-	-	2.23E-02	5.74E-03
PrePPI	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	239	-	-	1.87E-02	2.51E-02
PrePPI	CC	GO:0051169	nuclear transport	-	325	206	-	-	1.35E-02	2.15E-02
PrePPI	BP	GO:0071496	cellular response to external stimulus	-	74	49	-	-	1.54E-03	5.22E-03
PrePPI	BP	GO:0042753	positive regulation of circadian rhythm	-	18	15	-	-	5.20E-04	1.57E-03
PrePPI	BP	GO:0032094	response to food	-	37	20	-	-	6.50E-04	2.09E-03
PrePPI	BP	GO:0001964	startle response	-	27	21	-	-	6.19E-03	2.22E-03
PrePPI	BP	GO:0007340	acrosome reaction	-	38	18	-	-	5.20E-04	1.96E-03
PrePPI	BP	GO:0046434	organophosphate catabolic process	-	232	103	-	-	6.42E-03	1.08E-02
PrePPI	BP	GO:0060037	pharyngeal system development	-	29	25	-	-	1.89E-03	2.61E-03
PrePPI	BP	GO:0009566	fertilization	-	205	84	-	-	4.99E-03	8.87E-03
PrePPI	BP	GO:0120255	olefinic compound biosynthetic process	-	24	15	-	-	5.21E-04	1.57E-03
PrePPI	BP	GO:0045907	positive regulation of vasoconstriction	-	30	17	-	-	3.17E-03	1.83E-03
PrePPI	BP	GO:0033044	regulation of chromosome organization	-	249	168	-	-	6.89E-03	1.76E-02
PrePPI	BP	GO:0009309	amine biosynthetic process	-	38	17	-	-	5.21E-04	1.83E-03
PrePPI	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	201	-	-	7.68E-03	2.10E-02
PrePPI	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	11	-	-	3.91E-04	1.17E-03
PrePPI	BP	GO:0061900	glial cell activation	-	56	37	-	-	8.71E-03	3.92E-03
PrePPI	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	83	-	-	6.84E-03	8.74E-03
PrePPI	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	228	-	-	8.07E-03	2.39E-02
PrePPI	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	12	-	-	3.89E-04	1.31E-03
PrePPI	CC	GO:0140467	integrated stress response signaling	-	41	25	-	-	6.70E-03	2.61E-03
PrePPI	BP	GO:0035902	response to immobilization stress	-	20	14	-	-	3.90E-04	1.57E-03
PrePPI	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	139	-	-	3.33E-02	1.46E-02
PrePPI	BP	GO:0043647	inositol phosphate metabolic process	-	44	21	-	-	6.48E-04	2.22E-03
PrePPI	BP	GO:0016180	snRNA processing	-	28	12	-	-	1.96E-01	1.31E-03
PrePPI	BP	GO:0051303	establishment of chromosome localization	-	104	64	-	-	2.34E-03	6.79E-03
PrePPI	BP	GO:0031349	positive regulation of defense response	-	473	226	-	-	1.18E-02	2.36E-02
PrePPI	BP	GO:0007164	establishment of tissue polarity	-	38	25	-	-	7.78E-04	2.61E-03
PrePPI	BP	GO:0021515	cell differentiation in spinal cord	-	51	34	-	-	2.63E-03	3.65E-03
PrePPI	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	15	-	-	5.20E-04	1.57E-03
PrePPI	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	17	-	-	5.19E-04	1.83E-03
PrePPI	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	19	-	-	5.18E-04	2.09E-03
PrePPI	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	15	-	-	5.18E-04	1.57E-03
PrePPI	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	21	-	-	6.50E-04	2.22E-03
PrePPI	BP	GO:0006605	protein targeting	-	327	166	-	-	8.74E-03	1.74E-02
PrePPI	BP	GO:0061318	renal filtration cell differentiation	-	22	15	-	-	5.19E-04	1.57E-03
PrePPI	BP	GO:0007566	embryo implantation	-	57	38	-	-	1.04E-03	4.05E-03
PrePPI	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	23	-	-	6.18E-03	2.48E-03
PrePPI	BP	GO:0061512	protein localization to cilium	-	394	154	-	-	7.43E-03	1.62E-02
PrePPI	BP	GO:0060306	regulation of membrane repolarization	-	38	16	-	-	3.33E-03	1.70E-03
PrePPI	BP	GO:0051017	actin filament bundle assembly	-	161	108	-	-	5.03E-03	1.14E-02
PrePPI	BP	GO:1905953	negative regulation of lipid localization	-	63	32	-	-	8.99E-04	3.39E-03
PrePPI	BP	GO:0021542	dentate gyrus development	-	19	14	-	-	3.90E-04	1.57E-03
PrePPI	BP	GO:0036302	atrioventricular canal development	-	13	11	-	-	3.90E-04	1.17E-03
PrePPI	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	24	-	-	1.40E-02	2.61E-03
PrePPI	BP	GO:0021756	striatum development	-	21	12	-	-	3.89E-04	1.31E-03
PrePPI	BP	GO:1901343	negative regulation of vasculature development	-	154	61	-	-	2.08E-03	6.40E-03
PrePPI	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	84	-	-	4.43E-03	8.87E-03
PrePPI	BP	GO:1902414	protein localization to cell junction	-	107	70	-	-	4.08E-03	7.31E-03
PrePPI	BP	GO:0071305	cellular response to vitamin D	-	23	12	-	-	3.90E-04	1.31E-03
PrePPI	BP	GO:0051304	chromosome separation	-	80	57	-	-	3.78E-03	6.00E-03
PrePPI	BP	GO:0090596	sensory organ morphogenesis	-	272	177	-	-	1.71E-02	1.85E-02
PrePPI	BP	GO:0048709	oligodendrocyte differentiation	-	101	62	-	-	2.64E-03	6.53E-03
PrePPI	BP	GO:0045017	glycerolipid biosynthetic process	-	254	100	-	-	1.88E-02	1.04E-02
PrePPI	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	13	-	-	3.91E-04	1.44E-03
PrePPI	BP	GO:0001776	leukocyte homeostasis	-	108	64	-	-	2.16E-03	6.79E-03
PrePPI	BP	GO:0050769	positive regulation of neurogenesis	-	240	166	-	-	8.33E-03	1.74E-02
PrePPI	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	13	-	-	1.37E-02	1.44E-03
PrePPI	BP	GO:0030193	regulation of blood coagulation	-	70	46	-	-	6.81E-03	4.83E-03
PrePPI	BP	GO:0050866	negative regulation of cell activation	-	216	111	-	-	3.68E-03	1.16E-02
PrePPI	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	20	-	-	1.31E-02	2.09E-03
PrePPI	BP	GO:0033500	carbohydrate homeostasis	-	251	143	-	-	5.41E-03	1.50E-02
PrePPI	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	26	-	-	7.74E-03	2.74E-03
PrePPI	BP	GO:0044088	regulation of vacuole organization	-	56	27	-	-	7.79E-04	2.87E-03
PrePPI	CC	GO:0051457	maintenance of protein location in nucleus	-	23	15	-	-	5.19E-04	1.57E-03
PrePPI	CC	GO:0099522	cytosolic region	-	20	14	-	-	3.90E-04	1.57E-03
PrePPI	CC	GO:0000791	euchromatin	-	60	33	-	-	1.50E-03	3.52E-03
PrePPI	CC	GO:0030666	endocytic vesicle membrane	-	196	121	-	-	4.50E-03	1.27E-02
PrePPI	CC	GO:0098857	membrane microdomain	-	324	204	-	-	1.14E-02	2.14E-02
PrePPI	CC	GO:1990752	microtubule end	-	34	17	-	-	5.21E-04	1.83E-03
PrePPI	CC	GO:0043204	perikaryon	-	156	77	-	-	4.05E-03	8.09E-03
PrePPI	CC	GO:0097542	ciliary tip	-	48	21	-	-	6.50E-04	2.22E-03
PrePPI	CC	GO:1905368	peptidase complex	-	124	73	-	-	1.31E-02	7.70E-03
PrePPI	CC	GO:0000792	heterochromatin	-	98	63	-	-	4.18E-03	6.66E-03
PrePPI	CC	GO:0097546	ciliary base	-	47	23	-	-	6.48E-04	2.48E-03
PrePPI	CC	GO:0071819	DUBm complex	-	25	13	-	-	5.04E-02	1.44E-03
PrePPI	CC	GO:0031201	SNARE complex	-	48	25	-	-	3.79E-02	2.61E-03
PrePPI	CC	GO:0016324	apical plasma membrane	-	392	151	-	-	7.43E-03	1.58E-02
PrePPI	CC	GO:0033260	nuclear DNA replication	-	40	25	-	-	9.47E-03	2.61E-03
PrePPI	CC	GO:0044391	ribosomal subunit	-	203	82	-	-	1.36E-01	8.61E-03
PrePPI	CC	GO:0071013	catalytic step 2 spliceosome	-	88	64	-	-	2.38E-02	6.79E-03
PrePPI	CC	GO:0031907	microbody lumen	-	51	23	-	-	2.02E-02	2.48E-03
PrePPI	CC	GO:0098862	cluster of actin-based cell projections	-	162	73	-	-	1.93E-03	7.70E-03
PrePPI	CC	GO:0016363	nuclear matrix	-	127	90	-	-	3.02E-03	9.40E-03
PrePPI	CC	GO:0031261	DNA replication preinitiation complex	-	46	30	-	-	9.10E-04	3.13E-03
PrePPI	CC	GO:0031966	mitochondrial membrane	-	746	218	-	-	1.94E-02	2.28E-02
PrePPI	CC	GO:0097060	synaptic membrane	-	413	237	-	-	1.57E-02	2.48E-02
PrePPI	CC	GO:0032432	actin filament bundle	-	249	133	-	-	5.16E-03	1.40E-02
PrePPI	CC	GO:0008088	axo-dendritic transport	-	78	43	-	-	2.04E-03	4.57E-03
PrePPI	CC	GO:0031519	PcG protein complex	-	38	23	-	-	4.22E-03	2.48E-03
PrePPI	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	17	-	-	5.22E-04	1.83E-03
PrePPI	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	141	-	-	1.15E-02	1.47E-02
PrePPI	CC	GO:0000313	organellar ribosome	-	89	12	-	-	6.70E-02	1.31E-03
PrePPI	CC	GO:0098791	Golgi apparatus subcompartment	-	378	153	-	-	1.75E-02	1.61E-02
PrePPI	CC	GO:0099643	signal release from synapse	-	147	96	-	-	1.62E-02	1.00E-02
PrePPI	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	20	-	-	6.51E-04	2.09E-03
PrePPI	CC	GO:0030018	Z disc	-	129	75	-	-	5.97E-03	7.83E-03
PrePPI	CC	GO:0032580	Golgi cisterna membrane	-	93	21	-	-	6.51E-04	2.22E-03
PrePPI	CC	GO:1905360	GTPase complex	-	41	24	-	-	1.65E-03	2.61E-03
PrePPI	CC	GO:0097540	axonemal central pair	-	161	43	-	-	4.72E-03	4.57E-03
PrePPI	CC	GO:0042641	actomyosin	-	77	54	-	-	4.01E-03	5.74E-03
PrePPI	CC	GO:0097386	glial cell projection	-	38	18	-	-	5.19E-04	1.96E-03
PrePPI	CC	GO:0032588	trans-Golgi network membrane	-	102	48	-	-	4.47E-03	5.09E-03
PrePPI	CC	GO:0070382	exocytic vesicle	-	224	127	-	-	1.44E-02	1.33E-02
PrePPI	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	19	-	-	5.63E-03	2.09E-03
PrePPI	CC	GO:0031903	microbody membrane	-	65	33	-	-	2.00E-02	3.52E-03
PrePPI	CC	GO:0046930	pore complex	-	26	11	-	-	3.91E-04	1.17E-03
PrePPI	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	133	-	-	1.44E-02	1.40E-02
PrePPI	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	13	-	-	3.91E-04	1.44E-03
PrePPI	CC	GO:0044298	cell body membrane	-	32	17	-	-	5.21E-04	1.83E-03
PrePPI	CC	GO:0051882	mitochondrial depolarization	-	21	17	-	-	5.19E-04	1.83E-03
PrePPI	CC	GO:0045495	pole plasm	-	25	12	-	-	3.91E-04	1.31E-03
PrePPI	CC	GO:0070993	translation preinitiation complex	-	19	13	-	-	3.91E-04	1.44E-03
PrePPI	CC	GO:0016323	basolateral plasma membrane	-	239	109	-	-	1.03E-02	1.15E-02
PrePPI	CC	GO:0045009	chitosome	-	21	12	-	-	3.48E-02	1.31E-03
PrePPI	CC	GO:0042645	mitochondrial nucleoid	-	45	17	-	-	5.22E-04	1.83E-03
PrePPI	CC	GO:1902495	transmembrane transporter complex	-	408	177	-	-	3.61E-02	1.85E-02
PrePPI	CC	GO:0098636	protein complex involved in cell adhesion	-	57	39	-	-	3.38E-03	4.18E-03
PrePPI	CC	GO:0001917	photoreceptor inner segment	-	71	31	-	-	9.10E-04	3.26E-03
PrePPI	CC	GO:0019897	extrinsic component of plasma membrane	-	156	106	-	-	5.71E-03	1.11E-02
PrePPI	CC	GO:0031594	neuromuscular junction	-	73	54	-	-	2.74E-03	5.74E-03
PrePPI	CC	GO:0000793	condensed chromosome	-	274	161	-	-	9.07E-03	1.68E-02
PrePPI	CC	GO:0000922	spindle pole	-	172	94	-	-	4.00E-03	9.92E-03
PrePPI	CC	GO:0120111	neuron projection cytoplasm	-	94	50	-	-	2.59E-03	5.22E-03
PrePPI	CC	GO:0070971	endoplasmic reticulum exit site	-	32	19	-	-	5.21E-04	2.09E-03
PrePPI	CC	GO:0004879	nuclear receptor activity	-	63	45	-	-	2.96E-03	4.70E-03
PrePPI	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	107	-	-	4.14E-03	1.12E-02
PrePPI	CC	GO:0000123	histone acetyltransferase complex	-	93	54	-	-	6.76E-03	5.74E-03
PrePPI	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	32	-	-	2.75E-02	3.39E-03
PrePPI	CC	GO:0048786	presynaptic active zone	-	80	47	-	-	9.69E-03	4.96E-03
PrePPI	CC	GO:0007034	vacuolar transport	-	168	84	-	-	5.85E-03	8.87E-03
PrePPI	CC	GO:0090741	pigment granule membrane	-	21	12	-	-	4.11E-02	1.31E-03
PrePPI	CC	GO:0043194	axon initial segment	-	21	14	-	-	3.90E-04	1.57E-03
PrePPI	CC	GO:0005776	autophagosome	-	111	55	-	-	1.15E-02	5.74E-03
PrePPI	CC	GO:0031430	M band	-	22	12	-	-	3.90E-04	1.31E-03
PrePPI	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	50	-	-	2.95E-02	5.22E-03
PrePPI	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	31	-	-	7.04E-02	3.26E-03
PrePPI	CC	GO:0000164	protein phosphatase type 1 complex	-	19	11	-	-	3.90E-04	1.17E-03
PrePPI	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	15	-	-	5.21E-04	1.57E-03
PrePPI	CC	GO:0032994	protein-lipid complex	-	39	16	-	-	1.31E-02	1.70E-03
PrePPI	CC	GO:0150034	distal axon	-	309	196	-	-	6.44E-03	2.05E-02
PrePPI	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	98	-	-	4.17E-02	1.03E-02
PrePPI	CC	GO:0072562	blood microparticle	-	144	82	-	-	2.71E-03	8.61E-03
PrePPI	CC	GO:0051233	spindle midzone	-	36	25	-	-	7.30E-03	2.61E-03
PrePPI	CC	GO:0005811	lipid droplet	-	102	39	-	-	3.52E-03	4.18E-03
PrePPI	CC	GO:0045022	early endosome to late endosome transport	-	44	28	-	-	1.84E-03	3.00E-03
PrePPI	CC	GO:0043113	receptor clustering	-	51	34	-	-	9.24E-03	3.65E-03
PrePPI	CC	GO:0044853	plasma membrane raft	-	114	75	-	-	6.27E-03	7.83E-03
PrePPI	CC	GO:0005881	cytoplasmic microtubule	-	256	79	-	-	4.73E-03	8.35E-03
PrePPI	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	27	-	-	7.78E-04	2.87E-03
PrePPI	CC	GO:0005905	clathrin-coated pit	-	73	45	-	-	7.56E-03	4.70E-03
PrePPI	CC	GO:0031904	endosome lumen	-	38	19	-	-	1.26E-02	2.09E-03
PrePPI	CC	GO:0060170	ciliary membrane	-	76	25	-	-	7.78E-04	2.61E-03
PrePPI	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	14	-	-	3.91E-04	1.57E-03
PrePPI	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	11	-	-	3.91E-04	1.17E-03
PrePPI	CC	GO:0000139	Golgi membrane	-	646	248	-	-	1.22E-02	2.60E-02
PrePPI	CC	GO:0032154	cleavage furrow	-	54	34	-	-	1.90E-03	3.65E-03
PrePPI	CC	GO:0005640	nuclear outer membrane	-	30	12	-	-	3.91E-04	1.31E-03
PrePPI	CC	GO:0007006	mitochondrial membrane organization	-	117	47	-	-	3.97E-02	4.96E-03
PrePPI	CC	GO:0001772	immunological synapse	-	44	32	-	-	1.86E-03	3.39E-03
PrePPI	CC	GO:0009897	external side of plasma membrane	-	425	196	-	-	3.08E-02	2.05E-02
PrePPI	CC	GO:0030863	cortical cytoskeleton	-	104	68	-	-	2.70E-03	7.18E-03
PrePPI	CC	GO:1905348	endonuclease complex	-	38	19	-	-	2.80E-03	2.09E-03
PrePPI	CC	GO:0030315	T-tubule	-	52	30	-	-	9.45E-03	3.13E-03
PrePPI	CC	GO:0060076	excitatory synapse	-	64	28	-	-	1.62E-03	3.00E-03
PrePPI	CC	GO:0036019	endolysosome	-	29	19	-	-	7.14E-03	2.09E-03
PrePPI	CC	GO:0001891	phagocytic cup	-	28	15	-	-	5.21E-04	1.57E-03
PrePPI	CC	GO:0099086	synaptonemal structure	-	40	15	-	-	7.07E-03	1.57E-03
PrePPI	CC	GO:0030427	site of polarized growth	-	172	107	-	-	3.50E-03	1.12E-02
PrePPI	CC	GO:0044309	neuron spine	-	213	134	-	-	5.24E-03	1.41E-02
PrePPI	CC	GO:0030658	transport vesicle membrane	-	231	112	-	-	9.65E-03	1.17E-02
PrePPI	CC	GO:0098918	structural constituent of synapse	-	27	20	-	-	1.02E-02	2.09E-03
PrePPI	CC	GO:0000940	outer kinetochore	-	17	13	-	-	8.71E-03	1.44E-03
PrePPI	CC	GO:0034719	SMN-Sm protein complex	-	18	13	-	-	3.91E-04	1.44E-03
PrePPI	CC	GO:0044232	organelle membrane contact site	-	50	11	-	-	3.90E-04	1.17E-03
PrePPI	CC	GO:0098803	respiratory chain complex	-	39	11	-	-	5.04E-02	1.17E-03
PrePPI	CC	GO:0030667	secretory granule membrane	-	319	132	-	-	7.78E-03	1.38E-02
PrePPI	CC	GO:0097545	axonemal outer doublet	-	164	44	-	-	4.13E-03	4.70E-03
PrePPI	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	12	-	-	3.90E-04	1.31E-03
PrePPI	CC	GO:0070069	cytochrome complex	-	42	13	-	-	3.37E-02	1.44E-03
PrePPI	CC	GO:0031143	pseudopodium	-	18	14	-	-	7.72E-03	1.57E-03
PrePPI	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	22	-	-	6.17E-03	2.35E-03
PrePPI	CC	GO:0055037	recycling endosome	-	200	95	-	-	6.04E-03	9.92E-03
PrePPI	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	71	-	-	3.85E-03	7.44E-03
PrePPI	CC	GO:0030684	preribosome	-	76	37	-	-	7.21E-02	3.92E-03
PrePPI	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	172	-	-	1.11E-02	1.80E-02
PrePPI	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	12	-	-	1.75E-02	1.31E-03
PrePPI	CC	GO:1990391	DNA repair complex	-	22	13	-	-	7.38E-03	1.44E-03
PrePPI	CC	GO:0005775	vacuolar lumen	-	176	79	-	-	1.06E-02	8.35E-03
PrePPI	CC	GO:0032982	myosin filament	-	24	18	-	-	5.21E-04	1.96E-03
PrePPI	CC	GO:0016327	apicolateral plasma membrane	-	23	12	-	-	2.89E-02	1.31E-03
PrePPI	CC	GO:0044306	neuron projection terminus	-	164	102	-	-	7.25E-03	1.07E-02
PrePPI	CC	GO:0034455	t-UTP complex	-	53	28	-	-	8.49E-02	3.00E-03
PrePPI	CC	GO:0005770	late endosome	-	299	120	-	-	6.08E-03	1.25E-02
PrePPI	CC	GO:0031970	organelle envelope lumen	-	94	32	-	-	6.73E-03	3.39E-03
PrePPI	CC	GO:0019866	organelle inner membrane	-	546	140	-	-	4.47E-02	1.46E-02
PrePPI	CC	GO:0098687	chromosomal region	-	397	246	-	-	2.11E-02	2.57E-02
PrePPI	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	15	-	-	5.19E-04	1.57E-03
PrePPI	CC	GO:0043292	contractile muscle fiber	-	245	140	-	-	2.22E-02	1.46E-02
PrePPI	CC	GO:0005849	mRNA cleavage factor complex	-	22	11	-	-	1.49E-02	1.17E-03
PrePPI	CC	GO:0000803	sex chromosome	-	32	25	-	-	1.02E-02	2.61E-03
PrePPI	CC	GO:0098982	GABA-ergic synapse	-	84	51	-	-	2.55E-03	5.35E-03
PrePPI	CC	GO:0035097	histone methyltransferase complex	-	63	40	-	-	2.26E-03	4.18E-03
PrePPI	CC	GO:0000242	pericentriolar material	-	22	11	-	-	3.90E-04	1.17E-03
PrePPI	CC	GO:1903293	phosphatase complex	-	54	27	-	-	4.67E-02	2.87E-03
PrePPI	CC	GO:0031941	filamentous actin	-	27	13	-	-	1.59E-02	1.44E-03
PrePPI	CC	GO:0000786	nucleosome	-	149	67	-	-	1.47E-02	7.05E-03
PrePPI	CC	GO:0001533	cornified envelope	-	59	24	-	-	6.52E-04	2.61E-03
PrePPI	CC	GO:1904724	tertiary granule lumen	-	55	24	-	-	6.50E-04	2.61E-03
PrePPI	CC	GO:0030027	lamellipodium	-	202	131	-	-	5.90E-03	1.37E-02
PrePPI	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	12	-	-	3.72E-02	1.31E-03
PrePPI	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	11	-	-	4.32E-02	1.17E-03
PrePPI	CC	GO:0002102	podosome	-	31	22	-	-	6.47E-04	2.35E-03
PrePPI	CC	GO:0090543	Flemming body	-	33	21	-	-	6.51E-04	2.22E-03
PrePPI	CC	GO:0016328	lateral plasma membrane	-	66	38	-	-	1.59E-03	4.05E-03
PrePPI	CC	GO:0001650	fibrillar center	-	151	88	-	-	2.31E-03	9.27E-03
PrePPI	CC	GO:0031332	RNAi effector complex	-	413	11	-	-	2.16E-02	1.17E-03
PrePPI	CC	GO:1990204	oxidoreductase complex	-	90	35	-	-	1.12E-02	3.65E-03
PrePPI	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	67	-	-	4.50E-03	7.05E-03
PrePPI	CC	GO:0001726	ruffle	-	181	125	-	-	6.30E-03	1.31E-02
PrePPI	CC	GO:0043198	dendritic shaft	-	38	21	-	-	6.50E-04	2.22E-03
PrePPI	CC	GO:0043073	germ cell nucleus	-	67	42	-	-	2.71E-03	4.44E-03
PrePPI	CC	GO:0005788	endoplasmic reticulum lumen	-	313	155	-	-	1.73E-02	1.62E-02
PrePPI	CC	GO:0016592	mediator complex	-	38	18	-	-	5.13E-02	1.96E-03
PrePPI	CC	GO:0034045	phagophore assembly site membrane	-	19	13	-	-	3.90E-04	1.44E-03
PrePPI	CC	GO:0022626	cytosolic ribosome	-	118	70	-	-	1.61E-01	7.31E-03
PrePPI	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	30	-	-	6.00E-03	3.13E-03
PrePPI	CC	GO:0034451	centriolar satellite	-	120	64	-	-	3.94E-03	6.79E-03
PrePPI	CC	GO:0045171	intercellular bridge	-	91	45	-	-	3.73E-03	4.70E-03
PrePPI	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	25	-	-	5.89E-03	2.61E-03
PrePPI	CC	GO:0098984	neuron to neuron synapse	-	384	244	-	-	7.78E-03	2.56E-02
PrePPI	CC	GO:0033268	node of Ranvier	-	16	11	-	-	3.90E-04	1.17E-03
PrePPI	CC	GO:0030527	structural constituent of chromatin	-	97	38	-	-	2.21E-02	4.05E-03
PrePPI	CC	GO:0036379	myofilament	-	26	14	-	-	3.90E-04	1.57E-03
PrePPI	CC	GO:0030286	dynein complex	-	210	64	-	-	6.44E-03	6.79E-03
PrePPI	CC	GO:0016482	cytosolic transport	-	135	80	-	-	8.99E-03	8.35E-03
PrePPI	CC	GO:0005796	Golgi lumen	-	106	49	-	-	4.61E-03	5.22E-03
PrePPI	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	16	-	-	5.20E-04	1.70E-03
PrePPI	CC	GO:0034358	plasma lipoprotein particle	-	36	15	-	-	1.16E-02	1.57E-03
PrePPI	CC	GO:0008023	transcription elongation factor complex	-	47	22	-	-	2.25E-03	2.35E-03
PrePPI	CC	GO:0030662	coated vesicle membrane	-	202	102	-	-	6.15E-03	1.07E-02
PrePPI	CC	GO:0007039	protein catabolic process in the vacuole	-	61	24	-	-	6.49E-04	2.61E-03
PrePPI	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	21	-	-	8.82E-02	2.22E-03
PrePPI	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	156	-	-	7.69E-03	1.63E-02
PrePPI	CC	GO:0005769	early endosome	-	425	215	-	-	1.13E-02	2.24E-02
PrePPI	CC	GO:0090734	site of DNA damage	-	118	64	-	-	3.31E-03	6.79E-03
PrePPI	MF	GO:0051861	glycolipid binding	-	30	11	-	-	3.90E-04	1.17E-03
PrePPI	MF	GO:0051087	protein-folding chaperone binding	-	135	74	-	-	4.56E-03	7.83E-03
PrePPI	CC	GO:0015464	acetylcholine receptor activity	-	21	15	-	-	5.21E-04	1.57E-03
PrePPI	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	22	-	-	1.24E-02	2.35E-03
PrePPI	MF	GO:0035613	RNA stem-loop binding	-	21	12	-	-	3.91E-04	1.31E-03
PrePPI	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	87	-	-	9.37E-03	9.14E-03
PrePPI	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	14	-	-	3.14E-03	1.57E-03
PrePPI	MF	GO:0016757	glycosyltransferase activity	-	286	67	-	-	9.93E-03	7.05E-03
PrePPI	MF	GO:0048306	calcium-dependent protein binding	-	61	32	-	-	9.09E-04	3.39E-03
PrePPI	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	49	-	-	3.90E-02	5.22E-03
PrePPI	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	17	-	-	5.22E-04	1.83E-03
PrePPI	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	46	-	-	5.73E-03	4.83E-03
PrePPI	MF	GO:0051020	GTPase binding	-	311	197	-	-	6.99E-03	2.06E-02
PrePPI	MF	GO:0140457	protein demethylase activity	-	31	16	-	-	9.41E-02	1.70E-03
PrePPI	MF	GO:0005158	insulin receptor binding	-	22	18	-	-	5.20E-03	1.96E-03
PrePPI	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	1.21E-03	1.57E-03
PrePPI	MF	GO:0061980	regulatory RNA binding	-	52	34	-	-	1.22E-02	3.65E-03
PrePPI	MF	GO:0015035	protein-disulfide reductase activity	-	32	21	-	-	1.03E-01	2.22E-03
PrePPI	MF	GO:0001671	ATPase activator activity	-	29	15	-	-	5.20E-04	1.57E-03
PrePPI	MF	GO:0070840	dynein complex binding	-	25	15	-	-	5.19E-04	1.57E-03
PrePPI	MF	GO:0035035	histone acetyltransferase binding	-	24	18	-	-	5.18E-04	1.96E-03
PrePPI	MF	GO:0061684	chaperone-mediated autophagy	-	16	14	-	-	3.90E-04	1.57E-03
PrePPI	MF	GO:0003688	DNA replication origin binding	-	18	13	-	-	6.70E-02	1.44E-03
PrePPI	MF	GO:0005178	integrin binding	-	153	105	-	-	6.45E-03	1.10E-02
PrePPI	MF	GO:0070064	proline-rich region binding	-	17	13	-	-	4.03E-03	1.44E-03
PrePPI	MF	GO:0005549	odorant binding	-	128	73	-	-	6.30E-02	7.70E-03
PrePPI	MF	GO:0008327	methyl-CpG binding	-	31	15	-	-	5.21E-04	1.57E-03
PrePPI	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	15	-	-	5.19E-04	1.57E-03
PrePPI	MF	GO:0140318	protein transporter activity	-	40	19	-	-	4.71E-02	2.09E-03
PrePPI	MF	GO:0070628	proteasome binding	-	17	12	-	-	1.83E-02	1.31E-03
PrePPI	MF	GO:0000217	DNA secondary structure binding	-	37	26	-	-	7.79E-04	2.74E-03
PrePPI	MF	GO:0002039	p53 binding	-	66	43	-	-	1.89E-03	4.57E-03
PrePPI	MF	GO:0005496	steroid binding	-	110	42	-	-	3.70E-03	4.44E-03
PrePPI	MF	GO:0008443	phosphofructokinase activity	-	27	15	-	-	4.52E-02	1.57E-03
PrePPI	MF	GO:0003684	damaged DNA binding	-	89	49	-	-	5.80E-03	5.22E-03
PrePPI	MF	GO:0016500	protein-hormone receptor activity	-	21	15	-	-	1.28E-02	1.57E-03
PrePPI	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	88	-	-	6.96E-03	9.27E-03
PrePPI	MF	GO:0070063	RNA polymerase binding	-	61	36	-	-	1.04E-03	3.78E-03
PrePPI	MF	GO:0030971	receptor tyrosine kinase binding	-	76	53	-	-	1.55E-03	5.61E-03
PrePPI	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	52	-	-	7.38E-03	5.48E-03
PrePPI	MF	GO:0140030	modification-dependent protein binding	-	179	92	-	-	1.01E-02	9.66E-03
PrePPI	MF	GO:0032794	GTPase activating protein binding	-	13	12	-	-	3.90E-04	1.31E-03
PrePPI	MF	GO:0042813	Wnt receptor activity	-	16	11	-	-	3.91E-04	1.17E-03
PrePPI	MF	GO:0141047	molecular tag activity	-	13	12	-	-	3.89E-04	1.31E-03
PrePPI	MF	GO:0030276	clathrin binding	-	70	39	-	-	6.00E-03	4.18E-03
PrePPI	MF	GO:0046875	ephrin receptor binding	-	29	21	-	-	1.41E-03	2.22E-03
PrePPI	MF	GO:0046790	virion binding	-	19	13	-	-	3.90E-04	1.44E-03
PrePPI	MF	GO:0030552	cAMP binding	-	48	26	-	-	7.77E-04	2.74E-03
PrePPI	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	22	-	-	4.74E-03	2.35E-03
PrePPI	MF	GO:0004857	enzyme inhibitor activity	-	395	189	-	-	6.00E-03	1.98E-02
PrePPI	MF	GO:0035173	histone kinase activity	-	17	15	-	-	5.16E-04	1.57E-03
PrePPI	MF	GO:0097602	cullin family protein binding	-	26	12	-	-	2.85E-02	1.31E-03
PrePPI	MF	GO:0016209	antioxidant activity	-	92	38	-	-	2.64E-02	4.05E-03
PrePPI	MF	GO:0070325	lipoprotein particle receptor binding	-	32	26	-	-	7.79E-04	2.74E-03
PrePPI	MF	GO:0044325	transmembrane transporter binding	-	159	88	-	-	3.21E-03	9.27E-03
PrePPI	MF	GO:0048156	tau protein binding	-	43	40	-	-	2.38E-03	4.18E-03
PrePPI	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	26	-	-	2.04E-02	2.74E-03
PrePPI	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	3.90E-04	1.44E-03
PrePPI	MF	GO:0140272	exogenous protein binding	-	79	42	-	-	3.29E-03	4.44E-03
PrePPI	MF	GO:0030145	manganese ion binding	-	65	19	-	-	5.20E-04	2.09E-03
PrePPI	MF	GO:0071814	protein-lipid complex binding	-	52	29	-	-	1.13E-02	3.13E-03
PrePPI	MF	GO:0008066	glutamate receptor activity	-	70	45	-	-	5.70E-03	4.70E-03
PrePPI	MF	GO:0017069	snRNA binding	-	54	23	-	-	7.53E-03	2.48E-03
PrePPI	MF	GO:0030215	semaphorin receptor binding	-	23	11	-	-	3.91E-04	1.17E-03
PrePPI	MF	GO:0031369	translation initiation factor binding	-	32	17	-	-	5.20E-04	1.83E-03
PrePPI	MF	GO:0019843	rRNA binding	-	69	36	-	-	3.89E-02	3.78E-03
PrePPI	MF	GO:0004713	protein tyrosine kinase activity	-	213	168	-	-	7.45E-03	1.76E-02
PrePPI	MF	GO:0016779	nucleotidyltransferase activity	-	264	129	-	-	5.88E-03	1.36E-02
PrePPI	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	38	-	-	2.20E-03	4.05E-03
PrePPI	MF	GO:0008093	cytoskeletal anchor activity	-	24	14	-	-	3.89E-04	1.57E-03
PrePPI	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	17	-	-	3.74E-03	1.83E-03
PrePPI	MF	GO:0000287	magnesium ion binding	-	225	112	-	-	5.16E-03	1.17E-02
PrePPI	MF	GO:0031490	chromatin DNA binding	-	120	78	-	-	2.19E-03	8.22E-03
PrePPI	MF	GO:0017022	myosin binding	-	73	55	-	-	2.80E-03	5.74E-03
PrePPI	MF	GO:0004896	cytokine receptor activity	-	93	40	-	-	1.94E-02	4.18E-03
PrePPI	MF	GO:0008301	"DNA binding, bending"	-	18	12	-	-	3.91E-04	1.31E-03
PrePPI	MF	GO:0015631	tubulin binding	-	410	208	-	-	1.33E-02	2.18E-02
PrePPI	MF	GO:0005539	glycosaminoglycan binding	-	236	104	-	-	3.29E-03	1.10E-02
PrePPI	MF	GO:0019207	kinase regulator activity	-	267	168	-	-	5.99E-03	1.76E-02
PrePPI	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	12	-	-	3.91E-04	1.31E-03
PrePPI	MF	GO:0044183	protein folding chaperone	-	67	34	-	-	3.10E-02	3.65E-03
PrePPI	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	84	-	-	2.04E-02	8.87E-03
PrePPI	MF	GO:0003725	double-stranded RNA binding	-	72	38	-	-	1.04E-03	4.05E-03
PrePPI	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	13	-	-	5.47E-02	1.44E-03
PrePPI	MF	GO:0051018	protein kinase A binding	-	52	30	-	-	1.56E-03	3.13E-03
PrePPI	MF	GO:0071889	14-3-3 protein binding	-	34	27	-	-	7.72E-04	2.87E-03
PrePPI	MF	GO:0004618	phosphoglycerate kinase activity	-	89	51	-	-	1.06E-02	5.35E-03
PrePPI	MF	GO:0042805	actinin binding	-	36	25	-	-	1.93E-02	2.61E-03
PrePPI	MF	GO:0043531	ADP binding	-	38	21	-	-	6.50E-04	2.22E-03
PrePPI	MF	GO:0043394	proteoglycan binding	-	36	25	-	-	6.06E-03	2.61E-03
PrePPI	MF	GO:0046332	SMAD binding	-	77	59	-	-	2.23E-03	6.26E-03
PrePPI	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.86E-04	1.44E-03
PrePPI	MF	GO:0001968	fibronectin binding	-	30	19	-	-	3.22E-03	2.09E-03
PrePPI	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	68	-	-	1.22E-02	7.18E-03
PrePPI	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	35	-	-	1.12E-02	3.65E-03
PrePPI	MF	GO:0003756	protein disulfide isomerase activity	-	18	13	-	-	1.71E-02	1.44E-03
PrePPI	MF	GO:0051117	ATPase binding	-	85	52	-	-	2.11E-03	5.48E-03
PrePPI	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	35	-	-	1.03E-03	3.65E-03
PrePPI	MF	GO:0051787	misfolded protein binding	-	20	13	-	-	3.90E-04	1.44E-03
PrePPI	MF	GO:0001098	basal transcription machinery binding	-	61	39	-	-	2.43E-03	4.18E-03
PrePPI	MF	GO:0036002	pre-mRNA binding	-	57	28	-	-	6.74E-03	3.00E-03
PrePPI	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	15	-	-	5.21E-04	1.57E-03
PrePPI	MF	GO:0051540	metal cluster binding	-	71	22	-	-	6.52E-04	2.35E-03
PrePPI	MF	GO:0051219	phosphoprotein binding	-	92	78	-	-	3.42E-03	8.22E-03
PrePPI	MF	GO:0019894	kinesin binding	-	45	31	-	-	9.10E-04	3.26E-03
PrePPI	MF	GO:0042287	MHC protein binding	-	68	34	-	-	9.10E-04	3.65E-03
PrePPI	MF	GO:0019003	GDP binding	-	89	75	-	-	9.98E-03	7.83E-03
PrePPI	MF	GO:0017171	serine hydrolase activity	-	207	133	-	-	8.24E-02	1.40E-02
PrePPI	MF	GO:0097110	scaffold protein binding	-	66	48	-	-	1.93E-03	5.09E-03
PrePPI	MF	GO:0003774	cytoskeletal motor activity	-	117	58	-	-	1.61E-02	6.13E-03
PrePPI	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	18	-	-	5.20E-04	1.96E-03
PrePPI	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	14	-	-	2.89E-02	1.57E-03
PrePPI	MF	GO:0061134	peptidase regulator activity	-	224	92	-	-	5.02E-03	9.66E-03
PrePPI	MF	GO:0008013	beta-catenin binding	-	86	68	-	-	3.37E-03	7.18E-03
PrePPI	MF	GO:0051015	actin filament binding	-	208	108	-	-	8.55E-03	1.14E-02
PrePPI	MF	GO:0019208	phosphatase regulator activity	-	107	47	-	-	1.82E-03	4.96E-03
PrePPI	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	13	-	-	3.90E-04	1.44E-03
PrePPI	MF	GO:0043236	laminin binding	-	29	17	-	-	5.20E-04	1.83E-03
PrePPI	MF	GO:0030507	spectrin binding	-	26	20	-	-	6.50E-04	2.09E-03
PrePPI	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	12	-	-	3.91E-04	1.31E-03
PrePPI	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	63	-	-	8.16E-03	6.66E-03
PrePPI	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	19	-	-	1.36E-02	2.09E-03
PrePPI	MF	GO:0042393	histone binding	-	240	129	-	-	1.20E-02	1.36E-02
PrePPI	MF	GO:0019838	growth factor binding	-	182	127	-	-	1.49E-02	1.33E-02
PrePPI	MF	GO:0000149	SNARE binding	-	107	64	-	-	3.93E-02	6.79E-03
PrePPI	MF	GO:0003727	single-stranded RNA binding	-	90	54	-	-	5.61E-03	5.74E-03
PrePPI	MF	GO:0051378	serotonin binding	-	24	15	-	-	5.21E-04	1.57E-03
PrePPI	MF	GO:0005516	calmodulin binding	-	206	117	-	-	4.84E-03	1.23E-02
PrePPI	MF	GO:0019825	oxygen binding	-	40	12	-	-	3.91E-04	1.31E-03
PrePPI	MF	GO:0045505	dynein intermediate chain binding	-	37	14	-	-	3.90E-04	1.57E-03
PrePPI	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	34	-	-	5.08E-02	3.65E-03
PrePPI	MF	GO:0032182	ubiquitin-like protein binding	-	117	82	-	-	6.63E-03	8.61E-03
PrePPI	MF	GO:0023023	MHC protein complex binding	-	36	22	-	-	5.29E-03	2.35E-03
PrePPI	MF	GO:0030742	GTP-dependent protein binding	-	22	18	-	-	5.20E-04	1.96E-03
PrePPI	MF	GO:0043274	phospholipase binding	-	23	19	-	-	5.15E-04	2.09E-03
PrePPI	MF	GO:0031072	heat shock protein binding	-	128	72	-	-	4.86E-03	7.57E-03
PrePPI	MF	GO:0030515	snoRNA binding	-	33	19	-	-	7.24E-03	2.09E-03
PrePPI	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	25	-	-	7.82E-04	2.61E-03
PrePPI	MF	GO:0001965	G-protein alpha-subunit binding	-	26	16	-	-	5.21E-04	1.70E-03
PrePPI	MF	GO:0001530	lipopolysaccharide binding	-	38	17	-	-	5.20E-04	1.83E-03
PrePPI	MF	GO:0046982	protein heterodimerization activity	-	343	187	-	-	9.12E-03	1.96E-02
PrePPI	MF	GO:0140223	general transcription initiation factor activity	-	55	29	-	-	6.27E-02	3.13E-03
PrePPI	MF	GO:0000049	tRNA binding	-	75	31	-	-	4.39E-02	3.26E-03
PrePPI	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	40	-	-	2.83E-03	4.18E-03
PrePPI	MF	GO:0015026	coreceptor activity	-	48	23	-	-	6.48E-04	2.48E-03
PrePPI	MF	GO:0001653	peptide receptor activity	-	128	65	-	-	3.51E-02	6.79E-03
PrePPI	MF	GO:0030506	ankyrin binding	-	19	12	-	-	3.90E-04	1.31E-03
PrePPI	MF	GO:0006469	negative regulation of protein kinase activity	-	222	140	-	-	5.56E-03	1.46E-02
PrePPI	MF	GO:0070182	DNA polymerase binding	-	22	15	-	-	4.21E-03	1.57E-03
PrePPI	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	20	-	-	6.45E-04	2.09E-03
PrePPI	MF	GO:0051427	hormone receptor binding	-	31	16	-	-	4.60E-03	1.70E-03
PrePPI	MF	GO:0070851	growth factor receptor binding	-	141	92	-	-	1.66E-02	9.66E-03
PrePPI	MF	GO:0031210	phosphatidylcholine binding	-	32	13	-	-	3.91E-04	1.44E-03
PrePPI	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	26	-	-	7.81E-04	2.74E-03
PrePPI	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	173	-	-	1.04E-02	1.81E-02
PrePPI	MF	GO:0034185	apolipoprotein binding	-	20	12	-	-	3.90E-04	1.31E-03
PrePPI	MF	GO:0051346	negative regulation of hydrolase activity	-	332	154	-	-	5.11E-03	1.62E-02
PrePPI	MF	GO:0005506	iron ion binding	-	154	45	-	-	4.47E-02	4.70E-03
PrePPI	MF	GO:0003925	G protein activity	-	45	39	-	-	1.25E-02	4.18E-03
PrePPI	MF	GO:0038187	pattern recognition receptor activity	-	33	14	-	-	3.91E-04	1.57E-03
PrePPI	MF	GO:0008276	protein methyltransferase activity	-	96	40	-	-	1.15E-02	4.18E-03
PrePPI	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	222	-	-	7.31E-03	2.32E-02
PrePPI	MF	GO:0070888	E-box binding	-	59	37	-	-	2.95E-03	3.92E-03
PrePPI	MF	GO:0015399	primary active transmembrane transporter activity	-	190	63	-	-	2.81E-02	6.66E-03
PrePPI	MF	GO:0035254	glutamate receptor binding	-	47	31	-	-	9.04E-04	3.26E-03
PrePPI	MF	GO:0050321	tau-protein kinase activity	-	36	30	-	-	3.67E-03	3.13E-03
PrePPI	MF	GO:0043021	ribonucleoprotein complex binding	-	158	94	-	-	6.56E-03	9.92E-03
PrePPI	MF	GO:0030170	pyridoxal phosphate binding	-	56	15	-	-	9.71E-02	1.57E-03
PrePPI	MF	GO:0005112	Notch binding	-	26	12	-	-	3.90E-04	1.31E-03
PrePPI	MF	GO:0048185	activin binding	-	16	15	-	-	2.13E-02	1.57E-03
PrePPI	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	13	-	-	3.91E-04	1.44E-03
PrePPI	MF	GO:0001664	G protein-coupled receptor binding	-	299	152	-	-	1.60E-02	1.59E-02
PrePPI	MF	GO:0140299	small molecule sensor activity	-	39	16	-	-	5.21E-04	1.70E-03
PrePPI	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	17	-	-	2.30E-03	1.83E-03
PrePPI	MF	GO:0016917	GABA receptor activity	-	23	11	-	-	3.91E-04	1.17E-03
PrePPI	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	11	-	-	3.90E-04	1.17E-03
PrePPI	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	25	-	-	7.80E-04	2.61E-03
PrePPI	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	17	-	-	7.04E-03	1.83E-03
PrePPI	MF	GO:0030594	neurotransmitter receptor activity	-	160	94	-	-	6.53E-03	9.92E-03
PrePPI	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	16	-	-	1.65E-02	1.70E-03
PrePPI	MF	GO:0005507	copper ion binding	-	63	23	-	-	6.50E-04	2.48E-03
PrePPI	MF	GO:0033558	protein lysine deacetylase activity	-	22	13	-	-	3.90E-04	1.44E-03
PrePPI	MF	GO:0070034	telomerase RNA binding	-	22	14	-	-	3.91E-04	1.57E-03
PROPER	CC	GO:0005730	nucleolus	3.12E-80	988	724	437	1.66	-	-
PROPER	CC	GO:0005739	mitochondrion	7.11E-66	1671	1073	740	1.45	-	-
PROPER	CC	GO:0005840	ribosome	1.17E-50	222	203	98	2.07	-	-
PROPER	CC	GO:0005815	microtubule organizing center	1.66E-46	843	575	373	1.54	-	-
PROPER	CC	GO:0005635	nuclear envelope	3.54E-28	493	338	218	1.55	-	-
PROPER	CC	GO:0031012	extracellular matrix	2.63E-20	564	145	250	0.58	-	-
PROPER	CC	GO:0000228	nuclear chromosome	9.33E-18	206	152	91	1.67	-	-
PROPER	CC	GO:0005783	endoplasmic reticulum	2.95E-09	2020	1020	894	1.14	-	-
PROPER	CC	GO:0005794	Golgi apparatus	3.74E-09	1636	838	724	1.16	-	-
PROPER	CC	GO:0005768	endosome	6.52E-09	1037	550	459	1.20	-	-
PROPER	CC	GO:0005764	lysosome	2.92E-05	747	387	331	1.17	-	-
PROPER	CC	GO:0005777	peroxisome	2.40E-04	142	85	63	1.35	-	-
PROPER	CC	GO:0005811	lipid droplet	6.74E-03	102	59	45	1.31	-	-
PROPER	CC	GO:0005615	extracellular space	4.18E-02	3190	1360	1412	0.96	-	-
PROPER	CC	GO:0005929	cilium	2.28E-01	842	390	373	1.05	-	-
PROPER	BP	GO:0050877	nervous system process	9.05E-81	1527	334	676	0.49	-	-
PROPER	BP	GO:0016071	mRNA metabolic process	1.64E-73	713	549	316	1.74	-	-
PROPER	BP	GO:0042254	ribosome biogenesis	2.23E-60	297	265	131	2.02	-	-
PROPER	BP	GO:0065003	protein-containing complex assembly	3.95E-53	1648	1026	730	1.41	-	-
PROPER	BP	GO:0006281	DNA repair	3.82E-51	587	437	260	1.68	-	-
PROPER	BP	GO:0007059	chromosome segregation	1.95E-47	403	319	178	1.79	-	-
PROPER	BP	GO:0006886	intracellular protein transport	3.98E-44	664	469	294	1.60	-	-
PROPER	BP	GO:0002181	cytoplasmic translation	2.78E-35	153	140	68	2.07	-	-
PROPER	BP	GO:0030163	protein catabolic process	8.76E-35	990	626	438	1.43	-	-
PROPER	BP	GO:0007005	mitochondrion organization	1.78E-32	484	342	214	1.60	-	-
PROPER	BP	GO:0006325	chromatin organization	5.61E-32	720	473	319	1.48	-	-
PROPER	BP	GO:0140053	mitochondrial gene expression	1.34E-29	164	142	73	1.96	-	-
PROPER	BP	GO:0006260	DNA replication	3.02E-29	279	215	124	1.74	-	-
PROPER	BP	GO:0007010	cytoskeleton organization	1.32E-28	1639	940	726	1.30	-	-
PROPER	BP	GO:0006913	nucleocytoplasmic transport	5.32E-24	326	234	144	1.62	-	-
PROPER	BP	GO:0016192	vesicle-mediated transport	3.28E-22	1894	1038	839	1.24	-	-
PROPER	BP	GO:0006914	autophagy	8.50E-20	568	358	251	1.42	-	-
PROPER	BP	GO:0006457	protein folding	3.43E-19	210	157	93	1.69	-	-
PROPER	BP	GO:0006399	tRNA metabolic process	2.26E-18	196	147	87	1.69	-	-
PROPER	BP	GO:0055085	transmembrane transport	5.95E-17	1784	624	790	0.79	-	-
PROPER	BP	GO:0006954	inflammatory response	8.76E-17	820	249	363	0.69	-	-
PROPER	BP	GO:0006310	DNA recombination	1.41E-16	333	222	147	1.51	-	-
PROPER	BP	GO:0012501	programmed cell death	1.44E-15	1954	1032	865	1.19	-	-
PROPER	BP	GO:0000910	cytokinesis	4.58E-15	186	135	82	1.64	-	-
PROPER	BP	GO:0032200	telomere organization	5.35E-14	186	133	82	1.61	-	-
PROPER	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.09E-13	729	420	323	1.30	-	-
PROPER	BP	GO:0006091	generation of precursor metabolites and energy	2.93E-11	502	296	222	1.33	-	-
PROPER	BP	GO:0007018	microtubule-based movement	4.89E-09	640	356	283	1.26	-	-
PROPER	BP	GO:0003013	circulatory system process	8.88E-08	584	196	259	0.76	-	-
PROPER	BP	GO:0007163	establishment or maintenance of cell polarity	1.26E-07	227	140	101	1.39	-	-
PROPER	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	2.15E-07	119	81	53	1.54	-	-
PROPER	BP	GO:0006355	regulation of DNA-templated transcription	5.84E-07	3342	1610	1480	1.09	-	-
PROPER	BP	GO:0098542	defense response to other organism	7.07E-07	1171	437	518	0.84	-	-
PROPER	BP	GO:0044782	cilium organization	1.95E-06	399	224	177	1.27	-	-
PROPER	BP	GO:0072659	protein localization to plasma membrane	3.01E-05	284	161	126	1.28	-	-
PROPER	BP	GO:0003014	renal system process	6.80E-05	127	34	56	0.60	-	-
PROPER	BP	GO:0140013	meiotic nuclear division	9.60E-05	279	156	124	1.26	-	-
PROPER	BP	GO:0006520	amino acid metabolic process	1.07E-03	292	157	129	1.21	-	-
PROPER	BP	GO:0030198	extracellular matrix organization	1.31E-03	314	111	139	0.80	-	-
PROPER	BP	GO:0022600	digestive system process	1.38E-03	110	32	49	0.66	-	-
PROPER	BP	GO:0003012	muscle system process	3.00E-03	425	158	188	0.84	-	-
PROPER	BP	GO:0007040	lysosome organization	4.60E-03	107	62	47	1.31	-	-
PROPER	BP	GO:0002376	immune system process	5.57E-03	2448	1020	1084	0.94	-	-
PROPER	BP	GO:0006629	lipid metabolic process	2.14E-02	1355	559	600	0.93	-	-
PROPER	BP	GO:0007155	cell adhesion	4.71E-02	1444	603	639	0.94	-	-
PROPER	BP	GO:0048870	cell motility	3.38E-01	1659	716	735	0.97	-	-
PROPER	BP	GO:0006486	protein glycosylation	3.45E-01	225	107	100	1.07	-	-
PROPER	BP	GO:0034330	cell junction organization	3.81E-01	727	310	322	0.96	-	-
PROPER	BP	GO:0042060	wound healing	4.92E-01	431	198	191	1.04	-	-
PROPER	BP	GO:0098754	detoxification	6.01E-01	134	56	59	0.94	-	-
PROPER	BP	GO:0006790	sulfur compound metabolic process	6.50E-01	320	146	142	1.03	-	-
PROPER	BP	GO:0005975	carbohydrate metabolic process	6.95E-01	551	239	244	0.98	-	-
PROPER	BP	GO:0006766	vitamin metabolic process	6.97E-01	107	45	47	0.95	-	-
PROPER	BP	GO:0006575	cellular modified amino acid metabolic process	8.24E-01	186	84	82	1.02	-	-
PROPER	MF	GO:0003723	RNA binding	5.72E-200	1679	1321	743	1.78	-	-
PROPER	MF	GO:0048018	receptor ligand activity	6.79E-52	504	67	223	0.30	-	-
PROPER	MF	GO:0016740	transferase activity	2.22E-34	3074	1670	1361	1.23	-	-
PROPER	MF	GO:0140097	"catalytic activity, acting on DNA"	3.70E-34	383	286	170	1.69	-	-
PROPER	MF	GO:0140657	ATP-dependent activity	1.34E-31	729	477	323	1.48	-	-
PROPER	MF	GO:0140098	"catalytic activity, acting on RNA"	2.92E-31	417	301	185	1.63	-	-
PROPER	MF	GO:0042393	histone binding	6.47E-20	237	174	105	1.66	-	-
PROPER	MF	GO:0005215	transporter activity	9.04E-18	1462	492	647	0.76	-	-
PROPER	MF	GO:0045182	translation regulator activity	4.72E-16	151	116	67	1.74	-	-
PROPER	MF	GO:0008092	cytoskeletal protein binding	1.28E-15	1023	577	453	1.27	-	-
PROPER	MF	GO:0140096	"catalytic activity, acting on a protein"	2.65E-15	3198	1619	1416	1.14	-	-
PROPER	MF	GO:0009975	cyclase activity	9.10E-15	277	61	123	0.50	-	-
PROPER	MF	GO:0016874	ligase activity	5.35E-10	283	177	125	1.41	-	-
PROPER	MF	GO:0003924	GTPase activity	7.80E-09	658	364	291	1.25	-	-
PROPER	MF	GO:0016853	isomerase activity	4.28E-08	252	155	112	1.39	-	-
PROPER	MF	GO:0140104	molecular carrier activity	9.19E-08	105	74	46	1.59	-	-
PROPER	MF	GO:0003677	DNA binding	2.11E-06	2865	1385	1269	1.09	-	-
PROPER	MF	GO:0038024	cargo receptor activity	3.43E-05	117	30	52	0.58	-	-
PROPER	MF	GO:0016829	lyase activity	4.18E-04	538	198	238	0.83	-	-
PROPER	MF	GO:0016491	oxidoreductase activity	4.05E-03	888	435	393	1.11	-	-
PROPER	MF	GO:0140110	transcription regulator activity	1.80E-02	2033	850	900	0.94	-	-
PROPER	MF	GO:0003774	cytoskeletal motor activity	4.91E-02	116	62	51	1.21	-	-
PROPER	MF	GO:0005198	structural molecule activity	2.03E-01	798	371	353	1.05	-	-
PROPER	MF	GO:0008289	lipid binding	1.00E+00	836	370	370	1.00	-	-
PROPER	BP	GO:0008038	neuron recognition	-	46	20	-	-	3.05E-03	1.88E-03
PROPER	BP	GO:1905145	cellular response to acetylcholine	-	33	12	-	-	2.47E-02	1.17E-03
PROPER	BP	GO:0098780	response to mitochondrial depolarisation	-	21	17	-	-	4.48E-04	1.64E-03
PROPER	BP	GO:0045666	positive regulation of neuron differentiation	-	91	26	-	-	1.02E-03	2.47E-03
PROPER	BP	GO:0043543	protein acylation	-	107	65	-	-	1.60E-03	6.11E-03
PROPER	BP	GO:0048679	regulation of axon regeneration	-	28	14	-	-	6.98E-03	1.41E-03
PROPER	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	34	-	-	1.29E-03	3.29E-03
PROPER	BP	GO:0071763	nuclear membrane organization	-	44	39	-	-	1.19E-03	3.76E-03
PROPER	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	24	-	-	1.90E-02	2.35E-03
PROPER	BP	GO:0071806	protein transmembrane transport	-	68	42	-	-	1.24E-03	3.99E-03
PROPER	BP	GO:0022038	corpus callosum development	-	25	14	-	-	3.48E-04	1.41E-03
PROPER	BP	GO:0043299	leukocyte degranulation	-	82	31	-	-	8.14E-04	2.94E-03
PROPER	BP	GO:0048864	stem cell development	-	88	40	-	-	1.61E-03	3.76E-03
PROPER	BP	GO:0051651	maintenance of location in cell	-	236	120	-	-	4.54E-03	1.13E-02
PROPER	BP	GO:0033119	negative regulation of RNA splicing	-	27	23	-	-	5.49E-04	2.23E-03
PROPER	CC	GO:0016197	endosomal transport	-	282	191	-	-	5.88E-03	1.80E-02
PROPER	BP	GO:0070663	regulation of leukocyte proliferation	-	268	108	-	-	3.60E-03	1.02E-02
PROPER	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	22	-	-	5.50E-04	2.11E-03
PROPER	BP	GO:0006949	syncytium formation	-	66	21	-	-	1.24E-03	2.00E-03
PROPER	BP	GO:0045861	negative regulation of proteolysis	-	320	128	-	-	3.68E-03	1.21E-02
PROPER	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	17	-	-	4.64E-04	1.64E-03
PROPER	BP	GO:0030574	collagen catabolic process	-	45	11	-	-	3.79E-03	1.06E-03
PROPER	CC	GO:0006984	ER-nucleus signaling pathway	-	46	34	-	-	7.84E-04	3.29E-03
PROPER	BP	GO:0009914	hormone transport	-	315	95	-	-	3.57E-03	8.92E-03
PROPER	BP	GO:0140112	extracellular vesicle biogenesis	-	23	15	-	-	4.57E-04	1.41E-03
PROPER	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	13	-	-	3.49E-04	1.29E-03
PROPER	BP	GO:0045785	positive regulation of cell adhesion	-	482	216	-	-	6.57E-03	2.03E-02
PROPER	BP	GO:0085029	extracellular matrix assembly	-	42	16	-	-	4.64E-04	1.53E-03
PROPER	BP	GO:0006413	translational initiation	-	122	100	-	-	9.32E-03	9.39E-03
PROPER	BP	GO:1902895	positive regulation of miRNA transcription	-	51	21	-	-	7.28E-04	2.00E-03
PROPER	CC	GO:0005200	structural constituent of cytoskeleton	-	112	56	-	-	5.07E-03	5.28E-03
PROPER	BP	GO:0030865	cortical cytoskeleton organization	-	51	42	-	-	1.34E-03	3.99E-03
PROPER	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	18	-	-	1.93E-03	1.76E-03
PROPER	BP	GO:1903036	positive regulation of response to wounding	-	76	31	-	-	2.30E-03	2.94E-03
PROPER	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	17	-	-	4.68E-04	1.64E-03
PROPER	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	63	-	-	2.20E-03	5.99E-03
PROPER	BP	GO:1903319	positive regulation of protein maturation	-	27	11	-	-	3.76E-03	1.06E-03
PROPER	BP	GO:0032528	microvillus organization	-	24	15	-	-	4.52E-04	1.41E-03
PROPER	BP	GO:0002263	cell activation involved in immune response	-	304	120	-	-	3.67E-03	1.13E-02
PROPER	BP	GO:0021954	central nervous system neuron development	-	85	39	-	-	8.52E-04	3.76E-03
PROPER	BP	GO:0055017	cardiac muscle tissue growth	-	92	32	-	-	8.09E-04	3.05E-03
PROPER	BP	GO:0048524	positive regulation of viral process	-	64	43	-	-	1.24E-03	4.11E-03
PROPER	BP	GO:0001946	lymphangiogenesis	-	18	11	-	-	3.50E-04	1.06E-03
PROPER	BP	GO:0098661	inorganic anion transmembrane transport	-	140	32	-	-	8.05E-04	3.05E-03
PROPER	BP	GO:0006099	tricarboxylic acid cycle	-	33	29	-	-	8.76E-04	2.82E-03
PROPER	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	13	-	-	3.45E-04	1.29E-03
PROPER	BP	GO:0009612	response to mechanical stimulus	-	215	88	-	-	4.68E-03	8.34E-03
PROPER	BP	GO:0048644	muscle organ morphogenesis	-	81	23	-	-	5.74E-04	2.23E-03
PROPER	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	61	-	-	2.62E-03	5.75E-03
PROPER	BP	GO:0140115	export across plasma membrane	-	82	18	-	-	1.47E-03	1.76E-03
PROPER	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	28	-	-	6.38E-03	2.70E-03
PROPER	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	13	-	-	3.50E-04	1.29E-03
PROPER	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	25	-	-	6.93E-04	2.35E-03
PROPER	MF	GO:0003714	transcription corepressor activity	-	190	123	-	-	3.48E-03	1.16E-02
PROPER	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	13	-	-	3.43E-04	1.29E-03
PROPER	CC	GO:0006858	extracellular transport	-	45	17	-	-	4.68E-04	1.64E-03
PROPER	BP	GO:0006304	DNA modification	-	30	11	-	-	2.00E-01	1.06E-03
PROPER	MF	GO:0140312	cargo adaptor activity	-	19	15	-	-	4.57E-04	1.41E-03
PROPER	BP	GO:0046835	carbohydrate phosphorylation	-	49	27	-	-	1.58E-03	2.58E-03
PROPER	CC	GO:1905349	ciliary transition zone assembly	-	371	210	-	-	5.61E-03	1.97E-02
PROPER	BP	GO:0043523	regulation of neuron apoptotic process	-	218	102	-	-	3.38E-03	9.63E-03
PROPER	BP	GO:0044380	protein localization to cytoskeleton	-	57	40	-	-	1.10E-03	3.76E-03
PROPER	BP	GO:2000209	regulation of anoikis	-	25	15	-	-	5.30E-03	1.41E-03
PROPER	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	19	-	-	4.61E-04	1.88E-03
PROPER	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	31	-	-	1.31E-03	2.94E-03
PROPER	CC	GO:0045324	late endosome to vacuole transport	-	37	28	-	-	6.88E-04	2.70E-03
PROPER	BP	GO:0043954	cellular component maintenance	-	72	30	-	-	1.54E-03	2.82E-03
PROPER	BP	GO:0050435	amyloid-beta metabolic process	-	65	28	-	-	6.90E-04	2.70E-03
PROPER	BP	GO:0014823	response to activity	-	70	35	-	-	8.88E-04	3.29E-03
PROPER	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	243	-	-	8.64E-03	2.29E-02
PROPER	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	24	-	-	9.62E-04	2.35E-03
PROPER	BP	GO:0034502	protein localization to chromosome	-	130	91	-	-	3.66E-03	8.57E-03
PROPER	BP	GO:0048562	embryonic organ morphogenesis	-	295	109	-	-	1.68E-02	1.03E-02
PROPER	BP	GO:0019233	sensory perception of pain	-	103	19	-	-	4.67E-04	1.88E-03
PROPER	CC	GO:0043574	peroxisomal transport	-	22	11	-	-	3.49E-04	1.06E-03
PROPER	BP	GO:0031343	positive regulation of cell killing	-	75	33	-	-	7.57E-02	3.17E-03
PROPER	BP	GO:0090077	foam cell differentiation	-	39	12	-	-	3.50E-04	1.17E-03
PROPER	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	28	-	-	7.34E-03	2.70E-03
PROPER	BP	GO:0017148	negative regulation of translation	-	390	80	-	-	2.85E-03	7.52E-03
PROPER	BP	GO:0030220	platelet formation	-	22	13	-	-	1.70E-03	1.29E-03
PROPER	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	31	-	-	1.67E-03	2.94E-03
PROPER	BP	GO:1903509	liposaccharide metabolic process	-	109	49	-	-	1.15E-03	4.70E-03
PROPER	BP	GO:0009582	detection of abiotic stimulus	-	140	35	-	-	9.26E-04	3.29E-03
PROPER	CC	GO:0140238	presynaptic endocytosis	-	72	38	-	-	1.58E-03	3.64E-03
PROPER	BP	GO:0051236	establishment of RNA localization	-	161	133	-	-	3.73E-03	1.26E-02
PROPER	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	98	-	-	2.61E-03	9.28E-03
PROPER	BP	GO:0034067	protein localization to Golgi apparatus	-	30	22	-	-	5.80E-04	2.11E-03
PROPER	BP	GO:0061842	microtubule organizing center localization	-	32	29	-	-	8.19E-04	2.82E-03
PROPER	BP	GO:0042246	tissue regeneration	-	496	214	-	-	1.02E-02	2.02E-02
PROPER	MF	GO:0048018	receptor ligand activity	-	510	68	-	-	1.72E-03	6.46E-03
PROPER	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	27	-	-	1.72E-03	2.58E-03
PROPER	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	25	-	-	1.60E-03	2.35E-03
PROPER	BP	GO:0050779	RNA destabilization	-	135	76	-	-	3.13E-03	7.16E-03
PROPER	BP	GO:0006023	aminoglycan biosynthetic process	-	74	24	-	-	5.80E-04	2.35E-03
PROPER	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	43	-	-	1.12E-02	4.11E-03
PROPER	BP	GO:0061025	membrane fusion	-	532	235	-	-	6.52E-03	2.21E-02
PROPER	BP	GO:0010762	regulation of fibroblast migration	-	40	26	-	-	3.18E-03	2.47E-03
PROPER	BP	GO:0090311	regulation of protein deacetylation	-	29	19	-	-	4.64E-04	1.88E-03
PROPER	BP	GO:0035272	exocrine system development	-	46	17	-	-	4.51E-04	1.64E-03
PROPER	BP	GO:0022406	membrane docking	-	90	58	-	-	1.92E-03	5.52E-03
PROPER	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	4.60E-04	1.41E-03
PROPER	BP	GO:0050777	negative regulation of immune response	-	196	76	-	-	1.50E-02	7.16E-03
PROPER	BP	GO:0016053	organic acid biosynthetic process	-	335	137	-	-	4.84E-03	1.29E-02
PROPER	BP	GO:0002063	chondrocyte development	-	33	13	-	-	3.48E-04	1.29E-03
PROPER	BP	GO:0099068	postsynapse assembly	-	40	14	-	-	3.43E-04	1.41E-03
PROPER	BP	GO:0021782	glial cell development	-	120	46	-	-	1.65E-03	4.34E-03
PROPER	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	47	-	-	1.41E-03	4.46E-03
PROPER	BP	GO:0001655	urogenital system development	-	66	27	-	-	6.81E-04	2.58E-03
PROPER	BP	GO:0071827	plasma lipoprotein particle organization	-	86	20	-	-	3.18E-03	1.88E-03
PROPER	BP	GO:0045494	photoreceptor cell maintenance	-	43	17	-	-	4.64E-04	1.64E-03
PROPER	BP	GO:0055088	lipid homeostasis	-	173	56	-	-	2.80E-03	5.28E-03
PROPER	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	19	-	-	6.86E-04	1.88E-03
PROPER	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	121	-	-	4.18E-03	1.14E-02
PROPER	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	26	-	-	6.87E-04	2.47E-03
PROPER	BP	GO:0045667	regulation of osteoblast differentiation	-	147	43	-	-	8.13E-03	4.11E-03
PROPER	BP	GO:0050801	monoatomic ion homeostasis	-	609	225	-	-	5.92E-03	2.11E-02
PROPER	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	161	-	-	4.23E-03	1.51E-02
PROPER	BP	GO:0045738	negative regulation of DNA repair	-	40	28	-	-	1.01E-03	2.70E-03
PROPER	BP	GO:0001704	formation of primary germ layer	-	195	84	-	-	4.61E-03	7.98E-03
PROPER	BP	GO:0045778	positive regulation of ossification	-	51	17	-	-	4.56E-04	1.64E-03
PROPER	BP	GO:0048708	astrocyte differentiation	-	88	36	-	-	1.72E-03	3.41E-03
PROPER	BP	GO:0048588	developmental cell growth	-	233	100	-	-	3.02E-03	9.39E-03
PROPER	CC	GO:0000963	mitochondrial RNA processing	-	20	19	-	-	4.66E-04	1.88E-03
PROPER	BP	GO:0021872	forebrain generation of neurons	-	52	22	-	-	9.15E-04	2.11E-03
PROPER	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	13	-	-	3.47E-04	1.29E-03
PROPER	BP	GO:0045023	G0 to G1 transition	-	41	28	-	-	1.07E-03	2.70E-03
PROPER	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	16	-	-	4.59E-04	1.53E-03
PROPER	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	12	-	-	1.61E-03	1.17E-03
PROPER	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	21	-	-	1.24E-02	2.00E-03
PROPER	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	14	-	-	3.49E-04	1.41E-03
PROPER	BP	GO:0010232	vascular transport	-	87	26	-	-	4.43E-03	2.47E-03
PROPER	BP	GO:0021987	cerebral cortex development	-	125	76	-	-	2.32E-03	7.16E-03
PROPER	BP	GO:0008637	apoptotic mitochondrial changes	-	108	63	-	-	3.08E-03	5.99E-03
PROPER	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	11	-	-	3.49E-04	1.06E-03
PROPER	BP	GO:0060999	positive regulation of dendritic spine development	-	35	18	-	-	4.57E-04	1.76E-03
PROPER	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	12	-	-	5.08E-04	1.17E-03
PROPER	BP	GO:2000736	regulation of stem cell differentiation	-	78	48	-	-	2.48E-03	4.58E-03
PROPER	BP	GO:0002064	epithelial cell development	-	210	104	-	-	4.11E-03	9.86E-03
PROPER	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	12	-	-	1.43E-03	1.17E-03
PROPER	BP	GO:2001222	regulation of neuron migration	-	46	19	-	-	8.80E-03	1.88E-03
PROPER	BP	GO:0034389	lipid droplet organization	-	38	22	-	-	5.70E-04	2.11E-03
PROPER	BP	GO:0051602	response to electrical stimulus	-	44	14	-	-	2.69E-03	1.41E-03
PROPER	BP	GO:0042177	negative regulation of protein catabolic process	-	109	70	-	-	2.33E-03	6.58E-03
PROPER	MF	GO:0038024	cargo receptor activity	-	121	30	-	-	9.56E-04	2.82E-03
PROPER	BP	GO:0033120	positive regulation of RNA splicing	-	46	31	-	-	1.44E-03	2.94E-03
PROPER	BP	GO:0051445	regulation of meiotic cell cycle	-	64	36	-	-	1.11E-03	3.41E-03
PROPER	BP	GO:0033619	membrane protein proteolysis	-	60	33	-	-	2.25E-03	3.17E-03
PROPER	BP	GO:0090087	regulation of peptide transport	-	195	60	-	-	4.14E-03	5.64E-03
PROPER	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	43	-	-	1.03E-03	4.11E-03
PROPER	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	13	-	-	3.44E-04	1.29E-03
PROPER	BP	GO:0006929	substrate-dependent cell migration	-	26	17	-	-	1.02E-03	1.64E-03
PROPER	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	13	-	-	6.88E-04	1.29E-03
PROPER	BP	GO:0072662	protein localization to peroxisome	-	20	11	-	-	3.49E-04	1.06E-03
PROPER	BP	GO:0022404	molting cycle process	-	95	36	-	-	1.24E-03	3.41E-03
PROPER	BP	GO:1903358	regulation of Golgi organization	-	17	13	-	-	3.43E-04	1.29E-03
PROPER	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	11	-	-	3.38E-04	1.06E-03
PROPER	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	18	-	-	1.33E-03	1.76E-03
PROPER	BP	GO:0007281	germ cell development	-	334	122	-	-	4.96E-03	1.15E-02
PROPER	BP	GO:0008299	isoprenoid biosynthetic process	-	30	16	-	-	4.66E-04	1.53E-03
PROPER	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	96	-	-	2.62E-03	9.04E-03
PROPER	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	22	-	-	2.29E-03	2.11E-03
PROPER	CC	GO:0098926	postsynaptic signal transduction	-	39	13	-	-	6.99E-03	1.29E-03
PROPER	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	76	-	-	2.28E-03	7.16E-03
PROPER	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	68	-	-	2.34E-03	6.46E-03
PROPER	BP	GO:0034249	negative regulation of amide metabolic process	-	34	13	-	-	3.49E-04	1.29E-03
PROPER	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	59	-	-	1.69E-03	5.64E-03
PROPER	BP	GO:0048799	animal organ maturation	-	33	12	-	-	3.49E-04	1.17E-03
PROPER	BP	GO:0006925	inflammatory cell apoptotic process	-	23	15	-	-	4.56E-04	1.41E-03
PROPER	BP	GO:0003013	circulatory system process	-	602	196	-	-	6.35E-03	1.84E-02
PROPER	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	81	-	-	2.11E-03	7.63E-03
PROPER	BP	GO:1903035	negative regulation of response to wounding	-	93	32	-	-	1.19E-03	3.05E-03
PROPER	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	16	-	-	4.36E-04	1.53E-03
PROPER	BP	GO:0036010	protein localization to endosome	-	27	17	-	-	1.08E-02	1.64E-03
PROPER	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	99	-	-	4.00E-03	9.39E-03
PROPER	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	71	-	-	2.70E-03	6.69E-03
PROPER	BP	GO:0009267	cellular response to starvation	-	170	91	-	-	2.14E-03	8.57E-03
PROPER	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	26	-	-	6.83E-04	2.47E-03
PROPER	CC	GO:0140239	postsynaptic endocytosis	-	23	14	-	-	1.51E-03	1.41E-03
PROPER	BP	GO:0046931	pore complex assembly	-	21	19	-	-	9.34E-04	1.88E-03
PROPER	CC	GO:0032008	positive regulation of TOR signaling	-	52	31	-	-	3.45E-03	2.94E-03
PROPER	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	29	-	-	9.64E-04	2.82E-03
PROPER	BP	GO:0060428	lung epithelium development	-	43	20	-	-	5.79E-04	1.88E-03
PROPER	BP	GO:1903318	negative regulation of protein maturation	-	29	15	-	-	1.75E-03	1.41E-03
PROPER	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	86	-	-	3.74E-03	8.10E-03
PROPER	BP	GO:0010457	centriole-centriole cohesion	-	15	14	-	-	3.37E-04	1.41E-03
PROPER	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	28	-	-	4.89E-03	2.70E-03
PROPER	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	32	-	-	2.13E-03	3.05E-03
PROPER	BP	GO:0065004	protein-DNA complex assembly	-	307	191	-	-	6.29E-03	1.80E-02
PROPER	CC	GO:0006406	mRNA export from nucleus	-	69	57	-	-	1.60E-03	5.40E-03
PROPER	BP	GO:0009880	embryonic pattern specification	-	70	15	-	-	4.54E-04	1.41E-03
PROPER	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	32	-	-	8.02E-04	3.05E-03
PROPER	BP	GO:0043043	peptide biosynthetic process	-	25	11	-	-	3.52E-04	1.06E-03
PROPER	BP	GO:0002367	cytokine production involved in immune response	-	121	39	-	-	7.54E-03	3.76E-03
PROPER	BP	GO:0044848	biological phase	-	211	121	-	-	3.28E-03	1.14E-02
PROPER	BP	GO:0046660	female sex differentiation	-	125	52	-	-	2.50E-03	4.93E-03
PROPER	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	17	-	-	1.96E-03	1.64E-03
PROPER	BP	GO:0060411	cardiac septum morphogenesis	-	72	27	-	-	2.37E-03	2.58E-03
PROPER	BP	GO:0071248	cellular response to metal ion	-	201	78	-	-	2.22E-03	7.40E-03
PROPER	BP	GO:0030308	negative regulation of cell growth	-	191	85	-	-	2.74E-03	7.98E-03
PROPER	BP	GO:0097306	cellular response to alcohol	-	99	45	-	-	1.15E-03	4.23E-03
PROPER	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	108	-	-	2.89E-03	1.02E-02
PROPER	BP	GO:0010453	regulation of cell fate commitment	-	40	15	-	-	4.27E-03	1.41E-03
PROPER	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	25	-	-	2.15E-03	2.35E-03
PROPER	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	21	-	-	5.83E-04	2.00E-03
PROPER	BP	GO:0002026	regulation of the force of heart contraction	-	26	11	-	-	3.47E-04	1.06E-03
PROPER	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	26	-	-	1.61E-02	2.47E-03
PROPER	BP	GO:0032890	regulation of organic acid transport	-	78	25	-	-	4.56E-03	2.35E-03
PROPER	BP	GO:0098771	inorganic ion homeostasis	-	531	187	-	-	5.70E-03	1.76E-02
PROPER	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	35	-	-	1.59E-03	3.29E-03
PROPER	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	12	-	-	3.43E-04	1.17E-03
PROPER	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	18	-	-	7.93E-03	1.76E-03
PROPER	BP	GO:0051259	protein complex oligomerization	-	251	115	-	-	4.63E-03	1.08E-02
PROPER	BP	GO:0009163	nucleoside biosynthetic process	-	16	12	-	-	3.51E-04	1.17E-03
PROPER	BP	GO:0009994	oocyte differentiation	-	57	24	-	-	5.77E-04	2.35E-03
PROPER	MF	GO:0031952	regulation of protein autophosphorylation	-	43	26	-	-	1.46E-03	2.47E-03
PROPER	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	105	-	-	2.86E-03	9.86E-03
PROPER	BP	GO:0044319	"wound healing, spreading of cells"	-	37	22	-	-	3.14E-03	2.11E-03
PROPER	BP	GO:0033688	regulation of osteoblast proliferation	-	31	11	-	-	3.43E-04	1.06E-03
PROPER	BP	GO:0060251	regulation of glial cell proliferation	-	39	18	-	-	4.64E-04	1.76E-03
PROPER	BP	GO:0072665	protein localization to vacuole	-	84	56	-	-	2.47E-03	5.28E-03
PROPER	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	34	-	-	1.44E-03	3.29E-03
PROPER	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	43	-	-	1.59E-03	4.11E-03
PROPER	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	11	-	-	3.39E-04	1.06E-03
PROPER	BP	GO:0070633	transepithelial transport	-	35	11	-	-	1.22E-03	1.06E-03
PROPER	BP	GO:0045661	regulation of myoblast differentiation	-	74	35	-	-	1.39E-03	3.29E-03
PROPER	BP	GO:0030307	positive regulation of cell growth	-	164	73	-	-	3.37E-03	6.93E-03
PROPER	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	147	-	-	4.38E-03	1.39E-02
PROPER	BP	GO:0014812	muscle cell migration	-	110	45	-	-	3.32E-03	4.23E-03
PROPER	BP	GO:0048525	negative regulation of viral process	-	90	43	-	-	1.56E-02	4.11E-03
PROPER	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	57	-	-	1.72E-03	5.40E-03
PROPER	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	91	-	-	2.96E-03	8.57E-03
PROPER	BP	GO:0051781	positive regulation of cell division	-	93	41	-	-	1.01E-03	3.88E-03
PROPER	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	14	-	-	9.70E-04	1.41E-03
PROPER	BP	GO:0035493	SNARE complex assembly	-	23	17	-	-	4.67E-04	1.64E-03
PROPER	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	12	-	-	8.69E-02	1.17E-03
PROPER	BP	GO:0002696	positive regulation of leukocyte activation	-	358	153	-	-	5.06E-03	1.44E-02
PROPER	BP	GO:0060711	labyrinthine layer development	-	47	24	-	-	1.04E-03	2.35E-03
PROPER	BP	GO:0007272	ensheathment of neurons	-	146	69	-	-	1.85E-03	6.58E-03
PROPER	CC	GO:0050806	positive regulation of synaptic transmission	-	171	52	-	-	3.12E-03	4.93E-03
PROPER	BP	GO:0060021	roof of mouth development	-	91	30	-	-	1.06E-03	2.82E-03
PROPER	BP	GO:0034504	protein localization to nucleus	-	312	212	-	-	1.49E-02	2.00E-02
PROPER	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	15	-	-	1.02E-03	1.41E-03
PROPER	BP	GO:0050819	negative regulation of coagulation	-	54	20	-	-	1.05E-03	1.88E-03
PROPER	BP	GO:0031647	regulation of protein stability	-	327	226	-	-	6.17E-03	2.13E-02
PROPER	BP	GO:0017004	cytochrome complex assembly	-	40	30	-	-	8.07E-04	2.82E-03
PROPER	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	43	-	-	2.33E-03	4.11E-03
PROPER	BP	GO:0097212	lysosomal membrane organization	-	15	11	-	-	3.49E-04	1.06E-03
PROPER	CC	GO:0050805	negative regulation of synaptic transmission	-	55	13	-	-	3.48E-04	1.29E-03
PROPER	BP	GO:0043248	proteasome assembly	-	13	13	-	-	3.44E-04	1.29E-03
PROPER	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	22	-	-	6.55E-04	2.11E-03
PROPER	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	15	-	-	8.71E-03	1.41E-03
PROPER	BP	GO:0016054	organic acid catabolic process	-	251	115	-	-	6.09E-03	1.08E-02
PROPER	BP	GO:0050890	cognition	-	317	112	-	-	3.12E-03	1.06E-02
PROPER	BP	GO:0008033	tRNA processing	-	136	102	-	-	2.35E-03	9.63E-03
PROPER	BP	GO:0046661	male sex differentiation	-	171	66	-	-	1.74E-03	6.22E-03
PROPER	BP	GO:0035188	hatching	-	27	16	-	-	4.63E-04	1.53E-03
PROPER	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	45	-	-	1.44E-03	4.23E-03
PROPER	BP	GO:1990778	protein localization to cell periphery	-	346	190	-	-	8.30E-03	1.78E-02
PROPER	BP	GO:0061326	renal tubule development	-	103	32	-	-	7.91E-04	3.05E-03
PROPER	BP	GO:0051258	protein polymerization	-	280	182	-	-	7.89E-03	1.71E-02
PROPER	BP	GO:0071985	multivesicular body sorting pathway	-	56	42	-	-	1.02E-03	3.99E-03
PROPER	BP	GO:0006450	regulation of translational fidelity	-	18	14	-	-	3.42E-04	1.41E-03
PROPER	BP	GO:0060325	face morphogenesis	-	31	12	-	-	8.25E-04	1.17E-03
PROPER	BP	GO:0090559	regulation of membrane permeability	-	72	41	-	-	7.44E-03	3.88E-03
PROPER	BP	GO:0031579	membrane raft organization	-	25	17	-	-	1.26E-03	1.64E-03
PROPER	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	12	-	-	3.43E-04	1.17E-03
PROPER	BP	GO:0046460	neutral lipid biosynthetic process	-	50	19	-	-	4.69E-04	1.88E-03
PROPER	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	44	-	-	1.01E-03	4.23E-03
PROPER	BP	GO:0002250	adaptive immune response	-	753	155	-	-	1.07E-02	1.46E-02
PROPER	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	108	-	-	3.50E-03	1.02E-02
PROPER	CC	GO:0048167	regulation of synaptic plasticity	-	210	66	-	-	3.15E-03	6.22E-03
PROPER	BP	GO:1903708	positive regulation of hemopoiesis	-	184	80	-	-	2.77E-03	7.52E-03
PROPER	BP	GO:1903008	organelle disassembly	-	154	114	-	-	4.22E-03	1.08E-02
PROPER	BP	GO:0001709	cell fate determination	-	44	13	-	-	3.49E-04	1.29E-03
PROPER	BP	GO:0045058	T cell selection	-	53	25	-	-	1.29E-03	2.35E-03
PROPER	CC	GO:0032387	negative regulation of intracellular transport	-	51	28	-	-	2.33E-03	2.70E-03
PROPER	BP	GO:0072091	regulation of stem cell proliferation	-	91	31	-	-	1.21E-03	2.94E-03
PROPER	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	25	-	-	6.93E-04	2.35E-03
PROPER	BP	GO:0099084	postsynaptic specialization organization	-	44	15	-	-	4.66E-04	1.41E-03
PROPER	BP	GO:0071501	cellular response to sterol depletion	-	15	11	-	-	3.46E-04	1.06E-03
PROPER	BP	GO:0060384	innervation	-	27	15	-	-	1.32E-03	1.41E-03
PROPER	BP	GO:0032535	regulation of cellular component size	-	360	189	-	-	5.90E-03	1.78E-02
PROPER	MF	GO:0098631	cell adhesion mediator activity	-	64	28	-	-	1.68E-03	2.70E-03
PROPER	BP	GO:0046112	nucleobase biosynthetic process	-	18	16	-	-	1.34E-02	1.53E-03
PROPER	BP	GO:0071453	cellular response to oxygen levels	-	168	84	-	-	2.58E-03	7.98E-03
PROPER	BP	GO:0090399	replicative senescence	-	17	12	-	-	3.14E-04	1.17E-03
PROPER	BP	GO:0031342	negative regulation of cell killing	-	29	11	-	-	1.19E-01	1.06E-03
PROPER	BP	GO:0070585	protein localization to mitochondrion	-	125	104	-	-	2.75E-03	9.86E-03
PROPER	BP	GO:0044242	cellular lipid catabolic process	-	224	93	-	-	4.16E-03	8.81E-03
PROPER	BP	GO:0002931	response to ischemia	-	58	24	-	-	5.80E-04	2.35E-03
PROPER	BP	GO:0043062	extracellular structure organization	-	317	111	-	-	8.27E-03	1.05E-02
PROPER	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	11	-	-	3.39E-04	1.06E-03
PROPER	BP	GO:0061005	cell differentiation involved in kidney development	-	58	24	-	-	5.81E-04	2.35E-03
PROPER	BP	GO:0030397	membrane disassembly	-	11	11	-	-	1.90E-03	1.06E-03
PROPER	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	17	-	-	2.31E-03	1.64E-03
PROPER	BP	GO:0060420	regulation of heart growth	-	74	23	-	-	5.77E-04	2.23E-03
PROPER	BP	GO:0009755	hormone-mediated signaling pathway	-	221	108	-	-	4.34E-03	1.02E-02
PROPER	BP	GO:0022612	gland morphogenesis	-	124	42	-	-	2.62E-03	3.99E-03
PROPER	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	19	-	-	4.56E-04	1.88E-03
PROPER	MF	GO:0140416	transcription regulator inhibitor activity	-	26	15	-	-	4.54E-04	1.41E-03
PROPER	BP	GO:0044782	cilium organization	-	400	224	-	-	6.63E-03	2.11E-02
PROPER	BP	GO:0090130	tissue migration	-	379	167	-	-	9.24E-03	1.57E-02
PROPER	BP	GO:1990845	adaptive thermogenesis	-	166	75	-	-	2.49E-03	7.05E-03
PROPER	BP	GO:0071320	cellular response to cAMP	-	54	19	-	-	6.19E-04	1.88E-03
PROPER	BP	GO:0015844	monoamine transport	-	88	18	-	-	4.43E-04	1.76E-03
PROPER	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	17	-	-	4.36E-04	1.64E-03
PROPER	BP	GO:0071392	cellular response to estradiol stimulus	-	40	20	-	-	1.13E-03	1.88E-03
PROPER	BP	GO:0009314	response to radiation	-	449	240	-	-	8.13E-03	2.25E-02
PROPER	BP	GO:0009451	RNA modification	-	169	126	-	-	7.23E-03	1.19E-02
PROPER	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	28	-	-	1.04E-03	2.70E-03
PROPER	BP	GO:1903729	regulation of plasma membrane organization	-	17	11	-	-	4.11E-03	1.06E-03
PROPER	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	84	-	-	2.50E-03	7.98E-03
PROPER	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	13	-	-	3.48E-04	1.29E-03
PROPER	BP	GO:0015807	L-amino acid transport	-	94	38	-	-	1.23E-03	3.64E-03
PROPER	BP	GO:0032941	secretion by tissue	-	85	30	-	-	8.08E-04	2.82E-03
PROPER	BP	GO:0046605	regulation of centrosome cycle	-	54	42	-	-	1.27E-03	3.99E-03
PROPER	BP	GO:0048753	pigment granule organization	-	40	26	-	-	6.99E-04	2.47E-03
PROPER	BP	GO:0003014	renal system process	-	130	34	-	-	5.63E-02	3.29E-03
PROPER	CC	GO:0070286	axonemal dynein complex assembly	-	40	11	-	-	3.52E-04	1.06E-03
PROPER	BP	GO:0045598	regulation of fat cell differentiation	-	148	44	-	-	1.22E-03	4.23E-03
PROPER	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	101	-	-	3.61E-03	9.51E-03
PROPER	BP	GO:1904646	cellular response to amyloid-beta	-	44	19	-	-	1.18E-03	1.88E-03
PROPER	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	47	-	-	5.22E-03	4.46E-03
PROPER	BP	GO:0008340	determination of adult lifespan	-	23	12	-	-	3.50E-04	1.17E-03
PROPER	BP	GO:0039694	viral RNA genome replication	-	30	20	-	-	8.44E-02	1.88E-03
PROPER	BP	GO:0071709	membrane assembly	-	68	42	-	-	1.42E-03	3.99E-03
PROPER	BP	GO:0008217	regulation of blood pressure	-	186	48	-	-	1.88E-03	4.58E-03
PROPER	BP	GO:0043101	purine-containing compound salvage	-	15	12	-	-	3.49E-04	1.17E-03
PROPER	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	27	-	-	6.80E-04	2.58E-03
PROPER	CC	GO:0042770	signal transduction in response to DNA damage	-	186	135	-	-	4.06E-03	1.27E-02
PROPER	BP	GO:0002200	somatic diversification of immune receptors	-	78	52	-	-	3.03E-03	4.93E-03
PROPER	BP	GO:0035315	hair cell differentiation	-	52	19	-	-	4.49E-04	1.88E-03
PROPER	BP	GO:0048645	animal organ formation	-	62	22	-	-	5.83E-04	2.11E-03
PROPER	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	64	-	-	2.33E-03	6.11E-03
PROPER	BP	GO:0033627	cell adhesion mediated by integrin	-	87	34	-	-	4.33E-03	3.29E-03
PROPER	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	17	-	-	4.51E-04	1.64E-03
PROPER	BP	GO:0035107	appendage morphogenesis	-	147	57	-	-	1.84E-03	5.40E-03
PROPER	BP	GO:1903707	negative regulation of hemopoiesis	-	116	39	-	-	1.24E-03	3.76E-03
PROPER	CC	GO:0048208	COPII vesicle coating	-	27	22	-	-	5.71E-04	2.11E-03
PROPER	BP	GO:0030149	sphingolipid catabolic process	-	32	13	-	-	3.47E-04	1.29E-03
PROPER	BP	GO:0050994	regulation of lipid catabolic process	-	61	16	-	-	4.68E-04	1.53E-03
PROPER	BP	GO:0009593	detection of chemical stimulus	-	511	15	-	-	3.13E-03	1.41E-03
PROPER	BP	GO:0045727	positive regulation of translation	-	141	101	-	-	2.75E-03	9.51E-03
PROPER	CC	GO:0032388	positive regulation of intracellular transport	-	137	89	-	-	3.08E-03	8.45E-03
PROPER	BP	GO:0002027	regulation of heart rate	-	106	37	-	-	1.72E-03	3.52E-03
PROPER	BP	GO:0050879	multicellular organismal movement	-	118	43	-	-	3.61E-03	4.11E-03
PROPER	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	27	-	-	8.41E-04	2.58E-03
PROPER	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	27	-	-	7.41E-03	2.58E-03
PROPER	BP	GO:0048515	spermatid differentiation	-	208	72	-	-	2.09E-03	6.81E-03
PROPER	BP	GO:0072132	mesenchyme morphogenesis	-	57	19	-	-	4.64E-04	1.88E-03
PROPER	MF	GO:0042887	amide transmembrane transporter activity	-	33	11	-	-	3.50E-04	1.06E-03
PROPER	BP	GO:0007130	synaptonemal complex assembly	-	23	12	-	-	3.52E-04	1.17E-03
PROPER	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	19	-	-	1.84E-03	1.88E-03
PROPER	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	15	-	-	8.93E-02	1.41E-03
PROPER	BP	GO:0060119	inner ear receptor cell development	-	44	22	-	-	5.59E-04	2.11E-03
PROPER	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	15	-	-	1.11E-03	1.41E-03
PROPER	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	13	-	-	3.39E-04	1.29E-03
PROPER	BP	GO:1901983	regulation of protein acetylation	-	26	17	-	-	1.09E-03	1.64E-03
PROPER	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	85	-	-	5.78E-03	7.98E-03
PROPER	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	35	-	-	1.16E-03	3.29E-03
PROPER	BP	GO:0010883	regulation of lipid storage	-	53	21	-	-	5.82E-04	2.00E-03
PROPER	BP	GO:1905954	positive regulation of lipid localization	-	110	30	-	-	7.50E-04	2.82E-03
PROPER	BP	GO:0002209	behavioral defense response	-	39	14	-	-	1.01E-01	1.41E-03
PROPER	BP	GO:0072523	purine-containing compound catabolic process	-	146	77	-	-	3.03E-03	7.28E-03
PROPER	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	15	-	-	7.24E-04	1.41E-03
PROPER	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	22	-	-	5.67E-04	2.11E-03
PROPER	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	51	-	-	1.98E-03	4.81E-03
PROPER	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	31	-	-	1.22E-03	2.94E-03
PROPER	BP	GO:0031345	negative regulation of cell projection organization	-	195	85	-	-	2.38E-03	7.98E-03
PROPER	BP	GO:0048278	vesicle docking	-	64	40	-	-	1.35E-03	3.76E-03
PROPER	BP	GO:0035050	embryonic heart tube development	-	86	39	-	-	9.00E-04	3.76E-03
PROPER	BP	GO:0030168	platelet activation	-	135	59	-	-	6.20E-03	5.64E-03
PROPER	BP	GO:0008213	protein alkylation	-	58	40	-	-	1.12E-03	3.76E-03
PROPER	BP	GO:0002253	activation of immune response	-	529	226	-	-	6.99E-03	2.13E-02
PROPER	BP	GO:0031529	ruffle organization	-	55	33	-	-	7.93E-04	3.17E-03
PROPER	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	14	-	-	3.50E-02	1.41E-03
PROPER	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	27	-	-	2.51E-02	2.58E-03
PROPER	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	20	-	-	4.60E-02	1.88E-03
PROPER	BP	GO:0035304	regulation of protein dephosphorylation	-	87	52	-	-	1.81E-03	4.93E-03
PROPER	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	98	-	-	3.28E-03	9.28E-03
PROPER	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	170	-	-	5.74E-03	1.60E-02
PROPER	BP	GO:0051785	positive regulation of nuclear division	-	61	26	-	-	6.68E-04	2.47E-03
PROPER	BP	GO:0044786	cell cycle DNA replication	-	45	37	-	-	9.00E-04	3.52E-03
PROPER	BP	GO:0051299	centrosome separation	-	15	14	-	-	3.45E-04	1.41E-03
PROPER	BP	GO:0048145	regulation of fibroblast proliferation	-	87	48	-	-	1.62E-03	4.58E-03
PROPER	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	14	-	-	3.49E-04	1.41E-03
PROPER	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	128	-	-	4.73E-03	1.21E-02
PROPER	BP	GO:0009306	protein secretion	-	376	147	-	-	4.39E-03	1.39E-02
PROPER	CC	GO:0008333	endosome to lysosome transport	-	73	47	-	-	1.13E-03	4.46E-03
PROPER	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	11	-	-	3.45E-04	1.06E-03
PROPER	BP	GO:0003016	respiratory system process	-	39	17	-	-	4.35E-04	1.64E-03
PROPER	BP	GO:0045732	positive regulation of protein catabolic process	-	202	127	-	-	3.55E-03	1.20E-02
PROPER	BP	GO:0031589	cell-substrate adhesion	-	360	171	-	-	7.59E-03	1.61E-02
PROPER	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	30	-	-	8.14E-04	2.82E-03
PROPER	BP	GO:1904018	positive regulation of vasculature development	-	185	65	-	-	3.28E-03	6.11E-03
PROPER	BP	GO:0010948	negative regulation of cell cycle process	-	317	212	-	-	5.30E-03	2.00E-02
PROPER	BP	GO:0050953	sensory perception of light stimulus	-	223	67	-	-	1.58E-03	6.34E-03
PROPER	BP	GO:0009303	rRNA transcription	-	37	31	-	-	1.78E-03	2.94E-03
PROPER	BP	GO:0035601	protein deacylation	-	56	36	-	-	8.82E-04	3.41E-03
PROPER	BP	GO:0061952	midbody abscission	-	18	15	-	-	4.64E-04	1.41E-03
PROPER	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	13	-	-	3.45E-04	1.29E-03
PROPER	BP	GO:0071300	cellular response to retinoic acid	-	66	20	-	-	5.68E-04	1.88E-03
PROPER	BP	GO:0045830	positive regulation of isotype switching	-	28	18	-	-	1.63E-03	1.76E-03
PROPER	BP	GO:0046697	decidualization	-	26	12	-	-	3.36E-03	1.17E-03
PROPER	BP	GO:0048284	organelle fusion	-	456	221	-	-	6.31E-03	2.08E-02
PROPER	BP	GO:0051588	regulation of neurotransmitter transport	-	99	35	-	-	1.72E-03	3.29E-03
PROPER	BP	GO:0051784	negative regulation of nuclear division	-	63	49	-	-	2.83E-03	4.70E-03
PROPER	BP	GO:0044703	multi-organism reproductive process	-	209	76	-	-	4.34E-03	7.16E-03
PROPER	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	62	-	-	2.07E-03	5.87E-03
PROPER	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	18	-	-	4.56E-04	1.76E-03
PROPER	BP	GO:0099022	vesicle tethering	-	32	26	-	-	6.95E-04	2.47E-03
PROPER	MF	GO:0004930	G protein-coupled receptor activity	-	873	50	-	-	1.28E-03	4.70E-03
PROPER	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	17	-	-	4.55E-04	1.64E-03
PROPER	BP	GO:0048857	neural nucleus development	-	65	33	-	-	1.84E-03	3.17E-03
PROPER	BP	GO:0048663	neuron fate commitment	-	74	19	-	-	4.66E-04	1.88E-03
PROPER	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	59	-	-	1.63E-03	5.64E-03
PROPER	BP	GO:0106027	neuron projection organization	-	90	44	-	-	1.57E-03	4.23E-03
PROPER	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	49	-	-	2.62E-03	4.70E-03
PROPER	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	18	-	-	3.24E-03	1.76E-03
PROPER	CC	GO:0043410	positive regulation of MAPK cascade	-	494	165	-	-	4.69E-03	1.55E-02
PROPER	BP	GO:0045685	regulation of glial cell differentiation	-	77	24	-	-	1.06E-03	2.35E-03
PROPER	BP	GO:0043414	macromolecule methylation	-	138	103	-	-	3.49E-03	9.75E-03
PROPER	BP	GO:0048268	clathrin coat assembly	-	16	12	-	-	3.47E-04	1.17E-03
PROPER	BP	GO:0050886	endocrine process	-	93	23	-	-	5.66E-04	2.23E-03
PROPER	BP	GO:0045807	positive regulation of endocytosis	-	155	68	-	-	2.85E-03	6.46E-03
PROPER	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	38	-	-	2.02E-03	3.64E-03
PROPER	BP	GO:0048308	organelle inheritance	-	14	11	-	-	6.20E-04	1.06E-03
PROPER	BP	GO:0001829	trophectodermal cell differentiation	-	19	13	-	-	3.48E-04	1.29E-03
PROPER	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	27	-	-	2.07E-03	2.58E-03
PROPER	BP	GO:0034394	protein localization to cell surface	-	69	40	-	-	1.65E-03	3.76E-03
PROPER	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	18	-	-	2.84E-03	1.76E-03
PROPER	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	14	-	-	3.48E-04	1.41E-03
PROPER	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	44	-	-	1.46E-03	4.23E-03
PROPER	MF	GO:0051100	negative regulation of binding	-	161	92	-	-	3.04E-03	8.69E-03
PROPER	BP	GO:0001818	negative regulation of cytokine production	-	379	110	-	-	2.92E-03	1.03E-02
PROPER	BP	GO:0003151	outflow tract morphogenesis	-	81	29	-	-	5.15E-03	2.82E-03
PROPER	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	29	-	-	1.30E-03	2.82E-03
PROPER	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	24	-	-	5.57E-04	2.35E-03
PROPER	BP	GO:0046621	negative regulation of organ growth	-	39	15	-	-	4.65E-04	1.41E-03
PROPER	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	39	-	-	1.68E-03	3.76E-03
PROPER	BP	GO:0032368	regulation of lipid transport	-	149	46	-	-	1.67E-03	4.34E-03
PROPER	BP	GO:0055094	response to lipoprotein particle	-	34	12	-	-	1.00E-03	1.17E-03
PROPER	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	111	-	-	3.99E-03	1.05E-02
PROPER	BP	GO:0033002	muscle cell proliferation	-	249	87	-	-	2.69E-03	8.22E-03
PROPER	BP	GO:0048880	sensory system development	-	399	151	-	-	5.06E-03	1.42E-02
PROPER	BP	GO:0043331	response to dsRNA	-	56	23	-	-	8.76E-04	2.23E-03
PROPER	BP	GO:0051904	pigment granule transport	-	23	15	-	-	4.30E-03	1.41E-03
PROPER	BP	GO:1901679	nucleotide transmembrane transport	-	32	20	-	-	4.22E-02	1.88E-03
PROPER	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	14	-	-	3.49E-04	1.41E-03
PROPER	BP	GO:0033363	secretory granule organization	-	63	32	-	-	8.09E-04	3.05E-03
PROPER	BP	GO:0060479	lung cell differentiation	-	28	13	-	-	3.48E-04	1.29E-03
PROPER	BP	GO:0120009	intermembrane lipid transfer	-	52	19	-	-	4.46E-04	1.88E-03
PROPER	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	1.16E-03	1.41E-03
PROPER	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	13	-	-	1.41E-03	1.29E-03
PROPER	BP	GO:0033622	integrin activation	-	26	12	-	-	1.81E-03	1.17E-03
PROPER	BP	GO:2000773	negative regulation of cellular senescence	-	25	14	-	-	3.42E-04	1.41E-03
PROPER	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	20	-	-	5.83E-04	1.88E-03
PROPER	BP	GO:0050820	positive regulation of coagulation	-	30	11	-	-	1.33E-03	1.06E-03
PROPER	BP	GO:0072164	mesonephric tubule development	-	98	31	-	-	8.14E-04	2.94E-03
PROPER	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	47	-	-	1.29E-03	4.46E-03
PROPER	BP	GO:1903524	positive regulation of blood circulation	-	39	12	-	-	3.14E-04	1.17E-03
PROPER	BP	GO:0030901	midbrain development	-	87	44	-	-	2.92E-03	4.23E-03
PROPER	BP	GO:0048485	sympathetic nervous system development	-	22	11	-	-	3.14E-03	1.06E-03
PROPER	BP	GO:0007162	negative regulation of cell adhesion	-	310	125	-	-	3.20E-03	1.17E-02
PROPER	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	28	-	-	5.13E-03	2.70E-03
PROPER	BP	GO:0002687	positive regulation of leukocyte migration	-	147	50	-	-	2.48E-03	4.70E-03
PROPER	BP	GO:0110154	RNA decapping	-	19	16	-	-	4.65E-04	1.53E-03
PROPER	BP	GO:0034605	cellular response to heat	-	66	40	-	-	2.06E-03	3.76E-03
PROPER	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	167	-	-	4.71E-03	1.57E-02
PROPER	BP	GO:0005996	monosaccharide metabolic process	-	250	112	-	-	4.86E-03	1.06E-02
PROPER	BP	GO:0033555	multicellular organismal response to stress	-	90	27	-	-	1.08E-02	2.58E-03
PROPER	BP	GO:0002262	myeloid cell homeostasis	-	172	110	-	-	3.06E-03	1.03E-02
PROPER	BP	GO:0000966	RNA 5'-end processing	-	39	32	-	-	1.27E-03	3.05E-03
PROPER	BP	GO:0050688	regulation of defense response to virus	-	65	31	-	-	1.63E-03	2.94E-03
PROPER	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	138	-	-	7.44E-03	1.30E-02
PROPER	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	12	-	-	3.48E-04	1.17E-03
PROPER	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	118	-	-	5.15E-03	1.12E-02
PROPER	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	15	-	-	4.47E-04	1.41E-03
PROPER	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	13	-	-	1.72E-03	1.29E-03
PROPER	BP	GO:0022618	protein-RNA complex assembly	-	227	171	-	-	5.84E-03	1.61E-02
PROPER	BP	GO:0051147	regulation of muscle cell differentiation	-	162	59	-	-	1.99E-03	5.64E-03
PROPER	BP	GO:0006066	alcohol metabolic process	-	374	160	-	-	3.79E-03	1.50E-02
PROPER	BP	GO:0090102	cochlea development	-	50	18	-	-	4.44E-04	1.76E-03
PROPER	BP	GO:0045933	positive regulation of muscle contraction	-	49	15	-	-	6.17E-04	1.41E-03
PROPER	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	29	-	-	1.84E-03	2.82E-03
PROPER	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	28	-	-	2.14E-02	2.70E-03
PROPER	BP	GO:0043555	regulation of translation in response to stress	-	22	18	-	-	5.19E-04	1.76E-03
PROPER	BP	GO:0032922	circadian regulation of gene expression	-	71	41	-	-	3.30E-03	3.88E-03
PROPER	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	21	-	-	5.80E-04	2.00E-03
PROPER	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	26	-	-	6.61E-04	2.47E-03
PROPER	BP	GO:0038179	neurotrophin signaling pathway	-	38	17	-	-	4.62E-04	1.64E-03
PROPER	BP	GO:0140253	cell-cell fusion	-	62	19	-	-	1.31E-03	1.88E-03
PROPER	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	21	-	-	2.53E-03	2.00E-03
PROPER	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	40	-	-	1.17E-02	3.76E-03
PROPER	BP	GO:0001941	postsynaptic membrane organization	-	37	14	-	-	1.71E-02	1.41E-03
PROPER	BP	GO:0051293	establishment of spindle localization	-	57	35	-	-	2.24E-03	3.29E-03
PROPER	BP	GO:0023061	signal release	-	491	152	-	-	5.09E-03	1.43E-02
PROPER	BP	GO:0043114	regulation of vascular permeability	-	49	18	-	-	4.96E-03	1.76E-03
PROPER	BP	GO:0018126	protein hydroxylation	-	26	18	-	-	2.71E-02	1.76E-03
PROPER	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	28	-	-	1.45E-03	2.70E-03
PROPER	BP	GO:0008360	regulation of cell shape	-	139	77	-	-	3.77E-03	7.28E-03
PROPER	BP	GO:0051222	positive regulation of protein transport	-	249	122	-	-	3.81E-03	1.15E-02
PROPER	CC	GO:0140632	canonical inflammasome complex assembly	-	40	23	-	-	7.60E-04	2.23E-03
PROPER	MF	GO:0034260	negative regulation of GTPase activity	-	36	20	-	-	5.74E-04	1.88E-03
PROPER	BP	GO:0045739	positive regulation of DNA repair	-	128	93	-	-	3.42E-03	8.81E-03
PROPER	BP	GO:0045185	maintenance of protein location	-	95	67	-	-	4.55E-03	6.34E-03
PROPER	BP	GO:0003158	endothelium development	-	140	63	-	-	3.57E-03	5.99E-03
PROPER	CC	GO:0072595	maintenance of protein localization in organelle	-	42	32	-	-	1.16E-03	3.05E-03
PROPER	BP	GO:0051224	negative regulation of protein transport	-	122	48	-	-	1.55E-03	4.58E-03
PROPER	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	52	-	-	2.08E-03	4.93E-03
PROPER	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	14	-	-	3.39E-04	1.41E-03
PROPER	MF	GO:0003713	transcription coactivator activity	-	281	187	-	-	5.76E-03	1.76E-02
PROPER	BP	GO:0021885	forebrain cell migration	-	63	28	-	-	6.87E-04	2.70E-03
PROPER	BP	GO:0007405	neuroblast proliferation	-	81	29	-	-	1.44E-03	2.82E-03
PROPER	BP	GO:0009581	detection of external stimulus	-	137	34	-	-	8.11E-04	3.29E-03
PROPER	BP	GO:1990542	mitochondrial transmembrane transport	-	93	62	-	-	2.32E-03	5.87E-03
PROPER	BP	GO:0045862	positive regulation of proteolysis	-	353	188	-	-	4.93E-03	1.77E-02
PROPER	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	21	-	-	5.75E-04	2.00E-03
PROPER	BP	GO:0031100	animal organ regeneration	-	66	32	-	-	1.24E-03	3.05E-03
PROPER	BP	GO:0045684	positive regulation of epidermis development	-	33	13	-	-	3.46E-04	1.29E-03
PROPER	BP	GO:1900047	negative regulation of hemostasis	-	51	18	-	-	8.72E-04	1.76E-03
PROPER	BP	GO:0021517	ventral spinal cord development	-	47	16	-	-	4.51E-04	1.53E-03
PROPER	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	50	-	-	1.51E-03	4.70E-03
PROPER	MF	GO:0034497	protein localization to phagophore assembly site	-	16	13	-	-	3.50E-04	1.29E-03
PROPER	BP	GO:0097722	sperm motility	-	133	38	-	-	9.01E-04	3.64E-03
PROPER	BP	GO:0051231	spindle elongation	-	14	11	-	-	3.40E-04	1.06E-03
PROPER	BP	GO:0042490	mechanoreceptor differentiation	-	67	29	-	-	6.73E-04	2.82E-03
PROPER	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	21	-	-	1.87E-03	2.00E-03
PROPER	BP	GO:0035148	tube formation	-	155	72	-	-	2.90E-03	6.81E-03
PROPER	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	37	-	-	2.94E-03	3.52E-03
PROPER	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	56	-	-	2.77E-03	5.28E-03
PROPER	BP	GO:0031123	RNA 3'-end processing	-	79	62	-	-	2.37E-03	5.87E-03
PROPER	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	44	-	-	1.66E-03	4.23E-03
PROPER	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	15	-	-	4.55E-04	1.41E-03
PROPER	CC	GO:0007097	nuclear migration	-	24	17	-	-	2.84E-03	1.64E-03
PROPER	BP	GO:0045229	external encapsulating structure organization	-	319	111	-	-	6.86E-03	1.05E-02
PROPER	BP	GO:0006885	regulation of pH	-	104	43	-	-	1.03E-03	4.11E-03
PROPER	BP	GO:0001667	ameboidal-type cell migration	-	495	219	-	-	9.36E-03	2.07E-02
PROPER	BP	GO:1990840	response to lectin	-	22	11	-	-	3.50E-04	1.06E-03
PROPER	BP	GO:0031018	endocrine pancreas development	-	47	18	-	-	4.15E-03	1.76E-03
PROPER	BP	GO:0001708	cell fate specification	-	108	32	-	-	1.63E-03	3.05E-03
PROPER	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	37	-	-	9.00E-04	3.52E-03
PROPER	BP	GO:0032970	regulation of actin filament-based process	-	368	208	-	-	1.04E-02	1.96E-02
PROPER	BP	GO:0042440	pigment metabolic process	-	80	38	-	-	6.28E-03	3.64E-03
PROPER	BP	GO:1901606	alpha-amino acid catabolic process	-	101	42	-	-	1.03E-03	3.99E-03
PROPER	BP	GO:0062197	cellular response to chemical stress	-	299	168	-	-	5.98E-03	1.59E-02
PROPER	BP	GO:1901890	positive regulation of cell junction assembly	-	106	35	-	-	1.92E-03	3.29E-03
PROPER	BP	GO:0070988	demethylation	-	27	13	-	-	3.49E-04	1.29E-03
PROPER	BP	GO:1901655	cellular response to ketone	-	107	49	-	-	1.22E-03	4.70E-03
PROPER	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	13	-	-	3.49E-04	1.29E-03
PROPER	BP	GO:0006968	cellular defense response	-	52	11	-	-	9.70E-04	1.06E-03
PROPER	BP	GO:0055006	cardiac cell development	-	93	36	-	-	1.31E-03	3.41E-03
PROPER	BP	GO:0031365	N-terminal protein amino acid modification	-	30	20	-	-	5.64E-04	1.88E-03
PROPER	BP	GO:0060004	reflex	-	63	22	-	-	5.81E-04	2.11E-03
PROPER	BP	GO:0044706	multi-multicellular organism process	-	217	77	-	-	3.71E-03	7.28E-03
PROPER	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	96	-	-	2.79E-03	9.04E-03
PROPER	BP	GO:0006026	aminoglycan catabolic process	-	34	15	-	-	4.58E-04	1.41E-03
PROPER	BP	GO:0031294	lymphocyte costimulation	-	47	21	-	-	5.77E-04	2.00E-03
PROPER	BP	GO:0050768	negative regulation of neurogenesis	-	150	57	-	-	1.36E-03	5.40E-03
PROPER	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	74	-	-	3.14E-03	7.05E-03
PROPER	BP	GO:0090068	positive regulation of cell cycle process	-	262	169	-	-	3.74E-03	1.60E-02
PROPER	MF	GO:0022803	passive transmembrane transporter activity	-	676	153	-	-	5.96E-03	1.44E-02
PROPER	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	21	-	-	1.09E-03	2.00E-03
PROPER	BP	GO:1902115	regulation of organelle assembly	-	210	142	-	-	4.00E-03	1.34E-02
PROPER	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	32	-	-	2.63E-03	3.05E-03
PROPER	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	88	-	-	2.91E-03	8.34E-03
PROPER	BP	GO:0043171	peptide catabolic process	-	19	11	-	-	1.43E-02	1.06E-03
PROPER	BP	GO:0046622	positive regulation of organ growth	-	52	15	-	-	4.63E-04	1.41E-03
PROPER	BP	GO:0051952	regulation of amine transport	-	98	24	-	-	1.59E-03	2.35E-03
PROPER	BP	GO:0006730	one-carbon metabolic process	-	24	17	-	-	4.86E-02	1.64E-03
PROPER	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	11	-	-	3.46E-04	1.06E-03
PROPER	CC	GO:0032365	intracellular lipid transport	-	51	28	-	-	6.62E-04	2.70E-03
PROPER	BP	GO:0045048	protein insertion into ER membrane	-	30	22	-	-	5.73E-04	2.11E-03
PROPER	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	30	-	-	1.83E-03	2.82E-03
PROPER	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	68	-	-	2.13E-03	6.46E-03
PROPER	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	14	-	-	3.45E-04	1.41E-03
PROPER	BP	GO:0071398	cellular response to fatty acid	-	35	11	-	-	3.41E-04	1.06E-03
PROPER	BP	GO:0097581	lamellipodium organization	-	91	63	-	-	2.44E-03	5.99E-03
PROPER	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	23	-	-	1.32E-03	2.23E-03
PROPER	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	133	-	-	3.27E-03	1.26E-02
PROPER	BP	GO:0060326	cell chemotaxis	-	311	92	-	-	2.80E-03	8.69E-03
PROPER	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	16	-	-	4.48E-04	1.53E-03
PROPER	BP	GO:0016485	protein processing	-	248	118	-	-	3.67E-03	1.12E-02
PROPER	BP	GO:0009649	entrainment of circadian clock	-	30	11	-	-	5.03E-02	1.06E-03
PROPER	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	34	-	-	7.69E-03	3.29E-03
PROPER	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	41	-	-	2.25E-03	3.88E-03
PROPER	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	17	-	-	5.30E-04	1.64E-03
PROPER	BP	GO:0006517	protein deglycosylation	-	26	18	-	-	4.64E-04	1.76E-03
PROPER	BP	GO:0031348	negative regulation of defense response	-	282	100	-	-	6.86E-03	9.39E-03
PROPER	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	30	-	-	9.37E-04	2.82E-03
PROPER	BP	GO:0007606	sensory perception of chemical stimulus	-	535	18	-	-	1.01E-03	1.76E-03
PROPER	BP	GO:0061180	mammary gland epithelium development	-	68	24	-	-	3.34E-03	2.35E-03
PROPER	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	113	-	-	4.30E-03	1.07E-02
PROPER	CC	GO:0051169	nuclear transport	-	325	233	-	-	6.00E-03	2.20E-02
PROPER	BP	GO:0071496	cellular response to external stimulus	-	74	34	-	-	4.26E-03	3.29E-03
PROPER	BP	GO:0032094	response to food	-	37	11	-	-	3.30E-04	1.06E-03
PROPER	BP	GO:0046434	organophosphate catabolic process	-	232	106	-	-	3.23E-03	9.98E-03
PROPER	BP	GO:0060037	pharyngeal system development	-	29	12	-	-	3.43E-04	1.17E-03
PROPER	BP	GO:0009566	fertilization	-	205	61	-	-	1.67E-03	5.75E-03
PROPER	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	55	-	-	5.34E-03	5.17E-03
PROPER	BP	GO:0033044	regulation of chromosome organization	-	249	212	-	-	5.58E-03	2.00E-02
PROPER	BP	GO:0009309	amine biosynthetic process	-	38	14	-	-	3.39E-04	1.41E-03
PROPER	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	174	-	-	4.36E-03	1.64E-02
PROPER	BP	GO:0061900	glial cell activation	-	56	14	-	-	5.53E-04	1.41E-03
PROPER	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	57	-	-	8.01E-03	5.40E-03
PROPER	CC	GO:0140467	integrated stress response signaling	-	41	26	-	-	2.67E-03	2.47E-03
PROPER	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	226	-	-	6.41E-03	2.13E-02
PROPER	BP	GO:0090235	regulation of metaphase plate congression	-	13	11	-	-	1.13E-03	1.06E-03
PROPER	BP	GO:0043647	inositol phosphate metabolic process	-	44	18	-	-	4.62E-04	1.76E-03
PROPER	BP	GO:0016180	snRNA processing	-	28	20	-	-	1.53E-03	1.88E-03
PROPER	BP	GO:0051303	establishment of chromosome localization	-	104	84	-	-	3.85E-03	7.98E-03
PROPER	BP	GO:0051382	kinetochore assembly	-	16	14	-	-	3.43E-04	1.41E-03
PROPER	BP	GO:0031349	positive regulation of defense response	-	473	192	-	-	5.37E-03	1.81E-02
PROPER	BP	GO:0007164	establishment of tissue polarity	-	38	19	-	-	4.59E-04	1.88E-03
PROPER	BP	GO:0021515	cell differentiation in spinal cord	-	51	14	-	-	3.46E-04	1.41E-03
PROPER	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	14	-	-	3.44E-04	1.41E-03
PROPER	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	20	-	-	5.67E-04	1.88E-03
PROPER	BP	GO:0006605	protein targeting	-	327	227	-	-	6.67E-03	2.14E-02
PROPER	BP	GO:0061318	renal filtration cell differentiation	-	22	12	-	-	3.50E-04	1.17E-03
PROPER	BP	GO:0007566	embryo implantation	-	57	27	-	-	7.59E-04	2.58E-03
PROPER	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	17	-	-	4.52E-04	1.64E-03
PROPER	BP	GO:0061512	protein localization to cilium	-	394	220	-	-	5.77E-03	2.07E-02
PROPER	BP	GO:0051017	actin filament bundle assembly	-	161	89	-	-	4.17E-03	8.45E-03
PROPER	BP	GO:1905953	negative regulation of lipid localization	-	63	17	-	-	6.79E-03	1.64E-03
PROPER	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	25	-	-	6.05E-04	2.35E-03
PROPER	BP	GO:0021756	striatum development	-	21	14	-	-	3.51E-04	1.41E-03
PROPER	BP	GO:1901343	negative regulation of vasculature development	-	154	48	-	-	1.86E-03	4.58E-03
PROPER	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	99	-	-	4.16E-03	9.39E-03
PROPER	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	13	-	-	1.09E-01	1.29E-03
PROPER	BP	GO:1902414	protein localization to cell junction	-	107	48	-	-	1.74E-03	4.58E-03
PROPER	BP	GO:0051304	chromosome separation	-	80	68	-	-	3.05E-03	6.46E-03
PROPER	BP	GO:0090596	sensory organ morphogenesis	-	272	97	-	-	3.51E-03	9.16E-03
PROPER	BP	GO:0048709	oligodendrocyte differentiation	-	101	33	-	-	9.83E-04	3.17E-03
PROPER	BP	GO:0045017	glycerolipid biosynthetic process	-	254	126	-	-	2.97E-03	1.19E-02
PROPER	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	12	-	-	3.42E-04	1.17E-03
PROPER	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	14	-	-	1.28E-02	1.41E-03
PROPER	BP	GO:0001776	leukocyte homeostasis	-	108	54	-	-	1.95E-03	5.17E-03
PROPER	BP	GO:0050769	positive regulation of neurogenesis	-	240	108	-	-	4.06E-03	1.02E-02
PROPER	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	14	-	-	3.42E-04	1.41E-03
PROPER	BP	GO:0030193	regulation of blood coagulation	-	70	25	-	-	1.54E-03	2.35E-03
PROPER	BP	GO:0050866	negative regulation of cell activation	-	216	73	-	-	1.95E-03	6.93E-03
PROPER	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	15	-	-	4.61E-04	1.41E-03
PROPER	BP	GO:0033500	carbohydrate homeostasis	-	251	94	-	-	2.19E-03	8.92E-03
PROPER	BP	GO:0044088	regulation of vacuole organization	-	56	39	-	-	3.16E-03	3.76E-03
PROPER	CC	GO:0051457	maintenance of protein location in nucleus	-	23	18	-	-	1.09E-03	1.76E-03
PROPER	CC	GO:0099522	cytosolic region	-	20	13	-	-	7.65E-04	1.29E-03
PROPER	CC	GO:0000791	euchromatin	-	60	38	-	-	1.85E-03	3.64E-03
PROPER	CC	GO:0030666	endocytic vesicle membrane	-	196	80	-	-	2.28E-02	7.52E-03
PROPER	CC	GO:0098857	membrane microdomain	-	324	144	-	-	5.11E-03	1.36E-02
PROPER	CC	GO:0030312	external encapsulating structure	-	567	145	-	-	7.80E-03	1.36E-02
PROPER	CC	GO:0071027	nuclear RNA surveillance	-	14	12	-	-	3.32E-04	1.17E-03
PROPER	CC	GO:1990752	microtubule end	-	34	24	-	-	1.24E-03	2.35E-03
PROPER	CC	GO:0043204	perikaryon	-	156	43	-	-	1.75E-03	4.11E-03
PROPER	CC	GO:0097542	ciliary tip	-	48	35	-	-	9.20E-04	3.29E-03
PROPER	CC	GO:1905368	peptidase complex	-	124	95	-	-	6.22E-03	8.92E-03
PROPER	CC	GO:0000792	heterochromatin	-	98	72	-	-	2.41E-03	6.81E-03
PROPER	CC	GO:0097546	ciliary base	-	47	21	-	-	3.04E-03	2.00E-03
PROPER	CC	GO:0071819	DUBm complex	-	25	16	-	-	4.63E-04	1.53E-03
PROPER	CC	GO:0031201	SNARE complex	-	48	32	-	-	8.09E-04	3.05E-03
PROPER	CC	GO:0016324	apical plasma membrane	-	392	124	-	-	4.24E-03	1.17E-02
PROPER	CC	GO:0033260	nuclear DNA replication	-	40	33	-	-	7.87E-04	3.17E-03
PROPER	CC	GO:0044391	ribosomal subunit	-	203	183	-	-	8.43E-03	1.73E-02
PROPER	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	12	-	-	3.41E-04	1.17E-03
PROPER	CC	GO:0071013	catalytic step 2 spliceosome	-	88	83	-	-	2.25E-03	7.87E-03
PROPER	CC	GO:0031907	microbody lumen	-	51	28	-	-	6.92E-04	2.70E-03
PROPER	CC	GO:0098862	cluster of actin-based cell projections	-	162	60	-	-	2.67E-03	5.64E-03
PROPER	CC	GO:0098978	glutamatergic synapse	-	411	182	-	-	6.62E-03	1.71E-02
PROPER	CC	GO:0016363	nuclear matrix	-	127	93	-	-	3.40E-03	8.81E-03
PROPER	CC	GO:0031261	DNA replication preinitiation complex	-	46	38	-	-	2.98E-03	3.64E-03
PROPER	CC	GO:0097060	synaptic membrane	-	413	112	-	-	3.56E-03	1.06E-02
PROPER	CC	GO:0032432	actin filament bundle	-	249	107	-	-	4.09E-03	1.01E-02
PROPER	CC	GO:0008088	axo-dendritic transport	-	78	55	-	-	1.64E-03	5.17E-03
PROPER	CC	GO:0031519	PcG protein complex	-	38	26	-	-	1.63E-03	2.47E-03
PROPER	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	17	-	-	4.58E-04	1.64E-03
PROPER	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	103	-	-	2.62E-03	9.75E-03
PROPER	CC	GO:0000313	organellar ribosome	-	89	80	-	-	2.45E-03	7.52E-03
PROPER	CC	GO:0098791	Golgi apparatus subcompartment	-	378	203	-	-	8.05E-03	1.91E-02
PROPER	CC	GO:0099643	signal release from synapse	-	147	55	-	-	1.53E-03	5.17E-03
PROPER	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	36	-	-	1.89E-03	3.41E-03
PROPER	CC	GO:0030018	Z disc	-	129	67	-	-	6.39E-03	6.34E-03
PROPER	CC	GO:0032580	Golgi cisterna membrane	-	93	45	-	-	1.98E-02	4.23E-03
PROPER	CC	GO:1905360	GTPase complex	-	41	20	-	-	5.76E-04	1.88E-03
PROPER	CC	GO:0097540	axonemal central pair	-	161	54	-	-	1.31E-03	5.17E-03
PROPER	CC	GO:0042641	actomyosin	-	77	43	-	-	6.17E-03	4.11E-03
PROPER	CC	GO:0097386	glial cell projection	-	38	15	-	-	8.65E-04	1.41E-03
PROPER	CC	GO:0032588	trans-Golgi network membrane	-	102	56	-	-	2.03E-03	5.28E-03
PROPER	CC	GO:0070382	exocytic vesicle	-	224	96	-	-	2.93E-03	9.04E-03
PROPER	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	39	-	-	9.23E-04	3.76E-03
PROPER	CC	GO:0031903	microbody membrane	-	65	40	-	-	1.04E-03	3.76E-03
PROPER	CC	GO:0046930	pore complex	-	26	14	-	-	2.00E-02	1.41E-03
PROPER	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	172	-	-	5.43E-03	1.62E-02
PROPER	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	17	-	-	1.60E-03	1.64E-03
PROPER	CC	GO:0070993	translation preinitiation complex	-	19	18	-	-	1.54E-03	1.76E-03
PROPER	CC	GO:0016323	basolateral plasma membrane	-	239	85	-	-	4.02E-03	7.98E-03
PROPER	CC	GO:0042405	nuclear inclusion body	-	12	11	-	-	3.42E-04	1.06E-03
PROPER	CC	GO:0042645	mitochondrial nucleoid	-	45	40	-	-	7.57E-03	3.76E-03
PROPER	CC	GO:1902495	transmembrane transporter complex	-	408	108	-	-	2.67E-03	1.02E-02
PROPER	CC	GO:0098636	protein complex involved in cell adhesion	-	57	22	-	-	2.84E-03	2.11E-03
PROPER	CC	GO:0001917	photoreceptor inner segment	-	71	25	-	-	6.94E-04	2.35E-03
PROPER	CC	GO:0019897	extrinsic component of plasma membrane	-	156	69	-	-	4.33E-03	6.58E-03
PROPER	CC	GO:0031594	neuromuscular junction	-	73	35	-	-	1.47E-03	3.29E-03
PROPER	CC	GO:0000793	condensed chromosome	-	274	217	-	-	6.49E-03	2.04E-02
PROPER	CC	GO:0000922	spindle pole	-	172	137	-	-	3.10E-03	1.29E-02
PROPER	CC	GO:0120111	neuron projection cytoplasm	-	94	61	-	-	1.92E-03	5.75E-03
PROPER	CC	GO:0070971	endoplasmic reticulum exit site	-	32	20	-	-	5.71E-04	1.88E-03
PROPER	CC	GO:0004879	nuclear receptor activity	-	63	27	-	-	6.96E-04	2.58E-03
PROPER	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	89	-	-	2.90E-03	8.45E-03
PROPER	CC	GO:0000123	histone acetyltransferase complex	-	93	70	-	-	2.00E-03	6.58E-03
PROPER	CC	GO:0034982	mitochondrial protein processing	-	13	12	-	-	3.49E-04	1.17E-03
PROPER	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	82	-	-	2.83E-03	7.75E-03
PROPER	CC	GO:0048786	presynaptic active zone	-	80	23	-	-	1.28E-03	2.23E-03
PROPER	CC	GO:0007034	vacuolar transport	-	168	117	-	-	3.47E-03	1.10E-02
PROPER	CC	GO:0005776	autophagosome	-	111	68	-	-	2.54E-03	6.46E-03
PROPER	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	64	-	-	4.10E-03	6.11E-03
PROPER	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	77	-	-	2.39E-03	7.28E-03
PROPER	CC	GO:0000164	protein phosphatase type 1 complex	-	19	12	-	-	3.46E-04	1.17E-03
PROPER	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	12	-	-	2.07E-01	1.17E-03
PROPER	CC	GO:0150034	distal axon	-	309	118	-	-	3.30E-03	1.12E-02
PROPER	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	134	-	-	3.69E-03	1.27E-02
PROPER	CC	GO:0071012	catalytic step 1 spliceosome	-	12	11	-	-	3.37E-04	1.06E-03
PROPER	CC	GO:0072562	blood microparticle	-	144	30	-	-	3.12E-03	2.82E-03
PROPER	CC	GO:0051233	spindle midzone	-	36	26	-	-	1.01E-03	2.47E-03
PROPER	CC	GO:0005811	lipid droplet	-	102	59	-	-	1.80E-03	5.64E-03
PROPER	CC	GO:0045022	early endosome to late endosome transport	-	44	35	-	-	3.17E-03	3.29E-03
PROPER	CC	GO:0043113	receptor clustering	-	51	22	-	-	7.42E-03	2.11E-03
PROPER	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	16	-	-	4.61E-04	1.53E-03
PROPER	CC	GO:0044853	plasma membrane raft	-	114	41	-	-	1.01E-03	3.88E-03
PROPER	CC	GO:0005881	cytoplasmic microtubule	-	256	103	-	-	3.17E-03	9.75E-03
PROPER	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	12	-	-	1.62E-03	1.17E-03
PROPER	CC	GO:0008180	COP9 signalosome	-	17	16	-	-	4.58E-04	1.53E-03
PROPER	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	39	-	-	9.01E-04	3.76E-03
PROPER	CC	GO:0005905	clathrin-coated pit	-	73	46	-	-	2.56E-03	4.34E-03
PROPER	CC	GO:0043034	costamere	-	18	15	-	-	1.19E-03	1.41E-03
PROPER	CC	GO:0031904	endosome lumen	-	38	15	-	-	6.39E-04	1.41E-03
PROPER	CC	GO:0060170	ciliary membrane	-	76	25	-	-	2.12E-03	2.35E-03
PROPER	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	21	-	-	1.19E-03	2.00E-03
PROPER	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	1.52E-03	1.41E-03
PROPER	CC	GO:0032154	cleavage furrow	-	54	35	-	-	1.57E-03	3.29E-03
PROPER	CC	GO:0005640	nuclear outer membrane	-	30	16	-	-	4.37E-04	1.53E-03
PROPER	CC	GO:0007006	mitochondrial membrane organization	-	117	84	-	-	2.77E-03	7.98E-03
PROPER	CC	GO:0001772	immunological synapse	-	44	28	-	-	7.80E-04	2.70E-03
PROPER	CC	GO:0030904	retromer complex	-	12	12	-	-	1.73E-03	1.17E-03
PROPER	CC	GO:0009897	external side of plasma membrane	-	425	103	-	-	1.98E-02	9.75E-03
PROPER	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	11	-	-	3.52E-04	1.06E-03
PROPER	CC	GO:0030863	cortical cytoskeleton	-	104	55	-	-	8.60E-03	5.17E-03
PROPER	CC	GO:1905348	endonuclease complex	-	38	25	-	-	6.84E-04	2.35E-03
PROPER	CC	GO:0030315	T-tubule	-	52	21	-	-	5.67E-04	2.00E-03
PROPER	CC	GO:0060076	excitatory synapse	-	64	17	-	-	8.14E-04	1.64E-03
PROPER	CC	GO:0036019	endolysosome	-	29	16	-	-	4.49E-04	1.53E-03
PROPER	CC	GO:0001891	phagocytic cup	-	28	16	-	-	8.03E-04	1.53E-03
PROPER	CC	GO:0099086	synaptonemal structure	-	40	21	-	-	5.70E-04	2.00E-03
PROPER	CC	GO:0030427	site of polarized growth	-	172	89	-	-	3.54E-03	8.45E-03
PROPER	CC	GO:0044309	neuron spine	-	213	79	-	-	2.43E-03	7.52E-03
PROPER	CC	GO:0030658	transport vesicle membrane	-	231	110	-	-	1.49E-02	1.03E-02
PROPER	CC	GO:0098918	structural constituent of synapse	-	27	12	-	-	4.07E-03	1.17E-03
PROPER	CC	GO:0000940	outer kinetochore	-	17	15	-	-	7.84E-04	1.41E-03
PROPER	CC	GO:0034719	SMN-Sm protein complex	-	18	15	-	-	1.16E-03	1.41E-03
PROPER	CC	GO:0044232	organelle membrane contact site	-	50	31	-	-	9.67E-04	2.94E-03
PROPER	CC	GO:0098803	respiratory chain complex	-	39	22	-	-	5.70E-04	2.11E-03
PROPER	CC	GO:0030667	secretory granule membrane	-	319	153	-	-	6.09E-03	1.44E-02
PROPER	CC	GO:0097545	axonemal outer doublet	-	164	54	-	-	1.26E-03	5.17E-03
PROPER	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	11	-	-	2.56E-03	1.06E-03
PROPER	CC	GO:0070069	cytochrome complex	-	42	25	-	-	6.85E-04	2.35E-03
PROPER	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	13	-	-	3.46E-04	1.29E-03
PROPER	CC	GO:0055037	recycling endosome	-	200	101	-	-	1.40E-02	9.51E-03
PROPER	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	43	-	-	1.44E-03	4.11E-03
PROPER	CC	GO:0030126	COPI vesicle coat	-	13	11	-	-	3.40E-04	1.06E-03
PROPER	CC	GO:0030684	preribosome	-	76	68	-	-	3.93E-03	6.46E-03
PROPER	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	179	-	-	4.23E-03	1.69E-02
PROPER	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	4.61E-04	1.76E-03
PROPER	CC	GO:1990391	DNA repair complex	-	22	19	-	-	8.21E-04	1.88E-03
PROPER	CC	GO:0005775	vacuolar lumen	-	176	87	-	-	2.24E-03	8.22E-03
PROPER	CC	GO:0032433	filopodium tip	-	19	14	-	-	3.42E-04	1.41E-03
PROPER	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	19	-	-	1.23E-03	1.88E-03
PROPER	CC	GO:0044306	neuron projection terminus	-	164	41	-	-	1.00E-03	3.88E-03
PROPER	CC	GO:0034455	t-UTP complex	-	53	45	-	-	1.55E-03	4.23E-03
PROPER	CC	GO:0005770	late endosome	-	299	162	-	-	4.12E-03	1.53E-02
PROPER	CC	GO:0030992	intraciliary transport particle B	-	17	15	-	-	4.61E-04	1.41E-03
PROPER	CC	GO:0031970	organelle envelope lumen	-	94	70	-	-	1.96E-03	6.58E-03
PROPER	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	17	-	-	2.61E-03	1.64E-03
PROPER	CC	GO:0043292	contractile muscle fiber	-	245	121	-	-	6.39E-03	1.14E-02
PROPER	CC	GO:0034709	methylosome	-	13	12	-	-	1.31E-03	1.17E-03
PROPER	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	11	-	-	9.69E-04	1.06E-03
PROPER	CC	GO:0005849	mRNA cleavage factor complex	-	22	17	-	-	4.62E-04	1.64E-03
PROPER	CC	GO:0000803	sex chromosome	-	32	22	-	-	1.24E-03	2.11E-03
PROPER	CC	GO:0098982	GABA-ergic synapse	-	84	17	-	-	4.62E-04	1.64E-03
PROPER	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	14	-	-	3.47E-04	1.41E-03
PROPER	CC	GO:0035097	histone methyltransferase complex	-	63	47	-	-	1.42E-03	4.46E-03
PROPER	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	13	-	-	1.79E-03	1.29E-03
PROPER	CC	GO:0000242	pericentriolar material	-	22	21	-	-	5.68E-04	2.00E-03
PROPER	CC	GO:1903293	phosphatase complex	-	54	33	-	-	7.96E-04	3.17E-03
PROPER	CC	GO:0031941	filamentous actin	-	27	17	-	-	4.54E-04	1.64E-03
PROPER	CC	GO:0000786	nucleosome	-	149	61	-	-	5.18E-03	5.75E-03
PROPER	CC	GO:0001533	cornified envelope	-	59	15	-	-	1.17E-03	1.41E-03
PROPER	CC	GO:1904724	tertiary granule lumen	-	55	27	-	-	7.88E-04	2.58E-03
PROPER	CC	GO:0030027	lamellipodium	-	202	140	-	-	6.13E-03	1.32E-02
PROPER	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	12	-	-	3.48E-04	1.17E-03
PROPER	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	14	-	-	5.88E-04	1.41E-03
PROPER	CC	GO:0031209	SCAR complex	-	12	12	-	-	3.46E-04	1.17E-03
PROPER	CC	GO:0001056	RNA polymerase III activity	-	16	15	-	-	4.65E-04	1.41E-03
PROPER	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	16	-	-	8.53E-04	1.53E-03
PROPER	CC	GO:0002102	podosome	-	31	19	-	-	1.59E-03	1.88E-03
PROPER	CC	GO:0090543	Flemming body	-	33	28	-	-	6.74E-04	2.70E-03
PROPER	CC	GO:0016328	lateral plasma membrane	-	66	31	-	-	7.97E-04	2.94E-03
PROPER	CC	GO:0001650	fibrillar center	-	151	107	-	-	3.76E-03	1.01E-02
PROPER	CC	GO:0031332	RNAi effector complex	-	413	12	-	-	3.43E-04	1.17E-03
PROPER	CC	GO:1990204	oxidoreductase complex	-	90	50	-	-	2.73E-03	4.70E-03
PROPER	CC	GO:0000930	gamma-tubulin complex	-	16	15	-	-	4.64E-04	1.41E-03
PROPER	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	99	-	-	3.05E-03	9.39E-03
PROPER	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	16	-	-	4.59E-04	1.53E-03
PROPER	CC	GO:0001726	ruffle	-	181	121	-	-	4.79E-03	1.14E-02
PROPER	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	12	-	-	3.49E-04	1.17E-03
PROPER	CC	GO:0043198	dendritic shaft	-	38	15	-	-	1.66E-03	1.41E-03
PROPER	CC	GO:0043073	germ cell nucleus	-	67	33	-	-	1.59E-03	3.17E-03
PROPER	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	17	-	-	9.44E-04	1.64E-03
PROPER	CC	GO:0005788	endoplasmic reticulum lumen	-	313	142	-	-	5.27E-03	1.34E-02
PROPER	CC	GO:0016592	mediator complex	-	38	27	-	-	8.20E-04	2.58E-03
PROPER	CC	GO:0034045	phagophore assembly site membrane	-	19	13	-	-	3.46E-04	1.29E-03
PROPER	CC	GO:0022626	cytosolic ribosome	-	118	107	-	-	4.43E-03	1.01E-02
PROPER	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	34	-	-	8.01E-04	3.29E-03
PROPER	CC	GO:0034451	centriolar satellite	-	120	88	-	-	3.38E-03	8.34E-03
PROPER	CC	GO:0045171	intercellular bridge	-	91	59	-	-	1.55E-03	5.64E-03
PROPER	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	53	-	-	3.03E-03	5.05E-03
PROPER	CC	GO:0008250	oligosaccharyltransferase complex	-	14	13	-	-	3.44E-04	1.29E-03
PROPER	CC	GO:0098984	neuron to neuron synapse	-	384	155	-	-	4.66E-03	1.46E-02
PROPER	CC	GO:0032039	integrator complex	-	19	14	-	-	3.47E-04	1.41E-03
PROPER	CC	GO:0030527	structural constituent of chromatin	-	97	22	-	-	2.22E-03	2.11E-03
PROPER	CC	GO:0030286	dynein complex	-	210	80	-	-	2.07E-03	7.52E-03
PROPER	CC	GO:0097228	sperm principal piece	-	33	11	-	-	3.49E-04	1.06E-03
PROPER	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	3.40E-04	1.17E-03
PROPER	CC	GO:0016482	cytosolic transport	-	135	93	-	-	3.75E-03	8.81E-03
PROPER	CC	GO:0005796	Golgi lumen	-	106	24	-	-	2.95E-03	2.35E-03
PROPER	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	26	-	-	4.31E-03	2.47E-03
PROPER	CC	GO:0008023	transcription elongation factor complex	-	47	40	-	-	2.66E-03	3.76E-03
PROPER	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	19	-	-	4.58E-04	1.88E-03
PROPER	CC	GO:0030662	coated vesicle membrane	-	202	114	-	-	1.40E-02	1.08E-02
PROPER	CC	GO:0007039	protein catabolic process in the vacuole	-	61	42	-	-	1.02E-03	3.99E-03
PROPER	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	54	-	-	2.62E-03	5.17E-03
PROPER	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	163	-	-	3.77E-03	1.54E-02
PROPER	CC	GO:0005769	early endosome	-	425	239	-	-	7.28E-03	2.25E-02
PROPER	CC	GO:0090734	site of DNA damage	-	118	88	-	-	2.87E-03	8.34E-03
PROPER	MF	GO:0051861	glycolipid binding	-	30	13	-	-	3.43E-04	1.29E-03
PROPER	MF	GO:0051087	protein-folding chaperone binding	-	135	92	-	-	2.80E-03	8.69E-03
PROPER	MF	GO:0051959	dynein light intermediate chain binding	-	27	13	-	-	3.47E-04	1.29E-03
PROPER	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	28	-	-	8.87E-04	2.70E-03
PROPER	MF	GO:0035613	RNA stem-loop binding	-	21	11	-	-	1.59E-03	1.06E-03
PROPER	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	162	-	-	5.55E-03	1.53E-02
PROPER	MF	GO:0016757	glycosyltransferase activity	-	286	126	-	-	6.85E-03	1.19E-02
PROPER	MF	GO:0048306	calcium-dependent protein binding	-	61	27	-	-	5.48E-03	2.58E-03
PROPER	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	13	-	-	3.35E-04	1.29E-03
PROPER	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	68	-	-	1.59E-03	6.46E-03
PROPER	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	39	-	-	9.14E-04	3.76E-03
PROPER	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	65	-	-	1.61E-02	6.11E-03
PROPER	MF	GO:0051020	GTPase binding	-	311	211	-	-	5.48E-03	1.98E-02
PROPER	MF	GO:0140457	protein demethylase activity	-	31	20	-	-	5.84E-04	1.88E-03
PROPER	MF	GO:0005158	insulin receptor binding	-	22	14	-	-	1.62E-03	1.41E-03
PROPER	MF	GO:0061980	regulatory RNA binding	-	52	29	-	-	7.77E-04	2.82E-03
PROPER	MF	GO:0015035	protein-disulfide reductase activity	-	32	22	-	-	1.59E-03	2.11E-03
PROPER	MF	GO:0001671	ATPase activator activity	-	29	19	-	-	6.75E-03	1.88E-03
PROPER	MF	GO:0070840	dynein complex binding	-	25	18	-	-	2.28E-03	1.76E-03
PROPER	MF	GO:0035035	histone acetyltransferase binding	-	24	15	-	-	4.62E-04	1.41E-03
PROPER	MF	GO:0061684	chaperone-mediated autophagy	-	16	12	-	-	4.69E-03	1.17E-03
PROPER	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	22	-	-	5.70E-04	2.11E-03
PROPER	MF	GO:0003688	DNA replication origin binding	-	18	16	-	-	2.68E-03	1.53E-03
PROPER	MF	GO:0005178	integrin binding	-	153	63	-	-	3.05E-03	5.99E-03
PROPER	MF	GO:0008327	methyl-CpG binding	-	31	19	-	-	1.17E-03	1.88E-03
PROPER	MF	GO:0031418	L-ascorbic acid binding	-	20	14	-	-	3.49E-04	1.41E-03
PROPER	MF	GO:0005521	lamin binding	-	15	13	-	-	3.45E-04	1.29E-03
PROPER	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	15	-	-	4.03E-03	1.41E-03
PROPER	MF	GO:0140318	protein transporter activity	-	40	25	-	-	2.01E-03	2.35E-03
PROPER	MF	GO:0070628	proteasome binding	-	17	15	-	-	4.53E-04	1.41E-03
PROPER	MF	GO:0000217	DNA secondary structure binding	-	37	29	-	-	4.14E-03	2.82E-03
PROPER	MF	GO:0002039	p53 binding	-	66	47	-	-	1.22E-03	4.46E-03
PROPER	MF	GO:0005496	steroid binding	-	110	40	-	-	1.32E-03	3.76E-03
PROPER	MF	GO:0008443	phosphofructokinase activity	-	27	15	-	-	3.59E-03	1.41E-03
PROPER	MF	GO:0003684	damaged DNA binding	-	89	64	-	-	3.04E-03	6.11E-03
PROPER	MF	GO:0000339	RNA cap binding	-	20	17	-	-	1.20E-03	1.64E-03
PROPER	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	76	-	-	3.26E-03	7.16E-03
PROPER	MF	GO:0070063	RNA polymerase binding	-	61	51	-	-	2.44E-03	4.81E-03
PROPER	MF	GO:0030971	receptor tyrosine kinase binding	-	76	38	-	-	4.01E-02	3.64E-03
PROPER	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	75	-	-	3.90E-03	7.05E-03
PROPER	MF	GO:0140030	modification-dependent protein binding	-	179	129	-	-	3.50E-03	1.22E-02
PROPER	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	18	-	-	4.66E-04	1.76E-03
PROPER	MF	GO:0030983	mismatched DNA binding	-	14	13	-	-	3.48E-04	1.29E-03
PROPER	MF	GO:0030276	clathrin binding	-	70	35	-	-	9.03E-04	3.29E-03
PROPER	MF	GO:0046875	ephrin receptor binding	-	29	16	-	-	4.57E-04	1.53E-03
PROPER	MF	GO:0106310	protein serine kinase activity	-	362	201	-	-	5.59E-03	1.89E-02
PROPER	MF	GO:0030552	cAMP binding	-	48	19	-	-	4.63E-04	1.88E-03
PROPER	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	27	-	-	6.87E-04	2.58E-03
PROPER	MF	GO:0004857	enzyme inhibitor activity	-	395	163	-	-	5.87E-03	1.54E-02
PROPER	MF	GO:0035173	histone kinase activity	-	17	12	-	-	8.00E-04	1.17E-03
PROPER	MF	GO:0097602	cullin family protein binding	-	26	15	-	-	4.61E-04	1.41E-03
PROPER	MF	GO:0016209	antioxidant activity	-	92	38	-	-	9.64E-04	3.64E-03
PROPER	MF	GO:0070325	lipoprotein particle receptor binding	-	32	18	-	-	6.44E-03	1.76E-03
PROPER	MF	GO:0044325	transmembrane transporter binding	-	159	75	-	-	2.39E-03	7.05E-03
PROPER	MF	GO:0048156	tau protein binding	-	43	30	-	-	1.93E-03	2.82E-03
PROPER	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	34	-	-	1.37E-03	3.29E-03
PROPER	MF	GO:0140272	exogenous protein binding	-	79	40	-	-	2.59E-03	3.76E-03
PROPER	MF	GO:0030145	manganese ion binding	-	65	34	-	-	8.05E-04	3.29E-03
PROPER	MF	GO:0071814	protein-lipid complex binding	-	52	17	-	-	9.21E-04	1.64E-03
PROPER	MF	GO:0008066	glutamate receptor activity	-	70	13	-	-	1.82E-03	1.29E-03
PROPER	MF	GO:0017069	snRNA binding	-	54	37	-	-	1.84E-03	3.52E-03
PROPER	MF	GO:0031369	translation initiation factor binding	-	32	25	-	-	8.89E-03	2.35E-03
PROPER	MF	GO:0019843	rRNA binding	-	69	60	-	-	1.72E-03	5.64E-03
PROPER	MF	GO:0004713	protein tyrosine kinase activity	-	213	98	-	-	3.33E-03	9.28E-03
PROPER	MF	GO:0016779	nucleotidyltransferase activity	-	264	183	-	-	5.84E-03	1.73E-02
PROPER	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	29	-	-	3.25E-03	2.82E-03
PROPER	MF	GO:0008093	cytoskeletal anchor activity	-	24	15	-	-	4.57E-04	1.41E-03
PROPER	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	16	-	-	4.68E-04	1.53E-03
PROPER	MF	GO:0016208	AMP binding	-	22	14	-	-	3.47E-04	1.41E-03
PROPER	MF	GO:0000287	magnesium ion binding	-	225	130	-	-	3.57E-03	1.22E-02
PROPER	MF	GO:0031490	chromatin DNA binding	-	120	64	-	-	2.84E-03	6.11E-03
PROPER	MF	GO:0017022	myosin binding	-	73	31	-	-	2.31E-03	2.94E-03
PROPER	MF	GO:0004896	cytokine receptor activity	-	93	14	-	-	1.67E-01	1.41E-03
PROPER	MF	GO:0005539	glycosaminoglycan binding	-	236	72	-	-	3.21E-03	6.81E-03
PROPER	MF	GO:0071933	Arp2/3 complex binding	-	14	11	-	-	3.50E-04	1.06E-03
PROPER	MF	GO:0019207	kinase regulator activity	-	267	139	-	-	3.57E-03	1.32E-02
PROPER	MF	GO:0044183	protein folding chaperone	-	67	45	-	-	1.69E-03	4.23E-03
PROPER	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	46	-	-	4.37E-03	4.34E-03
PROPER	MF	GO:0003725	double-stranded RNA binding	-	72	50	-	-	1.91E-03	4.70E-03
PROPER	MF	GO:0051018	protein kinase A binding	-	52	28	-	-	5.32E-03	2.70E-03
PROPER	MF	GO:0071889	14-3-3 protein binding	-	34	22	-	-	5.71E-04	2.11E-03
PROPER	MF	GO:0004618	phosphoglycerate kinase activity	-	89	48	-	-	1.52E-03	4.58E-03
PROPER	MF	GO:0042805	actinin binding	-	36	12	-	-	3.51E-04	1.17E-03
PROPER	MF	GO:0043531	ADP binding	-	38	23	-	-	9.44E-04	2.23E-03
PROPER	MF	GO:0043394	proteoglycan binding	-	36	14	-	-	9.28E-04	1.41E-03
PROPER	MF	GO:0046332	SMAD binding	-	77	46	-	-	2.21E-03	4.34E-03
PROPER	MF	GO:0001968	fibronectin binding	-	30	14	-	-	1.83E-02	1.41E-03
PROPER	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	81	-	-	3.17E-03	7.63E-03
PROPER	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	38	-	-	4.13E-03	3.64E-03
PROPER	MF	GO:0003756	protein disulfide isomerase activity	-	18	14	-	-	1.11E-03	1.41E-03
PROPER	MF	GO:0051117	ATPase binding	-	85	47	-	-	3.07E-03	4.46E-03
PROPER	MF	GO:0005216	monoatomic ion channel activity	-	618	140	-	-	5.12E-03	1.32E-02
PROPER	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	16	-	-	4.14E-03	1.53E-03
PROPER	MF	GO:0051787	misfolded protein binding	-	20	15	-	-	4.54E-04	1.41E-03
PROPER	MF	GO:0001098	basal transcription machinery binding	-	61	50	-	-	1.96E-03	4.70E-03
PROPER	MF	GO:0036002	pre-mRNA binding	-	57	25	-	-	8.91E-04	2.35E-03
PROPER	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	28	-	-	2.27E-03	2.70E-03
PROPER	MF	GO:0051540	metal cluster binding	-	71	52	-	-	2.73E-03	4.93E-03
PROPER	MF	GO:0051219	phosphoprotein binding	-	92	57	-	-	2.03E-03	5.40E-03
PROPER	MF	GO:0019894	kinesin binding	-	45	25	-	-	1.44E-03	2.35E-03
PROPER	MF	GO:0042287	MHC protein binding	-	68	16	-	-	4.50E-04	1.53E-03
PROPER	MF	GO:0019003	GDP binding	-	89	63	-	-	2.68E-03	5.99E-03
PROPER	MF	GO:0017171	serine hydrolase activity	-	207	45	-	-	2.39E-02	4.23E-03
PROPER	MF	GO:0097110	scaffold protein binding	-	66	32	-	-	8.44E-03	3.05E-03
PROPER	MF	GO:0003774	cytoskeletal motor activity	-	117	62	-	-	2.27E-03	5.87E-03
PROPER	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	18	-	-	6.73E-04	1.76E-03
PROPER	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	11	-	-	3.36E-04	1.06E-03
PROPER	MF	GO:0061134	peptidase regulator activity	-	224	76	-	-	2.63E-03	7.16E-03
PROPER	MF	GO:0008013	beta-catenin binding	-	86	45	-	-	2.79E-03	4.23E-03
PROPER	MF	GO:0051015	actin filament binding	-	208	121	-	-	7.99E-03	1.14E-02
PROPER	MF	GO:0019208	phosphatase regulator activity	-	107	59	-	-	2.23E-03	5.64E-03
PROPER	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	18	-	-	4.36E-04	1.76E-03
PROPER	MF	GO:0043236	laminin binding	-	29	14	-	-	2.00E-03	1.41E-03
PROPER	MF	GO:0030507	spectrin binding	-	26	15	-	-	1.27E-03	1.41E-03
PROPER	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	26	-	-	6.89E-04	2.47E-03
PROPER	MF	GO:0045860	positive regulation of protein kinase activity	-	397	163	-	-	4.16E-03	1.54E-02
PROPER	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	76	-	-	1.79E-03	7.16E-03
PROPER	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	11	-	-	3.50E-04	1.06E-03
PROPER	MF	GO:0042393	histone binding	-	240	174	-	-	4.68E-03	1.64E-02
PROPER	MF	GO:0019838	growth factor binding	-	182	76	-	-	6.21E-03	7.16E-03
PROPER	MF	GO:0000149	SNARE binding	-	107	61	-	-	2.01E-03	5.75E-03
PROPER	MF	GO:0003727	single-stranded RNA binding	-	90	56	-	-	1.65E-03	5.28E-03
PROPER	MF	GO:0005516	calmodulin binding	-	206	87	-	-	3.39E-03	8.22E-03
PROPER	MF	GO:0045505	dynein intermediate chain binding	-	37	17	-	-	4.50E-04	1.64E-03
PROPER	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	41	-	-	1.01E-03	3.88E-03
PROPER	MF	GO:0032182	ubiquitin-like protein binding	-	117	86	-	-	2.50E-03	8.10E-03
PROPER	MF	GO:0023023	MHC protein complex binding	-	36	12	-	-	3.77E-04	1.17E-03
PROPER	MF	GO:0043274	phospholipase binding	-	23	13	-	-	3.48E-04	1.29E-03
PROPER	MF	GO:0031072	heat shock protein binding	-	128	82	-	-	2.77E-03	7.75E-03
PROPER	MF	GO:0030515	snoRNA binding	-	33	27	-	-	1.41E-03	2.58E-03
PROPER	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	19	-	-	4.47E-04	1.88E-03
PROPER	MF	GO:0001965	G-protein alpha-subunit binding	-	26	14	-	-	8.40E-04	1.41E-03
PROPER	MF	GO:0046982	protein heterodimerization activity	-	343	159	-	-	4.71E-03	1.50E-02
PROPER	MF	GO:0140223	general transcription initiation factor activity	-	55	41	-	-	2.52E-03	3.88E-03
PROPER	MF	GO:0070403	NAD+ binding	-	16	11	-	-	1.26E-02	1.06E-03
PROPER	MF	GO:0000049	tRNA binding	-	75	62	-	-	1.00E-02	5.87E-03
PROPER	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	26	-	-	7.00E-04	2.47E-03
PROPER	MF	GO:0015026	coreceptor activity	-	48	12	-	-	1.04E-02	1.17E-03
PROPER	MF	GO:0006469	negative regulation of protein kinase activity	-	222	117	-	-	2.97E-03	1.10E-02
PROPER	MF	GO:0070182	DNA polymerase binding	-	22	17	-	-	8.10E-04	1.64E-03
PROPER	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	12	-	-	3.38E-04	1.17E-03
PROPER	MF	GO:0070851	growth factor receptor binding	-	141	49	-	-	2.59E-03	4.70E-03
PROPER	MF	GO:0031210	phosphatidylcholine binding	-	32	13	-	-	4.02E-03	1.29E-03
PROPER	MF	GO:0005525	GTP binding	-	396	235	-	-	8.25E-03	2.21E-02
PROPER	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	22	-	-	9.38E-03	2.11E-03
PROPER	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	110	-	-	3.43E-03	1.03E-02
PROPER	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	11	-	-	3.48E-04	1.06E-03
PROPER	MF	GO:0051346	negative regulation of hydrolase activity	-	332	124	-	-	4.26E-03	1.17E-02
PROPER	MF	GO:0005506	iron ion binding	-	154	51	-	-	8.11E-03	4.81E-03
PROPER	MF	GO:0003925	G protein activity	-	45	29	-	-	5.18E-03	2.82E-03
PROPER	MF	GO:0008276	protein methyltransferase activity	-	96	67	-	-	3.73E-03	6.34E-03
PROPER	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	219	-	-	6.88E-03	2.07E-02
PROPER	MF	GO:0070888	E-box binding	-	59	19	-	-	7.64E-04	1.88E-03
PROPER	MF	GO:0015399	primary active transmembrane transporter activity	-	190	102	-	-	2.54E-03	9.63E-03
PROPER	MF	GO:0035254	glutamate receptor binding	-	47	20	-	-	7.27E-04	1.88E-03
PROPER	MF	GO:0050321	tau-protein kinase activity	-	36	18	-	-	7.17E-04	1.76E-03
PROPER	MF	GO:0043021	ribonucleoprotein complex binding	-	158	131	-	-	4.12E-03	1.23E-02
PROPER	MF	GO:0030170	pyridoxal phosphate binding	-	56	22	-	-	5.78E-04	2.11E-03
PROPER	MF	GO:0005112	Notch binding	-	26	15	-	-	4.55E-04	1.41E-03
PROPER	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	19	-	-	4.66E-04	1.88E-03
PROPER	MF	GO:0001664	G protein-coupled receptor binding	-	299	69	-	-	2.12E-03	6.58E-03
PROPER	MF	GO:0140299	small molecule sensor activity	-	39	23	-	-	5.79E-04	2.23E-03
PROPER	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	14	-	-	2.44E-03	1.41E-03
PROPER	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	12	-	-	3.49E-04	1.17E-03
PROPER	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	35	-	-	9.06E-04	3.29E-03
PROPER	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	15	-	-	4.44E-04	1.41E-03
PROPER	MF	GO:0003916	DNA topoisomerase activity	-	12	11	-	-	1.67E-02	1.06E-03
PROPER	MF	GO:0030594	neurotransmitter receptor activity	-	160	25	-	-	1.97E-03	2.35E-03
PROPER	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	14	-	-	3.49E-04	1.41E-03
PROPER	MF	GO:0120227	acyl-CoA binding	-	22	13	-	-	3.31E-04	1.29E-03
PROPER	MF	GO:0005507	copper ion binding	-	63	25	-	-	6.77E-04	2.35E-03
PROPER	MF	GO:0033558	protein lysine deacetylase activity	-	22	16	-	-	1.22E-03	1.53E-03
PROPER	MF	GO:0070034	telomerase RNA binding	-	22	20	-	-	7.52E-04	1.88E-03
ProteomeHD	CC	GO:0005739	mitochondrion	1.13E-21	1671	186	91	2.04	-	-
ProteomeHD	CC	GO:0005730	nucleolus	1.70E-11	988	106	54	1.97	-	-
ProteomeHD	CC	GO:0031012	extracellular matrix	8.28E-09	564	5	31	0.16	-	-
ProteomeHD	CC	GO:0005840	ribosome	1.43E-08	222	35	12	2.89	-	-
ProteomeHD	CC	GO:0000228	nuclear chromosome	2.67E-06	206	29	11	2.58	-	-
ProteomeHD	CC	GO:0005768	endosome	1.15E-05	1037	90	57	1.59	-	-
ProteomeHD	CC	GO:0005764	lysosome	6.96E-05	747	67	41	1.64	-	-
ProteomeHD	CC	GO:0005635	nuclear envelope	1.12E-04	493	48	27	1.78	-	-
ProteomeHD	CC	GO:0005815	microtubule organizing center	2.52E-04	843	71	46	1.54	-	-
ProteomeHD	CC	GO:0005929	cilium	6.51E-03	842	29	46	0.63	-	-
ProteomeHD	CC	GO:0005615	extracellular space	2.33E-02	3190	201	174	1.15	-	-
ProteomeHD	CC	GO:0005783	endoplasmic reticulum	6.95E-02	2020	128	110	1.16	-	-
ProteomeHD	CC	GO:0005811	lipid droplet	5.08E-01	102	7	6	1.26	-	-
ProteomeHD	CC	GO:0005777	peroxisome	5.78E-01	142	9	8	1.16	-	-
ProteomeHD	CC	GO:0005794	Golgi apparatus	8.20E-01	1636	91	89	1.02	-	-
ProteomeHD	BP	GO:0016071	mRNA metabolic process	2.51E-45	713	145	39	3.72	-	-
ProteomeHD	BP	GO:0065003	protein-containing complex assembly	3.85E-22	1648	185	90	2.06	-	-
ProteomeHD	BP	GO:0006886	intracellular protein transport	3.85E-15	664	89	36	2.46	-	-
ProteomeHD	BP	GO:0006913	nucleocytoplasmic transport	2.25E-13	326	54	18	3.03	-	-
ProteomeHD	BP	GO:0002181	cytoplasmic translation	2.98E-13	153	35	8	4.19	-	-
ProteomeHD	BP	GO:0050877	nervous system process	2.31E-12	1527	30	83	0.36	-	-
ProteomeHD	BP	GO:0007059	chromosome segregation	1.22E-11	403	58	22	2.64	-	-
ProteomeHD	BP	GO:0055086	nucleobase-containing small molecule metabolic process	3.23E-11	729	85	40	2.14	-	-
ProteomeHD	BP	GO:0006091	generation of precursor metabolites and energy	8.92E-11	502	65	27	2.37	-	-
ProteomeHD	BP	GO:0006281	DNA repair	1.12E-10	587	72	32	2.25	-	-
ProteomeHD	BP	GO:0007005	mitochondrion organization	2.79E-09	484	60	26	2.27	-	-
ProteomeHD	BP	GO:0030163	protein catabolic process	9.01E-09	990	98	54	1.81	-	-
ProteomeHD	BP	GO:0006399	tRNA metabolic process	2.53E-08	196	32	11	2.99	-	-
ProteomeHD	BP	GO:0006325	chromatin organization	8.86E-08	720	75	39	1.91	-	-
ProteomeHD	BP	GO:0016192	vesicle-mediated transport	1.43E-06	1894	151	103	1.46	-	-
ProteomeHD	BP	GO:0006457	protein folding	3.94E-06	210	29	11	2.53	-	-
ProteomeHD	BP	GO:0006520	amino acid metabolic process	5.45E-06	292	36	16	2.26	-	-
ProteomeHD	BP	GO:0042254	ribosome biogenesis	7.17E-06	297	36	16	2.22	-	-
ProteomeHD	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	2.34E-05	119	19	6	2.92	-	-
ProteomeHD	BP	GO:0006260	DNA replication	2.73E-05	279	33	15	2.17	-	-
ProteomeHD	BP	GO:0140053	mitochondrial gene expression	2.98E-05	164	23	9	2.57	-	-
ProteomeHD	BP	GO:0055085	transmembrane transport	9.53E-05	1784	63	97	0.65	-	-
ProteomeHD	BP	GO:0007155	cell adhesion	1.07E-04	1444	48	79	0.61	-	-
ProteomeHD	BP	GO:0032200	telomere organization	2.38E-04	186	23	10	2.26	-	-
ProteomeHD	BP	GO:0006914	autophagy	3.22E-04	568	52	31	1.68	-	-
ProteomeHD	BP	GO:0012501	programmed cell death	5.02E-04	1954	141	107	1.32	-	-
ProteomeHD	BP	GO:0006310	DNA recombination	5.39E-04	333	34	18	1.87	-	-
ProteomeHD	BP	GO:0003013	circulatory system process	8.22E-04	584	15	32	0.47	-	-
ProteomeHD	BP	GO:0003012	muscle system process	1.07E-03	425	9	23	0.39	-	-
ProteomeHD	BP	GO:0030198	extracellular matrix organization	2.48E-03	314	6	17	0.35	-	-
ProteomeHD	BP	GO:0044782	cilium organization	1.37E-02	399	11	22	0.50	-	-
ProteomeHD	BP	GO:0140013	meiotic nuclear division	1.58E-02	279	25	15	1.64	-	-
ProteomeHD	BP	GO:0048870	cell motility	1.01E-01	1659	76	91	0.84	-	-
ProteomeHD	BP	GO:0098542	defense response to other organism	1.44E-01	1171	75	64	1.17	-	-
ProteomeHD	BP	GO:0006629	lipid metabolic process	1.53E-01	1355	62	74	0.84	-	-
ProteomeHD	BP	GO:0034330	cell junction organization	1.57E-01	727	31	40	0.78	-	-
ProteomeHD	BP	GO:0006355	regulation of DNA-templated transcription	1.66E-01	3342	199	182	1.09	-	-
ProteomeHD	BP	GO:0003014	renal system process	1.66E-01	127	3	7	0.43	-	-
ProteomeHD	BP	GO:0005975	carbohydrate metabolic process	1.83E-01	551	37	30	1.23	-	-
ProteomeHD	BP	GO:0000910	cytokinesis	1.96E-01	186	14	10	1.38	-	-
ProteomeHD	BP	GO:0007018	microtubule-based movement	2.49E-01	640	28	35	0.80	-	-
ProteomeHD	BP	GO:0098754	detoxification	2.53E-01	134	4	7	0.55	-	-
ProteomeHD	BP	GO:0042060	wound healing	2.82E-01	431	18	24	0.76	-	-
ProteomeHD	BP	GO:0022600	digestive system process	2.89E-01	110	3	6	0.50	-	-
ProteomeHD	BP	GO:0006486	protein glycosylation	4.58E-01	225	9	12	0.73	-	-
ProteomeHD	BP	GO:0006954	inflammatory response	5.29E-01	820	40	45	0.89	-	-
ProteomeHD	BP	GO:0006790	sulfur compound metabolic process	5.33E-01	320	20	17	1.14	-	-
ProteomeHD	BP	GO:0007163	establishment or maintenance of cell polarity	6.58E-01	227	14	12	1.13	-	-
ProteomeHD	BP	GO:0006766	vitamin metabolic process	6.66E-01	107	4	6	0.68	-	-
ProteomeHD	BP	GO:0072659	protein localization to plasma membrane	6.92E-01	284	17	16	1.10	-	-
ProteomeHD	BP	GO:0002376	immune system process	7.38E-01	2448	137	134	1.03	-	-
ProteomeHD	BP	GO:0006575	cellular modified amino acid metabolic process	7.45E-01	186	11	10	1.08	-	-
ProteomeHD	BP	GO:0007040	lysosome organization	8.32E-01	107	6	6	1.03	-	-
ProteomeHD	BP	GO:0007010	cytoskeleton organization	1.00E+00	1639	89	89	0.99	-	-
ProteomeHD	MF	GO:0003723	RNA binding	3.34E-71	1679	281	92	3.07	-	-
ProteomeHD	MF	GO:0045182	translation regulator activity	3.52E-14	151	36	8	4.37	-	-
ProteomeHD	MF	GO:0140657	ATP-dependent activity	2.66E-12	729	88	40	2.21	-	-
ProteomeHD	MF	GO:0140097	"catalytic activity, acting on DNA"	4.57E-11	383	55	21	2.63	-	-
ProteomeHD	MF	GO:0048018	receptor ligand activity	3.38E-09	504	3	28	0.11	-	-
ProteomeHD	MF	GO:0140098	"catalytic activity, acting on RNA"	2.38E-08	417	52	23	2.28	-	-
ProteomeHD	MF	GO:0042393	histone binding	7.73E-08	237	35	13	2.70	-	-
ProteomeHD	MF	GO:0016491	oxidoreductase activity	7.09E-07	888	84	48	1.73	-	-
ProteomeHD	MF	GO:0016874	ligase activity	1.55E-05	283	34	15	2.20	-	-
ProteomeHD	MF	GO:0005215	transporter activity	6.08E-04	1462	52	80	0.65	-	-
ProteomeHD	MF	GO:0140104	molecular carrier activity	1.69E-03	105	14	6	2.44	-	-
ProteomeHD	MF	GO:0008092	cytoskeletal protein binding	2.85E-03	1023	78	56	1.40	-	-
ProteomeHD	MF	GO:0016853	isomerase activity	4.59E-03	252	25	14	1.82	-	-
ProteomeHD	MF	GO:0038024	cargo receptor activity	2.22E-02	117	1	6	0.16	-	-
ProteomeHD	MF	GO:0016740	transferase activity	2.67E-02	3074	194	168	1.16	-	-
ProteomeHD	MF	GO:0003924	GTPase activity	2.84E-02	658	49	36	1.36	-	-
ProteomeHD	MF	GO:0009975	cyclase activity	6.09E-02	277	8	15	0.53	-	-
ProteomeHD	MF	GO:0005198	structural molecule activity	7.91E-02	798	55	44	1.26	-	-
ProteomeHD	MF	GO:0140110	transcription regulator activity	1.34E-01	2033	96	111	0.86	-	-
ProteomeHD	MF	GO:0008289	lipid binding	1.39E-01	836	36	46	0.79	-	-
ProteomeHD	MF	GO:0140096	"catalytic activity, acting on a protein"	1.46E-01	3198	192	175	1.10	-	-
ProteomeHD	MF	GO:0016829	lyase activity	1.48E-01	538	37	29	1.26	-	-
ProteomeHD	MF	GO:0003774	cytoskeletal motor activity	5.34E-01	116	4	6	0.63	-	-
ProteomeHD	MF	GO:0003677	DNA binding	6.88E-01	2865	161	156	1.03	-	-
ProteomeHD	BP	GO:0007346	regulation of mitotic cell cycle	-	518	44	-	-	4.86E-02	3.51E-02
ProteomeHD	BP	GO:0001525	angiogenesis	-	616	13	-	-	2.67E-03	1.07E-02
ProteomeHD	BP	GO:0043543	protein acylation	-	107	12	-	-	1.17E-02	9.74E-03
ProteomeHD	CC	GO:0016197	endosomal transport	-	282	42	-	-	2.92E-02	3.31E-02
ProteomeHD	BP	GO:0045861	negative regulation of proteolysis	-	320	12	-	-	8.97E-02	9.74E-03
ProteomeHD	BP	GO:0009914	hormone transport	-	315	15	-	-	3.53E-03	1.17E-02
ProteomeHD	BP	GO:0045785	positive regulation of cell adhesion	-	482	20	-	-	4.95E-02	1.56E-02
ProteomeHD	BP	GO:0006413	translational initiation	-	122	27	-	-	2.67E-02	2.14E-02
ProteomeHD	CC	GO:0005200	structural constituent of cytoskeleton	-	112	12	-	-	1.57E-01	9.74E-03
ProteomeHD	BP	GO:0002263	cell activation involved in immune response	-	304	12	-	-	2.84E-03	9.74E-03
ProteomeHD	MF	GO:0003714	transcription corepressor activity	-	190	18	-	-	1.36E-02	1.46E-02
ProteomeHD	BP	GO:0098609	cell-cell adhesion	-	954	28	-	-	7.84E-03	2.24E-02
ProteomeHD	BP	GO:0043523	regulation of neuron apoptotic process	-	218	11	-	-	7.12E-03	8.76E-03
ProteomeHD	BP	GO:0070647	protein modification by small protein conjugation or removal	-	968	77	-	-	7.95E-02	6.04E-02
ProteomeHD	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	25	-	-	2.31E-02	1.95E-02
ProteomeHD	BP	GO:0034502	protein localization to chromosome	-	130	14	-	-	1.03E-02	1.17E-02
ProteomeHD	BP	GO:0017148	negative regulation of translation	-	390	23	-	-	1.65E-02	1.85E-02
ProteomeHD	BP	GO:0051236	establishment of RNA localization	-	161	32	-	-	4.59E-02	2.53E-02
ProteomeHD	BP	GO:0042246	tissue regeneration	-	496	20	-	-	2.45E-02	1.56E-02
ProteomeHD	BP	GO:0050779	RNA destabilization	-	135	20	-	-	4.69E-02	1.56E-02
ProteomeHD	BP	GO:0061025	membrane fusion	-	532	40	-	-	5.63E-02	3.12E-02
ProteomeHD	BP	GO:0016053	organic acid biosynthetic process	-	335	18	-	-	6.21E-03	1.46E-02
ProteomeHD	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	14	-	-	7.77E-02	1.17E-02
ProteomeHD	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	11	-	-	2.60E-03	8.76E-03
ProteomeHD	BP	GO:0050801	monoatomic ion homeostasis	-	609	25	-	-	2.45E-02	1.95E-02
ProteomeHD	BP	GO:0009792	embryo development ending in birth or egg hatching	-	683	37	-	-	1.22E-02	2.92E-02
ProteomeHD	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	17	-	-	3.39E-03	1.36E-02
ProteomeHD	BP	GO:0048588	developmental cell growth	-	233	14	-	-	2.63E-03	1.17E-02
ProteomeHD	BP	GO:0021987	cerebral cortex development	-	125	11	-	-	4.97E-03	8.76E-03
ProteomeHD	BP	GO:0008637	apoptotic mitochondrial changes	-	108	11	-	-	6.65E-03	8.76E-03
ProteomeHD	CC	GO:1902532	negative regulation of intracellular signal transduction	-	710	50	-	-	1.70E-02	3.89E-02
ProteomeHD	BP	GO:0002064	epithelial cell development	-	210	12	-	-	2.86E-03	9.74E-03
ProteomeHD	BP	GO:0033120	positive regulation of RNA splicing	-	46	13	-	-	2.33E-02	1.07E-02
ProteomeHD	BP	GO:0007281	germ cell development	-	334	14	-	-	2.59E-03	1.17E-02
ProteomeHD	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	13	-	-	7.15E-03	1.07E-02
ProteomeHD	BP	GO:0003013	circulatory system process	-	602	15	-	-	3.58E-03	1.17E-02
ProteomeHD	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	33	-	-	3.34E-02	2.63E-02
ProteomeHD	BP	GO:0009267	cellular response to starvation	-	170	16	-	-	5.40E-03	1.27E-02
ProteomeHD	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	19	-	-	2.11E-01	1.56E-02
ProteomeHD	BP	GO:0002521	leukocyte differentiation	-	616	28	-	-	5.67E-02	2.24E-02
ProteomeHD	BP	GO:0065004	protein-DNA complex assembly	-	307	40	-	-	2.57E-02	3.12E-02
ProteomeHD	CC	GO:0006406	mRNA export from nucleus	-	69	15	-	-	1.15E-02	1.17E-02
ProteomeHD	BP	GO:0019693	ribose phosphate metabolic process	-	556	64	-	-	2.15E-01	5.06E-02
ProteomeHD	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	28	-	-	1.20E-02	2.24E-02
ProteomeHD	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	40	-	-	2.57E-01	3.12E-02
ProteomeHD	BP	GO:0098771	inorganic ion homeostasis	-	531	21	-	-	4.29E-02	1.66E-02
ProteomeHD	BP	GO:0051259	protein complex oligomerization	-	251	14	-	-	7.14E-03	1.17E-02
ProteomeHD	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	12	-	-	1.69E-01	9.74E-03
ProteomeHD	BP	GO:0072665	protein localization to vacuole	-	84	11	-	-	1.11E-02	8.76E-03
ProteomeHD	BP	GO:0006914	autophagy	-	574	52	-	-	3.04E-02	4.09E-02
ProteomeHD	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	14	-	-	7.19E-03	1.17E-02
ProteomeHD	BP	GO:0008285	negative regulation of cell population proliferation	-	787	35	-	-	8.76E-03	2.73E-02
ProteomeHD	BP	GO:0048858	cell projection morphogenesis	-	643	31	-	-	3.47E-02	2.43E-02
ProteomeHD	BP	GO:0030307	positive regulation of cell growth	-	164	15	-	-	1.25E-02	1.17E-02
ProteomeHD	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	19	-	-	4.12E-02	1.56E-02
ProteomeHD	BP	GO:0018193	peptidyl-amino acid modification	-	933	52	-	-	1.23E-02	4.09E-02
ProteomeHD	BP	GO:0044770	cell cycle phase transition	-	558	55	-	-	3.98E-02	4.28E-02
ProteomeHD	BP	GO:0002696	positive regulation of leukocyte activation	-	358	19	-	-	2.43E-02	1.56E-02
ProteomeHD	BP	GO:0034504	protein localization to nucleus	-	312	38	-	-	1.67E-02	3.02E-02
ProteomeHD	BP	GO:0031647	regulation of protein stability	-	327	39	-	-	2.18E-02	3.12E-02
ProteomeHD	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	12	-	-	4.63E-02	9.74E-03
ProteomeHD	BP	GO:0016054	organic acid catabolic process	-	251	28	-	-	7.19E-02	2.24E-02
ProteomeHD	BP	GO:0050890	cognition	-	317	11	-	-	2.89E-03	8.76E-03
ProteomeHD	BP	GO:0008033	tRNA processing	-	136	19	-	-	8.03E-03	1.56E-02
ProteomeHD	BP	GO:1990778	protein localization to cell periphery	-	346	18	-	-	1.65E-02	1.46E-02
ProteomeHD	BP	GO:0001568	blood vessel development	-	790	23	-	-	4.31E-03	1.85E-02
ProteomeHD	BP	GO:0051258	protein polymerization	-	280	23	-	-	5.66E-02	1.85E-02
ProteomeHD	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	12	-	-	4.72E-03	9.74E-03
ProteomeHD	BP	GO:1903708	positive regulation of hemopoiesis	-	184	13	-	-	8.53E-03	1.07E-02
ProteomeHD	BP	GO:1903008	organelle disassembly	-	154	17	-	-	5.22E-02	1.36E-02
ProteomeHD	BP	GO:0032535	regulation of cellular component size	-	360	23	-	-	6.03E-02	1.85E-02
ProteomeHD	BP	GO:0001934	positive regulation of protein phosphorylation	-	701	28	-	-	8.98E-03	2.24E-02
ProteomeHD	BP	GO:0051603	proteolysis involved in protein catabolic process	-	759	76	-	-	4.81E-02	5.94E-02
ProteomeHD	BP	GO:0070585	protein localization to mitochondrion	-	125	15	-	-	1.05E-02	1.17E-02
ProteomeHD	BP	GO:0044242	cellular lipid catabolic process	-	224	11	-	-	4.75E-02	8.76E-03
ProteomeHD	BP	GO:0055082	intracellular chemical homeostasis	-	706	31	-	-	6.65E-03	2.43E-02
ProteomeHD	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	30	-	-	7.46E-03	2.34E-02
ProteomeHD	BP	GO:0009755	hormone-mediated signaling pathway	-	221	21	-	-	1.04E-02	1.66E-02
ProteomeHD	BP	GO:0044782	cilium organization	-	400	11	-	-	2.65E-03	8.76E-03
ProteomeHD	BP	GO:0090130	tissue migration	-	379	12	-	-	2.81E-03	9.74E-03
ProteomeHD	BP	GO:0009314	response to radiation	-	449	29	-	-	3.51E-02	2.34E-02
ProteomeHD	BP	GO:0009451	RNA modification	-	169	21	-	-	6.26E-02	1.66E-02
ProteomeHD	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	13	-	-	1.09E-01	1.07E-02
ProteomeHD	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	11	-	-	1.19E-02	8.76E-03
ProteomeHD	CC	GO:0042770	signal transduction in response to DNA damage	-	186	17	-	-	4.97E-03	1.36E-02
ProteomeHD	BP	GO:0045727	positive regulation of translation	-	141	22	-	-	3.29E-02	1.75E-02
ProteomeHD	CC	GO:0032388	positive regulation of intracellular transport	-	137	18	-	-	1.01E-02	1.46E-02
ProteomeHD	BP	GO:0072523	purine-containing compound catabolic process	-	146	15	-	-	3.57E-03	1.17E-02
ProteomeHD	BP	GO:0008284	positive regulation of cell population proliferation	-	992	45	-	-	9.53E-03	3.51E-02
ProteomeHD	BP	GO:0008213	protein alkylation	-	58	12	-	-	4.24E-03	9.74E-03
ProteomeHD	BP	GO:0002253	activation of immune response	-	529	49	-	-	3.40E-02	3.89E-02
ProteomeHD	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	15	-	-	3.52E-03	1.17E-02
ProteomeHD	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	25	-	-	1.82E-02	1.95E-02
ProteomeHD	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	24	-	-	7.05E-03	1.95E-02
ProteomeHD	BP	GO:0009306	protein secretion	-	376	17	-	-	3.69E-03	1.36E-02
ProteomeHD	MF	GO:0043086	negative regulation of catalytic activity	-	717	35	-	-	2.75E-02	2.73E-02
ProteomeHD	BP	GO:0045732	positive regulation of protein catabolic process	-	202	17	-	-	5.53E-03	1.36E-02
ProteomeHD	BP	GO:0031589	cell-substrate adhesion	-	360	16	-	-	1.88E-01	1.27E-02
ProteomeHD	BP	GO:0010948	negative regulation of cell cycle process	-	317	24	-	-	3.89E-02	1.95E-02
ProteomeHD	BP	GO:0048284	organelle fusion	-	456	40	-	-	5.12E-02	3.12E-02
ProteomeHD	CC	GO:0043410	positive regulation of MAPK cascade	-	494	15	-	-	3.67E-03	1.17E-02
ProteomeHD	BP	GO:0043414	macromolecule methylation	-	138	18	-	-	5.10E-03	1.46E-02
ProteomeHD	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	13	-	-	2.07E-02	1.07E-02
ProteomeHD	BP	GO:0048880	sensory system development	-	399	11	-	-	3.95E-03	8.76E-03
ProteomeHD	BP	GO:0043331	response to dsRNA	-	56	11	-	-	2.78E-03	8.76E-03
ProteomeHD	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	12	-	-	4.50E-03	9.74E-03
ProteomeHD	BP	GO:0005996	monosaccharide metabolic process	-	250	19	-	-	2.02E-02	1.56E-02
ProteomeHD	BP	GO:0002262	myeloid cell homeostasis	-	172	12	-	-	4.00E-03	9.74E-03
ProteomeHD	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	22	-	-	4.01E-02	1.75E-02
ProteomeHD	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	18	-	-	5.76E-03	1.46E-02
ProteomeHD	BP	GO:0022618	protein-RNA complex assembly	-	227	43	-	-	5.53E-02	3.41E-02
ProteomeHD	BP	GO:0006066	alcohol metabolic process	-	374	20	-	-	1.26E-01	1.56E-02
ProteomeHD	BP	GO:0023061	signal release	-	491	22	-	-	2.29E-02	1.75E-02
ProteomeHD	BP	GO:0051222	positive regulation of protein transport	-	249	19	-	-	1.18E-02	1.56E-02
ProteomeHD	BP	GO:0045739	positive regulation of DNA repair	-	128	17	-	-	5.16E-03	1.36E-02
ProteomeHD	MF	GO:0003713	transcription coactivator activity	-	281	41	-	-	1.87E-02	3.21E-02
ProteomeHD	BP	GO:0045862	positive regulation of proteolysis	-	353	21	-	-	1.58E-02	1.66E-02
ProteomeHD	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	17	-	-	4.74E-02	1.36E-02
ProteomeHD	BP	GO:0030001	metal ion transport	-	933	28	-	-	1.88E-02	2.24E-02
ProteomeHD	BP	GO:0031123	RNA 3'-end processing	-	79	19	-	-	5.00E-02	1.56E-02
ProteomeHD	BP	GO:0001667	ameboidal-type cell migration	-	495	17	-	-	3.69E-03	1.36E-02
ProteomeHD	BP	GO:0032970	regulation of actin filament-based process	-	368	16	-	-	6.58E-02	1.27E-02
ProteomeHD	BP	GO:1901606	alpha-amino acid catabolic process	-	101	12	-	-	2.93E-02	9.74E-03
ProteomeHD	BP	GO:0062197	cellular response to chemical stress	-	299	19	-	-	2.71E-02	1.56E-02
ProteomeHD	MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	-	925	43	-	-	2.02E-01	3.41E-02
ProteomeHD	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	11	-	-	3.13E-02	8.76E-03
ProteomeHD	BP	GO:0090068	positive regulation of cell cycle process	-	262	22	-	-	1.16E-02	1.75E-02
ProteomeHD	MF	GO:0022803	passive transmembrane transporter activity	-	676	21	-	-	6.83E-02	1.66E-02
ProteomeHD	BP	GO:0043632	modification-dependent macromolecule catabolic process	-	642	71	-	-	5.78E-02	5.55E-02
ProteomeHD	BP	GO:1902115	regulation of organelle assembly	-	210	16	-	-	5.73E-03	1.27E-02
ProteomeHD	BP	GO:0006397	mRNA processing	-	482	110	-	-	1.40E-01	8.57E-02
ProteomeHD	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	13	-	-	2.22E-01	1.07E-02
ProteomeHD	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	20	-	-	5.84E-01	1.56E-02
ProteomeHD	BP	GO:0060326	cell chemotaxis	-	311	11	-	-	2.79E-03	8.76E-03
ProteomeHD	BP	GO:0016485	protein processing	-	248	13	-	-	3.74E-02	1.07E-02
ProteomeHD	BP	GO:0031348	negative regulation of defense response	-	282	11	-	-	3.66E-02	8.76E-03
ProteomeHD	CC	GO:0051169	nuclear transport	-	325	54	-	-	2.64E-02	4.28E-02
ProteomeHD	BP	GO:0046434	organophosphate catabolic process	-	232	15	-	-	3.57E-03	1.17E-02
ProteomeHD	BP	GO:0009566	fertilization	-	205	12	-	-	3.43E-03	9.74E-03
ProteomeHD	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	17	-	-	2.78E-01	1.36E-02
ProteomeHD	BP	GO:0033044	regulation of chromosome organization	-	249	49	-	-	4.99E-02	3.89E-02
ProteomeHD	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	19	-	-	3.79E-03	1.56E-02
ProteomeHD	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	26	-	-	1.09E-02	2.04E-02
ProteomeHD	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	54	-	-	2.49E-01	4.28E-02
ProteomeHD	BP	GO:0051303	establishment of chromosome localization	-	104	13	-	-	2.53E-03	1.07E-02
ProteomeHD	BP	GO:0031349	positive regulation of defense response	-	473	43	-	-	1.53E-02	3.41E-02
ProteomeHD	BP	GO:0006605	protein targeting	-	327	35	-	-	4.48E-02	2.73E-02
ProteomeHD	BP	GO:0061512	protein localization to cilium	-	394	11	-	-	2.76E-03	8.76E-03
ProteomeHD	BP	GO:0051017	actin filament bundle assembly	-	161	11	-	-	2.89E-03	8.76E-03
ProteomeHD	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	15	-	-	1.03E-01	1.17E-02
ProteomeHD	BP	GO:0051304	chromosome separation	-	80	14	-	-	3.93E-02	1.17E-02
ProteomeHD	BP	GO:0045017	glycerolipid biosynthetic process	-	254	13	-	-	2.02E-01	1.07E-02
ProteomeHD	BP	GO:0033500	carbohydrate homeostasis	-	251	13	-	-	1.27E-02	1.07E-02
ProteomeHD	BP	GO:0120035	regulation of plasma membrane bounded cell projection organization	-	647	32	-	-	7.60E-03	2.53E-02
ProteomeHD	CC	GO:0098857	membrane microdomain	-	324	18	-	-	1.12E-02	1.46E-02
ProteomeHD	CC	GO:1905368	peptidase complex	-	124	27	-	-	1.10E-01	2.14E-02
ProteomeHD	CC	GO:0070161	anchoring junction	-	897	63	-	-	7.23E-02	4.97E-02
ProteomeHD	CC	GO:0044391	ribosomal subunit	-	203	31	-	-	1.60E-01	2.43E-02
ProteomeHD	CC	GO:0071013	catalytic step 2 spliceosome	-	88	27	-	-	1.97E-02	2.14E-02
ProteomeHD	CC	GO:0098978	glutamatergic synapse	-	411	29	-	-	7.11E-03	2.34E-02
ProteomeHD	CC	GO:0016363	nuclear matrix	-	127	20	-	-	1.41E-02	1.56E-02
ProteomeHD	CC	GO:0031966	mitochondrial membrane	-	746	83	-	-	2.30E-01	6.52E-02
ProteomeHD	CC	GO:0032432	actin filament bundle	-	249	13	-	-	2.65E-03	1.07E-02
ProteomeHD	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	14	-	-	1.33E-02	1.17E-02
ProteomeHD	CC	GO:0000313	organellar ribosome	-	89	12	-	-	9.24E-01	9.74E-03
ProteomeHD	CC	GO:0098791	Golgi apparatus subcompartment	-	378	27	-	-	1.93E-02	2.14E-02
ProteomeHD	CC	GO:0005814	centriole	-	692	60	-	-	2.34E-02	4.67E-02
ProteomeHD	CC	GO:0032588	trans-Golgi network membrane	-	102	17	-	-	6.07E-02	1.36E-02
ProteomeHD	CC	GO:0070382	exocytic vesicle	-	224	15	-	-	2.08E-02	1.17E-02
ProteomeHD	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	44	-	-	3.27E-02	3.51E-02
ProteomeHD	CC	GO:0000793	condensed chromosome	-	274	40	-	-	2.99E-02	3.12E-02
ProteomeHD	CC	GO:0000922	spindle pole	-	172	18	-	-	3.68E-03	1.46E-02
ProteomeHD	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	13	-	-	8.12E-02	1.07E-02
ProteomeHD	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	13	-	-	8.68E-02	1.07E-02
ProteomeHD	CC	GO:0007034	vacuolar transport	-	168	20	-	-	2.12E-02	1.56E-02
ProteomeHD	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	20	-	-	4.65E-01	1.56E-02
ProteomeHD	CC	GO:0150034	distal axon	-	309	17	-	-	4.60E-03	1.36E-02
ProteomeHD	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	34	-	-	3.00E-02	2.73E-02
ProteomeHD	CC	GO:0005881	cytoplasmic microtubule	-	256	11	-	-	3.24E-02	8.76E-03
ProteomeHD	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	13	-	-	8.90E-02	1.07E-02
ProteomeHD	CC	GO:0005905	clathrin-coated pit	-	73	11	-	-	4.99E-02	8.76E-03
ProteomeHD	CC	GO:0000139	Golgi membrane	-	646	41	-	-	4.90E-02	3.21E-02
ProteomeHD	CC	GO:0007006	mitochondrial membrane organization	-	117	13	-	-	4.40E-02	1.07E-02
ProteomeHD	CC	GO:0030427	site of polarized growth	-	172	13	-	-	2.70E-03	1.07E-02
ProteomeHD	CC	GO:0044309	neuron spine	-	213	14	-	-	2.75E-03	1.17E-02
ProteomeHD	CC	GO:0030658	transport vesicle membrane	-	231	21	-	-	7.10E-03	1.66E-02
ProteomeHD	CC	GO:0030667	secretory granule membrane	-	319	22	-	-	1.02E-01	1.75E-02
ProteomeHD	CC	GO:0055037	recycling endosome	-	200	17	-	-	1.43E-02	1.36E-02
ProteomeHD	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	36	-	-	6.15E-02	2.82E-02
ProteomeHD	CC	GO:0005775	vacuolar lumen	-	176	15	-	-	4.15E-02	1.17E-02
ProteomeHD	CC	GO:0005770	late endosome	-	299	23	-	-	2.33E-02	1.85E-02
ProteomeHD	CC	GO:0031970	organelle envelope lumen	-	94	13	-	-	8.10E-02	1.07E-02
ProteomeHD	CC	GO:0019866	organelle inner membrane	-	546	66	-	-	1.70E-01	5.16E-02
ProteomeHD	CC	GO:0098687	chromosomal region	-	397	46	-	-	3.15E-02	3.60E-02
ProteomeHD	CC	GO:0043292	contractile muscle fiber	-	245	16	-	-	7.00E-02	1.27E-02
ProteomeHD	CC	GO:0000323	lytic vacuole	-	749	67	-	-	4.33E-02	5.26E-02
ProteomeHD	CC	GO:1903293	phosphatase complex	-	54	11	-	-	1.30E-02	8.76E-03
ProteomeHD	CC	GO:0000786	nucleosome	-	149	15	-	-	1.55E-01	1.17E-02
ProteomeHD	CC	GO:0030027	lamellipodium	-	202	26	-	-	3.51E-02	2.04E-02
ProteomeHD	CC	GO:0001650	fibrillar center	-	151	13	-	-	6.06E-02	1.07E-02
ProteomeHD	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	24	-	-	4.17E-02	1.95E-02
ProteomeHD	CC	GO:0001726	ruffle	-	181	17	-	-	3.62E-03	1.36E-02
ProteomeHD	CC	GO:0005788	endoplasmic reticulum lumen	-	313	13	-	-	5.95E-02	1.07E-02
ProteomeHD	CC	GO:0022626	cytosolic ribosome	-	118	19	-	-	6.54E-02	1.56E-02
ProteomeHD	CC	GO:0098984	neuron to neuron synapse	-	384	21	-	-	4.46E-02	1.66E-02
ProteomeHD	CC	GO:0016604	nuclear body	-	847	108	-	-	8.31E-02	8.47E-02
ProteomeHD	CC	GO:0016482	cytosolic transport	-	135	26	-	-	1.72E-02	2.04E-02
ProteomeHD	CC	GO:0030662	coated vesicle membrane	-	202	26	-	-	8.51E-02	2.04E-02
ProteomeHD	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	23	-	-	3.22E-01	1.85E-02
ProteomeHD	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	22	-	-	2.31E-02	1.75E-02
ProteomeHD	CC	GO:0005769	early endosome	-	425	44	-	-	3.40E-02	3.51E-02
ProteomeHD	CC	GO:0090734	site of DNA damage	-	118	11	-	-	1.11E-01	8.76E-03
ProteomeHD	MF	GO:0140640	"catalytic activity, acting on a nucleic acid"	-	762	96	-	-	5.42E-02	7.50E-02
ProteomeHD	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	21	-	-	5.19E-02	1.66E-02
ProteomeHD	MF	GO:0016757	glycosyltransferase activity	-	286	11	-	-	6.93E-02	8.76E-03
ProteomeHD	MF	GO:0051020	GTPase binding	-	311	23	-	-	5.69E-03	1.85E-02
ProteomeHD	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	40	-	-	1.88E-02	3.12E-02
ProteomeHD	MF	GO:0008233	peptidase activity	-	998	51	-	-	3.00E-02	3.99E-02
ProteomeHD	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	22	-	-	2.71E-02	1.75E-02
ProteomeHD	MF	GO:0140030	modification-dependent protein binding	-	179	26	-	-	2.26E-02	2.04E-02
ProteomeHD	MF	GO:0003712	transcription coregulator activity	-	499	61	-	-	2.80E-02	4.77E-02
ProteomeHD	MF	GO:0106310	protein serine kinase activity	-	362	18	-	-	9.18E-03	1.46E-02
ProteomeHD	MF	GO:0016788	"hydrolase activity, acting on ester bonds"	-	936	65	-	-	2.42E-02	5.06E-02
ProteomeHD	MF	GO:0004857	enzyme inhibitor activity	-	395	17	-	-	4.08E-02	1.36E-02
ProteomeHD	MF	GO:0044325	transmembrane transporter binding	-	159	17	-	-	3.36E-03	1.36E-02
ProteomeHD	MF	GO:0030145	manganese ion binding	-	65	11	-	-	2.84E-03	8.76E-03
ProteomeHD	MF	GO:0017069	snRNA binding	-	54	12	-	-	7.04E-03	9.74E-03
ProteomeHD	MF	GO:0008270	zinc ion binding	-	821	38	-	-	2.74E-02	3.02E-02
ProteomeHD	MF	GO:0016779	nucleotidyltransferase activity	-	264	37	-	-	5.59E-02	2.92E-02
ProteomeHD	MF	GO:0000287	magnesium ion binding	-	225	17	-	-	3.51E-03	1.36E-02
ProteomeHD	MF	GO:0031490	chromatin DNA binding	-	120	12	-	-	8.17E-03	9.74E-03
ProteomeHD	MF	GO:0015631	tubulin binding	-	410	35	-	-	1.14E-02	2.73E-02
ProteomeHD	MF	GO:0019207	kinase regulator activity	-	267	18	-	-	1.09E-02	1.46E-02
ProteomeHD	MF	GO:0008047	enzyme activator activity	-	697	53	-	-	1.70E-02	4.19E-02
ProteomeHD	MF	GO:0004674	protein serine/threonine kinase activity	-	761	39	-	-	2.23E-02	3.12E-02
ProteomeHD	MF	GO:0003725	double-stranded RNA binding	-	72	13	-	-	9.15E-03	1.07E-02
ProteomeHD	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	13	-	-	6.92E-02	1.07E-02
ProteomeHD	MF	GO:0051117	ATPase binding	-	85	12	-	-	4.31E-03	9.74E-03
ProteomeHD	MF	GO:0005216	monoatomic ion channel activity	-	618	20	-	-	6.70E-02	1.56E-02
ProteomeHD	MF	GO:0016746	acyltransferase activity	-	895	57	-	-	1.34E-02	4.48E-02
ProteomeHD	MF	GO:0036002	pre-mRNA binding	-	57	11	-	-	3.38E-02	8.76E-03
ProteomeHD	MF	GO:0019003	GDP binding	-	89	13	-	-	1.26E-01	1.07E-02
ProteomeHD	MF	GO:0051015	actin filament binding	-	208	12	-	-	4.37E-01	9.74E-03
ProteomeHD	MF	GO:0019208	phosphatase regulator activity	-	107	11	-	-	2.62E-03	8.76E-03
ProteomeHD	MF	GO:0045860	positive regulation of protein kinase activity	-	397	18	-	-	8.53E-03	1.46E-02
ProteomeHD	MF	GO:0008134	transcription factor binding	-	597	64	-	-	1.60E-02	5.06E-02
ProteomeHD	MF	GO:0042393	histone binding	-	240	35	-	-	3.65E-02	2.73E-02
ProteomeHD	MF	GO:0000149	SNARE binding	-	107	11	-	-	9.98E-03	8.76E-03
ProteomeHD	MF	GO:0003727	single-stranded RNA binding	-	90	21	-	-	1.41E-02	1.66E-02
ProteomeHD	MF	GO:0005516	calmodulin binding	-	206	11	-	-	1.69E-01	8.76E-03
ProteomeHD	MF	GO:0005198	structural molecule activity	-	823	56	-	-	1.08E-01	4.38E-02
ProteomeHD	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	12	-	-	1.03E-01	9.74E-03
ProteomeHD	MF	GO:0032182	ubiquitin-like protein binding	-	117	15	-	-	1.01E-02	1.17E-02
ProteomeHD	MF	GO:0019904	protein domain specific binding	-	656	65	-	-	2.86E-02	5.06E-02
ProteomeHD	MF	GO:0031072	heat shock protein binding	-	128	17	-	-	1.35E-02	1.36E-02
ProteomeHD	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	30	-	-	1.17E-02	2.34E-02
ProteomeHD	MF	GO:0046982	protein heterodimerization activity	-	343	27	-	-	1.46E-01	2.14E-02
ProteomeHD	MF	GO:0000049	tRNA binding	-	75	13	-	-	8.85E-03	1.07E-02
ProteomeHD	MF	GO:0006469	negative regulation of protein kinase activity	-	222	15	-	-	3.52E-03	1.17E-02
ProteomeHD	MF	GO:0005525	GTP binding	-	396	39	-	-	1.37E-01	3.12E-02
ProteomeHD	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	15	-	-	9.89E-03	1.17E-02
ProteomeHD	MF	GO:0042803	protein homodimerization activity	-	699	55	-	-	1.17E-02	4.28E-02
ProteomeHD	MF	GO:0051346	negative regulation of hydrolase activity	-	332	11	-	-	6.30E-02	8.76E-03
ProteomeHD	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	29	-	-	1.01E-02	2.34E-02
ProteomeHD	MF	GO:0051345	positive regulation of hydrolase activity	-	535	27	-	-	1.81E-02	2.14E-02
ProteomeHD	MF	GO:0015399	primary active transmembrane transporter activity	-	190	21	-	-	5.59E-01	1.66E-02
ProteomeHD	MF	GO:0043021	ribonucleoprotein complex binding	-	158	34	-	-	3.43E-02	2.73E-02
ProteomeHD	MF	GO:0019900	kinase binding	-	893	49	-	-	1.15E-02	3.89E-02
PTMCode2	CC	GO:0005615	extracellular space	9.76E-51	3190	1295	936	1.38	-	-
PTMCode2	CC	GO:0005730	nucleolus	3.29E-26	988	443	290	1.53	-	-
PTMCode2	CC	GO:0005768	endosome	6.89E-18	1037	431	304	1.42	-	-
PTMCode2	CC	GO:0005815	microtubule organizing center	2.56E-15	843	353	247	1.43	-	-
PTMCode2	CC	GO:0005840	ribosome	6.63E-13	222	116	65	1.78	-	-
PTMCode2	CC	GO:0000228	nuclear chromosome	2.51E-11	206	106	60	1.75	-	-
PTMCode2	CC	GO:0005794	Golgi apparatus	3.19E-11	1636	599	480	1.25	-	-
PTMCode2	CC	GO:0031012	extracellular matrix	4.92E-11	564	238	165	1.44	-	-
PTMCode2	CC	GO:0005764	lysosome	2.96E-10	747	298	219	1.36	-	-
PTMCode2	CC	GO:0005635	nuclear envelope	8.93E-09	493	204	145	1.41	-	-
PTMCode2	CC	GO:0005783	endoplasmic reticulum	5.25E-04	2020	660	592	1.11	-	-
PTMCode2	CC	GO:0005739	mitochondrion	5.20E-02	1671	525	490	1.07	-	-
PTMCode2	CC	GO:0005811	lipid droplet	3.27E-01	102	25	30	0.84	-	-
PTMCode2	CC	GO:0005929	cilium	6.15E-01	842	240	247	0.97	-	-
PTMCode2	CC	GO:0005777	peroxisome	8.53E-01	142	40	42	0.96	-	-
PTMCode2	BP	GO:0012501	programmed cell death	1.57E-113	1954	1024	573	1.79	-	-
PTMCode2	BP	GO:0002376	immune system process	5.53E-103	2448	1188	718	1.65	-	-
PTMCode2	BP	GO:0007155	cell adhesion	2.22E-75	1444	743	424	1.75	-	-
PTMCode2	BP	GO:0006355	regulation of DNA-templated transcription	1.36E-66	3342	1402	980	1.43	-	-
PTMCode2	BP	GO:0048870	cell motility	2.63E-63	1659	796	487	1.64	-	-
PTMCode2	BP	GO:0065003	protein-containing complex assembly	8.61E-59	1648	780	483	1.61	-	-
PTMCode2	BP	GO:0042060	wound healing	1.87E-49	431	273	126	2.16	-	-
PTMCode2	BP	GO:0016192	vesicle-mediated transport	1.47E-48	1894	840	555	1.51	-	-
PTMCode2	BP	GO:0034330	cell junction organization	9.07E-46	727	393	213	1.84	-	-
PTMCode2	BP	GO:0006954	inflammatory response	1.54E-44	820	428	240	1.78	-	-
PTMCode2	BP	GO:0098542	defense response to other organism	1.98E-37	1171	544	343	1.58	-	-
PTMCode2	BP	GO:0030163	protein catabolic process	3.74E-36	990	473	290	1.63	-	-
PTMCode2	BP	GO:0006281	DNA repair	5.71E-31	587	304	172	1.77	-	-
PTMCode2	BP	GO:0007010	cytoskeleton organization	2.03E-29	1639	685	481	1.43	-	-
PTMCode2	BP	GO:0006886	intracellular protein transport	3.37E-29	664	330	195	1.69	-	-
PTMCode2	BP	GO:0003012	muscle system process	1.58E-28	425	233	125	1.87	-	-
PTMCode2	BP	GO:0003013	circulatory system process	1.82E-28	584	297	171	1.73	-	-
PTMCode2	BP	GO:0006913	nucleocytoplasmic transport	2.84E-25	326	185	96	1.93	-	-
PTMCode2	BP	GO:0007059	chromosome segregation	3.87E-21	403	208	118	1.76	-	-
PTMCode2	BP	GO:0006325	chromatin organization	1.23E-19	720	324	211	1.53	-	-
PTMCode2	BP	GO:0006260	DNA replication	1.27E-19	279	154	82	1.88	-	-
PTMCode2	BP	GO:0007163	establishment or maintenance of cell polarity	6.05E-19	227	131	67	1.97	-	-
PTMCode2	BP	GO:0016071	mRNA metabolic process	8.45E-19	713	319	209	1.53	-	-
PTMCode2	BP	GO:0072659	protein localization to plasma membrane	1.80E-18	284	154	83	1.85	-	-
PTMCode2	BP	GO:0032200	telomere organization	9.16E-17	186	109	55	2.00	-	-
PTMCode2	BP	GO:0006914	autophagy	4.13E-16	568	257	167	1.54	-	-
PTMCode2	BP	GO:0002181	cytoplasmic translation	2.68E-15	153	92	45	2.05	-	-
PTMCode2	BP	GO:0006457	protein folding	4.17E-11	210	107	62	1.74	-	-
PTMCode2	BP	GO:0006310	DNA recombination	1.91E-09	333	149	98	1.53	-	-
PTMCode2	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	3.09E-09	119	66	35	1.89	-	-
PTMCode2	BP	GO:0006091	generation of precursor metabolites and energy	4.98E-09	502	208	147	1.41	-	-
PTMCode2	BP	GO:0042254	ribosome biogenesis	1.65E-08	297	133	87	1.53	-	-
PTMCode2	BP	GO:0007005	mitochondrion organization	7.03E-08	484	197	142	1.39	-	-
PTMCode2	BP	GO:0030198	extracellular matrix organization	1.21E-07	314	136	92	1.48	-	-
PTMCode2	BP	GO:0000910	cytokinesis	2.38E-07	186	88	55	1.61	-	-
PTMCode2	BP	GO:0140013	meiotic nuclear division	2.76E-07	279	122	82	1.49	-	-
PTMCode2	BP	GO:0003014	renal system process	6.48E-07	127	64	37	1.72	-	-
PTMCode2	BP	GO:0006790	sulfur compound metabolic process	2.21E-06	320	57	94	0.61	-	-
PTMCode2	BP	GO:0055085	transmembrane transport	2.88E-06	1784	610	523	1.17	-	-
PTMCode2	BP	GO:0022600	digestive system process	1.27E-05	110	54	32	1.67	-	-
PTMCode2	BP	GO:0006486	protein glycosylation	4.52E-05	225	39	66	0.59	-	-
PTMCode2	BP	GO:0006520	amino acid metabolic process	7.30E-04	292	60	86	0.70	-	-
PTMCode2	BP	GO:0005975	carbohydrate metabolic process	4.36E-03	551	192	162	1.19	-	-
PTMCode2	BP	GO:0006575	cellular modified amino acid metabolic process	7.38E-03	186	38	55	0.70	-	-
PTMCode2	BP	GO:0007040	lysosome organization	1.02E-02	107	44	31	1.40	-	-
PTMCode2	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.51E-02	729	241	214	1.13	-	-
PTMCode2	BP	GO:0007018	microtubule-based movement	7.72E-02	640	208	188	1.11	-	-
PTMCode2	BP	GO:0044782	cilium organization	2.43E-01	399	106	117	0.91	-	-
PTMCode2	BP	GO:0140053	mitochondrial gene expression	2.63E-01	164	41	48	0.85	-	-
PTMCode2	BP	GO:0098754	detoxification	5.05E-01	134	43	39	1.09	-	-
PTMCode2	BP	GO:0006766	vitamin metabolic process	6.71E-01	107	29	31	0.92	-	-
PTMCode2	BP	GO:0006629	lipid metabolic process	9.26E-01	1355	399	397	1.00	-	-
PTMCode2	BP	GO:0006399	tRNA metabolic process	9.37E-01	196	58	57	1.01	-	-
PTMCode2	BP	GO:0050877	nervous system process	9.77E-01	1527	447	448	1.00	-	-
PTMCode2	MF	GO:0140096	"catalytic activity, acting on a protein"	1.17E-80	3198	1397	938	1.49	-	-
PTMCode2	MF	GO:0016740	transferase activity	5.53E-56	3074	1275	902	1.41	-	-
PTMCode2	MF	GO:0140110	transcription regulator activity	6.23E-36	2033	846	596	1.42	-	-
PTMCode2	MF	GO:0008092	cytoskeletal protein binding	1.25E-34	1023	481	300	1.60	-	-
PTMCode2	MF	GO:0003677	DNA binding	2.92E-30	2865	1102	840	1.31	-	-
PTMCode2	MF	GO:0003723	RNA binding	1.17E-29	1679	700	492	1.42	-	-
PTMCode2	MF	GO:0140097	"catalytic activity, acting on DNA"	3.15E-25	383	209	112	1.86	-	-
PTMCode2	MF	GO:0009975	cyclase activity	1.00E-16	277	147	81	1.81	-	-
PTMCode2	MF	GO:0005198	structural molecule activity	2.26E-16	798	341	234	1.46	-	-
PTMCode2	MF	GO:0048018	receptor ligand activity	2.54E-14	504	228	148	1.54	-	-
PTMCode2	MF	GO:0003924	GTPase activity	6.07E-14	658	282	193	1.46	-	-
PTMCode2	MF	GO:0008289	lipid binding	4.91E-13	836	341	245	1.39	-	-
PTMCode2	MF	GO:0016829	lyase activity	7.70E-13	538	235	158	1.49	-	-
PTMCode2	MF	GO:0042393	histone binding	2.31E-08	237	110	70	1.58	-	-
PTMCode2	MF	GO:0140104	molecular carrier activity	7.89E-07	105	55	31	1.79	-	-
PTMCode2	MF	GO:0045182	translation regulator activity	8.82E-07	151	73	44	1.65	-	-
PTMCode2	MF	GO:0140657	ATP-dependent activity	3.22E-05	729	265	214	1.24	-	-
PTMCode2	MF	GO:0038024	cargo receptor activity	4.97E-04	117	52	34	1.52	-	-
PTMCode2	MF	GO:0016853	isomerase activity	6.27E-04	252	99	74	1.34	-	-
PTMCode2	MF	GO:0003774	cytoskeletal motor activity	1.24E-01	116	26	34	0.76	-	-
PTMCode2	MF	GO:0016874	ligase activity	1.89E-01	283	93	83	1.12	-	-
PTMCode2	MF	GO:0140098	"catalytic activity, acting on RNA"	3.55E-01	417	131	122	1.07	-	-
PTMCode2	MF	GO:0016491	oxidoreductase activity	5.71E-01	888	268	260	1.03	-	-
PTMCode2	MF	GO:0005215	transporter activity	8.58E-01	1462	432	429	1.01	-	-
PTMCode2	BP	GO:0008038	neuron recognition	-	46	21	-	-	1.07E-02	3.07E-03
PTMCode2	BP	GO:1905145	cellular response to acetylcholine	-	33	18	-	-	1.53E-02	2.71E-03
PTMCode2	BP	GO:0097094	craniofacial suture morphogenesis	-	18	11	-	-	1.32E-02	1.63E-03
PTMCode2	BP	GO:0098780	response to mitochondrial depolarisation	-	21	12	-	-	3.94E-02	1.81E-03
PTMCode2	BP	GO:0051931	regulation of sensory perception	-	36	18	-	-	1.19E-02	2.71E-03
PTMCode2	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	18	-	-	1.41E-03	2.71E-03
PTMCode2	BP	GO:0009268	response to pH	-	43	17	-	-	3.64E-03	2.53E-03
PTMCode2	BP	GO:0045666	positive regulation of neuron differentiation	-	91	46	-	-	5.74E-03	6.68E-03
PTMCode2	BP	GO:0043543	protein acylation	-	107	40	-	-	8.55E-03	5.78E-03
PTMCode2	MF	GO:0051349	positive regulation of lyase activity	-	41	24	-	-	1.77E-02	3.61E-03
PTMCode2	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	11	-	-	3.55E-02	1.63E-03
PTMCode2	BP	GO:0048679	regulation of axon regeneration	-	28	13	-	-	2.46E-03	1.99E-03
PTMCode2	BP	GO:0022401	negative adaptation of signaling pathway	-	21	15	-	-	9.19E-02	2.17E-03
PTMCode2	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	26	-	-	3.72E-03	3.79E-03
PTMCode2	BP	GO:0071763	nuclear membrane organization	-	44	22	-	-	4.09E-02	3.25E-03
PTMCode2	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	18	-	-	1.00E-02	2.71E-03
PTMCode2	BP	GO:0071806	protein transmembrane transport	-	68	32	-	-	2.44E-01	4.70E-03
PTMCode2	BP	GO:0021548	pons development	-	11	11	-	-	5.35E-04	1.63E-03
PTMCode2	BP	GO:0043299	leukocyte degranulation	-	82	56	-	-	1.87E-02	8.13E-03
PTMCode2	BP	GO:0048864	stem cell development	-	88	39	-	-	5.75E-03	5.78E-03
PTMCode2	BP	GO:0051651	maintenance of location in cell	-	236	131	-	-	1.57E-02	1.90E-02
PTMCode2	BP	GO:0033119	negative regulation of RNA splicing	-	27	13	-	-	8.23E-02	1.99E-03
PTMCode2	CC	GO:0016197	endosomal transport	-	282	108	-	-	1.15E-01	1.57E-02
PTMCode2	BP	GO:0070663	regulation of leukocyte proliferation	-	268	159	-	-	1.91E-02	2.31E-02
PTMCode2	BP	GO:0001833	inner cell mass cell proliferation	-	14	12	-	-	9.88E-03	1.81E-03
PTMCode2	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	23	-	-	5.67E-02	3.43E-03
PTMCode2	BP	GO:0006949	syncytium formation	-	66	38	-	-	7.06E-03	5.60E-03
PTMCode2	BP	GO:0045861	negative regulation of proteolysis	-	320	149	-	-	1.05E-02	2.17E-02
PTMCode2	BP	GO:0030574	collagen catabolic process	-	45	21	-	-	8.32E-03	3.07E-03
PTMCode2	CC	GO:0006984	ER-nucleus signaling pathway	-	46	20	-	-	2.37E-02	2.89E-03
PTMCode2	BP	GO:0060343	trabecula formation	-	26	18	-	-	4.21E-03	2.71E-03
PTMCode2	BP	GO:0009914	hormone transport	-	315	174	-	-	2.34E-02	2.53E-02
PTMCode2	BP	GO:0140112	extracellular vesicle biogenesis	-	23	14	-	-	2.63E-02	2.17E-03
PTMCode2	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	11	-	-	2.59E-01	1.63E-03
PTMCode2	BP	GO:1900424	regulation of defense response to bacterium	-	21	11	-	-	7.38E-02	1.63E-03
PTMCode2	BP	GO:0085029	extracellular matrix assembly	-	42	18	-	-	7.11E-04	2.71E-03
PTMCode2	BP	GO:0006413	translational initiation	-	122	62	-	-	2.30E-01	9.03E-03
PTMCode2	BP	GO:1902895	positive regulation of miRNA transcription	-	51	38	-	-	7.23E-03	5.60E-03
PTMCode2	CC	GO:0005200	structural constituent of cytoskeleton	-	112	50	-	-	2.11E-02	7.23E-03
PTMCode2	BP	GO:0030865	cortical cytoskeleton organization	-	51	32	-	-	5.60E-03	4.70E-03
PTMCode2	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	14	-	-	4.41E-02	2.17E-03
PTMCode2	BP	GO:1903036	positive regulation of response to wounding	-	76	40	-	-	2.66E-02	5.78E-03
PTMCode2	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	50	-	-	2.23E-02	7.23E-03
PTMCode2	BP	GO:1903319	positive regulation of protein maturation	-	27	14	-	-	1.33E-02	2.17E-03
PTMCode2	BP	GO:0002263	cell activation involved in immune response	-	304	165	-	-	3.08E-02	2.38E-02
PTMCode2	BP	GO:0021954	central nervous system neuron development	-	85	33	-	-	1.95E-03	4.88E-03
PTMCode2	BP	GO:0055017	cardiac muscle tissue growth	-	92	46	-	-	1.04E-02	6.68E-03
PTMCode2	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	23	-	-	8.77E-03	3.43E-03
PTMCode2	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	11	-	-	5.37E-04	1.63E-03
PTMCode2	BP	GO:0048524	positive regulation of viral process	-	64	45	-	-	3.65E-03	6.50E-03
PTMCode2	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	12	-	-	2.74E-02	1.81E-03
PTMCode2	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	12	-	-	3.70E-02	1.81E-03
PTMCode2	BP	GO:0098661	inorganic anion transmembrane transport	-	140	26	-	-	1.08E-03	3.79E-03
PTMCode2	BP	GO:0006099	tricarboxylic acid cycle	-	33	16	-	-	4.00E-01	2.35E-03
PTMCode2	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	16	-	-	4.36E-03	2.35E-03
PTMCode2	BP	GO:0009612	response to mechanical stimulus	-	215	117	-	-	9.20E-03	1.70E-02
PTMCode2	BP	GO:0048644	muscle organ morphogenesis	-	81	48	-	-	1.13E-02	7.05E-03
PTMCode2	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	96	-	-	1.02E-02	1.39E-02
PTMCode2	BP	GO:0071542	dopaminergic neuron differentiation	-	36	17	-	-	1.70E-02	2.53E-03
PTMCode2	BP	GO:0140115	export across plasma membrane	-	82	24	-	-	1.67E-01	3.61E-03
PTMCode2	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	21	-	-	3.96E-03	3.07E-03
PTMCode2	MF	GO:0003714	transcription corepressor activity	-	190	97	-	-	2.60E-02	1.41E-02
PTMCode2	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	31	-	-	2.26E-02	4.52E-03
PTMCode2	BP	GO:0061101	neuroendocrine cell differentiation	-	16	12	-	-	4.67E-03	1.81E-03
PTMCode2	MF	GO:0140312	cargo adaptor activity	-	19	17	-	-	1.65E-01	2.53E-03
PTMCode2	BP	GO:0046835	carbohydrate phosphorylation	-	49	19	-	-	1.51E-01	2.89E-03
PTMCode2	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	12	-	-	2.18E-03	1.81E-03
PTMCode2	CC	GO:1905349	ciliary transition zone assembly	-	371	99	-	-	7.84E-02	1.45E-02
PTMCode2	BP	GO:0043523	regulation of neuron apoptotic process	-	218	122	-	-	8.41E-03	1.77E-02
PTMCode2	BP	GO:1902894	negative regulation of miRNA transcription	-	22	17	-	-	1.93E-03	2.53E-03
PTMCode2	BP	GO:0044380	protein localization to cytoskeleton	-	57	35	-	-	1.21E-02	5.06E-03
PTMCode2	BP	GO:2000209	regulation of anoikis	-	25	17	-	-	1.47E-02	2.53E-03
PTMCode2	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	15	-	-	5.55E-03	2.17E-03
PTMCode2	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	22	-	-	2.93E-02	3.25E-03
PTMCode2	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	45	-	-	8.92E-03	6.50E-03
PTMCode2	BP	GO:0003188	heart valve formation	-	16	12	-	-	2.27E-02	1.81E-03
PTMCode2	CC	GO:0045324	late endosome to vacuole transport	-	37	14	-	-	3.44E-01	2.17E-03
PTMCode2	BP	GO:0043954	cellular component maintenance	-	72	43	-	-	1.49E-02	6.32E-03
PTMCode2	BP	GO:0050435	amyloid-beta metabolic process	-	65	33	-	-	8.28E-02	4.88E-03
PTMCode2	BP	GO:0014823	response to activity	-	70	45	-	-	3.62E-02	6.50E-03
PTMCode2	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	11	-	-	8.28E-03	1.63E-03
PTMCode2	BP	GO:0034502	protein localization to chromosome	-	130	65	-	-	5.02E-02	9.39E-03
PTMCode2	BP	GO:0048562	embryonic organ morphogenesis	-	295	139	-	-	1.97E-02	2.02E-02
PTMCode2	BP	GO:0019233	sensory perception of pain	-	103	53	-	-	1.10E-02	7.77E-03
PTMCode2	CC	GO:0043574	peroxisomal transport	-	22	15	-	-	7.22E-01	2.17E-03
PTMCode2	BP	GO:0031343	positive regulation of cell killing	-	75	38	-	-	3.76E-02	5.60E-03
PTMCode2	BP	GO:0090077	foam cell differentiation	-	39	24	-	-	7.44E-03	3.61E-03
PTMCode2	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	56	-	-	2.93E-02	8.13E-03
PTMCode2	BP	GO:0017148	negative regulation of translation	-	390	64	-	-	5.19E-02	9.39E-03
PTMCode2	BP	GO:0030220	platelet formation	-	22	11	-	-	1.67E-02	1.63E-03
PTMCode2	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	44	-	-	1.90E-02	6.50E-03
PTMCode2	BP	GO:1903509	liposaccharide metabolic process	-	109	20	-	-	1.79E-01	2.89E-03
PTMCode2	BP	GO:0009582	detection of abiotic stimulus	-	140	54	-	-	1.10E-02	7.95E-03
PTMCode2	CC	GO:0140238	presynaptic endocytosis	-	72	48	-	-	1.82E-02	7.05E-03
PTMCode2	BP	GO:0051236	establishment of RNA localization	-	161	73	-	-	1.99E-01	1.07E-02
PTMCode2	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	105	-	-	3.26E-02	1.52E-02
PTMCode2	BP	GO:0034067	protein localization to Golgi apparatus	-	30	15	-	-	6.36E-02	2.17E-03
PTMCode2	BP	GO:0061842	microtubule organizing center localization	-	32	17	-	-	4.91E-03	2.53E-03
PTMCode2	MF	GO:0048018	receptor ligand activity	-	510	228	-	-	1.44E-02	3.31E-02
PTMCode2	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	16	-	-	7.07E-04	2.35E-03
PTMCode2	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	30	-	-	1.01E-02	4.34E-03
PTMCode2	BP	GO:0050779	RNA destabilization	-	135	47	-	-	2.43E-01	6.87E-03
PTMCode2	BP	GO:0006023	aminoglycan biosynthetic process	-	74	12	-	-	1.92E-03	1.81E-03
PTMCode2	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	13	-	-	5.41E-04	1.99E-03
PTMCode2	BP	GO:0010762	regulation of fibroblast migration	-	40	23	-	-	1.32E-02	3.43E-03
PTMCode2	BP	GO:0090311	regulation of protein deacetylation	-	29	18	-	-	2.61E-02	2.71E-03
PTMCode2	BP	GO:0035272	exocrine system development	-	46	23	-	-	5.75E-03	3.43E-03
PTMCode2	BP	GO:0022406	membrane docking	-	90	47	-	-	7.81E-02	6.87E-03
PTMCode2	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	12	-	-	9.65E-04	1.81E-03
PTMCode2	BP	GO:0050777	negative regulation of immune response	-	196	94	-	-	3.51E-02	1.37E-02
PTMCode2	BP	GO:0016053	organic acid biosynthetic process	-	335	85	-	-	6.93E-02	1.23E-02
PTMCode2	BP	GO:0002063	chondrocyte development	-	33	15	-	-	6.41E-03	2.17E-03
PTMCode2	BP	GO:0099068	postsynapse assembly	-	40	24	-	-	9.85E-03	3.61E-03
PTMCode2	BP	GO:0021782	glial cell development	-	120	63	-	-	6.86E-03	9.21E-03
PTMCode2	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	39	-	-	3.94E-03	5.78E-03
PTMCode2	BP	GO:0001655	urogenital system development	-	66	48	-	-	5.78E-03	7.05E-03
PTMCode2	BP	GO:0071827	plasma lipoprotein particle organization	-	86	35	-	-	5.09E-02	5.06E-03
PTMCode2	BP	GO:0045494	photoreceptor cell maintenance	-	43	14	-	-	1.77E-01	2.17E-03
PTMCode2	BP	GO:0055088	lipid homeostasis	-	173	56	-	-	2.84E-02	8.13E-03
PTMCode2	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	16	-	-	8.30E-03	2.35E-03
PTMCode2	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	121	-	-	1.12E-02	1.75E-02
PTMCode2	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	22	-	-	1.81E-02	3.25E-03
PTMCode2	BP	GO:0045667	regulation of osteoblast differentiation	-	147	76	-	-	3.00E-02	1.10E-02
PTMCode2	BP	GO:2001212	regulation of vasculogenesis	-	16	13	-	-	1.09E-02	1.99E-03
PTMCode2	BP	GO:0061037	negative regulation of cartilage development	-	32	18	-	-	4.56E-03	2.71E-03
PTMCode2	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	212	-	-	2.25E-02	3.07E-02
PTMCode2	BP	GO:0045738	negative regulation of DNA repair	-	40	16	-	-	7.09E-04	2.35E-03
PTMCode2	BP	GO:0001704	formation of primary germ layer	-	195	119	-	-	1.99E-02	1.73E-02
PTMCode2	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	11	-	-	2.14E-02	1.63E-03
PTMCode2	BP	GO:0045778	positive regulation of ossification	-	51	33	-	-	1.82E-02	4.88E-03
PTMCode2	BP	GO:0048708	astrocyte differentiation	-	88	58	-	-	1.04E-02	8.49E-03
PTMCode2	BP	GO:0042092	type 2 immune response	-	41	29	-	-	3.08E-02	4.34E-03
PTMCode2	BP	GO:0048588	developmental cell growth	-	233	116	-	-	8.31E-03	1.68E-02
PTMCode2	BP	GO:0021872	forebrain generation of neurons	-	52	23	-	-	3.37E-03	3.43E-03
PTMCode2	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	13	-	-	4.00E-02	1.99E-03
PTMCode2	BP	GO:0045023	G0 to G1 transition	-	41	23	-	-	4.12E-01	3.43E-03
PTMCode2	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	33	-	-	4.79E-02	4.88E-03
PTMCode2	BP	GO:0034367	protein-containing complex remodeling	-	35	21	-	-	9.24E-02	3.07E-03
PTMCode2	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	21	-	-	2.43E-03	3.07E-03
PTMCode2	BP	GO:0010232	vascular transport	-	87	26	-	-	1.20E-02	3.79E-03
PTMCode2	BP	GO:0021987	cerebral cortex development	-	125	68	-	-	8.30E-03	9.94E-03
PTMCode2	BP	GO:0008637	apoptotic mitochondrial changes	-	108	59	-	-	9.50E-02	8.67E-03
PTMCode2	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	18	-	-	3.19E-03	2.71E-03
PTMCode2	BP	GO:0060999	positive regulation of dendritic spine development	-	35	20	-	-	5.50E-03	2.89E-03
PTMCode2	BP	GO:2000736	regulation of stem cell differentiation	-	78	43	-	-	2.69E-02	6.32E-03
PTMCode2	BP	GO:0060973	cell migration involved in heart development	-	21	12	-	-	4.81E-03	1.81E-03
PTMCode2	BP	GO:0002064	epithelial cell development	-	210	112	-	-	1.97E-02	1.63E-02
PTMCode2	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	23	-	-	2.47E-02	3.43E-03
PTMCode2	BP	GO:2001222	regulation of neuron migration	-	46	19	-	-	3.11E-03	2.89E-03
PTMCode2	BP	GO:0034389	lipid droplet organization	-	38	14	-	-	3.98E-03	2.17E-03
PTMCode2	BP	GO:0051602	response to electrical stimulus	-	44	30	-	-	1.21E-03	4.34E-03
PTMCode2	BP	GO:0042177	negative regulation of protein catabolic process	-	109	54	-	-	3.19E-03	7.95E-03
PTMCode2	MF	GO:0038024	cargo receptor activity	-	121	52	-	-	7.89E-03	7.59E-03
PTMCode2	BP	GO:0033120	positive regulation of RNA splicing	-	46	17	-	-	6.96E-04	2.53E-03
PTMCode2	BP	GO:0051445	regulation of meiotic cell cycle	-	64	38	-	-	2.86E-01	5.60E-03
PTMCode2	BP	GO:0033619	membrane protein proteolysis	-	60	34	-	-	1.94E-02	5.06E-03
PTMCode2	BP	GO:0038065	collagen-activated signaling pathway	-	15	12	-	-	5.99E-02	1.81E-03
PTMCode2	BP	GO:0090087	regulation of peptide transport	-	195	110	-	-	2.25E-02	1.59E-02
PTMCode2	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	57	-	-	1.82E-02	8.31E-03
PTMCode2	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	13	-	-	5.35E-04	1.99E-03
PTMCode2	BP	GO:0006929	substrate-dependent cell migration	-	26	16	-	-	7.08E-04	2.35E-03
PTMCode2	BP	GO:0072662	protein localization to peroxisome	-	20	15	-	-	6.59E-01	2.17E-03
PTMCode2	BP	GO:0022404	molting cycle process	-	95	52	-	-	3.99E-03	7.59E-03
PTMCode2	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	14	-	-	2.15E-02	2.17E-03
PTMCode2	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	22	-	-	1.01E-02	3.25E-03
PTMCode2	BP	GO:0007281	germ cell development	-	334	129	-	-	1.25E-02	1.88E-02
PTMCode2	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	91	-	-	6.74E-02	1.32E-02
PTMCode2	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	21	-	-	1.75E-03	3.07E-03
PTMCode2	BP	GO:0034104	negative regulation of tissue remodeling	-	22	14	-	-	5.34E-04	2.17E-03
PTMCode2	CC	GO:0098926	postsynaptic signal transduction	-	39	22	-	-	4.63E-03	3.25E-03
PTMCode2	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	78	-	-	5.21E-03	1.14E-02
PTMCode2	CC	GO:0016082	synaptic vesicle priming	-	19	14	-	-	1.27E-01	2.17E-03
PTMCode2	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	27	-	-	1.06E-03	3.97E-03
PTMCode2	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	77	-	-	2.54E-02	1.12E-02
PTMCode2	BP	GO:0034249	negative regulation of amide metabolic process	-	34	14	-	-	1.73E-02	2.17E-03
PTMCode2	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	65	-	-	1.39E-02	9.39E-03
PTMCode2	BP	GO:0042832	defense response to protozoan	-	28	13	-	-	7.03E-03	1.99E-03
PTMCode2	BP	GO:0048799	animal organ maturation	-	33	13	-	-	5.32E-04	1.99E-03
PTMCode2	BP	GO:0006925	inflammatory cell apoptotic process	-	23	13	-	-	5.34E-04	1.99E-03
PTMCode2	BP	GO:2000291	regulation of myoblast proliferation	-	25	12	-	-	5.26E-04	1.81E-03
PTMCode2	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	103	-	-	1.85E-02	1.50E-02
PTMCode2	BP	GO:1903035	negative regulation of response to wounding	-	93	60	-	-	3.50E-02	8.67E-03
PTMCode2	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	16	-	-	7.06E-04	2.35E-03
PTMCode2	BP	GO:0036010	protein localization to endosome	-	27	12	-	-	7.13E-03	1.81E-03
PTMCode2	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	59	-	-	1.80E-01	8.67E-03
PTMCode2	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	45	-	-	1.52E-02	6.50E-03
PTMCode2	BP	GO:0045056	transcytosis	-	20	11	-	-	2.56E-03	1.63E-03
PTMCode2	BP	GO:0009267	cellular response to starvation	-	170	83	-	-	6.10E-02	1.21E-02
PTMCode2	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	30	-	-	1.25E-02	4.34E-03
PTMCode2	CC	GO:0140239	postsynaptic endocytosis	-	23	16	-	-	1.95E-02	2.35E-03
PTMCode2	BP	GO:0046931	pore complex assembly	-	21	12	-	-	7.58E-02	1.81E-03
PTMCode2	CC	GO:0032008	positive regulation of TOR signaling	-	52	27	-	-	3.37E-02	3.97E-03
PTMCode2	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	12	-	-	4.37E-02	1.81E-03
PTMCode2	BP	GO:0060428	lung epithelium development	-	43	28	-	-	7.39E-03	4.16E-03
PTMCode2	BP	GO:0030431	sleep	-	30	20	-	-	3.34E-02	2.89E-03
PTMCode2	BP	GO:1903318	negative regulation of protein maturation	-	29	14	-	-	5.36E-04	2.17E-03
PTMCode2	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	36	-	-	3.59E-01	5.24E-03
PTMCode2	BP	GO:0071732	cellular response to nitric oxide	-	17	11	-	-	2.02E-03	1.63E-03
PTMCode2	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	46	-	-	3.27E-03	6.68E-03
PTMCode2	BP	GO:0065004	protein-DNA complex assembly	-	307	168	-	-	1.25E-01	2.44E-02
PTMCode2	CC	GO:0006406	mRNA export from nucleus	-	69	31	-	-	1.48E-01	4.52E-03
PTMCode2	BP	GO:0009880	embryonic pattern specification	-	70	25	-	-	1.24E-02	3.61E-03
PTMCode2	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	27	-	-	3.48E-01	3.97E-03
PTMCode2	BP	GO:0002367	cytokine production involved in immune response	-	121	68	-	-	1.44E-02	9.94E-03
PTMCode2	BP	GO:0044848	biological phase	-	211	103	-	-	3.69E-02	1.50E-02
PTMCode2	BP	GO:0046660	female sex differentiation	-	125	74	-	-	1.49E-02	1.08E-02
PTMCode2	BP	GO:0019693	ribose phosphate metabolic process	-	556	202	-	-	2.52E-01	2.93E-02
PTMCode2	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	27	-	-	4.94E-03	3.97E-03
PTMCode2	BP	GO:0060411	cardiac septum morphogenesis	-	72	44	-	-	1.72E-02	6.50E-03
PTMCode2	BP	GO:0071248	cellular response to metal ion	-	201	94	-	-	9.31E-03	1.37E-02
PTMCode2	BP	GO:0030308	negative regulation of cell growth	-	191	89	-	-	6.95E-03	1.30E-02
PTMCode2	BP	GO:0097306	cellular response to alcohol	-	99	50	-	-	1.89E-02	7.23E-03
PTMCode2	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	44	-	-	7.72E-02	6.50E-03
PTMCode2	BP	GO:0010453	regulation of cell fate commitment	-	40	21	-	-	1.58E-01	3.07E-03
PTMCode2	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	33	-	-	3.11E-02	4.88E-03
PTMCode2	BP	GO:0002026	regulation of the force of heart contraction	-	26	15	-	-	7.14E-04	2.17E-03
PTMCode2	BP	GO:0032890	regulation of organic acid transport	-	78	49	-	-	1.69E-02	7.23E-03
PTMCode2	BP	GO:0071498	cellular response to fluid shear stress	-	21	13	-	-	3.85E-03	1.99E-03
PTMCode2	BP	GO:0098771	inorganic ion homeostasis	-	531	240	-	-	3.34E-02	3.47E-02
PTMCode2	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	55	-	-	5.21E-03	7.95E-03
PTMCode2	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	14	-	-	2.49E-02	2.17E-03
PTMCode2	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	29	-	-	5.76E-03	4.34E-03
PTMCode2	BP	GO:0051259	protein complex oligomerization	-	251	88	-	-	1.46E-02	1.28E-02
PTMCode2	BP	GO:0098743	cell aggregation	-	24	14	-	-	5.35E-04	2.17E-03
PTMCode2	BP	GO:0009994	oocyte differentiation	-	57	27	-	-	4.51E-03	3.97E-03
PTMCode2	MF	GO:0031952	regulation of protein autophosphorylation	-	43	29	-	-	3.40E-03	4.34E-03
PTMCode2	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	79	-	-	6.80E-03	1.16E-02
PTMCode2	BP	GO:0044319	"wound healing, spreading of cells"	-	37	22	-	-	3.26E-03	3.25E-03
PTMCode2	BP	GO:0033688	regulation of osteoblast proliferation	-	31	15	-	-	4.86E-03	2.17E-03
PTMCode2	BP	GO:0060251	regulation of glial cell proliferation	-	39	23	-	-	8.60E-04	3.43E-03
PTMCode2	BP	GO:0072665	protein localization to vacuole	-	84	37	-	-	5.81E-02	5.42E-03
PTMCode2	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	34	-	-	2.58E-01	5.06E-03
PTMCode2	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	14	-	-	1.79E-02	2.17E-03
PTMCode2	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	31	-	-	9.20E-03	4.52E-03
PTMCode2	BP	GO:0042044	fluid transport	-	35	11	-	-	5.39E-04	1.63E-03
PTMCode2	BP	GO:0070633	transepithelial transport	-	35	14	-	-	5.05E-02	2.17E-03
PTMCode2	BP	GO:0045661	regulation of myoblast differentiation	-	74	46	-	-	1.44E-01	6.68E-03
PTMCode2	BP	GO:0030307	positive regulation of cell growth	-	164	86	-	-	1.38E-02	1.25E-02
PTMCode2	BP	GO:0034250	positive regulation of amide metabolic process	-	27	13	-	-	6.95E-03	1.99E-03
PTMCode2	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	165	-	-	2.46E-02	2.38E-02
PTMCode2	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	11	-	-	5.36E-04	1.63E-03
PTMCode2	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	11	-	-	3.84E-03	1.63E-03
PTMCode2	BP	GO:0014812	muscle cell migration	-	110	52	-	-	7.08E-03	7.59E-03
PTMCode2	BP	GO:0048525	negative regulation of viral process	-	90	37	-	-	1.22E-02	5.42E-03
PTMCode2	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	31	-	-	6.03E-02	4.52E-03
PTMCode2	BP	GO:0030238	male sex determination	-	14	12	-	-	4.21E-02	1.81E-03
PTMCode2	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	62	-	-	2.02E-02	9.03E-03
PTMCode2	BP	GO:0051781	positive regulation of cell division	-	93	51	-	-	1.32E-02	7.41E-03
PTMCode2	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	12	-	-	2.73E-03	1.81E-03
PTMCode2	BP	GO:0035493	SNARE complex assembly	-	23	12	-	-	2.92E-02	1.81E-03
PTMCode2	BP	GO:0002696	positive regulation of leukocyte activation	-	358	215	-	-	5.14E-02	3.11E-02
PTMCode2	BP	GO:0060711	labyrinthine layer development	-	47	28	-	-	8.67E-03	4.16E-03
PTMCode2	BP	GO:0007272	ensheathment of neurons	-	146	74	-	-	9.06E-03	1.08E-02
PTMCode2	CC	GO:0050806	positive regulation of synaptic transmission	-	171	80	-	-	1.22E-02	1.16E-02
PTMCode2	BP	GO:0060021	roof of mouth development	-	91	49	-	-	1.38E-02	7.23E-03
PTMCode2	BP	GO:0034504	protein localization to nucleus	-	312	192	-	-	3.02E-02	2.78E-02
PTMCode2	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	22	-	-	1.59E-02	3.25E-03
PTMCode2	BP	GO:0050819	negative regulation of coagulation	-	54	38	-	-	1.04E-01	5.60E-03
PTMCode2	BP	GO:0031647	regulation of protein stability	-	327	183	-	-	1.60E-02	2.66E-02
PTMCode2	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	51	-	-	3.48E-01	7.41E-03
PTMCode2	CC	GO:0050805	negative regulation of synaptic transmission	-	55	33	-	-	9.30E-03	4.88E-03
PTMCode2	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	26	-	-	1.06E-03	3.79E-03
PTMCode2	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	55	-	-	5.00E-02	7.95E-03
PTMCode2	BP	GO:0016054	organic acid catabolic process	-	251	55	-	-	4.87E-02	7.95E-03
PTMCode2	BP	GO:0050890	cognition	-	317	160	-	-	9.33E-03	2.31E-02
PTMCode2	BP	GO:1900048	positive regulation of hemostasis	-	28	18	-	-	9.43E-02	2.71E-03
PTMCode2	BP	GO:0065005	protein-lipid complex assembly	-	29	12	-	-	7.71E-02	1.81E-03
PTMCode2	BP	GO:0008033	tRNA processing	-	136	36	-	-	3.96E-01	5.24E-03
PTMCode2	BP	GO:0046661	male sex differentiation	-	171	92	-	-	1.96E-02	1.34E-02
PTMCode2	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	15	-	-	5.45E-03	2.17E-03
PTMCode2	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	52	-	-	9.89E-03	7.59E-03
PTMCode2	BP	GO:1990778	protein localization to cell periphery	-	346	181	-	-	1.21E-02	2.62E-02
PTMCode2	BP	GO:0090713	immunological memory process	-	18	11	-	-	5.38E-04	1.63E-03
PTMCode2	BP	GO:0061326	renal tubule development	-	103	55	-	-	7.79E-03	7.95E-03
PTMCode2	BP	GO:0051258	protein polymerization	-	280	139	-	-	1.75E-02	2.02E-02
PTMCode2	BP	GO:0071985	multivesicular body sorting pathway	-	56	19	-	-	2.20E-01	2.89E-03
PTMCode2	BP	GO:0060325	face morphogenesis	-	31	18	-	-	4.32E-02	2.71E-03
PTMCode2	BP	GO:0090559	regulation of membrane permeability	-	72	33	-	-	3.21E-02	4.88E-03
PTMCode2	BP	GO:0031579	membrane raft organization	-	25	13	-	-	1.81E-02	1.99E-03
PTMCode2	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	13	-	-	4.14E-03	1.99E-03
PTMCode2	BP	GO:0046460	neutral lipid biosynthetic process	-	50	13	-	-	7.06E-03	1.99E-03
PTMCode2	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	30	-	-	2.67E-02	4.34E-03
PTMCode2	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	99	-	-	1.12E-02	1.45E-02
PTMCode2	BP	GO:0002251	organ or tissue specific immune response	-	43	11	-	-	7.27E-02	1.63E-03
PTMCode2	CC	GO:0048167	regulation of synaptic plasticity	-	210	102	-	-	1.19E-02	1.48E-02
PTMCode2	BP	GO:1903708	positive regulation of hemopoiesis	-	184	114	-	-	3.35E-02	1.66E-02
PTMCode2	BP	GO:1903008	organelle disassembly	-	154	72	-	-	5.73E-02	1.05E-02
PTMCode2	BP	GO:0001709	cell fate determination	-	44	28	-	-	3.23E-02	4.16E-03
PTMCode2	BP	GO:0051873	killing by host of symbiont cells	-	28	13	-	-	7.42E-03	1.99E-03
PTMCode2	BP	GO:0045058	T cell selection	-	53	42	-	-	1.63E-02	6.14E-03
PTMCode2	CC	GO:0032387	negative regulation of intracellular transport	-	51	25	-	-	8.06E-03	3.61E-03
PTMCode2	BP	GO:0072091	regulation of stem cell proliferation	-	91	47	-	-	4.74E-03	6.87E-03
PTMCode2	BP	GO:0099084	postsynaptic specialization organization	-	44	28	-	-	2.36E-02	4.16E-03
PTMCode2	BP	GO:0060384	innervation	-	27	11	-	-	1.65E-02	1.63E-03
PTMCode2	BP	GO:0032535	regulation of cellular component size	-	360	171	-	-	2.40E-02	2.48E-02
PTMCode2	MF	GO:0031281	positive regulation of cyclase activity	-	40	25	-	-	1.37E-02	3.61E-03
PTMCode2	MF	GO:0098631	cell adhesion mediator activity	-	64	33	-	-	5.17E-02	4.88E-03
PTMCode2	BP	GO:0071453	cellular response to oxygen levels	-	168	90	-	-	1.23E-02	1.30E-02
PTMCode2	BP	GO:0090399	replicative senescence	-	17	12	-	-	6.61E-03	1.81E-03
PTMCode2	BP	GO:0031342	negative regulation of cell killing	-	29	18	-	-	8.06E-02	2.71E-03
PTMCode2	BP	GO:0070585	protein localization to mitochondrion	-	125	55	-	-	8.55E-02	7.95E-03
PTMCode2	BP	GO:0010623	programmed cell death involved in cell development	-	25	15	-	-	6.91E-03	2.17E-03
PTMCode2	BP	GO:0044242	cellular lipid catabolic process	-	224	62	-	-	7.16E-02	9.03E-03
PTMCode2	BP	GO:0002931	response to ischemia	-	58	35	-	-	6.40E-03	5.06E-03
PTMCode2	BP	GO:0043062	extracellular structure organization	-	317	136	-	-	2.78E-02	1.97E-02
PTMCode2	BP	GO:0014047	glutamate secretion	-	25	19	-	-	2.77E-02	2.89E-03
PTMCode2	BP	GO:0061005	cell differentiation involved in kidney development	-	58	35	-	-	1.35E-02	5.06E-03
PTMCode2	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	244	-	-	4.68E-02	3.54E-02
PTMCode2	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	37	-	-	3.18E-02	5.42E-03
PTMCode2	BP	GO:0060420	regulation of heart growth	-	74	40	-	-	9.18E-03	5.78E-03
PTMCode2	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	11	-	-	5.32E-04	1.63E-03
PTMCode2	BP	GO:0009755	hormone-mediated signaling pathway	-	221	123	-	-	3.02E-02	1.79E-02
PTMCode2	BP	GO:0022612	gland morphogenesis	-	124	81	-	-	9.87E-03	1.17E-02
PTMCode2	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	18	-	-	3.02E-03	2.71E-03
PTMCode2	MF	GO:0140416	transcription regulator inhibitor activity	-	26	17	-	-	6.77E-03	2.53E-03
PTMCode2	BP	GO:0044782	cilium organization	-	400	106	-	-	5.95E-02	1.54E-02
PTMCode2	BP	GO:0090130	tissue migration	-	379	180	-	-	1.77E-02	2.60E-02
PTMCode2	BP	GO:1990845	adaptive thermogenesis	-	166	88	-	-	2.05E-02	1.28E-02
PTMCode2	BP	GO:0071320	cellular response to cAMP	-	54	26	-	-	3.37E-02	3.79E-03
PTMCode2	BP	GO:0015844	monoamine transport	-	88	45	-	-	1.27E-02	6.50E-03
PTMCode2	BP	GO:0060039	pericardium development	-	19	11	-	-	5.35E-04	1.63E-03
PTMCode2	BP	GO:0071392	cellular response to estradiol stimulus	-	40	25	-	-	2.48E-03	3.61E-03
PTMCode2	BP	GO:0009314	response to radiation	-	449	246	-	-	2.87E-02	3.56E-02
PTMCode2	BP	GO:0009451	RNA modification	-	169	46	-	-	1.67E-01	6.68E-03
PTMCode2	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	24	-	-	2.98E-03	3.61E-03
PTMCode2	BP	GO:1903729	regulation of plasma membrane organization	-	17	12	-	-	1.33E-02	1.81E-03
PTMCode2	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	47	-	-	2.15E-02	6.87E-03
PTMCode2	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	25	-	-	9.39E-03	3.61E-03
PTMCode2	BP	GO:0015807	L-amino acid transport	-	94	20	-	-	2.00E-02	2.89E-03
PTMCode2	BP	GO:0032941	secretion by tissue	-	85	49	-	-	4.33E-03	7.23E-03
PTMCode2	BP	GO:0046605	regulation of centrosome cycle	-	54	31	-	-	1.02E-02	4.52E-03
PTMCode2	BP	GO:0048753	pigment granule organization	-	40	23	-	-	1.76E-01	3.43E-03
PTMCode2	BP	GO:0003014	renal system process	-	130	64	-	-	2.05E-02	9.39E-03
PTMCode2	BP	GO:0045598	regulation of fat cell differentiation	-	148	64	-	-	7.09E-03	9.39E-03
PTMCode2	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	118	-	-	1.78E-02	1.72E-02
PTMCode2	BP	GO:1904646	cellular response to amyloid-beta	-	44	24	-	-	1.06E-02	3.61E-03
PTMCode2	BP	GO:1901863	positive regulation of muscle tissue development	-	24	18	-	-	2.71E-03	2.71E-03
PTMCode2	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	132	-	-	1.28E-01	1.92E-02
PTMCode2	BP	GO:0039694	viral RNA genome replication	-	30	15	-	-	1.06E-02	2.17E-03
PTMCode2	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	19	-	-	1.74E-02	2.89E-03
PTMCode2	BP	GO:0071709	membrane assembly	-	68	31	-	-	5.25E-02	4.52E-03
PTMCode2	BP	GO:0008217	regulation of blood pressure	-	186	109	-	-	3.03E-02	1.59E-02
PTMCode2	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	33	-	-	4.27E-03	4.88E-03
PTMCode2	CC	GO:0042770	signal transduction in response to DNA damage	-	186	121	-	-	4.12E-02	1.75E-02
PTMCode2	BP	GO:0002200	somatic diversification of immune receptors	-	78	45	-	-	4.60E-02	6.50E-03
PTMCode2	BP	GO:0035315	hair cell differentiation	-	52	24	-	-	4.96E-03	3.61E-03
PTMCode2	BP	GO:0048645	animal organ formation	-	62	40	-	-	7.86E-03	5.78E-03
PTMCode2	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	84	-	-	1.54E-02	1.23E-02
PTMCode2	BP	GO:0033627	cell adhesion mediated by integrin	-	87	56	-	-	3.33E-02	8.13E-03
PTMCode2	BP	GO:0035107	appendage morphogenesis	-	147	68	-	-	1.10E-02	9.94E-03
PTMCode2	BP	GO:1903707	negative regulation of hemopoiesis	-	116	59	-	-	6.60E-03	8.67E-03
PTMCode2	BP	GO:0036342	post-anal tail morphogenesis	-	19	12	-	-	5.36E-04	1.81E-03
PTMCode2	BP	GO:0050994	regulation of lipid catabolic process	-	61	32	-	-	9.33E-03	4.70E-03
PTMCode2	BP	GO:0035988	chondrocyte proliferation	-	24	14	-	-	4.63E-03	2.17E-03
PTMCode2	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	17	-	-	2.20E-02	2.53E-03
PTMCode2	BP	GO:0009593	detection of chemical stimulus	-	511	19	-	-	3.31E-02	2.89E-03
PTMCode2	BP	GO:0045727	positive regulation of translation	-	141	73	-	-	2.16E-02	1.07E-02
PTMCode2	CC	GO:0032388	positive regulation of intracellular transport	-	137	73	-	-	3.69E-03	1.07E-02
PTMCode2	BP	GO:0002027	regulation of heart rate	-	106	61	-	-	8.33E-02	8.85E-03
PTMCode2	BP	GO:0050879	multicellular organismal movement	-	118	51	-	-	2.60E-02	7.41E-03
PTMCode2	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	43	-	-	4.93E-03	6.32E-03
PTMCode2	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	31	-	-	1.10E-02	4.52E-03
PTMCode2	BP	GO:0048515	spermatid differentiation	-	208	62	-	-	2.55E-02	9.03E-03
PTMCode2	BP	GO:0072132	mesenchyme morphogenesis	-	57	31	-	-	1.76E-02	4.52E-03
PTMCode2	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	13	-	-	6.67E-02	1.99E-03
PTMCode2	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	19	-	-	7.05E-04	2.89E-03
PTMCode2	BP	GO:0060119	inner ear receptor cell development	-	44	16	-	-	2.37E-02	2.35E-03
PTMCode2	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	17	-	-	6.71E-02	2.53E-03
PTMCode2	BP	GO:1901983	regulation of protein acetylation	-	26	13	-	-	5.34E-03	1.99E-03
PTMCode2	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	154	-	-	1.94E-02	2.24E-02
PTMCode2	BP	GO:1900006	positive regulation of dendrite development	-	17	11	-	-	1.25E-02	1.63E-03
PTMCode2	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	25	-	-	8.06E-02	3.61E-03
PTMCode2	BP	GO:0010883	regulation of lipid storage	-	53	29	-	-	8.48E-03	4.34E-03
PTMCode2	BP	GO:0072170	metanephric tubule development	-	26	13	-	-	5.38E-04	1.99E-03
PTMCode2	BP	GO:1905954	positive regulation of lipid localization	-	110	54	-	-	4.01E-02	7.95E-03
PTMCode2	BP	GO:0002209	behavioral defense response	-	39	18	-	-	3.64E-02	2.71E-03
PTMCode2	BP	GO:0072523	purine-containing compound catabolic process	-	146	54	-	-	7.94E-02	7.95E-03
PTMCode2	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	20	-	-	9.81E-03	2.89E-03
PTMCode2	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	17	-	-	7.06E-04	2.53E-03
PTMCode2	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	48	-	-	1.05E-01	7.05E-03
PTMCode2	BP	GO:0007218	neuropeptide signaling pathway	-	113	55	-	-	1.69E-01	7.95E-03
PTMCode2	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	102	-	-	1.69E-02	1.48E-02
PTMCode2	BP	GO:0031345	negative regulation of cell projection organization	-	195	94	-	-	8.88E-03	1.37E-02
PTMCode2	BP	GO:0048278	vesicle docking	-	64	34	-	-	7.07E-02	5.06E-03
PTMCode2	BP	GO:0035050	embryonic heart tube development	-	86	35	-	-	1.17E-02	5.06E-03
PTMCode2	BP	GO:0030168	platelet activation	-	135	87	-	-	2.56E-02	1.26E-02
PTMCode2	CC	GO:0098810	neurotransmitter reuptake	-	35	14	-	-	5.34E-04	2.17E-03
PTMCode2	BP	GO:0008213	protein alkylation	-	58	20	-	-	1.96E-02	2.89E-03
PTMCode2	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	11	-	-	8.44E-03	1.63E-03
PTMCode2	BP	GO:0031338	regulation of vesicle fusion	-	24	17	-	-	7.15E-04	2.53E-03
PTMCode2	BP	GO:0031529	ruffle organization	-	55	35	-	-	8.09E-03	5.06E-03
PTMCode2	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	33	-	-	1.02E-01	4.88E-03
PTMCode2	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	26	-	-	1.07E-03	3.79E-03
PTMCode2	BP	GO:0035304	regulation of protein dephosphorylation	-	87	50	-	-	5.63E-03	7.23E-03
PTMCode2	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	121	-	-	9.39E-03	1.75E-02
PTMCode2	BP	GO:0099637	neurotransmitter receptor transport	-	26	12	-	-	3.14E-02	1.81E-03
PTMCode2	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	21	-	-	3.40E-03	3.07E-03
PTMCode2	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	247	-	-	3.46E-02	3.58E-02
PTMCode2	BP	GO:0051785	positive regulation of nuclear division	-	61	40	-	-	1.04E-02	5.78E-03
PTMCode2	BP	GO:0060749	mammary gland alveolus development	-	20	13	-	-	6.00E-03	1.99E-03
PTMCode2	BP	GO:0044786	cell cycle DNA replication	-	45	27	-	-	2.52E-02	3.97E-03
PTMCode2	BP	GO:0048145	regulation of fibroblast proliferation	-	87	55	-	-	4.88E-03	7.95E-03
PTMCode2	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	49	-	-	2.99E-01	7.23E-03
PTMCode2	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	124	-	-	1.02E-02	1.81E-02
PTMCode2	BP	GO:0032098	regulation of appetite	-	20	11	-	-	7.16E-02	1.63E-03
PTMCode2	BP	GO:0009306	protein secretion	-	376	185	-	-	2.20E-02	2.67E-02
PTMCode2	CC	GO:0008333	endosome to lysosome transport	-	73	31	-	-	1.87E-01	4.52E-03
PTMCode2	BP	GO:0003016	respiratory system process	-	39	13	-	-	5.38E-04	1.99E-03
PTMCode2	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	16	-	-	1.63E-02	2.35E-03
PTMCode2	BP	GO:0045732	positive regulation of protein catabolic process	-	202	121	-	-	1.71E-02	1.75E-02
PTMCode2	BP	GO:0031589	cell-substrate adhesion	-	360	206	-	-	3.34E-02	2.98E-02
PTMCode2	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	12	-	-	6.71E-02	1.81E-03
PTMCode2	BP	GO:0007588	excretion	-	40	25	-	-	4.40E-02	3.61E-03
PTMCode2	BP	GO:1904018	positive regulation of vasculature development	-	185	89	-	-	9.29E-03	1.30E-02
PTMCode2	BP	GO:0010948	negative regulation of cell cycle process	-	317	171	-	-	6.43E-02	2.48E-02
PTMCode2	BP	GO:0050953	sensory perception of light stimulus	-	223	77	-	-	1.65E-01	1.12E-02
PTMCode2	BP	GO:0009303	rRNA transcription	-	37	28	-	-	2.13E-01	4.16E-03
PTMCode2	BP	GO:0035601	protein deacylation	-	56	29	-	-	1.18E-02	4.34E-03
PTMCode2	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	13	-	-	7.28E-03	1.99E-03
PTMCode2	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	24	-	-	2.39E-03	3.61E-03
PTMCode2	BP	GO:0071300	cellular response to retinoic acid	-	66	30	-	-	4.18E-03	4.34E-03
PTMCode2	BP	GO:0045830	positive regulation of isotype switching	-	28	13	-	-	4.58E-03	1.99E-03
PTMCode2	BP	GO:0031069	hair follicle morphogenesis	-	33	20	-	-	9.59E-03	2.89E-03
PTMCode2	BP	GO:0046697	decidualization	-	26	14	-	-	5.33E-04	2.17E-03
PTMCode2	BP	GO:0048284	organelle fusion	-	456	226	-	-	1.29E-01	3.27E-02
PTMCode2	BP	GO:0051588	regulation of neurotransmitter transport	-	99	53	-	-	7.19E-03	7.77E-03
PTMCode2	BP	GO:0051784	negative regulation of nuclear division	-	63	41	-	-	4.53E-02	5.96E-03
PTMCode2	BP	GO:0044703	multi-organism reproductive process	-	209	114	-	-	1.93E-02	1.66E-02
PTMCode2	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	91	-	-	8.00E-03	1.32E-02
PTMCode2	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	31	-	-	1.77E-02	4.52E-03
PTMCode2	MF	GO:0004930	G protein-coupled receptor activity	-	873	165	-	-	1.87E-02	2.38E-02
PTMCode2	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	13	-	-	5.40E-04	1.99E-03
PTMCode2	BP	GO:0048857	neural nucleus development	-	65	33	-	-	4.19E-03	4.88E-03
PTMCode2	BP	GO:0048663	neuron fate commitment	-	74	43	-	-	1.24E-02	6.32E-03
PTMCode2	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	66	-	-	1.37E-02	9.58E-03
PTMCode2	BP	GO:0106027	neuron projection organization	-	90	48	-	-	7.66E-03	7.05E-03
PTMCode2	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	74	-	-	1.21E-02	1.08E-02
PTMCode2	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	20	-	-	6.28E-03	2.89E-03
PTMCode2	BP	GO:0045685	regulation of glial cell differentiation	-	77	42	-	-	1.40E-02	6.14E-03
PTMCode2	BP	GO:0043414	macromolecule methylation	-	138	39	-	-	6.70E-02	5.78E-03
PTMCode2	BP	GO:0048268	clathrin coat assembly	-	16	12	-	-	1.06E-01	1.81E-03
PTMCode2	BP	GO:0050886	endocrine process	-	93	57	-	-	2.61E-02	8.31E-03
PTMCode2	BP	GO:0050951	sensory perception of temperature stimulus	-	28	15	-	-	4.07E-03	2.17E-03
PTMCode2	BP	GO:0045807	positive regulation of endocytosis	-	155	109	-	-	1.94E-02	1.59E-02
PTMCode2	BP	GO:0002418	immune response to tumor cell	-	29	14	-	-	2.64E-02	2.17E-03
PTMCode2	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	37	-	-	9.21E-03	5.42E-03
PTMCode2	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	12	-	-	1.19E-03	1.81E-03
PTMCode2	BP	GO:0034394	protein localization to cell surface	-	69	34	-	-	4.18E-03	5.06E-03
PTMCode2	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	15	-	-	5.34E-02	2.17E-03
PTMCode2	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	12	-	-	5.37E-04	1.81E-03
PTMCode2	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	65	-	-	6.08E-03	9.39E-03
PTMCode2	MF	GO:0051100	negative regulation of binding	-	161	94	-	-	1.99E-02	1.37E-02
PTMCode2	BP	GO:0001818	negative regulation of cytokine production	-	379	148	-	-	1.16E-02	2.15E-02
PTMCode2	BP	GO:0003151	outflow tract morphogenesis	-	81	53	-	-	1.53E-02	7.77E-03
PTMCode2	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	33	-	-	6.20E-03	4.88E-03
PTMCode2	BP	GO:0055093	response to hyperoxia	-	20	12	-	-	2.88E-03	1.81E-03
PTMCode2	BP	GO:0061036	positive regulation of cartilage development	-	33	19	-	-	1.58E-02	2.89E-03
PTMCode2	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	22	-	-	2.72E-03	3.25E-03
PTMCode2	BP	GO:0046621	negative regulation of organ growth	-	39	21	-	-	6.44E-03	3.07E-03
PTMCode2	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	32	-	-	3.32E-01	4.70E-03
PTMCode2	BP	GO:0032368	regulation of lipid transport	-	149	70	-	-	1.40E-02	1.01E-02
PTMCode2	BP	GO:0055094	response to lipoprotein particle	-	34	15	-	-	6.75E-03	2.17E-03
PTMCode2	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	112	-	-	1.39E-02	1.63E-02
PTMCode2	BP	GO:0033002	muscle cell proliferation	-	249	130	-	-	1.19E-02	1.88E-02
PTMCode2	BP	GO:0048880	sensory system development	-	399	189	-	-	2.83E-02	2.75E-02
PTMCode2	BP	GO:0043331	response to dsRNA	-	56	25	-	-	9.11E-03	3.61E-03
PTMCode2	BP	GO:0051904	pigment granule transport	-	23	14	-	-	1.95E-02	2.17E-03
PTMCode2	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	24	-	-	6.86E-03	3.61E-03
PTMCode2	BP	GO:0033363	secretory granule organization	-	63	31	-	-	6.86E-02	4.52E-03
PTMCode2	BP	GO:0060479	lung cell differentiation	-	28	19	-	-	3.29E-03	2.89E-03
PTMCode2	BP	GO:0120009	intermembrane lipid transfer	-	52	18	-	-	1.04E-01	2.71E-03
PTMCode2	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	13	-	-	3.34E-01	1.99E-03
PTMCode2	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	25	-	-	3.50E-03	3.61E-03
PTMCode2	BP	GO:0033622	integrin activation	-	26	14	-	-	2.42E-02	2.17E-03
PTMCode2	BP	GO:0098751	bone cell development	-	18	11	-	-	4.43E-03	1.63E-03
PTMCode2	BP	GO:2000773	negative regulation of cellular senescence	-	25	16	-	-	4.36E-03	2.35E-03
PTMCode2	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	34	-	-	6.13E-03	5.06E-03
PTMCode2	BP	GO:0050820	positive regulation of coagulation	-	30	18	-	-	1.38E-01	2.71E-03
PTMCode2	BP	GO:0002076	osteoblast development	-	17	11	-	-	8.98E-03	1.63E-03
PTMCode2	BP	GO:0072164	mesonephric tubule development	-	98	58	-	-	1.53E-02	8.49E-03
PTMCode2	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	63	-	-	7.31E-03	9.21E-03
PTMCode2	BP	GO:1903524	positive regulation of blood circulation	-	39	24	-	-	3.11E-03	3.61E-03
PTMCode2	BP	GO:0030901	midbrain development	-	87	48	-	-	5.99E-03	7.05E-03
PTMCode2	BP	GO:0007162	negative regulation of cell adhesion	-	310	155	-	-	1.76E-02	2.24E-02
PTMCode2	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	12	-	-	3.29E-03	1.81E-03
PTMCode2	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	36	-	-	2.68E-02	5.24E-03
PTMCode2	BP	GO:0002687	positive regulation of leukocyte migration	-	147	83	-	-	8.79E-03	1.21E-02
PTMCode2	BP	GO:0034605	cellular response to heat	-	66	34	-	-	6.89E-03	5.06E-03
PTMCode2	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	206	-	-	5.14E-02	2.98E-02
PTMCode2	BP	GO:0005996	monosaccharide metabolic process	-	250	98	-	-	1.62E-02	1.43E-02
PTMCode2	BP	GO:0033555	multicellular organismal response to stress	-	90	42	-	-	3.46E-03	6.14E-03
PTMCode2	BP	GO:0002262	myeloid cell homeostasis	-	172	96	-	-	1.10E-02	1.39E-02
PTMCode2	BP	GO:0000966	RNA 5'-end processing	-	39	12	-	-	1.63E-01	1.81E-03
PTMCode2	BP	GO:0050688	regulation of defense response to virus	-	65	31	-	-	1.34E-02	4.52E-03
PTMCode2	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	165	-	-	4.98E-02	2.38E-02
PTMCode2	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	13	-	-	5.42E-02	1.99E-03
PTMCode2	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	149	-	-	2.97E-02	2.17E-02
PTMCode2	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	22	-	-	6.43E-03	3.25E-03
PTMCode2	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	16	-	-	3.28E-03	2.35E-03
PTMCode2	BP	GO:0003272	endocardial cushion formation	-	28	16	-	-	5.30E-02	2.35E-03
PTMCode2	BP	GO:0022618	protein-RNA complex assembly	-	227	113	-	-	2.19E-01	1.64E-02
PTMCode2	BP	GO:0051147	regulation of muscle cell differentiation	-	162	81	-	-	1.06E-02	1.17E-02
PTMCode2	BP	GO:0006066	alcohol metabolic process	-	374	119	-	-	8.13E-02	1.73E-02
PTMCode2	BP	GO:0090102	cochlea development	-	50	26	-	-	4.38E-03	3.79E-03
PTMCode2	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	20	-	-	5.38E-03	2.89E-03
PTMCode2	BP	GO:0045933	positive regulation of muscle contraction	-	49	30	-	-	2.94E-03	4.34E-03
PTMCode2	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	21	-	-	2.04E-02	3.07E-03
PTMCode2	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	33	-	-	3.79E-02	4.88E-03
PTMCode2	BP	GO:0043555	regulation of translation in response to stress	-	22	14	-	-	2.41E-02	2.17E-03
PTMCode2	BP	GO:0032922	circadian regulation of gene expression	-	71	44	-	-	2.13E-01	6.50E-03
PTMCode2	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	37	-	-	7.26E-03	5.42E-03
PTMCode2	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	34	-	-	1.46E-02	5.06E-03
PTMCode2	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	12	-	-	5.05E-02	1.81E-03
PTMCode2	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	38	-	-	1.98E-02	5.60E-03
PTMCode2	BP	GO:0038179	neurotrophin signaling pathway	-	38	28	-	-	2.81E-02	4.16E-03
PTMCode2	BP	GO:0140253	cell-cell fusion	-	62	36	-	-	1.00E-02	5.24E-03
PTMCode2	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	12	-	-	1.50E-02	1.81E-03
PTMCode2	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	11	-	-	5.41E-04	1.63E-03
PTMCode2	BP	GO:0001941	postsynaptic membrane organization	-	37	23	-	-	8.66E-02	3.43E-03
PTMCode2	BP	GO:0051293	establishment of spindle localization	-	57	40	-	-	1.66E-02	5.78E-03
PTMCode2	BP	GO:0043114	regulation of vascular permeability	-	49	27	-	-	9.53E-03	3.97E-03
PTMCode2	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	34	-	-	1.93E-03	5.06E-03
PTMCode2	BP	GO:0008360	regulation of cell shape	-	139	70	-	-	1.96E-02	1.01E-02
PTMCode2	BP	GO:0051222	positive regulation of protein transport	-	249	125	-	-	1.69E-02	1.81E-02
PTMCode2	CC	GO:0140632	canonical inflammasome complex assembly	-	40	19	-	-	4.92E-02	2.89E-03
PTMCode2	MF	GO:0034260	negative regulation of GTPase activity	-	36	19	-	-	1.04E-02	2.89E-03
PTMCode2	BP	GO:0045932	negative regulation of muscle contraction	-	24	13	-	-	3.13E-02	1.99E-03
PTMCode2	BP	GO:0045739	positive regulation of DNA repair	-	128	71	-	-	8.99E-02	1.03E-02
PTMCode2	BP	GO:0045185	maintenance of protein location	-	95	58	-	-	8.94E-03	8.49E-03
PTMCode2	BP	GO:0003158	endothelium development	-	140	71	-	-	2.69E-02	1.03E-02
PTMCode2	CC	GO:0072595	maintenance of protein localization in organelle	-	42	27	-	-	2.89E-03	3.97E-03
PTMCode2	BP	GO:0051224	negative regulation of protein transport	-	122	61	-	-	6.01E-03	8.85E-03
PTMCode2	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	83	-	-	9.84E-03	1.21E-02
PTMCode2	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	15	-	-	6.31E-02	2.17E-03
PTMCode2	MF	GO:0003713	transcription coactivator activity	-	281	169	-	-	4.41E-02	2.46E-02
PTMCode2	BP	GO:0021885	forebrain cell migration	-	63	37	-	-	1.40E-02	5.42E-03
PTMCode2	BP	GO:0007405	neuroblast proliferation	-	81	49	-	-	5.61E-03	7.23E-03
PTMCode2	BP	GO:0009581	detection of external stimulus	-	137	51	-	-	1.48E-02	7.41E-03
PTMCode2	BP	GO:1990542	mitochondrial transmembrane transport	-	93	16	-	-	1.56E-01	2.35E-03
PTMCode2	BP	GO:0045862	positive regulation of proteolysis	-	353	202	-	-	1.97E-02	2.93E-02
PTMCode2	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	22	-	-	2.78E-02	3.25E-03
PTMCode2	BP	GO:0097186	amelogenesis	-	26	12	-	-	5.37E-04	1.81E-03
PTMCode2	BP	GO:0031128	developmental induction	-	26	19	-	-	1.62E-03	2.89E-03
PTMCode2	BP	GO:0031100	animal organ regeneration	-	66	40	-	-	4.18E-03	5.78E-03
PTMCode2	BP	GO:0045684	positive regulation of epidermis development	-	33	14	-	-	3.65E-03	2.17E-03
PTMCode2	BP	GO:1900047	negative regulation of hemostasis	-	51	37	-	-	9.38E-02	5.42E-03
PTMCode2	BP	GO:0021517	ventral spinal cord development	-	47	23	-	-	9.35E-02	3.43E-03
PTMCode2	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	52	-	-	1.09E-02	7.59E-03
PTMCode2	BP	GO:0097722	sperm motility	-	133	28	-	-	2.42E-02	4.16E-03
PTMCode2	BP	GO:0042490	mechanoreceptor differentiation	-	67	28	-	-	1.68E-02	4.16E-03
PTMCode2	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	24	-	-	4.05E-03	3.61E-03
PTMCode2	BP	GO:0035148	tube formation	-	155	87	-	-	1.26E-02	1.26E-02
PTMCode2	BP	GO:0048520	positive regulation of behavior	-	27	14	-	-	2.50E-01	2.17E-03
PTMCode2	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	29	-	-	3.10E-02	4.34E-03
PTMCode2	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	56	-	-	2.19E-02	8.13E-03
PTMCode2	BP	GO:0031123	RNA 3'-end processing	-	79	38	-	-	1.61E-01	5.60E-03
PTMCode2	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	63	-	-	1.47E-02	9.21E-03
PTMCode2	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	11	-	-	5.35E-02	1.63E-03
PTMCode2	CC	GO:0007097	nuclear migration	-	24	15	-	-	1.43E-02	2.17E-03
PTMCode2	BP	GO:0045229	external encapsulating structure organization	-	319	138	-	-	4.24E-02	2.01E-02
PTMCode2	BP	GO:0006885	regulation of pH	-	104	43	-	-	1.82E-01	6.32E-03
PTMCode2	BP	GO:0001667	ameboidal-type cell migration	-	495	237	-	-	2.00E-02	3.43E-02
PTMCode2	BP	GO:0071800	podosome assembly	-	19	12	-	-	3.35E-03	1.81E-03
PTMCode2	BP	GO:0031018	endocrine pancreas development	-	47	31	-	-	8.16E-03	4.52E-03
PTMCode2	BP	GO:0001708	cell fate specification	-	108	63	-	-	6.27E-02	9.21E-03
PTMCode2	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	44	-	-	5.12E-03	6.50E-03
PTMCode2	BP	GO:0030279	negative regulation of ossification	-	39	24	-	-	2.66E-03	3.61E-03
PTMCode2	BP	GO:0032970	regulation of actin filament-based process	-	368	189	-	-	3.39E-02	2.75E-02
PTMCode2	BP	GO:0042440	pigment metabolic process	-	80	21	-	-	1.65E-02	3.07E-03
PTMCode2	BP	GO:1901606	alpha-amino acid catabolic process	-	101	17	-	-	1.51E-01	2.53E-03
PTMCode2	BP	GO:0062197	cellular response to chemical stress	-	299	153	-	-	1.21E-02	2.22E-02
PTMCode2	BP	GO:1901890	positive regulation of cell junction assembly	-	106	53	-	-	1.21E-02	7.77E-03
PTMCode2	BP	GO:1901655	cellular response to ketone	-	107	61	-	-	2.73E-02	8.85E-03
PTMCode2	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	12	-	-	1.04E-01	1.81E-03
PTMCode2	BP	GO:0006968	cellular defense response	-	52	25	-	-	2.66E-03	3.61E-03
PTMCode2	BP	GO:0055006	cardiac cell development	-	93	49	-	-	2.98E-02	7.23E-03
PTMCode2	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	21	-	-	1.33E-02	3.07E-03
PTMCode2	BP	GO:0060004	reflex	-	63	26	-	-	8.48E-03	3.79E-03
PTMCode2	BP	GO:0044706	multi-multicellular organism process	-	217	117	-	-	2.07E-02	1.70E-02
PTMCode2	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	82	-	-	1.12E-02	1.19E-02
PTMCode2	BP	GO:0031294	lymphocyte costimulation	-	47	31	-	-	2.32E-02	4.52E-03
PTMCode2	BP	GO:0050768	negative regulation of neurogenesis	-	150	81	-	-	5.55E-03	1.17E-02
PTMCode2	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	59	-	-	7.33E-03	8.67E-03
PTMCode2	BP	GO:0090068	positive regulation of cell cycle process	-	262	144	-	-	3.25E-02	2.10E-02
PTMCode2	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	16	-	-	7.16E-04	2.35E-03
PTMCode2	MF	GO:0022803	passive transmembrane transporter activity	-	676	227	-	-	1.30E-01	3.29E-02
PTMCode2	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	15	-	-	1.30E-02	2.17E-03
PTMCode2	BP	GO:1902115	regulation of organelle assembly	-	210	105	-	-	2.23E-02	1.52E-02
PTMCode2	BP	GO:0006397	mRNA processing	-	482	183	-	-	3.15E-01	2.66E-02
PTMCode2	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	40	-	-	4.55E-03	5.78E-03
PTMCode2	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	63	-	-	4.13E-03	9.21E-03
PTMCode2	BP	GO:0046622	positive regulation of organ growth	-	52	26	-	-	3.26E-03	3.79E-03
PTMCode2	BP	GO:0051952	regulation of amine transport	-	98	59	-	-	2.91E-02	8.67E-03
PTMCode2	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	11	-	-	5.38E-04	1.63E-03
PTMCode2	BP	GO:0040019	positive regulation of embryonic development	-	23	17	-	-	6.11E-02	2.53E-03
PTMCode2	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	11	-	-	5.35E-04	1.63E-03
PTMCode2	CC	GO:0032365	intracellular lipid transport	-	51	15	-	-	4.64E-02	2.17E-03
PTMCode2	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	30	-	-	1.24E-03	4.34E-03
PTMCode2	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	55	-	-	2.85E-02	7.95E-03
PTMCode2	BP	GO:0018149	peptide cross-linking	-	28	15	-	-	1.81E-01	2.17E-03
PTMCode2	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	15	-	-	3.50E-03	2.17E-03
PTMCode2	BP	GO:0071398	cellular response to fatty acid	-	35	14	-	-	2.49E-03	2.17E-03
PTMCode2	BP	GO:0097581	lamellipodium organization	-	91	57	-	-	2.41E-02	8.31E-03
PTMCode2	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	99	-	-	2.15E-01	1.45E-02
PTMCode2	BP	GO:0060326	cell chemotaxis	-	311	155	-	-	4.25E-02	2.24E-02
PTMCode2	BP	GO:0016485	protein processing	-	248	116	-	-	2.69E-02	1.68E-02
PTMCode2	BP	GO:0009649	entrainment of circadian clock	-	30	18	-	-	8.44E-02	2.71E-03
PTMCode2	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	80	-	-	3.76E-02	1.16E-02
PTMCode2	BP	GO:1903523	negative regulation of blood circulation	-	27	13	-	-	2.11E-03	1.99E-03
PTMCode2	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	36	-	-	1.25E-02	5.24E-03
PTMCode2	BP	GO:0099054	presynapse assembly	-	49	23	-	-	9.27E-03	3.43E-03
PTMCode2	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	19	-	-	9.65E-03	2.89E-03
PTMCode2	BP	GO:0031348	negative regulation of defense response	-	282	121	-	-	1.53E-02	1.75E-02
PTMCode2	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	39	-	-	5.89E-03	5.78E-03
PTMCode2	BP	GO:0007606	sensory perception of chemical stimulus	-	535	27	-	-	3.04E-02	3.97E-03
PTMCode2	BP	GO:0061180	mammary gland epithelium development	-	68	49	-	-	5.09E-03	7.23E-03
PTMCode2	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	107	-	-	4.36E-02	1.55E-02
PTMCode2	CC	GO:0051169	nuclear transport	-	325	184	-	-	1.03E-01	2.67E-02
PTMCode2	BP	GO:0071496	cellular response to external stimulus	-	74	42	-	-	9.29E-03	6.14E-03
PTMCode2	BP	GO:0042753	positive regulation of circadian rhythm	-	18	14	-	-	1.31E-01	2.17E-03
PTMCode2	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	1.77E-03	1.63E-03
PTMCode2	BP	GO:0032094	response to food	-	37	22	-	-	6.06E-03	3.25E-03
PTMCode2	BP	GO:0001964	startle response	-	27	16	-	-	6.74E-03	2.35E-03
PTMCode2	BP	GO:0007340	acrosome reaction	-	38	13	-	-	1.12E-02	1.99E-03
PTMCode2	BP	GO:0046434	organophosphate catabolic process	-	232	78	-	-	5.99E-02	1.14E-02
PTMCode2	BP	GO:0060037	pharyngeal system development	-	29	18	-	-	7.25E-02	2.71E-03
PTMCode2	BP	GO:0009566	fertilization	-	205	50	-	-	5.39E-03	7.23E-03
PTMCode2	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	29	-	-	3.90E-01	4.34E-03
PTMCode2	BP	GO:0045907	positive regulation of vasoconstriction	-	30	15	-	-	1.40E-01	2.17E-03
PTMCode2	BP	GO:0033044	regulation of chromosome organization	-	249	161	-	-	1.31E-01	2.33E-02
PTMCode2	BP	GO:0009309	amine biosynthetic process	-	38	11	-	-	1.74E-01	1.63E-03
PTMCode2	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	191	-	-	1.23E-02	2.76E-02
PTMCode2	BP	GO:0061900	glial cell activation	-	56	32	-	-	3.92E-02	4.70E-03
PTMCode2	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	69	-	-	2.37E-02	1.01E-02
PTMCode2	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	181	-	-	6.66E-02	2.62E-02
PTMCode2	CC	GO:0140467	integrated stress response signaling	-	41	29	-	-	7.55E-02	4.34E-03
PTMCode2	BP	GO:0035902	response to immobilization stress	-	20	12	-	-	5.35E-04	1.81E-03
PTMCode2	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	133	-	-	3.28E-01	1.93E-02
PTMCode2	BP	GO:0090235	regulation of metaphase plate congression	-	13	11	-	-	1.36E-02	1.63E-03
PTMCode2	BP	GO:0043647	inositol phosphate metabolic process	-	44	21	-	-	8.63E-03	3.07E-03
PTMCode2	BP	GO:0016180	snRNA processing	-	28	14	-	-	2.25E-01	2.17E-03
PTMCode2	BP	GO:0051303	establishment of chromosome localization	-	104	54	-	-	4.37E-02	7.95E-03
PTMCode2	BP	GO:0031349	positive regulation of defense response	-	473	235	-	-	5.14E-02	3.40E-02
PTMCode2	BP	GO:0007164	establishment of tissue polarity	-	38	19	-	-	1.73E-02	2.89E-03
PTMCode2	BP	GO:0021515	cell differentiation in spinal cord	-	51	21	-	-	6.48E-02	3.07E-03
PTMCode2	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	13	-	-	1.17E-02	1.99E-03
PTMCode2	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	13	-	-	6.04E-03	1.99E-03
PTMCode2	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	15	-	-	2.06E-03	2.17E-03
PTMCode2	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	17	-	-	3.00E-02	2.53E-03
PTMCode2	BP	GO:0006605	protein targeting	-	327	144	-	-	6.50E-02	2.10E-02
PTMCode2	BP	GO:0007566	embryo implantation	-	57	31	-	-	9.39E-03	4.52E-03
PTMCode2	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	18	-	-	3.50E-03	2.71E-03
PTMCode2	BP	GO:0031268	pseudopodium organization	-	17	12	-	-	5.24E-02	1.81E-03
PTMCode2	BP	GO:0061512	protein localization to cilium	-	394	106	-	-	6.35E-02	1.54E-02
PTMCode2	BP	GO:0060306	regulation of membrane repolarization	-	38	20	-	-	2.55E-02	2.89E-03
PTMCode2	BP	GO:0051017	actin filament bundle assembly	-	161	90	-	-	9.23E-03	1.30E-02
PTMCode2	BP	GO:1905953	negative regulation of lipid localization	-	63	26	-	-	1.20E-02	3.79E-03
PTMCode2	BP	GO:0021542	dentate gyrus development	-	19	12	-	-	1.79E-02	1.81E-03
PTMCode2	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	23	-	-	1.55E-01	3.43E-03
PTMCode2	BP	GO:1901343	negative regulation of vasculature development	-	154	64	-	-	6.37E-03	9.39E-03
PTMCode2	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	64	-	-	1.97E-02	9.39E-03
PTMCode2	BP	GO:1902414	protein localization to cell junction	-	107	55	-	-	3.71E-02	7.95E-03
PTMCode2	BP	GO:0051304	chromosome separation	-	80	51	-	-	1.24E-01	7.41E-03
PTMCode2	BP	GO:0090596	sensory organ morphogenesis	-	272	141	-	-	2.60E-02	2.04E-02
PTMCode2	BP	GO:0045780	positive regulation of bone resorption	-	18	11	-	-	4.03E-03	1.63E-03
PTMCode2	BP	GO:0048709	oligodendrocyte differentiation	-	101	51	-	-	1.13E-02	7.41E-03
PTMCode2	BP	GO:0045017	glycerolipid biosynthetic process	-	254	79	-	-	8.59E-02	1.16E-02
PTMCode2	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	12	-	-	6.66E-02	1.81E-03
PTMCode2	BP	GO:0001776	leukocyte homeostasis	-	108	62	-	-	1.07E-02	9.03E-03
PTMCode2	BP	GO:0050769	positive regulation of neurogenesis	-	240	127	-	-	1.34E-02	1.84E-02
PTMCode2	BP	GO:0030193	regulation of blood coagulation	-	70	48	-	-	5.92E-02	7.05E-03
PTMCode2	BP	GO:0050866	negative regulation of cell activation	-	216	111	-	-	1.31E-02	1.61E-02
PTMCode2	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	20	-	-	1.14E-02	2.89E-03
PTMCode2	BP	GO:0033500	carbohydrate homeostasis	-	251	126	-	-	2.25E-02	1.82E-02
PTMCode2	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	15	-	-	7.73E-03	2.17E-03
PTMCode2	BP	GO:0044088	regulation of vacuole organization	-	56	23	-	-	2.40E-03	3.43E-03
PTMCode2	CC	GO:0051457	maintenance of protein location in nucleus	-	23	17	-	-	1.75E-02	2.53E-03
PTMCode2	CC	GO:0099522	cytosolic region	-	20	16	-	-	7.04E-04	2.35E-03
PTMCode2	CC	GO:0000791	euchromatin	-	60	29	-	-	4.91E-03	4.34E-03
PTMCode2	CC	GO:0030666	endocytic vesicle membrane	-	196	109	-	-	5.03E-02	1.59E-02
PTMCode2	CC	GO:0098857	membrane microdomain	-	324	192	-	-	2.60E-02	2.78E-02
PTMCode2	CC	GO:0030312	external encapsulating structure	-	567	238	-	-	1.76E-01	3.45E-02
PTMCode2	CC	GO:1990752	microtubule end	-	34	17	-	-	6.62E-02	2.53E-03
PTMCode2	CC	GO:0043204	perikaryon	-	156	68	-	-	3.64E-03	9.94E-03
PTMCode2	CC	GO:0097542	ciliary tip	-	48	16	-	-	1.10E-01	2.35E-03
PTMCode2	CC	GO:1905368	peptidase complex	-	124	72	-	-	5.05E-01	1.05E-02
PTMCode2	CC	GO:0000792	heterochromatin	-	98	50	-	-	7.12E-02	7.23E-03
PTMCode2	CC	GO:0097546	ciliary base	-	47	15	-	-	8.02E-02	2.17E-03
PTMCode2	CC	GO:0071819	DUBm complex	-	25	16	-	-	4.18E-01	2.35E-03
PTMCode2	CC	GO:0031201	SNARE complex	-	48	29	-	-	2.01E-01	4.34E-03
PTMCode2	CC	GO:0016324	apical plasma membrane	-	392	152	-	-	2.48E-02	2.20E-02
PTMCode2	CC	GO:0033260	nuclear DNA replication	-	40	24	-	-	2.02E-02	3.61E-03
PTMCode2	CC	GO:0044391	ribosomal subunit	-	203	103	-	-	7.91E-01	1.50E-02
PTMCode2	CC	GO:0071013	catalytic step 2 spliceosome	-	88	39	-	-	1.60E-01	5.78E-03
PTMCode2	CC	GO:0098862	cluster of actin-based cell projections	-	162	46	-	-	1.23E-02	6.68E-03
PTMCode2	CC	GO:0098978	glutamatergic synapse	-	411	239	-	-	2.59E-02	3.47E-02
PTMCode2	CC	GO:0016363	nuclear matrix	-	127	81	-	-	1.02E-02	1.17E-02
PTMCode2	CC	GO:0031261	DNA replication preinitiation complex	-	46	25	-	-	2.96E-01	3.61E-03
PTMCode2	CC	GO:0031966	mitochondrial membrane	-	746	214	-	-	3.52E-01	3.11E-02
PTMCode2	CC	GO:0097060	synaptic membrane	-	413	196	-	-	6.45E-02	2.84E-02
PTMCode2	CC	GO:0032432	actin filament bundle	-	249	94	-	-	1.12E-02	1.37E-02
PTMCode2	CC	GO:0008088	axo-dendritic transport	-	78	48	-	-	4.01E-02	7.05E-03
PTMCode2	CC	GO:0031519	PcG protein complex	-	38	19	-	-	3.91E-01	2.89E-03
PTMCode2	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	14	-	-	1.64E-01	2.17E-03
PTMCode2	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	131	-	-	6.45E-02	1.90E-02
PTMCode2	CC	GO:0000313	organellar ribosome	-	89	23	-	-	7.20E-01	3.43E-03
PTMCode2	CC	GO:0098791	Golgi apparatus subcompartment	-	378	129	-	-	9.57E-02	1.88E-02
PTMCode2	CC	GO:0099643	signal release from synapse	-	147	79	-	-	5.81E-02	1.16E-02
PTMCode2	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	14	-	-	5.22E-02	2.17E-03
PTMCode2	CC	GO:0030018	Z disc	-	129	71	-	-	7.30E-02	1.03E-02
PTMCode2	CC	GO:0032580	Golgi cisterna membrane	-	93	16	-	-	7.17E-04	2.35E-03
PTMCode2	CC	GO:1905360	GTPase complex	-	41	22	-	-	2.39E-02	3.25E-03
PTMCode2	CC	GO:0097540	axonemal central pair	-	161	38	-	-	1.31E-02	5.60E-03
PTMCode2	CC	GO:0042641	actomyosin	-	77	34	-	-	8.42E-03	5.06E-03
PTMCode2	CC	GO:0097386	glial cell projection	-	38	16	-	-	3.85E-03	2.35E-03
PTMCode2	CC	GO:0032588	trans-Golgi network membrane	-	102	48	-	-	1.32E-01	7.05E-03
PTMCode2	CC	GO:0070382	exocytic vesicle	-	224	103	-	-	4.76E-02	1.50E-02
PTMCode2	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	12	-	-	1.00E-01	1.81E-03
PTMCode2	CC	GO:0031903	microbody membrane	-	65	26	-	-	4.95E-01	3.79E-03
PTMCode2	CC	GO:0046930	pore complex	-	26	18	-	-	3.16E-01	2.71E-03
PTMCode2	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	125	-	-	6.11E-02	1.81E-02
PTMCode2	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	11	-	-	1.09E-01	1.63E-03
PTMCode2	CC	GO:0044298	cell body membrane	-	32	15	-	-	7.15E-04	2.17E-03
PTMCode2	CC	GO:0051882	mitochondrial depolarization	-	21	11	-	-	1.99E-02	1.63E-03
PTMCode2	CC	GO:0070993	translation preinitiation complex	-	19	13	-	-	6.23E-01	1.99E-03
PTMCode2	CC	GO:0016323	basolateral plasma membrane	-	239	93	-	-	1.20E-02	1.36E-02
PTMCode2	CC	GO:0042645	mitochondrial nucleoid	-	45	18	-	-	1.05E-01	2.71E-03
PTMCode2	CC	GO:1902495	transmembrane transporter complex	-	408	149	-	-	3.51E-01	2.17E-02
PTMCode2	CC	GO:0098636	protein complex involved in cell adhesion	-	57	40	-	-	1.34E-01	5.78E-03
PTMCode2	CC	GO:0001917	photoreceptor inner segment	-	71	27	-	-	1.35E-02	3.97E-03
PTMCode2	CC	GO:0019897	extrinsic component of plasma membrane	-	156	93	-	-	4.47E-02	1.36E-02
PTMCode2	CC	GO:0031594	neuromuscular junction	-	73	47	-	-	2.99E-02	6.87E-03
PTMCode2	CC	GO:0000793	condensed chromosome	-	274	145	-	-	1.52E-01	2.10E-02
PTMCode2	CC	GO:0000922	spindle pole	-	172	73	-	-	1.36E-02	1.07E-02
PTMCode2	CC	GO:0120111	neuron projection cytoplasm	-	94	55	-	-	6.97E-02	7.95E-03
PTMCode2	CC	GO:0004879	nuclear receptor activity	-	63	38	-	-	1.11E-01	5.60E-03
PTMCode2	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	100	-	-	1.15E-02	1.45E-02
PTMCode2	CC	GO:0000123	histone acetyltransferase complex	-	93	51	-	-	3.25E-01	7.41E-03
PTMCode2	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	39	-	-	5.47E-01	5.78E-03
PTMCode2	CC	GO:0048786	presynaptic active zone	-	80	48	-	-	7.08E-03	7.05E-03
PTMCode2	CC	GO:0007034	vacuolar transport	-	168	75	-	-	1.28E-01	1.08E-02
PTMCode2	CC	GO:0043194	axon initial segment	-	21	13	-	-	2.35E-02	1.99E-03
PTMCode2	CC	GO:0005776	autophagosome	-	111	46	-	-	4.82E-02	6.68E-03
PTMCode2	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	48	-	-	5.68E-01	7.05E-03
PTMCode2	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	55	-	-	6.64E-01	7.95E-03
PTMCode2	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	12	-	-	1.54E-01	1.81E-03
PTMCode2	CC	GO:0032994	protein-lipid complex	-	39	19	-	-	1.72E-01	2.89E-03
PTMCode2	CC	GO:0150034	distal axon	-	309	159	-	-	1.45E-02	2.31E-02
PTMCode2	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	73	-	-	2.53E-01	1.07E-02
PTMCode2	CC	GO:0072562	blood microparticle	-	144	66	-	-	6.70E-02	9.58E-03
PTMCode2	CC	GO:0051233	spindle midzone	-	36	20	-	-	6.07E-03	2.89E-03
PTMCode2	CC	GO:0005811	lipid droplet	-	102	25	-	-	4.29E-02	3.61E-03
PTMCode2	CC	GO:0045022	early endosome to late endosome transport	-	44	23	-	-	2.00E-01	3.43E-03
PTMCode2	CC	GO:0043113	receptor clustering	-	51	36	-	-	4.36E-02	5.24E-03
PTMCode2	CC	GO:0044853	plasma membrane raft	-	114	67	-	-	1.70E-02	9.76E-03
PTMCode2	CC	GO:0005881	cytoplasmic microtubule	-	256	71	-	-	1.30E-02	1.03E-02
PTMCode2	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	33	-	-	2.81E-01	4.88E-03
PTMCode2	CC	GO:0005905	clathrin-coated pit	-	73	48	-	-	6.19E-02	7.05E-03
PTMCode2	CC	GO:0043034	costamere	-	18	13	-	-	3.05E-02	1.99E-03
PTMCode2	CC	GO:0031904	endosome lumen	-	38	24	-	-	2.27E-02	3.61E-03
PTMCode2	CC	GO:0060170	ciliary membrane	-	76	29	-	-	6.94E-02	4.34E-03
PTMCode2	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	15	-	-	4.39E-01	2.17E-03
PTMCode2	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	11	-	-	4.62E-01	1.63E-03
PTMCode2	CC	GO:0000139	Golgi membrane	-	646	203	-	-	1.08E-01	2.94E-02
PTMCode2	CC	GO:0032154	cleavage furrow	-	54	26	-	-	2.60E-02	3.79E-03
PTMCode2	CC	GO:0007006	mitochondrial membrane organization	-	117	48	-	-	5.31E-02	7.05E-03
PTMCode2	CC	GO:0001772	immunological synapse	-	44	28	-	-	6.11E-02	4.16E-03
PTMCode2	CC	GO:0009897	external side of plasma membrane	-	425	178	-	-	3.71E-02	2.58E-02
PTMCode2	CC	GO:0030863	cortical cytoskeleton	-	104	54	-	-	1.46E-02	7.95E-03
PTMCode2	CC	GO:1905348	endonuclease complex	-	38	19	-	-	1.92E-01	2.89E-03
PTMCode2	CC	GO:0030315	T-tubule	-	52	24	-	-	2.88E-02	3.61E-03
PTMCode2	CC	GO:0060076	excitatory synapse	-	64	32	-	-	1.27E-02	4.70E-03
PTMCode2	CC	GO:0036019	endolysosome	-	29	13	-	-	1.89E-02	1.99E-03
PTMCode2	CC	GO:0001891	phagocytic cup	-	28	11	-	-	5.39E-04	1.63E-03
PTMCode2	CC	GO:0099086	synaptonemal structure	-	40	12	-	-	1.32E-02	1.81E-03
PTMCode2	CC	GO:0030427	site of polarized growth	-	172	90	-	-	1.15E-02	1.30E-02
PTMCode2	CC	GO:0044309	neuron spine	-	213	113	-	-	1.70E-02	1.64E-02
PTMCode2	CC	GO:0030658	transport vesicle membrane	-	231	107	-	-	1.25E-01	1.55E-02
PTMCode2	CC	GO:0098918	structural constituent of synapse	-	27	14	-	-	3.61E-02	2.17E-03
PTMCode2	CC	GO:0000940	outer kinetochore	-	17	11	-	-	6.65E-02	1.63E-03
PTMCode2	CC	GO:0034719	SMN-Sm protein complex	-	18	14	-	-	5.88E-01	2.17E-03
PTMCode2	CC	GO:0044232	organelle membrane contact site	-	50	11	-	-	1.49E-02	1.63E-03
PTMCode2	CC	GO:0098803	respiratory chain complex	-	39	19	-	-	8.50E-01	2.89E-03
PTMCode2	CC	GO:0030667	secretory granule membrane	-	319	130	-	-	1.62E-02	1.88E-02
PTMCode2	CC	GO:0097545	axonemal outer doublet	-	164	38	-	-	8.85E-03	5.60E-03
PTMCode2	CC	GO:0070069	cytochrome complex	-	42	20	-	-	8.00E-01	2.89E-03
PTMCode2	CC	GO:0031143	pseudopodium	-	18	11	-	-	1.04E-02	1.63E-03
PTMCode2	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	17	-	-	2.22E-01	2.53E-03
PTMCode2	CC	GO:0055037	recycling endosome	-	200	80	-	-	5.28E-02	1.16E-02
PTMCode2	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	56	-	-	7.25E-03	8.13E-03
PTMCode2	CC	GO:0071682	endocytic vesicle lumen	-	23	17	-	-	4.68E-02	2.53E-03
PTMCode2	CC	GO:0030684	preribosome	-	76	35	-	-	2.24E-01	5.06E-03
PTMCode2	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	166	-	-	2.95E-02	2.40E-02
PTMCode2	CC	GO:1990391	DNA repair complex	-	22	15	-	-	1.20E-01	2.17E-03
PTMCode2	CC	GO:0005775	vacuolar lumen	-	176	85	-	-	4.46E-02	1.23E-02
PTMCode2	CC	GO:0016327	apicolateral plasma membrane	-	23	15	-	-	2.60E-02	2.17E-03
PTMCode2	CC	GO:0044306	neuron projection terminus	-	164	87	-	-	8.22E-03	1.26E-02
PTMCode2	CC	GO:0034455	t-UTP complex	-	53	24	-	-	4.67E-01	3.61E-03
PTMCode2	CC	GO:0005770	late endosome	-	299	93	-	-	5.14E-02	1.36E-02
PTMCode2	CC	GO:0031970	organelle envelope lumen	-	94	38	-	-	4.43E-02	5.60E-03
PTMCode2	CC	GO:0019866	organelle inner membrane	-	546	146	-	-	3.63E-01	2.11E-02
PTMCode2	CC	GO:0098687	chromosomal region	-	397	219	-	-	1.10E-01	3.18E-02
PTMCode2	CC	GO:0043292	contractile muscle fiber	-	245	122	-	-	1.27E-01	1.77E-02
PTMCode2	CC	GO:0000803	sex chromosome	-	32	16	-	-	7.93E-03	2.35E-03
PTMCode2	CC	GO:0098982	GABA-ergic synapse	-	84	41	-	-	1.50E-02	5.96E-03
PTMCode2	CC	GO:0035097	histone methyltransferase complex	-	63	36	-	-	2.19E-01	5.24E-03
PTMCode2	CC	GO:1903293	phosphatase complex	-	54	27	-	-	6.71E-02	3.97E-03
PTMCode2	CC	GO:0000786	nucleosome	-	149	49	-	-	3.14E-01	7.23E-03
PTMCode2	CC	GO:0001533	cornified envelope	-	59	33	-	-	3.80E-01	4.88E-03
PTMCode2	CC	GO:1904724	tertiary granule lumen	-	55	26	-	-	2.77E-02	3.79E-03
PTMCode2	CC	GO:0030027	lamellipodium	-	202	121	-	-	3.61E-02	1.75E-02
PTMCode2	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	14	-	-	1.95E-01	2.17E-03
PTMCode2	CC	GO:0031209	SCAR complex	-	12	11	-	-	3.74E-01	1.63E-03
PTMCode2	CC	GO:0002102	podosome	-	31	17	-	-	1.06E-02	2.53E-03
PTMCode2	CC	GO:0090543	Flemming body	-	33	13	-	-	2.97E-02	1.99E-03
PTMCode2	CC	GO:0016328	lateral plasma membrane	-	66	49	-	-	1.67E-02	7.23E-03
PTMCode2	CC	GO:0001650	fibrillar center	-	151	78	-	-	3.52E-02	1.14E-02
PTMCode2	CC	GO:0031332	RNAi effector complex	-	413	12	-	-	3.39E-01	1.81E-03
PTMCode2	CC	GO:1990204	oxidoreductase complex	-	90	42	-	-	5.64E-01	6.14E-03
PTMCode2	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	63	-	-	9.31E-03	9.21E-03
PTMCode2	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	13	-	-	1.04E-01	1.99E-03
PTMCode2	CC	GO:0001726	ruffle	-	181	105	-	-	1.52E-02	1.52E-02
PTMCode2	CC	GO:1990909	Wnt signalosome	-	13	11	-	-	2.66E-02	1.63E-03
PTMCode2	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	14	-	-	5.29E-01	2.17E-03
PTMCode2	CC	GO:0043198	dendritic shaft	-	38	19	-	-	3.71E-03	2.89E-03
PTMCode2	CC	GO:0043073	germ cell nucleus	-	67	34	-	-	7.43E-03	5.06E-03
PTMCode2	CC	GO:0005788	endoplasmic reticulum lumen	-	313	146	-	-	4.31E-02	2.11E-02
PTMCode2	CC	GO:0016592	mediator complex	-	38	27	-	-	8.60E-01	3.97E-03
PTMCode2	CC	GO:0022626	cytosolic ribosome	-	118	82	-	-	8.95E-01	1.19E-02
PTMCode2	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	27	-	-	5.47E-01	3.97E-03
PTMCode2	CC	GO:0034451	centriolar satellite	-	120	52	-	-	6.29E-03	7.59E-03
PTMCode2	CC	GO:0045171	intercellular bridge	-	91	44	-	-	1.13E-02	6.50E-03
PTMCode2	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	28	-	-	2.55E-02	4.16E-03
PTMCode2	CC	GO:0098984	neuron to neuron synapse	-	384	209	-	-	4.80E-02	3.04E-02
PTMCode2	CC	GO:0030527	structural constituent of chromatin	-	97	25	-	-	3.69E-01	3.61E-03
PTMCode2	CC	GO:0036379	myofilament	-	26	12	-	-	8.54E-02	1.81E-03
PTMCode2	CC	GO:0030286	dynein complex	-	210	51	-	-	4.10E-02	7.41E-03
PTMCode2	CC	GO:0016482	cytosolic transport	-	135	50	-	-	6.45E-02	7.23E-03
PTMCode2	CC	GO:0090665	glycoprotein complex	-	23	17	-	-	4.27E-01	2.53E-03
PTMCode2	CC	GO:0005796	Golgi lumen	-	106	51	-	-	1.50E-02	7.41E-03
PTMCode2	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	24	-	-	4.24E-01	3.61E-03
PTMCode2	CC	GO:0034358	plasma lipoprotein particle	-	36	17	-	-	3.48E-01	2.53E-03
PTMCode2	CC	GO:0008023	transcription elongation factor complex	-	47	26	-	-	1.77E-01	3.79E-03
PTMCode2	CC	GO:0030662	coated vesicle membrane	-	202	112	-	-	1.78E-01	1.63E-02
PTMCode2	CC	GO:0007039	protein catabolic process in the vacuole	-	61	21	-	-	2.26E-01	3.07E-03
PTMCode2	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	38	-	-	5.32E-01	5.60E-03
PTMCode2	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	172	-	-	2.40E-01	2.49E-02
PTMCode2	CC	GO:0005769	early endosome	-	425	176	-	-	4.49E-02	2.55E-02
PTMCode2	CC	GO:0090734	site of DNA damage	-	118	52	-	-	2.11E-02	7.59E-03
PTMCode2	MF	GO:0051861	glycolipid binding	-	30	17	-	-	2.89E-02	2.53E-03
PTMCode2	MF	GO:0051087	protein-folding chaperone binding	-	135	76	-	-	3.34E-02	1.10E-02
PTMCode2	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	16	-	-	7.11E-04	2.35E-03
PTMCode2	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	53	-	-	2.63E-02	7.77E-03
PTMCode2	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	12	-	-	7.34E-03	1.81E-03
PTMCode2	MF	GO:0016757	glycosyltransferase activity	-	286	54	-	-	9.79E-02	7.95E-03
PTMCode2	MF	GO:0048306	calcium-dependent protein binding	-	61	37	-	-	3.26E-02	5.42E-03
PTMCode2	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	41	-	-	5.44E-02	5.96E-03
PTMCode2	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	23	-	-	1.62E-01	3.43E-03
PTMCode2	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	34	-	-	1.02E-01	5.06E-03
PTMCode2	MF	GO:0051020	GTPase binding	-	311	159	-	-	1.90E-02	2.31E-02
PTMCode2	MF	GO:0005158	insulin receptor binding	-	22	13	-	-	2.05E-02	1.99E-03
PTMCode2	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	11	-	-	6.68E-03	1.63E-03
PTMCode2	MF	GO:0061980	regulatory RNA binding	-	52	23	-	-	2.10E-01	3.43E-03
PTMCode2	MF	GO:0015035	protein-disulfide reductase activity	-	32	14	-	-	1.99E-02	2.17E-03
PTMCode2	MF	GO:0001671	ATPase activator activity	-	29	13	-	-	5.40E-04	1.99E-03
PTMCode2	MF	GO:0070840	dynein complex binding	-	25	12	-	-	3.20E-03	1.81E-03
PTMCode2	MF	GO:0035035	histone acetyltransferase binding	-	24	15	-	-	2.89E-03	2.17E-03
PTMCode2	MF	GO:0061684	chaperone-mediated autophagy	-	16	11	-	-	3.09E-02	1.63E-03
PTMCode2	MF	GO:0003688	DNA replication origin binding	-	18	15	-	-	9.49E-02	2.17E-03
PTMCode2	MF	GO:0005178	integrin binding	-	153	87	-	-	1.30E-01	1.26E-02
PTMCode2	MF	GO:0070064	proline-rich region binding	-	17	13	-	-	3.03E-03	1.99E-03
PTMCode2	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	11	-	-	4.13E-03	1.63E-03
PTMCode2	MF	GO:0140318	protein transporter activity	-	40	19	-	-	1.91E-02	2.89E-03
PTMCode2	MF	GO:0000217	DNA secondary structure binding	-	37	23	-	-	2.55E-02	3.43E-03
PTMCode2	MF	GO:0002039	p53 binding	-	66	46	-	-	1.66E-02	6.68E-03
PTMCode2	MF	GO:0005496	steroid binding	-	110	45	-	-	8.06E-02	6.50E-03
PTMCode2	MF	GO:0008443	phosphofructokinase activity	-	27	12	-	-	1.14E-01	1.81E-03
PTMCode2	MF	GO:0003684	damaged DNA binding	-	89	53	-	-	1.18E-01	7.77E-03
PTMCode2	MF	GO:0000339	RNA cap binding	-	20	11	-	-	1.85E-02	1.63E-03
PTMCode2	MF	GO:0016500	protein-hormone receptor activity	-	21	11	-	-	1.06E-02	1.63E-03
PTMCode2	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	82	-	-	7.09E-02	1.19E-02
PTMCode2	MF	GO:0070063	RNA polymerase binding	-	61	30	-	-	2.78E-02	4.34E-03
PTMCode2	MF	GO:0030971	receptor tyrosine kinase binding	-	76	50	-	-	6.86E-03	7.23E-03
PTMCode2	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	43	-	-	2.39E-01	6.32E-03
PTMCode2	MF	GO:0140030	modification-dependent protein binding	-	179	85	-	-	1.38E-02	1.23E-02
PTMCode2	MF	GO:0042813	Wnt receptor activity	-	16	11	-	-	1.75E-02	1.63E-03
PTMCode2	MF	GO:0044548	S100 protein binding	-	14	11	-	-	9.25E-02	1.63E-03
PTMCode2	MF	GO:0030276	clathrin binding	-	70	42	-	-	1.65E-01	6.14E-03
PTMCode2	MF	GO:0046875	ephrin receptor binding	-	29	24	-	-	7.19E-02	3.61E-03
PTMCode2	MF	GO:0106310	protein serine kinase activity	-	362	210	-	-	2.93E-02	3.04E-02
PTMCode2	MF	GO:0046790	virion binding	-	19	15	-	-	7.15E-04	2.17E-03
PTMCode2	MF	GO:0030552	cAMP binding	-	48	23	-	-	1.70E-02	3.43E-03
PTMCode2	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	21	-	-	3.42E-03	3.07E-03
PTMCode2	MF	GO:0004857	enzyme inhibitor activity	-	395	195	-	-	9.89E-03	2.82E-02
PTMCode2	MF	GO:0035173	histone kinase activity	-	17	12	-	-	5.22E-04	1.81E-03
PTMCode2	MF	GO:0016209	antioxidant activity	-	92	27	-	-	1.13E-01	3.97E-03
PTMCode2	MF	GO:0070325	lipoprotein particle receptor binding	-	32	23	-	-	1.24E-02	3.43E-03
PTMCode2	MF	GO:0044325	transmembrane transporter binding	-	159	76	-	-	1.05E-02	1.10E-02
PTMCode2	MF	GO:0048156	tau protein binding	-	43	28	-	-	7.98E-03	4.16E-03
PTMCode2	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	17	-	-	5.61E-02	2.53E-03
PTMCode2	MF	GO:0140272	exogenous protein binding	-	79	46	-	-	1.66E-02	6.68E-03
PTMCode2	MF	GO:0030145	manganese ion binding	-	65	15	-	-	2.51E-03	2.17E-03
PTMCode2	MF	GO:0071814	protein-lipid complex binding	-	52	28	-	-	5.28E-02	4.16E-03
PTMCode2	MF	GO:0008066	glutamate receptor activity	-	70	36	-	-	1.50E-02	5.24E-03
PTMCode2	MF	GO:0017069	snRNA binding	-	54	27	-	-	1.38E-01	3.97E-03
PTMCode2	MF	GO:0031369	translation initiation factor binding	-	32	18	-	-	1.45E-02	2.71E-03
PTMCode2	MF	GO:0019843	rRNA binding	-	69	38	-	-	2.54E-02	5.60E-03
PTMCode2	MF	GO:0004713	protein tyrosine kinase activity	-	213	144	-	-	3.75E-02	2.10E-02
PTMCode2	MF	GO:0016779	nucleotidyltransferase activity	-	264	136	-	-	1.53E-01	1.97E-02
PTMCode2	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	37	-	-	9.06E-03	5.42E-03
PTMCode2	MF	GO:0008093	cytoskeletal anchor activity	-	24	17	-	-	7.10E-04	2.53E-03
PTMCode2	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	13	-	-	1.16E-02	1.99E-03
PTMCode2	MF	GO:0000287	magnesium ion binding	-	225	84	-	-	1.76E-02	1.23E-02
PTMCode2	MF	GO:0031490	chromatin DNA binding	-	120	55	-	-	1.99E-02	7.95E-03
PTMCode2	MF	GO:0017022	myosin binding	-	73	40	-	-	8.14E-03	5.78E-03
PTMCode2	MF	GO:0004896	cytokine receptor activity	-	93	61	-	-	2.97E-02	8.85E-03
PTMCode2	MF	GO:0015631	tubulin binding	-	410	184	-	-	4.70E-02	2.67E-02
PTMCode2	MF	GO:0005539	glycosaminoglycan binding	-	236	98	-	-	4.91E-02	1.43E-02
PTMCode2	MF	GO:0071933	Arp2/3 complex binding	-	14	11	-	-	5.39E-04	1.63E-03
PTMCode2	MF	GO:0019207	kinase regulator activity	-	267	168	-	-	2.05E-02	2.44E-02
PTMCode2	MF	GO:0044183	protein folding chaperone	-	67	35	-	-	2.43E-02	5.06E-03
PTMCode2	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	79	-	-	2.75E-02	1.16E-02
PTMCode2	MF	GO:0003725	double-stranded RNA binding	-	72	30	-	-	8.22E-02	4.34E-03
PTMCode2	MF	GO:0051018	protein kinase A binding	-	52	31	-	-	1.20E-02	4.52E-03
PTMCode2	MF	GO:0071889	14-3-3 protein binding	-	34	21	-	-	4.73E-03	3.07E-03
PTMCode2	MF	GO:0004618	phosphoglycerate kinase activity	-	89	47	-	-	4.86E-02	6.87E-03
PTMCode2	MF	GO:0042805	actinin binding	-	36	20	-	-	8.81E-04	2.89E-03
PTMCode2	MF	GO:0043531	ADP binding	-	38	19	-	-	1.68E-02	2.89E-03
PTMCode2	MF	GO:0043394	proteoglycan binding	-	36	20	-	-	1.53E-02	2.89E-03
PTMCode2	MF	GO:0046332	SMAD binding	-	77	52	-	-	3.94E-02	7.59E-03
PTMCode2	MF	GO:0001968	fibronectin binding	-	30	21	-	-	8.31E-03	3.07E-03
PTMCode2	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	48	-	-	9.29E-02	7.05E-03
PTMCode2	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	32	-	-	1.24E-03	4.70E-03
PTMCode2	MF	GO:0051117	ATPase binding	-	85	47	-	-	1.25E-02	6.87E-03
PTMCode2	MF	GO:0005216	monoatomic ion channel activity	-	618	214	-	-	1.04E-01	3.11E-02
PTMCode2	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	29	-	-	5.52E-03	4.34E-03
PTMCode2	MF	GO:0001098	basal transcription machinery binding	-	61	37	-	-	2.50E-02	5.42E-03
PTMCode2	MF	GO:0036002	pre-mRNA binding	-	57	11	-	-	7.98E-02	1.63E-03
PTMCode2	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	17	-	-	9.98E-03	2.53E-03
PTMCode2	MF	GO:0051540	metal cluster binding	-	71	24	-	-	5.00E-02	3.61E-03
PTMCode2	MF	GO:0051219	phosphoprotein binding	-	92	66	-	-	9.92E-03	9.58E-03
PTMCode2	MF	GO:0019894	kinesin binding	-	45	21	-	-	5.03E-02	3.07E-03
PTMCode2	MF	GO:0042287	MHC protein binding	-	68	22	-	-	8.19E-02	3.25E-03
PTMCode2	MF	GO:0019003	GDP binding	-	89	45	-	-	1.27E-02	6.50E-03
PTMCode2	MF	GO:0017171	serine hydrolase activity	-	207	67	-	-	1.87E-02	9.76E-03
PTMCode2	MF	GO:0097110	scaffold protein binding	-	66	47	-	-	6.22E-03	6.87E-03
PTMCode2	MF	GO:0003774	cytoskeletal motor activity	-	117	26	-	-	1.65E-02	3.79E-03
PTMCode2	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	20	-	-	1.42E-02	2.89E-03
PTMCode2	MF	GO:0061134	peptidase regulator activity	-	224	100	-	-	2.72E-02	1.45E-02
PTMCode2	MF	GO:0008013	beta-catenin binding	-	86	53	-	-	1.47E-02	7.77E-03
PTMCode2	MF	GO:0051015	actin filament binding	-	208	79	-	-	1.18E-02	1.16E-02
PTMCode2	MF	GO:0019208	phosphatase regulator activity	-	107	54	-	-	4.34E-02	7.95E-03
PTMCode2	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	12	-	-	2.18E-02	1.81E-03
PTMCode2	MF	GO:0043236	laminin binding	-	29	16	-	-	3.29E-02	2.35E-03
PTMCode2	MF	GO:0030507	spectrin binding	-	26	14	-	-	5.35E-02	2.17E-03
PTMCode2	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	16	-	-	5.57E-02	2.35E-03
PTMCode2	MF	GO:0045860	positive regulation of protein kinase activity	-	397	235	-	-	2.70E-02	3.40E-02
PTMCode2	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	43	-	-	1.66E-01	6.32E-03
PTMCode2	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	23	-	-	2.93E-03	3.43E-03
PTMCode2	MF	GO:0042393	histone binding	-	240	110	-	-	3.38E-02	1.59E-02
PTMCode2	MF	GO:0019838	growth factor binding	-	182	128	-	-	2.70E-02	1.86E-02
PTMCode2	MF	GO:0000149	SNARE binding	-	107	57	-	-	4.00E-01	8.31E-03
PTMCode2	MF	GO:0003727	single-stranded RNA binding	-	90	33	-	-	2.72E-02	4.88E-03
PTMCode2	MF	GO:0051378	serotonin binding	-	24	11	-	-	8.38E-02	1.63E-03
PTMCode2	MF	GO:0005516	calmodulin binding	-	206	104	-	-	7.71E-03	1.52E-02
PTMCode2	MF	GO:0019825	oxygen binding	-	40	13	-	-	3.14E-02	1.99E-03
PTMCode2	MF	GO:0045505	dynein intermediate chain binding	-	37	12	-	-	4.45E-02	1.81E-03
PTMCode2	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	20	-	-	4.56E-03	2.89E-03
PTMCode2	MF	GO:0032182	ubiquitin-like protein binding	-	117	61	-	-	2.77E-02	8.85E-03
PTMCode2	MF	GO:0023023	MHC protein complex binding	-	36	18	-	-	1.04E-01	2.71E-03
PTMCode2	MF	GO:0030742	GTP-dependent protein binding	-	22	13	-	-	2.58E-02	1.99E-03
PTMCode2	MF	GO:0043274	phospholipase binding	-	23	15	-	-	7.42E-03	2.17E-03
PTMCode2	MF	GO:0031072	heat shock protein binding	-	128	70	-	-	2.63E-02	1.01E-02
PTMCode2	MF	GO:0030515	snoRNA binding	-	33	16	-	-	2.35E-01	2.35E-03
PTMCode2	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	16	-	-	1.02E-02	2.35E-03
PTMCode2	MF	GO:0001965	G-protein alpha-subunit binding	-	26	19	-	-	7.16E-04	2.89E-03
PTMCode2	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	208	-	-	2.17E-02	3.02E-02
PTMCode2	MF	GO:0001530	lipopolysaccharide binding	-	38	14	-	-	1.94E-02	2.17E-03
PTMCode2	MF	GO:0046982	protein heterodimerization activity	-	343	172	-	-	6.86E-02	2.49E-02
PTMCode2	MF	GO:0140223	general transcription initiation factor activity	-	55	35	-	-	5.94E-01	5.06E-03
PTMCode2	MF	GO:0000049	tRNA binding	-	75	25	-	-	4.11E-02	3.61E-03
PTMCode2	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	27	-	-	6.22E-03	3.97E-03
PTMCode2	MF	GO:0015026	coreceptor activity	-	48	29	-	-	3.24E-02	4.34E-03
PTMCode2	MF	GO:0001653	peptide receptor activity	-	128	77	-	-	2.28E-02	1.12E-02
PTMCode2	MF	GO:0006469	negative regulation of protein kinase activity	-	222	132	-	-	1.89E-02	1.92E-02
PTMCode2	MF	GO:0070182	DNA polymerase binding	-	22	15	-	-	8.30E-03	2.17E-03
PTMCode2	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	21	-	-	1.09E-02	3.07E-03
PTMCode2	MF	GO:0051427	hormone receptor binding	-	31	18	-	-	2.15E-03	2.71E-03
PTMCode2	MF	GO:0070851	growth factor receptor binding	-	141	89	-	-	2.04E-02	1.30E-02
PTMCode2	MF	GO:0031210	phosphatidylcholine binding	-	32	12	-	-	1.48E-02	1.81E-03
PTMCode2	MF	GO:0005525	GTP binding	-	396	141	-	-	1.07E-02	2.04E-02
PTMCode2	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	20	-	-	9.65E-03	2.89E-03
PTMCode2	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	165	-	-	2.31E-02	2.38E-02
PTMCode2	MF	GO:0034185	apolipoprotein binding	-	20	12	-	-	4.27E-03	1.81E-03
PTMCode2	MF	GO:0051346	negative regulation of hydrolase activity	-	332	157	-	-	9.59E-03	2.28E-02
PTMCode2	MF	GO:0005506	iron ion binding	-	154	36	-	-	2.03E-02	5.24E-03
PTMCode2	MF	GO:0003925	G protein activity	-	45	20	-	-	1.52E-03	2.89E-03
PTMCode2	MF	GO:0008276	protein methyltransferase activity	-	96	28	-	-	1.39E-02	4.16E-03
PTMCode2	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	206	-	-	2.48E-02	2.98E-02
PTMCode2	MF	GO:0070888	E-box binding	-	59	34	-	-	4.30E-02	5.06E-03
PTMCode2	MF	GO:0015399	primary active transmembrane transporter activity	-	190	87	-	-	2.69E-01	1.26E-02
PTMCode2	MF	GO:0035254	glutamate receptor binding	-	47	29	-	-	7.25E-03	4.34E-03
PTMCode2	MF	GO:0050321	tau-protein kinase activity	-	36	25	-	-	7.96E-03	3.61E-03
PTMCode2	MF	GO:0043021	ribonucleoprotein complex binding	-	158	71	-	-	1.09E-02	1.03E-02
PTMCode2	MF	GO:0005112	Notch binding	-	26	14	-	-	3.04E-02	2.17E-03
PTMCode2	MF	GO:0048185	activin binding	-	16	11	-	-	4.32E-02	1.63E-03
PTMCode2	MF	GO:0001664	G protein-coupled receptor binding	-	299	158	-	-	2.26E-02	2.29E-02
PTMCode2	MF	GO:0140299	small molecule sensor activity	-	39	13	-	-	1.69E-01	1.99E-03
PTMCode2	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	15	-	-	8.83E-03	2.17E-03
PTMCode2	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	11	-	-	1.26E-01	1.63E-03
PTMCode2	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	24	-	-	2.26E-02	3.61E-03
PTMCode2	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	13	-	-	5.20E-04	1.99E-03
PTMCode2	MF	GO:0030594	neurotransmitter receptor activity	-	160	71	-	-	9.24E-02	1.03E-02
PTMCode2	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	11	-	-	5.36E-04	1.63E-03
PTMCode2	MF	GO:0005507	copper ion binding	-	63	28	-	-	2.96E-02	4.16E-03
PTMCode2	MF	GO:0033558	protein lysine deacetylase activity	-	22	11	-	-	2.33E-02	1.63E-03
PTMCode2	MF	GO:0070034	telomerase RNA binding	-	22	17	-	-	1.68E-01	2.53E-03
Reactome	CC	GO:0005615	extracellular space	2.51E-68	3190	1198	795	1.51	-	-
Reactome	CC	GO:0005768	endosome	1.63E-45	1037	462	259	1.79	-	-
Reactome	CC	GO:0005794	Golgi apparatus	1.18E-20	1636	569	408	1.39	-	-
Reactome	CC	GO:0005783	endoplasmic reticulum	2.96E-18	2020	668	504	1.33	-	-
Reactome	CC	GO:0005764	lysosome	6.25E-18	747	291	186	1.56	-	-
Reactome	CC	GO:0000228	nuclear chromosome	3.52E-15	206	104	51	2.02	-	-
Reactome	CC	GO:0031012	extracellular matrix	1.53E-13	564	219	141	1.56	-	-
Reactome	CC	GO:0005840	ribosome	1.70E-09	222	20	55	0.36	-	-
Reactome	CC	GO:0005635	nuclear envelope	3.59E-07	493	173	123	1.41	-	-
Reactome	CC	GO:0005815	microtubule organizing center	4.12E-07	843	274	210	1.30	-	-
Reactome	CC	GO:0005739	mitochondrion	5.24E-04	1671	476	417	1.14	-	-
Reactome	CC	GO:0005730	nucleolus	8.79E-04	988	291	246	1.18	-	-
Reactome	CC	GO:0005929	cilium	2.49E-02	842	238	210	1.13	-	-
Reactome	CC	GO:0005811	lipid droplet	5.17E-02	102	34	25	1.34	-	-
Reactome	CC	GO:0005777	peroxisome	1.44E-01	142	43	35	1.21	-	-
Reactome	BP	GO:0002376	immune system process	4.28E-177	2448	1212	610	1.99	-	-
Reactome	BP	GO:0012501	programmed cell death	2.46E-144	1954	981	487	2.01	-	-
Reactome	BP	GO:0007155	cell adhesion	6.15E-104	1444	726	360	2.02	-	-
Reactome	BP	GO:0048870	cell motility	9.45E-87	1659	766	414	1.85	-	-
Reactome	BP	GO:0006954	inflammatory response	7.02E-84	820	459	204	2.25	-	-
Reactome	BP	GO:0098542	defense response to other organism	1.17E-69	1171	562	292	1.92	-	-
Reactome	BP	GO:0042060	wound healing	8.48E-61	431	267	107	2.48	-	-
Reactome	BP	GO:0016192	vesicle-mediated transport	1.19E-57	1894	772	472	1.63	-	-
Reactome	BP	GO:0034330	cell junction organization	3.58E-53	727	370	181	2.04	-	-
Reactome	BP	GO:0003013	circulatory system process	1.16E-45	584	303	146	2.08	-	-
Reactome	BP	GO:0006886	intracellular protein transport	7.27E-45	664	331	166	2.00	-	-
Reactome	BP	GO:0006355	regulation of DNA-templated transcription	1.61E-37	3342	1131	833	1.36	-	-
Reactome	BP	GO:0006281	DNA repair	5.84E-36	587	285	146	1.95	-	-
Reactome	BP	GO:0003012	muscle system process	1.24E-34	425	223	106	2.10	-	-
Reactome	BP	GO:0006914	autophagy	1.18E-33	568	273	142	1.93	-	-
Reactome	BP	GO:0030163	protein catabolic process	2.59E-33	990	415	247	1.68	-	-
Reactome	BP	GO:0065003	protein-containing complex assembly	4.20E-29	1648	606	411	1.47	-	-
Reactome	BP	GO:0006260	DNA replication	7.02E-27	279	153	70	2.20	-	-
Reactome	BP	GO:0072659	protein localization to plasma membrane	1.81E-21	284	145	71	2.05	-	-
Reactome	BP	GO:0055085	transmembrane transport	7.68E-21	1784	613	445	1.38	-	-
Reactome	BP	GO:0006310	DNA recombination	4.09E-20	333	160	83	1.93	-	-
Reactome	BP	GO:0007163	establishment or maintenance of cell polarity	4.39E-20	227	121	57	2.14	-	-
Reactome	BP	GO:0006325	chromatin organization	1.70E-17	720	281	180	1.57	-	-
Reactome	BP	GO:0006913	nucleocytoplasmic transport	9.02E-17	326	150	81	1.85	-	-
Reactome	BP	GO:0007010	cytoskeleton organization	2.43E-15	1639	545	409	1.33	-	-
Reactome	BP	GO:0030198	extracellular matrix organization	2.21E-14	314	140	78	1.79	-	-
Reactome	BP	GO:0007005	mitochondrion organization	5.55E-13	484	192	121	1.59	-	-
Reactome	BP	GO:0007059	chromosome segregation	2.36E-12	403	164	100	1.63	-	-
Reactome	BP	GO:0003014	renal system process	1.86E-10	127	65	32	2.05	-	-
Reactome	BP	GO:0000910	cytokinesis	3.50E-10	186	86	46	1.85	-	-
Reactome	BP	GO:0032200	telomere organization	5.91E-09	186	83	46	1.79	-	-
Reactome	BP	GO:0140013	meiotic nuclear division	1.09E-08	279	113	70	1.62	-	-
Reactome	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	5.49E-08	119	57	30	1.92	-	-
Reactome	BP	GO:0006091	generation of precursor metabolites and energy	1.09E-07	502	178	125	1.42	-	-
Reactome	BP	GO:0050877	nervous system process	1.76E-07	1527	467	381	1.23	-	-
Reactome	BP	GO:0006629	lipid metabolic process	2.46E-07	1355	419	338	1.24	-	-
Reactome	BP	GO:0005975	carbohydrate metabolic process	3.96E-07	551	190	137	1.38	-	-
Reactome	BP	GO:0140053	mitochondrial gene expression	8.26E-05	164	20	41	0.49	-	-
Reactome	BP	GO:0022600	digestive system process	5.33E-04	110	44	27	1.60	-	-
Reactome	BP	GO:0042254	ribosome biogenesis	8.92E-04	297	50	74	0.68	-	-
Reactome	BP	GO:0044782	cilium organization	1.04E-03	399	72	99	0.72	-	-
Reactome	BP	GO:0098754	detoxification	2.69E-02	134	45	33	1.35	-	-
Reactome	BP	GO:0006486	protein glycosylation	2.97E-02	225	42	56	0.75	-	-
Reactome	BP	GO:0006766	vitamin metabolic process	4.32E-02	107	36	27	1.35	-	-
Reactome	BP	GO:0006457	protein folding	4.50E-02	210	65	52	1.24	-	-
Reactome	BP	GO:0006520	amino acid metabolic process	6.54E-02	292	59	73	0.81	-	-
Reactome	BP	GO:0006575	cellular modified amino acid metabolic process	8.80E-02	186	36	46	0.78	-	-
Reactome	BP	GO:0002181	cytoplasmic translation	9.14E-02	153	29	38	0.76	-	-
Reactome	BP	GO:0016071	mRNA metabolic process	9.35E-02	713	197	178	1.11	-	-
Reactome	BP	GO:0006399	tRNA metabolic process	1.58E-01	196	40	49	0.82	-	-
Reactome	BP	GO:0006790	sulfur compound metabolic process	1.71E-01	320	69	80	0.86	-	-
Reactome	BP	GO:0007018	microtubule-based movement	4.03E-01	640	150	160	0.94	-	-
Reactome	BP	GO:0007040	lysosome organization	4.35E-01	107	30	27	1.12	-	-
Reactome	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.00E+00	729	182	182	1.00	-	-
Reactome	MF	GO:0140096	"catalytic activity, acting on a protein"	1.39E-118	3198	1336	797	1.68	-	-
Reactome	MF	GO:0016740	transferase activity	2.37E-58	3074	1132	766	1.48	-	-
Reactome	MF	GO:0048018	receptor ligand activity	3.08E-54	504	287	126	2.28	-	-
Reactome	MF	GO:0140097	"catalytic activity, acting on DNA"	8.99E-28	383	194	95	2.03	-	-
Reactome	MF	GO:0009975	cyclase activity	1.76E-24	277	148	69	2.14	-	-
Reactome	MF	GO:0003924	GTPase activity	6.02E-21	658	272	164	1.66	-	-
Reactome	MF	GO:0003677	DNA binding	1.40E-17	2865	900	714	1.26	-	-
Reactome	MF	GO:0016829	lyase activity	7.35E-17	538	221	134	1.65	-	-
Reactome	MF	GO:0008092	cytoskeletal protein binding	2.25E-15	1023	366	255	1.43	-	-
Reactome	MF	GO:0038024	cargo receptor activity	4.48E-13	117	66	29	2.26	-	-
Reactome	MF	GO:0140657	ATP-dependent activity	1.06E-12	729	267	182	1.47	-	-
Reactome	MF	GO:0008289	lipid binding	1.10E-12	836	299	208	1.43	-	-
Reactome	MF	GO:0140110	transcription regulator activity	8.07E-11	2033	629	507	1.24	-	-
Reactome	MF	GO:0042393	histone binding	5.64E-08	237	97	59	1.64	-	-
Reactome	MF	GO:0016491	oxidoreductase activity	5.63E-06	888	280	221	1.26	-	-
Reactome	MF	GO:0005215	transporter activity	1.77E-04	1462	425	365	1.17	-	-
Reactome	MF	GO:0140104	molecular carrier activity	3.02E-03	105	40	26	1.53	-	-
Reactome	MF	GO:0016874	ligase activity	1.26E-02	283	89	71	1.26	-	-
Reactome	MF	GO:0003774	cytoskeletal motor activity	2.32E-02	116	40	29	1.38	-	-
Reactome	MF	GO:0016853	isomerase activity	1.43E-01	252	73	63	1.16	-	-
Reactome	MF	GO:0045182	translation regulator activity	2.57E-01	151	44	38	1.17	-	-
Reactome	MF	GO:0140098	"catalytic activity, acting on RNA"	3.31E-01	417	95	104	0.91	-	-
Reactome	MF	GO:0003723	RNA binding	4.25E-01	1679	432	419	1.03	-	-
Reactome	MF	GO:0005198	structural molecule activity	8.34E-01	798	196	199	0.99	-	-
Reactome	BP	GO:0008038	neuron recognition	-	46	24	-	-	1.04E-02	4.26E-03
Reactome	BP	GO:1905145	cellular response to acetylcholine	-	33	19	-	-	2.23E-02	3.41E-03
Reactome	BP	GO:0098780	response to mitochondrial depolarisation	-	21	12	-	-	1.61E-01	2.13E-03
Reactome	BP	GO:0051931	regulation of sensory perception	-	36	17	-	-	1.15E-02	2.98E-03
Reactome	BP	GO:0007346	regulation of mitotic cell cycle	-	518	243	-	-	8.12E-02	4.16E-02
Reactome	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	16	-	-	1.50E-03	2.77E-03
Reactome	BP	GO:0009268	response to pH	-	43	22	-	-	1.56E-01	3.84E-03
Reactome	BP	GO:0045666	positive regulation of neuron differentiation	-	91	33	-	-	3.32E-03	5.75E-03
Reactome	BP	GO:0043543	protein acylation	-	107	54	-	-	5.64E-02	9.38E-03
Reactome	MF	GO:0051349	positive regulation of lyase activity	-	41	28	-	-	2.09E-02	4.90E-03
Reactome	BP	GO:0048679	regulation of axon regeneration	-	28	14	-	-	8.55E-03	2.56E-03
Reactome	BP	GO:0022401	negative adaptation of signaling pathway	-	21	12	-	-	6.32E-04	2.13E-03
Reactome	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	25	-	-	3.82E-01	4.26E-03
Reactome	BP	GO:0071763	nuclear membrane organization	-	44	25	-	-	1.45E-01	4.26E-03
Reactome	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	15	-	-	1.40E-02	2.56E-03
Reactome	BP	GO:0071806	protein transmembrane transport	-	68	31	-	-	2.17E-01	5.33E-03
Reactome	BP	GO:0043299	leukocyte degranulation	-	82	49	-	-	4.28E-02	8.52E-03
Reactome	BP	GO:0048864	stem cell development	-	88	50	-	-	9.52E-03	8.52E-03
Reactome	BP	GO:0051651	maintenance of location in cell	-	236	111	-	-	1.84E-02	1.90E-02
Reactome	CC	GO:0016197	endosomal transport	-	282	122	-	-	1.32E-01	2.09E-02
Reactome	BP	GO:0070663	regulation of leukocyte proliferation	-	268	179	-	-	2.87E-02	3.07E-02
Reactome	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	22	-	-	6.85E-02	3.84E-03
Reactome	BP	GO:0006949	syncytium formation	-	66	38	-	-	6.31E-03	6.61E-03
Reactome	BP	GO:0045861	negative regulation of proteolysis	-	320	120	-	-	3.23E-02	2.05E-02
Reactome	BP	GO:0030574	collagen catabolic process	-	45	21	-	-	3.51E-02	3.62E-03
Reactome	CC	GO:0006984	ER-nucleus signaling pathway	-	46	29	-	-	1.78E-01	5.11E-03
Reactome	BP	GO:0060343	trabecula formation	-	26	18	-	-	8.40E-04	3.20E-03
Reactome	BP	GO:0009914	hormone transport	-	315	162	-	-	3.02E-02	2.77E-02
Reactome	BP	GO:0140112	extracellular vesicle biogenesis	-	23	18	-	-	3.12E-02	3.20E-03
Reactome	BP	GO:0085029	extracellular matrix assembly	-	42	24	-	-	9.66E-03	4.26E-03
Reactome	BP	GO:0006413	translational initiation	-	122	45	-	-	1.71E-01	7.67E-03
Reactome	BP	GO:1902895	positive regulation of miRNA transcription	-	51	44	-	-	8.05E-03	7.67E-03
Reactome	CC	GO:0005200	structural constituent of cytoskeleton	-	112	34	-	-	2.12E-02	5.97E-03
Reactome	BP	GO:0030865	cortical cytoskeleton organization	-	51	30	-	-	5.09E-03	5.11E-03
Reactome	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	11	-	-	3.17E-01	1.92E-03
Reactome	BP	GO:1903036	positive regulation of response to wounding	-	76	43	-	-	2.09E-02	7.46E-03
Reactome	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	74	-	-	2.46E-01	1.28E-02
Reactome	BP	GO:1903319	positive regulation of protein maturation	-	27	14	-	-	5.96E-02	2.56E-03
Reactome	BP	GO:0002263	cell activation involved in immune response	-	304	178	-	-	4.12E-02	3.05E-02
Reactome	BP	GO:0021954	central nervous system neuron development	-	85	35	-	-	4.33E-03	5.97E-03
Reactome	BP	GO:0055017	cardiac muscle tissue growth	-	92	50	-	-	1.47E-02	8.52E-03
Reactome	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	21	-	-	1.15E-02	3.62E-03
Reactome	BP	GO:0048524	positive regulation of viral process	-	64	41	-	-	2.91E-03	7.03E-03
Reactome	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	13	-	-	4.81E-02	2.34E-03
Reactome	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	14	-	-	6.16E-04	2.56E-03
Reactome	BP	GO:0098661	inorganic anion transmembrane transport	-	140	22	-	-	3.47E-01	3.84E-03
Reactome	BP	GO:0006099	tricarboxylic acid cycle	-	33	18	-	-	4.90E-01	3.20E-03
Reactome	BP	GO:0009612	response to mechanical stimulus	-	215	129	-	-	1.41E-02	2.22E-02
Reactome	BP	GO:0048644	muscle organ morphogenesis	-	81	47	-	-	2.48E-02	8.10E-03
Reactome	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	105	-	-	1.27E-02	1.79E-02
Reactome	BP	GO:0071542	dopaminergic neuron differentiation	-	36	17	-	-	2.41E-02	2.98E-03
Reactome	BP	GO:0140115	export across plasma membrane	-	82	24	-	-	3.24E-01	4.26E-03
Reactome	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	18	-	-	1.30E-02	3.20E-03
Reactome	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	11	-	-	1.74E-01	1.92E-03
Reactome	MF	GO:0003714	transcription corepressor activity	-	190	81	-	-	2.66E-02	1.39E-02
Reactome	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	26	-	-	3.07E-02	4.47E-03
Reactome	BP	GO:0006304	DNA modification	-	30	13	-	-	7.39E-02	2.34E-03
Reactome	MF	GO:0140312	cargo adaptor activity	-	19	16	-	-	3.78E-02	2.77E-03
Reactome	BP	GO:0046835	carbohydrate phosphorylation	-	49	15	-	-	8.40E-02	2.56E-03
Reactome	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	11	-	-	6.10E-03	1.92E-03
Reactome	CC	GO:1905349	ciliary transition zone assembly	-	371	67	-	-	5.89E-02	1.15E-02
Reactome	BP	GO:0043523	regulation of neuron apoptotic process	-	218	131	-	-	2.10E-02	2.24E-02
Reactome	BP	GO:1902894	negative regulation of miRNA transcription	-	22	18	-	-	6.71E-03	3.20E-03
Reactome	BP	GO:0044380	protein localization to cytoskeleton	-	57	20	-	-	3.57E-02	3.41E-03
Reactome	BP	GO:0051918	negative regulation of fibrinolysis	-	13	11	-	-	1.01E-01	1.92E-03
Reactome	BP	GO:2000209	regulation of anoikis	-	25	16	-	-	4.84E-03	2.77E-03
Reactome	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	15	-	-	1.28E-02	2.56E-03
Reactome	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	24	-	-	3.97E-02	4.26E-03
Reactome	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	31	-	-	1.03E-02	5.33E-03
Reactome	CC	GO:0045324	late endosome to vacuole transport	-	37	23	-	-	6.23E-01	4.05E-03
Reactome	BP	GO:0043954	cellular component maintenance	-	72	40	-	-	8.94E-02	6.82E-03
Reactome	BP	GO:0050435	amyloid-beta metabolic process	-	65	36	-	-	1.58E-02	6.18E-03
Reactome	BP	GO:0014823	response to activity	-	70	40	-	-	4.74E-03	6.82E-03
Reactome	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	13	-	-	7.28E-02	2.34E-03
Reactome	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	13	-	-	4.08E-01	2.34E-03
Reactome	BP	GO:0034502	protein localization to chromosome	-	130	54	-	-	7.06E-02	9.38E-03
Reactome	BP	GO:0048562	embryonic organ morphogenesis	-	295	116	-	-	3.12E-02	1.98E-02
Reactome	BP	GO:0019233	sensory perception of pain	-	103	51	-	-	1.38E-02	8.74E-03
Reactome	CC	GO:0043574	peroxisomal transport	-	22	19	-	-	3.62E-01	3.41E-03
Reactome	BP	GO:0031343	positive regulation of cell killing	-	75	49	-	-	5.20E-02	8.52E-03
Reactome	BP	GO:0090077	foam cell differentiation	-	39	24	-	-	3.93E-03	4.26E-03
Reactome	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	58	-	-	3.34E-01	1.00E-02
Reactome	BP	GO:0017148	negative regulation of translation	-	390	34	-	-	7.43E-02	5.97E-03
Reactome	BP	GO:0030220	platelet formation	-	22	16	-	-	5.74E-02	2.77E-03
Reactome	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	48	-	-	2.59E-02	8.31E-03
Reactome	BP	GO:1903509	liposaccharide metabolic process	-	109	25	-	-	3.34E-01	4.26E-03
Reactome	BP	GO:0009582	detection of abiotic stimulus	-	140	59	-	-	9.18E-02	1.02E-02
Reactome	CC	GO:0140238	presynaptic endocytosis	-	72	37	-	-	3.69E-02	6.39E-03
Reactome	BP	GO:0051236	establishment of RNA localization	-	161	63	-	-	2.95E-01	1.09E-02
Reactome	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	116	-	-	9.03E-02	1.98E-02
Reactome	BP	GO:0034067	protein localization to Golgi apparatus	-	30	15	-	-	1.13E-01	2.56E-03
Reactome	BP	GO:0061842	microtubule organizing center localization	-	32	12	-	-	3.65E-03	2.13E-03
Reactome	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	11	-	-	4.64E-02	1.92E-03
Reactome	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	12	-	-	2.71E-01	2.13E-03
Reactome	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	22	-	-	1.11E-02	3.84E-03
Reactome	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	34	-	-	1.20E-02	5.97E-03
Reactome	BP	GO:0050779	RNA destabilization	-	135	32	-	-	1.50E-01	5.54E-03
Reactome	BP	GO:0006023	aminoglycan biosynthetic process	-	74	14	-	-	5.34E-02	2.56E-03
Reactome	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	11	-	-	7.41E-02	1.92E-03
Reactome	BP	GO:0061025	membrane fusion	-	532	235	-	-	6.22E-02	4.01E-02
Reactome	BP	GO:0010762	regulation of fibroblast migration	-	40	18	-	-	5.21E-03	3.20E-03
Reactome	BP	GO:0090311	regulation of protein deacetylation	-	29	14	-	-	6.63E-02	2.56E-03
Reactome	BP	GO:0035272	exocrine system development	-	46	26	-	-	1.25E-02	4.47E-03
Reactome	BP	GO:0022406	membrane docking	-	90	44	-	-	7.81E-02	7.67E-03
Reactome	BP	GO:0050777	negative regulation of immune response	-	196	110	-	-	1.49E-02	1.88E-02
Reactome	BP	GO:0016053	organic acid biosynthetic process	-	335	88	-	-	8.23E-02	1.51E-02
Reactome	MF	GO:0005035	death receptor activity	-	16	14	-	-	5.05E-02	2.56E-03
Reactome	BP	GO:0002063	chondrocyte development	-	33	14	-	-	1.64E-02	2.56E-03
Reactome	BP	GO:0099068	postsynapse assembly	-	40	19	-	-	2.45E-02	3.41E-03
Reactome	BP	GO:0021782	glial cell development	-	120	65	-	-	2.38E-02	1.11E-02
Reactome	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	45	-	-	1.06E-02	7.67E-03
Reactome	BP	GO:0001655	urogenital system development	-	66	33	-	-	7.13E-03	5.75E-03
Reactome	BP	GO:0071827	plasma lipoprotein particle organization	-	86	38	-	-	6.68E-02	6.61E-03
Reactome	BP	GO:0045494	photoreceptor cell maintenance	-	43	12	-	-	7.04E-02	2.13E-03
Reactome	BP	GO:0055088	lipid homeostasis	-	173	65	-	-	6.31E-02	1.11E-02
Reactome	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	15	-	-	5.52E-03	2.56E-03
Reactome	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	114	-	-	1.23E-02	1.96E-02
Reactome	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	22	-	-	4.52E-02	3.84E-03
Reactome	BP	GO:0045667	regulation of osteoblast differentiation	-	147	79	-	-	3.25E-02	1.36E-02
Reactome	BP	GO:2001212	regulation of vasculogenesis	-	16	11	-	-	1.78E-02	1.92E-03
Reactome	BP	GO:0061037	negative regulation of cartilage development	-	32	17	-	-	3.59E-02	2.98E-03
Reactome	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	206	-	-	3.22E-02	3.52E-02
Reactome	BP	GO:0045738	negative regulation of DNA repair	-	40	14	-	-	6.26E-03	2.56E-03
Reactome	BP	GO:0001704	formation of primary germ layer	-	195	111	-	-	5.57E-02	1.90E-02
Reactome	BP	GO:0045778	positive regulation of ossification	-	51	30	-	-	1.21E-02	5.11E-03
Reactome	BP	GO:0048708	astrocyte differentiation	-	88	62	-	-	1.22E-02	1.07E-02
Reactome	BP	GO:0042092	type 2 immune response	-	41	28	-	-	1.29E-02	4.90E-03
Reactome	BP	GO:0048588	developmental cell growth	-	233	114	-	-	1.43E-02	1.96E-02
Reactome	BP	GO:0021872	forebrain generation of neurons	-	52	23	-	-	2.94E-03	4.05E-03
Reactome	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	11	-	-	6.23E-04	1.92E-03
Reactome	BP	GO:0045023	G0 to G1 transition	-	41	15	-	-	1.15E-01	2.56E-03
Reactome	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	40	-	-	4.42E-02	6.82E-03
Reactome	BP	GO:0034367	protein-containing complex remodeling	-	35	17	-	-	1.96E-01	2.98E-03
Reactome	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	14	-	-	1.67E-03	2.56E-03
Reactome	BP	GO:0010232	vascular transport	-	87	24	-	-	2.54E-02	4.26E-03
Reactome	BP	GO:0021987	cerebral cortex development	-	125	51	-	-	6.63E-03	8.74E-03
Reactome	BP	GO:0008637	apoptotic mitochondrial changes	-	108	50	-	-	5.28E-02	8.52E-03
Reactome	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	22	-	-	2.43E-02	3.84E-03
Reactome	BP	GO:0060999	positive regulation of dendritic spine development	-	35	18	-	-	5.15E-03	3.20E-03
Reactome	BP	GO:2000736	regulation of stem cell differentiation	-	78	45	-	-	1.09E-02	7.67E-03
Reactome	BP	GO:0060973	cell migration involved in heart development	-	21	11	-	-	1.30E-02	1.92E-03
Reactome	BP	GO:0002064	epithelial cell development	-	210	102	-	-	9.45E-03	1.75E-02
Reactome	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	22	-	-	2.54E-02	3.84E-03
Reactome	BP	GO:2001222	regulation of neuron migration	-	46	17	-	-	2.47E-03	2.98E-03
Reactome	BP	GO:0034389	lipid droplet organization	-	38	18	-	-	1.71E-02	3.20E-03
Reactome	BP	GO:0051602	response to electrical stimulus	-	44	25	-	-	1.21E-03	4.26E-03
Reactome	BP	GO:0042177	negative regulation of protein catabolic process	-	109	56	-	-	4.26E-03	9.59E-03
Reactome	MF	GO:0038024	cargo receptor activity	-	121	66	-	-	2.25E-02	1.13E-02
Reactome	BP	GO:0051445	regulation of meiotic cell cycle	-	64	23	-	-	3.59E-03	4.05E-03
Reactome	BP	GO:0033619	membrane protein proteolysis	-	60	38	-	-	1.04E-02	6.61E-03
Reactome	BP	GO:0038065	collagen-activated signaling pathway	-	15	12	-	-	1.35E-01	2.13E-03
Reactome	BP	GO:0090087	regulation of peptide transport	-	195	97	-	-	1.78E-02	1.66E-02
Reactome	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	55	-	-	6.43E-02	9.38E-03
Reactome	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	12	-	-	1.17E-01	2.13E-03
Reactome	BP	GO:0006929	substrate-dependent cell migration	-	26	17	-	-	4.23E-03	2.98E-03
Reactome	BP	GO:0072662	protein localization to peroxisome	-	20	16	-	-	5.90E-01	2.77E-03
Reactome	BP	GO:0022404	molting cycle process	-	95	52	-	-	1.40E-02	8.95E-03
Reactome	BP	GO:1903358	regulation of Golgi organization	-	17	12	-	-	1.24E-02	2.13E-03
Reactome	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	15	-	-	1.06E-02	2.56E-03
Reactome	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	15	-	-	6.89E-03	2.56E-03
Reactome	BP	GO:0007281	germ cell development	-	334	100	-	-	2.84E-02	1.70E-02
Reactome	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	91	-	-	8.63E-02	1.56E-02
Reactome	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	21	-	-	6.25E-03	3.62E-03
Reactome	BP	GO:0034104	negative regulation of tissue remodeling	-	22	12	-	-	6.29E-04	2.13E-03
Reactome	CC	GO:0098926	postsynaptic signal transduction	-	39	23	-	-	2.34E-02	4.05E-03
Reactome	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	77	-	-	2.86E-02	1.32E-02
Reactome	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	27	-	-	2.09E-03	4.69E-03
Reactome	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	73	-	-	1.81E-02	1.26E-02
Reactome	BP	GO:0034249	negative regulation of amide metabolic process	-	34	15	-	-	8.32E-04	2.56E-03
Reactome	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	51	-	-	6.27E-02	8.74E-03
Reactome	BP	GO:0048799	animal organ maturation	-	33	16	-	-	2.83E-03	2.77E-03
Reactome	BP	GO:0006925	inflammatory cell apoptotic process	-	23	15	-	-	3.68E-03	2.56E-03
Reactome	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	94	-	-	1.18E-02	1.62E-02
Reactome	BP	GO:1903035	negative regulation of response to wounding	-	93	58	-	-	6.41E-02	1.00E-02
Reactome	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	19	-	-	8.23E-04	3.41E-03
Reactome	BP	GO:0036010	protein localization to endosome	-	27	15	-	-	8.37E-04	2.56E-03
Reactome	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	42	-	-	1.13E-01	7.24E-03
Reactome	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	44	-	-	1.14E-01	7.67E-03
Reactome	BP	GO:0045056	transcytosis	-	20	13	-	-	6.07E-04	2.34E-03
Reactome	BP	GO:0009267	cellular response to starvation	-	170	101	-	-	5.90E-02	1.73E-02
Reactome	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	34	-	-	1.23E-02	5.97E-03
Reactome	CC	GO:0140239	postsynaptic endocytosis	-	23	13	-	-	1.44E-02	2.34E-03
Reactome	BP	GO:0046931	pore complex assembly	-	21	11	-	-	6.16E-02	1.92E-03
Reactome	CC	GO:0032008	positive regulation of TOR signaling	-	52	23	-	-	4.79E-02	4.05E-03
Reactome	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	15	-	-	4.84E-01	2.56E-03
Reactome	BP	GO:0060428	lung epithelium development	-	43	24	-	-	8.50E-03	4.26E-03
Reactome	BP	GO:0030431	sleep	-	30	15	-	-	6.71E-02	2.56E-03
Reactome	BP	GO:1903318	negative regulation of protein maturation	-	29	18	-	-	1.28E-02	3.20E-03
Reactome	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	25	-	-	5.06E-01	4.26E-03
Reactome	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	45	-	-	7.84E-03	7.67E-03
Reactome	BP	GO:0065004	protein-DNA complex assembly	-	307	101	-	-	4.68E-02	1.73E-02
Reactome	CC	GO:0006406	mRNA export from nucleus	-	69	21	-	-	8.05E-02	3.62E-03
Reactome	BP	GO:0009880	embryonic pattern specification	-	70	34	-	-	1.29E-02	5.97E-03
Reactome	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	12	-	-	3.29E-01	2.13E-03
Reactome	BP	GO:0002367	cytokine production involved in immune response	-	121	83	-	-	3.13E-02	1.43E-02
Reactome	BP	GO:0044848	biological phase	-	211	107	-	-	9.55E-02	1.83E-02
Reactome	BP	GO:0046660	female sex differentiation	-	125	75	-	-	4.15E-02	1.28E-02
Reactome	BP	GO:0019693	ribose phosphate metabolic process	-	556	154	-	-	1.10E-01	2.64E-02
Reactome	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	24	-	-	1.35E-03	4.26E-03
Reactome	BP	GO:0060411	cardiac septum morphogenesis	-	72	49	-	-	2.67E-02	8.52E-03
Reactome	BP	GO:0071248	cellular response to metal ion	-	201	93	-	-	1.27E-02	1.60E-02
Reactome	BP	GO:0030308	negative regulation of cell growth	-	191	93	-	-	1.35E-02	1.60E-02
Reactome	BP	GO:0097306	cellular response to alcohol	-	99	52	-	-	3.31E-02	8.95E-03
Reactome	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	65	-	-	2.82E-01	1.11E-02
Reactome	BP	GO:0010453	regulation of cell fate commitment	-	40	22	-	-	3.77E-02	3.84E-03
Reactome	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	34	-	-	3.58E-02	5.97E-03
Reactome	BP	GO:0002026	regulation of the force of heart contraction	-	26	18	-	-	1.36E-01	3.20E-03
Reactome	BP	GO:0032890	regulation of organic acid transport	-	78	38	-	-	1.08E-02	6.61E-03
Reactome	BP	GO:0071498	cellular response to fluid shear stress	-	21	12	-	-	1.03E-02	2.13E-03
Reactome	BP	GO:0098771	inorganic ion homeostasis	-	531	234	-	-	8.30E-02	4.01E-02
Reactome	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	47	-	-	1.05E-02	8.10E-03
Reactome	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	16	-	-	4.69E-03	2.77E-03
Reactome	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	22	-	-	1.20E-02	3.84E-03
Reactome	BP	GO:0051259	protein complex oligomerization	-	251	92	-	-	1.96E-02	1.58E-02
Reactome	BP	GO:0009994	oocyte differentiation	-	57	28	-	-	1.58E-02	4.90E-03
Reactome	MF	GO:0031952	regulation of protein autophosphorylation	-	43	25	-	-	3.61E-03	4.26E-03
Reactome	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	11	-	-	1.05E-02	1.92E-03
Reactome	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	55	-	-	3.72E-02	9.38E-03
Reactome	BP	GO:0044319	"wound healing, spreading of cells"	-	37	22	-	-	4.34E-03	3.84E-03
Reactome	BP	GO:0033688	regulation of osteoblast proliferation	-	31	17	-	-	8.15E-04	2.98E-03
Reactome	BP	GO:0060251	regulation of glial cell proliferation	-	39	27	-	-	1.74E-03	4.69E-03
Reactome	BP	GO:0072665	protein localization to vacuole	-	84	51	-	-	1.62E-01	8.74E-03
Reactome	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	24	-	-	2.35E-02	4.26E-03
Reactome	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	15	-	-	1.40E-02	2.56E-03
Reactome	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	22	-	-	5.60E-02	3.84E-03
Reactome	BP	GO:0042953	lipoprotein transport	-	20	13	-	-	5.06E-02	2.34E-03
Reactome	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	11	-	-	8.64E-02	1.92E-03
Reactome	BP	GO:0042044	fluid transport	-	35	12	-	-	7.52E-02	2.13E-03
Reactome	BP	GO:0070633	transepithelial transport	-	35	14	-	-	1.65E-02	2.56E-03
Reactome	BP	GO:0045661	regulation of myoblast differentiation	-	74	35	-	-	2.02E-02	5.97E-03
Reactome	BP	GO:0030307	positive regulation of cell growth	-	164	91	-	-	9.90E-03	1.56E-02
Reactome	BP	GO:0034250	positive regulation of amide metabolic process	-	27	14	-	-	7.04E-03	2.56E-03
Reactome	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	188	-	-	3.60E-02	3.22E-02
Reactome	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	11	-	-	6.29E-04	1.92E-03
Reactome	BP	GO:0014812	muscle cell migration	-	110	53	-	-	2.39E-02	9.16E-03
Reactome	BP	GO:0048525	negative regulation of viral process	-	90	35	-	-	5.24E-03	5.97E-03
Reactome	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	34	-	-	1.46E-01	5.97E-03
Reactome	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	82	-	-	1.26E-01	1.41E-02
Reactome	BP	GO:0051781	positive regulation of cell division	-	93	58	-	-	9.11E-02	1.00E-02
Reactome	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	13	-	-	5.99E-02	2.34E-03
Reactome	BP	GO:0002696	positive regulation of leukocyte activation	-	358	245	-	-	5.83E-02	4.18E-02
Reactome	BP	GO:0060711	labyrinthine layer development	-	47	26	-	-	2.63E-03	4.47E-03
Reactome	BP	GO:0007272	ensheathment of neurons	-	146	73	-	-	2.46E-02	1.26E-02
Reactome	CC	GO:0050806	positive regulation of synaptic transmission	-	171	96	-	-	1.84E-02	1.64E-02
Reactome	BP	GO:0060021	roof of mouth development	-	91	40	-	-	1.28E-02	6.82E-03
Reactome	BP	GO:0034504	protein localization to nucleus	-	312	151	-	-	2.03E-02	2.58E-02
Reactome	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	19	-	-	1.54E-02	3.41E-03
Reactome	BP	GO:0050819	negative regulation of coagulation	-	54	40	-	-	8.91E-02	6.82E-03
Reactome	BP	GO:0031647	regulation of protein stability	-	327	155	-	-	2.78E-02	2.64E-02
Reactome	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	15	-	-	1.89E-02	2.56E-03
Reactome	CC	GO:0050805	negative regulation of synaptic transmission	-	55	24	-	-	3.63E-03	4.26E-03
Reactome	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	22	-	-	1.03E-03	3.84E-03
Reactome	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	51	-	-	3.43E-02	8.74E-03
Reactome	BP	GO:0016054	organic acid catabolic process	-	251	67	-	-	9.59E-02	1.15E-02
Reactome	BP	GO:0050890	cognition	-	317	158	-	-	1.81E-02	2.71E-02
Reactome	BP	GO:1900048	positive regulation of hemostasis	-	28	21	-	-	9.83E-02	3.62E-03
Reactome	BP	GO:0065005	protein-lipid complex assembly	-	29	15	-	-	1.71E-01	2.56E-03
Reactome	BP	GO:0008033	tRNA processing	-	136	34	-	-	5.30E-01	5.97E-03
Reactome	BP	GO:0046661	male sex differentiation	-	171	94	-	-	5.88E-02	1.62E-02
Reactome	BP	GO:0072520	seminiferous tubule development	-	15	11	-	-	8.99E-03	1.92E-03
Reactome	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	13	-	-	5.76E-03	2.34E-03
Reactome	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	46	-	-	1.25E-02	7.88E-03
Reactome	BP	GO:1990778	protein localization to cell periphery	-	346	180	-	-	2.30E-02	3.07E-02
Reactome	BP	GO:0090713	immunological memory process	-	18	12	-	-	1.25E-01	2.13E-03
Reactome	BP	GO:0061326	renal tubule development	-	103	48	-	-	1.34E-02	8.31E-03
Reactome	BP	GO:0051258	protein polymerization	-	280	112	-	-	7.25E-02	1.92E-02
Reactome	BP	GO:0071985	multivesicular body sorting pathway	-	56	29	-	-	5.71E-01	5.11E-03
Reactome	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	11	-	-	2.13E-02	1.92E-03
Reactome	BP	GO:0060325	face morphogenesis	-	31	18	-	-	1.76E-03	3.20E-03
Reactome	BP	GO:0090559	regulation of membrane permeability	-	72	29	-	-	1.17E-02	5.11E-03
Reactome	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	12	-	-	1.98E-02	2.13E-03
Reactome	BP	GO:0031579	membrane raft organization	-	25	13	-	-	1.02E-01	2.34E-03
Reactome	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	15	-	-	8.92E-03	2.56E-03
Reactome	BP	GO:0046460	neutral lipid biosynthetic process	-	50	15	-	-	9.29E-02	2.56E-03
Reactome	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	23	-	-	9.07E-02	4.05E-03
Reactome	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	89	-	-	1.25E-02	1.53E-02
Reactome	BP	GO:0002251	organ or tissue specific immune response	-	43	16	-	-	3.01E-02	2.77E-03
Reactome	CC	GO:0048167	regulation of synaptic plasticity	-	210	107	-	-	2.04E-02	1.83E-02
Reactome	BP	GO:1903708	positive regulation of hemopoiesis	-	184	118	-	-	2.49E-02	2.02E-02
Reactome	BP	GO:1903008	organelle disassembly	-	154	76	-	-	5.45E-02	1.30E-02
Reactome	BP	GO:0001709	cell fate determination	-	44	20	-	-	1.22E-02	3.41E-03
Reactome	BP	GO:0051873	killing by host of symbiont cells	-	28	16	-	-	1.72E-02	2.77E-03
Reactome	BP	GO:0045058	T cell selection	-	53	43	-	-	2.56E-02	7.46E-03
Reactome	CC	GO:0032387	negative regulation of intracellular transport	-	51	26	-	-	6.68E-03	4.47E-03
Reactome	BP	GO:0072091	regulation of stem cell proliferation	-	91	51	-	-	5.13E-03	8.74E-03
Reactome	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	11	-	-	1.94E-01	1.92E-03
Reactome	BP	GO:0099084	postsynaptic specialization organization	-	44	24	-	-	2.60E-02	4.26E-03
Reactome	BP	GO:0060384	innervation	-	27	17	-	-	1.68E-02	2.98E-03
Reactome	BP	GO:0032535	regulation of cellular component size	-	360	153	-	-	3.67E-02	2.62E-02
Reactome	MF	GO:0031281	positive regulation of cyclase activity	-	40	28	-	-	2.30E-02	4.90E-03
Reactome	MF	GO:0098631	cell adhesion mediator activity	-	64	35	-	-	2.93E-02	5.97E-03
Reactome	BP	GO:0071453	cellular response to oxygen levels	-	168	92	-	-	1.06E-02	1.58E-02
Reactome	BP	GO:0090399	replicative senescence	-	17	13	-	-	7.31E-03	2.34E-03
Reactome	BP	GO:0031342	negative regulation of cell killing	-	29	23	-	-	1.05E-01	4.05E-03
Reactome	BP	GO:0070585	protein localization to mitochondrion	-	125	55	-	-	1.22E-01	9.38E-03
Reactome	BP	GO:0010623	programmed cell death involved in cell development	-	25	20	-	-	2.13E-03	3.41E-03
Reactome	BP	GO:0044242	cellular lipid catabolic process	-	224	76	-	-	5.46E-02	1.30E-02
Reactome	BP	GO:0002931	response to ischemia	-	58	34	-	-	8.46E-02	5.97E-03
Reactome	BP	GO:0043062	extracellular structure organization	-	317	140	-	-	6.83E-02	2.39E-02
Reactome	BP	GO:0014047	glutamate secretion	-	25	15	-	-	4.34E-02	2.56E-03
Reactome	BP	GO:0061005	cell differentiation involved in kidney development	-	58	34	-	-	8.06E-03	5.97E-03
Reactome	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	189	-	-	3.31E-02	3.24E-02
Reactome	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	51	-	-	1.95E-01	8.74E-03
Reactome	BP	GO:0060420	regulation of heart growth	-	74	43	-	-	1.15E-02	7.46E-03
Reactome	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	11	-	-	6.27E-04	1.92E-03
Reactome	BP	GO:0009755	hormone-mediated signaling pathway	-	221	125	-	-	3.03E-02	2.13E-02
Reactome	BP	GO:0022612	gland morphogenesis	-	124	81	-	-	1.23E-02	1.39E-02
Reactome	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	14	-	-	6.32E-04	2.56E-03
Reactome	MF	GO:0140416	transcription regulator inhibitor activity	-	26	11	-	-	6.30E-04	1.92E-03
Reactome	BP	GO:0044782	cilium organization	-	400	72	-	-	3.94E-02	1.24E-02
Reactome	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	12	-	-	1.68E-01	2.13E-03
Reactome	BP	GO:0090130	tissue migration	-	379	171	-	-	2.89E-02	2.92E-02
Reactome	BP	GO:1990845	adaptive thermogenesis	-	166	88	-	-	2.81E-02	1.51E-02
Reactome	BP	GO:0071320	cellular response to cAMP	-	54	27	-	-	3.28E-02	4.69E-03
Reactome	BP	GO:0015844	monoamine transport	-	88	37	-	-	3.21E-02	6.39E-03
Reactome	BP	GO:0060039	pericardium development	-	19	12	-	-	4.67E-03	2.13E-03
Reactome	BP	GO:0071392	cellular response to estradiol stimulus	-	40	23	-	-	3.91E-03	4.05E-03
Reactome	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	12	-	-	6.48E-03	2.13E-03
Reactome	BP	GO:0009451	RNA modification	-	169	42	-	-	3.43E-01	7.24E-03
Reactome	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	26	-	-	4.20E-03	4.47E-03
Reactome	BP	GO:1903729	regulation of plasma membrane organization	-	17	11	-	-	4.21E-02	1.92E-03
Reactome	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	54	-	-	3.46E-02	9.38E-03
Reactome	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	31	-	-	1.76E-02	5.33E-03
Reactome	BP	GO:0015807	L-amino acid transport	-	94	25	-	-	9.01E-02	4.26E-03
Reactome	BP	GO:0032941	secretion by tissue	-	85	32	-	-	4.92E-03	5.54E-03
Reactome	BP	GO:0046605	regulation of centrosome cycle	-	54	23	-	-	3.63E-02	4.05E-03
Reactome	BP	GO:0048753	pigment granule organization	-	40	14	-	-	7.43E-02	2.56E-03
Reactome	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	12	-	-	6.36E-04	2.13E-03
Reactome	BP	GO:0003014	renal system process	-	130	67	-	-	2.64E-02	1.15E-02
Reactome	BP	GO:0045598	regulation of fat cell differentiation	-	148	64	-	-	1.06E-02	1.11E-02
Reactome	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	111	-	-	3.30E-02	1.90E-02
Reactome	BP	GO:1904646	cellular response to amyloid-beta	-	44	30	-	-	4.91E-03	5.11E-03
Reactome	BP	GO:1901863	positive regulation of muscle tissue development	-	24	20	-	-	1.30E-02	3.41E-03
Reactome	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	123	-	-	1.60E-01	2.11E-02
Reactome	BP	GO:0008340	determination of adult lifespan	-	23	11	-	-	5.58E-03	1.92E-03
Reactome	BP	GO:0039694	viral RNA genome replication	-	30	13	-	-	2.04E-02	2.34E-03
Reactome	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	14	-	-	1.37E-02	2.56E-03
Reactome	BP	GO:0071709	membrane assembly	-	68	32	-	-	5.29E-02	5.54E-03
Reactome	BP	GO:0008217	regulation of blood pressure	-	186	116	-	-	7.38E-02	1.98E-02
Reactome	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	42	-	-	3.73E-02	7.24E-03
Reactome	CC	GO:0042770	signal transduction in response to DNA damage	-	186	108	-	-	5.04E-02	1.85E-02
Reactome	BP	GO:0002200	somatic diversification of immune receptors	-	78	51	-	-	1.35E-01	8.74E-03
Reactome	BP	GO:0035315	hair cell differentiation	-	52	24	-	-	1.52E-02	4.26E-03
Reactome	BP	GO:0048645	animal organ formation	-	62	42	-	-	9.36E-03	7.24E-03
Reactome	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	90	-	-	2.54E-02	1.53E-02
Reactome	BP	GO:0033627	cell adhesion mediated by integrin	-	87	54	-	-	6.33E-02	9.38E-03
Reactome	BP	GO:0035107	appendage morphogenesis	-	147	64	-	-	1.33E-02	1.11E-02
Reactome	BP	GO:1903707	negative regulation of hemopoiesis	-	116	63	-	-	6.50E-03	1.09E-02
Reactome	BP	GO:0036342	post-anal tail morphogenesis	-	19	12	-	-	7.19E-02	2.13E-03
Reactome	CC	GO:0048208	COPII vesicle coating	-	27	11	-	-	5.27E-02	1.92E-03
Reactome	BP	GO:0030149	sphingolipid catabolic process	-	32	12	-	-	1.45E-01	2.13E-03
Reactome	BP	GO:0050994	regulation of lipid catabolic process	-	61	34	-	-	1.91E-02	5.97E-03
Reactome	BP	GO:0035988	chondrocyte proliferation	-	24	14	-	-	8.77E-03	2.56E-03
Reactome	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	15	-	-	8.50E-04	2.56E-03
Reactome	BP	GO:0009593	detection of chemical stimulus	-	511	34	-	-	5.46E-02	5.97E-03
Reactome	BP	GO:0045727	positive regulation of translation	-	141	51	-	-	1.09E-02	8.74E-03
Reactome	BP	GO:0036315	cellular response to sterol	-	24	11	-	-	3.18E-02	1.92E-03
Reactome	CC	GO:0032388	positive regulation of intracellular transport	-	137	75	-	-	4.51E-03	1.28E-02
Reactome	BP	GO:0002027	regulation of heart rate	-	106	52	-	-	1.75E-01	8.95E-03
Reactome	BP	GO:0050879	multicellular organismal movement	-	118	58	-	-	1.15E-01	1.00E-02
Reactome	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	54	-	-	7.88E-03	9.38E-03
Reactome	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	34	-	-	2.09E-02	5.97E-03
Reactome	BP	GO:0048515	spermatid differentiation	-	208	46	-	-	6.19E-02	7.88E-03
Reactome	BP	GO:0072132	mesenchyme morphogenesis	-	57	32	-	-	1.25E-02	5.54E-03
Reactome	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	21	-	-	8.72E-02	3.62E-03
Reactome	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	18	-	-	2.93E-03	3.20E-03
Reactome	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	11	-	-	7.56E-02	1.92E-03
Reactome	BP	GO:0060119	inner ear receptor cell development	-	44	18	-	-	1.22E-01	3.20E-03
Reactome	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	16	-	-	1.23E-01	2.77E-03
Reactome	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	17	-	-	6.37E-02	2.98E-03
Reactome	BP	GO:1901983	regulation of protein acetylation	-	26	14	-	-	1.26E-03	2.56E-03
Reactome	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	170	-	-	3.19E-02	2.90E-02
Reactome	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	22	-	-	1.03E-01	3.84E-03
Reactome	BP	GO:0010883	regulation of lipid storage	-	53	32	-	-	3.14E-03	5.54E-03
Reactome	BP	GO:1905954	positive regulation of lipid localization	-	110	59	-	-	2.18E-02	1.02E-02
Reactome	BP	GO:0002209	behavioral defense response	-	39	20	-	-	1.76E-03	3.41E-03
Reactome	BP	GO:0072523	purine-containing compound catabolic process	-	146	51	-	-	3.68E-02	8.74E-03
Reactome	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	23	-	-	2.18E-02	4.05E-03
Reactome	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	14	-	-	6.26E-04	2.56E-03
Reactome	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	44	-	-	3.48E-02	7.67E-03
Reactome	BP	GO:0007218	neuropeptide signaling pathway	-	113	74	-	-	3.01E-01	1.28E-02
Reactome	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	110	-	-	2.96E-02	1.88E-02
Reactome	BP	GO:0031345	negative regulation of cell projection organization	-	195	86	-	-	1.60E-02	1.47E-02
Reactome	BP	GO:0048278	vesicle docking	-	64	27	-	-	7.80E-02	4.69E-03
Reactome	BP	GO:0035050	embryonic heart tube development	-	86	40	-	-	1.61E-02	6.82E-03
Reactome	BP	GO:0030168	platelet activation	-	135	92	-	-	2.52E-02	1.58E-02
Reactome	CC	GO:0098810	neurotransmitter reuptake	-	35	12	-	-	4.69E-03	2.13E-03
Reactome	BP	GO:0008213	protein alkylation	-	58	26	-	-	8.67E-02	4.47E-03
Reactome	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	11	-	-	1.67E-02	1.92E-03
Reactome	BP	GO:0031338	regulation of vesicle fusion	-	24	13	-	-	8.63E-03	2.34E-03
Reactome	BP	GO:0031529	ruffle organization	-	55	19	-	-	6.59E-03	3.41E-03
Reactome	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	35	-	-	7.10E-02	5.97E-03
Reactome	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	34	-	-	4.14E-02	5.97E-03
Reactome	MF	GO:0170055	lipid transmembrane transporter activity	-	56	15	-	-	9.27E-02	2.56E-03
Reactome	BP	GO:0035304	regulation of protein dephosphorylation	-	87	49	-	-	7.86E-03	8.52E-03
Reactome	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	119	-	-	1.94E-02	2.05E-02
Reactome	BP	GO:0099637	neurotransmitter receptor transport	-	26	13	-	-	6.00E-03	2.34E-03
Reactome	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	18	-	-	7.07E-03	3.20E-03
Reactome	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	245	-	-	6.28E-02	4.18E-02
Reactome	BP	GO:0051785	positive regulation of nuclear division	-	61	36	-	-	4.17E-03	6.18E-03
Reactome	BP	GO:0060749	mammary gland alveolus development	-	20	14	-	-	7.02E-03	2.56E-03
Reactome	BP	GO:0044786	cell cycle DNA replication	-	45	29	-	-	1.40E-01	5.11E-03
Reactome	BP	GO:0048145	regulation of fibroblast proliferation	-	87	58	-	-	6.61E-03	1.00E-02
Reactome	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	51	-	-	3.68E-01	8.74E-03
Reactome	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	135	-	-	2.22E-02	2.30E-02
Reactome	BP	GO:0009306	protein secretion	-	376	169	-	-	1.54E-02	2.90E-02
Reactome	CC	GO:0008333	endosome to lysosome transport	-	73	26	-	-	3.59E-02	4.47E-03
Reactome	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	14	-	-	5.33E-02	2.56E-03
Reactome	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	16	-	-	8.16E-03	2.77E-03
Reactome	BP	GO:0045732	positive regulation of protein catabolic process	-	202	114	-	-	1.03E-02	1.96E-02
Reactome	BP	GO:0031589	cell-substrate adhesion	-	360	200	-	-	5.82E-02	3.41E-02
Reactome	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	13	-	-	1.93E-01	2.34E-03
Reactome	BP	GO:0007588	excretion	-	40	24	-	-	1.67E-02	4.26E-03
Reactome	BP	GO:1904018	positive regulation of vasculature development	-	185	105	-	-	1.67E-02	1.79E-02
Reactome	BP	GO:0010948	negative regulation of cell cycle process	-	317	151	-	-	1.04E-01	2.58E-02
Reactome	BP	GO:0050953	sensory perception of light stimulus	-	223	58	-	-	2.48E-01	1.00E-02
Reactome	BP	GO:0035601	protein deacylation	-	56	33	-	-	1.46E-02	5.75E-03
Reactome	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	14	-	-	1.90E-02	2.56E-03
Reactome	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	19	-	-	1.73E-03	3.41E-03
Reactome	BP	GO:0071300	cellular response to retinoic acid	-	66	34	-	-	5.93E-03	5.97E-03
Reactome	BP	GO:0045830	positive regulation of isotype switching	-	28	20	-	-	1.23E-02	3.41E-03
Reactome	BP	GO:0031069	hair follicle morphogenesis	-	33	19	-	-	1.36E-02	3.41E-03
Reactome	BP	GO:0046697	decidualization	-	26	13	-	-	3.23E-02	2.34E-03
Reactome	BP	GO:0048284	organelle fusion	-	456	199	-	-	5.62E-02	3.41E-02
Reactome	BP	GO:0051588	regulation of neurotransmitter transport	-	99	46	-	-	1.00E-02	7.88E-03
Reactome	BP	GO:0051784	negative regulation of nuclear division	-	63	33	-	-	1.86E-01	5.75E-03
Reactome	BP	GO:0044703	multi-organism reproductive process	-	209	111	-	-	3.54E-02	1.90E-02
Reactome	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	85	-	-	2.56E-02	1.45E-02
Reactome	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	29	-	-	1.83E-02	5.11E-03
Reactome	MF	GO:0004930	G protein-coupled receptor activity	-	873	165	-	-	1.32E-02	2.81E-02
Reactome	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	12	-	-	2.91E-02	2.13E-03
Reactome	BP	GO:0048857	neural nucleus development	-	65	27	-	-	3.89E-03	4.69E-03
Reactome	BP	GO:0048663	neuron fate commitment	-	74	28	-	-	1.88E-02	4.90E-03
Reactome	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	70	-	-	1.19E-01	1.19E-02
Reactome	BP	GO:0106027	neuron projection organization	-	90	53	-	-	1.02E-02	9.16E-03
Reactome	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	68	-	-	2.84E-02	1.17E-02
Reactome	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	21	-	-	1.04E-01	3.62E-03
Reactome	BP	GO:0045685	regulation of glial cell differentiation	-	77	43	-	-	7.14E-03	7.46E-03
Reactome	BP	GO:0043414	macromolecule methylation	-	138	40	-	-	4.65E-02	6.82E-03
Reactome	BP	GO:0050886	endocrine process	-	93	66	-	-	5.32E-02	1.13E-02
Reactome	BP	GO:0050951	sensory perception of temperature stimulus	-	28	11	-	-	1.20E-02	1.92E-03
Reactome	BP	GO:0045807	positive regulation of endocytosis	-	155	106	-	-	1.67E-02	1.81E-02
Reactome	BP	GO:0002418	immune response to tumor cell	-	29	16	-	-	6.69E-02	2.77E-03
Reactome	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	36	-	-	7.06E-03	6.18E-03
Reactome	BP	GO:0048308	organelle inheritance	-	14	12	-	-	1.21E-02	2.13E-03
Reactome	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	11	-	-	6.39E-03	1.92E-03
Reactome	BP	GO:0034394	protein localization to cell surface	-	69	46	-	-	2.41E-03	7.88E-03
Reactome	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	15	-	-	1.01E-01	2.56E-03
Reactome	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	68	-	-	8.12E-03	1.17E-02
Reactome	MF	GO:0051100	negative regulation of binding	-	161	92	-	-	7.16E-03	1.58E-02
Reactome	BP	GO:0001818	negative regulation of cytokine production	-	379	162	-	-	1.51E-02	2.77E-02
Reactome	BP	GO:0003151	outflow tract morphogenesis	-	81	57	-	-	1.63E-02	9.80E-03
Reactome	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	38	-	-	9.74E-03	6.61E-03
Reactome	BP	GO:0055093	response to hyperoxia	-	20	15	-	-	4.10E-03	2.56E-03
Reactome	BP	GO:0061036	positive regulation of cartilage development	-	33	17	-	-	3.98E-02	2.98E-03
Reactome	BP	GO:1901857	positive regulation of cellular respiration	-	13	11	-	-	8.87E-03	1.92E-03
Reactome	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	28	-	-	1.02E-02	4.90E-03
Reactome	BP	GO:0046621	negative regulation of organ growth	-	39	23	-	-	1.62E-02	4.05E-03
Reactome	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	14	-	-	6.12E-02	2.56E-03
Reactome	BP	GO:0032368	regulation of lipid transport	-	149	78	-	-	2.22E-02	1.34E-02
Reactome	BP	GO:0055094	response to lipoprotein particle	-	34	23	-	-	4.50E-03	4.05E-03
Reactome	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	91	-	-	1.13E-02	1.56E-02
Reactome	BP	GO:0033002	muscle cell proliferation	-	249	145	-	-	1.53E-02	2.47E-02
Reactome	BP	GO:0048880	sensory system development	-	399	157	-	-	2.06E-02	2.68E-02
Reactome	BP	GO:0043331	response to dsRNA	-	56	28	-	-	8.51E-03	4.90E-03
Reactome	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	26	-	-	2.37E-03	4.47E-03
Reactome	BP	GO:0033363	secretory granule organization	-	63	22	-	-	2.95E-02	3.84E-03
Reactome	BP	GO:0060479	lung cell differentiation	-	28	15	-	-	5.04E-03	2.56E-03
Reactome	BP	GO:0120009	intermembrane lipid transfer	-	52	18	-	-	8.65E-02	3.20E-03
Reactome	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	25	-	-	1.01E-02	4.26E-03
Reactome	BP	GO:0033622	integrin activation	-	26	14	-	-	3.42E-02	2.56E-03
Reactome	BP	GO:0098751	bone cell development	-	18	12	-	-	1.55E-02	2.13E-03
Reactome	BP	GO:2000773	negative regulation of cellular senescence	-	25	16	-	-	3.14E-03	2.77E-03
Reactome	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	31	-	-	2.01E-02	5.33E-03
Reactome	BP	GO:0050820	positive regulation of coagulation	-	30	22	-	-	5.32E-02	3.84E-03
Reactome	BP	GO:0002076	osteoblast development	-	17	13	-	-	2.62E-02	2.34E-03
Reactome	BP	GO:0072164	mesonephric tubule development	-	98	51	-	-	1.66E-02	8.74E-03
Reactome	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	73	-	-	2.07E-02	1.26E-02
Reactome	BP	GO:1903524	positive regulation of blood circulation	-	39	23	-	-	1.04E-03	4.05E-03
Reactome	BP	GO:0030901	midbrain development	-	87	39	-	-	1.73E-02	6.82E-03
Reactome	BP	GO:0048485	sympathetic nervous system development	-	22	16	-	-	9.58E-03	2.77E-03
Reactome	BP	GO:0007162	negative regulation of cell adhesion	-	310	166	-	-	1.88E-02	2.83E-02
Reactome	BP	GO:0048532	anatomical structure arrangement	-	16	12	-	-	8.85E-03	2.13E-03
Reactome	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	11	-	-	9.04E-03	1.92E-03
Reactome	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	46	-	-	2.17E-02	7.88E-03
Reactome	BP	GO:0002687	positive regulation of leukocyte migration	-	147	102	-	-	2.00E-02	1.75E-02
Reactome	BP	GO:0034605	cellular response to heat	-	66	41	-	-	5.81E-02	7.03E-03
Reactome	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	148	-	-	6.27E-02	2.54E-02
Reactome	BP	GO:0005996	monosaccharide metabolic process	-	250	95	-	-	3.66E-02	1.62E-02
Reactome	BP	GO:0033555	multicellular organismal response to stress	-	90	47	-	-	1.21E-02	8.10E-03
Reactome	BP	GO:0002262	myeloid cell homeostasis	-	172	87	-	-	1.07E-02	1.49E-02
Reactome	BP	GO:0050688	regulation of defense response to virus	-	65	37	-	-	3.70E-02	6.39E-03
Reactome	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	198	-	-	1.05E-01	3.39E-02
Reactome	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	16	-	-	8.35E-04	2.77E-03
Reactome	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	150	-	-	5.67E-02	2.56E-02
Reactome	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	19	-	-	1.84E-02	3.41E-03
Reactome	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	24	-	-	6.82E-03	4.26E-03
Reactome	BP	GO:0003272	endocardial cushion formation	-	28	13	-	-	6.79E-03	2.34E-03
Reactome	BP	GO:0022618	protein-RNA complex assembly	-	227	37	-	-	1.32E-01	6.39E-03
Reactome	BP	GO:0051147	regulation of muscle cell differentiation	-	162	81	-	-	1.38E-02	1.39E-02
Reactome	BP	GO:0006066	alcohol metabolic process	-	374	122	-	-	1.32E-01	2.09E-02
Reactome	BP	GO:0090102	cochlea development	-	50	21	-	-	5.42E-03	3.62E-03
Reactome	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	16	-	-	5.72E-03	2.77E-03
Reactome	BP	GO:0045933	positive regulation of muscle contraction	-	49	30	-	-	1.64E-02	5.11E-03
Reactome	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	14	-	-	1.09E-02	2.56E-03
Reactome	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	27	-	-	1.03E-01	4.69E-03
Reactome	BP	GO:0043555	regulation of translation in response to stress	-	22	17	-	-	5.40E-02	2.98E-03
Reactome	BP	GO:0032922	circadian regulation of gene expression	-	71	44	-	-	1.63E-01	7.67E-03
Reactome	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	21	-	-	1.57E-02	3.62E-03
Reactome	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	40	-	-	5.14E-02	6.82E-03
Reactome	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	31	-	-	1.43E-02	5.33E-03
Reactome	BP	GO:0038179	neurotrophin signaling pathway	-	38	25	-	-	1.88E-02	4.26E-03
Reactome	BP	GO:0140253	cell-cell fusion	-	62	36	-	-	8.28E-03	6.18E-03
Reactome	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	30	-	-	2.04E-01	5.11E-03
Reactome	BP	GO:0001941	postsynaptic membrane organization	-	37	16	-	-	4.08E-02	2.77E-03
Reactome	BP	GO:0051293	establishment of spindle localization	-	57	26	-	-	2.30E-03	4.47E-03
Reactome	BP	GO:0023061	signal release	-	491	238	-	-	3.57E-02	4.07E-02
Reactome	BP	GO:0043114	regulation of vascular permeability	-	49	29	-	-	5.35E-03	5.11E-03
Reactome	BP	GO:0018126	protein hydroxylation	-	26	18	-	-	7.31E-02	3.20E-03
Reactome	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	35	-	-	1.05E-02	5.97E-03
Reactome	BP	GO:0008360	regulation of cell shape	-	139	73	-	-	2.71E-02	1.26E-02
Reactome	BP	GO:0051222	positive regulation of protein transport	-	249	129	-	-	1.54E-02	2.22E-02
Reactome	CC	GO:0140632	canonical inflammasome complex assembly	-	40	23	-	-	2.64E-02	4.05E-03
Reactome	MF	GO:0034260	negative regulation of GTPase activity	-	36	14	-	-	6.23E-04	2.56E-03
Reactome	BP	GO:0045932	negative regulation of muscle contraction	-	24	14	-	-	4.44E-03	2.56E-03
Reactome	BP	GO:0045739	positive regulation of DNA repair	-	128	59	-	-	6.52E-02	1.02E-02
Reactome	BP	GO:0045185	maintenance of protein location	-	95	43	-	-	7.54E-03	7.46E-03
Reactome	BP	GO:0003158	endothelium development	-	140	70	-	-	1.05E-02	1.19E-02
Reactome	CC	GO:0072595	maintenance of protein localization in organelle	-	42	21	-	-	7.58E-03	3.62E-03
Reactome	BP	GO:0051224	negative regulation of protein transport	-	122	54	-	-	1.07E-02	9.38E-03
Reactome	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	75	-	-	8.22E-03	1.28E-02
Reactome	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	17	-	-	3.79E-02	2.98E-03
Reactome	MF	GO:0003713	transcription coactivator activity	-	281	118	-	-	2.86E-02	2.02E-02
Reactome	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	12	-	-	2.40E-01	2.13E-03
Reactome	BP	GO:0021885	forebrain cell migration	-	63	31	-	-	8.35E-03	5.33E-03
Reactome	BP	GO:0007405	neuroblast proliferation	-	81	40	-	-	9.98E-03	6.82E-03
Reactome	BP	GO:0009581	detection of external stimulus	-	137	55	-	-	1.32E-01	9.38E-03
Reactome	BP	GO:1990542	mitochondrial transmembrane transport	-	93	15	-	-	7.62E-02	2.56E-03
Reactome	BP	GO:0045862	positive regulation of proteolysis	-	353	192	-	-	3.18E-02	3.28E-02
Reactome	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	17	-	-	1.52E-02	2.98E-03
Reactome	BP	GO:0097186	amelogenesis	-	26	11	-	-	3.39E-02	1.92E-03
Reactome	BP	GO:0031128	developmental induction	-	26	16	-	-	1.98E-03	2.77E-03
Reactome	BP	GO:0031100	animal organ regeneration	-	66	42	-	-	3.79E-03	7.24E-03
Reactome	BP	GO:0045684	positive regulation of epidermis development	-	33	11	-	-	3.69E-02	1.92E-03
Reactome	BP	GO:1900047	negative regulation of hemostasis	-	51	40	-	-	9.72E-02	6.82E-03
Reactome	BP	GO:0021517	ventral spinal cord development	-	47	16	-	-	6.05E-02	2.77E-03
Reactome	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	44	-	-	2.33E-02	7.67E-03
Reactome	BP	GO:0097722	sperm motility	-	133	23	-	-	9.74E-02	4.05E-03
Reactome	BP	GO:0051231	spindle elongation	-	14	11	-	-	4.24E-01	1.92E-03
Reactome	BP	GO:0042490	mechanoreceptor differentiation	-	67	30	-	-	4.31E-02	5.11E-03
Reactome	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	12	-	-	3.16E-03	2.13E-03
Reactome	BP	GO:0035148	tube formation	-	155	74	-	-	1.95E-02	1.28E-02
Reactome	BP	GO:0048520	positive regulation of behavior	-	27	19	-	-	6.99E-02	3.41E-03
Reactome	BP	GO:0098543	detection of other organism	-	19	14	-	-	2.18E-01	2.56E-03
Reactome	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	29	-	-	1.87E-01	5.11E-03
Reactome	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	53	-	-	1.71E-02	9.16E-03
Reactome	BP	GO:0031123	RNA 3'-end processing	-	79	27	-	-	1.51E-01	4.69E-03
Reactome	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	55	-	-	1.96E-02	9.38E-03
Reactome	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	11	-	-	6.11E-01	1.92E-03
Reactome	BP	GO:0045229	external encapsulating structure organization	-	319	141	-	-	7.53E-02	2.41E-02
Reactome	BP	GO:0006885	regulation of pH	-	104	36	-	-	1.39E-01	6.18E-03
Reactome	BP	GO:0001667	ameboidal-type cell migration	-	495	234	-	-	4.28E-02	4.01E-02
Reactome	BP	GO:1990840	response to lectin	-	22	19	-	-	8.64E-02	3.41E-03
Reactome	BP	GO:0031018	endocrine pancreas development	-	47	26	-	-	2.01E-02	4.47E-03
Reactome	BP	GO:0001708	cell fate specification	-	108	51	-	-	1.76E-02	8.74E-03
Reactome	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	38	-	-	5.04E-02	6.61E-03
Reactome	BP	GO:0030279	negative regulation of ossification	-	39	22	-	-	4.89E-03	3.84E-03
Reactome	BP	GO:0032970	regulation of actin filament-based process	-	368	147	-	-	4.53E-02	2.51E-02
Reactome	BP	GO:0042440	pigment metabolic process	-	80	16	-	-	8.45E-04	2.77E-03
Reactome	BP	GO:1901606	alpha-amino acid catabolic process	-	101	16	-	-	1.69E-01	2.77E-03
Reactome	BP	GO:0062197	cellular response to chemical stress	-	299	162	-	-	1.51E-02	2.77E-02
Reactome	BP	GO:1901890	positive regulation of cell junction assembly	-	106	47	-	-	1.03E-02	8.10E-03
Reactome	BP	GO:1901655	cellular response to ketone	-	107	55	-	-	2.48E-02	9.38E-03
Reactome	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	15	-	-	1.99E-01	2.56E-03
Reactome	BP	GO:0006968	cellular defense response	-	52	36	-	-	1.36E-02	6.18E-03
Reactome	BP	GO:0055006	cardiac cell development	-	93	45	-	-	6.84E-03	7.67E-03
Reactome	BP	GO:0031365	N-terminal protein amino acid modification	-	30	14	-	-	2.81E-02	2.56E-03
Reactome	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	16	-	-	2.40E-03	2.77E-03
Reactome	BP	GO:0060004	reflex	-	63	32	-	-	9.03E-03	5.54E-03
Reactome	BP	GO:0044706	multi-multicellular organism process	-	217	113	-	-	2.80E-02	1.94E-02
Reactome	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	83	-	-	2.64E-02	1.43E-02
Reactome	BP	GO:0006026	aminoglycan catabolic process	-	34	12	-	-	1.06E-01	2.13E-03
Reactome	BP	GO:0031294	lymphocyte costimulation	-	47	41	-	-	4.37E-02	7.03E-03
Reactome	BP	GO:0050768	negative regulation of neurogenesis	-	150	73	-	-	8.40E-03	1.26E-02
Reactome	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	54	-	-	6.35E-03	9.38E-03
Reactome	BP	GO:0090068	positive regulation of cell cycle process	-	262	125	-	-	3.68E-02	2.13E-02
Reactome	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	12	-	-	6.35E-04	2.13E-03
Reactome	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	16	-	-	1.25E-01	2.77E-03
Reactome	BP	GO:1902115	regulation of organelle assembly	-	210	87	-	-	2.12E-02	1.49E-02
Reactome	BP	GO:0006397	mRNA processing	-	482	104	-	-	1.58E-01	1.79E-02
Reactome	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	44	-	-	9.26E-03	7.67E-03
Reactome	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	60	-	-	2.97E-02	1.02E-02
Reactome	BP	GO:0046622	positive regulation of organ growth	-	52	27	-	-	1.35E-02	4.69E-03
Reactome	BP	GO:0051952	regulation of amine transport	-	98	46	-	-	2.50E-02	7.88E-03
Reactome	CC	GO:0032365	intracellular lipid transport	-	51	23	-	-	4.21E-02	4.05E-03
Reactome	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	38	-	-	1.03E-02	6.61E-03
Reactome	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	70	-	-	1.22E-02	1.19E-02
Reactome	BP	GO:0018149	peptide cross-linking	-	28	12	-	-	9.48E-02	2.13E-03
Reactome	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	15	-	-	7.64E-03	2.56E-03
Reactome	BP	GO:0071398	cellular response to fatty acid	-	35	19	-	-	8.14E-04	3.41E-03
Reactome	BP	GO:0097581	lamellipodium organization	-	91	44	-	-	1.17E-02	7.67E-03
Reactome	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	18	-	-	7.51E-01	3.20E-03
Reactome	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	54	-	-	1.81E-01	9.38E-03
Reactome	BP	GO:0060326	cell chemotaxis	-	311	169	-	-	4.32E-02	2.90E-02
Reactome	BP	GO:1903975	regulation of glial cell migration	-	20	12	-	-	2.01E-01	2.13E-03
Reactome	BP	GO:0016485	protein processing	-	248	138	-	-	3.55E-02	2.37E-02
Reactome	BP	GO:0009649	entrainment of circadian clock	-	30	19	-	-	8.78E-02	3.41E-03
Reactome	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	95	-	-	2.15E-01	1.62E-02
Reactome	BP	GO:1903523	negative regulation of blood circulation	-	27	13	-	-	2.33E-03	2.34E-03
Reactome	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	55	-	-	2.60E-01	9.38E-03
Reactome	BP	GO:0099054	presynapse assembly	-	49	25	-	-	1.66E-02	4.26E-03
Reactome	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	13	-	-	3.21E-02	2.34E-03
Reactome	BP	GO:0031348	negative regulation of defense response	-	282	134	-	-	1.44E-02	2.30E-02
Reactome	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	51	-	-	5.78E-02	8.74E-03
Reactome	BP	GO:0007606	sensory perception of chemical stimulus	-	535	34	-	-	2.21E-01	5.97E-03
Reactome	BP	GO:0061180	mammary gland epithelium development	-	68	45	-	-	5.49E-03	7.67E-03
Reactome	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	72	-	-	3.69E-02	1.24E-02
Reactome	CC	GO:0051169	nuclear transport	-	325	150	-	-	8.31E-02	2.56E-02
Reactome	BP	GO:0071496	cellular response to external stimulus	-	74	52	-	-	1.35E-02	8.95E-03
Reactome	BP	GO:0042753	positive regulation of circadian rhythm	-	18	13	-	-	5.44E-02	2.34E-03
Reactome	BP	GO:0032094	response to food	-	37	20	-	-	1.50E-02	3.41E-03
Reactome	BP	GO:0001964	startle response	-	27	15	-	-	1.84E-02	2.56E-03
Reactome	BP	GO:0046434	organophosphate catabolic process	-	232	74	-	-	3.18E-02	1.28E-02
Reactome	BP	GO:0060037	pharyngeal system development	-	29	17	-	-	2.15E-01	2.98E-03
Reactome	BP	GO:0009566	fertilization	-	205	53	-	-	2.81E-02	9.16E-03
Reactome	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	21	-	-	6.21E-01	3.62E-03
Reactome	BP	GO:0120255	olefinic compound biosynthetic process	-	24	11	-	-	6.36E-04	1.92E-03
Reactome	BP	GO:0045907	positive regulation of vasoconstriction	-	30	17	-	-	2.37E-02	2.98E-03
Reactome	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	16	-	-	8.99E-02	2.77E-03
Reactome	BP	GO:0033044	regulation of chromosome organization	-	249	111	-	-	7.43E-02	1.90E-02
Reactome	BP	GO:0009309	amine biosynthetic process	-	38	14	-	-	3.01E-01	2.56E-03
Reactome	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	164	-	-	1.47E-02	2.81E-02
Reactome	BP	GO:0061900	glial cell activation	-	56	39	-	-	1.32E-02	6.82E-03
Reactome	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	100	-	-	3.76E-02	1.70E-02
Reactome	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	123	-	-	5.58E-02	2.11E-02
Reactome	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	11	-	-	2.09E-02	1.92E-03
Reactome	CC	GO:0140467	integrated stress response signaling	-	41	27	-	-	5.01E-02	4.69E-03
Reactome	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	86	-	-	1.05E-01	1.47E-02
Reactome	BP	GO:0043647	inositol phosphate metabolic process	-	44	20	-	-	2.82E-02	3.41E-03
Reactome	BP	GO:0051303	establishment of chromosome localization	-	104	51	-	-	1.06E-01	8.74E-03
Reactome	BP	GO:0007164	establishment of tissue polarity	-	38	19	-	-	2.09E-02	3.41E-03
Reactome	BP	GO:0021515	cell differentiation in spinal cord	-	51	14	-	-	2.34E-02	2.56E-03
Reactome	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	11	-	-	5.83E-03	1.92E-03
Reactome	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	17	-	-	7.55E-03	2.98E-03
Reactome	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	14	-	-	1.30E-03	2.56E-03
Reactome	BP	GO:0006605	protein targeting	-	327	152	-	-	9.23E-02	2.60E-02
Reactome	BP	GO:0061318	renal filtration cell differentiation	-	22	15	-	-	3.02E-02	2.56E-03
Reactome	BP	GO:0007566	embryo implantation	-	57	31	-	-	1.41E-02	5.33E-03
Reactome	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	18	-	-	4.01E-02	3.20E-03
Reactome	BP	GO:0061512	protein localization to cilium	-	394	75	-	-	7.61E-02	1.28E-02
Reactome	BP	GO:0060306	regulation of membrane repolarization	-	38	17	-	-	2.59E-01	2.98E-03
Reactome	BP	GO:0051017	actin filament bundle assembly	-	161	74	-	-	1.43E-02	1.28E-02
Reactome	BP	GO:1905953	negative regulation of lipid localization	-	63	31	-	-	8.35E-03	5.33E-03
Reactome	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	22	-	-	2.15E-02	3.84E-03
Reactome	BP	GO:1901343	negative regulation of vasculature development	-	154	61	-	-	1.40E-02	1.04E-02
Reactome	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	66	-	-	5.14E-02	1.13E-02
Reactome	BP	GO:1902414	protein localization to cell junction	-	107	64	-	-	1.41E-02	1.11E-02
Reactome	BP	GO:0051304	chromosome separation	-	80	37	-	-	2.07E-01	6.39E-03
Reactome	BP	GO:0090596	sensory organ morphogenesis	-	272	108	-	-	1.69E-02	1.85E-02
Reactome	BP	GO:0045780	positive regulation of bone resorption	-	18	14	-	-	1.50E-02	2.56E-03
Reactome	BP	GO:0048709	oligodendrocyte differentiation	-	101	43	-	-	4.91E-03	7.46E-03
Reactome	BP	GO:0045017	glycerolipid biosynthetic process	-	254	88	-	-	8.05E-02	1.51E-02
Reactome	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	15	-	-	8.45E-04	2.56E-03
Reactome	BP	GO:0001776	leukocyte homeostasis	-	108	74	-	-	1.06E-02	1.28E-02
Reactome	BP	GO:0050769	positive regulation of neurogenesis	-	240	143	-	-	2.19E-02	2.45E-02
Reactome	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	12	-	-	1.20E-01	2.13E-03
Reactome	BP	GO:0030193	regulation of blood coagulation	-	70	52	-	-	9.32E-02	8.95E-03
Reactome	BP	GO:0050866	negative regulation of cell activation	-	216	112	-	-	1.21E-02	1.92E-02
Reactome	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	15	-	-	8.37E-04	2.56E-03
Reactome	BP	GO:0033500	carbohydrate homeostasis	-	251	112	-	-	3.58E-02	1.92E-02
Reactome	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	20	-	-	1.48E-02	3.41E-03
Reactome	BP	GO:0044088	regulation of vacuole organization	-	56	25	-	-	7.31E-02	4.26E-03
Reactome	CC	GO:0051457	maintenance of protein location in nucleus	-	23	12	-	-	1.53E-02	2.13E-03
Reactome	CC	GO:0099522	cytosolic region	-	20	14	-	-	6.34E-03	2.56E-03
Reactome	CC	GO:0000791	euchromatin	-	60	30	-	-	1.62E-02	5.11E-03
Reactome	CC	GO:0030666	endocytic vesicle membrane	-	196	147	-	-	6.10E-02	2.51E-02
Reactome	CC	GO:0098857	membrane microdomain	-	324	205	-	-	2.50E-02	3.49E-02
Reactome	CC	GO:0030312	external encapsulating structure	-	567	219	-	-	1.36E-01	3.75E-02
Reactome	CC	GO:1990752	microtubule end	-	34	11	-	-	6.34E-04	1.92E-03
Reactome	CC	GO:0043204	perikaryon	-	156	54	-	-	4.23E-03	9.38E-03
Reactome	CC	GO:0097542	ciliary tip	-	48	20	-	-	3.43E-01	3.41E-03
Reactome	CC	GO:1905368	peptidase complex	-	124	36	-	-	8.64E-02	6.18E-03
Reactome	CC	GO:0000792	heterochromatin	-	98	48	-	-	3.51E-02	8.31E-03
Reactome	CC	GO:0097546	ciliary base	-	47	21	-	-	7.67E-02	3.62E-03
Reactome	CC	GO:0031201	SNARE complex	-	48	26	-	-	2.71E-01	4.47E-03
Reactome	CC	GO:0016324	apical plasma membrane	-	392	132	-	-	4.78E-02	2.26E-02
Reactome	CC	GO:0005677	chromatin silencing complex	-	13	12	-	-	1.63E-01	2.13E-03
Reactome	CC	GO:0033260	nuclear DNA replication	-	40	25	-	-	1.47E-01	4.26E-03
Reactome	CC	GO:0044391	ribosomal subunit	-	203	13	-	-	6.72E-02	2.34E-03
Reactome	CC	GO:0071013	catalytic step 2 spliceosome	-	88	24	-	-	1.69E-01	4.26E-03
Reactome	CC	GO:0031907	microbody lumen	-	51	14	-	-	2.14E-01	2.56E-03
Reactome	CC	GO:0098862	cluster of actin-based cell projections	-	162	54	-	-	6.19E-02	9.38E-03
Reactome	CC	GO:0098978	glutamatergic synapse	-	411	217	-	-	6.23E-02	3.71E-02
Reactome	CC	GO:0016363	nuclear matrix	-	127	61	-	-	6.38E-03	1.04E-02
Reactome	CC	GO:0031261	DNA replication preinitiation complex	-	46	36	-	-	2.32E-01	6.18E-03
Reactome	CC	GO:0031966	mitochondrial membrane	-	746	164	-	-	3.26E-01	2.81E-02
Reactome	CC	GO:0097060	synaptic membrane	-	413	189	-	-	2.15E-01	3.24E-02
Reactome	CC	GO:0032432	actin filament bundle	-	249	97	-	-	1.85E-02	1.66E-02
Reactome	CC	GO:0008088	axo-dendritic transport	-	78	30	-	-	6.11E-03	5.11E-03
Reactome	CC	GO:0031519	PcG protein complex	-	38	21	-	-	2.70E-01	3.62E-03
Reactome	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	95	-	-	5.84E-02	1.62E-02
Reactome	CC	GO:0098791	Golgi apparatus subcompartment	-	378	129	-	-	2.18E-01	2.22E-02
Reactome	CC	GO:0099643	signal release from synapse	-	147	66	-	-	2.04E-02	1.13E-02
Reactome	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	23	-	-	2.62E-01	4.05E-03
Reactome	CC	GO:0030018	Z disc	-	129	47	-	-	1.12E-02	8.10E-03
Reactome	CC	GO:0032580	Golgi cisterna membrane	-	93	15	-	-	1.16E-02	2.56E-03
Reactome	CC	GO:0005814	centriole	-	692	233	-	-	4.91E-02	3.98E-02
Reactome	CC	GO:0097381	photoreceptor disc membrane	-	25	13	-	-	5.11E-01	2.34E-03
Reactome	CC	GO:1905360	GTPase complex	-	41	30	-	-	4.66E-02	5.11E-03
Reactome	CC	GO:0097540	axonemal central pair	-	161	34	-	-	3.17E-02	5.97E-03
Reactome	CC	GO:0042641	actomyosin	-	77	29	-	-	3.46E-02	5.11E-03
Reactome	CC	GO:0097386	glial cell projection	-	38	17	-	-	8.19E-04	2.98E-03
Reactome	CC	GO:0032588	trans-Golgi network membrane	-	102	51	-	-	3.21E-01	8.74E-03
Reactome	CC	GO:0070382	exocytic vesicle	-	224	86	-	-	6.56E-02	1.47E-02
Reactome	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	14	-	-	6.13E-01	2.56E-03
Reactome	CC	GO:0031903	microbody membrane	-	65	26	-	-	3.97E-01	4.47E-03
Reactome	CC	GO:0046930	pore complex	-	26	17	-	-	1.98E-01	2.98E-03
Reactome	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	79	-	-	1.22E-01	1.36E-02
Reactome	CC	GO:0044298	cell body membrane	-	32	12	-	-	7.04E-03	2.13E-03
Reactome	CC	GO:0051882	mitochondrial depolarization	-	21	13	-	-	8.11E-02	2.34E-03
Reactome	CC	GO:0016323	basolateral plasma membrane	-	239	99	-	-	4.37E-02	1.70E-02
Reactome	CC	GO:0042645	mitochondrial nucleoid	-	45	16	-	-	4.16E-01	2.77E-03
Reactome	CC	GO:1902495	transmembrane transporter complex	-	408	179	-	-	4.97E-01	3.07E-02
Reactome	CC	GO:0098636	protein complex involved in cell adhesion	-	57	45	-	-	1.32E-01	7.67E-03
Reactome	CC	GO:0001917	photoreceptor inner segment	-	71	30	-	-	4.90E-02	5.11E-03
Reactome	CC	GO:0019897	extrinsic component of plasma membrane	-	156	93	-	-	3.81E-02	1.60E-02
Reactome	CC	GO:0031594	neuromuscular junction	-	73	42	-	-	7.54E-03	7.24E-03
Reactome	CC	GO:0000793	condensed chromosome	-	274	136	-	-	1.15E-01	2.32E-02
Reactome	CC	GO:0000922	spindle pole	-	172	63	-	-	1.72E-02	1.09E-02
Reactome	CC	GO:0120111	neuron projection cytoplasm	-	94	37	-	-	5.73E-03	6.39E-03
Reactome	CC	GO:0070971	endoplasmic reticulum exit site	-	32	17	-	-	3.81E-01	2.98E-03
Reactome	CC	GO:0004879	nuclear receptor activity	-	63	39	-	-	2.52E-02	6.82E-03
Reactome	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	102	-	-	1.97E-02	1.75E-02
Reactome	CC	GO:0000123	histone acetyltransferase complex	-	93	31	-	-	1.87E-01	5.33E-03
Reactome	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	16	-	-	7.05E-01	2.77E-03
Reactome	CC	GO:0048786	presynaptic active zone	-	80	45	-	-	1.13E-01	7.67E-03
Reactome	CC	GO:0007034	vacuolar transport	-	168	77	-	-	1.77E-01	1.32E-02
Reactome	CC	GO:0005776	autophagosome	-	111	46	-	-	5.04E-02	7.88E-03
Reactome	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	23	-	-	3.16E-01	4.05E-03
Reactome	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	26	-	-	1.75E-01	4.47E-03
Reactome	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	15	-	-	2.20E-02	2.56E-03
Reactome	CC	GO:0032994	protein-lipid complex	-	39	19	-	-	3.35E-01	3.41E-03
Reactome	CC	GO:0150034	distal axon	-	309	125	-	-	2.92E-02	2.13E-02
Reactome	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	32	-	-	1.76E-01	5.54E-03
Reactome	CC	GO:0072562	blood microparticle	-	144	74	-	-	7.70E-02	1.28E-02
Reactome	CC	GO:0051233	spindle midzone	-	36	16	-	-	4.72E-02	2.77E-03
Reactome	CC	GO:0005811	lipid droplet	-	102	34	-	-	2.59E-02	5.97E-03
Reactome	CC	GO:0045022	early endosome to late endosome transport	-	44	21	-	-	1.58E-02	3.62E-03
Reactome	CC	GO:0043113	receptor clustering	-	51	29	-	-	6.53E-02	5.11E-03
Reactome	CC	GO:0044853	plasma membrane raft	-	114	72	-	-	1.23E-02	1.24E-02
Reactome	CC	GO:0005881	cytoplasmic microtubule	-	256	55	-	-	3.49E-02	9.38E-03
Reactome	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	35	-	-	2.05E-01	5.97E-03
Reactome	CC	GO:0005905	clathrin-coated pit	-	73	45	-	-	9.74E-02	7.67E-03
Reactome	CC	GO:0031904	endosome lumen	-	38	25	-	-	1.89E-01	4.26E-03
Reactome	CC	GO:0060170	ciliary membrane	-	76	35	-	-	7.29E-02	5.97E-03
Reactome	CC	GO:0000139	Golgi membrane	-	646	226	-	-	9.63E-02	3.86E-02
Reactome	CC	GO:0032154	cleavage furrow	-	54	26	-	-	3.42E-02	4.47E-03
Reactome	CC	GO:0007006	mitochondrial membrane organization	-	117	44	-	-	1.43E-01	7.67E-03
Reactome	CC	GO:0001772	immunological synapse	-	44	28	-	-	2.75E-02	4.90E-03
Reactome	CC	GO:0009897	external side of plasma membrane	-	425	238	-	-	5.65E-02	4.07E-02
Reactome	CC	GO:0030863	cortical cytoskeleton	-	104	44	-	-	9.83E-03	7.67E-03
Reactome	CC	GO:1905348	endonuclease complex	-	38	21	-	-	3.01E-01	3.62E-03
Reactome	CC	GO:0030315	T-tubule	-	52	28	-	-	1.26E-01	4.90E-03
Reactome	CC	GO:0060076	excitatory synapse	-	64	28	-	-	2.01E-02	4.90E-03
Reactome	CC	GO:0036019	endolysosome	-	29	20	-	-	7.16E-02	3.41E-03
Reactome	CC	GO:0001891	phagocytic cup	-	28	11	-	-	1.18E-02	1.92E-03
Reactome	CC	GO:0099086	synaptonemal structure	-	40	17	-	-	1.58E-01	2.98E-03
Reactome	CC	GO:0030427	site of polarized growth	-	172	62	-	-	7.22E-03	1.07E-02
Reactome	CC	GO:0044309	neuron spine	-	213	107	-	-	2.40E-02	1.83E-02
Reactome	CC	GO:0030658	transport vesicle membrane	-	231	102	-	-	1.33E-01	1.75E-02
Reactome	CC	GO:0098918	structural constituent of synapse	-	27	13	-	-	9.56E-02	2.34E-03
Reactome	CC	GO:0000940	outer kinetochore	-	17	12	-	-	7.00E-01	2.13E-03
Reactome	CC	GO:0044232	organelle membrane contact site	-	50	15	-	-	1.09E-01	2.56E-03
Reactome	CC	GO:0030667	secretory granule membrane	-	319	130	-	-	2.77E-02	2.22E-02
Reactome	CC	GO:0097545	axonemal outer doublet	-	164	34	-	-	2.59E-02	5.97E-03
Reactome	CC	GO:0031143	pseudopodium	-	18	11	-	-	6.55E-03	1.92E-03
Reactome	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	21	-	-	1.32E-01	3.62E-03
Reactome	CC	GO:0055037	recycling endosome	-	200	82	-	-	5.37E-02	1.41E-02
Reactome	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	57	-	-	1.04E-02	9.80E-03
Reactome	CC	GO:0071682	endocytic vesicle lumen	-	23	16	-	-	3.08E-02	2.77E-03
Reactome	CC	GO:0030684	preribosome	-	76	15	-	-	6.02E-01	2.56E-03
Reactome	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	140	-	-	1.22E-02	2.39E-02
Reactome	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	11	-	-	1.67E-01	1.92E-03
Reactome	CC	GO:1990391	DNA repair complex	-	22	19	-	-	1.17E-01	3.41E-03
Reactome	CC	GO:0005775	vacuolar lumen	-	176	73	-	-	8.58E-02	1.26E-02
Reactome	CC	GO:0032982	myosin filament	-	24	12	-	-	1.75E-01	2.13E-03
Reactome	CC	GO:0044306	neuron projection terminus	-	164	78	-	-	2.83E-02	1.34E-02
Reactome	CC	GO:0034455	t-UTP complex	-	53	14	-	-	6.31E-01	2.56E-03
Reactome	CC	GO:0005770	late endosome	-	299	120	-	-	7.81E-02	2.05E-02
Reactome	CC	GO:0031970	organelle envelope lumen	-	94	37	-	-	7.16E-02	6.39E-03
Reactome	CC	GO:0019866	organelle inner membrane	-	546	95	-	-	4.77E-01	1.62E-02
Reactome	CC	GO:0098687	chromosomal region	-	397	202	-	-	1.60E-01	3.45E-02
Reactome	CC	GO:0043292	contractile muscle fiber	-	245	92	-	-	1.47E-01	1.58E-02
Reactome	CC	GO:0000803	sex chromosome	-	32	15	-	-	8.68E-03	2.56E-03
Reactome	CC	GO:0098982	GABA-ergic synapse	-	84	32	-	-	1.43E-01	5.54E-03
Reactome	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	11	-	-	5.84E-01	1.92E-03
Reactome	CC	GO:0035097	histone methyltransferase complex	-	63	44	-	-	2.90E-01	7.67E-03
Reactome	CC	GO:1903293	phosphatase complex	-	54	30	-	-	1.03E-01	5.11E-03
Reactome	CC	GO:0000786	nucleosome	-	149	32	-	-	1.18E-02	5.54E-03
Reactome	CC	GO:0001533	cornified envelope	-	59	21	-	-	1.86E-01	3.62E-03
Reactome	CC	GO:1904724	tertiary granule lumen	-	55	16	-	-	8.25E-04	2.77E-03
Reactome	CC	GO:0030027	lamellipodium	-	202	92	-	-	2.52E-02	1.58E-02
Reactome	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	11	-	-	7.00E-01	1.92E-03
Reactome	CC	GO:0002102	podosome	-	31	13	-	-	1.76E-02	2.34E-03
Reactome	CC	GO:0090543	Flemming body	-	33	14	-	-	1.02E-01	2.56E-03
Reactome	CC	GO:0016328	lateral plasma membrane	-	66	34	-	-	2.25E-02	5.97E-03
Reactome	CC	GO:0001650	fibrillar center	-	151	54	-	-	2.94E-03	9.38E-03
Reactome	CC	GO:0031332	RNAi effector complex	-	413	13	-	-	2.47E-01	2.34E-03
Reactome	CC	GO:1990204	oxidoreductase complex	-	90	36	-	-	2.89E-01	6.18E-03
Reactome	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	44	-	-	3.98E-03	7.67E-03
Reactome	CC	GO:0001726	ruffle	-	181	79	-	-	1.48E-02	1.36E-02
Reactome	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	14	-	-	1.66E-01	2.56E-03
Reactome	CC	GO:0043198	dendritic shaft	-	38	17	-	-	1.71E-03	2.98E-03
Reactome	CC	GO:0043073	germ cell nucleus	-	67	28	-	-	6.27E-03	4.90E-03
Reactome	CC	GO:0005788	endoplasmic reticulum lumen	-	313	145	-	-	9.39E-02	2.47E-02
Reactome	CC	GO:0022626	cytosolic ribosome	-	118	11	-	-	2.23E-02	1.92E-03
Reactome	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	17	-	-	2.10E-01	2.98E-03
Reactome	CC	GO:0034451	centriolar satellite	-	120	31	-	-	2.32E-03	5.33E-03
Reactome	CC	GO:0045171	intercellular bridge	-	91	25	-	-	1.25E-03	4.26E-03
Reactome	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	50	-	-	3.06E-01	8.52E-03
Reactome	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.78E-01	1.92E-03
Reactome	CC	GO:0098984	neuron to neuron synapse	-	384	194	-	-	1.29E-01	3.32E-02
Reactome	CC	GO:0030527	structural constituent of chromatin	-	97	14	-	-	2.93E-02	2.56E-03
Reactome	CC	GO:0036379	myofilament	-	26	11	-	-	8.00E-01	1.92E-03
Reactome	CC	GO:0030286	dynein complex	-	210	49	-	-	3.73E-02	8.52E-03
Reactome	CC	GO:0016482	cytosolic transport	-	135	55	-	-	8.09E-02	9.38E-03
Reactome	CC	GO:0005796	Golgi lumen	-	106	58	-	-	1.53E-02	1.00E-02
Reactome	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	19	-	-	8.81E-02	3.41E-03
Reactome	CC	GO:0034358	plasma lipoprotein particle	-	36	17	-	-	3.25E-01	2.98E-03
Reactome	CC	GO:0008023	transcription elongation factor complex	-	47	31	-	-	5.35E-01	5.33E-03
Reactome	CC	GO:0030662	coated vesicle membrane	-	202	134	-	-	1.67E-01	2.30E-02
Reactome	CC	GO:0007039	protein catabolic process in the vacuole	-	61	34	-	-	3.35E-01	5.97E-03
Reactome	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	17	-	-	4.20E-01	2.98E-03
Reactome	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	140	-	-	6.34E-02	2.39E-02
Reactome	CC	GO:0005769	early endosome	-	425	185	-	-	8.19E-02	3.15E-02
Reactome	CC	GO:0090734	site of DNA damage	-	118	52	-	-	2.60E-02	8.95E-03
Reactome	MF	GO:0051861	glycolipid binding	-	30	14	-	-	1.27E-02	2.56E-03
Reactome	MF	GO:0051087	protein-folding chaperone binding	-	135	73	-	-	4.90E-02	1.26E-02
Reactome	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	17	-	-	3.68E-03	2.98E-03
Reactome	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	78	-	-	3.27E-02	1.34E-02
Reactome	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	13	-	-	3.87E-03	2.34E-03
Reactome	MF	GO:0016757	glycosyltransferase activity	-	286	58	-	-	8.62E-02	1.00E-02
Reactome	MF	GO:0048306	calcium-dependent protein binding	-	61	30	-	-	6.51E-02	5.11E-03
Reactome	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	8.79E-02	2.34E-03
Reactome	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	48	-	-	1.56E-01	8.31E-03
Reactome	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	19	-	-	1.39E-01	3.41E-03
Reactome	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	30	-	-	3.79E-02	5.11E-03
Reactome	MF	GO:0051020	GTPase binding	-	311	152	-	-	3.28E-02	2.60E-02
Reactome	MF	GO:0140457	protein demethylase activity	-	31	16	-	-	8.46E-04	2.77E-03
Reactome	MF	GO:0005158	insulin receptor binding	-	22	15	-	-	1.13E-01	2.56E-03
Reactome	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	14	-	-	2.25E-02	2.56E-03
Reactome	MF	GO:0061980	regulatory RNA binding	-	52	24	-	-	9.14E-02	4.26E-03
Reactome	MF	GO:0015035	protein-disulfide reductase activity	-	32	13	-	-	8.10E-02	2.34E-03
Reactome	MF	GO:0001671	ATPase activator activity	-	29	13	-	-	9.29E-03	2.34E-03
Reactome	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	200	-	-	6.49E-02	3.41E-02
Reactome	MF	GO:0035035	histone acetyltransferase binding	-	24	12	-	-	6.16E-04	2.13E-03
Reactome	MF	GO:0061684	chaperone-mediated autophagy	-	16	11	-	-	1.71E-02	1.92E-03
Reactome	MF	GO:0003688	DNA replication origin binding	-	18	15	-	-	2.88E-01	2.56E-03
Reactome	MF	GO:0005178	integrin binding	-	153	107	-	-	1.09E-01	1.83E-02
Reactome	MF	GO:0070064	proline-rich region binding	-	17	11	-	-	9.83E-03	1.92E-03
Reactome	MF	GO:0008327	methyl-CpG binding	-	31	11	-	-	2.11E-02	1.92E-03
Reactome	MF	GO:0031418	L-ascorbic acid binding	-	20	13	-	-	2.43E-01	2.34E-03
Reactome	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	13	-	-	1.42E-02	2.34E-03
Reactome	MF	GO:0140318	protein transporter activity	-	40	24	-	-	2.14E-01	4.26E-03
Reactome	MF	GO:0000217	DNA secondary structure binding	-	37	29	-	-	2.02E-01	5.11E-03
Reactome	MF	GO:0002039	p53 binding	-	66	44	-	-	1.00E-01	7.67E-03
Reactome	MF	GO:0005496	steroid binding	-	110	45	-	-	1.41E-01	7.67E-03
Reactome	MF	GO:0003684	damaged DNA binding	-	89	68	-	-	1.47E-01	1.17E-02
Reactome	MF	GO:0016500	protein-hormone receptor activity	-	21	15	-	-	1.43E-02	2.56E-03
Reactome	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	60	-	-	1.12E-01	1.02E-02
Reactome	MF	GO:0070063	RNA polymerase binding	-	61	34	-	-	1.28E-01	5.97E-03
Reactome	MF	GO:0030971	receptor tyrosine kinase binding	-	76	51	-	-	2.85E-02	8.74E-03
Reactome	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	35	-	-	2.53E-01	5.97E-03
Reactome	MF	GO:0140030	modification-dependent protein binding	-	179	85	-	-	2.51E-02	1.45E-02
Reactome	MF	GO:0042813	Wnt receptor activity	-	16	11	-	-	9.05E-03	1.92E-03
Reactome	MF	GO:0030983	mismatched DNA binding	-	14	12	-	-	6.29E-01	2.13E-03
Reactome	MF	GO:0030276	clathrin binding	-	70	36	-	-	1.09E-01	6.18E-03
Reactome	MF	GO:0003712	transcription coregulator activity	-	499	187	-	-	4.27E-02	3.20E-02
Reactome	MF	GO:0046875	ephrin receptor binding	-	29	18	-	-	1.37E-02	3.20E-03
Reactome	MF	GO:0106310	protein serine kinase activity	-	362	171	-	-	2.88E-02	2.92E-02
Reactome	MF	GO:0046790	virion binding	-	19	13	-	-	4.67E-03	2.34E-03
Reactome	MF	GO:0030552	cAMP binding	-	48	28	-	-	4.81E-02	4.90E-03
Reactome	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	20	-	-	1.03E-03	3.41E-03
Reactome	MF	GO:0004857	enzyme inhibitor activity	-	395	140	-	-	9.23E-03	2.39E-02
Reactome	MF	GO:0035173	histone kinase activity	-	17	12	-	-	6.09E-04	2.13E-03
Reactome	MF	GO:0017154	semaphorin receptor activity	-	12	11	-	-	1.88E-02	1.92E-03
Reactome	MF	GO:0016209	antioxidant activity	-	92	33	-	-	3.35E-02	5.75E-03
Reactome	MF	GO:0070325	lipoprotein particle receptor binding	-	32	22	-	-	1.35E-02	3.84E-03
Reactome	MF	GO:0044325	transmembrane transporter binding	-	159	75	-	-	5.03E-02	1.28E-02
Reactome	MF	GO:0048156	tau protein binding	-	43	31	-	-	2.60E-02	5.33E-03
Reactome	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	14	-	-	1.11E-02	2.56E-03
Reactome	MF	GO:0140272	exogenous protein binding	-	79	48	-	-	8.46E-03	8.31E-03
Reactome	MF	GO:0030145	manganese ion binding	-	65	21	-	-	2.01E-03	3.62E-03
Reactome	MF	GO:0071814	protein-lipid complex binding	-	52	30	-	-	1.74E-02	5.11E-03
Reactome	MF	GO:0008066	glutamate receptor activity	-	70	46	-	-	2.06E-01	7.88E-03
Reactome	MF	GO:0019843	rRNA binding	-	69	12	-	-	1.19E-01	2.13E-03
Reactome	MF	GO:0004713	protein tyrosine kinase activity	-	213	128	-	-	2.39E-02	2.19E-02
Reactome	MF	GO:0016779	nucleotidyltransferase activity	-	264	97	-	-	9.10E-02	1.66E-02
Reactome	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	41	-	-	7.18E-03	7.03E-03
Reactome	MF	GO:0008093	cytoskeletal anchor activity	-	24	12	-	-	6.29E-04	2.13E-03
Reactome	MF	GO:0016208	AMP binding	-	22	15	-	-	1.07E-01	2.56E-03
Reactome	MF	GO:0000287	magnesium ion binding	-	225	70	-	-	4.64E-02	1.19E-02
Reactome	MF	GO:0031490	chromatin DNA binding	-	120	57	-	-	2.05E-02	9.80E-03
Reactome	MF	GO:0017022	myosin binding	-	73	34	-	-	3.31E-02	5.97E-03
Reactome	MF	GO:0004896	cytokine receptor activity	-	93	85	-	-	2.69E-02	1.45E-02
Reactome	MF	GO:0015631	tubulin binding	-	410	131	-	-	7.26E-02	2.24E-02
Reactome	MF	GO:0005539	glycosaminoglycan binding	-	236	111	-	-	3.31E-02	1.90E-02
Reactome	MF	GO:0019207	kinase regulator activity	-	267	156	-	-	2.87E-02	2.66E-02
Reactome	MF	GO:0044183	protein folding chaperone	-	67	17	-	-	2.13E-02	2.98E-03
Reactome	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	69	-	-	1.98E-02	1.19E-02
Reactome	MF	GO:0003725	double-stranded RNA binding	-	72	34	-	-	9.79E-02	5.97E-03
Reactome	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	11	-	-	4.50E-01	1.92E-03
Reactome	MF	GO:0051018	protein kinase A binding	-	52	23	-	-	3.01E-01	4.05E-03
Reactome	MF	GO:0071889	14-3-3 protein binding	-	34	16	-	-	4.27E-03	2.77E-03
Reactome	MF	GO:0004618	phosphoglycerate kinase activity	-	89	43	-	-	2.16E-02	7.46E-03
Reactome	MF	GO:0042805	actinin binding	-	36	12	-	-	4.04E-03	2.13E-03
Reactome	MF	GO:0043531	ADP binding	-	38	22	-	-	5.22E-03	3.84E-03
Reactome	MF	GO:0043394	proteoglycan binding	-	36	25	-	-	9.67E-03	4.26E-03
Reactome	MF	GO:0046332	SMAD binding	-	77	54	-	-	1.20E-01	9.38E-03
Reactome	MF	GO:0001968	fibronectin binding	-	30	18	-	-	2.46E-02	3.20E-03
Reactome	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	57	-	-	8.50E-02	9.80E-03
Reactome	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	24	-	-	1.04E-03	4.26E-03
Reactome	MF	GO:0051117	ATPase binding	-	85	47	-	-	4.92E-02	8.10E-03
Reactome	MF	GO:0005216	monoatomic ion channel activity	-	618	245	-	-	2.33E-01	4.18E-02
Reactome	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	38	-	-	5.08E-03	6.61E-03
Reactome	MF	GO:0001098	basal transcription machinery binding	-	61	34	-	-	5.25E-02	5.97E-03
Reactome	MF	GO:0051540	metal cluster binding	-	71	33	-	-	1.04E-01	5.75E-03
Reactome	MF	GO:0051219	phosphoprotein binding	-	92	59	-	-	7.21E-03	1.02E-02
Reactome	MF	GO:0019894	kinesin binding	-	45	17	-	-	7.26E-02	2.98E-03
Reactome	MF	GO:0042287	MHC protein binding	-	68	43	-	-	5.04E-02	7.46E-03
Reactome	MF	GO:0019003	GDP binding	-	89	51	-	-	1.77E-02	8.74E-03
Reactome	MF	GO:0017171	serine hydrolase activity	-	207	84	-	-	6.90E-02	1.45E-02
Reactome	MF	GO:0097110	scaffold protein binding	-	66	48	-	-	1.15E-02	8.31E-03
Reactome	MF	GO:0003774	cytoskeletal motor activity	-	117	40	-	-	1.35E-01	6.82E-03
Reactome	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	14	-	-	3.78E-02	2.56E-03
Reactome	MF	GO:0061134	peptidase regulator activity	-	224	75	-	-	3.70E-02	1.28E-02
Reactome	MF	GO:0008013	beta-catenin binding	-	86	56	-	-	1.33E-02	9.59E-03
Reactome	MF	GO:0051015	actin filament binding	-	208	73	-	-	2.39E-02	1.26E-02
Reactome	MF	GO:0019208	phosphatase regulator activity	-	107	39	-	-	3.64E-02	6.82E-03
Reactome	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	11	-	-	1.59E-02	1.92E-03
Reactome	MF	GO:0043236	laminin binding	-	29	15	-	-	3.18E-02	2.56E-03
Reactome	MF	GO:0030507	spectrin binding	-	26	17	-	-	1.34E-01	2.98E-03
Reactome	MF	GO:0045860	positive regulation of protein kinase activity	-	397	237	-	-	3.84E-02	4.05E-02
Reactome	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	51	-	-	5.84E-02	8.74E-03
Reactome	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	19	-	-	8.32E-04	3.41E-03
Reactome	MF	GO:0042393	histone binding	-	240	97	-	-	6.05E-02	1.66E-02
Reactome	MF	GO:0019838	growth factor binding	-	182	124	-	-	2.60E-02	2.13E-02
Reactome	MF	GO:0000149	SNARE binding	-	107	50	-	-	1.56E-01	8.52E-03
Reactome	MF	GO:0003727	single-stranded RNA binding	-	90	30	-	-	2.96E-02	5.11E-03
Reactome	MF	GO:0005516	calmodulin binding	-	206	101	-	-	4.05E-02	1.73E-02
Reactome	MF	GO:0005198	structural molecule activity	-	823	196	-	-	1.01E-01	3.35E-02
Reactome	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	28	-	-	7.79E-03	4.90E-03
Reactome	MF	GO:0032182	ubiquitin-like protein binding	-	117	66	-	-	1.83E-02	1.13E-02
Reactome	MF	GO:0023023	MHC protein complex binding	-	36	24	-	-	2.02E-01	4.26E-03
Reactome	MF	GO:0030742	GTP-dependent protein binding	-	22	12	-	-	1.01E-01	2.13E-03
Reactome	MF	GO:0043274	phospholipase binding	-	23	17	-	-	6.22E-03	2.98E-03
Reactome	MF	GO:0031072	heat shock protein binding	-	128	69	-	-	1.03E-01	1.19E-02
Reactome	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	15	-	-	7.50E-02	2.56E-03
Reactome	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	192	-	-	6.75E-02	3.28E-02
Reactome	MF	GO:0001530	lipopolysaccharide binding	-	38	12	-	-	4.10E-02	2.13E-03
Reactome	MF	GO:0046982	protein heterodimerization activity	-	343	154	-	-	4.02E-02	2.64E-02
Reactome	MF	GO:0140223	general transcription initiation factor activity	-	55	15	-	-	2.35E-01	2.56E-03
Reactome	MF	GO:0000049	tRNA binding	-	75	19	-	-	5.42E-02	3.41E-03
Reactome	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	29	-	-	1.44E-02	5.11E-03
Reactome	MF	GO:0015026	coreceptor activity	-	48	39	-	-	9.65E-03	6.82E-03
Reactome	MF	GO:0001653	peptide receptor activity	-	128	93	-	-	6.99E-03	1.60E-02
Reactome	MF	GO:0030506	ankyrin binding	-	19	11	-	-	7.87E-03	1.92E-03
Reactome	MF	GO:0006469	negative regulation of protein kinase activity	-	222	110	-	-	8.22E-03	1.88E-02
Reactome	MF	GO:0070182	DNA polymerase binding	-	22	13	-	-	7.19E-03	2.34E-03
Reactome	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	20	-	-	2.02E-02	3.41E-03
Reactome	MF	GO:0051427	hormone receptor binding	-	31	28	-	-	9.86E-03	4.90E-03
Reactome	MF	GO:0070851	growth factor receptor binding	-	141	103	-	-	4.16E-02	1.77E-02
Reactome	MF	GO:0031210	phosphatidylcholine binding	-	32	13	-	-	2.01E-01	2.34E-03
Reactome	MF	GO:0005525	GTP binding	-	396	149	-	-	9.76E-03	2.56E-02
Reactome	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	27	-	-	8.63E-03	4.69E-03
Reactome	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	171	-	-	4.26E-02	2.92E-02
Reactome	MF	GO:0034185	apolipoprotein binding	-	20	16	-	-	2.98E-03	2.77E-03
Reactome	MF	GO:0051346	negative regulation of hydrolase activity	-	332	119	-	-	9.82E-03	2.05E-02
Reactome	MF	GO:0005506	iron ion binding	-	154	46	-	-	1.98E-02	7.88E-03
Reactome	MF	GO:0003925	G protein activity	-	45	27	-	-	1.20E-03	4.69E-03
Reactome	MF	GO:0038187	pattern recognition receptor activity	-	33	25	-	-	3.55E-02	4.26E-03
Reactome	MF	GO:0008276	protein methyltransferase activity	-	96	41	-	-	1.88E-02	7.03E-03
Reactome	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	192	-	-	2.61E-02	3.28E-02
Reactome	MF	GO:0070888	E-box binding	-	59	26	-	-	6.40E-02	4.47E-03
Reactome	MF	GO:0015399	primary active transmembrane transporter activity	-	190	58	-	-	3.12E-01	1.00E-02
Reactome	MF	GO:0035254	glutamate receptor binding	-	47	26	-	-	2.04E-02	4.47E-03
Reactome	MF	GO:0050321	tau-protein kinase activity	-	36	24	-	-	3.72E-02	4.26E-03
Reactome	MF	GO:0043021	ribonucleoprotein complex binding	-	158	52	-	-	1.43E-01	8.95E-03
Reactome	MF	GO:0030170	pyridoxal phosphate binding	-	56	14	-	-	1.25E-01	2.56E-03
Reactome	MF	GO:0005112	Notch binding	-	26	14	-	-	1.87E-01	2.56E-03
Reactome	MF	GO:0048185	activin binding	-	16	14	-	-	4.00E-02	2.56E-03
Reactome	MF	GO:0001664	G protein-coupled receptor binding	-	299	187	-	-	2.73E-02	3.20E-02
Reactome	MF	GO:0140299	small molecule sensor activity	-	39	26	-	-	2.30E-01	4.47E-03
Reactome	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	20	-	-	2.25E-02	3.41E-03
Reactome	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	24	-	-	5.63E-02	4.26E-03
Reactome	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	16	-	-	1.53E-03	2.77E-03
Reactome	MF	GO:0030594	neurotransmitter receptor activity	-	160	88	-	-	3.30E-01	1.51E-02
Reactome	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	15	-	-	1.42E-01	2.56E-03
Reactome	MF	GO:0005507	copper ion binding	-	63	20	-	-	5.94E-03	3.41E-03
Reactome	MF	GO:0033558	protein lysine deacetylase activity	-	22	14	-	-	5.94E-03	2.56E-03
ReactomeFI	CC	GO:0005730	nucleolus	2.69E-26	988	960	869	1.10	-	-
ReactomeFI	MF	GO:0000049	tRNA binding	-	75	54	-	-	8.07E-02	3.18E-03
ReactomeFI	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	14	-	-	2.37E-01	8.66E-04
ReactomeFI	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	3.46E-02	6.50E-04
ReactomeFI	CC	GO:0000123	histone acetyltransferase complex	-	93	92	-	-	3.90E-01	5.34E-03
ReactomeFI	MF	GO:0000149	SNARE binding	-	107	101	-	-	3.76E-01	5.85E-03
ReactomeFI	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	8.16E-02	2.60E-03
ReactomeFI	CC	GO:0000164	protein phosphatase type 1 complex	-	19	18	-	-	8.99E-02	1.08E-03
ReactomeFI	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	1.41E-01	8.66E-04
ReactomeFI	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	2.67E-02	2.17E-03
ReactomeFI	CC	GO:0000228	nuclear chromosome	1.30E-15	206	194	149	1.30	-	-
ReactomeFI	CC	GO:0000242	pericentriolar material	-	22	21	-	-	1.61E-02	1.23E-03
ReactomeFI	BP	GO:0000272	polysaccharide catabolic process	-	19	15	-	-	6.78E-02	8.66E-04
ReactomeFI	MF	GO:0000287	magnesium ion binding	-	225	189	-	-	8.61E-02	1.10E-02
ReactomeFI	CC	GO:0000313	organellar ribosome	-	89	88	-	-	4.37E-01	5.12E-03
ReactomeFI	MF	GO:0000339	RNA cap binding	-	20	19	-	-	1.47E-01	1.15E-03
ReactomeFI	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	9.79E-02	7.22E-04
ReactomeFI	CC	GO:0000786	nucleosome	-	149	103	-	-	2.18E-01	5.99E-03
ReactomeFI	CC	GO:0000791	euchromatin	-	60	56	-	-	5.15E-03	3.25E-03
ReactomeFI	CC	GO:0000792	heterochromatin	-	98	95	-	-	2.54E-02	5.49E-03
ReactomeFI	CC	GO:0000800	lateral element	-	14	11	-	-	1.90E-02	6.50E-04
ReactomeFI	CC	GO:0000803	sex chromosome	-	32	28	-	-	7.50E-03	1.66E-03
ReactomeFI	CC	GO:0000815	ESCRT III complex	-	11	11	-	-	9.12E-02	6.50E-04
ReactomeFI	BP	GO:0000910	cytokinesis	2.13E-08	186	166	134	1.24	-	-
ReactomeFI	CC	GO:0000922	spindle pole	-	172	149	-	-	2.94E-02	8.66E-03
ReactomeFI	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	4.56E-02	9.38E-04
ReactomeFI	CC	GO:0000940	outer kinetochore	-	17	17	-	-	2.40E-02	1.01E-03
ReactomeFI	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	37	-	-	2.72E-01	2.17E-03
ReactomeFI	CC	GO:0000963	mitochondrial RNA processing	-	20	15	-	-	4.00E-01	8.66E-04
ReactomeFI	BP	GO:0000966	RNA 5'-end processing	-	39	33	-	-	1.09E-01	1.95E-03
ReactomeFI	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	18	-	-	1.90E-03	1.08E-03
ReactomeFI	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	3.14E-02	7.22E-04
ReactomeFI	CC	GO:0001055	RNA polymerase II activity	-	11	11	-	-	4.00E-03	6.50E-04
ReactomeFI	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	8.92E-02	9.38E-04
ReactomeFI	MF	GO:0001098	basal transcription machinery binding	-	61	57	-	-	8.35E-03	3.32E-03
ReactomeFI	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	4.75E-02	8.66E-04
ReactomeFI	MF	GO:0001530	lipopolysaccharide binding	-	38	27	-	-	3.91E-02	1.59E-03
ReactomeFI	CC	GO:0001533	cornified envelope	-	59	59	-	-	3.57E-01	3.46E-03
ReactomeFI	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	100	-	-	7.95E-02	5.77E-03
ReactomeFI	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	18	-	-	4.49E-01	1.08E-03
ReactomeFI	CC	GO:0001650	fibrillar center	-	151	140	-	-	8.10E-03	8.08E-03
ReactomeFI	MF	GO:0001653	peptide receptor activity	-	128	119	-	-	5.32E-02	6.93E-03
ReactomeFI	BP	GO:0001655	urogenital system development	-	66	65	-	-	5.51E-03	3.75E-03
ReactomeFI	MF	GO:0001671	ATPase activator activity	-	29	26	-	-	9.56E-03	1.52E-03
ReactomeFI	BP	GO:0001704	formation of primary germ layer	-	195	179	-	-	1.42E-02	1.04E-02
ReactomeFI	BP	GO:0001708	cell fate specification	-	108	105	-	-	1.55E-02	6.06E-03
ReactomeFI	BP	GO:0001709	cell fate determination	-	44	41	-	-	4.21E-03	2.38E-03
ReactomeFI	CC	GO:0001726	ruffle	-	181	159	-	-	2.47E-02	9.24E-03
ReactomeFI	CC	GO:0001772	immunological synapse	-	44	42	-	-	1.69E-02	2.45E-03
ReactomeFI	BP	GO:0001776	leukocyte homeostasis	-	108	99	-	-	7.35E-03	5.77E-03
ReactomeFI	BP	GO:0001829	trophectodermal cell differentiation	-	19	18	-	-	2.94E-03	1.08E-03
ReactomeFI	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.08E-02	8.66E-04
ReactomeFI	BP	GO:0001845	phagolysosome assembly	-	19	15	-	-	1.18E-01	8.66E-04
ReactomeFI	CC	GO:0001891	phagocytic cup	-	28	25	-	-	6.11E-03	1.44E-03
ReactomeFI	CC	GO:0001917	photoreceptor inner segment	-	71	56	-	-	1.89E-02	3.25E-03
ReactomeFI	BP	GO:0001921	positive regulation of receptor recycling	-	12	11	-	-	1.30E-03	6.50E-04
ReactomeFI	CC	GO:0001931	uropod	-	13	13	-	-	1.74E-02	7.94E-04
ReactomeFI	BP	GO:0001941	postsynaptic membrane organization	-	37	30	-	-	2.13E-02	1.73E-03
ReactomeFI	BP	GO:0001946	lymphangiogenesis	-	18	16	-	-	5.22E-02	9.38E-04
ReactomeFI	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	67	-	-	2.36E-03	3.90E-03
ReactomeFI	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	57	-	-	7.16E-03	3.32E-03
ReactomeFI	BP	GO:0001964	startle response	-	27	26	-	-	1.29E-02	1.52E-03
ReactomeFI	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	7.07E-02	1.52E-03
ReactomeFI	MF	GO:0001968	fibronectin binding	-	30	26	-	-	7.49E-03	1.52E-03
ReactomeFI	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	3.15E-03	8.66E-04
ReactomeFI	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	9.47E-03	1.52E-03
ReactomeFI	BP	GO:0002027	regulation of heart rate	-	106	95	-	-	6.98E-02	5.49E-03
ReactomeFI	MF	GO:0002039	p53 binding	-	66	63	-	-	5.18E-03	3.68E-03
ReactomeFI	BP	GO:0002063	chondrocyte development	-	33	28	-	-	5.22E-02	1.66E-03
ReactomeFI	BP	GO:0002064	epithelial cell development	-	210	191	-	-	1.14E-02	1.10E-02
ReactomeFI	BP	GO:0002076	osteoblast development	-	17	17	-	-	1.74E-02	1.01E-03
ReactomeFI	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	3.37E-03	7.22E-04
ReactomeFI	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	3.04E-03	1.23E-03
ReactomeFI	CC	GO:0002102	podosome	-	31	27	-	-	4.52E-03	1.59E-03
ReactomeFI	BP	GO:0002181	cytoplasmic translation	9.55E-18	153	150	110	1.36	-	-
ReactomeFI	BP	GO:0002200	somatic diversification of immune receptors	-	78	72	-	-	2.07E-02	4.19E-03
ReactomeFI	BP	GO:0002209	behavioral defense response	-	39	38	-	-	1.48E-03	2.24E-03
ReactomeFI	BP	GO:0002251	organ or tissue specific immune response	-	43	36	-	-	9.22E-02	2.09E-03
ReactomeFI	BP	GO:0002262	myeloid cell homeostasis	-	172	157	-	-	1.10E-02	9.09E-03
ReactomeFI	BP	GO:0002367	cytokine production involved in immune response	-	121	115	-	-	1.25E-02	6.64E-03
ReactomeFI	BP	GO:0002376	immune system process	4.75E-88	2448	2151	1768	1.22	-	-
ReactomeFI	BP	GO:0002418	immune response to tumor cell	-	29	26	-	-	2.02E-02	1.52E-03
ReactomeFI	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	73	-	-	1.28E-02	4.26E-03
ReactomeFI	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.69E-03	8.66E-04
ReactomeFI	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	19	-	-	5.25E-02	1.15E-03
ReactomeFI	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	77	-	-	2.86E-02	4.47E-03
ReactomeFI	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	3.71E-03	7.22E-04
ReactomeFI	BP	GO:0002679	respiratory burst involved in defense response	-	16	14	-	-	4.75E-04	8.66E-04
ReactomeFI	BP	GO:0002687	positive regulation of leukocyte migration	-	147	135	-	-	1.50E-02	7.80E-03
ReactomeFI	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	46	-	-	3.58E-03	2.67E-03
ReactomeFI	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	126	-	-	1.41E-02	7.29E-03
ReactomeFI	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	11	-	-	8.89E-02	6.50E-04
ReactomeFI	BP	GO:0002931	response to ischemia	-	58	52	-	-	2.64E-02	3.03E-03
ReactomeFI	BP	GO:0003012	muscle system process	1.78E-27	425	395	307	1.29	-	-
ReactomeFI	BP	GO:0003013	circulatory system process	3.34E-32	584	535	422	1.27	-	-
ReactomeFI	BP	GO:0003014	renal system process	2.04E-06	127	114	92	1.24	-	-
ReactomeFI	BP	GO:0003014	renal system process	-	130	117	-	-	6.77E-03	6.78E-03
ReactomeFI	BP	GO:0003016	respiratory system process	-	39	31	-	-	4.94E-03	1.80E-03
ReactomeFI	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	8.65E-03	4.55E-03
ReactomeFI	BP	GO:0003158	endothelium development	-	140	120	-	-	2.93E-02	6.93E-03
ReactomeFI	BP	GO:0003188	heart valve formation	-	16	16	-	-	4.77E-03	9.38E-04
ReactomeFI	BP	GO:0003207	cardiac chamber formation	-	14	13	-	-	3.48E-02	7.94E-04
ReactomeFI	BP	GO:0003272	endocardial cushion formation	-	28	27	-	-	1.67E-02	1.59E-03
ReactomeFI	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	22	-	-	2.06E-02	1.30E-03
ReactomeFI	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	13	-	-	2.70E-02	7.94E-04
ReactomeFI	MF	GO:0003677	DNA binding	2.28E-152	2865	2600	2069	1.26	-	-
ReactomeFI	MF	GO:0003684	damaged DNA binding	-	89	84	-	-	6.41E-02	4.91E-03
ReactomeFI	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	5.04E-02	1.08E-03
ReactomeFI	MF	GO:0003714	transcription corepressor activity	-	190	178	-	-	3.86E-02	1.03E-02
ReactomeFI	MF	GO:0003723	RNA binding	5.40E-42	1679	1437	1212	1.19	-	-
ReactomeFI	MF	GO:0003725	double-stranded RNA binding	-	72	66	-	-	8.05E-02	3.83E-03
ReactomeFI	MF	GO:0003727	single-stranded RNA binding	-	90	74	-	-	4.10E-02	4.33E-03
ReactomeFI	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	28	-	-	1.38E-01	1.66E-03
ReactomeFI	MF	GO:0003756	protein disulfide isomerase activity	-	18	16	-	-	5.75E-02	9.38E-04
ReactomeFI	MF	GO:0003774	cytoskeletal motor activity	1.07E-07	116	107	84	1.28	-	-
ReactomeFI	MF	GO:0003774	cytoskeletal motor activity	-	117	107	-	-	1.07E-01	6.21E-03
ReactomeFI	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	21	-	-	7.44E-02	1.23E-03
ReactomeFI	MF	GO:0003916	DNA topoisomerase activity	-	12	11	-	-	4.02E-02	6.50E-04
ReactomeFI	MF	GO:0003924	GTPase activity	2.18E-34	658	600	475	1.26	-	-
ReactomeFI	MF	GO:0003925	G protein activity	-	45	38	-	-	5.20E-03	2.24E-03
ReactomeFI	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	3.24E-02	7.22E-04
ReactomeFI	MF	GO:0004396	hexokinase activity	-	16	13	-	-	8.25E-02	7.94E-04
ReactomeFI	MF	GO:0004618	phosphoglycerate kinase activity	-	89	84	-	-	1.30E-01	4.91E-03
ReactomeFI	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	16	-	-	1.33E-01	9.38E-04
ReactomeFI	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	44	-	-	1.18E-02	2.60E-03
ReactomeFI	MF	GO:0004713	protein tyrosine kinase activity	-	213	202	-	-	5.29E-02	1.17E-02
ReactomeFI	MF	GO:0004875	complement receptor activity	-	12	11	-	-	1.83E-01	6.50E-04
ReactomeFI	CC	GO:0004879	nuclear receptor activity	-	63	61	-	-	1.48E-02	3.54E-03
ReactomeFI	MF	GO:0004896	cytokine receptor activity	-	93	91	-	-	2.58E-02	5.27E-03
ReactomeFI	MF	GO:0005035	death receptor activity	-	16	16	-	-	4.84E-02	9.38E-04
ReactomeFI	MF	GO:0005112	Notch binding	-	26	20	-	-	2.29E-02	1.15E-03
ReactomeFI	MF	GO:0005132	type I interferon receptor binding	-	17	17	-	-	6.33E-02	1.01E-03
ReactomeFI	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	2.21E-02	1.30E-03
ReactomeFI	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	2.51E-03	8.66E-04
ReactomeFI	MF	GO:0005178	integrin binding	-	153	147	-	-	8.92E-02	8.52E-03
ReactomeFI	MF	GO:0005198	structural molecule activity	1.13E-22	798	690	576	1.20	-	-
ReactomeFI	CC	GO:0005200	structural constituent of cytoskeleton	-	112	108	-	-	1.04E-01	6.28E-03
ReactomeFI	MF	GO:0005215	transporter activity	9.55E-07	1462	1135	1056	1.08	-	-
ReactomeFI	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	18	-	-	7.27E-02	1.08E-03
ReactomeFI	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	172	-	-	2.47E-01	9.96E-03
ReactomeFI	MF	GO:0005496	steroid binding	-	110	96	-	-	1.15E-01	5.56E-03
ReactomeFI	MF	GO:0005506	iron ion binding	-	154	115	-	-	5.34E-02	6.64E-03
ReactomeFI	MF	GO:0005507	copper ion binding	-	63	49	-	-	8.07E-02	2.89E-03
ReactomeFI	MF	GO:0005516	calmodulin binding	-	206	186	-	-	2.57E-02	1.08E-02
ReactomeFI	MF	GO:0005521	lamin binding	-	15	13	-	-	7.60E-03	7.94E-04
ReactomeFI	MF	GO:0005523	tropomyosin binding	-	15	12	-	-	1.88E-01	7.22E-04
ReactomeFI	MF	GO:0005527	macrolide binding	-	12	12	-	-	7.74E-02	7.22E-04
ReactomeFI	MF	GO:0005539	glycosaminoglycan binding	-	236	195	-	-	5.48E-02	1.13E-02
ReactomeFI	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	68	-	-	1.67E-02	3.97E-03
ReactomeFI	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	32	-	-	3.37E-03	1.88E-03
ReactomeFI	MF	GO:0005549	odorant binding	-	128	114	-	-	5.36E-02	6.64E-03
ReactomeFI	CC	GO:0005615	extracellular space	4.76E-43	3190	2610	2303	1.13	-	-
ReactomeFI	CC	GO:0005635	nuclear envelope	4.29E-04	493	390	356	1.10	-	-
ReactomeFI	CC	GO:0005640	nuclear outer membrane	-	30	18	-	-	1.05E-02	1.08E-03
ReactomeFI	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	8.51E-03	7.94E-04
ReactomeFI	CC	GO:0005730	nucleolus	1.14E-28	988	856	713	1.20	-	-
ReactomeFI	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	23	-	-	2.77E-01	1.37E-03
ReactomeFI	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	7.60E-02	7.94E-04
ReactomeFI	CC	GO:0005739	mitochondrion	6.97E-06	1671	1284	1207	1.06	-	-
ReactomeFI	CC	GO:0005764	lysosome	5.65E-13	747	622	539	1.15	-	-
ReactomeFI	CC	GO:0005768	endosome	4.71E-23	1037	880	749	1.18	-	-
ReactomeFI	CC	GO:0005775	vacuolar lumen	-	176	147	-	-	1.49E-02	8.52E-03
ReactomeFI	CC	GO:0005776	autophagosome	-	111	99	-	-	7.62E-02	5.77E-03
ReactomeFI	CC	GO:0005777	peroxisome	1.47E-04	142	122	103	1.19	-	-
ReactomeFI	CC	GO:0005783	endoplasmic reticulum	7.53E-12	2020	1586	1459	1.09	-	-
ReactomeFI	CC	GO:0005794	Golgi apparatus	3.87E-08	1636	1275	1181	1.08	-	-
ReactomeFI	CC	GO:0005796	Golgi lumen	-	106	101	-	-	1.50E-02	5.85E-03
ReactomeFI	CC	GO:0005811	lipid droplet	3.76E-01	102	78	74	1.06	-	-
ReactomeFI	CC	GO:0005811	lipid droplet	-	102	78	-	-	4.27E-02	4.55E-03
ReactomeFI	CC	GO:0005815	microtubule organizing center	1.01E-05	843	664	609	1.09	-	-
ReactomeFI	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	2.66E-01	6.50E-04
ReactomeFI	CC	GO:0005840	ribosome	3.11E-22	222	215	160	1.34	-	-
ReactomeFI	CC	GO:0005849	mRNA cleavage factor complex	-	22	16	-	-	6.10E-02	9.38E-04
ReactomeFI	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	1.96E-01	8.66E-04
ReactomeFI	CC	GO:0005881	cytoplasmic microtubule	-	256	158	-	-	3.45E-02	9.17E-03
ReactomeFI	CC	GO:0005905	clathrin-coated pit	-	73	68	-	-	6.81E-02	3.97E-03
ReactomeFI	CC	GO:0005929	cilium	2.71E-01	842	594	608	0.98	-	-
ReactomeFI	CC	GO:0005940	septin ring	-	14	13	-	-	9.29E-01	7.94E-04
ReactomeFI	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	27	-	-	1.13E-02	1.59E-03
ReactomeFI	BP	GO:0005975	carbohydrate metabolic process	5.30E-06	551	444	398	1.12	-	-
ReactomeFI	BP	GO:0005996	monosaccharide metabolic process	-	250	204	-	-	5.01E-02	1.18E-02
ReactomeFI	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	1.57E-01	7.22E-04
ReactomeFI	BP	GO:0006023	aminoglycan biosynthetic process	-	74	68	-	-	4.13E-02	3.97E-03
ReactomeFI	BP	GO:0006026	aminoglycan catabolic process	-	34	23	-	-	2.36E-01	1.37E-03
ReactomeFI	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	12	-	-	5.36E-01	7.22E-04
ReactomeFI	BP	GO:0006091	generation of precursor metabolites and energy	1.32E-14	502	434	362	1.20	-	-
ReactomeFI	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	5.52E-01	1.88E-03
ReactomeFI	BP	GO:0006260	DNA replication	1.98E-17	279	258	201	1.28	-	-
ReactomeFI	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	8.08E-02	1.01E-03
ReactomeFI	BP	GO:0006281	DNA repair	5.18E-30	587	534	424	1.26	-	-
ReactomeFI	BP	GO:0006304	DNA modification	-	30	29	-	-	1.86E-01	1.73E-03
ReactomeFI	BP	GO:0006310	DNA recombination	3.35E-14	333	297	240	1.24	-	-
ReactomeFI	BP	GO:0006325	chromatin organization	5.43E-26	720	635	520	1.22	-	-
ReactomeFI	BP	GO:0006355	regulation of DNA-templated transcription	5.39E-220	3342	3087	2413	1.28	-	-
ReactomeFI	BP	GO:0006399	tRNA metabolic process	1.00E+00	196	142	142	1.00	-	-
ReactomeFI	CC	GO:0006406	mRNA export from nucleus	-	69	63	-	-	3.14E-01	3.68E-03
ReactomeFI	BP	GO:0006413	translational initiation	-	122	112	-	-	2.81E-01	6.50E-03
ReactomeFI	BP	GO:0006450	regulation of translational fidelity	-	18	13	-	-	4.47E-01	7.94E-04
ReactomeFI	BP	GO:0006457	protein folding	3.63E-09	210	187	152	1.23	-	-
ReactomeFI	MF	GO:0006469	negative regulation of protein kinase activity	-	222	194	-	-	1.18E-02	1.13E-02
ReactomeFI	BP	GO:0006486	protein glycosylation	5.49E-01	225	167	162	1.03	-	-
ReactomeFI	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	19	-	-	7.01E-01	1.15E-03
ReactomeFI	BP	GO:0006517	protein deglycosylation	-	26	24	-	-	1.51E-01	1.44E-03
ReactomeFI	BP	GO:0006520	amino acid metabolic process	3.23E-01	292	203	211	0.96	-	-
ReactomeFI	BP	GO:0006575	cellular modified amino acid metabolic process	2.18E-01	186	142	134	1.06	-	-
ReactomeFI	BP	GO:0006629	lipid metabolic process	4.87E-06	1355	1050	978	1.07	-	-
ReactomeFI	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	19	-	-	6.58E-03	1.15E-03
ReactomeFI	BP	GO:0006730	one-carbon metabolic process	-	24	19	-	-	6.13E-01	1.15E-03
ReactomeFI	BP	GO:0006766	vitamin metabolic process	5.90E-01	107	80	77	1.04	-	-
ReactomeFI	BP	GO:0006790	sulfur compound metabolic process	1.94E-04	320	260	231	1.13	-	-
ReactomeFI	CC	GO:0006858	extracellular transport	-	45	30	-	-	1.10E-01	1.73E-03
ReactomeFI	BP	GO:0006885	regulation of pH	-	104	85	-	-	1.91E-01	4.91E-03
ReactomeFI	BP	GO:0006886	intracellular protein transport	8.79E-42	664	616	479	1.28	-	-
ReactomeFI	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	118	-	-	2.85E-01	6.86E-03
ReactomeFI	BP	GO:0006913	nucleocytoplasmic transport	1.63E-14	326	292	235	1.24	-	-
ReactomeFI	BP	GO:0006914	autophagy	3.52E-25	568	510	410	1.24	-	-
ReactomeFI	BP	GO:0006925	inflammatory cell apoptotic process	-	23	21	-	-	7.59E-04	1.23E-03
ReactomeFI	BP	GO:0006929	substrate-dependent cell migration	-	26	24	-	-	1.56E-03	1.44E-03
ReactomeFI	BP	GO:0006949	syncytium formation	-	66	54	-	-	5.21E-03	3.18E-03
ReactomeFI	BP	GO:0006954	inflammatory response	1.11E-43	820	749	592	1.27	-	-
ReactomeFI	BP	GO:0006968	cellular defense response	-	52	50	-	-	2.09E-02	2.89E-03
ReactomeFI	CC	GO:0006984	ER-nucleus signaling pathway	-	46	43	-	-	3.05E-02	2.53E-03
ReactomeFI	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	1.35E-02	8.66E-04
ReactomeFI	BP	GO:0007005	mitochondrion organization	5.06E-09	484	404	349	1.16	-	-
ReactomeFI	CC	GO:0007006	mitochondrial membrane organization	-	117	100	-	-	2.11E-01	5.77E-03
ReactomeFI	BP	GO:0007010	cytoskeleton organization	3.32E-23	1639	1349	1183	1.14	-	-
ReactomeFI	BP	GO:0007018	microtubule-based movement	5.01E-01	640	470	462	1.02	-	-
ReactomeFI	CC	GO:0007034	vacuolar transport	-	168	157	-	-	1.39E-01	9.09E-03
ReactomeFI	CC	GO:0007039	protein catabolic process in the vacuole	-	61	56	-	-	1.74E-01	3.25E-03
ReactomeFI	BP	GO:0007040	lysosome organization	9.36E-03	107	89	77	1.15	-	-
ReactomeFI	BP	GO:0007059	chromosome segregation	7.43E-20	403	365	291	1.25	-	-
ReactomeFI	CC	GO:0007097	nuclear migration	-	24	20	-	-	1.32E-02	1.15E-03
ReactomeFI	BP	GO:0007130	synaptonemal complex assembly	-	23	18	-	-	7.95E-02	1.08E-03
ReactomeFI	BP	GO:0007155	cell adhesion	9.95E-59	1444	1286	1043	1.23	-	-
ReactomeFI	BP	GO:0007163	establishment or maintenance of cell polarity	2.06E-14	227	210	164	1.28	-	-
ReactomeFI	BP	GO:0007164	establishment of tissue polarity	-	38	33	-	-	1.81E-02	1.95E-03
ReactomeFI	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	2.50E-01	6.50E-04
ReactomeFI	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	56	-	-	2.67E-02	3.25E-03
ReactomeFI	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	206	-	-	1.02E-01	1.19E-02
ReactomeFI	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	87	-	-	4.23E-02	5.05E-03
ReactomeFI	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	165	-	-	3.76E-02	9.53E-03
ReactomeFI	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	6.15E-03	1.59E-03
ReactomeFI	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	36	-	-	6.17E-03	2.09E-03
ReactomeFI	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	3.49E-03	1.23E-03
ReactomeFI	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	24	-	-	2.46E-01	1.44E-03
ReactomeFI	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	13	-	-	4.72E-02	7.94E-04
ReactomeFI	BP	GO:0007218	neuropeptide signaling pathway	-	113	101	-	-	1.69E-01	5.85E-03
ReactomeFI	BP	GO:0007272	ensheathment of neurons	-	146	122	-	-	1.36E-02	7.07E-03
ReactomeFI	BP	GO:0007281	germ cell development	-	334	246	-	-	3.30E-02	1.42E-02
ReactomeFI	BP	GO:0007340	acrosome reaction	-	38	24	-	-	4.44E-02	1.44E-03
ReactomeFI	BP	GO:0007405	neuroblast proliferation	-	81	77	-	-	4.43E-02	4.47E-03
ReactomeFI	BP	GO:0007566	embryo implantation	-	57	44	-	-	3.34E-03	2.60E-03
ReactomeFI	BP	GO:0007588	excretion	-	40	34	-	-	6.36E-03	2.02E-03
ReactomeFI	BP	GO:0007635	chemosensory behavior	-	20	18	-	-	8.11E-03	1.08E-03
ReactomeFI	MF	GO:0008013	beta-catenin binding	-	86	80	-	-	8.31E-03	4.62E-03
ReactomeFI	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	3.12E-01	2.74E-03
ReactomeFI	BP	GO:0008033	tRNA processing	-	136	92	-	-	4.25E-01	5.34E-03
ReactomeFI	BP	GO:0008038	neuron recognition	-	46	42	-	-	1.39E-02	2.45E-03
ReactomeFI	MF	GO:0008066	glutamate receptor activity	-	70	64	-	-	9.49E-02	3.75E-03
ReactomeFI	CC	GO:0008088	axo-dendritic transport	-	78	71	-	-	1.40E-01	4.11E-03
ReactomeFI	MF	GO:0008092	cytoskeletal protein binding	1.10E-23	1023	871	739	1.18	-	-
ReactomeFI	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	6.46E-02	1.44E-03
ReactomeFI	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	81	-	-	2.79E-01	4.69E-03
ReactomeFI	CC	GO:0008180	COP9 signalosome	-	17	16	-	-	6.56E-03	9.38E-04
ReactomeFI	BP	GO:0008212	mineralocorticoid metabolic process	-	14	13	-	-	6.35E-03	7.94E-04
ReactomeFI	BP	GO:0008213	protein alkylation	-	58	49	-	-	8.32E-02	2.89E-03
ReactomeFI	BP	GO:0008217	regulation of blood pressure	-	186	171	-	-	2.60E-02	9.89E-03
ReactomeFI	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	7.21E-01	8.66E-04
ReactomeFI	MF	GO:0008276	protein methyltransferase activity	-	96	77	-	-	1.34E-01	4.47E-03
ReactomeFI	MF	GO:0008289	lipid binding	4.78E-10	836	680	604	1.13	-	-
ReactomeFI	BP	GO:0008299	isoprenoid biosynthetic process	-	30	26	-	-	2.60E-01	1.52E-03
ReactomeFI	MF	GO:0008301	"DNA binding, bending"	-	18	17	-	-	7.25E-02	1.01E-03
ReactomeFI	MF	GO:0008327	methyl-CpG binding	-	31	25	-	-	1.42E-02	1.44E-03
ReactomeFI	CC	GO:0008333	endosome to lysosome transport	-	73	67	-	-	8.18E-02	3.90E-03
ReactomeFI	BP	GO:0008340	determination of adult lifespan	-	23	22	-	-	3.70E-03	1.30E-03
ReactomeFI	BP	GO:0008360	regulation of cell shape	-	139	121	-	-	4.68E-02	7.00E-03
ReactomeFI	MF	GO:0008443	phosphofructokinase activity	-	27	25	-	-	2.02E-01	1.44E-03
ReactomeFI	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	123	-	-	4.49E-01	7.15E-03
ReactomeFI	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	219	-	-	2.39E-01	1.27E-02
ReactomeFI	MF	GO:0008527	taste receptor activity	-	28	26	-	-	1.66E-01	1.52E-03
ReactomeFI	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	42	-	-	2.14E-02	2.45E-03
ReactomeFI	BP	GO:0008637	apoptotic mitochondrial changes	-	108	93	-	-	3.90E-02	5.41E-03
ReactomeFI	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	110	-	-	1.04E-01	6.35E-03
ReactomeFI	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	17	-	-	2.66E-01	1.01E-03
ReactomeFI	BP	GO:0009110	vitamin biosynthetic process	-	23	18	-	-	6.26E-02	1.08E-03
ReactomeFI	BP	GO:0009163	nucleoside biosynthetic process	-	16	12	-	-	3.83E-01	7.22E-04
ReactomeFI	BP	GO:0009164	nucleoside catabolic process	-	25	15	-	-	1.71E-01	8.66E-04
ReactomeFI	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	13	-	-	5.20E-01	7.94E-04
ReactomeFI	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	30	-	-	1.04E-01	1.73E-03
ReactomeFI	BP	GO:0009267	cellular response to starvation	-	170	157	-	-	1.84E-02	9.09E-03
ReactomeFI	BP	GO:0009268	response to pH	-	43	38	-	-	1.85E-02	2.24E-03
ReactomeFI	BP	GO:0009303	rRNA transcription	-	37	36	-	-	1.65E-02	2.09E-03
ReactomeFI	BP	GO:0009309	amine biosynthetic process	-	38	26	-	-	8.89E-02	1.52E-03
ReactomeFI	BP	GO:0009310	amine catabolic process	-	20	11	-	-	1.07E-01	6.50E-04
ReactomeFI	BP	GO:0009404	toxin metabolic process	-	17	13	-	-	1.18E-02	7.94E-04
ReactomeFI	BP	GO:0009451	RNA modification	-	169	119	-	-	3.58E-01	6.93E-03
ReactomeFI	BP	GO:0009566	fertilization	-	205	147	-	-	4.82E-02	8.52E-03
ReactomeFI	BP	GO:0009581	detection of external stimulus	-	137	117	-	-	9.16E-02	6.78E-03
ReactomeFI	BP	GO:0009582	detection of abiotic stimulus	-	140	120	-	-	7.69E-02	6.93E-03
ReactomeFI	BP	GO:0009612	response to mechanical stimulus	-	215	198	-	-	9.84E-03	1.15E-02
ReactomeFI	BP	GO:0009649	entrainment of circadian clock	-	30	29	-	-	1.11E-02	1.73E-03
ReactomeFI	BP	GO:0009755	hormone-mediated signaling pathway	-	221	209	-	-	2.01E-02	1.21E-02
ReactomeFI	BP	GO:0009812	flavonoid metabolic process	-	14	14	-	-	1.91E-01	8.66E-04
ReactomeFI	BP	GO:0009880	embryonic pattern specification	-	70	63	-	-	9.18E-03	3.68E-03
ReactomeFI	MF	GO:0009881	photoreceptor activity	-	17	12	-	-	4.71E-01	7.22E-04
ReactomeFI	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	155	-	-	6.68E-03	8.95E-03
ReactomeFI	MF	GO:0009975	cyclase activity	1.84E-11	277	246	200	1.23	-	-
ReactomeFI	BP	GO:0009994	oocyte differentiation	-	57	48	-	-	4.90E-03	2.81E-03
ReactomeFI	MF	GO:0010181	FMN binding	-	15	12	-	-	8.22E-02	7.22E-04
ReactomeFI	BP	GO:0010232	vascular transport	-	87	68	-	-	6.26E-02	3.97E-03
ReactomeFI	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	8.10E-02	7.22E-04
ReactomeFI	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	50	-	-	5.05E-01	2.89E-03
ReactomeFI	CC	GO:0010369	chromocenter	-	14	13	-	-	1.82E-03	7.94E-04
ReactomeFI	BP	GO:0010453	regulation of cell fate commitment	-	40	34	-	-	7.57E-03	2.02E-03
ReactomeFI	BP	GO:0010457	centriole-centriole cohesion	-	15	11	-	-	3.53E-03	6.50E-04
ReactomeFI	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	8.16E-03	1.80E-03
ReactomeFI	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	1.48E-01	1.08E-03
ReactomeFI	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	20	-	-	1.56E-03	1.15E-03
ReactomeFI	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	14	-	-	9.30E-03	8.66E-04
ReactomeFI	BP	GO:0010623	programmed cell death involved in cell development	-	25	22	-	-	1.49E-02	1.30E-03
ReactomeFI	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	63	-	-	8.87E-03	3.68E-03
ReactomeFI	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	11	-	-	2.12E-04	6.50E-04
ReactomeFI	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	15	-	-	1.02E-01	8.66E-04
ReactomeFI	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	61	-	-	2.84E-03	3.54E-03
ReactomeFI	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	48	-	-	1.02E-02	2.81E-03
ReactomeFI	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	32	-	-	1.25E-02	1.88E-03
ReactomeFI	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	4.81E-03	1.80E-03
ReactomeFI	BP	GO:0010762	regulation of fibroblast migration	-	40	32	-	-	5.38E-03	1.88E-03
ReactomeFI	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	38	-	-	9.41E-03	2.24E-03
ReactomeFI	BP	GO:0010842	retina layer formation	-	25	15	-	-	1.60E-03	8.66E-04
ReactomeFI	MF	GO:0010851	cyclase regulator activity	-	17	16	-	-	1.74E-01	9.38E-04
ReactomeFI	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	4.49E-03	1.44E-03
ReactomeFI	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	13	-	-	5.57E-03	7.94E-04
ReactomeFI	BP	GO:0010883	regulation of lipid storage	-	53	43	-	-	7.64E-03	2.53E-03
ReactomeFI	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	107	-	-	7.40E-02	6.21E-03
ReactomeFI	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	1.93E-02	6.50E-04
ReactomeFI	BP	GO:0012501	programmed cell death	1.34E-80	1954	1740	1411	1.23	-	-
ReactomeFI	BP	GO:0014029	neural crest formation	-	15	15	-	-	3.31E-02	8.66E-04
ReactomeFI	BP	GO:0014047	glutamate secretion	-	25	23	-	-	7.82E-03	1.37E-03
ReactomeFI	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	29	-	-	9.07E-03	1.73E-03
ReactomeFI	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	23	-	-	1.14E-03	1.37E-03
ReactomeFI	BP	GO:0014812	muscle cell migration	-	110	80	-	-	8.88E-03	4.62E-03
ReactomeFI	BP	GO:0014823	response to activity	-	70	62	-	-	5.84E-03	3.61E-03
ReactomeFI	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.76E-02	7.22E-04
ReactomeFI	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	14	-	-	7.49E-04	8.66E-04
ReactomeFI	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	12	-	-	1.39E-02	7.22E-04
ReactomeFI	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	62	-	-	4.48E-03	3.61E-03
ReactomeFI	MF	GO:0015026	coreceptor activity	-	48	46	-	-	5.15E-03	2.67E-03
ReactomeFI	MF	GO:0015035	protein-disulfide reductase activity	-	32	27	-	-	4.20E-02	1.59E-03
ReactomeFI	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	48	-	-	1.31E-01	2.81E-03
ReactomeFI	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	22	-	-	3.58E-01	1.30E-03
ReactomeFI	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	104	-	-	1.64E-01	6.06E-03
ReactomeFI	MF	GO:0015399	primary active transmembrane transporter activity	-	190	164	-	-	1.80E-01	9.53E-03
ReactomeFI	CC	GO:0015464	acetylcholine receptor activity	-	21	20	-	-	2.14E-01	1.15E-03
ReactomeFI	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	20	-	-	1.62E-01	1.15E-03
ReactomeFI	BP	GO:0015669	gas transport	-	23	18	-	-	2.86E-01	1.08E-03
ReactomeFI	BP	GO:0015697	quaternary ammonium group transport	-	16	13	-	-	4.19E-02	7.94E-04
ReactomeFI	BP	GO:0015803	branched-chain amino acid transport	-	14	12	-	-	1.04E-01	7.22E-04
ReactomeFI	BP	GO:0015807	L-amino acid transport	-	94	65	-	-	2.11E-01	3.75E-03
ReactomeFI	BP	GO:0015810	aspartate transmembrane transport	-	19	16	-	-	2.09E-01	9.38E-04
ReactomeFI	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	16	-	-	1.56E-01	9.38E-04
ReactomeFI	BP	GO:0015844	monoamine transport	-	88	84	-	-	7.03E-02	4.91E-03
ReactomeFI	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	25	-	-	2.06E-01	1.44E-03
ReactomeFI	BP	GO:0016054	organic acid catabolic process	-	251	174	-	-	2.79E-01	1.01E-02
ReactomeFI	BP	GO:0016071	mRNA metabolic process	4.09E-33	713	643	515	1.25	-	-
ReactomeFI	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	1.19E-01	1.15E-03
ReactomeFI	BP	GO:0016180	snRNA processing	-	28	23	-	-	8.78E-02	1.37E-03
ReactomeFI	BP	GO:0016192	vesicle-mediated transport	8.09E-39	1894	1597	1368	1.17	-	-
ReactomeFI	CC	GO:0016197	endosomal transport	-	282	240	-	-	1.65E-01	1.39E-02
ReactomeFI	MF	GO:0016208	AMP binding	-	22	21	-	-	8.46E-03	1.23E-03
ReactomeFI	MF	GO:0016209	antioxidant activity	-	92	73	-	-	8.51E-02	4.26E-03
ReactomeFI	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	1.90E-01	2.31E-03
ReactomeFI	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	11	-	-	1.64E-01	6.50E-04
ReactomeFI	CC	GO:0016323	basolateral plasma membrane	-	239	197	-	-	3.47E-02	1.14E-02
ReactomeFI	CC	GO:0016327	apicolateral plasma membrane	-	23	20	-	-	1.72E-02	1.15E-03
ReactomeFI	CC	GO:0016328	lateral plasma membrane	-	66	62	-	-	1.12E-02	3.61E-03
ReactomeFI	CC	GO:0016363	nuclear matrix	-	127	118	-	-	6.90E-03	6.86E-03
ReactomeFI	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	2.17E-03	6.50E-04
ReactomeFI	CC	GO:0016482	cytosolic transport	-	135	107	-	-	1.32E-01	6.21E-03
ReactomeFI	BP	GO:0016485	protein processing	-	248	214	-	-	1.98E-02	1.24E-02
ReactomeFI	MF	GO:0016491	oxidoreductase activity	2.35E-02	888	671	641	1.05	-	-
ReactomeFI	MF	GO:0016500	protein-hormone receptor activity	-	21	20	-	-	3.79E-03	1.15E-03
ReactomeFI	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	2.65E-02	1.37E-03
ReactomeFI	MF	GO:0016530	metallochaperone activity	-	14	13	-	-	5.34E-02	7.94E-04
ReactomeFI	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	1.78E-01	4.33E-03
ReactomeFI	CC	GO:0016592	mediator complex	-	38	37	-	-	3.44E-01	2.17E-03
ReactomeFI	MF	GO:0016740	transferase activity	2.20E-59	3074	2573	2220	1.16	-	-
ReactomeFI	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	175	-	-	1.01E-01	1.01E-02
ReactomeFI	MF	GO:0016757	glycosyltransferase activity	-	286	221	-	-	9.33E-02	1.28E-02
ReactomeFI	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	51	-	-	5.99E-02	2.96E-03
ReactomeFI	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	19	-	-	2.05E-01	1.15E-03
ReactomeFI	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	30	-	-	3.48E-01	1.73E-03
ReactomeFI	MF	GO:0016779	nucleotidyltransferase activity	-	264	225	-	-	8.35E-02	1.30E-02
ReactomeFI	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	15	-	-	6.68E-01	8.66E-04
ReactomeFI	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	69	-	-	1.95E-01	4.04E-03
ReactomeFI	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	102	-	-	2.45E-01	5.92E-03
ReactomeFI	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	97	-	-	2.06E-01	5.63E-03
ReactomeFI	MF	GO:0016829	lyase activity	5.21E-06	538	434	388	1.12	-	-
ReactomeFI	MF	GO:0016853	isomerase activity	1.62E-04	252	208	182	1.14	-	-
ReactomeFI	MF	GO:0016874	ligase activity	4.18E-05	283	234	204	1.15	-	-
ReactomeFI	MF	GO:0016917	GABA receptor activity	-	23	21	-	-	2.91E-01	1.23E-03
ReactomeFI	BP	GO:0017004	cytochrome complex assembly	-	40	25	-	-	3.54E-01	1.44E-03
ReactomeFI	BP	GO:0017014	protein nitrosylation	-	17	14	-	-	4.00E-02	8.66E-04
ReactomeFI	MF	GO:0017022	myosin binding	-	73	63	-	-	2.24E-02	3.68E-03
ReactomeFI	MF	GO:0017069	snRNA binding	-	54	42	-	-	6.37E-02	2.45E-03
ReactomeFI	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	5.28E-01	6.50E-04
ReactomeFI	BP	GO:0017148	negative regulation of translation	-	390	107	-	-	1.26E-01	6.21E-03
ReactomeFI	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	4.94E-02	7.22E-04
ReactomeFI	MF	GO:0017166	vinculin binding	-	12	11	-	-	1.11E-02	6.50E-04
ReactomeFI	MF	GO:0017171	serine hydrolase activity	-	207	170	-	-	2.92E-01	9.82E-03
ReactomeFI	BP	GO:0018126	protein hydroxylation	-	26	21	-	-	6.11E-02	1.23E-03
ReactomeFI	BP	GO:0018149	peptide cross-linking	-	28	26	-	-	1.71E-01	1.52E-03
ReactomeFI	BP	GO:0018158	protein oxidation	-	15	11	-	-	3.52E-02	6.50E-04
ReactomeFI	BP	GO:0018342	protein prenylation	-	15	14	-	-	2.12E-01	8.66E-04
ReactomeFI	BP	GO:0018410	C-terminal protein amino acid modification	-	15	12	-	-	8.25E-03	7.22E-04
ReactomeFI	CC	GO:0018995	host cellular component	-	12	12	-	-	2.24E-02	7.22E-04
ReactomeFI	MF	GO:0019003	GDP binding	-	89	81	-	-	1.10E-02	4.69E-03
ReactomeFI	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	1.38E-01	1.01E-03
ReactomeFI	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	105	-	-	5.22E-02	6.06E-03
ReactomeFI	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	34	-	-	5.00E-01	2.02E-03
ReactomeFI	MF	GO:0019207	kinase regulator activity	-	267	238	-	-	2.91E-02	1.38E-02
ReactomeFI	MF	GO:0019208	phosphatase regulator activity	-	107	84	-	-	3.85E-02	4.91E-03
ReactomeFI	BP	GO:0019233	sensory perception of pain	-	103	91	-	-	1.30E-02	5.27E-03
ReactomeFI	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	30	-	-	8.70E-02	1.73E-03
ReactomeFI	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	16	-	-	6.67E-01	9.38E-04
ReactomeFI	BP	GO:0019755	one-carbon compound transport	-	28	21	-	-	1.70E-01	1.23E-03
ReactomeFI	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	1.12E-02	6.50E-04
ReactomeFI	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	103	-	-	1.57E-01	5.99E-03
ReactomeFI	MF	GO:0019825	oxygen binding	-	40	32	-	-	8.40E-02	1.88E-03
ReactomeFI	MF	GO:0019838	growth factor binding	-	182	166	-	-	2.05E-02	9.60E-03
ReactomeFI	MF	GO:0019843	rRNA binding	-	69	66	-	-	2.81E-02	3.83E-03
ReactomeFI	MF	GO:0019894	kinesin binding	-	45	40	-	-	7.13E-02	2.31E-03
ReactomeFI	CC	GO:0019897	extrinsic component of plasma membrane	-	156	146	-	-	7.72E-03	8.44E-03
ReactomeFI	BP	GO:0021515	cell differentiation in spinal cord	-	51	49	-	-	8.02E-03	2.89E-03
ReactomeFI	BP	GO:0021516	dorsal spinal cord development	-	20	19	-	-	6.35E-03	1.15E-03
ReactomeFI	BP	GO:0021517	ventral spinal cord development	-	47	45	-	-	1.15E-02	2.60E-03
ReactomeFI	BP	GO:0021533	cell differentiation in hindbrain	-	23	20	-	-	4.44E-03	1.15E-03
ReactomeFI	BP	GO:0021535	cell migration in hindbrain	-	16	15	-	-	2.99E-03	8.66E-04
ReactomeFI	BP	GO:0021542	dentate gyrus development	-	19	17	-	-	2.77E-04	1.01E-03
ReactomeFI	BP	GO:0021548	pons development	-	11	11	-	-	3.51E-02	6.50E-04
ReactomeFI	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	14	-	-	6.26E-03	8.66E-04
ReactomeFI	BP	GO:0021756	striatum development	-	21	20	-	-	7.18E-03	1.15E-03
ReactomeFI	BP	GO:0021782	glial cell development	-	120	102	-	-	7.92E-03	5.92E-03
ReactomeFI	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	1.05E-02	9.38E-04
ReactomeFI	BP	GO:0021794	thalamus development	-	12	11	-	-	2.95E-03	6.50E-04
ReactomeFI	BP	GO:0021819	layer formation in cerebral cortex	-	14	12	-	-	3.06E-02	7.22E-04
ReactomeFI	BP	GO:0021859	pyramidal neuron differentiation	-	14	12	-	-	2.13E-04	7.22E-04
ReactomeFI	BP	GO:0021872	forebrain generation of neurons	-	52	48	-	-	3.22E-03	2.81E-03
ReactomeFI	BP	GO:0021885	forebrain cell migration	-	63	58	-	-	7.61E-03	3.39E-03
ReactomeFI	BP	GO:0021954	central nervous system neuron development	-	85	74	-	-	6.52E-03	4.33E-03
ReactomeFI	BP	GO:0021979	hypothalamus cell differentiation	-	13	12	-	-	2.12E-02	7.22E-04
ReactomeFI	BP	GO:0021987	cerebral cortex development	-	125	113	-	-	1.88E-02	6.57E-03
ReactomeFI	BP	GO:0022038	corpus callosum development	-	25	20	-	-	1.14E-02	1.15E-03
ReactomeFI	BP	GO:0022401	negative adaptation of signaling pathway	-	21	19	-	-	1.77E-03	1.15E-03
ReactomeFI	BP	GO:0022404	molting cycle process	-	95	88	-	-	4.36E-03	5.12E-03
ReactomeFI	BP	GO:0022406	membrane docking	-	90	84	-	-	1.01E-01	4.91E-03
ReactomeFI	BP	GO:0022600	digestive system process	8.44E-06	110	99	79	1.25	-	-
ReactomeFI	BP	GO:0022612	gland morphogenesis	-	124	121	-	-	8.34E-03	7.00E-03
ReactomeFI	BP	GO:0022618	protein-RNA complex assembly	-	227	183	-	-	1.11E-01	1.06E-02
ReactomeFI	CC	GO:0022626	cytosolic ribosome	-	118	113	-	-	1.35E-01	6.57E-03
ReactomeFI	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	240	-	-	2.09E-01	1.39E-02
ReactomeFI	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	30	-	-	8.16E-02	1.73E-03
ReactomeFI	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	20	-	-	3.86E-03	1.15E-03
ReactomeFI	MF	GO:0023023	MHC protein complex binding	-	36	34	-	-	2.79E-02	2.02E-03
ReactomeFI	CC	GO:0030018	Z disc	-	129	118	-	-	7.30E-02	6.86E-03
ReactomeFI	CC	GO:0030027	lamellipodium	-	202	185	-	-	2.90E-02	1.07E-02
ReactomeFI	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	35	-	-	2.79E-01	2.02E-03
ReactomeFI	CC	GO:0030126	COPI vesicle coat	-	13	12	-	-	5.39E-02	7.22E-04
ReactomeFI	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	17	-	-	1.07E-01	1.01E-03
ReactomeFI	MF	GO:0030145	manganese ion binding	-	65	50	-	-	8.76E-03	2.89E-03
ReactomeFI	BP	GO:0030149	sphingolipid catabolic process	-	32	22	-	-	2.91E-01	1.30E-03
ReactomeFI	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	5.25E-03	2.96E-03
ReactomeFI	BP	GO:0030163	protein catabolic process	2.63E-44	990	890	715	1.25	-	-
ReactomeFI	BP	GO:0030168	platelet activation	-	135	126	-	-	1.48E-02	7.29E-03
ReactomeFI	MF	GO:0030170	pyridoxal phosphate binding	-	56	34	-	-	8.70E-02	2.02E-03
ReactomeFI	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	129	-	-	2.68E-02	7.51E-03
ReactomeFI	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	136	-	-	2.36E-02	7.87E-03
ReactomeFI	BP	GO:0030193	regulation of blood coagulation	-	70	66	-	-	6.59E-02	3.83E-03
ReactomeFI	BP	GO:0030198	extracellular matrix organization	4.25E-07	314	265	227	1.17	-	-
ReactomeFI	MF	GO:0030215	semaphorin receptor binding	-	23	23	-	-	2.46E-01	1.37E-03
ReactomeFI	BP	GO:0030220	platelet formation	-	22	20	-	-	3.93E-03	1.15E-03
ReactomeFI	BP	GO:0030238	male sex determination	-	14	14	-	-	1.26E-01	8.66E-04
ReactomeFI	MF	GO:0030276	clathrin binding	-	70	61	-	-	1.57E-01	3.54E-03
ReactomeFI	BP	GO:0030279	negative regulation of ossification	-	39	32	-	-	1.42E-02	1.88E-03
ReactomeFI	CC	GO:0030286	dynein complex	-	210	140	-	-	7.59E-02	8.08E-03
ReactomeFI	BP	GO:0030307	positive regulation of cell growth	-	164	145	-	-	9.30E-03	8.37E-03
ReactomeFI	BP	GO:0030308	negative regulation of cell growth	-	191	169	-	-	1.53E-02	9.82E-03
ReactomeFI	CC	GO:0030315	T-tubule	-	52	48	-	-	1.71E-02	2.81E-03
ReactomeFI	BP	GO:0030397	membrane disassembly	-	11	11	-	-	4.83E-04	6.50E-04
ReactomeFI	CC	GO:0030427	site of polarized growth	-	172	148	-	-	2.25E-02	8.59E-03
ReactomeFI	BP	GO:0030431	sleep	-	30	27	-	-	1.21E-02	1.59E-03
ReactomeFI	MF	GO:0030506	ankyrin binding	-	19	19	-	-	1.64E-01	1.15E-03
ReactomeFI	MF	GO:0030507	spectrin binding	-	26	26	-	-	5.65E-02	1.52E-03
ReactomeFI	MF	GO:0030515	snoRNA binding	-	33	30	-	-	2.82E-02	1.73E-03
ReactomeFI	CC	GO:0030527	structural constituent of chromatin	-	97	53	-	-	2.98E-01	3.10E-03
ReactomeFI	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	146	-	-	2.24E-01	8.44E-03
ReactomeFI	MF	GO:0030552	cAMP binding	-	48	41	-	-	3.49E-02	2.38E-03
ReactomeFI	MF	GO:0030553	cGMP binding	-	15	15	-	-	2.47E-01	8.66E-04
ReactomeFI	BP	GO:0030574	collagen catabolic process	-	45	42	-	-	5.66E-02	2.45E-03
ReactomeFI	MF	GO:0030594	neurotransmitter receptor activity	-	160	149	-	-	2.24E-01	8.66E-03
ReactomeFI	CC	GO:0030658	transport vesicle membrane	-	231	204	-	-	7.81E-02	1.18E-02
ReactomeFI	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	53	-	-	5.38E-02	3.10E-03
ReactomeFI	CC	GO:0030662	coated vesicle membrane	-	202	192	-	-	8.14E-02	1.11E-02
ReactomeFI	CC	GO:0030666	endocytic vesicle membrane	-	196	192	-	-	2.96E-02	1.11E-02
ReactomeFI	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	2.45E-01	7.94E-04
ReactomeFI	CC	GO:0030684	preribosome	-	76	72	-	-	1.82E-01	4.19E-03
ReactomeFI	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	3.00E-02	1.30E-03
ReactomeFI	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	18	-	-	1.73E-03	1.08E-03
ReactomeFI	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	49	-	-	3.22E-03	2.89E-03
ReactomeFI	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	141	-	-	6.13E-03	8.16E-03
ReactomeFI	CC	GO:0030863	cortical cytoskeleton	-	104	89	-	-	2.52E-02	5.20E-03
ReactomeFI	BP	GO:0030865	cortical cytoskeleton organization	-	51	50	-	-	1.31E-02	2.89E-03
ReactomeFI	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	4.22E-02	6.50E-04
ReactomeFI	BP	GO:0030901	midbrain development	-	87	85	-	-	1.70E-02	4.91E-03
ReactomeFI	CC	GO:0030904	retromer complex	-	12	12	-	-	3.26E-01	7.22E-04
ReactomeFI	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	2.10E-03	6.50E-04
ReactomeFI	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	12	-	-	2.92E-03	7.22E-04
ReactomeFI	MF	GO:0030971	receptor tyrosine kinase binding	-	76	67	-	-	8.43E-03	3.90E-03
ReactomeFI	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	5.56E-01	8.66E-04
ReactomeFI	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	3.09E-01	1.01E-03
ReactomeFI	CC	GO:0031012	extracellular matrix	2.73E-06	564	455	407	1.12	-	-
ReactomeFI	BP	GO:0031018	endocrine pancreas development	-	47	44	-	-	3.73E-02	2.60E-03
ReactomeFI	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	6.40E-04	119	102	86	1.19	-	-
ReactomeFI	BP	GO:0031069	hair follicle morphogenesis	-	33	30	-	-	3.56E-03	1.73E-03
ReactomeFI	MF	GO:0031072	heat shock protein binding	-	128	113	-	-	4.56E-02	6.57E-03
ReactomeFI	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	4.86E-02	7.22E-04
ReactomeFI	BP	GO:0031100	animal organ regeneration	-	66	64	-	-	2.96E-03	3.75E-03
ReactomeFI	CC	GO:0031105	septin complex	-	14	13	-	-	9.29E-01	7.94E-04
ReactomeFI	BP	GO:0031123	RNA 3'-end processing	-	79	63	-	-	5.75E-02	3.68E-03
ReactomeFI	BP	GO:0031128	developmental induction	-	26	25	-	-	5.04E-03	1.44E-03
ReactomeFI	CC	GO:0031143	pseudopodium	-	18	18	-	-	7.76E-02	1.08E-03
ReactomeFI	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	28	-	-	6.99E-01	1.66E-03
ReactomeFI	CC	GO:0031201	SNARE complex	-	48	48	-	-	4.99E-01	2.81E-03
ReactomeFI	CC	GO:0031209	SCAR complex	-	12	11	-	-	1.92E-01	6.50E-04
ReactomeFI	MF	GO:0031210	phosphatidylcholine binding	-	32	30	-	-	1.27E-01	1.73E-03
ReactomeFI	CC	GO:0031261	DNA replication preinitiation complex	-	46	44	-	-	7.66E-02	2.60E-03
ReactomeFI	BP	GO:0031268	pseudopodium organization	-	17	15	-	-	1.11E-01	8.66E-04
ReactomeFI	MF	GO:0031281	positive regulation of cyclase activity	-	40	39	-	-	1.38E-02	2.31E-03
ReactomeFI	BP	GO:0031294	lymphocyte costimulation	-	47	44	-	-	1.51E-02	2.60E-03
ReactomeFI	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	102	-	-	4.91E-03	5.92E-03
ReactomeFI	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	2.34E-01	8.66E-04
ReactomeFI	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	128	-	-	3.89E-02	7.43E-03
ReactomeFI	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	177	-	-	9.11E-03	1.02E-02
ReactomeFI	BP	GO:0031338	regulation of vesicle fusion	-	24	23	-	-	1.98E-02	1.37E-03
ReactomeFI	BP	GO:0031342	negative regulation of cell killing	-	29	28	-	-	1.33E-02	1.66E-03
ReactomeFI	BP	GO:0031343	positive regulation of cell killing	-	75	71	-	-	6.40E-02	4.11E-03
ReactomeFI	BP	GO:0031345	negative regulation of cell projection organization	-	195	165	-	-	2.78E-02	9.53E-03
ReactomeFI	BP	GO:0031348	negative regulation of defense response	-	282	220	-	-	8.90E-03	1.27E-02
ReactomeFI	BP	GO:0031365	N-terminal protein amino acid modification	-	30	22	-	-	3.64E-01	1.30E-03
ReactomeFI	MF	GO:0031369	translation initiation factor binding	-	32	28	-	-	2.80E-02	1.66E-03
ReactomeFI	MF	GO:0031418	L-ascorbic acid binding	-	20	15	-	-	2.20E-01	8.66E-04
ReactomeFI	MF	GO:0031420	alkali metal ion binding	-	17	15	-	-	3.81E-03	8.66E-04
ReactomeFI	CC	GO:0031430	M band	-	22	16	-	-	2.85E-02	9.38E-04
ReactomeFI	MF	GO:0031432	titin binding	-	13	12	-	-	2.71E-02	7.22E-04
ReactomeFI	MF	GO:0031490	chromatin DNA binding	-	120	116	-	-	1.47E-02	6.71E-03
ReactomeFI	CC	GO:0031519	PcG protein complex	-	38	38	-	-	7.43E-02	2.24E-03
ReactomeFI	BP	GO:0031529	ruffle organization	-	55	45	-	-	2.22E-02	2.60E-03
ReactomeFI	BP	GO:0031579	membrane raft organization	-	25	18	-	-	1.20E-02	1.08E-03
ReactomeFI	CC	GO:0031594	neuromuscular junction	-	73	68	-	-	3.53E-02	3.97E-03
ReactomeFI	BP	GO:0031643	positive regulation of myelination	-	19	15	-	-	1.68E-03	8.66E-04
ReactomeFI	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	9.82E-03	1.15E-03
ReactomeFI	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	3.78E-03	1.30E-03
ReactomeFI	CC	GO:0031903	microbody membrane	-	65	61	-	-	2.11E-01	3.54E-03
ReactomeFI	CC	GO:0031904	endosome lumen	-	38	38	-	-	1.52E-01	2.24E-03
ReactomeFI	CC	GO:0031907	microbody lumen	-	51	46	-	-	1.44E-01	2.67E-03
ReactomeFI	CC	GO:0031941	filamentous actin	-	27	21	-	-	3.06E-02	1.23E-03
ReactomeFI	MF	GO:0031952	regulation of protein autophosphorylation	-	43	42	-	-	5.69E-03	2.45E-03
ReactomeFI	CC	GO:0031970	organelle envelope lumen	-	94	79	-	-	6.53E-02	4.62E-03
ReactomeFI	MF	GO:0031996	thioesterase binding	-	11	11	-	-	2.52E-03	6.50E-04
ReactomeFI	CC	GO:0032008	positive regulation of TOR signaling	-	52	47	-	-	2.74E-02	2.74E-03
ReactomeFI	CC	GO:0032039	integrator complex	-	19	15	-	-	3.42E-01	8.66E-04
ReactomeFI	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	19	-	-	1.44E-01	1.15E-03
ReactomeFI	BP	GO:0032094	response to food	-	37	31	-	-	1.22E-02	1.80E-03
ReactomeFI	BP	GO:0032098	regulation of appetite	-	20	16	-	-	1.89E-02	9.38E-04
ReactomeFI	CC	GO:0032154	cleavage furrow	-	54	47	-	-	1.50E-02	2.74E-03
ReactomeFI	MF	GO:0032182	ubiquitin-like protein binding	-	117	106	-	-	5.56E-02	6.13E-03
ReactomeFI	BP	GO:0032200	telomere organization	1.70E-03	186	153	134	1.14	-	-
ReactomeFI	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	14	-	-	2.75E-02	8.66E-04
ReactomeFI	BP	GO:0032328	alanine transport	-	19	11	-	-	2.50E-01	6.50E-04
ReactomeFI	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	47	-	-	1.33E-02	2.74E-03
ReactomeFI	CC	GO:0032365	intracellular lipid transport	-	51	40	-	-	1.12E-01	2.31E-03
ReactomeFI	BP	GO:0032368	regulation of lipid transport	-	149	121	-	-	1.90E-02	7.00E-03
ReactomeFI	CC	GO:0032387	negative regulation of intracellular transport	-	51	47	-	-	1.48E-02	2.74E-03
ReactomeFI	CC	GO:0032388	positive regulation of intracellular transport	-	137	123	-	-	4.05E-03	7.15E-03
ReactomeFI	MF	GO:0032393	MHC class I receptor activity	-	15	15	-	-	2.84E-02	8.66E-04
ReactomeFI	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	8.35E-02	6.50E-04
ReactomeFI	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	62	-	-	3.57E-02	3.61E-03
ReactomeFI	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	98	-	-	1.82E-02	5.70E-03
ReactomeFI	CC	GO:0032426	stereocilium tip	-	21	17	-	-	8.83E-02	1.01E-03
ReactomeFI	CC	GO:0032432	actin filament bundle	-	249	216	-	-	3.17E-02	1.25E-02
ReactomeFI	CC	GO:0032433	filopodium tip	-	19	15	-	-	1.01E-02	8.66E-04
ReactomeFI	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	20	-	-	2.60E-02	1.15E-03
ReactomeFI	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	44	-	-	8.72E-02	2.60E-03
ReactomeFI	BP	GO:0032528	microvillus organization	-	24	20	-	-	6.92E-02	1.15E-03
ReactomeFI	CC	GO:0032580	Golgi cisterna membrane	-	93	54	-	-	4.61E-02	3.18E-03
ReactomeFI	CC	GO:0032588	trans-Golgi network membrane	-	102	92	-	-	1.15E-01	5.34E-03
ReactomeFI	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	15	-	-	8.20E-03	8.66E-04
ReactomeFI	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	19	-	-	2.91E-03	1.15E-03
ReactomeFI	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	21	-	-	1.89E-02	1.23E-03
ReactomeFI	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	9.40E-03	7.94E-04
ReactomeFI	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	8.66E-02	1.08E-03
ReactomeFI	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	7.32E-03	6.50E-04
ReactomeFI	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	25	-	-	8.41E-03	1.44E-03
ReactomeFI	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	34	-	-	7.57E-03	2.02E-03
ReactomeFI	BP	GO:0032890	regulation of organic acid transport	-	78	70	-	-	1.01E-02	4.04E-03
ReactomeFI	BP	GO:0032922	circadian regulation of gene expression	-	71	66	-	-	2.68E-02	3.83E-03
ReactomeFI	BP	GO:0032941	secretion by tissue	-	85	72	-	-	8.49E-03	4.19E-03
ReactomeFI	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	24	-	-	3.29E-03	1.44E-03
ReactomeFI	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	47	-	-	1.01E-01	2.74E-03
ReactomeFI	CC	GO:0032982	myosin filament	-	24	23	-	-	1.58E-01	1.37E-03
ReactomeFI	CC	GO:0032994	protein-lipid complex	-	39	38	-	-	2.46E-01	2.24E-03
ReactomeFI	BP	GO:0033002	muscle cell proliferation	-	249	193	-	-	8.90E-03	1.12E-02
ReactomeFI	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	34	-	-	3.03E-01	2.02E-03
ReactomeFI	BP	GO:0033044	regulation of chromosome organization	-	249	240	-	-	5.27E-02	1.39E-02
ReactomeFI	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	76	-	-	3.81E-01	4.40E-03
ReactomeFI	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	73	-	-	4.56E-02	4.26E-03
ReactomeFI	BP	GO:0033119	negative regulation of RNA splicing	-	27	26	-	-	3.25E-02	1.52E-03
ReactomeFI	BP	GO:0033120	positive regulation of RNA splicing	-	46	40	-	-	6.36E-02	2.31E-03
ReactomeFI	MF	GO:0033130	acetylcholine receptor binding	-	12	11	-	-	4.28E-03	6.50E-04
ReactomeFI	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	135	-	-	1.27E-02	7.80E-03
ReactomeFI	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	4.34E-02	7.22E-04
ReactomeFI	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	23	-	-	3.61E-01	1.37E-03
ReactomeFI	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	5.13E-02	1.08E-03
ReactomeFI	CC	GO:0033260	nuclear DNA replication	-	40	38	-	-	4.48E-02	2.24E-03
ReactomeFI	CC	GO:0033268	node of Ranvier	-	16	15	-	-	1.81E-02	8.66E-04
ReactomeFI	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	1.14E-02	7.22E-04
ReactomeFI	BP	GO:0033363	secretory granule organization	-	63	51	-	-	4.61E-02	2.96E-03
ReactomeFI	BP	GO:0033500	carbohydrate homeostasis	-	251	216	-	-	1.24E-02	1.25E-02
ReactomeFI	BP	GO:0033555	multicellular organismal response to stress	-	90	83	-	-	7.21E-03	4.84E-03
ReactomeFI	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	1.30E-02	1.30E-03
ReactomeFI	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	19	-	-	1.11E-02	1.15E-03
ReactomeFI	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	15	-	-	4.00E-01	8.66E-04
ReactomeFI	BP	GO:0033619	membrane protein proteolysis	-	60	57	-	-	2.84E-02	3.32E-03
ReactomeFI	BP	GO:0033622	integrin activation	-	26	25	-	-	3.71E-02	1.44E-03
ReactomeFI	BP	GO:0033627	cell adhesion mediated by integrin	-	87	82	-	-	1.62E-02	4.76E-03
ReactomeFI	BP	GO:0033688	regulation of osteoblast proliferation	-	31	27	-	-	1.37E-02	1.59E-03
ReactomeFI	MF	GO:0033691	sialic acid binding	-	22	21	-	-	1.82E-01	1.23E-03
ReactomeFI	CC	GO:0034045	phagophore assembly site membrane	-	19	18	-	-	2.39E-01	1.08E-03
ReactomeFI	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	8.15E-03	6.50E-04
ReactomeFI	BP	GO:0034067	protein localization to Golgi apparatus	-	30	27	-	-	6.01E-02	1.59E-03
ReactomeFI	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	12	-	-	2.80E-02	7.22E-04
ReactomeFI	BP	GO:0034104	negative regulation of tissue remodeling	-	22	19	-	-	3.26E-03	1.15E-03
ReactomeFI	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	15	-	-	2.73E-04	8.66E-04
ReactomeFI	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	3.63E-03	1.15E-03
ReactomeFI	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	1.24E-03	1.30E-03
ReactomeFI	BP	GO:0034250	positive regulation of amide metabolic process	-	27	22	-	-	1.97E-03	1.30E-03
ReactomeFI	MF	GO:0034260	negative regulation of GTPase activity	-	36	31	-	-	2.74E-03	1.80E-03
ReactomeFI	BP	GO:0034330	cell junction organization	3.91E-31	727	651	525	1.24	-	-
ReactomeFI	CC	GO:0034358	plasma lipoprotein particle	-	36	35	-	-	2.56E-01	2.02E-03
ReactomeFI	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	7.10E-02	2.02E-03
ReactomeFI	BP	GO:0034389	lipid droplet organization	-	38	32	-	-	5.09E-02	1.88E-03
ReactomeFI	BP	GO:0034394	protein localization to cell surface	-	69	58	-	-	3.68E-03	3.39E-03
ReactomeFI	CC	GO:0034451	centriolar satellite	-	120	97	-	-	3.67E-02	5.63E-03
ReactomeFI	MF	GO:0034452	dynactin binding	-	12	11	-	-	2.02E-02	6.50E-04
ReactomeFI	CC	GO:0034455	t-UTP complex	-	53	49	-	-	1.42E-01	2.89E-03
ReactomeFI	MF	GO:0034497	protein localization to phagophore assembly site	-	16	15	-	-	8.62E-02	8.66E-04
ReactomeFI	BP	GO:0034502	protein localization to chromosome	-	130	108	-	-	1.80E-02	6.28E-03
ReactomeFI	BP	GO:0034605	cellular response to heat	-	66	64	-	-	5.73E-03	3.75E-03
ReactomeFI	CC	GO:0034709	methylosome	-	13	13	-	-	9.14E-02	7.94E-04
ReactomeFI	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	1.23E-01	1.01E-03
ReactomeFI	CC	GO:0034982	mitochondrial protein processing	-	13	12	-	-	1.74E-01	7.22E-04
ReactomeFI	MF	GO:0035035	histone acetyltransferase binding	-	24	22	-	-	8.81E-04	1.30E-03
ReactomeFI	BP	GO:0035050	embryonic heart tube development	-	86	81	-	-	2.81E-02	4.69E-03
ReactomeFI	CC	GO:0035097	histone methyltransferase complex	-	63	60	-	-	1.12E-01	3.46E-03
ReactomeFI	BP	GO:0035107	appendage morphogenesis	-	147	143	-	-	1.50E-02	8.30E-03
ReactomeFI	BP	GO:0035148	tube formation	-	155	150	-	-	9.64E-03	8.66E-03
ReactomeFI	MF	GO:0035173	histone kinase activity	-	17	17	-	-	1.40E-03	1.01E-03
ReactomeFI	BP	GO:0035188	hatching	-	27	18	-	-	4.44E-04	1.08E-03
ReactomeFI	CC	GO:0035253	ciliary rootlet	-	13	11	-	-	6.72E-03	6.50E-04
ReactomeFI	MF	GO:0035254	glutamate receptor binding	-	47	39	-	-	1.03E-02	2.31E-03
ReactomeFI	BP	GO:0035272	exocrine system development	-	46	42	-	-	5.87E-03	2.45E-03
ReactomeFI	BP	GO:0035304	regulation of protein dephosphorylation	-	87	79	-	-	1.03E-02	4.62E-03
ReactomeFI	BP	GO:0035315	hair cell differentiation	-	52	46	-	-	2.48E-02	2.67E-03
ReactomeFI	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	4.61E-02	7.94E-04
ReactomeFI	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	11	-	-	1.08E-02	6.50E-04
ReactomeFI	BP	GO:0035493	SNARE complex assembly	-	23	22	-	-	2.38E-01	1.30E-03
ReactomeFI	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	4.70E-03	7.22E-04
ReactomeFI	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	11	-	-	2.94E-03	6.50E-04
ReactomeFI	BP	GO:0035601	protein deacylation	-	56	51	-	-	3.91E-02	2.96E-03
ReactomeFI	MF	GO:0035613	RNA stem-loop binding	-	21	15	-	-	3.69E-02	8.66E-04
ReactomeFI	BP	GO:0035672	oligopeptide transmembrane transport	-	15	12	-	-	1.35E-01	7.22E-04
ReactomeFI	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	8.44E-03	7.94E-04
ReactomeFI	BP	GO:0035821	modulation of process of another organism	-	14	13	-	-	1.13E-02	7.94E-04
ReactomeFI	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	13	-	-	1.70E-01	7.94E-04
ReactomeFI	BP	GO:0035878	nail development	-	11	11	-	-	4.77E-03	6.50E-04
ReactomeFI	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	1.07E-02	7.22E-04
ReactomeFI	BP	GO:0035902	response to immobilization stress	-	20	19	-	-	1.23E-03	1.15E-03
ReactomeFI	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	87	-	-	8.16E-02	5.05E-03
ReactomeFI	BP	GO:0035988	chondrocyte proliferation	-	24	21	-	-	7.01E-03	1.23E-03
ReactomeFI	MF	GO:0036002	pre-mRNA binding	-	57	34	-	-	1.22E-02	2.02E-03
ReactomeFI	BP	GO:0036010	protein localization to endosome	-	27	23	-	-	1.69E-02	1.37E-03
ReactomeFI	CC	GO:0036019	endolysosome	-	29	28	-	-	3.68E-02	1.66E-03
ReactomeFI	CC	GO:0036038	MKS complex	-	13	13	-	-	3.42E-01	7.94E-04
ReactomeFI	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	2.39E-03	7.94E-04
ReactomeFI	BP	GO:0036315	cellular response to sterol	-	24	19	-	-	7.74E-02	1.15E-03
ReactomeFI	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	2.84E-03	1.15E-03
ReactomeFI	CC	GO:0036379	myofilament	-	26	22	-	-	3.01E-01	1.30E-03
ReactomeFI	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	231	-	-	1.54E-01	1.34E-02
ReactomeFI	MF	GO:0038024	cargo receptor activity	1.47E-01	117	92	84	1.09	-	-
ReactomeFI	MF	GO:0038024	cargo receptor activity	-	121	92	-	-	2.05E-02	5.34E-03
ReactomeFI	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	1.16E-01	8.66E-04
ReactomeFI	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	5.24E-02	7.94E-04
ReactomeFI	BP	GO:0038179	neurotrophin signaling pathway	-	38	37	-	-	1.99E-02	2.17E-03
ReactomeFI	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	1.22E-01	7.22E-04
ReactomeFI	MF	GO:0038187	pattern recognition receptor activity	-	33	32	-	-	6.81E-02	1.88E-03
ReactomeFI	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	77	-	-	2.31E-02	4.47E-03
ReactomeFI	BP	GO:0039694	viral RNA genome replication	-	30	27	-	-	9.81E-02	1.59E-03
ReactomeFI	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.44E-02	8.66E-04
ReactomeFI	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	1.07E-02	7.22E-04
ReactomeFI	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	28	-	-	5.15E-03	1.66E-03
ReactomeFI	BP	GO:0040019	positive regulation of embryonic development	-	23	20	-	-	5.07E-03	1.15E-03
ReactomeFI	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	16	-	-	1.33E-01	9.38E-04
ReactomeFI	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.17E-01	8.66E-04
ReactomeFI	BP	GO:0042044	fluid transport	-	35	25	-	-	3.63E-02	1.44E-03
ReactomeFI	BP	GO:0042060	wound healing	2.58E-30	431	404	311	1.30	-	-
ReactomeFI	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	2.55E-03	1.15E-03
ReactomeFI	BP	GO:0042092	type 2 immune response	-	41	41	-	-	5.52E-03	2.38E-03
ReactomeFI	BP	GO:0042177	negative regulation of protein catabolic process	-	109	99	-	-	9.45E-03	5.77E-03
ReactomeFI	BP	GO:0042178	xenobiotic catabolic process	-	26	23	-	-	1.79E-01	1.37E-03
ReactomeFI	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	13	-	-	2.47E-01	7.94E-04
ReactomeFI	BP	GO:0042254	ribosome biogenesis	2.04E-14	297	268	214	1.25	-	-
ReactomeFI	MF	GO:0042287	MHC protein binding	-	68	64	-	-	3.84E-02	3.75E-03
ReactomeFI	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	1.84E-02	7.22E-04
ReactomeFI	MF	GO:0042393	histone binding	5.24E-13	237	216	171	1.26	-	-
ReactomeFI	MF	GO:0042393	histone binding	-	240	217	-	-	6.76E-02	1.26E-02
ReactomeFI	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	32	-	-	1.35E-01	1.88E-03
ReactomeFI	CC	GO:0042405	nuclear inclusion body	-	12	11	-	-	4.68E-03	6.50E-04
ReactomeFI	BP	GO:0042440	pigment metabolic process	-	80	65	-	-	2.46E-01	3.75E-03
ReactomeFI	BP	GO:0042490	mechanoreceptor differentiation	-	67	58	-	-	2.91E-02	3.39E-03
ReactomeFI	BP	GO:0042537	benzene-containing compound metabolic process	-	27	16	-	-	9.36E-02	9.38E-04
ReactomeFI	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	7.38E-03	6.50E-04
ReactomeFI	CC	GO:0042641	actomyosin	-	77	70	-	-	4.66E-02	4.04E-03
ReactomeFI	CC	GO:0042645	mitochondrial nucleoid	-	45	42	-	-	1.11E-01	2.45E-03
ReactomeFI	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	26	-	-	1.79E-01	1.52E-03
ReactomeFI	BP	GO:0042753	positive regulation of circadian rhythm	-	18	18	-	-	3.79E-02	1.08E-03
ReactomeFI	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	1.85E-02	7.22E-04
ReactomeFI	CC	GO:0042770	signal transduction in response to DNA damage	-	186	182	-	-	3.79E-02	1.05E-02
ReactomeFI	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	86	-	-	3.33E-01	4.98E-03
ReactomeFI	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	55	-	-	1.79E-01	3.18E-03
ReactomeFI	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	45	-	-	8.27E-03	2.60E-03
ReactomeFI	MF	GO:0042805	actinin binding	-	36	32	-	-	4.70E-03	1.88E-03
ReactomeFI	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	9.71E-02	9.38E-04
ReactomeFI	BP	GO:0042832	defense response to protozoan	-	28	24	-	-	6.87E-02	1.44E-03
ReactomeFI	MF	GO:0042887	amide transmembrane transporter activity	-	33	18	-	-	1.96E-01	1.08E-03
ReactomeFI	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	21	-	-	1.27E-01	1.23E-03
ReactomeFI	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	2.12E-02	9.38E-04
ReactomeFI	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	35	-	-	1.06E-02	2.02E-03
ReactomeFI	MF	GO:0043021	ribonucleoprotein complex binding	-	158	137	-	-	3.69E-02	7.94E-03
ReactomeFI	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	41	-	-	2.71E-02	2.38E-03
ReactomeFI	CC	GO:0043034	costamere	-	18	16	-	-	5.94E-03	9.38E-04
ReactomeFI	BP	GO:0043043	peptide biosynthetic process	-	25	18	-	-	4.37E-02	1.08E-03
ReactomeFI	CC	GO:0043073	germ cell nucleus	-	67	59	-	-	5.64E-03	3.46E-03
ReactomeFI	CC	GO:0043083	synaptic cleft	-	21	14	-	-	6.07E-04	8.66E-04
ReactomeFI	BP	GO:0043101	purine-containing compound salvage	-	15	13	-	-	6.17E-01	7.94E-04
ReactomeFI	CC	GO:0043113	receptor clustering	-	51	44	-	-	1.38E-02	2.60E-03
ReactomeFI	BP	GO:0043114	regulation of vascular permeability	-	49	45	-	-	2.20E-02	2.60E-03
ReactomeFI	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	174	-	-	3.92E-02	1.01E-02
ReactomeFI	BP	GO:0043144	sno(s)RNA processing	-	14	12	-	-	2.65E-02	7.22E-04
ReactomeFI	BP	GO:0043171	peptide catabolic process	-	19	12	-	-	4.52E-02	7.22E-04
ReactomeFI	CC	GO:0043194	axon initial segment	-	21	18	-	-	4.31E-02	1.08E-03
ReactomeFI	CC	GO:0043198	dendritic shaft	-	38	31	-	-	2.84E-03	1.80E-03
ReactomeFI	CC	GO:0043204	perikaryon	-	156	132	-	-	5.16E-03	7.65E-03
ReactomeFI	MF	GO:0043236	laminin binding	-	29	25	-	-	1.00E-02	1.44E-03
ReactomeFI	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	1.90E-01	7.94E-04
ReactomeFI	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	32	-	-	2.22E-02	1.88E-03
ReactomeFI	BP	GO:0043248	proteasome assembly	-	13	12	-	-	2.92E-01	7.22E-04
ReactomeFI	MF	GO:0043274	phospholipase binding	-	23	23	-	-	1.58E-02	1.37E-03
ReactomeFI	CC	GO:0043292	contractile muscle fiber	-	245	215	-	-	2.15E-01	1.24E-02
ReactomeFI	BP	GO:0043299	leukocyte degranulation	-	82	74	-	-	7.07E-03	4.33E-03
ReactomeFI	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	18	-	-	2.71E-03	1.08E-03
ReactomeFI	BP	GO:0043331	response to dsRNA	-	56	54	-	-	1.54E-02	3.18E-03
ReactomeFI	MF	GO:0043394	proteoglycan binding	-	36	34	-	-	9.01E-03	2.02E-03
ReactomeFI	BP	GO:0043414	macromolecule methylation	-	138	98	-	-	1.64E-01	5.70E-03
ReactomeFI	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	162	-	-	1.06E-02	9.38E-03
ReactomeFI	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	57	-	-	3.44E-03	3.32E-03
ReactomeFI	BP	GO:0043482	cellular pigment accumulation	-	12	11	-	-	1.13E-01	6.50E-04
ReactomeFI	BP	GO:0043523	regulation of neuron apoptotic process	-	218	196	-	-	1.31E-02	1.13E-02
ReactomeFI	MF	GO:0043531	ADP binding	-	38	36	-	-	5.05E-03	2.09E-03
ReactomeFI	BP	GO:0043543	protein acylation	-	107	82	-	-	8.46E-02	4.76E-03
ReactomeFI	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	30	-	-	3.94E-02	1.73E-03
ReactomeFI	BP	GO:0043555	regulation of translation in response to stress	-	22	21	-	-	8.77E-03	1.23E-03
ReactomeFI	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.64E-03	7.94E-04
ReactomeFI	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	12	-	-	1.96E-02	7.22E-04
ReactomeFI	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	1.66E-01	1.30E-03
ReactomeFI	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	22	-	-	1.74E-02	1.30E-03
ReactomeFI	BP	GO:0043589	skin morphogenesis	-	12	11	-	-	3.60E-03	6.50E-04
ReactomeFI	BP	GO:0043647	inositol phosphate metabolic process	-	44	40	-	-	2.99E-01	2.31E-03
ReactomeFI	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	55	-	-	4.88E-02	3.18E-03
ReactomeFI	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	13	-	-	2.92E-02	7.94E-04
ReactomeFI	BP	GO:0043954	cellular component maintenance	-	72	64	-	-	3.06E-02	3.75E-03
ReactomeFI	BP	GO:0044088	regulation of vacuole organization	-	56	48	-	-	1.51E-02	2.81E-03
ReactomeFI	MF	GO:0044183	protein folding chaperone	-	67	64	-	-	1.22E-01	3.75E-03
ReactomeFI	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	3.53E-02	6.50E-04
ReactomeFI	CC	GO:0044232	organelle membrane contact site	-	50	35	-	-	6.60E-02	2.02E-03
ReactomeFI	BP	GO:0044242	cellular lipid catabolic process	-	224	171	-	-	1.58E-01	9.89E-03
ReactomeFI	CC	GO:0044292	dendrite terminus	-	13	11	-	-	2.67E-03	6.50E-04
ReactomeFI	CC	GO:0044298	cell body membrane	-	32	31	-	-	2.82E-02	1.80E-03
ReactomeFI	CC	GO:0044306	neuron projection terminus	-	164	151	-	-	2.11E-02	8.73E-03
ReactomeFI	CC	GO:0044309	neuron spine	-	213	185	-	-	1.72E-02	1.07E-02
ReactomeFI	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	7.09E-03	2.02E-03
ReactomeFI	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	6.36E-02	1.44E-03
ReactomeFI	MF	GO:0044325	transmembrane transporter binding	-	159	141	-	-	2.79E-02	8.16E-03
ReactomeFI	BP	GO:0044380	protein localization to cytoskeleton	-	57	55	-	-	6.83E-02	3.18E-03
ReactomeFI	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	34	-	-	8.07E-03	2.02E-03
ReactomeFI	CC	GO:0044391	ribosomal subunit	-	203	198	-	-	2.74E-01	1.15E-02
ReactomeFI	BP	GO:0044539	long-chain fatty acid import into cell	-	17	15	-	-	9.44E-03	8.66E-04
ReactomeFI	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.72E-01	8.66E-04
ReactomeFI	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.59E-01	7.22E-04
ReactomeFI	BP	GO:0044703	multi-organism reproductive process	-	209	181	-	-	3.61E-02	1.05E-02
ReactomeFI	BP	GO:0044706	multi-multicellular organism process	-	217	186	-	-	3.04E-02	1.08E-02
ReactomeFI	BP	GO:0044782	cilium organization	1.75E-01	399	276	288	0.96	-	-
ReactomeFI	BP	GO:0044786	cell cycle DNA replication	-	45	43	-	-	3.74E-02	2.53E-03
ReactomeFI	BP	GO:0044848	biological phase	-	211	182	-	-	5.35E-02	1.05E-02
ReactomeFI	CC	GO:0044853	plasma membrane raft	-	114	106	-	-	7.65E-03	6.13E-03
ReactomeFI	CC	GO:0045009	chitosome	-	21	16	-	-	1.62E-01	9.38E-04
ReactomeFI	BP	GO:0045017	glycerolipid biosynthetic process	-	254	208	-	-	1.66E-01	1.21E-02
ReactomeFI	CC	GO:0045022	early endosome to late endosome transport	-	44	37	-	-	1.10E-01	2.17E-03
ReactomeFI	BP	GO:0045023	G0 to G1 transition	-	41	38	-	-	1.89E-01	2.24E-03
ReactomeFI	BP	GO:0045048	protein insertion into ER membrane	-	30	19	-	-	3.68E-01	1.15E-03
ReactomeFI	BP	GO:0045056	transcytosis	-	20	20	-	-	7.73E-03	1.15E-03
ReactomeFI	BP	GO:0045058	T cell selection	-	53	53	-	-	8.25E-03	3.10E-03
ReactomeFI	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	88	-	-	6.17E-01	5.12E-03
ReactomeFI	CC	GO:0045120	pronucleus	-	14	12	-	-	2.18E-03	7.22E-04
ReactomeFI	BP	GO:0045161	neuronal ion channel clustering	-	12	11	-	-	3.09E-02	6.50E-04
ReactomeFI	CC	GO:0045171	intercellular bridge	-	91	81	-	-	7.68E-03	4.69E-03
ReactomeFI	BP	GO:0045176	apical protein localization	-	15	14	-	-	9.99E-04	8.66E-04
ReactomeFI	MF	GO:0045182	translation regulator activity	5.91E-11	151	141	109	1.29	-	-
ReactomeFI	BP	GO:0045185	maintenance of protein location	-	95	85	-	-	1.85E-02	4.91E-03
ReactomeFI	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	17	-	-	1.00E+00	1.01E-03
ReactomeFI	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	5.49E-03	7.94E-04
ReactomeFI	CC	GO:0045324	late endosome to vacuole transport	-	37	37	-	-	3.46E-01	2.17E-03
ReactomeFI	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	13	-	-	1.77E-02	7.94E-04
ReactomeFI	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	36	-	-	4.76E-03	2.09E-03
ReactomeFI	BP	GO:0045494	photoreceptor cell maintenance	-	43	34	-	-	7.16E-02	2.02E-03
ReactomeFI	CC	GO:0045495	pole plasm	-	25	19	-	-	4.07E-01	1.15E-03
ReactomeFI	MF	GO:0045504	dynein heavy chain binding	-	16	13	-	-	2.51E-02	7.94E-04
ReactomeFI	MF	GO:0045505	dynein intermediate chain binding	-	37	33	-	-	9.12E-02	1.95E-03
ReactomeFI	BP	GO:0045598	regulation of fat cell differentiation	-	148	116	-	-	9.41E-03	6.71E-03
ReactomeFI	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	3.87E-03	1.01E-03
ReactomeFI	BP	GO:0045661	regulation of myoblast differentiation	-	74	70	-	-	1.70E-02	4.04E-03
ReactomeFI	BP	GO:0045666	positive regulation of neuron differentiation	-	91	81	-	-	3.18E-02	4.69E-03
ReactomeFI	BP	GO:0045667	regulation of osteoblast differentiation	-	147	115	-	-	1.21E-02	6.64E-03
ReactomeFI	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	2.85E-03	7.94E-04
ReactomeFI	BP	GO:0045684	positive regulation of epidermis development	-	33	29	-	-	2.05E-03	1.73E-03
ReactomeFI	BP	GO:0045685	regulation of glial cell differentiation	-	77	65	-	-	5.84E-03	3.75E-03
ReactomeFI	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	1.22E-02	1.08E-03
ReactomeFI	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	13	-	-	6.37E-04	7.94E-04
ReactomeFI	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	2.76E-03	1.15E-03
ReactomeFI	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	20	-	-	1.49E-02	1.15E-03
ReactomeFI	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	8.91E-03	8.66E-04
ReactomeFI	BP	GO:0045727	positive regulation of translation	-	141	126	-	-	8.73E-02	7.29E-03
ReactomeFI	BP	GO:0045732	positive regulation of protein catabolic process	-	202	185	-	-	1.20E-02	1.07E-02
ReactomeFI	BP	GO:0045738	negative regulation of DNA repair	-	40	32	-	-	5.74E-03	1.88E-03
ReactomeFI	BP	GO:0045739	positive regulation of DNA repair	-	128	113	-	-	1.14E-01	6.57E-03
ReactomeFI	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	55	-	-	5.59E-03	3.18E-03
ReactomeFI	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	33	-	-	3.79E-03	1.95E-03
ReactomeFI	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	32	-	-	1.44E-02	1.88E-03
ReactomeFI	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	35	-	-	1.03E-02	2.02E-03
ReactomeFI	BP	GO:0045778	positive regulation of ossification	-	51	49	-	-	1.27E-02	2.89E-03
ReactomeFI	BP	GO:0045780	positive regulation of bone resorption	-	18	17	-	-	6.88E-02	1.01E-03
ReactomeFI	BP	GO:0045807	positive regulation of endocytosis	-	155	146	-	-	1.66E-02	8.44E-03
ReactomeFI	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	104	-	-	5.44E-02	6.06E-03
ReactomeFI	BP	GO:0045830	positive regulation of isotype switching	-	28	24	-	-	4.59E-03	1.44E-03
ReactomeFI	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	14	-	-	2.96E-01	8.66E-04
ReactomeFI	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	35	-	-	1.04E-02	2.02E-03
ReactomeFI	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	30	-	-	1.47E-02	1.73E-03
ReactomeFI	BP	GO:0045907	positive regulation of vasoconstriction	-	30	27	-	-	2.48E-03	1.59E-03
ReactomeFI	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	7.22E-03	1.30E-03
ReactomeFI	BP	GO:0045933	positive regulation of muscle contraction	-	49	46	-	-	2.86E-03	2.67E-03
ReactomeFI	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	32	-	-	1.14E-02	1.88E-03
ReactomeFI	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	8.80E-03	1.08E-03
ReactomeFI	BP	GO:0046112	nucleobase biosynthetic process	-	18	15	-	-	1.97E-01	8.66E-04
ReactomeFI	BP	GO:0046184	aldehyde biosynthetic process	-	16	13	-	-	1.15E-02	7.94E-04
ReactomeFI	MF	GO:0046332	SMAD binding	-	77	73	-	-	2.18E-02	4.26E-03
ReactomeFI	BP	GO:0046415	urate metabolic process	-	12	11	-	-	1.34E-01	6.50E-04
ReactomeFI	BP	GO:0046434	organophosphate catabolic process	-	232	173	-	-	8.47E-02	1.00E-02
ReactomeFI	BP	GO:0046460	neutral lipid biosynthetic process	-	50	38	-	-	7.33E-02	2.24E-03
ReactomeFI	BP	GO:0046605	regulation of centrosome cycle	-	54	47	-	-	1.89E-02	2.74E-03
ReactomeFI	BP	GO:0046621	negative regulation of organ growth	-	39	32	-	-	1.40E-02	1.88E-03
ReactomeFI	BP	GO:0046622	positive regulation of organ growth	-	52	41	-	-	3.21E-03	2.38E-03
ReactomeFI	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	32	-	-	7.92E-03	1.88E-03
ReactomeFI	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	23	-	-	2.33E-03	1.37E-03
ReactomeFI	BP	GO:0046660	female sex differentiation	-	125	114	-	-	1.16E-02	6.64E-03
ReactomeFI	BP	GO:0046661	male sex differentiation	-	171	161	-	-	1.26E-02	9.31E-03
ReactomeFI	BP	GO:0046697	decidualization	-	26	24	-	-	2.48E-03	1.44E-03
ReactomeFI	MF	GO:0046790	virion binding	-	19	17	-	-	3.02E-02	1.01E-03
ReactomeFI	BP	GO:0046834	lipid phosphorylation	-	16	15	-	-	4.70E-02	8.66E-04
ReactomeFI	BP	GO:0046835	carbohydrate phosphorylation	-	49	38	-	-	1.17E-01	2.24E-03
ReactomeFI	MF	GO:0046875	ephrin receptor binding	-	29	27	-	-	2.58E-02	1.59E-03
ReactomeFI	CC	GO:0046930	pore complex	-	26	26	-	-	8.65E-02	1.52E-03
ReactomeFI	BP	GO:0046931	pore complex assembly	-	21	20	-	-	2.13E-02	1.15E-03
ReactomeFI	BP	GO:0047484	regulation of response to osmotic stress	-	16	14	-	-	2.13E-04	8.66E-04
ReactomeFI	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	30	-	-	1.65E-02	1.73E-03
ReactomeFI	MF	GO:0048018	receptor ligand activity	1.38E-18	504	445	364	1.22	-	-
ReactomeFI	MF	GO:0048019	receptor antagonist activity	-	31	20	-	-	1.02E-01	1.15E-03
ReactomeFI	MF	GO:0048038	quinone binding	-	16	13	-	-	9.30E-02	7.94E-04
ReactomeFI	BP	GO:0048145	regulation of fibroblast proliferation	-	87	80	-	-	4.62E-03	4.62E-03
ReactomeFI	MF	GO:0048156	tau protein binding	-	43	43	-	-	8.49E-03	2.53E-03
ReactomeFI	CC	GO:0048167	regulation of synaptic plasticity	-	210	173	-	-	2.23E-02	1.00E-02
ReactomeFI	MF	GO:0048185	activin binding	-	16	16	-	-	6.17E-02	9.38E-04
ReactomeFI	CC	GO:0048208	COPII vesicle coating	-	27	26	-	-	8.85E-02	1.52E-03
ReactomeFI	BP	GO:0048268	clathrin coat assembly	-	16	14	-	-	3.61E-02	8.66E-04
ReactomeFI	BP	GO:0048278	vesicle docking	-	64	61	-	-	1.11E-01	3.54E-03
ReactomeFI	MF	GO:0048306	calcium-dependent protein binding	-	61	55	-	-	4.15E-02	3.18E-03
ReactomeFI	BP	GO:0048308	organelle inheritance	-	14	14	-	-	7.03E-03	8.66E-04
ReactomeFI	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	2.23E-03	6.50E-04
ReactomeFI	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	2.10E-02	1.30E-03
ReactomeFI	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	7.87E-03	6.50E-04
ReactomeFI	BP	GO:0048515	spermatid differentiation	-	208	141	-	-	4.23E-02	8.16E-03
ReactomeFI	BP	GO:0048520	positive regulation of behavior	-	27	26	-	-	7.65E-03	1.52E-03
ReactomeFI	BP	GO:0048521	negative regulation of behavior	-	12	11	-	-	1.71E-02	6.50E-04
ReactomeFI	BP	GO:0048524	positive regulation of viral process	-	64	60	-	-	5.69E-03	3.46E-03
ReactomeFI	BP	GO:0048525	negative regulation of viral process	-	90	80	-	-	3.79E-02	4.62E-03
ReactomeFI	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	1.10E-02	9.38E-04
ReactomeFI	BP	GO:0048588	developmental cell growth	-	233	201	-	-	2.36E-02	1.16E-02
ReactomeFI	BP	GO:0048644	muscle organ morphogenesis	-	81	74	-	-	2.09E-02	4.33E-03
ReactomeFI	BP	GO:0048645	animal organ formation	-	62	59	-	-	3.98E-03	3.46E-03
ReactomeFI	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	135	-	-	6.71E-03	7.80E-03
ReactomeFI	BP	GO:0048663	neuron fate commitment	-	74	71	-	-	8.72E-03	4.11E-03
ReactomeFI	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	4.26E-03	1.44E-03
ReactomeFI	BP	GO:0048708	astrocyte differentiation	-	88	81	-	-	3.34E-03	4.69E-03
ReactomeFI	BP	GO:0048709	oligodendrocyte differentiation	-	101	86	-	-	1.61E-02	4.98E-03
ReactomeFI	BP	GO:0048753	pigment granule organization	-	40	38	-	-	2.33E-01	2.24E-03
ReactomeFI	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	3.61E-03	6.50E-04
ReactomeFI	CC	GO:0048786	presynaptic active zone	-	80	78	-	-	5.44E-02	4.55E-03
ReactomeFI	BP	GO:0048799	animal organ maturation	-	33	27	-	-	6.02E-03	1.59E-03
ReactomeFI	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	3.52E-02	7.94E-04
ReactomeFI	BP	GO:0048857	neural nucleus development	-	65	63	-	-	1.51E-02	3.68E-03
ReactomeFI	BP	GO:0048864	stem cell development	-	88	87	-	-	1.94E-02	5.05E-03
ReactomeFI	BP	GO:0048870	cell motility	9.02E-54	1659	1449	1198	1.21	-	-
ReactomeFI	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	2.82E-04	8.66E-04
ReactomeFI	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	6.23E-03	1.95E-03
ReactomeFI	BP	GO:0050435	amyloid-beta metabolic process	-	65	49	-	-	8.57E-03	2.89E-03
ReactomeFI	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	62	-	-	8.85E-02	3.61E-03
ReactomeFI	BP	GO:0050688	regulation of defense response to virus	-	65	55	-	-	9.95E-03	3.18E-03
ReactomeFI	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	237	-	-	1.95E-02	1.37E-02
ReactomeFI	BP	GO:0050768	negative regulation of neurogenesis	-	150	136	-	-	1.25E-02	7.87E-03
ReactomeFI	BP	GO:0050769	positive regulation of neurogenesis	-	240	223	-	-	2.30E-02	1.29E-02
ReactomeFI	BP	GO:0050777	negative regulation of immune response	-	196	181	-	-	1.05E-02	1.05E-02
ReactomeFI	BP	GO:0050779	RNA destabilization	-	135	92	-	-	2.45E-01	5.34E-03
ReactomeFI	CC	GO:0050805	negative regulation of synaptic transmission	-	55	49	-	-	9.04E-03	2.89E-03
ReactomeFI	CC	GO:0050806	positive regulation of synaptic transmission	-	171	141	-	-	1.41E-02	8.16E-03
ReactomeFI	MF	GO:0050811	GABA receptor binding	-	18	13	-	-	2.34E-02	7.94E-04
ReactomeFI	BP	GO:0050819	negative regulation of coagulation	-	54	50	-	-	6.40E-02	2.89E-03
ReactomeFI	BP	GO:0050820	positive regulation of coagulation	-	30	29	-	-	9.28E-02	1.73E-03
ReactomeFI	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	34	-	-	1.62E-02	2.02E-03
ReactomeFI	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	2.56E-02	1.44E-03
ReactomeFI	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	28	-	-	7.57E-03	1.66E-03
ReactomeFI	BP	GO:0050866	negative regulation of cell activation	-	216	192	-	-	1.84E-02	1.11E-02
ReactomeFI	BP	GO:0050877	nervous system process	4.42E-49	1527	1333	1103	1.21	-	-
ReactomeFI	BP	GO:0050879	multicellular organismal movement	-	118	99	-	-	2.53E-02	5.77E-03
ReactomeFI	BP	GO:0050886	endocrine process	-	93	88	-	-	1.11E-02	5.12E-03
ReactomeFI	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	6.44E-02	8.66E-04
ReactomeFI	BP	GO:0050951	sensory perception of temperature stimulus	-	28	25	-	-	1.01E-02	1.44E-03
ReactomeFI	BP	GO:0050953	sensory perception of light stimulus	-	223	186	-	-	2.45E-01	1.08E-02
ReactomeFI	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	148	-	-	3.67E-02	8.59E-03
ReactomeFI	BP	GO:0050994	regulation of lipid catabolic process	-	61	56	-	-	8.19E-03	3.25E-03
ReactomeFI	MF	GO:0051015	actin filament binding	-	208	183	-	-	8.79E-02	1.06E-02
ReactomeFI	BP	GO:0051017	actin filament bundle assembly	-	161	142	-	-	2.21E-02	8.23E-03
ReactomeFI	MF	GO:0051018	protein kinase A binding	-	52	41	-	-	6.99E-02	2.38E-03
ReactomeFI	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	64	-	-	5.90E-02	3.75E-03
ReactomeFI	MF	GO:0051087	protein-folding chaperone binding	-	135	120	-	-	2.06E-02	6.93E-03
ReactomeFI	MF	GO:0051100	negative regulation of binding	-	161	146	-	-	8.33E-03	8.44E-03
ReactomeFI	MF	GO:0051117	ATPase binding	-	85	77	-	-	8.66E-03	4.47E-03
ReactomeFI	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	20	-	-	1.91E-02	1.15E-03
ReactomeFI	BP	GO:0051147	regulation of muscle cell differentiation	-	162	129	-	-	5.27E-03	7.51E-03
ReactomeFI	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	31	-	-	1.01E-01	1.80E-03
ReactomeFI	MF	GO:0051219	phosphoprotein binding	-	92	84	-	-	1.00E-02	4.91E-03
ReactomeFI	BP	GO:0051222	positive regulation of protein transport	-	249	226	-	-	7.47E-03	1.31E-02
ReactomeFI	BP	GO:0051224	negative regulation of protein transport	-	122	102	-	-	8.69E-03	5.92E-03
ReactomeFI	BP	GO:0051231	spindle elongation	-	14	13	-	-	1.82E-02	7.94E-04
ReactomeFI	CC	GO:0051233	spindle midzone	-	36	34	-	-	1.19E-02	2.02E-03
ReactomeFI	BP	GO:0051236	establishment of RNA localization	-	161	144	-	-	1.71E-01	8.37E-03
ReactomeFI	BP	GO:0051255	spindle midzone assembly	-	14	11	-	-	1.51E-02	6.50E-04
ReactomeFI	BP	GO:0051258	protein polymerization	-	280	241	-	-	3.95E-02	1.39E-02
ReactomeFI	BP	GO:0051259	protein complex oligomerization	-	251	219	-	-	9.72E-02	1.27E-02
ReactomeFI	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	122	-	-	9.20E-02	7.07E-03
ReactomeFI	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	13	-	-	1.61E-01	7.94E-04
ReactomeFI	BP	GO:0051293	establishment of spindle localization	-	57	49	-	-	4.56E-02	2.89E-03
ReactomeFI	BP	GO:0051299	centrosome separation	-	15	14	-	-	1.20E-02	8.66E-04
ReactomeFI	BP	GO:0051303	establishment of chromosome localization	-	104	95	-	-	4.03E-02	5.49E-03
ReactomeFI	BP	GO:0051304	chromosome separation	-	80	78	-	-	4.84E-02	4.55E-03
ReactomeFI	MF	GO:0051349	positive regulation of lyase activity	-	41	40	-	-	1.64E-02	2.31E-03
ReactomeFI	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	58	-	-	2.71E-02	3.39E-03
ReactomeFI	MF	GO:0051378	serotonin binding	-	24	24	-	-	9.32E-03	1.44E-03
ReactomeFI	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	6.04E-02	9.38E-04
ReactomeFI	MF	GO:0051427	hormone receptor binding	-	31	31	-	-	2.19E-02	1.80E-03
ReactomeFI	BP	GO:0051445	regulation of meiotic cell cycle	-	64	56	-	-	3.08E-02	3.25E-03
ReactomeFI	CC	GO:0051457	maintenance of protein location in nucleus	-	23	21	-	-	1.29E-02	1.23E-03
ReactomeFI	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.15E-02	7.94E-04
ReactomeFI	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	128	-	-	6.67E-02	7.43E-03
ReactomeFI	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	169	-	-	1.89E-02	9.82E-03
ReactomeFI	MF	GO:0051540	metal cluster binding	-	71	61	-	-	1.21E-01	3.54E-03
ReactomeFI	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	21	-	-	3.72E-01	1.23E-03
ReactomeFI	BP	GO:0051588	regulation of neurotransmitter transport	-	99	90	-	-	2.00E-02	5.20E-03
ReactomeFI	BP	GO:0051593	response to folic acid	-	12	11	-	-	3.69E-02	6.50E-04
ReactomeFI	BP	GO:0051602	response to electrical stimulus	-	44	40	-	-	5.05E-03	2.31E-03
ReactomeFI	BP	GO:0051608	histamine transport	-	14	13	-	-	4.35E-03	7.94E-04
ReactomeFI	BP	GO:0051651	maintenance of location in cell	-	236	207	-	-	7.68E-02	1.20E-02
ReactomeFI	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	53	-	-	1.66E-02	3.10E-03
ReactomeFI	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	17	-	-	3.18E-03	1.01E-03
ReactomeFI	BP	GO:0051775	response to redox state	-	13	12	-	-	9.15E-03	7.22E-04
ReactomeFI	BP	GO:0051781	positive regulation of cell division	-	93	86	-	-	8.51E-03	4.98E-03
ReactomeFI	BP	GO:0051782	negative regulation of cell division	-	18	14	-	-	3.22E-03	8.66E-04
ReactomeFI	BP	GO:0051784	negative regulation of nuclear division	-	63	61	-	-	4.64E-02	3.54E-03
ReactomeFI	BP	GO:0051785	positive regulation of nuclear division	-	61	56	-	-	4.68E-03	3.25E-03
ReactomeFI	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	7.47E-02	1.15E-03
ReactomeFI	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.25E-03	7.22E-04
ReactomeFI	MF	GO:0051861	glycolipid binding	-	30	25	-	-	2.72E-02	1.44E-03
ReactomeFI	BP	GO:0051873	killing by host of symbiont cells	-	28	25	-	-	5.69E-02	1.44E-03
ReactomeFI	CC	GO:0051882	mitochondrial depolarization	-	21	20	-	-	1.54E-02	1.15E-03
ReactomeFI	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	97	-	-	8.66E-03	5.63E-03
ReactomeFI	BP	GO:0051904	pigment granule transport	-	23	22	-	-	5.12E-02	1.30E-03
ReactomeFI	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	5.05E-02	7.94E-04
ReactomeFI	BP	GO:0051931	regulation of sensory perception	-	36	29	-	-	6.04E-03	1.73E-03
ReactomeFI	BP	GO:0051952	regulation of amine transport	-	98	89	-	-	4.89E-02	5.20E-03
ReactomeFI	MF	GO:0051959	dynein light intermediate chain binding	-	27	25	-	-	1.68E-01	1.44E-03
ReactomeFI	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	7.49E-02	1.44E-03
ReactomeFI	BP	GO:0055006	cardiac cell development	-	93	78	-	-	7.20E-03	4.55E-03
ReactomeFI	BP	GO:0055017	cardiac muscle tissue growth	-	92	70	-	-	6.50E-03	4.04E-03
ReactomeFI	CC	GO:0055037	recycling endosome	-	200	168	-	-	5.07E-02	9.74E-03
ReactomeFI	BP	GO:0055085	transmembrane transport	9.07E-21	1784	1451	1288	1.13	-	-
ReactomeFI	BP	GO:0055086	nucleobase-containing small molecule metabolic process	4.06E-06	729	580	526	1.10	-	-
ReactomeFI	BP	GO:0055088	lipid homeostasis	-	173	131	-	-	8.38E-02	7.58E-03
ReactomeFI	BP	GO:0055093	response to hyperoxia	-	20	19	-	-	2.55E-03	1.15E-03
ReactomeFI	BP	GO:0055094	response to lipoprotein particle	-	34	28	-	-	5.82E-03	1.66E-03
ReactomeFI	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	27	-	-	2.06E-03	1.59E-03
ReactomeFI	BP	GO:0060004	reflex	-	63	54	-	-	6.34E-03	3.18E-03
ReactomeFI	BP	GO:0060021	roof of mouth development	-	91	89	-	-	9.04E-03	5.20E-03
ReactomeFI	BP	GO:0060033	anatomical structure regression	-	16	14	-	-	9.60E-03	8.66E-04
ReactomeFI	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	2.54E-02	1.73E-03
ReactomeFI	BP	GO:0060039	pericardium development	-	19	18	-	-	9.03E-04	1.08E-03
ReactomeFI	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	37	-	-	8.10E-03	2.17E-03
ReactomeFI	CC	GO:0060076	excitatory synapse	-	64	55	-	-	3.57E-02	3.18E-03
ReactomeFI	CC	GO:0060077	inhibitory synapse	-	20	15	-	-	3.92E-02	8.66E-04
ReactomeFI	BP	GO:0060119	inner ear receptor cell development	-	44	37	-	-	5.64E-02	2.17E-03
ReactomeFI	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	23	-	-	3.72E-03	1.37E-03
ReactomeFI	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	5.18E-03	1.08E-03
ReactomeFI	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	16	-	-	9.28E-03	9.38E-04
ReactomeFI	CC	GO:0060170	ciliary membrane	-	76	68	-	-	6.38E-02	3.97E-03
ReactomeFI	BP	GO:0060174	limb bud formation	-	11	11	-	-	2.28E-02	6.50E-04
ReactomeFI	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	1.54E-03	2.02E-03
ReactomeFI	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	5.58E-02	3.61E-03
ReactomeFI	BP	GO:0060306	regulation of membrane repolarization	-	38	29	-	-	2.97E-02	1.73E-03
ReactomeFI	BP	GO:0060325	face morphogenesis	-	31	28	-	-	2.40E-03	1.66E-03
ReactomeFI	BP	GO:0060343	trabecula formation	-	26	25	-	-	4.77E-03	1.44E-03
ReactomeFI	BP	GO:0060384	innervation	-	27	27	-	-	2.21E-02	1.59E-03
ReactomeFI	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	8.17E-03	1.15E-03
ReactomeFI	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	1.64E-02	4.04E-03
ReactomeFI	BP	GO:0060420	regulation of heart growth	-	74	58	-	-	4.73E-03	3.39E-03
ReactomeFI	BP	GO:0060428	lung epithelium development	-	43	39	-	-	2.63E-03	2.31E-03
ReactomeFI	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	1.80E-03	6.50E-04
ReactomeFI	BP	GO:0060456	positive regulation of digestive system process	-	16	15	-	-	3.60E-03	8.66E-04
ReactomeFI	BP	GO:0060457	negative regulation of digestive system process	-	17	15	-	-	1.51E-01	8.66E-04
ReactomeFI	BP	GO:0060479	lung cell differentiation	-	28	26	-	-	3.48E-03	1.52E-03
ReactomeFI	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	209	-	-	2.99E-02	1.21E-02
ReactomeFI	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	5.22E-03	1.52E-03
ReactomeFI	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	49	-	-	3.05E-03	2.89E-03
ReactomeFI	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	1.09E-02	1.44E-03
ReactomeFI	BP	GO:0060711	labyrinthine layer development	-	47	46	-	-	1.43E-03	2.67E-03
ReactomeFI	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	2.11E-04	8.66E-04
ReactomeFI	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	2.24E-03	1.15E-03
ReactomeFI	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	1.52E-03	7.22E-04
ReactomeFI	BP	GO:0060856	establishment of blood-brain barrier	-	16	15	-	-	3.21E-02	8.66E-04
ReactomeFI	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	2.11E-04	6.50E-04
ReactomeFI	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	16	-	-	9.44E-03	9.38E-04
ReactomeFI	BP	GO:0060973	cell migration involved in heart development	-	21	19	-	-	2.56E-03	1.15E-03
ReactomeFI	BP	GO:0060999	positive regulation of dendritic spine development	-	35	31	-	-	7.05E-03	1.80E-03
ReactomeFI	BP	GO:0061000	negative regulation of dendritic spine development	-	13	12	-	-	2.12E-03	7.22E-04
ReactomeFI	BP	GO:0061005	cell differentiation involved in kidney development	-	58	56	-	-	3.58E-03	3.25E-03
ReactomeFI	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	8.27E-04	8.66E-04
ReactomeFI	BP	GO:0061036	positive regulation of cartilage development	-	33	32	-	-	1.88E-02	1.88E-03
ReactomeFI	BP	GO:0061037	negative regulation of cartilage development	-	32	27	-	-	9.65E-03	1.59E-03
ReactomeFI	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	2.22E-03	9.38E-04
ReactomeFI	MF	GO:0061134	peptidase regulator activity	-	224	182	-	-	1.95E-01	1.05E-02
ReactomeFI	BP	GO:0061180	mammary gland epithelium development	-	68	67	-	-	2.80E-03	3.90E-03
ReactomeFI	BP	GO:0061303	cornea development in camera-type eye	-	12	11	-	-	2.13E-04	6.50E-04
ReactomeFI	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	1.75E-02	1.01E-03
ReactomeFI	BP	GO:0061318	renal filtration cell differentiation	-	22	21	-	-	1.05E-02	1.23E-03
ReactomeFI	BP	GO:0061326	renal tubule development	-	103	96	-	-	8.69E-03	5.56E-03
ReactomeFI	BP	GO:0061548	ganglion development	-	17	17	-	-	1.94E-02	1.01E-03
ReactomeFI	BP	GO:0061635	regulation of protein complex stability	-	14	12	-	-	7.35E-04	7.22E-04
ReactomeFI	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	2.41E-02	9.38E-04
ReactomeFI	CC	GO:0061702	canonical inflammasome complex	-	17	16	-	-	1.40E-01	9.38E-04
ReactomeFI	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	42	-	-	3.63E-02	2.45E-03
ReactomeFI	BP	GO:0061842	microtubule organizing center localization	-	32	29	-	-	1.45E-02	1.73E-03
ReactomeFI	BP	GO:0061900	glial cell activation	-	56	49	-	-	3.49E-03	2.89E-03
ReactomeFI	BP	GO:0061952	midbody abscission	-	18	18	-	-	1.83E-01	1.08E-03
ReactomeFI	MF	GO:0061980	regulatory RNA binding	-	52	39	-	-	1.38E-01	2.31E-03
ReactomeFI	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	29	-	-	1.12E-02	1.73E-03
ReactomeFI	BP	GO:0065003	protein-containing complex assembly	9.95E-50	1648	1431	1190	1.20	-	-
ReactomeFI	BP	GO:0065005	protein-lipid complex assembly	-	29	27	-	-	4.49E-02	1.59E-03
ReactomeFI	MF	GO:0070034	telomerase RNA binding	-	22	21	-	-	1.20E-01	1.23E-03
ReactomeFI	MF	GO:0070063	RNA polymerase binding	-	61	56	-	-	2.93E-02	3.25E-03
ReactomeFI	MF	GO:0070064	proline-rich region binding	-	17	15	-	-	1.20E-02	8.66E-04
ReactomeFI	CC	GO:0070069	cytochrome complex	-	42	34	-	-	5.54E-01	2.02E-03
ReactomeFI	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	11	-	-	3.50E-01	6.50E-04
ReactomeFI	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	87	-	-	4.24E-01	5.05E-03
ReactomeFI	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	23	-	-	5.02E-03	1.37E-03
ReactomeFI	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	50	-	-	1.08E-02	2.89E-03
ReactomeFI	MF	GO:0070182	DNA polymerase binding	-	22	18	-	-	2.27E-03	1.08E-03
ReactomeFI	CC	GO:0070286	axonemal dynein complex assembly	-	40	25	-	-	5.26E-01	1.44E-03
ReactomeFI	MF	GO:0070300	phosphatidic acid binding	-	20	16	-	-	1.43E-02	9.38E-04
ReactomeFI	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	18	-	-	3.85E-02	1.08E-03
ReactomeFI	MF	GO:0070325	lipoprotein particle receptor binding	-	32	27	-	-	2.11E-02	1.59E-03
ReactomeFI	CC	GO:0070382	exocytic vesicle	-	224	197	-	-	9.26E-02	1.14E-02
ReactomeFI	MF	GO:0070402	NADPH binding	-	16	12	-	-	2.16E-04	7.22E-04
ReactomeFI	MF	GO:0070403	NAD+ binding	-	16	14	-	-	8.10E-02	8.66E-04
ReactomeFI	BP	GO:0070417	cellular response to cold	-	13	12	-	-	9.47E-04	7.22E-04
ReactomeFI	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	6.30E-03	7.94E-04
ReactomeFI	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	2.14E-04	7.94E-04
ReactomeFI	BP	GO:0070585	protein localization to mitochondrion	-	125	117	-	-	2.22E-01	6.78E-03
ReactomeFI	MF	GO:0070628	proteasome binding	-	17	15	-	-	3.76E-02	8.66E-04
ReactomeFI	BP	GO:0070633	transepithelial transport	-	35	33	-	-	1.10E-02	1.95E-03
ReactomeFI	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	15	-	-	1.13E-01	8.66E-04
ReactomeFI	MF	GO:0070840	dynein complex binding	-	25	19	-	-	1.53E-02	1.15E-03
ReactomeFI	MF	GO:0070851	growth factor receptor binding	-	141	139	-	-	4.60E-02	8.08E-03
ReactomeFI	MF	GO:0070888	E-box binding	-	59	56	-	-	3.87E-02	3.25E-03
ReactomeFI	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	14	-	-	4.13E-03	8.66E-04
ReactomeFI	CC	GO:0070971	endoplasmic reticulum exit site	-	32	25	-	-	1.14E-01	1.44E-03
ReactomeFI	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	66	-	-	1.09E-01	3.83E-03
ReactomeFI	BP	GO:0070988	demethylation	-	27	19	-	-	5.36E-02	1.15E-03
ReactomeFI	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	3.66E-01	1.15E-03
ReactomeFI	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	1.33E-02	7.22E-04
ReactomeFI	CC	GO:0071013	catalytic step 2 spliceosome	-	88	86	-	-	8.80E-02	4.98E-03
ReactomeFI	CC	GO:0071027	nuclear RNA surveillance	-	14	13	-	-	1.26E-01	7.94E-04
ReactomeFI	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	1.82E-02	6.50E-04
ReactomeFI	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	1.41E-03	7.94E-04
ReactomeFI	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	16	-	-	9.18E-04	9.38E-04
ReactomeFI	BP	GO:0071248	cellular response to metal ion	-	201	178	-	-	2.00E-02	1.03E-02
ReactomeFI	BP	GO:0071300	cellular response to retinoic acid	-	66	64	-	-	6.85E-03	3.75E-03
ReactomeFI	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	3.91E-02	1.30E-03
ReactomeFI	BP	GO:0071318	cellular response to ATP	-	18	17	-	-	1.03E-02	1.01E-03
ReactomeFI	BP	GO:0071320	cellular response to cAMP	-	54	47	-	-	2.65E-02	2.74E-03
ReactomeFI	BP	GO:0071392	cellular response to estradiol stimulus	-	40	37	-	-	1.14E-02	2.17E-03
ReactomeFI	BP	GO:0071398	cellular response to fatty acid	-	35	33	-	-	1.24E-02	1.95E-03
ReactomeFI	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	31	-	-	1.05E-02	1.80E-03
ReactomeFI	BP	GO:0071453	cellular response to oxygen levels	-	168	140	-	-	8.69E-03	8.08E-03
ReactomeFI	BP	GO:0071496	cellular response to external stimulus	-	74	68	-	-	8.84E-03	3.97E-03
ReactomeFI	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	7.09E-03	1.15E-03
ReactomeFI	BP	GO:0071501	cellular response to sterol depletion	-	15	14	-	-	9.65E-02	8.66E-04
ReactomeFI	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	44	-	-	6.37E-01	2.60E-03
ReactomeFI	BP	GO:0071542	dopaminergic neuron differentiation	-	36	34	-	-	4.62E-03	2.02E-03
ReactomeFI	BP	GO:0071599	otic vesicle development	-	15	14	-	-	1.00E-02	8.66E-04
ReactomeFI	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	2.35E-02	1.30E-03
ReactomeFI	BP	GO:0071709	membrane assembly	-	68	61	-	-	6.63E-02	3.54E-03
ReactomeFI	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	4.06E-04	1.01E-03
ReactomeFI	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	7.26E-02	2.45E-03
ReactomeFI	BP	GO:0071800	podosome assembly	-	19	16	-	-	1.67E-03	9.38E-04
ReactomeFI	BP	GO:0071806	protein transmembrane transport	-	68	65	-	-	6.08E-02	3.75E-03
ReactomeFI	MF	GO:0071814	protein-lipid complex binding	-	52	42	-	-	1.73E-02	2.45E-03
ReactomeFI	CC	GO:0071819	DUBm complex	-	25	25	-	-	5.85E-01	1.44E-03
ReactomeFI	BP	GO:0071827	plasma lipoprotein particle organization	-	86	68	-	-	1.57E-02	3.97E-03
ReactomeFI	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	58	-	-	1.26E-02	3.39E-03
ReactomeFI	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	1.69E-03	6.50E-04
ReactomeFI	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	27	-	-	9.46E-03	1.59E-03
ReactomeFI	MF	GO:0071889	14-3-3 protein binding	-	34	31	-	-	6.23E-03	1.80E-03
ReactomeFI	MF	GO:0071933	Arp2/3 complex binding	-	14	13	-	-	1.20E-01	7.94E-04
ReactomeFI	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	2.34E-01	3.18E-03
ReactomeFI	BP	GO:0072044	collecting duct development	-	16	15	-	-	1.23E-03	8.66E-04
ReactomeFI	BP	GO:0072091	regulation of stem cell proliferation	-	91	76	-	-	6.38E-03	4.40E-03
ReactomeFI	BP	GO:0072132	mesenchyme morphogenesis	-	57	55	-	-	9.11E-03	3.18E-03
ReactomeFI	BP	GO:0072164	mesonephric tubule development	-	98	94	-	-	1.65E-02	5.49E-03
ReactomeFI	BP	GO:0072170	metanephric tubule development	-	26	25	-	-	1.66E-03	1.44E-03
ReactomeFI	BP	GO:0072176	nephric duct development	-	15	14	-	-	9.91E-03	8.66E-04
ReactomeFI	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	23	-	-	1.06E-01	1.37E-03
ReactomeFI	BP	GO:0072520	seminiferous tubule development	-	15	14	-	-	1.97E-03	8.66E-04
ReactomeFI	BP	GO:0072523	purine-containing compound catabolic process	-	146	118	-	-	9.01E-02	6.86E-03
ReactomeFI	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	11	-	-	3.00E-01	6.50E-04
ReactomeFI	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	86	-	-	1.70E-01	4.98E-03
ReactomeFI	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	27	-	-	1.99E-01	1.59E-03
ReactomeFI	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	18	-	-	1.69E-01	1.08E-03
ReactomeFI	CC	GO:0072562	blood microparticle	-	144	130	-	-	4.75E-02	7.51E-03
ReactomeFI	CC	GO:0072595	maintenance of protein localization in organelle	-	42	38	-	-	8.90E-03	2.24E-03
ReactomeFI	BP	GO:0072659	protein localization to plasma membrane	8.19E-15	284	258	205	1.26	-	-
ReactomeFI	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	7.36E-02	1.15E-03
ReactomeFI	BP	GO:0072665	protein localization to vacuole	-	84	78	-	-	5.62E-02	4.55E-03
ReactomeFI	BP	GO:0072710	response to hydroxyurea	-	12	11	-	-	1.92E-02	6.50E-04
ReactomeFI	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	13	-	-	1.88E-03	7.94E-04
ReactomeFI	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	20	-	-	6.56E-02	1.15E-03
ReactomeFI	BP	GO:0085029	extracellular matrix assembly	-	42	36	-	-	2.64E-02	2.09E-03
ReactomeFI	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	33	-	-	1.40E-01	1.95E-03
ReactomeFI	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	2.43E-03	7.94E-04
ReactomeFI	BP	GO:0090068	positive regulation of cell cycle process	-	262	228	-	-	1.85E-02	1.32E-02
ReactomeFI	BP	GO:0090077	foam cell differentiation	-	39	36	-	-	3.44E-03	2.09E-03
ReactomeFI	BP	GO:0090087	regulation of peptide transport	-	195	178	-	-	9.38E-03	1.03E-02
ReactomeFI	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	122	-	-	2.57E-02	7.07E-03
ReactomeFI	BP	GO:0090102	cochlea development	-	50	45	-	-	4.16E-03	2.60E-03
ReactomeFI	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	1.77E-01	8.66E-04
ReactomeFI	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	20	-	-	1.48E-01	1.15E-03
ReactomeFI	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	31	-	-	3.51E-01	1.80E-03
ReactomeFI	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	5.72E-02	7.94E-04
ReactomeFI	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	1.91E-03	6.50E-04
ReactomeFI	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	7.20E-03	1.08E-03
ReactomeFI	BP	GO:0090235	regulation of metaphase plate congression	-	13	12	-	-	3.25E-03	7.22E-04
ReactomeFI	BP	GO:0090311	regulation of protein deacetylation	-	29	28	-	-	9.92E-02	1.66E-03
ReactomeFI	BP	GO:0090399	replicative senescence	-	17	16	-	-	3.84E-03	9.38E-04
ReactomeFI	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	21	-	-	1.59E-01	1.23E-03
ReactomeFI	CC	GO:0090543	Flemming body	-	33	28	-	-	1.63E-02	1.66E-03
ReactomeFI	BP	GO:0090559	regulation of membrane permeability	-	72	54	-	-	1.75E-02	3.18E-03
ReactomeFI	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	3.97E-03	8.66E-04
ReactomeFI	BP	GO:0090596	sensory organ morphogenesis	-	272	241	-	-	1.65E-02	1.39E-02
ReactomeFI	CC	GO:0090665	glycoprotein complex	-	23	22	-	-	3.95E-01	1.30E-03
ReactomeFI	BP	GO:0090713	immunological memory process	-	18	18	-	-	4.14E-03	1.08E-03
ReactomeFI	CC	GO:0090734	site of DNA damage	-	118	102	-	-	2.30E-02	5.92E-03
ReactomeFI	CC	GO:0090741	pigment granule membrane	-	21	16	-	-	1.16E-01	9.38E-04
ReactomeFI	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	1.49E-01	1.15E-03
ReactomeFI	BP	GO:0097094	craniofacial suture morphogenesis	-	18	16	-	-	1.38E-02	9.38E-04
ReactomeFI	MF	GO:0097110	scaffold protein binding	-	66	65	-	-	8.31E-03	3.75E-03
ReactomeFI	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	182	-	-	3.12E-02	1.05E-02
ReactomeFI	BP	GO:0097154	GABAergic neuron differentiation	-	20	19	-	-	2.80E-04	1.15E-03
ReactomeFI	BP	GO:0097164	ammonium ion metabolic process	-	23	14	-	-	2.00E-01	8.66E-04
ReactomeFI	BP	GO:0097186	amelogenesis	-	26	22	-	-	1.95E-02	1.30E-03
ReactomeFI	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	213	-	-	2.89E-02	1.23E-02
ReactomeFI	BP	GO:0097212	lysosomal membrane organization	-	15	14	-	-	4.15E-02	8.66E-04
ReactomeFI	CC	GO:0097228	sperm principal piece	-	33	21	-	-	1.31E-01	1.23E-03
ReactomeFI	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.23E-02	7.22E-04
ReactomeFI	BP	GO:0097306	cellular response to alcohol	-	99	90	-	-	6.82E-03	5.20E-03
ReactomeFI	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	2.12E-03	6.50E-04
ReactomeFI	CC	GO:0097381	photoreceptor disc membrane	-	25	23	-	-	2.18E-01	1.37E-03
ReactomeFI	CC	GO:0097386	glial cell projection	-	38	34	-	-	2.03E-03	2.02E-03
ReactomeFI	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	1.41E-01	9.38E-04
ReactomeFI	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	13	-	-	9.90E-03	7.94E-04
ReactomeFI	CC	GO:0097470	ribbon synapse	-	13	13	-	-	3.94E-03	7.94E-04
ReactomeFI	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	116	-	-	1.15E-01	6.71E-03
ReactomeFI	CC	GO:0097540	axonemal central pair	-	161	100	-	-	3.95E-02	5.77E-03
ReactomeFI	CC	GO:0097542	ciliary tip	-	48	45	-	-	5.17E-01	2.60E-03
ReactomeFI	CC	GO:0097545	axonemal outer doublet	-	164	100	-	-	4.20E-02	5.77E-03
ReactomeFI	CC	GO:0097546	ciliary base	-	47	36	-	-	6.67E-03	2.09E-03
ReactomeFI	CC	GO:0097550	transcription preinitiation complex	-	13	12	-	-	2.02E-02	7.22E-04
ReactomeFI	BP	GO:0097581	lamellipodium organization	-	91	81	-	-	1.96E-02	4.69E-03
ReactomeFI	MF	GO:0097602	cullin family protein binding	-	26	23	-	-	1.27E-01	1.37E-03
ReactomeFI	BP	GO:0097722	sperm motility	-	133	83	-	-	6.47E-02	4.84E-03
ReactomeFI	BP	GO:0098542	defense response to other organism	4.47E-27	1171	997	846	1.18	-	-
ReactomeFI	BP	GO:0098543	detection of other organism	-	19	17	-	-	2.28E-01	1.01E-03
ReactomeFI	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	28	-	-	3.44E-02	1.66E-03
ReactomeFI	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	13	-	-	8.82E-02	7.94E-04
ReactomeFI	MF	GO:0098631	cell adhesion mediator activity	-	64	56	-	-	1.73E-02	3.25E-03
ReactomeFI	CC	GO:0098636	protein complex involved in cell adhesion	-	57	54	-	-	4.38E-02	3.18E-03
ReactomeFI	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	1.22E-02	7.22E-04
ReactomeFI	BP	GO:0098661	inorganic anion transmembrane transport	-	140	118	-	-	3.80E-01	6.86E-03
ReactomeFI	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	4.55E-03	1.37E-03
ReactomeFI	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	91	-	-	6.11E-03	5.27E-03
ReactomeFI	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	1.02E-02	8.66E-04
ReactomeFI	BP	GO:0098743	cell aggregation	-	24	22	-	-	2.32E-03	1.30E-03
ReactomeFI	BP	GO:0098751	bone cell development	-	18	18	-	-	1.72E-02	1.08E-03
ReactomeFI	BP	GO:0098754	detoxification	3.28E-02	134	108	97	1.12	-	-
ReactomeFI	BP	GO:0098780	response to mitochondrial depolarisation	-	21	20	-	-	2.24E-02	1.15E-03
ReactomeFI	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	4.94E-01	1.37E-03
ReactomeFI	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	96	-	-	4.42E-01	5.56E-03
ReactomeFI	CC	GO:0098803	respiratory chain complex	-	39	31	-	-	5.49E-01	1.80E-03
ReactomeFI	CC	GO:0098810	neurotransmitter reuptake	-	35	31	-	-	5.54E-02	1.80E-03
ReactomeFI	CC	GO:0098845	postsynaptic endosome	-	14	12	-	-	7.32E-03	7.22E-04
ReactomeFI	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	2.76E-02	8.66E-04
ReactomeFI	CC	GO:0098862	cluster of actin-based cell projections	-	162	137	-	-	1.26E-01	7.94E-03
ReactomeFI	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	129	-	-	6.63E-02	7.51E-03
ReactomeFI	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	1.82E-01	1.59E-03
ReactomeFI	CC	GO:0098926	postsynaptic signal transduction	-	39	38	-	-	1.28E-02	2.24E-03
ReactomeFI	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	9.02E-02	6.50E-04
ReactomeFI	CC	GO:0098982	GABA-ergic synapse	-	84	78	-	-	3.49E-02	4.55E-03
ReactomeFI	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	208	-	-	1.03E-01	1.21E-02
ReactomeFI	BP	GO:0099022	vesicle tethering	-	32	27	-	-	2.25E-01	1.59E-03
ReactomeFI	BP	GO:0099054	presynapse assembly	-	49	46	-	-	8.32E-02	2.67E-03
ReactomeFI	BP	GO:0099068	postsynapse assembly	-	40	35	-	-	2.20E-02	2.02E-03
ReactomeFI	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	76	-	-	1.38E-02	4.40E-03
ReactomeFI	BP	GO:0099084	postsynaptic specialization organization	-	44	38	-	-	2.60E-02	2.24E-03
ReactomeFI	CC	GO:0099086	synaptonemal structure	-	40	32	-	-	2.71E-01	1.88E-03
ReactomeFI	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	12	-	-	2.33E-03	7.22E-04
ReactomeFI	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	7.20E-03	6.50E-04
ReactomeFI	BP	GO:0099118	microtubule-based protein transport	-	14	13	-	-	8.34E-03	7.94E-04
ReactomeFI	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	15	-	-	2.21E-03	8.66E-04
ReactomeFI	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	4.06E-01	1.15E-03
ReactomeFI	CC	GO:0099522	cytosolic region	-	20	20	-	-	9.35E-04	1.15E-03
ReactomeFI	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	151	-	-	1.38E-01	8.73E-03
ReactomeFI	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	2.53E-01	7.22E-04
ReactomeFI	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	2.97E-01	1.01E-03
ReactomeFI	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	112	-	-	2.00E-01	6.50E-03
ReactomeFI	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	21	-	-	9.78E-03	1.23E-03
ReactomeFI	BP	GO:0099637	neurotransmitter receptor transport	-	26	23	-	-	2.23E-03	1.37E-03
ReactomeFI	CC	GO:0099643	signal release from synapse	-	147	136	-	-	1.07E-01	7.87E-03
ReactomeFI	BP	GO:0106027	neuron projection organization	-	90	79	-	-	9.21E-03	4.62E-03
ReactomeFI	BP	GO:0110096	cellular response to aldehyde	-	17	16	-	-	5.41E-02	9.38E-04
ReactomeFI	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	24	-	-	6.56E-03	1.44E-03
ReactomeFI	BP	GO:0110154	RNA decapping	-	19	17	-	-	2.96E-01	1.01E-03
ReactomeFI	BP	GO:0120009	intermembrane lipid transfer	-	52	34	-	-	1.20E-01	2.02E-03
ReactomeFI	CC	GO:0120111	neuron projection cytoplasm	-	94	84	-	-	1.28E-01	4.91E-03
ReactomeFI	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	95	-	-	6.28E-03	5.49E-03
ReactomeFI	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	43	-	-	2.35E-02	2.53E-03
ReactomeFI	MF	GO:0120227	acyl-CoA binding	-	22	15	-	-	9.66E-02	8.66E-04
ReactomeFI	BP	GO:0120255	olefinic compound biosynthetic process	-	24	22	-	-	2.98E-02	1.30E-03
ReactomeFI	CC	GO:0120293	dynein axonemal particle	-	20	15	-	-	6.75E-02	8.66E-04
ReactomeFI	BP	GO:0120305	regulation of pigmentation	-	15	12	-	-	1.91E-02	7.22E-04
ReactomeFI	BP	GO:0140013	meiotic nuclear division	2.01E-05	279	232	201	1.15	-	-
ReactomeFI	MF	GO:0140030	modification-dependent protein binding	-	179	157	-	-	2.65E-02	9.09E-03
ReactomeFI	BP	GO:0140053	mitochondrial gene expression	1.22E-09	164	150	118	1.27	-	-
ReactomeFI	MF	GO:0140096	"catalytic activity, acting on a protein"	1.48E-80	3198	2726	2309	1.18	-	-
ReactomeFI	MF	GO:0140097	"catalytic activity, acting on DNA"	2.00E-18	383	346	277	1.25	-	-
ReactomeFI	MF	GO:0140098	"catalytic activity, acting on RNA"	5.65E-03	417	326	301	1.08	-	-
ReactomeFI	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	18	-	-	2.17E-01	1.08E-03
ReactomeFI	MF	GO:0140104	molecular carrier activity	4.72E-07	105	97	76	1.28	-	-
ReactomeFI	MF	GO:0140110	transcription regulator activity	9.18E-154	2033	1913	1468	1.30	-	-
ReactomeFI	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.15E-02	1.37E-03
ReactomeFI	BP	GO:0140115	export across plasma membrane	-	82	56	-	-	1.09E-01	3.25E-03
ReactomeFI	MF	GO:0140223	general transcription initiation factor activity	-	55	51	-	-	1.43E-01	2.96E-03
ReactomeFI	CC	GO:0140238	presynaptic endocytosis	-	72	69	-	-	2.98E-02	4.04E-03
ReactomeFI	CC	GO:0140239	postsynaptic endocytosis	-	23	22	-	-	2.45E-03	1.30E-03
ReactomeFI	BP	GO:0140253	cell-cell fusion	-	62	51	-	-	6.39E-03	2.96E-03
ReactomeFI	MF	GO:0140272	exogenous protein binding	-	79	73	-	-	7.71E-03	4.26E-03
ReactomeFI	MF	GO:0140299	small molecule sensor activity	-	39	33	-	-	2.37E-01	1.95E-03
ReactomeFI	MF	GO:0140311	protein sequestering activity	-	14	13	-	-	7.68E-03	7.94E-04
ReactomeFI	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	4.91E-02	1.08E-03
ReactomeFI	MF	GO:0140318	protein transporter activity	-	40	38	-	-	5.73E-02	2.24E-03
ReactomeFI	MF	GO:0140416	transcription regulator inhibitor activity	-	26	26	-	-	2.64E-03	1.52E-03
ReactomeFI	MF	GO:0140457	protein demethylase activity	-	31	26	-	-	2.74E-01	1.52E-03
ReactomeFI	CC	GO:0140467	integrated stress response signaling	-	41	40	-	-	9.90E-03	2.31E-03
ReactomeFI	MF	GO:0140537	transcription regulator activator activity	-	13	11	-	-	1.37E-03	6.50E-04
ReactomeFI	CC	GO:0140632	canonical inflammasome complex assembly	-	40	35	-	-	3.44E-02	2.02E-03
ReactomeFI	MF	GO:0140657	ATP-dependent activity	1.02E-29	729	650	526	1.23	-	-
ReactomeFI	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	32	-	-	3.30E-02	1.88E-03
ReactomeFI	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	66	-	-	1.04E-02	3.83E-03
ReactomeFI	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	16	-	-	5.42E-02	9.38E-04
ReactomeFI	MF	GO:0141047	molecular tag activity	-	13	13	-	-	1.45E-03	7.94E-04
ReactomeFI	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	85	-	-	1.07E-01	4.91E-03
ReactomeFI	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	18	-	-	1.66E-02	1.08E-03
ReactomeFI	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	5.92E-03	2.02E-03
ReactomeFI	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	2.71E-03	1.80E-03
ReactomeFI	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	48	-	-	1.73E-01	2.81E-03
ReactomeFI	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	41	-	-	2.41E-01	2.38E-03
ReactomeFI	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	13	-	-	4.17E-02	7.94E-04
ReactomeFI	MF	GO:0170055	lipid transmembrane transporter activity	-	56	42	-	-	2.15E-01	2.45E-03
ReactomeFI	BP	GO:1900006	positive regulation of dendrite development	-	17	14	-	-	4.14E-03	8.66E-04
ReactomeFI	BP	GO:1900047	negative regulation of hemostasis	-	51	48	-	-	6.32E-02	2.81E-03
ReactomeFI	BP	GO:1900048	positive regulation of hemostasis	-	28	27	-	-	7.47E-02	1.59E-03
ReactomeFI	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	4.94E-02	7.94E-04
ReactomeFI	CC	GO:1900115	extracellular regulation of signal transduction	-	13	11	-	-	1.13E-01	6.50E-04
ReactomeFI	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	11	-	-	1.21E-01	6.50E-04
ReactomeFI	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	17	-	-	3.06E-02	1.01E-03
ReactomeFI	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	9.11E-03	6.50E-04
ReactomeFI	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	11	-	-	3.23E-03	6.50E-04
ReactomeFI	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	1.17E-01	1.08E-03
ReactomeFI	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	2.01E-03	6.50E-04
ReactomeFI	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	19	-	-	2.75E-02	1.15E-03
ReactomeFI	BP	GO:1901096	regulation of autophagosome maturation	-	17	14	-	-	4.14E-03	8.66E-04
ReactomeFI	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	33	-	-	3.78E-03	1.95E-03
ReactomeFI	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	1.15E-02	8.66E-04
ReactomeFI	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	30	-	-	1.09E-02	1.73E-03
ReactomeFI	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	3.42E-03	1.52E-03
ReactomeFI	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	64	-	-	1.03E-02	3.75E-03
ReactomeFI	BP	GO:1901343	negative regulation of vasculature development	-	154	88	-	-	1.55E-02	5.12E-03
ReactomeFI	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	29	-	-	3.03E-01	1.73E-03
ReactomeFI	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	36	-	-	2.41E-03	2.09E-03
ReactomeFI	BP	GO:1901606	alpha-amino acid catabolic process	-	101	52	-	-	2.07E-01	3.03E-03
ReactomeFI	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	54	-	-	2.14E-01	3.18E-03
ReactomeFI	MF	GO:1901611	phosphatidylglycerol binding	-	15	13	-	-	6.87E-03	7.94E-04
ReactomeFI	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	44	-	-	1.18E-01	2.60E-03
ReactomeFI	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	201	-	-	9.18E-02	1.16E-02
ReactomeFI	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	39	-	-	8.30E-02	2.31E-03
ReactomeFI	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	2.13E-04	6.50E-04
ReactomeFI	BP	GO:1901655	cellular response to ketone	-	107	103	-	-	5.80E-03	5.99E-03
ReactomeFI	BP	GO:1901679	nucleotide transmembrane transport	-	32	18	-	-	1.16E-01	1.08E-03
ReactomeFI	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	45	-	-	4.25E-01	2.60E-03
ReactomeFI	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	8.60E-04	8.66E-04
ReactomeFI	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.89E-03	1.73E-03
ReactomeFI	BP	GO:1901857	positive regulation of cellular respiration	-	13	12	-	-	3.84E-03	7.22E-04
ReactomeFI	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.78E-03	7.94E-04
ReactomeFI	BP	GO:1901863	positive regulation of muscle tissue development	-	24	23	-	-	8.91E-03	1.37E-03
ReactomeFI	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	87	-	-	3.00E-03	5.05E-03
ReactomeFI	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	131	-	-	1.35E-02	7.58E-03
ReactomeFI	BP	GO:1901890	positive regulation of cell junction assembly	-	106	93	-	-	7.79E-02	5.41E-03
ReactomeFI	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	4.01E-02	1.08E-03
ReactomeFI	BP	GO:1901983	regulation of protein acetylation	-	26	20	-	-	2.27E-03	1.15E-03
ReactomeFI	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	19	-	-	1.26E-01	1.15E-03
ReactomeFI	BP	GO:1902115	regulation of organelle assembly	-	210	179	-	-	1.66E-02	1.04E-02
ReactomeFI	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	64	-	-	1.01E-01	3.75E-03
ReactomeFI	BP	GO:1902414	protein localization to cell junction	-	107	95	-	-	9.61E-03	5.49E-03
ReactomeFI	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	24	-	-	2.73E-02	1.44E-03
ReactomeFI	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	46	-	-	3.21E-02	2.67E-03
ReactomeFI	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	31	-	-	2.20E-02	1.80E-03
ReactomeFI	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.64E-03	1.30E-03
ReactomeFI	BP	GO:1902895	positive regulation of miRNA transcription	-	51	50	-	-	3.95E-03	2.89E-03
ReactomeFI	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	1.09E-03	7.94E-04
ReactomeFI	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	2.23E-03	1.15E-03
ReactomeFI	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	21	-	-	1.96E-03	1.23E-03
ReactomeFI	BP	GO:1903008	organelle disassembly	-	154	139	-	-	5.54E-02	8.08E-03
ReactomeFI	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	1.46E-01	6.50E-04
ReactomeFI	BP	GO:1903035	negative regulation of response to wounding	-	93	82	-	-	3.06E-02	4.76E-03
ReactomeFI	BP	GO:1903036	positive regulation of response to wounding	-	76	68	-	-	2.28E-02	3.97E-03
ReactomeFI	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	25	-	-	4.52E-03	1.44E-03
ReactomeFI	CC	GO:1903293	phosphatase complex	-	54	51	-	-	3.85E-02	2.96E-03
ReactomeFI	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	123	-	-	2.02E-01	7.15E-03
ReactomeFI	BP	GO:1903318	negative regulation of protein maturation	-	29	26	-	-	2.97E-03	1.52E-03
ReactomeFI	BP	GO:1903319	positive regulation of protein maturation	-	27	22	-	-	3.62E-03	1.30E-03
ReactomeFI	BP	GO:1903358	regulation of Golgi organization	-	17	16	-	-	1.25E-02	9.38E-04
ReactomeFI	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	24	-	-	1.18E-03	1.44E-03
ReactomeFI	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	12	-	-	3.87E-03	7.22E-04
ReactomeFI	BP	GO:1903509	liposaccharide metabolic process	-	109	80	-	-	2.67E-01	4.62E-03
ReactomeFI	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	1.34E-01	1.66E-03
ReactomeFI	BP	GO:1903523	negative regulation of blood circulation	-	27	22	-	-	7.18E-03	1.30E-03
ReactomeFI	BP	GO:1903524	positive regulation of blood circulation	-	39	36	-	-	2.43E-03	2.09E-03
ReactomeFI	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	36	-	-	1.14E-02	2.09E-03
ReactomeFI	MF	GO:1903624	regulation of DNA catabolic process	-	14	11	-	-	8.18E-02	6.50E-04
ReactomeFI	BP	GO:1903707	negative regulation of hemopoiesis	-	116	100	-	-	5.65E-03	5.77E-03
ReactomeFI	BP	GO:1903708	positive regulation of hemopoiesis	-	184	178	-	-	1.20E-02	1.03E-02
ReactomeFI	BP	GO:1903729	regulation of plasma membrane organization	-	17	16	-	-	2.27E-02	9.38E-04
ReactomeFI	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	31	-	-	4.72E-03	1.80E-03
ReactomeFI	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	1.48E-02	7.22E-04
ReactomeFI	BP	GO:1903975	regulation of glial cell migration	-	20	17	-	-	5.10E-03	1.01E-03
ReactomeFI	BP	GO:1904018	positive regulation of vasculature development	-	185	144	-	-	1.02E-02	8.37E-03
ReactomeFI	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	92	-	-	2.93E-02	5.34E-03
ReactomeFI	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	90	-	-	3.98E-03	5.20E-03
ReactomeFI	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	13	-	-	2.52E-02	7.94E-04
ReactomeFI	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	2.60E-02	6.50E-04
ReactomeFI	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	4.79E-04	6.50E-04
ReactomeFI	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	1.43E-01	8.66E-04
ReactomeFI	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	5.19E-03	2.24E-03
ReactomeFI	CC	GO:1904724	tertiary granule lumen	-	55	43	-	-	2.89E-03	2.53E-03
ReactomeFI	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	113	-	-	5.82E-03	6.57E-03
ReactomeFI	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	1.34E-01	8.66E-04
ReactomeFI	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	24	-	-	1.40E-03	1.44E-03
ReactomeFI	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	49	-	-	1.13E-02	2.89E-03
ReactomeFI	BP	GO:1905145	cellular response to acetylcholine	-	33	33	-	-	7.76E-03	1.95E-03
ReactomeFI	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	2.53E-03	7.94E-04
ReactomeFI	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	2.04E-04	6.50E-04
ReactomeFI	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	1.26E-03	7.94E-04
ReactomeFI	CC	GO:1905348	endonuclease complex	-	38	36	-	-	2.44E-01	2.09E-03
ReactomeFI	CC	GO:1905360	GTPase complex	-	41	39	-	-	3.98E-03	2.31E-03
ReactomeFI	CC	GO:1905368	peptidase complex	-	124	122	-	-	9.08E-02	7.07E-03
ReactomeFI	BP	GO:1905874	regulation of postsynaptic density organization	-	13	11	-	-	3.33E-02	6.50E-04
ReactomeFI	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	4.26E-02	7.22E-04
ReactomeFI	BP	GO:1905953	negative regulation of lipid localization	-	63	40	-	-	5.31E-03	2.31E-03
ReactomeFI	BP	GO:1905954	positive regulation of lipid localization	-	110	100	-	-	2.78E-02	5.77E-03
ReactomeFI	BP	GO:1905962	glutamatergic neuron differentiation	-	14	11	-	-	2.16E-04	6.50E-04
ReactomeFI	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	5.58E-01	6.50E-04
ReactomeFI	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.58E-01	6.50E-04
ReactomeFI	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	4.41E-01	7.22E-04
ReactomeFI	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	1.28E-02	7.22E-04
ReactomeFI	CC	GO:1990204	oxidoreductase complex	-	90	80	-	-	1.98E-01	4.62E-03
ReactomeFI	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	6.18E-04	8.66E-04
ReactomeFI	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	15	-	-	4.47E-01	8.66E-04
ReactomeFI	CC	GO:1990391	DNA repair complex	-	22	20	-	-	5.55E-02	1.15E-03
ReactomeFI	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	27	-	-	2.31E-01	1.59E-03
ReactomeFI	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	3.34E-02	7.22E-04
ReactomeFI	BP	GO:1990542	mitochondrial transmembrane transport	-	93	76	-	-	2.60E-01	4.40E-03
ReactomeFI	CC	GO:1990752	microtubule end	-	34	27	-	-	2.37E-02	1.59E-03
ReactomeFI	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	70	-	-	8.27E-02	4.04E-03
ReactomeFI	BP	GO:1990840	response to lectin	-	22	21	-	-	7.35E-03	1.23E-03
ReactomeFI	BP	GO:1990845	adaptive thermogenesis	-	166	153	-	-	1.24E-02	8.88E-03
ReactomeFI	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	1.19E-02	7.94E-04
ReactomeFI	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	147	-	-	1.14E-02	8.52E-03
ReactomeFI	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	4.11E-03	1.01E-03
ReactomeFI	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	93	-	-	2.71E-02	5.41E-03
ReactomeFI	BP	GO:2000209	regulation of anoikis	-	25	23	-	-	1.78E-03	1.37E-03
ReactomeFI	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	17	-	-	6.51E-04	1.01E-03
ReactomeFI	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	24	-	-	4.12E-03	1.44E-03
ReactomeFI	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	1.86E-03	2.67E-03
ReactomeFI	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	35	-	-	1.27E-02	2.02E-03
ReactomeFI	BP	GO:2000291	regulation of myoblast proliferation	-	25	15	-	-	3.55E-03	8.66E-04
ReactomeFI	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	31	-	-	4.70E-02	1.80E-03
ReactomeFI	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	70	-	-	2.28E-02	4.04E-03
ReactomeFI	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	24	-	-	1.45E-03	1.44E-03
ReactomeFI	BP	GO:2000736	regulation of stem cell differentiation	-	78	72	-	-	5.81E-03	4.19E-03
ReactomeFI	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	2.44E-03	1.23E-03
ReactomeFI	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	2.34E-03	1.15E-03
ReactomeFI	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	12	-	-	2.69E-02	7.22E-04
ReactomeFI	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	3.00E-03	7.94E-04
ReactomeFI	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	69	-	-	4.80E-02	4.04E-03
ReactomeFI	BP	GO:2001212	regulation of vasculogenesis	-	16	14	-	-	9.11E-03	8.66E-04
ReactomeFI	BP	GO:2001222	regulation of neuron migration	-	46	41	-	-	9.95E-03	2.38E-03
ReactomeFI	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	214	-	-	1.89E-02	1.24E-02
ReactomeFI	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	54	-	-	5.73E-03	3.18E-03
SignaLink	CC	GO:0005739	mitochondrion	2.50E-29	1671	1632	1524	1.07	-	-
SignaLink	CC	GO:0005815	microtubule organizing center	3.66E-23	843	834	769	1.08	-	-
SignaLink	CC	GO:0005615	extracellular space	5.48E-20	3190	3035	2909	1.04	-	-
SignaLink	CC	GO:0005730	nucleolus	1.80E-17	988	965	901	1.07	-	-
SignaLink	CC	GO:0005768	endosome	4.66E-16	1037	1009	946	1.07	-	-
SignaLink	CC	GO:0005764	lysosome	3.37E-14	747	731	681	1.07	-	-
SignaLink	CC	GO:0005783	endoplasmic reticulum	1.57E-12	2020	1922	1842	1.04	-	-
SignaLink	CC	GO:0005794	Golgi apparatus	2.76E-12	1636	1563	1492	1.05	-	-
SignaLink	CC	GO:0005635	nuclear envelope	1.01E-08	493	481	450	1.07	-	-
SignaLink	CC	GO:0005840	ribosome	5.81E-08	222	221	202	1.09	-	-
SignaLink	CC	GO:0000228	nuclear chromosome	2.58E-06	206	204	188	1.09	-	-
SignaLink	CC	GO:0005929	cilium	3.36E-03	842	791	768	1.03	-	-
SignaLink	CC	GO:0005777	peroxisome	7.01E-03	142	138	130	1.07	-	-
SignaLink	CC	GO:0031012	extracellular matrix	1.02E-02	564	531	514	1.03	-	-
SignaLink	CC	GO:0005811	lipid droplet	3.38E-02	102	99	93	1.06	-	-
SignaLink	BP	GO:0050877	nervous system process	1.27E-102	1527	1123	1393	0.81	-	-
SignaLink	BP	GO:0016192	vesicle-mediated transport	7.44E-33	1894	1849	1727	1.07	-	-
SignaLink	BP	GO:0007010	cytoskeleton organization	6.63E-29	1639	1601	1495	1.07	-	-
SignaLink	BP	GO:0006355	regulation of DNA-templated transcription	1.36E-23	3342	3187	3048	1.05	-	-
SignaLink	BP	GO:0012501	programmed cell death	3.82E-23	1954	1888	1782	1.06	-	-
SignaLink	BP	GO:0048870	cell motility	4.21E-23	1659	1610	1513	1.06	-	-
SignaLink	BP	GO:0007155	cell adhesion	5.15E-20	1444	1401	1317	1.06	-	-
SignaLink	BP	GO:0002376	immune system process	2.08E-18	2448	2339	2233	1.05	-	-
SignaLink	BP	GO:0006886	intracellular protein transport	1.66E-17	664	656	606	1.08	-	-
SignaLink	BP	GO:0006281	DNA repair	1.95E-16	587	581	535	1.09	-	-
SignaLink	BP	GO:0006914	autophagy	4.54E-14	568	560	518	1.08	-	-
SignaLink	BP	GO:0007005	mitochondrion organization	5.37E-12	484	477	441	1.08	-	-
SignaLink	BP	GO:0006091	generation of precursor metabolites and energy	7.69E-12	502	494	458	1.08	-	-
SignaLink	BP	GO:0072659	protein localization to plasma membrane	7.95E-12	284	284	259	1.10	-	-
SignaLink	BP	GO:0003012	muscle system process	1.47E-11	425	420	388	1.08	-	-
SignaLink	BP	GO:0030163	protein catabolic process	3.21E-11	990	955	903	1.06	-	-
SignaLink	BP	GO:0016071	mRNA metabolic process	8.53E-11	713	693	650	1.07	-	-
SignaLink	BP	GO:0007059	chromosome segregation	9.76E-11	403	398	368	1.08	-	-
SignaLink	BP	GO:0065003	protein-containing complex assembly	2.67E-10	1648	1568	1503	1.04	-	-
SignaLink	BP	GO:0034330	cell junction organization	2.93E-09	727	703	663	1.06	-	-
SignaLink	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.96E-09	729	705	665	1.06	-	-
SignaLink	BP	GO:0006913	nucleocytoplasmic transport	8.12E-09	326	322	297	1.08	-	-
SignaLink	BP	GO:0003013	circulatory system process	1.11E-08	584	567	533	1.06	-	-
SignaLink	BP	GO:0006629	lipid metabolic process	1.57E-08	1355	1289	1236	1.04	-	-
SignaLink	BP	GO:0055085	transmembrane transport	3.48E-08	1784	1687	1627	1.04	-	-
SignaLink	BP	GO:0006260	DNA replication	4.63E-08	279	276	254	1.08	-	-
SignaLink	BP	GO:0042254	ribosome biogenesis	7.14E-08	297	293	271	1.08	-	-
SignaLink	BP	GO:0007018	microtubule-based movement	7.60E-08	640	618	584	1.06	-	-
SignaLink	BP	GO:0006954	inflammatory response	9.35E-08	820	787	748	1.05	-	-
SignaLink	BP	GO:0006310	DNA recombination	1.36E-07	333	327	304	1.08	-	-
SignaLink	BP	GO:0042060	wound healing	1.66E-07	431	420	393	1.07	-	-
SignaLink	BP	GO:0007163	establishment or maintenance of cell polarity	3.70E-07	227	225	207	1.09	-	-
SignaLink	BP	GO:0006520	amino acid metabolic process	6.07E-07	292	287	266	1.08	-	-
SignaLink	BP	GO:0044782	cilium organization	4.25E-06	399	387	364	1.06	-	-
SignaLink	BP	GO:0140053	mitochondrial gene expression	7.34E-05	164	162	150	1.08	-	-
SignaLink	BP	GO:0140013	meiotic nuclear division	1.06E-04	279	271	254	1.06	-	-
SignaLink	BP	GO:0006399	tRNA metabolic process	1.84E-04	196	192	179	1.07	-	-
SignaLink	BP	GO:0003014	renal system process	2.08E-04	127	126	116	1.09	-	-
SignaLink	BP	GO:0005975	carbohydrate metabolic process	5.63E-04	551	524	503	1.04	-	-
SignaLink	BP	GO:0030198	extracellular matrix organization	8.33E-04	314	302	286	1.05	-	-
SignaLink	BP	GO:0002181	cytoplasmic translation	8.39E-04	153	150	140	1.07	-	-
SignaLink	BP	GO:0006457	protein folding	2.97E-03	210	203	192	1.06	-	-
SignaLink	BP	GO:0098542	defense response to other organism	4.71E-03	1171	1094	1068	1.02	-	-
SignaLink	BP	GO:0098754	detoxification	1.33E-02	134	130	122	1.06	-	-
SignaLink	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.33E-02	119	116	109	1.07	-	-
SignaLink	BP	GO:0022600	digestive system process	1.76E-02	110	107	100	1.07	-	-
SignaLink	BP	GO:0000910	cytokinesis	2.64E-02	186	178	170	1.05	-	-
SignaLink	BP	GO:0006575	cellular modified amino acid metabolic process	2.64E-02	186	178	170	1.05	-	-
SignaLink	BP	GO:0006790	sulfur compound metabolic process	2.78E-02	320	303	292	1.04	-	-
SignaLink	BP	GO:0032200	telomere organization	5.10E-02	186	162	170	0.95	-	-
SignaLink	BP	GO:0006486	protein glycosylation	7.44E-02	225	213	205	1.04	-	-
SignaLink	BP	GO:0006325	chromatin organization	8.06E-02	720	670	657	1.02	-	-
SignaLink	BP	GO:0006766	vitamin metabolic process	8.34E-02	107	103	98	1.06	-	-
SignaLink	BP	GO:0007040	lysosome organization	8.34E-02	107	103	98	1.06	-	-
SignaLink	MF	GO:0016740	transferase activity	2.65E-27	3074	2947	2804	1.05	-	-
SignaLink	MF	GO:0140096	"catalytic activity, acting on a protein"	7.23E-23	3198	3051	2917	1.05	-	-
SignaLink	MF	GO:0008092	cytoskeletal protein binding	3.45E-21	1023	1004	933	1.08	-	-
SignaLink	MF	GO:0003723	RNA binding	1.12E-20	1679	1624	1531	1.06	-	-
SignaLink	MF	GO:0140657	ATP-dependent activity	1.69E-16	729	717	665	1.08	-	-
SignaLink	MF	GO:0003677	DNA binding	4.91E-12	2865	2705	2613	1.04	-	-
SignaLink	MF	GO:0140110	transcription regulator activity	1.44E-11	2033	1931	1854	1.04	-	-
SignaLink	MF	GO:0003924	GTPase activity	2.21E-11	658	642	600	1.07	-	-
SignaLink	MF	GO:0016491	oxidoreductase activity	3.37E-11	888	859	810	1.06	-	-
SignaLink	MF	GO:0016874	ligase activity	2.13E-07	283	279	258	1.08	-	-
SignaLink	MF	GO:0140098	"catalytic activity, acting on RNA"	4.40E-07	417	406	380	1.07	-	-
SignaLink	MF	GO:0140097	"catalytic activity, acting on DNA"	4.04E-06	383	372	349	1.06	-	-
SignaLink	MF	GO:0016853	isomerase activity	1.46E-05	252	247	230	1.07	-	-
SignaLink	MF	GO:0016829	lyase activity	2.66E-05	538	516	491	1.05	-	-
SignaLink	MF	GO:0008289	lipid binding	3.43E-05	836	794	762	1.04	-	-
SignaLink	MF	GO:0005215	transporter activity	6.30E-04	1462	1368	1333	1.03	-	-
SignaLink	MF	GO:0045182	translation regulator activity	1.23E-03	151	148	138	1.07	-	-
SignaLink	MF	GO:0042393	histone binding	3.73E-03	237	228	216	1.05	-	-
SignaLink	MF	GO:0140104	molecular carrier activity	8.32E-03	105	103	96	1.08	-	-
SignaLink	MF	GO:0003774	cytoskeletal motor activity	1.27E-02	116	113	106	1.07	-	-
SignaLink	MF	GO:0048018	receptor ligand activity	2.06E-02	504	474	460	1.03	-	-
SignaLink	MF	GO:0009975	cyclase activity	2.44E-02	277	263	253	1.04	-	-
SignaLink	MF	GO:0038024	cargo receptor activity	3.33E-02	117	113	107	1.06	-	-
SignaLink	MF	GO:0005198	structural molecule activity	6.09E-01	798	724	728	0.99	-	-
SignaLink	BP	GO:0008038	neuron recognition	-	46	46	-	-	1.33E-03	2.08E-03
SignaLink	BP	GO:1905145	cellular response to acetylcholine	-	33	32	-	-	1.04E-02	1.46E-03
SignaLink	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	1.06E-03	8.45E-04
SignaLink	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	8.36E-03	9.57E-04
SignaLink	BP	GO:0051931	regulation of sensory perception	-	36	35	-	-	1.62E-03	1.58E-03
SignaLink	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	1.13E-03	1.13E-03
SignaLink	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.66E-04	6.19E-04
SignaLink	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	1.67E-04	6.19E-04
SignaLink	BP	GO:0009268	response to pH	-	43	40	-	-	6.31E-03	1.80E-03
SignaLink	BP	GO:0045666	positive regulation of neuron differentiation	-	91	86	-	-	1.39E-03	3.89E-03
SignaLink	BP	GO:0043543	protein acylation	-	107	101	-	-	2.18E-03	4.56E-03
SignaLink	MF	GO:0051349	positive regulation of lyase activity	-	41	38	-	-	1.93E-03	1.75E-03
SignaLink	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	3.33E-03	6.76E-04
SignaLink	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	8.12E-04	1.13E-03
SignaLink	BP	GO:0022401	negative adaptation of signaling pathway	-	21	20	-	-	3.77E-03	9.01E-04
SignaLink	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	132	-	-	4.98E-03	5.97E-03
SignaLink	BP	GO:0071763	nuclear membrane organization	-	44	43	-	-	1.09E-02	1.97E-03
SignaLink	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	33	-	-	3.13E-03	1.52E-03
SignaLink	BP	GO:0034085	establishment of sister chromatid cohesion	-	12	11	-	-	5.24E-02	5.07E-04
SignaLink	BP	GO:0071806	protein transmembrane transport	-	68	68	-	-	6.51E-03	3.10E-03
SignaLink	BP	GO:0022038	corpus callosum development	-	25	25	-	-	2.70E-03	1.13E-03
SignaLink	BP	GO:0021548	pons development	-	11	11	-	-	1.63E-04	5.07E-04
SignaLink	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	11	-	-	7.23E-02	5.07E-04
SignaLink	BP	GO:0043299	leukocyte degranulation	-	82	82	-	-	3.02E-03	3.72E-03
SignaLink	BP	GO:0048864	stem cell development	-	88	85	-	-	2.76E-03	3.83E-03
SignaLink	BP	GO:0009310	amine catabolic process	-	20	16	-	-	4.74E-03	7.32E-04
SignaLink	BP	GO:0051651	maintenance of location in cell	-	236	223	-	-	8.04E-03	1.01E-02
SignaLink	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	3.20E-03	1.24E-03
SignaLink	BP	GO:0014004	microglia differentiation	-	12	12	-	-	8.51E-04	5.63E-04
SignaLink	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	30	-	-	3.90E-04	1.35E-03
SignaLink	BP	GO:1905962	glutamatergic neuron differentiation	-	14	12	-	-	1.67E-04	5.63E-04
SignaLink	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	2.55E-03	6.76E-04
SignaLink	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	1.83E-03	1.35E-03
SignaLink	BP	GO:0006949	syncytium formation	-	66	63	-	-	5.58E-03	2.87E-03
SignaLink	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.18E-04	6.76E-04
SignaLink	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	1.66E-04	6.76E-04
SignaLink	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	54	-	-	3.15E-03	2.48E-03
SignaLink	BP	GO:0030574	collagen catabolic process	-	45	42	-	-	2.58E-02	1.91E-03
SignaLink	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	2.06E-03	2.08E-03
SignaLink	BP	GO:0060343	trabecula formation	-	26	26	-	-	1.09E-03	1.18E-03
SignaLink	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	11	-	-	1.65E-04	5.07E-04
SignaLink	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.66E-03	1.07E-03
SignaLink	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	4.54E-02	7.32E-04
SignaLink	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	2.49E-03	8.45E-04
SignaLink	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	5.98E-03	1.86E-03
SignaLink	BP	GO:0006413	translational initiation	-	122	120	-	-	5.99E-02	5.41E-03
SignaLink	BP	GO:0072176	nephric duct development	-	15	15	-	-	1.37E-03	6.76E-04
SignaLink	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	4.07E-04	2.31E-03
SignaLink	CC	GO:0005200	structural constituent of cytoskeleton	-	112	110	-	-	7.14E-03	4.96E-03
SignaLink	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	3.29E-03	2.31E-03
SignaLink	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	5.88E-03	6.76E-04
SignaLink	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	6.60E-02	1.13E-03
SignaLink	BP	GO:1903036	positive regulation of response to wounding	-	76	69	-	-	3.28E-03	3.15E-03
SignaLink	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	2.80E-04	9.57E-04
SignaLink	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	218	-	-	1.24E-02	9.85E-03
SignaLink	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	1.71E-03	1.24E-03
SignaLink	BP	GO:0032528	microvillus organization	-	24	24	-	-	1.04E-03	1.13E-03
SignaLink	BP	GO:0021954	central nervous system neuron development	-	85	82	-	-	1.20E-03	3.72E-03
SignaLink	BP	GO:0055017	cardiac muscle tissue growth	-	92	74	-	-	2.30E-03	3.38E-03
SignaLink	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	6.10E-03	1.41E-03
SignaLink	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	9.03E-04	6.19E-04
SignaLink	BP	GO:0048524	positive regulation of viral process	-	64	64	-	-	1.78E-03	2.93E-03
SignaLink	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	14	-	-	1.55E-02	6.76E-04
SignaLink	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	1.52E-02	9.57E-04
SignaLink	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	22	-	-	1.23E-03	1.01E-03
SignaLink	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	4.97E-03	7.88E-04
SignaLink	BP	GO:0098661	inorganic anion transmembrane transport	-	140	129	-	-	3.14E-03	5.86E-03
SignaLink	BP	GO:0006099	tricarboxylic acid cycle	-	33	32	-	-	2.94E-02	1.46E-03
SignaLink	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	7.13E-04	8.45E-04
SignaLink	BP	GO:0009612	response to mechanical stimulus	-	215	212	-	-	3.68E-03	9.57E-03
SignaLink	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	7.12E-03	3.55E-03
SignaLink	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	140	-	-	4.08E-03	6.31E-03
SignaLink	BP	GO:1905874	regulation of postsynaptic density organization	-	13	12	-	-	1.29E-03	5.63E-04
SignaLink	BP	GO:0071542	dopaminergic neuron differentiation	-	36	35	-	-	4.05E-03	1.58E-03
SignaLink	BP	GO:0140115	export across plasma membrane	-	82	63	-	-	2.37E-02	2.87E-03
SignaLink	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	2.05E-04	5.63E-04
SignaLink	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	2.88E-03	1.75E-03
SignaLink	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	6.76E-03	5.63E-04
SignaLink	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	1.67E-04	5.07E-04
SignaLink	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	28	-	-	3.34E-04	1.30E-03
SignaLink	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	40	-	-	8.46E-03	1.80E-03
SignaLink	MF	GO:0003714	transcription corepressor activity	-	190	186	-	-	3.30E-03	8.39E-03
SignaLink	BP	GO:0035878	nail development	-	11	11	-	-	1.99E-03	5.07E-04
SignaLink	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	53	-	-	7.96E-03	2.42E-03
SignaLink	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	9.85E-04	7.32E-04
SignaLink	CC	GO:0006858	extracellular transport	-	45	43	-	-	4.95E-04	1.97E-03
SignaLink	BP	GO:0006304	DNA modification	-	30	30	-	-	2.59E-02	1.35E-03
SignaLink	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	9.57E-02	8.45E-04
SignaLink	BP	GO:0046835	carbohydrate phosphorylation	-	49	48	-	-	6.03E-03	2.20E-03
SignaLink	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	5.47E-04	8.45E-04
SignaLink	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	6.56E-03	6.76E-04
SignaLink	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	36	-	-	6.69E-03	1.63E-03
SignaLink	BP	GO:0070417	cellular response to cold	-	13	13	-	-	4.57E-03	6.19E-04
SignaLink	BP	GO:0043523	regulation of neuron apoptotic process	-	218	211	-	-	4.77E-03	9.52E-03
SignaLink	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	8.99E-04	1.01E-03
SignaLink	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	2.43E-03	6.76E-04
SignaLink	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	1.24E-02	2.59E-03
SignaLink	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	2.31E-02	6.19E-04
SignaLink	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	9.56E-04	1.13E-03
SignaLink	BP	GO:0014029	neural crest formation	-	15	15	-	-	4.14E-03	6.76E-04
SignaLink	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	9.90E-04	1.07E-03
SignaLink	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	40	-	-	1.35E-02	1.80E-03
SignaLink	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	68	-	-	1.03E-02	3.10E-03
SignaLink	BP	GO:0003188	heart valve formation	-	16	16	-	-	4.59E-02	7.32E-04
SignaLink	CC	GO:0045324	late endosome to vacuole transport	-	37	36	-	-	1.82E-02	1.63E-03
SignaLink	BP	GO:0043954	cellular component maintenance	-	72	68	-	-	3.22E-03	3.10E-03
SignaLink	BP	GO:0050435	amyloid-beta metabolic process	-	65	51	-	-	7.48E-03	2.31E-03
SignaLink	BP	GO:0014823	response to activity	-	70	68	-	-	8.00E-04	3.10E-03
SignaLink	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	17	-	-	1.97E-03	7.88E-04
SignaLink	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	1.96E-02	1.30E-03
SignaLink	BP	GO:0034502	protein localization to chromosome	-	130	114	-	-	2.16E-03	5.18E-03
SignaLink	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	9.81E-04	5.07E-04
SignaLink	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	1.61E-04	5.07E-04
SignaLink	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	5.93E-03	7.88E-04
SignaLink	BP	GO:0019233	sensory perception of pain	-	103	101	-	-	2.54E-03	4.56E-03
SignaLink	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	2.89E-02	1.01E-03
SignaLink	BP	GO:0031343	positive regulation of cell killing	-	75	74	-	-	3.71E-02	3.38E-03
SignaLink	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	4.70E-03	1.75E-03
SignaLink	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	121	-	-	2.16E-02	5.46E-03
SignaLink	BP	GO:0017148	negative regulation of translation	-	390	112	-	-	3.81E-03	5.07E-03
SignaLink	BP	GO:0030220	platelet formation	-	22	22	-	-	1.06E-02	1.01E-03
SignaLink	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	80	-	-	5.17E-03	3.60E-03
SignaLink	MF	GO:1903624	regulation of DNA catabolic process	-	14	13	-	-	2.23E-03	6.19E-04
SignaLink	BP	GO:1901142	insulin metabolic process	-	14	13	-	-	3.05E-03	6.19E-04
SignaLink	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	5.37E-02	6.76E-04
SignaLink	BP	GO:1903509	liposaccharide metabolic process	-	109	104	-	-	1.19E-03	4.73E-03
SignaLink	BP	GO:0009582	detection of abiotic stimulus	-	140	127	-	-	4.54E-03	5.74E-03
SignaLink	BP	GO:0045683	negative regulation of epidermis development	-	13	12	-	-	2.48E-03	5.63E-04
SignaLink	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	16	-	-	2.24E-04	7.32E-04
SignaLink	CC	GO:0140238	presynaptic endocytosis	-	72	69	-	-	9.63E-03	3.15E-03
SignaLink	BP	GO:0051236	establishment of RNA localization	-	161	158	-	-	1.14E-02	7.15E-03
SignaLink	BP	GO:0042178	xenobiotic catabolic process	-	26	24	-	-	1.53E-01	1.13E-03
SignaLink	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	1.13E-02	7.88E-04
SignaLink	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	190	-	-	1.68E-02	8.56E-03
SignaLink	BP	GO:0034067	protein localization to Golgi apparatus	-	30	30	-	-	3.42E-03	1.35E-03
SignaLink	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	2.22E-03	1.46E-03
SignaLink	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	1.88E-03	5.07E-04
SignaLink	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	6.29E-03	7.88E-04
SignaLink	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	47	-	-	5.53E-04	2.14E-03
SignaLink	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	39	-	-	9.61E-04	1.80E-03
SignaLink	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	2.04E-03	2.36E-03
SignaLink	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	2.24E-04	7.32E-04
SignaLink	BP	GO:0050779	RNA destabilization	-	135	99	-	-	1.09E-02	4.50E-03
SignaLink	BP	GO:0006023	aminoglycan biosynthetic process	-	74	69	-	-	1.97E-03	3.15E-03
SignaLink	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	6.41E-03	3.10E-03
SignaLink	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	2.03E-03	1.80E-03
SignaLink	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	3.25E-03	1.35E-03
SignaLink	BP	GO:0035272	exocrine system development	-	46	46	-	-	1.65E-03	2.08E-03
SignaLink	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	1.06E-02	7.88E-04
SignaLink	BP	GO:0022406	membrane docking	-	90	89	-	-	2.44E-02	4.05E-03
SignaLink	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	1.71E-02	6.76E-04
SignaLink	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	4.32E-04	7.32E-04
SignaLink	BP	GO:0050777	negative regulation of immune response	-	196	186	-	-	4.64E-03	8.39E-03
SignaLink	MF	GO:0005035	death receptor activity	-	16	15	-	-	5.04E-03	6.76E-04
SignaLink	BP	GO:0002063	chondrocyte development	-	33	32	-	-	1.98E-03	1.46E-03
SignaLink	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	4.58E-04	7.88E-04
SignaLink	BP	GO:0099068	postsynapse assembly	-	40	37	-	-	9.34E-03	1.69E-03
SignaLink	BP	GO:0021782	glial cell development	-	120	112	-	-	2.56E-03	5.07E-03
SignaLink	BP	GO:0051782	negative regulation of cell division	-	18	17	-	-	4.40E-04	7.88E-04
SignaLink	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	1.05E-03	5.07E-04
SignaLink	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	85	-	-	5.56E-03	3.83E-03
SignaLink	BP	GO:0001655	urogenital system development	-	66	65	-	-	8.25E-04	2.93E-03
SignaLink	BP	GO:0071827	plasma lipoprotein particle organization	-	86	70	-	-	1.20E-02	3.15E-03
SignaLink	BP	GO:0045494	photoreceptor cell maintenance	-	43	43	-	-	1.93E-02	1.97E-03
SignaLink	BP	GO:0055088	lipid homeostasis	-	173	153	-	-	7.75E-03	6.93E-03
SignaLink	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	1.99E-03	1.18E-03
SignaLink	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	195	-	-	3.97E-03	8.78E-03
SignaLink	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	27	-	-	9.03E-04	1.24E-03
SignaLink	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	5.53E-04	1.58E-03
SignaLink	BP	GO:0045667	regulation of osteoblast differentiation	-	147	123	-	-	4.79E-03	5.57E-03
SignaLink	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	2.62E-03	7.32E-04
SignaLink	BP	GO:0061037	negative regulation of cartilage development	-	32	29	-	-	6.84E-04	1.35E-03
SignaLink	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	2.08E-03	1.80E-03
SignaLink	BP	GO:0001704	formation of primary germ layer	-	195	187	-	-	4.18E-03	8.45E-03
SignaLink	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	1.72E-03	6.19E-04
SignaLink	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	3.42E-03	2.31E-03
SignaLink	BP	GO:0060174	limb bud formation	-	11	11	-	-	7.45E-03	5.07E-04
SignaLink	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	2.23E-03	3.83E-03
SignaLink	BP	GO:0042092	type 2 immune response	-	41	41	-	-	2.20E-03	1.86E-03
SignaLink	BP	GO:0048588	developmental cell growth	-	233	219	-	-	3.53E-03	9.91E-03
SignaLink	CC	GO:0000963	mitochondrial RNA processing	-	20	19	-	-	4.14E-03	9.01E-04
SignaLink	BP	GO:0021872	forebrain generation of neurons	-	52	51	-	-	8.37E-04	2.31E-03
SignaLink	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	22	-	-	7.66E-04	1.01E-03
SignaLink	BP	GO:0045023	G0 to G1 transition	-	41	39	-	-	1.76E-02	1.80E-03
SignaLink	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	50	-	-	3.70E-02	2.25E-03
SignaLink	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	1.67E-04	5.07E-04
SignaLink	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	1.32E-02	1.58E-03
SignaLink	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	7.26E-04	1.18E-03
SignaLink	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	47	-	-	1.37E-03	2.14E-03
SignaLink	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	18	-	-	1.98E-02	8.45E-04
SignaLink	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	2.23E-04	9.01E-04
SignaLink	BP	GO:0010232	vascular transport	-	87	83	-	-	1.47E-03	3.77E-03
SignaLink	BP	GO:0021987	cerebral cortex development	-	125	121	-	-	3.23E-03	5.46E-03
SignaLink	BP	GO:0008637	apoptotic mitochondrial changes	-	108	100	-	-	8.12E-03	4.50E-03
SignaLink	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	4.10E-03	1.58E-03
SignaLink	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.17E-02	6.76E-04
SignaLink	BP	GO:0060999	positive regulation of dendritic spine development	-	35	34	-	-	1.48E-03	1.58E-03
SignaLink	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	17	-	-	7.58E-04	7.88E-04
SignaLink	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	5.62E-03	3.49E-03
SignaLink	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	1.37E-03	9.01E-04
SignaLink	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	2.97E-03	9.01E-04
SignaLink	BP	GO:0002064	epithelial cell development	-	210	206	-	-	2.07E-03	9.29E-03
SignaLink	BP	GO:0071318	cellular response to ATP	-	18	17	-	-	6.19E-04	7.88E-04
SignaLink	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	39	-	-	1.35E-03	1.80E-03
SignaLink	BP	GO:2001222	regulation of neuron migration	-	46	44	-	-	1.94E-03	2.03E-03
SignaLink	BP	GO:0034389	lipid droplet organization	-	38	36	-	-	1.77E-03	1.63E-03
SignaLink	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	1.23E-03	2.03E-03
SignaLink	BP	GO:0042177	negative regulation of protein catabolic process	-	109	105	-	-	1.96E-03	4.73E-03
SignaLink	MF	GO:0038024	cargo receptor activity	-	121	113	-	-	8.53E-03	5.12E-03
SignaLink	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	21	-	-	4.79E-04	9.57E-04
SignaLink	BP	GO:0033120	positive regulation of RNA splicing	-	46	41	-	-	1.66E-02	1.86E-03
SignaLink	BP	GO:0051445	regulation of meiotic cell cycle	-	64	63	-	-	5.45E-02	2.87E-03
SignaLink	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.63E-04	5.63E-04
SignaLink	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	9.75E-03	2.70E-03
SignaLink	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	5.06E-03	6.76E-04
SignaLink	BP	GO:0090087	regulation of peptide transport	-	195	189	-	-	3.47E-03	8.56E-03
SignaLink	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	100	-	-	1.90E-03	4.50E-03
SignaLink	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	9.85E-04	1.13E-03
SignaLink	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	1.31E-03	1.13E-03
SignaLink	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	14	-	-	1.67E-04	6.76E-04
SignaLink	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	8.03E-02	1.24E-03
SignaLink	BP	GO:0099118	microtubule-based protein transport	-	14	13	-	-	1.06E-03	6.19E-04
SignaLink	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	2.92E-03	6.76E-04
SignaLink	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	4.54E-02	9.01E-04
SignaLink	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	1.45E-03	6.19E-04
SignaLink	BP	GO:0022404	molting cycle process	-	95	95	-	-	2.31E-03	4.28E-03
SignaLink	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	4.46E-04	5.07E-04
SignaLink	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	5.85E-03	7.88E-04
SignaLink	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	3.56E-03	9.01E-04
SignaLink	BP	GO:0042754	negative regulation of circadian rhythm	-	12	11	-	-	1.53E-03	5.07E-04
SignaLink	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	18	-	-	7.18E-04	8.45E-04
SignaLink	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	2.18E-03	1.46E-03
SignaLink	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	4.75E-03	6.76E-04
SignaLink	BP	GO:0008299	isoprenoid biosynthetic process	-	30	30	-	-	3.90E-04	1.35E-03
SignaLink	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	235	-	-	4.92E-03	1.06E-02
SignaLink	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	1.80E-03	1.41E-03
SignaLink	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	1.90E-03	1.01E-03
SignaLink	CC	GO:0098926	postsynaptic signal transduction	-	39	38	-	-	4.44E-03	1.75E-03
SignaLink	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	139	-	-	1.73E-03	6.31E-03
SignaLink	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	2.85E-02	9.01E-04
SignaLink	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	9.97E-04	2.14E-03
SignaLink	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	139	-	-	7.51E-03	6.31E-03
SignaLink	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	1.94E-03	1.01E-03
SignaLink	BP	GO:0061548	ganglion development	-	17	17	-	-	1.87E-03	7.88E-04
SignaLink	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	98	-	-	2.01E-03	4.45E-03
SignaLink	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.67E-04	6.76E-04
SignaLink	BP	GO:0042832	defense response to protozoan	-	28	25	-	-	2.73E-03	1.13E-03
SignaLink	BP	GO:0048799	animal organ maturation	-	33	32	-	-	1.18E-03	1.46E-03
SignaLink	BP	GO:0006925	inflammatory cell apoptotic process	-	23	21	-	-	3.82E-04	9.57E-04
SignaLink	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	5.41E-04	7.32E-04
SignaLink	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	167	-	-	3.26E-03	7.55E-03
SignaLink	BP	GO:1903035	negative regulation of response to wounding	-	93	88	-	-	1.08E-02	4.00E-03
SignaLink	BP	GO:0015697	quaternary ammonium group transport	-	16	15	-	-	1.11E-01	6.76E-04
SignaLink	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	27	-	-	1.32E-03	1.24E-03
SignaLink	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	2.30E-03	1.24E-03
SignaLink	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	131	-	-	7.03E-03	5.91E-03
SignaLink	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	94	-	-	3.59E-03	4.28E-03
SignaLink	BP	GO:0045056	transcytosis	-	20	20	-	-	2.36E-03	9.01E-04
SignaLink	BP	GO:0018342	protein prenylation	-	15	15	-	-	9.60E-03	6.76E-04
SignaLink	BP	GO:0009267	cellular response to starvation	-	170	168	-	-	3.32E-03	7.60E-03
SignaLink	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	1.54E-04	5.07E-04
SignaLink	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	1.00E-02	2.42E-03
SignaLink	BP	GO:0046834	lipid phosphorylation	-	16	15	-	-	2.32E-02	6.76E-04
SignaLink	BP	GO:0007343	egg activation	-	11	11	-	-	1.65E-04	5.07E-04
SignaLink	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	2.16E-03	1.07E-03
SignaLink	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	26	-	-	3.33E-04	1.18E-03
SignaLink	BP	GO:0046931	pore complex assembly	-	21	20	-	-	3.86E-03	9.01E-04
SignaLink	CC	GO:0032008	positive regulation of TOR signaling	-	52	51	-	-	3.82E-02	2.31E-03
SignaLink	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	4.67E-04	1.52E-03
SignaLink	BP	GO:0046618	xenobiotic export from cell	-	27	13	-	-	1.67E-04	6.19E-04
SignaLink	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	15	-	-	2.24E-04	6.76E-04
SignaLink	BP	GO:0060428	lung epithelium development	-	43	43	-	-	6.50E-04	1.97E-03
SignaLink	BP	GO:0030431	sleep	-	30	29	-	-	6.71E-04	1.35E-03
SignaLink	BP	GO:1903318	negative regulation of protein maturation	-	29	28	-	-	2.02E-03	1.30E-03
SignaLink	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	99	-	-	2.56E-01	4.50E-03
SignaLink	BP	GO:0071732	cellular response to nitric oxide	-	17	16	-	-	5.33E-04	7.32E-04
SignaLink	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	4.03E-03	6.76E-04
SignaLink	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	1.69E-03	5.63E-04
SignaLink	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	5.56E-04	6.19E-04
SignaLink	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	73	-	-	1.58E-02	3.32E-03
SignaLink	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	1.51E-03	2.93E-03
SignaLink	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	16	-	-	3.14E-03	7.32E-04
SignaLink	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	1.68E-04	6.76E-04
SignaLink	CC	GO:0006406	mRNA export from nucleus	-	69	68	-	-	4.80E-02	3.10E-03
SignaLink	BP	GO:0009880	embryonic pattern specification	-	70	69	-	-	3.07E-03	3.15E-03
SignaLink	BP	GO:0015791	polyol transmembrane transport	-	14	12	-	-	1.67E-04	5.63E-04
SignaLink	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	9.74E-02	1.80E-03
SignaLink	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	1.66E-03	1.13E-03
SignaLink	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	1.75E-03	5.07E-04
SignaLink	BP	GO:0002367	cytokine production involved in immune response	-	121	119	-	-	4.02E-03	5.41E-03
SignaLink	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	5.08E-03	6.19E-04
SignaLink	BP	GO:0044848	biological phase	-	211	203	-	-	1.70E-02	9.18E-03
SignaLink	BP	GO:0002645	positive regulation of tolerance induction	-	12	12	-	-	6.21E-04	5.63E-04
SignaLink	BP	GO:0046660	female sex differentiation	-	125	123	-	-	4.68E-03	5.57E-03
SignaLink	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	6.87E-04	7.88E-04
SignaLink	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	40	-	-	8.58E-04	1.80E-03
SignaLink	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	1.65E-04	5.07E-04
SignaLink	BP	GO:0060411	cardiac septum morphogenesis	-	72	69	-	-	5.21E-03	3.15E-03
SignaLink	BP	GO:0071248	cellular response to metal ion	-	201	195	-	-	2.69E-03	8.78E-03
SignaLink	BP	GO:0030308	negative regulation of cell growth	-	191	184	-	-	2.32E-03	8.33E-03
SignaLink	BP	GO:0097306	cellular response to alcohol	-	99	94	-	-	2.26E-03	4.28E-03
SignaLink	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	125	-	-	6.82E-03	5.63E-03
SignaLink	BP	GO:0010453	regulation of cell fate commitment	-	40	35	-	-	4.10E-03	1.58E-03
SignaLink	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	56	-	-	2.55E-03	2.53E-03
SignaLink	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	55	-	-	6.62E-04	2.48E-03
SignaLink	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	1.58E-03	1.18E-03
SignaLink	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	1.76E-02	1.13E-03
SignaLink	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	43	-	-	1.57E-03	1.97E-03
SignaLink	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	3.32E-03	3.49E-03
SignaLink	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	1.17E-03	9.01E-04
SignaLink	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	7.53E-02	1.13E-03
SignaLink	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	94	-	-	1.39E-03	4.28E-03
SignaLink	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	1.61E-03	1.18E-03
SignaLink	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	1.10E-03	5.07E-04
SignaLink	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	52	-	-	3.22E-03	2.36E-03
SignaLink	BP	GO:0051259	protein complex oligomerization	-	251	244	-	-	4.70E-03	1.10E-02
SignaLink	BP	GO:0009163	nucleoside biosynthetic process	-	16	15	-	-	2.23E-04	6.76E-04
SignaLink	BP	GO:0098743	cell aggregation	-	24	23	-	-	2.77E-03	1.07E-03
SignaLink	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	2.93E-04	5.63E-04
SignaLink	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	2.09E-02	5.07E-04
SignaLink	BP	GO:0009994	oocyte differentiation	-	57	55	-	-	1.10E-03	2.48E-03
SignaLink	MF	GO:0031952	regulation of protein autophosphorylation	-	43	41	-	-	7.48E-04	1.86E-03
SignaLink	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	3.82E-03	6.76E-04
SignaLink	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	153	-	-	5.29E-03	6.93E-03
SignaLink	BP	GO:0044319	"wound healing, spreading of cells"	-	37	35	-	-	4.73E-03	1.58E-03
SignaLink	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	6.07E-04	1.30E-03
SignaLink	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	5.16E-04	1.58E-03
SignaLink	BP	GO:0072665	protein localization to vacuole	-	84	83	-	-	3.16E-03	3.77E-03
SignaLink	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	45	-	-	7.05E-03	2.03E-03
SignaLink	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	23	-	-	2.16E-02	1.07E-03
SignaLink	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	74	-	-	1.47E-03	3.38E-03
SignaLink	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	1.26E-03	7.32E-04
SignaLink	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	14	-	-	5.36E-03	6.76E-04
SignaLink	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	1.66E-04	5.07E-04
SignaLink	BP	GO:0042044	fluid transport	-	35	33	-	-	2.08E-03	1.52E-03
SignaLink	BP	GO:0070633	transepithelial transport	-	35	35	-	-	5.93E-04	1.58E-03
SignaLink	BP	GO:0033015	tetrapyrrole catabolic process	-	13	11	-	-	8.05E-03	5.07E-04
SignaLink	BP	GO:0045661	regulation of myoblast differentiation	-	74	73	-	-	4.84E-03	3.32E-03
SignaLink	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	13	-	-	1.68E-04	6.19E-04
SignaLink	BP	GO:0030307	positive regulation of cell growth	-	164	156	-	-	2.82E-03	7.04E-03
SignaLink	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	8.52E-04	1.13E-03
SignaLink	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	4.42E-03	8.45E-04
SignaLink	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	1.20E-03	6.19E-04
SignaLink	BP	GO:0014812	muscle cell migration	-	110	85	-	-	3.58E-03	3.83E-03
SignaLink	BP	GO:0048525	negative regulation of viral process	-	90	88	-	-	2.44E-03	4.00E-03
SignaLink	BP	GO:0072044	collecting duct development	-	16	16	-	-	2.31E-03	7.32E-04
SignaLink	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	13	-	-	4.18E-02	6.19E-04
SignaLink	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	69	-	-	3.61E-03	3.15E-03
SignaLink	BP	GO:0030238	male sex determination	-	14	14	-	-	1.38E-03	6.76E-04
SignaLink	BP	GO:0051781	positive regulation of cell division	-	93	87	-	-	1.72E-03	3.94E-03
SignaLink	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	2.73E-02	9.57E-04
SignaLink	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	9.43E-04	5.07E-04
SignaLink	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	9.94E-03	1.07E-03
SignaLink	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	20	-	-	9.46E-04	9.01E-04
SignaLink	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.16E-03	2.14E-03
SignaLink	BP	GO:0007272	ensheathment of neurons	-	146	141	-	-	5.93E-03	6.36E-03
SignaLink	CC	GO:0050806	positive regulation of synaptic transmission	-	171	150	-	-	4.33E-03	6.76E-03
SignaLink	BP	GO:0060021	roof of mouth development	-	91	91	-	-	1.04E-02	4.11E-03
SignaLink	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	39	-	-	4.30E-03	1.80E-03
SignaLink	BP	GO:0050819	negative regulation of coagulation	-	54	52	-	-	3.68E-02	2.36E-03
SignaLink	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	2.01E-03	5.07E-04
SignaLink	BP	GO:0017004	cytochrome complex assembly	-	40	38	-	-	4.45E-04	1.75E-03
SignaLink	BP	GO:0018410	C-terminal protein amino acid modification	-	15	14	-	-	4.36E-02	6.76E-04
SignaLink	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	2.95E-02	2.82E-03
SignaLink	BP	GO:0097212	lysosomal membrane organization	-	15	15	-	-	6.42E-02	6.76E-04
SignaLink	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	13	-	-	2.36E-03	6.19E-04
SignaLink	CC	GO:0050805	negative regulation of synaptic transmission	-	55	53	-	-	3.62E-03	2.42E-03
SignaLink	BP	GO:0043248	proteasome assembly	-	13	13	-	-	7.29E-02	6.19E-04
SignaLink	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	56	-	-	2.62E-03	2.53E-03
SignaLink	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	1.66E-04	5.07E-04
SignaLink	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	83	-	-	8.32E-03	3.77E-03
SignaLink	BP	GO:0016054	organic acid catabolic process	-	251	244	-	-	1.77E-02	1.10E-02
SignaLink	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	1.64E-04	6.19E-04
SignaLink	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.10E-02	1.30E-03
SignaLink	BP	GO:0065005	protein-lipid complex assembly	-	29	27	-	-	6.38E-03	1.24E-03
SignaLink	BP	GO:0008033	tRNA processing	-	136	133	-	-	3.62E-02	6.03E-03
SignaLink	BP	GO:0046661	male sex differentiation	-	171	167	-	-	3.20E-03	7.55E-03
SignaLink	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	2.79E-04	6.76E-04
SignaLink	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	3.48E-03	7.88E-04
SignaLink	BP	GO:0035188	hatching	-	27	25	-	-	4.86E-04	1.13E-03
SignaLink	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	86	-	-	4.64E-03	3.89E-03
SignaLink	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	15	-	-	2.20E-04	6.76E-04
SignaLink	BP	GO:0090713	immunological memory process	-	18	18	-	-	2.35E-02	8.45E-04
SignaLink	BP	GO:0061326	renal tubule development	-	103	102	-	-	4.44E-03	4.62E-03
SignaLink	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	7.44E-03	2.48E-03
SignaLink	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	2.21E-04	7.88E-04
SignaLink	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	4.69E-04	9.01E-04
SignaLink	BP	GO:0060325	face morphogenesis	-	31	30	-	-	1.08E-03	1.35E-03
SignaLink	BP	GO:0090559	regulation of membrane permeability	-	72	62	-	-	5.43E-03	2.82E-03
SignaLink	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	14	-	-	1.04E-02	6.76E-04
SignaLink	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	2.86E-03	5.63E-04
SignaLink	BP	GO:0031579	membrane raft organization	-	25	24	-	-	2.96E-03	1.13E-03
SignaLink	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	24	-	-	1.21E-03	1.13E-03
SignaLink	BP	GO:0060033	anatomical structure regression	-	16	14	-	-	6.45E-04	6.76E-04
SignaLink	BP	GO:0046460	neutral lipid biosynthetic process	-	50	45	-	-	1.76E-03	2.03E-03
SignaLink	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	146	-	-	2.27E-03	6.59E-03
SignaLink	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	2.97E-03	5.07E-04
SignaLink	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	159	-	-	2.41E-03	7.21E-03
SignaLink	BP	GO:0002251	organ or tissue specific immune response	-	43	37	-	-	4.86E-03	1.69E-03
SignaLink	CC	GO:0048167	regulation of synaptic plasticity	-	210	186	-	-	5.18E-03	8.39E-03
SignaLink	BP	GO:1903708	positive regulation of hemopoiesis	-	184	177	-	-	2.66E-03	8.00E-03
SignaLink	BP	GO:1903008	organelle disassembly	-	154	153	-	-	6.60E-03	6.93E-03
SignaLink	BP	GO:0001709	cell fate determination	-	44	43	-	-	1.12E-03	1.97E-03
SignaLink	BP	GO:0051873	killing by host of symbiont cells	-	28	24	-	-	3.83E-03	1.13E-03
SignaLink	BP	GO:0045058	T cell selection	-	53	53	-	-	6.12E-03	2.42E-03
SignaLink	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	9.92E-04	2.20E-03
SignaLink	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	20	-	-	3.66E-03	9.01E-04
SignaLink	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	1.32E-03	3.55E-03
SignaLink	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	40	-	-	1.06E-02	1.80E-03
SignaLink	BP	GO:0099084	postsynaptic specialization organization	-	44	42	-	-	3.48E-03	1.91E-03
SignaLink	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	3.15E-03	5.07E-04
SignaLink	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	2.01E-02	6.76E-04
SignaLink	BP	GO:0060384	innervation	-	27	27	-	-	2.81E-03	1.24E-03
SignaLink	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	3.85E-04	5.63E-04
SignaLink	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	34	-	-	3.90E-04	1.58E-03
SignaLink	MF	GO:0031281	positive regulation of cyclase activity	-	40	37	-	-	1.79E-03	1.69E-03
SignaLink	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	4.64E-03	2.87E-03
SignaLink	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	1.96E-03	8.45E-04
SignaLink	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	1.19E-02	5.63E-04
SignaLink	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	1.72E-03	8.45E-04
SignaLink	BP	GO:0071453	cellular response to oxygen levels	-	168	152	-	-	2.55E-03	6.87E-03
SignaLink	BP	GO:0090399	replicative senescence	-	17	16	-	-	6.27E-04	7.32E-04
SignaLink	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	1.67E-04	6.76E-04
SignaLink	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	9.71E-03	1.35E-03
SignaLink	BP	GO:0070585	protein localization to mitochondrion	-	125	125	-	-	5.61E-03	5.63E-03
SignaLink	BP	GO:0006855	xenobiotic transmembrane transport	-	14	12	-	-	1.68E-04	5.63E-04
SignaLink	BP	GO:0010623	programmed cell death involved in cell development	-	25	24	-	-	5.41E-04	1.13E-03
SignaLink	BP	GO:0044242	cellular lipid catabolic process	-	224	218	-	-	2.17E-02	9.85E-03
SignaLink	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	3.17E-04	6.19E-04
SignaLink	BP	GO:0002931	response to ischemia	-	58	56	-	-	8.26E-04	2.53E-03
SignaLink	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	1.72E-03	5.63E-04
SignaLink	BP	GO:0014047	glutamate secretion	-	25	25	-	-	6.40E-03	1.13E-03
SignaLink	BP	GO:0061005	cell differentiation involved in kidney development	-	58	57	-	-	5.69E-03	2.59E-03
SignaLink	BP	GO:0030397	membrane disassembly	-	11	11	-	-	1.06E-03	5.07E-04
SignaLink	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	74	-	-	2.02E-02	3.38E-03
SignaLink	BP	GO:0060420	regulation of heart growth	-	74	59	-	-	1.27E-03	2.70E-03
SignaLink	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	1.47E-04	6.76E-04
SignaLink	BP	GO:0009755	hormone-mediated signaling pathway	-	221	214	-	-	3.28E-03	9.69E-03
SignaLink	BP	GO:0022612	gland morphogenesis	-	124	123	-	-	2.24E-03	5.57E-03
SignaLink	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	36	-	-	7.91E-04	1.63E-03
SignaLink	MF	GO:0140416	transcription regulator inhibitor activity	-	26	23	-	-	1.25E-03	1.07E-03
SignaLink	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	26	-	-	1.87E-03	1.18E-03
SignaLink	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	1.06E-03	6.76E-04
SignaLink	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	1.35E-02	7.88E-04
SignaLink	BP	GO:1990845	adaptive thermogenesis	-	166	165	-	-	2.35E-03	7.43E-03
SignaLink	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	1.93E-03	2.42E-03
SignaLink	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	7.83E-02	5.07E-04
SignaLink	BP	GO:0015844	monoamine transport	-	88	87	-	-	5.49E-03	3.94E-03
SignaLink	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	21	-	-	2.22E-03	9.57E-04
SignaLink	BP	GO:0060039	pericardium development	-	19	19	-	-	1.11E-03	9.01E-04
SignaLink	BP	GO:0071392	cellular response to estradiol stimulus	-	40	40	-	-	3.40E-03	1.80E-03
SignaLink	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	2.74E-03	6.19E-04
SignaLink	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	1.29E-03	9.01E-04
SignaLink	BP	GO:0009451	RNA modification	-	169	160	-	-	1.91E-02	7.21E-03
SignaLink	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	3.52E-02	5.07E-04
SignaLink	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	39	-	-	9.88E-04	1.80E-03
SignaLink	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	1.38E-03	7.88E-04
SignaLink	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	108	-	-	3.76E-03	4.90E-03
SignaLink	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	37	-	-	1.38E-03	1.69E-03
SignaLink	BP	GO:0015807	L-amino acid transport	-	94	90	-	-	3.16E-03	4.05E-03
SignaLink	BP	GO:0032941	secretion by tissue	-	85	82	-	-	2.66E-03	3.72E-03
SignaLink	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	12	-	-	1.09E-02	5.63E-04
SignaLink	BP	GO:0046605	regulation of centrosome cycle	-	54	53	-	-	3.27E-03	2.42E-03
SignaLink	BP	GO:0048753	pigment granule organization	-	40	40	-	-	2.90E-02	1.80E-03
SignaLink	BP	GO:0021516	dorsal spinal cord development	-	20	18	-	-	2.72E-03	8.45E-04
SignaLink	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	1.85E-03	9.01E-04
SignaLink	BP	GO:0032196	transposition	-	11	11	-	-	1.66E-04	5.07E-04
SignaLink	BP	GO:0003014	renal system process	-	130	129	-	-	4.64E-03	5.86E-03
SignaLink	CC	GO:0070286	axonemal dynein complex assembly	-	40	39	-	-	4.46E-04	1.80E-03
SignaLink	BP	GO:0045598	regulation of fat cell differentiation	-	148	129	-	-	2.04E-03	5.86E-03
SignaLink	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	191	-	-	9.09E-03	8.62E-03
SignaLink	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	1.05E-03	1.75E-03
SignaLink	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	1.02E-03	1.13E-03
SignaLink	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	222	-	-	2.57E-02	1.00E-02
SignaLink	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	1.60E-04	6.19E-04
SignaLink	BP	GO:0008340	determination of adult lifespan	-	23	21	-	-	1.23E-03	9.57E-04
SignaLink	BP	GO:0018158	protein oxidation	-	15	15	-	-	2.23E-04	6.76E-04
SignaLink	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	8.12E-04	1.35E-03
SignaLink	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	2.22E-04	7.88E-04
SignaLink	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	2.41E-03	1.24E-03
SignaLink	BP	GO:0071709	membrane assembly	-	68	62	-	-	1.07E-02	2.82E-03
SignaLink	BP	GO:0008217	regulation of blood pressure	-	186	178	-	-	9.08E-03	8.05E-03
SignaLink	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	2.20E-04	8.45E-04
SignaLink	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	8.47E-03	6.76E-04
SignaLink	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	62	-	-	3.42E-03	2.82E-03
SignaLink	CC	GO:0042770	signal transduction in response to DNA damage	-	186	185	-	-	1.25E-02	8.33E-03
SignaLink	BP	GO:0002200	somatic diversification of immune receptors	-	78	78	-	-	2.96E-03	3.55E-03
SignaLink	BP	GO:0035315	hair cell differentiation	-	52	51	-	-	1.86E-03	2.31E-03
SignaLink	BP	GO:0048645	animal organ formation	-	62	61	-	-	1.88E-03	2.76E-03
SignaLink	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	162	-	-	4.82E-03	7.32E-03
SignaLink	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	1.72E-03	6.76E-04
SignaLink	BP	GO:0033627	cell adhesion mediated by integrin	-	87	86	-	-	8.17E-03	3.89E-03
SignaLink	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	4.78E-03	9.57E-04
SignaLink	BP	GO:0015824	proline transport	-	13	12	-	-	2.11E-02	5.63E-04
SignaLink	BP	GO:0035107	appendage morphogenesis	-	147	146	-	-	1.26E-02	6.59E-03
SignaLink	BP	GO:1903707	negative regulation of hemopoiesis	-	116	107	-	-	1.24E-03	4.84E-03
SignaLink	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	1.45E-03	9.01E-04
SignaLink	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	7.24E-03	1.13E-03
SignaLink	BP	GO:0030149	sphingolipid catabolic process	-	32	31	-	-	7.23E-03	1.41E-03
SignaLink	BP	GO:0050994	regulation of lipid catabolic process	-	61	60	-	-	3.42E-03	2.70E-03
SignaLink	BP	GO:0035988	chondrocyte proliferation	-	24	23	-	-	1.48E-03	1.07E-03
SignaLink	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	3.17E-03	1.35E-03
SignaLink	BP	GO:0009593	detection of chemical stimulus	-	511	136	-	-	3.44E-03	6.14E-03
SignaLink	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	2.22E-03	5.63E-04
SignaLink	BP	GO:0045727	positive regulation of translation	-	141	137	-	-	2.47E-03	6.19E-03
SignaLink	BP	GO:0036315	cellular response to sterol	-	24	21	-	-	2.06E-03	9.57E-04
SignaLink	CC	GO:0032388	positive regulation of intracellular transport	-	137	135	-	-	1.90E-03	6.08E-03
SignaLink	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	1.65E-04	6.19E-04
SignaLink	BP	GO:0002027	regulation of heart rate	-	106	97	-	-	1.93E-02	4.39E-03
SignaLink	BP	GO:0050879	multicellular organismal movement	-	118	113	-	-	1.73E-03	5.12E-03
SignaLink	BP	GO:0120305	regulation of pigmentation	-	15	14	-	-	1.38E-03	6.76E-04
SignaLink	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	73	-	-	2.18E-03	3.32E-03
SignaLink	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	61	-	-	2.10E-03	2.76E-03
SignaLink	BP	GO:0048515	spermatid differentiation	-	208	193	-	-	3.27E-03	8.73E-03
SignaLink	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	2.27E-02	2.59E-03
SignaLink	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	3.96E-03	1.41E-03
SignaLink	BP	GO:0007130	synaptonemal complex assembly	-	23	21	-	-	2.75E-04	9.57E-04
SignaLink	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	34	-	-	9.57E-03	1.58E-03
SignaLink	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	34	-	-	4.86E-04	1.58E-03
SignaLink	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	35	-	-	4.95E-02	1.58E-03
SignaLink	BP	GO:0060119	inner ear receptor cell development	-	44	43	-	-	1.44E-03	1.97E-03
SignaLink	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	4.72E-04	8.45E-04
SignaLink	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	34	-	-	1.79E-02	1.58E-03
SignaLink	BP	GO:1901983	regulation of protein acetylation	-	26	23	-	-	1.13E-03	1.07E-03
SignaLink	BP	GO:0014854	response to inactivity	-	12	12	-	-	1.32E-03	5.63E-04
SignaLink	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	242	-	-	6.13E-03	1.09E-02
SignaLink	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	7.85E-04	7.88E-04
SignaLink	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	47	-	-	1.15E-02	2.14E-03
SignaLink	BP	GO:0010883	regulation of lipid storage	-	53	48	-	-	3.86E-03	2.20E-03
SignaLink	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	1.51E-03	1.18E-03
SignaLink	BP	GO:0007635	chemosensory behavior	-	20	19	-	-	6.44E-04	9.01E-04
SignaLink	BP	GO:1905954	positive regulation of lipid localization	-	110	105	-	-	6.96E-03	4.73E-03
SignaLink	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	2.45E-03	5.63E-04
SignaLink	BP	GO:0002209	behavioral defense response	-	39	39	-	-	6.09E-03	1.80E-03
SignaLink	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	1.56E-02	1.35E-03
SignaLink	BP	GO:0072523	purine-containing compound catabolic process	-	146	142	-	-	4.29E-03	6.42E-03
SignaLink	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	31	-	-	2.20E-03	1.41E-03
SignaLink	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	28	-	-	8.38E-04	1.30E-03
SignaLink	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	2.20E-04	7.32E-04
SignaLink	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	95	-	-	4.77E-03	4.28E-03
SignaLink	BP	GO:0007218	neuropeptide signaling pathway	-	113	107	-	-	4.59E-03	4.84E-03
SignaLink	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	9.58E-03	5.63E-04
SignaLink	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	163	-	-	4.79E-03	7.38E-03
SignaLink	BP	GO:0031345	negative regulation of cell projection organization	-	195	186	-	-	4.68E-03	8.39E-03
SignaLink	BP	GO:0048278	vesicle docking	-	64	64	-	-	2.54E-02	2.93E-03
SignaLink	BP	GO:0035050	embryonic heart tube development	-	86	84	-	-	4.98E-03	3.83E-03
SignaLink	BP	GO:0030168	platelet activation	-	135	131	-	-	6.19E-03	5.91E-03
SignaLink	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	2.55E-02	7.32E-04
SignaLink	CC	GO:0098810	neurotransmitter reuptake	-	35	35	-	-	1.44E-02	1.58E-03
SignaLink	BP	GO:0008213	protein alkylation	-	58	54	-	-	1.06E-03	2.48E-03
SignaLink	BP	GO:0009812	flavonoid metabolic process	-	14	13	-	-	1.50E-01	6.19E-04
SignaLink	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	4.90E-03	6.19E-04
SignaLink	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	3.67E-02	1.13E-03
SignaLink	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.90E-03	6.19E-04
SignaLink	BP	GO:0031529	ruffle organization	-	55	54	-	-	1.52E-03	2.48E-03
SignaLink	BP	GO:0010842	retina layer formation	-	25	25	-	-	2.25E-02	1.13E-03
SignaLink	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	85	-	-	2.31E-02	3.83E-03
SignaLink	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	1.27E-03	5.07E-04
SignaLink	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	71	-	-	5.13E-03	3.21E-03
SignaLink	MF	GO:0170055	lipid transmembrane transporter activity	-	56	53	-	-	6.10E-04	2.42E-03
SignaLink	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	34	-	-	6.04E-03	1.58E-03
SignaLink	BP	GO:0035304	regulation of protein dephosphorylation	-	87	83	-	-	2.03E-03	3.77E-03
SignaLink	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	228	-	-	3.58E-03	1.03E-02
SignaLink	BP	GO:0099637	neurotransmitter receptor transport	-	26	25	-	-	1.65E-03	1.13E-03
SignaLink	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	34	-	-	1.17E-03	1.58E-03
SignaLink	BP	GO:0051775	response to redox state	-	13	13	-	-	4.90E-03	6.19E-04
SignaLink	BP	GO:0051785	positive regulation of nuclear division	-	61	60	-	-	2.53E-03	2.70E-03
SignaLink	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	2.21E-04	7.32E-04
SignaLink	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	7.81E-04	7.32E-04
SignaLink	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	5.30E-04	9.01E-04
SignaLink	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	5.12E-02	5.63E-04
SignaLink	BP	GO:0044786	cell cycle DNA replication	-	45	43	-	-	8.90E-03	1.97E-03
SignaLink	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	13	-	-	1.36E-02	6.19E-04
SignaLink	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	1.25E-03	7.88E-04
SignaLink	BP	GO:0051299	centrosome separation	-	15	15	-	-	2.97E-03	6.76E-04
SignaLink	BP	GO:0048145	regulation of fibroblast proliferation	-	87	84	-	-	1.36E-03	3.83E-03
SignaLink	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	87	-	-	1.53E-01	3.94E-03
SignaLink	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	2.03E-02	5.07E-04
SignaLink	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	222	-	-	3.46E-03	1.00E-02
SignaLink	BP	GO:0032098	regulation of appetite	-	20	20	-	-	5.56E-02	9.01E-04
SignaLink	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	2.42E-03	6.76E-04
SignaLink	CC	GO:0008333	endosome to lysosome transport	-	73	72	-	-	3.07E-02	3.27E-03
SignaLink	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	21	-	-	3.90E-03	9.57E-04
SignaLink	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	15	-	-	8.70E-04	6.76E-04
SignaLink	BP	GO:0003016	respiratory system process	-	39	38	-	-	1.56E-03	1.75E-03
SignaLink	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	24	-	-	1.13E-02	1.13E-03
SignaLink	BP	GO:0045732	positive regulation of protein catabolic process	-	202	198	-	-	4.21E-03	8.95E-03
SignaLink	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	72	-	-	5.79E-03	3.27E-03
SignaLink	BP	GO:0007588	excretion	-	40	39	-	-	2.86E-03	1.80E-03
SignaLink	BP	GO:1904018	positive regulation of vasculature development	-	185	157	-	-	2.59E-03	7.09E-03
SignaLink	BP	GO:0050953	sensory perception of light stimulus	-	223	203	-	-	1.92E-02	9.18E-03
SignaLink	BP	GO:0009164	nucleoside catabolic process	-	25	22	-	-	2.79E-04	1.01E-03
SignaLink	BP	GO:0002357	defense response to tumor cell	-	13	11	-	-	6.64E-04	5.07E-04
SignaLink	BP	GO:0009303	rRNA transcription	-	37	37	-	-	7.80E-04	1.69E-03
SignaLink	BP	GO:0035601	protein deacylation	-	56	56	-	-	2.67E-03	2.53E-03
SignaLink	BP	GO:0061952	midbody abscission	-	18	17	-	-	1.99E-01	7.88E-04
SignaLink	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	1.65E-04	5.07E-04
SignaLink	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	1.36E-03	9.01E-04
SignaLink	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	6.78E-04	1.35E-03
SignaLink	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	2.15E-03	2.93E-03
SignaLink	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	15	-	-	7.20E-02	6.76E-04
SignaLink	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	1.98E-03	1.30E-03
SignaLink	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	2.80E-03	1.52E-03
SignaLink	BP	GO:0046697	decidualization	-	26	26	-	-	5.76E-04	1.18E-03
SignaLink	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	3.78E-03	6.76E-04
SignaLink	BP	GO:0051588	regulation of neurotransmitter transport	-	99	97	-	-	3.53E-03	4.39E-03
SignaLink	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	29	-	-	3.36E-04	1.35E-03
SignaLink	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	1.60E-02	5.63E-04
SignaLink	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	1.67E-02	2.87E-03
SignaLink	BP	GO:0044703	multi-organism reproductive process	-	209	199	-	-	8.15E-03	9.01E-03
SignaLink	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	139	-	-	6.60E-03	6.31E-03
SignaLink	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	53	-	-	2.18E-03	2.42E-03
SignaLink	BP	GO:0099022	vesicle tethering	-	32	31	-	-	4.42E-02	1.41E-03
SignaLink	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	37	-	-	1.04E-02	1.69E-03
SignaLink	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	1.66E-04	5.63E-04
SignaLink	BP	GO:0048857	neural nucleus development	-	65	61	-	-	2.05E-03	2.76E-03
SignaLink	BP	GO:0048663	neuron fate commitment	-	74	72	-	-	1.20E-03	3.27E-03
SignaLink	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	172	-	-	2.78E-03	7.77E-03
SignaLink	BP	GO:0106027	neuron projection organization	-	90	87	-	-	3.26E-03	3.94E-03
SignaLink	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	129	-	-	1.35E-02	5.86E-03
SignaLink	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	2.90E-03	1.58E-03
SignaLink	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	7.05E-04	5.07E-04
SignaLink	BP	GO:0045685	regulation of glial cell differentiation	-	77	72	-	-	2.80E-03	3.27E-03
SignaLink	BP	GO:0051608	histamine transport	-	14	14	-	-	1.68E-03	6.76E-04
SignaLink	BP	GO:0043414	macromolecule methylation	-	138	129	-	-	5.90E-03	5.86E-03
SignaLink	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	1.67E-04	5.63E-04
SignaLink	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	2.73E-02	7.32E-04
SignaLink	BP	GO:0050886	endocrine process	-	93	91	-	-	8.38E-03	4.11E-03
SignaLink	MF	GO:0015562	efflux transmembrane transporter activity	-	15	14	-	-	1.67E-04	6.76E-04
SignaLink	BP	GO:0050951	sensory perception of temperature stimulus	-	28	27	-	-	2.69E-03	1.24E-03
SignaLink	BP	GO:0045807	positive regulation of endocytosis	-	155	150	-	-	3.25E-03	6.76E-03
SignaLink	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	3.72E-03	5.07E-04
SignaLink	BP	GO:0002418	immune response to tumor cell	-	29	27	-	-	9.49E-04	1.24E-03
SignaLink	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	1.73E-03	2.65E-03
SignaLink	BP	GO:0048308	organelle inheritance	-	14	14	-	-	2.24E-03	6.76E-04
SignaLink	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	4.71E-04	8.45E-04
SignaLink	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	1.55E-03	9.01E-04
SignaLink	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	49	-	-	2.02E-03	2.25E-03
SignaLink	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	1.69E-03	3.04E-03
SignaLink	BP	GO:0042447	hormone catabolic process	-	12	11	-	-	1.65E-04	5.07E-04
SignaLink	BP	GO:0009110	vitamin biosynthetic process	-	23	22	-	-	9.19E-04	1.01E-03
SignaLink	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	3.41E-03	1.01E-03
SignaLink	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	2.60E-02	7.88E-04
SignaLink	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	22	-	-	5.62E-04	1.01E-03
SignaLink	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	95	-	-	1.48E-03	4.28E-03
SignaLink	BP	GO:0009111	vitamin catabolic process	-	13	12	-	-	1.68E-04	5.63E-04
SignaLink	MF	GO:0051100	negative regulation of binding	-	161	154	-	-	2.04E-03	6.98E-03
SignaLink	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	4.84E-03	3.55E-03
SignaLink	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	1.73E-03	2.70E-03
SignaLink	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	1.20E-03	9.01E-04
SignaLink	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	3.17E-03	5.63E-04
SignaLink	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	1.79E-02	1.52E-03
SignaLink	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	2.20E-03	7.32E-04
SignaLink	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	1.74E-03	6.19E-04
SignaLink	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	1.39E-03	2.14E-03
SignaLink	BP	GO:0046621	negative regulation of organ growth	-	39	32	-	-	6.48E-04	1.46E-03
SignaLink	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	1.20E-01	2.25E-03
SignaLink	BP	GO:0032368	regulation of lipid transport	-	149	129	-	-	8.72E-03	5.86E-03
SignaLink	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	1.48E-02	1.35E-03
SignaLink	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	178	-	-	6.02E-03	8.05E-03
SignaLink	BP	GO:0033002	muscle cell proliferation	-	249	202	-	-	3.42E-03	9.12E-03
SignaLink	BP	GO:0043331	response to dsRNA	-	56	55	-	-	2.69E-02	2.48E-03
SignaLink	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	1.29E-03	5.63E-04
SignaLink	BP	GO:0051904	pigment granule transport	-	23	23	-	-	1.78E-02	1.07E-03
SignaLink	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	9.76E-04	1.46E-03
SignaLink	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	32	-	-	6.44E-04	1.46E-03
SignaLink	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	12	-	-	1.90E-03	5.63E-04
SignaLink	BP	GO:0033363	secretory granule organization	-	63	60	-	-	4.95E-03	2.70E-03
SignaLink	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	5.58E-04	1.30E-03
SignaLink	BP	GO:0120009	intermembrane lipid transfer	-	52	49	-	-	4.46E-03	2.25E-03
SignaLink	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	5.76E-03	6.76E-04
SignaLink	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	38	-	-	1.58E-03	1.75E-03
SignaLink	BP	GO:0033622	integrin activation	-	26	26	-	-	4.95E-03	1.18E-03
SignaLink	BP	GO:0098751	bone cell development	-	18	16	-	-	5.52E-04	7.32E-04
SignaLink	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	5.59E-04	9.57E-04
SignaLink	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	1.26E-03	2.31E-03
SignaLink	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	1.34E-02	1.35E-03
SignaLink	BP	GO:0002076	osteoblast development	-	17	17	-	-	1.44E-02	7.88E-04
SignaLink	BP	GO:0072164	mesonephric tubule development	-	98	97	-	-	4.08E-03	4.39E-03
SignaLink	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	6.05E-04	7.88E-04
SignaLink	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	105	-	-	3.11E-03	4.73E-03
SignaLink	BP	GO:1903524	positive regulation of blood circulation	-	39	35	-	-	1.17E-03	1.58E-03
SignaLink	BP	GO:0030901	midbrain development	-	87	84	-	-	3.03E-03	3.83E-03
SignaLink	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	1.34E-03	1.01E-03
SignaLink	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	9.82E-04	7.32E-04
SignaLink	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	1.95E-03	6.19E-04
SignaLink	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	67	-	-	2.17E-03	3.04E-03
SignaLink	MF	GO:1901474	azole transmembrane transporter activity	-	13	12	-	-	1.68E-04	5.63E-04
SignaLink	BP	GO:0002687	positive regulation of leukocyte migration	-	147	145	-	-	4.59E-03	6.53E-03
SignaLink	BP	GO:0019755	one-carbon compound transport	-	28	25	-	-	4.99E-03	1.13E-03
SignaLink	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.63E-04	6.19E-04
SignaLink	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	1.07E-03	7.32E-04
SignaLink	BP	GO:0110154	RNA decapping	-	19	19	-	-	6.28E-02	9.01E-04
SignaLink	BP	GO:0034605	cellular response to heat	-	66	65	-	-	1.54E-03	2.93E-03
SignaLink	BP	GO:0005996	monosaccharide metabolic process	-	250	238	-	-	8.01E-03	1.08E-02
SignaLink	BP	GO:0033555	multicellular organismal response to stress	-	90	88	-	-	2.21E-03	4.00E-03
SignaLink	BP	GO:0002262	myeloid cell homeostasis	-	172	165	-	-	2.04E-03	7.43E-03
SignaLink	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	2.39E-02	1.75E-03
SignaLink	BP	GO:0050688	regulation of defense response to virus	-	65	63	-	-	4.63E-03	2.87E-03
SignaLink	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	2.11E-03	9.01E-04
SignaLink	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	223	-	-	5.50E-03	1.01E-02
SignaLink	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	1.32E-03	1.41E-03
SignaLink	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	5.95E-04	6.76E-04
SignaLink	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	6.36E-03	1.46E-03
SignaLink	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	17	-	-	2.89E-03	7.88E-04
SignaLink	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	1.61E-02	1.30E-03
SignaLink	BP	GO:0022618	protein-RNA complex assembly	-	227	190	-	-	2.40E-02	8.56E-03
SignaLink	BP	GO:0051147	regulation of muscle cell differentiation	-	162	135	-	-	2.29E-03	6.08E-03
SignaLink	BP	GO:0090102	cochlea development	-	50	50	-	-	1.13E-03	2.25E-03
SignaLink	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	5.71E-04	1.18E-03
SignaLink	BP	GO:0045933	positive regulation of muscle contraction	-	49	47	-	-	1.14E-03	2.14E-03
SignaLink	BP	GO:0015803	branched-chain amino acid transport	-	14	13	-	-	2.89E-02	6.19E-04
SignaLink	BP	GO:0002679	respiratory burst involved in defense response	-	16	15	-	-	8.74E-04	6.76E-04
SignaLink	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	35	-	-	7.48E-04	1.58E-03
SignaLink	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	90	-	-	2.93E-02	4.05E-03
SignaLink	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.65E-04	5.63E-04
SignaLink	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	3.60E-03	1.01E-03
SignaLink	BP	GO:0032922	circadian regulation of gene expression	-	71	70	-	-	2.79E-03	3.15E-03
SignaLink	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	55	-	-	2.18E-03	2.48E-03
SignaLink	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	171	-	-	2.75E-03	7.71E-03
SignaLink	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	1.04E-03	1.07E-03
SignaLink	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	57	-	-	5.37E-03	2.59E-03
SignaLink	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	1.13E-03	5.07E-04
SignaLink	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	2.40E-03	1.75E-03
SignaLink	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.65E-04	5.63E-04
SignaLink	BP	GO:0140253	cell-cell fusion	-	62	59	-	-	6.88E-03	2.70E-03
SignaLink	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	2.67E-03	5.63E-04
SignaLink	BP	GO:0071599	otic vesicle development	-	15	15	-	-	3.25E-03	6.76E-04
SignaLink	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	42	-	-	1.25E-02	1.91E-03
SignaLink	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	4.48E-04	6.76E-04
SignaLink	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	1.42E-02	2.70E-03
SignaLink	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	2.27E-02	1.63E-03
SignaLink	BP	GO:0051293	establishment of spindle localization	-	57	57	-	-	2.33E-03	2.59E-03
SignaLink	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	1.64E-04	6.19E-04
SignaLink	BP	GO:0043114	regulation of vascular permeability	-	49	46	-	-	2.61E-03	2.08E-03
SignaLink	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	1.18E-02	1.18E-03
SignaLink	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	66	-	-	2.63E-03	2.98E-03
SignaLink	BP	GO:0008360	regulation of cell shape	-	139	136	-	-	4.58E-03	6.14E-03
SignaLink	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	3.07E-03	7.32E-04
SignaLink	BP	GO:0051222	positive regulation of protein transport	-	249	241	-	-	3.91E-03	1.09E-02
SignaLink	CC	GO:0140632	canonical inflammasome complex assembly	-	40	39	-	-	6.85E-03	1.80E-03
SignaLink	MF	GO:0034260	negative regulation of GTPase activity	-	36	32	-	-	1.20E-03	1.46E-03
SignaLink	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	1.57E-03	1.01E-03
SignaLink	BP	GO:0045739	positive regulation of DNA repair	-	128	127	-	-	7.25E-03	5.74E-03
SignaLink	BP	GO:0001845	phagolysosome assembly	-	19	18	-	-	1.99E-03	8.45E-04
SignaLink	BP	GO:0045185	maintenance of protein location	-	95	89	-	-	2.00E-03	4.05E-03
SignaLink	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	12	-	-	1.09E-03	5.63E-04
SignaLink	BP	GO:0003158	endothelium development	-	140	127	-	-	3.49E-03	5.74E-03
SignaLink	CC	GO:0072595	maintenance of protein localization in organelle	-	42	41	-	-	1.75E-03	1.86E-03
SignaLink	BP	GO:0051224	negative regulation of protein transport	-	122	106	-	-	2.67E-03	4.79E-03
SignaLink	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	145	-	-	2.88E-03	6.53E-03
SignaLink	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	3.41E-03	6.19E-04
SignaLink	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	29	-	-	1.07E-03	1.35E-03
SignaLink	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	6.23E-02	9.01E-04
SignaLink	BP	GO:0021885	forebrain cell migration	-	63	62	-	-	2.61E-03	2.82E-03
SignaLink	BP	GO:0007405	neuroblast proliferation	-	81	78	-	-	1.18E-03	3.55E-03
SignaLink	BP	GO:0009581	detection of external stimulus	-	137	124	-	-	4.08E-03	5.63E-03
SignaLink	BP	GO:1990542	mitochondrial transmembrane transport	-	93	91	-	-	4.46E-03	4.11E-03
SignaLink	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	1.94E-03	1.41E-03
SignaLink	BP	GO:0033504	floor plate development	-	11	11	-	-	2.61E-02	5.07E-04
SignaLink	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	4.25E-04	5.07E-04
SignaLink	BP	GO:0097186	amelogenesis	-	26	25	-	-	3.18E-04	1.13E-03
SignaLink	BP	GO:0031128	developmental induction	-	26	26	-	-	9.74E-04	1.18E-03
SignaLink	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	2.23E-04	6.76E-04
SignaLink	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	1.27E-03	2.98E-03
SignaLink	BP	GO:0021533	cell differentiation in hindbrain	-	23	22	-	-	8.41E-04	1.01E-03
SignaLink	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	6.84E-04	1.41E-03
SignaLink	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	4.95E-03	5.63E-04
SignaLink	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	4.99E-02	2.31E-03
SignaLink	BP	GO:0021517	ventral spinal cord development	-	47	46	-	-	1.51E-03	2.08E-03
SignaLink	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	5.44E-03	3.38E-03
SignaLink	BP	GO:0032328	alanine transport	-	19	18	-	-	3.98E-02	8.45E-04
SignaLink	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	3.18E-03	7.32E-04
SignaLink	BP	GO:0097722	sperm motility	-	133	121	-	-	1.64E-03	5.46E-03
SignaLink	BP	GO:0051231	spindle elongation	-	14	14	-	-	1.24E-01	6.76E-04
SignaLink	BP	GO:0042490	mechanoreceptor differentiation	-	67	65	-	-	2.96E-03	2.93E-03
SignaLink	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.71E-03	1.35E-03
SignaLink	BP	GO:0035148	tube formation	-	155	154	-	-	5.42E-03	6.98E-03
SignaLink	BP	GO:0048520	positive regulation of behavior	-	27	26	-	-	1.77E-03	1.18E-03
SignaLink	BP	GO:0098543	detection of other organism	-	19	19	-	-	2.36E-02	9.01E-04
SignaLink	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	9.29E-03	1.97E-03
SignaLink	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	121	-	-	4.97E-03	5.46E-03
SignaLink	BP	GO:0031123	RNA 3'-end processing	-	79	77	-	-	2.01E-02	3.49E-03
SignaLink	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	1.66E-04	5.07E-04
SignaLink	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	105	-	-	3.50E-03	4.73E-03
SignaLink	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	8.95E-03	8.45E-04
SignaLink	CC	GO:0007097	nuclear migration	-	24	23	-	-	2.00E-03	1.07E-03
SignaLink	BP	GO:0006885	regulation of pH	-	104	97	-	-	5.45E-03	4.39E-03
SignaLink	BP	GO:0002467	germinal center formation	-	14	14	-	-	6.82E-04	6.76E-04
SignaLink	BP	GO:1990840	response to lectin	-	22	21	-	-	6.47E-02	9.57E-04
SignaLink	BP	GO:0071800	podosome assembly	-	19	19	-	-	1.17E-03	9.01E-04
SignaLink	BP	GO:0031018	endocrine pancreas development	-	47	45	-	-	2.25E-03	2.03E-03
SignaLink	BP	GO:0001708	cell fate specification	-	108	105	-	-	3.29E-03	4.73E-03
SignaLink	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	67	-	-	2.74E-03	3.04E-03
SignaLink	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	1.43E-03	1.69E-03
SignaLink	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	9.68E-04	6.76E-04
SignaLink	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	12	-	-	1.71E-03	5.63E-04
SignaLink	BP	GO:0042440	pigment metabolic process	-	80	76	-	-	1.44E-02	3.43E-03
SignaLink	BP	GO:1901606	alpha-amino acid catabolic process	-	101	99	-	-	4.96E-03	4.50E-03
SignaLink	BP	GO:1901890	positive regulation of cell junction assembly	-	106	98	-	-	1.97E-03	4.45E-03
SignaLink	BP	GO:0070988	demethylation	-	27	26	-	-	7.18E-04	1.18E-03
SignaLink	BP	GO:1901655	cellular response to ketone	-	107	104	-	-	1.49E-03	4.73E-03
SignaLink	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	4.41E-03	6.76E-04
SignaLink	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	6.55E-02	6.76E-04
SignaLink	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	1.65E-01	7.88E-04
SignaLink	BP	GO:0006968	cellular defense response	-	52	52	-	-	1.68E-02	2.36E-03
SignaLink	BP	GO:0055006	cardiac cell development	-	93	84	-	-	1.90E-03	3.83E-03
SignaLink	BP	GO:0031365	N-terminal protein amino acid modification	-	30	29	-	-	1.03E-03	1.35E-03
SignaLink	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	1.68E-04	5.63E-04
SignaLink	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	27	-	-	5.58E-04	1.24E-03
SignaLink	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	4.77E-04	5.63E-04
SignaLink	BP	GO:0060004	reflex	-	63	61	-	-	1.15E-03	2.76E-03
SignaLink	BP	GO:0044706	multi-multicellular organism process	-	217	208	-	-	8.00E-03	9.40E-03
SignaLink	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	1.37E-03	5.63E-04
SignaLink	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	138	-	-	2.75E-03	6.25E-03
SignaLink	BP	GO:0006026	aminoglycan catabolic process	-	34	33	-	-	3.95E-02	1.52E-03
SignaLink	BP	GO:0031294	lymphocyte costimulation	-	47	46	-	-	2.35E-02	2.08E-03
SignaLink	BP	GO:0050768	negative regulation of neurogenesis	-	150	143	-	-	5.45E-03	6.48E-03
SignaLink	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	91	-	-	2.02E-03	4.11E-03
SignaLink	BP	GO:0090068	positive regulation of cell cycle process	-	262	244	-	-	6.00E-03	1.10E-02
SignaLink	BP	GO:0043605	amide catabolic process	-	16	16	-	-	2.23E-04	7.32E-04
SignaLink	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	26	-	-	1.28E-03	1.18E-03
SignaLink	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	34	-	-	2.82E-02	1.58E-03
SignaLink	BP	GO:1902115	regulation of organelle assembly	-	210	205	-	-	5.11E-03	9.23E-03
SignaLink	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	65	-	-	2.09E-03	2.93E-03
SignaLink	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	2.18E-04	7.32E-04
SignaLink	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	140	-	-	4.03E-03	6.31E-03
SignaLink	BP	GO:0043171	peptide catabolic process	-	19	17	-	-	2.21E-04	7.88E-04
SignaLink	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	3.50E-03	1.91E-03
SignaLink	BP	GO:0051952	regulation of amine transport	-	98	97	-	-	3.52E-03	4.39E-03
SignaLink	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	9.24E-04	1.07E-03
SignaLink	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	1.05E-02	9.01E-04
SignaLink	BP	GO:0015801	aromatic amino acid transport	-	13	11	-	-	1.28E-02	5.07E-04
SignaLink	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	2.11E-02	1.07E-03
SignaLink	BP	GO:0097154	GABAergic neuron differentiation	-	20	19	-	-	2.15E-04	9.01E-04
SignaLink	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	3.63E-04	7.32E-04
SignaLink	CC	GO:0032365	intracellular lipid transport	-	51	48	-	-	2.89E-03	2.20E-03
SignaLink	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	3.39E-03	1.35E-03
SignaLink	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	68	-	-	2.10E-03	3.10E-03
SignaLink	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	113	-	-	5.35E-03	5.12E-03
SignaLink	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	5.05E-03	1.30E-03
SignaLink	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	8.06E-04	1.13E-03
SignaLink	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	5.60E-04	6.19E-04
SignaLink	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	1.64E-04	6.76E-04
SignaLink	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	1.61E-04	6.19E-04
SignaLink	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	5.60E-04	1.58E-03
SignaLink	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	1.17E-01	5.07E-04
SignaLink	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	7.93E-03	4.05E-03
SignaLink	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	29	-	-	7.41E-03	1.35E-03
SignaLink	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	3.02E-03	8.45E-04
SignaLink	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	1.07E-02	9.57E-04
SignaLink	BP	GO:0015669	gas transport	-	23	22	-	-	3.05E-02	1.01E-03
SignaLink	BP	GO:0016485	protein processing	-	248	242	-	-	7.23E-03	1.09E-02
SignaLink	BP	GO:0009649	entrainment of circadian clock	-	30	28	-	-	1.77E-03	1.30E-03
SignaLink	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	160	-	-	1.86E-02	7.21E-03
SignaLink	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	1.19E-03	1.13E-03
SignaLink	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	135	-	-	1.49E-02	6.08E-03
SignaLink	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	3.37E-02	5.63E-04
SignaLink	BP	GO:0099054	presynapse assembly	-	49	41	-	-	1.85E-03	1.86E-03
SignaLink	BP	GO:0003353	positive regulation of cilium movement	-	12	11	-	-	3.78E-03	5.07E-04
SignaLink	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	24	-	-	7.32E-04	1.13E-03
SignaLink	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	3.33E-04	1.13E-03
SignaLink	BP	GO:0031348	negative regulation of defense response	-	282	238	-	-	3.94E-03	1.08E-02
SignaLink	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	76	-	-	3.42E-03	3.43E-03
SignaLink	BP	GO:0007606	sensory perception of chemical stimulus	-	535	157	-	-	5.40E-03	7.09E-03
SignaLink	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	1.24E-03	3.10E-03
SignaLink	BP	GO:0071496	cellular response to external stimulus	-	74	73	-	-	4.12E-03	3.32E-03
SignaLink	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	2.45E-03	6.19E-04
SignaLink	BP	GO:0042753	positive regulation of circadian rhythm	-	18	17	-	-	4.51E-03	7.88E-04
SignaLink	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	4.79E-04	5.07E-04
SignaLink	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	3.70E-03	5.63E-04
SignaLink	BP	GO:0032094	response to food	-	37	37	-	-	9.55E-03	1.69E-03
SignaLink	BP	GO:0001964	startle response	-	27	27	-	-	7.93E-03	1.24E-03
SignaLink	BP	GO:0007340	acrosome reaction	-	38	34	-	-	1.21E-02	1.58E-03
SignaLink	BP	GO:0046434	organophosphate catabolic process	-	232	225	-	-	6.23E-03	1.01E-02
SignaLink	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	1.57E-02	1.35E-03
SignaLink	BP	GO:0009566	fertilization	-	205	179	-	-	2.58E-03	8.11E-03
SignaLink	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	4.10E-01	2.70E-03
SignaLink	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	6.40E-04	1.13E-03
SignaLink	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	1.30E-02	6.19E-04
SignaLink	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	3.67E-03	1.35E-03
SignaLink	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	22	-	-	2.68E-03	1.01E-03
SignaLink	BP	GO:0033044	regulation of chromosome organization	-	249	248	-	-	4.46E-03	1.12E-02
SignaLink	BP	GO:0009309	amine biosynthetic process	-	38	35	-	-	8.72E-03	1.58E-03
SignaLink	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	2.59E-03	9.01E-04
SignaLink	BP	GO:0061900	glial cell activation	-	56	52	-	-	1.62E-03	2.36E-03
SignaLink	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	134	-	-	5.08E-03	6.08E-03
SignaLink	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	1.95E-03	6.19E-04
SignaLink	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	5.66E-03	6.76E-04
SignaLink	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	3.70E-03	1.86E-03
SignaLink	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	1.07E-03	9.01E-04
SignaLink	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	7.96E-04	6.76E-04
SignaLink	BP	GO:0072537	fibroblast activation	-	13	13	-	-	8.45E-03	6.19E-04
SignaLink	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	4.78E-03	6.19E-04
SignaLink	BP	GO:0043647	inositol phosphate metabolic process	-	44	43	-	-	2.46E-03	1.97E-03
SignaLink	BP	GO:0016180	snRNA processing	-	28	27	-	-	3.60E-02	1.24E-03
SignaLink	BP	GO:0051303	establishment of chromosome localization	-	104	102	-	-	7.58E-03	4.62E-03
SignaLink	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	3.76E-02	7.32E-04
SignaLink	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	6.67E-03	1.75E-03
SignaLink	BP	GO:0097164	ammonium ion metabolic process	-	23	23	-	-	5.97E-03	1.07E-03
SignaLink	BP	GO:0021515	cell differentiation in spinal cord	-	51	49	-	-	9.71E-04	2.25E-03
SignaLink	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	3.20E-03	8.45E-04
SignaLink	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	1.57E-03	9.57E-04
SignaLink	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	1.11E-03	1.30E-03
SignaLink	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.64E-03	8.45E-04
SignaLink	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	37	-	-	2.33E-03	1.69E-03
SignaLink	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	2.56E-02	1.01E-03
SignaLink	BP	GO:0007566	embryo implantation	-	57	51	-	-	9.07E-04	2.31E-03
SignaLink	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	32	-	-	1.03E-03	1.46E-03
SignaLink	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	9.14E-03	7.32E-04
SignaLink	BP	GO:0060306	regulation of membrane repolarization	-	38	30	-	-	3.84E-02	1.35E-03
SignaLink	BP	GO:0051017	actin filament bundle assembly	-	161	155	-	-	9.41E-03	6.98E-03
SignaLink	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	3.68E-03	1.91E-03
SignaLink	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	3.22E-04	8.45E-04
SignaLink	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	6.46E-04	9.01E-04
SignaLink	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	7.89E-04	6.19E-04
SignaLink	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	37	-	-	5.80E-03	1.69E-03
SignaLink	BP	GO:0021756	striatum development	-	21	21	-	-	9.64E-04	9.57E-04
SignaLink	BP	GO:1901343	negative regulation of vasculature development	-	154	100	-	-	2.75E-03	4.50E-03
SignaLink	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	148	-	-	1.02E-02	6.70E-03
SignaLink	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	29	-	-	9.68E-04	1.35E-03
SignaLink	BP	GO:1902414	protein localization to cell junction	-	107	104	-	-	5.49E-03	4.73E-03
SignaLink	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	7.32E-03	1.01E-03
SignaLink	BP	GO:0051304	chromosome separation	-	80	80	-	-	1.83E-02	3.60E-03
SignaLink	BP	GO:0045780	positive regulation of bone resorption	-	18	17	-	-	2.16E-03	7.88E-04
SignaLink	BP	GO:0048709	oligodendrocyte differentiation	-	101	98	-	-	2.65E-03	4.45E-03
SignaLink	BP	GO:0045017	glycerolipid biosynthetic process	-	254	243	-	-	5.53E-03	1.10E-02
SignaLink	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	2.41E-01	6.76E-04
SignaLink	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	24	-	-	1.48E-02	1.13E-03
SignaLink	BP	GO:0001776	leukocyte homeostasis	-	108	103	-	-	1.85E-03	4.67E-03
SignaLink	BP	GO:0050769	positive regulation of neurogenesis	-	240	231	-	-	3.87E-03	1.04E-02
SignaLink	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	2.22E-04	6.76E-04
SignaLink	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	1.95E-02	3.15E-03
SignaLink	BP	GO:0050866	negative regulation of cell activation	-	216	205	-	-	4.48E-03	9.23E-03
SignaLink	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	8.13E-04	1.63E-03
SignaLink	BP	GO:0033500	carbohydrate homeostasis	-	251	231	-	-	3.32E-03	1.04E-02
SignaLink	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	29	-	-	8.14E-03	1.35E-03
SignaLink	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	7.61E-04	5.63E-04
SignaLink	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	5.38E-03	2.53E-03
SignaLink	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	2.91E-03	1.07E-03
SignaLink	CC	GO:0099522	cytosolic region	-	20	20	-	-	7.02E-04	9.01E-04
SignaLink	CC	GO:0000791	euchromatin	-	60	58	-	-	1.16E-03	2.65E-03
SignaLink	CC	GO:0030666	endocytic vesicle membrane	-	196	193	-	-	1.21E-02	8.73E-03
SignaLink	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	3.73E-02	6.76E-04
SignaLink	CC	GO:1990752	microtubule end	-	34	34	-	-	3.08E-02	1.58E-03
SignaLink	CC	GO:0043204	perikaryon	-	156	153	-	-	2.57E-03	6.93E-03
SignaLink	CC	GO:0061702	canonical inflammasome complex	-	17	16	-	-	1.06E-01	7.32E-04
SignaLink	CC	GO:0098643	banded collagen fibril	-	12	11	-	-	5.39E-02	5.07E-04
SignaLink	CC	GO:0097542	ciliary tip	-	48	48	-	-	5.55E-02	2.20E-03
SignaLink	CC	GO:1905368	peptidase complex	-	124	122	-	-	4.66E-02	5.52E-03
SignaLink	CC	GO:0000792	heterochromatin	-	98	97	-	-	4.87E-03	4.39E-03
SignaLink	CC	GO:0097546	ciliary base	-	47	45	-	-	1.02E-02	2.03E-03
SignaLink	CC	GO:0071819	DUBm complex	-	25	23	-	-	5.71E-02	1.07E-03
SignaLink	CC	GO:0031201	SNARE complex	-	48	48	-	-	2.25E-01	2.20E-03
SignaLink	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.49E-03	6.19E-04
SignaLink	CC	GO:0033260	nuclear DNA replication	-	40	38	-	-	1.13E-02	1.75E-03
SignaLink	CC	GO:0044391	ribosomal subunit	-	203	202	-	-	3.17E-01	9.12E-03
SignaLink	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	12	-	-	1.00E-01	5.63E-04
SignaLink	CC	GO:0071013	catalytic step 2 spliceosome	-	88	87	-	-	3.84E-02	3.94E-03
SignaLink	CC	GO:0031907	microbody lumen	-	51	49	-	-	1.22E-01	2.25E-03
SignaLink	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	1.68E-04	5.07E-04
SignaLink	CC	GO:0098862	cluster of actin-based cell projections	-	162	153	-	-	4.88E-03	6.93E-03
SignaLink	CC	GO:0016363	nuclear matrix	-	127	126	-	-	2.95E-03	5.69E-03
SignaLink	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	4.44E-02	2.08E-03
SignaLink	CC	GO:0032432	actin filament bundle	-	249	239	-	-	6.43E-03	1.08E-02
SignaLink	CC	GO:0008088	axo-dendritic transport	-	78	76	-	-	4.20E-03	3.43E-03
SignaLink	CC	GO:0031519	PcG protein complex	-	38	38	-	-	5.78E-02	1.75E-03
SignaLink	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	41	-	-	2.10E-02	1.86E-03
SignaLink	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	215	-	-	1.89E-02	9.69E-03
SignaLink	CC	GO:0000313	organellar ribosome	-	89	89	-	-	5.60E-02	4.05E-03
SignaLink	CC	GO:0099643	signal release from synapse	-	147	143	-	-	1.39E-02	6.48E-03
SignaLink	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	1.20E-02	2.08E-03
SignaLink	CC	GO:0005818	aster	-	11	11	-	-	2.11E-02	5.07E-04
SignaLink	CC	GO:0030018	Z disc	-	129	125	-	-	1.44E-02	5.63E-03
SignaLink	CC	GO:0032580	Golgi cisterna membrane	-	93	82	-	-	2.18E-03	3.72E-03
SignaLink	CC	GO:0097381	photoreceptor disc membrane	-	25	22	-	-	1.18E-02	1.01E-03
SignaLink	CC	GO:1905360	GTPase complex	-	41	39	-	-	5.97E-02	1.80E-03
SignaLink	CC	GO:0097540	axonemal central pair	-	161	143	-	-	2.44E-03	6.48E-03
SignaLink	CC	GO:0042641	actomyosin	-	77	75	-	-	7.66E-03	3.38E-03
SignaLink	CC	GO:0097386	glial cell projection	-	38	38	-	-	1.22E-03	1.75E-03
SignaLink	CC	GO:0032588	trans-Golgi network membrane	-	102	99	-	-	5.81E-03	4.50E-03
SignaLink	CC	GO:0070382	exocytic vesicle	-	224	218	-	-	8.70E-03	9.85E-03
SignaLink	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	45	-	-	5.37E-03	2.03E-03
SignaLink	CC	GO:0031903	microbody membrane	-	65	63	-	-	3.96E-02	2.87E-03
SignaLink	CC	GO:0046930	pore complex	-	26	26	-	-	2.98E-02	1.18E-03
SignaLink	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	6.94E-03	5.07E-04
SignaLink	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	6.47E-04	7.32E-04
SignaLink	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	246	-	-	6.65E-03	1.11E-02
SignaLink	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	3.73E-03	1.13E-03
SignaLink	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.68E-04	5.07E-04
SignaLink	CC	GO:0099571	postsynaptic cytoskeleton	-	18	18	-	-	1.13E-02	8.45E-04
SignaLink	CC	GO:0044298	cell body membrane	-	32	31	-	-	2.73E-03	1.41E-03
SignaLink	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	9.46E-02	5.07E-04
SignaLink	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	8.83E-04	9.57E-04
SignaLink	CC	GO:0045495	pole plasm	-	25	23	-	-	1.47E-02	1.07E-03
SignaLink	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	4.18E-03	6.76E-04
SignaLink	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	4.25E-01	9.01E-04
SignaLink	CC	GO:0010369	chromocenter	-	14	14	-	-	5.09E-03	6.76E-04
SignaLink	CC	GO:0002177	manchette	-	19	17	-	-	2.20E-04	7.88E-04
SignaLink	CC	GO:0016323	basolateral plasma membrane	-	239	231	-	-	5.74E-03	1.04E-02
SignaLink	CC	GO:0045009	chitosome	-	21	21	-	-	8.76E-03	9.57E-04
SignaLink	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	1.99E-03	5.63E-04
SignaLink	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	3.98E-03	2.03E-03
SignaLink	CC	GO:0098636	protein complex involved in cell adhesion	-	57	55	-	-	2.16E-02	2.48E-03
SignaLink	CC	GO:0001917	photoreceptor inner segment	-	71	68	-	-	5.08E-03	3.10E-03
SignaLink	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	1.16E-03	6.76E-04
SignaLink	CC	GO:0019897	extrinsic component of plasma membrane	-	156	150	-	-	1.02E-02	6.76E-03
SignaLink	CC	GO:0031594	neuromuscular junction	-	73	71	-	-	2.03E-03	3.21E-03
SignaLink	CC	GO:0045120	pronucleus	-	14	14	-	-	7.59E-04	6.76E-04
SignaLink	CC	GO:0043083	synaptic cleft	-	21	19	-	-	2.22E-04	9.01E-04
SignaLink	CC	GO:0000922	spindle pole	-	172	168	-	-	1.00E-02	7.60E-03
SignaLink	CC	GO:0120111	neuron projection cytoplasm	-	94	92	-	-	4.09E-03	4.17E-03
SignaLink	CC	GO:0070971	endoplasmic reticulum exit site	-	32	28	-	-	3.85E-03	1.30E-03
SignaLink	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	1.66E-04	6.19E-04
SignaLink	CC	GO:0004879	nuclear receptor activity	-	63	63	-	-	1.99E-03	2.87E-03
SignaLink	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	167	-	-	1.01E-02	7.55E-03
SignaLink	CC	GO:0000123	histone acetyltransferase complex	-	93	90	-	-	4.69E-02	4.05E-03
SignaLink	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	3.22E-03	6.19E-04
SignaLink	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	108	-	-	1.39E-01	4.90E-03
SignaLink	CC	GO:0048786	presynaptic active zone	-	80	80	-	-	4.23E-03	3.60E-03
SignaLink	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	1.67E-04	5.07E-04
SignaLink	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	1.66E-04	5.63E-04
SignaLink	CC	GO:0007034	vacuolar transport	-	168	164	-	-	1.01E-02	7.43E-03
SignaLink	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	2.77E-04	9.57E-04
SignaLink	CC	GO:0043194	axon initial segment	-	21	20	-	-	1.79E-02	9.01E-04
SignaLink	CC	GO:1900115	extracellular regulation of signal transduction	-	13	12	-	-	2.18E-03	5.63E-04
SignaLink	CC	GO:0005776	autophagosome	-	111	108	-	-	3.27E-02	4.90E-03
SignaLink	CC	GO:0031430	M band	-	22	22	-	-	1.13E-03	1.01E-03
SignaLink	CC	GO:0001931	uropod	-	13	13	-	-	2.15E-02	6.19E-04
SignaLink	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	75	-	-	1.01E-01	3.38E-03
SignaLink	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	96	-	-	4.06E-01	4.34E-03
SignaLink	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	2.56E-01	6.19E-04
SignaLink	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	2.71E-02	9.01E-04
SignaLink	CC	GO:0071203	WASH complex	-	12	11	-	-	8.77E-02	5.07E-04
SignaLink	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	29	-	-	1.63E-02	1.35E-03
SignaLink	CC	GO:0032994	protein-lipid complex	-	39	38	-	-	2.26E-02	1.75E-03
SignaLink	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	147	-	-	5.67E-02	6.64E-03
SignaLink	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	7.31E-03	5.63E-04
SignaLink	CC	GO:0001527	microfibril	-	13	13	-	-	1.68E-04	6.19E-04
SignaLink	CC	GO:0072562	blood microparticle	-	144	131	-	-	9.69E-03	5.91E-03
SignaLink	CC	GO:0005883	neurofilament	-	11	11	-	-	1.82E-02	5.07E-04
SignaLink	CC	GO:0051233	spindle midzone	-	36	35	-	-	1.84E-03	1.58E-03
SignaLink	CC	GO:0005811	lipid droplet	-	102	99	-	-	3.44E-03	4.50E-03
SignaLink	CC	GO:0045022	early endosome to late endosome transport	-	44	44	-	-	6.62E-03	2.03E-03
SignaLink	CC	GO:0043113	receptor clustering	-	51	51	-	-	2.49E-03	2.31E-03
SignaLink	CC	GO:0005940	septin ring	-	14	14	-	-	2.53E-01	6.76E-04
SignaLink	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	2.03E-02	5.07E-04
SignaLink	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	23	-	-	2.79E-04	1.07E-03
SignaLink	CC	GO:0044853	plasma membrane raft	-	114	113	-	-	5.21E-03	5.12E-03
SignaLink	CC	GO:0005881	cytoplasmic microtubule	-	256	233	-	-	5.32E-03	1.05E-02
SignaLink	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	1.91E-03	6.76E-04
SignaLink	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	3.14E-02	7.88E-04
SignaLink	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	58	-	-	9.20E-03	2.65E-03
SignaLink	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	1.66E-02	3.27E-03
SignaLink	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	3.60E-02	5.63E-04
SignaLink	CC	GO:0043034	costamere	-	18	18	-	-	1.39E-02	8.45E-04
SignaLink	CC	GO:0031904	endosome lumen	-	38	36	-	-	2.59E-03	1.63E-03
SignaLink	CC	GO:0060170	ciliary membrane	-	76	70	-	-	1.40E-02	3.15E-03
SignaLink	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	7.60E-01	6.19E-04
SignaLink	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	4.88E-02	5.63E-04
SignaLink	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	1.52E-01	1.13E-03
SignaLink	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	3.44E-01	6.76E-04
SignaLink	CC	GO:0032154	cleavage furrow	-	54	52	-	-	7.26E-03	2.36E-03
SignaLink	CC	GO:0005640	nuclear outer membrane	-	30	27	-	-	9.72E-04	1.24E-03
SignaLink	CC	GO:0005652	nuclear lamina	-	12	12	-	-	9.91E-04	5.63E-04
SignaLink	CC	GO:0007006	mitochondrial membrane organization	-	117	109	-	-	6.33E-03	4.96E-03
SignaLink	CC	GO:0001772	immunological synapse	-	44	44	-	-	4.63E-03	2.03E-03
SignaLink	CC	GO:0030904	retromer complex	-	12	12	-	-	2.24E-02	5.63E-04
SignaLink	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	1.68E-04	5.63E-04
SignaLink	CC	GO:0030863	cortical cytoskeleton	-	104	100	-	-	1.04E-02	4.50E-03
SignaLink	CC	GO:1905348	endonuclease complex	-	38	36	-	-	3.13E-02	1.63E-03
SignaLink	CC	GO:0005833	hemoglobin complex	-	12	11	-	-	1.77E-01	5.07E-04
SignaLink	CC	GO:0030315	T-tubule	-	52	52	-	-	3.73E-03	2.36E-03
SignaLink	CC	GO:0060076	excitatory synapse	-	64	60	-	-	9.91E-03	2.70E-03
SignaLink	CC	GO:0036019	endolysosome	-	29	29	-	-	6.65E-03	1.35E-03
SignaLink	CC	GO:0001891	phagocytic cup	-	28	28	-	-	1.22E-03	1.30E-03
SignaLink	CC	GO:0099086	synaptonemal structure	-	40	39	-	-	1.64E-02	1.80E-03
SignaLink	CC	GO:0030427	site of polarized growth	-	172	172	-	-	3.77E-03	7.77E-03
SignaLink	CC	GO:0044309	neuron spine	-	213	210	-	-	6.96E-03	9.46E-03
SignaLink	CC	GO:0030658	transport vesicle membrane	-	231	225	-	-	1.31E-02	1.01E-02
SignaLink	CC	GO:0098918	structural constituent of synapse	-	27	27	-	-	8.20E-03	1.24E-03
SignaLink	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.97E-01	5.63E-04
SignaLink	CC	GO:0000940	outer kinetochore	-	17	17	-	-	2.24E-02	7.88E-04
SignaLink	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	6.04E-02	7.88E-04
SignaLink	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	9.87E-03	2.25E-03
SignaLink	CC	GO:0098803	respiratory chain complex	-	39	35	-	-	4.10E-01	1.58E-03
SignaLink	CC	GO:0097545	axonemal outer doublet	-	164	146	-	-	3.02E-03	6.59E-03
SignaLink	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	3.98E-03	9.01E-04
SignaLink	CC	GO:0070069	cytochrome complex	-	42	38	-	-	3.76E-01	1.75E-03
SignaLink	CC	GO:0031143	pseudopodium	-	18	18	-	-	1.89E-03	8.45E-04
SignaLink	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	26	-	-	2.44E-02	1.18E-03
SignaLink	CC	GO:0055037	recycling endosome	-	200	195	-	-	6.13E-03	8.78E-03
SignaLink	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	91	-	-	4.70E-03	4.11E-03
SignaLink	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	3.65E-02	6.19E-04
SignaLink	CC	GO:0035253	ciliary rootlet	-	13	12	-	-	1.90E-03	5.63E-04
SignaLink	CC	GO:0071682	endocytic vesicle lumen	-	23	22	-	-	1.20E-03	1.01E-03
SignaLink	CC	GO:0030684	preribosome	-	76	73	-	-	2.53E-02	3.32E-03
SignaLink	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	18	-	-	4.77E-01	8.45E-04
SignaLink	CC	GO:1990391	DNA repair complex	-	22	22	-	-	7.97E-03	1.01E-03
SignaLink	CC	GO:0005775	vacuolar lumen	-	176	171	-	-	3.37E-03	7.71E-03
SignaLink	CC	GO:0032433	filopodium tip	-	19	19	-	-	3.23E-03	9.01E-04
SignaLink	CC	GO:0032982	myosin filament	-	24	24	-	-	4.74E-03	1.13E-03
SignaLink	CC	GO:0016327	apicolateral plasma membrane	-	23	22	-	-	1.22E-03	1.01E-03
SignaLink	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	4.24E-02	1.07E-03
SignaLink	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	11	-	-	6.02E-04	5.07E-04
SignaLink	CC	GO:0044306	neuron projection terminus	-	164	160	-	-	7.61E-03	7.21E-03
SignaLink	CC	GO:0034455	t-UTP complex	-	53	51	-	-	4.22E-03	2.31E-03
SignaLink	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	4.54E-01	7.88E-04
SignaLink	CC	GO:0031970	organelle envelope lumen	-	94	92	-	-	6.78E-03	4.17E-03
SignaLink	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.87E-02	6.19E-04
SignaLink	CC	GO:0120293	dynein axonemal particle	-	20	19	-	-	3.12E-04	9.01E-04
SignaLink	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	9.50E-04	1.13E-03
SignaLink	CC	GO:0043292	contractile muscle fiber	-	245	239	-	-	2.39E-02	1.08E-02
SignaLink	CC	GO:0018995	host cellular component	-	12	12	-	-	2.41E-03	5.63E-04
SignaLink	CC	GO:0034709	methylosome	-	13	12	-	-	1.79E-02	5.63E-04
SignaLink	CC	GO:0032426	stereocilium tip	-	21	19	-	-	2.22E-04	9.01E-04
SignaLink	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	1.56E-02	5.63E-04
SignaLink	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	1.42E-01	9.01E-04
SignaLink	CC	GO:0000803	sex chromosome	-	32	29	-	-	1.80E-03	1.35E-03
SignaLink	CC	GO:0098982	GABA-ergic synapse	-	84	78	-	-	2.13E-03	3.55E-03
SignaLink	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	16	-	-	2.61E-02	7.32E-04
SignaLink	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	2.17E-02	2.87E-03
SignaLink	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	1.61E-01	6.76E-04
SignaLink	CC	GO:0000242	pericentriolar material	-	22	22	-	-	6.52E-03	1.01E-03
SignaLink	CC	GO:1903293	phosphatase complex	-	54	53	-	-	1.83E-02	2.42E-03
SignaLink	CC	GO:0097470	ribbon synapse	-	13	13	-	-	1.08E-03	6.19E-04
SignaLink	CC	GO:0031941	filamentous actin	-	27	26	-	-	3.28E-04	1.18E-03
SignaLink	CC	GO:0000786	nucleosome	-	149	104	-	-	2.24E-02	4.73E-03
SignaLink	CC	GO:0001533	cornified envelope	-	59	58	-	-	1.14E-02	2.65E-03
SignaLink	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	2.10E-03	2.48E-03
SignaLink	CC	GO:0030027	lamellipodium	-	202	199	-	-	9.88E-03	9.01E-03
SignaLink	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	7.65E-04	6.76E-04
SignaLink	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	25	-	-	5.97E-02	1.13E-03
SignaLink	CC	GO:0000800	lateral element	-	14	14	-	-	3.73E-02	6.76E-04
SignaLink	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	12	-	-	6.20E-02	5.63E-04
SignaLink	CC	GO:0060077	inhibitory synapse	-	20	19	-	-	1.88E-02	9.01E-04
SignaLink	CC	GO:0031209	SCAR complex	-	12	12	-	-	5.58E-02	5.63E-04
SignaLink	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	2.68E-02	5.07E-04
SignaLink	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	2.22E-04	7.32E-04
SignaLink	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	8.38E-02	9.57E-04
SignaLink	CC	GO:0002102	podosome	-	31	31	-	-	1.82E-03	1.41E-03
SignaLink	CC	GO:0090543	Flemming body	-	33	32	-	-	9.26E-03	1.46E-03
SignaLink	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	4.94E-03	2.98E-03
SignaLink	CC	GO:0001650	fibrillar center	-	151	149	-	-	1.76E-03	6.76E-03
SignaLink	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	8.13E-03	6.76E-04
SignaLink	CC	GO:1990204	oxidoreductase complex	-	90	85	-	-	1.87E-01	3.83E-03
SignaLink	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	2.40E-02	7.32E-04
SignaLink	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.04E-01	5.07E-04
SignaLink	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	122	-	-	3.80E-03	5.52E-03
SignaLink	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	19	-	-	3.21E-02	9.01E-04
SignaLink	CC	GO:0001726	ruffle	-	181	180	-	-	6.39E-03	8.11E-03
SignaLink	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	6.36E-02	5.07E-04
SignaLink	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	5.32E-03	6.19E-04
SignaLink	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	8.64E-02	8.45E-04
SignaLink	CC	GO:0043198	dendritic shaft	-	38	38	-	-	9.50E-04	1.75E-03
SignaLink	CC	GO:0043073	germ cell nucleus	-	67	64	-	-	9.99E-04	2.93E-03
SignaLink	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	21	-	-	1.34E-03	9.57E-04
SignaLink	CC	GO:0016592	mediator complex	-	38	38	-	-	3.26E-01	1.75E-03
SignaLink	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	1.88E-02	9.01E-04
SignaLink	CC	GO:0022626	cytosolic ribosome	-	118	117	-	-	4.64E-01	5.29E-03
SignaLink	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	44	-	-	3.57E-02	2.03E-03
SignaLink	CC	GO:0034451	centriolar satellite	-	120	120	-	-	8.29E-03	5.41E-03
SignaLink	CC	GO:0045171	intercellular bridge	-	91	90	-	-	9.18E-03	4.05E-03
SignaLink	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	81	-	-	8.86E-03	3.66E-03
SignaLink	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	1.68E-04	6.76E-04
SignaLink	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.68E-02	5.07E-04
SignaLink	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	1.67E-04	5.07E-04
SignaLink	CC	GO:0044292	dendrite terminus	-	13	13	-	-	2.23E-03	6.19E-04
SignaLink	CC	GO:0032039	integrator complex	-	19	18	-	-	2.24E-04	8.45E-04
SignaLink	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	1.06E-03	6.76E-04
SignaLink	CC	GO:0033268	node of Ranvier	-	16	16	-	-	1.10E-02	7.32E-04
SignaLink	CC	GO:0036038	MKS complex	-	13	13	-	-	1.67E-04	6.19E-04
SignaLink	CC	GO:0030527	structural constituent of chromatin	-	97	53	-	-	1.14E-02	2.42E-03
SignaLink	CC	GO:0036379	myofilament	-	26	26	-	-	3.26E-02	1.18E-03
SignaLink	CC	GO:0030286	dynein complex	-	210	190	-	-	6.35E-03	8.56E-03
SignaLink	CC	GO:0031105	septin complex	-	14	14	-	-	2.57E-01	6.76E-04
SignaLink	CC	GO:0097228	sperm principal piece	-	33	28	-	-	1.23E-01	1.30E-03
SignaLink	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	1.93E-02	5.63E-04
SignaLink	CC	GO:0016482	cytosolic transport	-	135	133	-	-	6.28E-03	6.03E-03
SignaLink	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	5.20E-02	1.07E-03
SignaLink	CC	GO:0005796	Golgi lumen	-	106	96	-	-	7.79E-03	4.34E-03
SignaLink	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	36	-	-	6.58E-02	1.63E-03
SignaLink	CC	GO:0034358	plasma lipoprotein particle	-	36	35	-	-	2.14E-02	1.58E-03
SignaLink	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	1.18E-01	2.14E-03
SignaLink	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	3.07E-03	1.13E-03
SignaLink	CC	GO:0030662	coated vesicle membrane	-	202	199	-	-	2.96E-02	9.01E-03
SignaLink	CC	GO:0007039	protein catabolic process in the vacuole	-	61	59	-	-	1.39E-02	2.70E-03
SignaLink	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	67	-	-	5.78E-01	3.04E-03
SignaLink	CC	GO:0090734	site of DNA damage	-	118	117	-	-	1.11E-02	5.29E-03
SignaLink	MF	GO:0051861	glycolipid binding	-	30	30	-	-	1.06E-03	1.35E-03
SignaLink	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.66E-04	5.07E-04
SignaLink	MF	GO:0051087	protein-folding chaperone binding	-	135	132	-	-	4.82E-03	5.97E-03
SignaLink	MF	GO:0051959	dynein light intermediate chain binding	-	27	26	-	-	3.33E-04	1.18E-03
SignaLink	CC	GO:0015464	acetylcholine receptor activity	-	21	19	-	-	2.23E-04	9.01E-04
SignaLink	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	1.63E-04	5.63E-04
SignaLink	MF	GO:0016594	glycine binding	-	12	12	-	-	1.80E-01	5.63E-04
SignaLink	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	7.68E-04	9.01E-04
SignaLink	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	1.06E-03	1.69E-03
SignaLink	MF	GO:0035613	RNA stem-loop binding	-	21	16	-	-	1.11E-03	7.32E-04
SignaLink	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	237	-	-	3.95E-03	1.07E-02
SignaLink	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	7.89E-04	9.01E-04
SignaLink	MF	GO:0033691	sialic acid binding	-	22	20	-	-	2.41E-03	9.01E-04
SignaLink	MF	GO:0048306	calcium-dependent protein binding	-	61	58	-	-	7.60E-03	2.65E-03
SignaLink	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	29	-	-	1.58E-02	1.35E-03
SignaLink	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	5.85E-02	6.19E-04
SignaLink	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	137	-	-	4.87E-03	6.19E-03
SignaLink	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	59	-	-	5.37E-02	2.70E-03
SignaLink	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	130	-	-	1.44E-02	5.86E-03
SignaLink	MF	GO:0045504	dynein heavy chain binding	-	16	15	-	-	2.24E-04	6.76E-04
SignaLink	MF	GO:0140457	protein demethylase activity	-	31	29	-	-	5.91E-04	1.35E-03
SignaLink	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	3.06E-03	1.01E-03
SignaLink	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	1.80E-03	6.76E-04
SignaLink	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	1.66E-04	6.76E-04
SignaLink	MF	GO:0061980	regulatory RNA binding	-	52	45	-	-	1.41E-03	2.03E-03
SignaLink	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	3.93E-03	1.46E-03
SignaLink	MF	GO:0000182	rDNA binding	-	11	11	-	-	5.14E-03	5.07E-04
SignaLink	MF	GO:0001671	ATPase activator activity	-	29	28	-	-	1.82E-03	1.30E-03
SignaLink	MF	GO:0070840	dynein complex binding	-	25	24	-	-	2.30E-03	1.13E-03
SignaLink	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	2.81E-04	1.13E-03
SignaLink	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.34E-03	7.32E-04
SignaLink	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	33	-	-	3.16E-03	1.52E-03
SignaLink	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	2.56E-02	8.45E-04
SignaLink	MF	GO:0005178	integrin binding	-	153	151	-	-	3.16E-02	6.81E-03
SignaLink	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	7.86E-04	7.88E-04
SignaLink	MF	GO:0005549	odorant binding	-	128	28	-	-	3.38E-04	1.30E-03
SignaLink	MF	GO:0042043	neurexin family protein binding	-	14	13	-	-	1.70E-03	6.19E-04
SignaLink	MF	GO:0008327	methyl-CpG binding	-	31	27	-	-	1.50E-02	1.24E-03
SignaLink	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	4.94E-03	9.01E-04
SignaLink	MF	GO:0048019	receptor antagonist activity	-	31	23	-	-	5.55E-04	1.07E-03
SignaLink	MF	GO:0005521	lamin binding	-	15	15	-	-	4.31E-03	6.76E-04
SignaLink	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	5.90E-04	7.88E-04
SignaLink	MF	GO:0140318	protein transporter activity	-	40	40	-	-	3.89E-03	1.80E-03
SignaLink	MF	GO:0070628	proteasome binding	-	17	17	-	-	2.78E-03	7.88E-04
SignaLink	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	5.37E-04	5.07E-04
SignaLink	MF	GO:0031432	titin binding	-	13	11	-	-	9.03E-03	5.07E-04
SignaLink	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.61E-04	5.07E-04
SignaLink	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	4.00E-03	1.69E-03
SignaLink	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	2.24E-04	7.88E-04
SignaLink	MF	GO:0002039	p53 binding	-	66	66	-	-	8.41E-04	2.98E-03
SignaLink	MF	GO:0005496	steroid binding	-	110	106	-	-	2.01E-03	4.79E-03
SignaLink	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	1.64E-02	1.24E-03
SignaLink	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.64E-03	5.07E-04
SignaLink	MF	GO:0003684	damaged DNA binding	-	89	85	-	-	3.74E-02	3.83E-03
SignaLink	MF	GO:0000339	RNA cap binding	-	20	20	-	-	2.45E-02	9.01E-04
SignaLink	MF	GO:0016500	protein-hormone receptor activity	-	21	18	-	-	1.08E-03	8.45E-04
SignaLink	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	125	-	-	7.09E-03	5.63E-03
SignaLink	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	2.23E-04	6.76E-04
SignaLink	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	2.60E-02	5.63E-04
SignaLink	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	1.67E-04	5.07E-04
SignaLink	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	3.30E-03	2.70E-03
SignaLink	MF	GO:0050811	GABA receptor binding	-	18	17	-	-	2.11E-03	7.88E-04
SignaLink	MF	GO:0030971	receptor tyrosine kinase binding	-	76	74	-	-	2.53E-03	3.38E-03
SignaLink	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	83	-	-	9.19E-02	3.77E-03
SignaLink	MF	GO:0140030	modification-dependent protein binding	-	179	177	-	-	3.67E-03	8.00E-03
SignaLink	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	2.80E-04	1.13E-03
SignaLink	MF	GO:0009881	photoreceptor activity	-	17	13	-	-	3.00E-03	6.19E-04
SignaLink	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	17	-	-	2.25E-04	7.88E-04
SignaLink	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.09E-03	6.19E-04
SignaLink	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	6.31E-03	7.32E-04
SignaLink	MF	GO:0141047	molecular tag activity	-	13	13	-	-	1.84E-03	6.19E-04
SignaLink	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	5.31E-02	5.07E-04
SignaLink	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	1.66E-04	5.63E-04
SignaLink	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	8.79E-04	6.76E-04
SignaLink	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	2.04E-03	5.63E-04
SignaLink	MF	GO:0044548	S100 protein binding	-	14	14	-	-	7.41E-03	6.76E-04
SignaLink	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	7.17E-03	6.76E-04
SignaLink	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.87E-02	6.76E-04
SignaLink	MF	GO:0030276	clathrin binding	-	70	68	-	-	3.47E-02	3.10E-03
SignaLink	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	2.18E-03	1.35E-03
SignaLink	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	3.10E-04	6.76E-04
SignaLink	MF	GO:0046790	virion binding	-	19	19	-	-	2.10E-04	9.01E-04
SignaLink	MF	GO:0030552	cAMP binding	-	48	46	-	-	9.52E-03	2.08E-03
SignaLink	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	1.86E-03	1.75E-03
SignaLink	MF	GO:0035173	histone kinase activity	-	17	17	-	-	1.06E-03	7.88E-04
SignaLink	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	9.51E-03	1.18E-03
SignaLink	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	3.74E-02	5.63E-04
SignaLink	MF	GO:0004984	olfactory receptor activity	-	429	82	-	-	9.58E-04	3.72E-03
SignaLink	MF	GO:0016209	antioxidant activity	-	92	86	-	-	6.34E-03	3.89E-03
SignaLink	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	2.72E-03	1.35E-03
SignaLink	MF	GO:0044325	transmembrane transporter binding	-	159	150	-	-	8.24E-03	6.76E-03
SignaLink	MF	GO:0048156	tau protein binding	-	43	43	-	-	2.15E-03	1.97E-03
SignaLink	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	4.97E-04	1.63E-03
SignaLink	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	3.29E-03	6.19E-04
SignaLink	MF	GO:0140272	exogenous protein binding	-	79	78	-	-	2.42E-03	3.55E-03
SignaLink	MF	GO:0030145	manganese ion binding	-	65	63	-	-	1.51E-03	2.87E-03
SignaLink	MF	GO:0071814	protein-lipid complex binding	-	52	46	-	-	5.82E-03	2.08E-03
SignaLink	MF	GO:0008066	glutamate receptor activity	-	70	68	-	-	2.34E-02	3.10E-03
SignaLink	MF	GO:0030553	cGMP binding	-	15	14	-	-	2.05E-02	6.76E-04
SignaLink	MF	GO:0017069	snRNA binding	-	54	47	-	-	8.92E-03	2.14E-03
SignaLink	MF	GO:0030215	semaphorin receptor binding	-	23	21	-	-	1.49E-02	9.57E-04
SignaLink	MF	GO:0031996	thioesterase binding	-	11	11	-	-	1.13E-03	5.07E-04
SignaLink	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	8.92E-03	1.41E-03
SignaLink	MF	GO:0019843	rRNA binding	-	69	68	-	-	1.37E-02	3.10E-03
SignaLink	MF	GO:0004713	protein tyrosine kinase activity	-	213	211	-	-	1.30E-02	9.52E-03
SignaLink	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	52	-	-	5.74E-03	2.36E-03
SignaLink	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.20E-03	1.13E-03
SignaLink	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	2.05E-03	9.01E-04
SignaLink	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	27	-	-	2.09E-03	1.24E-03
SignaLink	MF	GO:0016208	AMP binding	-	22	22	-	-	2.08E-02	1.01E-03
SignaLink	MF	GO:0000287	magnesium ion binding	-	225	219	-	-	4.01E-03	9.91E-03
SignaLink	MF	GO:0031490	chromatin DNA binding	-	120	116	-	-	1.23E-03	5.24E-03
SignaLink	MF	GO:0017022	myosin binding	-	73	72	-	-	2.52E-03	3.27E-03
SignaLink	MF	GO:0004896	cytokine receptor activity	-	93	89	-	-	1.34E-02	4.05E-03
SignaLink	MF	GO:0017166	vinculin binding	-	12	12	-	-	1.96E-02	5.63E-04
SignaLink	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	4.24E-04	8.45E-04
SignaLink	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	2.51E-03	5.63E-04
SignaLink	MF	GO:0005539	glycosaminoglycan binding	-	236	220	-	-	1.02E-02	9.91E-03
SignaLink	MF	GO:0140666	annealing activity	-	11	11	-	-	7.05E-04	5.07E-04
SignaLink	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.63E-04	6.76E-04
SignaLink	MF	GO:0010181	FMN binding	-	15	15	-	-	2.21E-04	6.76E-04
SignaLink	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	19	-	-	2.24E-04	9.01E-04
SignaLink	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	23	-	-	2.74E-04	1.07E-03
SignaLink	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	8.69E-04	7.88E-04
SignaLink	MF	GO:0044183	protein folding chaperone	-	67	65	-	-	4.06E-03	2.93E-03
SignaLink	MF	GO:0005132	type I interferon receptor binding	-	17	16	-	-	3.49E-01	7.32E-04
SignaLink	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	7.10E-03	4.90E-03
SignaLink	MF	GO:0003725	double-stranded RNA binding	-	72	68	-	-	5.25E-03	3.10E-03
SignaLink	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	1.51E-01	7.32E-04
SignaLink	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	3.07E-02	2.36E-03
SignaLink	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	7.88E-04	1.58E-03
SignaLink	MF	GO:0004618	phosphoglycerate kinase activity	-	89	88	-	-	5.33E-03	4.00E-03
SignaLink	MF	GO:0042805	actinin binding	-	36	35	-	-	1.15E-03	1.58E-03
SignaLink	MF	GO:0043531	ADP binding	-	38	38	-	-	2.27E-03	1.75E-03
SignaLink	MF	GO:0043394	proteoglycan binding	-	36	35	-	-	2.94E-03	1.58E-03
SignaLink	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	1.14E-02	5.07E-04
SignaLink	MF	GO:0046332	SMAD binding	-	77	77	-	-	5.31E-03	3.49E-03
SignaLink	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	5.08E-03	6.19E-04
SignaLink	MF	GO:0001968	fibronectin binding	-	30	30	-	-	5.98E-03	1.35E-03
SignaLink	MF	GO:0048038	quinone binding	-	16	16	-	-	4.66E-03	7.32E-04
SignaLink	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	120	-	-	2.02E-02	5.41E-03
SignaLink	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	80	-	-	2.22E-03	3.60E-03
SignaLink	MF	GO:0003756	protein disulfide isomerase activity	-	18	17	-	-	2.93E-03	7.88E-04
SignaLink	MF	GO:0051117	ATPase binding	-	85	83	-	-	1.52E-03	3.77E-03
SignaLink	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	46	-	-	1.09E-03	2.08E-03
SignaLink	MF	GO:0051787	misfolded protein binding	-	20	18	-	-	5.40E-03	8.45E-04
SignaLink	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	8.43E-03	5.07E-04
SignaLink	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.23E-04	6.76E-04
SignaLink	MF	GO:0031404	chloride ion binding	-	14	12	-	-	1.68E-04	5.63E-04
SignaLink	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	1.71E-03	2.76E-03
SignaLink	MF	GO:0036002	pre-mRNA binding	-	57	35	-	-	1.35E-03	1.58E-03
SignaLink	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	36	-	-	1.71E-03	1.63E-03
SignaLink	MF	GO:0051540	metal cluster binding	-	71	69	-	-	2.80E-03	3.15E-03
SignaLink	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	3.03E-04	5.07E-04
SignaLink	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	5.34E-03	4.17E-03
SignaLink	MF	GO:0019894	kinesin binding	-	45	44	-	-	6.57E-03	2.03E-03
SignaLink	MF	GO:0042287	MHC protein binding	-	68	57	-	-	5.41E-02	2.59E-03
SignaLink	MF	GO:0019003	GDP binding	-	89	87	-	-	1.87E-02	3.94E-03
SignaLink	MF	GO:0017171	serine hydrolase activity	-	207	186	-	-	1.43E-02	8.39E-03
SignaLink	MF	GO:0097110	scaffold protein binding	-	66	65	-	-	2.82E-03	2.93E-03
SignaLink	MF	GO:0003774	cytoskeletal motor activity	-	117	113	-	-	6.01E-03	5.12E-03
SignaLink	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	29	-	-	1.84E-03	1.35E-03
SignaLink	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	4.54E-03	7.88E-04
SignaLink	MF	GO:0061134	peptidase regulator activity	-	224	201	-	-	4.03E-03	9.07E-03
SignaLink	MF	GO:0008013	beta-catenin binding	-	86	85	-	-	3.28E-03	3.83E-03
SignaLink	MF	GO:0051015	actin filament binding	-	208	205	-	-	2.13E-02	9.23E-03
SignaLink	MF	GO:0019208	phosphatase regulator activity	-	107	102	-	-	8.82E-03	4.62E-03
SignaLink	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	31	-	-	4.60E-03	1.41E-03
SignaLink	MF	GO:0043236	laminin binding	-	29	28	-	-	3.56E-03	1.30E-03
SignaLink	MF	GO:0030507	spectrin binding	-	26	26	-	-	1.09E-02	1.18E-03
SignaLink	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	40	-	-	1.73E-03	1.80E-03
SignaLink	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	113	-	-	2.20E-02	5.12E-03
SignaLink	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	2.79E-03	1.13E-03
SignaLink	MF	GO:0042393	histone binding	-	240	229	-	-	5.97E-03	1.04E-02
SignaLink	MF	GO:0019838	growth factor binding	-	182	179	-	-	9.84E-03	8.11E-03
SignaLink	MF	GO:0000149	SNARE binding	-	107	104	-	-	5.91E-02	4.73E-03
SignaLink	MF	GO:0003727	single-stranded RNA binding	-	90	83	-	-	6.30E-03	3.77E-03
SignaLink	MF	GO:0051378	serotonin binding	-	24	24	-	-	2.76E-04	1.13E-03
SignaLink	MF	GO:0005516	calmodulin binding	-	206	204	-	-	5.84E-03	9.23E-03
SignaLink	MF	GO:0019825	oxygen binding	-	40	37	-	-	4.64E-03	1.69E-03
SignaLink	MF	GO:0045505	dynein intermediate chain binding	-	37	35	-	-	9.97E-03	1.58E-03
SignaLink	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	86	-	-	1.44E-03	3.89E-03
SignaLink	MF	GO:0032182	ubiquitin-like protein binding	-	117	116	-	-	6.48E-03	5.24E-03
SignaLink	MF	GO:0023023	MHC protein complex binding	-	36	36	-	-	4.37E-02	1.63E-03
SignaLink	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	9.40E-04	1.01E-03
SignaLink	MF	GO:0043274	phospholipase binding	-	23	23	-	-	1.13E-03	1.07E-03
SignaLink	MF	GO:0031072	heat shock protein binding	-	128	124	-	-	8.02E-03	5.63E-03
SignaLink	MF	GO:0030515	snoRNA binding	-	33	33	-	-	2.10E-02	1.52E-03
SignaLink	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	68	-	-	2.57E-03	3.10E-03
SignaLink	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	21	-	-	2.81E-04	9.57E-04
SignaLink	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	3.23E-04	1.18E-03
SignaLink	MF	GO:0001530	lipopolysaccharide binding	-	38	31	-	-	2.83E-03	1.41E-03
SignaLink	MF	GO:0140223	general transcription initiation factor activity	-	55	54	-	-	1.18E-01	2.48E-03
SignaLink	MF	GO:0070403	NAD+ binding	-	16	16	-	-	7.52E-04	7.32E-04
SignaLink	MF	GO:0000049	tRNA binding	-	75	72	-	-	6.10E-03	3.27E-03
SignaLink	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	45	-	-	3.41E-03	2.03E-03
SignaLink	MF	GO:0015026	coreceptor activity	-	48	46	-	-	4.64E-03	2.08E-03
SignaLink	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.35E-03	5.63E-04
SignaLink	MF	GO:0001653	peptide receptor activity	-	128	118	-	-	3.14E-03	5.35E-03
SignaLink	MF	GO:0031005	filamin binding	-	15	14	-	-	2.52E-02	6.76E-04
SignaLink	MF	GO:0030506	ankyrin binding	-	19	19	-	-	1.30E-03	9.01E-04
SignaLink	MF	GO:0006469	negative regulation of protein kinase activity	-	222	208	-	-	2.75E-03	9.40E-03
SignaLink	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	4.54E-04	9.01E-04
SignaLink	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	2.50E-03	6.76E-04
SignaLink	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	31	-	-	9.33E-03	1.41E-03
SignaLink	MF	GO:0051427	hormone receptor binding	-	31	30	-	-	3.58E-02	1.35E-03
SignaLink	MF	GO:0070851	growth factor receptor binding	-	141	140	-	-	7.27E-03	6.31E-03
SignaLink	MF	GO:0031210	phosphatidylcholine binding	-	32	32	-	-	6.06E-03	1.46E-03
SignaLink	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	7.66E-03	5.07E-04
SignaLink	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	43	-	-	8.00E-03	1.97E-03
SignaLink	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	1.84E-03	9.01E-04
SignaLink	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	2.22E-04	7.88E-04
SignaLink	MF	GO:0005506	iron ion binding	-	154	144	-	-	3.55E-03	6.53E-03
SignaLink	MF	GO:0003925	G protein activity	-	45	45	-	-	1.14E-02	2.03E-03
SignaLink	MF	GO:0038187	pattern recognition receptor activity	-	33	32	-	-	9.61E-02	1.46E-03
SignaLink	MF	GO:0008276	protein methyltransferase activity	-	96	92	-	-	3.17E-03	4.17E-03
SignaLink	MF	GO:0004396	hexokinase activity	-	16	16	-	-	1.70E-02	7.32E-04
SignaLink	MF	GO:0070888	E-box binding	-	59	59	-	-	5.12E-03	2.70E-03
SignaLink	MF	GO:0039706	co-receptor binding	-	14	14	-	-	3.35E-03	6.76E-04
SignaLink	MF	GO:0015399	primary active transmembrane transporter activity	-	190	187	-	-	1.67E-01	8.45E-03
SignaLink	MF	GO:0035254	glutamate receptor binding	-	47	46	-	-	2.17E-03	2.08E-03
SignaLink	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	9.34E-04	1.52E-03
SignaLink	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	2.74E-03	5.07E-04
SignaLink	MF	GO:0043021	ribonucleoprotein complex binding	-	158	156	-	-	6.44E-03	7.04E-03
SignaLink	MF	GO:0030170	pyridoxal phosphate binding	-	56	54	-	-	3.42E-03	2.48E-03
SignaLink	MF	GO:0032393	MHC class I receptor activity	-	15	13	-	-	2.93E-01	6.19E-04
SignaLink	MF	GO:0005112	Notch binding	-	26	25	-	-	1.35E-02	1.13E-03
SignaLink	MF	GO:0048185	activin binding	-	16	16	-	-	2.90E-02	7.32E-04
SignaLink	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	27	-	-	7.65E-04	1.24E-03
SignaLink	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	2.20E-03	5.07E-04
SignaLink	MF	GO:0140299	small molecule sensor activity	-	39	35	-	-	7.67E-03	1.58E-03
SignaLink	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	1.39E-02	1.01E-03
SignaLink	MF	GO:0016917	GABA receptor activity	-	23	20	-	-	2.80E-04	9.01E-04
SignaLink	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	1.99E-03	6.76E-04
SignaLink	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	24	-	-	2.77E-04	1.13E-03
SignaLink	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	44	-	-	8.87E-03	2.03E-03
SignaLink	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.13E-03	1.13E-03
SignaLink	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	1.81E-03	5.63E-04
SignaLink	MF	GO:0030594	neurotransmitter receptor activity	-	160	153	-	-	1.31E-02	6.93E-03
SignaLink	MF	GO:0034452	dynactin binding	-	12	12	-	-	9.71E-04	5.63E-04
SignaLink	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	23	-	-	3.77E-03	1.07E-03
SignaLink	MF	GO:0120227	acyl-CoA binding	-	22	20	-	-	2.78E-04	9.01E-04
SignaLink	MF	GO:0005507	copper ion binding	-	63	60	-	-	3.59E-03	2.70E-03
SignaLink	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	2.95E-03	1.01E-03
SignaLink	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	1.43E-02	1.01E-03
SignaLink	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	11	-	-	2.37E-02	5.07E-04
SIGNOR	CC	GO:0005615	extracellular space	1.03E-44	3190	1183	855	1.38	-	-
SIGNOR	CC	GO:0005815	microtubule organizing center	1.60E-21	843	351	226	1.55	-	-
SIGNOR	CC	GO:0005768	endosome	1.96E-17	1037	400	278	1.44	-	-
SIGNOR	CC	GO:0005794	Golgi apparatus	8.78E-12	1636	558	438	1.27	-	-
SIGNOR	CC	GO:0005730	nucleolus	2.03E-09	988	348	265	1.31	-	-
SIGNOR	CC	GO:0005840	ribosome	8.52E-07	222	29	59	0.49	-	-
SIGNOR	CC	GO:0005635	nuclear envelope	1.92E-06	493	180	132	1.36	-	-
SIGNOR	CC	GO:0005783	endoplasmic reticulum	1.12E-05	2020	625	541	1.15	-	-
SIGNOR	CC	GO:0031012	extracellular matrix	2.53E-05	564	196	151	1.30	-	-
SIGNOR	CC	GO:0005764	lysosome	1.03E-04	747	247	200	1.23	-	-
SIGNOR	CC	GO:0000228	nuclear chromosome	1.49E-03	206	76	55	1.38	-	-
SIGNOR	CC	GO:0005739	mitochondrion	1.83E-01	1671	471	448	1.05	-	-
SIGNOR	CC	GO:0005777	peroxisome	2.16E-01	142	31	38	0.81	-	-
SIGNOR	CC	GO:0005811	lipid droplet	2.17E-01	102	33	27	1.21	-	-
SIGNOR	CC	GO:0005929	cilium	2.83E-01	842	239	226	1.06	-	-
SIGNOR	BP	GO:0012501	programmed cell death	3.39E-243	1954	1182	523	2.26	-	-
SIGNOR	BP	GO:0002376	immune system process	2.80E-163	2448	1242	656	1.89	-	-
SIGNOR	BP	GO:0006355	regulation of DNA-templated transcription	4.38E-157	3342	1541	895	1.72	-	-
SIGNOR	BP	GO:0048870	cell motility	2.03E-130	1659	889	444	2.00	-	-
SIGNOR	BP	GO:0007155	cell adhesion	2.61E-93	1444	738	387	1.91	-	-
SIGNOR	BP	GO:0006954	inflammatory response	7.89E-93	820	492	220	2.24	-	-
SIGNOR	BP	GO:0034330	cell junction organization	1.30E-61	727	402	195	2.06	-	-
SIGNOR	BP	GO:0030163	protein catabolic process	5.92E-53	990	485	265	1.83	-	-
SIGNOR	BP	GO:0003013	circulatory system process	4.46E-51	584	326	156	2.08	-	-
SIGNOR	BP	GO:0042060	wound healing	1.65E-50	431	262	115	2.27	-	-
SIGNOR	BP	GO:0007010	cytoskeleton organization	1.77E-47	1639	698	439	1.59	-	-
SIGNOR	BP	GO:0098542	defense response to other organism	8.74E-46	1171	533	314	1.70	-	-
SIGNOR	BP	GO:0006914	autophagy	5.16E-43	568	305	152	2.00	-	-
SIGNOR	BP	GO:0065003	protein-containing complex assembly	3.11E-37	1648	669	442	1.52	-	-
SIGNOR	BP	GO:0003012	muscle system process	7.46E-35	425	233	114	2.05	-	-
SIGNOR	BP	GO:0006325	chromatin organization	2.01E-32	720	339	193	1.76	-	-
SIGNOR	BP	GO:0006281	DNA repair	4.52E-26	587	275	157	1.75	-	-
SIGNOR	BP	GO:0016192	vesicle-mediated transport	4.61E-24	1894	698	507	1.38	-	-
SIGNOR	BP	GO:0007163	establishment or maintenance of cell polarity	2.88E-22	227	130	61	2.14	-	-
SIGNOR	BP	GO:0006913	nucleocytoplasmic transport	3.98E-22	326	169	87	1.93	-	-
SIGNOR	BP	GO:0007059	chromosome segregation	6.62E-18	403	188	108	1.74	-	-
SIGNOR	BP	GO:0000910	cytokinesis	1.81E-13	186	97	50	1.95	-	-
SIGNOR	BP	GO:0072659	protein localization to plasma membrane	3.35E-13	284	133	76	1.75	-	-
SIGNOR	BP	GO:0006886	intracellular protein transport	9.21E-13	664	261	178	1.47	-	-
SIGNOR	BP	GO:0006260	DNA replication	2.63E-12	279	129	75	1.73	-	-
SIGNOR	BP	GO:0003014	renal system process	1.39E-11	127	70	34	2.06	-	-
SIGNOR	BP	GO:0022600	digestive system process	1.53E-11	110	63	29	2.14	-	-
SIGNOR	BP	GO:0006310	DNA recombination	7.51E-11	333	144	89	1.61	-	-
SIGNOR	BP	GO:0032200	telomere organization	1.85E-09	186	88	50	1.77	-	-
SIGNOR	BP	GO:0007005	mitochondrion organization	3.28E-09	484	189	130	1.46	-	-
SIGNOR	BP	GO:0005975	carbohydrate metabolic process	6.99E-09	551	209	148	1.42	-	-
SIGNOR	BP	GO:0006091	generation of precursor metabolites and energy	4.01E-08	502	190	134	1.41	-	-
SIGNOR	BP	GO:0030198	extracellular matrix organization	4.47E-07	314	125	84	1.49	-	-
SIGNOR	BP	GO:0055085	transmembrane transport	8.51E-07	1784	567	478	1.19	-	-
SIGNOR	BP	GO:0006486	protein glycosylation	1.45E-06	225	30	60	0.50	-	-
SIGNOR	BP	GO:0042254	ribosome biogenesis	4.47E-06	297	46	80	0.58	-	-
SIGNOR	BP	GO:0140013	meiotic nuclear division	1.19E-05	279	108	75	1.44	-	-
SIGNOR	BP	GO:0140053	mitochondrial gene expression	1.79E-05	164	21	44	0.48	-	-
SIGNOR	BP	GO:0098754	detoxification	3.76E-04	134	55	36	1.53	-	-
SIGNOR	BP	GO:0016071	mRNA metabolic process	7.59E-04	713	231	191	1.21	-	-
SIGNOR	BP	GO:0006629	lipid metabolic process	1.44E-03	1355	414	363	1.14	-	-
SIGNOR	BP	GO:0006790	sulfur compound metabolic process	2.20E-03	320	62	86	0.72	-	-
SIGNOR	BP	GO:0050877	nervous system process	2.56E-03	1527	460	409	1.12	-	-
SIGNOR	BP	GO:0006399	tRNA metabolic process	1.18E-02	196	37	53	0.70	-	-
SIGNOR	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.64E-02	119	44	32	1.38	-	-
SIGNOR	BP	GO:0044782	cilium organization	2.23E-02	399	87	107	0.81	-	-
SIGNOR	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.38E-02	729	222	195	1.14	-	-
SIGNOR	BP	GO:0006766	vitamin metabolic process	1.25E-01	107	36	29	1.26	-	-
SIGNOR	BP	GO:0006457	protein folding	1.83E-01	210	65	56	1.16	-	-
SIGNOR	BP	GO:0006575	cellular modified amino acid metabolic process	2.12E-01	186	42	50	0.84	-	-
SIGNOR	BP	GO:0002181	cytoplasmic translation	2.72E-01	153	47	41	1.15	-	-
SIGNOR	BP	GO:0007040	lysosome organization	5.86E-01	107	31	29	1.08	-	-
SIGNOR	BP	GO:0006520	amino acid metabolic process	6.41E-01	292	82	78	1.05	-	-
SIGNOR	BP	GO:0007018	microtubule-based movement	8.56E-01	640	169	171	0.99	-	-
SIGNOR	MF	GO:0140096	"catalytic activity, acting on a protein"	3.86E-197	3198	1572	857	1.83	-	-
SIGNOR	MF	GO:0016740	transferase activity	3.85E-132	3074	1396	824	1.70	-	-
SIGNOR	MF	GO:0140110	transcription regulator activity	1.18E-118	2033	1005	545	1.85	-	-
SIGNOR	MF	GO:0003677	DNA binding	3.02E-100	2865	1250	768	1.63	-	-
SIGNOR	MF	GO:0048018	receptor ligand activity	2.98E-42	504	278	135	2.06	-	-
SIGNOR	MF	GO:0009975	cyclase activity	1.60E-41	277	181	74	2.44	-	-
SIGNOR	MF	GO:0008092	cytoskeletal protein binding	3.29E-36	1023	456	274	1.66	-	-
SIGNOR	MF	GO:0016829	lyase activity	1.85E-34	538	276	144	1.91	-	-
SIGNOR	MF	GO:0003924	GTPase activity	2.42E-23	658	293	176	1.66	-	-
SIGNOR	MF	GO:0140097	"catalytic activity, acting on DNA"	2.39E-20	383	187	103	1.82	-	-
SIGNOR	MF	GO:0008289	lipid binding	4.70E-13	836	318	224	1.42	-	-
SIGNOR	MF	GO:0016874	ligase activity	6.04E-09	283	121	76	1.60	-	-
SIGNOR	MF	GO:0140657	ATP-dependent activity	2.87E-07	729	257	195	1.32	-	-
SIGNOR	MF	GO:0042393	histone binding	1.27E-06	237	98	63	1.54	-	-
SIGNOR	MF	GO:0045182	translation regulator activity	1.77E-06	151	68	40	1.68	-	-
SIGNOR	MF	GO:0016853	isomerase activity	1.52E-05	252	99	68	1.47	-	-
SIGNOR	MF	GO:0003723	RNA binding	1.34E-03	1679	506	450	1.12	-	-
SIGNOR	MF	GO:0016491	oxidoreductase activity	7.36E-03	888	273	238	1.15	-	-
SIGNOR	MF	GO:0005198	structural molecule activity	1.00E-02	798	246	214	1.15	-	-
SIGNOR	MF	GO:0140104	molecular carrier activity	1.09E-02	105	40	28	1.42	-	-
SIGNOR	MF	GO:0038024	cargo receptor activity	1.15E-02	117	44	31	1.40	-	-
SIGNOR	MF	GO:0005215	transporter activity	1.51E-02	1462	352	392	0.90	-	-
SIGNOR	MF	GO:0140098	"catalytic activity, acting on RNA"	1.61E-02	417	90	112	0.81	-	-
SIGNOR	MF	GO:0003774	cytoskeletal motor activity	1.71E-01	116	38	31	1.22	-	-
SIGNOR	BP	GO:0008038	neuron recognition	-	46	27	-	-	4.36E-03	4.33E-03
SIGNOR	BP	GO:1905145	cellular response to acetylcholine	-	33	23	-	-	1.66E-02	3.74E-03
SIGNOR	BP	GO:0097094	craniofacial suture morphogenesis	-	18	12	-	-	1.96E-02	1.97E-03
SIGNOR	BP	GO:0098780	response to mitochondrial depolarisation	-	21	15	-	-	2.37E-02	2.36E-03
SIGNOR	BP	GO:0051931	regulation of sensory perception	-	36	23	-	-	3.13E-03	3.74E-03
SIGNOR	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	24	-	-	2.58E-03	3.94E-03
SIGNOR	BP	GO:0009268	response to pH	-	43	16	-	-	7.68E-04	2.56E-03
SIGNOR	BP	GO:0045666	positive regulation of neuron differentiation	-	91	52	-	-	4.37E-03	8.27E-03
SIGNOR	BP	GO:0043543	protein acylation	-	107	40	-	-	6.04E-03	6.30E-03
SIGNOR	MF	GO:0051349	positive regulation of lyase activity	-	41	27	-	-	3.58E-03	4.33E-03
SIGNOR	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	13	-	-	5.41E-02	2.17E-03
SIGNOR	BP	GO:0048679	regulation of axon regeneration	-	28	15	-	-	3.59E-03	2.36E-03
SIGNOR	BP	GO:0022401	negative adaptation of signaling pathway	-	21	14	-	-	5.88E-04	2.36E-03
SIGNOR	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	28	-	-	4.98E-03	4.53E-03
SIGNOR	BP	GO:0071763	nuclear membrane organization	-	44	24	-	-	7.96E-03	3.94E-03
SIGNOR	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	16	-	-	7.13E-03	2.56E-03
SIGNOR	BP	GO:0071806	protein transmembrane transport	-	68	20	-	-	1.93E-02	3.15E-03
SIGNOR	BP	GO:0022038	corpus callosum development	-	25	12	-	-	5.84E-04	1.97E-03
SIGNOR	BP	GO:0043299	leukocyte degranulation	-	82	53	-	-	1.04E-02	8.47E-03
SIGNOR	BP	GO:0048864	stem cell development	-	88	59	-	-	8.63E-03	9.46E-03
SIGNOR	BP	GO:0051651	maintenance of location in cell	-	236	125	-	-	9.70E-03	1.97E-02
SIGNOR	BP	GO:0033119	negative regulation of RNA splicing	-	27	12	-	-	5.89E-04	1.97E-03
SIGNOR	CC	GO:0016197	endosomal transport	-	282	82	-	-	2.02E-02	1.30E-02
SIGNOR	BP	GO:0070663	regulation of leukocyte proliferation	-	268	182	-	-	1.80E-02	2.88E-02
SIGNOR	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	24	-	-	1.10E-02	3.94E-03
SIGNOR	BP	GO:0006949	syncytium formation	-	66	28	-	-	5.00E-03	4.53E-03
SIGNOR	BP	GO:0045861	negative regulation of proteolysis	-	320	136	-	-	8.92E-03	2.15E-02
SIGNOR	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	15	-	-	7.86E-04	2.36E-03
SIGNOR	BP	GO:0030574	collagen catabolic process	-	45	12	-	-	5.86E-04	1.97E-03
SIGNOR	CC	GO:0006984	ER-nucleus signaling pathway	-	46	30	-	-	4.98E-03	4.73E-03
SIGNOR	BP	GO:0060343	trabecula formation	-	26	16	-	-	7.82E-04	2.56E-03
SIGNOR	BP	GO:0009914	hormone transport	-	315	187	-	-	2.10E-02	2.96E-02
SIGNOR	BP	GO:0085029	extracellular matrix assembly	-	42	21	-	-	4.67E-02	3.35E-03
SIGNOR	BP	GO:0006413	translational initiation	-	122	63	-	-	6.37E-02	1.00E-02
SIGNOR	BP	GO:0072176	nephric duct development	-	15	13	-	-	5.87E-04	2.17E-03
SIGNOR	BP	GO:1902895	positive regulation of miRNA transcription	-	51	48	-	-	5.85E-03	7.68E-03
SIGNOR	CC	GO:0005200	structural constituent of cytoskeleton	-	112	58	-	-	5.80E-03	9.26E-03
SIGNOR	BP	GO:0030865	cortical cytoskeleton organization	-	51	33	-	-	4.02E-03	5.32E-03
SIGNOR	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	15	-	-	5.27E-03	2.36E-03
SIGNOR	BP	GO:1903036	positive regulation of response to wounding	-	76	46	-	-	7.21E-03	7.29E-03
SIGNOR	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	59	-	-	8.44E-03	9.46E-03
SIGNOR	BP	GO:1903319	positive regulation of protein maturation	-	27	14	-	-	1.74E-02	2.36E-03
SIGNOR	BP	GO:0032528	microvillus organization	-	24	14	-	-	1.96E-02	2.36E-03
SIGNOR	BP	GO:0002263	cell activation involved in immune response	-	304	189	-	-	1.86E-02	2.99E-02
SIGNOR	BP	GO:0021954	central nervous system neuron development	-	85	49	-	-	4.96E-03	7.88E-03
SIGNOR	BP	GO:0055017	cardiac muscle tissue growth	-	92	54	-	-	1.48E-02	8.67E-03
SIGNOR	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	20	-	-	5.70E-03	3.15E-03
SIGNOR	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	12	-	-	5.82E-04	1.97E-03
SIGNOR	BP	GO:0048524	positive regulation of viral process	-	64	40	-	-	5.78E-03	6.30E-03
SIGNOR	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	20	-	-	1.95E-02	3.15E-03
SIGNOR	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	18	-	-	4.26E-03	2.96E-03
SIGNOR	BP	GO:0001946	lymphangiogenesis	-	18	13	-	-	1.40E-02	2.17E-03
SIGNOR	BP	GO:0098661	inorganic anion transmembrane transport	-	140	28	-	-	1.18E-03	4.53E-03
SIGNOR	BP	GO:0006099	tricarboxylic acid cycle	-	33	13	-	-	5.05E-02	2.17E-03
SIGNOR	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	11	-	-	3.06E-03	1.77E-03
SIGNOR	BP	GO:0009612	response to mechanical stimulus	-	215	147	-	-	1.03E-02	2.32E-02
SIGNOR	BP	GO:0048644	muscle organ morphogenesis	-	81	58	-	-	1.06E-02	9.26E-03
SIGNOR	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	114	-	-	8.66E-03	1.81E-02
SIGNOR	BP	GO:0071542	dopaminergic neuron differentiation	-	36	25	-	-	7.29E-03	3.94E-03
SIGNOR	BP	GO:0140115	export across plasma membrane	-	82	20	-	-	9.76E-04	3.15E-03
SIGNOR	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	16	-	-	4.92E-03	2.56E-03
SIGNOR	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	12	-	-	1.51E-01	1.97E-03
SIGNOR	MF	GO:0003714	transcription corepressor activity	-	190	114	-	-	2.78E-02	1.81E-02
SIGNOR	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	41	-	-	3.39E-02	6.50E-03
SIGNOR	BP	GO:0061101	neuroendocrine cell differentiation	-	16	12	-	-	5.81E-03	1.97E-03
SIGNOR	BP	GO:0006304	DNA modification	-	30	11	-	-	5.89E-04	1.77E-03
SIGNOR	BP	GO:0046835	carbohydrate phosphorylation	-	49	23	-	-	2.65E-03	3.74E-03
SIGNOR	CC	GO:1905349	ciliary transition zone assembly	-	371	82	-	-	2.25E-02	1.30E-02
SIGNOR	BP	GO:0003207	cardiac chamber formation	-	14	11	-	-	2.62E-03	1.77E-03
SIGNOR	BP	GO:0043523	regulation of neuron apoptotic process	-	218	157	-	-	1.41E-02	2.48E-02
SIGNOR	BP	GO:1902894	negative regulation of miRNA transcription	-	22	20	-	-	4.10E-03	3.15E-03
SIGNOR	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	11	-	-	5.90E-04	1.77E-03
SIGNOR	BP	GO:0044380	protein localization to cytoskeleton	-	57	36	-	-	5.01E-03	5.71E-03
SIGNOR	BP	GO:2000209	regulation of anoikis	-	25	21	-	-	4.96E-03	3.35E-03
SIGNOR	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	19	-	-	7.67E-04	3.15E-03
SIGNOR	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	29	-	-	1.80E-02	4.73E-03
SIGNOR	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	39	-	-	5.38E-03	6.30E-03
SIGNOR	BP	GO:0003188	heart valve formation	-	16	13	-	-	5.68E-04	2.17E-03
SIGNOR	BP	GO:0043954	cellular component maintenance	-	72	39	-	-	8.94E-03	6.30E-03
SIGNOR	BP	GO:0050435	amyloid-beta metabolic process	-	65	37	-	-	9.86E-02	5.91E-03
SIGNOR	BP	GO:0014823	response to activity	-	70	47	-	-	3.89E-03	7.49E-03
SIGNOR	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	13	-	-	4.72E-03	2.17E-03
SIGNOR	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	12	-	-	2.75E-01	1.97E-03
SIGNOR	BP	GO:0034502	protein localization to chromosome	-	130	60	-	-	9.50E-03	9.46E-03
SIGNOR	BP	GO:0048562	embryonic organ morphogenesis	-	295	170	-	-	1.38E-02	2.68E-02
SIGNOR	BP	GO:0060457	negative regulation of digestive system process	-	17	12	-	-	1.28E-02	1.97E-03
SIGNOR	BP	GO:0019233	sensory perception of pain	-	103	67	-	-	6.82E-03	1.06E-02
SIGNOR	BP	GO:0031343	positive regulation of cell killing	-	75	38	-	-	9.70E-02	6.11E-03
SIGNOR	BP	GO:0090077	foam cell differentiation	-	39	23	-	-	4.48E-03	3.74E-03
SIGNOR	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	52	-	-	1.37E-02	8.27E-03
SIGNOR	BP	GO:0017148	negative regulation of translation	-	390	58	-	-	1.00E-02	9.26E-03
SIGNOR	BP	GO:0030220	platelet formation	-	22	16	-	-	7.27E-03	2.56E-03
SIGNOR	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	46	-	-	6.74E-03	7.29E-03
SIGNOR	BP	GO:1903509	liposaccharide metabolic process	-	109	16	-	-	7.85E-03	2.56E-03
SIGNOR	BP	GO:0009582	detection of abiotic stimulus	-	140	51	-	-	4.15E-03	8.08E-03
SIGNOR	CC	GO:0140238	presynaptic endocytosis	-	72	44	-	-	2.07E-02	7.09E-03
SIGNOR	BP	GO:0051236	establishment of RNA localization	-	161	60	-	-	1.62E-02	9.46E-03
SIGNOR	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	135	-	-	3.86E-02	2.13E-02
SIGNOR	BP	GO:0061842	microtubule organizing center localization	-	32	19	-	-	6.20E-03	3.15E-03
SIGNOR	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	13	-	-	1.38E-02	2.17E-03
SIGNOR	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	11	-	-	5.90E-04	1.77E-03
SIGNOR	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	30	-	-	1.38E-02	4.73E-03
SIGNOR	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	41	-	-	4.25E-03	6.50E-03
SIGNOR	BP	GO:0050779	RNA destabilization	-	135	39	-	-	1.80E-02	6.30E-03
SIGNOR	BP	GO:0006023	aminoglycan biosynthetic process	-	74	14	-	-	1.92E-03	2.36E-03
SIGNOR	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	17	-	-	7.86E-04	2.76E-03
SIGNOR	BP	GO:0061025	membrane fusion	-	532	218	-	-	3.76E-02	3.45E-02
SIGNOR	BP	GO:0010762	regulation of fibroblast migration	-	40	30	-	-	1.05E-02	4.73E-03
SIGNOR	BP	GO:0090311	regulation of protein deacetylation	-	29	15	-	-	6.42E-03	2.36E-03
SIGNOR	BP	GO:0035272	exocrine system development	-	46	33	-	-	6.80E-03	5.32E-03
SIGNOR	BP	GO:0022406	membrane docking	-	90	33	-	-	8.73E-03	5.32E-03
SIGNOR	BP	GO:0050777	negative regulation of immune response	-	196	115	-	-	7.93E-03	1.81E-02
SIGNOR	BP	GO:0016053	organic acid biosynthetic process	-	335	99	-	-	2.75E-02	1.58E-02
SIGNOR	MF	GO:0005035	death receptor activity	-	16	13	-	-	6.05E-02	2.17E-03
SIGNOR	BP	GO:0002063	chondrocyte development	-	33	16	-	-	2.03E-03	2.56E-03
SIGNOR	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	11	-	-	5.79E-04	1.77E-03
SIGNOR	BP	GO:0099068	postsynapse assembly	-	40	29	-	-	6.00E-02	4.73E-03
SIGNOR	BP	GO:0021782	glial cell development	-	120	71	-	-	1.30E-02	1.12E-02
SIGNOR	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	44	-	-	9.94E-03	7.09E-03
SIGNOR	BP	GO:0001655	urogenital system development	-	66	54	-	-	5.38E-03	8.67E-03
SIGNOR	BP	GO:0071827	plasma lipoprotein particle organization	-	86	33	-	-	5.93E-02	5.32E-03
SIGNOR	BP	GO:0045494	photoreceptor cell maintenance	-	43	11	-	-	5.89E-04	1.77E-03
SIGNOR	BP	GO:0055088	lipid homeostasis	-	173	64	-	-	7.76E-02	1.02E-02
SIGNOR	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	18	-	-	2.07E-02	2.96E-03
SIGNOR	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	131	-	-	8.10E-03	2.07E-02
SIGNOR	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	22	-	-	4.30E-03	3.55E-03
SIGNOR	BP	GO:0045667	regulation of osteoblast differentiation	-	147	85	-	-	1.91E-02	1.34E-02
SIGNOR	BP	GO:0061037	negative regulation of cartilage development	-	32	19	-	-	2.33E-03	3.15E-03
SIGNOR	BP	GO:0045738	negative regulation of DNA repair	-	40	18	-	-	2.90E-03	2.96E-03
SIGNOR	BP	GO:0001704	formation of primary germ layer	-	195	124	-	-	1.27E-02	1.97E-02
SIGNOR	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	5.43E-03	2.17E-03
SIGNOR	BP	GO:0045778	positive regulation of ossification	-	51	32	-	-	6.08E-03	5.12E-03
SIGNOR	BP	GO:0048708	astrocyte differentiation	-	88	64	-	-	9.68E-03	1.02E-02
SIGNOR	BP	GO:0042092	type 2 immune response	-	41	35	-	-	5.94E-03	5.52E-03
SIGNOR	BP	GO:0048588	developmental cell growth	-	233	131	-	-	1.22E-02	2.07E-02
SIGNOR	BP	GO:0021872	forebrain generation of neurons	-	52	31	-	-	2.61E-03	4.93E-03
SIGNOR	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	13	-	-	2.71E-03	2.17E-03
SIGNOR	BP	GO:0045023	G0 to G1 transition	-	41	24	-	-	1.24E-01	3.94E-03
SIGNOR	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	40	-	-	3.64E-02	6.30E-03
SIGNOR	BP	GO:0034367	protein-containing complex remodeling	-	35	14	-	-	2.05E-01	2.36E-03
SIGNOR	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	20	-	-	9.72E-04	3.15E-03
SIGNOR	BP	GO:0010232	vascular transport	-	87	30	-	-	1.36E-03	4.73E-03
SIGNOR	BP	GO:0021987	cerebral cortex development	-	125	81	-	-	5.09E-03	1.28E-02
SIGNOR	BP	GO:0008637	apoptotic mitochondrial changes	-	108	68	-	-	2.51E-02	1.08E-02
SIGNOR	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	27	-	-	3.63E-03	4.33E-03
SIGNOR	BP	GO:0060999	positive regulation of dendritic spine development	-	35	26	-	-	1.16E-03	4.14E-03
SIGNOR	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	11	-	-	5.86E-04	1.77E-03
SIGNOR	BP	GO:2000736	regulation of stem cell differentiation	-	78	50	-	-	5.63E-03	7.88E-03
SIGNOR	BP	GO:0060973	cell migration involved in heart development	-	21	13	-	-	2.82E-03	2.17E-03
SIGNOR	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	11	-	-	1.01E-02	1.77E-03
SIGNOR	BP	GO:0002064	epithelial cell development	-	210	130	-	-	9.60E-03	2.05E-02
SIGNOR	BP	GO:0071318	cellular response to ATP	-	18	12	-	-	5.88E-04	1.97E-03
SIGNOR	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	17	-	-	7.75E-04	2.76E-03
SIGNOR	BP	GO:2001222	regulation of neuron migration	-	46	27	-	-	1.58E-03	4.33E-03
SIGNOR	BP	GO:0034389	lipid droplet organization	-	38	12	-	-	5.83E-04	1.97E-03
SIGNOR	BP	GO:0051602	response to electrical stimulus	-	44	32	-	-	2.31E-03	5.12E-03
SIGNOR	BP	GO:0042177	negative regulation of protein catabolic process	-	109	58	-	-	2.84E-03	9.26E-03
SIGNOR	MF	GO:0038024	cargo receptor activity	-	121	44	-	-	6.83E-03	7.09E-03
SIGNOR	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	12	-	-	4.69E-03	1.97E-03
SIGNOR	BP	GO:0033120	positive regulation of RNA splicing	-	46	18	-	-	7.80E-04	2.96E-03
SIGNOR	BP	GO:0051445	regulation of meiotic cell cycle	-	64	32	-	-	1.20E-02	5.12E-03
SIGNOR	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	5.83E-04	1.97E-03
SIGNOR	BP	GO:0033619	membrane protein proteolysis	-	60	36	-	-	6.67E-02	5.71E-03
SIGNOR	BP	GO:0038065	collagen-activated signaling pathway	-	15	11	-	-	4.05E-02	1.77E-03
SIGNOR	BP	GO:0090087	regulation of peptide transport	-	195	117	-	-	1.62E-02	1.85E-02
SIGNOR	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	65	-	-	1.61E-02	1.02E-02
SIGNOR	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	16	-	-	7.76E-04	2.56E-03
SIGNOR	BP	GO:0006929	substrate-dependent cell migration	-	26	19	-	-	7.75E-04	3.15E-03
SIGNOR	BP	GO:0022404	molting cycle process	-	95	62	-	-	1.34E-02	9.85E-03
SIGNOR	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	15	-	-	6.53E-03	2.36E-03
SIGNOR	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	12	-	-	1.19E-02	1.97E-03
SIGNOR	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	17	-	-	7.79E-04	2.76E-03
SIGNOR	BP	GO:0007281	germ cell development	-	334	111	-	-	5.83E-03	1.75E-02
SIGNOR	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	106	-	-	9.57E-03	1.67E-02
SIGNOR	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	22	-	-	4.29E-03	3.55E-03
SIGNOR	BP	GO:0034104	negative regulation of tissue remodeling	-	22	14	-	-	5.84E-04	2.36E-03
SIGNOR	CC	GO:0098926	postsynaptic signal transduction	-	39	26	-	-	1.07E-02	4.14E-03
SIGNOR	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	96	-	-	8.51E-03	1.52E-02
SIGNOR	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	32	-	-	3.01E-03	5.12E-03
SIGNOR	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	76	-	-	7.29E-03	1.20E-02
SIGNOR	BP	GO:0034249	negative regulation of amide metabolic process	-	34	13	-	-	1.66E-02	2.17E-03
SIGNOR	BP	GO:0061548	ganglion development	-	17	14	-	-	9.95E-03	2.36E-03
SIGNOR	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	66	-	-	3.50E-03	1.04E-02
SIGNOR	BP	GO:0042832	defense response to protozoan	-	28	11	-	-	5.84E-04	1.77E-03
SIGNOR	BP	GO:0048799	animal organ maturation	-	33	17	-	-	7.71E-04	2.76E-03
SIGNOR	BP	GO:0006925	inflammatory cell apoptotic process	-	23	15	-	-	7.70E-04	2.36E-03
SIGNOR	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	119	-	-	9.93E-03	1.89E-02
SIGNOR	BP	GO:1903035	negative regulation of response to wounding	-	93	56	-	-	3.37E-02	8.87E-03
SIGNOR	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	21	-	-	3.83E-03	3.35E-03
SIGNOR	BP	GO:0036010	protein localization to endosome	-	27	13	-	-	5.87E-04	2.17E-03
SIGNOR	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	54	-	-	1.61E-02	8.67E-03
SIGNOR	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	59	-	-	1.96E-02	9.46E-03
SIGNOR	BP	GO:0009267	cellular response to starvation	-	170	108	-	-	1.38E-02	1.71E-02
SIGNOR	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	39	-	-	5.69E-03	6.30E-03
SIGNOR	CC	GO:0140239	postsynaptic endocytosis	-	23	12	-	-	5.87E-04	1.97E-03
SIGNOR	CC	GO:0032008	positive regulation of TOR signaling	-	52	27	-	-	2.91E-02	4.33E-03
SIGNOR	BP	GO:0060428	lung epithelium development	-	43	32	-	-	2.40E-03	5.12E-03
SIGNOR	BP	GO:0030431	sleep	-	30	22	-	-	9.76E-04	3.55E-03
SIGNOR	BP	GO:1903318	negative regulation of protein maturation	-	29	14	-	-	5.88E-04	2.36E-03
SIGNOR	BP	GO:0071732	cellular response to nitric oxide	-	17	12	-	-	2.90E-03	1.97E-03
SIGNOR	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	55	-	-	4.69E-03	8.67E-03
SIGNOR	BP	GO:0065004	protein-DNA complex assembly	-	307	119	-	-	1.42E-02	1.89E-02
SIGNOR	CC	GO:0006406	mRNA export from nucleus	-	69	23	-	-	5.76E-02	3.74E-03
SIGNOR	BP	GO:0009880	embryonic pattern specification	-	70	41	-	-	7.73E-03	6.50E-03
SIGNOR	BP	GO:0002367	cytokine production involved in immune response	-	121	92	-	-	1.51E-02	1.46E-02
SIGNOR	BP	GO:0044848	biological phase	-	211	104	-	-	2.47E-02	1.65E-02
SIGNOR	BP	GO:0046660	female sex differentiation	-	125	86	-	-	9.36E-03	1.36E-02
SIGNOR	BP	GO:0019693	ribose phosphate metabolic process	-	556	182	-	-	2.54E-02	2.88E-02
SIGNOR	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	12	-	-	5.83E-04	1.97E-03
SIGNOR	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	25	-	-	2.45E-03	3.94E-03
SIGNOR	BP	GO:0060411	cardiac septum morphogenesis	-	72	60	-	-	9.65E-03	9.46E-03
SIGNOR	BP	GO:0071248	cellular response to metal ion	-	201	108	-	-	8.29E-03	1.71E-02
SIGNOR	BP	GO:0030308	negative regulation of cell growth	-	191	110	-	-	7.06E-03	1.73E-02
SIGNOR	BP	GO:0097306	cellular response to alcohol	-	99	71	-	-	5.47E-03	1.12E-02
SIGNOR	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	41	-	-	5.52E-02	6.50E-03
SIGNOR	BP	GO:0010453	regulation of cell fate commitment	-	40	22	-	-	2.38E-02	3.55E-03
SIGNOR	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	36	-	-	1.06E-02	5.71E-03
SIGNOR	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	201	-	-	7.88E-02	3.17E-02
SIGNOR	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	12	-	-	5.90E-04	1.97E-03
SIGNOR	BP	GO:0002026	regulation of the force of heart contraction	-	26	15	-	-	7.80E-04	2.36E-03
SIGNOR	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	18	-	-	3.11E-02	2.96E-03
SIGNOR	BP	GO:0032890	regulation of organic acid transport	-	78	45	-	-	4.50E-03	7.09E-03
SIGNOR	BP	GO:0071498	cellular response to fluid shear stress	-	21	17	-	-	5.51E-03	2.76E-03
SIGNOR	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	63	-	-	4.71E-03	1.00E-02
SIGNOR	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	22	-	-	8.63E-03	3.55E-03
SIGNOR	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	32	-	-	2.99E-03	5.12E-03
SIGNOR	BP	GO:0051259	protein complex oligomerization	-	251	100	-	-	5.00E-03	1.58E-02
SIGNOR	BP	GO:0098743	cell aggregation	-	24	18	-	-	4.36E-03	2.96E-03
SIGNOR	BP	GO:0009994	oocyte differentiation	-	57	27	-	-	5.25E-03	4.33E-03
SIGNOR	MF	GO:0031952	regulation of protein autophosphorylation	-	43	25	-	-	4.40E-03	3.94E-03
SIGNOR	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	74	-	-	4.43E-03	1.18E-02
SIGNOR	BP	GO:0044319	"wound healing, spreading of cells"	-	37	26	-	-	2.43E-03	4.14E-03
SIGNOR	BP	GO:0033688	regulation of osteoblast proliferation	-	31	19	-	-	1.17E-03	3.15E-03
SIGNOR	BP	GO:0060251	regulation of glial cell proliferation	-	39	29	-	-	3.02E-03	4.73E-03
SIGNOR	BP	GO:0072665	protein localization to vacuole	-	84	26	-	-	2.77E-03	4.14E-03
SIGNOR	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	27	-	-	8.90E-03	4.33E-03
SIGNOR	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	16	-	-	2.06E-03	2.56E-03
SIGNOR	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	36	-	-	2.21E-02	5.71E-03
SIGNOR	BP	GO:0042044	fluid transport	-	35	16	-	-	7.55E-03	2.56E-03
SIGNOR	BP	GO:0070633	transepithelial transport	-	35	23	-	-	4.14E-03	3.74E-03
SIGNOR	BP	GO:0045661	regulation of myoblast differentiation	-	74	43	-	-	2.92E-02	6.90E-03
SIGNOR	BP	GO:0030307	positive regulation of cell growth	-	164	95	-	-	5.33E-03	1.50E-02
SIGNOR	BP	GO:0034250	positive regulation of amide metabolic process	-	27	17	-	-	3.15E-03	2.76E-03
SIGNOR	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	212	-	-	1.66E-02	3.35E-02
SIGNOR	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	12	-	-	5.85E-04	1.97E-03
SIGNOR	BP	GO:0014812	muscle cell migration	-	110	67	-	-	6.51E-03	1.06E-02
SIGNOR	BP	GO:0048525	negative regulation of viral process	-	90	44	-	-	7.70E-03	7.09E-03
SIGNOR	BP	GO:0072044	collecting duct development	-	16	13	-	-	1.99E-03	2.17E-03
SIGNOR	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	27	-	-	5.36E-02	4.33E-03
SIGNOR	BP	GO:0030238	male sex determination	-	14	11	-	-	6.54E-03	1.77E-03
SIGNOR	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	70	-	-	1.08E-02	1.10E-02
SIGNOR	BP	GO:0051781	positive regulation of cell division	-	93	65	-	-	7.02E-03	1.02E-02
SIGNOR	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	13	-	-	5.74E-04	2.17E-03
SIGNOR	BP	GO:0002696	positive regulation of leukocyte activation	-	358	244	-	-	2.95E-02	3.86E-02
SIGNOR	BP	GO:0060711	labyrinthine layer development	-	47	29	-	-	3.27E-03	4.73E-03
SIGNOR	BP	GO:0007272	ensheathment of neurons	-	146	67	-	-	4.42E-03	1.06E-02
SIGNOR	CC	GO:0050806	positive regulation of synaptic transmission	-	171	89	-	-	7.76E-03	1.42E-02
SIGNOR	BP	GO:0060021	roof of mouth development	-	91	58	-	-	6.33E-03	9.26E-03
SIGNOR	BP	GO:0034504	protein localization to nucleus	-	312	179	-	-	1.21E-02	2.84E-02
SIGNOR	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	29	-	-	2.57E-02	4.73E-03
SIGNOR	BP	GO:0050819	negative regulation of coagulation	-	54	37	-	-	5.69E-02	5.91E-03
SIGNOR	BP	GO:0031647	regulation of protein stability	-	327	165	-	-	1.11E-02	2.60E-02
SIGNOR	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	22	-	-	4.07E-03	3.55E-03
SIGNOR	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	11	-	-	2.10E-03	1.77E-03
SIGNOR	CC	GO:0050805	negative regulation of synaptic transmission	-	55	34	-	-	9.22E-03	5.52E-03
SIGNOR	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	29	-	-	1.01E-02	4.73E-03
SIGNOR	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	78	-	-	6.42E-02	1.24E-02
SIGNOR	BP	GO:0016054	organic acid catabolic process	-	251	47	-	-	1.11E-02	7.49E-03
SIGNOR	BP	GO:0050890	cognition	-	317	185	-	-	1.48E-02	2.92E-02
SIGNOR	BP	GO:1900048	positive regulation of hemostasis	-	28	18	-	-	3.63E-02	2.96E-03
SIGNOR	BP	GO:0065005	protein-lipid complex assembly	-	29	15	-	-	1.68E-02	2.36E-03
SIGNOR	BP	GO:0008033	tRNA processing	-	136	15	-	-	1.06E-02	2.36E-03
SIGNOR	BP	GO:0046661	male sex differentiation	-	171	111	-	-	1.01E-02	1.75E-02
SIGNOR	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	15	-	-	2.01E-03	2.36E-03
SIGNOR	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	46	-	-	2.68E-03	7.29E-03
SIGNOR	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	11	-	-	7.95E-03	1.77E-03
SIGNOR	BP	GO:1990778	protein localization to cell periphery	-	346	157	-	-	1.17E-02	2.48E-02
SIGNOR	BP	GO:0090713	immunological memory process	-	18	14	-	-	9.71E-02	2.36E-03
SIGNOR	BP	GO:0061326	renal tubule development	-	103	77	-	-	6.68E-03	1.22E-02
SIGNOR	BP	GO:0051258	protein polymerization	-	280	139	-	-	1.29E-02	2.21E-02
SIGNOR	BP	GO:0071985	multivesicular body sorting pathway	-	56	14	-	-	5.88E-04	2.36E-03
SIGNOR	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	12	-	-	1.36E-02	1.97E-03
SIGNOR	BP	GO:0060325	face morphogenesis	-	31	20	-	-	2.80E-03	3.15E-03
SIGNOR	BP	GO:0090559	regulation of membrane permeability	-	72	34	-	-	5.59E-03	5.52E-03
SIGNOR	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	11	-	-	1.45E-02	1.77E-03
SIGNOR	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	18	-	-	4.22E-03	2.96E-03
SIGNOR	BP	GO:0060033	anatomical structure regression	-	16	11	-	-	5.07E-03	1.77E-03
SIGNOR	BP	GO:0046460	neutral lipid biosynthetic process	-	50	18	-	-	1.98E-02	2.96E-03
SIGNOR	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	21	-	-	9.83E-04	3.35E-03
SIGNOR	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	107	-	-	6.67E-03	1.69E-02
SIGNOR	BP	GO:0002251	organ or tissue specific immune response	-	43	21	-	-	2.55E-02	3.35E-03
SIGNOR	CC	GO:0048167	regulation of synaptic plasticity	-	210	109	-	-	8.24E-03	1.73E-02
SIGNOR	BP	GO:1903708	positive regulation of hemopoiesis	-	184	123	-	-	3.32E-02	1.95E-02
SIGNOR	BP	GO:1903008	organelle disassembly	-	154	92	-	-	1.54E-02	1.46E-02
SIGNOR	BP	GO:0001709	cell fate determination	-	44	33	-	-	4.05E-03	5.32E-03
SIGNOR	BP	GO:0045058	T cell selection	-	53	41	-	-	9.48E-03	6.50E-03
SIGNOR	CC	GO:0032387	negative regulation of intracellular transport	-	51	29	-	-	1.17E-03	4.73E-03
SIGNOR	BP	GO:0072091	regulation of stem cell proliferation	-	91	61	-	-	4.27E-03	9.65E-03
SIGNOR	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	12	-	-	1.51E-01	1.97E-03
SIGNOR	BP	GO:0099084	postsynaptic specialization organization	-	44	31	-	-	2.42E-02	4.93E-03
SIGNOR	BP	GO:0060384	innervation	-	27	16	-	-	2.48E-02	2.56E-03
SIGNOR	BP	GO:0032535	regulation of cellular component size	-	360	185	-	-	1.24E-02	2.92E-02
SIGNOR	MF	GO:0031281	positive regulation of cyclase activity	-	40	29	-	-	1.37E-03	4.73E-03
SIGNOR	MF	GO:0098631	cell adhesion mediator activity	-	64	27	-	-	5.65E-03	4.33E-03
SIGNOR	BP	GO:0046112	nucleobase biosynthetic process	-	18	11	-	-	5.87E-04	1.77E-03
SIGNOR	BP	GO:0071453	cellular response to oxygen levels	-	168	106	-	-	8.91E-03	1.67E-02
SIGNOR	BP	GO:0090399	replicative senescence	-	17	12	-	-	4.59E-03	1.97E-03
SIGNOR	BP	GO:0031342	negative regulation of cell killing	-	29	21	-	-	2.13E-02	3.35E-03
SIGNOR	BP	GO:0070585	protein localization to mitochondrion	-	125	56	-	-	2.18E-02	8.87E-03
SIGNOR	BP	GO:0010623	programmed cell death involved in cell development	-	25	16	-	-	9.90E-03	2.56E-03
SIGNOR	BP	GO:0044242	cellular lipid catabolic process	-	224	52	-	-	8.01E-03	8.27E-03
SIGNOR	BP	GO:0002931	response to ischemia	-	58	36	-	-	8.26E-03	5.71E-03
SIGNOR	BP	GO:0043062	extracellular structure organization	-	317	126	-	-	1.03E-02	1.99E-02
SIGNOR	BP	GO:0014047	glutamate secretion	-	25	17	-	-	7.81E-04	2.76E-03
SIGNOR	BP	GO:0061005	cell differentiation involved in kidney development	-	58	45	-	-	4.31E-03	7.09E-03
SIGNOR	BP	GO:0030397	membrane disassembly	-	11	11	-	-	9.07E-03	1.77E-03
SIGNOR	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	242	-	-	2.40E-02	3.82E-02
SIGNOR	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	43	-	-	1.58E-02	6.90E-03
SIGNOR	BP	GO:0060420	regulation of heart growth	-	74	44	-	-	3.77E-03	7.09E-03
SIGNOR	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	11	-	-	5.76E-04	1.77E-03
SIGNOR	BP	GO:0009755	hormone-mediated signaling pathway	-	221	150	-	-	2.22E-02	2.36E-02
SIGNOR	BP	GO:0022612	gland morphogenesis	-	124	103	-	-	9.33E-03	1.64E-02
SIGNOR	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	18	-	-	7.73E-04	2.96E-03
SIGNOR	MF	GO:0140416	transcription regulator inhibitor activity	-	26	17	-	-	7.76E-04	2.76E-03
SIGNOR	BP	GO:0044782	cilium organization	-	400	87	-	-	3.09E-02	1.38E-02
SIGNOR	BP	GO:0048935	peripheral nervous system neuron development	-	15	11	-	-	5.86E-04	1.77E-03
SIGNOR	BP	GO:0090130	tissue migration	-	379	215	-	-	1.96E-02	3.39E-02
SIGNOR	BP	GO:1990845	adaptive thermogenesis	-	166	103	-	-	1.09E-02	1.64E-02
SIGNOR	BP	GO:0071320	cellular response to cAMP	-	54	32	-	-	4.78E-03	5.12E-03
SIGNOR	BP	GO:0015844	monoamine transport	-	88	55	-	-	3.20E-03	8.67E-03
SIGNOR	BP	GO:0060039	pericardium development	-	19	13	-	-	3.11E-03	2.17E-03
SIGNOR	BP	GO:0071392	cellular response to estradiol stimulus	-	40	30	-	-	6.74E-03	4.73E-03
SIGNOR	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	5.32E-03	2.17E-03
SIGNOR	BP	GO:0000272	polysaccharide catabolic process	-	19	11	-	-	1.46E-02	1.77E-03
SIGNOR	BP	GO:0009451	RNA modification	-	169	22	-	-	7.63E-03	3.55E-03
SIGNOR	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	26	-	-	2.89E-03	4.14E-03
SIGNOR	BP	GO:1903729	regulation of plasma membrane organization	-	17	14	-	-	5.82E-04	2.36E-03
SIGNOR	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	58	-	-	3.75E-03	9.26E-03
SIGNOR	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	30	-	-	4.09E-03	4.73E-03
SIGNOR	BP	GO:0015807	L-amino acid transport	-	94	17	-	-	7.76E-04	2.76E-03
SIGNOR	BP	GO:0032941	secretion by tissue	-	85	50	-	-	3.09E-03	7.88E-03
SIGNOR	BP	GO:0046605	regulation of centrosome cycle	-	54	31	-	-	1.51E-02	4.93E-03
SIGNOR	BP	GO:0048753	pigment granule organization	-	40	11	-	-	5.86E-04	1.77E-03
SIGNOR	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	12	-	-	5.85E-04	1.97E-03
SIGNOR	BP	GO:0003014	renal system process	-	130	70	-	-	7.48E-03	1.10E-02
SIGNOR	BP	GO:0045598	regulation of fat cell differentiation	-	148	90	-	-	1.31E-02	1.42E-02
SIGNOR	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	138	-	-	1.30E-02	2.19E-02
SIGNOR	BP	GO:1904646	cellular response to amyloid-beta	-	44	30	-	-	7.49E-03	4.73E-03
SIGNOR	BP	GO:1901863	positive regulation of muscle tissue development	-	24	19	-	-	3.85E-03	3.15E-03
SIGNOR	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	156	-	-	7.83E-02	2.46E-02
SIGNOR	BP	GO:0039694	viral RNA genome replication	-	30	15	-	-	7.82E-04	2.36E-03
SIGNOR	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	11	-	-	5.78E-04	1.77E-03
SIGNOR	BP	GO:0071709	membrane assembly	-	68	30	-	-	4.97E-02	4.73E-03
SIGNOR	BP	GO:0008217	regulation of blood pressure	-	186	113	-	-	1.98E-02	1.79E-02
SIGNOR	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	37	-	-	5.29E-03	5.91E-03
SIGNOR	CC	GO:0042770	signal transduction in response to DNA damage	-	186	132	-	-	4.35E-02	2.09E-02
SIGNOR	BP	GO:0002200	somatic diversification of immune receptors	-	78	54	-	-	1.69E-02	8.67E-03
SIGNOR	BP	GO:0035315	hair cell differentiation	-	52	23	-	-	9.15E-03	3.74E-03
SIGNOR	BP	GO:0048645	animal organ formation	-	62	50	-	-	1.78E-02	7.88E-03
SIGNOR	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	103	-	-	1.01E-02	1.64E-02
SIGNOR	BP	GO:0033627	cell adhesion mediated by integrin	-	87	57	-	-	1.97E-02	9.06E-03
SIGNOR	BP	GO:0035107	appendage morphogenesis	-	147	89	-	-	1.20E-02	1.42E-02
SIGNOR	BP	GO:1903707	negative regulation of hemopoiesis	-	116	73	-	-	7.86E-03	1.16E-02
SIGNOR	CC	GO:0048208	COPII vesicle coating	-	27	11	-	-	1.29E-01	1.77E-03
SIGNOR	BP	GO:0050994	regulation of lipid catabolic process	-	61	34	-	-	8.08E-03	5.52E-03
SIGNOR	BP	GO:0035988	chondrocyte proliferation	-	24	16	-	-	4.18E-03	2.56E-03
SIGNOR	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	23	-	-	9.78E-04	3.74E-03
SIGNOR	BP	GO:0009593	detection of chemical stimulus	-	511	17	-	-	7.83E-04	2.76E-03
SIGNOR	BP	GO:0060788	ectodermal placode formation	-	12	11	-	-	5.78E-04	1.77E-03
SIGNOR	BP	GO:0045727	positive regulation of translation	-	141	71	-	-	7.13E-03	1.12E-02
SIGNOR	BP	GO:0036315	cellular response to sterol	-	24	12	-	-	5.09E-03	1.97E-03
SIGNOR	CC	GO:0032388	positive regulation of intracellular transport	-	137	83	-	-	4.89E-03	1.32E-02
SIGNOR	BP	GO:0002027	regulation of heart rate	-	106	53	-	-	1.05E-02	8.47E-03
SIGNOR	BP	GO:0050879	multicellular organismal movement	-	118	44	-	-	5.91E-03	7.09E-03
SIGNOR	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	51	-	-	6.81E-03	8.08E-03
SIGNOR	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	43	-	-	6.64E-03	6.90E-03
SIGNOR	BP	GO:0048515	spermatid differentiation	-	208	46	-	-	2.44E-03	7.29E-03
SIGNOR	BP	GO:0072132	mesenchyme morphogenesis	-	57	46	-	-	8.59E-03	7.29E-03
SIGNOR	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	24	-	-	7.15E-02	3.94E-03
SIGNOR	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	17	-	-	1.90E-03	2.76E-03
SIGNOR	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	11	-	-	5.90E-04	1.77E-03
SIGNOR	BP	GO:0060119	inner ear receptor cell development	-	44	13	-	-	5.86E-04	2.17E-03
SIGNOR	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	13	-	-	3.50E-03	2.17E-03
SIGNOR	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	16	-	-	7.85E-04	2.56E-03
SIGNOR	BP	GO:1901983	regulation of protein acetylation	-	26	15	-	-	3.82E-03	2.36E-03
SIGNOR	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	179	-	-	2.13E-02	2.84E-02
SIGNOR	BP	GO:1900006	positive regulation of dendrite development	-	17	12	-	-	7.05E-03	1.97E-03
SIGNOR	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	26	-	-	1.83E-02	4.14E-03
SIGNOR	BP	GO:0010883	regulation of lipid storage	-	53	28	-	-	1.05E-02	4.53E-03
SIGNOR	BP	GO:0072170	metanephric tubule development	-	26	20	-	-	2.21E-03	3.15E-03
SIGNOR	BP	GO:1905954	positive regulation of lipid localization	-	110	57	-	-	8.21E-03	9.06E-03
SIGNOR	BP	GO:0002209	behavioral defense response	-	39	26	-	-	8.89E-03	4.14E-03
SIGNOR	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	17	-	-	5.61E-03	2.76E-03
SIGNOR	BP	GO:0072523	purine-containing compound catabolic process	-	146	70	-	-	8.94E-03	1.10E-02
SIGNOR	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	23	-	-	1.51E-03	3.74E-03
SIGNOR	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	15	-	-	4.00E-03	2.36E-03
SIGNOR	BP	GO:0021535	cell migration in hindbrain	-	16	11	-	-	5.86E-04	1.77E-03
SIGNOR	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	59	-	-	5.82E-03	9.46E-03
SIGNOR	BP	GO:0007218	neuropeptide signaling pathway	-	113	72	-	-	8.53E-02	1.14E-02
SIGNOR	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	117	-	-	8.87E-03	1.85E-02
SIGNOR	BP	GO:0031345	negative regulation of cell projection organization	-	195	109	-	-	7.72E-03	1.73E-02
SIGNOR	BP	GO:0048278	vesicle docking	-	64	23	-	-	2.04E-02	3.74E-03
SIGNOR	BP	GO:0035050	embryonic heart tube development	-	86	54	-	-	7.56E-03	8.67E-03
SIGNOR	BP	GO:0030168	platelet activation	-	135	82	-	-	1.17E-02	1.30E-02
SIGNOR	CC	GO:0098810	neurotransmitter reuptake	-	35	15	-	-	4.52E-03	2.36E-03
SIGNOR	BP	GO:0008213	protein alkylation	-	58	12	-	-	5.89E-04	1.97E-03
SIGNOR	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	11	-	-	8.19E-03	1.77E-03
SIGNOR	BP	GO:0031529	ruffle organization	-	55	31	-	-	3.54E-03	4.93E-03
SIGNOR	BP	GO:0010842	retina layer formation	-	25	13	-	-	5.05E-02	2.17E-03
SIGNOR	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	27	-	-	2.39E-03	4.33E-03
SIGNOR	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	35	-	-	3.28E-03	5.52E-03
SIGNOR	BP	GO:0035304	regulation of protein dephosphorylation	-	87	48	-	-	3.78E-03	7.68E-03
SIGNOR	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	145	-	-	1.45E-02	2.29E-02
SIGNOR	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	23	-	-	1.86E-03	3.74E-03
SIGNOR	BP	GO:0051785	positive regulation of nuclear division	-	61	45	-	-	3.41E-03	7.09E-03
SIGNOR	BP	GO:0060749	mammary gland alveolus development	-	20	18	-	-	6.16E-03	2.96E-03
SIGNOR	BP	GO:0044786	cell cycle DNA replication	-	45	23	-	-	2.18E-02	3.74E-03
SIGNOR	BP	GO:0048145	regulation of fibroblast proliferation	-	87	64	-	-	5.25E-03	1.02E-02
SIGNOR	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	48	-	-	2.43E-01	7.68E-03
SIGNOR	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	158	-	-	1.48E-02	2.50E-02
SIGNOR	BP	GO:0032098	regulation of appetite	-	20	13	-	-	7.00E-03	2.17E-03
SIGNOR	BP	GO:0009306	protein secretion	-	376	186	-	-	1.47E-02	2.94E-02
SIGNOR	CC	GO:0008333	endosome to lysosome transport	-	73	20	-	-	2.33E-02	3.15E-03
SIGNOR	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	13	-	-	3.21E-03	2.17E-03
SIGNOR	BP	GO:0003016	respiratory system process	-	39	16	-	-	7.81E-04	2.56E-03
SIGNOR	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	12	-	-	1.18E-02	1.97E-03
SIGNOR	BP	GO:0045732	positive regulation of protein catabolic process	-	202	121	-	-	1.19E-02	1.91E-02
SIGNOR	BP	GO:0031589	cell-substrate adhesion	-	360	200	-	-	1.73E-02	3.15E-02
SIGNOR	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	17	-	-	7.84E-04	2.76E-03
SIGNOR	BP	GO:0007588	excretion	-	40	27	-	-	1.95E-02	4.33E-03
SIGNOR	BP	GO:1904018	positive regulation of vasculature development	-	185	116	-	-	1.02E-02	1.83E-02
SIGNOR	BP	GO:0010948	negative regulation of cell cycle process	-	317	187	-	-	3.28E-02	2.96E-02
SIGNOR	BP	GO:0050953	sensory perception of light stimulus	-	223	54	-	-	7.65E-02	8.67E-03
SIGNOR	BP	GO:0009303	rRNA transcription	-	37	14	-	-	5.72E-04	2.36E-03
SIGNOR	BP	GO:0035601	protein deacylation	-	56	31	-	-	7.69E-03	4.93E-03
SIGNOR	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	13	-	-	2.54E-03	2.17E-03
SIGNOR	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	20	-	-	4.95E-03	3.15E-03
SIGNOR	BP	GO:0071300	cellular response to retinoic acid	-	66	49	-	-	4.12E-03	7.88E-03
SIGNOR	BP	GO:0045830	positive regulation of isotype switching	-	28	20	-	-	4.31E-03	3.15E-03
SIGNOR	BP	GO:0031069	hair follicle morphogenesis	-	33	20	-	-	4.58E-03	3.15E-03
SIGNOR	BP	GO:0046697	decidualization	-	26	18	-	-	2.94E-02	2.96E-03
SIGNOR	BP	GO:0048284	organelle fusion	-	456	202	-	-	2.62E-02	3.19E-02
SIGNOR	BP	GO:0051588	regulation of neurotransmitter transport	-	99	55	-	-	7.02E-03	8.67E-03
SIGNOR	BP	GO:0051784	negative regulation of nuclear division	-	63	39	-	-	2.91E-02	6.30E-03
SIGNOR	BP	GO:0044703	multi-organism reproductive process	-	209	117	-	-	1.77E-02	1.85E-02
SIGNOR	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	97	-	-	1.42E-02	1.54E-02
SIGNOR	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	31	-	-	6.83E-03	4.93E-03
SIGNOR	MF	GO:0004930	G protein-coupled receptor activity	-	873	233	-	-	1.03E-02	3.68E-02
SIGNOR	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	17	-	-	2.85E-02	2.76E-03
SIGNOR	BP	GO:0048857	neural nucleus development	-	65	37	-	-	2.89E-03	5.91E-03
SIGNOR	BP	GO:0048663	neuron fate commitment	-	74	53	-	-	7.14E-03	8.47E-03
SIGNOR	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	64	-	-	3.91E-02	1.02E-02
SIGNOR	BP	GO:0106027	neuron projection organization	-	90	58	-	-	5.85E-03	9.26E-03
SIGNOR	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	81	-	-	8.56E-03	1.28E-02
SIGNOR	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	23	-	-	4.15E-03	3.74E-03
SIGNOR	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	5.82E-04	1.77E-03
SIGNOR	BP	GO:0045685	regulation of glial cell differentiation	-	77	49	-	-	3.50E-03	7.88E-03
SIGNOR	BP	GO:0043414	macromolecule methylation	-	138	22	-	-	8.71E-03	3.55E-03
SIGNOR	BP	GO:0050886	endocrine process	-	93	65	-	-	1.14E-02	1.02E-02
SIGNOR	BP	GO:0050951	sensory perception of temperature stimulus	-	28	16	-	-	9.57E-03	2.56E-03
SIGNOR	BP	GO:0045807	positive regulation of endocytosis	-	155	96	-	-	1.41E-02	1.52E-02
SIGNOR	BP	GO:0002418	immune response to tumor cell	-	29	17	-	-	1.08E-01	2.76E-03
SIGNOR	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	45	-	-	5.57E-03	7.09E-03
SIGNOR	BP	GO:0048308	organelle inheritance	-	14	12	-	-	5.07E-03	1.97E-03
SIGNOR	BP	GO:0001829	trophectodermal cell differentiation	-	19	12	-	-	8.11E-03	1.97E-03
SIGNOR	BP	GO:0034394	protein localization to cell surface	-	69	30	-	-	1.91E-03	4.73E-03
SIGNOR	BP	GO:0009110	vitamin biosynthetic process	-	23	12	-	-	3.34E-02	1.97E-03
SIGNOR	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	14	-	-	1.87E-02	2.36E-03
SIGNOR	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	15	-	-	1.28E-03	2.36E-03
SIGNOR	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	19	-	-	2.38E-03	3.15E-03
SIGNOR	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	72	-	-	6.26E-03	1.14E-02
SIGNOR	MF	GO:0051100	negative regulation of binding	-	161	99	-	-	5.23E-03	1.58E-02
SIGNOR	BP	GO:0001818	negative regulation of cytokine production	-	379	174	-	-	1.64E-02	2.76E-02
SIGNOR	BP	GO:0003151	outflow tract morphogenesis	-	81	67	-	-	8.50E-03	1.06E-02
SIGNOR	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	46	-	-	4.90E-03	7.29E-03
SIGNOR	BP	GO:0055093	response to hyperoxia	-	20	15	-	-	7.78E-04	2.36E-03
SIGNOR	BP	GO:0061036	positive regulation of cartilage development	-	33	26	-	-	5.16E-02	4.14E-03
SIGNOR	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	31	-	-	3.26E-03	4.93E-03
SIGNOR	BP	GO:0046621	negative regulation of organ growth	-	39	20	-	-	3.66E-02	3.15E-03
SIGNOR	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	14	-	-	1.09E-02	2.36E-03
SIGNOR	BP	GO:0032368	regulation of lipid transport	-	149	73	-	-	8.01E-03	1.16E-02
SIGNOR	BP	GO:0055094	response to lipoprotein particle	-	34	17	-	-	1.64E-03	2.76E-03
SIGNOR	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	122	-	-	1.09E-02	1.93E-02
SIGNOR	BP	GO:0033002	muscle cell proliferation	-	249	159	-	-	1.18E-02	2.52E-02
SIGNOR	BP	GO:0048880	sensory system development	-	399	221	-	-	2.18E-02	3.49E-02
SIGNOR	BP	GO:0043331	response to dsRNA	-	56	33	-	-	5.77E-03	5.32E-03
SIGNOR	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	26	-	-	3.10E-03	4.14E-03
SIGNOR	BP	GO:0033363	secretory granule organization	-	63	12	-	-	5.84E-04	1.97E-03
SIGNOR	BP	GO:0060479	lung cell differentiation	-	28	22	-	-	1.75E-03	3.55E-03
SIGNOR	BP	GO:0120009	intermembrane lipid transfer	-	52	15	-	-	2.78E-02	2.36E-03
SIGNOR	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	26	-	-	3.19E-03	4.14E-03
SIGNOR	BP	GO:0033622	integrin activation	-	26	18	-	-	7.52E-02	2.96E-03
SIGNOR	BP	GO:0098751	bone cell development	-	18	12	-	-	3.47E-03	1.97E-03
SIGNOR	BP	GO:2000773	negative regulation of cellular senescence	-	25	19	-	-	2.07E-03	3.15E-03
SIGNOR	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	43	-	-	3.87E-03	6.90E-03
SIGNOR	BP	GO:0050820	positive regulation of coagulation	-	30	19	-	-	1.14E-02	3.15E-03
SIGNOR	BP	GO:0002076	osteoblast development	-	17	12	-	-	8.57E-03	1.97E-03
SIGNOR	BP	GO:0072164	mesonephric tubule development	-	98	75	-	-	7.73E-03	1.18E-02
SIGNOR	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	77	-	-	7.82E-03	1.22E-02
SIGNOR	BP	GO:1903524	positive regulation of blood circulation	-	39	23	-	-	9.72E-04	3.74E-03
SIGNOR	BP	GO:0030901	midbrain development	-	87	55	-	-	5.97E-03	8.67E-03
SIGNOR	BP	GO:0048485	sympathetic nervous system development	-	22	20	-	-	1.28E-02	3.15E-03
SIGNOR	BP	GO:0007162	negative regulation of cell adhesion	-	310	174	-	-	1.04E-02	2.76E-02
SIGNOR	BP	GO:0048532	anatomical structure arrangement	-	16	14	-	-	3.43E-02	2.36E-03
SIGNOR	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	12	-	-	5.79E-04	1.97E-03
SIGNOR	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	45	-	-	5.69E-03	7.09E-03
SIGNOR	BP	GO:0002687	positive regulation of leukocyte migration	-	147	95	-	-	6.56E-03	1.50E-02
SIGNOR	BP	GO:0034605	cellular response to heat	-	66	42	-	-	3.10E-03	6.70E-03
SIGNOR	BP	GO:0005996	monosaccharide metabolic process	-	250	113	-	-	2.25E-02	1.79E-02
SIGNOR	BP	GO:0033555	multicellular organismal response to stress	-	90	56	-	-	5.56E-03	8.87E-03
SIGNOR	BP	GO:0002262	myeloid cell homeostasis	-	172	108	-	-	1.01E-02	1.71E-02
SIGNOR	BP	GO:0050688	regulation of defense response to virus	-	65	41	-	-	1.86E-02	6.50E-03
SIGNOR	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	189	-	-	3.50E-02	2.99E-02
SIGNOR	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	13	-	-	2.19E-02	2.17E-03
SIGNOR	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	169	-	-	1.74E-02	2.68E-02
SIGNOR	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	28	-	-	4.01E-03	4.53E-03
SIGNOR	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	18	-	-	2.35E-03	2.96E-03
SIGNOR	BP	GO:0003272	endocardial cushion formation	-	28	23	-	-	8.79E-03	3.74E-03
SIGNOR	BP	GO:0022618	protein-RNA complex assembly	-	227	56	-	-	1.19E-02	8.87E-03
SIGNOR	BP	GO:0051147	regulation of muscle cell differentiation	-	162	94	-	-	1.06E-02	1.50E-02
SIGNOR	BP	GO:0006066	alcohol metabolic process	-	374	119	-	-	2.27E-02	1.89E-02
SIGNOR	BP	GO:0090102	cochlea development	-	50	28	-	-	2.03E-03	4.53E-03
SIGNOR	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	24	-	-	2.69E-03	3.94E-03
SIGNOR	BP	GO:0045933	positive regulation of muscle contraction	-	49	35	-	-	2.71E-03	5.52E-03
SIGNOR	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	19	-	-	3.14E-03	3.15E-03
SIGNOR	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	30	-	-	1.35E-03	4.73E-03
SIGNOR	BP	GO:0043555	regulation of translation in response to stress	-	22	15	-	-	1.43E-01	2.36E-03
SIGNOR	BP	GO:0032922	circadian regulation of gene expression	-	71	58	-	-	6.87E-03	9.26E-03
SIGNOR	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	53	-	-	8.08E-03	8.47E-03
SIGNOR	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	31	-	-	5.56E-03	4.93E-03
SIGNOR	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	22	-	-	4.17E-02	3.55E-03
SIGNOR	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	34	-	-	2.56E-03	5.52E-03
SIGNOR	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	2.44E-03	1.77E-03
SIGNOR	BP	GO:0038179	neurotrophin signaling pathway	-	38	31	-	-	1.76E-02	4.93E-03
SIGNOR	BP	GO:0140253	cell-cell fusion	-	62	27	-	-	6.86E-03	4.33E-03
SIGNOR	BP	GO:0071599	otic vesicle development	-	15	14	-	-	6.80E-03	2.36E-03
SIGNOR	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	24	-	-	3.15E-01	3.94E-03
SIGNOR	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	14	-	-	5.90E-04	2.36E-03
SIGNOR	BP	GO:0001941	postsynaptic membrane organization	-	37	24	-	-	1.79E-01	3.94E-03
SIGNOR	BP	GO:0051293	establishment of spindle localization	-	57	38	-	-	4.70E-03	6.11E-03
SIGNOR	BP	GO:0043114	regulation of vascular permeability	-	49	34	-	-	4.11E-03	5.52E-03
SIGNOR	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	51	-	-	3.26E-03	8.08E-03
SIGNOR	BP	GO:0008360	regulation of cell shape	-	139	78	-	-	1.11E-02	1.24E-02
SIGNOR	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	15	-	-	4.88E-02	2.36E-03
SIGNOR	BP	GO:0051222	positive regulation of protein transport	-	249	150	-	-	8.50E-03	2.36E-02
SIGNOR	CC	GO:0140632	canonical inflammasome complex assembly	-	40	22	-	-	5.25E-03	3.55E-03
SIGNOR	MF	GO:0034260	negative regulation of GTPase activity	-	36	18	-	-	3.06E-03	2.96E-03
SIGNOR	BP	GO:0045932	negative regulation of muscle contraction	-	24	12	-	-	5.84E-04	1.97E-03
SIGNOR	BP	GO:0045739	positive regulation of DNA repair	-	128	59	-	-	7.53E-02	9.46E-03
SIGNOR	BP	GO:0045185	maintenance of protein location	-	95	47	-	-	3.19E-03	7.49E-03
SIGNOR	BP	GO:0003158	endothelium development	-	140	92	-	-	1.82E-02	1.46E-02
SIGNOR	CC	GO:0072595	maintenance of protein localization in organelle	-	42	22	-	-	5.25E-03	3.55E-03
SIGNOR	BP	GO:0051224	negative regulation of protein transport	-	122	61	-	-	9.29E-03	9.65E-03
SIGNOR	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	103	-	-	7.18E-03	1.64E-02
SIGNOR	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	16	-	-	2.20E-02	2.56E-03
SIGNOR	MF	GO:0003713	transcription coactivator activity	-	281	154	-	-	2.27E-02	2.44E-02
SIGNOR	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	12	-	-	5.91E-04	1.97E-03
SIGNOR	BP	GO:0021885	forebrain cell migration	-	63	43	-	-	2.15E-03	6.90E-03
SIGNOR	BP	GO:0007405	neuroblast proliferation	-	81	54	-	-	5.16E-03	8.67E-03
SIGNOR	BP	GO:0009581	detection of external stimulus	-	137	48	-	-	5.51E-03	7.68E-03
SIGNOR	BP	GO:1990542	mitochondrial transmembrane transport	-	93	13	-	-	5.90E-04	2.17E-03
SIGNOR	BP	GO:0045862	positive regulation of proteolysis	-	353	209	-	-	1.52E-02	3.31E-02
SIGNOR	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	20	-	-	2.09E-02	3.15E-03
SIGNOR	BP	GO:0097186	amelogenesis	-	26	11	-	-	5.87E-04	1.77E-03
SIGNOR	BP	GO:0031128	developmental induction	-	26	25	-	-	1.73E-03	3.94E-03
SIGNOR	BP	GO:0031100	animal organ regeneration	-	66	47	-	-	3.00E-03	7.49E-03
SIGNOR	BP	GO:0045684	positive regulation of epidermis development	-	33	19	-	-	7.70E-04	3.15E-03
SIGNOR	BP	GO:1900047	negative regulation of hemostasis	-	51	37	-	-	6.35E-02	5.91E-03
SIGNOR	BP	GO:0021517	ventral spinal cord development	-	47	30	-	-	2.16E-02	4.73E-03
SIGNOR	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	47	-	-	3.11E-03	7.49E-03
SIGNOR	MF	GO:0034497	protein localization to phagophore assembly site	-	16	12	-	-	3.38E-02	1.97E-03
SIGNOR	BP	GO:0097722	sperm motility	-	133	18	-	-	7.86E-04	2.96E-03
SIGNOR	BP	GO:0051231	spindle elongation	-	14	12	-	-	3.26E-02	1.97E-03
SIGNOR	BP	GO:0042490	mechanoreceptor differentiation	-	67	26	-	-	4.38E-02	4.14E-03
SIGNOR	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	16	-	-	1.69E-03	2.56E-03
SIGNOR	BP	GO:0035148	tube formation	-	155	103	-	-	1.70E-02	1.64E-02
SIGNOR	BP	GO:0048520	positive regulation of behavior	-	27	18	-	-	2.26E-02	2.96E-03
SIGNOR	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	30	-	-	1.35E-02	4.73E-03
SIGNOR	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	56	-	-	1.81E-02	8.87E-03
SIGNOR	BP	GO:0031123	RNA 3'-end processing	-	79	19	-	-	3.88E-03	3.15E-03
SIGNOR	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	48	-	-	1.16E-02	7.68E-03
SIGNOR	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	15	-	-	1.64E-02	2.36E-03
SIGNOR	CC	GO:0007097	nuclear migration	-	24	17	-	-	8.54E-03	2.76E-03
SIGNOR	BP	GO:0045229	external encapsulating structure organization	-	319	126	-	-	2.56E-02	1.99E-02
SIGNOR	BP	GO:0006885	regulation of pH	-	104	33	-	-	2.77E-03	5.32E-03
SIGNOR	BP	GO:1990840	response to lectin	-	22	14	-	-	2.81E-03	2.36E-03
SIGNOR	BP	GO:0071800	podosome assembly	-	19	16	-	-	4.70E-03	2.56E-03
SIGNOR	BP	GO:0031018	endocrine pancreas development	-	47	32	-	-	4.21E-03	5.12E-03
SIGNOR	BP	GO:0001708	cell fate specification	-	108	79	-	-	1.65E-02	1.26E-02
SIGNOR	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	49	-	-	6.99E-03	7.88E-03
SIGNOR	BP	GO:0030279	negative regulation of ossification	-	39	26	-	-	5.91E-03	4.14E-03
SIGNOR	BP	GO:0032970	regulation of actin filament-based process	-	368	211	-	-	2.00E-02	3.33E-02
SIGNOR	BP	GO:0042440	pigment metabolic process	-	80	31	-	-	5.42E-03	4.93E-03
SIGNOR	BP	GO:1901606	alpha-amino acid catabolic process	-	101	19	-	-	7.83E-04	3.15E-03
SIGNOR	BP	GO:0062197	cellular response to chemical stress	-	299	180	-	-	1.24E-02	2.84E-02
SIGNOR	BP	GO:1901890	positive regulation of cell junction assembly	-	106	53	-	-	6.02E-03	8.47E-03
SIGNOR	BP	GO:0070988	demethylation	-	27	12	-	-	5.89E-04	1.97E-03
SIGNOR	BP	GO:1901655	cellular response to ketone	-	107	82	-	-	5.02E-03	1.30E-02
SIGNOR	MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	-	925	240	-	-	6.59E-02	3.78E-02
SIGNOR	BP	GO:0006968	cellular defense response	-	52	26	-	-	7.36E-03	4.14E-03
SIGNOR	BP	GO:0055006	cardiac cell development	-	93	52	-	-	3.76E-03	8.27E-03
SIGNOR	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	20	-	-	6.94E-03	3.15E-03
SIGNOR	BP	GO:0060004	reflex	-	63	37	-	-	6.32E-03	5.91E-03
SIGNOR	BP	GO:0044706	multi-multicellular organism process	-	217	117	-	-	1.48E-02	1.85E-02
SIGNOR	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	96	-	-	1.59E-02	1.52E-02
SIGNOR	BP	GO:0031294	lymphocyte costimulation	-	47	36	-	-	1.05E-02	5.71E-03
SIGNOR	BP	GO:0050768	negative regulation of neurogenesis	-	150	95	-	-	5.53E-03	1.50E-02
SIGNOR	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	50	-	-	3.44E-03	7.88E-03
SIGNOR	BP	GO:0090068	positive regulation of cell cycle process	-	262	158	-	-	1.49E-02	2.50E-02
SIGNOR	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	15	-	-	7.84E-04	2.36E-03
SIGNOR	MF	GO:0022803	passive transmembrane transporter activity	-	676	203	-	-	5.99E-02	3.21E-02
SIGNOR	BP	GO:1902115	regulation of organelle assembly	-	210	110	-	-	1.31E-02	1.73E-02
SIGNOR	BP	GO:0006397	mRNA processing	-	482	129	-	-	4.88E-02	2.05E-02
SIGNOR	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	52	-	-	5.26E-03	8.27E-03
SIGNOR	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	71	-	-	4.49E-03	1.12E-02
SIGNOR	BP	GO:0046622	positive regulation of organ growth	-	52	34	-	-	2.89E-03	5.52E-03
SIGNOR	BP	GO:0051952	regulation of amine transport	-	98	59	-	-	4.33E-03	9.46E-03
SIGNOR	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	13	-	-	3.05E-02	2.17E-03
SIGNOR	BP	GO:0040019	positive regulation of embryonic development	-	23	17	-	-	1.36E-02	2.76E-03
SIGNOR	BP	GO:0097154	GABAergic neuron differentiation	-	20	12	-	-	5.38E-02	1.97E-03
SIGNOR	CC	GO:0032365	intracellular lipid transport	-	51	11	-	-	5.85E-04	1.77E-03
SIGNOR	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	39	-	-	1.53E-03	6.30E-03
SIGNOR	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	70	-	-	9.05E-03	1.10E-02
SIGNOR	BP	GO:0018149	peptide cross-linking	-	28	12	-	-	5.88E-04	1.97E-03
SIGNOR	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	19	-	-	7.70E-04	3.15E-03
SIGNOR	BP	GO:0071398	cellular response to fatty acid	-	35	25	-	-	1.48E-03	3.94E-03
SIGNOR	BP	GO:0097581	lamellipodium organization	-	91	53	-	-	7.49E-03	8.47E-03
SIGNOR	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	61	-	-	7.32E-03	9.65E-03
SIGNOR	BP	GO:0060326	cell chemotaxis	-	311	170	-	-	1.98E-02	2.68E-02
SIGNOR	BP	GO:1903975	regulation of glial cell migration	-	20	13	-	-	4.50E-02	2.17E-03
SIGNOR	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	13	-	-	2.42E-02	2.17E-03
SIGNOR	BP	GO:0016485	protein processing	-	248	118	-	-	7.42E-02	1.87E-02
SIGNOR	BP	GO:0009649	entrainment of circadian clock	-	30	22	-	-	2.50E-02	3.55E-03
SIGNOR	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	85	-	-	3.44E-02	1.34E-02
SIGNOR	BP	GO:1903523	negative regulation of blood circulation	-	27	18	-	-	1.55E-03	2.96E-03
SIGNOR	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	41	-	-	1.10E-02	6.50E-03
SIGNOR	BP	GO:0099054	presynapse assembly	-	49	26	-	-	9.16E-03	4.14E-03
SIGNOR	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	16	-	-	2.68E-02	2.56E-03
SIGNOR	BP	GO:0031348	negative regulation of defense response	-	282	156	-	-	9.29E-03	2.46E-02
SIGNOR	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	49	-	-	3.63E-03	7.88E-03
SIGNOR	BP	GO:0007606	sensory perception of chemical stimulus	-	535	22	-	-	1.14E-02	3.55E-03
SIGNOR	BP	GO:0061180	mammary gland epithelium development	-	68	60	-	-	5.61E-03	9.46E-03
SIGNOR	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	140	-	-	9.07E-03	2.21E-02
SIGNOR	CC	GO:0051169	nuclear transport	-	325	167	-	-	1.89E-02	2.64E-02
SIGNOR	BP	GO:0071496	cellular response to external stimulus	-	74	57	-	-	2.42E-02	9.06E-03
SIGNOR	BP	GO:0042753	positive regulation of circadian rhythm	-	18	14	-	-	1.30E-02	2.36E-03
SIGNOR	BP	GO:0032094	response to food	-	37	24	-	-	4.63E-03	3.94E-03
SIGNOR	BP	GO:0001964	startle response	-	27	18	-	-	7.75E-04	2.96E-03
SIGNOR	BP	GO:0046434	organophosphate catabolic process	-	232	91	-	-	9.20E-03	1.44E-02
SIGNOR	BP	GO:0060037	pharyngeal system development	-	29	23	-	-	1.48E-02	3.74E-03
SIGNOR	BP	GO:0009566	fertilization	-	205	50	-	-	3.68E-03	7.88E-03
SIGNOR	BP	GO:0120255	olefinic compound biosynthetic process	-	24	13	-	-	5.85E-04	2.17E-03
SIGNOR	BP	GO:0045907	positive regulation of vasoconstriction	-	30	25	-	-	5.02E-03	3.94E-03
SIGNOR	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	11	-	-	7.40E-03	1.77E-03
SIGNOR	BP	GO:0033044	regulation of chromosome organization	-	249	137	-	-	2.34E-02	2.17E-02
SIGNOR	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	201	-	-	1.26E-02	3.17E-02
SIGNOR	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	11	-	-	4.99E-03	1.77E-03
SIGNOR	BP	GO:0061900	glial cell activation	-	56	40	-	-	1.33E-02	6.30E-03
SIGNOR	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	95	-	-	1.32E-02	1.50E-02
SIGNOR	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	145	-	-	2.48E-02	2.29E-02
SIGNOR	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	12	-	-	4.25E-03	1.97E-03
SIGNOR	CC	GO:0140467	integrated stress response signaling	-	41	28	-	-	7.03E-03	4.53E-03
SIGNOR	BP	GO:0035902	response to immobilization stress	-	20	14	-	-	5.85E-04	2.36E-03
SIGNOR	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	102	-	-	4.02E-02	1.62E-02
SIGNOR	BP	GO:0035821	modulation of process of another organism	-	14	11	-	-	5.67E-04	1.77E-03
SIGNOR	BP	GO:0072537	fibroblast activation	-	13	12	-	-	5.31E-03	1.97E-03
SIGNOR	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	7.48E-03	2.17E-03
SIGNOR	BP	GO:0043647	inositol phosphate metabolic process	-	44	23	-	-	1.15E-02	3.74E-03
SIGNOR	BP	GO:0051303	establishment of chromosome localization	-	104	60	-	-	3.67E-02	9.46E-03
SIGNOR	BP	GO:0007164	establishment of tissue polarity	-	38	20	-	-	1.67E-02	3.15E-03
SIGNOR	BP	GO:0021515	cell differentiation in spinal cord	-	51	29	-	-	9.66E-03	4.73E-03
SIGNOR	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	17	-	-	1.06E-02	2.76E-03
SIGNOR	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	13	-	-	5.73E-04	2.17E-03
SIGNOR	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	19	-	-	1.50E-03	3.15E-03
SIGNOR	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	16	-	-	2.51E-03	2.56E-03
SIGNOR	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	20	-	-	9.15E-03	3.15E-03
SIGNOR	BP	GO:0006605	protein targeting	-	327	113	-	-	1.74E-02	1.79E-02
SIGNOR	BP	GO:0061318	renal filtration cell differentiation	-	22	16	-	-	5.91E-03	2.56E-03
SIGNOR	BP	GO:0007566	embryo implantation	-	57	31	-	-	8.60E-03	4.93E-03
SIGNOR	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	20	-	-	2.93E-03	3.15E-03
SIGNOR	BP	GO:0061512	protein localization to cilium	-	394	87	-	-	4.15E-02	1.38E-02
SIGNOR	BP	GO:0060306	regulation of membrane repolarization	-	38	12	-	-	5.87E-04	1.97E-03
SIGNOR	BP	GO:0051017	actin filament bundle assembly	-	161	104	-	-	1.36E-02	1.65E-02
SIGNOR	BP	GO:1905953	negative regulation of lipid localization	-	63	27	-	-	3.89E-03	4.33E-03
SIGNOR	BP	GO:0021542	dentate gyrus development	-	19	13	-	-	5.81E-04	2.17E-03
SIGNOR	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	20	-	-	5.72E-03	3.15E-03
SIGNOR	BP	GO:1901343	negative regulation of vasculature development	-	154	65	-	-	4.78E-03	1.02E-02
SIGNOR	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	43	-	-	3.26E-03	6.90E-03
SIGNOR	BP	GO:1902414	protein localization to cell junction	-	107	57	-	-	1.92E-02	9.06E-03
SIGNOR	BP	GO:0071305	cellular response to vitamin D	-	23	19	-	-	3.72E-03	3.15E-03
SIGNOR	BP	GO:0051304	chromosome separation	-	80	49	-	-	1.50E-02	7.88E-03
SIGNOR	BP	GO:0090596	sensory organ morphogenesis	-	272	153	-	-	9.72E-03	2.42E-02
SIGNOR	BP	GO:0045780	positive regulation of bone resorption	-	18	11	-	-	6.19E-03	1.77E-03
SIGNOR	BP	GO:0048709	oligodendrocyte differentiation	-	101	62	-	-	5.17E-03	9.85E-03
SIGNOR	BP	GO:0045017	glycerolipid biosynthetic process	-	254	86	-	-	2.22E-02	1.36E-02
SIGNOR	BP	GO:0001776	leukocyte homeostasis	-	108	69	-	-	4.33E-03	1.10E-02
SIGNOR	BP	GO:0050769	positive regulation of neurogenesis	-	240	161	-	-	1.09E-02	2.54E-02
SIGNOR	BP	GO:0030193	regulation of blood coagulation	-	70	49	-	-	4.17E-02	7.88E-03
SIGNOR	BP	GO:0050866	negative regulation of cell activation	-	216	125	-	-	8.39E-03	1.97E-02
SIGNOR	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	26	-	-	3.20E-03	4.14E-03
SIGNOR	BP	GO:0033500	carbohydrate homeostasis	-	251	142	-	-	1.27E-02	2.25E-02
SIGNOR	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	21	-	-	1.39E-02	3.35E-03
SIGNOR	BP	GO:0044088	regulation of vacuole organization	-	56	30	-	-	1.06E-02	4.73E-03
SIGNOR	CC	GO:0051457	maintenance of protein location in nucleus	-	23	12	-	-	5.85E-04	1.97E-03
SIGNOR	CC	GO:0099522	cytosolic region	-	20	13	-	-	5.83E-04	2.17E-03
SIGNOR	CC	GO:0000791	euchromatin	-	60	33	-	-	2.02E-03	5.32E-03
SIGNOR	CC	GO:0030666	endocytic vesicle membrane	-	196	115	-	-	7.74E-03	1.81E-02
SIGNOR	CC	GO:0098857	membrane microdomain	-	324	195	-	-	1.67E-02	3.07E-02
SIGNOR	CC	GO:0030312	external encapsulating structure	-	567	196	-	-	3.12E-02	3.09E-02
SIGNOR	CC	GO:1990752	microtubule end	-	34	16	-	-	3.31E-02	2.56E-03
SIGNOR	CC	GO:0043204	perikaryon	-	156	70	-	-	9.99E-03	1.10E-02
SIGNOR	CC	GO:0097542	ciliary tip	-	48	16	-	-	3.62E-02	2.56E-03
SIGNOR	CC	GO:1905368	peptidase complex	-	124	37	-	-	2.61E-02	5.91E-03
SIGNOR	CC	GO:0000792	heterochromatin	-	98	58	-	-	1.84E-02	9.26E-03
SIGNOR	CC	GO:0097546	ciliary base	-	47	16	-	-	2.04E-02	2.56E-03
SIGNOR	CC	GO:0031201	SNARE complex	-	48	13	-	-	5.90E-04	2.17E-03
SIGNOR	CC	GO:0016324	apical plasma membrane	-	392	136	-	-	8.79E-03	2.15E-02
SIGNOR	CC	GO:0033260	nuclear DNA replication	-	40	22	-	-	3.33E-02	3.55E-03
SIGNOR	CC	GO:0044391	ribosomal subunit	-	203	23	-	-	9.80E-04	3.74E-03
SIGNOR	CC	GO:0071013	catalytic step 2 spliceosome	-	88	23	-	-	3.30E-02	3.74E-03
SIGNOR	CC	GO:0098862	cluster of actin-based cell projections	-	162	49	-	-	2.65E-02	7.88E-03
SIGNOR	CC	GO:0098978	glutamatergic synapse	-	411	239	-	-	3.00E-02	3.78E-02
SIGNOR	CC	GO:0016363	nuclear matrix	-	127	76	-	-	6.30E-03	1.20E-02
SIGNOR	CC	GO:0031261	DNA replication preinitiation complex	-	46	19	-	-	2.74E-02	3.15E-03
SIGNOR	CC	GO:0031966	mitochondrial membrane	-	746	174	-	-	3.01E-02	2.76E-02
SIGNOR	CC	GO:0097060	synaptic membrane	-	413	183	-	-	4.71E-02	2.90E-02
SIGNOR	CC	GO:0032432	actin filament bundle	-	249	99	-	-	8.23E-03	1.58E-02
SIGNOR	CC	GO:0008088	axo-dendritic transport	-	78	32	-	-	5.29E-03	5.12E-03
SIGNOR	CC	GO:0031519	PcG protein complex	-	38	21	-	-	7.30E-02	3.35E-03
SIGNOR	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	13	-	-	1.40E-01	2.17E-03
SIGNOR	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	110	-	-	7.85E-02	1.73E-02
SIGNOR	CC	GO:0098791	Golgi apparatus subcompartment	-	378	106	-	-	1.45E-02	1.67E-02
SIGNOR	CC	GO:0099643	signal release from synapse	-	147	75	-	-	4.78E-02	1.18E-02
SIGNOR	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	20	-	-	8.84E-02	3.15E-03
SIGNOR	CC	GO:0030018	Z disc	-	129	62	-	-	3.86E-02	9.85E-03
SIGNOR	CC	GO:0032580	Golgi cisterna membrane	-	93	15	-	-	3.07E-02	2.36E-03
SIGNOR	CC	GO:1905360	GTPase complex	-	41	28	-	-	1.53E-03	4.53E-03
SIGNOR	CC	GO:0097540	axonemal central pair	-	161	43	-	-	4.48E-03	6.90E-03
SIGNOR	CC	GO:0042641	actomyosin	-	77	43	-	-	1.49E-02	6.90E-03
SIGNOR	CC	GO:0097386	glial cell projection	-	38	20	-	-	4.38E-03	3.15E-03
SIGNOR	CC	GO:0032588	trans-Golgi network membrane	-	102	26	-	-	1.65E-02	4.14E-03
SIGNOR	CC	GO:0070382	exocytic vesicle	-	224	82	-	-	4.80E-02	1.30E-02
SIGNOR	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	14	-	-	2.22E-03	2.36E-03
SIGNOR	CC	GO:0031903	microbody membrane	-	65	13	-	-	5.87E-04	2.17E-03
SIGNOR	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	99	-	-	1.29E-02	1.58E-02
SIGNOR	CC	GO:0044298	cell body membrane	-	32	15	-	-	7.80E-04	2.36E-03
SIGNOR	CC	GO:0051882	mitochondrial depolarization	-	21	11	-	-	3.01E-03	1.77E-03
SIGNOR	CC	GO:0016323	basolateral plasma membrane	-	239	97	-	-	7.22E-03	1.54E-02
SIGNOR	CC	GO:0042645	mitochondrial nucleoid	-	45	15	-	-	3.41E-02	2.36E-03
SIGNOR	CC	GO:1902495	transmembrane transporter complex	-	408	91	-	-	1.27E-02	1.44E-02
SIGNOR	CC	GO:0098636	protein complex involved in cell adhesion	-	57	28	-	-	4.77E-03	4.53E-03
SIGNOR	CC	GO:0001917	photoreceptor inner segment	-	71	23	-	-	1.14E-02	3.74E-03
SIGNOR	CC	GO:0019897	extrinsic component of plasma membrane	-	156	105	-	-	9.38E-03	1.65E-02
SIGNOR	CC	GO:0031594	neuromuscular junction	-	73	40	-	-	6.79E-03	6.30E-03
SIGNOR	CC	GO:0000793	condensed chromosome	-	274	130	-	-	3.39E-02	2.05E-02
SIGNOR	CC	GO:0000922	spindle pole	-	172	89	-	-	1.20E-02	1.42E-02
SIGNOR	CC	GO:0120111	neuron projection cytoplasm	-	94	40	-	-	1.18E-02	6.30E-03
SIGNOR	CC	GO:0070971	endoplasmic reticulum exit site	-	32	13	-	-	6.72E-02	2.17E-03
SIGNOR	CC	GO:0004879	nuclear receptor activity	-	63	52	-	-	3.74E-02	8.27E-03
SIGNOR	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	100	-	-	7.00E-03	1.58E-02
SIGNOR	CC	GO:0000123	histone acetyltransferase complex	-	93	22	-	-	9.65E-04	3.55E-03
SIGNOR	CC	GO:0048786	presynaptic active zone	-	80	42	-	-	1.08E-02	6.70E-03
SIGNOR	CC	GO:0007034	vacuolar transport	-	168	49	-	-	1.63E-02	7.88E-03
SIGNOR	CC	GO:0005776	autophagosome	-	111	59	-	-	9.32E-02	9.46E-03
SIGNOR	CC	GO:0031430	M band	-	22	12	-	-	1.67E-01	1.97E-03
SIGNOR	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	18	-	-	5.21E-02	2.96E-03
SIGNOR	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	15	-	-	2.01E-02	2.36E-03
SIGNOR	CC	GO:0000164	protein phosphatase type 1 complex	-	19	11	-	-	2.65E-02	1.77E-03
SIGNOR	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	16	-	-	7.87E-04	2.56E-03
SIGNOR	CC	GO:0032994	protein-lipid complex	-	39	17	-	-	1.04E-01	2.76E-03
SIGNOR	CC	GO:0150034	distal axon	-	309	163	-	-	1.38E-02	2.58E-02
SIGNOR	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	32	-	-	1.96E-02	5.12E-03
SIGNOR	CC	GO:0072562	blood microparticle	-	144	54	-	-	1.30E-02	8.67E-03
SIGNOR	CC	GO:0051233	spindle midzone	-	36	23	-	-	7.17E-02	3.74E-03
SIGNOR	CC	GO:0005811	lipid droplet	-	102	33	-	-	5.57E-03	5.32E-03
SIGNOR	CC	GO:0045022	early endosome to late endosome transport	-	44	22	-	-	2.10E-02	3.55E-03
SIGNOR	CC	GO:0043113	receptor clustering	-	51	34	-	-	2.91E-02	5.52E-03
SIGNOR	CC	GO:0044853	plasma membrane raft	-	114	69	-	-	6.41E-03	1.10E-02
SIGNOR	CC	GO:0005881	cytoplasmic microtubule	-	256	73	-	-	6.93E-03	1.16E-02
SIGNOR	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	15	-	-	9.99E-03	2.36E-03
SIGNOR	CC	GO:0005905	clathrin-coated pit	-	73	38	-	-	2.99E-02	6.11E-03
SIGNOR	CC	GO:0031904	endosome lumen	-	38	21	-	-	6.09E-02	3.35E-03
SIGNOR	CC	GO:0060170	ciliary membrane	-	76	29	-	-	5.51E-02	4.73E-03
SIGNOR	CC	GO:0000139	Golgi membrane	-	646	195	-	-	2.03E-02	3.07E-02
SIGNOR	CC	GO:0032154	cleavage furrow	-	54	33	-	-	8.79E-03	5.32E-03
SIGNOR	CC	GO:0007006	mitochondrial membrane organization	-	117	43	-	-	1.20E-02	6.90E-03
SIGNOR	CC	GO:0001772	immunological synapse	-	44	31	-	-	1.59E-02	4.93E-03
SIGNOR	CC	GO:0009897	external side of plasma membrane	-	425	178	-	-	1.08E-02	2.82E-02
SIGNOR	CC	GO:0030863	cortical cytoskeleton	-	104	53	-	-	3.66E-03	8.47E-03
SIGNOR	CC	GO:0030315	T-tubule	-	52	24	-	-	9.76E-04	3.94E-03
SIGNOR	CC	GO:0060076	excitatory synapse	-	64	31	-	-	1.06E-02	4.93E-03
SIGNOR	CC	GO:0036019	endolysosome	-	29	14	-	-	1.78E-02	2.36E-03
SIGNOR	CC	GO:0001891	phagocytic cup	-	28	18	-	-	7.79E-04	2.96E-03
SIGNOR	CC	GO:0099086	synaptonemal structure	-	40	11	-	-	4.02E-03	1.77E-03
SIGNOR	CC	GO:0030427	site of polarized growth	-	172	105	-	-	7.75E-03	1.65E-02
SIGNOR	CC	GO:0044309	neuron spine	-	213	106	-	-	1.68E-02	1.67E-02
SIGNOR	CC	GO:0030658	transport vesicle membrane	-	231	74	-	-	9.04E-03	1.18E-02
SIGNOR	CC	GO:0098918	structural constituent of synapse	-	27	13	-	-	2.27E-02	2.17E-03
SIGNOR	CC	GO:0030667	secretory granule membrane	-	319	104	-	-	8.28E-03	1.65E-02
SIGNOR	CC	GO:0097545	axonemal outer doublet	-	164	43	-	-	4.61E-03	6.90E-03
SIGNOR	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	18	-	-	2.21E-02	2.96E-03
SIGNOR	CC	GO:0055037	recycling endosome	-	200	68	-	-	6.42E-03	1.08E-02
SIGNOR	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	66	-	-	5.13E-03	1.04E-02
SIGNOR	CC	GO:0071682	endocytic vesicle lumen	-	23	15	-	-	1.00E-01	2.36E-03
SIGNOR	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	145	-	-	7.99E-03	2.29E-02
SIGNOR	CC	GO:1990391	DNA repair complex	-	22	15	-	-	9.24E-02	2.36E-03
SIGNOR	CC	GO:0005775	vacuolar lumen	-	176	59	-	-	5.05E-03	9.46E-03
SIGNOR	CC	GO:0016327	apicolateral plasma membrane	-	23	12	-	-	5.07E-03	1.97E-03
SIGNOR	CC	GO:0044306	neuron projection terminus	-	164	73	-	-	5.27E-03	1.16E-02
SIGNOR	CC	GO:0005770	late endosome	-	299	100	-	-	2.09E-02	1.58E-02
SIGNOR	CC	GO:0031970	organelle envelope lumen	-	94	31	-	-	1.02E-02	4.93E-03
SIGNOR	CC	GO:0019866	organelle inner membrane	-	546	85	-	-	1.12E-02	1.34E-02
SIGNOR	CC	GO:0098687	chromosomal region	-	397	201	-	-	4.74E-02	3.17E-02
SIGNOR	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	16	-	-	2.61E-03	2.56E-03
SIGNOR	CC	GO:0043292	contractile muscle fiber	-	245	102	-	-	2.05E-02	1.62E-02
SIGNOR	CC	GO:0000803	sex chromosome	-	32	17	-	-	2.07E-03	2.76E-03
SIGNOR	CC	GO:0098982	GABA-ergic synapse	-	84	35	-	-	1.56E-03	5.52E-03
SIGNOR	CC	GO:0035097	histone methyltransferase complex	-	63	26	-	-	1.56E-02	4.14E-03
SIGNOR	CC	GO:0000323	lytic vacuole	-	749	247	-	-	2.59E-02	3.90E-02
SIGNOR	CC	GO:0000242	pericentriolar material	-	22	14	-	-	8.14E-03	2.36E-03
SIGNOR	CC	GO:1903293	phosphatase complex	-	54	33	-	-	1.32E-02	5.32E-03
SIGNOR	CC	GO:0000786	nucleosome	-	149	68	-	-	9.07E-03	1.08E-02
SIGNOR	CC	GO:0001533	cornified envelope	-	59	20	-	-	9.78E-04	3.15E-03
SIGNOR	CC	GO:1904724	tertiary granule lumen	-	55	23	-	-	1.91E-03	3.74E-03
SIGNOR	CC	GO:0030027	lamellipodium	-	202	122	-	-	3.51E-02	1.93E-02
SIGNOR	CC	GO:0002102	podosome	-	31	18	-	-	1.81E-02	2.96E-03
SIGNOR	CC	GO:0090543	Flemming body	-	33	19	-	-	7.85E-04	3.15E-03
SIGNOR	CC	GO:0016328	lateral plasma membrane	-	66	38	-	-	4.18E-03	6.11E-03
SIGNOR	CC	GO:0001650	fibrillar center	-	151	67	-	-	7.81E-03	1.06E-02
SIGNOR	CC	GO:1990204	oxidoreductase complex	-	90	24	-	-	1.76E-02	3.94E-03
SIGNOR	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	56	-	-	3.09E-03	8.87E-03
SIGNOR	CC	GO:0001726	ruffle	-	181	109	-	-	9.48E-03	1.73E-02
SIGNOR	CC	GO:1990909	Wnt signalosome	-	13	11	-	-	4.99E-02	1.77E-03
SIGNOR	CC	GO:0043198	dendritic shaft	-	38	22	-	-	9.76E-04	3.55E-03
SIGNOR	CC	GO:0043073	germ cell nucleus	-	67	34	-	-	3.78E-03	5.52E-03
SIGNOR	CC	GO:0005788	endoplasmic reticulum lumen	-	313	128	-	-	1.13E-02	2.03E-02
SIGNOR	CC	GO:0016592	mediator complex	-	38	11	-	-	5.90E-04	1.77E-03
SIGNOR	CC	GO:0034045	phagophore assembly site membrane	-	19	12	-	-	6.83E-02	1.97E-03
SIGNOR	CC	GO:0022626	cytosolic ribosome	-	118	22	-	-	3.52E-03	3.55E-03
SIGNOR	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	23	-	-	2.37E-02	3.74E-03
SIGNOR	CC	GO:0034451	centriolar satellite	-	120	45	-	-	5.06E-03	7.09E-03
SIGNOR	CC	GO:0045171	intercellular bridge	-	91	34	-	-	2.81E-03	5.52E-03
SIGNOR	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	30	-	-	6.45E-02	4.73E-03
SIGNOR	CC	GO:0098984	neuron to neuron synapse	-	384	186	-	-	3.09E-02	2.94E-02
SIGNOR	CC	GO:0030527	structural constituent of chromatin	-	97	49	-	-	1.96E-03	7.88E-03
SIGNOR	CC	GO:0030286	dynein complex	-	210	53	-	-	6.21E-03	8.47E-03
SIGNOR	CC	GO:0016482	cytosolic transport	-	135	36	-	-	2.50E-02	5.71E-03
SIGNOR	CC	GO:0005796	Golgi lumen	-	106	53	-	-	2.00E-02	8.47E-03
SIGNOR	CC	GO:0034358	plasma lipoprotein particle	-	36	16	-	-	1.25E-01	2.56E-03
SIGNOR	CC	GO:0008023	transcription elongation factor complex	-	47	16	-	-	1.93E-01	2.56E-03
SIGNOR	CC	GO:0030662	coated vesicle membrane	-	202	96	-	-	1.47E-02	1.52E-02
SIGNOR	CC	GO:0007039	protein catabolic process in the vacuole	-	61	17	-	-	1.14E-02	2.76E-03
SIGNOR	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	151	-	-	1.61E-02	2.38E-02
SIGNOR	CC	GO:0005769	early endosome	-	425	173	-	-	2.61E-02	2.74E-02
SIGNOR	CC	GO:0090734	site of DNA damage	-	118	57	-	-	9.35E-03	9.06E-03
SIGNOR	MF	GO:0051087	protein-folding chaperone binding	-	135	68	-	-	6.70E-03	1.08E-02
SIGNOR	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	20	-	-	9.72E-04	3.15E-03
SIGNOR	MF	GO:0140640	"catalytic activity, acting on a nucleic acid"	-	762	248	-	-	2.36E-02	3.92E-02
SIGNOR	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	61	-	-	3.36E-03	9.65E-03
SIGNOR	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	15	-	-	2.33E-03	2.36E-03
SIGNOR	MF	GO:0016757	glycosyltransferase activity	-	286	55	-	-	3.95E-03	8.67E-03
SIGNOR	MF	GO:0048306	calcium-dependent protein binding	-	61	28	-	-	2.81E-02	4.53E-03
SIGNOR	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	31	-	-	3.96E-03	4.93E-03
SIGNOR	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	40	-	-	8.57E-03	6.30E-03
SIGNOR	MF	GO:0051020	GTPase binding	-	311	156	-	-	1.31E-02	2.46E-02
SIGNOR	MF	GO:0140457	protein demethylase activity	-	31	19	-	-	2.56E-03	3.15E-03
SIGNOR	MF	GO:0005158	insulin receptor binding	-	22	16	-	-	4.82E-02	2.56E-03
SIGNOR	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	6.02E-03	2.36E-03
SIGNOR	MF	GO:0061980	regulatory RNA binding	-	52	24	-	-	6.20E-02	3.94E-03
SIGNOR	MF	GO:0070840	dynein complex binding	-	25	15	-	-	7.80E-04	2.36E-03
SIGNOR	MF	GO:0035035	histone acetyltransferase binding	-	24	16	-	-	7.66E-04	2.56E-03
SIGNOR	MF	GO:0061684	chaperone-mediated autophagy	-	16	12	-	-	6.93E-03	1.97E-03
SIGNOR	MF	GO:0003688	DNA replication origin binding	-	18	11	-	-	2.12E-02	1.77E-03
SIGNOR	MF	GO:0005178	integrin binding	-	153	85	-	-	1.19E-02	1.34E-02
SIGNOR	MF	GO:0070064	proline-rich region binding	-	17	13	-	-	5.35E-03	2.17E-03
SIGNOR	MF	GO:0008327	methyl-CpG binding	-	31	15	-	-	1.24E-02	2.36E-03
SIGNOR	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	14	-	-	7.38E-03	2.36E-03
SIGNOR	MF	GO:0000217	DNA secondary structure binding	-	37	27	-	-	1.86E-02	4.33E-03
SIGNOR	MF	GO:0002039	p53 binding	-	66	53	-	-	9.23E-03	8.47E-03
SIGNOR	MF	GO:0005496	steroid binding	-	110	44	-	-	7.19E-03	7.09E-03
SIGNOR	MF	GO:0008443	phosphofructokinase activity	-	27	18	-	-	7.64E-04	2.96E-03
SIGNOR	MF	GO:0003684	damaged DNA binding	-	89	58	-	-	2.53E-02	9.26E-03
SIGNOR	MF	GO:0016500	protein-hormone receptor activity	-	21	14	-	-	5.85E-04	2.36E-03
SIGNOR	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	86	-	-	8.35E-03	1.36E-02
SIGNOR	MF	GO:0070063	RNA polymerase binding	-	61	26	-	-	1.16E-03	4.14E-03
SIGNOR	MF	GO:0030971	receptor tyrosine kinase binding	-	76	53	-	-	1.50E-02	8.47E-03
SIGNOR	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	33	-	-	2.26E-01	5.32E-03
SIGNOR	MF	GO:0140030	modification-dependent protein binding	-	179	81	-	-	2.05E-02	1.28E-02
SIGNOR	MF	GO:0042813	Wnt receptor activity	-	16	15	-	-	2.08E-02	2.36E-03
SIGNOR	MF	GO:0035497	cAMP response element binding	-	12	11	-	-	9.03E-02	1.77E-03
SIGNOR	MF	GO:0030276	clathrin binding	-	70	24	-	-	3.59E-02	3.94E-03
SIGNOR	MF	GO:0046875	ephrin receptor binding	-	29	26	-	-	2.03E-02	4.14E-03
SIGNOR	MF	GO:0030552	cAMP binding	-	48	28	-	-	1.87E-02	4.53E-03
SIGNOR	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	19	-	-	2.74E-03	3.15E-03
SIGNOR	MF	GO:0004857	enzyme inhibitor activity	-	395	159	-	-	9.00E-03	2.52E-02
SIGNOR	MF	GO:0035173	histone kinase activity	-	17	16	-	-	1.45E-03	2.56E-03
SIGNOR	MF	GO:0097602	cullin family protein binding	-	26	12	-	-	5.88E-04	1.97E-03
SIGNOR	MF	GO:0016209	antioxidant activity	-	92	38	-	-	8.95E-03	6.11E-03
SIGNOR	MF	GO:0070325	lipoprotein particle receptor binding	-	32	19	-	-	7.96E-03	3.15E-03
SIGNOR	MF	GO:0044325	transmembrane transporter binding	-	159	80	-	-	6.17E-03	1.26E-02
SIGNOR	MF	GO:0048156	tau protein binding	-	43	40	-	-	2.98E-03	6.30E-03
SIGNOR	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	14	-	-	5.89E-04	2.36E-03
SIGNOR	MF	GO:0045295	gamma-catenin binding	-	13	11	-	-	8.97E-03	1.77E-03
SIGNOR	MF	GO:0140272	exogenous protein binding	-	79	40	-	-	1.93E-03	6.30E-03
SIGNOR	MF	GO:0030145	manganese ion binding	-	65	22	-	-	2.32E-03	3.55E-03
SIGNOR	MF	GO:0071814	protein-lipid complex binding	-	52	24	-	-	4.66E-02	3.94E-03
SIGNOR	MF	GO:0008066	glutamate receptor activity	-	70	41	-	-	1.28E-02	6.50E-03
SIGNOR	MF	GO:0031369	translation initiation factor binding	-	32	17	-	-	1.45E-02	2.76E-03
SIGNOR	MF	GO:0019843	rRNA binding	-	69	14	-	-	5.84E-04	2.36E-03
SIGNOR	MF	GO:0004713	protein tyrosine kinase activity	-	213	171	-	-	2.85E-02	2.70E-02
SIGNOR	MF	GO:0016779	nucleotidyltransferase activity	-	264	83	-	-	7.43E-03	1.32E-02
SIGNOR	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	39	-	-	9.07E-03	6.30E-03
SIGNOR	MF	GO:0008093	cytoskeletal anchor activity	-	24	16	-	-	7.85E-04	2.56E-03
SIGNOR	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	13	-	-	6.43E-03	2.17E-03
SIGNOR	MF	GO:0016208	AMP binding	-	22	14	-	-	8.63E-03	2.36E-03
SIGNOR	MF	GO:0000287	magnesium ion binding	-	225	103	-	-	6.61E-03	1.64E-02
SIGNOR	MF	GO:0031490	chromatin DNA binding	-	120	79	-	-	7.02E-03	1.26E-02
SIGNOR	MF	GO:0017022	myosin binding	-	73	33	-	-	1.36E-03	5.32E-03
SIGNOR	MF	GO:0004896	cytokine receptor activity	-	93	72	-	-	4.01E-03	1.14E-02
SIGNOR	MF	GO:0008301	"DNA binding, bending"	-	18	11	-	-	5.88E-04	1.77E-03
SIGNOR	MF	GO:0015631	tubulin binding	-	410	184	-	-	2.65E-02	2.92E-02
SIGNOR	MF	GO:0005539	glycosaminoglycan binding	-	236	96	-	-	1.42E-02	1.52E-02
SIGNOR	MF	GO:0019207	kinase regulator activity	-	267	163	-	-	1.47E-02	2.58E-02
SIGNOR	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	11	-	-	5.90E-04	1.77E-03
SIGNOR	MF	GO:0044183	protein folding chaperone	-	67	23	-	-	8.59E-03	3.74E-03
SIGNOR	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	92	-	-	3.47E-02	1.46E-02
SIGNOR	MF	GO:0003725	double-stranded RNA binding	-	72	29	-	-	1.36E-02	4.73E-03
SIGNOR	MF	GO:0051018	protein kinase A binding	-	52	33	-	-	4.73E-02	5.32E-03
SIGNOR	MF	GO:0071889	14-3-3 protein binding	-	34	21	-	-	3.61E-03	3.35E-03
SIGNOR	MF	GO:0004618	phosphoglycerate kinase activity	-	89	59	-	-	7.27E-03	9.46E-03
SIGNOR	MF	GO:0042805	actinin binding	-	36	16	-	-	1.73E-02	2.56E-03
SIGNOR	MF	GO:0043531	ADP binding	-	38	21	-	-	9.78E-04	3.35E-03
SIGNOR	MF	GO:0043394	proteoglycan binding	-	36	20	-	-	9.77E-04	3.15E-03
SIGNOR	MF	GO:0046332	SMAD binding	-	77	67	-	-	4.91E-02	1.06E-02
SIGNOR	MF	GO:0043560	insulin receptor substrate binding	-	13	11	-	-	1.20E-03	1.77E-03
SIGNOR	MF	GO:0001968	fibronectin binding	-	30	13	-	-	5.86E-04	2.17E-03
SIGNOR	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	66	-	-	1.07E-01	1.04E-02
SIGNOR	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	25	-	-	8.02E-03	3.94E-03
SIGNOR	MF	GO:0051117	ATPase binding	-	85	47	-	-	5.27E-03	7.49E-03
SIGNOR	MF	GO:0005216	monoatomic ion channel activity	-	618	186	-	-	7.02E-02	2.94E-02
SIGNOR	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	36	-	-	3.60E-02	5.71E-03
SIGNOR	MF	GO:0001098	basal transcription machinery binding	-	61	27	-	-	8.72E-03	4.33E-03
SIGNOR	MF	GO:0036002	pre-mRNA binding	-	57	17	-	-	7.61E-03	2.76E-03
SIGNOR	MF	GO:0051540	metal cluster binding	-	71	14	-	-	5.90E-04	2.36E-03
SIGNOR	MF	GO:0051219	phosphoprotein binding	-	92	69	-	-	7.43E-03	1.10E-02
SIGNOR	MF	GO:0019894	kinesin binding	-	45	20	-	-	1.60E-02	3.15E-03
SIGNOR	MF	GO:0042287	MHC protein binding	-	68	24	-	-	2.19E-02	3.94E-03
SIGNOR	MF	GO:0019003	GDP binding	-	89	43	-	-	1.69E-03	6.90E-03
SIGNOR	MF	GO:0017171	serine hydrolase activity	-	207	59	-	-	5.93E-02	9.46E-03
SIGNOR	MF	GO:0097110	scaffold protein binding	-	66	56	-	-	5.62E-03	8.87E-03
SIGNOR	MF	GO:0003774	cytoskeletal motor activity	-	117	38	-	-	8.37E-03	6.11E-03
SIGNOR	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	17	-	-	3.09E-03	2.76E-03
SIGNOR	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	13	-	-	5.86E-04	2.17E-03
SIGNOR	MF	GO:0061134	peptidase regulator activity	-	224	63	-	-	5.82E-03	1.00E-02
SIGNOR	MF	GO:0008013	beta-catenin binding	-	86	66	-	-	9.79E-03	1.04E-02
SIGNOR	MF	GO:0051015	actin filament binding	-	208	73	-	-	3.99E-03	1.16E-02
SIGNOR	MF	GO:0019208	phosphatase regulator activity	-	107	52	-	-	4.25E-03	8.27E-03
SIGNOR	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	11	-	-	5.87E-04	1.77E-03
SIGNOR	MF	GO:0043236	laminin binding	-	29	15	-	-	6.32E-03	2.36E-03
SIGNOR	MF	GO:0030507	spectrin binding	-	26	11	-	-	5.89E-04	1.77E-03
SIGNOR	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	64	-	-	1.21E-01	1.02E-02
SIGNOR	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	23	-	-	3.62E-03	3.74E-03
SIGNOR	MF	GO:0042393	histone binding	-	240	98	-	-	2.47E-02	1.56E-02
SIGNOR	MF	GO:0019838	growth factor binding	-	182	116	-	-	3.52E-02	1.83E-02
SIGNOR	MF	GO:0000149	SNARE binding	-	107	38	-	-	2.76E-02	6.11E-03
SIGNOR	MF	GO:0003727	single-stranded RNA binding	-	90	30	-	-	1.37E-03	4.73E-03
SIGNOR	MF	GO:0051378	serotonin binding	-	24	22	-	-	9.85E-04	3.55E-03
SIGNOR	MF	GO:0005516	calmodulin binding	-	206	104	-	-	9.51E-03	1.65E-02
SIGNOR	MF	GO:0019825	oxygen binding	-	40	17	-	-	8.84E-03	2.76E-03
SIGNOR	MF	GO:0045505	dynein intermediate chain binding	-	37	12	-	-	5.90E-04	1.97E-03
SIGNOR	MF	GO:0005198	structural molecule activity	-	823	246	-	-	3.05E-02	3.88E-02
SIGNOR	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	20	-	-	9.78E-04	3.15E-03
SIGNOR	MF	GO:0032182	ubiquitin-like protein binding	-	117	66	-	-	7.42E-03	1.04E-02
SIGNOR	MF	GO:0023023	MHC protein complex binding	-	36	24	-	-	9.80E-04	3.94E-03
SIGNOR	MF	GO:0030742	GTP-dependent protein binding	-	22	14	-	-	1.23E-02	2.36E-03
SIGNOR	MF	GO:0043274	phospholipase binding	-	23	17	-	-	6.94E-03	2.76E-03
SIGNOR	MF	GO:0031072	heat shock protein binding	-	128	68	-	-	1.29E-02	1.08E-02
SIGNOR	MF	GO:0001965	G-protein alpha-subunit binding	-	26	13	-	-	5.86E-04	2.17E-03
SIGNOR	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	237	-	-	1.36E-02	3.74E-02
SIGNOR	MF	GO:0001530	lipopolysaccharide binding	-	38	16	-	-	1.73E-02	2.56E-03
SIGNOR	MF	GO:0046982	protein heterodimerization activity	-	343	180	-	-	1.13E-02	2.84E-02
SIGNOR	MF	GO:0000049	tRNA binding	-	75	25	-	-	1.18E-03	3.94E-03
SIGNOR	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	41	-	-	4.15E-03	6.50E-03
SIGNOR	MF	GO:0015026	coreceptor activity	-	48	26	-	-	1.16E-03	4.14E-03
SIGNOR	MF	GO:0001653	peptide receptor activity	-	128	85	-	-	4.72E-03	1.34E-02
SIGNOR	MF	GO:0006469	negative regulation of protein kinase activity	-	222	141	-	-	1.12E-02	2.23E-02
SIGNOR	MF	GO:0070182	DNA polymerase binding	-	22	15	-	-	7.81E-04	2.36E-03
SIGNOR	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	24	-	-	1.50E-02	3.94E-03
SIGNOR	MF	GO:0051427	hormone receptor binding	-	31	21	-	-	2.23E-03	3.35E-03
SIGNOR	MF	GO:0070851	growth factor receptor binding	-	141	106	-	-	2.48E-02	1.67E-02
SIGNOR	MF	GO:0031210	phosphatidylcholine binding	-	32	12	-	-	5.88E-04	1.97E-03
SIGNOR	MF	GO:0005525	GTP binding	-	396	144	-	-	7.20E-03	2.29E-02
SIGNOR	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	27	-	-	3.81E-03	4.33E-03
SIGNOR	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	198	-	-	2.26E-02	3.13E-02
SIGNOR	MF	GO:0034185	apolipoprotein binding	-	20	14	-	-	5.74E-04	2.36E-03
SIGNOR	MF	GO:0051346	negative regulation of hydrolase activity	-	332	137	-	-	7.27E-03	2.17E-02
SIGNOR	MF	GO:0005506	iron ion binding	-	154	43	-	-	4.49E-03	6.90E-03
SIGNOR	MF	GO:0003925	G protein activity	-	45	22	-	-	9.54E-04	3.55E-03
SIGNOR	MF	GO:0038187	pattern recognition receptor activity	-	33	17	-	-	7.84E-04	2.76E-03
SIGNOR	MF	GO:0008276	protein methyltransferase activity	-	96	32	-	-	1.37E-03	5.12E-03
SIGNOR	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	239	-	-	1.61E-02	3.78E-02
SIGNOR	MF	GO:0070888	E-box binding	-	59	43	-	-	1.14E-02	6.90E-03
SIGNOR	MF	GO:0015399	primary active transmembrane transporter activity	-	190	44	-	-	7.57E-03	7.09E-03
SIGNOR	MF	GO:0035254	glutamate receptor binding	-	47	24	-	-	6.83E-03	3.94E-03
SIGNOR	MF	GO:0050321	tau-protein kinase activity	-	36	32	-	-	2.14E-03	5.12E-03
SIGNOR	MF	GO:0043021	ribonucleoprotein complex binding	-	158	45	-	-	4.83E-02	7.09E-03
SIGNOR	MF	GO:0005112	Notch binding	-	26	19	-	-	7.44E-02	3.15E-03
SIGNOR	MF	GO:0048185	activin binding	-	16	16	-	-	5.16E-02	2.56E-03
SIGNOR	MF	GO:0001664	G protein-coupled receptor binding	-	299	177	-	-	2.08E-02	2.80E-02
SIGNOR	MF	GO:0140299	small molecule sensor activity	-	39	15	-	-	6.73E-02	2.36E-03
SIGNOR	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	20	-	-	2.63E-03	3.15E-03
SIGNOR	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	20	-	-	9.67E-04	3.15E-03
SIGNOR	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	18	-	-	1.94E-03	2.96E-03
SIGNOR	MF	GO:0030594	neurotransmitter receptor activity	-	160	77	-	-	3.25E-02	1.22E-02
SIGNOR	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	18	-	-	1.88E-03	2.96E-03
SIGNOR	MF	GO:0005507	copper ion binding	-	63	25	-	-	6.74E-03	3.94E-03
SIGNOR	MF	GO:0033558	protein lysine deacetylase activity	-	22	18	-	-	5.30E-03	2.96E-03
SPIKE	CC	GO:0005615	extracellular space	8.98E-77	3190	2080	1606	1.30	-	-
SPIKE	CC	GO:0005730	nucleolus	6.29E-63	988	748	497	1.50	-	-
SPIKE	CC	GO:0005635	nuclear envelope	8.74E-22	493	352	248	1.42	-	-
SPIKE	CC	GO:0000228	nuclear chromosome	6.23E-20	206	167	104	1.61	-	-
SPIKE	CC	GO:0005815	microtubule organizing center	7.23E-20	843	553	424	1.30	-	-
SPIKE	CC	GO:0005840	ribosome	1.99E-18	222	175	112	1.57	-	-
SPIKE	CC	GO:0005768	endosome	1.56E-16	1037	651	522	1.25	-	-
SPIKE	CC	GO:0005739	mitochondrion	5.84E-11	1671	969	841	1.15	-	-
SPIKE	CC	GO:0005764	lysosome	4.03E-09	747	455	376	1.21	-	-
SPIKE	CC	GO:0005794	Golgi apparatus	1.66E-07	1636	925	824	1.12	-	-
SPIKE	CC	GO:0005783	endoplasmic reticulum	5.82E-07	2020	1123	1017	1.10	-	-
SPIKE	CC	GO:0031012	extracellular matrix	6.19E-04	564	324	284	1.14	-	-
SPIKE	CC	GO:0005777	peroxisome	5.41E-03	142	88	71	1.23	-	-
SPIKE	CC	GO:0005929	cilium	4.44E-02	842	395	424	0.93	-	-
SPIKE	CC	GO:0005811	lipid droplet	1.98E-01	102	58	51	1.13	-	-
SPIKE	BP	GO:0012501	programmed cell death	2.96E-154	1954	1523	984	1.55	-	-
SPIKE	BP	GO:0002376	immune system process	1.20E-98	2448	1713	1232	1.39	-	-
SPIKE	BP	GO:0006355	regulation of DNA-templated transcription	9.66E-91	3342	2208	1683	1.31	-	-
SPIKE	BP	GO:0065003	protein-containing complex assembly	4.89E-76	1648	1182	830	1.42	-	-
SPIKE	BP	GO:0006325	chromatin organization	3.57E-61	720	573	362	1.58	-	-
SPIKE	BP	GO:0048870	cell motility	9.01E-55	1659	1135	835	1.36	-	-
SPIKE	BP	GO:0006281	DNA repair	9.87E-55	587	475	296	1.61	-	-
SPIKE	BP	GO:0007155	cell adhesion	1.74E-49	1444	994	727	1.37	-	-
SPIKE	BP	GO:0016071	mRNA metabolic process	7.16E-46	713	541	359	1.51	-	-
SPIKE	BP	GO:0030163	protein catabolic process	4.13E-45	990	711	498	1.43	-	-
SPIKE	BP	GO:0007010	cytoskeleton organization	8.02E-42	1639	1085	825	1.31	-	-
SPIKE	BP	GO:0016192	vesicle-mediated transport	4.67E-35	1894	1207	954	1.27	-	-
SPIKE	BP	GO:0042060	wound healing	5.36E-35	431	340	217	1.57	-	-
SPIKE	BP	GO:0006914	autophagy	1.25E-34	568	427	286	1.49	-	-
SPIKE	BP	GO:0006886	intracellular protein transport	2.75E-33	664	484	334	1.45	-	-
SPIKE	BP	GO:0006913	nucleocytoplasmic transport	7.92E-33	326	267	164	1.63	-	-
SPIKE	BP	GO:0032200	telomere organization	8.42E-31	186	167	94	1.78	-	-
SPIKE	BP	GO:0098542	defense response to other organism	9.06E-31	1171	779	590	1.32	-	-
SPIKE	BP	GO:0006260	DNA replication	6.96E-30	279	231	140	1.64	-	-
SPIKE	BP	GO:0006954	inflammatory response	3.99E-29	820	568	413	1.38	-	-
SPIKE	BP	GO:0007059	chromosome segregation	2.24E-28	403	310	203	1.53	-	-
SPIKE	BP	GO:0002181	cytoplasmic translation	4.02E-26	153	138	77	1.79	-	-
SPIKE	BP	GO:0034330	cell junction organization	2.68E-24	727	499	366	1.36	-	-
SPIKE	BP	GO:0006310	DNA recombination	6.59E-22	333	253	168	1.51	-	-
SPIKE	BP	GO:0007163	establishment or maintenance of cell polarity	5.02E-20	227	181	114	1.58	-	-
SPIKE	BP	GO:0072659	protein localization to plasma membrane	9.56E-16	284	209	143	1.46	-	-
SPIKE	BP	GO:0050877	nervous system process	1.82E-15	1527	620	769	0.81	-	-
SPIKE	BP	GO:0003013	circulatory system process	6.53E-15	584	386	294	1.31	-	-
SPIKE	BP	GO:0000910	cytokinesis	3.96E-14	186	144	94	1.54	-	-
SPIKE	BP	GO:0042254	ribosome biogenesis	4.91E-14	297	213	150	1.42	-	-
SPIKE	BP	GO:0003012	muscle system process	4.99E-14	425	290	214	1.36	-	-
SPIKE	BP	GO:0006091	generation of precursor metabolites and energy	8.18E-12	502	328	253	1.30	-	-
SPIKE	BP	GO:0006457	protein folding	1.19E-11	210	154	106	1.46	-	-
SPIKE	BP	GO:0007005	mitochondrion organization	9.62E-10	484	310	244	1.27	-	-
SPIKE	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	5.72E-09	119	91	60	1.52	-	-
SPIKE	BP	GO:0055086	nucleobase-containing small molecule metabolic process	3.21E-08	729	440	367	1.20	-	-
SPIKE	BP	GO:0006486	protein glycosylation	1.29E-07	225	74	113	0.65	-	-
SPIKE	BP	GO:0005975	carbohydrate metabolic process	2.33E-04	551	320	277	1.15	-	-
SPIKE	BP	GO:0140013	meiotic nuclear division	8.92E-04	279	168	140	1.20	-	-
SPIKE	BP	GO:0055085	transmembrane transport	2.02E-03	1784	836	898	0.93	-	-
SPIKE	BP	GO:0006520	amino acid metabolic process	2.15E-03	292	173	147	1.18	-	-
SPIKE	BP	GO:0098754	detoxification	2.36E-03	134	85	67	1.26	-	-
SPIKE	BP	GO:0030198	extracellular matrix organization	3.64E-03	314	184	158	1.16	-	-
SPIKE	BP	GO:0003014	renal system process	4.32E-03	127	80	64	1.25	-	-
SPIKE	BP	GO:0140053	mitochondrial gene expression	1.19E-02	164	99	83	1.20	-	-
SPIKE	BP	GO:0022600	digestive system process	4.47E-02	110	66	55	1.19	-	-
SPIKE	BP	GO:0044782	cilium organization	6.10E-02	399	182	201	0.91	-	-
SPIKE	BP	GO:0006399	tRNA metabolic process	6.17E-02	196	112	99	1.14	-	-
SPIKE	BP	GO:0007040	lysosome organization	8.13E-02	107	63	54	1.17	-	-
SPIKE	BP	GO:0006766	vitamin metabolic process	3.34E-01	107	59	54	1.10	-	-
SPIKE	BP	GO:0006629	lipid metabolic process	3.52E-01	1355	699	682	1.02	-	-
SPIKE	BP	GO:0006790	sulfur compound metabolic process	3.67E-01	320	153	161	0.95	-	-
SPIKE	BP	GO:0007018	microtubule-based movement	4.94E-01	640	331	322	1.03	-	-
SPIKE	BP	GO:0006575	cellular modified amino acid metabolic process	1.00E+00	186	94	94	1.00	-	-
SPIKE	MF	GO:0003723	RNA binding	5.32E-113	1679	1277	845	1.51	-	-
SPIKE	MF	GO:0140096	"catalytic activity, acting on a protein"	2.95E-99	3198	2150	1610	1.34	-	-
SPIKE	MF	GO:0016740	transferase activity	1.14E-75	3074	2011	1548	1.30	-	-
SPIKE	MF	GO:0003677	DNA binding	1.71E-62	2865	1851	1442	1.28	-	-
SPIKE	MF	GO:0008092	cytoskeletal protein binding	2.94E-50	1023	743	515	1.44	-	-
SPIKE	MF	GO:0140110	transcription regulator activity	4.57E-44	2033	1318	1024	1.29	-	-
SPIKE	MF	GO:0140097	"catalytic activity, acting on DNA"	1.58E-36	383	311	193	1.61	-	-
SPIKE	MF	GO:0005198	structural molecule activity	2.04E-28	798	553	402	1.38	-	-
SPIKE	MF	GO:0140657	ATP-dependent activity	1.52E-23	729	498	367	1.36	-	-
SPIKE	MF	GO:0003924	GTPase activity	8.59E-19	658	442	331	1.33	-	-
SPIKE	MF	GO:0042393	histone binding	5.93E-16	237	180	119	1.51	-	-
SPIKE	MF	GO:0005215	transporter activity	8.91E-14	1462	599	736	0.81	-	-
SPIKE	MF	GO:0045182	translation regulator activity	7.00E-12	151	117	76	1.54	-	-
SPIKE	MF	GO:0008289	lipid binding	6.40E-11	836	513	421	1.22	-	-
SPIKE	MF	GO:0016874	ligase activity	1.02E-09	283	193	142	1.35	-	-
SPIKE	MF	GO:0016853	isomerase activity	6.33E-07	252	166	127	1.31	-	-
SPIKE	MF	GO:0048018	receptor ligand activity	1.57E-06	504	307	254	1.21	-	-
SPIKE	MF	GO:0140098	"catalytic activity, acting on RNA"	4.88E-06	417	256	210	1.22	-	-
SPIKE	MF	GO:0140104	molecular carrier activity	3.26E-05	105	74	53	1.40	-	-
SPIKE	MF	GO:0016829	lyase activity	2.33E-04	538	313	271	1.16	-	-
SPIKE	MF	GO:0003774	cytoskeletal motor activity	2.57E-04	116	78	58	1.34	-	-
SPIKE	MF	GO:0016491	oxidoreductase activity	5.09E-04	888	498	447	1.11	-	-
SPIKE	MF	GO:0038024	cargo receptor activity	4.14E-02	117	70	59	1.19	-	-
SPIKE	MF	GO:0009975	cyclase activity	8.56E-01	277	141	139	1.01	-	-
Spike	BP	GO:0008038	neuron recognition	-	46	30	-	-	1.26E-03	2.48E-03
Spike	BP	GO:1905145	cellular response to acetylcholine	-	33	21	-	-	9.37E-03	1.76E-03
Spike	BP	GO:0097094	craniofacial suture morphogenesis	-	18	11	-	-	3.09E-04	9.32E-04
Spike	BP	GO:0098780	response to mitochondrial depolarisation	-	21	20	-	-	4.04E-03	1.66E-03
Spike	BP	GO:0051931	regulation of sensory perception	-	36	24	-	-	8.28E-03	2.07E-03
Spike	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	22	-	-	1.11E-02	1.86E-03
Spike	BP	GO:0009268	response to pH	-	43	19	-	-	4.07E-04	1.66E-03
Spike	BP	GO:0045666	positive regulation of neuron differentiation	-	91	61	-	-	4.07E-03	5.07E-03
Spike	BP	GO:0043543	protein acylation	-	107	64	-	-	2.32E-03	5.38E-03
Spike	MF	GO:0051349	positive regulation of lyase activity	-	41	25	-	-	2.25E-02	2.07E-03
Spike	BP	GO:0048679	regulation of axon regeneration	-	28	17	-	-	1.98E-03	1.45E-03
Spike	BP	GO:0022401	negative adaptation of signaling pathway	-	21	17	-	-	7.17E-02	1.45E-03
Spike	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	43	-	-	7.11E-03	3.62E-03
Spike	BP	GO:0071763	nuclear membrane organization	-	44	38	-	-	5.56E-03	3.21E-03
Spike	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	32	-	-	5.87E-03	2.69E-03
Spike	BP	GO:0071806	protein transmembrane transport	-	68	47	-	-	1.35E-01	3.93E-03
Spike	BP	GO:0022038	corpus callosum development	-	25	18	-	-	4.12E-04	1.55E-03
Spike	BP	GO:0043299	leukocyte degranulation	-	82	58	-	-	3.03E-02	4.87E-03
Spike	BP	GO:0048864	stem cell development	-	88	63	-	-	2.46E-02	5.28E-03
Spike	BP	GO:0051651	maintenance of location in cell	-	236	170	-	-	7.60E-03	1.41E-02
Spike	BP	GO:0033119	negative regulation of RNA splicing	-	27	24	-	-	1.72E-02	2.07E-03
Spike	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	13	-	-	3.10E-04	1.14E-03
Spike	CC	GO:0016197	endosomal transport	-	282	190	-	-	1.39E-02	1.57E-02
Spike	BP	GO:0070663	regulation of leukocyte proliferation	-	268	212	-	-	8.32E-03	1.76E-02
Spike	BP	GO:0001833	inner cell mass cell proliferation	-	14	13	-	-	2.64E-03	1.14E-03
Spike	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	33	-	-	3.58E-03	2.80E-03
Spike	BP	GO:0006949	syncytium formation	-	66	39	-	-	2.10E-03	3.31E-03
Spike	BP	GO:0045176	apical protein localization	-	15	13	-	-	3.06E-04	1.14E-03
Spike	BP	GO:0045861	negative regulation of proteolysis	-	320	215	-	-	8.07E-03	1.78E-02
Spike	BP	GO:0043144	sno(s)RNA processing	-	14	13	-	-	1.91E-02	1.14E-03
Spike	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	24	-	-	5.15E-04	2.07E-03
Spike	BP	GO:0030574	collagen catabolic process	-	45	24	-	-	1.17E-02	2.07E-03
Spike	CC	GO:0006984	ER-nucleus signaling pathway	-	46	39	-	-	2.01E-03	3.31E-03
Spike	BP	GO:0060343	trabecula formation	-	26	22	-	-	3.17E-03	1.86E-03
Spike	BP	GO:0009914	hormone transport	-	315	207	-	-	1.11E-02	1.72E-02
Spike	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	3.07E-04	1.04E-03
Spike	BP	GO:0140112	extracellular vesicle biogenesis	-	23	19	-	-	7.13E-03	1.66E-03
Spike	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	12	-	-	2.43E-02	1.04E-03
Spike	BP	GO:1900424	regulation of defense response to bacterium	-	21	13	-	-	1.69E-02	1.14E-03
Spike	BP	GO:0085029	extracellular matrix assembly	-	42	31	-	-	1.11E-03	2.59E-03
Spike	BP	GO:0006413	translational initiation	-	122	101	-	-	7.76E-02	8.39E-03
Spike	BP	GO:0072176	nephric duct development	-	15	13	-	-	3.09E-04	1.14E-03
Spike	BP	GO:1902895	positive regulation of miRNA transcription	-	51	50	-	-	3.47E-03	4.14E-03
Spike	CC	GO:0005200	structural constituent of cytoskeleton	-	112	91	-	-	2.63E-02	7.56E-03
Spike	BP	GO:1901298	regulation of hydrogen peroxide-mediated programmed cell death	-	13	13	-	-	3.89E-03	1.14E-03
Spike	BP	GO:0030865	cortical cytoskeleton organization	-	51	45	-	-	1.23E-02	3.73E-03
Spike	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	11	-	-	3.06E-04	9.32E-04
Spike	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	23	-	-	2.03E-02	1.97E-03
Spike	BP	GO:1903036	positive regulation of response to wounding	-	76	58	-	-	1.49E-02	4.87E-03
Spike	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	11	-	-	3.10E-04	9.32E-04
Spike	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	91	-	-	1.50E-02	7.56E-03
Spike	BP	GO:1903319	positive regulation of protein maturation	-	27	18	-	-	1.05E-02	1.55E-03
Spike	BP	GO:0032528	microvillus organization	-	24	19	-	-	8.56E-04	1.66E-03
Spike	BP	GO:0002263	cell activation involved in immune response	-	304	238	-	-	1.23E-02	1.98E-02
Spike	BP	GO:0021954	central nervous system neuron development	-	85	60	-	-	2.87E-03	4.97E-03
Spike	BP	GO:0055017	cardiac muscle tissue growth	-	92	71	-	-	7.95E-03	5.90E-03
Spike	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	26	-	-	8.43E-03	2.17E-03
Spike	BP	GO:0048524	positive regulation of viral process	-	64	56	-	-	2.81E-03	4.66E-03
Spike	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	16	-	-	1.37E-02	1.35E-03
Spike	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	21	-	-	2.99E-03	1.76E-03
Spike	BP	GO:0001946	lymphangiogenesis	-	18	14	-	-	1.43E-02	1.24E-03
Spike	BP	GO:0098661	inorganic anion transmembrane transport	-	140	40	-	-	1.84E-03	3.31E-03
Spike	BP	GO:0006099	tricarboxylic acid cycle	-	33	21	-	-	8.45E-02	1.76E-03
Spike	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	17	-	-	4.05E-04	1.45E-03
Spike	BP	GO:0009612	response to mechanical stimulus	-	215	159	-	-	8.03E-03	1.33E-02
Spike	BP	GO:0048644	muscle organ morphogenesis	-	81	65	-	-	9.87E-03	5.38E-03
Spike	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	144	-	-	8.05E-03	1.20E-02
Spike	BP	GO:0071542	dopaminergic neuron differentiation	-	36	29	-	-	1.54E-02	2.48E-03
Spike	BP	GO:0140115	export across plasma membrane	-	82	39	-	-	7.75E-03	3.31E-03
Spike	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	11	-	-	4.14E-03	9.32E-04
Spike	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	28	-	-	1.86E-03	2.38E-03
Spike	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	30	-	-	1.05E-02	2.48E-03
Spike	MF	GO:0003714	transcription corepressor activity	-	190	156	-	-	1.02E-02	1.29E-02
Spike	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	34	-	-	3.06E-03	2.90E-03
Spike	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	2.79E-03	1.35E-03
Spike	CC	GO:0006858	extracellular transport	-	45	19	-	-	4.11E-04	1.66E-03
Spike	BP	GO:0006304	DNA modification	-	30	24	-	-	9.19E-03	2.07E-03
Spike	MF	GO:0140312	cargo adaptor activity	-	19	15	-	-	1.52E-01	1.24E-03
Spike	BP	GO:0046835	carbohydrate phosphorylation	-	49	36	-	-	8.26E-03	3.00E-03
Spike	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	15	-	-	1.13E-03	1.24E-03
Spike	CC	GO:1905349	ciliary transition zone assembly	-	371	173	-	-	1.38E-02	1.44E-02
Spike	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	12	-	-	3.10E-04	1.04E-03
Spike	BP	GO:0043523	regulation of neuron apoptotic process	-	218	179	-	-	9.47E-03	1.49E-02
Spike	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.63E-03	1.86E-03
Spike	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	12	-	-	1.31E-02	1.04E-03
Spike	BP	GO:0044380	protein localization to cytoskeleton	-	57	43	-	-	3.22E-03	3.62E-03
Spike	BP	GO:0051918	negative regulation of fibrinolysis	-	13	11	-	-	1.46E-01	9.32E-04
Spike	BP	GO:2000209	regulation of anoikis	-	25	22	-	-	2.01E-03	1.86E-03
Spike	BP	GO:0014029	neural crest formation	-	15	13	-	-	1.83E-02	1.14E-03
Spike	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	27	-	-	4.34E-03	2.28E-03
Spike	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	31	-	-	4.34E-02	2.59E-03
Spike	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	52	-	-	5.55E-03	4.35E-03
Spike	BP	GO:0003188	heart valve formation	-	16	14	-	-	3.03E-04	1.24E-03
Spike	CC	GO:0045324	late endosome to vacuole transport	-	37	27	-	-	6.55E-03	2.28E-03
Spike	BP	GO:0043954	cellular component maintenance	-	72	48	-	-	5.60E-03	4.04E-03
Spike	BP	GO:0050435	amyloid-beta metabolic process	-	65	50	-	-	4.62E-02	4.14E-03
Spike	BP	GO:0014823	response to activity	-	70	56	-	-	8.41E-03	4.66E-03
Spike	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	14	-	-	2.92E-03	1.24E-03
Spike	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	20	-	-	6.17E-02	1.66E-03
Spike	BP	GO:0034502	protein localization to chromosome	-	130	110	-	-	9.63E-03	9.11E-03
Spike	BP	GO:0048562	embryonic organ morphogenesis	-	295	200	-	-	1.52E-02	1.66E-02
Spike	BP	GO:0019233	sensory perception of pain	-	103	63	-	-	2.72E-03	5.28E-03
Spike	CC	GO:0043574	peroxisomal transport	-	22	20	-	-	3.33E-01	1.66E-03
Spike	BP	GO:0031343	positive regulation of cell killing	-	75	55	-	-	4.42E-02	4.55E-03
Spike	BP	GO:0090077	foam cell differentiation	-	39	30	-	-	9.02E-03	2.48E-03
Spike	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	61	-	-	5.70E-03	5.07E-03
Spike	BP	GO:0017148	negative regulation of translation	-	390	179	-	-	7.13E-03	1.49E-02
Spike	BP	GO:0030220	platelet formation	-	22	20	-	-	1.32E-03	1.66E-03
Spike	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	81	-	-	7.66E-03	6.73E-03
Spike	MF	GO:1903624	regulation of DNA catabolic process	-	14	11	-	-	1.91E-03	9.32E-04
Spike	BP	GO:1903509	liposaccharide metabolic process	-	109	41	-	-	1.40E-01	3.42E-03
Spike	BP	GO:0009582	detection of abiotic stimulus	-	140	65	-	-	7.16E-03	5.38E-03
Spike	CC	GO:0140238	presynaptic endocytosis	-	72	54	-	-	1.02E-02	4.55E-03
Spike	BP	GO:0051236	establishment of RNA localization	-	161	129	-	-	2.66E-02	1.08E-02
Spike	BP	GO:0042178	xenobiotic catabolic process	-	26	16	-	-	4.61E-02	1.35E-03
Spike	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	155	-	-	1.76E-02	1.28E-02
Spike	BP	GO:0034067	protein localization to Golgi apparatus	-	30	19	-	-	4.11E-04	1.66E-03
Spike	BP	GO:0061842	microtubule organizing center localization	-	32	24	-	-	5.28E-03	2.07E-03
Spike	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	15	-	-	2.62E-02	1.24E-03
Spike	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	14	-	-	3.10E-04	1.24E-03
Spike	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	35	-	-	1.53E-03	2.90E-03
Spike	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	45	-	-	7.93E-03	3.73E-03
Spike	BP	GO:0050779	RNA destabilization	-	135	90	-	-	2.75E-02	7.45E-03
Spike	BP	GO:0006023	aminoglycan biosynthetic process	-	74	27	-	-	7.08E-03	2.28E-03
Spike	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	50	-	-	1.12E-03	4.14E-03
Spike	BP	GO:0010762	regulation of fibroblast migration	-	40	31	-	-	7.28E-03	2.59E-03
Spike	BP	GO:0090311	regulation of protein deacetylation	-	29	28	-	-	2.22E-02	2.38E-03
Spike	BP	GO:0035272	exocrine system development	-	46	38	-	-	5.53E-03	3.21E-03
Spike	BP	GO:1901096	regulation of autophagosome maturation	-	17	14	-	-	1.11E-02	1.24E-03
Spike	BP	GO:0022406	membrane docking	-	90	64	-	-	1.20E-02	5.38E-03
Spike	BP	GO:0006999	nuclear pore organization	-	15	13	-	-	1.39E-01	1.14E-03
Spike	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	12	-	-	2.06E-03	1.04E-03
Spike	BP	GO:0050777	negative regulation of immune response	-	196	152	-	-	1.31E-02	1.26E-02
Spike	BP	GO:0016053	organic acid biosynthetic process	-	335	193	-	-	7.16E-03	1.60E-02
Spike	MF	GO:0005035	death receptor activity	-	16	15	-	-	3.49E-03	1.24E-03
Spike	BP	GO:0002063	chondrocyte development	-	33	23	-	-	8.17E-03	1.97E-03
Spike	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	13	-	-	3.06E-04	1.14E-03
Spike	BP	GO:0099068	postsynapse assembly	-	40	27	-	-	1.27E-03	2.28E-03
Spike	BP	GO:0021782	glial cell development	-	120	92	-	-	6.25E-03	7.66E-03
Spike	BP	GO:0051782	negative regulation of cell division	-	18	14	-	-	7.34E-04	1.24E-03
Spike	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	63	-	-	1.67E-02	5.28E-03
Spike	BP	GO:0001655	urogenital system development	-	66	56	-	-	6.71E-03	4.66E-03
Spike	BP	GO:0071827	plasma lipoprotein particle organization	-	86	54	-	-	3.08E-02	4.55E-03
Spike	BP	GO:0045494	photoreceptor cell maintenance	-	43	27	-	-	4.41E-02	2.28E-03
Spike	BP	GO:0055088	lipid homeostasis	-	173	100	-	-	1.12E-02	8.28E-03
Spike	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	21	-	-	4.61E-03	1.76E-03
Spike	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	154	-	-	6.69E-03	1.28E-02
Spike	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	31	-	-	5.26E-03	2.59E-03
Spike	BP	GO:0045667	regulation of osteoblast differentiation	-	147	116	-	-	2.11E-02	9.63E-03
Spike	BP	GO:2001212	regulation of vasculogenesis	-	16	11	-	-	3.09E-04	9.32E-04
Spike	BP	GO:0061037	negative regulation of cartilage development	-	32	26	-	-	9.66E-03	2.17E-03
Spike	BP	GO:0045738	negative regulation of DNA repair	-	40	28	-	-	7.25E-04	2.38E-03
Spike	BP	GO:0001704	formation of primary germ layer	-	195	154	-	-	1.05E-02	1.28E-02
Spike	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	11	-	-	2.53E-02	9.32E-04
Spike	BP	GO:0045778	positive regulation of ossification	-	51	40	-	-	5.71E-03	3.31E-03
Spike	BP	GO:0048708	astrocyte differentiation	-	88	75	-	-	5.62E-03	6.21E-03
Spike	BP	GO:0042092	type 2 immune response	-	41	36	-	-	3.47E-03	3.00E-03
Spike	BP	GO:0048588	developmental cell growth	-	233	166	-	-	1.39E-02	1.38E-02
Spike	CC	GO:0000963	mitochondrial RNA processing	-	20	12	-	-	2.03E-02	1.04E-03
Spike	BP	GO:0021872	forebrain generation of neurons	-	52	40	-	-	9.07E-04	3.31E-03
Spike	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	16	-	-	7.07E-03	1.35E-03
Spike	BP	GO:0045023	G0 to G1 transition	-	41	35	-	-	1.17E-01	2.90E-03
Spike	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	42	-	-	1.60E-02	3.52E-03
Spike	BP	GO:0034367	protein-containing complex remodeling	-	35	28	-	-	7.44E-02	2.38E-03
Spike	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	23	-	-	5.02E-04	1.97E-03
Spike	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	16	-	-	5.28E-03	1.35E-03
Spike	BP	GO:0015810	aspartate transmembrane transport	-	19	11	-	-	3.09E-04	9.32E-04
Spike	BP	GO:0010232	vascular transport	-	87	47	-	-	3.77E-03	3.93E-03
Spike	BP	GO:0021987	cerebral cortex development	-	125	97	-	-	4.20E-03	8.07E-03
Spike	BP	GO:0008637	apoptotic mitochondrial changes	-	108	90	-	-	2.96E-02	7.45E-03
Spike	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	29	-	-	7.60E-03	2.48E-03
Spike	BP	GO:0060999	positive regulation of dendritic spine development	-	35	24	-	-	9.02E-03	2.07E-03
Spike	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	14	-	-	3.06E-04	1.24E-03
Spike	BP	GO:2000736	regulation of stem cell differentiation	-	78	66	-	-	5.15E-03	5.49E-03
Spike	BP	GO:0060973	cell migration involved in heart development	-	21	16	-	-	1.35E-02	1.35E-03
Spike	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	14	-	-	5.28E-02	1.24E-03
Spike	BP	GO:0002064	epithelial cell development	-	210	158	-	-	6.32E-03	1.31E-02
Spike	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	30	-	-	1.82E-02	2.48E-03
Spike	BP	GO:2001222	regulation of neuron migration	-	46	29	-	-	1.48E-02	2.48E-03
Spike	BP	GO:0034389	lipid droplet organization	-	38	26	-	-	5.86E-03	2.17E-03
Spike	BP	GO:0051602	response to electrical stimulus	-	44	33	-	-	7.68E-04	2.80E-03
Spike	BP	GO:0042177	negative regulation of protein catabolic process	-	109	87	-	-	3.32E-03	7.25E-03
Spike	MF	GO:0038024	cargo receptor activity	-	121	71	-	-	1.08E-02	5.90E-03
Spike	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	13	-	-	7.04E-04	1.14E-03
Spike	BP	GO:0033120	positive regulation of RNA splicing	-	46	33	-	-	1.22E-03	2.80E-03
Spike	BP	GO:0051445	regulation of meiotic cell cycle	-	64	40	-	-	1.00E-02	3.31E-03
Spike	BP	GO:0033619	membrane protein proteolysis	-	60	52	-	-	4.92E-02	4.35E-03
Spike	BP	GO:0038065	collagen-activated signaling pathway	-	15	13	-	-	3.06E-04	1.14E-03
Spike	BP	GO:0090087	regulation of peptide transport	-	195	122	-	-	1.33E-02	1.01E-02
Spike	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	70	-	-	5.04E-03	5.80E-03
Spike	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	18	-	-	2.42E-03	1.55E-03
Spike	BP	GO:0006929	substrate-dependent cell migration	-	26	20	-	-	5.05E-04	1.66E-03
Spike	BP	GO:0042537	benzene-containing compound metabolic process	-	27	16	-	-	4.13E-04	1.35E-03
Spike	BP	GO:0099118	microtubule-based protein transport	-	14	11	-	-	3.09E-04	9.32E-04
Spike	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	12	-	-	3.06E-04	1.04E-03
Spike	BP	GO:0072662	protein localization to peroxisome	-	20	18	-	-	6.29E-01	1.55E-03
Spike	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	12	-	-	3.09E-04	1.04E-03
Spike	BP	GO:0022404	molting cycle process	-	95	62	-	-	5.79E-03	5.18E-03
Spike	BP	GO:1903358	regulation of Golgi organization	-	17	14	-	-	4.11E-03	1.24E-03
Spike	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	18	-	-	1.11E-02	1.55E-03
Spike	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	16	-	-	1.22E-03	1.35E-03
Spike	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	28	-	-	2.50E-03	2.38E-03
Spike	BP	GO:0017014	protein nitrosylation	-	17	14	-	-	4.50E-03	1.24E-03
Spike	BP	GO:0007281	germ cell development	-	334	164	-	-	5.62E-03	1.37E-02
Spike	BP	GO:0008299	isoprenoid biosynthetic process	-	30	19	-	-	4.13E-04	1.66E-03
Spike	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	152	-	-	8.46E-03	1.26E-02
Spike	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	27	-	-	2.15E-03	2.28E-03
Spike	BP	GO:0034104	negative regulation of tissue remodeling	-	22	14	-	-	3.05E-04	1.24E-03
Spike	CC	GO:0098926	postsynaptic signal transduction	-	39	26	-	-	3.47E-03	2.17E-03
Spike	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	109	-	-	5.27E-03	9.11E-03
Spike	CC	GO:0016082	synaptic vesicle priming	-	19	12	-	-	2.72E-02	1.04E-03
Spike	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	38	-	-	2.89E-03	3.21E-03
Spike	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	124	-	-	6.44E-03	1.04E-02
Spike	BP	GO:0034249	negative regulation of amide metabolic process	-	34	24	-	-	2.44E-03	2.07E-03
Spike	BP	GO:0061548	ganglion development	-	17	14	-	-	2.94E-03	1.24E-03
Spike	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	85	-	-	3.96E-03	7.04E-03
Spike	BP	GO:0042832	defense response to protozoan	-	28	22	-	-	1.41E-03	1.86E-03
Spike	BP	GO:0048799	animal organ maturation	-	33	22	-	-	7.82E-04	1.86E-03
Spike	BP	GO:0006925	inflammatory cell apoptotic process	-	23	18	-	-	4.04E-04	1.55E-03
Spike	BP	GO:2000291	regulation of myoblast proliferation	-	25	18	-	-	4.06E-04	1.55E-03
Spike	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	153	-	-	6.05E-03	1.27E-02
Spike	BP	GO:1903035	negative regulation of response to wounding	-	93	66	-	-	4.92E-02	5.49E-03
Spike	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	32	-	-	1.49E-03	2.69E-03
Spike	BP	GO:0036010	protein localization to endosome	-	27	21	-	-	1.56E-03	1.76E-03
Spike	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	111	-	-	1.60E-02	9.21E-03
Spike	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	72	-	-	6.74E-03	6.00E-03
Spike	BP	GO:0045056	transcytosis	-	20	17	-	-	3.05E-03	1.45E-03
Spike	BP	GO:0009267	cellular response to starvation	-	170	133	-	-	1.35E-02	1.11E-02
Spike	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	47	-	-	5.38E-03	3.93E-03
Spike	CC	GO:0140239	postsynaptic endocytosis	-	23	16	-	-	2.84E-02	1.35E-03
Spike	BP	GO:0046931	pore complex assembly	-	21	16	-	-	2.97E-02	1.35E-03
Spike	CC	GO:0032008	positive regulation of TOR signaling	-	52	36	-	-	5.68E-02	3.00E-03
Spike	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	24	-	-	1.77E-01	2.07E-03
Spike	BP	GO:0046618	xenobiotic export from cell	-	27	13	-	-	3.10E-04	1.14E-03
Spike	BP	GO:0060428	lung epithelium development	-	43	39	-	-	1.70E-03	3.31E-03
Spike	BP	GO:0030431	sleep	-	30	22	-	-	1.58E-03	1.86E-03
Spike	BP	GO:1903318	negative regulation of protein maturation	-	29	25	-	-	1.74E-02	2.07E-03
Spike	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	35	-	-	2.46E-02	2.90E-03
Spike	BP	GO:0071732	cellular response to nitric oxide	-	17	14	-	-	2.41E-03	1.24E-03
Spike	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	21	-	-	5.45E-03	1.76E-03
Spike	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	77	-	-	1.08E-02	6.42E-03
Spike	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	12	-	-	3.09E-04	1.04E-03
Spike	CC	GO:0006406	mRNA export from nucleus	-	69	57	-	-	1.28E-01	4.76E-03
Spike	BP	GO:0009880	embryonic pattern specification	-	70	47	-	-	4.89E-03	3.93E-03
Spike	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	36	-	-	1.39E-01	3.00E-03
Spike	BP	GO:0043043	peptide biosynthetic process	-	25	17	-	-	6.53E-03	1.45E-03
Spike	BP	GO:0034105	positive regulation of tissue remodeling	-	23	17	-	-	4.10E-04	1.45E-03
Spike	BP	GO:0002367	cytokine production involved in immune response	-	121	98	-	-	7.19E-03	8.18E-03
Spike	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	12	-	-	3.05E-04	1.04E-03
Spike	BP	GO:0044848	biological phase	-	211	141	-	-	1.67E-02	1.17E-02
Spike	BP	GO:0046660	female sex differentiation	-	125	95	-	-	2.37E-02	7.87E-03
Spike	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	12	-	-	3.05E-04	1.04E-03
Spike	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	38	-	-	7.11E-03	3.21E-03
Spike	BP	GO:0060411	cardiac septum morphogenesis	-	72	61	-	-	1.23E-02	5.07E-03
Spike	BP	GO:0071248	cellular response to metal ion	-	201	140	-	-	5.56E-03	1.16E-02
Spike	BP	GO:0030308	negative regulation of cell growth	-	191	125	-	-	4.70E-03	1.04E-02
Spike	BP	GO:0097306	cellular response to alcohol	-	99	72	-	-	4.38E-03	6.00E-03
Spike	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	85	-	-	5.69E-02	7.04E-03
Spike	BP	GO:0010453	regulation of cell fate commitment	-	40	33	-	-	1.42E-02	2.80E-03
Spike	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	40	-	-	6.92E-03	3.31E-03
Spike	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	21	-	-	5.16E-04	1.76E-03
Spike	BP	GO:0002026	regulation of the force of heart contraction	-	26	20	-	-	1.19E-02	1.66E-03
Spike	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	31	-	-	7.48E-03	2.59E-03
Spike	BP	GO:0032890	regulation of organic acid transport	-	78	52	-	-	4.37E-03	4.35E-03
Spike	BP	GO:0071498	cellular response to fluid shear stress	-	21	21	-	-	1.70E-03	1.76E-03
Spike	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	80	-	-	5.68E-03	6.63E-03
Spike	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	21	-	-	6.14E-03	1.76E-03
Spike	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	41	-	-	8.07E-03	3.42E-03
Spike	BP	GO:0051259	protein complex oligomerization	-	251	155	-	-	5.18E-03	1.28E-02
Spike	BP	GO:0098743	cell aggregation	-	24	18	-	-	4.07E-04	1.55E-03
Spike	BP	GO:0009994	oocyte differentiation	-	57	34	-	-	2.27E-03	2.90E-03
Spike	MF	GO:0031952	regulation of protein autophosphorylation	-	43	38	-	-	1.47E-03	3.21E-03
Spike	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	11	-	-	3.10E-04	9.32E-04
Spike	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	113	-	-	1.59E-02	9.42E-03
Spike	BP	GO:0044319	"wound healing, spreading of cells"	-	37	28	-	-	2.05E-03	2.38E-03
Spike	BP	GO:0033688	regulation of osteoblast proliferation	-	31	24	-	-	1.93E-03	2.07E-03
Spike	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	1.42E-03	2.90E-03
Spike	BP	GO:0072665	protein localization to vacuole	-	84	49	-	-	9.00E-03	4.14E-03
Spike	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	40	-	-	1.00E-02	3.31E-03
Spike	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	12	-	-	3.90E-03	1.04E-03
Spike	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	58	-	-	7.76E-03	4.87E-03
Spike	BP	GO:0042953	lipoprotein transport	-	20	15	-	-	7.33E-03	1.24E-03
Spike	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	13	-	-	2.40E-01	1.14E-03
Spike	BP	GO:0042044	fluid transport	-	35	17	-	-	1.16E-02	1.45E-03
Spike	BP	GO:0070633	transepithelial transport	-	35	21	-	-	3.29E-03	1.76E-03
Spike	BP	GO:0045661	regulation of myoblast differentiation	-	74	59	-	-	1.34E-02	4.97E-03
Spike	BP	GO:0030307	positive regulation of cell growth	-	164	127	-	-	4.36E-03	1.06E-02
Spike	BP	GO:0034250	positive regulation of amide metabolic process	-	27	22	-	-	5.82E-03	1.86E-03
Spike	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	237	-	-	9.43E-03	1.97E-02
Spike	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	17	-	-	4.11E-04	1.45E-03
Spike	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	13	-	-	9.27E-04	1.14E-03
Spike	BP	GO:0014812	muscle cell migration	-	110	85	-	-	5.70E-03	7.04E-03
Spike	BP	GO:0048525	negative regulation of viral process	-	90	72	-	-	2.41E-02	6.00E-03
Spike	BP	GO:0072044	collecting duct development	-	16	13	-	-	1.18E-02	1.14E-03
Spike	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	54	-	-	6.66E-03	4.55E-03
Spike	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	114	-	-	7.26E-03	9.52E-03
Spike	BP	GO:0051781	positive regulation of cell division	-	93	70	-	-	9.55E-03	5.80E-03
Spike	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	17	-	-	1.68E-02	1.45E-03
Spike	BP	GO:0035493	SNARE complex assembly	-	23	22	-	-	7.09E-02	1.86E-03
Spike	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	17	-	-	4.04E-04	1.45E-03
Spike	BP	GO:0060711	labyrinthine layer development	-	47	35	-	-	1.48E-02	2.90E-03
Spike	BP	GO:0007272	ensheathment of neurons	-	146	109	-	-	1.68E-02	9.11E-03
Spike	CC	GO:0050806	positive regulation of synaptic transmission	-	171	107	-	-	6.93E-03	8.90E-03
Spike	BP	GO:0060021	roof of mouth development	-	91	64	-	-	7.29E-03	5.38E-03
Spike	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	30	-	-	1.86E-03	2.48E-03
Spike	BP	GO:0050819	negative regulation of coagulation	-	54	46	-	-	1.36E-01	3.83E-03
Spike	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	60	-	-	5.93E-02	4.97E-03
Spike	BP	GO:0097212	lysosomal membrane organization	-	15	12	-	-	3.10E-04	1.04E-03
Spike	CC	GO:0050805	negative regulation of synaptic transmission	-	55	35	-	-	1.56E-02	2.90E-03
Spike	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	44	-	-	1.94E-03	3.73E-03
Spike	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	50	-	-	7.87E-03	4.14E-03
Spike	BP	GO:0016054	organic acid catabolic process	-	251	133	-	-	1.34E-02	1.11E-02
Spike	BP	GO:0050890	cognition	-	317	209	-	-	1.03E-02	1.74E-02
Spike	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	12	-	-	3.07E-04	1.04E-03
Spike	BP	GO:1900048	positive regulation of hemostasis	-	28	22	-	-	6.53E-02	1.86E-03
Spike	BP	GO:0065005	protein-lipid complex assembly	-	29	21	-	-	5.42E-02	1.76E-03
Spike	BP	GO:0008033	tRNA processing	-	136	67	-	-	1.10E-01	5.59E-03
Spike	BP	GO:0046661	male sex differentiation	-	171	134	-	-	1.80E-02	1.12E-02
Spike	BP	GO:0072520	seminiferous tubule development	-	15	13	-	-	3.02E-04	1.14E-03
Spike	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	8.70E-03	1.45E-03
Spike	BP	GO:0035188	hatching	-	27	11	-	-	3.08E-04	9.32E-04
Spike	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	53	-	-	4.61E-03	4.45E-03
Spike	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	12	-	-	3.06E-04	1.04E-03
Spike	BP	GO:1990778	protein localization to cell periphery	-	346	243	-	-	9.00E-03	2.02E-02
Spike	BP	GO:0090713	immunological memory process	-	18	15	-	-	1.84E-02	1.24E-03
Spike	BP	GO:0061326	renal tubule development	-	103	81	-	-	1.70E-02	6.73E-03
Spike	BP	GO:0051258	protein polymerization	-	280	201	-	-	1.17E-02	1.67E-02
Spike	BP	GO:0071985	multivesicular body sorting pathway	-	56	43	-	-	2.50E-02	3.62E-03
Spike	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	14	-	-	3.07E-04	1.24E-03
Spike	BP	GO:0060325	face morphogenesis	-	31	21	-	-	2.67E-03	1.76E-03
Spike	BP	GO:0090559	regulation of membrane permeability	-	72	53	-	-	1.38E-02	4.45E-03
Spike	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	14	-	-	9.01E-03	1.24E-03
Spike	BP	GO:0031579	membrane raft organization	-	25	17	-	-	1.24E-02	1.45E-03
Spike	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	19	-	-	1.18E-03	1.66E-03
Spike	BP	GO:0060033	anatomical structure regression	-	16	11	-	-	1.84E-02	9.32E-04
Spike	BP	GO:0046460	neutral lipid biosynthetic process	-	50	22	-	-	1.49E-03	1.86E-03
Spike	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	56	-	-	1.04E-02	4.66E-03
Spike	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	3.10E-04	9.32E-04
Spike	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	138	-	-	5.25E-03	1.15E-02
Spike	BP	GO:0002251	organ or tissue specific immune response	-	43	27	-	-	2.00E-03	2.28E-03
Spike	CC	GO:0048167	regulation of synaptic plasticity	-	210	138	-	-	7.69E-03	1.15E-02
Spike	BP	GO:1903708	positive regulation of hemopoiesis	-	184	158	-	-	7.29E-03	1.31E-02
Spike	BP	GO:1903008	organelle disassembly	-	154	121	-	-	1.42E-02	1.00E-02
Spike	BP	GO:0001709	cell fate determination	-	44	31	-	-	6.25E-03	2.59E-03
Spike	BP	GO:0051873	killing by host of symbiont cells	-	28	16	-	-	4.09E-04	1.35E-03
Spike	BP	GO:0045058	T cell selection	-	53	48	-	-	6.52E-03	4.04E-03
Spike	CC	GO:0032387	negative regulation of intracellular transport	-	51	38	-	-	3.87E-03	3.21E-03
Spike	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	12	-	-	3.28E-03	1.04E-03
Spike	BP	GO:0072091	regulation of stem cell proliferation	-	91	69	-	-	3.42E-03	5.80E-03
Spike	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	30	-	-	9.14E-03	2.48E-03
Spike	BP	GO:0099084	postsynaptic specialization organization	-	44	28	-	-	5.79E-03	2.38E-03
Spike	BP	GO:0071501	cellular response to sterol depletion	-	15	11	-	-	3.08E-04	9.32E-04
Spike	BP	GO:0060384	innervation	-	27	18	-	-	7.44E-03	1.55E-03
Spike	BP	GO:0032535	regulation of cellular component size	-	360	247	-	-	9.84E-03	2.05E-02
Spike	BP	GO:2000774	positive regulation of cellular senescence	-	19	13	-	-	2.68E-03	1.14E-03
Spike	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	11	-	-	3.10E-04	9.32E-04
Spike	MF	GO:0031281	positive regulation of cyclase activity	-	40	25	-	-	1.38E-02	2.07E-03
Spike	MF	GO:0098631	cell adhesion mediator activity	-	64	44	-	-	4.96E-03	3.73E-03
Spike	BP	GO:0046112	nucleobase biosynthetic process	-	18	17	-	-	4.10E-04	1.45E-03
Spike	BP	GO:0071453	cellular response to oxygen levels	-	168	135	-	-	5.98E-03	1.12E-02
Spike	BP	GO:0090399	replicative senescence	-	17	14	-	-	8.67E-04	1.24E-03
Spike	BP	GO:0031342	negative regulation of cell killing	-	29	26	-	-	9.50E-02	2.17E-03
Spike	BP	GO:0070585	protein localization to mitochondrion	-	125	94	-	-	5.98E-02	7.87E-03
Spike	BP	GO:0010623	programmed cell death involved in cell development	-	25	19	-	-	9.44E-03	1.66E-03
Spike	BP	GO:0044242	cellular lipid catabolic process	-	224	119	-	-	1.93E-02	9.94E-03
Spike	BP	GO:0071236	cellular response to antibiotic	-	13	12	-	-	1.03E-03	1.04E-03
Spike	BP	GO:0002931	response to ischemia	-	58	43	-	-	6.48E-03	3.62E-03
Spike	BP	GO:0043062	extracellular structure organization	-	317	186	-	-	1.61E-02	1.54E-02
Spike	BP	GO:0014047	glutamate secretion	-	25	15	-	-	4.10E-04	1.24E-03
Spike	BP	GO:0061005	cell differentiation involved in kidney development	-	58	51	-	-	7.68E-03	4.24E-03
Spike	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	41	-	-	1.41E-02	3.42E-03
Spike	BP	GO:0060420	regulation of heart growth	-	74	57	-	-	9.94E-03	4.76E-03
Spike	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	11	-	-	7.00E-03	9.32E-04
Spike	BP	GO:0009755	hormone-mediated signaling pathway	-	221	170	-	-	2.12E-02	1.41E-02
Spike	BP	GO:0022612	gland morphogenesis	-	124	105	-	-	8.31E-03	8.70E-03
Spike	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	28	-	-	6.10E-04	2.38E-03
Spike	MF	GO:0140416	transcription regulator inhibitor activity	-	26	22	-	-	8.51E-04	1.86E-03
Spike	BP	GO:0044782	cilium organization	-	400	182	-	-	8.35E-03	1.51E-02
Spike	BP	GO:0048935	peripheral nervous system neuron development	-	15	12	-	-	3.09E-04	1.04E-03
Spike	BP	GO:0110096	cellular response to aldehyde	-	17	16	-	-	4.10E-04	1.35E-03
Spike	BP	GO:1990845	adaptive thermogenesis	-	166	121	-	-	4.66E-03	1.00E-02
Spike	BP	GO:0071320	cellular response to cAMP	-	54	42	-	-	7.86E-03	3.52E-03
Spike	BP	GO:0015844	monoamine transport	-	88	51	-	-	8.66E-03	4.24E-03
Spike	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	17	-	-	5.46E-03	1.45E-03
Spike	BP	GO:0060039	pericardium development	-	19	15	-	-	3.57E-03	1.24E-03
Spike	BP	GO:0071392	cellular response to estradiol stimulus	-	40	32	-	-	1.20E-03	2.69E-03
Spike	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	16	-	-	4.09E-04	1.35E-03
Spike	BP	GO:0000272	polysaccharide catabolic process	-	19	15	-	-	1.62E-02	1.24E-03
Spike	BP	GO:0009451	RNA modification	-	169	79	-	-	1.10E-02	6.63E-03
Spike	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	33	-	-	2.47E-03	2.80E-03
Spike	BP	GO:1903729	regulation of plasma membrane organization	-	17	16	-	-	8.45E-03	1.35E-03
Spike	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	87	-	-	1.18E-02	7.25E-03
Spike	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	36	-	-	3.78E-03	3.00E-03
Spike	BP	GO:0015807	L-amino acid transport	-	94	42	-	-	2.85E-03	3.52E-03
Spike	BP	GO:0032941	secretion by tissue	-	85	67	-	-	2.00E-03	5.59E-03
Spike	BP	GO:0046605	regulation of centrosome cycle	-	54	41	-	-	2.74E-03	3.42E-03
Spike	BP	GO:0048753	pigment granule organization	-	40	31	-	-	2.14E-01	2.59E-03
Spike	BP	GO:0021516	dorsal spinal cord development	-	20	13	-	-	1.34E-02	1.14E-03
Spike	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	15	-	-	4.11E-04	1.24E-03
Spike	BP	GO:0003014	renal system process	-	130	82	-	-	5.19E-03	6.83E-03
Spike	CC	GO:0070286	axonemal dynein complex assembly	-	40	12	-	-	3.09E-04	1.04E-03
Spike	BP	GO:0045598	regulation of fat cell differentiation	-	148	110	-	-	1.62E-02	9.11E-03
Spike	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	172	-	-	1.25E-02	1.43E-02
Spike	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	4.16E-03	3.21E-03
Spike	BP	GO:1901863	positive regulation of muscle tissue development	-	24	22	-	-	4.96E-04	1.86E-03
Spike	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	118	-	-	2.78E-02	9.83E-03
Spike	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	12	-	-	3.07E-04	1.04E-03
Spike	BP	GO:0008340	determination of adult lifespan	-	23	15	-	-	1.51E-03	1.24E-03
Spike	BP	GO:0039694	viral RNA genome replication	-	30	24	-	-	3.04E-03	2.07E-03
Spike	BP	GO:0009404	toxin metabolic process	-	17	12	-	-	3.09E-04	1.04E-03
Spike	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	24	-	-	5.06E-04	2.07E-03
Spike	BP	GO:0071709	membrane assembly	-	68	45	-	-	2.06E-03	3.73E-03
Spike	BP	GO:0008217	regulation of blood pressure	-	186	121	-	-	6.42E-03	1.00E-02
Spike	BP	GO:0031643	positive regulation of myelination	-	19	15	-	-	7.94E-03	1.24E-03
Spike	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	48	-	-	2.45E-03	4.04E-03
Spike	CC	GO:0042770	signal transduction in response to DNA damage	-	186	166	-	-	1.80E-02	1.38E-02
Spike	BP	GO:0002200	somatic diversification of immune receptors	-	78	67	-	-	1.02E-02	5.59E-03
Spike	BP	GO:0035315	hair cell differentiation	-	52	37	-	-	3.28E-02	3.11E-03
Spike	BP	GO:0048645	animal organ formation	-	62	54	-	-	6.07E-03	4.55E-03
Spike	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	127	-	-	8.46E-03	1.06E-02
Spike	BP	GO:0033627	cell adhesion mediated by integrin	-	87	71	-	-	1.22E-02	5.90E-03
Spike	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	11	-	-	8.23E-02	9.32E-04
Spike	BP	GO:0035107	appendage morphogenesis	-	147	95	-	-	9.25E-03	7.87E-03
Spike	BP	GO:1903707	negative regulation of hemopoiesis	-	116	88	-	-	3.98E-03	7.35E-03
Spike	BP	GO:0036342	post-anal tail morphogenesis	-	19	13	-	-	9.80E-03	1.14E-03
Spike	CC	GO:0048208	COPII vesicle coating	-	27	21	-	-	1.08E-01	1.76E-03
Spike	BP	GO:0030149	sphingolipid catabolic process	-	32	14	-	-	1.28E-02	1.24E-03
Spike	BP	GO:0050994	regulation of lipid catabolic process	-	61	39	-	-	2.64E-03	3.31E-03
Spike	BP	GO:0035988	chondrocyte proliferation	-	24	18	-	-	4.08E-04	1.55E-03
Spike	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	21	-	-	5.15E-04	1.76E-03
Spike	BP	GO:0009593	detection of chemical stimulus	-	511	34	-	-	2.86E-03	2.90E-03
Spike	BP	GO:0060788	ectodermal placode formation	-	12	11	-	-	2.11E-03	9.32E-04
Spike	BP	GO:0045727	positive regulation of translation	-	141	107	-	-	7.94E-03	8.90E-03
Spike	BP	GO:0036315	cellular response to sterol	-	24	12	-	-	9.65E-03	1.04E-03
Spike	CC	GO:0032388	positive regulation of intracellular transport	-	137	108	-	-	3.11E-03	9.01E-03
Spike	BP	GO:0002027	regulation of heart rate	-	106	68	-	-	9.28E-03	5.69E-03
Spike	BP	GO:0050879	multicellular organismal movement	-	118	80	-	-	1.37E-02	6.63E-03
Spike	BP	GO:0120305	regulation of pigmentation	-	15	12	-	-	1.18E-02	1.04E-03
Spike	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	58	-	-	3.19E-03	4.87E-03
Spike	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	46	-	-	3.41E-03	3.83E-03
Spike	BP	GO:0048515	spermatid differentiation	-	208	91	-	-	3.66E-03	7.56E-03
Spike	BP	GO:0072132	mesenchyme morphogenesis	-	57	51	-	-	4.19E-03	4.24E-03
Spike	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	22	-	-	6.06E-03	1.86E-03
Spike	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	20	-	-	5.07E-04	1.66E-03
Spike	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	22	-	-	5.15E-04	1.86E-03
Spike	BP	GO:0060119	inner ear receptor cell development	-	44	29	-	-	6.89E-02	2.48E-03
Spike	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	16	-	-	3.00E-03	1.35E-03
Spike	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	18	-	-	4.11E-04	1.55E-03
Spike	BP	GO:1901983	regulation of protein acetylation	-	26	19	-	-	3.21E-03	1.66E-03
Spike	BP	GO:0014854	response to inactivity	-	12	11	-	-	3.08E-04	9.32E-04
Spike	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	210	-	-	1.17E-02	1.74E-02
Spike	BP	GO:1900006	positive regulation of dendrite development	-	17	12	-	-	1.13E-02	1.04E-03
Spike	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	40	-	-	2.74E-02	3.31E-03
Spike	BP	GO:0010883	regulation of lipid storage	-	53	37	-	-	3.94E-03	3.11E-03
Spike	BP	GO:0072170	metanephric tubule development	-	26	24	-	-	1.01E-03	2.07E-03
Spike	BP	GO:0007635	chemosensory behavior	-	20	11	-	-	3.09E-04	9.32E-04
Spike	BP	GO:1905954	positive regulation of lipid localization	-	110	68	-	-	4.50E-03	5.69E-03
Spike	BP	GO:0002209	behavioral defense response	-	39	26	-	-	1.24E-03	2.17E-03
Spike	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	19	-	-	9.30E-02	1.66E-03
Spike	BP	GO:0072523	purine-containing compound catabolic process	-	146	98	-	-	1.21E-02	8.18E-03
Spike	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	26	-	-	5.39E-03	2.17E-03
Spike	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	21	-	-	5.04E-04	1.76E-03
Spike	BP	GO:0021535	cell migration in hindbrain	-	16	11	-	-	3.08E-04	9.32E-04
Spike	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	75	-	-	1.38E-02	6.21E-03
Spike	BP	GO:0007218	neuropeptide signaling pathway	-	113	36	-	-	4.80E-02	3.00E-03
Spike	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	102	-	-	7.83E-03	8.49E-03
Spike	BP	GO:0031345	negative regulation of cell projection organization	-	195	135	-	-	1.43E-02	1.12E-02
Spike	BP	GO:0048278	vesicle docking	-	64	43	-	-	8.99E-03	3.62E-03
Spike	BP	GO:0035050	embryonic heart tube development	-	86	56	-	-	5.67E-03	4.66E-03
Spike	BP	GO:0030168	platelet activation	-	135	106	-	-	8.70E-03	8.80E-03
Spike	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	12	-	-	3.09E-04	1.04E-03
Spike	CC	GO:0098810	neurotransmitter reuptake	-	35	20	-	-	2.65E-03	1.66E-03
Spike	BP	GO:0008213	protein alkylation	-	58	32	-	-	5.47E-03	2.69E-03
Spike	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	1.26E-02	1.14E-03
Spike	BP	GO:0031338	regulation of vesicle fusion	-	24	17	-	-	4.10E-04	1.45E-03
Spike	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	11	-	-	3.03E-04	9.32E-04
Spike	BP	GO:0031529	ruffle organization	-	55	41	-	-	2.86E-03	3.42E-03
Spike	BP	GO:0010842	retina layer formation	-	25	15	-	-	4.12E-04	1.24E-03
Spike	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	56	-	-	7.96E-02	4.66E-03
Spike	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	51	-	-	8.93E-03	4.24E-03
Spike	MF	GO:0170055	lipid transmembrane transporter activity	-	56	21	-	-	5.47E-02	1.76E-03
Spike	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	11	-	-	1.27E-02	9.32E-04
Spike	BP	GO:0035304	regulation of protein dephosphorylation	-	87	67	-	-	2.21E-03	5.59E-03
Spike	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	167	-	-	1.30E-02	1.39E-02
Spike	BP	GO:0099637	neurotransmitter receptor transport	-	26	16	-	-	4.11E-04	1.35E-03
Spike	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	30	-	-	4.56E-03	2.48E-03
Spike	BP	GO:0051785	positive regulation of nuclear division	-	61	49	-	-	3.19E-03	4.14E-03
Spike	BP	GO:0060749	mammary gland alveolus development	-	20	18	-	-	2.20E-03	1.55E-03
Spike	BP	GO:0044786	cell cycle DNA replication	-	45	40	-	-	1.02E-02	3.31E-03
Spike	BP	GO:0044539	long-chain fatty acid import into cell	-	17	12	-	-	2.27E-03	1.04E-03
Spike	BP	GO:0051299	centrosome separation	-	15	14	-	-	1.73E-02	1.24E-03
Spike	BP	GO:0048145	regulation of fibroblast proliferation	-	87	73	-	-	2.65E-03	6.11E-03
Spike	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	61	-	-	1.01E-01	5.07E-03
Spike	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	207	-	-	9.27E-03	1.72E-02
Spike	BP	GO:0032098	regulation of appetite	-	20	11	-	-	3.09E-04	9.32E-04
Spike	CC	GO:0008333	endosome to lysosome transport	-	73	53	-	-	3.04E-03	4.45E-03
Spike	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	15	-	-	3.15E-03	1.24E-03
Spike	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	11	-	-	3.01E-04	9.32E-04
Spike	BP	GO:0003016	respiratory system process	-	39	21	-	-	5.00E-04	1.76E-03
Spike	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	18	-	-	4.07E-04	1.55E-03
Spike	BP	GO:0045732	positive regulation of protein catabolic process	-	202	166	-	-	8.16E-03	1.38E-02
Spike	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	39	-	-	8.20E-04	3.31E-03
Spike	BP	GO:0007588	excretion	-	40	22	-	-	6.59E-03	1.86E-03
Spike	BP	GO:1904018	positive regulation of vasculature development	-	185	139	-	-	8.35E-03	1.16E-02
Spike	BP	GO:0050953	sensory perception of light stimulus	-	223	106	-	-	9.95E-02	8.80E-03
Spike	BP	GO:0009164	nucleoside catabolic process	-	25	14	-	-	3.10E-04	1.24E-03
Spike	BP	GO:0009303	rRNA transcription	-	37	35	-	-	4.81E-03	2.90E-03
Spike	BP	GO:0035601	protein deacylation	-	56	47	-	-	1.11E-02	3.93E-03
Spike	BP	GO:0061952	midbody abscission	-	18	15	-	-	5.13E-02	1.24E-03
Spike	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	16	-	-	1.93E-03	1.35E-03
Spike	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	2.51E-03	2.48E-03
Spike	BP	GO:0071300	cellular response to retinoic acid	-	66	56	-	-	3.06E-03	4.66E-03
Spike	BP	GO:0045830	positive regulation of isotype switching	-	28	25	-	-	1.71E-03	2.07E-03
Spike	BP	GO:0031069	hair follicle morphogenesis	-	33	22	-	-	5.04E-04	1.86E-03
Spike	BP	GO:0046697	decidualization	-	26	19	-	-	2.12E-03	1.66E-03
Spike	BP	GO:0051588	regulation of neurotransmitter transport	-	99	69	-	-	5.83E-03	5.80E-03
Spike	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	11	-	-	3.10E-04	9.32E-04
Spike	BP	GO:0051784	negative regulation of nuclear division	-	63	51	-	-	2.72E-02	4.24E-03
Spike	BP	GO:0044703	multi-organism reproductive process	-	209	155	-	-	5.91E-03	1.28E-02
Spike	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	122	-	-	6.25E-03	1.01E-02
Spike	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	40	-	-	6.03E-03	3.31E-03
Spike	BP	GO:0099022	vesicle tethering	-	32	21	-	-	7.79E-02	1.76E-03
Spike	MF	GO:0004930	G protein-coupled receptor activity	-	873	157	-	-	5.41E-03	1.30E-02
Spike	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	17	-	-	4.00E-03	1.45E-03
Spike	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	1.77E-02	1.04E-03
Spike	BP	GO:0048857	neural nucleus development	-	65	48	-	-	1.24E-03	4.04E-03
Spike	BP	GO:0048663	neuron fate commitment	-	74	52	-	-	1.06E-02	4.35E-03
Spike	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	108	-	-	2.95E-02	9.01E-03
Spike	BP	GO:0106027	neuron projection organization	-	90	76	-	-	6.22E-03	6.31E-03
Spike	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	98	-	-	9.05E-03	8.18E-03
Spike	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	29	-	-	1.60E-03	2.48E-03
Spike	BP	GO:0045685	regulation of glial cell differentiation	-	77	64	-	-	3.14E-03	5.38E-03
Spike	BP	GO:0043414	macromolecule methylation	-	138	71	-	-	9.05E-03	5.90E-03
Spike	BP	GO:0048268	clathrin coat assembly	-	16	11	-	-	1.79E-02	9.32E-04
Spike	BP	GO:0050886	endocrine process	-	93	65	-	-	5.08E-03	5.38E-03
Spike	BP	GO:0050951	sensory perception of temperature stimulus	-	28	15	-	-	4.11E-04	1.24E-03
Spike	BP	GO:0045807	positive regulation of endocytosis	-	155	125	-	-	7.19E-03	1.04E-02
Spike	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	4.50E-03	9.32E-04
Spike	BP	GO:0002418	immune response to tumor cell	-	29	19	-	-	2.53E-03	1.66E-03
Spike	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	54	-	-	1.96E-03	4.55E-03
Spike	BP	GO:0048308	organelle inheritance	-	14	14	-	-	3.49E-03	1.24E-03
Spike	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	15	-	-	3.92E-04	1.24E-03
Spike	BP	GO:0001829	trophectodermal cell differentiation	-	19	15	-	-	4.01E-02	1.24E-03
Spike	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	16	-	-	2.48E-03	1.35E-03
Spike	BP	GO:0034394	protein localization to cell surface	-	69	46	-	-	2.05E-03	3.83E-03
Spike	BP	GO:0009110	vitamin biosynthetic process	-	23	17	-	-	6.13E-03	1.45E-03
Spike	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	21	-	-	1.12E-02	1.76E-03
Spike	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	14	-	-	1.83E-03	1.24E-03
Spike	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	19	-	-	1.43E-03	1.66E-03
Spike	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	87	-	-	6.90E-03	7.25E-03
Spike	MF	GO:0051100	negative regulation of binding	-	161	135	-	-	5.78E-03	1.12E-02
Spike	BP	GO:0003151	outflow tract morphogenesis	-	81	70	-	-	1.12E-02	5.80E-03
Spike	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	53	-	-	5.50E-03	4.45E-03
Spike	BP	GO:0055093	response to hyperoxia	-	20	18	-	-	3.95E-03	1.55E-03
Spike	BP	GO:0061036	positive regulation of cartilage development	-	33	22	-	-	1.28E-02	1.86E-03
Spike	BP	GO:0046184	aldehyde biosynthetic process	-	16	12	-	-	3.09E-04	1.04E-03
Spike	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	39	-	-	2.34E-03	3.31E-03
Spike	BP	GO:0046621	negative regulation of organ growth	-	39	32	-	-	6.35E-03	2.69E-03
Spike	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	47	-	-	9.67E-02	3.93E-03
Spike	BP	GO:0032368	regulation of lipid transport	-	149	101	-	-	8.60E-03	8.39E-03
Spike	BP	GO:0055094	response to lipoprotein particle	-	34	25	-	-	7.26E-03	2.07E-03
Spike	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	144	-	-	8.44E-03	1.20E-02
Spike	BP	GO:0033002	muscle cell proliferation	-	249	199	-	-	1.26E-02	1.66E-02
Spike	BP	GO:0043331	response to dsRNA	-	56	47	-	-	5.04E-02	3.93E-03
Spike	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	7.88E-03	1.04E-03
Spike	BP	GO:0051904	pigment granule transport	-	23	18	-	-	1.54E-02	1.55E-03
Spike	BP	GO:1901679	nucleotide transmembrane transport	-	32	11	-	-	8.36E-03	9.32E-04
Spike	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	31	-	-	9.74E-04	2.59E-03
Spike	BP	GO:0033363	secretory granule organization	-	63	38	-	-	1.45E-02	3.21E-03
Spike	BP	GO:0060479	lung cell differentiation	-	28	26	-	-	8.40E-04	2.17E-03
Spike	BP	GO:0120009	intermembrane lipid transfer	-	52	27	-	-	2.75E-02	2.28E-03
Spike	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	12	-	-	5.08E-03	1.04E-03
Spike	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	32	-	-	1.32E-03	2.69E-03
Spike	BP	GO:0033622	integrin activation	-	26	16	-	-	4.07E-04	1.35E-03
Spike	BP	GO:0098751	bone cell development	-	18	12	-	-	1.77E-03	1.04E-03
Spike	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.61E-03	1.76E-03
Spike	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	43	-	-	7.32E-03	3.62E-03
Spike	BP	GO:0050820	positive regulation of coagulation	-	30	23	-	-	3.43E-02	1.97E-03
Spike	BP	GO:0002076	osteoblast development	-	17	12	-	-	1.59E-02	1.04E-03
Spike	BP	GO:0072164	mesonephric tubule development	-	98	80	-	-	4.45E-03	6.63E-03
Spike	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	13	-	-	3.08E-04	1.14E-03
Spike	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	87	-	-	1.39E-02	7.25E-03
Spike	BP	GO:1903524	positive regulation of blood circulation	-	39	28	-	-	3.31E-03	2.38E-03
Spike	BP	GO:0030901	midbrain development	-	87	71	-	-	4.15E-03	5.90E-03
Spike	BP	GO:0048485	sympathetic nervous system development	-	22	15	-	-	4.07E-04	1.24E-03
Spike	BP	GO:0007162	negative regulation of cell adhesion	-	310	230	-	-	7.88E-03	1.90E-02
Spike	BP	GO:0048532	anatomical structure arrangement	-	16	15	-	-	4.11E-04	1.24E-03
Spike	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	11	-	-	3.04E-04	9.32E-04
Spike	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	59	-	-	5.51E-03	4.97E-03
Spike	BP	GO:0002687	positive regulation of leukocyte migration	-	147	112	-	-	5.24E-03	9.32E-03
Spike	BP	GO:0019755	one-carbon compound transport	-	28	12	-	-	1.99E-01	1.04E-03
Spike	BP	GO:1901862	negative regulation of muscle tissue development	-	13	11	-	-	3.07E-04	9.32E-04
Spike	BP	GO:0110154	RNA decapping	-	19	13	-	-	2.17E-01	1.14E-03
Spike	BP	GO:0034605	cellular response to heat	-	66	49	-	-	2.76E-03	4.14E-03
Spike	BP	GO:0005996	monosaccharide metabolic process	-	250	169	-	-	8.36E-03	1.41E-02
Spike	BP	GO:0033555	multicellular organismal response to stress	-	90	55	-	-	2.10E-03	4.55E-03
Spike	BP	GO:0002262	myeloid cell homeostasis	-	172	141	-	-	6.66E-03	1.17E-02
Spike	BP	GO:0000966	RNA 5'-end processing	-	39	27	-	-	3.09E-01	2.28E-03
Spike	BP	GO:0050688	regulation of defense response to virus	-	65	49	-	-	2.80E-03	4.14E-03
Spike	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	247	-	-	4.19E-02	2.05E-02
Spike	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	23	-	-	1.39E-03	1.97E-03
Spike	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	207	-	-	1.94E-02	1.72E-02
Spike	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	28	-	-	1.45E-03	2.38E-03
Spike	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	26	-	-	3.65E-03	2.17E-03
Spike	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	14	-	-	3.07E-04	1.24E-03
Spike	BP	GO:0003272	endocardial cushion formation	-	28	25	-	-	2.54E-02	2.07E-03
Spike	BP	GO:0022618	protein-RNA complex assembly	-	227	164	-	-	2.16E-02	1.37E-02
Spike	BP	GO:0051147	regulation of muscle cell differentiation	-	162	125	-	-	2.09E-02	1.04E-02
Spike	BP	GO:0006066	alcohol metabolic process	-	374	199	-	-	1.21E-02	1.66E-02
Spike	BP	GO:0090102	cochlea development	-	50	31	-	-	8.83E-03	2.59E-03
Spike	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	2.71E-03	2.17E-03
Spike	BP	GO:0045933	positive regulation of muscle contraction	-	49	34	-	-	9.54E-04	2.90E-03
Spike	BP	GO:0002679	respiratory burst involved in defense response	-	16	11	-	-	3.08E-04	9.32E-04
Spike	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	27	-	-	2.92E-03	2.28E-03
Spike	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	63	-	-	2.99E-02	5.28E-03
Spike	BP	GO:0097264	self proteolysis	-	12	11	-	-	3.09E-04	9.32E-04
Spike	BP	GO:0043555	regulation of translation in response to stress	-	22	21	-	-	2.69E-02	1.76E-03
Spike	BP	GO:0032922	circadian regulation of gene expression	-	71	62	-	-	2.08E-02	5.18E-03
Spike	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	30	-	-	1.34E-02	2.48E-03
Spike	BP	GO:0050906	detection of stimulus involved in sensory perception	-	547	47	-	-	5.96E-03	3.93E-03
Spike	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	12	-	-	3.10E-04	1.04E-03
Spike	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	44	-	-	1.06E-02	3.73E-03
Spike	BP	GO:0038179	neurotrophin signaling pathway	-	38	34	-	-	8.74E-02	2.90E-03
Spike	BP	GO:0140253	cell-cell fusion	-	62	36	-	-	2.46E-03	3.00E-03
Spike	BP	GO:0071599	otic vesicle development	-	15	13	-	-	2.47E-02	1.14E-03
Spike	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	28	-	-	8.87E-02	2.38E-03
Spike	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	3.07E-04	1.24E-03
Spike	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	43	-	-	9.20E-04	3.62E-03
Spike	BP	GO:0001941	postsynaptic membrane organization	-	37	20	-	-	1.65E-02	1.66E-03
Spike	BP	GO:0051293	establishment of spindle localization	-	57	44	-	-	2.53E-03	3.73E-03
Spike	BP	GO:0048853	forebrain morphogenesis	-	13	12	-	-	3.08E-04	1.04E-03
Spike	BP	GO:0043114	regulation of vascular permeability	-	49	31	-	-	2.14E-03	2.59E-03
Spike	BP	GO:0018126	protein hydroxylation	-	26	13	-	-	2.90E-02	1.14E-03
Spike	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	40	-	-	3.31E-03	3.31E-03
Spike	BP	GO:0008360	regulation of cell shape	-	139	109	-	-	1.85E-02	9.11E-03
Spike	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	13	-	-	3.09E-04	1.14E-03
Spike	BP	GO:0051222	positive regulation of protein transport	-	249	181	-	-	6.45E-03	1.50E-02
Spike	CC	GO:0140632	canonical inflammasome complex assembly	-	40	30	-	-	2.04E-02	2.48E-03
Spike	MF	GO:0034260	negative regulation of GTPase activity	-	36	29	-	-	1.21E-03	2.48E-03
Spike	BP	GO:0045932	negative regulation of muscle contraction	-	24	15	-	-	4.09E-04	1.24E-03
Spike	BP	GO:0045739	positive regulation of DNA repair	-	128	109	-	-	4.36E-02	9.11E-03
Spike	BP	GO:0045185	maintenance of protein location	-	95	75	-	-	2.41E-03	6.21E-03
Spike	BP	GO:0003158	endothelium development	-	140	106	-	-	1.33E-02	8.80E-03
Spike	CC	GO:0072595	maintenance of protein localization in organelle	-	42	34	-	-	2.78E-03	2.90E-03
Spike	BP	GO:0051224	negative regulation of protein transport	-	122	86	-	-	6.62E-03	7.14E-03
Spike	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	124	-	-	8.43E-03	1.04E-02
Spike	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	4.97E-03	1.14E-03
Spike	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	23	-	-	2.21E-03	1.97E-03
Spike	MF	GO:0003713	transcription coactivator activity	-	281	230	-	-	1.16E-02	1.90E-02
Spike	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	15	-	-	1.38E-01	1.24E-03
Spike	BP	GO:0021885	forebrain cell migration	-	63	46	-	-	2.85E-03	3.83E-03
Spike	BP	GO:0007405	neuroblast proliferation	-	81	68	-	-	4.63E-03	5.69E-03
Spike	BP	GO:0009581	detection of external stimulus	-	137	64	-	-	8.02E-03	5.38E-03
Spike	BP	GO:1990542	mitochondrial transmembrane transport	-	93	45	-	-	1.08E-02	3.73E-03
Spike	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	30	-	-	1.47E-03	2.48E-03
Spike	BP	GO:0097186	amelogenesis	-	26	11	-	-	3.05E-04	9.32E-04
Spike	BP	GO:0031128	developmental induction	-	26	23	-	-	1.30E-02	1.97E-03
Spike	BP	GO:0031100	animal organ regeneration	-	66	57	-	-	7.61E-03	4.76E-03
Spike	BP	GO:0021533	cell differentiation in hindbrain	-	23	13	-	-	3.08E-04	1.14E-03
Spike	BP	GO:0045684	positive regulation of epidermis development	-	33	24	-	-	1.85E-03	2.07E-03
Spike	BP	GO:1900047	negative regulation of hemostasis	-	51	44	-	-	1.82E-01	3.73E-03
Spike	BP	GO:0021517	ventral spinal cord development	-	47	27	-	-	4.02E-02	2.28E-03
Spike	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	65	-	-	2.58E-03	5.38E-03
Spike	MF	GO:0034497	protein localization to phagophore assembly site	-	16	12	-	-	8.54E-03	1.04E-03
Spike	BP	GO:0097722	sperm motility	-	133	46	-	-	1.47E-02	3.83E-03
Spike	BP	GO:0051231	spindle elongation	-	14	11	-	-	7.94E-02	9.32E-04
Spike	BP	GO:0042490	mechanoreceptor differentiation	-	67	48	-	-	7.85E-02	4.04E-03
Spike	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	25	-	-	1.11E-03	2.07E-03
Spike	BP	GO:0035148	tube formation	-	155	121	-	-	9.97E-03	1.00E-02
Spike	BP	GO:0048520	positive regulation of behavior	-	27	14	-	-	6.74E-03	1.24E-03
Spike	BP	GO:0098543	detection of other organism	-	19	14	-	-	3.00E-04	1.24E-03
Spike	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	40	-	-	3.79E-02	3.31E-03
Spike	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	83	-	-	6.61E-03	6.94E-03
Spike	BP	GO:0031123	RNA 3'-end processing	-	79	60	-	-	2.22E-02	4.97E-03
Spike	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	15	-	-	1.04E-02	1.24E-03
Spike	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	74	-	-	4.44E-03	6.21E-03
Spike	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	15	-	-	3.75E-02	1.24E-03
Spike	CC	GO:0007097	nuclear migration	-	24	17	-	-	1.61E-03	1.45E-03
Spike	BP	GO:0045229	external encapsulating structure organization	-	319	189	-	-	3.03E-02	1.57E-02
Spike	BP	GO:0006885	regulation of pH	-	104	48	-	-	6.94E-03	4.04E-03
Spike	BP	GO:0002467	germinal center formation	-	14	11	-	-	1.96E-03	9.32E-04
Spike	BP	GO:1990840	response to lectin	-	22	20	-	-	1.28E-02	1.66E-03
Spike	BP	GO:0071800	podosome assembly	-	19	16	-	-	1.17E-02	1.35E-03
Spike	BP	GO:0031018	endocrine pancreas development	-	47	38	-	-	2.27E-03	3.21E-03
Spike	BP	GO:0001708	cell fate specification	-	108	81	-	-	3.49E-02	6.73E-03
Spike	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	77	-	-	3.58E-03	6.42E-03
Spike	BP	GO:0060354	negative regulation of cell adhesion molecule production	-	15	11	-	-	3.08E-04	9.32E-04
Spike	BP	GO:0030279	negative regulation of ossification	-	39	28	-	-	1.73E-03	2.38E-03
Spike	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	3.09E-04	1.24E-03
Spike	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	15	-	-	2.27E-02	1.24E-03
Spike	BP	GO:0032966	negative regulation of collagen biosynthetic process	-	13	11	-	-	3.07E-04	9.32E-04
Spike	BP	GO:0042440	pigment metabolic process	-	80	40	-	-	7.47E-03	3.31E-03
Spike	BP	GO:1901606	alpha-amino acid catabolic process	-	101	50	-	-	8.43E-03	4.14E-03
Spike	BP	GO:0062197	cellular response to chemical stress	-	299	242	-	-	9.70E-03	2.01E-02
Spike	BP	GO:1901890	positive regulation of cell junction assembly	-	106	65	-	-	5.81E-03	5.38E-03
Spike	BP	GO:0070988	demethylation	-	27	13	-	-	3.10E-04	1.14E-03
Spike	BP	GO:1901655	cellular response to ketone	-	107	87	-	-	3.45E-03	7.25E-03
Spike	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	15	-	-	5.98E-02	1.24E-03
Spike	BP	GO:0006968	cellular defense response	-	52	31	-	-	2.61E-02	2.59E-03
Spike	BP	GO:0055006	cardiac cell development	-	93	73	-	-	4.64E-03	6.11E-03
Spike	BP	GO:0031365	N-terminal protein amino acid modification	-	30	20	-	-	4.50E-02	1.66E-03
Spike	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	23	-	-	2.55E-03	1.97E-03
Spike	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	1.41E-03	1.04E-03
Spike	BP	GO:0060004	reflex	-	63	43	-	-	1.82E-03	3.62E-03
Spike	BP	GO:0044706	multi-multicellular organism process	-	217	162	-	-	6.62E-03	1.35E-02
Spike	BP	GO:0043589	skin morphogenesis	-	12	11	-	-	1.22E-02	9.32E-04
Spike	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	119	-	-	8.13E-03	9.94E-03
Spike	BP	GO:0006026	aminoglycan catabolic process	-	34	15	-	-	4.11E-04	1.24E-03
Spike	BP	GO:0031294	lymphocyte costimulation	-	47	37	-	-	1.07E-02	3.11E-03
Spike	BP	GO:0050768	negative regulation of neurogenesis	-	150	111	-	-	5.30E-03	9.21E-03
Spike	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	79	-	-	2.69E-03	6.63E-03
Spike	BP	GO:0090068	positive regulation of cell cycle process	-	262	205	-	-	1.52E-02	1.70E-02
Spike	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	18	-	-	4.09E-04	1.55E-03
Spike	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	21	-	-	1.78E-01	1.76E-03
Spike	BP	GO:1902115	regulation of organelle assembly	-	210	162	-	-	6.00E-03	1.35E-02
Spike	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	67	-	-	3.88E-03	5.59E-03
Spike	BP	GO:0047484	regulation of response to osmotic stress	-	16	11	-	-	3.07E-04	9.32E-04
Spike	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	103	-	-	1.06E-02	8.59E-03
Spike	BP	GO:0043171	peptide catabolic process	-	19	11	-	-	3.10E-04	9.32E-04
Spike	BP	GO:0046622	positive regulation of organ growth	-	52	38	-	-	1.61E-03	3.21E-03
Spike	BP	GO:0051952	regulation of amine transport	-	98	56	-	-	3.63E-03	4.66E-03
Spike	BP	GO:0006730	one-carbon metabolic process	-	24	18	-	-	4.12E-04	1.55E-03
Spike	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	16	-	-	8.36E-03	1.35E-03
Spike	BP	GO:0040019	positive regulation of embryonic development	-	23	16	-	-	9.88E-03	1.35E-03
Spike	BP	GO:0097154	GABAergic neuron differentiation	-	20	13	-	-	3.09E-04	1.14E-03
Spike	BP	GO:1903242	regulation of cardiac muscle hypertrophy in response to stress	-	18	15	-	-	2.09E-03	1.24E-03
Spike	CC	GO:0032365	intracellular lipid transport	-	51	27	-	-	2.84E-02	2.28E-03
Spike	BP	GO:0045048	protein insertion into ER membrane	-	30	18	-	-	1.22E-02	1.55E-03
Spike	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	62	-	-	6.26E-03	5.18E-03
Spike	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	94	-	-	5.15E-02	7.87E-03
Spike	BP	GO:0018149	peptide cross-linking	-	28	18	-	-	1.71E-02	1.55E-03
Spike	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	24	-	-	1.01E-03	2.07E-03
Spike	MF	GO:0140537	transcription regulator activator activity	-	13	12	-	-	2.28E-03	1.04E-03
Spike	BP	GO:0021859	pyramidal neuron differentiation	-	14	11	-	-	3.06E-04	9.32E-04
Spike	BP	GO:0071398	cellular response to fatty acid	-	35	23	-	-	1.03E-03	1.97E-03
Spike	BP	GO:0097581	lamellipodium organization	-	91	75	-	-	5.97E-03	6.21E-03
Spike	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	16	-	-	9.34E-02	1.35E-03
Spike	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	126	-	-	5.70E-03	1.05E-02
Spike	BP	GO:0060326	cell chemotaxis	-	311	221	-	-	2.43E-02	1.83E-02
Spike	BP	GO:1903975	regulation of glial cell migration	-	20	14	-	-	9.55E-02	1.24E-03
Spike	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	17	-	-	3.90E-03	1.45E-03
Spike	BP	GO:0015669	gas transport	-	23	12	-	-	1.97E-01	1.04E-03
Spike	BP	GO:0016485	protein processing	-	248	158	-	-	2.37E-02	1.31E-02
Spike	BP	GO:0009649	entrainment of circadian clock	-	30	25	-	-	3.49E-03	2.07E-03
Spike	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	88	-	-	8.74E-03	7.35E-03
Spike	BP	GO:1903523	negative regulation of blood circulation	-	27	17	-	-	9.94E-03	1.45E-03
Spike	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	56	-	-	1.04E-02	4.66E-03
Spike	BP	GO:0099054	presynapse assembly	-	49	22	-	-	2.75E-03	1.86E-03
Spike	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	24	-	-	5.20E-03	2.07E-03
Spike	BP	GO:0006517	protein deglycosylation	-	26	18	-	-	4.12E-04	1.55E-03
Spike	BP	GO:0031348	negative regulation of defense response	-	282	198	-	-	7.81E-03	1.65E-02
Spike	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	63	-	-	1.63E-03	5.28E-03
Spike	BP	GO:0007606	sensory perception of chemical stimulus	-	535	38	-	-	7.67E-03	3.21E-03
Spike	BP	GO:0061180	mammary gland epithelium development	-	68	58	-	-	3.20E-03	4.87E-03
Spike	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	177	-	-	6.22E-03	1.47E-02
Spike	BP	GO:0071496	cellular response to external stimulus	-	74	64	-	-	9.14E-03	5.38E-03
Spike	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	12	-	-	3.08E-04	1.04E-03
Spike	BP	GO:0042753	positive regulation of circadian rhythm	-	18	14	-	-	4.63E-02	1.24E-03
Spike	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	13	-	-	1.52E-03	1.14E-03
Spike	BP	GO:0032094	response to food	-	37	24	-	-	1.15E-03	2.07E-03
Spike	BP	GO:0001964	startle response	-	27	19	-	-	4.09E-04	1.66E-03
Spike	BP	GO:0007340	acrosome reaction	-	38	14	-	-	3.09E-04	1.24E-03
Spike	BP	GO:0046434	organophosphate catabolic process	-	232	145	-	-	1.51E-02	1.20E-02
Spike	BP	GO:0060037	pharyngeal system development	-	29	23	-	-	6.34E-02	1.97E-03
Spike	BP	GO:0009566	fertilization	-	205	95	-	-	1.33E-02	7.87E-03
Spike	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	21	-	-	1.00E-01	1.76E-03
Spike	BP	GO:0120255	olefinic compound biosynthetic process	-	24	16	-	-	4.11E-04	1.35E-03
Spike	BP	GO:0045907	positive regulation of vasoconstriction	-	30	19	-	-	2.17E-02	1.66E-03
Spike	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	15	-	-	2.76E-02	1.24E-03
Spike	BP	GO:0033044	regulation of chromosome organization	-	249	219	-	-	2.92E-02	1.82E-02
Spike	BP	GO:0009309	amine biosynthetic process	-	38	23	-	-	3.04E-02	1.97E-03
Spike	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	14	-	-	2.18E-02	1.24E-03
Spike	BP	GO:0061900	glial cell activation	-	56	47	-	-	2.52E-03	3.93E-03
Spike	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	108	-	-	1.52E-02	9.01E-03
Spike	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	12	-	-	1.03E-02	1.04E-03
Spike	CC	GO:0140467	integrated stress response signaling	-	41	36	-	-	1.63E-02	3.00E-03
Spike	BP	GO:0035902	response to immobilization stress	-	20	15	-	-	2.46E-03	1.24E-03
Spike	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	225	-	-	1.57E-02	1.86E-02
Spike	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	1.18E-03	1.24E-03
Spike	BP	GO:0090235	regulation of metaphase plate congression	-	13	12	-	-	9.44E-03	1.04E-03
Spike	BP	GO:0043647	inositol phosphate metabolic process	-	44	23	-	-	5.12E-04	1.97E-03
Spike	BP	GO:0016180	snRNA processing	-	28	21	-	-	6.07E-02	1.76E-03
Spike	BP	GO:0051303	establishment of chromosome localization	-	104	87	-	-	7.47E-03	7.25E-03
Spike	BP	GO:0051382	kinetochore assembly	-	16	15	-	-	4.12E-04	1.24E-03
Spike	BP	GO:0007164	establishment of tissue polarity	-	38	26	-	-	1.78E-02	2.17E-03
Spike	BP	GO:0021515	cell differentiation in spinal cord	-	51	31	-	-	1.99E-02	2.59E-03
Spike	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	15	-	-	2.05E-02	1.24E-03
Spike	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	17	-	-	8.86E-03	1.45E-03
Spike	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	22	-	-	1.07E-03	1.86E-03
Spike	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	4.70E-02	1.55E-03
Spike	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	28	-	-	1.83E-02	2.38E-03
Spike	BP	GO:0006605	protein targeting	-	327	219	-	-	1.85E-02	1.82E-02
Spike	BP	GO:0061318	renal filtration cell differentiation	-	22	19	-	-	4.11E-04	1.66E-03
Spike	BP	GO:0007566	embryo implantation	-	57	45	-	-	1.90E-03	3.73E-03
Spike	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	26	-	-	4.75E-03	2.17E-03
Spike	BP	GO:0031268	pseudopodium organization	-	17	12	-	-	3.29E-02	1.04E-03
Spike	BP	GO:0061512	protein localization to cilium	-	394	186	-	-	1.44E-02	1.54E-02
Spike	BP	GO:0060306	regulation of membrane repolarization	-	38	24	-	-	1.52E-02	2.07E-03
Spike	BP	GO:0051017	actin filament bundle assembly	-	161	133	-	-	4.80E-03	1.11E-02
Spike	BP	GO:1905953	negative regulation of lipid localization	-	63	48	-	-	2.48E-03	4.04E-03
Spike	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	13	-	-	3.06E-04	1.14E-03
Spike	BP	GO:0021542	dentate gyrus development	-	19	15	-	-	2.65E-03	1.24E-03
Spike	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	27	-	-	4.66E-02	2.28E-03
Spike	BP	GO:0021756	striatum development	-	21	18	-	-	3.65E-03	1.55E-03
Spike	BP	GO:1901343	negative regulation of vasculature development	-	154	107	-	-	4.89E-03	8.90E-03
Spike	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	105	-	-	1.06E-02	8.70E-03
Spike	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	13	-	-	3.09E-04	1.14E-03
Spike	BP	GO:1902414	protein localization to cell junction	-	107	74	-	-	8.19E-03	6.21E-03
Spike	BP	GO:0071305	cellular response to vitamin D	-	23	15	-	-	4.09E-04	1.24E-03
Spike	BP	GO:0051304	chromosome separation	-	80	72	-	-	2.72E-02	6.00E-03
Spike	BP	GO:0090596	sensory organ morphogenesis	-	272	185	-	-	1.81E-02	1.53E-02
Spike	BP	GO:0045780	positive regulation of bone resorption	-	18	13	-	-	6.81E-03	1.14E-03
Spike	BP	GO:0048709	oligodendrocyte differentiation	-	101	81	-	-	1.92E-02	6.73E-03
Spike	BP	GO:0045017	glycerolipid biosynthetic process	-	254	141	-	-	1.51E-02	1.17E-02
Spike	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	1.79E-01	1.24E-03
Spike	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	21	-	-	8.27E-03	1.76E-03
Spike	BP	GO:0001776	leukocyte homeostasis	-	108	88	-	-	3.98E-03	7.35E-03
Spike	BP	GO:0014744	positive regulation of muscle adaptation	-	14	11	-	-	3.08E-04	9.32E-04
Spike	BP	GO:0050769	positive regulation of neurogenesis	-	240	198	-	-	7.88E-03	1.65E-02
Spike	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	12	-	-	8.54E-02	1.04E-03
Spike	BP	GO:0030193	regulation of blood coagulation	-	70	58	-	-	5.10E-02	4.87E-03
Spike	BP	GO:0050866	negative regulation of cell activation	-	216	162	-	-	5.46E-03	1.35E-02
Spike	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	26	-	-	9.11E-04	2.17E-03
Spike	BP	GO:0033500	carbohydrate homeostasis	-	251	166	-	-	1.33E-02	1.38E-02
Spike	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	24	-	-	3.06E-02	2.07E-03
Spike	BP	GO:0044088	regulation of vacuole organization	-	56	45	-	-	1.19E-02	3.73E-03
Spike	CC	GO:0051457	maintenance of protein location in nucleus	-	23	19	-	-	4.06E-04	1.66E-03
Spike	CC	GO:0099522	cytosolic region	-	20	19	-	-	2.52E-03	1.66E-03
Spike	CC	GO:0000791	euchromatin	-	60	49	-	-	2.85E-03	4.14E-03
Spike	CC	GO:0030666	endocytic vesicle membrane	-	196	147	-	-	2.03E-02	1.22E-02
Spike	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.40E-01	1.24E-03
Spike	CC	GO:1990752	microtubule end	-	34	27	-	-	1.15E-02	2.28E-03
Spike	CC	GO:0043204	perikaryon	-	156	90	-	-	2.77E-03	7.45E-03
Spike	CC	GO:0061702	canonical inflammasome complex	-	17	12	-	-	2.77E-01	1.04E-03
Spike	CC	GO:0097542	ciliary tip	-	48	28	-	-	3.03E-02	2.38E-03
Spike	CC	GO:1905368	peptidase complex	-	124	103	-	-	9.23E-02	8.59E-03
Spike	CC	GO:0000792	heterochromatin	-	98	86	-	-	1.09E-02	7.14E-03
Spike	CC	GO:0097546	ciliary base	-	47	31	-	-	4.20E-03	2.59E-03
Spike	CC	GO:0071819	DUBm complex	-	25	22	-	-	4.56E-02	1.86E-03
Spike	CC	GO:0031201	SNARE complex	-	48	31	-	-	1.21E-01	2.59E-03
Spike	CC	GO:0016324	apical plasma membrane	-	392	211	-	-	8.28E-03	1.75E-02
Spike	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	1.62E-02	1.14E-03
Spike	CC	GO:0033260	nuclear DNA replication	-	40	35	-	-	1.06E-02	2.90E-03
Spike	CC	GO:0044391	ribosomal subunit	-	203	159	-	-	1.49E-02	1.33E-02
Spike	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	3.19E-02	9.32E-04
Spike	CC	GO:0071013	catalytic step 2 spliceosome	-	88	76	-	-	4.58E-02	6.31E-03
Spike	CC	GO:0031907	microbody lumen	-	51	34	-	-	1.54E-03	2.90E-03
Spike	CC	GO:0098862	cluster of actin-based cell projections	-	162	104	-	-	5.19E-02	8.70E-03
Spike	CC	GO:0016363	nuclear matrix	-	127	117	-	-	5.77E-03	9.73E-03
Spike	CC	GO:0031261	DNA replication preinitiation complex	-	46	42	-	-	8.32E-02	3.52E-03
Spike	CC	GO:0097060	synaptic membrane	-	413	227	-	-	3.60E-02	1.88E-02
Spike	CC	GO:0032432	actin filament bundle	-	249	174	-	-	1.59E-02	1.45E-02
Spike	CC	GO:0008088	axo-dendritic transport	-	78	66	-	-	6.54E-02	5.49E-03
Spike	CC	GO:0031519	PcG protein complex	-	38	31	-	-	2.15E-02	2.59E-03
Spike	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	26	-	-	7.01E-02	2.17E-03
Spike	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	153	-	-	2.61E-02	1.27E-02
Spike	CC	GO:0000313	organellar ribosome	-	89	58	-	-	2.24E-02	4.87E-03
Spike	CC	GO:0098791	Golgi apparatus subcompartment	-	378	203	-	-	3.10E-02	1.69E-02
Spike	CC	GO:0099643	signal release from synapse	-	147	97	-	-	3.50E-02	8.07E-03
Spike	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	29	-	-	2.96E-02	2.48E-03
Spike	CC	GO:0030018	Z disc	-	129	97	-	-	2.64E-02	8.07E-03
Spike	CC	GO:0032580	Golgi cisterna membrane	-	93	27	-	-	6.88E-03	2.28E-03
Spike	CC	GO:1905360	GTPase complex	-	41	29	-	-	3.68E-02	2.48E-03
Spike	CC	GO:0097540	axonemal central pair	-	161	71	-	-	2.13E-03	5.90E-03
Spike	CC	GO:0042641	actomyosin	-	77	63	-	-	4.49E-03	5.28E-03
Spike	CC	GO:0097386	glial cell projection	-	38	20	-	-	2.98E-03	1.66E-03
Spike	CC	GO:0032588	trans-Golgi network membrane	-	102	52	-	-	1.17E-01	4.35E-03
Spike	CC	GO:0070382	exocytic vesicle	-	224	137	-	-	2.32E-02	1.14E-02
Spike	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	31	-	-	4.83E-02	2.59E-03
Spike	CC	GO:0031903	microbody membrane	-	65	45	-	-	2.93E-01	3.73E-03
Spike	CC	GO:0046930	pore complex	-	26	22	-	-	8.69E-02	1.86E-03
Spike	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	1.37E-02	9.32E-04
Spike	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	12	-	-	1.55E-03	1.04E-03
Spike	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	193	-	-	2.04E-02	1.60E-02
Spike	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	19	-	-	2.58E-03	1.66E-03
Spike	CC	GO:0044298	cell body membrane	-	32	16	-	-	4.12E-04	1.35E-03
Spike	CC	GO:0051882	mitochondrial depolarization	-	21	17	-	-	3.03E-03	1.45E-03
Spike	CC	GO:0045495	pole plasm	-	25	11	-	-	3.09E-04	9.32E-04
Spike	CC	GO:0072379	ER membrane insertion complex	-	14	13	-	-	1.05E-02	1.14E-03
Spike	CC	GO:0070993	translation preinitiation complex	-	19	18	-	-	1.86E-01	1.55E-03
Spike	CC	GO:0010369	chromocenter	-	14	12	-	-	9.64E-03	1.04E-03
Spike	CC	GO:0016323	basolateral plasma membrane	-	239	136	-	-	5.22E-03	1.13E-02
Spike	CC	GO:0042405	nuclear inclusion body	-	12	11	-	-	6.51E-03	9.32E-04
Spike	CC	GO:0042645	mitochondrial nucleoid	-	45	37	-	-	8.35E-02	3.11E-03
Spike	CC	GO:1902495	transmembrane transporter complex	-	408	170	-	-	2.11E-02	1.41E-02
Spike	CC	GO:0098636	protein complex involved in cell adhesion	-	57	43	-	-	1.93E-02	3.62E-03
Spike	CC	GO:0001917	photoreceptor inner segment	-	71	40	-	-	3.07E-02	3.31E-03
Spike	CC	GO:0098845	postsynaptic endosome	-	14	11	-	-	1.75E-02	9.32E-04
Spike	CC	GO:0019897	extrinsic component of plasma membrane	-	156	110	-	-	1.18E-02	9.11E-03
Spike	CC	GO:0031594	neuromuscular junction	-	73	51	-	-	5.19E-03	4.24E-03
Spike	CC	GO:0000793	condensed chromosome	-	274	225	-	-	3.35E-02	1.86E-02
Spike	CC	GO:0000922	spindle pole	-	172	122	-	-	6.65E-03	1.01E-02
Spike	CC	GO:0120111	neuron projection cytoplasm	-	94	75	-	-	4.69E-02	6.21E-03
Spike	CC	GO:0070971	endoplasmic reticulum exit site	-	32	18	-	-	1.08E-01	1.55E-03
Spike	CC	GO:0005736	RNA polymerase I complex	-	13	12	-	-	3.13E-02	1.04E-03
Spike	CC	GO:0004879	nuclear receptor activity	-	63	58	-	-	1.77E-02	4.87E-03
Spike	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	129	-	-	6.83E-03	1.08E-02
Spike	CC	GO:0000123	histone acetyltransferase complex	-	93	78	-	-	2.44E-02	6.52E-03
Spike	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	64	-	-	2.70E-02	5.38E-03
Spike	CC	GO:0048786	presynaptic active zone	-	80	54	-	-	8.37E-03	4.55E-03
Spike	CC	GO:0001054	RNA polymerase I activity	-	12	11	-	-	4.07E-02	9.32E-04
Spike	CC	GO:0007034	vacuolar transport	-	168	108	-	-	6.23E-03	9.01E-03
Spike	CC	GO:0043194	axon initial segment	-	21	17	-	-	8.61E-02	1.45E-03
Spike	CC	GO:0005776	autophagosome	-	111	77	-	-	1.11E-02	6.42E-03
Spike	CC	GO:0031430	M band	-	22	12	-	-	2.90E-02	1.04E-03
Spike	CC	GO:0001931	uropod	-	13	11	-	-	3.08E-04	9.32E-04
Spike	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	70	-	-	5.47E-02	5.80E-03
Spike	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	55	-	-	1.08E-02	4.55E-03
Spike	CC	GO:0030677	ribonuclease P complex	-	14	12	-	-	9.80E-01	1.04E-03
Spike	CC	GO:0000164	protein phosphatase type 1 complex	-	19	16	-	-	3.98E-02	1.35E-03
Spike	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	23	-	-	5.03E-02	1.97E-03
Spike	CC	GO:0032994	protein-lipid complex	-	39	28	-	-	1.18E-01	2.38E-03
Spike	CC	GO:0150034	distal axon	-	309	215	-	-	1.06E-02	1.78E-02
Spike	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	128	-	-	5.55E-02	1.07E-02
Spike	CC	GO:0071012	catalytic step 1 spliceosome	-	12	11	-	-	1.32E-01	9.32E-04
Spike	CC	GO:0072562	blood microparticle	-	144	101	-	-	4.78E-02	8.39E-03
Spike	CC	GO:0051233	spindle midzone	-	36	29	-	-	5.82E-03	2.48E-03
Spike	CC	GO:0005811	lipid droplet	-	102	58	-	-	2.55E-03	4.87E-03
Spike	CC	GO:0045022	early endosome to late endosome transport	-	44	37	-	-	1.30E-02	3.11E-03
Spike	CC	GO:0043113	receptor clustering	-	51	34	-	-	7.76E-03	2.90E-03
Spike	CC	GO:0005940	septin ring	-	14	11	-	-	5.70E-01	9.32E-04
Spike	CC	GO:0044853	plasma membrane raft	-	114	87	-	-	7.50E-03	7.25E-03
Spike	CC	GO:0005881	cytoplasmic microtubule	-	256	122	-	-	4.34E-03	1.01E-02
Spike	CC	GO:0008180	COP9 signalosome	-	17	14	-	-	1.61E-03	1.24E-03
Spike	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	39	-	-	5.65E-02	3.31E-03
Spike	CC	GO:0005905	clathrin-coated pit	-	73	60	-	-	1.21E-02	4.97E-03
Spike	CC	GO:0043034	costamere	-	18	15	-	-	9.70E-03	1.24E-03
Spike	CC	GO:0031904	endosome lumen	-	38	30	-	-	7.64E-03	2.48E-03
Spike	CC	GO:0060170	ciliary membrane	-	76	29	-	-	1.63E-03	2.48E-03
Spike	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	12	-	-	3.92E-01	1.04E-03
Spike	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	20	-	-	2.29E-01	1.66E-03
Spike	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	14	-	-	1.30E-01	1.24E-03
Spike	CC	GO:0032154	cleavage furrow	-	54	46	-	-	3.56E-02	3.83E-03
Spike	CC	GO:0005640	nuclear outer membrane	-	30	21	-	-	5.12E-04	1.76E-03
Spike	CC	GO:0005652	nuclear lamina	-	12	11	-	-	1.13E-03	9.32E-04
Spike	CC	GO:0007006	mitochondrial membrane organization	-	117	85	-	-	3.48E-02	7.04E-03
Spike	CC	GO:0001772	immunological synapse	-	44	37	-	-	1.48E-02	3.11E-03
Spike	CC	GO:0030904	retromer complex	-	12	11	-	-	1.04E-01	9.32E-04
Spike	CC	GO:0009897	external side of plasma membrane	-	425	234	-	-	2.04E-02	1.95E-02
Spike	CC	GO:0030863	cortical cytoskeleton	-	104	85	-	-	7.92E-03	7.04E-03
Spike	CC	GO:1905348	endonuclease complex	-	38	32	-	-	2.92E-01	2.69E-03
Spike	CC	GO:0061638	CENP-A containing chromatin	-	18	17	-	-	4.10E-04	1.45E-03
Spike	CC	GO:0030315	T-tubule	-	52	30	-	-	7.17E-04	2.48E-03
Spike	CC	GO:0060076	excitatory synapse	-	64	30	-	-	1.89E-02	2.48E-03
Spike	CC	GO:0036019	endolysosome	-	29	19	-	-	1.10E-02	1.66E-03
Spike	CC	GO:0001891	phagocytic cup	-	28	20	-	-	3.72E-03	1.66E-03
Spike	CC	GO:0099086	synaptonemal structure	-	40	19	-	-	8.67E-03	1.66E-03
Spike	CC	GO:0030427	site of polarized growth	-	172	138	-	-	5.67E-03	1.15E-02
Spike	CC	GO:0044309	neuron spine	-	213	151	-	-	8.37E-03	1.25E-02
Spike	CC	GO:0030658	transport vesicle membrane	-	231	141	-	-	3.56E-02	1.17E-02
Spike	CC	GO:0098918	structural constituent of synapse	-	27	17	-	-	1.17E-03	1.45E-03
Spike	CC	GO:0000940	outer kinetochore	-	17	16	-	-	2.04E-01	1.35E-03
Spike	CC	GO:0034719	SMN-Sm protein complex	-	18	16	-	-	3.59E-01	1.35E-03
Spike	CC	GO:0044232	organelle membrane contact site	-	50	23	-	-	5.08E-04	1.97E-03
Spike	CC	GO:0098803	respiratory chain complex	-	39	20	-	-	1.69E-02	1.66E-03
Spike	CC	GO:0030667	secretory granule membrane	-	319	196	-	-	1.55E-02	1.63E-02
Spike	CC	GO:0097545	axonemal outer doublet	-	164	72	-	-	2.31E-03	6.00E-03
Spike	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	14	-	-	3.26E-03	1.24E-03
Spike	CC	GO:0070069	cytochrome complex	-	42	21	-	-	5.16E-04	1.76E-03
Spike	CC	GO:0031143	pseudopodium	-	18	17	-	-	6.64E-03	1.45E-03
Spike	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	26	-	-	6.36E-03	2.17E-03
Spike	CC	GO:0055037	recycling endosome	-	200	114	-	-	7.66E-03	9.52E-03
Spike	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	68	-	-	4.69E-03	5.69E-03
Spike	CC	GO:0071682	endocytic vesicle lumen	-	23	19	-	-	2.22E-02	1.66E-03
Spike	CC	GO:0030684	preribosome	-	76	52	-	-	7.37E-03	4.35E-03
Spike	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	237	-	-	1.09E-02	1.97E-02
Spike	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	17	-	-	6.02E-02	1.45E-03
Spike	CC	GO:1990391	DNA repair complex	-	22	20	-	-	1.03E-01	1.66E-03
Spike	CC	GO:0005775	vacuolar lumen	-	176	111	-	-	7.29E-03	9.21E-03
Spike	CC	GO:0032433	filopodium tip	-	19	15	-	-	9.94E-03	1.24E-03
Spike	CC	GO:0032982	myosin filament	-	24	17	-	-	4.12E-04	1.45E-03
Spike	CC	GO:0016327	apicolateral plasma membrane	-	23	14	-	-	1.01E-03	1.24E-03
Spike	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	14	-	-	2.42E-01	1.24E-03
Spike	CC	GO:0044306	neuron projection terminus	-	164	102	-	-	5.01E-03	8.49E-03
Spike	CC	GO:0034455	t-UTP complex	-	53	35	-	-	1.41E-03	2.90E-03
Spike	CC	GO:0005770	late endosome	-	299	169	-	-	1.30E-02	1.41E-02
Spike	CC	GO:0031970	organelle envelope lumen	-	94	64	-	-	1.97E-02	5.38E-03
Spike	CC	GO:0097550	transcription preinitiation complex	-	13	12	-	-	3.08E-04	1.04E-03
Spike	CC	GO:0120293	dynein axonemal particle	-	20	11	-	-	1.66E-03	9.32E-04
Spike	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	21	-	-	4.31E-03	1.76E-03
Spike	CC	GO:0043292	contractile muscle fiber	-	245	171	-	-	2.42E-02	1.42E-02
Spike	CC	GO:0034709	methylosome	-	13	12	-	-	1.20E-02	1.04E-03
Spike	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	11	-	-	7.48E-03	9.32E-04
Spike	CC	GO:0005849	mRNA cleavage factor complex	-	22	16	-	-	1.15E-01	1.35E-03
Spike	CC	GO:0000803	sex chromosome	-	32	23	-	-	7.04E-04	1.97E-03
Spike	CC	GO:0098982	GABA-ergic synapse	-	84	32	-	-	1.06E-03	2.69E-03
Spike	CC	GO:0035097	histone methyltransferase complex	-	63	56	-	-	2.86E-02	4.66E-03
Spike	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	12	-	-	1.71E-01	1.04E-03
Spike	CC	GO:0000242	pericentriolar material	-	22	14	-	-	5.25E-02	1.24E-03
Spike	CC	GO:1903293	phosphatase complex	-	54	46	-	-	2.31E-02	3.83E-03
Spike	CC	GO:0031941	filamentous actin	-	27	21	-	-	1.00E-02	1.76E-03
Spike	CC	GO:0000786	nucleosome	-	149	114	-	-	4.39E-02	9.52E-03
Spike	CC	GO:0001533	cornified envelope	-	59	40	-	-	2.88E-03	3.31E-03
Spike	CC	GO:1904724	tertiary granule lumen	-	55	33	-	-	3.24E-03	2.80E-03
Spike	CC	GO:0030027	lamellipodium	-	202	173	-	-	1.95E-02	1.44E-02
Spike	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	14	-	-	3.08E-04	1.24E-03
Spike	CC	GO:0031209	SCAR complex	-	12	11	-	-	1.41E-01	9.32E-04
Spike	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	14	-	-	3.08E-04	1.24E-03
Spike	CC	GO:0002102	podosome	-	31	29	-	-	2.02E-03	2.48E-03
Spike	CC	GO:0090543	Flemming body	-	33	26	-	-	6.56E-03	2.17E-03
Spike	CC	GO:0016328	lateral plasma membrane	-	66	51	-	-	1.06E-02	4.24E-03
Spike	CC	GO:0001650	fibrillar center	-	151	124	-	-	4.42E-03	1.04E-02
Spike	CC	GO:0031332	RNAi effector complex	-	413	127	-	-	5.86E-03	1.06E-02
Spike	CC	GO:1990204	oxidoreductase complex	-	90	53	-	-	6.65E-02	4.45E-03
Spike	CC	GO:0000930	gamma-tubulin complex	-	16	12	-	-	1.50E-01	1.04E-03
Spike	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	8.03E-02	9.32E-04
Spike	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	105	-	-	6.11E-03	8.70E-03
Spike	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	13	-	-	2.80E-02	1.14E-03
Spike	CC	GO:0001726	ruffle	-	181	142	-	-	8.84E-03	1.18E-02
Spike	CC	GO:1990909	Wnt signalosome	-	13	12	-	-	7.31E-03	1.04E-03
Spike	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	14	-	-	2.36E-01	1.24E-03
Spike	CC	GO:0043198	dendritic shaft	-	38	22	-	-	5.16E-03	1.86E-03
Spike	CC	GO:0043073	germ cell nucleus	-	67	45	-	-	2.87E-03	3.73E-03
Spike	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	16	-	-	1.99E-02	1.35E-03
Spike	CC	GO:0005788	endoplasmic reticulum lumen	-	313	215	-	-	1.23E-02	1.78E-02
Spike	CC	GO:0016592	mediator complex	-	38	36	-	-	2.91E-01	3.00E-03
Spike	CC	GO:0034045	phagophore assembly site membrane	-	19	17	-	-	1.49E-01	1.45E-03
Spike	CC	GO:0022626	cytosolic ribosome	-	118	104	-	-	2.00E-02	8.70E-03
Spike	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	39	-	-	2.49E-02	3.31E-03
Spike	CC	GO:0034451	centriolar satellite	-	120	79	-	-	3.92E-03	6.63E-03
Spike	CC	GO:0045171	intercellular bridge	-	91	66	-	-	3.60E-03	5.49E-03
Spike	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	46	-	-	3.19E-02	3.83E-03
Spike	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	4.96E-02	9.32E-04
Spike	CC	GO:0044292	dendrite terminus	-	13	11	-	-	8.99E-04	9.32E-04
Spike	CC	GO:0032039	integrator complex	-	19	11	-	-	3.10E-04	9.32E-04
Spike	CC	GO:0033268	node of Ranvier	-	16	12	-	-	6.70E-02	1.04E-03
Spike	CC	GO:0030527	structural constituent of chromatin	-	97	75	-	-	1.74E-03	6.21E-03
Spike	CC	GO:0036379	myofilament	-	26	15	-	-	4.32E-02	1.24E-03
Spike	CC	GO:0030286	dynein complex	-	210	93	-	-	5.31E-03	7.76E-03
Spike	CC	GO:0031105	septin complex	-	14	11	-	-	6.00E-01	9.32E-04
Spike	CC	GO:0044615	nuclear pore nuclear basket	-	12	11	-	-	4.87E-02	9.32E-04
Spike	CC	GO:0016482	cytosolic transport	-	135	85	-	-	1.91E-02	7.04E-03
Spike	CC	GO:0090665	glycoprotein complex	-	23	15	-	-	6.63E-02	1.24E-03
Spike	CC	GO:0005796	Golgi lumen	-	106	66	-	-	1.01E-02	5.49E-03
Spike	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	22	-	-	8.06E-02	1.86E-03
Spike	CC	GO:0034358	plasma lipoprotein particle	-	36	25	-	-	1.44E-01	2.07E-03
Spike	CC	GO:0008023	transcription elongation factor complex	-	47	41	-	-	1.40E-02	3.42E-03
Spike	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	13	-	-	1.41E-03	1.14E-03
Spike	CC	GO:0030662	coated vesicle membrane	-	202	145	-	-	4.48E-02	1.20E-02
Spike	CC	GO:0007039	protein catabolic process in the vacuole	-	61	41	-	-	3.27E-02	3.42E-03
Spike	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	35	-	-	2.27E-02	2.90E-03
Spike	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	232	-	-	3.99E-02	1.93E-02
Spike	CC	GO:0090734	site of DNA damage	-	118	92	-	-	1.89E-02	7.66E-03
Spike	MF	GO:0051861	glycolipid binding	-	30	19	-	-	4.11E-04	1.66E-03
Spike	MF	GO:0051087	protein-folding chaperone binding	-	135	110	-	-	7.01E-03	9.11E-03
Spike	MF	GO:0051959	dynein light intermediate chain binding	-	27	13	-	-	3.09E-04	1.14E-03
Spike	MF	GO:0031681	G-protein beta-subunit binding	-	22	14	-	-	3.10E-04	1.24E-03
Spike	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	26	-	-	9.65E-04	2.17E-03
Spike	MF	GO:0035613	RNA stem-loop binding	-	21	13	-	-	3.07E-04	1.14E-03
Spike	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	131	-	-	1.35E-02	1.09E-02
Spike	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	15	-	-	3.05E-03	1.24E-03
Spike	MF	GO:0016757	glycosyltransferase activity	-	286	99	-	-	1.05E-02	8.28E-03
Spike	MF	GO:0048306	calcium-dependent protein binding	-	61	53	-	-	1.04E-02	4.45E-03
Spike	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	17	-	-	4.10E-04	1.45E-03
Spike	MF	GO:0035325	Toll-like receptor binding	-	13	12	-	-	1.16E-01	1.04E-03
Spike	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	75	-	-	8.51E-03	6.21E-03
Spike	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	31	-	-	2.73E-03	2.59E-03
Spike	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	80	-	-	1.49E-02	6.63E-03
Spike	MF	GO:0051020	GTPase binding	-	311	241	-	-	9.85E-03	2.00E-02
Spike	MF	GO:0140457	protein demethylase activity	-	31	23	-	-	5.16E-04	1.97E-03
Spike	MF	GO:0005158	insulin receptor binding	-	22	21	-	-	7.19E-03	1.76E-03
Spike	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	15	-	-	2.12E-03	1.24E-03
Spike	MF	GO:0061980	regulatory RNA binding	-	52	37	-	-	3.69E-02	3.11E-03
Spike	MF	GO:0015035	protein-disulfide reductase activity	-	32	22	-	-	1.60E-02	1.86E-03
Spike	MF	GO:0001671	ATPase activator activity	-	29	22	-	-	5.07E-04	1.86E-03
Spike	MF	GO:0070840	dynein complex binding	-	25	17	-	-	5.58E-03	1.45E-03
Spike	MF	GO:0035035	histone acetyltransferase binding	-	24	19	-	-	9.42E-04	1.66E-03
Spike	MF	GO:0061684	chaperone-mediated autophagy	-	16	14	-	-	3.09E-03	1.24E-03
Spike	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	24	-	-	8.48E-03	2.07E-03
Spike	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	1.83E-01	1.55E-03
Spike	MF	GO:0005178	integrin binding	-	153	124	-	-	3.22E-02	1.04E-02
Spike	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	1.27E-03	1.45E-03
Spike	MF	GO:0008327	methyl-CpG binding	-	31	19	-	-	4.21E-03	1.66E-03
Spike	MF	GO:0031418	L-ascorbic acid binding	-	20	13	-	-	3.10E-04	1.14E-03
Spike	MF	GO:0048019	receptor antagonist activity	-	31	12	-	-	3.08E-04	1.04E-03
Spike	MF	GO:0005521	lamin binding	-	15	13	-	-	4.57E-03	1.14E-03
Spike	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	7.54E-03	1.66E-03
Spike	MF	GO:0140318	protein transporter activity	-	40	27	-	-	9.73E-02	2.28E-03
Spike	MF	GO:0070628	proteasome binding	-	17	15	-	-	4.79E-03	1.24E-03
Spike	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	5.91E-03	9.32E-04
Spike	MF	GO:0000217	DNA secondary structure binding	-	37	35	-	-	1.59E-02	2.90E-03
Spike	MF	GO:0002039	p53 binding	-	66	61	-	-	4.35E-03	5.07E-03
Spike	MF	GO:0005496	steroid binding	-	110	66	-	-	7.26E-03	5.49E-03
Spike	MF	GO:0008443	phosphofructokinase activity	-	27	24	-	-	1.88E-02	2.07E-03
Spike	MF	GO:0003684	damaged DNA binding	-	89	82	-	-	6.08E-02	6.83E-03
Spike	MF	GO:0000339	RNA cap binding	-	20	15	-	-	5.39E-02	1.24E-03
Spike	MF	GO:0016500	protein-hormone receptor activity	-	21	11	-	-	3.09E-04	9.32E-04
Spike	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	106	-	-	2.58E-02	8.80E-03
Spike	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	4.31E-02	9.32E-04
Spike	MF	GO:0070063	RNA polymerase binding	-	61	52	-	-	1.74E-03	4.35E-03
Spike	MF	GO:0030971	receptor tyrosine kinase binding	-	76	58	-	-	4.31E-03	4.87E-03
Spike	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	66	-	-	7.17E-02	5.49E-03
Spike	MF	GO:0140030	modification-dependent protein binding	-	179	138	-	-	6.47E-03	1.15E-02
Spike	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	3.05E-04	1.14E-03
Spike	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	9.65E-02	1.35E-03
Spike	MF	GO:0141047	molecular tag activity	-	13	11	-	-	1.71E-03	9.32E-04
Spike	MF	GO:0035497	cAMP response element binding	-	12	11	-	-	5.47E-03	9.32E-04
Spike	MF	GO:0044548	S100 protein binding	-	14	14	-	-	6.81E-02	1.24E-03
Spike	MF	GO:0030983	mismatched DNA binding	-	14	13	-	-	1.09E-01	1.14E-03
Spike	MF	GO:0030276	clathrin binding	-	70	47	-	-	9.14E-02	3.93E-03
Spike	MF	GO:0046875	ephrin receptor binding	-	29	26	-	-	3.71E-03	2.17E-03
Spike	MF	GO:0140311	protein sequestering activity	-	14	11	-	-	2.93E-04	9.32E-04
Spike	MF	GO:0046790	virion binding	-	19	16	-	-	4.07E-04	1.35E-03
Spike	MF	GO:0030552	cAMP binding	-	48	33	-	-	7.68E-03	2.80E-03
Spike	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	32	-	-	7.02E-04	2.69E-03
Spike	MF	GO:0035173	histone kinase activity	-	17	15	-	-	4.02E-04	1.24E-03
Spike	MF	GO:0097602	cullin family protein binding	-	26	14	-	-	2.02E-03	1.24E-03
Spike	MF	GO:0016209	antioxidant activity	-	92	55	-	-	3.08E-02	4.55E-03
Spike	MF	GO:0070325	lipoprotein particle receptor binding	-	32	27	-	-	5.26E-03	2.28E-03
Spike	MF	GO:0044325	transmembrane transporter binding	-	159	109	-	-	4.53E-03	9.11E-03
Spike	MF	GO:0048156	tau protein binding	-	43	40	-	-	2.45E-03	3.31E-03
Spike	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	32	-	-	4.78E-03	2.69E-03
Spike	MF	GO:0045295	gamma-catenin binding	-	13	12	-	-	3.53E-03	1.04E-03
Spike	MF	GO:0140272	exogenous protein binding	-	79	65	-	-	4.53E-03	5.38E-03
Spike	MF	GO:0030145	manganese ion binding	-	65	32	-	-	1.25E-03	2.69E-03
Spike	MF	GO:0071814	protein-lipid complex binding	-	52	34	-	-	9.44E-03	2.90E-03
Spike	MF	GO:0008066	glutamate receptor activity	-	70	33	-	-	1.53E-02	2.80E-03
Spike	MF	GO:0017069	snRNA binding	-	54	42	-	-	2.53E-02	3.52E-03
Spike	MF	GO:0030215	semaphorin receptor binding	-	23	11	-	-	2.68E-02	9.32E-04
Spike	MF	GO:0031369	translation initiation factor binding	-	32	28	-	-	1.60E-02	2.38E-03
Spike	MF	GO:0019843	rRNA binding	-	69	51	-	-	2.24E-03	4.24E-03
Spike	MF	GO:0004713	protein tyrosine kinase activity	-	213	178	-	-	1.95E-02	1.48E-02
Spike	MF	GO:0016779	nucleotidyltransferase activity	-	264	190	-	-	1.59E-02	1.57E-02
Spike	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	47	-	-	7.23E-03	3.93E-03
Spike	MF	GO:0008093	cytoskeletal anchor activity	-	24	20	-	-	2.04E-03	1.66E-03
Spike	MF	GO:0070300	phosphatidic acid binding	-	20	14	-	-	3.09E-04	1.24E-03
Spike	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	22	-	-	5.06E-04	1.86E-03
Spike	MF	GO:0016208	AMP binding	-	22	19	-	-	1.49E-02	1.66E-03
Spike	MF	GO:0000287	magnesium ion binding	-	225	158	-	-	6.52E-03	1.31E-02
Spike	MF	GO:0031490	chromatin DNA binding	-	120	94	-	-	7.71E-03	7.87E-03
Spike	MF	GO:0017022	myosin binding	-	73	52	-	-	2.65E-02	4.35E-03
Spike	MF	GO:0004896	cytokine receptor activity	-	93	68	-	-	9.00E-03	5.69E-03
Spike	MF	GO:0017166	vinculin binding	-	12	11	-	-	1.14E-02	9.32E-04
Spike	MF	GO:0008301	"DNA binding, bending"	-	18	14	-	-	3.37E-03	1.24E-03
Spike	MF	GO:1990459	transferrin receptor binding	-	12	11	-	-	2.44E-02	9.32E-04
Spike	MF	GO:0005539	glycosaminoglycan binding	-	236	141	-	-	1.21E-02	1.17E-02
Spike	MF	GO:0019207	kinase regulator activity	-	267	220	-	-	8.02E-03	1.82E-02
Spike	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	11	-	-	3.08E-04	9.32E-04
Spike	MF	GO:0044183	protein folding chaperone	-	67	49	-	-	4.59E-03	4.14E-03
Spike	MF	GO:0005132	type I interferon receptor binding	-	17	14	-	-	3.11E-04	1.24E-03
Spike	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	91	-	-	1.26E-02	7.56E-03
Spike	MF	GO:0003725	double-stranded RNA binding	-	72	57	-	-	8.24E-03	4.76E-03
Spike	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	2.50E-03	1.35E-03
Spike	MF	GO:0051018	protein kinase A binding	-	52	41	-	-	8.44E-03	3.42E-03
Spike	MF	GO:0071889	14-3-3 protein binding	-	34	27	-	-	2.48E-03	2.28E-03
Spike	MF	GO:0004618	phosphoglycerate kinase activity	-	89	71	-	-	1.61E-02	5.90E-03
Spike	MF	GO:0042805	actinin binding	-	36	28	-	-	5.97E-04	2.38E-03
Spike	MF	GO:0043531	ADP binding	-	38	32	-	-	4.09E-03	2.69E-03
Spike	MF	GO:0043394	proteoglycan binding	-	36	24	-	-	6.38E-03	2.07E-03
Spike	MF	GO:0046332	SMAD binding	-	77	65	-	-	1.25E-02	5.38E-03
Spike	MF	GO:0043560	insulin receptor substrate binding	-	13	12	-	-	2.15E-03	1.04E-03
Spike	MF	GO:0001968	fibronectin binding	-	30	25	-	-	1.37E-02	2.07E-03
Spike	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	93	-	-	3.75E-02	7.76E-03
Spike	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	56	-	-	1.78E-03	4.66E-03
Spike	MF	GO:0003756	protein disulfide isomerase activity	-	18	13	-	-	3.86E-03	1.14E-03
Spike	MF	GO:0051117	ATPase binding	-	85	68	-	-	3.49E-03	5.69E-03
Spike	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	34	-	-	1.74E-03	2.90E-03
Spike	MF	GO:0051787	misfolded protein binding	-	20	15	-	-	4.27E-03	1.24E-03
Spike	MF	GO:0031404	chloride ion binding	-	14	11	-	-	3.09E-04	9.32E-04
Spike	MF	GO:0001098	basal transcription machinery binding	-	61	58	-	-	6.08E-03	4.87E-03
Spike	MF	GO:0036002	pre-mRNA binding	-	57	31	-	-	1.67E-02	2.59E-03
Spike	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	23	-	-	3.75E-03	1.97E-03
Spike	MF	GO:0051540	metal cluster binding	-	71	40	-	-	9.23E-04	3.31E-03
Spike	MF	GO:0051219	phosphoprotein binding	-	92	84	-	-	4.81E-03	7.04E-03
Spike	MF	GO:0019894	kinesin binding	-	45	33	-	-	8.63E-03	2.80E-03
Spike	MF	GO:0042287	MHC protein binding	-	68	36	-	-	3.79E-02	3.00E-03
Spike	MF	GO:0019003	GDP binding	-	89	70	-	-	8.48E-03	5.80E-03
Spike	MF	GO:0017171	serine hydrolase activity	-	207	92	-	-	1.13E-02	7.66E-03
Spike	MF	GO:0097110	scaffold protein binding	-	66	56	-	-	3.44E-03	4.66E-03
Spike	MF	GO:0003774	cytoskeletal motor activity	-	117	78	-	-	5.17E-03	6.52E-03
Spike	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	26	-	-	7.58E-03	2.17E-03
Spike	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	16	-	-	4.10E-04	1.35E-03
Spike	MF	GO:0061134	peptidase regulator activity	-	224	132	-	-	1.30E-02	1.10E-02
Spike	MF	GO:0008013	beta-catenin binding	-	86	73	-	-	7.64E-03	6.11E-03
Spike	MF	GO:0051015	actin filament binding	-	208	159	-	-	8.58E-03	1.33E-02
Spike	MF	GO:0019208	phosphatase regulator activity	-	107	74	-	-	3.04E-03	6.21E-03
Spike	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	21	-	-	2.83E-03	1.76E-03
Spike	MF	GO:0043236	laminin binding	-	29	20	-	-	3.70E-03	1.66E-03
Spike	MF	GO:0030507	spectrin binding	-	26	22	-	-	7.96E-03	1.86E-03
Spike	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	29	-	-	1.55E-02	2.48E-03
Spike	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	84	-	-	4.55E-02	7.04E-03
Spike	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	2.55E-03	2.07E-03
Spike	MF	GO:0042393	histone binding	-	240	180	-	-	9.57E-03	1.49E-02
Spike	MF	GO:0019838	growth factor binding	-	182	146	-	-	1.51E-02	1.21E-02
Spike	MF	GO:0000149	SNARE binding	-	107	69	-	-	7.31E-02	5.80E-03
Spike	MF	GO:0003727	single-stranded RNA binding	-	90	70	-	-	4.29E-03	5.80E-03
Spike	MF	GO:0051378	serotonin binding	-	24	13	-	-	3.10E-04	1.14E-03
Spike	MF	GO:0005516	calmodulin binding	-	206	149	-	-	6.50E-03	1.24E-02
Spike	MF	GO:0019825	oxygen binding	-	40	22	-	-	4.51E-02	1.86E-03
Spike	MF	GO:0045505	dynein intermediate chain binding	-	37	17	-	-	5.84E-03	1.45E-03
Spike	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	46	-	-	1.03E-03	3.83E-03
Spike	MF	GO:0032182	ubiquitin-like protein binding	-	117	99	-	-	8.81E-03	8.28E-03
Spike	MF	GO:0023023	MHC protein complex binding	-	36	27	-	-	1.04E-01	2.28E-03
Spike	MF	GO:0030742	GTP-dependent protein binding	-	22	15	-	-	1.53E-02	1.24E-03
Spike	MF	GO:0043274	phospholipase binding	-	23	20	-	-	2.54E-03	1.66E-03
Spike	MF	GO:0031072	heat shock protein binding	-	128	101	-	-	9.58E-03	8.39E-03
Spike	MF	GO:0030515	snoRNA binding	-	33	25	-	-	1.49E-03	2.07E-03
Spike	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	26	-	-	1.42E-02	2.17E-03
Spike	MF	GO:0001965	G-protein alpha-subunit binding	-	26	22	-	-	5.14E-04	1.86E-03
Spike	MF	GO:0001530	lipopolysaccharide binding	-	38	21	-	-	6.26E-02	1.76E-03
Spike	MF	GO:0140223	general transcription initiation factor activity	-	55	47	-	-	1.31E-01	3.93E-03
Spike	MF	GO:0000049	tRNA binding	-	75	41	-	-	5.09E-03	3.42E-03
Spike	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	41	-	-	2.74E-02	3.42E-03
Spike	MF	GO:0015026	coreceptor activity	-	48	37	-	-	1.10E-02	3.11E-03
Spike	MF	GO:0001653	peptide receptor activity	-	128	49	-	-	7.98E-03	4.14E-03
Spike	MF	GO:0030506	ankyrin binding	-	19	13	-	-	3.07E-04	1.14E-03
Spike	MF	GO:0006469	negative regulation of protein kinase activity	-	222	186	-	-	9.57E-03	1.54E-02
Spike	MF	GO:0070182	DNA polymerase binding	-	22	18	-	-	1.61E-03	1.55E-03
Spike	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	25	-	-	4.50E-03	2.07E-03
Spike	MF	GO:0051427	hormone receptor binding	-	31	21	-	-	1.55E-03	1.76E-03
Spike	MF	GO:0070851	growth factor receptor binding	-	141	114	-	-	8.44E-03	9.52E-03
Spike	MF	GO:0031210	phosphatidylcholine binding	-	32	23	-	-	8.27E-02	1.97E-03
Spike	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	38	-	-	5.85E-03	3.21E-03
Spike	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	221	-	-	1.84E-02	1.83E-02
Spike	MF	GO:0034185	apolipoprotein binding	-	20	14	-	-	3.04E-04	1.24E-03
Spike	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	12	-	-	3.09E-04	1.04E-03
Spike	MF	GO:0051346	negative regulation of hydrolase activity	-	332	221	-	-	6.43E-03	1.83E-02
Spike	MF	GO:0005506	iron ion binding	-	154	75	-	-	5.73E-03	6.21E-03
Spike	MF	GO:0003925	G protein activity	-	45	33	-	-	2.01E-03	2.80E-03
Spike	MF	GO:0038187	pattern recognition receptor activity	-	33	22	-	-	2.40E-02	1.86E-03
Spike	MF	GO:0008276	protein methyltransferase activity	-	96	58	-	-	4.78E-03	4.87E-03
Spike	MF	GO:0004396	hexokinase activity	-	16	13	-	-	6.32E-02	1.14E-03
Spike	MF	GO:0070888	E-box binding	-	59	42	-	-	4.45E-03	3.52E-03
Spike	MF	GO:0039706	co-receptor binding	-	14	13	-	-	3.09E-04	1.14E-03
Spike	MF	GO:0015399	primary active transmembrane transporter activity	-	190	97	-	-	8.41E-03	8.07E-03
Spike	MF	GO:0035254	glutamate receptor binding	-	47	36	-	-	1.93E-03	3.00E-03
Spike	MF	GO:0050321	tau-protein kinase activity	-	36	32	-	-	5.16E-03	2.69E-03
Spike	MF	GO:0043021	ribonucleoprotein complex binding	-	158	117	-	-	6.09E-03	9.73E-03
Spike	MF	GO:0030170	pyridoxal phosphate binding	-	56	34	-	-	1.29E-02	2.90E-03
Spike	MF	GO:0005112	Notch binding	-	26	19	-	-	9.30E-02	1.66E-03
Spike	MF	GO:0048185	activin binding	-	16	16	-	-	5.06E-02	1.35E-03
Spike	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	17	-	-	4.07E-04	1.45E-03
Spike	MF	GO:0001664	G protein-coupled receptor binding	-	299	184	-	-	1.27E-02	1.53E-02
Spike	MF	GO:0140299	small molecule sensor activity	-	39	25	-	-	1.09E-01	2.07E-03
Spike	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	17	-	-	7.69E-03	1.45E-03
Spike	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	14	-	-	1.89E-02	1.24E-03
Spike	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	38	-	-	2.25E-03	3.21E-03
Spike	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.63E-03	2.07E-03
Spike	MF	GO:0030594	neurotransmitter receptor activity	-	160	74	-	-	1.23E-02	6.21E-03
Spike	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	21	-	-	4.81E-04	1.76E-03
Spike	MF	GO:0120227	acyl-CoA binding	-	22	13	-	-	3.10E-04	1.14E-03
Spike	MF	GO:0005507	copper ion binding	-	63	38	-	-	1.69E-03	3.21E-03
Spike	MF	GO:0033558	protein lysine deacetylase activity	-	22	20	-	-	7.53E-03	1.66E-03
Spike	MF	GO:0070034	telomerase RNA binding	-	22	18	-	-	3.17E-03	1.55E-03
STRING	CC	GO:0005739	mitochondrion	2.16E-03	1671	1651	1634	1.01	-	-
STRING	CC	GO:0005615	extracellular space	5.52E-02	3190	3134	3119	1.00	-	-
STRING	CC	GO:0005730	nucleolus	9.41E-02	988	974	966	1.01	-	-
STRING	CC	GO:0005783	endoplasmic reticulum	1.28E-01	2020	1985	1975	1.00	-	-
STRING	CC	GO:0031012	extracellular matrix	1.43E-01	564	557	552	1.01	-	-
STRING	CC	GO:0005815	microtubule organizing center	2.29E-01	843	830	824	1.01	-	-
STRING	CC	GO:0005840	ribosome	2.49E-01	222	220	217	1.01	-	-
STRING	CC	GO:0005635	nuclear envelope	2.77E-01	493	486	482	1.01	-	-
STRING	CC	GO:0005768	endosome	3.28E-01	1037	1019	1014	1.00	-	-
STRING	CC	GO:0000228	nuclear chromosome	3.36E-01	206	204	201	1.01	-	-
STRING	CC	GO:0005929	cilium	3.36E-01	842	828	823	1.01	-	-
STRING	CC	GO:0005777	peroxisome	3.81E-01	142	141	139	1.02	-	-
STRING	CC	GO:0005794	Golgi apparatus	4.28E-01	1636	1605	1600	1.00	-	-
STRING	CC	GO:0005764	lysosome	4.46E-01	747	734	730	1.00	-	-
STRING	CC	GO:0005811	lipid droplet	7.30E-01	102	101	100	1.01	-	-
STRING	BP	GO:0050877	nervous system process	3.75E-15	1527	1443	1493	0.97	-	-
STRING	BP	GO:0007010	cytoskeleton organization	1.47E-03	1639	1620	1603	1.01	-	-
STRING	BP	GO:0048870	cell motility	2.15E-03	1659	1639	1622	1.01	-	-
STRING	BP	GO:0006520	amino acid metabolic process	2.22E-03	292	292	286	1.02	-	-
STRING	BP	GO:0006355	regulation of DNA-templated transcription	4.20E-03	3342	3290	3268	1.01	-	-
STRING	BP	GO:0016071	mRNA metabolic process	8.66E-03	713	707	697	1.01	-	-
STRING	BP	GO:0007005	mitochondrion organization	1.11E-02	484	481	473	1.02	-	-
STRING	BP	GO:0006399	tRNA metabolic process	2.43E-02	196	196	192	1.02	-	-
STRING	BP	GO:0065003	protein-containing complex assembly	4.35E-02	1648	1623	1612	1.01	-	-
STRING	BP	GO:0006281	DNA repair	4.49E-02	587	581	574	1.01	-	-
STRING	BP	GO:0016192	vesicle-mediated transport	4.81E-02	1894	1864	1852	1.01	-	-
STRING	BP	GO:0012501	programmed cell death	5.06E-02	1954	1923	1911	1.01	-	-
STRING	BP	GO:0140053	mitochondrial gene expression	5.48E-02	164	164	160	1.02	-	-
STRING	BP	GO:0006091	generation of precursor metabolites and energy	6.33E-02	502	497	491	1.01	-	-
STRING	BP	GO:0034330	cell junction organization	7.11E-02	727	718	711	1.01	-	-
STRING	BP	GO:0006457	protein folding	9.60E-02	210	209	205	1.02	-	-
STRING	BP	GO:0022600	digestive system process	9.72E-02	110	105	108	0.98	-	-
STRING	BP	GO:0006629	lipid metabolic process	1.02E-01	1355	1334	1325	1.01	-	-
STRING	BP	GO:0044782	cilium organization	1.18E-01	399	395	390	1.01	-	-
STRING	BP	GO:0055085	transmembrane transport	1.27E-01	1784	1754	1745	1.01	-	-
STRING	BP	GO:0000910	cytokinesis	1.35E-01	186	179	182	0.98	-	-
STRING	BP	GO:0006886	intracellular protein transport	1.39E-01	664	655	649	1.01	-	-
STRING	BP	GO:0030198	extracellular matrix organization	1.71E-01	314	311	307	1.01	-	-
STRING	BP	GO:0007155	cell adhesion	2.25E-01	1444	1419	1412	1.00	-	-
STRING	BP	GO:0006914	autophagy	2.44E-01	568	560	555	1.01	-	-
STRING	BP	GO:0055086	nucleobase-containing small molecule metabolic process	2.45E-01	729	718	713	1.01	-	-
STRING	BP	GO:0006486	protein glycosylation	2.50E-01	225	223	220	1.01	-	-
STRING	BP	GO:0007163	establishment or maintenance of cell polarity	2.51E-01	227	225	222	1.01	-	-
STRING	BP	GO:0002181	cytoplasmic translation	2.69E-01	153	152	150	1.02	-	-
STRING	BP	GO:0006260	DNA replication	2.99E-01	279	276	273	1.01	-	-
STRING	BP	GO:0140013	meiotic nuclear division	2.99E-01	279	276	273	1.01	-	-
STRING	BP	GO:0007040	lysosome organization	3.03E-01	107	103	105	0.98	-	-
STRING	BP	GO:0003012	muscle system process	3.17E-01	425	419	416	1.01	-	-
STRING	BP	GO:0042060	wound healing	3.18E-01	431	425	421	1.01	-	-
STRING	BP	GO:0007018	microtubule-based movement	3.36E-01	640	630	626	1.01	-	-
STRING	BP	GO:0006913	nucleocytoplasmic transport	3.37E-01	326	322	319	1.01	-	-
STRING	BP	GO:0007059	chromosome segregation	3.93E-01	403	397	394	1.01	-	-
STRING	BP	GO:0006954	inflammatory response	3.94E-01	820	806	802	1.01	-	-
STRING	BP	GO:0006790	sulfur compound metabolic process	4.39E-01	320	311	313	0.99	-	-
STRING	BP	GO:0005975	carbohydrate metabolic process	4.60E-01	551	542	539	1.01	-	-
STRING	BP	GO:0006766	vitamin metabolic process	5.14E-01	107	104	105	0.99	-	-
STRING	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	5.27E-01	119	118	116	1.01	-	-
STRING	BP	GO:0098754	detoxification	5.45E-01	134	130	131	0.99	-	-
STRING	BP	GO:0030163	protein catabolic process	5.80E-01	990	971	968	1.00	-	-
STRING	BP	GO:0002376	immune system process	6.06E-01	2448	2398	2394	1.00	-	-
STRING	BP	GO:0098542	defense response to other organism	6.81E-01	1171	1143	1145	1.00	-	-
STRING	BP	GO:0042254	ribosome biogenesis	6.91E-01	297	292	290	1.01	-	-
STRING	BP	GO:0006325	chromatin organization	6.99E-01	720	706	704	1.00	-	-
STRING	BP	GO:0003014	renal system process	7.61E-01	127	124	124	1.00	-	-
STRING	BP	GO:0032200	telomere organization	8.02E-01	186	183	182	1.01	-	-
STRING	BP	GO:0072659	protein localization to plasma membrane	8.38E-01	284	279	278	1.00	-	-
STRING	BP	GO:0003013	circulatory system process	1.00E+00	584	572	571	1.00	-	-
STRING	BP	GO:0006310	DNA recombination	1.00E+00	333	326	326	1.00	-	-
STRING	BP	GO:0006575	cellular modified amino acid metabolic process	1.00E+00	186	182	182	1.00	-	-
STRING	MF	GO:0003723	RNA binding	1.69E-03	1679	1659	1642	1.01	-	-
STRING	MF	GO:0003677	DNA binding	1.56E-02	2865	2819	2802	1.01	-	-
STRING	MF	GO:0140110	transcription regulator activity	5.53E-02	2033	2000	1988	1.01	-	-
STRING	MF	GO:0140657	ATP-dependent activity	7.11E-02	729	720	713	1.01	-	-
STRING	MF	GO:0140096	"catalytic activity, acting on a protein"	7.44E-02	3198	3141	3127	1.00	-	-
STRING	MF	GO:0016740	transferase activity	9.31E-02	3074	3019	3006	1.00	-	-
STRING	MF	GO:0016874	ligase activity	9.93E-02	283	281	277	1.02	-	-
STRING	MF	GO:0008092	cytoskeletal protein binding	1.01E-01	1023	1008	1000	1.01	-	-
STRING	MF	GO:0005198	structural molecule activity	1.10E-01	798	787	780	1.01	-	-
STRING	MF	GO:0140098	"catalytic activity, acting on RNA"	1.79E-01	417	412	408	1.01	-	-
STRING	MF	GO:0038024	cargo receptor activity	1.90E-01	117	117	114	1.02	-	-
STRING	MF	GO:0005215	transporter activity	1.95E-01	1462	1437	1430	1.01	-	-
STRING	MF	GO:0016491	oxidoreductase activity	2.40E-01	888	874	868	1.01	-	-
STRING	MF	GO:0003774	cytoskeletal motor activity	3.29E-01	116	112	113	0.99	-	-
STRING	MF	GO:0008289	lipid binding	4.70E-01	836	821	818	1.00	-	-
STRING	MF	GO:0042393	histone binding	5.00E-01	237	234	232	1.01	-	-
STRING	MF	GO:0048018	receptor ligand activity	6.44E-01	504	495	493	1.00	-	-
STRING	MF	GO:0016853	isomerase activity	6.66E-01	252	248	246	1.01	-	-
STRING	MF	GO:0003924	GTPase activity	6.84E-01	658	642	643	1.00	-	-
STRING	MF	GO:0140097	"catalytic activity, acting on DNA"	7.27E-01	383	376	375	1.00	-	-
STRING	MF	GO:0140104	molecular carrier activity	7.33E-01	105	104	103	1.01	-	-
STRING	MF	GO:0016829	lyase activity	7.65E-01	538	528	526	1.00	-	-
STRING	MF	GO:0045182	translation regulator activity	7.77E-01	151	149	148	1.01	-	-
STRING	MF	GO:0009975	cyclase activity	1.00E+00	277	271	271	1.00	-	-
STRING	BP	GO:0008038	neuron recognition	-	46	46	-	-	1.09E-02	1.95E-03
STRING	BP	GO:1905145	cellular response to acetylcholine	-	33	33	-	-	2.44E-02	1.42E-03
STRING	BP	GO:0097094	craniofacial suture morphogenesis	-	18	17	-	-	5.38E-03	7.38E-04
STRING	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	7.15E-03	8.97E-04
STRING	BP	GO:0051931	regulation of sensory perception	-	36	33	-	-	4.44E-03	1.42E-03
STRING	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	1.05E-02	1.05E-03
STRING	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.17E-03	5.80E-04
STRING	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	7.11E-04	5.80E-04
STRING	BP	GO:0009268	response to pH	-	43	43	-	-	2.20E-02	1.85E-03
STRING	BP	GO:0045666	positive regulation of neuron differentiation	-	91	86	-	-	8.71E-03	3.64E-03
STRING	BP	GO:0043543	protein acylation	-	107	103	-	-	1.55E-01	4.38E-03
STRING	MF	GO:0051349	positive regulation of lyase activity	-	41	40	-	-	8.15E-03	1.69E-03
STRING	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	13	-	-	2.51E-03	5.80E-04
STRING	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	3.26E-03	1.05E-03
STRING	BP	GO:0022401	negative adaptation of signaling pathway	-	21	21	-	-	3.23E-03	8.97E-04
STRING	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	139	-	-	1.92E-01	5.91E-03
STRING	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	2.56E-02	1.79E-03
STRING	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	36	-	-	1.18E-02	1.53E-03
STRING	BP	GO:0071806	protein transmembrane transport	-	68	66	-	-	3.53E-02	2.80E-03
STRING	BP	GO:0022038	corpus callosum development	-	25	25	-	-	2.27E-03	1.05E-03
STRING	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	13	-	-	4.92E-03	5.80E-04
STRING	BP	GO:0021548	pons development	-	11	11	-	-	1.80E-03	4.75E-04
STRING	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	3.41E-03	5.27E-04
STRING	BP	GO:0043299	leukocyte degranulation	-	82	79	-	-	2.91E-02	3.38E-03
STRING	BP	GO:0048864	stem cell development	-	88	87	-	-	5.72E-02	3.69E-03
STRING	BP	GO:0097384	cellular lipid biosynthetic process	-	11	11	-	-	2.76E-02	4.75E-04
STRING	BP	GO:0009310	amine catabolic process	-	20	18	-	-	2.69E-02	7.91E-04
STRING	BP	GO:0051651	maintenance of location in cell	-	236	229	-	-	1.89E-02	9.70E-03
STRING	BP	GO:0033119	negative regulation of RNA splicing	-	27	26	-	-	1.22E-02	1.11E-03
STRING	BP	GO:0014004	microglia differentiation	-	12	11	-	-	3.45E-04	4.75E-04
STRING	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	1.29E-01	1.32E-03
STRING	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	2.14E-03	6.33E-04
STRING	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	9.73E-04	6.33E-04
STRING	BP	GO:0046415	urate metabolic process	-	12	12	-	-	1.45E-01	5.27E-04
STRING	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	2.67E-02	1.27E-03
STRING	BP	GO:0006949	syncytium formation	-	66	64	-	-	2.92E-02	2.74E-03
STRING	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.82E-03	6.33E-04
STRING	BP	GO:0043144	sno(s)RNA processing	-	14	14	-	-	6.06E-03	6.33E-04
STRING	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	57	-	-	2.79E-02	2.43E-03
STRING	BP	GO:0030574	collagen catabolic process	-	45	45	-	-	2.07E-01	1.90E-03
STRING	CC	GO:0006984	ER-nucleus signaling pathway	-	46	46	-	-	2.53E-02	1.95E-03
STRING	BP	GO:0060343	trabecula formation	-	26	26	-	-	6.69E-03	1.11E-03
STRING	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	1.20E-03	5.27E-04
STRING	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	3.02E-02	1.00E-03
STRING	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	2.20E-02	6.86E-04
STRING	BP	GO:1900424	regulation of defense response to bacterium	-	21	17	-	-	3.66E-03	7.38E-04
STRING	BP	GO:0085029	extracellular matrix assembly	-	42	39	-	-	4.76E-03	1.69E-03
STRING	BP	GO:0006413	translational initiation	-	122	121	-	-	1.12E-01	5.12E-03
STRING	BP	GO:0072176	nephric duct development	-	15	15	-	-	1.39E-02	6.33E-04
STRING	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	3.53E-03	2.16E-03
STRING	CC	GO:0005200	structural constituent of cytoskeleton	-	112	111	-	-	1.38E-02	4.69E-03
STRING	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	2.76E-02	2.16E-03
STRING	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	6.69E-04	6.33E-04
STRING	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	2.66E-02	1.05E-03
STRING	BP	GO:1903036	positive regulation of response to wounding	-	76	70	-	-	8.66E-03	2.95E-03
STRING	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	1.89E-01	8.97E-04
STRING	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	225	-	-	1.55E-01	9.49E-03
STRING	BP	GO:1903319	positive regulation of protein maturation	-	27	26	-	-	1.73E-03	1.11E-03
STRING	BP	GO:0032528	microvillus organization	-	24	24	-	-	1.40E-02	1.05E-03
STRING	BP	GO:0021954	central nervous system neuron development	-	85	85	-	-	1.49E-02	3.59E-03
STRING	BP	GO:0055017	cardiac muscle tissue growth	-	92	73	-	-	1.07E-02	3.11E-03
STRING	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	8.53E-03	1.32E-03
STRING	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	3.91E-03	5.80E-04
STRING	BP	GO:0048524	positive regulation of viral process	-	64	62	-	-	6.08E-03	2.64E-03
STRING	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	13	-	-	1.07E-02	5.80E-04
STRING	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	5.01E-03	8.97E-04
STRING	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	24	-	-	1.86E-03	1.05E-03
STRING	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	3.03E-02	7.38E-04
STRING	BP	GO:0098661	inorganic anion transmembrane transport	-	140	135	-	-	1.17E-01	5.70E-03
STRING	BP	GO:0006099	tricarboxylic acid cycle	-	33	31	-	-	9.28E-03	1.32E-03
STRING	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	3.42E-03	7.91E-04
STRING	BP	GO:0009612	response to mechanical stimulus	-	215	212	-	-	1.55E-02	8.97E-03
STRING	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	2.60E-02	3.32E-03
STRING	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	136	-	-	1.12E-02	5.75E-03
STRING	BP	GO:1905874	regulation of postsynaptic density organization	-	13	13	-	-	5.42E-03	5.80E-04
STRING	BP	GO:0071542	dopaminergic neuron differentiation	-	36	34	-	-	1.83E-02	1.48E-03
STRING	BP	GO:0140115	export across plasma membrane	-	82	65	-	-	3.26E-02	2.74E-03
STRING	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	1.02E-02	5.27E-04
STRING	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	4.75E-03	1.64E-03
STRING	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	1.41E-02	5.27E-04
STRING	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	3.32E-03	4.75E-04
STRING	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	29	-	-	2.54E-02	1.27E-03
STRING	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	42	-	-	9.39E-02	1.79E-03
STRING	MF	GO:0003714	transcription corepressor activity	-	190	187	-	-	2.38E-02	7.91E-03
STRING	BP	GO:0035878	nail development	-	11	11	-	-	8.32E-03	4.75E-04
STRING	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	55	-	-	1.44E-02	2.32E-03
STRING	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	5.46E-03	6.86E-04
STRING	CC	GO:0006858	extracellular transport	-	45	44	-	-	4.74E-02	1.90E-03
STRING	BP	GO:0006304	DNA modification	-	30	30	-	-	7.71E-02	1.27E-03
STRING	MF	GO:0140312	cargo adaptor activity	-	19	19	-	-	3.71E-02	8.44E-04
STRING	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	3.17E-02	2.11E-03
STRING	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	2.96E-03	7.91E-04
STRING	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	6.16E-02	6.33E-04
STRING	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	42	-	-	3.84E-02	1.79E-03
STRING	BP	GO:0070417	cellular response to cold	-	13	13	-	-	8.74E-04	5.80E-04
STRING	BP	GO:0043523	regulation of neuron apoptotic process	-	218	212	-	-	1.69E-02	8.97E-03
STRING	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	6.63E-03	9.49E-04
STRING	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	6.75E-04	6.33E-04
STRING	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	1.84E-02	2.43E-03
STRING	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	3.63E-03	5.80E-04
STRING	BP	GO:2000209	regulation of anoikis	-	25	25	-	-	1.64E-03	1.05E-03
STRING	BP	GO:0014029	neural crest formation	-	15	15	-	-	8.66E-03	6.33E-04
STRING	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	5.86E-03	1.00E-03
STRING	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	42	-	-	1.49E-02	1.79E-03
STRING	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	66	-	-	2.33E-02	2.80E-03
STRING	BP	GO:0003188	heart valve formation	-	16	16	-	-	6.42E-03	6.86E-04
STRING	CC	GO:0045324	late endosome to vacuole transport	-	37	35	-	-	1.96E-01	1.48E-03
STRING	BP	GO:0043954	cellular component maintenance	-	72	70	-	-	8.24E-03	2.95E-03
STRING	BP	GO:0050435	amyloid-beta metabolic process	-	65	51	-	-	3.27E-02	2.16E-03
STRING	BP	GO:0014823	response to activity	-	70	68	-	-	6.62E-03	2.90E-03
STRING	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	17	-	-	4.94E-02	7.38E-04
STRING	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	7.36E-02	1.21E-03
STRING	BP	GO:0034502	protein localization to chromosome	-	130	127	-	-	1.54E-02	5.38E-03
STRING	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	2.25E-03	4.75E-04
STRING	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	2.15E-03	4.75E-04
STRING	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	4.80E-03	7.38E-04
STRING	BP	GO:0019233	sensory perception of pain	-	103	99	-	-	2.38E-02	4.22E-03
STRING	CC	GO:0043574	peroxisomal transport	-	22	21	-	-	1.34E-01	8.97E-04
STRING	BP	GO:0031343	positive regulation of cell killing	-	75	73	-	-	7.27E-02	3.11E-03
STRING	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	9.95E-03	1.64E-03
STRING	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	123	-	-	8.56E-02	5.22E-03
STRING	BP	GO:0017148	negative regulation of translation	-	390	115	-	-	7.48E-02	4.85E-03
STRING	BP	GO:0030220	platelet formation	-	22	22	-	-	1.61E-02	9.49E-04
STRING	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	80	-	-	6.74E-03	3.38E-03
STRING	MF	GO:1903624	regulation of DNA catabolic process	-	14	12	-	-	7.74E-02	5.27E-04
STRING	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	6.74E-03	6.33E-04
STRING	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	13	-	-	1.02E-02	5.80E-04
STRING	BP	GO:1903509	liposaccharide metabolic process	-	109	107	-	-	1.77E-01	4.54E-03
STRING	BP	GO:0009582	detection of abiotic stimulus	-	140	138	-	-	6.97E-02	5.85E-03
STRING	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	2.95E-03	5.80E-04
STRING	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	19	-	-	5.31E-02	8.44E-04
STRING	CC	GO:0140238	presynaptic endocytosis	-	72	72	-	-	3.67E-02	3.06E-03
STRING	BP	GO:0051236	establishment of RNA localization	-	161	158	-	-	1.57E-01	6.70E-03
STRING	BP	GO:0042178	xenobiotic catabolic process	-	26	25	-	-	2.08E-02	1.05E-03
STRING	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	17	-	-	1.06E-02	7.38E-04
STRING	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	188	-	-	2.82E-02	7.96E-03
STRING	BP	GO:0034067	protein localization to Golgi apparatus	-	30	30	-	-	1.59E-02	1.27E-03
STRING	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	8.52E-03	1.37E-03
STRING	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	5.71E-03	7.38E-04
STRING	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	51	-	-	3.67E-02	2.16E-03
STRING	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	40	-	-	1.80E-02	1.69E-03
STRING	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	51	-	-	3.74E-03	2.16E-03
STRING	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	16	-	-	1.42E-02	6.86E-04
STRING	BP	GO:0050779	RNA destabilization	-	135	100	-	-	1.27E-01	4.22E-03
STRING	BP	GO:0006023	aminoglycan biosynthetic process	-	74	73	-	-	2.99E-01	3.11E-03
STRING	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	68	-	-	6.86E-02	2.90E-03
STRING	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	2.25E-03	1.69E-03
STRING	BP	GO:0090311	regulation of protein deacetylation	-	29	28	-	-	6.43E-03	1.21E-03
STRING	BP	GO:0035272	exocrine system development	-	46	45	-	-	8.00E-03	1.90E-03
STRING	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	1.22E-02	7.38E-04
STRING	BP	GO:0022406	membrane docking	-	90	88	-	-	4.89E-02	3.74E-03
STRING	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	1.17E-02	6.33E-04
STRING	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	4.91E-03	6.86E-04
STRING	BP	GO:0050777	negative regulation of immune response	-	196	187	-	-	1.99E-02	7.91E-03
STRING	MF	GO:0005035	death receptor activity	-	16	16	-	-	4.32E-02	6.86E-04
STRING	BP	GO:0002063	chondrocyte development	-	33	32	-	-	1.20E-02	1.37E-03
STRING	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	4.05E-04	7.38E-04
STRING	BP	GO:0099068	postsynapse assembly	-	40	39	-	-	1.66E-02	1.69E-03
STRING	BP	GO:0021782	glial cell development	-	120	115	-	-	1.48E-02	4.85E-03
STRING	BP	GO:0051782	negative regulation of cell division	-	18	17	-	-	4.87E-03	7.38E-04
STRING	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	3.12E-03	4.75E-04
STRING	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	86	-	-	1.71E-02	3.64E-03
STRING	BP	GO:0001655	urogenital system development	-	66	65	-	-	1.30E-02	2.74E-03
STRING	BP	GO:0071827	plasma lipoprotein particle organization	-	86	71	-	-	2.29E-02	3.01E-03
STRING	BP	GO:0045494	photoreceptor cell maintenance	-	43	43	-	-	4.06E-02	1.85E-03
STRING	BP	GO:0055088	lipid homeostasis	-	173	155	-	-	5.76E-02	6.54E-03
STRING	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	26	-	-	2.55E-03	1.11E-03
STRING	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	196	-	-	1.61E-02	8.28E-03
STRING	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	29	-	-	7.96E-03	1.27E-03
STRING	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	3.56E-03	1.48E-03
STRING	BP	GO:0045667	regulation of osteoblast differentiation	-	147	122	-	-	2.38E-02	5.17E-03
STRING	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	7.45E-03	6.86E-04
STRING	BP	GO:0061037	negative regulation of cartilage development	-	32	30	-	-	1.91E-02	1.27E-03
STRING	BP	GO:0045738	negative regulation of DNA repair	-	40	39	-	-	1.03E-01	1.69E-03
STRING	BP	GO:0001704	formation of primary germ layer	-	195	188	-	-	5.87E-02	7.96E-03
STRING	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	5.91E-03	5.80E-04
STRING	BP	GO:0045778	positive regulation of ossification	-	51	48	-	-	6.39E-03	2.06E-03
STRING	BP	GO:0060174	limb bud formation	-	11	11	-	-	2.44E-03	4.75E-04
STRING	BP	GO:0048708	astrocyte differentiation	-	88	84	-	-	9.55E-03	3.59E-03
STRING	BP	GO:0042092	type 2 immune response	-	41	39	-	-	5.78E-03	1.69E-03
STRING	BP	GO:0048588	developmental cell growth	-	233	221	-	-	5.87E-02	9.34E-03
STRING	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	1.41E-01	8.44E-04
STRING	BP	GO:0021872	forebrain generation of neurons	-	52	52	-	-	1.32E-02	2.22E-03
STRING	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	23	-	-	1.59E-02	1.00E-03
STRING	BP	GO:0045023	G0 to G1 transition	-	41	38	-	-	8.33E-02	1.64E-03
STRING	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	48	-	-	1.05E-02	2.06E-03
STRING	BP	GO:0072488	ammonium transmembrane transport	-	12	11	-	-	1.61E-02	4.75E-04
STRING	BP	GO:0034367	protein-containing complex remodeling	-	35	35	-	-	2.22E-02	1.48E-03
STRING	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	6.65E-04	1.11E-03
STRING	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	51	-	-	3.72E-02	2.16E-03
STRING	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	18	-	-	9.28E-02	7.91E-04
STRING	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	1.63E-02	8.44E-04
STRING	BP	GO:0010232	vascular transport	-	87	87	-	-	5.85E-02	3.69E-03
STRING	BP	GO:0021987	cerebral cortex development	-	125	124	-	-	2.32E-02	5.27E-03
STRING	BP	GO:0008637	apoptotic mitochondrial changes	-	108	101	-	-	5.05E-02	4.27E-03
STRING	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	34	-	-	1.58E-02	1.48E-03
STRING	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	13	-	-	1.36E-02	5.80E-04
STRING	BP	GO:0060999	positive regulation of dendritic spine development	-	35	35	-	-	4.73E-03	1.48E-03
STRING	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	5.09E-03	7.91E-04
STRING	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	6.04E-03	3.27E-03
STRING	BP	GO:0060973	cell migration involved in heart development	-	21	19	-	-	2.72E-02	8.44E-04
STRING	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	4.33E-03	8.44E-04
STRING	BP	GO:0002064	epithelial cell development	-	210	205	-	-	1.51E-02	8.65E-03
STRING	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	2.69E-02	7.91E-04
STRING	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	39	-	-	2.12E-03	1.69E-03
STRING	BP	GO:2001222	regulation of neuron migration	-	46	46	-	-	4.08E-03	1.95E-03
STRING	BP	GO:0034389	lipid droplet organization	-	38	38	-	-	3.55E-02	1.64E-03
STRING	BP	GO:0051602	response to electrical stimulus	-	44	43	-	-	3.06E-03	1.85E-03
STRING	BP	GO:0042177	negative regulation of protein catabolic process	-	109	106	-	-	6.17E-03	4.48E-03
STRING	MF	GO:0038024	cargo receptor activity	-	121	117	-	-	5.36E-02	4.96E-03
STRING	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	16	-	-	3.00E-03	6.86E-04
STRING	BP	GO:0033120	positive regulation of RNA splicing	-	46	43	-	-	9.33E-03	1.85E-03
STRING	BP	GO:0051445	regulation of meiotic cell cycle	-	64	63	-	-	1.89E-02	2.69E-03
STRING	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	7.61E-03	5.27E-04
STRING	BP	GO:0033619	membrane protein proteolysis	-	60	58	-	-	1.98E-02	2.48E-03
STRING	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	1.76E-02	6.33E-04
STRING	BP	GO:0090087	regulation of peptide transport	-	195	194	-	-	3.16E-02	8.23E-03
STRING	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	98	-	-	2.63E-02	4.17E-03
STRING	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	6.84E-03	1.05E-03
STRING	BP	GO:0006929	substrate-dependent cell migration	-	26	26	-	-	3.06E-03	1.11E-03
STRING	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	3.41E-02	6.33E-04
STRING	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	2.65E-02	1.16E-03
STRING	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	2.32E-03	6.33E-04
STRING	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	2.61E-03	6.33E-04
STRING	BP	GO:0072662	protein localization to peroxisome	-	20	19	-	-	1.45E-01	8.44E-04
STRING	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	8.01E-03	5.80E-04
STRING	BP	GO:0022404	molting cycle process	-	95	95	-	-	3.06E-02	4.01E-03
STRING	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	8.94E-04	4.75E-04
STRING	BP	GO:1903358	regulation of Golgi organization	-	17	17	-	-	9.22E-04	7.38E-04
STRING	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	2.63E-03	8.44E-04
STRING	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	5.45E-03	5.27E-04
STRING	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	18	-	-	1.19E-03	7.91E-04
STRING	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	31	-	-	9.82E-03	1.32E-03
STRING	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	2.19E-03	6.33E-04
STRING	BP	GO:0008299	isoprenoid biosynthetic process	-	30	29	-	-	3.42E-02	1.27E-03
STRING	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	235	-	-	5.62E-02	9.92E-03
STRING	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	30	-	-	4.27E-03	1.27E-03
STRING	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	2.09E-03	9.49E-04
STRING	CC	GO:0098926	postsynaptic signal transduction	-	39	39	-	-	1.44E-02	1.69E-03
STRING	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	139	-	-	1.99E-02	5.91E-03
STRING	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	2.53E-02	8.44E-04
STRING	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	46	-	-	6.70E-03	1.95E-03
STRING	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	144	-	-	3.50E-02	6.12E-03
STRING	BP	GO:0034249	negative regulation of amide metabolic process	-	34	23	-	-	7.13E-03	1.00E-03
STRING	BP	GO:0061548	ganglion development	-	17	17	-	-	9.40E-03	7.38E-04
STRING	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	105	-	-	9.83E-02	4.43E-03
STRING	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	4.17E-03	6.33E-04
STRING	BP	GO:0042832	defense response to protozoan	-	28	26	-	-	8.76E-03	1.11E-03
STRING	BP	GO:0048799	animal organ maturation	-	33	32	-	-	3.92E-03	1.37E-03
STRING	BP	GO:0006925	inflammatory cell apoptotic process	-	23	22	-	-	1.11E-03	9.49E-04
STRING	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	1.48E-03	6.86E-04
STRING	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	171	-	-	1.47E-02	7.23E-03
STRING	BP	GO:1903035	negative regulation of response to wounding	-	93	88	-	-	1.45E-02	3.74E-03
STRING	BP	GO:0015697	quaternary ammonium group transport	-	16	16	-	-	3.81E-02	6.86E-04
STRING	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	27	-	-	5.78E-03	1.16E-03
STRING	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	6.37E-03	1.16E-03
STRING	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	135	-	-	9.17E-02	5.70E-03
STRING	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	97	-	-	6.03E-02	4.11E-03
STRING	BP	GO:0045056	transcytosis	-	20	19	-	-	2.81E-03	8.44E-04
STRING	BP	GO:0018342	protein prenylation	-	15	15	-	-	2.94E-02	6.33E-04
STRING	BP	GO:0009267	cellular response to starvation	-	170	167	-	-	3.03E-02	7.07E-03
STRING	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	3.81E-03	4.75E-04
STRING	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	4.95E-03	2.27E-03
STRING	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	7.44E-02	6.86E-04
STRING	BP	GO:0007343	egg activation	-	11	11	-	-	6.97E-03	4.75E-04
STRING	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	1.76E-03	1.00E-03
STRING	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	27	-	-	3.39E-02	1.16E-03
STRING	BP	GO:0046931	pore complex assembly	-	21	21	-	-	5.94E-03	8.97E-04
STRING	CC	GO:0032008	positive regulation of TOR signaling	-	52	51	-	-	5.08E-02	2.16E-03
STRING	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	33	-	-	3.47E-02	1.42E-03
STRING	BP	GO:0046618	xenobiotic export from cell	-	27	14	-	-	1.95E-02	6.33E-04
STRING	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	15	-	-	4.02E-03	6.33E-04
STRING	BP	GO:0060428	lung epithelium development	-	43	42	-	-	3.20E-03	1.79E-03
STRING	BP	GO:0030431	sleep	-	30	30	-	-	8.15E-03	1.27E-03
STRING	BP	GO:1903318	negative regulation of protein maturation	-	29	27	-	-	5.47E-03	1.16E-03
STRING	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	100	-	-	1.77E-01	4.22E-03
STRING	BP	GO:0071732	cellular response to nitric oxide	-	17	16	-	-	4.14E-04	6.86E-04
STRING	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	2.84E-02	6.33E-04
STRING	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	9.20E-03	5.27E-04
STRING	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	1.80E-03	5.80E-04
STRING	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	75	-	-	9.07E-02	3.16E-03
STRING	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	5.93E-03	2.74E-03
STRING	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	4.78E-03	7.38E-04
STRING	CC	GO:0090660	cerebrospinal fluid circulation	-	15	14	-	-	7.09E-03	6.33E-04
STRING	CC	GO:0006406	mRNA export from nucleus	-	69	68	-	-	1.12E-01	2.90E-03
STRING	BP	GO:0009880	embryonic pattern specification	-	70	69	-	-	3.00E-02	2.95E-03
STRING	BP	GO:0015791	polyol transmembrane transport	-	14	13	-	-	2.95E-03	5.80E-04
STRING	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	39	-	-	6.26E-02	1.69E-03
STRING	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	4.18E-02	1.05E-03
STRING	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	7.07E-03	4.75E-04
STRING	BP	GO:0002367	cytokine production involved in immune response	-	121	118	-	-	1.28E-02	5.01E-03
STRING	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	4.00E-04	5.80E-04
STRING	BP	GO:0044848	biological phase	-	211	206	-	-	1.10E-01	8.70E-03
STRING	BP	GO:0002645	positive regulation of tolerance induction	-	12	11	-	-	3.63E-03	4.75E-04
STRING	BP	GO:0046660	female sex differentiation	-	125	123	-	-	2.56E-02	5.22E-03
STRING	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	18	-	-	2.69E-02	7.91E-04
STRING	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	41	-	-	1.40E-03	1.74E-03
STRING	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	2.30E-02	2.95E-03
STRING	BP	GO:0071248	cellular response to metal ion	-	201	198	-	-	3.03E-02	8.39E-03
STRING	BP	GO:0030308	negative regulation of cell growth	-	191	185	-	-	2.30E-02	7.81E-03
STRING	BP	GO:0097306	cellular response to alcohol	-	99	94	-	-	3.60E-03	4.01E-03
STRING	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	128	-	-	2.18E-01	5.43E-03
STRING	BP	GO:0010453	regulation of cell fate commitment	-	40	36	-	-	5.30E-03	1.53E-03
STRING	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	58	-	-	9.77E-03	2.48E-03
STRING	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	56	-	-	2.67E-02	2.37E-03
STRING	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	9.74E-03	1.11E-03
STRING	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	24	-	-	4.64E-03	1.05E-03
STRING	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	43	-	-	3.31E-02	1.85E-03
STRING	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	8.90E-03	3.27E-03
STRING	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	2.65E-03	8.44E-04
STRING	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	4.58E-02	1.05E-03
STRING	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	95	-	-	1.00E-02	4.01E-03
STRING	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	2.20E-03	1.11E-03
STRING	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	7.45E-04	4.75E-04
STRING	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	53	-	-	2.21E-02	2.27E-03
STRING	BP	GO:0051259	protein complex oligomerization	-	251	248	-	-	2.29E-02	1.05E-02
STRING	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	1.55E-02	6.86E-04
STRING	BP	GO:0098743	cell aggregation	-	24	23	-	-	5.96E-03	1.00E-03
STRING	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	6.83E-03	5.27E-04
STRING	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	4.11E-02	4.75E-04
STRING	BP	GO:0006369	termination of RNA polymerase II transcription	-	12	12	-	-	7.94E-02	5.27E-04
STRING	BP	GO:0009994	oocyte differentiation	-	57	57	-	-	2.62E-02	2.43E-03
STRING	MF	GO:0031952	regulation of protein autophosphorylation	-	43	40	-	-	2.86E-03	1.69E-03
STRING	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	1.73E-03	6.33E-04
STRING	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	157	-	-	4.80E-02	6.65E-03
STRING	BP	GO:0044319	"wound healing, spreading of cells"	-	37	36	-	-	5.70E-03	1.53E-03
STRING	BP	GO:0033688	regulation of osteoblast proliferation	-	31	27	-	-	4.93E-03	1.16E-03
STRING	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	2.51E-03	1.48E-03
STRING	BP	GO:0072665	protein localization to vacuole	-	84	83	-	-	3.23E-02	3.53E-03
STRING	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	45	-	-	9.92E-03	1.90E-03
STRING	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	24	-	-	8.72E-03	1.05E-03
STRING	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	73	-	-	1.36E-02	3.11E-03
STRING	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	2.77E-03	6.86E-04
STRING	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	15	-	-	1.41E-02	6.33E-04
STRING	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	5.63E-04	4.75E-04
STRING	BP	GO:0042044	fluid transport	-	35	33	-	-	4.41E-03	1.42E-03
STRING	BP	GO:0070633	transepithelial transport	-	35	35	-	-	1.09E-02	1.48E-03
STRING	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	9.29E-03	5.80E-04
STRING	BP	GO:0045661	regulation of myoblast differentiation	-	74	72	-	-	7.66E-03	3.06E-03
STRING	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	15	-	-	4.62E-02	6.33E-04
STRING	BP	GO:0030307	positive regulation of cell growth	-	164	157	-	-	5.72E-03	6.65E-03
STRING	BP	GO:0034250	positive regulation of amide metabolic process	-	27	26	-	-	1.46E-03	1.11E-03
STRING	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	6.82E-03	7.91E-04
STRING	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	14	-	-	6.55E-03	6.33E-04
STRING	BP	GO:0014812	muscle cell migration	-	110	84	-	-	1.70E-02	3.59E-03
STRING	BP	GO:0048525	negative regulation of viral process	-	90	86	-	-	3.93E-02	3.64E-03
STRING	BP	GO:0072044	collecting duct development	-	16	16	-	-	6.39E-03	6.86E-04
STRING	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	13	-	-	2.37E-02	5.80E-04
STRING	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	68	-	-	6.36E-02	2.90E-03
STRING	BP	GO:0030238	male sex determination	-	14	14	-	-	8.25E-03	6.33E-04
STRING	BP	GO:0051781	positive regulation of cell division	-	93	90	-	-	1.44E-02	3.80E-03
STRING	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	19	-	-	8.20E-03	8.44E-04
STRING	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	1.04E-03	4.75E-04
STRING	BP	GO:0035524	proline transmembrane transport	-	12	12	-	-	4.97E-02	5.27E-04
STRING	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	2.44E-02	1.00E-03
STRING	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	22	-	-	5.63E-03	9.49E-04
STRING	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	1.04E-02	2.00E-03
STRING	BP	GO:0070857	regulation of bile acid biosynthetic process	-	12	11	-	-	3.51E-02	4.75E-04
STRING	BP	GO:0007272	ensheathment of neurons	-	146	143	-	-	6.59E-02	6.07E-03
STRING	CC	GO:0050806	positive regulation of synaptic transmission	-	171	153	-	-	2.39E-02	6.49E-03
STRING	BP	GO:0060021	roof of mouth development	-	91	89	-	-	1.98E-02	3.80E-03
STRING	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	40	-	-	4.54E-03	1.69E-03
STRING	BP	GO:0050819	negative regulation of coagulation	-	54	53	-	-	1.83E-02	2.27E-03
STRING	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	4.82E-03	4.75E-04
STRING	BP	GO:0017004	cytochrome complex assembly	-	40	40	-	-	1.28E-01	1.69E-03
STRING	BP	GO:0018410	C-terminal protein amino acid modification	-	15	14	-	-	3.53E-03	6.33E-04
STRING	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	61	-	-	7.24E-02	2.58E-03
STRING	BP	GO:0097212	lysosomal membrane organization	-	15	14	-	-	3.87E-02	6.33E-04
STRING	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	15	-	-	2.69E-02	6.33E-04
STRING	CC	GO:0050805	negative regulation of synaptic transmission	-	55	54	-	-	1.42E-02	2.32E-03
STRING	BP	GO:0043248	proteasome assembly	-	13	13	-	-	1.68E-01	5.80E-04
STRING	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	60	-	-	1.06E-02	2.53E-03
STRING	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	2.32E-03	4.75E-04
STRING	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	88	-	-	3.16E-02	3.74E-03
STRING	BP	GO:0016054	organic acid catabolic process	-	251	249	-	-	9.75E-02	1.05E-02
STRING	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	12	-	-	9.65E-03	5.27E-04
STRING	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.05E-02	1.21E-03
STRING	BP	GO:0065005	protein-lipid complex assembly	-	29	28	-	-	3.34E-03	1.21E-03
STRING	BP	GO:0008033	tRNA processing	-	136	135	-	-	3.68E-01	5.70E-03
STRING	BP	GO:0046661	male sex differentiation	-	171	170	-	-	3.47E-02	7.17E-03
STRING	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	1.50E-03	6.33E-04
STRING	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	2.95E-03	7.38E-04
STRING	BP	GO:0035188	hatching	-	27	27	-	-	4.09E-01	1.16E-03
STRING	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	87	-	-	1.63E-02	3.69E-03
STRING	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	16	-	-	1.55E-03	6.86E-04
STRING	BP	GO:0090713	immunological memory process	-	18	18	-	-	6.03E-03	7.91E-04
STRING	BP	GO:0061326	renal tubule development	-	103	101	-	-	6.54E-02	4.27E-03
STRING	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	2.67E-01	2.32E-03
STRING	BP	GO:0006450	regulation of translational fidelity	-	18	17	-	-	3.81E-02	7.38E-04
STRING	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	1.56E-03	8.44E-04
STRING	BP	GO:0060325	face morphogenesis	-	31	31	-	-	5.24E-03	1.32E-03
STRING	BP	GO:0090559	regulation of membrane permeability	-	72	65	-	-	1.41E-02	2.74E-03
STRING	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	15	-	-	7.10E-03	6.33E-04
STRING	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	5.06E-02	5.27E-04
STRING	BP	GO:0031579	membrane raft organization	-	25	24	-	-	1.99E-02	1.05E-03
STRING	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	25	-	-	2.72E-03	1.05E-03
STRING	BP	GO:0060033	anatomical structure regression	-	16	16	-	-	3.11E-03	6.86E-04
STRING	BP	GO:0046460	neutral lipid biosynthetic process	-	50	47	-	-	4.23E-02	2.00E-03
STRING	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	158	-	-	6.41E-02	6.70E-03
STRING	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	9.84E-03	4.75E-04
STRING	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	160	-	-	1.17E-02	6.75E-03
STRING	BP	GO:0002251	organ or tissue specific immune response	-	43	43	-	-	1.42E-02	1.85E-03
STRING	CC	GO:0048167	regulation of synaptic plasticity	-	210	192	-	-	3.97E-02	8.12E-03
STRING	BP	GO:1903708	positive regulation of hemopoiesis	-	184	181	-	-	2.15E-02	7.65E-03
STRING	BP	GO:1903008	organelle disassembly	-	154	151	-	-	3.81E-02	6.38E-03
STRING	BP	GO:0001709	cell fate determination	-	44	43	-	-	1.08E-02	1.85E-03
STRING	BP	GO:0051873	killing by host of symbiont cells	-	28	27	-	-	2.11E-02	1.16E-03
STRING	BP	GO:0045058	T cell selection	-	53	53	-	-	8.87E-03	2.27E-03
STRING	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	4.60E-03	2.06E-03
STRING	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	1.74E-03	8.44E-04
STRING	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	8.54E-03	3.32E-03
STRING	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	42	-	-	9.20E-02	1.79E-03
STRING	BP	GO:0099084	postsynaptic specialization organization	-	44	43	-	-	1.79E-02	1.85E-03
STRING	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	8.83E-03	4.75E-04
STRING	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	2.03E-02	6.33E-04
STRING	BP	GO:0060384	innervation	-	27	27	-	-	1.87E-03	1.16E-03
STRING	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	6.89E-04	5.27E-04
STRING	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	34	-	-	3.16E-02	1.48E-03
STRING	MF	GO:0031281	positive regulation of cyclase activity	-	40	39	-	-	8.55E-03	1.69E-03
STRING	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	8.81E-03	2.69E-03
STRING	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	8.44E-03	7.91E-04
STRING	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	8.53E-03	5.27E-04
STRING	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	3.02E-03	7.91E-04
STRING	BP	GO:0071453	cellular response to oxygen levels	-	168	150	-	-	1.54E-02	6.33E-03
STRING	BP	GO:0090399	replicative senescence	-	17	16	-	-	2.57E-03	6.86E-04
STRING	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	6.52E-02	6.33E-04
STRING	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	1.70E-02	1.27E-03
STRING	BP	GO:0070585	protein localization to mitochondrion	-	125	124	-	-	5.09E-02	5.27E-03
STRING	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	6.83E-02	6.33E-04
STRING	BP	GO:0010623	programmed cell death involved in cell development	-	25	25	-	-	2.05E-03	1.05E-03
STRING	BP	GO:0044242	cellular lipid catabolic process	-	224	221	-	-	6.92E-02	9.34E-03
STRING	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	5.96E-04	5.80E-04
STRING	BP	GO:0002931	response to ischemia	-	58	57	-	-	6.00E-03	2.43E-03
STRING	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	5.05E-03	5.27E-04
STRING	BP	GO:0014047	glutamate secretion	-	25	25	-	-	5.08E-03	1.05E-03
STRING	BP	GO:0061005	cell differentiation involved in kidney development	-	58	58	-	-	3.72E-02	2.48E-03
STRING	BP	GO:0030397	membrane disassembly	-	11	11	-	-	7.62E-04	4.75E-04
STRING	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	76	-	-	6.65E-02	3.22E-03
STRING	BP	GO:0060420	regulation of heart growth	-	74	58	-	-	9.67E-03	2.48E-03
STRING	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	1.00E-03	6.33E-04
STRING	BP	GO:0009755	hormone-mediated signaling pathway	-	221	217	-	-	3.64E-02	9.18E-03
STRING	BP	GO:0022612	gland morphogenesis	-	124	122	-	-	1.54E-02	5.17E-03
STRING	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	35	-	-	1.85E-03	1.48E-03
STRING	MF	GO:0140416	transcription regulator inhibitor activity	-	26	26	-	-	1.87E-03	1.11E-03
STRING	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	27	-	-	5.08E-02	1.16E-03
STRING	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	7.89E-03	6.33E-04
STRING	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	3.65E-03	7.38E-04
STRING	BP	GO:1990845	adaptive thermogenesis	-	166	163	-	-	3.54E-02	6.91E-03
STRING	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	3.96E-03	2.27E-03
STRING	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	2.38E-03	4.75E-04
STRING	BP	GO:0015844	monoamine transport	-	88	87	-	-	4.41E-02	3.69E-03
STRING	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	23	-	-	9.91E-03	1.00E-03
STRING	BP	GO:0060039	pericardium development	-	19	19	-	-	4.93E-03	8.44E-04
STRING	BP	GO:0071392	cellular response to estradiol stimulus	-	40	38	-	-	3.95E-03	1.64E-03
STRING	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	9.51E-04	5.80E-04
STRING	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	1.13E-01	8.44E-04
STRING	BP	GO:0009451	RNA modification	-	169	165	-	-	2.77E-01	6.96E-03
STRING	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	7.00E-03	4.75E-04
STRING	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	40	-	-	2.03E-03	1.69E-03
STRING	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	1.99E-03	7.38E-04
STRING	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	111	-	-	3.25E-02	4.69E-03
STRING	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	37	-	-	1.03E-02	1.58E-03
STRING	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	3.29E-02	4.75E-04
STRING	BP	GO:0015807	L-amino acid transport	-	94	93	-	-	1.61E-01	3.96E-03
STRING	BP	GO:0032941	secretion by tissue	-	85	79	-	-	7.79E-03	3.38E-03
STRING	BP	GO:0051284	positive regulation of sequestering of calcium ion	-	15	12	-	-	9.92E-03	5.27E-04
STRING	BP	GO:0046605	regulation of centrosome cycle	-	54	54	-	-	1.75E-02	2.32E-03
STRING	BP	GO:0048753	pigment granule organization	-	40	40	-	-	2.08E-01	1.69E-03
STRING	BP	GO:0021516	dorsal spinal cord development	-	20	20	-	-	1.84E-02	8.44E-04
STRING	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	9.74E-03	8.44E-04
STRING	BP	GO:0032196	transposition	-	11	11	-	-	2.12E-02	4.75E-04
STRING	BP	GO:0003014	renal system process	-	130	124	-	-	1.19E-02	5.27E-03
STRING	CC	GO:0070286	axonemal dynein complex assembly	-	40	40	-	-	7.40E-02	1.69E-03
STRING	BP	GO:0045598	regulation of fat cell differentiation	-	148	134	-	-	1.28E-02	5.70E-03
STRING	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	186	-	-	3.50E-02	7.86E-03
STRING	BP	GO:1904646	cellular response to amyloid-beta	-	44	37	-	-	4.16E-03	1.58E-03
STRING	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	4.28E-03	1.05E-03
STRING	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	229	-	-	7.46E-02	9.70E-03
STRING	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	4.71E-04	5.80E-04
STRING	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	1.03E-03	1.00E-03
STRING	BP	GO:0018158	protein oxidation	-	15	14	-	-	2.69E-03	6.33E-04
STRING	BP	GO:0039694	viral RNA genome replication	-	30	30	-	-	2.99E-03	1.27E-03
STRING	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	4.93E-03	7.38E-04
STRING	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	25	-	-	3.26E-03	1.05E-03
STRING	BP	GO:0071709	membrane assembly	-	68	65	-	-	1.46E-02	2.74E-03
STRING	BP	GO:0008217	regulation of blood pressure	-	186	180	-	-	4.77E-02	7.59E-03
STRING	BP	GO:0031643	positive regulation of myelination	-	19	18	-	-	6.82E-03	7.91E-04
STRING	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	1.34E-02	6.33E-04
STRING	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	60	-	-	4.31E-03	2.53E-03
STRING	CC	GO:0042770	signal transduction in response to DNA damage	-	186	183	-	-	2.62E-02	7.75E-03
STRING	BP	GO:0002200	somatic diversification of immune receptors	-	78	77	-	-	4.89E-02	3.27E-03
STRING	BP	GO:0035315	hair cell differentiation	-	52	52	-	-	3.84E-02	2.22E-03
STRING	BP	GO:0048645	animal organ formation	-	62	61	-	-	2.03E-02	2.58E-03
STRING	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	163	-	-	9.54E-02	6.91E-03
STRING	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	4.17E-03	6.33E-04
STRING	BP	GO:0033627	cell adhesion mediated by integrin	-	87	85	-	-	9.26E-02	3.59E-03
STRING	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	1.54E-02	8.97E-04
STRING	BP	GO:0015824	proline transport	-	13	13	-	-	3.40E-02	5.80E-04
STRING	BP	GO:0035107	appendage morphogenesis	-	147	145	-	-	5.26E-02	6.12E-03
STRING	BP	GO:1903707	negative regulation of hemopoiesis	-	116	109	-	-	8.63E-03	4.64E-03
STRING	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	7.02E-03	8.44E-04
STRING	CC	GO:0048208	COPII vesicle coating	-	27	26	-	-	8.68E-02	1.11E-03
STRING	BP	GO:0030149	sphingolipid catabolic process	-	32	30	-	-	1.43E-01	1.27E-03
STRING	BP	GO:0050994	regulation of lipid catabolic process	-	61	61	-	-	1.38E-02	2.58E-03
STRING	BP	GO:0035988	chondrocyte proliferation	-	24	23	-	-	3.37E-03	1.00E-03
STRING	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	3.38E-02	1.27E-03
STRING	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	5.18E-02	4.75E-04
STRING	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	2.73E-03	5.27E-04
STRING	BP	GO:0045727	positive regulation of translation	-	141	136	-	-	2.04E-02	5.75E-03
STRING	BP	GO:0036315	cellular response to sterol	-	24	20	-	-	2.42E-03	8.44E-04
STRING	CC	GO:0032388	positive regulation of intracellular transport	-	137	135	-	-	3.95E-03	5.70E-03
STRING	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	7.99E-03	5.80E-04
STRING	BP	GO:0002027	regulation of heart rate	-	106	99	-	-	1.07E-01	4.22E-03
STRING	BP	GO:0050879	multicellular organismal movement	-	118	117	-	-	1.83E-02	4.96E-03
STRING	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	1.16E-02	6.33E-04
STRING	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	72	-	-	8.80E-03	3.06E-03
STRING	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	62	-	-	6.46E-03	2.64E-03
STRING	BP	GO:0048515	spermatid differentiation	-	208	204	-	-	5.05E-02	8.65E-03
STRING	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	1.00E-02	2.43E-03
STRING	MF	GO:0042887	amide transmembrane transporter activity	-	33	32	-	-	1.52E-02	1.37E-03
STRING	BP	GO:0007130	synaptonemal complex assembly	-	23	23	-	-	9.10E-02	1.00E-03
STRING	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	36	-	-	5.06E-03	1.53E-03
STRING	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	34	-	-	1.03E-03	1.48E-03
STRING	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	37	-	-	1.24E-01	1.58E-03
STRING	BP	GO:0060119	inner ear receptor cell development	-	44	43	-	-	6.35E-02	1.85E-03
STRING	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	4.77E-03	7.91E-04
STRING	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	34	-	-	8.09E-02	1.48E-03
STRING	BP	GO:1901983	regulation of protein acetylation	-	26	24	-	-	1.41E-03	1.05E-03
STRING	BP	GO:0014854	response to inactivity	-	12	11	-	-	3.38E-03	4.75E-04
STRING	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	240	-	-	3.28E-02	1.01E-02
STRING	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	5.10E-04	7.38E-04
STRING	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	5.31E-02	2.06E-03
STRING	BP	GO:0010883	regulation of lipid storage	-	53	49	-	-	1.11E-02	2.11E-03
STRING	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	2.05E-02	1.11E-03
STRING	BP	GO:0007635	chemosensory behavior	-	20	20	-	-	1.91E-03	8.44E-04
STRING	BP	GO:1905954	positive regulation of lipid localization	-	110	106	-	-	1.83E-02	4.48E-03
STRING	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	3.61E-03	5.27E-04
STRING	BP	GO:0002209	behavioral defense response	-	39	39	-	-	1.91E-03	1.69E-03
STRING	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	29	-	-	6.81E-02	1.27E-03
STRING	BP	GO:0072523	purine-containing compound catabolic process	-	146	144	-	-	3.39E-02	6.12E-03
STRING	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	31	-	-	6.01E-03	1.32E-03
STRING	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	28	-	-	1.37E-03	1.21E-03
STRING	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	3.00E-03	6.86E-04
STRING	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	94	-	-	2.39E-02	4.01E-03
STRING	BP	GO:0007218	neuropeptide signaling pathway	-	113	106	-	-	1.79E-01	4.48E-03
STRING	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	2.23E-03	5.27E-04
STRING	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	164	-	-	4.45E-02	6.96E-03
STRING	BP	GO:0031345	negative regulation of cell projection organization	-	195	188	-	-	5.25E-02	7.96E-03
STRING	BP	GO:0048278	vesicle docking	-	64	63	-	-	7.23E-02	2.69E-03
STRING	BP	GO:0035050	embryonic heart tube development	-	86	85	-	-	2.79E-02	3.59E-03
STRING	BP	GO:0030168	platelet activation	-	135	134	-	-	3.43E-02	5.70E-03
STRING	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	16	-	-	4.63E-02	6.86E-04
STRING	CC	GO:0098810	neurotransmitter reuptake	-	35	35	-	-	6.69E-02	1.48E-03
STRING	BP	GO:0008213	protein alkylation	-	58	56	-	-	1.98E-01	2.37E-03
STRING	BP	GO:0009812	flavonoid metabolic process	-	14	13	-	-	1.24E-01	5.80E-04
STRING	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	12	-	-	1.42E-03	5.27E-04
STRING	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	8.97E-03	1.05E-03
STRING	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.77E-03	5.80E-04
STRING	BP	GO:0031529	ruffle organization	-	55	55	-	-	8.82E-03	2.32E-03
STRING	BP	GO:0010842	retina layer formation	-	25	24	-	-	1.60E-03	1.05E-03
STRING	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	94	-	-	4.08E-02	4.01E-03
STRING	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	1.05E-03	4.75E-04
STRING	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	69	-	-	8.72E-03	2.95E-03
STRING	MF	GO:0170055	lipid transmembrane transporter activity	-	56	56	-	-	8.49E-02	2.37E-03
STRING	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	35	-	-	6.35E-02	1.48E-03
STRING	BP	GO:0035304	regulation of protein dephosphorylation	-	87	84	-	-	2.17E-02	3.59E-03
STRING	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	231	-	-	6.00E-02	9.76E-03
STRING	BP	GO:0099637	neurotransmitter receptor transport	-	26	26	-	-	8.83E-03	1.11E-03
STRING	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	6.68E-03	1.48E-03
STRING	BP	GO:0051775	response to redox state	-	13	13	-	-	1.81E-03	5.80E-04
STRING	BP	GO:0051785	positive regulation of nuclear division	-	61	60	-	-	5.19E-03	2.53E-03
STRING	BP	GO:0060456	positive regulation of digestive system process	-	16	15	-	-	4.27E-03	6.33E-04
STRING	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	16	-	-	6.62E-03	6.86E-04
STRING	BP	GO:0060749	mammary gland alveolus development	-	20	19	-	-	7.09E-03	8.44E-04
STRING	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	9.03E-03	5.27E-04
STRING	BP	GO:0044786	cell cycle DNA replication	-	45	44	-	-	1.50E-02	1.90E-03
STRING	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	13	-	-	6.95E-03	5.80E-04
STRING	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	3.98E-03	7.38E-04
STRING	BP	GO:0051299	centrosome separation	-	15	15	-	-	4.21E-03	6.33E-04
STRING	BP	GO:0048145	regulation of fibroblast proliferation	-	87	84	-	-	4.81E-03	3.59E-03
STRING	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	87	-	-	1.04E-01	3.69E-03
STRING	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	2.07E-02	4.75E-04
STRING	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	224	-	-	1.12E-02	9.49E-03
STRING	BP	GO:0032098	regulation of appetite	-	20	20	-	-	1.28E-02	8.44E-04
STRING	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	3.84E-03	6.33E-04
STRING	CC	GO:0008333	endosome to lysosome transport	-	73	70	-	-	2.99E-02	2.95E-03
STRING	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	22	-	-	6.03E-03	9.49E-04
STRING	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	16	-	-	1.62E-03	6.86E-04
STRING	BP	GO:0003016	respiratory system process	-	39	39	-	-	2.63E-03	1.69E-03
STRING	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	24	-	-	2.44E-02	1.05E-03
STRING	BP	GO:0045732	positive regulation of protein catabolic process	-	202	198	-	-	1.47E-02	8.39E-03
STRING	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	72	-	-	7.85E-02	3.06E-03
STRING	BP	GO:0007588	excretion	-	40	40	-	-	8.26E-03	1.69E-03
STRING	BP	GO:1904018	positive regulation of vasculature development	-	185	157	-	-	2.73E-02	6.65E-03
STRING	BP	GO:0050953	sensory perception of light stimulus	-	223	218	-	-	2.61E-01	9.23E-03
STRING	BP	GO:0009164	nucleoside catabolic process	-	25	25	-	-	4.59E-02	1.05E-03
STRING	BP	GO:0002357	defense response to tumor cell	-	13	12	-	-	9.57E-04	5.27E-04
STRING	BP	GO:0009303	rRNA transcription	-	37	37	-	-	2.29E-02	1.58E-03
STRING	BP	GO:0035601	protein deacylation	-	56	55	-	-	1.04E-02	2.32E-03
STRING	BP	GO:0061952	midbody abscission	-	18	16	-	-	5.40E-02	6.86E-04
STRING	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	7.36E-04	4.75E-04
STRING	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	1.22E-03	8.44E-04
STRING	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	29	-	-	1.42E-03	1.27E-03
STRING	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	1.74E-02	2.74E-03
STRING	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	15	-	-	3.14E-02	6.33E-04
STRING	BP	GO:0045830	positive regulation of isotype switching	-	28	28	-	-	2.60E-02	1.21E-03
STRING	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	1.06E-02	1.42E-03
STRING	BP	GO:0046697	decidualization	-	26	24	-	-	1.79E-03	1.05E-03
STRING	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	7.12E-03	6.33E-04
STRING	BP	GO:0051588	regulation of neurotransmitter transport	-	99	97	-	-	2.12E-02	4.11E-03
STRING	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	30	-	-	1.39E-02	1.27E-03
STRING	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	8.42E-03	5.27E-04
STRING	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	1.85E-02	2.69E-03
STRING	BP	GO:0044703	multi-organism reproductive process	-	209	200	-	-	1.85E-02	8.44E-03
STRING	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	137	-	-	1.64E-02	5.80E-03
STRING	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	2.30E-02	4.75E-04
STRING	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	50	-	-	1.21E-02	2.11E-03
STRING	BP	GO:0099022	vesicle tethering	-	32	31	-	-	9.19E-02	1.32E-03
STRING	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	38	-	-	2.77E-02	1.64E-03
STRING	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	3.65E-04	5.27E-04
STRING	BP	GO:0048857	neural nucleus development	-	65	62	-	-	3.44E-03	2.64E-03
STRING	BP	GO:0048663	neuron fate commitment	-	74	72	-	-	5.02E-02	3.06E-03
STRING	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	174	-	-	1.45E-01	7.38E-03
STRING	BP	GO:0106027	neuron projection organization	-	90	86	-	-	1.59E-02	3.64E-03
STRING	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	129	-	-	2.29E-02	5.49E-03
STRING	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	34	-	-	4.93E-03	1.48E-03
STRING	BP	GO:0045685	regulation of glial cell differentiation	-	77	71	-	-	1.35E-02	3.01E-03
STRING	BP	GO:0051608	histamine transport	-	14	14	-	-	1.93E-03	6.33E-04
STRING	BP	GO:0043414	macromolecule methylation	-	138	132	-	-	1.80E-01	5.59E-03
STRING	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	4.43E-03	5.27E-04
STRING	BP	GO:0048268	clathrin coat assembly	-	16	15	-	-	1.83E-02	6.33E-04
STRING	BP	GO:0050886	endocrine process	-	93	92	-	-	1.81E-02	3.90E-03
STRING	MF	GO:0015562	efflux transmembrane transporter activity	-	15	15	-	-	6.37E-03	6.33E-04
STRING	BP	GO:0050951	sensory perception of temperature stimulus	-	28	27	-	-	4.97E-03	1.16E-03
STRING	BP	GO:0045807	positive regulation of endocytosis	-	155	149	-	-	1.23E-02	6.33E-03
STRING	BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	-	11	11	-	-	2.05E-03	4.75E-04
STRING	BP	GO:0002418	immune response to tumor cell	-	29	26	-	-	1.70E-02	1.11E-03
STRING	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	58	-	-	1.54E-02	2.48E-03
STRING	BP	GO:0048308	organelle inheritance	-	14	14	-	-	2.12E-03	6.33E-04
STRING	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	3.76E-03	7.91E-04
STRING	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	5.75E-03	8.44E-04
STRING	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	52	-	-	4.37E-02	2.22E-03
STRING	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	2.58E-03	2.85E-03
STRING	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	3.70E-03	5.27E-04
STRING	BP	GO:0009110	vitamin biosynthetic process	-	23	22	-	-	9.86E-04	9.49E-04
STRING	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	4.72E-03	9.49E-04
STRING	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	19	-	-	4.58E-02	8.44E-04
STRING	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	22	-	-	1.04E-01	9.49E-04
STRING	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	97	-	-	5.95E-03	4.11E-03
STRING	BP	GO:0009111	vitamin catabolic process	-	13	13	-	-	7.00E-03	5.80E-04
STRING	MF	GO:0051100	negative regulation of binding	-	161	157	-	-	6.02E-03	6.65E-03
STRING	BP	GO:0003151	outflow tract morphogenesis	-	81	75	-	-	2.19E-02	3.16E-03
STRING	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	59	-	-	4.75E-03	2.53E-03
STRING	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	3.36E-03	8.44E-04
STRING	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	2.61E-03	5.27E-04
STRING	BP	GO:0046504	glycerol ether biosynthetic process	-	11	11	-	-	2.74E-02	4.75E-04
STRING	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	3.14E-02	1.42E-03
STRING	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	1.82E-03	6.86E-04
STRING	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	6.23E-04	5.80E-04
STRING	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	5.46E-03	2.00E-03
STRING	BP	GO:0046621	negative regulation of organ growth	-	39	31	-	-	1.22E-02	1.32E-03
STRING	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	48	-	-	6.17E-02	2.06E-03
STRING	BP	GO:0032368	regulation of lipid transport	-	149	129	-	-	1.73E-02	5.49E-03
STRING	BP	GO:0055094	response to lipoprotein particle	-	34	27	-	-	2.25E-03	1.16E-03
STRING	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	181	-	-	3.05E-02	7.65E-03
STRING	BP	GO:0033002	muscle cell proliferation	-	249	199	-	-	1.88E-02	8.44E-03
STRING	BP	GO:0043331	response to dsRNA	-	56	56	-	-	4.22E-02	2.37E-03
STRING	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	4.13E-03	5.27E-04
STRING	BP	GO:0051904	pigment granule transport	-	23	23	-	-	7.03E-02	1.00E-03
STRING	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	7.51E-02	1.37E-03
STRING	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	34	-	-	1.09E-03	1.48E-03
STRING	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	12	-	-	4.16E-02	5.27E-04
STRING	BP	GO:0033363	secretory granule organization	-	63	63	-	-	3.33E-02	2.69E-03
STRING	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	4.18E-03	1.21E-03
STRING	BP	GO:0120009	intermembrane lipid transfer	-	52	51	-	-	1.37E-01	2.16E-03
STRING	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	1.42E-03	6.33E-04
STRING	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	37	-	-	2.00E-03	1.58E-03
STRING	BP	GO:0033622	integrin activation	-	26	26	-	-	2.01E-02	1.11E-03
STRING	BP	GO:0098751	bone cell development	-	18	17	-	-	1.80E-03	7.38E-04
STRING	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	1.36E-03	8.97E-04
STRING	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	50	-	-	9.02E-03	2.11E-03
STRING	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	8.61E-03	1.27E-03
STRING	BP	GO:0002076	osteoblast development	-	17	16	-	-	3.76E-03	6.86E-04
STRING	BP	GO:0072164	mesonephric tubule development	-	98	97	-	-	6.03E-02	4.11E-03
STRING	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	1.19E-03	7.38E-04
STRING	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	105	-	-	7.45E-03	4.43E-03
STRING	BP	GO:1903524	positive regulation of blood circulation	-	39	37	-	-	2.61E-02	1.58E-03
STRING	BP	GO:0030901	midbrain development	-	87	84	-	-	8.71E-03	3.59E-03
STRING	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	2.56E-02	9.49E-04
STRING	BP	GO:0048532	anatomical structure arrangement	-	16	15	-	-	2.47E-03	6.33E-04
STRING	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	6.14E-04	5.80E-04
STRING	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	68	-	-	4.41E-03	2.90E-03
STRING	MF	GO:1901474	azole transmembrane transporter activity	-	13	13	-	-	4.79E-02	5.80E-04
STRING	BP	GO:0002687	positive regulation of leukocyte migration	-	147	143	-	-	2.41E-02	6.07E-03
STRING	BP	GO:0019755	one-carbon compound transport	-	28	26	-	-	1.25E-02	1.11E-03
STRING	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	6.77E-04	5.80E-04
STRING	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	1.94E-02	6.86E-04
STRING	BP	GO:0110154	RNA decapping	-	19	19	-	-	6.71E-02	8.44E-04
STRING	BP	GO:0034605	cellular response to heat	-	66	61	-	-	4.69E-03	2.58E-03
STRING	BP	GO:0005996	monosaccharide metabolic process	-	250	244	-	-	6.36E-02	1.03E-02
STRING	BP	GO:0033555	multicellular organismal response to stress	-	90	88	-	-	1.25E-02	3.74E-03
STRING	BP	GO:0002262	myeloid cell homeostasis	-	172	168	-	-	1.85E-02	7.12E-03
STRING	BP	GO:0000966	RNA 5'-end processing	-	39	39	-	-	4.94E-02	1.69E-03
STRING	BP	GO:0050688	regulation of defense response to virus	-	65	64	-	-	1.13E-02	2.74E-03
STRING	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	21	-	-	4.93E-03	8.97E-04
STRING	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	222	-	-	3.25E-02	9.39E-03
STRING	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	30	-	-	5.10E-03	1.27E-03
STRING	BP	GO:0061029	eyelid development in camera-type eye	-	14	13	-	-	1.06E-03	5.80E-04
STRING	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	30	-	-	2.73E-03	1.27E-03
STRING	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	19	-	-	1.22E-03	8.44E-04
STRING	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	8.44E-03	1.21E-03
STRING	BP	GO:0022618	protein-RNA complex assembly	-	227	190	-	-	3.68E-02	8.02E-03
STRING	BP	GO:0051147	regulation of muscle cell differentiation	-	162	133	-	-	1.88E-02	5.64E-03
STRING	BP	GO:0090102	cochlea development	-	50	47	-	-	8.56E-03	2.00E-03
STRING	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	25	-	-	3.92E-03	1.05E-03
STRING	BP	GO:0061303	cornea development in camera-type eye	-	12	12	-	-	7.73E-03	5.27E-04
STRING	BP	GO:0045933	positive regulation of muscle contraction	-	49	47	-	-	1.17E-02	2.00E-03
STRING	BP	GO:0015803	branched-chain amino acid transport	-	14	14	-	-	4.13E-02	6.33E-04
STRING	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	1.22E-03	6.86E-04
STRING	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	34	-	-	4.41E-03	1.48E-03
STRING	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	92	-	-	1.08E-01	3.90E-03
STRING	BP	GO:0097264	self proteolysis	-	12	12	-	-	8.10E-04	5.27E-04
STRING	BP	GO:0043555	regulation of translation in response to stress	-	22	22	-	-	9.68E-03	9.49E-04
STRING	BP	GO:0032922	circadian regulation of gene expression	-	71	71	-	-	3.94E-02	3.01E-03
STRING	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	56	-	-	3.99E-02	2.37E-03
STRING	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	4.47E-02	1.00E-03
STRING	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	56	-	-	3.99E-03	2.37E-03
STRING	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	5.16E-04	4.75E-04
STRING	BP	GO:0038179	neurotrophin signaling pathway	-	38	37	-	-	7.86E-03	1.58E-03
STRING	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	5.93E-04	5.27E-04
STRING	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	1.60E-03	4.75E-04
STRING	BP	GO:0140253	cell-cell fusion	-	62	61	-	-	3.57E-02	2.58E-03
STRING	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	7.04E-04	5.27E-04
STRING	BP	GO:0071599	otic vesicle development	-	15	15	-	-	3.46E-03	6.33E-04
STRING	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	44	-	-	2.33E-01	1.90E-03
STRING	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	7.66E-04	6.33E-04
STRING	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	60	-	-	5.14E-02	2.53E-03
STRING	BP	GO:0001941	postsynaptic membrane organization	-	37	37	-	-	1.39E-02	1.58E-03
STRING	BP	GO:0051293	establishment of spindle localization	-	57	57	-	-	1.15E-02	2.43E-03
STRING	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	3.24E-03	5.80E-04
STRING	BP	GO:0043114	regulation of vascular permeability	-	49	47	-	-	1.00E-02	2.00E-03
STRING	BP	GO:0018126	protein hydroxylation	-	26	25	-	-	8.92E-02	1.05E-03
STRING	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	66	-	-	7.99E-03	2.80E-03
STRING	BP	GO:0008360	regulation of cell shape	-	139	136	-	-	2.45E-02	5.75E-03
STRING	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	15	-	-	5.51E-03	6.33E-04
STRING	BP	GO:0051222	positive regulation of protein transport	-	249	245	-	-	1.32E-02	1.03E-02
STRING	CC	GO:0140632	canonical inflammasome complex assembly	-	40	38	-	-	4.61E-02	1.64E-03
STRING	MF	GO:0034260	negative regulation of GTPase activity	-	36	32	-	-	5.95E-04	1.37E-03
STRING	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	2.74E-03	9.49E-04
STRING	BP	GO:0045739	positive regulation of DNA repair	-	128	125	-	-	5.52E-02	5.27E-03
STRING	BP	GO:0001845	phagolysosome assembly	-	19	18	-	-	7.61E-03	7.91E-04
STRING	BP	GO:0045185	maintenance of protein location	-	95	94	-	-	3.93E-03	4.01E-03
STRING	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	1.38E-02	5.80E-04
STRING	BP	GO:0003158	endothelium development	-	140	124	-	-	3.22E-02	5.27E-03
STRING	CC	GO:0072595	maintenance of protein localization in organelle	-	42	42	-	-	2.60E-03	1.79E-03
STRING	BP	GO:0051224	negative regulation of protein transport	-	122	104	-	-	4.86E-03	4.43E-03
STRING	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	148	-	-	2.13E-02	6.28E-03
STRING	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	5.49E-03	5.80E-04
STRING	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	30	-	-	1.01E-02	1.27E-03
STRING	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	18	-	-	8.44E-03	7.91E-04
STRING	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	9.93E-03	2.69E-03
STRING	BP	GO:0007405	neuroblast proliferation	-	81	79	-	-	8.45E-03	3.38E-03
STRING	BP	GO:0009581	detection of external stimulus	-	137	135	-	-	8.07E-02	5.70E-03
STRING	BP	GO:1990542	mitochondrial transmembrane transport	-	93	91	-	-	1.16E-01	3.85E-03
STRING	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	31	-	-	6.86E-03	1.32E-03
STRING	BP	GO:0097186	amelogenesis	-	26	26	-	-	1.21E-01	1.11E-03
STRING	BP	GO:0031128	developmental induction	-	26	26	-	-	5.64E-03	1.11E-03
STRING	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	7.76E-03	6.33E-04
STRING	BP	GO:0031100	animal organ regeneration	-	66	65	-	-	3.46E-03	2.74E-03
STRING	BP	GO:0021533	cell differentiation in hindbrain	-	23	23	-	-	4.25E-03	1.00E-03
STRING	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	1.53E-03	1.32E-03
STRING	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	11	-	-	1.78E-03	4.75E-04
STRING	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	1.56E-02	2.16E-03
STRING	BP	GO:0021517	ventral spinal cord development	-	47	46	-	-	3.91E-02	1.95E-03
STRING	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	73	-	-	8.90E-03	3.11E-03
STRING	BP	GO:0032328	alanine transport	-	19	19	-	-	4.79E-02	8.44E-04
STRING	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	2.89E-02	6.86E-04
STRING	BP	GO:0097722	sperm motility	-	133	132	-	-	4.77E-02	5.59E-03
STRING	BP	GO:0051231	spindle elongation	-	14	14	-	-	7.43E-03	6.33E-04
STRING	BP	GO:0042490	mechanoreceptor differentiation	-	67	66	-	-	4.31E-02	2.80E-03
STRING	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	1.14E-03	1.27E-03
STRING	BP	GO:0035148	tube formation	-	155	153	-	-	1.69E-02	6.49E-03
STRING	BP	GO:0048520	positive regulation of behavior	-	27	26	-	-	5.20E-02	1.11E-03
STRING	BP	GO:0098543	detection of other organism	-	19	18	-	-	2.81E-02	7.91E-04
STRING	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	42	-	-	1.53E-02	1.79E-03
STRING	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	123	-	-	4.48E-02	5.22E-03
STRING	BP	GO:0031123	RNA 3'-end processing	-	79	78	-	-	4.78E-02	3.32E-03
STRING	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	6.36E-03	4.75E-04
STRING	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	108	-	-	1.23E-02	4.59E-03
STRING	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	1.86E-03	7.91E-04
STRING	CC	GO:0007097	nuclear migration	-	24	23	-	-	1.27E-02	1.00E-03
STRING	BP	GO:0006885	regulation of pH	-	104	103	-	-	9.40E-02	4.38E-03
STRING	BP	GO:0002467	germinal center formation	-	14	14	-	-	2.19E-03	6.33E-04
STRING	BP	GO:1990840	response to lectin	-	22	21	-	-	1.00E-02	8.97E-04
STRING	BP	GO:0071800	podosome assembly	-	19	17	-	-	1.52E-03	7.38E-04
STRING	BP	GO:0031018	endocrine pancreas development	-	47	45	-	-	3.89E-02	1.90E-03
STRING	BP	GO:0001708	cell fate specification	-	108	106	-	-	3.37E-02	4.48E-03
STRING	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	68	-	-	1.14E-02	2.90E-03
STRING	BP	GO:0030279	negative regulation of ossification	-	39	37	-	-	4.15E-03	1.58E-03
STRING	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	9.17E-03	6.33E-04
STRING	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	13	-	-	4.54E-04	5.80E-04
STRING	BP	GO:0042440	pigment metabolic process	-	80	78	-	-	5.05E-02	3.32E-03
STRING	BP	GO:1901606	alpha-amino acid catabolic process	-	101	99	-	-	1.15E-01	4.22E-03
STRING	BP	GO:1901890	positive regulation of cell junction assembly	-	106	105	-	-	1.44E-02	4.43E-03
STRING	BP	GO:0070988	demethylation	-	27	26	-	-	1.70E-02	1.11E-03
STRING	BP	GO:1901655	cellular response to ketone	-	107	106	-	-	4.21E-03	4.48E-03
STRING	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	3.74E-03	6.33E-04
STRING	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	5.45E-03	6.33E-04
STRING	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	4.22E-02	7.38E-04
STRING	BP	GO:0006968	cellular defense response	-	52	50	-	-	2.26E-02	2.11E-03
STRING	BP	GO:0055006	cardiac cell development	-	93	81	-	-	2.61E-02	3.43E-03
STRING	BP	GO:0031365	N-terminal protein amino acid modification	-	30	30	-	-	9.49E-02	1.27E-03
STRING	BP	GO:0035881	amacrine cell differentiation	-	12	12	-	-	3.48E-02	5.27E-04
STRING	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	28	-	-	2.34E-03	1.21E-03
STRING	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	1.07E-03	5.27E-04
STRING	BP	GO:0060004	reflex	-	63	60	-	-	3.03E-03	2.53E-03
STRING	BP	GO:0044706	multi-multicellular organism process	-	217	207	-	-	1.84E-02	8.76E-03
STRING	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	5.60E-04	5.27E-04
STRING	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	135	-	-	1.57E-02	5.70E-03
STRING	BP	GO:0006026	aminoglycan catabolic process	-	34	34	-	-	3.95E-02	1.48E-03
STRING	BP	GO:0031294	lymphocyte costimulation	-	47	45	-	-	3.59E-02	1.90E-03
STRING	BP	GO:0050768	negative regulation of neurogenesis	-	150	145	-	-	5.57E-02	6.12E-03
STRING	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	94	-	-	1.64E-03	4.01E-03
STRING	BP	GO:0090068	positive regulation of cell cycle process	-	262	247	-	-	1.65E-02	1.04E-02
STRING	BP	GO:0043605	amide catabolic process	-	16	16	-	-	3.09E-02	6.86E-04
STRING	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	4.14E-02	1.16E-03
STRING	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	32	-	-	7.34E-03	1.37E-03
STRING	BP	GO:1902115	regulation of organelle assembly	-	210	206	-	-	1.85E-02	8.70E-03
STRING	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	64	-	-	1.99E-02	2.74E-03
STRING	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	2.34E-03	6.86E-04
STRING	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	143	-	-	3.55E-02	6.07E-03
STRING	BP	GO:0043171	peptide catabolic process	-	19	18	-	-	3.03E-02	7.91E-04
STRING	BP	GO:0046622	positive regulation of organ growth	-	52	41	-	-	7.78E-03	1.74E-03
STRING	BP	GO:0051952	regulation of amine transport	-	98	97	-	-	3.36E-02	4.11E-03
STRING	BP	GO:0006730	one-carbon metabolic process	-	24	22	-	-	1.96E-02	9.49E-04
STRING	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	3.27E-03	8.44E-04
STRING	BP	GO:0015801	aromatic amino acid transport	-	13	13	-	-	4.89E-02	5.80E-04
STRING	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	3.70E-03	1.00E-03
STRING	BP	GO:0097154	GABAergic neuron differentiation	-	20	20	-	-	1.61E-02	8.44E-04
STRING	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	4.18E-04	6.86E-04
STRING	CC	GO:0032365	intracellular lipid transport	-	51	47	-	-	4.63E-02	2.00E-03
STRING	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	3.88E-01	1.27E-03
STRING	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	68	-	-	4.37E-03	2.90E-03
STRING	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	112	-	-	6.04E-03	4.75E-03
STRING	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	1.75E-02	1.21E-03
STRING	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	2.41E-03	1.05E-03
STRING	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	1.88E-03	5.80E-04
STRING	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	5.46E-04	6.33E-04
STRING	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	1.38E-03	5.80E-04
STRING	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	3.80E-03	1.48E-03
STRING	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	3.11E-02	4.75E-04
STRING	BP	GO:0097581	lamellipodium organization	-	91	87	-	-	2.52E-02	3.69E-03
STRING	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	30	-	-	9.63E-02	1.27E-03
STRING	BP	GO:1903975	regulation of glial cell migration	-	20	17	-	-	2.99E-03	7.38E-04
STRING	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	2.85E-02	8.97E-04
STRING	BP	GO:0015669	gas transport	-	23	22	-	-	7.47E-02	9.49E-04
STRING	BP	GO:0016485	protein processing	-	248	243	-	-	3.48E-02	1.03E-02
STRING	BP	GO:0009649	entrainment of circadian clock	-	30	29	-	-	1.76E-02	1.27E-03
STRING	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	166	-	-	1.28E-01	7.01E-03
STRING	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	2.23E-03	1.05E-03
STRING	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	139	-	-	1.38E-01	5.91E-03
STRING	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	3.47E-02	5.27E-04
STRING	BP	GO:0099054	presynapse assembly	-	49	47	-	-	4.16E-02	2.00E-03
STRING	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	1.26E-02	5.27E-04
STRING	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	23	-	-	9.51E-03	1.00E-03
STRING	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	4.44E-02	1.05E-03
STRING	BP	GO:0031348	negative regulation of defense response	-	282	240	-	-	1.64E-02	1.01E-02
STRING	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	74	-	-	7.69E-03	3.16E-03
STRING	BP	GO:0061180	mammary gland epithelium development	-	68	66	-	-	6.49E-03	2.80E-03
STRING	BP	GO:0071496	cellular response to external stimulus	-	74	72	-	-	1.01E-02	3.06E-03
STRING	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	6.18E-04	5.80E-04
STRING	BP	GO:0042753	positive regulation of circadian rhythm	-	18	18	-	-	1.29E-02	7.91E-04
STRING	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	3.39E-03	4.75E-04
STRING	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	9.64E-03	5.27E-04
STRING	BP	GO:0032094	response to food	-	37	37	-	-	6.86E-03	1.58E-03
STRING	BP	GO:0001964	startle response	-	27	27	-	-	7.25E-03	1.16E-03
STRING	BP	GO:0007340	acrosome reaction	-	38	38	-	-	1.91E-02	1.64E-03
STRING	BP	GO:0046434	organophosphate catabolic process	-	232	228	-	-	6.77E-02	9.65E-03
STRING	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	1.23E-02	1.27E-03
STRING	BP	GO:0009566	fertilization	-	205	202	-	-	6.02E-02	8.54E-03
STRING	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	59	-	-	8.77E-02	2.53E-03
STRING	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	3.04E-02	1.05E-03
STRING	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	1.03E-02	5.80E-04
STRING	BP	GO:0045907	positive regulation of vasoconstriction	-	30	28	-	-	3.40E-02	1.21E-03
STRING	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	23	-	-	4.56E-04	1.00E-03
STRING	BP	GO:0033044	regulation of chromosome organization	-	249	247	-	-	3.35E-02	1.04E-02
STRING	BP	GO:0009309	amine biosynthetic process	-	38	35	-	-	1.07E-01	1.48E-03
STRING	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	3.30E-03	8.44E-04
STRING	BP	GO:0061900	glial cell activation	-	56	52	-	-	3.95E-03	2.22E-03
STRING	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	133	-	-	2.03E-02	5.64E-03
STRING	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	3.84E-03	5.80E-04
STRING	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	3.27E-03	6.33E-04
STRING	BP	GO:0021794	thalamus development	-	12	12	-	-	2.19E-03	5.27E-04
STRING	CC	GO:0140467	integrated stress response signaling	-	41	41	-	-	1.76E-02	1.74E-03
STRING	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	3.43E-03	8.44E-04
STRING	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	1.24E-03	6.33E-04
STRING	BP	GO:0072537	fibroblast activation	-	13	13	-	-	1.14E-03	5.80E-04
STRING	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	1.17E-03	5.80E-04
STRING	BP	GO:0043647	inositol phosphate metabolic process	-	44	42	-	-	2.10E-01	1.79E-03
STRING	BP	GO:0016180	snRNA processing	-	28	27	-	-	5.83E-02	1.16E-03
STRING	BP	GO:0051303	establishment of chromosome localization	-	104	100	-	-	2.64E-02	4.22E-03
STRING	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	4.71E-02	6.86E-04
STRING	BP	GO:0007164	establishment of tissue polarity	-	38	37	-	-	2.92E-02	1.58E-03
STRING	BP	GO:0097164	ammonium ion metabolic process	-	23	23	-	-	7.84E-03	1.00E-03
STRING	BP	GO:0021515	cell differentiation in spinal cord	-	51	50	-	-	7.40E-02	2.11E-03
STRING	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	17	-	-	8.48E-03	7.38E-04
STRING	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	3.81E-03	8.97E-04
STRING	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	27	-	-	1.13E-03	1.16E-03
STRING	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	1.51E-03	7.91E-04
STRING	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	38	-	-	3.37E-02	1.64E-03
STRING	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	1.35E-02	9.49E-04
STRING	BP	GO:0007566	embryo implantation	-	57	53	-	-	3.16E-03	2.27E-03
STRING	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	1.90E-02	1.42E-03
STRING	BP	GO:0031268	pseudopodium organization	-	17	16	-	-	2.24E-02	6.86E-04
STRING	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	7.98E-02	1.37E-03
STRING	BP	GO:0051017	actin filament bundle assembly	-	161	153	-	-	2.70E-02	6.49E-03
STRING	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	7.50E-03	1.79E-03
STRING	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	1.72E-03	7.91E-04
STRING	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	6.74E-03	8.44E-04
STRING	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	4.06E-03	5.80E-04
STRING	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	34	-	-	1.12E-02	1.48E-03
STRING	BP	GO:0021756	striatum development	-	21	20	-	-	1.90E-03	8.44E-04
STRING	BP	GO:1901343	negative regulation of vasculature development	-	154	101	-	-	1.88E-02	4.27E-03
STRING	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	147	-	-	6.55E-02	6.22E-03
STRING	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	31	-	-	4.55E-02	1.32E-03
STRING	BP	GO:1902414	protein localization to cell junction	-	107	106	-	-	2.26E-02	4.48E-03
STRING	BP	GO:0071305	cellular response to vitamin D	-	23	21	-	-	5.11E-03	8.97E-04
STRING	BP	GO:0051304	chromosome separation	-	80	80	-	-	2.21E-02	3.38E-03
STRING	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	1.83E-02	7.91E-04
STRING	BP	GO:0048709	oligodendrocyte differentiation	-	101	98	-	-	3.77E-02	4.17E-03
STRING	BP	GO:0045017	glycerolipid biosynthetic process	-	254	245	-	-	1.83E-01	1.03E-02
STRING	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	1.33E-02	6.33E-04
STRING	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	23	-	-	4.00E-03	1.00E-03
STRING	BP	GO:0001776	leukocyte homeostasis	-	108	107	-	-	9.57E-03	4.54E-03
STRING	BP	GO:0050769	positive regulation of neurogenesis	-	240	232	-	-	2.14E-02	9.81E-03
STRING	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	1.61E-02	6.33E-04
STRING	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	2.17E-02	2.95E-03
STRING	BP	GO:0050866	negative regulation of cell activation	-	216	206	-	-	2.31E-02	8.70E-03
STRING	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	3.28E-03	1.53E-03
STRING	BP	GO:0033500	carbohydrate homeostasis	-	251	230	-	-	2.74E-02	9.70E-03
STRING	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	31	-	-	1.20E-02	1.32E-03
STRING	BP	GO:0038183	bile acid signaling pathway	-	12	11	-	-	4.32E-03	4.75E-04
STRING	BP	GO:0044088	regulation of vacuole organization	-	56	55	-	-	1.21E-02	2.32E-03
STRING	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	2.12E-03	1.00E-03
STRING	CC	GO:0099522	cytosolic region	-	20	19	-	-	1.42E-03	8.44E-04
STRING	CC	GO:0000791	euchromatin	-	60	60	-	-	5.85E-03	2.53E-03
STRING	CC	GO:0030666	endocytic vesicle membrane	-	196	190	-	-	4.87E-02	8.02E-03
STRING	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.28E-02	6.33E-04
STRING	CC	GO:1990752	microtubule end	-	34	34	-	-	4.63E-02	1.48E-03
STRING	CC	GO:0043204	perikaryon	-	156	154	-	-	1.20E-02	6.54E-03
STRING	CC	GO:0061702	canonical inflammasome complex	-	17	16	-	-	4.30E-02	6.86E-04
STRING	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	5.21E-03	5.27E-04
STRING	CC	GO:0097542	ciliary tip	-	48	48	-	-	6.18E-02	2.06E-03
STRING	CC	GO:1905368	peptidase complex	-	124	121	-	-	2.34E-02	5.12E-03
STRING	CC	GO:0000792	heterochromatin	-	98	97	-	-	3.14E-02	4.11E-03
STRING	CC	GO:0097546	ciliary base	-	47	46	-	-	1.01E-02	1.95E-03
STRING	CC	GO:0071819	DUBm complex	-	25	23	-	-	1.75E-02	1.00E-03
STRING	CC	GO:0031201	SNARE complex	-	48	48	-	-	3.02E-01	2.06E-03
STRING	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	3.04E-02	5.80E-04
STRING	CC	GO:0033260	nuclear DNA replication	-	40	39	-	-	1.58E-02	1.69E-03
STRING	CC	GO:0044391	ribosomal subunit	-	203	197	-	-	3.79E-02	8.33E-03
STRING	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	12	-	-	6.59E-02	5.27E-04
STRING	CC	GO:0071013	catalytic step 2 spliceosome	-	88	87	-	-	2.65E-02	3.69E-03
STRING	CC	GO:0031907	microbody lumen	-	51	51	-	-	1.06E-01	2.16E-03
STRING	CC	GO:1990072	TRAPPIII protein complex	-	12	12	-	-	1.32E-01	5.27E-04
STRING	CC	GO:0098862	cluster of actin-based cell projections	-	162	161	-	-	9.29E-02	6.80E-03
STRING	CC	GO:0016363	nuclear matrix	-	127	126	-	-	7.95E-03	5.33E-03
STRING	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	3.44E-02	1.95E-03
STRING	CC	GO:0032432	actin filament bundle	-	249	245	-	-	5.82E-02	1.03E-02
STRING	CC	GO:0008088	axo-dendritic transport	-	78	76	-	-	5.56E-02	3.22E-03
STRING	CC	GO:0031519	PcG protein complex	-	38	38	-	-	2.42E-01	1.64E-03
STRING	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	43	-	-	1.04E-01	1.85E-03
STRING	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	219	-	-	9.30E-02	9.28E-03
STRING	CC	GO:0000313	organellar ribosome	-	89	89	-	-	7.37E-02	3.80E-03
STRING	CC	GO:0099643	signal release from synapse	-	147	145	-	-	7.90E-02	6.12E-03
STRING	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	7.32E-02	1.95E-03
STRING	CC	GO:0005818	aster	-	11	11	-	-	5.58E-03	4.75E-04
STRING	CC	GO:0030018	Z disc	-	129	127	-	-	6.50E-02	5.38E-03
STRING	CC	GO:0032580	Golgi cisterna membrane	-	93	88	-	-	3.74E-02	3.74E-03
STRING	CC	GO:0097381	photoreceptor disc membrane	-	25	24	-	-	9.88E-02	1.05E-03
STRING	CC	GO:1905360	GTPase complex	-	41	40	-	-	1.47E-02	1.69E-03
STRING	CC	GO:0097540	axonemal central pair	-	161	155	-	-	4.93E-02	6.54E-03
STRING	CC	GO:0042641	actomyosin	-	77	75	-	-	4.49E-02	3.16E-03
STRING	CC	GO:0097386	glial cell projection	-	38	37	-	-	5.49E-03	1.58E-03
STRING	CC	GO:0032588	trans-Golgi network membrane	-	102	97	-	-	4.89E-02	4.11E-03
STRING	CC	GO:0070382	exocytic vesicle	-	224	221	-	-	1.05E-01	9.34E-03
STRING	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	47	-	-	7.27E-02	2.00E-03
STRING	CC	GO:0031903	microbody membrane	-	65	64	-	-	2.19E-01	2.74E-03
STRING	CC	GO:0046930	pore complex	-	26	26	-	-	3.32E-01	1.11E-03
STRING	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	3.11E-02	4.75E-04
STRING	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	1.31E-03	6.86E-04
STRING	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	5.86E-02	1.05E-03
STRING	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.77E-01	4.75E-04
STRING	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	1.37E-03	7.38E-04
STRING	CC	GO:0044298	cell body membrane	-	32	32	-	-	3.82E-03	1.37E-03
STRING	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	5.21E-02	4.75E-04
STRING	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	1.17E-03	8.97E-04
STRING	CC	GO:0045495	pole plasm	-	25	24	-	-	5.83E-02	1.05E-03
STRING	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	2.36E-01	6.33E-04
STRING	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	1.58E-02	8.44E-04
STRING	CC	GO:0010369	chromocenter	-	14	14	-	-	1.92E-03	6.33E-04
STRING	CC	GO:0002177	manchette	-	19	19	-	-	4.64E-03	8.44E-04
STRING	CC	GO:0016323	basolateral plasma membrane	-	239	233	-	-	5.94E-02	9.86E-03
STRING	CC	GO:0045009	chitosome	-	21	21	-	-	4.51E-02	8.97E-04
STRING	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	1.38E-03	5.27E-04
STRING	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	5.03E-02	1.90E-03
STRING	CC	GO:0098636	protein complex involved in cell adhesion	-	57	57	-	-	1.13E-01	2.43E-03
STRING	CC	GO:0001917	photoreceptor inner segment	-	71	70	-	-	4.30E-02	2.95E-03
STRING	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	1.40E-02	6.33E-04
STRING	CC	GO:0019897	extrinsic component of plasma membrane	-	156	153	-	-	1.24E-02	6.49E-03
STRING	CC	GO:0031594	neuromuscular junction	-	73	73	-	-	2.83E-02	3.11E-03
STRING	CC	GO:0045120	pronucleus	-	14	13	-	-	1.37E-03	5.80E-04
STRING	CC	GO:0043083	synaptic cleft	-	21	21	-	-	5.06E-03	8.97E-04
STRING	CC	GO:0000922	spindle pole	-	172	168	-	-	3.24E-02	7.12E-03
STRING	CC	GO:0120111	neuron projection cytoplasm	-	94	93	-	-	3.64E-02	3.96E-03
STRING	CC	GO:0070971	endoplasmic reticulum exit site	-	32	31	-	-	1.01E-01	1.32E-03
STRING	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	3.50E-03	5.80E-04
STRING	CC	GO:0004879	nuclear receptor activity	-	63	62	-	-	5.90E-02	2.64E-03
STRING	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	165	-	-	9.43E-03	6.96E-03
STRING	CC	GO:0000123	histone acetyltransferase complex	-	93	88	-	-	7.50E-02	3.74E-03
STRING	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	9.36E-03	5.80E-04
STRING	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	108	-	-	8.64E-02	4.59E-03
STRING	CC	GO:0048786	presynaptic active zone	-	80	80	-	-	3.41E-02	3.38E-03
STRING	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	1.95E-02	4.75E-04
STRING	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	2.29E-03	5.27E-04
STRING	CC	GO:0007034	vacuolar transport	-	168	162	-	-	8.27E-02	6.86E-03
STRING	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	4.02E-02	8.97E-04
STRING	CC	GO:0043194	axon initial segment	-	21	21	-	-	9.31E-03	8.97E-04
STRING	CC	GO:1900115	extracellular regulation of signal transduction	-	13	12	-	-	2.98E-02	5.27E-04
STRING	CC	GO:0005776	autophagosome	-	111	106	-	-	7.02E-02	4.48E-03
STRING	CC	GO:0031430	M band	-	22	21	-	-	3.30E-02	8.97E-04
STRING	CC	GO:0001931	uropod	-	13	13	-	-	2.79E-03	5.80E-04
STRING	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	87	-	-	2.20E-01	3.69E-03
STRING	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	97	-	-	6.14E-02	4.11E-03
STRING	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	1.29E-01	5.80E-04
STRING	CC	GO:0000164	protein phosphatase type 1 complex	-	19	19	-	-	1.90E-01	8.44E-04
STRING	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	26	-	-	8.09E-03	1.11E-03
STRING	CC	GO:0032994	protein-lipid complex	-	39	39	-	-	1.72E-01	1.69E-03
STRING	CC	GO:0031838	haptoglobin-hemoglobin complex	-	11	11	-	-	8.43E-02	4.75E-04
STRING	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	147	-	-	7.92E-02	6.22E-03
STRING	CC	GO:0071012	catalytic step 1 spliceosome	-	12	12	-	-	1.12E-02	5.27E-04
STRING	CC	GO:0001527	microfibril	-	13	13	-	-	9.12E-02	5.80E-04
STRING	CC	GO:0072562	blood microparticle	-	144	110	-	-	5.95E-02	4.64E-03
STRING	CC	GO:0005883	neurofilament	-	11	11	-	-	2.20E-03	4.75E-04
STRING	CC	GO:0051233	spindle midzone	-	36	34	-	-	4.91E-03	1.48E-03
STRING	CC	GO:0005811	lipid droplet	-	102	101	-	-	8.04E-02	4.27E-03
STRING	CC	GO:0045022	early endosome to late endosome transport	-	44	43	-	-	1.71E-02	1.85E-03
STRING	CC	GO:0043113	receptor clustering	-	51	51	-	-	8.98E-03	2.16E-03
STRING	CC	GO:0005940	septin ring	-	14	14	-	-	2.54E-01	6.33E-04
STRING	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	25	-	-	1.47E-01	1.05E-03
STRING	CC	GO:0044853	plasma membrane raft	-	114	112	-	-	9.47E-03	4.75E-03
STRING	CC	GO:0005881	cytoplasmic microtubule	-	256	249	-	-	5.25E-02	1.05E-02
STRING	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	4.04E-03	6.33E-04
STRING	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	2.34E-01	7.38E-04
STRING	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	56	-	-	3.34E-02	2.37E-03
STRING	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	5.31E-02	3.06E-03
STRING	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	8.13E-03	5.27E-04
STRING	CC	GO:0043034	costamere	-	18	17	-	-	2.63E-03	7.38E-04
STRING	CC	GO:0031904	endosome lumen	-	38	37	-	-	1.05E-02	1.58E-03
STRING	CC	GO:0060170	ciliary membrane	-	76	75	-	-	5.41E-02	3.16E-03
STRING	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	13	-	-	3.28E-01	5.80E-04
STRING	CC	GO:0000783	nuclear telomere cap complex	-	12	11	-	-	7.18E-02	4.75E-04
STRING	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	24	-	-	2.42E-01	1.05E-03
STRING	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	1.27E-02	6.33E-04
STRING	CC	GO:0032154	cleavage furrow	-	54	53	-	-	1.21E-02	2.27E-03
STRING	CC	GO:0005640	nuclear outer membrane	-	30	30	-	-	9.91E-03	1.27E-03
STRING	CC	GO:0005652	nuclear lamina	-	12	12	-	-	7.15E-03	5.27E-04
STRING	CC	GO:0007006	mitochondrial membrane organization	-	117	112	-	-	5.65E-02	4.75E-03
STRING	CC	GO:0001772	immunological synapse	-	44	43	-	-	1.16E-02	1.85E-03
STRING	CC	GO:0030904	retromer complex	-	12	12	-	-	2.14E-02	5.27E-04
STRING	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	1.13E-01	5.27E-04
STRING	CC	GO:0030863	cortical cytoskeleton	-	104	104	-	-	3.63E-02	4.43E-03
STRING	CC	GO:1905348	endonuclease complex	-	38	36	-	-	3.60E-01	1.53E-03
STRING	CC	GO:0005833	hemoglobin complex	-	12	12	-	-	7.44E-02	5.27E-04
STRING	CC	GO:0061638	CENP-A containing chromatin	-	18	17	-	-	5.15E-03	7.38E-04
STRING	CC	GO:0030315	T-tubule	-	52	50	-	-	2.92E-02	2.11E-03
STRING	CC	GO:0060076	excitatory synapse	-	64	64	-	-	1.34E-02	2.74E-03
STRING	CC	GO:0036019	endolysosome	-	29	28	-	-	9.66E-03	1.21E-03
STRING	CC	GO:0001891	phagocytic cup	-	28	27	-	-	4.41E-03	1.16E-03
STRING	CC	GO:0099086	synaptonemal structure	-	40	39	-	-	1.03E-01	1.69E-03
STRING	CC	GO:0030427	site of polarized growth	-	172	172	-	-	1.63E-02	7.28E-03
STRING	CC	GO:0044309	neuron spine	-	213	211	-	-	3.51E-02	8.91E-03
STRING	CC	GO:0030658	transport vesicle membrane	-	231	223	-	-	7.08E-02	9.44E-03
STRING	CC	GO:0000813	ESCRT I complex	-	11	11	-	-	2.85E-01	4.75E-04
STRING	CC	GO:0098918	structural constituent of synapse	-	27	26	-	-	5.35E-03	1.11E-03
STRING	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	5.42E-02	5.27E-04
STRING	CC	GO:0000940	outer kinetochore	-	17	17	-	-	7.74E-02	7.38E-04
STRING	CC	GO:0034719	SMN-Sm protein complex	-	18	17	-	-	5.41E-02	7.38E-04
STRING	CC	GO:0044232	organelle membrane contact site	-	50	49	-	-	6.14E-02	2.11E-03
STRING	CC	GO:0098803	respiratory chain complex	-	39	36	-	-	7.42E-02	1.53E-03
STRING	CC	GO:0097545	axonemal outer doublet	-	164	158	-	-	4.80E-02	6.70E-03
STRING	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	1.04E-03	8.44E-04
STRING	CC	GO:0070069	cytochrome complex	-	42	39	-	-	8.45E-02	1.69E-03
STRING	CC	GO:0031143	pseudopodium	-	18	18	-	-	1.76E-03	7.91E-04
STRING	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	28	-	-	3.04E-01	1.21E-03
STRING	CC	GO:0055037	recycling endosome	-	200	193	-	-	3.61E-02	8.18E-03
STRING	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	93	-	-	9.17E-03	3.96E-03
STRING	CC	GO:0030126	COPI vesicle coat	-	13	13	-	-	8.13E-02	5.80E-04
STRING	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	1.01E-03	5.80E-04
STRING	CC	GO:0071682	endocytic vesicle lumen	-	23	23	-	-	6.19E-03	1.00E-03
STRING	CC	GO:0030684	preribosome	-	76	73	-	-	3.49E-02	3.11E-03
STRING	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	17	-	-	1.94E-02	7.38E-04
STRING	CC	GO:1990391	DNA repair complex	-	22	22	-	-	3.33E-02	9.49E-04
STRING	CC	GO:0005775	vacuolar lumen	-	176	174	-	-	8.14E-02	7.38E-03
STRING	CC	GO:0032433	filopodium tip	-	19	19	-	-	3.83E-03	8.44E-04
STRING	CC	GO:0032982	myosin filament	-	24	23	-	-	2.03E-02	1.00E-03
STRING	CC	GO:0016327	apicolateral plasma membrane	-	23	23	-	-	7.03E-03	1.00E-03
STRING	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	1.21E-01	1.00E-03
STRING	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	8.45E-02	5.27E-04
STRING	CC	GO:0044306	neuron projection terminus	-	164	162	-	-	2.56E-02	6.86E-03
STRING	CC	GO:0034455	t-UTP complex	-	53	50	-	-	2.48E-02	2.11E-03
STRING	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	2.88E-02	7.38E-04
STRING	CC	GO:0031970	organelle envelope lumen	-	94	91	-	-	3.17E-02	3.85E-03
STRING	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	1.24E-02	5.80E-04
STRING	CC	GO:0033270	paranode region of axon	-	11	11	-	-	8.82E-03	4.75E-04
STRING	CC	GO:0120293	dynein axonemal particle	-	20	20	-	-	5.68E-02	8.44E-04
STRING	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	26	-	-	1.74E-02	1.11E-03
STRING	CC	GO:0043292	contractile muscle fiber	-	245	238	-	-	1.54E-01	1.01E-02
STRING	CC	GO:0018995	host cellular component	-	12	12	-	-	7.57E-04	5.27E-04
STRING	CC	GO:0034709	methylosome	-	13	13	-	-	2.02E-03	5.80E-04
STRING	CC	GO:0032426	stereocilium tip	-	21	20	-	-	3.78E-02	8.44E-04
STRING	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	8.80E-03	5.27E-04
STRING	CC	GO:0005849	mRNA cleavage factor complex	-	22	22	-	-	9.39E-02	9.49E-04
STRING	CC	GO:0000803	sex chromosome	-	32	29	-	-	6.59E-03	1.27E-03
STRING	CC	GO:0098982	GABA-ergic synapse	-	84	83	-	-	4.12E-02	3.53E-03
STRING	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	17	-	-	6.96E-02	7.38E-04
STRING	CC	GO:0035097	histone methyltransferase complex	-	63	62	-	-	4.42E-02	2.64E-03
STRING	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	2.09E-02	6.33E-04
STRING	CC	GO:0000242	pericentriolar material	-	22	21	-	-	1.88E-02	8.97E-04
STRING	CC	GO:1903293	phosphatase complex	-	54	53	-	-	7.74E-02	2.27E-03
STRING	CC	GO:0097470	ribbon synapse	-	13	13	-	-	2.17E-03	5.80E-04
STRING	CC	GO:0031941	filamentous actin	-	27	27	-	-	6.40E-01	1.16E-03
STRING	CC	GO:0000786	nucleosome	-	149	144	-	-	9.70E-02	6.12E-03
STRING	CC	GO:0001533	cornified envelope	-	59	59	-	-	1.02E-01	2.53E-03
STRING	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	1.49E-02	2.32E-03
STRING	CC	GO:0030027	lamellipodium	-	202	199	-	-	3.68E-02	8.44E-03
STRING	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	2.49E-01	6.33E-04
STRING	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	26	-	-	1.40E-01	1.11E-03
STRING	CC	GO:0000800	lateral element	-	14	14	-	-	6.17E-03	6.33E-04
STRING	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	13	-	-	8.24E-03	5.80E-04
STRING	CC	GO:0060077	inhibitory synapse	-	20	20	-	-	1.06E-02	8.44E-04
STRING	CC	GO:0031209	SCAR complex	-	12	12	-	-	7.57E-02	5.27E-04
STRING	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	6.51E-02	4.75E-04
STRING	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	1.05E-02	6.86E-04
STRING	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	2.33E-02	8.97E-04
STRING	CC	GO:0002102	podosome	-	31	29	-	-	1.00E-02	1.27E-03
STRING	CC	GO:0090543	Flemming body	-	33	33	-	-	4.01E-03	1.42E-03
STRING	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	1.03E-02	2.80E-03
STRING	CC	GO:0001650	fibrillar center	-	151	150	-	-	5.59E-03	6.33E-03
STRING	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	1.81E-02	6.33E-04
STRING	CC	GO:1990204	oxidoreductase complex	-	90	82	-	-	4.79E-02	3.48E-03
STRING	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	2.74E-01	6.86E-04
STRING	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	4.02E-03	4.75E-04
STRING	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	123	-	-	1.25E-02	5.22E-03
STRING	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	2.31E-02	7.91E-04
STRING	CC	GO:0001726	ruffle	-	181	181	-	-	3.10E-02	7.65E-03
STRING	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	8.40E-02	4.75E-04
STRING	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	1.48E-02	5.80E-04
STRING	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	16	-	-	1.20E-01	6.86E-04
STRING	CC	GO:0043198	dendritic shaft	-	38	38	-	-	5.00E-03	1.64E-03
STRING	CC	GO:0043073	germ cell nucleus	-	67	66	-	-	6.31E-03	2.80E-03
STRING	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	22	-	-	1.96E-02	9.49E-04
STRING	CC	GO:0016592	mediator complex	-	38	37	-	-	2.86E-01	1.58E-03
STRING	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	3.74E-02	8.44E-04
STRING	CC	GO:0022626	cytosolic ribosome	-	118	112	-	-	1.64E-02	4.75E-03
STRING	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	43	-	-	2.76E-01	1.85E-03
STRING	CC	GO:0034451	centriolar satellite	-	120	118	-	-	4.62E-02	5.01E-03
STRING	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	2.71E-03	4.75E-04
STRING	CC	GO:0045171	intercellular bridge	-	91	89	-	-	2.46E-03	3.80E-03
STRING	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	80	-	-	6.48E-02	3.38E-03
STRING	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	1.04E-01	6.33E-04
STRING	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	1.10E-02	4.75E-04
STRING	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	6.97E-03	4.75E-04
STRING	CC	GO:0044292	dendrite terminus	-	13	13	-	-	1.00E-03	5.80E-04
STRING	CC	GO:0032039	integrator complex	-	19	18	-	-	1.07E-01	7.91E-04
STRING	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	1.81E-02	6.33E-04
STRING	CC	GO:0033268	node of Ranvier	-	16	15	-	-	5.99E-03	6.33E-04
STRING	CC	GO:0036038	MKS complex	-	13	13	-	-	5.20E-02	5.80E-04
STRING	CC	GO:0030527	structural constituent of chromatin	-	97	94	-	-	7.17E-02	4.01E-03
STRING	CC	GO:0036379	myofilament	-	26	26	-	-	5.34E-02	1.11E-03
STRING	CC	GO:0030286	dynein complex	-	210	203	-	-	8.22E-02	8.60E-03
STRING	CC	GO:0031105	septin complex	-	14	14	-	-	3.64E-01	6.33E-04
STRING	CC	GO:0097228	sperm principal piece	-	33	33	-	-	4.57E-02	1.42E-03
STRING	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	8.18E-03	5.27E-04
STRING	CC	GO:0016482	cytosolic transport	-	135	130	-	-	7.82E-02	5.49E-03
STRING	CC	GO:0090665	glycoprotein complex	-	23	22	-	-	3.56E-01	9.49E-04
STRING	CC	GO:0005796	Golgi lumen	-	106	100	-	-	1.89E-02	4.22E-03
STRING	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	36	-	-	2.01E-01	1.53E-03
STRING	CC	GO:0034358	plasma lipoprotein particle	-	36	36	-	-	1.59E-01	1.53E-03
STRING	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	4.24E-01	2.00E-03
STRING	CC	GO:0043220	Schmidt-Lanterman incisure	-	11	11	-	-	1.51E-02	4.75E-04
STRING	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	24	-	-	1.40E-01	1.05E-03
STRING	CC	GO:0030662	coated vesicle membrane	-	202	194	-	-	1.41E-01	8.23E-03
STRING	CC	GO:0007039	protein catabolic process in the vacuole	-	61	59	-	-	2.47E-01	2.53E-03
STRING	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	65	-	-	2.18E-02	2.74E-03
STRING	CC	GO:0090734	site of DNA damage	-	118	117	-	-	1.07E-01	4.96E-03
STRING	MF	GO:0051861	glycolipid binding	-	30	28	-	-	4.95E-03	1.21E-03
STRING	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.59E-02	4.75E-04
STRING	MF	GO:0051087	protein-folding chaperone binding	-	135	132	-	-	2.53E-02	5.59E-03
STRING	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	9.77E-03	1.16E-03
STRING	CC	GO:0015464	acetylcholine receptor activity	-	21	21	-	-	1.68E-01	8.97E-04
STRING	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	1.01E-03	5.27E-04
STRING	MF	GO:0016594	glycine binding	-	12	12	-	-	1.88E-02	5.27E-04
STRING	MF	GO:0031681	G-protein beta-subunit binding	-	22	21	-	-	9.42E-03	8.97E-04
STRING	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	3.29E-02	1.58E-03
STRING	MF	GO:0035613	RNA stem-loop binding	-	21	16	-	-	2.31E-03	6.86E-04
STRING	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	245	-	-	2.57E-01	1.03E-02
STRING	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	19	-	-	7.20E-03	8.44E-04
STRING	MF	GO:0033691	sialic acid binding	-	22	20	-	-	1.55E-02	8.44E-04
STRING	MF	GO:0004875	complement receptor activity	-	12	11	-	-	1.40E-02	4.75E-04
STRING	MF	GO:0048306	calcium-dependent protein binding	-	61	59	-	-	1.16E-02	2.53E-03
STRING	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	29	-	-	2.47E-02	1.27E-03
STRING	MF	GO:0035325	Toll-like receptor binding	-	13	11	-	-	7.19E-03	4.75E-04
STRING	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	143	-	-	8.20E-02	6.07E-03
STRING	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	58	-	-	5.93E-02	2.48E-03
STRING	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	136	-	-	4.07E-02	5.75E-03
STRING	MF	GO:0045504	dynein heavy chain binding	-	16	16	-	-	3.04E-02	6.86E-04
STRING	MF	GO:0140457	protein demethylase activity	-	31	30	-	-	1.42E-01	1.27E-03
STRING	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	3.50E-03	9.49E-04
STRING	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	1.21E-03	6.86E-04
STRING	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	6.69E-03	6.33E-04
STRING	MF	GO:0061980	regulatory RNA binding	-	52	45	-	-	2.71E-02	1.90E-03
STRING	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	4.36E-02	1.37E-03
STRING	MF	GO:0000182	rDNA binding	-	11	11	-	-	1.50E-03	4.75E-04
STRING	MF	GO:0001671	ATPase activator activity	-	29	28	-	-	3.77E-03	1.21E-03
STRING	MF	GO:0070840	dynein complex binding	-	25	25	-	-	7.95E-03	1.05E-03
STRING	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.55E-03	1.05E-03
STRING	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	1.24E-03	6.86E-04
STRING	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	35	-	-	2.65E-03	1.48E-03
STRING	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	8.04E-03	7.91E-04
STRING	MF	GO:0005178	integrin binding	-	153	153	-	-	1.26E-01	6.49E-03
STRING	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	2.34E-03	7.38E-04
STRING	MF	GO:0005549	odorant binding	-	128	102	-	-	1.12E-01	4.32E-03
STRING	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.06E-02	6.33E-04
STRING	MF	GO:0008327	methyl-CpG binding	-	31	31	-	-	5.04E-02	1.32E-03
STRING	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	9.15E-02	8.44E-04
STRING	MF	GO:0048019	receptor antagonist activity	-	31	17	-	-	4.13E-03	7.38E-04
STRING	MF	GO:0005521	lamin binding	-	15	15	-	-	5.52E-03	6.33E-04
STRING	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	19	-	-	1.77E-03	8.44E-04
STRING	MF	GO:0140318	protein transporter activity	-	40	38	-	-	1.04E-02	1.64E-03
STRING	MF	GO:0070628	proteasome binding	-	17	17	-	-	8.01E-03	7.38E-04
STRING	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	2.67E-03	4.75E-04
STRING	MF	GO:0031432	titin binding	-	13	11	-	-	7.60E-03	4.75E-04
STRING	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.45E-02	4.75E-04
STRING	MF	GO:0000217	DNA secondary structure binding	-	37	36	-	-	6.75E-03	1.53E-03
STRING	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	5.44E-02	7.38E-04
STRING	MF	GO:0002039	p53 binding	-	66	64	-	-	4.42E-03	2.74E-03
STRING	MF	GO:0005496	steroid binding	-	110	109	-	-	8.95E-02	4.64E-03
STRING	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	2.11E-02	1.16E-03
STRING	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.32E-02	4.75E-04
STRING	MF	GO:0003684	damaged DNA binding	-	89	85	-	-	5.71E-02	3.59E-03
STRING	MF	GO:0000339	RNA cap binding	-	20	20	-	-	1.55E-02	8.44E-04
STRING	MF	GO:0016500	protein-hormone receptor activity	-	21	19	-	-	9.91E-03	8.44E-04
STRING	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	132	-	-	9.95E-02	5.59E-03
STRING	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	6.28E-02	6.33E-04
STRING	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	3.84E-02	5.27E-04
STRING	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	2.23E-03	4.75E-04
STRING	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	1.34E-02	2.53E-03
STRING	MF	GO:0050811	GABA receptor binding	-	18	17	-	-	4.45E-03	7.38E-04
STRING	MF	GO:0030971	receptor tyrosine kinase binding	-	76	74	-	-	3.68E-02	3.16E-03
STRING	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	82	-	-	6.67E-02	3.48E-03
STRING	MF	GO:0140030	modification-dependent protein binding	-	179	177	-	-	4.10E-02	7.49E-03
STRING	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	4.22E-02	1.05E-03
STRING	MF	GO:0009881	photoreceptor activity	-	17	17	-	-	1.11E-01	7.38E-04
STRING	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	19	-	-	6.10E-02	8.44E-04
STRING	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	8.47E-04	5.80E-04
STRING	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	1.53E-02	6.86E-04
STRING	MF	GO:0141047	molecular tag activity	-	13	12	-	-	1.32E-03	5.27E-04
STRING	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	4.69E-03	4.75E-04
STRING	MF	GO:0033130	acetylcholine receptor binding	-	12	12	-	-	1.31E-02	5.27E-04
STRING	MF	GO:1990226	histone methyltransferase binding	-	15	14	-	-	1.79E-03	6.33E-04
STRING	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	1.14E-02	5.27E-04
STRING	MF	GO:0044548	S100 protein binding	-	14	14	-	-	9.87E-03	6.33E-04
STRING	MF	GO:0010851	cyclase regulator activity	-	17	14	-	-	3.09E-03	6.33E-04
STRING	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.15E-02	6.33E-04
STRING	MF	GO:0030276	clathrin binding	-	70	67	-	-	1.26E-01	2.85E-03
STRING	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	4.41E-02	1.27E-03
STRING	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	1.10E-03	6.33E-04
STRING	MF	GO:0046790	virion binding	-	19	18	-	-	1.27E-02	7.91E-04
STRING	MF	GO:0030552	cAMP binding	-	48	47	-	-	7.76E-03	2.00E-03
STRING	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	38	-	-	2.03E-02	1.64E-03
STRING	MF	GO:0035173	histone kinase activity	-	17	16	-	-	4.70E-03	6.86E-04
STRING	MF	GO:0097602	cullin family protein binding	-	26	26	-	-	9.48E-02	1.11E-03
STRING	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	2.65E-02	5.27E-04
STRING	MF	GO:0016209	antioxidant activity	-	92	87	-	-	3.91E-02	3.69E-03
STRING	MF	GO:0070325	lipoprotein particle receptor binding	-	32	29	-	-	9.37E-03	1.27E-03
STRING	MF	GO:0044325	transmembrane transporter binding	-	159	156	-	-	4.42E-02	6.59E-03
STRING	MF	GO:0048156	tau protein binding	-	43	42	-	-	1.83E-02	1.79E-03
STRING	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	35	-	-	7.81E-03	1.48E-03
STRING	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	6.90E-03	5.80E-04
STRING	MF	GO:0140272	exogenous protein binding	-	79	76	-	-	2.95E-02	3.22E-03
STRING	MF	GO:0030145	manganese ion binding	-	65	65	-	-	1.37E-02	2.74E-03
STRING	MF	GO:0071814	protein-lipid complex binding	-	52	47	-	-	3.79E-02	2.00E-03
STRING	MF	GO:0008066	glutamate receptor activity	-	70	69	-	-	6.24E-02	2.95E-03
STRING	MF	GO:0030553	cGMP binding	-	15	15	-	-	4.29E-02	6.33E-04
STRING	MF	GO:0017069	snRNA binding	-	54	47	-	-	1.51E-02	2.00E-03
STRING	MF	GO:0030215	semaphorin receptor binding	-	23	23	-	-	9.89E-02	1.00E-03
STRING	MF	GO:0031369	translation initiation factor binding	-	32	31	-	-	7.70E-02	1.32E-03
STRING	MF	GO:0019843	rRNA binding	-	69	68	-	-	1.18E-02	2.90E-03
STRING	MF	GO:0004713	protein tyrosine kinase activity	-	213	206	-	-	3.39E-02	8.70E-03
STRING	MF	GO:0061783	peptidoglycan muralytic activity	-	14	14	-	-	7.31E-02	6.33E-04
STRING	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	52	-	-	1.72E-02	2.22E-03
STRING	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	1.66E-03	1.05E-03
STRING	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	6.19E-04	8.44E-04
STRING	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	28	-	-	7.52E-03	1.21E-03
STRING	MF	GO:0016208	AMP binding	-	22	22	-	-	2.33E-03	9.49E-04
STRING	MF	GO:0000287	magnesium ion binding	-	225	220	-	-	1.20E-02	9.28E-03
STRING	MF	GO:0031490	chromatin DNA binding	-	120	118	-	-	1.18E-02	5.01E-03
STRING	MF	GO:0017022	myosin binding	-	73	73	-	-	2.25E-02	3.11E-03
STRING	MF	GO:0004896	cytokine receptor activity	-	93	90	-	-	8.14E-02	3.80E-03
STRING	MF	GO:0017166	vinculin binding	-	12	11	-	-	5.71E-03	4.75E-04
STRING	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	3.09E-03	7.91E-04
STRING	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	1.72E-03	5.27E-04
STRING	MF	GO:0005539	glycosaminoglycan binding	-	236	230	-	-	3.55E-02	9.70E-03
STRING	MF	GO:0140666	annealing activity	-	11	11	-	-	1.39E-03	4.75E-04
STRING	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.60E-02	6.33E-04
STRING	MF	GO:0010181	FMN binding	-	15	15	-	-	7.49E-03	6.33E-04
STRING	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	20	-	-	8.91E-02	8.44E-04
STRING	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	26	-	-	1.96E-02	1.11E-03
STRING	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	9.47E-04	7.38E-04
STRING	MF	GO:0044183	protein folding chaperone	-	67	58	-	-	5.92E-03	2.48E-03
STRING	MF	GO:0005132	type I interferon receptor binding	-	17	17	-	-	6.51E-02	7.38E-04
STRING	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	105	-	-	3.14E-02	4.43E-03
STRING	MF	GO:0003725	double-stranded RNA binding	-	72	69	-	-	1.94E-02	2.95E-03
STRING	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	2.22E-02	6.86E-04
STRING	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	4.98E-02	2.22E-03
STRING	MF	GO:0071889	14-3-3 protein binding	-	34	34	-	-	1.22E-03	1.48E-03
STRING	MF	GO:0004618	phosphoglycerate kinase activity	-	89	87	-	-	2.24E-02	3.69E-03
STRING	MF	GO:0042805	actinin binding	-	36	34	-	-	1.46E-02	1.48E-03
STRING	MF	GO:0043531	ADP binding	-	38	37	-	-	1.63E-03	1.58E-03
STRING	MF	GO:0043394	proteoglycan binding	-	36	36	-	-	8.23E-03	1.53E-03
STRING	MF	GO:0005542	folic acid binding	-	13	12	-	-	5.05E-02	5.27E-04
STRING	MF	GO:0046332	SMAD binding	-	77	76	-	-	2.70E-02	3.22E-03
STRING	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	1.42E-03	5.80E-04
STRING	MF	GO:0001968	fibronectin binding	-	30	29	-	-	6.64E-03	1.27E-03
STRING	MF	GO:0048038	quinone binding	-	16	16	-	-	1.24E-02	6.86E-04
STRING	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	118	-	-	7.57E-02	5.01E-03
STRING	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	79	-	-	1.04E-02	3.38E-03
STRING	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	1.72E-02	7.91E-04
STRING	MF	GO:0051117	ATPase binding	-	85	83	-	-	5.76E-03	3.53E-03
STRING	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	45	-	-	3.99E-03	1.90E-03
STRING	MF	GO:0051787	misfolded protein binding	-	20	20	-	-	1.35E-02	8.44E-04
STRING	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.40E-03	6.33E-04
STRING	MF	GO:0031404	chloride ion binding	-	14	13	-	-	1.21E-03	5.80E-04
STRING	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	8.06E-03	2.58E-03
STRING	MF	GO:0036002	pre-mRNA binding	-	57	35	-	-	2.16E-02	1.48E-03
STRING	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	38	-	-	1.70E-02	1.64E-03
STRING	MF	GO:0051540	metal cluster binding	-	71	69	-	-	5.65E-02	2.95E-03
STRING	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	7.77E-04	4.75E-04
STRING	MF	GO:0051219	phosphoprotein binding	-	92	89	-	-	1.69E-02	3.80E-03
STRING	MF	GO:0019894	kinesin binding	-	45	45	-	-	2.14E-02	1.90E-03
STRING	MF	GO:0042287	MHC protein binding	-	68	55	-	-	3.91E-02	2.32E-03
STRING	MF	GO:0019003	GDP binding	-	89	86	-	-	1.66E-02	3.64E-03
STRING	MF	GO:0017171	serine hydrolase activity	-	207	199	-	-	1.80E-01	8.44E-03
STRING	MF	GO:0097110	scaffold protein binding	-	66	66	-	-	4.12E-03	2.80E-03
STRING	MF	GO:0003774	cytoskeletal motor activity	-	117	112	-	-	7.82E-02	4.75E-03
STRING	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	28	-	-	1.26E-03	1.21E-03
STRING	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	16	-	-	2.60E-02	6.86E-04
STRING	MF	GO:0061134	peptidase regulator activity	-	224	212	-	-	1.14E-01	8.97E-03
STRING	MF	GO:0008013	beta-catenin binding	-	86	84	-	-	2.43E-02	3.59E-03
STRING	MF	GO:0051015	actin filament binding	-	208	204	-	-	6.59E-02	8.65E-03
STRING	MF	GO:0019208	phosphatase regulator activity	-	107	102	-	-	7.72E-02	4.32E-03
STRING	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	32	-	-	1.60E-01	1.37E-03
STRING	MF	GO:0043236	laminin binding	-	29	27	-	-	5.46E-03	1.16E-03
STRING	MF	GO:0030507	spectrin binding	-	26	26	-	-	1.37E-02	1.11E-03
STRING	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	42	-	-	3.89E-03	1.79E-03
STRING	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	111	-	-	7.08E-02	4.69E-03
STRING	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	9.83E-03	1.05E-03
STRING	MF	GO:0042393	histone binding	-	240	234	-	-	5.02E-02	9.92E-03
STRING	MF	GO:0019838	growth factor binding	-	182	178	-	-	2.54E-02	7.54E-03
STRING	MF	GO:0000149	SNARE binding	-	107	106	-	-	1.53E-01	4.48E-03
STRING	MF	GO:0003727	single-stranded RNA binding	-	90	85	-	-	1.75E-02	3.59E-03
STRING	MF	GO:0051378	serotonin binding	-	24	24	-	-	5.78E-02	1.05E-03
STRING	MF	GO:0005516	calmodulin binding	-	206	204	-	-	1.83E-02	8.65E-03
STRING	MF	GO:0019825	oxygen binding	-	40	39	-	-	1.30E-02	1.69E-03
STRING	MF	GO:0045505	dynein intermediate chain binding	-	37	37	-	-	3.82E-02	1.58E-03
STRING	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	86	-	-	2.08E-02	3.64E-03
STRING	MF	GO:0032182	ubiquitin-like protein binding	-	117	117	-	-	4.69E-02	4.96E-03
STRING	MF	GO:0023023	MHC protein complex binding	-	36	34	-	-	1.56E-02	1.48E-03
STRING	MF	GO:0030742	GTP-dependent protein binding	-	22	20	-	-	8.73E-03	8.44E-04
STRING	MF	GO:0043274	phospholipase binding	-	23	22	-	-	9.50E-04	9.49E-04
STRING	MF	GO:0031072	heat shock protein binding	-	128	125	-	-	2.51E-02	5.27E-03
STRING	MF	GO:0030515	snoRNA binding	-	33	33	-	-	9.18E-03	1.42E-03
STRING	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	80	-	-	3.83E-01	3.38E-03
STRING	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	23	-	-	1.30E-01	1.00E-03
STRING	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	1.54E-02	1.11E-03
STRING	MF	GO:0001530	lipopolysaccharide binding	-	38	37	-	-	1.65E-02	1.58E-03
STRING	MF	GO:0140223	general transcription initiation factor activity	-	55	51	-	-	6.98E-02	2.16E-03
STRING	MF	GO:0070403	NAD+ binding	-	16	16	-	-	4.00E-03	6.86E-04
STRING	MF	GO:0000049	tRNA binding	-	75	75	-	-	5.09E-02	3.16E-03
STRING	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	42	-	-	1.28E-02	1.79E-03
STRING	MF	GO:0015026	coreceptor activity	-	48	48	-	-	1.13E-02	2.06E-03
STRING	MF	GO:0005527	macrolide binding	-	12	11	-	-	1.79E-03	4.75E-04
STRING	MF	GO:0001653	peptide receptor activity	-	128	120	-	-	1.18E-01	5.06E-03
STRING	MF	GO:0031005	filamin binding	-	15	14	-	-	1.49E-02	6.33E-04
STRING	MF	GO:0030506	ankyrin binding	-	19	19	-	-	9.69E-03	8.44E-04
STRING	MF	GO:0006469	negative regulation of protein kinase activity	-	222	209	-	-	1.33E-02	8.86E-03
STRING	MF	GO:0070182	DNA polymerase binding	-	22	19	-	-	7.79E-03	8.44E-04
STRING	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	9.69E-04	6.33E-04
STRING	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	30	-	-	5.37E-03	1.27E-03
STRING	MF	GO:0051427	hormone receptor binding	-	31	31	-	-	2.68E-02	1.32E-03
STRING	MF	GO:0070851	growth factor receptor binding	-	141	139	-	-	3.50E-02	5.91E-03
STRING	MF	GO:0031210	phosphatidylcholine binding	-	32	30	-	-	8.57E-03	1.27E-03
STRING	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	5.75E-03	4.75E-04
STRING	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	41	-	-	1.21E-02	1.74E-03
STRING	MF	GO:0034185	apolipoprotein binding	-	20	20	-	-	9.99E-03	8.44E-04
STRING	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	17	-	-	1.99E-02	7.38E-04
STRING	MF	GO:0005506	iron ion binding	-	154	149	-	-	5.04E-02	6.33E-03
STRING	MF	GO:0003925	G protein activity	-	45	42	-	-	2.35E-03	1.79E-03
STRING	MF	GO:0038187	pattern recognition receptor activity	-	33	32	-	-	2.74E-02	1.37E-03
STRING	MF	GO:0008276	protein methyltransferase activity	-	96	93	-	-	1.39E-01	3.96E-03
STRING	MF	GO:0004396	hexokinase activity	-	16	16	-	-	1.75E-02	6.86E-04
STRING	MF	GO:0070888	E-box binding	-	59	58	-	-	4.31E-02	2.48E-03
STRING	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.09E-02	6.33E-04
STRING	MF	GO:0015399	primary active transmembrane transporter activity	-	190	187	-	-	6.23E-02	7.91E-03
STRING	MF	GO:0035254	glutamate receptor binding	-	47	47	-	-	1.11E-02	2.00E-03
STRING	MF	GO:0050321	tau-protein kinase activity	-	36	32	-	-	2.81E-02	1.37E-03
STRING	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	3.69E-03	4.75E-04
STRING	MF	GO:0043021	ribonucleoprotein complex binding	-	158	157	-	-	1.61E-02	6.65E-03
STRING	MF	GO:0030170	pyridoxal phosphate binding	-	56	54	-	-	5.38E-02	2.32E-03
STRING	MF	GO:0032393	MHC class I receptor activity	-	15	12	-	-	3.74E-02	5.27E-04
STRING	MF	GO:0005112	Notch binding	-	26	26	-	-	8.38E-03	1.11E-03
STRING	MF	GO:0048185	activin binding	-	16	16	-	-	1.73E-02	6.86E-04
STRING	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	27	-	-	8.23E-03	1.16E-03
STRING	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	6.57E-03	4.75E-04
STRING	MF	GO:0140299	small molecule sensor activity	-	39	35	-	-	6.21E-03	1.48E-03
STRING	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	3.58E-03	9.49E-04
STRING	MF	GO:0016917	GABA receptor activity	-	23	22	-	-	4.41E-02	9.49E-04
STRING	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	14	-	-	9.77E-03	6.33E-04
STRING	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	25	-	-	5.87E-01	1.05E-03
STRING	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	44	-	-	2.31E-02	1.90E-03
STRING	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	1.21E-03	1.05E-03
STRING	MF	GO:0008527	taste receptor activity	-	28	26	-	-	2.53E-01	1.11E-03
STRING	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	1.20E-03	5.27E-04
STRING	MF	GO:0030594	neurotransmitter receptor activity	-	160	157	-	-	3.94E-01	6.65E-03
STRING	MF	GO:0034452	dynactin binding	-	12	12	-	-	7.16E-03	5.27E-04
STRING	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	7.23E-02	1.05E-03
STRING	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	6.81E-02	8.97E-04
STRING	MF	GO:0005507	copper ion binding	-	63	59	-	-	2.55E-02	2.53E-03
STRING	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	5.85E-03	9.49E-04
STRING	MF	GO:0008046	axon guidance receptor activity	-	11	11	-	-	1.95E-03	4.75E-04
STRING	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	2.72E-02	9.49E-04
STRING	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	9.01E-02	5.27E-04
TFLink	CC	GO:0005739	mitochondrion	5.21E-13	1671	1655	1609	1.03	-	-
TFLink	CC	GO:0005783	endoplasmic reticulum	8.29E-09	2020	1987	1945	1.02	-	-
TFLink	CC	GO:0005764	lysosome	5.69E-07	747	741	719	1.03	-	-
TFLink	CC	GO:0005794	Golgi apparatus	5.74E-06	1636	1606	1575	1.02	-	-
TFLink	CC	GO:0005768	endosome	1.02E-05	1037	1022	998	1.02	-	-
TFLink	CC	GO:0005815	microtubule organizing center	8.08E-05	843	831	812	1.02	-	-
TFLink	CC	GO:0005730	nucleolus	9.43E-05	988	972	951	1.02	-	-
TFLink	CC	GO:0005929	cilium	5.10E-03	842	825	811	1.02	-	-
TFLink	CC	GO:0031012	extracellular matrix	9.17E-03	564	554	543	1.02	-	-
TFLink	CC	GO:0000228	nuclear chromosome	3.85E-02	206	204	198	1.03	-	-
TFLink	CC	GO:0005635	nuclear envelope	4.03E-02	493	483	475	1.02	-	-
TFLink	CC	GO:0005777	peroxisome	6.93E-02	142	141	137	1.03	-	-
TFLink	CC	GO:0005840	ribosome	7.12E-02	222	219	214	1.02	-	-
TFLink	CC	GO:0005615	extracellular space	8.13E-02	3190	3088	3071	1.01	-	-
TFLink	CC	GO:0005811	lipid droplet	1.89E-01	102	101	98	1.03	-	-
TFLink	BP	GO:0055085	transmembrane transport	4.85E-14	1784	1767	1717	1.03	-	-
TFLink	BP	GO:0016192	vesicle-mediated transport	6.54E-12	1894	1871	1823	1.03	-	-
TFLink	BP	GO:0032200	telomere organization	6.46E-11	186	157	179	0.88	-	-
TFLink	BP	GO:0007155	cell adhesion	1.15E-10	1444	1429	1390	1.03	-	-
TFLink	BP	GO:0048870	cell motility	3.06E-08	1659	1634	1597	1.02	-	-
TFLink	BP	GO:0012501	programmed cell death	9.70E-08	1954	1920	1881	1.02	-	-
TFLink	BP	GO:0006325	chromatin organization	2.00E-07	720	664	693	0.96	-	-
TFLink	BP	GO:0006914	autophagy	2.04E-07	568	566	547	1.04	-	-
TFLink	BP	GO:0006629	lipid metabolic process	2.14E-07	1355	1336	1304	1.02	-	-
TFLink	BP	GO:0006886	intracellular protein transport	3.30E-07	664	660	639	1.03	-	-
TFLink	BP	GO:0007010	cytoskeleton organization	3.67E-07	1639	1612	1578	1.02	-	-
TFLink	BP	GO:0034330	cell junction organization	1.14E-06	727	721	700	1.03	-	-
TFLink	BP	GO:0006091	generation of precursor metabolites and energy	1.84E-06	502	500	483	1.03	-	-
TFLink	BP	GO:0007018	microtubule-based movement	3.58E-06	640	635	616	1.03	-	-
TFLink	BP	GO:0006954	inflammatory response	1.78E-05	820	810	789	1.03	-	-
TFLink	BP	GO:0042060	wound healing	2.52E-05	431	429	415	1.03	-	-
TFLink	BP	GO:0055086	nucleobase-containing small molecule metabolic process	5.67E-05	729	720	702	1.03	-	-
TFLink	BP	GO:0007005	mitochondrion organization	1.27E-04	484	480	466	1.03	-	-
TFLink	BP	GO:0030198	extracellular matrix organization	1.31E-04	314	313	302	1.04	-	-
TFLink	BP	GO:0072659	protein localization to plasma membrane	4.04E-04	284	283	273	1.04	-	-
TFLink	BP	GO:0044782	cilium organization	4.07E-04	399	396	384	1.03	-	-
TFLink	BP	GO:0006260	DNA replication	6.13E-04	279	278	269	1.04	-	-
TFLink	BP	GO:0003013	circulatory system process	8.20E-04	584	576	562	1.02	-	-
TFLink	BP	GO:0140053	mitochondrial gene expression	3.16E-03	164	164	158	1.04	-	-
TFLink	BP	GO:0005975	carbohydrate metabolic process	5.81E-03	551	542	530	1.02	-	-
TFLink	BP	GO:0006520	amino acid metabolic process	7.78E-03	292	289	281	1.03	-	-
TFLink	BP	GO:0006355	regulation of DNA-templated transcription	1.18E-02	3342	3242	3217	1.01	-	-
TFLink	BP	GO:0006281	DNA repair	1.43E-02	587	576	565	1.02	-	-
TFLink	BP	GO:0140013	meiotic nuclear division	1.54E-02	279	276	269	1.03	-	-
TFLink	BP	GO:0030163	protein catabolic process	1.55E-02	990	967	953	1.01	-	-
TFLink	BP	GO:0003014	renal system process	1.59E-02	127	127	122	1.04	-	-
TFLink	BP	GO:0003012	muscle system process	1.89E-02	425	418	409	1.02	-	-
TFLink	BP	GO:0006486	protein glycosylation	1.94E-02	225	223	217	1.03	-	-
TFLink	BP	GO:0007163	establishment or maintenance of cell polarity	1.97E-02	227	225	219	1.03	-	-
TFLink	BP	GO:0065003	protein-containing complex assembly	2.06E-02	1648	1569	1586	0.99	-	-
TFLink	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	2.43E-02	119	119	115	1.04	-	-
TFLink	BP	GO:0006310	DNA recombination	2.74E-02	333	328	321	1.02	-	-
TFLink	BP	GO:0042254	ribosome biogenesis	2.87E-02	297	293	286	1.02	-	-
TFLink	BP	GO:0006766	vitamin metabolic process	3.56E-02	107	107	103	1.04	-	-
TFLink	BP	GO:0006913	nucleocytoplasmic transport	3.70E-02	326	321	314	1.02	-	-
TFLink	BP	GO:0007059	chromosome segregation	6.22E-02	403	395	388	1.02	-	-
TFLink	BP	GO:0002376	immune system process	8.60E-02	2448	2372	2357	1.01	-	-
TFLink	BP	GO:0006790	sulfur compound metabolic process	9.88E-02	320	314	308	1.02	-	-
TFLink	BP	GO:0006399	tRNA metabolic process	1.26E-01	196	193	189	1.02	-	-
TFLink	BP	GO:0007040	lysosome organization	1.93E-01	107	106	103	1.03	-	-
TFLink	BP	GO:0098542	defense response to other organism	2.64E-01	1171	1120	1127	0.99	-	-
TFLink	BP	GO:0006575	cellular modified amino acid metabolic process	3.30E-01	186	182	179	1.02	-	-
TFLink	BP	GO:0002181	cytoplasmic translation	3.86E-01	153	150	147	1.02	-	-
TFLink	BP	GO:0016071	mRNA metabolic process	4.20E-01	713	691	686	1.01	-	-
TFLink	BP	GO:0000910	cytokinesis	4.32E-01	186	177	179	0.99	-	-
TFLink	BP	GO:0022600	digestive system process	4.45E-01	110	108	106	1.02	-	-
TFLink	BP	GO:0050877	nervous system process	7.78E-01	1527	1468	1470	1.00	-	-
TFLink	BP	GO:0098754	detoxification	8.21E-01	134	130	129	1.01	-	-
TFLink	BP	GO:0006457	protein folding	1.00E+00	210	203	202	1.00	-	-
TFLink	MF	GO:0005215	transporter activity	3.80E-09	1462	1444	1407	1.03	-	-
TFLink	MF	GO:0005198	structural molecule activity	8.52E-09	798	734	768	0.96	-	-
TFLink	MF	GO:0016740	transferase activity	4.00E-08	3074	3009	2959	1.02	-	-
TFLink	MF	GO:0140657	ATP-dependent activity	2.23E-07	729	724	702	1.03	-	-
TFLink	MF	GO:0008092	cytoskeletal protein binding	2.35E-06	1023	1010	985	1.03	-	-
TFLink	MF	GO:0016491	oxidoreductase activity	7.19E-06	888	877	855	1.03	-	-
TFLink	MF	GO:0008289	lipid binding	2.44E-04	836	823	805	1.02	-	-
TFLink	MF	GO:0140096	"catalytic activity, acting on a protein"	3.26E-04	3198	3113	3079	1.01	-	-
TFLink	MF	GO:0016829	lyase activity	1.10E-03	538	531	518	1.03	-	-
TFLink	MF	GO:0009975	cyclase activity	3.49E-03	277	275	267	1.03	-	-
TFLink	MF	GO:0140098	"catalytic activity, acting on RNA"	2.50E-02	417	410	401	1.02	-	-
TFLink	MF	GO:0016874	ligase activity	3.80E-02	283	279	272	1.02	-	-
TFLink	MF	GO:0045182	translation regulator activity	4.78E-02	151	150	145	1.03	-	-
TFLink	MF	GO:0003924	GTPase activity	7.49E-02	658	642	633	1.01	-	-
TFLink	MF	GO:0140097	"catalytic activity, acting on DNA"	1.00E-01	383	375	369	1.02	-	-
TFLink	MF	GO:0003677	DNA binding	1.08E-01	2865	2743	2758	0.99	-	-
TFLink	MF	GO:0003723	RNA binding	1.21E-01	1679	1628	1616	1.01	-	-
TFLink	MF	GO:0003774	cytoskeletal motor activity	1.35E-01	116	115	112	1.03	-	-
TFLink	MF	GO:0016853	isomerase activity	1.78E-01	252	247	243	1.02	-	-
TFLink	MF	GO:0140110	transcription regulator activity	2.39E-01	2033	1967	1957	1.01	-	-
TFLink	MF	GO:0038024	cargo receptor activity	3.31E-01	117	115	113	1.02	-	-
TFLink	MF	GO:0140104	molecular carrier activity	4.43E-01	105	103	101	1.02	-	-
TFLink	MF	GO:0042393	histone binding	6.06E-01	237	227	228	0.99	-	-
TFLink	MF	GO:0048018	receptor ligand activity	1.00E+00	504	486	485	1.00	-	-
TFLink	BP	GO:0008038	neuron recognition	-	46	46	-	-	5.52E-04	1.99E-03
TFLink	BP	GO:1905145	cellular response to acetylcholine	-	33	32	-	-	3.60E-04	1.40E-03
TFLink	BP	GO:0097094	craniofacial suture morphogenesis	-	18	18	-	-	2.40E-04	8.07E-04
TFLink	BP	GO:0098780	response to mitochondrial depolarisation	-	21	21	-	-	3.26E-04	9.15E-04
TFLink	BP	GO:0051931	regulation of sensory perception	-	36	36	-	-	5.46E-04	1.56E-03
TFLink	BP	GO:0110110	positive regulation of animal organ morphogenesis	-	25	25	-	-	2.81E-04	1.08E-03
TFLink	BP	GO:0070571	negative regulation of neuron projection regeneration	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	BP	GO:0060049	regulation of protein glycosylation	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	BP	GO:0009268	response to pH	-	43	43	-	-	7.23E-04	1.88E-03
TFLink	BP	GO:0045666	positive regulation of neuron differentiation	-	91	86	-	-	9.34E-04	3.71E-03
TFLink	BP	GO:0043543	protein acylation	-	107	102	-	-	1.14E-03	4.41E-03
TFLink	MF	GO:0051349	positive regulation of lyase activity	-	41	39	-	-	4.11E-04	1.72E-03
TFLink	BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	-	14	14	-	-	1.56E-04	6.46E-04
TFLink	BP	GO:0048679	regulation of axon regeneration	-	28	25	-	-	1.24E-03	1.08E-03
TFLink	BP	GO:0022401	negative adaptation of signaling pathway	-	21	21	-	-	5.02E-04	9.15E-04
TFLink	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	140	-	-	1.48E-03	6.03E-03
TFLink	BP	GO:0071763	nuclear membrane organization	-	44	42	-	-	6.33E-04	1.83E-03
TFLink	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	35	-	-	5.70E-04	1.51E-03
TFLink	BP	GO:0071806	protein transmembrane transport	-	68	67	-	-	7.81E-04	2.90E-03
TFLink	BP	GO:0022038	corpus callosum development	-	25	25	-	-	3.08E-04	1.08E-03
TFLink	BP	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0021548	pons development	-	11	11	-	-	8.20E-04	4.84E-04
TFLink	BP	GO:0002759	regulation of antimicrobial humoral response	-	12	12	-	-	4.33E-04	5.38E-04
TFLink	BP	GO:0043299	leukocyte degranulation	-	82	82	-	-	1.66E-03	3.55E-03
TFLink	BP	GO:0048864	stem cell development	-	88	88	-	-	1.30E-03	3.82E-03
TFLink	BP	GO:0009310	amine catabolic process	-	20	16	-	-	2.05E-04	6.99E-04
TFLink	BP	GO:0051651	maintenance of location in cell	-	236	224	-	-	2.76E-03	9.68E-03
TFLink	BP	GO:0033119	negative regulation of RNA splicing	-	27	27	-	-	5.51E-04	1.18E-03
TFLink	BP	GO:0014004	microglia differentiation	-	12	12	-	-	5.29E-04	5.38E-04
TFLink	BP	GO:0072525	pyridine-containing compound biosynthetic process	-	31	31	-	-	3.59E-04	1.34E-03
TFLink	BP	GO:1905962	glutamatergic neuron differentiation	-	14	14	-	-	1.42E-04	6.46E-04
TFLink	BP	GO:0001833	inner cell mass cell proliferation	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0046415	urate metabolic process	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	30	-	-	3.61E-04	1.29E-03
TFLink	BP	GO:0006949	syncytium formation	-	66	65	-	-	1.57E-03	2.80E-03
TFLink	BP	GO:0045176	apical protein localization	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	BP	GO:0043144	sno(s)RNA processing	-	14	13	-	-	5.70E-04	5.92E-04
TFLink	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	55	-	-	6.16E-04	2.37E-03
TFLink	BP	GO:0030574	collagen catabolic process	-	45	45	-	-	5.14E-04	1.94E-03
TFLink	CC	GO:0006984	ER-nucleus signaling pathway	-	46	45	-	-	5.24E-04	1.94E-03
TFLink	BP	GO:0060343	trabecula formation	-	26	26	-	-	3.03E-04	1.13E-03
TFLink	BP	GO:0010561	negative regulation of glycoprotein biosynthetic process	-	25	12	-	-	4.84E-04	5.38E-04
TFLink	BP	GO:0140112	extracellular vesicle biogenesis	-	23	23	-	-	2.56E-04	1.02E-03
TFLink	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	16	-	-	2.05E-04	6.99E-04
TFLink	BP	GO:1900424	regulation of defense response to bacterium	-	21	18	-	-	1.10E-03	8.07E-04
TFLink	BP	GO:0085029	extracellular matrix assembly	-	42	41	-	-	4.80E-04	1.78E-03
TFLink	BP	GO:0006413	translational initiation	-	122	119	-	-	1.39E-03	5.16E-03
TFLink	BP	GO:0072176	nephric duct development	-	15	15	-	-	3.89E-04	6.46E-04
TFLink	BP	GO:1902895	positive regulation of miRNA transcription	-	51	51	-	-	3.66E-04	2.21E-03
TFLink	CC	GO:0005200	structural constituent of cytoskeleton	-	112	107	-	-	1.34E-03	4.63E-03
TFLink	BP	GO:0030865	cortical cytoskeleton organization	-	51	51	-	-	5.62E-04	2.21E-03
TFLink	BP	GO:0045348	positive regulation of MHC class II biosynthetic process	-	14	14	-	-	4.71E-04	6.46E-04
TFLink	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	25	-	-	4.33E-04	1.08E-03
TFLink	BP	GO:1903036	positive regulation of response to wounding	-	76	70	-	-	8.21E-04	3.01E-03
TFLink	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	21	-	-	2.56E-04	9.15E-04
TFLink	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	228	-	-	2.28E-03	9.84E-03
TFLink	BP	GO:1903319	positive regulation of protein maturation	-	27	27	-	-	4.40E-04	1.18E-03
TFLink	BP	GO:0032528	microvillus organization	-	24	24	-	-	7.31E-04	1.08E-03
TFLink	BP	GO:0021954	central nervous system neuron development	-	85	85	-	-	1.15E-03	3.66E-03
TFLink	BP	GO:0055017	cardiac muscle tissue growth	-	92	74	-	-	8.39E-04	3.23E-03
TFLink	BP	GO:0010743	regulation of macrophage derived foam cell differentiation	-	32	31	-	-	9.03E-04	1.34E-03
TFLink	BP	GO:2001053	regulation of mesenchymal cell apoptotic process	-	13	13	-	-	2.78E-04	5.92E-04
TFLink	BP	GO:0048524	positive regulation of viral process	-	64	64	-	-	8.43E-04	2.80E-03
TFLink	CC	GO:0043950	positive regulation of cAMP-mediated signaling	-	14	14	-	-	1.56E-04	6.46E-04
TFLink	CC	GO:0007213	G protein-coupled acetylcholine receptor signaling pathway	-	21	21	-	-	2.58E-04	9.15E-04
TFLink	BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	-	25	22	-	-	2.98E-04	9.68E-04
TFLink	BP	GO:0001946	lymphangiogenesis	-	18	17	-	-	5.26E-04	7.53E-04
TFLink	BP	GO:0098661	inorganic anion transmembrane transport	-	140	139	-	-	1.69E-03	6.03E-03
TFLink	BP	GO:0006099	tricarboxylic acid cycle	-	33	33	-	-	3.58E-04	1.45E-03
TFLink	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	18	-	-	1.73E-04	8.07E-04
TFLink	BP	GO:0009612	response to mechanical stimulus	-	215	214	-	-	2.86E-03	9.25E-03
TFLink	BP	GO:0048644	muscle organ morphogenesis	-	81	78	-	-	1.51E-03	3.39E-03
TFLink	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	140	-	-	1.68E-03	6.03E-03
TFLink	BP	GO:1905874	regulation of postsynaptic density organization	-	13	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0071542	dopaminergic neuron differentiation	-	36	36	-	-	6.81E-04	1.56E-03
TFLink	BP	GO:0140115	export across plasma membrane	-	82	64	-	-	1.30E-03	2.80E-03
TFLink	CC	GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway	-	12	12	-	-	1.16E-04	5.38E-04
TFLink	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	38	-	-	4.09E-04	1.67E-03
TFLink	BP	GO:0035588	G protein-coupled purinergic receptor signaling pathway	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:1901653	cellular response to peptide	-	11	11	-	-	4.37E-04	4.84E-04
TFLink	MF	GO:0072349	modified amino acid transmembrane transporter activity	-	29	29	-	-	3.08E-04	1.29E-03
TFLink	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	42	-	-	4.92E-04	1.83E-03
TFLink	MF	GO:0003714	transcription corepressor activity	-	190	184	-	-	1.43E-03	7.96E-03
TFLink	BP	GO:0035878	nail development	-	11	11	-	-	1.53E-04	4.84E-04
TFLink	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	54	-	-	1.42E-03	2.37E-03
TFLink	BP	GO:0061101	neuroendocrine cell differentiation	-	16	16	-	-	2.72E-04	6.99E-04
TFLink	CC	GO:0006858	extracellular transport	-	45	45	-	-	2.57E-02	1.94E-03
TFLink	BP	GO:0006304	DNA modification	-	30	29	-	-	5.53E-04	1.29E-03
TFLink	MF	GO:0140312	cargo adaptor activity	-	19	18	-	-	2.05E-04	8.07E-04
TFLink	BP	GO:0046835	carbohydrate phosphorylation	-	49	49	-	-	5.00E-04	2.15E-03
TFLink	BP	GO:0060149	negative regulation of post-transcriptional gene silencing	-	23	18	-	-	1.70E-04	8.07E-04
TFLink	BP	GO:0003207	cardiac chamber formation	-	14	14	-	-	1.65E-04	6.46E-04
TFLink	MF	GO:0015144	carbohydrate transmembrane transporter activity	-	43	40	-	-	4.63E-04	1.72E-03
TFLink	BP	GO:0070417	cellular response to cold	-	13	13	-	-	2.15E-04	5.92E-04
TFLink	BP	GO:0043523	regulation of neuron apoptotic process	-	218	212	-	-	2.23E-03	9.15E-03
TFLink	BP	GO:1902894	negative regulation of miRNA transcription	-	22	22	-	-	1.78E-04	9.68E-04
TFLink	BP	GO:0075294	positive regulation by symbiont of entry into host	-	14	14	-	-	4.78E-04	6.46E-04
TFLink	BP	GO:0044380	protein localization to cytoskeleton	-	57	57	-	-	6.53E-04	2.47E-03
TFLink	BP	GO:0051918	negative regulation of fibrinolysis	-	13	13	-	-	6.42E-04	5.92E-04
TFLink	BP	GO:2000209	regulation of anoikis	-	25	24	-	-	2.78E-04	1.08E-03
TFLink	BP	GO:0014029	neural crest formation	-	15	15	-	-	7.22E-04	6.46E-04
TFLink	BP	GO:0003299	muscle hypertrophy in response to stress	-	31	23	-	-	3.04E-04	1.02E-03
TFLink	BP	GO:0045747	positive regulation of Notch signaling pathway	-	45	40	-	-	6.39E-04	1.72E-03
TFLink	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	67	-	-	7.20E-04	2.90E-03
TFLink	BP	GO:0003188	heart valve formation	-	16	16	-	-	5.92E-04	6.99E-04
TFLink	CC	GO:0045324	late endosome to vacuole transport	-	37	35	-	-	4.09E-04	1.51E-03
TFLink	BP	GO:0043954	cellular component maintenance	-	72	71	-	-	9.34E-04	3.07E-03
TFLink	BP	GO:0050435	amyloid-beta metabolic process	-	65	51	-	-	5.82E-04	2.21E-03
TFLink	BP	GO:0014823	response to activity	-	70	69	-	-	1.18E-03	3.01E-03
TFLink	BP	GO:0010522	regulation of calcium ion transport into cytosol	-	18	18	-	-	3.01E-04	8.07E-04
TFLink	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	28	-	-	3.07E-04	1.24E-03
TFLink	BP	GO:0034502	protein localization to chromosome	-	130	112	-	-	7.74E-04	4.84E-03
TFLink	BP	GO:0090184	positive regulation of kidney development	-	11	11	-	-	1.52E-04	4.84E-04
TFLink	BP	GO:0016479	negative regulation of transcription by RNA polymerase I	-	11	11	-	-	2.88E-04	4.84E-04
TFLink	BP	GO:0060457	negative regulation of digestive system process	-	17	17	-	-	2.93E-03	7.53E-04
TFLink	BP	GO:0019233	sensory perception of pain	-	103	103	-	-	1.63E-03	4.47E-03
TFLink	CC	GO:0043574	peroxisomal transport	-	22	22	-	-	3.39E-04	9.68E-04
TFLink	BP	GO:0031343	positive regulation of cell killing	-	75	72	-	-	2.55E-03	3.12E-03
TFLink	BP	GO:0090077	foam cell differentiation	-	39	38	-	-	9.49E-04	1.67E-03
TFLink	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	128	-	-	1.91E-03	5.54E-03
TFLink	BP	GO:0017148	negative regulation of translation	-	390	117	-	-	1.48E-03	5.06E-03
TFLink	BP	GO:0030220	platelet formation	-	22	22	-	-	4.77E-04	9.68E-04
TFLink	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	81	-	-	1.29E-03	3.50E-03
TFLink	MF	GO:1903624	regulation of DNA catabolic process	-	14	13	-	-	4.69E-04	5.92E-04
TFLink	BP	GO:1901142	insulin metabolic process	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0007216	G protein-coupled glutamate receptor signaling pathway	-	14	14	-	-	1.55E-04	6.46E-04
TFLink	BP	GO:1903509	liposaccharide metabolic process	-	109	109	-	-	1.27E-03	4.73E-03
TFLink	BP	GO:0009582	detection of abiotic stimulus	-	140	135	-	-	2.19E-03	5.81E-03
TFLink	BP	GO:0045683	negative regulation of epidermis development	-	13	13	-	-	6.46E-04	5.92E-04
TFLink	MF	GO:0005326	neurotransmitter transmembrane transporter activity	-	19	19	-	-	2.07E-04	8.61E-04
TFLink	CC	GO:0140238	presynaptic endocytosis	-	72	70	-	-	1.05E-03	3.01E-03
TFLink	BP	GO:0051236	establishment of RNA localization	-	161	155	-	-	1.59E-03	6.67E-03
TFLink	BP	GO:0042178	xenobiotic catabolic process	-	26	26	-	-	1.08E-01	1.13E-03
TFLink	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	16	-	-	2.06E-04	6.99E-04
TFLink	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	190	-	-	2.16E-03	8.18E-03
TFLink	BP	GO:0034067	protein localization to Golgi apparatus	-	30	30	-	-	3.59E-04	1.29E-03
TFLink	BP	GO:0061842	microtubule organizing center localization	-	32	32	-	-	5.89E-04	1.40E-03
TFLink	BP	GO:0038003	G protein-coupled opioid receptor signaling pathway	-	11	11	-	-	1.56E-04	4.84E-04
TFLink	BP	GO:0061311	cell surface receptor signaling pathway involved in heart development	-	17	17	-	-	4.10E-04	7.53E-04
TFLink	MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	-	52	49	-	-	5.15E-04	2.15E-03
TFLink	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	38	-	-	4.75E-04	1.67E-03
TFLink	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	52	-	-	6.10E-04	2.26E-03
TFLink	BP	GO:0070071	proton-transporting two-sector ATPase complex assembly	-	16	15	-	-	2.05E-04	6.46E-04
TFLink	BP	GO:0050779	RNA destabilization	-	135	101	-	-	1.20E-03	4.36E-03
TFLink	BP	GO:0006023	aminoglycan biosynthetic process	-	74	74	-	-	9.76E-04	3.23E-03
TFLink	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	67	-	-	7.15E-04	2.90E-03
TFLink	BP	GO:0010762	regulation of fibroblast migration	-	40	39	-	-	1.56E-03	1.72E-03
TFLink	BP	GO:0090311	regulation of protein deacetylation	-	29	29	-	-	3.69E-04	1.29E-03
TFLink	BP	GO:0035272	exocrine system development	-	46	46	-	-	9.94E-04	1.99E-03
TFLink	BP	GO:1901096	regulation of autophagosome maturation	-	17	17	-	-	2.05E-04	7.53E-04
TFLink	BP	GO:0022406	membrane docking	-	90	89	-	-	9.87E-04	3.87E-03
TFLink	BP	GO:0006999	nuclear pore organization	-	15	15	-	-	4.19E-04	6.46E-04
TFLink	BP	GO:0070920	regulation of regulatory ncRNA processing	-	17	16	-	-	1.75E-04	6.99E-04
TFLink	BP	GO:0050777	negative regulation of immune response	-	196	190	-	-	3.52E-03	8.18E-03
TFLink	MF	GO:0005035	death receptor activity	-	16	15	-	-	2.07E-04	6.46E-04
TFLink	BP	GO:0002063	chondrocyte development	-	33	31	-	-	7.65E-04	1.34E-03
TFLink	BP	GO:0045618	positive regulation of keratinocyte differentiation	-	19	17	-	-	2.96E-04	7.53E-04
TFLink	BP	GO:0099068	postsynapse assembly	-	40	39	-	-	1.23E-03	1.72E-03
TFLink	BP	GO:0021782	glial cell development	-	120	116	-	-	1.38E-03	5.00E-03
TFLink	BP	GO:0051782	negative regulation of cell division	-	18	17	-	-	1.83E-04	7.53E-04
TFLink	BP	GO:0048755	branching morphogenesis of a nerve	-	11	11	-	-	6.02E-04	4.84E-04
TFLink	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	86	-	-	9.09E-04	3.71E-03
TFLink	BP	GO:0001655	urogenital system development	-	66	66	-	-	6.09E-04	2.85E-03
TFLink	BP	GO:0071827	plasma lipoprotein particle organization	-	86	70	-	-	2.55E-03	3.01E-03
TFLink	BP	GO:0045494	photoreceptor cell maintenance	-	43	43	-	-	6.37E-04	1.88E-03
TFLink	BP	GO:0055088	lipid homeostasis	-	173	155	-	-	2.47E-03	6.67E-03
TFLink	CC	GO:1903421	regulation of synaptic vesicle recycling	-	26	25	-	-	3.08E-04	1.08E-03
TFLink	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	195	-	-	2.18E-03	8.39E-03
TFLink	BP	GO:1902019	regulation of cilium-dependent cell motility	-	30	29	-	-	2.06E-03	1.29E-03
TFLink	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	35	-	-	2.64E-04	1.51E-03
TFLink	BP	GO:0045667	regulation of osteoblast differentiation	-	147	124	-	-	1.18E-03	5.38E-03
TFLink	BP	GO:2001212	regulation of vasculogenesis	-	16	16	-	-	9.29E-04	6.99E-04
TFLink	BP	GO:0061037	negative regulation of cartilage development	-	32	29	-	-	7.09E-04	1.29E-03
TFLink	BP	GO:0045738	negative regulation of DNA repair	-	40	38	-	-	3.76E-04	1.67E-03
TFLink	BP	GO:0001704	formation of primary germ layer	-	195	190	-	-	2.55E-03	8.18E-03
TFLink	BP	GO:0035815	positive regulation of renal sodium excretion	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	BP	GO:0045778	positive regulation of ossification	-	51	51	-	-	5.98E-04	2.21E-03
TFLink	BP	GO:0060174	limb bud formation	-	11	11	-	-	2.46E-04	4.84E-04
TFLink	BP	GO:0048708	astrocyte differentiation	-	88	85	-	-	9.94E-04	3.66E-03
TFLink	BP	GO:0042092	type 2 immune response	-	41	41	-	-	1.52E-03	1.78E-03
TFLink	BP	GO:0048588	developmental cell growth	-	233	223	-	-	2.63E-03	9.63E-03
TFLink	CC	GO:0000963	mitochondrial RNA processing	-	20	20	-	-	2.56E-04	8.61E-04
TFLink	BP	GO:0021872	forebrain generation of neurons	-	52	51	-	-	5.81E-04	2.21E-03
TFLink	MF	GO:0032780	negative regulation of ATP-dependent activity	-	23	23	-	-	6.32E-04	1.02E-03
TFLink	BP	GO:0045023	G0 to G1 transition	-	41	38	-	-	3.58E-04	1.67E-03
TFLink	BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	-	52	49	-	-	7.80E-04	2.15E-03
TFLink	BP	GO:0072488	ammonium transmembrane transport	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0034367	protein-containing complex remodeling	-	35	34	-	-	1.89E-03	1.51E-03
TFLink	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	26	-	-	3.30E-04	1.13E-03
TFLink	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	51	-	-	5.63E-04	2.21E-03
TFLink	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	19	-	-	2.06E-04	8.61E-04
TFLink	BP	GO:0015810	aspartate transmembrane transport	-	19	19	-	-	2.06E-04	8.61E-04
TFLink	BP	GO:0010232	vascular transport	-	87	86	-	-	9.53E-04	3.71E-03
TFLink	BP	GO:0021987	cerebral cortex development	-	125	122	-	-	1.27E-03	5.27E-03
TFLink	BP	GO:0008637	apoptotic mitochondrial changes	-	108	103	-	-	1.01E-03	4.47E-03
TFLink	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	35	-	-	5.15E-04	1.51E-03
TFLink	BP	GO:0042559	pteridine-containing compound biosynthetic process	-	15	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0060999	positive regulation of dendritic spine development	-	35	32	-	-	3.59E-04	1.40E-03
TFLink	BP	GO:0071243	cellular response to arsenic-containing substance	-	18	18	-	-	2.42E-04	8.07E-04
TFLink	BP	GO:2000736	regulation of stem cell differentiation	-	78	77	-	-	7.62E-04	3.34E-03
TFLink	BP	GO:0060973	cell migration involved in heart development	-	21	20	-	-	3.75E-04	8.61E-04
TFLink	BP	GO:0042069	regulation of catecholamine metabolic process	-	20	20	-	-	1.54E-02	8.61E-04
TFLink	BP	GO:0002064	epithelial cell development	-	210	208	-	-	1.84E-03	8.98E-03
TFLink	BP	GO:0071318	cellular response to ATP	-	18	18	-	-	3.62E-04	8.07E-04
TFLink	CC	GO:0050850	positive regulation of calcium-mediated signaling	-	40	39	-	-	6.75E-04	1.72E-03
TFLink	BP	GO:2001222	regulation of neuron migration	-	46	46	-	-	1.03E-03	1.99E-03
TFLink	BP	GO:0034389	lipid droplet organization	-	38	38	-	-	7.22E-04	1.67E-03
TFLink	BP	GO:0051602	response to electrical stimulus	-	44	44	-	-	7.07E-04	1.94E-03
TFLink	BP	GO:0042177	negative regulation of protein catabolic process	-	109	106	-	-	1.18E-03	4.57E-03
TFLink	MF	GO:0038024	cargo receptor activity	-	121	115	-	-	1.87E-03	4.95E-03
TFLink	BP	GO:1900117	regulation of execution phase of apoptosis	-	29	24	-	-	3.09E-04	1.08E-03
TFLink	BP	GO:0033120	positive regulation of RNA splicing	-	46	39	-	-	7.59E-04	1.72E-03
TFLink	BP	GO:0051445	regulation of meiotic cell cycle	-	64	64	-	-	8.90E-04	2.80E-03
TFLink	BP	GO:0051798	positive regulation of hair follicle development	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	BP	GO:0033619	membrane protein proteolysis	-	60	60	-	-	1.07E-03	2.58E-03
TFLink	BP	GO:0038065	collagen-activated signaling pathway	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	BP	GO:0090087	regulation of peptide transport	-	195	194	-	-	2.45E-03	8.39E-03
TFLink	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	101	-	-	1.17E-03	4.36E-03
TFLink	BP	GO:0060706	cell differentiation involved in embryonic placenta development	-	25	25	-	-	4.11E-04	1.08E-03
TFLink	BP	GO:0006929	substrate-dependent cell migration	-	26	25	-	-	4.59E-04	1.08E-03
TFLink	BP	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	BP	GO:0042537	benzene-containing compound metabolic process	-	27	27	-	-	3.09E-04	1.18E-03
TFLink	BP	GO:0099118	microtubule-based protein transport	-	14	14	-	-	1.55E-04	6.46E-04
TFLink	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	15	-	-	2.12E-03	6.46E-04
TFLink	BP	GO:0072662	protein localization to peroxisome	-	20	20	-	-	3.91E-04	8.61E-04
TFLink	BP	GO:2001046	positive regulation of integrin-mediated signaling pathway	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	BP	GO:0022404	molting cycle process	-	95	95	-	-	1.27E-03	4.09E-03
TFLink	BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	-	12	11	-	-	1.48E-04	4.84E-04
TFLink	BP	GO:1903358	regulation of Golgi organization	-	17	16	-	-	2.04E-04	6.99E-04
TFLink	CC	GO:0060391	positive regulation of SMAD protein signal transduction	-	19	19	-	-	3.12E-04	8.61E-04
TFLink	BP	GO:0042754	negative regulation of circadian rhythm	-	12	12	-	-	1.00E-03	5.38E-04
TFLink	BP	GO:2000269	regulation of fibroblast apoptotic process	-	20	18	-	-	1.97E-04	8.07E-04
TFLink	BP	GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	-	33	32	-	-	6.65E-04	1.40E-03
TFLink	BP	GO:0017014	protein nitrosylation	-	17	15	-	-	2.06E-04	6.46E-04
TFLink	BP	GO:0008299	isoprenoid biosynthetic process	-	30	29	-	-	3.07E-04	1.29E-03
TFLink	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	238	-	-	2.89E-03	1.03E-02
TFLink	BP	GO:0150117	positive regulation of cell-substrate junction organization	-	31	31	-	-	6.81E-04	1.34E-03
TFLink	BP	GO:0034104	negative regulation of tissue remodeling	-	22	22	-	-	4.35E-04	9.68E-04
TFLink	CC	GO:0098926	postsynaptic signal transduction	-	39	38	-	-	8.41E-04	1.67E-03
TFLink	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	139	-	-	1.41E-03	6.03E-03
TFLink	CC	GO:0016082	synaptic vesicle priming	-	19	19	-	-	2.05E-04	8.61E-04
TFLink	BP	GO:0002701	negative regulation of production of molecular mediator of immune response	-	47	47	-	-	2.09E-03	2.04E-03
TFLink	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	142	-	-	1.44E-03	6.13E-03
TFLink	BP	GO:0034249	negative regulation of amide metabolic process	-	34	22	-	-	2.56E-04	9.68E-04
TFLink	BP	GO:0061548	ganglion development	-	17	17	-	-	2.91E-04	7.53E-04
TFLink	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	102	-	-	1.04E-03	4.41E-03
TFLink	BP	GO:0042182	ketone catabolic process	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0042832	defense response to protozoan	-	28	25	-	-	2.28E-03	1.08E-03
TFLink	BP	GO:0048799	animal organ maturation	-	33	31	-	-	4.99E-04	1.34E-03
TFLink	BP	GO:0006925	inflammatory cell apoptotic process	-	23	22	-	-	4.57E-04	9.68E-04
TFLink	BP	GO:2000291	regulation of myoblast proliferation	-	25	16	-	-	1.09E-03	6.99E-04
TFLink	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	171	-	-	1.47E-03	7.37E-03
TFLink	BP	GO:0010269	response to selenium ion	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	BP	GO:1903035	negative regulation of response to wounding	-	93	88	-	-	1.61E-03	3.82E-03
TFLink	BP	GO:0015697	quaternary ammonium group transport	-	16	16	-	-	2.06E-04	6.99E-04
TFLink	BP	GO:0014742	positive regulation of muscle hypertrophy	-	37	27	-	-	6.01E-04	1.18E-03
TFLink	BP	GO:0036010	protein localization to endosome	-	27	27	-	-	3.07E-04	1.18E-03
TFLink	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	131	-	-	1.86E-03	5.65E-03
TFLink	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	95	-	-	1.14E-03	4.09E-03
TFLink	BP	GO:0045056	transcytosis	-	20	20	-	-	6.78E-04	8.61E-04
TFLink	BP	GO:0018342	protein prenylation	-	15	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0009267	cellular response to starvation	-	170	169	-	-	1.76E-03	7.32E-03
TFLink	BP	GO:0001547	antral ovarian follicle growth	-	11	11	-	-	8.59E-04	4.84E-04
TFLink	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	53	-	-	8.33E-04	2.31E-03
TFLink	BP	GO:0046834	lipid phosphorylation	-	16	16	-	-	2.06E-04	6.99E-04
TFLink	BP	GO:0007343	egg activation	-	11	11	-	-	1.56E-04	4.84E-04
TFLink	CC	GO:0140239	postsynaptic endocytosis	-	23	23	-	-	2.57E-04	1.02E-03
TFLink	MF	GO:0042910	xenobiotic transmembrane transporter activity	-	27	27	-	-	3.08E-04	1.18E-03
TFLink	BP	GO:0046931	pore complex assembly	-	21	21	-	-	4.30E-04	9.15E-04
TFLink	CC	GO:0032008	positive regulation of TOR signaling	-	52	51	-	-	6.62E-04	2.21E-03
TFLink	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	32	-	-	3.58E-04	1.40E-03
TFLink	BP	GO:0046618	xenobiotic export from cell	-	27	14	-	-	1.55E-04	6.46E-04
TFLink	BP	GO:0021694	cerebellar Purkinje cell layer formation	-	15	15	-	-	3.60E-04	6.46E-04
TFLink	BP	GO:0060428	lung epithelium development	-	43	43	-	-	4.27E-04	1.88E-03
TFLink	BP	GO:0030431	sleep	-	30	30	-	-	8.99E-04	1.29E-03
TFLink	BP	GO:1903318	negative regulation of protein maturation	-	29	29	-	-	3.08E-04	1.29E-03
TFLink	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	101	-	-	1.15E-03	4.36E-03
TFLink	BP	GO:0071732	cellular response to nitric oxide	-	17	17	-	-	6.80E-04	7.53E-04
TFLink	BP	GO:0010457	centriole-centriole cohesion	-	15	15	-	-	4.23E-04	6.46E-04
TFLink	BP	GO:0045161	neuronal ion channel clustering	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	BP	GO:1905155	positive regulation of membrane invagination	-	13	13	-	-	5.86E-04	5.92E-04
TFLink	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	76	-	-	8.19E-04	3.28E-03
TFLink	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	64	-	-	6.53E-04	2.80E-03
TFLink	BP	GO:0170043	non-proteinogenic amino acid biosynthetic process	-	17	17	-	-	2.05E-04	7.53E-04
TFLink	BP	GO:0065004	protein-DNA complex assembly	-	307	246	-	-	2.21E-03	1.06E-02
TFLink	CC	GO:0090660	cerebrospinal fluid circulation	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	CC	GO:0006406	mRNA export from nucleus	-	69	66	-	-	1.42E-03	2.85E-03
TFLink	BP	GO:0009880	embryonic pattern specification	-	70	68	-	-	1.57E-03	2.96E-03
TFLink	BP	GO:0015791	polyol transmembrane transport	-	14	11	-	-	1.56E-04	4.84E-04
TFLink	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	40	-	-	5.28E-04	1.72E-03
TFLink	BP	GO:0043043	peptide biosynthetic process	-	25	24	-	-	4.21E-04	1.08E-03
TFLink	BP	GO:0034105	positive regulation of tissue remodeling	-	23	11	-	-	1.55E-04	4.84E-04
TFLink	BP	GO:0002367	cytokine production involved in immune response	-	121	120	-	-	3.06E-03	5.16E-03
TFLink	BP	GO:1902931	negative regulation of alcohol biosynthetic process	-	17	13	-	-	2.11E-04	5.92E-04
TFLink	BP	GO:0044848	biological phase	-	211	207	-	-	2.08E-03	8.93E-03
TFLink	BP	GO:0002645	positive regulation of tolerance induction	-	12	11	-	-	2.65E-03	4.84E-04
TFLink	BP	GO:0046660	female sex differentiation	-	125	125	-	-	1.33E-03	5.38E-03
TFLink	BP	GO:0045721	negative regulation of gluconeogenesis	-	18	17	-	-	4.22E-04	7.53E-04
TFLink	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	40	-	-	5.83E-04	1.72E-03
TFLink	BP	GO:0021603	cranial nerve formation	-	11	11	-	-	6.98E-04	4.84E-04
TFLink	BP	GO:0060411	cardiac septum morphogenesis	-	72	70	-	-	8.86E-04	3.01E-03
TFLink	BP	GO:0071248	cellular response to metal ion	-	201	198	-	-	2.43E-03	8.55E-03
TFLink	BP	GO:0030308	negative regulation of cell growth	-	191	186	-	-	1.98E-03	8.02E-03
TFLink	BP	GO:0097306	cellular response to alcohol	-	99	93	-	-	1.17E-03	4.03E-03
TFLink	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	125	-	-	1.36E-03	5.38E-03
TFLink	BP	GO:0010453	regulation of cell fate commitment	-	40	36	-	-	3.93E-04	1.56E-03
TFLink	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	55	-	-	1.03E-03	2.37E-03
TFLink	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	57	-	-	6.14E-04	2.47E-03
TFLink	BP	GO:0002026	regulation of the force of heart contraction	-	26	26	-	-	3.08E-04	1.13E-03
TFLink	BP	GO:0043576	regulation of respiratory gaseous exchange	-	24	23	-	-	6.17E-04	1.02E-03
TFLink	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	42	-	-	6.08E-04	1.83E-03
TFLink	BP	GO:0032890	regulation of organic acid transport	-	78	77	-	-	1.31E-03	3.34E-03
TFLink	BP	GO:0071498	cellular response to fluid shear stress	-	21	19	-	-	5.25E-04	8.61E-04
TFLink	BP	GO:0009074	aromatic amino acid family catabolic process	-	24	24	-	-	2.57E-04	1.08E-03
TFLink	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	96	-	-	1.27E-03	4.14E-03
TFLink	BP	GO:0032967	positive regulation of collagen biosynthetic process	-	27	26	-	-	4.14E-04	1.13E-03
TFLink	BP	GO:0071872	cellular response to epinephrine stimulus	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	52	-	-	6.52E-04	2.26E-03
TFLink	BP	GO:0009163	nucleoside biosynthetic process	-	16	16	-	-	1.99E-04	6.99E-04
TFLink	BP	GO:0098743	cell aggregation	-	24	24	-	-	6.61E-04	1.08E-03
TFLink	BP	GO:0035112	genitalia morphogenesis	-	12	12	-	-	2.15E-04	5.38E-04
TFLink	BP	GO:0048484	enteric nervous system development	-	11	11	-	-	2.40E-03	4.84E-04
TFLink	BP	GO:0009994	oocyte differentiation	-	57	56	-	-	1.56E-03	2.42E-03
TFLink	MF	GO:0031952	regulation of protein autophosphorylation	-	43	40	-	-	5.84E-04	1.72E-03
TFLink	BP	GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure	-	14	14	-	-	1.12E-03	6.46E-04
TFLink	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	153	-	-	1.83E-03	6.62E-03
TFLink	BP	GO:0044319	"wound healing, spreading of cells"	-	37	36	-	-	5.20E-04	1.56E-03
TFLink	BP	GO:0033688	regulation of osteoblast proliferation	-	31	28	-	-	5.02E-04	1.24E-03
TFLink	BP	GO:0060251	regulation of glial cell proliferation	-	39	35	-	-	4.24E-04	1.51E-03
TFLink	BP	GO:0072665	protein localization to vacuole	-	84	83	-	-	9.13E-04	3.60E-03
TFLink	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	46	-	-	3.61E-04	1.99E-03
TFLink	BP	GO:0099633	protein localization to postsynaptic specialization membrane	-	25	25	-	-	3.08E-04	1.08E-03
TFLink	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	74	-	-	7.10E-04	3.23E-03
TFLink	BP	GO:0042953	lipoprotein transport	-	20	16	-	-	7.06E-04	6.99E-04
TFLink	BP	GO:0001325	formation of extrachromosomal circular DNA	-	15	13	-	-	1.88E-04	5.92E-04
TFLink	BP	GO:0007028	cytoplasm organization	-	11	11	-	-	2.03E-04	4.84E-04
TFLink	BP	GO:0042044	fluid transport	-	35	33	-	-	3.60E-04	1.45E-03
TFLink	BP	GO:0070633	transepithelial transport	-	35	35	-	-	4.10E-04	1.51E-03
TFLink	BP	GO:0033015	tetrapyrrole catabolic process	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	BP	GO:0045661	regulation of myoblast differentiation	-	74	73	-	-	7.10E-04	3.17E-03
TFLink	BP	GO:0072531	pyrimidine-containing compound transmembrane transport	-	15	15	-	-	2.07E-04	6.46E-04
TFLink	BP	GO:0030307	positive regulation of cell growth	-	164	157	-	-	1.93E-03	6.78E-03
TFLink	BP	GO:0034250	positive regulation of amide metabolic process	-	27	24	-	-	2.61E-04	1.08E-03
TFLink	BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	-	24	18	-	-	3.47E-04	8.07E-04
TFLink	BP	GO:0038166	angiotensin-activated signaling pathway	-	16	14	-	-	4.15E-04	6.46E-04
TFLink	BP	GO:0014812	muscle cell migration	-	110	85	-	-	1.53E-03	3.66E-03
TFLink	BP	GO:0048525	negative regulation of viral process	-	90	87	-	-	1.12E-03	3.77E-03
TFLink	BP	GO:0072044	collecting duct development	-	16	16	-	-	4.11E-04	6.99E-04
TFLink	BP	GO:0006047	UDP-N-acetylglucosamine metabolic process	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	70	-	-	7.66E-04	3.01E-03
TFLink	BP	GO:0030238	male sex determination	-	14	14	-	-	2.26E-03	6.46E-04
TFLink	BP	GO:0051781	positive regulation of cell division	-	93	88	-	-	1.69E-03	3.82E-03
TFLink	CC	GO:0141087	positive regulation of inflammasome-mediated signaling pathway	-	21	21	-	-	2.57E-04	9.15E-04
TFLink	BP	GO:0034350	regulation of glial cell apoptotic process	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	BP	GO:0035524	proline transmembrane transport	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0035493	SNARE complex assembly	-	23	23	-	-	2.56E-04	1.02E-03
TFLink	CC	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	-	22	21	-	-	2.92E-04	9.15E-04
TFLink	BP	GO:0060711	labyrinthine layer development	-	47	47	-	-	7.80E-04	2.04E-03
TFLink	BP	GO:0070857	regulation of bile acid biosynthetic process	-	12	11	-	-	5.84E-04	4.84E-04
TFLink	BP	GO:0007272	ensheathment of neurons	-	146	145	-	-	2.01E-03	6.24E-03
TFLink	CC	GO:0050806	positive regulation of synaptic transmission	-	171	151	-	-	2.18E-03	6.51E-03
TFLink	BP	GO:0060021	roof of mouth development	-	91	91	-	-	1.26E-03	3.93E-03
TFLink	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	38	-	-	1.05E-03	1.67E-03
TFLink	BP	GO:0050819	negative regulation of coagulation	-	54	53	-	-	1.04E-03	2.31E-03
TFLink	MF	GO:0099105	"ion channel modulating, G protein-coupled receptor signaling pathway"	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	BP	GO:0017004	cytochrome complex assembly	-	40	40	-	-	4.60E-04	1.72E-03
TFLink	BP	GO:0018410	C-terminal protein amino acid modification	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	62	-	-	5.62E-04	2.69E-03
TFLink	BP	GO:0097212	lysosomal membrane organization	-	15	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0003376	sphingosine-1-phosphate receptor signaling pathway	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	CC	GO:0050805	negative regulation of synaptic transmission	-	55	53	-	-	1.27E-03	2.31E-03
TFLink	BP	GO:0043248	proteasome assembly	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	60	-	-	1.80E-03	2.58E-03
TFLink	BP	GO:2000833	positive regulation of steroid hormone secretion	-	11	11	-	-	7.93E-04	4.84E-04
TFLink	MF	GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway	-	90	89	-	-	1.92E-03	3.87E-03
TFLink	BP	GO:0016054	organic acid catabolic process	-	251	247	-	-	2.98E-03	1.07E-02
TFLink	BP	GO:0014874	response to stimulus involved in regulation of muscle adaptation	-	13	13	-	-	2.45E-04	5.92E-04
TFLink	BP	GO:1900048	positive regulation of hemostasis	-	28	28	-	-	1.08E-03	1.24E-03
TFLink	BP	GO:0065005	protein-lipid complex assembly	-	29	27	-	-	5.60E-04	1.18E-03
TFLink	BP	GO:0008033	tRNA processing	-	136	135	-	-	1.43E-03	5.81E-03
TFLink	BP	GO:0046661	male sex differentiation	-	171	169	-	-	2.05E-03	7.32E-03
TFLink	BP	GO:0072520	seminiferous tubule development	-	15	15	-	-	2.19E-04	6.46E-04
TFLink	BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	-	18	17	-	-	2.20E-04	7.53E-04
TFLink	BP	GO:0035188	hatching	-	27	26	-	-	3.06E-04	1.13E-03
TFLink	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	88	-	-	9.20E-04	3.82E-03
TFLink	BP	GO:0014857	regulation of skeletal muscle cell proliferation	-	16	16	-	-	2.56E-04	6.99E-04
TFLink	BP	GO:0090713	immunological memory process	-	18	18	-	-	4.57E-04	8.07E-04
TFLink	BP	GO:0061326	renal tubule development	-	103	103	-	-	1.20E-03	4.47E-03
TFLink	BP	GO:0071985	multivesicular body sorting pathway	-	56	54	-	-	7.14E-04	2.37E-03
TFLink	BP	GO:0006450	regulation of translational fidelity	-	18	16	-	-	2.05E-04	6.99E-04
TFLink	BP	GO:0030810	positive regulation of nucleotide biosynthetic process	-	22	20	-	-	2.52E-04	8.61E-04
TFLink	BP	GO:0060325	face morphogenesis	-	31	31	-	-	3.62E-04	1.34E-03
TFLink	BP	GO:0090559	regulation of membrane permeability	-	72	65	-	-	6.89E-04	2.80E-03
TFLink	BP	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	-	15	15	-	-	1.93E-04	6.46E-04
TFLink	BP	GO:0043482	cellular pigment accumulation	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	BP	GO:0031579	membrane raft organization	-	25	24	-	-	2.56E-04	1.08E-03
TFLink	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	25	-	-	5.27E-04	1.08E-03
TFLink	BP	GO:0060033	anatomical structure regression	-	16	16	-	-	3.01E-04	6.99E-04
TFLink	BP	GO:0046460	neutral lipid biosynthetic process	-	50	46	-	-	1.08E-03	1.99E-03
TFLink	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	155	-	-	3.78E-03	6.67E-03
TFLink	BP	GO:0032836	glomerular basement membrane development	-	11	11	-	-	7.22E-04	4.84E-04
TFLink	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	160	-	-	1.59E-03	6.89E-03
TFLink	BP	GO:0002251	organ or tissue specific immune response	-	43	33	-	-	3.60E-04	1.45E-03
TFLink	CC	GO:0048167	regulation of synaptic plasticity	-	210	190	-	-	3.18E-03	8.18E-03
TFLink	BP	GO:1903708	positive regulation of hemopoiesis	-	184	180	-	-	2.23E-03	7.75E-03
TFLink	BP	GO:1903008	organelle disassembly	-	154	153	-	-	1.49E-03	6.62E-03
TFLink	BP	GO:0001709	cell fate determination	-	44	44	-	-	4.11E-04	1.94E-03
TFLink	BP	GO:0051873	killing by host of symbiont cells	-	28	24	-	-	5.87E-04	1.08E-03
TFLink	BP	GO:0045058	T cell selection	-	53	53	-	-	1.63E-03	2.31E-03
TFLink	CC	GO:0032387	negative regulation of intracellular transport	-	51	48	-	-	8.64E-04	2.10E-03
TFLink	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	19	-	-	2.06E-04	8.61E-04
TFLink	BP	GO:0072091	regulation of stem cell proliferation	-	91	78	-	-	6.87E-04	3.39E-03
TFLink	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	42	-	-	5.34E-04	1.83E-03
TFLink	BP	GO:0099084	postsynaptic specialization organization	-	44	42	-	-	1.18E-03	1.83E-03
TFLink	BP	GO:0048505	regulation of timing of cell differentiation	-	11	11	-	-	1.27E-04	4.84E-04
TFLink	BP	GO:0071501	cellular response to sterol depletion	-	15	15	-	-	7.74E-04	6.46E-04
TFLink	BP	GO:0060384	innervation	-	27	27	-	-	6.56E-04	1.18E-03
TFLink	BP	GO:2000774	positive regulation of cellular senescence	-	19	12	-	-	7.62E-04	5.38E-04
TFLink	MF	GO:0090482	vitamin transmembrane transporter activity	-	35	35	-	-	4.11E-04	1.51E-03
TFLink	MF	GO:0031281	positive regulation of cyclase activity	-	40	38	-	-	4.32E-04	1.67E-03
TFLink	MF	GO:0098631	cell adhesion mediator activity	-	64	63	-	-	6.66E-04	2.74E-03
TFLink	BP	GO:0015812	gamma-aminobutyric acid transport	-	18	18	-	-	2.06E-04	8.07E-04
TFLink	BP	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0046112	nucleobase biosynthetic process	-	18	18	-	-	3.52E-04	8.07E-04
TFLink	BP	GO:0071453	cellular response to oxygen levels	-	168	152	-	-	1.43E-03	6.56E-03
TFLink	BP	GO:0090399	replicative senescence	-	17	16	-	-	3.50E-04	6.99E-04
TFLink	BP	GO:0035845	photoreceptor cell outer segment organization	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0031342	negative regulation of cell killing	-	29	29	-	-	3.09E-04	1.29E-03
TFLink	BP	GO:0070585	protein localization to mitochondrion	-	125	123	-	-	1.92E-03	5.33E-03
TFLink	BP	GO:0006855	xenobiotic transmembrane transport	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0010623	programmed cell death involved in cell development	-	25	25	-	-	3.67E-04	1.08E-03
TFLink	BP	GO:0044242	cellular lipid catabolic process	-	224	221	-	-	3.02E-03	9.52E-03
TFLink	BP	GO:0071236	cellular response to antibiotic	-	13	13	-	-	1.16E-04	5.92E-04
TFLink	BP	GO:0002931	response to ischemia	-	58	57	-	-	6.95E-04	2.47E-03
TFLink	BP	GO:0034086	maintenance of sister chromatid cohesion	-	12	12	-	-	2.74E-04	5.38E-04
TFLink	BP	GO:0014047	glutamate secretion	-	25	25	-	-	3.08E-04	1.08E-03
TFLink	BP	GO:0061005	cell differentiation involved in kidney development	-	58	58	-	-	7.85E-04	2.53E-03
TFLink	BP	GO:0030397	membrane disassembly	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	MF	GO:1990806	ligand-gated ion channel signaling pathway	-	77	74	-	-	9.42E-04	3.23E-03
TFLink	BP	GO:0060420	regulation of heart growth	-	74	59	-	-	6.31E-04	2.58E-03
TFLink	BP	GO:1901722	regulation of cell proliferation involved in kidney development	-	15	14	-	-	2.34E-04	6.46E-04
TFLink	BP	GO:0009755	hormone-mediated signaling pathway	-	221	216	-	-	1.91E-03	9.31E-03
TFLink	BP	GO:0022612	gland morphogenesis	-	124	124	-	-	1.20E-03	5.38E-03
TFLink	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	36	-	-	1.02E-03	1.56E-03
TFLink	MF	GO:0140416	transcription regulator inhibitor activity	-	26	24	-	-	2.96E-04	1.08E-03
TFLink	BP	GO:0007214	gamma-aminobutyric acid signaling pathway	-	28	28	-	-	1.21E-03	1.24E-03
TFLink	BP	GO:0048935	peripheral nervous system neuron development	-	15	15	-	-	1.75E-04	6.46E-04
TFLink	BP	GO:0110096	cellular response to aldehyde	-	17	17	-	-	2.05E-04	7.53E-04
TFLink	BP	GO:1990845	adaptive thermogenesis	-	166	166	-	-	1.71E-03	7.15E-03
TFLink	BP	GO:0071320	cellular response to cAMP	-	54	53	-	-	8.61E-04	2.31E-03
TFLink	BP	GO:1903059	regulation of protein lipidation	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	BP	GO:0015844	monoamine transport	-	88	87	-	-	1.19E-03	3.77E-03
TFLink	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	22	-	-	2.56E-04	9.68E-04
TFLink	BP	GO:0060039	pericardium development	-	19	19	-	-	3.44E-04	8.61E-04
TFLink	BP	GO:0071392	cellular response to estradiol stimulus	-	40	40	-	-	4.71E-04	1.72E-03
TFLink	BP	GO:1905209	positive regulation of cardiocyte differentiation	-	18	13	-	-	3.09E-04	5.92E-04
TFLink	BP	GO:0000272	polysaccharide catabolic process	-	19	19	-	-	2.06E-04	8.61E-04
TFLink	BP	GO:0009451	RNA modification	-	169	163	-	-	1.70E-03	7.05E-03
TFLink	BP	GO:0007168	receptor guanylyl cyclase signaling pathway	-	11	11	-	-	1.56E-04	4.84E-04
TFLink	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	40	-	-	4.11E-04	1.72E-03
TFLink	BP	GO:1903729	regulation of plasma membrane organization	-	17	17	-	-	2.05E-04	7.53E-04
TFLink	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	106	-	-	8.33E-04	4.57E-03
TFLink	BP	GO:0060043	regulation of cardiac muscle cell proliferation	-	49	37	-	-	4.11E-04	1.61E-03
TFLink	BP	GO:0015780	nucleotide-sugar transmembrane transport	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	BP	GO:0015807	L-amino acid transport	-	94	94	-	-	9.71E-04	4.09E-03
TFLink	BP	GO:0032941	secretion by tissue	-	85	83	-	-	1.37E-02	3.60E-03
TFLink	BP	GO:0046605	regulation of centrosome cycle	-	54	52	-	-	9.98E-04	2.26E-03
TFLink	BP	GO:0048753	pigment granule organization	-	40	40	-	-	7.29E-04	1.72E-03
TFLink	BP	GO:0021516	dorsal spinal cord development	-	20	20	-	-	3.02E-04	8.61E-04
TFLink	BP	GO:0006700	C21-steroid hormone biosynthetic process	-	20	20	-	-	4.98E-04	8.61E-04
TFLink	BP	GO:0032196	transposition	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	BP	GO:0003014	renal system process	-	130	127	-	-	1.77E-03	5.49E-03
TFLink	CC	GO:0070286	axonemal dynein complex assembly	-	40	40	-	-	4.61E-04	1.72E-03
TFLink	BP	GO:0045598	regulation of fat cell differentiation	-	148	133	-	-	1.21E-03	5.76E-03
TFLink	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	194	-	-	1.90E-03	8.39E-03
TFLink	BP	GO:1904646	cellular response to amyloid-beta	-	44	38	-	-	1.11E-03	1.67E-03
TFLink	BP	GO:1901863	positive regulation of muscle tissue development	-	24	24	-	-	9.57E-04	1.08E-03
TFLink	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	233	-	-	2.40E-03	1.01E-02
TFLink	BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	-	13	13	-	-	6.32E-04	5.92E-04
TFLink	BP	GO:0008340	determination of adult lifespan	-	23	23	-	-	5.49E-04	1.02E-03
TFLink	BP	GO:0018158	protein oxidation	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	BP	GO:0039694	viral RNA genome replication	-	30	29	-	-	3.23E-04	1.29E-03
TFLink	BP	GO:0009404	toxin metabolic process	-	17	17	-	-	6.42E-04	7.53E-04
TFLink	MF	GO:2000272	negative regulation of signaling receptor activity	-	30	27	-	-	6.30E-04	1.18E-03
TFLink	BP	GO:0071709	membrane assembly	-	68	65	-	-	1.45E-03	2.80E-03
TFLink	BP	GO:0008217	regulation of blood pressure	-	186	183	-	-	3.35E-03	7.91E-03
TFLink	BP	GO:0031643	positive regulation of myelination	-	19	19	-	-	4.46E-04	8.61E-04
TFLink	BP	GO:0043101	purine-containing compound salvage	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	61	-	-	8.64E-04	2.64E-03
TFLink	CC	GO:0042770	signal transduction in response to DNA damage	-	186	186	-	-	1.63E-03	8.02E-03
TFLink	BP	GO:0002200	somatic diversification of immune receptors	-	78	77	-	-	1.67E-03	3.34E-03
TFLink	BP	GO:0035315	hair cell differentiation	-	52	52	-	-	6.77E-04	2.26E-03
TFLink	BP	GO:0048645	animal organ formation	-	62	61	-	-	7.58E-04	2.64E-03
TFLink	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	161	-	-	1.88E-03	6.94E-03
TFLink	BP	GO:0010867	positive regulation of triglyceride biosynthetic process	-	15	14	-	-	2.15E-04	6.46E-04
TFLink	BP	GO:0033627	cell adhesion mediated by integrin	-	87	87	-	-	1.37E-03	3.77E-03
TFLink	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	21	-	-	2.56E-04	9.15E-04
TFLink	BP	GO:0015824	proline transport	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	BP	GO:0035107	appendage morphogenesis	-	147	147	-	-	1.70E-03	6.35E-03
TFLink	BP	GO:1903707	negative regulation of hemopoiesis	-	116	109	-	-	1.34E-03	4.73E-03
TFLink	BP	GO:0036342	post-anal tail morphogenesis	-	19	19	-	-	3.02E-04	8.61E-04
TFLink	CC	GO:0048208	COPII vesicle coating	-	27	25	-	-	3.07E-04	1.08E-03
TFLink	BP	GO:0030149	sphingolipid catabolic process	-	32	32	-	-	3.58E-04	1.40E-03
TFLink	BP	GO:0050994	regulation of lipid catabolic process	-	61	58	-	-	1.42E-03	2.53E-03
TFLink	BP	GO:0035988	chondrocyte proliferation	-	24	23	-	-	3.22E-04	1.02E-03
TFLink	BP	GO:0071875	adrenergic receptor signaling pathway	-	30	29	-	-	3.08E-04	1.29E-03
TFLink	BP	GO:0070213	protein auto-ADP-ribosylation	-	11	11	-	-	1.86E-04	4.84E-04
TFLink	BP	GO:0060788	ectodermal placode formation	-	12	12	-	-	1.72E-04	5.38E-04
TFLink	BP	GO:0045727	positive regulation of translation	-	141	138	-	-	1.58E-03	5.97E-03
TFLink	BP	GO:0036315	cellular response to sterol	-	24	21	-	-	2.55E-04	9.15E-04
TFLink	CC	GO:0032388	positive regulation of intracellular transport	-	137	134	-	-	1.55E-03	5.81E-03
TFLink	BP	GO:0021979	hypothalamus cell differentiation	-	13	13	-	-	3.94E-04	5.92E-04
TFLink	BP	GO:0002027	regulation of heart rate	-	106	98	-	-	1.43E-03	4.25E-03
TFLink	BP	GO:0050879	multicellular organismal movement	-	118	116	-	-	1.37E-03	5.00E-03
TFLink	BP	GO:0120305	regulation of pigmentation	-	15	15	-	-	3.67E-04	6.46E-04
TFLink	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	74	-	-	1.51E-03	3.23E-03
TFLink	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	60	-	-	8.66E-04	2.58E-03
TFLink	BP	GO:0048515	spermatid differentiation	-	208	206	-	-	3.08E-03	8.88E-03
TFLink	BP	GO:0072132	mesenchyme morphogenesis	-	57	57	-	-	7.62E-04	2.47E-03
TFLink	MF	GO:0042887	amide transmembrane transporter activity	-	33	31	-	-	3.59E-04	1.34E-03
TFLink	BP	GO:0007130	synaptonemal complex assembly	-	23	22	-	-	5.98E-04	9.68E-04
TFLink	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	36	-	-	6.16E-04	1.56E-03
TFLink	BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	-	34	34	-	-	6.04E-04	1.51E-03
TFLink	BP	GO:0072529	pyrimidine-containing compound catabolic process	-	38	36	-	-	7.26E-04	1.56E-03
TFLink	BP	GO:0060119	inner ear receptor cell development	-	44	44	-	-	5.91E-04	1.94E-03
TFLink	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	18	-	-	1.47E-04	8.07E-04
TFLink	BP	GO:0086019	cell-cell signaling involved in cardiac conduction	-	37	35	-	-	4.87E-03	1.51E-03
TFLink	BP	GO:1901983	regulation of protein acetylation	-	26	22	-	-	2.69E-04	9.68E-04
TFLink	BP	GO:0014854	response to inactivity	-	12	12	-	-	4.95E-04	5.38E-04
TFLink	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	242	-	-	2.91E-03	1.04E-02
TFLink	BP	GO:1900006	positive regulation of dendrite development	-	17	17	-	-	5.85E-04	7.53E-04
TFLink	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	48	-	-	3.42E-04	2.10E-03
TFLink	BP	GO:0010883	regulation of lipid storage	-	53	49	-	-	7.76E-04	2.15E-03
TFLink	BP	GO:0072170	metanephric tubule development	-	26	26	-	-	6.14E-04	1.13E-03
TFLink	BP	GO:0007635	chemosensory behavior	-	20	20	-	-	7.99E-04	8.61E-04
TFLink	BP	GO:1905954	positive regulation of lipid localization	-	110	106	-	-	1.57E-03	4.57E-03
TFLink	BP	GO:0001921	positive regulation of receptor recycling	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	BP	GO:0002209	behavioral defense response	-	39	39	-	-	6.35E-04	1.72E-03
TFLink	BP	GO:0042744	hydrogen peroxide catabolic process	-	30	27	-	-	1.17E-03	1.18E-03
TFLink	BP	GO:0072523	purine-containing compound catabolic process	-	146	144	-	-	1.40E-03	6.24E-03
TFLink	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	32	-	-	4.19E-04	1.40E-03
TFLink	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	28	-	-	6.92E-04	1.24E-03
TFLink	BP	GO:0021535	cell migration in hindbrain	-	16	16	-	-	2.58E-04	6.99E-04
TFLink	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	96	-	-	1.02E-03	4.14E-03
TFLink	BP	GO:0007218	neuropeptide signaling pathway	-	113	110	-	-	2.09E-03	4.73E-03
TFLink	BP	GO:1905907	negative regulation of amyloid fibril formation	-	13	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	167	-	-	2.98E-03	7.21E-03
TFLink	BP	GO:0031345	negative regulation of cell projection organization	-	195	188	-	-	2.55E-03	8.12E-03
TFLink	BP	GO:0048278	vesicle docking	-	64	64	-	-	7.96E-04	2.80E-03
TFLink	BP	GO:0035050	embryonic heart tube development	-	86	86	-	-	1.07E-03	3.71E-03
TFLink	BP	GO:0030168	platelet activation	-	135	135	-	-	1.82E-03	5.81E-03
TFLink	BP	GO:0000097	sulfur amino acid biosynthetic process	-	17	15	-	-	2.06E-04	6.46E-04
TFLink	CC	GO:0098810	neurotransmitter reuptake	-	35	35	-	-	4.11E-04	1.51E-03
TFLink	BP	GO:0008213	protein alkylation	-	58	57	-	-	6.89E-04	2.47E-03
TFLink	BP	GO:0009812	flavonoid metabolic process	-	14	12	-	-	1.56E-04	5.38E-04
TFLink	BP	GO:0086103	G protein-coupled receptor signaling pathway involved in heart process	-	14	13	-	-	5.63E-04	5.92E-04
TFLink	BP	GO:0031338	regulation of vesicle fusion	-	24	24	-	-	2.56E-04	1.08E-03
TFLink	BP	GO:0051481	negative regulation of cytosolic calcium ion concentration	-	13	13	-	-	1.29E-03	5.92E-04
TFLink	BP	GO:0031529	ruffle organization	-	55	54	-	-	7.98E-04	2.37E-03
TFLink	BP	GO:0010842	retina layer formation	-	25	25	-	-	1.52E-03	1.08E-03
TFLink	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	90	-	-	1.21E-03	3.87E-03
TFLink	BP	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	-	16	11	-	-	1.55E-04	4.84E-04
TFLink	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	71	-	-	1.70E-03	3.07E-03
TFLink	MF	GO:0170055	lipid transmembrane transporter activity	-	56	56	-	-	6.16E-04	2.42E-03
TFLink	MF	GO:0015605	organophosphate ester transmembrane transporter activity	-	35	35	-	-	4.10E-04	1.51E-03
TFLink	BP	GO:0035304	regulation of protein dephosphorylation	-	87	79	-	-	9.81E-04	3.44E-03
TFLink	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	232	-	-	2.72E-03	1.00E-02
TFLink	BP	GO:0099637	neurotransmitter receptor transport	-	26	26	-	-	3.08E-04	1.13E-03
TFLink	BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	-	43	35	-	-	3.77E-04	1.51E-03
TFLink	BP	GO:0051775	response to redox state	-	13	13	-	-	2.33E-04	5.92E-04
TFLink	BP	GO:0051785	positive regulation of nuclear division	-	61	61	-	-	1.14E-03	2.64E-03
TFLink	BP	GO:0060456	positive regulation of digestive system process	-	16	16	-	-	2.49E-04	6.99E-04
TFLink	MF	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	-	16	15	-	-	4.34E-04	6.46E-04
TFLink	BP	GO:0060749	mammary gland alveolus development	-	20	20	-	-	3.09E-04	8.61E-04
TFLink	BP	GO:0006002	fructose 6-phosphate metabolic process	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0044786	cell cycle DNA replication	-	45	45	-	-	7.08E-04	1.94E-03
TFLink	BP	GO:0010649	regulation of cell communication by electrical coupling	-	15	12	-	-	4.36E-03	5.38E-04
TFLink	BP	GO:0044539	long-chain fatty acid import into cell	-	17	17	-	-	2.05E-04	7.53E-04
TFLink	BP	GO:0051299	centrosome separation	-	15	15	-	-	2.05E-04	6.46E-04
TFLink	BP	GO:0048145	regulation of fibroblast proliferation	-	87	83	-	-	7.69E-04	3.60E-03
TFLink	BP	GO:0070098	chemokine-mediated signaling pathway	-	91	87	-	-	2.11E-03	3.77E-03
TFLink	BP	GO:0071233	cellular response to L-leucine	-	11	11	-	-	3.91E-04	4.84E-04
TFLink	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	222	-	-	1.89E-03	9.58E-03
TFLink	BP	GO:0032098	regulation of appetite	-	20	20	-	-	2.57E-04	8.61E-04
TFLink	BP	GO:0021819	layer formation in cerebral cortex	-	14	14	-	-	2.54E-04	6.46E-04
TFLink	CC	GO:0008333	endosome to lysosome transport	-	73	72	-	-	8.99E-04	3.12E-03
TFLink	BP	GO:0045723	positive regulation of fatty acid biosynthetic process	-	24	21	-	-	3.11E-04	9.15E-04
TFLink	BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	-	19	16	-	-	2.04E-04	6.99E-04
TFLink	BP	GO:0003016	respiratory system process	-	39	39	-	-	6.46E-04	1.72E-03
TFLink	BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	-	24	24	-	-	4.90E-04	1.08E-03
TFLink	BP	GO:0045732	positive regulation of protein catabolic process	-	202	197	-	-	2.05E-03	8.50E-03
TFLink	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	71	-	-	7.67E-04	3.07E-03
TFLink	BP	GO:0007588	excretion	-	40	40	-	-	4.62E-04	1.72E-03
TFLink	BP	GO:1904018	positive regulation of vasculature development	-	185	158	-	-	2.12E-03	6.83E-03
TFLink	BP	GO:0050953	sensory perception of light stimulus	-	223	216	-	-	1.21E-02	9.31E-03
TFLink	BP	GO:0009164	nucleoside catabolic process	-	25	24	-	-	3.47E-04	1.08E-03
TFLink	BP	GO:0002357	defense response to tumor cell	-	13	12	-	-	2.35E-04	5.38E-04
TFLink	BP	GO:0009303	rRNA transcription	-	37	37	-	-	3.51E-04	1.61E-03
TFLink	BP	GO:0035601	protein deacylation	-	56	56	-	-	5.65E-04	2.42E-03
TFLink	BP	GO:0061952	midbody abscission	-	18	16	-	-	2.06E-04	6.99E-04
TFLink	BP	GO:0070344	regulation of fat cell proliferation	-	11	11	-	-	1.93E-04	4.84E-04
TFLink	BP	GO:0045722	positive regulation of gluconeogenesis	-	21	19	-	-	2.78E-04	8.61E-04
TFLink	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	30	-	-	4.28E-04	1.29E-03
TFLink	BP	GO:0071300	cellular response to retinoic acid	-	66	65	-	-	9.52E-04	2.80E-03
TFLink	BP	GO:0034638	phosphatidylcholine catabolic process	-	16	16	-	-	2.06E-04	6.99E-04
TFLink	BP	GO:0045830	positive regulation of isotype switching	-	28	27	-	-	1.81E-03	1.18E-03
TFLink	BP	GO:0031069	hair follicle morphogenesis	-	33	33	-	-	7.62E-04	1.45E-03
TFLink	BP	GO:0046697	decidualization	-	26	26	-	-	3.11E-04	1.13E-03
TFLink	BP	GO:0008212	mineralocorticoid metabolic process	-	14	14	-	-	5.10E-04	6.46E-04
TFLink	BP	GO:0051588	regulation of neurotransmitter transport	-	99	96	-	-	1.09E-03	4.14E-03
TFLink	BP	GO:0042219	cellular modified amino acid catabolic process	-	32	29	-	-	3.08E-04	1.29E-03
TFLink	BP	GO:0002087	regulation of respiratory gaseous exchange by nervous system process	-	12	12	-	-	3.17E-04	5.38E-04
TFLink	BP	GO:0051784	negative regulation of nuclear division	-	63	63	-	-	2.28E-03	2.74E-03
TFLink	BP	GO:0044703	multi-organism reproductive process	-	209	200	-	-	2.74E-03	8.61E-03
TFLink	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	141	-	-	1.77E-03	6.08E-03
TFLink	BP	GO:0052646	alditol phosphate metabolic process	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	BP	GO:0070169	positive regulation of biomineral tissue development	-	53	53	-	-	7.78E-04	2.31E-03
TFLink	BP	GO:0099022	vesicle tethering	-	32	31	-	-	3.58E-04	1.34E-03
TFLink	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	38	-	-	4.62E-04	1.67E-03
TFLink	BP	GO:1903867	extraembryonic membrane development	-	12	12	-	-	1.62E-04	5.38E-04
TFLink	BP	GO:0048857	neural nucleus development	-	65	61	-	-	6.76E-04	2.64E-03
TFLink	BP	GO:0048663	neuron fate commitment	-	74	74	-	-	5.78E-04	3.23E-03
TFLink	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	176	-	-	2.72E-03	7.59E-03
TFLink	BP	GO:0106027	neuron projection organization	-	90	86	-	-	1.25E-03	3.71E-03
TFLink	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	129	-	-	2.02E-03	5.59E-03
TFLink	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	35	-	-	5.48E-04	1.51E-03
TFLink	BP	GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	BP	GO:0045685	regulation of glial cell differentiation	-	77	74	-	-	1.03E-03	3.23E-03
TFLink	BP	GO:0051608	histamine transport	-	14	14	-	-	1.55E-04	6.46E-04
TFLink	BP	GO:0043414	macromolecule methylation	-	138	132	-	-	1.51E-03	5.70E-03
TFLink	BP	GO:0048521	negative regulation of behavior	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0048268	clathrin coat assembly	-	16	16	-	-	2.05E-04	6.99E-04
TFLink	BP	GO:0050886	endocrine process	-	93	92	-	-	1.36E-03	3.98E-03
TFLink	MF	GO:0015562	efflux transmembrane transporter activity	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	BP	GO:0050951	sensory perception of temperature stimulus	-	28	28	-	-	8.42E-04	1.24E-03
TFLink	BP	GO:0045807	positive regulation of endocytosis	-	155	150	-	-	1.71E-03	6.46E-03
TFLink	BP	GO:0002418	immune response to tumor cell	-	29	27	-	-	3.55E-04	1.18E-03
TFLink	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	59	-	-	5.81E-04	2.58E-03
TFLink	BP	GO:0048308	organelle inheritance	-	14	14	-	-	1.53E-04	6.46E-04
TFLink	BP	GO:0060967	negative regulation of gene silencing by regulatory ncRNA	-	23	18	-	-	2.23E-04	8.07E-04
TFLink	BP	GO:0001829	trophectodermal cell differentiation	-	19	19	-	-	3.53E-04	8.61E-04
TFLink	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	52	-	-	5.63E-04	2.26E-03
TFLink	BP	GO:0034394	protein localization to cell surface	-	69	67	-	-	7.81E-04	2.90E-03
TFLink	BP	GO:0042447	hormone catabolic process	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0009110	vitamin biosynthetic process	-	23	23	-	-	3.30E-04	1.02E-03
TFLink	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	22	-	-	1.95E-04	9.68E-04
TFLink	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	17	-	-	1.45E-04	7.53E-04
TFLink	BP	GO:0023019	signal transduction involved in regulation of gene expression	-	22	22	-	-	6.45E-04	9.68E-04
TFLink	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	96	-	-	1.12E-03	4.14E-03
TFLink	BP	GO:0009111	vitamin catabolic process	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	MF	GO:0051100	negative regulation of binding	-	161	157	-	-	1.48E-03	6.78E-03
TFLink	BP	GO:0003151	outflow tract morphogenesis	-	81	78	-	-	9.16E-04	3.39E-03
TFLink	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	60	-	-	5.99E-04	2.58E-03
TFLink	BP	GO:0055093	response to hyperoxia	-	20	20	-	-	4.55E-04	8.61E-04
TFLink	BP	GO:0006521	regulation of cellular amino acid metabolic process	-	13	12	-	-	1.90E-02	5.38E-04
TFLink	BP	GO:0061036	positive regulation of cartilage development	-	33	33	-	-	7.21E-04	1.45E-03
TFLink	BP	GO:0046184	aldehyde biosynthetic process	-	16	16	-	-	3.85E-04	6.99E-04
TFLink	BP	GO:1901857	positive regulation of cellular respiration	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	47	-	-	6.06E-04	2.04E-03
TFLink	BP	GO:0046621	negative regulation of organ growth	-	39	32	-	-	4.14E-04	1.40E-03
TFLink	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	49	-	-	4.65E-04	2.15E-03
TFLink	BP	GO:0032368	regulation of lipid transport	-	149	127	-	-	1.82E-03	5.49E-03
TFLink	BP	GO:0055094	response to lipoprotein particle	-	34	29	-	-	7.99E-04	1.29E-03
TFLink	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	179	-	-	2.33E-03	7.75E-03
TFLink	BP	GO:0033002	muscle cell proliferation	-	249	203	-	-	2.30E-03	8.77E-03
TFLink	BP	GO:0043331	response to dsRNA	-	56	55	-	-	6.57E-03	2.37E-03
TFLink	BP	GO:0033327	Leydig cell differentiation	-	12	12	-	-	3.87E-04	5.38E-04
TFLink	BP	GO:0051904	pigment granule transport	-	23	23	-	-	2.56E-04	1.02E-03
TFLink	BP	GO:1901679	nucleotide transmembrane transport	-	32	32	-	-	3.58E-04	1.40E-03
TFLink	BP	GO:1901099	negative regulation of signal transduction in absence of ligand	-	35	31	-	-	8.25E-04	1.34E-03
TFLink	CC	GO:1900116	extracellular negative regulation of signal transduction	-	13	11	-	-	1.76E-03	4.84E-04
TFLink	BP	GO:0033363	secretory granule organization	-	63	63	-	-	1.23E-03	2.74E-03
TFLink	BP	GO:0060479	lung cell differentiation	-	28	28	-	-	2.51E-04	1.24E-03
TFLink	BP	GO:0120009	intermembrane lipid transfer	-	52	49	-	-	7.60E-04	2.15E-03
TFLink	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	15	-	-	2.04E-04	6.46E-04
TFLink	BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	-	42	37	-	-	6.38E-04	1.61E-03
TFLink	BP	GO:0033622	integrin activation	-	26	26	-	-	7.15E-04	1.13E-03
TFLink	BP	GO:0098751	bone cell development	-	18	18	-	-	3.11E-04	8.07E-04
TFLink	BP	GO:2000773	negative regulation of cellular senescence	-	25	21	-	-	2.76E-04	9.15E-04
TFLink	BP	GO:0060688	regulation of morphogenesis of a branching structure	-	51	51	-	-	5.75E-04	2.21E-03
TFLink	BP	GO:0050820	positive regulation of coagulation	-	30	30	-	-	5.93E-04	1.29E-03
TFLink	BP	GO:0002076	osteoblast development	-	17	17	-	-	4.27E-04	7.53E-04
TFLink	BP	GO:0072164	mesonephric tubule development	-	98	98	-	-	1.25E-03	4.25E-03
TFLink	BP	GO:0010566	regulation of ketone biosynthetic process	-	17	17	-	-	3.30E-04	7.53E-04
TFLink	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	107	-	-	2.52E-03	4.63E-03
TFLink	BP	GO:1903524	positive regulation of blood circulation	-	39	38	-	-	6.74E-03	1.67E-03
TFLink	BP	GO:0030901	midbrain development	-	87	83	-	-	9.94E-04	3.60E-03
TFLink	BP	GO:0048485	sympathetic nervous system development	-	22	22	-	-	6.31E-04	9.68E-04
TFLink	BP	GO:0048532	anatomical structure arrangement	-	16	16	-	-	2.54E-04	6.99E-04
TFLink	BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	-	17	13	-	-	3.49E-04	5.92E-04
TFLink	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	68	-	-	1.05E-03	2.96E-03
TFLink	MF	GO:1901474	azole transmembrane transporter activity	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	BP	GO:0002687	positive regulation of leukocyte migration	-	147	146	-	-	2.28E-03	6.29E-03
TFLink	BP	GO:0019755	one-carbon compound transport	-	28	24	-	-	1.08E-03	1.08E-03
TFLink	BP	GO:1901862	negative regulation of muscle tissue development	-	13	13	-	-	1.75E-04	5.92E-04
TFLink	BP	GO:0060856	establishment of blood-brain barrier	-	16	16	-	-	8.00E-04	6.99E-04
TFLink	BP	GO:0110154	RNA decapping	-	19	19	-	-	2.63E-04	8.61E-04
TFLink	BP	GO:0034605	cellular response to heat	-	66	59	-	-	6.59E-04	2.58E-03
TFLink	BP	GO:0005996	monosaccharide metabolic process	-	250	244	-	-	2.28E-03	1.05E-02
TFLink	BP	GO:0033555	multicellular organismal response to stress	-	90	89	-	-	2.18E-03	3.87E-03
TFLink	BP	GO:0002262	myeloid cell homeostasis	-	172	167	-	-	1.64E-03	7.21E-03
TFLink	BP	GO:0000966	RNA 5'-end processing	-	39	38	-	-	6.26E-04	1.67E-03
TFLink	BP	GO:0050688	regulation of defense response to virus	-	65	64	-	-	9.95E-04	2.80E-03
TFLink	BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	-	33	20	-	-	2.57E-04	8.61E-04
TFLink	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	221	-	-	2.15E-03	9.52E-03
TFLink	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	31	-	-	3.32E-04	1.34E-03
TFLink	BP	GO:0061029	eyelid development in camera-type eye	-	14	14	-	-	1.16E-04	6.46E-04
TFLink	BP	GO:0071402	cellular response to lipoprotein particle stimulus	-	37	32	-	-	8.32E-04	1.40E-03
TFLink	BP	GO:0034122	negative regulation of toll-like receptor signaling pathway	-	21	19	-	-	6.14E-04	8.61E-04
TFLink	BP	GO:0003272	endocardial cushion formation	-	28	28	-	-	3.96E-04	1.24E-03
TFLink	BP	GO:0022618	protein-RNA complex assembly	-	227	185	-	-	3.29E-03	7.96E-03
TFLink	BP	GO:0051147	regulation of muscle cell differentiation	-	162	135	-	-	1.65E-03	5.81E-03
TFLink	BP	GO:0090102	cochlea development	-	50	50	-	-	8.91E-04	2.15E-03
TFLink	BP	GO:0060561	apoptotic process involved in morphogenesis	-	26	26	-	-	3.00E-04	1.13E-03
TFLink	BP	GO:0061303	cornea development in camera-type eye	-	12	12	-	-	4.85E-03	5.38E-04
TFLink	BP	GO:0045933	positive regulation of muscle contraction	-	49	47	-	-	1.48E-03	2.04E-03
TFLink	BP	GO:0015803	branched-chain amino acid transport	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0002679	respiratory burst involved in defense response	-	16	16	-	-	2.06E-04	6.99E-04
TFLink	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	33	-	-	3.25E-04	1.45E-03
TFLink	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	91	-	-	1.46E-03	3.93E-03
TFLink	BP	GO:0097264	self proteolysis	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:0043555	regulation of translation in response to stress	-	22	21	-	-	2.56E-04	9.15E-04
TFLink	BP	GO:0032922	circadian regulation of gene expression	-	71	70	-	-	6.64E-04	3.01E-03
TFLink	BP	GO:0007187	"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	-	56	56	-	-	6.19E-04	2.42E-03
TFLink	BP	GO:0098664	G protein-coupled serotonin receptor signaling pathway	-	23	23	-	-	2.59E-04	1.02E-03
TFLink	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	58	-	-	1.02E-03	2.53E-03
TFLink	BP	GO:0060439	trachea morphogenesis	-	11	11	-	-	2.43E-03	4.84E-04
TFLink	BP	GO:0038179	neurotrophin signaling pathway	-	38	38	-	-	4.59E-04	1.67E-03
TFLink	BP	GO:0021670	lateral ventricle development	-	12	12	-	-	1.99E-04	5.38E-04
TFLink	BP	GO:1904238	pericyte cell differentiation	-	11	11	-	-	2.15E-04	4.84E-04
TFLink	BP	GO:0140253	cell-cell fusion	-	62	61	-	-	2.77E-03	2.64E-03
TFLink	BP	GO:0040015	negative regulation of multicellular organism growth	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	BP	GO:0071599	otic vesicle development	-	15	15	-	-	3.72E-04	6.46E-04
TFLink	BP	GO:0071526	semaphorin-plexin signaling pathway	-	44	44	-	-	1.88E-03	1.94E-03
TFLink	BP	GO:0061635	regulation of protein complex stability	-	14	14	-	-	1.50E-04	6.46E-04
TFLink	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	59	-	-	6.13E-04	2.58E-03
TFLink	BP	GO:0001941	postsynaptic membrane organization	-	37	36	-	-	4.11E-04	1.56E-03
TFLink	BP	GO:0051293	establishment of spindle localization	-	57	57	-	-	1.07E-03	2.47E-03
TFLink	BP	GO:0048853	forebrain morphogenesis	-	13	13	-	-	5.12E-04	5.92E-04
TFLink	BP	GO:0043114	regulation of vascular permeability	-	49	48	-	-	8.57E-04	2.10E-03
TFLink	BP	GO:0018126	protein hydroxylation	-	26	26	-	-	4.17E-04	1.13E-03
TFLink	CC	GO:0051057	positive regulation of small GTPase mediated signal transduction	-	68	67	-	-	1.09E-03	2.90E-03
TFLink	BP	GO:0008360	regulation of cell shape	-	139	137	-	-	1.42E-03	5.92E-03
TFLink	BP	GO:0021783	preganglionic parasympathetic fiber development	-	16	16	-	-	4.37E-04	6.99E-04
TFLink	BP	GO:0051222	positive regulation of protein transport	-	249	244	-	-	2.73E-03	1.05E-02
TFLink	CC	GO:0140632	canonical inflammasome complex assembly	-	40	40	-	-	4.61E-04	1.72E-03
TFLink	MF	GO:0034260	negative regulation of GTPase activity	-	36	32	-	-	3.59E-04	1.40E-03
TFLink	BP	GO:0045932	negative regulation of muscle contraction	-	24	22	-	-	2.57E-04	9.68E-04
TFLink	BP	GO:0045739	positive regulation of DNA repair	-	128	126	-	-	1.21E-03	5.43E-03
TFLink	BP	GO:0001845	phagolysosome assembly	-	19	19	-	-	2.05E-04	8.61E-04
TFLink	BP	GO:0045185	maintenance of protein location	-	95	90	-	-	1.41E-03	3.87E-03
TFLink	BP	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	-	13	13	-	-	8.52E-04	5.92E-04
TFLink	BP	GO:0003158	endothelium development	-	140	129	-	-	1.72E-03	5.59E-03
TFLink	CC	GO:0072595	maintenance of protein localization in organelle	-	42	42	-	-	1.04E-03	1.83E-03
TFLink	BP	GO:0051224	negative regulation of protein transport	-	122	106	-	-	1.28E-03	4.57E-03
TFLink	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	150	-	-	1.60E-03	6.46E-03
TFLink	CC	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	-	13	13	-	-	2.10E-04	5.92E-04
TFLink	BP	GO:0040018	positive regulation of multicellular organism growth	-	31	31	-	-	4.42E-04	1.34E-03
TFLink	BP	GO:0002501	peptide antigen assembly with MHC protein complex	-	20	20	-	-	2.59E-04	8.61E-04
TFLink	BP	GO:0021885	forebrain cell migration	-	63	63	-	-	7.23E-04	2.74E-03
TFLink	BP	GO:0007405	neuroblast proliferation	-	81	80	-	-	8.85E-04	3.44E-03
TFLink	BP	GO:0009581	detection of external stimulus	-	137	132	-	-	2.61E-03	5.70E-03
TFLink	BP	GO:1990542	mitochondrial transmembrane transport	-	93	92	-	-	9.71E-04	3.98E-03
TFLink	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	32	-	-	7.62E-04	1.40E-03
TFLink	BP	GO:0033504	floor plate development	-	11	11	-	-	3.19E-04	4.84E-04
TFLink	BP	GO:0060900	embryonic camera-type eye formation	-	11	11	-	-	3.47E-04	4.84E-04
TFLink	BP	GO:0097186	amelogenesis	-	26	26	-	-	4.07E-04	1.13E-03
TFLink	BP	GO:0031128	developmental induction	-	26	26	-	-	2.86E-04	1.13E-03
TFLink	BP	GO:0035672	oligopeptide transmembrane transport	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	BP	GO:0031100	animal organ regeneration	-	66	66	-	-	8.08E-04	2.85E-03
TFLink	BP	GO:0021533	cell differentiation in hindbrain	-	23	23	-	-	2.42E-04	1.02E-03
TFLink	BP	GO:0045684	positive regulation of epidermis development	-	33	31	-	-	2.96E-04	1.34E-03
TFLink	CC	GO:0010739	positive regulation of protein kinase A signaling	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	BP	GO:1900047	negative regulation of hemostasis	-	51	51	-	-	1.14E-03	2.21E-03
TFLink	BP	GO:0021517	ventral spinal cord development	-	47	47	-	-	5.43E-04	2.04E-03
TFLink	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	74	-	-	7.47E-04	3.23E-03
TFLink	BP	GO:0032328	alanine transport	-	19	19	-	-	2.05E-04	8.61E-04
TFLink	MF	GO:0034497	protein localization to phagophore assembly site	-	16	16	-	-	2.05E-04	6.99E-04
TFLink	BP	GO:0097722	sperm motility	-	133	130	-	-	1.94E-03	5.59E-03
TFLink	BP	GO:0051231	spindle elongation	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0042490	mechanoreceptor differentiation	-	67	67	-	-	8.61E-04	2.90E-03
TFLink	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	29	-	-	2.85E-04	1.29E-03
TFLink	BP	GO:0035148	tube formation	-	155	154	-	-	1.60E-03	6.67E-03
TFLink	BP	GO:0048520	positive regulation of behavior	-	27	27	-	-	1.74E-03	1.18E-03
TFLink	BP	GO:0098543	detection of other organism	-	19	19	-	-	2.08E-04	8.61E-04
TFLink	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	43	-	-	1.12E-03	1.88E-03
TFLink	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	125	-	-	4.05E-03	5.38E-03
TFLink	BP	GO:0031123	RNA 3'-end processing	-	79	77	-	-	1.01E-03	3.34E-03
TFLink	BP	GO:0010985	negative regulation of lipoprotein particle clearance	-	21	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	108	-	-	1.21E-03	4.68E-03
TFLink	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	18	-	-	2.36E-04	8.07E-04
TFLink	CC	GO:0007097	nuclear migration	-	24	24	-	-	4.24E-04	1.08E-03
TFLink	BP	GO:0006885	regulation of pH	-	104	102	-	-	1.11E-03	4.41E-03
TFLink	BP	GO:0002467	germinal center formation	-	14	14	-	-	1.02E-03	6.46E-04
TFLink	BP	GO:1990840	response to lectin	-	22	20	-	-	6.56E-04	8.61E-04
TFLink	BP	GO:0071800	podosome assembly	-	19	19	-	-	1.80E-03	8.61E-04
TFLink	BP	GO:0031018	endocrine pancreas development	-	47	46	-	-	4.86E-04	1.99E-03
TFLink	BP	GO:0001708	cell fate specification	-	108	107	-	-	1.07E-03	4.63E-03
TFLink	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	68	-	-	1.11E-03	2.96E-03
TFLink	BP	GO:0030279	negative regulation of ossification	-	39	36	-	-	5.74E-04	1.56E-03
TFLink	BP	GO:0042983	amyloid precursor protein biosynthetic process	-	27	14	-	-	4.23E-04	6.46E-04
TFLink	BP	GO:0097468	programmed cell death in response to reactive oxygen species	-	16	13	-	-	2.03E-03	5.92E-04
TFLink	BP	GO:0042440	pigment metabolic process	-	80	78	-	-	1.20E-03	3.39E-03
TFLink	BP	GO:1901606	alpha-amino acid catabolic process	-	101	98	-	-	1.02E-03	4.25E-03
TFLink	BP	GO:1901890	positive regulation of cell junction assembly	-	106	105	-	-	2.13E-03	4.52E-03
TFLink	BP	GO:0070988	demethylation	-	27	26	-	-	2.81E-04	1.13E-03
TFLink	BP	GO:1901655	cellular response to ketone	-	107	103	-	-	1.21E-03	4.47E-03
TFLink	BP	GO:0046185	aldehyde catabolic process	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0051255	spindle midzone assembly	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	17	-	-	2.05E-04	7.53E-04
TFLink	BP	GO:0006968	cellular defense response	-	52	50	-	-	1.53E-03	2.15E-03
TFLink	BP	GO:0055006	cardiac cell development	-	93	84	-	-	2.68E-03	3.66E-03
TFLink	BP	GO:0031365	N-terminal protein amino acid modification	-	30	30	-	-	3.49E-04	1.29E-03
TFLink	BP	GO:0035881	amacrine cell differentiation	-	12	11	-	-	2.07E-04	4.84E-04
TFLink	BP	GO:0070168	negative regulation of biomineral tissue development	-	30	27	-	-	6.28E-04	1.18E-03
TFLink	CC	GO:1900272	negative regulation of long-term synaptic potentiation	-	13	12	-	-	1.49E-04	5.38E-04
TFLink	BP	GO:0060004	reflex	-	63	62	-	-	1.17E-03	2.69E-03
TFLink	BP	GO:0044706	multi-multicellular organism process	-	217	208	-	-	2.81E-03	8.98E-03
TFLink	BP	GO:0043589	skin morphogenesis	-	12	12	-	-	9.43E-04	5.38E-04
TFLink	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	133	-	-	1.48E-03	5.76E-03
TFLink	BP	GO:0006026	aminoglycan catabolic process	-	34	34	-	-	3.59E-04	1.51E-03
TFLink	BP	GO:0031294	lymphocyte costimulation	-	47	44	-	-	7.09E-04	1.94E-03
TFLink	BP	GO:0050768	negative regulation of neurogenesis	-	150	146	-	-	1.69E-03	6.29E-03
TFLink	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	91	-	-	1.05E-03	3.93E-03
TFLink	BP	GO:0090068	positive regulation of cell cycle process	-	262	245	-	-	2.44E-03	1.05E-02
TFLink	BP	GO:0043605	amide catabolic process	-	16	16	-	-	2.06E-04	6.99E-04
TFLink	MF	GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway	-	27	27	-	-	3.08E-04	1.18E-03
TFLink	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	33	-	-	5.02E-04	1.45E-03
TFLink	BP	GO:1902115	regulation of organelle assembly	-	210	203	-	-	2.58E-03	8.77E-03
TFLink	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	65	-	-	9.88E-04	2.80E-03
TFLink	BP	GO:0047484	regulation of response to osmotic stress	-	16	16	-	-	2.04E-04	6.99E-04
TFLink	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	142	-	-	1.59E-03	6.13E-03
TFLink	BP	GO:0043171	peptide catabolic process	-	19	18	-	-	2.05E-04	8.07E-04
TFLink	BP	GO:0046622	positive regulation of organ growth	-	52	42	-	-	6.47E-04	1.83E-03
TFLink	BP	GO:0051952	regulation of amine transport	-	98	97	-	-	1.02E-03	4.20E-03
TFLink	BP	GO:0006730	one-carbon metabolic process	-	24	23	-	-	2.56E-04	1.02E-03
TFLink	CC	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	-	20	20	-	-	2.57E-04	8.61E-04
TFLink	BP	GO:0015801	aromatic amino acid transport	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	BP	GO:0040019	positive regulation of embryonic development	-	23	23	-	-	2.39E-04	1.02E-03
TFLink	BP	GO:0097154	GABAergic neuron differentiation	-	20	19	-	-	2.45E-04	8.61E-04
TFLink	CC	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	-	16	16	-	-	2.06E-04	6.99E-04
TFLink	CC	GO:0032365	intracellular lipid transport	-	51	48	-	-	5.11E-04	2.10E-03
TFLink	BP	GO:0045048	protein insertion into ER membrane	-	30	30	-	-	3.58E-04	1.29E-03
TFLink	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	71	-	-	1.47E-03	3.07E-03
TFLink	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	113	-	-	1.30E-03	4.90E-03
TFLink	BP	GO:0018149	peptide cross-linking	-	28	28	-	-	3.10E-04	1.24E-03
TFLink	BP	GO:1904893	negative regulation of receptor signaling pathway via STAT	-	33	25	-	-	3.52E-04	1.08E-03
TFLink	MF	GO:0140537	transcription regulator activator activity	-	13	13	-	-	1.04E-04	5.92E-04
TFLink	BP	GO:0021859	pyramidal neuron differentiation	-	14	14	-	-	3.01E-04	6.46E-04
TFLink	BP	GO:0061000	negative regulation of dendritic spine development	-	13	13	-	-	2.94E-04	5.92E-04
TFLink	BP	GO:0071398	cellular response to fatty acid	-	35	34	-	-	6.50E-04	1.51E-03
TFLink	MF	GO:1903027	regulation of opsonization	-	11	11	-	-	3.03E-04	4.84E-04
TFLink	BP	GO:0097581	lamellipodium organization	-	91	89	-	-	1.24E-03	3.87E-03
TFLink	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	28	-	-	3.07E-04	1.24E-03
TFLink	BP	GO:1903975	regulation of glial cell migration	-	20	18	-	-	2.06E-04	8.07E-04
TFLink	BP	GO:0090141	positive regulation of mitochondrial fission	-	21	21	-	-	2.57E-04	9.15E-04
TFLink	BP	GO:0015669	gas transport	-	23	21	-	-	2.50E-04	9.15E-04
TFLink	BP	GO:0016485	protein processing	-	248	245	-	-	2.84E-03	1.05E-02
TFLink	BP	GO:0009649	entrainment of circadian clock	-	30	28	-	-	4.03E-04	1.24E-03
TFLink	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	164	-	-	2.98E-03	7.10E-03
TFLink	BP	GO:1903523	negative regulation of blood circulation	-	27	24	-	-	2.57E-04	1.08E-03
TFLink	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	140	-	-	1.64E-03	6.03E-03
TFLink	BP	GO:0000101	sulfur amino acid transport	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	BP	GO:0099054	presynapse assembly	-	49	48	-	-	2.96E-03	2.10E-03
TFLink	BP	GO:0003353	positive regulation of cilium movement	-	12	12	-	-	5.13E-03	5.38E-04
TFLink	BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	-	27	25	-	-	4.17E-04	1.08E-03
TFLink	BP	GO:0006517	protein deglycosylation	-	26	25	-	-	3.07E-04	1.08E-03
TFLink	BP	GO:0031348	negative regulation of defense response	-	282	244	-	-	3.09E-03	1.05E-02
TFLink	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	75	-	-	1.06E-03	3.23E-03
TFLink	BP	GO:0061180	mammary gland epithelium development	-	68	68	-	-	7.16E-04	2.96E-03
TFLink	BP	GO:0071496	cellular response to external stimulus	-	74	74	-	-	1.20E-03	3.23E-03
TFLink	BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	-	17	13	-	-	1.54E-04	5.92E-04
TFLink	BP	GO:0042753	positive regulation of circadian rhythm	-	18	18	-	-	2.87E-04	8.07E-04
TFLink	BP	GO:1905208	negative regulation of cardiocyte differentiation	-	14	11	-	-	4.01E-04	4.84E-04
TFLink	BP	GO:0072710	response to hydroxyurea	-	12	12	-	-	4.20E-04	5.38E-04
TFLink	BP	GO:0032094	response to food	-	37	37	-	-	1.13E-03	1.61E-03
TFLink	BP	GO:0001964	startle response	-	27	27	-	-	8.59E-04	1.18E-03
TFLink	BP	GO:0007340	acrosome reaction	-	38	38	-	-	4.11E-04	1.67E-03
TFLink	BP	GO:0046434	organophosphate catabolic process	-	232	228	-	-	2.19E-03	9.84E-03
TFLink	BP	GO:0060037	pharyngeal system development	-	29	29	-	-	5.33E-04	1.29E-03
TFLink	BP	GO:0009566	fertilization	-	205	198	-	-	2.95E-03	8.55E-03
TFLink	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	60	-	-	6.87E-04	2.58E-03
TFLink	BP	GO:0120255	olefinic compound biosynthetic process	-	24	24	-	-	4.72E-04	1.08E-03
TFLink	BP	GO:0090158	endoplasmic reticulum membrane organization	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	BP	GO:0045907	positive regulation of vasoconstriction	-	30	29	-	-	3.09E-04	1.29E-03
TFLink	BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	-	23	23	-	-	3.64E-04	1.02E-03
TFLink	BP	GO:0033044	regulation of chromosome organization	-	249	247	-	-	2.73E-03	1.07E-02
TFLink	BP	GO:0009309	amine biosynthetic process	-	38	37	-	-	1.20E-03	1.61E-03
TFLink	BP	GO:2001014	regulation of skeletal muscle cell differentiation	-	20	19	-	-	6.08E-04	8.61E-04
TFLink	BP	GO:0061900	glial cell activation	-	56	52	-	-	1.02E-03	2.26E-03
TFLink	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	132	-	-	2.53E-03	5.70E-03
TFLink	BP	GO:0070493	thrombin-activated receptor signaling pathway	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	BP	GO:0045725	positive regulation of glycogen biosynthetic process	-	15	15	-	-	1.50E-03	6.46E-04
TFLink	BP	GO:0021794	thalamus development	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	CC	GO:0140467	integrated stress response signaling	-	41	40	-	-	3.57E-04	1.72E-03
TFLink	BP	GO:0035902	response to immobilization stress	-	20	20	-	-	7.46E-04	8.61E-04
TFLink	BP	GO:0035821	modulation of process of another organism	-	14	14	-	-	1.55E-04	6.46E-04
TFLink	BP	GO:0072537	fibroblast activation	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	BP	GO:0090235	regulation of metaphase plate congression	-	13	13	-	-	6.75E-04	5.92E-04
TFLink	BP	GO:0043647	inositol phosphate metabolic process	-	44	43	-	-	4.62E-04	1.88E-03
TFLink	BP	GO:0016180	snRNA processing	-	28	27	-	-	3.90E-04	1.18E-03
TFLink	BP	GO:0051303	establishment of chromosome localization	-	104	101	-	-	2.11E-03	4.36E-03
TFLink	BP	GO:0051382	kinetochore assembly	-	16	16	-	-	4.00E-04	6.99E-04
TFLink	BP	GO:0007164	establishment of tissue polarity	-	38	38	-	-	5.17E-04	1.67E-03
TFLink	BP	GO:0097164	ammonium ion metabolic process	-	23	23	-	-	3.99E-04	1.02E-03
TFLink	BP	GO:0021515	cell differentiation in spinal cord	-	51	51	-	-	5.59E-04	2.21E-03
TFLink	BP	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	-	18	18	-	-	3.70E-04	8.07E-04
TFLink	BP	GO:0002089	lens morphogenesis in camera-type eye	-	21	21	-	-	3.14E-04	9.15E-04
TFLink	BP	GO:1903055	positive regulation of extracellular matrix organization	-	28	28	-	-	2.99E-04	1.24E-03
TFLink	BP	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	-	18	18	-	-	9.25E-04	8.07E-04
TFLink	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	38	-	-	3.83E-04	1.67E-03
TFLink	BP	GO:0061318	renal filtration cell differentiation	-	22	22	-	-	9.71E-04	9.68E-04
TFLink	BP	GO:0007566	embryo implantation	-	57	53	-	-	8.75E-04	2.31E-03
TFLink	CC	GO:0048015	phosphatidylinositol-mediated signaling	-	34	33	-	-	5.41E-04	1.45E-03
TFLink	BP	GO:0031268	pseudopodium organization	-	17	17	-	-	2.83E-04	7.53E-04
TFLink	BP	GO:0060306	regulation of membrane repolarization	-	38	32	-	-	7.15E-04	1.40E-03
TFLink	BP	GO:0051017	actin filament bundle assembly	-	161	155	-	-	1.83E-03	6.67E-03
TFLink	BP	GO:1905953	negative regulation of lipid localization	-	63	42	-	-	8.76E-04	1.83E-03
TFLink	BP	GO:0045717	negative regulation of fatty acid biosynthetic process	-	24	18	-	-	3.43E-04	8.07E-04
TFLink	BP	GO:0021542	dentate gyrus development	-	19	19	-	-	6.86E-04	8.61E-04
TFLink	BP	GO:0036302	atrioventricular canal development	-	13	13	-	-	1.89E-04	5.92E-04
TFLink	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	37	-	-	5.63E-04	1.61E-03
TFLink	BP	GO:0021756	striatum development	-	21	20	-	-	4.34E-04	8.61E-04
TFLink	BP	GO:1901343	negative regulation of vasculature development	-	154	102	-	-	1.63E-03	4.41E-03
TFLink	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	147	-	-	1.53E-03	6.35E-03
TFLink	BP	GO:0072530	purine-containing compound transmembrane transport	-	31	31	-	-	3.59E-04	1.34E-03
TFLink	BP	GO:1902414	protein localization to cell junction	-	107	107	-	-	1.12E-03	4.63E-03
TFLink	BP	GO:0071305	cellular response to vitamin D	-	23	22	-	-	8.01E-04	9.68E-04
TFLink	BP	GO:0051304	chromosome separation	-	80	80	-	-	9.31E-04	3.44E-03
TFLink	BP	GO:0045780	positive regulation of bone resorption	-	18	18	-	-	3.11E-04	8.07E-04
TFLink	BP	GO:0048709	oligodendrocyte differentiation	-	101	100	-	-	1.29E-03	4.30E-03
TFLink	BP	GO:0045017	glycerolipid biosynthetic process	-	254	248	-	-	3.04E-03	1.07E-02
TFLink	BP	GO:1904507	positive regulation of telomere maintenance in response to DNA damage	-	15	15	-	-	2.67E-04	6.46E-04
TFLink	MF	GO:0016505	peptidase activator activity involved in apoptotic process	-	24	24	-	-	3.57E-04	1.08E-03
TFLink	BP	GO:0001776	leukocyte homeostasis	-	108	107	-	-	1.60E-03	4.63E-03
TFLink	BP	GO:0050769	positive regulation of neurogenesis	-	240	234	-	-	2.62E-03	1.01E-02
TFLink	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	15	-	-	2.05E-04	6.46E-04
TFLink	BP	GO:0030193	regulation of blood coagulation	-	70	70	-	-	1.15E-03	3.01E-03
TFLink	BP	GO:0050866	negative regulation of cell activation	-	216	207	-	-	4.06E-03	8.93E-03
TFLink	BP	GO:0045746	negative regulation of Notch signaling pathway	-	37	36	-	-	6.21E-04	1.56E-03
TFLink	BP	GO:0033500	carbohydrate homeostasis	-	251	234	-	-	2.46E-03	1.01E-02
TFLink	CC	GO:2000463	positive regulation of excitatory postsynaptic potential	-	31	29	-	-	1.40E-03	1.29E-03
TFLink	BP	GO:0038183	bile acid signaling pathway	-	12	12	-	-	4.86E-03	5.38E-04
TFLink	BP	GO:0044088	regulation of vacuole organization	-	56	56	-	-	8.10E-04	2.42E-03
TFLink	CC	GO:0051457	maintenance of protein location in nucleus	-	23	23	-	-	3.84E-04	1.02E-03
TFLink	CC	GO:0099522	cytosolic region	-	20	20	-	-	4.36E-04	8.61E-04
TFLink	CC	GO:0000791	euchromatin	-	60	57	-	-	3.95E-04	2.47E-03
TFLink	CC	GO:0030666	endocytic vesicle membrane	-	196	194	-	-	2.00E-03	8.39E-03
TFLink	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	CC	GO:1990752	microtubule end	-	34	34	-	-	3.58E-04	1.51E-03
TFLink	CC	GO:0043204	perikaryon	-	156	154	-	-	1.84E-03	6.67E-03
TFLink	CC	GO:0061702	canonical inflammasome complex	-	17	17	-	-	2.06E-04	7.53E-04
TFLink	CC	GO:0098643	banded collagen fibril	-	12	12	-	-	1.56E-04	5.38E-04
TFLink	CC	GO:0097542	ciliary tip	-	48	48	-	-	1.13E-03	2.10E-03
TFLink	CC	GO:1905368	peptidase complex	-	124	121	-	-	1.50E-03	5.22E-03
TFLink	CC	GO:0000792	heterochromatin	-	98	96	-	-	7.10E-04	4.14E-03
TFLink	CC	GO:0097546	ciliary base	-	47	46	-	-	7.12E-04	1.99E-03
TFLink	CC	GO:0071819	DUBm complex	-	25	23	-	-	7.27E-04	1.02E-03
TFLink	CC	GO:0031201	SNARE complex	-	48	48	-	-	5.10E-04	2.10E-03
TFLink	CC	GO:0005677	chromatin silencing complex	-	13	13	-	-	1.11E-04	5.92E-04
TFLink	CC	GO:0033260	nuclear DNA replication	-	40	40	-	-	8.17E-04	1.72E-03
TFLink	CC	GO:0044391	ribosomal subunit	-	203	196	-	-	2.04E-03	8.45E-03
TFLink	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	1.53E-04	4.84E-04
TFLink	CC	GO:0071013	catalytic step 2 spliceosome	-	88	84	-	-	1.13E-03	3.66E-03
TFLink	CC	GO:0031907	microbody lumen	-	51	51	-	-	7.37E-04	2.21E-03
TFLink	CC	GO:1990072	TRAPPIII protein complex	-	12	11	-	-	1.54E-04	4.84E-04
TFLink	CC	GO:0098862	cluster of actin-based cell projections	-	162	159	-	-	1.64E-03	6.89E-03
TFLink	CC	GO:0016363	nuclear matrix	-	127	126	-	-	9.40E-04	5.43E-03
TFLink	CC	GO:0031261	DNA replication preinitiation complex	-	46	46	-	-	5.56E-04	1.99E-03
TFLink	CC	GO:0032432	actin filament bundle	-	249	244	-	-	2.80E-03	1.05E-02
TFLink	CC	GO:0008088	axo-dendritic transport	-	78	78	-	-	7.91E-04	3.39E-03
TFLink	CC	GO:0031519	PcG protein complex	-	38	37	-	-	2.61E-04	1.61E-03
TFLink	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	42	-	-	4.62E-04	1.83E-03
TFLink	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	217	-	-	3.53E-03	9.36E-03
TFLink	CC	GO:0000313	organellar ribosome	-	89	89	-	-	9.19E-04	3.87E-03
TFLink	CC	GO:0099643	signal release from synapse	-	147	144	-	-	2.04E-03	6.24E-03
TFLink	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	46	-	-	5.11E-04	1.99E-03
TFLink	CC	GO:0005818	aster	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	CC	GO:0030018	Z disc	-	129	125	-	-	1.26E-03	5.38E-03
TFLink	CC	GO:0032580	Golgi cisterna membrane	-	93	82	-	-	8.70E-04	3.55E-03
TFLink	CC	GO:0097381	photoreceptor disc membrane	-	25	20	-	-	2.59E-04	8.61E-04
TFLink	CC	GO:1905360	GTPase complex	-	41	39	-	-	4.10E-04	1.72E-03
TFLink	CC	GO:0097540	axonemal central pair	-	161	153	-	-	1.58E-03	6.62E-03
TFLink	CC	GO:0042641	actomyosin	-	77	76	-	-	8.84E-04	3.28E-03
TFLink	CC	GO:0097386	glial cell projection	-	38	38	-	-	4.10E-04	1.67E-03
TFLink	CC	GO:0032588	trans-Golgi network membrane	-	102	102	-	-	1.07E-03	4.41E-03
TFLink	CC	GO:0070382	exocytic vesicle	-	224	221	-	-	2.30E-03	9.52E-03
TFLink	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	47	-	-	7.08E-04	2.04E-03
TFLink	CC	GO:0031903	microbody membrane	-	65	65	-	-	7.23E-04	2.80E-03
TFLink	CC	GO:0046930	pore complex	-	26	26	-	-	3.08E-04	1.13E-03
TFLink	CC	GO:0030877	beta-catenin destruction complex	-	11	11	-	-	2.85E-04	4.84E-04
TFLink	CC	GO:0099091	"postsynaptic specialization, intracellular component"	-	16	16	-	-	4.28E-04	6.99E-04
TFLink	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	246	-	-	2.87E-03	1.06E-02
TFLink	CC	GO:0044322	endoplasmic reticulum quality control compartment	-	25	24	-	-	2.56E-04	1.08E-03
TFLink	CC	GO:1990071	TRAPPII protein complex	-	12	11	-	-	1.54E-04	4.84E-04
TFLink	CC	GO:0099571	postsynaptic cytoskeleton	-	18	17	-	-	2.06E-04	7.53E-04
TFLink	CC	GO:0044298	cell body membrane	-	32	32	-	-	1.77E-03	1.40E-03
TFLink	CC	GO:0035145	exon-exon junction complex	-	11	11	-	-	9.13E-03	4.84E-04
TFLink	CC	GO:0051882	mitochondrial depolarization	-	21	21	-	-	5.43E-04	9.15E-04
TFLink	CC	GO:0045495	pole plasm	-	25	24	-	-	2.57E-04	1.08E-03
TFLink	CC	GO:0072379	ER membrane insertion complex	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	2.05E-04	8.61E-04
TFLink	CC	GO:0010369	chromocenter	-	14	14	-	-	2.53E-04	6.46E-04
TFLink	CC	GO:0002177	manchette	-	19	19	-	-	2.06E-04	8.61E-04
TFLink	CC	GO:0016323	basolateral plasma membrane	-	239	236	-	-	2.20E-03	1.02E-02
TFLink	CC	GO:0045009	chitosome	-	21	21	-	-	5.89E-04	9.15E-04
TFLink	CC	GO:0042405	nuclear inclusion body	-	12	12	-	-	2.79E-04	5.38E-04
TFLink	CC	GO:0042645	mitochondrial nucleoid	-	45	45	-	-	5.72E-04	1.94E-03
TFLink	CC	GO:0098636	protein complex involved in cell adhesion	-	57	57	-	-	6.15E-04	2.47E-03
TFLink	CC	GO:0001917	photoreceptor inner segment	-	71	70	-	-	7.60E-04	3.01E-03
TFLink	CC	GO:0098845	postsynaptic endosome	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	CC	GO:0019897	extrinsic component of plasma membrane	-	156	152	-	-	1.64E-03	6.56E-03
TFLink	CC	GO:0031594	neuromuscular junction	-	73	73	-	-	7.66E-04	3.17E-03
TFLink	CC	GO:0045120	pronucleus	-	14	14	-	-	1.38E-04	6.46E-04
TFLink	CC	GO:0043083	synaptic cleft	-	21	21	-	-	2.58E-04	9.15E-04
TFLink	CC	GO:0000922	spindle pole	-	172	168	-	-	1.48E-03	7.26E-03
TFLink	CC	GO:0120111	neuron projection cytoplasm	-	94	94	-	-	9.16E-04	4.09E-03
TFLink	CC	GO:0070971	endoplasmic reticulum exit site	-	32	28	-	-	3.07E-04	1.24E-03
TFLink	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	CC	GO:0004879	nuclear receptor activity	-	63	62	-	-	5.10E-04	2.69E-03
TFLink	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	167	-	-	1.97E-03	7.21E-03
TFLink	CC	GO:0000123	histone acetyltransferase complex	-	93	89	-	-	1.44E-03	3.87E-03
TFLink	CC	GO:0034982	mitochondrial protein processing	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	108	-	-	1.12E-03	4.68E-03
TFLink	CC	GO:0048786	presynaptic active zone	-	80	80	-	-	2.17E-03	3.44E-03
TFLink	CC	GO:0098981	cholinergic synapse	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	CC	GO:0007034	vacuolar transport	-	168	164	-	-	1.93E-03	7.10E-03
TFLink	CC	GO:0090741	pigment granule membrane	-	21	21	-	-	5.59E-04	9.15E-04
TFLink	CC	GO:0043194	axon initial segment	-	21	21	-	-	2.57E-04	9.15E-04
TFLink	CC	GO:1900115	extracellular regulation of signal transduction	-	13	11	-	-	1.59E-03	4.84E-04
TFLink	CC	GO:0005776	autophagosome	-	111	107	-	-	1.12E-03	4.63E-03
TFLink	CC	GO:0031430	M band	-	22	22	-	-	2.56E-04	9.68E-04
TFLink	CC	GO:0001931	uropod	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	73	-	-	8.76E-04	3.17E-03
TFLink	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	98	-	-	1.01E-03	4.25E-03
TFLink	CC	GO:0030677	ribonuclease P complex	-	14	13	-	-	1.54E-04	5.92E-04
TFLink	CC	GO:0000164	protein phosphatase type 1 complex	-	19	18	-	-	2.04E-04	8.07E-04
TFLink	CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	-	29	28	-	-	3.09E-04	1.24E-03
TFLink	CC	GO:0032994	protein-lipid complex	-	39	37	-	-	4.11E-04	1.61E-03
TFLink	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	144	-	-	1.62E-03	6.24E-03
TFLink	CC	GO:0071012	catalytic step 1 spliceosome	-	12	11	-	-	2.79E-04	4.84E-04
TFLink	CC	GO:0001527	microfibril	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	CC	GO:0072562	blood microparticle	-	144	103	-	-	1.13E-03	4.47E-03
TFLink	CC	GO:0051233	spindle midzone	-	36	36	-	-	4.10E-04	1.56E-03
TFLink	CC	GO:0005811	lipid droplet	-	102	101	-	-	1.07E-03	4.36E-03
TFLink	CC	GO:0045022	early endosome to late endosome transport	-	44	42	-	-	6.88E-04	1.83E-03
TFLink	CC	GO:0043113	receptor clustering	-	51	50	-	-	5.63E-04	2.15E-03
TFLink	CC	GO:0005940	septin ring	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	CC	GO:1904090	peptidase inhibitor complex	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	CC	GO:0033617	mitochondrial cytochrome c oxidase assembly	-	25	25	-	-	3.07E-04	1.08E-03
TFLink	CC	GO:0044853	plasma membrane raft	-	114	113	-	-	1.30E-03	4.90E-03
TFLink	CC	GO:0005881	cytoplasmic microtubule	-	256	248	-	-	2.40E-03	1.07E-02
TFLink	CC	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	-	15	15	-	-	2.05E-04	6.46E-04
TFLink	CC	GO:0008180	COP9 signalosome	-	17	17	-	-	2.05E-04	7.53E-04
TFLink	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	56	-	-	6.14E-04	2.42E-03
TFLink	CC	GO:0005905	clathrin-coated pit	-	73	72	-	-	9.44E-04	3.12E-03
TFLink	CC	GO:0099569	presynaptic cytoskeleton	-	12	12	-	-	4.81E-04	5.38E-04
TFLink	CC	GO:0043034	costamere	-	18	18	-	-	1.97E-04	8.07E-04
TFLink	CC	GO:0031904	endosome lumen	-	38	38	-	-	4.10E-04	1.67E-03
TFLink	CC	GO:0060170	ciliary membrane	-	76	75	-	-	8.19E-04	3.23E-03
TFLink	CC	GO:0043240	Fanconi anaemia nuclear complex	-	13	12	-	-	1.42E-04	5.38E-04
TFLink	CC	GO:0000783	nuclear telomere cap complex	-	12	12	-	-	4.51E-04	5.38E-04
TFLink	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	23	-	-	2.57E-04	1.02E-03
TFLink	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	2.05E-04	6.46E-04
TFLink	CC	GO:0032154	cleavage furrow	-	54	53	-	-	6.17E-04	2.31E-03
TFLink	CC	GO:0005640	nuclear outer membrane	-	30	29	-	-	3.08E-04	1.29E-03
TFLink	CC	GO:0005652	nuclear lamina	-	12	12	-	-	1.73E-04	5.38E-04
TFLink	CC	GO:0007006	mitochondrial membrane organization	-	117	111	-	-	1.04E-03	4.79E-03
TFLink	CC	GO:0001772	immunological synapse	-	44	44	-	-	4.84E-04	1.94E-03
TFLink	CC	GO:0030904	retromer complex	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	CC	GO:0034551	mitochondrial respiratory chain complex III assembly	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	CC	GO:0030863	cortical cytoskeleton	-	104	103	-	-	1.07E-03	4.47E-03
TFLink	CC	GO:1905348	endonuclease complex	-	38	36	-	-	4.92E-04	1.56E-03
TFLink	CC	GO:0030315	T-tubule	-	52	51	-	-	5.62E-04	2.21E-03
TFLink	CC	GO:0060076	excitatory synapse	-	64	64	-	-	2.04E-03	2.80E-03
TFLink	CC	GO:0036019	endolysosome	-	29	29	-	-	3.07E-04	1.29E-03
TFLink	CC	GO:0001891	phagocytic cup	-	28	27	-	-	3.07E-04	1.18E-03
TFLink	CC	GO:0099086	synaptonemal structure	-	40	40	-	-	8.69E-04	1.72E-03
TFLink	CC	GO:0030427	site of polarized growth	-	172	170	-	-	2.11E-03	7.32E-03
TFLink	CC	GO:0044309	neuron spine	-	213	212	-	-	2.88E-03	9.15E-03
TFLink	CC	GO:0030658	transport vesicle membrane	-	231	224	-	-	2.44E-03	9.68E-03
TFLink	CC	GO:0000813	ESCRT I complex	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	CC	GO:0098918	structural constituent of synapse	-	27	26	-	-	9.81E-04	1.13E-03
TFLink	CC	GO:0016281	eukaryotic translation initiation factor 4F complex	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	CC	GO:0000940	outer kinetochore	-	17	16	-	-	2.05E-04	6.99E-04
TFLink	CC	GO:0034719	SMN-Sm protein complex	-	18	15	-	-	8.22E-04	6.46E-04
TFLink	CC	GO:0044232	organelle membrane contact site	-	50	50	-	-	5.63E-04	2.15E-03
TFLink	CC	GO:0098803	respiratory chain complex	-	39	36	-	-	4.10E-04	1.56E-03
TFLink	CC	GO:0097545	axonemal outer doublet	-	164	156	-	-	1.64E-03	6.72E-03
TFLink	CC	GO:0097038	perinuclear endoplasmic reticulum	-	19	19	-	-	2.05E-04	8.61E-04
TFLink	CC	GO:0070069	cytochrome complex	-	42	39	-	-	4.10E-04	1.72E-03
TFLink	CC	GO:0031143	pseudopodium	-	18	18	-	-	4.34E-04	8.07E-04
TFLink	CC	GO:0005942	phosphatidylinositol 3-kinase complex	-	28	28	-	-	3.08E-04	1.24E-03
TFLink	CC	GO:0055037	recycling endosome	-	200	195	-	-	2.04E-03	8.39E-03
TFLink	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	94	-	-	9.23E-04	4.09E-03
TFLink	CC	GO:0030126	COPI vesicle coat	-	13	12	-	-	1.54E-04	5.38E-04
TFLink	CC	GO:0035253	ciliary rootlet	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	CC	GO:0071682	endocytic vesicle lumen	-	23	21	-	-	2.57E-04	9.15E-04
TFLink	CC	GO:0030684	preribosome	-	76	72	-	-	9.68E-04	3.12E-03
TFLink	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	17	-	-	2.28E-04	7.53E-04
TFLink	CC	GO:1990391	DNA repair complex	-	22	22	-	-	2.11E-04	9.68E-04
TFLink	CC	GO:0005775	vacuolar lumen	-	176	174	-	-	2.01E-03	7.53E-03
TFLink	CC	GO:0032433	filopodium tip	-	19	19	-	-	2.06E-04	8.61E-04
TFLink	CC	GO:0032982	myosin filament	-	24	24	-	-	2.49E-04	1.08E-03
TFLink	CC	GO:0016327	apicolateral plasma membrane	-	23	23	-	-	7.61E-04	1.02E-03
TFLink	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	23	-	-	2.56E-04	1.02E-03
TFLink	CC	GO:1990124	messenger ribonucleoprotein complex	-	12	12	-	-	4.74E-04	5.38E-04
TFLink	CC	GO:0044306	neuron projection terminus	-	164	164	-	-	1.61E-03	7.10E-03
TFLink	CC	GO:0034455	t-UTP complex	-	53	50	-	-	8.86E-04	2.15E-03
TFLink	CC	GO:0030992	intraciliary transport particle B	-	17	17	-	-	2.05E-04	7.53E-04
TFLink	CC	GO:0031970	organelle envelope lumen	-	94	94	-	-	8.05E-04	4.09E-03
TFLink	CC	GO:0097550	transcription preinitiation complex	-	13	13	-	-	4.27E-04	5.92E-04
TFLink	CC	GO:0033270	paranode region of axon	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	CC	GO:0120293	dynein axonemal particle	-	20	20	-	-	7.95E-04	8.61E-04
TFLink	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	25	-	-	5.16E-04	1.08E-03
TFLink	CC	GO:0043292	contractile muscle fiber	-	245	236	-	-	4.07E-03	1.02E-02
TFLink	CC	GO:0018995	host cellular component	-	12	12	-	-	9.76E-04	5.38E-04
TFLink	CC	GO:0034709	methylosome	-	13	13	-	-	3.89E-04	5.92E-04
TFLink	CC	GO:0032426	stereocilium tip	-	21	20	-	-	2.57E-04	8.61E-04
TFLink	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	CC	GO:0005849	mRNA cleavage factor complex	-	22	19	-	-	5.10E-04	8.61E-04
TFLink	CC	GO:0000803	sex chromosome	-	32	29	-	-	2.56E-04	1.29E-03
TFLink	CC	GO:0098982	GABA-ergic synapse	-	84	84	-	-	4.80E-03	3.66E-03
TFLink	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	15	-	-	2.05E-04	6.46E-04
TFLink	CC	GO:0035097	histone methyltransferase complex	-	63	63	-	-	4.63E-04	2.74E-03
TFLink	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	15	-	-	2.05E-04	6.46E-04
TFLink	CC	GO:0000242	pericentriolar material	-	22	22	-	-	2.56E-04	9.68E-04
TFLink	CC	GO:1903293	phosphatase complex	-	54	52	-	-	5.59E-04	2.26E-03
TFLink	CC	GO:0097470	ribbon synapse	-	13	13	-	-	3.32E-04	5.92E-04
TFLink	CC	GO:0031941	filamentous actin	-	27	27	-	-	3.08E-04	1.18E-03
TFLink	CC	GO:0000786	nucleosome	-	149	93	-	-	1.02E-03	4.03E-03
TFLink	CC	GO:0001533	cornified envelope	-	59	59	-	-	6.17E-04	2.58E-03
TFLink	CC	GO:1904724	tertiary granule lumen	-	55	55	-	-	6.13E-04	2.37E-03
TFLink	CC	GO:0030027	lamellipodium	-	202	200	-	-	2.15E-03	8.61E-03
TFLink	CC	GO:0090571	RNA polymerase II transcription repressor complex	-	15	15	-	-	1.54E-04	6.46E-04
TFLink	CC	GO:0033177	"proton-transporting two-sector ATPase complex, proton-transporting domain"	-	26	26	-	-	3.07E-04	1.13E-03
TFLink	CC	GO:0000800	lateral element	-	14	14	-	-	1.48E-04	6.46E-04
TFLink	CC	GO:0035437	maintenance of protein localization in endoplasmic reticulum	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	CC	GO:0060077	inhibitory synapse	-	20	20	-	-	2.57E-04	8.61E-04
TFLink	CC	GO:0031209	SCAR complex	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	CC	GO:0034992	microtubule organizing center attachment site	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	2.05E-04	6.99E-04
TFLink	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	21	-	-	2.57E-04	9.15E-04
TFLink	CC	GO:0002102	podosome	-	31	31	-	-	6.52E-04	1.34E-03
TFLink	CC	GO:0090543	Flemming body	-	33	32	-	-	6.63E-04	1.40E-03
TFLink	CC	GO:0016328	lateral plasma membrane	-	66	66	-	-	7.80E-04	2.85E-03
TFLink	CC	GO:0001650	fibrillar center	-	151	149	-	-	1.39E-03	6.46E-03
TFLink	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	2.41E-04	6.46E-04
TFLink	CC	GO:1990204	oxidoreductase complex	-	90	85	-	-	1.19E-03	3.66E-03
TFLink	CC	GO:0000930	gamma-tubulin complex	-	16	16	-	-	6.92E-04	6.99E-04
TFLink	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	121	-	-	1.33E-03	5.22E-03
TFLink	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	18	-	-	2.05E-04	8.07E-04
TFLink	CC	GO:0001726	ruffle	-	181	180	-	-	2.07E-03	7.75E-03
TFLink	CC	GO:0106083	nuclear membrane protein complex	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	CC	GO:1990909	Wnt signalosome	-	13	13	-	-	6.31E-04	5.92E-04
TFLink	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	18	-	-	2.05E-04	8.07E-04
TFLink	CC	GO:0043198	dendritic shaft	-	38	38	-	-	4.10E-04	1.67E-03
TFLink	CC	GO:0043073	germ cell nucleus	-	67	66	-	-	5.98E-04	2.85E-03
TFLink	CC	GO:0032042	mitochondrial DNA metabolic process	-	22	22	-	-	2.70E-04	9.68E-04
TFLink	CC	GO:0016592	mediator complex	-	38	38	-	-	5.06E-04	1.67E-03
TFLink	CC	GO:0034045	phagophore assembly site membrane	-	19	19	-	-	2.05E-04	8.61E-04
TFLink	CC	GO:0022626	cytosolic ribosome	-	118	111	-	-	1.17E-03	4.79E-03
TFLink	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	43	-	-	4.63E-04	1.88E-03
TFLink	CC	GO:0034451	centriolar satellite	-	120	119	-	-	1.64E-03	5.16E-03
TFLink	CC	GO:0044224	juxtaparanode region of axon	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	CC	GO:0045171	intercellular bridge	-	91	90	-	-	1.17E-03	3.87E-03
TFLink	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	80	-	-	8.69E-04	3.44E-03
TFLink	CC	GO:0008250	oligosaccharyltransferase complex	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	CC	GO:0000109	nucleotide-excision repair complex	-	11	11	-	-	8.93E-04	4.84E-04
TFLink	CC	GO:0019774	"proteasome core complex, beta-subunit complex"	-	11	11	-	-	1.53E-04	4.84E-04
TFLink	CC	GO:0044292	dendrite terminus	-	13	13	-	-	5.04E-04	5.92E-04
TFLink	CC	GO:0032039	integrator complex	-	19	18	-	-	2.61E-04	8.07E-04
TFLink	CC	GO:0098691	dopaminergic synapse	-	15	15	-	-	2.07E-04	6.46E-04
TFLink	CC	GO:0033268	node of Ranvier	-	16	16	-	-	2.06E-04	6.99E-04
TFLink	CC	GO:0036038	MKS complex	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	CC	GO:0030527	structural constituent of chromatin	-	97	43	-	-	3.55E-04	1.88E-03
TFLink	CC	GO:0036379	myofilament	-	26	25	-	-	3.09E-04	1.08E-03
TFLink	CC	GO:0030286	dynein complex	-	210	201	-	-	2.10E-03	8.66E-03
TFLink	CC	GO:0031105	septin complex	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	CC	GO:0097228	sperm principal piece	-	33	33	-	-	3.59E-04	1.45E-03
TFLink	CC	GO:0044615	nuclear pore nuclear basket	-	12	12	-	-	2.14E-04	5.38E-04
TFLink	CC	GO:0016482	cytosolic transport	-	135	133	-	-	1.47E-03	5.76E-03
TFLink	CC	GO:0090665	glycoprotein complex	-	23	23	-	-	2.57E-04	1.02E-03
TFLink	CC	GO:0005796	Golgi lumen	-	106	98	-	-	1.06E-03	4.25E-03
TFLink	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	36	-	-	4.09E-04	1.56E-03
TFLink	CC	GO:0034358	plasma lipoprotein particle	-	36	34	-	-	3.60E-04	1.51E-03
TFLink	CC	GO:0008023	transcription elongation factor complex	-	47	47	-	-	5.65E-04	2.04E-03
TFLink	CC	GO:0043220	Schmidt-Lanterman incisure	-	11	11	-	-	1.30E-03	4.84E-04
TFLink	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	25	-	-	3.08E-04	1.08E-03
TFLink	CC	GO:0030662	coated vesicle membrane	-	202	198	-	-	2.72E-03	8.55E-03
TFLink	CC	GO:0007039	protein catabolic process in the vacuole	-	61	59	-	-	8.96E-04	2.58E-03
TFLink	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	66	-	-	7.15E-04	2.85E-03
TFLink	CC	GO:0090734	site of DNA damage	-	118	116	-	-	1.11E-03	5.00E-03
TFLink	MF	GO:0051861	glycolipid binding	-	30	30	-	-	3.59E-04	1.29E-03
TFLink	MF	GO:0047429	nucleoside triphosphate diphosphatase activity	-	12	11	-	-	1.54E-04	4.84E-04
TFLink	MF	GO:0051087	protein-folding chaperone binding	-	135	132	-	-	1.41E-03	5.70E-03
TFLink	MF	GO:0051959	dynein light intermediate chain binding	-	27	27	-	-	3.08E-04	1.18E-03
TFLink	CC	GO:0015464	acetylcholine receptor activity	-	21	20	-	-	2.59E-04	8.61E-04
TFLink	MF	GO:0042301	phosphate ion binding	-	12	12	-	-	4.48E-04	5.38E-04
TFLink	MF	GO:0016594	glycine binding	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	MF	GO:0031681	G-protein beta-subunit binding	-	22	20	-	-	2.58E-04	8.61E-04
TFLink	MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	-	37	37	-	-	8.50E-04	1.61E-03
TFLink	MF	GO:0035613	RNA stem-loop binding	-	21	16	-	-	2.05E-04	6.99E-04
TFLink	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	242	-	-	2.04E-03	1.04E-02
TFLink	MF	GO:0033612	receptor serine/threonine kinase binding	-	20	20	-	-	2.81E-04	8.61E-04
TFLink	MF	GO:0033691	sialic acid binding	-	22	21	-	-	2.60E-04	9.15E-04
TFLink	MF	GO:0004875	complement receptor activity	-	12	11	-	-	1.57E-04	4.84E-04
TFLink	MF	GO:0048306	calcium-dependent protein binding	-	61	58	-	-	6.36E-04	2.53E-03
TFLink	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	29	-	-	3.08E-04	1.29E-03
TFLink	MF	GO:0035325	Toll-like receptor binding	-	13	13	-	-	1.55E-04	5.92E-04
TFLink	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	140	-	-	1.64E-03	6.03E-03
TFLink	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	56	-	-	6.13E-04	2.42E-03
TFLink	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	137	-	-	1.52E-03	5.92E-03
TFLink	MF	GO:0045504	dynein heavy chain binding	-	16	16	-	-	2.05E-04	6.99E-04
TFLink	MF	GO:0140457	protein demethylase activity	-	31	30	-	-	2.40E-04	1.29E-03
TFLink	MF	GO:0005158	insulin receptor binding	-	22	22	-	-	9.11E-04	9.68E-04
TFLink	MF	GO:0005159	insulin-like growth factor receptor binding	-	16	16	-	-	5.28E-04	6.99E-04
TFLink	MF	GO:0016530	metallochaperone activity	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	MF	GO:0061980	regulatory RNA binding	-	52	45	-	-	5.48E-04	1.94E-03
TFLink	MF	GO:0015035	protein-disulfide reductase activity	-	32	32	-	-	3.58E-04	1.40E-03
TFLink	MF	GO:0000182	rDNA binding	-	11	11	-	-	4.44E-04	4.84E-04
TFLink	MF	GO:0001671	ATPase activator activity	-	29	28	-	-	3.07E-04	1.24E-03
TFLink	MF	GO:0070840	dynein complex binding	-	25	25	-	-	2.84E-04	1.08E-03
TFLink	MF	GO:0035035	histone acetyltransferase binding	-	24	24	-	-	1.65E-04	1.08E-03
TFLink	MF	GO:0061684	chaperone-mediated autophagy	-	16	16	-	-	9.64E-04	6.99E-04
TFLink	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	34	-	-	3.58E-04	1.51E-03
TFLink	MF	GO:0003688	DNA replication origin binding	-	18	18	-	-	5.50E-04	8.07E-04
TFLink	MF	GO:0005178	integrin binding	-	153	153	-	-	1.55E-03	6.62E-03
TFLink	MF	GO:0070064	proline-rich region binding	-	17	17	-	-	3.33E-04	7.53E-04
TFLink	MF	GO:0005549	odorant binding	-	128	110	-	-	1.22E-03	4.73E-03
TFLink	MF	GO:0042043	neurexin family protein binding	-	14	14	-	-	1.55E-04	6.46E-04
TFLink	MF	GO:0008327	methyl-CpG binding	-	31	26	-	-	3.09E-04	1.13E-03
TFLink	MF	GO:0031418	L-ascorbic acid binding	-	20	20	-	-	8.43E-04	8.61E-04
TFLink	MF	GO:0048019	receptor antagonist activity	-	31	26	-	-	2.84E-03	1.13E-03
TFLink	MF	GO:0005521	lamin binding	-	15	15	-	-	2.05E-04	6.46E-04
TFLink	MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	-	19	17	-	-	1.23E-04	7.53E-04
TFLink	MF	GO:0140318	protein transporter activity	-	40	39	-	-	6.49E-04	1.72E-03
TFLink	MF	GO:0070628	proteasome binding	-	17	17	-	-	3.42E-04	7.53E-04
TFLink	MF	GO:0034056	estrogen response element binding	-	11	11	-	-	1.10E-04	4.84E-04
TFLink	MF	GO:0046812	host cell surface binding	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:0000217	DNA secondary structure binding	-	37	37	-	-	3.65E-04	1.61E-03
TFLink	MF	GO:0017110	nucleoside diphosphate phosphatase activity	-	17	17	-	-	2.06E-04	7.53E-04
TFLink	MF	GO:0002039	p53 binding	-	66	66	-	-	4.62E-04	2.85E-03
TFLink	MF	GO:0005496	steroid binding	-	110	109	-	-	1.59E-03	4.73E-03
TFLink	MF	GO:0008443	phosphofructokinase activity	-	27	27	-	-	3.92E-04	1.18E-03
TFLink	MF	GO:0035727	lysophosphatidic acid binding	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:0003684	damaged DNA binding	-	89	84	-	-	6.92E-04	3.66E-03
TFLink	MF	GO:0000339	RNA cap binding	-	20	20	-	-	3.77E-04	8.61E-04
TFLink	MF	GO:0016500	protein-hormone receptor activity	-	21	20	-	-	1.72E-03	8.61E-04
TFLink	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	129	-	-	1.18E-03	5.59E-03
TFLink	MF	GO:0005523	tropomyosin binding	-	15	15	-	-	2.07E-04	6.46E-04
TFLink	MF	GO:0031543	peptidyl-proline dioxygenase activity	-	12	12	-	-	3.80E-04	5.38E-04
TFLink	MF	GO:1900121	negative regulation of receptor binding	-	13	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:0070063	RNA polymerase binding	-	61	60	-	-	6.36E-04	2.58E-03
TFLink	MF	GO:0050811	GABA receptor binding	-	18	17	-	-	2.06E-04	7.53E-04
TFLink	MF	GO:0030971	receptor tyrosine kinase binding	-	76	76	-	-	8.25E-04	3.28E-03
TFLink	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	82	-	-	1.07E-03	3.55E-03
TFLink	MF	GO:0140030	modification-dependent protein binding	-	179	175	-	-	1.43E-03	7.53E-03
TFLink	MF	GO:0016780	"phosphotransferase activity, for other substituted phosphate groups"	-	24	24	-	-	2.56E-04	1.08E-03
TFLink	MF	GO:0009881	photoreceptor activity	-	17	13	-	-	5.04E-03	5.92E-04
TFLink	MF	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	-	19	18	-	-	2.07E-04	8.07E-04
TFLink	MF	GO:0032794	GTPase activating protein binding	-	13	13	-	-	1.54E-04	5.92E-04
TFLink	MF	GO:0042813	Wnt receptor activity	-	16	16	-	-	2.06E-04	6.99E-04
TFLink	MF	GO:0141047	molecular tag activity	-	13	12	-	-	2.55E-04	5.38E-04
TFLink	MF	GO:0032404	mismatch repair complex binding	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	MF	GO:0033130	acetylcholine receptor binding	-	12	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:1990226	histone methyltransferase binding	-	15	15	-	-	2.29E-04	6.46E-04
TFLink	MF	GO:0035497	cAMP response element binding	-	12	12	-	-	9.62E-05	5.38E-04
TFLink	MF	GO:0044548	S100 protein binding	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	MF	GO:0010851	cyclase regulator activity	-	17	13	-	-	1.55E-04	5.92E-04
TFLink	MF	GO:0030983	mismatched DNA binding	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	MF	GO:0030276	clathrin binding	-	70	68	-	-	7.16E-04	2.96E-03
TFLink	MF	GO:0046875	ephrin receptor binding	-	29	29	-	-	9.70E-04	1.29E-03
TFLink	MF	GO:0140311	protein sequestering activity	-	14	14	-	-	5.58E-04	6.46E-04
TFLink	MF	GO:0046790	virion binding	-	19	18	-	-	2.05E-04	8.07E-04
TFLink	MF	GO:0030552	cAMP binding	-	48	47	-	-	5.51E-03	2.04E-03
TFLink	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	39	-	-	6.17E-04	1.72E-03
TFLink	MF	GO:0035173	histone kinase activity	-	17	17	-	-	2.81E-04	7.53E-04
TFLink	MF	GO:0097602	cullin family protein binding	-	26	25	-	-	3.08E-04	1.08E-03
TFLink	MF	GO:0017154	semaphorin receptor activity	-	12	12	-	-	1.55E-04	5.38E-04
TFLink	MF	GO:0016209	antioxidant activity	-	92	86	-	-	1.32E-03	3.71E-03
TFLink	MF	GO:0070325	lipoprotein particle receptor binding	-	32	30	-	-	3.58E-04	1.29E-03
TFLink	MF	GO:0044325	transmembrane transporter binding	-	159	152	-	-	1.66E-03	6.56E-03
TFLink	MF	GO:0048156	tau protein binding	-	43	43	-	-	4.50E-04	1.88E-03
TFLink	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	36	-	-	3.22E-04	1.56E-03
TFLink	MF	GO:0045295	gamma-catenin binding	-	13	13	-	-	2.57E-04	5.92E-04
TFLink	MF	GO:0140272	exogenous protein binding	-	79	77	-	-	8.24E-04	3.34E-03
TFLink	MF	GO:0030145	manganese ion binding	-	65	64	-	-	8.01E-04	2.80E-03
TFLink	MF	GO:0071814	protein-lipid complex binding	-	52	47	-	-	8.84E-04	2.04E-03
TFLink	MF	GO:0008066	glutamate receptor activity	-	70	69	-	-	1.63E-03	3.01E-03
TFLink	MF	GO:0030553	cGMP binding	-	15	15	-	-	2.07E-04	6.46E-04
TFLink	MF	GO:0017069	snRNA binding	-	54	47	-	-	8.72E-04	2.04E-03
TFLink	MF	GO:0030215	semaphorin receptor binding	-	23	23	-	-	2.57E-04	1.02E-03
TFLink	MF	GO:0031996	thioesterase binding	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:0031369	translation initiation factor binding	-	32	32	-	-	4.82E-04	1.40E-03
TFLink	MF	GO:0019843	rRNA binding	-	69	66	-	-	1.75E-03	2.85E-03
TFLink	MF	GO:0004713	protein tyrosine kinase activity	-	213	212	-	-	2.19E-03	9.15E-03
TFLink	MF	GO:0061783	peptidoglycan muralytic activity	-	14	12	-	-	1.58E-04	5.38E-04
TFLink	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	51	-	-	5.63E-04	2.21E-03
TFLink	MF	GO:0008093	cytoskeletal anchor activity	-	24	24	-	-	2.56E-04	1.08E-03
TFLink	MF	GO:0070300	phosphatidic acid binding	-	20	20	-	-	2.56E-04	8.61E-04
TFLink	MF	GO:0043325	"phosphatidylinositol-3,4-bisphosphate binding"	-	29	28	-	-	5.68E-04	1.24E-03
TFLink	MF	GO:0016208	AMP binding	-	22	22	-	-	2.57E-04	9.68E-04
TFLink	MF	GO:0000287	magnesium ion binding	-	225	222	-	-	2.60E-03	9.58E-03
TFLink	MF	GO:0031490	chromatin DNA binding	-	120	115	-	-	9.80E-04	4.95E-03
TFLink	MF	GO:0017022	myosin binding	-	73	72	-	-	7.67E-04	3.12E-03
TFLink	MF	GO:0004896	cytokine receptor activity	-	93	93	-	-	9.75E-04	4.03E-03
TFLink	MF	GO:0017166	vinculin binding	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	MF	GO:0008301	"DNA binding, bending"	-	18	18	-	-	2.80E-04	8.07E-04
TFLink	MF	GO:1990459	transferrin receptor binding	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	MF	GO:0005539	glycosaminoglycan binding	-	236	231	-	-	2.62E-03	9.95E-03
TFLink	MF	GO:0140666	annealing activity	-	11	11	-	-	1.89E-04	4.84E-04
TFLink	MF	GO:0071933	Arp2/3 complex binding	-	14	14	-	-	1.54E-04	6.46E-04
TFLink	MF	GO:0010181	FMN binding	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	MF	GO:0001614	purinergic nucleotide receptor activity	-	20	20	-	-	2.59E-04	8.61E-04
TFLink	MF	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	-	26	26	-	-	1.24E-03	1.13E-03
TFLink	MF	GO:0031420	alkali metal ion binding	-	17	17	-	-	2.02E-04	7.53E-04
TFLink	MF	GO:0044183	protein folding chaperone	-	67	56	-	-	6.13E-04	2.42E-03
TFLink	MF	GO:0005132	type I interferon receptor binding	-	17	17	-	-	2.13E-04	7.53E-04
TFLink	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	108	-	-	1.27E-03	4.68E-03
TFLink	MF	GO:0003725	double-stranded RNA binding	-	72	72	-	-	1.32E-03	3.12E-03
TFLink	MF	GO:0070679	"inositol 1,4,5 trisphosphate binding"	-	17	16	-	-	2.06E-04	6.99E-04
TFLink	MF	GO:0051018	protein kinase A binding	-	52	52	-	-	7.15E-04	2.26E-03
TFLink	MF	GO:0071889	14-3-3 protein binding	-	34	33	-	-	4.11E-04	1.45E-03
TFLink	MF	GO:0004618	phosphoglycerate kinase activity	-	89	89	-	-	8.83E-04	3.87E-03
TFLink	MF	GO:0042805	actinin binding	-	36	36	-	-	5.89E-04	1.56E-03
TFLink	MF	GO:0043531	ADP binding	-	38	38	-	-	6.33E-04	1.67E-03
TFLink	MF	GO:0043394	proteoglycan binding	-	36	36	-	-	3.96E-04	1.56E-03
TFLink	MF	GO:0005542	folic acid binding	-	13	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:0042608	T cell receptor binding	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:0046332	SMAD binding	-	77	77	-	-	7.68E-04	3.34E-03
TFLink	MF	GO:0043560	insulin receptor substrate binding	-	13	13	-	-	3.33E-04	5.92E-04
TFLink	MF	GO:0001968	fibronectin binding	-	30	29	-	-	3.08E-04	1.29E-03
TFLink	MF	GO:0048038	quinone binding	-	16	16	-	-	2.05E-04	6.99E-04
TFLink	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	119	-	-	1.24E-03	5.16E-03
TFLink	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	78	-	-	1.01E-03	3.39E-03
TFLink	MF	GO:0003756	protein disulfide isomerase activity	-	18	18	-	-	2.06E-04	8.07E-04
TFLink	MF	GO:0051117	ATPase binding	-	85	84	-	-	8.11E-04	3.66E-03
TFLink	MF	GO:2000273	positive regulation of signaling receptor activity	-	46	45	-	-	7.47E-04	1.94E-03
TFLink	MF	GO:0051787	misfolded protein binding	-	20	19	-	-	2.00E-03	8.61E-04
TFLink	MF	GO:0002162	dystroglycan binding	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	MF	GO:0070402	NADPH binding	-	16	15	-	-	2.06E-04	6.46E-04
TFLink	MF	GO:0031404	chloride ion binding	-	14	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:0001098	basal transcription machinery binding	-	61	61	-	-	5.02E-04	2.64E-03
TFLink	MF	GO:0036002	pre-mRNA binding	-	57	34	-	-	3.41E-04	1.51E-03
TFLink	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	34	-	-	3.58E-04	1.51E-03
TFLink	MF	GO:0051540	metal cluster binding	-	71	68	-	-	8.24E-04	2.96E-03
TFLink	MF	GO:0097371	MDM2/MDM4 family protein binding	-	11	11	-	-	1.06E-04	4.84E-04
TFLink	MF	GO:0051219	phosphoprotein binding	-	92	92	-	-	1.14E-03	3.98E-03
TFLink	MF	GO:0019894	kinesin binding	-	45	45	-	-	7.38E-04	1.94E-03
TFLink	MF	GO:0042287	MHC protein binding	-	68	53	-	-	5.64E-04	2.31E-03
TFLink	MF	GO:0019003	GDP binding	-	89	87	-	-	9.20E-04	3.77E-03
TFLink	MF	GO:0017171	serine hydrolase activity	-	207	194	-	-	2.68E-03	8.39E-03
TFLink	MF	GO:0097110	scaffold protein binding	-	66	65	-	-	9.19E-04	2.80E-03
TFLink	MF	GO:0003774	cytoskeletal motor activity	-	117	115	-	-	1.72E-03	4.95E-03
TFLink	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	28	-	-	4.04E-04	1.24E-03
TFLink	MF	GO:0019198	transmembrane receptor protein phosphatase activity	-	17	17	-	-	2.05E-04	7.53E-04
TFLink	MF	GO:0061134	peptidase regulator activity	-	224	213	-	-	2.67E-03	9.20E-03
TFLink	MF	GO:0008013	beta-catenin binding	-	86	86	-	-	6.81E-04	3.71E-03
TFLink	MF	GO:0051015	actin filament binding	-	208	206	-	-	2.15E-03	8.88E-03
TFLink	MF	GO:0019208	phosphatase regulator activity	-	107	99	-	-	1.64E-03	4.30E-03
TFLink	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	32	-	-	6.03E-04	1.40E-03
TFLink	MF	GO:0043236	laminin binding	-	29	28	-	-	3.08E-04	1.24E-03
TFLink	MF	GO:0030507	spectrin binding	-	26	26	-	-	3.08E-04	1.13E-03
TFLink	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	41	-	-	4.60E-04	1.78E-03
TFLink	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	112	-	-	1.23E-03	4.84E-03
TFLink	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	24	-	-	6.57E-04	1.08E-03
TFLink	MF	GO:0042393	histone binding	-	240	228	-	-	1.73E-03	9.84E-03
TFLink	MF	GO:0019838	growth factor binding	-	182	181	-	-	1.97E-03	7.80E-03
TFLink	MF	GO:0000149	SNARE binding	-	107	105	-	-	1.12E-03	4.52E-03
TFLink	MF	GO:0003727	single-stranded RNA binding	-	90	84	-	-	1.74E-03	3.66E-03
TFLink	MF	GO:0051378	serotonin binding	-	24	24	-	-	2.59E-04	1.08E-03
TFLink	MF	GO:0005516	calmodulin binding	-	206	206	-	-	2.85E-03	8.88E-03
TFLink	MF	GO:0019825	oxygen binding	-	40	35	-	-	6.95E-04	1.51E-03
TFLink	MF	GO:0045505	dynein intermediate chain binding	-	37	37	-	-	4.10E-04	1.61E-03
TFLink	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	86	-	-	1.18E-03	3.71E-03
TFLink	MF	GO:0032182	ubiquitin-like protein binding	-	117	117	-	-	1.24E-03	5.06E-03
TFLink	MF	GO:0023023	MHC protein complex binding	-	36	35	-	-	4.10E-04	1.51E-03
TFLink	MF	GO:0030742	GTP-dependent protein binding	-	22	22	-	-	2.56E-04	9.68E-04
TFLink	MF	GO:0043274	phospholipase binding	-	23	23	-	-	4.98E-04	1.02E-03
TFLink	MF	GO:0031072	heat shock protein binding	-	128	123	-	-	1.42E-03	5.33E-03
TFLink	MF	GO:0030515	snoRNA binding	-	33	33	-	-	8.82E-04	1.45E-03
TFLink	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	77	-	-	8.19E-04	3.34E-03
TFLink	MF	GO:0140103	"catalytic activity, acting on a glycoprotein"	-	23	23	-	-	2.57E-04	1.02E-03
TFLink	MF	GO:0001965	G-protein alpha-subunit binding	-	26	26	-	-	3.07E-04	1.13E-03
TFLink	MF	GO:0001530	lipopolysaccharide binding	-	38	36	-	-	1.25E-03	1.56E-03
TFLink	MF	GO:0140223	general transcription initiation factor activity	-	55	51	-	-	6.46E-04	2.21E-03
TFLink	MF	GO:0070403	NAD+ binding	-	16	16	-	-	2.69E-04	6.99E-04
TFLink	MF	GO:0000049	tRNA binding	-	75	74	-	-	7.63E-04	3.23E-03
TFLink	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	45	-	-	7.78E-04	1.94E-03
TFLink	MF	GO:0015026	coreceptor activity	-	48	47	-	-	5.13E-04	2.04E-03
TFLink	MF	GO:0005527	macrolide binding	-	12	12	-	-	1.59E-04	5.38E-04
TFLink	MF	GO:0001653	peptide receptor activity	-	128	123	-	-	1.29E-03	5.33E-03
TFLink	MF	GO:0031005	filamin binding	-	15	13	-	-	1.12E-03	5.92E-04
TFLink	MF	GO:0030506	ankyrin binding	-	19	19	-	-	2.06E-04	8.61E-04
TFLink	MF	GO:0006469	negative regulation of protein kinase activity	-	222	210	-	-	2.27E-03	9.04E-03
TFLink	MF	GO:0070182	DNA polymerase binding	-	22	20	-	-	2.24E-04	8.61E-04
TFLink	MF	GO:1901611	phosphatidylglycerol binding	-	15	15	-	-	2.06E-04	6.46E-04
TFLink	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	30	-	-	3.74E-04	1.29E-03
TFLink	MF	GO:0051427	hormone receptor binding	-	31	30	-	-	3.57E-04	1.29E-03
TFLink	MF	GO:0070851	growth factor receptor binding	-	141	141	-	-	2.07E-03	6.08E-03
TFLink	MF	GO:0031210	phosphatidylcholine binding	-	32	29	-	-	3.08E-04	1.29E-03
TFLink	MF	GO:0016744	transketolase or transaldolase activity	-	11	11	-	-	1.55E-04	4.84E-04
TFLink	MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	-	43	43	-	-	4.41E-04	1.88E-03
TFLink	MF	GO:0034185	apolipoprotein binding	-	20	19	-	-	3.93E-03	8.61E-04
TFLink	MF	GO:1904047	S-adenosyl-L-methionine binding	-	18	16	-	-	3.22E-04	6.99E-04
TFLink	MF	GO:0005506	iron ion binding	-	154	148	-	-	1.47E-03	6.40E-03
TFLink	MF	GO:0003925	G protein activity	-	45	44	-	-	4.60E-04	1.94E-03
TFLink	MF	GO:0038187	pattern recognition receptor activity	-	33	33	-	-	3.61E-04	1.45E-03
TFLink	MF	GO:0008276	protein methyltransferase activity	-	96	94	-	-	9.00E-04	4.09E-03
TFLink	MF	GO:0004396	hexokinase activity	-	16	16	-	-	3.80E-04	6.99E-04
TFLink	MF	GO:0070888	E-box binding	-	59	59	-	-	6.19E-04	2.58E-03
TFLink	MF	GO:0039706	co-receptor binding	-	14	14	-	-	1.55E-04	6.46E-04
TFLink	MF	GO:0015399	primary active transmembrane transporter activity	-	190	187	-	-	2.12E-03	8.07E-03
TFLink	MF	GO:0035254	glutamate receptor binding	-	47	45	-	-	5.11E-04	1.94E-03
TFLink	MF	GO:0050321	tau-protein kinase activity	-	36	33	-	-	4.18E-04	1.45E-03
TFLink	MF	GO:0019215	intermediate filament binding	-	11	11	-	-	4.17E-04	4.84E-04
TFLink	MF	GO:0043021	ribonucleoprotein complex binding	-	158	157	-	-	1.67E-03	6.78E-03
TFLink	MF	GO:0030170	pyridoxal phosphate binding	-	56	52	-	-	5.64E-04	2.26E-03
TFLink	MF	GO:0032393	MHC class I receptor activity	-	15	11	-	-	1.57E-04	4.84E-04
TFLink	MF	GO:0005112	Notch binding	-	26	24	-	-	5.22E-04	1.08E-03
TFLink	MF	GO:0048185	activin binding	-	16	16	-	-	2.17E-02	6.99E-04
TFLink	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	28	-	-	4.79E-04	1.24E-03
TFLink	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	1.54E-04	4.84E-04
TFLink	MF	GO:0140299	small molecule sensor activity	-	39	35	-	-	4.72E-04	1.51E-03
TFLink	MF	GO:0031683	G-protein beta/gamma-subunit complex binding	-	22	22	-	-	2.57E-04	9.68E-04
TFLink	MF	GO:0016917	GABA receptor activity	-	23	23	-	-	2.60E-04	1.02E-03
TFLink	MF	GO:0098847	sequence-specific single stranded DNA binding	-	15	15	-	-	2.67E-04	6.46E-04
TFLink	MF	GO:0019707	protein-cysteine S-acyltransferase activity	-	26	25	-	-	3.08E-04	1.08E-03
TFLink	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	42	-	-	3.47E-04	1.83E-03
TFLink	MF	GO:2000679	positive regulation of transcription regulatory region DNA binding	-	25	25	-	-	4.25E-04	1.08E-03
TFLink	MF	GO:0008527	taste receptor activity	-	28	26	-	-	3.12E-04	1.13E-03
TFLink	MF	GO:0003916	DNA topoisomerase activity	-	12	12	-	-	3.48E-04	5.38E-04
TFLink	MF	GO:0030594	neurotransmitter receptor activity	-	160	156	-	-	1.57E-03	6.72E-03
TFLink	MF	GO:0034452	dynactin binding	-	12	12	-	-	1.54E-04	5.38E-04
TFLink	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	24	-	-	2.56E-04	1.08E-03
TFLink	MF	GO:0120227	acyl-CoA binding	-	22	21	-	-	2.56E-04	9.15E-04
TFLink	MF	GO:0005507	copper ion binding	-	63	59	-	-	1.05E-03	2.58E-03
TFLink	MF	GO:0033558	protein lysine deacetylase activity	-	22	22	-	-	2.63E-04	9.68E-04
TFLink	MF	GO:0070034	telomerase RNA binding	-	22	22	-	-	2.55E-04	9.68E-04
TFLink	MF	GO:0004143	ATP-dependent diacylglycerol kinase activity	-	12	12	-	-	1.55E-04	5.38E-04
Wan	CC	GO:0005840	ribosome	3.15E-76	222	166	41	4.10	-	-
Wan	CC	GO:0005730	nucleolus	2.01E-70	988	413	180	2.29	-	-
Wan	CC	GO:0005739	mitochondrion	2.06E-55	1671	559	305	1.83	-	-
Wan	CC	GO:0005615	extracellular space	3.62E-39	3190	853	582	1.47	-	-
Wan	CC	GO:0000228	nuclear chromosome	1.79E-21	206	97	38	2.58	-	-
Wan	CC	GO:0005635	nuclear envelope	1.06E-16	493	166	90	1.85	-	-
Wan	CC	GO:0031012	extracellular matrix	1.34E-10	564	49	103	0.48	-	-
Wan	CC	GO:0005764	lysosome	1.57E-06	747	188	136	1.38	-	-
Wan	CC	GO:0005815	microtubule organizing center	3.04E-06	843	207	154	1.35	-	-
Wan	CC	GO:0005768	endosome	4.30E-04	1037	233	189	1.23	-	-
Wan	CC	GO:0005777	peroxisome	1.17E-02	142	38	26	1.47	-	-
Wan	CC	GO:0005929	cilium	1.10E-01	842	136	154	0.89	-	-
Wan	CC	GO:0005811	lipid droplet	2.49E-01	102	23	19	1.24	-	-
Wan	CC	GO:0005794	Golgi apparatus	3.84E-01	1636	285	299	0.95	-	-
Wan	CC	GO:0005783	endoplasmic reticulum	8.55E-01	2020	365	369	0.99	-	-
Wan	BP	GO:0016071	mRNA metabolic process	1.75E-99	713	375	130	2.88	-	-
Wan	BP	GO:0042254	ribosome biogenesis	1.28E-72	297	194	54	3.58	-	-
Wan	BP	GO:0002181	cytoplasmic translation	1.69E-72	153	130	28	4.66	-	-
Wan	BP	GO:0065003	protein-containing complex assembly	5.60E-67	1648	581	301	1.93	-	-
Wan	BP	GO:0006886	intracellular protein transport	4.59E-46	664	276	121	2.28	-	-
Wan	BP	GO:0055086	nucleobase-containing small molecule metabolic process	1.96E-42	729	287	133	2.16	-	-
Wan	BP	GO:0006457	protein folding	1.44E-41	210	126	38	3.29	-	-
Wan	BP	GO:0006281	DNA repair	5.69E-39	587	241	107	2.25	-	-
Wan	BP	GO:0006091	generation of precursor metabolites and energy	2.59E-38	502	215	92	2.35	-	-
Wan	BP	GO:0007059	chromosome segregation	8.79E-33	403	176	74	2.39	-	-
Wan	BP	GO:0006913	nucleocytoplasmic transport	2.45E-32	326	152	59	2.55	-	-
Wan	BP	GO:0050877	nervous system process	2.20E-30	1527	126	279	0.45	-	-
Wan	BP	GO:0006520	amino acid metabolic process	3.39E-27	292	133	53	2.50	-	-
Wan	BP	GO:0006399	tRNA metabolic process	3.87E-24	196	98	36	2.74	-	-
Wan	BP	GO:0030163	protein catabolic process	7.52E-23	990	305	181	1.69	-	-
Wan	BP	GO:0006260	DNA replication	1.55E-22	279	121	51	2.38	-	-
Wan	BP	GO:0006325	chromatin organization	2.87E-22	720	238	131	1.81	-	-
Wan	BP	GO:0140053	mitochondrial gene expression	7.40E-18	164	78	30	2.61	-	-
Wan	BP	GO:0006310	DNA recombination	1.25E-15	333	122	61	2.01	-	-
Wan	BP	GO:0000910	cytokinesis	1.83E-13	186	77	34	2.27	-	-
Wan	BP	GO:0007010	cytoskeleton organization	8.36E-13	1639	410	299	1.37	-	-
Wan	BP	GO:0016192	vesicle-mediated transport	3.61E-12	1894	460	346	1.33	-	-
Wan	BP	GO:0032200	telomere organization	5.02E-12	186	74	34	2.18	-	-
Wan	BP	GO:0012501	programmed cell death	2.54E-11	1954	468	357	1.31	-	-
Wan	BP	GO:0005975	carbohydrate metabolic process	5.47E-11	551	163	101	1.62	-	-
Wan	BP	GO:0006914	autophagy	1.06E-10	568	166	104	1.60	-	-
Wan	BP	GO:0006954	inflammatory response	2.55E-10	820	85	150	0.57	-	-
Wan	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.45E-07	119	46	22	2.12	-	-
Wan	BP	GO:0007005	mitochondrion organization	4.63E-07	484	133	88	1.51	-	-
Wan	BP	GO:0055085	transmembrane transport	1.79E-06	1784	253	326	0.78	-	-
Wan	BP	GO:0007163	establishment or maintenance of cell polarity	3.67E-06	227	70	41	1.69	-	-
Wan	BP	GO:0006790	sulfur compound metabolic process	1.43E-05	320	90	58	1.54	-	-
Wan	BP	GO:0006575	cellular modified amino acid metabolic process	3.51E-05	186	57	34	1.68	-	-
Wan	BP	GO:0030198	extracellular matrix organization	2.12E-04	314	33	57	0.58	-	-
Wan	BP	GO:0140013	meiotic nuclear division	3.12E-04	279	75	51	1.47	-	-
Wan	BP	GO:0007040	lysosome organization	1.52E-03	107	33	20	1.69	-	-
Wan	BP	GO:0003013	circulatory system process	1.56E-03	584	78	107	0.73	-	-
Wan	BP	GO:0072659	protein localization to plasma membrane	2.49E-03	284	72	52	1.39	-	-
Wan	BP	GO:0007155	cell adhesion	3.64E-03	1444	223	264	0.85	-	-
Wan	BP	GO:0006486	protein glycosylation	4.07E-03	225	25	41	0.61	-	-
Wan	BP	GO:0002376	immune system process	5.95E-03	2448	398	447	0.89	-	-
Wan	BP	GO:0006629	lipid metabolic process	1.76E-02	1355	215	247	0.87	-	-
Wan	BP	GO:0003014	renal system process	2.04E-02	127	13	23	0.56	-	-
Wan	BP	GO:0042060	wound healing	5.82E-02	431	94	79	1.20	-	-
Wan	BP	GO:0098542	defense response to other organism	7.87E-02	1171	191	214	0.89	-	-
Wan	BP	GO:0022600	digestive system process	8.34E-02	110	13	20	0.65	-	-
Wan	BP	GO:0006766	vitamin metabolic process	1.04E-01	107	26	20	1.33	-	-
Wan	BP	GO:0098754	detoxification	1.45E-01	134	31	24	1.27	-	-
Wan	BP	GO:0044782	cilium organization	1.69E-01	399	62	73	0.85	-	-
Wan	BP	GO:0003012	muscle system process	2.28E-01	425	87	78	1.12	-	-
Wan	BP	GO:0007018	microtubule-based movement	2.52E-01	640	128	117	1.10	-	-
Wan	BP	GO:0048870	cell motility	4.85E-01	1659	292	303	0.96	-	-
Wan	BP	GO:0006355	regulation of DNA-templated transcription	6.57E-01	3342	619	610	1.01	-	-
Wan	BP	GO:0034330	cell junction organization	6.60E-01	727	137	133	1.03	-	-
Wan	MF	GO:0003723	RNA binding	8.36E-296	1679	938	306	3.06	-	-
Wan	MF	GO:0140657	ATP-dependent activity	1.40E-50	729	303	133	2.28	-	-
Wan	MF	GO:0140098	"catalytic activity, acting on RNA"	1.55E-46	417	203	76	2.67	-	-
Wan	MF	GO:0045182	translation regulator activity	3.78E-33	151	94	28	3.41	-	-
Wan	MF	GO:0016853	isomerase activity	1.98E-27	252	121	46	2.63	-	-
Wan	MF	GO:0140097	"catalytic activity, acting on DNA"	1.49E-26	383	159	70	2.27	-	-
Wan	MF	GO:0016491	oxidoreductase activity	9.72E-26	888	289	162	1.78	-	-
Wan	MF	GO:0048018	receptor ligand activity	9.49E-25	504	17	92	0.18	-	-
Wan	MF	GO:0005198	structural molecule activity	6.07E-24	798	262	146	1.80	-	-
Wan	MF	GO:0016740	transferase activity	2.65E-23	3074	762	561	1.36	-	-
Wan	MF	GO:0008092	cytoskeletal protein binding	1.61E-19	1023	302	187	1.62	-	-
Wan	MF	GO:0016874	ligase activity	8.72E-19	283	115	52	2.23	-	-
Wan	MF	GO:0042393	histone binding	1.11E-13	237	92	43	2.13	-	-
Wan	MF	GO:0140104	molecular carrier activity	2.94E-13	105	52	19	2.71	-	-
Wan	MF	GO:0140110	transcription regulator activity	1.06E-11	2033	263	371	0.71	-	-
Wan	MF	GO:0005215	transporter activity	2.33E-08	1462	190	267	0.71	-	-
Wan	MF	GO:0140096	"catalytic activity, acting on a protein"	9.28E-07	3198	683	584	1.17	-	-
Wan	MF	GO:0009975	cyclase activity	1.11E-04	277	27	51	0.53	-	-
Wan	MF	GO:0003774	cytoskeletal motor activity	1.54E-04	116	38	21	1.80	-	-
Wan	MF	GO:0003924	GTPase activity	5.46E-03	658	148	120	1.23	-	-
Wan	MF	GO:0038024	cargo receptor activity	1.12E-02	117	11	21	0.52	-	-
Wan	MF	GO:0016829	lyase activity	1.26E-02	538	121	98	1.23	-	-
Wan	MF	GO:0003677	DNA binding	3.79E-02	2865	483	523	0.92	-	-
Wan	MF	GO:0008289	lipid binding	7.49E-01	836	156	153	1.02	-	-
Wan	BP	GO:0007346	regulation of mitotic cell cycle	-	518	168	-	-	1.38E-01	3.94E-02
Wan	BP	GO:0001525	angiogenesis	-	616	80	-	-	1.80E-02	1.87E-02
Wan	BP	GO:0043543	protein acylation	-	107	27	-	-	1.14E-02	6.42E-03
Wan	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	11	-	-	8.51E-04	2.63E-03
Wan	BP	GO:0071763	nuclear membrane organization	-	44	22	-	-	8.68E-02	5.25E-03
Wan	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	14	-	-	1.30E-02	3.50E-03
Wan	BP	GO:0071806	protein transmembrane transport	-	68	20	-	-	2.10E-02	4.67E-03
Wan	BP	GO:0043299	leukocyte degranulation	-	82	12	-	-	8.67E-04	2.92E-03
Wan	BP	GO:0048864	stem cell development	-	88	12	-	-	4.82E-03	2.92E-03
Wan	BP	GO:0051651	maintenance of location in cell	-	236	54	-	-	4.37E-03	1.28E-02
Wan	BP	GO:0033119	negative regulation of RNA splicing	-	27	15	-	-	5.26E-02	3.50E-03
Wan	CC	GO:0016197	endosomal transport	-	282	113	-	-	1.21E-01	2.66E-02
Wan	BP	GO:0070663	regulation of leukocyte proliferation	-	268	32	-	-	1.95E-03	7.59E-03
Wan	BP	GO:0045861	negative regulation of proteolysis	-	320	64	-	-	6.71E-03	1.52E-02
Wan	BP	GO:1901616	organic hydroxy compound catabolic process	-	59	14	-	-	1.33E-01	3.50E-03
Wan	CC	GO:0006984	ER-nucleus signaling pathway	-	46	12	-	-	8.58E-04	2.92E-03
Wan	BP	GO:0009914	hormone transport	-	315	34	-	-	2.93E-03	8.17E-03
Wan	BP	GO:0140112	extracellular vesicle biogenesis	-	23	12	-	-	1.91E-02	2.92E-03
Wan	CC	GO:0097401	synaptic vesicle lumen acidification	-	16	11	-	-	1.99E-01	2.63E-03
Wan	BP	GO:0045785	positive regulation of cell adhesion	-	482	92	-	-	3.69E-02	2.16E-02
Wan	BP	GO:0006413	translational initiation	-	122	74	-	-	1.94E-01	1.75E-02
Wan	CC	GO:0005200	structural constituent of cytoskeleton	-	112	48	-	-	1.27E-01	1.14E-02
Wan	BP	GO:0030865	cortical cytoskeleton organization	-	51	29	-	-	1.84E-02	7.00E-03
Wan	BP	GO:1903036	positive regulation of response to wounding	-	76	11	-	-	8.57E-04	2.63E-03
Wan	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	16	-	-	1.15E-03	3.79E-03
Wan	BP	GO:0002263	cell activation involved in immune response	-	304	45	-	-	9.77E-03	1.05E-02
Wan	BP	GO:0021954	central nervous system neuron development	-	85	16	-	-	1.14E-03	3.79E-03
Wan	BP	GO:0055017	cardiac muscle tissue growth	-	92	11	-	-	8.67E-04	2.63E-03
Wan	BP	GO:0048524	positive regulation of viral process	-	64	33	-	-	3.19E-03	7.88E-03
Wan	BP	GO:0006099	tricarboxylic acid cycle	-	33	27	-	-	3.12E-01	6.42E-03
Wan	BP	GO:0009612	response to mechanical stimulus	-	215	33	-	-	1.99E-03	7.88E-03
Wan	BP	GO:0048644	muscle organ morphogenesis	-	81	11	-	-	2.13E-01	2.63E-03
Wan	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	22	-	-	4.28E-02	5.25E-03
Wan	BP	GO:0140115	export across plasma membrane	-	82	12	-	-	1.74E-02	2.92E-03
Wan	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	11	-	-	8.59E-04	2.63E-03
Wan	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	16	-	-	1.24E-01	3.79E-03
Wan	MF	GO:0003714	transcription corepressor activity	-	190	66	-	-	1.20E-02	1.55E-02
Wan	BP	GO:0098609	cell-cell adhesion	-	954	141	-	-	4.18E-02	3.30E-02
Wan	MF	GO:0140312	cargo adaptor activity	-	19	12	-	-	4.65E-01	2.92E-03
Wan	BP	GO:0046835	carbohydrate phosphorylation	-	49	30	-	-	8.42E-03	7.00E-03
Wan	CC	GO:1905349	ciliary transition zone assembly	-	371	57	-	-	2.05E-02	1.34E-02
Wan	BP	GO:0043523	regulation of neuron apoptotic process	-	218	44	-	-	5.01E-03	1.05E-02
Wan	BP	GO:0044380	protein localization to cytoskeleton	-	57	19	-	-	1.14E-03	4.67E-03
Wan	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	17	-	-	2.34E-03	4.09E-03
Wan	CC	GO:0045324	late endosome to vacuole transport	-	37	26	-	-	1.93E-01	6.13E-03
Wan	BP	GO:0070647	protein modification by small protein conjugation or removal	-	968	225	-	-	1.32E-01	5.25E-02
Wan	BP	GO:0043954	cellular component maintenance	-	72	12	-	-	8.66E-04	2.92E-03
Wan	BP	GO:0050435	amyloid-beta metabolic process	-	65	13	-	-	8.57E-04	3.21E-03
Wan	BP	GO:0014823	response to activity	-	70	16	-	-	1.71E-02	3.79E-03
Wan	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	105	-	-	1.33E-02	2.45E-02
Wan	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	11	-	-	7.55E-03	2.63E-03
Wan	BP	GO:0034502	protein localization to chromosome	-	130	45	-	-	4.04E-02	1.05E-02
Wan	BP	GO:0048562	embryonic organ morphogenesis	-	295	27	-	-	1.65E-03	6.42E-03
Wan	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	13	-	-	2.27E-02	3.21E-03
Wan	BP	GO:0017148	negative regulation of translation	-	390	46	-	-	1.17E-02	1.08E-02
Wan	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	11	-	-	8.48E-04	2.63E-03
Wan	BP	GO:1903509	liposaccharide metabolic process	-	109	13	-	-	8.72E-04	3.21E-03
Wan	CC	GO:0140238	presynaptic endocytosis	-	72	24	-	-	1.01E-02	5.84E-03
Wan	BP	GO:0051236	establishment of RNA localization	-	161	90	-	-	1.48E-01	2.10E-02
Wan	BP	GO:0170044	non-proteinogenic amino acid catabolic process	-	18	12	-	-	4.54E-02	2.92E-03
Wan	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	33	-	-	3.72E-03	7.88E-03
Wan	BP	GO:0034067	protein localization to Golgi apparatus	-	30	11	-	-	8.67E-04	2.63E-03
Wan	BP	GO:0061842	microtubule organizing center localization	-	32	12	-	-	6.48E-03	2.92E-03
Wan	BP	GO:0042246	tissue regeneration	-	496	98	-	-	2.24E-02	2.31E-02
Wan	MF	GO:0048018	receptor ligand activity	-	510	17	-	-	1.44E-02	4.09E-03
Wan	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	15	-	-	1.14E-03	3.50E-03
Wan	BP	GO:0050779	RNA destabilization	-	135	46	-	-	4.10E-02	1.08E-02
Wan	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	37	-	-	3.20E-02	8.75E-03
Wan	BP	GO:0061025	membrane fusion	-	532	117	-	-	1.07E-01	2.74E-02
Wan	BP	GO:0010762	regulation of fibroblast migration	-	40	11	-	-	8.64E-04	2.63E-03
Wan	BP	GO:0022406	membrane docking	-	90	30	-	-	3.19E-01	7.00E-03
Wan	BP	GO:0006999	nuclear pore organization	-	15	11	-	-	2.37E-01	2.63E-03
Wan	BP	GO:0050777	negative regulation of immune response	-	196	28	-	-	6.23E-03	6.71E-03
Wan	BP	GO:0016053	organic acid biosynthetic process	-	335	85	-	-	2.13E-02	1.98E-02
Wan	BP	GO:0021782	glial cell development	-	120	24	-	-	1.22E-01	5.84E-03
Wan	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	19	-	-	2.07E-03	4.67E-03
Wan	BP	GO:0055088	lipid homeostasis	-	173	22	-	-	1.41E-03	5.25E-03
Wan	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	59	-	-	7.50E-03	1.40E-02
Wan	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	16	-	-	1.90E-02	3.79E-03
Wan	BP	GO:0045667	regulation of osteoblast differentiation	-	147	11	-	-	8.64E-04	2.63E-03
Wan	BP	GO:0050801	monoatomic ion homeostasis	-	609	92	-	-	1.48E-02	2.16E-02
Wan	BP	GO:0009792	embryo development ending in birth or egg hatching	-	683	143	-	-	1.52E-02	3.36E-02
Wan	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	53	-	-	1.37E-02	1.25E-02
Wan	BP	GO:0045738	negative regulation of DNA repair	-	40	12	-	-	8.53E-04	2.92E-03
Wan	BP	GO:0001704	formation of primary germ layer	-	195	30	-	-	2.83E-02	7.00E-03
Wan	BP	GO:0048708	astrocyte differentiation	-	88	14	-	-	5.00E-03	3.50E-03
Wan	BP	GO:0048588	developmental cell growth	-	233	43	-	-	4.05E-03	1.02E-02
Wan	BP	GO:0045023	G0 to G1 transition	-	41	25	-	-	4.47E-01	5.84E-03
Wan	BP	GO:0009226	nucleotide-sugar biosynthetic process	-	19	16	-	-	3.05E-02	3.79E-03
Wan	BP	GO:0021987	cerebral cortex development	-	125	31	-	-	4.21E-03	7.30E-03
Wan	BP	GO:0008637	apoptotic mitochondrial changes	-	108	34	-	-	3.52E-03	8.17E-03
Wan	CC	GO:1902532	negative regulation of intracellular signal transduction	-	710	139	-	-	1.22E-02	3.27E-02
Wan	BP	GO:2000736	regulation of stem cell differentiation	-	78	35	-	-	1.70E-01	8.17E-03
Wan	BP	GO:0002064	epithelial cell development	-	210	39	-	-	7.17E-03	9.34E-03
Wan	BP	GO:0042177	negative regulation of protein catabolic process	-	109	33	-	-	3.99E-03	7.88E-03
Wan	MF	GO:0038024	cargo receptor activity	-	121	11	-	-	8.69E-04	2.63E-03
Wan	BP	GO:0033120	positive regulation of RNA splicing	-	46	24	-	-	2.26E-02	5.84E-03
Wan	BP	GO:0051445	regulation of meiotic cell cycle	-	64	19	-	-	6.30E-01	4.67E-03
Wan	BP	GO:0090087	regulation of peptide transport	-	195	24	-	-	7.03E-03	5.84E-03
Wan	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	19	-	-	1.12E-03	4.67E-03
Wan	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	11	-	-	8.63E-04	2.63E-03
Wan	BP	GO:0022404	molting cycle process	-	95	14	-	-	2.78E-03	3.50E-03
Wan	BP	GO:0007281	germ cell development	-	334	50	-	-	2.97E-03	1.17E-02
Wan	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	41	-	-	6.19E-03	9.63E-03
Wan	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	33	-	-	1.07E-02	7.88E-03
Wan	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	26	-	-	1.45E-01	6.13E-03
Wan	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	28	-	-	3.37E-02	6.71E-03
Wan	BP	GO:0003013	circulatory system process	-	602	78	-	-	9.41E-03	1.84E-02
Wan	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	31	-	-	2.31E-02	7.30E-03
Wan	BP	GO:1903035	negative regulation of response to wounding	-	93	11	-	-	8.67E-04	2.63E-03
Wan	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	66	-	-	5.23E-02	1.55E-02
Wan	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	27	-	-	1.69E-03	6.42E-03
Wan	BP	GO:0009267	cellular response to starvation	-	170	34	-	-	1.40E-02	8.17E-03
Wan	CC	GO:0032008	positive regulation of TOR signaling	-	52	13	-	-	8.65E-04	3.21E-03
Wan	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	17	-	-	1.55E-01	4.09E-03
Wan	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	28	-	-	1.20E-01	6.71E-03
Wan	BP	GO:0002521	leukocyte differentiation	-	616	97	-	-	3.58E-02	2.28E-02
Wan	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	15	-	-	1.16E-03	3.50E-03
Wan	BP	GO:0065004	protein-DNA complex assembly	-	307	112	-	-	1.82E-01	2.63E-02
Wan	CC	GO:0006406	mRNA export from nucleus	-	69	40	-	-	8.35E-02	9.34E-03
Wan	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	24	-	-	4.19E-01	5.84E-03
Wan	BP	GO:0044848	biological phase	-	211	47	-	-	3.78E-02	1.11E-02
Wan	BP	GO:0046660	female sex differentiation	-	125	17	-	-	1.54E-02	4.09E-03
Wan	BP	GO:0019693	ribose phosphate metabolic process	-	556	217	-	-	8.40E-02	5.08E-02
Wan	BP	GO:0071248	cellular response to metal ion	-	201	38	-	-	2.71E-03	9.05E-03
Wan	BP	GO:0030308	negative regulation of cell growth	-	191	26	-	-	3.30E-03	6.13E-03
Wan	BP	GO:0097306	cellular response to alcohol	-	99	21	-	-	3.56E-02	4.96E-03
Wan	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	59	-	-	1.09E-01	1.40E-02
Wan	BP	GO:0010453	regulation of cell fate commitment	-	40	12	-	-	5.89E-01	2.92E-03
Wan	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	127	-	-	1.40E-01	2.98E-02
Wan	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	19	-	-	1.26E-02	4.67E-03
Wan	BP	GO:0032890	regulation of organic acid transport	-	78	14	-	-	8.52E-04	3.50E-03
Wan	BP	GO:0098771	inorganic ion homeostasis	-	531	77	-	-	1.41E-02	1.81E-02
Wan	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	13	-	-	1.08E-02	3.21E-03
Wan	BP	GO:0051259	protein complex oligomerization	-	251	56	-	-	1.44E-02	1.31E-02
Wan	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	51	-	-	1.83E-02	1.20E-02
Wan	BP	GO:0044319	"wound healing, spreading of cells"	-	37	11	-	-	2.67E-02	2.63E-03
Wan	BP	GO:0072665	protein localization to vacuole	-	84	33	-	-	8.77E-02	7.88E-03
Wan	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	20	-	-	2.15E-01	4.67E-03
Wan	BP	GO:0006914	autophagy	-	574	166	-	-	5.48E-02	3.88E-02
Wan	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	26	-	-	7.38E-03	6.13E-03
Wan	BP	GO:0008285	negative regulation of cell population proliferation	-	787	112	-	-	1.02E-02	2.63E-02
Wan	BP	GO:0048858	cell projection morphogenesis	-	643	124	-	-	2.74E-02	2.92E-02
Wan	BP	GO:0045661	regulation of myoblast differentiation	-	74	23	-	-	1.45E-01	5.54E-03
Wan	BP	GO:0030307	positive regulation of cell growth	-	164	39	-	-	3.69E-03	9.34E-03
Wan	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	77	-	-	8.89E-03	1.81E-02
Wan	BP	GO:0048525	negative regulation of viral process	-	90	13	-	-	8.61E-04	3.21E-03
Wan	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	32	-	-	1.44E-01	7.59E-03
Wan	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	20	-	-	6.63E-02	4.67E-03
Wan	BP	GO:0018193	peptidyl-amino acid modification	-	933	212	-	-	2.49E-02	4.96E-02
Wan	BP	GO:0051781	positive regulation of cell division	-	93	13	-	-	4.65E-03	3.21E-03
Wan	BP	GO:0044770	cell cycle phase transition	-	558	190	-	-	9.00E-02	4.44E-02
Wan	BP	GO:0002696	positive regulation of leukocyte activation	-	358	66	-	-	4.40E-02	1.55E-02
Wan	BP	GO:0007272	ensheathment of neurons	-	146	26	-	-	7.48E-03	6.13E-03
Wan	CC	GO:0050806	positive regulation of synaptic transmission	-	171	18	-	-	1.16E-03	4.38E-03
Wan	BP	GO:0034504	protein localization to nucleus	-	312	126	-	-	5.19E-02	2.95E-02
Wan	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	15	-	-	3.91E-02	3.50E-03
Wan	BP	GO:0031647	regulation of protein stability	-	327	132	-	-	6.06E-02	3.09E-02
Wan	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	40	-	-	5.05E-01	9.34E-03
Wan	BP	GO:0043248	proteasome assembly	-	13	12	-	-	9.69E-03	2.92E-03
Wan	BP	GO:0016054	organic acid catabolic process	-	251	90	-	-	5.10E-02	2.10E-02
Wan	BP	GO:0050890	cognition	-	317	40	-	-	1.14E-02	9.34E-03
Wan	BP	GO:0008033	tRNA processing	-	136	59	-	-	5.30E-02	1.40E-02
Wan	BP	GO:0046661	male sex differentiation	-	171	24	-	-	4.52E-03	5.84E-03
Wan	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	24	-	-	8.64E-02	5.84E-03
Wan	BP	GO:1990778	protein localization to cell periphery	-	346	83	-	-	2.00E-02	1.96E-02
Wan	BP	GO:0001568	blood vessel development	-	790	103	-	-	1.61E-02	2.42E-02
Wan	BP	GO:0051258	protein polymerization	-	280	96	-	-	4.38E-02	2.25E-02
Wan	BP	GO:0071985	multivesicular body sorting pathway	-	56	29	-	-	1.89E-01	7.00E-03
Wan	BP	GO:0090559	regulation of membrane permeability	-	72	20	-	-	6.33E-03	4.67E-03
Wan	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	24	-	-	1.41E-03	5.84E-03
Wan	BP	GO:0002250	adaptive immune response	-	753	47	-	-	6.82E-03	1.11E-02
Wan	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	56	-	-	1.07E-02	1.31E-02
Wan	CC	GO:0048167	regulation of synaptic plasticity	-	210	28	-	-	1.42E-02	6.71E-03
Wan	BP	GO:1903708	positive regulation of hemopoiesis	-	184	41	-	-	8.25E-02	9.63E-03
Wan	BP	GO:1903008	organelle disassembly	-	154	53	-	-	3.66E-02	1.25E-02
Wan	CC	GO:0032387	negative regulation of intracellular transport	-	51	19	-	-	1.12E-03	4.67E-03
Wan	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	16	-	-	1.40E-01	3.79E-03
Wan	BP	GO:0032535	regulation of cellular component size	-	360	90	-	-	1.92E-02	2.10E-02
Wan	BP	GO:0001934	positive regulation of protein phosphorylation	-	701	107	-	-	1.53E-02	2.51E-02
Wan	MF	GO:0098631	cell adhesion mediator activity	-	64	14	-	-	8.48E-04	3.50E-03
Wan	BP	GO:0046112	nucleobase biosynthetic process	-	18	16	-	-	5.27E-02	3.79E-03
Wan	BP	GO:0071453	cellular response to oxygen levels	-	168	34	-	-	1.38E-02	8.17E-03
Wan	BP	GO:0070585	protein localization to mitochondrion	-	125	50	-	-	4.19E-02	1.17E-02
Wan	BP	GO:0044242	cellular lipid catabolic process	-	224	49	-	-	2.99E-02	1.17E-02
Wan	BP	GO:0002931	response to ischemia	-	58	11	-	-	7.65E-03	2.63E-03
Wan	BP	GO:0043062	extracellular structure organization	-	317	33	-	-	3.64E-03	7.88E-03
Wan	BP	GO:0055082	intracellular chemical homeostasis	-	706	119	-	-	1.58E-02	2.80E-02
Wan	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	126	-	-	2.36E-02	2.95E-02
Wan	BP	GO:0009755	hormone-mediated signaling pathway	-	221	52	-	-	4.26E-03	1.23E-02
Wan	BP	GO:0022612	gland morphogenesis	-	124	15	-	-	4.62E-03	3.50E-03
Wan	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	11	-	-	6.54E-03	2.63E-03
Wan	BP	GO:0044782	cilium organization	-	400	62	-	-	4.75E-02	1.46E-02
Wan	BP	GO:0090130	tissue migration	-	379	65	-	-	8.15E-03	1.52E-02
Wan	BP	GO:1990845	adaptive thermogenesis	-	166	31	-	-	5.07E-03	7.30E-03
Wan	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	12	-	-	3.53E-02	2.92E-03
Wan	BP	GO:0009314	response to radiation	-	449	106	-	-	3.92E-02	2.48E-02
Wan	BP	GO:0009451	RNA modification	-	169	72	-	-	1.15E-01	1.69E-02
Wan	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	13	-	-	8.52E-04	3.21E-03
Wan	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	39	-	-	1.66E-02	9.34E-03
Wan	BP	GO:0015807	L-amino acid transport	-	94	13	-	-	8.66E-04	3.21E-03
Wan	BP	GO:0032941	secretion by tissue	-	85	13	-	-	7.95E-03	3.21E-03
Wan	BP	GO:0046605	regulation of centrosome cycle	-	54	19	-	-	1.01E-01	4.67E-03
Wan	BP	GO:0048753	pigment granule organization	-	40	13	-	-	5.76E-01	3.21E-03
Wan	BP	GO:0003014	renal system process	-	130	13	-	-	8.61E-04	3.21E-03
Wan	BP	GO:0045598	regulation of fat cell differentiation	-	148	14	-	-	3.83E-02	3.50E-03
Wan	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	48	-	-	3.56E-03	1.14E-02
Wan	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	19	-	-	2.61E-02	4.67E-03
Wan	BP	GO:0039694	viral RNA genome replication	-	30	13	-	-	5.52E-02	3.21E-03
Wan	BP	GO:0071709	membrane assembly	-	68	21	-	-	1.14E-01	4.96E-03
Wan	BP	GO:0008217	regulation of blood pressure	-	186	18	-	-	8.38E-03	4.38E-03
Wan	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	12	-	-	5.15E-02	2.92E-03
Wan	CC	GO:0042770	signal transduction in response to DNA damage	-	186	60	-	-	7.98E-03	1.40E-02
Wan	BP	GO:0002200	somatic diversification of immune receptors	-	78	24	-	-	2.81E-02	5.84E-03
Wan	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	21	-	-	3.51E-02	4.96E-03
Wan	BP	GO:0033627	cell adhesion mediated by integrin	-	87	16	-	-	4.26E-02	3.79E-03
Wan	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	14	-	-	1.38E-01	3.50E-03
Wan	BP	GO:0035107	appendage morphogenesis	-	147	15	-	-	1.15E-03	3.50E-03
Wan	CC	GO:0048208	COPII vesicle coating	-	27	14	-	-	8.44E-02	3.50E-03
Wan	BP	GO:0045727	positive regulation of translation	-	141	64	-	-	2.13E-02	1.52E-02
Wan	CC	GO:0032388	positive regulation of intracellular transport	-	137	48	-	-	8.07E-03	1.14E-02
Wan	BP	GO:0002027	regulation of heart rate	-	106	13	-	-	8.57E-04	3.21E-03
Wan	BP	GO:0050879	multicellular organismal movement	-	118	22	-	-	1.17E-02	5.25E-03
Wan	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	11	-	-	2.25E-02	2.63E-03
Wan	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	22	-	-	2.06E-02	5.25E-03
Wan	BP	GO:0048515	spermatid differentiation	-	208	31	-	-	1.96E-03	7.30E-03
Wan	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	34	-	-	1.63E-02	8.17E-03
Wan	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	27	-	-	2.98E-01	6.42E-03
Wan	BP	GO:1905954	positive regulation of lipid localization	-	110	13	-	-	8.61E-04	3.21E-03
Wan	BP	GO:0072523	purine-containing compound catabolic process	-	146	58	-	-	1.52E-02	1.37E-02
Wan	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	45	-	-	1.44E-02	1.05E-02
Wan	BP	GO:0031345	negative regulation of cell projection organization	-	195	29	-	-	4.75E-03	7.00E-03
Wan	BP	GO:0048278	vesicle docking	-	64	22	-	-	3.73E-01	5.25E-03
Wan	BP	GO:0030168	platelet activation	-	135	30	-	-	4.03E-03	7.00E-03
Wan	BP	GO:0008284	positive regulation of cell population proliferation	-	992	156	-	-	1.59E-02	3.65E-02
Wan	BP	GO:0008213	protein alkylation	-	58	21	-	-	1.42E-03	4.96E-03
Wan	BP	GO:0002253	activation of immune response	-	529	82	-	-	2.56E-02	1.93E-02
Wan	BP	GO:0031529	ruffle organization	-	55	16	-	-	1.14E-03	3.79E-03
Wan	BP	GO:0035304	regulation of protein dephosphorylation	-	87	32	-	-	1.69E-02	7.59E-03
Wan	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	42	-	-	3.59E-03	9.92E-03
Wan	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	66	-	-	1.17E-02	1.55E-02
Wan	BP	GO:0051785	positive regulation of nuclear division	-	61	12	-	-	1.36E-02	2.92E-03
Wan	BP	GO:0044786	cell cycle DNA replication	-	45	22	-	-	3.95E-02	5.25E-03
Wan	BP	GO:0048145	regulation of fibroblast proliferation	-	87	22	-	-	1.43E-03	5.25E-03
Wan	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	64	-	-	7.26E-03	1.52E-02
Wan	BP	GO:0009306	protein secretion	-	376	70	-	-	1.41E-02	1.63E-02
Wan	CC	GO:0008333	endosome to lysosome transport	-	73	25	-	-	1.44E-01	5.84E-03
Wan	MF	GO:0043086	negative regulation of catalytic activity	-	717	136	-	-	1.02E-02	3.18E-02
Wan	BP	GO:0045732	positive regulation of protein catabolic process	-	202	62	-	-	1.17E-02	1.46E-02
Wan	BP	GO:0031589	cell-substrate adhesion	-	360	77	-	-	5.04E-02	1.81E-02
Wan	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	27	-	-	5.50E-02	6.42E-03
Wan	BP	GO:1904018	positive regulation of vasculature development	-	185	22	-	-	4.74E-02	5.25E-03
Wan	BP	GO:0010948	negative regulation of cell cycle process	-	317	83	-	-	3.21E-02	1.96E-02
Wan	BP	GO:0050953	sensory perception of light stimulus	-	223	15	-	-	6.21E-02	3.50E-03
Wan	BP	GO:0009303	rRNA transcription	-	37	19	-	-	4.12E-02	4.67E-03
Wan	BP	GO:0035601	protein deacylation	-	56	16	-	-	5.12E-02	3.79E-03
Wan	BP	GO:0061952	midbody abscission	-	18	13	-	-	4.98E-01	3.21E-03
Wan	BP	GO:0071300	cellular response to retinoic acid	-	66	11	-	-	8.56E-04	2.63E-03
Wan	BP	GO:0048284	organelle fusion	-	456	111	-	-	1.64E-01	2.60E-02
Wan	BP	GO:0051588	regulation of neurotransmitter transport	-	99	19	-	-	2.90E-02	4.67E-03
Wan	BP	GO:0051784	negative regulation of nuclear division	-	63	20	-	-	1.17E-01	4.67E-03
Wan	BP	GO:0044703	multi-organism reproductive process	-	209	30	-	-	2.05E-02	7.00E-03
Wan	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	27	-	-	8.50E-03	6.42E-03
Wan	BP	GO:0099022	vesicle tethering	-	32	16	-	-	8.15E-01	3.79E-03
Wan	BP	GO:0048857	neural nucleus development	-	65	20	-	-	4.76E-03	4.67E-03
Wan	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	24	-	-	1.86E-02	5.84E-03
Wan	BP	GO:0106027	neuron projection organization	-	90	25	-	-	1.40E-02	5.84E-03
Wan	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	22	-	-	2.91E-03	5.25E-03
Wan	CC	GO:0043410	positive regulation of MAPK cascade	-	494	57	-	-	5.22E-03	1.34E-02
Wan	BP	GO:0045685	regulation of glial cell differentiation	-	77	14	-	-	3.08E-03	3.50E-03
Wan	BP	GO:0043414	macromolecule methylation	-	138	57	-	-	4.78E-02	1.34E-02
Wan	BP	GO:0045807	positive regulation of endocytosis	-	155	27	-	-	1.32E-02	6.42E-03
Wan	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	19	-	-	2.25E-03	4.67E-03
Wan	BP	GO:0034394	protein localization to cell surface	-	69	21	-	-	1.42E-03	4.96E-03
Wan	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	12	-	-	4.58E-03	2.92E-03
Wan	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	21	-	-	1.44E-03	4.96E-03
Wan	MF	GO:0051100	negative regulation of binding	-	161	47	-	-	4.46E-03	1.11E-02
Wan	BP	GO:0001818	negative regulation of cytokine production	-	379	39	-	-	3.35E-03	9.34E-03
Wan	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	18	-	-	1.14E-03	4.38E-03
Wan	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	35	-	-	5.15E-01	8.17E-03
Wan	BP	GO:0032368	regulation of lipid transport	-	149	21	-	-	1.43E-03	4.96E-03
Wan	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	49	-	-	1.17E-02	1.17E-02
Wan	BP	GO:0033002	muscle cell proliferation	-	249	31	-	-	3.49E-02	7.30E-03
Wan	BP	GO:0048880	sensory system development	-	399	43	-	-	3.90E-03	1.02E-02
Wan	BP	GO:0043331	response to dsRNA	-	56	11	-	-	6.06E-03	2.63E-03
Wan	BP	GO:0033363	secretory granule organization	-	63	15	-	-	2.62E-01	3.50E-03
Wan	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	14	-	-	8.71E-02	3.50E-03
Wan	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	19	-	-	3.63E-03	4.67E-03
Wan	BP	GO:0030901	midbrain development	-	87	24	-	-	2.15E-03	5.84E-03
Wan	BP	GO:0007162	negative regulation of cell adhesion	-	310	43	-	-	7.27E-03	1.02E-02
Wan	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	15	-	-	1.51E-02	3.50E-03
Wan	BP	GO:0002687	positive regulation of leukocyte migration	-	147	21	-	-	3.35E-03	4.96E-03
Wan	BP	GO:0034605	cellular response to heat	-	66	27	-	-	4.50E-03	6.42E-03
Wan	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	19	-	-	1.51E-01	4.67E-03
Wan	BP	GO:0005996	monosaccharide metabolic process	-	250	93	-	-	1.74E-02	2.19E-02
Wan	BP	GO:0033555	multicellular organismal response to stress	-	90	11	-	-	7.02E-02	2.63E-03
Wan	BP	GO:0002262	myeloid cell homeostasis	-	172	46	-	-	5.51E-03	1.08E-02
Wan	BP	GO:0000966	RNA 5'-end processing	-	39	21	-	-	1.22E-01	4.96E-03
Wan	BP	GO:0050688	regulation of defense response to virus	-	65	15	-	-	1.14E-03	3.50E-03
Wan	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	44	-	-	4.51E-02	1.05E-02
Wan	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	41	-	-	2.67E-02	9.63E-03
Wan	BP	GO:0022618	protein-RNA complex assembly	-	227	131	-	-	1.61E-01	3.06E-02
Wan	BP	GO:0051147	regulation of muscle cell differentiation	-	162	26	-	-	1.69E-03	6.13E-03
Wan	BP	GO:0006066	alcohol metabolic process	-	374	63	-	-	3.77E-02	1.49E-02
Wan	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	21	-	-	3.39E-02	4.96E-03
Wan	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	17	-	-	3.44E-01	4.09E-03
Wan	BP	GO:0043555	regulation of translation in response to stress	-	22	11	-	-	8.61E-04	2.63E-03
Wan	BP	GO:0032922	circadian regulation of gene expression	-	71	18	-	-	1.58E-02	4.38E-03
Wan	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	11	-	-	8.63E-04	2.63E-03
Wan	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	32	-	-	2.10E-02	7.59E-03
Wan	BP	GO:0051293	establishment of spindle localization	-	57	21	-	-	8.26E-03	4.96E-03
Wan	BP	GO:0023061	signal release	-	491	62	-	-	1.41E-02	1.46E-02
Wan	BP	GO:0018126	protein hydroxylation	-	26	12	-	-	3.91E-01	2.92E-03
Wan	BP	GO:0008360	regulation of cell shape	-	139	31	-	-	6.86E-03	7.30E-03
Wan	BP	GO:0051222	positive regulation of protein transport	-	249	63	-	-	7.34E-03	1.49E-02
Wan	BP	GO:0045739	positive regulation of DNA repair	-	128	64	-	-	2.79E-01	1.52E-02
Wan	BP	GO:0045185	maintenance of protein location	-	95	29	-	-	2.29E-03	7.00E-03
Wan	BP	GO:0003158	endothelium development	-	140	22	-	-	1.00E-02	5.25E-03
Wan	CC	GO:0072595	maintenance of protein localization in organelle	-	42	16	-	-	4.15E-03	3.79E-03
Wan	BP	GO:0051224	negative regulation of protein transport	-	122	26	-	-	7.82E-03	6.13E-03
Wan	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	13	-	-	8.56E-04	3.21E-03
Wan	MF	GO:0003713	transcription coactivator activity	-	281	105	-	-	3.78E-02	2.45E-02
Wan	BP	GO:0021885	forebrain cell migration	-	63	11	-	-	8.66E-04	2.63E-03
Wan	BP	GO:0007405	neuroblast proliferation	-	81	13	-	-	1.26E-02	3.21E-03
Wan	BP	GO:1990542	mitochondrial transmembrane transport	-	93	28	-	-	6.77E-02	6.71E-03
Wan	BP	GO:0045862	positive regulation of proteolysis	-	353	94	-	-	8.57E-03	2.22E-02
Wan	BP	GO:0031100	animal organ regeneration	-	66	20	-	-	1.40E-03	4.67E-03
Wan	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	35	-	-	1.21E-01	8.17E-03
Wan	BP	GO:0097722	sperm motility	-	133	23	-	-	1.42E-03	5.54E-03
Wan	BP	GO:0030001	metal ion transport	-	933	114	-	-	1.36E-02	2.68E-02
Wan	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	12	-	-	7.60E-03	2.92E-03
Wan	BP	GO:0035148	tube formation	-	155	25	-	-	2.53E-02	5.84E-03
Wan	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	15	-	-	3.00E-02	3.50E-03
Wan	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	28	-	-	1.79E-02	6.71E-03
Wan	BP	GO:0031123	RNA 3'-end processing	-	79	49	-	-	5.93E-02	1.17E-02
Wan	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	20	-	-	1.41E-03	4.67E-03
Wan	CC	GO:0007097	nuclear migration	-	24	12	-	-	1.08E-02	2.92E-03
Wan	BP	GO:0045229	external encapsulating structure organization	-	319	33	-	-	2.00E-03	7.88E-03
Wan	BP	GO:0006885	regulation of pH	-	104	17	-	-	3.02E-02	4.09E-03
Wan	BP	GO:0001667	ameboidal-type cell migration	-	495	83	-	-	1.04E-02	1.96E-02
Wan	BP	GO:0001708	cell fate specification	-	108	16	-	-	3.63E-01	3.79E-03
Wan	BP	GO:0032970	regulation of actin filament-based process	-	368	98	-	-	2.19E-02	2.31E-02
Wan	BP	GO:0042440	pigment metabolic process	-	80	14	-	-	8.65E-04	3.50E-03
Wan	BP	GO:1901606	alpha-amino acid catabolic process	-	101	42	-	-	7.09E-02	9.92E-03
Wan	BP	GO:0062197	cellular response to chemical stress	-	299	86	-	-	9.76E-03	2.01E-02
Wan	BP	GO:1901655	cellular response to ketone	-	107	31	-	-	1.96E-03	7.30E-03
Wan	MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	-	925	140	-	-	1.05E-01	3.27E-02
Wan	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	12	-	-	3.60E-01	2.92E-03
Wan	BP	GO:0055006	cardiac cell development	-	93	19	-	-	7.45E-03	4.67E-03
Wan	BP	GO:0031365	N-terminal protein amino acid modification	-	30	14	-	-	3.17E-02	3.50E-03
Wan	BP	GO:0044706	multi-multicellular organism process	-	217	32	-	-	1.32E-02	7.59E-03
Wan	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	44	-	-	5.29E-03	1.05E-02
Wan	BP	GO:0050768	negative regulation of neurogenesis	-	150	18	-	-	5.54E-02	4.38E-03
Wan	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	35	-	-	2.56E-02	8.17E-03
Wan	BP	GO:0090068	positive regulation of cell cycle process	-	262	84	-	-	4.81E-02	1.98E-02
Wan	MF	GO:0022803	passive transmembrane transporter activity	-	676	62	-	-	4.72E-02	1.46E-02
Wan	BP	GO:0043632	modification-dependent macromolecule catabolic process	-	642	214	-	-	1.54E-01	5.02E-02
Wan	BP	GO:1902115	regulation of organelle assembly	-	210	64	-	-	3.93E-02	1.52E-02
Wan	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	50	-	-	2.20E-02	1.17E-02
Wan	BP	GO:0006730	one-carbon metabolic process	-	24	14	-	-	8.57E-04	3.50E-03
Wan	CC	GO:0032365	intracellular lipid transport	-	51	14	-	-	2.58E-02	3.50E-03
Wan	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	23	-	-	1.43E-03	5.54E-03
Wan	BP	GO:0097581	lamellipodium organization	-	91	35	-	-	1.73E-02	8.17E-03
Wan	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	18	-	-	2.29E-01	4.38E-03
Wan	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	73	-	-	1.98E-01	1.72E-02
Wan	BP	GO:0060326	cell chemotaxis	-	311	40	-	-	3.69E-03	9.34E-03
Wan	BP	GO:0016485	protein processing	-	248	45	-	-	5.35E-03	1.05E-02
Wan	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	13	-	-	8.68E-04	3.21E-03
Wan	BP	GO:0031348	negative regulation of defense response	-	282	37	-	-	6.47E-03	8.75E-03
Wan	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	18	-	-	1.36E-02	4.38E-03
Wan	BP	GO:0061180	mammary gland epithelium development	-	68	11	-	-	8.56E-04	2.63E-03
Wan	CC	GO:0051169	nuclear transport	-	325	152	-	-	1.07E-01	3.56E-02
Wan	BP	GO:0071496	cellular response to external stimulus	-	74	16	-	-	1.15E-03	3.79E-03
Wan	BP	GO:0046434	organophosphate catabolic process	-	232	71	-	-	1.80E-02	1.66E-02
Wan	BP	GO:0009566	fertilization	-	205	32	-	-	2.68E-02	7.59E-03
Wan	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	22	-	-	1.47E-01	5.25E-03
Wan	BP	GO:0033044	regulation of chromosome organization	-	249	133	-	-	1.49E-01	3.12E-02
Wan	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	73	-	-	6.89E-03	1.72E-02
Wan	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	22	-	-	2.87E-02	5.25E-03
Wan	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	107	-	-	5.38E-02	2.51E-02
Wan	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	147	-	-	1.03E-01	3.44E-02
Wan	BP	GO:0016180	snRNA processing	-	28	24	-	-	3.46E-01	5.84E-03
Wan	BP	GO:0051303	establishment of chromosome localization	-	104	42	-	-	9.04E-02	9.92E-03
Wan	BP	GO:0031349	positive regulation of defense response	-	473	74	-	-	1.24E-02	1.75E-02
Wan	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	21	-	-	1.36E-02	4.96E-03
Wan	BP	GO:0006605	protein targeting	-	327	105	-	-	4.54E-02	2.45E-02
Wan	BP	GO:0007566	embryo implantation	-	57	11	-	-	8.45E-04	2.63E-03
Wan	BP	GO:0061512	protein localization to cilium	-	394	59	-	-	3.96E-02	1.40E-02
Wan	BP	GO:0051017	actin filament bundle assembly	-	161	42	-	-	8.65E-03	9.92E-03
Wan	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	11	-	-	8.52E-04	2.63E-03
Wan	BP	GO:1901343	negative regulation of vasculature development	-	154	15	-	-	1.14E-03	3.50E-03
Wan	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	57	-	-	8.92E-02	1.34E-02
Wan	BP	GO:1902414	protein localization to cell junction	-	107	27	-	-	1.17E-02	6.42E-03
Wan	BP	GO:0051304	chromosome separation	-	80	41	-	-	1.05E-01	9.63E-03
Wan	BP	GO:0090596	sensory organ morphogenesis	-	272	29	-	-	2.84E-03	7.00E-03
Wan	BP	GO:0048709	oligodendrocyte differentiation	-	101	22	-	-	1.45E-01	5.25E-03
Wan	BP	GO:0045017	glycerolipid biosynthetic process	-	254	32	-	-	4.08E-02	7.59E-03
Wan	BP	GO:0001776	leukocyte homeostasis	-	108	24	-	-	1.18E-02	5.84E-03
Wan	BP	GO:0050769	positive regulation of neurogenesis	-	240	43	-	-	4.56E-03	1.02E-02
Wan	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	12	-	-	3.82E-01	2.92E-03
Wan	BP	GO:0050866	negative regulation of cell activation	-	216	21	-	-	1.43E-03	4.96E-03
Wan	BP	GO:0033500	carbohydrate homeostasis	-	251	44	-	-	2.59E-03	1.05E-02
Wan	BP	GO:0120035	regulation of plasma membrane bounded cell projection organization	-	647	127	-	-	1.29E-02	2.98E-02
Wan	BP	GO:0044088	regulation of vacuole organization	-	56	16	-	-	1.37E-01	3.79E-03
Wan	CC	GO:0000791	euchromatin	-	60	18	-	-	1.92E-02	4.38E-03
Wan	CC	GO:0030666	endocytic vesicle membrane	-	196	32	-	-	8.02E-02	7.59E-03
Wan	CC	GO:0098857	membrane microdomain	-	324	59	-	-	2.10E-02	1.40E-02
Wan	CC	GO:0030312	external encapsulating structure	-	567	49	-	-	1.69E-02	1.17E-02
Wan	CC	GO:0071027	nuclear RNA surveillance	-	14	12	-	-	3.07E-01	2.92E-03
Wan	CC	GO:1990752	microtubule end	-	34	11	-	-	2.85E-02	2.63E-03
Wan	CC	GO:0043204	perikaryon	-	156	21	-	-	1.42E-03	4.96E-03
Wan	CC	GO:1905368	peptidase complex	-	124	70	-	-	3.42E-01	1.63E-02
Wan	CC	GO:0000792	heterochromatin	-	98	34	-	-	4.42E-02	8.17E-03
Wan	CC	GO:0031201	SNARE complex	-	48	11	-	-	1.89E-01	2.63E-03
Wan	CC	GO:0016324	apical plasma membrane	-	392	47	-	-	5.43E-03	1.11E-02
Wan	CC	GO:0033260	nuclear DNA replication	-	40	21	-	-	4.99E-02	4.96E-03
Wan	CC	GO:0044391	ribosomal subunit	-	203	153	-	-	8.06E-01	3.59E-02
Wan	CC	GO:0071013	catalytic step 2 spliceosome	-	88	69	-	-	1.71E-01	1.63E-02
Wan	CC	GO:0031907	microbody lumen	-	51	18	-	-	3.23E-02	4.38E-03
Wan	CC	GO:0098862	cluster of actin-based cell projections	-	162	33	-	-	1.22E-02	7.88E-03
Wan	CC	GO:0098978	glutamatergic synapse	-	411	105	-	-	1.40E-02	2.45E-02
Wan	CC	GO:0016363	nuclear matrix	-	127	62	-	-	3.78E-02	1.46E-02
Wan	CC	GO:0031261	DNA replication preinitiation complex	-	46	27	-	-	2.29E-01	6.42E-03
Wan	CC	GO:0031966	mitochondrial membrane	-	746	223	-	-	3.22E-01	5.22E-02
Wan	CC	GO:0097060	synaptic membrane	-	413	50	-	-	1.88E-02	1.17E-02
Wan	CC	GO:0032432	actin filament bundle	-	249	68	-	-	1.88E-02	1.60E-02
Wan	CC	GO:0008088	axo-dendritic transport	-	78	27	-	-	8.14E-02	6.42E-03
Wan	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	62	-	-	5.99E-02	1.46E-02
Wan	CC	GO:0000313	organellar ribosome	-	89	53	-	-	7.69E-01	1.25E-02
Wan	CC	GO:0098791	Golgi apparatus subcompartment	-	378	76	-	-	1.43E-01	1.78E-02
Wan	CC	GO:0099643	signal release from synapse	-	147	26	-	-	3.63E-02	6.13E-03
Wan	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	17	-	-	3.42E-03	4.09E-03
Wan	CC	GO:0030018	Z disc	-	129	42	-	-	7.71E-03	9.92E-03
Wan	CC	GO:0005814	centriole	-	692	167	-	-	4.27E-02	3.91E-02
Wan	CC	GO:1905360	GTPase complex	-	41	11	-	-	2.79E-01	2.63E-03
Wan	CC	GO:0097540	axonemal central pair	-	161	33	-	-	6.55E-03	7.88E-03
Wan	CC	GO:0042641	actomyosin	-	77	34	-	-	2.65E-02	8.17E-03
Wan	CC	GO:0032588	trans-Golgi network membrane	-	102	29	-	-	2.64E-01	7.00E-03
Wan	CC	GO:0070382	exocytic vesicle	-	224	46	-	-	3.40E-02	1.08E-02
Wan	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	16	-	-	2.94E-03	3.79E-03
Wan	CC	GO:0031903	microbody membrane	-	65	15	-	-	1.15E-03	3.50E-03
Wan	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	103	-	-	3.21E-02	2.42E-02
Wan	CC	GO:0070993	translation preinitiation complex	-	19	19	-	-	6.07E-01	4.67E-03
Wan	CC	GO:0016323	basolateral plasma membrane	-	239	30	-	-	1.40E-02	7.00E-03
Wan	CC	GO:0042645	mitochondrial nucleoid	-	45	24	-	-	1.51E-02	5.84E-03
Wan	CC	GO:1902495	transmembrane transporter complex	-	408	57	-	-	1.50E-01	1.34E-02
Wan	CC	GO:0019897	extrinsic component of plasma membrane	-	156	35	-	-	1.63E-01	8.17E-03
Wan	CC	GO:0031594	neuromuscular junction	-	73	13	-	-	7.26E-03	3.21E-03
Wan	CC	GO:0000793	condensed chromosome	-	274	126	-	-	1.20E-01	2.95E-02
Wan	CC	GO:0000922	spindle pole	-	172	54	-	-	6.01E-02	1.28E-02
Wan	CC	GO:0120111	neuron projection cytoplasm	-	94	34	-	-	1.23E-02	8.17E-03
Wan	CC	GO:0070971	endoplasmic reticulum exit site	-	32	15	-	-	3.18E-01	3.50E-03
Wan	CC	GO:0005736	RNA polymerase I complex	-	13	13	-	-	5.10E-01	3.21E-03
Wan	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	46	-	-	7.17E-02	1.08E-02
Wan	CC	GO:0000123	histone acetyltransferase complex	-	93	36	-	-	1.15E-01	8.46E-03
Wan	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	41	-	-	1.65E-01	9.63E-03
Wan	CC	GO:0048786	presynaptic active zone	-	80	16	-	-	5.14E-03	3.79E-03
Wan	CC	GO:0001054	RNA polymerase I activity	-	12	12	-	-	3.20E-01	2.92E-03
Wan	CC	GO:0007034	vacuolar transport	-	168	61	-	-	1.50E-01	1.43E-02
Wan	CC	GO:0005776	autophagosome	-	111	28	-	-	8.91E-02	6.71E-03
Wan	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	53	-	-	2.96E-01	1.25E-02
Wan	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	45	-	-	2.16E-01	1.05E-02
Wan	CC	GO:0150034	distal axon	-	309	57	-	-	1.55E-02	1.34E-02
Wan	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	110	-	-	3.06E-01	2.57E-02
Wan	CC	GO:0072562	blood microparticle	-	144	19	-	-	1.12E-03	4.67E-03
Wan	CC	GO:0051233	spindle midzone	-	36	17	-	-	1.14E-03	4.09E-03
Wan	CC	GO:0005811	lipid droplet	-	102	23	-	-	3.93E-03	5.54E-03
Wan	CC	GO:0045022	early endosome to late endosome transport	-	44	20	-	-	3.70E-02	4.67E-03
Wan	CC	GO:0044853	plasma membrane raft	-	114	17	-	-	3.86E-02	4.09E-03
Wan	CC	GO:0005881	cytoplasmic microtubule	-	256	51	-	-	6.61E-03	1.20E-02
Wan	CC	GO:0008180	COP9 signalosome	-	17	11	-	-	8.40E-01	2.63E-03
Wan	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	23	-	-	3.08E-01	5.54E-03
Wan	CC	GO:0005905	clathrin-coated pit	-	73	28	-	-	1.11E-01	6.71E-03
Wan	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	16	-	-	1.03E-01	3.79E-03
Wan	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	15	-	-	8.28E-01	3.50E-03
Wan	CC	GO:0000139	Golgi membrane	-	646	111	-	-	1.45E-01	2.60E-02
Wan	CC	GO:0032154	cleavage furrow	-	54	17	-	-	9.50E-03	4.09E-03
Wan	CC	GO:0007006	mitochondrial membrane organization	-	117	41	-	-	4.14E-02	9.63E-03
Wan	CC	GO:0009897	external side of plasma membrane	-	425	21	-	-	5.76E-02	4.96E-03
Wan	CC	GO:0030863	cortical cytoskeleton	-	104	41	-	-	2.05E-02	9.63E-03
Wan	CC	GO:1905348	endonuclease complex	-	38	12	-	-	8.57E-04	2.92E-03
Wan	CC	GO:0036019	endolysosome	-	29	12	-	-	1.80E-01	2.92E-03
Wan	CC	GO:0030427	site of polarized growth	-	172	44	-	-	2.20E-02	1.05E-02
Wan	CC	GO:0044309	neuron spine	-	213	48	-	-	4.46E-03	1.14E-02
Wan	CC	GO:0030658	transport vesicle membrane	-	231	58	-	-	6.88E-02	1.37E-02
Wan	CC	GO:0044232	organelle membrane contact site	-	50	13	-	-	8.50E-04	3.21E-03
Wan	CC	GO:0098803	respiratory chain complex	-	39	14	-	-	4.19E-02	3.50E-03
Wan	CC	GO:0030667	secretory granule membrane	-	319	68	-	-	7.90E-03	1.60E-02
Wan	CC	GO:0097545	axonemal outer doublet	-	164	33	-	-	7.04E-03	7.88E-03
Wan	CC	GO:0070069	cytochrome complex	-	42	14	-	-	1.22E-01	3.50E-03
Wan	CC	GO:0055037	recycling endosome	-	200	43	-	-	6.40E-02	1.02E-02
Wan	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	20	-	-	1.43E-03	4.67E-03
Wan	CC	GO:0030684	preribosome	-	76	60	-	-	1.83E-01	1.40E-02
Wan	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	120	-	-	1.70E-02	2.80E-02
Wan	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	17	-	-	6.59E-01	4.09E-03
Wan	CC	GO:0005775	vacuolar lumen	-	176	55	-	-	8.21E-03	1.28E-02
Wan	CC	GO:0032982	myosin filament	-	24	11	-	-	8.71E-04	2.63E-03
Wan	CC	GO:0044306	neuron projection terminus	-	164	20	-	-	9.18E-03	4.67E-03
Wan	CC	GO:0034455	t-UTP complex	-	53	42	-	-	2.30E-01	9.92E-03
Wan	CC	GO:0005770	late endosome	-	299	71	-	-	3.97E-02	1.66E-02
Wan	CC	GO:0031970	organelle envelope lumen	-	94	42	-	-	2.53E-02	9.92E-03
Wan	CC	GO:0019866	organelle inner membrane	-	546	179	-	-	3.77E-01	4.20E-02
Wan	CC	GO:0098687	chromosomal region	-	397	183	-	-	1.69E-01	4.29E-02
Wan	CC	GO:0043292	contractile muscle fiber	-	245	81	-	-	7.71E-02	1.90E-02
Wan	CC	GO:0031074	nucleocytoplasmic transport complex	-	12	11	-	-	7.50E-02	2.63E-03
Wan	CC	GO:0005849	mRNA cleavage factor complex	-	22	16	-	-	4.69E-01	3.79E-03
Wan	CC	GO:0000803	sex chromosome	-	32	12	-	-	1.58E-02	2.92E-03
Wan	CC	GO:1990229	iron-sulfur cluster assembly complex	-	17	12	-	-	6.67E-01	2.92E-03
Wan	CC	GO:0035097	histone methyltransferase complex	-	63	29	-	-	7.38E-02	7.00E-03
Wan	CC	GO:0000323	lytic vacuole	-	749	188	-	-	8.06E-02	4.41E-02
Wan	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	13	-	-	4.37E-01	3.21E-03
Wan	CC	GO:1903293	phosphatase complex	-	54	23	-	-	3.82E-01	5.54E-03
Wan	CC	GO:0000786	nucleosome	-	149	24	-	-	9.38E-02	5.84E-03
Wan	CC	GO:0001533	cornified envelope	-	59	15	-	-	1.25E-01	3.50E-03
Wan	CC	GO:1904724	tertiary granule lumen	-	55	15	-	-	8.18E-03	3.50E-03
Wan	CC	GO:0030027	lamellipodium	-	202	71	-	-	5.13E-02	1.66E-02
Wan	CC	GO:0001056	RNA polymerase III activity	-	16	16	-	-	5.57E-01	3.79E-03
Wan	CC	GO:0045259	proton-transporting ATP synthase complex	-	22	12	-	-	3.85E-01	2.92E-03
Wan	CC	GO:0002102	podosome	-	31	13	-	-	8.54E-04	3.21E-03
Wan	CC	GO:0090543	Flemming body	-	33	18	-	-	5.58E-02	4.38E-03
Wan	CC	GO:0016328	lateral plasma membrane	-	66	16	-	-	2.00E-02	3.79E-03
Wan	CC	GO:0001650	fibrillar center	-	151	62	-	-	2.34E-02	1.46E-02
Wan	CC	GO:1990204	oxidoreductase complex	-	90	42	-	-	8.18E-02	9.92E-03
Wan	CC	GO:0017101	aminoacyl-tRNA synthetase multienzyme complex	-	11	11	-	-	4.59E-01	2.63E-03
Wan	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	85	-	-	1.48E-02	1.98E-02
Wan	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	14	-	-	1.24E-01	3.50E-03
Wan	CC	GO:0001726	ruffle	-	181	61	-	-	1.83E-02	1.43E-02
Wan	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	12	-	-	1.36E-01	2.92E-03
Wan	CC	GO:0043073	germ cell nucleus	-	67	28	-	-	3.31E-02	6.71E-03
Wan	CC	GO:0005788	endoplasmic reticulum lumen	-	313	56	-	-	5.73E-02	1.31E-02
Wan	CC	GO:0016592	mediator complex	-	38	28	-	-	9.38E-01	6.71E-03
Wan	CC	GO:0022626	cytosolic ribosome	-	118	100	-	-	7.68E-01	2.33E-02
Wan	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	15	-	-	7.10E-01	3.50E-03
Wan	CC	GO:0034451	centriolar satellite	-	120	21	-	-	1.43E-03	4.96E-03
Wan	CC	GO:0045171	intercellular bridge	-	91	20	-	-	1.42E-03	4.67E-03
Wan	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	19	-	-	2.21E-01	4.67E-03
Wan	CC	GO:0098984	neuron to neuron synapse	-	384	79	-	-	1.00E-02	1.87E-02
Wan	CC	GO:0032039	integrator complex	-	19	17	-	-	7.99E-01	4.09E-03
Wan	CC	GO:0030286	dynein complex	-	210	47	-	-	4.65E-02	1.11E-02
Wan	CC	GO:0016482	cytosolic transport	-	135	47	-	-	6.98E-02	1.11E-02
Wan	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	17	-	-	4.96E-01	4.09E-03
Wan	CC	GO:0008023	transcription elongation factor complex	-	47	27	-	-	1.18E-01	6.42E-03
Wan	CC	GO:0030662	coated vesicle membrane	-	202	70	-	-	1.63E-01	1.63E-02
Wan	CC	GO:0007039	protein catabolic process in the vacuole	-	61	31	-	-	2.91E-01	7.30E-03
Wan	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	38	-	-	3.43E-01	9.05E-03
Wan	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	95	-	-	4.86E-01	2.22E-02
Wan	CC	GO:0005769	early endosome	-	425	99	-	-	6.81E-02	2.33E-02
Wan	CC	GO:0090734	site of DNA damage	-	118	40	-	-	1.10E-01	9.34E-03
Wan	MF	GO:0051087	protein-folding chaperone binding	-	135	57	-	-	3.30E-02	1.34E-02
Wan	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	83	-	-	3.23E-02	1.96E-02
Wan	MF	GO:0016757	glycosyltransferase activity	-	286	41	-	-	3.58E-02	9.63E-03
Wan	MF	GO:0048306	calcium-dependent protein binding	-	61	18	-	-	5.05E-02	4.38E-03
Wan	MF	GO:0016769	"transferase activity, transferring nitrogenous groups"	-	29	16	-	-	1.64E-02	3.79E-03
Wan	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	24	-	-	2.36E-02	5.84E-03
Wan	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	24	-	-	6.81E-02	5.84E-03
Wan	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	32	-	-	2.66E-02	7.59E-03
Wan	MF	GO:0051020	GTPase binding	-	311	108	-	-	1.67E-02	2.54E-02
Wan	MF	GO:0061980	regulatory RNA binding	-	52	15	-	-	1.75E-02	3.50E-03
Wan	MF	GO:0015035	protein-disulfide reductase activity	-	32	21	-	-	4.75E-02	4.96E-03
Wan	MF	GO:0001671	ATPase activator activity	-	29	14	-	-	2.48E-03	3.50E-03
Wan	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	123	-	-	4.30E-02	2.89E-02
Wan	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	12	-	-	8.34E-03	2.92E-03
Wan	MF	GO:0003688	DNA replication origin binding	-	18	14	-	-	1.25E-01	3.50E-03
Wan	MF	GO:0005178	integrin binding	-	153	27	-	-	3.27E-02	6.42E-03
Wan	MF	GO:0008233	peptidase activity	-	998	180	-	-	2.20E-02	4.20E-02
Wan	MF	GO:0140318	protein transporter activity	-	40	12	-	-	1.43E-02	2.92E-03
Wan	MF	GO:0070628	proteasome binding	-	17	11	-	-	5.72E-03	2.63E-03
Wan	MF	GO:0002039	p53 binding	-	66	30	-	-	6.13E-03	7.00E-03
Wan	MF	GO:0005496	steroid binding	-	110	15	-	-	2.28E-02	3.50E-03
Wan	MF	GO:0008443	phosphofructokinase activity	-	27	21	-	-	1.16E-02	4.96E-03
Wan	MF	GO:0003684	damaged DNA binding	-	89	32	-	-	2.39E-02	7.59E-03
Wan	MF	GO:0000339	RNA cap binding	-	20	12	-	-	4.46E-02	2.92E-03
Wan	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	37	-	-	8.58E-02	8.75E-03
Wan	MF	GO:0070063	RNA polymerase binding	-	61	37	-	-	1.01E-02	8.75E-03
Wan	MF	GO:0030971	receptor tyrosine kinase binding	-	76	14	-	-	8.57E-04	3.50E-03
Wan	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	62	-	-	2.48E-01	1.46E-02
Wan	MF	GO:0140030	modification-dependent protein binding	-	179	56	-	-	1.04E-02	1.31E-02
Wan	MF	GO:0030276	clathrin binding	-	70	23	-	-	3.68E-01	5.54E-03
Wan	MF	GO:0003712	transcription coregulator activity	-	499	175	-	-	1.30E-01	4.09E-02
Wan	MF	GO:0106310	protein serine kinase activity	-	362	95	-	-	2.15E-02	2.22E-02
Wan	MF	GO:0016788	"hydrolase activity, acting on ester bonds"	-	936	214	-	-	4.21E-02	5.02E-02
Wan	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	11	-	-	8.64E-04	2.63E-03
Wan	MF	GO:0004857	enzyme inhibitor activity	-	395	72	-	-	7.66E-03	1.69E-02
Wan	MF	GO:0016209	antioxidant activity	-	92	24	-	-	8.52E-02	5.84E-03
Wan	MF	GO:0044325	transmembrane transporter binding	-	159	41	-	-	6.37E-03	9.63E-03
Wan	MF	GO:0048156	tau protein binding	-	43	20	-	-	3.21E-03	4.67E-03
Wan	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	19	-	-	7.49E-03	4.67E-03
Wan	MF	GO:0140272	exogenous protein binding	-	79	15	-	-	1.18E-01	3.50E-03
Wan	MF	GO:0030145	manganese ion binding	-	65	16	-	-	5.72E-03	3.79E-03
Wan	MF	GO:0017069	snRNA binding	-	54	32	-	-	5.78E-02	7.59E-03
Wan	MF	GO:0008270	zinc ion binding	-	821	154	-	-	2.72E-02	3.62E-02
Wan	MF	GO:0031369	translation initiation factor binding	-	32	20	-	-	1.25E-01	4.67E-03
Wan	MF	GO:0019843	rRNA binding	-	69	45	-	-	4.18E-02	1.05E-02
Wan	MF	GO:0004713	protein tyrosine kinase activity	-	213	32	-	-	1.99E-03	7.59E-03
Wan	MF	GO:0016779	nucleotidyltransferase activity	-	264	120	-	-	2.15E-01	2.80E-02
Wan	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	15	-	-	1.16E-03	3.50E-03
Wan	MF	GO:0016208	AMP binding	-	22	14	-	-	1.33E-01	3.50E-03
Wan	MF	GO:0000287	magnesium ion binding	-	225	93	-	-	3.16E-02	2.19E-02
Wan	MF	GO:0031490	chromatin DNA binding	-	120	35	-	-	4.38E-02	8.17E-03
Wan	MF	GO:0017022	myosin binding	-	73	21	-	-	1.09E-02	4.96E-03
Wan	MF	GO:0015631	tubulin binding	-	410	106	-	-	9.65E-03	2.48E-02
Wan	MF	GO:0005539	glycosaminoglycan binding	-	236	16	-	-	1.13E-03	3.79E-03
Wan	MF	GO:0019207	kinase regulator activity	-	267	53	-	-	1.26E-02	1.25E-02
Wan	MF	GO:0044183	protein folding chaperone	-	67	38	-	-	7.02E-02	9.05E-03
Wan	MF	GO:0008047	enzyme activator activity	-	697	137	-	-	2.88E-02	3.21E-02
Wan	MF	GO:0004674	protein serine/threonine kinase activity	-	761	166	-	-	3.28E-02	3.88E-02
Wan	MF	GO:0003725	double-stranded RNA binding	-	72	28	-	-	7.99E-03	6.71E-03
Wan	MF	GO:0051018	protein kinase A binding	-	52	15	-	-	4.07E-02	3.50E-03
Wan	MF	GO:0004618	phosphoglycerate kinase activity	-	89	43	-	-	1.37E-02	1.02E-02
Wan	MF	GO:0043531	ADP binding	-	38	20	-	-	4.52E-03	4.67E-03
Wan	MF	GO:0046332	SMAD binding	-	77	17	-	-	2.86E-03	4.09E-03
Wan	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	36	-	-	9.31E-02	8.46E-03
Wan	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	14	-	-	2.60E-03	3.50E-03
Wan	MF	GO:0051117	ATPase binding	-	85	25	-	-	4.00E-03	5.84E-03
Wan	MF	GO:0005216	monoatomic ion channel activity	-	618	57	-	-	5.56E-02	1.34E-02
Wan	MF	GO:0016746	acyltransferase activity	-	895	173	-	-	4.07E-02	4.06E-02
Wan	MF	GO:0001098	basal transcription machinery binding	-	61	40	-	-	1.72E-02	9.34E-03
Wan	MF	GO:0036002	pre-mRNA binding	-	57	15	-	-	9.39E-03	3.50E-03
Wan	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	24	-	-	1.22E-02	5.84E-03
Wan	MF	GO:0051540	metal cluster binding	-	71	37	-	-	1.32E-02	8.75E-03
Wan	MF	GO:0051219	phosphoprotein binding	-	92	30	-	-	5.12E-03	7.00E-03
Wan	MF	GO:0019894	kinesin binding	-	45	13	-	-	1.21E-01	3.21E-03
Wan	MF	GO:0019003	GDP binding	-	89	36	-	-	1.45E-01	8.46E-03
Wan	MF	GO:0017171	serine hydrolase activity	-	207	15	-	-	5.22E-02	3.50E-03
Wan	MF	GO:0097110	scaffold protein binding	-	66	15	-	-	1.15E-03	3.50E-03
Wan	MF	GO:0003774	cytoskeletal motor activity	-	117	38	-	-	3.68E-02	9.05E-03
Wan	MF	GO:0061134	peptidase regulator activity	-	224	32	-	-	3.07E-03	7.59E-03
Wan	MF	GO:0008013	beta-catenin binding	-	86	18	-	-	7.45E-03	4.38E-03
Wan	MF	GO:0051015	actin filament binding	-	208	94	-	-	1.45E-01	2.22E-02
Wan	MF	GO:0019208	phosphatase regulator activity	-	107	31	-	-	2.99E-02	7.30E-03
Wan	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	19	-	-	4.46E-03	4.67E-03
Wan	MF	GO:0045860	positive regulation of protein kinase activity	-	397	67	-	-	1.35E-02	1.58E-02
Wan	MF	GO:0008134	transcription factor binding	-	597	185	-	-	5.58E-02	4.32E-02
Wan	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	29	-	-	3.60E-02	7.00E-03
Wan	MF	GO:0042393	histone binding	-	240	92	-	-	2.34E-02	2.16E-02
Wan	MF	GO:0019838	growth factor binding	-	182	17	-	-	1.13E-03	4.09E-03
Wan	MF	GO:0000149	SNARE binding	-	107	29	-	-	7.34E-02	7.00E-03
Wan	MF	GO:0003727	single-stranded RNA binding	-	90	47	-	-	1.48E-02	1.11E-02
Wan	MF	GO:0005516	calmodulin binding	-	206	53	-	-	2.08E-02	1.25E-02
Wan	MF	GO:0045505	dynein intermediate chain binding	-	37	12	-	-	1.40E-02	2.92E-03
Wan	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	31	-	-	1.73E-02	7.30E-03
Wan	MF	GO:0032182	ubiquitin-like protein binding	-	117	48	-	-	1.58E-02	1.14E-02
Wan	MF	GO:0019904	protein domain specific binding	-	656	200	-	-	2.73E-02	4.67E-02
Wan	MF	GO:0031072	heat shock protein binding	-	128	53	-	-	4.21E-02	1.25E-02
Wan	MF	GO:0030515	snoRNA binding	-	33	22	-	-	5.68E-02	5.25E-03
Wan	MF	GO:0016782	"transferase activity, transferring sulphur-containing groups"	-	83	11	-	-	8.66E-04	2.63E-03
Wan	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	95	-	-	4.85E-02	2.22E-02
Wan	MF	GO:0046982	protein heterodimerization activity	-	343	76	-	-	3.12E-02	1.78E-02
Wan	MF	GO:0140223	general transcription initiation factor activity	-	55	28	-	-	3.23E-01	6.71E-03
Wan	MF	GO:0000049	tRNA binding	-	75	39	-	-	1.19E-02	9.34E-03
Wan	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	13	-	-	4.51E-03	3.21E-03
Wan	MF	GO:0006469	negative regulation of protein kinase activity	-	222	51	-	-	7.80E-03	1.20E-02
Wan	MF	GO:0070182	DNA polymerase binding	-	22	11	-	-	1.02E-02	2.63E-03
Wan	MF	GO:0070851	growth factor receptor binding	-	141	17	-	-	2.33E-02	4.09E-03
Wan	MF	GO:0005525	GTP binding	-	396	124	-	-	1.32E-01	2.92E-02
Wan	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	46	-	-	3.14E-03	1.08E-02
Wan	MF	GO:0042803	protein homodimerization activity	-	699	181	-	-	2.03E-02	4.23E-02
Wan	MF	GO:0051346	negative regulation of hydrolase activity	-	332	61	-	-	5.18E-03	1.43E-02
Wan	MF	GO:0005506	iron ion binding	-	154	22	-	-	1.43E-03	5.25E-03
Wan	MF	GO:0003925	G protein activity	-	45	22	-	-	1.24E-01	5.25E-03
Wan	MF	GO:0008276	protein methyltransferase activity	-	96	30	-	-	1.60E-02	7.00E-03
Wan	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	115	-	-	2.30E-02	2.68E-02
Wan	MF	GO:0051345	positive regulation of hydrolase activity	-	535	95	-	-	1.00E-02	2.22E-02
Wan	MF	GO:0015399	primary active transmembrane transporter activity	-	190	71	-	-	1.33E-01	1.66E-02
Wan	MF	GO:0035254	glutamate receptor binding	-	47	11	-	-	1.41E-02	2.63E-03
Wan	MF	GO:0043021	ribonucleoprotein complex binding	-	158	90	-	-	1.36E-02	2.10E-02
Wan	MF	GO:0030170	pyridoxal phosphate binding	-	56	26	-	-	2.33E-02	6.13E-03
Wan	MF	GO:0001664	G protein-coupled receptor binding	-	299	38	-	-	2.78E-03	9.05E-03
Wan	MF	GO:0019900	kinase binding	-	893	203	-	-	2.30E-02	4.76E-02
Wan	MF	GO:0070034	telomerase RNA binding	-	22	12	-	-	2.24E-01	2.92E-03
Youn	CC	GO:0005730	nucleolus	1.10E-89	988	553	263	2.11	-	-
Youn	CC	GO:0005840	ribosome	2.86E-66	222	181	59	3.07	-	-
Youn	CC	GO:0005815	microtubule organizing center	6.34E-52	843	426	224	1.90	-	-
Youn	CC	GO:0005635	nuclear envelope	6.72E-23	493	232	131	1.77	-	-
Youn	CC	GO:0000228	nuclear chromosome	1.31E-20	206	118	55	2.15	-	-
Youn	CC	GO:0031012	extracellular matrix	2.76E-20	564	62	150	0.41	-	-
Youn	CC	GO:0005739	mitochondrion	3.85E-14	1671	578	444	1.30	-	-
Youn	CC	GO:0005783	endoplasmic reticulum	1.52E-04	2020	609	537	1.13	-	-
Youn	CC	GO:0005768	endosome	1.28E-03	1037	321	276	1.16	-	-
Youn	CC	GO:0005811	lipid droplet	3.22E-02	102	37	27	1.36	-	-
Youn	CC	GO:0005777	peroxisome	3.58E-02	142	49	38	1.30	-	-
Youn	CC	GO:0005929	cilium	3.38E-01	842	236	224	1.05	-	-
Youn	CC	GO:0005794	Golgi apparatus	5.98E-01	1636	444	435	1.02	-	-
Youn	CC	GO:0005764	lysosome	8.66E-01	747	196	199	0.99	-	-
Youn	CC	GO:0005615	extracellular space	8.95E-01	3190	851	848	1.00	-	-
Youn	BP	GO:0016071	mRNA metabolic process	1.46E-162	713	530	190	2.80	-	-
Youn	BP	GO:0042254	ribosome biogenesis	8.50E-75	297	229	79	2.90	-	-
Youn	BP	GO:0002181	cytoplasmic translation	5.87E-61	153	137	41	3.37	-	-
Youn	BP	GO:0065003	protein-containing complex assembly	1.76E-56	1648	722	438	1.65	-	-
Youn	BP	GO:0007059	chromosome segregation	3.80E-54	403	254	107	2.37	-	-
Youn	BP	GO:0007010	cytoskeleton organization	5.04E-51	1639	704	436	1.62	-	-
Youn	BP	GO:0050877	nervous system process	2.54E-45	1527	188	406	0.46	-	-
Youn	BP	GO:0006913	nucleocytoplasmic transport	1.09E-40	326	201	87	2.32	-	-
Youn	BP	GO:0006281	DNA repair	4.29E-38	587	301	156	1.93	-	-
Youn	BP	GO:0006325	chromatin organization	1.67E-37	720	349	191	1.82	-	-
Youn	BP	GO:0006886	intracellular protein transport	4.55E-35	664	323	177	1.83	-	-
Youn	BP	GO:0006260	DNA replication	3.45E-23	279	152	74	2.05	-	-
Youn	BP	GO:0140053	mitochondrial gene expression	9.21E-22	164	102	44	2.34	-	-
Youn	BP	GO:0031047	regulatory ncRNA-mediated gene silencing	1.03E-19	119	79	32	2.50	-	-
Youn	BP	GO:0006914	autophagy	1.27E-15	568	238	151	1.58	-	-
Youn	BP	GO:0016192	vesicle-mediated transport	1.86E-15	1894	652	503	1.30	-	-
Youn	BP	GO:0006457	protein folding	1.91E-15	210	110	56	1.97	-	-
Youn	BP	GO:0006399	tRNA metabolic process	4.56E-14	196	102	52	1.96	-	-
Youn	BP	GO:0030163	protein catabolic process	6.25E-14	990	368	263	1.40	-	-
Youn	BP	GO:0000910	cytokinesis	1.35E-13	186	97	49	1.96	-	-
Youn	BP	GO:0032200	telomere organization	8.34E-12	186	93	49	1.88	-	-
Youn	BP	GO:0055085	transmembrane transport	6.99E-11	1784	361	474	0.76	-	-
Youn	BP	GO:0012501	programmed cell death	2.27E-10	1954	639	519	1.23	-	-
Youn	BP	GO:0006355	regulation of DNA-templated transcription	5.47E-10	3342	1034	888	1.16	-	-
Youn	BP	GO:0006310	DNA recombination	1.86E-09	333	139	89	1.57	-	-
Youn	BP	GO:0007018	microtubule-based movement	2.69E-09	640	238	170	1.40	-	-
Youn	BP	GO:0006954	inflammatory response	6.91E-08	820	153	218	0.70	-	-
Youn	BP	GO:0055086	nucleobase-containing small molecule metabolic process	5.26E-07	729	254	194	1.31	-	-
Youn	BP	GO:0007005	mitochondrion organization	6.55E-07	484	178	129	1.38	-	-
Youn	BP	GO:0007163	establishment or maintenance of cell polarity	1.08E-06	227	94	60	1.56	-	-
Youn	BP	GO:0072659	protein localization to plasma membrane	2.53E-06	284	112	75	1.48	-	-
Youn	BP	GO:0030198	extracellular matrix organization	7.80E-06	314	50	83	0.60	-	-
Youn	BP	GO:0003013	circulatory system process	6.18E-05	584	114	155	0.73	-	-
Youn	BP	GO:0006629	lipid metabolic process	7.46E-05	1355	299	360	0.83	-	-
Youn	BP	GO:0140013	meiotic nuclear division	9.14E-05	279	104	74	1.40	-	-
Youn	BP	GO:0007155	cell adhesion	1.05E-04	1444	322	384	0.84	-	-
Youn	BP	GO:0022600	digestive system process	1.55E-03	110	15	29	0.51	-	-
Youn	BP	GO:0098754	detoxification	3.15E-03	134	21	36	0.59	-	-
Youn	BP	GO:0044782	cilium organization	3.47E-03	399	132	106	1.24	-	-
Youn	BP	GO:0006486	protein glycosylation	6.18E-03	225	42	60	0.70	-	-
Youn	BP	GO:0007040	lysosome organization	8.12E-03	107	41	28	1.44	-	-
Youn	BP	GO:0003014	renal system process	8.69E-03	127	21	34	0.62	-	-
Youn	BP	GO:0002376	immune system process	9.97E-03	2448	598	651	0.92	-	-
Youn	BP	GO:0006091	generation of precursor metabolites and energy	1.04E-02	502	159	133	1.19	-	-
Youn	BP	GO:0098542	defense response to other organism	2.87E-02	1171	279	311	0.90	-	-
Youn	BP	GO:0034330	cell junction organization	4.42E-02	727	217	193	1.12	-	-
Youn	BP	GO:0006520	amino acid metabolic process	4.50E-02	292	93	78	1.20	-	-
Youn	BP	GO:0042060	wound healing	6.88E-02	431	98	115	0.86	-	-
Youn	BP	GO:0006766	vitamin metabolic process	7.83E-02	107	20	28	0.70	-	-
Youn	BP	GO:0005975	carbohydrate metabolic process	2.40E-01	551	134	146	0.91	-	-
Youn	BP	GO:0003012	muscle system process	3.45E-01	425	104	113	0.92	-	-
Youn	BP	GO:0048870	cell motility	4.67E-01	1659	428	441	0.97	-	-
Youn	BP	GO:0006790	sulfur compound metabolic process	4.83E-01	320	79	85	0.93	-	-
Youn	BP	GO:0006575	cellular modified amino acid metabolic process	7.39E-01	186	47	49	0.95	-	-
Youn	MF	GO:0003723	RNA binding	0.00E+00	1679	1239	446	2.78	-	-
Youn	MF	GO:0140657	ATP-dependent activity	2.18E-49	729	378	194	1.95	-	-
Youn	MF	GO:0048018	receptor ligand activity	2.15E-40	504	22	134	0.16	-	-
Youn	MF	GO:0008092	cytoskeletal protein binding	6.14E-35	1023	450	272	1.65	-	-
Youn	MF	GO:0140098	"catalytic activity, acting on RNA"	5.54E-33	417	225	111	2.03	-	-
Youn	MF	GO:0045182	translation regulator activity	1.56E-27	151	104	40	2.59	-	-
Youn	MF	GO:0140097	"catalytic activity, acting on DNA"	1.87E-27	383	201	102	1.97	-	-
Youn	MF	GO:0005198	structural molecule activity	3.47E-26	798	348	212	1.64	-	-
Youn	MF	GO:0042393	histone binding	1.43E-23	237	136	63	2.16	-	-
Youn	MF	GO:0016874	ligase activity	2.60E-14	283	135	75	1.79	-	-
Youn	MF	GO:0005215	transporter activity	3.72E-11	1462	284	389	0.73	-	-
Youn	MF	GO:0140104	molecular carrier activity	2.01E-10	105	59	28	2.11	-	-
Youn	MF	GO:0009975	cyclase activity	2.50E-09	277	33	74	0.45	-	-
Youn	MF	GO:0016740	transferase activity	1.79E-08	3074	945	817	1.16	-	-
Youn	MF	GO:0003677	DNA binding	1.73E-06	2865	867	762	1.14	-	-
Youn	MF	GO:0016853	isomerase activity	3.81E-05	252	97	67	1.45	-	-
Youn	MF	GO:0003774	cytoskeletal motor activity	5.13E-05	116	51	31	1.65	-	-
Youn	MF	GO:0003924	GTPase activity	7.49E-05	658	220	175	1.26	-	-
Youn	MF	GO:0016829	lyase activity	2.92E-04	538	107	143	0.75	-	-
Youn	MF	GO:0038024	cargo receptor activity	1.13E-02	117	19	31	0.61	-	-
Youn	MF	GO:0140096	"catalytic activity, acting on a protein"	2.95E-02	3198	900	850	1.06	-	-
Youn	MF	GO:0140110	transcription regulator activity	3.39E-01	2033	522	540	0.97	-	-
Youn	MF	GO:0008289	lipid binding	4.71E-01	836	213	222	0.96	-	-
Youn	MF	GO:0016491	oxidoreductase activity	6.69E-01	888	230	236	0.97	-	-
Youn	BP	GO:0098780	response to mitochondrial depolarisation	-	21	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0007346	regulation of mitotic cell cycle	-	518	232	-	-	9.83E-03	3.68E-02
Youn	BP	GO:0001525	angiogenesis	-	616	107	-	-	5.84E-03	1.70E-02
Youn	BP	GO:0045666	positive regulation of neuron differentiation	-	91	14	-	-	3.08E-03	2.37E-03
Youn	BP	GO:0043543	protein acylation	-	107	37	-	-	3.54E-02	5.93E-03
Youn	MF	GO:0008509	monoatomic anion transmembrane transporter activity	-	143	22	-	-	9.69E-04	3.56E-03
Youn	BP	GO:0071763	nuclear membrane organization	-	44	23	-	-	9.70E-04	3.76E-03
Youn	CC	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	-	39	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:0071806	protein transmembrane transport	-	68	28	-	-	1.16E-03	4.55E-03
Youn	BP	GO:0043299	leukocyte degranulation	-	82	13	-	-	5.88E-04	2.18E-03
Youn	BP	GO:0048864	stem cell development	-	88	21	-	-	9.69E-04	3.36E-03
Youn	BP	GO:0051651	maintenance of location in cell	-	236	72	-	-	5.91E-03	1.15E-02
Youn	BP	GO:0033119	negative regulation of RNA splicing	-	27	23	-	-	9.70E-04	3.76E-03
Youn	CC	GO:0016197	endosomal transport	-	282	141	-	-	2.08E-02	2.23E-02
Youn	BP	GO:0070663	regulation of leukocyte proliferation	-	268	49	-	-	1.95E-03	7.91E-03
Youn	BP	GO:0062098	regulation of programmed necrotic cell death	-	37	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0045861	negative regulation of proteolysis	-	320	76	-	-	3.72E-03	1.21E-02
Youn	BP	GO:0043144	sno(s)RNA processing	-	14	12	-	-	1.59E-02	1.98E-03
Youn	CC	GO:0006984	ER-nucleus signaling pathway	-	46	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0009914	hormone transport	-	315	58	-	-	2.34E-03	9.29E-03
Youn	BP	GO:0045785	positive regulation of cell adhesion	-	482	117	-	-	4.72E-03	1.86E-02
Youn	BP	GO:0006413	translational initiation	-	122	83	-	-	5.41E-03	1.32E-02
Youn	BP	GO:1902895	positive regulation of miRNA transcription	-	51	14	-	-	5.81E-04	2.37E-03
Youn	CC	GO:0005200	structural constituent of cytoskeleton	-	112	64	-	-	2.54E-03	1.03E-02
Youn	BP	GO:0030865	cortical cytoskeleton organization	-	51	30	-	-	1.36E-03	4.75E-03
Youn	BP	GO:1902455	negative regulation of stem cell population maintenance	-	26	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:1903036	positive regulation of response to wounding	-	76	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0006490	oligosaccharide-lipid intermediate biosynthetic process	-	21	12	-	-	6.19E-04	1.98E-03
Youn	MF	GO:0005342	organic acid transmembrane transporter activity	-	229	39	-	-	1.56E-03	6.33E-03
Youn	BP	GO:0002263	cell activation involved in immune response	-	304	62	-	-	3.63E-03	9.89E-03
Youn	BP	GO:0021954	central nervous system neuron development	-	85	27	-	-	1.16E-03	4.35E-03
Youn	BP	GO:0055017	cardiac muscle tissue growth	-	92	19	-	-	7.75E-04	3.16E-03
Youn	BP	GO:0048524	positive regulation of viral process	-	64	35	-	-	1.74E-03	5.54E-03
Youn	BP	GO:0098661	inorganic anion transmembrane transport	-	140	18	-	-	7.75E-04	2.97E-03
Youn	BP	GO:0006099	tricarboxylic acid cycle	-	33	14	-	-	5.84E-04	2.37E-03
Youn	BP	GO:0060148	positive regulation of post-transcriptional gene silencing	-	18	12	-	-	1.57E-03	1.98E-03
Youn	BP	GO:0009612	response to mechanical stimulus	-	215	35	-	-	1.55E-03	5.54E-03
Youn	BP	GO:0048644	muscle organ morphogenesis	-	81	18	-	-	7.75E-04	2.97E-03
Youn	BP	GO:0048660	regulation of smooth muscle cell proliferation	-	176	31	-	-	3.00E-03	4.94E-03
Youn	BP	GO:0140115	export across plasma membrane	-	82	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:0043001	Golgi to plasma membrane protein transport	-	38	21	-	-	9.69E-04	3.36E-03
Youn	BP	GO:0019692	deoxyribose phosphate metabolic process	-	43	17	-	-	7.77E-04	2.77E-03
Youn	MF	GO:0003714	transcription corepressor activity	-	190	101	-	-	1.01E-02	1.60E-02
Youn	BP	GO:0098609	cell-cell adhesion	-	954	190	-	-	1.44E-02	3.01E-02
Youn	BP	GO:0051703	biological process involved in intraspecies interaction between organisms	-	55	12	-	-	5.81E-04	1.98E-03
Youn	MF	GO:0140312	cargo adaptor activity	-	19	14	-	-	5.81E-04	2.37E-03
Youn	BP	GO:0046835	carbohydrate phosphorylation	-	49	18	-	-	7.75E-04	2.97E-03
Youn	CC	GO:1905349	ciliary transition zone assembly	-	371	125	-	-	9.37E-03	1.98E-02
Youn	BP	GO:0043523	regulation of neuron apoptotic process	-	218	53	-	-	2.23E-03	8.50E-03
Youn	BP	GO:0044380	protein localization to cytoskeleton	-	57	34	-	-	1.36E-03	5.54E-03
Youn	MF	GO:0032413	negative regulation of ion transmembrane transporter activity	-	88	13	-	-	2.13E-03	2.18E-03
Youn	CC	GO:0045324	late endosome to vacuole transport	-	37	18	-	-	7.76E-04	2.97E-03
Youn	BP	GO:0043954	cellular component maintenance	-	72	21	-	-	9.69E-04	3.36E-03
Youn	BP	GO:0050435	amyloid-beta metabolic process	-	65	16	-	-	7.77E-04	2.57E-03
Youn	BP	GO:0014823	response to activity	-	70	20	-	-	9.69E-04	3.16E-03
Youn	BP	GO:0048667	cell morphogenesis involved in neuron differentiation	-	559	155	-	-	9.51E-03	2.45E-02
Youn	CC	GO:1903513	endoplasmic reticulum to cytosol transport	-	29	17	-	-	7.76E-04	2.77E-03
Youn	BP	GO:0034502	protein localization to chromosome	-	130	70	-	-	2.93E-03	1.11E-02
Youn	BP	GO:0048562	embryonic organ morphogenesis	-	295	60	-	-	2.57E-03	9.49E-03
Youn	BP	GO:0031343	positive regulation of cell killing	-	75	11	-	-	5.93E-04	1.78E-03
Youn	BP	GO:0099587	inorganic ion import across plasma membrane	-	135	19	-	-	7.79E-04	3.16E-03
Youn	BP	GO:0017148	negative regulation of translation	-	390	75	-	-	4.40E-03	1.19E-02
Youn	BP	GO:0002532	production of molecular mediator involved in inflammatory response	-	103	18	-	-	2.60E-03	2.97E-03
Youn	BP	GO:1903509	liposaccharide metabolic process	-	109	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0009582	detection of abiotic stimulus	-	140	15	-	-	7.80E-04	2.37E-03
Youn	CC	GO:0140238	presynaptic endocytosis	-	72	33	-	-	1.36E-03	5.34E-03
Youn	BP	GO:0051236	establishment of RNA localization	-	161	118	-	-	6.39E-03	1.88E-02
Youn	CC	GO:0043123	positive regulation of canonical NF-kappaB signal transduction	-	193	53	-	-	4.98E-03	8.50E-03
Youn	BP	GO:0034067	protein localization to Golgi apparatus	-	30	16	-	-	7.75E-04	2.57E-03
Youn	BP	GO:0061842	microtubule organizing center localization	-	32	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0042246	tissue regeneration	-	496	106	-	-	4.32E-03	1.68E-02
Youn	MF	GO:0048018	receptor ligand activity	-	510	22	-	-	9.70E-04	3.56E-03
Youn	BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	-	41	18	-	-	7.75E-04	2.97E-03
Youn	BP	GO:0030811	regulation of nucleotide catabolic process	-	52	21	-	-	9.69E-04	3.36E-03
Youn	BP	GO:0050779	RNA destabilization	-	135	82	-	-	4.40E-03	1.31E-02
Youn	BP	GO:1901607	alpha-amino acid biosynthetic process	-	70	29	-	-	1.16E-03	4.75E-03
Youn	BP	GO:0061025	membrane fusion	-	532	146	-	-	5.84E-03	2.31E-02
Youn	BP	GO:0010762	regulation of fibroblast migration	-	40	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:0090311	regulation of protein deacetylation	-	29	16	-	-	7.77E-04	2.57E-03
Youn	BP	GO:0022406	membrane docking	-	90	36	-	-	1.55E-03	5.73E-03
Youn	BP	GO:0006999	nuclear pore organization	-	15	14	-	-	1.11E-03	2.37E-03
Youn	BP	GO:0050777	negative regulation of immune response	-	196	45	-	-	4.33E-03	7.12E-03
Youn	BP	GO:0016053	organic acid biosynthetic process	-	335	88	-	-	3.53E-03	1.40E-02
Youn	BP	GO:0021782	glial cell development	-	120	31	-	-	1.36E-03	4.94E-03
Youn	CC	GO:0039531	regulation of cytoplasmic pattern recognition receptor signaling pathway	-	90	27	-	-	2.99E-03	4.35E-03
Youn	BP	GO:0001655	urogenital system development	-	66	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0071827	plasma lipoprotein particle organization	-	86	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:0055088	lipid homeostasis	-	173	29	-	-	1.16E-03	4.75E-03
Youn	BP	GO:0031334	positive regulation of protein-containing complex assembly	-	199	77	-	-	6.18E-03	1.23E-02
Youn	BP	GO:0141137	"positive regulation of gene expression, epigenetic"	-	36	21	-	-	9.69E-04	3.36E-03
Youn	BP	GO:0045667	regulation of osteoblast differentiation	-	147	26	-	-	1.17E-03	4.15E-03
Youn	BP	GO:0050801	monoatomic ion homeostasis	-	609	144	-	-	7.41E-03	2.29E-02
Youn	BP	GO:0009792	embryo development ending in birth or egg hatching	-	683	234	-	-	9.47E-03	3.72E-02
Youn	BP	GO:0050678	regulation of epithelial cell proliferation	-	418	86	-	-	3.69E-03	1.36E-02
Youn	BP	GO:0045738	negative regulation of DNA repair	-	40	18	-	-	7.75E-04	2.97E-03
Youn	BP	GO:0001704	formation of primary germ layer	-	195	52	-	-	2.14E-03	8.31E-03
Youn	BP	GO:0048708	astrocyte differentiation	-	88	20	-	-	2.15E-03	3.16E-03
Youn	BP	GO:0048588	developmental cell growth	-	233	64	-	-	2.54E-03	1.03E-02
Youn	BP	GO:0021872	forebrain generation of neurons	-	52	14	-	-	5.84E-04	2.37E-03
Youn	BP	GO:0045023	G0 to G1 transition	-	41	23	-	-	9.71E-04	3.76E-03
Youn	BP	GO:1901186	positive regulation of ERBB signaling pathway	-	27	11	-	-	3.64E-03	1.78E-03
Youn	MF	GO:1901505	carbohydrate derivative transmembrane transporter activity	-	51	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0010232	vascular transport	-	87	22	-	-	9.69E-04	3.56E-03
Youn	BP	GO:0021987	cerebral cortex development	-	125	48	-	-	1.95E-03	7.71E-03
Youn	BP	GO:0008637	apoptotic mitochondrial changes	-	108	37	-	-	1.55E-03	5.93E-03
Youn	BP	GO:0032885	regulation of polysaccharide biosynthetic process	-	38	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0060999	positive regulation of dendritic spine development	-	35	15	-	-	5.81E-03	2.37E-03
Youn	CC	GO:1902532	negative regulation of intracellular signal transduction	-	710	186	-	-	8.74E-03	2.95E-02
Youn	BP	GO:2000736	regulation of stem cell differentiation	-	78	40	-	-	2.92E-03	6.33E-03
Youn	BP	GO:0002064	epithelial cell development	-	210	60	-	-	2.54E-03	9.49E-03
Youn	BP	GO:2001222	regulation of neuron migration	-	46	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0034389	lipid droplet organization	-	38	17	-	-	7.76E-04	2.77E-03
Youn	BP	GO:0042177	negative regulation of protein catabolic process	-	109	40	-	-	1.75E-03	6.33E-03
Youn	MF	GO:0038024	cargo receptor activity	-	121	19	-	-	7.75E-04	3.16E-03
Youn	BP	GO:0033120	positive regulation of RNA splicing	-	46	31	-	-	2.50E-03	4.94E-03
Youn	BP	GO:0051445	regulation of meiotic cell cycle	-	64	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0033619	membrane protein proteolysis	-	60	17	-	-	7.75E-04	2.77E-03
Youn	BP	GO:0090087	regulation of peptide transport	-	195	35	-	-	1.55E-03	5.54E-03
Youn	BP	GO:0120162	positive regulation of cold-induced thermogenesis	-	101	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0006929	substrate-dependent cell migration	-	26	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:0032239	regulation of nucleobase-containing compound transport	-	15	11	-	-	5.47E-03	1.78E-03
Youn	BP	GO:0022404	molting cycle process	-	95	27	-	-	1.16E-03	4.35E-03
Youn	BP	GO:1903358	regulation of Golgi organization	-	17	12	-	-	5.82E-04	1.98E-03
Youn	BP	GO:0007281	germ cell development	-	334	87	-	-	5.59E-03	1.38E-02
Youn	BP	GO:1901617	organic hydroxy compound biosynthetic process	-	247	55	-	-	2.34E-03	8.70E-03
Youn	CC	GO:0098926	postsynaptic signal transduction	-	39	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0030177	positive regulation of Wnt signaling pathway	-	143	49	-	-	3.65E-03	7.91E-03
Youn	BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	-	170	34	-	-	3.46E-03	5.54E-03
Youn	MF	GO:1904029	regulation of cyclin-dependent protein kinase activity	-	117	36	-	-	1.55E-03	5.73E-03
Youn	BP	GO:0003013	circulatory system process	-	602	114	-	-	4.52E-03	1.82E-02
Youn	MF	GO:0043433	negative regulation of DNA-binding transcription factor activity	-	193	49	-	-	1.95E-03	7.91E-03
Youn	BP	GO:1903035	negative regulation of response to wounding	-	93	16	-	-	7.75E-04	2.57E-03
Youn	BP	GO:0036010	protein localization to endosome	-	27	14	-	-	5.83E-04	2.37E-03
Youn	BP	GO:1903313	positive regulation of mRNA metabolic process	-	171	104	-	-	4.69E-03	1.66E-02
Youn	BP	GO:0035967	cellular response to topologically incorrect protein	-	98	40	-	-	1.75E-03	6.33E-03
Youn	BP	GO:0009267	cellular response to starvation	-	170	60	-	-	5.08E-03	9.49E-03
Youn	BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	-	57	15	-	-	7.78E-04	2.37E-03
Youn	BP	GO:0046931	pore complex assembly	-	21	15	-	-	1.98E-03	2.37E-03
Youn	CC	GO:0032008	positive regulation of TOR signaling	-	52	19	-	-	7.75E-04	3.16E-03
Youn	CC	GO:0090151	establishment of protein localization to mitochondrial membrane	-	33	16	-	-	7.75E-04	2.57E-03
Youn	BP	GO:0060428	lung epithelium development	-	43	14	-	-	5.82E-04	2.37E-03
Youn	BP	GO:0033108	mitochondrial respiratory chain complex assembly	-	101	28	-	-	1.17E-03	4.55E-03
Youn	BP	GO:0010457	centriole-centriole cohesion	-	15	11	-	-	5.84E-04	1.78E-03
Youn	BP	GO:0002521	leukocyte differentiation	-	616	146	-	-	1.00E-02	2.31E-02
Youn	MF	GO:0015101	organic cation transmembrane transporter activity	-	76	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:0010660	regulation of muscle cell apoptotic process	-	85	20	-	-	9.26E-03	3.16E-03
Youn	BP	GO:0065004	protein-DNA complex assembly	-	307	143	-	-	9.88E-03	2.27E-02
Youn	CC	GO:0006406	mRNA export from nucleus	-	69	59	-	-	2.82E-02	9.49E-03
Youn	MF	GO:0016251	RNA polymerase II general transcription initiation factor activity	-	40	26	-	-	1.17E-03	4.15E-03
Youn	BP	GO:0002367	cytokine production involved in immune response	-	121	24	-	-	3.59E-03	3.95E-03
Youn	BP	GO:0044848	biological phase	-	211	69	-	-	2.73E-03	1.11E-02
Youn	BP	GO:0046660	female sex differentiation	-	125	29	-	-	1.16E-03	4.75E-03
Youn	BP	GO:0019693	ribose phosphate metabolic process	-	556	199	-	-	9.28E-03	3.16E-02
Youn	BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	-	45	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:0060411	cardiac septum morphogenesis	-	72	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:0071248	cellular response to metal ion	-	201	43	-	-	1.75E-03	6.92E-03
Youn	BP	GO:0030308	negative regulation of cell growth	-	191	43	-	-	3.08E-03	6.92E-03
Youn	BP	GO:0097306	cellular response to alcohol	-	99	27	-	-	2.04E-03	4.35E-03
Youn	CC	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	-	131	71	-	-	2.93E-03	1.13E-02
Youn	BP	GO:0010453	regulation of cell fate commitment	-	40	14	-	-	5.81E-04	2.37E-03
Youn	BP	GO:0001961	positive regulation of cytokine-mediated signaling pathway	-	59	17	-	-	9.01E-04	2.77E-03
Youn	MF	GO:0008324	monoatomic cation transmembrane transporter activity	-	826	167	-	-	6.74E-03	2.65E-02
Youn	MF	GO:1901682	sulfur compound transmembrane transporter activity	-	57	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:0042398	cellular modified amino acid biosynthetic process	-	46	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0032890	regulation of organic acid transport	-	78	20	-	-	9.70E-04	3.16E-03
Youn	BP	GO:0098771	inorganic ion homeostasis	-	531	120	-	-	5.63E-03	1.90E-02
Youn	BP	GO:2000177	regulation of neural precursor cell proliferation	-	97	28	-	-	1.16E-03	4.55E-03
Youn	BP	GO:0032330	regulation of chondrocyte differentiation	-	54	12	-	-	5.83E-04	1.98E-03
Youn	BP	GO:0051259	protein complex oligomerization	-	251	86	-	-	6.26E-03	1.36E-02
Youn	BP	GO:0009994	oocyte differentiation	-	57	20	-	-	1.78E-03	3.16E-03
Youn	MF	GO:0031952	regulation of protein autophosphorylation	-	43	12	-	-	2.75E-03	1.98E-03
Youn	BP	GO:0051494	negative regulation of cytoskeleton organization	-	164	63	-	-	2.54E-03	1.01E-02
Youn	BP	GO:0044319	"wound healing, spreading of cells"	-	37	13	-	-	5.82E-04	2.18E-03
Youn	BP	GO:0060251	regulation of glial cell proliferation	-	39	15	-	-	7.75E-04	2.37E-03
Youn	BP	GO:0072665	protein localization to vacuole	-	84	33	-	-	1.36E-03	5.34E-03
Youn	BP	GO:0042789	mRNA transcription by RNA polymerase II	-	46	26	-	-	8.64E-03	4.15E-03
Youn	BP	GO:0006914	autophagy	-	574	238	-	-	9.95E-03	3.78E-02
Youn	BP	GO:1902373	negative regulation of mRNA catabolic process	-	75	41	-	-	3.49E-03	6.53E-03
Youn	BP	GO:0008285	negative regulation of cell population proliferation	-	787	176	-	-	9.06E-03	2.79E-02
Youn	BP	GO:0048858	cell projection morphogenesis	-	643	190	-	-	9.71E-03	3.01E-02
Youn	BP	GO:0045661	regulation of myoblast differentiation	-	74	21	-	-	9.72E-04	3.36E-03
Youn	BP	GO:0030307	positive regulation of cell growth	-	164	51	-	-	3.56E-03	8.11E-03
Youn	BP	GO:0071375	cellular response to peptide hormone stimulus	-	310	122	-	-	4.92E-03	1.94E-02
Youn	BP	GO:0014812	muscle cell migration	-	110	17	-	-	7.76E-04	2.77E-03
Youn	BP	GO:0048525	negative regulation of viral process	-	90	28	-	-	1.71E-03	4.55E-03
Youn	BP	GO:0070972	protein localization to endoplasmic reticulum	-	81	41	-	-	1.75E-03	6.53E-03
Youn	MF	GO:0008514	organic anion transmembrane transporter activity	-	304	57	-	-	2.34E-03	9.10E-03
Youn	BP	GO:0051781	positive regulation of cell division	-	93	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0002696	positive regulation of leukocyte activation	-	358	81	-	-	3.33E-03	1.29E-02
Youn	BP	GO:0060711	labyrinthine layer development	-	47	14	-	-	5.83E-04	2.37E-03
Youn	BP	GO:0007272	ensheathment of neurons	-	146	36	-	-	1.55E-03	5.73E-03
Youn	CC	GO:0050806	positive regulation of synaptic transmission	-	171	26	-	-	1.11E-03	4.15E-03
Youn	BP	GO:0060021	roof of mouth development	-	91	21	-	-	9.74E-04	3.36E-03
Youn	BP	GO:0034504	protein localization to nucleus	-	312	177	-	-	8.84E-03	2.81E-02
Youn	CC	GO:0007212	G protein-coupled dopamine receptor signaling pathway	-	40	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:0031647	regulation of protein stability	-	327	161	-	-	6.54E-03	2.55E-02
Youn	BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	-	62	38	-	-	1.56E-03	6.13E-03
Youn	BP	GO:0043903	regulation of biological process involved in symbiotic interaction	-	60	13	-	-	4.90E-04	2.18E-03
Youn	BP	GO:0016054	organic acid catabolic process	-	251	54	-	-	2.14E-03	8.70E-03
Youn	BP	GO:0050890	cognition	-	317	74	-	-	4.88E-03	1.19E-02
Youn	BP	GO:0008033	tRNA processing	-	136	63	-	-	9.75E-03	1.01E-02
Youn	BP	GO:0046661	male sex differentiation	-	171	48	-	-	9.45E-03	7.71E-03
Youn	BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	-	88	30	-	-	1.36E-03	4.75E-03
Youn	BP	GO:1990778	protein localization to cell periphery	-	346	127	-	-	5.12E-03	2.02E-02
Youn	BP	GO:0001568	blood vessel development	-	790	148	-	-	6.66E-03	2.35E-02
Youn	BP	GO:0061326	renal tubule development	-	103	15	-	-	7.76E-04	2.37E-03
Youn	BP	GO:0051258	protein polymerization	-	280	124	-	-	4.93E-03	1.98E-02
Youn	BP	GO:0071985	multivesicular body sorting pathway	-	56	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0060325	face morphogenesis	-	31	11	-	-	5.84E-04	1.78E-03
Youn	BP	GO:0090559	regulation of membrane permeability	-	72	22	-	-	9.69E-04	3.56E-03
Youn	BP	GO:0046628	positive regulation of insulin receptor signaling pathway	-	25	12	-	-	5.82E-04	1.98E-03
Youn	BP	GO:0046460	neutral lipid biosynthetic process	-	50	11	-	-	5.92E-04	1.78E-03
Youn	BP	GO:0001539	cilium or flagellum-dependent cell motility	-	159	25	-	-	1.16E-03	3.95E-03
Youn	BP	GO:0002250	adaptive immune response	-	753	83	-	-	8.41E-03	1.32E-02
Youn	BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	-	163	71	-	-	2.93E-03	1.13E-02
Youn	CC	GO:0048167	regulation of synaptic plasticity	-	210	45	-	-	1.94E-03	7.12E-03
Youn	BP	GO:1903708	positive regulation of hemopoiesis	-	184	45	-	-	1.95E-03	7.12E-03
Youn	BP	GO:1903008	organelle disassembly	-	154	87	-	-	3.53E-03	1.38E-02
Youn	CC	GO:0032387	negative regulation of intracellular transport	-	51	20	-	-	9.69E-04	3.16E-03
Youn	BP	GO:0099188	postsynaptic cytoskeleton organization	-	20	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:0072091	regulation of stem cell proliferation	-	91	19	-	-	7.75E-04	3.16E-03
Youn	BP	GO:0009262	deoxyribonucleotide metabolic process	-	43	17	-	-	7.77E-04	2.77E-03
Youn	BP	GO:0032535	regulation of cellular component size	-	360	111	-	-	4.52E-03	1.76E-02
Youn	BP	GO:0001934	positive regulation of protein phosphorylation	-	701	169	-	-	1.36E-02	2.69E-02
Youn	MF	GO:0098631	cell adhesion mediator activity	-	64	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0046112	nucleobase biosynthetic process	-	18	14	-	-	5.81E-04	2.37E-03
Youn	BP	GO:0071453	cellular response to oxygen levels	-	168	48	-	-	3.93E-03	7.71E-03
Youn	BP	GO:0070585	protein localization to mitochondrion	-	125	55	-	-	2.34E-03	8.70E-03
Youn	BP	GO:0044242	cellular lipid catabolic process	-	224	44	-	-	1.75E-03	7.12E-03
Youn	BP	GO:0002931	response to ischemia	-	58	17	-	-	4.33E-03	2.77E-03
Youn	BP	GO:0043062	extracellular structure organization	-	317	50	-	-	2.28E-02	7.91E-03
Youn	BP	GO:0055082	intracellular chemical homeostasis	-	706	174	-	-	7.44E-03	2.77E-02
Youn	BP	GO:0120031	plasma membrane bounded cell projection assembly	-	661	213	-	-	9.68E-03	3.38E-02
Youn	BP	GO:0060420	regulation of heart growth	-	74	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0009755	hormone-mediated signaling pathway	-	221	75	-	-	5.93E-03	1.19E-02
Youn	BP	GO:0022612	gland morphogenesis	-	124	26	-	-	1.16E-03	4.15E-03
Youn	BP	GO:0043243	positive regulation of protein-containing complex disassembly	-	36	12	-	-	5.82E-04	1.98E-03
Youn	BP	GO:0044782	cilium organization	-	400	132	-	-	9.00E-03	2.10E-02
Youn	BP	GO:0090130	tissue migration	-	379	80	-	-	3.33E-03	1.27E-02
Youn	BP	GO:1990845	adaptive thermogenesis	-	166	43	-	-	2.52E-03	6.92E-03
Youn	BP	GO:0071320	cellular response to cAMP	-	54	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:0051131	chaperone-mediated protein complex assembly	-	23	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:0071392	cellular response to estradiol stimulus	-	40	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0009314	response to radiation	-	449	133	-	-	5.33E-03	2.12E-02
Youn	BP	GO:0009451	RNA modification	-	169	75	-	-	5.72E-03	1.19E-02
Youn	BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	-	40	18	-	-	1.10E-03	2.97E-03
Youn	BP	GO:0045814	"negative regulation of gene expression, epigenetic"	-	116	68	-	-	5.70E-03	1.09E-02
Youn	BP	GO:0015807	L-amino acid transport	-	94	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0032941	secretion by tissue	-	85	19	-	-	7.77E-04	3.16E-03
Youn	BP	GO:0046605	regulation of centrosome cycle	-	54	31	-	-	1.36E-03	4.94E-03
Youn	BP	GO:0048753	pigment granule organization	-	40	18	-	-	7.75E-04	2.97E-03
Youn	BP	GO:0003014	renal system process	-	130	21	-	-	9.75E-04	3.36E-03
Youn	BP	GO:0045598	regulation of fat cell differentiation	-	148	35	-	-	2.95E-03	5.54E-03
Youn	MF	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	-	199	60	-	-	3.20E-03	9.49E-03
Youn	CC	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	-	236	27	-	-	1.16E-03	4.35E-03
Youn	BP	GO:0039694	viral RNA genome replication	-	30	14	-	-	5.09E-03	2.37E-03
Youn	BP	GO:0071709	membrane assembly	-	68	24	-	-	9.70E-04	3.95E-03
Youn	BP	GO:0008217	regulation of blood pressure	-	186	23	-	-	9.70E-04	3.76E-03
Youn	MF	GO:0051353	positive regulation of oxidoreductase activity	-	63	16	-	-	7.75E-04	2.57E-03
Youn	CC	GO:0042770	signal transduction in response to DNA damage	-	186	84	-	-	5.78E-03	1.34E-02
Youn	BP	GO:0002200	somatic diversification of immune receptors	-	78	35	-	-	2.53E-02	5.54E-03
Youn	BP	GO:0035315	hair cell differentiation	-	52	14	-	-	5.83E-04	2.37E-03
Youn	BP	GO:0048645	animal organ formation	-	62	12	-	-	5.83E-04	1.98E-03
Youn	BP	GO:0030178	negative regulation of Wnt signaling pathway	-	171	49	-	-	3.08E-03	7.91E-03
Youn	BP	GO:0033627	cell adhesion mediated by integrin	-	87	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0009083	branched-chain amino acid catabolic process	-	21	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:0035107	appendage morphogenesis	-	147	41	-	-	1.75E-03	6.53E-03
Youn	BP	GO:1903707	negative regulation of hemopoiesis	-	116	19	-	-	2.92E-03	3.16E-03
Youn	CC	GO:0048208	COPII vesicle coating	-	27	14	-	-	5.82E-04	2.37E-03
Youn	BP	GO:0050994	regulation of lipid catabolic process	-	61	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:0045727	positive regulation of translation	-	141	83	-	-	4.16E-03	1.32E-02
Youn	CC	GO:0032388	positive regulation of intracellular transport	-	137	57	-	-	2.55E-03	9.10E-03
Youn	BP	GO:0002027	regulation of heart rate	-	106	22	-	-	9.69E-04	3.56E-03
Youn	BP	GO:0050879	multicellular organismal movement	-	118	22	-	-	9.69E-04	3.56E-03
Youn	BP	GO:0002437	inflammatory response to antigenic stimulus	-	79	14	-	-	1.55E-03	2.37E-03
Youn	BP	GO:0071870	cellular response to catecholamine stimulus	-	62	17	-	-	7.75E-04	2.77E-03
Youn	BP	GO:0048515	spermatid differentiation	-	208	53	-	-	3.07E-03	8.50E-03
Youn	BP	GO:0045879	negative regulation of smoothened signaling pathway	-	36	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0045945	positive regulation of transcription by RNA polymerase III	-	18	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:1901983	regulation of protein acetylation	-	26	14	-	-	2.63E-03	2.37E-03
Youn	BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	-	251	53	-	-	5.47E-03	8.50E-03
Youn	BP	GO:1902459	positive regulation of stem cell population maintenance	-	49	27	-	-	1.16E-03	4.35E-03
Youn	BP	GO:0010883	regulation of lipid storage	-	53	14	-	-	5.81E-04	2.37E-03
Youn	BP	GO:1905954	positive regulation of lipid localization	-	110	24	-	-	9.70E-04	3.95E-03
Youn	BP	GO:0072523	purine-containing compound catabolic process	-	146	56	-	-	2.34E-03	8.90E-03
Youn	BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	-	34	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0032878	regulation of establishment or maintenance of cell polarity	-	28	12	-	-	5.82E-04	1.98E-03
Youn	BP	GO:0072526	pyridine-containing compound catabolic process	-	96	40	-	-	1.75E-03	6.33E-03
Youn	BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	-	169	19	-	-	7.84E-04	3.16E-03
Youn	BP	GO:0031345	negative regulation of cell projection organization	-	195	45	-	-	1.95E-03	7.12E-03
Youn	BP	GO:0048278	vesicle docking	-	64	22	-	-	9.70E-04	3.56E-03
Youn	BP	GO:0035050	embryonic heart tube development	-	86	24	-	-	9.70E-04	3.95E-03
Youn	BP	GO:0030168	platelet activation	-	135	28	-	-	1.16E-03	4.55E-03
Youn	BP	GO:0008284	positive regulation of cell population proliferation	-	992	226	-	-	8.66E-03	3.58E-02
Youn	BP	GO:0008213	protein alkylation	-	58	23	-	-	2.04E-03	3.76E-03
Youn	BP	GO:0002253	activation of immune response	-	529	125	-	-	7.58E-03	1.98E-02
Youn	BP	GO:0031529	ruffle organization	-	55	25	-	-	1.16E-03	3.95E-03
Youn	BP	GO:0141060	disruption of anatomical structure in another organism	-	95	13	-	-	5.82E-04	2.18E-03
Youn	BP	GO:0140962	multicellular organismal-level chemical homeostasis	-	71	12	-	-	5.83E-04	1.98E-03
Youn	BP	GO:0035304	regulation of protein dephosphorylation	-	87	35	-	-	1.55E-03	5.54E-03
Youn	BP	GO:0060560	developmental growth involved in morphogenesis	-	235	60	-	-	2.54E-03	9.49E-03
Youn	CC	GO:0099177	regulation of trans-synaptic signaling	-	492	101	-	-	4.01E-03	1.60E-02
Youn	BP	GO:0051785	positive regulation of nuclear division	-	61	17	-	-	7.76E-04	2.77E-03
Youn	BP	GO:0044786	cell cycle DNA replication	-	45	30	-	-	1.36E-03	4.75E-03
Youn	BP	GO:0048145	regulation of fibroblast proliferation	-	87	26	-	-	1.16E-03	4.15E-03
Youn	BP	GO:2001234	negative regulation of apoptotic signaling pathway	-	233	87	-	-	4.24E-03	1.38E-02
Youn	BP	GO:0009306	protein secretion	-	376	85	-	-	3.52E-03	1.34E-02
Youn	CC	GO:0008333	endosome to lysosome transport	-	73	29	-	-	1.16E-03	4.75E-03
Youn	MF	GO:0043086	negative regulation of catalytic activity	-	717	181	-	-	9.58E-03	2.87E-02
Youn	BP	GO:0045732	positive regulation of protein catabolic process	-	202	77	-	-	3.21E-03	1.23E-02
Youn	BP	GO:0031589	cell-substrate adhesion	-	360	94	-	-	3.73E-03	1.50E-02
Youn	BP	GO:0170040	proteinogenic amino acid catabolic process	-	74	14	-	-	5.81E-04	2.37E-03
Youn	BP	GO:1904018	positive regulation of vasculature development	-	185	32	-	-	1.13E-02	5.14E-03
Youn	BP	GO:0010948	negative regulation of cell cycle process	-	317	128	-	-	7.55E-03	2.04E-02
Youn	BP	GO:0050953	sensory perception of light stimulus	-	223	27	-	-	1.17E-03	4.35E-03
Youn	BP	GO:0009303	rRNA transcription	-	37	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0035601	protein deacylation	-	56	26	-	-	1.16E-03	4.15E-03
Youn	BP	GO:0014741	negative regulation of muscle hypertrophy	-	38	11	-	-	5.86E-04	1.78E-03
Youn	BP	GO:0071300	cellular response to retinoic acid	-	66	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:0045830	positive regulation of isotype switching	-	28	12	-	-	5.82E-04	1.98E-03
Youn	BP	GO:0048284	organelle fusion	-	456	144	-	-	6.65E-03	2.29E-02
Youn	BP	GO:0051588	regulation of neurotransmitter transport	-	99	19	-	-	3.36E-03	3.16E-03
Youn	BP	GO:0051784	negative regulation of nuclear division	-	63	34	-	-	1.36E-03	5.54E-03
Youn	BP	GO:0044703	multi-organism reproductive process	-	209	40	-	-	1.94E-03	6.33E-03
Youn	BP	GO:0033135	regulation of peptidyl-serine phosphorylation	-	144	46	-	-	2.33E-03	7.32E-03
Youn	BP	GO:0099022	vesicle tethering	-	32	14	-	-	5.82E-04	2.37E-03
Youn	MF	GO:0004930	G protein-coupled receptor activity	-	873	21	-	-	9.88E-04	3.36E-03
Youn	BP	GO:0045880	positive regulation of smoothened signaling pathway	-	38	11	-	-	5.86E-04	1.78E-03
Youn	BP	GO:0048857	neural nucleus development	-	65	25	-	-	1.16E-03	3.95E-03
Youn	BP	GO:0048663	neuron fate commitment	-	74	17	-	-	7.86E-04	2.77E-03
Youn	BP	GO:0050954	sensory perception of mechanical stimulus	-	180	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0106027	neuron projection organization	-	90	35	-	-	3.32E-02	5.54E-03
Youn	BP	GO:0051283	negative regulation of sequestering of calcium ion	-	135	27	-	-	1.04E-02	4.35E-03
Youn	BP	GO:0046627	negative regulation of insulin receptor signaling pathway	-	40	16	-	-	7.75E-04	2.57E-03
Youn	CC	GO:0043410	positive regulation of MAPK cascade	-	494	88	-	-	3.53E-03	1.40E-02
Youn	BP	GO:0045685	regulation of glial cell differentiation	-	77	13	-	-	2.08E-03	2.18E-03
Youn	BP	GO:0043414	macromolecule methylation	-	138	60	-	-	2.76E-03	9.49E-03
Youn	BP	GO:0048268	clathrin coat assembly	-	16	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0050886	endocrine process	-	93	13	-	-	5.83E-04	2.18E-03
Youn	BP	GO:0045807	positive regulation of endocytosis	-	155	39	-	-	2.61E-03	6.33E-03
Youn	CC	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	-	63	25	-	-	1.16E-03	3.95E-03
Youn	MF	GO:0015932	nucleobase-containing compound transmembrane transporter activity	-	52	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0034394	protein localization to cell surface	-	69	19	-	-	7.75E-04	3.16E-03
Youn	BP	GO:0032785	"negative regulation of DNA-templated transcription, elongation"	-	23	16	-	-	2.12E-02	2.57E-03
Youn	MF	GO:0140994	RNA polymerase II CTD heptapeptide repeat modifying activity	-	20	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:1904035	regulation of epithelial cell apoptotic process	-	111	25	-	-	3.71E-03	3.95E-03
Youn	MF	GO:0051100	negative regulation of binding	-	161	60	-	-	3.60E-03	9.49E-03
Youn	BP	GO:0001818	negative regulation of cytokine production	-	379	53	-	-	4.04E-03	8.50E-03
Youn	BP	GO:0003151	outflow tract morphogenesis	-	81	15	-	-	7.75E-04	2.37E-03
Youn	BP	GO:0043470	regulation of carbohydrate catabolic process	-	61	25	-	-	1.16E-03	3.95E-03
Youn	BP	GO:0120163	negative regulation of cold-induced thermogenesis	-	47	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0032968	positive regulation of transcription elongation by RNA polymerase II	-	49	32	-	-	6.46E-03	5.14E-03
Youn	BP	GO:0032368	regulation of lipid transport	-	149	30	-	-	1.36E-03	4.75E-03
Youn	BP	GO:0051495	positive regulation of cytoskeleton organization	-	183	78	-	-	3.13E-03	1.25E-02
Youn	BP	GO:0033002	muscle cell proliferation	-	249	45	-	-	7.73E-03	7.12E-03
Youn	BP	GO:0048880	sensory system development	-	399	91	-	-	4.31E-03	1.44E-02
Youn	BP	GO:0043331	response to dsRNA	-	56	15	-	-	2.40E-03	2.37E-03
Youn	BP	GO:0033363	secretory granule organization	-	63	23	-	-	9.70E-04	3.76E-03
Youn	BP	GO:0060479	lung cell differentiation	-	28	11	-	-	5.84E-04	1.78E-03
Youn	BP	GO:0120009	intermembrane lipid transfer	-	52	11	-	-	5.82E-04	1.78E-03
Youn	BP	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	-	15	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:0072164	mesonephric tubule development	-	98	11	-	-	5.83E-04	1.78E-03
Youn	CC	GO:0051897	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	-	118	26	-	-	1.16E-03	4.15E-03
Youn	BP	GO:0030901	midbrain development	-	87	28	-	-	1.16E-03	4.55E-03
Youn	BP	GO:0007162	negative regulation of cell adhesion	-	310	55	-	-	2.99E-03	8.70E-03
Youn	CC	GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	-	69	19	-	-	8.73E-04	3.16E-03
Youn	BP	GO:0002687	positive regulation of leukocyte migration	-	147	29	-	-	1.16E-03	4.75E-03
Youn	BP	GO:0110154	RNA decapping	-	19	14	-	-	1.89E-03	2.37E-03
Youn	BP	GO:0034605	cellular response to heat	-	66	35	-	-	1.55E-03	5.54E-03
Youn	CC	GO:0001228	"DNA-binding transcription activator activity, RNA polymerase II-specific"	-	469	80	-	-	3.36E-03	1.27E-02
Youn	BP	GO:0005996	monosaccharide metabolic process	-	250	68	-	-	2.73E-03	1.09E-02
Youn	BP	GO:0002262	myeloid cell homeostasis	-	172	55	-	-	4.46E-03	8.70E-03
Youn	BP	GO:0000966	RNA 5'-end processing	-	39	29	-	-	7.94E-03	4.75E-03
Youn	BP	GO:0050688	regulation of defense response to virus	-	65	19	-	-	7.75E-04	3.16E-03
Youn	BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	-	335	68	-	-	4.34E-03	1.09E-02
Youn	BP	GO:0097191	extrinsic apoptotic signaling pathway	-	229	63	-	-	5.58E-03	1.01E-02
Youn	BP	GO:0010464	regulation of mesenchymal cell proliferation	-	31	11	-	-	5.83E-04	1.78E-03
Youn	BP	GO:0022618	protein-RNA complex assembly	-	227	162	-	-	1.49E-02	2.57E-02
Youn	BP	GO:0051147	regulation of muscle cell differentiation	-	162	33	-	-	3.08E-03	5.34E-03
Youn	BP	GO:0006066	alcohol metabolic process	-	374	89	-	-	3.49E-03	1.42E-02
Youn	BP	GO:0045943	positive regulation of transcription by RNA polymerase I	-	35	27	-	-	1.16E-03	4.35E-03
Youn	BP	GO:0045104	intermediate filament cytoskeleton organization	-	93	48	-	-	1.95E-03	7.71E-03
Youn	BP	GO:0043555	regulation of translation in response to stress	-	22	14	-	-	1.26E-02	2.37E-03
Youn	BP	GO:0032922	circadian regulation of gene expression	-	71	29	-	-	1.16E-03	4.75E-03
Youn	BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	-	59	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0038179	neurotrophin signaling pathway	-	38	11	-	-	5.81E-04	1.78E-03
Youn	BP	GO:0170038	proteinogenic amino acid biosynthetic process	-	62	25	-	-	1.16E-03	3.95E-03
Youn	BP	GO:0051293	establishment of spindle localization	-	57	29	-	-	1.16E-03	4.75E-03
Youn	BP	GO:0023061	signal release	-	491	96	-	-	4.49E-03	1.52E-02
Youn	BP	GO:0008360	regulation of cell shape	-	139	41	-	-	1.75E-03	6.53E-03
Youn	BP	GO:0051222	positive regulation of protein transport	-	249	75	-	-	3.13E-03	1.19E-02
Youn	CC	GO:0140632	canonical inflammasome complex assembly	-	40	11	-	-	1.05E-01	1.78E-03
Youn	MF	GO:0034260	negative regulation of GTPase activity	-	36	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0045739	positive regulation of DNA repair	-	128	69	-	-	2.73E-03	1.11E-02
Youn	BP	GO:0001845	phagolysosome assembly	-	19	11	-	-	5.89E-04	1.78E-03
Youn	BP	GO:0045185	maintenance of protein location	-	95	46	-	-	1.95E-03	7.32E-03
Youn	BP	GO:0003158	endothelium development	-	140	31	-	-	1.36E-03	4.94E-03
Youn	CC	GO:0072595	maintenance of protein localization in organelle	-	42	24	-	-	9.70E-04	3.95E-03
Youn	BP	GO:0051224	negative regulation of protein transport	-	122	27	-	-	1.16E-03	4.35E-03
Youn	BP	GO:0030856	regulation of epithelial cell differentiation	-	166	31	-	-	1.70E-03	4.94E-03
Youn	MF	GO:0003713	transcription coactivator activity	-	281	140	-	-	7.99E-03	2.21E-02
Youn	BP	GO:0021885	forebrain cell migration	-	63	17	-	-	7.80E-04	2.77E-03
Youn	BP	GO:0007405	neuroblast proliferation	-	81	25	-	-	1.16E-03	3.95E-03
Youn	BP	GO:0009581	detection of external stimulus	-	137	14	-	-	5.85E-04	2.37E-03
Youn	BP	GO:1990542	mitochondrial transmembrane transport	-	93	31	-	-	1.36E-03	4.94E-03
Youn	BP	GO:0045862	positive regulation of proteolysis	-	353	112	-	-	5.43E-03	1.78E-02
Youn	BP	GO:1901185	negative regulation of ERBB signaling pathway	-	33	11	-	-	5.83E-04	1.78E-03
Youn	BP	GO:0031100	animal organ regeneration	-	66	17	-	-	7.75E-04	2.77E-03
Youn	BP	GO:2000573	positive regulation of DNA biosynthetic process	-	74	40	-	-	3.89E-03	6.33E-03
Youn	BP	GO:0097722	sperm motility	-	133	22	-	-	9.70E-04	3.56E-03
Youn	BP	GO:0051231	spindle elongation	-	14	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0030001	metal ion transport	-	933	182	-	-	8.20E-03	2.89E-02
Youn	BP	GO:0042490	mechanoreceptor differentiation	-	67	15	-	-	7.78E-04	2.37E-03
Youn	CC	GO:1901798	positive regulation of signal transduction by p53 class mediator	-	30	15	-	-	7.75E-04	2.37E-03
Youn	BP	GO:0035148	tube formation	-	155	50	-	-	2.14E-03	7.91E-03
Youn	MF	GO:0008608	attachment of spindle microtubules to kinetochore	-	43	31	-	-	1.36E-03	4.94E-03
Youn	BP	GO:0010927	cellular component assembly involved in morphogenesis	-	126	40	-	-	1.75E-03	6.33E-03
Youn	BP	GO:0031123	RNA 3'-end processing	-	79	59	-	-	6.13E-03	9.49E-03
Youn	MF	GO:0032414	positive regulation of ion transmembrane transporter activity	-	113	24	-	-	9.71E-04	3.95E-03
Youn	CC	GO:1901978	positive regulation of cell cycle checkpoint	-	18	13	-	-	5.81E-04	2.18E-03
Youn	CC	GO:0007097	nuclear migration	-	24	17	-	-	7.75E-04	2.77E-03
Youn	BP	GO:0045229	external encapsulating structure organization	-	319	52	-	-	6.46E-03	8.31E-03
Youn	BP	GO:0006885	regulation of pH	-	104	32	-	-	1.36E-03	5.14E-03
Youn	BP	GO:0001667	ameboidal-type cell migration	-	495	114	-	-	5.62E-03	1.82E-02
Youn	BP	GO:0001708	cell fate specification	-	108	31	-	-	1.36E-03	4.94E-03
Youn	BP	GO:0010633	negative regulation of epithelial cell migration	-	116	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0032970	regulation of actin filament-based process	-	368	127	-	-	5.12E-03	2.02E-02
Youn	BP	GO:0042440	pigment metabolic process	-	80	12	-	-	5.84E-04	1.98E-03
Youn	BP	GO:1901606	alpha-amino acid catabolic process	-	101	19	-	-	7.75E-04	3.16E-03
Youn	BP	GO:0062197	cellular response to chemical stress	-	299	98	-	-	5.43E-03	1.56E-02
Youn	BP	GO:1901890	positive regulation of cell junction assembly	-	106	18	-	-	7.76E-04	2.97E-03
Youn	BP	GO:0070988	demethylation	-	27	12	-	-	5.89E-04	1.98E-03
Youn	BP	GO:1901655	cellular response to ketone	-	107	29	-	-	2.73E-03	4.75E-03
Youn	MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	-	925	180	-	-	8.42E-03	2.85E-02
Youn	BP	GO:0051255	spindle midzone assembly	-	14	11	-	-	7.97E-04	1.78E-03
Youn	BP	GO:0006269	"DNA replication, synthesis of primer"	-	17	13	-	-	5.82E-04	2.18E-03
Youn	BP	GO:0055006	cardiac cell development	-	93	27	-	-	1.77E-03	4.35E-03
Youn	BP	GO:0031365	N-terminal protein amino acid modification	-	30	13	-	-	5.82E-04	2.18E-03
Youn	BP	GO:0060004	reflex	-	63	14	-	-	5.85E-04	2.37E-03
Youn	BP	GO:0044706	multi-multicellular organism process	-	217	41	-	-	2.00E-03	6.53E-03
Youn	BP	GO:1901875	positive regulation of post-translational protein modification	-	140	53	-	-	5.44E-03	8.50E-03
Youn	BP	GO:0050768	negative regulation of neurogenesis	-	150	28	-	-	1.16E-03	4.55E-03
Youn	BP	GO:1901874	negative regulation of post-translational protein modification	-	98	48	-	-	1.95E-03	7.71E-03
Youn	BP	GO:0090068	positive regulation of cell cycle process	-	262	125	-	-	7.86E-03	1.98E-02
Youn	MF	GO:0022803	passive transmembrane transporter activity	-	676	97	-	-	5.02E-03	1.54E-02
Youn	MF	GO:0022884	macromolecule transmembrane transporter activity	-	34	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:1902115	regulation of organelle assembly	-	210	100	-	-	9.27E-03	1.58E-02
Youn	BP	GO:0014910	regulation of smooth muscle cell migration	-	90	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0031333	negative regulation of protein-containing complex assembly	-	148	52	-	-	4.64E-03	8.31E-03
Youn	BP	GO:0051952	regulation of amine transport	-	98	12	-	-	5.89E-04	1.98E-03
Youn	BP	GO:0006730	one-carbon metabolic process	-	24	13	-	-	5.81E-04	2.18E-03
Youn	CC	GO:0032365	intracellular lipid transport	-	51	17	-	-	7.75E-04	2.77E-03
Youn	BP	GO:0045048	protein insertion into ER membrane	-	30	18	-	-	7.77E-04	2.97E-03
Youn	BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	-	87	23	-	-	4.42E-03	3.76E-03
Youn	BP	GO:0031330	negative regulation of cellular catabolic process	-	116	48	-	-	1.95E-03	7.71E-03
Youn	BP	GO:0097581	lamellipodium organization	-	91	38	-	-	1.55E-03	6.13E-03
Youn	BP	GO:0031163	metallo-sulfur cluster assembly	-	30	12	-	-	5.81E-04	1.98E-03
Youn	MF	GO:0022853	active monoatomic ion transmembrane transporter activity	-	313	77	-	-	3.13E-03	1.23E-02
Youn	BP	GO:0060326	cell chemotaxis	-	311	64	-	-	2.54E-03	1.03E-02
Youn	BP	GO:0016485	protein processing	-	248	52	-	-	2.14E-03	8.31E-03
Youn	CC	GO:0099565	"chemical synaptic transmission, postsynaptic"	-	168	17	-	-	6.26E-04	2.77E-03
Youn	MF	GO:0015171	amino acid transmembrane transporter activity	-	141	21	-	-	9.69E-04	3.36E-03
Youn	BP	GO:0099054	presynapse assembly	-	49	12	-	-	5.81E-04	1.98E-03
Youn	BP	GO:0031348	negative regulation of defense response	-	282	61	-	-	4.29E-03	9.69E-03
Youn	BP	GO:2001057	reactive nitrogen species metabolic process	-	84	15	-	-	7.75E-04	2.37E-03
Youn	BP	GO:0007606	sensory perception of chemical stimulus	-	535	16	-	-	7.79E-04	2.57E-03
Youn	BP	GO:0061180	mammary gland epithelium development	-	68	24	-	-	9.70E-04	3.95E-03
Youn	CC	GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific"	-	308	62	-	-	2.54E-03	9.89E-03
Youn	CC	GO:0051169	nuclear transport	-	325	201	-	-	1.56E-02	3.18E-02
Youn	BP	GO:0071496	cellular response to external stimulus	-	74	12	-	-	5.83E-04	1.98E-03
Youn	BP	GO:0046434	organophosphate catabolic process	-	232	74	-	-	2.93E-03	1.19E-02
Youn	BP	GO:0009566	fertilization	-	205	45	-	-	6.16E-03	7.12E-03
Youn	BP	GO:0010257	NADH dehydrogenase complex assembly	-	60	19	-	-	7.78E-04	3.16E-03
Youn	BP	GO:0033044	regulation of chromosome organization	-	249	162	-	-	1.08E-02	2.57E-02
Youn	BP	GO:0001933	negative regulation of protein phosphorylation	-	335	98	-	-	5.08E-03	1.56E-02
Youn	BP	GO:0002702	positive regulation of production of molecular mediator of immune response	-	134	32	-	-	3.40E-03	5.14E-03
Youn	CC	GO:0030705	cytoskeleton-dependent intracellular transport	-	533	217	-	-	1.11E-02	3.44E-02
Youn	CC	GO:0140467	integrated stress response signaling	-	41	13	-	-	5.81E-04	2.18E-03
Youn	BP	GO:1901293	nucleoside phosphate biosynthetic process	-	382	136	-	-	5.53E-03	2.16E-02
Youn	BP	GO:0016180	snRNA processing	-	28	22	-	-	9.72E-04	3.56E-03
Youn	BP	GO:0051303	establishment of chromosome localization	-	104	64	-	-	2.54E-03	1.03E-02
Youn	BP	GO:0031349	positive regulation of defense response	-	473	109	-	-	4.98E-03	1.74E-02
Youn	BP	GO:0051156	glucose 6-phosphate metabolic process	-	38	14	-	-	5.81E-04	2.37E-03
Youn	BP	GO:0006605	protein targeting	-	327	131	-	-	5.32E-03	2.08E-02
Youn	BP	GO:0007566	embryo implantation	-	57	12	-	-	9.51E-04	1.98E-03
Youn	BP	GO:0061512	protein localization to cilium	-	394	129	-	-	9.36E-03	2.06E-02
Youn	BP	GO:0051017	actin filament bundle assembly	-	161	68	-	-	2.73E-03	1.09E-02
Youn	BP	GO:2000279	negative regulation of DNA biosynthetic process	-	37	16	-	-	1.84E-02	2.57E-03
Youn	BP	GO:1901343	negative regulation of vasculature development	-	154	22	-	-	9.70E-04	3.56E-03
Youn	BP	GO:0098876	vesicle-mediated transport to the plasma membrane	-	149	73	-	-	8.07E-03	1.17E-02
Youn	BP	GO:1902414	protein localization to cell junction	-	107	38	-	-	6.65E-03	6.13E-03
Youn	BP	GO:0051304	chromosome separation	-	80	56	-	-	2.34E-03	8.90E-03
Youn	BP	GO:0090596	sensory organ morphogenesis	-	272	56	-	-	2.34E-03	8.90E-03
Youn	BP	GO:0048709	oligodendrocyte differentiation	-	101	24	-	-	9.70E-04	3.95E-03
Youn	BP	GO:0045017	glycerolipid biosynthetic process	-	254	72	-	-	2.93E-03	1.15E-02
Youn	BP	GO:0001776	leukocyte homeostasis	-	108	26	-	-	2.32E-03	4.15E-03
Youn	BP	GO:0050769	positive regulation of neurogenesis	-	240	68	-	-	4.19E-03	1.09E-02
Youn	CC	GO:0090110	COPII-coated vesicle cargo loading	-	15	12	-	-	5.82E-04	1.98E-03
Youn	BP	GO:0050866	negative regulation of cell activation	-	216	27	-	-	3.23E-03	4.35E-03
Youn	BP	GO:0033500	carbohydrate homeostasis	-	251	66	-	-	2.73E-03	1.05E-02
Youn	BP	GO:0120035	regulation of plasma membrane bounded cell projection organization	-	647	193	-	-	1.17E-02	3.07E-02
Youn	BP	GO:0044088	regulation of vacuole organization	-	56	26	-	-	1.16E-03	4.15E-03
Youn	CC	GO:0051457	maintenance of protein location in nucleus	-	23	17	-	-	7.75E-04	2.77E-03
Youn	CC	GO:0000791	euchromatin	-	60	38	-	-	7.89E-03	6.13E-03
Youn	CC	GO:0030666	endocytic vesicle membrane	-	196	52	-	-	2.14E-03	8.31E-03
Youn	CC	GO:0098857	membrane microdomain	-	324	70	-	-	2.93E-03	1.11E-02
Youn	CC	GO:0030312	external encapsulating structure	-	567	62	-	-	2.54E-03	9.89E-03
Youn	CC	GO:0071027	nuclear RNA surveillance	-	14	14	-	-	3.06E-02	2.37E-03
Youn	CC	GO:1990752	microtubule end	-	34	22	-	-	9.69E-04	3.56E-03
Youn	CC	GO:0043204	perikaryon	-	156	33	-	-	3.02E-03	5.34E-03
Youn	CC	GO:0097542	ciliary tip	-	48	25	-	-	1.17E-03	3.95E-03
Youn	CC	GO:1905368	peptidase complex	-	124	74	-	-	2.93E-03	1.19E-02
Youn	CC	GO:0000792	heterochromatin	-	98	62	-	-	2.54E-03	9.89E-03
Youn	CC	GO:0097546	ciliary base	-	47	20	-	-	9.79E-04	3.16E-03
Youn	CC	GO:0071819	DUBm complex	-	25	19	-	-	7.76E-04	3.16E-03
Youn	CC	GO:0031201	SNARE complex	-	48	23	-	-	9.74E-04	3.76E-03
Youn	CC	GO:0016324	apical plasma membrane	-	392	80	-	-	3.33E-03	1.27E-02
Youn	CC	GO:0033260	nuclear DNA replication	-	40	28	-	-	1.16E-03	4.55E-03
Youn	CC	GO:0044391	ribosomal subunit	-	203	168	-	-	6.74E-03	2.67E-02
Youn	CC	GO:1990062	RPAP3/R2TP/prefoldin-like complex	-	12	11	-	-	5.81E-04	1.78E-03
Youn	CC	GO:0071013	catalytic step 2 spliceosome	-	88	84	-	-	1.08E-02	1.34E-02
Youn	CC	GO:0031907	microbody lumen	-	51	14	-	-	5.81E-04	2.37E-03
Youn	CC	GO:0098862	cluster of actin-based cell projections	-	162	49	-	-	1.95E-03	7.91E-03
Youn	CC	GO:0098978	glutamatergic synapse	-	411	127	-	-	4.81E-03	2.02E-02
Youn	CC	GO:0016363	nuclear matrix	-	127	86	-	-	5.21E-03	1.36E-02
Youn	CC	GO:0031261	DNA replication preinitiation complex	-	46	33	-	-	1.36E-03	5.34E-03
Youn	CC	GO:0097060	synaptic membrane	-	413	62	-	-	2.54E-03	9.89E-03
Youn	CC	GO:0032432	actin filament bundle	-	249	95	-	-	3.92E-03	1.50E-02
Youn	CC	GO:0008088	axo-dendritic transport	-	78	48	-	-	3.40E-03	7.71E-03
Youn	CC	GO:0031519	PcG protein complex	-	38	25	-	-	1.54E-03	3.95E-03
Youn	CC	GO:0033017	sarcoplasmic reticulum membrane	-	43	17	-	-	7.75E-04	2.77E-03
Youn	CC	GO:0099003	vesicle-mediated transport in synapse	-	220	77	-	-	3.47E-03	1.23E-02
Youn	CC	GO:0000313	organellar ribosome	-	89	71	-	-	2.94E-03	1.13E-02
Youn	CC	GO:0098791	Golgi apparatus subcompartment	-	378	114	-	-	6.67E-03	1.82E-02
Youn	CC	GO:0099643	signal release from synapse	-	147	35	-	-	3.36E-03	5.54E-03
Youn	CC	GO:0032527	protein exit from endoplasmic reticulum	-	48	23	-	-	9.70E-04	3.76E-03
Youn	CC	GO:0030018	Z disc	-	129	46	-	-	1.95E-03	7.32E-03
Youn	CC	GO:0032580	Golgi cisterna membrane	-	93	13	-	-	5.83E-04	2.18E-03
Youn	CC	GO:1905360	GTPase complex	-	41	12	-	-	5.83E-04	1.98E-03
Youn	CC	GO:0097540	axonemal central pair	-	161	31	-	-	1.36E-03	4.94E-03
Youn	CC	GO:0042641	actomyosin	-	77	43	-	-	1.75E-03	6.92E-03
Youn	CC	GO:0032588	trans-Golgi network membrane	-	102	39	-	-	1.56E-03	6.33E-03
Youn	CC	GO:0070382	exocytic vesicle	-	224	57	-	-	2.38E-03	9.10E-03
Youn	CC	GO:0000959	mitochondrial RNA metabolic process	-	47	21	-	-	9.70E-04	3.36E-03
Youn	CC	GO:0031903	microbody membrane	-	65	24	-	-	9.70E-04	3.95E-03
Youn	CC	GO:0036464	cytoplasmic ribonucleoprotein granule	-	254	164	-	-	9.15E-03	2.61E-02
Youn	CC	GO:0070993	translation preinitiation complex	-	19	15	-	-	7.75E-04	2.37E-03
Youn	CC	GO:0016323	basolateral plasma membrane	-	239	59	-	-	2.34E-03	9.49E-03
Youn	CC	GO:0042645	mitochondrial nucleoid	-	45	28	-	-	1.16E-03	4.55E-03
Youn	CC	GO:1902495	transmembrane transporter complex	-	408	65	-	-	2.73E-03	1.03E-02
Youn	CC	GO:0098636	protein complex involved in cell adhesion	-	57	13	-	-	5.93E-04	2.18E-03
Youn	CC	GO:0001917	photoreceptor inner segment	-	71	12	-	-	5.82E-04	1.98E-03
Youn	CC	GO:0019897	extrinsic component of plasma membrane	-	156	45	-	-	2.77E-03	7.12E-03
Youn	CC	GO:0031594	neuromuscular junction	-	73	21	-	-	9.69E-04	3.36E-03
Youn	CC	GO:0000793	condensed chromosome	-	274	161	-	-	8.89E-03	2.55E-02
Youn	CC	GO:0000922	spindle pole	-	172	109	-	-	7.55E-03	1.74E-02
Youn	CC	GO:0120111	neuron projection cytoplasm	-	94	53	-	-	3.80E-03	8.50E-03
Youn	CC	GO:0070971	endoplasmic reticulum exit site	-	32	20	-	-	9.69E-04	3.16E-03
Youn	CC	GO:0004879	nuclear receptor activity	-	63	13	-	-	5.81E-04	2.18E-03
Youn	CC	GO:0009898	cytoplasmic side of plasma membrane	-	171	54	-	-	2.14E-03	8.70E-03
Youn	CC	GO:0000123	histone acetyltransferase complex	-	93	58	-	-	2.34E-03	9.29E-03
Youn	CC	GO:0098800	inner mitochondrial membrane protein complex	-	113	41	-	-	1.75E-03	6.53E-03
Youn	CC	GO:0048786	presynaptic active zone	-	80	25	-	-	1.16E-03	3.95E-03
Youn	CC	GO:0007034	vacuolar transport	-	168	72	-	-	2.93E-03	1.15E-02
Youn	CC	GO:0005776	autophagosome	-	111	41	-	-	1.75E-03	6.53E-03
Youn	CC	GO:0016591	"RNA polymerase II, holoenzyme"	-	90	56	-	-	2.34E-03	8.90E-03
Youn	CC	GO:0042775	mitochondrial ATP synthesis coupled electron transport	-	102	32	-	-	1.36E-03	5.14E-03
Youn	CC	GO:0150034	distal axon	-	309	89	-	-	4.81E-03	1.42E-02
Youn	CC	GO:0030532	small nuclear ribonucleoprotein complex	-	180	136	-	-	2.05E-02	2.16E-02
Youn	CC	GO:0071012	catalytic step 1 spliceosome	-	12	11	-	-	2.59E-03	1.78E-03
Youn	CC	GO:0072562	blood microparticle	-	144	31	-	-	1.36E-03	4.94E-03
Youn	CC	GO:0051233	spindle midzone	-	36	24	-	-	9.70E-04	3.95E-03
Youn	CC	GO:0005811	lipid droplet	-	102	37	-	-	2.04E-03	5.93E-03
Youn	CC	GO:0045022	early endosome to late endosome transport	-	44	23	-	-	9.70E-04	3.76E-03
Youn	CC	GO:0043113	receptor clustering	-	51	11	-	-	5.81E-04	1.78E-03
Youn	CC	GO:0044853	plasma membrane raft	-	114	26	-	-	1.16E-03	4.15E-03
Youn	CC	GO:0005881	cytoplasmic microtubule	-	256	67	-	-	2.73E-03	1.07E-02
Youn	CC	GO:0030660	Golgi-associated vesicle membrane	-	58	27	-	-	1.16E-03	4.35E-03
Youn	CC	GO:0005905	clathrin-coated pit	-	73	46	-	-	1.95E-03	7.32E-03
Youn	CC	GO:0043034	costamere	-	18	11	-	-	2.15E-03	1.78E-03
Youn	CC	GO:0031904	endosome lumen	-	38	12	-	-	5.91E-04	1.98E-03
Youn	CC	GO:0060170	ciliary membrane	-	76	12	-	-	5.83E-04	1.98E-03
Youn	CC	GO:0005732	sno(s)RNA-containing ribonucleoprotein complex	-	30	20	-	-	9.69E-04	3.16E-03
Youn	CC	GO:0005852	eukaryotic translation initiation factor 3 complex	-	15	14	-	-	5.81E-04	2.37E-03
Youn	CC	GO:0000139	Golgi membrane	-	646	163	-	-	6.54E-03	2.59E-02
Youn	CC	GO:0032154	cleavage furrow	-	54	24	-	-	9.70E-04	3.95E-03
Youn	CC	GO:0005640	nuclear outer membrane	-	30	12	-	-	5.81E-04	1.98E-03
Youn	CC	GO:0007006	mitochondrial membrane organization	-	117	49	-	-	1.95E-03	7.91E-03
Youn	CC	GO:0001772	immunological synapse	-	44	14	-	-	5.81E-04	2.37E-03
Youn	CC	GO:0009897	external side of plasma membrane	-	425	41	-	-	1.77E-03	6.53E-03
Youn	CC	GO:0030863	cortical cytoskeleton	-	104	51	-	-	2.14E-03	8.11E-03
Youn	CC	GO:1905348	endonuclease complex	-	38	26	-	-	6.06E-03	4.15E-03
Youn	CC	GO:0030315	T-tubule	-	52	11	-	-	5.81E-04	1.78E-03
Youn	CC	GO:0099086	synaptonemal structure	-	40	12	-	-	5.81E-04	1.98E-03
Youn	CC	GO:0030427	site of polarized growth	-	172	68	-	-	3.75E-03	1.09E-02
Youn	CC	GO:0044309	neuron spine	-	213	56	-	-	2.86E-03	8.90E-03
Youn	CC	GO:0030658	transport vesicle membrane	-	231	72	-	-	2.93E-03	1.15E-02
Youn	CC	GO:0098918	structural constituent of synapse	-	27	15	-	-	7.75E-04	2.37E-03
Youn	CC	GO:0000940	outer kinetochore	-	17	13	-	-	5.81E-04	2.18E-03
Youn	CC	GO:0034719	SMN-Sm protein complex	-	18	16	-	-	3.27E-02	2.57E-03
Youn	CC	GO:0044232	organelle membrane contact site	-	50	23	-	-	9.73E-04	3.76E-03
Youn	CC	GO:0030667	secretory granule membrane	-	319	79	-	-	3.13E-03	1.27E-02
Youn	CC	GO:0097545	axonemal outer doublet	-	164	31	-	-	1.36E-03	4.94E-03
Youn	CC	GO:0055037	recycling endosome	-	200	69	-	-	4.93E-03	1.11E-02
Youn	CC	GO:0098685	Schaffer collateral - CA1 synapse	-	94	28	-	-	1.16E-03	4.55E-03
Youn	CC	GO:0030684	preribosome	-	76	68	-	-	2.73E-03	1.09E-02
Youn	CC	GO:0060205	cytoplasmic vesicle lumen	-	325	115	-	-	6.97E-03	1.82E-02
Youn	CC	GO:0032806	carboxy-terminal domain protein kinase complex	-	19	15	-	-	7.77E-04	2.37E-03
Youn	CC	GO:1990391	DNA repair complex	-	22	16	-	-	7.75E-04	2.57E-03
Youn	CC	GO:0005775	vacuolar lumen	-	176	39	-	-	1.56E-03	6.33E-03
Youn	CC	GO:0098799	outer mitochondrial membrane protein complex	-	23	12	-	-	5.81E-04	1.98E-03
Youn	CC	GO:0044306	neuron projection terminus	-	164	30	-	-	2.28E-03	4.75E-03
Youn	CC	GO:0034455	t-UTP complex	-	53	47	-	-	1.95E-03	7.51E-03
Youn	CC	GO:0005770	late endosome	-	299	78	-	-	3.13E-03	1.25E-02
Youn	CC	GO:0030992	intraciliary transport particle B	-	17	11	-	-	5.88E-04	1.78E-03
Youn	CC	GO:0031970	organelle envelope lumen	-	94	33	-	-	1.36E-03	5.34E-03
Youn	CC	GO:0019866	organelle inner membrane	-	546	209	-	-	8.39E-03	3.32E-02
Youn	CC	GO:0098687	chromosomal region	-	397	242	-	-	1.23E-02	3.84E-02
Youn	CC	GO:0032469	endoplasmic reticulum calcium ion homeostasis	-	26	12	-	-	5.81E-04	1.98E-03
Youn	CC	GO:0043292	contractile muscle fiber	-	245	84	-	-	3.85E-03	1.34E-02
Youn	CC	GO:0034709	methylosome	-	13	12	-	-	5.81E-04	1.98E-03
Youn	CC	GO:0005849	mRNA cleavage factor complex	-	22	16	-	-	2.81E-02	2.57E-03
Youn	CC	GO:0000803	sex chromosome	-	32	18	-	-	7.75E-04	2.97E-03
Youn	CC	GO:0098982	GABA-ergic synapse	-	84	14	-	-	5.82E-04	2.37E-03
Youn	CC	GO:0035097	histone methyltransferase complex	-	63	46	-	-	1.95E-03	7.32E-03
Youn	CC	GO:0000323	lytic vacuole	-	749	196	-	-	7.97E-03	3.10E-02
Youn	CC	GO:0000177	cytoplasmic exosome (RNase complex)	-	15	13	-	-	2.35E-03	2.18E-03
Youn	CC	GO:0000242	pericentriolar material	-	22	16	-	-	7.76E-02	2.57E-03
Youn	CC	GO:1903293	phosphatase complex	-	54	22	-	-	9.69E-04	3.56E-03
Youn	CC	GO:0031941	filamentous actin	-	27	12	-	-	5.81E-04	1.98E-03
Youn	CC	GO:0000786	nucleosome	-	149	54	-	-	2.14E-03	8.70E-03
Youn	CC	GO:0001533	cornified envelope	-	59	22	-	-	9.69E-04	3.56E-03
Youn	CC	GO:1904724	tertiary granule lumen	-	55	16	-	-	7.75E-04	2.57E-03
Youn	CC	GO:0030027	lamellipodium	-	202	100	-	-	7.07E-03	1.58E-02
Youn	CC	GO:0002102	podosome	-	31	17	-	-	7.75E-04	2.77E-03
Youn	CC	GO:0090543	Flemming body	-	33	18	-	-	7.75E-04	2.97E-03
Youn	CC	GO:0016328	lateral plasma membrane	-	66	27	-	-	1.16E-03	4.35E-03
Youn	CC	GO:0001650	fibrillar center	-	151	79	-	-	3.13E-03	1.27E-02
Youn	CC	GO:0031332	RNAi effector complex	-	413	15	-	-	7.00E-03	2.37E-03
Youn	CC	GO:1990204	oxidoreductase complex	-	90	25	-	-	1.16E-03	3.95E-03
Youn	CC	GO:1904813	ficolin-1-rich granule lumen	-	124	70	-	-	6.67E-03	1.11E-02
Youn	CC	GO:0033178	"proton-transporting two-sector ATPase complex, catalytic domain"	-	19	11	-	-	5.81E-04	1.78E-03
Youn	CC	GO:0001726	ruffle	-	181	77	-	-	3.13E-03	1.23E-02
Youn	CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	-	18	11	-	-	5.82E-04	1.78E-03
Youn	CC	GO:0043073	germ cell nucleus	-	67	38	-	-	3.15E-03	6.13E-03
Youn	CC	GO:0005788	endoplasmic reticulum lumen	-	313	51	-	-	2.14E-03	8.11E-03
Youn	CC	GO:0016592	mediator complex	-	38	17	-	-	7.77E-04	2.77E-03
Youn	CC	GO:0022626	cytosolic ribosome	-	118	97	-	-	3.92E-03	1.54E-02
Youn	CC	GO:0000152	nuclear ubiquitin ligase complex	-	44	27	-	-	1.16E-03	4.35E-03
Youn	CC	GO:0034451	centriolar satellite	-	120	65	-	-	3.05E-03	1.03E-02
Youn	CC	GO:0045171	intercellular bridge	-	91	39	-	-	1.56E-03	6.33E-03
Youn	CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	-	81	27	-	-	1.16E-03	4.35E-03
Youn	CC	GO:0098984	neuron to neuron synapse	-	384	116	-	-	6.48E-03	1.84E-02
Youn	CC	GO:0032039	integrator complex	-	19	14	-	-	5.86E-04	2.37E-03
Youn	CC	GO:0030527	structural constituent of chromatin	-	97	24	-	-	9.70E-04	3.95E-03
Youn	CC	GO:0030286	dynein complex	-	210	50	-	-	2.14E-03	7.91E-03
Youn	CC	GO:0016482	cytosolic transport	-	135	70	-	-	2.93E-03	1.11E-02
Youn	CC	GO:0030119	AP-type membrane coat adaptor complex	-	37	24	-	-	9.70E-04	3.95E-03
Youn	CC	GO:0008023	transcription elongation factor complex	-	47	34	-	-	8.31E-03	5.54E-03
Youn	CC	GO:0051560	mitochondrial calcium ion homeostasis	-	25	12	-	-	5.86E-04	1.98E-03
Youn	CC	GO:0030662	coated vesicle membrane	-	202	91	-	-	3.72E-03	1.44E-02
Youn	CC	GO:0007039	protein catabolic process in the vacuole	-	61	27	-	-	1.16E-03	4.35E-03
Youn	CC	GO:0042776	proton motive force-driven mitochondrial ATP synthesis	-	67	29	-	-	1.16E-03	4.75E-03
Youn	CC	GO:0090575	RNA polymerase II transcription regulator complex	-	266	108	-	-	4.32E-03	1.72E-02
Youn	CC	GO:0005769	early endosome	-	425	153	-	-	8.99E-03	2.43E-02
Youn	CC	GO:0090734	site of DNA damage	-	118	62	-	-	3.29E-03	9.89E-03
Youn	MF	GO:0051087	protein-folding chaperone binding	-	135	49	-	-	1.95E-03	7.91E-03
Youn	MF	GO:0051959	dynein light intermediate chain binding	-	27	11	-	-	5.81E-04	1.78E-03
Youn	MF	GO:0035613	RNA stem-loop binding	-	21	14	-	-	7.52E-04	2.37E-03
Youn	MF	GO:0016741	"transferase activity, transferring one-carbon groups"	-	255	89	-	-	3.53E-03	1.42E-02
Youn	MF	GO:0016757	glycosyltransferase activity	-	286	54	-	-	3.11E-03	8.70E-03
Youn	MF	GO:0048306	calcium-dependent protein binding	-	61	22	-	-	9.69E-04	3.56E-03
Youn	MF	GO:0016798	"hydrolase activity, acting on glycosyl bonds"	-	151	17	-	-	7.78E-04	2.77E-03
Youn	MF	GO:0016765	"transferase activity, transferring alkyl or aryl (other than methyl) groups"	-	61	14	-	-	5.83E-04	2.37E-03
Youn	MF	GO:0016810	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds"	-	138	27	-	-	1.16E-03	4.35E-03
Youn	MF	GO:0051020	GTPase binding	-	311	156	-	-	8.90E-03	2.47E-02
Youn	MF	GO:0140457	protein demethylase activity	-	31	13	-	-	5.84E-04	2.18E-03
Youn	MF	GO:0005158	insulin receptor binding	-	22	12	-	-	5.81E-04	1.98E-03
Youn	MF	GO:0061980	regulatory RNA binding	-	52	31	-	-	2.34E-03	4.94E-03
Youn	MF	GO:0015035	protein-disulfide reductase activity	-	32	14	-	-	5.81E-04	2.37E-03
Youn	MF	GO:0001671	ATPase activator activity	-	29	16	-	-	7.75E-04	2.57E-03
Youn	MF	GO:0019787	ubiquitin-like protein transferase activity	-	622	193	-	-	9.02E-03	3.07E-02
Youn	MF	GO:0070840	dynein complex binding	-	25	14	-	-	1.84E-03	2.37E-03
Youn	MF	GO:0016776	"phosphotransferase activity, phosphate group as acceptor"	-	36	14	-	-	5.82E-04	2.37E-03
Youn	MF	GO:0003688	DNA replication origin binding	-	18	14	-	-	5.81E-04	2.37E-03
Youn	MF	GO:0005178	integrin binding	-	153	33	-	-	1.36E-03	5.34E-03
Youn	MF	GO:0070064	proline-rich region binding	-	17	11	-	-	5.81E-04	1.78E-03
Youn	MF	GO:0008327	methyl-CpG binding	-	31	14	-	-	5.81E-04	2.37E-03
Youn	MF	GO:0008233	peptidase activity	-	998	211	-	-	9.84E-03	3.34E-02
Youn	MF	GO:0140318	protein transporter activity	-	40	17	-	-	7.75E-04	2.77E-03
Youn	MF	GO:0000217	DNA secondary structure binding	-	37	22	-	-	9.70E-04	3.56E-03
Youn	MF	GO:0002039	p53 binding	-	66	37	-	-	2.57E-03	5.93E-03
Youn	MF	GO:0005496	steroid binding	-	110	26	-	-	1.16E-03	4.15E-03
Youn	MF	GO:0008443	phosphofructokinase activity	-	27	15	-	-	7.75E-04	2.37E-03
Youn	MF	GO:0003684	damaged DNA binding	-	89	44	-	-	1.75E-03	7.12E-03
Youn	MF	GO:0000339	RNA cap binding	-	20	15	-	-	1.61E-03	2.37E-03
Youn	MF	GO:0097472	cyclin-dependent protein kinase activity	-	144	47	-	-	1.95E-03	7.51E-03
Youn	MF	GO:0070063	RNA polymerase binding	-	61	44	-	-	2.83E-03	7.12E-03
Youn	MF	GO:0030971	receptor tyrosine kinase binding	-	76	28	-	-	1.16E-03	4.55E-03
Youn	MF	GO:0008135	"translation factor activity, RNA binding"	-	84	65	-	-	7.47E-03	1.03E-02
Youn	MF	GO:0140030	modification-dependent protein binding	-	179	90	-	-	3.29E-03	1.42E-02
Youn	MF	GO:0030276	clathrin binding	-	70	31	-	-	1.36E-03	4.94E-03
Youn	MF	GO:0046875	ephrin receptor binding	-	29	11	-	-	5.81E-04	1.78E-03
Youn	MF	GO:0106310	protein serine kinase activity	-	362	149	-	-	5.90E-03	2.37E-02
Youn	MF	GO:0030552	cAMP binding	-	48	11	-	-	5.81E-04	1.78E-03
Youn	MF	GO:0005547	"phosphatidylinositol-3,4,5-trisphosphate binding"	-	40	18	-	-	7.75E-04	2.97E-03
Youn	MF	GO:0004857	enzyme inhibitor activity	-	395	90	-	-	5.93E-03	1.42E-02
Youn	MF	GO:0016209	antioxidant activity	-	92	17	-	-	7.75E-04	2.77E-03
Youn	MF	GO:0070325	lipoprotein particle receptor binding	-	32	12	-	-	5.81E-04	1.98E-03
Youn	MF	GO:0044325	transmembrane transporter binding	-	159	49	-	-	2.53E-03	7.91E-03
Youn	MF	GO:0048156	tau protein binding	-	43	26	-	-	1.16E-03	4.15E-03
Youn	MF	GO:0140658	ATP-dependent chromatin remodeler activity	-	36	23	-	-	9.70E-04	3.76E-03
Youn	MF	GO:0140272	exogenous protein binding	-	79	18	-	-	1.25E-03	2.97E-03
Youn	MF	GO:0030145	manganese ion binding	-	65	17	-	-	7.75E-04	2.77E-03
Youn	MF	GO:0017069	snRNA binding	-	54	42	-	-	8.07E-03	6.72E-03
Youn	MF	GO:0008270	zinc ion binding	-	821	230	-	-	1.15E-02	3.64E-02
Youn	MF	GO:0031369	translation initiation factor binding	-	32	20	-	-	2.03E-03	3.16E-03
Youn	MF	GO:0019843	rRNA binding	-	69	49	-	-	1.95E-03	7.91E-03
Youn	MF	GO:0004713	protein tyrosine kinase activity	-	213	53	-	-	2.14E-03	8.50E-03
Youn	MF	GO:0016779	nucleotidyltransferase activity	-	264	132	-	-	9.19E-03	2.10E-02
Youn	MF	GO:0030159	signaling receptor complex adaptor activity	-	52	21	-	-	9.69E-04	3.36E-03
Youn	MF	GO:0008093	cytoskeletal anchor activity	-	24	13	-	-	5.82E-04	2.18E-03
Youn	MF	GO:0016208	AMP binding	-	22	13	-	-	5.81E-04	2.18E-03
Youn	MF	GO:0000287	magnesium ion binding	-	225	92	-	-	3.72E-03	1.46E-02
Youn	MF	GO:0031490	chromatin DNA binding	-	120	59	-	-	2.34E-03	9.49E-03
Youn	MF	GO:0017022	myosin binding	-	73	20	-	-	9.69E-04	3.16E-03
Youn	MF	GO:0015631	tubulin binding	-	410	207	-	-	1.13E-02	3.28E-02
Youn	MF	GO:0005539	glycosaminoglycan binding	-	236	26	-	-	1.16E-03	4.15E-03
Youn	MF	GO:0019207	kinase regulator activity	-	267	82	-	-	3.49E-03	1.31E-02
Youn	MF	GO:0044183	protein folding chaperone	-	67	41	-	-	1.75E-03	6.53E-03
Youn	MF	GO:0008047	enzyme activator activity	-	697	213	-	-	1.05E-02	3.38E-02
Youn	MF	GO:0019199	transmembrane receptor protein kinase activity	-	108	16	-	-	7.83E-04	2.57E-03
Youn	MF	GO:0004674	protein serine/threonine kinase activity	-	761	247	-	-	1.10E-02	3.92E-02
Youn	MF	GO:0003725	double-stranded RNA binding	-	72	45	-	-	5.25E-03	7.12E-03
Youn	MF	GO:0051018	protein kinase A binding	-	52	26	-	-	1.16E-03	4.15E-03
Youn	MF	GO:0071889	14-3-3 protein binding	-	34	17	-	-	1.40E-03	2.77E-03
Youn	MF	GO:0004618	phosphoglycerate kinase activity	-	89	37	-	-	1.55E-03	5.93E-03
Youn	MF	GO:0043531	ADP binding	-	38	21	-	-	9.69E-04	3.36E-03
Youn	MF	GO:0046332	SMAD binding	-	77	26	-	-	1.16E-03	4.15E-03
Youn	MF	GO:0008641	ubiquitin-like modifier activating enzyme activity	-	121	55	-	-	2.34E-03	8.70E-03
Youn	MF	GO:0005546	"phosphatidylinositol-4,5-bisphosphate binding"	-	82	27	-	-	1.16E-03	4.35E-03
Youn	MF	GO:0051117	ATPase binding	-	85	31	-	-	1.36E-03	4.94E-03
Youn	MF	GO:0005216	monoatomic ion channel activity	-	618	93	-	-	6.39E-03	1.48E-02
Youn	MF	GO:0001098	basal transcription machinery binding	-	61	49	-	-	2.52E-03	7.91E-03
Youn	MF	GO:0036002	pre-mRNA binding	-	57	26	-	-	8.01E-03	4.15E-03
Youn	MF	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	-	39	16	-	-	7.77E-04	2.57E-03
Youn	MF	GO:0051540	metal cluster binding	-	71	33	-	-	1.36E-03	5.34E-03
Youn	MF	GO:0051219	phosphoprotein binding	-	92	43	-	-	6.88E-03	6.92E-03
Youn	MF	GO:0019894	kinesin binding	-	45	26	-	-	1.68E-03	4.15E-03
Youn	MF	GO:0042287	MHC protein binding	-	68	11	-	-	5.81E-04	1.78E-03
Youn	MF	GO:0019003	GDP binding	-	89	39	-	-	1.56E-03	6.33E-03
Youn	MF	GO:0017171	serine hydrolase activity	-	207	22	-	-	9.72E-04	3.56E-03
Youn	MF	GO:0097110	scaffold protein binding	-	66	27	-	-	1.16E-03	4.35E-03
Youn	MF	GO:0003774	cytoskeletal motor activity	-	117	51	-	-	5.58E-03	8.11E-03
Youn	MF	GO:0055106	ubiquitin-protein transferase regulator activity	-	29	17	-	-	7.75E-04	2.77E-03
Youn	MF	GO:0061134	peptidase regulator activity	-	224	35	-	-	1.55E-03	5.54E-03
Youn	MF	GO:0008013	beta-catenin binding	-	86	38	-	-	1.55E-03	6.13E-03
Youn	MF	GO:0051015	actin filament binding	-	208	96	-	-	3.92E-03	1.52E-02
Youn	MF	GO:0019208	phosphatase regulator activity	-	107	37	-	-	1.55E-03	5.93E-03
Youn	MF	GO:1990404	NAD+-protein ADP-ribosyltransferase activity	-	33	12	-	-	5.81E-04	1.98E-03
Youn	MF	GO:0030507	spectrin binding	-	26	12	-	-	5.82E-04	1.98E-03
Youn	MF	GO:0019205	nucleobase-containing compound kinase activity	-	43	21	-	-	9.70E-04	3.36E-03
Youn	MF	GO:0045860	positive regulation of protein kinase activity	-	397	88	-	-	4.17E-03	1.40E-02
Youn	MF	GO:0019786	protein-phosphatidylethanolamide deconjugating activity	-	114	48	-	-	1.95E-03	7.71E-03
Youn	MF	GO:0010857	calcium-dependent protein kinase activity	-	24	12	-	-	5.87E-04	1.98E-03
Youn	MF	GO:0042393	histone binding	-	240	136	-	-	6.40E-03	2.16E-02
Youn	MF	GO:0019838	growth factor binding	-	182	26	-	-	1.16E-03	4.15E-03
Youn	MF	GO:0000149	SNARE binding	-	107	38	-	-	1.56E-03	6.13E-03
Youn	MF	GO:0003727	single-stranded RNA binding	-	90	57	-	-	3.03E-03	9.10E-03
Youn	MF	GO:0005516	calmodulin binding	-	206	74	-	-	2.93E-03	1.19E-02
Youn	MF	GO:0045505	dynein intermediate chain binding	-	37	15	-	-	7.75E-04	2.37E-03
Youn	MF	GO:0050660	flavin adenine dinucleotide binding	-	86	18	-	-	7.76E-04	2.97E-03
Youn	MF	GO:0032182	ubiquitin-like protein binding	-	117	57	-	-	2.34E-03	9.10E-03
Youn	MF	GO:0031072	heat shock protein binding	-	128	66	-	-	8.43E-03	1.05E-02
Youn	MF	GO:0030515	snoRNA binding	-	33	30	-	-	1.36E-03	4.75E-03
Youn	MF	GO:0060589	nucleoside-triphosphatase regulator activity	-	501	174	-	-	1.08E-02	2.77E-02
Youn	MF	GO:0046982	protein heterodimerization activity	-	343	119	-	-	6.85E-03	1.90E-02
Youn	MF	GO:0140223	general transcription initiation factor activity	-	55	32	-	-	1.36E-03	5.14E-03
Youn	MF	GO:0000049	tRNA binding	-	75	40	-	-	1.75E-03	6.33E-03
Youn	MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	-	45	20	-	-	9.69E-04	3.16E-03
Youn	MF	GO:0006469	negative regulation of protein kinase activity	-	222	66	-	-	3.45E-03	1.05E-02
Youn	MF	GO:0070182	DNA polymerase binding	-	22	14	-	-	1.86E-03	2.37E-03
Youn	MF	GO:0043548	phosphatidylinositol 3-kinase binding	-	31	15	-	-	7.75E-04	2.37E-03
Youn	MF	GO:0070851	growth factor receptor binding	-	141	26	-	-	1.59E-03	4.15E-03
Youn	MF	GO:0005525	GTP binding	-	396	159	-	-	8.42E-03	2.53E-02
Youn	MF	GO:0051091	positive regulation of DNA-binding transcription factor activity	-	268	80	-	-	3.29E-03	1.27E-02
Youn	MF	GO:0042803	protein homodimerization activity	-	699	200	-	-	8.18E-03	3.16E-02
Youn	MF	GO:0051346	negative regulation of hydrolase activity	-	332	71	-	-	3.48E-03	1.13E-02
Youn	MF	GO:0005506	iron ion binding	-	154	22	-	-	9.72E-04	3.56E-03
Youn	MF	GO:0003925	G protein activity	-	45	14	-	-	5.81E-04	2.37E-03
Youn	MF	GO:0008276	protein methyltransferase activity	-	96	37	-	-	1.55E-03	5.93E-03
Youn	MF	GO:0044389	ubiquitin-like protein ligase binding	-	322	156	-	-	6.34E-03	2.47E-02
Youn	MF	GO:0051345	positive regulation of hydrolase activity	-	535	154	-	-	7.36E-03	2.45E-02
Youn	MF	GO:0070888	E-box binding	-	59	13	-	-	5.81E-04	2.18E-03
Youn	MF	GO:0015399	primary active transmembrane transporter activity	-	190	58	-	-	2.34E-03	9.29E-03
Youn	MF	GO:0035254	glutamate receptor binding	-	47	11	-	-	5.81E-04	1.78E-03
Youn	MF	GO:0050321	tau-protein kinase activity	-	36	17	-	-	7.75E-04	2.77E-03
Youn	MF	GO:0043021	ribonucleoprotein complex binding	-	158	116	-	-	7.58E-03	1.84E-02
Youn	MF	GO:0030170	pyridoxal phosphate binding	-	56	14	-	-	5.86E-04	2.37E-03
Youn	MF	GO:0080025	"phosphatidylinositol-3,5-bisphosphate binding"	-	28	12	-	-	5.82E-04	1.98E-03
Youn	MF	GO:0001664	G protein-coupled receptor binding	-	299	46	-	-	1.95E-03	7.32E-03
Youn	MF	GO:1990247	N6-methyladenosine-containing RNA reader activity	-	11	11	-	-	1.03E-03	1.78E-03
Youn	MF	GO:0140299	small molecule sensor activity	-	39	12	-	-	5.82E-04	1.98E-03
Youn	MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	-	46	24	-	-	9.73E-04	3.95E-03
Youn	MF	GO:0052742	phosphatidylinositol kinase activity	-	24	11	-	-	5.85E-04	1.78E-03
Youn	MF	GO:0070034	telomerase RNA binding	-	22	18	-	-	2.01E-03	2.97E-03
